Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" AACS "ACSF1, FLJ12389, SUR-5" ENSG00000081760 "Acetoacetyl-CoA synthetase" Q86V21 12 125065379-125143333 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058815 Approved Approved Vesicles Vesicles "HPA058815: " "unprognostic (1.28e-1)" "unprognostic (9.78e-2)" "unprognostic (1.86e-1)" "unprognostic (1.06e-1)" "unprognostic (1.98e-3)" "unprognostic (9.46e-3)" "unprognostic (6.60e-6)" "unprognostic (3.03e-2)" "unprognostic (3.32e-2)" "unprognostic (2.45e-2)" "unprognostic (2.38e-2)" "unprognostic (3.04e-1)" "unprognostic (2.69e-2)" "unprognostic (1.69e-1)" "unprognostic (3.73e-2)" "unprognostic (7.71e-2)" "unprognostic (6.80e-2)" 21.1 6.5 9.0 10.5 13.0 2.5 33.7 6.6 22.0 11.7 9.3 5.3 7.4 12.9 5.2 7.7 22.3 6.6 12.9 5.8 8.1 5.6 6.8 3.3 4.9 4.9 5.1 13.1 4.9 9.7 5.8 6.7 4.8 10.0 6.7 8.6 5.1 33.7 12.9 3.7 26.9 8.7 4.5 4.2 4.3 12.7 9.7 3.6 6.8 7.6 12.2 8.7 5.0 9.9 3.0 11.8 6.9 2.3 5.8 5.7 3.8 14.5 14.5 6.3 8.6 23.4 15.3 10.6 11.8 11.3 14.0 12.6 18.7 9.7 9.0 12.2 14.2 15.9 11.8 12.7 7.6 9.7 10.8 7.2 9.7 14.2 19.5 5.1 7.3 16.9 10.4 11.9 12.1 10.2 5.0 5.6 8.9 26.6 5.9 6.8 8.0 17.2 1.1 16.1 12.4 14.3 22.2 17.0 4.9 12.5 19.8 9.1 14.8 11.3 9.7 6.8 10.8 7.6 9.0 12.7 7.2 9.8 8.5 8.4 7.4 6.9 2.3 6.7 4.2 0.7 5.4 3.0 3.9 3.2 2.8 1.7 5.7 3.8 0.3 5.8 0.8 11.8 2.4 3.8 9.0 13.0 6.6 22.0 8.1 5.6 5.1 13.1 10.0 3.6 AADAT "KAT2, KATII, KYAT2" ENSG00000109576 "Aminoadipate aminotransferase" Q8N5Z0 4 170060222-170091699 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 56.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA037502 Enhanced Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA037502: AB_10671759" "unprognostic (1.90e-1)" "unprognostic (1.82e-2)" "prognostic favourable (5.59e-4)" "unprognostic (4.21e-2)" "unprognostic (1.30e-1)" "unprognostic (1.06e-1)" "unprognostic (7.41e-2)" "unprognostic (1.03e-2)" "unprognostic (2.97e-2)" "unprognostic (3.38e-2)" "unprognostic (1.23e-2)" "unprognostic (3.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.39e-1)" "unprognostic (7.28e-3)" "unprognostic (1.17e-2)" 3.0 3.1 9.2 2.2 9.0 0.9 4.7 0.8 10.8 8.3 4.7 10.3 2.9 1.9 9.7 5.8 2.8 5.7 3.9 2.8 7.2 6.4 6.3 56.5 4.7 1.1 8.2 8.0 4.7 4.6 7.6 8.9 2.2 6.0 13.3 5.0 6.6 1.7 5.4 3.6 1.8 2.0 7.0 7.0 2.0 3.2 7.2 9.2 0.9 7.0 1.2 1.3 5.5 4.9 0.4 0.4 0.0 0.7 0.0 0.7 0.0 2.1 5.4 16.4 0.0 3.2 12.8 5.9 5.6 2.7 3.2 3.3 5.2 0.6 0.0 0.9 6.2 1.9 7.3 2.6 2.3 0.0 6.3 0.0 6.1 8.8 2.6 0.0 2.4 5.2 1.6 2.6 3.4 3.0 0.9 0.1 12.3 5.5 2.6 0.1 12.4 4.9 0.0 5.1 0.0 2.9 9.8 13.2 15.5 4.4 1.1 5.4 0.0 1.0 2.0 8.3 8.9 9.3 8.7 0.0 0.0 0.0 8.3 0.0 9.7 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.4 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.7 0.0 9.2 9.0 0.8 10.8 7.2 6.4 8.2 8.0 6.0 9.2 AASS "LKRSDH, LORSDH" ENSG00000008311 "Aminoadipate-semialdehyde synthase" Q9UDR5 7 122075647-122144280 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 26.1;NTERA-2: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020637, HPA020728, HPA020734" Enhanced Enhanced Vesicles,Mitochondria 17000 Mitochondria Vesicles "HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417" "unprognostic (4.84e-2)" "unprognostic (2.29e-1)" "unprognostic (7.91e-4)" "unprognostic (6.08e-2)" "unprognostic (1.49e-2)" "unprognostic (8.00e-2)" "prognostic favourable (9.81e-4)" "unprognostic (4.48e-3)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (1.98e-1)" "unprognostic (1.99e-1)" "unprognostic (7.76e-3)" "unprognostic (8.56e-3)" "unprognostic (1.55e-1)" "unprognostic (6.50e-2)" "unprognostic (2.67e-1)" 13.9 9.5 7.4 4.8 11.8 1.6 11.2 2.7 9.8 16.0 8.1 12.5 8.2 2.2 16.8 11.6 6.4 14.9 6.7 12.6 8.8 3.7 14.4 35.8 9.1 3.3 15.2 5.0 36.7 10.7 14.9 10.4 7.1 9.9 9.2 3.8 9.2 5.4 10.4 11.3 4.4 5.5 9.3 12.1 5.2 9.0 5.1 13.2 0.8 7.8 8.3 3.1 11.0 9.0 1.0 0.4 3.5 0.1 0.3 1.2 0.1 0.1 0.0 16.2 26.1 13.5 8.7 6.3 4.4 4.7 4.6 6.7 7.4 0.2 0.0 0.3 3.1 2.8 18.6 8.4 6.3 0.0 6.8 5.6 3.6 4.8 11.1 0.0 1.8 7.6 0.2 5.5 5.8 11.0 1.5 10.3 3.1 0.0 0.5 0.0 25.5 1.0 8.4 8.6 0.3 2.1 1.8 1.6 0.5 1.4 0.0 2.7 0.4 0.0 5.0 9.0 2.7 4.1 4.2 2.2 1.6 0.0 3.3 0.5 3.4 3.5 0.1 0.0 0.7 0.0 0.1 0.5 0.8 0.0 0.4 1.0 1.2 0.5 0.0 0.3 0.0 0.0 0.7 0.1 7.4 11.8 2.7 7.3 8.8 3.7 15.2 5.0 9.9 13.2 ABCA1 "ABC1, HDLDT1, TGD" ENSG00000165029 "ATP binding cassette subfamily A member 1" O95477 9 104781002-104928237 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" "Atherosclerosis, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 16.9;U-87 MG: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.6;neutrophil: 10.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057283, CAB069889" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB069889: AB_10002789, HPA057283: " "unprognostic (1.58e-2)" "unprognostic (2.54e-1)" "unprognostic (1.46e-1)" "unprognostic (2.80e-1)" "unprognostic (7.47e-3)" "unprognostic (1.85e-1)" "unprognostic (9.22e-2)" "unprognostic (9.80e-2)" "unprognostic (2.04e-1)" "unprognostic (7.28e-3)" "unprognostic (2.14e-1)" "unprognostic (4.78e-2)" "unprognostic (1.04e-2)" "unprognostic (2.00e-3)" "unprognostic (2.51e-2)" "unprognostic (6.71e-2)" "unprognostic (2.57e-1)" 25.7 38.1 6.3 9.8 13.1 15.8 23.0 2.3 8.5 8.2 14.8 8.0 6.5 4.4 7.8 9.6 7.0 7.9 13.6 10.7 7.5 3.7 7.1 33.3 12.7 29.4 18.9 2.3 8.7 5.4 1.8 3.3 20.1 10.2 9.4 9.4 7.7 6.3 8.7 21.3 12.1 8.1 25.2 16.1 12.8 7.3 8.8 8.0 16.9 5.8 2.2 5.0 16.4 20.0 1.8 0.2 11.6 1.5 0.1 0.6 0.1 0.0 2.6 2.2 0.0 6.5 2.4 2.0 2.8 10.8 0.9 1.0 0.4 0.3 3.8 3.1 2.8 0.0 1.2 0.1 0.8 0.0 0.0 0.4 0.9 9.4 11.7 0.0 6.7 16.9 0.7 11.0 0.2 1.0 0.0 9.7 0.2 0.3 2.3 5.1 3.1 0.8 0.0 0.0 0.2 1.8 1.8 0.3 0.1 2.9 0.5 0.6 0.0 1.9 0.9 2.9 0.2 3.8 3.1 3.8 1.8 2.3 38.7 0.0 0.0 2.2 0.8 11.6 0.2 1.0 0.2 1.2 0.3 0.0 0.2 1.8 0.6 0.0 10.6 0.1 1.5 0.1 0.1 0.1 6.3 13.1 2.3 4.0 7.5 3.7 18.9 2.3 10.2 8.0 ABCA12 "DKFZP434G232, ICR2B, LI2" ENSG00000144452 "ATP binding cassette subfamily A member 12" Q86UK0 2 214931542-215138428 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 23.1;tongue: 29.3" "Cell line enhanced" "Detected in some" "hTCEpi: 28.0;SK-BR-3: 13.1;T-47d: 6.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "cerebral cortex: 1.6;hippocampal formation: 1.8" HPA078239 Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoli, Cytosol" "HPA078239: " "unprognostic (6.12e-2)" "unprognostic (4.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.49e-1)" "unprognostic (2.13e-1)" "unprognostic (2.09e-4)" "unprognostic (6.52e-3)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (2.50e-2)" "unprognostic (7.69e-2)" "unprognostic (5.92e-2)" "unprognostic (2.64e-2)" "unprognostic (2.36e-1)" "unprognostic (5.08e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 6.9 0.1 0.1 6.2 0.3 0.0 1.4 0.0 0.0 4.4 8.4 0.1 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 6.1 4.9 0.0 0.1 0.4 0.0 0.3 0.0 0.1 23.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.1 0.0 29.3 6.1 0.1 3.7 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.0 0.0 2.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 2.0 0.0 13.1 0.0 6.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.0 0.0 ABCA13 "FLJ33876, FLJ33951" ENSG00000179869 "ATP binding cassette subfamily A member 13" 7 48171458-48647496 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4" "Cell line enhanced" "Detected in some" "HDLM-2: 8.5;LHCN-M2: 3.6;U-2 OS: 10.2;U-266/84: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063601 Approved Vesicles,Centrosome,Cytosol Vesicles "Centrosome, Cytosol" "HPA063601: " "unprognostic (8.97e-2)" "unprognostic (5.82e-2)" "unprognostic (3.18e-1)" "unprognostic (6.48e-2)" "unprognostic (2.65e-2)" "unprognostic (5.59e-2)" "unprognostic (5.19e-2)" "unprognostic (2.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.86e-3)" "unprognostic (6.03e-3)" "unprognostic (3.26e-1)" "unprognostic (1.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (3.62e-2)" 0.3 0.2 0.1 0.3 1.0 35.4 0.7 0.0 1.1 1.2 0.3 0.4 0.0 0.3 0.3 1.1 10.3 1.8 0.5 3.5 1.8 0.2 1.1 0.7 15.7 0.2 0.1 0.0 0.4 1.2 0.1 8.7 1.2 0.4 0.2 0.4 0.0 1.7 0.4 0.8 1.3 0.3 0.2 0.9 1.3 0.2 4.2 0.0 4.6 7.1 5.4 14.4 0.5 0.3 0.6 0.6 3.2 0.7 1.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.3 1.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.5 1.2 2.1 0.0 8.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.0 0.0 0.1 3.6 0.0 0.0 0.1 0.1 2.1 0.3 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.6 10.2 0.4 1.5 3.0 4.1 0.0 1.3 0.4 0.4 3.2 0.7 0.6 0.3 0.4 0.3 0.4 0.2 0.2 0.1 0.6 0.4 0.4 1.6 1.0 0.3 0.6 0.1 0.2 0.1 1.0 0.0 1.1 1.8 0.2 0.1 0.0 0.4 0.0 ABCB9 EST122234 ENSG00000150967 "ATP binding cassette subfamily B member 9" Q9NP78 12 122920951-122981649 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 6.2" "Group enriched" "Detected in many" 5 "B-cells: 6.2;granulocytes: 4.1;T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033052, HPA035113, HPA035114" Approved Supported Vesicles Vesicles "CAB033052: AB_2273463, HPA035113: , HPA035114: AB_10601329" "unprognostic (1.47e-2)" "unprognostic (6.46e-4)" "unprognostic (3.96e-2)" "unprognostic (2.73e-1)" "prognostic unfavourable (5.65e-4)" "unprognostic (1.46e-1)" "unprognostic (2.67e-2)" "unprognostic (2.35e-1)" "unprognostic (4.08e-2)" "unprognostic (6.07e-2)" "unprognostic (2.28e-1)" "unprognostic (1.24e-1)" "unprognostic (1.37e-2)" "unprognostic (6.97e-2)" "unprognostic (1.70e-1)" "unprognostic (3.58e-3)" "unprognostic (2.71e-2)" 3.6 4.2 9.5 3.0 13.1 5.3 3.8 19.7 17.0 2.9 4.0 5.8 2.3 5.0 4.2 9.7 4.7 4.7 4.6 4.6 9.0 11.5 3.3 2.7 3.4 3.1 10.8 10.9 4.7 4.3 6.6 9.9 3.5 9.8 3.5 4.1 3.0 7.7 5.6 3.4 6.0 6.1 3.9 7.5 4.0 4.0 21.3 6.4 2.5 3.6 2.0 3.7 2.9 2.7 6.2 0.4 4.1 0.7 0.5 1.9 1.8 3.7 6.9 3.8 3.7 1.6 3.2 1.8 2.4 3.5 4.2 2.7 2.9 4.2 4.2 2.8 2.4 3.5 2.8 5.8 1.6 0.8 5.6 18.0 5.6 4.6 1.9 0.8 7.3 4.5 2.3 6.1 1.9 4.6 3.6 3.1 2.3 8.2 1.3 1.7 1.2 6.8 5.0 1.1 3.9 2.0 2.4 4.1 1.3 1.2 8.8 8.5 10.1 1.2 2.0 3.0 10.3 9.3 6.8 10.0 5.6 1.1 5.3 2.0 16.3 4.1 0.7 0.7 0.8 0.4 1.9 6.2 0.8 0.7 0.4 1.2 1.5 1.4 1.7 0.5 0.3 0.3 0.5 1.8 9.5 13.1 19.7 17.0 9.0 11.5 10.8 10.9 9.8 6.4 ABCG1 ABC8 ENSG00000160179 "ATP binding cassette subfamily G member 1" P45844 21 42199689-42297244 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 15.0;MCF7: 18.7;MOLT-4: 17.3;RPMI-8226: 14.2;SCLC-21H: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 19.2;neutrophil: 20.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031470, HPA031471" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA031470: AB_10599188, HPA031471: AB_10600201" "unprognostic (2.89e-2)" "unprognostic (2.53e-2)" "unprognostic (9.96e-2)" "unprognostic (4.20e-3)" "unprognostic (2.87e-1)" "unprognostic (3.09e-2)" "unprognostic (5.74e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.66e-3)" "unprognostic (3.66e-3)" "unprognostic (6.37e-2)" "prognostic favourable (7.16e-6)" "unprognostic (1.40e-2)" "unprognostic (2.00e-2)" "unprognostic (1.66e-1)" "unprognostic (2.42e-2)" 19.9 36.4 14.2 10.0 17.6 6.2 13.3 15.9 15.3 7.7 12.1 17.8 3.8 15.3 5.6 3.8 4.1 6.5 11.9 9.7 12.4 8.0 8.2 5.6 25.2 23.1 20.8 12.2 6.0 4.7 15.4 11.1 12.0 9.6 6.3 13.5 12.1 13.7 6.7 26.8 15.1 18.6 5.8 7.0 29.4 13.7 1.9 19.5 15.4 8.5 5.2 10.4 12.5 12.6 4.8 1.4 20.5 0.9 3.7 4.0 1.0 0.0 3.4 2.7 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 1.0 0.4 0.0 0.5 0.0 5.0 0.0 4.7 0.3 5.7 11.4 0.0 10.5 0.0 0.2 1.2 15.0 0.0 2.3 10.6 0.0 0.0 0.0 18.7 17.3 0.1 0.8 5.9 0.2 0.0 14.2 0.0 1.6 13.1 3.4 2.1 7.9 0.0 3.3 0.5 6.7 0.0 2.8 0.0 0.0 7.7 2.2 0.0 0.0 1.9 0.3 0.9 0.9 19.2 1.8 0.3 3.4 3.1 3.7 3.6 0.6 4.8 3.5 2.9 20.5 3.7 0.1 1.4 4.0 1.0 14.2 17.6 15.9 15.3 12.4 8.0 20.8 12.2 9.6 19.5 ABCG8 GBD4 ENSG00000143921 "ATP binding cassette subfamily G member 8" Q9H221 2 43831942-43882987 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "intestine: 62.4;liver: 64.4" "Cell line enriched" "Detected in single" 47 "Hep G2: 14.4" "Cancer enriched" "Detected in some" 30 "liver cancer: 21.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA019556 Uncertain Approved Vesicles Vesicles "HPA019556: AB_1844444" "unprognostic (1.99e-1)" "unprognostic (4.49e-1)" "unprognostic (3.22e-1)" "unprognostic (1.37e-1)" "unprognostic (3.09e-2)" "unprognostic (2.43e-1)" "unprognostic (1.99e-3)" "unprognostic (1.27e-1)" "unprognostic (6.28e-1)" "unprognostic (6.14e-3)" "unprognostic (4.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.68e-1)" "unprognostic (7.86e-3)" "unprognostic (5.03e-1)" "unprognostic (1.50e-1)" 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.4 0.1 21.2 0.0 0.0 24.0 0.1 0.1 0.1 0.1 1.7 0.1 0.2 0.3 0.2 64.4 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 62.4 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.6 2.1 0.3 0.5 0.8 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 14.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 2.1 0.3 0.4 0.7 0.3 0.5 0.5 0.6 0.5 0.1 0.7 0.8 0.7 1.7 0.5 0.3 0.6 0.3 0.2 0.2 0.3 0.1 0.4 0.2 0.3 0.2 0.0 0.0 0.0 ABHD14A "DKFZP564O243, DORZ1" ENSG00000248487 "Abhydrolase domain containing 14A" Q9BUJ0 3 51971426-51981199 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038153, HPA056913" Approved Enhanced Vesicles 260000 Vesicles "HPA038153: , HPA056913: " "unprognostic (4.15e-3)" "unprognostic (6.73e-2)" "unprognostic (1.98e-1)" "unprognostic (3.34e-2)" "unprognostic (2.71e-1)" "unprognostic (1.08e-2)" "unprognostic (8.92e-2)" "prognostic favourable (4.72e-4)" "unprognostic (3.96e-1)" "unprognostic (2.46e-2)" "unprognostic (5.52e-3)" "unprognostic (1.51e-2)" "unprognostic (1.97e-2)" "unprognostic (9.74e-2)" "unprognostic (2.17e-1)" "unprognostic (1.33e-1)" "unprognostic (1.30e-2)" 11.8 28.0 23.3 6.0 25.8 9.0 9.2 39.6 45.0 18.3 7.3 12.2 8.5 8.0 6.9 23.2 5.4 19.6 9.3 16.4 22.3 27.8 26.2 13.0 9.7 8.9 16.6 23.4 14.8 20.6 15.6 21.3 7.0 18.7 11.6 5.6 26.1 17.7 12.5 23.8 3.9 6.6 8.8 14.5 7.7 11.0 6.2 7.0 6.6 24.1 8.4 8.8 9.2 7.4 15.4 13.9 4.5 6.0 12.0 30.9 15.3 2.8 5.4 3.4 10.4 34.7 17.5 1.9 3.7 6.2 4.5 6.1 6.1 11.3 3.1 2.6 9.2 2.4 3.8 4.1 1.4 10.2 4.2 9.2 15.9 20.2 9.7 12.6 12.4 16.5 2.9 3.8 1.9 5.8 3.7 10.7 7.0 3.2 5.8 12.9 1.9 12.8 4.2 1.8 29.8 8.6 4.4 7.1 11.1 9.4 2.0 5.5 2.9 13.9 3.4 4.1 4.5 9.9 4.3 15.7 14.6 2.6 7.7 20.2 5.9 2.1 6.0 4.5 30.2 3.5 30.9 15.4 26.7 26.8 10.4 12.4 24.6 26.2 0.6 12.0 2.2 13.9 25.7 15.3 23.3 25.8 39.6 45.0 22.3 27.8 16.6 23.4 18.7 7.0 ABHD14A-ACY1 ENSG00000114786 "ABHD14A-ACY1 readthrough" 3 51974706-51989183 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.4;HUVEC TERT2: 4.1;SH-SY5Y: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA036174, HPA036175, HPA038153" Approved Uncertain Vesicles Vesicles "HPA036174: , HPA036175: , HPA038153: " "unprognostic (8.40e-2)" "unprognostic (1.37e-1)" "unprognostic (4.90e-2)" "unprognostic (7.22e-3)" "unprognostic (3.83e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.35e-1)" "unprognostic (6.23e-2)" "unprognostic (2.71e-1)" "unprognostic (1.10e-1)" "unprognostic (1.29e-2)" "unprognostic (9.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (7.11e-4)" 2.7 2.9 3.5 2.6 8.2 2.0 2.3 8.3 15.1 3.7 3.5 3.2 1.9 4.8 2.5 3.2 2.0 3.3 3.5 4.8 3.2 4.1 5.8 8.4 3.0 1.9 2.7 7.2 2.7 4.6 1.4 3.7 1.7 5.6 2.8 1.6 8.2 4.1 2.2 8.0 2.0 10.5 2.0 3.9 3.3 2.6 2.2 1.3 0.9 4.7 1.8 2.8 2.3 2.7 2.4 5.2 1.2 4.0 4.7 4.1 2.7 0.0 0.0 0.3 0.5 2.0 1.1 0.2 0.0 2.0 0.4 0.4 1.9 3.4 0.8 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.1 0.0 0.0 0.0 2.6 1.0 0.0 0.0 4.1 2.1 0.0 0.0 0.0 2.0 1.5 1.2 1.8 0.5 0.0 0.2 0.0 0.0 0.3 3.3 0.0 2.4 0.0 0.8 0.0 0.0 0.9 0.0 2.1 0.0 0.0 0.0 2.0 1.6 0.0 0.0 0.2 1.7 1.2 4.1 4.0 2.4 2.4 2.3 4.1 5.2 1.7 2.1 2.7 0.0 4.7 2.0 2.4 2.5 2.7 3.5 8.2 8.3 15.1 3.2 4.1 2.7 7.2 5.6 1.3 ABHD17A "C19orf27, FAM108A1, MGC5244" ENSG00000129968 "Abhydrolase domain containing 17A" Q96GS6 19 1876810-1885547 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043270, HPA047226" Uncertain Approved Vesicles Vesicles "HPA043270: AB_2678401, HPA047226: AB_2679991" "unprognostic (3.77e-2)" "unprognostic (1.85e-1)" "unprognostic (3.57e-2)" "prognostic favourable (1.73e-4)" "unprognostic (3.70e-2)" "prognostic favourable (6.46e-4)" "unprognostic (1.69e-2)" "unprognostic (1.92e-2)" "unprognostic (5.09e-1)" "unprognostic (1.44e-1)" "prognostic favourable (1.76e-5)" "unprognostic (1.29e-2)" "unprognostic (1.85e-3)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (3.17e-1)" "unprognostic (1.60e-2)" 28.1 11.9 26.6 8.9 23.9 10.0 6.8 16.4 29.4 9.0 14.1 15.3 10.3 16.5 8.8 7.0 9.9 7.1 11.7 12.9 30.9 14.4 11.9 8.2 13.0 9.1 19.0 16.7 9.4 16.6 3.8 7.7 13.4 13.2 13.9 2.1 8.4 21.0 11.2 47.4 20.7 15.8 5.2 25.5 25.7 23.3 12.1 7.9 10.9 11.4 9.6 7.1 6.3 7.3 4.5 1.5 5.9 1.5 4.7 8.5 1.0 16.6 5.7 1.7 6.5 3.0 3.8 13.1 11.2 3.4 3.1 3.0 2.7 2.9 8.2 4.6 2.4 10.4 1.1 4.3 0.1 18.8 24.8 6.0 2.2 7.4 4.4 6.0 20.6 4.0 3.5 1.7 1.2 6.5 10.3 9.2 2.2 9.4 10.8 11.9 12.7 13.0 12.7 5.8 12.2 2.2 3.4 7.8 17.8 5.9 6.3 10.7 6.6 11.0 12.3 3.7 8.7 15.0 10.9 37.1 22.2 6.8 8.4 8.1 6.1 2.5 1.5 5.9 8.5 0.9 6.2 4.5 3.9 5.5 1.5 2.4 4.1 4.4 1.7 4.7 1.0 1.5 3.5 1.0 26.6 23.9 16.4 29.4 30.9 14.4 19.0 16.7 13.2 7.9 ABHD3 LABH3 ENSG00000158201 "Abhydrolase domain containing 3" Q8WU67 18 21650897-21704805 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 54.1;RPMI-8226: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010729 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Vesicles" "Plasma membrane" "HPA010729: AB_1844449" "unprognostic (1.46e-1)" "unprognostic (4.61e-2)" "unprognostic (2.37e-2)" "unprognostic (3.52e-1)" "unprognostic (8.46e-2)" "unprognostic (3.14e-3)" "unprognostic (3.54e-3)" "unprognostic (1.52e-1)" "prognostic unfavourable (8.52e-4)" "unprognostic (6.21e-2)" "unprognostic (1.98e-1)" "unprognostic (6.37e-2)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (3.98e-2)" "unprognostic (4.58e-2)" 9.2 5.4 12.0 14.2 10.7 8.6 20.7 19.5 11.1 6.4 34.2 4.8 5.1 23.8 6.0 5.4 12.7 7.8 13.5 7.1 8.8 8.5 8.7 21.7 12.8 21.3 11.5 5.0 9.4 8.8 10.7 11.8 10.8 16.6 6.9 37.1 14.7 10.3 4.1 10.1 3.8 45.3 5.5 12.3 17.9 19.0 4.4 10.8 20.9 12.9 6.7 13.7 9.2 25.5 7.1 6.1 33.0 23.3 7.1 17.6 9.1 7.4 5.4 5.3 3.4 3.4 2.2 0.0 4.9 2.0 3.5 4.8 5.6 7.7 21.4 9.0 1.6 24.8 8.6 4.0 4.9 13.4 6.0 2.3 9.1 9.6 5.2 10.1 7.8 2.0 4.8 5.2 2.4 2.3 5.9 12.8 3.1 3.0 9.7 11.3 2.6 12.8 54.1 4.0 60.2 9.7 7.2 4.5 2.0 11.2 10.0 2.8 3.1 17.9 1.8 3.4 4.9 6.0 7.5 14.4 9.3 22.1 4.4 13.3 7.8 29.1 10.2 11.4 11.1 17.9 8.5 7.1 10.0 10.6 6.1 5.1 8.2 10.3 33.0 7.1 23.3 4.2 17.6 9.1 12.0 10.7 19.5 11.1 8.8 8.5 11.5 5.0 16.6 10.8 ABHD5 "CGI-58, NCIE2" ENSG00000011198 "Abhydrolase domain containing 5" Q8WTS1 3 43690108-43734371 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Cataract, Deafness, Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 70.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 26.1;classical monocyte: 7.6;neutrophil: 21.0" "Group enriched" "Detected in many" 5 "granulocytes: 26.1;monocytes: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020685, HPA035851, HPA035852" Approved Approved Vesicles Vesicles "CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073" "unprognostic (2.58e-1)" "unprognostic (2.73e-1)" "prognostic favourable (8.89e-4)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (2.26e-1)" "unprognostic (6.13e-2)" "unprognostic (2.40e-2)" "unprognostic (5.33e-2)" "unprognostic (3.50e-3)" "unprognostic (2.56e-2)" "unprognostic (4.13e-3)" "prognostic favourable (9.17e-5)" "unprognostic (2.48e-1)" "unprognostic (8.87e-2)" "unprognostic (4.18e-2)" "unprognostic (4.18e-2)" 26.5 10.5 5.2 7.4 12.2 32.2 70.3 8.5 10.3 7.6 10.2 10.5 5.9 7.4 4.6 4.0 22.7 3.7 10.4 9.8 7.4 4.5 10.1 18.4 14.1 8.7 18.5 4.6 4.2 12.8 9.1 8.6 20.2 14.9 5.8 6.7 4.4 21.1 7.4 10.4 24.8 15.1 8.1 19.0 7.0 8.9 8.1 12.5 3.3 13.2 9.9 6.7 11.2 16.0 1.7 3.6 26.1 7.6 0.9 2.4 2.5 8.3 2.9 3.5 3.7 14.9 5.7 7.3 34.2 13.6 9.4 7.1 4.6 2.9 7.0 4.7 10.7 2.8 5.5 8.3 9.6 25.3 5.4 17.8 11.4 3.1 7.4 4.0 5.8 6.3 28.9 15.8 13.5 15.7 10.6 5.3 20.9 4.5 2.9 2.8 9.5 9.6 1.2 10.2 4.0 12.2 16.7 4.4 5.9 15.0 8.1 3.5 8.7 3.5 8.7 8.3 6.6 15.4 14.8 4.8 13.3 3.3 8.9 7.4 6.4 26.1 7.6 4.4 1.2 3.7 1.0 1.7 0.9 1.4 3.6 1.2 0.8 1.3 21.0 0.9 2.7 0.9 2.4 2.5 5.2 12.2 8.5 10.3 7.4 4.5 18.5 4.6 14.9 12.5 ABHD6 ENSG00000163686 "Abhydrolase domain containing 6" Q9BV23 3 58237506-58295693 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017283, HPA073225" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA017283: AB_1844452, HPA073225: " "unprognostic (4.20e-2)" "unprognostic (7.92e-2)" "prognostic favourable (1.13e-4)" "unprognostic (2.35e-2)" "unprognostic (1.16e-2)" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (1.15e-2)" "unprognostic (9.54e-2)" "unprognostic (1.11e-3)" "unprognostic (1.34e-2)" "unprognostic (1.94e-1)" "prognostic favourable (1.11e-11)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (2.72e-1)" "unprognostic (6.31e-2)" 8.3 10.0 11.6 4.6 14.0 1.0 5.8 17.7 22.5 3.7 8.1 30.0 10.3 26.3 4.7 10.8 4.8 6.9 4.4 4.1 19.0 9.2 24.3 43.4 6.3 5.2 18.6 12.2 4.1 2.4 4.8 15.2 4.8 19.0 4.4 8.1 10.5 3.0 12.9 3.1 17.2 33.5 6.8 24.0 22.8 9.0 3.1 14.3 2.0 6.6 2.1 5.4 4.6 4.1 3.9 7.0 2.1 9.3 0.7 2.6 1.1 2.1 8.0 1.2 5.3 15.1 2.7 14.0 5.6 5.1 5.9 8.1 4.2 2.9 4.0 0.5 3.1 6.3 5.4 2.5 5.3 6.9 2.7 3.4 5.4 5.8 5.1 1.0 18.4 2.6 11.6 5.4 2.7 3.3 4.1 9.4 4.8 1.6 7.0 0.4 3.9 17.7 2.6 2.4 9.1 9.1 2.9 7.0 2.8 6.2 3.4 11.6 2.3 2.8 3.5 4.3 4.7 10.6 6.6 2.8 8.0 0.2 11.0 10.3 5.8 0.0 2.8 2.1 2.1 9.3 2.0 3.9 1.2 2.6 4.6 3.0 1.2 1.5 0.0 0.7 6.2 7.0 1.4 1.1 11.6 14.0 17.7 22.5 19.0 9.2 18.6 12.2 19.0 14.3 ABI2 "ABI-2, ABI2B, AblBP3, AIP-1, argBPIA, SSH3BP2" ENSG00000138443 "Abl interactor 2" Q9NYB9 2 203328219-203447723 "Predicted intracellular proteins" "Host-virus interaction, Neurogenesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070567 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA070567: " "unprognostic (5.26e-3)" "unprognostic (5.26e-3)" "unprognostic (1.86e-1)" "unprognostic (4.11e-3)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (1.81e-3)" "unprognostic (7.05e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-3)" "unprognostic (6.19e-3)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (4.24e-2)" "unprognostic (2.94e-1)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" 8.6 11.6 28.8 7.7 41.8 2.8 12.8 24.4 50.7 17.2 11.5 18.7 8.4 5.1 23.3 16.1 10.5 19.4 11.4 25.1 26.0 24.0 17.8 6.3 13.4 6.4 19.1 30.2 24.3 6.5 18.6 21.5 15.9 17.6 16.4 9.5 11.7 7.1 20.3 5.9 6.4 6.9 21.2 18.8 10.2 6.9 22.2 16.8 11.6 22.2 3.2 7.3 10.2 8.4 1.7 13.8 0.4 3.7 3.9 5.3 3.4 7.4 11.6 41.7 26.2 9.9 17.0 9.1 13.1 11.7 11.4 13.2 10.7 14.2 0.0 9.0 15.3 8.3 18.9 13.8 22.8 3.7 10.8 18.9 12.5 8.3 15.1 8.1 8.6 12.0 6.6 20.8 16.2 21.1 13.3 16.9 20.0 13.6 20.3 7.7 21.6 26.0 13.4 21.1 1.3 11.7 7.8 16.8 22.0 2.5 7.7 14.6 10.1 9.4 15.6 21.0 17.8 11.3 14.2 12.0 10.9 10.4 22.6 3.4 13.3 0.2 1.5 0.0 3.8 1.7 4.1 1.7 4.3 4.4 4.3 1.7 5.3 4.5 0.4 3.9 3.7 13.8 4.6 3.4 28.8 41.8 24.4 45.2 26.0 24.0 19.1 30.2 17.6 16.8 ABT1 Esf2 ENSG00000146109 "Activator of basal transcription 1" Q9ULW3 6 26596952-26600744 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077039 Approved Vesicles Vesicles "HPA077039: " "unprognostic (1.32e-1)" "unprognostic (3.94e-2)" "unprognostic (3.05e-1)" "unprognostic (1.15e-3)" "unprognostic (1.77e-1)" "unprognostic (7.74e-2)" "unprognostic (2.55e-2)" "unprognostic (2.36e-2)" "unprognostic (1.85e-2)" "prognostic favourable (1.89e-4)" "unprognostic (2.30e-3)" "unprognostic (2.93e-2)" "unprognostic (7.25e-3)" "unprognostic (7.20e-2)" "unprognostic (9.57e-2)" "unprognostic (1.49e-1)" "prognostic favourable (3.80e-4)" 13.1 11.0 11.2 14.6 10.7 28.9 13.0 15.8 14.1 13.3 12.1 9.8 13.5 14.5 16.2 14.3 19.4 13.9 9.0 10.8 9.6 7.6 10.1 19.1 11.4 20.4 9.5 9.3 14.2 18.2 8.4 10.9 19.6 8.3 13.5 10.1 9.3 13.4 12.0 16.1 18.2 15.6 9.2 6.3 23.2 13.5 17.9 9.4 23.9 13.1 17.4 22.4 12.9 13.2 32.0 18.5 29.1 20.1 24.9 34.7 37.0 12.5 6.6 9.2 15.9 5.1 5.4 13.5 7.4 7.6 11.3 11.1 11.8 5.6 18.4 17.1 6.1 8.0 10.6 10.8 6.7 10.2 21.6 12.1 6.0 21.9 8.3 16.4 12.3 7.2 10.1 9.0 5.4 9.8 20.9 12.4 6.3 12.7 18.9 21.1 9.4 8.9 11.5 7.4 19.4 7.0 10.3 12.1 9.8 4.6 12.1 17.7 11.6 13.4 8.3 8.7 6.4 6.9 14.9 14.6 21.5 16.7 4.1 20.4 13.2 29.1 20.1 24.0 32.8 18.1 31.4 31.2 32.3 32.7 18.5 32.0 34.7 31.2 17.4 24.9 18.0 17.1 34.1 37.0 11.2 10.7 15.8 14.1 9.6 7.6 9.5 9.3 8.3 9.4 AC005726.1 ENSG00000258472 17 28455752-28614197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.8" "Cell line enhanced" "Detected in some" "A549: 6.4;Karpas-707: 3.4;PC-3: 3.2;THP-1: 3.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: " "unprognostic (1.26e-2)" "unprognostic (1.82e-1)" "unprognostic (6.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (7.25e-2)" "unprognostic (5.96e-2)" "unprognostic (4.58e-2)" "unprognostic (9.22e-3)" "unprognostic (3.17e-3)" "unprognostic (1.49e-4)" "unprognostic (1.25e-1)" "unprognostic (2.65e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-4)" 0.5 0.6 6.3 0.4 16.4 1.6 0.5 3.5 16.8 2.8 0.9 0.0 0.0 1.6 1.3 0.6 1.4 2.3 2.4 1.0 5.1 3.6 0.9 1.5 3.6 0.5 1.6 6.6 0.8 3.6 0.2 3.1 0.4 6.9 1.0 0.2 3.6 0.5 0.2 0.6 0.5 0.5 0.8 1.1 0.5 1.0 0.6 2.1 0.0 2.6 0.0 1.3 3.5 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.4 0.2 0.8 0.0 0.0 0.2 0.3 0.0 0.2 0.0 2.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 3.4 0.0 0.5 0.0 0.9 0.0 3.2 0.3 0.0 0.0 0.2 1.3 0.0 0.4 0.3 0.9 0.0 0.6 3.4 0.0 0.8 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 6.3 16.4 3.5 16.8 5.1 3.6 1.6 6.6 6.9 2.1 AC011455.2 ENSG00000269547 19 38915404-38949855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.6;ovary: 3.0" "Cell line enhanced" "Detected in some" "A-431: 3.7;A549: 5.1;T-47d: 4.3;U-251 MG: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052730, HPA056957" Uncertain Uncertain Nucleoplasm,Vesicles,Mitochondria "Nucleoplasm, Mitochondria" Vesicles "HPA052730: , HPA056957: " "unprognostic (6.10e-2)" "unprognostic (3.79e-2)" 1.3 2.6 0.3 1.7 0.3 0.0 0.1 0.4 1.1 0.3 0.1 0.0 1.2 0.5 0.1 0.4 0.8 1.1 0.1 0.1 1.6 1.1 0.2 0.0 0.2 3.0 0.6 0.0 0.1 0.5 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.3 0.1 0.1 0.5 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.1 0.0 2.8 0.9 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.5 0.3 1.1 0.5 1.1 0.3 1.9 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.3 0.2 0.0 1.4 1.3 0.0 6.3 0.0 0.5 0.0 2.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC091057.5 ENSG00000284906 "Rho GTPase-activating protein 11B " Q3KRB8 15 30624548-30685606 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 7.1;lymphoid tissue: 14.4;testis: 5.8" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA064479 Uncertain Uncertain Vesicles Vesicles "HPA064479: " 0.2 0.1 0.8 10.3 1.8 7.1 0.5 0.7 0.9 0.1 5.1 0.6 0.0 1.1 0.8 0.2 1.8 0.2 0.3 0.2 1.0 0.0 0.1 0.9 2.8 0.1 0.0 0.1 0.0 0.0 0.4 0.7 0.6 0.0 1.2 0.3 0.1 0.1 0.4 0.9 1.5 0.8 1.9 1.4 1.0 5.8 2.1 14.4 0.0 1.4 5.7 0.5 0.0 1.0 1.0 1.6 0.3 0.0 0.8 0.0 4.3 2.9 5.0 2.5 0.1 0.6 2.8 4.6 1.8 3.2 3.7 3.0 3.7 2.8 1.8 1.9 4.0 2.5 1.6 2.8 6.1 3.0 7.4 9.9 1.3 0.0 4.7 5.3 0.2 0.2 2.1 1.6 2.2 4.4 8.6 2.2 2.1 3.6 4.0 1.5 1.5 5.1 5.1 1.3 0.9 2.8 2.4 2.2 5.4 2.0 1.0 2.5 2.4 2.5 5.0 4.2 2.4 3.9 3.0 3.2 6.1 1.7 5.3 4.0 1.6 0.3 0.2 0.4 0.0 0.0 0.6 0.8 0.6 0.1 1.0 0.1 0.1 0.1 0.0 0.1 1.0 0.6 0.0 AC092718.3 ENSG00000260643 16 81053587-81096296 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 13.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA041368 Approved Approved Vesicles Vesicles "HPA041368: AB_10804001" "unprognostic (3.87e-2)" "unprognostic (1.79e-1)" "unprognostic (1.95e-1)" "unprognostic (2.12e-2)" "unprognostic (8.06e-2)" "unprognostic (1.08e-1)" "unprognostic (3.95e-2)" "unprognostic (8.11e-2)" "unprognostic (2.85e-1)" "unprognostic (2.42e-1)" "unprognostic (3.94e-2)" "unprognostic (3.19e-1)" "unprognostic (2.69e-2)" "unprognostic (2.11e-1)" "unprognostic (1.95e-1)" "unprognostic (9.56e-3)" "unprognostic (3.03e-1)" 5.1 2.7 4.4 1.6 6.3 1.0 2.6 2.6 10.3 1.8 1.3 5.9 5.5 0.8 3.4 7.6 1.3 7.0 1.9 3.4 5.0 6.1 6.0 1.8 1.6 6.8 6.2 2.9 3.6 5.0 2.2 4.0 7.6 2.9 1.3 3.7 3.3 2.6 8.4 1.8 1.1 2.3 5.3 1.4 2.0 5.8 7.2 2.0 15.0 1.6 0.9 1.5 0.0 4.5 5.1 1.5 1.3 3.9 3.6 2.1 4.2 3.4 5.2 3.7 12.0 4.4 5.6 2.2 1.0 2.0 0.3 0.4 5.0 0.8 4.6 1.0 3.6 3.2 1.3 2.9 1.5 5.6 0.9 1.6 3.1 4.3 3.1 2.8 5.3 6.4 3.0 2.8 2.0 3.8 0.4 2.7 4.7 4.2 13.8 2.6 1.8 12.3 1.1 2.1 7.7 1.7 4.2 4.1 2.6 1.1 4.1 1.2 4.9 2.4 0.9 1.9 2.5 1.8 3.0 3.3 5.6 2.6 2.3 2.2 1.5 1.1 1.0 3.6 0.8 3.5 4.5 2.3 1.3 2.9 3.5 3.3 2.4 0.9 3.9 1.3 5.1 0.6 2.1 AC092718.8 ENSG00000284512 16 81022316-81096284 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 20.6" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA041368 Uncertain Approved Vesicles Vesicles "HPA041368: AB_10804001" 1.4 1.9 3.2 2.1 4.7 4.0 1.7 1.8 6.9 1.4 1.3 4.4 4.0 1.4 2.0 4.2 1.3 1.7 1.6 2.4 3.7 2.5 4.2 1.4 1.9 5.1 4.7 2.2 2.5 3.6 1.4 1.7 5.7 4.0 1.3 2.6 2.3 1.7 3.2 1.9 1.6 1.3 3.9 1.5 1.7 20.6 5.4 1.2 4.5 0.9 1.2 1.7 0.0 1.9 2.8 2.3 1.0 1.7 2.1 0.9 1.3 0.7 1.8 1.5 0.3 0.0 1.6 2.4 0.2 0.5 0.1 1.1 1.8 1.8 1.0 0.6 2.8 0.1 0.1 0.5 0.3 1.1 1.0 2.4 1.7 0.2 1.8 3.3 0.6 0.2 0.4 0.0 0.0 1.0 3.2 0.0 3.6 1.6 3.9 1.9 1.1 1.5 1.3 0.5 0.2 0.8 2.7 0.8 1.8 1.1 0.3 1.1 0.5 0.3 1.7 1.9 1.3 1.1 1.6 0.7 3.4 0.6 0.8 0.8 1.9 1.0 0.6 1.2 0.6 1.0 1.1 0.9 2.1 0.6 1.9 1.2 1.5 2.3 1.7 0.9 2.8 1.8 0.9 AC118553.2 ENSG00000283761 1 99970011-100083321 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA073681 Approved Vesicles Vesicles "HPA073681: " 2.5 1.9 1.9 6.5 2.0 3.0 6.3 2.3 4.0 3.1 8.2 1.4 6.3 3.3 3.1 3.9 5.9 3.1 4.6 2.1 1.4 3.8 6.1 7.1 3.9 2.1 1.8 4.2 5.2 3.0 2.8 4.4 3.3 3.5 4.2 1.6 5.8 8.9 2.2 1.5 17.6 5.9 2.1 1.8 2.8 4.6 1.5 10.2 2.9 2.5 3.1 3.5 3.8 4.4 8.7 9.1 7.8 9.1 8.6 6.7 0.9 1.2 1.6 0.5 0.0 1.1 1.5 2.4 1.0 2.4 5.0 0.8 3.5 0.2 6.0 3.6 3.9 4.7 1.7 3.1 1.6 2.4 3.9 6.9 0.2 0.5 0.8 0.8 0.0 1.6 4.5 4.0 2.9 3.1 2.1 1.4 2.1 3.9 0.2 0.1 2.0 0.9 3.8 1.6 1.4 1.9 1.1 1.4 1.9 1.2 1.0 1.0 0.1 0.9 1.5 2.5 1.4 2.6 1.3 5.0 0.7 1.9 1.9 0.6 9.1 7.5 5.0 6.9 7.8 7.9 4.4 7.2 8.2 8.7 2.9 6.9 5.9 1.1 9.1 4.5 6.7 8.6 6.7 ACBD4 FLJ13322 ENSG00000181513 "Acyl-CoA binding domain containing 4" Q8NC06 17 45132600-45144181 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051772 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA051772: " "unprognostic (1.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.59e-2)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (1.60e-2)" "prognostic favourable (4.76e-4)" "unprognostic (2.27e-2)" "unprognostic (9.06e-2)" "unprognostic (4.86e-2)" "prognostic favourable (4.64e-4)" "unprognostic (8.24e-2)" "unprognostic (2.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-1)" "prognostic favourable (6.53e-4)" 7.5 9.5 8.1 8.5 15.3 3.5 6.7 10.8 10.9 8.6 19.6 4.9 14.4 25.9 9.2 6.8 8.3 10.1 10.7 6.2 8.1 6.8 12.3 43.1 6.3 8.0 6.1 11.1 10.4 14.2 13.6 8.5 5.4 6.3 11.1 5.4 9.9 12.3 13.6 5.4 7.5 29.0 10.3 4.8 8.3 7.3 2.5 6.3 3.9 11.3 4.4 7.3 8.5 7.2 8.8 3.5 5.6 4.3 6.3 7.7 5.4 5.9 11.7 1.5 3.3 2.7 5.2 4.1 2.2 4.8 3.7 7.3 4.5 8.4 6.4 5.8 3.2 5.7 2.0 3.8 1.5 9.1 4.6 3.1 7.5 8.9 6.1 1.2 8.7 5.1 3.6 1.3 1.9 3.6 2.0 10.2 1.8 4.0 4.4 1.6 0.2 3.2 3.7 0.3 14.0 9.2 3.8 2.5 1.1 1.6 2.4 6.4 15.7 2.3 1.3 0.9 2.9 1.4 1.4 16.1 4.4 1.9 5.4 1.6 1.6 5.5 3.8 5.6 5.3 4.3 5.7 6.8 6.2 5.9 3.5 8.8 6.7 7.7 1.0 6.3 2.8 2.2 7.1 5.4 8.1 15.3 10.8 10.9 8.1 6.8 6.1 11.1 6.3 6.3 ACBD7 "bA455B2.2, FLJ38219" ENSG00000176244 "Acyl-CoA binding domain containing 7" Q8N6N7 10 15077523-15088776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 35.3" "Cell line enhanced" "Detected in many" "MOLT-4: 21.7;U-266/84: 16.3;U-698: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 5 "olfactory region: 21.6" "Low region specificity" "Detected in all" "HPA043326, HPA062478" Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA043326: , HPA062478: " "unprognostic (2.15e-1)" "unprognostic (8.94e-2)" "unprognostic (7.79e-3)" "unprognostic (6.53e-3)" "unprognostic (7.30e-2)" "unprognostic (6.89e-3)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.32e-1)" "unprognostic (6.34e-2)" "unprognostic (3.59e-3)" "unprognostic (3.06e-1)" "unprognostic (2.18e-4)" "unprognostic (9.72e-2)" "unprognostic (2.95e-1)" "unprognostic (2.14e-1)" "unprognostic (6.90e-2)" 1.1 1.1 25.0 1.5 27.1 3.9 8.3 12.9 35.3 1.1 1.4 9.3 0.0 2.5 1.4 2.7 1.7 4.4 1.7 1.2 25.3 9.8 1.4 1.7 1.4 2.1 15.0 16.2 1.7 1.5 1.5 0.7 1.3 14.0 1.5 1.6 0.0 4.7 1.4 2.0 3.0 1.9 1.3 6.6 1.6 1.8 5.9 11.7 2.9 4.2 0.0 1.7 1.4 0.5 1.7 1.5 3.8 0.6 2.1 1.1 0.2 2.6 0.6 10.5 5.0 0.6 0.5 1.2 0.7 0.6 1.9 3.2 2.9 3.2 2.4 3.6 2.4 0.6 6.2 1.9 2.7 5.4 8.5 2.6 0.8 1.6 0.1 0.5 1.1 0.1 0.2 0.7 0.1 2.6 2.0 2.9 2.1 8.3 21.7 2.3 5.2 1.9 11.7 3.7 5.7 1.2 1.0 8.6 5.2 2.6 5.9 1.1 8.5 0.7 0.7 0.4 5.8 1.0 2.2 8.2 16.3 18.7 1.7 0.5 0.7 3.8 0.6 0.8 1.1 0.6 0.9 1.3 0.6 0.6 0.3 1.7 1.1 1.1 3.7 2.1 0.5 1.5 0.5 0.2 25.0 27.1 12.9 21.8 25.3 9.8 15.0 16.2 14.0 11.7 ACE "ACE1, CD143, DCP1" ENSG00000159640 "Angiotensin I converting enzyme" P12821 17 63477061-63498380 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 205.6" "Group enriched" "Detected in some" 4 "ASC TERT1: 35.9;HUVEC TERT2: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Group enriched" "Detected in many" 23 "B-cells: 3.7;monocytes: 2.0;T-cells: 1.9" "CAB002426, CAB002921, HPA029298, HPA069790" Enhanced Approved Vesicles "Secreted to blood" 121920000 92000000 Vesicles "CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: " "unprognostic (4.72e-2)" "unprognostic (4.16e-1)" "unprognostic (1.93e-3)" "unprognostic (6.06e-2)" "unprognostic (2.78e-1)" "unprognostic (1.35e-2)" "unprognostic (4.37e-1)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (1.25e-2)" "unprognostic (3.13e-2)" "unprognostic (2.38e-1)" "unprognostic (7.66e-2)" "unprognostic (9.07e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (2.76e-2)" 6.8 2.0 0.5 2.4 4.2 0.0 2.9 0.5 1.1 5.3 83.2 0.7 37.7 46.4 4.5 5.1 1.7 1.5 4.4 4.7 0.6 0.7 2.6 1.4 16.3 2.2 0.4 0.7 1.4 3.0 3.6 3.6 3.6 0.8 3.4 1.4 1.7 2.5 20.1 3.6 1.3 205.6 2.4 0.6 1.4 1.9 32.6 1.3 0.5 6.9 3.1 2.2 1.7 1.6 3.7 0.1 0.0 2.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 1.5 35.9 0.4 1.3 2.6 0.0 0.0 0.5 3.1 0.7 1.0 6.1 0.0 1.7 0.0 0.0 0.0 0.7 3.4 0.0 0.0 0.8 0.0 0.0 2.4 0.0 0.0 0.0 18.3 3.0 0.0 0.0 0.6 0.0 0.7 0.2 0.3 0.1 0.2 0.5 0.0 0.0 4.5 3.2 0.0 0.0 0.0 1.6 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.6 0.9 3.7 1.9 1.4 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.5 4.2 0.5 1.1 0.6 0.7 0.4 0.7 0.8 1.3 ACHE YT ENSG00000087085 "Acetylcholinesterase (Cartwright blood group)" P22303 7 100889994-100896974 "Blood group antigen proteins, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter degradation" "Blood group antigen, Hydrolase, Serine esterase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 43.8;skeletal muscle: 98.2" "Cell line enhanced" "Detected in some" "BEWO: 8.0;CACO-2: 12.6;K-562: 14.8;Karpas-707: 24.7;U-2 OS: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027098 Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" 650000 "Golgi apparatus" Vesicles "HPA027098: " "unprognostic (2.23e-1)" "unprognostic (9.44e-2)" "unprognostic (2.71e-2)" "unprognostic (5.80e-3)" "prognostic unfavourable (5.27e-4)" "unprognostic (2.49e-1)" "unprognostic (2.54e-1)" "unprognostic (1.36e-2)" "unprognostic (2.48e-2)" "unprognostic (8.92e-2)" "unprognostic (2.65e-2)" "unprognostic (1.78e-1)" "prognostic unfavourable (3.88e-5)" "unprognostic (2.95e-1)" "unprognostic (2.59e-2)" "unprognostic (9.28e-2)" "unprognostic (8.38e-2)" 1.4 4.8 5.8 3.5 16.1 10.3 1.4 22.8 11.8 1.4 4.2 2.7 1.4 5.7 1.9 2.6 2.8 1.8 3.1 4.5 5.5 43.8 1.4 1.8 1.8 5.9 22.2 4.8 1.7 1.6 7.0 3.2 2.0 37.9 3.3 3.4 4.6 6.5 3.3 98.2 1.4 7.9 1.9 8.7 2.3 2.1 1.9 2.6 3.5 1.6 15.9 3.2 2.1 1.2 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.3 0.2 0.5 0.0 8.0 0.3 0.0 0.1 0.2 12.6 0.3 0.0 0.4 0.0 0.4 2.1 0.1 0.0 4.3 0.5 0.2 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 14.8 24.7 0.1 3.5 0.0 0.1 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 1.0 0.0 0.0 0.0 0.1 0.7 5.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 16.1 22.8 11.8 5.5 43.8 22.2 4.8 37.9 2.6 ACKR2 "CCBP2, CCR10, CCR9, CMKBR9, D6" ENSG00000144648 "Atypical chemokine receptor 2" O00590 3 42804752-42887974 "G-protein coupled receptors, Predicted membrane proteins" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "placenta: 96.2;salivary gland: 74.8" "Cell line enhanced" "Detected in some" "BEWO: 31.4;HEL: 10.0;SK-BR-3: 16.8;U-937: 6.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 7.3;NK-cell: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 7.3;NK-cells: 2.2" "Group enriched" "Detected in many" 9 "amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6" "Low region specificity" "Detected in all" "HPA013819, HPA073493" Enhanced Supported Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA013819: AB_1846126, HPA073493: " "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.90e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (1.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.74e-1)" "unprognostic (2.99e-1)" "unprognostic (6.20e-2)" "unprognostic (8.47e-2)" "unprognostic (8.45e-2)" "unprognostic (1.13e-4)" "unprognostic (5.13e-3)" "unprognostic (3.22e-1)" "unprognostic (5.58e-3)" "unprognostic (6.09e-2)" 10.4 0.9 0.4 0.7 0.5 0.4 5.3 0.2 0.4 2.9 1.8 0.1 0.6 0.7 2.0 5.2 2.5 2.4 1.2 1.0 0.5 0.4 1.1 14.5 1.5 1.0 0.5 0.2 0.9 0.7 0.3 0.6 96.2 0.2 1.1 2.0 0.3 74.8 0.4 2.1 2.5 1.0 3.2 0.7 1.1 0.9 1.5 0.1 0.4 3.8 2.3 2.0 3.2 4.1 0.8 0.4 7.3 0.6 2.2 0.4 0.3 0.1 0.0 0.1 0.2 1.4 0.1 31.4 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.1 10.0 0.2 1.7 0.0 0.1 1.1 0.3 0.3 0.0 0.0 0.0 1.3 0.2 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 4.4 0.1 0.1 0.7 16.8 0.0 1.6 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.0 6.4 0.1 0.7 0.2 7.3 0.4 0.5 0.1 0.2 0.1 0.2 0.4 0.8 0.3 0.3 1.0 2.2 0.6 0.3 0.1 0.3 0.4 0.5 0.2 0.4 0.5 0.4 0.5 0.2 0.2 0.1 ACKR3 "CMKOR1, CXCR7, GPR159, RDC1" ENSG00000144476 "Atypical chemokine receptor 3" P25106 2 236567787-236582358 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 22.8;MCF7: 16.8;RT4: 66.7;SiHa: 20.4;U-2197: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 6.1;T-cells: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032003, HPA049718" Approved Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA032003: , HPA049718: " "unprognostic (1.65e-2)" "prognostic unfavourable (4.64e-4)" "unprognostic (2.50e-1)" "unprognostic (1.92e-3)" "unprognostic (2.10e-1)" "unprognostic (1.23e-1)" "unprognostic (7.34e-3)" "unprognostic (1.55e-2)" "unprognostic (1.85e-2)" "unprognostic (1.35e-1)" "unprognostic (9.70e-3)" "unprognostic (6.69e-2)" "prognostic unfavourable (1.76e-6)" "prognostic unfavourable (2.01e-4)" "unprognostic (9.71e-2)" "unprognostic (8.57e-3)" "prognostic unfavourable (2.93e-4)" 56.1 2.9 5.4 6.9 5.6 1.7 28.5 2.2 6.4 10.7 15.2 8.9 9.1 5.7 9.9 20.4 23.6 14.6 15.3 30.2 8.4 3.0 3.8 29.6 10.9 7.2 3.8 6.5 19.3 25.7 2.2 10.7 59.6 8.4 14.2 12.8 25.2 8.9 8.9 36.4 16.0 15.7 32.6 7.2 70.9 12.6 9.4 5.5 0.2 34.3 22.3 8.6 59.2 17.8 1.0 0.2 0.1 0.5 6.1 6.1 0.6 0.0 0.0 1.3 0.0 2.3 0.0 9.8 0.5 0.3 0.4 1.0 0.1 0.0 0.0 1.1 0.0 14.3 0.0 5.1 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.6 13.1 0.0 0.0 2.3 0.2 0.0 0.0 16.8 0.0 0.0 2.3 0.1 0.0 1.6 0.1 0.0 66.7 0.0 0.0 20.4 0.1 0.0 0.0 0.0 0.0 0.1 5.3 70.1 0.0 0.2 0.0 0.0 0.2 1.4 0.1 0.0 0.1 0.0 4.1 0.3 6.1 0.6 2.1 5.0 0.2 1.0 1.8 2.3 0.1 6.1 0.5 0.0 3.1 0.6 5.4 5.6 2.2 6.4 8.4 3.0 3.8 6.5 8.4 5.5 ACKR4 "CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1" ENSG00000129048 "Atypical chemokine receptor 4" Q9NPB9 3 132597237-132618967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.6;salivary gland: 29.0" "Cell line enriched" "Detected in some" 6 "BJ hTERT+: 86.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "basophil: 1.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.8" "Group enriched" "Detected in some" 7 "cerebellum: 5.3;pons and medulla: 1.6" "Low region specificity" "Detected in all" HPA054926 Approved Vesicles,Mitochondria "Vesicles, Mitochondria" "HPA054926: " "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.62e-2)" "unprognostic (8.27e-2)" "unprognostic (5.17e-2)" "unprognostic (4.55e-3)" "unprognostic (8.93e-2)" "unprognostic (2.26e-1)" "unprognostic (4.85e-2)" "unprognostic (4.20e-3)" "unprognostic (1.03e-3)" "unprognostic (2.69e-3)" "unprognostic (1.95e-1)" "unprognostic (2.01e-1)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-1)" 13.9 1.9 0.3 2.9 0.4 0.5 10.9 0.4 0.4 3.7 8.7 0.2 4.5 16.2 5.6 7.1 5.7 2.6 9.8 7.1 0.6 0.6 6.6 2.0 10.0 2.7 0.6 0.2 2.1 3.0 0.0 8.2 0.7 0.6 5.2 1.2 1.3 29.0 2.0 3.1 10.7 35.6 5.0 0.4 1.5 10.5 3.4 0.1 0.8 1.8 12.8 1.5 8.2 4.5 0.2 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.2 3.4 0.0 14.2 86.6 0.8 2.4 0.0 0.1 0.9 0.0 8.8 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.4 0.6 0.6 0.6 0.2 0.6 0.1 ACOT8 "hACTE-III, hTE, NAP1, PTE-2, PTE1" ENSG00000101473 "Acyl-CoA thioesterase 8" O14734 20 45841721-45857406 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010261 Approved Supported Vesicles,Mitochondria Vesicles Mitochondria "CAB010261: AB_2221664" "unprognostic (2.36e-2)" "unprognostic (6.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (4.27e-1)" "unprognostic (1.03e-3)" "unprognostic (2.92e-2)" "unprognostic (4.70e-1)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" "unprognostic (2.03e-2)" "prognostic favourable (3.18e-4)" "unprognostic (2.79e-1)" "unprognostic (1.23e-1)" "unprognostic (4.61e-2)" "unprognostic (2.98e-1)" 7.0 22.6 23.5 10.9 24.3 16.5 8.7 14.4 32.6 6.8 17.1 13.5 9.9 23.3 6.5 13.1 15.8 12.2 10.1 27.0 22.8 19.3 15.3 19.0 9.7 12.1 22.1 19.0 8.3 17.4 5.9 11.4 8.1 19.5 9.6 14.3 10.4 14.4 7.3 21.7 16.7 22.2 7.3 14.6 9.1 16.7 12.8 11.1 17.1 12.4 8.6 12.2 10.9 7.2 20.5 27.0 31.0 26.2 11.2 22.5 18.8 7.6 9.2 3.1 6.3 8.9 5.4 5.5 5.2 4.2 7.3 6.8 13.4 10.7 9.6 23.6 7.1 15.0 6.0 13.0 2.5 7.1 10.6 9.6 12.4 12.8 8.0 9.1 9.0 6.3 9.9 7.0 5.0 4.5 8.5 11.9 5.1 21.5 13.0 11.9 5.6 24.5 6.3 5.8 17.1 7.7 8.7 10.9 5.1 11.5 29.4 17.8 16.1 22.5 5.1 18.1 4.0 9.3 8.6 10.1 15.0 6.0 22.4 9.6 9.6 20.0 26.2 31.0 18.8 25.0 17.1 20.5 18.1 17.0 27.0 19.3 16.1 17.3 18.7 11.2 23.4 17.0 22.5 18.8 23.5 24.3 14.4 32.6 22.8 19.3 22.1 19.0 19.5 11.1 ACOX2 "BRCACOX, BRCOX, THCCox" ENSG00000168306 "Acyl-CoA oxidase 2" Q99424 3 58505136-58537319 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 70.5" "Cell line enhanced" "Detected in some" "ASC diff: 12.2;ASC TERT1: 20.2;fHDF/TERT166: 6.6;Hep G2: 7.8;HSkMC: 13.1" "Cancer enhanced" "Detected in many" "liver cancer: 25.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA038280, HPA064845" Enhanced Approved Vesicles,Cytosol 190000 Vesicles Cytosol "HPA038280: AB_10672623, HPA064845: AB_2685368" "unprognostic (6.62e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-1)" "unprognostic (2.51e-2)" "unprognostic (8.34e-2)" "unprognostic (1.48e-2)" "unprognostic (8.67e-3)" "unprognostic (6.45e-2)" "unprognostic (1.00e-1)" "unprognostic (1.85e-1)" "unprognostic (1.70e-3)" "unprognostic (1.26e-2)" "unprognostic (1.68e-3)" "unprognostic (4.00e-3)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (5.63e-3)" 4.0 5.3 1.9 3.8 2.5 0.1 3.4 1.6 2.1 4.4 10.2 2.7 9.5 10.0 9.0 6.2 3.8 4.4 4.8 8.8 2.4 1.4 17.1 70.5 2.8 0.7 2.0 1.7 5.1 2.9 3.8 3.0 1.4 4.0 7.2 3.4 11.4 3.0 5.9 4.2 1.7 13.7 10.6 2.5 0.9 2.6 4.0 2.0 1.0 7.7 2.7 1.6 5.4 5.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.2 20.2 3.5 2.3 0.2 0.0 0.3 0.6 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 1.8 0.0 0.0 13.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.5 1.6 2.1 2.4 1.4 2.0 1.7 4.0 2.0 ACRBP "CT23, OY-TES-1, SP32" ENSG00000111644 "Acrosin binding protein" Q8NEB7 12 6638075-6647460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 170.4" "Cell line enhanced" "Detected in some" "HEL: 5.4;HMC-1: 7.2;U-266/70: 16.0;U-266/84: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "classical monocyte: 7.7;intermediate monocyte: 9.8;myeloid DC: 11.0;non-classical monocyte: 17.6" "Group enriched" "Detected in many" 8 "dendritic cells: 11.0;monocytes: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039081, HPA039082" Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "HPA039081: AB_10670920, HPA039082: AB_10671036" "unprognostic (7.76e-3)" "unprognostic (2.27e-1)" "unprognostic (3.41e-3)" "unprognostic (2.31e-2)" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (2.42e-1)" "unprognostic (3.40e-3)" "unprognostic (2.85e-1)" "unprognostic (5.47e-3)" "unprognostic (1.17e-2)" "unprognostic (1.43e-1)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-4)" 0.8 0.4 0.3 0.9 0.8 2.5 0.5 1.3 0.6 0.4 1.6 0.6 0.5 2.2 0.4 4.2 0.5 0.6 1.7 1.0 0.6 0.3 0.9 0.7 0.8 3.6 0.4 0.3 0.4 1.5 0.0 0.5 0.4 0.8 0.7 0.4 0.8 0.5 0.1 0.3 0.4 3.3 0.6 0.6 2.3 0.6 170.4 0.3 0.5 3.9 0.3 0.8 0.7 0.5 1.2 11.0 1.6 17.6 0.3 0.1 6.5 0.2 0.1 0.8 2.7 0.9 1.3 1.4 0.0 0.0 0.1 0.1 0.0 1.9 0.3 0.9 0.2 0.0 0.5 0.0 0.2 0.6 0.0 5.4 0.6 0.0 2.0 0.1 7.2 0.1 3.6 1.0 0.1 0.6 3.6 0.0 0.1 0.4 0.2 1.9 1.6 0.0 0.3 0.1 0.3 0.6 0.1 1.1 0.1 0.0 0.7 1.2 0.0 2.0 0.8 0.1 0.8 0.6 0.0 16.0 10.5 0.5 0.6 2.0 0.0 0.9 7.7 0.7 0.1 9.8 0.0 0.8 0.0 0.0 11.0 1.2 0.1 0.1 1.6 0.3 17.6 2.8 0.0 6.5 0.3 0.8 1.3 0.6 0.6 0.3 0.4 0.3 0.8 0.3 ACSBG1 "BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352" ENSG00000103740 "Acyl-CoA synthetase bubblegum family member 1" Q96GR2 15 78167468-78245688 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 11.4;brain: 40.5;skin 1: 19.9" "Cell line enhanced" "Detected in some" "NTERA-2: 7.9;SK-MEL-30: 3.7" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041642, CAB045955, HPA058869" Approved Approved Vesicles Vesicles "CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840" "unprognostic (1.28e-1)" "unprognostic (1.63e-2)" "unprognostic (1.29e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-2)" "unprognostic (4.18e-2)" "unprognostic (1.32e-2)" "unprognostic (1.58e-2)" "unprognostic (1.86e-1)" "unprognostic (5.64e-2)" "unprognostic (2.02e-1)" "unprognostic (4.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (4.19e-2)" "unprognostic (1.42e-2)" 1.1 11.4 16.9 1.5 26.9 4.5 3.8 6.6 27.0 1.1 1.2 10.5 0.0 1.6 1.2 2.3 1.3 5.9 1.3 1.1 16.4 8.5 1.0 1.0 1.7 1.6 21.1 13.9 1.2 1.0 0.9 0.3 1.1 32.9 2.0 1.1 0.0 1.5 1.4 1.2 19.9 1.5 1.2 40.5 1.3 1.2 5.4 19.0 0.0 1.2 0.0 1.1 1.5 0.2 0.4 3.9 1.2 0.2 0.6 0.2 1.5 0.7 0.1 1.6 2.3 0.0 0.0 0.6 0.5 0.0 0.5 0.1 0.5 0.6 0.7 0.2 0.1 0.9 0.1 0.3 0.2 0.4 1.3 0.7 1.4 0.6 0.0 0.7 1.6 0.6 0.0 0.4 0.2 0.2 0.5 1.1 0.1 0.4 0.6 1.4 7.9 0.3 0.3 1.0 0.5 0.0 0.9 0.5 0.9 0.4 1.0 3.7 0.5 0.5 0.9 0.6 0.6 0.5 0.3 0.9 0.3 0.8 0.3 0.5 1.5 0.4 0.2 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.1 0.4 0.2 0.1 1.2 0.6 0.2 3.9 0.0 1.5 16.9 26.9 6.6 17.9 16.4 8.5 21.1 13.9 32.9 19.0 ACSM5 FLJ20581 ENSG00000183549 "Acyl-CoA synthetase medium chain family member 5" Q6NUN0 16 20409534-20441336 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 94.6" "Group enriched" "Detected in some" 5 "ASC diff: 5.6;ASC TERT1: 12.3;HSkMC: 14.6;U-87 MG: 9.0" "Group enriched" "Detected in some" 7 "liver cancer: 20.5;renal cancer: 9.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.8;intermediate monocyte: 1.9;myeloid DC: 3.2;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 8 "dendritic cells: 3.2;monocytes: 2.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA041435 Uncertain Uncertain Vesicles Vesicles "HPA041435: AB_10961121" "unprognostic (1.01e-1)" "unprognostic (1.61e-3)" "unprognostic (3.73e-2)" "unprognostic (1.98e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-2)" "unprognostic (1.84e-2)" "unprognostic (4.64e-3)" "unprognostic (1.64e-1)" "unprognostic (2.01e-2)" "unprognostic (2.15e-2)" "unprognostic (2.33e-1)" "unprognostic (5.11e-3)" "unprognostic (2.09e-2)" "unprognostic (3.85e-2)" "unprognostic (2.78e-2)" "unprognostic (1.57e-1)" 11.1 1.1 1.9 0.7 2.1 0.4 3.2 1.3 1.6 1.0 1.0 2.9 0.0 0.5 0.3 2.8 0.5 0.6 1.0 0.9 3.0 1.9 8.9 94.6 0.9 1.6 2.9 2.1 0.4 1.4 0.4 0.1 0.7 2.0 0.4 0.6 0.5 0.5 0.5 4.4 0.6 0.6 0.5 2.9 1.7 0.9 1.0 3.0 0.1 1.7 0.6 0.4 0.5 0.7 0.3 3.2 0.3 2.8 0.0 0.3 0.5 0.0 0.0 0.1 0.1 5.6 12.3 0.0 0.1 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.0 14.6 0.0 0.8 0.1 0.0 0.1 0.6 1.7 0.0 0.0 0.3 0.2 0.0 0.0 0.1 2.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 9.0 0.1 0.0 0.3 2.8 0.1 0.1 1.9 0.1 0.1 0.3 0.2 3.2 0.3 0.2 0.3 0.1 0.0 1.3 0.1 0.0 0.5 1.9 2.1 1.3 1.6 3.0 1.9 2.9 2.1 2.0 3.0 ACSS2 "ACAS2, AceCS, ACS, ACSA, dJ1161H23.1" ENSG00000131069 "Acyl-CoA synthetase short chain family member 2" Q9NR19 20 34872146-34927962 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.4" "Cell line enhanced" "Detected in many" "RPMI-8226: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 5 "dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004141 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA004141: AB_1078094" "unprognostic (1.97e-2)" "unprognostic (1.33e-1)" "unprognostic (1.70e-1)" "unprognostic (2.25e-2)" "unprognostic (1.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.42e-1)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (3.92e-2)" "unprognostic (1.66e-1)" "unprognostic (1.42e-2)" "prognostic favourable (2.04e-4)" "unprognostic (2.72e-1)" "unprognostic (2.32e-1)" "unprognostic (3.08e-1)" "unprognostic (2.54e-1)" 30.3 12.6 2.8 9.2 7.0 1.9 12.4 5.6 7.0 6.8 21.0 10.6 8.3 21.4 6.6 7.0 8.1 4.5 7.7 24.8 2.9 2.5 11.2 15.7 11.7 3.2 6.8 3.2 5.1 3.2 4.7 2.5 4.6 5.5 3.4 10.4 3.5 9.8 6.8 63.4 6.8 24.1 3.0 6.1 2.7 13.4 3.1 7.1 1.1 3.9 7.3 3.0 6.5 6.1 0.7 12.6 17.0 11.6 0.3 3.0 4.7 11.6 1.6 1.1 1.6 8.3 8.8 12.2 7.0 5.4 1.9 3.4 4.2 6.5 0.0 7.9 3.0 8.9 2.9 17.6 1.4 0.0 2.8 16.3 0.8 2.0 6.1 1.5 9.0 6.0 3.8 2.9 2.7 3.0 10.3 1.2 2.7 1.3 0.5 7.1 0.8 19.9 4.3 7.6 25.7 6.7 1.2 1.0 5.3 8.5 6.3 6.8 3.1 3.6 11.5 2.3 3.2 4.2 2.3 11.1 8.1 3.8 6.6 2.6 1.9 17.0 11.6 3.0 0.6 7.2 0.5 0.4 1.6 0.7 12.6 0.7 3.0 1.5 6.5 0.3 3.4 2.1 1.1 4.7 2.8 7.0 5.6 7.0 2.9 2.5 6.8 3.2 5.5 7.1 ADAM10 "CD156c, HsT18717, kuz, MADM" ENSG00000137845 "ADAM metallopeptidase domain 10" O14672 15 58588807-58749978 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001709, HPA050670" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" 8200000 "Plasma membrane" "Nucleoplasm, Vesicles" "CAB001709: , HPA050670: " "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (5.04e-2)" "unprognostic (3.09e-1)" "unprognostic (2.70e-3)" "unprognostic (7.48e-2)" "prognostic unfavourable (8.46e-5)" "unprognostic (3.99e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (6.69e-2)" "unprognostic (2.57e-2)" "unprognostic (2.57e-3)" "unprognostic (9.14e-2)" "unprognostic (2.09e-2)" "unprognostic (1.60e-2)" 25.9 11.1 15.5 17.1 17.7 15.6 20.0 25.2 17.6 18.6 20.1 15.7 12.7 13.9 19.9 11.8 17.1 13.8 18.0 18.8 17.6 13.7 20.8 14.8 25.0 26.1 23.1 12.4 13.9 13.1 10.9 11.6 36.1 14.5 23.6 16.7 14.6 12.4 19.1 8.9 15.4 15.6 12.8 30.4 40.4 18.4 8.5 18.9 38.5 27.3 9.2 14.9 30.0 19.1 6.2 12.7 26.9 23.7 9.8 12.2 12.8 11.8 26.9 7.3 8.0 9.4 13.6 18.5 10.2 30.4 7.5 10.5 12.4 15.7 5.5 31.6 9.1 24.3 4.4 10.8 10.0 8.2 5.6 9.4 9.8 11.5 10.5 6.6 27.2 11.9 8.0 5.2 7.7 14.6 5.9 15.0 13.2 4.4 21.9 7.6 10.0 3.8 9.1 24.0 14.1 17.5 32.1 8.0 5.2 11.1 12.9 17.6 7.7 13.3 10.3 9.9 11.0 76.0 9.8 8.4 18.1 6.0 13.8 12.9 17.3 12.9 18.8 10.4 8.1 21.5 12.2 5.3 8.0 7.1 12.7 6.2 8.4 7.0 26.9 9.8 23.7 5.8 10.3 12.8 15.5 17.7 25.2 16.9 17.6 13.7 23.1 12.4 14.5 18.9 ADAM15 MDC15 ENSG00000143537 "ADAM metallopeptidase domain 15" Q13444 1 155050566-155062775 "Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion, Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 63.6;RPMI-8226: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 17.2;intermediate monocyte: 12.0;myeloid DC: 28.7" "Group enriched" "Detected in many" 5 "dendritic cells: 28.7;monocytes: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011633, HPA072878" Uncertain Uncertain Vesicles 13000 Vesicles "HPA011633: AB_1844574, HPA072878: " "unprognostic (6.35e-3)" "unprognostic (1.51e-1)" "unprognostic (1.60e-1)" "unprognostic (7.60e-2)" "prognostic unfavourable (5.83e-5)" "unprognostic (2.09e-1)" "prognostic unfavourable (3.49e-4)" "unprognostic (2.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-2)" "unprognostic (2.70e-1)" "prognostic unfavourable (5.64e-9)" "unprognostic (3.35e-2)" "unprognostic (6.20e-2)" "unprognostic (2.04e-2)" "unprognostic (7.40e-2)" 32.7 8.3 7.3 13.3 8.9 19.3 47.9 7.8 13.9 19.9 21.2 22.2 11.9 10.7 20.4 16.2 36.0 19.3 30.3 42.3 8.0 7.7 12.4 12.8 29.2 23.3 10.8 8.3 15.7 17.5 18.9 6.9 25.5 13.9 17.8 15.9 15.4 20.4 12.1 13.6 45.8 20.3 25.6 13.6 16.0 19.6 8.3 7.4 2.7 14.6 41.5 19.7 13.4 26.5 1.1 28.7 0.7 17.2 0.7 4.5 8.1 20.7 6.6 1.3 29.6 10.9 9.1 12.8 9.2 11.7 11.7 8.0 4.8 11.9 5.8 41.3 12.0 26.0 6.6 28.2 3.1 2.6 8.6 1.4 13.1 4.7 19.1 11.7 1.5 9.7 29.9 11.8 17.0 52.9 2.1 24.2 8.7 11.3 0.1 8.6 4.1 63.6 1.8 4.0 67.0 8.5 5.4 4.0 8.7 20.1 25.3 7.9 37.4 7.3 39.0 11.5 4.9 11.4 10.1 2.7 2.1 2.5 8.4 8.9 12.5 0.0 17.2 0.3 4.5 12.0 3.1 1.0 2.3 2.6 28.7 1.1 1.0 1.2 0.7 0.7 2.8 2.3 3.8 8.1 7.3 8.9 7.8 13.9 8.0 7.7 10.8 8.3 13.9 7.4 ADAM19 MLTNB ENSG00000135074 "ADAM metallopeptidase domain 19" Q9H013 5 157395534-157575775 "Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 49.4;smooth muscle: 46.1" "Cell line enhanced" "Detected in many" "HDLM-2: 31.1;U-251 MG: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 32.3;eosinophil: 37.5;memory B-cell: 14.1;naive B-cell: 15.8;neutrophil: 20.1;plasmacytoid DC: 18.5" "Group enriched" "Detected in many" 5 "B-cells: 15.8;dendritic cells: 18.5;granulocytes: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055537 Approved Vesicles Vesicles "HPA055537: " "unprognostic (4.71e-1)" "unprognostic (1.01e-1)" "unprognostic (1.77e-1)" "unprognostic (4.64e-2)" "unprognostic (1.81e-3)" "unprognostic (2.63e-1)" "unprognostic (2.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (2.80e-1)" "unprognostic (1.42e-1)" "unprognostic (1.56e-1)" "prognostic unfavourable (3.90e-12)" "unprognostic (1.44e-1)" "unprognostic (4.38e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-2)" 3.7 2.5 1.3 49.4 1.5 4.8 2.8 6.9 2.4 4.4 15.1 1.1 3.6 3.9 8.6 5.9 4.6 5.9 14.7 18.9 1.6 1.7 1.6 4.3 9.1 19.2 1.6 1.0 3.0 0.5 0.0 1.4 33.0 3.4 5.9 4.9 5.0 6.8 4.6 3.9 0.8 14.0 46.1 2.8 16.8 7.7 1.3 0.5 5.6 3.1 3.3 29.4 17.0 3.9 15.8 18.5 37.5 3.9 0.1 4.4 2.2 10.9 1.7 3.4 0.0 0.2 0.2 21.9 13.1 4.7 8.2 6.1 5.7 9.0 5.7 0.7 6.7 9.3 0.5 0.8 7.5 31.1 0.3 0.0 0.9 0.7 2.0 0.0 0.0 1.5 0.0 6.4 1.3 9.2 1.6 0.8 17.4 0.0 0.0 0.0 3.6 5.7 0.1 19.6 4.8 0.8 0.1 1.5 1.0 0.0 4.7 0.6 0.0 0.1 14.1 8.9 9.6 2.0 59.2 3.5 0.1 20.5 2.0 0.0 3.9 32.3 3.9 37.5 0.4 0.3 1.0 14.1 4.4 1.0 1.1 15.8 0.1 0.1 20.1 0.1 0.0 18.5 4.4 2.2 1.3 1.5 6.9 2.3 1.6 1.7 1.6 1.0 3.4 0.5 ADAM32 ENSG00000197140 "ADAM metallopeptidase domain 32" Q8TC27 8 39106990-39284911 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 47.0" "Cell line enhanced" "Detected in some" "MCF7: 2.7;U-2 OS: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA044156, HPA062151" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA044156: AB_10796798, HPA062151: " "unprognostic (2.13e-1)" "unprognostic (6.92e-2)" "unprognostic (4.63e-3)" "unprognostic (8.99e-2)" "unprognostic (1.48e-1)" "unprognostic (1.52e-2)" "unprognostic (5.66e-3)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-1)" "unprognostic (3.38e-2)" "unprognostic (1.13e-7)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (8.34e-3)" "unprognostic (7.82e-2)" 0.6 0.6 0.3 0.2 0.4 0.4 0.6 0.3 0.5 0.6 0.3 0.2 0.2 0.0 0.3 0.8 0.2 0.3 0.5 0.4 0.3 0.7 0.2 0.2 0.2 0.2 0.3 0.6 0.5 1.2 0.1 0.2 0.2 0.4 0.3 0.4 0.4 0.2 0.7 0.2 0.8 0.3 0.2 0.2 0.5 0.1 47.0 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.9 0.2 1.5 0.4 2.6 0.9 0.0 0.7 0.3 0.1 0.4 2.0 0.2 0.2 1.3 0.4 1.2 0.4 0.1 2.6 0.0 0.5 2.3 0.2 0.5 0.0 1.5 0.1 0.3 0.0 2.2 0.3 0.3 0.2 0.8 2.7 0.2 0.1 0.0 0.1 0.2 0.5 1.3 2.7 0.4 0.6 0.0 0.0 0.2 0.1 0.0 0.1 0.3 0.9 0.4 0.2 0.3 0.0 1.1 0.0 0.0 2.6 3.7 0.1 1.4 0.0 0.4 0.1 0.9 0.1 0.7 1.5 0.4 0.2 0.7 0.4 0.3 0.9 0.6 0.9 0.1 0.8 0.7 0.8 1.0 2.6 0.4 0.2 0.2 0.0 0.3 0.4 0.3 0.5 0.3 0.7 0.3 0.6 0.4 0.2 ADAM9 "CORD9, KIAA0021, MCMP, MDC9, Mltng" ENSG00000168615 "ADAM metallopeptidase domain 9" Q13443 8 38996869-39105144 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Cone-rod dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 11.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004000 Approved "Endoplasmic reticulum,Vesicles" "Secreted - unknown location" 640000 Vesicles "Endoplasmic reticulum" "HPA004000: AB_1844584" "prognostic unfavourable (1.14e-4)" "prognostic unfavourable (2.25e-4)" "unprognostic (1.32e-3)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (7.21e-6)" "unprognostic (5.77e-2)" "unprognostic (1.55e-1)" "unprognostic (1.48e-2)" "prognostic unfavourable (2.52e-5)" "unprognostic (5.83e-2)" "prognostic unfavourable (3.99e-4)" "unprognostic (2.80e-1)" "unprognostic (5.76e-2)" "unprognostic (2.27e-1)" "unprognostic (1.23e-2)" 36.7 25.0 14.7 21.7 13.6 10.4 17.1 20.9 14.4 21.8 24.4 13.2 21.8 19.4 24.9 19.8 24.1 15.5 31.7 28.5 12.5 10.1 29.4 11.6 39.2 20.3 19.2 12.9 17.6 11.1 37.5 10.4 30.1 15.8 23.8 23.8 15.4 44.5 21.4 18.3 12.8 25.4 32.8 22.0 25.7 33.2 13.7 12.7 2.4 24.0 14.9 11.7 34.8 19.2 0.6 8.1 3.4 11.4 3.1 0.8 2.8 41.1 29.8 11.8 7.2 19.1 61.6 15.3 55.9 61.1 31.4 29.4 14.1 29.9 2.1 21.1 38.4 17.6 5.0 39.5 60.9 2.0 5.1 2.2 20.7 12.2 38.7 1.6 4.8 47.4 23.5 30.9 35.2 42.7 4.3 14.0 65.3 4.0 1.6 1.0 1.7 9.6 1.4 21.3 7.1 51.0 11.8 1.6 2.4 14.9 17.9 13.6 14.5 3.0 73.4 24.0 23.1 45.3 25.6 4.5 6.9 2.3 39.8 2.7 16.3 1.4 11.4 2.2 0.6 6.1 0.3 0.1 0.3 0.8 8.1 0.6 0.1 0.6 3.4 3.1 2.6 2.7 0.4 2.8 14.7 13.6 20.9 14.4 12.5 10.1 19.2 12.9 15.8 12.7 ADAMTS13 "C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP" ENSG00000160323 "ADAM metallopeptidase with thrombospondin type 1 motif 13" Q76LX8 9 133414358-133459402 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 53.7" "Cell line enhanced" "Detected in many" "SH-SY5Y: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042014, HPA042844, HPA052077" Approved Approved Vesicles "Secreted to blood" 1301000000 38000000 Vesicles "HPA042014: , HPA042844: , HPA052077: " "unprognostic (1.09e-1)" "unprognostic (1.45e-1)" "unprognostic (8.75e-4)" "unprognostic (1.49e-2)" "unprognostic (1.83e-1)" "unprognostic (3.02e-1)" "unprognostic (4.76e-2)" "unprognostic (2.54e-1)" "unprognostic (2.33e-2)" "unprognostic (1.88e-1)" "unprognostic (4.52e-5)" "unprognostic (1.11e-1)" "unprognostic (9.91e-2)" "unprognostic (4.78e-2)" "unprognostic (3.57e-1)" "unprognostic (1.82e-2)" "unprognostic (2.30e-3)" 1.4 1.0 3.1 1.4 3.7 0.5 1.4 6.6 4.2 1.4 1.4 1.4 1.4 4.1 1.6 4.0 1.4 2.1 1.5 1.7 3.4 2.2 1.8 53.7 4.8 1.4 2.1 1.4 2.3 1.8 2.2 4.2 1.7 1.6 1.6 1.1 1.6 2.5 2.0 2.6 2.9 4.4 1.4 2.0 1.4 5.5 3.8 1.4 1.4 1.7 1.4 1.4 1.7 1.4 0.3 0.0 2.3 0.0 0.0 0.5 0.1 0.0 1.4 3.4 4.7 2.7 2.5 1.2 1.1 0.9 0.5 0.7 0.5 3.7 0.4 1.5 0.8 0.6 0.3 0.6 0.1 2.0 3.1 0.4 1.4 0.7 2.0 0.1 1.1 6.6 1.7 0.5 1.3 0.3 0.1 1.4 0.5 5.6 0.1 1.5 3.6 2.0 0.4 0.4 1.6 1.5 1.4 2.2 6.9 2.4 1.3 1.8 5.9 0.6 0.8 2.5 1.4 1.6 0.0 2.5 0.6 0.5 2.1 0.4 2.8 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 3.7 6.6 4.2 3.4 2.2 2.1 1.4 1.6 1.4 ADAMTS19 ENSG00000145808 "ADAM metallopeptidase with thrombospondin type 1 motif 19" Q8TE59 5 129460265-129738683 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0" "Group enriched" "Detected in some" 8 "MCF7: 11.7;SH-SY5Y: 27.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "olfactory region: 4.8" "Low region specificity" "Detected in all" "HPA056171, HPA058438" Uncertain Approved Vesicles,Midbody "Secreted to extracellular matrix" "Vesicles, Midbody" "HPA056171: , HPA058438: " "unprognostic (1.14e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.10e-3)" "unprognostic (1.09e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-2)" "unprognostic (4.17e-2)" "unprognostic (5.99e-3)" "unprognostic (5.17e-1)" "unprognostic (1.14e-1)" "unprognostic (5.88e-2)" "unprognostic (3.06e-2)" 0.2 1.2 0.7 0.6 3.6 0.1 0.2 0.0 4.9 16.6 0.5 1.2 0.0 0.4 14.6 0.3 1.5 2.6 0.8 0.5 1.0 0.8 0.7 0.1 0.2 0.2 0.5 4.3 2.8 0.2 0.2 0.1 5.3 1.8 0.4 0.6 0.9 1.1 0.2 0.8 0.2 0.3 9.0 1.0 0.2 0.2 0.4 0.8 0.0 0.1 1.8 0.1 0.9 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 27.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.6 0.0 4.9 1.0 0.8 0.5 4.3 1.8 0.8 ADAMTS2 "ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP" ENSG00000087116 "ADAM metallopeptidase with thrombospondin type 1 motif 2" O95450 5 179110851-179345430 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 13.7;ASC TERT1: 13.7;BJ: 12.1;fHDF/TERT166: 14.2;HHSteC: 44.5;HSkMC: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA028363, HPA028444" Uncertain Approved "Vesicles,Plasma membrane" "Secreted to extracellular matrix" "Plasma membrane" Vesicles "HPA028363: , HPA028444: AB_10601964" "unprognostic (6.78e-2)" "unprognostic (7.83e-2)" "unprognostic (1.13e-1)" "unprognostic (5.50e-2)" "unprognostic (8.85e-3)" "unprognostic (4.80e-2)" "unprognostic (1.09e-1)" "unprognostic (2.22e-2)" "unprognostic (1.58e-1)" "unprognostic (1.91e-2)" "unprognostic (2.08e-1)" "unprognostic (2.45e-1)" "prognostic unfavourable (1.71e-8)" "unprognostic (1.32e-3)" "unprognostic (1.03e-2)" "unprognostic (7.16e-3)" "unprognostic (1.48e-2)" 24.2 4.3 0.9 5.8 0.7 0.7 29.1 0.9 2.3 16.3 10.1 0.4 3.9 2.7 12.0 9.5 6.0 7.2 9.5 10.1 0.7 1.2 4.2 7.4 13.1 25.9 1.0 1.3 6.3 2.7 1.0 8.7 15.1 2.4 6.0 2.6 3.8 2.5 3.8 3.8 4.6 4.6 13.8 0.7 16.5 4.2 4.3 0.5 0.8 3.2 5.9 1.2 8.8 14.7 1.4 1.3 2.1 0.3 0.8 0.6 0.1 0.0 0.0 0.0 0.3 13.7 13.7 0.0 12.1 2.0 4.6 4.9 0.0 0.0 0.0 0.1 14.2 0.0 0.7 0.0 2.0 0.0 0.6 0.0 0.0 0.9 44.5 0.0 0.0 35.5 0.0 1.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.5 0.0 0.0 0.1 0.0 3.9 0.0 7.7 1.2 10.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 1.5 0.3 0.4 0.6 0.2 0.3 0.6 0.5 0.4 1.3 1.4 0.5 0.5 2.1 0.8 0.1 0.8 0.5 0.1 0.9 0.7 0.9 2.3 0.7 1.2 1.0 1.3 2.4 0.5 ADAMTS7 "ADAM-TS7, DKFZp434H204" ENSG00000136378 "ADAM metallopeptidase with thrombospondin type 1 motif 7" Q9UKP4 15 78759203-78811431 "Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 31.9" "Cell line enriched" "Detected in some" 9 "HMC-1: 76.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA045284, HPA048453" Uncertain Supported Vesicles "Secreted to extracellular matrix" Vesicles "HPA045284: , HPA048453: " "unprognostic (5.94e-3)" "unprognostic (9.94e-3)" "unprognostic (2.76e-2)" "unprognostic (7.09e-2)" "unprognostic (3.38e-1)" "unprognostic (1.93e-1)" "unprognostic (5.88e-4)" "unprognostic (3.34e-3)" "unprognostic (2.89e-2)" "unprognostic (3.31e-2)" "unprognostic (1.83e-2)" "unprognostic (3.79e-1)" "unprognostic (1.34e-2)" "prognostic unfavourable (9.53e-4)" "unprognostic (1.59e-1)" "unprognostic (2.66e-2)" "unprognostic (8.86e-2)" 6.0 4.1 0.7 4.1 2.5 0.3 2.8 1.5 1.8 4.3 2.9 1.7 1.4 2.2 8.6 1.9 2.2 1.6 9.9 31.9 1.7 0.6 1.5 0.8 5.3 3.2 1.2 0.7 8.7 1.0 0.4 0.7 4.0 2.3 1.5 0.6 4.4 0.9 1.1 1.8 1.4 2.8 4.5 1.3 4.1 1.7 3.5 2.6 0.3 1.6 1.1 1.4 3.1 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.8 2.1 2.0 2.4 6.1 1.0 0.3 0.3 0.1 0.0 0.0 0.0 1.4 0.1 0.1 0.1 0.5 0.0 0.0 0.1 0.5 0.1 0.0 2.0 0.0 76.1 0.9 0.6 0.5 0.3 6.9 0.0 0.2 1.6 0.0 0.0 1.3 1.3 0.4 4.8 2.2 0.0 0.1 0.2 0.0 7.0 1.3 0.0 0.1 0.9 0.1 8.5 2.8 0.3 0.9 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 2.5 1.5 1.8 1.7 0.6 1.2 0.7 2.3 2.6 ADAMTS9 KIAA1312 ENSG00000163638 "ADAM metallopeptidase with thrombospondin type 1 motif 9" Q9P2N4 3 64515654-64688000 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 51.4" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028567, HPA028577, HPA028601" Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" Vesicles "Endoplasmic reticulum" "HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: " "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (4.83e-2)" "unprognostic (3.08e-1)" "unprognostic (1.37e-2)" "unprognostic (7.80e-3)" "unprognostic (5.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.64e-1)" "unprognostic (1.11e-1)" "unprognostic (7.67e-2)" "unprognostic (3.16e-3)" "unprognostic (1.46e-2)" "unprognostic (3.01e-1)" "unprognostic (1.98e-3)" "unprognostic (5.00e-3)" 51.4 4.7 5.6 12.0 11.5 0.5 15.2 3.9 8.0 10.4 10.4 2.8 7.2 1.6 13.9 5.6 6.8 7.7 8.2 29.6 5.7 2.7 9.0 3.1 11.5 7.7 6.8 0.3 17.4 9.9 17.2 2.4 30.5 12.4 7.4 3.2 0.7 3.5 4.3 10.8 2.6 3.2 12.2 12.6 4.4 4.6 3.1 5.9 0.0 6.4 3.7 1.6 19.6 29.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 5.6 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 3.5 1.0 0.0 0.0 0.2 9.4 0.2 0.0 0.1 0.0 0.0 0.0 3.0 0.0 0.0 0.9 0.0 11.2 0.1 0.0 52.2 0.0 0.0 0.0 0.0 0.2 2.1 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.6 11.5 3.9 8.0 5.7 2.7 6.8 0.3 12.4 5.9 ADAMTSL1 "ADAMTSR1, C9orf94, FLJ35283" ENSG00000178031 "ADAMTS like 1" Q8N6G6 9 17906563-18910950 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 50.7;retina: 39.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 34.6;HSkMC: 17.6;hTEC/SVTERT24-B: 18.1;LHCN-M2: 17.8;TIME: 57.0;U-138 MG: 27.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057437, HPA074973" Uncertain Approved Vesicles "Secreted in other tissues" 74000000 Vesicles "HPA057437: , HPA074973: " "unprognostic (4.64e-2)" "unprognostic (2.41e-1)" "unprognostic (3.95e-2)" "unprognostic (7.21e-2)" "unprognostic (2.45e-3)" "unprognostic (1.89e-1)" "unprognostic (1.52e-2)" "unprognostic (7.77e-2)" "unprognostic (2.01e-4)" "unprognostic (3.66e-2)" "unprognostic (1.21e-1)" "unprognostic (6.41e-2)" "unprognostic (7.29e-3)" "unprognostic (2.58e-2)" "unprognostic (1.87e-1)" "unprognostic (6.59e-2)" "unprognostic (1.50e-2)" 6.3 7.6 0.5 5.9 0.8 0.0 4.4 3.9 1.5 14.3 5.2 0.6 6.5 1.6 50.7 12.0 9.0 5.2 4.4 2.9 1.6 1.0 3.4 1.0 1.9 2.2 0.4 1.2 4.9 1.3 0.1 3.9 0.8 0.9 8.4 4.6 39.3 3.1 5.6 0.5 2.0 2.7 13.3 0.7 0.9 5.0 2.3 0.0 0.0 2.0 1.7 1.5 2.8 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.3 0.0 5.0 34.6 0.0 1.0 4.4 4.1 9.3 0.0 0.0 0.0 0.0 12.1 0.0 1.8 0.2 12.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 17.6 0.0 18.1 0.0 7.6 0.0 0.0 17.8 0.0 0.0 0.0 1.6 0.1 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 27.8 0.7 0.7 4.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 3.9 1.5 1.6 1.0 0.4 1.2 0.9 0.0 ADAMTSL2 KIAA0605 ENSG00000197859 "ADAMTS like 2" Q86TH1 9 133532164-133575519 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 30.4;heart muscle: 36.4" "Cell line enhanced" "Detected in some" "Hep G2: 5.8;RPMI-8226: 8.0;SH-SY5Y: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045634, HPA053812" Approved Approved Vesicles "Secreted in other tissues" 67000000 Vesicles "HPA045634: , HPA053812: " "unprognostic (5.10e-2)" "unprognostic (1.50e-2)" "prognostic unfavourable (5.01e-4)" "unprognostic (8.35e-2)" "unprognostic (1.07e-1)" "unprognostic (5.50e-2)" "unprognostic (6.78e-3)" "unprognostic (1.31e-2)" "unprognostic (5.49e-2)" "unprognostic (1.35e-1)" "prognostic favourable (6.70e-4)" "unprognostic (5.17e-2)" "unprognostic (7.37e-2)" "unprognostic (1.56e-1)" "unprognostic (3.40e-1)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" 3.6 30.4 5.5 1.8 5.4 0.7 0.9 6.4 9.3 1.6 1.6 8.8 0.9 2.4 1.9 4.9 1.8 1.8 11.0 36.4 4.7 4.0 15.1 24.8 11.3 6.8 5.7 4.9 6.9 7.9 1.4 8.6 2.6 9.9 4.3 1.1 4.5 5.4 3.8 5.5 0.9 2.6 1.8 5.1 3.5 2.3 3.2 6.8 0.0 6.5 1.3 1.3 2.2 6.0 0.3 0.2 1.0 0.2 0.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.0 0.8 0.6 8.0 0.0 0.0 1.2 25.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.3 0.7 0.3 0.8 0.4 0.0 0.2 0.0 0.3 5.5 5.4 6.4 9.3 4.7 4.0 5.7 4.9 9.9 6.8 ADAMTSL3 "KIAA1233, punctin-2" ENSG00000156218 "ADAMTS like 3" P82987 15 83654086-84039842 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "EFO-21: 12.0;RPTEC TERT1: 14.0;TIME: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA034773, HPA034774" Uncertain Approved Vesicles "Secreted in other tissues" 110000 Vesicles "HPA034773: AB_10601965, HPA034774: " "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (2.98e-2)" "unprognostic (1.07e-2)" "unprognostic (1.56e-1)" "unprognostic (9.89e-2)" "unprognostic (4.07e-2)" "unprognostic (3.27e-1)" "unprognostic (9.18e-3)" "unprognostic (5.92e-2)" "unprognostic (9.97e-2)" "unprognostic (3.85e-1)" "unprognostic (8.59e-3)" "unprognostic (5.00e-3)" "unprognostic (4.62e-1)" "unprognostic (8.64e-2)" "unprognostic (3.95e-5)" 6.9 5.0 1.5 6.2 2.9 0.0 5.3 2.8 2.8 8.7 14.3 4.4 1.8 1.5 12.0 3.7 5.4 5.6 4.7 15.9 3.1 1.3 3.8 12.1 10.6 1.5 5.1 2.9 2.0 12.9 1.1 2.6 12.0 7.2 8.1 3.7 19.9 4.7 8.7 2.6 2.2 3.1 26.8 3.6 2.0 7.5 2.9 4.2 0.2 4.6 2.2 0.5 8.0 13.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.9 0.0 14.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 12.8 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.9 2.8 2.8 3.1 1.3 5.1 2.9 7.2 4.2 ADCYAP1R1 "PAC1, PAC1R, PACAPR" ENSG00000078549 "ADCYAP receptor type I" P41586 7 31052461-31111479 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.2;fallopian tube: 25.1" "Group enriched" "Detected in some" 6 "AF22: 5.4;NTERA-2: 7.2;SCLC-21H: 6.1;SH-SY5Y: 10.9" "Cancer enriched" "Detected in some" 11 "glioma: 45.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030739, HPA049877" Enhanced Enhanced Vesicles Vesicles "HPA030739: , HPA049877: " "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.16e-2)" "prognostic favourable (5.78e-4)" "unprognostic (2.17e-1)" "unprognostic (8.36e-2)" "unprognostic (4.93e-2)" "unprognostic (5.75e-2)" "unprognostic (3.50e-2)" "unprognostic (3.88e-1)" "unprognostic (1.58e-1)" "unprognostic (6.67e-3)" "unprognostic (6.43e-4)" "unprognostic (1.09e-3)" "unprognostic (9.55e-2)" "unprognostic (3.85e-2)" "unprognostic (2.75e-4)" 5.4 10.6 23.6 2.7 24.2 0.9 2.9 13.7 71.2 12.8 2.7 13.4 0.0 1.6 5.4 2.3 3.3 25.1 2.0 2.8 22.1 21.6 1.0 1.1 1.6 1.0 19.0 20.2 1.9 2.2 2.9 4.4 1.0 18.7 2.1 2.0 0.0 2.6 3.7 1.9 1.8 2.0 3.9 6.5 1.3 1.6 2.2 13.3 0.0 2.3 0.9 1.6 1.4 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 10.9 0.0 0.0 0.0 0.0 0.0 0.3 0.9 1.3 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.6 24.2 13.7 17.3 22.1 21.6 19.0 20.2 18.7 13.3 ADGRE2 "CD312, EMR2" ENSG00000127507 "Adhesion G protein-coupled receptor E2" Q9UHX3 19 14732393-14778541 "CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Cell adhesion, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.7;lymphoid tissue: 38.9" "Cell line enhanced" "Detected in some" "HEL: 10.1;HMC-1: 16.3;NB-4: 9.8;RPMI-8226: 7.2;U-937: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 19.6;eosinophil: 24.2;intermediate monocyte: 15.7;neutrophil: 19.1;non-classical monocyte: 28.7" "Group enriched" "Detected in many" 8 "granulocytes: 24.2;monocytes: 28.7" HPA055200 Uncertain Vesicles,Cytosol Vesicles Cytosol "HPA055200: " "unprognostic (2.46e-2)" "unprognostic (3.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (9.10e-2)" "unprognostic (3.58e-2)" "unprognostic (2.77e-2)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.32e-1)" "unprognostic (2.70e-2)" "prognostic unfavourable (4.35e-6)" "unprognostic (1.46e-1)" "unprognostic (2.45e-3)" "unprognostic (2.50e-1)" "unprognostic (1.01e-1)" 6.3 3.1 1.7 22.9 1.9 7.2 4.4 1.0 1.3 14.9 8.1 2.5 0.9 2.4 12.0 1.0 1.9 2.3 3.3 7.3 2.0 1.8 3.4 4.3 15.6 37.4 2.2 0.0 5.3 3.5 0.7 1.6 10.9 2.4 3.8 2.5 3.2 2.4 3.9 3.5 3.0 3.0 2.0 3.1 38.9 2.0 2.2 1.4 2.8 3.4 5.2 2.8 7.5 2.1 0.1 3.1 24.2 28.7 1.2 0.0 1.8 0.2 1.0 0.1 0.2 0.1 0.3 1.1 0.8 1.1 0.0 0.0 0.2 0.2 0.2 0.1 0.6 1.7 0.3 0.1 0.0 0.2 0.2 10.1 3.2 0.2 0.5 3.7 16.3 0.8 1.4 3.6 0.6 0.1 2.3 0.4 1.2 0.5 1.3 9.8 0.4 0.2 0.1 1.4 7.2 0.0 0.3 0.1 0.2 2.1 1.7 0.4 0.3 4.7 0.3 0.3 0.2 0.2 0.1 0.2 0.1 0.2 1.0 12.9 0.5 19.6 4.4 24.2 0.0 15.7 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 19.1 1.2 28.7 0.6 0.0 1.8 1.7 1.9 1.0 1.3 2.0 1.8 2.2 0.0 2.4 1.4 ADGRG5 "GPR114, PGR27" ENSG00000159618 "Adhesion G protein-coupled receptor G5" Q8IZF4 16 57542421-57591681 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 37.7;lymphoid tissue: 25.6" "Cell line enriched" "Detected in some" 6 "HMC-1: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 37.7" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in single" "thalamus: 0.4" "Low region specificity" "Detected in single" HPA007133 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" Nucleoplasm "HPA007133: AB_1849253" "unprognostic (6.11e-3)" "prognostic favourable (4.25e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (6.14e-2)" "unprognostic (1.14e-2)" "unprognostic (6.43e-2)" "unprognostic (1.42e-2)" "unprognostic (8.09e-4)" "unprognostic (3.80e-3)" "unprognostic (3.02e-3)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (7.69e-3)" "unprognostic (4.52e-1)" "unprognostic (1.62e-3)" "unprognostic (6.32e-3)" 0.7 0.6 2.4 20.2 2.7 1.4 0.8 0.6 2.1 0.6 2.1 2.5 0.0 4.3 0.5 0.2 1.7 0.8 0.8 0.5 1.6 1.1 0.5 0.6 2.9 12.1 2.6 0.9 0.5 0.4 0.2 0.8 0.0 2.9 1.2 1.7 0.5 4.6 0.8 0.4 0.7 7.5 0.3 3.5 12.8 0.5 1.2 3.5 3.4 1.1 0.2 25.6 2.8 0.9 4.0 21.9 37.7 0.0 8.8 11.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.4 2.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 37.7 11.1 0.0 5.6 4.0 1.6 6.4 0.7 2.8 0.4 4.0 0.1 8.8 0.0 21.9 0.0 2.3 2.4 2.7 0.6 2.1 1.6 1.1 2.6 0.9 2.9 3.5 ADHFE1 "ADHFe1, FLJ32430" ENSG00000147576 "Alcohol dehydrogenase, iron containing 1" Q8IWW8 8 66430185-66471601 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.5" "Cell line enhanced" "Detected in some" "ASC diff: 4.6;HHSteC: 3.0;HSkMC: 2.7;RPTEC TERT1: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023062 Enhanced Approved Vesicles Vesicles "HPA023062: AB_1844611" "prognostic favourable (5.76e-5)" "unprognostic (8.69e-2)" "unprognostic (6.71e-2)" "unprognostic (2.70e-1)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "prognostic favourable (9.90e-5)" "unprognostic (7.76e-3)" "unprognostic (2.88e-1)" "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (9.43e-2)" "prognostic favourable (4.55e-5)" "unprognostic (1.37e-2)" "unprognostic (2.06e-1)" "unprognostic (4.66e-2)" "unprognostic (5.94e-3)" 12.5 3.2 10.3 2.2 9.7 1.8 4.3 2.2 10.7 5.9 3.8 10.9 4.8 2.7 4.2 8.6 3.1 5.9 5.0 34.6 6.9 5.4 11.8 44.5 3.6 2.3 8.6 7.5 5.2 8.3 11.6 9.8 3.7 6.9 7.3 3.1 10.7 6.6 10.5 35.7 2.4 2.4 6.9 4.8 2.8 8.6 3.2 7.3 0.0 4.5 12.9 2.5 6.2 1.9 1.3 0.4 3.4 1.1 2.2 2.6 0.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.5 0.4 0.3 0.0 0.0 1.7 0.0 0.0 0.7 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.0 3.0 0.0 0.2 2.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.2 0.9 0.0 0.5 1.2 2.0 0.0 0.0 0.3 0.2 0.0 0.0 1.2 0.1 0.1 0.8 0.0 0.3 3.4 1.1 0.0 2.6 0.0 2.4 1.3 0.5 2.2 0.4 0.8 0.7 2.2 0.1 2.2 0.0 0.3 0.0 0.6 10.3 9.7 2.2 7.8 6.9 5.4 8.6 7.5 6.9 7.3 AEBP1 ACLP ENSG00000106624 "AE binding protein 1" Q8IUX7 7 44104361-44114562 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "Calmodulin-binding, DNA-binding, Repressor" "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 177.1" "Cell line enhanced" "Detected in many" "ASC diff: 35.0;BJ: 46.1;BJ hTERT+: 30.4;fHDF/TERT166: 49.4;WM-115: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 10.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009966, HPA047724, HPA063595, HPA064970" Supported Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" 2300000 Vesicles "Nucleoplasm, Cytosol" "CAB009966: AB_2225690, HPA047724: , HPA063595: , HPA064970: " "unprognostic (1.70e-2)" "unprognostic (5.42e-2)" "unprognostic (1.66e-2)" "unprognostic (1.45e-1)" "prognostic unfavourable (1.60e-4)" "unprognostic (1.13e-1)" "unprognostic (7.00e-2)" "unprognostic (8.79e-2)" "unprognostic (2.52e-1)" "unprognostic (3.27e-2)" "unprognostic (1.26e-1)" "unprognostic (1.94e-1)" "prognostic unfavourable (9.31e-9)" "unprognostic (2.88e-3)" "unprognostic (9.58e-2)" "unprognostic (1.17e-2)" "unprognostic (6.28e-3)" 46.5 19.0 8.9 23.9 9.5 3.1 90.9 1.7 5.4 78.1 20.5 17.9 15.8 5.8 73.7 39.4 20.7 43.7 47.9 35.4 12.7 6.4 19.6 6.3 35.5 13.0 12.5 10.8 84.8 8.8 2.7 10.9 26.7 17.2 46.1 7.9 33.3 11.9 70.2 11.4 19.7 16.9 42.6 43.7 16.6 17.6 30.6 9.6 48.0 19.6 12.3 7.5 58.2 177.1 2.3 10.5 0.0 0.0 0.2 1.4 0.4 0.1 0.0 10.8 0.0 35.0 12.4 0.2 46.1 30.4 5.2 1.1 0.0 0.0 1.2 5.1 49.4 0.0 0.5 0.8 2.2 0.1 0.0 3.1 0.0 0.0 9.8 0.0 0.0 18.8 0.0 17.7 0.0 2.3 1.9 0.0 0.0 0.0 19.9 3.7 4.6 0.0 16.6 0.4 0.3 1.2 0.0 1.1 6.1 0.0 0.0 20.2 0.1 3.3 8.1 0.0 21.4 0.1 0.0 0.2 0.2 24.3 0.1 0.0 28.3 0.0 0.0 0.0 0.4 0.0 0.3 2.1 0.4 0.0 0.0 2.3 1.4 0.8 0.0 0.2 0.0 10.5 0.0 0.4 8.9 9.5 1.7 5.4 12.7 6.4 12.5 10.8 17.2 9.6 AFTPH "FLJ20080, FLJ23793, MGC33965, Nbla10388" ENSG00000119844 Aftiphilin Q6ULP2 2 64524305-64593005 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034990, HPA034991" Approved Supported "Golgi apparatus,Vesicles,Cytosol" Cytosol "Golgi apparatus, Vesicles" "HPA034990: AB_2674398, HPA034991: AB_10603577" "unprognostic (7.30e-2)" "unprognostic (4.72e-2)" "unprognostic (9.16e-2)" "unprognostic (8.54e-2)" "unprognostic (3.24e-1)" "unprognostic (4.25e-2)" "unprognostic (2.54e-2)" "unprognostic (1.75e-2)" "unprognostic (1.52e-1)" "unprognostic (8.44e-2)" "unprognostic (3.42e-2)" "unprognostic (4.65e-2)" "prognostic favourable (2.37e-5)" "prognostic favourable (8.44e-4)" "unprognostic (3.12e-1)" "unprognostic (1.74e-1)" "prognostic favourable (1.83e-4)" 12.4 14.8 18.0 25.8 20.0 11.4 20.8 29.8 22.9 14.9 20.1 9.5 16.7 14.1 12.9 28.6 20.7 14.7 16.9 13.5 15.6 14.5 34.8 20.3 18.7 20.7 12.8 21.4 13.1 19.4 26.8 22.6 9.8 16.3 22.3 21.5 9.8 18.5 17.4 12.2 21.8 19.0 14.7 12.2 17.1 20.0 15.1 16.7 20.0 16.0 9.9 24.7 16.5 20.9 16.4 11.8 21.4 10.2 4.9 9.0 4.2 14.0 9.3 7.0 8.4 9.0 7.7 11.6 8.1 12.2 13.4 10.1 10.7 10.7 20.9 8.0 10.0 11.5 12.0 11.3 17.5 20.3 6.6 10.0 5.9 12.5 9.6 19.0 17.2 3.8 24.1 8.6 19.8 10.4 7.4 19.1 8.2 8.0 10.2 23.3 6.4 7.0 8.4 11.2 13.6 24.1 15.2 12.9 6.5 8.6 19.6 16.6 11.8 14.6 8.9 10.0 11.6 8.4 9.0 21.6 12.8 32.3 7.6 21.7 11.0 21.4 6.9 11.6 5.8 6.7 6.9 16.4 7.3 7.0 9.0 14.8 7.0 5.6 12.1 4.9 10.2 11.8 9.0 4.2 18.0 20.0 29.8 22.9 15.6 14.5 12.8 21.4 16.3 16.7 AGFG1 "HRB, RAB, RIP" ENSG00000173744 "ArfGAP with FG repeats 1" P52594 2 227472152-227561214 "Predicted intracellular proteins" "Differentiation, mRNA transport, Spermatogenesis, Transport" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008741 Approved Supported Vesicles 28000 Vesicles "HPA008741: AB_1850752" "unprognostic (5.76e-2)" "prognostic unfavourable (7.13e-4)" "unprognostic (8.73e-3)" "unprognostic (6.31e-3)" "prognostic favourable (6.10e-4)" "unprognostic (9.30e-3)" "prognostic unfavourable (7.31e-6)" "prognostic unfavourable (1.85e-4)" "unprognostic (1.30e-1)" "prognostic unfavourable (3.43e-5)" "unprognostic (2.03e-2)" "unprognostic (5.78e-2)" "prognostic unfavourable (6.92e-4)" "unprognostic (1.25e-1)" "unprognostic (2.37e-1)" "unprognostic (1.98e-1)" "unprognostic (4.24e-3)" 43.2 26.4 19.9 27.7 26.5 80.1 34.4 18.1 31.3 16.7 26.2 31.5 15.7 25.6 18.1 16.8 29.3 18.2 23.6 28.2 22.6 19.7 22.7 24.7 35.0 33.0 25.4 20.4 20.9 20.9 25.3 13.8 44.0 24.6 14.0 20.5 18.2 19.7 15.3 21.2 22.8 29.1 23.4 39.2 32.2 19.7 51.5 20.8 26.4 21.0 17.3 30.4 23.5 19.8 5.3 5.2 9.0 8.4 1.6 5.5 2.5 18.3 30.5 16.1 15.7 27.6 20.4 61.2 24.5 23.5 29.4 26.2 23.9 21.2 13.1 18.7 26.9 19.5 27.7 31.7 38.3 22.0 15.4 28.8 26.5 44.1 29.7 19.5 18.3 12.5 34.0 37.2 35.3 29.5 30.1 35.5 35.3 26.2 23.3 17.6 25.1 15.9 21.6 26.6 9.3 29.3 25.3 15.1 11.7 20.0 26.1 23.3 11.1 22.3 28.8 25.4 20.3 36.5 21.4 20.6 13.8 18.5 27.6 16.7 29.1 5.4 8.4 2.7 2.6 6.8 5.5 3.0 3.1 2.6 5.2 5.3 2.6 4.7 9.0 1.6 6.4 3.6 3.6 2.5 19.9 26.5 18.1 31.3 22.6 19.7 25.4 20.4 24.6 20.8 AGK "FLJ10842, MULK" ENSG00000006530 "Acylglycerol kinase" Q53H12 7 141551189-141655244 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Cardiomyopathy, Cataract, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 37.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020959, HPA053471" Supported Supported Vesicles,Mitochondria "Intracellular and membrane" Mitochondria Vesicles "HPA020959: AB_1854206, HPA053471: " "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (2.79e-1)" "unprognostic (1.28e-2)" "unprognostic (9.47e-3)" "unprognostic (5.43e-2)" "unprognostic (2.15e-2)" "unprognostic (3.68e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (1.14e-1)" "unprognostic (6.24e-3)" "unprognostic (7.90e-2)" "unprognostic (9.29e-2)" "unprognostic (9.65e-2)" "unprognostic (3.30e-1)" "unprognostic (1.18e-1)" 8.7 12.0 11.9 8.0 19.0 5.9 10.6 21.3 23.7 8.8 8.9 10.2 8.8 6.4 16.8 17.1 9.5 11.9 6.8 24.5 16.1 12.3 16.0 10.5 8.4 10.0 11.8 18.8 10.8 8.0 15.7 13.3 9.9 14.2 10.1 13.4 10.6 13.5 10.7 8.4 6.8 8.8 15.0 13.9 12.2 9.0 12.9 9.0 7.8 9.8 8.4 15.6 8.4 8.5 4.6 6.4 0.4 5.5 37.9 10.3 5.7 12.2 13.3 13.2 10.9 10.5 13.0 9.0 13.0 12.7 20.9 20.9 10.3 9.5 13.8 11.7 12.4 9.1 18.4 15.1 22.5 16.2 16.4 12.8 6.3 10.2 15.6 8.8 6.9 14.4 13.3 18.3 18.0 16.0 19.0 19.7 10.1 12.3 23.9 4.1 14.0 15.0 15.5 2.3 41.2 13.3 10.4 11.6 15.9 13.5 16.3 13.4 8.7 9.7 8.9 9.7 7.6 12.9 18.7 15.0 14.8 6.6 15.9 4.1 26.6 0.0 2.6 0.4 9.1 5.5 6.5 4.6 7.4 10.3 6.4 2.5 5.5 9.6 0.2 37.9 3.2 2.5 7.2 5.7 11.9 19.0 21.3 23.7 16.1 12.3 11.8 18.8 14.2 9.0 AGMO "FLJ16237, TMEM195" ENSG00000187546 "Alkylglycerol monooxygenase" Q6ZNB7 7 15200318-15562015 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 41.9;liver: 57.9" "Cell line enhanced" "Detected in some" "HSkMC: 4.0;Karpas-707: 8.5;NTERA-2: 3.8;SCLC-21H: 3.6;TIME: 4.3;WM-115: 16.8" "Cancer enriched" "Detected in many" 5 "liver cancer: 15.7" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basophil: 3.6;neutrophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057900 Uncertain Vesicles Vesicles "HPA057900: " "unprognostic (2.82e-1)" "unprognostic (9.28e-2)" "unprognostic (5.60e-3)" "unprognostic (1.44e-4)" "unprognostic (7.52e-2)" "unprognostic (1.07e-2)" "unprognostic (3.61e-2)" "unprognostic (6.56e-2)" "unprognostic (3.31e-1)" "unprognostic (3.35e-1)" "unprognostic (4.18e-3)" "unprognostic (3.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.04e-2)" "unprognostic (3.45e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" 6.8 0.2 0.8 1.0 1.2 0.1 3.7 0.3 0.5 0.3 16.5 1.1 0.1 4.6 0.3 7.3 0.3 0.3 4.7 0.9 0.7 0.6 5.3 57.9 0.4 0.5 1.1 0.8 0.3 0.3 0.0 0.7 0.4 0.7 0.4 0.3 0.0 0.4 0.1 0.5 0.5 41.9 0.1 1.1 0.3 0.3 1.8 2.0 0.0 0.7 0.1 0.1 1.0 0.4 0.2 0.1 3.6 0.1 0.6 0.1 0.0 0.0 2.4 0.0 2.1 0.2 3.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 1.2 0.0 0.7 3.6 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.5 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 16.8 3.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 3.1 0.6 0.0 0.1 0.0 0.0 0.8 1.2 0.3 0.4 0.7 0.6 1.1 0.8 0.7 2.0 AGPAT4 "dJ473J16.2, LPAAT-delta" ENSG00000026652 "1-acylglycerol-3-phosphate O-acyltransferase 4" Q9NRZ5 6 161129979-161274061 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.0" "Cell line enhanced" "Detected in many" "AF22: 19.8;HEL: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053287, HPA060525" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoli, Vesicles" "HPA053287: , HPA060525: " "unprognostic (5.69e-2)" "prognostic unfavourable (1.45e-4)" "unprognostic (1.73e-1)" "unprognostic (3.43e-2)" "unprognostic (4.14e-2)" "unprognostic (6.67e-3)" "unprognostic (1.94e-4)" "unprognostic (1.05e-1)" "unprognostic (3.42e-2)" "unprognostic (2.77e-2)" "unprognostic (1.76e-3)" "unprognostic (1.67e-1)" "prognostic unfavourable (4.08e-4)" "unprognostic (1.82e-2)" "unprognostic (8.87e-2)" "unprognostic (3.63e-4)" "unprognostic (5.51e-2)" 5.6 4.2 10.5 3.5 19.1 8.0 4.5 9.6 26.6 5.3 4.2 35.6 1.0 2.6 10.7 4.5 5.2 7.2 8.0 2.9 14.2 11.8 5.2 2.0 6.1 2.0 25.8 12.4 10.0 2.3 1.3 9.8 14.6 27.4 3.7 4.4 0.7 2.7 4.9 2.1 1.9 2.5 8.5 49.0 5.2 3.0 4.2 19.8 0.6 4.8 2.0 2.2 4.0 3.8 1.1 1.9 0.6 3.5 5.8 7.0 2.1 0.3 0.8 19.8 3.9 3.7 7.6 0.8 0.7 0.2 1.5 2.5 1.1 3.5 0.5 1.4 3.1 0.3 3.6 3.0 1.4 2.2 6.2 14.8 3.5 0.0 2.9 0.1 2.1 9.1 1.5 4.0 2.1 4.6 7.3 6.8 1.8 0.0 1.0 1.6 4.7 7.6 0.0 0.9 0.4 4.3 0.3 11.5 4.4 3.0 1.6 0.8 0.8 1.0 5.1 2.1 2.6 1.4 3.3 0.5 0.7 0.0 7.8 0.8 1.3 0.0 3.5 0.0 7.0 2.8 2.3 0.4 3.3 4.1 1.9 1.1 1.7 2.7 0.6 5.8 2.5 1.5 2.9 2.1 10.5 19.1 9.6 15.8 14.2 11.8 25.8 12.4 27.4 19.8 AGR3 "BCMP11, hAG-3, HAG3, PDIA18" ENSG00000173467 "Anterior gradient 3, protein disulphide isomerase family member" Q8TD06 7 16859405-16881987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 40.5;intestine: 99.1" "Cell line enriched" "Detected in some" 41 "T-47d: 86.2" "Cancer enhanced" "Detected in many" "breast cancer: 104.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "olfactory region: 5.6" HPA053942 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" 31000 "Endoplasmic reticulum" Vesicles "HPA053942: " "unprognostic (2.18e-2)" "unprognostic (2.02e-1)" "unprognostic (2.13e-1)" "unprognostic (9.59e-2)" "unprognostic (3.32e-3)" "unprognostic (3.08e-2)" "unprognostic (1.49e-1)" "unprognostic (1.46e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-1)" "unprognostic (8.56e-3)" "unprognostic (2.32e-1)" "unprognostic (2.96e-1)" "unprognostic (6.66e-2)" "unprognostic (1.57e-1)" 0.6 0.0 0.6 7.5 0.7 0.0 13.1 0.7 0.6 4.4 45.8 0.6 0.6 29.2 1.2 5.4 0.9 40.5 11.8 0.6 0.6 0.3 1.5 0.6 26.3 0.6 0.6 0.6 5.1 1.9 0.0 12.9 2.8 1.9 1.1 38.9 0.6 9.4 0.6 0.6 0.3 99.1 1.2 0.8 0.6 17.1 1.0 0.6 0.6 1.4 1.9 3.9 4.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.3 0.1 0.0 0.1 0.0 86.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.7 0.6 0.6 0.3 0.6 0.6 1.9 0.6 AGTPBP1 "CCP1, KIAA1035, Nna1" ENSG00000135049 "ATP/GTP binding protein 1" Q9UPW5 9 85546539-85742029 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057208 Approved Approved Nucleoli,Vesicles "Nucleoli, Vesicles" "HPA057208: " "unprognostic (2.15e-1)" "unprognostic (3.78e-2)" "unprognostic (4.93e-3)" "unprognostic (6.12e-2)" "unprognostic (1.42e-1)" "unprognostic (8.95e-3)" "unprognostic (1.86e-2)" "unprognostic (1.65e-1)" "unprognostic (1.71e-1)" "unprognostic (8.26e-3)" "unprognostic (5.69e-3)" "unprognostic (6.31e-2)" "unprognostic (3.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (9.60e-3)" "unprognostic (1.25e-1)" 7.9 5.7 13.1 8.6 14.6 48.2 6.0 14.2 21.4 5.1 5.0 21.6 1.8 3.8 5.0 4.2 5.4 4.2 5.3 11.2 17.3 13.5 6.8 4.5 11.9 16.0 18.8 14.5 3.5 6.4 8.0 4.8 6.0 23.5 4.9 5.9 7.4 3.9 3.4 13.6 6.0 4.3 6.4 24.1 12.8 5.3 12.5 14.4 8.8 5.8 4.3 7.8 5.7 3.8 1.6 10.7 20.3 9.5 4.5 6.6 5.7 2.9 5.7 16.8 6.7 3.5 3.8 6.4 4.4 3.8 4.5 5.1 3.0 5.1 18.3 3.7 4.5 1.7 7.8 5.6 4.3 19.4 6.9 3.1 6.9 5.4 7.3 14.1 3.7 3.5 6.6 4.2 14.5 7.2 3.9 14.7 2.0 4.6 10.9 8.4 11.7 4.0 10.0 6.2 5.6 7.8 3.2 20.4 14.5 5.0 5.5 9.1 2.1 4.6 7.1 2.9 5.2 18.5 5.2 10.1 8.4 8.4 6.2 13.9 5.9 20.3 9.5 8.3 6.6 5.7 6.4 1.6 3.3 5.1 10.7 1.2 2.7 5.2 14.0 4.5 4.3 1.7 3.4 5.7 13.1 14.6 14.2 21.4 17.3 13.5 18.8 14.5 23.5 14.4 AGTR1 "AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R" ENSG00000144891 "Angiotensin II receptor type 1" P30556 3 148697784-148743008 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 29.6;placenta: 44.9" "Cell line enhanced" "Detected in some" "ASC diff: 62.9;ASC TERT1: 8.8;BJ hTERT+ SV40 Large T+: 12.0;HBF TERT88: 18.9;HSkMC: 11.4" "Group enriched" "Detected in many" 8 "breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003596 Enhanced Uncertain Vesicles Vesicles "HPA003596: AB_1845163" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.48e-4)" "unprognostic (5.28e-3)" "unprognostic (1.55e-1)" "unprognostic (3.46e-1)" "unprognostic (1.28e-2)" "unprognostic (3.26e-2)" "unprognostic (3.08e-2)" "unprognostic (9.25e-3)" "unprognostic (4.11e-2)" "unprognostic (4.79e-2)" "unprognostic (3.21e-3)" "unprognostic (1.46e-1)" "unprognostic (2.54e-1)" "unprognostic (5.41e-3)" 18.8 11.6 0.0 0.1 0.0 0.0 10.8 0.0 0.0 0.8 5.5 0.0 0.6 0.5 0.5 2.2 1.6 3.1 0.0 0.1 5.7 29.6 2.6 0.0 0.9 0.8 0.6 0.6 0.8 44.9 1.3 1.0 1.0 1.0 2.9 4.4 0.7 1.1 0.0 2.3 1.7 0.2 4.1 0.0 4.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 62.9 8.8 0.0 0.0 1.3 12.0 6.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 1.1 0.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AGTRAP ATRAP ENSG00000177674 "Angiotensin II receptor associated protein" Q6RW13 1 11736084-11754802 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 96.5" "Cell line enhanced" "Detected in many" "U-937: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044120 Approved Supported Vesicles Vesicles "HPA044120: AB_10960748" "unprognostic (1.08e-3)" "unprognostic (2.98e-3)" "unprognostic (6.10e-2)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (7.92e-3)" "prognostic unfavourable (6.57e-7)" "unprognostic (4.44e-2)" "unprognostic (7.96e-2)" "unprognostic (4.31e-2)" "unprognostic (1.61e-2)" "unprognostic (7.22e-2)" "unprognostic (1.61e-2)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (2.33e-3)" "unprognostic (5.89e-2)" 16.5 19.2 8.7 16.6 10.8 65.5 31.0 3.1 10.0 13.0 9.7 16.7 15.6 6.5 10.3 37.0 19.6 28.4 14.5 22.0 8.9 6.9 29.7 11.0 26.4 35.6 14.2 6.6 15.0 27.2 7.9 12.2 15.2 16.5 33.2 5.6 17.1 22.2 13.5 25.3 13.2 8.4 13.4 12.9 31.0 12.3 15.3 10.7 11.4 25.5 12.6 14.6 15.2 26.0 5.2 35.2 85.3 96.5 7.7 21.7 53.1 14.8 18.4 4.6 10.2 7.8 10.0 8.6 7.8 13.5 9.6 8.4 11.7 36.2 1.6 35.7 9.5 12.6 7.7 37.2 3.0 0.8 16.9 0.4 11.1 13.9 24.3 7.3 18.1 9.9 29.5 31.6 16.8 12.9 19.5 14.7 5.4 12.2 3.6 21.6 8.2 18.8 1.2 4.2 7.4 15.8 1.4 4.1 6.1 14.4 7.3 13.3 16.6 15.6 7.3 12.5 8.7 19.5 8.2 5.5 6.4 8.7 31.7 53.0 5.7 45.4 96.5 74.3 21.7 47.6 10.8 5.2 8.2 12.9 35.2 4.0 8.8 11.7 85.3 7.7 39.8 2.9 9.6 53.1 8.7 10.8 3.1 10.0 8.9 6.9 14.2 6.6 16.5 10.7 AGXT "AGT, AGT1, AGXT1, PH1, SPAT, SPT" ENSG00000172482 "Alanine-glyoxylate aminotransferase" P21549 2 240868479-240880502 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 172 "liver: 247.3" "Cell line enriched" "Detected in some" 5 "Hep G2: 13.1" "Cancer enriched" "Detected in some" 425 "liver cancer: 253.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035370, HPA035371" Enhanced Supported Vesicles 5200000 Vesicles "HPA035370: AB_10673218, HPA035371: AB_2674593" "unprognostic (3.14e-2)" "unprognostic (2.58e-1)" "unprognostic (3.37e-4)" "unprognostic (1.04e-1)" "unprognostic (1.23e-2)" "unprognostic (9.56e-2)" "prognostic favourable (5.92e-5)" "unprognostic (8.28e-2)" "unprognostic (2.77e-1)" "unprognostic (5.39e-2)" "unprognostic (1.55e-1)" "unprognostic (7.57e-3)" "unprognostic (2.54e-1)" "unprognostic (9.22e-2)" "unprognostic (1.37e-1)" "unprognostic (3.26e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 247.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 13.1 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.2 0.0 0.0 0.0 0.1 0.0 0.8 2.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 AIFM2 "AMID, FLJ14497, PRG3" ENSG00000042286 "Apoptosis inducing factor, mitochondria associated 2" Q9BRQ8 10 70098223-70132934 "Predicted intracellular proteins" Apoptosis "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 41.9" "Cell line enhanced" "Detected in many" "Hep G2: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028961, HPA042309, HPA075576" Approved Supported "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA028961: , HPA042309: AB_10796575, HPA075576: " "unprognostic (6.62e-2)" "unprognostic (2.73e-1)" "unprognostic (4.29e-1)" "prognostic favourable (2.80e-4)" "unprognostic (7.26e-3)" "unprognostic (2.57e-2)" "unprognostic (7.95e-3)" "unprognostic (2.80e-1)" "unprognostic (5.31e-2)" "unprognostic (8.90e-2)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (4.49e-1)" "unprognostic (4.59e-3)" "unprognostic (2.17e-1)" "unprognostic (1.11e-1)" "prognostic favourable (2.92e-4)" 32.9 7.8 3.1 6.6 5.9 1.3 41.9 5.0 3.7 3.5 9.0 2.1 22.1 7.6 4.5 9.6 9.1 4.0 7.6 19.7 2.8 4.1 10.2 18.2 8.1 4.0 2.9 2.4 7.5 3.6 3.9 3.1 5.2 3.5 6.4 5.9 9.2 5.8 15.2 9.1 2.8 9.9 7.8 3.7 5.9 6.5 3.1 2.1 1.0 10.8 6.4 7.3 11.8 15.7 3.4 0.7 1.5 1.0 7.8 3.5 1.2 8.6 15.1 0.4 3.9 9.1 3.4 0.1 3.5 8.6 7.2 8.1 11.6 16.8 1.2 8.9 4.8 9.4 4.3 1.2 2.0 16.9 0.7 0.0 8.9 56.6 19.6 0.0 2.2 4.6 2.8 11.5 2.4 3.2 6.6 7.5 3.7 11.0 0.3 0.4 1.5 4.9 0.2 1.4 4.1 3.8 6.4 1.3 0.3 6.4 5.6 9.8 0.2 2.4 3.9 0.1 8.9 5.3 10.1 5.6 10.4 2.4 4.8 0.3 4.7 1.5 0.9 1.0 3.5 0.8 3.1 3.4 1.2 3.0 0.7 2.9 1.7 2.7 1.0 7.8 1.0 0.5 2.4 1.2 3.1 5.9 5.0 3.7 2.8 4.1 2.9 2.4 3.5 2.1 AKAP7 "AKAP15, AKAP18" ENSG00000118507 "A-kinase anchoring protein 7" "O43687, Q9P0M2" 6 131135666-131283535 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 39.4;pancreas: 37.5" "Cell line enhanced" "Detected in many" "NTERA-2: 19.0;RPTEC TERT1: 16.6;RT4: 18.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027172, HPA027200, HPA028327" Approved Approved Vesicles Vesicles "HPA027172: AB_1844689, HPA027200: , HPA028327: AB_10601353" "unprognostic (2.83e-2)" "unprognostic (2.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.45e-3)" "unprognostic (4.57e-2)" "unprognostic (1.24e-1)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (4.41e-1)" "unprognostic (1.18e-1)" "unprognostic (3.89e-1)" "unprognostic (1.54e-1)" "unprognostic (1.32e-3)" "unprognostic (2.52e-1)" "unprognostic (6.03e-3)" "unprognostic (2.53e-1)" "prognostic favourable (2.56e-4)" 5.7 39.4 16.1 6.2 11.2 6.3 4.7 16.6 15.4 6.0 12.9 4.9 4.1 19.9 4.5 4.1 3.0 4.9 6.8 4.4 12.0 9.9 5.6 15.7 6.2 11.6 8.1 11.7 7.2 37.5 3.1 3.5 2.8 7.2 10.0 13.3 2.9 3.4 4.8 9.8 2.3 12.4 5.2 6.2 6.2 3.7 5.8 6.4 18.9 4.2 2.1 5.5 8.6 4.3 4.4 1.8 9.5 3.4 3.2 14.9 5.0 0.8 1.5 5.5 2.6 3.1 6.6 3.8 2.3 3.7 3.9 5.2 1.8 1.5 0.1 4.3 3.9 0.0 1.5 2.4 2.9 0.0 2.3 5.4 1.8 8.2 4.4 0.2 1.8 5.6 1.7 2.5 3.3 4.0 0.9 7.9 3.7 1.4 2.4 1.4 19.0 2.1 4.9 3.6 0.1 16.6 18.4 0.0 1.9 3.1 0.3 7.4 1.2 11.5 1.3 1.8 2.5 5.2 5.6 7.4 0.0 1.3 4.4 5.5 4.1 9.5 1.5 0.2 6.8 2.9 10.5 2.6 9.4 9.1 1.8 4.4 14.9 9.3 0.4 3.2 3.4 0.1 3.2 5.0 16.1 11.2 16.6 15.4 12.0 9.9 8.1 11.7 7.2 6.4 AKAP9 "AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO" ENSG00000127914 "A-kinase anchoring protein 9" Q99996 7 91940867-92110673 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008548, CAB012909, HPA026109" Supported Enhanced "Golgi apparatus,Vesicles,Centrosome" "Golgi apparatus" "Vesicles, Centrosome" "CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688" "unprognostic (9.57e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (5.97e-3)" "unprognostic (1.20e-1)" "unprognostic (1.47e-1)" "unprognostic (4.75e-2)" "unprognostic (1.31e-2)" "unprognostic (1.28e-1)" "unprognostic (6.59e-2)" "unprognostic (7.59e-2)" "unprognostic (6.32e-2)" "prognostic favourable (2.10e-6)" "unprognostic (8.89e-2)" "unprognostic (1.73e-1)" "unprognostic (7.77e-2)" "unprognostic (3.96e-2)" 13.7 15.9 18.0 22.6 17.1 14.9 15.6 35.8 17.5 14.4 24.5 4.7 17.2 25.5 13.0 17.1 15.3 12.4 15.0 14.8 13.3 7.0 19.5 25.1 19.9 13.2 12.4 12.3 22.3 21.3 22.1 40.5 12.9 14.0 11.9 25.3 11.1 20.1 25.9 29.6 16.1 29.1 12.0 11.1 10.4 15.0 6.9 14.4 10.3 14.9 15.7 8.6 14.0 14.2 34.4 39.5 31.9 16.6 10.6 20.3 3.4 11.2 7.0 10.4 6.6 14.9 11.0 7.4 8.4 5.7 4.3 5.5 11.9 9.8 10.2 12.2 7.4 10.4 10.0 5.5 8.1 9.2 8.5 11.2 12.2 7.8 6.1 18.5 11.9 6.9 8.8 8.9 10.2 9.3 16.6 16.7 7.3 16.3 12.6 7.3 8.0 8.7 7.7 17.4 8.2 5.9 12.4 17.0 11.9 17.8 20.0 8.6 5.2 9.0 17.1 8.7 11.2 15.2 11.4 12.0 13.2 13.7 7.7 9.4 9.8 31.9 16.6 21.4 18.4 9.3 15.4 31.4 18.7 16.7 7.2 34.4 20.3 19.3 23.2 10.6 16.3 39.5 14.9 3.4 18.0 17.1 35.8 17.5 13.3 7.0 12.4 12.3 14.0 14.4 AKT2 ENSG00000105221 "AKT serine/threonine kinase 2" P31751 19 40230317-40285536 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Diabetes mellitus, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004204, HPA064521" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles, Cytosol" "CAB004204: AB_626659, HPA064521: " "unprognostic (6.13e-2)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "prognostic unfavourable (1.05e-6)" "unprognostic (2.85e-1)" "unprognostic (6.40e-3)" "unprognostic (9.59e-2)" "unprognostic (1.22e-2)" "unprognostic (2.98e-2)" "unprognostic (2.49e-2)" "unprognostic (3.02e-1)" "prognostic unfavourable (4.74e-4)" "unprognostic (1.30e-2)" "unprognostic (1.89e-1)" "unprognostic (3.28e-1)" "unprognostic (6.16e-2)" "unprognostic (2.00e-1)" 31.1 20.3 15.4 17.6 15.2 21.3 18.2 46.3 18.2 23.3 18.2 23.4 21.2 12.3 22.8 28.0 22.1 22.7 14.0 23.1 15.4 10.0 23.0 62.5 14.6 17.8 17.9 13.3 27.8 24.5 21.1 24.0 17.5 14.7 19.7 12.3 26.8 18.5 24.3 48.5 18.3 17.1 20.0 16.8 18.7 15.5 21.3 15.7 26.6 52.6 29.5 23.6 19.6 19.9 6.3 8.8 7.7 4.4 3.2 4.9 2.4 22.4 55.4 21.1 21.7 26.3 32.2 11.7 15.0 22.2 31.1 27.8 24.3 20.9 22.9 13.4 33.1 9.8 23.4 31.3 20.1 21.9 26.7 15.0 35.1 15.3 16.5 17.2 18.1 29.7 18.8 21.1 20.1 6.7 19.3 24.0 17.3 18.7 27.3 8.4 11.4 14.9 18.2 11.5 16.5 24.2 36.8 29.1 17.8 15.4 26.4 12.5 20.8 22.2 6.7 19.0 18.8 17.0 23.5 22.4 19.2 18.8 18.6 20.4 15.5 7.6 4.4 3.6 4.5 2.0 4.5 3.9 3.6 3.0 3.0 6.3 3.5 4.9 7.7 3.2 2.6 8.8 2.7 2.4 15.4 15.2 46.3 18.2 15.4 10.0 17.9 13.3 14.7 15.7 AL049629.2 ENSG00000284969 "CD59 glycoprotein " 11 33698261-33722467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "placenta: 65.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.0;HUVEC TERT2: 24.4;TIME: 29.9;U-2197: 25.5" "Group enriched" "Detected in some" 6 "memory CD8 T-cell: 1.6;T-reg: 2.5" "Lineage enriched" "Detected in single" 8 "T-cells: 2.5" HPA026494 Uncertain Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA026494: AB_1846321" 3.2 0.4 0.3 2.8 0.5 1.2 2.2 0.4 2.6 0.7 0.5 0.1 0.9 1.5 1.3 2.3 1.5 0.3 2.6 2.4 1.6 2.0 0.6 1.9 2.0 0.9 1.0 0.4 1.3 0.1 0.2 65.2 0.9 0.4 0.4 0.5 3.1 1.3 3.9 0.0 0.1 1.4 0.7 0.4 3.6 1.0 0.5 0.2 1.0 1.4 1.4 0.8 2.9 0.0 0.3 0.0 0.0 0.0 2.5 0.2 0.5 1.5 0.1 1.0 1.6 3.7 0.0 8.2 3.7 1.1 1.0 0.0 4.2 0.0 0.9 5.6 0.9 0.1 19.0 1.8 0.8 0.1 0.1 3.3 0.3 0.4 0.2 0.5 1.3 1.3 0.4 6.7 24.4 0.2 3.2 7.0 0.4 0.7 0.3 0.2 11.2 0.2 0.7 0.5 2.2 0.9 0.0 0.1 0.9 1.5 2.7 0.4 0.0 29.9 3.1 1.2 25.5 3.2 1.7 1.5 0.1 7.2 0.0 7.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 AL162231.1 ENSG00000187186 9 34664163-34666112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 68.6" "Cell line enhanced" "Detected in many" "HeLa: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069617 Enhanced Approved "Nucleoli,Endoplasmic reticulum,Vesicles" Vesicles "Nucleoli, Endoplasmic reticulum" "HPA069617: " "unprognostic (8.20e-3)" "unprognostic (3.13e-1)" "unprognostic (1.17e-2)" "unprognostic (2.03e-1)" "prognostic unfavourable (6.63e-5)" "unprognostic (2.30e-1)" "unprognostic (2.46e-2)" "unprognostic (9.22e-2)" "unprognostic (2.11e-1)" "unprognostic (2.55e-2)" "unprognostic (5.99e-4)" "unprognostic (8.02e-2)" "unprognostic (1.39e-5)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.08e-3)" "unprognostic (2.00e-2)" 3.0 6.9 12.1 2.1 21.6 1.8 2.9 6.9 20.2 2.3 1.8 1.9 1.1 2.8 4.0 13.9 1.8 1.8 2.2 9.1 11.8 9.5 4.9 2.5 2.2 1.4 9.6 12.2 7.8 6.2 3.4 13.1 2.3 7.0 3.7 1.2 1.8 4.6 2.1 21.9 2.2 2.0 3.8 5.0 1.0 1.4 68.6 5.3 0.6 3.5 2.0 0.7 1.5 2.5 4.0 11.8 12.0 2.5 3.5 2.9 1.6 0.3 5.9 5.4 7.0 4.5 2.2 4.9 4.7 1.4 2.9 3.4 0.9 2.3 0.0 0.6 3.1 1.3 3.5 1.6 0.5 12.6 0.6 0.0 27.7 1.7 1.1 2.5 4.4 2.4 1.9 1.8 1.8 0.8 3.1 7.2 2.1 0.0 0.5 2.6 4.5 1.5 0.0 5.2 0.9 5.3 0.0 5.6 9.1 3.3 1.1 7.9 2.8 7.2 1.1 10.4 14.5 3.3 1.1 7.7 2.6 1.0 12.9 1.5 14.3 12.0 2.5 2.6 1.8 1.3 1.7 4.0 2.3 1.0 0.8 1.6 2.9 1.5 3.5 3.5 0.8 11.8 2.0 1.6 12.1 21.6 6.9 20.2 11.8 9.5 9.6 12.2 7.0 5.3 AL592490.1 ENSG00000197991 13 61409858-61427849 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "brain: 1.6;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062669 Approved "Vesicles,Cytokinetic bridge" Vesicles "Cytokinetic bridge" "HPA062669: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL645922.1 ENSG00000244255 6 31927698-31952048 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 115.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.3;Hep G2: 1.5;Karpas-707: 2.4;U-266/84: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000951, HPA001817, HPA001832" Approved Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" "Endoplasmic reticulum, Vesicles" "Cell Junctions" "HPA000951: , HPA001817: AB_1078779, HPA001832: AB_1078778" "unprognostic (7.68e-2)" "unprognostic (1.86e-2)" 5.3 0.9 0.6 2.9 0.7 0.3 3.9 0.6 0.7 0.7 3.7 0.3 0.0 0.8 0.9 3.0 0.9 1.1 0.8 4.4 0.7 0.6 10.8 115.5 15.8 9.7 0.7 0.0 1.5 0.7 0.3 0.7 5.0 0.6 0.8 0.6 1.1 0.8 0.3 0.8 0.7 4.3 1.5 0.8 9.7 1.3 1.3 0.0 0.3 0.7 0.0 1.3 1.5 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.7 0.6 0.7 0.7 0.6 0.7 0.0 0.6 0.0 ALDH1B1 "ALDH5, ALDHX" ENSG00000137124 "Aldehyde dehydrogenase 1 family member B1" P30837 9 38392664-38398661 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 113.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021037 Approved Supported Nucleoplasm,Vesicles,Mitochondria 210000 Mitochondria "Nucleoplasm, Vesicles" "HPA021037: AB_1844724" "unprognostic (4.16e-1)" "unprognostic (1.98e-2)" "unprognostic (5.84e-2)" "unprognostic (1.55e-3)" "unprognostic (2.47e-2)" "unprognostic (4.48e-3)" "unprognostic (2.84e-3)" "unprognostic (2.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (1.00e-1)" "prognostic favourable (2.05e-4)" "unprognostic (1.04e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (1.17e-5)" "unprognostic (2.89e-2)" 7.4 4.9 2.1 16.8 2.1 0.6 5.4 1.1 5.4 5.8 25.4 1.7 6.1 7.0 27.3 10.7 21.6 16.7 30.8 11.6 3.1 2.0 18.0 55.2 3.5 5.9 2.4 2.0 12.2 14.6 1.4 1.4 1.6 3.0 22.7 11.5 5.2 5.9 18.2 19.4 3.0 11.2 113.9 2.7 2.8 15.8 7.8 1.7 1.6 6.3 7.0 2.0 54.5 8.3 5.9 9.4 1.2 10.5 7.5 10.2 5.1 23.9 22.3 6.9 11.0 9.8 11.7 5.5 11.5 5.8 9.7 10.0 14.9 4.7 15.1 6.9 16.1 3.4 22.7 24.3 9.7 16.9 9.8 7.5 16.4 44.2 7.1 11.9 8.5 13.9 5.3 7.9 6.9 9.2 21.6 14.8 14.7 9.1 0.0 4.8 20.5 10.0 4.9 41.8 11.5 8.7 10.8 15.1 7.0 8.7 5.8 6.7 5.5 9.3 6.2 11.2 18.6 9.3 14.3 2.2 4.3 6.0 5.8 12.2 7.6 0.2 4.2 0.2 7.3 9.1 10.2 5.9 7.0 6.6 9.4 3.1 5.8 6.8 1.2 7.5 10.5 1.3 4.8 5.1 2.1 2.1 1.1 5.4 3.1 2.0 2.4 2.0 3.0 1.7 ALDH3A1 ALDH3 ENSG00000108602 "Aldehyde dehydrogenase 3 family member A1" P30838 17 19737984-19748943 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6" "Cell line enriched" "Detected in some" 20 "A549: 321.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 1.8" "Cell type enhanced" "Detected in some" "NK-cell: 2.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB045957, HPA051150, HPA063783" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Vesicles" "CAB045957: AB_11127164, HPA051150: , HPA063783: " "unprognostic (3.11e-5)" "unprognostic (1.20e-2)" "unprognostic (1.08e-1)" "unprognostic (7.04e-3)" "unprognostic (4.36e-3)" "prognostic favourable (7.55e-5)" "unprognostic (3.12e-1)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.69e-3)" "unprognostic (5.54e-2)" "unprognostic (1.72e-1)" "unprognostic (3.84e-2)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (7.23e-2)" 0.7 0.1 0.2 0.8 0.4 0.0 0.5 0.2 0.3 1.3 0.9 0.8 0.3 1.3 0.2 0.4 88.2 1.2 3.8 0.2 0.4 0.0 0.4 0.4 26.0 0.2 0.2 0.3 0.6 0.2 0.0 0.3 0.2 1.8 0.5 0.6 0.5 26.7 0.3 0.4 16.2 0.6 0.3 0.3 0.3 49.9 0.3 0.2 0.2 0.2 106.6 70.3 1.6 3.9 1.1 0.3 0.0 0.0 2.4 0.7 0.1 0.0 321.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 16.1 0.0 0.1 0.0 1.9 0.0 0.8 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 5.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.3 1.1 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.1 0.2 0.4 0.2 0.3 0.4 0.0 0.2 0.3 1.8 0.2 ALDOC ENSG00000109107 "Aldolase, fructose-bisphosphate C" P09972 17 28573115-28577264 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 166.7;heart muscle: 56.9" "Cell line enhanced" "Detected in many" "RPMI-8226: 62.2;U-266/70: 42.9" "Cancer enriched" "Detected in all" 6 "glioma: 128.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003282, CAB020828, HPA067442" Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" 280000000 "Nucleoplasm, Nucleoli fibrillar center" "Vesicles, Cytosol" "CAB020828: , HPA003282: AB_1078130, HPA067442: " "unprognostic (2.90e-1)" "unprognostic (4.45e-3)" "unprognostic (5.69e-3)" "unprognostic (1.43e-1)" "unprognostic (3.56e-1)" "prognostic unfavourable (9.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (6.03e-3)" "unprognostic (3.90e-1)" "unprognostic (3.24e-2)" "prognostic unfavourable (1.29e-7)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.74e-2)" "unprognostic (1.23e-1)" 26.0 9.4 86.7 4.8 78.9 7.5 9.8 100.1 166.7 3.8 5.3 17.4 0.3 7.0 4.4 4.6 7.1 3.9 4.4 56.9 64.6 54.3 3.3 26.2 4.6 6.5 69.9 51.4 12.8 1.6 4.7 2.3 2.1 98.1 6.0 5.6 16.5 4.2 6.1 1.7 12.5 15.0 4.6 34.4 6.7 8.7 4.6 23.4 0.0 2.1 0.5 10.0 3.4 3.5 12.2 4.6 8.8 4.1 13.7 20.5 8.8 7.4 0.5 3.5 14.4 7.2 7.4 0.7 3.8 8.6 2.9 18.1 4.3 0.7 3.5 4.6 3.4 9.7 2.3 23.6 5.5 3.0 2.2 6.7 2.7 7.4 6.8 2.4 7.8 6.8 3.3 0.3 5.9 1.3 4.6 18.8 2.5 3.5 2.8 8.1 5.4 3.9 2.4 0.4 62.2 0.4 1.0 9.2 16.4 2.2 17.7 0.1 9.6 5.5 0.9 0.3 1.4 0.5 0.6 42.9 12.3 2.6 28.1 7.0 0.5 0.1 3.5 1.4 11.4 4.1 16.2 12.2 15.6 9.2 4.6 11.5 20.5 15.1 8.8 13.7 2.3 2.2 19.5 8.8 86.7 78.9 100.1 78.5 64.6 54.3 69.9 51.4 98.1 23.4 AMACR "P504S, RACE" ENSG00000242110 "Alpha-methylacyl-CoA racemase" Q9UHK6 5 33986178-34008108 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 68.0;liver: 63.6" "Cell line enhanced" "Detected in many" "U-266/70: 58.5;U-266/84: 30.5" "Cancer enhanced" "Detected in all" "prostate cancer: 34.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001809, HPA019527, HPA020912" Enhanced Supported "Vesicles,Plasma membrane" 65000 "Vesicles, Plasma membrane" "CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034" "unprognostic (8.96e-2)" "unprognostic (5.20e-3)" "prognostic favourable (7.11e-4)" "unprognostic (9.55e-2)" "unprognostic (1.39e-1)" "unprognostic (9.12e-3)" "unprognostic (1.68e-1)" "unprognostic (5.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.60e-1)" "unprognostic (5.59e-5)" "unprognostic (1.95e-2)" "unprognostic (5.52e-3)" "unprognostic (6.32e-2)" "unprognostic (3.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" 2.8 8.3 5.2 2.7 8.2 0.9 2.8 4.7 7.8 4.4 14.1 4.3 6.5 6.2 4.0 3.6 8.2 2.3 11.0 3.5 4.5 6.8 68.0 63.6 3.3 2.0 4.5 4.5 2.9 5.1 5.4 4.3 3.2 7.0 13.9 15.5 5.5 25.4 5.4 6.0 2.6 7.4 3.7 3.8 2.9 15.9 2.1 2.1 3.8 3.3 3.4 3.3 5.7 4.5 7.8 10.2 11.2 14.2 9.9 10.0 6.8 4.0 6.5 3.7 4.7 2.6 4.0 6.3 5.4 4.0 2.5 1.9 21.1 4.9 1.3 2.9 7.6 1.9 0.9 3.9 2.6 4.0 3.4 3.1 4.7 6.1 1.8 1.9 1.0 6.1 1.9 3.2 1.2 2.8 1.1 4.8 7.3 2.9 1.5 2.4 3.3 10.6 1.9 6.1 2.0 11.1 20.3 2.0 2.8 8.9 6.4 5.4 4.9 1.9 5.0 8.3 1.8 2.0 4.3 58.5 30.5 2.3 2.3 3.9 6.1 0.3 7.1 10.2 10.0 8.8 8.4 7.8 8.7 7.8 10.2 7.0 8.1 6.1 11.2 9.9 14.2 5.3 8.9 6.8 5.2 8.2 4.7 7.8 4.5 6.8 4.5 4.5 7.0 2.1 AMBN ENSG00000178522 Ameloblastin Q9NP70 4 70592256-70607288 "Disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 10.6" "Cell line enriched" "Detected in some" 8 "HEK 293: 12.1" "Group enriched" "Detected in some" 7 "cervical cancer: 2.6;endometrial cancer: 2.9" "Region enriched" "Detected in some" 5 "basal ganglia: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036099 Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "HPA036099: " "unprognostic (3.22e-1)" 0.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 2.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.1 0.0 1.2 0.2 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 10.6 0.0 2.0 0.0 0.4 0.1 0.0 0.4 2.0 AMBRA1 "DCAF3, FLJ20294, KIAA1736, WDR94" ENSG00000110497 "Autophagy and beclin 1 regulator 1" Q9C0C7 11 46396414-46594125 "Predicted intracellular proteins" "Autophagy, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017825, HPA038535" Approved Approved Vesicles,Mitochondria Vesicles Mitochondria "CAB017825: , HPA038535: " "unprognostic (1.76e-3)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (1.56e-1)" "unprognostic (6.00e-2)" "unprognostic (1.87e-1)" "unprognostic (1.46e-3)" "unprognostic (7.78e-2)" "unprognostic (1.32e-1)" "unprognostic (1.98e-2)" "unprognostic (5.53e-3)" "unprognostic (2.32e-1)" "prognostic favourable (1.61e-4)" "unprognostic (2.90e-1)" "unprognostic (8.17e-2)" "unprognostic (1.61e-2)" "unprognostic (7.98e-2)" 15.4 26.4 15.8 18.4 20.6 19.4 20.5 25.6 24.6 16.6 15.4 23.5 12.0 18.9 18.7 15.1 15.5 18.0 15.5 13.1 14.5 11.4 13.7 14.6 14.7 15.0 15.5 18.4 21.4 13.7 33.5 23.2 17.8 15.8 15.3 14.0 20.2 17.0 20.4 18.7 25.8 17.0 17.4 12.7 17.4 15.7 18.9 17.4 26.3 16.9 10.8 18.2 14.6 14.9 3.4 3.0 12.9 2.9 2.0 4.5 2.2 6.8 18.5 12.8 13.8 13.6 10.2 8.0 6.8 13.2 11.2 11.8 13.9 12.1 13.9 7.1 12.2 12.5 6.4 12.1 8.3 12.0 20.8 9.4 11.7 17.7 8.9 13.6 12.1 14.1 9.6 7.1 13.6 11.6 16.2 9.6 8.3 16.9 17.3 9.6 21.4 10.2 17.0 17.5 7.7 10.9 12.4 10.4 11.6 11.9 13.6 12.5 14.1 9.2 12.3 10.4 9.3 12.0 10.2 11.0 8.7 14.5 9.2 7.7 9.2 12.9 2.9 2.2 3.8 1.5 3.2 3.4 2.8 2.9 2.8 3.4 2.9 2.6 3.4 2.0 2.6 3.0 4.5 2.2 15.8 20.6 25.6 24.6 14.5 11.4 15.5 18.4 15.8 17.4 AMER1 "FAM123B, FLJ39827, RP11-403E24.2, WTX" ENSG00000184675 "APC membrane recruitment protein 1" Q5JTC6 X 64185117-64205744 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065214, HPA065265" Approved Supported "Nuclear bodies,Vesicles,Plasma membrane" "Nuclear bodies" "Vesicles, Plasma membrane" "HPA065214: , HPA065265: " "unprognostic (1.56e-2)" "unprognostic (8.85e-2)" "unprognostic (6.86e-2)" "unprognostic (2.74e-1)" "unprognostic (2.12e-2)" "unprognostic (1.86e-1)" "unprognostic (3.57e-2)" "unprognostic (1.48e-1)" "unprognostic (8.02e-2)" "unprognostic (1.75e-1)" "unprognostic (6.31e-2)" "unprognostic (3.43e-1)" "unprognostic (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (1.13e-1)" "unprognostic (6.19e-2)" "unprognostic (2.89e-1)" 3.0 3.4 3.0 2.8 5.6 2.3 3.0 8.8 4.9 6.8 4.7 3.1 7.8 3.3 9.8 11.3 6.9 5.2 2.4 3.5 3.0 3.4 4.2 7.1 2.8 2.6 4.5 1.6 15.5 8.1 5.1 3.9 2.0 6.3 4.5 3.2 6.8 7.0 5.3 9.0 4.8 3.7 6.6 2.9 3.7 5.1 1.4 4.3 2.4 3.4 6.5 3.4 4.3 5.7 0.4 0.2 0.0 0.3 2.0 1.0 0.1 2.9 2.2 5.6 4.5 2.2 2.1 4.5 1.4 1.2 2.0 1.3 7.1 1.0 5.6 1.8 2.9 4.1 12.0 3.9 2.0 2.6 2.4 3.4 4.4 4.5 1.6 7.2 0.9 3.0 5.2 1.5 3.1 1.2 5.2 5.7 1.1 3.4 4.7 3.9 15.1 4.3 11.3 9.2 4.1 0.9 0.9 2.5 3.8 3.5 4.8 1.9 1.5 2.1 0.7 2.5 5.8 6.5 1.8 2.9 2.0 4.3 1.1 8.2 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.4 0.0 0.4 0.0 0.3 1.0 0.0 0.0 2.0 0.0 0.2 0.9 0.1 3.0 5.6 8.8 4.9 3.0 3.4 4.5 1.6 6.3 4.3 AMH MIS ENSG00000104899 "Anti-Mullerian hormone" P03971 19 2249309-2252073 "Disease related genes, Predicted secreted proteins" "Differentiation, Gonadal differentiation" "Growth factor" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 35.7" "Cell line enhanced" "Detected in some" "HEK 293: 17.4;NTERA-2: 6.7;REH: 6.9;SH-SY5Y: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA066973 Approved Vesicles,Aggresome "Secreted to blood" 56000 "Vesicles, Aggresome" "HPA066973: " "unprognostic (8.10e-5)" "unprognostic (1.15e-1)" "prognostic unfavourable (9.21e-5)" "unprognostic (8.73e-3)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "unprognostic (8.03e-2)" "unprognostic (8.99e-2)" "unprognostic (2.55e-1)" "unprognostic (3.53e-1)" "unprognostic (5.95e-3)" "unprognostic (1.34e-2)" "unprognostic (8.73e-8)" "unprognostic (4.64e-2)" "unprognostic (4.14e-2)" "unprognostic (2.15e-1)" "unprognostic (2.76e-1)" 0.3 0.2 1.0 0.3 2.8 0.3 0.3 4.8 1.4 0.3 0.5 0.3 0.3 0.2 0.4 0.6 0.3 0.2 0.3 0.3 0.5 1.3 0.3 0.3 0.4 0.5 0.3 0.3 1.1 0.7 0.2 3.5 0.4 0.3 0.3 0.2 0.3 0.3 0.3 2.6 0.4 0.6 0.3 0.3 0.5 0.6 35.7 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.1 0.4 0.0 0.0 4.4 0.7 0.0 0.0 0.0 0.1 0.2 0.5 1.7 0.0 0.0 0.0 0.0 0.0 2.9 17.4 0.1 0.6 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 2.5 0.4 0.0 0.5 0.1 1.3 6.7 1.5 6.9 1.4 0.9 0.0 0.2 0.5 8.0 0.1 0.0 1.5 0.8 0.0 0.7 0.6 1.3 0.9 2.5 4.9 3.6 0.8 0.3 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.8 4.8 1.4 0.5 1.3 0.3 0.3 0.3 0.3 AMHR2 "MISR2, MISRII" ENSG00000135409 "Anti-Mullerian hormone receptor type 2" Q16671 12 53423855-53431534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 27.1;ovary: 38.2;testis: 15.2" "Group enriched" "Detected in some" 18 "HEL: 27.6;K-562: 15.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "hippocampal formation: 14.3" "HPA060228, HPA069636" Approved "Nucleoplasm,Vesicles,Centriolar satellite,Cytosol" Vesicles "Nucleoplasm, Centriolar satellite, Cytosol" "HPA060228: , HPA069636: " "unprognostic (5.79e-2)" "unprognostic (3.65e-1)" "unprognostic (3.98e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-3)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.32e-1)" "unprognostic (2.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.97e-1)" 0.3 27.1 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.6 0.4 0.2 0.4 0.8 0.2 0.0 0.2 1.1 0.3 0.2 0.2 0.2 38.2 8.8 0.1 0.2 0.2 0.3 0.4 0.0 0.2 0.2 0.2 2.5 0.0 0.4 0.5 0.2 3.7 0.3 15.2 0.2 0.2 0.2 0.5 0.3 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 27.6 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 ANAPC1 "APC1, MCPR, TSG24" ENSG00000153107 "Anaphase promoting complex subunit 1" Q9H1A4 2 111611639-111884690 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036329, HPA036330, HPA042998" Approved Approved Vesicles Vesicles "HPA036329: AB_10670714, HPA036330: , HPA042998: " "unprognostic (1.74e-1)" "unprognostic (5.04e-2)" "unprognostic (1.10e-2)" "prognostic unfavourable (1.34e-4)" "unprognostic (3.49e-1)" "unprognostic (2.15e-1)" "unprognostic (2.16e-4)" "unprognostic (1.23e-1)" "unprognostic (3.94e-2)" "unprognostic (2.59e-1)" "unprognostic (3.65e-2)" "unprognostic (1.23e-1)" "unprognostic (2.13e-2)" "unprognostic (1.94e-1)" "unprognostic (1.98e-1)" "unprognostic (1.15e-2)" "unprognostic (1.92e-1)" 4.9 4.4 3.2 6.1 4.4 4.3 5.8 6.0 4.6 4.9 6.0 5.6 5.6 2.5 6.5 5.2 3.4 4.5 3.5 3.2 3.8 4.0 4.1 7.5 3.0 6.7 5.3 8.7 4.1 4.8 4.1 7.3 4.7 3.7 7.5 5.2 5.5 4.8 2.9 6.0 4.5 6.5 3.9 8.4 5.4 4.9 6.3 5.6 0.7 3.0 6.4 8.7 4.5 18.1 12.9 14.5 10.1 6.1 8.1 14.3 11.0 7.9 13.6 11.9 25.8 11.7 30.9 9.0 9.8 15.6 21.9 12.0 17.3 13.8 12.4 33.1 12.4 13.9 6.3 35.9 11.9 5.6 5.7 20.0 18.8 12.3 31.0 13.6 9.2 7.6 20.8 9.1 22.0 11.1 21.8 16.9 17.6 7.4 17.4 11.9 6.9 11.2 9.9 9.5 6.4 12.3 8.6 11.3 12.8 9.6 11.4 10.5 21.0 28.3 9.5 15.2 9.6 0.0 2.7 0.7 5.9 3.0 8.7 6.3 5.3 5.0 5.6 4.2 8.6 7.3 0.5 6.4 2.4 2.2 2.3 4.5 ANAPC15 "APC15, C11orf51, DKFZP564M082, HSPC020" ENSG00000110200 "Anaphase promoting complex subunit 15" P60006 11 72106378-72112780 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036596 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA036596: AB_10671961" "unprognostic (1.17e-1)" "unprognostic (5.83e-2)" "unprognostic (4.23e-2)" "unprognostic (3.05e-2)" "unprognostic (1.86e-2)" "unprognostic (2.09e-2)" "prognostic unfavourable (4.37e-4)" "unprognostic (9.18e-2)" "unprognostic (3.35e-2)" "prognostic favourable (2.55e-4)" "unprognostic (9.34e-3)" "unprognostic (1.76e-1)" "unprognostic (1.26e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.77e-1)" "unprognostic (9.08e-2)" 10.7 14.9 29.5 13.8 30.1 40.3 14.0 9.1 32.5 9.9 20.0 13.7 13.2 14.9 15.3 19.9 17.2 13.4 13.3 22.2 23.6 19.8 16.0 16.9 12.2 19.5 25.2 20.6 8.0 16.6 9.4 11.7 12.7 19.3 17.4 20.5 11.6 18.2 20.6 41.5 14.1 14.8 21.8 17.7 14.4 15.1 22.1 12.6 22.5 21.6 23.1 20.9 12.8 9.4 27.0 45.6 39.9 52.7 20.5 44.0 35.5 19.7 29.9 24.5 15.5 7.3 11.9 11.6 21.1 19.4 34.1 22.7 34.9 21.6 26.7 20.6 30.0 33.7 36.9 39.5 32.3 17.1 17.5 30.4 34.2 22.6 8.7 29.5 28.5 12.4 15.7 19.3 25.9 22.3 22.0 18.6 22.1 34.0 56.6 27.5 19.8 17.3 24.0 60.9 18.1 29.3 13.8 17.4 15.2 21.7 21.3 33.5 24.9 15.8 20.2 15.7 20.7 31.0 22.3 19.1 18.5 34.1 9.6 23.7 8.7 7.5 52.7 39.9 24.0 33.4 25.4 27.0 30.9 27.9 45.6 19.9 37.1 33.9 21.7 20.5 30.4 36.6 44.0 35.5 29.5 30.1 9.1 32.5 23.6 19.8 25.2 20.6 19.3 12.6 ANGPTL4 "ARP4, FIAF, HFARP, NL2, PGAR, pp1158" ENSG00000167772 "Angiopoietin like 4" Q9BY76 19 8363289-8374373 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 55.5;liver: 68.4;pancreas: 51.7" "Cell line enhanced" "Detected in some" "ASC diff: 16.1;HBEC3-KT: 64.0;LHCN-M2: 17.3;TIME: 32.2;U-138 MG: 19.0" "Cancer enhanced" "Detected in all" "renal cancer: 212.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 5.8;neutrophil: 2.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 5.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007879, CAB033770" Approved Approved Nucleoplasm,Vesicles "Secreted to blood" 7750000 1500000 "Nucleoplasm, Vesicles" "CAB033770: AB_2057427, HPA007879: AB_1078158" "unprognostic (1.26e-1)" "unprognostic (5.29e-3)" "prognostic unfavourable (7.53e-4)" "unprognostic (1.88e-2)" "unprognostic (7.68e-3)" "unprognostic (3.58e-1)" "unprognostic (1.03e-2)" "prognostic unfavourable (9.50e-4)" "unprognostic (3.18e-1)" "unprognostic (3.90e-3)" "unprognostic (9.69e-3)" "unprognostic (2.87e-1)" "prognostic unfavourable (1.34e-5)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.00e-2)" 55.5 9.6 23.3 13.5 24.7 2.3 33.0 5.1 37.6 3.3 11.8 9.2 0.3 10.6 5.9 1.5 11.8 3.2 8.8 11.4 17.1 5.5 9.4 68.4 9.0 2.7 21.4 3.1 2.9 51.7 2.3 3.3 21.4 36.8 6.7 2.1 2.5 3.9 3.7 5.9 6.5 23.5 6.0 20.6 2.5 4.4 3.7 27.7 0.0 7.1 2.5 3.5 10.7 6.0 0.5 0.3 5.8 0.4 0.8 0.6 0.2 0.0 0.6 0.3 0.9 16.1 3.5 0.1 1.2 0.1 0.2 0.0 0.0 5.9 0.0 8.8 2.4 0.8 0.0 64.0 0.1 0.5 0.1 0.1 0.2 0.1 0.3 0.0 0.0 1.6 0.2 9.8 0.2 4.9 0.3 0.2 17.3 0.5 0.0 0.5 0.1 0.5 0.3 0.0 0.2 3.2 1.1 0.0 0.1 7.4 0.7 1.1 1.9 0.1 32.2 19.0 0.1 9.5 0.0 0.0 0.0 0.0 13.0 0.0 3.5 5.8 0.4 0.9 0.4 0.2 0.3 0.5 0.5 0.4 0.2 0.4 0.3 0.3 2.3 0.8 0.2 0.3 0.6 0.2 23.3 24.7 5.1 37.6 17.1 5.5 21.4 3.1 36.8 27.7 ANKRD13B FLJ25555 ENSG00000198720 "Ankyrin repeat domain 13B" Q86YJ7 17 29589769-29614761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.9" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.1;SH-SY5Y: 31.6;SK-BR-3: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051886, HPA063748" Uncertain Supported Vesicles Vesicles "HPA051886: AB_2681652, HPA063748: " "unprognostic (1.61e-1)" "unprognostic (2.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.66e-2)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (3.10e-4)" "unprognostic (1.84e-1)" "unprognostic (1.84e-1)" "unprognostic (1.03e-2)" "prognostic favourable (7.58e-4)" "unprognostic (3.94e-2)" "prognostic unfavourable (5.92e-6)" "unprognostic (9.93e-2)" "unprognostic (1.18e-1)" "unprognostic (3.94e-2)" "unprognostic (5.36e-3)" 8.0 6.6 10.2 4.2 14.3 2.6 12.0 34.9 28.6 7.2 4.2 16.4 2.6 2.7 12.3 3.5 5.4 9.9 7.5 6.4 12.4 9.3 1.7 1.1 3.9 3.6 14.7 10.0 10.5 3.6 5.5 6.9 2.7 7.7 5.2 2.7 3.4 4.8 4.8 8.5 10.0 3.3 8.2 13.7 3.1 3.5 16.1 12.7 2.0 2.8 2.2 2.2 7.2 8.5 0.7 0.3 0.0 0.0 0.1 1.6 0.1 3.6 7.7 8.2 17.4 4.6 4.3 2.7 0.9 0.6 1.4 1.6 3.5 0.6 4.1 3.4 1.6 13.6 4.8 4.0 0.2 6.9 16.4 2.2 15.1 2.9 1.7 1.9 2.4 4.0 5.2 1.4 2.7 6.0 3.4 3.4 1.4 3.5 10.3 4.9 6.6 6.0 16.6 5.0 11.5 1.7 1.6 28.1 31.6 3.0 24.3 2.8 3.9 2.4 4.3 3.7 4.0 3.9 3.6 5.7 7.4 5.0 2.5 6.7 2.6 0.0 0.0 0.0 0.2 0.0 0.8 0.7 0.0 1.6 0.3 0.1 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.1 10.2 14.3 34.9 17.5 12.4 9.3 14.7 10.0 7.7 12.7 ANKRD2 ARPP ENSG00000165887 "Ankyrin repeat domain 2" Q9GZV1 10 97572499-97583884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 472.2" "Cell line enhanced" "Detected in some" "A-431: 14.5;BJ hTERT+ SV40 Large T+: 5.4;HaCaT: 11.5;RPTEC TERT1: 12.8" "Cancer enhanced" "Detected in many" "testis cancer: 5.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 18 "granulocytes: 1.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040842, HPA040884" Enhanced Enhanced Vesicles Vesicles "HPA040842: AB_10963794, HPA040884: AB_10969453" "unprognostic (1.27e-2)" "unprognostic (9.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.39e-2)" "unprognostic (1.37e-1)" "unprognostic (1.61e-2)" "unprognostic (2.53e-1)" "unprognostic (5.60e-3)" "unprognostic (2.17e-1)" "unprognostic (3.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.22e-1)" "unprognostic (1.05e-2)" "unprognostic (3.69e-3)" "unprognostic (4.56e-2)" "unprognostic (1.39e-1)" "unprognostic (2.13e-1)" 2.3 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.2 2.7 0.0 0.1 47.2 0.0 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.3 472.2 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 3.0 1.2 1.1 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 14.5 5.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 5.4 3.5 0.2 4.5 0.0 0.6 0.1 11.5 0.0 3.9 3.6 0.1 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.6 1.7 3.2 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.8 0.7 0.0 0.0 0.0 3.7 0.0 1.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 ANKRD26 "KIAA1074, THC2" ENSG00000107890 "Ankyrin repeat domain 26" Q9UPS8 10 26991914-27100498 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA040654, HPA041460" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA040654: AB_10795370, HPA041460: AB_10795120" "unprognostic (1.92e-1)" "unprognostic (3.41e-1)" "unprognostic (2.99e-1)" "unprognostic (1.46e-1)" "unprognostic (1.02e-1)" "unprognostic (2.09e-2)" "unprognostic (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (1.01e-1)" "unprognostic (4.08e-2)" "unprognostic (1.53e-2)" "unprognostic (1.03e-2)" "unprognostic (2.53e-3)" "unprognostic (5.35e-2)" "unprognostic (1.04e-2)" "unprognostic (1.99e-2)" "unprognostic (2.99e-1)" 6.5 7.2 11.8 5.0 18.2 3.8 9.2 16.9 15.7 7.3 6.7 4.6 6.3 4.6 8.7 7.8 6.0 7.0 5.9 8.6 11.0 5.6 7.4 6.7 5.5 8.3 9.0 10.7 10.0 6.2 10.1 24.4 7.5 9.9 7.6 7.2 6.6 7.0 8.6 14.1 7.0 5.4 6.0 7.0 6.6 5.6 9.7 8.4 6.4 9.1 4.7 6.2 7.0 7.3 3.4 5.0 1.7 1.0 3.4 4.6 0.5 7.8 5.1 9.4 5.8 6.1 7.3 4.3 9.4 3.6 8.8 8.5 4.9 5.6 18.1 3.2 4.5 8.4 9.2 4.5 10.6 7.7 7.4 1.2 7.1 8.2 4.4 4.2 2.0 5.6 3.8 9.0 3.3 7.8 12.9 5.2 9.6 4.7 5.2 4.1 4.0 3.4 5.9 13.0 4.7 6.4 2.8 8.9 4.9 8.7 2.4 9.3 8.4 2.7 6.3 8.2 5.6 9.7 5.5 2.4 2.9 11.5 6.7 10.9 3.4 1.7 1.0 0.2 2.3 0.7 2.0 2.8 2.7 2.5 1.2 3.4 4.6 3.9 0.6 3.4 1.0 5.0 1.4 0.5 11.8 18.2 16.9 15.7 11.0 5.6 9.0 10.7 9.9 8.4 ANKRD39 MGC41816 ENSG00000213337 "Ankyrin repeat domain 39" Q53RE8 2 96836611-96858095 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 71.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042678 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA042678: AB_10794532" "unprognostic (6.26e-2)" "unprognostic (1.32e-1)" "prognostic unfavourable (2.26e-4)" "unprognostic (9.53e-2)" "unprognostic (2.28e-2)" "unprognostic (2.09e-1)" "unprognostic (4.03e-2)" "unprognostic (1.68e-1)" "unprognostic (9.25e-2)" "unprognostic (3.12e-3)" "prognostic favourable (6.12e-5)" "unprognostic (6.15e-2)" "prognostic unfavourable (6.78e-9)" "unprognostic (3.16e-1)" "unprognostic (1.14e-1)" "unprognostic (5.03e-2)" "prognostic favourable (5.21e-4)" 8.9 16.2 17.1 9.2 19.2 12.0 6.9 29.4 20.8 7.4 8.3 15.0 7.2 11.2 11.7 5.9 7.6 10.9 7.9 17.6 14.8 14.7 6.5 12.6 7.6 13.0 13.5 14.0 7.3 11.2 11.7 14.2 7.4 13.4 10.4 5.6 10.3 9.5 10.1 6.3 10.9 8.4 9.5 10.7 8.9 7.9 3.7 13.0 5.4 6.3 4.3 8.7 9.0 5.8 15.5 29.0 7.1 9.0 14.4 27.8 8.7 6.2 4.1 2.4 5.2 0.8 1.6 5.7 4.9 2.3 6.1 4.7 10.2 2.6 4.0 7.3 3.5 2.7 3.0 4.6 1.3 4.6 9.1 2.8 3.7 13.8 4.1 6.5 7.1 3.0 2.7 5.6 2.1 4.4 6.0 71.9 2.2 9.9 6.0 5.0 3.0 9.6 4.6 1.7 22.5 3.1 3.2 5.5 3.6 3.5 8.3 6.2 2.5 3.5 2.1 3.8 3.8 4.3 8.6 3.7 4.0 6.5 3.9 7.5 4.0 7.1 6.9 5.3 19.6 8.3 16.4 15.5 19.4 17.2 6.8 13.6 10.8 13.3 3.5 14.4 9.0 29.0 27.8 8.7 17.1 19.2 29.4 20.8 14.8 14.7 13.5 14.0 13.4 13.0 ANKRD6 KIAA0957 ENSG00000135299 "Ankyrin repeat domain 6" Q9Y2G4 6 89433170-89633834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.8" "Cell line enhanced" "Detected in many" "AF22: 10.0;BEWO: 30.6;HAP1: 9.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.0;intermediate monocyte: 2.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020693, HPA035694, HPA064642" Approved Enhanced Vesicles Vesicles "CAB020693: , HPA035694: , HPA064642: " "unprognostic (3.80e-1)" "unprognostic (3.16e-2)" "unprognostic (2.39e-3)" "unprognostic (2.03e-1)" "unprognostic (1.36e-1)" "unprognostic (3.06e-2)" "unprognostic (2.91e-2)" "unprognostic (3.29e-2)" "unprognostic (4.95e-2)" "unprognostic (2.09e-1)" "unprognostic (7.84e-2)" "unprognostic (2.26e-1)" "unprognostic (1.81e-1)" "unprognostic (1.43e-3)" "unprognostic (2.28e-1)" "unprognostic (3.01e-1)" "unprognostic (2.10e-1)" 3.9 2.2 11.7 3.0 7.8 1.6 3.9 47.8 17.8 5.7 2.9 2.8 1.1 1.0 6.1 4.4 4.9 11.7 5.7 8.9 7.8 9.1 5.4 4.5 5.7 2.5 4.2 12.0 15.6 4.3 9.3 4.2 4.3 7.3 3.6 1.1 6.6 7.7 2.3 4.0 1.9 1.8 5.4 5.0 2.0 2.6 6.1 3.7 2.0 5.6 3.3 2.5 4.4 4.0 0.3 0.1 3.0 2.9 0.6 1.0 0.3 0.0 1.2 10.0 4.2 0.1 0.4 30.6 0.1 0.1 0.0 0.6 0.3 0.8 0.0 1.0 0.0 0.0 9.1 5.1 0.4 0.0 6.8 3.6 0.0 0.3 0.1 0.0 1.4 0.6 1.4 0.0 0.0 1.0 0.3 2.3 0.0 1.1 0.1 0.3 2.8 1.0 3.6 0.0 0.0 1.5 5.1 6.6 2.3 0.8 6.7 3.3 1.9 2.2 0.0 1.6 0.6 0.1 0.8 0.3 0.0 0.0 0.1 0.0 1.2 0.0 0.4 3.0 1.0 2.9 0.0 0.0 0.7 0.0 0.1 0.3 0.3 0.4 0.7 0.6 0.0 0.0 0.2 0.3 11.7 7.8 47.8 11.6 7.8 9.1 4.2 12.0 7.3 3.7 ANKS1B "AIDA-1, ANKS2, cajalin-2, EB-1" ENSG00000185046 "Ankyrin repeat and sterile alpha motif domain containing 1B" Q7Z6G8 12 98726457-99984654 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 66.2;skeletal muscle: 28.2" "Cell line enhanced" "Detected in some" "AF22: 11.8;ASC TERT1: 7.0;SCLC-21H: 12.9" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA044628, HPA078230" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "HPA044628: , HPA078230: " "unprognostic (5.50e-2)" "unprognostic (3.26e-2)" "unprognostic (1.01e-2)" "unprognostic (6.87e-3)" "unprognostic (1.18e-1)" "unprognostic (1.14e-4)" "unprognostic (7.94e-2)" "unprognostic (2.47e-1)" "unprognostic (1.84e-2)" "unprognostic (3.03e-2)" "unprognostic (4.97e-4)" "unprognostic (2.81e-1)" "unprognostic (1.14e-3)" "unprognostic (1.64e-2)" "unprognostic (1.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.75e-3)" 2.3 4.5 21.4 1.7 41.2 1.2 3.7 21.0 66.2 3.3 2.3 27.5 0.0 1.5 3.3 2.4 3.9 4.4 2.2 2.2 28.3 17.3 5.4 1.8 2.0 1.6 20.3 24.8 9.7 2.1 1.9 4.4 2.7 16.0 4.1 2.1 0.1 3.8 3.7 28.2 1.9 1.6 3.3 25.8 2.0 1.8 7.6 23.0 0.0 6.3 0.0 1.3 2.1 0.8 2.1 2.4 5.3 3.1 3.1 8.3 1.3 0.3 2.5 11.8 2.8 4.8 7.0 0.7 0.0 1.2 0.9 0.9 0.2 0.9 1.0 0.5 1.7 0.5 0.1 0.1 0.2 1.4 0.8 0.1 0.8 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.3 0.3 0.9 0.2 0.7 0.5 0.5 3.4 2.2 0.8 0.0 0.3 0.1 0.0 12.9 1.4 1.1 3.8 1.5 4.4 0.1 0.1 1.0 1.1 0.7 0.7 0.1 0.7 0.6 1.1 0.3 1.1 5.3 1.4 2.1 1.7 2.1 2.5 1.9 2.9 1.6 1.3 2.1 2.4 2.3 3.9 3.1 3.1 2.4 8.3 1.3 21.4 41.2 21.0 27.9 28.3 17.3 20.3 24.8 16.0 23.0 ANO10 "FLJ10375, MGC47890, SCAR10, TMEM16K" ENSG00000160746 "Anoctamin 10" Q9NW15 3 43354859-43691594 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016624, HPA051569" Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA016624: , HPA051569: " "unprognostic (1.51e-3)" "unprognostic (1.38e-2)" "prognostic favourable (6.70e-4)" "prognostic favourable (1.11e-4)" "unprognostic (4.23e-1)" "unprognostic (2.69e-2)" "prognostic unfavourable (3.19e-4)" "unprognostic (7.99e-3)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "prognostic favourable (6.41e-6)" "unprognostic (9.83e-3)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (5.71e-2)" 21.6 12.7 11.8 12.6 13.2 20.6 22.0 18.2 14.1 17.5 27.4 14.3 13.2 42.0 17.9 12.4 19.8 10.4 16.7 10.5 12.3 15.2 22.2 10.5 13.6 10.7 17.3 12.3 12.7 14.4 18.6 14.4 17.5 19.4 10.7 24.4 18.6 23.1 19.5 11.3 24.6 52.9 19.9 23.6 9.4 11.1 9.1 8.8 5.5 17.7 15.8 13.9 13.7 17.0 2.0 8.5 22.4 12.5 6.3 4.6 4.3 8.8 7.1 7.9 8.3 32.2 17.3 9.7 26.2 43.6 13.4 17.1 4.8 8.3 1.0 8.4 34.5 4.9 6.2 14.3 16.3 9.9 4.4 11.6 9.6 5.2 14.1 2.0 9.5 16.1 11.4 16.5 22.5 31.3 8.7 7.6 29.6 6.3 2.2 1.5 9.4 8.3 1.8 5.7 3.0 26.4 9.4 1.9 5.8 10.3 8.5 6.0 18.1 4.3 25.4 20.4 7.6 21.4 11.9 4.9 6.4 0.3 18.6 4.4 13.4 4.4 12.5 0.9 4.6 7.1 2.7 1.9 3.2 3.1 8.5 2.0 2.8 4.3 22.4 6.3 7.7 1.5 3.5 4.3 11.8 13.2 18.2 14.1 12.3 15.2 17.3 12.3 19.4 8.8 ANTXR1 "ATR, FLJ10601, FLJ21776, TEM8" ENSG00000169604 "Anthrax toxin receptor 1" Q9H6X2 2 69013178-69249327 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor Hypotrichosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 72.6;RH-30: 39.4;TIME: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054785 Uncertain Vesicles "Intracellular and membrane" 4100000 Vesicles "HPA054785: " "unprognostic (1.44e-1)" "prognostic unfavourable (5.76e-4)" "unprognostic (8.49e-2)" "unprognostic (4.77e-2)" "unprognostic (3.61e-1)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (4.15e-3)" "unprognostic (9.05e-3)" "unprognostic (1.15e-1)" "unprognostic (3.48e-3)" "unprognostic (2.26e-3)" "unprognostic (9.84e-2)" "prognostic unfavourable (1.22e-5)" "unprognostic (2.09e-2)" 27.5 25.8 10.0 10.1 14.9 0.1 21.1 11.0 9.6 33.4 14.2 23.6 8.5 4.9 35.7 13.5 14.0 20.7 51.5 18.8 17.0 10.1 6.1 3.1 20.1 4.4 19.4 6.5 45.5 3.1 30.5 10.4 32.3 23.6 21.7 8.8 37.2 13.8 23.0 12.4 17.9 8.9 30.4 21.4 11.7 7.4 6.6 16.7 2.6 17.5 10.4 6.7 29.1 24.5 0.0 0.1 0.1 0.0 0.2 0.4 0.0 6.8 8.6 7.6 4.8 35.4 17.3 0.1 11.2 23.0 12.0 9.6 0.0 0.6 0.0 6.6 29.7 6.5 5.3 6.7 11.3 0.0 4.3 1.8 19.2 2.2 15.7 1.5 1.0 28.1 2.7 11.8 7.4 3.3 1.1 0.0 72.6 3.1 4.2 0.1 7.2 5.6 0.0 39.4 0.1 2.9 6.0 4.3 19.4 21.9 0.1 7.7 2.2 0.4 49.3 15.2 12.8 15.3 11.9 0.0 0.0 0.0 7.9 1.3 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 10.0 14.9 11.0 9.0 17.0 10.1 19.4 6.5 23.6 16.7 ANXA10 ANX14 ENSG00000109511 "Annexin A10" Q9UJ72 4 168092515-168187690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 33.5;stomach 1: 105.3" "Group enriched" "Detected in some" 6 "PC-3: 41.0;RT4: 55.4" "Group enriched" "Detected in many" 5 "pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA005469 Enhanced Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Nucleoli" Vesicles "HPA005469: AB_1844849" "unprognostic (2.29e-2)" "unprognostic (8.71e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (4.69e-1)" "unprognostic (2.29e-2)" "prognostic favourable (3.64e-6)" "unprognostic (1.18e-3)" "unprognostic (2.88e-1)" "unprognostic (8.61e-4)" "unprognostic (3.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-3)" "unprognostic (8.41e-2)" "unprognostic (4.01e-1)" "unprognostic (2.04e-1)" "unprognostic (8.89e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 1.4 0.1 4.2 0.1 0.1 0.5 0.0 33.5 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 1.5 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 105.3 0.1 0.1 0.1 0.1 0.1 0.1 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.2 0.0 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 AP1B1 "ADTB1, AP105A, BAM22, CLAPB2" ENSG00000100280 "Adaptor related protein complex 1 beta 1 subunit" Q10567 22 29327680-29423179 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065226, HPA068520" Approved Enhanced "Golgi apparatus,Vesicles,Cytosol" 1000000 "Golgi apparatus, Vesicles" Cytosol "HPA065226: AB_2685438, HPA068520: AB_2685998" "unprognostic (1.78e-1)" "prognostic favourable (4.81e-4)" "unprognostic (2.40e-1)" "unprognostic (2.21e-2)" "unprognostic (2.37e-1)" "unprognostic (1.03e-1)" "prognostic unfavourable (5.55e-5)" "unprognostic (4.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.27e-1)" "unprognostic (4.98e-3)" "unprognostic (1.60e-1)" "prognostic favourable (7.24e-6)" "unprognostic (1.85e-2)" "unprognostic (3.78e-2)" "unprognostic (2.94e-2)" "unprognostic (3.76e-2)" 22.2 25.8 28.0 32.3 35.2 29.9 17.2 37.3 43.1 17.2 23.9 26.5 23.9 32.1 14.8 18.4 46.4 17.7 22.0 16.6 24.4 30.4 24.2 25.8 21.2 37.2 29.4 24.1 12.7 28.4 48.2 31.1 32.3 31.9 27.3 21.8 24.1 29.5 31.2 31.3 34.0 28.7 19.3 22.4 33.0 24.9 23.4 16.7 25.2 21.6 25.5 37.4 25.6 21.0 12.2 16.9 3.1 17.3 4.0 5.8 11.6 26.9 15.4 16.0 17.0 12.3 9.0 20.0 19.0 21.2 23.4 22.4 23.5 11.1 14.9 12.6 21.6 24.3 22.9 32.0 14.9 19.1 33.4 24.7 20.0 13.3 13.7 35.2 34.2 12.9 11.9 22.3 18.0 32.4 16.9 18.2 15.4 29.5 14.8 11.7 12.4 17.5 28.4 17.6 39.6 16.5 61.4 25.4 18.0 23.5 27.6 11.8 22.4 16.1 27.9 27.0 16.7 15.4 19.8 19.8 10.3 27.3 19.2 15.3 15.7 0.0 15.5 3.1 5.8 17.3 5.8 10.1 3.9 4.9 16.9 12.2 3.2 3.2 1.7 4.0 17.3 5.2 5.2 11.6 28.0 35.2 37.3 43.1 24.4 30.4 29.4 24.1 31.9 16.7 AP1G1 "ADTG, CLAPG1" ENSG00000166747 "Adaptor related protein complex 1 gamma 1 subunit" O43747 16 71729000-71809201 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009049, HPA041224" Approved Enhanced Vesicles,Cytosol 150000 Vesicles Cytosol "CAB009049: AB_2058329, HPA041224: " "unprognostic (4.84e-2)" "unprognostic (5.07e-2)" "unprognostic (2.65e-2)" "unprognostic (2.91e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (1.01e-1)" "unprognostic (8.90e-2)" "unprognostic (9.16e-2)" "unprognostic (2.72e-1)" "unprognostic (2.22e-2)" "unprognostic (4.30e-2)" "prognostic favourable (2.96e-8)" "unprognostic (1.27e-1)" "unprognostic (2.04e-1)" "unprognostic (5.68e-2)" "unprognostic (1.75e-1)" 23.2 29.8 20.4 19.2 26.3 59.1 22.4 31.8 29.2 19.7 20.4 29.2 19.8 19.2 19.6 23.9 30.1 17.9 18.7 14.5 18.5 17.4 32.8 29.5 23.8 20.0 24.2 20.1 18.3 25.6 53.5 27.4 25.1 27.9 20.8 23.4 20.8 28.2 20.2 30.0 27.7 24.4 16.0 20.3 24.3 24.8 26.5 26.7 30.0 23.1 21.8 28.3 18.1 20.1 7.5 8.5 17.6 8.8 7.6 9.0 4.2 16.2 23.8 18.3 18.6 19.7 18.7 15.9 16.9 16.2 22.7 21.9 22.9 18.1 20.2 16.3 23.0 20.8 24.8 18.6 30.6 8.1 12.7 13.2 12.5 17.4 11.6 15.8 43.9 15.6 13.2 30.2 18.7 19.2 17.5 8.6 22.2 29.0 14.6 13.3 16.7 10.4 23.6 14.7 21.6 21.2 18.7 16.9 10.1 20.9 13.2 9.4 23.1 12.5 22.6 19.5 15.2 10.4 12.3 13.6 17.5 41.8 15.7 12.8 16.6 5.8 7.9 10.9 8.3 8.8 8.3 6.3 7.3 9.0 8.5 7.5 5.9 7.2 17.6 7.6 6.8 6.0 7.3 4.2 20.4 26.3 31.8 29.2 18.5 17.4 24.2 20.1 27.9 26.7 AP1M2 "AP1-mu2, HSMU1B, mu2" ENSG00000129354 "Adaptor related protein complex 1 mu 2 subunit" Q9Y6Q5 19 10572671-10587315 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 34.7;Hep G2: 61.9;MCF7: 53.3;RT4: 33.2;U-2 OS: 34.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "basophil: 5.6;neutrophil: 9.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA054999 Supported Vesicles Vesicles "HPA054999: " "unprognostic (8.31e-2)" "unprognostic (2.38e-1)" "unprognostic (1.87e-1)" "prognostic favourable (2.07e-4)" "unprognostic (2.07e-1)" "unprognostic (7.76e-2)" "unprognostic (2.11e-3)" "unprognostic (4.83e-2)" "unprognostic (1.93e-1)" "unprognostic (2.49e-2)" "unprognostic (2.65e-1)" "unprognostic (2.23e-2)" "prognostic favourable (3.73e-6)" "unprognostic (1.80e-2)" "unprognostic (8.10e-2)" "unprognostic (2.05e-2)" "unprognostic (1.06e-1)" 1.6 0.2 1.0 6.1 0.7 0.0 9.1 0.6 0.8 7.5 24.5 0.8 44.4 17.3 1.8 20.4 22.2 12.9 34.4 0.6 0.6 0.3 37.3 1.2 10.5 0.6 0.6 0.6 4.7 33.5 16.0 16.1 31.5 0.8 12.5 17.7 0.6 28.4 36.4 1.2 15.3 38.2 1.1 0.6 0.6 20.4 10.3 0.6 3.0 36.6 17.5 14.2 9.6 7.7 0.0 0.3 9.4 1.7 0.0 0.2 3.7 28.3 14.4 0.0 2.1 0.0 0.0 13.4 0.0 0.0 0.4 0.3 34.7 16.7 0.0 13.5 0.2 19.8 0.0 22.1 0.6 0.1 0.2 1.3 10.1 61.9 0.2 0.0 0.1 0.0 16.8 0.8 0.0 0.0 0.0 0.1 0.2 53.3 0.1 0.3 6.4 0.0 0.5 1.9 0.1 0.5 33.2 14.0 0.0 0.0 24.6 0.1 25.2 0.0 0.0 0.1 34.9 0.2 0.4 0.0 0.1 0.2 0.0 0.0 0.0 5.6 0.5 3.5 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 9.4 0.0 1.7 0.2 0.0 3.7 1.0 0.7 0.6 0.8 0.6 0.3 0.6 0.6 0.8 0.6 AP1S1 "AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2" ENSG00000106367 "Adaptor related protein complex 1 sigma 1 subunit" P61966 7 101154400-101161596 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Deafness, Ichthyosis, Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060945 Supported Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA060945: " "unprognostic (1.98e-2)" "unprognostic (5.41e-3)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.98e-3)" "unprognostic (8.70e-3)" "unprognostic (7.06e-3)" "unprognostic (1.12e-1)" "unprognostic (1.76e-1)" "unprognostic (7.79e-2)" "unprognostic (1.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.81e-2)" "unprognostic (2.14e-2)" "unprognostic (1.74e-1)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" 7.6 9.7 30.6 7.9 41.1 3.0 10.8 7.9 45.8 6.8 16.5 6.4 4.6 23.3 6.6 10.6 10.9 8.9 9.3 4.2 22.9 14.6 16.6 15.5 6.7 6.9 12.3 25.3 7.9 8.0 6.3 10.5 10.2 10.1 10.9 14.2 4.6 10.4 6.1 3.5 12.3 18.0 7.9 8.7 7.7 13.2 6.9 9.3 4.7 9.3 7.4 8.5 8.7 6.1 4.4 8.2 2.1 5.5 1.9 5.9 4.2 26.2 21.3 14.3 27.1 10.6 17.5 31.1 17.6 11.9 12.0 12.8 11.4 33.5 5.9 30.8 19.2 13.0 8.2 27.1 10.7 13.3 13.3 4.0 13.4 14.2 13.1 10.7 19.9 19.5 20.7 11.8 5.1 17.7 12.8 23.7 29.6 65.4 8.9 23.1 22.9 43.0 5.6 6.5 12.3 28.8 22.4 11.3 37.0 10.0 26.6 32.1 11.7 10.0 18.3 17.3 30.2 6.5 12.1 5.3 11.2 11.3 44.0 11.9 34.8 0.8 5.5 0.5 4.2 4.9 3.7 4.4 5.9 4.7 7.4 3.8 3.5 3.2 2.1 1.9 2.8 8.2 5.5 4.2 30.6 41.1 7.9 35.1 22.9 14.6 12.3 25.3 10.1 9.3 AP1S2 "MRX59, MRXS5, PGS, SIGMA1B" ENSG00000182287 "Adaptor related protein complex 1 sigma 2 subunit" P56377 X 15825806-15854931 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 218.0" "Cell line enhanced" "Detected in many" "Karpas-707: 66.0;SK-MEL-30: 87.3" "Cancer enhanced" "Detected in all" "melanoma: 49.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 55.2;monocytes: 74.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049894, HPA060945" Enhanced Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA049894: , HPA060945: " "prognostic favourable (9.86e-4)" "unprognostic (4.62e-2)" "unprognostic (2.11e-1)" "unprognostic (1.68e-1)" "unprognostic (2.47e-3)" "unprognostic (3.85e-1)" "unprognostic (2.03e-3)" "unprognostic (5.76e-2)" "unprognostic (1.43e-2)" "prognostic favourable (5.53e-6)" "unprognostic (1.85e-2)" "unprognostic (5.61e-2)" "unprognostic (5.08e-2)" "unprognostic (6.35e-2)" "unprognostic (3.13e-1)" "unprognostic (9.34e-2)" "unprognostic (6.47e-2)" 10.1 8.2 21.2 11.7 17.9 12.6 9.7 13.0 17.6 12.0 17.3 9.8 12.6 4.8 25.7 218.0 9.8 5.6 7.0 34.2 12.7 19.9 5.2 5.8 8.9 11.6 16.1 11.8 4.5 4.1 8.2 11.7 13.1 39.7 5.5 8.0 13.3 5.1 13.2 41.4 5.0 8.7 24.9 18.5 14.1 9.9 8.6 11.4 9.8 10.7 8.6 9.6 8.5 5.9 8.2 55.2 12.5 74.9 5.5 8.4 44.8 3.3 2.8 31.9 15.7 6.0 4.1 1.1 10.0 4.7 7.8 10.0 2.0 3.5 5.7 44.7 14.6 3.9 8.8 2.7 13.0 8.1 14.1 3.4 5.0 3.1 5.3 12.7 3.8 2.4 2.8 7.4 7.6 15.6 3.1 66.0 14.0 1.8 3.3 6.7 42.5 10.5 7.2 23.3 11.5 8.7 0.8 3.9 15.5 4.5 1.3 87.3 14.9 13.0 8.2 13.3 5.1 18.5 9.3 7.6 17.3 12.1 7.1 5.7 32.3 8.2 74.9 8.0 5.6 67.8 5.4 8.2 5.7 4.5 55.2 7.5 4.1 4.0 12.5 5.5 34.7 17.9 8.4 44.8 21.2 17.9 13.0 17.6 12.7 19.9 16.1 11.8 39.7 11.4 AP1S3 ENSG00000152056 "Adaptor related protein complex 1 sigma 3 subunit" Q96PC3 2 223751686-223838027 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 50.0;epididymis: 64.5;seminal vesicle: 39.6" "Cell line enhanced" "Detected in many" "CACO-2: 55.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 8.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA066782 Approved Supported Vesicles Vesicles "HPA066782: " "unprognostic (9.45e-3)" "unprognostic (1.79e-1)" "unprognostic (7.52e-2)" "unprognostic (5.80e-2)" "unprognostic (4.37e-2)" "unprognostic (4.89e-1)" "unprognostic (1.65e-3)" "prognostic unfavourable (3.36e-5)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "prognostic unfavourable (2.08e-5)" "unprognostic (1.56e-1)" "unprognostic (2.33e-1)" "unprognostic (2.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.32e-2)" "unprognostic (4.61e-2)" 1.9 1.4 1.6 5.4 3.0 1.8 1.6 2.2 1.9 1.6 1.8 0.2 50.0 3.1 0.8 64.5 5.8 1.7 7.6 1.0 2.3 1.7 7.0 1.9 5.2 3.8 1.1 1.0 0.8 5.1 3.3 6.8 4.6 0.9 2.5 2.0 1.9 4.1 39.6 0.5 1.6 4.1 0.9 1.0 3.1 6.2 1.1 0.4 0.8 10.5 3.1 5.7 8.1 2.9 8.8 5.3 4.9 0.5 0.7 1.6 0.7 8.9 8.5 1.0 3.2 0.5 0.2 4.6 3.7 0.9 1.9 1.7 55.0 7.0 3.5 3.1 0.5 14.8 2.7 10.2 2.8 5.1 4.3 0.3 13.5 5.6 0.2 1.1 0.4 0.1 11.1 3.4 11.7 1.3 0.5 0.8 1.1 3.8 0.1 0.2 1.2 6.0 1.3 0.0 1.5 17.4 17.6 2.5 0.7 2.0 3.6 1.2 1.7 1.6 0.6 0.3 1.9 1.0 2.9 3.5 3.0 9.6 1.3 0.4 2.0 4.9 0.5 0.4 1.1 0.3 0.8 8.8 0.5 0.4 2.2 3.5 0.4 0.7 1.9 0.7 0.2 5.3 1.6 0.7 1.6 3.0 2.2 1.9 2.3 1.7 1.1 1.0 0.9 0.4 AP2A1 "ADTAA, CLAPA1" ENSG00000196961 "Adaptor related protein complex 2 alpha 1 subunit" O95782 19 49766968-49807113 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 15.8" "Lineage enriched" "Detected in all" 4 "monocytes: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB004306 Approved Supported Vesicles 300000 Vesicles "CAB004306: AB_2274034" "unprognostic (4.33e-2)" "unprognostic (1.52e-1)" "unprognostic (4.61e-1)" "unprognostic (7.18e-2)" "unprognostic (1.88e-1)" "unprognostic (1.23e-1)" "unprognostic (1.92e-2)" "unprognostic (5.85e-3)" "unprognostic (4.84e-1)" "prognostic unfavourable (2.91e-4)" "unprognostic (2.82e-2)" "unprognostic (2.38e-2)" "prognostic unfavourable (2.83e-9)" "unprognostic (2.63e-1)" "unprognostic (1.45e-1)" "unprognostic (7.90e-2)" "unprognostic (1.72e-3)" 26.5 37.8 23.7 21.7 34.3 40.9 19.8 32.2 58.6 18.4 15.9 22.2 11.5 22.3 25.2 13.1 23.0 23.0 17.9 23.7 21.5 22.0 15.2 31.7 15.3 23.7 20.1 28.2 26.1 22.5 10.3 15.1 29.4 37.6 15.3 9.7 16.5 16.5 18.8 39.6 26.2 22.8 19.8 18.1 22.8 15.8 48.5 14.6 15.5 13.2 14.3 13.5 20.1 18.0 1.1 3.9 3.4 15.8 2.0 1.8 3.0 23.1 33.5 11.6 26.7 20.9 25.5 23.7 27.5 18.8 17.1 17.9 17.2 14.7 10.4 10.5 28.4 21.1 8.7 19.8 7.3 16.3 19.8 15.4 22.5 18.5 23.0 12.3 25.8 40.1 14.5 19.0 9.9 20.2 38.3 14.5 16.1 18.3 13.4 16.4 11.8 34.5 15.3 27.3 13.2 10.1 29.5 8.9 11.9 30.3 21.1 11.4 17.7 17.5 27.8 44.6 24.7 18.6 19.5 21.7 26.7 10.9 31.4 18.1 18.6 0.2 3.9 2.6 1.8 10.9 1.3 1.1 1.1 1.1 3.9 0.9 0.9 1.1 3.4 2.0 15.8 1.2 1.5 3.0 23.7 34.3 32.2 58.6 21.5 22.0 20.1 28.2 37.6 14.6 AP2A2 "ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899" ENSG00000183020 "Adaptor related protein complex 2 alpha 2 subunit" O94973 11 924894-1012245 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017514, HPA043040" Supported Supported Nucleoplasm,Vesicles 93000 Vesicles Nucleoplasm "CAB017514: AB_2056344, HPA043040: " "unprognostic (1.90e-1)" "unprognostic (1.54e-1)" "unprognostic (2.20e-1)" "unprognostic (2.09e-2)" "unprognostic (1.28e-2)" "unprognostic (5.72e-2)" "prognostic unfavourable (9.27e-5)" "unprognostic (1.34e-2)" "unprognostic (4.09e-1)" "unprognostic (1.70e-1)" "prognostic favourable (4.57e-4)" "unprognostic (2.41e-1)" "unprognostic (2.86e-3)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" "unprognostic (1.40e-1)" "unprognostic (2.08e-2)" 21.9 11.1 20.2 8.7 20.7 18.4 23.2 50.9 32.4 17.5 13.9 9.5 10.4 16.8 16.3 8.5 12.2 21.5 10.1 14.7 22.6 20.0 19.4 16.3 13.3 18.1 16.1 21.1 11.2 14.7 7.8 15.5 16.3 16.9 15.5 16.3 11.5 21.7 14.7 13.3 16.5 12.0 18.5 18.1 34.5 17.0 16.4 6.7 12.4 12.1 5.0 9.1 10.5 10.5 3.4 3.7 6.8 4.6 3.4 5.4 1.7 5.5 2.5 3.0 8.7 11.3 11.6 7.3 7.9 2.7 4.9 4.0 0.9 6.0 5.8 6.9 9.4 7.3 7.0 4.4 3.1 4.2 18.1 1.7 7.7 3.0 4.4 2.2 4.1 13.7 4.8 2.4 4.9 6.7 5.8 4.5 4.9 0.5 2.0 2.5 1.7 14.1 3.5 2.0 6.3 7.4 5.0 9.4 8.0 8.9 7.3 1.1 4.2 0.8 10.5 1.6 1.9 2.2 4.0 3.6 2.9 4.3 3.0 2.8 2.4 3.3 4.6 3.8 3.1 4.6 1.8 1.7 3.2 1.8 3.7 3.4 3.4 3.5 6.8 3.4 3.8 3.7 5.4 1.7 20.2 20.7 50.9 32.4 22.6 20.0 16.1 21.1 16.9 6.7 AP2B1 "ADTB2, CLAPB1" ENSG00000006125 "Adaptor related protein complex 2 beta 1 subunit" P63010 17 35578046-35726409 "Cancer-related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017631, HPA056733, HPA067983" Approved Supported Vesicles 680000 Vesicles "CAB017631: AB_2058201, HPA056733: , HPA067983: " "unprognostic (1.49e-2)" "unprognostic (4.04e-3)" "unprognostic (2.15e-3)" "unprognostic (1.48e-1)" "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (1.51e-3)" "unprognostic (2.64e-2)" "unprognostic (1.06e-1)" "unprognostic (4.73e-2)" "unprognostic (2.58e-2)" "unprognostic (2.50e-1)" "prognostic favourable (2.62e-4)" "unprognostic (1.70e-1)" "unprognostic (1.10e-1)" "unprognostic (3.25e-2)" "unprognostic (1.57e-2)" 20.1 19.9 36.6 16.3 51.3 18.6 27.6 32.8 59.0 27.8 29.8 35.2 17.0 15.1 20.0 33.1 13.1 22.9 20.2 30.3 36.8 36.1 32.9 16.0 23.6 16.0 35.5 39.9 28.7 15.4 75.6 30.0 30.6 40.7 20.0 39.0 21.8 18.7 25.3 23.3 13.1 16.7 26.1 37.0 18.4 21.6 45.3 27.4 18.5 31.5 10.6 20.1 19.6 21.5 12.6 10.7 15.8 15.4 9.5 19.4 10.3 42.4 54.5 28.1 32.9 46.4 51.0 12.0 21.9 33.5 32.3 34.9 30.5 37.2 20.7 19.5 40.8 40.6 38.4 62.8 46.2 24.7 35.5 28.0 39.9 16.6 26.6 26.9 19.8 32.5 24.9 32.7 49.7 50.8 42.4 30.0 50.5 8.6 26.1 13.1 22.6 39.3 22.0 40.1 15.1 40.7 24.6 23.1 28.4 27.2 9.6 29.9 39.2 18.2 50.4 24.6 22.7 26.5 32.7 12.7 23.0 19.5 31.5 20.1 26.0 15.0 11.3 15.8 16.6 15.4 17.8 12.6 14.9 14.9 10.6 11.5 6.9 8.7 13.3 9.5 15.1 10.7 19.4 10.3 36.6 51.3 32.8 59.0 36.8 36.1 35.5 39.9 40.7 27.4 AP3S1 CLAPS3 ENSG00000177879 "Adaptor related protein complex 3 sigma 1 subunit" Q92572 5 115841481-115914081 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049270 Uncertain Approved Vesicles Vesicles "HPA049270: " "prognostic unfavourable (1.22e-4)" "unprognostic (2.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.68e-2)" "prognostic unfavourable (3.33e-4)" "unprognostic (2.60e-2)" "unprognostic (3.83e-3)" "unprognostic (4.42e-3)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "prognostic unfavourable (1.13e-5)" "unprognostic (1.73e-1)" "prognostic unfavourable (9.57e-8)" "unprognostic (2.73e-2)" "unprognostic (3.62e-2)" "unprognostic (2.75e-1)" "unprognostic (1.64e-1)" 22.0 13.8 28.6 15.0 28.6 33.0 26.1 21.7 30.8 30.8 22.5 10.4 60.4 17.6 20.6 27.6 23.4 16.7 17.0 17.0 30.7 21.1 11.7 23.8 12.7 18.3 23.7 19.4 23.3 34.8 9.1 20.9 20.9 19.8 15.3 20.8 9.7 26.8 64.1 8.5 15.7 28.9 28.7 20.6 11.5 12.8 26.9 13.2 12.1 19.0 12.7 20.1 21.6 19.7 20.1 23.8 39.8 21.9 11.8 17.1 15.4 19.5 5.0 16.5 8.2 42.5 69.8 10.8 22.9 31.9 20.3 36.0 9.6 18.3 14.9 12.9 28.5 5.7 9.0 38.1 30.3 44.2 15.6 6.5 6.6 14.4 24.3 9.3 12.9 30.9 30.5 16.1 15.3 20.5 6.9 11.5 26.4 4.0 11.2 11.8 10.1 9.5 13.9 23.5 26.0 19.4 5.7 5.8 8.0 32.7 6.2 18.8 11.0 10.6 14.1 27.4 16.7 20.5 15.2 8.5 9.1 17.6 22.5 21.5 10.1 17.6 18.5 39.8 10.9 21.9 17.0 20.1 13.8 14.8 15.4 13.0 12.3 12.4 26.7 11.8 19.0 23.8 17.1 15.4 28.6 28.6 21.7 30.8 30.7 21.1 23.7 19.4 19.8 13.2 AP3S2 sigma3b ENSG00000157823 "Adaptor related protein complex 3 sigma 2 subunit" P59780 15 89830599-89894638 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049270 Uncertain Approved Vesicles Vesicles "HPA049270: " "unprognostic (1.46e-1)" "unprognostic (1.60e-2)" "unprognostic (1.18e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "unprognostic (2.68e-1)" "unprognostic (3.78e-2)" "unprognostic (5.27e-2)" "unprognostic (3.03e-1)" "unprognostic (7.59e-2)" "unprognostic (1.22e-1)" "unprognostic (4.31e-2)" "prognostic favourable (5.55e-16)" "unprognostic (7.97e-2)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (8.67e-3)" 18.0 20.9 18.4 7.9 20.2 6.7 14.3 16.8 24.7 13.5 13.2 20.4 13.4 7.9 9.9 12.6 15.3 13.2 12.8 22.2 16.6 19.4 27.3 29.3 11.6 8.6 19.8 14.6 15.2 20.0 36.4 17.3 15.3 19.2 11.5 14.4 21.6 10.8 16.6 43.3 9.5 12.8 13.2 20.1 11.5 10.8 10.9 12.8 12.2 19.4 9.2 12.8 11.7 8.9 6.0 10.1 13.9 16.4 7.2 7.4 7.8 5.1 24.9 13.4 14.0 27.1 18.7 11.3 23.1 29.7 29.8 24.2 10.5 13.7 4.7 20.9 15.2 12.1 22.6 12.9 23.5 19.7 11.4 14.3 11.2 13.7 11.3 6.1 8.9 12.5 16.2 8.3 16.7 15.3 11.2 13.0 19.1 11.2 10.3 3.2 14.8 4.7 6.0 13.5 9.5 16.8 14.6 10.2 8.9 27.2 16.8 15.8 10.6 5.4 6.3 16.1 7.8 24.6 7.6 11.3 35.1 11.3 14.2 7.3 9.4 3.9 14.6 6.9 5.0 13.0 7.3 3.9 7.0 7.1 10.1 6.0 5.6 3.9 13.9 7.2 16.4 6.8 7.4 7.8 18.4 20.2 16.8 24.7 16.6 19.4 19.8 14.6 19.2 12.8 AP4B1 "BETA-4, SPG47" ENSG00000134262 "Adaptor related protein complex 4 beta 1 subunit" Q9Y6B7 1 113894748-113905201 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028162, HPA028652" Approved Approved Vesicles Vesicles "HPA028162: AB_10610976, HPA028652: AB_10601451" "unprognostic (8.90e-2)" "unprognostic (2.25e-2)" "unprognostic (1.77e-1)" "unprognostic (2.40e-2)" "unprognostic (1.53e-1)" "unprognostic (5.01e-2)" "prognostic unfavourable (8.60e-7)" "unprognostic (3.45e-2)" "unprognostic (1.54e-2)" "unprognostic (8.34e-3)" "unprognostic (1.55e-1)" "unprognostic (2.07e-2)" "prognostic unfavourable (3.73e-6)" "unprognostic (5.08e-3)" "unprognostic (7.88e-2)" "unprognostic (3.12e-1)" "unprognostic (1.55e-2)" 9.5 8.8 11.5 18.3 19.1 23.3 11.4 23.1 16.7 12.4 13.3 14.1 4.1 16.4 12.5 18.5 12.2 10.5 12.6 11.0 12.2 11.4 9.2 8.2 9.5 16.4 15.3 13.2 16.1 14.1 8.1 19.7 7.6 13.4 9.4 16.8 14.0 10.7 8.3 13.0 13.9 13.6 11.9 14.2 20.0 10.6 10.5 14.7 13.7 11.6 7.7 17.2 9.9 12.5 11.8 12.8 14.0 10.9 11.7 16.6 9.3 6.5 5.8 6.6 6.7 10.1 8.4 3.8 5.9 5.6 7.7 9.5 3.9 4.5 12.7 9.6 7.5 5.8 7.4 7.8 9.6 10.1 6.1 10.3 9.2 5.3 5.8 11.3 10.5 9.8 3.8 15.3 9.6 13.3 7.4 11.4 9.9 39.9 9.0 11.9 5.9 11.7 8.8 13.3 7.4 7.6 3.2 6.6 5.0 6.9 11.1 4.2 3.7 9.2 12.1 9.5 8.4 10.3 11.4 9.1 8.8 14.0 14.3 14.9 14.6 14.0 10.0 8.2 15.5 10.9 16.6 9.7 12.3 13.2 12.8 11.8 13.9 12.0 1.1 11.7 8.3 9.3 10.3 9.3 11.5 19.1 23.1 16.7 12.2 11.4 15.3 13.2 13.4 14.7 AP4S1 "AP47B, CLA20, SPG52" ENSG00000100478 "Adaptor related protein complex 4 sigma 1 subunit" Q9Y587 14 31025106-31096450 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039963 Approved Supported Vesicles Vesicles "HPA039963: AB_10795240" "unprognostic (4.03e-2)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (2.43e-1)" "unprognostic (1.14e-1)" "unprognostic (8.00e-3)" "unprognostic (1.03e-1)" "prognostic favourable (7.44e-4)" "unprognostic (3.79e-2)" "unprognostic (8.62e-3)" "unprognostic (1.15e-2)" "unprognostic (3.02e-1)" "prognostic favourable (2.87e-6)" "unprognostic (2.20e-3)" "unprognostic (5.44e-2)" "unprognostic (7.75e-2)" "unprognostic (5.59e-2)" 4.2 6.1 16.6 5.8 18.4 4.8 8.2 15.9 22.2 6.0 6.6 5.9 4.0 3.3 7.3 6.6 4.6 7.0 6.4 8.2 12.2 10.8 7.2 5.6 4.9 10.7 8.5 11.3 10.8 8.0 6.5 7.7 6.3 9.0 5.8 3.9 4.7 5.0 6.5 11.0 4.1 3.8 7.6 7.3 6.9 4.0 16.5 7.3 4.5 8.3 2.4 6.9 5.5 4.4 5.5 4.6 7.0 4.8 11.5 8.8 2.4 7.7 10.9 9.5 2.7 4.1 7.3 7.5 5.0 9.2 8.2 8.6 10.5 12.7 8.9 5.1 6.3 8.6 6.3 8.7 14.1 7.5 3.7 13.1 4.3 16.4 8.4 11.7 8.0 5.7 5.4 8.0 11.3 9.8 6.7 6.2 9.8 10.9 7.6 6.6 11.3 9.4 8.0 8.7 1.3 9.3 11.1 5.2 5.6 9.1 4.7 13.6 10.1 5.7 7.6 6.6 5.6 4.6 4.5 7.6 13.9 13.0 3.8 3.7 4.8 7.0 1.8 3.0 3.7 4.8 5.8 5.1 5.7 4.5 1.8 5.5 5.3 6.7 3.7 11.5 3.7 4.6 8.8 2.4 16.6 18.4 15.9 22.2 12.2 10.8 8.5 11.3 9.0 7.3 AP5B1 "AP-5, DKFZp761E198, PP1030" ENSG00000254470 "Adaptor related protein complex 5 beta 1 subunit" Q2VPB7 11 65775893-65780802 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 16 "neutrophil: 22.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065739, HPA067880" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Vesicles" "Golgi apparatus" "HPA065739: , HPA067880: " "unprognostic (3.64e-1)" "unprognostic (9.40e-2)" "unprognostic (4.37e-3)" "unprognostic (1.45e-2)" "unprognostic (5.56e-3)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "unprognostic (2.15e-1)" "prognostic favourable (2.31e-5)" "unprognostic (2.03e-2)" "unprognostic (2.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.67e-1)" 11.2 6.8 5.3 10.2 8.2 48.6 10.3 10.7 9.1 6.3 6.7 4.0 6.9 9.6 9.8 6.8 13.2 7.2 8.2 6.6 5.7 3.5 7.7 9.3 11.3 13.3 6.0 5.5 4.5 16.1 9.9 5.5 14.8 5.3 6.4 4.2 8.0 10.9 10.7 11.9 10.3 9.5 5.1 5.6 13.0 7.9 3.1 6.2 9.2 7.9 7.4 7.8 11.0 6.5 0.2 0.3 22.5 1.3 0.3 0.4 0.5 10.0 7.8 1.8 10.2 4.9 2.5 14.7 4.3 4.1 4.5 3.6 6.7 4.7 5.7 8.3 3.7 12.0 5.0 3.2 1.4 9.1 8.7 5.2 8.8 3.3 3.9 6.8 11.1 4.8 6.2 3.1 1.6 3.5 11.8 7.6 2.3 7.0 4.3 6.7 3.6 8.9 13.8 0.3 12.6 3.3 11.4 2.4 4.2 3.1 2.0 19.2 3.9 9.9 5.5 8.3 7.5 10.5 4.3 7.8 7.8 5.8 5.8 5.8 7.9 0.6 1.3 0.5 0.4 0.8 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 22.5 0.3 1.0 0.2 0.1 0.5 5.3 8.2 10.7 9.1 5.7 3.5 6.0 5.5 5.3 6.2 APBA3 "mint3, X11L2" ENSG00000011132 "Amyloid beta precursor protein binding family A member 3" O96018 19 3750819-3761699 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045577 Approved Approved Vesicles Vesicles "HPA045577: AB_10964881" "unprognostic (3.47e-2)" "unprognostic (3.58e-2)" "unprognostic (5.00e-2)" "prognostic favourable (5.97e-4)" "unprognostic (1.69e-1)" "prognostic favourable (4.91e-4)" "unprognostic (6.64e-2)" "unprognostic (7.60e-3)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "prognostic favourable (1.51e-4)" "unprognostic (5.58e-3)" "unprognostic (2.67e-3)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "unprognostic (6.12e-2)" "prognostic favourable (1.83e-4)" 10.2 7.8 5.4 12.7 8.3 6.3 7.6 8.6 7.2 7.8 8.6 10.5 11.9 11.7 9.0 4.0 8.0 6.9 7.8 7.1 5.1 4.3 8.8 14.2 7.0 12.9 11.9 7.3 10.7 10.3 4.6 10.0 7.2 7.1 8.0 3.0 6.7 16.8 9.6 20.5 8.6 11.7 8.5 6.1 14.1 11.7 6.0 9.1 13.2 11.5 7.2 11.8 8.0 7.1 13.0 8.1 10.8 7.1 6.5 18.8 8.2 7.3 5.6 1.2 2.2 2.4 1.9 6.1 4.7 2.9 2.5 3.7 5.1 2.3 4.9 4.2 1.9 3.4 1.3 4.1 0.6 18.3 4.3 2.8 3.8 3.7 7.8 1.8 10.9 3.7 5.0 3.3 2.1 3.6 4.7 8.1 1.1 4.0 5.6 7.0 3.5 8.1 5.8 2.6 8.2 1.8 4.7 4.5 4.7 3.0 4.4 6.9 1.9 4.1 5.8 4.5 4.2 7.6 6.0 16.8 6.1 4.6 4.1 5.6 4.5 8.7 7.1 10.8 13.8 5.5 12.8 10.2 13.6 13.5 8.1 13.0 9.0 10.5 10.4 6.5 4.6 7.7 18.8 8.2 5.4 8.3 8.6 7.2 5.1 4.3 11.9 7.3 7.1 9.1 APEX2 "APE2, APEXL2, XTH2, ZGRF2" ENSG00000169188 "Apurinic/apyrimidinic endodeoxyribonuclease 2" Q9UBZ4 X 55000357-55009057 "Enzymes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair" "DNA-binding, Endonuclease, Exonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048577 Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoplasm, Nucleoli fibrillar center" Vesicles "HPA048577: " "unprognostic (2.90e-2)" "prognostic favourable (6.17e-4)" "unprognostic (4.32e-2)" "unprognostic (2.39e-1)" "unprognostic (1.62e-1)" "unprognostic (5.62e-2)" "prognostic unfavourable (6.13e-7)" "unprognostic (5.89e-2)" "unprognostic (4.87e-2)" "prognostic favourable (5.21e-4)" "unprognostic (7.46e-2)" "unprognostic (3.16e-1)" "unprognostic (6.86e-2)" "unprognostic (1.03e-2)" "unprognostic (3.17e-2)" "unprognostic (1.40e-1)" "prognostic favourable (6.63e-4)" 11.1 12.8 8.6 12.0 12.3 11.9 10.2 8.7 11.8 10.0 12.3 13.7 8.2 12.3 11.5 12.6 20.8 10.7 13.9 10.6 8.7 7.2 15.4 18.5 10.3 14.2 9.7 6.0 14.4 10.7 10.7 12.7 17.8 8.8 11.0 15.1 9.1 10.4 10.0 10.3 16.7 18.7 10.0 9.9 18.0 10.8 7.7 8.9 21.9 10.6 10.2 27.4 11.6 12.7 6.7 9.4 9.2 9.9 26.6 7.5 6.3 22.0 19.8 7.9 11.4 11.5 7.7 13.4 9.1 12.3 17.6 17.3 10.8 18.6 14.6 14.3 8.5 16.6 18.0 17.3 13.4 11.8 13.7 17.7 19.8 10.9 7.4 10.9 16.8 7.6 14.2 24.9 9.0 14.0 9.1 9.9 13.1 21.5 14.7 14.3 15.6 24.0 13.1 13.1 15.9 9.5 11.1 7.3 8.0 17.2 20.9 8.8 16.4 8.5 8.1 10.5 15.2 21.1 11.8 10.3 13.3 12.1 11.2 18.7 12.4 9.2 7.8 8.5 7.5 9.9 6.2 6.1 7.1 7.4 9.4 6.7 6.4 6.2 2.9 26.6 8.3 5.1 7.5 6.3 8.6 12.3 8.7 11.8 8.7 7.2 9.7 6.0 8.8 8.9 APLP2 "APPH, APPL2" ENSG00000084234 "Amyloid beta precursor like protein 2" Q06481 11 130069837-130144811 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 52.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039319 Approved Approved Vesicles 480000 Vesicles "HPA039319: AB_10673141" "unprognostic (2.83e-2)" "unprognostic (1.29e-1)" "unprognostic (2.06e-1)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.10e-2)" "prognostic unfavourable (3.37e-4)" "unprognostic (3.86e-2)" "unprognostic (2.33e-1)" "unprognostic (2.70e-2)" "unprognostic (3.12e-3)" "unprognostic (7.44e-2)" "prognostic favourable (1.33e-9)" "unprognostic (3.20e-3)" "unprognostic (4.95e-2)" "prognostic favourable (2.90e-4)" "unprognostic (4.42e-2)" 72.4 32.9 41.4 29.8 48.5 35.2 43.9 106.0 61.4 39.8 44.9 29.0 31.8 56.6 48.7 42.4 36.2 37.9 51.1 55.6 35.6 49.7 79.2 73.8 82.2 27.3 39.7 43.0 42.0 28.4 76.9 22.3 67.6 48.2 63.4 39.0 105.5 35.4 65.9 17.3 27.3 52.1 46.0 40.9 24.3 33.2 18.2 26.0 12.5 128.7 21.0 17.0 51.0 46.7 12.3 26.0 36.5 52.5 3.6 4.7 25.8 17.8 15.0 27.1 24.3 113.6 74.9 33.9 51.0 62.2 25.5 21.7 111.7 130.7 8.9 133.9 124.2 46.2 20.8 48.5 14.5 13.9 17.3 15.3 11.0 42.8 17.5 46.1 31.2 50.2 31.8 22.4 42.9 78.3 14.6 19.1 42.0 17.7 2.3 20.7 15.8 25.3 5.9 6.3 8.6 68.0 49.9 9.5 20.8 61.5 32.6 7.9 49.8 42.7 134.8 27.5 18.8 42.8 24.6 3.0 4.2 20.9 31.0 42.3 19.5 8.7 52.5 14.3 4.5 28.8 3.4 3.4 3.3 4.2 26.0 12.3 2.5 3.3 36.5 3.6 20.8 2.4 4.7 25.8 41.4 48.5 106.0 61.4 35.6 49.7 39.7 43.0 48.2 26.0 APOA1 ENSG00000118137 "Apolipoprotein A1" P02647 11 116835751-116837950 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Amyloidosis, Atherosclerosis, Cancer-related genes, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 573.5" "Cell line enriched" "Detected in some" 18 "Hep G2: 247.4" "Cancer enriched" "Detected in many" 48 "liver cancer: 4515.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 4 "dendritic cells: 3.6;T-cells: 2.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB016778, HPA046715" Supported Approved Vesicles,Cytosol "Secreted to blood" 2185000000000 220000000000 Vesicles Cytosol "CAB016778: , HPA046715: " "unprognostic (1.88e-3)" "unprognostic (4.53e-2)" "unprognostic (7.46e-2)" "unprognostic (4.00e-3)" "unprognostic (3.70e-2)" "unprognostic (1.41e-1)" "prognostic favourable (5.05e-4)" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (9.60e-3)" "unprognostic (1.59e-3)" "unprognostic (7.02e-2)" "prognostic unfavourable (1.67e-8)" "unprognostic (3.46e-3)" "unprognostic (1.15e-1)" "unprognostic (6.24e-2)" "unprognostic (9.54e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 24.6 0.2 0.2 55.6 0.2 0.3 0.2 0.1 0.3 1.3 0.2 0.0 0.2 573.5 0.2 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.0 127.9 0.2 0.2 0.4 0.3 11.8 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.5 3.6 0.0 0.7 0.7 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 13.8 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 247.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 1.2 1.5 0.0 0.2 0.4 1.7 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.2 0.0 2.4 0.7 0.3 0.0 0.2 1.8 0.8 0.5 0.8 1.7 0.0 0.7 0.0 3.6 2.1 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 APOA4 ENSG00000110244 "Apolipoprotein A4" P06727 11 116820700-116823306 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 593.6" "Cell line enhanced" "Detected in some" "BEWO: 7.9;CACO-2: 8.0;Hep G2: 7.5;NB-4: 7.3;RPMI-8226: 11.7;SH-SY5Y: 10.8" "Cancer enriched" "Detected in some" 29 "liver cancer: 291.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA001352, HPA002549, CAB068250, CAB068251, CAB068252" Enhanced Approved Vesicles "Secreted to blood" 148500000000 140000000000 Vesicles "CAB068250: , CAB068251: , CAB068252: , HPA001352: AB_1078179, HPA002549: AB_1078177" "unprognostic (8.81e-2)" "unprognostic (2.12e-2)" "unprognostic (1.75e-2)" "unprognostic (7.91e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 293.8 0.0 0.0 175.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 93.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 593.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 11.7 0.0 0.0 3.2 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOB ENSG00000084674 "Apolipoprotein B" P04114 2 21001429-21044073 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Heparin-binding "Atherosclerosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 145 "intestine: 224.8;liver: 442.2" "Cell line enriched" "Detected in some" 30 "Hep G2: 151.8" "Cancer enriched" "Detected in some" 99 "liver cancer: 295.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016070, HPA049793" Supported Supported Vesicles,Cytosol "Secreted to blood" 1290000000000 89000000000 "Vesicles, Cytosol" "CAB016070: AB_626690, HPA049793: " "unprognostic (1.63e-2)" "unprognostic (2.71e-2)" "unprognostic (1.75e-1)" "unprognostic (1.06e-1)" "unprognostic (1.04e-2)" "unprognostic (7.31e-2)" "unprognostic (1.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.43e-2)" "unprognostic (8.89e-3)" "unprognostic (3.01e-1)" "unprognostic (4.59e-3)" "unprognostic (3.60e-3)" "unprognostic (2.89e-2)" "unprognostic (2.38e-1)" "unprognostic (2.99e-1)" "unprognostic (6.23e-2)" 0.3 0.1 0.1 0.0 0.1 0.0 2.3 0.1 0.1 0.1 68.9 0.0 0.0 24.9 0.1 0.0 0.1 0.1 0.0 1.2 0.1 0.1 0.1 442.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 224.8 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.3 0.9 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.2 0.2 0.1 0.0 0.4 0.2 0.1 0.9 0.3 0.0 0.3 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 APOE AD2 ENSG00000130203 "Apolipoprotein E" P02649 19 44905754-44909393 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Heparin-binding "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Hyperlipidemia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 226.8;liver: 508.1" "Cell line enhanced" "Detected in some" "ASC diff: 163.3;Hep G2: 75.9;HSkMC: 119.7;SK-MEL-30: 151.8" "Cancer enhanced" "Detected in all" "liver cancer: 3183.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008363, HPA065539, HPA068768, CAB069921" Enhanced Approved Vesicles "Secreted to blood" 37650000000 63000000000 Vesicles "CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029" "unprognostic (8.98e-2)" "unprognostic (2.32e-2)" "unprognostic (2.49e-2)" "unprognostic (5.28e-2)" "unprognostic (3.77e-2)" "unprognostic (7.25e-2)" "unprognostic (5.22e-3)" "unprognostic (6.13e-2)" "unprognostic (5.06e-2)" "unprognostic (4.13e-1)" "unprognostic (5.78e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (7.76e-2)" "unprognostic (1.64e-1)" "unprognostic (1.12e-3)" "unprognostic (4.13e-2)" 76.8 226.8 78.4 14.6 106.8 9.7 12.8 26.6 109.8 13.6 15.1 40.3 0.8 7.7 9.4 10.9 2.6 4.3 17.1 6.9 41.4 57.9 121.8 508.1 21.5 46.0 104.0 34.5 23.5 5.2 2.7 4.9 17.2 54.1 6.6 5.2 11.2 8.5 3.4 5.7 33.0 10.2 3.6 35.1 89.2 13.4 12.6 33.9 4.9 6.0 1.3 8.6 11.8 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.2 163.3 6.7 5.9 0.1 0.3 0.7 0.1 38.7 0.2 0.1 0.8 0.0 0.5 1.0 0.1 0.0 0.1 0.3 0.2 0.1 75.9 16.8 0.5 0.1 119.7 0.2 1.2 0.1 0.0 9.9 0.2 0.1 0.2 0.1 0.2 20.4 0.1 0.2 0.6 0.1 0.2 0.0 0.4 0.2 0.3 0.1 151.8 14.0 4.3 0.2 1.1 0.2 0.1 0.1 0.4 0.6 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.4 106.8 26.6 53.4 41.4 57.9 104.0 34.5 54.1 33.9 APOL4 APOLIV ENSG00000100336 "Apolipoprotein L4" Q9BPW4 22 36189124-36204840 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 8.1;HDLM-2: 45.5;HSkMC: 7.4;K-562: 9.7;SCLC-21H: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 4.3;intermediate monocyte: 2.3;myeloid DC: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;monocytes: 4.3" "HPA049797, HPA055435" Uncertain Supported Vesicles "Secreted to blood" Vesicles "HPA049797: , HPA055435: " "unprognostic (2.73e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" "unprognostic (1.51e-1)" "unprognostic (5.31e-1)" "unprognostic (3.39e-2)" "unprognostic (2.44e-2)" "unprognostic (1.55e-1)" "unprognostic (1.91e-1)" "prognostic favourable (3.45e-4)" "unprognostic (1.33e-2)" "unprognostic (2.24e-1)" "prognostic unfavourable (2.00e-5)" "unprognostic (4.26e-2)" "unprognostic (3.69e-1)" "unprognostic (4.18e-2)" "prognostic favourable (2.40e-6)" 2.3 0.8 1.1 2.7 1.3 0.0 2.3 0.9 1.0 2.4 1.2 0.7 0.7 2.2 2.0 0.7 2.4 3.1 3.2 2.8 0.8 1.0 10.3 1.1 7.3 1.7 1.0 0.7 4.2 0.9 0.0 1.9 3.0 1.2 9.0 1.5 1.8 2.9 1.6 1.0 1.6 5.4 2.1 2.3 1.1 2.3 0.7 1.2 7.1 1.1 0.7 2.3 7.4 1.4 0.4 3.8 0.6 4.3 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.9 8.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 45.5 0.0 2.4 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.3 9.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 20.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 4.3 0.0 0.0 2.3 0.0 0.4 0.0 0.0 3.8 0.3 0.0 0.0 0.2 0.8 0.2 0.0 0.0 1.2 1.1 1.3 0.9 1.0 0.8 1.0 1.0 0.7 1.2 1.2 APP AD1 ENSG00000142192 "Amyloid beta precursor protein" P05067 21 25880550-26171128 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Alzheimer disease, Amyloidosis, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 24.0" "Lineage enriched" "Detected in many" 6 "dendritic cells: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000157, HPA001462" Enhanced Approved "Golgi apparatus,Vesicles" 15000000 "Golgi apparatus" Vesicles "CAB000157: AB_323833, HPA001462: AB_1078185" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (3.69e-3)" "unprognostic (2.54e-1)" "unprognostic (8.22e-2)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "unprognostic (4.28e-2)" "unprognostic (5.35e-2)" "prognostic favourable (2.79e-6)" "unprognostic (3.77e-2)" "unprognostic (2.46e-1)" "unprognostic (5.23e-2)" "unprognostic (2.08e-3)" 44.8 92.5 89.9 26.3 109.3 21.2 79.9 64.5 139.1 51.7 63.4 86.9 72.0 39.7 52.2 57.2 33.0 57.6 63.4 69.1 104.6 97.7 102.2 54.5 50.2 12.9 97.4 95.8 58.9 57.1 36.4 34.1 79.7 83.2 49.2 59.6 48.9 47.2 66.6 17.2 38.2 34.9 69.3 109.0 26.3 37.9 32.2 67.5 13.9 85.0 21.5 16.7 52.5 58.4 1.5 24.0 0.9 3.9 0.3 1.5 1.8 31.5 40.8 44.8 37.3 61.1 75.8 48.4 64.1 85.6 32.5 38.3 23.4 77.6 0.0 74.7 50.1 21.6 27.3 75.3 27.5 1.2 22.0 0.0 24.6 16.4 59.6 29.9 1.6 68.3 83.3 38.1 70.0 145.5 0.0 3.3 51.0 35.4 0.5 0.3 35.2 36.5 19.6 43.2 26.3 110.1 22.2 22.8 33.3 68.8 45.3 32.2 40.1 32.6 155.5 72.4 30.7 26.3 30.3 19.9 0.2 0.3 58.9 0.1 69.5 0.4 3.9 0.0 0.1 1.2 0.2 0.5 1.4 0.5 3.4 1.5 1.5 0.4 0.9 0.3 0.9 24.0 0.3 1.8 89.9 109.3 64.5 124.6 104.6 97.7 97.4 95.8 83.2 67.5 AQP10 ENSG00000143595 "Aquaporin 10" Q96PS8 1 154321090-154325325 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 59.9" "Cell line enhanced" "Detected in some" "HEL: 15.6;HMC-1: 6.5;K-562: 17.9;SH-SY5Y: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062621, HPA065947" Enhanced Approved "Nuclear bodies,Vesicles,Plasma membrane" "Nuclear bodies, Vesicles, Plasma membrane" "HPA062621: , HPA065947: " "unprognostic (6.84e-2)" "unprognostic (4.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (8.45e-4)" "unprognostic (1.63e-1)" "unprognostic (3.07e-1)" "unprognostic (4.08e-2)" "unprognostic (3.99e-1)" "unprognostic (1.22e-1)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (7.64e-3)" 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 36.0 0.0 0.0 37.2 0.2 0.3 0.1 4.3 0.5 0.7 0.4 0.0 0.0 0.1 2.2 0.4 0.1 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 59.9 0.0 0.0 2.7 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.9 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 6.5 0.0 0.1 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 7.6 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 AQP11 ENSG00000178301 "Aquaporin 11" Q8NBQ7 11 77589391-77610355 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 60.1" "Cell line enhanced" "Detected in many" "CACO-2: 8.7;Hep G2: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042879 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA042879: AB_10794919" "unprognostic (4.95e-2)" "unprognostic (7.61e-2)" "unprognostic (2.15e-2)" "unprognostic (9.62e-5)" "unprognostic (2.42e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (3.48e-2)" "unprognostic (2.65e-1)" "prognostic favourable (9.89e-4)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.73e-2)" "unprognostic (2.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.66e-3)" 1.0 14.5 4.2 0.8 3.5 0.6 1.1 5.0 4.8 0.6 22.4 2.1 0.7 24.7 0.8 1.2 0.5 0.9 2.4 0.7 2.5 4.5 5.2 13.9 0.6 0.9 3.4 3.4 9.3 3.6 0.9 1.8 3.5 3.4 3.9 2.1 3.8 0.8 0.7 1.0 1.0 60.1 0.6 1.5 1.0 2.3 7.4 1.7 0.0 1.6 0.2 0.4 0.8 0.6 2.0 0.1 0.3 0.1 2.0 2.3 0.8 1.1 3.6 1.5 2.4 3.5 0.9 1.6 1.9 0.8 1.8 0.8 8.7 1.7 1.8 0.9 0.8 1.1 0.6 0.1 0.9 5.3 1.5 1.4 1.2 14.4 1.1 3.0 1.7 0.9 0.3 1.0 0.2 0.3 0.9 1.1 2.0 1.8 1.1 2.0 1.6 3.4 1.6 3.9 0.6 1.0 1.4 1.5 1.1 2.4 0.5 0.9 1.8 0.4 1.0 1.4 4.6 2.8 1.2 1.2 0.8 1.4 0.5 0.2 2.0 0.0 0.0 0.3 1.9 0.0 1.3 0.3 0.8 1.5 0.1 2.0 2.3 0.7 0.0 2.0 0.1 0.1 0.1 0.8 4.2 3.5 5.0 4.8 2.5 4.5 3.4 3.4 3.4 1.7 ARAP1 CENTD2 ENSG00000186635 "ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1" Q96P48 11 72685069-72793599 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020703, HPA070383" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" 39000 "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "CAB020703: , HPA070383: " "unprognostic (3.60e-2)" "unprognostic (7.68e-2)" "unprognostic (6.19e-2)" "unprognostic (5.98e-2)" "unprognostic (5.76e-2)" "unprognostic (1.64e-2)" "prognostic unfavourable (6.45e-4)" "unprognostic (4.01e-2)" "unprognostic (4.07e-1)" "unprognostic (5.95e-2)" "prognostic favourable (2.04e-5)" "unprognostic (1.84e-1)" "unprognostic (1.05e-3)" "unprognostic (6.93e-2)" "unprognostic (2.57e-2)" "prognostic favourable (6.41e-4)" "unprognostic (7.56e-3)" 19.2 29.6 28.8 32.9 29.1 51.1 17.9 34.0 37.5 19.6 16.8 26.6 20.0 17.4 23.7 20.0 21.1 30.3 26.1 20.3 27.7 14.4 20.9 16.6 35.5 27.8 27.5 17.8 28.8 18.9 14.3 31.0 20.9 23.0 21.3 11.2 18.1 19.9 19.0 12.9 27.5 23.6 17.1 25.6 53.8 16.2 23.5 32.3 18.8 24.7 14.0 18.6 28.4 19.6 3.3 7.4 24.0 22.5 6.1 4.4 6.4 7.1 15.1 5.8 7.0 24.8 16.8 8.7 9.8 17.7 11.2 11.1 20.7 19.0 15.8 19.8 16.5 24.1 8.8 23.4 4.8 18.6 10.3 13.4 14.3 28.5 17.2 9.1 37.7 17.9 24.9 18.3 8.8 11.8 11.2 6.4 5.2 14.7 13.8 31.8 3.6 9.8 13.5 8.8 7.7 10.4 22.8 6.0 12.3 7.1 10.6 31.6 9.3 20.8 14.0 15.9 11.0 16.1 6.0 10.3 5.0 8.3 8.4 13.7 8.4 7.5 11.0 13.3 4.4 18.7 2.6 3.3 2.9 3.3 7.4 2.6 2.3 2.7 24.0 6.1 22.5 2.5 3.1 6.4 28.8 29.1 34.0 37.5 27.7 14.4 27.5 17.8 23.0 32.3 ARC "Arg3.1, KIAA0278" ENSG00000198576 "Activity regulated cytoskeleton associated protein" Q7LC44 8 142611044-142614472 "Predicted intracellular proteins" "Endocytosis, Transport" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 25.8;seminal vesicle: 67.7" "Cell line enhanced" "Detected in some" "AN3-CA: 6.8;HEK 293: 8.4;SCLC-21H: 20.0;U-2 OS: 9.7;U-87 MG: 10.9" "Cancer enriched" "Detected in many" 12 "glioma: 36.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.6" "Lineage enhanced" "Detected in single" "T-cells: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 48.9;basal ganglia: 51.6;cerebral cortex: 144.6;hippocampal formation: 99.8;olfactory region: 50.5" "Group enriched" "Detected in many" 7 "basal ganglia: 25.3;cerebral cortex: 87.7;hippocampal formation: 55.8;olfactory region: 47.5" "HPA056430, CAB079013" Supported Approved Vesicles,Microtubules "Vesicles, Microtubules" "CAB079013: , HPA056430: " "unprognostic (1.40e-3)" "unprognostic (2.95e-2)" "unprognostic (4.35e-3)" "unprognostic (4.87e-4)" "unprognostic (6.83e-2)" "unprognostic (8.12e-2)" "unprognostic (5.13e-2)" "unprognostic (1.77e-1)" "unprognostic (5.07e-2)" "unprognostic (9.43e-2)" "unprognostic (4.15e-3)" "unprognostic (1.40e-1)" "unprognostic (2.14e-2)" "unprognostic (1.01e-2)" "unprognostic (7.42e-2)" "unprognostic (1.54e-1)" "unprognostic (3.35e-2)" 18.1 15.9 6.1 1.0 6.5 0.7 1.0 0.8 17.0 1.5 0.9 4.2 11.8 0.8 1.4 1.8 0.9 1.2 3.5 0.5 13.9 7.1 1.5 0.7 2.7 0.4 2.4 2.1 0.5 6.2 0.4 25.8 1.8 4.0 1.0 0.6 0.0 0.5 67.7 0.5 3.5 0.7 0.9 1.2 0.7 2.1 0.6 1.1 0.0 1.5 0.8 1.9 0.6 1.5 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.1 0.3 6.8 0.1 0.7 0.0 1.4 0.0 0.3 0.1 0.1 0.0 0.0 0.9 0.2 0.1 0.4 0.0 0.0 0.0 8.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 3.1 1.5 0.0 0.6 0.0 0.0 0.0 20.0 4.7 0.4 0.0 0.2 0.0 0.1 0.0 1.1 9.7 0.7 0.2 1.8 0.0 0.0 10.9 0.0 2.9 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 6.5 0.8 17.0 13.9 7.1 2.4 2.1 4.0 1.1 ARCN1 COPD ENSG00000095139 "Archain 1" P48444 11 118572390-118603033 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037573, HPA044874" Approved Enhanced "Golgi apparatus,Vesicles" 340000 Vesicles "Golgi apparatus" "HPA037573: AB_10696938, HPA044874: " "unprognostic (1.46e-2)" "unprognostic (4.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.20e-1)" "unprognostic (9.99e-2)" "unprognostic (2.30e-2)" "prognostic unfavourable (2.97e-5)" "unprognostic (3.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-3)" "unprognostic (9.39e-2)" "unprognostic (3.56e-2)" "unprognostic (7.99e-2)" "unprognostic (9.20e-2)" "unprognostic (4.14e-3)" "unprognostic (5.56e-3)" 46.9 37.4 26.7 30.3 32.9 15.0 35.7 34.4 38.8 48.8 36.7 37.3 39.9 36.0 39.8 61.6 38.6 32.6 38.0 39.5 28.7 30.6 39.1 61.4 34.0 27.3 30.4 24.7 45.1 65.2 49.7 64.7 46.0 38.3 42.4 39.6 29.3 62.0 46.9 25.8 31.9 47.1 41.9 34.3 34.9 38.1 37.9 29.7 39.0 44.1 29.3 39.2 46.9 42.1 22.7 29.1 46.2 33.0 34.1 39.5 26.7 24.3 20.4 35.8 26.1 44.1 47.1 19.3 61.5 54.7 27.9 33.3 64.4 32.3 25.7 52.8 68.6 33.0 40.0 36.2 38.9 35.3 18.7 55.1 14.8 35.0 50.1 33.8 32.3 41.1 30.1 46.0 42.9 42.2 28.4 36.1 52.4 39.1 30.4 30.1 22.5 27.3 26.5 34.8 39.1 33.7 26.5 24.6 24.7 34.2 33.4 17.3 42.5 30.3 38.5 35.2 17.3 33.2 28.4 21.2 18.8 37.4 20.7 31.7 41.8 46.2 26.4 26.3 30.5 33.0 39.5 22.7 30.2 29.3 29.1 20.7 29.1 26.6 23.1 34.1 32.1 24.4 28.3 26.7 26.7 32.9 34.4 38.8 28.7 30.6 30.4 24.7 38.3 29.7 ARFGAP1 "ARF1GAP, bA261N11.3, FLJ10767" ENSG00000101199 "ADP ribosylation factor GTPase activating protein 1" Q8N6T3 20 63272785-63289793 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051019, HPA056273" Approved Supported "Nuclear membrane,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "Nuclear membrane" "HPA051019: AB_2681313, HPA056273: AB_2683084" "unprognostic (1.81e-1)" "unprognostic (4.64e-2)" "unprognostic (1.27e-1)" "unprognostic (3.93e-1)" "unprognostic (1.38e-1)" "unprognostic (1.24e-1)" "unprognostic (1.57e-3)" "unprognostic (7.76e-2)" "unprognostic (8.86e-3)" "unprognostic (8.62e-2)" "prognostic favourable (4.57e-4)" "unprognostic (3.23e-2)" "prognostic unfavourable (3.48e-7)" "unprognostic (1.16e-1)" "unprognostic (7.59e-2)" "unprognostic (4.34e-2)" "unprognostic (2.86e-1)" 12.3 13.8 17.8 16.7 21.8 12.4 10.4 29.2 28.9 16.0 16.6 27.1 15.3 14.8 17.3 17.9 13.4 16.0 20.0 14.3 17.5 17.2 13.7 14.8 13.1 16.6 26.0 19.9 16.7 32.8 13.7 40.9 17.9 19.2 16.2 11.7 20.1 21.3 18.1 10.4 21.9 15.7 14.8 15.9 17.2 21.1 19.9 22.7 11.2 15.0 10.3 15.5 16.0 11.9 7.4 8.2 8.3 12.6 6.6 9.9 7.0 11.0 21.0 9.2 10.9 11.0 12.5 18.0 16.2 13.4 33.0 16.6 50.0 12.4 8.4 14.9 19.4 15.3 8.3 26.2 10.3 5.5 9.3 6.5 20.3 42.1 16.9 9.8 13.6 10.7 16.9 15.9 9.0 11.6 11.7 9.8 8.8 18.2 17.6 9.2 12.2 18.1 9.9 13.2 8.1 8.1 13.5 9.8 10.8 19.4 20.7 20.2 15.2 12.6 15.0 20.2 27.4 12.2 12.8 10.1 6.5 9.2 20.5 6.9 12.5 6.9 7.6 8.3 8.8 10.5 9.9 4.8 4.8 8.0 8.2 7.4 4.9 4.6 3.6 6.6 12.6 6.2 5.9 7.0 17.8 21.8 29.2 28.9 17.5 17.2 26.0 19.9 19.2 22.7 ARFIP1 HSU52521 ENSG00000164144 "ADP ribosylation factor interacting protein 1" P53367 4 152779937-152918463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005080, HPA037375, HPA063759" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "CAB005080: AB_2058797, HPA037375: , HPA063759: " "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "prognostic favourable (5.75e-5)" "unprognostic (1.49e-3)" "unprognostic (4.32e-1)" "unprognostic (1.24e-1)" "unprognostic (3.54e-2)" "unprognostic (5.34e-1)" "unprognostic (1.03e-2)" "unprognostic (3.56e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-2)" "prognostic favourable (2.83e-10)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (7.02e-2)" "unprognostic (4.22e-3)" 17.8 15.6 12.2 22.6 13.2 2.8 22.3 15.7 12.3 22.8 25.3 17.5 25.6 20.9 21.1 23.8 23.4 17.6 20.8 11.9 12.6 13.2 23.6 15.3 20.3 14.9 16.1 9.5 22.9 18.8 20.4 22.5 29.0 13.5 23.8 26.4 19.1 19.6 23.9 12.7 19.1 29.9 18.5 18.3 18.5 20.2 12.7 13.9 14.7 23.9 10.2 17.9 24.3 20.4 8.4 10.9 35.7 13.8 12.3 7.6 7.7 13.0 9.8 13.7 13.4 21.6 22.1 16.9 15.8 22.3 15.9 15.2 11.4 27.5 10.5 5.3 21.9 9.4 14.1 15.9 19.9 8.8 8.8 10.4 10.0 11.2 15.3 19.5 22.0 15.5 17.8 13.5 13.4 14.6 12.1 22.8 22.3 15.2 10.9 10.9 11.5 10.0 6.3 7.7 9.7 28.8 17.6 17.3 14.3 11.9 22.4 15.7 20.1 10.5 9.1 15.5 11.0 14.9 11.1 25.1 20.6 14.4 19.6 19.5 21.3 12.1 12.0 17.9 6.7 13.8 6.7 8.4 5.3 5.5 10.9 7.7 4.1 5.5 35.7 12.3 12.6 1.3 7.6 7.7 12.2 13.2 15.7 12.3 12.6 13.2 16.1 9.5 13.5 13.9 ARHGAP1 "CDC42GAP, p50rhoGAP, RhoGAP" ENSG00000175220 "Rho GTPase activating protein 1" Q07960 11 46677080-46700615 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004689, HPA008285" Approved Approved Supported Vesicles 16000000 Vesicles "HPA004689: AB_1078194, HPA008285: AB_1078195" "unprognostic (1.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.05e-3)" "unprognostic (5.19e-2)" "unprognostic (2.48e-2)" "unprognostic (9.07e-2)" "prognostic unfavourable (2.14e-4)" "unprognostic (1.34e-3)" "unprognostic (1.24e-1)" "unprognostic (7.96e-2)" "unprognostic (1.35e-2)" "unprognostic (4.94e-1)" "unprognostic (4.79e-2)" "unprognostic (4.13e-2)" "unprognostic (3.49e-2)" "unprognostic (2.55e-1)" "unprognostic (9.24e-2)" 39.9 23.0 17.5 21.3 24.0 17.5 25.8 9.5 30.1 35.6 23.9 42.9 13.1 15.2 43.0 23.9 36.8 31.0 40.2 63.3 23.0 14.8 19.8 19.4 17.9 22.0 17.5 17.7 32.6 17.0 18.6 16.7 32.0 17.1 36.3 20.0 33.8 21.6 39.3 15.1 26.9 19.5 58.5 18.1 29.0 21.4 21.4 24.1 21.0 20.0 16.2 27.2 59.5 27.1 7.9 17.1 18.8 33.4 11.6 14.3 10.3 7.0 17.7 8.9 12.6 44.6 32.9 10.6 15.6 16.0 14.5 13.3 10.6 9.4 10.3 8.6 32.0 17.7 7.0 23.9 10.9 7.1 7.7 11.3 9.1 12.5 14.7 9.6 17.0 43.4 15.0 11.1 13.9 12.4 7.3 9.7 17.6 25.6 6.4 9.5 23.0 9.3 7.7 12.8 15.2 13.7 26.7 3.2 10.2 14.4 22.4 6.0 28.2 11.0 15.4 26.8 8.4 31.6 15.7 10.3 11.3 7.7 25.1 16.2 12.5 12.0 16.3 15.6 14.3 28.2 10.2 7.7 11.3 12.1 16.1 7.9 9.9 11.2 18.8 11.6 33.4 17.1 13.4 10.3 17.5 24.0 9.5 30.1 23.0 14.8 17.5 17.7 17.1 24.1 ARHGAP11B ENSG00000285077 "Rho GTPase activating protein 11B" Q3KRB8 15 30624494-30638805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 2.6;intestine: 2.7;stomach 1: 1.9" "Cell line enhanced" "Detected in many" "HeLa: 17.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA064479 Uncertain Uncertain Vesicles Vesicles "HPA064479: " 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.1 1.1 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 0.0 1.0 0.0 2.7 0.0 0.0 0.0 0.3 0.1 0.0 0.3 1.9 0.4 0.0 0.9 0.3 1.0 0.8 0.0 0.0 0.0 1.3 0.0 2.8 0.4 0.0 1.7 0.6 0.6 1.6 0.2 1.0 1.3 0.5 4.6 3.0 0.0 1.4 1.0 5.2 4.1 0.1 2.4 4.0 0.4 0.0 17.6 1.4 0.4 0.8 0.2 0.4 0.1 0.5 1.1 1.5 1.3 7.6 3.8 0.2 2.4 0.6 0.9 0.2 0.8 1.8 1.1 1.3 4.5 2.7 1.0 1.1 1.3 0.6 1.5 3.3 1.3 4.7 2.6 0.1 3.0 2.9 2.1 1.4 1.1 3.6 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.3 0.9 0.8 1.0 0.3 0.6 0.0 0.0 0.0 0.3 0.2 0.0 ARHGAP15 BM046 ENSG00000075884 "Rho GTPase activating protein 15" Q53QZ3 2 143091362-143768352 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 52.0;bone marrow: 33.5;lymphoid tissue: 94.4" "Cell line enhanced" "Detected in some" "Daudi: 18.0;HEL: 25.0;HL-60: 35.3;MOLT-4: 23.3;NB-4: 27.3;THP-1: 37.2;U-698: 28.0;U-937: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA032125 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA032125: AB_10671370" "unprognostic (1.59e-2)" "unprognostic (2.40e-3)" "unprognostic (8.63e-2)" "unprognostic (2.19e-2)" "unprognostic (2.99e-1)" "unprognostic (6.62e-3)" "unprognostic (6.14e-2)" "unprognostic (2.18e-3)" "unprognostic (1.32e-2)" "unprognostic (3.58e-2)" "unprognostic (2.13e-1)" "unprognostic (1.66e-1)" "prognostic unfavourable (6.95e-5)" "unprognostic (4.40e-2)" "unprognostic (2.12e-2)" "unprognostic (4.58e-2)" "unprognostic (6.94e-2)" 5.5 2.7 3.6 36.6 4.6 33.5 3.7 0.6 2.9 2.4 4.3 1.5 2.1 2.7 2.1 4.3 3.6 2.4 4.9 5.0 3.8 2.1 4.5 4.8 9.1 36.9 7.8 1.7 1.5 1.2 0.4 1.3 1.6 4.6 3.9 3.3 1.0 8.1 2.2 1.1 1.7 12.2 1.6 11.3 51.8 3.0 3.5 5.9 94.4 4.2 2.2 21.7 6.0 3.9 25.2 14.5 52.0 9.6 28.7 46.0 23.2 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 25.0 0.1 0.0 0.0 35.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 23.3 27.3 0.1 0.0 13.1 0.1 6.6 0.0 0.0 0.1 0.1 0.1 0.0 0.2 1.2 37.2 0.1 0.1 0.8 0.0 0.0 0.3 0.1 28.0 0.2 18.7 1.0 38.6 8.6 34.9 26.6 8.8 42.3 25.2 46.0 33.3 14.5 22.5 33.9 28.4 52.0 28.7 9.6 14.4 36.5 23.2 3.6 4.6 0.6 2.9 3.8 2.1 7.8 1.7 4.6 5.9 ARHGAP25 KIAA0053 ENSG00000163219 "Rho GTPase activating protein 25" P42331 2 68679601-68826833 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 94.2;lymphoid tissue: 48.7" "Cell line enriched" "Detected in some" 4 "HMC-1: 73.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 94.2" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 3.2;basal ganglia: 7.8;cerebral cortex: 8.5;hippocampal formation: 6.4" "Low region specificity" "Detected in all" "HPA035346, HPA061395" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA035346: AB_10601116, HPA061395: AB_2684501" "unprognostic (1.13e-3)" "prognostic favourable (7.72e-4)" "unprognostic (2.45e-2)" "unprognostic (4.44e-3)" "unprognostic (8.07e-2)" "unprognostic (1.36e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.00e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (1.93e-4)" "unprognostic (3.10e-1)" "unprognostic (4.26e-2)" "unprognostic (3.61e-1)" "unprognostic (4.49e-2)" 7.4 3.5 2.6 33.1 3.6 14.6 5.7 0.9 3.2 3.1 4.9 6.7 1.6 2.5 4.0 10.5 3.5 3.5 7.2 4.3 2.8 2.3 5.7 4.6 12.9 39.0 5.9 1.9 8.1 2.2 0.6 3.1 4.5 4.2 3.7 4.2 3.1 5.7 1.5 2.0 3.3 14.3 3.5 6.3 48.7 3.4 2.2 3.3 20.9 4.0 2.3 40.6 6.1 4.7 23.6 7.5 94.2 12.5 22.8 26.3 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.1 0.0 0.7 0.0 5.7 0.0 0.6 0.0 18.3 0.0 0.0 0.2 4.0 73.6 0.0 0.7 0.1 2.3 0.0 0.1 6.7 0.0 0.0 4.6 12.9 0.3 0.0 5.1 1.2 0.2 0.0 1.5 1.1 0.1 0.0 0.0 0.4 0.0 3.4 0.9 0.0 0.2 0.0 0.1 14.5 7.7 4.6 0.0 9.1 0.1 27.5 8.7 72.8 26.3 10.9 16.4 23.6 11.8 22.7 5.3 14.5 8.5 15.0 94.2 22.8 12.5 7.5 14.2 15.7 2.6 3.6 0.9 3.2 2.8 2.3 5.9 1.9 4.2 3.3 ARHGAP30 FLJ00267 ENSG00000186517 "Rho GTPase activating protein 30" Q7Z6I6 1 161046946-161069970 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.1;lymphoid tissue: 45.9" "Cell line enhanced" "Detected in some" "Daudi: 31.0;HL-60: 23.9;HMC-1: 33.7;Karpas-707: 25.0;THP-1: 23.8;U-266/70: 37.7;U-266/84: 24.9;U-698: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA036300 Enhanced Supported Vesicles Vesicles "HPA036300: AB_10601117" "unprognostic (7.31e-2)" "unprognostic (8.83e-3)" "unprognostic (7.46e-3)" "unprognostic (1.77e-3)" "unprognostic (7.41e-2)" "unprognostic (1.68e-3)" "unprognostic (3.05e-1)" "unprognostic (6.78e-3)" "unprognostic (1.94e-2)" "unprognostic (3.89e-2)" "unprognostic (7.91e-2)" "unprognostic (3.09e-1)" "prognostic unfavourable (9.78e-4)" "unprognostic (1.18e-1)" "unprognostic (1.08e-2)" "unprognostic (6.64e-2)" "unprognostic (2.65e-2)" 6.1 3.0 2.6 23.3 3.9 20.4 3.1 0.6 2.4 2.2 3.9 3.5 1.4 3.5 2.0 3.7 8.0 3.3 5.9 4.1 1.9 1.7 3.0 3.3 11.3 27.9 4.3 0.7 1.8 1.8 0.3 1.5 2.5 3.4 2.3 3.2 2.6 6.1 1.8 0.9 11.2 13.7 2.9 4.3 45.9 4.1 1.4 4.5 38.1 2.0 2.4 33.2 5.6 3.8 8.3 12.3 27.1 24.0 10.2 19.7 14.7 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 31.0 0.1 0.0 0.6 0.0 0.0 0.0 14.4 0.0 10.3 0.0 0.0 0.0 23.9 33.7 0.0 0.3 0.0 0.0 0.0 0.0 25.0 0.0 0.2 19.3 5.5 0.0 0.0 12.2 0.1 0.4 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 23.8 0.2 0.0 0.1 0.0 0.1 37.7 24.9 26.5 0.1 19.1 0.0 3.3 15.5 17.6 19.7 18.3 15.1 7.1 13.2 16.1 12.3 8.3 11.0 14.7 27.1 10.2 24.0 8.4 13.2 14.7 2.6 3.9 0.6 2.4 1.9 1.7 4.3 0.7 3.4 4.5 ARHGAP36 FLJ30058 ENSG00000147256 "Rho GTPase activating protein 36" Q6ZRI8 X 131058242-131089883 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3" "Cell line enriched" "Detected in single" 164 "SH-SY5Y: 62.9" "Cancer enriched" "Detected in some" 21 "thyroid cancer: 62.5" "Region enriched" "Detected in many" 5 "hypothalamus: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 104.3" "Group enriched" "Detected in many" 5 "basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1" "HPA002064, HPA076209" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" Nucleoplasm "Vesicles, Plasma membrane" "HPA002064: AB_1078891, HPA076209: " "unprognostic (2.92e-2)" "unprognostic (7.71e-9)" "unprognostic (2.19e-1)" "unprognostic (8.15e-2)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (2.31e-1)" 6.9 58.4 1.4 0.2 3.6 0.1 1.0 0.0 2.7 0.5 0.2 0.0 0.0 0.1 0.1 2.0 0.3 0.2 0.2 0.1 1.0 25.5 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 50.3 0.3 5.4 0.3 0.2 0.6 0.2 0.2 13.7 0.1 0.1 0.1 0.8 0.1 0.2 0.6 0.0 0.5 0.5 4.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 62.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.6 0.0 0.4 1.0 25.5 0.5 0.0 5.4 0.0 ARHGEF10L "FLJ10521, KIAA1626" ENSG00000074964 "Rho guanine nucleotide exchange factor 10 like" Q9HCE6 1 17539835-17697874 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 50.7" "Cell line enhanced" "Detected in many" "Hep G2: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 40 "classical monocyte: 13.1;intermediate monocyte: 13.0;myeloid DC: 9.7;non-classical monocyte: 3.3" "Group enriched" "Detected in many" 46 "dendritic cells: 9.7;monocytes: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026426, HPA026440, HPA028115" Approved Approved "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles, Cytosol" "HPA026426: AB_10599487, HPA026440: AB_10599422, HPA028115: AB_10602285" "unprognostic (4.34e-2)" "unprognostic (1.35e-1)" "unprognostic (1.13e-2)" "unprognostic (2.59e-1)" "unprognostic (1.03e-1)" "prognostic favourable (8.13e-5)" "unprognostic (3.61e-2)" "unprognostic (7.90e-2)" "unprognostic (2.10e-2)" "unprognostic (1.75e-3)" "unprognostic (1.94e-3)" "unprognostic (5.83e-2)" "prognostic favourable (5.65e-4)" "unprognostic (4.11e-2)" "unprognostic (1.66e-1)" "unprognostic (8.17e-2)" "unprognostic (5.21e-3)" 9.5 6.1 6.2 6.1 6.2 0.7 7.8 31.7 7.5 8.5 13.4 7.1 9.9 9.0 7.7 11.2 14.4 6.4 11.7 16.0 5.7 6.1 16.4 50.7 7.8 2.2 6.3 3.8 5.3 30.2 8.1 2.7 3.3 9.1 6.6 7.4 9.6 13.2 12.3 33.4 13.4 9.7 10.5 5.9 5.4 6.5 3.9 5.9 0.4 10.4 7.4 2.9 9.6 11.9 0.0 9.7 0.2 13.1 0.0 0.0 4.5 5.2 6.0 7.7 2.6 13.1 4.4 5.2 3.6 7.2 4.3 3.6 6.2 15.9 0.0 6.8 6.7 4.1 1.0 1.9 0.8 0.1 1.9 0.0 6.2 17.6 3.0 0.0 0.0 5.9 3.7 2.7 0.7 0.8 0.0 0.1 12.0 5.0 0.0 0.1 3.4 0.0 0.0 3.0 1.9 9.2 11.0 11.3 8.3 2.8 2.0 8.2 7.5 6.3 0.0 3.8 4.6 4.4 1.5 0.0 1.6 0.0 5.8 0.1 2.0 0.0 13.1 0.0 0.0 13.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.0 4.5 6.2 6.2 31.7 7.5 5.7 6.1 6.3 3.8 9.1 5.9 ARHGEF25 "GEFT, p63RhoGEF" ENSG00000240771 "Rho guanine nucleotide exchange factor 25" Q86VW2 12 57610180-57619379 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 50.0;SH-SY5Y: 22.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 26.2;cerebellum: 54.2;cerebral cortex: 47.7;hippocampal formation: 59.8;olfactory region: 39.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052016 Approved Approved Vesicles Vesicles "HPA052016: AB_2681695" "unprognostic (8.43e-2)" "unprognostic (4.24e-3)" "unprognostic (2.13e-3)" "unprognostic (6.95e-3)" "unprognostic (8.12e-2)" "unprognostic (1.99e-2)" "unprognostic (1.38e-1)" "unprognostic (9.18e-2)" "unprognostic (2.45e-2)" "unprognostic (2.39e-2)" "unprognostic (4.63e-3)" "unprognostic (2.51e-1)" "prognostic unfavourable (4.20e-7)" "unprognostic (1.41e-2)" "unprognostic (2.03e-1)" "unprognostic (6.82e-3)" "unprognostic (3.22e-3)" 10.4 7.6 26.2 6.1 11.1 0.5 10.5 54.2 47.7 15.4 41.1 3.6 19.8 6.3 40.0 27.0 17.9 24.3 13.9 11.5 59.8 10.5 4.6 1.7 7.6 3.6 7.5 39.3 22.6 3.7 4.9 7.8 5.8 11.2 23.5 12.0 6.1 7.9 49.2 6.3 3.5 10.3 40.7 8.9 7.9 15.0 4.6 6.2 0.0 4.2 3.7 3.1 21.8 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 15.9 9.9 0.0 0.0 1.3 4.8 14.1 6.3 7.8 1.9 3.0 1.3 4.1 8.7 0.1 6.1 0.2 5.3 4.3 5.3 2.7 2.1 4.1 4.6 0.0 7.4 4.5 1.3 2.8 0.4 2.4 5.6 6.1 4.6 1.1 0.9 0.1 10.3 0.1 0.0 50.0 0.2 0.3 0.2 9.3 22.8 0.9 0.4 1.7 1.6 3.3 0.0 5.8 5.5 3.7 1.7 12.9 1.9 0.0 4.8 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 11.1 54.2 47.7 59.8 10.5 7.5 39.3 11.2 6.2 ARHGEF33 ENSG00000214694 "Rho guanine nucleotide exchange factor 33" A8MVX0 2 38889841-38975449 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 42.5" "Group enriched" "Detected in some" 4 "BEWO: 8.8;HeLa: 3.9;SiHa: 11.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 42.5" "Cell type enriched" "Detected in single" 8 "eosinophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Region enriched" "Detected in single" 32 "cerebellum: 314.4" "Region enriched" "Detected in many" 11 "cerebellum: 47.0" "HPA034661, HPA041051" Enhanced Supported Vesicles Vesicles "HPA034661: AB_10669679, HPA041051: " "unprognostic (8.38e-2)" "unprognostic (7.05e-4)" "unprognostic (1.95e-1)" "unprognostic (4.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-1)" "unprognostic (3.66e-1)" "unprognostic (3.37e-1)" "unprognostic (5.82e-2)" "unprognostic (2.05e-3)" "unprognostic (4.99e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.56e-1)" "unprognostic (2.42e-1)" "unprognostic (1.99e-1)" 0.3 4.0 3.7 1.0 8.6 0.0 1.7 42.5 3.4 2.3 0.7 0.6 0.7 0.1 2.8 5.1 0.7 2.2 1.4 0.8 3.3 3.6 1.4 0.2 1.2 0.5 2.0 2.9 6.8 0.2 2.2 3.5 0.8 3.2 1.7 0.6 0.8 0.4 1.2 0.4 1.3 0.6 1.0 1.5 0.5 0.9 10.1 2.4 0.2 1.4 0.2 0.4 1.2 0.6 0.2 0.1 6.7 0.8 0.0 0.2 0.1 0.3 0.0 0.4 0.2 0.2 0.2 8.8 0.8 0.0 0.0 0.0 0.1 0.2 0.4 0.1 0.8 0.0 0.0 0.0 0.0 1.8 0.9 0.2 3.9 0.3 0.7 0.3 0.3 0.8 0.9 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.9 0.4 0.4 0.3 11.0 0.4 0.0 0.0 0.3 0.6 0.2 1.4 0.0 0.1 0.5 0.2 0.0 0.2 0.2 0.1 0.0 0.6 6.7 0.0 0.8 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 3.7 8.6 42.5 3.4 3.3 3.6 2.0 2.9 3.2 2.4 ARID4B "BCAA, BRCAA1, RBP1L1, SAP180" ENSG00000054267 "AT-rich interaction domain 4B" Q4LE39 1 235131634-235328219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027333, HPA053692" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA027333: AB_1845013, HPA053692: " "unprognostic (2.62e-1)" "unprognostic (2.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-3)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.30e-2)" "unprognostic (1.03e-1)" "unprognostic (5.69e-2)" "unprognostic (1.23e-1)" "prognostic unfavourable (2.23e-4)" "unprognostic (1.42e-2)" "unprognostic (1.25e-1)" "unprognostic (3.52e-2)" "unprognostic (8.84e-3)" 15.3 13.8 14.9 19.0 22.5 34.1 15.9 32.8 17.6 19.7 13.4 19.2 18.2 9.1 18.7 18.1 12.0 15.0 15.2 10.6 15.2 14.5 13.1 14.0 15.5 22.3 26.9 13.9 21.8 16.8 23.8 25.7 14.7 20.3 17.9 10.7 12.0 16.7 17.0 12.3 12.3 14.2 14.6 19.8 19.8 14.7 19.5 23.4 33.7 20.2 8.2 18.9 18.2 18.6 17.1 11.7 35.9 11.8 16.6 17.0 6.0 12.3 9.3 16.3 12.6 12.0 12.6 13.4 14.1 12.4 9.8 9.6 9.5 13.2 14.5 16.4 10.6 11.0 13.2 5.9 14.2 18.7 14.3 11.7 11.1 8.0 9.2 12.5 17.2 8.4 8.0 12.0 10.3 13.2 15.1 20.9 9.1 5.6 18.6 11.4 15.0 6.1 7.0 11.5 12.1 10.7 10.4 13.3 18.4 18.0 14.9 13.9 15.8 20.3 18.2 12.1 9.2 14.7 13.7 20.4 16.1 14.5 8.3 9.2 16.1 24.6 7.1 19.5 16.1 7.6 14.7 15.6 17.0 13.7 6.8 17.1 16.9 14.4 35.9 16.6 11.8 11.7 13.6 6.0 14.9 22.5 32.8 17.6 15.2 14.5 26.9 13.9 20.3 23.4 ARL14EP "ARF7EP, C11orf46, FLJ38968" ENSG00000152219 "ADP ribosylation factor like GTPase 14 effector protein" Q8N8R7 11 30323051-30338227 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039634, HPA048127" Approved Supported "Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol" "Vesicles, Focal adhesion sites, Cytosol" Nucleoplasm "HPA039634: , HPA048127: AB_2680277" "prognostic favourable (2.50e-5)" "unprognostic (8.93e-2)" "unprognostic (6.19e-3)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (3.09e-1)" "prognostic unfavourable (5.26e-4)" "unprognostic (2.50e-2)" "unprognostic (6.50e-3)" "unprognostic (5.76e-2)" "unprognostic (8.86e-2)" "unprognostic (1.04e-1)" "unprognostic (8.57e-3)" "unprognostic (1.60e-1)" "unprognostic (3.47e-1)" "unprognostic (4.50e-2)" "prognostic favourable (7.49e-4)" 13.9 21.5 24.5 12.9 29.1 6.3 18.7 22.7 23.4 17.0 14.5 8.0 22.4 8.7 18.1 22.7 11.1 15.8 12.4 20.5 17.7 15.5 16.5 17.6 10.3 23.5 15.5 20.5 20.1 15.0 33.4 28.6 10.6 15.1 19.0 10.3 9.0 17.0 19.9 28.0 11.6 12.5 18.3 16.0 18.2 14.4 14.5 15.0 11.6 23.3 13.9 19.1 16.1 15.1 17.6 12.7 5.5 9.6 24.4 28.7 11.2 5.7 8.3 9.3 8.2 15.3 16.6 4.7 11.2 14.2 10.2 11.3 4.6 2.2 23.4 7.7 8.1 9.7 13.5 9.5 14.5 18.5 16.8 7.0 6.6 8.0 24.1 12.6 8.1 17.2 19.2 4.8 18.3 11.2 11.1 12.8 17.8 5.4 11.3 10.4 10.8 11.6 10.0 22.8 9.5 13.7 8.0 10.6 11.3 8.8 11.7 13.8 12.5 7.1 9.8 11.7 6.2 23.0 10.6 20.0 11.3 15.2 11.2 7.9 11.1 5.5 9.6 3.0 12.1 9.4 28.7 17.6 14.8 13.4 12.7 14.0 13.7 13.1 1.7 24.4 7.0 9.1 9.5 11.2 24.5 29.1 22.7 23.4 17.7 15.5 15.5 20.5 15.1 15.0 ARL4D ARF4L ENSG00000175906 "ADP ribosylation factor like GTPase 4D" P49703 17 43398959-43401137 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 25.6;hTCEpi: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory B-cell: 18.5;myeloid DC: 4.9;naive B-cell: 18.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 9.7;cerebral cortex: 11.2;hippocampal formation: 7.5;olfactory region: 8.6" HPA060379 Uncertain Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA060379: " "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (2.34e-2)" "prognostic favourable (1.16e-5)" "unprognostic (7.71e-2)" "prognostic unfavourable (6.66e-4)" "unprognostic (2.47e-1)" "unprognostic (4.59e-2)" "unprognostic (4.45e-1)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (7.87e-2)" "unprognostic (2.00e-3)" "unprognostic (3.49e-2)" "unprognostic (6.48e-2)" "unprognostic (1.27e-3)" "prognostic unfavourable (9.25e-4)" 7.4 3.3 2.5 3.4 6.4 0.8 6.7 3.7 8.9 20.9 10.4 1.1 4.6 1.5 15.2 6.6 38.4 15.6 7.0 6.8 2.6 2.0 21.6 26.0 6.0 1.2 1.3 2.8 12.6 1.5 1.1 15.1 6.9 2.3 10.8 2.7 22.0 14.0 11.6 2.9 16.8 2.2 22.0 1.0 9.0 3.3 17.3 0.5 0.5 52.5 13.9 10.5 23.3 14.5 18.9 4.9 1.1 2.4 1.1 3.3 2.6 3.6 4.6 2.9 2.2 5.5 7.7 1.3 9.0 9.3 6.4 8.3 4.1 16.2 0.0 4.5 9.6 10.0 1.9 13.7 4.4 0.8 3.2 0.3 3.8 9.4 25.6 1.0 0.9 8.6 33.3 9.3 20.2 2.7 0.6 0.2 6.2 0.2 2.2 2.0 3.0 4.3 3.8 0.6 0.4 10.7 8.0 3.4 2.4 7.0 0.1 6.5 13.3 3.6 0.5 9.2 3.0 11.9 2.6 0.9 0.4 0.0 11.4 0.8 3.0 0.0 1.6 1.1 3.2 2.4 2.0 18.5 2.7 2.9 4.9 18.9 3.0 3.3 0.0 1.1 0.8 1.4 0.6 2.6 2.5 6.4 3.7 8.9 2.6 2.0 1.3 2.8 2.3 0.5 ARL6 "BBS3, RP55" ENSG00000113966 "ADP ribosylation factor like GTPase 6" Q9H0F7 3 97764521-97801242 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019361 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA019361: AB_1845028" "unprognostic (1.31e-1)" "unprognostic (2.82e-2)" "unprognostic (7.12e-2)" "unprognostic (4.66e-2)" "unprognostic (2.08e-1)" "unprognostic (1.02e-1)" "unprognostic (8.78e-3)" "unprognostic (2.88e-2)" "unprognostic (5.55e-3)" "unprognostic (9.43e-2)" "unprognostic (1.19e-1)" "unprognostic (3.31e-1)" "prognostic favourable (2.53e-7)" "unprognostic (9.49e-2)" "unprognostic (1.67e-1)" "unprognostic (2.16e-2)" "unprognostic (2.97e-1)" 5.5 9.2 8.8 3.6 18.6 1.6 6.0 10.0 17.7 6.5 4.9 5.0 7.3 2.7 7.9 7.3 5.3 11.9 6.2 5.9 17.1 11.0 13.2 4.4 8.4 3.9 8.9 14.1 6.4 5.6 22.6 22.3 5.0 12.9 7.1 4.6 7.3 9.1 6.5 2.9 5.2 3.2 7.2 8.0 4.7 5.0 10.9 9.0 4.2 9.1 2.0 3.8 5.6 5.1 2.7 1.0 0.5 1.0 4.1 4.8 1.6 7.6 4.3 3.9 3.3 9.9 7.0 1.0 5.0 4.7 4.4 5.7 1.6 3.1 4.2 4.8 2.4 3.7 5.0 5.7 9.0 5.1 3.0 1.2 3.2 1.7 4.8 5.2 2.7 3.6 4.1 5.9 1.5 4.3 1.4 0.8 7.1 2.7 2.9 2.5 4.9 4.9 1.5 4.1 2.5 5.0 2.2 21.6 11.5 4.3 3.0 9.0 3.5 2.0 3.2 4.4 3.9 3.8 6.6 3.4 4.1 4.8 8.1 2.9 5.3 0.5 0.5 0.2 2.4 0.7 4.8 1.9 2.1 2.5 0.9 2.7 3.6 3.0 0.0 4.1 1.0 1.0 3.6 1.6 8.8 18.6 10.0 17.7 17.1 11.0 8.9 14.1 12.9 9.0 ARMC8 "DKFZP434A043, GID5, HSPC056, VID28" ENSG00000114098 "Armadillo repeat containing 8" Q8IUR7 3 138187248-138298389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036996, HPA044869" Approved Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA036996: AB_10672786, HPA044869: " "unprognostic (2.04e-1)" "unprognostic (1.60e-2)" "unprognostic (1.44e-1)" "prognostic unfavourable (2.05e-4)" "unprognostic (3.51e-2)" "unprognostic (2.39e-2)" "prognostic unfavourable (8.90e-5)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (7.48e-3)" "unprognostic (1.64e-1)" "prognostic unfavourable (2.15e-4)" "unprognostic (3.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.06e-2)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" 19.4 13.5 16.9 14.3 21.9 43.5 14.5 52.6 26.4 17.1 14.4 16.8 9.4 9.9 15.2 10.8 18.0 13.7 13.0 14.4 16.9 20.9 16.6 13.8 13.9 16.3 17.6 16.1 14.3 11.9 20.5 26.1 16.3 26.3 14.5 15.9 12.5 11.9 15.8 34.6 11.8 13.1 20.6 18.7 16.7 14.2 14.7 19.1 21.3 18.2 12.1 18.4 16.9 12.9 25.6 25.4 40.1 23.8 25.3 26.5 19.3 20.2 9.9 13.1 10.6 16.5 14.6 17.6 15.7 15.2 21.5 21.1 15.5 10.7 19.1 16.2 13.5 10.6 16.8 15.3 26.7 12.8 11.8 34.0 6.6 10.5 20.9 26.3 38.2 21.7 9.8 13.8 19.9 16.7 12.7 10.9 26.6 17.7 18.4 12.4 18.1 8.7 14.5 21.0 15.2 14.1 18.9 15.2 11.1 22.5 7.8 13.0 15.5 14.0 18.1 11.5 9.4 15.2 11.5 20.9 15.9 29.3 10.4 12.6 11.4 32.3 22.1 40.1 22.8 23.8 26.0 25.6 21.0 24.0 25.4 22.0 24.6 24.4 15.6 25.3 23.5 11.2 26.5 19.3 16.9 21.9 52.6 26.4 16.9 20.9 17.6 16.1 26.3 19.1 ARMCX4 "CXorf35, GASP4, MGC40053" ENSG00000196440 "Armadillo repeat containing, X-linked 4" X 101418287-101533459 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 10.8" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 9.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000429, HPA051930" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA000429: AB_1078210, HPA051930: " "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.10e-2)" "unprognostic (6.91e-3)" "unprognostic (2.81e-3)" "unprognostic (7.28e-2)" "unprognostic (3.67e-4)" "unprognostic (2.33e-2)" "unprognostic (4.29e-1)" "prognostic favourable (8.20e-5)" "unprognostic (1.94e-2)" "unprognostic (1.40e-2)" "unprognostic (6.94e-3)" "unprognostic (1.69e-1)" "unprognostic (1.88e-1)" "unprognostic (4.92e-2)" 1.5 4.6 1.9 0.8 2.7 0.3 2.9 3.2 5.7 2.4 1.7 0.6 4.0 2.8 0.7 2.8 1.1 1.2 2.0 2.9 1.2 0.5 1.5 0.5 1.9 8.5 1.4 10.8 4.3 1.6 4.1 1.6 1.2 5.7 1.6 2.1 1.5 2.8 1.4 1.3 1.3 0.4 2.4 0.5 2.1 1.4 0.0 0.1 0.0 0.0 0.0 0.5 0.0 2.3 0.6 8.1 0.0 3.9 4.1 0.8 5.5 4.4 4.5 8.9 1.9 0.8 0.0 2.2 8.1 0.9 0.0 0.1 7.5 0.0 0.9 0.6 2.3 0.0 2.3 0.0 3.1 2.6 0.4 9.8 0.0 7.9 0.0 0.7 2.0 0.0 0.3 0.3 6.0 0.0 0.4 6.7 0.0 1.2 1.4 5.5 5.1 0.8 0.0 3.0 0.6 1.2 2.9 2.1 1.3 6.3 0.0 0.0 0.0 0.0 3.8 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 ARNTL "bHLHe5, BMAL1, JAP3, MOP3, PASD3" ENSG00000133794 "Aryl hydrocarbon receptor nuclear translocator like" O00327 11 13276652-13387266 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045962, HPA050938" Supported Supported Nucleoplasm,Vesicles "Intracellular and membrane" Nucleoplasm Vesicles "CAB045962: AB_11124144, HPA050938: " "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (9.00e-2)" "unprognostic (1.77e-1)" "unprognostic (3.72e-1)" "unprognostic (3.76e-2)" "unprognostic (8.92e-2)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (2.10e-1)" "unprognostic (2.77e-2)" "unprognostic (3.11e-2)" "unprognostic (7.08e-2)" 12.3 28.5 13.4 10.3 13.3 13.4 18.2 24.4 25.2 16.4 10.3 5.7 10.6 11.8 10.4 6.5 9.3 9.7 9.4 8.1 11.5 7.5 11.1 17.3 12.1 15.0 6.7 13.1 21.1 9.8 6.1 17.8 9.2 9.3 7.5 8.9 8.6 11.2 8.2 19.2 27.2 10.9 11.7 9.6 10.4 9.6 16.2 9.3 29.2 17.6 0.7 12.2 8.1 17.0 2.8 6.1 20.0 7.8 9.8 19.7 7.3 6.8 6.6 6.1 4.1 11.8 7.6 4.8 6.9 7.4 6.8 8.0 3.3 10.0 0.1 2.2 5.2 2.6 4.8 8.2 5.9 11.7 5.0 3.1 5.4 1.7 21.1 1.4 13.0 9.4 21.7 2.5 18.2 4.8 1.8 12.2 6.8 3.7 3.2 0.7 1.7 3.6 4.2 7.7 3.3 6.6 1.6 1.3 11.9 5.7 2.0 6.6 4.4 5.8 9.3 7.1 5.5 16.7 3.9 3.5 9.4 0.0 7.0 3.6 6.1 4.4 6.7 13.7 14.3 6.9 19.7 2.4 13.4 12.9 6.1 2.8 7.8 9.1 20.0 9.8 7.8 1.1 8.5 7.3 13.4 13.3 24.4 25.2 11.5 7.5 6.7 13.1 9.3 9.3 ARPC1B "ARC41, p40-ARC, p41-ARC" ENSG00000130429 "Actin related protein 2/3 complex subunit 1B" O15143 7 99374249-99394814 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 213.6" "Cell line enhanced" "Detected in all" "SK-MEL-30: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004832 Approved Supported Vesicles,Cytosol 53000000 "Vesicles, Cytosol" "HPA004832: AB_1845044" "unprognostic (5.94e-2)" "unprognostic (2.40e-2)" "unprognostic (2.84e-3)" "unprognostic (2.47e-2)" "unprognostic (1.43e-2)" "unprognostic (2.69e-2)" "prognostic unfavourable (2.57e-4)" "unprognostic (4.37e-2)" "unprognostic (7.76e-2)" "unprognostic (1.02e-2)" "unprognostic (1.56e-1)" "unprognostic (4.86e-1)" "prognostic unfavourable (1.62e-6)" "unprognostic (1.18e-1)" "unprognostic (1.87e-2)" "unprognostic (1.24e-1)" "unprognostic (7.27e-2)" 31.8 17.8 8.7 50.7 14.4 56.4 35.4 1.9 7.7 17.9 30.7 8.4 18.1 32.6 17.4 21.8 16.0 18.3 23.4 24.4 5.7 7.0 27.9 34.8 40.0 92.8 10.7 3.7 11.6 13.0 3.8 13.1 36.2 9.4 15.6 10.5 20.6 18.3 15.1 10.6 10.0 42.3 12.1 10.2 81.8 16.3 10.8 9.3 31.0 23.0 13.7 37.2 19.0 21.1 53.5 133.7 127.2 154.4 38.9 83.4 213.6 15.7 28.6 2.2 6.2 8.3 30.2 21.9 21.9 22.1 8.8 7.8 18.6 61.4 27.3 41.0 23.8 11.9 2.8 19.3 3.6 22.2 10.3 19.9 8.3 12.8 24.0 19.9 67.8 16.8 10.0 12.4 12.4 23.2 22.1 66.0 12.8 72.7 22.0 43.6 7.8 62.4 17.8 1.9 67.0 18.2 7.8 1.8 5.8 14.9 65.8 110.1 15.5 40.6 34.0 25.2 20.9 44.4 27.5 12.3 24.4 33.5 25.1 52.0 45.1 53.7 153.2 121.6 53.8 154.4 50.2 53.5 62.8 59.6 133.7 42.8 37.0 49.3 127.2 38.9 142.0 77.9 83.4 213.6 8.7 14.4 1.9 7.7 5.7 7.0 10.7 3.7 9.4 9.3 ARPC5 "ARC16, dJ127C7.3, p16-Arc" ENSG00000162704 "Actin related protein 2/3 complex subunit 5" O15511 1 183620846-183635757 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 154.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022013, HPA031972" Approved Approved "Vesicles,Plasma membrane,Cell Junctions,Cytosol" 15000000 "Vesicles, Plasma membrane, Cell Junctions, Cytosol" "HPA022013: AB_1845045, HPA031972: " "unprognostic (3.82e-1)" "unprognostic (8.78e-2)" "unprognostic (1.43e-1)" "unprognostic (2.36e-2)" "unprognostic (1.74e-1)" "unprognostic (1.85e-2)" "prognostic unfavourable (3.63e-4)" "unprognostic (5.90e-3)" "unprognostic (3.84e-2)" "unprognostic (3.17e-3)" "unprognostic (1.14e-1)" "unprognostic (1.29e-1)" "prognostic unfavourable (1.21e-10)" "unprognostic (3.03e-2)" "unprognostic (4.66e-2)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" 46.6 25.1 24.9 57.5 24.3 25.2 28.9 13.8 24.8 26.6 42.3 26.5 18.6 40.8 39.0 26.7 44.5 29.3 24.6 36.8 28.2 22.3 28.8 29.7 52.3 58.3 28.4 18.7 27.3 21.5 12.4 18.2 84.8 20.0 23.2 29.2 17.0 25.4 16.5 16.4 25.2 47.3 32.8 46.0 79.9 35.6 21.7 23.5 61.2 27.5 22.7 52.8 30.6 30.8 27.4 68.9 154.0 96.6 30.7 40.7 124.3 50.8 28.2 24.3 16.7 20.1 28.7 58.2 69.9 53.9 30.5 24.9 25.5 36.1 46.8 79.6 40.2 35.4 17.1 23.8 16.1 67.4 15.3 28.3 38.4 22.0 32.7 41.0 55.2 34.7 25.4 36.9 29.4 35.7 21.5 38.8 39.5 20.9 38.2 11.0 23.2 10.8 35.6 21.6 45.2 17.1 26.4 10.5 28.3 72.9 31.5 27.0 31.6 36.7 79.5 44.6 23.2 49.8 67.3 46.3 51.1 32.0 35.1 29.6 34.2 79.3 80.0 124.1 34.8 89.8 27.7 27.4 34.2 35.5 68.9 24.4 37.1 37.6 154.0 30.7 96.6 32.5 40.7 124.3 24.9 24.3 13.8 21.1 28.2 22.3 28.4 18.7 20.0 23.5 ARRB2 "ARR2, BARR2, DKFZp686L0365" ENSG00000141480 "Arrestin beta 2" P32121 17 4710489-4721499 "Predicted intracellular proteins" "Protein transport, Transport" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 102.8;lymphoid tissue: 66.6" "Cell line enhanced" "Detected in all" "HMC-1: 70.2;NB-4: 42.1;U-937: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065681 Supported Vesicles Vesicles "HPA065681: " "unprognostic (1.12e-1)" "prognostic favourable (2.93e-5)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" "unprognostic (7.43e-2)" "unprognostic (3.37e-2)" "unprognostic (2.62e-3)" "unprognostic (3.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.58e-1)" "unprognostic (1.66e-3)" "prognostic unfavourable (2.61e-5)" "unprognostic (1.32e-2)" "unprognostic (8.61e-2)" "unprognostic (4.92e-2)" "unprognostic (1.49e-1)" "unprognostic (1.88e-1)" 21.6 15.6 23.7 47.8 18.3 102.8 10.0 28.1 26.3 8.7 16.1 20.4 1.9 23.0 7.4 7.8 7.1 10.8 14.8 10.2 27.3 20.9 10.5 15.6 35.0 31.3 20.1 19.6 8.7 8.3 6.6 10.2 16.0 19.7 7.4 13.2 10.7 8.7 6.2 5.5 5.8 21.0 13.7 21.7 66.6 12.5 5.0 18.3 23.5 6.4 3.2 17.0 15.7 7.1 2.2 18.0 52.9 32.8 5.9 11.4 16.0 3.6 19.5 7.7 7.3 1.5 2.1 4.0 2.9 3.9 8.6 10.7 6.7 3.1 10.2 2.6 2.2 6.2 12.7 4.0 8.9 24.3 18.4 41.5 9.9 11.8 2.3 18.5 70.2 2.0 5.2 10.5 4.2 6.5 2.7 10.3 1.9 6.5 18.5 42.1 4.1 4.1 21.7 6.8 11.3 2.9 2.0 8.0 11.0 6.5 11.2 5.0 5.4 8.7 5.6 3.2 6.4 5.5 10.9 4.3 5.8 5.8 8.5 60.1 4.7 22.6 30.4 52.5 11.0 31.5 7.8 2.2 7.1 11.4 18.0 1.9 6.8 9.0 52.9 5.9 32.8 4.4 6.0 16.0 23.7 18.3 28.1 26.3 27.3 20.9 20.1 19.6 19.7 18.3 ARRDC4 FLJ36045 ENSG00000140450 "Arrestin domain containing 4" Q8NCT1 15 97960698-97973838 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.7;BJ: 38.5;HSkMC: 21.7;hTCEpi: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 2.3;classical monocyte: 5.1;eosinophil: 3.1;intermediate monocyte: 3.6;myeloid DC: 2.4;neutrophil: 3.0" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 3.1;monocytes: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039934, HPA042109" Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA039934: , HPA042109: AB_10795606" "unprognostic (2.13e-1)" "unprognostic (1.10e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-3)" "unprognostic (4.49e-3)" "unprognostic (8.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.78e-1)" "unprognostic (7.65e-2)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-2)" "unprognostic (2.02e-3)" "unprognostic (2.90e-2)" "unprognostic (1.65e-1)" "unprognostic (3.04e-2)" "unprognostic (6.77e-2)" 9.2 9.3 11.4 11.5 18.4 6.7 14.8 3.3 16.3 9.4 27.4 67.3 11.6 11.2 10.7 11.9 11.8 10.8 14.7 9.7 18.7 9.2 14.1 21.8 14.1 6.4 18.1 15.2 7.4 25.0 3.7 6.5 13.0 29.4 8.3 17.0 4.6 6.5 13.5 10.1 25.3 15.3 14.0 48.7 5.9 18.1 10.2 41.9 1.9 14.9 4.5 3.5 11.7 12.4 0.5 2.4 3.1 5.1 0.1 0.1 0.8 2.1 0.0 0.3 5.6 2.5 18.7 0.0 38.5 17.2 5.1 2.3 2.3 1.3 0.0 5.4 1.7 2.2 1.4 13.4 8.3 0.0 3.6 3.7 0.7 1.5 1.0 2.5 5.8 21.7 33.3 5.8 6.9 0.2 5.1 0.0 1.8 6.9 0.4 2.1 1.1 0.8 0.0 0.3 0.0 10.0 4.7 1.9 3.3 5.8 2.1 10.4 0.8 3.9 0.0 1.5 1.1 8.0 1.8 0.0 0.0 0.0 3.3 0.4 4.0 2.3 5.1 3.1 0.1 3.6 0.0 0.5 0.0 0.0 2.4 0.4 0.1 0.0 3.0 0.1 0.6 0.6 0.0 0.8 11.4 18.4 3.3 16.3 18.7 9.2 18.1 15.2 29.4 41.9 ARSD ENSG00000006756 "Arylsulfatase D" P51689 X 2903970-2929351 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.7;EFO-21: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA004694, HPA063835" Approved Approved "Vesicles,Lipid droplets" "Vesicles, Lipid droplets" "HPA004694: AB_1078221, HPA063835: " "unprognostic (3.92e-1)" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "prognostic favourable (5.21e-4)" "unprognostic (5.90e-3)" "unprognostic (6.32e-3)" "unprognostic (1.73e-1)" "unprognostic (1.34e-1)" "unprognostic (2.44e-1)" "unprognostic (4.09e-3)" "unprognostic (7.18e-2)" "unprognostic (3.93e-1)" "prognostic favourable (1.97e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (4.99e-2)" "unprognostic (2.11e-3)" 8.1 5.6 3.7 10.1 3.5 2.3 14.2 3.2 5.0 14.7 15.4 5.8 27.4 11.9 8.9 19.2 9.3 16.6 16.8 8.7 5.7 3.6 34.1 23.8 13.1 11.3 3.1 3.3 13.0 48.1 8.5 3.9 16.2 8.7 11.5 8.5 7.8 15.8 30.9 1.6 5.9 22.3 12.0 4.5 5.7 19.5 5.2 3.3 1.8 12.9 5.6 7.1 12.4 6.9 2.1 6.3 5.7 8.5 3.0 2.6 3.2 4.5 8.1 2.2 10.5 9.5 5.5 0.1 2.6 4.8 1.2 0.8 0.5 15.7 0.0 16.9 5.3 0.0 0.4 1.3 1.1 0.1 0.0 0.0 0.0 2.6 5.2 0.0 6.3 8.6 4.3 2.3 2.5 7.8 0.0 0.0 5.2 11.0 0.0 1.1 1.8 3.4 1.9 0.0 0.1 8.4 0.1 0.0 5.9 3.6 4.3 2.7 11.6 8.7 7.1 0.0 0.3 0.8 1.2 0.1 0.0 0.0 7.7 5.5 5.9 2.1 8.5 5.7 2.6 7.1 1.0 2.1 1.3 2.0 6.3 1.4 0.3 1.5 1.5 3.0 2.7 4.4 0.4 3.2 3.7 3.5 3.2 5.0 5.7 3.6 3.1 3.3 8.7 3.3 ARSK "DKFZp313G1735, TSULF" ENSG00000164291 "Arylsulfatase family member K" Q6UWY0 5 95555074-95605064 "Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042384 Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "HPA042384: AB_10795703" "unprognostic (9.50e-2)" "unprognostic (1.37e-1)" "unprognostic (2.03e-3)" "unprognostic (2.39e-1)" "unprognostic (3.33e-2)" "unprognostic (1.20e-1)" "prognostic unfavourable (2.59e-4)" "unprognostic (3.39e-1)" "unprognostic (1.37e-1)" "unprognostic (5.19e-2)" "unprognostic (7.61e-2)" "unprognostic (2.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.91e-2)" "unprognostic (2.32e-1)" "unprognostic (8.20e-2)" "unprognostic (1.06e-2)" 8.5 10.2 6.9 4.8 7.6 4.7 7.6 14.2 12.3 8.9 8.6 4.3 9.6 5.1 8.5 9.6 6.7 7.4 6.9 8.5 7.9 7.1 11.5 9.7 7.4 5.6 8.4 9.9 12.8 11.7 29.3 14.5 11.2 7.2 10.7 5.9 7.3 6.7 11.2 5.5 8.4 5.4 6.7 8.8 5.5 9.7 4.5 7.5 10.6 15.8 2.8 4.5 9.2 14.0 6.7 2.7 10.0 1.6 3.9 9.2 2.3 3.3 2.1 4.6 4.6 22.8 11.9 6.6 10.7 6.2 4.2 8.7 2.7 5.3 4.6 5.6 3.6 3.2 4.0 6.8 9.3 4.9 5.8 3.7 5.5 4.4 6.6 2.0 3.0 8.7 6.1 6.4 4.1 6.8 3.7 5.0 9.3 1.6 5.5 3.9 5.9 10.4 3.4 7.3 7.2 9.7 0.8 3.2 3.3 6.6 2.2 6.4 6.1 2.1 12.2 6.7 5.4 10.3 6.5 4.3 7.3 5.5 6.6 5.4 24.8 10.0 1.6 2.5 5.3 1.5 6.1 5.3 6.0 6.7 0.8 6.7 9.2 6.9 1.5 3.9 1.0 2.7 4.5 2.3 6.9 7.6 14.2 12.3 7.9 7.1 8.4 9.9 7.2 7.5 ARV1 ENSG00000173409 "ARV1 homolog, fatty acid homeostasis modulator" Q9H2C2 1 230978981-231000595 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035709 Approved Approved Vesicles Vesicles "HPA035709: " "unprognostic (2.32e-1)" "unprognostic (4.69e-2)" "prognostic favourable (1.33e-4)" "unprognostic (3.29e-1)" "unprognostic (1.42e-1)" "unprognostic (9.95e-2)" "unprognostic (5.66e-2)" "prognostic favourable (3.27e-5)" "unprognostic (1.37e-1)" "unprognostic (1.12e-2)" "unprognostic (9.57e-2)" "unprognostic (9.82e-2)" "unprognostic (2.31e-1)" "unprognostic (4.82e-1)" "unprognostic (5.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.12e-3)" 8.2 16.3 22.0 10.1 31.0 10.0 16.1 17.1 24.3 11.0 20.0 16.5 13.9 13.8 8.1 20.6 13.6 12.3 17.0 24.2 23.8 21.8 21.0 20.9 12.5 11.0 22.7 17.7 9.8 14.9 18.4 25.8 9.4 22.0 14.0 21.6 15.4 16.9 13.4 15.7 14.6 15.6 10.7 27.1 10.5 13.7 24.6 18.2 11.0 18.4 16.8 11.9 12.7 9.3 15.3 13.9 7.3 17.7 12.5 14.0 8.3 20.1 21.9 11.0 13.1 15.9 13.9 10.2 9.5 17.6 17.4 20.2 8.1 15.7 5.8 11.8 10.9 16.5 20.6 12.9 20.7 14.8 28.9 18.0 15.9 10.9 16.3 26.4 14.7 15.1 13.6 9.4 11.0 11.7 26.4 16.0 11.5 7.0 10.7 8.0 14.0 14.8 12.8 16.3 16.4 23.3 16.6 11.5 17.4 11.3 13.4 27.9 24.1 23.5 6.4 6.9 4.4 12.6 22.7 24.7 21.7 14.5 18.9 23.1 18.8 6.4 7.6 7.3 9.8 10.8 13.3 15.3 11.0 11.7 9.1 10.1 13.8 12.7 1.9 12.5 17.7 13.9 14.0 8.3 22.0 31.0 17.1 24.3 23.8 21.8 22.7 17.7 22.0 18.2 ASAP3 "CENTB6, DDEFL1, FLJ20199, UPLC1" ENSG00000088280 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 3" Q8TDY4 1 23428563-23484568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.3;ASC TERT1: 18.3;HSkMC: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.6" "Lineage enhanced" "Detected in single" "monocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020537, HPA020546" Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA020537: , HPA020546: " "unprognostic (2.51e-1)" "unprognostic (2.70e-2)" "unprognostic (4.35e-3)" "prognostic unfavourable (5.56e-4)" "unprognostic (3.87e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-3)" "prognostic favourable (2.80e-4)" "unprognostic (1.88e-2)" "prognostic unfavourable (8.30e-4)" "unprognostic (2.24e-1)" "unprognostic (1.18e-1)" "prognostic favourable (5.12e-5)" "unprognostic (3.39e-3)" "unprognostic (3.92e-2)" "unprognostic (2.02e-2)" "unprognostic (7.27e-2)" 10.6 15.5 8.7 5.9 9.9 0.7 15.2 2.6 8.3 11.0 8.9 6.6 13.5 2.4 7.9 7.7 12.9 8.7 7.8 20.7 6.9 5.1 10.7 7.4 7.9 2.3 9.2 6.1 29.6 13.7 13.7 7.4 12.4 16.3 12.0 6.8 8.2 14.6 25.5 24.2 32.5 3.7 9.9 15.4 1.9 8.9 9.4 6.7 0.2 12.0 12.0 6.2 7.0 17.7 0.1 0.0 0.0 1.6 0.0 0.4 0.4 1.0 1.0 10.4 6.8 19.3 18.3 12.9 1.9 2.2 2.9 3.8 0.7 0.0 5.3 2.2 3.6 4.9 7.2 1.7 1.7 0.2 0.9 0.3 2.8 6.6 10.4 0.0 0.5 23.3 2.6 4.7 4.2 2.2 3.6 0.0 1.8 2.2 0.7 0.0 1.8 2.4 2.7 1.1 0.0 2.0 2.1 0.3 3.5 8.2 2.0 2.0 7.8 0.0 0.8 1.2 3.1 3.5 0.1 2.3 2.3 0.6 0.5 0.0 0.7 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.4 8.7 9.9 2.6 8.3 6.9 5.1 9.2 6.1 16.3 6.7 ASB7 ENSG00000183475 "Ankyrin repeat and SOCS box containing 7" Q9H672 15 100602534-100651705 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003300 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA003300: AB_1845071" "unprognostic (1.38e-1)" "unprognostic (3.48e-2)" "unprognostic (3.91e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.82e-1)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" 8.6 8.9 8.9 15.5 11.9 20.2 10.2 12.7 10.2 10.3 12.1 8.1 13.5 8.3 11.6 12.5 10.0 10.9 9.5 7.0 10.4 8.3 12.5 12.1 8.8 12.9 10.6 6.7 11.2 11.0 13.7 11.8 14.0 9.4 10.1 11.8 7.6 10.3 11.3 8.0 9.5 15.5 11.2 9.7 10.4 8.3 13.8 9.2 21.2 11.5 9.6 11.1 11.6 9.2 6.6 7.0 13.6 8.0 5.5 9.4 6.3 6.2 13.9 6.4 7.6 8.5 9.2 7.4 6.9 12.5 11.6 12.1 8.3 12.7 10.2 6.4 8.8 13.9 8.9 9.0 12.1 7.2 9.5 13.6 9.2 8.2 12.9 7.9 12.0 8.8 10.1 9.4 15.6 10.6 8.0 8.6 6.5 6.7 6.1 8.0 6.1 6.8 8.5 13.9 8.5 11.4 14.1 6.4 9.1 10.6 10.4 14.3 7.3 10.0 8.0 10.2 9.5 7.0 9.6 10.4 21.4 9.8 7.8 7.3 8.0 1.7 8.0 13.6 7.6 6.5 6.1 6.3 6.7 9.3 7.0 6.6 9.4 6.7 7.3 5.5 4.1 4.5 7.7 6.3 8.9 11.9 12.7 10.2 10.4 8.3 10.6 6.7 9.4 9.2 ASGR1 CLEC4H1 ENSG00000141505 "Asialoglycoprotein receptor 1" P07306 17 7173431-7179564 "Predicted intracellular proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 171.0" "Cell line enriched" "Detected in some" 30 "Hep G2: 102.0" "Cancer enriched" "Detected in many" 90 "liver cancer: 131.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7" "Group enriched" "Detected in many" 13 "dendritic cells: 13.7;monocytes: 39.1" "Region enriched" "Detected in many" 9 "cerebellum: 49.4" "Not detected" "Not detected" "HPA011954, HPA012852" Enhanced Supported "Vesicles,Cell Junctions" "Intracellular and membrane" Vesicles "Cell Junctions" "HPA011954: AB_1845079, HPA012852: AB_1845080" "unprognostic (3.56e-3)" "unprognostic (3.57e-1)" "unprognostic (8.76e-2)" "unprognostic (4.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-2)" "unprognostic (5.37e-2)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (8.55e-5)" "unprognostic (1.55e-1)" "unprognostic (8.33e-11)" "unprognostic (1.45e-1)" "unprognostic (2.00e-1)" "unprognostic (1.73e-3)" "unprognostic (4.46e-3)" 0.2 0.1 0.8 0.9 0.6 0.6 0.2 2.8 1.8 0.1 0.2 0.2 0.2 0.5 0.2 0.1 0.1 0.1 0.7 0.1 0.8 0.8 0.1 171.0 0.7 0.3 0.4 1.2 0.1 0.3 0.9 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.3 0.7 0.3 0.3 0.3 0.5 0.2 2.9 0.2 0.1 1.4 0.1 0.1 0.3 0.1 0.2 13.7 2.1 39.1 0.1 0.3 10.1 0.0 0.1 2.0 0.9 0.0 0.0 0.1 0.1 0.1 0.2 0.3 3.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.3 102.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 1.8 0.2 0.1 0.1 0.0 0.1 0.2 0.3 0.1 0.1 0.7 0.0 0.0 0.1 0.1 0.8 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 2.1 39.1 0.1 0.1 17.9 0.3 0.1 0.0 0.0 13.7 0.2 0.1 0.1 1.1 0.1 4.5 0.6 0.1 10.1 0.8 0.6 2.8 1.8 0.8 0.8 0.4 1.2 0.7 0.2 ASIP "AGTIL, ASP" ENSG00000101440 "Agouti signaling protein" P42127 20 34194569-34269344 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.7;epididymis: 18.4;ovary: 24.8" "Cell line enhanced" "Detected in some" "CACO-2: 6.5;HSkMC: 5.3;U-698: 3.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "hippocampal formation: 5.4" "Cell type enriched" "Detected in single" 321 "plasmacytoid DC: 43.7" "Lineage enriched" "Detected in single" 321 "dendritic cells: 43.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA048636 Uncertain Supported Vesicles "Secreted to blood" Vesicles "HPA048636: " "unprognostic (4.81e-2)" "unprognostic (7.46e-2)" "unprognostic (1.97e-3)" "unprognostic (3.26e-2)" "unprognostic (2.24e-1)" "unprognostic (3.07e-2)" "unprognostic (5.13e-2)" "unprognostic (4.57e-2)" "unprognostic (4.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (5.53e-6)" "unprognostic (1.02e-1)" "unprognostic (3.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.33e-1)" 0.5 0.1 0.3 0.3 0.3 0.2 1.9 0.3 0.8 2.0 1.0 0.3 0.3 0.0 2.0 18.4 0.3 2.1 0.3 10.3 5.4 0.0 0.3 0.5 0.3 0.4 0.3 0.3 24.8 0.3 0.0 0.3 0.3 0.7 2.5 0.0 0.3 0.3 0.3 0.3 5.4 0.3 0.3 1.3 0.3 0.1 7.1 0.3 0.3 0.3 0.3 0.8 0.5 0.4 0.1 43.7 0.0 0.0 0.0 0.0 0.2 0.1 2.3 0.8 0.8 0.5 1.6 0.2 0.2 0.0 0.0 0.0 6.5 0.1 2.4 0.5 0.6 0.3 0.0 0.0 0.0 0.1 1.6 3.4 0.7 1.1 0.0 0.0 0.9 5.3 0.0 0.0 0.0 0.0 1.2 2.0 0.0 0.7 0.5 3.4 0.0 1.3 0.7 0.6 2.9 0.0 0.2 0.6 0.6 0.0 0.4 3.8 0.6 0.4 0.7 1.2 1.2 0.2 0.6 0.8 0.7 3.9 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 43.7 0.0 0.2 0.3 0.3 0.3 0.8 5.4 0.0 0.3 0.3 0.7 0.3 ASPSCR1 "ASPL, ASPS, TUG, UBXD9, UBXN9" ENSG00000169696 "ASPSCR1, UBX domain containing tether for SLC2A4" Q9BZE9 17 81976807-82017406 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "Hep G2: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026749 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" Nucleoplasm "Vesicles, Plasma membrane" "HPA026749: AB_1845114" "unprognostic (5.01e-2)" "unprognostic (1.19e-3)" "unprognostic (7.61e-2)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "prognostic favourable (8.55e-4)" "unprognostic (2.02e-1)" "unprognostic (2.07e-2)" "unprognostic (3.43e-1)" "unprognostic (1.71e-3)" "prognostic favourable (2.67e-4)" "unprognostic (1.13e-1)" "prognostic unfavourable (1.26e-4)" "unprognostic (3.16e-2)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (1.01e-2)" 10.3 12.6 14.3 12.6 14.5 16.8 10.6 16.5 20.8 9.9 12.9 16.7 11.8 17.5 10.1 15.8 11.9 9.3 15.1 11.5 13.1 12.6 15.8 31.9 14.1 14.8 18.9 12.9 8.8 17.8 17.0 19.7 21.8 14.8 13.2 7.1 14.4 22.6 9.9 25.1 15.5 14.4 9.1 12.6 13.2 13.0 16.9 14.6 9.8 16.4 12.9 13.0 9.7 8.3 8.1 14.6 15.7 11.3 7.2 10.5 5.2 4.9 8.8 3.4 5.0 2.2 2.7 14.9 4.7 3.6 5.7 5.6 5.1 5.8 5.1 4.9 3.4 2.4 3.7 3.6 1.8 3.5 11.2 5.7 7.2 80.8 7.1 5.0 8.3 3.1 3.9 2.9 2.0 5.5 5.7 7.3 3.2 17.0 4.6 10.9 4.3 6.4 5.1 5.0 10.4 5.6 4.6 9.2 9.4 3.9 12.3 8.8 7.4 12.0 4.5 9.9 6.8 7.2 5.9 5.3 3.2 5.7 5.3 5.1 5.9 15.7 11.3 8.0 6.7 7.6 4.0 7.9 10.5 9.0 14.6 8.1 8.0 6.0 2.9 7.2 9.3 9.1 4.9 5.2 14.3 14.5 16.5 20.8 13.1 12.6 18.9 12.9 14.8 14.6 ASTN1 ASTN ENSG00000152092 "Astrotactin 1" O14525 1 176857302-177164973 "Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 19.9;brain: 52.5" "Cell line enhanced" "Detected in some" "Karpas-707: 5.9;NTERA-2: 4.5;SCLC-21H: 2.8;U-2 OS: 3.6;U-266/84: 20.1" "Cancer enriched" "Detected in some" 14 "glioma: 15.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074112 Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA074112: " "unprognostic (4.41e-3)" "unprognostic (1.48e-2)" "unprognostic (4.03e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "unprognostic (7.61e-2)" "unprognostic (2.03e-4)" "unprognostic (3.86e-3)" "unprognostic (1.08e-1)" "unprognostic (4.36e-1)" "unprognostic (1.67e-3)" "unprognostic (1.98e-1)" "unprognostic (6.77e-2)" "unprognostic (4.74e-3)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (1.16e-1)" 1.4 19.9 21.5 1.6 23.8 1.1 1.7 15.0 52.5 1.3 1.5 7.4 1.9 1.5 2.3 5.4 1.2 3.2 1.9 1.7 17.4 13.7 1.3 1.4 1.4 1.2 8.5 18.8 8.9 1.7 1.2 8.2 1.6 9.8 2.4 1.6 2.2 2.0 3.3 1.3 1.1 1.5 2.2 5.8 3.6 1.2 1.9 7.2 0.0 1.2 0.0 1.5 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.9 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 23.8 15.0 27.2 17.4 13.7 8.5 18.8 9.8 7.2 ATG2A KIAA0404 ENSG00000110046 "Autophagy related 2A" Q2TAZ0 11 64894546-64917248 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 16.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038715 Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" Cytosol "Nucleoplasm, Vesicles" "HPA038715: AB_10673474" "unprognostic (3.05e-2)" "unprognostic (2.33e-1)" "unprognostic (7.55e-2)" "unprognostic (1.18e-1)" "unprognostic (3.42e-1)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.37e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "prognostic favourable (4.79e-5)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" 8.4 8.3 6.0 8.4 10.4 63.7 7.1 12.2 14.3 7.2 9.2 11.6 8.2 10.0 9.5 5.5 6.1 7.7 8.9 6.4 7.0 6.4 9.0 33.2 9.3 7.7 7.5 7.5 11.8 11.7 7.6 8.7 8.9 9.0 8.5 4.3 12.1 9.3 8.4 12.4 15.9 11.4 9.7 6.7 11.1 9.2 8.0 8.2 13.2 8.4 7.8 9.4 7.9 6.2 1.0 2.3 16.5 2.0 1.5 2.6 0.9 9.9 9.6 3.6 9.6 4.7 3.3 9.5 5.5 8.3 7.6 5.6 8.6 7.9 7.1 11.7 4.7 8.6 3.6 6.6 2.0 6.6 12.4 6.4 14.4 7.7 6.6 5.0 14.9 9.1 5.8 9.5 5.1 6.3 12.0 5.8 3.3 16.2 6.0 17.0 4.1 10.8 6.7 5.6 10.4 4.1 8.5 13.0 5.1 8.0 11.7 10.1 11.3 6.4 7.9 7.2 7.1 14.2 4.1 11.5 4.0 5.1 10.6 4.0 4.5 2.8 2.0 2.0 2.6 1.9 2.2 0.8 1.7 2.2 1.3 1.0 1.4 2.5 16.5 1.5 1.5 2.3 0.9 0.9 6.0 10.4 12.2 14.3 7.0 6.4 7.5 7.5 9.0 8.2 ATG9A "APG9L1, FLJ22169" ENSG00000198925 "Autophagy related 9A" Q7Z3C6 2 219219380-219229717 "Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA059551 Uncertain Supported Vesicles Vesicles "HPA059551: " "unprognostic (1.53e-2)" "unprognostic (4.03e-1)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (4.80e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (2.18e-5)" "unprognostic (8.99e-3)" "unprognostic (2.07e-1)" "unprognostic (3.55e-3)" "unprognostic (4.67e-2)" "unprognostic (4.21e-1)" "unprognostic (2.23e-2)" "unprognostic (4.84e-2)" "unprognostic (3.15e-1)" "unprognostic (5.61e-2)" "unprognostic (1.95e-2)" 13.9 14.3 15.2 9.0 26.1 23.3 13.2 26.7 37.9 12.2 15.0 23.8 10.0 17.1 14.9 9.4 17.6 10.4 13.3 23.4 14.2 13.2 12.6 21.0 13.6 10.2 18.5 14.0 12.9 16.7 27.0 10.8 20.3 20.6 12.8 14.3 12.5 14.0 14.9 61.3 17.5 19.8 18.0 14.3 13.0 13.0 47.0 16.3 7.8 13.1 16.6 12.6 14.7 12.3 5.0 6.6 8.8 16.8 8.4 7.6 8.5 9.5 12.6 9.9 22.7 20.4 21.4 12.7 17.9 21.1 25.1 22.9 19.1 13.4 2.4 14.4 29.3 21.3 16.0 20.6 19.2 7.7 24.4 19.2 32.5 21.8 20.2 5.1 14.7 21.4 34.2 26.1 24.5 25.7 26.1 9.8 17.3 12.5 4.1 10.7 6.9 10.1 5.6 13.1 9.7 14.7 14.1 15.2 8.8 18.1 16.8 15.8 6.2 12.4 17.4 25.0 11.6 10.1 16.1 5.3 5.0 3.9 20.3 12.0 13.5 4.8 9.4 4.3 6.2 14.4 6.6 5.0 4.9 7.6 6.6 3.4 4.7 5.5 8.8 8.4 16.8 2.9 5.6 8.5 15.2 26.1 26.7 37.9 14.2 13.2 18.5 14.0 20.6 16.3 ATM "ATA, ATC, ATD, ATDC, TEL1, TELO1" ENSG00000149311 "ATM serine/threonine kinase" Q13315 11 108222484-108369102 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000102, HPA067142" Supported Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB000102: , HPA067142: " "unprognostic (9.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.04e-1)" "unprognostic (2.36e-1)" "unprognostic (5.70e-2)" "unprognostic (2.86e-2)" "unprognostic (6.32e-3)" "unprognostic (1.05e-1)" "unprognostic (8.19e-2)" "unprognostic (1.63e-1)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (2.17e-3)" "unprognostic (3.10e-1)" "unprognostic (7.87e-2)" "unprognostic (1.21e-1)" "unprognostic (2.81e-1)" 8.3 10.9 12.7 26.5 19.3 16.8 9.4 17.7 14.4 10.9 8.5 10.9 8.8 6.0 11.2 11.4 6.9 9.5 9.2 9.6 12.4 8.5 7.7 9.5 10.1 33.4 19.6 6.7 20.5 20.7 15.7 29.2 8.8 14.5 9.1 7.9 7.2 15.1 9.8 6.2 8.4 16.5 10.6 23.4 22.6 8.9 6.1 17.9 19.5 10.7 5.1 26.9 10.7 10.7 13.7 6.1 13.5 12.5 7.6 18.5 4.4 2.6 3.8 7.5 4.0 9.8 14.3 1.9 6.0 6.7 3.5 5.8 4.7 6.3 9.4 8.9 4.8 4.0 5.7 5.0 5.4 7.5 3.3 8.5 4.7 4.7 5.1 10.2 9.2 9.2 3.1 5.2 10.2 7.2 8.2 6.4 6.8 1.9 7.0 9.4 6.1 3.8 5.5 5.2 14.8 3.9 5.4 5.1 6.3 6.9 3.2 10.3 4.9 5.8 11.3 8.6 4.8 4.9 5.6 4.3 4.5 47.4 5.7 11.3 9.6 13.5 5.7 3.8 14.9 5.3 10.4 11.1 10.5 11.3 2.7 13.7 18.5 17.9 10.8 7.6 12.5 6.1 5.3 4.4 12.7 19.3 17.7 14.4 12.4 8.5 19.6 6.7 14.5 17.9 ATP11A "ATPIH, ATPIS, KIAA1021" ENSG00000068650 "ATPase phospholipid transporting 11A" P98196 13 112690329-112887168 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035583, HPA035584" Approved Enhanced Vesicles Vesicles "HPA035583: AB_10671106, HPA035584: AB_10672096" "unprognostic (1.67e-1)" "unprognostic (5.06e-3)" "unprognostic (1.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.58e-2)" "unprognostic (8.84e-2)" "unprognostic (5.87e-3)" "unprognostic (1.80e-2)" "unprognostic (6.97e-2)" "unprognostic (1.54e-3)" "unprognostic (3.93e-2)" "unprognostic (4.23e-1)" "prognostic favourable (7.44e-4)" "unprognostic (3.85e-2)" "unprognostic (3.69e-1)" "unprognostic (3.26e-2)" "unprognostic (7.40e-3)" 11.1 11.5 7.2 8.3 16.4 15.7 7.9 5.0 12.5 13.6 5.8 24.4 8.7 9.5 13.7 9.2 8.5 10.8 14.6 19.6 7.2 5.4 12.9 12.3 36.9 7.5 17.7 6.9 8.6 13.2 36.1 17.8 11.2 12.8 5.0 3.6 10.0 12.0 9.0 11.2 11.4 8.7 9.1 12.5 10.2 6.1 9.7 16.2 2.1 16.4 6.4 6.0 5.7 11.3 4.2 1.1 6.4 3.1 0.0 1.0 0.6 13.8 7.1 9.0 10.6 4.6 6.2 16.1 6.6 3.9 5.7 4.6 22.3 16.1 7.0 8.1 5.6 11.8 8.1 5.5 5.5 7.0 7.6 8.1 5.9 11.6 7.3 15.2 13.3 4.2 4.2 6.8 4.2 14.8 5.6 1.2 3.9 5.2 6.9 9.6 3.9 5.1 6.0 3.6 4.0 30.9 3.2 14.5 4.0 6.4 8.4 5.5 3.2 20.3 9.7 0.0 12.3 7.3 5.0 3.8 7.5 2.9 2.5 14.3 6.2 0.0 2.3 3.1 1.0 3.1 0.6 1.3 0.6 0.5 1.1 4.2 0.7 0.4 6.4 0.0 2.7 1.1 0.1 0.6 7.2 16.4 5.0 12.5 7.2 5.4 17.7 6.9 12.8 16.2 ATP13A1 "ATP13A, CGI-152, FLJ31858, KIAA1825" ENSG00000105726 "ATPase 13A1" Q9HD20 19 19645198-19663693 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031798, HPA049717" Approved Approved Vesicles Vesicles "HPA031798: , HPA049717: " "unprognostic (2.08e-1)" "unprognostic (4.92e-2)" "unprognostic (4.30e-2)" "unprognostic (7.29e-2)" "unprognostic (3.33e-1)" "unprognostic (4.40e-3)" "unprognostic (3.97e-3)" "unprognostic (1.73e-2)" "unprognostic (3.17e-1)" "unprognostic (2.60e-2)" "unprognostic (1.16e-2)" "unprognostic (9.43e-3)" "prognostic unfavourable (6.51e-4)" "unprognostic (2.26e-3)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.57e-1)" 13.7 20.8 18.6 22.6 20.4 16.0 15.4 19.9 22.4 16.6 15.3 18.9 11.7 20.5 19.1 13.3 17.5 17.4 15.8 11.4 14.4 11.5 17.6 22.9 15.6 23.9 21.6 14.5 24.6 23.4 38.1 21.0 15.4 15.7 16.8 15.0 18.4 18.9 16.8 13.5 17.0 23.2 13.2 16.1 29.9 18.1 16.7 20.7 24.7 23.1 11.0 22.2 15.4 15.6 3.1 8.1 4.1 10.8 1.8 4.5 2.6 12.2 17.3 9.5 20.6 15.4 10.2 26.0 11.1 15.6 9.7 9.9 16.5 21.0 17.0 19.2 13.1 6.8 14.4 14.2 5.3 6.1 30.0 9.3 17.3 12.9 15.8 17.5 27.7 14.7 13.5 10.4 12.6 6.9 15.9 38.1 9.6 20.3 11.7 12.7 17.4 21.2 9.3 6.8 37.8 10.2 17.1 13.2 22.3 10.3 16.6 11.5 10.5 19.2 11.0 20.5 3.1 23.2 13.3 31.0 18.5 10.2 14.3 22.6 15.3 0.0 4.2 4.1 3.9 7.4 4.2 3.1 4.5 4.1 8.1 2.7 3.0 3.7 0.1 1.8 10.8 6.3 3.7 2.6 18.6 20.4 19.9 22.4 14.4 11.5 21.6 14.5 15.7 20.7 ATP23 "KUB3, XRCC6BP1" ENSG00000166896 "ATP23 metallopeptidase and ATP synthase assembly factor homolog" Q9Y6H3 12 57941541-57957269 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.5" "Cell line enhanced" "Detected in many" "NB-4: 14.8;RH-30: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035804, HPA043204" Uncertain Enhanced "Vesicles,Plasma membrane,Cell Junctions,Cytosol" "Vesicles, Plasma membrane" "Cell Junctions, Cytosol" "HPA035804: AB_10601026, HPA043204: " "unprognostic (2.56e-1)" "unprognostic (1.31e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (5.28e-2)" "unprognostic (5.41e-3)" "unprognostic (1.03e-2)" "unprognostic (1.24e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (1.44e-5)" "unprognostic (4.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-1)" 6.7 4.9 4.3 5.2 5.3 11.3 4.8 6.1 4.8 5.6 8.2 1.3 2.5 3.9 3.2 4.2 7.3 3.1 2.4 6.4 4.2 3.6 5.4 6.2 2.7 6.8 2.7 3.8 4.2 5.8 3.2 3.0 3.5 2.9 5.1 8.2 2.3 3.4 3.3 11.7 5.6 4.3 6.5 3.4 3.7 3.8 39.5 2.0 20.8 4.7 5.9 4.7 6.3 6.2 3.0 4.5 12.0 4.5 2.6 5.6 3.0 1.9 1.5 1.9 2.2 2.8 2.7 1.0 1.9 1.9 2.2 2.1 1.2 2.4 6.8 2.4 1.4 1.8 1.8 1.9 3.8 3.4 1.8 4.4 1.2 1.9 1.2 8.9 3.0 1.4 1.5 1.3 0.5 1.5 4.6 4.9 1.8 3.0 4.8 14.8 1.6 3.7 3.1 48.8 2.8 1.8 2.5 1.2 1.8 3.0 2.8 1.5 4.9 8.4 0.8 1.6 2.8 2.1 1.8 4.0 2.1 3.5 1.8 9.6 2.7 7.6 4.5 12.0 3.5 2.4 2.6 3.0 4.0 3.3 4.5 3.0 4.3 4.0 1.9 2.6 4.2 2.1 5.6 3.0 4.3 5.3 6.1 4.8 4.2 3.6 2.7 3.8 2.9 2.0 ATP6V0A1 "a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1" ENSG00000033627 "ATPase H+ transporting V0 subunit a1" Q93050 17 42458844-42522611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.2;parathyroid gland: 65.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022144 Enhanced Approved "Nuclear speckles,Golgi apparatus,Vesicles,Cytosol" 21000 "Golgi apparatus, Vesicles" "Nuclear speckles, Cytosol" "HPA022144: AB_1845189" "unprognostic (3.93e-2)" "unprognostic (2.02e-1)" "unprognostic (4.35e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-2)" "unprognostic (8.69e-2)" "unprognostic (1.84e-2)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.85e-1)" "prognostic favourable (2.05e-4)" "unprognostic (3.25e-1)" "prognostic favourable (1.28e-4)" "unprognostic (3.07e-1)" "unprognostic (3.68e-2)" "unprognostic (2.62e-2)" "prognostic unfavourable (6.90e-4)" 9.4 15.6 19.3 9.3 46.1 9.9 9.1 55.8 66.2 8.0 11.6 25.8 5.1 17.9 11.4 11.1 9.6 9.7 12.2 9.9 23.8 32.8 20.3 11.3 12.7 6.6 23.6 24.8 11.4 9.3 65.6 23.6 11.2 43.3 9.9 11.3 19.7 8.2 10.7 28.9 14.7 12.4 11.7 23.7 11.1 8.8 9.8 13.1 5.2 16.3 6.7 7.8 6.7 6.9 6.3 9.1 14.2 10.5 0.1 2.8 4.2 6.5 13.5 8.3 14.8 14.0 12.1 4.8 4.6 8.6 9.9 13.0 8.6 14.7 1.2 8.5 9.5 14.2 12.7 7.8 11.5 10.1 13.4 10.5 10.2 6.8 8.6 4.5 19.2 9.0 11.3 15.8 6.8 7.0 38.1 41.4 14.7 5.6 1.8 4.0 5.3 0.1 0.1 8.6 18.2 11.4 5.2 22.9 12.2 7.2 6.6 13.7 15.9 6.8 4.1 8.4 0.3 12.3 5.5 16.9 22.9 2.5 11.3 0.1 9.8 12.1 10.5 8.0 0.8 3.4 1.2 3.5 0.6 0.1 9.1 6.3 1.0 0.8 14.2 0.1 2.4 4.7 2.8 4.2 19.3 46.1 55.8 65.9 23.8 32.8 23.6 24.8 43.3 13.1 ATP6V0D2 "ATP6D2, FLJ38708, VMA6" ENSG00000147614 "ATPase H+ transporting V0 subunit d2" Q8N8Y2 8 85987323-86154228 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 56.8" "Cell line enhanced" "Detected in some" "SK-MEL-30: 6.2;U-87 MG: 9.5" "Cancer enriched" "Detected in many" 9 "renal cancer: 36.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055327, HPA058496" Enhanced Approved Vesicles Vesicles "HPA055327: , HPA058496: " "unprognostic (3.79e-2)" "unprognostic (1.59e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (8.43e-3)" "unprognostic (5.36e-5)" "unprognostic (4.02e-2)" "unprognostic (1.16e-1)" "unprognostic (7.75e-3)" "unprognostic (2.32e-2)" "unprognostic (1.61e-1)" "prognostic favourable (2.20e-6)" "unprognostic (8.58e-2)" "unprognostic (1.77e-2)" "unprognostic (3.67e-1)" "unprognostic (1.97e-2)" 6.6 0.3 0.2 1.3 0.3 0.8 0.3 0.2 0.2 0.2 1.5 0.0 11.9 0.7 0.2 1.0 0.2 0.2 0.1 0.2 0.3 0.3 56.8 0.3 12.2 1.2 0.5 0.0 0.8 0.2 0.3 0.2 0.2 0.0 0.8 2.0 5.7 1.1 1.2 0.2 0.9 1.0 0.0 0.3 0.4 0.3 0.2 0.0 1.0 0.4 0.3 0.6 0.3 0.2 2.2 1.7 4.6 1.0 2.0 1.5 0.3 0.6 1.3 0.7 0.8 0.0 0.6 2.5 0.0 0.0 1.1 0.3 0.3 0.4 0.4 0.3 0.1 2.8 0.8 1.8 0.5 0.4 0.1 0.9 1.8 0.2 0.0 0.8 1.5 0.6 0.1 1.0 0.8 0.5 0.5 0.8 0.5 1.0 0.0 0.8 0.3 0.2 0.2 0.3 0.3 0.0 1.2 3.8 0.3 0.1 0.9 6.2 2.0 0.1 0.3 0.7 0.9 0.8 0.5 0.5 0.2 0.7 9.5 0.7 0.8 2.6 1.0 0.8 1.1 0.5 0.8 1.2 1.0 0.9 0.5 2.2 1.5 1.3 4.6 2.0 1.0 1.7 0.9 0.3 0.2 0.3 0.2 0.2 0.3 0.3 0.5 0.0 0.0 0.0 ATP6V1A "ATP6A1, ATP6V1A1, VA68, Vma1, VPP2" ENSG00000114573 "ATPase H+ transporting V1 subunit A" P38606 3 113747019-113812056 "Disease related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.6" "Group enriched" "Detected in all" 6 "dendritic cells: 16.4;granulocytes: 33.6;monocytes: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006910, HPA035083, HPA035084" Approved Supported Nucleoplasm,Vesicles,Cytosol 2700000 "Nucleoplasm, Vesicles" Cytosol "CAB006910: , HPA035083: AB_2674453, HPA035084: AB_2674454" "unprognostic (1.32e-1)" "unprognostic (8.68e-2)" "unprognostic (5.87e-2)" "unprognostic (4.70e-2)" "unprognostic (1.36e-1)" "unprognostic (2.00e-1)" "unprognostic (3.43e-2)" "unprognostic (2.90e-2)" "unprognostic (1.42e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-2)" "unprognostic (5.19e-3)" "prognostic favourable (3.82e-12)" "unprognostic (8.82e-2)" "unprognostic (2.46e-3)" "unprognostic (2.43e-1)" "unprognostic (1.52e-2)" 12.8 19.8 24.1 10.4 33.2 7.4 12.7 34.8 52.8 14.0 11.1 10.3 5.6 9.3 7.5 8.2 13.2 10.0 10.8 4.7 26.2 38.2 47.9 18.2 12.3 11.4 25.4 25.0 6.2 10.5 39.3 13.5 12.3 52.0 11.2 11.8 14.7 18.0 8.4 4.5 12.6 7.9 8.2 13.6 13.7 10.9 8.9 8.3 9.6 21.0 5.7 13.6 10.2 8.2 3.8 16.4 33.6 15.4 3.8 3.4 6.0 25.0 11.4 14.4 12.5 30.3 13.6 15.3 13.6 20.8 14.3 19.8 21.5 20.2 20.5 32.3 19.8 16.3 32.4 17.9 18.8 9.3 8.9 18.2 17.7 16.5 25.1 13.3 21.3 18.3 12.4 18.5 12.9 23.2 20.8 15.6 21.2 16.4 9.7 6.0 18.0 14.3 8.4 10.4 23.3 39.1 23.9 27.9 10.3 23.8 16.2 17.8 24.6 10.8 21.3 13.3 10.0 9.1 8.1 16.3 17.5 19.0 26.2 16.9 14.8 9.2 15.4 5.2 2.8 11.7 2.6 3.8 2.6 2.7 16.4 2.9 2.5 2.9 33.6 3.8 9.5 4.6 3.4 6.0 24.1 33.2 34.8 52.8 26.2 38.2 25.4 25.0 52.0 8.3 ATP6V1B2 "ATP6B2, HO57, VATB, Vma2, VPP3" ENSG00000147416 "ATPase H+ transporting V1 subunit B2" P21281 8 20197367-20226819 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 116.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 69.7;eosinophil: 47.6;intermediate monocyte: 62.5;myeloid DC: 34.5;neutrophil: 116.0;non-classical monocyte: 54.1" "Group enriched" "Detected in all" 10 "dendritic cells: 34.5;granulocytes: 116.0;monocytes: 69.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008147 Enhanced Supported Vesicles 240000 Vesicles "HPA008147: AB_1845195" "unprognostic (1.90e-1)" "unprognostic (7.24e-3)" "unprognostic (3.62e-2)" "unprognostic (2.57e-1)" "unprognostic (2.84e-2)" "unprognostic (5.59e-3)" "unprognostic (1.76e-2)" "unprognostic (3.78e-2)" "unprognostic (4.68e-2)" "unprognostic (4.23e-3)" "unprognostic (1.29e-2)" "unprognostic (1.34e-1)" "prognostic favourable (8.41e-4)" "unprognostic (2.41e-1)" "unprognostic (2.09e-2)" "unprognostic (2.47e-2)" "unprognostic (5.25e-2)" 17.1 29.9 31.7 25.8 45.0 14.4 13.2 39.2 72.9 12.2 13.9 15.9 5.5 16.2 10.6 12.2 15.3 10.3 14.8 13.9 33.8 47.8 53.9 18.0 22.8 17.5 46.9 47.1 10.9 12.2 18.8 23.6 18.5 64.2 11.0 16.5 17.3 12.8 10.9 18.2 18.2 21.1 15.0 19.2 20.9 10.7 24.0 12.7 10.3 12.7 9.3 17.5 14.3 12.4 4.9 34.5 116.0 69.7 4.8 7.1 51.1 10.7 18.0 22.4 7.3 30.7 19.0 20.2 24.2 15.6 31.3 32.4 20.3 6.3 19.1 9.8 23.1 9.2 17.7 16.1 33.3 8.0 11.9 13.2 8.2 15.5 36.0 9.4 27.7 16.9 14.8 19.4 17.9 19.5 19.7 18.5 33.4 6.1 27.5 11.2 16.6 7.9 11.4 28.9 9.9 28.9 17.0 17.4 25.1 11.7 15.9 77.1 20.6 17.4 20.6 15.7 12.0 25.9 19.3 7.5 10.1 22.5 21.8 22.5 39.8 15.9 69.7 47.6 5.7 62.5 6.2 4.9 5.9 6.1 34.5 4.3 6.1 6.0 116.0 4.8 54.1 8.4 7.1 51.1 31.7 45.0 39.2 69.0 33.8 47.8 46.9 47.1 64.2 12.7 ATP7A MNK ENSG00000165240 "ATPase copper transporting alpha" Q04656 X 77910656-78050395 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012887, HPA048107" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA012887: AB_1845205, HPA048107: " "unprognostic (3.14e-2)" "unprognostic (3.48e-1)" "unprognostic (4.90e-2)" "unprognostic (1.49e-2)" "unprognostic (1.26e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-3)" "unprognostic (2.59e-2)" "unprognostic (3.17e-2)" "unprognostic (2.47e-1)" "unprognostic (2.30e-2)" "unprognostic (1.14e-1)" "prognostic favourable (8.38e-4)" "unprognostic (1.06e-1)" "unprognostic (2.16e-1)" "unprognostic (3.69e-1)" "unprognostic (2.52e-1)" 9.8 7.4 2.6 8.6 4.6 6.4 8.5 2.3 2.9 8.2 7.7 5.9 9.6 4.8 9.5 7.6 10.0 5.7 4.5 5.1 2.9 2.8 9.0 3.3 9.3 9.3 4.1 1.7 7.3 6.3 13.2 15.9 5.0 4.3 8.2 4.4 5.2 12.3 10.3 6.1 15.9 8.5 7.8 6.3 10.8 7.0 2.7 6.0 15.6 6.0 7.1 11.7 11.8 7.0 2.3 1.4 10.7 2.4 1.7 3.0 1.2 2.5 6.7 4.5 4.6 4.3 4.5 0.8 3.9 5.4 2.3 4.8 0.9 3.0 3.7 5.8 3.8 3.1 5.8 3.1 4.4 5.5 4.0 1.9 6.5 0.7 5.4 3.3 3.5 4.8 1.3 5.0 1.5 6.1 15.3 14.4 4.3 2.2 3.5 1.1 1.3 1.4 2.9 7.5 12.6 3.9 7.2 1.4 17.1 9.6 2.4 4.9 1.8 1.1 7.7 3.1 3.1 4.3 1.5 4.7 8.3 4.3 5.1 2.0 4.7 8.3 2.0 5.5 2.4 1.9 1.2 2.0 1.7 1.7 1.3 2.3 2.1 3.0 10.7 1.7 2.4 1.4 0.6 1.2 2.6 4.6 2.3 2.9 2.9 2.8 4.1 1.7 4.3 6.0 ATP8A1 ATPIA ENSG00000124406 "ATPase phospholipid transporting 8A1" Q9Y2Q0 4 42408373-42657105 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 38.9" "Cell line enhanced" "Detected in many" "AN3-CA: 16.8;Daudi: 27.6;HEL: 9.7;REH: 9.5;SH-SY5Y: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052935 Enhanced Supported Vesicles 20000 Vesicles "HPA052935: " "unprognostic (8.63e-2)" "unprognostic (3.43e-2)" "unprognostic (1.16e-2)" "unprognostic (7.61e-2)" "unprognostic (6.59e-2)" "unprognostic (6.82e-3)" "unprognostic (7.69e-2)" "unprognostic (2.02e-3)" "unprognostic (3.99e-1)" "unprognostic (2.99e-3)" "unprognostic (4.39e-2)" "unprognostic (9.71e-2)" "prognostic favourable (5.54e-10)" "unprognostic (2.43e-1)" "unprognostic (3.25e-1)" "unprognostic (8.21e-2)" "unprognostic (2.25e-1)" 5.3 8.6 14.2 8.0 29.6 18.5 4.8 7.2 32.0 3.1 11.3 27.3 8.4 4.2 3.4 11.6 2.9 3.5 2.8 8.0 13.7 8.8 4.0 2.1 10.6 12.5 18.0 17.4 15.1 10.0 38.9 6.9 2.6 15.3 7.9 10.7 3.9 4.4 15.2 16.9 3.2 8.1 3.1 23.1 7.8 10.5 2.8 24.9 8.9 34.9 1.9 10.3 4.5 4.0 4.4 3.8 0.9 3.3 3.2 7.3 0.9 0.0 0.1 0.2 16.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.2 27.6 7.8 0.1 1.4 4.0 0.0 0.0 4.4 2.7 9.7 0.9 0.4 0.0 2.3 0.2 0.3 0.0 0.0 0.0 0.1 0.0 3.1 0.0 1.2 3.5 0.8 1.2 0.3 9.5 0.0 3.1 6.0 0.3 3.0 9.2 0.2 5.8 0.0 1.9 0.0 0.2 0.0 1.3 0.3 0.0 1.1 0.0 5.6 0.4 3.3 0.1 0.0 1.0 0.9 6.0 0.4 3.2 2.6 1.9 6.5 0.9 4.4 2.9 7.3 0.9 3.2 3.3 3.8 1.4 0.9 14.2 29.6 7.2 22.1 13.7 8.8 18.0 17.4 15.3 24.9 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2" "Cell line enhanced" "Detected in some" "HMC-1: 18.6;NB-4: 7.1;THP-1: 12.0;U-937: 37.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 6.9;NK-cell: 10.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040254 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 2.3 1.2 1.6 1.5 2.1 28.1 1.0 0.6 0.9 26.0 1.5 1.7 1.6 0.4 18.2 3.5 0.6 9.5 3.1 0.8 2.5 0.9 1.0 1.2 3.2 0.7 2.7 0.1 3.9 0.4 0.2 1.1 2.9 2.1 0.7 1.2 0.8 0.9 0.6 0.4 0.5 1.1 2.7 3.1 2.3 0.6 0.9 4.6 0.8 0.5 0.8 2.1 1.3 1.5 0.0 2.2 6.9 1.7 10.6 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.1 0.0 3.0 0.6 0.0 0.0 5.2 18.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 12.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 37.6 0.0 6.9 1.7 2.4 0.5 0.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.8 10.6 0.3 0.0 0.0 0.8 1.6 2.1 0.6 0.9 2.5 0.9 2.7 0.1 2.1 4.6 ATXN7L2 "FLJ00381, MGC46534" ENSG00000162650 "Ataxin 7 like 2" Q5T6C5 1 109483479-109492804 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029827, HPA054952" Uncertain Approved Nucleoli,Vesicles,Cytosol Nucleoli "Vesicles, Cytosol" "HPA029827: AB_10602390, HPA054952: " "unprognostic (4.53e-2)" "unprognostic (6.55e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (7.65e-4)" "unprognostic (3.90e-2)" "unprognostic (4.61e-5)" "unprognostic (2.40e-4)" "unprognostic (1.75e-1)" "unprognostic (3.53e-2)" "unprognostic (8.07e-2)" "unprognostic (2.77e-4)" "unprognostic (2.85e-2)" "prognostic unfavourable (1.19e-8)" "unprognostic (3.70e-2)" "unprognostic (1.08e-1)" "unprognostic (8.27e-2)" "unprognostic (3.94e-3)" 4.2 5.2 7.5 4.0 9.2 10.2 2.6 15.2 10.9 2.8 2.8 5.1 1.2 2.7 4.4 1.8 2.8 3.3 3.8 2.0 6.5 3.3 3.4 3.0 3.4 3.8 5.7 7.0 7.3 2.4 1.6 9.9 2.5 4.7 2.2 1.4 5.7 1.8 3.2 13.3 3.5 3.1 2.0 3.1 5.4 2.9 8.8 4.8 2.7 4.2 1.0 2.6 3.2 2.4 2.4 1.3 2.4 2.4 2.7 5.6 2.2 2.2 1.7 1.2 4.5 1.6 2.9 3.2 1.6 2.1 3.4 2.2 3.6 1.5 5.8 2.6 2.0 2.5 2.4 2.2 0.4 5.3 3.4 3.2 3.6 1.6 1.0 4.8 7.6 3.1 1.2 3.5 0.0 0.8 5.3 3.3 0.6 7.0 8.4 6.3 7.0 2.5 5.9 2.9 4.1 1.2 2.3 10.6 4.3 1.7 5.7 2.6 1.0 5.0 0.3 2.4 7.0 2.2 6.4 2.1 1.4 5.5 2.8 4.0 6.0 0.0 1.9 2.4 5.4 2.4 5.0 2.3 4.3 5.6 1.3 2.4 4.0 3.8 1.9 2.7 1.6 1.0 3.8 2.2 7.5 9.2 15.2 10.9 6.5 3.3 5.7 7.0 4.7 4.8 AUP1 ENSG00000115307 "AUP1, lipid droplet regulating VLDL assembly factor" Q9Y679 2 74526645-74529939 "Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007674 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA007674: AB_1078251" "unprognostic (1.09e-1)" "unprognostic (2.95e-2)" "unprognostic (1.97e-2)" "unprognostic (2.11e-2)" "unprognostic (5.97e-2)" "unprognostic (2.96e-3)" "prognostic unfavourable (2.29e-4)" "unprognostic (2.00e-1)" "unprognostic (2.73e-1)" "unprognostic (3.79e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-1)" "prognostic unfavourable (2.97e-9)" "unprognostic (9.68e-2)" "unprognostic (1.59e-1)" "unprognostic (3.35e-1)" "unprognostic (3.96e-2)" 18.8 21.7 13.9 15.5 16.9 9.4 24.2 18.0 16.7 25.7 28.2 14.6 18.4 14.0 14.6 17.8 25.6 15.4 12.5 14.1 11.8 11.2 19.2 44.5 14.4 21.1 18.4 8.0 11.8 44.2 26.4 14.1 20.6 15.1 13.6 25.9 13.5 29.8 17.6 34.6 25.2 31.3 18.0 12.2 18.2 26.0 10.6 14.4 13.5 19.0 11.7 19.9 16.7 13.5 26.3 38.0 30.6 46.3 20.7 31.6 36.4 16.0 24.2 6.2 10.5 36.8 18.4 17.0 11.7 26.8 21.7 11.4 37.6 11.6 16.5 8.3 22.7 19.8 26.6 20.5 15.4 14.2 25.3 24.4 12.3 31.3 38.9 12.7 12.7 24.3 45.3 32.7 30.3 22.7 32.2 22.8 23.1 23.1 13.2 15.3 16.0 20.7 17.1 25.5 48.4 24.2 13.7 9.9 11.1 11.6 35.8 27.7 15.7 20.3 8.6 17.6 10.9 4.2 18.5 5.8 9.2 20.2 21.0 17.3 31.0 28.4 39.3 30.6 25.0 46.3 30.2 24.3 26.4 27.3 38.0 26.3 22.1 24.7 19.1 20.7 40.4 35.8 31.6 36.4 13.9 16.9 18.0 16.7 11.8 11.2 18.4 8.0 15.1 14.4 AXIN1 PPP1R49 ENSG00000103126 "Axin 1" O15169 16 287440-352673 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012987 Approved Supported Nucleoli,Vesicles "Nucleoli, Vesicles" "CAB012987: AB_2533178" "unprognostic (3.81e-2)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (7.64e-2)" "unprognostic (1.90e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (3.38e-5)" "unprognostic (1.23e-1)" "unprognostic (3.58e-1)" "unprognostic (1.56e-1)" "unprognostic (4.58e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (4.41e-2)" "unprognostic (1.94e-1)" "unprognostic (1.23e-2)" "unprognostic (1.03e-1)" 10.8 8.3 13.7 18.9 17.1 28.1 21.0 26.4 13.6 10.4 15.8 12.7 9.4 17.3 12.6 8.5 14.1 10.7 12.7 11.0 11.5 7.7 9.8 9.6 13.6 13.4 15.6 10.6 13.3 17.7 11.1 11.9 8.4 13.9 11.4 10.2 9.6 13.9 9.5 17.7 16.9 17.6 18.9 9.6 15.1 15.2 9.6 14.6 17.5 12.7 7.5 14.5 11.9 22.9 1.8 1.4 5.5 1.1 3.6 10.4 2.4 9.4 13.8 7.3 12.9 5.5 5.1 15.5 6.4 5.9 8.9 7.7 20.2 11.1 14.7 9.9 6.6 13.7 11.5 10.0 4.0 14.4 18.8 9.5 11.5 14.7 9.4 10.9 10.6 5.0 17.5 9.2 11.3 5.8 23.7 8.1 4.0 25.4 11.7 7.6 16.8 8.4 22.2 6.7 20.4 6.7 5.6 16.8 10.3 12.2 13.7 20.1 9.0 13.9 6.6 8.9 9.5 10.2 9.2 9.4 9.2 18.0 4.2 7.3 8.7 1.4 1.1 5.5 10.4 0.9 9.5 1.8 3.0 7.0 0.8 1.6 3.2 4.3 3.2 3.6 0.7 1.4 3.0 2.4 13.7 17.1 26.4 13.6 11.5 7.7 15.6 10.6 13.9 14.6 AXL "ARK, JTK11, Tyro7, UFO" ENSG00000167601 "AXL receptor tyrosine kinase" P30530 19 41219203-41261766 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Differentiation, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Oncogene, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 66.1;U-251 MG: 70.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 8.8;plasmacytoid DC: 18.3" "Group enriched" "Detected in many" 14 "dendritic cells: 18.3;NK-cells: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032501, HPA037422, HPA037423, HPA075217" Uncertain Supported "Vesicles,Plasma membrane,Actin filaments" 61000000 "Plasma membrane" "Vesicles, Actin filaments" "CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: , HPA075217: " "unprognostic (2.20e-1)" "unprognostic (2.02e-1)" "unprognostic (6.79e-3)" "unprognostic (1.01e-1)" "unprognostic (1.40e-1)" "unprognostic (8.49e-3)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (3.15e-2)" "unprognostic (2.82e-2)" "unprognostic (9.57e-3)" "unprognostic (1.98e-1)" "prognostic unfavourable (2.53e-7)" "unprognostic (1.16e-3)" "unprognostic (1.52e-2)" "unprognostic (5.56e-2)" "unprognostic (4.83e-3)" 38.0 15.4 10.6 11.7 12.7 1.3 27.1 6.3 12.1 26.2 26.8 13.4 8.1 9.1 28.0 19.4 21.8 17.4 17.8 18.5 11.5 6.1 7.8 13.0 20.0 7.6 10.6 9.3 20.9 5.1 9.6 5.6 26.6 10.1 19.5 10.2 16.8 7.8 20.4 14.1 13.8 12.8 29.4 10.7 27.3 16.2 22.4 10.4 3.4 12.0 8.4 5.8 35.6 18.3 0.1 18.3 0.9 0.2 8.8 0.3 0.2 52.5 21.2 1.3 0.1 4.8 4.8 0.0 41.8 37.6 61.4 38.1 1.1 24.7 0.0 17.0 66.1 4.4 0.0 28.1 52.9 0.0 0.0 0.0 14.0 0.8 17.4 0.0 0.0 3.6 0.5 36.2 56.2 22.7 2.0 0.0 38.0 0.0 0.0 0.0 0.5 10.2 0.0 22.4 0.0 27.4 0.0 0.0 0.0 10.8 0.0 0.2 0.1 0.9 46.6 43.5 29.7 41.5 70.8 0.0 0.1 0.1 29.0 0.0 32.3 0.9 0.2 0.1 0.1 0.2 0.2 0.1 0.3 0.1 4.2 0.1 0.2 0.2 0.3 8.8 0.1 18.3 0.2 0.2 10.6 12.7 6.3 12.1 11.5 6.1 10.6 9.3 10.1 10.4 AZIN1 "OAZI, OAZIN, ODC1L" ENSG00000155096 "Antizyme inhibitor 1" O14977 8 102826357-102893864 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027948 Approved Approved Vesicles Vesicles "HPA027948: AB_10602391" "unprognostic (1.16e-2)" "unprognostic (4.81e-3)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (8.55e-2)" "unprognostic (3.41e-2)" "unprognostic (7.19e-2)" "unprognostic (1.51e-2)" "unprognostic (2.10e-1)" "unprognostic (2.24e-1)" "unprognostic (2.07e-3)" "unprognostic (4.33e-3)" "unprognostic (1.25e-2)" "unprognostic (1.08e-1)" "unprognostic (2.83e-1)" "unprognostic (3.08e-2)" "unprognostic (1.68e-1)" 29.4 31.4 42.1 30.5 33.3 62.5 43.8 35.1 56.7 30.3 33.7 23.0 22.4 33.3 23.2 19.8 27.5 33.2 22.5 25.8 42.0 36.0 20.5 38.4 39.3 46.0 36.5 37.2 22.5 94.0 21.0 42.1 90.2 45.9 27.6 27.8 16.5 27.3 32.1 23.8 18.9 43.8 29.9 62.6 20.2 25.9 17.6 14.4 23.9 34.9 21.4 29.6 31.8 50.0 24.4 28.9 35.6 32.9 19.8 25.6 28.8 67.6 18.0 28.9 20.4 27.8 19.1 17.2 32.1 36.9 23.1 24.0 18.8 48.2 31.6 26.0 26.1 26.2 25.0 24.7 37.2 54.2 12.6 31.7 7.0 15.2 35.2 16.9 27.1 13.3 30.2 16.0 40.8 15.9 23.8 27.4 36.3 19.7 42.3 11.9 32.1 27.2 19.3 30.3 18.0 23.8 31.9 46.4 73.3 10.7 21.8 30.8 28.9 18.1 18.6 18.8 19.2 30.3 25.7 27.4 23.1 45.7 22.3 25.7 25.8 32.7 28.7 33.8 17.3 32.9 20.3 24.4 22.6 16.4 28.9 15.6 18.8 17.8 35.6 19.8 31.3 22.9 25.6 28.8 42.1 33.3 35.1 56.7 42.0 36.0 36.5 37.2 45.9 14.4 AZU1 "AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC" ENSG00000172232 "Azurocidin 1" P20160 19 825097-832018 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 238.2" "Cell line enriched" "Detected in some" 7 "THP-1: 150.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "classical monocyte: 3.3;neutrophil: 7.6" "Group enriched" "Detected in many" 6 "granulocytes: 7.6;monocytes: 3.3" "Not detected" "Not detected" "HPA055851, HPA075964" Enhanced Enhanced Vesicles "Secreted to blood" 290000 Vesicles "HPA055851: , HPA075964: " "unprognostic (1.12e-2)" "unprognostic (3.71e-2)" "unprognostic (4.44e-2)" "unprognostic (8.85e-3)" "unprognostic (1.62e-2)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (8.12e-2)" "unprognostic (3.32e-1)" "unprognostic (4.22e-3)" "unprognostic (2.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-6)" "unprognostic (1.11e-2)" "unprognostic (1.10e-1)" "unprognostic (2.46e-2)" "unprognostic (3.04e-2)" 0.3 0.2 0.4 0.2 0.5 238.2 0.6 0.0 0.6 0.2 0.2 1.0 0.0 0.2 0.2 0.2 0.2 0.8 0.2 34.6 0.4 0.5 0.2 1.5 15.3 0.2 0.2 0.0 0.5 0.1 0.1 0.9 3.8 0.2 0.2 0.2 0.2 0.6 0.2 1.0 0.4 0.2 0.2 0.1 18.6 0.2 1.2 0.0 20.6 1.3 0.0 0.2 0.1 0.4 0.0 0.8 7.6 3.3 0.0 0.3 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 150.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 3.3 0.2 0.3 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 7.6 0.0 0.5 0.0 0.0 4.1 0.4 0.5 0.0 0.6 0.4 0.5 0.2 0.0 0.2 0.0 B3GALNT1 "B3GALT3, beta3Gal-T3, galT3, GLOB, P1" ENSG00000169255 "Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)" O75752 3 161083883-161105384 "Blood group antigen proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 36.8" "Cell line enhanced" "Detected in many" "PC-3: 16.9;RT4: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 4.9;NK-cell: 16.7" "Group enriched" "Detected in many" 7 "granulocytes: 4.9;NK-cells: 16.7" "Low region specificity" "Detected in all" HPA041204 Approved Vesicles 290000 Vesicles "HPA041204: AB_10795585" "unprognostic (3.85e-2)" "unprognostic (5.11e-3)" "unprognostic (3.02e-1)" "unprognostic (1.06e-2)" "unprognostic (7.83e-2)" "unprognostic (4.07e-2)" "unprognostic (9.26e-5)" "unprognostic (1.49e-2)" "unprognostic (1.12e-2)" "unprognostic (1.88e-2)" "unprognostic (3.44e-2)" "unprognostic (3.24e-1)" "unprognostic (2.09e-3)" "unprognostic (1.32e-1)" "unprognostic (4.90e-2)" "unprognostic (3.66e-2)" "unprognostic (3.19e-3)" 3.8 5.4 14.0 3.0 24.5 3.1 7.4 17.2 24.7 15.5 2.3 5.5 2.6 1.5 8.3 6.9 5.4 10.4 7.1 36.8 15.4 21.6 14.3 1.0 10.8 3.5 11.3 16.2 13.8 7.8 6.5 8.5 10.0 17.7 8.9 2.0 7.5 14.8 6.7 1.1 2.2 1.9 7.2 7.6 4.2 7.5 6.2 5.0 1.1 19.5 2.3 3.9 10.5 4.7 1.4 1.4 4.9 0.2 16.7 0.7 0.5 6.6 0.2 3.1 0.1 0.3 1.0 0.1 3.7 3.2 8.1 2.8 4.4 5.0 0.0 14.8 3.0 1.5 0.0 6.4 2.6 0.1 0.0 3.6 2.8 0.0 4.7 0.1 0.1 9.9 1.9 2.2 0.5 11.8 0.0 0.0 3.3 10.7 0.0 0.0 7.4 16.9 0.1 0.0 0.1 3.8 51.5 6.2 0.0 9.3 3.4 2.7 14.2 5.4 0.0 0.1 6.5 0.2 0.1 1.5 0.0 0.0 5.7 0.0 0.0 4.9 0.2 0.0 0.4 0.1 0.4 1.4 0.2 0.4 1.4 0.3 0.5 0.7 0.4 16.7 0.0 1.0 0.0 0.5 14.0 24.5 17.2 24.7 15.4 21.6 11.3 16.2 17.7 5.0 B3GAT1 "CD57, GlcAT-P, HNK-1, LEU7, NK-1" ENSG00000109956 "Beta-1,3-glucuronyltransferase 1" Q9P2W7 11 134378504-134411918 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 76.0" "Cell line enhanced" "Detected in some" "AF22: 17.0;HMC-1: 18.8;NTERA-2: 16.3;SH-SY5Y: 6.2" "Group enriched" "Detected in some" 11 "glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.8;naive CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 39 "T-cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002500, CAB010893, HPA069468" Enhanced Supported Vesicles "Secreted in brain" Vesicles "CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: " "unprognostic (6.72e-2)" "unprognostic (3.97e-4)" "unprognostic (2.13e-2)" "unprognostic (1.40e-3)" "unprognostic (5.52e-2)" "unprognostic (2.60e-3)" "unprognostic (6.30e-2)" "unprognostic (1.96e-2)" "unprognostic (8.74e-2)" "unprognostic (2.72e-1)" "unprognostic (1.57e-3)" "unprognostic (1.58e-1)" "unprognostic (9.34e-3)" "unprognostic (3.87e-3)" "unprognostic (2.42e-1)" "unprognostic (4.07e-2)" "unprognostic (2.26e-2)" 1.5 5.8 38.9 1.7 23.7 2.1 5.6 9.2 76.0 1.7 1.5 25.8 0.0 1.8 1.6 1.7 1.4 1.6 1.7 1.5 43.4 14.9 2.1 6.0 1.8 3.3 30.3 19.5 1.5 1.7 1.4 0.9 1.4 19.7 4.2 1.5 2.1 2.2 1.8 1.4 1.8 1.6 1.5 45.1 2.1 6.0 1.8 25.2 0.0 7.7 0.0 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.4 0.0 0.0 17.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.9 0.0 0.8 1.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 16.3 0.0 0.3 0.0 1.2 0.0 0.1 2.3 6.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.2 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.8 1.9 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.4 38.9 23.7 9.2 33.7 43.4 14.9 30.3 19.5 19.7 25.2 B3GNT2 "B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT" ENSG00000170340 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2" Q9NY97 2 62196113-62224731 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005997 Approved Approved Vesicles 43000000 Vesicles "HPA005997: AB_1845234" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (2.64e-2)" "unprognostic (1.23e-2)" "unprognostic (1.67e-1)" "unprognostic (1.51e-1)" "unprognostic (1.55e-2)" "unprognostic (2.13e-2)" "unprognostic (3.76e-1)" "prognostic unfavourable (1.62e-4)" "unprognostic (3.63e-1)" "unprognostic (1.11e-2)" "unprognostic (9.55e-2)" "unprognostic (3.05e-2)" "unprognostic (3.18e-1)" "unprognostic (1.25e-1)" 18.9 14.3 8.6 10.8 23.0 41.6 17.5 3.1 14.1 18.4 17.9 7.4 5.6 17.9 19.8 8.0 24.5 8.7 18.1 20.9 7.6 11.5 24.4 14.2 23.9 13.9 9.7 7.1 9.0 43.2 5.4 25.9 22.8 9.5 7.5 16.3 14.4 17.2 6.0 5.2 13.0 21.7 16.3 7.6 14.6 12.0 7.0 10.6 27.0 15.6 8.5 18.5 11.8 14.7 8.4 6.8 28.3 5.6 20.3 19.3 8.2 7.6 5.3 8.1 3.5 8.9 4.0 23.3 7.5 8.3 6.0 8.0 10.9 12.4 8.3 6.9 6.9 7.4 5.1 6.3 10.4 17.3 4.1 20.5 2.5 6.4 6.7 12.2 9.2 4.9 11.9 11.5 4.1 8.9 11.1 5.2 7.2 5.8 23.2 18.3 7.7 2.2 42.6 5.6 4.5 11.4 7.5 7.8 5.8 5.3 11.5 8.6 3.3 14.4 10.1 7.3 6.4 12.2 7.4 14.8 5.2 35.9 5.7 21.2 7.0 7.2 4.5 28.3 11.0 4.4 15.6 7.6 8.2 19.3 5.5 8.4 9.9 14.4 11.3 20.3 5.6 6.8 13.2 8.2 8.6 23.0 3.1 14.1 7.6 11.5 9.7 7.1 9.5 10.6 B4GALNT3 "B4GalNac-T3, FLJ16224, FLJ40362" ENSG00000139044 "Beta-1,4-N-acetyl-galactosaminyltransferase 3" Q6L9W6 12 460364-563509 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 43.1" "Cell line enhanced" "Detected in some" "BEWO: 25.8;HDLM-2: 9.1;HEK 293: 9.1;NTERA-2: 11.4;U-937: 11.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011404 Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" "Golgi apparatus" Vesicles "HPA011404: AB_1845242" "unprognostic (2.38e-2)" "unprognostic (9.59e-3)" "unprognostic (1.38e-1)" "prognostic favourable (1.69e-10)" "unprognostic (4.22e-2)" "unprognostic (4.63e-2)" "unprognostic (1.46e-2)" "unprognostic (9.53e-3)" "unprognostic (3.29e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (9.99e-3)" "unprognostic (2.82e-1)" "unprognostic (2.48e-2)" "unprognostic (2.98e-1)" 0.3 5.7 1.4 2.1 3.8 1.5 1.1 0.3 8.2 6.1 12.8 0.6 0.4 0.8 8.5 2.9 6.0 3.4 9.6 16.8 5.6 0.9 4.1 0.3 6.2 0.2 0.9 1.7 2.1 7.9 2.5 14.7 0.1 2.0 1.6 9.8 1.5 3.8 1.1 2.7 11.0 1.7 1.9 0.5 0.4 43.1 8.0 0.1 1.0 2.1 9.1 4.1 1.8 4.0 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 25.8 0.0 0.0 0.0 0.0 6.4 5.0 0.0 0.6 0.0 2.8 6.4 0.7 0.0 9.1 9.1 0.0 0.0 1.3 0.0 0.0 3.8 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.4 0.5 0.4 3.5 0.0 6.2 5.5 3.1 2.0 0.6 0.2 0.7 0.6 2.0 0.0 0.0 2.0 0.2 0.6 0.0 0.1 0.1 0.0 11.1 4.3 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 3.8 0.3 8.2 5.6 0.9 0.9 1.7 2.0 0.1 B4GALT2 beta4Gal-T2 ENSG00000117411 "Beta-1,4-galactosyltransferase 2" O60909 1 43978943-43991170 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007620, HPA047739" Supported Supported "Golgi apparatus,Vesicles" 12000 "Golgi apparatus, Vesicles" "HPA007620: , HPA047739: " "unprognostic (1.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (7.59e-2)" "unprognostic (1.19e-1)" "unprognostic (2.35e-1)" "prognostic unfavourable (2.96e-5)" "unprognostic (1.12e-2)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" "unprognostic (4.23e-3)" "unprognostic (7.58e-2)" "prognostic unfavourable (3.62e-5)" "unprognostic (6.54e-2)" "unprognostic (1.52e-1)" "unprognostic (7.66e-2)" "unprognostic (3.12e-3)" 18.6 8.6 34.5 10.1 22.4 4.6 15.6 8.1 35.7 18.4 16.1 16.1 10.7 9.4 13.3 8.5 20.2 11.4 11.9 23.3 25.3 18.9 8.4 24.2 7.7 4.4 18.9 15.6 15.3 39.5 9.9 10.6 9.9 12.7 13.5 10.4 8.7 21.4 21.5 41.0 19.5 9.4 21.3 16.1 5.2 11.2 11.4 11.3 1.9 9.0 12.1 10.1 16.5 11.7 1.7 0.4 0.1 0.6 0.2 2.6 0.7 19.8 14.5 15.2 25.8 20.6 18.5 15.2 22.6 18.6 18.0 16.5 9.5 17.6 13.1 11.5 36.0 13.8 13.5 23.1 8.4 13.2 25.7 8.7 10.1 21.8 16.7 8.3 0.3 16.1 27.0 12.9 26.4 20.8 16.4 8.5 14.0 14.3 4.3 8.3 21.1 18.2 15.6 20.4 20.5 12.7 9.3 27.6 22.9 9.9 31.2 15.1 13.6 9.9 16.3 31.3 40.2 21.6 25.1 3.0 5.9 5.6 14.0 6.3 20.9 0.0 0.2 0.0 2.6 0.6 2.4 1.7 1.2 2.2 0.4 0.5 0.0 2.0 0.1 0.2 0.1 0.2 1.1 0.7 34.5 22.4 8.1 35.7 25.3 18.9 18.9 15.6 12.7 11.3 BAAT BAT ENSG00000136881 "Bile acid-CoA:amino acid N-acyltransferase" Q14032 9 101360417-101383519 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Serine esterase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 128.4" "Cell line enhanced" "Detected in some" "A549: 6.1;CACO-2: 3.4;Hep G2: 2.4" "Cancer enriched" "Detected in many" 42 "liver cancer: 181.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021251, HPA021330" Enhanced Uncertain Vesicles 470000 Vesicles "HPA021251: AB_1845247, HPA021330: " "unprognostic (2.53e-2)" "unprognostic (1.81e-1)" "unprognostic (9.97e-2)" "unprognostic (9.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.68e-2)" "prognostic favourable (4.97e-4)" "unprognostic (2.14e-2)" "unprognostic (6.19e-2)" "unprognostic (4.43e-4)" "unprognostic (3.65e-1)" "unprognostic (2.15e-1)" "prognostic unfavourable (4.24e-7)" "unprognostic (1.74e-1)" "unprognostic (2.12e-1)" "unprognostic (2.17e-2)" "unprognostic (1.75e-1)" 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.8 0.0 0.1 0.1 0.2 128.4 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.7 0.1 0.1 6.1 0.4 0.3 0.0 0.0 0.0 0.3 0.1 0.1 0.3 3.4 0.1 0.6 0.2 0.0 0.3 0.1 0.2 0.5 0.3 0.1 0.5 0.2 2.4 0.0 0.9 0.3 0.0 1.0 0.1 0.0 0.0 0.7 0.4 0.5 0.1 0.2 0.3 1.0 0.7 0.2 1.1 0.2 0.6 0.2 0.3 0.4 0.4 0.2 0.5 0.0 0.2 0.1 0.6 0.6 0.2 0.4 0.4 0.6 0.5 0.5 0.2 0.6 0.3 0.2 0.0 0.7 0.1 0.1 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 BAG5 ENSG00000166170 "BCL2 associated athanogene 5" Q9UL15 14 103556544-103562831 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 69.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016429 Enhanced Supported Vesicles Vesicles "HPA016429: AB_1845261" "unprognostic (3.02e-2)" "unprognostic (2.98e-2)" "unprognostic (1.05e-2)" "unprognostic (6.26e-2)" "unprognostic (2.54e-1)" "unprognostic (5.22e-2)" "unprognostic (1.99e-3)" "unprognostic (2.78e-1)" "unprognostic (1.04e-1)" "unprognostic (4.77e-3)" "unprognostic (2.34e-1)" "unprognostic (3.80e-2)" "prognostic favourable (1.58e-8)" "unprognostic (2.51e-1)" "unprognostic (1.52e-1)" "unprognostic (3.69e-2)" "unprognostic (2.53e-1)" 16.0 6.7 8.4 8.1 9.4 13.2 10.6 14.8 10.6 11.5 10.1 10.6 9.5 7.0 11.7 9.5 13.6 9.3 7.4 7.3 8.9 8.4 13.5 8.5 8.8 9.3 8.7 7.6 11.4 7.0 9.0 13.2 16.1 10.3 10.3 8.4 8.2 10.4 11.2 9.3 13.1 11.5 10.7 9.7 11.9 8.4 69.8 8.6 11.1 17.0 10.7 11.8 11.7 9.4 10.1 15.3 22.8 21.2 14.7 14.2 12.7 14.6 13.4 16.0 14.3 14.8 15.1 18.0 16.9 11.8 12.1 11.4 11.1 17.4 26.0 15.0 16.5 21.3 12.7 17.9 19.3 11.9 9.6 17.1 15.7 8.2 9.5 22.5 17.6 10.7 23.2 12.7 15.9 12.5 13.7 19.1 16.3 17.7 20.8 10.0 9.6 16.4 21.4 20.2 11.0 19.7 37.6 18.6 12.4 19.7 16.0 12.8 20.8 12.1 16.8 13.3 11.5 20.6 17.2 13.2 20.7 30.6 15.0 11.8 16.5 22.8 14.1 12.8 11.6 15.7 13.9 8.3 12.8 10.8 15.3 10.1 14.2 12.9 10.7 14.7 21.2 7.2 11.3 12.7 8.4 9.4 14.8 10.6 8.9 8.4 8.7 7.6 10.3 8.6 BAMBI NMA ENSG00000095739 "BMP and activin membrane bound inhibitor" Q13145 10 28677342-28682939 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 46.8;seminal vesicle: 52.4" "Cell line enhanced" "Detected in many" "CACO-2: 42.8;SK-MEL-30: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA010819, HPA010866" Approved Approved "Nucleoli fibrillar center,Vesicles,Lipid droplets" Vesicles "Nucleoli fibrillar center, Lipid droplets" "HPA010819: , HPA010866: AB_10601686" "unprognostic (7.02e-3)" "unprognostic (4.52e-2)" "unprognostic (1.28e-2)" "unprognostic (3.17e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "prognostic unfavourable (9.42e-6)" "unprognostic (1.09e-1)" "unprognostic (6.45e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-3)" "unprognostic (9.29e-2)" "prognostic favourable (5.25e-4)" "unprognostic (1.01e-1)" "unprognostic (3.24e-1)" "unprognostic (2.38e-2)" "unprognostic (2.10e-2)" 2.0 24.7 6.7 1.8 6.9 3.0 13.6 2.2 6.3 3.9 2.3 12.9 15.5 1.1 10.1 2.0 1.1 2.8 3.0 22.8 6.7 6.4 11.2 12.9 5.7 3.1 12.0 2.9 46.8 3.9 7.4 4.5 20.9 10.5 6.5 2.8 30.4 3.8 52.4 1.2 2.7 1.1 12.7 10.8 9.0 2.3 4.8 7.9 0.1 0.6 2.1 1.3 13.8 11.6 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.2 10.8 1.1 0.6 1.3 0.0 6.5 2.6 0.9 4.2 2.7 42.8 4.5 0.1 1.6 1.9 3.2 2.6 0.4 1.9 2.6 6.0 10.1 1.6 16.2 1.5 0.6 13.4 1.0 0.6 2.8 0.4 0.6 5.7 4.9 0.8 17.8 0.0 0.7 19.6 2.7 0.1 2.0 0.9 3.4 10.4 1.8 1.4 3.5 20.8 51.1 6.1 0.7 0.0 2.8 2.1 4.5 1.3 0.1 3.7 0.0 0.2 2.3 17.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.7 6.9 2.2 4.8 6.7 6.4 12.0 2.9 10.5 7.9 BARX1 ENSG00000131668 "BARX homeobox 1" Q9HBU1 9 93951622-93955372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "stomach 1: 59.7" "Group enriched" "Detected in some" 7 "AN3-CA: 15.2;HMC-1: 36.4;NTERA-2: 10.8;THP-1: 14.4" "Cancer enhanced" "Detected in many" "stomach cancer: 19.3" "Region enhanced" "Detected in single" "hippocampal formation: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055858 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA055858: " "unprognostic (6.19e-4)" "unprognostic (4.81e-2)" "unprognostic (1.58e-2)" "prognostic unfavourable (8.16e-6)" "unprognostic (4.96e-3)" "prognostic unfavourable (1.02e-4)" "unprognostic (1.46e-2)" "unprognostic (5.20e-3)" "unprognostic (1.23e-2)" "unprognostic (8.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (9.68e-13)" "unprognostic (7.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.60e-1)" "unprognostic (2.16e-2)" 4.3 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.2 2.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.4 1.5 0.0 0.2 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 59.7 5.6 0.0 0.0 0.5 12.3 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 10.8 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.2 0.0 BBOX1 "BBH, BBOX, G-BBH, gamma-BBH" ENSG00000129151 "Gamma-butyrobetaine hydroxylase 1" O75936 11 27040725-27127809 "Enzymes, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 139.4;liver: 39.3" "Group enriched" "Detected in some" 5 "hTCEpi: 15.9;RPTEC TERT1: 9.8" "Group enriched" "Detected in many" 6 "glioma: 23.7;renal cancer: 59.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007600, HPA027823" Enhanced Approved Uncertain "Vesicles,Actin filaments" 25000 Vesicles "Actin filaments" "HPA007600: AB_1845284, HPA027823: AB_10602394" "unprognostic (9.96e-3)" "unprognostic (1.80e-2)" "unprognostic (8.17e-2)" "prognostic unfavourable (6.65e-4)" "unprognostic (7.03e-2)" "unprognostic (6.66e-2)" "unprognostic (7.05e-3)" "unprognostic (1.13e-2)" "unprognostic (3.03e-1)" "unprognostic (6.89e-2)" "unprognostic (2.03e-2)" "unprognostic (1.60e-1)" "prognostic favourable (1.45e-5)" "unprognostic (1.71e-2)" "unprognostic (2.70e-1)" "unprognostic (3.22e-1)" "unprognostic (1.73e-3)" 0.9 0.5 9.2 0.5 7.1 0.5 8.2 3.9 7.5 1.5 0.6 4.9 0.1 0.5 0.6 3.6 5.7 3.8 3.6 0.5 7.9 6.3 139.4 39.3 0.6 0.6 10.9 4.3 0.5 0.8 0.5 8.3 1.3 9.2 0.7 0.5 0.0 2.2 2.0 0.6 16.4 0.5 0.5 7.1 0.5 0.6 0.6 5.8 0.0 8.9 1.6 0.7 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.0 15.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 7.1 3.9 7.5 7.9 6.3 10.9 4.3 9.2 5.8 BCAS1 "AIBC1, NABC1" ENSG00000064787 "Breast carcinoma amplified sequence 1" O75363 20 53936777-54070594 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 134.0;intestine: 40.3;stomach 1: 85.5" "Group enriched" "Detected in some" 6 "RT4: 41.0;SK-BR-3: 85.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033558, HPA051816, HPA054745" Enhanced Approved Vesicles Vesicles "CAB033558: AB_2274632, HPA051816: AB_2681623, HPA054745: AB_2682590" "unprognostic (6.41e-2)" "unprognostic (1.01e-2)" "unprognostic (6.20e-2)" "unprognostic (7.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "unprognostic (5.54e-2)" "unprognostic (1.86e-1)" "unprognostic (3.80e-1)" "unprognostic (1.19e-1)" "unprognostic (5.25e-2)" "unprognostic (2.91e-2)" "unprognostic (4.70e-3)" "unprognostic (3.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.75e-1)" "unprognostic (7.77e-3)" 1.3 1.0 49.8 3.8 63.4 0.9 2.8 5.4 37.2 5.1 36.9 97.6 0.0 10.7 1.6 2.1 4.7 1.7 5.4 0.9 51.6 35.6 1.7 0.9 2.4 1.1 75.3 14.7 0.9 1.0 0.8 0.3 0.9 69.7 19.1 40.3 0.0 2.9 1.0 0.9 1.1 17.1 2.4 134.0 1.1 85.5 2.5 49.2 0.0 0.8 0.0 4.1 21.8 1.1 1.6 0.2 1.0 0.2 0.3 5.7 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 41.0 0.0 0.0 0.0 85.9 0.0 2.8 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.5 0.2 0.1 0.5 0.2 3.0 1.6 1.0 0.3 0.0 0.5 0.2 0.1 1.0 0.3 0.2 0.2 5.7 0.2 49.8 63.4 5.4 32.3 51.6 35.6 75.3 14.7 69.7 49.2 BCL2L12 ENSG00000126453 "BCL2 like 12" Q9HB09 19 49665142-49673916 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020856 Approved Approved "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA020856: AB_1845320" "unprognostic (2.59e-1)" "unprognostic (3.96e-2)" "unprognostic (2.24e-1)" "unprognostic (5.72e-2)" "unprognostic (3.64e-1)" "unprognostic (3.68e-2)" "unprognostic (6.80e-3)" "unprognostic (3.87e-3)" "unprognostic (6.12e-2)" "unprognostic (8.90e-2)" "unprognostic (1.60e-2)" "unprognostic (2.33e-2)" "prognostic unfavourable (8.75e-5)" "unprognostic (8.67e-2)" "unprognostic (3.62e-2)" "unprognostic (2.37e-1)" "unprognostic (2.56e-1)" 6.7 6.5 2.8 15.3 3.3 12.6 7.9 1.2 3.2 8.8 11.8 2.9 9.3 8.3 8.2 9.1 14.0 7.2 11.3 9.5 3.3 1.8 8.1 15.3 12.0 15.5 3.7 2.2 9.2 18.0 3.2 2.6 21.5 3.8 9.0 5.8 6.3 10.6 9.4 12.5 6.5 9.0 8.1 3.4 14.8 8.9 10.0 3.8 29.8 6.6 18.1 15.1 8.4 7.0 13.9 22.4 13.4 9.8 12.0 13.6 5.6 32.9 20.0 16.2 30.4 4.2 4.1 19.0 18.7 7.6 18.8 20.1 27.8 18.0 18.6 9.0 6.3 16.4 14.7 12.3 10.3 23.2 32.3 17.1 13.6 19.3 3.7 17.6 20.9 4.9 6.0 21.0 6.0 12.5 43.7 24.0 9.9 18.7 21.1 30.5 20.8 26.0 27.4 17.3 20.1 8.2 16.2 0.3 9.5 19.1 25.9 13.3 10.8 22.6 7.5 21.3 25.3 14.9 30.7 20.2 31.2 35.4 9.1 25.0 21.1 9.6 6.8 13.4 11.4 9.8 13.6 13.9 12.3 11.0 6.0 11.6 11.9 11.6 9.2 12.0 7.1 22.4 12.4 5.6 2.8 3.3 1.2 3.2 3.3 1.8 3.7 2.2 3.8 3.8 BCL3 "BCL4, D19S37" ENSG00000069399 "B cell CLL/lymphoma 3" P20749 19 44747705-44760044 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 26.5;Karpas-707: 22.0;SiHa: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 16.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 16.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002051, HPA047514" Approved Supported Nucleoplasm,Vesicles,Midbody Nucleoplasm "Vesicles, Midbody" "CAB002051: AB_563428, HPA047514: " "prognostic favourable (9.67e-4)" "unprognostic (8.82e-2)" "unprognostic (2.81e-1)" "unprognostic (7.54e-2)" "prognostic unfavourable (4.01e-4)" "unprognostic (3.49e-2)" "unprognostic (2.34e-3)" "unprognostic (2.79e-1)" "prognostic favourable (3.74e-4)" "unprognostic (2.09e-2)" "unprognostic (9.23e-2)" "unprognostic (1.81e-1)" "prognostic unfavourable (3.13e-14)" "unprognostic (8.24e-2)" "unprognostic (1.36e-1)" "unprognostic (3.77e-2)" "unprognostic (3.04e-2)" 17.7 13.0 4.0 21.1 5.6 35.2 18.7 1.4 4.7 11.7 14.9 2.4 5.9 24.5 10.4 9.7 27.1 12.5 22.7 20.1 3.9 2.0 17.8 52.1 36.4 20.5 4.3 0.5 26.5 13.2 2.4 9.2 9.5 5.6 16.0 8.0 8.8 13.7 13.7 20.2 9.0 35.5 11.5 6.5 41.6 15.0 8.3 4.0 6.5 13.9 22.9 37.0 18.7 11.9 1.3 2.6 16.5 2.4 1.8 1.5 0.7 3.8 13.4 0.3 7.1 2.6 5.4 0.6 2.4 2.6 1.5 2.2 2.8 7.1 3.8 5.5 4.7 4.3 0.9 4.0 0.9 26.5 0.2 0.4 7.0 3.6 6.2 0.3 11.4 9.4 3.2 3.3 4.2 4.0 0.5 22.0 0.9 3.2 0.0 2.9 0.3 5.6 1.7 2.7 1.4 6.8 8.1 0.0 0.4 28.2 14.4 0.7 5.0 2.9 6.7 4.8 5.0 7.5 0.9 20.9 8.2 3.9 8.9 0.5 3.6 0.2 2.4 4.2 0.7 1.6 1.0 1.3 0.9 1.1 2.1 1.1 0.5 0.6 16.5 1.8 0.9 2.6 1.5 0.7 4.0 5.6 1.4 4.7 3.9 2.0 4.3 0.5 5.6 4.0 BCL6B "BAZF, ZBTB28, ZNF62" ENSG00000161940 "B cell CLL/lymphoma 6B" Q8N143 17 7023020-7030290 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 7.7;HMC-1: 23.5;HUVEC TERT2: 41.7;TIME: 16.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059147, HPA075112" Uncertain Approved Vesicles Vesicles "HPA059147: , HPA075112: " "unprognostic (5.61e-2)" "unprognostic (9.43e-3)" "unprognostic (2.33e-2)" "unprognostic (2.12e-1)" "unprognostic (1.40e-1)" "prognostic favourable (8.56e-5)" "unprognostic (2.81e-1)" "unprognostic (2.28e-2)" "unprognostic (4.81e-2)" "unprognostic (1.80e-1)" "unprognostic (6.10e-2)" "unprognostic (1.76e-1)" "prognostic unfavourable (4.04e-4)" "unprognostic (7.14e-2)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "unprognostic (4.26e-2)" 23.9 4.0 2.5 4.4 3.4 0.0 11.5 2.0 4.1 5.2 3.9 2.3 1.2 2.5 9.7 3.9 4.0 4.2 10.8 12.7 2.4 2.4 6.0 6.1 26.2 5.2 3.4 0.8 7.4 3.0 2.4 4.7 15.9 4.9 6.8 1.8 4.5 4.6 2.9 8.6 3.5 4.0 6.3 2.9 17.9 3.4 2.3 2.4 0.5 10.0 8.2 2.5 6.6 28.6 1.1 0.6 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.7 0.0 0.0 0.2 0.0 23.5 0.0 0.0 0.0 0.0 41.7 1.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 16.4 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 3.4 2.0 4.1 2.4 2.4 3.4 0.8 4.9 2.4 BCL7A BCL7 ENSG00000110987 "BCL tumor suppressor 7A" Q4VC05 12 122019422-122062044 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 25.9;MOLT-4: 19.0;U-698: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 8.4;plasmacytoid DC: 9.7" "Group enriched" "Detected in many" 10 "B-cells: 8.4;dendritic cells: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019762 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA019762: AB_10962489" "unprognostic (3.27e-1)" "unprognostic (2.97e-2)" "prognostic unfavourable (6.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.46e-1)" "unprognostic (1.23e-1)" "prognostic unfavourable (2.04e-4)" "unprognostic (5.18e-1)" "unprognostic (5.13e-2)" "unprognostic (1.06e-2)" "unprognostic (3.13e-1)" "unprognostic (3.11e-1)" "prognostic favourable (1.54e-6)" "unprognostic (4.86e-2)" "unprognostic (8.56e-2)" "unprognostic (6.16e-3)" "unprognostic (1.51e-2)" 3.8 3.7 13.0 9.8 14.5 9.9 6.5 19.8 18.2 6.7 4.2 6.8 3.3 3.6 6.0 7.4 3.3 10.3 4.3 9.4 9.5 7.5 10.7 5.3 5.1 19.4 6.6 15.9 4.9 11.7 8.3 6.1 2.8 6.8 6.3 3.8 3.8 8.2 7.2 12.8 8.2 3.4 4.1 5.1 6.5 4.4 3.1 7.9 26.4 11.1 3.5 15.8 6.9 5.4 8.4 9.7 0.1 0.1 0.5 0.9 0.6 1.7 2.4 7.9 5.6 0.5 0.3 1.7 1.0 1.0 1.7 1.5 1.0 0.7 25.9 2.9 0.8 2.3 5.7 5.5 1.4 0.0 9.4 1.3 0.2 1.4 1.7 4.0 2.3 1.2 5.2 1.2 7.1 2.1 5.8 0.0 1.0 3.6 19.0 0.3 2.8 4.0 10.5 2.7 0.3 3.1 4.4 7.9 8.9 1.3 0.3 3.3 5.3 3.3 1.9 0.3 1.7 2.9 1.7 2.7 1.8 29.9 0.5 2.5 1.8 0.1 0.0 0.0 0.1 0.0 0.0 2.9 0.2 0.2 2.2 8.4 0.9 0.6 0.1 0.5 0.1 9.7 0.0 0.6 13.0 14.5 19.8 18.0 9.5 7.5 6.6 15.9 6.8 7.9 BEND7 "C10orf30, FLJ40283" ENSG00000165626 "BEN domain containing 7" Q8N7W2 10 13438484-13528974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.6" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037835 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoplasm, Nucleoli fibrillar center, Vesicles" "HPA037835: AB_10669722" "unprognostic (6.22e-2)" "unprognostic (1.80e-1)" "unprognostic (1.89e-1)" "unprognostic (1.33e-2)" "unprognostic (1.18e-2)" "unprognostic (4.62e-3)" "unprognostic (3.24e-3)" "unprognostic (3.52e-2)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.06e-1)" "unprognostic (4.19e-3)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (5.20e-3)" 2.3 1.7 1.1 0.3 1.3 0.0 3.0 5.4 0.8 3.0 3.6 7.4 2.9 6.2 0.5 5.7 2.6 1.5 0.8 1.4 8.4 3.6 3.3 0.0 1.2 3.3 5.4 9.8 4.4 1.5 2.1 2.6 5.3 2.6 4.5 0.8 8.7 2.4 0.6 0.9 3.5 8.1 11.2 0.0 2.1 1.4 0.0 0.0 2.7 0.0 0.1 0.0 0.0 7.7 4.4 5.7 2.5 0.1 0.0 7.4 3.0 0.1 8.7 5.1 3.6 14.6 0.0 4.2 6.5 0.4 8.1 2.2 7.4 0.0 7.3 0.1 0.0 11.0 3.3 0.0 0.0 0.2 5.1 1.3 0.0 8.2 4.5 0.0 7.5 5.8 0.1 0.0 2.5 1.0 0.0 4.1 0.0 6.1 1.3 0.5 4.4 8.9 0.0 0.2 0.2 3.7 6.8 1.7 11.4 10.5 4.0 0.0 0.0 0.0 2.7 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 BHLHE41 "BHLHB3, bHLHe41, DEC2, SHARP-1, SHARP1" ENSG00000123095 "Basic helix-loop-helix family member e41" Q9C0J9 12 26120026-26125127 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.9" "Cell line enhanced" "Detected in many" "Karpas-707: 15.1;RT4: 47.2;U-266/70: 20.2;U-87 MG: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 35 "memory B-cell: 5.3;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 54 "B-cells: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056035, HPA077617" Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA056035: , HPA077617: " "unprognostic (1.57e-3)" "unprognostic (1.57e-2)" "unprognostic (2.32e-2)" "unprognostic (6.62e-2)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" "unprognostic (5.86e-2)" "unprognostic (2.59e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.96e-2)" "prognostic unfavourable (8.73e-5)" "unprognostic (5.23e-2)" "unprognostic (1.65e-1)" "unprognostic (5.61e-3)" "prognostic favourable (1.09e-4)" 7.0 11.7 23.8 5.8 32.3 1.2 10.7 22.9 26.9 30.6 7.6 33.3 3.0 2.8 6.9 15.6 3.2 34.5 14.1 14.7 25.9 19.6 3.8 1.4 9.1 6.0 38.9 14.0 10.9 6.4 6.2 11.2 8.3 28.3 8.2 9.1 19.0 13.4 11.7 58.9 3.8 4.3 4.3 49.6 6.2 4.4 4.0 44.0 0.9 43.6 6.4 13.3 16.5 6.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.0 8.0 3.7 1.8 0.8 1.4 0.1 0.5 0.0 5.0 0.0 0.7 1.6 4.2 0.1 0.7 0.4 0.0 0.6 0.3 0.0 0.0 0.3 2.1 0.1 0.6 0.4 2.9 5.8 0.0 0.0 15.1 0.9 0.4 0.0 1.4 3.9 2.9 0.0 0.7 11.5 1.9 47.2 0.0 0.1 0.5 0.2 10.6 0.0 0.0 2.5 2.7 3.2 0.3 2.2 20.2 11.6 0.0 17.4 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 32.3 22.9 26.9 25.9 19.6 38.9 14.0 28.3 44.0 BICD1 ENSG00000151746 "BICD cargo adaptor 1" Q96G01 12 32106835-32383633 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 39.0" "Cell line enhanced" "Detected in many" "NTERA-2: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041309 Approved Approved Vesicles Vesicles "HPA041309: AB_10804000" "unprognostic (1.40e-1)" "unprognostic (1.18e-2)" "unprognostic (1.73e-2)" "unprognostic (2.10e-1)" "unprognostic (2.06e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-6)" "unprognostic (5.93e-2)" "unprognostic (4.57e-1)" "unprognostic (3.64e-1)" "unprognostic (8.19e-2)" "unprognostic (9.66e-2)" "prognostic unfavourable (2.33e-7)" "unprognostic (1.72e-1)" "unprognostic (1.74e-1)" "unprognostic (5.37e-2)" "unprognostic (1.36e-1)" 6.2 5.3 11.7 8.3 10.6 4.1 5.3 39.0 13.7 19.9 4.4 9.2 1.9 3.3 13.8 10.4 3.1 14.8 7.7 6.0 10.7 7.6 6.7 1.9 6.6 8.6 6.6 10.9 29.0 2.5 12.6 9.9 12.1 8.3 6.5 4.5 5.6 3.7 4.1 4.6 2.9 4.5 8.2 8.3 10.4 4.0 4.4 8.0 8.8 9.5 1.9 7.4 6.2 4.9 5.4 6.3 0.1 0.9 2.8 4.7 1.6 8.4 6.8 4.5 2.7 4.1 4.7 4.3 10.0 4.2 10.0 6.7 6.3 5.1 13.4 7.5 9.1 3.3 18.9 7.8 14.4 8.4 5.5 13.8 5.2 3.3 4.9 11.2 8.4 3.2 3.6 11.0 9.0 9.5 7.1 22.6 4.3 3.4 12.1 4.2 38.1 6.1 9.4 13.5 7.9 11.5 4.6 17.7 10.6 6.7 0.4 6.2 5.3 2.9 10.6 14.1 13.3 9.4 13.5 7.6 10.8 21.7 9.4 5.8 16.3 0.0 0.9 0.0 3.5 0.3 4.7 5.4 3.2 2.2 1.5 5.2 3.6 2.8 0.1 2.8 0.0 6.3 4.1 1.6 11.7 10.6 39.0 13.7 10.7 7.6 6.6 10.9 8.3 8.0 BICDL1 "BICDR-1, CCDC64, FLJ26450" ENSG00000135127 "BICD family like cargo adaptor 1" Q6ZP65 12 119989869-120094494 "Predicted intracellular proteins" "Neurogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 29.9;skin 1: 20.5" "Cell line enhanced" "Detected in many" "hTCEpi: 27.3;MCF7: 14.7;SCLC-21H: 17.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061116 Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA061116: " "unprognostic (2.17e-1)" "prognostic favourable (6.50e-4)" "unprognostic (1.68e-3)" "unprognostic (3.05e-2)" "unprognostic (6.81e-4)" "prognostic favourable (3.15e-4)" "prognostic unfavourable (6.84e-4)" "unprognostic (5.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.63e-2)" "unprognostic (3.31e-3)" "unprognostic (7.26e-2)" "prognostic favourable (3.93e-5)" "prognostic favourable (1.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.15e-1)" 4.0 0.8 2.7 3.8 2.3 0.7 0.9 11.9 6.5 0.8 0.9 1.3 0.0 16.5 7.5 0.7 1.4 0.0 3.1 5.1 29.9 0.5 0.7 8.7 1.5 0.0 1.1 1.2 18.4 0.1 0.9 1.0 1.4 0.1 0.0 20.5 1.1 0.0 0.7 2.3 8.6 8.0 6.3 6.0 1.2 3.5 0.5 0.1 0.9 0.8 0.2 3.4 0.7 1.8 5.7 0.3 0.0 0.5 0.0 7.0 0.0 0.0 0.0 0.0 5.1 3.2 9.0 2.4 0.0 4.3 0.7 0.9 0.0 0.6 0.9 0.0 2.5 9.7 0.0 1.1 9.5 0.0 27.3 0.0 0.3 0.0 0.3 1.1 0.0 14.7 6.4 0.1 11.7 2.7 0.7 0.5 2.4 3.5 4.5 17.2 1.2 2.0 5.4 1.4 12.3 4.4 0.0 0.1 1.6 0.0 0.1 2.3 8.7 3.5 0.3 1.3 0.9 0.9 0.0 0.0 3.4 0.0 1.3 0.5 3.4 2.9 0.0 0.5 2.6 2.0 0.0 0.2 0.8 0.1 0.6 0.7 BIRC6 BRUCE ENSG00000115760 "Baculoviral IAP repeat containing 6" Q9NR09 2 32357028-32618899 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074409, HPA074738" Supported "Golgi apparatus,Vesicles,Mitotic spindle" "Golgi apparatus, Vesicles" "Mitotic spindle" "HPA074409: , HPA074738: " "unprognostic (3.38e-2)" "unprognostic (8.13e-3)" "unprognostic (8.88e-2)" "unprognostic (7.06e-3)" "unprognostic (6.69e-3)" "unprognostic (9.01e-2)" "unprognostic (4.51e-2)" "unprognostic (2.07e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (4.49e-2)" "unprognostic (4.00e-2)" "unprognostic (2.07e-2)" "unprognostic (1.30e-1)" "unprognostic (4.61e-1)" "unprognostic (7.32e-2)" "unprognostic (3.37e-1)" 15.0 16.7 10.3 20.7 14.4 18.4 16.1 21.9 13.7 16.2 13.0 15.3 15.6 8.7 17.2 13.9 13.2 13.1 11.7 11.4 9.8 7.3 14.1 14.8 12.5 16.1 13.9 11.8 23.6 24.8 32.5 17.4 14.1 14.8 11.3 13.6 11.5 14.7 17.1 20.9 14.9 16.0 12.5 13.3 16.1 13.9 13.0 14.4 23.1 21.5 9.2 17.2 16.2 12.0 3.8 2.8 10.6 2.4 2.3 3.4 0.7 15.1 12.7 11.8 5.1 9.3 13.2 7.1 6.7 9.5 8.3 7.9 8.7 3.6 16.3 5.4 12.6 7.0 16.5 10.0 10.3 13.0 7.5 22.0 8.0 7.2 5.1 20.4 7.8 8.8 4.9 13.0 11.6 12.3 17.8 7.0 7.7 5.8 10.2 4.7 7.9 7.5 10.4 19.0 5.5 6.0 15.6 8.8 13.5 13.3 6.9 6.1 4.6 7.3 19.2 8.7 9.8 5.9 10.2 9.4 13.1 21.8 6.3 10.1 5.7 10.6 1.6 0.9 2.7 1.2 3.4 1.7 2.1 2.3 1.3 3.8 2.3 2.6 2.7 2.3 2.4 2.8 1.6 0.7 10.3 14.4 21.9 13.7 9.8 7.3 13.9 11.8 14.8 14.4 BLOC1S4 "BCAS4L, CNO, FLJ11230" ENSG00000186222 "Biogenesis of lysosomal organelles complex 1 subunit 4" Q9NUP1 4 6716055-6717671 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043840 Approved Approved Vesicles,Cytosol Vesicles Cytosol "HPA043840: AB_10965701" "unprognostic (3.09e-1)" "unprognostic (8.40e-2)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (7.49e-2)" "unprognostic (1.70e-1)" "prognostic unfavourable (1.06e-4)" "unprognostic (3.28e-2)" "unprognostic (2.72e-1)" "unprognostic (1.19e-2)" "unprognostic (1.04e-1)" "unprognostic (7.51e-2)" "unprognostic (1.80e-1)" "unprognostic (3.53e-1)" "unprognostic (1.76e-1)" "unprognostic (9.24e-3)" "unprognostic (5.62e-3)" 14.6 15.5 9.2 11.8 11.5 13.6 11.4 10.7 14.4 15.4 15.2 9.5 10.1 14.6 13.8 14.3 14.1 12.3 15.7 9.6 9.3 7.7 13.6 13.8 8.7 16.9 8.6 9.4 19.1 18.4 8.4 9.8 23.2 9.8 13.7 9.4 13.3 10.8 11.2 16.6 10.7 15.8 8.2 7.4 17.7 13.3 14.0 8.9 20.9 16.8 10.1 15.5 12.3 10.9 6.1 3.8 13.7 4.8 2.5 9.6 1.8 9.9 6.8 10.4 10.6 8.1 10.5 21.0 8.1 8.9 7.6 6.7 6.1 10.8 9.5 8.8 7.2 6.8 5.8 9.3 5.9 7.6 9.5 14.5 6.5 15.0 10.0 7.0 13.6 9.9 9.3 6.0 5.2 6.9 19.0 8.7 7.8 9.9 11.4 24.4 13.6 13.7 11.9 11.5 8.5 10.4 8.9 9.0 12.1 6.8 4.9 14.4 15.4 13.7 7.7 7.1 6.2 8.1 10.2 13.0 12.6 12.6 7.8 12.9 11.1 2.5 3.1 13.7 5.1 4.8 5.2 6.1 6.2 5.5 3.8 4.9 9.6 5.3 1.8 2.5 3.1 3.7 5.1 1.8 9.2 11.5 10.7 14.4 9.3 7.7 8.6 9.4 9.8 8.9 BLOC1S5 "dJ303A1.3, MU, MUTED" ENSG00000188428 "Biogenesis of lysosomal organelles complex 1 subunit 5" Q8TDH9 6 8013567-8064414 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB025613, HPA077525" Uncertain Supported Vesicles Vesicles "CAB025613: , HPA077525: " "unprognostic (1.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.92e-1)" "unprognostic (5.06e-2)" "prognostic unfavourable (8.12e-4)" "unprognostic (4.24e-2)" "unprognostic (1.20e-2)" "unprognostic (1.47e-2)" "unprognostic (2.87e-2)" "unprognostic (1.00e-1)" "unprognostic (1.62e-3)" "unprognostic (1.83e-1)" "unprognostic (1.13e-1)" "unprognostic (6.16e-2)" "unprognostic (7.60e-3)" 12.2 13.9 10.1 11.0 11.1 4.8 14.1 8.8 8.9 12.0 9.7 9.0 6.4 5.9 14.3 10.5 10.7 9.2 8.2 9.7 7.6 7.0 23.2 14.7 8.0 11.8 10.3 6.0 14.2 8.8 17.2 8.6 9.2 7.4 12.0 7.8 10.6 9.6 13.6 11.3 10.3 10.0 13.4 12.4 12.0 9.2 8.2 9.2 24.1 14.6 7.2 13.8 12.1 10.4 15.7 14.8 16.9 11.2 15.1 15.2 11.4 3.6 3.9 8.6 11.1 9.5 11.9 5.8 3.9 5.5 5.7 5.6 8.0 3.5 12.5 27.1 5.0 3.3 6.3 3.0 8.1 12.5 6.8 7.5 3.0 14.5 8.5 12.8 8.7 5.2 8.0 5.7 8.6 10.1 15.3 2.3 8.0 4.0 14.9 8.5 4.7 5.5 12.3 9.9 19.8 10.7 3.1 8.1 4.3 4.0 6.1 12.1 7.7 6.8 4.4 9.0 6.5 5.3 3.4 10.2 20.3 11.4 3.6 10.6 9.2 13.6 9.0 16.9 11.5 11.2 14.8 15.7 14.8 14.6 14.8 14.8 15.2 15.1 2.1 15.1 6.1 6.0 13.0 11.4 10.1 11.1 8.8 8.9 7.6 7.0 10.3 6.0 7.4 9.2 BMP2 BMP2A ENSG00000125845 "Bone morphogenetic protein 2" P12643 20 6767664-6780280 "Cancer-related genes, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 20.7;HeLa: 13.5;hTERT-HME1: 12.2;RT4: 16.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "NK-cell: 2.2" "Lineage enriched" "Detected in single" 7 "NK-cells: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA058610, CAB078457" Enhanced Vesicles "Secreted to blood" 24353 Vesicles "CAB078457: AB_2532532, HPA058610: " "unprognostic (2.22e-2)" "unprognostic (9.32e-2)" "unprognostic (6.12e-2)" "unprognostic (3.56e-2)" "unprognostic (1.94e-2)" "unprognostic (2.48e-1)" "unprognostic (3.70e-3)" "unprognostic (3.12e-3)" "unprognostic (8.51e-2)" "unprognostic (8.46e-2)" "unprognostic (2.53e-3)" "unprognostic (5.39e-3)" "unprognostic (7.81e-2)" "unprognostic (3.76e-1)" "unprognostic (2.77e-1)" "unprognostic (3.01e-2)" "unprognostic (7.49e-2)" 11.1 1.1 1.6 10.5 3.1 0.6 5.3 1.8 7.5 3.7 13.1 2.6 1.9 4.2 3.4 6.7 3.7 3.7 15.6 3.9 2.4 1.6 3.6 3.8 12.8 1.3 2.9 1.3 3.1 9.2 4.7 2.3 7.6 2.7 8.8 9.5 18.3 2.0 1.2 2.6 9.1 13.4 3.4 1.4 8.0 13.8 1.1 2.7 0.3 13.2 6.2 3.1 14.1 9.1 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.5 2.3 0.0 0.0 20.7 0.0 0.0 0.3 0.7 6.9 4.1 1.8 0.0 0.0 3.7 0.0 13.5 0.0 1.0 0.0 0.5 0.1 6.3 0.0 12.2 4.2 0.0 0.0 0.1 0.0 0.0 3.9 0.5 0.5 4.0 0.0 0.3 1.5 16.5 0.7 1.0 4.9 0.0 0.0 0.0 4.3 1.0 1.2 1.8 0.0 0.5 0.2 0.5 0.0 2.1 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 1.6 3.1 1.8 3.3 2.4 1.6 2.9 1.3 2.7 2.7 BMP7 OP-1 ENSG00000101144 "Bone morphogenetic protein 7" P18075 20 57168748-57266629 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.0;thyroid gland: 44.3" "Cell line enhanced" "Detected in some" "Daudi: 41.5;MCF7: 48.0;RPMI-8226: 18.4;SK-BR-3: 31.3;U-698: 56.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.4" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057757 Approved Nucleoplasm,Nucleoli,Vesicles "Secreted to blood" 247500 Vesicles "Nucleoplasm, Nucleoli" "HPA057757: " "unprognostic (1.67e-1)" "unprognostic (9.72e-3)" "unprognostic (9.67e-2)" "prognostic unfavourable (2.91e-4)" "unprognostic (2.62e-1)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (4.63e-3)" "unprognostic (4.03e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (4.30e-2)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (1.59e-1)" 1.5 7.2 16.8 2.4 17.5 0.7 2.1 3.8 19.7 9.2 2.3 23.6 6.0 2.7 1.9 17.7 17.2 10.0 1.2 8.5 13.9 9.9 4.5 0.7 1.8 1.6 14.3 11.2 0.8 1.0 0.8 1.9 24.4 12.2 5.0 2.4 37.0 2.6 10.3 1.0 15.5 2.4 1.0 13.8 1.3 4.1 1.4 13.4 1.8 44.3 5.7 4.9 7.8 7.0 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 5.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 1.6 41.5 10.6 0.0 12.0 1.2 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 48.0 0.0 0.0 3.0 0.0 0.0 0.0 18.4 0.0 0.0 0.1 4.5 1.3 31.3 0.1 0.2 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 56.7 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 16.8 17.5 3.8 12.5 13.9 9.9 14.3 11.2 12.2 13.4 BORCS8 MEF2BNB ENSG00000254901 "BLOC-1 related complex subunit 8" Q96FH0 19 19176903-19192591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045700 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA045700: AB_10968570" "unprognostic (4.23e-3)" "unprognostic (1.61e-2)" "unprognostic (2.75e-1)" "unprognostic (3.58e-2)" "unprognostic (2.28e-1)" "unprognostic (3.01e-2)" "unprognostic (5.51e-2)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (6.82e-2)" "prognostic favourable (4.05e-5)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" "unprognostic (3.16e-1)" "unprognostic (1.38e-2)" "unprognostic (3.00e-2)" 11.3 17.0 25.0 12.9 26.8 12.2 13.3 19.3 31.0 10.1 13.5 17.3 14.5 15.5 12.9 15.8 13.8 14.0 14.8 17.9 23.9 30.0 16.0 14.1 12.0 14.0 26.3 12.2 10.5 10.1 11.7 20.1 11.3 15.6 10.9 15.3 13.6 12.4 15.5 12.0 9.6 9.5 13.0 13.9 11.9 11.2 11.1 12.9 12.4 13.0 11.1 13.8 10.9 8.5 8.7 9.8 25.6 14.6 5.0 7.1 6.7 9.6 5.4 8.9 7.3 9.8 5.3 8.9 10.1 8.5 16.0 14.8 9.4 9.4 7.1 14.1 11.7 6.4 9.7 12.4 7.6 3.9 12.3 5.4 12.3 10.1 8.0 3.9 7.6 6.4 9.3 12.2 6.1 14.0 9.5 10.3 16.9 17.4 14.6 9.0 4.8 11.9 6.9 3.6 8.1 13.8 5.9 18.3 10.1 9.2 6.1 7.5 6.7 7.5 7.1 5.5 8.1 18.7 15.3 6.5 7.7 8.2 10.9 6.6 11.2 10.6 9.6 16.0 4.9 13.7 4.8 8.7 5.7 5.6 7.4 6.3 4.7 5.2 25.6 5.0 14.6 9.8 7.1 6.7 25.0 26.8 19.3 31.0 23.9 30.0 26.3 12.2 15.6 12.9 BPIFB2 "BPIL1, C20orf184, dJ726C3.2, LPLUNC2" ENSG00000078898 "BPI fold containing family B member 2" Q8N4F0 20 33007600-33023709 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "lymphoid tissue: 218.0;salivary gland: 191.2" "Cell line enriched" "Detected in single" 552 "Hep G2: 67.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 0.5" "Not detected" "Not detected" "HPA049491, HPA060121" Enhanced Approved Vesicles "Intracellular and membrane" 68000 Vesicles "HPA049491: AB_2680792, HPA060121: AB_2684207" "unprognostic (1.94e-1)" "prognostic favourable (1.97e-5)" "unprognostic (2.24e-4)" "unprognostic (9.48e-2)" "unprognostic (9.81e-2)" "unprognostic (2.02e-3)" "unprognostic (1.72e-2)" "unprognostic (2.71e-1)" "unprognostic (9.28e-2)" "unprognostic (5.35e-1)" "unprognostic (8.19e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 191.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.6 218.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BRAF BRAF1 ENSG00000157764 "B-Raf proto-oncogene, serine/threonine kinase" P15056 7 140719327-140924928 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001328, CAB004552, HPA071048" Approved Approved Vesicles,Cytosol Vesicles Cytosol "CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: " "unprognostic (2.98e-3)" "unprognostic (5.66e-2)" "unprognostic (2.20e-2)" "unprognostic (2.66e-3)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.07e-2)" "unprognostic (4.23e-2)" "unprognostic (4.07e-2)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (1.91e-2)" "unprognostic (3.79e-3)" "unprognostic (2.08e-1)" "unprognostic (1.76e-1)" "unprognostic (8.01e-2)" "unprognostic (5.46e-2)" 13.1 12.1 20.1 16.5 20.4 27.8 14.2 29.9 21.5 12.4 12.3 9.5 12.5 9.3 15.3 17.0 11.8 11.5 12.0 13.6 13.2 12.2 13.7 12.8 15.9 13.3 9.9 17.8 16.8 13.2 28.9 24.8 13.7 15.3 14.5 11.0 10.7 11.6 16.6 12.9 15.6 10.5 13.0 10.9 12.3 12.0 24.9 12.2 13.5 16.6 7.5 12.1 18.6 18.1 2.6 1.9 7.5 2.4 7.0 5.6 1.1 5.4 4.6 6.8 8.1 8.3 10.7 10.9 6.1 6.5 4.9 7.1 5.0 5.9 9.3 4.7 6.2 3.0 6.0 4.8 9.0 8.6 4.9 6.0 4.5 4.6 7.0 9.8 6.1 7.1 5.4 5.2 10.8 5.7 9.5 16.7 8.7 2.9 13.0 10.3 6.3 2.9 8.5 5.8 7.6 4.8 10.4 7.9 6.6 7.0 4.3 6.3 4.0 6.7 8.4 5.3 4.1 11.5 4.9 19.4 11.0 14.8 8.7 9.9 5.7 3.3 2.0 7.5 3.1 1.7 2.1 2.6 3.0 2.4 1.6 2.6 5.6 2.8 4.1 7.0 2.4 1.9 2.7 1.1 20.1 20.4 29.9 21.5 13.2 12.2 9.9 17.8 15.3 12.2 BSG "CD147, EMMPRIN, OK" ENSG00000172270 "Basigin (Ok blood group)" P35613 19 571277-583493 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002427, HPA036048, HPA074870" Enhanced Approved Vesicles 3400000 Vesicles "CAB002427: AB_563501, HPA036048: , HPA074870: " "unprognostic (1.88e-1)" "unprognostic (4.85e-2)" "unprognostic (9.53e-3)" "prognostic favourable (2.59e-4)" "unprognostic (3.34e-1)" "unprognostic (1.38e-2)" "prognostic unfavourable (5.48e-6)" "unprognostic (1.54e-3)" "unprognostic (1.55e-1)" "unprognostic (9.46e-2)" "unprognostic (4.48e-3)" "unprognostic (2.61e-2)" "prognostic favourable (1.95e-6)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (7.30e-2)" "unprognostic (3.22e-1)" 53.0 74.8 60.0 33.3 73.0 86.3 42.3 36.2 103.0 41.7 93.4 57.8 37.3 50.1 56.0 62.2 35.1 48.8 52.0 205.8 58.5 45.9 78.5 39.1 36.1 22.6 57.6 44.0 51.3 64.2 28.2 48.2 96.2 57.9 49.5 39.6 109.4 44.0 48.4 97.4 38.1 45.5 52.9 34.9 28.3 63.9 76.8 30.4 31.8 61.9 45.9 31.2 48.5 31.5 22.0 43.8 89.4 58.7 30.9 44.5 65.5 63.7 86.1 41.1 92.3 122.3 52.6 87.4 53.1 66.4 64.1 55.8 68.6 69.1 22.9 61.7 48.0 104.1 41.6 64.5 22.2 48.0 89.2 15.7 72.8 92.8 77.3 37.9 74.0 54.7 65.5 36.8 41.1 45.9 73.9 108.2 37.6 114.5 27.6 72.7 96.4 44.1 55.5 33.6 75.4 75.7 47.9 63.7 58.0 110.2 44.5 78.8 46.7 117.3 50.5 61.5 39.1 101.9 80.1 69.8 70.2 21.7 116.7 52.6 76.1 32.0 58.7 62.0 44.5 45.2 39.5 22.0 30.2 42.6 39.9 18.3 23.1 29.1 89.4 30.9 48.3 43.8 35.1 65.5 60.0 73.0 36.2 103.0 58.5 45.9 57.6 44.0 57.9 30.4 BTAF1 "MOT1, TAF-172, TAF(II)170, TAF172, TAFII170" ENSG00000095564 "B-TFIID TATA-box binding protein associated factor 1" O14981 10 91923769-92030325 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070682 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA070682: " "unprognostic (2.41e-1)" "unprognostic (1.29e-1)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-1)" "prognostic favourable (5.07e-4)" "unprognostic (2.72e-1)" "unprognostic (9.28e-2)" "unprognostic (1.16e-1)" "unprognostic (7.34e-2)" "unprognostic (9.70e-3)" "unprognostic (4.27e-2)" "prognostic unfavourable (4.04e-5)" "unprognostic (6.45e-2)" "unprognostic (1.10e-1)" "unprognostic (4.79e-2)" "unprognostic (1.98e-1)" 21.8 13.7 15.1 20.2 23.1 26.7 20.8 19.9 21.6 20.8 19.7 18.3 17.4 15.9 24.3 22.0 19.4 26.2 15.5 15.9 16.0 7.0 13.8 15.5 20.1 29.3 22.2 13.4 30.4 19.7 21.1 22.3 13.8 16.5 18.2 16.4 18.1 21.0 18.3 15.8 48.6 23.4 22.1 22.4 22.4 19.6 21.2 23.8 29.0 19.5 10.8 25.8 24.3 21.2 6.9 9.6 6.8 6.3 4.4 5.3 2.6 17.0 8.3 19.6 23.8 10.4 16.5 9.8 10.0 11.9 9.9 14.9 11.4 10.5 18.4 6.5 9.8 18.5 13.1 8.9 14.9 12.5 14.2 13.0 19.5 11.9 10.7 19.5 13.7 11.6 11.5 15.1 22.0 9.5 10.6 21.2 10.1 7.4 15.0 12.4 8.9 6.6 12.2 12.2 8.5 9.3 10.6 7.6 8.9 9.6 4.9 12.3 9.9 13.1 10.2 9.0 7.2 12.0 14.2 24.7 11.3 15.2 14.1 18.1 2.3 6.8 5.5 2.9 5.3 3.7 4.6 5.1 3.9 3.6 4.0 6.9 4.9 3.7 3.9 4.4 6.3 9.6 3.1 2.6 15.1 23.1 19.9 21.6 16.0 7.0 22.2 13.4 16.5 23.8 BTBD3 "dJ742J24.1, KIAA0952" ENSG00000132640 "BTB domain containing 3" Q9Y2F9 20 11890723-11926609 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell line enhanced" "Detected in many" "AN3-CA: 65.0;HeLa: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041424, HPA042048" Uncertain Supported Vesicles Vesicles "HPA041424: AB_10794667, HPA042048: AB_10796469" "unprognostic (3.93e-2)" "unprognostic (2.25e-1)" "unprognostic (1.32e-1)" "unprognostic (3.56e-3)" "unprognostic (4.24e-3)" "unprognostic (8.45e-2)" "prognostic unfavourable (2.51e-5)" "prognostic unfavourable (6.94e-4)" "unprognostic (4.87e-2)" "unprognostic (2.95e-1)" "unprognostic (1.07e-2)" "unprognostic (7.05e-2)" "unprognostic (6.66e-2)" "unprognostic (7.68e-3)" "unprognostic (1.67e-1)" "unprognostic (6.29e-2)" "unprognostic (1.37e-2)" 8.9 18.5 32.9 5.5 25.2 8.7 10.4 53.8 40.7 12.2 17.1 32.4 3.8 8.7 15.8 10.1 8.3 12.9 11.1 11.1 56.8 19.8 9.8 6.2 10.0 3.0 25.6 21.2 9.0 10.6 10.5 6.7 33.6 20.9 13.0 14.7 8.4 10.9 9.3 11.5 16.7 8.7 13.8 24.3 6.0 21.2 11.7 22.5 4.1 9.6 5.0 2.5 13.8 7.3 0.3 2.9 0.6 6.3 1.4 0.7 1.1 1.8 5.2 14.1 65.0 2.9 3.1 3.8 5.8 3.7 6.6 4.2 2.9 2.8 0.5 4.9 8.4 4.8 7.3 4.1 10.7 0.0 6.5 1.8 51.3 6.2 3.1 3.0 1.1 5.6 5.1 5.9 4.8 3.7 3.2 5.0 6.5 1.3 3.5 2.7 6.7 1.4 4.7 2.8 1.8 6.0 9.0 6.2 10.9 16.2 6.6 14.0 3.9 3.0 2.8 3.6 9.2 3.3 6.4 1.8 2.4 0.0 2.3 0.8 23.5 0.0 2.2 0.2 0.0 3.4 0.0 0.1 0.0 0.0 2.9 0.3 0.7 0.0 0.6 1.4 6.3 2.0 0.0 1.1 32.9 25.2 53.8 40.7 56.8 19.8 25.6 21.2 20.9 22.5 BTG2 "APRO1, MGC126063, MGC126064, PC3, TIS21" ENSG00000159388 "BTG anti-proliferation factor 2" P78543 1 203305491-203309602 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.9;HMC-1: 38.6;U-266/70: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002355 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA002355: AB_1078304" "prognostic favourable (8.53e-4)" "unprognostic (1.54e-1)" "unprognostic (4.63e-2)" "unprognostic (4.81e-3)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (2.47e-1)" "unprognostic (7.87e-3)" "unprognostic (4.72e-1)" "unprognostic (1.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.18e-2)" "unprognostic (4.46e-2)" "unprognostic (6.22e-2)" "unprognostic (4.34e-1)" "unprognostic (1.17e-1)" "unprognostic (2.86e-3)" 61.6 45.9 10.1 61.4 20.6 46.9 27.8 13.0 10.4 23.0 53.3 27.8 27.0 15.2 27.1 24.6 55.7 103.7 76.1 65.3 10.4 10.0 22.3 4.3 40.7 20.0 12.2 5.5 102.0 117.6 7.0 52.2 42.7 28.3 61.0 38.5 30.4 18.1 104.1 98.9 30.5 36.6 50.8 22.7 32.7 67.1 11.5 9.9 82.9 36.7 45.2 49.0 64.7 21.5 14.1 17.3 34.5 14.2 5.7 8.5 7.1 0.9 1.4 2.6 1.0 3.3 2.4 21.7 2.5 5.0 0.6 2.5 1.9 0.4 36.9 1.8 0.8 16.2 9.4 9.9 1.2 2.4 4.6 19.3 2.7 4.2 7.2 0.1 38.6 2.4 18.4 2.4 4.5 13.5 8.9 25.6 6.7 0.8 4.0 1.2 1.1 0.2 2.5 8.7 18.5 1.2 30.1 0.4 2.7 2.0 0.8 0.3 2.1 2.3 3.3 0.0 4.3 0.6 0.1 59.8 30.2 23.6 0.5 0.9 1.5 3.2 8.1 9.9 4.7 12.1 7.1 14.1 5.3 4.8 5.1 13.1 8.5 5.9 34.5 5.7 14.2 17.3 4.9 7.1 10.1 20.6 13.0 10.4 10.4 10.0 12.2 5.5 28.3 9.9 BTN3A1 "BT3.1, BTF5, BTN3.1, CD277" ENSG00000026950 "Butyrophilin subfamily 3 member A1" O00481 6 26402237-26415216 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA012565 Approved Uncertain Vesicles Vesicles "HPA012565: AB_1845494" "unprognostic (2.82e-2)" "unprognostic (6.43e-2)" "unprognostic (1.45e-3)" "unprognostic (4.72e-3)" "unprognostic (1.41e-2)" "unprognostic (1.42e-1)" "unprognostic (3.10e-2)" "unprognostic (9.31e-2)" "unprognostic (9.81e-2)" "unprognostic (8.60e-3)" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "prognostic unfavourable (4.15e-5)" "unprognostic (2.45e-1)" "unprognostic (5.02e-2)" "unprognostic (3.26e-2)" "prognostic favourable (4.81e-4)" 11.3 14.3 6.7 33.5 5.4 10.3 10.2 10.7 5.9 18.5 14.9 10.0 10.1 11.5 22.3 14.1 13.1 9.6 16.5 9.0 5.3 6.1 9.7 11.4 29.9 24.1 7.1 5.4 15.5 9.4 5.6 11.2 8.5 7.8 17.9 12.1 12.3 16.7 10.0 4.8 9.7 20.6 10.2 9.0 45.2 12.5 4.9 6.7 16.5 8.5 9.8 32.9 11.6 12.9 9.8 4.4 17.4 5.9 18.4 23.4 12.1 3.7 3.2 4.7 4.8 13.6 14.5 0.5 3.0 12.0 6.9 20.3 0.1 8.1 9.7 10.6 5.5 2.5 1.5 4.8 4.0 9.5 3.3 5.1 3.9 2.2 6.1 4.7 4.7 7.8 2.7 6.0 2.8 9.7 1.2 12.7 2.8 0.3 8.5 2.9 0.5 1.0 11.8 2.1 22.0 4.2 4.7 2.5 5.0 1.7 3.6 6.8 3.3 1.9 2.4 5.3 1.3 1.5 2.9 21.7 22.1 3.5 8.1 10.6 4.1 17.4 5.3 13.5 23.4 5.7 20.9 9.8 14.6 21.7 4.4 5.3 12.7 16.8 11.9 18.4 5.9 2.1 16.9 12.1 6.7 5.4 10.7 5.9 5.3 6.1 7.1 5.4 7.8 6.7 BTNL9 "BTN8, FLJ32535" ENSG00000165810 "Butyrophilin like 9" Q6UXG8 5 181040225-181061523 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.2;breast: 76.8" "Cell line enriched" "Detected in some" 6 "U-698: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.8" "Group enriched" "Detected in many" 6 "B-cells: 3.8;granulocytes: 1.3" "Not detected" "Not detected" HPA043429 Approved "Nuclear membrane,Vesicles" "Nuclear membrane" Vesicles "HPA043429: AB_10961264" "unprognostic (2.69e-1)" "unprognostic (1.44e-2)" "unprognostic (5.76e-2)" "prognostic unfavourable (7.51e-4)" "unprognostic (2.07e-1)" "unprognostic (1.43e-1)" "prognostic favourable (1.55e-9)" "unprognostic (2.15e-2)" "unprognostic (8.51e-2)" "unprognostic (1.78e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.71e-2)" "unprognostic (3.43e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-2)" 128.2 2.5 1.5 5.3 1.7 0.3 76.8 1.0 1.8 3.2 11.3 0.8 3.5 0.7 3.9 3.7 2.9 6.0 3.7 11.0 3.4 1.3 3.4 3.0 25.4 2.7 2.5 1.2 1.0 2.0 3.0 1.6 4.3 1.5 3.4 1.5 3.8 3.0 3.5 34.4 2.0 1.9 3.2 2.1 12.7 2.0 3.0 0.9 1.1 6.1 4.0 5.5 3.1 18.3 3.8 0.4 1.3 0.3 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.6 0.0 0.2 1.1 0.0 0.2 0.5 0.0 0.0 0.2 2.8 1.1 0.2 0.1 0.0 0.5 3.3 0.0 0.1 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.1 0.1 0.1 1.8 0.0 0.2 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 4.3 0.1 0.0 0.2 0.1 28.0 0.1 0.0 0.0 1.0 0.3 0.5 0.2 0.1 0.1 3.8 0.2 0.2 0.1 1.9 0.2 0.2 1.3 0.3 0.1 0.4 0.0 0.1 1.5 1.7 1.0 1.8 3.4 1.3 2.5 1.2 1.5 0.9 BZW1 "BZAP45, KIAA0005" ENSG00000082153 "Basic leucine zipper and W2 domains 1" Q7L1Q6 2 200810594-200827338 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047288, HPA053272" Uncertain Approved Vesicles Vesicles "HPA047288: , HPA053272: " "unprognostic (2.45e-2)" "prognostic unfavourable (4.28e-4)" "unprognostic (2.08e-3)" "unprognostic (1.56e-2)" "unprognostic (1.93e-1)" "unprognostic (3.31e-3)" "unprognostic (3.98e-3)" "prognostic unfavourable (5.10e-4)" "unprognostic (4.49e-3)" "unprognostic (7.93e-3)" "unprognostic (1.08e-3)" "unprognostic (8.97e-3)" "unprognostic (4.38e-2)" "unprognostic (3.04e-1)" "unprognostic (7.61e-2)" "unprognostic (8.03e-2)" "unprognostic (1.24e-1)" 55.7 43.2 23.5 29.2 26.8 60.1 35.2 19.4 36.1 26.1 30.3 26.4 18.5 20.1 25.4 25.4 49.1 24.8 30.5 31.1 23.3 20.9 39.5 108.5 29.5 33.9 30.5 19.2 40.5 20.5 22.9 23.5 55.4 37.0 33.1 29.9 22.2 29.7 21.3 45.5 20.2 32.0 25.9 28.1 31.2 23.7 55.2 24.6 68.0 32.0 43.2 35.4 39.6 28.1 27.7 43.9 50.1 48.3 56.4 59.5 65.7 44.3 35.4 48.4 29.1 48.8 57.3 34.5 65.5 77.9 44.3 38.9 55.1 30.2 21.3 22.9 51.9 24.6 44.1 78.9 83.0 23.1 23.5 56.0 75.9 42.2 39.4 62.3 31.3 33.0 36.7 58.7 63.4 76.7 48.4 36.5 58.8 35.6 57.3 29.6 61.1 89.5 44.1 52.5 22.4 40.3 66.6 29.3 34.2 50.1 18.8 33.6 19.7 32.3 85.2 66.2 38.5 39.8 41.8 44.9 61.8 57.6 54.2 31.6 48.3 50.1 37.2 44.2 51.1 46.2 59.5 27.7 36.9 47.9 43.9 23.4 33.4 46.1 31.7 56.4 48.3 20.4 45.0 65.7 23.5 26.8 19.4 36.1 23.3 20.9 30.5 19.2 37.0 24.6 C10orf76 FLJ13114 ENSG00000120029 "Chromosome 10 open reading frame 76" Q5T2E6 10 101845599-102056193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050913, HPA053580" Approved Approved Vesicles Vesicles "HPA050913: , HPA053580: " "unprognostic (5.88e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "unprognostic (3.41e-2)" "unprognostic (9.41e-2)" "unprognostic (9.55e-2)" "unprognostic (5.28e-2)" "unprognostic (1.92e-2)" "unprognostic (1.18e-1)" "unprognostic (6.03e-3)" "unprognostic (1.40e-3)" "unprognostic (2.76e-1)" "unprognostic (1.86e-2)" "unprognostic (1.16e-1)" "unprognostic (2.48e-1)" "unprognostic (3.85e-1)" "unprognostic (4.87e-2)" 16.8 16.3 16.0 16.2 19.5 25.0 15.7 25.5 19.3 17.7 16.7 18.3 19.5 16.3 19.5 14.0 20.9 14.3 14.1 21.2 12.0 12.9 13.2 15.1 18.1 15.0 13.9 14.2 16.0 13.2 22.8 21.0 14.3 16.1 14.8 17.6 17.7 17.3 14.6 27.2 19.3 18.5 17.2 14.4 16.9 14.4 18.0 14.9 18.9 14.2 16.6 20.1 20.6 20.7 7.6 8.5 16.4 10.8 5.2 7.4 4.9 15.7 13.0 11.7 14.2 9.9 13.4 9.8 13.2 17.8 14.9 12.7 8.8 13.4 11.5 9.5 16.7 12.7 15.1 16.3 13.9 11.6 13.5 19.6 11.6 10.2 11.7 14.1 18.8 12.2 13.3 16.9 15.1 11.2 0.6 11.9 12.3 10.1 11.3 9.8 6.2 7.9 11.2 19.9 7.9 12.3 13.3 5.5 8.9 10.8 8.1 15.5 21.2 9.0 10.4 7.9 12.7 7.2 10.2 10.8 10.8 12.3 12.7 16.8 5.9 16.4 8.1 7.9 7.0 9.5 6.5 7.1 7.4 5.3 8.5 7.6 5.8 5.9 2.2 5.2 10.8 8.4 6.3 4.9 16.0 19.5 25.5 19.3 12.0 12.9 13.9 14.2 16.1 14.9 C11orf24 DM4E3 ENSG00000171067 "Chromosome 11 open reading frame 24" Q96F05 11 68261335-68272001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 65.7" "Cell line enhanced" "Detected in all" "SK-MEL-30: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA012748 Uncertain Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA012748: AB_1845526" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "prognostic unfavourable (7.38e-4)" "unprognostic (2.31e-2)" "unprognostic (7.91e-2)" "prognostic unfavourable (6.05e-4)" "unprognostic (1.56e-1)" "unprognostic (2.68e-2)" "unprognostic (4.99e-2)" "unprognostic (1.55e-1)" "prognostic unfavourable (1.60e-9)" "unprognostic (2.18e-2)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (8.67e-3)" 12.9 9.3 6.6 12.9 10.6 2.7 14.7 6.7 13.7 14.1 32.6 23.3 8.4 35.2 21.8 12.3 8.6 12.2 19.2 19.1 9.1 6.5 10.0 44.3 12.6 14.4 10.3 8.1 14.1 17.5 5.8 8.1 12.6 14.5 12.2 11.8 14.7 22.1 12.6 6.9 8.9 65.7 21.5 13.8 11.3 13.5 7.8 10.3 3.4 9.2 11.4 18.8 14.6 10.5 23.7 16.4 9.3 11.0 5.5 9.2 6.9 12.3 12.8 7.6 14.8 18.4 18.7 8.8 29.9 19.4 15.1 15.6 27.0 7.6 5.6 9.3 37.0 14.0 11.2 13.4 9.7 6.1 6.6 5.9 13.0 18.0 14.9 5.0 20.0 15.4 10.0 22.8 9.4 6.0 10.4 9.2 12.7 15.4 1.2 7.3 12.7 15.6 2.3 13.0 28.9 6.8 5.9 5.0 9.3 9.7 7.8 62.4 7.3 4.2 6.6 23.7 14.7 29.9 13.1 11.4 11.2 5.2 19.0 3.9 22.8 9.3 7.2 7.5 9.2 11.0 6.2 17.3 5.3 5.7 12.0 23.7 5.0 5.3 1.1 5.5 8.1 16.4 4.8 6.9 6.6 10.6 6.7 13.7 9.1 6.5 10.3 8.1 14.5 10.3 C11orf91 ENSG00000205177 "Chromosome 11 open reading frame 91" Q3C1V1 11 33698261-33700801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 7.2;gallbladder: 7.2;testis: 16.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 14.9;hTERT-HME1: 9.6;HUVEC TERT2: 7.6;TIME: 11.6;U-2197: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA047064, HPA050487" Uncertain Supported Vesicles Vesicles "HPA047064: , HPA050487: " "unprognostic (9.22e-3)" "unprognostic (1.51e-2)" "unprognostic (1.76e-1)" "unprognostic (6.60e-2)" "unprognostic (1.62e-2)" "unprognostic (3.63e-2)" "unprognostic (2.31e-1)" "unprognostic (5.68e-3)" "unprognostic (7.41e-2)" "unprognostic (2.97e-2)" "unprognostic (1.99e-2)" "unprognostic (3.01e-1)" "unprognostic (8.33e-2)" "unprognostic (4.06e-2)" "unprognostic (3.95e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" 7.2 0.2 1.2 2.1 3.0 0.9 2.1 0.3 1.3 0.3 0.3 0.3 0.3 0.0 0.4 0.9 4.3 0.3 7.2 0.7 0.4 0.6 0.9 0.9 1.4 0.3 0.7 0.3 0.6 1.9 0.0 0.3 1.0 1.3 0.3 0.0 0.3 0.9 0.3 0.4 1.3 0.3 0.8 0.8 0.3 2.7 16.6 0.3 0.6 0.3 0.3 0.3 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 1.4 0.0 0.0 0.0 1.7 0.0 0.8 0.4 0.2 0.6 0.0 0.1 1.7 0.6 0.4 14.9 1.2 0.4 0.0 0.0 2.8 0.7 0.3 0.0 0.0 0.0 0.1 1.2 9.6 7.6 0.0 2.3 3.6 0.0 0.0 0.3 0.0 4.7 0.0 0.0 0.0 1.0 1.9 0.0 0.3 0.0 1.5 0.1 0.0 0.0 11.6 1.1 0.3 9.6 0.3 0.7 0.5 0.0 2.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.0 0.3 1.3 0.4 0.6 0.7 0.3 1.3 0.3 C12orf29 DKFZp434N2030 ENSG00000133641 "Chromosome 12 open reading frame 29" Q8N999 12 88033846-88050160 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039663 Uncertain Approved Vesicles Vesicles "HPA039663: AB_10795253" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (7.80e-2)" "unprognostic (6.88e-2)" "unprognostic (2.51e-2)" "unprognostic (2.06e-2)" "unprognostic (1.75e-3)" "unprognostic (4.72e-3)" "unprognostic (1.07e-2)" "unprognostic (1.84e-1)" "unprognostic (8.81e-2)" "unprognostic (6.49e-2)" "prognostic unfavourable (3.44e-4)" "unprognostic (1.03e-1)" "unprognostic (9.29e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" 7.9 12.9 13.3 6.1 20.0 11.5 14.5 12.6 19.6 10.2 7.1 5.7 7.8 6.3 9.4 14.8 24.9 8.2 8.0 8.7 13.6 12.6 10.4 15.5 7.2 9.2 14.9 15.0 11.7 11.3 8.7 15.1 7.6 12.6 11.5 7.4 3.1 11.8 9.5 10.1 19.8 6.6 9.1 15.5 7.8 8.6 9.5 13.2 9.3 13.9 8.8 12.1 12.3 16.4 7.5 2.8 6.8 1.7 5.6 11.7 5.6 9.4 6.1 5.6 6.4 11.5 15.0 4.5 12.1 9.9 10.5 9.1 5.7 3.6 16.7 1.8 6.1 8.1 11.0 8.5 17.5 7.4 12.5 14.8 4.9 5.0 15.0 18.8 6.8 10.5 11.9 9.5 12.3 7.8 13.7 3.3 15.4 3.3 12.4 8.0 8.7 12.8 7.3 9.7 14.2 11.5 7.7 13.7 12.5 7.2 16.4 7.9 10.4 11.3 6.5 9.2 3.4 9.6 9.3 8.4 11.2 11.2 7.1 13.3 8.2 6.8 1.7 1.3 7.1 1.7 9.7 7.5 8.8 7.6 2.3 5.3 11.7 9.0 0.0 5.6 1.5 2.8 7.3 5.6 13.3 20.0 12.6 19.6 13.6 12.6 14.9 15.0 12.6 13.2 C12orf75 "AGD3, OCC-1, OCC1" ENSG00000235162 "Chromosome 12 open reading frame 75" Q8TAD7 12 105235290-105396097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 97.7" "Cell line enhanced" "Detected in many" "BJ: 118.1;BJ hTERT+: 66.2;fHDF/TERT166: 54.5;RPTEC TERT1: 54.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 97.7" "Group enriched" "Detected in many" 6 "dendritic cells: 97.7;T-cells: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065311 Uncertain Approved Vesicles Vesicles "HPA065311: " "unprognostic (5.96e-2)" "unprognostic (3.85e-1)" "unprognostic (9.86e-2)" "unprognostic (1.02e-1)" "unprognostic (6.73e-2)" "unprognostic (8.58e-2)" "prognostic unfavourable (1.70e-4)" "unprognostic (8.61e-2)" "unprognostic (1.01e-1)" "unprognostic (2.60e-2)" "unprognostic (1.33e-1)" "unprognostic (7.00e-2)" "prognostic favourable (1.69e-5)" "unprognostic (1.80e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-1)" "unprognostic (4.47e-3)" 7.1 3.4 5.5 17.1 5.3 4.2 14.3 3.4 3.3 22.3 10.9 4.9 57.0 4.1 12.8 9.5 5.7 9.7 48.8 3.6 3.5 6.4 37.5 1.4 8.1 6.0 5.4 2.5 7.7 26.8 15.2 2.5 15.0 4.6 19.6 10.2 1.3 3.4 54.9 16.8 5.7 7.7 3.1 4.7 5.7 22.4 28.4 3.7 13.5 2.0 6.5 8.7 4.7 18.1 2.7 97.7 4.3 0.2 9.6 26.3 11.3 5.2 8.4 2.1 1.9 8.1 15.7 3.8 118.1 66.2 25.3 14.4 16.8 0.4 1.5 47.4 54.5 8.8 4.6 6.4 28.1 28.5 8.7 4.9 2.4 3.2 1.0 3.7 5.1 6.6 1.5 8.7 9.5 3.3 0.2 7.8 24.7 1.8 15.3 33.1 5.0 19.1 2.6 5.7 1.3 54.6 0.5 9.6 2.3 4.6 1.0 1.8 2.9 0.9 5.7 26.3 9.9 10.2 14.7 4.5 7.1 7.3 6.0 1.2 7.1 4.3 0.1 0.1 25.9 0.0 12.4 2.7 11.2 26.3 3.4 1.7 3.2 16.2 0.5 9.6 0.2 97.7 20.5 11.3 5.5 5.3 3.4 3.3 3.5 6.4 5.4 2.5 4.6 3.7 C15orf38-AP3S2 ENSG00000250021 "C15orf38-AP3S2 readthrough" 15 89834308-89912882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA040513, HPA047173, HPA049270, HPA052278" Uncertain Approved Vesicles Vesicles "HPA040513: , HPA047173: , HPA049270: , HPA052278: " "unprognostic (1.27e-1)" "unprognostic (8.88e-2)" "unprognostic (4.94e-2)" "unprognostic (1.04e-1)" "unprognostic (3.25e-2)" "unprognostic (3.44e-1)" "unprognostic (2.56e-1)" "unprognostic (1.80e-1)" "unprognostic (1.84e-1)" "unprognostic (2.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.42e-1)" "unprognostic (1.44e-2)" "unprognostic (1.27e-1)" "unprognostic (8.35e-2)" "unprognostic (2.29e-1)" "unprognostic (4.49e-2)" 15.1 13.5 13.3 12.0 14.4 7.1 20.3 11.4 16.4 17.4 22.2 16.7 11.4 13.3 15.3 20.1 17.0 12.3 16.4 20.7 13.1 17.1 13.9 23.5 13.1 10.0 16.5 11.5 17.9 52.9 14.8 10.9 11.6 12.9 19.9 19.7 14.5 12.5 15.4 21.1 9.7 23.7 14.4 17.5 9.8 9.7 11.7 9.1 2.5 14.3 12.0 9.9 15.4 13.5 5.2 14.8 13.9 19.8 7.5 7.1 11.1 6.8 14.7 11.7 15.6 17.4 7.9 8.4 12.0 13.8 15.4 15.5 4.9 15.9 3.6 12.7 10.2 8.7 9.6 10.6 10.6 7.5 9.0 5.3 7.0 10.7 10.4 2.6 4.2 9.6 9.0 9.1 9.8 13.7 4.9 8.8 11.8 9.6 4.0 4.2 12.3 3.7 3.0 5.1 2.8 14.8 7.9 4.0 6.2 21.5 21.3 16.4 14.0 5.3 7.0 13.8 10.3 19.3 7.7 3.3 7.9 4.1 12.0 3.7 10.2 7.1 19.8 8.4 5.5 16.3 7.1 5.2 6.7 5.9 14.8 4.9 5.0 5.0 13.9 7.5 11.9 6.2 6.7 11.1 13.3 14.4 11.4 16.4 13.1 17.1 16.5 11.5 12.9 9.1 C15orf61 LOC145853 ENSG00000189227 "Chromosome 15 open reading frame 61" A6NNL5 15 67521068-67530143 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062820 Approved Nucleoli,Vesicles,Cytosol "Secreted - unknown location" "Nucleoli, Vesicles" Cytosol "HPA062820: " "unprognostic (1.35e-1)" "unprognostic (9.42e-3)" "unprognostic (2.11e-1)" "unprognostic (5.41e-2)" "unprognostic (2.40e-1)" "unprognostic (2.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.87e-3)" "unprognostic (8.95e-2)" "unprognostic (4.01e-2)" "unprognostic (1.04e-2)" "unprognostic (8.45e-2)" "prognostic favourable (5.31e-5)" "unprognostic (2.42e-2)" "unprognostic (9.78e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" 9.9 10.0 10.8 4.7 18.1 11.0 17.9 14.5 17.2 5.5 6.0 2.4 5.6 7.5 6.3 5.9 5.5 5.2 5.1 21.0 8.7 7.2 8.4 6.4 7.2 7.5 6.9 10.9 7.9 20.7 8.8 10.9 5.8 7.3 7.2 6.4 5.9 7.0 6.4 45.8 8.4 5.0 7.0 5.8 5.0 6.6 25.2 5.5 3.6 7.7 16.9 3.7 4.6 8.0 7.2 7.2 10.7 6.6 5.1 9.8 5.0 4.3 4.6 1.2 5.1 5.4 7.9 3.3 1.9 3.4 3.6 2.8 3.5 3.1 3.6 4.1 2.1 5.1 4.6 1.3 2.9 2.1 10.9 3.9 3.5 4.6 3.5 4.7 3.2 8.1 3.6 1.2 4.3 1.6 4.3 8.1 1.1 2.4 3.8 7.7 2.0 5.9 5.2 2.6 13.2 2.5 3.0 6.9 5.2 3.3 3.2 5.8 2.8 7.3 1.7 4.8 7.3 5.9 4.9 7.7 11.1 8.8 2.0 9.3 2.4 8.6 6.6 10.7 7.0 5.2 8.0 7.2 9.2 6.9 6.9 5.6 9.8 7.9 0.8 5.1 4.4 7.2 5.6 5.0 10.8 18.1 14.5 17.2 8.7 7.2 6.9 10.9 7.3 5.5 C16orf58 FLJ13868 ENSG00000140688 "Chromosome 16 open reading frame 58" Q96GQ5 16 31489471-31509309 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024406 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol" "Nucleoli, Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA024406: AB_1845580" "unprognostic (1.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.25e-2)" "unprognostic (4.22e-1)" "unprognostic (6.21e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (9.89e-2)" "unprognostic (3.20e-1)" "unprognostic (1.58e-1)" "unprognostic (6.34e-3)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "unprognostic (5.69e-2)" "unprognostic (2.24e-2)" 13.5 17.7 15.9 15.3 22.3 11.0 15.7 17.9 30.8 22.6 17.5 16.6 34.2 18.6 24.2 21.4 16.8 21.0 20.0 16.7 12.9 15.3 19.1 51.0 13.9 15.7 13.8 16.4 29.5 49.1 30.7 27.6 23.1 13.1 22.0 11.6 22.9 36.9 26.7 4.8 14.1 22.2 15.6 9.1 12.9 19.7 11.9 14.3 15.1 26.4 14.2 19.3 15.9 17.4 8.9 12.0 8.8 9.8 10.8 11.3 8.4 11.4 15.2 9.5 16.5 22.1 14.8 17.6 13.7 23.5 10.7 12.8 4.6 20.2 9.8 29.2 20.2 16.0 9.5 12.7 5.0 14.3 9.4 10.0 8.6 11.4 32.1 11.7 12.0 17.8 13.8 14.1 29.0 10.3 14.7 17.0 10.4 21.6 5.4 7.8 7.4 10.0 12.4 14.3 29.7 12.2 7.1 10.4 16.0 10.3 27.2 21.4 23.5 17.3 8.9 18.7 10.5 12.0 8.9 24.8 14.4 7.4 23.9 18.0 25.7 3.8 6.9 8.8 10.3 9.8 9.6 8.9 10.7 10.2 12.0 8.5 10.8 9.3 1.2 10.8 9.6 11.0 11.3 8.4 15.9 22.3 17.9 30.8 12.9 15.3 13.8 16.4 13.1 14.3 C16orf72 "FLJ41272, PRO0149" ENSG00000182831 "Chromosome 16 open reading frame 72" Q14CZ0 16 9091648-9121640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041568, HPA067492" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA041568: AB_10796677, HPA067492: " "unprognostic (3.98e-2)" "unprognostic (4.74e-2)" "unprognostic (5.87e-3)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (3.62e-4)" "unprognostic (1.37e-1)" "unprognostic (3.17e-2)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (6.74e-2)" "unprognostic (8.64e-2)" "unprognostic (7.92e-3)" "unprognostic (2.03e-1)" "unprognostic (1.29e-2)" "unprognostic (6.64e-3)" "unprognostic (6.51e-2)" 20.1 16.5 15.4 15.8 22.5 80.1 17.7 15.2 25.5 20.1 19.5 18.3 17.4 13.5 17.3 16.7 24.0 14.9 22.6 24.9 13.6 14.4 17.2 23.7 19.3 20.1 14.3 19.3 17.3 16.8 31.3 14.0 20.5 19.0 16.5 14.3 17.8 16.6 16.3 34.5 19.2 17.3 16.7 14.1 19.4 16.6 20.2 12.6 20.1 17.5 20.6 21.2 17.7 21.5 4.1 3.8 14.3 4.1 3.0 5.8 1.9 9.0 10.1 16.2 14.7 19.4 15.1 8.5 17.9 14.9 10.3 10.7 8.4 11.8 16.2 10.3 20.6 10.7 14.9 15.8 21.8 10.6 8.3 10.9 14.0 17.7 25.0 13.7 12.8 22.9 24.9 17.3 24.9 17.9 16.4 24.9 18.3 13.1 12.1 12.2 19.7 8.9 20.8 19.8 17.4 13.5 16.7 10.5 11.8 21.4 15.2 18.0 17.5 14.0 20.5 20.3 13.4 26.0 11.4 28.4 24.4 23.1 18.1 12.3 16.4 5.5 3.8 4.0 5.1 4.0 5.8 3.5 4.4 3.6 2.8 4.1 5.1 4.5 14.3 3.0 4.1 3.8 3.4 1.9 15.4 22.5 15.2 25.5 13.6 14.4 14.3 19.3 19.0 12.6 C17orf51 "FLJ12977, FLJ31874, FLJ33618" ENSG00000212719 "Chromosome 17 open reading frame 51" A8MQB3 17 21524790-21574458 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 41.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA052106 Enhanced Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA052106: " "unprognostic (1.99e-1)" "unprognostic (5.29e-2)" "unprognostic (6.35e-3)" "unprognostic (2.78e-3)" "unprognostic (3.72e-1)" "unprognostic (4.09e-2)" "unprognostic (4.36e-3)" "unprognostic (5.80e-2)" "unprognostic (2.55e-1)" "unprognostic (1.53e-1)" "unprognostic (2.51e-3)" "unprognostic (7.42e-3)" "unprognostic (2.29e-2)" "unprognostic (1.23e-1)" "unprognostic (3.17e-1)" "unprognostic (6.42e-5)" "unprognostic (9.05e-3)" 6.1 7.2 8.0 4.2 8.4 0.8 3.0 41.2 20.5 5.3 4.5 5.2 3.1 3.2 8.3 10.1 3.2 6.7 3.6 6.5 8.6 7.3 4.0 3.8 3.0 3.0 5.9 8.1 5.9 6.6 7.8 8.9 2.1 5.5 6.3 3.2 3.8 5.0 7.0 7.3 3.0 2.4 6.6 5.0 3.3 4.1 9.2 5.9 1.2 2.9 2.2 3.0 4.0 4.7 4.2 4.1 1.2 3.9 2.6 6.0 1.8 2.6 6.1 2.3 7.9 7.3 6.9 2.1 7.1 3.5 5.2 5.9 12.1 0.4 3.5 4.0 3.9 0.3 9.8 3.7 8.6 11.0 15.2 0.7 5.6 5.0 13.6 0.9 3.9 6.5 3.4 10.5 11.4 3.7 1.9 0.8 4.4 0.0 7.6 0.3 4.3 5.2 7.4 4.8 0.5 1.9 0.5 5.1 0.9 6.6 0.2 5.2 0.1 0.3 6.6 6.1 6.3 14.5 8.5 2.3 2.8 13.5 7.3 1.3 7.1 0.0 3.9 0.0 4.0 1.8 3.1 2.2 1.9 1.8 1.9 4.2 6.0 5.1 1.2 2.6 1.0 4.1 1.7 1.8 8.0 8.4 41.2 14.5 8.6 7.3 5.9 8.1 5.5 5.9 C17orf64 ENSG00000141371 "Chromosome 17 open reading frame 64" Q86WR6 17 60392429-60431421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 74.5" "Cell line enhanced" "Detected in some" "MCF7: 10.8;THP-1: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.8" "Group enriched" "Detected in many" 4 "dendritic cells: 5.8;granulocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA044415 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA044415: AB_10797148" "unprognostic (3.00e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.77e-1)" "unprognostic (1.51e-2)" "unprognostic (2.30e-2)" "unprognostic (3.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (6.85e-2)" "unprognostic (1.68e-6)" "unprognostic (3.30e-1)" "unprognostic (2.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.46e-2)" 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 74.5 0.1 0.2 0.0 0.1 0.1 0.0 0.0 1.0 5.8 2.5 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 1.2 0.0 0.0 0.0 0.6 0.7 1.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.7 0.2 0.5 1.7 0.0 0.1 0.0 0.0 0.0 0.6 0.0 10.8 0.3 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 2.7 0.3 0.0 0.1 0.0 0.0 1.7 1.3 0.2 0.0 1.4 0.0 0.0 0.6 0.0 0.1 0.5 0.0 1.0 0.3 0.0 1.8 0.2 0.0 0.6 2.5 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.1 C17orf80 "FLJ20721, HLC-8, MIG3, SPEP1" ENSG00000141219 "Chromosome 17 open reading frame 80" Q9BSJ5 17 73232233-73248947 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012896 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA012896: AB_1850766" "unprognostic (9.22e-2)" "unprognostic (1.62e-1)" "prognostic favourable (1.43e-4)" "unprognostic (5.55e-3)" "unprognostic (8.58e-2)" "unprognostic (2.66e-1)" "prognostic unfavourable (9.02e-6)" "unprognostic (1.08e-1)" "unprognostic (1.00e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (6.09e-2)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.52e-1)" "unprognostic (2.36e-3)" "unprognostic (1.37e-1)" 8.0 10.5 12.8 8.5 13.2 2.4 10.6 27.8 15.4 11.3 11.7 8.4 5.3 9.1 13.1 9.0 10.8 11.2 7.8 13.5 13.8 10.0 11.5 8.6 10.2 11.0 11.8 12.7 16.0 10.1 17.2 24.9 10.9 11.8 11.6 9.0 9.4 9.0 11.2 22.2 7.5 10.4 12.4 14.4 9.9 9.7 32.5 11.3 16.1 14.6 8.3 10.3 10.3 13.3 6.5 7.1 14.6 5.0 5.2 8.7 3.9 9.8 10.4 14.5 8.8 10.7 9.2 14.1 13.0 11.3 18.5 17.6 9.9 8.2 18.8 9.3 6.6 9.9 20.1 7.5 21.7 6.8 13.7 17.3 11.0 11.5 9.3 18.1 10.2 7.1 9.4 12.3 10.2 15.8 18.6 11.3 12.3 5.6 21.0 8.6 11.5 11.3 12.7 39.9 9.6 9.6 7.5 17.8 16.0 6.9 12.7 15.1 13.9 11.5 8.6 19.4 17.9 6.2 12.3 12.8 15.2 18.1 7.8 8.3 12.3 14.6 4.0 5.7 8.5 5.0 8.7 6.5 6.3 7.5 4.6 5.8 6.0 8.6 1.9 5.2 4.7 7.1 8.6 3.9 12.8 13.2 27.8 15.4 13.8 10.0 11.8 12.7 11.8 11.3 C18orf32 FLJ23458 ENSG00000177576 "Chromosome 18 open reading frame 32" Q8TCD1 18 49477250-49487252 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040921 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA040921: AB_10795423" "unprognostic (5.83e-2)" "unprognostic (5.48e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-2)" "unprognostic (4.19e-2)" "unprognostic (1.44e-1)" "unprognostic (1.72e-1)" "unprognostic (2.80e-2)" "unprognostic (6.36e-2)" "unprognostic (4.36e-3)" "unprognostic (2.58e-3)" "unprognostic (2.76e-2)" "prognostic favourable (8.89e-9)" "unprognostic (1.02e-1)" "unprognostic (7.42e-2)" "unprognostic (1.28e-2)" "unprognostic (4.36e-2)" 17.1 16.5 67.0 7.1 59.0 19.1 25.5 27.4 48.4 22.2 24.2 29.5 16.1 10.7 12.7 35.0 13.6 17.2 19.4 25.1 57.5 49.8 42.2 38.6 19.6 14.8 67.8 28.3 16.5 20.1 23.8 20.5 15.7 47.0 21.3 22.4 17.0 21.6 18.9 10.8 10.2 14.2 14.9 78.5 13.6 23.4 15.5 25.2 8.3 28.8 8.0 12.7 19.4 9.6 16.1 21.4 57.2 22.1 9.8 15.4 21.0 7.6 8.8 16.7 10.4 15.2 13.5 19.2 11.6 12.8 11.3 9.6 1.6 3.5 6.9 29.3 9.8 8.9 3.8 13.1 9.7 22.1 7.8 6.2 5.9 10.6 24.2 12.2 13.3 11.7 29.1 7.6 11.3 15.1 7.1 13.3 23.4 4.8 7.7 6.3 4.6 8.8 7.3 5.8 13.9 30.1 15.0 19.2 33.1 7.6 6.0 15.7 8.6 4.5 16.1 11.7 9.9 3.3 12.5 40.6 24.1 7.5 9.2 8.2 10.9 36.3 17.1 43.2 13.9 19.3 15.4 16.1 13.7 14.3 14.1 12.8 11.7 15.4 57.2 9.8 22.1 21.4 14.6 21.0 67.0 59.0 27.4 48.4 57.5 49.8 67.8 28.3 47.0 25.2 C19orf81 ENSG00000235034 "Chromosome 19 open reading frame 81" C9J6K1 19 50649445-50659310 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 10.7" "Cell line enhanced" "Detected in some" "HEK 293: 9.2;HMC-1: 3.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA060238 Enhanced Approved Vesicles,Aggresome "Vesicles, Aggresome" "HPA060238: " "unprognostic (2.29e-2)" "unprognostic (2.75e-2)" "unprognostic (2.17e-3)" "unprognostic (1.15e-1)" "unprognostic (3.39e-2)" "unprognostic (2.03e-2)" "unprognostic (1.70e-2)" "unprognostic (4.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.48e-2)" "unprognostic (6.01e-4)" "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (1.95e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 1.1 1.4 0.0 0.0 0.7 0.0 0.0 1.2 9.2 0.9 0.0 0.0 0.5 0.0 3.3 0.0 0.0 0.0 0.0 0.4 2.1 1.8 0.0 0.0 0.5 1.5 0.5 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.7 0.0 0.0 1.1 0.5 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.6 0.0 0.1 C19orf84 ENSG00000262874 "Chromosome 19 open reading frame 84" I3L1E1 19 51388289-51390574 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 39.0" "Cell line enriched" "Detected in some" 8 "K-562: 12.1" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 1.5;plasmacytoid DC: 1.7" "Group enriched" "Detected in many" 6 "dendritic cells: 1.7;T-cells: 1.5" "Low region specificity" "Detected in single" HPA068082 Uncertain Approved Vesicles Vesicles "HPA068082: " "unprognostic (5.94e-2)" "unprognostic (7.72e-2)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (2.08e-1)" "unprognostic (1.47e-1)" "unprognostic (2.13e-3)" "unprognostic (9.28e-4)" "unprognostic (1.31e-1)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (3.84e-1)" "unprognostic (2.61e-7)" "unprognostic (8.30e-3)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (3.99e-3)" 0.0 0.0 0.1 0.3 0.2 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.1 0.1 0.2 0.6 0.1 0.0 0.0 0.1 0.3 0.4 0.0 0.4 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.5 0.0 39.0 0.2 1.0 0.0 0.2 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.2 1.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.1 0.2 0.2 0.2 0.6 0.1 0.4 0.0 0.6 0.2 C1orf123 FLJ20580 ENSG00000162384 "Chromosome 1 open reading frame 123" Q9NWV4 1 53214099-53220617 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043835 Uncertain Approved "Vesicles,Mitotic spindle,Cytosol" 380000 Cytosol "Vesicles, Mitotic spindle" "HPA043835: AB_10796797" "unprognostic (1.09e-2)" "unprognostic (5.91e-2)" "unprognostic (2.03e-2)" "unprognostic (4.55e-2)" "unprognostic (5.43e-2)" "unprognostic (1.53e-1)" "unprognostic (9.20e-3)" "unprognostic (2.27e-1)" "unprognostic (5.52e-2)" "unprognostic (9.37e-3)" "unprognostic (1.46e-1)" "unprognostic (3.05e-1)" "prognostic unfavourable (1.53e-4)" "unprognostic (6.31e-3)" "unprognostic (1.39e-1)" "unprognostic (1.32e-1)" "unprognostic (2.43e-1)" 32.6 21.4 27.8 19.1 29.4 12.9 26.3 16.4 25.4 29.2 33.2 25.0 22.7 15.4 34.0 28.9 25.7 32.2 22.7 28.8 24.3 22.3 26.9 29.3 20.3 18.3 24.7 26.3 33.5 17.5 21.0 20.1 22.5 23.7 31.7 24.7 24.0 16.6 33.5 44.4 14.3 16.9 48.4 22.5 18.4 23.4 26.0 23.8 18.9 26.0 18.0 19.4 28.9 26.0 25.5 38.4 31.5 39.1 30.5 36.5 26.4 11.6 12.7 16.8 15.3 39.0 50.0 14.9 17.5 18.7 17.8 19.3 10.8 10.1 18.1 14.7 21.2 4.6 10.3 17.2 21.6 23.3 17.6 18.4 9.8 16.2 38.4 21.1 12.2 32.4 18.8 19.0 20.2 29.0 19.0 5.1 22.2 19.6 25.9 19.9 27.9 20.2 19.0 21.3 14.2 20.6 11.9 14.2 13.7 16.6 15.2 16.5 10.8 21.7 18.1 20.7 12.2 14.3 17.0 7.4 10.7 20.4 16.6 21.2 15.9 28.3 32.1 31.5 30.4 39.1 27.7 25.5 30.2 31.7 38.4 23.6 33.7 33.4 13.0 30.5 31.8 25.9 36.5 26.4 27.8 29.4 16.4 25.4 24.3 22.3 24.7 26.3 23.7 23.8 C1orf53 ENSG00000203724 "Chromosome 1 open reading frame 53" Q5VUE5 1 197902647-197907367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 20.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 10.5" "Lineage enriched" "Detected in many" 4 "monocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA065352 Approved Vesicles,Aggresome Vesicles Aggresome "HPA065352: " "prognostic favourable (1.63e-4)" "unprognostic (1.48e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (3.78e-4)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (2.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.90e-3)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (5.53e-3)" "unprognostic (9.85e-2)" "unprognostic (1.12e-1)" "unprognostic (8.58e-3)" "unprognostic (1.37e-1)" 3.3 10.8 6.5 1.5 3.2 1.7 2.1 1.0 6.6 3.1 5.6 2.8 4.0 4.2 1.6 6.2 3.2 1.7 4.7 7.5 4.8 4.0 8.6 20.9 5.0 2.4 2.7 2.9 2.9 8.2 0.5 6.0 2.9 3.7 2.7 3.0 4.5 4.8 1.5 6.6 1.2 4.3 2.2 1.6 2.2 3.5 4.7 3.5 0.1 4.6 2.1 1.4 1.6 1.5 0.1 2.6 0.0 10.5 0.0 0.8 1.1 4.3 5.2 0.4 2.0 2.6 8.0 2.9 6.6 4.4 5.3 2.7 4.6 3.1 7.1 10.5 7.0 1.7 1.7 1.2 0.5 2.3 13.4 4.2 3.8 7.8 1.1 9.4 6.2 4.6 3.9 1.9 0.7 1.9 1.2 1.6 3.1 6.4 0.5 8.3 4.3 7.6 1.0 2.8 2.8 8.2 6.2 15.8 11.8 8.2 1.5 2.4 3.6 3.6 4.5 6.3 7.2 8.8 3.8 3.2 2.4 1.7 4.1 2.8 6.4 0.0 3.6 0.0 0.4 10.5 0.0 0.0 0.2 0.8 2.6 0.1 0.4 0.4 0.0 0.0 5.1 0.7 0.1 1.1 6.5 3.2 1.0 6.6 4.8 4.0 2.7 2.9 3.7 3.5 C1QTNF12 "ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127" ENSG00000184163 "C1q and TNF related 12" Q5T7M4 1 1242446-1246722 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 11.0;skin 1: 7.8" "Group enriched" "Detected in some" 5 "EFO-21: 8.1;U-2 OS: 8.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.6;NK-cell: 2.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024107 Uncertain Approved Vesicles "Secreted to blood" 38190000 Vesicles "HPA024107: AB_2101207" "unprognostic (1.10e-2)" "unprognostic (5.68e-3)" "unprognostic (3.45e-1)" "unprognostic (1.24e-2)" "unprognostic (6.60e-3)" "unprognostic (2.43e-1)" "unprognostic (2.67e-3)" "unprognostic (1.01e-2)" "unprognostic (2.58e-1)" "unprognostic (1.05e-2)" "unprognostic (8.02e-3)" "unprognostic (1.10e-2)" "unprognostic (9.68e-3)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.09e-1)" "unprognostic (1.20e-1)" 1.0 0.0 0.5 0.2 0.0 0.0 0.5 0.2 0.2 0.1 3.4 11.0 0.1 0.0 1.2 0.2 0.1 0.2 0.0 1.0 3.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 1.2 0.4 0.0 0.1 7.8 10.4 0.1 0.2 0.0 0.3 2.4 0.2 0.1 0.0 0.4 0.3 0.6 2.6 0.3 2.2 0.4 0.2 0.3 0.0 0.0 0.6 0.4 0.1 1.5 1.1 0.0 0.1 0.0 0.6 0.4 0.1 8.1 0.3 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.2 0.3 0.1 0.1 0.1 0.3 0.0 0.3 0.0 0.0 0.5 0.3 0.1 0.8 0.1 0.3 0.0 1.3 0.0 0.0 1.2 0.3 0.0 0.0 0.7 0.6 0.1 0.0 0.0 8.1 0.1 0.0 1.6 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.6 0.3 0.4 0.0 2.6 2.2 0.3 0.0 0.0 0.2 C1QTNF7 CTRP7 ENSG00000163145 "C1q and TNF related 7" Q9BXJ2 4 15339818-15446166 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 39.6" "Group enriched" "Detected in some" 5 "ASC diff: 9.0;ASC TERT1: 6.2;HSkMC: 3.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB007055, HPA051797, HPA055392" Uncertain Approved Vesicles "Secreted to blood" 238000000 Vesicles "CAB007055: , HPA051797: , HPA055392: " "unprognostic (6.61e-2)" "unprognostic (4.50e-2)" "unprognostic (6.16e-2)" "unprognostic (6.50e-4)" "unprognostic (1.24e-1)" "unprognostic (4.98e-3)" "unprognostic (2.31e-2)" "unprognostic (7.69e-3)" "unprognostic (7.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.41e-1)" "unprognostic (1.38e-1)" "unprognostic (2.97e-4)" "unprognostic (3.01e-3)" "unprognostic (8.31e-2)" "unprognostic (7.56e-3)" "unprognostic (7.28e-3)" 16.0 0.9 0.6 24.7 0.8 0.0 7.4 0.3 0.7 39.6 12.0 0.5 3.3 0.6 24.6 10.1 17.3 6.2 20.3 5.4 0.6 0.6 4.0 1.0 7.9 0.5 0.8 0.5 15.9 1.3 0.0 1.4 5.4 0.8 22.0 3.2 5.4 2.7 2.4 2.2 3.5 4.1 22.1 0.7 10.2 10.4 4.4 0.1 0.3 4.2 13.0 2.0 16.3 15.8 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 3.3 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.3 0.7 0.6 0.6 0.8 0.5 0.8 0.1 C20orf196 FLJ25067 ENSG00000171984 "Chromosome 20 open reading frame 196" Q8IYI0 20 5750393-5863912 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 30.4;U-698: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040749 Approved Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" "Endoplasmic reticulum, Golgi apparatus, Vesicles" "HPA040749: AB_10673093" "unprognostic (2.03e-1)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "unprognostic (4.20e-3)" "unprognostic (6.15e-2)" "unprognostic (1.66e-1)" "unprognostic (1.72e-3)" "unprognostic (6.66e-2)" "unprognostic (9.04e-3)" "unprognostic (1.67e-2)" "unprognostic (1.44e-2)" "unprognostic (7.59e-3)" "unprognostic (1.63e-1)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.76e-1)" "prognostic favourable (4.05e-5)" 5.4 13.9 7.1 15.5 7.3 17.8 8.1 10.6 8.7 6.8 7.9 9.2 12.6 11.9 7.7 8.7 7.4 6.7 8.0 12.3 7.0 7.0 6.9 4.1 9.3 17.6 8.9 6.7 7.7 11.1 2.8 10.6 5.1 6.9 8.7 7.4 10.9 19.1 12.9 15.1 5.6 13.7 6.7 7.1 14.2 6.2 4.2 7.8 20.4 9.6 9.4 16.8 6.4 6.6 21.7 10.9 15.6 10.8 16.2 22.7 10.2 4.7 6.0 3.0 1.3 1.9 1.5 1.3 1.4 2.4 1.9 2.8 2.7 5.4 18.7 3.6 1.4 2.2 1.9 3.5 2.2 5.6 2.3 6.8 0.9 10.1 4.2 8.2 3.2 2.4 5.1 2.9 1.9 3.8 9.5 7.5 3.4 2.1 11.4 30.4 3.6 3.2 9.4 4.0 8.4 2.8 2.4 4.8 4.5 2.8 2.7 5.5 2.1 8.7 2.2 2.1 3.0 1.9 3.0 5.2 8.7 24.8 1.0 8.6 3.6 11.2 8.7 15.6 17.0 10.4 13.2 19.7 19.5 16.7 9.2 21.7 18.8 13.4 3.9 16.2 10.8 10.9 22.7 10.2 7.1 7.3 10.6 8.7 7.0 7.0 8.9 6.7 6.9 7.8 C21orf2 "A2, LRRC76, YF5" ENSG00000160226 "Chromosome 21 open reading frame 2" O43822 21 44328944-44339402 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, DNA damage" "Ciliopathy, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030283, HPA030284, CAB034126, CAB034128" Supported Supported Vesicles,Mitochondria,Cytosol Mitochondria "Vesicles, Cytosol" "CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700" "unprognostic (1.84e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (9.73e-2)" "unprognostic (2.77e-1)" "prognostic favourable (1.32e-4)" "unprognostic (1.49e-1)" "prognostic favourable (4.08e-4)" "unprognostic (2.98e-1)" "unprognostic (2.79e-1)" "unprognostic (1.32e-2)" "unprognostic (1.06e-1)" 18.8 13.4 19.8 11.3 21.6 19.7 9.2 10.3 23.4 13.8 14.7 18.2 14.3 13.4 12.6 19.1 6.9 14.7 13.2 11.3 19.5 16.6 18.0 11.6 12.8 12.4 16.4 19.1 15.2 14.5 7.4 17.6 12.4 13.2 12.3 3.9 14.3 16.1 17.2 21.0 22.3 15.4 5.8 12.6 16.1 21.1 16.7 11.2 10.9 16.4 8.1 13.0 8.1 7.0 10.8 21.7 1.2 8.5 12.1 9.7 4.9 7.8 3.3 3.2 4.1 2.1 1.4 12.6 4.1 2.4 1.6 0.9 6.0 2.4 5.7 8.2 1.4 3.8 0.6 0.7 0.4 8.6 8.2 5.9 2.6 7.0 2.8 6.3 6.4 1.9 1.4 0.7 1.4 1.0 7.2 9.8 1.0 9.8 6.9 15.6 8.0 5.1 17.8 4.1 12.7 1.9 11.6 8.4 7.8 5.7 1.3 6.8 6.1 14.0 4.6 3.6 4.6 3.8 3.0 16.1 8.4 3.9 8.8 12.8 6.4 1.2 7.1 1.0 7.1 8.5 8.5 10.8 7.3 9.7 7.3 8.6 8.5 8.2 0.9 12.1 6.2 21.7 4.0 4.9 19.8 21.6 10.3 22.4 19.5 16.6 16.4 19.1 13.2 11.2 C2CD4C "FAM148C, KIAA1957, NLF3" ENSG00000183186 "C2 calcium dependent domain containing 4C" Q8TF44 19 405438-409170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4" "Cell line enhanced" "Detected in some" "HDLM-2: 7.2;MCF7: 4.9;NTERA-2: 7.3;SCLC-21H: 13.1;U-2 OS: 7.8" "Cancer enhanced" "Detected in many" "testis cancer: 7.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055915 Uncertain Approved Vesicles Vesicles "HPA055915: " "unprognostic (1.29e-1)" "unprognostic (9.43e-2)" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "unprognostic (9.39e-3)" "unprognostic (2.14e-1)" "unprognostic (1.67e-1)" "unprognostic (9.81e-2)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (1.35e-1)" "unprognostic (1.12e-2)" "unprognostic (1.43e-2)" "unprognostic (5.04e-2)" "unprognostic (5.09e-2)" "unprognostic (1.74e-1)" 6.9 2.1 15.8 1.7 7.4 0.8 5.4 1.0 19.4 2.2 1.3 0.7 0.0 2.0 2.4 0.9 1.2 1.6 8.6 2.2 7.1 13.5 1.6 1.0 1.5 1.2 4.7 10.8 0.9 1.1 0.9 1.7 2.0 6.5 1.1 1.0 2.2 1.1 1.0 3.1 2.4 1.8 1.3 3.0 1.2 1.6 1.9 3.0 0.0 6.7 0.0 0.9 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 1.5 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.1 2.3 0.0 0.6 0.0 2.8 2.8 0.2 0.1 7.2 1.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 4.9 0.0 0.0 7.3 0.1 0.0 0.0 0.0 0.0 0.0 13.1 3.8 1.2 0.0 0.0 0.2 0.0 0.0 0.1 7.8 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 7.4 1.0 18.2 7.1 13.5 4.7 10.8 6.5 3.0 C2orf70 LOC339778 ENSG00000173557 "Chromosome 2 open reading frame 70" A6NJV1 2 26562582-26579532 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 11.5;testis: 44.9" "Cell line enhanced" "Detected in some" "A-431: 7.3;CAPAN-2: 5.6;EFO-21: 3.6;RPTEC TERT1: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062453 Enhanced Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA062453: " "unprognostic (5.44e-2)" "unprognostic (9.30e-3)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (1.99e-2)" "unprognostic (9.40e-6)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.07e-1)" "prognostic favourable (6.49e-4)" "unprognostic (4.58e-2)" "unprognostic (1.52e-1)" "unprognostic (2.98e-1)" "unprognostic (2.01e-1)" "unprognostic (2.16e-3)" "unprognostic (7.08e-3)" 0.1 0.3 1.1 0.3 2.2 0.0 0.3 0.1 0.8 0.5 1.0 3.1 2.3 0.3 0.4 5.2 0.2 11.5 0.6 1.4 1.1 2.7 0.7 0.1 1.0 0.1 0.8 0.7 2.7 4.5 0.0 1.2 0.1 4.4 0.4 0.6 0.0 3.1 1.7 0.2 0.1 0.2 0.1 0.7 0.1 7.6 44.9 0.5 0.0 3.1 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.6 0.0 3.6 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 1.7 0.3 0.7 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.2 0.1 0.8 1.1 2.7 0.8 0.7 4.4 0.5 C4orf47 LOC441054 ENSG00000205129 "Chromosome 4 open reading frame 47" A7E2U8 4 185426249-185449826 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8;fallopian tube: 20.3;testis: 20.6" "Cell line enhanced" "Detected in some" "A-431: 4.1;ASC TERT1: 4.3;U-87 MG: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 4 "granulocytes: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043662, HPA063485" Enhanced Approved Vesicles Vesicles "HPA043662: AB_10964715, HPA063485: " "unprognostic (3.38e-2)" "unprognostic (2.66e-1)" "unprognostic (5.78e-3)" "unprognostic (2.84e-3)" "unprognostic (3.61e-3)" "unprognostic (1.31e-1)" "unprognostic (5.82e-5)" "unprognostic (3.72e-2)" "unprognostic (4.62e-2)" "unprognostic (2.84e-1)" "unprognostic (1.25e-1)" "unprognostic (8.71e-3)" "prognostic unfavourable (4.75e-4)" "unprognostic (1.05e-1)" "unprognostic (3.64e-2)" "unprognostic (9.88e-3)" "unprognostic (1.50e-1)" 0.9 0.5 4.4 0.7 13.3 0.8 3.7 1.7 4.0 1.8 0.7 3.6 0.8 0.6 2.2 12.3 0.7 20.3 1.8 1.2 3.8 3.8 2.4 1.0 3.3 0.5 2.4 2.9 3.0 1.3 1.0 7.1 0.7 20.8 1.2 0.7 2.1 1.0 1.4 0.6 1.9 0.7 1.0 4.7 0.8 0.5 20.6 5.5 0.0 7.3 0.0 0.6 1.0 0.6 0.1 0.7 4.1 0.6 0.9 0.6 0.2 4.1 0.0 0.4 2.2 0.8 4.3 1.3 0.1 0.3 0.4 0.5 0.6 2.5 0.1 0.8 0.2 0.3 0.5 0.6 1.0 0.8 0.7 0.0 0.1 0.6 1.0 0.0 0.3 0.9 1.0 1.0 0.5 0.0 0.6 0.3 3.2 0.5 0.0 0.0 0.5 1.6 0.1 0.1 0.3 1.2 0.1 2.3 1.0 0.7 0.1 2.6 0.2 0.7 1.3 0.7 0.3 0.0 0.1 1.8 0.0 0.0 10.7 0.0 0.3 0.0 0.6 0.6 0.2 0.1 0.4 0.0 0.6 0.6 0.2 0.1 0.1 0.2 4.1 0.9 0.2 0.7 0.0 0.2 4.4 13.3 1.7 4.0 3.8 3.8 2.4 2.9 20.8 5.5 C5AR1 "C5A, C5AR, C5R1, CD88" ENSG00000197405 "Complement C5a receptor 1" P21730 19 47290023-47322066 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 5.8;HMC-1: 7.4;U-87 MG: 8.8;U-937: 8.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 75.8" "Group enriched" "Detected in many" 42 "granulocytes: 75.8;monocytes: 20.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002720, HPA014520, HPA048012" Approved Supported Vesicles Vesicles "CAB002720: , HPA014520: AB_1846337, HPA048012: " "unprognostic (5.95e-2)" "prognostic favourable (4.71e-4)" "unprognostic (1.70e-2)" "unprognostic (1.25e-1)" "unprognostic (4.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.80e-2)" "unprognostic (4.41e-2)" "unprognostic (5.45e-2)" "prognostic unfavourable (9.55e-4)" "unprognostic (2.02e-1)" "unprognostic (9.56e-2)" "prognostic unfavourable (1.16e-4)" "unprognostic (1.96e-3)" "prognostic unfavourable (7.99e-4)" "unprognostic (1.82e-2)" "unprognostic (6.54e-2)" 33.7 8.0 1.9 34.9 7.0 46.2 8.7 0.7 3.0 5.6 6.0 3.7 1.6 1.0 4.1 4.9 3.5 14.3 16.5 11.7 7.6 3.2 5.3 9.1 38.1 26.9 3.8 1.2 7.6 3.6 1.3 27.9 12.8 10.9 4.2 1.9 7.8 2.9 1.1 7.0 1.1 3.0 11.4 11.2 48.8 4.2 6.3 1.3 2.3 2.5 1.7 3.4 12.2 2.7 0.1 1.1 75.8 20.5 0.1 0.1 2.6 1.4 5.3 0.3 0.5 1.0 0.4 1.1 1.0 0.6 0.3 0.1 0.2 5.8 0.4 1.1 1.2 2.0 0.7 0.8 0.2 1.0 0.7 0.2 4.9 0.8 0.6 2.6 7.4 0.8 3.0 0.6 0.9 0.0 0.3 2.6 0.2 1.5 0.3 3.4 1.8 0.8 0.3 0.1 0.4 1.8 1.2 0.0 0.1 0.5 0.5 0.8 0.4 3.0 0.0 0.1 3.1 0.4 0.3 0.4 0.4 0.3 8.8 8.9 0.3 7.0 8.9 6.9 0.1 15.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 75.8 0.1 20.5 0.2 0.0 2.6 1.9 7.0 0.7 3.0 7.6 3.2 3.8 1.2 10.9 1.3 C5orf38 "CEI, IRX2NB" ENSG00000186493 "Chromosome 5 open reading frame 38" Q86SI9 5 2752131-2755397 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 34.9" "Cell line enhanced" "Detected in many" "BEWO: 37.4;HaCaT: 12.8;hTCEpi: 20.5;MCF7: 10.9;SiHa: 15.7;SK-BR-3: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA073667 Approved "Golgi apparatus,Vesicles" "Secreted - unknown location" "Golgi apparatus, Vesicles" "HPA073667: " "unprognostic (5.00e-3)" "unprognostic (4.10e-2)" "unprognostic (1.71e-2)" "unprognostic (3.72e-5)" "unprognostic (4.08e-2)" "unprognostic (2.24e-2)" "unprognostic (2.67e-2)" "unprognostic (8.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-2)" "unprognostic (7.60e-2)" "unprognostic (3.84e-7)" "unprognostic (2.60e-2)" "unprognostic (8.01e-2)" "unprognostic (3.01e-2)" "unprognostic (5.60e-2)" 8.3 0.5 4.5 0.6 7.6 0.5 16.3 10.4 3.0 0.6 1.1 1.5 9.8 0.7 0.7 6.8 4.1 0.6 0.6 2.4 6.0 7.0 6.6 0.5 19.4 1.1 10.5 2.0 0.5 3.8 5.0 2.6 4.3 14.8 5.9 0.7 3.4 34.9 3.9 0.9 10.6 0.5 0.5 12.2 0.7 11.2 1.5 4.7 0.0 5.0 1.6 2.4 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 6.7 0.0 2.9 2.1 37.4 4.8 3.8 3.2 2.8 1.9 0.0 0.0 0.0 0.9 12.8 0.7 3.7 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 20.5 0.8 2.6 0.0 0.0 0.0 0.8 10.9 0.0 0.1 1.0 0.0 0.0 1.3 0.0 4.2 0.0 1.0 0.0 15.7 14.7 0.0 6.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 7.6 10.4 0.3 6.0 7.0 10.5 2.0 14.8 4.7 C7orf43 FLJ10925 ENSG00000146826 "Chromosome 7 open reading frame 43" Q8WVR3 7 100154420-100158715 "Predicted intracellular proteins" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019359, HPA029463, HPA029464" Approved Enhanced "Vesicles,Plasma membrane,Centriolar satellite" Vesicles "Plasma membrane, Centriolar satellite" "HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205" "unprognostic (1.57e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-3)" "unprognostic (2.59e-1)" "unprognostic (5.23e-2)" "unprognostic (1.06e-1)" "unprognostic (9.36e-3)" "unprognostic (5.68e-3)" "unprognostic (6.97e-3)" "unprognostic (1.25e-1)" "prognostic favourable (6.19e-5)" "unprognostic (2.42e-2)" "unprognostic (1.85e-2)" "unprognostic (4.26e-2)" "unprognostic (2.81e-1)" "unprognostic (3.26e-1)" "unprognostic (6.54e-3)" 7.0 10.4 10.6 23.0 11.3 12.2 12.2 24.8 23.2 6.7 14.0 9.4 13.6 16.2 9.6 10.8 12.1 8.4 10.5 6.4 12.8 13.9 12.3 12.9 19.0 21.4 10.8 10.6 5.7 11.6 18.7 14.5 21.6 14.6 10.2 13.5 8.8 13.5 10.8 10.1 28.1 16.4 6.9 6.0 25.8 14.9 26.8 6.9 17.6 12.2 7.4 14.0 8.5 7.8 2.1 0.7 5.2 1.7 0.5 2.6 1.0 4.8 6.2 7.3 12.3 4.6 2.5 8.2 9.0 7.1 6.2 4.6 4.8 5.7 6.1 8.3 6.8 9.3 3.5 7.1 2.4 11.4 6.7 4.5 7.8 4.2 5.5 5.7 21.4 5.1 4.9 6.1 4.7 5.4 9.9 11.1 8.1 14.9 12.8 12.2 8.2 9.0 7.7 3.3 6.8 5.4 5.5 9.3 9.9 8.0 23.5 4.8 4.8 6.9 7.5 12.4 10.6 16.5 6.9 16.6 15.6 6.1 7.0 7.8 13.2 1.7 1.0 3.5 2.0 1.6 1.4 0.9 2.6 1.8 0.7 2.1 1.5 2.2 5.2 0.5 1.7 0.6 0.2 1.0 10.6 11.3 24.8 23.2 12.8 13.9 10.8 10.6 14.6 6.9 C7orf61 IMAGE:4839025 ENSG00000185955 "Chromosome 7 open reading frame 61" Q8IZ16 7 100456615-100464271 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 80.4" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 21.7;NB-4: 8.0;TIME: 12.7" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA060395 Enhanced Approved Vesicles Vesicles "HPA060395: " "unprognostic (1.88e-1)" "unprognostic (5.02e-1)" "unprognostic (1.26e-2)" "unprognostic (7.70e-5)" "unprognostic (1.65e-1)" "unprognostic (2.63e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (4.26e-1)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (2.53e-1)" "unprognostic (6.39e-13)" "unprognostic (9.54e-2)" "unprognostic (2.93e-1)" "unprognostic (1.33e-2)" "unprognostic (1.24e-2)" 0.5 0.3 2.8 0.6 3.1 1.2 0.5 1.4 3.4 0.5 0.5 0.5 0.5 0.1 0.8 0.8 0.5 0.7 0.6 0.5 3.0 2.3 0.5 0.5 0.5 0.8 3.2 0.5 1.0 0.5 0.4 0.9 0.6 0.6 0.5 0.2 0.5 0.5 0.7 0.5 0.7 0.5 0.5 3.1 1.0 0.1 80.4 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.6 1.3 1.2 0.8 2.9 0.2 0.8 0.2 0.7 0.8 0.8 1.9 0.3 0.3 1.3 0.2 0.7 0.9 0.4 0.6 1.4 0.7 0.5 0.3 0.0 0.5 0.8 1.4 1.2 1.6 0.0 1.0 0.4 0.3 0.3 0.3 0.8 1.2 21.7 0.6 1.1 1.2 2.0 0.4 8.0 0.5 0.9 2.1 0.0 0.4 0.3 0.3 0.0 0.0 0.5 0.7 1.3 0.3 2.2 12.7 1.1 1.9 2.4 0.3 0.3 0.2 0.8 0.2 1.9 0.1 0.0 1.2 0.0 0.8 0.7 0.3 0.0 1.1 0.6 0.6 0.1 0.1 1.6 1.3 0.8 0.4 0.0 2.9 0.2 2.8 3.1 1.4 1.5 3.0 2.3 3.2 0.5 0.6 0.5 C9orf84 FLJ32779 ENSG00000165181 "Chromosome 9 open reading frame 84" Q5VXU9 9 111686173-111795008 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 33.0" "Cell line enriched" "Detected in some" 5 "U-2 OS: 21.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 15 "granulocytes: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA032108 Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA032108: AB_10669884" "unprognostic (2.63e-1)" "unprognostic (1.83e-4)" "unprognostic (9.12e-2)" "unprognostic (3.17e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (9.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.22e-2)" "unprognostic (1.65e-1)" "unprognostic (8.14e-2)" "unprognostic (2.30e-1)" "unprognostic (8.33e-5)" "unprognostic (6.93e-2)" "unprognostic (2.84e-1)" "unprognostic (3.77e-1)" "unprognostic (7.31e-2)" 0.1 2.9 0.1 0.5 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.0 0.3 0.6 0.2 0.0 0.1 0.1 0.1 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 1.1 33.0 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.2 0.2 4.1 0.0 0.1 0.2 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 4.7 1.1 0.4 0.0 0.2 0.0 0.0 21.9 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 4.1 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CA10 "CA-RPX, CARPX, HUCEP-15" ENSG00000154975 "Carbonic anhydrase 10" Q9NS85 17 51630313-52160017 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 59.5;cervix, uterine: 23.4" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.1;RT4: 3.7;SCLC-21H: 11.4" "Cancer enhanced" "Detected in some" "glioma: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054825, HPA057837" Supported Approved Vesicles "Secreted in brain" Vesicles "HPA054825: , HPA057837: " "unprognostic (2.66e-1)" "unprognostic (1.76e-1)" "unprognostic (6.06e-2)" "unprognostic (2.10e-1)" "unprognostic (3.43e-1)" "unprognostic (8.22e-2)" "unprognostic (4.43e-3)" "unprognostic (1.02e-3)" "unprognostic (1.01e-1)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (7.21e-3)" "unprognostic (9.18e-5)" "unprognostic (1.60e-1)" "unprognostic (1.51e-1)" 0.5 3.8 14.4 0.5 6.3 0.5 0.5 59.5 36.7 23.4 0.8 1.7 0.0 0.8 0.7 0.5 0.6 0.7 0.6 0.5 8.0 12.4 7.8 0.5 0.5 0.5 7.0 5.0 2.5 0.8 0.5 1.8 14.2 18.3 0.5 0.7 2.9 1.5 0.5 0.5 0.5 1.1 0.6 4.2 0.5 0.6 6.0 1.3 0.0 0.5 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.1 3.7 11.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 6.3 59.5 17.9 8.0 12.4 7.0 5.0 18.3 1.3 CA11 "CARP2, CARPX1" ENSG00000063180 "Carbonic anhydrase 11" O75493 19 48637942-48646312 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.7" "Cell line enhanced" "Detected in many" "AN3-CA: 24.6;SCLC-21H: 17.6;U-266/84: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041778 Approved Vesicles,Microtubules "Secreted in brain" "Vesicles, Microtubules" "HPA041778: AB_10794525" "unprognostic (1.39e-1)" "prognostic favourable (4.33e-4)" "unprognostic (2.59e-3)" "unprognostic (5.72e-2)" "unprognostic (1.54e-1)" "unprognostic (9.80e-3)" "unprognostic (6.02e-2)" "prognostic favourable (2.11e-5)" "unprognostic (3.79e-2)" "unprognostic (2.98e-1)" "prognostic favourable (8.60e-5)" "unprognostic (4.88e-2)" "unprognostic (8.64e-3)" "unprognostic (1.21e-1)" "unprognostic (7.15e-2)" "unprognostic (4.09e-3)" "unprognostic (1.75e-1)" 2.3 9.6 60.2 2.3 58.2 1.5 4.1 54.1 87.7 3.8 2.5 4.5 1.7 5.3 17.7 16.0 3.5 10.5 3.5 2.9 44.1 12.2 4.2 1.2 3.2 3.0 18.5 31.6 24.6 3.3 16.7 5.4 1.3 8.9 4.6 2.0 2.7 4.0 8.4 5.0 6.6 4.0 10.7 11.0 2.8 3.1 2.7 17.8 0.1 4.3 0.8 3.4 2.1 1.8 3.4 4.5 0.0 1.1 2.6 3.7 1.4 1.0 6.7 12.2 24.6 1.7 0.7 0.3 0.8 7.8 0.8 1.8 1.6 8.5 4.0 1.0 0.8 2.7 5.0 2.5 0.7 0.8 7.1 1.7 3.6 0.1 1.6 0.1 5.5 3.0 5.0 0.7 1.1 0.9 3.1 11.3 0.4 2.5 2.1 0.7 5.4 2.6 1.4 0.5 8.3 5.4 0.2 17.6 10.2 0.9 0.9 1.5 3.5 0.4 0.1 2.2 8.2 0.0 0.2 10.7 17.9 0.7 3.1 2.3 1.1 0.0 0.9 0.0 3.7 1.1 3.1 2.4 2.9 2.8 1.6 3.4 3.6 3.3 0.0 2.6 0.0 4.5 3.0 1.4 60.2 58.2 54.1 63.8 44.1 12.2 18.5 31.6 8.9 17.8 CA12 HsT18816 ENSG00000074410 "Carbonic anhydrase 12" O43570 15 63321378-63382161 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 103.5" "Cell line enhanced" "Detected in many" "A549: 38.2;ASC TERT1: 40.3;RT4: 40.5;SK-BR-3: 32.5;T-47d: 52.3;U-138 MG: 55.8;U-87 MG: 67.0" "Cancer enhanced" "Detected in all" "renal cancer: 109.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008773, CAB025181, CAB062549, CAB068179, HPA073203" Enhanced Approved Nucleoplasm,Vesicles 29000 Nucleoplasm Vesicles "CAB025181: , CAB062549: , CAB068179: , HPA008773: AB_1078394, HPA073203: " "unprognostic (2.01e-1)" "unprognostic (8.38e-3)" "unprognostic (3.47e-1)" "unprognostic (3.25e-3)" "unprognostic (2.73e-2)" "unprognostic (2.47e-2)" "unprognostic (7.48e-2)" "unprognostic (3.43e-3)" "unprognostic (2.29e-1)" "unprognostic (4.67e-2)" "prognostic unfavourable (3.80e-6)" "unprognostic (2.59e-1)" "unprognostic (1.51e-1)" "unprognostic (2.38e-1)" "unprognostic (6.56e-2)" "unprognostic (7.26e-2)" "unprognostic (1.21e-1)" 3.7 0.3 4.7 15.0 27.4 0.3 14.5 3.7 2.3 15.7 32.0 2.6 5.0 0.4 9.8 12.3 42.8 8.5 2.6 1.6 4.9 1.4 103.5 0.3 1.2 0.3 1.8 0.2 2.1 43.8 0.3 3.9 5.9 16.9 3.8 30.3 8.5 8.2 17.9 0.5 44.1 2.4 18.1 0.1 0.4 2.2 1.3 6.7 0.0 1.7 18.4 25.9 10.6 14.5 0.3 0.2 0.6 0.7 0.3 0.2 0.0 0.0 38.2 0.6 0.0 5.1 40.3 2.0 2.7 2.5 0.4 0.7 0.2 0.0 0.0 9.4 2.2 0.2 0.0 1.8 1.1 0.0 1.3 0.0 2.6 0.0 0.1 0.0 0.0 15.2 2.1 11.6 3.7 0.4 0.0 0.0 0.5 22.0 0.0 0.0 0.6 6.0 0.0 0.0 0.0 0.0 40.5 0.3 0.0 0.1 32.5 0.0 52.3 0.0 0.0 55.8 3.0 1.8 0.0 0.0 0.0 0.0 67.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.7 0.2 0.1 0.0 4.7 27.4 3.7 1.3 4.9 1.4 1.8 0.2 16.9 6.7 CA13 "CAXIII, FLJ37995, MGC59868" ENSG00000185015 "Carbonic anhydrase 13" Q8N1Q1 8 85220587-85284073 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.7" "Cell line enhanced" "Detected in many" "HEL: 16.1;RPTEC TERT1: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024689, CAB025567" Enhanced Uncertain Nucleoplasm,Nucleoli,Vesicles 100000 Nucleoli "Nucleoplasm, Vesicles" "CAB025567: , HPA024689: AB_1846004" "unprognostic (1.12e-2)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (9.16e-5)" "unprognostic (2.21e-2)" "unprognostic (2.08e-1)" "unprognostic (9.39e-2)" "unprognostic (7.90e-3)" "unprognostic (1.97e-1)" "unprognostic (1.34e-2)" "unprognostic (3.58e-2)" "unprognostic (3.13e-1)" "prognostic favourable (9.40e-4)" "unprognostic (7.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.55e-2)" "unprognostic (3.00e-1)" 2.6 2.6 2.0 1.9 3.1 0.5 2.9 2.4 2.4 3.2 18.2 0.8 0.0 14.2 1.8 1.7 6.7 1.4 25.6 5.8 1.6 1.9 10.4 17.1 9.5 2.4 2.0 0.1 2.2 1.6 9.3 6.5 1.0 5.7 2.6 3.7 1.9 7.0 1.0 1.9 7.1 56.7 1.9 5.2 2.2 7.0 0.9 0.9 0.4 10.3 3.9 5.6 2.9 5.2 0.8 2.1 3.2 2.5 0.5 0.5 1.0 0.3 0.4 0.9 0.1 0.6 0.7 0.4 1.1 1.1 0.1 3.1 7.5 5.8 0.4 0.5 1.3 2.4 2.3 3.0 0.2 1.6 1.0 16.1 2.1 6.9 1.6 0.2 0.7 2.4 0.5 0.2 1.3 1.7 4.1 3.2 2.7 0.1 0.3 0.2 0.5 0.5 0.2 2.4 0.2 8.7 0.3 0.3 0.1 0.5 0.0 1.6 0.6 0.8 1.6 3.0 4.3 0.1 1.6 1.3 0.6 2.0 6.3 2.3 2.8 3.2 2.5 1.3 0.4 0.7 0.2 0.2 0.2 0.1 2.1 0.8 0.3 0.5 0.9 0.5 0.8 0.9 0.1 1.0 2.0 3.1 2.4 2.4 1.6 1.9 2.0 0.1 5.7 0.9 CA4 "CAIV, Car4, RP17" ENSG00000167434 "Carbonic anhydrase 4" P22748 17 60149936-60170899 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 81.7" "Cell line enhanced" "Detected in some" "HEK 293: 1.4;HUVEC TERT2: 1.7;NTERA-2: 3.9;RPMI-8226: 1.5;RPTEC TERT1: 2.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "cerebellum: 50.1" "Cell type enriched" "Detected in some" 7 "neutrophil: 37.0" "Lineage enriched" "Detected in single" 370 "granulocytes: 37.0" "Region enriched" "Detected in all" 5 "cerebellum: 336.9" "Low region specificity" "Detected in many" "HPA011089, HPA017258" Enhanced Supported Vesicles 190000 Vesicles "HPA011089: AB_1845996, HPA017258: AB_1845997" "unprognostic (2.07e-2)" "unprognostic (7.85e-2)" "unprognostic (1.55e-2)" "unprognostic (7.78e-3)" "unprognostic (8.42e-2)" "unprognostic (1.19e-1)" "unprognostic (3.19e-2)" "unprognostic (5.84e-2)" "unprognostic (7.76e-2)" "unprognostic (9.74e-2)" "unprognostic (1.54e-1)" "unprognostic (1.71e-2)" "unprognostic (2.68e-3)" "unprognostic (8.59e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-1)" "unprognostic (4.57e-2)" 32.2 0.9 3.4 9.8 4.4 5.7 46.4 50.1 11.8 2.3 81.7 2.0 31.5 1.4 2.3 17.4 0.9 1.7 12.2 8.8 4.7 2.6 12.0 0.3 33.3 2.4 3.5 5.2 1.9 9.5 3.3 5.1 3.2 3.0 2.4 54.9 20.3 4.8 24.0 10.0 1.0 3.2 1.1 2.1 4.9 2.5 1.2 0.3 0.2 23.1 5.0 0.2 1.7 7.9 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.5 0.9 0.0 0.3 0.0 0.0 0.4 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.3 3.9 0.0 0.0 0.2 1.5 2.2 0.0 0.8 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.9 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 3.4 4.4 50.1 11.8 4.7 2.6 3.5 5.2 3.0 0.3 CAAP1 "C9orf82, CAAP, FLJ13657" ENSG00000120159 "Caspase activity and apoptosis inhibitor 1" Q9H8G2 9 26840685-26892804 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020404, HPA024029, HPA024100" Uncertain Approved Vesicles Vesicles "HPA020404: AB_1845841, HPA024029: AB_1845842, HPA024100: AB_1845843" "unprognostic (1.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.73e-2)" "unprognostic (6.74e-2)" "unprognostic (8.83e-2)" "unprognostic (1.35e-2)" "unprognostic (4.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.11e-2)" "prognostic favourable (1.27e-5)" "unprognostic (1.46e-1)" "unprognostic (1.89e-1)" "prognostic favourable (7.94e-9)" "unprognostic (2.74e-2)" "unprognostic (7.57e-2)" "unprognostic (1.46e-1)" "unprognostic (1.43e-2)" 9.5 26.3 10.5 14.3 11.7 10.0 11.6 12.9 12.9 10.1 16.9 9.1 16.4 14.9 13.6 19.5 14.3 9.1 12.3 9.1 10.2 10.6 25.6 30.1 7.9 12.7 9.7 7.2 8.1 20.7 17.7 20.0 9.1 10.7 10.8 19.1 14.2 17.5 15.5 9.9 10.6 17.6 10.0 8.8 14.1 10.8 19.4 9.6 25.6 27.1 10.6 16.7 10.1 9.8 16.2 15.0 12.7 14.5 15.1 17.6 12.7 12.8 8.1 13.7 14.4 9.2 7.8 10.0 8.9 9.6 9.3 11.5 2.5 8.5 16.1 8.9 8.5 6.6 14.0 9.5 13.2 19.2 7.1 27.1 13.5 15.2 15.7 11.2 12.8 7.9 12.3 7.1 17.6 15.5 7.1 11.8 10.6 7.1 17.8 4.8 18.0 5.2 12.5 6.4 9.9 24.2 9.7 10.6 22.0 8.4 10.1 8.6 8.6 14.2 8.5 0.0 14.1 5.7 9.0 5.2 9.7 17.6 4.7 12.2 5.7 12.7 9.4 6.4 14.1 14.5 17.6 16.2 15.6 16.3 15.0 14.1 13.0 13.6 1.2 15.1 12.1 13.8 15.1 12.7 10.5 11.7 12.9 12.9 10.2 10.6 9.7 7.2 10.7 9.6 CAB39L "bA103J18.3, FLJ12577, MO2L" ENSG00000102547 "Calcium binding protein 39 like" Q9H9S4 13 49308650-49444126 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 23.9;RT4: 25.0" "Cancer enhanced" "Detected in all" "prostate cancer: 28.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003686, HPA045954" Uncertain Approved Vesicles Vesicles "CAB003686: AB_426084, HPA045954: " "unprognostic (3.90e-2)" "unprognostic (1.09e-1)" "unprognostic (4.13e-1)" "unprognostic (5.01e-1)" "unprognostic (3.29e-1)" "unprognostic (1.94e-1)" "unprognostic (2.82e-1)" "unprognostic (2.94e-2)" "unprognostic (2.78e-2)" "prognostic unfavourable (2.28e-4)" "unprognostic (3.08e-2)" "prognostic favourable (7.91e-4)" "prognostic favourable (1.94e-13)" "unprognostic (6.59e-2)" "unprognostic (8.31e-2)" "unprognostic (4.96e-2)" "unprognostic (8.05e-3)" 19.6 32.1 18.4 5.6 18.2 2.1 32.6 17.6 22.6 12.9 33.2 13.1 19.0 5.5 11.5 14.8 25.6 12.5 13.6 14.5 22.2 16.3 12.8 5.0 12.2 3.7 29.6 19.5 17.6 10.2 17.9 10.7 10.3 26.4 35.8 10.2 7.6 13.8 20.7 4.9 10.6 8.0 21.1 23.3 3.8 18.8 24.1 24.9 2.5 8.9 9.1 4.6 21.3 13.0 3.8 3.9 9.9 3.8 2.7 5.3 3.2 0.9 1.0 6.6 1.9 6.4 6.5 9.0 5.8 12.5 3.6 2.9 23.9 3.4 8.1 0.8 3.9 1.8 3.4 4.3 6.8 2.8 3.2 2.1 1.4 1.6 3.4 1.7 1.0 4.8 3.7 2.9 4.6 4.6 0.3 1.9 5.6 1.6 1.9 1.6 5.1 1.6 1.6 0.9 1.2 5.7 25.0 0.8 2.6 3.1 7.1 7.6 11.0 3.4 4.7 1.7 1.7 3.3 4.8 1.5 1.4 9.4 1.8 1.7 4.0 9.9 3.8 7.9 4.4 3.5 3.2 3.8 5.2 5.3 3.9 2.9 4.0 3.7 8.4 2.7 2.9 0.5 5.2 3.2 18.4 18.2 17.6 22.2 22.2 16.3 29.6 19.5 26.4 24.9 CACNA1H Cav3.2 ENSG00000196557 "Calcium voltage-gated channel subunit alpha1 H" O95180 16 1153121-1221772 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 49.5" "Cell line enhanced" "Detected in some" "A549: 10.8;AN3-CA: 15.6;MCF7: 28.6;T-47d: 8.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA039125 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA039125: AB_10795578" "unprognostic (1.66e-3)" "unprognostic (2.10e-1)" "unprognostic (4.07e-2)" "unprognostic (1.21e-3)" "unprognostic (1.37e-2)" "unprognostic (2.15e-1)" "unprognostic (4.39e-2)" "unprognostic (2.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" "prognostic favourable (3.12e-5)" "unprognostic (1.66e-2)" "prognostic unfavourable (1.78e-5)" "unprognostic (1.93e-2)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (5.55e-2)" 5.0 6.8 5.1 4.2 12.0 0.3 3.3 0.3 4.3 17.5 28.1 1.6 10.2 5.4 25.7 5.9 16.3 11.7 26.0 2.2 2.5 2.1 4.7 5.5 3.5 0.7 1.0 2.8 31.8 2.1 6.6 14.8 1.9 2.0 21.0 2.2 4.2 1.7 24.9 2.9 4.8 8.5 49.5 1.1 0.5 9.7 11.7 2.1 0.0 5.2 1.4 0.5 34.6 20.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 10.8 1.8 15.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 6.4 0.0 0.0 6.5 1.9 0.0 2.8 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 28.6 0.0 0.0 5.8 2.2 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.5 8.5 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.0 0.3 4.3 2.5 2.1 1.0 2.8 2.0 2.1 CACNA2D2 KIAA0558 ENSG00000007402 "Calcium voltage-gated channel auxiliary subunit alpha2delta 2" Q9NY47 3 50362799-50504244 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lung: 86.1" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 64.9" "Cancer enhanced" "Detected in many" "testis cancer: 20.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034771, HPA071829" Enhanced Approved Vesicles 1000000 Vesicles "HPA034771: AB_10603555, HPA071829: " "unprognostic (2.06e-1)" "unprognostic (2.37e-1)" "unprognostic (1.72e-2)" "prognostic unfavourable (7.62e-5)" "unprognostic (6.59e-2)" "unprognostic (6.37e-2)" "unprognostic (6.91e-2)" "unprognostic (6.57e-3)" "unprognostic (4.39e-2)" "unprognostic (1.17e-1)" "prognostic favourable (1.21e-4)" "unprognostic (2.71e-2)" "unprognostic (1.57e-4)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (3.55e-1)" "unprognostic (4.22e-2)" 1.0 0.9 1.6 1.3 11.1 1.1 1.4 14.9 6.5 1.1 1.7 0.9 0.6 1.4 1.7 1.2 0.9 1.1 0.9 7.6 1.7 9.1 1.6 0.5 86.1 1.3 3.9 3.2 2.2 4.0 3.8 6.0 1.9 6.1 3.0 2.0 6.1 1.5 1.4 1.7 2.6 1.7 1.4 1.4 1.5 4.1 5.8 2.5 0.2 2.3 0.1 0.7 0.7 0.7 1.8 0.3 0.7 0.1 2.3 3.6 1.1 0.0 0.0 1.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2.6 0.1 0.0 0.0 0.2 0.0 0.0 6.2 64.9 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 2.2 0.0 2.7 1.8 2.6 2.0 0.0 1.3 3.6 2.2 0.0 2.3 0.1 0.3 3.2 1.1 1.6 11.1 14.9 6.5 1.7 9.1 3.9 3.2 6.1 2.5 CACNB3 CACNLB3 ENSG00000167535 "Calcium voltage-gated channel auxiliary subunit beta 3" P54284 12 48813794-48828941 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.9" "Cell line enhanced" "Detected in many" "U-937: 45.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.7" "Lineage enriched" "Detected in single" 9 "T-cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059515 Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA059515: " "unprognostic (1.77e-2)" "unprognostic (4.84e-2)" "unprognostic (2.16e-3)" "unprognostic (2.12e-2)" "unprognostic (8.76e-2)" "unprognostic (2.68e-1)" "unprognostic (2.06e-1)" "unprognostic (3.60e-2)" "unprognostic (3.27e-2)" "unprognostic (2.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.04e-1)" "unprognostic (5.44e-3)" "unprognostic (6.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" 3.8 3.7 27.4 2.9 22.4 1.2 4.2 18.5 42.9 11.9 9.1 1.5 3.0 3.8 22.6 8.1 11.6 16.1 6.7 2.6 16.4 12.2 3.9 1.3 6.1 1.7 10.0 14.5 24.1 2.1 2.8 4.2 5.3 4.4 5.7 7.8 3.4 4.5 9.1 2.1 7.8 5.8 20.4 2.4 2.2 4.7 4.7 2.3 4.6 6.1 3.4 3.6 7.5 6.9 0.2 0.5 0.0 0.3 0.0 4.7 0.5 6.8 5.4 9.1 18.5 11.1 7.9 5.5 7.0 14.8 10.4 6.2 1.7 5.6 0.8 9.2 11.7 7.3 8.2 7.6 3.9 7.9 2.5 3.6 4.4 0.2 4.4 0.6 3.9 5.0 4.6 4.3 2.1 11.8 0.5 2.9 6.7 17.0 8.4 0.9 5.6 4.6 9.7 2.0 2.7 7.5 12.9 12.9 12.8 2.1 15.5 5.1 10.6 3.0 11.3 6.6 9.4 3.2 3.8 3.3 1.3 0.2 5.5 45.1 2.0 0.0 0.3 0.0 0.9 0.1 0.4 0.2 1.8 1.8 0.5 0.0 0.4 0.2 0.0 0.0 0.0 0.4 4.7 0.5 27.4 22.4 18.5 42.9 16.4 12.2 10.0 14.5 4.4 2.3 CADPS "CAPS, CAPS1, KIAA1121, UNC-31" ENSG00000163618 "Calcium dependent secretion activator" Q9ULU8 3 62398346-62875389 "Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.0" "Cell line enhanced" "Detected in some" "SCLC-21H: 16.5;SK-MEL-30: 7.3;U-698: 10.5;U-87 MG: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 11 "B-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059328 Enhanced Approved Vesicles Vesicles "HPA059328: " "unprognostic (3.46e-3)" "unprognostic (1.40e-2)" "unprognostic (1.61e-2)" "unprognostic (3.87e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (3.12e-2)" "unprognostic (9.27e-2)" "unprognostic (5.73e-2)" "unprognostic (2.08e-3)" "unprognostic (3.21e-1)" "unprognostic (4.20e-3)" "unprognostic (1.90e-2)" "unprognostic (2.04e-1)" "unprognostic (7.91e-3)" "unprognostic (5.35e-3)" 1.2 17.2 18.2 2.8 16.0 1.0 1.6 22.4 58.0 4.0 3.5 2.4 0.0 3.9 1.5 3.4 1.1 1.1 3.2 11.6 21.9 24.7 1.1 1.1 1.6 1.4 33.7 18.4 2.8 13.5 0.9 19.6 1.1 43.6 4.5 3.3 5.3 1.3 3.8 1.0 2.2 4.0 1.7 7.1 1.4 4.1 3.2 2.7 0.0 1.1 0.0 1.6 1.2 0.6 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 3.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 16.5 1.2 0.0 0.0 7.3 0.0 0.0 0.0 1.4 0.1 2.7 0.7 0.0 1.4 10.5 17.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.2 16.0 22.4 32.0 21.9 24.7 33.7 18.4 43.6 2.7 CADPS2 CAPS2 ENSG00000081803 "Calcium dependent secretion activator 2" Q86UW7 7 122318425-122886759 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 105.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 21.6;Karpas-707: 28.2;MCF7: 14.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 105.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 325.7" HPA056398 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA056398: " "unprognostic (1.93e-1)" "unprognostic (5.05e-2)" "unprognostic (1.91e-1)" "unprognostic (3.67e-3)" "unprognostic (8.69e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (1.33e-1)" "unprognostic (4.07e-1)" "unprognostic (4.33e-2)" "unprognostic (3.93e-2)" "unprognostic (1.30e-1)" "prognostic favourable (1.01e-7)" "unprognostic (9.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.71e-2)" "unprognostic (3.45e-2)" 5.1 11.2 5.1 1.9 7.1 0.0 9.5 105.4 21.1 16.5 5.3 1.4 13.3 6.1 16.3 16.4 5.7 5.7 8.0 4.6 6.8 8.8 20.3 6.2 9.0 1.3 14.0 9.3 5.2 13.2 15.4 17.7 2.7 7.0 10.4 5.4 4.7 23.0 11.5 2.6 2.4 4.7 11.2 4.1 3.3 9.8 1.9 1.4 0.4 9.4 2.4 1.6 4.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.6 2.7 0.1 0.2 6.7 1.5 6.8 0.0 6.2 0.0 0.0 3.1 0.0 0.2 0.9 0.6 0.0 5.5 2.1 0.0 12.1 8.7 0.0 0.1 2.8 1.2 1.1 0.9 21.6 0.0 28.2 0.1 14.8 0.0 0.0 6.3 10.7 0.0 0.0 11.1 0.3 7.0 10.9 0.0 0.3 12.2 0.5 4.7 0.0 6.1 2.4 1.6 0.0 4.3 8.4 0.3 0.0 9.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 7.1 105.4 21.1 6.8 8.8 14.0 9.3 7.0 1.4 CALB1 CALB ENSG00000104327 "Calbindin 1" P05937 8 90058608-90095475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 15 "brain: 73.8;kidney: 121.9" "Cell line enhanced" "Detected in many" "A-431: 39.2;EFO-21: 59.4;NTERA-2: 19.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.4" "Group enriched" "Detected in many" 7 "granulocytes: 6.4;monocytes: 2.5" "Region enhanced" "Detected in many" "cerebellum: 483.1" "Group enriched" "Detected in many" 4 "basal ganglia: 88.7;cerebellum: 312.3" "CAB002138, HPA023099, HPA056734" Enhanced Supported Vesicles Vesicles "CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220" "unprognostic (2.19e-1)" "unprognostic (2.28e-3)" "unprognostic (2.61e-2)" "prognostic unfavourable (1.60e-4)" "unprognostic (1.82e-1)" "unprognostic (5.39e-2)" "unprognostic (2.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" "unprognostic (1.37e-2)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (2.11e-1)" "unprognostic (7.88e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-1)" 1.6 1.2 19.6 1.4 73.8 1.0 1.4 66.0 10.9 3.1 1.3 0.5 0.0 1.0 1.0 2.0 1.7 2.0 0.9 1.0 13.8 15.2 121.9 1.5 2.1 1.0 2.8 6.4 0.9 2.0 1.3 3.2 2.2 12.8 0.9 1.4 0.8 1.3 0.8 1.4 1.7 1.1 1.2 14.7 1.1 1.3 2.1 10.6 0.0 1.4 0.0 1.0 1.0 0.1 0.5 0.6 6.4 2.5 0.0 0.2 1.0 39.2 2.1 8.8 0.6 0.2 1.4 1.2 0.6 4.0 0.3 0.5 0.3 4.7 0.2 59.4 0.0 13.7 12.7 15.7 2.7 0.1 0.7 1.4 16.5 0.3 1.7 0.2 0.7 0.6 5.1 0.8 7.8 10.5 2.7 1.1 10.5 0.2 0.6 0.1 19.3 7.9 0.3 0.2 0.7 4.7 0.3 1.4 0.9 10.6 0.7 0.1 0.5 0.4 0.0 1.5 8.4 1.9 3.4 1.0 1.3 0.3 0.2 0.1 0.1 2.6 0.5 1.5 0.2 0.7 0.0 0.0 0.0 0.1 0.1 0.5 0.2 0.2 6.4 0.0 2.5 0.6 0.0 1.0 19.6 73.8 66.0 10.9 13.8 15.2 2.8 6.4 12.8 10.6 CALCOCO1 "calphoglin, Cocoa, KIAA1536" ENSG00000012822 "Calcium binding and coiled-coil domain 1" Q9P1Z2 12 53708517-53727745 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 45.2;HSkMC: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038313, HPA038314" Approved Enhanced Vesicles,Cytosol 11000 Cytosol Vesicles "HPA038313: AB_10675794, HPA038314: AB_10672587" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" "unprognostic (3.11e-2)" "unprognostic (8.42e-2)" "unprognostic (3.03e-1)" "unprognostic (3.63e-2)" "unprognostic (1.30e-1)" "unprognostic (9.66e-2)" "unprognostic (3.31e-2)" "unprognostic (1.83e-1)" "unprognostic (2.62e-2)" "unprognostic (1.71e-2)" "unprognostic (2.85e-3)" "unprognostic (8.01e-2)" "unprognostic (2.80e-1)" "unprognostic (5.63e-3)" "unprognostic (9.88e-3)" 31.6 18.9 30.9 13.6 45.6 14.2 27.7 88.2 46.5 22.5 34.9 27.7 23.5 13.7 27.3 29.7 24.0 25.5 28.0 44.8 32.1 15.4 19.7 14.6 35.0 13.6 28.8 25.3 29.1 26.0 36.9 28.1 23.2 30.3 26.1 15.6 27.1 33.0 33.8 59.2 54.4 20.3 35.8 20.5 22.1 30.7 14.4 38.7 11.1 22.5 20.4 16.3 34.6 23.0 8.1 5.4 34.7 10.3 8.3 14.7 10.1 5.0 5.1 7.3 9.1 45.2 30.1 5.0 9.5 22.5 8.2 10.5 2.2 17.9 2.0 10.2 25.3 5.4 3.4 9.6 7.2 8.3 6.2 3.6 10.3 1.7 23.3 1.4 8.3 43.2 22.1 8.2 7.1 14.9 3.0 16.7 14.3 2.1 4.1 5.1 1.6 5.5 5.0 4.3 6.6 12.3 3.1 4.5 8.0 7.1 2.7 9.7 8.0 4.6 16.4 3.3 4.9 3.8 1.5 16.6 5.3 0.7 16.1 1.7 4.6 34.7 9.2 33.4 12.7 10.2 9.3 6.7 9.0 10.1 5.4 8.1 8.0 8.6 32.6 8.3 10.3 4.0 14.7 10.1 30.9 45.6 88.2 46.5 32.1 15.4 28.8 25.3 30.3 38.7 CALCOCO2 "MGC17318, NDP52" ENSG00000136436 "Calcium binding and coiled-coil domain 2" Q13137 17 48830988-48866522 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022989, HPA023019, HPA023195" Enhanced Supported Vesicles,Cytosol Cytosol Vesicles "HPA022989: AB_1845914, HPA023019: AB_1845915, HPA023195: AB_1845916" "unprognostic (3.71e-1)" "unprognostic (2.87e-1)" "unprognostic (3.84e-2)" "unprognostic (3.37e-2)" "unprognostic (4.90e-2)" "unprognostic (4.46e-2)" "unprognostic (2.05e-1)" "unprognostic (2.28e-1)" "unprognostic (3.88e-1)" "unprognostic (2.15e-1)" "unprognostic (2.41e-1)" "unprognostic (4.03e-2)" "unprognostic (3.52e-2)" "unprognostic (1.06e-1)" "unprognostic (3.80e-2)" "unprognostic (7.57e-2)" "unprognostic (5.65e-2)" 70.5 30.8 20.6 21.0 29.5 22.2 50.8 22.1 28.1 38.5 40.2 26.8 32.7 27.0 39.4 35.6 41.3 36.1 28.4 55.5 24.8 16.6 36.6 48.7 42.6 28.2 36.8 24.8 37.7 22.7 24.6 46.3 26.5 32.3 37.3 42.1 46.9 30.0 31.8 70.1 31.3 35.2 47.8 42.8 29.5 35.5 51.8 37.3 25.0 48.4 32.3 26.0 46.4 74.2 18.0 22.0 44.4 40.7 33.2 34.2 24.7 26.3 17.1 7.2 13.9 53.9 39.1 20.9 25.6 34.5 29.7 33.4 31.9 17.3 8.9 25.8 31.1 14.7 17.5 21.7 35.8 40.8 14.5 8.4 10.7 12.4 62.0 28.5 43.2 57.5 32.4 31.4 22.9 21.7 15.4 27.1 25.7 7.7 24.5 15.2 2.2 21.1 16.3 35.4 16.8 11.4 8.4 2.9 6.2 8.0 5.2 22.8 33.5 16.0 21.0 32.5 9.9 19.8 18.1 24.1 33.4 6.3 19.7 14.5 13.3 30.2 36.2 36.3 19.8 39.5 18.9 18.0 17.7 20.3 22.0 16.6 18.1 19.6 44.4 33.2 40.7 11.1 34.2 24.7 20.6 29.5 22.1 28.1 24.8 16.6 36.8 24.8 32.3 37.3 CALM1 "CALML2, CAMI, DD132, PHKD" ENSG00000198668 "Calmodulin 1" P0DP23 14 90396502-90408261 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 176.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB018558, HPA044999" Supported Approved Vesicles Vesicles "CAB018558: AB_2069454, HPA044999: " "unprognostic (5.35e-3)" "unprognostic (3.96e-1)" "unprognostic (4.99e-3)" "unprognostic (2.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.87e-2)" "unprognostic (1.99e-3)" "unprognostic (1.52e-1)" "unprognostic (6.44e-2)" "unprognostic (1.16e-3)" "prognostic favourable (5.62e-4)" "unprognostic (2.77e-1)" "prognostic favourable (6.49e-4)" "unprognostic (2.66e-1)" "unprognostic (2.68e-1)" "unprognostic (1.11e-2)" "prognostic unfavourable (2.38e-5)" 47.5 28.1 141.5 26.9 148.2 57.2 21.5 149.6 176.0 27.4 55.9 49.4 20.7 53.9 20.3 41.7 58.8 48.6 29.5 52.3 139.8 86.1 61.5 39.0 38.7 27.8 85.2 100.1 20.9 22.6 41.4 27.6 38.6 106.1 33.7 60.5 22.2 33.2 43.5 100.2 19.3 50.6 42.6 71.1 29.3 35.6 22.3 49.8 12.6 22.7 18.8 37.8 32.7 21.8 45.7 42.8 90.3 53.7 88.8 118.3 109.4 27.0 37.7 45.0 17.3 50.6 44.6 38.4 49.9 42.8 38.6 41.9 40.1 48.0 29.3 26.0 58.8 45.3 28.1 69.3 64.3 56.9 18.0 30.9 32.4 36.7 27.7 46.9 25.0 28.0 34.7 37.8 13.4 86.9 14.3 40.2 52.8 91.9 15.5 45.9 26.1 52.7 31.0 40.2 19.7 31.9 83.4 94.2 39.6 43.6 76.4 27.8 50.5 16.4 53.9 32.6 20.9 34.1 41.5 22.4 50.7 32.1 51.5 39.4 45.2 90.3 31.8 71.0 96.0 37.9 118.3 45.7 102.5 101.0 42.8 35.7 74.8 88.1 47.0 88.8 53.7 40.5 105.6 109.4 141.5 148.2 149.6 176.0 139.8 86.1 85.2 100.1 106.1 49.8 CALN1 CABP8 ENSG00000183166 "Calneuron 1" Q9BXU9 7 71779491-72447151 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.0;brain: 48.5;lymphoid tissue: 20.0" "Cell line enriched" "Detected in some" 6 "Karpas-707: 30.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036278, HPA036708" Approved Uncertain "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA036278: AB_10673125, HPA036708: " "unprognostic (6.38e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (1.32e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-2)" "unprognostic (3.67e-4)" "unprognostic (3.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.57e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (7.72e-4)" "unprognostic (2.99e-1)" 0.8 16.0 10.8 0.8 17.7 1.5 1.0 48.5 39.1 2.3 0.9 5.1 0.0 0.9 1.4 0.8 0.8 1.0 1.3 0.8 9.5 4.4 0.8 1.0 0.9 0.8 6.8 7.3 1.0 1.9 0.8 0.3 0.8 18.6 1.0 0.9 0.0 0.8 2.4 0.9 4.2 0.8 0.9 8.4 0.8 0.8 11.3 3.3 20.0 0.9 0.0 0.8 0.9 1.9 0.3 1.3 0.6 0.4 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 30.7 0.0 0.0 0.0 0.0 4.1 0.0 4.7 0.0 0.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 4.9 4.7 0.0 0.2 0.0 0.0 0.6 0.4 0.3 0.2 0.1 0.1 0.2 0.2 0.2 1.3 0.3 0.2 0.2 0.5 0.3 0.1 0.4 0.1 0.1 10.8 17.7 48.5 11.6 9.5 4.4 6.8 7.3 18.6 3.3 CAMLG "CAML, GET2" ENSG00000164615 "Calcium modulating ligand" P49069 5 134738501-134752160 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052636, HPA056472" Approved Approved Nucleoplasm,Nucleoli,Vesicles Vesicles "Nucleoplasm, Nucleoli" "HPA052636: , HPA056472: " "unprognostic (9.23e-2)" "unprognostic (8.54e-2)" "unprognostic (2.95e-1)" "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (3.68e-2)" "unprognostic (5.41e-3)" "unprognostic (3.07e-1)" "unprognostic (8.54e-2)" "unprognostic (5.34e-3)" "unprognostic (4.58e-2)" "prognostic unfavourable (1.09e-5)" "unprognostic (3.26e-2)" "unprognostic (1.43e-2)" "unprognostic (2.19e-1)" "unprognostic (3.16e-1)" 24.2 29.0 37.6 14.3 32.4 22.7 29.3 28.2 39.3 33.3 32.7 15.5 20.2 26.1 31.7 45.2 21.4 23.0 21.8 22.3 32.4 38.3 20.1 19.7 18.9 18.4 36.2 22.7 53.0 25.7 14.8 21.9 14.0 22.4 27.5 14.3 21.7 15.9 26.2 32.5 19.7 22.2 30.4 26.0 15.1 17.7 36.6 14.0 21.1 21.6 18.5 19.3 40.3 20.0 25.0 16.1 32.1 23.3 16.6 28.6 17.4 9.5 7.4 12.8 23.7 28.4 44.0 5.7 13.6 19.8 10.2 19.3 13.6 14.6 39.1 20.0 9.5 12.4 10.5 16.6 14.5 18.2 19.4 10.4 13.6 11.1 20.9 5.5 32.9 35.6 18.1 12.5 21.6 19.2 6.5 18.2 15.1 10.7 14.5 23.2 6.5 7.5 16.3 16.9 15.1 17.5 9.4 18.9 13.3 9.8 6.2 32.6 17.2 11.5 18.4 9.9 6.1 15.1 12.3 17.2 18.5 15.0 16.7 17.3 5.4 32.1 15.2 32.1 18.3 17.3 24.6 25.0 26.4 22.9 16.1 22.4 27.8 26.8 27.6 16.6 23.3 14.7 28.6 17.4 37.6 32.4 28.2 39.3 32.4 38.3 36.2 22.7 22.4 14.0 CAPN6 "CalpM, CANPX, CAPNX" ENSG00000077274 "Calpain 6" Q9Y6Q1 X 111245103-111270523 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 62.9;placenta: 173.5" "Cell line enhanced" "Detected in some" "HAP1: 3.5;HDLM-2: 11.0;NTERA-2: 17.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 25.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 1.2;plasmacytoid DC: 2.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA040259 Approved Vesicles Vesicles "HPA040259: " "unprognostic (1.27e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-2)" "unprognostic (5.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.93e-2)" "unprognostic (8.39e-3)" "unprognostic (1.06e-1)" "unprognostic (2.08e-1)" "unprognostic (9.45e-3)" "unprognostic (5.12e-1)" "unprognostic (6.25e-2)" "unprognostic (7.67e-2)" "unprognostic (6.50e-2)" "unprognostic (5.02e-3)" "unprognostic (2.66e-1)" "unprognostic (6.30e-2)" 1.7 0.0 0.2 1.7 0.2 0.0 6.0 0.3 0.3 3.9 4.2 0.2 23.4 0.2 18.2 62.9 2.4 2.9 2.6 0.4 0.2 0.0 5.1 0.4 0.3 1.1 0.2 0.4 1.9 4.1 0.0 0.2 173.5 0.3 3.6 2.2 2.1 5.6 21.7 1.7 1.0 1.3 2.0 0.3 1.0 7.2 2.8 0.2 0.5 1.7 4.7 2.9 1.4 2.6 0.1 2.0 0.8 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 17.3 0.0 0.0 0.0 0.1 1.5 0.0 0.1 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.2 0.2 0.3 0.3 0.2 0.0 0.2 0.4 0.3 0.2 CAPN8 nCL-2 ENSG00000203697 "Calpain 8" A6NHC0 1 223538007-223665734 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 32.0;stomach 1: 85.8" "Cell line enriched" "Detected in some" 9 "RT4: 41.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 28.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA073939 Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA073939: " "unprognostic (4.87e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-1)" "unprognostic (2.06e-2)" "unprognostic (1.32e-2)" "unprognostic (1.49e-1)" "unprognostic (7.97e-3)" "unprognostic (1.19e-1)" "unprognostic (1.26e-1)" "unprognostic (8.08e-2)" "unprognostic (2.72e-3)" "unprognostic (3.55e-1)" "unprognostic (4.12e-6)" "unprognostic (6.95e-2)" "unprognostic (5.59e-2)" "unprognostic (3.83e-2)" "unprognostic (5.44e-3)" 0.2 0.0 0.5 10.3 0.3 0.0 7.5 0.2 0.3 1.0 7.9 0.6 0.2 2.2 0.3 3.3 0.6 0.4 32.0 0.2 0.2 0.1 2.5 0.2 13.0 0.2 0.2 0.2 0.2 8.0 0.0 0.2 0.8 0.2 4.6 9.9 0.2 4.6 0.3 0.3 1.5 4.0 3.2 0.2 0.2 85.8 0.4 0.2 0.3 0.2 1.5 1.2 15.1 3.9 0.4 0.0 1.1 0.0 0.0 1.4 1.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 2.4 0.0 0.0 0.0 4.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.2 2.1 0.0 0.0 0.0 0.9 41.1 0.6 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.9 0.7 0.0 0.0 0.1 1.4 1.1 0.0 0.0 0.0 0.0 1.5 0.5 0.3 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.2 CAPZB ENSG00000077549 "Capping actin protein of muscle Z-line beta subunit" P47756 1 19338776-19485539 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031531 Approved Approved Nucleoplasm,Vesicles,Cytosol 35000000 "Nucleoplasm, Cytosol" Vesicles "HPA031531: AB_10603556" "unprognostic (7.52e-2)" "unprognostic (2.13e-1)" "unprognostic (5.25e-2)" "unprognostic (1.31e-2)" "unprognostic (1.45e-2)" "unprognostic (2.18e-1)" "prognostic unfavourable (1.85e-4)" "unprognostic (4.55e-2)" "unprognostic (7.70e-2)" "unprognostic (3.08e-1)" "unprognostic (4.15e-2)" "unprognostic (2.55e-1)" "prognostic unfavourable (3.57e-4)" "unprognostic (1.18e-1)" "unprognostic (2.41e-1)" "unprognostic (4.00e-1)" "unprognostic (3.78e-1)" 29.6 24.8 57.1 38.4 47.3 27.9 28.1 23.0 39.7 34.8 84.1 34.3 19.3 29.2 40.3 28.2 41.8 29.2 29.3 80.3 53.8 40.7 29.3 37.5 29.7 50.4 53.5 33.6 38.6 24.9 23.7 18.1 36.9 29.5 42.2 43.5 30.4 23.7 35.9 160.5 27.0 43.7 49.5 72.0 42.1 32.6 70.5 22.3 51.2 34.2 35.3 54.3 56.9 32.3 39.8 55.6 155.9 96.3 27.1 57.2 78.0 47.7 28.4 51.2 36.8 70.3 90.5 36.0 81.3 84.9 72.1 74.2 35.4 67.4 33.0 35.5 101.6 40.6 43.9 56.1 81.2 51.9 31.1 64.6 38.1 55.2 72.1 42.8 106.8 83.4 46.7 61.7 58.4 65.6 22.9 47.2 72.0 33.9 47.4 49.8 38.4 30.8 42.9 36.0 43.3 90.9 27.5 31.1 24.1 47.8 40.0 53.8 43.9 37.5 67.6 48.6 39.9 79.5 38.7 29.2 35.1 41.6 63.7 56.4 52.3 53.8 54.4 155.9 49.1 79.4 41.8 39.8 51.1 52.3 55.6 29.1 43.1 46.1 87.8 27.1 96.3 30.2 57.2 78.0 57.1 47.3 23.0 39.7 53.8 40.7 53.5 33.6 29.5 22.3 CARD10 "BIMP1, CARMA3" ENSG00000100065 "Caspase recruitment domain family member 10" Q9BWT7 22 37490362-37519542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 33.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 23.6;U-2197: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029359, HPA055612" Approved Approved "Vesicles,Intermediate filaments,Cytosol" "Vesicles, Intermediate filaments" Cytosol "HPA029359: AB_10601354, HPA055612: " "unprognostic (9.12e-3)" "unprognostic (2.28e-1)" "unprognostic (7.51e-2)" "prognostic favourable (3.47e-4)" "unprognostic (4.54e-1)" "unprognostic (2.70e-2)" "prognostic unfavourable (7.73e-6)" "unprognostic (3.66e-2)" "unprognostic (7.70e-2)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "unprognostic (3.68e-2)" "unprognostic (2.78e-2)" "unprognostic (2.87e-2)" "unprognostic (4.34e-1)" "unprognostic (4.31e-2)" "unprognostic (9.69e-2)" 8.1 6.8 3.5 4.5 2.3 0.0 10.2 1.5 2.7 5.7 16.4 2.4 4.1 23.7 9.8 6.4 6.8 5.9 14.1 7.6 1.7 1.1 14.0 10.5 7.0 2.4 1.6 1.3 6.8 8.9 1.6 1.7 4.9 3.8 5.6 6.2 5.6 12.6 3.2 8.0 7.3 33.6 4.1 1.3 3.3 7.0 11.1 1.3 0.7 5.6 13.5 3.9 4.9 9.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 12.8 9.4 1.7 1.3 0.0 3.8 8.5 1.2 2.8 5.5 4.3 5.8 9.2 0.0 4.6 2.2 18.2 2.1 23.6 1.7 0.0 5.1 0.3 5.9 9.0 2.3 0.2 0.8 1.3 4.9 10.5 13.5 11.0 1.3 0.0 4.1 4.4 0.0 0.8 3.1 5.7 0.0 16.9 1.3 8.2 2.2 0.6 1.0 9.0 4.0 0.9 4.3 0.7 14.6 4.1 12.1 35.4 6.7 0.0 0.0 0.0 13.1 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 3.5 2.3 1.5 2.7 1.7 1.1 1.6 1.3 3.8 1.3 CARF "ALS2CR8, CaRF, FLJ21579, NYD-SP24" ENSG00000138380 "Calcium responsive transcription factor" Q8N187 2 202912214-202987063 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034557, HPA043191" Approved Approved "Nucleoli fibrillar center,Vesicles,Cytosol" Vesicles "Nucleoli fibrillar center, Cytosol" "HPA034557: AB_10601663, HPA043191: " "unprognostic (4.63e-2)" "unprognostic (3.11e-1)" "unprognostic (1.30e-1)" "unprognostic (1.93e-2)" "unprognostic (6.09e-2)" "unprognostic (8.65e-3)" "unprognostic (1.12e-1)" "unprognostic (2.13e-3)" "unprognostic (4.39e-2)" "unprognostic (1.10e-1)" "unprognostic (7.58e-3)" "unprognostic (1.08e-1)" "unprognostic (6.12e-2)" "unprognostic (2.00e-1)" "unprognostic (2.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.55e-2)" 8.3 8.7 9.8 7.9 15.0 7.1 11.5 10.7 18.2 9.4 8.8 18.3 9.3 6.7 15.4 15.4 8.2 11.1 8.8 7.4 12.1 8.7 10.5 6.5 7.6 11.8 18.4 14.5 13.9 8.1 12.0 18.8 7.4 19.1 10.3 9.0 10.7 8.9 11.1 7.9 11.4 9.4 10.2 15.8 10.5 8.8 27.3 16.3 16.4 15.4 3.8 11.1 12.8 9.7 4.1 2.4 1.7 2.6 11.9 6.0 1.0 2.5 2.4 6.5 5.6 4.7 9.3 4.9 4.0 4.6 4.1 3.7 3.3 6.4 3.9 1.7 4.6 4.6 3.2 2.6 4.4 3.0 1.9 6.9 3.0 1.7 4.1 3.5 3.1 8.5 5.6 3.4 8.8 2.4 2.7 16.1 6.1 5.0 7.2 5.7 2.8 3.5 4.9 4.5 3.1 7.1 2.7 4.6 5.0 4.3 2.4 1.9 3.6 6.9 2.9 7.5 1.9 4.8 2.5 14.4 8.0 4.3 6.4 4.1 4.6 1.7 1.4 1.1 3.2 2.6 3.6 2.9 3.3 2.9 1.5 4.1 4.7 3.2 0.6 11.9 1.6 2.4 6.0 1.0 9.8 15.0 10.7 18.2 12.1 8.7 18.4 14.5 19.1 16.3 CASP10 MCH4 ENSG00000003400 "Caspase 10" Q92851 2 201182881-201229406 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 42.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003780, HPA017059" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "CAB003780: AB_289592, HPA017059: AB_1846040" "unprognostic (4.01e-2)" "unprognostic (8.24e-2)" "unprognostic (4.80e-1)" "unprognostic (1.28e-3)" "unprognostic (4.74e-2)" "unprognostic (2.25e-1)" "prognostic unfavourable (8.54e-4)" "unprognostic (1.73e-2)" "unprognostic (1.48e-2)" "unprognostic (3.68e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" "prognostic unfavourable (6.05e-7)" "unprognostic (3.23e-2)" "unprognostic (2.19e-2)" "unprognostic (4.49e-2)" "unprognostic (1.38e-2)" 16.0 3.3 3.4 10.1 3.4 14.9 7.6 1.9 3.3 7.0 17.7 4.4 4.3 18.6 8.3 8.2 10.4 4.9 7.2 4.8 3.6 3.0 10.3 7.8 14.2 10.4 4.1 1.4 3.4 6.1 1.4 2.1 8.5 4.7 5.0 11.9 4.1 6.9 6.9 3.6 5.4 42.4 4.8 5.6 26.1 8.7 2.1 2.5 17.1 6.8 8.2 17.9 9.4 6.1 7.8 6.0 4.7 15.4 7.1 7.1 5.8 2.9 2.3 0.1 0.2 0.1 0.2 5.1 0.5 3.4 0.3 1.3 3.1 6.8 0.2 4.9 1.7 1.9 0.1 1.6 0.9 1.4 3.3 8.2 2.4 10.2 1.1 5.4 8.9 0.3 1.4 3.7 0.3 17.7 9.8 12.1 0.3 0.1 10.5 5.1 0.3 1.5 5.7 0.3 12.1 6.2 4.1 0.1 0.1 2.8 0.1 1.3 0.0 5.2 7.1 0.2 0.5 2.3 0.1 13.2 7.8 0.3 3.3 4.2 0.1 4.7 9.6 0.6 6.2 13.5 5.2 7.8 5.2 3.4 5.3 5.0 7.1 6.0 1.9 7.1 15.4 6.0 1.0 5.8 3.4 3.4 1.9 3.3 3.6 3.0 4.1 1.4 4.7 2.5 CAT ENSG00000121691 Catalase P04040 11 34438925-34472062 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Hydrogen peroxide" "Mitogen, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 258.3;liver: 184.8" "Cell line enhanced" "Detected in many" "HL-60: 75.2;THP-1: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 13 "eosinophil: 258.3" "Lineage enriched" "Detected in all" 13 "granulocytes: 258.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001515, HPA051282, HPA055838" Enhanced Enhanced Vesicles 960000000 Vesicles "CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937" "unprognostic (3.62e-2)" "unprognostic (2.72e-1)" "unprognostic (3.59e-3)" "unprognostic (5.43e-2)" "unprognostic (4.44e-2)" "unprognostic (5.80e-3)" "prognostic favourable (9.67e-4)" "unprognostic (9.95e-3)" "unprognostic (3.22e-1)" "unprognostic (7.23e-2)" "unprognostic (3.34e-2)" "unprognostic (9.77e-2)" "prognostic favourable (1.96e-8)" "unprognostic (1.01e-1)" "unprognostic (7.31e-2)" "unprognostic (4.77e-2)" "unprognostic (6.59e-3)" 70.0 33.0 9.4 10.1 9.6 54.2 36.1 3.1 7.7 15.3 26.6 18.6 15.7 22.2 13.5 9.5 14.8 14.2 19.0 22.4 10.7 5.2 50.4 184.8 26.1 21.3 14.5 6.0 11.0 24.7 7.1 5.0 16.4 10.2 23.2 11.3 11.4 14.5 13.2 27.8 19.7 29.2 11.6 11.3 17.9 15.9 6.2 11.6 23.4 41.7 14.9 11.5 20.4 24.9 7.6 19.9 258.3 17.5 5.5 5.0 17.8 6.1 6.8 5.0 7.8 48.4 21.1 10.6 7.8 9.9 8.8 9.7 3.8 6.2 15.2 7.6 15.5 14.7 8.4 8.5 9.8 13.2 7.7 12.8 7.3 21.9 5.7 75.2 6.4 11.3 5.9 2.6 1.0 10.6 26.5 6.3 11.1 5.8 15.4 13.4 0.0 16.6 10.9 23.8 12.4 24.1 23.3 2.6 4.0 8.8 14.2 11.6 20.3 62.8 7.5 5.3 5.2 13.2 4.6 5.1 2.9 3.2 10.4 51.8 3.8 12.5 17.5 258.3 3.2 14.7 3.8 7.6 3.8 3.6 19.9 6.8 3.8 4.0 17.1 5.5 15.5 13.4 5.0 17.8 9.4 9.6 3.1 7.7 10.7 5.2 14.5 6.0 10.2 11.6 CATSPERB "C14orf161, FLJ14298" ENSG00000133962 "Cation channel sperm associated auxiliary subunit beta" Q9H7T0 14 91580696-91780707 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 15.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.9;U-937: 3.8" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA035134 Uncertain Uncertain Vesicles Vesicles "HPA035134: AB_10671510" "unprognostic (2.69e-2)" "unprognostic (1.95e-1)" "unprognostic (1.16e-3)" "unprognostic (1.93e-1)" "unprognostic (7.04e-3)" "unprognostic (2.72e-5)" "unprognostic (1.81e-1)" "unprognostic (5.01e-3)" "unprognostic (1.81e-3)" "unprognostic (3.52e-3)" "unprognostic (2.30e-2)" "unprognostic (4.34e-1)" "unprognostic (8.99e-3)" "unprognostic (6.85e-2)" "unprognostic (8.31e-2)" "unprognostic (8.88e-2)" "unprognostic (2.71e-3)" 0.6 0.1 0.0 0.6 0.0 0.0 1.4 0.0 0.2 0.4 0.9 0.3 0.4 0.4 0.6 0.7 1.2 0.6 0.0 0.0 0.3 0.2 0.9 1.1 0.0 0.2 15.1 1.0 0.3 0.0 0.9 0.7 3.7 0.0 1.7 4.2 1.2 0.1 0.0 0.8 2.0 2.0 0.9 0.6 0.5 0.3 0.4 0.2 1.1 0.2 0.7 1.6 0.4 0.6 0.0 0.7 1.7 0.0 0.0 1.9 0.3 0.3 0.0 0.0 2.4 3.9 1.2 0.9 0.0 0.7 0.0 0.5 0.7 1.4 2.1 0.4 1.3 2.3 0.0 1.7 0.8 0.6 0.7 0.4 0.5 0.0 0.5 0.2 0.5 2.3 0.6 0.7 0.2 0.5 0.3 0.0 0.0 0.4 0.9 1.7 0.1 0.0 0.8 1.6 0.4 2.2 0.9 0.2 0.2 0.0 0.3 0.9 0.9 0.3 0.2 3.8 1.0 1.1 0.2 0.6 1.1 0.0 1.5 0.4 1.6 1.0 0.0 0.2 1.1 1.4 0.4 0.7 0.2 0.2 0.0 0.4 CAV2 CAV ENSG00000105971 "Caveolin 2" P51636 7 116287380-116508541 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 48.1;HBEC3-KT: 55.0;LHCN-M2: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 82 "basophil: 31.8" "Lineage enriched" "Detected in single" 318 "granulocytes: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013488, HPA044810" Enhanced Approved Vesicles Vesicles "CAB013488: AB_2533493, HPA044810: " "unprognostic (4.76e-2)" "unprognostic (3.91e-3)" "unprognostic (4.56e-2)" "unprognostic (2.91e-1)" "unprognostic (5.09e-3)" "prognostic unfavourable (5.80e-5)" "unprognostic (3.66e-2)" "unprognostic (2.27e-2)" "unprognostic (3.81e-1)" "unprognostic (3.34e-1)" "prognostic unfavourable (1.21e-4)" "unprognostic (6.32e-2)" "unprognostic (3.44e-3)" "unprognostic (7.84e-3)" "unprognostic (2.88e-1)" "unprognostic (2.42e-1)" "unprognostic (6.34e-3)" 61.9 4.5 3.0 9.5 6.6 0.2 39.9 1.0 3.7 26.3 15.7 3.1 10.3 3.3 23.4 19.6 25.2 10.8 31.3 54.6 4.4 3.1 9.5 17.4 59.4 6.0 7.5 3.8 17.7 16.0 1.4 2.8 35.2 4.6 20.6 5.0 12.1 10.7 10.5 15.3 13.3 8.3 34.0 8.6 25.3 8.9 12.1 5.3 1.7 61.2 23.2 4.9 29.5 15.4 0.0 0.0 31.8 0.0 0.0 0.0 0.2 38.7 10.5 0.4 0.0 18.0 19.3 0.8 27.1 32.3 9.0 8.1 2.0 48.1 0.0 32.5 27.8 37.7 0.5 55.0 13.0 0.0 2.6 0.3 8.1 0.0 11.0 0.0 0.1 11.3 31.8 12.1 25.1 28.9 1.9 1.5 59.3 2.0 0.0 0.0 0.5 6.8 0.4 13.2 0.5 33.1 1.1 0.0 0.0 20.7 0.7 5.0 0.0 0.2 41.3 0.0 5.7 18.0 8.8 1.7 0.0 0.1 3.6 0.0 19.4 31.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 3.0 6.6 1.0 3.7 4.4 3.1 7.5 3.8 4.6 5.3 CAV3 "LGMD1C, LQT9, VIP-21, VIP21" ENSG00000182533 "Caveolin 3" P56539 3 8733800-8841808 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 65.8;tongue: 44.6" "Cell line enriched" "Detected in some" 4 "RH-30: 45.1" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB017518, CAB018557, HPA054488" Enhanced Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: " "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-2)" "unprognostic (6.43e-2)" "unprognostic (8.79e-2)" "unprognostic (3.05e-3)" "unprognostic (8.38e-3)" "unprognostic (9.79e-2)" "unprognostic (1.36e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 6.3 2.3 0.0 0.3 10.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.7 1.3 0.1 65.8 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 44.6 1.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 CAVIN1 "cavin-1, CGL4, PTRF" ENSG00000177469 "Caveolae associated protein 1" Q6NZI2 17 42402452-42423517 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" "RNA-binding, rRNA-binding" "Congenital generalized lipodystrophy, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 110.3;TIME: 91.5;U-138 MG: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049838, HPA074213" Supported Supported "Vesicles,Plasma membrane" 29000 "Plasma membrane" Vesicles "HPA049838: AB_2680907, HPA074213: " "unprognostic (1.59e-1)" "unprognostic (4.46e-2)" "prognostic unfavourable (6.36e-4)" "unprognostic (1.56e-1)" "unprognostic (1.76e-3)" "unprognostic (6.33e-3)" "unprognostic (1.72e-1)" "unprognostic (1.04e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (5.92e-4)" "unprognostic (7.18e-3)" "unprognostic (2.36e-1)" "unprognostic (3.44e-3)" "unprognostic (4.24e-3)" "unprognostic (3.21e-2)" "unprognostic (2.07e-3)" "prognostic unfavourable (5.87e-4)" 105.6 12.7 4.7 26.4 5.4 0.7 111.2 4.5 7.6 68.6 52.0 15.3 31.9 7.1 65.6 45.6 60.3 37.1 74.0 37.3 6.4 4.6 12.1 6.6 47.0 15.6 7.7 6.1 57.8 6.8 7.5 6.9 47.7 13.6 51.8 12.4 34.0 17.4 53.8 45.4 28.6 18.6 115.4 14.7 23.9 27.0 24.3 5.2 3.3 30.4 47.9 12.6 80.6 57.9 0.9 0.6 2.7 0.5 0.7 1.2 0.2 30.6 26.3 0.5 7.0 35.6 42.9 0.7 110.3 48.1 44.1 35.0 13.2 2.0 0.0 22.1 78.8 50.7 4.7 33.0 36.1 0.1 0.9 13.4 16.1 6.4 22.5 0.0 0.1 29.4 12.2 34.6 11.9 59.4 9.1 0.1 18.8 0.4 0.7 0.1 2.6 0.1 0.0 17.6 0.0 18.8 0.1 0.0 0.2 37.0 0.6 8.8 3.0 0.2 91.5 93.8 44.1 33.5 40.0 0.0 0.0 0.1 27.8 0.0 10.5 2.7 0.5 0.3 0.5 0.4 0.3 0.3 1.2 0.3 0.2 0.9 0.6 0.3 2.3 0.7 0.4 0.6 0.3 0.2 4.7 5.4 4.5 7.6 6.4 4.6 7.7 6.1 13.6 5.2 CBS HIP4 ENSG00000160200 Cystathionine-beta-synthase P35520 21 43053191-43076943 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" "Allosteric enzyme, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 55.7;pancreas: 43.0" "Cell line enhanced" "Detected in many" "BEWO: 40.2;HAP1: 38.3;HHSteC: 51.8;MCF7: 44.3;RPMI-8226: 42.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 84 "neutrophil: 8.3" "Lineage enriched" "Detected in single" 84 "granulocytes: 8.3" HPA001223 Supported Approved Nucleoli,Vesicles Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (4.86e-2)" "unprognostic (1.48e-2)" "unprognostic (6.81e-2)" "unprognostic (1.12e-3)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (9.68e-4)" "unprognostic (3.62e-1)" "unprognostic (6.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.50e-2)" "unprognostic (2.13e-1)" "unprognostic (1.61e-2)" "unprognostic (6.73e-3)" "unprognostic (2.62e-1)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" 1.3 1.5 6.5 2.4 5.1 0.4 1.0 12.3 6.7 4.8 1.3 2.0 0.8 1.6 0.9 0.8 0.8 2.0 2.1 2.0 5.6 5.5 1.3 55.7 1.7 1.4 4.8 2.8 13.9 43.0 0.3 1.4 1.4 2.3 4.0 0.7 2.8 9.3 3.4 0.8 0.6 2.9 1.4 3.7 0.8 2.7 2.2 3.3 0.8 5.0 0.8 0.9 2.6 0.8 0.0 0.0 8.3 0.0 0.0 0.0 0.0 6.3 3.8 5.0 19.6 11.3 7.3 40.2 7.8 2.0 3.2 3.3 11.8 0.3 0.0 4.2 14.7 0.4 38.3 2.7 0.6 0.0 4.8 2.6 15.3 14.2 51.8 1.6 3.8 4.4 0.4 3.5 3.1 8.6 29.6 22.3 2.4 44.3 2.7 0.0 4.7 6.7 0.0 0.0 42.4 0.1 3.5 10.4 15.3 17.2 1.0 7.4 6.1 20.0 1.1 0.2 9.9 0.1 0.8 7.8 6.2 8.8 3.6 2.3 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 6.5 5.1 12.3 5.2 5.6 5.5 4.8 2.8 2.3 3.3 CBSL ENSG00000274276 "Cystathionine-beta-synthase like" P0DN79 21 6444869-6468040 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.5;liver: 21.2;pancreas: 18.5" "Cell line enhanced" "Detected in many" "AN3-CA: 35.7;NTERA-2: 66.2;SH-SY5Y: 21.1;U-266/70: 20.9" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 47 "neutrophil: 4.6" "Lineage enriched" "Detected in single" 47 "granulocytes: 4.6" HPA001223 Supported Approved Nucleoli,Vesicles 190000 Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (2.39e-1)" "unprognostic (1.54e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-3)" "unprognostic (6.49e-2)" "unprognostic (1.42e-2)" "unprognostic (1.28e-2)" "unprognostic (6.62e-3)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (7.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (3.17e-3)" "unprognostic (8.44e-2)" "unprognostic (2.46e-1)" "unprognostic (3.61e-1)" 0.0 0.0 0.0 0.0 0.0 11.5 1.8 0.0 0.4 0.0 0.0 0.0 0.3 0.0 1.0 0.0 21.2 0.0 0.0 1.6 18.5 0.0 0.0 1.8 0.0 0.0 3.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 5.0 0.0 0.3 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 11.9 35.7 0.0 0.0 0.4 7.4 4.3 2.7 8.3 0.1 4.8 0.0 0.0 0.0 3.1 0.0 3.8 1.7 0.0 9.4 0.0 0.0 0.0 0.2 0.0 5.1 4.2 13.9 0.0 7.0 0.0 0.2 16.5 0.1 0.0 5.6 0.6 66.2 0.0 0.0 0.0 0.0 10.8 0.0 13.8 21.1 0.0 1.1 14.4 0.0 0.0 0.0 0.7 0.0 4.6 1.4 20.9 7.7 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 CC2D1B KIAA1836 ENSG00000154222 "Coiled-coil and C2 domain containing 1B" Q5T0F9 1 52345723-52366193 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027500, HPA031426" Uncertain Supported Nucleoplasm,Vesicles 140000 Nucleoplasm Vesicles "HPA027500: AB_10600693, HPA031426: " "unprognostic (1.11e-2)" "unprognostic (1.06e-1)" "unprognostic (2.38e-2)" "unprognostic (2.50e-2)" "unprognostic (5.85e-2)" "unprognostic (2.04e-2)" "prognostic unfavourable (1.45e-5)" "unprognostic (3.39e-2)" "unprognostic (4.75e-1)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-2)" "unprognostic (2.63e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-2)" "unprognostic (1.87e-1)" 14.6 16.0 12.6 14.5 20.0 7.4 11.5 12.9 18.8 9.6 13.0 22.5 10.8 14.3 11.1 15.2 16.5 9.6 13.6 14.9 14.3 14.9 17.7 15.5 17.9 18.7 21.0 17.2 14.1 17.2 15.3 20.0 16.2 20.6 12.7 11.0 17.3 16.1 14.0 25.6 15.6 14.9 11.3 29.2 16.9 14.4 24.3 19.2 17.9 17.1 17.1 15.7 12.8 10.8 2.9 1.7 11.2 1.8 2.7 4.0 1.9 10.0 14.2 6.4 9.3 22.0 8.2 15.5 13.3 20.1 16.1 12.7 9.9 7.9 7.2 11.3 13.9 7.2 7.8 15.7 6.7 11.8 9.2 7.9 12.0 7.6 16.3 9.0 17.6 12.8 14.6 18.4 13.0 10.1 12.1 7.2 16.0 7.6 9.9 7.3 11.7 14.0 6.6 12.9 8.4 14.9 14.7 7.6 6.5 12.4 18.4 16.7 6.6 11.9 13.6 20.6 11.5 10.9 14.7 10.5 9.9 7.8 22.9 10.4 20.7 11.2 1.8 4.0 4.0 1.0 3.0 2.9 3.2 2.9 1.7 2.2 2.5 3.4 2.6 2.7 0.8 1.7 2.3 1.9 12.6 20.0 12.9 18.8 14.3 14.9 21.0 17.2 20.6 19.2 CCDC115 "ccp1, FLJ30131, MGC12981" ENSG00000136710 "Coiled-coil domain containing 115" Q96NT0 2 130338241-130342349 "Disease related genes, Predicted intracellular proteins" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034598 Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA034598: AB_10601697" "prognostic favourable (7.59e-4)" "unprognostic (1.28e-2)" "unprognostic (1.10e-3)" "unprognostic (6.80e-3)" "unprognostic (3.23e-1)" "unprognostic (1.08e-1)" "unprognostic (4.20e-2)" "unprognostic (8.13e-3)" "unprognostic (2.63e-1)" "unprognostic (4.29e-1)" "unprognostic (2.87e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.07e-1)" "unprognostic (7.83e-2)" "unprognostic (2.16e-1)" "unprognostic (3.16e-2)" 18.7 18.4 25.1 14.7 25.9 17.2 21.5 23.4 39.8 27.1 22.3 24.6 17.9 18.1 22.3 28.9 24.2 25.6 19.9 15.0 25.2 24.1 24.9 14.9 21.8 22.6 26.1 22.5 36.1 24.0 25.3 17.1 23.2 28.1 21.3 17.2 19.1 23.8 25.4 9.4 26.5 19.1 17.7 24.1 19.5 16.9 13.0 16.8 17.1 25.3 14.2 28.4 20.3 20.1 34.0 32.8 51.5 56.2 26.7 34.4 38.7 12.6 6.7 8.2 5.2 16.8 17.8 10.4 6.6 16.0 13.2 15.3 14.9 28.2 16.7 22.6 10.1 13.3 6.9 10.9 10.4 19.9 12.6 12.1 3.8 18.5 14.2 13.8 24.1 15.2 25.9 8.3 4.8 13.6 11.9 14.0 15.8 12.1 21.1 22.8 11.3 17.2 16.9 9.4 14.0 11.5 12.2 9.4 14.4 8.6 15.1 14.6 15.0 14.8 10.9 7.4 8.0 11.9 5.0 7.7 8.0 15.7 13.8 13.4 8.8 36.8 33.1 51.5 29.7 45.3 26.6 33.8 32.1 31.7 32.8 34.0 30.9 28.8 11.4 26.7 56.2 25.8 34.4 38.7 25.1 25.9 23.4 39.8 25.2 24.1 26.1 22.5 28.1 16.8 CCDC122 FLJ31846 ENSG00000151773 "Coiled-coil domain containing 122" Q5T0U0 13 43823909-43879727 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 11.2;hTERT-HME1: 11.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034233, HPA054995, HPA061456" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB034233: AB_2228702, HPA054995: , HPA061456: " "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (1.07e-1)" "unprognostic (1.67e-2)" "unprognostic (1.39e-2)" "unprognostic (1.68e-2)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (5.28e-2)" "unprognostic (2.79e-2)" "unprognostic (1.30e-3)" "unprognostic (2.74e-1)" "unprognostic (1.16e-2)" "unprognostic (2.14e-2)" "unprognostic (3.79e-2)" "unprognostic (1.32e-1)" "unprognostic (6.75e-2)" 4.3 6.7 5.0 8.5 9.5 1.8 7.5 2.4 5.6 5.5 5.5 7.2 8.8 3.3 8.0 10.7 4.5 8.6 5.9 8.3 6.1 5.0 10.4 5.7 5.5 4.6 9.8 5.8 12.2 6.9 8.4 15.6 8.2 6.0 9.8 6.9 3.6 5.7 4.8 3.3 7.8 7.3 9.8 6.4 7.7 5.8 9.7 11.0 5.2 10.9 4.5 4.7 6.2 11.8 3.6 3.0 6.4 2.6 3.6 1.9 1.0 2.1 1.8 0.8 0.0 0.7 4.5 2.3 5.8 6.4 3.0 3.4 3.1 7.9 3.6 3.3 3.5 3.5 0.8 0.9 4.3 5.7 2.7 1.5 1.0 1.7 8.4 0.8 0.4 11.2 7.1 4.4 11.6 1.5 0.0 1.1 4.1 2.6 0.5 0.5 1.0 1.8 0.8 0.0 1.9 4.7 1.2 2.1 3.1 3.9 0.1 3.5 0.7 0.6 6.8 0.2 0.8 5.2 0.0 0.0 0.0 1.6 2.9 0.1 3.0 6.4 1.6 2.4 1.3 1.4 1.6 2.4 1.9 1.4 1.2 3.6 1.3 1.4 3.9 3.6 2.6 3.0 1.7 1.0 5.0 9.5 2.4 5.6 6.1 5.0 9.8 5.8 6.0 11.0 CCDC130 MGC10471 ENSG00000104957 "Coiled-coil domain containing 130" P13994 19 13731760-13763296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056977 Approved Approved Vesicles Vesicles "HPA056977: " "unprognostic (6.54e-2)" "unprognostic (5.72e-3)" "unprognostic (2.13e-3)" "unprognostic (1.27e-3)" "unprognostic (2.71e-1)" "prognostic favourable (7.83e-5)" "unprognostic (7.04e-2)" "unprognostic (1.25e-2)" "unprognostic (2.47e-1)" "unprognostic (9.69e-2)" "prognostic favourable (2.34e-4)" "unprognostic (2.06e-2)" "prognostic unfavourable (1.97e-4)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.94e-1)" "prognostic favourable (1.82e-4)" 17.5 20.1 17.4 23.6 22.1 28.2 20.4 22.2 24.5 18.7 17.8 32.9 23.8 21.3 27.2 18.0 17.6 20.7 18.1 22.6 16.9 14.5 20.6 17.9 19.8 28.9 24.7 19.7 30.1 19.1 24.9 26.1 21.0 19.4 20.2 11.0 23.6 24.3 21.0 26.6 22.5 21.9 16.9 17.0 26.1 20.3 22.0 24.0 22.0 25.3 11.5 19.6 17.9 21.4 19.2 16.9 23.1 17.2 17.0 20.0 13.3 8.5 6.7 12.9 12.9 8.7 7.0 6.9 9.2 9.0 9.5 8.8 5.3 6.2 7.5 7.1 8.3 8.6 5.6 5.0 3.0 11.5 16.0 5.7 17.1 9.2 17.2 5.9 15.7 9.3 11.5 12.2 8.1 11.0 5.9 14.5 5.7 6.1 14.7 11.7 8.1 12.7 13.3 6.4 9.6 6.7 9.7 7.4 9.7 6.3 5.3 15.5 5.3 13.6 8.4 15.3 6.2 17.9 12.3 21.9 8.1 5.7 13.0 13.9 10.7 22.2 17.2 23.1 17.3 14.7 20.0 18.6 18.1 18.2 16.9 19.2 16.8 19.4 17.0 17.0 16.6 12.4 14.8 13.3 17.4 22.1 22.2 24.5 16.9 14.5 24.7 19.7 19.4 24.0 CCDC144A "FLJ43983, KIAA0565" ENSG00000170160 "Coiled-coil domain containing 144A" A2RUR9 17 16689537-16777881 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 44.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.9;TIME: 9.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA022996, HPA047220, HPA047851" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA022996: AB_1846136, HPA047220: , HPA047851: " "unprognostic (8.54e-2)" "unprognostic (4.49e-3)" "unprognostic (1.07e-1)" "unprognostic (8.34e-2)" "unprognostic (1.10e-1)" "unprognostic (2.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.69e-2)" "unprognostic (6.95e-2)" "unprognostic (2.60e-2)" "unprognostic (2.73e-1)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (9.49e-2)" "unprognostic (3.32e-1)" "unprognostic (1.41e-1)" "unprognostic (1.74e-1)" 3.7 1.9 2.5 2.7 3.5 5.5 2.7 12.0 3.6 2.1 3.1 2.8 0.4 0.9 5.4 3.9 1.3 2.6 1.7 2.5 4.7 0.8 1.0 1.5 2.8 2.3 4.3 1.8 7.3 5.4 0.2 16.7 3.7 10.3 3.0 1.4 1.7 2.2 1.5 2.4 3.7 2.0 2.5 4.2 2.4 2.2 44.4 2.8 2.4 1.8 0.4 1.5 2.8 4.9 1.0 0.8 0.8 1.3 1.0 3.8 0.0 0.5 3.8 0.9 2.4 3.4 10.9 0.4 0.2 0.0 0.2 0.2 4.8 0.1 0.5 3.3 6.7 5.9 4.9 0.3 0.3 3.4 0.3 0.5 0.5 0.3 0.2 0.7 3.1 2.0 0.1 2.3 0.2 0.1 0.5 0.3 2.2 0.2 0.1 1.2 0.8 0.4 1.5 0.2 0.1 0.1 4.6 1.2 1.3 0.7 0.2 1.4 4.0 0.2 9.3 0.8 0.5 5.2 1.5 6.6 6.8 0.2 0.4 6.8 1.8 0.7 0.6 0.3 2.2 0.5 1.4 1.0 2.1 1.4 0.4 0.5 3.8 1.9 0.8 1.0 1.3 0.8 2.1 0.0 2.5 3.5 12.0 3.6 4.7 0.8 4.3 1.8 10.3 2.8 CCDC146 KIAA1505 ENSG00000135205 "Coiled-coil domain containing 146" Q8IYE0 7 77122434-77329533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.7;fallopian tube: 27.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "pons and medulla: 32.7" "Cell type enhanced" "Detected in many" "eosinophil: 12.5;neutrophil: 14.0" "Group enriched" "Detected in many" 4 "granulocytes: 14.0;NK-cells: 5.0;T-cells: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA020082, HPA020105" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA020082: AB_1852410, HPA020105: AB_2072056" "unprognostic (3.07e-3)" "unprognostic (9.94e-3)" "unprognostic (1.56e-1)" "unprognostic (2.54e-3)" "unprognostic (1.85e-1)" "prognostic favourable (7.37e-4)" "unprognostic (1.95e-3)" "unprognostic (8.02e-3)" "unprognostic (4.05e-4)" "unprognostic (1.73e-1)" "unprognostic (4.63e-1)" "unprognostic (4.09e-2)" "unprognostic (7.38e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-1)" "unprognostic (2.70e-3)" "unprognostic (5.58e-3)" 1.8 0.8 6.5 1.9 7.2 1.3 1.9 1.8 8.3 4.3 3.2 4.5 2.7 1.9 3.7 9.1 3.5 27.9 2.6 1.4 7.4 3.4 4.2 1.3 4.9 2.2 1.6 4.2 6.4 1.8 2.9 10.9 1.5 32.7 3.4 2.2 4.4 3.9 1.8 1.6 7.4 2.2 2.4 2.8 2.8 2.5 22.2 2.9 0.5 6.3 0.9 2.0 3.1 3.4 1.0 1.8 14.0 0.7 5.0 4.4 0.6 1.0 1.5 4.4 2.4 2.9 3.0 0.5 1.1 1.0 1.1 1.9 0.0 7.5 2.5 0.2 0.3 1.5 0.6 1.4 1.9 3.0 0.5 2.9 2.0 1.3 0.9 3.2 2.4 1.7 2.2 2.0 0.3 1.0 0.0 2.8 0.3 0.3 2.6 4.7 0.5 1.1 6.9 0.7 0.3 4.6 0.8 3.4 2.2 1.6 1.5 0.9 1.4 1.1 1.4 1.7 0.6 2.4 0.7 4.4 6.8 2.1 3.9 4.9 4.0 0.6 0.5 12.5 4.4 0.7 3.1 1.0 1.9 3.0 0.8 0.2 1.2 1.9 14.0 5.0 0.3 1.8 1.4 0.6 6.5 7.2 1.8 8.3 7.4 3.4 1.6 4.2 32.7 2.9 CCDC169-SOHLH2 C13orf38-SOHLH2 ENSG00000250709 "CCDC169-SOHLH2 readthrough" 13 36168794-36297842 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 42.2" "Cell line enhanced" "Detected in some" "BEWO: 3.3;HEL: 2.3;HL-60: 6.1;LHCN-M2: 2.3;NB-4: 3.5;U-937: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA029182 Uncertain Vesicles Vesicles "HPA029182: AB_10602409" "unprognostic (5.56e-2)" "unprognostic (3.93e-1)" "unprognostic (3.60e-2)" "unprognostic (4.66e-1)" "unprognostic (2.17e-1)" "unprognostic (1.84e-2)" "unprognostic (6.12e-2)" "unprognostic (3.43e-2)" 0.4 0.5 0.5 0.2 1.8 0.2 0.4 0.4 1.4 0.5 0.8 0.3 4.9 0.2 1.0 2.0 0.3 0.4 0.3 1.1 0.5 0.6 0.7 0.3 0.3 0.2 0.5 1.3 0.4 0.4 0.3 0.3 3.3 1.1 0.6 0.3 0.5 0.4 9.1 0.5 0.3 0.4 3.0 1.0 0.3 0.6 42.2 0.0 0.0 0.4 0.0 0.2 1.6 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 3.3 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.3 6.1 0.0 0.1 0.0 0.8 0.0 0.8 0.1 0.0 2.3 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.1 0.0 0.1 1.1 0.6 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.1 5.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.4 1.4 0.5 0.6 0.5 1.3 1.1 0.0 CCDC190 "C1orf110, MGC48998" ENSG00000185860 "Coiled-coil domain containing 190" Q86UF4 1 162824458-162868815 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 8.3;lung: 7.2;tongue: 7.5" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 4.1;HUVEC TERT2: 4.9;LHCN-M2: 7.5;TIME: 17.0;U-2197: 9.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028579, HPA028584, HPA028592" Uncertain Approved Vesicles Vesicles "HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001" "unprognostic (4.29e-1)" "unprognostic (8.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (8.33e-3)" "unprognostic (3.04e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (7.41e-5)" "unprognostic (2.64e-1)" "unprognostic (1.52e-1)" "unprognostic (5.26e-1)" "unprognostic (1.70e-1)" 0.2 0.1 1.1 0.2 1.7 0.0 0.2 0.2 0.9 0.3 0.2 0.2 0.2 0.0 0.2 0.8 8.3 1.1 1.3 1.0 1.2 0.7 0.2 0.2 7.2 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.5 0.0 0.2 0.2 0.3 0.2 0.1 0.7 0.2 0.6 0.2 7.5 2.4 0.3 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.9 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 4.1 2.6 4.9 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.4 0.0 9.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 1.7 0.2 0.6 1.2 0.7 0.4 0.2 0.2 0.2 CCDC32 "C15orf57, MGC20481" ENSG00000128891 "Coiled-coil domain containing 32" Q9BV29 15 40528683-40565057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041688 Uncertain Approved "Nuclear speckles,Vesicles" "Nuclear speckles" Vesicles "HPA041688: AB_10796779" "unprognostic (7.10e-2)" "unprognostic (1.04e-1)" "unprognostic (9.86e-3)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (4.25e-5)" "unprognostic (4.03e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-1)" "unprognostic (4.70e-2)" "unprognostic (2.34e-1)" "unprognostic (1.23e-2)" "unprognostic (5.77e-2)" "unprognostic (3.72e-1)" "unprognostic (1.18e-1)" "unprognostic (2.20e-1)" "unprognostic (6.47e-2)" 22.7 23.5 17.9 17.2 24.3 19.0 17.9 17.6 24.0 17.1 18.4 17.6 17.4 18.4 24.5 20.0 12.6 20.3 19.4 21.4 20.7 21.9 25.9 15.3 16.6 27.8 17.6 21.0 28.2 32.6 15.8 26.5 22.6 20.8 16.5 22.0 20.5 20.7 17.4 22.4 11.5 18.5 18.5 16.7 25.2 18.9 9.2 16.1 16.2 24.4 9.4 26.8 26.9 22.2 50.6 16.3 12.7 9.6 7.7 13.8 11.6 7.8 5.7 7.5 12.1 15.3 16.1 4.5 6.3 9.4 11.2 11.8 8.5 11.1 2.9 17.7 9.3 14.8 7.4 7.1 8.1 17.8 8.5 32.2 9.6 10.6 10.4 12.1 17.0 13.9 7.6 8.8 5.9 14.1 17.6 19.6 8.5 6.8 5.5 10.5 3.0 7.3 9.7 9.5 9.7 20.7 19.1 8.3 8.5 9.4 9.8 4.6 10.4 22.4 15.5 10.5 9.2 18.4 9.0 10.7 10.5 9.4 11.1 19.1 14.7 12.7 9.4 9.3 9.8 9.6 7.9 40.9 11.0 10.6 12.2 50.6 11.2 9.5 9.9 7.7 9.4 16.3 13.8 11.6 17.9 24.3 17.6 24.0 20.7 21.9 17.6 21.0 20.8 16.1 CCDC63 "FLJ35843, ODA5" ENSG00000173093 "Coiled-coil domain containing 63" Q8NA47 12 110846769-110907535 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 26.2" "Cell line enriched" "Detected in single" 18 "MCF7: 9.7" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "cerebellum: 10.3" "Not detected" "Not detected" HPA061568 Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA061568: " "unprognostic (1.98e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (2.65e-1)" "unprognostic (5.59e-2)" "unprognostic (1.09e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC65 "CFAP250, CILD27, DRC2, FAP250, FLJ35732, NYD-SP28" ENSG00000139537 "Coiled-coil domain containing 65" Q8IXS2 12 48904110-48931840 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 22.5;testis: 53.2" "Cell line enhanced" "Detected in many" "HeLa: 7.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 13.7" "Group enriched" "Detected in many" 11 "gdT-cell: 8.9;MAIT T-cell: 9.5;memory CD4 T-cell: 7.6;memory CD8 T-cell: 7.1;naive CD4 T-cell: 4.7;naive CD8 T-cell: 6.3;T-reg: 4.1" "Lineage enriched" "Detected in single" 15 "T-cells: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038520, HPA057573" Uncertain Approved "Vesicles,Centriolar satellite" Vesicles "Centriolar satellite" "HPA038520: AB_10672714, HPA057573: " "unprognostic (3.06e-2)" "unprognostic (1.17e-1)" "unprognostic (4.22e-2)" "unprognostic (4.20e-3)" "unprognostic (1.44e-2)" "unprognostic (3.43e-2)" "unprognostic (2.86e-2)" "unprognostic (5.79e-3)" "unprognostic (3.23e-1)" "unprognostic (9.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.03e-4)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (6.16e-2)" 0.3 0.4 2.2 0.6 5.1 1.1 0.5 0.6 2.2 1.6 0.3 4.5 0.5 0.4 1.3 5.1 0.3 22.5 1.1 0.3 2.9 3.2 2.0 0.2 5.0 0.8 0.6 2.0 2.7 0.7 1.1 3.9 0.2 13.7 0.3 0.1 2.1 0.4 0.5 0.3 1.3 0.5 0.2 0.7 1.0 0.3 53.2 1.0 0.0 2.2 0.0 0.3 0.3 0.2 0.3 0.0 0.1 0.0 0.6 9.5 2.2 1.2 4.8 2.2 4.2 0.1 0.0 2.1 1.1 0.1 0.6 2.0 5.8 2.9 1.6 1.6 0.0 1.4 0.0 0.1 0.9 2.6 2.3 2.6 7.3 2.1 0.3 2.1 2.4 0.0 0.1 1.2 0.0 0.0 1.1 0.6 0.1 2.7 0.6 2.8 4.7 1.2 1.5 1.0 1.8 3.5 3.1 1.2 2.0 1.3 1.7 1.6 4.5 1.8 1.9 1.6 1.6 1.8 0.9 2.1 2.1 1.5 1.7 1.7 0.4 0.0 0.0 0.0 8.9 0.0 9.5 0.3 7.6 7.1 0.0 0.3 4.7 6.3 0.1 0.6 0.0 0.0 4.1 2.2 2.2 5.1 0.6 2.2 2.9 3.2 0.6 2.0 13.7 1.0 CCDC74A FLJ40345 ENSG00000163040 "Coiled-coil domain containing 74A" Q96AQ1 2 131527675-131533666 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.1;testis: 41.2" "Cell line enhanced" "Detected in many" "NTERA-2: 19.0;SCLC-21H: 15.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 3.3" "Lineage enhanced" "Detected in single" "dendritic cells: 3.3" HPA060727 Uncertain Vesicles Vesicles "HPA060727: " "prognostic favourable (5.11e-4)" "unprognostic (2.89e-3)" "unprognostic (6.49e-2)" "unprognostic (1.39e-2)" "prognostic unfavourable (2.33e-4)" "unprognostic (1.91e-1)" "unprognostic (1.36e-2)" "unprognostic (2.18e-3)" "unprognostic (1.71e-1)" "unprognostic (2.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.25e-1)" "prognostic unfavourable (1.70e-7)" "unprognostic (7.28e-3)" "prognostic favourable (4.92e-4)" "unprognostic (5.96e-2)" "unprognostic (3.53e-2)" 1.3 12.8 5.8 2.7 6.5 0.2 6.8 1.1 4.4 5.6 1.9 3.2 4.7 0.9 7.1 7.1 1.9 26.1 5.1 2.2 5.1 6.8 3.0 0.5 3.0 0.9 2.2 4.1 7.1 1.5 13.3 14.1 0.9 13.6 5.2 1.3 2.4 1.8 5.1 0.9 3.5 0.8 5.9 3.0 1.0 1.0 41.2 1.9 2.2 2.6 0.9 1.2 4.5 2.7 0.0 3.3 0.0 0.1 0.0 0.8 0.2 0.0 3.9 4.0 0.2 5.7 13.9 0.3 3.3 5.6 3.1 2.3 0.1 5.9 1.5 2.1 5.1 3.0 1.7 1.0 1.2 3.9 7.4 0.0 3.7 0.1 0.7 0.1 0.3 4.5 0.4 3.0 0.0 1.2 2.1 4.3 2.7 2.4 8.4 2.3 19.0 2.5 4.0 0.0 1.7 7.8 0.0 15.6 11.4 0.4 0.5 0.5 5.4 0.8 1.2 0.9 2.9 12.0 2.5 0.9 0.7 0.5 12.9 0.3 5.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.4 3.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 5.8 6.5 1.1 4.4 5.1 6.8 2.2 4.1 13.6 1.9 CCDC74B DKFZp434E2321 ENSG00000152076 "Coiled-coil domain containing 74B" Q96LY2 2 130139287-130145134 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 12.4;testis: 22.7" "Cell line enhanced" "Detected in many" "SCLC-21H: 10.4;SH-SY5Y: 14.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA060727 Uncertain Vesicles Vesicles "HPA060727: " "prognostic favourable (4.46e-4)" "unprognostic (4.75e-3)" "unprognostic (2.67e-1)" "unprognostic (2.76e-3)" "unprognostic (2.81e-1)" "unprognostic (1.73e-1)" "unprognostic (8.69e-3)" "unprognostic (9.43e-2)" "unprognostic (2.99e-1)" "unprognostic (2.10e-1)" "unprognostic (6.43e-3)" "unprognostic (7.74e-2)" "prognostic unfavourable (1.55e-4)" "unprognostic (2.43e-2)" "unprognostic (1.48e-4)" "unprognostic (8.31e-3)" "unprognostic (9.94e-3)" 0.0 1.4 2.8 0.1 2.4 0.0 0.4 0.0 2.2 8.3 0.1 0.0 3.5 0.6 0.1 12.4 1.1 0.1 3.0 4.0 1.0 0.0 1.0 0.1 0.9 2.1 0.2 7.5 7.7 0.0 2.7 0.0 0.2 2.5 0.0 0.1 0.0 1.0 1.4 0.0 0.0 22.7 3.7 0.0 0.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.8 2.8 0.1 2.6 5.7 0.6 2.2 1.1 0.3 0.5 0.8 0.7 0.0 3.6 2.0 1.0 0.2 0.3 0.4 1.9 5.4 0.0 6.7 0.1 0.3 0.1 0.2 1.2 0.0 0.9 0.0 0.1 0.1 1.7 0.8 2.0 0.0 0.0 5.8 5.8 4.4 0.0 3.1 1.7 0.0 10.4 14.8 1.6 0.1 0.2 5.9 0.6 0.4 1.1 4.9 5.9 0.5 0.1 0.2 0.0 6.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 CCDC93 FLJ10996 ENSG00000125633 "Coiled-coil domain containing 93" Q567U6 2 117915478-118014133 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054183 Approved Enhanced "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA054183: " "unprognostic (1.47e-1)" "unprognostic (6.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.02e-2)" "unprognostic (3.32e-2)" "unprognostic (2.47e-3)" "prognostic unfavourable (2.97e-6)" "unprognostic (2.51e-1)" "unprognostic (8.12e-2)" "unprognostic (8.99e-2)" "unprognostic (1.52e-3)" "unprognostic (8.56e-2)" "unprognostic (4.87e-1)" "unprognostic (1.79e-2)" "unprognostic (2.67e-1)" "prognostic unfavourable (9.66e-4)" "unprognostic (2.40e-2)" 23.0 20.6 12.9 21.9 14.3 27.2 14.5 23.9 15.6 12.3 18.1 12.8 16.0 17.3 16.8 16.9 10.9 12.3 14.9 23.4 13.1 13.0 14.6 11.0 15.9 16.0 11.8 11.5 20.3 18.0 24.0 26.8 18.6 13.3 11.4 16.0 14.6 13.6 24.9 20.6 16.0 18.1 17.2 15.1 17.1 12.1 15.9 12.0 17.4 17.1 10.2 20.4 11.9 19.2 4.2 3.0 6.3 5.5 3.9 5.7 2.3 13.5 6.0 16.6 14.6 24.1 16.6 14.1 16.1 10.6 10.6 10.9 13.0 8.7 11.6 11.1 12.6 11.8 9.6 8.3 13.9 15.0 9.8 14.6 10.5 17.4 10.7 15.8 16.7 11.3 8.7 16.6 19.8 11.2 8.0 8.2 11.8 5.8 10.0 17.2 7.5 9.8 12.8 13.0 7.8 8.8 14.5 13.3 7.9 10.5 8.0 11.3 6.7 9.8 15.7 18.3 15.4 15.4 11.1 10.9 11.3 18.4 10.6 11.8 10.6 6.3 4.2 4.5 5.7 5.5 5.6 4.2 4.1 4.7 3.0 4.1 5.6 4.8 4.4 3.9 3.4 1.5 1.8 2.3 12.9 14.3 23.9 15.6 13.1 13.0 11.8 11.5 13.3 12.0 CCL15 "HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3" ENSG00000275718 "C-C motif chemokine ligand 15" Q16663 17 35996440-36002038 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Cytokine, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 36.4;liver: 17.9" "Cell line enriched" "Detected in some" 14 "Hep G2: 26.6" "Cancer enhanced" "Detected in many" "liver cancer: 11.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA058608 Approved "Golgi apparatus,Vesicles" "Secreted to blood" 7900000 "Golgi apparatus" Vesicles "HPA058608: " "unprognostic (1.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.31e-2)" "unprognostic (1.40e-1)" "unprognostic (8.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-1)" "unprognostic (2.41e-2)" "unprognostic (1.96e-2)" "unprognostic (9.94e-2)" "unprognostic (1.15e-1)" "unprognostic (1.07e-2)" "prognostic favourable (3.02e-4)" 0.0 0.0 0.0 6.1 0.0 0.0 0.6 0.0 0.0 0.1 18.0 0.0 0.0 11.6 0.0 0.4 0.0 1.1 7.4 0.8 0.0 6.4 17.9 2.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 15.8 0.0 0.0 0.0 0.0 0.4 36.4 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.7 1.0 2.2 0.3 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.3 0.2 0.2 0.3 0.3 0.5 0.0 0.7 0.4 0.2 2.2 0.9 0.1 1.0 0.3 0.0 CCL2 "GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF" ENSG00000108691 "C-C motif chemokine ligand 2" P13500 17 34255218-34257203 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "BJ hTERT+: 159.2;HMC-1: 207.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 10.3;eosinophil: 3.9" "Group enriched" "Detected in many" 6 "granulocytes: 3.9;monocytes: 10.3" "Low region specificity" "Detected in many" "CAB013676, HPA019163" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" 342420 "Golgi apparatus" Vesicles "CAB013676: , HPA019163: AB_1846179" "unprognostic (6.43e-2)" "unprognostic (4.14e-2)" "unprognostic (4.78e-2)" "unprognostic (5.57e-2)" "unprognostic (2.37e-3)" "unprognostic (8.64e-2)" "unprognostic (2.78e-2)" "unprognostic (7.53e-2)" "unprognostic (2.90e-1)" "unprognostic (1.19e-1)" "unprognostic (9.33e-2)" "unprognostic (2.65e-1)" "prognostic unfavourable (4.51e-4)" "unprognostic (1.33e-1)" "unprognostic (2.50e-2)" "unprognostic (1.81e-1)" "unprognostic (4.92e-2)" 78.1 31.2 10.3 52.3 50.6 19.1 19.0 1.5 23.3 9.7 41.9 28.6 3.0 9.4 7.2 7.6 14.4 25.8 62.0 76.9 45.1 6.7 32.5 38.4 105.2 16.9 16.0 2.0 28.6 32.8 15.2 17.3 22.8 63.6 42.0 25.3 22.3 13.5 13.4 17.8 10.5 16.7 34.6 85.4 16.1 30.2 4.6 8.6 4.8 20.8 21.6 19.1 27.2 9.0 0.0 1.1 3.9 10.3 0.0 0.1 2.3 0.0 1.2 3.4 0.0 9.6 8.2 0.0 9.7 159.2 20.7 44.4 0.5 0.0 0.0 7.7 2.2 5.3 0.3 0.0 10.5 0.0 0.0 0.0 1.1 0.0 0.3 0.0 207.5 9.1 0.0 4.3 0.2 9.4 0.5 1.7 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.2 1.7 29.6 0.0 0.0 0.6 0.0 0.5 0.2 0.3 0.2 0.5 11.1 0.4 0.3 0.0 0.1 0.0 0.0 6.5 3.0 7.0 0.0 10.3 3.9 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.7 0.0 0.0 0.3 0.0 2.3 10.3 50.6 1.5 23.3 45.1 6.7 16.0 2.0 63.6 8.6 CCZ1 "C7orf28A, CCZ1A, CGI-43" ENSG00000122674 "CCZ1 homolog, vacuolar protein trafficking and biogenesis associated" P86791 7 5898725-5926550 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA045114, HPA050006" Uncertain Enhanced Vesicles Vesicles "HPA045114: , HPA050006: " "unprognostic (1.91e-1)" "unprognostic (2.97e-3)" "unprognostic (3.15e-2)" "unprognostic (1.25e-2)" "unprognostic (1.82e-1)" "unprognostic (5.35e-2)" "unprognostic (3.74e-3)" "unprognostic (4.10e-1)" "unprognostic (9.25e-3)" "unprognostic (7.66e-2)" "unprognostic (6.64e-2)" "unprognostic (2.67e-2)" "unprognostic (5.27e-3)" "unprognostic (3.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.74e-1)" "unprognostic (4.41e-1)" 17.2 33.0 19.0 16.5 22.6 25.7 27.9 19.5 28.2 15.5 15.7 15.4 10.5 16.5 18.9 15.8 23.2 15.2 16.7 23.3 19.1 17.0 15.9 21.2 17.1 32.3 17.8 23.5 13.5 39.1 25.7 17.2 15.7 19.4 15.6 19.9 13.7 28.9 13.9 33.3 19.3 18.5 16.7 18.6 18.4 16.0 36.1 12.6 19.4 17.7 23.9 20.3 19.7 15.8 3.7 7.1 10.2 10.4 9.2 16.6 2.8 47.0 18.4 25.3 32.5 26.3 24.3 17.7 18.8 22.5 18.7 20.0 8.9 24.2 28.9 10.8 28.0 25.5 17.5 20.0 20.5 12.9 26.8 14.5 22.7 16.2 26.6 29.3 17.0 24.7 24.7 13.9 13.5 33.9 33.7 22.3 27.0 28.2 19.3 38.5 47.5 25.0 27.7 25.2 23.5 15.1 28.4 24.2 43.3 18.2 36.4 19.0 26.8 37.3 25.4 19.0 49.4 22.3 29.6 17.0 28.8 34.6 12.9 39.3 41.3 10.2 4.9 8.6 5.5 7.6 5.5 3.7 7.2 7.1 7.1 2.7 4.6 5.4 4.7 9.2 10.4 4.3 16.6 2.8 19.0 22.6 19.5 28.2 19.1 17.0 17.8 23.5 19.4 12.6 CCZ1B "C7orf28B, DKFZP586I1023, H_NH0577018.2, MGC19819" ENSG00000146574 "CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated" P86790 7 6794134-6826770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA045114, HPA050006" Uncertain Enhanced Vesicles Vesicles "HPA045114: , HPA050006: " "unprognostic (8.06e-3)" "unprognostic (1.53e-1)" "unprognostic (2.94e-2)" "unprognostic (1.00e-1)" "unprognostic (4.94e-2)" "unprognostic (1.45e-2)" "unprognostic (1.88e-3)" "unprognostic (2.74e-1)" "unprognostic (9.14e-2)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (2.86e-1)" "unprognostic (2.96e-3)" "unprognostic (9.61e-2)" "unprognostic (1.27e-1)" "unprognostic (2.73e-2)" "unprognostic (1.24e-1)" 2.5 4.5 3.6 2.1 4.4 3.2 4.2 3.8 8.4 2.7 3.5 10.7 2.1 2.6 3.5 7.0 5.7 5.3 3.5 2.6 4.0 3.6 3.0 2.4 3.4 3.7 2.9 2.1 3.0 3.3 11.8 2.6 2.7 9.1 3.0 2.5 5.2 6.6 7.0 10.6 3.4 2.7 2.1 2.7 3.0 3.2 5.4 2.1 3.0 2.5 2.1 3.5 4.3 2.6 4.3 5.6 10.5 9.5 6.1 6.6 1.8 12.8 4.7 9.3 23.1 8.3 8.2 10.3 8.0 12.1 9.8 10.8 5.3 8.5 5.4 9.6 11.5 8.8 17.5 10.1 11.1 3.2 6.2 3.8 5.7 13.2 8.6 27.2 19.3 5.4 5.4 9.3 4.9 8.4 7.2 6.3 9.7 22.1 13.0 12.2 25.9 8.7 8.1 20.0 6.7 7.2 9.6 14.5 23.2 9.0 17.6 12.0 14.4 31.2 9.2 2.7 8.7 11.3 17.2 6.4 13.1 3.9 9.0 28.5 16.6 10.5 3.8 6.5 3.8 4.6 4.5 4.3 4.5 5.6 4.8 3.9 3.2 4.2 4.8 6.1 9.5 5.6 6.6 1.8 3.6 4.4 3.8 8.4 4.0 3.6 2.9 2.1 9.1 2.1 CD14 ENSG00000170458 "CD14 molecule" P08571 5 140631728-140633701 "Cancer-related genes, CD markers, Plasma proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 189.4;liver: 165.8" "Cell line enhanced" "Detected in many" "A549: 8.9;CACO-2: 13.6;SiHa: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 189.4" "Group enriched" "Detected in many" 5 "granulocytes: 52.3;monocytes: 189.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001887, HPA002127, CAB033631, CAB072865, CAB072866" Enhanced Supported Vesicles "Secreted to blood" 2752500000 15000000000 Vesicles "CAB033631: AB_781932, CAB072865: , CAB072866: , HPA001887: AB_1078442, HPA002127: AB_1078440" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.42e-3)" "unprognostic (3.89e-2)" "unprognostic (3.29e-2)" "unprognostic (1.54e-1)" "unprognostic (4.71e-3)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (2.43e-1)" "prognostic unfavourable (6.80e-5)" "unprognostic (1.20e-2)" "unprognostic (6.87e-3)" "unprognostic (8.12e-2)" "unprognostic (6.92e-2)" 27.9 44.1 9.0 42.7 25.2 9.8 11.7 3.5 8.9 5.6 10.0 6.0 1.8 5.4 5.6 24.0 4.5 12.0 14.6 18.9 11.7 7.4 12.7 165.8 23.8 34.7 21.6 2.9 14.2 5.3 4.3 10.1 37.3 18.9 8.5 9.2 14.6 28.5 5.8 10.2 3.5 12.1 21.4 18.2 35.5 6.6 6.5 17.3 2.2 7.9 5.8 6.6 15.9 3.8 0.5 23.6 52.3 189.4 0.2 0.4 124.2 0.1 8.9 0.1 0.5 1.2 0.3 0.4 0.8 4.1 1.3 1.6 13.6 2.1 0.4 0.6 4.9 3.8 0.0 1.6 0.2 0.1 0.9 0.3 0.5 1.8 4.8 1.0 0.4 3.9 0.2 0.2 1.3 0.0 0.2 0.2 1.2 0.3 0.0 0.5 0.2 0.3 0.3 0.4 1.1 0.2 0.0 2.4 1.0 16.3 0.4 0.5 0.3 1.7 0.6 0.2 0.3 1.5 1.2 0.7 0.9 0.5 0.4 0.4 0.1 0.4 189.4 1.0 0.3 36.6 0.4 0.5 0.2 0.2 23.6 0.1 0.3 0.2 52.3 0.2 4.8 1.3 0.1 124.2 9.0 25.2 3.5 8.9 11.7 7.4 21.6 2.9 18.9 17.3 CD24 CD24A ENSG00000272398 "CD24 molecule" 6 106969831-106975627 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "kidney: 383.7" "Cell line enhanced" "Detected in many" "NTERA-2: 65.1;RPTEC TERT1: 307.7;SK-BR-3: 89.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 26 "eosinophil: 30.4;memory B-cell: 23.4;naive B-cell: 15.0" "Group enriched" "Detected in many" 202 "B-cells: 23.4;granulocytes: 30.4" "HPA045879, CAB078471" Enhanced Vesicles "Intracellular and membrane" Vesicles "CAB078471: AB_10983158, HPA045879: " "prognostic unfavourable (2.44e-5)" "unprognostic (6.64e-2)" "prognostic favourable (3.29e-4)" "unprognostic (1.87e-1)" "unprognostic (1.41e-2)" "unprognostic (9.98e-2)" "prognostic unfavourable (7.58e-4)" "unprognostic (2.32e-1)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (2.28e-2)" "unprognostic (1.51e-1)" "unprognostic (5.10e-2)" "unprognostic (2.92e-1)" "unprognostic (1.16e-1)" "unprognostic (2.01e-1)" "unprognostic (3.13e-1)" 0.5 0.5 12.8 2.4 9.9 17.9 25.5 0.5 2.9 69.5 30.6 0.7 1.6 1.2 34.5 5.9 38.1 6.0 25.1 4.2 22.7 383.7 0.8 0.7 0.9 4.8 7.2 15.6 40.0 0.0 5.7 48.2 13.0 3.2 21.2 0.7 15.9 16.6 0.4 0.5 0.8 2.2 4.9 0.7 16.4 0.5 6.5 0.4 48.8 1.2 11.3 4.0 8.1 23.4 0.0 30.4 0.1 0.0 0.0 0.6 22.9 14.2 0.2 1.8 0.0 0.0 27.0 0.0 0.1 0.1 0.0 0.2 0.1 2.2 7.1 0.0 47.5 8.1 17.9 0.1 0.0 0.1 0.0 17.6 1.0 0.0 0.3 0.1 0.1 20.7 0.2 1.2 0.1 0.5 0.0 0.4 28.8 0.1 0.1 65.1 5.5 53.8 0.0 0.2 307.7 59.3 40.3 29.7 16.3 89.5 0.0 41.3 0.1 0.0 0.0 0.2 0.2 0.7 0.0 0.1 30.4 0.3 0.1 0.1 0.1 0.0 30.4 0.0 0.0 0.0 23.4 0.0 0.0 0.0 15.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.6 CD276 "B7-H3, B7H3, B7RP-2" ENSG00000103855 "CD276 molecule" Q5ZPR3 15 73683966-73714518 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 4.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009285, HPA017139, CAB017826" Enhanced Approved Vesicles 8900000 Vesicles "CAB017826: , HPA009285: AB_1078258, HPA017139: AB_1845246" "unprognostic (1.05e-1)" "unprognostic (4.74e-3)" "unprognostic (4.57e-3)" "unprognostic (9.62e-2)" "unprognostic (1.26e-2)" "unprognostic (5.50e-3)" "prognostic unfavourable (9.81e-4)" "unprognostic (2.57e-3)" "unprognostic (1.89e-1)" "unprognostic (3.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.29e-2)" "prognostic unfavourable (6.31e-5)" "unprognostic (1.17e-1)" "unprognostic (9.22e-2)" "unprognostic (1.21e-1)" "unprognostic (1.34e-3)" 32.3 16.6 5.8 9.2 3.9 0.6 17.1 3.6 5.3 19.4 8.3 5.1 4.2 8.8 17.2 17.9 6.3 8.1 14.3 12.3 5.6 3.6 7.2 22.9 9.3 6.7 4.6 3.8 16.8 14.3 3.5 5.3 27.7 7.9 16.5 4.2 20.5 12.8 7.8 7.1 12.6 7.0 13.8 4.4 7.4 8.4 9.9 3.9 1.2 7.8 8.3 4.7 12.4 13.6 0.4 0.5 4.0 0.6 0.8 0.2 0.0 9.7 12.1 8.3 18.1 15.2 9.2 25.3 11.4 9.4 7.5 6.8 21.2 20.4 0.1 18.6 10.8 41.6 8.8 10.1 1.2 7.4 20.1 0.7 12.6 10.2 4.6 0.1 12.1 7.3 4.9 6.8 4.4 9.8 3.1 0.2 1.7 15.0 0.1 0.5 20.1 8.8 0.1 12.2 1.6 6.5 13.5 5.7 13.8 10.5 5.2 20.5 8.7 5.3 11.4 16.6 14.9 54.4 11.5 0.2 0.2 0.2 27.5 0.8 11.4 0.9 0.3 0.5 0.1 0.6 0.2 0.2 0.1 0.2 0.2 0.4 0.2 0.1 4.0 0.8 0.3 0.5 0.1 0.0 5.8 3.9 3.6 5.2 5.6 3.6 4.6 3.8 7.9 3.9 CD300C "CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR" ENSG00000167850 "CD300c molecule" Q08708 17 74541108-74546143 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 46.8" "Cell line enhanced" "Detected in some" "HEL: 5.2;HMC-1: 25.6;THP-1: 4.8;U-937: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 28.6;intermediate monocyte: 46.8;myeloid DC: 32.5;non-classical monocyte: 46.4" "Group enriched" "Detected in many" 5 "dendritic cells: 32.5;monocytes: 46.8" "HPA014523, HPA060349" Approved Uncertain "Golgi apparatus,Vesicles,Mitochondria" "Golgi apparatus" "Vesicles, Mitochondria" "HPA014523: AB_1846293, HPA060349: " "unprognostic (1.55e-2)" "unprognostic (2.60e-1)" "unprognostic (9.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.21e-1)" "unprognostic (3.47e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.68e-2)" "unprognostic (7.51e-2)" "unprognostic (6.51e-2)" "unprognostic (1.50e-2)" "unprognostic (1.37e-3)" "unprognostic (6.27e-2)" "prognostic unfavourable (8.53e-5)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" 9.8 2.8 3.6 9.0 4.6 10.9 1.8 0.4 2.9 1.2 1.7 2.9 0.0 1.5 1.4 1.9 1.0 1.9 2.8 3.4 2.0 1.7 1.9 2.1 11.2 12.3 5.3 1.3 1.1 1.3 0.5 1.2 3.8 3.9 1.9 1.8 1.8 1.8 0.7 1.1 0.9 2.3 4.1 7.1 14.2 1.6 0.9 2.7 0.1 1.6 0.1 1.4 3.5 1.1 0.4 32.5 8.4 46.8 8.6 0.1 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 2.4 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 12.1 0.0 8.4 28.6 1.4 0.1 46.8 0.1 0.4 0.0 0.0 32.5 0.3 0.0 0.0 1.0 8.6 46.4 2.1 0.0 10.7 3.6 4.6 0.4 2.9 2.0 1.7 5.3 1.3 3.9 2.7 CD47 "IAP, MER6, OA3" ENSG00000196776 "CD47 molecule" Q08722 3 108043094-108091862 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016055, HPA044659" Approved Supported "Vesicles,Plasma membrane" 2000000 "Plasma membrane" Vesicles "CAB016055: AB_627086, HPA044659: AB_2679040" "unprognostic (3.54e-2)" "unprognostic (4.74e-2)" "unprognostic (3.19e-2)" "prognostic unfavourable (2.44e-4)" "unprognostic (4.49e-2)" "unprognostic (2.14e-1)" "unprognostic (2.05e-3)" "unprognostic (8.77e-3)" "unprognostic (7.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.69e-2)" "unprognostic (2.87e-1)" "prognostic unfavourable (1.69e-4)" "unprognostic (7.37e-2)" "unprognostic (3.78e-1)" "prognostic favourable (7.29e-5)" "unprognostic (1.83e-1)" 16.2 24.3 23.0 28.8 46.5 58.0 29.0 44.0 55.5 20.5 25.7 42.5 13.4 19.8 16.2 30.4 46.7 31.7 26.0 26.7 24.1 24.4 19.1 22.1 49.6 35.1 27.4 28.8 16.2 25.7 11.5 34.8 23.3 43.6 40.2 29.0 15.7 43.8 18.9 18.1 19.3 21.2 21.0 37.7 29.0 33.4 20.6 25.0 34.4 30.1 22.0 42.5 25.1 29.1 40.1 35.6 44.1 64.4 45.1 65.3 51.7 45.4 8.2 16.4 9.3 23.6 25.4 21.7 17.2 26.9 13.4 22.9 0.4 25.7 20.9 27.9 16.5 31.2 9.1 17.3 17.5 12.3 6.3 53.1 7.6 0.7 13.7 37.8 71.8 16.3 10.6 12.8 10.3 13.2 12.5 49.6 19.9 23.3 45.9 14.2 6.8 20.9 24.5 12.1 29.5 34.0 18.1 12.5 7.8 10.2 20.4 17.4 36.9 12.4 12.7 34.7 6.4 19.4 11.6 19.2 13.0 29.3 25.3 19.0 9.5 31.7 24.7 44.1 40.2 48.1 35.0 40.1 47.0 42.0 35.6 39.2 35.4 38.3 30.1 45.1 64.4 27.7 65.3 51.7 23.0 46.5 44.0 55.5 24.1 24.4 27.4 28.8 43.6 25.0 CD59 "16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20" ENSG00000085063 "CD59 molecule (CD59 blood group)" P13987 11 33703010-33736491 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 285.5" "Cell line enhanced" "Detected in many" "TIME: 213.3;U-2197: 176.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB001448, HPA026494" Supported Uncertain "Golgi apparatus,Vesicles" "Intracellular and membrane" 98000000 "Golgi apparatus, Vesicles" "CAB001448: AB_563604, HPA026494: AB_1846321" "unprognostic (2.07e-2)" "prognostic unfavourable (3.81e-5)" "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (2.11e-2)" "prognostic unfavourable (3.10e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (4.47e-2)" "unprognostic (2.98e-1)" "prognostic unfavourable (2.92e-5)" "unprognostic (1.66e-2)" "prognostic favourable (1.39e-10)" "prognostic unfavourable (9.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (3.09e-1)" 96.7 41.0 36.7 26.3 44.3 23.8 76.0 25.9 32.7 44.8 36.9 24.0 57.9 16.5 45.4 132.8 68.4 53.2 67.6 90.5 35.6 38.4 100.0 61.0 86.4 39.8 39.7 25.8 39.3 52.3 60.6 48.0 285.5 68.7 47.4 37.7 51.4 114.8 62.6 70.6 43.4 25.0 52.4 32.9 26.2 54.7 28.1 23.1 16.1 85.9 57.7 40.0 51.2 63.4 13.5 20.5 42.8 4.8 17.7 60.4 11.1 16.5 15.5 4.6 13.5 107.8 84.5 2.7 94.2 105.1 23.6 27.7 7.2 49.8 1.2 16.8 101.4 18.7 8.5 93.9 33.2 26.3 12.9 1.7 54.9 10.8 29.4 9.9 5.7 39.2 23.8 20.0 96.4 144.0 11.6 38.3 148.6 15.1 4.6 4.1 2.5 80.9 1.7 14.4 13.3 71.3 28.3 3.2 4.3 32.8 15.2 17.3 11.6 1.0 213.3 54.3 13.0 176.7 32.6 17.0 33.2 1.6 46.7 0.0 94.3 30.5 4.8 42.8 11.3 1.6 14.4 13.5 24.0 12.7 20.5 10.6 15.7 9.3 28.4 17.7 0.9 10.5 60.4 11.1 36.7 44.3 25.9 32.7 35.6 38.4 39.7 25.8 68.7 23.1 CD63 "ME491, MLA1, TSPAN30" ENSG00000135404 "CD63 molecule" P08962 12 55725323-55729707 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 272.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010088, CAB026356" Supported Supported Vesicles "Intracellular and membrane" Vesicles "CAB026356: AB_629864, HPA010088: AB_1846323" "unprognostic (8.76e-3)" "unprognostic (8.81e-2)" "unprognostic (1.27e-1)" "unprognostic (1.28e-3)" "unprognostic (9.48e-2)" "unprognostic (3.66e-3)" "prognostic unfavourable (1.37e-4)" "unprognostic (1.11e-1)" "unprognostic (6.50e-2)" "unprognostic (1.08e-1)" "unprognostic (1.66e-2)" "unprognostic (3.10e-1)" "unprognostic (2.70e-2)" "unprognostic (4.82e-2)" "unprognostic (5.21e-2)" "unprognostic (1.85e-3)" "unprognostic (9.02e-2)" 115.3 88.2 42.5 44.9 37.2 67.4 106.3 13.7 33.1 80.6 84.7 34.4 71.5 39.9 99.7 177.9 70.9 60.4 102.7 154.4 36.9 39.0 106.6 92.5 109.6 113.8 49.8 27.2 93.8 187.1 33.3 49.3 176.9 50.8 82.9 81.8 102.1 105.0 83.7 92.7 38.5 72.4 88.2 43.6 107.7 74.8 52.1 30.5 17.6 108.1 50.7 47.4 96.3 82.2 9.6 40.3 147.4 50.8 58.4 29.8 56.6 21.9 38.3 21.0 20.4 272.1 170.6 27.7 89.3 163.9 52.9 57.7 42.7 44.3 6.3 28.5 133.0 20.4 15.2 37.0 68.1 17.8 14.3 34.5 29.9 23.5 108.3 15.3 82.2 125.6 36.8 58.8 53.9 58.3 19.4 44.2 168.3 35.1 3.1 20.8 19.1 44.5 6.9 46.1 15.8 89.5 74.8 8.2 21.0 24.5 18.5 160.6 26.1 51.2 43.3 34.2 25.0 47.2 29.9 18.1 11.2 4.4 98.1 9.9 62.5 89.6 50.8 147.4 29.8 38.5 21.8 9.6 11.9 23.7 40.3 6.5 5.3 18.1 55.7 58.4 26.1 27.0 10.0 56.6 42.5 37.2 13.7 33.1 36.9 39.0 49.8 27.2 50.8 30.5 CD68 "DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1" ENSG00000129226 "CD68 molecule" P34810 17 7579467-7582113 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 179.1;lymphoid tissue: 139.1" "Cell line enhanced" "Detected in many" "ASC diff: 73.3;U-87 MG: 115.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 155.1;intermediate monocyte: 179.1;non-classical monocyte: 170.1" "Group enriched" "Detected in many" 11 "dendritic cells: 68.4;monocytes: 179.1" "Low region specificity" "Detected in all" "CAB000051, CAB000066, HPA048982, CAB072861, CAB072862" Enhanced Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: , CAB072862: , HPA048982: " "unprognostic (2.16e-2)" "unprognostic (1.47e-2)" "unprognostic (6.46e-2)" "unprognostic (1.49e-3)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (4.75e-4)" "unprognostic (2.83e-2)" "unprognostic (1.31e-1)" "unprognostic (6.85e-2)" "unprognostic (1.04e-1)" "unprognostic (2.59e-1)" "prognostic unfavourable (1.14e-5)" "unprognostic (1.58e-1)" "unprognostic (8.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.65e-2)" 118.4 28.5 12.5 46.8 21.6 46.8 40.9 2.9 11.2 27.1 38.1 15.5 2.1 57.0 9.6 24.1 26.9 17.3 33.7 39.0 10.1 6.9 20.9 43.1 84.4 102.5 21.1 4.4 15.8 7.5 2.1 8.5 34.7 15.7 12.1 18.5 12.8 22.2 4.4 16.1 9.4 58.3 15.6 26.0 139.1 17.6 9.4 16.3 13.3 8.8 12.3 21.1 31.4 19.1 3.7 68.4 11.0 179.1 0.9 0.5 125.6 35.1 7.1 0.4 0.5 73.3 28.0 0.3 11.2 30.7 14.9 17.4 1.5 10.6 0.4 12.8 32.6 1.5 0.1 7.1 10.1 0.3 1.3 5.6 1.7 8.5 6.2 2.7 31.7 8.8 1.4 31.2 23.0 3.9 2.2 3.6 14.4 0.2 0.2 2.4 0.4 5.2 0.4 0.6 20.7 3.0 1.5 0.2 0.4 9.3 4.7 10.9 0.2 21.6 12.2 19.0 1.1 19.0 14.6 0.2 0.2 0.2 115.5 6.9 9.6 10.1 155.1 0.9 0.4 179.1 0.5 3.7 0.2 0.3 40.9 2.0 0.3 0.2 11.0 0.9 170.1 68.4 0.3 125.6 12.5 21.6 2.9 11.2 10.1 6.9 21.1 4.4 15.7 16.3 CD82 "IA4, KAI1, R2, ST6, TSPAN27" ENSG00000085117 "CD82 molecule" P27701 11 44564427-44620363 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 77.3;LHCN-M2: 45.7;U-87 MG: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 80.5" "Group enriched" "Detected in all" 6 "B-cells: 51.1;granulocytes: 80.5;T-cells: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002508, HPA028900, HPA061418" Supported Approved Vesicles Vesicles "CAB002508: AB_563640, HPA028900: AB_10603558, HPA061418: " "unprognostic (5.31e-2)" "unprognostic (4.62e-1)" "unprognostic (2.38e-2)" "unprognostic (1.33e-1)" "unprognostic (2.79e-1)" "unprognostic (1.37e-2)" "unprognostic (1.78e-1)" "unprognostic (7.29e-2)" "unprognostic (3.48e-1)" "unprognostic (2.97e-1)" "unprognostic (2.58e-2)" "unprognostic (1.58e-1)" "unprognostic (3.48e-3)" "unprognostic (1.86e-3)" "unprognostic (2.33e-2)" "unprognostic (2.88e-2)" "unprognostic (6.30e-2)" 14.7 4.9 16.3 21.6 23.1 43.6 13.8 6.3 13.6 17.5 20.7 23.0 53.0 25.9 4.8 13.5 58.3 19.8 21.7 12.7 16.9 13.3 10.2 18.8 38.8 22.8 17.9 9.2 9.0 11.6 2.8 3.9 20.7 14.0 14.3 6.8 18.6 29.8 55.2 10.5 34.6 36.0 8.9 10.2 21.9 22.5 4.5 12.6 23.9 8.3 23.5 33.5 16.3 28.1 51.1 6.7 80.5 9.1 7.2 25.6 9.5 5.0 0.7 6.6 1.3 4.5 17.2 0.2 2.9 23.6 5.1 13.0 0.3 3.4 5.2 3.5 1.4 19.2 0.9 15.0 11.8 23.2 0.4 32.5 1.5 0.1 3.3 8.9 77.3 23.7 17.6 21.4 11.4 9.0 0.2 1.6 45.7 3.6 8.6 16.7 0.2 0.3 0.2 27.6 7.3 3.0 4.9 0.2 0.3 1.8 27.6 3.8 26.3 8.8 5.0 16.2 2.1 0.3 27.5 0.6 0.0 0.1 54.7 4.9 8.6 48.4 9.1 16.0 4.9 4.8 8.5 51.1 24.9 11.6 2.2 30.9 8.6 3.8 80.5 7.2 3.4 6.7 25.6 9.5 16.3 23.1 6.3 13.6 16.9 13.3 17.9 9.2 14.0 12.6 CD84 "hCD84, mCD84, SLAMF5" ENSG00000066294 "CD84 molecule" Q9UIB8 1 160541095-160579516 "CD markers, Predicted membrane proteins" "Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.0" "Cell line enhanced" "Detected in some" "Daudi: 12.4;HEL: 23.7;HL-60: 6.7;HMC-1: 27.1;MOLT-4: 6.6;U-698: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063316, HPA068020, HPA070502" Enhanced Enhanced "Vesicles,Plasma membrane" 36000000 "Plasma membrane" Vesicles "HPA063316: , HPA068020: , HPA070502: " "unprognostic (4.38e-2)" "unprognostic (6.16e-3)" "unprognostic (1.00e-2)" "unprognostic (8.16e-2)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (3.84e-1)" "unprognostic (2.54e-2)" "unprognostic (8.60e-2)" "unprognostic (1.80e-1)" "unprognostic (8.26e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" 15.9 4.8 3.8 18.5 4.5 6.7 3.7 1.3 3.4 3.3 3.2 7.9 7.7 2.5 2.5 4.3 2.7 3.1 6.4 5.0 3.8 3.0 3.1 5.1 9.2 26.0 6.0 2.2 1.8 4.3 0.9 1.9 7.1 5.3 3.7 4.7 2.4 4.3 9.8 1.6 2.7 9.6 4.1 11.1 25.6 3.5 2.8 5.9 13.8 2.9 2.3 16.3 5.8 2.7 5.1 5.4 21.0 7.3 1.0 8.2 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 6.7 27.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 6.6 5.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 1.5 0.0 21.0 7.3 11.0 6.9 6.3 5.2 5.1 5.9 8.2 5.4 4.7 3.5 6.3 1.0 1.0 2.4 3.2 7.9 6.1 3.8 4.5 1.3 3.4 3.8 3.0 6.0 2.2 5.3 5.9 CD93 "C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4" ENSG00000125810 "CD93 molecule" Q9NPY3 20 23079349-23086340 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 57.0;TIME: 72.2;U-937: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 14.4;neutrophil: 17.4" "Group enriched" "Detected in many" 40 "dendritic cells: 5.5;granulocytes: 17.4;monocytes: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009300, HPA012368" Enhanced Approved "Vesicles,Plasma membrane" 440000000 "Vesicles, Plasma membrane" "HPA009300: AB_1846342, HPA012368: AB_1846341" "unprognostic (2.05e-1)" "unprognostic (2.85e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (2.31e-1)" "unprognostic (2.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.77e-1)" "unprognostic (4.51e-1)" "unprognostic (3.74e-2)" "unprognostic (2.61e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (2.74e-4)" "unprognostic (8.81e-3)" "unprognostic (6.13e-2)" "unprognostic (4.49e-2)" "unprognostic (3.11e-2)" 50.5 6.1 2.4 15.0 3.4 4.7 31.4 1.0 3.0 13.6 8.1 1.7 3.9 3.2 14.3 12.5 10.0 13.6 14.2 33.3 2.4 2.2 10.8 10.9 34.8 25.3 4.1 1.2 11.6 5.9 5.1 4.3 48.9 5.3 9.7 4.3 4.9 5.9 3.9 16.2 6.8 7.7 15.4 4.3 17.5 7.5 6.9 3.3 6.9 12.3 9.3 4.5 15.6 12.2 0.0 5.5 17.4 14.4 0.0 0.3 4.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 72.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.6 0.0 0.0 14.4 0.2 0.2 10.3 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 17.4 0.0 4.2 0.7 0.3 4.7 2.4 3.4 1.0 3.0 2.4 2.2 4.1 1.2 5.3 3.3 CDC25A ENSG00000164045 "Cell division cycle 25A" P30304 3 48157146-48188402 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in many" "testis cancer: 19.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005855 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA005855: AB_1846364" "unprognostic (1.49e-1)" "unprognostic (8.13e-2)" "unprognostic (1.20e-2)" "unprognostic (1.43e-3)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (7.05e-7)" "unprognostic (1.35e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-3)" "unprognostic (4.41e-2)" "unprognostic (9.09e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-3)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" 0.8 1.2 1.1 5.5 1.1 13.0 0.8 0.7 1.2 1.1 3.3 0.6 1.0 1.8 0.6 0.9 3.9 0.4 2.2 0.7 1.3 2.4 1.2 0.9 0.7 4.1 1.4 0.2 2.1 3.6 0.4 2.3 4.2 1.2 1.0 4.0 1.5 1.8 0.5 0.7 0.8 2.1 0.8 0.7 3.6 1.3 19.4 0.2 23.0 1.6 8.8 7.4 0.8 1.3 1.7 0.9 0.5 0.1 0.0 1.0 0.1 7.5 3.7 17.8 9.6 0.6 1.2 12.3 10.5 4.0 13.2 10.7 16.1 3.9 22.4 4.1 2.7 5.7 30.5 7.2 13.9 7.3 16.0 28.7 6.8 7.9 0.6 20.2 8.3 0.6 1.1 16.4 7.1 5.0 22.8 11.9 7.1 4.0 25.2 15.7 26.0 8.5 11.3 11.7 12.2 3.3 7.1 8.4 10.4 6.5 7.6 3.3 4.0 14.3 2.5 6.5 10.0 7.2 14.2 6.0 17.9 35.2 4.8 22.5 5.4 0.0 0.0 0.5 0.4 0.0 0.0 1.7 0.6 0.2 0.9 0.0 0.0 1.0 0.0 0.0 0.1 0.5 0.0 0.1 1.1 1.1 0.7 1.2 1.3 2.4 1.4 0.2 1.2 0.2 CDC25B ENSG00000101224 "Cell division cycle 25B" P30305 20 3786772-3806121 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 4.5;NK-cells: 9.3;T-cells: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038892, HPA038893, HPA075215" Enhanced Supported "Vesicles,Mitotic spindle" Vesicles "Mitotic spindle" "HPA038892: , HPA038893: , HPA075215: " "unprognostic (4.69e-2)" "unprognostic (5.74e-2)" "unprognostic (2.93e-2)" "prognostic unfavourable (4.76e-4)" "unprognostic (1.13e-1)" "unprognostic (4.23e-1)" "prognostic unfavourable (1.19e-4)" "unprognostic (1.31e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-1)" "unprognostic (6.03e-2)" "prognostic unfavourable (2.94e-13)" "unprognostic (1.15e-1)" "unprognostic (2.38e-1)" "unprognostic (3.94e-1)" "unprognostic (9.46e-2)" 12.1 8.7 15.1 27.7 23.3 26.0 28.8 49.6 21.1 13.0 14.7 12.8 4.6 14.9 17.0 10.3 11.7 13.0 18.6 7.5 15.7 12.5 13.3 11.0 33.0 42.8 21.9 12.5 17.3 5.7 7.5 21.0 30.3 13.8 11.0 12.0 7.7 7.4 10.2 6.2 19.8 16.8 14.8 14.7 24.5 14.1 6.3 22.3 33.3 18.7 20.8 31.6 15.3 16.3 4.5 1.3 1.5 1.8 9.3 15.5 5.9 29.8 64.5 8.6 14.3 10.6 10.4 4.3 14.8 22.2 24.8 18.5 11.2 43.3 20.8 6.4 15.1 43.7 11.7 24.6 11.7 8.0 12.6 11.2 20.7 13.5 42.3 8.7 5.8 10.2 19.8 23.0 27.2 13.7 7.2 55.1 14.6 24.0 27.1 12.7 6.4 27.6 14.2 24.4 14.9 16.9 2.8 6.2 13.5 35.1 33.5 17.2 11.3 4.5 11.3 13.3 16.1 24.1 19.6 13.4 21.2 8.4 6.8 8.6 12.8 1.5 1.4 0.0 13.6 1.8 12.7 3.5 13.6 13.7 1.3 4.5 11.4 13.2 0.1 9.3 0.9 0.7 15.5 5.9 15.1 23.3 49.6 21.1 15.7 12.5 21.9 12.5 13.8 22.3 CDH12 "Br-cadherin, CDHB" ENSG00000154162 "Cadherin 12" P55289 5 21750673-22853622 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;cervix, uterine: 9.3;pituitary gland: 8.6" "Cell line enhanced" "Detected in some" "HeLa: 1.5;PC-3: 5.1;SCLC-21H: 7.4;U-2 OS: 3.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029325 Uncertain Uncertain Vesicles Vesicles "HPA029325: " "unprognostic (2.38e-1)" "unprognostic (3.21e-1)" "unprognostic (4.95e-2)" "unprognostic (8.61e-2)" "unprognostic (3.31e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (3.26e-2)" "unprognostic (1.34e-1)" "unprognostic (3.51e-2)" "unprognostic (3.25e-4)" "unprognostic (7.35e-2)" "unprognostic (3.48e-2)" "unprognostic (5.19e-2)" 0.5 5.2 5.8 0.3 17.7 0.4 1.7 2.0 13.8 9.3 0.5 0.0 0.0 0.5 1.3 1.0 0.4 6.7 0.3 0.5 6.3 3.4 0.7 0.5 0.8 0.3 1.4 4.8 0.5 0.5 0.6 8.6 0.7 4.2 0.5 0.6 1.4 3.1 0.9 0.5 2.5 0.4 0.9 2.5 0.3 0.4 2.9 0.5 0.0 0.4 0.0 0.5 1.5 0.2 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.0 1.0 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.7 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.1 0.2 0.0 0.1 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.0 5.8 17.7 2.0 13.8 6.3 3.4 1.4 4.8 4.2 0.5 CDK19 "bA346C16.3, CDC2L6, CDK11, KIAA1028" ENSG00000155111 "Cyclin dependent kinase 19" Q9BWU1 6 110609978-110815958 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007053 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA007053: AB_1846369" "unprognostic (1.66e-2)" "unprognostic (1.84e-1)" "unprognostic (3.63e-1)" "unprognostic (3.00e-3)" "unprognostic (1.62e-1)" "unprognostic (2.66e-3)" "prognostic unfavourable (3.56e-4)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" "unprognostic (2.00e-3)" "unprognostic (3.94e-1)" "unprognostic (4.04e-1)" "prognostic unfavourable (4.72e-5)" "unprognostic (1.75e-1)" "unprognostic (9.78e-2)" "unprognostic (6.51e-2)" "unprognostic (9.50e-3)" 5.3 3.3 18.1 6.1 29.4 9.7 6.0 13.8 21.3 6.6 6.3 31.1 2.4 4.8 9.6 3.7 7.8 5.3 7.8 4.1 20.8 10.1 6.3 4.6 6.2 8.0 22.1 12.9 9.7 3.1 8.0 4.1 10.5 14.4 25.8 6.1 3.4 4.5 5.9 3.2 7.9 5.9 7.1 20.8 7.0 6.5 16.4 26.3 6.1 5.8 1.3 8.4 5.9 6.4 1.3 1.8 8.5 2.2 1.3 0.8 0.6 3.6 3.8 13.4 16.2 7.3 10.5 7.0 11.6 12.4 4.4 5.8 4.8 4.0 9.1 4.2 8.2 2.1 5.1 2.5 10.1 11.3 3.0 15.6 5.7 5.6 4.4 6.3 11.7 7.2 5.5 6.0 9.3 4.3 4.7 12.8 9.4 5.8 8.4 9.4 1.3 2.6 9.1 6.9 3.5 5.1 6.6 6.9 12.8 8.9 7.2 10.4 2.4 23.2 4.8 9.2 4.9 18.6 7.1 1.4 1.8 7.9 9.7 8.5 9.5 3.3 2.2 1.5 0.8 1.2 0.8 1.1 0.7 0.7 1.8 1.3 0.5 0.7 8.5 1.3 0.7 0.9 0.8 0.6 18.1 29.4 13.8 21.3 20.8 10.1 22.1 12.9 14.4 26.3 CDK5R1 "Nck5a, p35, p35nck5a" ENSG00000176749 "Cyclin dependent kinase 5 regulatory subunit 1" Q15078 17 32486619-32491256 "Predicted intracellular proteins" "Biological rhythms" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 58.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 31.5;SK-MEL-30: 22.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000252 Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000252: " "unprognostic (1.08e-1)" "unprognostic (9.13e-2)" "unprognostic (1.79e-2)" "unprognostic (3.65e-1)" "unprognostic (1.97e-1)" "unprognostic (8.09e-2)" "unprognostic (2.74e-5)" "unprognostic (1.81e-2)" "unprognostic (3.32e-1)" "unprognostic (2.18e-1)" "unprognostic (5.90e-2)" "unprognostic (5.60e-1)" "unprognostic (6.98e-2)" "unprognostic (1.60e-1)" "unprognostic (7.92e-2)" "unprognostic (8.81e-2)" "unprognostic (1.03e-1)" 1.6 3.3 21.9 6.4 21.1 4.9 1.8 26.0 58.8 1.2 1.6 3.6 0.0 2.0 1.6 1.0 5.5 1.5 1.6 1.6 21.4 17.3 1.5 1.3 1.4 11.5 7.6 24.5 3.2 2.0 1.3 3.0 1.4 7.8 1.4 1.5 0.9 1.2 1.3 1.8 2.2 2.0 1.3 4.1 7.7 2.2 5.2 3.2 1.2 1.1 0.3 12.3 1.7 1.1 0.6 1.8 2.9 0.9 0.7 4.2 1.5 2.0 1.1 5.2 1.6 0.6 1.0 0.6 1.2 0.7 1.5 2.0 3.0 0.5 1.0 1.2 1.0 0.9 2.0 1.2 2.1 0.3 3.9 0.3 0.5 1.1 0.2 0.6 1.1 0.6 3.1 1.6 1.3 1.1 2.0 1.2 3.2 0.8 1.7 0.8 3.3 1.1 1.5 3.1 3.6 0.7 0.9 31.5 8.5 1.2 0.7 22.6 1.3 2.4 1.1 2.1 3.2 0.8 3.2 0.6 0.8 1.0 1.8 2.9 5.1 0.0 0.9 1.2 2.3 0.8 1.8 0.6 3.1 1.3 0.2 0.5 4.2 2.6 2.9 0.7 0.4 1.8 0.4 1.5 21.9 21.1 26.0 37.3 21.4 17.3 7.6 24.5 7.8 3.2 CDK5RAP3 "C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114" ENSG00000108465 "CDK5 regulatory subunit associated protein 3" Q96JB5 17 47967810-47981774 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022141, HPA022882, HPA027883" Supported Supported Nucleoli,Vesicles,Cytosol Cytosol "Nucleoli, Vesicles" "HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797" "unprognostic (4.27e-2)" "unprognostic (1.01e-3)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "unprognostic (5.98e-2)" "unprognostic (7.19e-3)" "unprognostic (3.84e-1)" "unprognostic (4.44e-2)" "unprognostic (7.55e-2)" "unprognostic (2.06e-1)" "unprognostic (2.59e-3)" "unprognostic (1.92e-2)" "prognostic unfavourable (3.61e-5)" "unprognostic (8.35e-3)" "unprognostic (2.30e-1)" "unprognostic (9.58e-2)" "prognostic favourable (7.31e-5)" 15.5 19.7 20.8 30.0 38.3 21.2 22.5 35.7 31.9 21.1 21.2 27.1 39.4 24.1 26.2 45.4 20.8 26.1 22.0 14.4 23.2 16.7 23.2 31.0 18.8 22.0 31.3 25.8 28.9 51.9 29.4 41.3 15.4 27.3 24.2 25.5 25.1 44.0 26.4 10.7 16.8 25.8 18.4 18.2 32.3 28.6 40.1 29.5 32.3 29.7 16.5 24.6 20.0 18.5 22.8 26.9 27.2 33.5 22.4 22.3 21.0 22.3 36.0 19.9 35.6 16.7 16.8 35.7 16.3 19.8 16.5 15.2 28.2 21.7 26.9 33.8 17.0 21.9 12.9 18.3 18.5 39.7 17.0 12.8 42.9 38.2 18.7 15.1 14.3 19.1 15.5 14.8 29.1 15.9 15.1 25.0 16.7 42.8 41.1 24.5 12.0 15.6 22.0 33.5 30.5 16.4 28.1 13.6 32.6 12.6 11.3 16.4 25.7 19.8 12.7 13.7 12.2 16.5 20.8 32.9 31.0 16.6 17.1 21.0 16.6 9.1 33.5 27.2 20.9 32.7 22.3 22.1 20.0 18.5 26.9 22.8 18.1 19.9 15.7 22.4 32.5 24.4 19.0 21.0 20.8 38.3 35.7 31.9 23.2 16.7 31.3 25.8 27.3 29.5 CDKAL1 FLJ20342 ENSG00000145996 "CDK5 regulatory subunit associated protein 1 like 1" Q5VV42 6 20534457-21232404 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "tRNA processing" Transferase "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "SCLC-21H: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057474 Uncertain Vesicles Vesicles "HPA057474: " "unprognostic (9.64e-2)" "unprognostic (7.23e-3)" "unprognostic (8.40e-2)" "prognostic unfavourable (1.03e-4)" "unprognostic (1.05e-1)" "unprognostic (1.51e-2)" "unprognostic (3.47e-2)" "unprognostic (4.25e-3)" "unprognostic (6.72e-3)" "unprognostic (1.61e-3)" "unprognostic (1.42e-1)" "unprognostic (3.73e-2)" "unprognostic (5.79e-3)" "unprognostic (3.11e-2)" "unprognostic (1.75e-2)" "unprognostic (1.83e-2)" "unprognostic (2.60e-2)" 18.5 9.8 10.9 18.0 12.2 14.7 13.9 24.1 10.6 16.6 11.4 14.6 9.6 8.1 19.4 12.1 12.1 13.5 11.4 10.8 9.0 7.8 10.8 9.7 11.9 13.4 12.4 7.7 16.6 14.1 12.0 29.9 12.6 11.2 10.8 12.0 14.3 15.7 11.0 22.2 15.0 11.4 13.7 13.4 13.9 11.7 11.4 13.8 22.9 17.1 13.6 19.4 13.2 12.6 8.1 5.4 3.3 11.2 12.0 9.7 3.6 2.9 1.8 4.2 5.4 2.4 3.2 4.4 3.0 2.8 4.5 6.0 3.3 2.6 6.9 7.7 2.6 2.9 5.6 3.1 6.1 12.4 3.1 5.9 3.1 4.4 3.1 5.8 4.1 2.9 3.3 4.3 4.0 4.1 7.6 2.8 3.3 2.4 7.3 6.9 2.9 2.0 4.3 5.6 6.5 5.8 3.3 66.0 3.9 3.4 5.5 4.4 4.0 2.9 4.0 5.3 3.7 2.1 5.6 4.5 11.9 6.1 1.9 3.3 8.9 1.5 3.6 3.3 7.8 5.9 6.5 8.1 7.7 7.7 4.9 7.8 9.7 8.6 1.9 12.0 11.2 5.4 8.2 3.6 10.9 12.2 24.1 10.6 9.0 7.8 12.4 7.7 11.2 13.8 CDKL1 KKIALRE ENSG00000100490 "Cyclin dependent kinase like 1" Q00532 14 50329404-50416461 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 16.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059605, HPA065919" Uncertain Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA059605: , HPA065919: " "unprognostic (4.12e-3)" "unprognostic (3.22e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.02e-1)" "unprognostic (3.23e-3)" "unprognostic (9.36e-3)" "unprognostic (2.63e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (9.36e-2)" "unprognostic (5.53e-8)" "unprognostic (1.21e-1)" "unprognostic (7.96e-2)" "unprognostic (9.39e-3)" "unprognostic (3.31e-3)" 7.1 2.1 7.5 1.8 5.1 0.9 3.0 2.7 20.2 14.1 5.9 1.6 2.5 8.4 12.1 2.3 2.6 16.4 2.6 2.9 7.1 2.4 18.8 1.1 4.3 3.0 2.0 12.3 10.5 2.0 1.4 1.4 4.9 2.9 4.0 5.7 1.6 2.5 8.4 1.7 3.0 3.0 7.7 3.1 3.7 2.0 1.9 1.4 1.3 5.0 6.1 2.1 7.0 5.6 5.7 1.3 6.0 2.5 3.8 6.7 2.6 6.0 4.8 0.6 2.4 6.5 7.8 0.3 2.1 3.8 2.2 2.5 1.9 5.7 0.4 2.6 4.6 4.2 0.9 0.6 2.5 6.6 2.3 6.4 2.1 1.7 7.3 5.8 3.5 1.7 3.5 4.5 10.0 8.4 2.6 2.6 1.0 0.3 1.9 3.1 0.7 2.3 0.7 2.8 1.8 6.9 2.3 1.1 1.3 2.4 16.5 0.6 0.2 4.9 2.6 5.7 2.9 5.6 4.7 0.8 0.4 0.4 0.9 6.1 6.9 6.0 2.5 4.4 6.3 2.3 6.2 4.6 4.4 6.7 1.3 5.7 3.4 3.7 1.4 3.8 0.3 1.2 4.1 2.6 7.5 5.1 2.7 20.2 7.1 2.4 2.0 12.3 2.9 1.4 CDKL3 NKIAMRE ENSG00000006837 "Cyclin dependent kinase like 3" Q8IVW4 5 134286350-134371047 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA027751 Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA027751: AB_10601256" "unprognostic (4.70e-2)" "unprognostic (2.15e-2)" "unprognostic (2.35e-1)" "unprognostic (1.48e-1)" "unprognostic (1.43e-1)" "unprognostic (3.98e-2)" "unprognostic (3.43e-3)" "unprognostic (5.93e-2)" "unprognostic (2.12e-3)" "unprognostic (1.49e-1)" "unprognostic (8.47e-4)" "unprognostic (2.82e-1)" "unprognostic (9.85e-4)" "unprognostic (8.33e-2)" "unprognostic (4.88e-2)" "unprognostic (7.10e-3)" "unprognostic (3.43e-3)" 2.5 2.7 7.0 2.2 7.1 1.6 2.5 7.0 8.5 2.6 2.4 5.9 5.5 2.3 3.9 5.3 2.6 3.7 2.6 6.6 6.1 6.5 4.5 2.8 2.2 2.5 8.0 4.3 3.0 2.4 3.2 6.5 2.2 8.6 2.8 2.6 3.9 2.0 3.2 7.5 2.7 2.5 4.6 8.4 2.7 2.2 33.4 9.3 1.3 3.9 2.1 3.0 2.8 2.2 1.5 2.7 1.0 1.1 1.4 4.0 1.3 1.0 2.2 3.3 2.2 5.6 4.8 1.4 3.0 2.7 1.4 3.3 2.0 1.5 2.8 1.9 1.9 0.9 2.7 1.9 2.7 3.0 2.1 1.5 2.4 3.4 3.4 0.6 1.0 2.2 4.9 4.1 1.3 1.3 1.5 1.2 3.6 1.1 2.1 8.3 2.2 1.0 3.6 1.4 0.8 1.8 1.0 5.0 1.5 2.2 0.6 3.6 1.9 1.7 1.0 2.7 0.6 3.6 1.0 3.4 4.5 5.4 4.1 2.2 2.1 0.0 0.9 1.0 0.9 1.1 4.0 1.5 1.4 2.5 2.7 1.0 3.8 3.8 0.2 1.4 0.4 1.6 2.3 1.3 7.0 7.1 7.0 8.5 6.1 6.5 8.0 4.3 8.6 9.3 CDKN1B "KIP1, P27KIP1" ENSG00000111276 "Cyclin dependent kinase inhibitor 1B" P46527 12 12715058-12722371 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003691, CAB021888, HPA059086" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB003691: AB_425362, CAB021888: , HPA059086: " "unprognostic (5.67e-2)" "unprognostic (9.76e-2)" "prognostic favourable (5.15e-4)" "unprognostic (6.90e-3)" "unprognostic (5.84e-3)" "unprognostic (1.03e-2)" "prognostic unfavourable (3.25e-4)" "unprognostic (4.04e-2)" "unprognostic (1.11e-1)" "unprognostic (2.85e-3)" "unprognostic (9.23e-3)" "unprognostic (2.96e-1)" "prognostic unfavourable (8.39e-4)" "unprognostic (1.23e-1)" "unprognostic (8.68e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" 29.8 30.9 30.2 25.0 30.0 40.2 45.3 64.5 50.6 31.6 34.4 35.6 19.9 29.2 33.1 19.8 26.0 24.3 24.3 21.2 33.0 29.5 20.8 23.3 29.2 38.5 42.9 25.1 46.2 15.1 22.2 15.9 26.8 26.3 25.1 22.2 31.4 23.5 24.2 48.8 26.1 26.4 19.4 46.0 34.3 19.4 19.2 39.0 43.0 29.4 21.4 25.5 34.1 29.1 6.2 3.3 19.2 4.5 6.2 10.6 2.9 12.8 6.4 34.3 5.9 11.8 6.7 16.8 12.1 19.2 16.7 20.6 18.3 14.6 0.1 4.6 6.9 12.3 16.0 5.9 15.0 21.8 11.3 10.0 17.6 18.4 15.8 8.5 7.1 7.4 12.8 5.5 16.1 9.9 10.7 36.7 5.9 16.5 11.9 12.2 13.7 6.0 8.8 11.2 21.5 8.0 13.9 13.0 21.4 17.3 12.5 22.6 6.6 19.1 6.7 8.3 13.2 7.5 11.7 31.8 21.0 11.6 10.3 12.8 8.0 4.5 3.1 6.8 5.4 3.1 5.6 6.2 6.9 6.5 3.2 4.8 7.4 5.2 19.2 6.2 4.5 3.3 10.6 2.9 30.2 30.0 64.5 50.6 33.0 29.5 42.9 25.1 26.3 39.0 CEBPA "C/EBP-alpha, CEBP" ENSG00000245848 "CCAAT/enhancer binding protein alpha" P49715 19 33299934-33302564 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 52.3;liver: 44.3" "Cell line enhanced" "Detected in some" "BEWO: 42.6;Hep G2: 22.8;NB-4: 23.5;THP-1: 85.0;U-937: 27.2" "Cancer enhanced" "Detected in all" "liver cancer: 70.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.0;non-classical monocyte: 11.8" "Group enriched" "Detected in many" 13 "dendritic cells: 4.1;granulocytes: 11.0;monocytes: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052734, HPA065037, HPA067937" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA052734: , HPA065037: , HPA067937: " "unprognostic (1.80e-1)" "unprognostic (7.62e-3)" "unprognostic (2.09e-3)" "unprognostic (2.21e-2)" "unprognostic (3.38e-1)" "unprognostic (3.99e-2)" "unprognostic (1.94e-1)" "unprognostic (2.43e-3)" "unprognostic (5.95e-2)" "unprognostic (3.96e-2)" "unprognostic (3.09e-1)" "unprognostic (9.45e-2)" "unprognostic (8.02e-3)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (2.49e-2)" "unprognostic (2.72e-2)" 40.7 1.5 2.3 7.6 4.6 8.4 52.3 2.1 4.0 3.5 9.0 5.2 1.1 9.0 2.2 2.1 6.1 2.4 6.4 6.6 3.9 2.4 2.0 44.3 39.9 10.3 4.1 3.1 1.3 9.0 4.5 1.7 17.4 2.7 3.8 5.1 1.9 5.6 1.6 15.4 23.7 12.7 2.9 6.6 3.0 3.5 1.2 2.6 2.2 2.5 10.7 3.5 5.4 7.9 0.1 4.1 11.0 11.8 0.0 0.6 1.5 0.5 1.0 0.0 1.5 12.3 0.0 42.6 0.0 0.3 0.0 0.0 5.1 0.0 0.0 0.6 0.0 1.9 1.2 0.1 0.0 7.3 1.5 0.0 0.0 22.8 0.2 7.5 9.1 0.4 5.5 0.0 0.0 0.0 0.4 0.0 0.0 2.6 0.0 23.5 1.0 0.5 0.0 0.0 0.2 0.0 3.7 0.0 0.3 0.1 0.1 0.1 2.9 85.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 27.2 0.0 11.0 6.0 0.0 0.6 9.4 0.6 0.0 0.1 0.4 4.1 0.1 0.2 0.4 2.1 0.0 11.8 0.2 0.0 1.5 2.3 4.6 2.1 4.0 3.9 2.4 4.1 3.1 2.7 2.6 CEBPZ "CBF2, CTF2" ENSG00000115816 "CCAAT/enhancer binding protein zeta" Q03701 2 37201612-37231713 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052065 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA052065: " "unprognostic (1.64e-2)" "unprognostic (1.20e-1)" "unprognostic (3.00e-3)" "prognostic unfavourable (5.07e-4)" "unprognostic (2.88e-1)" "unprognostic (1.72e-2)" "prognostic unfavourable (2.94e-5)" "unprognostic (8.84e-2)" "unprognostic (3.85e-3)" "unprognostic (2.66e-1)" "prognostic unfavourable (8.13e-4)" "unprognostic (2.65e-2)" "unprognostic (5.36e-2)" "unprognostic (4.19e-2)" "unprognostic (8.76e-2)" "unprognostic (2.05e-1)" "unprognostic (8.01e-2)" 21.3 23.0 13.1 23.7 14.4 20.0 21.7 17.0 16.4 22.4 17.8 8.4 17.2 12.8 17.2 16.6 18.6 17.4 12.6 19.4 12.0 12.9 30.5 22.6 15.4 16.7 13.2 12.9 24.2 17.2 18.8 27.3 18.2 16.5 20.4 15.5 8.2 15.5 17.9 88.0 14.0 19.1 19.5 15.4 23.1 15.5 27.3 14.1 19.5 22.5 18.7 17.5 30.1 41.0 20.8 17.4 17.2 14.7 17.0 23.1 9.2 19.7 15.3 15.8 8.7 15.7 17.0 13.5 18.9 13.1 16.0 17.3 24.3 15.0 36.3 16.8 11.1 16.9 41.0 19.3 20.7 23.2 18.1 33.8 15.9 19.7 12.4 33.9 15.3 12.9 19.1 21.2 21.7 14.4 36.7 16.8 16.3 10.2 19.6 26.6 51.6 14.5 15.7 25.8 27.4 15.4 18.7 17.0 27.5 15.7 19.3 21.2 14.0 14.9 11.7 15.7 17.9 13.9 25.8 18.8 19.8 29.5 13.9 31.3 17.1 17.2 11.7 10.6 17.2 14.7 21.7 20.3 18.2 16.6 11.8 20.8 23.1 19.1 4.2 17.0 14.3 17.4 14.0 9.2 13.1 14.4 17.0 16.4 12.0 12.9 13.2 12.9 16.5 14.1 CECR2 KIAA1740 ENSG00000099954 "CECR2, histone acetyl-lysine reader" Q9BXF3 22 17359949-17558149 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.1;skeletal muscle: 30.6" "Cell line enhanced" "Detected in some" "AF22: 12.6;HAP1: 11.6;HEK 293: 5.8;K-562: 6.4;NTERA-2: 18.5;SCLC-21H: 8.3" "Cancer enriched" "Detected in many" 6 "testis cancer: 8.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002943 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA002943: AB_1078496" "unprognostic (2.46e-2)" "unprognostic (4.10e-2)" "unprognostic (7.99e-2)" "unprognostic (1.92e-3)" "unprognostic (7.48e-3)" "unprognostic (2.46e-3)" "unprognostic (2.49e-1)" "unprognostic (6.67e-2)" "unprognostic (8.18e-2)" "unprognostic (3.94e-1)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (8.13e-6)" "unprognostic (1.13e-1)" "unprognostic (1.59e-1)" "unprognostic (6.56e-2)" "unprognostic (1.94e-2)" 1.8 1.3 4.6 1.0 8.8 1.5 2.0 25.1 8.4 1.1 1.2 10.6 0.8 1.0 4.3 1.7 1.4 2.5 1.0 4.4 6.1 2.8 1.9 6.5 4.1 0.9 8.0 4.0 5.4 5.6 0.8 8.4 4.7 5.8 2.3 1.1 4.9 1.9 1.1 30.6 1.6 1.2 2.2 5.7 1.4 1.1 6.0 8.0 0.0 2.7 2.2 0.9 2.3 2.5 0.2 0.1 0.9 0.8 0.5 0.1 0.0 0.1 0.0 12.6 4.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 11.6 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.1 0.0 0.4 18.5 0.0 1.4 0.8 0.0 0.0 4.0 8.3 0.0 0.0 0.1 0.7 1.3 1.9 0.1 0.1 2.8 0.0 0.0 4.7 1.1 1.0 0.0 0.0 0.1 0.3 0.8 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.9 0.5 0.1 0.0 0.0 0.0 4.6 8.8 25.1 5.0 6.1 2.8 8.0 4.0 5.8 8.0 CENPBD1 MGC16385 ENSG00000177946 "CENPB DNA-binding domain containing 1" B2RD01 16 89969773-89972832 "Predicted intracellular proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEK 293: 7.6;K-562: 4.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA052759, HPA060522" Uncertain Approved Nucleoli,Vesicles "Nucleoli, Vesicles" "HPA052759: , HPA060522: " "unprognostic (2.63e-2)" "unprognostic (2.22e-3)" "unprognostic (4.43e-2)" "unprognostic (3.48e-3)" "unprognostic (7.76e-2)" "unprognostic (1.03e-2)" "unprognostic (1.37e-2)" "unprognostic (1.86e-3)" "unprognostic (1.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-2)" "unprognostic (6.44e-2)" "prognostic favourable (5.27e-11)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-2)" 7.2 5.9 6.6 2.6 7.3 4.5 6.3 6.1 9.5 3.3 4.0 4.9 10.5 5.9 3.6 5.0 4.0 3.6 4.6 4.2 6.6 6.1 7.6 5.6 6.7 7.1 7.9 7.0 7.6 8.9 3.9 7.1 4.4 6.2 4.9 6.0 3.8 6.0 4.8 4.2 5.1 2.9 3.8 5.6 6.6 4.7 8.2 6.3 2.5 3.5 1.8 2.5 4.8 2.7 3.7 3.6 1.4 1.6 1.4 2.7 1.3 1.2 0.0 0.2 0.4 0.5 0.9 2.1 0.8 0.3 0.0 0.0 0.6 0.0 1.3 1.2 0.9 2.0 0.0 0.0 0.3 0.0 7.6 0.0 0.3 0.5 0.4 0.4 1.2 0.0 1.3 0.0 0.0 0.0 4.6 0.9 0.0 1.1 1.4 0.5 0.6 0.5 3.1 1.6 0.0 0.0 0.0 2.7 1.9 2.8 0.3 0.1 0.7 0.0 0.0 0.2 1.8 0.2 1.2 0.8 1.3 1.0 0.5 1.2 0.5 0.6 1.6 1.4 2.4 0.7 2.1 1.2 1.9 0.8 3.6 3.7 2.7 2.3 0.5 1.4 1.4 3.1 1.1 1.3 6.6 7.3 6.1 9.5 6.6 6.1 7.9 7.0 6.2 6.3 CEP295NL "DDC8, KIAA1731NL" ENSG00000178404 "CEP295 N-terminal like" Q96MC4 17 78870910-78903217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 37.7" "Cell line enhanced" "Detected in some" "BEWO: 4.0;Karpas-707: 3.2;TIME: 3.2;U-2 OS: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 3.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.5" "HPA023609, HPA024619, HPA025717" Uncertain Approved Vesicles Vesicles "HPA023609: AB_10610974, HPA024619: AB_10602076, HPA025717: AB_10601900" "unprognostic (1.68e-3)" "unprognostic (4.56e-2)" "unprognostic (2.62e-1)" "unprognostic (5.04e-3)" "unprognostic (1.88e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-1)" "unprognostic (9.03e-2)" "unprognostic (8.16e-2)" "unprognostic (9.80e-2)" "unprognostic (2.08e-1)" "unprognostic (3.89e-3)" "unprognostic (3.65e-3)" "unprognostic (1.03e-1)" "unprognostic (2.09e-1)" "unprognostic (1.28e-1)" "unprognostic (6.75e-3)" 0.1 0.0 0.1 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 37.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.2 3.5 0.4 0.1 0.1 0.0 0.7 0.1 0.0 0.9 0.2 0.6 4.0 1.7 0.1 0.6 1.1 0.2 0.6 0.0 1.1 0.6 0.1 0.0 0.2 0.6 0.0 0.0 0.0 1.3 0.3 0.4 0.2 0.1 0.3 0.0 1.2 0.0 0.4 0.0 3.2 0.1 0.0 0.3 0.0 0.3 0.6 0.8 0.5 0.1 0.2 0.0 0.1 0.9 0.5 0.4 0.7 0.1 1.0 3.2 1.4 5.4 1.7 0.7 1.2 1.6 0.0 0.0 0.1 1.7 0.0 0.4 0.7 0.0 0.4 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.0 3.5 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CEP95 "CCDC45, DKFZp667E1824" ENSG00000258890 "Centrosomal protein 95" Q96GE4 17 64506588-64542461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023654, HPA052426, HPA052428, HPA061371" Approved Approved "Nucleoplasm,Vesicles,Mitotic spindle,Centrosome" Nucleoplasm "Vesicles, Mitotic spindle, Centrosome" "HPA023654: AB_2072077, HPA052426: , HPA052428: , HPA061371: " "unprognostic (1.28e-2)" "unprognostic (9.12e-2)" "unprognostic (3.66e-3)" "unprognostic (4.09e-2)" "unprognostic (3.30e-2)" "prognostic favourable (5.78e-4)" "prognostic unfavourable (2.52e-5)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (3.57e-3)" "prognostic unfavourable (5.76e-5)" "unprognostic (3.48e-1)" "unprognostic (1.84e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" 13.0 8.6 10.9 17.1 13.1 37.9 15.5 27.9 15.6 16.7 14.2 16.2 11.6 11.9 26.5 16.6 10.7 17.1 12.3 10.6 11.5 7.8 14.1 11.7 13.0 20.7 13.6 7.9 27.3 15.5 11.8 20.4 8.5 13.0 15.2 13.5 15.6 13.8 19.8 14.6 21.7 14.2 15.0 17.4 13.2 13.3 16.9 13.9 26.4 21.0 8.6 14.7 14.3 14.0 5.9 3.7 2.2 3.6 2.1 10.8 2.4 10.0 6.4 13.1 11.3 3.5 9.0 13.1 5.1 5.2 6.4 9.7 7.7 5.8 16.1 3.4 7.2 12.8 11.2 9.9 13.2 4.2 8.6 14.3 12.4 14.8 11.6 15.5 7.7 10.2 10.4 7.1 15.9 5.4 16.4 11.8 7.0 11.8 19.6 9.9 8.1 8.0 14.1 23.7 11.9 7.4 16.1 8.3 15.0 7.0 10.3 13.3 11.4 10.4 8.0 14.6 11.4 6.7 6.9 12.0 9.6 17.1 6.3 11.9 8.9 2.2 3.6 2.2 4.5 2.9 10.8 4.5 5.2 4.5 3.4 5.9 8.0 5.4 1.4 2.1 3.4 3.7 4.2 2.4 10.9 13.1 27.9 15.6 11.5 7.8 13.6 7.9 13.0 13.9 CERK "dA59H18.2, dA59H18.3, DKFZp434E0211, FLJ21430, FLJ23239, hCERK, KIAA1646, LK4" ENSG00000100422 "Ceramide kinase" Q8TCT0 22 46684411-46738261 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064699 Approved Vesicles Vesicles "HPA064699: " "unprognostic (2.93e-2)" "unprognostic (1.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavourable (4.75e-4)" "unprognostic (2.67e-2)" "unprognostic (1.49e-3)" "unprognostic (8.55e-2)" "unprognostic (3.60e-2)" "unprognostic (3.87e-1)" "unprognostic (1.35e-2)" "prognostic favourable (2.35e-4)" "unprognostic (2.26e-1)" "unprognostic (1.50e-3)" "unprognostic (1.27e-1)" "unprognostic (4.78e-1)" "unprognostic (3.38e-1)" "prognostic unfavourable (1.58e-4)" 10.6 15.5 10.6 16.7 10.8 14.5 12.9 29.3 21.7 10.8 14.6 9.8 15.8 24.9 14.1 7.5 10.0 15.3 18.9 36.5 11.4 16.8 15.2 12.1 10.6 19.1 21.7 13.1 22.7 23.2 7.2 33.3 7.9 23.9 8.2 12.2 12.3 11.8 11.6 12.8 11.9 25.1 12.5 10.2 14.5 14.0 6.0 6.5 39.2 16.1 8.7 19.5 10.7 17.4 2.0 4.9 3.6 6.9 2.0 16.4 3.6 9.3 5.6 27.4 8.6 15.8 12.0 2.5 16.4 12.8 9.4 6.6 8.2 3.1 13.0 7.7 17.5 6.1 11.5 7.4 9.6 4.6 12.5 5.8 14.2 10.7 11.0 18.2 1.5 9.9 9.6 10.2 3.5 27.9 4.3 16.9 17.2 0.7 12.3 9.1 12.4 6.2 23.0 31.1 14.8 5.6 0.1 25.6 23.3 8.0 3.9 17.2 4.3 13.9 25.3 19.5 10.4 14.3 23.7 17.6 21.2 8.2 20.7 10.4 15.8 0.6 2.6 3.0 9.4 6.0 16.4 1.8 9.9 9.0 4.5 2.0 5.8 5.4 3.6 2.0 6.9 4.9 8.6 3.6 10.6 10.8 29.3 21.7 11.4 16.8 21.7 13.1 23.9 6.5 CERS4 "FLJ12089, LASS4, Trh1" ENSG00000090661 "Ceramide synthase 4" Q9HA82 19 8206736-8262421 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 21.2;NB-4: 38.2;U-937: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033734, HPA054729" Uncertain Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB033734: AB_2132977, HPA054729: " "unprognostic (5.96e-2)" "prognostic favourable (2.71e-4)" "unprognostic (2.46e-2)" "unprognostic (2.82e-2)" "unprognostic (1.30e-1)" "prognostic favourable (7.83e-4)" "unprognostic (1.74e-1)" "prognostic favourable (3.45e-5)" "unprognostic (1.48e-2)" "unprognostic (3.32e-1)" "prognostic favourable (8.05e-4)" "unprognostic (1.77e-1)" "prognostic favourable (9.63e-5)" "unprognostic (6.08e-3)" "unprognostic (2.69e-2)" "unprognostic (2.91e-2)" "unprognostic (8.08e-3)" 6.2 6.7 17.5 10.5 22.9 2.5 21.6 14.5 19.3 13.2 6.8 24.3 7.8 4.6 9.9 41.8 26.4 11.9 7.7 9.7 16.1 10.8 16.5 32.4 12.9 12.2 26.9 13.3 13.8 56.7 11.6 10.1 2.2 16.8 22.4 3.2 26.2 34.8 12.8 2.1 20.9 6.1 8.5 20.3 8.6 9.9 8.4 29.0 6.4 38.1 9.5 15.9 9.3 13.2 13.3 2.7 16.9 4.4 13.5 5.2 3.5 0.1 0.9 0.9 10.0 0.3 0.0 0.7 1.3 3.3 1.5 0.7 7.5 0.8 15.6 11.1 0.0 5.3 6.5 0.1 0.7 13.7 5.1 3.0 0.1 21.2 12.9 0.0 8.5 5.0 8.4 3.5 7.6 0.1 2.2 0.5 0.0 0.3 1.2 38.2 10.2 3.7 18.8 0.2 1.2 2.5 0.0 3.8 5.1 1.6 0.3 5.4 7.4 3.5 0.0 1.1 3.2 7.5 0.0 9.8 7.8 11.9 0.0 23.9 1.1 5.9 4.4 16.9 5.2 2.3 3.9 13.3 3.0 3.1 2.7 12.1 2.8 2.6 14.0 13.5 1.5 2.6 3.5 3.5 17.5 22.9 14.5 19.3 16.1 10.8 26.9 13.3 16.8 29.0 CFAP58 "bA554P13.1, C10orf80, CCDC147, FLJ35908" ENSG00000120051 "Cilia and flagella associated protein 58" Q5T655 10 104353764-104455090 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 10.9;testis: 17.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 5.1;U-2 OS: 10.7" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 6.8" "Cell type enriched" "Detected in single" 6 "neutrophil: 5.5" "Lineage enriched" "Detected in single" 55 "granulocytes: 5.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036555, HPA071938" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA036555: AB_10673622, HPA071938: " "unprognostic (5.32e-1)" "unprognostic (2.59e-1)" "unprognostic (6.26e-2)" "unprognostic (1.57e-3)" "unprognostic (5.41e-3)" "unprognostic (1.01e-1)" "unprognostic (9.62e-2)" "unprognostic (5.64e-2)" "unprognostic (3.11e-1)" "unprognostic (2.18e-1)" "unprognostic (8.93e-2)" "unprognostic (3.15e-1)" "unprognostic (1.65e-1)" "unprognostic (3.97e-2)" "unprognostic (6.81e-2)" "unprognostic (4.19e-2)" "unprognostic (1.59e-1)" 0.3 0.5 0.8 0.6 2.0 0.4 0.3 0.7 1.0 3.0 0.3 2.9 0.3 0.1 2.3 0.3 0.3 10.9 0.3 3.0 1.4 1.5 0.3 0.3 2.1 0.3 0.3 0.3 2.0 0.3 1.5 1.9 0.4 6.8 0.4 0.0 0.6 0.3 0.4 1.4 0.2 0.3 0.8 0.3 0.3 0.1 17.5 0.7 0.3 0.8 0.3 0.4 0.3 0.7 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.2 0.6 0.2 1.7 5.1 1.0 2.8 0.0 0.0 3.9 0.4 0.6 0.3 0.0 0.3 3.1 0.4 0.2 0.9 1.2 0.0 0.6 0.5 0.7 0.6 2.2 0.8 2.7 1.6 1.0 1.2 1.3 0.0 0.0 1.1 0.3 0.0 0.4 0.3 0.5 0.6 0.0 0.6 0.4 0.0 0.2 0.9 0.3 0.6 3.3 1.1 10.7 0.6 3.0 0.3 0.1 0.2 1.2 1.3 3.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.8 2.0 0.7 1.0 1.4 1.5 0.3 0.3 6.8 0.7 CFAP73 "CCDC42B, MIA2" ENSG00000186710 "Cilia and flagella associated protein 73" A6NFT4 12 113149858-113159276 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;epididymis: 17.8;fallopian tube: 35.5" "Cell line enhanced" "Detected in some" "Daudi: 6.3;REH: 3.2;T-47d: 3.8;U-698: 12.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Region enhanced" "Detected in many" "pons and medulla: 27.2" "Cell type enhanced" "Detected in some" "naive B-cell: 1.0;naive CD4 T-cell: 1.3" "Group enriched" "Detected in many" 9 "B-cells: 1.0;T-cells: 1.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA048539 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA048539: " "unprognostic (2.42e-2)" "prognostic favourable (1.29e-4)" "unprognostic (1.90e-3)" "prognostic favourable (5.52e-4)" "unprognostic (2.32e-2)" "unprognostic (1.18e-3)" "unprognostic (6.49e-2)" "unprognostic (2.94e-1)" "unprognostic (1.33e-1)" "unprognostic (3.14e-1)" "unprognostic (5.68e-2)" "unprognostic (3.43e-2)" "unprognostic (1.62e-4)" "unprognostic (2.03e-4)" "unprognostic (1.60e-1)" "unprognostic (4.03e-2)" "unprognostic (1.55e-2)" 0.2 0.3 4.3 0.5 16.9 2.0 0.3 0.5 0.9 3.1 0.3 15.3 1.0 0.5 1.0 17.8 0.6 35.5 0.4 0.2 5.8 6.1 0.6 0.2 5.7 0.9 0.2 0.9 6.8 0.3 0.7 0.9 0.2 27.2 0.3 0.3 0.0 2.2 0.9 0.5 4.5 0.6 0.2 1.1 0.5 3.9 1.5 4.7 0.0 0.5 0.5 1.3 0.4 0.0 1.0 0.1 0.0 0.0 0.0 1.3 0.2 0.3 0.1 0.4 0.4 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.5 3.0 6.3 0.2 0.0 1.0 0.0 0.0 0.0 0.2 0.5 0.3 2.1 0.2 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.3 1.1 0.4 0.2 3.2 0.0 0.5 0.8 0.7 0.6 0.1 0.0 0.9 0.0 3.8 0.0 0.1 0.1 1.0 0.3 0.2 0.6 0.2 12.7 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 4.3 16.9 0.5 0.9 5.8 6.1 0.2 0.9 27.2 4.7 CFB "BF, BFD, H2-Bf" ENSG00000243649 "Complement factor B" P00751 6 31945650-31952084 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "liver: 461.5" "Cell line enhanced" "Detected in some" "ASC diff: 6.0;ASC TERT1: 5.8;CAPAN-2: 6.9;fHDF/TERT166: 11.3;HSkMC: 18.7" "Cancer enhanced" "Detected in all" "liver cancer: 78.3" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "HPA000951, HPA001817, HPA001832, CAB016381" Supported Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" "Secreted to blood" 878700000 180000000000 "Endoplasmic reticulum, Vesicles" "Cell Junctions" "CAB016381: AB_627562, HPA000951: , HPA001817: AB_1078779, HPA001832: AB_1078778" "prognostic favourable (2.76e-5)" "unprognostic (1.02e-1)" "unprognostic (1.44e-1)" "unprognostic (7.94e-2)" "unprognostic (1.82e-2)" "unprognostic (8.56e-2)" "unprognostic (8.08e-3)" "unprognostic (8.81e-2)" "unprognostic (3.51e-1)" "unprognostic (2.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.57e-2)" "prognostic unfavourable (1.53e-5)" "unprognostic (1.36e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-2)" "unprognostic (3.68e-2)" 9.3 1.0 0.3 4.1 0.4 0.3 2.4 0.2 0.4 1.3 9.0 0.4 0.9 3.2 0.5 3.7 2.2 4.0 8.9 3.3 0.2 0.0 16.1 461.5 2.5 2.1 0.7 0.1 2.8 5.8 0.4 1.0 4.0 1.0 4.0 1.6 2.6 3.1 0.3 0.5 0.5 4.7 2.6 0.6 0.8 4.1 1.4 0.3 0.3 1.8 0.5 1.7 1.6 0.4 0.1 1.6 0.0 0.8 0.0 0.2 0.0 0.0 1.8 0.1 0.1 6.0 5.8 0.0 0.0 0.3 1.5 0.6 0.0 6.9 0.1 5.1 11.3 0.0 0.0 1.9 1.4 0.4 0.3 0.4 0.3 0.5 0.0 0.7 0.1 18.7 0.1 0.9 0.6 0.2 0.2 0.7 0.1 0.1 0.1 0.4 0.3 0.1 0.2 0.4 0.2 1.6 0.0 0.0 0.0 0.5 1.2 0.2 0.0 0.2 0.0 0.2 0.5 0.3 0.3 0.5 1.9 0.5 3.1 0.5 0.5 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.3 0.4 0.2 0.3 0.2 0.0 0.7 0.1 1.0 0.3 CFDP1 "BCNT, CENP-29, CP27, p97, SWC5, Yeti" ENSG00000153774 "Craniofacial development protein 1" Q9UEE9 16 75293698-75433485 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041316, HPA048242" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA041316: AB_10794371, HPA048242: " "unprognostic (1.45e-1)" "unprognostic (8.64e-2)" "unprognostic (1.13e-1)" "unprognostic (4.88e-1)" "unprognostic (3.97e-2)" "prognostic unfavourable (9.63e-5)" "unprognostic (5.81e-3)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.61e-2)" "unprognostic (1.42e-1)" "unprognostic (7.37e-2)" "unprognostic (2.85e-2)" "unprognostic (6.54e-2)" "unprognostic (1.36e-1)" "unprognostic (4.92e-3)" "unprognostic (1.25e-1)" 21.3 33.0 38.3 23.3 32.9 18.7 28.5 31.8 35.4 35.6 24.3 19.5 24.6 18.9 37.4 40.9 21.3 36.1 18.8 19.2 33.7 40.5 40.2 26.6 20.6 16.9 33.6 28.4 54.5 26.9 20.9 53.0 38.5 32.7 28.4 25.8 21.1 23.8 25.6 25.9 20.8 22.2 33.8 38.6 18.0 19.1 38.5 29.7 27.2 28.7 12.6 21.4 26.0 41.1 20.1 28.2 33.7 27.6 15.1 37.8 15.0 16.4 12.2 41.7 15.4 38.0 42.5 12.5 16.5 19.2 21.9 31.7 21.0 22.5 15.8 24.5 20.3 18.5 32.0 26.2 44.0 6.8 15.2 16.5 11.8 44.7 26.2 17.3 14.4 26.4 22.5 26.4 32.3 23.8 22.9 7.4 24.4 37.4 25.4 38.3 20.4 6.4 46.1 17.1 27.3 24.3 9.1 25.0 21.1 27.6 5.8 22.6 24.0 30.8 14.1 15.7 17.0 16.5 10.4 14.4 22.4 59.4 15.7 23.0 13.8 28.7 27.3 33.7 19.4 27.6 27.3 19.8 26.7 21.3 28.2 20.1 24.5 23.1 22.4 15.1 25.0 28.1 37.8 15.0 38.3 32.9 31.8 35.4 33.7 40.5 33.6 28.4 32.7 29.7 CFH "ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS" ENSG00000000971 "Complement factor H" P08603 1 196651878-196747504 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity" "Age-related macular degeneration, Cancer-related genes, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 295.2" "Cell line enhanced" "Detected in many" "ASC diff: 25.2;HHSteC: 31.8;HSkMC: 31.0;RH-30: 23.2;RT4: 56.3" "Cancer enriched" "Detected in all" 9 "liver cancer: 151.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 16.5" "Lineage enriched" "Detected in single" 27 "T-cells: 16.5" "CAB016385, CAB016769, HPA038922, HPA049176, HPA053326" Supported Approved Vesicles "Secreted to blood" 395836666667 110000000000 Vesicles "CAB016385: AB_627572, CAB016769: , HPA038922: , HPA049176: , HPA053326: " "unprognostic (2.40e-1)" "unprognostic (9.86e-2)" "unprognostic (1.22e-1)" "unprognostic (8.39e-2)" "unprognostic (5.40e-3)" "unprognostic (1.80e-1)" "unprognostic (3.75e-3)" "unprognostic (7.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.04e-1)" "unprognostic (9.08e-2)" "unprognostic (2.08e-1)" "prognostic unfavourable (1.92e-6)" "unprognostic (6.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.73e-1)" "unprognostic (1.37e-1)" 28.6 5.5 1.6 3.7 3.8 0.1 8.8 2.6 2.7 10.4 9.1 1.0 3.9 3.7 2.5 8.7 15.2 3.4 17.0 47.3 2.0 1.2 7.0 295.2 11.0 10.3 5.3 1.7 40.9 1.9 1.7 4.3 5.1 5.3 10.3 10.4 6.3 19.0 3.3 10.0 11.5 8.1 12.6 4.2 3.3 5.8 6.4 2.9 0.7 22.0 22.8 5.8 17.2 16.8 0.0 0.1 0.6 0.1 0.0 16.5 1.0 0.0 16.1 0.0 0.0 25.2 14.3 0.0 6.5 15.9 0.9 3.5 0.0 3.0 0.0 2.4 0.0 0.5 0.0 5.9 0.6 0.3 0.0 4.8 19.1 0.0 31.8 0.2 0.0 31.0 0.1 4.7 2.0 19.8 18.1 0.6 22.5 0.0 0.1 0.0 0.1 0.0 0.0 23.2 5.1 0.0 56.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 19.2 0.2 0.2 0.2 0.2 0.0 0.0 3.4 0.0 1.4 0.0 0.1 0.0 1.8 0.0 16.5 0.0 6.0 3.5 0.1 0.0 0.4 1.4 0.6 0.0 0.0 0.0 0.0 1.0 1.6 3.8 2.6 2.7 2.0 1.2 5.3 1.7 5.3 2.9 CFHR1 "CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2" ENSG00000244414 "Complement factor H related 1" Q03591 1 196819757-196832189 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 174 "liver: 218.9" "Cell line enhanced" "Detected in some" "ASC diff: 2.6;HeLa: 3.1;HL-60: 4.7;U-266/70: 6.2" "Cancer enriched" "Detected in single" 798 "liver cancer: 182.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038915, HPA038922, HPA040726" Supported Approved Vesicles "Secreted to blood" 15000000000 Vesicles "HPA038915: , HPA038922: , HPA040726: " "unprognostic (2.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.50e-2)" "unprognostic (1.88e-2)" "prognostic favourable (8.71e-6)" "unprognostic (3.02e-1)" "unprognostic (3.70e-1)" "unprognostic (2.50e-1)" "unprognostic (8.48e-2)" "unprognostic (7.21e-4)" "unprognostic (7.01e-4)" "unprognostic (1.13e-1)" "unprognostic (6.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 218.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.3 0.2 2.6 1.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.2 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 1.6 3.1 0.2 0.2 4.7 0.8 0.1 0.0 0.0 0.0 0.1 0.3 2.3 0.8 0.0 1.4 0.0 0.8 0.0 0.8 2.0 0.0 0.0 0.3 0.0 0.1 0.9 0.0 0.2 0.4 0.0 1.4 0.9 0.4 0.2 0.2 6.2 0.0 1.1 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 CGRRF1 "CGR19, RNF197" ENSG00000100532 "Cell growth regulator with ring finger domain 1" Q99675 14 54509812-54539309 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002930 Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA002930: AB_1078507" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (5.61e-2)" "unprognostic (4.38e-1)" "unprognostic (1.01e-1)" "unprognostic (3.21e-1)" "prognostic unfavourable (6.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.58e-2)" "unprognostic (2.63e-1)" "unprognostic (7.29e-2)" "unprognostic (2.64e-3)" "prognostic favourable (2.57e-8)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (1.48e-1)" "unprognostic (1.74e-1)" 13.3 12.8 18.3 5.7 19.2 10.2 17.3 21.9 18.9 12.7 11.4 16.2 12.7 8.0 14.3 20.1 8.4 12.6 8.3 12.7 15.2 15.4 20.8 10.3 9.9 10.9 16.6 14.6 11.4 19.5 11.2 16.5 10.0 20.1 14.7 9.9 9.8 9.7 16.3 20.7 5.0 9.6 12.4 18.2 8.8 10.2 24.9 16.7 3.0 18.0 6.3 7.2 12.6 9.2 11.9 6.4 31.3 10.7 12.4 13.7 11.7 8.3 7.5 7.8 7.1 13.6 8.5 6.0 8.2 7.4 11.9 11.7 6.9 9.4 4.6 10.3 6.7 7.4 8.3 6.9 14.1 9.6 7.1 6.4 1.9 8.7 16.9 3.7 3.7 8.4 13.4 8.9 14.6 8.3 2.6 5.7 10.8 14.8 3.8 5.7 5.2 11.9 8.5 9.5 2.7 9.2 11.0 5.7 4.7 6.5 3.5 12.3 9.2 3.3 7.1 14.7 12.5 6.2 6.8 4.2 4.9 6.6 9.1 4.5 9.7 31.3 7.9 13.4 12.3 9.0 12.3 11.1 13.4 13.5 6.4 11.9 13.7 12.6 8.0 12.4 10.7 5.6 13.5 11.7 18.3 19.2 21.9 18.9 15.2 15.4 16.6 14.6 20.1 16.7 CHEK1 CHK1 ENSG00000149554 "Checkpoint kinase 1" O14757 11 125625136-125676255 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 80.0;seminal vesicle: 66.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 11.7" "Lineage enriched" "Detected in many" 6 "T-cells: 11.7" "Low region specificity" "Detected in single" HPA044364 Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA044364: " "unprognostic (6.74e-2)" "unprognostic (3.63e-1)" "prognostic favourable (3.62e-4)" "unprognostic (5.54e-2)" "unprognostic (2.17e-1)" "unprognostic (1.03e-1)" "prognostic unfavourable (3.70e-6)" "unprognostic (3.95e-3)" "unprognostic (1.26e-3)" "unprognostic (2.54e-2)" "prognostic unfavourable (3.10e-6)" "unprognostic (1.75e-1)" "prognostic unfavourable (1.04e-8)" "unprognostic (2.89e-2)" "unprognostic (2.64e-1)" "unprognostic (8.16e-2)" "unprognostic (1.33e-1)" 3.0 2.5 2.5 9.0 2.8 14.9 2.1 1.1 2.2 2.5 5.2 1.3 80.0 5.0 1.9 10.2 6.5 1.7 3.6 1.5 2.4 2.4 3.7 2.0 1.8 9.6 3.0 1.2 3.8 4.0 25.5 3.5 3.8 1.5 2.9 6.3 1.6 2.6 66.8 1.2 2.9 5.2 2.3 3.0 3.6 2.8 7.2 1.5 22.4 1.8 4.5 8.8 3.8 3.3 1.9 1.8 1.9 0.7 1.2 11.7 1.0 12.7 10.4 23.4 14.2 4.8 10.3 10.2 17.9 8.6 11.5 12.4 25.4 28.3 33.4 18.5 7.0 15.4 14.3 9.4 14.2 20.9 6.6 61.9 8.7 13.0 1.5 31.6 11.8 5.3 2.0 14.5 10.3 13.6 31.3 29.4 15.1 6.6 46.9 15.5 23.7 9.4 28.6 21.9 17.5 10.6 17.0 14.8 15.7 14.7 10.2 4.3 27.5 10.3 9.1 16.6 14.1 8.0 16.4 6.6 11.8 47.6 6.1 23.8 19.4 1.9 0.5 0.3 1.3 0.7 1.2 1.9 3.5 1.6 1.1 1.5 3.3 2.0 0.4 1.2 0.4 1.8 11.7 1.0 2.5 2.8 1.1 2.2 2.4 2.4 3.0 1.2 1.5 1.5 CHGA ENSG00000100604 "Chromogranin A" P10645 14 92923080-92935293 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "parathyroid gland: 577.6" "Group enriched" "Detected in some" 134 "SCLC-21H: 43.3;SH-SY5Y: 117.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 114.8" "Region enhanced" "Detected in many" "cerebral cortex: 97.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000023, HPA017369, CAB040544, CAB055506, CAB058688" Enhanced Supported Vesicles "Intracellular and membrane" 78000000 Vesicles "CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: , HPA017369: AB_1846698" "prognostic favourable (7.85e-5)" "unprognostic (4.89e-2)" "unprognostic (5.96e-2)" "unprognostic (1.17e-1)" "unprognostic (1.43e-2)" "unprognostic (5.95e-2)" "prognostic unfavourable (2.40e-4)" "unprognostic (1.74e-1)" "unprognostic (2.23e-1)" "unprognostic (4.56e-2)" "prognostic favourable (4.07e-4)" "unprognostic (1.85e-1)" "unprognostic (8.81e-13)" "unprognostic (1.07e-2)" "unprognostic (1.77e-1)" "unprognostic (9.17e-2)" "prognostic unfavourable (3.99e-4)" 2.0 81.9 6.6 3.1 18.7 1.3 1.3 0.5 97.9 1.9 36.1 4.0 0.0 15.8 1.3 1.3 1.2 1.3 1.3 1.2 11.2 14.0 1.3 1.2 1.4 1.2 8.0 36.1 1.2 15.9 577.6 81.1 1.2 17.1 2.0 7.9 0.4 1.3 1.3 1.2 1.3 38.8 1.3 2.5 1.3 51.9 32.5 0.7 0.0 5.9 0.0 1.2 1.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 43.3 117.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.6 18.7 0.5 97.9 11.2 14.0 8.0 36.1 17.1 0.7 CHGB "SCG1, SgI" ENSG00000089199 "Chromogranin B" P05060 20 5911430-5925361 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 424.9;pituitary gland: 177.5" "Group enriched" "Detected in some" 23 "SCLC-21H: 65.1;SH-SY5Y: 99.7" "Cancer enriched" "Detected in many" 6 "pancreatic cancer: 154.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.6;T-reg: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008759, CAB009403, HPA012602" Enhanced Supported Enhanced Vesicles "Intracellular and membrane" 24000000 Vesicles "CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706" "unprognostic (1.79e-3)" "unprognostic (7.72e-2)" "unprognostic (3.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.68e-2)" "prognostic unfavourable (1.89e-4)" "unprognostic (7.96e-3)" "unprognostic (2.86e-1)" "unprognostic (6.18e-3)" "unprognostic (7.93e-2)" "prognostic favourable (9.96e-4)" "unprognostic (8.56e-2)" "unprognostic (8.21e-2)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "unprognostic (2.73e-1)" "unprognostic (1.01e-2)" 3.4 424.9 8.2 1.4 10.2 0.8 1.0 82.5 16.4 0.8 3.0 2.1 1.2 7.7 0.9 1.3 0.8 2.5 0.8 7.6 20.7 15.4 1.7 0.7 1.0 1.1 7.2 9.1 3.0 17.0 0.8 177.5 0.8 51.8 5.6 2.5 0.7 0.9 1.2 2.1 0.9 4.4 0.9 2.3 0.8 19.7 2.4 0.8 0.0 1.9 0.4 0.9 0.8 0.1 0.0 0.6 0.0 0.0 0.0 2.6 0.2 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 65.1 99.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.1 0.4 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.2 8.2 10.2 82.5 16.4 20.7 15.4 7.2 9.1 51.8 0.8 CHIC1 BRX ENSG00000204116 "Cysteine rich hydrophobic domain 1" Q5VXU3 X 73563200-73687102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA052062" Uncertain Approved "Nuclear speckles,Vesicles,Cytosol" "Nuclear speckles, Vesicles" Cytosol "HPA026782: AB_1846654, HPA052062: " "unprognostic (9.85e-3)" "unprognostic (3.91e-2)" "unprognostic (3.10e-2)" "unprognostic (9.95e-2)" "unprognostic (6.22e-2)" "unprognostic (1.91e-1)" "unprognostic (1.57e-1)" "unprognostic (1.36e-2)" "unprognostic (2.43e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-3)" "unprognostic (2.65e-1)" "prognostic favourable (2.75e-4)" "unprognostic (1.37e-2)" "unprognostic (2.19e-1)" "unprognostic (3.51e-1)" "unprognostic (2.76e-2)" 5.6 13.9 11.0 7.1 16.3 1.5 7.5 14.7 17.6 14.6 8.2 8.5 7.7 4.7 11.1 7.9 5.1 8.7 9.2 10.3 11.7 13.2 12.4 3.4 5.6 7.2 11.2 13.8 11.8 4.1 13.3 18.2 4.4 16.8 9.9 8.6 6.8 5.1 13.0 4.6 6.0 5.9 10.7 15.4 7.7 4.9 3.3 12.5 3.7 12.8 2.6 6.8 7.4 10.1 1.1 0.2 1.0 0.3 1.2 3.0 0.6 4.0 4.1 2.1 2.7 6.0 8.2 0.0 4.5 6.1 3.7 4.5 2.7 5.1 1.9 6.3 4.0 1.2 3.0 2.2 8.3 4.6 3.7 2.7 3.4 0.0 3.9 0.0 5.5 5.6 2.7 7.0 3.8 5.3 0.7 18.3 7.2 0.6 1.6 0.0 6.6 4.1 1.6 5.3 1.2 4.7 2.0 1.2 1.7 5.1 2.4 5.4 2.0 1.1 6.1 4.3 4.2 8.5 2.7 5.2 12.9 0.0 6.3 3.0 3.3 1.0 0.1 0.0 1.9 0.1 3.0 1.1 1.5 1.9 0.0 1.1 1.5 2.0 0.0 1.2 0.3 0.2 1.2 0.6 11.0 16.3 14.7 17.6 11.7 13.2 11.2 13.8 16.8 12.5 CHIC2 BTL ENSG00000109220 "Cysteine rich hydrophobic domain 2" Q9UKJ5 4 54009789-54064690 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA026784, HPA076603" Uncertain Enhanced "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA026782: AB_1846654, HPA026784: , HPA076603: " "unprognostic (4.56e-2)" "unprognostic (2.24e-3)" "unprognostic (3.47e-3)" "unprognostic (9.58e-2)" "unprognostic (1.49e-1)" "unprognostic (2.25e-2)" "unprognostic (7.87e-2)" "unprognostic (1.22e-1)" "unprognostic (3.65e-2)" "unprognostic (7.81e-3)" "unprognostic (2.94e-2)" "unprognostic (5.63e-2)" "prognostic unfavourable (1.56e-4)" "unprognostic (2.89e-1)" "unprognostic (1.77e-1)" "unprognostic (4.56e-2)" "unprognostic (9.40e-2)" 17.0 17.5 9.5 14.6 9.7 23.7 17.1 17.9 12.0 12.8 14.2 7.1 11.9 13.0 16.8 14.9 25.3 11.0 22.1 14.3 7.3 7.9 12.3 20.2 17.7 13.5 6.6 10.0 13.2 9.9 5.5 16.7 18.5 9.9 12.3 9.6 15.9 15.3 9.9 10.9 24.7 20.6 10.8 8.1 18.5 12.9 50.1 8.3 32.3 11.8 11.6 20.5 12.9 16.3 8.4 10.9 63.8 15.9 13.6 15.6 13.6 11.5 2.1 6.4 5.6 10.7 8.2 6.3 16.0 17.0 9.6 9.7 8.3 10.4 9.8 14.4 10.3 3.5 8.6 11.7 10.4 5.4 4.4 5.3 2.0 6.2 32.1 8.7 11.1 11.1 9.6 14.5 22.2 14.0 5.7 7.4 19.1 3.1 10.2 14.0 4.2 7.9 6.6 3.5 3.8 11.0 3.9 9.3 8.8 3.8 5.6 11.7 3.0 13.0 23.9 12.3 9.6 17.6 10.3 8.8 4.2 8.0 9.1 8.7 8.9 56.0 15.9 32.2 12.6 12.4 12.1 8.4 12.8 14.2 10.9 8.2 11.8 12.7 63.8 13.6 12.5 9.1 15.6 13.6 9.5 9.7 17.9 12.0 7.3 7.9 6.6 10.0 9.9 8.3 CHP1 "CHP, p22, p24, Sid470p, SLC9A1BP" ENSG00000187446 "Calcineurin like EF-hand protein 1" Q99653 15 41230839-41281890 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006616 Approved Approved Vesicles Vesicles "HPA006616: AB_1857461" "unprognostic (2.06e-2)" "unprognostic (3.26e-1)" "unprognostic (2.84e-1)" "prognostic favourable (9.63e-4)" "unprognostic (7.29e-2)" "unprognostic (3.74e-1)" "prognostic favourable (4.07e-6)" "unprognostic (2.20e-1)" "unprognostic (7.46e-2)" "unprognostic (3.26e-2)" "unprognostic (1.26e-3)" "unprognostic (2.79e-1)" "prognostic favourable (2.79e-6)" "unprognostic (1.06e-1)" "unprognostic (1.49e-1)" "unprognostic (4.62e-3)" "unprognostic (2.04e-1)" 39.4 32.5 21.2 17.0 21.5 25.7 32.3 13.5 34.1 17.0 51.0 19.0 18.9 41.0 13.4 16.4 39.1 11.2 38.8 27.3 22.7 23.8 35.6 82.3 31.6 14.4 22.4 15.6 13.6 31.1 27.1 13.9 12.2 32.1 16.8 37.6 15.2 28.7 23.1 42.2 24.2 55.6 15.8 19.0 12.6 52.5 7.5 11.3 10.3 23.6 34.2 24.7 21.7 22.5 8.6 30.5 52.5 47.4 11.0 11.8 19.4 21.4 21.0 8.1 31.1 34.5 32.8 12.7 16.7 21.0 13.1 14.1 18.6 41.5 3.6 18.7 21.9 26.4 15.7 25.3 14.6 15.2 5.9 14.4 17.4 28.8 26.9 19.0 22.8 33.6 27.6 15.1 15.1 23.5 23.3 23.7 14.4 11.8 7.9 19.4 8.8 11.3 11.3 13.3 10.3 25.6 39.4 5.5 13.7 28.4 52.5 13.9 31.0 18.0 33.6 14.8 16.0 23.2 10.9 13.9 36.8 17.6 26.5 11.7 13.4 42.9 47.4 52.5 10.7 40.0 11.0 8.6 10.1 10.7 30.5 6.8 6.5 9.3 35.6 11.0 38.5 19.2 11.8 19.4 21.2 21.5 13.5 34.1 22.7 23.8 22.4 15.6 32.1 11.3 CHPF "CHSY2, CSS2" ENSG00000123989 "Chondroitin polymerizing factor" Q8IZ52 2 219538947-219543787 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035123 Approved Supported Vesicles,Centrosome,Cytosol "Intracellular and membrane" Cytosol "Vesicles, Centrosome" "HPA035123: AB_10602799" "unprognostic (1.13e-3)" "prognostic unfavourable (1.57e-4)" "unprognostic (3.65e-3)" "unprognostic (2.55e-3)" "unprognostic (1.86e-3)" "prognostic unfavourable (1.68e-4)" "unprognostic (1.37e-1)" "unprognostic (6.59e-3)" "unprognostic (7.74e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (6.79e-2)" "unprognostic (1.64e-1)" "unprognostic (6.55e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (2.96e-4)" 8.6 14.1 9.7 8.4 11.8 1.4 6.8 8.5 19.4 22.1 8.6 11.3 23.0 18.4 17.0 24.6 7.9 9.2 17.1 36.3 12.2 10.7 11.3 52.1 11.6 5.4 9.0 10.5 38.1 60.7 16.3 36.9 62.7 10.4 19.3 3.8 27.4 31.6 19.9 4.3 9.0 13.3 9.1 8.3 4.5 15.6 34.2 7.0 3.8 17.9 7.4 10.6 11.9 8.5 1.3 11.1 6.9 0.1 2.1 3.0 0.8 18.5 3.7 2.7 23.2 10.6 16.6 31.8 18.9 16.0 5.4 4.9 10.3 16.4 5.8 40.7 18.2 23.8 1.8 11.4 0.8 8.9 6.4 2.0 5.2 44.5 14.8 1.8 12.2 22.3 20.1 5.4 5.2 0.0 12.9 14.2 5.1 29.2 0.2 4.8 11.5 14.3 0.0 8.8 11.3 6.4 8.4 6.8 10.4 9.1 8.8 25.8 3.0 6.3 0.4 19.9 10.9 23.7 9.8 17.1 5.3 2.6 18.2 1.8 20.0 2.1 0.0 6.9 2.4 0.1 3.0 1.3 1.9 1.6 0.0 0.1 2.2 0.8 0.0 2.1 0.0 11.1 1.2 0.8 9.7 11.8 8.5 19.4 12.2 10.7 9.0 10.5 10.4 7.0 CHPT1 CPT1 ENSG00000111666 "Choline phosphotransferase 1" Q8WUD6 12 101696947-101744140 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 19.4;eosinophil: 9.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067643 Approved Supported Vesicles Vesicles "HPA067643: " "unprognostic (1.59e-3)" "unprognostic (1.02e-1)" "unprognostic (1.91e-1)" "unprognostic (9.48e-2)" "unprognostic (3.15e-1)" "unprognostic (9.17e-2)" "unprognostic (5.79e-2)" "unprognostic (4.83e-2)" "unprognostic (1.12e-1)" "unprognostic (4.70e-1)" "unprognostic (5.27e-2)" "unprognostic (1.16e-2)" "unprognostic (1.52e-2)" "unprognostic (3.35e-1)" "unprognostic (1.72e-1)" "prognostic favourable (7.41e-4)" "unprognostic (1.79e-1)" 18.0 21.6 19.3 14.3 20.4 21.4 76.7 12.8 16.7 22.2 40.0 11.0 15.8 36.5 9.3 25.0 10.9 14.7 17.1 71.4 18.5 14.5 30.6 64.6 20.2 30.5 17.8 14.5 11.3 14.2 12.6 7.6 9.6 12.8 16.3 21.0 14.0 53.1 22.8 18.5 13.5 42.9 16.7 17.4 13.0 23.1 28.3 12.6 3.3 26.0 7.4 8.7 17.7 38.7 3.0 2.5 19.4 1.5 3.3 0.8 0.4 3.4 16.3 4.4 9.4 35.2 11.8 12.6 12.7 14.6 12.8 8.3 6.0 2.4 5.3 7.2 17.2 5.3 26.6 4.4 12.2 8.0 22.5 21.6 8.7 35.0 19.7 10.6 4.4 11.1 1.3 5.7 10.6 6.3 31.3 13.8 12.5 8.5 6.3 36.8 11.7 21.6 4.9 8.6 3.8 5.8 13.7 4.3 3.3 11.7 16.9 31.5 17.2 7.3 4.6 11.7 6.1 9.1 12.3 7.9 2.4 6.5 9.2 12.4 17.0 19.4 1.5 9.7 0.4 1.2 0.4 3.0 0.8 0.7 2.0 2.0 0.3 0.4 2.2 3.3 1.4 2.5 0.4 0.4 19.3 20.4 12.8 16.7 18.5 14.5 17.8 14.5 12.8 12.6 CHST14 "D4ST-1, D4ST1, HD4ST" ENSG00000169105 "Carbohydrate sulfotransferase 14" Q8NCH0 15 40470998-40474571 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057697, HPA071601" Enhanced Approved Vesicles Vesicles "HPA057697: , HPA071601: " "unprognostic (5.46e-2)" "unprognostic (9.23e-2)" "unprognostic (4.03e-2)" "unprognostic (2.63e-3)" "unprognostic (1.44e-1)" "unprognostic (1.86e-1)" "unprognostic (2.96e-2)" "unprognostic (6.94e-2)" "unprognostic (1.70e-1)" "unprognostic (9.95e-2)" "unprognostic (2.84e-1)" "unprognostic (3.17e-2)" "unprognostic (5.85e-3)" "unprognostic (2.01e-3)" "unprognostic (1.94e-1)" "unprognostic (6.34e-2)" "unprognostic (2.25e-2)" 10.3 7.9 7.1 7.5 6.9 2.3 22.7 6.5 7.4 14.9 7.9 6.0 13.8 3.6 17.5 11.1 6.5 12.3 14.1 12.6 5.5 2.9 8.1 9.6 15.9 20.9 8.1 4.5 18.8 11.6 10.2 11.4 22.4 7.1 10.7 3.8 9.8 12.7 17.2 5.5 6.8 7.1 13.3 5.9 10.5 7.3 9.2 6.3 7.5 12.4 8.3 6.1 12.1 18.2 2.1 3.4 8.0 1.9 5.5 4.0 1.1 11.0 7.3 11.7 31.6 18.4 14.3 18.3 10.9 20.8 19.4 18.4 8.8 5.6 1.8 16.7 18.5 19.1 10.4 6.1 9.1 13.2 6.1 5.7 7.8 8.4 10.0 2.4 14.8 17.4 5.1 6.8 5.2 17.0 5.5 6.6 14.4 8.4 4.0 12.7 7.5 8.5 11.1 14.9 3.2 13.0 5.7 8.5 13.0 9.6 10.8 3.6 15.7 10.2 13.8 32.9 12.2 10.3 10.8 13.4 9.2 5.1 14.8 8.4 23.6 8.0 1.9 3.6 4.0 1.9 1.1 0.5 2.0 3.4 3.4 2.1 1.8 1.4 0.3 5.5 0.9 1.2 1.3 1.1 7.1 6.9 6.5 7.4 5.5 2.9 8.1 4.5 7.1 6.3 CHST7 "C6ST-2, C6ST2" ENSG00000147119 "Carbohydrate sulfotransferase 7" Q9NS84 X 46573784-46598408 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 17.8;HHSteC: 13.2;NTERA-2: 15.8;PC-3: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 15.4" "Group enriched" "Detected in many" 10 "granulocytes: 9.4;monocytes: 8.0;T-cells: 15.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003919, HPA030503" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "HPA003919: AB_10601258, HPA030503: " "unprognostic (3.16e-1)" "prognostic favourable (7.20e-4)" "unprognostic (1.11e-1)" "unprognostic (2.66e-1)" "unprognostic (1.82e-2)" "unprognostic (7.85e-2)" "unprognostic (9.82e-3)" "unprognostic (3.52e-2)" "unprognostic (2.61e-1)" "unprognostic (2.81e-1)" "unprognostic (2.39e-3)" "unprognostic (6.71e-2)" "unprognostic (1.19e-1)" "unprognostic (8.85e-3)" "unprognostic (8.28e-2)" "unprognostic (1.50e-1)" "unprognostic (4.39e-2)" 13.1 7.5 4.9 3.8 6.6 4.7 12.1 4.7 10.3 10.5 4.4 3.6 2.5 2.2 5.0 4.1 4.2 3.2 10.7 25.6 4.1 4.0 3.6 11.0 5.4 3.7 4.5 4.7 27.0 3.4 2.4 3.4 5.9 3.6 3.9 2.2 1.4 2.7 3.7 4.3 5.4 3.3 3.5 1.9 17.1 3.4 3.6 1.8 2.4 4.2 1.4 2.0 4.1 8.7 1.0 1.0 9.4 8.0 0.4 15.4 1.6 4.1 3.4 2.9 2.7 8.5 6.0 0.1 5.7 4.1 1.5 2.0 0.9 1.6 0.0 17.8 2.3 3.1 2.8 1.0 1.3 2.4 6.2 0.8 0.3 3.0 13.2 1.4 0.1 2.0 0.8 2.9 2.4 4.7 0.0 3.6 1.1 1.9 0.5 1.8 15.8 13.2 2.7 2.5 7.4 4.2 0.1 6.8 2.6 0.8 0.2 0.6 1.0 0.3 1.1 4.8 0.5 2.5 2.6 8.5 1.7 1.2 5.3 0.0 0.3 1.2 1.9 0.6 1.4 5.9 1.3 1.0 5.3 2.5 1.0 0.6 1.1 1.0 9.4 0.4 8.0 0.6 15.4 1.6 4.9 6.6 4.7 10.3 4.1 4.0 4.5 4.7 3.6 1.8 CHUK "IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16" ENSG00000213341 "Conserved helix-loop-helix ubiquitous kinase" O15111 10 100188298-100229619 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001402, CAB004240, CAB018564" Approved Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (3.74e-2)" "unprognostic (3.01e-1)" "unprognostic (3.02e-2)" "unprognostic (5.93e-2)" "unprognostic (4.02e-2)" "unprognostic (2.09e-1)" "unprognostic (8.58e-2)" "unprognostic (8.39e-2)" "unprognostic (6.73e-2)" "unprognostic (1.49e-1)" "prognostic favourable (1.27e-4)" "unprognostic (2.48e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-3)" "unprognostic (2.22e-1)" 16.6 16.6 14.0 14.3 18.9 21.3 14.2 16.0 15.8 11.8 15.0 13.0 13.9 16.1 14.7 12.4 13.5 12.0 11.7 14.5 13.3 17.6 27.2 35.8 14.0 20.8 17.9 6.9 11.4 14.5 19.6 18.2 14.2 16.4 12.9 17.6 9.5 13.9 12.5 23.6 11.0 20.6 16.1 18.6 18.7 15.1 12.5 15.6 22.5 14.5 11.7 15.5 13.8 13.6 3.7 3.4 7.2 4.8 4.0 4.3 1.4 15.6 13.2 13.6 20.2 13.1 11.8 10.5 19.9 19.6 18.6 22.8 14.8 9.3 21.2 11.8 13.5 15.5 22.6 10.6 21.0 22.5 19.5 14.1 10.5 16.3 11.2 26.0 20.7 9.4 11.3 21.5 21.0 13.2 15.9 17.6 20.3 9.5 20.5 16.1 8.8 9.7 13.4 15.1 9.7 11.8 10.1 8.1 12.1 10.8 8.4 17.3 16.7 15.9 13.9 11.7 13.2 12.7 22.6 20.8 18.7 20.7 12.8 21.2 9.2 2.6 3.0 5.1 2.4 4.8 4.0 3.7 3.0 4.3 3.4 2.1 3.3 4.2 7.2 4.0 3.2 2.1 2.8 1.4 14.0 18.9 16.0 15.8 13.3 17.6 17.9 6.9 16.4 15.6 CIC KIAA0306 ENSG00000079432 "Capicua transcriptional repressor" Q96RK0 19 42268537-42295797 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026388, HPA044341, HPA064725" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB026388: , HPA044341: , HPA064725: " "unprognostic (2.02e-2)" "unprognostic (4.08e-1)" "unprognostic (1.41e-2)" "unprognostic (3.54e-3)" "unprognostic (3.67e-1)" "unprognostic (4.17e-3)" "unprognostic (1.49e-1)" "unprognostic (2.06e-1)" "unprognostic (4.87e-1)" "unprognostic (1.85e-2)" "unprognostic (1.72e-3)" "unprognostic (3.10e-1)" "unprognostic (4.23e-2)" "unprognostic (1.00e-1)" "unprognostic (2.38e-1)" "unprognostic (1.88e-2)" "unprognostic (1.56e-1)" 18.6 15.7 30.5 22.8 29.9 28.1 20.3 46.8 31.6 17.5 14.7 24.7 13.0 16.5 28.6 12.3 12.3 22.1 17.4 12.1 25.5 15.2 14.9 15.1 15.8 21.5 25.2 20.1 31.5 22.6 16.6 22.6 13.2 20.4 14.4 6.2 19.0 23.8 20.8 21.0 34.1 16.1 16.3 16.5 24.7 14.5 31.5 25.6 13.6 16.8 10.6 13.4 13.6 17.4 2.3 2.0 5.0 2.6 0.6 2.5 1.6 17.6 32.0 12.3 16.9 8.0 15.1 6.0 13.5 11.3 11.4 10.6 9.0 10.9 12.3 12.9 10.6 8.6 6.8 20.4 3.7 29.8 9.2 10.3 20.2 10.7 10.1 5.8 29.4 18.0 12.0 12.9 7.6 10.4 10.1 25.9 6.4 16.8 11.4 11.1 7.7 18.2 9.8 10.5 7.3 9.5 16.6 15.9 13.1 12.8 8.0 10.1 9.5 12.5 19.9 27.3 22.2 9.3 16.4 21.5 14.8 8.4 21.2 9.2 16.1 3.4 1.8 1.0 2.5 2.6 1.9 1.7 1.3 1.6 1.7 2.3 0.9 1.5 5.0 0.6 1.9 2.0 0.5 1.6 30.5 29.9 46.8 31.6 25.5 15.2 25.2 20.1 20.4 25.6 CITED4 ENSG00000179862 "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4" Q96RK1 1 40861051-40862366 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 25.2;THP-1: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA056434 Approved Approved Vesicles Vesicles "HPA056434: " "unprognostic (5.39e-3)" "unprognostic (5.41e-2)" "unprognostic (1.53e-1)" "prognostic favourable (4.38e-5)" "unprognostic (3.43e-3)" "unprognostic (1.90e-2)" "unprognostic (3.44e-3)" "unprognostic (3.42e-2)" "unprognostic (2.67e-1)" "unprognostic (1.98e-3)" "unprognostic (2.25e-2)" "unprognostic (6.00e-2)" "unprognostic (2.29e-3)" "unprognostic (2.10e-1)" "unprognostic (2.11e-1)" "unprognostic (2.11e-1)" "unprognostic (6.13e-2)" 17.3 10.1 2.9 2.5 5.2 21.5 22.1 3.2 9.4 18.3 12.3 8.0 13.8 3.0 11.3 14.4 14.9 7.1 15.7 10.4 2.4 5.5 12.9 27.8 8.6 4.8 5.5 2.8 12.2 39.4 4.0 2.3 12.9 6.0 11.0 1.5 26.1 15.9 19.1 37.1 22.6 3.7 8.0 2.7 33.4 7.4 12.3 2.7 1.5 8.1 16.0 11.4 8.5 10.1 0.0 1.3 2.2 1.0 0.0 1.5 0.4 7.9 1.5 0.4 9.7 0.2 0.3 9.7 0.5 0.6 0.2 0.2 0.8 10.7 0.0 1.3 0.1 12.3 0.6 6.6 0.2 0.0 0.1 0.0 0.8 1.3 1.7 0.2 0.1 1.2 2.8 0.6 2.1 0.5 0.0 0.0 0.3 0.2 0.1 5.3 3.1 1.1 0.0 0.0 0.0 25.2 4.6 1.9 0.5 0.4 10.1 0.5 4.9 72.4 0.6 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 3.8 0.2 0.0 1.0 0.4 0.1 0.5 0.3 0.0 0.3 0.0 1.3 0.0 1.1 1.5 2.2 0.0 0.3 0.0 0.0 0.4 2.9 5.2 3.2 9.4 2.4 5.5 5.5 2.8 6.0 2.7 CKLF "C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1" ENSG00000217555 "Chemokine like factor" Q9UBR5 16 66552563-66566251 "Predicted membrane proteins, Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 142.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 142.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA062779 Approved Vesicles "Secreted to blood" Vesicles "HPA062779: " "unprognostic (1.64e-2)" "unprognostic (2.17e-2)" "unprognostic (1.88e-1)" "unprognostic (4.97e-2)" "unprognostic (3.06e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (5.67e-5)" "unprognostic (2.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.79e-2)" "unprognostic (8.05e-3)" "unprognostic (1.48e-1)" "prognostic unfavourable (1.06e-9)" "unprognostic (2.36e-1)" "unprognostic (2.65e-1)" "prognostic favourable (2.22e-4)" "unprognostic (1.07e-1)" 18.8 21.1 16.1 27.7 16.9 29.9 18.8 19.0 14.9 14.8 20.6 11.0 9.1 15.7 14.8 15.2 12.5 16.4 22.8 11.0 14.9 13.4 15.0 14.6 28.9 41.2 23.1 11.0 14.5 12.0 11.4 13.5 14.6 15.0 14.6 22.0 10.9 13.0 9.7 6.8 9.0 26.5 16.9 20.8 44.4 12.2 42.5 18.6 40.2 12.3 11.7 24.6 17.6 13.0 9.4 32.2 142.0 39.6 17.7 25.6 34.2 35.3 31.6 6.6 19.1 17.9 14.7 4.8 17.7 13.5 19.4 29.0 29.4 43.5 13.9 22.4 15.2 19.1 13.2 10.6 27.4 17.2 6.7 10.1 28.1 35.9 10.8 31.7 27.5 10.0 8.6 24.1 8.6 23.0 16.2 40.3 24.2 11.8 30.6 31.5 2.1 51.3 52.5 35.1 38.8 64.7 19.7 9.3 11.3 54.3 3.6 16.4 10.5 21.5 14.1 28.1 25.4 9.7 20.8 19.2 39.3 71.1 23.7 27.9 22.7 64.6 39.6 74.8 20.6 19.8 25.6 9.4 19.2 20.0 32.2 8.8 10.2 14.1 142.0 17.7 18.6 16.3 22.9 34.2 16.1 16.9 19.0 14.9 14.9 13.4 23.1 11.0 15.0 18.6 CKS1B "CKS1, ckshs1" ENSG00000173207 "CDC28 protein kinase regulatory subunit 1B" P61024 1 154974653-154979249 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: , HPA030762: AB_10670044" "unprognostic (1.06e-2)" "unprognostic (1.62e-1)" "unprognostic (2.84e-1)" "prognostic unfavourable (7.89e-4)" "unprognostic (1.34e-1)" "unprognostic (2.59e-2)" "prognostic unfavourable (2.94e-5)" "unprognostic (2.01e-3)" "prognostic unfavourable (3.12e-5)" "unprognostic (3.63e-2)" "prognostic unfavourable (6.13e-4)" "unprognostic (3.19e-1)" "prognostic unfavourable (6.03e-7)" "unprognostic (3.12e-2)" "unprognostic (1.44e-1)" "prognostic favourable (4.87e-4)" "unprognostic (1.37e-1)" 25.3 14.5 13.5 13.4 19.0 36.4 24.8 4.2 14.6 15.6 17.4 12.4 19.8 14.7 14.7 13.8 28.2 15.2 14.1 16.5 15.3 8.0 16.6 29.5 12.9 23.8 29.5 8.8 14.2 12.8 8.3 9.4 35.6 15.9 11.7 18.8 7.5 12.8 13.1 5.9 22.6 22.9 12.5 19.8 18.0 14.7 22.8 21.5 30.2 15.5 19.3 25.5 11.1 23.3 23.9 30.4 2.2 32.8 9.0 12.2 8.7 59.4 82.1 61.5 33.3 8.9 9.1 49.2 27.7 21.5 60.1 48.2 79.3 88.0 56.7 47.4 18.3 55.2 61.0 39.7 56.5 50.9 39.5 38.3 36.5 55.7 2.7 46.1 35.3 5.3 17.2 51.4 71.3 30.1 62.2 77.1 45.2 59.2 43.2 35.6 78.0 74.1 43.5 50.7 72.6 21.4 21.8 25.1 63.4 41.9 39.7 45.8 53.1 64.6 16.8 39.1 40.5 32.2 65.9 47.6 92.3 80.0 24.8 39.3 53.9 0.7 4.4 2.2 7.0 26.0 8.4 23.9 9.9 9.5 7.2 22.6 12.2 11.5 0.6 9.0 32.8 30.4 10.6 8.7 13.5 19.0 4.2 14.6 15.3 8.0 29.5 8.8 15.9 21.5 CKS2 ENSG00000123975 "CDC28 protein kinase regulatory subunit 2" P33552 9 89311198-89316703 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.6;testis: 103.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 54.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: , HPA030762: AB_10670044" "unprognostic (8.30e-2)" "unprognostic (3.00e-1)" "unprognostic (1.50e-2)" "unprognostic (2.80e-2)" "unprognostic (2.96e-1)" "unprognostic (1.35e-1)" "prognostic unfavourable (2.51e-6)" "unprognostic (3.57e-3)" "unprognostic (7.04e-2)" "unprognostic (1.34e-2)" "prognostic unfavourable (6.85e-4)" "unprognostic (1.24e-2)" "prognostic unfavourable (1.78e-5)" "unprognostic (2.13e-3)" "unprognostic (1.44e-1)" "unprognostic (2.84e-1)" "unprognostic (1.84e-1)" 4.8 22.4 4.2 22.7 6.1 38.1 10.7 4.0 7.5 3.6 10.8 3.0 16.7 10.8 4.6 4.4 20.4 2.8 4.7 3.3 6.1 3.2 11.0 10.2 9.5 24.6 5.2 4.3 3.9 2.6 7.0 2.2 12.4 5.0 4.8 10.7 3.2 4.4 7.6 3.6 6.1 9.3 4.1 5.4 12.6 6.8 103.2 3.6 41.6 4.6 13.5 20.8 8.1 16.7 18.3 54.6 12.4 7.5 11.6 17.9 6.5 86.6 74.3 45.5 30.4 13.4 12.2 33.2 51.6 27.9 57.2 45.8 30.5 43.0 64.9 30.6 19.3 61.0 54.5 39.7 65.8 50.6 44.1 32.9 54.4 80.9 5.8 67.0 37.5 4.4 9.2 40.9 36.2 52.9 39.2 56.9 73.2 65.0 52.6 118.1 66.4 68.6 45.6 50.0 38.7 44.9 19.9 38.5 22.9 42.8 41.6 41.6 50.1 39.0 30.0 24.7 47.0 59.7 75.0 46.1 93.5 52.4 36.5 38.8 35.2 10.5 5.9 12.4 7.0 7.5 7.9 18.3 9.6 6.7 6.5 13.5 5.2 6.8 4.2 11.6 4.1 54.6 17.9 6.5 4.2 6.1 4.0 7.5 6.1 3.2 5.2 4.3 5.0 3.6 CLCF1 "BSF-3, BSF3, CISS2, CLC, NNT-1, NNT1, NR6" ENSG00000175505 "Cardiotrophin like cytokine factor 1" Q9UBD9 11 67364168-67374177 "Disease related genes, Predicted secreted proteins" Cytokine "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042444 Uncertain Approved "Nuclear bodies,Vesicles" "Secreted to blood" "Nuclear bodies, Vesicles" "HPA042444: AB_10794527" "unprognostic (2.68e-1)" "unprognostic (7.87e-3)" "unprognostic (6.21e-3)" "unprognostic (2.62e-2)" "prognostic unfavourable (9.91e-4)" "unprognostic (1.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.47e-2)" "unprognostic (5.08e-2)" "unprognostic (2.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.54e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" "unprognostic (1.17e-2)" "unprognostic (2.37e-1)" 10.5 2.9 1.2 11.6 1.5 10.2 7.5 0.8 1.8 11.2 7.6 2.0 3.5 1.1 18.9 5.9 3.9 12.2 16.5 5.7 1.1 0.7 17.3 2.6 6.0 4.3 0.9 1.3 12.1 5.8 0.1 4.3 11.6 3.1 4.7 1.4 3.9 5.9 1.5 4.6 1.4 5.5 7.5 1.9 7.2 7.7 3.8 1.5 1.1 6.3 9.8 11.6 5.6 5.1 11.9 1.0 11.1 8.0 0.2 8.8 2.1 6.8 14.4 1.0 4.6 1.9 2.7 0.0 9.6 5.3 6.7 3.3 2.3 19.0 4.2 8.2 12.0 4.8 0.2 4.8 2.9 0.2 0.1 0.0 9.7 1.8 6.4 0.8 1.1 3.6 1.2 6.9 3.1 1.4 1.6 0.2 6.8 5.5 0.0 3.1 3.8 13.2 0.4 2.3 0.2 10.4 0.3 0.0 0.7 26.3 1.0 0.5 0.6 1.1 5.8 13.2 5.7 16.6 14.1 0.9 0.0 0.5 16.7 0.8 5.2 0.0 0.7 11.1 8.8 2.6 5.1 8.2 4.1 6.8 1.0 11.9 0.1 3.0 0.2 0.2 8.0 0.0 0.7 2.1 1.2 1.5 0.8 1.6 1.1 0.7 0.9 1.3 3.1 1.5 CLCN3 "ClC-3, CLC3" ENSG00000109572 "Chloride voltage-gated channel 3" P51790 4 169612633-169723673 "Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044723 Approved Supported Vesicles Vesicles "HPA044723: AB_10959733" "unprognostic (1.92e-1)" "unprognostic (3.92e-2)" "unprognostic (1.95e-3)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (2.25e-1)" "unprognostic (3.32e-1)" "unprognostic (1.79e-1)" "unprognostic (5.40e-2)" "unprognostic (1.30e-1)" "prognostic favourable (1.10e-4)" "unprognostic (2.49e-2)" "unprognostic (2.49e-1)" "unprognostic (1.45e-1)" "unprognostic (6.38e-3)" 11.6 21.1 27.6 10.9 29.9 5.9 18.4 24.9 37.7 15.0 26.7 32.4 15.5 17.1 11.1 17.7 26.6 15.6 22.0 19.6 29.3 29.7 22.2 14.7 11.9 9.0 32.7 22.7 14.0 23.4 29.4 38.7 14.5 36.1 19.5 30.8 20.6 48.5 13.5 14.6 18.0 16.5 10.4 46.1 9.0 23.2 18.4 25.4 10.8 21.7 18.4 13.5 20.5 16.7 8.6 11.9 6.2 8.1 6.9 11.5 7.9 11.8 12.2 18.3 23.3 37.4 31.5 9.0 15.9 19.9 10.7 13.1 8.6 26.8 14.6 9.9 13.2 10.1 22.8 9.8 18.0 12.9 8.9 12.2 19.9 9.9 25.5 14.6 20.5 21.9 22.6 19.0 18.9 19.3 30.2 33.5 18.9 4.2 20.0 3.4 7.5 8.3 9.0 8.1 11.4 22.4 24.4 19.9 19.6 14.1 15.5 24.8 10.5 6.9 16.3 8.6 9.7 13.8 12.3 14.9 22.4 13.0 25.9 5.6 22.7 6.2 6.5 4.7 9.0 8.1 11.5 8.6 6.7 8.2 9.5 7.4 10.4 9.2 5.3 6.9 6.5 11.9 8.1 7.9 27.6 29.9 24.9 36.8 29.3 29.7 32.7 22.7 36.1 25.4 CLCN4 "ClC-4, CLC4" ENSG00000073464 "Chloride voltage-gated channel 4" P51793 X 10156945-10237660 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;epididymis: 22.8;skeletal muscle: 34.6" "Cell line enhanced" "Detected in many" "HEL: 16.7;SCLC-21H: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.3;memory B-cell: 1.7;naive B-cell: 6.8;neutrophil: 4.4" "Group enriched" "Detected in many" 9 "B-cells: 6.8;granulocytes: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031313, HPA063637" Enhanced Approved Vesicles Vesicles "HPA031313: AB_10601358, HPA063637: " "unprognostic (1.01e-1)" "unprognostic (1.20e-2)" "unprognostic (5.07e-2)" "prognostic unfavourable (2.13e-5)" "unprognostic (2.96e-1)" "unprognostic (3.75e-1)" "unprognostic (1.04e-2)" "unprognostic (3.66e-1)" "unprognostic (1.75e-1)" "unprognostic (5.99e-2)" "prognostic favourable (9.55e-4)" "unprognostic (9.70e-2)" "unprognostic (9.78e-3)" "unprognostic (1.68e-1)" "unprognostic (1.49e-1)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" 3.1 3.4 9.7 2.0 21.3 2.1 1.6 18.6 29.1 2.0 1.4 15.7 0.0 1.2 1.3 22.8 2.3 3.0 2.8 11.4 13.0 10.5 3.4 3.5 3.4 2.9 23.5 10.4 2.2 2.4 8.9 3.9 1.7 18.2 2.1 1.1 6.0 2.3 1.7 34.6 1.2 1.2 1.4 15.2 3.2 2.1 2.2 17.9 0.0 6.8 2.0 2.2 2.3 0.8 6.8 0.6 4.4 0.5 0.0 0.0 0.6 4.9 3.1 2.3 0.0 1.1 2.0 0.1 0.1 0.0 0.0 0.0 6.0 3.4 3.7 9.0 1.0 1.1 1.4 3.4 0.1 0.0 3.5 16.7 1.7 2.5 5.5 0.0 0.0 10.0 2.7 4.3 1.1 6.4 1.2 0.0 2.3 0.5 0.0 0.1 2.9 10.8 0.0 3.8 0.0 1.5 0.5 17.3 6.5 7.1 0.7 0.0 1.8 2.1 6.3 2.7 4.6 11.8 0.4 0.4 8.3 1.3 8.6 0.0 3.4 2.3 0.5 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.6 6.8 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.6 9.7 21.3 18.6 26.7 13.0 10.5 23.5 10.4 18.2 17.9 CLDN14 DFNB29 ENSG00000159261 "Claudin 14" O95500 21 36460621-36576569 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 7.4;liver: 25.0" "Cell line enriched" "Detected in some" 14 "HDLM-2: 68.6" "Cancer enriched" "Detected in many" 6 "liver cancer: 7.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 2.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA054707 Uncertain Vesicles Vesicles "HPA054707: " "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.43e-2)" "unprognostic (8.20e-3)" "unprognostic (5.54e-2)" "prognostic favourable (1.53e-4)" "unprognostic (3.50e-4)" "unprognostic (2.28e-1)" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (4.87e-1)" "unprognostic (7.44e-4)" "unprognostic (2.77e-2)" "unprognostic (7.65e-2)" "unprognostic (2.45e-2)" "unprognostic (9.71e-2)" 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.1 0.3 0.0 7.4 25.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 1.8 0.1 0.2 0.1 0.0 0.2 0.0 0.3 0.2 0.4 0.0 0.5 1.4 0.1 0.1 0.0 0.0 0.2 0.0 0.6 0.2 0.0 0.2 0.2 2.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.7 5.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.3 1.3 0.0 0.2 0.1 1.8 3.6 0.0 0.3 0.1 0.0 0.7 0.2 2.1 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.2 1.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 CLDN7 "CEPTRL2, CPETRL2, Hs.84359" ENSG00000181885 "Claudin 7" O95471 17 7259903-7263983 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 166.7" "Cell line enhanced" "Detected in some" "BEWO: 26.6;CACO-2: 27.7;CAPAN-2: 53.9;HaCaT: 113.3;MCF7: 39.4;SK-BR-3: 47.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013063, HPA014703, HPA073662" Enhanced Approved "Vesicles,Cell Junctions" Vesicles "Cell Junctions" "CAB013063: , HPA014703: AB_1846873, HPA073662: " "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (4.12e-2)" "unprognostic (2.90e-1)" "unprognostic (1.05e-1)" "unprognostic (8.67e-2)" "unprognostic (3.41e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-3)" "unprognostic (8.34e-2)" "unprognostic (4.89e-3)" "unprognostic (1.62e-2)" "prognostic favourable (8.96e-11)" "prognostic favourable (4.09e-4)" "unprognostic (1.87e-1)" "prognostic favourable (1.85e-4)" "unprognostic (1.62e-1)" 1.6 2.0 0.4 28.0 0.4 0.0 9.5 0.4 0.4 9.9 71.4 0.4 47.6 47.2 2.4 49.3 73.4 13.4 47.2 0.7 0.4 0.3 30.0 12.1 32.3 0.8 0.4 0.4 3.4 70.9 12.3 7.3 25.0 0.4 9.8 42.5 0.7 40.9 42.2 0.9 2.9 166.7 1.8 0.5 1.4 1.2 1.8 0.4 1.5 40.5 28.3 45.6 12.2 19.3 3.8 1.6 0.0 3.0 2.2 6.7 2.3 3.2 0.3 0.0 0.0 0.0 0.2 26.6 0.0 0.0 0.0 0.0 27.7 53.9 0.0 1.0 0.1 113.3 0.0 3.4 0.0 0.0 0.6 0.0 0.7 0.0 2.1 0.0 0.2 0.5 5.4 0.0 0.2 2.5 0.3 0.1 0.0 39.4 0.0 0.3 0.1 1.0 0.0 0.0 0.7 0.0 0.0 6.5 0.1 0.3 47.2 0.0 17.2 0.4 5.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 2.2 3.0 4.8 0.5 1.5 3.3 1.6 3.8 3.7 6.7 0.0 2.2 0.1 0.2 0.9 2.3 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.4 CLDN9 ENSG00000213937 "Claudin 9" O95484 16 3012456-3014505 "Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2" "Group enriched" "Detected in some" 4 "CAPAN-2: 5.5;MCF7: 19.1;SCLC-21H: 15.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076613 Supported "Vesicles,Cell Junctions" "Cell Junctions" Vesicles "HPA076613: " "unprognostic (7.93e-2)" "unprognostic (1.40e-1)" "unprognostic (1.43e-2)" "prognostic unfavourable (2.24e-6)" "unprognostic (4.91e-2)" "unprognostic (6.04e-2)" "unprognostic (1.13e-1)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (5.06e-2)" "unprognostic (8.97e-3)" "unprognostic (4.51e-2)" "unprognostic (2.89e-2)" "prognostic unfavourable (4.67e-4)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.55e-2)" 0.3 0.4 0.4 0.5 2.1 5.2 0.3 16.5 1.4 0.6 1.0 0.3 0.3 1.8 0.3 0.9 0.3 2.3 1.1 0.4 0.8 0.8 0.6 2.6 1.5 0.3 1.4 0.3 0.3 9.6 4.8 15.9 10.2 0.5 0.3 0.1 0.3 1.7 0.3 1.5 0.4 1.2 0.3 2.2 1.0 0.3 0.3 0.3 1.2 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.2 0.1 0.0 2.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 5.5 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 19.1 0.0 1.6 0.0 0.1 0.0 0.0 0.2 0.2 0.1 15.0 0.1 0.7 0.8 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 2.1 16.5 1.4 0.8 0.8 1.4 0.3 0.5 0.3 CLEC16A "Gop-1, KIAA0350" ENSG00000038532 "C-type lectin domain containing 16A" Q2KHT3 16 10944488-11182189 "Disease related genes, Predicted intracellular proteins" Autophagy "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035814, HPA035815, HPA061385" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA035814: AB_10600801, HPA035815: AB_10671937, HPA061385: " "unprognostic (3.41e-1)" "unprognostic (4.58e-2)" "unprognostic (7.36e-2)" "unprognostic (1.56e-2)" "unprognostic (3.44e-1)" "unprognostic (1.33e-2)" "unprognostic (3.44e-1)" "unprognostic (2.22e-3)" "unprognostic (4.54e-2)" "unprognostic (7.78e-3)" "unprognostic (2.08e-1)" "unprognostic (3.49e-1)" "prognostic favourable (2.92e-6)" "unprognostic (2.69e-1)" "unprognostic (1.79e-1)" "unprognostic (8.22e-2)" "unprognostic (3.03e-1)" 9.2 9.7 11.1 12.7 13.7 15.8 8.3 17.2 19.5 8.7 9.4 14.2 9.5 11.0 9.4 10.8 11.5 9.7 6.9 10.7 11.0 10.7 11.2 12.9 12.0 11.4 12.4 10.1 7.7 7.3 22.5 21.8 9.6 13.6 8.6 8.6 12.2 9.4 9.2 14.0 15.9 10.8 9.7 14.4 9.5 8.5 43.1 11.6 15.4 11.5 5.2 12.9 8.3 8.7 7.7 5.0 6.6 6.7 4.0 5.6 2.4 5.2 5.5 4.3 5.6 7.2 5.1 3.8 5.4 5.4 4.6 6.1 6.1 9.9 10.4 12.8 6.7 4.7 5.5 10.2 6.0 50.7 5.8 4.7 7.6 6.5 5.1 5.1 10.3 6.0 5.0 7.6 6.5 6.3 7.8 6.5 5.5 8.6 8.1 4.1 3.4 4.4 11.1 3.6 6.1 9.6 3.9 5.5 7.3 7.8 8.1 4.2 5.7 8.2 6.6 5.9 7.8 8.7 4.8 4.6 4.0 8.7 7.5 7.6 6.1 5.5 4.5 3.2 5.5 3.7 3.4 4.4 4.7 3.7 3.6 7.7 5.6 4.8 6.6 4.0 6.7 5.0 3.3 2.4 11.1 13.7 17.2 19.5 11.0 10.7 12.4 10.1 13.6 11.6 CLINT1 "CLINT, ENTH, EPNR, KIAA0171" ENSG00000113282 "Clathrin interactor 1" Q14677 5 157785743-157859175 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 95.0;eosinophil: 27.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 95.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043280, HPA056947" Supported Supported Nucleoplasm,Vesicles 340000 Vesicles Nucleoplasm "HPA043280: AB_10793944, HPA056947: AB_2683283" "unprognostic (1.92e-2)" "unprognostic (6.93e-2)" "prognostic favourable (2.95e-4)" "unprognostic (7.23e-2)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (2.53e-1)" "unprognostic (8.13e-2)" "unprognostic (1.05e-1)" "unprognostic (3.19e-2)" "unprognostic (4.89e-3)" "unprognostic (1.04e-1)" "prognostic favourable (8.88e-5)" "unprognostic (1.91e-1)" "unprognostic (1.66e-1)" "prognostic unfavourable (6.77e-4)" "unprognostic (3.56e-1)" 22.0 23.3 12.6 27.1 18.8 38.1 18.8 13.6 14.7 22.0 27.9 10.0 43.8 28.8 19.1 30.3 56.4 17.1 40.3 23.4 14.0 12.7 40.8 48.6 22.3 19.2 11.7 11.7 20.1 25.3 47.9 25.9 30.1 14.3 21.5 23.7 11.3 39.9 47.1 38.7 26.0 34.6 30.9 13.0 19.0 29.4 12.1 13.0 23.6 30.3 23.3 32.8 37.1 33.8 7.8 9.9 95.0 7.8 8.8 12.7 7.5 22.7 32.9 23.5 21.8 32.7 27.6 33.7 32.1 33.3 31.8 44.9 45.8 36.0 42.9 36.9 30.5 34.4 31.8 37.1 45.4 20.2 25.7 28.6 29.6 22.9 33.4 39.0 38.8 20.5 27.9 35.6 40.2 29.7 24.4 23.9 25.5 20.0 30.6 21.7 24.6 34.1 27.6 35.2 36.2 31.8 41.0 20.7 22.5 23.2 40.2 31.6 27.7 27.6 29.8 27.8 20.6 25.3 31.4 27.9 26.5 55.0 22.5 44.7 24.3 95.0 7.4 27.6 7.4 7.8 12.7 7.8 7.1 7.3 9.9 7.0 6.2 6.6 2.8 8.8 7.8 7.8 10.1 7.5 12.6 18.8 13.6 14.7 14.0 12.7 11.7 11.7 14.3 13.0 CLIP4 "FLJ21069, RSNL2" ENSG00000115295 "CAP-Gly domain containing linker protein family member 4" Q8N3C7 2 29097705-29189643 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 29.9;hTERT-HME1: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043366, HPA056246" Uncertain Enhanced Vesicles Vesicles "HPA043366: AB_10963051, HPA056246: " "unprognostic (1.97e-2)" "unprognostic (1.49e-2)" "unprognostic (2.14e-2)" "unprognostic (2.47e-3)" "unprognostic (3.64e-1)" "unprognostic (6.82e-2)" "unprognostic (1.15e-2)" "unprognostic (8.82e-3)" "unprognostic (3.62e-1)" "unprognostic (4.32e-2)" "unprognostic (2.73e-1)" "unprognostic (7.99e-2)" "prognostic unfavourable (1.83e-4)" "unprognostic (3.59e-3)" "unprognostic (6.35e-2)" "unprognostic (2.14e-1)" "unprognostic (1.99e-2)" 16.8 9.7 12.1 8.6 19.5 2.0 18.8 12.7 19.7 8.3 13.4 17.3 7.2 4.8 13.1 8.8 22.1 12.5 12.7 26.6 13.7 12.1 7.7 4.6 17.2 8.7 19.8 12.8 22.3 6.2 12.1 22.9 39.2 15.8 16.5 7.1 15.7 10.4 15.2 46.0 28.0 7.3 23.5 18.4 9.1 8.1 15.2 14.4 7.1 31.1 16.8 9.8 19.6 13.0 1.1 1.8 1.3 17.5 3.9 9.8 3.7 28.7 8.0 1.2 4.4 11.8 17.8 0.0 11.4 19.6 6.4 7.4 0.2 19.0 3.6 5.8 19.6 11.9 1.3 8.8 9.2 6.6 1.9 0.0 10.1 0.4 29.9 0.0 5.9 12.4 22.6 8.5 31.0 4.4 0.1 11.4 9.7 0.2 2.7 1.2 0.3 1.8 0.0 7.3 0.5 11.8 5.1 1.9 5.0 9.9 4.0 10.3 0.0 1.7 14.0 1.5 11.7 5.0 4.9 5.9 0.0 0.0 7.0 0.0 4.6 1.3 4.6 0.1 6.3 10.7 9.8 1.1 4.8 6.5 1.8 0.4 5.5 5.4 0.9 3.9 17.5 0.0 1.7 3.7 12.1 19.5 12.7 19.7 13.7 12.1 19.8 12.8 15.8 14.4 CLN6 "FLJ20561, HsT18960, nclf" ENSG00000128973 "CLN6, transmembrane ER protein" Q9NWW5 15 68206992-68257211 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066046, HPA066759" Approved Approved "Nucleoli,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" "Nucleoli, Vesicles" "HPA066046: , HPA066759: " "unprognostic (1.01e-1)" "unprognostic (1.54e-3)" "unprognostic (7.01e-2)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (3.08e-1)" "unprognostic (2.24e-2)" "unprognostic (5.07e-2)" "unprognostic (2.40e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.85e-1)" "prognostic favourable (4.87e-4)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-1)" "unprognostic (6.78e-2)" 21.2 17.8 11.6 16.5 11.8 29.8 13.9 14.9 20.7 14.4 20.2 13.2 11.6 17.1 11.7 14.3 16.7 12.0 17.1 10.4 11.7 10.8 22.0 29.5 18.8 27.0 11.1 12.2 12.4 19.7 11.7 11.5 18.6 14.3 13.4 18.0 28.6 16.0 17.9 16.3 17.0 18.5 12.4 11.6 26.5 15.7 13.8 9.7 27.7 14.5 18.2 21.7 11.0 10.9 2.9 4.6 9.4 13.4 1.8 4.1 2.7 11.4 28.7 7.5 10.5 4.6 3.8 18.1 11.0 5.3 13.5 11.1 22.1 18.7 17.9 5.4 6.5 21.4 21.5 10.6 5.4 11.8 26.3 25.7 20.9 16.4 9.5 28.9 18.4 6.7 3.5 10.8 7.5 9.0 16.9 36.3 10.3 31.4 13.1 20.7 17.9 12.2 12.8 22.9 24.3 11.3 30.0 15.4 6.3 12.3 19.3 10.5 10.3 28.9 5.9 15.2 18.1 11.2 38.7 26.6 28.9 14.6 9.5 35.2 14.7 0.0 7.3 0.4 2.8 11.5 3.8 2.9 2.1 4.1 4.6 2.3 2.7 1.2 9.4 1.8 13.4 3.8 1.9 2.7 11.6 11.8 14.9 20.7 11.7 10.8 11.1 12.2 14.3 9.7 CLNK MIST ENSG00000109684 "Cytokine dependent hematopoietic cell linker" Q7Z7G1 4 10486395-10684865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 10.9;lymphoid tissue: 10.8" "Group enriched" "Detected in some" 6 "HDLM-2: 9.0;U-937: 4.7" "Cancer enriched" "Detected in single" 13 "renal cancer: 3.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035671, HPA035672" Uncertain Uncertain Vesicles Vesicles "HPA035671: AB_10669673, HPA035672: AB_10669775" "unprognostic (2.47e-3)" "unprognostic (4.74e-4)" "unprognostic (1.99e-4)" "unprognostic (2.24e-3)" "unprognostic (1.17e-1)" "unprognostic (2.23e-6)" "unprognostic (2.05e-2)" "unprognostic (5.37e-4)" "unprognostic (9.87e-2)" "unprognostic (3.75e-2)" "unprognostic (2.55e-1)" "unprognostic (7.74e-3)" "unprognostic (1.55e-1)" "unprognostic (6.05e-3)" "unprognostic (6.65e-3)" "unprognostic (1.45e-1)" "unprognostic (2.99e-2)" 0.4 0.5 0.3 5.7 0.3 0.5 0.7 0.4 0.3 1.9 1.8 0.1 0.1 0.7 0.8 1.7 2.0 0.4 1.4 0.3 0.3 0.3 10.9 1.2 3.2 5.0 0.3 0.1 0.5 0.7 0.0 3.2 1.5 0.5 0.5 0.4 1.6 2.5 0.1 0.3 1.2 2.3 1.7 0.3 6.3 1.6 1.1 0.1 8.4 0.5 1.5 10.8 0.4 0.4 3.4 5.5 1.6 0.4 4.3 3.6 0.5 0.1 0.5 0.5 0.3 0.8 0.2 0.6 0.4 0.0 0.1 0.2 0.0 0.4 0.3 0.1 0.4 0.4 0.0 0.0 0.1 9.0 0.4 0.4 0.5 0.1 0.1 0.3 0.3 0.3 0.1 0.0 0.3 0.1 0.1 0.6 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.1 1.1 0.1 0.6 0.8 0.1 0.3 0.5 0.2 0.3 0.0 1.0 0.2 0.3 0.6 0.3 0.5 0.1 0.4 0.5 4.7 0.2 1.0 0.4 0.6 0.7 0.3 0.3 3.4 1.2 0.4 5.5 2.9 0.5 0.5 1.6 4.3 0.2 1.4 3.6 0.5 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.1 0.5 0.1 CLOCK "bHLHe8, KAT13D, KIAA0334" ENSG00000134852 "Clock circadian regulator" O15516 4 55427903-55547138 "Enzymes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001867, HPA027565" Supported Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA001867: AB_1078537, HPA027565: AB_1846975" "unprognostic (1.30e-2)" "unprognostic (9.02e-2)" "unprognostic (4.25e-3)" "unprognostic (2.48e-1)" "unprognostic (3.94e-2)" "unprognostic (2.00e-2)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.32e-2)" "unprognostic (3.01e-2)" "unprognostic (5.96e-2)" "unprognostic (4.07e-2)" "unprognostic (8.31e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "unprognostic (7.16e-2)" 9.3 9.2 7.8 5.8 11.7 1.7 8.4 16.2 14.3 12.5 9.5 5.2 9.2 7.1 10.5 8.4 13.9 8.1 6.7 10.5 7.9 7.9 12.4 9.1 8.2 9.4 7.0 9.8 11.7 8.6 18.7 21.9 8.5 8.4 9.7 8.4 5.6 8.2 9.2 16.1 9.4 12.6 13.8 8.3 9.1 9.6 18.5 5.0 4.0 14.7 5.9 5.2 8.4 17.1 2.5 3.6 0.6 3.0 2.9 4.7 1.4 13.4 5.9 5.3 8.3 8.0 8.1 2.6 13.9 11.4 9.7 9.0 3.7 10.7 3.6 7.2 16.1 11.3 6.8 10.8 16.5 4.4 2.4 2.9 6.2 4.6 7.1 4.7 3.4 4.7 10.7 13.4 13.2 9.1 6.6 7.4 14.6 7.4 2.6 2.6 3.8 6.8 1.7 6.1 2.4 7.5 7.3 5.2 4.7 10.0 12.4 6.3 4.2 2.6 12.5 13.2 14.1 4.3 18.7 6.7 4.8 2.3 11.7 4.2 10.4 0.0 3.0 0.6 2.8 3.0 4.7 1.4 3.2 2.5 3.6 2.5 1.9 2.4 0.6 2.9 2.7 2.1 3.1 1.4 7.8 11.7 16.2 14.3 7.9 7.9 7.0 9.8 8.4 5.0 CLSTN2 "CDHR13, CS2, CSTN2, FLJ39113" ENSG00000158258 "Calsyntenin 2" Q9H4D0 3 139935185-140577397 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;ovary: 59.4" "Cell line enhanced" "Detected in some" "AF22: 5.7;SCLC-21H: 16.1;THP-1: 10.1" "Cancer enriched" "Detected in many" 7 "breast cancer: 15.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031342, HPA061800" Approved Uncertain "Vesicles,Cytokinetic bridge" 9100 Vesicles "Cytokinetic bridge" "HPA031342: AB_10602800, HPA061800: " "unprognostic (7.58e-2)" "unprognostic (2.64e-2)" "unprognostic (8.02e-2)" "unprognostic (1.51e-3)" "unprognostic (5.52e-3)" "unprognostic (8.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (5.58e-1)" "unprognostic (6.25e-2)" "unprognostic (2.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-2)" "unprognostic (3.16e-2)" "unprognostic (7.63e-5)" "unprognostic (7.22e-5)" 14.2 5.0 4.9 1.0 9.8 0.8 8.5 1.5 19.7 4.1 1.8 2.4 0.3 1.2 5.2 1.8 1.6 3.6 2.6 5.9 15.4 4.0 4.5 1.5 1.7 2.8 4.1 14.3 59.4 2.0 1.5 1.3 1.5 23.7 5.4 1.4 3.0 1.6 1.8 1.9 2.1 1.5 6.6 1.4 0.8 1.4 1.9 0.5 0.0 2.9 0.5 1.0 1.9 4.7 0.3 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.1 5.7 0.0 2.5 0.6 0.1 0.7 0.0 0.0 0.0 3.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 2.3 0.0 0.0 0.0 2.4 10.1 0.0 1.2 0.5 1.6 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 4.9 9.8 1.5 19.7 15.4 4.0 4.1 14.3 23.7 0.5 CLTA Lca ENSG00000122705 "Clathrin light chain A" P09496 9 36190856-36304781 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002665, HPA050918, HPA054667" Enhanced Enhanced Vesicles,Endosomes,Lysosomes 2100000 "Vesicles, Endosomes, Lysosomes" "CAB002665: , HPA050918: , HPA054667: " "prognostic favourable (5.64e-4)" "unprognostic (7.62e-2)" "unprognostic (9.22e-2)" "unprognostic (8.45e-3)" "unprognostic (1.71e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (9.46e-5)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.92e-3)" "unprognostic (7.27e-2)" "unprognostic (2.15e-1)" "unprognostic (1.23e-3)" "unprognostic (5.92e-2)" "unprognostic (1.56e-1)" "prognostic favourable (1.01e-4)" "unprognostic (4.98e-2)" 60.0 64.8 65.0 46.9 60.8 35.4 55.5 68.6 86.3 58.1 71.4 55.5 35.8 65.6 58.1 64.5 63.8 65.2 56.4 31.4 62.6 62.0 72.2 60.0 48.7 53.1 67.1 67.0 78.1 52.8 42.8 47.0 78.2 67.9 53.3 67.6 48.1 58.8 47.6 33.2 47.5 58.3 52.4 71.5 59.6 56.3 48.3 41.9 58.2 77.1 49.4 54.5 46.2 60.5 31.3 57.3 29.1 59.5 22.6 40.5 45.9 60.3 48.5 36.6 27.8 53.5 53.9 59.0 62.7 47.8 50.5 59.5 36.3 27.2 45.7 34.8 41.7 25.8 45.8 43.6 46.5 30.9 37.0 35.0 49.4 37.1 71.9 37.1 32.5 59.2 48.4 57.9 46.0 62.3 30.4 24.1 76.0 21.0 33.3 47.3 58.4 69.5 32.2 24.3 25.9 68.2 43.3 28.4 47.8 26.2 30.8 51.5 27.8 45.9 79.6 40.8 45.9 46.6 65.2 16.2 38.0 48.5 50.3 52.2 35.9 29.1 56.6 28.0 26.5 59.5 27.8 31.3 28.9 27.2 57.3 30.6 26.4 22.8 22.2 22.6 45.6 49.5 40.5 45.9 65.0 60.8 68.6 86.3 62.6 62.0 67.1 67.0 67.9 41.9 CLTB Lcb ENSG00000175416 "Clathrin light chain B" P09497 5 176392455-176416569 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 103.7;MCF7: 92.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003692, HPA036458" Approved Supported "Vesicles,Plasma membrane,Cytosol" 350000 Vesicles "Plasma membrane, Cytosol" "CAB003692: AB_425372, HPA036458: AB_2675136" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (4.51e-2)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" "unprognostic (3.54e-3)" "unprognostic (1.83e-2)" "unprognostic (1.74e-2)" "unprognostic (1.93e-1)" "unprognostic (7.42e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (7.89e-5)" "unprognostic (3.55e-1)" "unprognostic (7.50e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-2)" 20.4 24.1 29.7 18.7 26.7 13.5 16.0 27.5 47.9 27.7 34.7 14.2 11.4 35.4 15.0 15.7 94.2 12.7 28.4 65.7 26.4 26.9 20.3 15.0 15.6 12.2 25.9 22.7 24.3 19.7 17.9 19.8 61.2 28.7 16.8 18.1 19.4 22.2 19.3 93.7 81.8 41.1 27.1 15.4 14.2 39.6 9.9 10.1 14.3 17.2 55.4 31.2 26.1 45.3 4.3 9.9 28.0 9.9 7.4 11.6 3.6 32.8 15.8 4.5 19.1 10.1 7.6 36.8 42.4 16.5 26.9 19.3 20.3 15.4 7.2 25.0 19.0 31.4 7.6 103.7 10.5 49.2 14.1 4.8 23.4 12.5 15.9 7.6 12.9 8.0 36.1 14.7 17.4 12.6 9.2 18.5 14.8 92.2 12.0 11.6 3.6 23.5 13.1 7.9 23.6 14.2 13.4 19.3 6.6 20.1 22.2 14.4 9.0 14.8 27.2 9.7 14.5 17.6 23.9 14.7 10.1 9.7 7.8 16.3 11.0 2.8 9.9 28.0 7.2 7.5 3.7 3.1 6.4 7.0 9.9 4.3 5.2 5.5 18.7 7.4 9.7 8.0 11.6 3.6 29.7 26.7 27.5 47.9 26.4 26.9 25.9 22.7 28.7 10.1 CLTC "CLTCL2, Hc" ENSG00000141367 "Clathrin heavy chain" Q00610 17 59619689-59696956 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB010389, CAB011571, CAB017155, HPA059143" Approved Enhanced "Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol" 51000000 "Vesicles, Endosomes, Lysosomes" "Mitotic spindle, Cytosol" "CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: " "unprognostic (1.56e-1)" "prognostic unfavourable (7.35e-4)" "prognostic favourable (7.65e-4)" "unprognostic (1.03e-1)" "unprognostic (2.62e-1)" "unprognostic (5.23e-3)" "prognostic unfavourable (5.54e-4)" "unprognostic (1.11e-1)" "unprognostic (6.43e-2)" "unprognostic (1.09e-1)" "unprognostic (3.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (9.22e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (2.02e-4)" 39.5 45.7 47.4 35.1 57.6 30.7 57.9 59.1 83.6 38.1 45.0 25.1 47.7 27.9 38.7 52.3 32.1 30.9 34.1 39.9 47.1 53.7 48.6 46.0 46.5 60.7 53.9 59.3 29.8 23.3 96.1 30.0 51.5 57.0 38.9 48.9 22.7 28.6 54.4 44.2 30.5 27.7 45.8 47.8 28.0 34.2 29.4 28.8 28.0 43.7 26.6 31.2 37.1 40.6 10.0 24.6 13.9 24.6 12.3 15.6 13.1 46.9 71.1 35.1 34.7 59.3 48.3 40.1 50.5 53.3 45.3 47.3 43.5 28.9 32.7 58.0 71.7 31.0 52.2 42.0 60.5 35.1 28.1 53.6 45.0 67.5 45.2 36.6 31.0 45.7 25.7 68.8 44.4 50.0 53.3 46.3 70.5 83.7 21.7 10.9 30.2 41.5 19.3 58.8 39.6 50.7 66.7 31.5 37.5 31.3 20.5 29.9 48.7 23.1 63.9 83.1 49.6 39.6 51.7 36.5 51.2 30.2 60.9 24.8 50.7 10.5 20.9 13.9 12.7 24.6 15.6 10.0 11.7 13.7 24.6 9.1 10.0 11.0 13.4 12.3 20.7 16.1 14.5 13.1 47.4 57.6 59.1 83.6 47.1 53.7 53.9 59.3 57.0 28.8 CLTCL1 "CHC22, CLH22, CLTCL, CLTD" ENSG00000070371 "Clathrin heavy chain like 1" P53675 22 19179473-19291716 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 53.0" "Cell line enhanced" "Detected in many" "HMC-1: 34.3;K-562: 16.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 3.3;neutrophil: 8.4" "Group enriched" "Detected in many" 15 "granulocytes: 8.4;monocytes: 3.3" "HPA075327, HPA075795" Enhanced Approved Vesicles Vesicles "HPA075327: , HPA075795: " "unprognostic (1.29e-2)" "unprognostic (3.13e-2)" "unprognostic (1.93e-2)" "unprognostic (3.16e-3)" "unprognostic (8.20e-2)" "unprognostic (6.93e-3)" "unprognostic (1.60e-1)" "unprognostic (3.28e-1)" "unprognostic (4.42e-2)" "unprognostic (2.93e-3)" "unprognostic (3.14e-1)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" "unprognostic (8.71e-4)" "unprognostic (1.61e-1)" "unprognostic (2.10e-2)" "unprognostic (1.06e-1)" 2.9 3.3 1.1 0.9 2.0 9.7 1.6 3.4 1.8 1.3 1.0 3.7 1.2 0.4 2.3 3.1 2.2 1.4 0.9 5.6 1.3 1.7 1.0 1.7 1.2 0.6 2.7 1.4 1.4 0.9 2.1 14.9 1.1 4.1 1.8 0.8 4.2 1.5 1.1 53.0 2.1 0.9 2.4 3.6 0.9 1.0 17.2 1.2 1.3 2.7 10.4 0.7 1.2 1.3 0.2 0.3 8.4 3.3 0.0 0.3 0.6 2.2 2.3 1.5 2.5 5.8 3.2 0.7 1.6 1.7 2.3 3.4 0.8 0.7 0.9 0.2 3.6 0.8 2.4 4.5 1.8 0.1 2.4 0.1 2.2 2.7 2.9 3.2 34.3 13.7 3.7 4.1 5.8 1.4 16.0 0.9 5.2 1.8 0.4 11.4 2.0 1.9 1.2 13.1 0.0 1.7 0.9 3.7 0.6 3.4 2.1 0.2 4.6 13.8 0.4 4.0 8.6 2.2 2.6 1.8 4.2 0.4 2.4 8.8 0.8 0.0 3.3 0.3 0.1 0.7 0.0 0.0 0.1 0.3 0.3 0.2 0.3 0.0 8.4 0.0 0.0 0.1 0.0 0.6 1.1 2.0 3.4 1.8 1.3 1.7 2.7 1.4 4.1 1.2 CLTRN "NX17, TMEM27" ENSG00000147003 "Collectrin, amino acid transport regulator" Q9HBJ8 X 15627318-15665031 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "kidney: 204.4" "Cell line enhanced" "Detected in many" "HaCaT: 10.7;hTERT-HME1: 6.1;RPTEC TERT1: 9.8" "Cancer enriched" "Detected in many" 35 "renal cancer: 106.2" "Region enriched" "Detected in single" 9 "pons and medulla: 5.0" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA048543 Enhanced Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" "HPA048543: " "unprognostic (1.27e-1)" "unprognostic (4.77e-2)" "unprognostic (2.45e-2)" "unprognostic (2.66e-2)" "unprognostic (5.20e-2)" "unprognostic (5.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-2)" "prognostic favourable (5.65e-4)" "unprognostic (1.05e-2)" "unprognostic (3.03e-1)" "prognostic favourable (6.78e-9)" "unprognostic (1.77e-1)" "unprognostic (2.60e-2)" "unprognostic (2.58e-1)" "unprognostic (1.33e-2)" 0.1 0.2 0.3 0.1 0.4 0.0 0.3 0.1 0.2 0.2 0.2 0.5 0.1 0.1 0.2 1.6 0.2 0.4 0.6 0.2 0.5 0.4 204.4 11.5 0.6 0.1 0.3 0.1 0.8 1.2 4.0 0.2 0.7 5.0 0.3 0.0 11.3 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 2.4 0.3 0.1 0.2 0.7 0.1 0.1 0.4 0.2 0.9 0.6 0.0 0.5 0.0 3.0 0.4 3.0 2.2 1.5 0.6 0.8 1.2 1.0 0.1 0.0 0.1 0.1 0.2 0.5 0.3 2.1 0.1 10.7 0.9 2.5 0.0 0.4 1.4 0.3 0.0 1.0 1.6 0.0 0.0 0.2 2.4 0.4 6.1 0.0 0.7 0.6 0.3 3.5 0.2 0.4 3.6 3.1 0.3 0.5 1.3 9.8 0.2 1.4 1.3 0.8 0.2 2.0 1.0 0.3 0.1 0.2 0.5 0.4 0.0 0.6 0.3 0.4 0.9 0.1 0.1 0.0 0.5 0.0 0.6 0.2 1.3 0.4 0.8 0.5 0.6 0.9 3.0 0.9 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.4 0.1 0.2 0.5 0.4 0.3 0.1 5.0 0.1 CLUAP1 "CFAP22, FAP22, FLJ13297, IFT38, KIAA0643" ENSG00000103351 "Clusterin associated protein 1" Q96AJ1 16 3500924-3539048 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036976, HPA044191" Uncertain Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA036976: AB_10602209, HPA044191: " "unprognostic (1.78e-1)" "unprognostic (9.28e-3)" "unprognostic (1.21e-1)" "prognostic favourable (3.01e-4)" "unprognostic (1.57e-1)" "unprognostic (3.67e-1)" "unprognostic (4.53e-2)" "unprognostic (3.63e-2)" "unprognostic (2.04e-1)" "unprognostic (8.44e-2)" "unprognostic (3.13e-1)" "unprognostic (6.94e-3)" "unprognostic (5.11e-3)" "unprognostic (8.43e-2)" "unprognostic (2.07e-1)" "unprognostic (8.94e-3)" "unprognostic (1.12e-2)" 8.3 10.4 12.3 6.8 22.3 3.3 12.7 13.6 18.8 19.2 11.7 12.1 15.7 4.0 23.0 14.7 10.2 27.6 9.5 9.4 11.4 12.5 16.5 6.8 10.5 6.7 11.9 17.8 22.7 10.7 30.5 22.1 9.3 15.8 15.4 8.9 12.0 10.0 18.3 8.8 6.0 6.0 17.6 11.7 5.7 8.8 34.6 10.3 8.2 19.5 6.2 5.2 12.7 9.1 4.7 4.5 2.7 2.7 5.5 19.8 4.1 8.2 10.0 11.5 15.4 17.5 18.2 6.0 10.5 14.1 17.1 12.8 2.7 16.9 4.0 9.2 17.0 8.7 7.5 12.3 14.7 3.3 7.1 3.7 5.7 5.4 20.5 6.6 4.1 11.7 13.7 16.0 15.9 9.3 10.8 0.6 12.6 9.9 6.1 7.3 11.9 5.8 13.7 8.0 8.1 25.7 2.5 12.8 11.0 6.2 4.9 7.6 10.2 15.3 6.1 11.7 7.9 9.0 8.1 6.9 5.6 1.1 4.5 3.9 8.1 2.7 2.5 0.7 4.5 2.7 8.5 4.7 13.0 7.7 4.5 4.0 19.8 13.4 1.0 5.5 1.6 4.5 6.7 4.1 12.3 22.3 13.6 18.8 11.4 12.5 11.9 17.8 15.8 10.3 CLUH "CLU1, KIAA0664" ENSG00000132361 "Clustered mitochondria homolog" O75153 17 2689386-2712663 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 75.2" "Cell line enhanced" "Detected in all" "CACO-2: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031505, HPA044346" Uncertain Supported "Nuclear bodies,Vesicles" Vesicles "Nuclear bodies" "HPA031505: , HPA044346: AB_10962153" "unprognostic (3.48e-2)" "unprognostic (3.97e-2)" "unprognostic (9.02e-2)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (2.85e-2)" "unprognostic (2.84e-2)" "unprognostic (1.84e-1)" "unprognostic (2.69e-2)" "unprognostic (5.64e-2)" "unprognostic (5.11e-2)" "prognostic favourable (1.92e-5)" "unprognostic (4.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-2)" "unprognostic (6.26e-2)" 14.1 21.0 9.6 10.4 12.4 7.8 10.2 16.0 20.9 7.6 17.5 10.6 7.4 29.4 8.4 6.9 28.7 7.6 11.2 31.8 8.5 6.9 28.6 75.2 7.4 8.2 7.0 9.7 8.3 20.3 7.0 8.2 6.2 12.5 9.4 8.1 9.9 18.9 8.4 65.6 20.0 20.9 9.9 6.5 9.9 13.6 11.4 7.5 6.8 10.1 22.1 15.9 12.4 10.0 4.5 5.0 0.4 5.9 1.1 4.7 1.5 18.6 33.3 2.4 8.4 5.0 3.6 27.8 10.0 3.5 10.8 7.8 67.1 7.6 34.1 12.0 4.7 34.2 11.1 13.0 3.6 12.2 24.6 18.7 25.8 23.2 4.6 14.8 12.2 6.0 7.8 12.2 6.3 5.5 22.8 10.3 3.2 20.1 16.6 14.5 7.6 19.2 27.2 10.4 18.0 6.8 28.9 11.2 8.9 11.4 31.5 11.7 18.9 7.7 10.5 9.0 12.4 24.6 21.9 5.2 5.9 12.9 9.3 19.8 10.6 0.0 4.3 0.0 3.4 5.9 2.6 4.1 2.0 1.8 4.4 4.5 4.7 4.1 0.4 1.1 3.6 5.0 2.6 1.5 9.6 12.4 16.0 20.9 8.5 6.9 7.0 9.7 12.5 7.5 CMTM4 CKLFSF4 ENSG00000183723 "CKLF like MARVEL transmembrane domain containing 4" Q8IZR5 16 66614750-66696707 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 39.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014704, HPA023890" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" "Golgi apparatus, Vesicles, Plasma membrane" "HPA014704: AB_1847005, HPA023890: AB_1847007" "unprognostic (2.65e-3)" "unprognostic (1.16e-1)" "unprognostic (6.17e-3)" "unprognostic (3.43e-1)" "unprognostic (5.13e-1)" "unprognostic (8.30e-2)" "unprognostic (2.88e-2)" "unprognostic (2.65e-1)" "unprognostic (3.35e-3)" "unprognostic (6.06e-3)" "unprognostic (2.07e-2)" "unprognostic (3.08e-1)" "prognostic favourable (4.72e-9)" "unprognostic (1.41e-1)" "unprognostic (2.31e-1)" "unprognostic (4.94e-2)" "unprognostic (1.00e-1)" 2.7 4.8 18.9 3.3 18.2 2.9 6.6 8.3 22.1 4.8 16.1 13.5 8.7 12.6 3.2 21.8 4.5 11.5 4.8 3.3 20.0 16.2 18.3 2.5 6.5 1.3 17.0 13.0 2.5 15.1 31.7 9.4 4.3 12.5 6.8 13.4 5.2 10.7 6.9 2.7 7.2 15.8 4.2 13.3 1.8 18.5 6.3 10.3 0.0 39.3 0.5 2.1 4.3 2.6 0.2 1.3 0.1 1.2 0.2 0.9 0.2 9.7 8.3 4.9 12.0 1.6 2.5 20.4 4.1 3.6 2.2 3.6 14.7 11.1 0.4 7.1 2.4 12.4 11.9 4.6 3.3 0.8 10.9 0.9 3.0 8.9 3.5 0.8 1.9 4.0 8.3 2.6 5.2 1.2 4.9 2.7 3.2 10.7 0.1 1.9 5.7 5.5 2.1 6.4 3.0 9.6 8.8 11.6 4.5 16.8 9.2 5.8 9.9 2.0 2.5 4.1 4.7 1.1 4.2 0.9 2.0 0.5 5.0 2.0 4.9 0.0 1.2 0.0 0.3 0.3 0.0 0.0 0.1 0.9 1.3 0.2 0.1 0.2 0.1 0.2 0.7 1.3 0.7 0.2 18.9 18.2 8.3 22.1 20.0 16.2 17.0 13.0 12.5 10.3 CMTM5 "CKLFSF5, FLJ37521" ENSG00000166091 "CKLF like MARVEL transmembrane domain containing 5" Q96DZ9 14 23376808-23379772 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 19.4;brain: 67.3" "Cell line enriched" "Detected in some" 6 "HEL: 41.7" "Group enriched" "Detected in some" 37 "glioma: 8.4;melanoma: 3.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 7.6;neutrophil: 2.8" "Lineage enriched" "Detected in single" 11 "granulocytes: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052338 Enhanced Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA052338: AB_2681793" "unprognostic (2.73e-3)" "unprognostic (1.51e-1)" "unprognostic (5.24e-1)" "unprognostic (2.43e-3)" "unprognostic (2.63e-1)" "unprognostic (6.40e-2)" "unprognostic (8.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.27e-2)" "unprognostic (8.40e-2)" "unprognostic (6.24e-4)" "unprognostic (3.03e-3)" "unprognostic (1.97e-3)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" 1.7 1.8 14.1 1.3 19.4 6.6 1.3 4.8 55.4 2.6 1.9 47.0 0.0 1.3 1.6 1.6 2.1 1.7 2.5 5.8 19.6 12.1 1.1 1.0 1.7 1.1 26.9 10.3 1.7 1.1 0.9 0.1 1.5 18.4 1.9 1.6 0.6 3.1 4.2 1.4 1.5 2.0 1.7 67.3 1.9 1.1 1.1 12.7 0.0 1.0 0.0 1.0 1.3 0.7 0.1 0.7 7.6 0.4 0.0 0.3 19.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 7.6 0.4 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.7 0.3 19.4 14.1 19.4 4.8 24.8 19.6 12.1 26.9 10.3 18.4 12.7 CMTM6 "CKLFSF6, FLJ20396" ENSG00000091317 "CKLF like MARVEL transmembrane domain containing 6" Q9NX76 3 32481312-32503408 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 55.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026980, HPA063491" Approved Approved Vesicles 390000 Vesicles "HPA026980: AB_10602801, HPA063491: " "unprognostic (1.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.34e-2)" "unprognostic (1.81e-2)" "unprognostic (7.25e-2)" "unprognostic (8.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.99e-1)" "unprognostic (2.44e-3)" "unprognostic (2.95e-1)" "unprognostic (1.04e-3)" "unprognostic (6.79e-2)" "unprognostic (2.27e-1)" "unprognostic (7.23e-2)" "unprognostic (6.58e-2)" "unprognostic (3.74e-2)" "unprognostic (1.55e-3)" 5.5 6.4 2.8 8.2 2.6 10.4 6.7 1.4 1.4 6.6 5.5 2.5 6.7 4.9 9.8 24.4 6.1 4.2 2.4 2.4 5.1 21.6 9.0 5.6 2.8 4.1 6.0 4.0 3.0 8.6 6.0 7.3 9.0 5.0 0.7 12.6 5.9 4.7 3.9 10.5 6.3 5.7 7.7 9.5 9.3 6.1 10.0 12.8 55.5 35.4 11.2 8.1 16.3 22.5 7.3 14.6 10.9 25.2 25.1 64.5 16.7 24.0 17.6 20.3 7.7 37.7 13.4 19.1 22.3 14.6 10.2 27.7 24.1 60.0 12.4 17.0 5.3 11.4 17.9 28.3 33.9 24.8 17.9 20.2 15.2 28.2 8.2 25.4 22.4 6.9 17.0 14.7 13.0 10.8 14.4 11.4 10.4 24.4 31.6 3.3 9.8 15.2 8.6 16.0 12.7 28.4 25.3 19.6 12.9 19.0 19.9 13.2 13.0 12.5 13.6 24.8 24.3 24.6 15.1 35.2 5.6 23.3 6.2 10.0 7.5 5.3 12.8 7.1 4.4 4.9 55.5 11.2 35.4 6.9 8.1 16.3 CNGA1 "CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49" ENSG00000198515 "Cyclic nucleotide gated channel alpha 1" P29973 4 47935977-48016672 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.1;RT4: 10.5;U-2 OS: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA076168 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA076168: " "unprognostic (2.68e-2)" "unprognostic (4.90e-2)" "unprognostic (1.33e-1)" "unprognostic (8.59e-2)" "unprognostic (2.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-2)" "unprognostic (3.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (3.18e-1)" "unprognostic (2.91e-1)" "unprognostic (5.48e-6)" "unprognostic (1.86e-1)" "unprognostic (1.04e-1)" "unprognostic (4.66e-2)" "unprognostic (8.23e-2)" 4.9 1.1 0.6 2.7 1.0 0.1 2.9 0.3 0.5 5.7 6.1 0.2 1.6 2.1 0.6 12.1 13.7 3.9 1.5 1.0 0.6 0.6 4.9 23.7 0.5 0.0 1.3 0.0 1.6 2.1 5.2 4.2 21.3 0.4 6.2 2.3 14.7 4.9 1.7 4.2 5.3 12.7 0.5 0.9 8.2 2.5 1.4 0.2 0.1 2.2 3.6 2.7 8.2 8.8 0.7 2.7 1.2 0.4 1.9 1.6 0.1 3.2 1.1 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.2 2.9 13.1 0.1 0.7 0.0 2.0 0.3 0.4 0.1 0.0 0.8 0.0 0.3 1.0 0.0 0.1 0.3 0.1 0.6 0.0 0.1 0.0 0.8 0.7 0.2 1.3 0.1 0.2 0.6 3.0 0.1 0.0 0.1 0.6 10.5 0.3 0.1 0.2 0.6 0.2 1.1 0.0 0.6 0.3 4.1 0.1 0.1 0.9 1.0 0.1 0.1 0.1 2.3 0.2 0.4 0.0 0.5 0.4 0.1 0.3 0.2 1.6 0.3 0.7 0.3 0.6 1.2 1.9 0.2 2.7 0.1 0.1 0.6 1.0 0.3 0.5 0.6 0.6 1.3 0.0 0.4 0.2 CNGB1 "CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45" ENSG00000070729 "Cyclic nucleotide gated channel beta 1" Q14028 16 57882340-57971116 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Olfaction, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 79.8" "Cell line enhanced" "Detected in some" "EFO-21: 2.9;RPMI-8226: 3.3;SCLC-21H: 9.4;SiHa: 5.4" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 2.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA039159, HPA060355" Approved Vesicles,Cytosol Cytosol Vesicles "HPA039159: AB_10795579, HPA060355: " "unprognostic (5.52e-3)" "unprognostic (4.51e-3)" "unprognostic (1.06e-1)" "unprognostic (2.73e-3)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (8.56e-4)" "unprognostic (3.08e-1)" "unprognostic (9.84e-2)" "unprognostic (2.83e-1)" "unprognostic (2.14e-4)" "unprognostic (5.42e-2)" "unprognostic (1.01e-3)" "unprognostic (5.20e-2)" "unprognostic (1.88e-1)" "unprognostic (4.57e-2)" "unprognostic (9.07e-2)" 0.2 7.2 13.1 3.0 3.0 0.7 0.2 0.2 6.3 0.2 1.7 0.0 0.0 0.5 0.2 0.5 0.2 0.4 0.8 0.2 7.1 11.0 0.2 0.2 0.4 0.7 1.3 4.0 0.1 1.5 0.0 0.5 1.2 4.2 0.2 1.2 79.8 0.3 0.4 0.1 0.5 1.8 0.2 0.7 0.2 0.2 1.3 0.0 0.0 0.2 0.0 0.4 0.3 0.2 0.4 0.3 2.6 0.3 0.3 0.4 0.0 0.6 1.2 0.0 0.2 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.6 1.7 0.9 0.0 0.0 0.2 0.0 0.1 0.0 1.7 0.0 0.0 0.4 0.0 0.1 0.6 0.1 0.2 0.2 0.1 0.0 3.3 0.0 1.2 9.4 0.1 5.4 2.7 0.0 0.1 0.1 0.7 0.3 0.4 0.4 0.1 0.2 0.5 0.1 0.1 0.3 0.1 0.6 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.4 0.4 0.2 2.6 0.3 0.3 0.3 0.0 0.0 13.1 3.0 0.2 6.3 7.1 11.0 1.3 4.0 4.2 0.0 CNIH1 "CNIH, CNIL, TGAM77" ENSG00000100528 "Cornichon family AMPA receptor auxiliary protein 1" O95406 14 54423560-54441431 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002544 Approved Approved Vesicles Vesicles "HPA002544: AB_2081856" "unprognostic (1.06e-1)" "unprognostic (1.18e-3)" "unprognostic (7.09e-2)" "unprognostic (5.06e-2)" "unprognostic (1.50e-1)" "unprognostic (8.93e-3)" "unprognostic (1.47e-1)" "unprognostic (2.71e-3)" "unprognostic (4.78e-2)" "unprognostic (4.62e-1)" "unprognostic (1.38e-2)" "unprognostic (1.79e-1)" "unprognostic (4.12e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-1)" "unprognostic (1.71e-2)" "prognostic unfavourable (8.95e-4)" 32.2 32.3 24.3 19.9 24.9 11.7 27.7 20.6 28.0 23.5 31.0 18.9 22.5 35.8 25.4 20.3 28.7 25.2 27.5 31.0 21.6 22.9 29.4 83.6 26.1 36.2 23.5 18.9 22.0 26.3 12.3 31.2 21.0 20.5 26.9 35.8 23.2 20.5 23.2 25.1 14.3 32.1 46.2 25.5 17.1 20.7 16.7 16.2 26.3 24.1 27.3 27.8 40.6 20.0 23.6 31.7 7.6 31.2 15.6 30.7 31.6 41.1 25.2 21.2 23.8 57.4 73.5 19.7 50.1 64.3 43.4 49.9 14.9 58.1 52.0 33.4 37.9 41.3 38.4 36.4 54.3 19.8 22.5 19.9 16.2 27.0 57.7 24.0 16.8 59.7 45.5 40.4 57.3 40.7 19.4 17.7 48.3 22.7 26.5 18.3 15.6 51.2 20.4 35.6 17.3 49.1 30.8 17.8 19.8 29.2 23.5 55.5 36.2 26.2 26.1 36.6 36.4 30.6 30.1 11.1 23.9 25.2 44.4 20.6 32.3 1.9 31.2 3.8 12.9 23.7 21.5 23.6 22.8 18.4 31.7 18.9 30.7 20.5 7.6 15.6 18.2 17.8 23.2 31.6 24.3 24.9 20.6 28.0 21.6 22.9 23.5 18.9 20.5 16.2 CNNM2 ACDP2 ENSG00000148842 "Cyclin and CBS domain divalent metal cation transport mediator 2" Q9H8M5 10 102918293-103090221 "Disease related genes, Predicted membrane proteins" "Ion transport, Transport" "Disease mutation, Epilepsy, Mental retardation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 35.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059954, HPA071631" Enhanced Vesicles Vesicles "HPA059954: , HPA071631: " "unprognostic (2.18e-1)" "unprognostic (6.46e-2)" "unprognostic (1.24e-1)" "unprognostic (2.65e-3)" "unprognostic (3.19e-1)" "unprognostic (2.44e-1)" "unprognostic (1.93e-1)" "unprognostic (4.80e-2)" "unprognostic (4.51e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-2)" "unprognostic (2.39e-1)" "prognostic favourable (2.39e-8)" "unprognostic (2.44e-1)" "unprognostic (1.13e-1)" "unprognostic (2.65e-3)" "unprognostic (1.56e-1)" 5.7 19.8 9.5 6.6 13.8 13.3 5.0 16.8 15.1 6.0 11.8 12.5 8.0 6.9 6.6 5.8 3.3 8.9 9.4 4.1 7.8 10.9 15.6 7.9 6.4 4.1 10.4 8.6 8.8 6.8 35.6 10.6 14.3 9.6 5.0 11.2 7.7 5.2 7.1 3.0 7.2 7.7 6.9 9.3 4.1 5.4 8.0 12.7 3.3 10.0 1.9 3.0 6.2 5.4 1.3 1.3 2.8 0.8 4.5 1.1 0.4 4.6 7.7 3.1 8.1 7.8 3.1 8.3 2.2 9.3 3.0 3.8 5.4 4.2 1.8 3.4 3.2 6.2 6.5 4.3 2.3 3.0 11.5 2.6 4.2 11.0 4.5 1.8 3.5 4.2 6.3 3.0 10.4 1.8 4.4 10.5 1.7 7.9 2.1 2.1 4.9 4.8 5.1 3.9 2.2 2.3 2.8 4.4 5.6 5.5 1.3 5.8 10.0 3.5 1.5 4.2 6.2 2.9 3.9 11.4 12.7 3.3 7.3 6.2 1.7 1.9 0.8 0.7 1.0 0.8 0.8 1.3 0.7 0.5 0.6 0.7 0.8 0.7 2.8 4.5 0.4 1.3 1.1 0.4 9.5 13.8 16.8 15.1 7.8 10.9 10.4 8.6 9.6 12.7 CNPY4 "MGC40499, PRAT4B" ENSG00000166997 "Canopy FGF signaling regulator 4" Q8N129 7 100119613-100125511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014166, HPA025240" Uncertain Approved Vesicles "Intracellular and membrane" Vesicles "HPA014166: AB_1853895, HPA025240: AB_2082630" "unprognostic (9.64e-2)" "unprognostic (1.59e-2)" "unprognostic (4.09e-3)" "unprognostic (8.44e-2)" "prognostic unfavourable (9.76e-4)" "unprognostic (2.71e-1)" "prognostic unfavourable (3.99e-4)" "unprognostic (2.86e-1)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (6.16e-3)" "unprognostic (1.07e-1)" "prognostic unfavourable (3.59e-5)" "unprognostic (6.92e-2)" "unprognostic (1.80e-1)" "unprognostic (1.88e-1)" "unprognostic (1.35e-2)" 12.9 18.3 10.9 13.4 9.9 5.5 11.6 16.5 13.1 22.8 13.0 14.8 8.8 6.1 23.5 15.8 6.3 16.2 20.3 13.6 9.9 9.1 11.0 6.7 9.2 15.5 9.5 9.9 26.1 7.2 17.6 17.8 20.8 10.4 14.0 10.3 18.0 6.5 17.0 4.7 8.3 9.5 21.7 11.4 14.0 8.4 9.1 13.7 16.4 11.1 9.6 9.5 13.0 16.2 2.8 5.2 8.8 9.3 8.3 15.2 4.7 3.3 5.8 14.4 25.8 34.0 16.4 7.2 12.4 13.4 6.5 12.3 3.1 3.0 7.2 14.4 22.2 3.3 5.6 6.0 6.8 6.7 5.7 3.0 9.5 4.3 9.6 5.0 5.6 14.9 1.7 5.9 2.7 22.6 2.4 4.8 9.3 9.5 10.6 6.6 7.4 8.3 3.1 10.8 3.8 6.7 0.8 3.6 7.4 11.9 9.6 6.3 4.9 2.8 18.2 20.9 12.7 8.7 5.5 4.1 6.6 6.5 12.2 7.8 8.5 8.8 3.7 5.7 11.8 8.0 15.2 2.8 12.1 14.7 5.2 2.4 9.9 14.9 1.7 8.3 9.3 3.3 9.6 4.7 10.9 9.9 16.5 13.1 9.9 9.1 9.5 9.9 10.4 13.7 CNST "C1orf71, FLJ32001, PPP1R64" ENSG00000162852 "Consortin, connexin sorting protein" Q6PJW8 1 246566444-246668584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007225, HPA007226" Approved Supported Vesicles 4600000 Vesicles "HPA007225: AB_1848869, HPA007226: " "unprognostic (1.55e-2)" "unprognostic (9.75e-2)" "unprognostic (3.33e-2)" "unprognostic (9.76e-2)" "unprognostic (2.78e-1)" "unprognostic (4.28e-2)" "unprognostic (3.72e-2)" "unprognostic (7.28e-3)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (3.52e-2)" "unprognostic (3.47e-2)" "unprognostic (2.73e-3)" "unprognostic (6.17e-2)" "unprognostic (2.63e-1)" "unprognostic (8.77e-3)" "unprognostic (2.26e-1)" 15.5 21.7 10.2 13.7 22.3 21.8 12.8 25.1 22.4 10.6 14.6 8.1 10.2 11.0 14.7 9.4 18.6 10.0 9.7 11.1 9.5 17.6 9.9 25.1 12.4 16.4 11.2 14.1 12.1 11.0 15.2 17.4 11.9 13.7 9.7 13.4 11.6 9.4 9.6 35.5 11.6 15.5 18.4 7.6 12.3 9.6 17.2 9.3 24.6 15.4 10.2 18.6 14.9 11.0 21.1 6.6 21.6 11.1 7.8 19.3 9.0 4.2 5.6 4.1 3.6 6.8 8.0 8.4 13.8 13.7 14.0 10.7 5.4 5.6 12.4 6.2 13.7 4.4 6.4 4.7 19.2 6.9 2.2 14.6 5.1 4.0 9.9 7.2 28.2 7.5 4.5 13.6 14.5 4.3 18.5 5.5 7.9 3.1 7.9 3.3 13.5 4.9 7.8 7.4 10.1 5.3 12.4 9.5 11.4 5.9 3.5 17.1 6.4 6.4 6.1 17.5 4.2 7.2 9.4 16.8 21.3 12.6 4.3 10.8 16.9 21.6 4.7 12.9 8.8 5.0 9.6 19.4 15.0 8.1 4.6 21.1 19.3 10.3 6.2 7.8 11.1 6.6 18.1 9.0 10.2 22.3 25.1 22.4 9.5 17.6 11.2 14.1 13.7 9.3 CNTF HCNTF ENSG00000242689 "Ciliary neurotrophic factor" P26441 11 58622673-58625733 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.5" "Cell line enhanced" "Detected in many" "U-2197: 12.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "midbrain: 47.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA019654 Approved Approved Vesicles Vesicles "HPA019654: AB_1859050" "unprognostic (1.88e-1)" "unprognostic (2.64e-3)" "unprognostic (1.01e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-1)" "unprognostic (5.91e-2)" "unprognostic (1.63e-1)" "unprognostic (9.24e-2)" "unprognostic (5.87e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-4)" "unprognostic (5.42e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-1)" "unprognostic (1.91e-1)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" 2.0 0.7 1.4 0.9 4.8 10.0 0.8 1.2 1.6 0.3 0.9 2.5 1.1 1.4 0.3 1.4 0.9 8.3 0.8 2.5 1.8 1.6 0.9 0.9 0.8 0.6 47.5 0.9 0.3 0.5 1.2 0.5 0.6 9.3 0.6 1.3 3.1 1.3 0.4 3.7 0.9 0.9 0.6 22.8 0.6 0.5 0.7 1.2 0.2 1.0 3.7 0.6 0.6 0.3 0.4 0.0 0.0 0.3 0.0 0.7 0.2 2.1 0.8 3.4 3.5 1.0 0.3 1.7 1.6 2.2 1.6 1.2 2.9 2.9 4.3 1.2 2.2 3.8 3.6 3.9 3.2 3.0 2.1 2.3 4.3 1.6 0.4 3.3 4.2 1.0 1.3 5.3 1.7 1.7 3.4 1.0 2.0 0.9 3.2 3.1 2.1 1.5 2.2 2.4 3.0 1.9 2.5 1.5 4.2 2.2 2.3 5.8 2.9 2.4 1.2 2.5 1.9 12.7 4.0 2.4 4.9 3.7 6.6 1.7 2.9 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 1.4 4.8 1.2 1.4 1.8 1.6 47.5 0.9 9.3 1.2 CNTNAP5 "caspr5, FLJ31966" ENSG00000155052 "Contactin associated protein like 5" Q8WYK1 2 124025287-124915287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 22.4" "Cell line enhanced" "Detected in some" "AF22: 3.2;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.2" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA069095, HPA069356" Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA069095: , HPA069356: " "unprognostic (6.32e-3)" "unprognostic (6.38e-2)" "unprognostic (1.23e-1)" "unprognostic (2.25e-1)" "unprognostic (1.68e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (3.11e-2)" "unprognostic (2.62e-6)" "unprognostic (3.65e-3)" "unprognostic (5.32e-2)" "unprognostic (9.58e-2)" 0.7 2.8 12.9 0.7 7.9 1.0 0.7 3.3 22.4 0.6 0.8 1.5 0.0 1.0 0.7 0.7 0.7 0.6 4.2 0.7 14.0 4.0 1.2 0.7 0.7 0.7 2.2 8.4 0.6 1.1 0.7 0.8 0.7 15.2 0.8 0.8 0.4 0.6 1.0 0.7 0.8 0.9 0.8 1.9 0.7 0.7 0.9 2.8 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.1 0.0 1.3 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 7.9 3.3 22.4 14.0 4.0 2.2 8.4 15.2 2.8 COCH "COCH-5B2, DFNA31, DFNA9" ENSG00000100473 Cochlin O43405 14 30874514-30895065 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 63.0;pancreas: 136.8" "Cell line enhanced" "Detected in many" "HEK 293: 30.1;Hep G2: 19.7;K-562: 38.7;NB-4: 32.1;SCLC-21H: 35.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "basal ganglia: 63.0" "Group enriched" "Detected in some" 13 "memory B-cell: 24.0;naive B-cell: 7.7" "Lineage enriched" "Detected in many" 20 "B-cells: 24.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 25.4;basal ganglia: 40.0;cerebral cortex: 16.6;hippocampal formation: 15.6" HPA065086 Supported Vesicles "Secreted to extracellular matrix" 88000 Vesicles "HPA065086: " "unprognostic (8.36e-3)" "unprognostic (2.51e-2)" "unprognostic (8.61e-2)" "unprognostic (1.64e-2)" "unprognostic (6.48e-2)" "unprognostic (6.53e-2)" "unprognostic (9.61e-2)" "unprognostic (4.03e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" "unprognostic (1.27e-2)" "unprognostic (2.91e-3)" "unprognostic (5.42e-3)" "unprognostic (3.92e-2)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (1.72e-1)" 1.1 1.4 2.1 1.1 63.0 1.3 0.9 1.1 2.3 4.0 0.8 1.4 1.6 0.6 0.6 1.0 0.6 2.2 1.2 0.9 1.2 2.9 1.8 0.5 0.5 3.1 0.8 1.9 0.6 136.8 0.4 3.3 0.9 2.1 14.7 1.0 0.8 1.8 21.8 0.6 4.6 0.7 0.7 1.4 0.8 0.8 1.8 7.9 0.0 0.6 0.7 2.4 1.1 7.8 24.0 0.0 0.1 0.3 0.0 1.1 0.6 0.0 11.0 1.0 0.0 0.2 0.0 6.9 0.0 0.0 2.0 5.5 6.5 0.3 0.1 0.5 0.0 0.0 6.9 0.0 3.4 0.0 30.1 5.5 2.5 19.7 0.0 0.5 2.3 0.4 0.0 0.2 0.0 0.1 38.7 1.6 0.5 0.2 2.7 32.1 3.7 1.1 8.1 0.0 0.2 0.3 1.0 35.7 9.6 0.8 0.1 0.0 0.0 15.0 0.2 0.0 0.0 0.1 0.0 1.8 4.7 3.4 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 24.0 0.2 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.6 2.1 63.0 1.1 2.3 1.2 2.9 0.8 1.9 2.1 7.9 COG4 "COD1, DKFZP586E1519" ENSG00000103051 "Component of oligomeric golgi complex 4" 16 70480568-70523565 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040924, HPA042539" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA040924: , HPA042539: " "unprognostic (1.30e-1)" "unprognostic (2.11e-2)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (6.08e-2)" "unprognostic (1.41e-2)" "prognostic unfavourable (1.64e-5)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (2.35e-1)" "unprognostic (2.30e-1)" "unprognostic (1.37e-1)" "unprognostic (1.25e-2)" "unprognostic (3.02e-1)" "unprognostic (3.35e-1)" "unprognostic (1.99e-2)" "unprognostic (1.79e-1)" 15.1 19.0 16.7 15.0 17.6 10.9 11.9 19.4 19.2 19.1 17.3 23.2 18.2 8.9 14.7 11.9 23.3 17.8 12.7 18.5 13.8 13.7 15.0 16.6 15.8 11.6 19.0 14.0 16.9 9.9 28.1 19.1 18.0 15.1 14.2 14.8 16.4 13.7 15.8 51.3 16.9 15.6 16.9 17.0 15.2 15.2 16.8 16.7 20.3 18.1 11.8 20.7 16.2 15.6 10.8 23.9 16.7 23.0 9.5 17.1 16.5 14.5 23.9 19.0 12.6 26.0 18.2 21.7 16.3 21.6 20.7 18.0 19.2 26.8 9.8 23.7 25.7 21.4 24.3 26.0 29.2 8.3 14.9 8.9 23.1 18.4 15.3 5.9 6.1 21.6 17.0 26.9 16.6 20.7 21.4 7.3 23.1 29.5 9.6 9.0 18.4 12.6 18.2 12.6 22.2 17.0 12.3 17.8 18.5 31.9 12.4 9.6 31.4 10.3 19.5 19.1 12.1 14.3 11.7 7.6 9.4 30.2 20.8 6.2 18.5 14.4 19.2 16.7 15.4 20.9 11.2 8.5 15.1 13.8 23.9 10.8 13.5 12.5 10.1 9.5 23.0 11.0 17.1 16.5 16.7 17.6 19.4 19.2 13.8 13.7 19.0 14.0 15.1 16.7 COL14A1 UND ENSG00000187955 "Collagen type XIV alpha 1 chain" Q05707 8 120059780-120372036 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 87.4" "Group enriched" "Detected in some" 6 "ASC TERT1: 18.0;RH-30: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023781 Uncertain Approved Vesicles "Secreted to extracellular matrix" 2000000 Vesicles "HPA023781: AB_1847098" "unprognostic (1.10e-1)" "unprognostic (3.15e-1)" "unprognostic (1.41e-1)" "unprognostic (2.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-3)" "unprognostic (5.96e-2)" "unprognostic (4.29e-2)" "unprognostic (7.61e-2)" "unprognostic (3.77e-2)" "unprognostic (4.36e-1)" "unprognostic (5.07e-2)" "prognostic unfavourable (5.79e-5)" "unprognostic (1.07e-2)" "unprognostic (8.21e-3)" "unprognostic (1.15e-1)" "prognostic unfavourable (1.01e-4)" 20.0 3.3 0.8 20.8 0.9 0.0 21.6 0.7 0.9 87.4 13.9 1.0 9.6 1.3 64.6 39.2 20.0 15.6 38.6 27.8 0.8 1.0 8.3 5.0 8.8 4.5 1.1 1.1 62.1 4.4 1.1 1.8 30.8 3.0 41.7 10.5 4.2 21.8 5.8 7.6 5.4 12.2 45.2 6.5 15.4 10.1 13.3 0.4 1.1 15.7 32.5 9.9 30.4 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 18.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.6 2.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 5.2 0.1 0.0 4.6 0.1 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.4 0.0 0.0 47.8 0.1 2.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 1.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.7 0.9 0.8 1.0 1.1 1.1 3.0 0.4 COL1A1 OI4 ENSG00000108821 "Collagen type I alpha 1 chain" P02452 17 50183289-50201632 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 415.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 89.7;BJ: 172.4;fHDF/TERT166: 260.2;HSkMC: 131.8;U-138 MG: 140.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 5 "T-cells: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA011795 Approved Approved Vesicles,Cytosol "Secreted to extracellular matrix" 58000000 Cytosol Vesicles "HPA011795: AB_1847088" "unprognostic (1.61e-1)" "unprognostic (3.60e-3)" "unprognostic (8.29e-2)" "unprognostic (5.52e-2)" "unprognostic (7.74e-2)" "unprognostic (2.22e-1)" "unprognostic (6.01e-2)" "prognostic unfavourable (4.43e-4)" "unprognostic (1.23e-2)" "unprognostic (2.55e-2)" "unprognostic (8.53e-2)" "unprognostic (9.90e-2)" "prognostic unfavourable (7.19e-12)" "unprognostic (2.74e-2)" "unprognostic (4.73e-2)" "unprognostic (7.26e-2)" "unprognostic (3.87e-3)" 30.2 5.7 0.7 28.2 4.0 0.1 31.7 0.6 0.9 415.7 25.7 1.6 23.9 3.0 121.8 70.9 17.4 33.0 110.3 43.9 0.7 0.1 7.5 4.6 18.8 38.5 0.7 1.2 73.6 10.5 1.0 10.7 89.1 2.2 31.5 4.0 9.2 9.1 21.0 11.0 35.5 10.6 88.0 1.3 13.7 15.0 44.6 0.7 7.7 6.7 15.5 8.7 67.3 49.7 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.2 0.9 0.1 36.9 89.7 1.5 172.4 46.8 43.0 27.0 3.4 0.8 0.0 0.4 260.2 0.5 0.4 0.1 7.7 0.2 0.3 0.0 4.3 0.2 70.3 0.0 0.0 131.8 2.5 52.5 0.2 0.0 0.1 0.0 21.6 0.4 0.0 0.0 0.9 0.5 0.3 0.1 0.1 0.2 0.0 0.1 0.4 0.3 0.2 0.0 2.2 0.0 0.0 140.1 30.6 20.9 0.8 0.1 0.3 0.0 10.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.0 0.6 0.9 0.7 0.1 0.7 1.2 2.2 0.7 COL22A1 ENSG00000169436 "Collagen type XXII alpha 1 chain" Q8NFW1 8 138588235-138914006 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 46.5" "Cell line enhanced" "Detected in some" "HDLM-2: 23.4;RT4: 9.9;SCLC-21H: 6.7;U-2 OS: 5.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024830 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" Vesicles "Endoplasmic reticulum" "HPA024830: AB_1847102" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (2.88e-2)" "unprognostic (4.19e-6)" "prognostic unfavourable (4.15e-4)" "unprognostic (1.05e-2)" "unprognostic (5.57e-3)" "prognostic unfavourable (2.13e-6)" "unprognostic (2.01e-1)" "unprognostic (9.24e-2)" "unprognostic (5.74e-2)" "unprognostic (3.62e-2)" "unprognostic (3.66e-15)" "unprognostic (2.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (1.09e-1)" 0.1 12.0 0.2 1.3 1.1 0.0 0.1 6.8 1.1 1.3 0.7 1.4 10.8 0.3 2.4 1.9 0.2 0.5 0.4 0.2 0.3 0.8 2.8 0.1 0.1 0.5 0.3 0.0 0.3 0.2 1.7 46.5 0.0 1.9 4.7 0.1 1.6 0.8 5.1 0.5 0.1 0.4 2.2 1.8 0.3 3.7 0.8 0.1 1.4 0.3 0.7 1.7 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 9.9 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 6.8 0.3 0.3 0.8 0.3 0.0 1.9 0.1 COL25A1 ENSG00000188517 "Collagen type XXV alpha 1 chain" Q9BXS0 4 108808725-109302752 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Heparin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.4;retina: 22.1;testis: 23.6" "Cell line enriched" "Detected in some" 8 "HeLa: 30.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029107 Approved "Endoplasmic reticulum,Vesicles,Cytosol" "Vesicles, Cytosol" "Endoplasmic reticulum" "HPA029107: AB_10600802" "unprognostic (1.77e-1)" "unprognostic (2.12e-1)" "unprognostic (1.18e-1)" "unprognostic (8.87e-5)" "unprognostic (2.43e-2)" "unprognostic (3.20e-1)" "unprognostic (7.62e-3)" "unprognostic (6.86e-2)" "unprognostic (2.83e-1)" "unprognostic (3.53e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-1)" "unprognostic (5.30e-3)" "unprognostic (2.82e-3)" "unprognostic (9.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" 9.0 0.8 6.7 0.2 4.4 0.0 5.1 0.8 3.4 1.6 0.9 0.4 0.9 4.0 2.1 3.5 0.8 1.4 3.1 2.0 4.7 2.1 2.9 3.2 0.9 0.1 0.8 0.0 1.6 0.9 3.9 17.4 0.4 2.5 0.9 0.4 22.1 6.7 1.4 1.4 1.1 3.1 1.5 0.9 1.0 0.9 23.6 1.5 0.0 3.7 0.1 0.0 1.6 3.4 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.9 0.0 0.1 0.0 2.3 4.1 30.8 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.8 0.2 3.9 0.0 0.5 0.0 1.1 0.1 0.0 2.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.4 0.8 3.4 4.7 2.1 0.8 0.0 2.5 1.5 COL26A1 "EMI6, EMID2, Emu2" ENSG00000160963 "Collagen type XXVI alpha 1 chain" Q96A83 7 101362820-101559024 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.4;brain: 18.3" "Group enriched" "Detected in some" 4 "AF22: 20.6;BEWO: 16.5;HAP1: 7.3;Hep G2: 5.2;NTERA-2: 17.4" "Group enriched" "Detected in many" 6 "endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7" "Cell type enriched" "Detected in single" 63 "plasmacytoid DC: 11.4" "Lineage enriched" "Detected in single" 63 "dendritic cells: 11.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027059 Approved Approved Vesicles "Secreted to extracellular matrix" Vesicles "HPA027059: AB_1848142" "unprognostic (5.94e-3)" "unprognostic (2.16e-2)" "unprognostic (2.19e-2)" "unprognostic (4.67e-2)" "unprognostic (1.66e-1)" "unprognostic (3.35e-1)" "prognostic favourable (2.32e-5)" "unprognostic (1.48e-1)" "unprognostic (1.16e-1)" "unprognostic (2.85e-2)" "unprognostic (1.26e-3)" "unprognostic (1.78e-1)" "unprognostic (4.24e-3)" "unprognostic (3.60e-1)" "unprognostic (1.50e-1)" "unprognostic (7.48e-4)" "unprognostic (2.83e-3)" 0.0 4.1 2.5 0.3 7.0 0.3 0.2 0.4 18.3 0.1 0.0 0.2 0.0 0.1 0.5 0.3 0.0 0.2 0.3 0.1 3.3 3.1 4.8 0.6 0.9 0.0 8.1 0.2 3.1 6.7 0.0 0.5 0.6 3.7 0.0 0.0 0.2 1.1 0.0 0.1 0.1 0.1 0.3 0.4 0.2 0.8 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.6 20.6 1.3 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.8 0.0 0.1 3.2 0.0 0.0 7.3 0.0 0.0 0.7 0.9 0.0 0.0 5.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 17.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 COL4A2 "DKFZp686I14213, FLJ22259" ENSG00000134871 "Collagen type IV alpha 2 chain" P08572 13 110305812-110513027 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 125.7" "Cell line enhanced" "Detected in many" "EFO-21: 142.4;WM-115: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010751, HPA029118" Enhanced Supported Vesicles "Secreted to extracellular matrix" 1900000 Vesicles "CAB010751: AB_476828, HPA029118: " "unprognostic (2.43e-1)" "unprognostic (4.13e-3)" "unprognostic (8.04e-2)" "unprognostic (6.03e-3)" "unprognostic (2.20e-1)" "unprognostic (2.64e-2)" "unprognostic (3.45e-2)" "unprognostic (1.15e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-1)" "unprognostic (1.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavourable (3.49e-5)" "unprognostic (1.33e-2)" "unprognostic (1.57e-2)" "unprognostic (6.95e-2)" "prognostic unfavourable (9.25e-4)" 87.2 9.5 4.6 26.1 3.3 0.1 50.1 2.0 3.0 37.2 53.1 1.9 30.3 7.6 48.4 25.5 23.0 26.3 52.4 26.6 3.6 1.4 18.4 5.7 35.9 17.5 3.8 1.7 25.7 8.3 7.3 3.8 125.7 5.0 26.9 5.5 12.2 7.6 29.3 26.3 9.2 16.9 84.1 2.8 58.5 23.4 11.0 1.9 4.2 16.0 8.0 5.7 65.3 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.4 6.5 29.5 0.0 38.5 16.0 46.5 40.1 14.5 23.9 11.2 0.7 0.0 0.0 142.4 9.3 11.2 0.0 12.0 4.6 1.5 6.1 0.0 11.0 0.3 28.4 0.0 0.1 7.2 0.7 16.7 11.5 24.9 0.0 0.0 3.9 0.2 0.0 1.0 4.6 2.3 0.0 12.2 0.0 26.3 0.2 0.9 4.8 0.0 0.1 12.5 0.0 0.5 42.8 13.1 33.4 0.3 21.7 0.0 0.2 0.5 0.3 0.0 60.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.6 3.3 2.0 3.0 3.6 1.4 3.8 1.7 5.0 1.9 COL4A3 ENSG00000169031 "Collagen type IV alpha 3 chain" Q01955 2 227164565-227314792 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Alport syndrome, Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 27.9" "Cell line enhanced" "Detected in some" "HeLa: 16.1;Karpas-707: 9.5;RPTEC TERT1: 10.7;U-266/70: 8.8" "Group enriched" "Detected in some" 6 "lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory B-cell: 3.8;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 7 "B-cells: 3.8" "Not detected" "Not detected" HPA042064 Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" Vesicles "Endoplasmic reticulum" "HPA042064: AB_10794410" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (2.23e-1)" "unprognostic (9.28e-6)" "unprognostic (1.43e-1)" "unprognostic (3.29e-2)" "unprognostic (1.84e-2)" "unprognostic (7.07e-3)" "unprognostic (2.30e-1)" "unprognostic (9.09e-3)" "unprognostic (9.30e-2)" "unprognostic (3.02e-2)" "prognostic favourable (2.51e-7)" "unprognostic (1.78e-1)" "unprognostic (3.10e-2)" "unprognostic (2.49e-2)" "unprognostic (1.26e-1)" 0.7 9.5 0.9 5.4 2.9 0.3 0.9 1.4 2.9 0.7 0.7 1.7 12.0 0.7 1.5 15.3 1.1 1.5 5.3 6.7 1.6 1.2 27.9 0.7 15.0 3.6 2.4 0.0 3.6 4.4 0.2 16.7 0.2 7.5 4.9 1.0 20.9 1.1 11.2 17.8 0.6 5.0 2.9 3.1 6.1 1.5 1.5 3.4 0.0 16.2 9.4 5.8 1.8 1.2 3.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.2 1.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.4 0.0 0.1 1.3 0.0 0.0 0.0 2.9 10.7 2.1 0.5 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 8.8 3.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 3.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.9 1.4 2.9 1.6 1.2 2.4 0.0 7.5 3.4 COL5A1 ENSG00000130635 "Collagen type V alpha 1 chain" P20908 9 134641774-134844843 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Cancer-related genes, Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 110.7" "Cell line enhanced" "Detected in many" "BJ: 71.5;fHDF/TERT166: 66.4;HeLa: 47.4;HHSteC: 45.1;SiHa: 47.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 2.3" "Lineage enriched" "Detected in single" 23 "T-cells: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA030769 Approved Approved Vesicles "Secreted to extracellular matrix" 12000000 Vesicles "HPA030769: " "unprognostic (7.77e-2)" "unprognostic (4.55e-3)" "unprognostic (2.22e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (9.56e-4)" "unprognostic (8.07e-2)" "unprognostic (8.09e-2)" "unprognostic (2.38e-3)" "unprognostic (1.54e-2)" "unprognostic (5.03e-3)" "unprognostic (5.05e-2)" "unprognostic (1.40e-1)" "prognostic unfavourable (2.07e-12)" "unprognostic (2.02e-2)" "unprognostic (4.73e-2)" "unprognostic (1.65e-2)" "unprognostic (2.50e-3)" 11.5 4.2 1.5 13.7 1.4 0.0 9.5 3.0 1.2 110.7 20.9 1.4 11.8 3.6 42.1 24.1 12.3 20.5 31.8 12.2 1.8 0.9 4.3 3.4 13.4 7.8 3.0 1.3 19.5 3.7 3.7 2.6 53.8 2.2 23.3 4.7 9.1 5.1 9.9 5.0 6.9 8.7 26.7 1.5 6.5 12.5 9.5 1.1 2.7 4.1 10.1 4.0 21.8 22.9 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 2.7 2.1 3.4 32.1 34.6 1.3 71.5 14.4 12.2 13.1 0.0 0.0 0.0 15.8 66.4 0.9 0.0 0.0 3.5 0.0 0.1 0.0 47.4 0.0 45.1 0.0 0.4 33.9 0.0 11.8 0.9 14.5 0.0 0.2 6.4 0.6 0.0 0.1 1.2 1.3 2.5 8.3 0.2 0.0 0.0 0.9 0.4 47.1 0.3 0.0 0.1 0.0 24.7 25.7 10.6 31.4 14.9 0.0 0.0 0.0 20.4 0.0 4.3 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 3.0 1.2 1.8 0.9 3.0 1.3 2.2 1.1 COL8A1 "C3orf7, MGC9568" ENSG00000144810 "Collagen type VIII alpha 1 chain" P27658 3 99638475-99799226 "Plasma proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 56.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.4;fHDF/TERT166: 149.5;LHCN-M2: 43.9;TIME: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA053107 Enhanced Supported Vesicles "Secreted to extracellular matrix" Vesicles "HPA053107: " "unprognostic (3.13e-2)" "unprognostic (2.92e-2)" "unprognostic (2.27e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-3)" "unprognostic (2.49e-1)" "unprognostic (2.31e-2)" "unprognostic (4.83e-2)" "unprognostic (2.62e-2)" "unprognostic (4.79e-2)" "unprognostic (3.58e-2)" "unprognostic (3.71e-1)" "prognostic unfavourable (9.39e-8)" "unprognostic (2.98e-3)" "unprognostic (1.72e-1)" "unprognostic (1.38e-2)" "unprognostic (1.32e-3)" 20.5 4.7 1.0 6.1 3.0 0.1 7.5 2.4 0.9 5.8 16.9 1.8 11.8 0.6 5.9 16.8 15.3 6.4 6.8 26.7 1.2 1.4 9.4 1.9 36.5 0.5 1.8 2.1 7.7 0.9 32.3 9.4 5.5 2.9 13.1 4.8 38.7 5.2 8.8 5.0 2.3 2.7 18.8 3.0 0.9 4.2 6.4 0.6 0.0 56.0 6.4 0.8 21.3 12.1 0.4 0.1 0.9 0.2 0.3 0.4 0.1 0.0 0.0 0.4 0.0 22.0 36.4 0.0 8.9 5.8 9.0 18.1 0.0 0.0 0.0 0.8 149.5 0.0 0.0 11.6 23.5 0.0 0.0 0.0 1.2 0.0 4.0 0.0 0.0 20.7 0.4 7.0 11.8 17.5 0.0 0.0 43.9 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.1 4.2 3.3 0.2 4.7 0.0 0.0 0.0 8.3 0.0 32.1 0.9 0.2 0.2 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.4 0.4 0.4 0.7 0.3 0.1 0.1 0.1 0.1 1.0 3.0 2.4 0.9 1.2 1.4 1.8 2.1 2.9 0.6 COL9A2 "EDM2, MED" ENSG00000049089 "Collagen type IX alpha 2 chain" Q14055 1 40300487-40317813 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Disease mutation, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.3;pituitary gland: 32.1;retina: 40.8" "Cell line enhanced" "Detected in some" "HDLM-2: 34.6;HMC-1: 33.4;THP-1: 37.4" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 6.4;myeloid DC: 2.7" "Group enriched" "Detected in many" 6 "dendritic cells: 2.7;granulocytes: 6.4" "Low region specificity" "Detected in all" "HPA056316, HPA075286" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" Vesicles Nucleoplasm "HPA056316: , HPA075286: " "unprognostic (1.42e-2)" "unprognostic (3.54e-2)" "unprognostic (8.94e-2)" "prognostic unfavourable (5.13e-4)" "unprognostic (4.46e-2)" "unprognostic (1.83e-3)" "unprognostic (2.06e-2)" "unprognostic (9.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.56e-3)" "unprognostic (2.26e-1)" "unprognostic (1.16e-3)" "unprognostic (4.28e-2)" "unprognostic (2.56e-1)" "unprognostic (5.89e-2)" "unprognostic (1.71e-2)" 0.7 2.3 17.2 2.6 19.5 7.6 3.1 2.3 12.1 10.0 3.6 32.0 17.4 4.6 3.9 1.5 0.7 3.7 6.5 1.0 20.8 14.5 4.3 0.6 2.8 4.2 29.8 10.5 0.6 1.7 28.3 32.1 0.9 16.3 8.8 2.6 40.8 13.7 21.3 0.3 2.0 3.3 1.3 35.3 3.2 12.8 0.8 19.7 0.2 4.3 0.9 2.5 4.0 0.5 0.7 2.7 6.4 0.7 0.4 0.3 0.1 4.2 0.1 0.6 0.3 0.9 0.5 2.9 0.0 0.0 0.2 0.5 0.1 2.4 1.2 3.7 0.1 0.7 0.0 0.0 0.1 34.6 0.5 0.7 0.3 9.7 0.6 0.3 33.4 1.8 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.9 0.4 0.7 0.8 0.4 0.8 0.0 2.4 0.0 5.1 0.5 0.8 0.0 4.3 0.4 5.4 37.4 0.0 0.0 4.4 0.0 0.1 0.5 0.0 1.1 0.3 4.4 0.2 0.0 0.2 6.4 0.0 0.5 0.0 0.5 0.2 0.0 2.7 0.7 0.1 0.0 1.1 0.4 0.7 0.3 0.3 0.1 17.2 19.5 2.3 10.8 20.8 14.5 29.8 10.5 16.3 19.7 COLEC12 "CL-P1, SCARA4, SRCL" ENSG00000158270 "Collectin subfamily member 12" Q5KU26 18 316740-500722 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 40.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.3;BJ: 8.4;HSkMC: 14.3;U-2197: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047917, HPA071056" Enhanced Approved "Golgi apparatus,Vesicles,Cell Junctions" 550000 "Golgi apparatus, Vesicles" "Cell Junctions" "HPA047917: , HPA071056: " "unprognostic (8.67e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (3.60e-2)" "unprognostic (6.94e-2)" "unprognostic (1.09e-2)" "unprognostic (1.14e-4)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "unprognostic (4.86e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (2.61e-1)" "unprognostic (2.24e-3)" "unprognostic (1.52e-2)" "prognostic unfavourable (8.10e-4)" "unprognostic (3.01e-3)" 14.2 3.7 6.9 4.6 9.7 1.2 9.4 3.5 6.4 40.8 8.0 7.7 5.1 3.4 13.1 9.9 7.5 6.6 8.1 13.5 7.0 6.3 2.7 1.4 18.7 13.9 8.1 5.8 6.8 2.4 1.5 1.5 32.0 10.5 9.6 5.0 23.5 4.8 3.5 6.3 4.4 5.0 14.3 5.2 1.2 5.0 5.0 4.7 0.7 7.6 3.8 4.9 15.0 7.3 0.9 0.9 3.3 0.8 0.7 0.5 0.3 0.0 0.0 1.5 0.0 1.6 17.3 0.6 8.4 2.9 1.2 2.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.0 4.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.3 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.8 0.4 0.5 0.3 0.3 0.5 0.5 0.4 0.2 0.9 0.4 0.4 3.3 0.7 0.5 0.9 0.3 0.3 6.9 9.7 3.5 6.4 7.0 6.3 8.1 5.8 10.5 4.7 COLGALT1 "FLJ22329, GLT25D1" ENSG00000130309 "Collagen beta(1-O)galactosyltransferase 1" Q8NBJ5 19 17555594-17583162 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047821 Approved Approved Vesicles "Intracellular and membrane" Vesicles "HPA047821: " "unprognostic (2.46e-1)" "unprognostic (1.16e-1)" "unprognostic (3.49e-1)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (1.56e-1)" "prognostic unfavourable (1.65e-5)" "unprognostic (2.92e-3)" "unprognostic (2.92e-1)" "unprognostic (1.66e-3)" "prognostic unfavourable (1.92e-4)" "unprognostic (3.89e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.43e-2)" "unprognostic (1.09e-1)" "unprognostic (8.87e-2)" "prognostic unfavourable (3.83e-4)" 29.8 11.4 12.1 26.9 16.5 21.3 36.2 15.6 13.1 18.2 18.5 10.8 9.6 12.0 21.9 20.2 17.6 19.2 18.1 21.7 10.8 7.1 11.1 17.8 25.1 46.1 19.4 7.3 19.0 15.2 7.9 8.1 29.6 11.8 12.6 11.6 9.5 12.0 13.0 10.7 16.7 17.3 25.7 11.3 30.9 13.9 11.2 17.9 10.3 11.3 12.7 11.9 19.6 19.1 2.5 11.5 7.6 17.4 1.4 3.6 7.1 23.0 27.3 13.3 18.3 52.7 32.8 21.2 21.6 12.7 28.5 29.7 20.6 36.4 11.8 38.8 37.9 20.6 13.5 25.1 17.4 6.7 21.7 11.3 35.5 19.5 28.9 27.0 34.6 27.1 22.5 32.0 13.4 32.0 23.1 6.0 10.3 10.2 13.6 17.5 9.8 26.6 14.5 17.0 18.0 6.0 15.3 9.6 7.0 23.2 18.5 21.9 9.6 39.4 22.3 56.8 16.1 50.3 35.1 10.7 27.1 13.0 33.5 51.5 25.7 1.1 15.0 7.6 3.4 17.4 2.0 2.3 3.2 3.2 11.5 2.5 2.3 3.6 2.4 1.4 12.6 4.4 1.9 7.1 12.1 16.5 15.6 13.1 10.8 7.1 19.4 7.3 11.8 17.9 COLGALT2 "C1orf17, GLT25D2, KIAA0584" ENSG00000198756 "Collagen beta(1-O)galactosyltransferase 2" Q8IYK4 1 183929854-184037729 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell line enhanced" "Detected in many" "Hep G2: 12.7;SK-MEL-30: 13.7;U-251 MG: 13.1;WM-115: 17.0" "Cancer enhanced" "Detected in many" "glioma: 11.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "basophil: 8.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031749, HPA031750" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" Nucleoplasm Vesicles "HPA031749: AB_10599298, HPA031750: AB_10611252" "unprognostic (5.44e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-5)" "unprognostic (2.08e-1)" "unprognostic (4.41e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (1.09e-2)" "unprognostic (2.52e-1)" "unprognostic (2.00e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (5.13e-9)" "unprognostic (1.53e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (3.80e-2)" 2.1 9.4 10.8 1.7 16.6 1.9 2.8 10.6 39.0 2.0 3.0 31.3 0.0 1.4 3.0 5.2 1.7 3.5 3.7 11.7 15.3 7.9 1.8 1.0 4.5 1.1 20.2 12.9 2.3 3.5 1.0 1.9 0.8 17.4 8.1 2.0 3.5 4.4 3.7 11.0 1.1 1.4 3.0 21.8 1.3 3.4 5.0 22.5 0.0 5.1 1.8 1.5 2.4 1.4 0.0 0.0 8.1 0.0 0.7 0.6 0.1 0.1 0.0 4.4 0.2 2.3 3.4 0.1 1.2 0.5 0.6 0.7 2.1 0.2 0.0 0.3 3.3 0.0 4.2 0.0 1.1 4.6 2.3 0.3 0.0 12.7 0.1 4.1 0.0 2.0 0.0 0.6 0.1 0.0 4.1 5.4 4.6 0.1 0.2 0.2 3.0 0.0 0.4 0.0 0.0 0.0 0.9 1.7 2.7 0.2 0.0 13.7 0.0 0.2 0.0 0.5 0.4 0.0 13.1 8.0 0.0 0.0 0.4 2.0 17.0 8.1 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 10.8 16.6 10.6 17.2 15.3 7.9 20.2 12.9 17.4 22.5 COMMD7 "C20orf92, dJ1085F17.3" ENSG00000149600 "COMM domain containing 7" Q86VX2 20 32702691-32743997 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA054119 Approved Vesicles Vesicles "HPA054119: " "unprognostic (1.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-1)" "unprognostic (1.84e-1)" "unprognostic (9.90e-2)" "unprognostic (1.64e-2)" "prognostic unfavourable (1.46e-4)" "unprognostic (5.31e-2)" "unprognostic (8.92e-2)" "unprognostic (2.31e-1)" "unprognostic (6.57e-2)" "unprognostic (2.98e-1)" "unprognostic (2.90e-3)" "unprognostic (5.04e-2)" "unprognostic (8.28e-2)" "unprognostic (8.52e-2)" "prognostic favourable (3.53e-4)" 22.4 22.6 32.8 18.4 25.3 23.6 24.0 25.0 30.7 18.0 21.9 19.3 26.9 12.6 19.5 35.5 18.5 19.4 19.0 27.8 25.3 21.5 30.5 25.5 19.0 18.2 23.5 26.6 17.6 27.3 19.9 14.7 32.3 17.8 21.1 21.6 22.3 23.4 22.7 41.8 19.4 15.4 25.9 17.3 21.9 20.3 10.5 16.6 13.4 37.3 16.7 22.2 21.1 16.0 19.3 36.8 46.5 45.4 27.9 24.3 43.8 16.1 11.1 10.9 7.6 8.0 14.9 19.5 13.8 23.7 23.8 16.5 20.9 10.7 12.5 12.3 17.1 7.2 9.2 11.9 18.2 4.9 5.7 35.5 7.1 15.7 20.9 14.8 20.4 11.3 15.0 18.0 10.7 23.3 12.3 6.5 15.2 12.3 12.8 30.7 9.2 10.3 12.1 1.1 4.5 25.2 11.3 6.6 10.2 14.3 20.1 23.9 11.8 24.8 15.2 24.4 13.1 14.9 14.1 7.0 5.8 4.4 29.4 81.0 9.7 29.4 32.2 46.5 24.3 42.0 21.2 19.3 20.1 22.3 36.8 17.7 22.3 21.5 3.3 27.9 45.4 23.9 21.9 43.8 32.8 25.3 25.0 30.7 25.3 21.5 23.5 26.6 17.8 16.6 COMT ENSG00000093010 Catechol-O-methyltransferase P21964 22 19941607-19969975 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" "Methyltransferase, Transferase" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 139.3" "Cell line enhanced" "Detected in many" "MCF7: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001169, CAB011233" Enhanced Supported "Endoplasmic reticulum,Vesicles" 560000 Vesicles "Endoplasmic reticulum" "CAB011233: , HPA001169: AB_1078402" "unprognostic (5.20e-2)" "unprognostic (2.73e-2)" "unprognostic (3.08e-2)" "prognostic favourable (3.68e-4)" "unprognostic (2.99e-2)" "unprognostic (2.32e-3)" "unprognostic (5.54e-3)" "unprognostic (9.14e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (2.14e-3)" "prognostic favourable (5.67e-4)" "prognostic unfavourable (9.76e-4)" "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (3.97e-1)" "unprognostic (1.07e-2)" 18.6 49.0 29.4 14.3 28.8 24.3 27.8 19.6 32.9 22.4 23.4 42.4 36.1 21.0 19.8 33.8 58.1 19.4 36.8 28.1 28.9 22.3 31.1 139.3 30.9 17.0 29.0 18.4 36.3 27.2 14.1 12.7 59.0 23.3 25.7 8.9 24.9 67.3 30.9 21.5 27.7 28.6 15.5 41.0 17.8 24.8 18.2 23.7 11.5 19.2 44.0 32.0 36.3 28.0 11.2 55.1 10.9 60.0 12.9 15.6 28.0 19.0 19.6 2.2 19.4 22.1 19.7 0.8 21.6 27.3 18.5 21.3 16.6 22.2 7.7 9.6 30.9 26.1 3.7 23.2 4.9 16.6 24.7 13.7 10.5 38.7 41.3 22.8 5.5 25.0 28.7 16.1 16.0 17.4 55.4 16.4 15.0 118.0 8.9 41.0 4.8 6.6 13.5 19.4 10.6 19.6 60.5 9.5 8.3 7.2 61.3 17.8 13.2 64.3 20.8 33.2 12.7 10.9 16.2 6.0 2.5 6.3 35.8 30.9 22.8 10.2 60.0 10.9 15.6 39.9 12.8 11.2 10.8 12.6 47.7 10.7 9.6 10.6 2.4 12.9 26.6 55.1 13.3 28.0 29.4 28.8 19.6 32.9 28.9 22.3 29.0 18.4 23.3 23.7 COPB1 COPB ENSG00000129083 "Coatomer protein complex subunit beta 1" P53618 11 14443440-14500027 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012338, HPA043954, HPA064403" Supported Enhanced "Golgi apparatus,Vesicles,Cytosol" 400000 "Golgi apparatus, Vesicles, Cytosol" "CAB012338: AB_726922, HPA043954: , HPA064403: " "unprognostic (2.35e-1)" "unprognostic (1.02e-3)" "unprognostic (1.36e-2)" "unprognostic (4.76e-2)" "unprognostic (3.48e-1)" "prognostic unfavourable (6.91e-4)" "prognostic unfavourable (5.63e-7)" "unprognostic (4.69e-3)" "unprognostic (3.42e-2)" "unprognostic (3.60e-1)" "prognostic unfavourable (8.04e-4)" "unprognostic (8.94e-2)" "unprognostic (1.78e-2)" "unprognostic (3.02e-2)" "unprognostic (8.00e-2)" "unprognostic (3.87e-1)" "unprognostic (1.69e-2)" 30.9 33.0 18.4 23.5 20.8 31.2 55.4 23.7 23.6 32.5 26.6 15.5 42.0 25.9 32.2 33.0 32.2 28.3 25.1 34.8 18.9 16.8 37.6 56.6 38.4 53.9 22.6 15.5 31.3 52.2 40.1 43.5 52.3 22.2 31.9 31.3 17.2 43.4 41.7 21.9 24.7 33.1 39.7 26.1 29.8 30.2 21.7 20.6 46.0 37.7 26.7 28.0 28.2 27.3 26.7 33.9 27.9 30.4 28.0 39.6 24.8 31.2 26.8 28.7 21.5 48.0 55.7 23.2 47.4 49.8 42.3 49.7 20.7 48.7 30.4 21.3 59.8 34.5 32.3 31.8 52.3 28.4 26.8 32.3 19.2 31.5 42.6 29.6 32.8 38.8 42.0 28.2 53.6 44.2 23.9 25.0 53.2 23.5 26.9 18.2 14.9 29.2 22.1 39.6 20.7 38.1 28.9 18.4 19.8 36.7 29.7 24.3 27.0 25.9 44.8 40.7 21.1 43.8 25.7 13.4 22.6 33.5 30.7 18.5 37.9 27.3 24.9 27.9 32.2 30.4 39.6 26.7 27.5 32.9 33.9 22.6 27.6 28.6 20.5 28.0 30.3 20.4 29.3 24.8 18.4 20.8 23.7 23.6 18.9 16.8 22.6 15.5 22.2 20.6 COPS2 "ALIEN, CSN2, TRIP15" ENSG00000166200 "COP9 signalosome subunit 2" P61201 15 49106068-49155661 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016867, HPA018271, HPA061071" Approved Supported "Vesicles,Cytokinetic bridge" 190000 Vesicles "Cytokinetic bridge" "HPA016867: AB_1858336, HPA018271: AB_1858335, HPA061071: " "unprognostic (3.47e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (1.86e-1)" "unprognostic (7.84e-3)" "unprognostic (1.04e-1)" "unprognostic (6.77e-2)" "unprognostic (2.49e-2)" "unprognostic (6.09e-2)" "unprognostic (3.86e-3)" "unprognostic (1.42e-1)" "unprognostic (4.35e-3)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (5.62e-2)" "unprognostic (1.10e-3)" 36.6 26.7 23.3 15.6 34.3 48.9 30.1 29.7 35.7 35.1 27.9 10.6 26.4 19.2 26.8 21.5 34.1 20.3 24.3 27.0 21.4 21.6 27.8 33.0 25.7 18.3 28.7 20.4 36.4 25.4 26.6 30.4 25.6 41.4 30.1 19.2 8.1 19.1 22.6 59.8 20.6 27.9 34.8 37.5 22.5 21.7 26.6 27.3 22.1 33.4 27.8 20.9 56.8 33.6 11.7 15.7 8.9 17.8 11.6 20.8 11.5 22.1 13.1 28.1 23.6 34.6 49.4 19.4 38.9 37.3 34.2 31.5 27.6 12.2 36.7 26.7 37.3 32.7 39.8 32.3 37.8 24.9 16.0 34.1 28.3 22.2 26.5 32.2 17.9 41.5 26.4 27.8 49.3 35.8 43.8 19.7 37.2 11.9 17.1 16.1 18.2 17.2 18.8 26.5 54.9 36.3 33.5 27.4 19.9 22.4 24.1 31.0 23.9 32.5 23.0 33.7 18.0 62.9 40.8 17.9 45.8 46.3 31.4 52.4 27.2 8.0 13.8 8.9 10.6 17.8 19.5 11.7 16.1 15.3 15.7 10.1 20.8 13.1 5.6 11.6 15.7 10.2 20.8 11.5 23.3 34.3 29.7 35.7 21.4 21.6 28.7 20.4 41.4 27.3 CPE ENSG00000109472 "Carboxypeptidase E" P16870 4 165361194-165498320 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 203.7" "Cell line enhanced" "Detected in many" "Hep G2: 49.9;SCLC-21H: 70.2;SiHa: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003819, CAB024907" Supported Approved Nucleoplasm,Vesicles,Centrosome "Intracellular and membrane" 470000 Centrosome "Nucleoplasm, Vesicles" "CAB024907: , HPA003819: " "unprognostic (1.84e-1)" "unprognostic (5.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.70e-2)" "unprognostic (2.51e-1)" "unprognostic (1.44e-2)" "unprognostic (1.65e-1)" "unprognostic (9.52e-2)" "unprognostic (2.91e-3)" "unprognostic (9.01e-2)" "unprognostic (4.84e-3)" "unprognostic (5.56e-3)" "prognostic unfavourable (2.60e-4)" "unprognostic (4.35e-3)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" "prognostic unfavourable (2.12e-4)" 27.7 33.8 123.1 4.4 135.5 0.9 21.5 82.9 203.7 10.7 9.6 31.6 5.3 5.0 13.3 94.3 16.4 15.7 14.0 19.6 116.9 56.3 12.0 6.3 11.0 7.6 56.9 70.7 23.4 35.5 33.9 40.0 2.2 53.0 66.5 8.8 13.2 12.0 20.1 11.0 5.5 6.2 18.5 40.5 2.8 19.2 30.4 53.3 0.9 40.7 4.3 7.7 6.3 9.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.3 9.0 1.7 7.2 0.8 0.4 0.0 3.6 1.3 2.9 0.0 0.0 0.0 2.6 0.0 0.2 3.4 0.7 0.8 0.0 13.2 0.0 3.7 49.9 0.5 0.0 0.0 17.6 3.7 0.0 0.0 0.0 0.0 0.3 1.8 2.5 0.0 0.4 5.7 2.0 0.0 0.0 0.1 0.1 0.5 70.2 23.2 103.0 12.9 0.0 7.7 0.3 0.0 2.8 7.2 0.2 0.2 3.9 0.0 0.3 2.6 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 123.1 135.5 82.9 82.2 116.9 56.3 56.9 70.7 53.0 53.3 CPEB4 KIAA1673 ENSG00000113742 "Cytoplasmic polyadenylation element binding protein 4" Q17RY0 5 173888280-173961976 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.1" "Cell line enhanced" "Detected in many" "U-266/70: 38.3;U-266/84: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 9.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038394 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus" Vesicles "HPA038394: AB_10671226" "unprognostic (2.12e-1)" "unprognostic (3.05e-1)" "unprognostic (1.12e-1)" "unprognostic (3.99e-1)" "unprognostic (8.80e-2)" "unprognostic (2.91e-1)" "unprognostic (4.58e-1)" "unprognostic (8.75e-2)" "unprognostic (2.54e-1)" "unprognostic (9.37e-3)" "unprognostic (1.44e-1)" "unprognostic (7.84e-2)" "prognostic favourable (4.99e-8)" "unprognostic (2.66e-1)" "unprognostic (4.73e-2)" "unprognostic (1.42e-2)" "unprognostic (3.83e-2)" 11.9 42.2 25.9 10.3 21.0 39.7 11.5 29.7 30.9 11.3 7.5 10.5 9.8 8.1 8.6 6.0 18.6 6.4 12.1 26.4 22.3 14.7 30.3 44.6 12.5 6.9 15.1 20.7 6.6 21.1 45.7 20.5 17.8 33.3 7.7 8.0 14.4 17.3 13.5 106.1 10.8 8.8 12.5 38.4 9.7 11.3 8.4 18.9 1.5 20.0 16.9 9.3 11.6 15.8 1.6 0.8 9.6 2.3 0.8 1.3 0.6 3.9 5.4 2.7 1.5 4.9 2.8 5.4 7.1 6.6 2.4 2.9 5.1 2.6 4.9 5.0 3.9 0.3 2.4 3.7 4.0 9.8 2.7 3.3 13.0 3.0 10.5 1.1 6.4 4.4 8.5 6.3 9.8 2.3 10.7 12.0 5.6 2.8 0.9 1.0 1.5 5.4 0.8 2.2 16.3 3.5 7.1 3.0 3.4 0.8 9.9 12.7 6.9 2.2 7.0 4.1 2.0 2.0 4.5 38.3 55.0 2.5 9.9 2.3 5.1 0.5 1.8 2.0 1.0 1.7 1.0 1.6 1.1 0.8 0.6 1.2 1.3 0.7 9.6 0.8 2.3 0.8 1.0 0.6 25.9 21.0 29.7 30.9 22.3 14.7 15.1 20.7 33.3 18.9 CPLX1 CPX-I ENSG00000168993 "Complexin 1" O14810 4 784957-826198 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 98.8" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles Vesicles "HPA071191: , HPA074390: " "unprognostic (9.21e-3)" "prognostic unfavourable (4.20e-4)" "unprognostic (3.45e-2)" "unprognostic (4.68e-2)" "unprognostic (1.16e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" "unprognostic (2.26e-2)" "unprognostic (9.52e-3)" "unprognostic (2.01e-2)" "prognostic favourable (5.05e-4)" "unprognostic (1.10e-3)" "unprognostic (3.32e-1)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" "unprognostic (1.34e-1)" "unprognostic (7.77e-2)" 7.8 6.5 13.1 2.9 40.7 1.5 2.4 26.3 98.8 2.2 2.5 3.9 0.0 2.8 4.2 1.5 1.6 2.3 1.9 3.0 16.9 7.6 2.4 2.4 2.8 2.4 16.3 18.3 2.4 3.0 3.4 1.7 1.8 52.8 4.4 1.7 3.8 4.4 2.5 4.5 3.0 2.8 2.0 5.4 5.6 3.2 4.9 4.2 0.0 1.8 0.0 1.6 1.7 1.7 0.2 2.3 0.1 0.0 0.0 0.8 0.0 2.7 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 8.0 0.8 2.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.2 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.1 1.1 0.0 1.3 1.3 0.0 0.0 0.7 0.0 0.2 42.0 5.8 0.2 2.7 0.0 4.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 2.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 13.1 40.7 26.3 98.8 16.9 7.6 16.3 18.3 52.8 4.2 CPLX2 "CPX-2, DKFZp547D155" ENSG00000145920 "Complexin 2" Q6PUV4 5 175796310-175884020 "Predicted intracellular proteins" "Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 95.3;epididymis: 80.1" "Group enriched" "Detected in some" 22 "A549: 103.7;Hep G2: 62.5;SCLC-21H: 44.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles Vesicles "HPA071191: , HPA074390: " "unprognostic (1.36e-1)" "unprognostic (1.12e-1)" "unprognostic (2.81e-1)" "unprognostic (8.98e-2)" "unprognostic (1.23e-2)" "unprognostic (5.73e-2)" "unprognostic (5.16e-2)" "unprognostic (2.49e-3)" "unprognostic (6.22e-2)" "unprognostic (1.20e-2)" "unprognostic (2.06e-1)" "unprognostic (1.90e-5)" "unprognostic (6.88e-2)" "unprognostic (2.20e-1)" "unprognostic (7.32e-2)" "unprognostic (6.87e-2)" 1.7 23.3 72.6 2.0 32.7 1.4 1.3 79.0 95.3 1.3 2.6 2.6 0.3 2.7 1.3 80.1 1.4 1.4 1.4 1.3 68.3 16.3 1.4 1.3 2.1 1.3 37.2 26.3 1.3 7.9 1.3 11.3 1.3 17.9 1.4 2.2 0.2 1.3 1.4 1.3 1.4 2.5 1.6 4.0 1.3 5.1 3.1 3.7 0.0 1.4 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 103.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 44.1 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 72.6 32.7 79.0 66.6 68.3 16.3 37.2 26.3 17.9 3.7 CPM ENSG00000135678 "Carboxypeptidase M" P14384 12 68842197-68971570 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 56.1" "Cell line enhanced" "Detected in many" "ASC diff: 28.8;ASC TERT1: 20.5;HSkMC: 37.0;SiHa: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 15.5;myeloid DC: 11.9" "Group enriched" "Detected in many" 5 "dendritic cells: 11.9;monocytes: 15.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002657, HPA077243" Enhanced Uncertain Vesicles 5000000 Vesicles "HPA002657: AB_1078398, HPA077243: " "unprognostic (1.74e-1)" "unprognostic (3.11e-1)" "unprognostic (2.88e-3)" "prognostic favourable (1.00e-4)" "unprognostic (4.58e-2)" "unprognostic (8.61e-2)" "unprognostic (1.57e-2)" "unprognostic (2.01e-1)" "unprognostic (8.42e-2)" "unprognostic (1.40e-1)" "unprognostic (1.35e-1)" "unprognostic (1.42e-1)" "unprognostic (1.47e-3)" "unprognostic (8.58e-2)" "unprognostic (6.85e-2)" "unprognostic (2.59e-2)" "unprognostic (1.06e-1)" 56.1 6.6 3.8 5.4 7.0 1.1 37.2 1.2 4.9 6.5 12.9 13.2 0.9 1.6 10.7 6.1 4.1 6.4 6.5 2.9 5.3 3.0 22.1 11.6 24.1 13.0 10.9 4.3 7.5 7.8 3.2 1.0 27.9 5.5 6.2 10.8 2.7 3.2 1.7 8.2 13.0 3.7 2.5 6.7 11.4 5.9 5.8 9.3 1.1 5.1 3.5 4.5 4.4 4.4 2.8 11.9 1.3 15.5 0.3 1.3 4.7 0.0 1.5 0.0 0.0 28.8 20.5 0.3 3.8 0.4 0.6 0.9 1.2 1.6 0.2 3.8 0.5 0.0 0.5 1.0 1.6 0.0 1.0 0.0 6.2 0.1 0.1 0.4 0.7 37.0 0.2 0.4 0.8 0.0 0.0 0.0 2.9 0.6 0.0 0.2 0.6 2.0 1.1 0.2 0.0 2.9 2.2 0.1 0.0 27.1 4.2 3.2 0.4 10.1 0.1 0.5 3.1 0.2 0.0 0.1 0.1 4.9 1.7 5.1 2.3 0.3 15.5 0.1 0.1 10.2 0.0 1.4 1.2 0.0 11.9 2.8 0.7 0.1 1.3 0.3 4.7 0.8 1.3 4.7 3.8 7.0 1.2 4.9 5.3 3.0 10.9 4.3 5.5 9.3 CPQ "LDP, PGCP" ENSG00000104324 "Carboxypeptidase Q" Q9Y646 8 96645227-97149654 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 94.4" "Cell line enhanced" "Detected in many" "ASC diff: 37.7;ASC TERT1: 43.3;Karpas-707: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 62.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023235, HPA024490" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" 51000000 "Golgi apparatus, Vesicles" "HPA023235: AB_1855257, HPA024490: AB_1855258" "unprognostic (4.04e-2)" "unprognostic (5.46e-2)" "unprognostic (4.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-3)" "unprognostic (3.98e-3)" "unprognostic (5.24e-2)" "unprognostic (2.92e-2)" "unprognostic (2.67e-2)" "unprognostic (9.19e-2)" "unprognostic (2.38e-3)" "unprognostic (6.16e-3)" "prognostic favourable (5.40e-5)" "unprognostic (6.74e-3)" "unprognostic (8.71e-2)" "unprognostic (3.21e-2)" "unprognostic (1.75e-1)" 17.4 12.6 12.5 10.1 18.3 9.5 15.4 8.3 11.3 26.3 16.5 19.4 21.1 9.4 24.5 19.5 9.1 16.8 20.0 24.1 14.0 9.2 26.4 22.1 13.9 12.3 27.6 8.8 35.3 18.8 20.7 14.2 12.4 16.6 18.1 10.9 19.8 10.9 18.6 5.0 9.1 14.1 30.8 15.3 12.9 14.5 7.3 24.5 1.3 94.4 8.1 7.2 16.9 19.3 1.8 12.8 62.6 17.5 6.3 7.3 8.4 0.6 1.9 1.6 0.4 37.7 43.3 0.5 11.5 17.5 4.1 8.5 1.3 0.8 1.1 9.4 18.2 0.6 0.7 0.8 3.9 10.4 1.5 9.8 1.8 5.7 8.3 2.3 12.7 22.6 2.1 4.7 1.2 1.8 9.5 31.5 9.2 0.6 0.3 4.8 1.2 1.9 2.2 0.3 0.5 8.5 4.4 1.2 0.8 4.1 0.4 8.9 4.4 9.5 8.2 18.0 2.1 0.8 4.2 3.1 0.7 0.4 11.4 7.8 11.9 5.4 17.5 10.8 7.3 12.0 7.3 1.5 5.5 6.3 12.8 1.8 5.0 6.7 62.6 6.3 11.0 3.7 5.7 8.4 12.5 18.3 8.3 11.3 14.0 9.2 27.6 8.8 16.6 24.5 CPSF2 "CPSF100, KIAA1367" ENSG00000165934 "Cleavage and polyadenylation specific factor 2" Q9P2I0 14 92121937-92172145 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024238 Supported Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA024238: AB_1847200" "unprognostic (2.31e-1)" "unprognostic (9.80e-2)" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (4.95e-2)" "unprognostic (2.14e-2)" "prognostic unfavourable (4.35e-7)" "unprognostic (1.34e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-2)" "unprognostic (2.33e-2)" "unprognostic (6.68e-2)" "unprognostic (8.78e-3)" "unprognostic (2.44e-1)" "unprognostic (2.91e-1)" "unprognostic (8.75e-2)" "unprognostic (4.90e-2)" 20.5 24.0 14.6 24.1 16.3 10.6 16.7 14.5 16.5 18.3 16.4 19.3 21.5 15.1 19.3 16.5 25.7 15.4 15.9 16.3 14.9 13.6 16.8 22.2 17.3 20.1 20.8 11.8 21.5 16.5 24.9 28.9 19.6 16.0 17.1 18.1 14.7 18.5 25.3 36.6 14.9 19.0 18.8 19.7 23.8 17.8 25.7 18.1 44.0 22.6 19.4 25.0 19.7 17.7 9.3 13.0 15.0 14.4 12.8 13.4 9.7 18.4 18.4 18.8 19.4 9.8 8.7 28.0 23.9 23.4 22.2 22.1 15.9 25.7 19.8 15.7 25.4 27.4 25.9 21.7 32.2 32.0 8.9 29.0 19.0 15.3 29.1 29.1 24.5 14.2 18.6 21.1 38.1 20.7 26.0 25.1 24.7 26.9 33.5 10.3 21.3 16.8 33.1 29.2 17.8 15.1 26.2 20.8 14.0 28.1 15.9 20.3 33.0 18.3 22.1 17.9 11.3 13.4 20.3 15.2 24.7 40.4 21.5 23.0 27.7 15.0 14.4 10.4 9.6 13.6 12.9 9.3 8.6 10.2 13.0 5.3 7.8 10.5 5.2 12.8 10.7 8.4 13.4 9.7 14.6 16.3 14.5 16.5 14.9 13.6 20.8 11.8 16.0 18.1 CRB1 "LCA8, RP12" ENSG00000134376 "Crumbs 1, cell polarity complex component" P82279 1 197268204-197478455 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Cell line enriched" "Detected in some" 8 "HeLa: 17.1" "Cancer enriched" "Detected in single" 12 "glioma: 2.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "basophil: 9.4" "Lineage enriched" "Detected in single" 22 "granulocytes: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA061250, HPA063127" Approved Uncertain Vesicles "Intracellular and membrane" Vesicles "HPA061250: , HPA063127: " "unprognostic (1.96e-1)" "unprognostic (5.38e-3)" "unprognostic (2.92e-3)" "unprognostic (1.50e-2)" "unprognostic (5.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.38e-1)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (1.48e-3)" "unprognostic (2.59e-1)" "unprognostic (2.01e-3)" "unprognostic (1.78e-3)" "unprognostic (1.56e-1)" "unprognostic (3.36e-2)" "unprognostic (2.96e-1)" 1.1 1.1 11.9 0.9 11.0 1.8 1.2 31.4 20.4 0.9 0.9 10.4 0.0 0.9 0.8 1.2 1.1 2.0 1.0 1.2 11.4 6.2 1.1 0.9 1.0 1.0 4.0 8.9 2.6 1.7 0.7 1.9 0.9 14.1 1.0 0.9 9.0 0.8 0.9 2.4 0.9 0.9 0.8 8.7 0.9 1.5 7.3 9.6 0.0 1.3 0.0 0.8 0.9 0.1 0.1 0.0 9.4 0.0 0.1 0.4 0.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 17.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.3 0.1 0.0 0.0 0.0 0.0 11.9 11.0 31.4 10.5 11.4 6.2 4.0 8.9 14.1 9.6 CREB5 "CRE-BPA, H_GS165L15.1" ENSG00000146592 "CAMP responsive element binding protein 5" Q02930 7 28299321-28825894 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.3;brain: 38.0" "Cell line enhanced" "Detected in many" "HL-60: 31.6;Karpas-707: 13.2;U-2 OS: 13.9;U-2197: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 53.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 53.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050020, HPA061622" Approved "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Plasma membrane" Vesicles "HPA050020: , HPA061622: " "unprognostic (3.59e-2)" "unprognostic (3.80e-1)" "unprognostic (1.06e-1)" "unprognostic (6.46e-2)" "unprognostic (1.01e-1)" "unprognostic (4.90e-3)" "unprognostic (2.01e-3)" "unprognostic (2.87e-1)" "unprognostic (3.31e-1)" "unprognostic (1.04e-1)" "unprognostic (3.49e-1)" "unprognostic (2.67e-1)" "unprognostic (4.91e-3)" "unprognostic (6.61e-2)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" 20.0 3.6 12.1 15.4 19.5 11.5 9.0 10.4 17.8 4.6 5.6 38.0 0.9 2.8 16.3 6.9 7.7 4.7 23.1 10.4 16.7 8.7 6.6 4.6 9.5 6.1 17.9 12.1 2.4 7.0 1.5 2.8 19.5 18.3 3.1 4.3 1.1 6.5 3.0 6.2 5.5 4.2 9.8 14.6 12.6 3.2 2.3 22.7 0.0 3.8 7.0 2.5 5.5 5.0 0.3 4.8 53.3 7.8 0.0 0.0 1.5 0.0 0.3 3.9 0.2 0.2 5.6 0.1 0.3 0.8 2.3 3.5 2.2 1.4 9.7 0.7 0.9 0.4 0.1 3.3 7.4 0.0 2.6 10.5 2.0 0.2 0.2 31.6 0.4 0.7 0.7 10.0 10.8 1.5 1.2 13.2 0.8 0.0 0.0 0.0 4.8 3.9 0.2 3.6 0.2 4.8 1.0 0.4 2.8 0.1 0.2 1.1 0.1 0.7 0.4 4.6 13.9 15.2 4.4 0.8 2.2 0.1 5.1 0.2 7.8 0.0 7.8 0.0 0.0 2.7 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.0 53.3 0.0 0.8 0.0 0.0 1.5 12.1 19.5 10.4 15.6 16.7 8.7 17.9 12.1 18.3 22.7 CREG1 CREG ENSG00000143162 "Cellular repressor of E1A stimulated genes 1" O75629 1 167529677-167553767 "Predicted secreted proteins" "Growth regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 155.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 15.1;classical monocyte: 36.8;eosinophil: 21.7;intermediate monocyte: 21.5;myeloid DC: 26.9;neutrophil: 13.0;non-classical monocyte: 19.9" "Group enriched" "Detected in all" 5 "dendritic cells: 26.9;granulocytes: 21.7;monocytes: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056390 Approved Vesicles,Microtubules "Secreted to blood" 550000 Microtubules Vesicles "HPA056390: " "unprognostic (3.25e-1)" "unprognostic (2.00e-1)" "unprognostic (1.91e-1)" "unprognostic (9.65e-3)" "unprognostic (4.64e-2)" "unprognostic (2.35e-2)" "unprognostic (1.55e-1)" "unprognostic (5.02e-2)" "unprognostic (2.07e-3)" "unprognostic (8.54e-2)" "unprognostic (8.65e-2)" "unprognostic (1.21e-1)" "unprognostic (8.24e-3)" "unprognostic (2.99e-1)" "unprognostic (4.63e-2)" "unprognostic (3.78e-3)" "unprognostic (3.16e-1)" 50.9 52.6 15.7 21.0 17.9 29.6 56.7 11.8 15.0 23.0 32.8 21.7 21.3 16.5 22.0 46.8 41.9 25.0 40.8 48.9 15.5 13.6 39.8 81.3 68.5 83.8 16.4 9.6 43.3 41.6 19.1 36.2 46.8 14.7 41.4 23.7 28.7 39.0 22.6 33.0 37.1 30.4 40.9 21.0 98.2 22.7 27.6 15.1 12.6 53.1 32.7 23.7 50.8 40.9 1.3 26.9 21.7 36.8 3.3 5.3 13.9 11.8 5.3 2.7 5.7 43.9 12.2 7.0 5.1 2.3 4.0 5.3 8.7 13.6 13.0 14.9 5.6 18.7 3.1 10.9 2.8 17.6 10.7 5.3 4.4 4.8 15.1 11.7 39.3 12.8 33.1 4.7 5.1 1.3 27.3 53.4 5.5 4.9 2.4 12.1 3.0 8.4 4.1 7.8 155.2 7.2 8.3 1.8 3.4 12.7 17.5 14.1 23.1 32.2 2.5 1.0 5.3 16.7 3.3 10.5 20.8 8.6 17.6 12.2 2.1 15.1 36.8 21.7 1.6 21.5 2.5 1.3 2.4 2.0 26.9 0.6 5.3 2.6 13.0 3.3 19.9 1.8 1.1 13.9 15.7 17.9 11.8 15.0 15.5 13.6 16.4 9.6 14.7 15.1 CREM hCREM-2 ENSG00000095794 "CAMP responsive element modulator" Q03060 10 35126791-35212958 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001818, CAB018352" Enhanced Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB018352: AB_673599, HPA001818: AB_1078566" "unprognostic (1.78e-1)" "unprognostic (6.26e-3)" "unprognostic (7.09e-2)" "unprognostic (2.51e-2)" "unprognostic (6.22e-3)" "unprognostic (9.27e-3)" "unprognostic (1.16e-1)" "unprognostic (2.41e-2)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" "unprognostic (8.98e-2)" "unprognostic (3.42e-1)" "prognostic unfavourable (1.23e-5)" "unprognostic (4.44e-2)" "unprognostic (4.19e-1)" "unprognostic (1.66e-2)" "unprognostic (1.52e-1)" 21.9 61.4 14.3 21.3 15.1 8.1 15.4 6.2 13.8 10.6 8.0 8.4 10.2 4.1 13.3 10.8 8.2 9.9 19.7 19.5 14.5 15.2 15.4 26.1 19.6 7.1 12.7 8.3 21.4 8.2 8.3 24.2 42.0 20.1 12.2 6.4 9.6 5.7 19.2 10.0 3.2 7.0 11.0 15.5 21.8 7.5 74.9 7.7 8.1 10.8 6.8 7.3 18.1 11.7 6.4 11.2 10.1 4.9 8.6 14.6 8.2 9.0 14.5 12.3 12.6 8.6 9.0 12.3 11.9 9.3 7.5 10.4 1.7 3.8 15.4 11.6 6.9 2.1 10.5 7.8 11.0 37.8 7.7 5.4 10.0 6.8 10.3 1.3 5.8 7.9 9.8 14.6 4.5 20.8 15.9 6.4 11.4 7.3 9.4 3.9 3.6 33.4 5.8 6.4 2.8 13.2 3.6 2.9 7.8 5.6 4.9 31.5 2.7 4.0 27.6 5.7 7.4 15.7 7.8 2.8 3.8 5.3 13.7 12.2 4.9 4.7 3.3 10.1 11.5 4.9 14.2 6.4 12.7 10.1 3.8 5.5 9.0 10.4 9.0 8.6 3.6 11.2 14.6 8.2 14.3 15.1 6.2 13.8 14.5 15.2 12.7 8.3 20.1 7.7 CROT COT ENSG00000005469 "Carnitine O-octanoyltransferase" Q9UKG9 7 87345681-87399795 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 34.6;RT4: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019052, HPA019364, HPA019365" Enhanced Approved Vesicles Vesicles "HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174" "unprognostic (2.80e-2)" "unprognostic (6.47e-2)" "unprognostic (1.75e-1)" "unprognostic (4.56e-2)" "unprognostic (1.70e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" "unprognostic (9.93e-3)" "unprognostic (2.13e-1)" "unprognostic (1.13e-1)" "unprognostic (9.84e-2)" "unprognostic (3.48e-1)" "prognostic favourable (2.55e-6)" "unprognostic (3.52e-2)" "unprognostic (1.34e-1)" "unprognostic (7.60e-3)" "prognostic favourable (4.02e-4)" 4.6 10.1 9.3 5.1 9.6 1.6 10.5 7.4 8.4 9.0 9.4 5.5 24.1 19.6 10.0 12.6 17.0 6.8 8.7 5.9 5.2 5.4 12.3 21.5 4.2 3.4 5.4 6.6 7.2 4.6 15.5 9.1 13.7 5.8 14.8 7.0 9.8 8.3 32.3 7.2 15.0 19.1 8.8 6.8 4.8 4.9 3.8 4.7 7.4 27.1 8.4 8.0 22.4 15.3 2.2 2.3 3.4 5.5 13.0 9.5 3.0 7.0 5.2 6.5 2.2 6.2 5.7 4.8 7.5 7.1 4.6 5.0 2.8 3.7 3.0 6.7 6.3 8.9 1.0 10.0 6.5 4.2 4.5 6.5 3.7 3.5 4.0 4.0 4.0 4.6 34.6 3.7 2.9 6.5 0.3 4.3 12.0 6.9 5.0 4.0 1.4 7.9 2.3 8.9 0.5 5.9 33.8 1.0 5.1 9.2 10.6 4.8 6.7 1.4 3.4 10.7 4.6 14.4 7.1 6.6 9.4 4.1 7.2 0.0 6.3 2.0 1.4 3.4 7.4 1.7 9.5 2.2 7.5 6.0 2.0 2.2 6.1 6.6 0.9 13.0 5.5 2.3 6.3 3.0 9.3 9.6 7.4 8.4 5.2 5.4 5.4 6.6 5.8 4.7 CRP PTX1 ENSG00000132693 "C-reactive protein" P02741 1 159712289-159714589 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "liver: 1139.7" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;HDLM-2: 7.6;U-2 OS: 5.4;U-266/84: 12.8" "Cancer enriched" "Detected in some" 13 "liver cancer: 1010.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005036, HPA027367, HPA027396" Supported Approved "Nucleoplasm,Vesicles,Intermediate filaments" "Secreted to blood" 1832500000 5400000000 "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217" "unprognostic (3.74e-1)" "unprognostic (5.31e-2)" "unprognostic (2.97e-2)" "unprognostic (1.27e-1)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" "unprognostic (3.13e-1)" "prognostic unfavourable (4.17e-10)" "unprognostic (3.39e-2)" "unprognostic (3.48e-1)" "unprognostic (5.60e-2)" "unprognostic (6.61e-2)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 17.2 0.1 0.1 0.0 0.1 1139.7 0.1 0.1 0.1 0.1 0.1 7.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.3 0.0 0.0 0.0 7.6 0.0 0.3 0.0 0.0 0.0 0.3 0.1 1.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.1 0.9 0.0 12.8 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CSF1R "C-FMS, CD115, CSFR, FMS" ENSG00000182578 "Colony stimulating factor 1 receptor" P07333 5 150053291-150113372 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.5;lymphoid tissue: 82.6" "Group enriched" "Detected in some" 5 "BEWO: 50.6;SK-BR-3: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 60.7;non-classical monocyte: 82.5" "Lineage enriched" "Detected in many" 4 "monocytes: 82.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008970, HPA012323" Uncertain Supported "Vesicles,Plasma membrane" "Intracellular and membrane" 1500000000 "Vesicles, Plasma membrane" "CAB008970: , HPA012323: AB_1848977" "unprognostic (3.82e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-3)" "unprognostic (9.83e-2)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (9.37e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavourable (1.08e-4)" "unprognostic (3.67e-2)" "prognostic unfavourable (4.92e-4)" "unprognostic (1.72e-2)" "unprognostic (4.61e-2)" 20.9 12.4 18.2 28.1 18.9 1.8 7.7 2.8 13.5 9.3 8.3 25.4 1.1 9.2 5.9 13.1 8.4 7.9 16.1 8.7 16.4 13.7 7.8 15.1 13.7 25.4 21.3 6.0 5.3 5.2 5.9 6.4 52.1 17.1 8.5 8.4 16.8 8.0 8.7 3.0 5.8 14.5 16.2 25.8 82.6 9.0 4.9 23.0 3.1 4.2 2.9 8.2 16.4 4.7 0.0 19.1 2.9 82.5 0.0 0.1 13.9 1.7 0.0 0.0 0.0 0.8 0.2 50.6 0.1 0.0 0.0 0.0 1.5 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.1 0.0 19.3 0.0 0.0 7.2 0.0 0.3 0.0 0.0 1.3 0.0 0.1 0.0 2.6 0.9 0.0 0.4 18.1 0.5 0.1 60.7 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 2.9 0.0 82.5 1.4 0.0 13.9 18.2 18.9 2.8 13.4 16.4 13.7 21.3 6.0 17.1 23.0 CSF2 "GM-CSF, GMCSF" ENSG00000164400 "Colony stimulating factor 2" P04141 5 132073790-132076170 "Cancer-related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 9.5;lung: 6.8;pancreas: 4.5" "Cell line enriched" "Detected in some" 4 "BJ hTERT+: 44.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "NK-cell: 9.5" "Lineage enriched" "Detected in single" 11 "NK-cells: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA057404, HPA062006" Enhanced Vesicles "Secreted to blood" 36150 Vesicles "HPA057404: , HPA062006: " "unprognostic (7.29e-2)" "unprognostic (2.49e-3)" "unprognostic (8.77e-2)" "unprognostic (2.09e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" "unprognostic (2.56e-1)" "unprognostic (1.47e-2)" "unprognostic (2.64e-1)" "unprognostic (3.68e-3)" "unprognostic (1.87e-8)" "unprognostic (4.81e-2)" "unprognostic (1.22e-1)" "unprognostic (9.07e-2)" "unprognostic (2.06e-2)" 0.2 0.1 0.1 3.9 0.1 1.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.7 0.0 1.5 0.1 1.1 0.2 0.1 0.1 0.3 0.9 6.8 0.3 0.1 0.0 0.1 4.5 0.0 0.1 0.5 0.0 0.2 0.7 0.0 1.9 0.0 0.1 0.4 1.0 0.6 0.1 1.0 0.2 0.2 0.0 0.4 0.2 0.0 1.8 2.3 0.1 0.0 0.0 0.0 0.0 9.5 0.8 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 2.5 0.0 3.5 0.0 0.7 0.0 0.1 0.0 3.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 10.2 6.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.1 1.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 CSK ENSG00000103653 "C-terminal Src kinase" P41240 15 74782057-74803198 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011203, HPA026488, HPA028425" Approved Approved Approved Vesicles,Cytosol 1500000 "Vesicles, Cytosol" "CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899" "unprognostic (1.05e-1)" "prognostic favourable (5.14e-5)" "unprognostic (2.59e-3)" "prognostic favourable (8.22e-4)" "unprognostic (4.15e-2)" "unprognostic (4.11e-2)" "unprognostic (1.87e-1)" "unprognostic (2.96e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-1)" "unprognostic (4.12e-2)" "unprognostic (4.61e-2)" "prognostic unfavourable (1.74e-4)" "prognostic favourable (1.07e-4)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "unprognostic (6.29e-2)" 9.3 8.0 9.5 39.3 11.0 19.9 12.6 18.7 13.4 12.1 13.5 11.8 7.3 16.1 13.9 6.4 33.3 10.6 11.2 14.0 9.8 8.5 8.0 20.9 15.6 67.2 11.1 7.4 10.5 6.7 6.6 10.4 8.8 12.2 9.8 8.9 9.8 13.2 7.0 8.7 14.9 26.2 8.5 10.9 62.7 13.1 8.1 10.6 62.7 8.1 9.5 47.4 17.4 13.2 35.6 22.8 49.6 46.8 16.3 30.7 19.9 12.7 18.0 8.8 14.5 8.4 6.5 7.6 8.6 8.2 16.3 11.6 16.4 11.8 57.1 11.4 7.7 13.3 18.5 17.3 4.6 27.6 22.8 48.3 6.6 16.5 11.7 25.2 61.6 9.2 8.5 11.6 10.4 12.3 13.9 19.9 9.7 21.5 18.1 14.9 10.9 12.9 20.1 7.6 41.6 7.5 28.4 14.7 10.2 11.1 23.4 14.8 16.1 37.2 10.6 19.8 10.4 15.5 14.8 10.7 21.5 58.3 10.2 48.2 13.3 20.7 19.7 49.6 23.4 42.4 20.0 29.4 20.3 23.1 22.8 35.6 15.7 18.4 39.1 16.3 46.8 13.2 30.7 19.9 9.5 11.0 18.7 13.4 9.8 8.5 11.1 7.4 12.2 10.6 CSMD1 "KIAA1890, PPP1R24" ENSG00000183117 "CUB and Sushi multiple domains 1" 8 2935353-4994972 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 29.5;testis: 9.0" "Cell line enhanced" "Detected in some" "K-562: 8.8;U-2 OS: 4.3;U-266/70: 4.2;U-266/84: 3.9;U-698: 3.6" "Cancer enhanced" "Detected in some" "testis cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074707 Approved Vesicles Vesicles "HPA074707: " "unprognostic (6.32e-2)" "unprognostic (4.23e-2)" "unprognostic (2.37e-1)" "unprognostic (1.67e-3)" "unprognostic (5.72e-2)" "unprognostic (4.26e-2)" "unprognostic (1.02e-2)" "unprognostic (4.66e-2)" "unprognostic (7.69e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-1)" "unprognostic (7.90e-2)" "unprognostic (1.01e-1)" "unprognostic (2.74e-2)" "unprognostic (5.09e-2)" "unprognostic (1.26e-2)" "unprognostic (1.11e-1)" 1.0 1.1 20.4 0.8 21.1 0.8 1.4 6.3 29.5 2.5 0.8 1.7 0.0 1.0 1.2 0.9 0.8 3.2 0.8 0.7 12.9 4.5 2.7 0.7 1.4 0.9 3.9 18.2 0.9 0.9 0.7 0.7 2.8 3.4 1.1 0.8 0.0 0.7 1.5 1.1 1.0 1.0 1.7 2.4 2.8 0.8 9.0 2.4 0.0 1.1 0.0 0.9 1.1 0.5 0.0 0.9 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.5 0.0 0.0 0.0 0.1 0.0 0.3 1.7 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.3 0.0 0.0 4.2 3.9 3.6 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 20.4 21.1 6.3 29.5 12.9 4.5 3.9 18.2 3.4 2.4 CSNK1G2 CK1g2 ENSG00000133275 "Casein kinase 1 gamma 2" P78368 19 1941149-1981338 "Enzymes, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034868, HPA056572" Uncertain Approved Vesicles Vesicles "HPA034868: AB_10671235, HPA056572: " "unprognostic (2.00e-1)" "unprognostic (2.15e-1)" "unprognostic (1.83e-1)" "unprognostic (2.42e-3)" "unprognostic (6.51e-3)" "unprognostic (2.27e-3)" "unprognostic (1.14e-3)" "unprognostic (2.00e-1)" "unprognostic (9.42e-2)" "unprognostic (5.78e-2)" "unprognostic (4.83e-3)" "unprognostic (4.09e-3)" "unprognostic (7.95e-2)" "unprognostic (4.65e-3)" "unprognostic (5.09e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-2)" 18.7 22.2 24.8 34.9 19.5 38.1 16.7 30.8 28.9 14.1 19.0 18.2 18.9 27.0 16.5 19.0 22.1 16.9 20.4 16.0 23.3 18.3 19.3 17.9 21.8 35.1 17.3 21.2 18.6 27.0 11.4 24.4 16.7 18.7 18.7 8.7 19.7 26.6 16.0 29.0 23.3 22.1 15.1 12.7 39.1 24.1 58.5 17.4 20.6 16.5 18.1 32.2 17.1 17.1 4.0 5.9 11.2 14.1 3.5 4.9 2.3 23.2 12.5 17.5 27.4 6.1 11.6 14.6 14.4 9.6 11.0 13.6 10.3 12.8 14.7 12.2 9.2 16.8 9.4 17.6 4.9 13.3 20.4 10.4 20.5 17.4 9.9 16.5 26.3 11.4 11.6 11.5 7.4 13.1 21.6 50.5 7.2 13.6 32.8 21.7 31.7 14.1 28.5 11.1 23.8 8.3 24.6 28.2 23.2 11.0 18.1 16.0 11.5 27.2 15.6 14.0 11.0 29.2 16.8 32.6 17.3 18.0 14.1 15.7 14.6 2.8 4.0 5.0 4.9 6.2 3.5 3.9 3.6 4.2 3.9 4.0 2.9 4.1 11.2 3.5 14.1 5.9 2.5 2.3 24.8 19.5 30.8 28.9 23.3 18.3 17.3 21.2 18.7 17.4 CSRNP1 "AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1" ENSG00000144655 "Cysteine and serine rich nuclear protein 1" Q96S65 3 39141855-39154562 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045207, HPA058463" Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA045207: AB_10967202, HPA058463: " "unprognostic (2.90e-2)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (1.46e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic favourable (1.07e-4)" "prognostic unfavourable (6.47e-4)" "unprognostic (2.42e-2)" "unprognostic (1.98e-1)" "unprognostic (1.51e-1)" 33.5 24.9 5.9 16.4 11.5 70.1 20.4 4.9 8.6 16.2 14.4 11.4 13.9 5.1 12.9 9.6 25.9 35.8 28.7 19.7 5.4 5.3 9.6 33.3 35.7 7.9 8.8 3.3 24.9 16.3 11.7 17.6 30.9 15.3 15.8 6.8 9.7 10.9 50.1 22.4 19.9 21.0 26.9 11.9 9.2 20.3 11.4 7.5 8.9 14.5 14.6 7.8 21.4 16.9 3.6 3.9 15.9 9.2 2.2 2.5 1.9 2.3 5.2 1.3 2.6 2.6 2.8 4.3 8.6 12.0 7.2 5.9 7.3 2.1 7.7 1.8 6.5 2.6 1.6 11.3 3.5 11.4 2.1 8.7 4.2 5.5 3.3 2.1 8.7 1.3 6.2 11.2 1.8 9.7 6.6 13.6 5.8 7.4 0.4 3.5 6.2 4.4 3.6 5.7 12.5 5.7 8.5 3.8 0.6 4.7 35.4 2.9 3.9 4.0 4.8 3.7 15.7 3.1 6.3 3.5 2.9 3.5 8.0 2.7 4.6 0.1 2.7 3.2 1.7 5.6 2.1 3.6 1.6 1.9 3.0 3.6 2.0 1.3 15.9 2.2 9.2 3.9 2.5 1.9 5.9 11.5 4.9 8.6 5.4 5.3 8.8 3.3 15.3 7.5 CST3 ENSG00000101439 "Cystatin C" P01034 20 23626706-23638473 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 160.1;ASC TERT1: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 163.9;intermediate monocyte: 211.0;myeloid DC: 269.6;non-classical monocyte: 135.1;plasmacytoid DC: 153.5" "Group enriched" "Detected in many" 9 "dendritic cells: 269.6;monocytes: 211.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000118, HPA013143" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" 4100000000 "Golgi apparatus, Vesicles" "CAB000118: , HPA013143: AB_1847417" "unprognostic (3.89e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-1)" "prognostic favourable (1.83e-4)" "unprognostic (8.53e-2)" "unprognostic (4.06e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-2)" "unprognostic (3.46e-2)" "unprognostic (3.72e-1)" "unprognostic (2.29e-3)" "unprognostic (3.51e-2)" "unprognostic (1.85e-1)" "unprognostic (1.16e-1)" "unprognostic (2.97e-1)" "unprognostic (5.01e-2)" "prognostic favourable (8.77e-4)" 95.8 72.6 229.0 37.9 254.7 22.2 68.6 61.4 196.7 76.6 78.2 75.4 39.5 59.4 47.6 143.6 73.8 64.9 89.4 79.7 157.4 96.2 35.9 67.3 58.0 91.2 148.3 90.6 51.4 142.1 34.5 45.6 25.8 69.9 55.2 66.1 195.0 338.2 74.2 44.2 44.9 77.9 57.3 73.3 85.5 105.5 57.4 68.4 40.7 43.2 40.1 31.9 49.4 50.2 0.6 269.6 27.4 211.0 6.4 2.4 106.7 12.6 28.8 6.7 15.5 160.1 109.6 12.6 22.1 30.8 15.2 12.3 54.7 19.6 0.0 20.8 30.1 43.0 6.2 44.1 4.7 0.0 21.3 13.0 5.7 93.0 57.3 0.6 21.9 84.8 37.2 20.4 21.9 23.7 11.8 0.3 21.1 20.2 0.1 13.8 9.0 63.2 0.4 8.2 17.5 62.4 28.7 7.4 8.5 16.1 4.8 27.4 13.6 47.7 59.8 14.4 10.4 20.1 8.2 13.6 0.4 0.1 12.3 28.6 16.2 1.4 163.9 1.0 2.4 211.0 0.9 0.6 0.6 1.6 269.6 0.5 0.6 1.2 27.4 6.4 135.1 153.5 0.4 106.7 229.0 254.7 61.4 196.7 157.4 96.2 148.3 90.6 69.9 68.4 CSTF2T "CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64" ENSG00000177613 "Cleavage stimulation factor subunit 2 tau variant" Q9H0L4 10 51695487-51699591 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039216, HPA062021" Approved Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA039216: AB_10795462, HPA062021: " "unprognostic (2.60e-2)" "unprognostic (3.75e-2)" "unprognostic (2.93e-2)" "unprognostic (2.17e-1)" "unprognostic (8.59e-2)" "unprognostic (1.06e-1)" "unprognostic (4.06e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (5.92e-2)" "unprognostic (5.36e-2)" "unprognostic (7.63e-2)" "unprognostic (5.19e-2)" "unprognostic (2.22e-1)" "unprognostic (3.31e-1)" "unprognostic (1.96e-1)" 20.2 23.5 16.5 20.0 21.6 14.0 15.2 16.2 24.0 14.8 13.5 29.6 9.9 14.3 16.8 13.4 13.1 19.0 12.7 17.4 18.4 16.6 15.5 15.4 11.9 21.7 21.3 16.5 23.3 16.3 30.2 14.1 14.6 23.5 15.8 13.5 12.6 13.4 12.5 25.0 13.3 16.8 16.8 28.0 24.6 17.7 11.6 20.1 31.9 17.0 12.6 22.9 17.0 13.2 4.6 5.5 5.5 5.1 13.9 6.8 3.2 8.3 10.0 15.1 15.8 21.3 14.6 1.0 11.9 11.1 13.8 13.5 13.2 12.3 24.2 6.9 10.4 13.2 11.3 12.5 12.6 14.0 12.8 13.9 10.6 2.4 10.3 5.3 12.8 21.0 9.7 12.1 14.1 10.3 14.9 13.8 11.9 7.1 21.8 8.6 5.5 21.6 17.4 30.4 5.1 10.6 7.0 12.7 16.3 9.9 10.4 10.6 19.4 10.0 10.9 8.8 12.1 8.1 14.8 17.6 6.5 17.4 18.4 12.6 7.6 3.7 5.0 5.5 4.9 5.1 6.8 2.3 3.6 3.8 5.5 4.6 6.2 5.3 1.5 13.9 3.4 3.5 5.7 3.2 16.5 21.6 16.2 24.0 18.4 16.6 21.3 16.5 23.5 20.1 CT55 "CXorf48, FLJ20527" ENSG00000169551 "Cancer/testis antigen 55" Q8WUE5 X 135156536-135171398 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 9.2" "Cell line enriched" "Detected in single" 14 "K-562: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059575 Approved Vesicles "Secreted in male reproductive system" Vesicles "HPA059575: " "unprognostic (6.20e-2)" "unprognostic (1.39e-1)" "unprognostic (8.36e-2)" "unprognostic (5.86e-3)" "unprognostic (3.47e-1)" "unprognostic (2.67e-1)" "unprognostic (4.44e-2)" "unprognostic (1.49e-1)" 0.1 0.2 0.5 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 9.2 0.2 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 12.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.2 0.6 0.8 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CTAG2 "CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803" ENSG00000126890 "Cancer/testis antigen 2" O75638 X 154651972-154653579 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 8.5;skeletal muscle: 5.7;testis: 11.9" "Group enriched" "Detected in some" 37 "K-562: 28.2;RPMI-8226: 62.9;SK-BR-3: 41.1;U-266/84: 71.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA071467, HPA076586" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA071467: , HPA076586: " "prognostic unfavourable (2.35e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (1.25e-2)" 0.2 1.0 0.4 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.2 0.0 0.0 0.0 1.0 2.9 0.0 8.5 0.0 0.0 0.1 0.8 0.2 0.0 0.2 0.8 3.6 0.0 0.4 4.4 0.2 0.0 0.1 0.0 5.7 0.2 0.0 0.0 0.0 0.3 0.6 11.9 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.9 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.5 71.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTDP1 FCP1 ENSG00000060069 "CTD phosphatase subunit 1" Q9Y5B0 18 79679801-79756623 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032641, HPA040394, HPA070389" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: " "unprognostic (1.71e-1)" "unprognostic (1.75e-1)" "unprognostic (1.37e-1)" "prognostic favourable (6.43e-4)" "unprognostic (2.64e-2)" "unprognostic (7.99e-2)" "unprognostic (3.47e-3)" "unprognostic (1.83e-1)" "unprognostic (2.54e-1)" "unprognostic (1.15e-1)" "unprognostic (5.21e-3)" "unprognostic (1.99e-2)" "prognostic favourable (5.51e-5)" "unprognostic (5.16e-2)" "unprognostic (8.58e-2)" "unprognostic (2.85e-2)" "unprognostic (4.74e-2)" 10.6 8.2 6.2 12.8 9.5 21.8 9.5 7.5 12.2 7.9 12.0 14.4 5.3 13.4 11.9 9.3 11.4 9.8 10.0 6.6 6.8 5.7 8.9 13.4 10.2 14.4 12.3 5.1 7.7 13.4 4.6 7.9 10.6 9.1 9.1 6.2 8.4 10.6 8.3 12.1 20.9 13.8 8.2 6.8 15.3 12.2 27.2 10.6 26.2 9.4 8.8 14.8 11.4 8.9 0.7 1.5 6.4 1.0 2.4 2.0 0.5 8.0 9.0 5.0 7.2 4.0 3.4 16.7 5.4 4.0 5.0 4.9 5.9 5.1 10.3 2.5 3.5 9.9 4.3 5.7 2.1 9.5 7.7 5.3 4.5 8.0 5.9 23.4 13.2 5.6 5.4 5.3 2.5 6.0 6.5 5.3 1.9 7.2 15.7 18.4 7.9 12.1 12.2 6.6 12.4 3.7 8.4 7.8 8.1 6.4 6.4 8.6 5.2 13.8 8.1 8.6 12.5 3.4 5.8 4.4 16.5 10.2 7.3 11.8 6.0 0.0 1.0 6.4 1.3 0.9 1.1 0.7 1.0 2.0 1.5 0.4 1.3 0.7 2.7 2.4 0.9 0.2 0.3 0.5 6.2 9.5 7.5 12.2 6.8 5.7 12.3 5.1 9.1 10.6 CTDSPL "C3orf8, HYA22, PSR1, RBSP3, SCP3" ENSG00000144677 "CTD small phosphatase like" O15194 3 37861960-37984469 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048325 Approved Approved Nucleoplasm,Vesicles 10000 Vesicles Nucleoplasm "HPA048325: " "unprognostic (7.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.21e-1)" "unprognostic (6.48e-3)" "unprognostic (1.73e-1)" "unprognostic (3.35e-2)" "unprognostic (1.66e-3)" "unprognostic (4.30e-2)" "unprognostic (1.96e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-3)" "unprognostic (1.20e-1)" "prognostic favourable (6.22e-14)" "unprognostic (3.48e-2)" "unprognostic (6.84e-2)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" 12.8 6.3 11.1 7.8 12.4 5.6 22.0 30.2 14.1 15.5 19.9 8.0 25.7 9.3 14.5 18.3 16.8 12.2 37.2 18.9 13.1 5.9 26.7 13.3 19.0 4.9 7.8 9.9 13.7 10.2 8.3 9.4 20.6 6.9 17.5 20.3 15.6 45.5 22.4 12.5 34.8 11.2 21.3 8.1 11.3 19.7 8.1 8.3 2.9 10.0 13.9 6.9 19.6 21.7 0.0 0.2 1.1 0.5 0.0 0.5 5.6 15.5 6.8 2.8 8.8 11.0 15.9 20.9 10.7 13.5 7.4 8.8 9.8 12.8 0.0 6.6 13.2 13.0 6.9 20.3 6.0 0.0 5.4 9.5 7.2 22.1 10.1 0.0 2.3 8.2 49.9 7.8 9.4 10.4 3.0 0.0 12.3 4.9 3.9 0.0 11.5 1.0 4.3 5.4 0.1 23.8 10.4 2.3 7.4 5.9 10.6 11.9 10.2 2.6 8.2 5.4 7.5 10.0 6.7 0.2 0.0 0.0 6.0 5.3 9.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.1 1.1 0.0 0.0 0.0 0.0 5.6 11.1 12.4 30.2 14.1 13.1 5.9 7.8 9.9 6.9 8.3 CTGF "CCN2, IGFBP8" ENSG00000118523 "Connective tissue growth factor" P29279 6 131948176-131951373 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion, DNA synthesis" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 128.3;HUVEC TERT2: 107.9;TIME: 222.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "naive B-cell: 11.6" "Lineage enriched" "Detected in single" 117 "B-cells: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB005123, HPA031074, HPA031075" Approved Approved "Golgi apparatus,Vesicles" "Secreted in other tissues" 5200000 "Golgi apparatus, Vesicles" "CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248" "unprognostic (2.87e-1)" "unprognostic (1.43e-1)" "unprognostic (4.41e-2)" "unprognostic (5.68e-2)" "unprognostic (9.79e-2)" "unprognostic (1.82e-2)" "unprognostic (3.38e-1)" "unprognostic (4.96e-2)" "unprognostic (1.68e-1)" "unprognostic (3.89e-2)" "unprognostic (2.39e-1)" "unprognostic (2.06e-1)" "unprognostic (1.27e-3)" "prognostic unfavourable (5.04e-4)" "unprognostic (1.62e-1)" "unprognostic (1.77e-2)" "unprognostic (3.84e-3)" 51.9 15.5 3.5 48.2 7.6 0.0 39.2 1.6 7.1 84.0 26.9 7.2 27.5 5.8 84.9 50.1 38.9 56.3 82.5 73.6 8.8 3.6 83.5 18.8 45.8 53.3 4.7 9.4 30.7 26.3 4.7 9.7 44.0 13.8 54.5 19.7 55.0 28.2 45.3 29.4 30.1 28.7 123.4 12.0 169.8 41.6 24.4 2.3 5.9 66.9 46.9 9.8 48.5 23.3 11.6 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 10.0 0.2 22.7 12.9 0.1 29.0 13.9 18.0 9.6 0.0 0.9 0.0 128.3 37.2 0.4 0.3 2.0 17.0 0.1 0.2 0.0 4.1 10.4 8.9 0.0 0.0 18.8 0.4 13.0 3.2 107.9 0.0 0.0 51.0 0.1 0.0 0.0 4.8 1.7 2.4 0.4 0.0 6.5 0.0 0.0 0.0 2.9 4.9 1.3 0.4 0.2 222.6 25.0 19.5 31.4 53.4 0.9 0.1 0.2 3.4 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.5 7.6 1.6 7.1 8.8 3.6 4.7 9.4 13.8 2.3 CTNS "CTNS-LSB, PQLC4" ENSG00000040531 "Cystinosin, lysosomal cystine transporter" O60931 17 3636468-3661542 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046947 Supported "Vesicles,Intermediate filaments" "Vesicles, Intermediate filaments" "HPA046947: " "unprognostic (1.64e-1)" "unprognostic (1.70e-1)" "unprognostic (1.21e-1)" "unprognostic (8.25e-2)" "unprognostic (8.39e-2)" "prognostic favourable (7.33e-4)" "unprognostic (1.28e-2)" "unprognostic (8.02e-2)" "unprognostic (1.94e-1)" "unprognostic (6.62e-3)" "prognostic favourable (6.39e-5)" "unprognostic (8.40e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-1)" "unprognostic (5.64e-2)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 9.6 19.0 8.5 8.2 11.9 8.3 12.1 5.0 9.9 18.8 8.2 16.1 34.8 10.8 10.3 7.2 7.3 8.3 10.6 9.3 7.7 5.9 23.9 16.4 11.4 9.1 12.1 5.6 12.6 32.7 11.3 14.5 13.2 8.5 10.2 6.4 11.4 10.5 46.2 22.6 18.0 9.2 7.9 10.2 12.2 12.9 27.0 13.0 11.7 9.0 6.5 9.0 10.1 9.1 3.5 19.6 13.7 5.6 2.5 3.3 3.7 6.1 13.8 8.1 6.9 13.2 6.7 5.1 6.0 10.1 6.9 8.7 7.7 6.1 3.7 6.4 4.0 15.8 7.1 4.1 5.3 46.0 12.5 4.2 10.4 6.2 17.8 2.8 28.8 8.3 5.2 7.3 5.9 7.6 4.3 5.8 6.5 5.6 2.8 2.7 3.6 6.1 6.2 3.3 8.7 6.2 6.3 1.6 5.9 7.0 9.4 7.0 6.6 2.8 8.9 6.8 4.3 15.4 4.9 4.7 6.0 1.7 10.5 3.0 4.6 13.7 5.6 12.1 1.9 3.7 2.7 3.5 2.3 3.3 5.4 3.1 2.9 3.1 2.0 2.5 3.8 19.6 2.6 3.7 8.5 11.9 5.0 9.9 7.7 5.9 12.1 5.6 8.5 13.0 CTSA "GSL, PPGB" ENSG00000064601 "Cathepsin A" P10619 20 45890144-45898820 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 125.7" "Cell line enhanced" "Detected in all" "ASC diff: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024930, HPA031068" Enhanced Enhanced Vesicles "Intracellular and membrane" 18000000 Vesicles "CAB024930: , HPA031068: AB_10601205" "unprognostic (8.61e-2)" "unprognostic (3.37e-1)" "unprognostic (4.30e-2)" "unprognostic (2.13e-1)" "unprognostic (6.42e-2)" "unprognostic (2.21e-1)" "prognostic unfavourable (1.95e-4)" "unprognostic (6.33e-2)" "unprognostic (9.53e-3)" "unprognostic (7.19e-2)" "unprognostic (1.83e-1)" "unprognostic (6.85e-2)" "unprognostic (7.57e-2)" "unprognostic (1.09e-1)" "unprognostic (6.05e-2)" "unprognostic (1.71e-1)" "unprognostic (8.40e-2)" 29.0 125.7 12.0 22.8 19.5 22.1 35.3 11.4 30.0 14.1 50.6 17.4 16.2 29.4 18.2 19.3 20.7 12.7 28.0 32.6 11.5 11.6 88.2 43.8 28.4 38.9 12.3 16.1 23.9 19.2 28.3 16.5 47.7 15.7 18.2 50.5 30.1 20.5 15.1 19.3 28.2 40.6 19.6 11.9 38.8 19.7 14.3 11.2 8.0 18.1 24.9 22.4 23.3 18.7 7.0 16.6 81.1 46.1 12.0 31.2 50.0 14.4 14.9 2.8 12.7 116.2 60.2 6.4 20.8 55.4 22.8 29.7 27.9 38.9 3.1 24.1 38.9 23.1 7.5 14.0 14.3 6.0 7.0 8.2 10.4 48.6 25.9 13.0 33.9 47.8 16.9 14.7 3.3 24.8 8.1 47.8 24.7 29.7 3.3 12.0 2.8 35.4 5.2 14.5 17.2 18.2 12.7 5.6 5.3 34.6 60.6 58.0 14.8 18.7 22.8 45.8 10.7 25.9 16.3 23.6 29.7 2.2 82.5 17.3 18.8 60.6 46.1 81.1 7.5 26.6 31.2 7.0 12.9 13.2 16.6 3.6 4.7 6.9 24.7 12.0 17.7 6.6 23.9 50.0 12.0 19.5 11.4 30.0 11.5 11.6 12.3 16.1 15.7 11.2 CTSB ENSG00000164733 "Cathepsin B" P07858 8 11842524-11869448 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 297.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 237.0;fHDF/TERT166: 137.7" "Cancer enhanced" "Detected in all" "thyroid cancer: 1446.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4" "Group enriched" "Detected in all" 5 "dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000457, HPA018156, HPA048998" Enhanced Supported Nucleoli,Vesicles "Secreted to blood" 130000000 Vesicles Nucleoli "CAB000457: , HPA018156: AB_1846069, HPA048998: " "unprognostic (5.74e-2)" "unprognostic (4.32e-2)" "unprognostic (1.38e-2)" "unprognostic (2.17e-2)" "unprognostic (2.98e-3)" "unprognostic (5.96e-2)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" "unprognostic (2.82e-2)" "unprognostic (1.06e-1)" "unprognostic (7.61e-2)" "unprognostic (8.30e-2)" "unprognostic (2.85e-1)" "unprognostic (7.39e-2)" "unprognostic (4.12e-2)" "prognostic favourable (5.76e-4)" "prognostic unfavourable (9.02e-4)" 227.9 42.1 19.6 67.2 24.4 14.7 67.6 14.9 31.4 76.7 49.1 30.1 22.7 29.9 53.2 44.8 54.2 52.4 43.6 120.7 18.3 23.7 95.6 167.8 94.3 175.1 29.1 16.5 44.2 31.6 13.8 21.6 68.7 24.8 42.6 27.9 33.8 63.7 33.6 41.3 22.8 51.2 51.1 35.9 116.4 26.7 21.5 20.4 18.1 297.0 25.9 38.4 56.8 62.2 7.9 95.4 53.1 127.4 5.3 17.1 108.5 6.4 29.1 3.7 16.0 65.8 74.1 11.6 121.4 237.0 42.5 50.4 13.9 37.9 0.1 17.6 137.7 35.4 5.1 33.5 26.9 3.1 5.0 9.4 3.4 34.1 67.0 2.1 7.0 81.1 45.7 38.4 34.4 83.1 7.8 21.5 35.3 5.1 0.8 3.4 3.1 9.8 3.3 3.8 16.4 12.9 10.1 1.6 9.5 14.0 7.6 63.3 12.3 6.3 115.1 72.3 24.5 23.1 22.6 21.4 15.5 0.5 82.9 8.1 33.8 53.1 127.4 16.3 5.2 97.0 7.2 7.9 17.1 5.8 68.0 6.1 9.6 4.1 18.5 5.3 54.7 95.4 13.4 108.5 19.6 24.4 14.9 28.0 18.3 23.7 29.1 16.5 24.8 20.4 CTSC "DPP1, PALS, PLS" ENSG00000109861 "Cathepsin C" P53634 11 88293592-88337787 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 218.6" "Cell line enhanced" "Detected in all" "BJ hTERT+: 112.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025364, HPA066610, HPA068434" Enhanced Supported Vesicles "Intracellular and membrane" 19000000 Vesicles "CAB025364: , HPA066610: , HPA068434: " "unprognostic (4.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.50e-1)" "unprognostic (1.10e-1)" "unprognostic (3.70e-2)" "unprognostic (1.45e-2)" "prognostic unfavourable (9.30e-5)" "unprognostic (1.62e-1)" "unprognostic (1.04e-1)" "unprognostic (1.56e-2)" "unprognostic (3.11e-2)" "unprognostic (3.35e-1)" "prognostic favourable (4.80e-4)" "unprognostic (2.93e-1)" "unprognostic (4.35e-2)" "unprognostic (8.10e-2)" "unprognostic (4.07e-2)" 40.7 20.5 6.7 44.5 10.6 12.0 35.3 1.5 5.6 14.0 25.3 7.1 6.2 20.4 16.1 24.0 21.8 16.7 36.6 53.3 6.8 6.5 62.7 18.1 110.1 218.6 12.5 3.6 11.0 24.8 3.8 17.3 43.4 9.4 13.8 33.1 27.0 35.1 5.8 10.0 11.7 28.5 14.2 14.6 86.6 13.5 10.8 9.2 19.5 17.7 25.3 30.0 30.2 16.9 8.5 75.9 52.5 92.6 34.7 42.4 31.2 11.2 11.5 4.5 9.4 12.2 33.0 30.2 77.1 112.0 44.0 31.8 31.2 51.8 17.5 41.0 41.8 18.2 7.0 32.6 35.2 30.8 12.7 22.8 31.9 35.1 16.2 28.9 15.4 45.9 23.1 33.9 69.6 43.2 20.7 21.1 5.3 2.1 13.0 40.0 23.6 35.7 17.0 4.7 31.0 56.6 18.9 1.2 9.5 13.0 17.2 10.1 3.8 19.8 21.0 3.0 27.3 20.9 48.9 9.0 12.8 17.7 8.0 61.1 16.7 12.5 32.5 52.5 42.4 69.3 36.5 8.5 19.5 37.8 35.1 4.6 9.9 23.8 37.2 34.7 92.6 75.9 28.4 31.2 6.7 10.6 1.5 5.6 6.8 6.5 12.5 3.6 9.4 9.2 CTSF "CATSF, CLN13" ENSG00000174080 "Cathepsin F" Q9UBX1 11 66563463-66568841 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 28.2;SK-MEL-30: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "NK-cells: 7.5;T-cells: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002141, HPA031431, HPA055610" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" 3600000 Cytosol "Vesicles, Plasma membrane" "CAB002141: AB_563471, HPA031431: , HPA055610: " "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (7.22e-3)" "unprognostic (2.25e-2)" "unprognostic (6.72e-2)" "unprognostic (2.67e-2)" "unprognostic (2.76e-2)" "unprognostic (3.69e-1)" "unprognostic (4.14e-1)" "unprognostic (1.69e-2)" "unprognostic (9.12e-2)" "prognostic favourable (8.92e-7)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (3.89e-1)" "unprognostic (2.42e-1)" 28.1 29.4 24.7 8.0 29.0 1.8 31.1 38.4 47.1 37.3 23.8 32.6 25.2 5.8 38.1 29.8 12.9 34.3 37.3 34.5 25.3 20.5 29.8 45.4 17.3 8.5 28.0 26.0 68.2 23.1 42.6 15.9 20.2 25.4 32.3 8.1 35.0 35.5 37.8 35.8 19.7 9.4 34.6 22.4 10.4 17.8 37.1 30.1 0.8 18.6 14.2 6.3 22.2 21.5 2.1 1.1 0.5 0.7 7.5 9.7 2.4 0.1 9.2 5.0 12.9 21.3 8.6 3.6 6.5 16.5 6.8 4.8 0.0 8.2 0.0 11.0 14.2 0.9 8.5 2.8 3.6 2.2 0.0 0.3 3.8 0.0 11.9 0.1 5.0 28.2 9.6 1.5 1.1 4.3 2.8 1.5 8.5 1.9 0.1 1.1 0.6 3.4 0.0 1.9 1.6 6.1 0.2 6.0 6.4 17.4 2.0 52.3 13.2 0.8 2.8 2.7 2.7 3.2 0.6 8.8 0.1 0.0 6.5 0.1 4.1 0.0 0.7 0.4 6.5 0.7 7.0 2.0 5.6 7.3 0.8 2.1 9.7 5.5 0.5 7.5 0.3 1.1 1.7 2.4 24.7 29.0 38.4 47.1 25.3 20.5 28.0 26.0 25.4 30.1 CTSH "ACC-4, ACC-5, ACC4, ACC5, CPSB" ENSG00000103811 "Cathepsin H" P09668 15 78921058-78949574 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 82.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.5;HaCaT: 31.0;RT4: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 42.8" "Group enriched" "Detected in all" 5 "B-cells: 20.6;dendritic cells: 41.2;monocytes: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000458, HPA003524" Enhanced Supported "Vesicles,Cytosol,Cytoplasmic bodies" "Intracellular and membrane" 10000000 "Vesicles, Cytosol, Cytoplasmic bodies" "CAB000458: , HPA003524: AB_1846075" "unprognostic (6.47e-2)" "unprognostic (4.65e-3)" "unprognostic (1.05e-1)" "prognostic favourable (6.90e-4)" "unprognostic (4.37e-2)" "unprognostic (1.93e-1)" "unprognostic (7.18e-2)" "unprognostic (3.30e-3)" "unprognostic (2.22e-1)" "unprognostic (5.96e-2)" "unprognostic (4.10e-2)" "unprognostic (3.89e-2)" "unprognostic (6.63e-3)" "unprognostic (3.83e-1)" "unprognostic (4.42e-2)" "unprognostic (2.70e-3)" "unprognostic (1.79e-3)" 16.7 10.6 9.5 24.2 7.0 5.4 23.9 4.5 9.8 25.1 11.4 17.7 14.7 10.6 10.3 17.1 7.8 13.1 29.2 16.5 14.8 6.7 66.7 18.7 82.6 65.4 12.1 11.6 14.6 25.8 12.3 6.5 7.7 9.4 18.6 6.6 6.7 15.4 15.9 7.0 13.5 16.6 9.8 10.8 20.3 15.6 6.7 15.7 6.6 8.5 4.8 34.8 39.6 13.5 20.6 41.2 1.4 42.8 1.3 7.6 27.3 16.0 1.1 0.4 4.7 1.1 0.0 5.2 1.6 0.6 2.8 1.5 7.0 42.5 5.6 1.7 0.1 31.0 2.0 7.7 2.3 23.6 0.1 0.1 0.2 16.2 1.6 0.0 1.0 0.8 2.2 0.0 0.0 0.2 11.4 0.0 3.8 1.7 3.6 9.8 1.2 0.3 0.0 0.3 0.9 9.8 118.0 0.5 1.1 6.9 3.9 9.6 1.5 5.3 2.2 0.0 1.0 0.0 0.7 0.1 12.2 3.1 0.0 10.3 1.7 0.0 42.8 0.4 1.4 28.3 7.6 20.6 4.1 2.1 41.2 12.0 0.4 0.7 1.4 1.3 17.0 4.2 3.1 27.3 9.5 7.0 4.5 9.8 14.8 6.7 12.1 11.6 9.4 15.7 CTSK "CTSO, CTSO2, PKND, PYCD" ENSG00000143387 "Cathepsin K" P43235 1 150796208-150808323 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 104.1" "Group enriched" "Detected in some" 8 "ASC diff: 200.2;ASC TERT1: 73.3;BJ hTERT+: 161.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 6.7" "Lineage enriched" "Detected in many" 6 "monocytes: 6.7" "Low region specificity" "Detected in all" HPA050346 Supported Vesicles "Intracellular and membrane" Vesicles "HPA050346: " "unprognostic (1.48e-1)" "unprognostic (9.29e-2)" "unprognostic (1.21e-1)" "unprognostic (7.61e-3)" "unprognostic (5.08e-2)" "unprognostic (6.57e-2)" "unprognostic (1.02e-1)" "unprognostic (6.60e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.49e-1)" "unprognostic (3.54e-2)" "prognostic unfavourable (7.12e-5)" "unprognostic (6.07e-3)" "unprognostic (2.98e-2)" "unprognostic (5.93e-3)" "unprognostic (6.41e-2)" 104.1 2.4 1.2 6.5 1.6 1.3 79.3 2.4 2.3 70.6 23.6 2.2 10.1 2.7 72.5 25.9 26.5 12.5 53.4 14.7 1.1 1.1 3.4 1.8 8.7 10.4 1.1 1.7 25.4 2.9 0.3 3.0 30.6 2.6 24.2 11.5 56.0 10.9 6.8 19.9 44.0 11.0 26.9 2.0 5.6 8.6 24.1 0.9 1.1 7.1 13.2 10.7 38.0 48.2 0.1 1.0 1.0 6.7 0.5 1.2 1.8 0.1 0.1 0.3 0.3 200.2 73.3 0.2 5.7 161.8 0.4 0.8 0.0 0.1 0.1 0.2 11.1 0.2 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.0 1.0 0.1 0.4 14.6 0.5 4.5 0.1 0.6 0.0 0.5 0.4 0.3 0.0 0.7 1.1 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.6 0.3 0.0 3.0 0.2 0.2 0.4 0.2 0.1 0.2 0.2 0.6 0.5 1.1 17.0 0.0 0.9 0.0 6.7 1.0 0.7 3.4 0.2 0.0 0.6 0.2 0.4 0.1 0.3 0.5 0.6 0.5 2.0 1.0 1.2 1.8 1.2 1.6 2.4 2.3 1.1 1.1 1.1 1.7 2.6 0.9 CTSL "CTSL1, FLJ31037" ENSG00000135047 "Cathepsin L" P07711 9 87725519-87731393 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 237.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 198.5;HSkMC: 91.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "intermediate monocyte: 31.0;non-classical monocyte: 44.3" "Lineage enriched" "Detected in many" 10 "monocytes: 44.3" "CAB000459, HPA070413" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" 17000000 "Golgi apparatus" Vesicles "CAB000459: AB_2292484, HPA070413: " "unprognostic (1.05e-1)" "unprognostic (1.01e-1)" "unprognostic (1.24e-2)" "unprognostic (1.53e-1)" "prognostic unfavourable (3.73e-4)" "unprognostic (1.19e-3)" "unprognostic (8.12e-3)" "prognostic unfavourable (5.15e-5)" "unprognostic (2.09e-1)" "unprognostic (3.15e-1)" "unprognostic (6.80e-2)" "unprognostic (3.21e-1)" "prognostic favourable (4.34e-4)" "unprognostic (5.64e-3)" "unprognostic (2.26e-2)" "unprognostic (1.72e-1)" "unprognostic (7.11e-3)" 60.3 21.5 10.4 27.2 24.6 18.4 23.3 6.9 12.3 14.8 23.2 14.1 13.7 9.0 24.1 22.3 11.4 25.7 20.7 37.7 10.7 11.4 65.4 98.0 53.1 80.5 18.9 7.7 25.0 14.3 18.8 18.0 237.0 18.4 19.4 13.0 23.2 22.0 23.5 29.3 9.1 12.0 36.6 16.1 108.1 17.5 14.1 15.7 6.8 19.2 9.4 10.1 41.3 26.5 0.0 1.7 0.1 44.3 0.0 4.3 2.4 6.3 36.8 2.5 4.3 46.3 198.5 15.4 20.5 59.7 17.6 22.1 3.5 5.9 0.0 9.6 26.5 5.4 3.3 6.6 14.5 0.1 3.2 1.1 10.4 8.6 30.0 0.0 4.4 91.8 11.2 28.8 11.2 13.8 11.9 0.0 25.3 10.6 0.0 0.7 4.9 7.0 1.5 1.5 0.0 12.3 3.3 3.7 4.5 4.3 9.6 23.5 1.1 7.3 21.7 15.8 8.6 57.5 8.6 1.6 5.9 0.0 57.8 0.0 5.2 0.1 3.5 0.1 0.0 31.0 0.0 0.0 1.8 0.0 1.7 0.0 4.3 0.3 0.1 0.0 44.3 0.1 0.3 2.4 10.4 24.6 6.9 11.7 10.7 11.4 18.9 7.7 18.4 15.7 CTSS ENSG00000163131 "Cathepsin S" P25774 1 150730196-150765957 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 171.4;lymphoid tissue: 111.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.1;HMC-1: 50.3;U-698: 106.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "classical monocyte: 171.4;intermediate monocyte: 151.2;myeloid DC: 43.5;neutrophil: 94.5;non-classical monocyte: 138.5" "Group enriched" "Detected in all" 9 "dendritic cells: 43.5;granulocytes: 94.5;monocytes: 171.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000460, HPA002988" Supported Approved Vesicles "Intracellular and membrane" 19000000 Vesicles "CAB000460: , HPA002988: AB_1078409" "unprognostic (7.81e-2)" "unprognostic (9.04e-2)" "unprognostic (3.23e-2)" "unprognostic (3.93e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-2)" "unprognostic (1.11e-1)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (6.00e-3)" "unprognostic (1.46e-1)" "unprognostic (3.89e-1)" "unprognostic (6.24e-2)" "unprognostic (7.50e-2)" "unprognostic (4.14e-2)" "unprognostic (2.13e-1)" "unprognostic (2.47e-3)" 41.6 9.3 6.8 32.3 10.3 30.3 9.7 1.9 6.2 4.7 32.9 6.6 5.6 19.6 3.7 12.9 8.8 10.7 15.9 17.3 6.4 5.1 9.6 21.5 55.8 99.5 12.6 2.3 7.6 6.4 0.4 3.4 14.4 9.3 7.5 33.4 6.5 12.9 3.3 3.5 3.8 38.0 6.8 17.1 111.4 13.8 3.8 9.5 12.9 7.6 4.6 22.8 21.5 5.3 11.1 43.5 94.5 171.4 3.3 5.6 145.4 1.0 3.2 0.0 0.0 0.4 0.3 0.3 0.0 3.2 0.2 0.6 0.0 21.1 14.5 1.6 0.1 0.4 0.0 0.1 0.0 8.1 0.0 6.4 0.1 0.0 0.0 8.7 50.3 0.6 0.0 1.8 0.1 1.2 0.6 12.7 0.4 0.0 0.0 6.2 0.0 0.0 3.6 1.2 17.8 3.9 3.1 0.0 0.1 0.2 0.9 0.3 0.0 17.8 1.7 1.3 0.2 0.0 0.2 8.8 0.8 106.9 7.4 9.4 0.8 1.2 171.4 16.5 3.2 151.2 3.9 11.1 3.9 3.8 43.5 10.2 3.9 3.6 94.5 3.3 138.5 9.4 5.6 145.4 6.8 10.3 1.9 6.2 6.4 5.1 12.6 2.3 9.3 9.5 CTSZ CTSX ENSG00000101160 "Cathepsin Z" Q9UBR2 20 58995185-59007247 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 3.2;intermediate monocyte: 2.7;memory B-cell: 1.0;myeloid DC: 3.9;naive B-cell: 1.9;neutrophil: 3.5;non-classical monocyte: 2.9;plasmacytoid DC: 2.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025114, HPA049876, HPA053504" Supported Supported Vesicles "Intracellular and membrane" 85000000 Vesicles "CAB025114: , HPA049876: , HPA053504: " "unprognostic (7.30e-2)" "unprognostic (3.98e-2)" "unprognostic (4.07e-2)" "unprognostic (1.11e-3)" "unprognostic (8.25e-3)" "unprognostic (1.15e-1)" "unprognostic (4.12e-2)" "unprognostic (6.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-1)" "unprognostic (1.33e-1)" "unprognostic (5.33e-2)" "prognostic unfavourable (5.72e-5)" "unprognostic (1.96e-1)" "unprognostic (6.92e-2)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" 70.7 27.9 12.4 40.8 20.4 20.7 51.2 14.6 13.5 25.4 52.8 16.0 19.9 40.8 20.6 25.5 20.1 20.7 22.3 50.1 9.8 13.3 34.9 83.7 54.3 61.2 18.8 10.5 29.7 29.0 30.6 27.6 38.6 19.2 28.8 37.8 31.5 40.3 17.7 20.7 12.9 63.6 26.4 22.1 56.5 19.2 13.8 14.9 18.4 42.4 17.5 35.8 29.8 21.5 1.9 3.9 3.5 3.2 0.3 0.6 0.8 27.2 21.2 0.0 0.0 25.0 28.8 15.0 44.9 49.7 34.4 30.8 41.0 45.9 15.0 29.7 118.0 21.8 13.5 42.5 23.6 47.9 1.8 13.7 34.4 0.0 26.2 1.6 47.7 24.5 25.7 15.0 18.0 54.4 9.9 7.6 23.0 0.0 0.1 14.8 1.7 21.2 0.3 0.1 18.0 25.1 6.4 0.4 0.3 34.9 40.4 0.1 18.7 23.2 59.8 0.0 23.2 30.2 0.2 36.2 22.0 2.8 0.4 33.1 0.0 0.0 3.2 0.3 0.6 2.7 0.0 1.0 0.4 0.1 3.9 1.9 0.4 0.1 3.5 0.3 2.9 2.2 0.2 0.8 12.4 20.4 14.6 13.5 9.8 13.3 18.8 10.5 19.2 14.9 CTTN EMS1 ENSG00000085733 Cortactin Q14247 11 70398404-70436584 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 128.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011235, HPA057242" Supported Supported "Golgi apparatus,Vesicles,Plasma membrane,Cytosol" 34000000 "Plasma membrane, Cytosol" "Golgi apparatus, Vesicles" "CAB011235: , HPA057242: " "unprognostic (6.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.05e-1)" "unprognostic (3.13e-2)" "unprognostic (5.81e-2)" "prognostic unfavourable (2.19e-6)" "prognostic unfavourable (4.45e-4)" "unprognostic (6.10e-2)" "unprognostic (2.39e-1)" "unprognostic (1.10e-1)" "unprognostic (1.25e-3)" "unprognostic (1.20e-1)" "unprognostic (1.50e-2)" "unprognostic (6.97e-2)" "unprognostic (2.79e-1)" "unprognostic (3.72e-3)" "unprognostic (1.94e-1)" 37.5 53.6 33.0 19.7 36.7 5.7 32.0 33.3 41.1 41.3 35.3 42.3 33.7 37.1 48.8 40.2 49.4 35.5 56.2 37.3 28.5 23.5 47.2 24.9 30.5 13.7 45.0 32.0 46.3 40.0 28.9 38.3 32.3 37.2 38.9 32.4 24.4 38.0 38.5 31.5 52.9 39.2 43.1 36.0 21.4 51.3 30.2 38.6 7.7 36.0 44.5 26.7 33.2 38.2 0.1 0.8 4.6 0.2 0.0 0.4 13.9 128.4 28.3 9.6 11.0 16.2 25.3 15.8 27.5 27.5 24.3 19.2 37.4 32.4 5.0 27.3 35.2 28.6 11.4 28.9 17.8 10.1 11.5 0.5 21.1 17.5 35.0 0.1 6.8 35.7 20.4 26.8 15.2 20.3 14.4 0.9 23.9 35.1 0.2 1.8 10.4 17.3 0.0 11.8 4.0 27.1 41.9 7.9 13.5 20.1 27.6 45.7 22.5 0.5 25.3 21.4 13.7 33.2 18.3 2.2 1.4 0.3 42.7 0.1 29.2 1.4 0.2 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.4 0.0 4.6 0.0 0.2 0.8 0.0 13.9 33.0 36.7 33.3 41.1 28.5 23.5 45.0 32.0 37.2 38.6 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832149-122850793 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 200 "pancreas: 650.6" "Cell line enhanced" "Detected in many" "hTERT-HME1: 7.1;LHCN-M2: 7.9" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 6 "B-cells: 1.1;T-cells: 3.2" "Low region specificity" "Detected in single" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: " "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 650.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.2 0.0 3.2 0.2 1.6 1.6 1.7 0.0 0.4 0.8 1.0 2.5 0.7 0.3 1.7 1.8 3.6 0.9 0.7 1.0 1.7 0.0 1.5 2.6 2.2 2.2 3.5 4.6 0.8 0.3 0.0 3.7 1.1 0.3 1.5 7.1 1.7 1.3 1.5 7.9 0.4 1.9 2.7 1.7 1.3 0.0 4.0 0.6 1.3 1.3 1.8 0.7 0.8 0.4 1.1 1.3 1.9 3.5 0.0 2.4 0.9 0.0 1.9 1.4 3.1 1.2 5.8 0.0 0.0 0.1 0.3 0.8 0.1 1.3 0.6 0.9 1.1 0.1 1.1 1.4 0.7 0.0 0.0 0.2 0.2 3.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CXCL16 "CXCLG16, SR-PSOX, SRPSOX" ENSG00000161921 "C-X-C motif chemokine ligand 16" Q9H2A7 17 4733526-4739922 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 34.3;CACO-2: 23.6;CAPAN-2: 18.7;HaCaT: 38.5;T-47d: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 18.3;intermediate monocyte: 29.3;myeloid DC: 10.7;neutrophil: 25.9;non-classical monocyte: 37.7" "Group enriched" "Detected in many" 7 "dendritic cells: 10.7;granulocytes: 25.9;monocytes: 37.7" "HPA053253, HPA066315" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" 1103333 4000000 "Golgi apparatus" Vesicles "HPA053253: , HPA066315: " "unprognostic (4.64e-3)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (3.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (4.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.78e-2)" "unprognostic (4.74e-2)" "unprognostic (2.37e-2)" "unprognostic (2.48e-2)" "unprognostic (2.60e-1)" 32.5 9.5 8.2 18.7 9.7 16.3 9.7 2.0 6.6 8.0 17.2 15.8 3.4 19.1 4.8 10.5 13.1 9.5 23.0 5.2 9.9 6.9 12.5 34.8 41.9 28.8 13.3 5.1 10.6 11.0 34.6 8.6 9.7 10.0 9.8 8.3 12.7 26.6 5.9 3.3 11.3 29.5 5.2 16.5 34.1 18.7 51.9 10.0 4.5 8.1 8.5 10.1 9.7 7.4 3.4 10.7 25.9 37.7 0.0 0.3 6.9 34.3 4.7 0.0 11.1 0.1 0.9 4.4 0.4 3.3 3.3 4.5 23.6 18.7 0.0 4.2 0.2 38.5 5.5 4.0 1.1 3.5 6.3 0.0 0.5 10.4 2.3 0.0 5.1 0.2 6.6 1.7 0.2 0.9 0.0 0.2 0.2 7.2 0.1 0.6 0.0 2.9 0.4 0.0 5.1 7.0 5.7 0.0 0.3 7.0 2.8 1.8 18.5 0.4 0.1 0.5 2.5 0.8 2.0 1.2 1.5 0.0 0.1 0.1 0.8 0.0 18.3 4.0 0.1 29.3 0.1 2.9 0.3 0.2 10.7 3.4 0.1 0.3 25.9 0.0 37.7 4.6 0.0 6.9 8.2 9.7 2.0 6.6 9.9 6.9 13.3 5.1 10.0 10.0 CXorf21 FLJ11577 ENSG00000120280 "Chromosome X open reading frame 21" Q9HAI6 X 30558824-30577844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.9;bone marrow: 16.0;lymphoid tissue: 16.7" "Cell line enriched" "Detected in some" 7 "THP-1: 57.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001185 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA001185: AB_1078591" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (4.37e-2)" "unprognostic (2.27e-2)" "unprognostic (3.47e-2)" "unprognostic (5.25e-3)" "unprognostic (9.07e-3)" "unprognostic (5.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (3.43e-1)" "unprognostic (3.60e-1)" "unprognostic (1.66e-3)" "unprognostic (8.99e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-2)" "unprognostic (3.23e-2)" 6.5 2.1 4.6 9.8 4.0 16.0 2.0 0.8 4.4 1.4 3.0 2.3 0.2 4.3 1.2 2.4 1.4 1.5 3.6 1.5 5.0 2.1 1.9 2.8 6.1 12.9 6.3 0.0 1.0 2.0 0.7 1.5 2.7 5.1 1.5 3.1 1.1 3.3 0.5 0.8 1.1 5.3 1.8 9.9 16.7 3.1 0.8 5.2 9.1 1.4 1.2 9.3 4.8 1.4 11.1 21.9 14.9 18.9 3.2 1.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 4.7 2.6 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 7.4 0.0 0.0 7.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.8 0.0 0.0 0.0 0.0 0.0 5.4 0.5 2.6 0.0 8.3 0.0 3.4 10.3 11.4 0.8 9.6 0.1 11.1 1.0 0.5 12.0 10.8 1.0 0.7 14.9 3.2 18.9 21.9 1.6 3.5 4.6 4.0 0.8 4.4 5.0 2.1 6.3 0.0 5.1 5.2 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348745-61362299 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.7;blood: 98.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8" "Group enriched" "Detected in all" 10 "B-cells: 50.1;dendritic cells: 98.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol "Nucleoli, Vesicles" "Nucleoplasm, Cytosol" "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 10.0 113.7 4.0 22.5 6.4 7.1 7.5 4.7 6.9 6.6 10.9 10.9 14.4 6.1 10.9 9.9 8.8 11.0 11.0 5.7 5.1 4.1 9.7 30.6 12.4 21.7 8.3 3.5 14.5 17.9 9.0 6.6 21.0 6.8 9.2 9.6 10.7 10.9 8.1 10.2 24.8 15.8 7.6 5.6 24.0 8.5 8.0 7.0 16.8 10.0 8.4 33.3 10.7 7.3 50.1 98.8 3.8 7.4 3.3 3.8 8.7 18.0 30.5 4.9 14.1 23.2 15.4 4.1 9.1 13.9 11.0 11.0 8.3 20.2 35.2 16.4 16.0 25.3 4.6 25.4 6.7 23.5 10.4 6.0 20.6 5.6 10.9 8.3 15.8 21.6 35.9 23.9 11.0 16.3 19.8 21.1 18.5 19.4 15.7 3.6 9.1 17.5 19.0 4.7 26.3 12.7 17.9 6.0 10.0 18.6 26.9 21.0 21.8 9.7 10.9 13.0 6.7 12.6 13.1 13.2 17.4 19.7 17.8 14.6 16.3 1.6 7.4 3.8 3.8 6.0 3.4 40.5 2.7 3.4 7.4 50.1 2.8 3.0 2.5 3.3 6.4 98.8 2.6 8.7 4.0 6.4 4.7 6.9 5.1 4.1 8.3 3.5 6.8 7.0 CYB5A CYB5 ENSG00000166347 "Cytochrome b5 type A" P00167 18 74250847-74292016 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 266.8" "Cell line enhanced" "Detected in many" "ASC diff: 151.3;RT4: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006333, HPA047548, HPA058547" Enhanced Enhanced Vesicles,Cytosol 780000 "Vesicles, Cytosol" "CAB006333: , HPA047548: , HPA058547: " "unprognostic (1.88e-1)" "unprognostic (1.28e-1)" "prognostic favourable (5.23e-4)" "unprognostic (1.08e-2)" "unprognostic (1.41e-1)" "unprognostic (9.14e-2)" "prognostic favourable (4.15e-4)" "unprognostic (7.79e-3)" "unprognostic (1.11e-1)" "unprognostic (3.33e-2)" "unprognostic (2.68e-2)" "unprognostic (1.65e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (4.64e-2)" "unprognostic (8.54e-2)" 25.0 13.2 4.3 11.0 5.8 1.5 39.4 6.9 5.9 7.5 68.2 4.3 38.5 37.7 4.9 16.0 8.3 7.0 34.8 14.5 4.1 3.7 76.2 266.8 67.0 9.2 6.5 3.4 25.1 75.3 10.1 6.5 7.2 5.2 13.5 9.0 6.2 7.6 54.9 4.3 11.4 70.7 21.2 11.5 10.3 18.0 12.2 5.5 4.6 4.6 7.9 4.3 21.6 18.8 34.9 16.9 2.1 12.9 10.2 38.0 13.5 9.8 16.8 8.8 0.0 151.3 26.9 11.7 6.8 14.7 14.5 21.8 19.8 10.7 12.0 4.8 12.4 22.0 0.0 9.3 11.6 22.4 11.7 4.4 9.2 52.5 23.5 8.4 5.8 45.0 7.4 8.2 4.2 7.9 7.1 4.5 12.1 17.7 4.7 10.0 3.9 10.9 11.7 2.8 0.2 14.4 66.0 25.1 10.4 6.6 18.0 8.0 35.6 8.0 7.4 0.0 11.4 3.5 8.6 3.2 13.0 3.7 8.9 2.3 8.4 1.1 9.6 2.1 16.7 10.8 38.0 28.5 18.7 19.6 16.9 34.9 18.4 23.1 1.1 10.2 12.9 14.8 14.4 13.5 4.3 5.8 6.9 5.9 4.1 3.7 6.5 3.4 5.2 5.5 CYP27C1 FLJ16008 ENSG00000186684 "Cytochrome P450 family 27 subfamily C member 1" Q4G0S4 2 127184120-127220078 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 10.6" "Cell line enhanced" "Detected in many" "HaCaT: 8.6;HDLM-2: 12.4;TIME: 12.5;U-138 MG: 12.7;U-251 MG: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA062460, HPA068731" Enhanced Vesicles Vesicles "HPA062460: , HPA068731: " "unprognostic (1.90e-1)" "unprognostic (4.07e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-2)" "unprognostic (3.03e-1)" "unprognostic (7.75e-3)" "unprognostic (3.48e-1)" "unprognostic (2.31e-3)" "unprognostic (4.38e-2)" "unprognostic (3.15e-1)" "unprognostic (1.81e-3)" "unprognostic (1.11e-1)" "unprognostic (6.29e-4)" "unprognostic (3.49e-4)" "unprognostic (1.83e-1)" "unprognostic (4.27e-2)" "unprognostic (8.64e-2)" 2.7 1.0 0.6 2.4 2.4 0.8 0.6 0.4 1.8 5.2 1.9 1.5 0.4 0.5 1.3 0.8 4.4 1.0 1.5 2.0 0.4 0.9 0.4 0.4 0.4 0.6 2.9 0.4 0.4 0.4 0.0 0.4 0.4 0.7 2.2 0.7 4.2 0.4 1.5 0.8 10.6 1.0 0.4 0.4 0.4 0.5 0.7 3.6 0.4 0.4 2.2 1.6 2.7 4.5 1.5 1.3 3.6 1.0 1.8 1.4 0.2 1.3 3.9 2.0 0.2 0.1 0.0 0.2 0.5 3.6 2.0 0.9 0.1 3.0 0.2 0.1 2.3 8.6 3.2 1.8 0.6 12.4 1.5 0.0 2.2 0.1 0.0 0.1 0.1 0.1 0.1 0.5 1.2 0.5 0.1 0.5 2.3 0.1 0.3 0.1 4.4 1.1 0.1 0.2 0.0 6.5 1.1 0.1 0.7 5.5 0.0 0.0 0.2 0.1 12.5 12.7 2.2 6.2 8.3 0.2 0.1 0.1 0.1 0.1 0.9 2.4 1.0 0.7 1.2 0.7 1.0 0.9 1.0 0.8 0.3 1.5 1.1 1.4 3.6 1.8 0.7 1.3 0.8 0.2 0.6 2.4 0.4 1.3 0.4 0.9 2.9 0.4 0.7 3.6 CYP2U1 SPG49 ENSG00000155016 "Cytochrome P450 family 2 subfamily U member 1" Q7Z449 4 107931369-107953457 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 122.7" "Cell line enhanced" "Detected in many" "ASC diff: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041622, HPA046754, HPA064827" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA041622: , HPA046754: , HPA064827: " "unprognostic (3.54e-1)" "unprognostic (2.45e-1)" "unprognostic (3.08e-1)" "unprognostic (2.84e-1)" "unprognostic (5.16e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (1.20e-3)" "unprognostic (3.19e-1)" "unprognostic (8.97e-3)" "unprognostic (5.41e-3)" "unprognostic (3.02e-1)" "prognostic favourable (2.75e-5)" "prognostic unfavourable (6.97e-4)" "unprognostic (1.19e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.6 7.9 7.7 4.4 9.1 0.4 7.3 11.3 9.2 7.8 7.3 7.0 4.1 4.0 9.5 4.6 6.3 9.8 6.6 8.8 7.1 7.9 6.4 6.8 6.6 6.7 8.3 5.2 12.0 2.6 10.3 8.1 2.7 7.8 12.4 4.7 8.6 4.5 11.0 4.3 3.1 6.0 12.3 7.0 8.5 4.6 3.9 7.4 122.7 4.7 3.5 5.4 7.3 5.3 2.6 2.7 0.7 5.9 1.6 1.7 0.4 2.5 1.2 3.4 6.3 18.8 9.0 0.5 10.8 16.3 6.6 10.5 0.0 1.7 6.9 0.8 6.4 0.1 5.3 4.0 10.4 1.9 1.6 1.4 2.4 0.3 7.5 2.0 0.0 10.1 3.4 3.1 2.1 2.5 0.1 3.3 5.5 1.8 7.4 0.0 3.5 3.0 4.2 4.1 0.0 2.1 4.3 6.7 5.0 2.7 4.7 11.5 2.3 1.0 6.8 4.3 0.5 6.1 4.3 14.0 13.2 2.2 3.5 0.0 4.8 0.0 0.3 0.7 1.2 1.1 0.9 2.0 0.9 1.0 2.2 2.6 1.7 1.3 0.0 1.6 5.9 2.7 0.0 0.4 7.7 9.1 11.3 6.9 7.1 7.9 8.3 5.2 7.8 7.4 CYP4B1 ENSG00000142973 "Cytochrome P450 family 4 subfamily B member 1" P13584 1 46757838-46819413 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 92.0" "Cell line enriched" "Detected in some" 8 "RT4: 79.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 56.9" "Region enhanced" "Detected in single" "midbrain: 1.7" "Cell type enriched" "Detected in single" 11 "memory CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA004331 Approved Supported Vesicles Vesicles "HPA004331: AB_1078616" "unprognostic (2.29e-2)" "prognostic favourable (5.99e-4)" "unprognostic (7.01e-2)" "unprognostic (1.11e-1)" "unprognostic (2.28e-1)" "unprognostic (8.31e-2)" "unprognostic (1.16e-2)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "unprognostic (2.59e-1)" "unprognostic (6.12e-2)" "unprognostic (5.46e-2)" "unprognostic (7.33e-2)" "unprognostic (1.80e-1)" "unprognostic (1.15e-1)" "unprognostic (1.22e-3)" "unprognostic (6.69e-3)" 41.6 2.2 0.0 0.6 0.1 0.3 45.5 0.1 0.3 9.5 6.7 0.1 7.2 0.7 2.1 2.8 17.9 18.5 0.8 13.5 0.0 0.0 1.4 0.2 92.0 1.5 1.7 0.1 3.3 0.9 0.5 4.8 0.9 0.8 15.4 0.5 2.8 5.0 6.9 14.4 10.4 3.4 6.8 3.5 0.5 3.0 1.7 0.1 0.7 12.7 4.5 5.7 36.5 18.9 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 1.7 0.1 0.8 0.1 CYSRT1 "C9orf169, MGC59937" ENSG00000197191 "Cysteine rich tail 1" 9 137224635-137226311 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "esophagus: 33.4" "Cell line enhanced" "Detected in many" "A-431: 9.8;CAPAN-2: 12.4;HaCaT: 13.8;HeLa: 12.2;MCF7: 19.1" "Cancer enhanced" "Detected in all" "head and neck cancer: 23.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 3.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021883, HPA021886" Approved Approved "Nuclear speckles,Vesicles,Midbody" "Nuclear speckles" "Vesicles, Midbody" "HPA021883: AB_1853190, HPA021886: AB_1853192" "unprognostic (1.35e-1)" "unprognostic (2.53e-2)" "unprognostic (8.31e-3)" "unprognostic (6.87e-3)" "unprognostic (2.14e-1)" "unprognostic (2.66e-2)" "unprognostic (8.11e-2)" "unprognostic (5.86e-2)" "unprognostic (3.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (6.24e-3)" "unprognostic (7.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 0.7 0.4 1.0 0.7 0.9 0.2 0.8 0.7 1.7 1.4 0.7 0.7 0.7 0.3 0.7 0.7 33.4 1.0 0.7 0.7 1.4 1.3 1.4 0.7 0.7 0.7 0.8 0.7 0.7 0.7 0.3 3.5 0.7 0.7 1.1 0.0 0.7 2.2 0.7 0.7 8.1 0.7 0.7 0.7 0.7 0.8 2.2 0.7 0.7 1.3 0.7 5.3 0.7 2.1 0.9 0.6 0.9 3.0 0.9 0.3 0.1 9.8 1.2 1.0 2.1 0.0 0.0 2.7 0.3 0.3 0.3 0.1 0.7 12.4 0.7 0.7 0.2 13.8 0.3 3.1 0.0 1.3 1.0 0.2 12.2 6.5 0.7 0.1 0.6 0.3 1.5 0.4 0.1 0.1 0.4 2.1 0.8 19.1 0.4 0.7 0.5 1.5 1.5 1.3 1.7 0.4 0.7 0.3 1.0 2.0 1.8 0.5 3.9 0.2 0.5 0.8 0.5 1.8 0.3 1.2 0.9 0.7 0.7 0.5 0.8 0.9 0.2 0.2 0.3 1.7 0.1 0.9 0.3 0.2 0.6 0.8 0.2 0.3 0.7 0.9 3.0 0.4 0.2 0.1 1.0 0.9 0.7 1.7 1.4 1.3 0.8 0.7 0.7 0.7 DAAM2 KIAA0381 ENSG00000146122 "Dishevelled associated activator of morphogenesis 2" Q86T65 6 39792298-39904877 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 83.3" "Cell line enhanced" "Detected in some" "HSkMC: 25.6;LHCN-M2: 25.1;SK-MEL-30: 31.0;U-138 MG: 9.6;WM-115: 12.1" "Cancer enhanced" "Detected in all" "melanoma: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 29 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051300, HPA054630" Approved Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA051300: , HPA054630: " "unprognostic (7.53e-2)" "unprognostic (6.02e-3)" "unprognostic (4.49e-2)" "unprognostic (7.93e-2)" "unprognostic (8.24e-2)" "unprognostic (4.28e-2)" "unprognostic (2.43e-2)" "unprognostic (1.05e-3)" "unprognostic (1.33e-1)" "unprognostic (5.89e-2)" "unprognostic (2.17e-1)" "unprognostic (5.24e-2)" "prognostic unfavourable (2.79e-4)" "unprognostic (2.67e-2)" "unprognostic (8.54e-2)" "unprognostic (7.94e-2)" "unprognostic (8.54e-4)" 21.5 17.8 34.8 6.7 43.0 1.7 7.8 4.4 52.2 9.3 6.4 83.3 8.0 7.6 7.5 8.5 28.3 8.9 5.9 6.1 40.4 25.2 5.9 4.0 8.4 2.8 42.8 24.8 7.3 5.2 3.5 2.1 9.4 41.3 8.7 7.1 5.1 4.3 17.6 23.8 4.4 8.9 13.7 48.8 15.5 7.0 8.7 51.9 0.0 5.0 2.1 2.2 4.6 4.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.7 0.1 0.1 4.4 5.9 1.0 0.5 0.4 0.0 0.0 0.2 6.5 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 4.1 0.0 0.0 25.6 0.0 0.1 0.0 0.0 0.0 0.0 25.1 0.0 0.6 0.0 0.7 0.0 0.0 4.5 3.5 0.0 0.0 0.9 1.0 0.0 0.3 31.0 0.0 0.0 0.2 9.6 2.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 34.8 43.0 4.4 28.9 40.4 25.2 42.8 24.8 41.3 51.9 DAB1 ENSG00000173406 "DAB1, reelin adaptor protein" O75553 1 56994778-58546734 "Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4;intestine: 20.8" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 29.3;HeLa: 10.5;NTERA-2: 13.0;RT4: 17.3;WM-115: 14.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 31.4" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.5" "Group enriched" "Detected in many" 16 "granulocytes: 1.4;T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032329, HPA052033, HPA067495" Enhanced Enhanced Vesicles Vesicles "CAB032329: AB_638973, HPA052033: , HPA067495: " "unprognostic (7.88e-2)" "unprognostic (1.02e-1)" "unprognostic (8.54e-2)" "unprognostic (2.09e-4)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (7.30e-4)" "unprognostic (3.90e-1)" "unprognostic (3.07e-2)" "unprognostic (1.47e-2)" "unprognostic (2.06e-3)" "unprognostic (1.27e-1)" "unprognostic (2.00e-3)" "unprognostic (1.78e-1)" "unprognostic (2.01e-1)" "unprognostic (1.44e-2)" "unprognostic (5.67e-2)" 1.8 1.7 5.8 0.3 3.8 0.0 0.7 31.4 6.2 1.7 1.0 1.8 0.5 15.0 1.0 1.0 0.6 1.6 0.8 1.8 5.3 1.4 0.7 7.5 0.8 0.2 1.1 4.2 1.2 0.7 0.0 0.7 0.0 2.0 4.0 0.3 2.9 5.2 10.2 0.6 0.6 20.8 0.3 1.1 0.6 1.0 0.9 0.7 0.0 0.8 0.0 0.1 1.9 1.0 0.0 0.0 1.4 0.0 0.2 5.5 0.1 0.0 0.0 5.9 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 13.0 0.0 3.2 0.0 0.1 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 1.4 0.5 0.0 5.5 0.0 2.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.1 5.8 3.8 31.4 6.2 5.3 1.4 1.1 4.2 2.0 0.7 DAB2 DOC-2 ENSG00000153071 "DAB2, clathrin adaptor protein" P98082 5 39371675-39462300 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 194.4" "Cell line enhanced" "Detected in many" "ASC diff: 42.2;ASC TERT1: 45.4;fHDF/TERT166: 65.6;TIME: 39.5;U-138 MG: 46.0" "Cancer enhanced" "Detected in all" "renal cancer: 52.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "plasmacytoid DC: 26.6" "Lineage enriched" "Detected in many" 10 "dendritic cells: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009314, HPA028888" Enhanced Enhanced "Nucleoli fibrillar center,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "Nucleoli fibrillar center" "CAB009314: AB_638976, HPA028888: " "unprognostic (1.24e-1)" "unprognostic (7.28e-2)" "unprognostic (2.16e-1)" "unprognostic (1.25e-1)" "unprognostic (5.37e-3)" "unprognostic (7.01e-2)" "prognostic unfavourable (7.38e-6)" "unprognostic (3.11e-1)" "unprognostic (2.82e-1)" "unprognostic (2.78e-2)" "unprognostic (1.50e-1)" "unprognostic (1.87e-1)" "unprognostic (3.16e-2)" "prognostic unfavourable (9.67e-4)" "unprognostic (1.27e-2)" "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" 51.6 44.2 2.6 12.2 3.5 0.6 21.8 6.1 2.6 16.6 14.0 4.1 4.5 3.3 16.6 34.8 10.8 9.6 13.3 25.1 2.9 3.0 75.2 6.9 22.4 31.8 4.0 2.1 12.7 11.3 3.2 3.9 194.4 4.7 11.6 14.6 14.6 12.9 5.3 12.7 9.3 10.4 16.0 5.2 21.1 7.2 8.7 2.5 7.3 10.9 8.4 7.4 17.8 14.7 0.1 26.6 2.2 2.5 0.9 1.3 7.0 0.0 1.5 2.4 5.3 42.2 45.4 3.0 27.2 27.9 10.7 17.7 19.9 0.0 0.0 1.7 65.6 0.0 0.3 0.9 15.1 0.0 0.8 3.6 36.2 6.5 10.2 0.0 4.7 28.2 0.0 17.5 3.1 32.2 0.0 0.9 17.7 0.1 0.3 0.0 1.6 3.0 0.9 6.2 0.0 7.1 0.5 0.0 0.0 3.2 1.7 15.2 0.1 0.9 39.5 46.0 5.1 5.3 2.2 0.0 0.0 0.0 16.0 3.4 5.9 2.2 1.2 0.2 1.3 2.5 0.0 0.1 0.2 0.7 3.4 0.1 0.1 1.0 1.8 0.9 0.6 26.6 0.2 7.0 2.6 3.5 6.1 2.6 2.9 3.0 4.0 2.1 4.7 2.5 DACH1 DACH ENSG00000276644 "Dachshund family transcription factor 1" Q9UI36 13 71437966-71867192 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 8.0;HAP1: 12.5;HEK 293: 9.3;HL-60: 20.3;NB-4: 9.0;SCLC-21H: 20.9;SH-SY5Y: 16.7;THP-1: 14.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 15 "basophil: 4.7;eosinophil: 9.2;NK-cell: 4.9;plasmacytoid DC: 7.5" "Group enriched" "Detected in many" 30 "dendritic cells: 7.5;granulocytes: 9.2;NK-cells: 4.9" "Region enriched" "Detected in many" 5 "basal ganglia: 34.7" "Region enriched" "Detected in all" 5 "basal ganglia: 34.0" HPA012672 Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA012672: AB_1847466" "unprognostic (3.16e-1)" "unprognostic (5.26e-2)" "unprognostic (1.41e-2)" "unprognostic (2.36e-1)" "unprognostic (4.21e-2)" "unprognostic (5.63e-2)" "unprognostic (2.22e-2)" "unprognostic (8.08e-3)" "unprognostic (2.12e-2)" "unprognostic (2.50e-1)" "unprognostic (3.04e-3)" "unprognostic (4.37e-1)" "unprognostic (2.18e-2)" "unprognostic (1.06e-1)" "unprognostic (2.19e-1)" "unprognostic (1.24e-1)" "unprognostic (5.17e-2)" 4.9 12.2 0.6 3.8 15.5 5.7 9.2 1.8 2.9 11.4 5.4 0.0 3.5 5.4 6.3 4.1 0.9 2.9 15.8 3.0 0.2 10.2 1.9 10.2 0.3 0.0 1.5 0.9 1.8 7.3 24.4 7.3 4.9 7.9 3.5 19.6 1.9 6.9 3.6 0.6 9.6 2.1 2.9 7.8 1.8 6.1 6.6 6.1 0.0 1.2 0.2 2.1 10.2 0.0 7.5 9.2 0.2 4.9 0.0 0.1 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 12.5 0.0 0.0 0.0 9.3 0.1 0.0 0.0 0.2 20.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 9.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 20.9 16.7 0.0 0.0 0.0 0.5 14.7 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.1 4.7 0.2 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 4.9 0.0 7.5 0.0 0.1 DACT3 "DAPPER3, MGC15476, RRR1" ENSG00000197380 "Dishevelled binding antagonist of beta catenin 3" Q96B18 19 46647612-46661138 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 9.3;SH-SY5Y: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043053 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA043053: AB_10794769" "unprognostic (2.35e-1)" "unprognostic (3.08e-1)" "unprognostic (5.30e-3)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.66e-1)" "unprognostic (2.03e-2)" "unprognostic (3.27e-2)" "unprognostic (2.03e-4)" "unprognostic (1.70e-1)" "unprognostic (2.67e-1)" "prognostic unfavourable (7.97e-8)" "unprognostic (1.59e-2)" "unprognostic (4.03e-2)" "unprognostic (3.54e-3)" "prognostic unfavourable (6.66e-4)" 5.2 3.8 21.0 5.8 15.9 1.7 1.6 3.7 32.3 10.7 17.3 24.6 3.5 4.2 21.6 14.8 7.8 10.9 7.4 10.5 21.7 13.9 3.9 2.2 5.6 1.5 17.4 13.6 8.8 1.5 1.4 1.2 2.1 14.1 11.7 7.2 13.7 1.7 25.1 1.7 2.8 4.7 30.3 17.0 4.8 7.4 5.7 9.4 0.0 1.6 1.5 1.3 13.2 6.0 1.6 1.2 5.9 0.9 2.0 0.7 0.3 0.2 0.3 5.1 4.8 1.7 1.4 0.5 2.8 4.7 0.9 1.4 0.3 0.3 0.4 1.9 9.3 0.3 3.2 0.1 1.0 0.4 1.7 1.2 0.7 0.2 2.6 0.2 2.1 4.6 0.1 1.2 0.0 0.4 1.6 1.7 0.8 0.4 0.2 1.2 2.0 0.7 4.1 1.4 0.3 0.3 0.4 2.0 22.7 0.5 0.2 0.4 0.4 0.4 0.5 2.4 2.9 2.5 0.5 1.5 0.5 0.7 0.6 0.8 1.8 5.9 0.9 1.0 0.7 0.5 0.5 0.7 0.7 0.5 0.2 1.6 0.7 0.7 4.6 2.0 0.7 1.2 0.5 0.3 21.0 15.9 3.7 32.3 21.7 13.9 17.4 13.6 14.1 9.4 DAG1 "156DAG, A3a, AGRNR, DAG" ENSG00000173402 "Dystroglycan 1" Q14118 3 49468703-49535618 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001960, CAB016353" Enhanced Supported Vesicles "Intracellular and membrane" 70000000 Vesicles "CAB001960: , CAB016353: AB_627292" "unprognostic (1.58e-1)" "unprognostic (5.14e-1)" "unprognostic (6.71e-3)" "unprognostic (3.32e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" "unprognostic (1.67e-1)" "unprognostic (3.27e-2)" "unprognostic (8.18e-2)" "unprognostic (3.91e-2)" "unprognostic (5.70e-3)" "unprognostic (1.10e-1)" "prognostic favourable (2.59e-4)" "unprognostic (9.22e-2)" "unprognostic (1.99e-2)" "unprognostic (7.43e-2)" "unprognostic (1.57e-2)" 19.2 17.4 16.5 10.1 21.1 2.8 16.2 17.3 27.1 17.3 23.9 24.1 13.1 14.1 23.4 14.3 19.1 19.6 19.7 40.9 19.9 10.3 22.7 31.7 18.9 6.3 16.7 15.7 22.6 35.0 32.7 15.8 45.6 18.1 18.6 18.9 22.2 19.9 24.3 57.3 18.7 17.5 27.9 14.0 7.3 22.2 29.4 16.3 6.0 15.3 24.0 14.3 20.4 15.0 3.2 3.6 1.8 6.1 1.9 3.7 3.3 19.5 19.5 13.6 33.6 18.2 8.9 62.0 13.8 20.5 23.7 15.3 16.0 20.8 2.7 14.0 22.5 36.7 11.8 17.9 14.7 2.6 3.9 1.8 19.6 18.2 8.1 2.4 3.9 7.8 16.2 22.5 7.5 21.2 2.8 2.1 6.4 15.7 2.0 1.6 14.5 6.5 1.2 13.2 4.6 18.6 27.5 4.8 9.9 16.6 45.8 22.4 38.6 4.8 11.0 9.0 14.3 16.7 19.7 2.4 4.9 1.7 10.9 2.6 54.2 1.8 2.8 1.1 3.3 3.5 3.7 3.2 2.8 2.5 1.8 2.6 3.0 2.4 0.6 1.9 6.1 3.6 1.9 3.3 16.5 21.1 17.3 27.1 19.9 10.3 16.7 15.7 18.1 16.3 DAP ENSG00000112977 "Death associated protein" P51397 5 10679230-10761272 "Predicted intracellular proteins" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 178.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA029456 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria "Vesicles, Mitochondria" Nucleoplasm "HPA029456: AB_10601262" "unprognostic (2.70e-2)" "unprognostic (3.48e-1)" "unprognostic (2.25e-1)" "unprognostic (1.88e-2)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (2.15e-5)" "unprognostic (4.05e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.91e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.39e-1)" "unprognostic (8.58e-3)" "unprognostic (2.04e-2)" 17.4 36.6 13.7 17.9 12.7 10.6 23.1 3.9 11.6 23.5 25.4 11.4 63.4 26.5 21.1 34.7 14.3 18.6 44.0 22.9 13.4 9.1 40.1 78.2 21.6 22.6 10.2 10.1 26.1 178.8 30.0 28.4 26.4 21.8 24.8 20.2 22.7 71.1 76.0 5.9 15.2 42.6 18.3 10.8 23.8 31.6 23.2 9.8 15.5 31.2 12.8 18.6 25.9 16.9 18.1 32.8 27.3 33.2 13.1 17.6 22.5 18.9 13.8 17.2 15.8 32.2 39.0 19.1 46.6 72.4 35.3 41.0 9.8 16.2 8.3 30.6 57.5 3.7 10.7 27.6 39.3 43.5 7.8 11.1 26.8 24.1 30.4 20.7 8.3 20.0 9.6 23.1 41.9 65.7 12.8 28.1 34.5 15.0 11.1 13.2 6.2 31.8 15.3 7.6 13.6 46.5 35.3 11.7 15.7 47.5 19.4 12.4 15.3 30.5 32.2 21.9 23.8 14.4 24.6 15.8 20.4 12.2 21.7 40.5 32.8 14.9 33.2 18.6 14.8 29.4 17.6 18.1 15.3 13.0 32.8 12.0 11.3 11.2 27.3 13.1 28.5 26.9 16.1 22.5 13.7 12.7 3.9 11.6 13.4 9.1 10.2 10.1 21.8 9.8 DAPK2 "DRP-1, MGC119312" ENSG00000035664 "Death associated protein kinase 2" Q9UIK4 15 63907036-64072033 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;skeletal muscle: 46.1" "Cell line enhanced" "Detected in many" "ASC diff: 10.0;HaCaT: 8.3;HMC-1: 17.0;MCF7: 8.6" "Cancer enriched" "Detected in many" 15 "thyroid cancer: 30.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "basophil: 19.1;eosinophil: 51.8;neutrophil: 16.4" "Lineage enriched" "Detected in many" 23 "granulocytes: 51.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071581 Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA071581: " "unprognostic (3.20e-2)" "unprognostic (4.07e-2)" "unprognostic (4.23e-2)" "unprognostic (1.95e-3)" "unprognostic (2.88e-2)" "unprognostic (1.30e-2)" "unprognostic (2.32e-1)" "prognostic favourable (5.63e-4)" "unprognostic (1.04e-1)" "unprognostic (3.18e-1)" "unprognostic (9.21e-2)" "unprognostic (8.51e-2)" "unprognostic (4.77e-7)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (3.20e-3)" "unprognostic (9.07e-2)" 8.2 1.6 2.6 6.8 5.0 10.3 5.2 1.4 3.9 3.6 16.6 12.0 8.3 14.2 1.7 1.5 2.1 1.2 1.7 17.6 3.6 2.0 2.2 1.4 14.0 2.5 6.8 3.0 0.7 1.7 1.1 1.1 0.3 4.7 3.1 4.7 1.9 4.8 4.8 46.1 4.6 25.8 1.2 3.4 4.7 6.9 2.0 6.5 1.1 22.3 8.7 3.3 2.1 9.6 0.3 2.2 51.8 0.0 0.7 0.6 0.3 2.8 2.0 5.6 1.4 10.0 0.4 0.1 1.9 6.0 1.0 1.1 0.8 1.4 0.2 0.6 6.0 8.3 3.5 0.1 0.6 0.2 0.1 1.1 3.9 0.1 0.1 0.1 17.0 1.0 7.2 0.3 0.2 0.6 0.4 0.1 0.7 8.6 0.0 0.3 0.6 2.0 2.6 0.0 0.3 0.0 2.8 0.4 0.3 0.4 1.1 0.0 4.8 0.4 0.4 0.8 1.0 1.3 1.6 0.6 0.2 0.0 0.0 2.7 0.2 19.1 0.0 51.8 0.6 0.0 0.2 0.3 0.1 0.5 0.0 0.1 0.0 0.4 16.4 0.7 0.0 2.2 0.0 0.3 2.6 5.0 1.4 3.9 3.6 2.0 6.8 3.0 4.7 6.5 DBH DBM ENSG00000123454 "Dopamine beta-hydroxylase" P09172 9 133636360-133659344 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adrenal gland: 86.6;brain: 36.2;liver: 35.6" "Cell line enriched" "Detected in single" 340 "SH-SY5Y: 201.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 45 "pons and medulla: 36.2" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.0" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Region enriched" "Detected in some" 6 "pons and medulla: 23.2" "Region enriched" "Detected in single" 37 "pons and medulla: 25.1" "HPA002130, HPA005960, HPA070789" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" 2000000000 Vesicles "Endoplasmic reticulum" "HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312" "unprognostic (1.93e-3)" "unprognostic (7.52e-3)" "unprognostic (8.53e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-3)" "unprognostic (3.38e-3)" "unprognostic (3.39e-3)" "unprognostic (3.97e-2)" "unprognostic (1.71e-1)" "unprognostic (8.99e-2)" "unprognostic (5.80e-2)" "unprognostic (7.69e-2)" "unprognostic (2.81e-7)" "unprognostic (9.31e-2)" "unprognostic (6.77e-2)" "unprognostic (1.49e-2)" "unprognostic (5.06e-3)" 0.7 86.6 0.1 0.3 0.1 0.0 0.0 0.1 0.8 0.3 0.0 1.9 0.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.5 35.6 0.3 0.6 0.0 0.0 0.1 1.3 0.0 0.6 0.4 36.2 0.8 0.0 1.0 0.2 5.9 0.0 0.0 0.2 0.0 1.4 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.2 201.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.0 0.0 36.2 0.0 DCAF15 "C19orf72, MGC99481" ENSG00000132017 "DDB1 and CUL4 associated factor 15" Q66K64 19 13952492-13961449 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068351 Approved Vesicles,Mitochondria Mitochondria Vesicles "HPA068351: " "unprognostic (6.91e-2)" "unprognostic (6.55e-3)" "unprognostic (3.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.95e-1)" "unprognostic (1.89e-2)" "unprognostic (1.83e-3)" "unprognostic (9.72e-2)" "unprognostic (8.03e-2)" "unprognostic (1.21e-1)" "prognostic favourable (7.97e-4)" "unprognostic (1.98e-2)" "prognostic unfavourable (1.34e-5)" "unprognostic (7.97e-3)" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" 10.3 6.5 10.4 15.1 8.5 27.5 11.1 20.1 13.3 13.9 12.7 8.7 8.9 10.7 11.4 8.4 14.7 11.3 10.0 11.0 12.1 7.0 11.1 13.1 14.8 19.4 9.0 8.5 10.3 8.4 11.0 10.7 18.6 8.8 10.4 8.4 9.8 10.0 9.1 13.3 21.0 13.8 8.2 7.4 21.4 9.9 41.0 6.5 29.2 10.7 16.5 23.4 9.9 12.8 2.2 2.8 5.1 2.2 0.8 3.6 1.3 15.4 9.6 25.3 13.9 2.7 4.0 11.6 10.7 7.5 22.5 22.5 17.0 6.6 14.3 12.4 10.2 14.1 16.1 10.1 8.0 17.2 28.6 17.6 16.1 17.6 5.7 14.5 26.0 5.2 9.5 16.6 7.5 11.2 18.5 21.2 9.8 23.6 25.9 27.1 30.1 15.1 24.0 8.9 9.8 12.0 12.0 16.2 16.7 9.6 7.0 8.7 8.9 18.8 7.7 15.4 11.4 24.3 19.9 15.0 16.4 14.9 9.9 21.3 13.2 1.2 2.0 5.1 2.1 2.2 1.6 2.1 1.7 2.4 1.2 2.2 0.9 2.4 4.1 0.8 1.4 2.8 3.6 1.3 10.4 8.5 20.1 13.3 12.1 7.0 9.0 8.5 8.8 6.5 DCHS2 "CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ" ENSG00000197410 "Dachsous cadherin-related 2" 4 154231742-154495570 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "endometrium 1: 8.6" "Cell line enriched" "Detected in some" 6 "U-2 OS: 7.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA064159 Uncertain Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA064159: " "unprognostic (1.38e-2)" "unprognostic (1.51e-1)" "unprognostic (5.74e-3)" "unprognostic (5.93e-2)" "unprognostic (7.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.27e-4)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (1.61e-1)" "unprognostic (2.53e-3)" "unprognostic (1.62e-1)" "unprognostic (1.06e-3)" "unprognostic (3.13e-1)" "unprognostic (2.62e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-3)" 0.9 1.6 3.4 1.3 7.0 1.1 1.0 0.6 4.8 2.6 4.0 1.9 1.1 1.3 8.6 1.5 1.0 2.0 1.6 0.8 3.5 2.6 0.9 0.7 1.1 0.8 3.0 2.3 1.9 0.6 1.1 1.7 0.8 4.6 1.6 1.5 2.7 0.8 3.6 1.0 2.1 1.0 3.0 7.0 0.8 4.9 2.6 2.9 0.0 1.0 0.0 0.9 2.3 1.2 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.4 7.0 0.6 4.8 3.5 2.6 3.0 2.3 4.6 2.9 DCP1B FLJ31638 ENSG00000151065 "Decapping mRNA 1B" Q8IZD4 12 1946054-2004535 "Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in all" 5 "T-cells: 19.1" "Low region specificity" "Detected in all" HPA039709 Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA039709: AB_10672901" "unprognostic (9.60e-2)" "unprognostic (7.19e-3)" "unprognostic (4.37e-3)" "unprognostic (2.13e-1)" "unprognostic (7.00e-2)" "unprognostic (1.08e-1)" "unprognostic (8.94e-2)" "unprognostic (3.26e-1)" "unprognostic (3.13e-1)" "unprognostic (1.53e-2)" "unprognostic (5.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.08e-2)" "unprognostic (3.98e-2)" "unprognostic (1.46e-1)" "unprognostic (1.84e-2)" "unprognostic (7.42e-2)" 7.3 14.3 8.6 7.1 9.9 2.4 7.4 10.7 8.4 11.0 17.9 6.7 5.6 4.8 18.1 9.8 6.1 11.5 9.2 3.2 10.3 4.9 6.5 7.2 6.4 7.0 7.6 8.2 12.9 8.5 8.5 19.8 6.0 6.1 11.7 8.4 7.5 7.2 11.6 8.7 6.2 7.7 29.1 8.5 7.5 9.9 15.8 7.5 10.0 8.0 1.7 7.1 14.4 8.2 3.8 3.9 2.6 3.4 4.0 19.1 3.8 0.1 3.4 6.2 4.8 7.9 10.0 10.4 4.2 8.3 5.3 6.6 0.2 5.3 8.2 1.5 6.1 0.0 4.2 4.4 4.6 13.9 4.6 3.5 2.6 4.9 10.6 4.8 4.0 7.6 7.3 4.8 4.1 8.6 2.1 3.4 6.4 4.2 6.7 4.1 13.6 1.5 3.9 2.9 1.5 6.2 0.0 0.9 4.5 3.6 3.0 3.0 3.0 4.5 5.0 2.5 9.3 5.8 4.2 2.9 2.1 5.6 6.1 3.2 6.4 2.6 2.1 0.2 7.9 3.1 9.7 3.8 8.0 7.6 3.9 3.8 6.3 8.0 0.4 4.0 3.4 2.0 19.1 3.8 8.6 9.9 10.7 8.4 10.3 4.9 7.6 8.2 6.1 7.5 DCT TYRP2 ENSG00000080166 "Dopachrome tautomerase" P40126 13 94436808-94479682 "Enzymes, Predicted membrane proteins" "Melanin biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 58 "retina: 151.5;skin 1: 54.2" "Cell line enriched" "Detected in single" 259 "SK-MEL-30: 75.0" "Cancer enriched" "Detected in some" 215 "melanoma: 155.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010742, HPA010743, HPA010800, CAB017634" Enhanced Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520" "unprognostic (5.99e-2)" "unprognostic (1.67e-2)" "unprognostic (1.54e-2)" "unprognostic (3.17e-2)" "unprognostic (2.45e-2)" "unprognostic (3.35e-2)" "unprognostic (2.15e-2)" "unprognostic (2.81e-2)" "unprognostic (6.07e-2)" "unprognostic (1.81e-1)" "unprognostic (3.64e-3)" "unprognostic (1.06e-2)" "unprognostic (6.18e-5)" "unprognostic (6.97e-2)" "unprognostic (9.87e-2)" "unprognostic (1.22e-3)" "unprognostic (2.42e-1)" 0.2 0.2 0.5 0.1 1.5 0.1 1.7 0.2 0.6 0.2 0.1 0.3 0.1 0.0 0.2 0.5 0.1 0.8 0.1 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 1.4 0.1 0.3 0.2 0.0 151.5 1.4 0.2 0.2 54.2 0.2 0.1 0.8 0.1 0.0 0.3 0.4 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.5 0.2 0.6 0.4 0.5 0.3 0.1 0.3 0.4 DCUN1D4 KIAA0276 ENSG00000109184 "Defective in cullin neddylation 1 domain containing 4" Q92564 4 51843000-51916837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036483, HPA036484" Uncertain Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA036483: AB_10670719, HPA036484: AB_10671843" "unprognostic (3.16e-2)" "unprognostic (2.65e-1)" "unprognostic (2.77e-3)" "unprognostic (1.41e-1)" "unprognostic (5.61e-2)" "unprognostic (1.61e-1)" "unprognostic (2.80e-2)" "unprognostic (1.37e-1)" "unprognostic (8.47e-3)" "unprognostic (1.61e-3)" "unprognostic (3.88e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-3)" "unprognostic (2.14e-1)" "unprognostic (5.25e-2)" "unprognostic (1.10e-3)" "unprognostic (1.40e-1)" 16.9 22.9 15.9 9.9 26.1 3.5 13.5 15.4 24.8 15.9 14.3 12.8 15.5 7.6 17.8 17.3 13.4 13.6 14.2 14.9 29.8 22.3 19.4 36.5 10.4 10.7 17.7 22.0 20.8 9.8 9.9 19.8 9.3 24.6 16.6 12.0 9.4 15.9 22.9 14.3 10.2 9.8 31.4 24.0 11.4 14.6 20.4 13.4 3.9 16.8 8.6 8.2 20.3 13.7 4.6 2.9 10.2 4.2 4.4 10.7 5.3 5.6 10.2 13.8 19.9 14.1 14.2 5.3 17.6 13.1 10.1 9.1 6.5 6.1 4.2 11.4 19.9 5.7 17.5 11.0 13.9 2.7 5.1 7.5 7.9 15.7 29.8 10.4 10.1 14.6 13.1 11.5 10.1 10.1 8.3 3.1 17.4 8.3 12.7 7.3 8.1 8.3 6.1 7.1 2.4 13.1 6.7 8.1 8.8 7.6 9.4 14.6 9.7 6.6 16.4 13.4 11.0 10.7 14.0 5.8 8.2 3.9 9.4 9.9 7.6 5.5 4.2 10.2 7.2 3.7 10.7 4.6 8.1 8.0 2.9 3.3 7.8 8.5 1.7 4.4 2.6 1.9 3.7 5.3 15.9 26.1 15.4 24.8 29.8 22.3 17.7 22.0 24.6 13.4 DDX31 "FLJ13633, FLJ14578, FLJ23349, PPP1R25" ENSG00000125485 "DEAD-box helicase 31" Q9H8H2 9 132592997-132670401 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020891 Supported "Nucleoli,Golgi apparatus,Vesicles" Nucleoli "Golgi apparatus, Vesicles" "HPA020891: " "unprognostic (5.71e-2)" "unprognostic (1.76e-2)" "unprognostic (2.56e-1)" "unprognostic (7.91e-2)" "unprognostic (5.79e-2)" "unprognostic (9.94e-2)" "prognostic unfavourable (1.68e-7)" "unprognostic (1.34e-1)" "unprognostic (2.02e-2)" "unprognostic (1.66e-1)" "unprognostic (3.90e-2)" "unprognostic (9.57e-3)" "unprognostic (4.57e-3)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" 6.8 6.9 8.2 15.3 11.2 6.0 12.3 18.4 8.5 7.5 6.6 9.4 12.6 5.0 8.9 8.8 9.8 8.8 7.5 5.4 6.3 6.3 8.4 9.2 12.0 15.1 9.1 5.7 16.9 17.3 10.0 8.8 5.8 9.8 9.2 8.0 7.4 12.7 12.6 12.9 14.0 7.2 12.7 12.9 8.7 6.8 15.2 8.3 6.8 22.7 10.8 13.8 7.2 12.6 5.0 4.5 1.9 2.7 3.1 6.9 3.0 7.1 13.2 6.5 8.9 7.9 7.2 12.7 7.6 7.5 12.1 9.2 14.7 14.7 17.8 7.0 7.1 20.0 20.3 8.9 9.7 10.9 7.5 9.6 11.8 7.7 9.6 17.1 7.9 6.3 12.2 12.3 17.4 7.9 17.7 7.0 10.0 15.3 11.9 9.3 16.0 13.6 12.6 11.5 20.5 11.0 6.8 11.7 8.3 14.0 12.4 10.6 26.0 5.0 6.6 20.5 9.3 11.6 11.8 3.4 10.7 13.9 7.4 10.9 15.4 0.0 1.9 1.9 5.7 2.7 4.7 4.2 5.5 4.4 4.5 5.0 6.9 5.1 0.3 3.1 1.9 2.8 3.6 3.0 8.2 11.2 18.4 8.5 6.3 6.3 9.1 5.7 9.8 8.3 DEFA5 "DEF5, HD-5" ENSG00000164816 "Defensin alpha 5" Q01523 8 7055304-7056734 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 231 "intestine: 574.2" "Group enriched" "Detected in some" 8 "BEWO: 19.5;NB-4: 16.0;RPMI-8226: 16.8;SH-SY5Y: 13.7;U-2197: 5.9" "Cancer enhanced" "Detected in many" "cervical cancer: 181.1;colorectal cancer: 147.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015309, HPA015775, CAB069919" Enhanced Approved Vesicles,Midbody "Secreted to digestive system" Vesicles Midbody "CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594" "prognostic favourable (9.44e-5)" "unprognostic (3.91e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 408.9 0.0 0.0 249.9 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.1 574.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 1.7 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 DENND1A "FAM31A, FLJ21129, KIAA1608" ENSG00000119522 "DENN domain containing 1A" Q8TEH3 9 123379654-123930152 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 8.4;granulocytes: 11.2;monocytes: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020481 Supported Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA020481: AB_2092106" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "unprognostic (2.00e-1)" "unprognostic (4.25e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.19e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (2.48e-3)" "unprognostic (5.63e-2)" "prognostic favourable (4.11e-5)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (9.66e-2)" "unprognostic (4.31e-2)" 11.4 12.2 17.4 13.9 19.8 32.5 10.0 18.6 21.2 10.9 14.8 12.8 10.3 15.8 13.3 9.0 11.3 13.0 10.5 10.3 15.9 12.8 16.4 14.5 9.4 11.6 11.8 14.9 12.0 8.9 20.1 19.0 23.9 13.9 11.0 14.1 14.5 8.5 11.8 11.0 9.3 17.2 14.4 10.1 20.2 9.9 12.1 13.2 10.6 15.5 5.6 9.5 10.6 17.4 1.5 8.4 11.2 15.2 0.5 1.3 3.2 14.7 8.7 7.9 14.9 5.4 8.5 36.6 14.4 21.7 12.3 10.6 11.9 6.6 11.9 3.0 11.6 8.4 6.7 10.4 12.0 5.0 5.1 5.6 21.2 8.7 7.2 6.7 3.8 7.8 9.4 10.1 17.4 10.9 15.3 9.1 9.9 8.4 8.0 9.7 15.7 13.3 12.4 7.7 10.1 6.1 5.2 16.8 13.6 11.6 7.7 8.9 10.5 17.0 5.0 13.3 5.1 15.4 7.5 14.0 10.8 8.2 11.1 13.4 8.7 11.2 15.2 2.8 1.3 10.1 0.7 1.1 0.9 0.6 8.4 1.5 0.6 0.7 9.3 0.5 8.2 1.3 0.4 3.2 17.4 19.8 18.6 21.2 15.9 12.8 11.8 14.9 13.9 13.2 DENND3 KIAA0870 ENSG00000105339 "DENN domain containing 3" A2RUS2 8 141117278-141195808 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.9" "Cell line enhanced" "Detected in many" "HDLM-2: 26.8;HeLa: 33.1;U-937: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 18.0;neutrophil: 22.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 22.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024491, HPA041668" Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA024491: , HPA041668: " "unprognostic (2.27e-1)" "unprognostic (9.62e-2)" "unprognostic (9.47e-3)" "unprognostic (1.66e-1)" "unprognostic (6.96e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (7.07e-3)" "unprognostic (2.71e-2)" "unprognostic (2.25e-2)" "unprognostic (7.74e-2)" "unprognostic (1.95e-1)" "unprognostic (2.02e-1)" "unprognostic (4.51e-2)" "unprognostic (5.42e-2)" 21.8 6.2 12.2 21.7 15.2 75.9 17.6 1.7 12.3 10.4 17.0 11.5 2.3 5.5 10.3 6.1 6.8 8.3 12.0 8.8 12.1 8.5 12.2 3.9 30.1 27.8 15.9 7.7 8.9 4.7 4.5 5.8 13.0 13.7 9.0 7.4 7.1 10.2 8.3 12.9 8.3 12.7 7.8 21.9 24.7 9.1 4.6 11.8 3.4 11.4 3.5 20.6 9.5 9.8 2.4 2.2 22.2 5.4 1.4 0.4 1.6 6.8 6.2 0.4 1.3 1.9 2.8 1.0 3.9 11.5 1.6 1.3 1.9 6.4 1.8 10.2 7.3 3.5 1.7 4.2 1.1 26.8 1.6 7.1 33.1 0.6 1.7 7.0 1.1 0.2 2.1 1.8 2.3 9.0 0.0 17.3 1.2 2.1 1.0 9.8 0.4 8.1 1.2 0.3 6.7 6.4 2.3 2.0 1.2 0.7 0.5 0.4 2.8 11.3 7.1 0.3 3.1 4.5 0.1 3.5 15.4 0.5 1.1 24.3 0.4 9.3 2.9 18.0 0.4 4.5 0.4 2.4 0.3 0.1 2.2 2.3 0.0 0.1 22.2 1.4 5.4 0.0 0.1 1.6 12.2 15.2 1.7 12.3 12.1 8.5 15.9 7.7 13.7 11.8 DENND4C "bA513M16.3, C9orf55, C9orf55B, FLJ20686, RAB10GEF" ENSG00000137145 "DENN domain containing 4C" Q5VZ89 9 19230435-19373545 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014917, HPA015096" Approved Supported "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles, Cytosol" "HPA014917: AB_2261659, HPA015096: AB_1845831" "unprognostic (4.57e-2)" "unprognostic (1.73e-2)" "unprognostic (6.81e-2)" "unprognostic (1.71e-1)" "unprognostic (1.87e-2)" "unprognostic (1.48e-1)" "unprognostic (2.43e-2)" "unprognostic (3.38e-1)" "unprognostic (1.14e-1)" "unprognostic (1.02e-1)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "prognostic favourable (3.51e-5)" "unprognostic (3.27e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" 31.5 14.0 7.4 11.2 9.4 5.8 17.8 17.7 10.4 18.8 17.9 7.3 17.5 17.4 15.0 12.7 15.8 12.5 9.9 13.7 8.0 5.7 10.2 10.1 16.3 7.2 9.1 6.7 16.3 16.0 16.9 18.2 14.6 8.4 14.9 14.5 10.4 16.9 12.2 11.5 20.5 18.4 19.1 8.9 9.8 13.8 9.0 9.6 14.3 12.9 8.3 11.0 22.3 17.7 3.0 4.0 8.5 2.1 8.1 10.2 3.4 11.6 10.9 7.9 10.2 17.3 21.0 14.4 6.7 10.1 7.1 9.5 5.4 7.7 4.9 5.6 8.8 6.3 9.2 5.6 8.7 32.5 5.2 22.6 12.6 6.3 8.6 5.2 12.9 8.2 12.8 6.2 10.6 13.2 6.1 5.7 9.0 4.4 9.2 11.6 5.9 5.5 8.3 4.6 7.1 18.7 22.4 8.0 5.9 6.0 13.5 4.7 8.3 7.1 12.3 6.3 3.5 6.9 6.9 3.9 9.4 2.6 5.2 5.1 3.5 8.5 2.1 2.5 7.8 1.1 10.2 2.5 6.7 7.8 4.0 3.0 6.1 7.3 1.1 8.1 1.1 4.0 4.8 3.4 7.4 9.4 17.7 10.4 8.0 5.7 9.1 6.7 8.4 9.6 DENND5A "FLJ22354, FLJ33829, FLJ43455, KIAA1091, RAB6IP1" ENSG00000184014 "DENN domain containing 5A" Q6IQ26 11 9138825-9265390 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052923, HPA055009" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA052923: , HPA055009: " "unprognostic (5.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" "unprognostic (1.28e-2)" "unprognostic (4.03e-1)" "unprognostic (3.48e-1)" "prognostic unfavourable (5.05e-6)" "unprognostic (1.84e-1)" "unprognostic (2.96e-1)" "unprognostic (1.02e-1)" "unprognostic (5.15e-2)" "unprognostic (3.10e-1)" "prognostic unfavourable (1.14e-6)" "unprognostic (9.86e-3)" "unprognostic (1.03e-1)" "unprognostic (4.32e-1)" "unprognostic (1.40e-2)" 26.7 13.0 36.6 18.6 37.2 22.9 15.8 23.7 43.8 20.0 16.8 56.8 9.3 4.4 23.2 16.7 13.8 18.1 19.8 35.2 36.3 31.6 13.1 11.4 22.8 13.4 44.4 20.4 18.2 17.5 18.1 9.2 22.1 35.3 14.5 10.2 13.6 9.0 26.6 12.1 7.3 8.0 32.8 51.0 21.9 10.5 10.4 34.9 7.3 11.5 5.9 12.4 17.9 20.3 1.8 5.1 14.7 9.9 1.7 5.5 2.0 6.4 8.8 24.2 21.6 35.2 32.3 24.1 21.1 31.1 29.2 34.4 8.2 4.9 0.0 9.1 38.8 5.4 21.5 7.1 35.9 22.3 11.7 2.3 13.5 11.9 20.0 11.1 4.8 25.1 4.8 17.4 25.0 26.1 10.6 0.2 30.5 4.9 6.2 7.6 6.8 9.4 10.6 14.4 0.1 13.9 5.0 5.5 11.3 19.8 9.5 10.6 5.1 7.2 18.5 23.0 13.7 27.6 15.5 0.5 0.1 5.5 22.4 5.7 17.3 5.3 5.2 6.1 0.3 7.8 0.8 1.8 1.9 1.6 5.1 0.5 5.5 2.6 14.7 1.7 9.9 1.6 0.0 2.0 36.6 37.2 23.7 33.9 36.3 31.6 44.4 20.4 35.3 34.9 DENND6A "AFI1A, FAM116A, FLJ34969" ENSG00000174839 "DENN domain containing 6A" Q8IWF6 3 57625457-57693089 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 13.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062618, HPA069725, HPA071711" Approved Supported Vesicles Vesicles "HPA062618: , HPA069725: , HPA071711: " "unprognostic (6.20e-2)" "unprognostic (3.86e-2)" "prognostic favourable (9.21e-4)" "unprognostic (1.76e-1)" "unprognostic (7.75e-2)" "unprognostic (3.17e-1)" "prognostic unfavourable (6.36e-4)" "unprognostic (7.16e-2)" "unprognostic (1.17e-2)" "unprognostic (2.28e-3)" "unprognostic (5.97e-3)" "unprognostic (1.12e-1)" "prognostic favourable (7.77e-6)" "unprognostic (3.06e-1)" "unprognostic (1.63e-1)" "unprognostic (3.61e-3)" "unprognostic (2.94e-1)" 18.6 12.0 8.6 16.7 12.4 15.0 18.1 18.6 12.8 19.8 16.9 15.3 15.3 9.7 23.7 16.8 16.1 16.3 13.7 11.4 9.3 9.7 14.6 10.5 15.1 20.9 10.7 10.6 29.8 10.5 16.1 17.2 16.0 12.1 15.3 13.0 21.4 14.8 17.2 22.0 14.2 16.9 22.3 12.2 21.8 13.8 11.3 9.6 23.0 19.6 11.3 19.8 18.2 17.4 1.7 1.5 13.5 1.6 2.4 4.4 1.0 12.0 9.9 13.3 8.2 7.1 8.1 7.6 6.3 8.0 7.8 6.2 6.3 13.5 14.2 2.7 6.5 6.4 10.6 13.3 6.6 3.6 9.5 11.2 10.7 4.8 6.9 8.5 6.6 8.6 9.7 5.3 14.1 11.1 7.6 15.7 5.6 5.2 18.4 10.6 7.6 6.8 7.8 7.9 10.5 9.6 20.4 4.6 16.5 12.4 10.4 9.0 6.7 10.5 12.2 9.6 5.1 10.1 16.3 11.7 15.0 14.9 11.2 14.4 13.9 13.5 1.2 1.6 3.2 1.3 3.6 1.1 2.9 3.0 1.5 1.7 4.4 3.2 2.0 2.4 1.6 1.2 1.5 1.0 8.6 12.4 18.6 12.8 9.3 9.7 10.7 10.6 12.1 9.6 DEPP1 "C10orf10, DEPP, FIG, Fseg" ENSG00000165507 "DEPP1, autophagy regulator" Q9NTK1 10 44970981-44978810 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 204.9;breast: 227.9" "Cell line enhanced" "Detected in many" "ASC diff: 34.4;HDLM-2: 23.9;HHSteC: 62.2;HSkMC: 48.4;HUVEC TERT2: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013687, HPA037818, HPA037819" Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" Mitochondria Vesicles "CAB013687: , HPA037818: , HPA037819: " "unprognostic (3.99e-2)" "unprognostic (4.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-1)" "unprognostic (1.88e-2)" "unprognostic (5.66e-3)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (4.25e-1)" "unprognostic (5.53e-2)" "unprognostic (1.15e-1)" "unprognostic (8.89e-2)" "prognostic unfavourable (2.29e-6)" "unprognostic (2.30e-3)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.74e-1)" 204.9 14.6 8.7 14.1 16.8 2.4 227.9 10.8 19.7 14.1 36.5 2.9 10.0 7.4 25.0 14.9 23.5 25.5 28.0 37.0 8.5 6.0 13.0 48.2 70.7 20.6 9.4 3.3 51.2 107.1 4.7 12.2 33.4 21.6 25.8 5.7 12.1 16.2 13.0 81.0 19.6 9.9 30.2 39.0 9.5 12.7 31.9 11.0 0.8 33.3 13.4 19.1 52.1 27.6 0.0 3.7 1.2 0.3 0.0 0.7 1.4 6.7 0.0 0.1 0.0 34.4 16.8 1.7 0.0 2.3 0.1 0.4 0.2 2.5 0.0 0.3 3.0 0.2 0.2 2.0 0.1 23.9 0.9 0.0 0.0 2.4 62.2 0.0 0.0 48.4 0.1 0.0 0.3 38.3 0.0 14.7 0.1 0.0 0.0 0.3 0.0 0.2 1.1 0.4 5.6 0.1 2.4 1.3 0.0 0.0 0.3 1.3 0.0 1.6 0.3 1.8 1.3 0.1 1.6 0.4 0.6 0.0 10.4 0.6 0.9 0.0 0.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.5 0.0 0.1 3.7 0.0 1.4 8.7 16.8 10.8 19.7 8.5 6.0 9.4 3.3 21.6 11.0 DERL3 "C22orf14, derlin-3, FLJ43842, IZP6, MGC71803" ENSG00000099958 "Derlin 3" Q96Q80 22 23834503-23839128 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.7;pancreas: 80.8" "Cell line enhanced" "Detected in some" "Karpas-707: 33.1;RPMI-8226: 19.4;U-266/70: 35.6;U-698: 8.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "plasmacytoid DC: 77.7" "Lineage enriched" "Detected in many" 9 "dendritic cells: 77.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB037234, HPA049306" Approved Uncertain Vesicles Vesicles "CAB037234: AB_1840802, HPA049306: " "unprognostic (2.01e-3)" "prognostic favourable (8.70e-5)" "unprognostic (9.72e-3)" "unprognostic (7.47e-2)" "unprognostic (9.77e-3)" "prognostic favourable (8.01e-4)" "unprognostic (2.23e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (4.74e-2)" "unprognostic (2.75e-1)" "prognostic unfavourable (7.76e-13)" "unprognostic (1.53e-2)" "unprognostic (4.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.95e-1)" 1.3 1.8 1.2 27.3 2.1 4.1 2.8 1.7 1.6 3.7 21.5 1.1 20.2 18.7 1.9 2.9 4.1 3.4 5.7 3.9 1.2 1.9 2.9 4.7 7.2 25.5 1.3 1.2 1.1 80.8 0.6 4.0 7.9 2.4 1.6 6.9 1.9 44.8 29.3 1.3 0.4 14.9 0.3 1.0 28.5 21.8 12.6 1.6 1.0 9.5 3.4 36.1 15.5 1.2 8.4 77.7 0.1 0.0 0.0 0.1 1.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.0 3.4 0.6 0.0 0.0 0.3 0.6 0.0 0.7 1.8 0.1 2.0 0.0 0.4 3.7 0.9 0.0 0.1 0.2 0.0 0.1 0.5 33.1 0.0 0.0 0.5 2.0 0.5 0.1 2.6 0.0 19.4 0.7 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.0 35.6 4.3 8.4 0.4 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.0 0.0 77.7 0.0 1.3 1.2 2.1 1.7 1.6 1.2 1.9 1.3 1.2 2.4 1.6 DESI2 "C1orf121, CGI-146, FAM152A, FLJ21998, PNAS-4, PPPDE1" ENSG00000121644 "Desumoylating isopeptidase 2" Q9BSY9 1 244652935-244709033 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049950 Approved Vesicles Vesicles "HPA049950: " "unprognostic (1.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.05e-1)" "unprognostic (3.09e-1)" "unprognostic (1.96e-1)" "unprognostic (5.40e-2)" "unprognostic (1.95e-2)" "unprognostic (7.62e-2)" "unprognostic (1.38e-3)" "unprognostic (1.51e-1)" "unprognostic (4.47e-3)" "unprognostic (1.45e-1)" "prognostic unfavourable (4.25e-5)" "unprognostic (4.52e-2)" "unprognostic (8.27e-2)" "unprognostic (2.27e-2)" "unprognostic (9.49e-2)" 16.4 13.3 6.4 16.1 12.9 10.5 19.9 17.4 6.5 18.5 19.4 7.6 14.6 10.9 27.7 12.8 14.7 12.4 12.7 27.6 6.5 5.8 9.6 13.5 28.4 11.5 7.7 3.2 16.3 10.0 14.8 11.8 20.4 6.9 14.9 13.1 17.8 12.1 14.8 16.2 11.6 17.5 23.2 6.6 14.3 14.9 49.2 7.4 16.8 25.8 14.5 14.7 16.8 14.4 8.0 4.8 9.1 4.0 3.9 5.6 1.2 24.2 9.1 17.9 15.4 20.5 21.5 22.5 14.1 24.7 14.1 13.0 16.1 11.6 43.3 19.4 17.6 10.7 21.8 16.0 19.5 14.8 16.0 11.0 6.8 12.0 18.0 18.8 13.3 14.9 21.8 18.8 23.7 19.8 16.5 24.1 21.1 4.2 17.1 10.1 40.5 22.1 12.3 27.1 16.4 10.8 10.2 15.9 21.3 20.0 10.0 17.6 10.4 14.3 21.4 16.1 16.8 21.7 24.5 24.5 31.5 25.5 13.0 20.3 29.3 4.6 3.0 9.1 4.0 3.9 4.2 8.0 4.2 5.6 4.8 4.7 5.5 5.4 2.5 3.9 4.0 4.2 5.2 1.2 6.4 12.9 17.4 6.5 6.5 5.8 7.7 3.2 6.9 7.4 DGKA "DAGK, DAGK1, DGK-alpha" ENSG00000065357 "Diacylglycerol kinase alpha" P23743 12 55927319-55954027 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 117.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 42.2;hTERT-HME1: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041645, HPA045462" Approved Approved Nucleoplasm,Vesicles,Mitochondria Vesicles "Nucleoplasm, Mitochondria" "HPA041645: , HPA045462: " "unprognostic (1.12e-3)" "unprognostic (1.43e-2)" "unprognostic (1.62e-2)" "unprognostic (2.63e-2)" "unprognostic (5.23e-2)" "unprognostic (2.04e-1)" "unprognostic (3.62e-1)" "unprognostic (3.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-2)" "unprognostic (2.46e-1)" "prognostic unfavourable (1.66e-5)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (1.47e-1)" "unprognostic (7.02e-2)" 4.9 4.7 7.1 31.8 8.2 9.7 4.8 6.0 10.8 8.4 13.4 3.6 3.1 20.5 6.9 4.1 42.0 4.9 7.9 3.8 4.6 2.4 3.9 1.5 7.6 28.6 2.1 4.1 4.9 6.4 6.2 3.1 10.2 3.3 10.6 11.0 4.1 16.2 5.3 1.0 33.0 27.2 5.7 3.7 23.1 4.8 4.4 2.6 117.1 4.5 9.6 57.0 13.0 15.1 7.6 4.0 5.4 2.8 5.2 30.2 10.9 6.7 4.3 3.0 4.0 7.5 9.8 0.9 15.2 15.6 6.0 4.4 2.0 11.5 3.8 3.6 10.1 12.4 3.2 42.2 7.2 3.2 0.7 6.1 9.1 1.1 6.5 1.9 6.0 8.4 22.7 8.3 44.8 12.2 0.7 5.9 16.1 0.7 12.5 2.4 0.6 5.1 5.8 1.0 0.6 14.2 19.5 0.5 1.7 5.0 0.2 0.5 2.7 2.0 10.9 3.9 2.8 0.8 0.5 0.7 0.3 9.2 4.7 5.2 1.1 5.2 2.8 5.4 6.5 2.0 11.7 7.6 24.3 11.7 4.0 6.4 30.2 18.1 5.2 5.2 1.2 4.0 26.7 10.9 7.1 8.2 6.0 10.8 4.6 2.4 2.1 4.1 3.3 2.6 DGKG DAGK3 ENSG00000058866 "Diacylglycerol kinase gamma" P49619 3 186105668-186362237 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.4" "Cell line enhanced" "Detected in some" "HDLM-2: 19.8;HL-60: 6.3;U-266/84: 7.5;U-87 MG: 12.5;U-937: 5.9" "Cancer enhanced" "Detected in some" "glioma: 2.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036577 Approved Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA036577: AB_10672358" "unprognostic (2.23e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-2)" "unprognostic (3.24e-5)" "unprognostic (2.70e-1)" "unprognostic (6.09e-4)" "unprognostic (1.21e-3)" "unprognostic (3.80e-2)" "unprognostic (5.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.94e-1)" "unprognostic (5.09e-2)" "unprognostic (8.05e-7)" "unprognostic (3.47e-3)" "unprognostic (7.19e-2)" "unprognostic (1.41e-1)" "unprognostic (9.16e-3)" 3.1 6.9 13.4 3.1 7.1 14.5 1.9 53.4 23.1 2.7 3.5 6.2 1.1 3.0 1.9 14.6 8.5 7.7 2.2 15.0 15.3 7.4 3.1 2.1 4.3 2.1 7.4 11.3 2.0 1.6 4.7 7.5 13.5 25.2 3.1 2.1 7.8 1.9 4.0 2.4 1.4 2.7 5.3 5.6 2.0 3.3 1.2 7.1 0.0 2.5 0.0 2.1 4.8 2.4 0.6 2.9 5.3 4.2 0.0 0.0 1.3 2.6 4.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 2.3 0.0 0.2 0.0 0.0 0.0 19.8 0.0 2.6 0.0 2.9 0.0 6.3 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.3 0.1 0.1 2.2 0.4 1.2 1.4 0.0 2.2 0.0 0.0 0.5 0.0 0.8 0.0 1.6 0.1 4.1 0.0 0.0 0.7 2.0 2.4 0.0 7.5 0.0 12.5 5.9 2.3 0.0 4.2 2.4 0.0 2.4 0.0 0.6 0.0 0.0 2.9 0.3 0.0 0.0 5.3 0.0 2.8 0.5 0.0 1.3 13.4 7.1 53.4 14.7 15.3 7.4 7.4 11.3 25.2 7.1 DHRS12 "FLJ13639, SDR40C1" ENSG00000102796 "Dehydrogenase/reductase 12" A0PJE2 13 51767993-51804157 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 36.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034238, HPA057028, HPA058315" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "CAB034238: AB_2091845, HPA057028: , HPA058315: " "prognostic favourable (1.41e-4)" "unprognostic (1.98e-2)" "unprognostic (2.98e-1)" "unprognostic (7.57e-2)" "unprognostic (2.98e-1)" "unprognostic (1.42e-1)" "unprognostic (8.47e-3)" "unprognostic (1.70e-1)" "unprognostic (3.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.21e-2)" "unprognostic (3.98e-1)" "prognostic favourable (2.22e-16)" "unprognostic (2.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.03e-2)" "unprognostic (3.44e-1)" 15.6 6.4 6.9 4.1 7.1 3.9 11.1 5.2 10.9 9.5 7.6 13.8 7.1 5.5 8.4 16.0 7.7 7.5 7.4 8.3 6.0 6.0 14.2 15.8 8.7 4.8 5.8 6.2 10.4 37.6 11.1 10.0 7.3 8.0 7.7 4.7 14.0 11.5 13.0 10.4 10.1 12.2 8.3 7.2 8.3 7.3 3.9 6.5 4.4 10.2 6.9 9.2 6.4 5.7 6.0 4.5 36.3 7.3 1.6 11.6 5.7 0.9 3.1 5.6 7.6 2.5 5.3 5.2 1.7 3.9 2.2 1.2 3.5 15.6 3.9 1.2 3.2 1.9 0.1 0.8 0.3 3.6 2.7 1.2 1.0 3.2 6.7 0.7 1.1 3.4 6.0 0.7 3.2 5.2 1.6 4.4 2.5 4.5 1.5 3.2 6.7 0.5 0.5 0.7 6.4 8.8 2.6 3.4 7.1 2.6 5.7 6.8 5.9 3.9 9.1 1.3 1.9 0.3 1.8 2.1 1.5 1.9 4.0 2.1 4.9 2.9 7.3 0.2 6.4 6.2 11.6 6.0 9.9 8.0 4.0 5.6 8.8 6.2 36.3 1.6 7.0 4.5 8.6 5.7 6.9 7.1 5.2 10.9 6.0 6.0 5.8 6.2 8.0 6.5 DHRS13 "MGC23280, SDR7C5" ENSG00000167536 "Dehydrogenase/reductase 13" Q6UX07 17 28897781-28903071 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 29.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022991 Uncertain Approved Vesicles "Secreted - unknown location" Vesicles "HPA022991: AB_1853865" "unprognostic (8.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.35e-1)" "unprognostic (1.21e-2)" "unprognostic (6.37e-2)" "prognostic unfavourable (3.39e-6)" "unprognostic (2.38e-1)" "unprognostic (4.74e-2)" "unprognostic (5.65e-2)" "unprognostic (1.20e-2)" "unprognostic (7.57e-2)" "unprognostic (1.73e-2)" "unprognostic (3.72e-2)" "unprognostic (2.63e-1)" "unprognostic (7.22e-3)" "unprognostic (2.55e-1)" 2.3 6.0 5.9 5.1 7.9 31.7 5.9 24.9 5.7 6.4 4.5 6.4 9.0 4.1 2.6 6.5 6.7 4.0 3.0 2.7 5.3 10.9 6.9 27.0 4.1 8.6 6.7 5.4 3.6 9.5 8.5 5.3 9.5 9.9 14.9 3.5 5.0 11.8 10.9 1.1 6.8 3.0 3.2 5.6 8.0 5.5 2.8 3.6 4.4 5.5 1.2 8.1 9.2 5.1 4.0 3.1 29.7 3.5 4.6 6.3 3.1 5.6 3.6 8.4 10.6 1.3 1.9 8.2 3.0 3.9 5.6 8.7 11.0 3.3 15.3 5.2 0.6 5.0 11.8 3.3 2.4 15.5 11.4 8.6 6.6 6.0 3.2 4.4 1.0 1.4 3.0 3.5 3.8 1.7 19.4 5.3 1.1 10.1 9.5 7.3 5.1 0.5 15.2 8.0 11.8 10.3 9.5 12.1 10.1 4.8 33.5 6.5 22.3 7.1 0.5 1.8 5.5 4.3 4.1 12.4 11.6 9.6 5.4 5.6 4.5 0.4 2.3 1.6 4.8 3.5 5.9 3.6 6.1 6.0 3.1 4.0 6.3 4.6 29.7 4.6 3.3 1.7 5.7 3.1 5.9 7.9 24.9 5.7 5.3 10.9 6.7 5.4 9.9 3.6 DHRS4 "FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2" ENSG00000157326 "Dehydrogenase/reductase 4" Q9BTZ2 14 23953586-23969279 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.21e-2)" "unprognostic (2.59e-1)" "unprognostic (3.46e-2)" "unprognostic (3.79e-3)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (7.35e-3)" "unprognostic (1.61e-3)" "unprognostic (2.66e-1)" "unprognostic (1.19e-2)" "unprognostic (1.06e-2)" "unprognostic (7.65e-2)" "prognostic favourable (4.55e-6)" "unprognostic (2.03e-2)" "unprognostic (1.48e-1)" "unprognostic (2.03e-1)" "unprognostic (5.68e-2)" 15.8 18.5 8.3 10.3 13.7 5.9 15.4 4.4 9.6 11.0 22.2 10.2 12.1 30.3 13.7 11.7 17.2 8.3 16.3 16.3 9.0 6.6 65.8 40.3 12.6 13.6 14.0 7.7 12.6 20.6 7.3 9.7 8.9 9.3 17.0 12.4 12.0 17.5 14.4 25.3 16.6 35.2 14.4 9.6 12.4 12.9 13.5 12.6 6.9 17.1 16.1 11.1 10.0 14.8 9.7 22.0 2.6 25.5 7.9 10.6 14.9 7.5 15.5 5.3 8.7 8.5 9.4 0.1 14.4 7.6 5.7 4.6 3.2 8.2 6.5 7.7 7.1 9.1 4.3 5.9 5.2 17.5 8.8 3.9 13.0 18.1 5.2 5.6 24.2 9.4 7.4 4.8 10.4 7.1 5.8 15.5 7.8 26.0 10.3 5.3 5.2 15.6 16.7 9.4 21.5 5.9 8.9 10.3 8.7 13.8 9.0 6.8 8.3 7.6 13.2 7.1 7.5 7.3 4.6 11.9 11.1 1.7 6.2 6.4 7.1 2.4 25.5 2.6 8.9 21.0 10.6 9.7 10.1 8.9 22.0 8.3 10.3 9.9 1.1 7.9 11.1 18.5 8.6 14.9 8.3 13.7 4.4 9.6 9.0 6.6 14.0 7.7 9.3 12.6 DHRS4L2 SDR25C3 ENSG00000187630 "Dehydrogenase/reductase 4 like 2" Q6PKH6 14 23969874-24006408 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA023972 Uncertain Uncertain "Nuclear membrane,Vesicles" "Secreted - unknown location" Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.41e-2)" "unprognostic (2.83e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-2)" "unprognostic (1.47e-1)" "unprognostic (2.53e-1)" "unprognostic (6.02e-2)" "unprognostic (3.97e-3)" "unprognostic (7.34e-2)" "prognostic favourable (3.21e-4)" "unprognostic (1.57e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-3)" "unprognostic (6.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (3.65e-2)" 6.3 11.2 6.9 12.8 7.9 3.0 11.4 14.6 9.6 7.2 9.9 3.4 2.6 12.1 5.6 10.4 25.5 5.4 4.3 8.9 5.0 4.1 42.0 33.0 16.7 7.2 4.6 2.4 7.1 28.4 6.0 5.2 3.1 7.6 8.3 9.5 5.4 14.2 10.9 18.7 9.8 14.9 6.4 5.6 8.1 7.1 28.2 4.5 13.8 5.9 32.8 14.5 5.3 7.1 10.4 22.3 3.2 27.2 7.9 11.5 14.7 8.5 12.8 2.2 10.9 21.3 22.3 0.2 7.7 15.2 11.2 8.4 3.7 10.1 5.5 5.3 15.4 9.3 9.9 12.8 9.4 18.1 5.9 1.3 11.1 22.9 15.7 7.1 22.1 23.0 16.3 7.3 10.8 13.1 4.3 19.8 12.0 26.7 17.6 7.3 4.4 14.2 27.8 9.0 17.3 16.1 11.3 11.9 7.2 10.5 9.7 6.4 11.8 10.6 9.2 5.9 6.2 7.0 3.8 11.6 9.1 1.6 5.1 10.3 8.4 2.3 27.2 3.2 10.1 22.5 10.4 10.4 10.8 11.5 22.3 8.2 11.1 10.1 1.3 7.9 13.2 18.3 10.3 14.7 6.9 7.9 14.6 9.6 5.0 4.1 4.6 2.4 7.6 4.5 DIAPH2 "DIA, DIA2, POF, POF2" ENSG00000147202 "Diaphanous related formin 2" O60879 X 96684663-97604997 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Oogenesis" "Developmental protein" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005647, CAB015461, CAB068183, CAB068184" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" Nucleoli "CAB015461: AB_831223, CAB068183: , CAB068184: , HPA005647: AB_1078657" "unprognostic (5.75e-2)" "unprognostic (4.13e-3)" "unprognostic (1.48e-1)" "prognostic unfavourable (2.16e-5)" "unprognostic (1.58e-1)" "unprognostic (6.48e-2)" "unprognostic (4.06e-1)" "unprognostic (1.07e-2)" "unprognostic (2.41e-1)" "unprognostic (1.43e-2)" "prognostic unfavourable (2.12e-4)" "unprognostic (3.39e-2)" "prognostic unfavourable (3.90e-4)" "unprognostic (6.44e-2)" "unprognostic (3.11e-2)" "unprognostic (6.99e-3)" "unprognostic (6.08e-3)" 25.3 5.7 8.2 16.5 13.6 19.9 12.0 1.6 4.6 17.8 18.5 2.9 15.1 5.5 10.7 9.1 16.3 10.4 12.6 13.0 6.6 3.0 6.1 15.7 16.8 6.9 4.1 4.4 14.2 6.6 8.7 5.5 37.2 7.1 16.0 11.4 4.7 9.4 17.2 19.9 9.3 12.0 18.5 7.3 9.8 9.9 12.3 5.1 9.4 7.5 12.0 4.9 19.8 26.9 2.7 4.3 5.7 5.8 1.4 2.8 1.0 0.0 4.0 1.9 3.9 11.0 18.4 0.0 6.9 7.3 3.7 7.9 3.3 7.6 11.3 5.5 5.9 0.0 10.3 1.1 4.9 0.3 5.9 0.0 4.8 3.5 9.2 14.5 5.2 9.2 3.7 5.0 15.7 7.2 0.0 9.3 6.9 3.2 5.4 5.9 15.3 5.9 0.0 10.4 0.0 2.1 6.0 0.0 4.0 0.0 2.0 5.5 1.7 8.0 9.1 8.1 3.7 6.6 4.4 0.1 0.0 9.5 6.8 14.8 4.7 0.0 5.8 5.7 2.3 5.4 1.8 2.7 2.4 2.8 4.3 2.4 1.6 1.5 0.6 1.4 4.5 4.1 1.3 1.0 8.2 13.6 1.6 4.6 6.6 3.0 4.1 4.4 7.1 5.1 DIDO1 "BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333" ENSG00000101191 "Death inducer-obliterator 1" Q9BTC0 20 62877738-62937952 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004374, HPA049904" Supported Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "CAB004374: AB_2093108, HPA049904: " "unprognostic (9.56e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-1)" "unprognostic (7.47e-2)" "unprognostic (2.68e-1)" "prognostic favourable (5.13e-4)" "unprognostic (9.92e-3)" "unprognostic (4.57e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "prognostic favourable (3.88e-4)" "unprognostic (2.20e-2)" "unprognostic (1.50e-3)" "unprognostic (1.06e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-2)" "unprognostic (9.82e-2)" 25.1 15.9 19.7 21.5 21.3 22.8 26.9 38.1 23.2 29.7 24.0 27.0 26.7 18.4 33.2 26.9 20.7 29.2 27.0 23.2 17.9 14.7 18.2 18.3 22.9 27.5 22.9 18.8 37.4 21.4 28.0 25.1 30.6 17.6 24.3 19.2 27.0 26.3 25.5 27.6 34.0 25.2 27.5 17.5 25.8 21.2 24.1 23.1 35.1 25.1 20.5 29.6 26.1 35.6 9.7 8.6 20.9 7.6 10.1 15.3 7.1 11.6 9.0 15.2 8.6 7.8 9.6 8.1 8.8 7.5 32.9 9.5 38.6 12.1 11.5 12.2 10.8 18.3 13.8 17.1 21.4 6.3 9.3 16.6 14.9 27.5 9.9 14.8 17.2 9.8 23.6 11.4 6.4 9.0 16.2 10.6 8.3 11.3 30.0 13.1 12.1 13.2 21.3 19.4 7.3 5.4 10.4 18.7 11.1 17.7 17.2 11.6 17.1 17.0 11.2 26.9 18.8 8.9 12.5 7.1 4.6 15.4 12.2 7.5 9.7 20.9 5.6 15.1 12.9 7.6 13.3 9.7 11.3 12.3 4.1 8.2 15.3 14.1 8.6 10.1 5.8 8.6 9.0 7.1 19.7 21.3 38.1 23.2 17.9 14.7 22.9 18.8 17.6 23.1 DIP2C KIAA0934 ENSG00000151240 "Disco interacting protein 2 homolog C" Q9Y2E4 10 274190-689668 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.8" "Group enriched" "Detected in many" 5 "B-cells: 3.8;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030264, HPA059325" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA030264: AB_10600903, HPA059325: " "unprognostic (1.72e-2)" "unprognostic (3.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavourable (8.92e-4)" "unprognostic (8.32e-2)" "unprognostic (1.50e-1)" "unprognostic (2.16e-2)" "unprognostic (1.58e-1)" "unprognostic (2.00e-1)" "unprognostic (6.28e-3)" "unprognostic (5.94e-2)" "unprognostic (3.65e-2)" "prognostic favourable (2.46e-6)" "unprognostic (8.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.09e-3)" "unprognostic (9.10e-3)" 15.4 8.1 19.9 5.0 25.0 0.9 9.9 23.0 24.7 12.6 20.8 21.2 6.4 6.2 14.1 7.8 12.2 9.1 11.3 17.3 16.3 10.1 19.2 11.5 6.7 3.4 21.7 14.4 18.1 10.4 10.4 7.4 6.3 16.5 11.5 6.3 13.0 5.6 12.7 38.2 5.5 7.3 16.1 14.9 4.5 8.3 9.4 23.1 0.0 7.3 2.9 2.5 11.6 13.0 3.8 0.5 0.1 0.3 0.3 1.3 0.4 0.4 4.0 7.4 3.9 12.6 13.7 6.1 8.8 5.5 6.8 5.6 1.1 1.2 0.3 2.4 14.1 0.1 4.5 0.7 4.2 0.2 4.0 0.1 2.7 1.2 6.1 0.0 5.5 11.1 3.6 4.3 0.0 1.5 0.0 0.7 5.1 10.8 0.4 0.0 1.9 1.6 6.1 3.1 1.2 4.8 4.5 3.7 5.3 1.5 3.2 12.7 4.2 0.0 0.1 7.2 1.9 21.5 2.9 0.5 8.5 4.6 9.1 0.2 4.1 0.0 0.3 0.0 0.4 0.0 0.4 2.6 0.8 1.0 0.0 3.8 1.2 1.3 0.1 0.3 0.0 0.5 0.5 0.4 19.9 25.0 23.0 24.7 16.3 10.1 21.7 14.4 16.5 23.1 DIRC2 "FLJ14784, RCC4" ENSG00000138463 "Disrupted in renal carcinoma 2" Q96SL1 3 122794795-122881139 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "neutrophil: 4.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072579 Supported Vesicles Vesicles "HPA072579: " "unprognostic (1.40e-1)" "unprognostic (8.53e-3)" "unprognostic (1.20e-1)" "unprognostic (1.09e-1)" "unprognostic (1.16e-1)" "unprognostic (5.36e-2)" "prognostic unfavourable (7.48e-4)" "unprognostic (9.74e-2)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "prognostic unfavourable (5.81e-5)" "unprognostic (1.87e-1)" "prognostic favourable (8.81e-11)" "unprognostic (2.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-1)" "unprognostic (7.13e-2)" 7.6 7.8 6.5 4.0 7.7 7.9 6.8 5.2 8.8 5.0 6.2 10.0 4.4 3.0 4.2 6.1 8.8 5.0 5.9 9.9 6.4 6.3 7.5 9.2 8.0 6.9 7.5 4.5 4.9 12.9 18.4 7.6 34.8 6.7 7.8 6.9 11.9 7.7 6.0 27.0 9.7 6.1 6.7 7.8 5.8 5.9 4.2 3.8 3.1 8.0 11.2 7.4 7.4 5.4 0.6 0.3 4.2 0.8 0.0 0.5 0.1 5.6 4.7 4.6 2.6 6.0 4.9 15.6 2.4 5.3 3.9 4.0 11.0 6.3 0.8 3.1 2.7 8.2 3.4 4.3 3.7 1.2 2.5 0.9 2.6 4.7 4.5 0.5 0.6 4.1 11.9 2.8 4.7 4.4 0.5 1.0 4.9 2.5 0.7 0.6 4.2 7.7 1.5 10.5 1.2 5.5 6.6 4.8 3.8 7.1 3.2 6.3 3.8 1.2 6.1 6.1 2.3 3.7 2.0 1.1 0.9 0.3 3.1 1.0 3.3 0.0 0.7 0.1 0.5 0.8 0.0 0.1 0.0 0.0 0.3 0.6 0.5 0.3 4.2 0.0 0.7 0.0 0.1 0.1 6.5 7.7 5.2 8.8 6.4 6.3 7.5 4.5 6.7 3.8 DISP2 "C15orf36, DISPB, HsT16908, KIAA1742, LINC00594" ENSG00000140323 "Dispatched RND transporter family member 2" A7MBM2 15 40358235-40378639 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 37.2" "Group enriched" "Detected in some" 5 "HaCaT: 8.0;SCLC-21H: 16.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059903 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA059903: " "unprognostic (3.43e-4)" "unprognostic (7.65e-3)" "unprognostic (4.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.90e-1)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (3.08e-2)" "unprognostic (1.98e-1)" "unprognostic (2.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" "unprognostic (4.47e-8)" "unprognostic (1.96e-1)" "unprognostic (3.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" 0.8 2.5 9.0 1.5 7.6 1.3 0.6 37.2 14.5 0.7 4.0 1.0 0.0 3.4 0.9 0.9 0.7 1.1 1.1 0.8 9.0 7.0 0.5 0.7 0.9 1.5 2.9 14.0 1.3 1.4 0.6 2.8 1.0 11.4 0.8 3.9 0.3 1.2 1.8 0.8 1.3 3.0 1.4 2.0 1.1 3.9 2.4 1.8 0.0 3.4 0.0 0.6 1.2 0.4 0.9 1.1 2.9 0.4 1.1 0.6 0.2 1.5 0.6 0.4 2.5 0.1 0.1 0.9 0.2 0.1 1.0 1.5 2.3 0.7 0.2 1.7 0.9 8.0 0.3 1.3 0.6 0.2 0.5 0.4 0.5 0.1 0.0 0.5 1.5 1.8 0.0 0.3 0.2 0.5 0.6 1.0 1.3 0.3 0.2 0.4 0.4 1.1 0.2 0.4 0.5 0.3 2.1 16.6 2.4 0.3 0.2 0.2 0.4 0.2 0.5 1.1 0.9 0.2 0.2 0.3 0.2 0.3 0.4 0.7 2.3 2.1 0.4 0.5 0.6 0.3 0.4 0.5 0.4 0.4 0.2 0.9 0.5 0.6 2.9 1.1 0.4 1.1 0.4 0.2 9.0 7.6 37.2 14.5 9.0 7.0 2.9 14.0 11.4 1.8 DKK3 "REIC, RIG" ENSG00000050165 "Dickkopf WNT signaling pathway inhibitor 3" Q9UBP4 11 11963106-12009769 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 94.7;heart muscle: 297.4" "Cell line enhanced" "Detected in many" "BJ: 60.0;BJ hTERT+: 92.8;fHDF/TERT166: 86.9;TIME: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 90 "T-cells: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011868, CAB024949" Approved Supported "Nuclear bodies,Vesicles,Cytosol" "Secreted in other tissues" 15000000 Vesicles "Nuclear bodies, Cytosol" "CAB024949: , HPA011868: AB_1847716" "unprognostic (4.24e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (7.84e-2)" "unprognostic (3.06e-3)" "unprognostic (6.58e-3)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-3)" "unprognostic (5.28e-2)" "unprognostic (4.51e-2)" "unprognostic (3.87e-2)" "prognostic unfavourable (6.31e-5)" "unprognostic (7.41e-3)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.02e-3)" 4.8 21.7 44.9 3.5 94.7 1.3 6.8 32.5 60.3 25.8 7.3 12.1 4.1 4.9 7.8 5.6 8.8 4.9 17.9 297.4 49.6 23.5 5.1 2.7 17.8 3.1 19.1 45.8 10.8 5.7 10.9 6.6 7.5 24.7 16.8 4.6 10.7 9.1 22.3 2.7 8.3 7.3 12.0 32.9 9.0 7.0 8.9 25.5 0.0 4.7 2.5 2.6 10.5 7.8 0.0 0.0 0.0 0.0 0.0 8.9 0.6 0.2 1.8 2.6 0.0 2.2 4.4 0.0 60.0 92.8 26.6 30.2 1.3 0.4 0.0 6.6 86.9 9.2 0.2 25.9 10.2 0.0 0.0 0.0 0.2 0.0 16.9 0.0 0.0 6.7 8.7 9.0 22.2 28.1 0.0 0.0 36.7 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 9.1 0.0 0.0 7.8 0.2 0.0 0.0 0.0 0.0 49.8 15.8 12.4 1.6 15.5 0.0 0.0 0.0 2.6 0.0 14.8 0.0 0.0 0.0 0.8 0.0 8.9 0.0 0.8 5.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 44.9 94.7 32.5 46.5 49.6 23.5 19.1 45.8 24.7 25.5 DKKL1 "CT34, SGY-1" ENSG00000104901 "Dickkopf like acrosomal protein 1" Q9UK85 19 49361783-49375116 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 91.5" "Cell line enhanced" "Detected in some" "AF22: 7.1;AN3-CA: 13.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory B-cell: 4.1" "Lineage enriched" "Detected in single" 42 "B-cells: 4.1" "Group enriched" "Detected in many" 17 "amygdala: 27.1;basal ganglia: 15.6;cerebral cortex: 50.1;hippocampal formation: 25.1;olfactory region: 20.8" "Low region specificity" "Detected in all" "CAB025410, HPA047194" Enhanced Approved Vesicles "Secreted in male reproductive system" Vesicles "CAB025410: , HPA047194: " "unprognostic (1.64e-1)" "unprognostic (5.30e-1)" "unprognostic (5.39e-4)" "unprognostic (1.85e-4)" "unprognostic (3.79e-2)" "unprognostic (4.30e-2)" "unprognostic (5.52e-4)" "unprognostic (1.00e-1)" "unprognostic (6.76e-2)" "unprognostic (4.08e-1)" "unprognostic (1.90e-1)" "unprognostic (5.65e-2)" "unprognostic (2.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.13e-1)" "unprognostic (1.18e-1)" "unprognostic (5.57e-2)" 0.2 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.4 0.5 0.3 0.4 0.2 0.3 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.2 0.1 0.3 0.0 0.3 0.3 0.1 0.0 0.0 0.3 0.4 0.0 0.1 0.0 91.5 0.0 0.0 0.0 0.2 0.1 0.3 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 7.1 13.5 0.1 0.5 0.6 1.3 0.0 0.2 0.4 0.0 0.6 0.0 1.0 0.3 0.1 0.2 0.0 0.0 0.0 2.5 0.0 3.4 0.3 0.0 0.0 1.2 1.0 0.4 0.2 0.5 1.2 1.4 0.6 0.1 0.6 0.0 0.1 2.8 1.5 0.1 0.1 0.1 0.0 0.0 0.0 2.9 1.2 0.0 0.7 1.4 2.7 1.7 1.5 0.9 1.0 0.0 0.6 0.8 0.3 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 DLC1 "ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12" ENSG00000164741 "DLC1 Rho GTPase activating protein" Q96QB1 8 13083361-13604610 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.7;hTERT-HME1: 13.8;HUVEC TERT2: 18.8;U-2197: 18.6;WM-115: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 6.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017753 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA017753: AB_10600805" "unprognostic (1.83e-1)" "unprognostic (1.67e-1)" "unprognostic (1.29e-1)" "prognostic favourable (1.11e-4)" "unprognostic (7.47e-2)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (1.12e-1)" "unprognostic (8.46e-3)" "unprognostic (6.49e-2)" "unprognostic (2.02e-2)" "unprognostic (3.56e-3)" "unprognostic (2.79e-2)" "unprognostic (7.33e-2)" "unprognostic (1.67e-1)" 33.9 8.0 8.5 8.8 15.4 4.9 31.9 3.1 11.4 13.6 13.1 16.0 2.0 6.1 12.4 7.4 8.6 10.4 13.1 15.1 10.0 7.3 9.2 24.1 32.4 5.6 18.0 6.8 8.0 6.3 6.3 4.4 22.3 16.2 5.7 4.5 13.6 4.9 4.1 7.6 5.4 8.5 18.7 15.0 16.6 11.1 5.5 16.5 0.0 12.0 6.1 2.9 17.1 17.2 0.0 0.2 6.5 1.3 0.0 0.1 0.0 0.0 0.1 1.6 0.0 12.3 7.0 5.9 0.6 0.1 0.2 0.5 3.9 2.4 0.0 0.2 11.7 2.0 1.0 1.6 1.1 0.0 0.9 0.3 0.0 4.1 6.4 0.0 3.5 5.4 0.1 18.7 13.8 18.8 1.0 0.0 5.6 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 5.9 0.0 0.8 0.0 0.2 6.2 0.0 0.0 1.9 13.5 7.3 18.6 4.4 0.0 0.0 0.0 10.4 0.0 13.7 6.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 8.5 15.4 3.1 11.0 10.0 7.3 18.0 6.8 16.2 16.5 DLG1 "dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97" ENSG00000075711 "Discs large MAGUK scaffold protein 1" Q12959 3 197042560-197299300 "Predicted intracellular proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016307, HPA069593" Supported Uncertain "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "CAB016307: AB_2092015, HPA069593: " "unprognostic (2.04e-2)" "unprognostic (1.37e-1)" "unprognostic (7.79e-2)" "unprognostic (4.56e-3)" "unprognostic (3.54e-2)" "unprognostic (8.56e-2)" "unprognostic (8.90e-3)" "unprognostic (2.97e-1)" "unprognostic (5.98e-2)" "unprognostic (2.33e-1)" "unprognostic (2.41e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-3)" "unprognostic (3.56e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (3.07e-1)" 12.3 12.6 30.0 10.2 34.5 9.6 14.2 42.1 37.7 19.9 17.8 32.3 17.0 16.1 15.4 8.8 30.2 12.7 12.9 13.8 26.9 19.2 21.0 18.6 12.9 10.6 32.9 27.3 18.7 11.9 28.2 19.8 15.1 29.1 12.1 20.2 10.4 16.5 14.7 18.7 13.7 18.4 15.3 32.2 8.8 16.7 11.1 39.4 14.7 34.6 13.9 14.8 13.8 15.7 3.7 2.9 2.9 1.0 1.4 3.9 1.5 46.9 7.4 14.8 26.8 12.2 11.5 15.1 16.8 15.4 16.9 19.9 21.7 20.3 13.7 48.2 16.6 31.0 13.5 26.1 32.6 3.7 9.0 12.0 11.5 15.8 12.1 11.9 11.9 10.3 14.2 15.5 34.0 21.2 9.7 16.7 40.6 18.2 17.7 4.6 11.6 14.3 9.5 17.9 9.8 17.6 19.9 7.3 12.3 26.3 17.5 19.1 40.0 9.2 20.1 45.9 12.1 12.6 28.3 26.5 19.0 17.8 16.9 18.2 14.3 0.0 0.9 2.9 1.5 1.0 3.9 3.7 2.9 2.7 2.2 2.0 3.0 3.1 1.1 1.4 0.4 2.9 2.9 1.5 30.0 34.5 42.1 37.7 26.9 19.2 32.9 27.3 29.1 39.4 DLG2 "chapsyn-110, PPP1R58, PSD-93, PSD93" ENSG00000150672 "Discs large MAGUK scaffold protein 2" Q15700 11 83455012-85627922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.7" "Cell line enhanced" "Detected in some" "BEWO: 7.5;CACO-2: 4.6;NTERA-2: 5.1;SCLC-21H: 5.2;SH-SY5Y: 7.8;SK-BR-3: 4.6;T-47d: 19.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021307, HPA023896, CAB072341" Enhanced Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "CAB072341: , HPA021307: AB_1846625, HPA023896: " "unprognostic (2.61e-3)" "unprognostic (2.81e-2)" "unprognostic (4.05e-2)" "unprognostic (9.03e-2)" "unprognostic (3.25e-1)" "unprognostic (1.09e-1)" "unprognostic (9.44e-3)" "unprognostic (7.78e-2)" "unprognostic (4.32e-1)" "unprognostic (4.61e-2)" "unprognostic (9.28e-3)" "unprognostic (4.84e-1)" "unprognostic (7.66e-6)" "unprognostic (2.92e-2)" "unprognostic (2.41e-1)" "unprognostic (6.52e-2)" "unprognostic (8.89e-2)" 1.4 11.0 20.0 1.4 30.7 0.7 2.5 9.3 44.7 2.4 1.7 39.5 0.6 1.5 3.3 4.4 7.8 6.0 2.3 2.8 19.9 9.9 3.7 2.8 1.9 1.3 28.7 21.2 6.2 3.3 14.6 7.9 2.7 25.7 4.3 1.5 2.9 3.1 5.4 1.2 19.5 1.5 2.6 19.7 2.6 1.5 6.6 37.3 0.0 15.6 0.0 2.9 1.5 2.1 1.3 0.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.1 0.0 0.2 1.4 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.1 5.1 0.0 0.0 0.7 0.4 0.0 0.0 5.2 7.8 0.0 4.6 0.0 19.2 0.0 0.0 0.3 0.9 0.2 0.0 0.0 0.0 3.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.3 0.0 0.0 0.0 0.5 0.0 0.2 20.0 30.7 9.3 34.9 19.9 9.9 28.7 21.2 25.7 37.3 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 19.3" "Cell line enhanced" "Detected in many" "HaCaT: 16.2;HBEC3-KT: 8.8;hTCEpi: 26.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA061223: , HPA068672: , HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 1.0 1.1 4.5 1.4 7.9 1.7 4.3 12.2 8.2 2.2 0.7 0.9 6.4 1.1 1.4 3.8 10.5 1.1 0.9 1.8 4.1 4.6 0.7 0.7 1.1 1.7 1.5 4.8 1.7 1.5 0.4 0.5 1.3 0.9 10.4 0.5 0.3 12.4 13.0 0.7 19.3 1.0 0.6 1.5 1.5 1.1 1.1 1.2 1.3 0.8 4.7 3.9 2.2 5.3 0.8 1.8 1.0 0.5 2.5 3.2 0.3 5.1 1.8 0.5 7.7 0.0 0.4 1.7 1.9 2.1 2.1 1.0 1.8 0.2 0.9 1.2 0.3 16.2 5.4 8.8 0.4 1.0 2.0 0.4 0.9 2.7 0.5 0.3 1.1 0.9 26.6 0.6 5.0 0.0 0.4 0.7 0.8 1.9 0.4 0.4 0.7 1.9 1.0 0.9 0.5 0.3 1.8 5.7 0.5 0.6 0.2 0.3 0.5 1.6 0.5 0.8 2.5 0.6 3.7 1.2 0.3 1.7 0.1 0.7 0.5 0.9 0.4 0.4 0.7 0.3 3.2 0.6 2.2 2.2 0.1 0.8 0.9 0.4 1.0 2.5 0.5 1.8 0.3 0.3 4.5 7.9 12.2 8.2 4.1 4.6 1.5 4.8 0.9 1.2 DMPK "DM, DM1, DM1PK, DMK, MDPK, MT-PK" ENSG00000104936 "DM1 protein kinase" Q09013 19 45769717-45782552 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.6" "Cell line enhanced" "Detected in many" "RH-30: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007164, HPA008905" Enhanced Approved Vesicles,Cytosol Cytosol Vesicles "HPA007164: AB_1078687, HPA008905: AB_1078685" "unprognostic (7.44e-2)" "unprognostic (2.66e-1)" "unprognostic (1.76e-3)" "unprognostic (2.61e-3)" "unprognostic (1.29e-1)" "unprognostic (5.46e-2)" "unprognostic (8.67e-2)" "unprognostic (1.50e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-1)" "prognostic favourable (9.39e-5)" "unprognostic (1.93e-1)" "unprognostic (1.60e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (4.24e-3)" 9.0 18.7 5.1 9.7 6.3 1.7 4.9 8.8 6.2 16.5 23.4 4.4 15.6 8.7 21.2 15.0 31.2 13.7 20.3 56.7 5.0 5.3 4.9 2.2 6.5 4.1 4.8 6.5 8.4 33.3 3.1 10.7 6.8 5.6 16.3 3.8 22.0 6.1 19.7 79.6 5.1 11.3 65.1 4.2 5.3 12.0 5.9 4.0 1.1 6.1 36.6 5.0 44.9 8.2 1.5 0.0 0.0 0.8 0.3 2.2 0.0 7.2 10.1 12.0 7.4 8.1 11.3 7.2 16.2 12.0 6.5 6.3 1.2 3.9 2.3 2.4 18.5 10.6 3.4 1.6 2.4 11.3 10.6 0.9 12.6 1.7 7.9 0.1 4.1 16.5 5.7 5.6 2.7 3.0 7.1 5.8 9.4 8.0 1.1 2.7 7.1 2.2 3.7 44.2 3.7 3.5 8.3 6.5 10.3 8.8 18.5 5.2 15.2 3.5 9.1 7.6 7.5 7.2 11.8 11.2 9.6 2.3 6.9 1.0 10.6 0.0 0.0 0.0 2.2 0.8 0.5 0.3 0.7 0.2 0.0 1.5 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 5.1 6.3 8.8 6.2 5.0 5.3 4.8 6.5 5.6 4.0 DMRTA1 ENSG00000176399 "DMRT like family A1" Q5VZB9 9 22446841-22455740 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 12.2;salivary gland: 16.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.1;LHCN-M2: 4.7;RPTEC TERT1: 4.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 2.5" "HPA044764, HPA062253" Uncertain Approved Vesicles Vesicles "HPA044764: AB_10959788, HPA062253: " "unprognostic (1.47e-1)" "unprognostic (2.48e-2)" "unprognostic (2.86e-1)" "unprognostic (7.74e-4)" "unprognostic (3.81e-2)" "unprognostic (2.67e-3)" "unprognostic (4.36e-2)" "unprognostic (2.36e-2)" "unprognostic (1.28e-1)" "unprognostic (9.64e-2)" "unprognostic (3.65e-3)" "unprognostic (2.92e-1)" "prognostic favourable (1.14e-6)" "unprognostic (8.58e-2)" "unprognostic (1.13e-1)" "unprognostic (1.61e-1)" "unprognostic (8.53e-3)" 2.1 0.2 0.7 1.4 0.7 0.0 5.6 0.8 0.7 2.4 1.0 0.7 1.1 0.7 1.2 1.8 5.5 0.3 1.2 0.6 0.6 0.5 5.5 12.2 1.1 1.4 0.8 0.4 0.6 2.7 6.1 2.9 0.0 0.9 2.4 0.4 1.9 16.3 0.5 0.9 0.5 0.8 0.7 0.7 0.4 2.8 0.6 0.0 1.1 5.0 0.6 2.0 0.9 1.7 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.6 0.1 0.0 0.4 0.1 0.2 0.0 10.1 0.3 0.4 0.1 0.1 0.0 2.2 0.0 0.3 2.0 2.7 0.3 0.0 0.7 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 1.9 0.7 0.0 3.7 4.7 1.0 0.0 0.0 2.0 3.4 0.0 0.2 1.4 4.8 0.0 0.2 0.0 1.3 0.8 2.2 0.0 0.0 3.4 0.0 3.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.8 0.7 0.6 0.5 0.8 0.4 0.9 0.0 DNAJA3 "hTid-1, TID1" ENSG00000103423 "DnaJ heat shock protein family (Hsp40) member A3" Q96EY1 16 4425805-4456775 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016095, HPA040875, HPA044229" Approved Enhanced Vesicles,Mitochondria Mitochondria Vesicles "CAB016095: AB_668801, HPA040875: , HPA044229: " "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (2.86e-3)" "unprognostic (2.91e-2)" "unprognostic (4.17e-1)" "unprognostic (5.18e-2)" "unprognostic (1.60e-1)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (3.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.27e-2)" "prognostic favourable (1.79e-4)" "unprognostic (4.17e-2)" "unprognostic (1.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.92e-1)" 10.8 26.6 10.7 11.3 15.5 6.2 13.0 15.3 20.8 10.0 14.0 13.9 11.1 17.3 11.3 8.7 15.6 12.6 12.5 28.8 13.9 12.6 19.0 44.8 9.1 13.4 13.0 13.0 13.2 18.1 21.6 12.1 13.7 14.2 11.5 13.4 10.6 14.4 13.4 46.7 12.8 13.2 11.4 12.6 11.4 12.8 15.1 11.1 13.6 16.1 16.2 13.3 13.4 11.2 10.4 6.5 2.2 7.0 7.8 11.9 7.9 8.9 17.9 6.3 11.8 7.9 6.9 11.7 11.8 8.9 16.5 13.6 14.9 12.6 17.6 11.0 7.6 13.6 20.4 14.0 9.6 12.1 17.6 9.0 15.5 14.3 19.5 15.6 8.6 8.4 16.8 14.5 24.3 7.9 23.1 14.6 9.3 20.4 14.6 11.3 13.7 16.6 18.2 10.0 32.9 12.3 9.6 15.5 6.7 12.9 29.6 19.5 16.9 13.1 7.4 12.3 8.4 29.6 14.7 15.1 20.2 24.0 6.6 15.1 14.4 0.7 4.6 2.2 9.5 7.0 11.0 10.4 9.1 8.9 6.5 8.9 11.9 9.2 0.5 7.8 5.2 4.6 7.4 7.9 10.7 15.5 15.3 20.8 13.9 12.6 13.0 13.0 14.2 11.1 DNAJC13 "KIAA0678, RME8" ENSG00000138246 "DnaJ heat shock protein family (Hsp40) member C13" O75165 3 132417526-132539032 "Predicted membrane proteins" "Protein transport, Transport" Chaperone "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036923, HPA036924" Approved Supported Vesicles,Cytosol Vesicles Cytosol "HPA036923: AB_10672480, HPA036924: " "unprognostic (3.35e-3)" "unprognostic (7.47e-2)" "unprognostic (9.16e-2)" "unprognostic (1.20e-2)" "unprognostic (9.71e-2)" "unprognostic (4.92e-2)" "prognostic unfavourable (7.49e-4)" "unprognostic (3.68e-2)" "unprognostic (3.38e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (8.36e-4)" "unprognostic (1.92e-1)" "unprognostic (4.81e-3)" "unprognostic (2.15e-1)" "unprognostic (1.71e-1)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" 23.3 17.8 20.4 15.1 14.4 20.5 16.2 18.0 19.9 20.8 23.1 8.1 23.3 14.5 25.0 18.7 22.3 16.8 13.1 20.5 19.9 11.0 23.6 12.1 17.7 14.9 11.5 17.8 20.1 12.2 21.1 12.3 22.9 17.3 17.8 18.8 10.2 16.1 24.6 20.0 13.7 20.1 26.3 12.5 19.4 16.0 10.3 16.4 13.0 20.6 13.8 13.6 24.5 32.4 2.2 5.7 3.4 7.0 1.7 2.1 1.6 14.6 8.4 11.5 5.8 26.8 23.9 7.0 15.9 29.9 15.5 17.2 9.4 9.3 7.7 10.2 21.6 12.0 10.7 11.6 21.6 8.7 3.0 9.5 8.4 6.2 14.1 9.5 9.3 17.4 8.5 14.0 17.4 21.6 5.3 12.8 21.9 11.2 7.8 4.5 6.7 7.6 7.6 8.2 6.1 14.0 15.5 4.1 6.8 15.2 8.0 17.2 12.5 9.0 20.1 17.5 9.0 17.0 6.8 7.3 7.1 10.4 18.3 6.7 12.8 3.4 5.2 0.7 1.9 4.3 1.8 2.2 2.0 1.7 5.7 1.4 1.5 2.1 1.2 1.7 7.0 2.7 1.1 1.6 20.4 14.4 18.0 19.9 19.9 11.0 11.5 17.8 17.3 16.4 DNAJC16 KIAA0962 ENSG00000116138 "DnaJ heat shock protein family (Hsp40) member C16" Q9Y2G8 1 15526813-15592379 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043643 Approved Approved Vesicles Vesicles "HPA043643: AB_10796794" "unprognostic (1.77e-1)" "unprognostic (4.95e-2)" "prognostic favourable (6.77e-4)" "unprognostic (4.52e-2)" "unprognostic (5.51e-2)" "unprognostic (2.05e-2)" "unprognostic (1.91e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (4.28e-2)" "unprognostic (2.35e-2)" "unprognostic (3.74e-2)" "prognostic favourable (7.24e-4)" "unprognostic (3.67e-2)" "unprognostic (3.74e-1)" "unprognostic (5.38e-2)" "unprognostic (4.70e-2)" 9.6 11.5 9.8 9.5 18.7 3.9 12.3 13.2 24.3 10.2 10.9 18.4 14.2 12.0 12.9 14.7 11.5 13.0 11.2 9.1 11.0 10.8 22.1 20.0 8.9 10.5 11.1 10.8 13.1 13.4 20.1 20.3 13.9 17.2 10.8 11.2 12.0 12.1 10.8 19.2 10.2 11.2 11.9 10.7 11.3 9.9 11.1 11.0 11.4 13.9 8.9 12.5 10.3 9.4 6.9 4.1 3.8 4.1 3.2 8.0 3.6 7.4 7.1 5.9 10.8 16.2 13.1 5.5 8.9 9.1 9.0 9.7 6.1 11.0 6.5 6.0 8.9 9.3 7.2 7.9 12.7 7.6 3.4 6.6 8.2 10.6 16.1 10.2 7.7 9.5 9.4 14.5 8.1 10.0 14.0 5.9 10.2 3.0 5.2 5.2 5.7 5.0 6.1 7.6 7.2 11.1 5.2 6.6 6.3 9.2 8.8 7.6 5.6 4.1 13.5 15.9 5.7 14.6 4.8 8.1 11.4 5.8 9.9 5.9 7.5 3.8 4.1 3.0 5.6 4.0 8.0 6.8 5.8 5.0 4.1 6.9 7.4 6.3 2.3 3.2 2.9 3.7 5.3 3.6 9.8 18.7 13.2 24.3 11.0 10.8 11.1 10.8 17.2 11.0 DNAJC21 "DNAJA5, GS3, JJJ1" ENSG00000168724 "DnaJ heat shock protein family (Hsp40) member C21" Q5F1R6 5 34929593-34958964 "Disease related genes, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040789, HPA049208" Approved Approved Vesicles Vesicles "HPA040789: AB_10794147, HPA049208: " "unprognostic (1.37e-1)" "unprognostic (6.01e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (1.42e-2)" "prognostic unfavourable (2.36e-5)" "unprognostic (1.77e-3)" "unprognostic (3.04e-2)" "unprognostic (6.68e-3)" "unprognostic (5.99e-2)" "unprognostic (6.02e-2)" "unprognostic (9.27e-3)" "unprognostic (1.54e-1)" "unprognostic (3.26e-1)" "unprognostic (2.57e-1)" "unprognostic (6.02e-2)" 13.8 12.2 13.5 12.1 16.5 15.9 20.9 17.2 16.0 20.7 17.9 7.9 13.6 11.6 16.0 11.6 20.1 11.0 10.5 26.7 12.1 11.7 19.0 19.3 13.3 16.6 16.2 12.2 13.6 17.0 16.6 18.7 19.2 17.6 16.6 14.4 6.7 15.4 14.5 50.6 11.6 13.3 23.1 14.5 12.9 15.4 41.9 17.0 17.2 16.5 18.9 14.2 23.8 25.2 5.8 4.8 8.3 3.5 7.5 6.3 1.9 14.0 9.8 12.5 16.6 16.2 19.5 23.4 18.9 15.3 14.8 10.0 16.5 17.1 29.8 8.6 17.4 10.1 14.8 18.8 17.5 17.6 11.0 16.1 37.3 13.8 26.6 23.1 15.6 13.8 17.8 16.7 27.2 13.9 25.1 23.5 10.9 11.9 19.8 17.5 8.7 8.6 18.0 31.3 13.1 15.2 18.0 6.8 7.1 50.1 23.6 15.8 16.1 25.9 16.9 18.7 18.7 11.3 14.9 16.9 15.3 20.3 15.4 28.1 9.9 4.0 2.9 8.3 3.6 2.4 5.1 5.8 5.1 3.2 4.8 3.7 5.2 5.1 0.6 7.5 3.5 4.6 6.3 1.9 13.5 16.5 17.2 16.0 12.1 11.7 16.2 12.2 17.6 17.0 DNAJC22 "FLJ13236, wus" ENSG00000178401 "DnaJ heat shock protein family (Hsp40) member C22" Q8N4W6 12 49346917-49357546 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 10.0;intestine: 10.0;liver: 18.9" "Cell line enhanced" "Detected in many" "AN3-CA: 11.2;CACO-2: 17.5;CAPAN-2: 11.0;EFO-21: 18.9;MCF7: 15.4;T-47d: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in single" "midbrain: 1.4" "Low region specificity" "Detected in many" HPA039953 Approved Vesicles Vesicles "HPA039953: " "unprognostic (5.23e-2)" "unprognostic (1.24e-1)" "unprognostic (9.01e-2)" "prognostic favourable (4.56e-5)" "unprognostic (4.77e-3)" "unprognostic (2.74e-1)" "unprognostic (1.28e-1)" "unprognostic (4.05e-2)" "prognostic unfavourable (7.54e-4)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-2)" "unprognostic (9.35e-2)" "unprognostic (1.58e-1)" "unprognostic (3.83e-2)" 1.1 0.3 0.5 0.4 1.0 0.0 0.4 0.4 2.2 1.5 5.4 0.8 0.4 10.0 2.2 1.3 0.4 0.8 10.0 0.4 0.7 0.5 5.2 18.9 0.4 0.4 1.0 1.2 0.4 5.2 2.7 0.4 0.9 4.6 0.4 5.2 0.8 1.2 0.4 0.4 0.2 8.3 0.4 0.8 0.4 4.4 0.6 0.4 0.4 6.6 0.4 0.4 0.4 0.7 0.7 0.8 2.7 0.5 0.5 0.5 0.4 1.6 10.4 0.0 11.2 0.0 0.0 3.7 0.4 3.3 1.1 2.4 17.5 11.0 0.0 18.9 0.4 0.1 1.6 0.0 1.9 0.1 2.5 0.3 0.2 8.7 2.7 0.0 1.9 0.1 0.0 1.7 0.3 1.6 0.1 0.3 0.8 15.4 0.0 0.0 0.0 5.4 0.0 5.4 0.1 0.3 0.0 1.8 0.9 0.3 0.5 3.5 13.9 0.2 0.2 1.2 3.5 0.1 1.5 0.0 0.0 0.0 2.6 0.0 2.3 2.3 0.5 0.5 0.5 0.3 0.3 0.4 0.4 0.3 0.1 0.7 0.3 0.3 2.7 0.5 0.4 0.8 0.2 0.4 0.5 1.0 0.4 2.2 0.7 0.5 1.0 1.2 4.6 0.4 DNASE1 DNL1 ENSG00000213918 "Deoxyribonuclease 1" P24855 16 3611728-3680143 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Actin-binding, Endonuclease, Hydrolase, Nuclease" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 26.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA010703 Enhanced Supported Vesicles "Secreted in other tissues" 160000 Vesicles "HPA010703: AB_10600806" "unprognostic (5.18e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-1)" "unprognostic (1.74e-1)" "unprognostic (2.38e-1)" "unprognostic (1.90e-2)" "unprognostic (3.73e-2)" "unprognostic (3.82e-1)" "unprognostic (3.20e-1)" "unprognostic (9.91e-2)" "unprognostic (1.69e-3)" "unprognostic (5.37e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.74e-1)" "unprognostic (1.45e-1)" "prognostic favourable (1.14e-4)" 1.5 1.4 1.5 2.6 1.6 1.7 1.5 3.8 2.5 2.2 12.2 1.8 1.5 14.9 1.5 2.2 3.4 1.2 2.5 1.5 1.5 1.2 11.4 1.5 1.5 4.4 1.5 1.5 2.0 13.7 1.6 12.2 1.9 3.1 5.1 2.1 1.5 3.3 1.5 1.5 3.9 26.7 1.5 1.5 2.3 6.0 2.7 1.5 1.5 1.6 2.6 3.8 1.9 2.3 4.5 2.2 9.2 2.0 1.9 3.4 1.0 2.4 5.7 10.0 5.2 2.9 2.5 4.8 4.0 0.7 3.2 4.7 6.8 6.0 10.5 3.2 0.6 4.2 3.6 1.1 3.5 4.6 5.5 3.7 8.5 4.5 1.5 2.6 8.5 2.0 4.2 4.3 1.0 2.1 9.2 4.7 2.7 10.2 5.2 11.3 6.1 3.1 12.4 4.6 5.1 2.7 2.1 7.1 6.6 2.9 9.1 1.6 9.0 6.5 2.9 6.0 4.5 3.8 2.2 4.2 6.0 18.2 1.7 4.8 5.8 4.3 2.0 5.3 3.0 1.3 1.9 2.5 2.3 2.4 1.0 4.5 2.7 3.4 9.2 1.9 1.2 2.2 2.4 1.0 1.5 1.6 3.8 2.5 1.5 1.2 1.5 1.5 3.1 1.5 DNM1L "DRP1, DVLP, DYMPLE, HDYNIV, VPS1" ENSG00000087470 "Dynamin 1 like" O00429 12 32679200-32745650 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Endocytosis, Necrosis" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009952, HPA039324" Supported Enhanced Vesicles,Cytosol 10000000 Cytosol Vesicles "CAB009952: AB_2093533, HPA039324: " "unprognostic (2.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.10e-3)" "unprognostic (1.12e-1)" "unprognostic (5.09e-1)" "unprognostic (4.06e-2)" "prognostic unfavourable (6.27e-6)" "unprognostic (8.68e-2)" "unprognostic (2.25e-2)" "unprognostic (1.04e-2)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (8.17e-2)" "unprognostic (7.48e-2)" "unprognostic (1.57e-2)" 15.4 16.2 24.9 14.8 34.4 22.3 14.3 40.5 37.8 13.0 14.5 12.4 14.9 12.3 16.5 16.5 19.8 13.3 11.9 25.4 26.1 28.1 19.4 12.8 11.2 13.8 23.4 23.2 14.1 9.8 28.7 18.8 16.0 27.9 19.3 16.0 12.1 11.1 21.1 25.6 11.8 11.0 21.7 21.7 11.6 12.2 23.1 14.9 13.4 15.2 17.4 15.8 16.9 12.2 5.9 17.0 5.0 14.6 7.2 7.9 7.1 22.1 22.1 23.2 23.8 18.8 19.3 44.9 24.9 19.2 23.5 21.8 31.0 17.0 29.8 17.5 22.5 19.9 24.4 28.6 28.3 15.7 19.9 33.9 21.3 17.0 15.5 24.0 17.9 17.4 14.5 24.9 25.7 28.4 24.5 12.9 26.9 8.6 9.6 20.2 48.9 10.8 16.2 43.7 20.3 19.8 30.5 20.3 20.8 26.5 18.2 19.4 20.9 16.4 25.6 20.1 20.2 47.1 23.1 9.1 24.6 31.1 19.5 16.1 15.2 5.0 9.7 3.1 5.6 14.6 6.8 5.9 6.0 5.9 17.0 5.2 7.3 7.9 1.7 7.2 13.6 5.4 6.1 7.1 24.9 34.4 40.5 37.8 26.1 28.1 23.4 23.2 27.9 14.9 DOK4 FLJ10488 ENSG00000125170 "Docking protein 4" Q8TEW6 16 57471922-57487327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 25.6;CACO-2: 29.1;SH-SY5Y: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "gdT-cell: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 5 "granulocytes: 4.3;T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055849 Supported Uncertain "Vesicles,Microtubules,Cytokinetic bridge" Microtubules "Vesicles, Cytokinetic bridge" "HPA055849: " "unprognostic (3.44e-2)" "unprognostic (2.04e-2)" "unprognostic (1.17e-1)" "unprognostic (4.73e-2)" "unprognostic (3.66e-1)" "unprognostic (9.71e-2)" "unprognostic (5.35e-2)" "unprognostic (1.39e-1)" "unprognostic (1.13e-2)" "unprognostic (3.00e-2)" "unprognostic (2.27e-2)" "unprognostic (1.53e-1)" "unprognostic (2.58e-3)" "unprognostic (4.30e-2)" "unprognostic (2.21e-1)" "unprognostic (4.42e-3)" "unprognostic (1.18e-3)" 5.0 4.6 7.8 9.5 4.5 0.7 13.6 15.6 6.9 14.2 29.2 2.0 17.7 24.4 9.9 11.8 15.5 8.1 21.0 7.3 5.0 6.9 27.1 25.8 12.3 1.9 3.4 4.7 12.8 14.8 7.2 10.1 6.6 5.2 12.9 16.9 8.4 7.5 15.0 3.1 22.7 51.5 9.6 2.1 5.1 19.9 8.4 2.9 1.9 8.6 12.9 6.3 8.8 14.1 0.5 0.1 4.3 0.0 0.1 1.4 0.2 2.7 25.6 4.1 7.4 5.8 6.5 4.6 4.8 6.4 3.4 1.0 29.1 14.5 0.2 21.1 10.0 5.7 2.5 1.3 1.5 0.7 1.9 5.9 7.5 16.7 8.3 0.0 0.6 4.5 3.9 4.5 0.5 5.2 1.9 1.2 4.1 2.6 0.3 1.1 2.6 1.1 2.3 2.1 0.3 18.0 1.0 20.5 67.0 3.9 1.7 1.2 1.5 1.1 5.5 0.6 4.3 1.7 0.2 0.8 1.0 0.2 1.9 1.2 2.5 0.0 0.0 0.0 1.4 0.0 0.6 0.1 0.3 0.2 0.1 0.5 0.4 0.3 4.3 0.1 0.0 0.0 0.1 0.2 7.8 4.5 15.6 6.9 5.0 6.9 3.4 4.7 5.2 2.9 DOLPP1 LSFR2 ENSG00000167130 "Dolichyldiphosphatase 1" Q86YN1 9 129081100-129090438 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019179 Approved Approved "Vesicles,Intermediate filaments" Vesicles "Intermediate filaments" "HPA019179: AB_1847827" "unprognostic (1.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.89e-1)" "unprognostic (6.12e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-2)" "unprognostic (3.18e-1)" "unprognostic (3.10e-2)" "unprognostic (6.96e-2)" "unprognostic (7.12e-2)" "unprognostic (1.65e-1)" "unprognostic (4.37e-3)" "unprognostic (7.59e-3)" "unprognostic (2.38e-2)" "unprognostic (1.35e-1)" "unprognostic (4.69e-2)" "unprognostic (5.34e-2)" 6.4 12.8 10.0 6.8 10.6 7.7 6.8 11.7 19.3 8.3 17.1 17.7 8.6 28.6 6.0 7.4 18.8 6.6 9.2 4.1 10.1 10.7 9.4 21.8 6.7 6.6 13.2 10.6 7.7 10.5 10.4 6.9 11.6 12.5 10.0 14.2 6.1 10.3 5.8 5.2 10.3 27.7 6.3 15.2 8.5 11.8 12.2 11.0 9.4 6.3 8.5 9.1 7.8 8.0 8.8 12.5 9.8 8.3 7.9 21.7 7.2 4.3 16.6 16.3 14.9 5.5 4.7 18.9 10.7 6.2 20.3 11.3 21.3 14.4 8.3 9.4 6.6 31.3 16.7 8.9 8.6 9.8 10.3 11.0 11.2 16.3 9.7 11.3 13.7 5.0 12.5 13.3 10.6 9.0 18.1 8.4 5.7 21.8 13.0 11.8 14.0 13.5 15.3 13.2 15.0 7.4 7.0 18.6 12.2 13.4 12.3 4.5 22.5 7.5 7.4 17.5 8.4 16.4 14.4 10.5 20.0 12.7 7.7 2.3 11.5 4.4 6.8 9.8 8.9 8.1 21.7 8.8 10.9 10.8 8.5 6.0 11.1 10.5 1.4 7.9 8.3 12.5 10.1 7.2 10.0 10.6 11.7 19.3 10.1 10.7 13.2 10.6 12.5 11.0 DOPEY1 "dJ202D23.2, KIAA1117" ENSG00000083097 "Dopey family member 1" Q5JWR5 6 83067666-83171350 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027902, HPA027904" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA027902: AB_10600003, HPA027904: AB_10600877" "unprognostic (7.18e-2)" "unprognostic (3.91e-1)" "unprognostic (6.11e-2)" "unprognostic (6.05e-3)" "unprognostic (8.21e-3)" "unprognostic (1.36e-2)" "unprognostic (3.32e-1)" "unprognostic (1.02e-2)" "unprognostic (2.84e-1)" "unprognostic (2.47e-1)" "prognostic favourable (7.36e-4)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" 9.7 8.7 15.7 11.3 19.5 5.5 13.3 25.2 21.2 11.9 9.5 10.1 10.1 9.5 13.9 9.5 9.5 12.0 8.9 10.6 15.2 7.0 8.9 7.5 9.1 8.3 10.9 12.9 17.7 12.1 20.3 21.7 7.3 17.3 12.4 11.0 9.0 13.8 14.9 12.7 16.6 11.7 9.5 13.1 9.5 9.5 14.9 12.8 10.7 16.9 8.5 8.9 12.2 10.7 2.3 2.8 1.4 1.4 1.2 4.1 1.3 3.7 2.7 9.0 8.1 8.2 8.6 4.3 6.3 5.3 4.3 6.3 5.7 0.9 7.2 4.5 6.8 5.0 9.1 6.9 5.5 6.3 10.2 6.0 3.7 2.1 4.4 8.8 6.3 6.8 9.7 6.0 15.8 6.4 12.5 5.4 4.7 3.5 2.6 4.0 1.8 5.5 7.2 6.8 2.6 5.8 10.4 16.2 3.0 4.7 3.0 1.2 4.8 5.0 10.6 5.5 2.0 5.5 4.9 6.7 4.7 4.2 2.9 4.1 4.3 0.1 1.3 1.4 1.9 1.4 1.6 2.3 1.6 4.1 2.8 1.9 3.0 1.4 0.2 1.2 1.2 1.2 1.5 1.3 15.7 19.5 25.2 21.2 15.2 7.0 10.9 12.9 17.3 12.8 DPP7 "DPP2, DPPII" ENSG00000176978 "Dipeptidyl peptidase 7" Q9UHL4 9 137110542-137115177 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 56.7;THP-1: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021282, CAB025541, HPA059381" Supported Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" 1300000 "Golgi apparatus, Vesicles" "CAB025541: , HPA021282: AB_1847673, HPA059381: " "unprognostic (1.15e-1)" "unprognostic (5.54e-2)" "prognostic unfavourable (6.07e-6)" "unprognostic (6.78e-3)" "unprognostic (1.25e-1)" "unprognostic (8.33e-2)" "unprognostic (7.49e-2)" "unprognostic (6.10e-2)" "unprognostic (2.28e-2)" "unprognostic (5.71e-3)" "prognostic favourable (8.31e-5)" "unprognostic (7.99e-2)" "unprognostic (1.46e-2)" "unprognostic (2.56e-2)" "unprognostic (1.72e-1)" "unprognostic (2.15e-1)" "unprognostic (1.02e-1)" 28.1 45.2 23.7 23.4 35.3 31.8 20.8 23.5 27.5 21.5 22.0 24.9 40.7 23.2 17.5 35.8 19.1 27.0 30.2 44.7 24.6 29.2 21.0 29.9 25.6 34.8 29.7 25.9 14.3 55.4 23.3 42.5 21.9 24.2 28.8 6.9 32.8 73.1 41.6 25.3 26.9 17.8 22.8 21.7 29.1 24.4 30.9 26.8 18.9 41.2 17.5 24.7 21.3 16.6 20.0 60.8 12.2 43.1 19.2 36.8 38.2 6.8 10.9 0.9 0.9 13.5 10.8 1.4 10.4 17.0 6.9 4.5 10.3 5.7 13.6 11.4 6.8 14.9 8.0 2.0 0.3 13.3 0.5 6.2 15.0 0.3 30.2 16.8 34.9 13.3 8.3 3.0 6.2 9.0 13.6 10.6 4.6 19.0 8.4 16.0 3.7 10.7 12.4 0.1 56.7 11.0 7.7 17.4 12.1 12.0 31.6 29.4 11.3 54.5 10.9 17.7 6.0 11.2 7.2 13.0 7.4 3.6 21.2 10.2 7.9 6.8 43.1 12.2 34.4 37.6 35.5 19.7 31.1 29.6 41.7 20.0 28.1 25.1 2.6 19.2 22.6 60.8 36.8 38.2 23.7 35.3 23.5 27.5 24.6 29.2 29.7 25.9 24.2 26.8 DPT ENSG00000143196 Dermatopontin Q07507 1 168695459-168729264 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.1" "Group enriched" "Detected in some" 13 "ASC diff: 54.0;fHDF/TERT166: 21.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA065548 Approved Vesicles "Secreted to extracellular matrix" 25000 Vesicles "HPA065548: " "unprognostic (1.49e-1)" "unprognostic (7.62e-2)" "unprognostic (5.66e-2)" "unprognostic (4.39e-2)" "unprognostic (4.64e-2)" "unprognostic (3.78e-3)" "unprognostic (4.09e-2)" "unprognostic (2.57e-1)" "unprognostic (1.48e-1)" "unprognostic (1.03e-2)" "unprognostic (8.88e-2)" "unprognostic (2.16e-2)" "prognostic unfavourable (4.74e-5)" "unprognostic (2.12e-3)" "unprognostic (2.89e-2)" "unprognostic (1.09e-1)" "unprognostic (8.98e-3)" 128.1 6.1 0.8 22.6 0.8 0.0 99.3 0.8 2.4 51.0 81.7 0.9 19.8 2.4 20.4 38.8 33.1 23.0 52.3 48.8 0.8 0.3 2.4 6.0 9.6 7.7 0.8 0.8 12.8 13.4 0.0 0.9 7.8 0.9 24.0 9.4 1.8 14.4 10.2 13.0 8.6 23.1 76.1 0.8 1.0 23.6 8.7 0.8 2.3 16.3 55.7 22.8 48.7 39.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.2 0.0 0.0 2.4 2.6 2.7 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.8 2.4 0.8 0.3 0.8 0.8 0.9 0.8 DPY19L1 KIAA0877 ENSG00000173852 "Dpy-19 like C-mannosyltransferase 1" Q2PZI1 7 34928876-35038271 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059139 Uncertain Approved Vesicles Vesicles "HPA059139: " "unprognostic (4.66e-2)" "unprognostic (1.11e-3)" "unprognostic (8.53e-3)" "unprognostic (2.47e-3)" "unprognostic (2.50e-2)" "unprognostic (3.80e-3)" "unprognostic (2.02e-3)" "unprognostic (3.57e-2)" "unprognostic (1.14e-1)" "unprognostic (4.84e-2)" "prognostic unfavourable (2.99e-4)" "unprognostic (3.21e-1)" "unprognostic (1.88e-2)" "unprognostic (3.99e-1)" "unprognostic (2.69e-2)" "unprognostic (1.37e-1)" "unprognostic (4.12e-2)" 9.7 12.2 11.0 10.2 13.0 9.0 13.7 16.9 27.0 15.6 9.3 13.5 4.5 4.8 17.7 4.3 7.1 10.3 13.8 18.1 11.8 13.4 7.2 25.2 13.0 9.9 16.3 12.0 8.6 6.7 5.0 11.2 19.0 23.6 8.6 11.3 10.3 6.4 8.4 4.0 4.5 6.8 17.5 38.1 14.1 9.0 31.7 5.8 2.3 10.4 3.6 8.4 11.5 11.3 1.6 1.6 2.8 2.3 1.6 4.1 1.0 5.3 21.1 12.0 15.3 23.7 19.0 2.5 11.9 10.8 7.5 10.6 5.0 14.1 7.7 17.5 12.3 9.5 9.1 6.5 16.9 4.1 7.3 11.3 13.4 8.2 8.6 10.6 10.6 9.7 5.4 10.1 6.7 30.7 8.4 31.7 26.1 3.0 0.1 10.5 7.7 9.5 7.8 15.9 11.0 28.3 18.6 5.5 14.5 10.7 1.5 6.1 10.7 12.7 35.5 14.9 18.1 10.3 16.1 14.4 30.9 8.8 18.4 9.8 41.4 2.8 1.7 0.1 3.9 2.3 4.1 1.3 1.7 3.1 1.5 1.6 0.6 1.8 0.3 1.6 0.8 1.6 1.0 1.0 11.0 13.0 16.9 27.0 11.8 13.4 16.3 12.0 23.6 5.8 DPYSL4 "DRP-4, ULIP4" ENSG00000151640 "Dihydropyrimidinase like 4" O14531 10 132186900-132205776 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0;heart muscle: 19.0" "Cell line enhanced" "Detected in many" "AF22: 23.2;AN3-CA: 30.4;SH-SY5Y: 31.6" "Cancer enhanced" "Detected in many" "glioma: 13.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049066 Approved Approved Vesicles,Mitochondria "Vesicles, Mitochondria" "HPA049066: " "unprognostic (6.27e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-1)" "unprognostic (1.81e-1)" "unprognostic (3.95e-1)" "unprognostic (5.99e-2)" "unprognostic (8.36e-5)" "unprognostic (1.72e-1)" "unprognostic (8.91e-2)" "unprognostic (1.08e-2)" "unprognostic (3.81e-2)" "unprognostic (6.36e-2)" "unprognostic (7.47e-6)" "unprognostic (3.04e-3)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "prognostic unfavourable (3.11e-4)" 1.5 4.4 11.8 2.0 12.3 1.1 1.5 8.9 32.0 1.7 1.4 6.5 0.2 1.1 6.4 2.2 1.4 1.4 2.1 19.0 13.6 9.6 1.0 1.0 1.5 1.4 9.0 9.1 3.0 1.9 1.0 5.0 1.3 6.0 4.8 1.0 4.6 1.5 4.2 2.5 1.6 1.2 2.7 8.1 2.5 1.8 6.7 4.8 0.0 1.0 0.0 1.3 1.4 0.4 0.7 0.0 0.0 0.6 1.1 2.5 0.8 0.0 6.5 23.2 30.4 0.0 0.2 0.0 1.9 0.2 1.2 0.3 0.0 0.2 0.0 0.8 1.0 0.0 4.5 4.4 0.1 0.0 0.8 0.0 0.0 2.4 4.1 0.0 4.6 2.1 2.1 0.7 0.1 2.3 0.0 0.2 3.3 1.9 0.0 0.0 4.0 2.2 0.0 0.0 3.6 0.0 0.4 3.6 31.6 0.7 0.0 4.0 0.1 0.0 3.8 5.8 9.7 0.0 5.4 0.0 1.5 0.0 9.7 0.0 0.6 0.0 0.1 0.0 1.4 0.6 0.0 0.0 1.1 0.1 0.0 0.7 2.5 0.7 0.0 1.1 0.5 0.0 0.0 0.8 11.8 12.3 8.9 18.7 13.6 9.6 9.0 9.1 6.0 4.8 DRAM2 "MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154" ENSG00000156171 "DNA damage regulated autophagy modulator 2" Q6UX65 1 111117333-111140216 "Predicted membrane proteins" "Apoptosis, Autophagy" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 17.6;THP-1: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018036, HPA061701" Supported Enhanced "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA018036: AB_1858134, HPA061701: " "unprognostic (9.38e-3)" "unprognostic (1.58e-2)" "unprognostic (2.16e-3)" "unprognostic (5.22e-2)" "unprognostic (1.12e-2)" "unprognostic (2.65e-2)" "prognostic unfavourable (3.45e-5)" "unprognostic (6.57e-3)" "prognostic unfavourable (6.43e-4)" "unprognostic (2.69e-1)" "unprognostic (4.37e-3)" "unprognostic (2.66e-1)" "prognostic unfavourable (7.45e-4)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (2.29e-1)" "unprognostic (1.77e-3)" 21.8 10.1 5.9 14.4 6.6 7.9 18.4 13.5 6.9 8.4 12.0 7.5 5.7 10.6 8.6 11.1 10.0 12.7 9.1 11.7 5.3 6.0 13.0 9.2 11.5 19.9 9.3 4.2 12.3 8.2 5.7 9.9 14.1 8.4 10.1 8.7 8.8 10.7 7.1 10.6 7.0 15.2 10.1 15.1 24.9 9.5 6.1 8.3 15.0 10.6 6.7 14.7 16.8 7.7 16.1 11.2 3.0 10.9 6.2 10.4 11.4 2.0 0.1 3.4 2.0 8.5 7.2 6.0 8.1 3.1 2.0 4.6 2.5 1.1 7.3 5.4 4.0 2.3 4.8 1.3 3.9 8.8 3.4 4.1 2.5 1.2 6.4 0.6 1.8 5.0 6.1 3.3 1.3 1.0 2.3 3.3 2.4 1.4 3.9 5.3 6.5 4.1 3.8 3.8 3.1 7.3 2.1 6.5 2.4 0.9 2.7 17.6 4.7 19.3 3.5 0.6 0.8 4.1 5.4 4.2 1.2 12.5 1.5 8.1 1.3 2.7 10.3 3.0 6.5 10.9 10.4 13.6 9.0 8.1 11.2 16.1 9.5 7.9 2.1 6.2 7.6 11.2 5.4 11.4 5.9 6.6 13.5 5.4 5.3 6.0 9.3 4.2 8.4 8.3 DRG2 ENSG00000108591 "Developmentally regulated GTP binding protein 2" P55039 17 18087886-18107971 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007716 Approved Supported Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA007716: AB_1078705" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "prognostic favourable (1.56e-4)" "unprognostic (1.26e-3)" "unprognostic (7.86e-2)" "unprognostic (8.85e-2)" "unprognostic (5.72e-2)" "unprognostic (8.49e-2)" "unprognostic (1.25e-1)" "unprognostic (2.88e-3)" "prognostic unfavourable (7.34e-4)" "unprognostic (3.10e-1)" "unprognostic (2.18e-1)" "unprognostic (1.49e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" 19.9 19.9 16.1 17.5 21.8 17.4 19.3 14.7 30.8 19.3 19.3 22.9 16.6 19.2 23.5 22.8 21.6 25.2 18.2 22.4 15.7 17.0 19.1 31.9 15.7 21.2 17.6 16.1 27.6 23.9 20.6 18.8 22.4 17.9 21.1 13.4 18.4 21.7 21.7 33.3 19.4 17.9 18.3 17.1 20.7 17.6 14.6 17.2 21.6 23.6 21.2 25.6 20.5 18.0 12.6 18.4 17.0 20.9 20.0 19.8 14.0 16.8 24.1 8.2 8.1 15.3 16.3 15.7 11.9 11.8 19.3 18.0 25.5 10.1 16.3 15.5 13.7 17.8 13.5 16.5 13.1 14.4 36.9 7.1 12.8 14.2 16.6 6.5 11.4 18.1 14.7 19.3 16.3 18.4 12.5 6.4 11.2 19.0 17.3 11.0 6.1 17.7 18.6 19.9 30.2 11.5 9.9 4.7 13.3 11.8 7.0 14.6 13.9 9.9 13.8 9.3 8.9 10.9 19.5 7.3 8.9 9.2 13.4 11.9 17.1 11.6 15.9 17.0 19.8 17.2 16.4 12.2 14.7 15.8 18.4 12.6 14.0 15.3 2.1 20.0 20.9 10.3 18.3 14.0 16.1 21.8 14.7 30.8 15.7 17.0 17.6 16.1 17.9 17.2 DTD2 "C14orf126, MGC9912" ENSG00000129480 "D-tyrosyl-tRNA deacylase 2 (putative)" Q96FN9 14 31446036-31457510 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA001117 Approved Approved Vesicles Vesicles "HPA001117: " "unprognostic (2.56e-3)" "unprognostic (9.38e-2)" "unprognostic (1.27e-3)" "unprognostic (3.24e-2)" "unprognostic (8.45e-2)" "prognostic unfavourable (9.33e-4)" "unprognostic (3.04e-2)" "unprognostic (1.64e-1)" "unprognostic (8.74e-3)" "unprognostic (2.91e-1)" "unprognostic (5.28e-2)" "unprognostic (6.96e-2)" "unprognostic (1.24e-1)" "unprognostic (2.32e-1)" "unprognostic (3.06e-2)" "unprognostic (1.22e-2)" "prognostic unfavourable (5.74e-6)" 11.9 11.0 12.4 6.8 16.0 2.9 13.1 9.1 19.6 6.7 6.8 15.2 3.8 5.6 8.0 7.7 9.9 7.5 6.9 6.0 13.2 11.0 8.6 11.6 10.0 8.0 13.6 8.9 8.6 9.9 8.3 9.6 6.2 13.3 8.8 8.2 7.1 10.3 6.1 2.3 8.2 5.3 8.3 10.9 6.7 5.7 14.6 9.9 12.3 9.4 2.8 7.8 7.5 6.5 6.4 6.6 3.5 4.8 6.9 9.1 4.8 8.4 7.1 6.2 8.1 11.6 9.8 4.3 7.8 7.6 6.2 5.5 3.8 8.1 16.1 5.3 8.8 8.2 9.9 8.7 10.6 8.7 4.4 4.6 5.2 21.5 12.5 9.2 5.7 11.0 10.0 5.4 12.4 9.0 8.9 7.7 8.2 10.2 13.3 8.3 8.4 7.4 9.1 4.6 8.4 11.5 7.4 9.4 6.2 12.7 16.6 8.9 15.2 4.9 6.5 6.8 6.0 5.4 6.7 9.6 17.8 15.7 3.0 8.5 10.9 3.5 4.8 1.7 4.0 4.1 5.6 4.9 5.9 4.3 6.6 6.4 9.1 6.0 3.0 6.9 2.0 4.0 2.9 4.8 12.4 16.0 9.1 19.6 13.2 11.0 13.6 8.9 13.3 9.9 DTWD1 "MDS009, MGC111207" ENSG00000104047 "DTW domain containing 1" Q8N5C7 15 49620980-49656232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042214 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA042214: " "unprognostic (2.60e-2)" "unprognostic (1.73e-1)" "unprognostic (3.00e-1)" "unprognostic (3.70e-4)" "unprognostic (8.12e-2)" "unprognostic (2.37e-1)" "unprognostic (1.82e-1)" "unprognostic (9.87e-2)" "unprognostic (4.44e-3)" "unprognostic (4.25e-2)" "unprognostic (5.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (1.02e-1)" "unprognostic (7.85e-2)" "unprognostic (2.80e-2)" "unprognostic (2.35e-1)" 19.1 12.6 15.7 11.3 27.5 4.2 17.5 16.7 16.0 24.5 20.1 10.9 9.4 6.9 25.2 15.8 11.7 17.0 19.9 12.0 11.5 9.3 10.3 9.9 11.6 10.4 12.9 12.2 21.6 28.5 8.7 22.1 11.2 11.9 19.2 11.2 11.6 18.0 14.2 10.7 10.8 8.9 22.4 11.7 9.4 15.6 8.2 13.1 12.1 15.5 11.8 8.7 21.5 17.2 8.6 21.6 5.4 11.9 11.1 11.5 5.2 4.4 5.2 9.6 5.1 19.1 37.4 7.6 12.9 12.9 17.2 12.7 1.6 3.6 7.0 9.7 16.1 8.0 6.8 6.8 16.7 4.7 4.8 6.1 10.6 6.2 12.8 7.9 5.3 18.0 9.1 10.7 13.2 7.0 11.3 7.5 18.0 8.9 5.3 6.4 6.0 7.1 7.7 19.8 27.7 5.5 3.1 8.6 6.5 15.6 5.3 12.0 5.3 11.5 4.6 20.4 8.1 11.4 14.3 6.0 9.1 4.2 17.9 22.7 12.6 5.4 8.6 4.2 6.5 9.8 8.9 8.6 9.6 10.4 10.8 8.6 11.5 10.6 2.1 11.1 11.9 21.6 7.5 5.2 15.7 27.5 16.7 16.0 11.5 9.3 12.9 12.2 11.9 13.1 DTX4 "KIAA0937, RNF155" ENSG00000110042 "Deltex E3 ubiquitin ligase 4" Q9Y2E6 11 59171430-59208587 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.8" "Cell line enhanced" "Detected in many" "AF22: 13.3;BEWO: 27.0;CACO-2: 14.6;CAPAN-2: 15.5;RT4: 40.5" "Cancer enhanced" "Detected in all" "thyroid cancer: 63.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056760, HPA059294" Approved Approved Vesicles Vesicles "HPA056760: , HPA059294: " "unprognostic (3.23e-2)" "unprognostic (1.57e-1)" "unprognostic (1.10e-2)" "unprognostic (4.98e-2)" "unprognostic (4.97e-2)" "unprognostic (5.03e-1)" "unprognostic (2.92e-1)" "unprognostic (1.06e-1)" "unprognostic (3.75e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (3.04e-1)" "prognostic unfavourable (8.94e-4)" "unprognostic (5.51e-2)" "unprognostic (2.51e-1)" "prognostic favourable (5.81e-4)" "unprognostic (2.57e-3)" 7.0 2.2 8.9 7.6 12.8 8.2 7.9 14.0 16.5 8.9 17.7 29.8 1.4 16.7 4.3 2.3 3.7 6.5 9.5 2.1 10.7 10.9 6.5 23.9 17.7 5.2 15.3 8.8 16.3 5.9 1.7 3.3 15.3 24.8 5.6 18.4 7.7 16.0 3.7 1.5 4.2 14.3 3.6 42.8 5.0 12.2 1.9 9.1 0.8 12.4 2.3 6.7 19.8 14.7 3.3 6.1 3.1 1.0 0.1 0.1 0.2 2.0 2.3 13.3 0.2 3.8 0.2 27.0 0.2 1.1 0.1 0.1 14.6 15.5 4.8 0.9 0.3 6.9 4.1 5.0 0.0 0.3 0.2 0.0 2.6 4.7 1.0 0.4 0.9 0.6 8.4 0.0 0.2 0.0 0.0 0.5 0.6 1.1 0.2 0.0 6.8 0.6 1.6 11.7 0.5 1.1 40.5 0.0 0.0 10.3 2.7 0.3 2.0 0.2 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.5 0.1 1.2 1.0 1.5 1.0 0.7 0.1 1.0 0.0 2.2 0.1 0.0 1.4 3.3 0.0 0.0 3.1 0.1 0.5 6.1 0.0 0.2 8.9 12.8 14.0 16.5 10.7 10.9 15.3 8.8 24.8 9.1 DUSP22 "JKAP, JSP1, MKPX, VHX" ENSG00000112679 "Dual specificity phosphatase 22" Q9NRW4 6 291630-351355 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 70.3;U-266/70: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031394 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA031394: AB_10604114" "unprognostic (7.34e-3)" "unprognostic (7.94e-3)" "unprognostic (1.37e-2)" "unprognostic (1.14e-1)" "unprognostic (3.46e-1)" "unprognostic (1.70e-2)" "unprognostic (9.08e-3)" "unprognostic (2.48e-1)" "unprognostic (9.06e-2)" "unprognostic (5.56e-3)" "unprognostic (3.10e-2)" "unprognostic (3.04e-1)" "unprognostic (1.77e-1)" "unprognostic (3.97e-2)" "unprognostic (3.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.09e-1)" 24.8 13.1 22.0 24.6 31.3 19.4 28.7 12.1 27.5 18.1 29.0 29.8 18.8 21.2 20.6 25.2 29.8 15.0 20.4 31.0 22.6 17.4 16.0 20.3 24.6 27.4 33.5 16.1 13.9 27.9 10.8 14.8 25.9 25.5 16.1 15.9 16.9 20.9 15.5 32.0 30.6 21.8 23.4 29.2 30.0 21.4 41.3 30.0 9.2 19.9 19.0 27.9 22.8 27.4 21.6 18.0 16.3 17.5 2.9 8.2 9.8 3.5 2.2 4.7 7.0 5.4 6.1 6.2 2.6 2.1 2.3 2.8 2.3 4.0 7.5 6.4 2.7 2.5 5.9 4.9 1.7 17.9 6.8 5.1 1.7 6.4 2.8 1.8 6.7 4.5 14.8 1.7 3.1 6.7 4.7 25.2 1.9 2.1 2.6 6.5 2.8 5.1 5.3 3.2 70.3 4.4 1.5 8.1 3.2 2.2 0.9 7.7 4.7 2.3 9.1 2.1 2.8 2.1 1.6 35.8 25.2 10.4 0.8 5.0 4.7 16.3 17.5 6.9 5.0 14.0 3.5 21.6 3.9 5.1 18.0 17.5 3.6 5.1 12.0 2.9 12.6 15.4 8.2 9.8 22.0 31.3 12.1 27.5 22.6 17.4 33.5 16.1 25.5 30.0 DYRK4 ENSG00000010219 "Dual specificity tyrosine phosphorylation regulated kinase 4" Q9NR20 12 4562204-4615302 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "testis: 85.9" "Cell line enhanced" "Detected in many" "HHSteC: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028065, HPA056073" Enhanced Enhanced Vesicles Vesicles "HPA028065: AB_10601212, HPA056073: AB_2683028" "unprognostic (2.50e-1)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (3.56e-3)" "unprognostic (2.62e-1)" "unprognostic (4.07e-3)" "unprognostic (2.03e-2)" "unprognostic (4.69e-2)" "unprognostic (1.29e-1)" "unprognostic (7.13e-2)" "unprognostic (1.22e-2)" "unprognostic (2.46e-1)" "prognostic unfavourable (6.52e-6)" "unprognostic (1.86e-1)" "unprognostic (9.71e-2)" "unprognostic (1.04e-1)" "unprognostic (3.98e-2)" 1.6 2.1 2.3 2.1 1.8 1.6 2.8 1.9 2.3 2.6 2.1 2.2 2.3 1.7 2.5 9.1 1.6 2.0 1.7 1.7 1.8 1.8 1.9 2.0 2.2 2.5 1.9 2.5 2.2 2.3 2.9 2.7 2.9 2.3 2.3 2.7 2.4 2.3 3.4 1.6 1.9 2.4 2.1 2.7 4.3 1.7 85.9 2.1 1.6 4.3 1.6 2.0 2.4 1.6 7.6 2.7 1.3 5.2 1.1 1.6 1.6 1.9 3.0 3.9 4.2 5.9 7.2 4.6 2.3 4.7 5.3 5.8 0.6 3.1 5.8 0.3 6.6 4.0 2.9 4.3 4.2 4.4 6.6 4.0 0.8 3.3 16.6 3.5 3.2 4.9 9.3 3.7 12.3 7.5 1.6 6.6 4.8 4.0 3.2 8.6 5.2 1.8 0.7 2.8 2.5 6.5 1.9 0.0 1.5 0.4 2.3 3.3 1.8 3.1 0.5 6.3 4.9 0.6 2.9 1.9 2.3 3.4 3.3 5.4 3.2 0.6 2.8 1.3 1.0 2.2 1.1 7.6 1.5 1.6 2.7 5.8 1.6 1.6 0.1 1.1 5.2 1.4 1.1 1.6 2.3 1.8 1.9 2.3 1.8 1.8 1.9 2.5 2.3 2.1 DZIP3 "hRUL138, PPP1R66" ENSG00000198919 "DAZ interacting zinc finger protein 3" Q86Y13 3 108589682-108694846 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 57.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035066, HPA049232" Approved Approved Vesicles Vesicles "HPA035066: AB_10601549, HPA049232: " "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (7.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (2.37e-2)" "unprognostic (3.33e-1)" "unprognostic (5.16e-2)" "unprognostic (2.74e-1)" "unprognostic (3.76e-2)" "unprognostic (2.59e-3)" "unprognostic (5.38e-2)" "prognostic favourable (3.65e-4)" "unprognostic (6.06e-2)" "unprognostic (2.78e-2)" "unprognostic (5.51e-3)" "unprognostic (3.81e-2)" 4.6 9.3 14.1 4.5 25.7 3.1 5.0 14.5 23.7 5.2 4.4 5.8 2.1 2.8 7.4 9.7 3.8 17.4 5.4 10.8 13.2 18.5 10.5 3.9 6.0 8.4 10.3 16.0 10.3 4.9 10.3 57.4 4.5 20.3 9.2 4.5 4.0 3.3 7.0 10.1 3.4 3.6 7.9 9.2 7.0 6.0 29.9 8.0 10.4 12.0 2.8 7.0 5.0 3.5 6.8 1.8 5.2 1.6 11.7 6.5 1.8 6.6 6.0 17.2 10.3 7.6 8.0 5.9 4.2 8.3 7.0 9.5 8.4 4.5 12.0 9.0 4.4 2.5 9.8 3.6 14.8 4.4 4.2 5.5 2.3 5.8 4.6 2.1 3.1 8.3 1.9 6.5 8.1 4.3 5.2 5.9 13.2 6.0 5.3 2.3 10.5 4.3 6.9 14.2 1.1 5.8 3.2 11.7 11.2 7.0 0.7 7.5 10.3 1.9 5.0 6.3 9.6 1.2 3.6 6.8 3.9 23.3 4.8 1.7 7.6 5.2 0.7 1.4 5.0 1.0 6.0 6.8 5.1 6.1 0.6 6.0 4.5 6.0 0.1 11.7 1.6 1.8 6.5 1.8 14.1 25.7 14.5 23.7 13.2 18.5 10.3 16.0 20.3 8.0 E2F5 ENSG00000133740 "E2F transcription factor 5" Q15329 8 85177225-85217158 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 27.0;Daudi: 53.1;U-698: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 13.3;naive B-cell: 7.6" "Lineage enriched" "Detected in many" 9 "B-cells: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055723, HPA065441" Enhanced Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA055723: , HPA065441: " "unprognostic (8.73e-2)" "unprognostic (3.45e-1)" "unprognostic (3.15e-2)" "unprognostic (1.02e-3)" "unprognostic (6.73e-3)" "unprognostic (1.62e-1)" "unprognostic (3.36e-5)" "unprognostic (1.23e-1)" "unprognostic (9.53e-2)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.87e-2)" "prognostic unfavourable (1.89e-6)" "unprognostic (2.88e-2)" "unprognostic (3.25e-2)" "unprognostic (3.64e-1)" "unprognostic (2.95e-3)" 3.0 9.0 6.4 22.2 8.1 1.5 5.9 2.6 5.3 5.0 5.9 4.0 3.4 4.6 5.4 7.4 4.7 7.2 6.6 3.2 5.6 5.6 9.0 4.5 5.1 22.4 4.6 2.7 8.3 14.6 12.7 10.6 4.3 3.8 5.1 7.2 3.4 5.7 5.9 1.1 1.7 7.3 3.8 4.5 9.9 5.1 10.5 3.2 13.6 10.2 3.0 26.0 6.0 7.6 13.3 1.4 0.0 0.0 1.1 0.6 0.6 4.8 5.2 27.0 10.0 0.5 0.7 8.7 0.9 2.1 0.8 2.3 3.1 5.7 53.1 3.8 1.1 1.0 15.7 1.3 1.0 5.5 7.2 5.3 2.9 7.3 4.3 1.6 0.0 1.0 2.1 1.0 3.8 0.8 11.2 0.4 1.4 3.1 5.4 3.5 8.7 4.6 4.3 1.1 5.7 8.7 3.4 3.3 10.4 0.6 1.8 8.0 11.3 1.7 0.0 1.3 1.0 1.5 3.5 10.0 6.7 25.4 1.5 1.3 2.6 0.0 0.0 0.0 0.1 0.0 0.0 13.3 0.0 0.0 0.1 7.6 0.2 0.4 0.0 1.1 0.0 1.4 0.6 0.6 6.4 8.1 2.6 4.5 5.6 5.6 4.6 2.7 3.8 3.2 EAF1 ENSG00000144597 "ELL associated factor 1" Q96JC9 3 15427355-15450635 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.7" "Cell line enhanced" "Detected in all" "BEWO: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059516, HPA060569, HPA069538" Supported Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytokinetic bridge" "Nucleoplasm, Nuclear bodies, Vesicles" "Cytokinetic bridge" "HPA059516: , HPA060569: , HPA069538: " "unprognostic (1.26e-1)" "unprognostic (1.61e-2)" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-3)" "prognostic unfavourable (6.87e-4)" "unprognostic (3.22e-1)" "unprognostic (3.16e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (2.06e-2)" "unprognostic (5.17e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" 15.6 11.5 13.9 12.2 20.0 55.7 11.4 18.1 19.1 9.8 11.7 13.3 11.5 12.7 10.1 9.9 13.1 9.4 12.9 7.6 14.3 18.1 13.7 22.2 12.0 12.4 14.7 13.0 8.0 11.8 13.0 17.6 18.9 18.6 12.7 12.4 9.6 9.5 15.4 8.6 15.9 12.5 10.4 13.7 15.1 13.7 9.7 10.1 14.0 13.0 9.1 12.9 11.9 9.0 5.1 9.9 7.1 7.4 8.1 15.4 4.3 3.9 6.4 6.8 7.0 4.0 3.4 55.0 5.8 4.1 6.7 6.5 8.8 4.4 11.0 3.7 4.2 3.3 8.9 5.1 7.7 9.0 6.4 9.5 5.8 8.0 9.0 8.9 7.7 4.5 9.1 9.6 6.5 6.6 10.1 8.2 5.5 8.1 8.8 5.0 12.2 6.7 8.1 5.6 6.1 5.8 6.9 7.0 12.3 7.1 6.6 6.7 9.9 7.1 6.4 7.0 5.2 6.2 8.3 10.8 21.6 11.6 6.8 10.7 8.3 7.1 7.4 4.5 12.0 5.4 15.4 5.1 10.1 9.3 4.3 3.8 6.0 9.8 6.7 8.1 6.5 9.9 10.5 4.3 13.9 20.0 18.1 19.1 14.3 18.1 14.7 13.0 18.6 10.1 EBF1 "EBF, OLF1" ENSG00000164330 "Early B cell factor 1" Q9UH73 5 158695916-159099761 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 19.0;HSkMC: 14.8;REH: 39.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 23.6" "Group enriched" "Detected in some" 62 "memory B-cell: 11.8;naive B-cell: 10.4" "Lineage enriched" "Detected in single" 66 "B-cells: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061169 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA061169: " "unprognostic (7.86e-2)" "unprognostic (3.08e-2)" "unprognostic (7.29e-2)" "unprognostic (4.70e-2)" "unprognostic (2.63e-1)" "unprognostic (1.39e-2)" "unprognostic (1.78e-1)" "unprognostic (1.60e-1)" "unprognostic (5.75e-2)" "unprognostic (1.60e-1)" "unprognostic (4.58e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (9.62e-7)" "prognostic unfavourable (7.80e-4)" "unprognostic (5.75e-2)" "unprognostic (5.81e-2)" "unprognostic (4.37e-3)" 33.7 3.3 1.9 9.7 2.5 3.1 25.0 23.6 2.0 15.9 5.8 1.1 9.0 1.2 19.7 13.0 5.0 8.5 9.4 15.5 2.0 2.4 3.3 0.9 5.2 12.7 3.2 1.2 7.4 3.7 1.8 2.6 10.7 4.7 8.5 3.4 10.4 4.7 10.8 15.5 4.8 4.5 25.7 6.6 5.4 3.4 8.4 1.0 0.1 6.8 13.2 9.1 11.7 12.5 11.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 6.1 0.0 19.0 8.2 0.0 0.0 0.0 0.2 0.5 0.0 0.0 5.4 0.0 2.2 0.0 0.2 0.0 0.1 1.2 0.0 0.0 1.6 0.0 0.3 0.0 0.0 14.8 0.0 5.8 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 39.7 0.2 0.0 0.0 0.0 3.2 0.8 0.3 0.0 0.0 0.0 0.0 0.0 7.3 0.8 8.3 0.1 0.0 0.0 5.5 4.8 0.4 6.6 0.1 0.0 0.1 0.0 0.0 0.0 11.8 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 2.5 23.6 1.6 2.0 2.4 3.2 1.2 4.7 1.0 EBF3 "COE3, DKFZp667B0210" ENSG00000108001 "Early B cell factor 3" Q9H4W6 10 129835283-129963841 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 25.8;lymphoid tissue: 29.9" "Cell line enhanced" "Detected in some" "ASC diff: 9.9;HAP1: 11.6;LHCN-M2: 18.5;NB-4: 23.3;RH-30: 10.1;SCLC-21H: 23.9;THP-1: 9.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "hypothalamus: 2.5;midbrain: 5.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061169 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA061169: " "unprognostic (2.96e-1)" "unprognostic (3.78e-2)" "unprognostic (8.63e-3)" "unprognostic (2.60e-2)" "unprognostic (7.68e-2)" "unprognostic (4.50e-3)" "unprognostic (8.53e-6)" "unprognostic (2.93e-2)" "unprognostic (3.99e-2)" "unprognostic (1.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.63e-1)" "unprognostic (4.16e-3)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (9.49e-2)" "unprognostic (4.58e-2)" 20.0 0.9 0.3 3.4 0.4 0.1 25.8 0.7 0.5 7.3 3.6 0.2 2.5 0.2 5.4 4.9 4.3 3.8 4.3 10.5 0.3 2.5 0.6 0.4 1.0 29.9 5.0 0.3 1.0 1.2 3.6 0.9 3.8 4.8 4.6 0.8 2.0 3.6 2.2 10.9 2.8 1.0 6.3 9.3 0.2 1.6 4.6 0.1 0.5 6.7 6.3 2.4 4.7 16.9 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 9.9 7.6 0.1 0.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 11.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 2.3 0.0 0.0 0.0 0.0 18.5 0.1 0.0 23.3 0.1 0.0 0.3 10.1 0.0 0.0 0.1 23.9 0.3 0.0 0.0 0.0 0.0 9.8 0.0 0.0 1.2 6.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.5 0.3 2.5 5.0 0.3 4.8 0.1 ECHDC1 dJ351K20.2 ENSG00000093144 "Ethylmalonyl-CoA decarboxylase 1" Q9NTX5 6 127288710-127343609 "Enzymes, Plasma proteins, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035445, HPA035446" Uncertain Approved Vesicles Vesicles "HPA035445: AB_10669860, HPA035446: " "unprognostic (9.57e-2)" "unprognostic (1.63e-2)" "unprognostic (2.46e-3)" "unprognostic (1.34e-1)" "unprognostic (4.09e-1)" "unprognostic (3.68e-2)" "unprognostic (5.03e-3)" "unprognostic (4.89e-3)" "unprognostic (4.97e-2)" "unprognostic (1.76e-1)" "unprognostic (3.99e-1)" "unprognostic (9.97e-2)" "unprognostic (8.21e-3)" "unprognostic (6.83e-2)" "unprognostic (2.86e-1)" "unprognostic (1.39e-1)" "unprognostic (1.40e-2)" 40.1 16.8 20.8 16.5 23.1 6.8 21.9 16.6 21.4 18.6 27.2 12.0 12.8 21.9 13.7 15.5 20.6 11.4 16.1 20.0 19.4 18.0 44.4 44.3 26.8 17.8 27.3 16.5 11.9 14.2 14.5 16.1 17.0 23.1 19.8 26.3 15.1 22.2 14.5 22.0 13.3 25.8 30.1 27.3 14.1 18.1 8.3 20.9 20.7 42.4 14.2 19.4 24.2 22.6 13.2 29.6 13.4 31.2 6.4 11.6 16.9 15.8 12.6 18.1 16.7 27.0 25.7 15.4 25.8 31.5 22.3 28.5 21.9 12.1 24.0 22.3 24.5 13.1 0.0 19.4 28.3 14.2 12.1 31.9 17.0 34.8 24.1 42.6 18.0 28.9 23.4 20.8 17.7 20.1 39.5 14.6 29.7 14.9 28.1 19.8 15.0 15.7 13.3 22.4 19.6 40.6 19.6 20.9 20.3 14.5 0.5 35.5 0.5 49.9 20.8 13.7 22.0 34.6 28.8 18.7 37.6 31.6 25.1 37.4 32.2 6.2 31.2 10.0 11.0 25.6 11.6 12.8 9.5 10.8 29.6 13.2 11.6 11.6 13.4 6.4 17.9 22.6 9.6 16.9 20.8 23.1 16.6 21.4 19.4 18.0 27.3 16.5 23.1 20.9 ECSCR "ARIA, ECSM2" ENSG00000249751 "Endothelial cell surface expressed chemotaxis and apoptosis regulator" Q19T08 5 139448556-139462743 "Predicted membrane proteins" "Angiogenesis, Apoptosis, Chemotaxis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 121 "EFO-21: 48.5;HUVEC TERT2: 122.6;TIME: 90.6" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.7" "Lineage enhanced" "Detected in single" "T-cells: 2.7" HPA063337 Supported "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA063337: " "unprognostic (5.91e-2)" "unprognostic (2.37e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.69e-2)" "unprognostic (2.15e-3)" "unprognostic (3.95e-2)" "unprognostic (1.12e-1)" "unprognostic (2.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.78e-2)" "unprognostic (1.91e-1)" "unprognostic (1.83e-3)" "unprognostic (2.41e-3)" "unprognostic (1.36e-1)" "unprognostic (9.90e-2)" "unprognostic (2.91e-1)" 14.8 1.9 0.8 5.7 1.6 0.0 17.5 0.4 0.7 13.7 6.1 1.0 5.1 1.9 14.3 14.4 11.0 7.9 8.6 26.9 0.8 5.6 4.3 23.4 26.9 1.4 0.7 7.9 1.0 1.3 0.4 19.6 2.9 9.3 4.3 6.8 3.6 5.5 13.4 2.9 3.4 14.3 4.3 12.1 1.1 6.8 1.1 0.1 11.5 14.5 4.6 13.2 13.1 0.6 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 122.6 0.0 0.0 0.4 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 90.6 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.6 1.1 1.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.6 0.0 EDA "ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED" ENSG00000158813 "Ectodysplasin A" Q92838 X 69616067-70039469 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 5.6;Hep G2: 18.2;Karpas-707: 5.1;RPMI-8226: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.0" "Group enriched" "Detected in many" 6 "monocytes: 3.0;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037972, HPA037973" Supported "Vesicles,Lipid droplets" "Intracellular and membrane" Vesicles "Lipid droplets" "HPA037972: , HPA037973: " "unprognostic (3.76e-2)" "unprognostic (8.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.59e-3)" "unprognostic (7.85e-2)" "unprognostic (1.25e-4)" "unprognostic (4.33e-4)" "unprognostic (5.03e-2)" "unprognostic (1.53e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-2)" "unprognostic (2.01e-1)" "prognostic favourable (1.04e-9)" "unprognostic (8.63e-4)" "unprognostic (7.64e-2)" "unprognostic (9.85e-2)" "unprognostic (2.79e-1)" 6.8 11.7 2.2 3.1 3.0 0.3 3.9 0.9 2.4 10.3 3.4 3.9 7.4 0.9 6.3 5.7 5.0 4.4 7.0 13.3 2.6 2.1 6.9 3.1 4.3 5.8 4.3 2.0 7.9 6.3 18.4 1.9 2.7 2.9 8.3 1.7 5.0 5.4 10.4 3.3 5.4 1.6 5.4 4.6 2.0 4.7 2.7 2.3 0.8 8.9 5.0 1.2 4.4 8.1 0.0 0.0 0.0 3.0 0.6 4.0 0.3 0.0 0.6 0.3 2.9 0.6 0.1 0.2 0.0 0.1 0.0 0.0 1.4 0.1 0.3 5.6 0.2 0.4 4.0 1.5 0.0 0.0 4.6 0.0 0.1 18.2 1.1 0.0 1.2 2.4 1.4 0.0 1.0 0.5 0.0 5.1 0.0 1.2 0.0 0.0 3.0 0.4 0.0 1.3 6.1 0.1 0.0 1.6 0.0 0.1 0.4 0.1 0.3 0.1 0.5 1.9 2.4 2.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 3.0 4.0 0.0 1.8 0.9 0.0 0.0 1.1 0.2 0.0 0.6 2.0 0.0 0.0 0.3 2.2 3.0 0.9 2.4 2.6 2.1 4.3 2.0 2.9 2.3 EEA1 ZFYVE2 ENSG00000102189 "Early endosome antigen 1" Q15075 12 92770637-92929331 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005861, CAB018782, HPA038158, HPA038159" Supported Supported Vesicles Vesicles "CAB005861: AB_2262056, CAB018782: AB_2277714, HPA038158: AB_10966710, HPA038159: AB_10962356" "unprognostic (5.38e-2)" "unprognostic (4.60e-1)" "unprognostic (2.00e-2)" "unprognostic (5.62e-2)" "unprognostic (1.62e-1)" "unprognostic (1.81e-2)" "unprognostic (6.75e-2)" "unprognostic (6.87e-2)" "unprognostic (1.31e-1)" "unprognostic (5.00e-2)" "unprognostic (2.81e-2)" "unprognostic (1.07e-1)" "unprognostic (2.68e-3)" "unprognostic (5.86e-2)" "unprognostic (2.85e-1)" "unprognostic (3.89e-2)" "unprognostic (1.65e-1)" 26.4 11.1 10.9 14.9 13.5 5.3 13.7 20.5 12.4 18.4 12.2 7.7 8.3 10.2 14.4 9.5 20.9 11.0 11.4 13.4 12.0 9.8 10.6 14.7 12.9 8.0 12.5 11.8 17.6 9.3 16.9 14.3 23.6 16.7 14.2 11.0 7.3 13.7 12.3 23.1 16.7 10.3 15.7 14.3 15.3 10.7 7.8 12.5 6.9 12.6 15.2 8.2 19.2 17.9 2.2 2.0 2.2 3.3 0.7 3.4 0.9 8.9 3.0 4.4 3.1 19.2 19.4 10.4 17.7 10.2 9.4 6.7 10.3 2.4 9.1 3.2 12.4 10.9 9.9 5.0 14.6 6.2 4.9 9.7 3.5 9.4 10.7 6.9 4.6 12.6 7.4 10.0 15.2 16.5 7.3 3.1 9.7 4.1 4.9 4.7 4.5 6.8 5.6 11.4 6.1 4.9 12.4 3.8 2.9 13.0 8.6 7.9 11.3 6.1 21.0 13.3 5.1 10.6 6.7 3.4 5.8 6.4 4.9 6.1 7.2 0.1 2.5 0.7 1.7 1.8 1.8 2.2 2.0 1.8 2.0 2.0 3.4 2.4 2.2 0.7 3.3 2.0 0.7 0.9 10.9 13.5 20.5 12.4 12.0 9.8 12.5 11.8 16.7 12.5 EEF2KMT "EFM3, FAM86A, MGC19636, SB153" ENSG00000118894 "Eukaryotic elongation factor 2 lysine methyltransferase" Q96G04 16 5084304-5097808 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RPMI-8226: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA041610 Approved Uncertain Vesicles Vesicles "HPA041610: " "unprognostic (4.50e-2)" "unprognostic (1.53e-1)" "unprognostic (8.89e-3)" "unprognostic (3.95e-2)" "unprognostic (2.01e-2)" "unprognostic (7.70e-2)" "prognostic unfavourable (8.85e-4)" "unprognostic (3.53e-1)" "unprognostic (1.37e-1)" "unprognostic (4.03e-2)" "unprognostic (9.73e-2)" "unprognostic (1.53e-1)" "unprognostic (5.24e-3)" "unprognostic (1.82e-1)" "unprognostic (2.07e-1)" "unprognostic (2.75e-2)" "prognostic unfavourable (2.35e-4)" 4.8 6.1 4.8 4.3 15.5 0.8 11.6 4.4 7.5 5.6 4.6 4.4 2.2 6.7 6.5 4.4 5.4 5.7 3.6 5.7 5.8 4.5 4.9 8.0 8.6 3.9 4.2 4.3 5.8 13.9 10.4 5.0 2.9 7.5 4.4 4.8 2.6 5.9 6.2 7.0 4.5 3.5 7.1 3.8 4.7 4.9 27.0 4.8 3.8 6.1 5.2 4.3 5.3 3.8 9.4 7.0 6.5 11.0 7.0 13.7 5.1 2.4 6.2 3.9 6.6 4.8 3.9 5.0 4.7 3.3 5.9 3.7 4.7 6.5 6.7 2.9 5.9 4.4 7.2 7.2 4.3 7.5 5.2 2.9 3.4 7.8 5.9 7.0 4.6 4.3 5.4 6.8 12.1 5.8 5.2 6.4 4.9 16.4 2.7 3.9 6.4 3.2 6.7 4.4 41.3 6.4 3.0 4.6 3.6 6.1 8.5 3.4 5.3 2.4 2.6 8.1 5.1 23.9 4.7 4.3 4.8 4.7 2.3 4.8 7.0 6.5 5.6 0.4 7.6 10.1 12.5 9.4 7.9 8.8 7.0 7.2 5.6 9.9 0.8 7.0 11.0 1.9 13.7 5.1 4.8 15.5 4.4 7.5 5.8 4.5 4.2 4.3 7.5 4.8 EEPD1 KIAA1706 ENSG00000122547 "Endonuclease/exonuclease/phosphatase family domain containing 1" Q7L9B9 7 36153149-36301543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 13.3;HDLM-2: 14.0;PC-3: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.2;neutrophil: 21.9" "Group enriched" "Detected in many" 6 "granulocytes: 23.2;T-cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053668 Approved "Nuclear speckles,Vesicles,Plasma membrane" "Nuclear speckles" "Vesicles, Plasma membrane" "HPA053668: " "unprognostic (1.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.54e-3)" "unprognostic (5.21e-3)" "unprognostic (1.14e-1)" "unprognostic (4.76e-1)" "unprognostic (1.19e-2)" "unprognostic (3.75e-2)" "unprognostic (7.89e-2)" "unprognostic (8.77e-2)" "unprognostic (7.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (6.52e-2)" "unprognostic (2.23e-2)" "unprognostic (4.59e-2)" 20.3 5.1 4.9 6.4 8.6 8.1 22.5 3.3 19.3 9.6 15.2 11.8 6.5 11.0 12.5 5.6 6.5 5.4 18.4 6.2 6.4 5.4 3.7 15.2 8.7 4.6 13.3 3.5 6.9 8.1 2.4 3.3 4.6 5.6 8.2 4.5 5.7 3.8 4.3 39.7 10.2 23.6 9.1 10.2 7.5 10.5 3.4 7.7 11.5 2.2 4.4 3.6 6.1 10.9 0.1 1.5 23.2 2.8 1.7 11.5 2.0 1.6 4.6 1.4 4.5 13.3 2.9 0.1 1.1 5.7 0.9 1.6 0.9 3.5 4.5 1.5 1.7 1.9 1.9 2.2 0.8 14.0 3.2 0.6 0.4 8.4 1.2 0.7 4.4 5.9 1.4 0.5 0.4 0.1 5.5 0.5 1.0 1.8 4.6 11.2 6.5 17.8 1.2 1.6 1.0 2.8 3.7 3.5 2.5 0.4 0.6 1.7 1.4 5.4 0.4 1.8 5.3 1.2 1.3 3.5 3.8 0.0 4.4 3.0 1.1 10.0 2.8 23.2 1.5 1.7 2.6 0.1 11.5 3.3 1.5 0.0 2.6 0.7 21.9 1.7 0.7 1.3 5.1 2.0 4.9 8.6 3.3 7.5 6.4 5.4 13.3 3.5 5.6 7.7 EFNA5 "AF1, EPLG7, LERK7" ENSG00000184349 "Ephrin A5" P52803 5 107376889-107670895 "Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 19.3;RPTEC TERT1: 29.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.5;memory CD8 T-cell: 3.0" "Group enriched" "Detected in many" 7 "NK-cells: 2.5;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013282, HPA054047" Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "CAB013282: AB_2533353, HPA054047: " "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.15e-3)" "unprognostic (3.98e-3)" "unprognostic (2.74e-2)" "unprognostic (8.91e-4)" "unprognostic (9.46e-3)" "unprognostic (4.92e-1)" "unprognostic (2.28e-3)" "unprognostic (1.26e-3)" "unprognostic (1.47e-1)" "prognostic unfavourable (1.92e-7)" "prognostic unfavourable (3.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (1.27e-1)" 5.3 1.9 1.9 2.3 6.0 0.0 7.3 10.1 22.2 15.0 4.2 0.9 2.5 1.2 1.6 2.8 9.1 3.9 3.6 8.3 2.5 5.3 5.3 0.6 7.0 3.2 2.1 8.9 5.5 0.7 6.9 18.5 3.1 4.8 6.2 3.6 3.3 11.2 6.8 1.1 13.3 2.3 2.8 3.5 6.3 3.1 1.8 1.1 0.1 2.5 6.0 3.3 4.0 8.1 0.0 0.0 0.4 0.1 2.5 3.5 0.4 6.2 11.1 19.3 0.0 9.3 8.1 1.8 0.2 3.3 2.4 6.0 0.1 7.0 0.0 10.6 1.2 6.5 10.7 9.2 2.3 0.0 6.5 0.0 6.1 0.0 1.8 0.3 0.0 8.6 8.8 0.0 7.8 7.6 0.0 0.0 4.6 6.0 0.0 0.0 2.3 0.9 0.0 8.7 0.2 29.4 8.1 2.9 7.7 3.0 4.5 1.9 1.9 1.2 0.1 14.6 2.6 8.9 3.5 0.5 0.0 4.0 6.4 0.4 15.7 0.2 0.0 0.1 3.5 0.0 0.0 0.0 0.8 3.0 0.0 0.0 0.3 1.4 0.4 2.5 0.1 0.0 0.1 0.4 1.9 6.0 10.1 22.2 2.5 5.3 2.1 8.9 4.8 1.1 EFTUD2 "SNRNP116, Snrp116, Snu114, U5-116KD" ENSG00000108883 "Elongation factor Tu GTP binding domain containing 2" Q15029 17 44849943-44899662 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022021 Supported Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA022021: AB_1848032" "unprognostic (4.28e-2)" "unprognostic (4.12e-2)" "unprognostic (1.98e-3)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (4.98e-2)" "prognostic unfavourable (2.71e-6)" "unprognostic (6.94e-2)" "unprognostic (4.52e-1)" "unprognostic (2.37e-1)" "unprognostic (4.11e-3)" "unprognostic (5.19e-2)" "unprognostic (5.48e-3)" "unprognostic (1.62e-2)" "unprognostic (5.30e-2)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" 22.5 26.5 16.0 23.1 27.0 25.0 17.7 13.4 34.9 14.8 20.3 22.0 10.4 16.6 22.1 15.4 27.0 20.2 12.7 22.6 16.6 16.7 21.5 27.7 17.3 25.2 15.8 19.8 15.3 20.0 21.2 15.3 27.5 22.6 14.9 23.2 19.1 27.2 15.7 49.6 22.0 20.3 18.5 15.7 25.9 18.5 30.2 13.1 36.9 18.6 17.9 34.9 18.6 16.0 12.8 31.8 31.6 31.5 15.6 16.9 23.3 22.8 45.8 22.3 36.2 17.1 17.0 26.3 18.2 24.4 46.0 40.0 35.2 19.6 39.6 21.5 22.9 26.2 48.5 31.8 53.8 39.7 40.2 39.2 28.6 37.4 18.9 46.2 29.2 18.4 18.2 42.5 23.2 39.8 48.3 15.4 26.1 22.8 46.2 30.5 23.0 38.3 32.6 45.4 34.3 26.2 25.7 36.8 22.0 17.9 13.3 18.8 35.2 29.2 24.1 34.6 26.7 20.9 45.8 16.3 20.5 39.8 27.8 25.7 35.2 12.3 31.5 31.6 15.2 31.0 16.9 12.8 13.5 14.6 31.8 12.5 12.0 13.3 5.1 15.6 29.7 13.7 13.2 23.3 16.0 27.0 13.4 34.9 16.6 16.7 15.8 19.8 22.6 13.1 EGFL8 "C6orf8, NG3" ENSG00000241404 "EGF like domain multiple 8" Q99944 6 32164583-32168281 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;Hep G2: 3.6;NB-4: 3.0;SK-MEL-30: 3.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061173 Uncertain Approved "Nuclear speckles,Vesicles" "Secreted - unknown location" Vesicles "Nuclear speckles" "HPA061173: " "unprognostic (7.13e-2)" "unprognostic (1.86e-1)" "unprognostic (6.79e-3)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (7.60e-4)" "unprognostic (3.42e-2)" "unprognostic (2.49e-1)" "unprognostic (6.42e-3)" "unprognostic (1.97e-1)" "unprognostic (7.60e-3)" "unprognostic (8.11e-3)" "unprognostic (1.07e-4)" "unprognostic (1.11e-1)" "unprognostic (6.79e-2)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" 4.5 6.3 7.3 2.6 7.6 4.5 5.0 6.3 9.4 7.1 6.7 8.4 8.7 4.7 6.4 5.5 4.3 4.8 8.4 4.8 8.2 4.4 4.3 1.8 4.3 2.0 25.7 3.9 14.4 2.9 1.3 2.9 9.2 14.1 6.0 2.7 14.7 3.9 5.3 3.8 12.9 5.8 3.0 11.9 3.5 3.9 2.3 7.0 0.2 3.1 8.3 2.0 5.2 6.8 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.6 0.3 1.3 3.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.2 0.0 2.0 1.3 0.4 0.0 0.0 1.9 0.0 0.9 3.6 1.1 0.0 0.7 0.0 0.3 0.3 0.0 0.7 0.3 0.0 0.0 1.7 0.9 3.0 0.0 0.0 1.1 0.1 0.0 0.2 0.6 0.5 1.2 0.0 0.1 3.7 1.4 2.2 0.0 0.8 1.7 0.0 0.1 0.0 0.1 0.1 0.1 1.1 1.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.3 7.6 6.3 9.4 8.2 4.4 25.7 3.9 14.1 7.0 EGR3 PILOT ENSG00000179388 "Early growth response 3" Q06889 8 22687659-22693302 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.5;HMC-1: 7.3;MCF7: 23.9;SK-MEL-30: 16.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 11.5;basal ganglia: 33.6;cerebral cortex: 35.0;hippocampal formation: 13.7;olfactory region: 12.8" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 10 "amygdala: 26.1;basal ganglia: 40.1;cerebral cortex: 47.9;hippocampal formation: 32.4;olfactory region: 18.2" "Group enriched" "Detected in many" 9 "amygdala: 29.0;basal ganglia: 68.2;cerebral cortex: 57.2;hippocampal formation: 56.6;olfactory region: 75.0" "HPA006206, CAB009373" Uncertain Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB009373: AB_2097202, HPA006206: AB_10602491" "prognostic favourable (1.83e-4)" "unprognostic (1.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "unprognostic (4.07e-2)" "unprognostic (1.00e-1)" "unprognostic (6.44e-2)" "prognostic favourable (4.78e-4)" "unprognostic (3.48e-2)" "unprognostic (5.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.11e-2)" "unprognostic (4.72e-2)" "unprognostic (2.35e-2)" "unprognostic (1.07e-2)" 20.7 17.7 11.5 12.3 33.6 5.6 7.1 0.8 35.0 7.4 3.3 11.1 0.2 0.9 3.8 1.0 4.0 14.6 20.6 8.5 13.7 2.0 3.0 2.0 4.1 7.3 1.9 12.8 10.6 2.9 12.8 5.0 1.2 3.6 10.3 2.2 2.6 2.3 4.0 1.6 28.4 3.6 8.3 1.6 2.8 5.3 4.1 2.1 5.5 5.8 1.3 5.8 12.3 2.5 0.8 0.0 2.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 1.4 4.5 0.1 0.4 0.5 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.3 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.3 0.4 0.2 0.2 0.0 0.1 0.2 0.1 0.0 23.9 0.0 0.2 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.4 0.0 16.0 1.1 0.0 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.0 0.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 11.5 33.6 0.8 35.0 13.7 2.0 1.9 12.8 3.6 2.1 EIF1AD "haponin, MGC11102" ENSG00000175376 "Eukaryotic translation initiation factor 1A domain containing" Q8N9N8 11 65996545-66002176 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054991, HPA058735" Uncertain Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA054991: , HPA058735: " "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (3.03e-1)" "prognostic unfavourable (3.59e-5)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavourable (8.63e-5)" "unprognostic (1.86e-2)" "unprognostic (1.17e-1)" "unprognostic (8.76e-2)" "unprognostic (1.36e-3)" "unprognostic (2.31e-1)" "unprognostic (1.59e-3)" "unprognostic (7.63e-3)" "unprognostic (1.40e-1)" "unprognostic (1.28e-3)" "unprognostic (3.96e-1)" 16.8 18.4 15.5 17.9 18.8 38.7 16.3 21.8 23.7 16.0 15.3 15.4 19.9 15.0 18.3 16.4 22.1 16.0 15.3 15.6 15.1 16.1 15.2 18.5 16.2 21.1 18.8 11.1 21.5 23.7 22.0 24.0 25.5 17.7 15.8 14.8 17.5 17.8 16.2 27.1 23.4 17.6 14.9 18.2 22.2 16.6 22.3 19.9 21.2 16.0 18.1 27.0 15.5 23.8 14.8 16.1 28.2 15.5 11.6 14.7 9.4 22.3 19.5 16.4 16.4 13.2 13.8 15.5 16.4 16.2 21.0 17.9 18.8 21.5 17.0 28.8 18.8 15.5 19.5 21.9 19.5 15.7 10.2 24.1 22.4 20.2 16.5 21.9 18.9 11.5 19.2 31.5 21.5 14.0 35.8 24.8 29.8 29.8 20.3 24.4 12.4 21.4 22.4 16.7 33.3 11.8 14.0 12.1 14.9 18.5 25.3 19.1 24.6 13.7 16.7 27.4 18.6 22.4 15.8 30.4 35.8 35.7 19.9 15.4 18.2 28.2 15.5 10.0 14.7 12.7 11.3 14.8 12.6 10.7 16.1 14.5 12.0 11.0 10.6 11.6 15.3 9.7 11.3 9.4 15.5 18.8 21.8 23.7 15.1 16.1 18.8 11.1 17.7 19.9 EIF2B3 "EIF-2B, EIF2Bgamma" ENSG00000070785 "Eukaryotic translation initiation factor 2B subunit gamma" Q9NR50 1 44850522-44986722 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024213, HPA024218, HPA024219" Supported Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069" "unprognostic (2.12e-2)" "unprognostic (7.49e-2)" "unprognostic (4.37e-3)" "unprognostic (5.14e-2)" "unprognostic (1.57e-2)" "unprognostic (4.45e-2)" "prognostic unfavourable (1.73e-5)" "unprognostic (4.55e-2)" "unprognostic (1.14e-2)" "unprognostic (7.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.36e-1)" "unprognostic (5.38e-2)" "unprognostic (6.98e-2)" "unprognostic (7.80e-2)" "unprognostic (5.69e-3)" "unprognostic (2.73e-2)" 16.5 18.3 12.9 9.2 14.6 7.1 16.1 22.2 16.5 11.6 10.1 13.1 11.2 6.6 13.1 10.1 11.8 9.6 7.5 22.5 10.7 11.1 11.9 20.7 8.8 9.9 13.7 11.1 12.3 18.5 23.3 26.7 7.3 16.0 10.6 10.6 12.3 17.9 11.9 52.1 10.5 6.6 14.8 12.1 9.8 9.1 13.7 12.3 11.1 9.8 13.7 12.4 12.2 10.9 11.3 21.9 2.3 21.4 14.1 15.4 12.5 13.8 11.3 12.5 10.6 15.3 18.4 15.0 22.4 17.1 23.0 21.8 16.3 8.3 36.2 16.5 16.9 8.2 26.3 19.0 28.2 12.5 24.1 17.9 12.5 15.6 19.5 27.5 10.2 12.7 10.4 25.1 28.7 21.1 41.1 12.6 24.9 9.5 26.4 12.0 17.4 22.5 21.4 20.9 25.8 11.8 6.5 22.6 8.2 22.6 26.0 14.3 10.1 12.8 11.3 15.0 17.9 21.9 29.0 13.1 14.7 27.0 11.6 23.1 17.8 1.0 14.3 2.3 12.2 21.4 14.4 9.5 12.0 13.5 21.9 11.3 15.2 15.4 1.2 14.1 18.5 15.4 9.9 12.5 12.9 14.6 22.2 16.5 10.7 11.1 13.7 11.1 16.0 12.3 EIF4ENIF1 "2610509L04Rik, 4E-T, Clast4, FLJ21601" ENSG00000184708 "Eukaryotic translation initiation factor 4E nuclear import factor 1" Q9NRA8 22 31436977-31496108 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001619, HPA002078" Enhanced Enhanced Vesicles Vesicles "HPA001619: AB_1078727, HPA002078: AB_1078728" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (2.40e-2)" "unprognostic (3.01e-2)" "unprognostic (1.53e-1)" "unprognostic (6.72e-2)" "unprognostic (2.28e-3)" "unprognostic (1.30e-2)" "unprognostic (4.95e-2)" "unprognostic (9.92e-2)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" "prognostic favourable (1.57e-4)" "unprognostic (2.30e-1)" "unprognostic (1.92e-1)" "unprognostic (7.32e-2)" "unprognostic (2.45e-2)" 10.9 10.9 18.8 13.4 18.9 12.6 10.8 19.4 20.8 11.9 15.9 14.4 12.3 11.8 14.9 14.5 12.6 13.3 8.6 13.2 16.3 11.8 11.9 7.6 10.7 12.3 12.5 15.7 16.9 10.9 18.1 12.2 14.3 16.2 12.5 12.6 12.7 11.2 15.2 17.4 13.7 10.3 13.8 11.8 11.4 11.3 43.6 14.8 8.8 13.3 7.7 15.3 14.1 12.9 6.6 6.5 3.1 10.7 1.7 5.7 3.0 13.3 8.2 20.9 11.3 11.8 10.5 8.4 9.7 11.8 15.3 14.3 9.3 4.8 17.4 5.7 14.4 13.2 18.8 8.7 14.1 13.6 19.4 7.1 13.2 10.6 12.3 27.6 12.7 12.4 12.0 11.4 12.9 12.8 17.1 18.7 14.3 15.8 18.1 13.4 9.6 6.8 21.2 17.5 17.9 15.5 10.1 16.2 15.1 13.4 10.8 10.0 11.6 10.9 14.2 10.2 13.4 10.1 10.7 13.8 13.3 17.0 9.8 10.1 11.9 2.0 3.5 1.6 5.4 4.2 5.7 6.6 3.0 5.1 3.2 3.3 3.1 5.1 3.1 1.7 10.7 6.5 2.0 3.0 18.8 18.9 19.4 20.8 16.3 11.8 12.5 15.7 16.2 14.8 EIF5A2 ENSG00000163577 "Eukaryotic translation initiation factor 5A2" Q9GZV4 3 170888415-170908693 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport" "Elongation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029090 Approved Supported Vesicles Vesicles "HPA029090: AB_10671359" "unprognostic (2.41e-1)" "unprognostic (2.42e-1)" "unprognostic (4.05e-1)" "unprognostic (5.75e-2)" "unprognostic (1.27e-1)" "prognostic unfavourable (7.42e-4)" "unprognostic (1.11e-3)" "unprognostic (1.47e-1)" "unprognostic (3.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (1.79e-1)" "unprognostic (2.66e-2)" "unprognostic (3.45e-2)" "unprognostic (5.92e-2)" "unprognostic (1.64e-2)" "unprognostic (4.29e-3)" 5.6 3.9 3.6 4.1 8.4 4.9 4.2 1.9 14.4 4.4 4.6 4.3 2.0 2.5 6.2 2.0 4.1 3.6 4.9 5.4 4.3 5.8 6.8 3.4 3.2 3.6 6.7 6.2 6.4 4.5 2.2 5.2 2.5 21.6 4.8 3.8 3.4 2.7 4.2 1.9 3.0 2.6 9.6 5.1 3.0 11.0 31.2 2.5 6.1 3.1 2.6 4.2 6.3 6.2 2.6 0.9 10.2 1.3 6.9 11.2 4.3 11.8 6.2 2.3 3.2 12.2 8.0 5.4 8.9 11.7 9.6 13.4 12.6 7.8 7.5 16.8 12.5 4.0 7.2 3.2 12.2 8.3 3.1 3.5 2.5 3.9 8.2 9.3 10.9 8.7 4.7 14.3 11.9 4.6 2.9 0.0 15.6 3.8 4.2 4.1 4.3 3.9 0.0 6.6 0.0 4.0 2.1 1.8 3.5 9.5 2.5 7.5 5.5 6.3 6.5 11.8 8.3 24.2 20.5 11.8 0.1 17.1 4.0 3.3 8.4 10.2 1.2 1.2 11.2 1.3 7.7 2.0 7.7 10.6 0.9 2.6 4.6 7.6 0.6 6.9 1.2 0.8 9.2 4.3 3.6 8.4 1.9 14.4 4.3 5.8 6.7 6.2 21.6 2.5 ELAVL4 "HUD, PNEM" ENSG00000162374 "ELAV like RNA binding protein 4" P26378 1 50048014-50203786 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.1" "Cell line enriched" "Detected in some" 19 "SH-SY5Y: 52.5" "Group enriched" "Detected in some" 10 "glioma: 2.6;pancreatic cancer: 0.6;testis cancer: 0.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.4;non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 5 "monocytes: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004442, HPA043047" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB004442: AB_627765, HPA043047: " "unprognostic (1.25e-1)" "unprognostic (6.63e-3)" "unprognostic (4.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.28e-2)" "unprognostic (3.83e-4)" "unprognostic (4.52e-2)" "unprognostic (2.63e-1)" "unprognostic (2.75e-1)" "unprognostic (3.75e-3)" "unprognostic (7.91e-2)" "unprognostic (2.39e-3)" "unprognostic (7.83e-2)" "unprognostic (2.81e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-2)" 0.9 11.4 11.5 3.3 12.8 0.8 1.0 11.6 43.1 0.9 3.0 0.9 0.0 2.3 0.9 0.8 1.1 0.9 1.0 1.0 12.3 16.5 0.9 1.0 1.0 0.9 10.6 30.7 0.8 2.8 0.8 7.1 0.9 37.0 1.0 3.8 0.0 0.9 0.9 0.8 1.2 3.1 2.0 8.5 1.0 1.9 7.8 1.4 0.1 0.8 0.0 1.0 0.9 0.5 0.0 0.6 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.6 0.0 0.0 11.5 12.8 11.6 40.4 12.3 16.5 10.6 30.7 37.0 1.4 ELFN2 "dJ63G5.3, KIAA1904, LRRC62, PPP1R29" ENSG00000166897 "Extracellular leucine rich repeat and fibronectin type III domain containing 2" Q5R3F8 22 37367960-37427470 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 30.0" "Cell line enhanced" "Detected in some" "A-431: 8.7;CAPAN-2: 8.4;PC-3: 7.9;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000781 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000781: AB_1079280" "unprognostic (2.74e-1)" "unprognostic (6.81e-2)" "unprognostic (2.80e-2)" "unprognostic (1.31e-5)" "unprognostic (3.28e-1)" "unprognostic (2.51e-2)" "unprognostic (7.76e-2)" "unprognostic (4.25e-2)" "unprognostic (6.05e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (4.51e-1)" "prognostic unfavourable (7.21e-4)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" 1.0 2.1 26.8 0.9 10.9 0.9 0.9 0.7 30.0 0.9 0.9 1.9 0.0 0.9 0.9 0.9 0.9 1.0 1.9 0.8 16.2 8.7 1.2 0.8 2.0 1.0 6.7 15.0 0.8 1.1 0.8 0.1 0.8 5.8 2.2 0.9 0.9 0.9 0.9 0.9 1.5 0.9 0.8 3.8 0.9 1.1 4.2 3.9 0.1 0.8 0.0 0.9 0.9 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.7 3.7 0.0 0.0 0.0 0.7 0.0 3.9 2.1 0.9 0.0 1.4 8.4 0.2 5.2 2.8 6.1 0.4 0.8 0.1 0.2 0.0 0.0 3.9 0.0 0.2 0.0 0.1 0.7 0.1 0.3 1.2 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.2 7.9 0.1 0.0 8.4 16.4 0.0 0.7 0.0 3.6 4.6 0.0 0.0 0.1 0.4 0.0 18.6 0.1 2.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 10.9 0.7 16.8 16.2 8.7 6.7 15.0 5.8 3.9 ELOC "SIII, TCEB1" ENSG00000154582 "Elongin C" Q15369 8 73939169-73972287 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078113 Approved "Nucleoli,Vesicles,Cell Junctions" 250000 Vesicles "Nucleoli, Cell Junctions" "HPA078113: " "prognostic unfavourable (6.48e-4)" "unprognostic (1.60e-1)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" "unprognostic (2.46e-2)" "unprognostic (8.02e-3)" "unprognostic (5.84e-3)" "unprognostic (2.19e-2)" "unprognostic (1.77e-1)" "unprognostic (6.99e-3)" "unprognostic (4.02e-3)" "unprognostic (3.33e-2)" "unprognostic (2.77e-3)" "unprognostic (3.84e-2)" "unprognostic (5.33e-2)" "unprognostic (1.67e-1)" "unprognostic (8.95e-2)" 27.0 29.5 39.1 19.2 37.6 35.4 24.2 25.6 43.3 17.5 19.6 12.2 21.0 13.4 18.2 31.7 24.5 17.2 17.9 50.1 33.9 29.5 28.2 36.1 21.2 35.2 32.5 28.4 17.9 25.5 17.6 20.0 25.7 27.3 19.2 20.6 12.1 16.3 21.0 62.5 16.6 14.5 24.4 33.9 18.7 18.5 51.0 18.8 19.7 19.6 31.9 27.9 19.3 16.7 38.9 55.3 51.7 35.4 32.5 44.9 26.4 44.6 36.6 33.6 24.3 25.7 33.6 24.1 44.4 36.3 43.6 44.8 32.5 39.0 22.8 36.0 39.3 32.1 37.0 44.3 57.7 26.2 30.7 39.7 39.1 51.5 33.6 25.4 29.8 34.0 35.6 39.4 51.0 40.5 34.9 30.6 57.2 33.1 65.3 45.7 30.5 59.3 23.8 21.1 21.6 47.5 39.2 31.7 30.0 18.6 101.5 41.4 37.4 27.4 30.9 31.7 35.8 34.6 44.5 34.8 42.4 42.0 38.1 27.8 38.4 51.7 32.2 38.2 31.2 35.4 34.0 38.9 37.5 34.8 34.2 34.0 34.3 34.4 37.7 32.5 33.8 55.3 44.9 26.4 39.1 37.6 25.6 43.3 33.9 29.5 32.5 28.4 27.3 18.8 ELOVL3 CIG-30 ENSG00000119915 "ELOVL fatty acid elongase 3" Q9HB03 10 102226328-102229589 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 24.6" "Cell line enhanced" "Detected in some" "ASC diff: 8.2;ASC TERT1: 8.1;HSkMC: 11.9;NB-4: 9.2;SiHa: 18.5" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 11 "classical monocyte: 9.4;intermediate monocyte: 3.1;myeloid DC: 2.6;non-classical monocyte: 6.6" "Group enriched" "Detected in many" 12 "dendritic cells: 2.6;monocytes: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036236 Enhanced Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA036236: AB_10601550" "unprognostic (1.52e-2)" "unprognostic (6.76e-2)" "unprognostic (1.84e-2)" "prognostic unfavourable (6.25e-5)" "unprognostic (8.23e-3)" "unprognostic (9.82e-2)" "unprognostic (2.17e-4)" "unprognostic (4.27e-2)" "unprognostic (2.28e-1)" "unprognostic (5.56e-2)" "unprognostic (1.84e-2)" "unprognostic (5.36e-3)" "unprognostic (2.66e-9)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (1.97e-1)" "unprognostic (1.79e-1)" 6.3 1.1 1.2 2.1 2.4 3.6 7.3 0.4 0.9 0.2 0.2 0.0 0.0 0.0 0.9 0.3 0.3 0.3 2.5 2.5 0.6 0.2 0.5 0.2 1.8 0.1 0.7 0.0 0.2 0.2 0.0 1.8 2.4 1.1 0.3 0.2 1.6 3.4 1.7 1.7 24.6 0.3 0.0 0.2 0.8 0.2 6.8 0.0 0.0 0.2 2.8 0.0 0.6 2.6 0.0 2.6 0.5 9.4 0.0 0.0 1.9 2.6 0.2 0.1 6.5 8.2 8.1 2.3 0.1 0.2 0.3 0.4 0.4 2.5 0.0 0.3 0.0 0.0 4.9 0.0 0.4 0.0 0.0 0.1 0.3 0.6 0.3 0.0 0.1 11.9 1.4 3.0 0.0 0.0 0.1 2.9 0.7 0.0 0.0 9.2 0.1 0.9 0.0 4.3 0.0 1.6 0.0 0.0 0.3 18.5 0.8 0.6 6.7 2.2 0.0 1.3 0.0 0.3 0.2 0.4 5.7 0.0 2.9 5.3 0.0 0.0 9.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.5 0.0 6.6 0.0 0.0 1.9 1.2 2.4 0.4 0.9 0.6 0.2 0.7 0.0 1.1 0.0 EML2 "ELP70, EMAP-2, EMAP2" ENSG00000125746 "Echinoderm microtubule associated protein like 2" O95834 19 45606994-45645629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012757 Approved Approved Vesicles 140000 Vesicles "HPA012757: AB_1848145" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.61e-3)" "unprognostic (2.12e-1)" "unprognostic (1.81e-3)" "unprognostic (1.13e-1)" "unprognostic (1.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.85e-1)" "unprognostic (3.05e-3)" "unprognostic (3.72e-1)" "unprognostic (2.75e-3)" "unprognostic (1.77e-1)" "unprognostic (2.85e-2)" "unprognostic (9.44e-2)" "unprognostic (7.48e-2)" "unprognostic (7.03e-2)" 7.7 23.0 13.0 9.4 25.3 9.5 10.0 11.3 20.7 12.6 15.5 32.8 13.5 8.6 5.9 6.4 26.8 9.3 9.9 14.7 15.8 18.9 11.0 5.4 9.6 9.3 32.4 12.0 3.6 15.6 47.9 9.7 16.9 26.6 11.2 11.1 12.4 21.2 17.5 4.1 22.0 7.9 8.9 24.1 8.6 13.5 2.9 25.5 9.9 15.7 6.2 10.6 15.6 14.3 7.8 8.8 10.6 7.0 3.7 9.7 4.9 17.8 6.0 1.2 0.4 9.9 5.5 6.8 11.2 14.5 5.0 5.8 2.3 15.0 4.6 6.6 5.9 15.1 2.2 22.3 1.8 20.2 5.6 2.4 6.6 4.1 18.8 6.8 5.0 8.4 29.4 5.9 28.8 3.6 6.8 13.5 3.8 17.7 3.7 1.4 0.7 5.4 0.7 2.1 6.7 13.1 21.9 6.6 1.2 6.2 12.2 8.3 7.1 7.4 5.8 0.0 2.1 1.8 0.1 25.4 15.6 2.8 7.9 7.6 14.6 10.6 4.9 7.1 9.6 6.2 7.0 7.8 6.5 9.7 5.9 3.4 4.2 5.7 1.3 3.7 7.0 8.8 7.7 4.9 13.0 25.3 11.3 20.7 15.8 18.9 32.4 12.0 26.6 25.5 EML6 FLJ42562 ENSG00000214595 "Echinoderm microtubule associated protein like 6" Q6ZMW3 2 54723499-54972025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.2;lymphoid tissue: 11.9" "Cell line enhanced" "Detected in some" "Daudi: 7.2;SCLC-21H: 20.1;U-698: 22.8" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "memory B-cell: 2.5" "Lineage enriched" "Detected in single" 26 "B-cells: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062808, HPA068759" Uncertain Approved Vesicles,Mitochondria Mitochondria Vesicles "HPA062808: , HPA068759: " "unprognostic (1.06e-1)" "unprognostic (6.89e-4)" "unprognostic (7.83e-2)" "unprognostic (9.96e-2)" "unprognostic (6.24e-2)" "unprognostic (3.26e-4)" "unprognostic (5.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-1)" "unprognostic (6.27e-2)" "unprognostic (6.85e-6)" "unprognostic (5.00e-1)" "unprognostic (5.81e-2)" "unprognostic (6.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (5.13e-3)" 0.1 3.3 1.8 4.0 2.8 0.0 0.2 7.2 4.2 0.0 0.6 0.6 0.0 1.3 0.3 0.4 0.1 0.0 1.9 2.1 1.3 0.2 0.1 7.9 1.5 0.0 0.5 3.0 3.4 1.4 0.4 0.8 0.1 0.4 0.6 0.8 1.8 0.3 0.5 2.7 0.4 1.5 3.1 11.9 0.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 1.1 0.7 0.2 1.5 0.1 0.2 0.2 0.2 0.6 0.2 7.2 0.1 0.4 0.2 1.0 0.3 0.3 0.7 0.3 0.4 0.5 2.7 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.0 1.1 0.0 0.7 1.4 0.2 0.3 1.1 0.6 0.5 0.6 0.0 0.7 20.1 2.7 0.3 0.0 0.0 0.0 0.0 0.2 0.3 1.6 0.4 0.4 4.9 1.2 22.8 1.2 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EMP3 YMP ENSG00000142227 "Epithelial membrane protein 3" P54852 19 48321509-48330553 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 165.9" "Cell line enhanced" "Detected in many" "NB-4: 114.2" "Cancer enhanced" "Detected in all" "melanoma: 195.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062030 Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA062030: " "unprognostic (5.06e-3)" "unprognostic (4.41e-1)" "unprognostic (1.83e-1)" "unprognostic (9.28e-3)" "unprognostic (1.33e-2)" "unprognostic (4.83e-3)" "unprognostic (1.49e-2)" "unprognostic (1.02e-1)" "unprognostic (9.31e-2)" "unprognostic (4.72e-2)" "unprognostic (3.41e-2)" "unprognostic (1.79e-1)" "prognostic unfavourable (2.31e-7)" "prognostic unfavourable (3.13e-4)" "unprognostic (1.16e-1)" "unprognostic (2.41e-1)" "unprognostic (2.90e-3)" 27.6 23.4 10.4 26.5 12.6 66.2 28.7 7.2 8.4 50.6 40.3 9.2 14.6 8.4 45.9 22.6 26.9 26.1 21.1 37.9 10.8 6.9 15.6 7.0 36.1 48.0 15.2 6.7 41.4 6.4 2.2 6.1 29.9 12.7 30.7 15.4 24.7 11.3 23.1 13.2 16.3 20.8 46.7 19.1 27.8 19.2 18.2 8.2 16.2 11.6 13.4 25.6 36.8 30.6 44.9 54.8 165.9 91.0 59.7 119.1 124.8 5.5 62.3 3.4 10.0 55.3 86.4 0.1 38.4 70.0 50.9 45.1 6.0 20.1 0.7 8.7 85.3 1.0 3.7 4.2 31.3 18.3 1.6 26.6 16.4 3.6 46.4 13.1 27.8 46.8 0.8 52.2 36.0 21.8 17.5 45.7 77.8 0.9 1.9 114.2 4.7 15.8 1.6 12.0 27.0 43.6 0.0 0.1 0.2 17.4 0.1 9.9 0.2 20.1 35.8 46.0 20.0 36.4 30.1 24.1 29.9 1.7 27.2 17.3 31.2 165.9 77.2 105.6 109.2 91.0 90.4 44.9 114.8 106.6 54.8 35.4 65.7 78.2 85.7 59.7 86.6 40.8 119.1 124.8 10.4 12.6 7.2 8.4 10.8 6.9 15.2 6.7 12.7 8.2 ENTPD4 "KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase" ENSG00000197217 "Ectonucleoside triphosphate diphosphohydrolase 4" Q9Y227 8 23385783-23457695 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA017655 Supported Supported Vesicles 28000 Vesicles "HPA017655: AB_1848181" "unprognostic (2.83e-2)" "unprognostic (1.50e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (5.06e-2)" "unprognostic (7.86e-3)" "unprognostic (2.00e-2)" "unprognostic (2.99e-3)" "unprognostic (2.07e-2)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.39e-1)" "unprognostic (1.11e-1)" "unprognostic (6.62e-2)" "unprognostic (3.72e-2)" 16.3 11.5 15.0 21.9 19.8 25.7 15.3 20.3 27.4 15.2 18.5 14.7 15.7 17.0 18.8 17.9 13.3 12.7 14.4 21.0 14.5 12.8 13.0 14.4 19.9 26.0 16.2 12.2 14.7 26.5 30.4 25.2 19.3 20.6 17.6 20.2 18.0 19.5 13.7 14.9 12.2 26.1 16.1 14.5 26.9 19.1 18.7 15.8 17.0 15.8 9.3 30.7 16.7 16.7 9.7 8.0 15.9 9.5 4.4 10.7 6.8 9.9 13.7 17.2 11.9 15.1 19.2 17.6 15.9 15.2 10.8 16.9 19.6 13.2 16.8 11.5 16.0 12.1 7.8 14.4 20.8 4.0 5.4 8.9 8.5 6.8 12.3 4.7 17.7 11.7 17.5 14.4 15.4 15.4 6.1 15.5 18.2 4.5 6.8 5.7 10.0 5.0 6.8 17.2 5.1 13.8 11.8 13.7 13.1 6.0 8.7 11.7 6.4 6.7 19.1 19.7 19.4 22.0 11.7 12.4 5.2 22.0 26.3 5.6 19.7 14.9 6.0 13.7 8.5 9.5 10.0 9.7 8.3 9.1 8.0 6.7 10.7 8.3 15.9 4.4 6.9 7.3 6.5 6.8 15.0 19.8 20.3 27.4 14.5 12.8 16.2 12.2 20.6 15.8 ENTPD8 "NTPDase-8, UNQ2492" ENSG00000188833 "Ectonucleoside triphosphate diphosphohydrolase 8" Q5MY95 9 137434364-137441816 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 48.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.0;RPMI-8226: 8.7;T-47d: 4.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021509 Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA021509: AB_1848185" "unprognostic (3.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.30e-1)" "unprognostic (1.40e-1)" "unprognostic (6.46e-3)" "unprognostic (8.70e-2)" "unprognostic (3.87e-2)" "unprognostic (8.48e-2)" "unprognostic (1.69e-1)" "unprognostic (2.34e-2)" "unprognostic (1.08e-5)" "prognostic favourable (7.17e-4)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-1)" 0.4 0.0 0.4 2.6 0.4 0.0 0.4 0.4 0.4 0.4 19.2 0.4 0.4 18.5 0.4 0.4 0.4 0.3 2.2 0.4 0.5 0.0 2.1 9.8 0.8 0.4 0.4 0.4 0.4 1.8 0.0 4.2 0.5 0.4 0.4 7.5 0.8 4.1 0.4 0.4 0.0 48.1 0.4 0.4 0.4 6.1 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.0 9.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 1.5 0.2 0.0 0.6 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 1.6 0.0 0.2 0.1 0.4 0.0 0.0 8.7 1.4 0.0 0.3 0.9 0.2 0.0 0.1 4.7 0.2 0.1 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.5 0.0 0.4 0.4 0.4 0.4 EOMES TBR2 ENSG00000163508 Eomesodermin O95936 3 27715949-27722711 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.9;brain: 22.6;lymphoid tissue: 21.4" "Cell line enhanced" "Detected in some" "HDLM-2: 11.6;MCF7: 3.4;SCLC-21H: 6.5" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Region enriched" "Detected in some" 20 "cerebellum: 22.6" "Group enriched" "Detected in many" 7 "gdT-cell: 10.0;MAIT T-cell: 16.5;memory CD8 T-cell: 12.0;naive CD8 T-cell: 7.5;NK-cell: 17.9" "Group enriched" "Detected in many" 102 "NK-cells: 17.9;T-cells: 16.5" "Region enriched" "Detected in some" 8 "olfactory region: 95.2" "Group enriched" "Detected in some" 13 "cerebellum: 44.2;olfactory region: 21.9" "HPA028896, HPA077118" Uncertain Uncertain Vesicles Vesicles "HPA028896: AB_10601370, HPA077118: " "unprognostic (1.53e-4)" "unprognostic (5.95e-3)" "unprognostic (3.01e-2)" "unprognostic (1.60e-4)" "unprognostic (4.13e-2)" "unprognostic (9.63e-4)" "unprognostic (4.29e-4)" "unprognostic (3.14e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-2)" "unprognostic (9.96e-2)" "unprognostic (1.85e-1)" "prognostic unfavourable (9.45e-6)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (6.32e-3)" "unprognostic (1.49e-2)" 1.4 0.7 0.5 6.8 0.4 1.6 1.6 22.6 0.4 1.8 0.8 0.0 0.0 0.3 3.2 0.9 1.4 0.6 5.0 0.7 0.4 0.7 1.0 4.9 10.1 15.6 0.5 0.3 1.3 0.9 0.0 0.6 1.6 1.1 2.1 0.9 3.3 2.2 0.1 0.4 0.4 1.8 0.7 0.9 21.4 1.4 0.5 0.0 1.8 1.1 0.9 11.2 3.3 0.8 0.0 0.0 0.1 0.0 17.9 16.5 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 2.2 0.0 11.6 1.7 0.0 0.1 0.9 0.0 1.4 0.0 0.1 1.4 0.0 1.6 0.0 0.3 0.0 0.0 3.4 3.1 0.0 0.4 1.4 2.1 0.0 0.0 1.1 0.0 6.5 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 10.0 0.0 16.5 0.0 1.9 12.0 0.0 0.0 0.1 7.5 0.1 17.9 0.0 0.0 0.0 1.4 0.5 0.4 22.6 0.4 0.4 0.7 0.5 0.3 1.1 0.0 EPGN "ALGV3072, EPG, epigen, PRO9904" ENSG00000182585 "Epithelial mitogen" Q6UW88 4 74308473-74315307 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.3;esophagus: 39.6;tongue: 25.7" "Group enriched" "Detected in some" 6 "hTCEpi: 61.2;U-2197: 27.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 7.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.9" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014420 Approved Nucleoplasm,Vesicles,Cytosol "Secreted in other tissues" "Nucleoplasm, Cytosol" Vesicles "HPA014420: AB_10601551" "unprognostic (7.51e-2)" "unprognostic (8.08e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-4)" "unprognostic (2.20e-1)" "unprognostic (2.01e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (4.06e-4)" "unprognostic (3.84e-1)" "unprognostic (7.89e-2)" "prognostic unfavourable (2.40e-4)" 1.1 0.0 0.0 1.3 0.0 0.1 1.0 0.0 0.0 7.9 0.3 0.0 1.0 0.0 0.0 14.3 39.6 1.2 0.3 0.6 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.7 0.0 0.3 0.0 0.0 2.5 2.8 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 25.7 5.4 0.6 6.5 0.4 0.1 0.0 0.6 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 1.1 0.0 1.0 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.1 0.0 61.2 1.0 4.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.2 1.1 0.0 0.1 0.0 0.0 0.1 0.0 27.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EPHX4 "ABHD7, EPHXRP, FLJ90341" ENSG00000172031 "Epoxide hydrolase 4" Q8IUS5 1 92029982-92063536 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 13.3;brain: 20.7" "Cell line enhanced" "Detected in some" "A-431: 9.9;CAPAN-2: 8.6;EFO-21: 17.6;RPTEC TERT1: 24.4;U-251 MG: 7.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 13.3" "Lineage enriched" "Detected in single" 24 "T-cells: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035067 Uncertain Approved Vesicles Vesicles "HPA035067: AB_10601465" "unprognostic (1.27e-1)" "unprognostic (4.17e-2)" "unprognostic (6.76e-3)" "unprognostic (6.10e-8)" "prognostic unfavourable (9.43e-4)" "unprognostic (5.36e-3)" "unprognostic (2.72e-4)" "unprognostic (4.85e-2)" "unprognostic (9.44e-3)" "unprognostic (7.93e-2)" "prognostic unfavourable (2.00e-4)" "unprognostic (2.53e-1)" "unprognostic (6.36e-6)" "unprognostic (6.93e-3)" "unprognostic (1.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" 1.0 1.3 5.8 1.3 14.1 0.3 3.2 1.7 20.7 2.4 1.0 0.3 0.1 1.6 1.7 1.3 2.1 1.3 1.2 1.2 3.3 2.4 0.9 0.4 1.5 0.7 3.1 9.8 0.6 0.3 0.5 1.3 1.9 4.4 2.2 1.4 1.5 0.4 4.1 0.4 0.6 0.9 2.5 1.1 0.4 0.5 2.6 2.1 0.0 3.9 0.0 0.7 1.9 0.4 0.1 0.0 0.0 0.0 0.5 13.3 1.4 9.9 0.3 1.9 0.0 0.0 0.0 0.5 0.2 3.7 0.3 0.2 0.0 8.6 0.0 17.6 0.0 0.1 0.3 0.8 0.3 0.0 5.3 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.4 0.0 0.0 3.0 0.0 0.0 0.3 0.6 1.4 0.3 1.9 3.5 0.3 0.2 0.0 24.4 1.9 1.2 1.5 6.0 0.0 1.8 0.0 1.4 0.1 0.0 0.0 0.0 7.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.3 0.0 2.3 0.1 1.7 3.3 0.0 0.0 0.4 3.4 0.0 0.5 0.0 0.0 0.0 1.4 5.8 14.1 1.7 20.7 3.3 2.4 3.1 9.8 4.4 2.1 EPN2 "EHB21, KIAA1065" ENSG00000072134 "Epsin 2" O95208 17 19215615-19336715 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 19.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049809, HPA053360" Approved Supported Vesicles Vesicles "HPA049809: , HPA053360: " "unprognostic (1.38e-2)" "unprognostic (2.54e-2)" "unprognostic (2.58e-2)" "unprognostic (2.09e-1)" "unprognostic (1.94e-1)" "unprognostic (8.12e-3)" "unprognostic (6.73e-3)" "unprognostic (1.43e-1)" "unprognostic (8.89e-2)" "unprognostic (4.58e-3)" "unprognostic (3.42e-2)" "unprognostic (1.57e-1)" "prognostic favourable (9.13e-5)" "unprognostic (1.32e-1)" "unprognostic (9.40e-2)" "unprognostic (2.23e-2)" "prognostic unfavourable (8.15e-5)" 6.5 5.1 16.3 6.2 11.8 3.4 4.4 9.9 34.8 7.0 5.2 4.3 3.6 2.9 9.9 7.0 13.9 7.7 4.8 10.7 16.7 10.5 4.5 3.6 6.1 3.6 14.9 13.1 7.2 4.3 8.4 3.6 7.7 8.5 7.3 3.0 5.6 5.0 9.2 9.8 18.4 3.6 8.7 14.7 4.5 3.2 6.7 10.6 3.6 4.4 8.1 3.6 5.4 6.9 2.9 0.7 19.9 1.1 0.6 1.5 0.4 14.8 14.9 21.9 9.6 11.5 18.6 17.1 14.3 9.3 8.9 7.7 9.7 4.5 2.3 14.0 14.2 14.1 9.7 10.7 11.0 11.1 10.8 1.6 9.4 4.8 12.1 0.7 6.6 10.4 9.7 14.0 11.4 19.0 4.2 2.0 7.8 10.8 0.6 1.0 5.6 9.8 3.4 9.3 3.9 10.5 4.1 6.5 14.5 10.1 6.8 7.4 10.2 1.9 17.3 9.9 11.4 15.4 6.2 3.3 2.0 1.9 27.0 0.2 15.1 7.1 1.1 19.9 1.5 0.7 1.0 2.3 1.1 1.2 0.5 2.9 1.3 1.2 7.3 0.6 0.8 0.7 0.9 0.4 16.3 11.8 9.9 34.8 16.7 10.5 14.9 13.1 8.5 10.6 EPN3 "FLJ20778, MGC129899" ENSG00000049283 "Epsin 3" Q9H201 17 50532543-50543750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 12.4;HBEC3-KT: 17.2;hTCEpi: 9.7;MCF7: 27.5;RT4: 21.6;SK-BR-3: 11.2;T-47d: 24.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebral cortex: 6.8;pons and medulla: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebellum: 4.7;midbrain: 7.9;pons and medulla: 7.5;thalamus: 10.2" "HPA055546, HPA063224" Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA055546: , HPA063224: " "unprognostic (1.91e-2)" "unprognostic (1.99e-2)" "unprognostic (2.41e-1)" "unprognostic (2.91e-2)" "unprognostic (1.25e-3)" "unprognostic (2.06e-1)" "unprognostic (5.70e-3)" "unprognostic (7.62e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (6.66e-3)" "unprognostic (1.00e-2)" "prognostic favourable (1.53e-5)" "unprognostic (1.45e-1)" "unprognostic (1.16e-1)" "unprognostic (4.90e-1)" "unprognostic (3.52e-3)" 0.4 7.7 0.5 1.9 0.7 0.4 1.9 1.1 6.8 5.3 7.8 1.5 24.0 5.1 0.7 3.8 26.2 6.0 12.6 6.6 0.5 0.7 10.9 0.4 0.7 0.0 2.0 1.4 10.3 18.3 9.6 0.9 8.4 17.8 9.3 3.4 0.3 16.7 18.7 0.4 19.7 5.1 0.5 0.6 0.3 23.8 2.2 0.0 3.4 1.2 15.9 21.9 8.2 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.1 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 6.3 5.4 0.0 0.1 0.0 12.4 0.0 17.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 9.7 0.0 1.3 0.0 0.0 0.0 0.0 27.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 21.6 0.2 0.0 0.0 11.2 0.0 24.9 0.1 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 1.1 6.8 0.5 0.7 2.0 1.4 17.8 0.0 EPS15 "AF-1P, MLLT5" ENSG00000085832 "Epidermal growth factor receptor pathway substrate 15" P42566 1 51354263-51519328 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Host-virus interaction, Protein transport, Transport" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008451, CAB010164, HPA061431" Approved Enhanced Vesicles,Cytosol "Intracellular and membrane" 67000 "Vesicles, Cytosol" "CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: " "unprognostic (1.45e-2)" "prognostic unfavourable (6.44e-4)" "unprognostic (1.05e-2)" "unprognostic (7.72e-3)" "unprognostic (3.99e-1)" "unprognostic (1.42e-1)" "unprognostic (4.96e-3)" "unprognostic (9.26e-2)" "unprognostic (4.13e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.41e-1)" "unprognostic (5.36e-2)" "unprognostic (8.73e-3)" "unprognostic (2.13e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" 39.0 26.9 35.5 25.3 27.8 13.2 19.3 22.2 41.0 25.7 16.7 35.7 16.2 11.4 21.8 21.3 19.6 14.1 19.3 18.9 40.7 26.0 21.0 19.1 24.4 30.7 36.2 11.2 22.4 10.9 17.0 14.6 22.8 20.3 22.5 15.5 25.7 24.3 16.4 30.9 18.1 19.3 18.2 36.8 33.8 15.2 32.4 33.1 25.0 20.3 23.4 32.1 25.3 17.0 16.1 10.8 14.9 12.2 10.7 18.7 8.0 14.7 4.4 9.6 9.0 22.2 22.2 23.9 10.3 16.4 8.5 12.6 6.0 8.2 30.2 10.7 16.2 14.1 12.4 9.9 12.9 34.1 7.8 26.9 7.6 7.2 20.9 15.2 24.8 18.0 9.2 14.8 20.2 15.8 16.6 13.8 12.9 7.2 12.2 8.3 13.1 7.2 10.0 14.5 6.6 11.2 18.4 6.6 9.2 12.3 21.9 17.9 8.9 10.8 21.8 7.9 8.5 15.8 8.6 16.5 16.7 20.4 11.7 17.3 6.9 14.9 10.1 11.6 10.1 10.7 15.3 16.1 12.2 15.6 10.8 10.0 7.3 10.5 7.8 10.7 12.2 7.1 18.7 8.0 35.5 27.8 22.2 41.0 40.7 26.0 36.2 11.2 20.3 33.1 EPS15L1 eps15R ENSG00000127527 "Epidermal growth factor receptor pathway substrate 15 like 1" Q9UBC2 19 16355239-16472085 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019237, HPA055309" Uncertain Approved Vesicles 8900 Vesicles "HPA019237: AB_1848223, HPA055309: " "unprognostic (3.06e-2)" "unprognostic (3.33e-3)" "unprognostic (2.19e-1)" "unprognostic (6.45e-3)" "unprognostic (1.35e-1)" "unprognostic (8.64e-2)" "unprognostic (2.58e-3)" "unprognostic (5.12e-2)" "unprognostic (1.07e-3)" "unprognostic (7.54e-2)" "unprognostic (5.21e-2)" "unprognostic (1.81e-2)" "prognostic favourable (8.10e-5)" "unprognostic (2.47e-1)" "unprognostic (9.59e-2)" "unprognostic (2.14e-1)" "unprognostic (3.32e-1)" 14.1 12.2 16.4 12.4 22.9 22.7 10.2 34.2 31.6 15.3 10.8 19.9 11.4 8.7 14.1 7.4 18.5 15.4 11.0 26.4 16.8 15.5 13.0 11.5 10.8 14.1 15.4 17.2 16.1 12.8 19.8 18.2 15.6 20.5 13.9 11.1 16.4 14.4 16.0 44.0 20.6 11.2 16.7 11.8 14.3 11.9 14.7 15.2 14.2 12.9 13.9 16.5 11.6 14.4 11.1 4.4 26.4 6.2 8.7 5.9 4.2 13.3 6.4 13.9 9.2 15.0 11.7 20.6 8.9 7.8 15.7 13.7 6.9 9.6 14.5 16.3 13.7 13.6 19.6 10.9 13.7 7.2 18.4 12.4 8.9 14.8 15.2 10.8 13.4 9.6 11.2 17.2 12.0 12.6 9.7 16.0 13.1 27.2 12.3 16.1 8.7 22.1 15.9 5.9 12.4 10.8 14.5 12.4 7.6 9.7 8.6 9.2 29.9 10.6 13.0 9.5 6.1 30.4 15.0 4.4 9.1 14.0 10.1 16.1 13.0 23.5 5.8 16.1 5.8 5.7 5.5 11.1 5.0 5.9 4.4 9.7 5.6 4.1 26.4 8.7 6.2 4.2 4.9 4.2 16.4 22.9 34.2 31.6 16.8 15.5 15.4 17.2 20.5 15.2 EPS8L3 "FLJ21522, MGC16817" ENSG00000198758 "EPS8 like 3" Q8TE67 1 109750080-109764027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 30.0;intestine: 115.1" "Cell line enhanced" "Detected in some" "CACO-2: 11.5;CAPAN-2: 10.9;EFO-21: 4.5;Hep G2: 25.9" "Group enriched" "Detected in many" 6 "colorectal cancer: 52.5;pancreatic cancer: 29.7;stomach cancer: 26.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 22 "NK-cell: 2.1" "Lineage enriched" "Detected in single" 22 "NK-cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030998 Approved Approved Vesicles Vesicles "HPA030998: " "unprognostic (1.73e-3)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (2.76e-2)" "unprognostic (2.48e-2)" "unprognostic (2.01e-1)" "prognostic unfavourable (4.13e-5)" "unprognostic (5.55e-3)" "unprognostic (3.71e-2)" "unprognostic (2.09e-1)" "unprognostic (2.33e-1)" "prognostic unfavourable (2.52e-5)" "unprognostic (5.87e-3)" "unprognostic (3.89e-1)" "prognostic favourable (1.82e-4)" 0.2 0.1 0.2 11.0 0.2 0.0 0.2 0.2 0.2 0.5 88.2 0.2 0.2 41.3 0.2 0.2 0.3 0.2 30.0 0.2 0.2 0.1 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.3 22.1 0.2 0.2 0.3 0.2 0.1 115.1 0.5 0.2 0.2 15.1 1.2 0.2 0.2 0.2 0.2 0.2 0.5 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.5 10.9 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 ERC1 "CAST2, ELKS, KIAA1081, MGC12974, RAB6IP2" ENSG00000082805 "ELKS/RAB6-interacting/CAST family member 1" Q8IUD2 12 990509-1495933 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019513, HPA019523, HPA024130" Approved Supported "Vesicles,Plasma membrane,Cytosol" Cytosol "Vesicles, Plasma membrane" "HPA019513: AB_1856012, HPA019523: AB_1856013, HPA024130: AB_1856014" "unprognostic (2.41e-1)" "unprognostic (4.00e-2)" "unprognostic (2.14e-1)" "unprognostic (5.70e-2)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "unprognostic (5.50e-2)" "unprognostic (8.49e-2)" "unprognostic (2.53e-1)" "unprognostic (3.26e-2)" "unprognostic (1.04e-1)" "unprognostic (6.79e-2)" "unprognostic (3.75e-3)" "unprognostic (4.19e-2)" "unprognostic (3.01e-1)" "unprognostic (7.37e-2)" "prognostic unfavourable (7.01e-4)" 12.6 11.4 10.3 12.5 14.7 7.4 15.1 41.7 10.4 11.2 11.9 8.5 9.2 4.3 17.1 11.0 13.7 9.8 9.9 14.7 10.0 11.2 11.2 8.0 8.8 5.4 9.0 6.4 12.5 8.6 24.3 19.4 13.2 10.7 11.4 7.5 10.1 9.3 14.4 9.2 9.9 6.4 22.1 8.5 7.3 8.6 11.0 9.9 9.8 15.3 7.2 8.6 15.7 15.3 8.6 2.9 2.1 3.8 1.1 3.5 0.5 2.9 7.3 3.9 2.6 10.4 8.8 5.4 9.2 7.4 6.3 5.8 6.4 3.6 4.5 1.3 11.9 5.0 8.3 7.1 8.8 9.5 4.2 11.1 7.3 3.2 7.9 5.7 2.6 7.1 6.2 11.1 20.8 8.1 3.3 9.0 4.7 3.2 1.8 1.2 6.2 3.5 3.6 14.8 1.4 6.2 5.3 2.3 4.6 14.4 3.3 5.2 3.4 2.4 15.0 10.9 11.1 8.0 8.6 2.4 4.5 6.7 7.1 3.4 4.8 1.4 2.8 2.1 1.6 1.0 2.2 8.6 2.4 2.4 2.4 5.6 3.5 2.6 2.1 1.1 3.8 2.9 2.2 0.5 10.3 14.7 41.7 10.4 10.0 11.2 9.0 6.4 10.7 9.9 EREG ER ENSG00000124882 Epiregulin O14944 4 74365143-74388751 "Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 52.1;tongue: 44.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 58.9;hTEC/SVTERT24-B: 18.5;U-2197: 40.1;U-87 MG: 68.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054373 Approved Vesicles "Secreted to blood" Vesicles "HPA054373: " "unprognostic (1.26e-2)" "prognostic unfavourable (1.67e-7)" "unprognostic (4.56e-3)" "unprognostic (3.94e-2)" "unprognostic (2.24e-3)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "prognostic unfavourable (1.45e-5)" "unprognostic (1.07e-1)" "unprognostic (7.34e-2)" "prognostic unfavourable (6.57e-5)" "unprognostic (2.94e-1)" "unprognostic (1.70e-6)" "unprognostic (2.42e-2)" "unprognostic (1.13e-2)" "unprognostic (6.59e-3)" "unprognostic (3.16e-3)" 2.2 0.0 0.1 4.6 0.3 52.1 1.2 0.0 0.1 5.0 1.2 0.1 0.0 0.0 0.1 0.5 15.3 1.2 7.3 0.8 0.0 0.0 0.4 0.2 6.7 1.1 0.0 0.2 0.5 0.1 0.0 0.0 2.0 0.3 0.2 1.6 0.1 1.6 0.0 0.5 10.7 1.0 1.3 0.1 1.9 0.3 0.3 0.0 0.2 0.0 44.0 7.2 4.1 4.6 0.6 1.3 2.6 1.2 0.4 0.3 0.3 0.3 8.9 0.0 0.0 0.8 1.5 0.0 2.0 58.9 0.5 0.3 6.9 16.7 0.0 9.8 0.0 0.5 0.0 12.8 0.6 0.0 0.0 0.2 0.3 0.2 0.2 0.0 0.0 0.9 4.5 18.5 9.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.3 0.1 40.1 0.0 0.0 0.0 0.0 68.9 0.0 0.0 1.9 1.2 2.6 0.3 1.0 0.2 0.2 0.2 0.2 1.3 0.6 0.3 0.2 1.0 0.4 0.2 0.4 0.2 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 ERGIC1 "ERGIC-32, ERGIC32, KIAA1181, NET24" ENSG00000113719 "Endoplasmic reticulum-golgi intermediate compartment 1" Q969X5 5 172834275-172952685 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018666, HPA018900" Enhanced Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA018666: AB_1848241, HPA018900: AB_1848242" "unprognostic (8.86e-2)" "unprognostic (3.50e-2)" "unprognostic (3.44e-2)" "unprognostic (5.71e-2)" "unprognostic (7.96e-2)" "unprognostic (2.46e-2)" "unprognostic (9.53e-3)" "unprognostic (7.02e-3)" "unprognostic (2.06e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "unprognostic (1.74e-2)" "unprognostic (1.67e-1)" "unprognostic (3.86e-2)" "unprognostic (9.28e-2)" "unprognostic (3.22e-2)" 30.2 56.5 14.2 20.6 13.8 12.0 44.6 25.5 18.1 42.9 30.5 12.3 35.6 24.6 26.4 24.9 22.6 23.7 30.3 20.7 14.2 11.4 36.4 120.8 28.6 29.3 14.5 11.4 22.5 55.5 15.6 18.9 25.5 13.5 48.1 32.9 19.2 51.5 29.3 27.1 16.7 32.6 22.0 10.8 30.8 36.5 15.8 13.2 29.1 41.5 20.9 25.8 21.3 45.8 6.6 4.2 20.8 9.2 8.5 3.8 3.0 20.3 19.5 16.8 37.3 64.3 48.1 9.3 41.6 31.5 18.8 17.6 27.7 21.0 19.7 29.8 70.2 7.5 12.3 55.2 22.1 15.6 12.1 12.1 28.7 14.8 47.1 5.6 3.9 40.8 23.1 27.7 26.0 30.1 7.2 27.6 31.1 25.5 16.1 9.7 10.0 18.1 55.6 11.2 60.4 43.9 11.9 9.5 17.1 14.5 41.5 20.8 17.2 6.4 22.9 30.7 12.6 29.4 16.9 44.0 49.0 8.2 42.7 13.5 13.4 2.1 4.9 12.1 2.3 7.1 3.8 6.6 1.2 1.5 4.2 4.9 1.0 1.6 20.8 8.5 9.2 2.1 0.7 3.0 14.2 13.8 25.5 18.1 14.2 11.4 14.5 11.4 13.5 13.2 ERGIC2 "Erv41, PTX1" ENSG00000087502 "ERGIC and golgi 2" Q96RQ1 12 29337352-29381189 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049695 Approved Supported "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoli "HPA049695: " "unprognostic (1.62e-2)" "unprognostic (3.50e-2)" "unprognostic (5.53e-2)" "unprognostic (3.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.19e-3)" "prognostic unfavourable (8.06e-6)" "unprognostic (3.70e-2)" "unprognostic (2.32e-2)" "prognostic favourable (8.18e-4)" "prognostic unfavourable (7.02e-6)" "unprognostic (2.67e-1)" "prognostic unfavourable (3.76e-6)" "unprognostic (6.02e-2)" "unprognostic (2.08e-1)" "unprognostic (3.19e-2)" "unprognostic (2.64e-1)" 26.6 21.0 24.4 21.9 32.8 5.5 29.9 28.1 36.1 25.4 22.7 14.6 25.8 21.2 23.1 33.1 32.5 16.6 21.2 33.7 25.3 22.6 27.7 36.2 18.6 18.9 29.8 24.2 24.9 32.6 27.3 40.1 40.9 31.2 29.5 21.4 12.1 28.8 23.8 29.2 15.6 24.3 31.4 31.0 25.6 21.1 32.8 30.7 25.7 28.6 21.6 25.8 33.4 20.6 27.0 39.0 59.2 30.1 22.1 40.8 27.5 24.6 22.7 18.6 12.5 26.9 31.7 45.4 40.2 33.9 25.2 27.3 29.9 41.7 13.6 40.1 31.9 25.9 17.7 26.6 40.4 29.1 19.1 22.1 32.5 17.3 15.8 30.7 18.7 22.4 21.4 31.8 32.2 19.5 18.0 38.7 33.6 13.3 15.3 33.3 26.2 64.2 14.2 51.3 27.6 21.4 36.2 7.1 11.6 20.5 23.3 23.8 45.0 25.2 21.6 34.4 29.3 45.4 43.3 28.5 36.0 27.2 28.7 23.0 27.8 24.2 17.0 22.1 29.7 25.3 35.8 27.0 38.1 34.8 17.8 22.3 38.4 32.3 59.2 22.1 30.1 39.0 40.8 27.5 24.4 32.8 28.1 36.1 25.3 22.6 29.8 24.2 31.2 30.7 ERI1 "3'HEXO, THEX1" ENSG00000104626 "Exoribonuclease 1" Q8IV48 8 9002147-9116746 "Predicted intracellular proteins" "RNA-mediated gene silencing, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033838, HPA055548, HPA056074" Uncertain Approved Vesicles,Microtubules Microtubules Vesicles "CAB033838: AB_2098575, HPA055548: , HPA056074: " "unprognostic (2.49e-1)" "unprognostic (1.13e-1)" "prognostic favourable (8.05e-5)" "unprognostic (1.96e-2)" "unprognostic (2.79e-2)" "unprognostic (2.61e-3)" "unprognostic (1.08e-3)" "unprognostic (2.90e-1)" "unprognostic (5.50e-2)" "unprognostic (1.49e-1)" "unprognostic (1.25e-3)" "unprognostic (4.23e-1)" "prognostic unfavourable (1.42e-4)" "unprognostic (4.27e-2)" "unprognostic (3.57e-1)" "unprognostic (8.75e-2)" "unprognostic (2.36e-2)" 11.9 6.9 6.6 12.2 8.6 20.0 15.4 10.8 8.0 8.8 9.3 7.9 6.6 8.8 15.3 7.1 10.0 10.0 7.5 6.9 6.4 6.3 10.1 9.9 10.9 12.6 8.4 4.9 9.1 7.4 9.1 11.9 32.2 6.3 8.5 9.2 9.2 9.0 7.4 6.8 6.4 8.8 9.7 9.0 13.0 7.9 18.7 8.0 17.8 7.6 4.6 13.2 11.4 15.6 7.5 5.4 7.6 7.3 8.3 13.5 5.0 17.0 11.1 9.9 7.4 7.8 12.9 13.3 14.8 8.1 11.4 14.1 8.2 8.2 19.0 3.8 8.8 6.1 8.6 10.2 15.9 7.9 5.3 10.7 9.3 6.4 8.0 8.3 16.2 7.5 3.5 9.2 8.4 14.8 11.9 13.1 12.9 5.7 24.5 10.4 11.0 7.0 10.7 14.0 7.2 14.4 25.7 1.4 10.5 8.8 7.0 7.4 5.3 7.5 12.7 11.9 11.9 22.9 11.7 2.6 9.3 17.2 8.9 12.0 9.4 7.6 6.5 4.7 6.2 7.3 6.4 7.5 7.5 6.6 5.4 5.8 6.1 5.6 4.9 8.3 4.6 4.1 13.5 5.0 6.6 8.6 10.8 8.0 6.4 6.3 8.4 4.9 6.3 8.0 ERICH2 ENSG00000204334 "Glutamate rich 2" A1L162 2 170783786-170798971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 61.2" "Cell line enriched" "Detected in many" 4 "hTCEpi: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Low region specificity" "Detected in all" HPA061010 Approved "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" Vesicles "HPA061010: " "unprognostic (1.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.26e-1)" "prognostic favourable (9.49e-4)" "unprognostic (7.57e-3)" "unprognostic (6.61e-2)" "unprognostic (9.62e-3)" "unprognostic (6.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.27e-2)" "unprognostic (1.12e-2)" "unprognostic (2.83e-1)" "prognostic unfavourable (8.98e-7)" "unprognostic (1.03e-1)" "unprognostic (5.28e-3)" "unprognostic (7.35e-2)" "unprognostic (2.76e-1)" 0.6 0.3 1.4 0.6 1.1 0.0 1.3 0.6 0.8 2.1 0.6 0.6 0.6 0.0 1.5 1.0 0.6 3.3 0.6 0.9 1.0 1.5 0.9 1.6 4.2 0.6 1.1 0.6 0.6 0.7 0.8 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 0.1 0.6 0.6 0.6 0.6 1.0 61.2 0.6 0.6 6.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 5.3 0.0 0.0 4.5 0.0 0.0 0.2 0.0 0.0 0.9 1.8 4.5 1.0 0.0 0.1 0.0 0.1 1.1 0.4 0.0 0.7 1.2 2.3 0.0 0.1 4.7 0.2 0.2 0.7 36.1 0.0 8.4 0.0 5.0 0.0 0.0 1.8 0.0 0.4 5.5 0.9 0.0 0.9 0.0 2.6 0.1 0.6 1.2 3.2 0.0 1.3 0.7 0.7 0.0 1.2 1.0 0.0 0.5 0.0 0.0 0.0 4.5 2.1 3.5 0.0 0.0 0.0 2.7 0.0 0.9 0.0 0.5 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 0.6 0.8 1.0 1.5 1.1 0.6 0.6 0.6 ERV3-1 "envR, ERV-R, ERV3, H-PLK, HERV-R" ENSG00000213462 "Endogenous retrovirus group 3 member 1, envelope" Q14264 7 64990809-65006743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.1" "Group enriched" "Detected in many" 4 "granulocytes: 10.1;monocytes: 2.5" "HPA017209, HPA046508" Enhanced Approved Vesicles Vesicles "HPA017209: , HPA046508: " "unprognostic (2.74e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-1)" "unprognostic (1.27e-2)" "unprognostic (4.48e-1)" "unprognostic (2.03e-1)" "unprognostic (7.00e-2)" "unprognostic (1.79e-1)" "unprognostic (4.05e-3)" "unprognostic (3.55e-1)" "unprognostic (1.57e-2)" "unprognostic (4.45e-2)" "unprognostic (4.27e-3)" "unprognostic (2.11e-1)" "unprognostic (2.19e-1)" "unprognostic (9.39e-2)" "unprognostic (1.88e-2)" 27.2 41.3 9.9 9.0 11.7 8.6 18.3 13.8 11.6 9.4 7.1 8.7 5.6 3.9 11.2 31.9 18.9 9.0 17.9 8.4 10.1 7.2 7.3 4.0 10.7 5.6 11.2 9.2 10.6 7.6 9.6 19.3 21.2 11.7 8.1 6.5 9.3 14.9 13.1 5.1 14.2 5.8 8.5 13.2 7.0 6.9 9.4 12.7 12.6 10.2 6.2 10.2 10.5 13.8 0.9 1.2 10.1 2.5 1.4 1.5 1.1 2.1 0.7 12.8 19.5 8.0 3.3 8.6 4.0 4.5 1.4 3.3 0.7 14.2 3.5 3.8 1.5 2.5 1.7 0.9 2.2 2.6 0.9 1.9 0.6 6.8 0.6 5.2 2.6 3.9 1.1 1.3 0.3 8.2 8.4 7.0 5.3 5.4 3.3 3.2 3.6 0.8 7.7 0.5 2.5 2.2 4.4 2.4 12.3 4.4 1.3 0.4 3.2 11.6 6.6 4.9 0.6 3.6 2.0 2.2 5.1 1.1 3.9 15.2 2.9 0.1 1.5 3.4 0.9 2.5 0.8 0.7 0.2 0.7 1.2 0.9 0.6 0.6 10.1 1.4 0.8 0.7 1.5 1.1 9.9 11.7 13.8 11.6 10.1 7.2 11.2 9.2 11.7 12.7 ESPL1 "ESP1, KIAA0165, SEPA" ENSG00000135476 "Extra spindle pole bodies like 1, separase" Q14674 12 53268299-53293643 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Chromosome partition" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 17.9;lymphoid tissue: 30.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 1.8" "Lineage enriched" "Detected in single" 5 "T-cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB012185, HPA073188" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB012185: AB_304056, HPA073188: " "unprognostic (1.57e-1)" "unprognostic (3.56e-2)" "unprognostic (3.84e-2)" "prognostic unfavourable (5.32e-5)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "prognostic unfavourable (2.01e-5)" "prognostic unfavourable (7.14e-4)" "unprognostic (1.59e-2)" "unprognostic (2.48e-1)" "unprognostic (4.17e-3)" "unprognostic (1.18e-2)" "unprognostic (7.42e-13)" "prognostic favourable (7.10e-4)" "unprognostic (2.39e-1)" "unprognostic (7.41e-2)" "unprognostic (1.42e-1)" 0.7 0.4 0.2 7.1 0.4 7.2 0.3 0.2 0.5 3.9 2.3 0.4 0.8 4.2 0.6 0.7 17.9 0.2 0.5 1.0 1.1 0.1 1.0 0.9 0.7 4.1 0.2 0.2 0.3 0.2 0.0 0.2 3.0 0.6 0.4 1.5 0.6 2.6 0.2 0.2 2.7 4.4 0.5 0.2 3.0 0.8 10.9 0.3 30.3 0.3 2.5 7.8 0.7 6.2 0.0 0.0 0.4 0.1 0.0 1.8 0.0 12.4 12.7 13.7 11.2 0.3 1.2 8.4 8.2 4.2 14.1 9.0 6.9 11.0 22.5 4.6 3.3 10.4 15.8 4.8 7.4 7.0 16.0 15.1 11.5 5.3 0.0 9.4 12.5 0.4 0.3 8.2 4.0 7.2 20.2 20.4 4.2 13.0 14.8 8.1 11.0 6.9 13.9 14.6 9.3 2.0 5.2 9.8 7.6 6.9 10.2 5.3 16.8 6.3 3.3 7.1 13.8 6.0 11.2 15.1 14.0 15.2 4.1 8.9 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 1.8 0.0 0.2 0.4 0.2 0.5 1.1 0.1 0.2 0.2 0.6 0.3 ESPN DFNB36 ENSG00000187017 Espin B1AK53 1 6424776-6461367 "Disease related genes, Predicted intracellular proteins" Hearing Actin-binding "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.4;liver: 54.9" "Cell line enhanced" "Detected in some" "BEWO: 16.7;Hep G2: 26.5;SK-BR-3: 54.3;T-47d: 18.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "cerebellum: 6.0" "Group enriched" "Detected in some" 4 "MAIT T-cell: 3.6;memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 37 "T-cells: 3.6" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "cerebellum: 4.8" "HPA028674, HPA060220" Enhanced Approved Vesicles Vesicles "HPA028674: AB_10601316, HPA060220: " "unprognostic (5.06e-2)" "unprognostic (1.18e-2)" "unprognostic (2.69e-1)" "unprognostic (1.28e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.28e-1)" "unprognostic (1.16e-1)" "unprognostic (5.71e-2)" "unprognostic (7.48e-3)" "unprognostic (5.53e-2)" "unprognostic (6.26e-3)" "unprognostic (5.51e-2)" "unprognostic (1.16e-1)" "unprognostic (3.04e-2)" "unprognostic (1.17e-2)" 0.6 1.4 0.6 2.5 0.8 6.7 2.9 6.0 0.7 13.3 44.8 0.6 9.2 27.1 1.2 19.7 9.9 6.3 1.2 0.6 1.0 0.1 14.3 54.9 1.6 0.6 0.6 0.6 2.4 0.6 12.9 12.1 1.3 0.6 2.6 1.7 19.5 2.9 4.7 0.6 27.1 70.4 1.0 0.6 0.6 0.4 37.7 0.6 1.2 0.7 2.4 3.2 0.8 5.9 0.0 0.0 0.0 0.0 0.0 3.6 0.3 4.5 0.2 0.2 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 9.9 0.5 0.1 2.2 0.0 10.8 0.8 0.0 0.0 0.6 0.2 0.1 0.2 26.5 0.0 0.2 0.9 0.0 0.2 0.0 0.0 0.0 5.6 0.0 0.0 9.2 0.0 0.3 0.2 4.1 0.0 0.1 3.5 0.0 0.0 7.1 0.3 1.3 54.3 1.6 18.1 2.4 5.2 0.0 0.2 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.6 0.0 1.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.6 0.8 6.0 0.7 1.0 0.1 0.6 0.6 0.6 0.6 ESR1 "ER-alpha, Era, ESR, NR3A1" ENSG00000091831 "Estrogen receptor 1" P03372 6 151656691-152129619 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 64.5;endometrium 1: 68.9" "Group enriched" "Detected in some" 9 "MCF7: 24.3;T-47d: 31.5" "Group enriched" "Detected in many" 9 "breast cancer: 40.2;endometrial cancer: 24.3;ovarian cancer: 8.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB000037, HPA000449, HPA000450, CAB055099, CAB072858" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: , HPA000449: AB_1078753, HPA000450: AB_1078754" "unprognostic (8.28e-2)" "unprognostic (3.02e-2)" "unprognostic (1.43e-2)" "prognostic favourable (5.47e-7)" "unprognostic (4.79e-1)" "unprognostic (2.43e-3)" "unprognostic (4.10e-5)" "unprognostic (9.92e-2)" "unprognostic (2.20e-1)" "unprognostic (7.17e-2)" "unprognostic (7.35e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-2)" "unprognostic (7.91e-3)" "unprognostic (6.45e-2)" "unprognostic (1.25e-1)" "unprognostic (1.52e-1)" 3.0 0.9 0.5 1.6 0.5 0.2 16.2 0.8 0.4 64.5 1.5 0.2 2.2 0.1 68.9 27.7 1.1 26.7 1.9 1.1 0.5 0.8 1.5 6.6 3.6 1.6 0.4 0.1 14.2 0.4 0.0 9.3 0.9 0.6 3.6 0.1 2.6 1.6 4.1 2.0 0.6 0.5 20.8 0.4 1.6 0.3 1.9 0.4 1.9 1.3 2.2 2.5 3.8 23.7 0.6 1.0 0.0 0.8 0.3 2.5 1.0 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.6 0.0 24.3 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.8 0.0 0.0 0.0 0.3 0.0 31.5 0.0 0.0 0.1 0.1 0.3 0.0 2.9 0.5 0.0 0.1 0.2 0.0 0.0 0.8 0.0 0.3 0.2 1.0 0.6 1.3 0.4 1.0 0.4 2.5 0.9 0.0 0.3 0.0 0.0 0.3 1.0 0.5 0.5 0.8 0.4 0.5 0.8 0.4 0.1 0.6 0.4 EVA1A "FAM176A, FLJ13391, TMEM166" ENSG00000115363 "Eva-1 homolog A, regulator of programmed cell death" Q9H8M9 2 75469302-75569722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 69.4;pancreas: 32.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.1;U-138 MG: 36.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008055 Approved Supported "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA008055: AB_1080308" "unprognostic (2.72e-1)" "unprognostic (2.61e-2)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.60e-2)" "unprognostic (5.02e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "prognostic favourable (5.67e-4)" "unprognostic (7.33e-2)" "unprognostic (1.22e-1)" "prognostic favourable (5.80e-4)" "unprognostic (8.19e-2)" "unprognostic (4.37e-2)" "unprognostic (2.43e-2)" "unprognostic (9.07e-2)" 0.6 0.3 0.3 0.7 0.5 0.0 1.2 0.3 0.2 3.7 0.6 0.1 11.4 0.5 1.6 5.1 0.5 1.3 0.4 0.6 0.3 0.3 23.6 69.4 15.2 0.1 0.8 0.0 0.8 32.3 0.8 0.8 26.6 0.5 0.6 0.2 5.7 14.3 13.5 0.9 1.5 1.1 0.7 0.4 5.9 0.4 2.2 0.3 3.3 1.2 0.8 0.8 0.3 0.6 0.8 0.0 0.0 0.0 0.0 1.1 0.7 0.3 4.6 0.5 0.1 1.0 7.1 0.5 21.7 14.6 19.3 9.9 0.1 0.4 0.0 2.0 27.1 3.0 0.5 4.6 12.2 0.0 0.3 0.0 0.8 14.3 0.7 0.0 0.0 5.0 2.7 23.8 11.0 12.0 0.0 0.0 14.8 0.0 0.0 0.0 1.0 7.5 2.4 0.0 0.0 10.7 0.1 0.3 0.5 2.0 0.1 16.5 0.0 0.1 9.8 36.4 15.3 0.6 22.6 0.2 0.0 0.0 20.6 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.5 0.3 0.2 0.3 0.3 0.8 0.0 0.5 0.3 EVL RNB6 ENSG00000196405 Enah/Vasp-like Q9UI08 14 99971449-100144236 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 98.2" "Cell line enhanced" "Detected in many" "MOLT-4: 70.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018849, HPA019536, CAB033987" Enhanced Approved Vesicles,Cytosol "Vesicles, Cytosol" "CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180" "unprognostic (1.12e-3)" "unprognostic (5.03e-3)" "unprognostic (6.46e-3)" "unprognostic (2.70e-1)" "unprognostic (2.65e-1)" "unprognostic (2.27e-3)" "unprognostic (3.65e-2)" "unprognostic (2.35e-1)" "unprognostic (2.06e-1)" "unprognostic (6.35e-3)" "prognostic favourable (4.07e-6)" "unprognostic (3.50e-3)" "prognostic unfavourable (4.14e-6)" "unprognostic (7.97e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-3)" "unprognostic (2.43e-1)" 14.5 15.0 50.9 37.0 57.8 19.9 28.5 57.4 66.2 11.8 12.4 20.7 10.7 12.7 23.6 25.1 11.2 18.0 20.1 19.7 42.4 43.3 12.4 24.4 28.4 63.5 34.8 31.4 23.3 17.1 9.8 28.6 13.5 26.2 16.4 12.0 24.2 20.0 16.5 12.8 15.6 18.7 29.4 23.1 44.2 15.2 13.2 20.3 98.2 11.0 7.5 55.8 18.3 9.3 7.8 2.5 14.2 8.7 9.3 20.6 5.4 4.0 3.6 27.4 8.2 5.5 15.9 15.8 5.4 6.8 3.5 4.8 0.2 2.8 7.7 7.1 4.9 0.1 12.9 9.3 4.4 8.3 8.2 12.7 2.9 2.1 4.6 3.8 30.2 8.4 4.8 2.4 9.3 9.5 6.3 0.5 3.8 5.6 70.9 20.3 5.7 5.4 17.1 14.2 1.3 4.5 0.1 33.3 19.5 3.8 5.9 1.6 4.5 11.2 5.8 2.9 4.6 17.9 2.9 14.5 10.9 21.8 3.8 6.4 4.7 1.5 1.5 14.2 11.6 7.6 8.9 6.2 13.6 11.0 2.5 7.8 16.5 14.6 0.3 9.3 8.7 0.4 20.6 5.4 50.9 57.8 57.4 66.2 42.4 43.3 34.8 31.4 26.2 20.3 EXOC2 "FLJ11026, SEC5L1, Sec5p" ENSG00000112685 "Exocyst complex component 2" Q96KP1 6 485133-693111 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032093 Supported Vesicles 5300 Vesicles "HPA032093: AB_10611964" "unprognostic (1.61e-1)" "unprognostic (4.69e-1)" "unprognostic (1.52e-1)" "unprognostic (9.32e-2)" "unprognostic (1.91e-2)" "unprognostic (2.48e-1)" "unprognostic (1.82e-3)" "unprognostic (1.34e-1)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "unprognostic (5.32e-2)" "unprognostic (2.02e-1)" "unprognostic (8.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (2.20e-1)" 15.9 13.8 16.6 18.2 19.9 8.8 16.7 17.0 20.8 16.4 13.5 22.2 9.3 12.8 14.3 12.5 18.7 10.5 13.6 16.7 17.0 19.0 14.5 15.3 16.8 18.2 19.7 11.6 12.6 11.0 22.8 22.0 26.4 22.4 12.5 15.5 24.4 13.4 12.9 15.7 17.5 14.5 14.1 22.2 18.4 13.4 25.7 17.1 24.8 21.5 12.2 20.2 16.5 14.5 12.5 12.1 8.9 13.6 12.2 18.8 11.4 10.4 8.1 13.5 14.7 12.4 11.2 8.3 9.5 11.1 11.4 13.6 10.3 5.6 7.8 23.4 11.3 9.1 15.1 16.5 13.6 24.3 16.1 9.9 9.7 10.2 15.5 10.5 9.9 9.7 13.5 8.1 9.5 19.0 19.4 5.7 14.1 9.1 14.0 10.3 13.7 7.8 13.3 11.7 15.6 10.2 11.4 13.3 7.8 7.5 4.6 14.9 12.0 6.5 27.6 10.3 7.6 12.8 8.7 14.2 28.3 8.3 10.5 8.8 31.5 8.9 7.8 8.6 15.7 9.5 18.8 12.5 15.9 16.4 12.1 12.0 15.2 14.5 2.5 12.2 13.6 9.9 17.2 11.4 16.6 19.9 17.0 20.8 17.0 19.0 19.7 11.6 22.4 17.1 EXOC3L1 "EXOC3L, FLJ35539, FLJ35587" ENSG00000179044 "Exocyst complex component 3 like 1" Q86VI1 16 67184366-67190204 "Predicted intracellular proteins" Exocytosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.6" "Cell line enhanced" "Detected in some" "BEWO: 3.1;HUVEC TERT2: 5.8;SCLC-21H: 11.0;TIME: 3.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 1.8;non-classical monocyte: 2.0" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029574 Uncertain Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA029574: AB_10602495" "unprognostic (1.15e-2)" "unprognostic (4.91e-2)" "unprognostic (6.87e-3)" "unprognostic (2.09e-3)" "unprognostic (2.33e-1)" "unprognostic (2.46e-2)" "unprognostic (6.77e-2)" "unprognostic (3.98e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-2)" "unprognostic (6.48e-3)" "unprognostic (2.88e-1)" "unprognostic (6.64e-3)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.35e-1)" 4.5 2.4 0.3 1.8 0.9 0.0 2.4 0.4 1.2 1.4 0.6 0.3 0.3 0.8 3.6 0.8 1.2 0.9 1.5 4.5 1.3 0.2 3.3 1.4 8.7 1.8 0.3 0.8 2.0 1.0 0.4 1.1 6.0 1.0 1.6 0.3 2.4 1.1 0.5 1.8 0.7 1.0 0.8 1.0 26.6 0.7 1.0 0.3 0.3 4.1 1.0 0.5 1.0 0.5 0.0 0.7 1.8 2.0 0.0 0.0 0.3 0.2 0.1 1.2 0.4 0.0 0.1 3.1 0.4 0.0 0.0 0.0 1.4 0.3 0.1 1.7 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.7 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.8 0.5 0.0 0.1 0.2 0.3 0.1 0.5 0.6 1.3 1.2 0.2 0.0 0.2 11.0 1.3 1.4 0.3 0.1 1.0 0.1 3.9 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.8 0.0 0.3 0.0 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 2.0 0.0 0.0 0.3 0.3 0.9 0.4 1.2 1.3 0.2 0.3 0.8 1.0 0.3 EXOC3L2 "FLJ36147, XTP7" ENSG00000283632 "Exocyst complex component 3 like 2" Q2M3D2 19 45212621-45245431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HEL: 17.8;K-562: 16.4" "Group enriched" "Detected in some" 4 "basophil: 1.6;neutrophil: 2.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.5" "HPA041595, HPA061110" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" Vesicles "Nucleoplasm, Golgi apparatus, Cytosol" "HPA041595: AB_10794521, HPA061110: " 3.2 4.3 0.0 2.0 0.0 0.9 3.0 0.0 0.3 3.6 2.1 0.1 2.4 2.3 14.5 1.2 2.3 0.6 6.9 1.9 0.0 12.7 9.4 3.4 6.3 0.0 0.0 3.4 2.8 2.4 3.5 0.4 0.0 3.7 0.2 13.7 3.3 3.6 1.0 2.4 3.9 1.6 0.0 12.6 2.4 2.1 0.0 0.0 4.6 1.5 3.2 1.6 3.3 0.5 0.3 2.5 0.4 0.2 0.4 0.2 0.1 0.3 2.3 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.1 2.1 0.0 1.1 0.0 0.1 0.0 0.1 0.0 17.8 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 16.4 0.3 0.0 0.2 0.0 0.0 0.2 0.5 1.2 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.3 0.4 0.8 1.6 0.3 0.1 0.2 0.1 0.0 0.1 0.2 0.1 1.6 0.4 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.3 2.5 0.2 0.3 0.3 0.1 0.2 EXOC6 "DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p" ENSG00000138190 "Exocyst complex component 6" Q8TAG9 10 92834713-93059493 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 21.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036285, HPA059111" Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA036285: AB_10673617, HPA059111: " "unprognostic (1.41e-1)" "unprognostic (1.39e-3)" "unprognostic (5.20e-2)" "unprognostic (2.65e-1)" "unprognostic (1.10e-1)" "unprognostic (1.64e-1)" "unprognostic (1.16e-3)" "unprognostic (7.21e-3)" "unprognostic (3.84e-1)" "unprognostic (2.70e-1)" "unprognostic (1.66e-1)" "unprognostic (8.13e-2)" "prognostic favourable (4.66e-4)" "unprognostic (2.12e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (6.41e-2)" 9.7 19.4 15.3 8.5 16.9 11.6 9.4 18.9 16.2 7.4 9.6 4.5 5.1 8.3 7.3 7.5 4.9 6.3 10.3 7.0 15.5 8.6 7.0 10.8 12.0 16.7 6.1 12.8 5.4 12.5 8.2 17.8 34.6 8.1 9.4 10.8 3.5 7.2 5.0 29.3 6.2 9.8 12.8 6.7 12.6 7.6 10.0 8.1 13.5 29.1 10.2 8.2 9.5 8.2 4.9 7.6 21.2 3.4 1.8 2.5 1.7 8.4 10.6 11.3 7.4 0.6 0.7 4.0 3.9 10.8 3.5 4.4 3.9 7.2 9.6 8.2 1.8 5.4 9.1 2.4 4.5 8.5 9.2 13.9 3.7 5.0 4.4 15.1 12.5 1.0 1.3 3.2 2.1 46.2 11.7 6.4 1.7 4.5 6.3 9.8 1.5 3.1 9.6 4.9 5.0 7.7 5.7 3.8 5.3 4.0 4.1 5.0 8.0 8.0 9.4 0.2 3.7 3.3 6.3 4.8 5.1 7.8 1.2 17.0 4.0 3.7 3.4 10.1 2.2 2.7 2.2 4.7 2.5 2.1 3.4 4.9 2.1 2.4 21.2 1.8 2.6 7.6 2.3 1.7 15.3 16.9 18.9 16.2 15.5 8.6 6.1 12.8 8.1 8.1 EXOC7 "BLOM4, EXO70, Exo70p, KIAA1067, YJL085W" ENSG00000182473 "Exocyst complex component 7" Q9UPT5 17 76081017-76121576 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022840, HPA022842" Supported Approved "Vesicles,Plasma membrane,Cytosol" Cytosol "Vesicles, Plasma membrane" "HPA022840: AB_1848316, HPA022842: AB_1848317" "unprognostic (5.20e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "unprognostic (3.49e-2)" "unprognostic (2.37e-2)" "unprognostic (1.88e-1)" "unprognostic (1.30e-1)" "unprognostic (1.02e-1)" "unprognostic (2.47e-2)" "unprognostic (7.39e-3)" "unprognostic (1.53e-2)" "unprognostic (1.73e-1)" "unprognostic (1.19e-1)" "unprognostic (1.05e-1)" "unprognostic (1.18e-1)" 23.2 22.2 30.5 18.2 37.1 27.5 20.4 27.8 46.2 23.8 24.4 33.0 20.8 19.1 28.7 20.8 31.8 32.6 21.3 27.5 29.2 23.5 21.0 22.6 21.2 17.6 20.9 28.2 31.5 24.1 40.5 29.3 24.0 34.6 30.0 17.0 27.0 29.2 27.9 24.0 21.8 21.6 31.1 21.7 21.4 19.6 14.5 23.0 23.7 29.5 14.1 26.4 30.2 20.5 12.8 13.7 29.6 34.4 15.5 17.9 19.0 21.2 26.4 24.4 19.7 23.2 16.5 25.4 19.5 26.1 35.4 25.7 22.2 14.4 11.0 14.3 34.1 17.5 14.7 19.0 23.8 9.5 19.9 18.3 20.7 23.4 16.2 20.3 19.0 23.0 15.0 27.4 13.4 39.2 12.2 11.3 22.0 19.5 32.6 9.0 12.8 28.2 17.6 41.8 11.2 20.4 44.1 13.3 31.1 22.1 16.4 15.1 26.9 16.8 25.6 38.0 22.9 25.0 21.4 15.6 5.7 10.2 22.7 9.2 19.6 21.1 19.2 29.6 17.9 26.6 12.3 12.4 13.7 15.3 13.7 12.8 14.5 12.2 22.2 15.5 34.4 5.9 14.8 19.0 30.5 37.1 27.8 46.2 29.2 23.5 20.9 28.2 34.6 23.0 EXOSC8 "bA421P11.3, CIP3, EAP2, OIP2, p9, RRP43, Rrp43p" ENSG00000120699 "Exosome component 8" Q96B26 13 36998816-37009613 "Disease related genes, Predicted intracellular proteins" "rRNA processing" RNA-binding "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034240, HPA039702, HPA043942, HPA075230" Uncertain Supported "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center, Vesicles" "CAB034240: AB_2101977, HPA039702: AB_2676634, HPA043942: , HPA075230: " "unprognostic (8.67e-2)" "unprognostic (9.39e-2)" "unprognostic (5.77e-2)" "unprognostic (1.03e-1)" "unprognostic (2.58e-2)" "unprognostic (1.24e-2)" "unprognostic (1.02e-1)" "unprognostic (4.01e-2)" "unprognostic (3.24e-3)" "unprognostic (2.45e-2)" "unprognostic (2.35e-2)" "unprognostic (7.32e-3)" "prognostic unfavourable (8.39e-7)" "unprognostic (9.58e-3)" "unprognostic (7.42e-2)" "unprognostic (1.10e-1)" "unprognostic (4.51e-1)" 15.1 14.5 16.0 18.0 15.7 24.5 20.1 15.4 16.3 17.3 17.1 16.7 13.5 13.0 15.6 15.2 18.8 16.3 10.1 16.8 14.9 12.7 16.5 22.9 15.5 22.8 19.8 15.5 19.4 14.5 6.9 15.3 21.6 15.2 18.3 19.8 12.6 13.1 14.4 22.5 16.2 20.0 19.3 18.5 20.0 14.9 30.4 19.6 31.5 18.9 21.1 24.6 20.4 14.5 27.6 23.5 9.3 16.0 18.0 30.7 21.3 12.8 9.8 28.0 18.9 8.6 9.1 21.4 20.1 14.1 27.7 22.6 21.3 26.4 18.7 8.8 11.2 18.1 27.3 19.6 32.7 27.2 23.0 50.9 10.8 25.8 11.1 41.0 17.5 5.4 14.9 18.8 30.3 21.0 24.1 11.8 19.4 16.7 20.8 33.4 29.2 12.9 13.6 28.6 15.2 15.4 9.2 7.2 13.8 10.9 12.5 17.8 9.6 32.8 10.4 10.1 14.5 12.3 26.5 6.9 8.2 39.8 16.0 29.3 18.6 9.3 13.0 9.2 19.2 16.0 19.9 27.6 24.6 22.7 14.3 22.9 30.7 28.5 2.8 18.0 15.7 23.5 22.2 21.3 16.0 15.7 15.4 16.3 14.9 12.7 19.8 15.5 15.2 19.6 F11 FXI ENSG00000088926 "Coagulation factor XI" P03951 4 186265945-186288806 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 88.9" "Cell line enriched" "Detected in some" 11 "Hep G2: 13.7" "Cancer enriched" "Detected in some" 13 "liver cancer: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039808 Approved Vesicles "Secreted to blood" 4400000000 Vesicles "HPA039808: " "unprognostic (1.28e-1)" "unprognostic (3.15e-1)" "prognostic favourable (3.29e-5)" "unprognostic (1.88e-1)" "unprognostic (2.08e-1)" "unprognostic (2.11e-1)" "unprognostic (1.85e-3)" "unprognostic (2.91e-2)" "unprognostic (7.65e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 2.7 0.1 0.1 5.5 0.2 0.3 0.1 0.1 4.8 0.1 0.1 0.1 10.2 88.9 2.8 0.1 0.1 0.1 0.1 19.0 0.0 0.2 0.1 0.3 0.1 0.0 0.4 0.1 0.1 0.1 0.1 6.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 F3 "CD142, TF" ENSG00000117525 "Coagulation factor III, tissue factor" P13726 1 94529225-94541800 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 115.2;HaCaT: 54.6;HBEC3-KT: 141.7;U-2197: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009438, HPA049292, HPA069132" Uncertain Approved Vesicles "Secreted to blood" 7733431000 Vesicles "CAB009438: AB_668005, HPA049292: , HPA069132: " "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (8.04e-2)" "unprognostic (1.64e-1)" "unprognostic (2.69e-2)" "unprognostic (1.23e-3)" "unprognostic (4.93e-2)" "unprognostic (8.00e-2)" "unprognostic (5.88e-1)" "unprognostic (1.35e-1)" "prognostic unfavourable (1.07e-4)" "unprognostic (1.25e-1)" "prognostic unfavourable (2.02e-8)" "unprognostic (4.84e-2)" "unprognostic (4.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.08e-1)" 45.5 9.8 27.0 14.1 42.9 2.1 55.1 3.4 27.9 14.8 18.7 20.9 18.7 18.3 30.5 23.7 21.3 25.4 30.9 18.8 26.9 14.5 6.6 2.8 31.4 5.8 14.1 20.3 41.6 35.0 6.1 28.8 65.4 39.2 29.7 22.2 49.9 29.2 33.0 2.4 17.7 19.2 5.9 46.3 2.9 18.2 16.4 16.0 0.0 21.8 17.3 11.9 24.7 22.3 0.5 0.9 2.8 0.8 0.7 0.4 0.2 115.2 0.2 0.2 0.0 12.6 6.2 6.5 16.4 9.8 17.8 19.4 2.0 24.7 0.0 8.4 20.3 54.6 1.4 141.7 29.3 0.1 0.1 0.0 3.5 0.3 4.2 0.0 0.0 10.7 3.2 8.4 41.1 0.1 0.1 0.1 12.4 0.2 0.1 2.4 1.1 0.2 0.1 1.1 0.0 2.2 0.3 0.1 0.3 13.1 5.4 0.4 0.1 1.5 0.0 10.8 0.3 53.8 4.9 0.1 0.1 0.0 8.2 0.6 0.4 1.7 0.8 0.1 0.3 0.3 0.4 0.2 0.3 0.2 0.2 0.5 0.3 0.3 2.8 0.7 0.2 0.9 0.2 0.2 27.0 42.9 3.4 27.1 26.9 14.5 14.1 20.3 39.2 16.0 FAAP24 "C19orf40, FLJ46828, MGC32020" ENSG00000131944 "Fanconi anemia core complex associated protein 24" Q9BTP7 19 32972209-32978222 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041168 Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA041168: AB_10960496" "unprognostic (1.18e-2)" "unprognostic (1.22e-2)" "unprognostic (1.34e-1)" "prognostic unfavourable (4.38e-4)" "unprognostic (6.52e-2)" "unprognostic (2.73e-1)" "unprognostic (2.58e-3)" "unprognostic (3.76e-2)" "unprognostic (1.88e-2)" "unprognostic (3.98e-2)" "unprognostic (2.82e-3)" "unprognostic (3.54e-2)" "prognostic unfavourable (4.00e-7)" "unprognostic (4.37e-3)" "unprognostic (5.30e-1)" "unprognostic (2.31e-3)" "unprognostic (2.15e-1)" 3.7 3.5 1.8 4.1 2.1 5.3 3.9 2.3 2.9 3.0 2.9 2.4 3.3 2.8 3.3 4.6 4.8 2.6 6.7 1.9 1.5 1.7 4.3 2.5 2.3 4.6 3.8 0.9 4.2 2.4 0.2 2.0 6.1 3.1 9.6 4.0 3.3 3.2 1.9 1.0 4.6 5.1 2.2 2.6 6.1 2.8 16.9 2.0 8.7 3.0 3.1 8.6 3.6 2.7 7.2 7.7 16.0 8.0 7.7 6.2 3.7 5.0 12.6 5.2 8.1 2.6 5.5 4.2 6.5 6.8 12.5 16.4 8.9 8.3 6.0 9.6 2.7 3.6 9.9 4.8 10.0 16.1 5.1 12.9 5.7 6.7 1.5 4.5 6.6 3.1 3.1 7.8 4.8 5.0 6.7 6.1 9.1 5.7 9.4 5.9 2.3 5.7 8.5 4.7 3.2 2.5 3.1 5.5 4.3 7.3 8.5 5.3 5.9 11.2 3.0 12.5 6.0 5.2 5.9 4.9 9.9 8.1 8.9 9.8 8.1 10.8 6.4 8.7 3.9 7.3 4.4 6.6 4.7 5.6 4.0 7.2 4.3 6.2 16.0 7.7 8.0 7.7 6.0 3.7 1.8 2.1 2.3 2.9 1.5 1.7 3.8 0.9 3.1 2.0 FAM110A "bA371L19.3, C20orf55" ENSG00000125898 "Family with sequence similarity 110 member A" Q9BQ89 20 833715-857463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.4" "Cell line enhanced" "Detected in many" "SK-BR-3: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 83.4;eosinophil: 24.8;intermediate monocyte: 25.1;non-classical monocyte: 37.7" "Group enriched" "Detected in all" 9 "granulocytes: 83.4;monocytes: 37.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034110, HPA069240" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles, Cytosol" "CAB034110: AB_1562838, HPA069240: " "unprognostic (6.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.57e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "unprognostic (4.90e-3)" "unprognostic (5.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.78e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "prognostic unfavourable (4.42e-4)" "unprognostic (9.64e-3)" "unprognostic (1.17e-2)" "unprognostic (6.42e-3)" "unprognostic (4.21e-3)" 5.2 3.6 1.7 17.7 4.2 7.4 7.7 1.9 3.9 6.5 8.8 2.0 7.7 10.0 4.0 6.1 22.1 1.9 6.9 4.8 1.7 2.5 4.8 3.9 15.2 18.7 2.1 1.9 2.6 3.5 9.3 5.1 11.1 3.6 11.1 3.4 3.1 12.7 10.5 3.7 39.9 9.2 1.3 1.6 15.1 5.5 2.8 1.3 22.9 7.7 8.0 18.9 7.8 9.7 1.9 5.8 83.4 37.7 1.0 6.4 3.2 12.4 3.4 1.9 3.5 2.1 0.9 13.2 3.9 2.2 2.5 2.2 7.3 7.9 4.1 1.7 2.4 20.3 1.5 10.3 2.1 3.3 1.1 8.4 2.1 1.9 0.9 2.3 3.0 0.5 12.8 3.4 3.4 1.7 4.5 10.1 2.3 7.5 6.4 6.2 2.5 5.8 6.4 3.3 5.3 1.9 9.1 3.6 4.3 3.3 39.7 1.7 16.4 3.4 2.2 6.0 4.4 5.4 4.3 3.7 3.2 1.7 0.9 6.0 4.3 83.4 4.4 24.8 2.2 25.1 2.0 1.1 4.0 4.6 5.8 1.9 4.9 4.7 2.5 1.0 37.7 0.6 6.4 3.2 1.7 4.2 1.9 3.9 1.7 2.5 2.1 1.9 3.6 1.3 FAM114A2 "133K02, C5orf3" ENSG00000055147 "Family with sequence similarity 114 member A2" Q9NRY5 5 153990128-154038936 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035869, HPA035870" Approved Approved Vesicles Vesicles "HPA035869: AB_10669534, HPA035870: AB_10673222" "unprognostic (1.81e-1)" "unprognostic (2.65e-1)" "unprognostic (3.45e-2)" "unprognostic (3.27e-1)" "unprognostic (7.99e-2)" "unprognostic (8.21e-2)" "unprognostic (5.18e-3)" "unprognostic (6.70e-2)" "unprognostic (1.92e-2)" "unprognostic (2.66e-1)" "unprognostic (9.70e-3)" "unprognostic (4.37e-1)" "unprognostic (7.80e-2)" "unprognostic (1.38e-3)" "unprognostic (4.17e-2)" "unprognostic (5.90e-3)" "unprognostic (2.85e-2)" 15.7 16.1 10.3 11.1 10.4 6.9 13.6 7.2 10.5 10.5 10.6 8.5 15.9 10.3 12.8 15.1 14.0 10.9 9.7 16.5 12.7 9.5 13.7 18.3 12.0 16.7 10.1 9.8 14.0 26.4 22.3 18.9 11.4 11.5 13.0 9.7 12.5 16.0 12.5 20.7 10.2 13.4 17.4 8.9 14.3 13.0 30.7 9.9 16.6 14.6 11.5 14.3 13.1 11.1 12.4 10.9 25.9 15.8 12.1 14.5 8.7 8.2 11.0 11.8 18.5 16.7 15.6 10.7 20.1 14.1 14.9 20.8 8.1 12.3 10.5 19.3 14.7 7.1 10.2 19.5 18.1 11.6 11.4 13.4 6.7 5.8 19.7 11.7 13.9 14.0 12.2 13.4 24.3 20.8 8.4 16.5 19.2 7.9 13.2 4.8 5.1 5.4 11.5 16.3 15.9 11.4 5.8 2.7 9.9 14.5 15.7 20.3 21.1 8.6 19.2 13.9 9.9 12.6 12.0 25.1 20.2 14.8 16.5 16.2 14.8 20.0 10.9 25.9 12.4 13.8 14.2 12.4 10.4 14.5 10.9 11.7 13.0 12.7 5.5 12.1 15.8 9.9 11.6 8.7 10.3 10.4 7.2 10.5 12.7 9.5 10.1 9.8 11.5 9.9 FAM155A ENSG00000204442 "Family with sequence similarity 155 member A" B1AL88 13 107163510-107866735 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0;pituitary gland: 10.3" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 11.6;SCLC-21H: 7.1;SH-SY5Y: 16.1;U-138 MG: 5.0;U-87 MG: 10.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039453, HPA058768" Enhanced Approved Nucleoplasm,Vesicles,Centrosome "Nucleoplasm, Vesicles" Centrosome "HPA039453: AB_10795290, HPA058768: " "unprognostic (8.40e-2)" "unprognostic (9.98e-3)" "unprognostic (1.48e-1)" "unprognostic (3.38e-3)" "unprognostic (2.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.26e-1)" "unprognostic (9.06e-2)" "unprognostic (1.02e-5)" "unprognostic (5.56e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-2)" "unprognostic (3.69e-3)" 0.9 2.7 10.7 0.6 4.3 0.4 0.6 6.9 19.0 1.5 0.7 0.6 0.0 0.5 1.7 4.0 0.7 0.7 1.3 0.7 8.8 10.8 0.7 0.4 1.2 0.5 6.4 4.9 0.7 0.5 0.4 10.3 1.2 2.0 2.7 0.7 0.7 0.3 3.8 0.4 0.5 0.7 1.2 2.7 0.6 0.7 2.3 0.5 0.0 1.3 0.0 0.9 1.4 0.2 0.2 0.0 0.4 0.1 0.8 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.0 2.4 0.1 2.3 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.2 0.0 11.6 1.9 7.1 16.1 0.0 0.0 0.0 4.1 0.0 0.2 5.0 2.0 1.7 0.2 0.0 0.0 0.0 10.2 0.0 3.4 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.4 0.8 0.0 0.0 0.0 0.0 10.7 4.3 6.9 12.3 8.8 10.8 6.4 4.9 2.0 0.5 FAM173B JS-2 ENSG00000150756 "Family with sequence similarity 173 member B" Q6P4H8 5 10226330-10249897 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SiHa: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074513 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA074513: " "prognostic unfavourable (1.32e-6)" "unprognostic (8.87e-3)" "unprognostic (1.23e-3)" "unprognostic (1.20e-1)" "unprognostic (9.24e-2)" "unprognostic (1.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-2)" "unprognostic (6.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-1)" "unprognostic (9.06e-2)" "unprognostic (5.61e-2)" "unprognostic (1.03e-1)" 10.1 14.6 17.7 10.4 16.2 3.3 9.0 20.1 18.6 7.9 9.7 12.2 8.8 7.7 9.3 12.6 7.9 9.2 9.9 8.8 14.9 18.1 12.1 13.1 7.5 8.9 18.8 9.9 8.6 6.8 19.2 22.8 5.3 18.6 12.2 12.4 10.3 8.8 12.3 7.3 7.4 7.1 10.1 13.2 5.6 7.8 6.5 18.9 8.4 12.7 6.2 8.7 11.6 13.9 5.7 8.9 11.6 9.7 5.1 8.6 4.5 7.3 8.0 7.9 7.5 8.7 6.6 2.7 11.3 5.7 6.0 4.7 8.4 12.1 9.4 20.3 8.0 5.5 12.1 10.3 9.8 15.6 7.4 7.8 27.3 6.3 5.9 12.0 9.4 6.1 11.4 9.9 3.4 11.6 10.9 9.6 17.0 6.8 5.9 10.7 4.8 9.7 8.2 5.5 8.3 15.4 9.6 6.3 6.3 39.7 14.0 6.3 14.3 12.6 6.4 12.9 7.6 7.8 8.2 6.5 7.2 10.5 8.1 13.8 5.2 5.0 9.3 11.6 7.0 9.7 8.4 5.7 6.7 8.5 8.9 4.2 6.8 8.6 3.4 5.1 7.7 3.1 7.8 4.5 17.7 16.2 20.1 18.6 14.9 18.1 18.8 9.9 18.6 18.9 FAM177A1 C14orf24 ENSG00000151327 "Family with sequence similarity 177 member A1" Q8N128 14 35044907-35113130 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053222, HPA055440" Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" 180000 Vesicles Nucleoplasm "HPA053222: , HPA055440: " "unprognostic (6.86e-2)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic unfavourable (9.70e-4)" "unprognostic (4.64e-3)" "unprognostic (6.28e-2)" "unprognostic (7.79e-2)" "prognostic favourable (8.51e-5)" "unprognostic (1.12e-2)" "unprognostic (7.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (1.69e-1)" "unprognostic (8.28e-2)" "unprognostic (1.91e-1)" 20.8 25.6 29.5 17.5 29.2 24.9 20.6 14.1 25.9 27.2 45.8 29.2 19.6 32.6 16.3 17.9 22.2 12.7 22.0 44.2 31.6 35.3 35.5 49.1 36.0 10.4 41.1 24.2 14.4 21.5 14.2 43.8 17.7 39.6 37.9 41.6 13.6 19.5 22.3 33.8 17.4 34.0 25.5 45.4 15.7 24.1 42.6 22.2 13.3 31.0 19.0 12.8 27.6 18.2 14.1 16.8 56.7 15.1 9.4 18.5 9.7 20.1 16.3 12.4 10.0 21.5 21.6 16.8 32.9 17.9 17.1 18.8 16.5 26.6 8.3 23.6 31.2 21.1 15.1 18.6 21.9 23.5 11.5 6.4 20.7 56.2 26.6 9.8 15.0 19.4 24.5 20.7 16.3 19.5 15.2 25.9 32.9 28.9 12.0 9.1 10.1 23.2 7.0 17.5 11.6 30.9 21.8 17.4 15.6 38.8 30.6 25.3 28.3 7.5 22.9 22.4 19.9 24.9 16.8 20.1 24.1 9.9 13.9 6.6 21.8 20.9 15.1 24.9 10.7 11.4 12.6 14.1 14.2 12.2 10.9 11.3 11.3 11.0 56.7 9.4 9.7 16.8 18.5 9.7 29.5 29.2 14.1 25.9 31.6 35.3 41.1 24.2 39.6 22.2 FAM192A "C16orf94, NIP30" ENSG00000172775 "Family with sequence similarity 192 member A" Q9GZU8 16 57152466-57186116 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054382, HPA059652" Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA054382: AB_2682469, HPA059652: " "unprognostic (1.69e-2)" "unprognostic (5.20e-2)" "unprognostic (1.36e-1)" "unprognostic (9.20e-3)" "unprognostic (4.69e-3)" "unprognostic (2.45e-2)" "unprognostic (1.01e-2)" "unprognostic (2.22e-1)" "unprognostic (6.09e-2)" "unprognostic (1.52e-2)" "unprognostic (1.41e-1)" "unprognostic (4.19e-1)" "unprognostic (3.00e-1)" "unprognostic (3.87e-3)" "unprognostic (4.14e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-3)" 21.2 23.1 39.3 31.3 42.5 60.4 31.0 38.0 45.6 22.4 33.4 41.8 19.1 30.3 25.2 31.0 28.0 25.4 21.9 25.8 37.2 36.3 26.9 27.0 25.3 39.6 44.8 32.5 26.1 33.9 52.1 31.1 28.4 36.7 28.1 41.1 24.7 24.8 24.6 31.8 40.7 32.4 25.4 40.8 42.0 27.5 41.4 40.0 47.2 33.2 21.9 42.6 23.1 23.9 26.6 30.4 48.5 38.1 17.9 22.2 20.8 31.0 39.8 44.4 29.8 19.5 24.2 41.9 36.7 27.6 45.5 29.5 37.6 33.0 47.1 41.4 28.0 41.8 30.8 36.9 46.2 20.9 24.8 32.8 35.7 38.9 28.2 40.1 46.8 24.1 36.9 43.2 35.0 32.5 43.8 15.2 29.9 23.1 43.6 37.5 28.6 30.0 53.7 64.8 45.6 30.7 25.7 32.0 36.8 67.1 28.6 24.7 23.7 27.9 32.1 33.8 28.3 24.6 27.3 36.5 28.6 60.6 34.5 29.1 32.2 48.5 26.6 40.1 17.3 30.6 16.8 26.6 16.7 16.0 30.4 23.9 17.4 18.0 36.8 17.9 38.1 21.0 22.2 20.8 39.3 42.5 38.0 45.6 37.2 36.3 44.8 32.5 36.7 40.0 FAM198A "C3orf41, DKFZP434B172" ENSG00000144649 "Family with sequence similarity 198 member A" Q9UFP1 3 42979267-43060211 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 5.8;RPMI-8226: 6.1;SK-BR-3: 4.2;T-47d: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047726 Approved Supported Vesicles "Secreted - unknown location" 440000 Vesicles "HPA047726: AB_10960554" "unprognostic (2.16e-3)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (2.93e-2)" "unprognostic (7.48e-2)" "unprognostic (2.18e-2)" "unprognostic (1.65e-2)" "unprognostic (5.79e-2)" "unprognostic (2.69e-1)" "unprognostic (6.21e-2)" "unprognostic (2.02e-1)" "unprognostic (1.50e-1)" "unprognostic (1.57e-4)" "unprognostic (4.45e-2)" "unprognostic (2.09e-2)" "unprognostic (3.49e-2)" "unprognostic (3.81e-1)" 8.9 3.5 6.2 3.7 8.3 0.1 5.4 4.1 6.8 10.8 3.5 6.1 2.4 1.3 11.7 9.4 4.0 13.8 13.0 2.0 7.2 2.6 1.3 12.1 3.8 1.1 5.1 5.5 9.4 3.0 0.3 2.6 3.2 11.2 2.7 1.8 4.0 4.1 3.8 1.4 1.8 2.5 9.2 5.2 1.2 4.3 3.1 6.8 0.0 2.0 1.1 0.6 3.8 4.2 0.0 1.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 5.8 0.2 0.0 1.7 0.3 0.6 0.0 0.0 0.2 1.8 0.0 1.8 0.0 0.0 0.7 0.0 0.0 0.0 2.4 0.9 0.0 0.0 1.3 0.5 2.1 1.2 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.3 0.0 0.0 0.0 6.1 0.0 0.8 0.1 0.4 0.0 4.2 0.0 11.7 1.4 0.0 0.7 1.2 2.3 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.2 1.2 0.0 0.0 6.2 8.3 4.1 6.8 7.2 2.6 5.1 5.5 11.2 6.8 FAM207A "C21orf70, PRED56" ENSG00000160256 "Family with sequence similarity 207 member A" Q9NSI2 21 44940010-44976989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034178, HPA036354" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "CAB034178: AB_1564323, HPA036354: AB_10672242" "unprognostic (1.83e-1)" "unprognostic (9.07e-2)" "unprognostic (4.99e-3)" "unprognostic (1.05e-2)" "unprognostic (1.37e-2)" "unprognostic (1.14e-3)" "prognostic unfavourable (7.04e-4)" "unprognostic (3.23e-2)" "unprognostic (4.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.84e-2)" "unprognostic (7.94e-2)" "prognostic unfavourable (7.80e-4)" "unprognostic (1.81e-1)" "unprognostic (2.56e-1)" "unprognostic (4.12e-1)" "unprognostic (5.77e-2)" 15.5 12.4 9.3 15.3 13.1 15.6 10.0 13.1 15.3 7.6 12.3 7.7 9.2 15.8 9.3 8.4 10.2 8.3 13.9 33.0 8.2 8.0 11.0 19.5 8.2 12.1 9.9 12.4 8.1 15.9 6.4 5.8 8.1 9.5 8.8 6.0 7.2 16.5 10.5 35.5 11.4 11.8 7.5 6.7 18.3 13.3 25.2 8.0 15.3 10.0 15.3 10.7 10.9 13.1 9.7 12.3 5.5 6.2 6.0 6.5 3.0 14.9 16.3 5.6 7.1 2.8 3.8 13.4 10.4 2.9 7.9 6.4 27.6 4.7 15.4 22.6 3.7 10.1 7.7 11.3 3.3 11.2 23.3 45.6 11.2 23.2 11.1 14.7 5.9 6.6 6.7 7.2 6.7 8.5 25.7 10.9 6.2 26.4 13.9 23.2 19.0 23.4 13.7 6.0 26.6 7.6 6.0 27.4 11.7 13.7 16.5 15.5 11.4 10.7 11.2 6.7 13.9 9.0 22.1 22.9 19.8 15.0 5.3 25.4 9.3 4.3 5.6 5.5 2.8 5.8 2.6 9.7 4.8 6.5 5.4 6.2 5.1 5.2 3.7 6.0 6.2 12.3 5.1 3.0 9.3 13.1 13.1 15.3 8.2 8.0 9.9 12.4 9.5 8.0 FAM212A "C3orf54, INKA1" ENSG00000185614 "Family with sequence similarity 212 member A" Q96EL1 3 49803254-49805030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.8;skin 1: 30.0" "Cell line enhanced" "Detected in many" "HEL: 31.3;HMC-1: 21.5;NB-4: 17.4;THP-1: 19.3;U-937: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 19.0;memory B-cell: 25.8;naive B-cell: 23.4" "Group enriched" "Detected in many" 6 "B-cells: 25.8;granulocytes: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041879 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA041879: AB_10797269" "unprognostic (1.36e-1)" "unprognostic (2.99e-2)" "unprognostic (6.97e-2)" "unprognostic (7.95e-2)" "unprognostic (1.34e-1)" "prognostic favourable (1.96e-4)" "unprognostic (2.70e-2)" "unprognostic (4.35e-2)" "unprognostic (7.28e-2)" "unprognostic (2.94e-1)" "unprognostic (3.35e-3)" "unprognostic (4.61e-2)" "unprognostic (1.90e-3)" "unprognostic (4.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.45e-1)" "unprognostic (1.40e-2)" 6.0 4.1 5.8 3.2 4.7 5.0 3.5 8.0 6.3 6.8 2.6 4.9 1.4 1.7 5.5 2.8 16.3 2.9 4.8 7.6 4.4 4.3 3.4 1.2 7.3 5.9 6.3 4.8 3.6 2.3 0.8 2.0 5.2 5.6 5.4 1.4 3.2 4.5 3.9 15.3 30.0 3.5 5.3 8.3 6.9 2.2 2.4 4.3 1.8 1.9 10.4 8.4 4.8 8.5 25.8 3.6 19.0 2.9 0.0 1.5 2.8 0.6 0.5 0.7 0.5 0.9 2.0 0.0 1.4 0.9 0.6 0.8 0.0 0.0 6.8 0.2 1.0 4.0 0.2 4.8 0.0 1.2 0.0 31.3 0.3 0.1 1.2 4.7 21.5 2.6 6.9 1.4 1.2 2.9 2.1 0.5 0.5 0.3 0.4 17.4 0.5 2.7 6.3 0.3 1.5 0.0 7.8 0.3 2.5 1.2 0.2 0.6 0.1 19.3 1.7 3.5 0.4 1.6 0.6 0.8 0.7 0.5 1.5 16.0 0.8 19.0 0.9 4.3 0.6 2.2 0.1 25.8 0.6 0.7 0.2 23.4 0.9 1.5 0.5 0.0 2.9 3.6 0.6 2.8 5.8 4.7 8.0 6.3 4.4 4.3 6.3 4.8 5.6 4.3 FAM219A "bA573M23.5, C9orf25, FLJ39031" ENSG00000164970 "Family with sequence similarity 219 member A" Q8IW50 9 34398184-34458570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.9" "Cell line enhanced" "Detected in all" "HDLM-2: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019338, HPA052909" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA019338: AB_1845819, HPA052909: " "unprognostic (9.96e-3)" "unprognostic (2.16e-1)" "unprognostic (1.50e-2)" "unprognostic (1.23e-2)" "unprognostic (6.81e-2)" "unprognostic (4.07e-2)" "prognostic unfavourable (1.98e-5)" "unprognostic (2.71e-2)" "unprognostic (2.50e-1)" "unprognostic (2.95e-1)" "prognostic favourable (2.46e-4)" "unprognostic (3.46e-3)" "prognostic unfavourable (5.54e-5)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (3.34e-1)" "unprognostic (2.76e-1)" 13.6 10.3 27.8 10.9 27.0 4.9 7.1 26.3 56.9 7.5 6.3 23.3 3.7 7.2 13.2 8.6 6.3 6.5 7.6 17.5 25.4 27.6 6.1 5.0 11.0 7.8 30.8 31.0 10.7 8.4 9.4 10.6 16.3 34.0 9.2 6.6 5.4 7.1 9.7 28.6 12.3 6.7 15.0 25.2 9.8 7.2 6.9 25.6 2.9 7.2 4.0 6.6 6.5 6.4 0.5 0.6 3.8 0.7 0.7 1.5 0.3 12.4 4.8 11.4 6.5 10.7 4.1 11.2 7.6 5.7 6.6 8.4 3.3 2.9 2.7 7.8 7.3 5.2 9.0 4.8 6.6 43.0 5.2 1.1 6.2 3.6 6.0 2.7 6.4 4.3 4.9 9.8 5.5 10.8 2.7 13.8 5.1 2.5 4.2 3.8 7.4 7.2 5.4 1.9 2.4 4.7 2.7 3.6 11.6 6.5 4.8 3.8 2.4 2.7 12.8 7.3 5.7 15.1 10.4 3.6 5.2 2.4 20.9 6.3 12.8 2.3 0.6 3.8 1.5 0.4 0.8 0.5 0.8 0.4 0.5 0.4 0.6 0.8 2.0 0.7 0.7 0.6 1.4 0.3 27.8 27.0 26.3 40.8 25.4 27.6 30.8 31.0 34.0 25.6 FAM220A "ACPIN1, C7orf70, MGC12966, SIPAR" ENSG00000178397 "Family with sequence similarity 220 member A" Q7Z4H9 7 6329409-6348981 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.7;testis: 40.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA055050 Approved Vesicles Vesicles "HPA055050: " "unprognostic (3.49e-2)" "unprognostic (3.53e-1)" "unprognostic (2.69e-2)" "unprognostic (9.79e-2)" "unprognostic (3.26e-2)" "unprognostic (4.02e-2)" "prognostic unfavourable (5.17e-6)" "unprognostic (2.78e-1)" "unprognostic (1.43e-2)" "unprognostic (2.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (8.84e-3)" "unprognostic (1.14e-2)" "prognostic unfavourable (3.47e-4)" "unprognostic (3.71e-2)" 5.8 6.9 10.5 5.1 9.3 2.3 7.7 14.0 16.6 7.5 6.1 6.8 3.8 4.3 8.1 6.1 8.9 6.2 5.9 12.6 10.3 9.7 6.5 5.1 4.9 6.8 8.3 11.6 8.7 10.5 15.3 7.2 6.0 7.9 6.6 4.4 5.6 7.2 6.9 56.7 7.7 4.6 7.3 7.9 5.8 5.3 40.9 5.4 9.7 9.1 11.8 7.7 7.5 6.3 11.1 9.6 9.5 5.5 16.2 10.2 3.8 15.8 10.0 7.4 17.2 17.1 14.5 8.1 8.1 10.2 9.9 11.6 6.6 8.9 13.2 9.4 9.6 11.7 11.1 6.9 12.9 9.2 7.1 4.4 8.0 7.4 18.5 7.9 6.7 8.1 23.3 7.4 17.9 9.2 8.5 12.7 8.5 12.4 4.9 14.6 17.2 13.1 12.7 11.1 11.1 9.0 5.8 7.5 13.1 11.4 14.1 17.0 13.6 20.9 6.9 7.8 18.0 15.2 10.4 13.7 21.2 14.4 9.1 14.4 24.0 6.7 5.5 9.5 5.5 4.5 5.7 11.1 6.6 8.5 9.6 10.6 10.2 8.4 2.4 16.2 4.7 7.7 8.3 3.8 10.5 9.3 14.0 16.6 10.3 9.7 8.3 11.6 7.9 5.4 FAM3B "2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44" ENSG00000183844 "Family with sequence similarity 3 member B" P58499 21 41304212-41357431 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.8;pancreas: 120.3;salivary gland: 67.9" "Cell line enhanced" "Detected in some" "CACO-2: 9.3;CAPAN-2: 5.9;Hep G2: 15.2;RPMI-8226: 42.1" "Cancer enhanced" "Detected in many" "prostate cancer: 40.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 3.0;neutrophil: 6.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015885, HPA029777" Approved Approved Vesicles "Secreted to blood" 2075500 57000 Vesicles "HPA015885: AB_1848396, HPA029777: " "unprognostic (2.88e-1)" "unprognostic (3.31e-3)" "unprognostic (5.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "unprognostic (6.32e-3)" "unprognostic (1.41e-1)" "unprognostic (8.79e-3)" "unprognostic (9.38e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "unprognostic (3.78e-1)" "unprognostic (5.60e-3)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (1.78e-1)" "unprognostic (1.55e-3)" 0.6 0.2 0.2 4.5 0.4 0.0 4.3 0.2 0.3 1.8 38.5 0.4 29.9 38.2 0.2 8.8 17.4 4.5 6.9 0.4 0.2 0.2 5.2 0.6 2.0 0.7 0.3 0.2 0.7 120.3 0.0 1.9 7.9 0.4 10.0 0.0 0.2 67.9 36.0 0.2 0.9 83.8 2.0 0.3 0.5 30.8 2.0 0.2 2.3 3.9 7.4 17.6 17.5 4.7 0.2 1.3 6.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.3 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.0 42.1 0.0 2.8 0.2 0.2 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 6.9 0.0 0.6 1.3 0.0 0.0 0.2 0.4 0.2 0.3 0.2 0.2 0.3 0.2 0.4 0.2 FAM43A FLJ90022 ENSG00000185112 "Family with sequence similarity 43 member A" Q8N2R8 3 194686544-194689037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 46.9;NB-4: 27.9;PC-3: 22.1;TIME: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048345 Uncertain Approved Vesicles Vesicles "HPA048345: " "unprognostic (1.61e-1)" "unprognostic (1.11e-1)" "unprognostic (9.18e-2)" "unprognostic (1.90e-2)" "unprognostic (5.71e-3)" "unprognostic (5.13e-3)" "unprognostic (9.80e-2)" "unprognostic (8.28e-2)" "unprognostic (4.96e-2)" "unprognostic (1.38e-1)" "unprognostic (3.92e-3)" "unprognostic (1.74e-1)" "unprognostic (2.14e-1)" "unprognostic (1.15e-1)" "unprognostic (1.45e-1)" "unprognostic (2.91e-3)" "prognostic unfavourable (9.96e-4)" 10.7 1.8 1.6 3.5 1.6 2.4 10.4 2.7 4.2 5.2 4.2 2.1 1.6 0.8 4.8 2.7 5.3 6.0 4.2 7.0 2.7 1.6 4.6 23.5 5.6 8.0 2.5 3.6 3.5 7.0 0.5 2.7 9.3 4.1 7.9 1.7 3.3 6.7 2.1 5.5 8.6 3.8 2.9 1.6 20.6 2.7 6.1 2.3 2.6 2.6 5.8 5.2 5.7 8.9 5.0 8.7 3.6 1.3 2.8 1.4 0.4 0.1 0.7 0.5 0.4 9.5 4.6 3.8 1.2 3.2 0.0 0.0 0.2 0.1 0.4 13.4 4.4 1.4 0.8 0.3 0.0 0.3 2.4 1.7 3.7 0.5 0.7 0.4 4.9 1.2 2.0 0.2 0.0 46.9 0.9 0.9 0.1 0.7 0.0 27.9 2.2 22.1 2.0 0.1 0.2 0.0 0.0 13.0 1.1 0.8 0.8 2.7 0.5 5.7 23.4 0.5 0.7 0.6 0.2 0.0 0.4 1.2 0.2 12.7 8.8 3.6 1.3 1.5 1.0 1.1 1.4 2.3 0.6 0.9 1.3 5.0 0.1 0.3 1.6 2.8 0.7 8.7 0.4 0.4 1.6 1.6 2.7 4.2 2.7 1.6 2.5 3.6 4.1 2.3 FAM69B "C9orf136, MGC20262" ENSG00000165716 "Family with sequence similarity 69 member B" Q5VUD6 9 136712570-136724050 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 28.1;HEK 293: 25.1;HUVEC TERT2: 31.2;REH: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "naive B-cell: 7.3;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 34 "B-cells: 7.3;dendritic cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046812, HPA054443" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA046812: , HPA054443: " "unprognostic (2.78e-2)" "unprognostic (8.07e-2)" "prognostic unfavourable (1.77e-5)" "unprognostic (3.82e-1)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (6.80e-2)" "unprognostic (2.10e-2)" "prognostic favourable (9.48e-5)" "unprognostic (2.77e-1)" "unprognostic (6.67e-3)" "unprognostic (4.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.84e-1)" "unprognostic (2.78e-1)" 8.0 3.8 12.3 3.6 14.2 8.2 5.6 19.8 21.4 6.1 4.6 4.9 2.3 4.7 9.6 5.0 4.7 11.0 5.9 18.8 12.3 14.6 6.6 5.5 11.0 4.5 12.4 15.9 5.4 11.9 7.9 11.4 24.5 14.2 6.5 1.3 17.5 11.2 4.5 9.9 13.0 4.4 4.1 5.3 7.9 3.5 7.5 3.2 1.6 7.6 4.1 2.1 3.2 3.1 7.3 1.9 0.0 0.1 0.0 0.0 0.7 0.5 3.3 9.4 9.2 0.0 0.0 8.4 0.3 0.0 0.3 0.4 9.5 1.5 0.8 28.1 0.0 2.9 4.8 0.1 0.0 1.3 25.1 5.3 0.4 0.3 0.1 0.8 2.8 0.1 0.0 0.1 0.0 31.2 6.2 0.9 0.0 4.1 3.6 8.4 14.5 2.1 20.0 0.2 9.4 0.5 1.0 16.0 17.3 0.4 1.8 7.0 5.2 4.9 16.0 0.8 7.0 1.3 0.5 5.5 0.5 2.4 0.6 0.8 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.7 12.3 14.2 19.8 21.4 12.3 14.6 12.4 15.9 14.2 3.2 FAM72A "LMPIP, MGC57827, RP11-312O7.1, UGENE" ENSG00000196550 "Family with sequence similarity 72 member A" Q5TYM5 1 206186179-206204414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA043271: , HPA067321: " "unprognostic (3.61e-2)" "unprognostic (1.58e-1)" "unprognostic (1.80e-1)" "unprognostic (5.20e-5)" "unprognostic (3.61e-1)" "unprognostic (1.19e-3)" "unprognostic (1.01e-5)" "unprognostic (7.70e-3)" "unprognostic (1.45e-2)" "unprognostic (5.58e-3)" "unprognostic (2.87e-2)" "unprognostic (1.03e-1)" "unprognostic (4.44e-16)" "unprognostic (1.82e-1)" "unprognostic (1.94e-2)" "unprognostic (4.83e-2)" "unprognostic (3.89e-1)" 3.4 2.5 1.9 4.7 1.6 6.3 3.2 8.0 1.3 0.8 1.5 2.4 0.6 0.0 2.5 1.8 2.2 0.9 2.4 1.8 1.0 1.3 2.4 8.9 2.6 0.8 0.7 2.3 0.4 2.8 0.5 1.7 0.7 0.2 0.2 5.0 2.2 1.3 3.1 6.3 0.8 6.3 0.5 6.2 1.1 1.2 2.1 5.6 1.2 9.2 0.6 3.6 2.4 9.7 8.0 8.4 3.6 1.2 1.5 10.1 7.0 3.0 8.1 6.1 4.7 14.6 25.1 6.0 1.8 11.7 9.7 3.8 9.7 13.8 8.0 11.3 7.3 6.3 0.8 19.5 12.8 2.1 0.7 7.2 12.8 5.0 22.5 17.3 5.0 5.7 12.1 17.5 15.2 10.7 13.4 14.6 18.9 4.5 1.5 8.4 4.9 5.0 4.6 4.1 9.7 10.6 2.6 6.5 7.5 8.4 11.5 14.0 20.5 22.5 5.3 16.0 8.9 0.0 7.5 0.0 0.9 9.2 0.2 2.1 1.8 1.8 5.6 0.8 0.2 0.4 1.2 0.6 5.4 2.3 3.6 2.4 FAM72B RP11-439A17.6 ENSG00000188610 "Family with sequence similarity 72 member B" Q86X60 1 121167646-121185539 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 6.5;lymphoid tissue: 9.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.3" "Low lineage specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA043271: , HPA067321: " "unprognostic (8.53e-2)" "unprognostic (1.97e-2)" "unprognostic (1.63e-3)" "unprognostic (1.25e-3)" "unprognostic (4.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.26e-4)" "unprognostic (8.22e-5)" "unprognostic (1.30e-2)" "unprognostic (1.79e-2)" "unprognostic (1.36e-4)" "unprognostic (2.46e-2)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-2)" "unprognostic (5.30e-2)" 1.0 0.8 1.3 4.1 1.0 6.5 0.6 5.1 1.0 0.5 1.0 1.3 0.4 0.2 3.0 0.5 1.0 0.2 1.6 0.9 0.3 0.4 0.8 9.3 1.4 0.4 0.1 1.5 0.1 1.4 0.2 1.3 0.5 0.0 0.0 2.1 1.3 0.7 1.4 3.2 0.9 3.6 0.2 7.9 0.9 0.9 0.8 3.3 0.1 2.4 0.8 1.4 1.1 11.9 4.4 7.4 3.6 0.7 1.1 5.8 6.4 2.7 7.5 6.3 0.1 6.3 26.6 8.9 1.2 7.5 10.1 3.6 11.6 17.6 7.5 11.5 4.9 5.3 0.4 19.9 10.3 0.6 0.4 5.9 12.0 4.5 15.0 16.4 5.4 5.0 10.0 16.4 13.9 9.1 15.0 15.8 12.1 2.9 1.4 8.0 4.6 4.8 3.7 3.7 5.0 15.6 1.5 6.2 10.5 12.0 11.2 14.6 18.1 26.3 5.5 21.7 14.3 0.0 2.4 0.0 0.0 0.9 0.0 0.8 0.4 0.5 3.3 0.3 0.0 0.1 0.1 0.8 1.1 0.4 1.4 1.1 FAM72C RP5-998N21.9 ENSG00000263513 "Family with sequence similarity 72 member C" H0Y354 1 143955364-143971965 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 3.6;lymphoid tissue: 6.4" "Cell line enhanced" "Detected in many" "U-266/84: 29.0" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.2" "Low lineage specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA043271: , HPA067321: " "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" "unprognostic (6.45e-3)" "unprognostic (2.69e-2)" "unprognostic (2.21e-1)" "unprognostic (3.98e-3)" "unprognostic (9.46e-5)" "unprognostic (1.23e-3)" "unprognostic (4.36e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-2)" "unprognostic (1.95e-1)" "unprognostic (0.00e+0)" "unprognostic (2.95e-1)" "unprognostic (4.70e-2)" "unprognostic (5.82e-2)" "unprognostic (1.47e-2)" 0.1 0.0 1.6 3.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.1 1.9 0.0 6.4 0.4 1.1 0.4 0.0 1.0 1.7 2.2 0.6 8.5 5.0 6.1 2.7 0.3 0.8 5.8 4.3 1.4 5.7 4.4 0.7 10.3 20.4 5.6 0.5 8.3 8.1 2.6 6.3 7.0 4.8 8.8 4.4 1.5 0.3 17.9 8.0 0.1 0.0 4.5 11.8 2.5 15.4 9.6 0.3 0.6 10.6 13.9 4.8 3.2 13.5 4.3 14.5 1.0 1.1 3.0 5.5 4.1 2.4 2.3 5.9 15.4 1.7 4.6 7.6 6.0 9.3 20.1 29.0 12.1 2.4 11.2 2.9 0.0 1.0 0.0 0.1 0.3 0.0 1.1 0.4 0.5 0.4 0.0 0.1 0.0 0.0 1.7 0.6 0.1 2.2 0.6 FAM72D ENSG00000215784 "Family with sequence similarity 72 member D" Q6L9T8 1 145096000-145112696 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.7" "Low lineage specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA043271: , HPA067321: " "unprognostic (2.70e-2)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (4.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.10e-3)" "unprognostic (5.88e-5)" "unprognostic (7.65e-4)" "unprognostic (6.72e-2)" "unprognostic (2.36e-2)" "unprognostic (1.22e-2)" "unprognostic (1.46e-1)" "unprognostic (0.00e+0)" "unprognostic (6.63e-2)" "unprognostic (1.72e-1)" "unprognostic (9.74e-2)" "unprognostic (6.50e-2)" 1.1 0.7 0.8 7.2 0.8 5.5 0.7 4.0 0.9 0.6 1.1 0.6 0.4 1.4 0.8 0.4 4.4 0.2 0.5 0.4 1.0 0.7 0.5 0.4 1.3 7.6 1.0 0.4 0.4 0.4 0.3 0.4 1.5 0.8 0.4 1.6 0.4 0.6 0.4 0.4 2.9 2.0 0.5 1.1 3.3 0.8 6.7 0.4 17.7 0.4 2.7 7.4 1.1 2.5 0.1 0.7 0.1 1.7 0.0 1.0 0.5 8.3 5.1 6.0 2.4 0.2 0.5 6.6 4.8 1.4 6.1 3.8 3.4 7.6 13.7 4.9 0.7 8.9 7.3 1.4 7.2 11.0 7.3 6.8 2.5 5.0 0.1 12.2 7.7 0.3 0.5 4.8 9.3 2.7 13.6 19.2 4.0 6.3 8.2 11.9 11.4 7.1 7.3 7.6 16.2 2.1 1.1 5.9 5.0 3.6 3.3 2.2 9.3 7.9 1.2 4.5 5.0 3.8 8.6 14.5 22.8 21.3 0.0 9.7 5.1 0.0 1.2 0.0 0.0 1.7 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.0 0.5 0.8 0.8 4.0 0.9 1.0 0.7 1.0 0.4 0.8 0.4 FAM78A "C9orf59, FLJ00024" ENSG00000126882 "Family with sequence similarity 78 member A" Q5JUQ0 9 131258076-131276547 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.7;skeletal muscle: 32.3" "Cell line enhanced" "Detected in many" "BEWO: 18.1;HEL: 17.1;HL-60: 16.9;NB-4: 26.6;THP-1: 23.8;U-937: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021472, HPA023914" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "HPA021472: AB_1848411, HPA023914: AB_1848412" "unprognostic (5.16e-2)" "prognostic favourable (3.67e-4)" "unprognostic (3.65e-2)" "unprognostic (2.07e-2)" "unprognostic (2.71e-1)" "prognostic favourable (2.00e-4)" "unprognostic (3.24e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-2)" "unprognostic (5.83e-1)" "unprognostic (5.84e-2)" "unprognostic (6.79e-2)" "unprognostic (1.59e-3)" "unprognostic (2.61e-3)" "unprognostic (7.42e-2)" "unprognostic (2.61e-2)" "unprognostic (2.39e-1)" 4.9 1.5 2.9 9.3 4.6 12.4 2.5 1.1 4.3 1.0 1.6 3.4 0.8 1.8 1.2 1.1 1.1 1.1 2.0 19.2 3.8 2.0 2.1 2.5 8.0 18.4 4.3 1.0 1.8 0.8 0.8 1.0 5.8 3.2 1.3 1.1 5.4 2.7 0.7 32.3 0.8 6.1 1.2 3.6 15.9 2.3 20.1 2.4 23.7 1.5 1.8 15.0 3.1 0.8 14.4 5.2 14.5 10.9 2.5 10.5 6.9 0.3 0.1 1.1 2.5 0.8 0.2 18.1 0.2 0.1 0.2 0.1 0.1 0.1 7.5 0.1 0.1 0.0 7.3 0.1 0.0 1.9 0.6 17.1 0.2 0.1 0.3 16.9 0.7 0.2 0.3 0.0 0.0 10.0 6.0 2.1 0.2 2.6 0.7 26.6 1.2 0.2 1.8 1.0 10.5 0.1 0.0 0.7 0.9 1.0 0.3 1.0 0.6 23.8 0.2 1.0 1.1 0.6 0.0 1.6 0.8 4.4 0.1 15.9 0.2 0.4 8.6 14.5 8.6 10.9 6.8 12.5 8.3 9.3 5.2 14.4 10.5 8.7 8.8 2.5 8.1 2.4 8.2 6.9 2.9 4.6 1.1 4.3 3.8 2.0 4.3 1.0 3.2 2.4 FAM78B ENSG00000188859 "Family with sequence similarity 78 member B" Q5VT40 1 166057426-166166969 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 12.2;SK-MEL-30: 10.9;U-2 OS: 3.0;WM-115: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052789, HPA073246" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA052789: , HPA073246: " "unprognostic (7.38e-3)" "unprognostic (1.14e-3)" "unprognostic (7.96e-2)" "unprognostic (3.16e-2)" "unprognostic (3.77e-2)" "unprognostic (3.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.22e-1)" "unprognostic (8.16e-3)" "unprognostic (3.25e-2)" "unprognostic (1.69e-3)" "unprognostic (3.87e-2)" "unprognostic (1.87e-11)" "unprognostic (7.41e-2)" "unprognostic (2.09e-1)" "unprognostic (5.41e-2)" "unprognostic (2.69e-2)" 3.3 1.5 5.1 2.7 6.4 1.4 3.1 8.6 10.5 3.6 2.8 1.0 0.3 3.5 3.6 1.1 1.6 1.1 2.3 3.2 2.4 1.1 2.7 2.8 1.6 1.8 1.1 3.1 2.1 5.2 1.1 3.5 1.4 2.1 1.8 1.1 5.7 2.2 1.3 3.1 2.0 1.6 1.1 1.2 2.2 3.6 3.7 1.5 0.0 1.7 1.7 1.3 2.7 2.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 12.2 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.3 0.1 0.6 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.3 0.8 0.5 0.0 0.2 10.9 0.3 0.4 0.2 0.7 3.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 6.4 8.6 10.5 2.4 1.1 1.1 3.1 2.1 1.5 FAM86B1 MGC16279 ENSG00000186523 "Family with sequence similarity 86 member B1" Q8N7N1 8 12182096-12194133 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Cell line enhanced" "Detected in many" "AN3-CA: 5.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041610, HPA055718" Uncertain Uncertain Vesicles Vesicles "HPA041610: , HPA055718: " "unprognostic (1.90e-2)" "unprognostic (8.67e-2)" "unprognostic (2.79e-1)" "unprognostic (3.74e-2)" "unprognostic (3.13e-3)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.74e-1)" "unprognostic (5.68e-2)" "unprognostic (1.91e-2)" "unprognostic (1.32e-1)" "unprognostic (6.69e-2)" "unprognostic (8.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.58e-1)" "unprognostic (7.02e-2)" "unprognostic (2.58e-2)" 0.9 2.0 3.2 1.0 6.9 1.2 0.7 4.8 7.5 0.8 0.5 2.2 4.0 1.3 1.2 2.8 1.3 1.1 3.3 4.1 1.3 0.1 1.2 0.7 2.8 5.0 0.9 2.0 5.4 0.3 2.6 0.0 2.4 1.0 2.0 3.0 0.7 0.1 2.3 1.4 0.3 0.6 2.6 0.0 0.8 1.1 0.2 0.6 0.9 0.1 0.0 0.8 0.2 0.5 2.8 0.0 5.7 0.0 0.7 2.4 4.6 0.3 1.0 0.7 1.6 1.3 1.0 0.2 0.2 4.8 0.9 0.8 0.8 0.5 0.7 0.2 0.7 0.8 3.0 1.9 2.1 0.3 0.4 0.5 1.3 0.2 1.6 1.6 0.2 2.6 0.0 1.3 1.8 0.4 1.5 0.9 0.7 0.3 1.3 4.7 0.9 0.9 0.5 0.6 2.1 0.0 0.0 1.0 0.9 3.9 1.6 0.6 1.3 0.6 0.8 0.1 0.7 0.8 0.1 0.7 0.1 0.0 0.7 0.2 0.8 0.5 0.3 0.0 0.6 0.7 0.9 0.0 0.0 0.6 0.4 0.2 FAM86B2 ENSG00000145002 "Family with sequence similarity 86 member B2" P0C5J1 8 12425614-12436343 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 4.6" "Group enriched" "Detected in some" 7 "hTERT-HME1: 6.2;RPMI-8226: 18.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA041610, HPA055718" Uncertain Uncertain Vesicles Vesicles "HPA041610: , HPA055718: " "unprognostic (3.75e-2)" "unprognostic (1.87e-1)" "unprognostic (6.57e-2)" "unprognostic (1.01e-1)" "unprognostic (3.26e-2)" "unprognostic (2.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.48e-1)" "unprognostic (3.82e-1)" "unprognostic (3.24e-1)" "unprognostic (6.04e-4)" "unprognostic (9.37e-2)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.13e-2)" 0.4 0.9 0.2 0.4 0.7 0.0 0.8 0.2 0.3 0.8 0.8 0.4 1.0 0.0 3.9 4.6 0.7 0.1 0.2 0.5 1.1 0.5 0.6 0.1 0.2 1.3 1.1 0.6 2.2 0.1 0.6 0.6 0.5 1.8 0.3 1.2 0.0 0.6 0.0 0.0 0.4 0.1 3.4 0.1 1.0 0.6 0.4 1.3 0.0 0.9 0.6 2.1 0.3 0.2 1.3 0.2 0.0 0.3 1.4 1.4 0.2 0.7 0.5 1.3 0.5 1.3 0.8 0.0 1.4 0.2 1.0 1.7 0.0 0.0 0.0 0.2 1.7 0.0 1.2 0.0 0.0 0.4 1.5 1.4 6.2 0.0 1.2 0.2 0.1 0.4 0.0 0.4 1.2 0.4 0.2 0.7 18.1 0.0 1.2 1.8 0.0 0.5 1.4 0.3 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.5 0.4 0.9 1.1 1.3 0.4 0.4 0.3 0.0 0.6 0.9 0.0 2.1 0.3 FAM89A "C1orf153, MGC15887" ENSG00000182118 "Family with sequence similarity 89 member A" Q96GI7 1 231018958-231040246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 39.6;placenta: 48.3" "Cell line enhanced" "Detected in many" "BEWO: 51.1;SK-MEL-30: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA059052, HPA059578" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA059052: , HPA059578: " "unprognostic (7.80e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-3)" "unprognostic (1.32e-2)" "unprognostic (2.77e-1)" "unprognostic (1.41e-2)" "unprognostic (1.98e-2)" "unprognostic (1.10e-1)" "unprognostic (8.05e-3)" "unprognostic (4.85e-1)" "unprognostic (1.54e-1)" "unprognostic (6.44e-2)" "prognostic unfavourable (1.75e-5)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.01e-1)" "unprognostic (9.26e-2)" 39.6 12.9 8.0 3.7 8.5 3.9 32.8 3.9 5.4 5.1 3.6 4.9 2.0 1.6 5.7 2.1 3.4 2.7 4.6 4.7 7.9 11.2 8.7 5.7 10.5 6.7 14.0 2.3 4.7 15.0 4.0 4.2 48.3 13.1 4.7 2.4 12.0 3.5 3.9 4.2 14.1 1.8 3.5 10.9 9.6 3.1 2.8 8.3 0.8 3.9 5.0 3.6 4.3 9.7 1.2 0.0 4.3 0.7 0.3 3.0 0.8 0.3 4.7 2.2 4.6 5.4 1.1 51.1 2.6 2.0 1.0 1.8 7.1 4.2 0.0 0.6 1.7 2.8 4.1 0.6 0.8 14.2 10.0 2.2 0.1 0.3 20.7 1.6 12.4 18.0 9.3 0.0 4.7 2.5 17.6 3.0 0.9 1.6 1.0 2.9 3.3 1.5 5.5 7.1 5.3 3.5 5.0 2.0 5.6 0.9 0.4 26.7 0.2 9.9 0.3 8.0 0.0 0.1 4.9 6.4 7.7 3.9 2.3 3.3 15.8 4.3 0.7 0.0 0.6 0.1 1.1 1.2 0.8 1.5 0.0 0.6 1.3 3.0 0.0 0.3 0.2 0.0 0.0 0.8 8.0 8.5 3.9 5.4 7.9 11.2 14.0 2.3 13.1 8.3 FAM98A DKFZP564F0522 ENSG00000119812 "Family with sequence similarity 98 member A" Q8NCA5 2 33583658-33599382 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036250, HPA036251" Uncertain Supported Vesicles Vesicles "HPA036250: , HPA036251: AB_10673124" "unprognostic (7.25e-2)" "unprognostic (9.92e-2)" "unprognostic (1.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.51e-1)" "unprognostic (2.42e-2)" "prognostic unfavourable (4.86e-7)" "unprognostic (1.07e-1)" "unprognostic (2.29e-1)" "unprognostic (2.78e-2)" "unprognostic (1.01e-1)" "unprognostic (3.51e-1)" "unprognostic (2.02e-2)" "unprognostic (2.38e-2)" "unprognostic (2.66e-1)" "prognostic unfavourable (8.18e-5)" "unprognostic (6.01e-2)" 19.5 18.5 17.6 13.5 19.7 4.5 11.6 15.0 27.1 16.4 13.8 23.5 9.3 9.6 16.1 14.0 16.4 9.6 11.7 26.6 22.5 16.3 19.2 19.1 9.6 11.6 20.9 17.9 13.8 11.8 57.7 26.4 26.6 26.0 16.8 12.3 8.4 24.8 12.4 38.4 11.5 9.9 24.8 23.4 11.5 13.5 36.3 16.5 8.2 14.8 17.7 14.8 12.6 10.1 12.0 6.8 3.0 8.9 4.4 10.0 4.6 25.3 12.6 7.3 12.3 28.9 31.6 11.6 63.0 22.6 17.3 22.7 13.2 5.2 39.0 11.7 27.4 11.4 23.2 17.3 23.6 17.9 15.6 32.4 13.5 18.4 13.9 25.8 12.6 16.6 11.7 23.4 15.1 22.7 22.1 12.1 30.3 12.3 14.2 7.5 18.1 16.9 11.3 23.6 13.9 18.1 19.4 12.9 7.3 16.4 25.5 7.5 10.5 4.2 38.0 11.1 19.0 23.5 24.7 23.0 27.7 38.7 26.4 18.7 15.6 1.3 4.9 3.0 8.0 8.9 8.3 12.0 6.6 6.8 6.8 7.2 8.8 6.9 0.1 4.4 4.8 4.2 10.0 4.6 17.6 19.7 15.0 27.1 22.5 16.3 20.9 17.9 26.0 16.5 FAM98B FLJ38426 ENSG00000171262 "Family with sequence similarity 98 member B" Q52LJ0 15 38454127-38487710 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008320, HPA008502" Enhanced Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA008320: AB_1848419, HPA008502: AB_1848420" "unprognostic (1.05e-2)" "unprognostic (3.13e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-2)" "unprognostic (1.54e-2)" "unprognostic (3.09e-2)" "unprognostic (9.25e-3)" "unprognostic (1.74e-1)" "unprognostic (4.69e-2)" "unprognostic (2.18e-1)" "unprognostic (3.15e-1)" "unprognostic (3.15e-2)" "unprognostic (1.51e-2)" "unprognostic (2.26e-1)" "unprognostic (4.36e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" 15.6 15.6 20.4 16.9 21.0 10.8 17.0 27.3 24.4 13.7 19.3 12.7 8.7 12.5 17.9 12.9 14.9 14.5 11.0 15.8 20.1 19.6 17.7 10.1 10.6 16.3 18.6 20.3 15.6 10.6 27.5 18.3 20.1 17.7 16.5 15.7 9.3 11.2 14.2 16.2 11.5 12.8 17.4 21.0 13.8 12.0 13.0 14.0 27.4 15.7 12.3 16.8 14.8 13.4 3.5 2.5 3.7 1.1 3.8 6.6 0.7 13.5 7.2 35.8 18.3 6.6 12.2 17.5 17.4 12.8 17.2 17.4 16.0 6.6 9.4 19.3 14.4 14.4 21.5 17.8 24.3 9.6 11.7 27.6 16.7 12.3 9.6 26.1 16.0 11.2 11.2 15.4 17.9 17.7 19.8 11.8 16.4 6.1 22.0 14.0 19.2 10.1 23.5 19.3 7.8 14.9 17.9 22.1 22.7 19.2 12.3 8.4 15.1 16.2 14.7 19.7 24.0 13.0 19.5 22.0 19.7 34.1 10.7 17.3 20.4 3.7 0.9 2.5 5.3 0.8 4.6 2.8 5.4 4.4 1.1 3.5 6.6 5.1 0.8 3.8 1.1 2.5 3.3 0.7 20.4 21.0 27.3 24.4 20.1 19.6 18.6 20.3 17.7 14.0 FANCL "FAAP43, FLJ10335, PHF9, Pog" ENSG00000115392 "Fanconi anemia complementation group L" Q9NW38 2 58159243-58241372 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 62.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033842, HPA036685, HPA036686" Supported Approved "Nuclear bodies,Vesicles" "Nuclear bodies" Vesicles "CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844" "unprognostic (3.02e-1)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (2.02e-3)" "unprognostic (6.24e-2)" "unprognostic (2.92e-2)" "prognostic unfavourable (2.81e-7)" "unprognostic (4.71e-2)" "unprognostic (2.63e-2)" "unprognostic (1.31e-2)" "unprognostic (3.50e-1)" "unprognostic (1.17e-2)" "prognostic unfavourable (1.12e-7)" "unprognostic (1.50e-1)" "unprognostic (1.39e-1)" "unprognostic (9.08e-3)" "prognostic favourable (7.80e-5)" 6.3 29.2 16.0 11.2 22.9 10.6 16.2 7.1 18.1 11.6 9.6 30.7 7.9 9.2 16.6 15.7 8.6 11.7 9.8 10.2 17.0 23.5 7.1 16.7 7.7 10.9 25.0 15.2 21.3 10.8 16.8 62.5 10.0 33.5 11.6 12.4 13.7 14.8 9.1 6.5 14.4 10.1 11.3 23.4 12.0 10.5 14.7 28.2 8.6 14.2 6.9 12.0 10.1 12.7 10.8 7.1 5.6 6.9 8.8 5.5 2.7 18.4 13.5 27.6 13.5 4.9 6.5 14.7 13.6 8.5 13.5 17.6 11.9 23.3 12.8 17.7 4.4 10.8 15.3 10.3 22.6 30.0 24.2 21.0 19.0 16.1 5.3 20.2 11.6 4.8 4.9 9.8 3.9 10.5 19.5 11.7 9.1 9.4 7.1 25.1 29.8 2.8 13.5 20.9 10.0 11.8 18.3 31.3 15.7 19.4 8.0 12.7 7.3 13.6 6.2 12.1 18.2 8.8 14.9 12.1 7.6 7.5 25.7 13.7 18.3 2.7 3.7 5.6 4.9 6.9 3.8 10.8 4.1 5.4 7.1 10.0 1.4 3.1 1.1 8.8 4.9 6.5 5.5 2.7 16.0 22.9 7.1 18.1 17.0 23.5 25.0 15.2 33.5 28.2 FBXL6 FBL6 ENSG00000182325 "F-box and leucine rich repeat protein 6" Q8N531 8 144355431-144359376 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 4.3" "Low lineage specificity" "Detected in many" HPA008867 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA008867: AB_2668161" "unprognostic (2.97e-2)" "unprognostic (3.30e-2)" "unprognostic (1.13e-3)" "unprognostic (3.13e-1)" "unprognostic (9.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.29e-3)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.43e-2)" "unprognostic (9.04e-2)" "unprognostic (9.73e-2)" "prognostic unfavourable (4.49e-10)" "unprognostic (3.93e-2)" "unprognostic (1.44e-1)" "unprognostic (3.53e-1)" "unprognostic (2.00e-1)" 6.1 5.8 3.1 7.7 3.6 6.0 8.2 8.1 5.6 6.9 13.4 3.7 9.9 14.3 4.4 7.5 8.3 4.4 12.0 2.7 2.9 3.1 5.7 15.5 11.6 9.9 3.8 2.6 2.7 13.8 5.1 4.6 6.1 3.2 4.9 6.3 3.6 9.6 9.4 4.6 7.5 19.1 3.1 2.9 8.3 6.2 5.6 3.5 6.0 3.9 6.8 6.5 5.1 4.7 0.7 2.4 1.9 4.3 0.8 1.2 0.2 8.1 2.5 1.8 11.9 2.5 0.6 3.7 4.2 4.6 4.1 2.8 2.7 3.5 3.9 5.2 1.9 5.4 2.2 5.4 0.9 7.0 3.2 7.9 1.4 6.8 3.8 1.9 7.9 1.1 4.9 2.3 6.1 3.4 3.7 5.9 1.5 14.1 5.2 1.9 2.6 7.9 6.3 2.2 12.4 5.3 2.6 2.9 2.9 4.7 7.2 6.9 11.9 3.3 2.9 1.9 7.8 9.8 4.9 2.4 1.8 2.7 3.1 4.7 2.6 0.0 0.6 1.9 1.2 1.3 1.1 0.7 0.9 0.8 0.5 0.5 0.1 0.4 0.2 0.8 4.3 2.4 0.1 0.2 3.1 3.6 8.1 5.6 2.9 3.1 3.8 2.6 3.2 3.5 FBXO16 FBX16 ENSG00000214050 "F-box protein 16" Q8IX29 8 28348287-28490318 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 22.9;pituitary gland: 42.3" "Cell line enhanced" "Detected in many" "AF22: 15.4;Karpas-707: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 8 "dendritic cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058676, HPA076472" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Nucleoplasm, Vesicles, Plasma membrane, Cytosol" "HPA058676: , HPA076472: " "unprognostic (3.44e-1)" "unprognostic (1.44e-1)" "unprognostic (3.37e-3)" "unprognostic (5.56e-3)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (2.55e-3)" "unprognostic (4.95e-3)" "unprognostic (6.49e-2)" "prognostic favourable (6.70e-5)" "unprognostic (3.41e-3)" "unprognostic (4.90e-2)" "unprognostic (7.15e-2)" "unprognostic (1.71e-2)" "unprognostic (4.85e-2)" "unprognostic (2.72e-2)" "unprognostic (2.07e-1)" 0.9 2.3 7.3 1.3 17.6 2.6 3.4 15.8 9.9 5.4 2.0 1.1 7.6 2.6 1.8 22.9 1.1 5.7 2.1 2.0 4.2 6.8 4.0 7.2 1.9 1.5 4.4 7.5 1.2 6.3 7.2 42.3 1.0 6.3 4.3 2.6 4.6 5.9 7.3 1.1 0.8 3.8 1.2 2.1 1.7 2.7 4.8 1.4 0.0 8.7 0.2 3.3 1.9 1.1 0.6 11.5 1.4 0.3 0.1 0.5 0.2 12.0 2.5 15.4 6.0 0.4 0.0 0.4 0.1 0.6 2.4 4.5 2.4 3.6 4.6 5.6 0.1 4.1 1.7 2.5 2.3 1.8 2.9 2.2 0.2 1.3 0.3 2.6 1.6 0.2 8.3 0.6 2.5 0.0 0.8 17.8 1.0 4.1 0.3 3.6 3.3 3.5 0.1 3.6 7.1 3.2 2.1 10.0 4.2 0.3 2.5 6.7 10.7 4.5 0.5 1.3 4.7 2.7 2.2 3.9 3.4 3.9 5.2 0.6 2.7 0.5 0.3 0.1 0.2 0.2 0.5 0.4 0.4 0.3 0.9 0.6 0.2 0.3 1.4 0.1 0.2 11.5 0.3 0.2 7.3 17.6 15.8 9.9 4.2 6.8 4.4 7.5 6.3 1.4 FBXO46 "20D7-FC4, Fbx46, FBXO34L" ENSG00000177051 "F-box protein 46" Q6PJ61 19 45710629-45730904 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049390 Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA049390: " "unprognostic (9.02e-3)" "unprognostic (1.01e-2)" "unprognostic (2.82e-2)" "prognostic unfavourable (2.13e-5)" "unprognostic (9.33e-2)" "prognostic favourable (5.44e-4)" "prognostic unfavourable (1.11e-4)" "unprognostic (1.08e-1)" "unprognostic (2.06e-1)" "unprognostic (6.13e-2)" "prognostic favourable (8.11e-4)" "unprognostic (9.77e-2)" "prognostic unfavourable (5.33e-4)" "unprognostic (5.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.27e-2)" "prognostic favourable (5.09e-6)" 7.4 7.4 13.8 12.9 13.1 10.4 9.8 10.4 15.7 11.2 10.3 8.6 10.6 9.6 15.7 10.0 20.7 10.7 7.3 8.7 13.3 4.8 7.6 10.5 7.7 17.2 13.9 10.1 17.1 12.6 8.4 10.4 12.3 10.2 10.1 9.7 8.6 11.0 9.0 12.8 12.8 11.4 10.9 9.7 15.8 13.3 11.5 13.0 13.6 12.8 9.2 17.1 10.0 12.4 5.9 2.6 7.1 2.3 1.1 3.7 1.2 6.9 10.8 8.4 9.8 2.2 3.9 9.6 3.7 2.0 2.9 3.4 9.0 9.2 12.1 5.0 2.0 10.1 6.2 4.6 2.2 14.9 13.1 9.8 36.6 4.8 3.3 4.4 12.7 3.3 4.2 4.9 3.1 4.3 7.7 14.8 2.4 6.6 10.0 5.1 5.3 3.8 13.6 4.7 11.2 3.4 8.4 8.4 7.4 5.8 12.3 4.8 10.4 5.4 4.9 6.2 5.6 3.4 6.0 14.2 19.6 8.1 6.9 6.2 5.0 7.1 2.3 2.3 3.7 1.8 2.5 4.0 2.8 2.5 1.5 5.9 2.6 3.0 6.7 1.1 2.1 2.6 2.6 1.2 13.8 13.1 10.4 15.7 13.3 4.8 13.9 10.1 10.2 13.0 FBXW11 "BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696" ENSG00000072803 "F-box and WD repeat domain containing 11" Q9UKB1 5 171861549-172006873 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062578, HPA072204" Approved Approved Nucleoli,Vesicles Nucleoli Vesicles "HPA062578: , HPA072204: " "unprognostic (4.04e-3)" "unprognostic (1.27e-1)" "unprognostic (2.69e-2)" "unprognostic (5.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (1.90e-2)" "unprognostic (1.63e-1)" "unprognostic (6.87e-2)" "unprognostic (9.43e-2)" "unprognostic (1.53e-1)" "unprognostic (8.14e-3)" "unprognostic (2.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.54e-1)" "unprognostic (3.76e-3)" "unprognostic (1.76e-1)" 15.0 17.1 28.1 11.5 29.4 7.9 17.2 29.7 34.4 17.5 11.2 24.7 9.4 10.2 19.2 10.7 20.0 22.7 14.5 30.3 28.9 26.3 19.5 16.5 14.0 14.0 28.8 20.1 21.8 24.1 37.8 15.8 11.2 23.3 16.2 13.3 12.4 11.6 18.1 24.5 11.0 10.3 21.6 30.6 13.6 15.8 11.3 21.2 12.0 17.5 7.0 17.0 12.9 16.0 9.0 8.2 19.1 7.0 12.9 6.2 5.5 16.2 16.7 24.9 21.7 19.6 19.9 12.7 17.5 25.1 21.9 27.6 17.0 11.0 14.9 21.6 22.4 10.7 17.9 26.4 36.6 19.7 17.7 12.1 17.4 13.1 17.8 13.4 17.3 14.4 18.4 17.6 28.9 18.3 7.5 15.1 26.6 12.2 9.3 7.0 9.5 18.6 13.8 20.9 10.1 16.9 13.8 10.4 18.4 15.4 13.1 32.3 16.4 14.4 15.8 21.7 10.8 13.1 17.2 15.4 17.4 10.4 15.2 12.9 16.5 19.1 7.0 6.5 5.7 4.7 6.2 8.7 4.9 5.7 6.9 9.0 4.7 5.8 6.7 12.9 5.1 8.2 5.3 5.5 28.1 29.4 29.7 29.9 28.9 26.3 28.8 20.1 23.3 21.2 FBXW7 "AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10" ENSG00000109670 "F-box and WD repeat domain containing 7" Q969H0 4 152320544-152536063 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 60.1;skin 1: 45.0" "Cell line enhanced" "Detected in all" "U-266/70: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013793, CAB029987" Supported Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB013793: AB_2533451, CAB029987: AB_2246842" "unprognostic (3.32e-1)" "unprognostic (9.02e-2)" "unprognostic (1.84e-2)" "unprognostic (3.08e-2)" "unprognostic (3.87e-1)" "unprognostic (1.36e-3)" "unprognostic (4.37e-1)" "unprognostic (1.94e-1)" "unprognostic (8.28e-2)" "unprognostic (3.29e-1)" "unprognostic (5.32e-3)" "unprognostic (3.19e-2)" "prognostic unfavourable (1.52e-4)" "unprognostic (3.38e-2)" "unprognostic (1.41e-1)" "unprognostic (5.49e-3)" "unprognostic (2.17e-3)" 9.2 6.8 27.0 8.9 27.9 11.1 9.8 27.2 60.1 5.5 6.1 3.6 3.8 4.9 6.0 18.3 9.8 10.6 6.3 10.9 21.4 10.1 4.1 7.3 6.9 9.8 9.1 40.5 6.4 8.0 6.4 7.3 6.2 37.2 5.1 6.9 2.8 7.6 5.3 15.8 45.0 6.5 6.1 6.4 10.1 8.0 13.7 5.7 6.5 6.8 10.6 12.3 7.9 6.5 2.9 2.2 16.6 3.4 7.8 5.0 1.3 4.9 3.9 10.2 7.4 7.1 5.1 8.4 7.1 6.5 4.4 4.2 7.9 6.3 12.7 2.0 6.8 2.9 8.7 16.0 6.2 7.2 4.1 5.9 4.8 5.6 7.2 14.4 5.4 8.1 25.3 7.6 12.9 7.7 9.3 13.6 5.5 6.9 16.5 5.7 5.0 3.1 16.6 4.3 2.5 5.4 8.5 6.5 5.6 4.5 6.2 3.9 3.4 6.8 8.1 6.0 6.8 3.1 4.0 37.4 21.3 12.4 4.8 4.7 4.3 16.6 3.1 1.7 5.0 3.4 3.3 2.9 3.7 3.2 1.8 2.4 3.9 3.2 5.5 7.8 2.5 2.2 3.3 1.3 27.0 27.9 27.2 60.1 21.4 10.1 9.1 40.5 37.2 5.7 FCHO2 ENSG00000157107 "FCH domain only 2" Q0JRZ9 5 72955981-73090522 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.9" "Group enriched" "Detected in many" 8 "granulocytes: 15.9;monocytes: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037685, HPA037686, HPA077850" Enhanced Approved Vesicles,Centrosome,Cytosol Centrosome "Vesicles, Cytosol" "HPA037685: AB_2675610, HPA037686: AB_10673636, HPA077850: " "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" "unprognostic (1.01e-2)" "unprognostic (1.10e-1)" "unprognostic (6.59e-2)" "unprognostic (2.68e-3)" "unprognostic (4.99e-2)" "unprognostic (6.25e-2)" "unprognostic (1.31e-1)" "unprognostic (5.67e-2)" "unprognostic (6.56e-3)" "unprognostic (1.21e-1)" "prognostic favourable (7.00e-5)" "unprognostic (1.43e-1)" "unprognostic (3.27e-3)" "unprognostic (9.59e-2)" "unprognostic (1.76e-1)" 32.2 9.6 10.7 10.0 12.2 8.3 18.0 23.1 18.3 16.2 18.3 8.9 15.3 15.5 23.7 13.0 30.2 14.6 15.7 12.5 11.2 7.0 18.6 16.0 22.8 18.5 10.8 9.5 16.1 11.1 17.5 11.4 19.2 10.9 12.6 16.1 9.9 17.1 12.6 17.7 15.2 20.8 16.6 11.9 18.9 12.2 10.5 12.4 3.2 22.4 11.7 11.8 14.6 22.5 0.7 1.1 15.9 4.5 0.7 1.3 0.5 9.0 7.4 7.1 6.2 10.0 13.3 20.9 8.0 11.9 6.1 9.6 3.7 15.9 2.2 11.3 11.1 6.9 6.0 14.1 8.3 2.3 7.0 4.4 6.1 4.6 5.0 0.9 4.6 8.9 7.3 8.2 13.1 13.8 5.0 3.9 12.5 4.2 0.0 4.4 2.2 3.7 2.0 6.9 2.6 14.8 12.9 2.8 4.5 11.0 7.8 5.0 9.5 6.3 14.3 8.0 3.8 8.8 5.6 1.4 2.5 0.4 5.2 0.6 9.8 11.5 2.6 6.4 1.3 3.5 0.8 0.3 0.4 0.5 1.1 0.7 0.2 0.4 15.9 0.7 4.5 0.4 0.3 0.5 10.7 12.2 23.1 18.3 11.2 7.0 10.8 9.5 10.9 12.4 FERMT3 "KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2" ENSG00000149781 "Fermitin family member 3" Q86UX7 11 64206678-64223886 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 59.4;bone marrow: 57.6;lymphoid tissue: 52.7" "Cell line enhanced" "Detected in many" "HEL: 61.5;HL-60: 26.9;HMC-1: 65.8;Karpas-707: 26.5;NB-4: 34.6;U-937: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065231 Approved Vesicles 450000000 Vesicles "HPA065231: " "unprognostic (1.96e-2)" "unprognostic (1.07e-2)" "unprognostic (3.38e-3)" "prognostic favourable (9.89e-4)" "unprognostic (8.77e-2)" "unprognostic (1.83e-2)" "unprognostic (3.56e-2)" "unprognostic (2.46e-1)" "unprognostic (4.20e-1)" "unprognostic (3.98e-1)" "unprognostic (2.70e-1)" "unprognostic (3.88e-1)" "prognostic unfavourable (2.12e-5)" "unprognostic (3.08e-3)" "unprognostic (5.25e-2)" "unprognostic (4.97e-2)" "unprognostic (1.75e-1)" 20.0 5.6 3.1 29.4 5.5 57.6 5.6 0.9 3.2 3.4 8.8 3.4 0.7 8.1 3.4 6.0 3.6 5.8 6.5 7.2 2.2 2.4 5.3 5.5 17.8 39.1 6.3 0.8 4.9 2.8 0.2 2.6 7.5 3.7 4.2 3.0 5.6 8.9 2.9 3.2 2.8 12.4 3.3 4.8 52.7 10.6 2.5 4.3 51.2 4.0 2.4 29.6 6.2 2.9 13.7 47.3 54.7 49.5 22.6 30.6 59.4 0.2 0.3 0.1 0.1 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.5 0.4 6.5 0.6 1.2 0.5 0.2 0.1 0.1 16.7 0.1 61.5 0.2 0.0 2.3 26.9 65.8 0.2 0.2 1.0 0.0 16.7 1.4 26.5 1.7 0.7 23.9 34.6 0.2 0.4 14.5 1.8 0.1 0.0 0.1 0.3 0.1 0.1 0.9 0.3 0.4 18.7 1.5 0.2 0.5 0.3 0.1 0.3 0.6 11.8 4.1 27.9 17.7 40.6 49.5 54.7 30.6 46.3 29.4 13.7 24.4 28.4 39.0 13.4 16.1 21.1 45.0 22.6 33.5 47.3 28.3 59.4 3.1 5.5 0.9 3.2 2.2 2.4 6.3 0.8 3.7 4.3 FES FPS ENSG00000182511 "FES proto-oncogene, tyrosine kinase" P07332 15 90883695-90895776 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.8;lymphoid tissue: 49.7" "Cell line enhanced" "Detected in many" "HEL: 20.9;HL-60: 18.6;HMC-1: 39.8;NB-4: 24.4;THP-1: 36.6;U-937: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 60.8" "Group enriched" "Detected in many" 4 "dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001376 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA001376: AB_1078847" "unprognostic (1.07e-2)" "unprognostic (2.54e-2)" "prognostic unfavourable (5.78e-4)" "unprognostic (2.31e-2)" "unprognostic (4.05e-3)" "unprognostic (7.33e-2)" "unprognostic (1.74e-1)" "unprognostic (2.22e-1)" "unprognostic (1.58e-3)" "unprognostic (1.35e-1)" "unprognostic (4.66e-2)" "unprognostic (5.15e-3)" "unprognostic (1.78e-3)" "unprognostic (2.53e-3)" "unprognostic (6.08e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-1)" 14.9 3.4 4.8 9.7 4.1 38.3 12.7 2.4 5.7 6.8 5.4 3.2 4.7 3.0 7.4 5.6 4.9 7.6 7.3 7.9 4.2 2.2 5.2 11.8 12.7 23.3 3.7 0.9 6.4 3.7 1.8 2.7 8.1 7.2 7.7 2.4 5.3 33.8 6.3 3.4 3.5 5.2 5.4 6.9 49.7 4.3 3.2 4.7 3.1 7.2 4.1 4.5 7.2 9.4 1.1 32.6 60.8 30.5 9.3 0.1 13.8 0.1 0.2 0.3 3.5 1.0 3.1 6.0 0.9 0.0 1.7 1.0 0.8 0.0 2.2 0.1 2.0 0.5 0.6 0.1 0.5 1.1 0.3 20.9 0.0 3.7 2.0 18.6 39.8 3.0 0.0 2.6 0.0 10.5 0.6 0.0 0.0 6.8 0.5 24.4 1.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.8 0.0 36.6 8.3 0.0 3.6 0.1 0.0 0.0 2.6 0.8 0.1 15.8 0.8 10.4 30.5 60.8 0.1 17.6 0.0 1.1 0.0 0.0 32.6 0.9 0.0 0.0 20.0 9.3 7.3 12.9 0.0 13.8 4.8 4.1 2.4 5.7 4.2 2.2 3.7 0.9 7.2 4.7 FGD6 "FLJ11183, ZFYVE24" ENSG00000180263 "FYVE, RhoGEF and PH domain containing 6" Q6ZV73 12 95076749-95217482 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5" "Group enriched" "Detected in many" 6 "B-cells: 2.0;dendritic cells: 1.9;monocytes: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007974 Approved Approved Vesicles Vesicles "HPA007974: AB_1848520" "unprognostic (1.28e-2)" "unprognostic (2.67e-3)" "unprognostic (6.06e-2)" "unprognostic (5.56e-2)" "unprognostic (1.65e-1)" "unprognostic (4.70e-2)" "unprognostic (4.66e-2)" "unprognostic (1.35e-3)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "prognostic unfavourable (4.62e-5)" "prognostic unfavourable (9.83e-4)" "prognostic unfavourable (5.46e-6)" "unprognostic (1.01e-2)" "unprognostic (1.38e-1)" "unprognostic (3.33e-2)" "unprognostic (1.92e-1)" 4.6 8.6 7.8 31.4 9.1 2.6 6.4 5.3 8.5 7.2 10.0 3.9 14.5 2.7 6.6 2.6 9.2 5.1 9.3 8.2 7.4 3.4 6.5 6.0 9.9 9.5 3.7 5.2 9.0 10.2 4.2 3.8 13.1 4.3 7.4 8.1 6.2 4.8 17.2 4.2 14.3 8.7 9.8 6.3 5.9 5.2 5.6 5.4 5.0 9.9 5.1 17.1 7.2 11.1 2.0 1.9 0.5 5.5 0.3 0.2 0.9 14.5 13.3 12.4 1.4 1.3 1.2 6.5 2.1 2.9 0.8 1.2 5.1 10.1 15.5 3.5 1.3 5.9 2.2 12.5 1.8 1.6 1.4 0.7 2.2 2.5 1.7 1.6 0.1 5.2 5.7 1.5 15.3 8.0 3.2 0.3 0.4 0.7 1.2 0.3 5.1 4.7 3.5 2.4 1.2 8.8 4.7 2.1 3.3 6.0 3.1 0.3 1.4 0.1 10.9 0.5 1.4 0.6 1.6 1.5 3.3 4.5 0.6 1.0 0.9 0.5 3.3 0.0 0.1 5.5 0.0 1.3 0.0 0.0 1.9 2.0 0.2 0.0 0.2 0.3 3.8 0.0 0.0 0.9 7.8 9.1 5.3 8.5 7.4 3.4 3.7 5.2 4.3 5.4 FGFR2 "BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25" ENSG00000066468 "Fibroblast growth factor receptor 2" P21802 10 121478334-121598458 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.8" "Cell line enhanced" "Detected in some" "AN3-CA: 57.8;BEWO: 19.4;CACO-2: 15.1;HaCaT: 17.4;HAP1: 18.7;NTERA-2: 18.5;T-47d: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 10.8;eosinophil: 4.6" "Lineage enriched" "Detected in single" 35 "granulocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010886, HPA035305" Uncertain Supported "Nucleoplasm,Vesicles,Cell Junctions" "Secreted - unknown location" 500000 "Cell Junctions" "Nucleoplasm, Vesicles" "CAB010886: AB_259379, HPA035305: AB_10672862" "unprognostic (5.53e-2)" "prognostic favourable (8.79e-4)" "unprognostic (1.08e-1)" "unprognostic (5.23e-2)" "unprognostic (1.73e-1)" "prognostic favourable (9.32e-4)" "unprognostic (1.53e-1)" "unprognostic (4.96e-3)" "unprognostic (1.74e-1)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "unprognostic (2.54e-1)" "unprognostic (6.93e-2)" "unprognostic (2.25e-1)" 2.1 8.8 16.4 3.0 30.3 0.0 9.9 15.8 21.3 6.8 14.1 55.7 5.6 4.2 22.0 6.6 10.2 12.5 12.5 1.4 20.6 11.1 11.4 16.1 13.1 1.0 41.2 13.3 7.4 12.8 25.5 2.5 6.2 30.2 11.7 8.7 16.4 23.8 24.3 0.4 45.4 4.7 18.3 74.8 0.5 9.3 2.9 32.1 0.8 23.4 1.6 3.4 6.9 8.5 0.1 0.1 10.8 0.1 0.1 0.3 0.0 2.2 0.1 9.0 57.8 0.0 0.0 19.4 0.1 0.0 0.0 0.0 15.1 0.3 0.0 4.1 0.9 17.4 18.7 4.0 0.0 0.0 4.0 0.0 0.0 0.3 0.4 0.0 3.8 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 18.5 0.0 0.0 0.0 2.2 5.6 4.9 0.1 0.1 0.1 10.6 0.0 15.5 0.0 0.0 0.1 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 10.8 0.1 4.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 16.4 30.3 15.8 21.3 20.6 11.1 41.2 13.3 30.2 32.1 FGFRL1 ENSG00000127418 "Fibroblast growth factor receptor like 1" Q8N441 4 1009936-1026897 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 51.1" "Cell line enhanced" "Detected in many" "U-251 MG: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.5;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;monocytes: 3.6;T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026019, HPA068828" Approved Supported Vesicles Vesicles "CAB026019: , HPA068828: " "unprognostic (1.30e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "unprognostic (2.80e-2)" "unprognostic (1.23e-2)" "unprognostic (1.48e-1)" "unprognostic (2.62e-2)" "unprognostic (9.79e-2)" "unprognostic (4.87e-3)" "unprognostic (8.46e-2)" "unprognostic (2.01e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-3)" "unprognostic (1.49e-1)" "unprognostic (7.80e-2)" "unprognostic (1.06e-2)" "unprognostic (1.96e-2)" 21.8 22.9 16.0 6.1 20.5 5.8 21.5 13.8 20.6 8.1 6.6 9.1 5.3 6.6 6.6 5.0 4.7 19.7 9.8 12.2 16.6 3.6 11.5 25.1 6.4 4.0 8.8 8.4 14.0 51.1 12.6 9.0 3.1 17.0 7.6 4.8 12.7 29.3 3.1 9.6 3.7 6.0 4.1 14.0 5.3 15.0 3.2 11.1 1.0 33.8 3.9 3.6 6.2 11.5 0.4 0.3 1.2 3.6 0.1 1.2 0.4 8.5 11.6 4.2 12.8 4.5 4.7 1.1 15.2 2.3 4.8 3.2 8.4 17.7 0.9 19.8 23.1 2.2 8.1 5.1 4.5 3.2 7.9 0.1 15.2 22.1 9.2 4.9 2.1 9.9 4.4 8.4 3.6 4.6 9.3 3.3 2.9 11.1 5.7 13.5 5.3 31.6 9.4 6.2 6.0 8.5 1.3 0.4 0.8 14.0 0.3 5.6 8.4 4.3 9.9 26.2 10.7 13.2 36.8 3.6 4.8 1.3 6.9 5.7 8.4 1.2 0.1 0.0 0.7 3.5 0.1 0.4 1.2 0.2 0.3 0.1 0.2 0.5 0.0 0.1 3.6 0.3 0.1 0.4 16.0 20.5 13.8 20.6 16.6 3.6 8.8 8.4 17.0 11.1 FIG4 "ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3" ENSG00000112367 "FIG4 phosphoinositide 5-phosphatase" Q92562 6 109691312-109825428 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017823, HPA068859" Approved Approved "Vesicles,Lipid droplets" "Vesicles, Lipid droplets" "CAB017823: , HPA068859: " "prognostic unfavourable (5.91e-4)" "unprognostic (4.12e-2)" "prognostic favourable (8.42e-4)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (4.73e-4)" "unprognostic (7.06e-2)" "unprognostic (2.69e-1)" "unprognostic (8.67e-2)" "unprognostic (3.44e-3)" "unprognostic (4.22e-2)" "prognostic favourable (8.19e-4)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (5.45e-2)" "unprognostic (2.00e-2)" 11.0 13.5 14.5 12.2 30.3 14.0 14.4 13.5 35.3 12.4 13.2 11.0 5.0 8.3 11.3 17.0 11.7 10.5 13.4 10.1 14.5 18.5 13.2 8.7 19.2 16.6 17.6 17.7 12.2 9.9 25.4 15.4 12.6 19.0 11.6 14.6 9.7 17.0 12.0 12.1 9.2 10.7 14.7 16.0 17.3 11.4 12.6 12.9 18.1 12.6 8.5 15.0 12.5 10.5 15.5 15.9 12.8 20.0 8.0 7.7 9.8 6.2 6.5 9.8 11.7 10.4 14.4 6.2 8.1 11.7 6.7 18.0 4.8 6.6 16.8 5.2 13.1 4.7 9.6 6.4 15.6 10.2 11.7 9.4 6.5 4.8 9.6 8.8 8.4 7.4 8.4 11.4 7.9 13.6 5.5 7.2 9.4 5.8 9.0 7.6 5.1 3.2 6.3 4.5 5.8 11.3 15.5 10.9 10.2 5.3 7.8 16.4 5.6 14.7 9.5 4.2 3.6 6.1 6.9 3.4 2.4 8.1 22.3 6.3 3.8 11.5 20.0 12.8 7.7 19.7 6.0 14.6 5.7 7.3 15.9 15.5 7.0 6.8 8.7 8.0 13.5 6.9 6.6 9.8 14.5 30.3 13.5 35.3 14.5 18.5 17.6 17.7 19.0 12.9 FIGN ENSG00000182263 "Fidgetin, microtubule severing factor" Q5HY92 2 163593396-163736012 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 54 "basophil: 5.4" "Lineage enriched" "Detected in single" 54 "granulocytes: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034987, HPA057919" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "Vesicles, Cell Junctions" "HPA034987: AB_10669681, HPA057919: " "unprognostic (3.93e-2)" "unprognostic (8.30e-3)" "unprognostic (1.48e-1)" "unprognostic (7.68e-5)" "unprognostic (3.45e-2)" "unprognostic (8.98e-4)" "unprognostic (5.23e-3)" "unprognostic (7.65e-3)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (2.07e-2)" "unprognostic (3.24e-2)" "unprognostic (3.85e-3)" "unprognostic (3.22e-2)" "unprognostic (2.69e-1)" "unprognostic (4.10e-2)" "unprognostic (3.78e-2)" 8.5 7.6 9.6 2.9 13.7 2.8 5.2 5.1 11.9 6.8 5.9 5.5 3.7 2.1 3.3 5.0 2.9 4.5 4.4 10.1 8.8 4.3 7.2 7.9 4.3 2.5 8.7 4.7 14.3 7.2 1.8 12.1 4.4 7.7 4.8 3.4 4.3 8.4 9.9 3.6 3.2 3.6 5.6 9.1 8.7 4.5 4.4 10.5 0.0 3.1 3.0 1.6 4.1 6.3 0.0 0.0 5.4 0.0 0.0 0.0 0.0 5.7 2.1 17.3 0.0 0.0 0.0 6.4 2.2 1.5 1.6 3.0 0.0 2.1 0.0 6.2 2.4 0.8 5.7 2.4 1.3 0.0 4.3 0.0 4.0 4.1 1.4 0.0 0.0 0.8 2.1 3.1 8.5 3.7 0.0 0.0 4.7 1.4 0.0 0.0 7.3 2.7 0.0 5.8 0.0 4.0 1.9 2.7 2.3 0.0 1.6 1.5 1.8 0.0 0.3 7.2 6.5 0.0 4.6 1.0 0.0 0.0 2.1 0.0 3.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 13.7 5.1 11.9 8.8 4.3 8.7 4.7 7.7 10.5 FJX1 "FLJ22416, FLJ25593" ENSG00000179431 "Four jointed box 1" Q86VR8 11 35618419-35620868 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4" "Cell line enhanced" "Detected in many" "U-251 MG: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059220 Uncertain Approved Vesicles "Intracellular and membrane" Vesicles "HPA059220: " "unprognostic (8.99e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-3)" "unprognostic (5.20e-2)" "unprognostic (5.72e-2)" "unprognostic (9.56e-3)" "unprognostic (5.16e-2)" "unprognostic (1.06e-2)" "unprognostic (1.74e-1)" "unprognostic (4.39e-3)" "unprognostic (5.28e-2)" "unprognostic (2.02e-1)" "prognostic unfavourable (9.24e-9)" "unprognostic (1.64e-2)" "unprognostic (9.64e-2)" "unprognostic (8.35e-2)" "prognostic unfavourable (6.56e-4)" 6.0 3.5 7.8 3.5 10.3 0.7 3.6 6.6 25.4 8.8 1.4 7.9 0.0 1.1 10.1 3.4 3.1 6.1 4.5 2.4 8.0 4.9 3.8 4.9 2.2 2.3 5.7 5.7 12.2 17.0 1.7 1.8 6.6 7.7 4.1 1.1 2.7 2.6 4.7 1.1 10.3 1.1 3.4 5.1 7.8 1.7 1.2 3.3 1.7 2.2 3.0 3.4 3.7 2.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 9.9 5.0 5.3 1.7 1.8 5.8 1.6 11.2 7.6 10.8 7.8 6.3 3.1 0.0 2.6 4.4 10.6 1.8 18.5 9.2 0.1 14.6 0.9 1.9 0.2 4.4 1.1 0.0 2.2 14.1 5.6 17.1 4.9 5.3 0.0 10.3 2.3 0.3 0.0 7.3 14.8 0.6 11.8 2.3 8.2 12.3 5.0 2.8 1.2 0.9 3.1 21.3 0.2 9.5 8.6 15.8 1.6 26.4 0.0 0.0 0.0 15.3 0.5 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 10.3 6.6 12.3 8.0 4.9 5.7 5.7 7.7 3.3 FKBP10 "FKBP6, FLJ20683, FLJ22041, FLJ23833, hFKBP65" ENSG00000141756 "FK506 binding protein 10" Q96AY3 17 41812680-41823217 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Isomerase, Rotamase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 72.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 2.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051171, HPA057021" Enhanced Approved Vesicles "Intracellular and membrane" 5500 Vesicles "HPA051171: , HPA057021: " "unprognostic (8.30e-2)" "prognostic unfavourable (4.16e-4)" "unprognostic (9.05e-2)" "unprognostic (1.71e-2)" "unprognostic (4.77e-2)" "unprognostic (2.95e-2)" "unprognostic (1.14e-2)" "unprognostic (9.98e-2)" "unprognostic (2.21e-2)" "unprognostic (7.57e-2)" "unprognostic (1.14e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.34e-2)" "unprognostic (5.77e-2)" "prognostic unfavourable (3.43e-5)" "prognostic unfavourable (4.99e-4)" 16.9 16.5 6.6 13.2 7.2 0.2 14.9 3.4 8.4 43.0 11.5 6.0 15.8 3.8 42.7 39.0 14.0 21.4 28.6 19.2 5.6 3.6 10.3 3.2 16.2 17.1 5.3 6.7 35.5 13.5 24.7 22.7 33.8 5.2 21.3 5.7 17.1 6.5 17.0 9.6 8.8 7.6 27.9 5.5 7.9 8.5 15.1 5.7 1.2 16.9 9.5 8.1 24.4 19.2 0.3 0.0 0.0 0.0 2.0 0.9 0.1 0.0 16.1 14.9 48.7 52.4 61.2 13.1 66.3 66.4 25.0 21.6 8.3 0.6 0.0 0.9 72.0 0.1 8.9 17.7 10.6 4.4 13.3 6.4 18.1 23.8 57.2 0.0 0.0 65.7 0.0 20.5 15.7 21.2 0.2 2.3 20.8 20.9 0.0 0.0 11.6 5.4 1.3 17.5 2.1 4.3 0.0 3.7 13.0 0.1 47.7 22.2 7.5 0.4 24.0 30.2 15.7 20.0 10.1 0.1 0.0 0.0 41.3 0.0 28.7 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.9 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.1 6.6 7.2 3.4 5.8 5.6 3.6 5.3 6.7 5.2 5.7 FKBP1B "FKBP12.6, FKBP1L, FKBP9, OTK4, PPIase" ENSG00000119782 "FK506 binding protein 1B" P68106 2 24049701-24063681 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.1;intestine: 24.9" "Cell line enhanced" "Detected in many" "Hep G2: 22.8;NTERA-2: 22.2;SH-SY5Y: 16.1;TIME: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 5.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045572, HPA051798" Uncertain Approved Vesicles Vesicles "HPA045572: , HPA051798: " "unprognostic (3.01e-3)" "unprognostic (3.35e-1)" "unprognostic (7.05e-2)" "unprognostic (9.89e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-2)" "unprognostic (9.19e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-1)" "unprognostic (9.55e-2)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (7.53e-2)" "unprognostic (3.43e-2)" "unprognostic (2.85e-2)" "unprognostic (1.45e-1)" 2.9 5.9 25.0 2.8 30.7 1.9 5.9 15.7 23.1 5.1 7.2 1.6 7.4 24.9 3.6 4.2 4.5 4.5 7.1 3.4 31.1 14.0 4.4 4.6 9.0 2.2 13.0 19.7 4.6 4.9 6.4 2.8 5.6 7.9 5.1 4.6 2.4 3.3 9.2 1.1 3.6 6.7 4.0 5.2 1.8 13.3 1.6 4.4 0.6 5.0 1.1 3.2 7.1 3.5 1.5 2.2 4.4 0.8 0.3 5.4 1.1 0.1 1.0 8.9 0.0 5.6 2.2 3.1 3.0 3.1 1.3 1.9 0.6 1.0 0.0 2.2 5.2 3.4 13.1 10.2 0.8 1.5 8.4 3.0 0.1 22.8 2.1 0.0 7.3 2.1 2.4 3.0 0.6 8.3 0.7 0.0 2.9 0.1 0.9 0.0 22.2 1.5 1.5 0.7 0.0 1.0 0.6 2.2 16.1 0.1 0.0 2.8 0.6 1.1 19.4 0.0 2.8 0.1 0.7 0.5 0.2 0.0 3.2 0.0 0.7 1.3 0.8 4.4 0.3 0.7 0.0 0.3 0.6 0.5 2.2 1.5 0.0 0.2 0.1 0.3 0.0 0.4 5.4 1.1 25.0 30.7 15.7 23.1 31.1 14.0 13.0 19.7 7.9 4.4 FKBP9 "FKBP60, FKBP63" ENSG00000122642 "FK506 binding protein 9" O95302 7 32957404-33006931 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 57.5;fHDF/TERT166: 70.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 7.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012595, HPA055256" Approved Approved "Golgi apparatus,Vesicles,Mitochondria" "Intracellular and membrane" "Golgi apparatus, Mitochondria" Vesicles "HPA012595: AB_1848629, HPA055256: " "unprognostic (1.23e-2)" "prognostic unfavourable (4.22e-4)" "unprognostic (6.94e-2)" "unprognostic (6.25e-3)" "prognostic unfavourable (5.80e-4)" "prognostic unfavourable (2.02e-4)" "prognostic unfavourable (8.69e-4)" "unprognostic (3.40e-2)" "unprognostic (9.59e-2)" "unprognostic (2.58e-1)" "unprognostic (3.63e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-2)" "unprognostic (6.31e-2)" "unprognostic (1.97e-1)" "unprognostic (8.90e-3)" "prognostic unfavourable (7.02e-6)" 35.4 21.1 9.7 12.5 13.6 0.9 43.7 4.5 16.3 33.6 18.3 9.3 16.8 8.8 31.3 30.9 23.7 24.1 28.8 44.4 9.7 11.9 18.2 10.1 30.6 17.5 10.8 9.7 25.9 26.0 12.9 16.0 35.2 13.2 23.7 21.2 30.4 16.0 25.6 17.1 28.0 13.4 37.0 12.8 10.7 17.4 16.3 6.4 2.9 18.9 19.4 11.1 23.7 23.6 0.4 1.4 7.4 4.1 0.3 0.1 0.9 7.0 13.4 5.2 21.6 49.7 57.5 7.0 38.1 39.7 12.6 20.1 5.8 16.8 0.0 15.6 70.8 13.8 7.7 18.6 14.5 0.0 2.3 1.2 14.4 5.8 20.7 0.0 2.0 37.3 11.3 11.2 10.9 15.8 2.7 1.4 25.6 6.8 0.0 3.5 1.1 7.1 0.0 14.1 0.0 14.1 2.4 4.9 12.0 21.7 11.1 13.5 7.8 3.4 21.2 20.7 19.9 12.8 8.7 4.6 8.8 0.0 20.2 0.0 41.1 1.5 4.1 0.9 0.1 2.6 0.1 0.4 0.1 0.0 1.4 0.3 0.1 0.1 7.4 0.3 0.7 0.3 0.0 0.9 9.7 13.6 4.5 16.3 9.7 11.9 10.8 9.7 13.2 6.4 FLOT1 ENSG00000137312 "Flotillin 1" O75955 6 30727709-30742733 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001393, CAB007766" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" 1500000 "Golgi apparatus" "Vesicles, Plasma membrane" "CAB007766: AB_562116, HPA001393: AB_1078892" "unprognostic (2.68e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (5.78e-4)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" "unprognostic (3.41e-3)" "unprognostic (2.68e-3)" "unprognostic (1.86e-1)" "unprognostic (2.65e-1)" "prognostic favourable (3.06e-4)" "unprognostic (1.81e-2)" "unprognostic (9.36e-2)" "prognostic unfavourable (1.49e-4)" "unprognostic (6.43e-3)" "unprognostic (3.92e-1)" "unprognostic (1.61e-2)" "unprognostic (2.46e-2)" 25.7 43.8 32.1 22.6 26.1 22.4 45.9 27.8 37.4 32.9 23.3 14.3 18.8 16.7 19.3 16.7 15.8 27.6 18.8 46.4 29.5 25.7 26.6 26.0 22.9 34.1 29.2 31.9 16.5 24.7 28.7 17.9 25.9 27.2 23.1 18.4 13.0 25.5 32.9 46.1 8.2 16.7 29.0 30.4 22.8 16.7 11.7 18.7 7.8 28.7 13.8 17.1 21.3 36.9 2.9 6.0 29.1 7.3 7.2 3.5 4.7 7.2 2.9 7.0 8.3 7.2 11.1 3.7 7.4 10.1 13.1 11.7 3.8 3.6 4.9 8.1 16.8 5.4 6.9 2.8 8.0 15.1 6.6 6.4 2.8 3.8 17.1 1.2 8.4 11.9 4.2 7.8 15.1 9.1 4.6 7.9 13.7 2.4 4.2 1.7 2.3 8.4 5.4 7.9 6.7 5.1 2.1 6.7 6.4 5.5 3.9 27.8 6.3 1.3 6.1 25.1 8.2 4.4 20.7 5.4 5.3 4.9 3.4 5.3 15.9 12.8 7.3 12.2 3.5 3.4 2.3 2.9 2.2 2.9 5.5 2.2 2.5 2.9 29.1 7.2 2.2 6.0 0.3 4.7 32.1 26.1 27.8 37.4 29.5 25.7 29.2 31.9 27.2 18.7 FLOT2 "ECS-1, ECS1, ESA, ESA1, M17S1" ENSG00000132589 "Flotillin 2" Q14254 17 28879335-28897679 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001396, CAB004395, HPA071038" Supported Supported "Vesicles,Plasma membrane" 1900000 "Plasma membrane" Vesicles "CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: " "unprognostic (6.04e-2)" "unprognostic (8.76e-3)" "unprognostic (3.01e-1)" "unprognostic (8.92e-2)" "unprognostic (4.15e-3)" "unprognostic (2.17e-2)" "unprognostic (4.36e-3)" "unprognostic (2.12e-1)" "unprognostic (5.21e-2)" "unprognostic (1.20e-1)" "unprognostic (9.98e-2)" "unprognostic (2.80e-1)" "unprognostic (4.12e-3)" "unprognostic (2.64e-2)" "unprognostic (1.09e-1)" "unprognostic (1.11e-3)" "unprognostic (2.20e-2)" 26.1 19.5 21.5 28.3 21.9 47.8 21.1 17.3 35.9 17.3 20.7 14.4 13.7 11.1 15.7 14.3 25.9 21.0 15.0 24.5 17.3 18.7 36.4 52.5 24.7 40.1 15.3 17.8 19.8 18.5 18.8 9.1 30.4 31.9 27.6 14.8 20.9 24.3 29.5 21.1 17.7 19.2 25.5 12.8 49.6 17.5 8.4 12.3 17.4 21.8 14.5 33.1 36.7 34.4 25.7 29.4 84.8 21.3 14.8 21.4 24.1 14.7 25.2 19.6 16.8 10.0 12.7 21.2 11.5 15.9 17.0 20.1 26.0 12.7 20.6 22.4 12.8 17.5 21.1 19.1 7.3 65.3 24.9 25.0 23.7 18.7 13.2 20.3 4.2 15.4 14.8 14.1 18.9 26.9 23.5 18.1 7.8 22.3 5.6 15.3 17.2 6.7 8.7 19.7 50.4 30.0 46.3 17.3 29.0 27.0 19.3 20.9 20.1 36.6 21.9 6.1 11.0 9.8 17.4 10.3 17.7 10.6 17.0 19.6 11.3 28.0 21.3 41.2 21.4 19.5 15.8 21.4 16.4 18.1 29.4 25.7 12.3 15.2 84.8 14.8 20.8 8.0 19.3 24.1 21.5 21.9 17.3 35.9 17.3 18.7 15.3 17.8 31.9 12.3 FMNL3 "DKFZp762B245, MGC45819, WBP3" ENSG00000161791 "Formin like 3" Q8IVF7 12 49636499-49708165 "Predicted intracellular proteins" Angiogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002552, HPA023201" Uncertain Supported "Golgi apparatus,Vesicles,Plasma membrane,Cytosol" "Golgi apparatus, Vesicles, Plasma membrane" Cytosol "HPA002552: AB_1078862, HPA023201: AB_1848575" "unprognostic (2.97e-1)" "unprognostic (2.77e-3)" "unprognostic (4.97e-3)" "unprognostic (7.19e-2)" "unprognostic (5.42e-2)" "unprognostic (2.33e-3)" "unprognostic (5.37e-3)" "unprognostic (1.52e-2)" "unprognostic (2.83e-1)" "unprognostic (1.54e-1)" "unprognostic (6.67e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (3.58e-5)" "unprognostic (1.04e-1)" "unprognostic (2.31e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" 18.3 6.4 10.1 19.9 10.7 5.0 13.8 8.5 11.2 9.3 8.0 23.2 6.3 6.0 13.5 20.8 5.1 7.5 13.0 12.6 10.6 9.0 10.1 3.1 18.0 22.5 14.0 7.7 18.9 3.8 3.7 5.0 14.4 12.9 7.5 6.2 9.8 5.0 5.1 6.3 4.8 10.7 12.3 14.2 13.0 6.7 10.5 11.3 16.2 15.0 5.1 27.9 9.6 7.7 1.7 8.6 3.6 0.7 1.1 1.5 0.7 4.4 1.3 10.0 3.3 2.8 11.3 0.1 5.5 11.3 7.6 6.7 5.1 1.2 9.6 10.7 6.6 0.2 5.1 2.3 7.0 8.4 1.9 10.5 1.5 0.2 4.9 2.1 13.8 7.1 0.3 11.8 5.0 20.0 2.3 7.1 11.1 3.3 8.5 3.1 3.3 2.9 4.1 12.5 1.4 7.1 0.6 1.7 4.7 3.2 0.4 6.5 0.8 3.1 25.2 18.9 6.6 0.3 9.5 3.7 0.2 5.2 11.7 6.5 7.9 3.6 0.3 1.2 1.5 0.7 0.7 0.4 0.5 0.9 0.4 1.7 0.8 0.9 0.0 1.1 0.6 8.6 0.3 0.7 10.1 10.7 8.5 11.2 10.6 9.0 14.0 7.7 12.9 11.3 FMO4 FMO2 ENSG00000076258 "Flavin containing monooxygenase 4" P31512 1 171314208-171342084 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 33.8;liver: 42.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 7.2;EFO-21: 7.9;HSkMC: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA049100, HPA072438" Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA049100: , HPA072438: " "unprognostic (1.83e-2)" "unprognostic (1.17e-1)" "unprognostic (6.18e-2)" "unprognostic (3.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.13e-1)" "prognostic favourable (1.09e-4)" "prognostic favourable (7.45e-4)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (5.99e-2)" "unprognostic (2.90e-1)" "prognostic favourable (6.96e-4)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-3)" "unprognostic (1.95e-1)" 5.3 3.6 1.4 5.1 4.8 0.9 4.5 0.6 2.7 4.5 6.0 4.8 3.1 4.2 3.0 10.0 4.6 3.8 4.6 6.3 2.3 1.5 33.8 42.2 3.4 2.8 7.5 2.8 4.1 3.2 5.5 5.0 2.3 3.7 3.9 3.7 6.7 2.7 2.0 1.6 2.9 16.1 2.0 7.0 3.8 3.9 2.0 6.2 2.7 4.5 3.3 3.4 2.9 3.7 5.3 2.9 0.9 4.0 3.9 4.9 2.0 0.1 0.0 0.4 0.6 5.4 4.9 0.2 1.1 5.0 1.6 1.7 0.8 7.2 4.4 7.9 0.0 0.3 0.8 1.3 2.2 2.1 1.1 0.0 0.0 0.1 0.8 0.9 1.0 9.3 3.1 0.6 1.3 0.3 0.2 3.3 0.7 1.0 2.1 1.9 0.5 1.6 0.4 0.4 2.5 3.5 0.0 0.2 0.0 1.4 1.5 3.0 3.1 1.3 0.1 1.3 0.4 1.4 1.0 4.0 1.3 2.7 2.4 1.4 1.1 0.6 2.6 0.9 2.5 4.0 1.8 3.1 2.4 3.3 2.2 5.3 3.3 2.5 0.5 3.9 2.7 2.9 4.9 2.0 1.4 4.8 0.6 2.7 2.3 1.5 7.5 2.8 3.7 6.2 FNDC11 "C20orf195, MGC5356" ENSG00000125531 "Fibronectin type III domain containing 11" Q9BVV2 20 63547891-63556708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 52.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.4;EFO-21: 4.9;HaCaT: 2.7;SH-SY5Y: 5.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 3.2;naive B-cell: 6.6" "Lineage enriched" "Detected in many" 6 "B-cells: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA041341 Approved Nucleoplasm,Vesicles,Aggresome "Nucleoplasm, Vesicles" Aggresome "HPA041341: AB_10794991" "unprognostic (2.01e-1)" "unprognostic (6.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (9.99e-3)" "unprognostic (7.94e-2)" "unprognostic (8.30e-4)" "unprognostic (3.68e-1)" "unprognostic (8.33e-2)" "unprognostic (3.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (3.75e-1)" "unprognostic (6.81e-2)" 0.1 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 2.2 0.2 1.1 0.2 0.1 0.1 0.3 0.2 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.3 52.5 0.2 0.1 0.1 0.1 0.3 0.2 0.2 6.6 0.0 1.0 0.0 0.0 0.8 0.2 0.3 0.0 1.8 0.0 0.1 0.1 0.0 0.3 0.6 0.0 0.0 0.1 9.4 0.5 4.9 0.1 2.7 0.2 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.0 1.2 0.0 0.2 0.7 0.0 0.9 0.7 0.0 0.0 1.0 0.0 0.1 0.2 0.8 0.0 0.0 0.1 1.7 0.0 0.4 5.9 0.0 0.0 0.3 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.6 0.3 0.0 0.0 1.0 0.1 0.0 0.0 3.2 0.2 0.6 0.0 6.6 0.4 0.2 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.4 0.2 FO393400.1 ENSG00000285382 20 32632183-32743567 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in single" 31 "HEL: 12.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA054119 Uncertain Vesicles Vesicles "HPA054119: " 3.3 2.9 2.8 2.4 3.0 3.1 3.3 3.8 5.1 2.2 2.2 2.6 4.2 1.9 3.3 4.4 2.4 3.6 2.5 4.4 2.2 3.7 4.6 3.2 2.1 1.4 4.2 3.5 4.3 2.6 1.6 5.4 2.3 3.0 2.0 3.2 3.5 3.1 3.1 3.9 2.6 4.0 0.8 2.5 3.0 3.3 2.0 1.3 6.5 2.0 2.9 3.9 1.7 1.0 0.8 1.6 0.3 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.6 0.3 0.8 0.4 0.2 0.3 0.4 0.3 0.3 0.1 1.0 0.3 0.6 0.5 0.6 0.2 0.8 0.5 0.2 FOSB "AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291" ENSG00000125740 "FosB proto-oncogene, AP-1 transcription factor subunit" P53539 19 45467995-45475179 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 14.6;hTCEpi: 9.1;Karpas-707: 7.5;SK-BR-3: 10.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.0" "Group enriched" "Detected in many" 4 "amygdala: 4.1;basal ganglia: 4.2;cerebral cortex: 5.3;hippocampal formation: 4.5;olfactory region: 8.8" "Low region specificity" "Detected in many" "CAB010267, HPA054663" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB010267: AB_640583, HPA054663: " "unprognostic (7.22e-2)" "unprognostic (9.74e-2)" "unprognostic (2.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (1.30e-3)" "unprognostic (9.43e-2)" "unprognostic (2.04e-2)" "unprognostic (2.99e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (4.99e-3)" "unprognostic (8.72e-2)" "unprognostic (4.45e-2)" "unprognostic (4.04e-2)" 72.7 13.0 2.3 111.4 7.4 39.2 10.0 5.5 7.7 62.9 9.0 14.9 2.2 1.7 32.1 6.1 18.9 135.1 102.6 14.1 2.5 2.9 3.4 8.6 22.9 6.0 2.0 1.2 29.1 12.2 8.1 8.1 129.0 8.5 12.2 7.9 38.6 8.7 59.1 2.2 59.5 10.8 36.3 2.5 2.6 30.5 21.7 1.3 4.0 33.6 114.5 8.2 16.7 4.4 0.2 1.7 9.0 1.6 0.2 0.7 0.2 0.4 0.8 0.2 0.3 1.3 0.3 2.4 2.5 1.1 0.8 0.7 0.5 1.0 2.1 0.4 1.6 0.9 0.5 1.7 0.5 0.3 0.8 0.6 0.8 0.4 0.9 1.2 14.6 0.5 9.1 1.9 2.1 1.0 0.8 7.5 0.2 0.2 0.2 1.2 0.5 0.4 0.6 0.1 1.4 0.7 1.4 3.4 0.4 1.5 10.7 1.3 0.6 0.8 0.2 0.6 0.7 1.2 0.8 5.6 0.7 0.6 1.2 0.8 1.4 1.5 1.6 1.7 0.3 0.2 0.7 0.1 0.4 0.3 1.7 0.2 0.0 0.0 9.0 0.2 0.1 0.1 0.1 0.2 2.3 7.4 5.5 7.7 2.5 2.9 2.0 1.2 8.5 1.3 FOXI1 "FKHL10, FREAC6" ENSG00000168269 "Forkhead box I1" Q12951 5 170105897-170109725 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 37.0;salivary gland: 12.4" "Cell line enhanced" "Detected in some" "EFO-21: 1.4;HaCaT: 1.4;MCF7: 5.3;SCLC-21H: 1.1" "Group enriched" "Detected in many" 7 "breast cancer: 5.8;renal cancer: 23.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 48 "eosinophil: 4.7" "Lineage enriched" "Detected in single" 48 "granulocytes: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA071469 Enhanced Uncertain Nucleoli,Vesicles "Nucleoli, Vesicles" "HPA071469: " "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.09e-1)" "unprognostic (2.48e-2)" "unprognostic (8.06e-2)" "unprognostic (7.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.52e-2)" "unprognostic (9.71e-3)" "unprognostic (4.88e-3)" "unprognostic (6.20e-2)" "unprognostic (1.34e-2)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 37.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 3.3 0.0 0.0 12.4 3.7 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 1.4 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXJ3 KIAA1041 ENSG00000198815 "Forkhead box J3" Q9UPW0 1 42176539-42335877 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067284 Approved "Nucleoplasm,Nuclear speckles,Vesicles" "Nucleoplasm, Nuclear speckles" Vesicles "HPA067284: " "unprognostic (5.60e-2)" "unprognostic (2.26e-2)" "unprognostic (4.24e-2)" "unprognostic (5.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.56e-2)" "prognostic unfavourable (5.17e-6)" "unprognostic (3.65e-3)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "prognostic unfavourable (4.51e-7)" "unprognostic (2.10e-1)" "unprognostic (1.83e-1)" "unprognostic (1.87e-2)" "unprognostic (5.43e-2)" 24.8 15.1 21.2 20.1 31.3 31.6 25.6 38.2 30.9 22.3 18.4 22.9 15.4 18.8 24.9 18.9 17.4 19.8 16.2 23.5 21.5 20.2 16.8 17.6 20.4 19.6 22.9 19.2 29.5 22.6 31.6 28.7 33.5 21.2 21.7 22.5 18.4 19.0 23.7 44.3 24.3 20.0 22.0 20.7 19.6 20.8 19.0 22.6 29.0 23.7 15.2 22.2 22.8 21.4 12.3 9.7 10.9 9.4 11.6 13.1 4.3 13.6 11.5 12.7 13.2 13.7 17.0 18.4 10.4 15.4 14.0 15.6 10.6 16.4 21.0 11.1 14.5 13.1 17.7 17.1 23.8 15.7 10.0 23.1 14.7 9.0 11.9 21.2 15.9 12.6 17.0 20.9 26.0 15.2 13.9 15.3 16.7 7.8 21.4 12.2 19.8 10.6 20.1 33.4 14.3 11.9 19.9 17.7 16.7 18.7 21.7 18.8 10.9 31.7 14.1 14.7 19.7 14.8 17.1 15.1 18.6 17.2 13.2 17.7 11.7 6.0 5.7 6.1 9.0 4.8 10.9 8.0 11.0 9.5 4.6 12.3 11.8 13.1 10.9 11.6 9.4 9.7 7.0 4.3 21.2 31.3 38.2 30.9 21.5 20.2 22.9 19.2 21.2 22.6 FOXK2 "ILF, ILF1" ENSG00000141568 "Forkhead box K2" Q01167 17 82519713-82644662 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027523, HPA073491" Approved Supported Nucleoplasm,Vesicles,Mitochondria Nucleoplasm "Vesicles, Mitochondria" "HPA027523: AB_10601013, HPA073491: " "unprognostic (2.39e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (9.52e-2)" "unprognostic (3.11e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (1.24e-6)" "unprognostic (3.35e-2)" "unprognostic (2.25e-1)" "unprognostic (5.19e-2)" "unprognostic (2.18e-2)" "unprognostic (2.26e-1)" "unprognostic (3.80e-3)" "unprognostic (2.24e-2)" "unprognostic (4.89e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" 16.8 21.2 17.5 14.3 19.2 8.7 19.1 21.3 30.5 17.7 17.1 17.1 16.9 11.2 22.2 13.7 24.2 14.6 13.4 17.1 14.9 14.9 13.0 13.6 15.2 13.6 13.7 17.2 17.6 19.2 25.4 19.8 18.6 15.6 14.9 11.7 13.8 17.1 16.3 41.5 21.6 12.6 19.9 10.3 13.2 15.5 32.3 15.8 21.8 18.6 12.4 13.9 16.4 16.4 4.0 5.9 4.1 2.9 4.1 4.4 1.6 21.4 22.9 21.5 23.4 12.4 13.7 14.3 12.6 14.5 22.1 22.5 22.2 13.8 18.3 9.2 15.6 12.5 22.9 14.5 21.0 12.5 21.9 18.9 15.1 21.9 19.6 21.0 12.7 12.9 26.7 23.4 26.7 22.3 25.2 18.8 12.1 12.8 35.8 13.4 12.3 17.6 23.5 18.4 15.1 10.1 18.1 35.6 26.3 12.5 31.9 29.7 22.4 24.4 17.4 29.2 20.5 19.5 25.4 21.7 19.2 23.7 15.8 17.6 15.3 4.1 2.9 3.3 4.4 2.2 3.5 4.0 3.3 4.2 3.3 2.8 2.6 2.9 0.5 4.1 2.3 5.9 3.4 1.6 17.5 19.2 21.3 30.5 14.9 14.9 13.7 17.2 15.6 15.8 FOXN2 HTLF ENSG00000170802 "Forkhead box N2" P32314 2 48314637-48379294 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 45.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003485 Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA003485: AB_1078905" "unprognostic (5.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "unprognostic (2.65e-3)" "prognostic favourable (3.85e-4)" "unprognostic (4.00e-1)" "unprognostic (2.32e-2)" "unprognostic (1.52e-1)" "unprognostic (8.95e-2)" "unprognostic (2.59e-1)" "unprognostic (5.15e-3)" "unprognostic (4.14e-2)" "prognostic unfavourable (2.81e-5)" "unprognostic (2.24e-2)" "unprognostic (1.55e-1)" "unprognostic (2.34e-2)" "unprognostic (1.12e-2)" 17.7 6.2 12.7 13.9 17.4 45.5 13.6 23.6 13.8 8.1 7.4 25.0 3.2 8.2 8.2 4.6 9.1 6.5 9.8 8.3 16.1 9.5 6.8 18.7 10.6 17.4 23.3 12.8 6.2 8.4 9.8 7.0 12.6 19.0 6.2 8.0 2.9 7.1 4.7 8.0 5.9 10.1 9.5 23.6 17.2 7.4 6.1 26.0 17.8 7.9 6.9 15.7 10.9 8.2 7.6 11.3 42.3 11.3 8.3 9.9 5.6 6.9 10.6 12.2 10.8 9.7 7.2 13.5 7.7 8.5 6.5 7.4 9.3 8.7 15.1 10.4 9.1 8.8 7.4 8.8 9.6 11.7 6.5 29.6 7.6 9.3 17.0 16.2 23.5 6.4 3.8 7.0 12.4 6.9 14.0 18.1 10.6 5.3 17.9 10.7 9.3 5.5 9.0 25.6 12.4 5.7 8.8 6.9 7.0 3.8 7.2 13.7 3.2 9.6 8.0 9.0 9.0 8.5 8.2 9.8 7.3 21.9 7.9 14.9 12.1 35.1 11.1 42.3 8.7 8.9 9.9 7.5 8.3 7.9 11.3 7.6 6.4 6.4 14.1 8.3 11.3 7.0 9.5 5.6 12.7 17.4 23.6 13.8 16.1 9.5 23.3 12.8 19.0 26.0 FPGT GFPP ENSG00000254685 "Fucose-1-phosphate guanylyltransferase" O14772 1 74198212-74234086 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072331 Uncertain Vesicles Vesicles "HPA072331: " "unprognostic (1.53e-1)" "unprognostic (1.94e-1)" "unprognostic (8.18e-3)" "unprognostic (4.32e-2)" "unprognostic (5.14e-2)" "unprognostic (2.46e-1)" "prognostic unfavourable (2.30e-4)" "unprognostic (1.86e-1)" "unprognostic (5.14e-2)" "unprognostic (2.58e-1)" "unprognostic (7.59e-2)" "unprognostic (1.33e-1)" "unprognostic (3.59e-3)" "unprognostic (1.44e-1)" "unprognostic (7.88e-2)" "unprognostic (3.53e-2)" "unprognostic (1.91e-1)" 14.6 11.6 10.9 9.1 12.6 3.4 13.0 19.0 15.8 15.9 11.7 13.0 7.5 11.5 17.7 11.1 15.7 15.4 13.3 12.8 10.9 7.1 15.9 13.7 10.8 8.0 15.5 10.6 14.1 10.2 14.2 27.7 10.6 14.4 11.1 11.3 10.6 11.7 9.1 15.7 12.0 12.0 11.8 16.3 11.0 12.3 8.7 13.9 6.6 20.0 6.8 9.2 17.9 12.9 4.3 9.2 15.2 14.9 3.8 5.4 7.4 9.2 7.7 5.8 8.5 13.5 12.7 8.7 12.2 8.1 8.4 10.0 4.3 7.0 5.7 15.1 7.2 7.8 10.4 11.1 13.4 11.5 4.4 12.9 9.3 7.2 11.3 9.8 9.9 10.4 14.5 8.4 4.0 8.7 13.2 6.8 13.2 2.4 5.4 2.0 6.3 7.0 5.8 13.6 8.0 7.4 6.7 6.1 6.1 9.0 13.2 14.0 15.9 11.2 7.8 3.7 7.1 20.2 9.2 7.5 5.3 7.6 15.0 9.7 12.5 12.0 14.9 15.2 4.3 14.5 5.0 3.6 4.4 3.9 9.2 4.3 4.9 4.4 4.4 3.8 12.5 0.9 5.4 7.4 10.9 12.6 19.0 15.8 10.9 7.1 15.5 10.6 14.4 13.9 FPGT-TNNI3K ENSG00000259030 "FPGT-TNNI3K readthrough" 1 74198235-74543982 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 28.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 4.9;CAPAN-2: 4.5;SiHa: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA072331 Approved Vesicles Vesicles "HPA072331: " "unprognostic (6.29e-2)" "unprognostic (4.96e-2)" "unprognostic (1.99e-1)" "unprognostic (1.46e-1)" "unprognostic (1.24e-1)" "unprognostic (3.44e-3)" "unprognostic (8.37e-2)" "unprognostic (1.70e-2)" "unprognostic (6.63e-2)" "unprognostic (6.85e-2)" "unprognostic (1.04e-1)" "unprognostic (8.37e-2)" "unprognostic (6.76e-3)" "unprognostic (3.20e-2)" "unprognostic (2.75e-1)" "unprognostic (1.11e-2)" "unprognostic (7.87e-3)" 8.5 5.5 5.4 3.1 6.3 2.7 6.1 16.1 8.2 6.4 6.3 6.6 3.4 2.5 9.3 4.2 6.0 5.7 4.2 28.0 5.4 4.9 6.3 3.7 6.1 3.5 8.0 5.2 5.6 3.1 4.7 15.0 3.8 7.4 5.5 3.7 5.2 5.4 6.0 11.2 8.0 5.1 6.3 8.5 5.9 4.9 4.1 7.1 2.9 5.1 3.0 3.5 5.5 4.9 2.4 2.4 4.9 4.7 0.8 4.9 3.5 0.0 1.1 0.7 1.5 0.8 4.9 0.1 2.0 1.0 0.2 0.4 1.1 4.5 0.0 3.2 0.2 0.0 0.3 3.0 0.4 0.1 0.2 1.7 0.1 0.1 0.8 0.4 0.3 2.0 2.0 0.2 0.2 0.2 0.0 1.6 1.0 0.0 0.1 0.2 0.1 0.9 2.2 3.8 0.0 0.4 0.0 1.1 3.3 6.4 0.3 0.3 0.0 2.2 0.1 0.7 0.2 0.2 0.8 0.2 0.1 1.7 1.0 1.0 1.1 3.6 4.1 3.5 1.1 4.7 3.5 2.1 3.9 2.2 2.4 2.4 4.9 2.5 4.9 0.8 1.2 2.1 3.8 3.5 5.4 6.3 16.1 8.2 5.4 4.9 8.0 5.2 7.4 7.1 FRAT1 ENSG00000165879 "FRAT1, WNT signaling pathway regulator" Q92837 10 97319267-97321915 "Predicted intracellular proteins" "Wnt signaling pathway" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 9.0;neutrophil: 11.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.2" "Low region specificity" "Detected in all" "CAB046472, HPA055258" Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "CAB046472: AB_1849131, HPA055258: " "unprognostic (1.48e-2)" "prognostic favourable (5.92e-4)" "unprognostic (3.54e-1)" "unprognostic (1.13e-2)" "unprognostic (1.45e-1)" "prognostic favourable (2.75e-4)" "unprognostic (1.11e-2)" "unprognostic (4.44e-3)" "unprognostic (5.73e-2)" "unprognostic (2.50e-2)" "unprognostic (6.36e-3)" "unprognostic (1.89e-1)" "prognostic favourable (6.36e-5)" "unprognostic (6.38e-2)" "unprognostic (5.27e-2)" "unprognostic (4.31e-2)" "unprognostic (1.43e-2)" 5.2 3.7 3.0 8.0 4.0 14.9 3.9 5.8 5.8 3.9 6.9 3.4 5.0 7.4 3.6 2.0 3.8 4.0 6.8 3.5 3.3 4.5 2.9 12.6 6.6 18.7 4.4 3.1 3.4 6.7 4.1 2.8 6.5 4.9 4.9 3.3 2.8 6.1 5.9 5.7 4.9 9.9 2.6 2.7 16.2 8.2 21.6 3.3 9.7 2.7 3.3 4.3 3.5 4.7 0.6 1.1 11.2 2.2 0.2 0.8 0.5 0.9 1.5 1.8 8.1 2.3 1.1 1.8 0.9 3.5 0.7 0.7 0.2 1.0 5.3 1.8 0.6 2.4 1.3 1.7 0.1 4.6 2.5 4.5 0.8 2.1 0.8 1.7 4.9 1.0 2.5 0.3 1.1 1.4 1.9 3.8 0.5 4.9 4.6 9.2 2.3 6.6 3.9 0.4 3.4 0.6 1.1 0.9 2.7 1.2 2.5 1.7 9.4 6.4 1.3 0.4 0.5 1.3 0.4 3.5 2.0 1.8 0.6 8.3 0.0 1.0 2.2 9.0 0.6 1.4 0.4 0.5 0.5 0.8 1.1 0.6 0.8 0.6 11.2 0.2 1.6 0.7 0.3 0.5 3.0 4.0 5.8 5.8 3.3 4.5 4.4 3.1 4.9 3.3 FSTL1 "FRP, FSL1, OCC-1, OCC1, tsc36" ENSG00000163430 "Follistatin like 1" Q12841 3 120392293-120451253 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 127.1;BJ: 147.5;fHDF/TERT166: 182.0;HBF TERT88: 121.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "basophil: 10.2" "Lineage enriched" "Detected in many" 8 "granulocytes: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035251, HPA040815" Uncertain Approved Vesicles,Cytosol "Secreted to blood" 32000000 "Vesicles, Cytosol" "HPA035251: AB_10601906, HPA040815: " "unprognostic (2.60e-1)" "unprognostic (1.59e-3)" "unprognostic (8.84e-2)" "unprognostic (4.54e-3)" "unprognostic (4.10e-2)" "unprognostic (1.35e-1)" "unprognostic (9.88e-2)" "unprognostic (3.05e-2)" "unprognostic (1.19e-2)" "unprognostic (3.88e-2)" "unprognostic (3.54e-2)" "unprognostic (2.64e-2)" "prognostic unfavourable (1.33e-4)" "unprognostic (4.89e-3)" "unprognostic (1.72e-2)" "unprognostic (1.05e-2)" "unprognostic (4.47e-3)" 72.3 28.6 4.8 23.1 5.8 0.0 104.0 2.5 6.7 52.1 39.1 7.3 28.7 5.8 41.6 58.1 39.2 42.6 45.6 69.4 5.9 3.2 15.1 5.5 33.6 44.4 4.3 4.3 26.9 8.7 5.5 7.9 110.0 13.2 36.3 15.4 26.2 17.5 32.5 23.6 18.4 18.6 90.2 9.4 16.7 22.1 19.8 4.9 4.7 23.8 29.1 11.1 67.1 65.8 0.1 1.2 10.2 0.1 0.0 0.0 3.6 5.3 1.4 15.3 6.3 92.4 127.1 0.0 147.5 82.8 95.5 84.8 0.0 12.3 0.0 12.5 182.0 1.4 4.7 18.3 121.8 0.0 2.2 0.0 11.6 0.0 20.3 0.0 0.0 96.6 0.5 61.7 13.5 55.3 0.0 0.0 15.5 0.0 1.4 0.1 12.6 12.3 0.0 6.4 0.0 10.2 0.1 2.7 6.5 52.4 0.9 5.3 1.6 0.4 67.5 35.9 34.5 18.7 21.8 0.0 0.0 0.1 12.5 0.0 4.6 10.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 1.2 0.0 3.6 4.8 5.8 2.5 6.7 5.9 3.2 4.3 4.3 13.2 4.9 FTCDNL1 FONG ENSG00000226124 "Formiminotransferase cyclodeaminase N-terminal like" E5RQL4 2 199760544-199851173 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA065748 Uncertain Vesicles "Secreted in other tissues" Vesicles "HPA065748: " "unprognostic (1.78e-1)" "unprognostic (1.70e-1)" "unprognostic (1.27e-2)" "unprognostic (9.80e-2)" "unprognostic (3.09e-1)" "unprognostic (7.21e-2)" "unprognostic (1.54e-3)" "unprognostic (1.59e-1)" "unprognostic (1.03e-1)" "unprognostic (4.82e-2)" "unprognostic (5.37e-2)" "unprognostic (9.86e-2)" "prognostic favourable (3.31e-4)" "unprognostic (3.92e-2)" "unprognostic (4.63e-2)" "prognostic unfavourable (5.74e-4)" "unprognostic (1.21e-2)" 4.5 9.4 5.5 1.8 19.0 4.0 4.2 1.6 12.0 1.7 2.3 9.7 2.6 2.1 1.2 3.9 2.9 3.9 2.0 5.3 5.8 4.8 8.0 17.9 2.8 3.5 7.6 7.5 2.4 4.3 1.9 2.0 1.5 7.9 2.8 2.5 2.7 4.8 1.7 13.1 2.4 1.8 3.4 9.1 8.0 2.1 2.8 4.0 0.1 11.0 2.4 1.8 1.6 1.9 3.8 10.6 2.0 6.2 1.2 2.4 1.9 0.7 2.4 0.1 0.1 2.5 1.5 1.8 0.9 0.9 1.3 0.5 0.0 4.4 2.5 0.3 1.0 0.0 1.1 6.5 1.5 3.0 0.8 1.9 1.0 2.1 0.9 6.4 8.2 1.1 0.3 0.5 0.1 0.0 3.4 0.1 0.9 7.5 2.4 2.6 2.1 5.1 0.4 0.2 0.1 0.5 0.0 3.0 0.0 4.2 4.0 4.1 6.0 8.6 0.7 3.5 0.0 2.2 1.5 6.5 3.5 1.4 6.5 3.3 1.7 0.0 5.3 2.0 0.6 6.2 2.3 3.8 2.2 0.8 6.9 2.1 1.5 2.4 0.0 1.2 5.6 10.6 0.0 1.9 5.5 19.0 1.6 12.0 5.8 4.8 7.6 7.5 7.9 4.0 FTO "ALKBH9, KIAA1752, MGC5149" ENSG00000140718 "FTO, alpha-ketoglutarate dependent dioxygenase" Q9C0B1 16 53701692-54158512 "Disease related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase, Transferase" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017123, HPA041086, HPA068695" Enhanced Approved Vesicles,Cytosol 130000 "Vesicles, Cytosol" "CAB017123: , HPA041086: , HPA068695: " "unprognostic (9.74e-2)" "unprognostic (2.49e-1)" "unprognostic (9.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.88e-2)" "unprognostic (6.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-1)" "unprognostic (4.30e-3)" "unprognostic (6.11e-3)" 17.5 25.4 19.7 8.7 37.4 5.6 27.1 29.7 37.5 20.2 13.5 30.1 11.4 5.8 22.7 16.8 13.2 19.5 16.2 19.5 19.9 25.9 19.0 13.0 27.3 10.1 21.8 19.6 21.2 15.2 42.0 31.6 14.7 28.9 15.8 10.9 18.9 13.4 19.1 19.9 13.6 8.1 22.6 23.8 11.5 10.1 6.2 22.2 10.0 20.7 7.8 10.6 16.1 12.5 12.3 15.3 8.1 14.8 16.3 22.1 14.0 6.6 12.0 16.0 16.4 31.6 23.9 5.3 16.0 14.6 13.5 3.9 7.5 8.8 15.1 17.7 20.6 9.8 14.8 15.7 19.8 7.0 11.6 6.8 16.3 13.9 21.8 5.4 7.8 26.2 16.7 12.2 15.1 19.9 6.6 3.8 21.7 5.2 12.0 8.3 8.3 7.9 18.5 24.3 14.2 20.4 5.6 19.8 13.7 18.2 10.8 4.9 14.2 13.0 18.9 16.9 11.3 9.0 9.8 7.3 5.9 15.6 15.7 10.1 12.9 8.1 11.6 6.0 17.7 14.8 22.1 12.3 17.0 17.7 15.3 11.7 16.0 17.2 2.0 16.3 10.0 6.1 16.5 14.0 19.7 37.4 29.7 37.5 19.9 25.9 21.8 19.6 28.9 22.2 FUK FLJ39408 ENSG00000157353 Fucokinase Q8N0W3 16 70454421-70480274 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041971 Approved Approved Vesicles Vesicles "HPA041971: AB_10795648" "unprognostic (4.55e-1)" "unprognostic (3.21e-1)" "unprognostic (1.73e-2)" "unprognostic (3.95e-2)" "unprognostic (3.79e-2)" "unprognostic (2.64e-2)" "unprognostic (8.79e-3)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.57e-1)" "unprognostic (4.82e-3)" "unprognostic (4.85e-2)" "prognostic favourable (8.91e-4)" "unprognostic (2.49e-2)" "unprognostic (9.68e-2)" "unprognostic (8.89e-2)" "prognostic favourable (8.38e-4)" 6.7 11.3 11.5 9.8 13.2 8.5 7.3 13.9 13.5 7.5 12.1 15.5 15.1 18.5 8.3 11.5 8.2 10.8 9.4 7.2 9.4 7.4 13.1 11.9 8.1 9.1 12.5 12.4 10.5 12.2 17.1 16.4 11.0 9.8 9.1 7.7 12.9 10.8 9.4 9.0 13.0 13.1 6.3 9.3 9.7 12.2 6.1 12.5 7.2 12.0 4.2 11.1 7.6 6.8 4.3 3.2 3.9 4.4 2.9 6.7 2.5 3.0 4.3 2.6 5.6 1.5 1.8 9.7 1.8 2.9 2.4 3.1 3.8 10.1 2.2 8.6 1.7 4.5 1.7 4.4 1.5 4.1 6.2 2.8 7.9 4.4 3.7 3.6 2.1 3.0 5.3 1.8 4.5 4.4 5.4 2.7 1.8 9.7 4.3 8.4 1.6 2.4 6.4 0.6 9.6 6.1 5.4 4.2 5.0 10.1 3.5 5.1 14.8 7.1 4.6 1.9 2.5 4.1 2.0 9.5 4.5 4.5 3.4 3.5 4.2 0.6 4.4 1.8 4.8 2.5 4.1 1.9 4.8 4.8 2.7 4.3 6.7 3.1 3.9 2.9 2.8 3.2 3.2 2.5 11.5 13.2 13.9 13.5 9.4 7.4 12.5 12.4 9.8 12.5 FUT4 "CD15, ELFT, FCT3A, FUC-TIV" ENSG00000196371 "Fucosyltransferase 4" P22083 11 94543840-94549898 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "bone marrow: 71.3" "Cell line enhanced" "Detected in many" "HL-60: 20.4;NB-4: 13.2;THP-1: 25.8;U-937: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB000014, CAB016129" Enhanced Supported Vesicles Vesicles "CAB000014: , CAB016129: AB_626918" "unprognostic (6.36e-2)" "unprognostic (7.53e-2)" "unprognostic (4.70e-3)" "unprognostic (2.46e-3)" "unprognostic (1.46e-2)" "unprognostic (2.29e-2)" "unprognostic (1.66e-2)" "prognostic unfavourable (3.64e-4)" "unprognostic (7.26e-2)" "unprognostic (4.14e-1)" "unprognostic (4.81e-3)" "unprognostic (1.27e-1)" "unprognostic (9.08e-3)" "unprognostic (8.17e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (3.10e-3)" 5.5 2.4 5.5 6.1 6.2 71.3 6.3 3.0 6.0 4.4 8.3 6.7 4.7 10.9 5.9 2.5 3.0 4.6 7.5 3.7 6.2 2.2 4.1 3.0 6.0 5.4 8.1 2.5 4.9 11.4 1.4 2.9 3.4 4.8 3.4 8.3 3.8 6.3 2.9 1.7 1.9 10.1 5.8 5.7 6.5 9.7 2.9 4.5 10.4 2.9 1.9 3.1 4.4 3.0 0.7 1.9 2.5 3.9 0.8 1.9 0.8 1.6 0.8 1.0 0.0 3.1 2.8 5.1 1.4 0.7 1.3 1.5 6.9 2.2 0.0 3.5 2.4 0.8 1.6 0.1 1.2 10.5 1.6 5.2 1.1 0.1 1.6 20.4 4.6 2.4 0.0 1.7 0.0 2.0 5.2 0.0 1.5 0.7 4.2 13.2 1.9 1.9 3.8 0.0 0.0 1.4 1.1 1.4 0.5 0.8 2.1 0.8 1.2 25.8 1.9 1.0 2.9 0.0 0.5 0.6 0.3 0.0 0.9 18.3 0.6 2.0 3.1 2.5 1.1 1.5 0.7 0.6 1.0 1.3 1.8 0.7 1.1 0.7 1.7 0.8 3.9 1.9 1.9 0.8 5.5 6.2 3.0 6.0 6.2 2.2 8.1 2.5 4.8 4.5 FXYD6-FXYD2 ENSG00000255245 "FXYD6-FXYD2 readthrough" 11 117820163-117876667 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "MOLT-4: 9.5;RPTEC TERT1: 10.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.3" "Low lineage specificity" "Detected in many" "HPA068838, HPA075209" Approved Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA068838: , HPA075209: " 2.8 2.7 7.4 1.8 12.4 1.8 2.7 4.2 22.2 6.0 4.5 7.9 1.4 1.8 11.4 5.2 2.5 3.9 6.6 3.0 4.8 2.9 23.0 2.8 3.1 2.1 2.5 16.5 10.2 9.6 2.4 4.2 2.5 4.6 9.4 2.0 2.2 19.5 2.2 2.9 2.5 3.0 13.7 2.5 4.2 2.9 3.6 4.3 0.0 2.9 0.5 2.3 10.1 2.8 0.0 0.5 0.0 1.1 0.8 1.3 0.7 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.7 0.0 0.0 0.4 0.0 10.9 0.0 0.6 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.3 0.0 0.4 0.3 0.0 0.8 0.0 0.5 0.0 0.7 7.4 12.4 4.2 22.2 4.8 2.9 2.5 16.5 4.6 4.3 FYCO1 "FLJ13335, ZFYVE7" ENSG00000163820 "FYVE and coiled-coil domain containing 1" Q9BQS8 3 45917899-45995824 "Disease related genes, Predicted intracellular proteins" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 105.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035526, HPA057966" Uncertain Enhanced Vesicles Vesicles "HPA035526: AB_10672867, HPA057966: " "unprognostic (2.45e-1)" "unprognostic (6.62e-2)" "unprognostic (6.97e-3)" "unprognostic (1.14e-3)" "unprognostic (7.65e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-2)" "unprognostic (4.53e-3)" "unprognostic (5.85e-2)" "unprognostic (8.85e-2)" "unprognostic (2.36e-1)" "unprognostic (2.98e-1)" "prognostic favourable (3.33e-11)" "unprognostic (2.90e-1)" "unprognostic (1.42e-1)" "unprognostic (2.89e-2)" "unprognostic (6.99e-2)" 11.6 7.8 4.1 11.4 4.7 3.1 11.6 1.4 3.5 13.5 20.2 7.3 11.4 4.2 19.8 11.1 12.6 7.9 22.0 29.1 4.2 2.7 5.7 6.2 7.9 5.0 4.7 3.5 14.8 15.9 11.4 4.9 4.3 6.1 14.5 5.6 16.2 9.5 11.6 105.8 9.9 7.7 39.9 6.4 6.4 11.6 5.0 5.3 8.5 10.4 25.5 9.5 23.3 27.0 0.6 2.8 1.1 1.1 3.0 6.0 1.3 6.3 6.2 1.8 8.0 17.6 13.9 3.0 6.2 14.4 8.3 9.1 3.4 5.6 4.8 3.5 8.7 4.8 5.2 10.4 9.8 2.0 5.5 6.7 5.1 3.7 12.0 5.1 4.9 15.4 10.4 13.0 12.9 16.3 4.4 6.9 5.8 3.9 5.2 3.2 2.8 5.9 1.8 5.1 2.6 9.9 22.5 1.3 2.1 3.9 12.3 10.7 6.0 3.4 12.5 3.1 3.7 10.5 3.4 3.9 2.5 1.6 10.8 6.6 5.8 1.1 1.0 0.6 4.4 1.1 6.0 0.6 2.6 4.6 0.4 0.6 1.1 1.8 0.9 3.0 0.7 2.8 2.6 1.3 4.1 4.7 1.4 3.5 4.2 2.7 4.7 3.5 6.1 5.3 FZD7 FzE3 ENSG00000155760 "Frizzled class receptor 7" O75084 2 202034587-202038445 "G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 25.2;CAPAN-2: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "eosinophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059979, HPA069165, HPA076183" Approved Supported Vesicles Vesicles "HPA059979: , HPA069165: , HPA076183: " "unprognostic (3.44e-2)" "unprognostic (6.89e-2)" "unprognostic (9.30e-3)" "unprognostic (2.44e-3)" "unprognostic (4.92e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (7.71e-5)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" "unprognostic (8.22e-2)" "unprognostic (2.73e-2)" "unprognostic (1.10e-1)" "unprognostic (1.87e-3)" "unprognostic (8.16e-3)" "unprognostic (1.43e-1)" "unprognostic (4.16e-2)" "unprognostic (2.05e-3)" 4.8 1.6 3.2 4.7 6.5 0.0 9.9 23.3 4.5 8.5 17.8 2.0 3.3 3.9 9.7 9.4 9.1 8.6 3.7 8.7 10.8 0.7 4.1 0.8 3.0 4.0 0.8 6.2 17.4 0.8 0.0 4.9 3.2 3.8 12.4 3.4 6.1 13.4 16.2 13.5 5.3 5.6 17.3 3.0 2.0 3.1 3.2 3.0 0.8 2.6 4.3 3.2 13.1 8.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 4.6 2.5 17.2 5.5 5.7 4.2 7.3 19.6 25.2 6.3 7.4 16.1 31.4 0.0 11.7 13.4 5.0 3.1 0.7 7.3 2.3 4.1 0.5 1.1 1.3 3.8 0.9 1.0 4.1 0.5 3.3 2.0 0.0 1.3 1.3 5.1 2.1 0.0 2.8 17.9 1.7 1.9 3.2 0.5 1.0 3.0 2.8 6.2 2.5 0.2 3.2 1.8 1.2 0.0 12.2 4.3 7.5 2.5 1.2 0.9 0.0 2.5 0.2 8.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 6.5 23.3 4.5 10.8 0.7 0.8 6.2 3.8 3.0 G2E3 "FLJ20333, KIAA1333, PHF7B" ENSG00000092140 "G2/M-phase specific E3 ubiquitin protein ligase" Q7L622 14 30559123-30620063 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001601 Approved Approved "Golgi apparatus,Vesicles,Cytosol" Cytosol "Golgi apparatus, Vesicles" "HPA001601: AB_1079198" "unprognostic (4.75e-2)" "unprognostic (6.31e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (9.10e-2)" "unprognostic (3.99e-2)" "unprognostic (5.44e-6)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (1.86e-1)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (2.32e-2)" "unprognostic (2.12e-2)" 7.6 5.1 5.6 7.6 14.2 8.5 6.6 10.8 10.4 8.1 5.8 5.8 4.2 5.9 8.5 4.8 7.0 5.4 4.5 4.9 6.7 5.2 5.4 5.5 5.4 8.6 7.3 4.9 7.1 5.7 6.0 10.9 6.9 7.6 6.0 6.1 5.3 5.9 7.1 5.2 6.1 5.8 6.7 7.1 7.9 5.4 39.6 8.8 20.9 7.3 4.8 9.5 6.0 8.3 11.5 8.1 16.5 12.5 7.9 12.4 5.0 20.8 9.5 21.3 9.8 6.9 8.5 18.0 19.6 7.1 11.9 13.4 9.2 12.7 17.5 6.3 10.7 17.6 20.4 11.2 24.2 14.4 8.3 9.6 10.4 16.9 6.2 18.5 12.2 5.3 4.5 9.5 21.7 14.0 11.8 14.6 16.6 12.1 12.4 4.6 17.8 16.7 11.4 0.0 4.8 7.0 13.0 18.1 12.2 15.8 10.7 4.5 12.2 6.3 10.4 12.7 13.6 9.3 12.8 8.4 24.6 21.0 3.8 9.3 18.8 16.5 7.5 14.1 9.6 9.7 12.4 10.8 9.4 7.7 6.4 11.5 12.0 10.1 6.8 7.9 12.5 8.1 7.3 5.0 5.6 14.2 10.8 10.4 6.7 5.2 7.3 4.9 7.6 8.8 GABARAP "ATG8A, MM46" ENSG00000170296 "GABA type A receptor-associated protein" O95166 17 7240014-7242770 "Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065883 Approved Vesicles Vesicles "HPA065883: " "unprognostic (2.58e-1)" "unprognostic (4.55e-3)" "unprognostic (1.92e-1)" "unprognostic (9.08e-2)" "unprognostic (1.19e-1)" "unprognostic (4.30e-2)" "unprognostic (1.36e-1)" "unprognostic (2.57e-1)" "unprognostic (1.01e-1)" "unprognostic (1.58e-1)" "prognostic favourable (9.52e-5)" "unprognostic (1.85e-1)" "unprognostic (1.45e-2)" "unprognostic (2.09e-1)" "unprognostic (2.85e-2)" "unprognostic (1.22e-2)" "unprognostic (1.58e-1)" 104.5 120.3 103.9 69.9 94.9 90.9 108.6 54.9 127.8 105.0 89.0 125.1 77.0 63.3 84.0 136.8 103.0 94.1 86.2 94.1 91.8 97.8 113.0 191.6 99.8 87.9 112.1 68.9 139.6 109.2 82.0 118.8 112.4 85.7 108.8 86.6 98.2 126.9 96.9 152.5 85.6 114.5 80.8 119.8 116.5 83.7 142.8 61.4 109.4 148.8 100.7 90.7 98.9 88.7 54.9 138.6 314.7 174.9 30.4 47.9 162.9 25.1 39.7 67.6 46.0 109.5 126.7 26.6 41.3 79.7 41.4 62.0 16.4 22.7 26.5 26.4 77.3 22.9 49.2 38.4 54.9 46.2 53.6 20.2 36.0 41.4 104.0 12.8 41.7 124.8 54.0 49.4 45.2 75.0 15.7 29.2 70.4 18.0 30.5 29.6 26.8 37.5 42.4 31.5 35.1 79.7 26.9 30.3 80.0 32.2 29.7 42.2 38.2 25.3 63.1 42.6 24.2 41.0 34.3 31.4 30.4 16.5 67.9 33.4 43.5 107.9 174.9 157.5 35.9 155.4 37.2 54.9 42.8 37.6 138.6 50.7 38.9 36.5 314.7 30.4 130.2 105.9 47.9 162.9 103.9 94.9 54.9 127.8 91.8 97.8 112.1 68.9 85.7 61.4 GABARAPL1 "APG8L, ATG8B, ATG8L, gec1" ENSG00000139112 "GABA type A receptor associated protein like 1" Q9H0R8 12 10212458-10223130 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 47.2;fHDF/TERT166: 47.7;HHSteC: 54.5;SiHa: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 27.1" "Group enriched" "Detected in many" 6 "granulocytes: 27.1;NK-cells: 9.1;T-cells: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051386, HPA065883" Approved Approved Vesicles Vesicles "HPA051386: , HPA065883: " "unprognostic (9.58e-3)" "unprognostic (1.16e-1)" "unprognostic (4.23e-2)" "unprognostic (1.06e-1)" "unprognostic (8.46e-2)" "unprognostic (1.85e-3)" "prognostic favourable (2.36e-4)" "unprognostic (2.90e-1)" "unprognostic (6.38e-2)" "unprognostic (2.79e-2)" "unprognostic (9.25e-3)" "unprognostic (1.72e-1)" "prognostic favourable (8.19e-8)" "unprognostic (5.42e-2)" "unprognostic (2.57e-2)" "unprognostic (1.10e-1)" "unprognostic (1.77e-1)" 41.7 34.7 35.9 11.3 61.8 48.5 24.8 39.9 95.5 16.5 15.9 18.6 17.7 13.9 23.1 46.3 13.2 13.0 26.8 78.5 35.5 42.3 88.0 68.7 25.5 5.2 35.8 48.3 27.9 31.9 42.0 41.1 65.7 52.6 24.9 14.7 27.5 35.6 27.3 63.0 12.0 12.2 24.1 19.8 10.3 22.4 10.1 20.3 2.2 21.6 14.0 5.5 23.7 24.0 0.1 1.2 27.1 2.7 9.1 12.1 2.5 1.7 3.6 7.9 7.0 47.2 12.6 6.1 41.7 19.3 7.2 9.5 15.6 6.0 0.4 3.4 47.7 11.3 7.4 4.9 6.5 1.2 6.3 2.4 22.9 4.2 54.5 2.9 2.7 22.1 11.1 5.6 5.0 17.4 2.9 0.1 3.0 0.1 2.4 2.9 18.2 3.6 0.1 14.4 0.1 31.4 4.4 0.7 1.5 50.1 7.7 14.1 3.4 1.7 23.5 2.4 7.7 3.6 1.9 7.3 11.7 11.8 7.9 1.4 3.2 17.0 1.9 17.2 12.1 1.1 3.9 0.1 1.6 7.2 1.2 0.0 1.6 6.6 27.1 9.1 2.7 0.5 2.4 2.5 35.9 61.8 39.9 74.7 35.5 42.3 35.8 48.3 52.6 20.3 GABRD ENSG00000187730 "Gamma-aminobutyric acid type A receptor delta subunit" O14764 1 2019298-2030758 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 87.0" "Cell line enhanced" "Detected in some" "EFO-21: 2.8;HMC-1: 2.5;MCF7: 8.2;NB-4: 5.2;SH-SY5Y: 3.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 87.0" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044371 Enhanced Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA044371: " "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-8)" "unprognostic (6.34e-3)" "unprognostic (2.66e-3)" "unprognostic (1.04e-2)" "unprognostic (3.44e-3)" "unprognostic (2.14e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.99e-1)" "prognostic unfavourable (4.12e-8)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "unprognostic (5.16e-2)" 1.2 3.4 8.8 0.9 16.8 1.0 1.0 87.0 40.0 1.0 1.2 1.7 0.0 0.9 1.3 1.2 1.3 1.0 1.5 1.7 6.0 1.7 1.1 0.9 1.4 1.3 3.3 11.1 0.9 0.9 1.4 0.7 1.2 17.1 1.0 1.0 0.0 1.1 0.9 1.3 1.4 1.0 1.4 1.4 1.0 1.0 3.3 1.5 0.0 1.6 0.0 1.0 1.2 0.1 0.0 1.2 0.2 0.1 0.0 0.0 0.8 0.0 0.7 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 5.2 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.1 0.0 0.0 1.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.8 8.8 16.8 87.0 40.0 6.0 1.7 3.3 11.1 17.1 1.5 GAD1 GAD ENSG00000128683 "Glutamate decarboxylase 1" Q99259 2 170813213-170861151 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Decarboxylase, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 53.9" "Cell line enhanced" "Detected in many" "HaCaT: 10.5;HEL: 34.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "olfactory region: 888.9" "CAB004415, HPA031949, HPA058412, CAB078176" Enhanced Supported Approved Vesicles Vesicles "CAB004415: AB_627650, CAB078176: , HPA031949: , HPA058412: " "unprognostic (1.28e-1)" "prognostic favourable (7.31e-4)" "unprognostic (1.87e-2)" "prognostic favourable (8.61e-4)" "unprognostic (1.12e-1)" "unprognostic (3.05e-1)" "unprognostic (4.97e-7)" "unprognostic (1.51e-1)" "unprognostic (7.72e-2)" "unprognostic (4.27e-4)" "unprognostic (6.75e-2)" "unprognostic (9.18e-3)" "unprognostic (6.90e-5)" "unprognostic (2.93e-2)" "unprognostic (6.57e-2)" "unprognostic (1.56e-2)" "unprognostic (3.08e-3)" 1.2 2.0 14.5 0.9 28.1 3.7 1.0 10.6 53.9 1.8 1.0 3.1 0.0 1.0 2.6 5.5 1.2 1.1 1.0 1.0 10.8 24.4 6.0 1.0 1.1 1.1 8.6 17.5 1.1 1.1 9.5 2.8 1.4 6.0 1.8 1.0 1.3 1.0 1.3 0.9 1.0 1.1 1.0 2.6 1.0 1.0 4.0 3.4 0.0 1.1 0.0 1.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.3 0.0 3.7 0.0 0.0 0.0 0.2 0.0 1.4 0.9 2.5 3.5 0.0 0.5 0.2 10.5 1.2 0.3 0.8 1.4 7.2 34.2 3.0 0.1 0.0 0.1 0.6 0.0 3.1 0.0 1.2 0.0 8.8 0.1 0.4 0.8 0.0 0.0 4.2 3.7 0.5 2.5 0.2 4.6 4.9 3.6 1.1 6.5 0.0 1.8 0.1 0.0 0.0 6.4 0.9 1.3 3.7 0.0 0.0 0.0 6.2 1.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 28.1 10.6 36.7 10.8 24.4 8.6 17.5 6.0 3.4 GAK DNAJC26 ENSG00000178950 "Cyclin G associated kinase" O14976 4 849276-932373 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027405, HPA027459, HPA027463" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-1)" "unprognostic (3.24e-3)" "unprognostic (1.07e-1)" "unprognostic (3.50e-3)" "unprognostic (1.68e-1)" "unprognostic (7.07e-2)" "unprognostic (1.39e-2)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (3.33e-3)" "prognostic favourable (1.70e-6)" "unprognostic (1.09e-3)" "unprognostic (1.79e-1)" "unprognostic (6.26e-2)" "prognostic favourable (7.41e-4)" 16.5 18.9 16.8 42.2 22.7 29.9 16.7 32.4 27.7 18.0 32.5 19.7 18.6 48.2 22.4 18.6 23.7 20.5 26.8 11.4 16.2 13.9 25.0 22.1 22.2 22.4 17.6 19.4 21.1 33.0 19.5 18.9 16.6 17.9 20.3 15.2 16.9 70.8 20.6 26.2 25.6 41.1 15.2 14.3 30.9 39.2 28.6 18.5 23.6 19.7 19.2 22.3 18.9 18.9 4.7 7.1 10.8 19.3 4.0 8.5 6.9 15.7 12.7 7.8 13.2 7.8 6.7 20.1 15.0 9.0 10.3 8.6 16.0 22.6 13.5 10.2 9.0 13.8 8.0 12.4 4.9 13.7 14.1 15.6 12.8 12.0 14.7 15.8 24.5 9.7 10.7 10.4 5.1 11.2 16.8 17.1 6.9 15.2 26.8 40.9 13.9 23.3 22.2 9.0 12.0 8.3 12.9 13.4 14.5 8.7 11.1 10.4 17.8 13.6 18.4 14.4 8.4 14.6 20.0 27.8 18.6 15.0 16.2 19.4 13.1 2.6 9.0 10.8 8.5 8.9 7.4 4.7 5.6 5.7 6.0 4.0 3.2 4.7 6.7 4.0 19.3 7.1 5.0 6.9 16.8 22.7 32.4 27.7 16.2 13.9 17.6 19.4 17.9 18.5 GAL "GAL-GMAP, GALN, GLNN, GMAP" ENSG00000069482 "Galanin and GMAP prepropeptide" P22466 11 68683779-68691175 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Hormone, Neuropeptide" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "pituitary gland: 149.9" "Cell line enhanced" "Detected in some" "CACO-2: 46.9;HEK 293: 21.9;K-562: 24.3;NB-4: 86.7;SH-SY5Y: 35.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 8 "hypothalamus: 18.8" "Cell type enriched" "Detected in single" 15 "intermediate monocyte: 1.5" "Lineage enriched" "Detected in single" 15 "monocytes: 1.5" "Region enhanced" "Detected in many" "hypothalamus: 111.6" "Low region specificity" "Detected in all" "HPA049864, CAB079779" Enhanced Supported Supported "Golgi apparatus,Vesicles" "Secreted to blood" 60030 "Golgi apparatus" Vesicles "CAB079779: , HPA049864: " "unprognostic (8.56e-2)" "unprognostic (1.45e-2)" "unprognostic (7.50e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (8.07e-3)" "prognostic unfavourable (8.17e-4)" "unprognostic (5.98e-2)" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (7.42e-2)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.38e-2)" "unprognostic (3.24e-2)" 2.8 0.2 0.1 14.8 0.5 0.4 4.5 0.6 2.0 0.2 6.0 0.1 0.4 1.7 0.2 0.7 0.7 0.2 0.3 0.6 1.3 18.8 0.3 0.2 0.2 0.1 0.2 0.6 0.2 2.9 0.0 149.9 0.9 2.2 0.7 4.1 0.6 0.5 1.8 0.3 4.5 2.2 9.7 0.3 0.2 1.5 0.5 0.4 0.7 0.2 0.4 0.3 1.5 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 4.4 6.6 0.0 0.1 0.0 46.9 1.7 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 21.9 1.1 14.1 0.0 0.2 0.6 0.0 0.3 0.7 0.0 0.0 1.1 24.3 0.0 0.0 13.3 0.0 86.7 11.2 4.2 0.0 0.0 8.9 0.1 0.0 9.1 35.0 4.6 0.2 0.0 0.2 10.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.7 1.3 18.8 0.2 0.6 2.2 0.4 GAL3ST1 CST ENSG00000128242 "Galactose-3-O-sulfotransferase 1" Q99999 22 30554635-30574587 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2" "Cell line enhanced" "Detected in some" "A549: 22.6;CACO-2: 6.2;EFO-21: 12.3;K-562: 5.2" "Cancer enriched" "Detected in many" 6 "renal cancer: 38.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001220 Approved Approved Vesicles "Intracellular and membrane" Vesicles "HPA001220: AB_1078933" "unprognostic (2.69e-2)" "unprognostic (3.12e-4)" "unprognostic (5.93e-2)" "unprognostic (1.08e-2)" "unprognostic (2.32e-1)" "unprognostic (6.50e-3)" "unprognostic (1.53e-2)" "unprognostic (2.23e-1)" "unprognostic (2.89e-1)" "unprognostic (5.18e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "prognostic unfavourable (1.79e-4)" "unprognostic (2.33e-1)" "unprognostic (4.23e-2)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" 0.8 0.6 8.4 0.7 9.6 1.2 0.8 1.4 12.3 1.4 11.3 25.8 0.0 24.2 1.3 2.3 0.8 2.2 13.4 0.5 12.1 8.3 13.3 1.6 1.5 0.9 14.0 2.6 1.2 2.9 0.6 0.5 1.3 12.4 1.2 2.8 0.3 1.0 1.9 1.9 2.1 25.1 0.7 28.7 0.7 7.2 2.5 7.8 0.0 0.6 0.0 0.4 1.0 0.7 2.3 2.8 2.3 0.7 0.3 0.8 0.0 0.1 22.6 0.4 0.2 0.0 0.0 1.7 0.0 0.1 0.0 0.0 6.2 3.1 0.3 12.3 0.0 0.2 0.0 0.0 0.0 0.2 0.8 0.3 0.2 4.1 0.5 0.1 0.3 0.2 0.0 0.1 0.1 0.0 5.2 0.6 0.0 0.1 0.3 0.8 3.2 0.3 0.2 0.1 0.6 0.9 0.1 0.3 1.5 0.0 0.4 0.2 0.1 0.1 0.6 0.2 0.1 0.2 0.0 2.0 1.2 0.3 0.1 0.1 0.2 0.9 0.7 0.1 0.4 0.5 0.7 1.8 0.7 0.8 0.2 2.3 0.5 0.8 2.3 0.3 0.3 2.8 0.1 0.0 8.4 9.6 1.4 10.3 12.1 8.3 14.0 2.6 12.4 7.8 GALNT5 GalNAc-T5 ENSG00000136542 "Polypeptide N-acetylgalactosaminyltransferase 5" Q7Z7M9 2 157257598-157314211 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2" "Cell line enhanced" "Detected in some" "A-431: 23.1;BJ: 15.2;BJ hTERT+: 27.2;fHDF/TERT166: 31.7;HaCaT: 27.1;K-562: 15.7;LHCN-M2: 27.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "cerebellum: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008963, HPA009035" Approved Approved "Nucleoli,Golgi apparatus,Vesicles,Cytosol" 630000 "Nucleoli, Golgi apparatus, Cytosol" Vesicles "HPA008963: AB_1078942, HPA009035: AB_1078943" "unprognostic (6.34e-3)" "unprognostic (9.31e-2)" "unprognostic (2.11e-2)" "unprognostic (9.89e-2)" "unprognostic (3.19e-2)" "unprognostic (2.46e-2)" "unprognostic (4.63e-3)" "unprognostic (1.88e-1)" "unprognostic (1.09e-1)" "unprognostic (6.93e-2)" "unprognostic (4.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-2)" "unprognostic (6.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-3)" 0.4 0.2 0.2 1.5 0.2 0.5 1.1 28.2 0.2 7.5 12.0 0.7 0.0 2.3 0.5 0.5 9.0 0.2 17.1 0.9 0.4 0.2 0.3 0.2 15.5 0.0 0.2 0.0 0.3 1.5 0.0 6.8 0.1 4.4 1.6 16.1 0.3 18.9 0.2 0.2 0.5 8.4 0.8 0.3 0.3 15.2 0.5 0.0 0.1 0.3 12.2 11.7 2.3 6.6 0.2 0.1 0.2 0.1 0.1 0.5 0.0 23.1 2.5 0.0 0.0 1.0 8.1 0.0 15.2 27.2 0.2 0.6 1.0 13.4 0.0 0.0 31.7 27.1 0.4 5.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.5 0.0 15.7 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.1 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.5 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.2 0.2 28.2 0.2 0.4 0.2 0.2 0.0 4.4 0.0 GALNT8 GALNAC-T8 ENSG00000130035 "Polypeptide N-acetylgalactosaminyltransferase 8" "Q9NY28, P17658" 12 4720341-4851927 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Glycosyltransferase, Ion channel, Potassium channel, Transferase, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 12.7;intestine: 33.2;testis: 18.5" "Group enriched" "Detected in some" 4 "Karpas-707: 26.3;NTERA-2: 9.3;U-266/84: 7.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA012638, HPA073461" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" "Golgi apparatus, Vesicles" "HPA012638: AB_2294503, HPA073461: " "unprognostic (2.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.13e-2)" "unprognostic (1.75e-2)" "unprognostic (6.24e-2)" "unprognostic (2.87e-1)" "unprognostic (2.59e-2)" "unprognostic (3.79e-1)" "unprognostic (2.72e-1)" "unprognostic (5.76e-2)" "unprognostic (8.06e-5)" "unprognostic (1.16e-2)" "unprognostic (6.67e-5)" "unprognostic (5.18e-2)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-2)" 1.1 2.2 5.3 2.2 6.5 0.5 3.1 1.4 12.7 1.0 15.5 9.4 0.0 7.2 0.9 0.4 0.7 1.2 1.1 3.7 8.0 1.7 1.2 0.8 0.9 1.0 5.7 9.6 1.6 0.9 0.2 3.7 0.5 6.0 1.1 33.2 0.1 1.0 0.9 0.7 0.9 14.7 2.1 3.5 1.2 1.3 18.5 11.5 0.0 0.8 0.5 0.9 1.2 0.9 1.0 0.7 0.1 0.1 0.9 3.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 26.3 0.0 0.0 0.2 0.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.3 7.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.3 0.7 1.2 0.0 1.0 0.0 0.1 0.1 0.9 0.0 0.7 3.0 0.0 5.3 6.5 1.4 12.7 8.0 1.7 5.7 9.6 6.0 11.5 GALNT9 GALNAC-T9 ENSG00000182870 "Polypeptide N-acetylgalactosaminyltransferase 9" Q9HCQ5 12 132196372-132329349 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 52.4" "Cell line enriched" "Detected in some" 5 "U-87 MG: 26.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 2.6;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 9 "B-cells: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075016 Approved Vesicles Vesicles "HPA075016: " "unprognostic (1.13e-1)" "unprognostic (3.47e-2)" "unprognostic (1.47e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (6.53e-2)" "unprognostic (2.65e-1)" "unprognostic (1.32e-2)" "unprognostic (2.03e-1)" "unprognostic (1.64e-3)" "unprognostic (2.85e-1)" "unprognostic (6.62e-2)" "unprognostic (5.17e-2)" "unprognostic (1.89e-1)" "unprognostic (1.71e-1)" "unprognostic (3.89e-2)" "unprognostic (5.69e-2)" 2.6 2.2 9.3 1.0 6.7 0.6 0.5 52.4 27.9 1.1 0.8 0.8 0.0 1.1 1.8 7.7 0.5 1.9 0.7 0.6 12.9 6.8 3.2 0.5 0.9 1.3 4.3 10.8 1.3 0.4 1.9 2.7 0.5 6.9 1.0 0.6 0.3 1.2 1.7 0.5 0.9 1.0 0.6 1.7 1.2 0.7 0.9 1.1 0.0 6.1 0.0 0.4 0.7 0.1 2.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 26.3 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 2.6 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.3 6.7 52.4 20.2 12.9 6.8 4.3 10.8 6.9 1.1 GAPDH GAPD ENSG00000111640 "Glyceraldehyde-3-phosphate dehydrogenase" P04406 12 6533927-6538374 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Glycolysis, Translation regulation" "Oxidoreductase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 1236.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB005197, CAB016392, HPA040067, HPA061280" Supported Supported "Nuclear membrane,Vesicles,Plasma membrane,Cytosol" 2200000000 "Plasma membrane, Cytosol" "Nuclear membrane, Vesicles" "CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463" "unprognostic (3.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.58e-2)" "unprognostic (4.20e-1)" "unprognostic (9.73e-3)" "unprognostic (1.77e-3)" "prognostic unfavourable (1.79e-6)" "unprognostic (2.89e-3)" "unprognostic (2.86e-1)" "unprognostic (2.06e-2)" "unprognostic (9.50e-3)" "unprognostic (4.52e-1)" "prognostic unfavourable (6.25e-10)" "unprognostic (2.33e-1)" "unprognostic (4.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.26e-2)" 50.0 59.4 104.1 57.6 101.0 195.5 38.4 58.0 151.3 49.4 73.3 80.7 24.0 75.8 37.3 46.8 146.9 50.2 58.0 215.1 95.0 95.5 88.4 221.0 41.3 90.1 111.8 58.0 62.0 27.0 66.1 46.1 98.2 115.9 48.3 76.7 74.5 60.8 63.2 1236.8 54.4 74.4 68.0 95.6 50.7 41.1 36.4 35.9 101.9 38.3 238.7 105.3 89.5 50.5 57.9 171.0 110.0 201.6 60.5 108.8 271.9 196.0 345.9 99.8 155.5 97.4 160.6 217.5 149.0 212.2 218.1 227.7 244.1 134.6 229.2 29.5 175.6 111.7 92.7 345.6 151.4 201.0 100.7 126.8 217.1 207.3 131.3 204.9 102.1 134.3 112.9 214.3 242.1 240.0 68.1 48.3 247.7 391.1 233.5 107.9 368.8 115.3 189.9 177.7 109.1 248.1 239.9 70.7 113.5 131.5 343.1 197.9 53.6 144.8 149.7 170.2 205.7 87.8 257.4 109.8 79.8 295.4 360.8 129.9 266.3 110.0 201.6 37.0 74.1 103.2 65.3 57.9 77.9 74.4 171.0 32.2 44.1 51.2 106.5 60.5 92.3 25.2 108.8 271.9 104.1 101.0 58.0 151.3 95.0 95.5 111.8 58.0 115.9 35.9 GARNL3 "bA356B19.1, DKFZp761J1523" ENSG00000136895 "GTPase activating Rap/RanGAP domain like 3" Q5VVW2 9 127224265-127393660 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell line enhanced" "Detected in many" "RPMI-8226: 5.9;SH-SY5Y: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 4 "dendritic cells: 3.8;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028757, HPA074886" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA028757: AB_2294383, HPA074886: " "unprognostic (3.15e-2)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (3.40e-2)" "unprognostic (3.12e-2)" "unprognostic (1.19e-3)" "unprognostic (5.58e-3)" "unprognostic (3.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (6.88e-4)" "unprognostic (2.22e-1)" "unprognostic (3.23e-7)" "unprognostic (6.39e-2)" "unprognostic (6.60e-2)" "unprognostic (7.04e-3)" "unprognostic (1.78e-5)" 4.2 8.4 11.4 2.5 13.5 0.4 6.4 33.3 19.6 9.1 3.6 12.9 3.8 3.0 10.6 6.6 7.0 8.5 5.8 16.3 7.5 9.6 3.4 3.0 3.8 2.0 7.8 10.7 6.6 3.5 15.7 3.1 2.3 12.9 9.0 3.1 4.3 7.0 6.4 2.2 4.3 2.7 10.1 7.2 2.4 2.9 4.0 9.4 0.0 8.6 1.5 2.1 7.9 4.8 0.5 3.8 0.0 0.5 0.0 1.3 0.2 0.8 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.6 0.3 1.8 1.9 0.6 0.0 1.7 0.1 0.9 3.3 0.0 0.3 0.0 1.4 0.0 2.9 1.9 0.8 0.7 0.3 0.2 2.6 0.0 0.0 1.3 1.4 1.1 0.1 1.0 0.0 0.6 0.7 2.7 0.2 2.0 5.9 3.2 4.1 2.1 6.5 1.3 4.7 0.5 1.6 0.1 0.0 0.4 1.9 0.0 0.6 4.1 3.9 2.0 0.9 1.0 0.8 0.0 0.5 0.0 1.2 0.1 0.3 0.2 0.1 1.3 0.5 0.5 0.8 0.0 0.0 0.0 0.0 3.8 0.6 0.2 11.4 13.5 33.3 19.6 7.5 9.6 7.8 10.7 12.9 9.4 GCG "GLP-1, GLP1, GLP2, GRPP" ENSG00000115263 Glucagon P01275 2 162142873-162152404 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "pancreas: 202.8" "Group enriched" "Detected in some" 5 "EFO-21: 37.1;U-2 OS: 52.8" "Cancer enriched" "Detected in some" 209 "pancreatic cancer: 428.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "pons and medulla: 3.7" "Region enhanced" "Detected in single" "midbrain: 2.0" "CAB000040, HPA036760, HPA036761" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to blood" 77950 "Endoplasmic reticulum" Vesicles "CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297" "unprognostic (3.13e-3)" "unprognostic (9.99e-2)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" 1.0 0.1 0.2 0.6 0.2 1.1 0.2 0.2 1.8 0.2 6.6 0.2 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 3.4 0.2 0.2 0.2 0.2 0.2 0.2 202.8 0.0 0.2 0.2 0.5 0.2 12.6 0.2 0.2 0.2 0.2 2.5 11.0 0.2 0.2 0.2 2.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.8 0.0 2.9 0.0 1.4 8.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.2 0.5 0.2 GCM1 "GCMA, hGCMa" ENSG00000137270 "Glial cells missing homolog 1" Q9NP62 6 53126964-53148829 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "placenta: 102.4" "Cell line enriched" "Detected in some" 22 "BEWO: 29.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.5" "Group enriched" "Detected in many" 8 "B-cells: 1.8;granulocytes: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011343, HPA073469" Enhanced Approved Vesicles Vesicles "HPA011343: , HPA073469: " "unprognostic (2.81e-2)" "unprognostic (4.09e-2)" "unprognostic (1.89e-2)" "unprognostic (1.53e-1)" "unprognostic (3.17e-1)" "unprognostic (7.68e-2)" "unprognostic (8.47e-3)" "unprognostic (2.83e-2)" "unprognostic (2.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.42e-1)" "unprognostic (5.98e-2)" "unprognostic (1.29e-4)" "unprognostic (1.86e-1)" "unprognostic (7.42e-2)" "unprognostic (2.96e-2)" 0.3 0.3 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.0 1.5 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.2 102.4 0.1 0.2 0.0 0.1 0.1 0.1 3.1 0.0 0.4 0.1 0.1 2.2 0.0 2.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.8 0.2 4.5 0.3 0.4 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 29.6 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.1 0.6 0.3 2.2 0.2 0.1 0.2 0.7 0.1 0.1 0.2 1.8 0.2 0.2 4.5 0.4 0.3 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 GCNA "ACRC, NAAR1" ENSG00000147174 "Germ cell nuclear acidic peptidase" Q96QF7 X 71578411-71613583 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 29.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA023476 Enhanced Approved Vesicles Vesicles "HPA023476: AB_1844530" "unprognostic (6.01e-2)" "unprognostic (2.30e-1)" "unprognostic (1.43e-2)" "unprognostic (4.37e-3)" "unprognostic (1.39e-1)" "unprognostic (2.35e-4)" "unprognostic (5.84e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-1)" "unprognostic (1.68e-1)" "unprognostic (1.03e-2)" "unprognostic (2.06e-1)" "unprognostic (5.07e-10)" "unprognostic (2.30e-1)" "unprognostic (5.06e-2)" "unprognostic (4.74e-1)" "unprognostic (1.15e-5)" 1.4 6.9 1.2 1.7 1.7 1.6 1.2 3.7 1.7 1.2 1.2 1.2 1.2 1.0 1.2 1.4 1.2 0.9 1.2 1.2 1.3 2.5 1.2 1.8 1.4 2.6 1.2 1.2 1.5 1.7 0.4 1.2 1.2 1.7 1.2 1.0 1.2 1.2 1.2 3.1 1.7 1.5 1.2 1.2 3.9 0.9 29.4 1.2 1.2 1.6 1.2 1.4 1.2 1.2 1.4 0.6 1.1 0.6 1.4 3.3 0.5 0.6 1.1 2.2 2.0 4.5 4.1 1.3 3.6 1.9 1.2 2.1 2.0 1.3 5.5 2.7 1.9 2.6 4.3 0.2 1.8 0.9 2.9 1.1 4.9 0.5 1.2 1.0 5.1 1.6 6.9 1.0 0.9 0.8 1.5 3.4 2.5 0.7 0.4 3.9 2.2 2.5 1.0 0.1 4.0 2.8 1.5 1.3 0.2 1.2 0.6 3.0 0.4 3.4 1.4 1.3 2.6 1.8 1.0 1.0 2.5 2.2 2.5 2.1 2.2 0.6 0.6 0.1 0.7 0.3 1.3 1.4 1.7 3.3 0.3 0.5 1.0 1.1 1.1 1.4 0.1 0.6 3.0 0.5 1.2 1.7 3.7 1.7 1.3 2.5 1.2 1.2 1.7 1.2 GCNT3 "C2/4GnT, C2GnT-M, C2GnT2" ENSG00000140297 "Glucosaminyl (N-acetyl) transferase 3, mucin type" O95395 15 59594875-59640239 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 29.6;intestine: 103.3;salivary gland: 27.4" "Cell line enriched" "Detected in some" 5 "A549: 55.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 29.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011154 Enhanced Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA011154: AB_1078961" "unprognostic (5.09e-2)" "unprognostic (2.39e-1)" "unprognostic (5.92e-2)" "prognostic favourable (1.78e-4)" "unprognostic (3.99e-3)" "unprognostic (2.02e-2)" "prognostic unfavourable (6.49e-5)" "unprognostic (1.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.34e-1)" "unprognostic (1.64e-2)" "unprognostic (1.63e-1)" "unprognostic (4.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-2)" "unprognostic (4.65e-2)" "unprognostic (2.43e-1)" 0.3 0.5 0.3 8.8 0.4 0.0 0.3 0.3 0.3 5.3 37.6 0.3 0.3 25.4 1.3 0.4 8.7 0.7 29.6 0.3 0.3 0.2 9.9 0.4 0.7 0.3 0.3 0.3 1.1 1.7 0.0 0.4 1.0 0.5 1.0 33.4 0.3 27.4 0.3 0.3 0.2 103.3 0.9 0.3 0.3 6.5 1.7 0.3 0.5 0.7 5.2 15.5 0.7 14.0 1.2 1.4 3.4 0.8 1.1 0.7 0.1 0.0 55.8 0.0 0.0 0.0 0.4 0.0 0.0 2.9 0.0 0.0 2.3 2.3 0.2 9.6 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 11.2 0.0 0.1 0.1 0.1 1.3 0.2 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 3.9 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.1 0.1 0.2 3.5 0.1 0.0 2.6 0.8 0.6 0.7 0.4 0.4 0.6 0.5 0.3 0.2 1.2 0.4 0.6 3.4 1.1 0.4 1.4 0.5 0.1 0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.5 0.3 GCSH ENSG00000140905 "Glycine cleavage system protein H" P23434 16 81081938-81096425 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 55.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA041368 Approved Approved Vesicles "Intracellular and membrane" Vesicles "HPA041368: AB_10804001" "unprognostic (4.09e-2)" "unprognostic (2.98e-2)" "unprognostic (2.29e-1)" "unprognostic (2.47e-3)" "unprognostic (2.55e-3)" "unprognostic (4.87e-2)" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.96e-2)" "unprognostic (6.92e-2)" "unprognostic (2.80e-2)" "prognostic favourable (6.26e-6)" "unprognostic (1.12e-2)" "unprognostic (2.59e-1)" "unprognostic (6.31e-2)" "unprognostic (6.47e-2)" 10.9 10.0 28.9 3.7 26.8 3.0 11.4 8.1 21.8 9.9 6.4 15.0 14.2 3.8 9.4 35.9 6.0 10.4 6.3 11.7 23.5 20.6 37.3 55.9 4.0 5.8 30.8 15.8 8.9 10.2 19.4 7.2 12.9 18.7 9.9 7.0 10.4 9.4 9.3 18.1 4.3 3.1 6.9 27.6 2.6 5.2 3.5 17.9 6.7 48.7 5.9 4.8 6.6 4.9 4.4 12.2 2.8 2.6 7.9 7.3 2.9 17.8 7.9 24.9 10.8 12.2 9.4 50.8 10.4 7.7 12.7 6.2 10.5 16.7 4.7 9.4 4.5 9.2 19.0 10.5 21.3 1.3 24.8 6.0 10.5 32.4 13.9 19.7 7.1 9.6 14.2 7.9 16.2 6.4 23.6 1.0 12.6 18.8 12.8 39.9 32.8 16.5 20.0 13.1 7.1 28.7 16.4 12.9 13.4 14.9 9.7 19.7 14.2 9.5 5.6 8.2 14.4 13.1 10.7 4.0 8.6 28.6 5.5 11.8 6.6 2.8 1.7 1.7 3.4 2.6 5.7 4.4 3.3 4.9 4.5 3.3 5.8 7.3 2.2 7.9 2.0 12.2 2.6 2.9 28.9 26.8 8.1 21.8 23.5 20.6 30.8 15.8 18.7 17.9 GDE1 MIR16 ENSG00000006007 "Glycerophosphodiester phosphodiesterase 1" Q9NZC3 16 19501689-19522145 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074747 Approved Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA074747: " "unprognostic (1.69e-1)" "unprognostic (5.13e-2)" "prognostic favourable (3.12e-4)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (4.10e-3)" "prognostic unfavourable (7.52e-5)" "unprognostic (2.10e-2)" "unprognostic (1.40e-2)" "unprognostic (4.31e-2)" "unprognostic (2.60e-3)" "unprognostic (9.92e-2)" "prognostic favourable (3.12e-5)" "unprognostic (8.36e-2)" "unprognostic (9.69e-3)" "unprognostic (1.88e-1)" "unprognostic (3.36e-2)" 20.3 18.5 30.6 11.7 34.3 17.5 23.9 13.5 32.2 18.1 31.0 24.5 23.0 22.7 15.0 22.6 19.0 13.4 17.5 40.7 31.1 17.5 21.1 21.3 22.1 13.1 29.2 20.6 9.9 28.3 35.3 13.9 15.5 20.8 21.4 32.5 12.5 20.4 24.9 42.4 18.5 20.8 27.2 25.3 10.1 22.8 14.8 23.8 9.6 17.9 21.7 12.7 22.8 12.4 4.6 7.4 23.9 12.4 3.7 7.4 4.6 14.6 17.6 9.7 11.5 46.8 17.4 13.9 15.1 26.0 11.8 14.7 10.0 26.2 11.0 19.5 22.0 12.7 13.5 17.8 14.4 11.9 20.8 9.2 17.3 21.6 28.4 12.1 8.6 18.3 28.9 12.6 14.8 15.8 5.1 11.4 12.8 26.4 10.5 11.2 11.3 13.7 15.2 17.8 15.9 29.2 22.5 11.3 10.3 14.7 17.6 13.9 18.0 14.5 16.6 10.0 9.0 13.2 9.2 10.7 10.1 7.6 15.4 18.0 8.9 23.9 11.8 6.4 5.7 10.5 7.3 4.6 6.8 6.6 7.4 3.7 3.6 5.7 19.8 3.7 12.4 4.6 7.4 4.6 30.6 34.3 13.5 32.2 31.1 17.5 29.2 20.6 20.8 23.8 GDF10 BMP-3b ENSG00000266524 "Growth differentiation factor 10" P55107 10 47300386-47313547 "Plasma proteins, Predicted secreted proteins" Osteogenesis "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.8;tongue: 14.8" "Cell line enhanced" "Detected in some" "AF22: 17.3;MOLT-4: 3.7;SH-SY5Y: 7.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.3;naive CD4 T-cell: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Region enriched" "Detected in many" 8 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA015498 Uncertain Approved Vesicles "Secreted in other tissues" Vesicles "HPA015498: AB_1849584" "unprognostic (4.34e-2)" "unprognostic (3.10e-1)" "unprognostic (1.41e-1)" "unprognostic (5.09e-1)" "unprognostic (3.17e-1)" "unprognostic (9.84e-3)" "unprognostic (1.37e-2)" "unprognostic (2.26e-2)" "unprognostic (1.55e-1)" "unprognostic (4.08e-2)" "unprognostic (1.15e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-7)" "unprognostic (3.49e-2)" "unprognostic (1.48e-1)" "unprognostic (2.59e-3)" "unprognostic (2.63e-1)" 6.8 4.4 1.4 0.3 2.8 0.0 10.8 7.6 5.2 1.9 0.4 1.7 0.0 0.0 2.3 2.4 5.4 0.5 2.9 2.1 3.0 0.0 0.0 15.8 0.9 0.0 5.0 0.1 11.6 0.2 0.0 0.0 0.9 2.8 0.3 6.8 3.0 0.3 2.5 0.3 0.1 0.6 0.8 0.1 0.1 10.5 0.8 0.0 3.7 14.8 2.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 GDF11 BMP-11 ENSG00000135414 "Growth differentiation factor 11" O95390 12 55743280-55757278 "Predicted secreted proteins" "Cytokine, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 35.4" "Cell line enhanced" "Detected in many" "HMC-1: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060985, HPA069609" Enhanced Approved Vesicles "Secreted to blood" 46350 270000 Vesicles "HPA060985: , HPA069609: " "unprognostic (5.21e-2)" "unprognostic (1.62e-1)" "unprognostic (3.20e-2)" "unprognostic (2.41e-2)" "unprognostic (2.78e-2)" "unprognostic (3.39e-1)" "unprognostic (2.13e-1)" "unprognostic (2.62e-2)" "unprognostic (8.96e-3)" "unprognostic (1.23e-2)" "prognostic favourable (1.08e-4)" "unprognostic (2.69e-1)" "unprognostic (1.62e-2)" "unprognostic (1.27e-1)" "unprognostic (3.13e-1)" "unprognostic (1.01e-3)" "unprognostic (9.48e-2)" 4.6 4.9 15.9 5.6 13.9 2.6 1.9 10.7 13.3 10.3 4.5 9.2 6.6 2.7 10.0 3.5 4.0 6.9 7.4 11.4 13.3 12.9 3.2 1.6 3.1 4.1 13.9 7.3 7.5 4.7 4.6 4.6 3.3 9.3 7.7 2.8 35.4 7.0 16.0 1.9 2.1 3.6 7.3 13.1 5.7 3.5 1.7 9.5 5.7 4.6 1.6 2.9 7.5 2.9 2.4 2.3 1.4 1.2 0.8 3.9 0.5 1.9 3.1 13.5 7.6 10.3 7.6 3.4 4.0 3.9 5.1 4.5 10.4 0.8 3.8 5.4 4.2 1.9 10.2 7.2 1.8 7.2 9.2 4.6 5.1 1.5 2.0 3.8 53.0 7.2 0.4 7.5 2.1 6.7 5.1 12.3 6.6 3.6 6.2 3.3 10.8 7.7 9.9 3.7 2.3 3.2 2.6 9.2 5.6 2.5 1.1 1.0 4.3 4.2 4.1 6.3 9.7 4.9 2.9 3.3 1.0 1.9 3.3 3.8 4.4 0.7 0.7 1.4 3.9 0.5 3.6 2.3 2.4 2.5 0.6 2.4 2.2 3.0 1.2 0.8 1.2 2.3 1.7 0.5 15.9 13.9 10.7 10.0 13.3 12.9 13.9 7.3 9.3 9.5 GDF6 "BMP13, KFS, KFS1, SGM1" ENSG00000156466 "Growth differentiation factor 6" Q6KF10 8 96142330-96160792 "Disease related genes, Predicted secreted proteins" Apoptosis "Cytokine, Developmental protein, Growth factor" "Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 11.8;placenta: 16.9" "Cell line enriched" "Detected in some" 8 "LHCN-M2: 26.8" "Cancer enhanced" "Detected in some" "renal cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.6" HPA045206 Uncertain Supported "Nucleoplasm,Nuclear membrane,Vesicles" "Secreted to blood" Vesicles "Nucleoplasm, Nuclear membrane" "HPA045206: AB_10962508" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (9.66e-9)" "unprognostic (6.49e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-3)" "unprognostic (5.37e-2)" "unprognostic (8.13e-3)" "prognostic unfavourable (2.17e-4)" "unprognostic (5.88e-4)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (1.71e-1)" 2.5 0.2 1.4 1.5 0.9 0.0 0.8 0.1 1.7 0.3 1.4 0.3 1.5 0.6 3.0 0.7 0.8 1.0 6.6 11.8 0.9 1.0 0.4 0.7 0.4 1.9 0.9 0.1 2.2 1.3 0.1 0.3 16.9 1.1 0.6 0.5 2.9 0.1 2.7 0.8 0.0 1.6 1.8 0.2 0.1 1.4 1.1 1.1 0.1 1.4 0.1 0.1 3.2 2.1 0.1 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.9 0.5 3.2 2.1 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 2.7 0.0 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 26.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 0.9 0.1 1.7 0.9 1.0 0.9 0.1 1.1 1.1 GDI1 "FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4" ENSG00000203879 "GDP dissociation inhibitor 1" P31150 X 154436913-154443467 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 122.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012979, HPA049290, HPA057668" Enhanced Approved Vesicles 70000000 Vesicles "CAB012979: AB_2533970, HPA049290: , HPA057668: " "prognostic unfavourable (6.84e-4)" "unprognostic (1.13e-2)" "prognostic unfavourable (3.83e-5)" "unprognostic (3.53e-1)" "unprognostic (1.22e-1)" "unprognostic (1.92e-3)" "unprognostic (1.31e-3)" "unprognostic (1.36e-1)" "unprognostic (1.46e-2)" "unprognostic (1.30e-1)" "unprognostic (2.98e-3)" "unprognostic (3.86e-2)" "unprognostic (3.88e-3)" "unprognostic (1.70e-1)" "unprognostic (8.12e-2)" "unprognostic (1.92e-2)" "unprognostic (1.72e-1)" 19.8 27.1 51.7 16.2 65.3 10.5 12.0 61.3 122.3 16.7 13.6 46.2 6.5 11.5 20.1 15.7 14.4 23.0 15.2 25.7 53.7 54.3 13.7 10.3 16.9 15.1 45.1 49.6 27.7 16.2 18.8 26.9 19.0 65.3 19.6 13.9 13.8 13.6 24.0 14.3 17.2 13.1 25.6 46.4 17.1 13.5 12.9 31.3 6.8 12.7 6.2 15.7 13.9 11.8 7.6 8.3 20.6 13.4 5.6 13.0 4.9 20.3 18.9 42.7 35.2 17.5 20.7 13.4 29.5 19.8 31.1 32.5 11.0 10.8 16.3 30.9 29.9 16.1 37.4 18.0 21.6 29.4 18.4 5.1 27.7 7.3 25.8 4.9 18.6 21.2 22.3 36.0 22.1 20.0 6.2 25.9 36.9 20.6 15.6 12.4 11.3 34.5 15.6 11.1 9.3 21.7 9.6 59.1 45.7 14.2 18.5 22.4 11.0 8.9 22.6 28.7 24.9 29.7 43.1 36.7 38.9 25.9 31.2 11.1 35.2 14.9 5.7 17.2 8.9 8.6 13.0 7.3 9.6 8.6 4.7 7.6 7.6 7.5 20.6 5.6 13.4 8.3 10.8 4.9 51.7 65.3 61.3 96.6 53.7 54.3 45.1 49.6 65.3 31.3 GDNF "ATF1, ATF2, HFB1-GDNF" ENSG00000168621 "Glial cell derived neurotrophic factor" P39905 5 37812677-37839686 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes, Disease mutation, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;skeletal muscle: 12.4" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 24.6;U-87 MG: 7.4;WM-115: 27.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 14.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in single" "basal ganglia: 2.5" "Low region specificity" "Detected in many" "CAB005210, HPA070283" Supported Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "CAB005210: AB_2247684, HPA070283: " "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (3.54e-2)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (5.33e-2)" "unprognostic (1.92e-1)" "unprognostic (3.71e-2)" "unprognostic (2.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.10e-1)" "unprognostic (1.16e-4)" "unprognostic (2.04e-1)" "unprognostic (8.86e-2)" "unprognostic (1.05e-1)" "unprognostic (4.42e-2)" 1.9 0.3 0.6 1.9 2.3 0.0 0.4 14.1 1.3 0.8 9.4 0.4 0.4 1.6 1.7 3.4 1.0 0.9 0.9 0.9 0.6 0.4 1.0 0.7 0.4 0.4 0.6 1.2 4.5 0.4 0.0 0.4 6.3 1.4 1.6 3.1 1.1 0.4 6.3 12.4 1.4 2.5 2.5 0.5 0.4 1.9 3.9 2.4 0.4 0.4 1.5 0.4 0.6 1.1 0.8 0.4 1.2 0.3 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 3.3 2.1 0.6 0.9 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.2 0.3 0.1 0.0 0.0 1.0 0.1 24.6 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.1 0.2 0.0 0.1 0.1 1.6 0.0 0.0 0.0 3.3 0.0 0.8 3.8 2.3 0.0 0.0 7.4 0.0 27.0 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.8 0.2 0.4 1.2 0.9 0.2 0.4 0.1 0.0 0.6 2.3 14.1 1.3 0.6 0.4 0.6 1.2 1.4 2.4 GFPT2 GFAT2 ENSG00000131459 "Glutamine-fructose-6-phosphate transaminase 2" O94808 5 180300690-180353387 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 65.6" "Cell line enhanced" "Detected in many" "ASC diff: 24.0;ASC TERT1: 41.2;HSkMC: 26.4;hTEC/SVTERT24-B: 49.0;U-87 MG: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 7.1" "Lineage enriched" "Detected in single" 49 "T-cells: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056892, HPA059910" Uncertain Supported Vesicles Vesicles "HPA056892: , HPA059910: " "unprognostic (3.48e-1)" "prognostic unfavourable (9.09e-4)" "unprognostic (1.91e-2)" "unprognostic (1.08e-2)" "unprognostic (6.28e-2)" "unprognostic (3.39e-3)" "unprognostic (3.05e-1)" "prognostic unfavourable (2.95e-4)" "unprognostic (7.65e-2)" "unprognostic (2.73e-2)" "unprognostic (4.50e-2)" "unprognostic (2.94e-2)" "prognostic unfavourable (2.58e-14)" "unprognostic (3.67e-3)" "unprognostic (1.23e-2)" "prognostic unfavourable (3.47e-4)" "unprognostic (1.52e-3)" 65.6 3.9 4.5 15.8 5.6 0.9 11.0 17.0 9.2 10.0 9.2 9.3 5.4 2.1 9.0 16.7 5.9 15.9 14.6 16.4 7.1 3.8 2.8 2.6 11.0 3.1 6.2 6.8 17.5 11.1 3.5 2.5 6.0 8.4 7.7 3.6 2.9 4.0 8.0 6.0 4.0 5.0 10.0 17.2 1.7 6.6 6.3 7.7 0.0 5.6 5.4 3.5 14.3 14.6 0.0 0.1 0.0 0.0 0.1 7.1 0.2 0.0 5.3 4.2 5.4 24.0 41.2 0.4 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.2 4.4 0.0 2.3 0.0 0.2 0.5 0.8 0.0 2.6 0.0 10.0 0.0 0.0 26.4 0.2 49.0 0.1 7.9 0.0 0.0 21.0 0.7 0.0 0.0 9.0 2.4 0.1 0.0 0.0 0.0 0.0 0.2 0.3 8.3 0.1 0.3 0.3 0.0 3.7 13.5 2.1 8.7 9.9 0.0 0.0 0.0 85.2 0.0 0.3 0.0 0.0 0.0 1.4 0.0 7.1 0.0 0.8 2.4 0.1 0.0 0.8 1.1 0.0 0.1 0.0 0.1 0.0 0.2 4.5 5.6 17.0 9.2 7.1 3.8 6.2 6.8 8.4 7.7 GFRA2 "GDNFRB, NTNRA, RETL2, TRNR2" ENSG00000168546 "GDNF family receptor alpha 2" O00451 8 21690403-21812357 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;thyroid gland: 17.4" "Cell line enhanced" "Detected in some" "HEL: 8.8;HMC-1: 20.2;WM-115: 3.7" "Cancer enriched" "Detected in some" 5 "thyroid cancer: 6.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 10.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.1;monocytes: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024704, CAB032791" Uncertain Uncertain Vesicles "Intracellular and membrane" 3300000 Vesicles "CAB032791: AB_2110428, HPA024704: AB_1849629" "unprognostic (4.24e-2)" "unprognostic (1.11e-2)" "unprognostic (4.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.93e-2)" "unprognostic (1.08e-2)" "unprognostic (7.48e-4)" "unprognostic (2.87e-1)" "unprognostic (6.11e-2)" "unprognostic (4.40e-3)" "unprognostic (2.11e-3)" "unprognostic (7.82e-2)" "unprognostic (1.50e-4)" "unprognostic (8.45e-4)" "unprognostic (1.74e-1)" "unprognostic (4.68e-2)" "unprognostic (9.63e-3)" 4.2 3.4 2.6 3.4 6.7 1.2 1.4 2.1 19.2 4.9 3.6 0.7 2.6 3.4 1.3 4.0 3.0 4.3 1.2 3.2 6.8 8.9 1.1 1.9 2.2 4.3 4.3 7.1 1.0 0.9 0.2 2.0 11.5 3.2 1.3 2.0 3.7 2.0 4.9 0.4 1.2 3.2 3.5 1.9 12.2 2.2 6.7 0.2 1.0 17.4 0.0 1.5 2.4 2.6 0.1 3.1 0.9 10.9 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 2.4 0.9 0.0 10.9 0.0 0.0 0.0 0.0 3.1 0.1 0.2 0.0 0.5 0.0 1.4 0.0 0.0 0.9 2.6 6.7 2.1 19.2 6.8 8.9 4.3 7.1 3.2 0.2 GGA1 ENSG00000100083 "Golgi associated, gamma adaptin ear containing, ARF binding protein 1" Q9UJY5 22 37608475-37633564 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048280, HPA051016" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA048280: , HPA051016: " "unprognostic (1.64e-1)" "unprognostic (1.42e-2)" "unprognostic (4.08e-1)" "unprognostic (9.23e-3)" "unprognostic (2.00e-1)" "unprognostic (2.77e-2)" "prognostic unfavourable (6.29e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "prognostic favourable (4.86e-4)" "unprognostic (1.42e-2)" "unprognostic (1.53e-2)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.16e-3)" 10.7 15.8 13.5 12.2 14.0 17.3 10.8 21.8 18.4 11.6 10.6 19.3 14.5 13.1 12.9 14.1 13.3 13.8 11.8 10.2 12.5 10.6 12.0 14.1 10.9 14.0 17.7 13.2 18.1 13.9 20.6 19.4 12.5 13.5 12.0 9.6 17.7 16.7 16.7 17.1 17.1 12.0 9.3 14.2 15.8 12.8 83.8 16.6 12.1 15.4 9.9 14.2 10.6 11.0 6.4 5.0 4.9 7.7 7.6 18.0 7.6 18.2 12.8 16.0 15.6 14.1 11.6 17.6 15.1 12.1 13.3 14.8 11.3 10.4 28.0 10.3 10.8 17.0 14.2 16.8 12.2 23.9 23.6 11.1 22.9 12.1 13.7 27.2 21.6 14.0 15.0 18.9 12.0 12.5 22.3 18.2 13.7 17.4 12.1 29.2 12.6 13.2 13.4 12.9 12.0 13.7 14.8 14.8 26.2 9.6 20.2 23.3 21.0 19.8 14.9 18.2 17.8 16.4 12.0 39.3 15.7 29.0 20.4 16.5 15.9 4.9 7.7 4.3 14.0 7.6 17.3 6.4 5.6 18.0 5.0 4.1 4.2 13.0 3.3 7.6 5.5 4.3 5.8 7.6 13.5 14.0 21.8 18.4 12.5 10.6 17.7 13.2 13.5 16.6 GGT1 "CD224, D22S672, D22S732, GGT" ENSG00000100031 "Gamma-glutamyltransferase 1" P19440 22 24583750-24629005 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Protease, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.1;seminal vesicle: 41.7" "Cell line enhanced" "Detected in many" "HDLM-2: 35.8;Karpas-707: 52.7;RPMI-8226: 51.8;RPTEC TERT1: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA045635, HPA047534, HPA065444" Supported Approved Vesicles "Intracellular and membrane" 4600000 Vesicles "HPA045635: , HPA047534: , HPA065444: " "unprognostic (8.13e-3)" "unprognostic (4.76e-1)" "unprognostic (8.29e-2)" "unprognostic (1.28e-2)" "unprognostic (3.70e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-3)" "unprognostic (1.68e-1)" "unprognostic (2.21e-1)" "prognostic favourable (7.44e-4)" "unprognostic (4.55e-2)" "unprognostic (2.55e-2)" "prognostic favourable (4.83e-4)" "unprognostic (1.44e-2)" "unprognostic (5.37e-2)" "unprognostic (1.74e-1)" "unprognostic (6.10e-2)" 1.6 0.5 1.7 1.7 2.2 2.7 8.2 2.3 2.6 7.3 7.9 1.6 23.7 22.3 1.4 19.9 1.2 0.8 12.2 2.0 1.8 1.2 54.1 29.2 14.3 3.2 1.7 1.6 1.3 17.3 0.0 1.6 1.4 2.2 14.7 2.4 1.4 8.7 41.7 0.9 1.1 20.9 1.7 1.9 4.7 6.6 5.0 2.1 2.4 4.8 1.6 5.5 2.1 1.1 3.3 7.5 15.9 14.6 6.6 8.6 6.6 0.2 19.4 0.2 0.0 0.0 0.1 0.5 0.1 0.6 0.2 0.2 2.6 4.3 0.2 4.3 0.0 2.8 1.4 0.2 0.1 35.8 2.9 0.1 8.6 14.1 1.5 0.3 12.0 0.4 0.2 0.6 0.4 0.1 2.0 52.7 0.2 0.4 0.3 14.6 1.4 0.2 0.2 2.2 51.8 48.2 0.6 0.2 0.3 0.1 9.4 0.2 9.4 11.1 2.2 3.5 2.3 10.9 0.3 15.8 6.0 0.2 7.4 15.1 0.1 5.2 14.6 0.4 1.4 6.8 5.2 3.3 7.7 3.4 7.5 0.3 1.0 1.9 15.9 6.6 5.5 0.1 8.6 6.6 1.7 2.2 2.3 2.6 1.8 1.2 1.7 1.6 2.2 2.1 GGT2 GGT ENSG00000133475 "Gamma-glutamyltransferase 2" P36268 22 21207973-21227637 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4" "Cell line enhanced" "Detected in some" "HDLM-2: 2.3;HeLa: 4.5;Karpas-707: 2.0;U-2197: 13.6" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045635, HPA047534, HPA065444" Supported Approved Vesicles Vesicles "HPA045635: , HPA047534: , HPA065444: " "unprognostic (4.27e-1)" "unprognostic (6.91e-2)" "unprognostic (7.03e-2)" "unprognostic (8.13e-2)" "unprognostic (1.01e-2)" "unprognostic (2.38e-5)" "unprognostic (1.05e-3)" "unprognostic (5.85e-4)" "unprognostic (7.97e-3)" "unprognostic (8.84e-2)" "unprognostic (1.16e-1)" "unprognostic (6.39e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-2)" "unprognostic (3.46e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 0.2 0.0 1.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.1 2.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 5.5 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.3 1.0 8.4 0.0 0.0 0.0 0.1 0.2 0.4 0.4 0.4 0.5 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.5 0.5 13.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.1 0.5 0.0 0.2 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.5 0.3 GGT7 "D20S101, dJ18C9.2, GGTL3, GGTL5" ENSG00000131067 "Gamma-glutamyltransferase 7" Q9UJ14 20 34844720-34872860 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013204, HPA013339" Approved Approved Nucleoplasm,Vesicles 1500000 Vesicles Nucleoplasm "HPA013204: AB_1850347, HPA013339: " "unprognostic (1.32e-3)" "unprognostic (2.33e-1)" "unprognostic (9.31e-2)" "prognostic unfavourable (1.26e-5)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.46e-3)" "unprognostic (2.49e-2)" "unprognostic (3.49e-1)" "unprognostic (1.16e-2)" "unprognostic (3.34e-3)" "unprognostic (3.61e-2)" "unprognostic (5.00e-3)" "unprognostic (1.81e-1)" "unprognostic (1.63e-1)" "unprognostic (5.50e-2)" "unprognostic (2.00e-1)" 6.8 6.7 21.6 6.7 23.7 2.9 8.5 42.6 29.1 9.5 11.5 9.7 14.3 9.8 12.3 19.5 6.4 10.5 11.4 13.8 19.7 17.0 9.9 7.2 9.0 10.3 11.2 32.1 13.4 19.5 20.8 18.3 8.5 19.2 11.4 9.6 6.9 18.8 15.3 31.6 11.1 9.0 9.6 11.0 8.3 12.9 5.0 15.6 4.9 16.3 4.3 8.2 9.3 8.5 6.1 2.6 1.5 3.0 3.2 12.8 1.8 2.2 3.3 17.0 17.4 13.4 12.0 15.1 9.4 9.6 7.8 11.6 17.4 11.1 0.0 11.2 7.3 1.5 7.3 4.1 5.1 0.7 13.1 6.7 5.9 9.1 12.0 0.3 11.1 17.4 4.7 8.7 4.0 0.6 5.0 1.2 5.3 3.8 1.7 3.4 3.9 1.7 0.0 11.6 10.7 11.3 3.3 9.9 11.6 4.8 7.7 12.1 5.9 6.1 0.2 26.8 10.7 2.5 5.3 13.1 1.7 0.8 31.5 0.6 9.8 1.5 3.0 1.4 7.4 2.0 2.1 5.6 6.3 2.8 2.6 6.1 12.8 8.9 0.3 3.2 0.7 1.4 4.8 1.8 21.6 23.7 42.6 29.1 19.7 17.0 11.2 32.1 19.2 15.6 GIGYF1 "GYF1, PERQ1" ENSG00000146830 "GRB10 interacting GYF protein 1" O75420 7 100679507-100694037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020999, HPA023995" Enhanced Approved Vesicles,Microtubules Vesicles Microtubules "HPA020999: AB_2111744, HPA023995: AB_1855221" "unprognostic (3.82e-3)" "unprognostic (1.58e-1)" "unprognostic (2.56e-2)" "unprognostic (2.67e-2)" "unprognostic (7.46e-2)" "prognostic favourable (7.42e-4)" "prognostic unfavourable (2.30e-4)" "unprognostic (1.43e-2)" "unprognostic (8.06e-2)" "unprognostic (1.65e-2)" "prognostic favourable (1.35e-5)" "unprognostic (3.66e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (1.89e-1)" "unprognostic (2.79e-1)" "unprognostic (2.67e-3)" 15.5 17.3 22.1 15.9 23.0 28.2 16.3 66.8 32.4 20.6 14.0 18.9 27.3 17.1 25.1 20.2 11.5 18.3 16.4 13.2 20.3 9.4 14.4 13.3 13.5 18.5 14.1 16.3 29.8 23.8 17.8 26.3 16.2 15.7 17.1 9.3 19.6 26.5 25.7 25.5 31.7 17.6 12.9 9.3 24.0 17.0 18.9 20.4 11.8 20.5 10.4 14.2 14.3 14.0 4.1 3.9 8.8 2.6 2.5 5.1 0.9 6.9 7.2 11.6 17.0 5.6 4.4 20.7 6.6 5.4 4.1 4.8 4.2 12.1 9.8 8.6 4.8 8.4 5.7 6.7 2.6 10.4 11.6 6.8 17.8 6.0 5.5 7.7 11.7 6.9 5.4 5.3 7.6 4.1 18.7 9.7 3.7 15.8 13.6 42.7 14.2 8.8 21.9 6.1 9.8 3.0 6.4 10.5 16.5 8.6 13.9 7.6 6.3 13.0 6.4 12.1 15.0 19.7 6.0 7.9 3.5 5.3 7.0 15.5 7.1 3.3 2.6 2.2 5.1 2.3 3.8 2.7 3.4 3.2 1.0 4.1 3.1 3.2 8.8 2.5 2.5 3.9 1.8 0.9 22.1 23.0 66.8 32.4 20.3 9.4 14.1 16.3 15.7 20.4 GIMAP7 "IAN7, MGC27027" ENSG00000179144 "GTPase, IMAP family member 7" Q8NHV1 7 150514830-150521073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 155.1" "Group enriched" "Detected in some" 12 "HUVEC TERT2: 39.0;MOLT-4: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "monocytes: 41.1;NK-cells: 65.0;T-cells: 155.1" "Low region specificity" "Detected in many" "HPA020266, HPA020268" Enhanced Supported Vesicles,Cytosol Vesicles Cytosol "HPA020266: AB_1849680, HPA020268: AB_1849682" "unprognostic (4.85e-3)" "unprognostic (1.65e-3)" "unprognostic (6.11e-2)" "unprognostic (1.32e-2)" "unprognostic (3.71e-1)" "prognostic favourable (7.43e-4)" "prognostic favourable (8.98e-5)" "unprognostic (6.49e-3)" "unprognostic (5.24e-2)" "unprognostic (6.12e-3)" "unprognostic (2.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.07e-3)" "unprognostic (2.07e-1)" "unprognostic (3.14e-2)" "unprognostic (2.01e-1)" "unprognostic (8.86e-2)" 32.2 7.3 6.2 30.1 9.8 1.9 19.7 4.3 8.0 19.9 9.5 2.1 5.3 7.6 13.4 11.9 12.2 10.2 9.4 14.6 9.3 6.4 20.1 10.5 22.8 54.7 10.0 3.3 7.0 4.7 3.3 4.9 12.5 7.2 13.5 8.8 6.2 10.7 4.6 17.0 4.6 20.5 12.4 8.1 51.5 7.7 6.7 8.2 18.7 16.7 11.3 34.9 13.4 11.0 0.4 18.0 3.4 41.1 65.0 155.1 131.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 41.1 0.5 79.6 36.9 77.6 0.4 118.6 95.4 18.0 0.3 155.1 108.0 3.4 65.0 38.6 1.0 64.7 131.0 6.2 9.8 4.3 8.0 9.3 6.4 10.0 3.3 7.2 8.2 GJA1 "CX43, GJAL, ODD, ODDD, ODOD, SDTY3" ENSG00000152661 "Gap junction protein alpha 1" P17302 6 121435692-121449727 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cancer-related genes, Cataract, Disease mutation, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 48.8;HUVEC TERT2: 61.6;NTERA-2: 62.7;TIME: 45.3;U-87 MG: 61.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010753, HPA035097, HPA047551, HPA069245" Enhanced Supported Supported "Nucleoplasm,Vesicles,Cell Junctions" "Vesicles, Cell Junctions" Nucleoplasm "CAB010753: AB_476857, HPA035097: , HPA047551: , HPA069245: " "unprognostic (3.37e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-1)" "unprognostic (4.18e-2)" "unprognostic (1.48e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (2.89e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.00e-1)" "unprognostic (4.88e-2)" "prognostic unfavourable (4.99e-5)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (3.00e-3)" 19.7 65.2 78.6 5.5 69.7 0.4 14.2 32.4 44.4 64.5 4.0 23.8 6.1 4.2 23.5 5.5 17.3 7.8 23.0 36.0 87.3 25.5 3.6 2.5 15.2 4.4 42.9 39.9 10.5 4.5 94.7 5.7 63.8 53.7 20.0 4.8 26.3 7.1 35.7 3.4 86.3 4.4 25.6 38.7 1.1 6.4 8.3 64.3 0.5 38.9 9.9 7.6 14.8 32.2 0.5 0.5 0.4 0.5 0.0 0.4 0.0 0.0 7.2 32.1 0.0 17.5 10.9 0.0 24.0 48.8 8.1 19.8 0.1 0.0 0.0 2.7 9.3 3.1 0.8 14.7 26.4 0.0 8.8 0.3 2.9 0.0 21.9 0.0 0.0 29.0 15.9 29.6 10.7 61.6 0.0 0.7 1.6 1.3 0.0 12.9 62.7 8.0 0.0 0.0 0.6 32.4 3.5 0.0 0.5 0.0 0.0 0.0 2.5 0.0 45.3 25.0 6.9 21.1 15.5 0.0 0.0 0.0 61.0 0.0 3.5 0.4 0.5 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.2 0.5 0.4 0.4 0.0 0.0 0.1 0.5 0.1 0.0 78.6 69.7 32.4 42.8 87.3 25.5 42.9 39.9 53.7 64.3 GJB3 "CX31, DFNA2, EKV" ENSG00000188910 "Gap junction protein beta 3" O75712 1 34781189-34786369 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1" "Cell line enhanced" "Detected in some" "A-431: 25.9;CAPAN-2: 36.9;HaCaT: 30.0;HBEC3-KT: 25.6;hTCEpi: 42.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA074472 Supported "Vesicles,Cell Junctions" "Vesicles, Cell Junctions" "HPA074472: " "unprognostic (1.34e-3)" "unprognostic (2.30e-1)" "unprognostic (2.84e-2)" "unprognostic (5.22e-3)" "unprognostic (3.82e-2)" "unprognostic (2.00e-2)" "unprognostic (1.21e-4)" "prognostic unfavourable (4.56e-4)" "unprognostic (2.30e-1)" "unprognostic (1.29e-1)" "prognostic unfavourable (7.56e-5)" "unprognostic (4.50e-2)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (1.22e-1)" "unprognostic (1.27e-2)" "unprognostic (2.46e-2)" 0.1 0.1 1.0 2.4 0.4 0.0 3.4 1.4 1.2 6.3 2.2 0.0 0.6 0.0 0.7 3.0 40.1 0.5 4.1 0.1 0.2 0.1 0.5 0.8 0.6 0.4 0.1 0.1 0.2 0.2 0.0 0.1 11.3 0.0 3.7 2.8 0.0 3.7 0.9 0.2 49.3 0.6 0.2 0.1 0.1 3.2 0.5 0.0 0.7 0.2 32.1 25.0 4.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 3.5 0.0 30.0 0.0 25.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 42.1 0.0 10.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 6.7 0.0 0.0 0.0 12.5 9.9 0.0 0.0 3.9 0.2 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 1.4 1.2 0.2 0.1 0.1 0.1 0.0 0.0 GLB1 "EBP, ELNR1" ENSG00000170266 "Galactosidase beta 1" P16278 3 32996608-33097230 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, Gangliosidosis, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 136.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008382, HPA040610, HPA069503" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" 1700000 Vesicles "Golgi apparatus" "CAB008382: AB_590642, HPA040610: , HPA069503: " "unprognostic (1.51e-2)" "unprognostic (3.66e-2)" "unprognostic (5.02e-3)" "unprognostic (9.66e-3)" "unprognostic (9.61e-3)" "unprognostic (1.04e-1)" "unprognostic (2.31e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (2.08e-1)" "prognostic favourable (1.14e-5)" "unprognostic (3.05e-1)" "unprognostic (2.33e-1)" "unprognostic (2.20e-1)" "unprognostic (5.85e-2)" 17.3 33.1 9.6 14.9 14.7 9.5 18.4 8.9 19.8 18.3 21.9 12.1 19.8 21.2 18.3 55.0 12.7 15.2 25.8 13.7 9.7 10.0 35.0 33.2 24.3 25.0 9.2 9.7 18.3 25.3 28.4 16.4 26.5 14.0 13.6 23.7 23.5 21.1 17.7 6.1 12.9 28.3 15.6 9.8 21.4 22.7 10.0 8.0 8.3 26.9 7.7 19.5 18.4 13.6 11.1 45.2 22.7 39.2 6.8 20.9 20.9 5.6 9.8 6.3 7.6 39.1 20.3 136.7 9.1 24.7 11.7 15.1 13.9 13.6 2.8 8.1 18.6 5.5 6.0 11.6 8.7 16.0 5.0 10.9 5.9 7.1 20.1 7.6 11.2 23.4 11.2 10.6 6.3 18.0 9.8 10.6 12.8 6.6 4.5 5.0 4.3 4.3 3.9 4.2 13.0 12.6 8.4 1.9 6.6 11.7 19.0 11.4 12.6 19.9 10.5 7.5 5.2 10.3 7.7 8.4 13.4 0.9 15.9 11.0 5.7 10.5 39.2 22.7 8.3 34.6 11.8 11.1 10.2 9.1 45.2 10.0 5.4 6.5 15.5 6.8 23.7 9.5 20.9 20.9 9.6 14.7 8.9 19.8 9.7 10.0 9.2 9.7 14.0 8.0 GLIPR1L2 MGC39497 ENSG00000180481 "GLIPR1 like 2" Q4G1C9 12 75391070-75432688 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 44.0" "Cell line enhanced" "Detected in some" "Hep G2: 5.7;SK-BR-3: 8.4;U-2 OS: 11.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039795, HPA039866" Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" Vesicles "Golgi apparatus, Cytosol" "HPA039795: AB_10805595, HPA039866: AB_10795235" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (3.32e-1)" "unprognostic (2.27e-1)" "unprognostic (7.74e-2)" "unprognostic (1.33e-1)" "unprognostic (8.78e-3)" "unprognostic (2.29e-2)" "unprognostic (1.48e-1)" "unprognostic (2.82e-1)" "unprognostic (7.68e-3)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (5.91e-2)" "unprognostic (2.57e-2)" 1.3 3.1 5.5 1.2 10.4 0.8 3.0 2.9 5.8 2.2 1.2 4.2 2.9 1.0 2.7 4.2 1.4 3.5 1.5 2.5 5.5 4.6 2.5 1.9 2.7 1.1 6.6 3.9 7.7 3.0 7.3 5.2 1.3 6.2 2.3 0.8 2.0 1.4 3.6 2.4 2.2 1.2 1.5 8.1 1.9 1.0 44.0 5.0 1.4 2.8 0.5 0.8 1.7 1.4 1.4 2.6 2.0 0.7 1.0 3.4 0.6 0.3 0.5 0.3 0.5 4.3 2.5 0.7 0.6 0.5 0.2 0.3 0.1 0.4 0.3 1.5 0.4 0.2 0.1 0.1 0.4 0.8 0.3 0.1 0.6 5.7 3.2 0.5 0.1 0.8 1.3 0.6 2.3 0.2 0.3 0.7 1.1 0.1 0.6 0.4 0.3 0.2 0.1 0.1 0.3 0.1 0.4 1.1 0.6 0.7 8.4 2.4 2.5 0.2 1.2 1.0 11.1 1.2 0.4 1.0 1.0 0.3 0.4 0.3 0.8 1.8 0.3 0.5 1.1 0.2 0.7 1.1 1.2 2.0 0.4 1.4 2.2 3.3 2.0 1.0 0.7 2.6 3.4 0.6 5.5 10.4 2.9 5.8 5.5 4.6 6.6 3.9 6.2 5.0 GLIPR2 "C9orf19, GAPR-1" ENSG00000122694 "GLI pathogenesis related 2" Q9H4G4 9 36136536-36163913 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.9" "Cell line enhanced" "Detected in many" "ASC diff: 26.4;HDLM-2: 25.2;TIME: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029478 Approved Uncertain Vesicles,Microtubules 18000000 Vesicles Microtubules "HPA029478: AB_10670038" "unprognostic (1.57e-2)" "unprognostic (5.70e-3)" "unprognostic (1.54e-1)" "unprognostic (1.28e-1)" "unprognostic (1.46e-2)" "unprognostic (1.33e-2)" "unprognostic (9.90e-2)" "unprognostic (2.50e-1)" "unprognostic (1.84e-2)" "unprognostic (4.26e-2)" "unprognostic (3.21e-1)" "unprognostic (5.87e-2)" "prognostic unfavourable (6.54e-7)" "unprognostic (6.57e-3)" "unprognostic (4.94e-1)" "unprognostic (1.02e-1)" "unprognostic (2.43e-2)" 28.5 10.8 8.1 25.5 12.1 32.5 15.6 5.7 11.2 19.9 32.4 23.3 9.1 7.5 40.3 16.8 16.3 18.7 13.0 11.7 9.4 7.1 4.9 3.5 31.2 26.5 14.7 6.5 13.4 2.8 0.4 2.9 4.7 12.3 20.1 17.1 11.6 7.9 21.3 4.8 6.1 14.9 35.5 21.8 21.1 13.8 5.0 13.2 10.1 10.6 7.4 9.4 19.2 14.2 3.3 28.8 92.9 48.6 15.8 24.8 45.5 1.2 1.0 7.5 7.9 26.4 12.6 0.8 12.0 7.2 2.8 5.1 0.4 0.1 0.0 3.7 10.8 0.0 2.7 0.4 1.7 25.2 2.3 3.0 2.4 0.1 10.5 1.9 10.3 8.5 0.3 16.1 2.8 22.2 0.1 1.8 6.4 2.8 9.4 5.2 7.2 3.8 6.5 15.9 0.3 0.6 0.6 2.0 4.1 1.5 0.7 1.2 0.8 8.3 44.7 3.9 9.1 3.5 9.7 2.8 0.7 4.3 4.0 12.2 0.9 30.1 48.6 71.9 24.8 22.3 13.1 3.2 17.2 15.8 28.8 3.3 7.3 11.5 92.9 15.8 16.2 2.5 17.6 45.5 8.1 12.1 5.7 9.8 9.4 7.1 14.7 6.5 12.3 13.2 GLRX2 "bA101E13.1, GRX2" ENSG00000023572 "Glutaredoxin 2" Q9NS18 1 193090866-193106114 "Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023087, HPA057224" Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA023087: AB_1849778, HPA057224: " "unprognostic (4.80e-2)" "unprognostic (3.77e-2)" "unprognostic (8.04e-2)" "unprognostic (2.33e-1)" "unprognostic (1.13e-1)" "unprognostic (4.99e-2)" "unprognostic (2.40e-3)" "unprognostic (5.11e-2)" "unprognostic (3.21e-2)" "unprognostic (2.38e-2)" "unprognostic (1.10e-2)" "unprognostic (2.38e-1)" "prognostic unfavourable (3.30e-7)" "unprognostic (6.23e-2)" "unprognostic (1.73e-1)" "unprognostic (6.21e-2)" "unprognostic (4.48e-2)" 14.1 17.9 13.8 9.7 12.2 10.7 16.3 7.4 22.0 7.8 14.9 6.6 7.4 14.7 6.7 14.5 13.1 5.1 8.8 23.5 13.0 13.3 14.3 28.2 7.8 6.1 16.5 13.1 5.4 10.4 4.6 9.9 9.5 22.3 21.8 11.7 7.4 8.6 11.6 28.5 8.9 12.7 10.9 12.3 7.6 10.3 27.9 8.7 2.3 7.7 11.6 9.0 9.6 10.2 10.8 17.4 19.6 21.4 11.6 14.1 10.9 13.8 17.0 4.3 9.7 16.1 10.5 7.8 20.4 8.8 16.8 14.0 10.5 13.2 6.2 11.4 8.4 13.5 5.1 11.6 17.3 13.6 9.6 11.9 11.5 12.2 17.3 9.7 12.0 7.1 10.1 23.1 11.6 10.6 17.6 6.5 20.3 19.1 7.7 17.9 5.1 12.5 7.1 7.0 14.0 16.2 9.1 4.2 3.7 8.2 24.4 68.9 10.6 11.0 6.4 13.2 3.3 28.6 20.9 13.2 13.6 11.8 12.6 11.2 18.3 7.8 15.2 19.6 10.8 17.9 11.9 10.8 11.3 9.7 17.4 8.2 10.2 11.4 7.6 11.6 21.4 7.3 14.1 10.9 13.8 12.2 7.4 22.0 13.0 13.3 16.5 13.1 22.3 8.7 GLT8D2 FLJ31494 ENSG00000120820 "Glycosyltransferase 8 domain containing 2" Q9H1C3 12 103988984-104064183 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.9;BJ hTERT+: 34.4;HSkMC: 25.8;RPTEC TERT1: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 5 "amygdala: 8.0;cerebral cortex: 20.1;hippocampal formation: 16.6" "Low region specificity" "Detected in many" "HPA012740, HPA026904, HPA070791" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA012740: , HPA026904: AB_1849731, HPA070791: " "unprognostic (4.02e-1)" "prognostic unfavourable (7.37e-4)" "unprognostic (9.53e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" "unprognostic (1.71e-1)" "unprognostic (4.34e-3)" "unprognostic (2.57e-1)" "unprognostic (1.25e-1)" "unprognostic (7.55e-2)" "unprognostic (5.03e-2)" "unprognostic (8.87e-2)" "prognostic unfavourable (1.58e-6)" "prognostic unfavourable (7.92e-4)" "unprognostic (7.15e-2)" "unprognostic (7.70e-3)" "unprognostic (7.03e-3)" 10.2 5.2 2.2 9.9 3.3 0.2 12.0 0.7 2.4 32.8 10.3 1.4 8.8 2.5 24.5 23.1 13.5 13.3 19.1 18.8 2.2 1.8 3.4 2.8 6.9 2.2 2.1 2.1 25.5 2.5 5.9 12.5 6.9 3.5 19.6 5.3 21.8 6.7 8.3 4.0 2.7 6.7 17.3 2.2 1.0 5.5 7.8 0.8 1.0 26.0 10.9 5.7 11.2 13.1 0.8 0.9 0.2 0.6 0.0 2.1 0.0 0.1 0.2 0.2 8.7 11.4 27.9 0.2 12.5 34.4 3.2 4.2 0.1 0.0 0.3 0.7 14.3 0.0 0.1 4.6 2.8 0.6 3.9 0.2 4.6 0.0 5.1 0.3 0.2 25.8 0.2 3.9 5.5 1.7 0.1 0.5 14.1 0.1 0.2 0.1 1.0 2.6 0.3 13.4 0.1 17.6 0.1 0.5 0.7 13.1 0.3 0.1 2.3 0.2 0.2 5.3 2.5 0.5 0.7 1.5 0.3 0.1 0.4 0.2 0.4 0.0 0.0 0.0 2.1 0.6 0.7 0.8 0.3 1.3 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.9 0.0 0.0 2.2 3.3 0.7 2.4 2.2 1.8 2.1 2.1 3.5 0.8 GLTPD2 ENSG00000182327 "Glycolipid transfer protein domain containing 2" A6NH11 17 4788959-4790390 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 13.0;kidney: 9.8;liver: 44.4" "Cell line enhanced" "Detected in some" "CACO-2: 11.5;Hep G2: 15.1;MCF7: 5.3" "Cancer enriched" "Detected in many" 5 "liver cancer: 25.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 3.2" "Lineage enriched" "Detected in single" 6 "monocytes: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA058295, HPA065267" Uncertain Approved Vesicles "Secreted - unknown location" Vesicles "HPA058295: , HPA065267: " "unprognostic (4.00e-1)" "unprognostic (1.93e-1)" "unprognostic (1.95e-3)" "unprognostic (1.70e-1)" "unprognostic (3.03e-2)" "unprognostic (1.79e-4)" "unprognostic (1.40e-1)" "unprognostic (1.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.33e-2)" "unprognostic (5.62e-4)" "unprognostic (7.80e-2)" "unprognostic (2.62e-1)" "unprognostic (4.25e-1)" "unprognostic (4.79e-1)" "unprognostic (1.71e-4)" "unprognostic (7.59e-3)" 0.2 0.3 0.5 0.2 0.7 0.8 0.2 0.8 1.8 0.2 8.0 0.3 0.2 8.6 0.3 0.2 0.4 0.3 0.2 0.2 0.5 0.7 9.8 44.4 0.6 0.2 0.5 0.4 0.2 0.5 0.2 0.5 0.2 0.4 0.2 0.0 0.5 0.8 0.2 0.8 1.4 13.0 0.2 0.4 0.8 0.9 0.2 0.2 0.4 0.2 1.6 0.3 0.4 0.3 0.0 0.5 0.0 3.2 0.0 0.2 0.2 0.6 2.5 0.2 2.0 0.0 0.0 4.6 0.4 0.0 0.0 0.0 11.5 0.9 1.2 1.3 0.0 2.2 0.0 0.1 0.0 2.2 1.7 0.1 1.0 15.1 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 5.3 0.2 0.2 0.2 1.0 0.9 0.6 0.3 0.0 0.9 1.5 1.0 2.2 0.4 0.6 1.3 0.1 2.4 0.8 0.9 0.5 0.4 0.2 0.6 0.1 0.3 0.6 0.9 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.2 0.5 0.7 0.8 0.7 0.5 0.7 0.5 0.4 0.4 0.2 GNAZ ENSG00000128266 "G protein subunit alpha z" P19086 22 23070361-23125037 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 24.7;SH-SY5Y: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003011 Enhanced Approved Vesicles 6900000 Vesicles "HPA003011: AB_1078918" "unprognostic (7.61e-2)" "unprognostic (1.63e-2)" "unprognostic (3.13e-2)" "prognostic unfavourable (4.85e-4)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (3.45e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-3)" "unprognostic (1.68e-2)" "unprognostic (9.69e-2)" "unprognostic (2.29e-1)" "unprognostic (6.63e-2)" "unprognostic (2.82e-1)" "unprognostic (1.30e-1)" 8.8 6.9 15.4 3.2 13.4 1.8 3.2 17.8 34.4 2.2 6.0 11.1 6.9 2.3 6.2 3.7 5.9 6.9 12.1 2.0 17.7 14.7 2.2 0.6 1.7 2.2 16.4 13.0 9.9 2.2 4.7 11.1 0.9 13.5 7.8 2.3 6.8 2.4 19.5 1.9 1.2 2.4 12.9 19.0 5.1 5.3 4.3 7.7 0.0 1.9 0.0 1.7 3.6 1.5 1.3 0.1 1.7 1.4 0.2 0.6 5.3 0.0 1.2 4.2 8.8 0.0 0.0 0.2 5.7 11.2 5.5 3.7 0.0 0.0 10.7 0.4 0.5 0.2 5.2 0.2 4.0 1.4 4.3 0.7 6.3 7.8 0.3 0.0 0.9 0.0 0.2 0.1 0.3 0.1 0.1 3.4 0.1 3.8 0.0 0.0 2.5 3.4 0.0 4.2 1.7 0.1 0.1 24.7 15.3 1.2 2.7 1.1 1.2 0.1 0.0 4.6 5.3 1.2 0.1 4.2 7.2 5.6 2.3 0.3 1.7 1.7 0.3 0.5 0.2 0.0 0.0 0.3 0.0 0.0 0.1 1.3 0.0 0.6 0.9 0.2 1.4 0.0 0.0 5.3 15.4 13.4 17.8 19.4 17.7 14.7 16.4 13.0 13.5 7.7 GNG2 ENSG00000186469 "G protein subunit gamma 2" P59768 14 51826195-51979342 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 68.4;brain: 50.5;testis: 55.7" "Cell line enhanced" "Detected in many" "AF22: 20.5;fHDF/TERT166: 36.3;MOLT-4: 28.2;SH-SY5Y: 23.9;WM-115: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003534, CAB018380" Uncertain Supported Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "CAB018380: AB_631547, HPA003534: AB_1079004" "unprognostic (6.11e-2)" "unprognostic (5.78e-3)" "unprognostic (2.06e-3)" "unprognostic (6.55e-2)" "unprognostic (1.33e-1)" "unprognostic (4.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (5.72e-2)" "unprognostic (1.24e-1)" "prognostic favourable (1.64e-4)" "unprognostic (8.47e-2)" "prognostic unfavourable (3.90e-6)" "unprognostic (9.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (3.59e-2)" 22.0 10.4 50.5 17.4 18.5 25.0 11.7 4.9 46.1 5.9 13.0 5.2 1.6 6.8 5.7 4.7 6.5 3.5 7.9 6.6 30.9 50.3 4.0 5.6 8.5 19.4 10.7 20.7 7.1 3.3 1.6 12.2 8.6 8.9 6.6 9.1 8.3 4.5 4.4 2.3 3.5 9.9 8.8 8.5 41.2 7.3 55.7 2.5 39.6 3.9 4.3 19.5 8.5 4.0 8.0 13.9 68.4 34.9 5.0 36.5 27.6 0.0 0.8 20.5 12.8 3.1 4.1 0.3 3.3 4.2 1.6 1.3 1.6 0.0 0.0 0.4 36.3 0.0 2.7 0.0 1.1 9.2 0.3 0.0 0.2 0.0 1.6 1.8 0.1 6.8 0.0 1.6 0.1 0.0 0.0 1.7 10.4 0.0 28.2 3.0 10.9 2.5 10.0 1.6 0.5 1.7 0.0 3.0 23.9 0.0 0.0 8.8 0.0 0.0 0.0 5.0 0.8 0.1 2.5 0.0 0.0 1.4 4.1 10.0 65.4 68.4 13.5 36.0 36.5 23.3 24.6 8.0 20.3 29.7 13.9 7.3 12.9 22.8 39.9 5.0 34.9 6.0 28.8 27.6 50.5 18.5 4.9 44.2 30.9 50.3 10.7 20.7 8.9 2.5 GNL1 HSR1 ENSG00000204590 "G protein nucleolar 1 (putative)" P36915 6 30541377-30557174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033575, HPA043338, HPA050455" Uncertain Supported Vesicles Vesicles "CAB033575: AB_2109945, HPA043338: AB_2678437, HPA050455: AB_2681132" "unprognostic (2.76e-2)" "unprognostic (3.68e-2)" "unprognostic (2.21e-1)" "unprognostic (3.53e-2)" "unprognostic (3.30e-2)" "unprognostic (2.75e-1)" "unprognostic (4.22e-2)" "unprognostic (8.33e-2)" "unprognostic (1.03e-1)" "unprognostic (3.84e-2)" "unprognostic (3.95e-3)" "unprognostic (7.32e-2)" "unprognostic (5.67e-3)" "unprognostic (4.42e-2)" "unprognostic (2.10e-1)" "unprognostic (4.15e-1)" "unprognostic (1.78e-1)" 14.2 9.2 15.6 12.9 18.6 7.7 13.4 18.8 29.2 13.3 7.9 12.1 7.6 4.3 15.2 15.1 8.4 17.4 10.6 6.9 14.6 14.1 13.5 9.3 12.8 9.7 13.1 17.3 25.9 13.0 40.3 11.6 11.1 14.3 9.0 13.2 9.3 10.1 15.3 8.0 13.8 7.8 16.9 13.9 8.8 8.8 31.7 12.5 12.8 13.5 7.6 16.7 11.1 10.6 1.4 0.3 0.8 0.7 1.2 3.6 1.7 7.9 1.7 4.6 13.3 8.8 10.4 0.3 2.4 5.0 2.1 3.2 11.5 5.0 3.6 4.8 8.0 5.3 12.0 9.8 3.5 1.3 6.9 5.9 5.7 1.1 0.0 1.0 3.9 8.9 7.9 16.0 5.3 0.9 10.3 0.4 5.0 1.8 2.8 0.2 2.6 1.3 6.1 2.9 4.0 6.9 3.4 4.0 3.8 3.2 2.4 1.4 2.3 3.7 4.8 8.3 2.4 1.5 2.8 6.2 6.7 7.3 0.2 5.0 10.1 0.8 0.5 0.7 2.7 0.7 3.6 1.4 2.9 3.4 0.3 1.2 0.6 1.1 0.7 1.2 0.7 0.3 1.7 1.7 15.6 18.6 18.8 29.2 14.6 14.1 13.1 17.3 14.3 12.5 GNPDA1 "GNPDA, GNPI, GPI, HLN, KIAA0060" ENSG00000113552 "Glucosamine-6-phosphate deaminase 1" P46926 5 141991749-142013041 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000499, HPA046891" Uncertain Approved "Golgi apparatus,Vesicles" 970000 Vesicles "Golgi apparatus" "HPA000499: AB_1079005, HPA046891: " "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (6.79e-2)" "unprognostic (1.04e-1)" "unprognostic (9.51e-2)" "unprognostic (8.89e-3)" "prognostic unfavourable (2.60e-6)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.09e-1)" "unprognostic (1.58e-1)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "unprognostic (5.82e-2)" "unprognostic (9.66e-2)" "unprognostic (2.05e-3)" 15.6 28.2 13.9 10.0 19.1 4.3 18.7 12.6 22.5 16.5 13.7 13.2 11.7 18.0 24.8 34.0 10.7 11.9 13.7 10.6 12.3 16.1 46.2 10.2 11.0 21.8 14.1 16.5 20.7 7.7 15.1 19.9 18.9 13.4 17.8 14.0 17.1 10.6 18.9 16.5 9.0 18.8 18.4 10.9 18.2 9.5 16.3 10.8 12.4 18.2 9.2 11.8 23.6 11.2 7.9 20.6 5.0 22.7 5.6 32.7 14.7 11.7 17.2 6.8 33.2 23.1 15.7 15.7 9.3 22.5 24.8 28.3 25.7 14.0 0.0 21.4 6.7 12.5 31.2 27.8 22.0 9.0 13.4 8.6 10.1 18.3 41.1 23.8 11.4 18.7 16.5 15.8 42.2 26.0 10.2 31.8 26.5 7.4 18.1 2.7 25.2 34.8 7.1 21.8 26.2 23.9 32.5 6.0 15.7 18.5 19.3 35.4 15.8 7.5 12.4 14.5 9.9 22.3 13.1 17.9 34.2 13.2 21.3 8.2 12.6 0.0 19.4 2.6 15.7 22.7 32.7 7.9 12.8 14.4 20.6 3.7 15.5 16.5 5.0 5.6 20.4 11.6 10.6 14.7 13.9 19.1 12.6 22.5 12.3 16.1 14.1 16.5 13.4 10.8 GNPDA2 SB52 ENSG00000163281 "Glucosamine-6-phosphate deaminase 2" Q8TDQ7 4 44682200-44726595 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000499, HPA046891" Uncertain Approved "Golgi apparatus,Vesicles" 710000 Vesicles "Golgi apparatus" "HPA000499: AB_1079005, HPA046891: " "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" "unprognostic (1.90e-2)" "unprognostic (3.29e-1)" "unprognostic (1.55e-3)" "unprognostic (1.02e-1)" "unprognostic (1.33e-1)" "unprognostic (9.57e-2)" "unprognostic (9.75e-3)" "unprognostic (1.03e-1)" "unprognostic (1.28e-3)" "unprognostic (4.18e-2)" "unprognostic (6.86e-2)" "unprognostic (1.63e-2)" "unprognostic (3.13e-2)" 12.3 13.7 14.8 11.2 21.5 7.3 14.9 47.5 24.5 15.2 12.3 7.3 8.7 8.0 17.5 15.3 11.2 13.3 10.8 17.8 14.5 13.9 14.3 4.3 10.0 11.7 13.7 17.6 24.2 8.1 13.0 29.9 6.6 16.5 15.7 8.5 11.5 9.8 16.2 10.9 10.2 8.7 16.6 12.7 11.4 9.9 11.1 11.3 10.0 18.9 8.4 10.2 13.5 11.0 11.6 3.3 5.8 4.1 8.4 11.4 4.4 9.0 6.3 6.8 5.7 10.6 14.8 2.2 16.1 17.5 10.3 9.7 3.2 11.1 7.8 9.3 13.7 3.1 6.2 15.0 11.7 10.4 7.1 11.2 10.3 5.6 11.8 11.7 10.4 17.4 10.6 10.6 7.9 15.4 6.7 10.4 19.5 0.4 14.0 6.6 3.2 11.7 9.3 14.5 4.4 10.3 5.4 11.7 9.5 7.0 4.1 15.2 8.8 6.9 15.8 14.2 13.3 22.8 18.2 13.5 21.3 11.3 23.2 8.3 12.6 5.8 2.3 4.5 9.7 3.3 11.3 11.6 9.1 9.0 3.3 10.4 11.4 10.9 1.1 8.4 4.1 2.6 9.6 4.4 14.8 21.5 47.5 24.5 14.5 13.9 13.7 17.6 16.5 11.3 GOLPH3 "GOPP1, GPP34, MIDAS, Vps74" ENSG00000113384 "Golgi phosphoprotein 3" Q9H4A6 5 32124704-32174350 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044564, HPA055841" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA044564: AB_10795169, HPA055841: " "unprognostic (1.64e-2)" "unprognostic (1.66e-1)" "unprognostic (9.27e-2)" "unprognostic (1.01e-1)" "unprognostic (2.28e-1)" "unprognostic (9.34e-2)" "unprognostic (1.89e-2)" "unprognostic (8.19e-2)" "unprognostic (2.95e-2)" "unprognostic (7.48e-2)" "unprognostic (2.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (8.56e-2)" "unprognostic (1.11e-1)" "unprognostic (1.52e-2)" 26.7 22.0 17.9 21.8 17.4 7.9 24.9 19.9 20.6 27.9 40.5 22.1 25.0 20.9 24.3 28.3 24.6 19.4 36.0 23.1 17.7 17.8 30.7 75.0 24.3 22.6 20.9 12.6 26.6 37.2 27.2 22.9 35.6 19.0 36.0 28.2 22.3 35.8 24.9 20.6 19.0 34.0 33.0 19.6 21.3 28.1 16.0 19.1 26.4 30.0 19.3 26.0 25.4 27.9 11.9 9.5 18.9 11.1 8.7 13.2 4.2 15.6 10.5 17.0 18.4 32.3 31.0 48.8 21.6 28.9 20.3 19.4 14.2 28.3 14.1 21.4 29.1 14.7 21.0 15.2 25.7 18.3 12.5 15.5 35.9 27.0 26.0 23.9 18.2 23.6 21.9 19.9 23.0 16.2 16.1 34.4 22.5 15.7 15.2 31.2 14.6 10.8 14.3 24.5 14.5 25.3 19.9 13.0 14.5 50.2 52.7 21.2 21.5 26.6 15.6 18.0 16.8 14.1 15.1 38.7 47.4 17.1 16.1 34.4 21.3 7.3 8.4 18.9 8.9 11.1 7.8 10.8 9.7 11.5 9.5 11.9 11.1 8.4 8.6 8.7 10.8 7.3 13.2 4.2 17.9 17.4 19.9 20.6 17.7 17.8 20.9 12.6 19.0 19.1 GOLT1B "CGI-141, GOT1, YMR292W" ENSG00000111711 "Golgi transport 1B" Q9Y3E0 12 21501781-21518408 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055909, HPA066383" Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA055909: , HPA066383: " "unprognostic (1.22e-2)" "unprognostic (3.07e-3)" "unprognostic (1.84e-1)" "unprognostic (3.65e-1)" "unprognostic (3.45e-1)" "unprognostic (5.37e-3)" "prognostic unfavourable (1.99e-8)" "unprognostic (2.24e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (2.32e-4)" "unprognostic (1.36e-1)" "prognostic unfavourable (4.83e-10)" "unprognostic (3.13e-1)" "unprognostic (2.14e-1)" "unprognostic (6.78e-2)" "unprognostic (1.04e-1)" 21.1 26.0 18.3 18.2 24.4 23.4 20.4 31.9 30.4 22.3 14.7 18.9 13.8 12.0 16.9 18.9 15.3 14.6 16.4 17.0 19.1 22.4 23.2 40.1 19.9 16.0 20.1 16.2 14.1 30.9 11.3 34.9 31.1 23.8 19.0 16.8 16.1 17.4 15.3 15.9 14.5 13.0 19.6 22.2 17.8 15.3 11.6 17.5 13.5 19.1 11.6 15.6 22.5 14.2 17.7 22.2 26.7 22.9 14.8 21.1 19.4 11.5 12.3 10.1 13.1 20.4 32.0 17.2 45.7 17.5 14.5 23.8 16.0 17.2 7.0 11.8 23.7 11.3 8.4 9.5 25.4 10.2 8.0 10.2 8.0 11.2 22.9 13.2 13.2 16.2 18.4 17.4 32.0 13.1 6.4 7.8 22.2 10.9 5.9 21.9 28.0 8.8 5.0 24.8 14.7 12.0 7.1 2.7 8.5 18.7 7.3 24.9 10.1 14.9 14.6 17.1 18.7 21.1 24.8 7.6 16.5 18.6 23.5 12.7 23.0 26.7 20.6 14.8 17.9 22.9 21.1 17.7 21.1 19.5 20.2 16.5 19.3 19.2 5.6 14.8 20.9 22.2 20.4 19.4 18.3 24.4 31.9 30.4 19.1 22.4 20.1 16.2 23.8 17.5 GPBP1 "DKFZp761C169, vasculin" ENSG00000062194 "GC-rich promoter binding protein 1" Q86WP2 5 57173948-57264679 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037773 Approved Approved "Vesicles,Plasma membrane,Cytosol" "Vesicles, Cytosol" "Plasma membrane" "HPA037773: AB_10671721" "unprognostic (1.53e-1)" "unprognostic (2.23e-2)" "unprognostic (1.57e-1)" "unprognostic (3.49e-1)" "unprognostic (8.30e-2)" "unprognostic (9.68e-3)" "unprognostic (1.24e-2)" "unprognostic (3.19e-2)" "unprognostic (6.85e-3)" "unprognostic (3.70e-1)" "unprognostic (5.93e-2)" "unprognostic (5.48e-2)" "unprognostic (3.75e-2)" "unprognostic (1.65e-1)" "unprognostic (4.89e-2)" "unprognostic (2.57e-1)" "prognostic favourable (4.15e-5)" 25.6 33.1 33.8 27.0 37.8 38.0 37.2 53.9 34.0 30.6 23.5 29.7 20.3 20.8 29.0 33.1 25.5 32.4 24.5 25.4 32.5 28.4 27.1 28.4 29.9 34.0 41.5 34.0 46.7 23.5 37.6 43.9 35.6 33.2 27.6 24.9 19.7 27.2 26.9 37.3 24.6 25.8 22.0 42.4 31.5 24.0 46.9 37.2 49.9 35.1 20.3 33.7 29.4 50.2 31.7 18.9 35.5 18.9 33.5 37.7 27.1 21.7 17.4 33.4 28.1 21.9 21.8 30.8 16.6 28.3 27.6 35.6 28.2 25.3 28.9 19.5 17.0 15.0 28.5 19.2 34.9 16.4 19.6 23.7 19.9 23.4 25.5 17.1 24.6 17.7 29.8 22.4 31.5 22.2 24.1 47.6 22.0 27.3 27.0 30.0 20.8 12.2 29.2 27.4 28.4 21.2 22.7 30.1 23.3 24.3 21.8 26.5 42.6 29.3 14.7 10.1 20.6 14.6 24.0 36.3 30.3 32.2 16.9 25.9 18.8 35.5 17.1 32.3 28.1 17.7 35.2 31.7 34.0 33.1 18.9 26.8 37.7 34.9 33.2 33.5 18.9 13.4 35.3 27.1 33.8 37.8 53.9 34.0 32.5 28.4 41.5 34.0 33.2 37.2 GPC6 ENSG00000183098 "Glypican 6" Q9Y625 13 93226842-94407401 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 27.3;HHSteC: 18.2;HSkMC: 31.0;U-87 MG: 22.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 23 "NK-cell: 2.3" "Lineage enriched" "Detected in single" 23 "NK-cells: 2.3" "Low region specificity" "Detected in all" HPA017671 Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" 360000 "Golgi apparatus, Vesicles" "HPA017671: AB_1849833" "unprognostic (5.24e-2)" "unprognostic (4.65e-2)" "unprognostic (2.28e-1)" "unprognostic (9.76e-2)" "unprognostic (1.72e-1)" "unprognostic (5.50e-2)" "unprognostic (1.28e-1)" "unprognostic (4.79e-3)" "unprognostic (5.25e-2)" "unprognostic (2.66e-2)" "unprognostic (2.33e-2)" "unprognostic (3.71e-2)" "unprognostic (2.53e-3)" "unprognostic (6.21e-3)" "unprognostic (7.42e-2)" "unprognostic (3.36e-1)" "unprognostic (3.35e-3)" 11.0 3.2 3.7 9.7 6.8 0.4 6.5 3.2 7.3 7.6 10.6 3.7 2.6 3.1 5.7 9.9 6.3 6.9 19.9 7.9 3.0 3.0 9.5 21.3 6.6 4.9 2.5 4.7 11.1 2.3 1.2 7.5 1.8 5.1 12.8 8.2 20.8 3.6 19.2 1.8 3.0 7.1 13.7 19.8 3.4 8.1 2.4 2.1 0.2 4.4 1.5 1.4 14.3 15.6 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 1.9 4.3 1.9 27.3 9.2 0.0 3.0 0.0 2.1 2.9 0.0 0.0 0.1 0.0 6.6 0.0 2.4 0.5 3.9 0.0 1.8 0.0 0.0 8.3 18.2 0.0 0.0 31.0 0.2 5.0 3.5 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.8 1.4 0.0 0.7 0.0 2.4 0.0 1.7 7.3 0.0 0.8 0.0 5.9 0.0 0.0 11.6 9.9 10.8 5.0 6.8 0.0 0.0 22.8 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 3.7 6.8 3.2 7.3 3.0 3.0 2.5 4.7 5.1 2.1 GPHA2 "A2, GPA2, MGC126572, ZSIG51" ENSG00000149735 "Glycoprotein hormone alpha 2" Q96T91 11 64934471-64935888 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pancreas: 98.0" "Cell line enriched" "Detected in some" 10 "Hep G2: 21.2" "Cancer enriched" "Detected in some" 7 "testis cancer: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA067068 Approved Vesicles "Secreted to blood" Vesicles "HPA067068: " "unprognostic (1.13e-1)" "unprognostic (8.31e-3)" "unprognostic (1.51e-2)" "unprognostic (9.22e-4)" "unprognostic (7.88e-3)" "unprognostic (2.62e-1)" "unprognostic (1.45e-1)" "unprognostic (3.20e-2)" "unprognostic (1.82e-1)" "unprognostic (1.75e-1)" "unprognostic (5.03e-2)" "unprognostic (9.86e-3)" "unprognostic (1.70e-1)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.2 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 6.7 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.7 98.0 0.0 15.1 0.1 0.2 0.7 0.0 0.7 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 4.2 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 21.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.3 0.2 0.1 0.0 0.1 0.1 0.2 0.1 GPR1 ENSG00000183671 "G protein-coupled receptor 1" P46091 2 206175316-206218047 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.1" "Group enriched" "Detected in some" 4 "HHSteC: 52.5;hTCEpi: 23.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 10.7;pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010525 Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" "Plasma membrane" "Nucleoplasm, Vesicles" "HPA010525: AB_1078919" "unprognostic (5.32e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (2.25e-2)" "unprognostic (3.27e-5)" "unprognostic (1.36e-1)" "unprognostic (4.00e-3)" "unprognostic (1.49e-2)" "unprognostic (7.89e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-3)" "unprognostic (5.65e-2)" "unprognostic (4.29e-4)" "unprognostic (8.48e-4)" "unprognostic (1.21e-1)" "unprognostic (2.68e-2)" "unprognostic (3.06e-3)" 2.3 5.0 0.5 0.6 10.7 0.1 1.7 0.4 1.2 4.1 0.6 4.8 1.6 0.2 1.3 0.7 6.6 1.1 2.7 3.8 1.6 0.5 0.7 0.0 0.5 3.1 0.2 0.3 3.2 0.1 0.0 0.4 19.1 6.6 0.7 0.6 1.1 1.5 0.4 1.5 6.7 0.5 2.3 0.3 0.2 0.2 1.6 1.0 0.0 0.7 2.2 1.2 3.1 7.7 0.5 0.1 1.4 0.2 0.5 0.2 0.6 0.8 0.1 0.7 0.0 0.1 2.9 0.2 5.4 9.3 3.3 2.8 0.0 0.0 0.0 0.3 2.7 0.1 0.2 0.0 1.1 0.0 0.1 0.0 1.8 0.0 52.5 0.0 0.0 2.1 23.7 4.8 7.7 0.0 0.0 0.0 6.7 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 2.3 1.1 0.0 0.0 0.0 0.0 0.1 4.1 1.8 4.7 0.4 0.0 0.0 0.0 1.4 0.0 0.1 1.3 0.2 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.5 0.2 0.2 1.4 0.5 0.1 0.1 0.2 0.6 0.5 10.7 0.4 1.2 1.6 0.5 0.2 0.3 6.6 1.0 GPR108 LUSTR2 ENSG00000125734 "G protein-coupled receptor 108" Q9NPR9 19 6729914-6737603 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041924, HPA041951, HPA063863" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: " "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "prognostic favourable (1.04e-7)" "unprognostic (1.58e-1)" "unprognostic (5.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (4.23e-2)" "unprognostic (3.01e-2)" "unprognostic (7.89e-2)" "unprognostic (3.57e-2)" "prognostic favourable (1.29e-9)" "unprognostic (8.68e-3)" "unprognostic (2.95e-2)" "unprognostic (4.96e-3)" "unprognostic (4.13e-3)" 17.6 29.7 15.4 13.8 17.9 14.2 20.1 15.2 23.1 22.2 24.3 24.3 27.0 20.4 20.6 20.8 25.1 26.1 23.5 14.0 14.6 12.3 35.4 33.9 19.6 17.1 20.5 12.9 22.6 41.5 30.9 15.1 27.1 17.2 24.0 17.7 31.3 35.4 27.4 10.6 19.1 29.2 16.9 15.7 20.9 20.6 26.3 19.4 17.2 38.8 14.7 23.1 21.4 19.8 14.8 25.8 54.3 36.3 23.1 26.7 35.5 11.5 12.6 7.8 15.2 30.6 16.6 8.8 9.0 27.4 12.5 13.4 7.7 13.3 5.5 16.8 18.4 9.9 8.8 18.8 6.5 22.1 10.1 8.9 13.3 10.2 30.1 5.7 12.2 18.0 36.0 12.1 24.5 14.7 8.9 36.9 12.6 8.0 10.0 8.3 5.6 11.2 8.2 8.9 20.8 26.1 11.4 0.0 8.5 9.1 14.9 13.8 14.3 13.9 12.1 7.2 4.6 22.8 9.5 23.9 12.9 3.8 24.7 18.4 7.7 20.4 35.8 35.7 26.7 32.7 24.3 14.8 21.4 22.5 25.8 14.1 15.5 17.7 54.3 23.1 36.3 9.2 23.4 35.5 15.4 17.9 15.2 23.1 14.6 12.3 20.5 12.9 17.2 19.4 GPR137C "DKFZp762F0713, TM7SF1L2" ENSG00000180998 "G protein-coupled receptor 137C" Q8N3F9 14 52553148-52637713 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.1;epididymis: 16.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 3.9;T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003640, HPA030763" Uncertain Approved Vesicles Vesicles "HPA003640: , HPA030763: AB_10602352" "unprognostic (1.39e-1)" "unprognostic (1.45e-1)" "unprognostic (1.23e-1)" "unprognostic (6.84e-2)" "unprognostic (8.50e-3)" "unprognostic (7.34e-3)" "unprognostic (5.95e-3)" "unprognostic (2.32e-2)" "unprognostic (4.41e-2)" "unprognostic (8.42e-4)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" "unprognostic (7.88e-2)" "unprognostic (4.08e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.60e-1)" 1.4 2.2 7.1 1.0 11.0 3.3 1.9 31.1 20.2 1.4 1.2 7.5 0.2 2.0 2.5 16.6 1.7 1.2 2.8 2.4 5.9 10.6 1.2 1.3 1.7 2.1 6.3 7.5 1.6 0.7 2.3 1.8 1.8 13.3 1.6 1.5 3.2 1.7 1.5 1.3 1.8 1.2 1.5 7.0 2.5 1.4 6.5 8.3 0.0 2.1 0.0 1.2 2.1 0.7 0.7 0.5 2.4 0.5 3.9 4.1 0.8 0.8 0.3 8.1 7.4 2.3 0.7 3.2 3.4 2.3 3.5 8.6 1.5 1.6 0.8 2.5 2.8 1.9 2.7 0.5 5.3 1.2 1.8 0.9 2.3 0.9 0.3 0.5 1.9 0.4 0.0 3.3 0.2 1.8 1.2 3.5 5.1 3.9 0.3 1.1 2.0 4.7 1.8 5.1 0.3 1.0 5.7 8.3 10.4 1.7 0.5 0.2 5.1 0.0 0.3 8.1 8.7 5.9 2.8 0.8 2.0 1.8 2.0 0.4 2.4 1.2 0.5 0.5 3.1 0.1 4.1 0.3 2.0 3.9 0.2 0.7 1.5 1.8 2.4 3.9 0.4 0.5 1.4 0.8 7.1 11.0 31.1 14.1 5.9 10.6 6.3 7.5 13.3 8.3 GPR17 ENSG00000144230 "G protein-coupled receptor 17" Q13304 2 127645864-127652639 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 43.8" "Cell line enhanced" "Detected in some" "HeLa: 4.5;REH: 7.5;TIME: 7.4;U-2 OS: 3.1;U-2197: 3.5;U-251 MG: 4.4" "Cancer enriched" "Detected in some" 32 "glioma: 16.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "naive B-cell: 4.0" "Lineage enriched" "Detected in single" 11 "B-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029766 Enhanced Supported Approved Vesicles Vesicles "HPA029766: AB_10612114" "unprognostic (8.10e-2)" "unprognostic (1.73e-1)" "unprognostic (2.61e-1)" "unprognostic (1.42e-2)" "unprognostic (1.54e-1)" "unprognostic (5.19e-2)" "unprognostic (2.77e-5)" "unprognostic (8.40e-3)" "unprognostic (2.92e-1)" "unprognostic (3.25e-2)" "unprognostic (1.61e-3)" "unprognostic (6.60e-2)" "unprognostic (2.11e-3)" "unprognostic (3.33e-2)" "unprognostic (2.19e-1)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" 7.0 2.2 23.7 6.8 21.3 0.8 5.4 4.1 25.6 2.4 16.4 43.8 0.0 3.3 11.2 3.3 5.0 4.0 4.3 12.5 20.6 1.2 2.3 1.6 9.3 2.4 9.1 9.9 1.4 4.6 0.5 0.4 2.7 18.8 3.9 0.8 0.1 1.7 0.5 13.1 6.7 3.8 0.5 6.3 12.6 5.0 1.8 22.6 0.0 2.8 0.0 0.5 6.1 3.9 4.0 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.3 0.6 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.5 0.8 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 0.0 0.0 0.6 0.2 0.1 0.2 7.5 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.3 0.0 7.4 0.0 3.1 3.5 4.4 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.7 21.3 4.1 25.6 20.6 1.2 9.1 9.9 18.8 22.6 GPR174 FKSG79 ENSG00000147138 "G protein-coupled receptor 174" Q9BXC1 X 79144663-79175315 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 73.8" "Cell line enriched" "Detected in some" 7 "MOLT-4: 41.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA041025 Enhanced Uncertain Vesicles Vesicles "HPA041025: AB_10794260" "unprognostic (6.38e-3)" "unprognostic (9.87e-3)" "unprognostic (4.36e-2)" "unprognostic (1.18e-2)" "unprognostic (1.84e-1)" "unprognostic (8.48e-4)" "unprognostic (7.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.75e-1)" "unprognostic (2.02e-1)" "unprognostic (2.46e-1)" "unprognostic (1.05e-1)" "unprognostic (6.53e-5)" "unprognostic (2.27e-1)" "unprognostic (2.64e-2)" "unprognostic (1.21e-1)" "unprognostic (1.78e-2)" 2.2 0.5 0.4 20.3 0.4 2.6 1.3 0.3 0.4 2.4 5.1 0.0 0.5 2.1 1.6 0.9 2.6 0.9 1.9 1.0 0.4 0.4 1.9 1.7 8.2 16.6 0.5 0.0 1.0 0.7 0.0 1.1 0.3 0.2 1.7 2.0 1.6 3.8 0.1 0.5 0.7 9.1 0.2 1.0 21.0 2.2 0.5 0.0 73.8 2.5 1.6 28.1 5.1 1.8 4.0 1.8 6.0 9.1 6.5 8.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 41.8 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.1 0.0 0.0 0.0 6.0 0.0 4.7 5.7 3.4 1.7 4.0 7.5 8.6 0.1 3.9 6.1 6.8 0.4 6.5 9.1 1.8 7.6 2.7 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.0 0.2 0.0 GPR180 ITR ENSG00000152749 "G protein-coupled receptor 180" Q86V85 13 94601903-94634645 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047250 Approved Approved Vesicles Vesicles "HPA047250: " "unprognostic (3.91e-3)" "unprognostic (3.28e-1)" "unprognostic (4.16e-3)" "unprognostic (2.95e-1)" "unprognostic (1.17e-2)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (6.71e-2)" "unprognostic (1.47e-1)" "unprognostic (2.86e-2)" "prognostic unfavourable (3.18e-5)" "unprognostic (2.49e-2)" "unprognostic (1.10e-1)" "unprognostic (8.47e-2)" "unprognostic (2.80e-2)" 14.6 6.8 7.6 6.6 11.4 2.7 15.9 14.7 13.1 8.3 6.1 7.6 5.2 5.7 7.1 5.8 5.3 7.3 5.3 7.6 7.9 8.8 7.5 18.7 6.8 6.3 8.8 7.8 7.3 10.6 7.5 18.8 9.9 10.8 7.6 7.4 12.3 7.5 7.2 5.6 5.7 5.1 8.1 12.1 6.0 7.7 3.5 8.8 8.6 10.2 3.9 7.3 6.4 6.9 1.5 2.5 0.3 1.5 1.5 4.3 1.3 13.0 3.3 4.7 5.0 10.1 11.0 2.0 8.9 7.1 8.7 11.7 4.0 9.0 4.3 3.9 7.6 8.3 6.7 6.3 12.0 11.3 4.3 8.4 4.6 0.0 8.0 12.0 6.9 6.3 5.4 5.3 7.3 8.8 2.3 2.1 8.6 1.9 6.0 2.7 3.1 3.7 7.0 6.4 1.8 9.8 3.9 7.0 5.0 4.1 9.3 10.9 6.5 5.0 7.9 5.4 4.3 6.4 7.4 3.6 3.6 2.0 9.0 9.9 7.3 0.3 1.5 0.3 2.4 1.0 4.3 1.5 2.9 1.7 2.5 1.5 3.5 2.9 0.0 1.5 1.1 1.8 3.4 1.3 7.6 11.4 14.7 13.1 7.9 8.8 8.8 7.8 10.8 8.8 GPR183 EBI2 ENSG00000169508 "G protein-coupled receptor 183" P32249 13 99294530-99307405 "G-protein coupled receptors, Predicted membrane proteins" "Adaptive immunity, Immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 101.7" "Group enriched" "Detected in some" 47 "HDLM-2: 52.5;HL-60: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028847, CAB033690" Uncertain Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "CAB033690: AB_2114269, HPA028847: AB_10603672" "unprognostic (3.28e-3)" "prognostic favourable (9.77e-4)" "unprognostic (6.03e-2)" "unprognostic (4.61e-3)" "unprognostic (3.45e-1)" "unprognostic (7.11e-2)" "unprognostic (1.71e-1)" "unprognostic (6.29e-2)" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (2.33e-1)" "unprognostic (4.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.97e-3)" "unprognostic (9.31e-3)" "unprognostic (9.86e-3)" 27.0 5.5 3.1 33.8 5.0 40.8 7.6 1.1 2.9 5.9 11.2 7.5 4.5 3.2 3.8 9.2 9.3 6.4 17.3 11.7 4.8 6.1 5.4 7.2 26.5 53.7 7.5 2.6 4.4 2.1 2.1 4.8 11.1 9.3 7.4 9.2 4.8 6.6 2.0 4.1 5.3 19.2 9.0 31.3 46.5 6.0 3.7 7.4 13.2 6.5 8.3 38.9 34.9 5.2 46.8 30.6 101.7 1.2 55.0 60.2 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 52.5 0.0 0.4 0.1 0.0 0.0 35.9 0.1 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.2 0.0 101.7 1.2 46.1 5.7 0.4 34.0 46.8 60.2 30.9 9.3 19.1 38.1 5.2 1.2 55.0 0.4 30.6 47.3 27.8 3.1 5.0 1.1 2.9 4.8 6.1 7.5 2.6 9.3 7.4 GPR65 "hTDAG8, TDAG8" ENSG00000140030 "G protein-coupled receptor 65" Q8IYL9 14 88005124-88014811 "G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.4;lymphoid tissue: 40.8" "Cell line enhanced" "Detected in some" "Daudi: 6.1;HEL: 6.6;HL-60: 7.9;HMC-1: 10.2;RH-30: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA072624, HPA077397" Enhanced Approved Nucleoli,Vesicles,Cytosol Vesicles "Nucleoli, Cytosol" "HPA072624: , HPA077397: " "unprognostic (8.56e-2)" "unprognostic (8.65e-3)" "unprognostic (1.98e-3)" "unprognostic (3.59e-3)" "unprognostic (3.10e-1)" "unprognostic (3.55e-3)" "unprognostic (1.15e-1)" "unprognostic (3.01e-2)" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (4.99e-4)" "unprognostic (3.79e-1)" "unprognostic (4.46e-3)" "unprognostic (9.03e-2)" "unprognostic (3.80e-1)" 9.8 3.1 1.8 12.1 6.4 15.2 2.3 0.7 3.0 1.9 2.4 0.9 0.9 2.3 2.2 2.2 2.3 2.2 4.1 2.3 6.0 2.1 4.0 6.9 10.6 13.1 8.2 0.0 1.7 1.8 0.8 6.2 3.6 6.3 2.9 2.3 1.2 2.6 0.9 0.9 1.2 7.7 3.3 15.7 40.8 2.5 1.5 6.2 12.5 1.8 2.3 8.9 4.8 2.3 4.3 5.9 19.1 13.7 21.3 30.4 9.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.6 0.0 0.0 0.3 7.9 10.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.2 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 14.6 9.1 19.1 16.5 12.8 30.4 4.3 8.4 12.6 5.9 4.0 4.4 9.7 6.9 21.3 13.7 2.7 4.0 9.4 1.8 6.4 0.7 3.0 6.0 2.1 8.2 0.0 6.3 6.2 GPRC5A "PEIG-1, RAI3, RAIG1, TIG1" ENSG00000013588 "G protein-coupled receptor class C group 5 member A" Q8NFJ5 12 12890782-12917937 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 155.0" "Cell line enhanced" "Detected in many" "A-431: 41.8;CAPAN-2: 161.0;HaCaT: 42.2;SiHa: 59.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 3.1" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA007928, HPA046526" Enhanced Enhanced "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA007928: AB_1849318, HPA046526: " "unprognostic (4.79e-2)" "unprognostic (8.35e-2)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (4.65e-3)" "unprognostic (1.73e-1)" "unprognostic (2.38e-2)" "unprognostic (1.89e-2)" "unprognostic (3.48e-1)" "unprognostic (8.69e-3)" "prognostic unfavourable (4.63e-6)" "unprognostic (3.81e-1)" "prognostic unfavourable (9.02e-5)" "unprognostic (9.30e-2)" "unprognostic (4.34e-1)" "unprognostic (1.62e-2)" "unprognostic (2.49e-1)" 9.8 1.4 0.2 6.0 0.6 0.4 5.4 0.1 0.3 12.1 19.8 0.5 2.0 6.2 4.3 1.9 9.1 3.0 15.5 7.1 0.1 0.2 5.1 0.6 155.0 0.1 0.5 0.1 18.5 1.1 0.0 0.9 20.1 3.1 10.4 16.9 4.8 9.6 1.5 1.1 2.0 36.9 14.2 1.1 0.1 11.4 4.8 0.3 0.1 54.2 14.9 11.5 32.1 14.0 0.6 0.6 3.1 0.3 0.5 0.4 0.0 41.8 33.5 0.0 0.1 0.4 0.2 2.1 12.6 4.8 8.2 6.3 5.8 161.0 0.0 1.0 10.0 42.2 0.1 6.1 12.6 0.0 0.5 0.0 13.8 0.2 3.0 0.0 0.0 0.2 8.2 3.4 0.8 5.0 0.0 0.0 0.3 29.3 0.0 0.0 0.1 5.2 0.0 0.9 0.0 16.3 8.3 0.0 0.0 59.2 4.5 1.9 1.3 0.1 0.5 0.3 10.7 19.2 0.5 0.0 0.0 0.0 4.3 0.0 0.2 3.1 0.3 0.4 0.3 0.2 0.3 0.3 0.2 0.3 0.1 0.6 0.4 0.4 1.3 0.5 0.2 0.6 0.3 0.0 0.2 0.6 0.1 0.3 0.1 0.2 0.5 0.1 3.1 0.3 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 108.0" "Cell line enhanced" "Detected in many" "EFO-21: 38.4;HHSteC: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavourable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favourable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 12.6 4.4 45.2 3.2 55.9 1.0 7.3 22.8 108.0 5.4 2.9 95.1 4.9 4.0 7.1 9.3 5.5 12.7 9.2 22.3 47.8 28.7 12.1 2.7 3.9 4.6 63.1 34.9 13.7 12.7 9.5 3.8 9.3 38.6 6.3 2.3 3.8 20.8 11.5 35.1 2.5 3.3 5.1 61.6 2.2 22.7 19.6 63.1 0.0 7.2 2.6 2.7 6.2 3.0 0.0 0.0 0.0 1.5 0.0 6.5 1.3 0.4 12.3 12.3 2.2 12.7 0.8 2.2 0.1 3.1 1.2 0.8 11.3 0.4 0.0 38.4 0.4 0.6 9.0 0.0 0.7 0.0 3.3 0.0 0.0 0.0 26.2 0.0 0.0 1.1 0.0 2.1 0.0 6.0 2.5 0.2 2.8 0.6 0.0 0.0 13.4 5.8 3.5 0.0 0.0 0.4 5.7 9.5 0.8 1.4 0.8 11.0 0.0 0.2 1.1 0.0 1.4 6.0 0.3 0.1 0.0 0.0 0.6 0.1 0.7 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 1.3 45.2 55.9 22.8 40.5 47.8 28.7 63.1 34.9 38.6 63.1 GPRIN1 "GRIN1, KIAA1893" ENSG00000169258 "G protein regulated inducer of neurite outgrowth 1" Q7Z2K8 5 176595802-176610133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 28.2" "Cell line enhanced" "Detected in many" "HDLM-2: 27.3;SCLC-21H: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036478, HPA070892" Enhanced Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA036478: , HPA070892: " "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.41e-2)" "unprognostic (5.66e-2)" "unprognostic (6.54e-3)" "unprognostic (3.06e-1)" "unprognostic (4.76e-6)" "prognostic unfavourable (6.83e-6)" "unprognostic (1.11e-1)" "unprognostic (1.45e-1)" "unprognostic (2.59e-3)" "unprognostic (1.56e-3)" "prognostic unfavourable (2.79e-7)" "unprognostic (4.24e-3)" "unprognostic (5.60e-2)" "unprognostic (2.21e-1)" "unprognostic (3.32e-3)" 1.3 3.2 16.9 1.8 6.4 0.9 0.9 16.9 28.2 1.1 1.6 0.2 0.0 6.4 1.3 0.6 1.1 0.7 1.1 0.7 11.1 11.1 0.7 0.7 1.1 1.7 3.6 11.4 0.5 1.5 0.7 5.8 1.0 4.4 0.7 1.3 0.7 0.7 0.6 0.7 1.5 4.0 1.7 1.9 0.9 1.9 2.2 0.7 0.0 0.8 0.0 2.3 0.9 0.1 0.9 0.0 0.0 0.0 0.5 0.3 0.0 3.6 3.9 4.9 7.1 1.1 2.4 4.2 4.9 2.5 3.8 4.9 4.7 2.4 8.3 10.0 2.6 3.2 3.1 3.4 3.3 27.3 2.1 0.1 2.1 1.6 0.4 0.2 2.1 1.1 2.6 4.1 0.6 2.7 4.3 12.1 3.1 9.5 0.8 0.0 5.0 7.7 15.4 5.5 4.9 4.3 3.8 30.3 17.4 5.6 1.6 8.5 3.7 3.1 3.3 7.1 8.2 2.7 7.1 0.2 1.0 2.3 6.1 0.4 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.9 6.4 16.9 14.3 11.1 11.1 3.6 11.4 4.4 0.7 GRASP Tamalin ENSG00000161835 "General receptor for phosphoinositides 1 associated scaffold protein" Q7Z6J2 12 52006940-52015889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 20.1;TIME: 14.5;WM-115: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 6 "amygdala: 31.9;basal ganglia: 22.2;cerebral cortex: 27.5;hippocampal formation: 25.8;olfactory region: 21.0" "Low region specificity" "Detected in all" "HPA040664, HPA062028" Approved Approved "Nuclear bodies,Vesicles" Vesicles "Nuclear bodies" "HPA040664: AB_10794066, HPA062028: " "unprognostic (1.90e-1)" "unprognostic (1.29e-2)" "unprognostic (2.48e-2)" "unprognostic (2.39e-2)" "unprognostic (2.00e-2)" "unprognostic (2.38e-2)" "unprognostic (2.23e-2)" "unprognostic (1.93e-1)" "unprognostic (2.86e-1)" "unprognostic (8.71e-2)" "unprognostic (3.16e-3)" "unprognostic (7.20e-2)" "unprognostic (3.90e-3)" "unprognostic (1.99e-3)" "unprognostic (1.44e-1)" "unprognostic (3.53e-2)" "unprognostic (2.77e-2)" 29.3 5.1 6.4 9.9 16.4 28.6 17.3 2.1 21.0 17.8 7.3 6.3 5.2 3.8 16.2 7.8 6.8 14.5 17.2 10.8 5.2 3.9 8.7 6.9 38.1 6.3 5.3 9.1 12.1 8.4 3.5 4.5 13.0 8.0 8.9 4.0 14.7 4.7 12.8 16.3 7.1 6.8 9.9 4.5 16.9 6.0 2.8 4.5 3.5 11.3 13.5 6.6 9.0 26.3 0.3 0.8 0.0 0.1 0.1 1.2 0.0 0.0 0.0 2.6 0.1 1.2 2.1 0.6 0.1 0.7 0.0 0.7 0.0 0.0 0.0 5.7 0.0 0.1 0.8 0.0 0.2 0.1 0.7 0.2 0.0 3.6 4.5 0.2 2.0 4.4 0.0 0.2 0.0 20.1 0.9 0.0 0.5 0.1 1.8 4.9 2.3 0.1 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.0 0.1 3.4 0.0 0.2 14.5 0.0 1.4 0.1 0.0 0.1 0.0 0.1 0.4 0.0 26.7 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.3 0.8 0.1 0.2 0.2 0.0 0.1 0.1 0.8 1.2 0.0 6.4 16.4 2.1 20.9 5.2 3.9 5.3 9.1 8.0 4.5 GRB10 ENSG00000106070 "Growth factor receptor bound protein 10" Q13322 7 50590063-50793462 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 65.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "basophil: 11.4;eosinophil: 3.5" "Lineage enriched" "Detected in single" 26 "granulocytes: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019423, HPA027502, HPA031818" Approved Supported Vesicles Vesicles "CAB019423: AB_2112883, HPA027502: AB_10602325, HPA031818: " "unprognostic (2.82e-2)" "unprognostic (1.69e-3)" "unprognostic (1.25e-2)" "unprognostic (1.45e-2)" "unprognostic (3.68e-2)" "unprognostic (1.60e-1)" "unprognostic (6.83e-2)" "unprognostic (5.91e-3)" "unprognostic (1.67e-2)" "unprognostic (2.31e-3)" "unprognostic (4.44e-1)" "unprognostic (2.07e-1)" "unprognostic (1.23e-3)" "unprognostic (1.73e-3)" "unprognostic (8.16e-3)" "unprognostic (2.63e-2)" "unprognostic (8.50e-2)" 14.3 14.6 14.7 4.9 26.7 6.5 18.8 22.0 20.9 9.7 10.5 14.6 2.0 12.3 8.9 8.0 7.3 9.0 15.6 19.1 13.8 14.8 19.8 15.6 8.3 4.3 19.8 10.7 6.5 65.8 6.0 21.5 10.6 20.9 10.6 5.1 16.5 7.0 11.7 35.7 3.7 8.4 13.0 9.9 15.9 7.2 11.4 16.9 0.4 18.3 4.2 3.2 12.7 17.3 0.0 0.1 11.4 0.2 0.0 0.4 0.1 0.1 10.6 17.4 7.0 8.2 6.3 9.2 4.3 3.7 8.3 10.1 6.4 0.1 0.2 7.6 5.4 1.0 17.9 4.5 4.1 0.1 7.2 18.3 10.8 4.6 17.4 11.4 28.3 16.3 7.1 12.8 12.7 21.2 34.5 0.2 6.3 1.2 2.0 15.4 19.0 18.4 5.3 0.0 0.1 5.5 4.2 7.6 0.0 0.5 2.7 22.7 9.2 23.2 25.9 7.4 10.1 15.0 16.2 0.7 0.2 0.1 23.4 10.4 24.9 11.4 0.1 3.5 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.1 0.0 0.1 14.7 26.7 22.0 20.9 13.8 14.8 19.8 10.7 20.9 16.9 GRHL1 "LBP-32, MGR, TFCP2L2" ENSG00000134317 "Grainyhead like transcription factor 1" Q9NZI5 2 9951693-10002277 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.3;skin 1: 34.4" "Group enriched" "Detected in some" 4 "BEWO: 64.8;SK-BR-3: 34.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 4.8;neutrophil: 1.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA005798, HPA006420" Enhanced Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA005798: AB_1079026, HPA006420: AB_1079025" "unprognostic (2.26e-3)" "unprognostic (5.80e-2)" "unprognostic (8.35e-2)" "unprognostic (7.33e-3)" "unprognostic (2.70e-1)" "unprognostic (2.76e-2)" "unprognostic (4.43e-3)" "unprognostic (6.73e-2)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-4)" "unprognostic (3.66e-1)" "unprognostic (3.40e-1)" "unprognostic (4.04e-2)" "unprognostic (2.14e-1)" 1.7 0.6 1.5 0.2 2.4 2.8 15.9 2.0 1.6 10.2 0.9 0.2 10.8 0.3 0.9 3.8 40.3 0.7 1.0 1.6 1.9 1.2 2.5 4.9 2.3 0.2 0.7 1.4 0.5 1.5 12.9 2.6 31.0 0.8 6.1 0.2 1.8 17.5 9.7 0.9 34.4 0.7 5.1 0.6 0.6 1.3 1.6 0.4 0.4 2.8 22.3 25.3 6.7 16.9 0.1 0.2 4.8 0.2 0.5 0.6 4.5 3.1 0.0 0.3 0.9 0.1 0.1 64.8 0.3 0.4 0.2 0.3 0.2 2.2 0.4 0.1 0.0 1.9 3.9 0.4 0.9 0.9 1.7 0.1 0.6 1.2 0.0 0.2 0.3 0.1 1.7 1.8 0.0 0.3 0.6 1.2 0.0 4.1 0.6 0.5 0.2 0.7 0.2 0.3 0.5 0.4 12.3 0.7 0.5 0.6 34.1 0.7 4.1 0.1 0.3 0.2 0.8 1.0 0.3 0.8 0.4 0.4 0.1 0.5 0.5 0.0 0.2 4.8 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.6 4.5 1.5 2.4 2.0 1.6 1.9 1.2 0.7 1.4 0.8 0.4 GRIPAP1 "DKFZp434P0630, GRASP-1, GRASP1, KIAA1167, MPMGp800B12492Q3" ENSG00000068400 "GRIP1 associated protein 1" Q4V328 X 48973720-49002264 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000282, HPA000615" Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA000282: AB_1079022, HPA000615: AB_1079023" "unprognostic (3.34e-1)" "unprognostic (2.86e-3)" "unprognostic (3.24e-3)" "unprognostic (3.93e-3)" "unprognostic (2.68e-1)" "unprognostic (1.23e-1)" "unprognostic (3.97e-3)" "unprognostic (1.01e-2)" "unprognostic (5.26e-2)" "unprognostic (3.65e-1)" "unprognostic (1.69e-3)" "unprognostic (1.06e-2)" "prognostic unfavourable (3.92e-7)" "unprognostic (4.24e-3)" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "prognostic favourable (4.63e-7)" 7.3 10.1 12.4 10.0 19.5 14.0 7.1 24.8 20.6 7.3 7.3 7.4 6.8 8.3 7.5 12.0 7.0 9.9 6.4 7.8 9.4 8.6 6.6 8.5 9.0 10.5 9.7 20.8 8.8 7.7 11.7 12.9 7.0 12.9 7.5 6.9 8.7 7.7 7.4 7.0 10.9 11.1 7.0 10.7 13.1 8.5 8.0 9.0 7.4 8.6 3.2 10.6 7.5 8.6 11.5 10.0 21.2 12.2 12.9 9.1 7.0 12.7 20.3 14.6 30.5 8.8 6.8 13.1 10.4 13.0 13.5 12.9 11.0 11.2 19.3 6.0 10.3 18.3 18.1 11.4 10.9 22.5 9.2 15.5 25.8 11.5 15.2 16.6 27.9 7.0 16.5 18.0 13.4 12.3 11.3 25.5 12.4 23.5 14.4 22.4 17.2 11.1 16.1 22.0 15.4 13.5 15.8 12.9 14.4 22.1 8.9 13.0 20.2 33.4 14.5 7.1 11.3 14.6 8.5 15.5 12.1 13.5 12.5 25.3 12.2 18.8 12.2 16.9 8.9 10.9 7.5 9.4 9.1 8.4 9.8 11.5 8.0 8.3 21.2 12.9 9.9 10.0 7.2 7.0 12.4 19.5 24.8 16.8 9.4 8.6 9.7 20.8 12.9 9.0 GRK2 "ADRBK1, BARK1" ENSG00000173020 "G protein-coupled receptor kinase 2" P25098 11 67266410-67286556 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 78.2" "Cell line enhanced" "Detected in all" "NB-4: 55.2;REH: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005021, CAB037248, HPA048330" Approved Approved Vesicles Vesicles "CAB005021: AB_562360, CAB037248: AB_1078280, HPA048330: " "unprognostic (5.58e-2)" "unprognostic (1.75e-1)" "unprognostic (2.01e-2)" "unprognostic (5.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.29e-3)" "unprognostic (3.31e-2)" "unprognostic (6.17e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-2)" "unprognostic (2.22e-1)" "unprognostic (2.55e-2)" "prognostic unfavourable (1.25e-4)" "unprognostic (3.66e-1)" "unprognostic (2.40e-1)" "unprognostic (4.04e-2)" "unprognostic (5.19e-3)" 13.1 10.7 24.5 35.8 17.0 78.2 17.0 32.9 35.3 12.8 17.2 12.2 12.6 17.5 11.4 9.9 20.2 12.6 17.6 13.6 21.9 17.4 13.0 14.1 19.1 42.8 13.4 19.0 9.8 10.4 9.7 12.2 12.7 15.7 17.8 16.2 9.3 17.4 20.8 20.8 23.5 26.3 12.2 12.5 59.6 17.4 6.8 11.1 35.9 10.1 13.6 37.5 17.1 15.5 4.1 6.0 21.0 18.3 3.8 5.3 7.4 7.5 5.3 5.2 8.8 4.2 3.8 5.2 4.5 4.3 6.2 5.1 11.8 12.5 38.8 7.3 4.2 10.2 7.6 6.1 3.2 47.2 4.7 22.0 6.1 5.3 5.2 46.1 44.2 3.4 7.1 4.9 6.6 7.9 7.9 19.9 5.3 14.0 25.6 55.2 6.5 8.0 73.3 10.3 11.5 6.3 9.9 10.5 5.7 6.7 9.8 16.0 9.1 50.2 4.3 4.9 6.5 6.2 5.0 12.7 11.6 34.8 6.4 27.3 4.5 6.9 10.3 10.5 5.3 15.9 4.0 3.8 4.0 4.3 6.0 4.1 3.2 3.1 21.0 3.8 18.3 5.3 2.6 7.4 24.5 17.0 32.9 35.3 21.9 17.4 13.4 19.0 15.7 11.1 GRK4 "GPRK2L, GPRK4" ENSG00000125388 "G protein-coupled receptor kinase 4" P32298 4 2963608-3040747 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028737, HPA057023" Approved Supported Vesicles Vesicles "HPA028737: , HPA057023: " "unprognostic (1.86e-2)" "unprognostic (2.88e-1)" "unprognostic (1.03e-1)" "unprognostic (9.51e-3)" "unprognostic (3.65e-1)" "unprognostic (1.84e-1)" "unprognostic (1.21e-1)" "unprognostic (2.39e-1)" "unprognostic (1.79e-1)" "unprognostic (1.87e-1)" "unprognostic (3.90e-4)" "unprognostic (3.20e-1)" "unprognostic (1.01e-2)" "unprognostic (4.74e-2)" "unprognostic (2.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.89e-1)" 3.4 3.6 5.4 1.6 5.1 1.7 4.8 12.5 5.9 3.0 2.1 4.2 1.0 1.5 2.7 3.1 2.4 2.0 3.0 5.6 5.2 4.8 2.8 2.3 2.4 1.6 5.3 5.3 3.4 7.9 3.9 6.2 2.2 5.9 2.4 2.0 3.1 4.0 2.9 5.0 2.9 1.7 2.8 5.4 1.9 2.5 41.2 3.7 1.6 4.1 1.6 1.7 2.5 3.3 1.2 2.5 4.5 2.0 1.6 1.7 1.0 2.4 0.9 3.0 8.5 7.3 7.0 1.8 4.8 2.1 2.7 2.4 2.4 0.8 5.5 2.1 7.6 0.8 3.9 4.0 2.4 3.8 3.9 6.0 3.4 2.8 4.3 2.4 2.2 4.7 6.2 4.8 2.3 5.1 5.6 7.2 6.4 2.8 5.1 5.1 2.3 6.7 6.5 3.8 2.2 2.6 3.1 17.3 5.3 2.9 1.3 4.3 6.5 3.7 5.9 7.4 1.9 5.0 4.2 7.4 4.2 4.2 3.7 5.3 2.5 4.5 1.1 2.1 1.1 2.0 1.4 1.1 0.7 0.7 0.3 1.2 1.7 1.6 4.0 1.6 0.7 2.5 0.4 1.0 5.4 5.1 12.5 5.9 5.2 4.8 5.3 5.3 5.9 3.7 GRM1 "GPRC1A, mGlu1, MGLUR1, PPP1R85" ENSG00000152822 "Glutamate metabotropic receptor 1" Q13255 6 146027646-146437598 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 39.9" "Cell line enhanced" "Detected in some" "AF22: 1.6;HeLa: 1.4;Karpas-707: 1.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 39.9" "Cell type enriched" "Detected in single" 4 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015701 Approved Supported Approved Vesicles Vesicles "HPA015701: AB_1853917" "unprognostic (1.04e-2)" "unprognostic (7.33e-2)" "unprognostic (3.73e-3)" "unprognostic (9.77e-3)" "unprognostic (6.75e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-2)" "unprognostic (4.31e-2)" "unprognostic (2.93e-2)" "unprognostic (9.48e-3)" "unprognostic (7.92e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (3.50e-2)" "unprognostic (8.33e-3)" "unprognostic (9.76e-2)" 0.5 0.5 6.6 0.4 6.0 0.4 0.5 39.9 13.0 0.5 0.5 0.9 0.0 0.4 0.5 0.7 0.5 0.7 0.5 7.7 6.0 2.7 2.7 0.5 0.6 0.5 2.6 4.1 0.5 0.5 0.4 0.2 0.5 3.6 0.5 0.4 2.6 0.5 0.8 0.4 0.5 0.5 0.5 1.0 0.6 0.5 1.3 0.9 0.0 0.8 0.0 0.4 0.5 0.1 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.1 1.6 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.4 1.4 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 1.5 0.1 0.0 0.0 0.4 0.2 0.8 0.0 0.0 0.0 0.1 0.0 1.1 0.6 0.1 0.1 0.5 0.0 0.5 0.1 0.1 0.1 0.7 0.2 0.2 0.1 0.1 0.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 6.6 6.0 39.9 10.5 6.0 2.7 2.6 4.1 3.6 0.9 GSAP "LOC54103, PION" ENSG00000186088 "Gamma-secretase activating protein" A4D1B5 7 77310751-77416400 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 33.1" "Cell line enhanced" "Detected in many" "hTERT-HME1: 11.2;U-937: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023994 Supported Vesicles Vesicles "HPA023994: AB_1855386" "prognostic favourable (3.36e-4)" "unprognostic (3.70e-1)" "unprognostic (8.55e-3)" "unprognostic (4.53e-3)" "unprognostic (6.80e-3)" "unprognostic (3.52e-3)" "unprognostic (4.36e-2)" "unprognostic (7.18e-3)" "unprognostic (1.09e-1)" "unprognostic (9.98e-3)" "unprognostic (2.07e-3)" "unprognostic (2.41e-1)" "prognostic unfavourable (3.51e-4)" "unprognostic (3.61e-1)" "unprognostic (1.82e-2)" "unprognostic (9.49e-2)" "prognostic favourable (4.15e-5)" 5.7 6.3 3.8 19.9 3.9 7.0 5.7 1.7 6.6 3.5 6.4 4.4 2.8 2.0 3.9 6.7 5.0 5.7 8.0 7.3 4.2 5.4 6.2 13.9 33.1 24.0 4.5 2.2 4.0 5.4 9.4 14.0 3.6 4.2 5.8 4.1 5.6 5.6 5.3 2.5 3.7 10.1 8.0 5.5 21.5 6.9 1.9 3.3 3.8 9.4 3.4 14.8 5.5 3.4 13.7 11.7 1.3 9.7 11.2 6.6 5.7 3.2 1.7 0.0 0.0 0.5 2.2 0.3 2.0 6.8 1.1 2.9 0.5 4.7 0.7 0.2 0.0 1.6 0.1 1.6 3.0 2.1 1.3 3.5 0.2 9.0 3.0 0.3 0.0 0.8 6.2 5.5 11.2 0.5 0.0 0.3 9.1 1.8 0.0 6.9 0.5 2.4 0.0 0.1 0.1 6.1 2.7 0.2 5.1 2.2 1.1 5.3 2.0 2.9 0.0 1.7 1.2 0.2 6.1 1.3 0.0 1.2 7.9 14.7 1.4 0.0 9.7 0.9 6.6 8.9 3.9 13.7 2.2 4.5 11.7 12.3 2.9 4.8 1.3 11.2 6.4 0.3 0.1 5.7 3.8 3.9 1.7 6.6 4.2 5.4 4.5 2.2 4.2 3.3 GSKIP C14orf129 ENSG00000100744 "GSK3B interacting protein" Q9P0R6 14 96363452-96387288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 63.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043054, HPA046782" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoli "HPA043054: , HPA046782: " "unprognostic (3.48e-1)" "unprognostic (1.16e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (6.23e-3)" "unprognostic (1.11e-1)" "unprognostic (9.35e-2)" "unprognostic (1.16e-3)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" "unprognostic (8.74e-3)" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" 6.6 7.1 11.2 8.0 21.9 7.1 6.7 5.1 14.6 6.6 29.5 5.4 6.7 23.5 5.5 6.4 20.8 5.5 7.0 5.2 12.0 9.6 12.8 36.4 5.3 8.7 9.2 9.7 3.6 6.1 4.0 10.8 11.1 10.7 7.1 28.3 8.7 7.8 5.2 5.5 8.5 63.0 8.0 10.4 6.6 11.3 26.4 7.2 9.0 5.8 10.7 10.7 8.2 9.0 20.1 11.2 27.5 16.6 17.8 34.1 14.8 9.4 13.6 15.2 10.3 11.5 13.4 25.8 17.7 13.5 11.7 13.0 10.0 16.1 9.1 10.8 13.4 10.5 9.9 10.6 17.1 21.6 9.4 3.8 7.8 7.6 10.7 9.7 6.6 10.8 16.9 15.0 15.1 15.2 8.2 8.3 14.8 23.5 7.1 7.9 16.9 17.2 7.2 14.2 8.2 27.5 35.5 5.4 17.4 20.0 18.9 15.4 14.2 6.3 16.7 5.4 7.0 11.5 5.5 9.8 27.9 7.7 13.9 7.0 8.6 27.5 10.8 24.3 15.5 12.6 24.0 20.1 21.7 18.3 11.2 16.6 21.4 19.8 21.7 17.8 16.6 9.6 34.1 14.8 11.2 21.9 5.1 14.6 12.0 9.6 9.2 9.7 10.7 7.2 GSPT1 "eRF3a, ETF3A, GST1" ENSG00000103342 "G1 to S phase transition 1" P15170 16 11868128-11916082 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Protein biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052488, HPA074588" Approved Approved Vesicles,Cytosol 150000 Cytosol Vesicles "HPA052488: , HPA074588: " "unprognostic (4.13e-2)" "unprognostic (1.66e-1)" "prognostic favourable (2.10e-5)" "unprognostic (1.64e-1)" "unprognostic (2.05e-1)" "unprognostic (6.44e-2)" "prognostic unfavourable (7.94e-4)" "unprognostic (2.38e-1)" "unprognostic (2.31e-1)" "unprognostic (1.74e-1)" "unprognostic (1.41e-3)" "unprognostic (1.65e-1)" "prognostic favourable (3.06e-5)" "unprognostic (3.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.61e-3)" "unprognostic (3.13e-2)" 28.5 36.5 27.0 31.2 25.0 30.1 52.5 18.1 33.9 21.7 25.8 18.5 23.3 15.6 20.8 23.1 42.8 18.7 20.1 35.6 22.4 15.3 26.2 46.0 31.3 38.1 26.4 21.6 20.8 48.2 40.9 18.5 23.1 24.1 24.3 29.1 12.6 26.4 30.8 74.1 25.3 20.5 25.6 27.4 26.3 28.1 30.6 23.2 34.8 27.7 24.8 37.0 23.9 30.1 8.8 7.8 7.9 12.0 7.3 11.4 4.6 45.1 44.8 25.0 34.4 36.2 37.7 36.2 50.3 52.3 40.5 40.5 31.9 42.0 61.3 66.1 43.5 34.8 63.3 46.5 68.3 29.3 32.8 41.8 36.4 67.3 30.5 52.9 22.4 29.4 36.7 45.7 62.9 44.7 67.4 31.8 46.9 43.5 44.6 27.5 49.9 25.6 52.9 43.2 71.6 40.0 39.7 40.4 21.6 72.2 54.9 29.4 47.6 25.5 34.4 45.1 28.4 32.6 39.5 31.7 46.8 53.5 31.7 54.0 27.3 1.5 6.5 7.9 7.6 12.0 10.6 8.8 9.8 9.0 7.8 6.4 9.9 9.5 2.2 7.3 10.1 4.3 11.4 4.6 27.0 25.0 18.1 33.9 22.4 15.3 26.4 21.6 24.1 23.2 GTPBP2 ENSG00000172432 "GTP binding protein 2" Q9BX10 6 43605316-43629162 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 55.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031418, HPA031419" Approved Enhanced Vesicles Vesicles "HPA031418: , HPA031419: AB_10600709" "unprognostic (1.35e-1)" "unprognostic (1.01e-1)" "unprognostic (8.94e-2)" "unprognostic (1.08e-3)" "unprognostic (2.56e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (1.08e-6)" "unprognostic (4.71e-2)" "unprognostic (2.58e-3)" "unprognostic (6.47e-2)" "unprognostic (8.31e-2)" "unprognostic (6.15e-3)" "prognostic unfavourable (1.44e-15)" "unprognostic (1.13e-1)" "unprognostic (3.36e-1)" "unprognostic (1.06e-1)" "unprognostic (2.89e-3)" 26.8 19.8 21.4 28.0 19.7 27.9 23.5 27.5 26.1 20.1 22.4 19.9 29.6 22.7 19.0 20.5 38.2 14.5 18.6 20.5 19.1 10.8 20.5 22.5 29.1 21.4 15.0 17.4 20.4 26.2 30.9 26.8 24.1 17.9 20.7 20.7 19.9 29.0 25.3 19.2 19.8 21.9 21.0 17.0 28.8 23.8 17.2 20.1 28.2 30.0 13.3 29.6 25.7 25.2 3.0 2.8 7.0 2.5 1.2 3.4 4.4 17.5 4.6 12.3 8.3 9.5 10.3 14.2 16.7 18.0 19.6 22.5 5.3 7.4 6.3 7.1 8.9 9.5 4.6 6.7 13.5 17.3 10.0 15.6 11.7 4.7 38.1 10.1 17.4 12.1 47.5 21.6 55.7 10.1 21.8 32.5 9.7 6.0 7.5 14.6 3.7 5.4 6.5 8.9 7.1 9.1 10.7 10.6 11.0 5.6 5.2 21.3 10.0 15.7 11.1 9.9 11.1 6.2 11.1 22.2 10.5 8.6 14.2 9.3 10.3 7.0 2.5 5.0 3.4 1.4 2.0 1.7 0.9 3.0 1.3 3.0 2.4 2.8 3.7 1.2 2.0 2.8 1.5 4.4 21.4 19.7 27.5 26.1 19.1 10.8 15.0 17.4 17.9 20.1 GUCY2C "GUC2C, STAR" ENSG00000070019 "Guanylate cyclase 2C" P25092 12 14612632-14696585 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters" "cGMP biosynthesis" "Lyase, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "intestine: 85.1" "Cell line enhanced" "Detected in some" "AN3-CA: 3.7;BEWO: 2.2;CACO-2: 3.1;CAPAN-2: 4.5;SiHa: 4.2" "Group enriched" "Detected in many" 5 "colorectal cancer: 23.9;stomach cancer: 9.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 4.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037655, HPA073759" Uncertain Uncertain Vesicles Vesicles "HPA037655: AB_10672388, HPA073759: " "unprognostic (1.08e-1)" "unprognostic (2.12e-1)" "unprognostic (3.58e-2)" "unprognostic (2.11e-2)" "unprognostic (1.60e-2)" "unprognostic (5.67e-3)" "prognostic unfavourable (1.37e-5)" "unprognostic (9.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (1.58e-1)" "unprognostic (5.40e-2)" "unprognostic (2.35e-4)" "unprognostic (8.02e-2)" "unprognostic (1.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.98e-1)" 0.2 0.1 0.2 3.4 0.2 0.0 0.2 0.2 0.2 0.2 38.8 0.2 0.2 28.0 0.3 0.2 0.4 0.2 0.3 0.4 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.2 17.5 0.2 0.5 0.2 0.2 1.0 85.1 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 4.3 0.7 2.7 1.7 0.0 0.0 0.6 1.1 0.1 0.0 3.7 0.0 0.0 2.2 0.1 0.0 0.0 0.0 3.1 4.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.4 0.4 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.5 4.2 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.9 0.1 1.3 0.8 1.3 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.5 0.0 4.3 0.0 0.0 0.7 2.3 0.0 0.0 2.7 0.0 0.0 0.7 0.0 0.6 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 GULP1 "CED-6, CED6, GULP" ENSG00000144366 "GULP, engulfment adaptor PTB domain containing 1" Q9UBP9 2 188291669-188595931 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid transport, Phagocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 86.0" "Cell line enhanced" "Detected in many" "AF22: 32.1;SH-SY5Y: 24.2;WM-115: 69.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA020587 Enhanced Approved Vesicles Vesicles "HPA020587: AB_1850452" "unprognostic (1.95e-1)" "unprognostic (3.32e-1)" "unprognostic (3.80e-2)" "unprognostic (5.19e-2)" "unprognostic (2.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.06e-1)" "unprognostic (9.28e-2)" "unprognostic (8.25e-3)" "unprognostic (2.23e-1)" "prognostic favourable (4.25e-6)" "prognostic unfavourable (6.17e-4)" "unprognostic (1.29e-1)" "unprognostic (7.33e-2)" "unprognostic (3.04e-4)" 8.0 15.0 3.1 7.6 9.8 0.0 9.7 0.7 8.0 22.6 11.8 2.2 14.4 6.5 23.3 40.6 11.5 10.4 8.9 5.1 2.5 4.8 11.4 1.0 9.0 1.2 2.4 4.5 17.9 32.3 23.9 3.7 86.0 14.3 14.3 3.8 19.4 10.7 16.1 5.9 5.0 10.5 15.1 2.8 3.2 11.9 17.0 2.2 0.3 8.0 6.1 3.1 11.3 20.2 0.6 0.4 1.5 1.9 0.6 0.2 0.3 3.7 9.3 32.1 7.1 5.0 4.9 6.0 5.2 8.8 8.5 6.9 5.8 18.5 0.0 3.9 4.2 2.5 6.4 0.4 6.2 0.0 4.3 7.9 6.9 0.0 4.6 0.0 0.0 3.0 1.1 4.0 4.3 3.9 6.6 0.1 5.8 0.5 0.0 0.1 8.1 14.4 0.0 7.6 3.8 17.0 1.6 0.1 24.2 0.0 4.3 11.1 1.4 0.0 1.9 2.6 1.2 8.6 2.9 0.0 0.0 0.0 1.4 0.0 69.9 1.3 1.9 0.4 0.2 1.1 0.1 0.3 0.1 0.1 0.4 0.6 0.2 0.2 1.5 0.6 0.7 0.2 0.1 0.3 3.1 9.8 0.7 8.0 2.5 4.8 2.4 4.5 14.3 2.2 GUSB ENSG00000169919 "Glucuronidase beta" P08236 7 65960684-65982314 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Cancer-related genes, Disease mutation, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036322, HPA036323" Approved Supported Vesicles "Intracellular and membrane" 48000 Vesicles "HPA036322: AB_10670796, HPA036323: " "unprognostic (1.54e-2)" "unprognostic (6.49e-2)" "unprognostic (1.18e-2)" "unprognostic (3.50e-1)" "unprognostic (2.58e-2)" "unprognostic (4.46e-2)" "unprognostic (2.89e-1)" "unprognostic (1.56e-3)" "unprognostic (1.32e-1)" "unprognostic (2.32e-1)" "unprognostic (7.00e-3)" "unprognostic (1.91e-1)" "unprognostic (3.34e-2)" "unprognostic (8.83e-3)" "unprognostic (1.98e-1)" "unprognostic (5.06e-1)" "unprognostic (1.45e-1)" 23.5 12.0 3.7 7.9 5.5 20.7 25.4 5.7 4.4 10.4 14.6 7.7 22.0 10.0 10.4 12.2 9.3 7.6 11.1 8.0 3.7 2.9 11.8 50.4 15.3 12.3 6.3 3.1 8.6 17.1 9.0 7.3 30.0 4.5 12.1 11.4 9.9 17.2 11.8 5.9 10.0 16.1 8.3 3.9 17.5 11.0 7.9 5.8 14.7 17.7 5.9 13.0 9.2 7.4 9.7 27.7 22.1 36.0 15.2 11.5 15.8 16.8 6.5 6.4 14.3 21.9 13.1 9.3 5.3 14.9 11.8 10.9 9.3 17.4 7.7 8.4 6.8 6.9 4.1 6.4 7.0 7.2 8.4 10.5 9.8 6.4 10.7 22.4 17.5 9.0 6.9 6.8 8.9 10.2 15.9 55.9 7.6 12.2 8.2 24.1 4.3 5.5 8.5 14.8 43.7 7.4 10.2 9.4 8.3 14.3 33.6 18.7 18.7 22.4 7.2 14.4 13.1 5.4 13.3 31.8 38.1 13.0 10.8 29.9 17.5 7.4 28.1 22.1 11.5 36.0 10.3 9.7 9.0 10.2 27.7 7.8 6.2 7.3 4.5 15.2 30.0 11.3 11.3 15.8 3.7 5.5 5.7 4.4 3.7 2.9 6.3 3.1 4.5 5.8 GYG1 GYG ENSG00000163754 "Glycogenin 1" P46976 3 148991341-149027668 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030497 Approved Supported Vesicles Vesicles "HPA030497: AB_10602326" "unprognostic (2.68e-2)" "unprognostic (6.31e-3)" "unprognostic (3.21e-1)" "unprognostic (1.81e-1)" "unprognostic (6.19e-2)" "unprognostic (1.49e-2)" "prognostic unfavourable (6.15e-5)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (1.10e-1)" "unprognostic (7.75e-3)" "unprognostic (1.29e-1)" "unprognostic (3.56e-2)" "unprognostic (1.27e-2)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" 10.8 7.9 7.0 8.5 8.5 55.7 10.0 9.2 7.5 10.6 31.0 6.0 11.9 4.8 15.6 15.4 18.1 11.1 12.0 32.0 8.0 9.0 8.5 6.3 9.1 14.7 11.6 7.1 13.3 14.3 6.5 7.8 6.5 10.0 16.3 7.6 7.7 11.3 19.4 113.0 4.7 8.4 32.5 8.1 13.6 12.8 47.3 7.4 4.2 9.4 39.6 8.5 28.7 14.6 7.0 26.7 16.8 26.7 17.7 32.5 17.5 18.5 12.0 9.0 10.0 24.9 26.1 12.2 27.4 22.8 40.0 37.4 15.7 19.0 0.0 13.6 31.7 5.7 23.5 12.1 40.4 6.2 10.1 14.2 5.7 17.8 22.5 14.4 21.4 14.3 19.8 13.2 16.7 22.9 8.7 33.8 22.9 32.6 2.8 11.5 10.7 9.8 7.9 13.6 26.6 11.0 17.4 7.4 3.5 14.4 19.9 15.5 19.8 15.4 19.0 20.5 6.1 14.6 20.0 30.7 17.1 13.2 17.3 22.2 6.6 7.2 23.4 16.8 17.4 24.5 32.5 7.0 11.6 18.1 26.7 5.1 6.3 10.7 11.6 17.7 26.7 10.7 15.9 17.5 7.0 8.5 9.2 7.5 8.0 9.0 11.6 7.1 10.0 7.4 HACL1 "2-HPCL, HPCL, PHYH2" ENSG00000131373 "2-hydroxyacyl-CoA lyase 1" Q9UJ83 3 15560704-15601852 "Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 34.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035496, HPA035497, HPA073760" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA035496: AB_10601328, HPA035497: , HPA073760: " "unprognostic (6.64e-3)" "unprognostic (2.82e-2)" "unprognostic (2.24e-3)" "unprognostic (3.82e-1)" "unprognostic (4.08e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (6.31e-2)" "unprognostic (8.27e-3)" "unprognostic (5.23e-2)" "unprognostic (3.30e-2)" "unprognostic (1.44e-1)" "prognostic favourable (2.63e-5)" "unprognostic (6.62e-2)" "unprognostic (2.66e-1)" "unprognostic (3.23e-2)" "unprognostic (9.07e-2)" 12.9 12.1 9.1 7.3 12.5 7.6 11.6 20.7 14.1 9.0 22.4 13.5 5.8 39.6 13.1 13.2 6.7 7.9 6.6 7.9 6.7 6.0 18.8 38.1 7.5 9.0 9.1 8.3 7.9 14.3 12.9 16.8 6.4 10.1 8.2 9.0 10.9 8.5 6.9 15.7 9.9 31.6 7.2 8.2 11.0 11.5 18.4 10.3 16.6 15.1 6.1 10.7 8.2 6.5 8.5 6.5 34.1 9.1 9.1 9.3 5.0 6.0 12.3 4.0 13.7 6.9 5.5 38.9 5.8 9.5 12.5 12.3 12.8 5.9 6.1 4.2 7.9 4.4 9.1 11.3 11.2 5.1 17.3 12.1 9.4 12.3 10.4 13.1 10.5 6.3 8.3 17.7 7.4 15.7 9.9 10.3 10.7 13.2 6.4 6.2 9.0 14.4 5.9 9.7 8.1 13.4 9.4 4.2 5.5 8.7 9.5 11.5 3.1 12.3 9.6 6.8 6.7 8.4 10.7 12.7 21.4 12.1 12.8 12.0 7.7 34.1 6.5 7.0 6.0 8.2 9.3 6.4 6.5 7.5 6.5 8.5 6.4 7.1 1.4 9.1 9.1 4.0 7.8 5.0 9.1 12.5 20.7 14.1 6.7 6.0 9.1 8.3 10.1 10.3 HAND2 "bHLHa26, dHand, Hed, Thing2" ENSG00000164107 "Heart and neural crest derivatives expressed 2" P61296 4 173524969-173530229 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 61.4;placenta: 62.9" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 117.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "hippocampal formation: 0.3" "HPA019591, CAB025576" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB025576: , HPA019591: " "unprognostic (4.11e-2)" "unprognostic (7.50e-3)" "unprognostic (2.43e-2)" "unprognostic (1.25e-2)" "unprognostic (1.95e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "unprognostic (2.24e-1)" "unprognostic (1.28e-2)" "unprognostic (2.56e-1)" "unprognostic (2.44e-1)" "unprognostic (1.35e-1)" "unprognostic (3.27e-2)" "unprognostic (4.95e-2)" "unprognostic (1.56e-1)" "unprognostic (6.39e-3)" 4.2 24.2 0.2 10.9 0.2 0.0 4.7 0.4 0.2 34.3 42.7 0.2 7.5 1.9 42.7 7.9 16.6 9.7 61.4 54.1 0.2 0.2 0.2 8.2 0.2 0.1 0.2 0.0 13.4 3.8 0.0 0.3 62.9 0.0 13.1 3.6 5.2 1.1 4.2 0.6 1.7 13.5 37.5 0.2 1.8 19.9 5.4 0.0 0.0 1.5 2.7 2.2 25.7 12.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 6.7 3.4 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.3 0.0 0.0 0.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.8 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 HAPLN1 CRTL1 ENSG00000145681 "Hyaluronan and proteoglycan link protein 1" P10915 5 83637805-83721613 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 41.8" "Group enriched" "Detected in some" 37 "PC-3: 44.7;TIME: 28.2;U-2 OS: 46.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019105, HPA019482, HPA025238" Enhanced Approved Supported Vesicles "Secreted to extracellular matrix" Vesicles "HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: " "unprognostic (5.74e-4)" "unprognostic (2.94e-2)" "unprognostic (6.58e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (2.76e-3)" "unprognostic (6.01e-4)" "unprognostic (2.52e-2)" "unprognostic (1.70e-1)" "unprognostic (9.04e-3)" "unprognostic (1.31e-1)" "unprognostic (2.28e-2)" "prognostic unfavourable (4.81e-9)" "unprognostic (6.87e-2)" "unprognostic (2.04e-1)" "unprognostic (8.62e-2)" "unprognostic (3.91e-2)" 0.1 0.0 5.4 1.5 3.9 0.0 0.1 0.6 4.7 0.1 4.7 0.1 0.1 3.8 0.5 0.1 1.2 0.0 0.5 1.8 3.4 1.3 0.4 0.1 0.9 0.1 1.7 0.7 0.2 0.2 0.0 0.1 41.8 1.5 4.9 5.8 1.5 0.9 0.1 0.1 0.5 9.3 0.3 0.6 0.1 2.4 0.1 0.1 0.1 0.3 0.5 0.3 0.9 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.2 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.4 3.9 0.6 4.4 3.4 1.3 1.7 0.7 1.5 0.1 HAVCR1 "CD365, HAVCR, HAVCR-1, KIM1, TIM-1, TIM1, TIMD1" ENSG00000113249 "Hepatitis A virus cellular receptor 1" Q96D42 5 157029413-157059119 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 37.6" "Group enriched" "Detected in some" 6 "A549: 35.8;CACO-2: 43.0;RPTEC TERT1: 17.1" "Cancer enriched" "Detected in many" 12 "renal cancer: 26.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA007173, CAB075697" Uncertain Approved Vesicles Vesicles "CAB075697: , HPA007173: AB_1080282" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (6.99e-2)" "unprognostic (2.46e-3)" "unprognostic (4.75e-3)" "unprognostic (3.20e-2)" "unprognostic (3.21e-1)" "unprognostic (8.70e-4)" "unprognostic (3.81e-3)" "unprognostic (7.10e-3)" "prognostic unfavourable (7.81e-4)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "prognostic favourable (1.32e-4)" 0.4 0.1 0.2 1.0 0.2 0.9 0.2 0.2 0.2 0.2 6.7 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.5 0.2 0.3 0.2 37.6 0.5 0.6 0.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 5.3 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.5 0.5 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.3 0.2 1.3 1.2 2.0 1.8 2.1 3.4 2.3 0.0 35.8 0.1 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.0 43.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.0 1.8 0.5 0.7 1.1 1.0 0.8 1.8 0.9 1.2 1.3 3.4 2.5 1.3 2.1 0.8 0.8 2.8 2.3 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.2 0.2 HCST "DAP10, DKFZP586C1522, KAP10, PIK3AP" ENSG00000126264 "Hematopoietic cell signal transducer" Q9UBK5 19 35902480-35904377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 134.0;bone marrow: 84.0;lymphoid tissue: 79.1" "Cell line enhanced" "Detected in some" "HEL: 51.7;HL-60: 29.8;HMC-1: 34.5;THP-1: 39.1;U-937: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB034435, HPA063026" Enhanced Supported "Vesicles,Plasma membrane,Centriolar satellite" "Plasma membrane" "Vesicles, Centriolar satellite" "CAB034435: AB_2117803, HPA063026: " "unprognostic (1.40e-3)" "unprognostic (3.07e-2)" "unprognostic (3.04e-2)" "unprognostic (7.27e-3)" "unprognostic (1.23e-1)" "unprognostic (8.23e-3)" "unprognostic (1.85e-1)" "unprognostic (2.54e-1)" "prognostic favourable (6.70e-4)" "unprognostic (5.97e-2)" "unprognostic (1.94e-3)" "unprognostic (1.02e-1)" "prognostic unfavourable (1.59e-10)" "unprognostic (3.78e-1)" "unprognostic (3.25e-2)" "unprognostic (1.65e-1)" "unprognostic (1.56e-1)" 29.4 4.0 6.5 19.9 5.2 84.0 5.9 1.4 3.1 3.9 4.9 4.8 0.5 4.5 5.4 6.0 3.0 4.5 6.3 7.3 5.7 5.9 5.6 6.9 38.4 79.1 7.7 2.2 3.4 2.9 0.7 4.3 10.6 4.9 5.5 3.6 7.1 6.2 3.7 2.4 2.8 10.9 4.5 12.7 49.5 5.6 1.7 4.4 56.8 3.4 3.3 26.7 5.2 3.6 6.1 66.6 15.9 57.0 96.4 134.0 89.5 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.2 0.0 0.1 0.1 0.2 5.6 0.3 0.4 0.2 0.0 0.0 0.0 0.1 0.0 51.7 0.1 0.1 0.1 29.8 34.5 0.3 0.0 0.0 0.0 0.0 0.4 7.4 0.1 0.0 3.4 11.6 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.1 39.1 0.1 0.3 0.4 0.0 0.0 0.3 0.2 8.5 0.3 58.7 0.0 7.3 57.0 7.9 134.0 42.0 99.3 6.1 57.4 108.5 32.6 3.7 48.3 96.4 15.9 96.4 23.0 66.6 48.5 89.5 6.5 5.2 1.4 3.1 5.7 5.9 7.7 2.2 4.9 4.4 HDHD2 DKFZP564D1378 ENSG00000167220 "Haloacid dehalogenase like hydrolase domain containing 2" Q9H0R4 18 47107403-47150520 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040697, CAB045978, HPA059818" Approved Approved Vesicles 170000 Vesicles "CAB045978: AB_11124418, HPA040697: , HPA059818: " "unprognostic (3.22e-1)" "unprognostic (6.32e-2)" "unprognostic (9.95e-2)" "unprognostic (7.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.58e-1)" "unprognostic (3.11e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-2)" "unprognostic (5.35e-3)" "unprognostic (1.82e-2)" "unprognostic (8.64e-3)" "prognostic favourable (3.52e-5)" "unprognostic (1.95e-1)" "unprognostic (1.61e-1)" "unprognostic (3.44e-1)" "unprognostic (1.17e-1)" 11.0 23.7 29.3 9.1 24.9 8.5 15.8 34.7 29.0 10.3 14.9 22.2 10.5 11.0 12.6 14.6 12.7 14.5 10.6 23.7 25.6 27.3 20.3 25.2 11.6 15.3 32.1 23.1 13.1 19.3 21.0 15.6 10.3 37.5 15.9 14.7 12.0 12.5 16.8 12.6 10.5 11.9 12.3 30.4 11.3 13.2 9.9 22.2 15.3 23.6 7.9 18.1 11.4 9.4 20.3 18.0 13.5 18.5 21.2 22.1 14.8 7.6 5.2 19.8 9.7 12.1 17.4 5.9 8.5 8.3 14.2 14.6 2.3 6.1 13.6 7.5 10.0 6.9 10.5 12.3 20.7 10.2 10.6 12.2 10.2 13.4 16.8 17.5 11.0 14.5 15.3 8.3 18.6 11.8 12.4 14.7 18.6 10.1 15.5 9.9 19.4 5.3 15.0 12.4 16.6 18.0 11.7 18.0 14.6 8.4 5.8 10.7 8.6 23.1 8.2 11.1 8.5 3.2 6.0 19.3 8.8 11.3 13.5 17.7 10.5 12.0 18.5 13.5 16.5 16.8 16.8 20.3 17.1 15.7 18.0 19.8 22.1 17.5 1.8 21.2 16.1 11.7 16.8 14.8 29.3 24.9 34.7 29.0 25.6 27.3 32.1 23.1 37.5 22.2 HDHD3 "C9orf158, MGC12904" ENSG00000119431 "Haloacid dehalogenase like hydrolase domain containing 3" Q9BSH5 9 113373419-113376999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 54.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020427, HPA024158, HPA024585" Enhanced Enhanced Nucleoli,Vesicles Nucleoli Vesicles "HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565" "unprognostic (1.30e-1)" "prognostic favourable (2.72e-4)" "unprognostic (3.01e-2)" "unprognostic (1.31e-2)" "unprognostic (8.24e-3)" "unprognostic (1.57e-2)" "unprognostic (6.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.76e-2)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (5.87e-2)" "prognostic favourable (3.54e-7)" "unprognostic (2.16e-2)" "unprognostic (1.84e-1)" "unprognostic (4.68e-1)" "unprognostic (1.19e-3)" 4.9 54.7 5.1 10.1 8.4 3.3 12.7 6.2 8.5 6.0 29.8 5.6 10.6 38.2 6.4 15.5 13.8 5.8 18.1 9.1 4.6 5.3 17.7 36.6 4.4 6.3 4.5 9.4 7.2 23.7 20.5 9.1 6.5 7.3 10.6 16.8 8.3 24.4 12.5 2.8 11.4 47.1 8.0 4.8 6.0 17.7 4.5 4.0 8.0 18.2 6.1 6.8 7.0 6.9 12.1 10.6 5.9 2.9 5.6 12.3 5.8 3.6 10.5 2.3 6.3 5.7 2.5 19.2 2.7 5.2 4.4 4.9 19.2 18.4 8.1 3.4 1.5 14.4 3.6 4.2 1.5 11.3 8.2 11.2 5.7 11.9 6.6 0.6 8.6 3.9 9.0 3.6 10.3 2.3 8.8 2.0 2.1 23.9 5.1 3.2 5.1 8.2 4.2 0.0 6.5 5.6 7.7 5.7 3.6 4.7 20.3 6.8 12.7 2.3 2.3 0.9 0.0 0.7 0.9 5.0 9.7 3.3 1.1 0.0 0.6 0.1 2.9 5.9 9.9 1.6 11.2 11.3 11.5 9.0 4.5 12.1 12.0 8.9 1.9 5.6 0.2 10.6 12.3 5.8 5.1 8.4 6.2 8.5 4.6 5.3 4.5 9.4 7.3 4.0 HEBP1 "HBP, HEBP" ENSG00000013583 "Heme binding protein 1" Q9NRV9 12 12974864-13000273 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056417, HPA075277" Approved Approved Nucleoplasm,Vesicles 130000 Vesicles Nucleoplasm "HPA056417: , HPA075277: " "unprognostic (1.65e-1)" "unprognostic (2.31e-2)" "unprognostic (9.28e-2)" "unprognostic (5.67e-3)" "unprognostic (4.45e-3)" "unprognostic (5.42e-3)" "unprognostic (2.70e-1)" "unprognostic (2.44e-1)" "unprognostic (6.04e-2)" "unprognostic (3.50e-2)" "unprognostic (1.94e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-3)" "unprognostic (5.71e-2)" "unprognostic (1.64e-1)" "unprognostic (4.02e-2)" "unprognostic (4.43e-2)" 23.4 36.0 12.3 7.6 21.1 16.0 24.5 7.7 14.0 17.7 46.8 18.0 20.0 79.8 14.2 13.9 13.9 13.6 25.4 18.3 11.8 11.7 20.4 48.5 16.2 11.2 16.7 8.0 27.8 27.6 13.3 9.0 13.9 17.2 17.8 7.6 20.0 18.2 16.4 12.8 19.1 79.1 22.9 22.2 19.3 13.4 11.2 15.1 5.5 52.8 13.9 8.7 18.2 23.9 5.3 21.4 9.0 27.4 7.1 9.4 9.9 17.3 10.4 7.3 12.8 55.2 43.0 5.0 15.7 22.4 15.1 20.2 6.6 6.3 5.1 6.3 30.7 15.7 9.0 12.5 17.6 0.7 7.4 2.8 12.5 16.7 39.6 5.0 2.7 33.0 11.8 20.0 24.8 30.8 3.1 4.3 25.5 10.8 4.0 8.2 10.1 7.4 9.4 20.7 5.2 12.1 16.6 4.0 3.7 20.9 9.7 19.5 5.1 7.5 33.7 11.1 13.5 17.6 8.1 4.1 3.3 1.8 17.7 9.1 4.4 4.6 27.4 6.8 4.3 19.8 6.0 4.9 7.3 4.7 21.4 5.3 9.4 5.4 9.0 7.1 26.5 10.7 4.1 9.9 12.3 21.1 7.7 14.0 11.8 11.7 16.7 8.0 17.2 15.1 HECTD4 "C12orf51, FLJ34154, KIAA0614" ENSG00000173064 "HECT domain E3 ubiquitin protein ligase 4" 12 112160188-112382439 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 43.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041062, HPA045473" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA041062: , HPA045473: " "unprognostic (9.27e-2)" "unprognostic (2.35e-1)" "unprognostic (6.50e-2)" "unprognostic (1.33e-1)" "unprognostic (3.38e-1)" "prognostic favourable (2.97e-4)" "unprognostic (3.52e-2)" "unprognostic (2.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.21e-2)" "unprognostic (4.95e-2)" "unprognostic (1.06e-1)" "unprognostic (2.89e-2)" "unprognostic (2.81e-2)" "unprognostic (1.89e-1)" "unprognostic (1.58e-2)" "unprognostic (4.51e-3)" 6.8 7.1 11.3 6.3 16.3 26.6 7.7 43.3 22.7 8.9 9.0 14.0 10.8 5.4 11.1 10.0 10.0 9.0 6.5 6.6 10.1 10.3 7.4 6.3 7.3 8.1 11.4 13.7 10.9 10.1 13.8 14.0 8.0 17.2 12.3 7.4 9.4 8.7 9.6 12.9 16.6 7.0 8.8 13.0 7.4 8.8 14.6 12.7 8.3 12.8 5.0 7.7 8.3 9.0 2.9 2.4 2.8 1.2 1.0 1.8 0.7 5.6 10.6 8.5 7.5 11.6 7.9 4.9 4.1 3.9 5.3 4.5 10.3 1.9 5.9 3.8 6.7 5.7 11.1 5.4 4.0 7.6 10.0 8.4 11.2 5.7 4.1 5.9 8.2 6.5 6.6 8.2 5.4 8.1 10.4 4.6 5.1 6.2 7.0 12.5 4.0 7.9 9.5 4.3 3.8 4.3 8.9 13.9 9.5 9.6 9.4 3.6 7.1 8.4 11.7 6.3 4.6 6.5 5.5 15.7 5.9 6.6 5.1 3.9 3.9 2.8 1.2 0.6 1.8 0.5 1.2 1.1 0.6 0.9 0.8 2.9 1.0 0.9 1.4 1.0 1.1 2.4 0.1 0.7 11.3 16.3 43.3 22.7 10.1 10.3 11.4 13.7 17.2 12.7 HEG1 "HEG, KIAA1237" ENSG00000173706 "Heart development protein with EGF like domains 1" Q9ULI3 3 124965710-125055958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 46.1;HHSteC: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010952, HPA011559" Approved Approved Vesicles "Intracellular and membrane" 360000000 Vesicles "HPA010952: , HPA011559: AB_1850580" "unprognostic (1.10e-1)" "unprognostic (2.21e-1)" "unprognostic (6.52e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.48e-2)" "unprognostic (2.89e-2)" "unprognostic (2.36e-1)" "unprognostic (9.80e-2)" "unprognostic (1.69e-1)" "unprognostic (8.33e-2)" "prognostic unfavourable (1.93e-5)" "unprognostic (1.11e-2)" "unprognostic (4.99e-2)" "unprognostic (6.20e-3)" "prognostic unfavourable (1.16e-4)" 23.6 8.2 5.8 12.1 8.4 0.7 16.4 2.6 8.9 12.2 9.6 14.7 8.0 3.9 12.0 7.3 9.0 11.4 29.6 36.3 6.9 5.5 8.9 5.5 42.4 7.7 9.7 4.7 8.1 16.6 14.2 4.0 17.4 11.6 7.2 6.5 26.2 7.1 7.4 6.2 4.3 7.9 14.4 11.9 11.5 7.5 11.3 6.5 3.0 29.1 10.8 8.7 13.0 15.6 1.0 0.9 1.2 3.9 7.3 4.0 1.1 2.0 2.1 14.7 1.2 18.2 16.2 5.5 17.3 22.6 19.2 21.1 15.0 0.2 0.6 11.8 46.1 3.6 2.2 8.4 23.2 1.6 1.1 0.3 11.1 1.8 56.0 0.4 22.4 19.7 2.4 25.0 5.9 18.7 0.0 0.2 5.8 0.3 0.9 0.0 2.5 1.3 1.3 11.1 0.0 3.3 0.3 0.2 1.3 38.3 2.6 1.5 6.2 0.9 28.9 10.8 12.1 38.9 7.3 1.5 4.7 0.0 20.4 1.6 21.1 1.2 0.3 0.0 4.0 3.6 2.7 0.9 1.6 3.6 0.7 1.0 2.4 1.5 0.0 7.3 3.9 0.9 0.5 1.1 5.8 8.4 2.6 8.9 6.9 5.5 9.7 4.7 11.6 6.5 HELLS "LSH, Nbla10143, PASG, SMARCA6" ENSG00000119969 "Helicase, lymphoid specific" Q9NRZ9 10 94501434-94613905 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Developmental protein, Helicase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.4" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in all" "testis cancer: 16.1" "Region enhanced" "Detected in many" "cerebellum: 11.9" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004491, HPA063242" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "CAB004491: AB_627895, HPA063242: " "unprognostic (1.94e-1)" "prognostic favourable (1.36e-4)" "unprognostic (9.85e-2)" "unprognostic (3.38e-2)" "unprognostic (8.65e-2)" "unprognostic (4.85e-3)" "unprognostic (1.76e-5)" "unprognostic (7.59e-3)" "unprognostic (7.03e-3)" "unprognostic (6.49e-2)" "unprognostic (2.05e-2)" "unprognostic (9.45e-5)" "unprognostic (9.93e-13)" "unprognostic (2.25e-2)" "unprognostic (1.72e-1)" "unprognostic (6.24e-2)" "unprognostic (3.03e-2)" 1.4 2.0 1.2 28.8 1.5 14.8 3.0 11.9 3.2 4.2 5.0 0.7 3.3 3.5 5.8 6.0 8.6 2.5 3.6 2.1 1.3 2.0 3.9 2.0 2.5 11.9 1.4 1.7 4.3 1.9 2.7 4.7 9.0 1.3 3.4 5.5 3.3 2.8 2.0 0.6 5.2 5.3 2.1 1.7 8.3 3.6 18.7 0.7 46.4 1.7 8.1 15.1 3.6 4.4 13.6 22.0 0.7 0.8 5.6 10.9 1.5 19.7 19.5 25.2 31.9 1.0 2.3 13.7 15.1 9.7 12.6 20.0 25.7 16.0 24.4 6.0 5.0 19.9 14.4 12.1 18.1 23.6 16.6 13.0 19.8 20.6 0.6 24.4 11.7 1.3 0.7 15.1 7.2 8.7 7.0 15.6 14.9 19.8 25.7 12.2 26.1 8.7 24.0 22.5 5.6 8.6 25.5 10.1 8.2 17.9 5.1 2.6 21.9 7.9 6.1 13.9 7.0 12.6 18.1 8.1 15.4 26.1 6.9 15.1 6.3 0.1 0.5 0.0 4.4 0.8 1.5 10.9 7.2 6.2 1.3 13.6 3.5 5.0 0.7 5.6 0.6 22.0 10.9 1.5 1.2 1.5 11.9 3.2 1.3 2.0 1.4 1.7 1.3 0.7 HEPACAM "FLJ25530, GLIALCAM, hepaCAM" ENSG00000165478 "Hepatic and glial cell adhesion molecule" Q14CZ8 11 124919193-124936412 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Cell cycle, Growth arrest, Growth regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "adipose tissue: 17.3;brain: 64.7;liver: 19.6" "Cell line enriched" "Detected in single" 31 "Hep G2: 24.3" "Cancer enriched" "Detected in some" 12 "glioma: 29.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017613, CAB025486" Enhanced Approved Vesicles Vesicles "CAB025486: , HPA017613: AB_1850595" "unprognostic (3.22e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-1)" "unprognostic (6.41e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (2.25e-1)" "unprognostic (7.58e-2)" "unprognostic (1.33e-2)" "unprognostic (1.06e-6)" "unprognostic (2.62e-1)" "unprognostic (3.21e-1)" 17.3 1.8 25.6 1.7 25.7 1.5 2.6 8.5 64.7 1.6 1.8 55.4 0.0 1.6 1.6 1.7 1.6 1.6 1.6 1.7 31.0 10.8 1.6 19.6 1.6 1.7 30.3 22.4 1.5 1.6 1.5 0.6 1.5 27.9 1.6 1.8 0.0 1.7 2.1 1.6 1.6 1.6 1.6 21.5 1.5 1.6 1.7 35.5 0.0 1.6 0.0 2.3 1.5 0.3 1.5 1.2 3.0 1.4 2.0 1.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 1.1 1.2 1.1 1.2 1.5 1.5 1.4 1.0 1.2 1.3 1.7 1.5 1.3 2.0 1.4 1.0 1.1 1.5 25.6 25.7 8.5 29.7 31.0 10.8 30.3 22.4 27.9 35.5 HEPACAM2 FLJ38683 ENSG00000188175 "HEPACAM family member 2" A8MVW5 7 93188586-93226524 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 43.4;kidney: 24.5;pituitary gland: 16.1" "Cell line enriched" "Detected in some" 37 "SCLC-21H: 61.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012381 Supported "Nucleoplasm,Vesicles,Mitotic spindle" 89000 "Vesicles, Mitotic spindle" Nucleoplasm "HPA012381: AB_1853037" "unprognostic (2.01e-3)" "unprognostic (6.05e-2)" "prognostic favourable (9.73e-5)" "unprognostic (1.33e-2)" "unprognostic (7.27e-2)" "unprognostic (2.24e-2)" "unprognostic (4.48e-2)" "unprognostic (8.40e-3)" "unprognostic (7.61e-2)" "unprognostic (8.68e-2)" "unprognostic (5.37e-3)" "unprognostic (4.93e-2)" "unprognostic (3.64e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (3.82e-1)" "unprognostic (6.34e-2)" 0.1 0.2 0.2 8.5 0.2 0.6 3.4 0.1 0.1 0.1 29.4 0.1 5.3 11.8 0.1 0.4 0.2 0.1 0.8 0.3 0.2 0.2 24.5 0.2 0.4 0.1 0.2 0.1 0.1 5.5 0.0 16.1 0.4 0.2 0.7 38.9 0.1 4.1 1.2 0.1 0.1 43.4 0.4 0.2 0.2 4.0 1.4 0.1 0.3 0.1 0.1 2.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 HES4 bHLHb42 ENSG00000188290 "Hes family bHLH transcription factor 4" Q9HCC6 1 998962-1000172 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in some" 8 "HEK 293: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 12.4" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.4" "Low region specificity" "Detected in all" HPA062465 Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA062465: " "unprognostic (6.23e-2)" "unprognostic (3.77e-2)" "unprognostic (7.07e-2)" "prognostic favourable (3.85e-4)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "prognostic unfavourable (2.99e-4)" "unprognostic (6.25e-3)" "unprognostic (2.34e-1)" "unprognostic (1.62e-2)" "unprognostic (3.77e-1)" "unprognostic (7.76e-2)" "prognostic unfavourable (6.27e-4)" "unprognostic (3.97e-1)" "unprognostic (3.87e-2)" "unprognostic (1.86e-1)" "unprognostic (5.08e-3)" 14.8 4.0 8.3 3.9 15.6 2.8 8.7 2.5 16.9 7.6 10.8 2.9 4.8 5.4 7.8 9.0 7.5 6.8 9.6 13.6 5.9 9.4 5.3 3.2 9.1 2.2 7.3 4.0 4.2 14.8 3.1 5.7 6.1 7.2 10.4 2.6 12.8 5.6 9.4 8.0 7.8 4.2 12.1 3.4 8.6 6.1 3.4 3.1 9.0 3.6 8.4 3.3 10.6 5.6 0.0 0.3 12.4 1.4 0.0 0.0 0.0 4.5 0.5 0.5 0.0 0.0 0.0 5.8 2.7 0.3 1.7 1.8 0.7 1.4 0.0 6.6 0.2 8.0 0.7 0.1 0.0 0.0 65.3 0.0 0.7 0.9 0.5 0.0 0.5 0.0 0.6 0.1 0.1 0.2 1.2 0.1 0.0 2.4 3.6 0.2 0.0 6.3 0.0 0.6 1.3 0.6 0.0 0.3 1.5 1.9 4.6 8.2 3.4 0.0 0.3 0.5 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 12.4 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 8.3 15.6 2.5 7.0 5.9 9.4 7.3 4.0 7.2 3.1 HEXIM1 "CLP-1, EDG1, HIS1, MAQ1" ENSG00000186834 "Hexamethylene bisacetamide inducible 1" O94992 17 45148502-45152101 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008926, CAB011625" Supported Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB011625: AB_2233058, HPA008926: AB_1079048" "unprognostic (2.82e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (2.39e-1)" "unprognostic (2.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.44e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.58e-1)" "unprognostic (2.89e-3)" "unprognostic (1.26e-2)" 14.8 25.3 30.0 12.6 25.3 30.4 13.7 41.4 37.4 16.2 21.0 10.7 18.5 17.8 17.0 17.2 18.6 18.2 18.6 16.0 31.1 15.6 20.9 19.0 15.8 11.8 24.9 19.2 14.8 15.6 12.2 24.4 56.7 27.5 19.9 10.8 12.6 16.4 25.2 29.7 22.6 20.2 19.5 31.4 20.7 17.3 17.1 21.7 8.9 17.2 14.3 12.3 17.8 30.6 3.7 3.4 15.9 6.7 3.8 4.6 2.3 12.9 41.2 8.6 12.4 14.3 7.7 21.1 11.5 10.4 9.5 10.7 19.3 18.4 5.6 35.6 12.1 10.5 5.2 11.3 7.7 11.6 12.3 17.6 22.7 23.5 12.5 10.9 23.4 8.9 9.7 7.0 3.1 4.7 7.7 13.8 7.1 17.3 11.4 12.7 7.9 12.5 4.8 7.5 6.9 25.0 23.0 4.6 3.5 17.3 19.6 18.6 20.4 8.6 9.0 9.6 13.3 5.5 21.3 12.6 4.0 3.7 8.8 10.3 10.9 15.9 4.3 6.6 4.5 6.1 2.7 3.3 4.6 4.0 3.3 3.7 4.2 4.4 10.5 3.8 6.7 3.4 3.9 2.3 30.0 25.3 41.4 37.4 31.1 15.6 24.9 19.2 27.5 21.7 HFM1 "FLJ36760, FLJ39011, MER3, SEC63D1" ENSG00000162669 "HFM1, ATP dependent DNA helicase homolog" A2PYH4 1 91260766-91404869 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Meiosis "Helicase, Hydrolase" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3;testis: 19.9" "Cell line enhanced" "Detected in some" "AF22: 9.1;AN3-CA: 4.8;K-562: 4.9;SCLC-21H: 3.1;SH-SY5Y: 3.8;U-266/70: 4.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035036, HPA035557" Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA035036: , HPA035557: AB_10696507" "unprognostic (1.35e-2)" "unprognostic (9.39e-2)" "unprognostic (1.17e-1)" "unprognostic (2.83e-4)" "unprognostic (2.05e-2)" "unprognostic (1.52e-1)" "unprognostic (7.43e-3)" "unprognostic (1.79e-1)" "unprognostic (7.75e-2)" "unprognostic (7.97e-2)" "unprognostic (1.76e-4)" "unprognostic (2.81e-2)" "unprognostic (1.06e-2)" "unprognostic (2.89e-3)" "unprognostic (2.78e-2)" "unprognostic (1.77e-4)" "unprognostic (9.59e-2)" 0.8 0.7 2.6 0.3 4.1 0.4 0.8 11.3 4.4 1.7 0.9 1.5 2.7 0.6 3.7 2.5 0.4 1.2 0.6 1.0 2.3 0.9 1.3 0.4 0.5 1.6 0.7 1.4 6.4 1.2 0.1 7.8 0.9 3.9 1.1 0.7 2.7 1.0 2.0 2.3 0.4 0.5 1.7 4.7 0.7 0.6 19.9 1.5 0.0 2.7 0.5 0.4 0.7 2.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.1 4.8 0.0 0.2 0.1 0.5 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 1.0 0.0 0.1 0.2 1.1 0.0 0.5 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.6 0.2 2.4 0.0 0.3 1.4 0.1 0.0 0.0 3.1 3.8 0.0 0.0 1.2 0.0 0.8 0.1 0.0 1.0 0.9 0.1 4.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 4.1 11.3 4.4 2.3 0.9 0.7 1.4 3.9 1.5 HHLA3 ENSG00000197568 "HERV-H LTR-associating 3" Q9XRX5 1 70354805-70385339 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA031323 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA031323: AB_10601477" "unprognostic (2.31e-3)" "unprognostic (8.35e-2)" "unprognostic (3.29e-2)" "unprognostic (6.61e-2)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (8.24e-3)" "unprognostic (9.87e-2)" "unprognostic (2.07e-1)" "unprognostic (3.08e-2)" "unprognostic (3.67e-1)" "unprognostic (1.69e-1)" "prognostic unfavourable (2.03e-4)" "unprognostic (1.75e-1)" "unprognostic (3.92e-2)" "unprognostic (5.16e-1)" "unprognostic (3.60e-2)" 6.9 20.0 18.2 4.1 19.5 7.6 8.5 6.9 19.3 8.9 6.4 20.1 7.2 4.6 8.2 25.7 8.0 15.8 6.8 5.1 15.8 16.5 16.8 17.6 4.6 9.7 17.5 14.6 18.0 15.5 15.8 14.1 6.8 13.4 11.4 6.1 13.1 14.4 8.6 2.8 11.0 4.3 7.9 17.0 7.3 5.2 8.9 15.4 5.8 13.6 3.2 9.0 7.6 13.2 13.4 8.5 4.5 3.0 5.2 11.2 3.9 7.8 3.6 14.1 8.0 12.2 9.9 2.1 2.2 5.2 3.7 4.8 1.2 9.1 7.5 9.7 9.4 4.9 13.8 6.4 6.6 21.3 7.9 5.0 7.5 3.5 11.9 2.4 4.0 12.9 7.6 8.0 9.4 1.2 9.2 21.3 5.4 5.9 5.0 8.6 13.9 4.9 10.4 1.0 3.6 17.2 1.3 5.1 4.0 16.9 5.3 9.9 3.1 5.5 3.1 4.0 2.3 8.3 2.7 10.7 8.6 20.3 8.1 7.6 7.7 4.5 2.5 1.4 6.5 3.0 6.5 10.5 6.7 7.0 3.7 13.4 11.2 9.9 0.7 5.2 2.2 8.5 10.8 3.9 18.2 19.5 6.9 19.3 15.8 16.5 17.5 14.6 13.4 15.4 HIP1 ILWEQ ENSG00000127946 "Huntingtin interacting protein 1" O00291 7 75533300-75738962 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Differentiation, Endocytosis, Transcription, Transcription regulation" "Actin-binding, Activator" "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013606, CAB015334, CAB016402, HPA017964" Enhanced Enhanced Vesicles Vesicles "CAB015334: AB_2117565, CAB016402: AB_627725, HPA013606: AB_1850717, HPA017964: AB_1850719" "unprognostic (8.23e-2)" "unprognostic (1.22e-1)" "unprognostic (2.20e-2)" "unprognostic (1.64e-1)" "unprognostic (1.04e-1)" "unprognostic (2.59e-1)" "unprognostic (2.73e-3)" "unprognostic (1.03e-2)" "unprognostic (1.11e-2)" "unprognostic (2.02e-2)" "unprognostic (2.70e-2)" "unprognostic (7.98e-2)" "unprognostic (1.73e-3)" "unprognostic (9.67e-2)" "unprognostic (1.75e-1)" "unprognostic (1.00e-2)" "unprognostic (1.09e-1)" 16.5 8.7 14.6 7.2 25.9 5.1 13.5 13.2 20.8 13.2 5.3 34.4 4.9 2.9 13.4 10.1 5.7 13.8 8.7 9.2 17.5 11.9 14.6 9.6 17.7 4.6 27.2 11.8 8.1 4.0 4.9 3.6 20.0 16.1 6.8 4.5 9.9 4.0 12.4 3.9 10.8 4.6 12.6 24.8 10.8 4.6 18.5 29.7 1.6 15.8 5.7 4.6 9.7 8.8 0.5 4.0 8.8 1.1 3.3 1.5 0.3 2.5 27.3 18.6 17.5 7.9 10.7 5.6 4.8 3.1 3.1 2.3 1.5 2.4 1.8 5.6 11.8 3.1 18.8 3.9 4.2 1.5 3.5 1.4 3.2 2.5 7.8 0.4 7.4 8.2 2.4 10.2 2.1 13.0 1.9 1.8 5.0 10.4 1.2 10.6 20.2 3.3 2.1 7.8 0.1 2.4 9.7 0.9 8.2 4.4 2.8 6.3 17.2 6.7 4.6 9.2 7.1 3.1 6.6 2.0 0.2 4.4 9.2 3.9 6.2 8.8 1.1 7.6 1.1 1.1 1.0 0.4 0.2 0.9 1.6 0.5 0.1 0.7 7.7 3.3 0.8 4.0 1.5 0.3 14.6 25.9 13.2 16.9 17.5 11.9 27.2 11.8 16.1 29.7 HIP1R "FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655" ENSG00000130787 "Huntingtin interacting protein 1 related" O75146 12 122834453-122862960 "Cancer-related genes, Predicted intracellular proteins" Endocytosis Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.5;naive B-cell: 12.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017187, HPA038135, HPA038136" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852" "unprognostic (4.52e-1)" "unprognostic (6.39e-2)" "unprognostic (7.07e-2)" "unprognostic (6.55e-3)" "unprognostic (8.67e-2)" "unprognostic (1.00e-2)" "unprognostic (1.02e-2)" "unprognostic (8.11e-2)" "unprognostic (6.37e-2)" "unprognostic (1.76e-1)" "unprognostic (1.39e-2)" "unprognostic (6.72e-2)" "prognostic favourable (6.50e-7)" "unprognostic (2.18e-2)" "unprognostic (2.84e-1)" "unprognostic (2.54e-3)" "prognostic favourable (7.26e-4)" 9.8 14.5 24.6 13.2 26.5 11.6 8.0 11.5 31.6 4.6 11.6 40.5 19.7 29.2 4.0 9.1 7.0 4.0 7.8 10.8 29.5 21.7 16.2 9.0 6.3 15.3 31.4 20.6 3.2 27.7 7.4 15.6 5.2 18.0 8.6 5.4 2.9 52.0 24.1 5.7 26.5 21.3 3.0 27.4 11.1 30.4 4.0 30.6 8.1 8.1 5.9 12.6 7.4 6.5 12.3 0.0 2.7 0.0 0.6 3.2 1.6 17.3 5.0 3.8 15.6 1.1 3.0 18.7 2.7 4.5 2.8 2.2 7.7 5.2 16.5 9.2 2.0 15.0 4.6 10.0 0.2 2.6 6.6 0.3 5.7 8.1 3.5 1.3 11.8 1.8 7.1 3.8 6.4 19.3 4.3 0.9 1.6 24.9 7.8 4.0 3.5 6.0 4.1 4.8 5.7 9.4 21.0 3.8 8.5 3.2 8.5 4.5 17.4 0.7 15.2 1.8 13.4 5.5 2.6 11.9 6.3 9.8 2.9 2.8 1.5 0.0 0.0 2.7 2.9 0.0 1.7 9.5 1.8 2.2 0.0 12.3 3.2 2.0 0.2 0.6 0.0 0.0 0.4 1.6 24.6 26.5 11.5 19.8 29.5 21.7 31.4 20.6 18.0 30.6 HLA-DMA "D6S222E, RING6" ENSG00000204257 "Major histocompatibility complex, class II, DM alpha" P28067 6 32948613-32969094 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "U-266/70: 15.3;U-698: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 4.1;intermediate monocyte: 4.0;memory B-cell: 6.8;myeloid DC: 7.9;naive B-cell: 7.0;plasmacytoid DC: 5.7" "Group enriched" "Detected in many" 12 "B-cells: 7.0;dendritic cells: 7.9;monocytes: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012750, HPA017295" Enhanced Approved Vesicles Vesicles "HPA012750: AB_1853926, HPA017295: " "unprognostic (1.69e-3)" "unprognostic (3.52e-2)" "unprognostic (8.03e-2)" "prognostic favourable (4.64e-5)" "unprognostic (3.99e-1)" "unprognostic (3.90e-2)" "unprognostic (1.60e-1)" "prognostic favourable (4.59e-4)" "unprognostic (7.01e-2)" "unprognostic (9.69e-2)" "unprognostic (6.66e-2)" "unprognostic (1.89e-1)" "unprognostic (2.12e-3)" "unprognostic (1.41e-1)" "unprognostic (4.95e-2)" "unprognostic (3.80e-1)" "unprognostic (2.14e-2)" 22.9 20.5 5.1 27.2 7.9 18.9 17.4 1.0 5.0 11.3 18.4 9.8 5.7 3.2 8.0 25.3 6.7 32.1 11.1 13.1 4.6 5.2 19.3 12.4 50.7 24.5 10.1 2.0 14.9 20.2 2.1 5.0 3.2 9.7 7.6 14.3 8.4 17.3 10.1 4.3 7.3 28.4 4.3 15.2 38.5 23.1 3.5 7.9 17.3 10.0 11.9 42.1 5.9 6.0 7.0 7.9 0.5 4.1 0.3 0.4 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.2 0.1 0.0 1.2 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.3 6.7 39.0 0.3 0.0 0.0 0.0 4.1 0.4 0.2 4.0 0.0 6.8 0.1 0.3 7.9 7.0 0.1 0.2 0.5 0.3 1.1 5.7 0.4 3.1 5.1 7.9 1.0 5.0 4.6 5.2 10.1 2.0 9.7 7.9 HLA-DMB "D6S221E, RING7" ENSG00000242574 "Major histocompatibility complex, class II, DM beta" P28068 6 32934629-32941070 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 13 "CAPAN-2: 7.2;Daudi: 10.1;EFO-21: 4.8;U-266/70: 3.8;U-698: 12.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 19.9;dendritic cells: 11.5;monocytes: 11.9" "HPA012298, HPA077524" Supported Supported Vesicles Vesicles "HPA012298: AB_1853927, HPA077524: " "unprognostic (5.34e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-2)" "prognostic favourable (3.89e-5)" "unprognostic (3.07e-1)" "unprognostic (7.64e-3)" "unprognostic (4.00e-1)" "unprognostic (3.46e-3)" "unprognostic (6.99e-2)" "unprognostic (8.76e-2)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (6.82e-3)" "unprognostic (2.03e-1)" "unprognostic (4.14e-2)" "unprognostic (8.35e-2)" "unprognostic (5.60e-2)" 12.0 13.0 5.9 20.2 7.5 4.3 7.9 0.4 4.9 8.1 9.7 8.8 2.1 1.2 6.2 10.2 3.3 12.6 6.0 8.0 5.7 4.2 13.1 5.4 20.8 24.0 10.2 2.3 7.4 5.0 1.2 3.2 6.2 8.1 6.3 10.5 6.3 7.8 3.2 2.9 4.5 31.8 1.9 14.5 35.6 6.1 2.1 7.3 10.5 33.7 3.8 34.5 10.6 3.2 19.9 11.5 2.2 11.9 2.2 1.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 10.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.3 12.3 0.0 0.0 0.0 0.0 11.9 2.2 0.3 10.1 0.4 15.1 0.2 0.5 11.1 19.9 0.1 0.5 0.5 2.2 3.5 11.5 1.0 10.3 5.9 7.5 0.4 4.9 5.7 4.2 10.2 2.3 8.1 7.3 HLA-DPA1 HLA-DP1A ENSG00000231389 "Major histocompatibility complex, class II, DP alpha 1" P20036 6 33064569-33080775 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 59.5" "Cell line enhanced" "Detected in some" "Daudi: 15.4;HDLM-2: 47.5;REH: 12.1;U-698: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 16.3;intermediate monocyte: 37.8;memory B-cell: 30.0;myeloid DC: 59.5;naive B-cell: 26.7;non-classical monocyte: 23.2;plasmacytoid DC: 17.1" "Group enriched" "Detected in all" 8 "B-cells: 30.0;dendritic cells: 59.5;monocytes: 37.8" HPA017967 Enhanced Supported Vesicles 92000 Vesicles "HPA017967: AB_1853929" "unprognostic (8.93e-3)" "unprognostic (3.15e-2)" "unprognostic (3.64e-2)" "unprognostic (9.40e-3)" "unprognostic (9.07e-2)" "unprognostic (2.80e-2)" "unprognostic (5.69e-2)" "unprognostic (1.82e-2)" "unprognostic (7.28e-2)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (8.38e-2)" "unprognostic (1.17e-1)" "unprognostic (4.69e-2)" "unprognostic (8.11e-2)" "unprognostic (1.06e-1)" 25.2 12.8 3.3 13.3 3.6 4.7 16.3 3.5 3.3 11.8 6.8 3.1 4.3 8.6 8.5 15.9 8.5 5.7 14.7 11.1 4.2 6.2 12.4 9.7 35.9 20.2 6.2 3.8 3.8 5.4 3.8 5.2 6.5 4.8 7.4 7.3 7.5 7.4 15.7 4.1 5.8 14.7 6.4 20.4 37.6 5.6 8.6 4.1 10.9 14.2 9.5 21.5 8.5 17.8 30.0 59.5 1.3 37.8 4.0 5.6 20.3 0.0 0.0 0.0 0.0 0.3 0.5 0.5 0.2 0.1 0.2 0.0 0.0 2.1 15.4 2.2 0.3 0.0 0.0 0.0 0.0 47.5 1.0 2.5 0.0 0.0 0.0 0.0 5.0 0.7 0.0 0.9 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 12.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.5 1.1 3.4 0.0 0.0 0.0 2.4 0.3 11.1 5.4 0.1 1.8 0.3 16.3 1.3 4.6 37.8 1.2 30.0 2.1 5.0 59.5 26.7 0.7 3.4 0.6 4.0 23.2 17.1 5.6 20.3 3.3 3.6 3.5 3.3 4.2 6.2 6.2 3.8 4.8 4.1 HLA-E ENSG00000204592 "Major histocompatibility complex, class I, E" 6 30489467-30494205 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 25.1;U-266/70: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB024589, HPA031454" Enhanced Approved Vesicles Vesicles "CAB024589: AB_324025, HPA031454: " "unprognostic (1.14e-2)" "unprognostic (1.38e-2)" "unprognostic (9.20e-2)" "unprognostic (2.47e-3)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.14e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-2)" "unprognostic (1.35e-2)" "unprognostic (5.57e-2)" "unprognostic (2.04e-2)" "prognostic unfavourable (3.86e-4)" "unprognostic (2.90e-1)" "unprognostic (4.14e-2)" "unprognostic (1.75e-3)" "unprognostic (1.42e-3)" 81.4 19.4 12.6 42.9 16.9 81.7 49.9 6.5 14.9 37.6 32.7 23.2 15.5 2.1 41.2 30.6 40.1 28.2 44.0 36.7 15.1 13.3 34.8 56.5 129.7 76.7 19.9 10.5 29.1 14.6 33.9 11.6 33.1 24.9 32.2 28.6 33.9 23.1 27.5 34.8 97.2 36.8 22.9 21.7 97.1 50.5 18.1 14.6 35.0 45.7 36.4 72.4 45.9 33.3 23.0 7.8 90.2 28.9 23.2 37.1 56.3 11.2 1.8 0.7 6.7 25.1 19.9 0.0 0.0 0.0 0.0 0.0 4.6 22.9 7.4 11.4 10.0 13.9 1.5 5.8 0.0 7.4 4.8 8.7 2.2 0.0 0.0 0.0 3.2 15.6 10.8 8.0 0.0 0.0 1.1 0.1 6.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 9.7 10.1 6.4 0.0 0.5 7.7 6.2 0.0 0.0 15.0 11.1 7.0 0.0 0.0 1.4 35.5 20.3 2.9 0.0 6.6 18.5 56.6 14.0 52.5 37.0 24.6 31.5 23.0 28.1 37.1 7.8 22.5 28.5 28.4 90.2 23.2 28.9 6.6 29.4 56.3 12.6 16.9 6.5 14.9 15.1 13.3 19.9 10.5 24.9 14.6 HMCN2 "DKFZp434P0216, FLJ23816" ENSG00000148357 "Hemicentin 2" Q8NDA2 9 130265882-130434123 "Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 8.1;RH-30: 18.7;SH-SY5Y: 4.4;U-138 MG: 3.1;U-87 MG: 4.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053903, HPA070647" Enhanced Approved Vesicles "Secreted to extracellular matrix" 7700000 Vesicles "HPA053903: , HPA070647: " "unprognostic (1.61e-1)" "unprognostic (8.05e-3)" "unprognostic (1.69e-1)" "unprognostic (5.53e-4)" "unprognostic (1.05e-1)" "unprognostic (1.12e-2)" "unprognostic (1.10e-1)" "unprognostic (8.78e-3)" "unprognostic (3.23e-1)" "unprognostic (3.97e-4)" "unprognostic (3.36e-2)" "unprognostic (3.93e-1)" "unprognostic (1.04e-3)" "unprognostic (1.53e-2)" "unprognostic (3.62e-2)" "unprognostic (8.96e-3)" "unprognostic (8.63e-2)" 7.4 1.7 0.2 10.2 0.2 0.1 3.8 0.1 0.4 18.3 25.0 0.0 1.0 5.9 21.9 25.1 4.9 5.1 5.0 8.7 0.4 0.4 1.4 0.4 2.7 2.3 0.0 0.0 8.9 0.8 0.2 0.1 0.3 0.8 5.1 2.3 0.1 1.7 3.4 24.3 2.8 11.2 20.8 0.5 0.3 2.3 6.3 0.0 1.8 2.6 10.9 1.5 12.1 7.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.5 0.0 18.7 0.1 0.0 0.1 2.8 4.4 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.4 0.4 0.4 0.0 0.0 0.8 0.0 HMOX2 HO-2 ENSG00000103415 "Heme oxygenase 2" P30519 16 4474690-4510347 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025464, HPA040611" Supported Approved Vesicles,Cytosol 1200000 "Vesicles, Cytosol" "CAB025464: , HPA040611: AB_10961034" "unprognostic (3.33e-1)" "unprognostic (3.58e-2)" "unprognostic (1.11e-1)" "prognostic favourable (7.91e-4)" "unprognostic (2.74e-1)" "unprognostic (4.27e-2)" "unprognostic (6.23e-2)" "unprognostic (5.77e-2)" "unprognostic (1.43e-2)" "unprognostic (3.60e-1)" "unprognostic (7.74e-3)" "unprognostic (9.87e-2)" "prognostic favourable (8.98e-6)" "unprognostic (3.51e-2)" "unprognostic (4.14e-2)" "unprognostic (1.65e-2)" "unprognostic (2.64e-1)" 19.4 19.2 32.1 15.7 50.7 13.6 16.6 19.7 38.6 13.3 17.9 22.9 12.2 23.5 11.9 18.7 36.6 15.6 19.7 57.2 29.3 22.0 32.2 39.7 15.8 20.8 27.3 35.1 12.5 22.4 20.6 14.7 12.5 36.5 12.1 19.9 8.6 16.0 10.0 20.1 16.6 19.3 16.6 27.2 23.3 29.7 48.1 28.2 8.7 13.8 16.7 25.3 16.5 15.0 14.5 14.5 48.7 8.9 18.7 35.8 25.8 24.6 10.5 6.3 13.6 18.8 9.7 10.5 17.0 8.4 14.5 12.6 13.3 16.8 11.4 19.2 15.6 14.9 19.7 36.5 16.5 14.6 13.4 8.3 10.1 18.0 12.7 18.0 14.2 15.1 12.3 16.8 12.3 26.6 13.4 5.8 13.3 30.5 14.8 14.1 9.6 10.0 15.7 11.0 24.0 20.1 16.2 10.6 6.2 13.6 28.9 18.3 18.0 10.1 25.9 8.2 12.2 35.1 8.7 7.2 8.9 25.2 5.2 14.9 10.4 13.7 7.4 48.7 35.2 8.9 29.9 14.5 32.7 35.8 14.5 13.0 31.7 32.7 26.1 18.7 6.5 8.2 30.0 25.8 32.1 50.7 19.7 38.6 29.3 22.0 27.3 35.1 36.5 28.2 HNF1B "HNF1beta, LFB3, MODY5, TCF2, VHNF1" ENSG00000275410 "HNF1 homeobox B" P35680 17 37686432-37745247 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 34.7;kidney: 66.2;pancreas: 18.6" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 52.0" "Cancer enhanced" "Detected in many" "renal cancer: 32.5" "Cell type enriched" "Detected in single" 5 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 5 "B-cells: 1.0" "Group enriched" "Detected in some" 5 "basal ganglia: 0.7;hypothalamus: 2.3" "Low region specificity" "Detected in some" "HPA002083, CAB068192" Enhanced Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB068192: , HPA002083: AB_1080232" "unprognostic (2.52e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (5.29e-3)" "unprognostic (5.29e-2)" "unprognostic (3.00e-2)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (1.29e-1)" "unprognostic (1.51e-1)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "prognostic favourable (6.00e-4)" "unprognostic (7.06e-2)" "unprognostic (2.26e-1)" "unprognostic (7.49e-2)" "prognostic favourable (2.51e-6)" 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.1 4.5 0.0 4.8 3.8 0.9 7.8 0.0 2.8 34.7 0.0 0.0 66.2 7.7 3.7 0.0 0.0 0.0 0.8 18.6 1.6 0.0 0.6 0.0 1.6 3.4 0.0 0.0 3.8 0.0 0.0 5.5 0.3 0.0 0.0 3.7 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.8 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 52.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 HOOK2 HK2 ENSG00000095066 "Hook microtubule tethering protein 2" Q96ED9 19 12763003-12872740 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 34.4;RT4: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043519, HPA050351" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA043519: , HPA050351: " "unprognostic (4.26e-1)" "unprognostic (3.80e-2)" "unprognostic (2.53e-3)" "unprognostic (1.16e-1)" "unprognostic (4.57e-1)" "unprognostic (1.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.25e-3)" "unprognostic (3.06e-2)" "unprognostic (2.52e-2)" "unprognostic (1.75e-3)" "prognostic unfavourable (7.59e-5)" "prognostic favourable (3.28e-4)" "unprognostic (3.27e-3)" "unprognostic (5.74e-2)" "unprognostic (1.54e-1)" "unprognostic (2.91e-2)" 18.6 6.6 14.9 5.7 13.5 1.9 15.5 21.9 17.5 8.5 14.5 4.2 32.7 25.5 8.0 24.9 18.5 8.9 16.8 15.5 12.2 6.9 16.0 15.0 8.1 4.1 10.2 8.4 8.7 31.9 28.4 49.1 11.3 12.9 17.3 12.2 6.6 22.9 35.9 29.8 26.4 27.1 5.3 10.8 6.0 18.1 7.4 12.1 3.5 33.5 15.8 11.4 10.1 12.0 3.9 3.7 2.2 2.7 2.6 6.8 2.4 15.3 3.8 4.7 3.2 5.0 4.8 16.6 4.6 2.2 2.6 3.4 12.8 18.3 2.8 8.7 4.6 20.4 4.8 14.0 2.7 8.8 3.4 3.0 7.1 4.3 2.9 1.5 4.8 5.8 13.4 3.7 5.4 1.5 5.0 2.5 5.3 34.4 1.6 2.9 2.2 4.0 5.1 2.8 7.0 5.5 39.8 12.5 6.0 3.3 10.4 3.1 15.1 4.0 3.1 6.0 3.5 8.8 1.7 9.7 9.5 1.8 5.6 5.8 3.9 0.8 1.6 0.0 3.4 2.7 2.1 3.9 4.0 1.5 3.7 3.1 6.8 4.4 2.2 2.6 1.6 1.3 1.0 2.4 14.9 13.5 21.9 17.5 12.2 6.9 10.2 8.4 12.9 12.1 HOXA2 HOX1K ENSG00000105996 "Homeobox A2" O43364 7 27100354-27102811 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1" "Cell line enhanced" "Detected in some" "AN3-CA: 16.5;HaCaT: 6.8;RPTEC TERT1: 5.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 44 "pons and medulla: 15.7" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Region enriched" "Detected in single" 35 "pons and medulla: 6.1" "Region enriched" "Detected in single" 27 "pons and medulla: 7.7" HPA078220 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA078220: " "unprognostic (7.30e-2)" "unprognostic (4.90e-4)" "unprognostic (2.81e-1)" "unprognostic (7.43e-4)" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (1.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.85e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (1.58e-2)" "unprognostic (4.98e-9)" "unprognostic (1.34e-1)" "unprognostic (1.33e-1)" "unprognostic (9.36e-2)" "unprognostic (1.28e-2)" 2.7 1.6 0.3 1.9 0.1 0.0 2.6 0.1 0.2 1.4 4.5 0.2 8.7 1.5 3.4 9.7 8.3 6.3 4.9 1.8 0.1 0.0 4.2 0.7 4.7 1.9 0.3 0.1 3.8 0.4 9.6 0.1 0.1 15.7 2.8 3.5 0.1 0.1 4.1 1.2 2.7 4.3 2.4 18.1 2.9 3.7 0.8 0.1 3.8 2.2 2.9 3.3 3.2 3.5 0.0 0.0 1.8 0.3 0.0 0.1 0.0 1.2 0.8 4.2 16.5 0.0 0.0 0.0 0.2 0.1 0.0 0.1 2.1 4.0 0.2 1.9 0.2 6.8 0.2 0.0 0.0 0.0 2.4 0.0 0.1 0.3 1.9 0.1 0.3 1.0 0.0 3.5 3.3 2.7 0.1 0.0 0.1 0.0 0.0 0.3 0.0 1.0 1.0 0.7 0.0 5.4 0.7 1.2 0.0 0.2 0.0 1.1 0.0 0.0 2.7 0.0 0.2 1.2 0.6 0.0 0.0 0.1 0.1 0.6 2.9 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.0 0.3 0.1 15.7 0.1 HP ENSG00000257017 Haptoglobin P00738 16 72054592-72061055 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Immunity" "Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "liver: 1156.9" "Group enriched" "Detected in some" 5 "Hep G2: 64.7;HSkMC: 37.1" "Cancer enriched" "Detected in many" 81 "liver cancer: 1297.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 20.0;eosinophil: 30.9" "Group enriched" "Detected in many" 7 "granulocytes: 30.9;monocytes: 20.0" "CAB003787, HPA047750" Enhanced Approved Vesicles "Secreted to blood" 181000000 140000000000 Vesicles "CAB003787: , HPA047750: " "unprognostic (6.38e-3)" "unprognostic (7.73e-3)" "unprognostic (1.23e-1)" "unprognostic (2.41e-2)" "unprognostic (2.34e-3)" "unprognostic (2.07e-1)" "unprognostic (7.79e-3)" "unprognostic (1.37e-1)" "unprognostic (2.31e-1)" "unprognostic (1.84e-1)" "unprognostic (6.30e-2)" "unprognostic (8.18e-2)" "prognostic unfavourable (6.94e-13)" "unprognostic (4.34e-4)" "unprognostic (1.80e-1)" "unprognostic (6.61e-2)" "unprognostic (2.49e-2)" 9.8 0.0 0.3 0.4 0.3 4.4 0.3 0.3 0.3 1.5 0.4 0.3 0.3 0.0 0.3 0.5 0.3 1.1 0.3 3.0 0.3 0.0 0.4 1156.9 1.4 0.4 0.3 0.3 0.3 0.5 0.0 0.5 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 1.4 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.5 0.0 3.5 30.9 20.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 64.7 0.1 9.2 1.7 37.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.5 0.1 0.7 0.0 0.3 6.9 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 2.1 1.4 0.0 0.2 0.0 0.0 1.2 0.0 4.4 0.0 3.6 0.0 2.6 20.0 30.9 0.0 0.8 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 5.8 0.0 0.9 0.0 0.0 5.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 HPGDS "GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS" ENSG00000163106 "Hematopoietic prostaglandin D synthase" O60760 4 94298535-94342876 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 24.8" "Group enriched" "Detected in some" 8 "HEL: 31.6;HMC-1: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 15.8" "Lineage enriched" "Detected in single" 25 "granulocytes: 15.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024035 Enhanced Approved Nucleoplasm,Vesicles,Cytosol 170000 "Vesicles, Cytosol" Nucleoplasm "HPA024035: AB_1855743" "unprognostic (5.71e-2)" "unprognostic (5.80e-3)" "unprognostic (1.17e-1)" "unprognostic (5.36e-3)" "unprognostic (2.76e-1)" "unprognostic (2.38e-4)" "unprognostic (1.01e-2)" "unprognostic (4.41e-3)" "unprognostic (1.35e-1)" "unprognostic (7.75e-4)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (5.15e-3)" "unprognostic (4.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" 14.3 2.9 8.0 1.6 12.1 1.6 5.8 2.0 7.7 5.4 6.9 4.4 0.2 7.5 4.7 3.3 4.1 2.5 9.3 3.0 8.4 3.6 2.5 1.3 12.7 0.9 9.6 2.4 1.5 1.8 1.7 1.5 24.8 9.0 6.4 7.5 2.9 3.8 2.2 1.4 5.8 8.6 5.8 14.6 1.4 4.4 1.8 12.1 1.5 1.2 2.8 1.5 4.5 3.5 0.0 0.1 15.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 2.4 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 8.0 12.1 2.0 7.7 8.4 3.6 9.6 2.4 9.0 12.1 HPR ENSG00000261701 "Haptoglobin-related protein" P00739 16 72063224-72077246 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "liver: 151.4" "Cell line enriched" "Detected in some" 14 "Hep G2: 32.8" "Cancer enriched" "Detected in some" 53 "liver cancer: 185.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA047750 Supported Approved Vesicles "Secreted to blood" 49000000000 77000000000 Vesicles "HPA047750: " "unprognostic (2.43e-1)" "unprognostic (4.69e-2)" "unprognostic (5.97e-3)" "unprognostic (2.42e-1)" "unprognostic (2.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.66e-1)" "unprognostic (8.21e-2)" "unprognostic (2.30e-1)" "unprognostic (3.44e-6)" "unprognostic (2.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.29e-1)" 0.2 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 15.2 0.7 0.8 0.1 151.4 0.0 0.1 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 2.9 1.1 1.0 0.4 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 1.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 1.3 1.0 0.1 0.5 0.4 0.4 0.3 1.1 2.0 1.1 0.3 0.4 0.3 2.9 2.3 0.3 HPSE "HPA, HPSE1, HSE1" ENSG00000173083 Heparanase Q9Y251 4 83292461-83335153 "Enzymes, Predicted secreted proteins" "Cell adhesion" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 24.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 17.8;neutrophil: 12.8" "Group enriched" "Detected in many" 5 "granulocytes: 12.8;monocytes: 17.8" "Region enhanced" "Detected in some" "olfactory region: 4.5" "Low region specificity" "Detected in all" "CAB009813, HPA055344" Supported Nucleoplasm,Vesicles "Secreted to extracellular matrix" 9700000 Nucleoplasm Vesicles "CAB009813: AB_2120854, HPA055344: " "unprognostic (6.57e-2)" "unprognostic (1.22e-2)" "unprognostic (9.13e-2)" "unprognostic (5.92e-3)" "unprognostic (1.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.24e-2)" "unprognostic (5.65e-2)" "unprognostic (7.06e-2)" "unprognostic (1.90e-1)" "unprognostic (1.50e-1)" "unprognostic (9.62e-3)" "unprognostic (3.27e-1)" "unprognostic (2.78e-1)" "unprognostic (3.04e-3)" "unprognostic (4.15e-2)" "unprognostic (3.70e-3)" 4.9 5.1 3.0 6.8 3.5 2.2 1.2 0.8 2.4 3.6 6.2 7.1 0.0 2.3 2.9 2.8 14.5 5.7 3.0 5.8 3.2 1.5 3.0 5.6 8.2 16.1 7.1 1.4 7.5 1.1 15.5 2.3 11.3 3.4 1.1 7.0 0.7 12.5 2.1 0.7 6.9 3.6 2.1 7.0 19.0 2.4 6.0 2.8 1.6 1.4 16.9 9.7 2.4 4.9 0.3 1.9 12.8 17.8 1.4 3.4 4.8 8.1 0.4 0.0 1.1 1.9 0.6 0.0 1.0 4.5 2.0 8.7 0.2 6.1 0.2 1.4 2.2 7.9 10.3 1.4 3.6 0.8 0.9 2.2 5.8 0.1 1.1 1.4 4.9 0.8 3.1 1.4 9.8 10.8 0.0 24.7 0.9 1.7 0.1 0.1 0.4 1.5 0.0 0.3 0.3 5.7 0.2 5.8 0.0 11.3 6.2 0.9 0.8 1.9 12.6 0.9 2.8 0.8 1.0 0.3 3.8 0.1 6.5 6.6 1.5 0.2 17.8 0.0 1.0 6.7 0.7 0.2 1.9 0.7 1.9 0.3 1.4 1.2 12.8 1.4 0.9 0.1 3.4 4.8 3.0 3.5 0.8 2.4 3.2 1.5 7.1 1.4 3.4 2.8 HS3ST1 3OST1 ENSG00000002587 "Heparan sulfate-glucosamine 3-sulfotransferase 1" O14792 4 11393150-11429765 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4;gallbladder: 31.9;ovary: 30.3" "Cell line enhanced" "Detected in some" "A-431: 4.4;CAPAN-2: 14.0;HaCaT: 4.2;RPTEC TERT1: 12.4;RT4: 10.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 8 "cerebellum: 27.4;cerebral cortex: 9.0" "Group enriched" "Detected in some" 39 "memory B-cell: 7.3;naive B-cell: 15.8;plasmacytoid DC: 22.3" "Group enriched" "Detected in many" 99 "B-cells: 15.8;dendritic cells: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002237 Approved Approved Vesicles "Intracellular and membrane" Vesicles "HPA002237: AB_1079085" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (4.01e-2)" "prognostic favourable (7.73e-4)" "unprognostic (3.32e-2)" "unprognostic (8.90e-3)" "unprognostic (4.21e-1)" "unprognostic (2.08e-1)" "unprognostic (2.22e-1)" "unprognostic (1.32e-1)" "unprognostic (1.77e-2)" "unprognostic (1.08e-1)" "prognostic favourable (5.99e-8)" "unprognostic (9.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.57e-1)" "prognostic favourable (8.67e-4)" 2.3 2.9 1.6 2.8 2.2 2.8 2.0 27.4 9.0 3.3 2.7 1.1 3.6 3.5 4.3 5.0 10.2 4.3 31.9 2.2 1.7 1.8 10.4 0.9 3.4 2.1 1.9 1.5 30.3 1.1 0.7 8.9 1.0 2.4 3.2 1.7 1.7 3.7 2.4 0.7 0.8 2.9 1.7 2.2 3.0 7.0 3.0 0.3 3.8 1.8 7.0 7.4 7.3 2.4 15.8 22.3 0.1 0.1 0.0 0.1 0.6 4.4 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.0 0.0 0.4 0.0 4.2 0.0 2.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.9 1.1 1.0 0.0 0.0 12.4 10.1 3.7 0.0 0.0 0.1 0.5 0.0 0.0 2.0 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.1 7.3 0.0 0.0 0.3 15.8 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.6 1.6 2.2 27.4 9.0 1.7 1.8 1.9 1.5 2.4 0.3 HS3ST3B1 "30ST3B1, 3OST3B1" ENSG00000125430 "Heparan sulfate-glucosamine 3-sulfotransferase 3B1" Q9Y662 17 14301083-14349404 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;liver: 29.1;lymphoid tissue: 26.6;placenta: 33.5;salivary gland: 12.6" "Cell line enhanced" "Detected in many" "AF22: 15.2;BEWO: 10.9;Hep G2: 13.2;HSkMC: 15.1;U-251 MG: 13.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 2.7;pons and medulla: 6.0" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 20.6" "Group enriched" "Detected in many" 5 "dendritic cells: 20.6;T-cells: 14.7" HPA064126 Approved Vesicles Vesicles "HPA064126: " "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (2.85e-3)" "unprognostic (5.22e-2)" "unprognostic (5.03e-3)" "unprognostic (1.79e-1)" "unprognostic (2.93e-1)" "unprognostic (8.13e-3)" "unprognostic (8.80e-2)" "unprognostic (1.13e-1)" "unprognostic (1.02e-3)" "unprognostic (7.77e-3)" "unprognostic (9.46e-2)" "unprognostic (1.91e-1)" "unprognostic (1.54e-3)" 1.4 1.4 0.6 8.7 0.8 1.3 3.0 0.9 2.7 3.8 1.8 0.0 0.8 1.4 1.0 0.3 2.8 1.7 2.6 2.0 0.6 0.7 3.6 29.1 3.7 26.6 0.6 0.0 4.7 1.3 0.4 1.4 33.5 6.0 2.4 1.9 5.3 12.6 2.5 1.8 2.2 2.5 0.6 2.9 4.9 1.4 0.7 0.0 13.2 1.5 2.5 5.9 1.5 5.3 0.4 20.6 0.5 0.4 3.8 14.7 2.7 0.0 0.3 15.2 0.0 4.6 5.2 10.9 4.3 6.3 3.9 4.1 0.0 0.1 0.0 0.0 5.9 0.0 0.4 2.4 2.0 1.2 3.1 0.3 2.0 13.2 6.0 0.5 2.3 15.1 0.8 1.3 3.6 0.0 4.5 0.0 3.1 0.8 0.7 0.6 0.5 0.4 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.0 3.8 0.0 0.0 13.9 0.0 0.0 0.0 3.0 0.0 0.9 0.1 0.2 0.0 6.3 0.4 5.0 0.4 7.6 4.9 0.4 0.4 7.7 7.5 0.5 3.8 0.4 20.6 14.7 2.7 0.6 0.8 0.9 2.7 0.6 0.7 0.6 0.0 6.0 0.0 HSD11B1L "SCDR10, SDR26C2" ENSG00000167733 "Hydroxysteroid 11-beta dehydrogenase 1 like" Q7Z5J1 19 5680604-5688523 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 34.4" "Cell line enhanced" "Detected in many" "SH-SY5Y: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049078 Supported Vesicles "Secreted in brain" Vesicles "HPA049078: " "unprognostic (2.34e-2)" "unprognostic (1.10e-1)" "unprognostic (4.73e-3)" "unprognostic (5.26e-2)" "unprognostic (9.37e-2)" "prognostic favourable (4.38e-4)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (1.18e-3)" "unprognostic (1.43e-1)" "unprognostic (3.33e-2)" "unprognostic (1.75e-1)" "unprognostic (5.77e-2)" "unprognostic (4.52e-1)" "unprognostic (1.73e-2)" 3.9 8.8 34.4 2.1 19.2 4.7 5.0 10.3 29.7 3.9 2.9 5.4 3.7 2.6 3.6 8.5 2.2 7.6 4.8 3.8 25.4 16.1 6.7 3.5 4.4 2.3 11.7 20.4 6.1 6.2 5.8 8.5 2.5 10.7 4.0 1.9 3.2 9.1 6.9 15.0 6.9 2.9 2.7 6.0 2.6 3.3 4.3 7.5 0.0 6.6 1.3 1.8 2.5 2.2 2.5 4.8 2.5 5.8 1.4 4.5 1.7 3.0 2.9 10.7 2.0 5.1 5.5 2.2 2.3 4.6 1.1 4.7 1.3 3.0 0.7 5.1 2.0 1.5 1.3 1.7 1.0 2.5 3.3 2.0 2.6 1.9 3.5 0.8 7.3 5.4 3.7 1.7 1.5 1.7 1.9 2.9 4.3 0.4 1.8 2.1 2.9 3.4 3.4 0.4 2.6 8.9 0.7 2.9 17.8 0.5 1.5 11.4 2.5 0.7 2.9 2.7 4.8 4.5 1.8 7.2 2.3 0.8 7.4 1.1 2.1 1.7 2.5 0.2 1.2 5.8 1.6 1.2 3.2 3.6 2.3 2.5 4.5 3.9 2.5 1.4 2.9 4.8 0.9 1.7 34.4 19.2 10.3 29.7 25.4 16.1 11.7 20.4 10.7 7.5 HSD11B2 SDR9C3 ENSG00000176387 "Hydroxysteroid 11-beta dehydrogenase 2" P80365 16 67430652-67437553 "Disease related genes, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 62.8;kidney: 119.9;salivary gland: 66.0" "Cell line enhanced" "Detected in some" "NTERA-2: 9.7;RPMI-8226: 11.5;RT4: 11.6;SCLC-21H: 12.8;SK-BR-3: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB032443, HPA042186, HPA056385" Enhanced Approved Vesicles Vesicles "CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110" "unprognostic (2.87e-3)" "unprognostic (5.24e-2)" "unprognostic (7.10e-2)" "unprognostic (6.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.14e-1)" "unprognostic (2.68e-2)" "unprognostic (2.07e-1)" "unprognostic (2.21e-3)" "unprognostic (2.25e-3)" "unprognostic (3.27e-2)" "unprognostic (2.34e-1)" "prognostic favourable (9.51e-5)" "unprognostic (7.20e-2)" "unprognostic (3.19e-1)" "unprognostic (1.55e-2)" "unprognostic (1.84e-1)" 0.4 1.0 0.6 22.2 2.3 0.0 3.2 2.0 1.7 4.8 42.8 0.3 1.3 9.4 3.8 3.6 2.5 2.4 8.3 0.5 0.5 0.1 119.9 1.2 2.3 0.7 0.3 0.8 4.8 2.1 0.0 0.4 42.3 1.1 3.7 24.5 0.4 66.0 1.4 0.4 13.8 62.8 4.3 0.3 1.5 2.1 1.4 1.3 0.5 3.8 3.3 1.6 1.5 4.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.9 0.4 1.2 0.1 1.5 3.1 0.0 0.0 0.1 0.1 5.1 1.1 0.0 2.3 0.1 6.5 4.3 0.4 0.0 0.0 1.5 0.0 0.5 5.4 0.5 0.6 0.0 1.5 2.6 0.2 0.1 0.0 0.3 0.0 0.0 3.1 0.1 0.1 9.7 0.8 0.0 0.1 11.5 0.4 11.6 12.8 0.8 0.7 11.5 0.5 5.5 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 2.3 2.0 1.7 0.5 0.1 0.3 0.8 1.1 1.3 HSD17B13 "SCDR9, SDR16C3" ENSG00000170509 "Hydroxysteroid 17-beta dehydrogenase 13" Q7Z5P4 4 87303789-87322906 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 158.8" "Cell line enhanced" "Detected in some" "NB-4: 4.8" "Cancer enriched" "Detected in some" 26 "liver cancer: 52.9" "Region enriched" "Detected in single" 6 "cerebellum: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA029125 Uncertain Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" Vesicles "Golgi apparatus" "HPA029125: AB_10601580" "unprognostic (2.49e-1)" "unprognostic (7.46e-2)" "unprognostic (7.02e-2)" "unprognostic (1.86e-4)" "unprognostic (4.74e-2)" "unprognostic (8.44e-2)" "prognostic favourable (2.94e-4)" "prognostic favourable (7.80e-4)" "unprognostic (4.97e-1)" "unprognostic (2.22e-2)" "unprognostic (1.00e-1)" "unprognostic (2.46e-1)" "unprognostic (7.18e-4)" "unprognostic (3.62e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-3)" 8.0 0.1 0.1 0.2 0.1 0.3 1.8 1.0 0.1 1.3 0.3 0.1 0.1 0.1 1.2 0.2 0.1 0.1 0.1 0.9 0.1 0.0 0.1 158.8 0.8 0.1 0.1 0.1 0.1 2.4 0.0 0.1 0.3 0.1 2.4 0.1 0.1 0.2 0.1 0.1 1.4 0.1 1.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.4 0.1 0.3 2.7 1.8 0.6 3.7 0.7 0.8 0.8 0.1 0.2 0.3 0.8 0.9 1.1 0.8 0.6 0.1 0.3 0.0 0.1 0.0 1.8 0.6 0.6 0.3 0.4 0.2 0.2 0.2 0.5 0.3 0.9 1.1 1.7 0.8 2.6 1.0 0.4 0.0 0.0 0.1 0.3 0.8 0.9 0.3 0.3 0.4 4.8 0.4 0.5 0.8 1.0 0.3 0.3 0.5 0.5 2.0 0.6 0.4 0.2 0.2 1.6 1.0 0.5 2.7 0.7 0.4 0.5 0.3 0.5 0.2 2.0 1.0 3.7 0.7 1.5 0.4 0.2 0.4 1.8 0.4 0.4 0.1 1.1 0.8 0.7 2.8 0.8 0.3 0.6 0.4 0.1 0.1 0.1 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 HSD17B3 SDR12C2 ENSG00000130948 "Hydroxysteroid 17-beta dehydrogenase 3" P37058 9 96235306-96302152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 41.9" "Group enriched" "Detected in some" 5 "HBEC3-KT: 4.9;HEL: 4.3;U-2 OS: 8.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056833 Enhanced Supported Vesicles Vesicles "HPA056833: " "unprognostic (2.78e-1)" "unprognostic (6.61e-3)" "unprognostic (1.03e-1)" "unprognostic (5.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (3.08e-2)" "unprognostic (6.15e-2)" "unprognostic (1.74e-1)" "unprognostic (5.13e-2)" "unprognostic (3.26e-4)" "unprognostic (3.45e-1)" "unprognostic (5.48e-8)" "unprognostic (8.47e-3)" "unprognostic (1.15e-1)" "unprognostic (7.24e-2)" "unprognostic (3.11e-2)" 0.5 0.4 1.0 0.5 1.0 0.4 0.5 0.5 0.9 0.8 0.5 0.5 0.5 0.4 0.5 0.5 0.5 1.3 0.5 0.5 1.7 0.5 1.0 6.3 0.5 0.5 1.6 0.5 0.5 1.3 0.4 0.5 0.5 0.5 0.8 0.4 0.5 0.5 0.5 0.5 0.5 1.1 0.5 1.9 0.5 0.4 41.9 0.5 0.5 4.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.0 1.0 0.5 0.9 1.7 0.5 1.6 0.5 0.5 0.5 HSD17B6 "HSE, RODH, SDR9C6" ENSG00000025423 "Hydroxysteroid 17-beta dehydrogenase 6" O14756 12 56752161-56787790 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 241.2" "Cell line enhanced" "Detected in many" "Karpas-707: 11.7;U-266/84: 14.6" "Cancer enriched" "Detected in many" 5 "liver cancer: 170.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059141 Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA059141: " "unprognostic (7.70e-2)" "unprognostic (8.76e-2)" "unprognostic (5.08e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-2)" "prognostic favourable (6.32e-4)" "unprognostic (1.06e-2)" "unprognostic (3.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (2.50e-10)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-1)" 1.1 0.5 3.6 1.4 5.2 0.2 0.3 1.2 2.4 9.4 3.3 0.5 2.6 0.6 4.1 0.7 1.6 0.9 2.6 0.4 1.6 1.4 0.5 241.2 8.7 0.3 2.0 2.6 1.1 0.3 0.2 0.0 0.9 0.6 7.9 1.3 1.4 0.2 10.2 0.2 0.2 0.7 11.3 1.0 6.2 0.8 3.2 0.8 0.0 13.3 0.0 0.3 9.9 2.3 2.0 2.0 0.1 1.3 0.1 3.4 0.8 0.3 0.7 1.6 0.3 1.7 1.2 2.0 3.6 3.1 1.7 1.7 0.4 0.4 10.2 1.5 0.4 0.3 5.3 0.9 1.0 6.5 2.0 3.2 1.0 0.5 1.1 1.6 5.3 0.9 0.3 1.0 0.5 0.0 0.9 11.7 0.8 2.1 4.6 1.0 6.6 0.6 6.3 0.7 2.5 0.2 1.2 9.7 2.0 1.7 3.1 0.8 0.5 1.3 0.3 0.8 0.8 3.6 0.9 10.3 14.6 6.7 1.2 5.8 0.6 0.0 0.2 0.1 3.0 0.6 3.4 2.0 2.5 2.4 0.6 1.1 3.3 2.2 0.0 0.1 1.3 2.0 2.8 0.8 3.6 5.2 1.2 2.4 1.6 1.4 2.0 2.6 0.6 0.8 HSDL1 SDR12C3 ENSG00000103160 "Hydroxysteroid dehydrogenase like 1" Q3SXM5 16 84122146-84145192 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045745 Approved "Vesicles,Intermediate filaments,Mitochondria" Mitochondria "Vesicles, Intermediate filaments" "HPA045745: " "unprognostic (2.16e-1)" "unprognostic (4.32e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-3)" "unprognostic (3.66e-2)" "unprognostic (1.68e-1)" "prognostic unfavourable (3.50e-4)" "unprognostic (1.25e-2)" "unprognostic (7.43e-2)" "unprognostic (3.39e-2)" "unprognostic (6.42e-2)" "unprognostic (3.66e-1)" "prognostic favourable (4.20e-7)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.14e-2)" 6.0 13.4 16.9 5.6 22.1 3.1 10.2 16.5 18.7 9.7 5.8 9.0 6.7 5.1 11.3 9.4 6.7 11.1 6.0 13.1 14.5 19.5 9.1 4.1 7.6 6.8 11.5 13.2 19.6 4.3 12.6 16.7 7.6 20.8 8.6 6.1 10.5 6.3 10.0 15.2 6.5 4.9 9.4 7.4 7.0 5.3 13.5 8.7 8.6 23.2 5.0 7.5 6.6 6.2 7.4 3.1 14.5 6.6 4.2 6.5 4.4 5.6 6.5 30.2 10.3 11.0 7.9 7.6 7.3 6.8 9.1 4.8 7.3 9.7 11.6 13.0 6.4 3.9 16.3 6.3 14.5 2.4 10.0 5.6 4.3 16.5 11.5 8.6 10.1 6.1 10.6 12.7 8.3 10.8 11.5 14.6 17.9 13.9 18.7 8.6 15.3 6.8 18.4 10.6 4.3 8.7 6.2 14.2 10.8 18.0 2.9 19.7 18.0 5.1 9.2 10.3 12.4 7.4 5.7 23.3 18.4 18.9 12.0 6.3 9.3 14.5 5.2 11.7 4.4 3.8 5.6 5.4 4.7 5.2 3.1 7.4 6.1 6.5 6.2 4.2 6.6 0.0 5.6 4.4 16.9 22.1 16.5 18.7 14.5 19.5 11.5 13.2 20.8 8.7 HSPA1A "HSP70-1, HSPA1" ENSG00000204389 "Heat shock protein family A (Hsp70) member 1A" P0DMV8 6 31815464-31817946 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "breast: 216.1;vagina: 741.6" "Cell line enriched" "Detected in some" 10 "HEK 293: 302.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5" "CAB017451, CAB032815, HPA052504" Supported Approved Nucleoplasm,Vesicles,Cytosol 77000000 "Nucleoplasm, Vesicles" Cytosol "CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: " "unprognostic (2.44e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (1.54e-5)" "unprognostic (6.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (6.17e-3)" "unprognostic (2.47e-2)" "unprognostic (1.74e-2)" "unprognostic (8.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" "unprognostic (6.48e-2)" "unprognostic (4.12e-2)" "unprognostic (1.51e-1)" 29.1 74.5 35.3 18.4 48.0 3.5 216.1 40.4 36.0 8.8 22.6 27.4 41.1 3.6 33.1 32.3 36.7 14.5 14.6 40.3 37.5 28.8 35.3 49.5 54.7 14.1 89.2 10.8 15.1 31.2 3.5 23.8 22.1 67.4 47.8 11.4 6.1 28.3 52.7 66.7 57.9 17.3 36.4 47.0 35.6 19.3 10.9 85.9 1.3 26.8 16.3 11.8 41.3 741.6 1.0 0.5 8.8 4.7 1.2 4.5 0.5 0.0 30.5 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 1.7 0.0 0.0 2.3 0.0 0.2 302.8 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.4 4.5 1.8 4.7 1.0 1.0 2.5 2.3 0.5 0.4 1.2 1.1 8.8 1.2 2.5 0.5 4.5 0.5 35.3 48.0 40.4 36.0 37.5 28.8 89.2 10.8 67.4 85.9 HSPA1B HSP70-2 ENSG00000204388 "Heat shock protein family A (Hsp70) member 1B" P0DMV9 6 31827735-31830255 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 508.1" "Group enriched" "Detected in some" 4 "A549: 23.9;Karpas-707: 71.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "CAB008640, HPA052504" Approved Approved Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "CAB008640: AB_1617331, HPA052504: " "unprognostic (1.20e-1)" "unprognostic (1.74e-1)" "unprognostic (4.23e-3)" "unprognostic (3.23e-2)" "unprognostic (3.54e-1)" "unprognostic (1.15e-1)" "unprognostic (2.76e-3)" "unprognostic (9.50e-2)" "unprognostic (3.45e-1)" "unprognostic (4.42e-2)" "unprognostic (6.92e-2)" "unprognostic (4.88e-2)" "unprognostic (5.74e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-3)" "unprognostic (4.69e-2)" "unprognostic (5.99e-2)" 21.9 89.9 25.0 20.3 31.1 5.7 129.4 30.8 23.6 8.4 14.6 17.0 36.6 6.2 19.9 40.5 24.4 13.2 12.6 29.2 25.5 22.5 18.6 28.7 30.8 6.3 61.9 8.5 29.3 36.7 35.1 21.6 6.4 53.8 31.1 8.4 5.6 39.7 48.5 102.8 11.3 11.0 27.9 33.4 10.0 20.5 11.8 55.1 0.9 32.1 14.3 9.7 43.4 508.1 1.1 0.6 1.4 1.3 0.4 0.4 0.3 0.2 23.9 0.1 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.2 0.2 7.5 1.3 1.0 0.0 0.0 0.0 0.5 7.4 0.0 0.2 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 71.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.8 0.0 0.1 0.0 0.1 0.0 1.8 0.4 0.0 0.0 0.1 5.0 0.0 0.1 11.6 0.1 0.1 0.0 0.0 0.0 0.5 1.3 1.4 0.1 0.2 0.1 0.2 0.4 0.0 0.6 1.1 0.0 0.0 0.8 0.4 0.7 0.5 0.3 0.3 25.0 31.1 30.8 23.6 25.5 22.5 61.9 8.5 53.8 55.1 HSPA1L "HSP70-HOM, hum70t" ENSG00000204390 "Heat shock protein family A (Hsp70) member 1 like" P34931 6 31809619-31815065 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "testis: 29.1;vagina: 17.0" "Cell line enhanced" "Detected in some" "ASC diff: 1.9;EFO-21: 2.1;HEK 293: 6.7;U-266/70: 2.8;U-266/84: 2.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 4 "T-cells: 1.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA043285, HPA052504" Enhanced Approved Nucleoplasm,Vesicles 49000000 Vesicles Nucleoplasm "HPA043285: AB_10962482, HPA052504: " "unprognostic (1.80e-1)" "unprognostic (8.70e-2)" "unprognostic (2.52e-3)" "unprognostic (6.97e-4)" "unprognostic (2.69e-2)" "unprognostic (1.17e-2)" "unprognostic (4.24e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "prognostic favourable (1.02e-4)" "unprognostic (5.26e-3)" "unprognostic (9.96e-2)" "prognostic favourable (4.63e-4)" "unprognostic (4.48e-2)" "unprognostic (4.30e-1)" "unprognostic (1.02e-1)" "unprognostic (1.53e-3)" 0.4 0.5 1.8 0.5 2.2 0.5 1.2 1.4 3.1 0.5 0.7 1.5 0.0 0.3 0.8 3.0 0.8 1.5 0.3 0.5 2.0 1.1 0.9 0.7 1.7 0.7 4.5 0.8 1.1 1.5 0.3 0.7 1.0 2.6 1.2 0.6 0.2 0.4 1.5 3.9 0.6 0.8 0.5 4.6 1.1 0.8 29.1 3.2 0.0 2.0 0.0 0.7 0.5 17.0 0.3 0.0 0.4 0.1 0.0 1.7 1.1 0.0 1.7 0.0 0.0 1.9 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.9 0.0 0.0 6.7 0.0 0.0 0.2 0.2 1.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 2.8 2.4 0.0 1.7 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 1.0 1.3 0.0 0.3 1.5 1.6 0.3 0.0 0.0 0.0 1.7 1.1 1.8 2.2 1.4 3.1 2.0 1.1 4.5 0.8 2.6 3.2 HSPA2 ENSG00000126803 "Heat shock protein family A (Hsp70) member 2" P54652 14 64535905-64546173 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0;skeletal muscle: 90.5" "Cell line enhanced" "Detected in many" "A549: 24.6;BEWO: 38.4;BJ hTERT+: 32.8;SCLC-21H: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000798, HPA052504" Enhanced Supported Approved Nucleoplasm,Vesicles 77000000 Vesicles Nucleoplasm "HPA000798: AB_1079090, HPA052504: " "prognostic favourable (1.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (1.08e-2)" "unprognostic (3.78e-2)" "unprognostic (2.90e-2)" "unprognostic (7.11e-2)" "prognostic unfavourable (9.11e-4)" "unprognostic (1.31e-1)" "unprognostic (3.14e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" 5.2 3.3 21.1 5.2 45.3 1.5 5.2 3.7 37.6 3.3 23.3 87.0 0.1 4.4 13.8 12.8 25.2 7.2 4.2 22.8 33.2 18.7 26.6 2.6 4.5 3.2 71.0 20.6 2.4 3.8 7.5 4.3 37.6 37.7 3.8 6.9 3.5 10.2 4.0 90.5 14.8 7.8 17.9 83.8 8.5 5.7 58.8 65.2 0.0 2.3 8.2 3.9 12.4 4.0 0.7 0.3 2.4 0.6 0.9 3.7 0.5 9.6 24.6 3.8 0.0 2.7 0.2 38.4 13.9 32.8 5.6 9.2 0.9 17.4 2.4 5.6 15.1 11.0 0.0 0.7 3.4 1.3 1.9 0.0 1.4 0.0 2.7 0.0 3.3 1.2 0.5 0.8 0.0 0.3 0.0 2.0 2.7 4.3 0.1 0.1 2.8 3.0 1.9 0.0 0.0 8.6 1.5 34.1 1.9 0.6 1.2 0.0 0.9 1.0 0.5 0.1 0.0 1.2 0.0 2.5 0.0 0.0 3.1 0.0 3.7 0.9 0.2 0.1 1.8 0.4 0.1 0.7 1.7 0.8 0.0 0.5 0.6 0.6 2.4 0.9 0.6 0.3 3.7 0.5 21.1 45.3 3.7 28.3 33.2 18.7 71.0 20.6 37.7 65.2 HSPA6 HSP70B' ENSG00000173110 "Heat shock protein family A (Hsp70) member 6" P17066 1 161524540-161526910 "Plasma proteins, Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;vagina: 99.8" "Cell line enriched" "Detected in some" 7 "Karpas-707: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 67.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 67.6" "CAB017452, HPA028549, HPA052504" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: " "unprognostic (3.90e-2)" "unprognostic (2.05e-1)" "unprognostic (5.87e-2)" "unprognostic (2.59e-1)" "unprognostic (2.40e-1)" "unprognostic (6.36e-3)" "prognostic unfavourable (7.26e-4)" "unprognostic (4.61e-2)" "unprognostic (1.29e-1)" "unprognostic (1.93e-1)" "unprognostic (1.68e-1)" "unprognostic (2.25e-1)" "prognostic unfavourable (1.98e-5)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" 6.8 11.9 9.4 10.3 12.4 3.5 43.0 3.5 6.0 1.4 1.9 2.2 1.7 1.9 2.2 1.3 3.2 1.1 9.6 4.5 4.5 9.3 3.1 14.6 13.5 2.1 13.7 1.3 9.3 5.4 0.9 5.4 20.8 5.7 3.3 1.9 1.7 2.9 5.8 1.4 4.4 1.7 4.2 13.2 11.2 3.6 1.4 5.0 1.3 5.8 1.8 2.8 3.1 99.8 0.0 2.5 67.6 9.0 1.6 1.4 2.1 0.5 0.9 0.0 0.2 0.0 0.8 0.7 0.4 0.3 0.1 0.3 0.3 0.5 0.1 1.5 0.1 0.2 0.3 0.2 0.2 0.3 0.0 0.2 0.9 0.0 0.0 0.1 2.2 0.1 0.7 0.3 0.0 0.0 0.4 33.3 0.0 0.0 0.1 0.8 0.0 3.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.5 1.9 0.2 0.4 0.1 0.1 0.3 0.2 2.2 4.5 0.2 0.0 0.8 0.8 1.5 0.8 7.5 2.7 1.4 9.0 0.2 0.0 0.1 0.7 2.5 0.0 0.0 0.3 67.6 1.6 7.3 0.0 0.0 2.1 9.4 12.4 3.5 6.0 4.5 9.3 13.7 1.3 5.7 5.0 HSPA8 "HSC70, HSC71, HSP73, HSPA10" ENSG00000109971 "Heat shock protein family A (Hsp70) member 8" P11142 11 123057489-123063230 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation" "Chaperone, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002056, HPA052504" Uncertain Approved Nucleoplasm,Vesicles 210000000 Nucleoplasm Vesicles "CAB002056: , HPA052504: " "unprognostic (2.28e-3)" "unprognostic (1.19e-3)" "prognostic favourable (6.14e-6)" "unprognostic (1.75e-1)" "unprognostic (1.84e-2)" "unprognostic (5.70e-2)" "prognostic unfavourable (1.93e-4)" "unprognostic (9.65e-3)" "unprognostic (3.82e-1)" "unprognostic (9.64e-2)" "unprognostic (2.93e-1)" "unprognostic (3.22e-1)" "prognostic favourable (3.81e-4)" "unprognostic (2.53e-1)" "unprognostic (1.83e-1)" "unprognostic (2.74e-1)" "unprognostic (7.16e-2)" 70.0 96.8 93.7 78.1 102.8 58.1 73.8 119.5 125.1 52.8 64.1 72.0 77.3 77.7 59.9 98.3 83.4 76.2 76.7 106.4 83.1 102.4 128.6 114.2 68.9 93.3 105.7 72.4 66.7 191.1 97.2 98.3 71.6 169.2 65.3 81.0 53.1 62.4 69.9 224.6 31.2 74.4 75.4 91.8 79.7 92.7 58.3 98.1 92.9 90.9 98.3 124.4 76.1 123.2 77.4 47.5 41.1 84.2 76.1 124.3 200.0 82.8 125.6 83.4 72.0 77.2 82.8 110.5 164.7 91.3 201.5 121.3 188.4 109.0 134.9 104.0 91.6 112.9 238.2 59.7 201.2 116.6 36.2 146.4 59.0 91.8 21.1 142.2 112.5 44.1 96.6 61.9 19.3 107.8 158.4 70.2 161.4 73.8 147.8 105.6 131.9 111.9 133.4 59.5 76.3 104.4 60.6 85.6 64.9 120.0 130.3 45.4 113.6 55.7 105.9 101.2 81.3 87.0 145.9 47.4 116.9 115.8 112.8 203.3 122.1 30.3 41.5 41.1 96.5 82.9 115.9 77.4 113.4 105.2 47.5 53.7 109.6 105.1 14.9 76.1 84.2 34.4 124.3 200.0 93.7 102.8 119.5 125.1 83.1 102.4 105.7 72.4 169.2 98.1 HSPBP1 "FES1, HspBP1" ENSG00000133265 "HSPA (Hsp70) binding protein 1" Q9NZL4 19 55262231-55280381 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005865, HPA070398, HPA071444" Supported Approved Vesicles,Centrosome,Cytosol Cytosol "Vesicles, Centrosome" "CAB005865: AB_304116, HPA070398: , HPA071444: " "unprognostic (3.07e-2)" "unprognostic (6.36e-2)" "unprognostic (5.41e-2)" "unprognostic (8.05e-2)" "unprognostic (9.24e-2)" "unprognostic (1.43e-1)" "unprognostic (3.71e-3)" "unprognostic (1.12e-2)" "unprognostic (5.72e-2)" "unprognostic (1.52e-1)" "unprognostic (6.20e-3)" "unprognostic (7.23e-2)" "unprognostic (4.28e-3)" "unprognostic (2.44e-2)" "unprognostic (2.62e-1)" "unprognostic (9.45e-2)" "unprognostic (2.14e-2)" 14.1 13.9 24.5 15.8 42.9 16.4 13.8 13.3 32.5 11.3 17.3 9.1 13.0 18.8 14.8 12.4 14.5 30.3 13.3 19.1 25.3 20.1 15.4 18.0 18.2 17.6 16.2 20.0 17.4 21.1 13.0 10.2 9.8 15.2 12.0 8.3 7.6 19.3 13.6 35.4 15.4 17.2 16.8 15.0 11.6 15.3 21.1 9.3 11.7 12.0 24.4 8.9 10.5 10.5 24.0 23.0 3.0 19.0 18.4 20.5 11.5 22.0 39.7 7.0 10.3 4.2 3.5 21.6 11.6 4.7 11.6 9.9 22.4 15.4 14.6 11.3 6.2 15.4 8.3 11.2 3.1 12.4 68.3 19.5 12.6 20.6 9.1 18.2 10.3 4.9 10.1 11.6 5.5 5.8 15.5 8.3 4.0 20.9 16.4 16.9 25.2 33.4 16.0 11.1 31.5 7.8 14.5 19.4 29.0 14.3 14.8 11.1 11.3 14.2 8.0 14.0 15.2 7.9 21.1 13.3 30.6 15.2 15.6 15.8 14.8 0.8 11.5 3.0 18.0 19.0 18.7 21.0 19.8 20.5 23.0 24.0 19.9 19.3 0.8 18.4 16.0 13.1 17.8 11.5 24.5 42.9 13.3 32.5 25.3 20.1 16.2 20.0 15.2 9.3 HTRA3 "Prsp, Tasp" ENSG00000170801 "HtrA serine peptidase 3" P83110 4 8269765-8307111 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 57.9" "Cell line enriched" "Detected in some" 5 "U-2197: 62.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 9 "basal ganglia: 8.2" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA021187, HPA063810" Approved Approved Vesicles "Secreted in female reproductive system" Vesicles "HPA021187: AB_1851311, HPA063810: " "unprognostic (5.87e-2)" "unprognostic (1.40e-2)" "unprognostic (2.89e-2)" "unprognostic (9.32e-2)" "unprognostic (1.84e-1)" "unprognostic (3.09e-2)" "unprognostic (1.12e-3)" "unprognostic (5.29e-2)" "unprognostic (3.81e-2)" "unprognostic (1.15e-1)" "unprognostic (1.95e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (1.61e-9)" "unprognostic (1.65e-3)" "unprognostic (2.56e-2)" "prognostic unfavourable (1.29e-4)" "unprognostic (1.34e-2)" 23.7 1.8 0.6 7.3 8.2 5.3 35.6 0.7 0.9 12.3 9.4 0.8 5.4 3.7 19.6 26.6 14.4 7.9 19.8 57.9 0.7 0.3 1.7 1.6 15.4 4.3 0.8 0.9 30.7 2.8 0.0 5.1 9.6 0.9 15.4 2.0 8.6 6.6 3.0 12.9 9.0 6.7 50.1 0.8 1.8 6.8 7.2 0.6 1.3 9.3 11.6 3.0 28.7 12.7 0.0 0.4 1.3 0.3 0.0 0.0 0.1 0.0 0.3 0.4 0.0 2.0 3.8 0.1 0.8 0.0 0.9 0.2 0.0 0.0 0.0 4.7 2.1 0.0 0.4 0.0 0.3 0.0 0.7 0.4 4.9 0.0 2.1 0.0 0.2 0.4 0.0 1.4 0.0 3.3 0.1 0.0 3.5 0.0 0.0 12.0 2.1 0.1 0.1 0.0 0.0 0.0 0.0 5.5 0.1 8.9 0.1 0.0 0.0 0.3 2.7 0.5 1.6 62.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.6 8.2 0.7 0.9 0.7 0.3 0.8 0.9 0.9 0.6 HYKK "AGPHD1, LOC123688" ENSG00000188266 "Hydroxylysine kinase" A2RU49 15 78507564-78537372 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 17.5;U-266/84: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 7.1" "Lineage enriched" "Detected in single" 8 "T-cells: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040706 Approved Approved Vesicles,Aggresome Vesicles Aggresome "HPA040706: AB_10795528" "unprognostic (9.26e-2)" "unprognostic (1.98e-4)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (2.72e-2)" "unprognostic (1.14e-1)" "unprognostic (8.00e-3)" "unprognostic (2.73e-1)" "unprognostic (5.16e-2)" "unprognostic (6.24e-3)" "unprognostic (6.37e-2)" "unprognostic (3.44e-3)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (3.11e-3)" "unprognostic (3.90e-2)" 6.3 7.5 6.4 4.8 8.0 1.7 7.7 2.3 6.1 8.2 14.3 2.5 6.8 11.1 6.4 11.0 7.0 6.5 7.5 8.5 4.3 3.5 19.4 10.5 3.6 4.3 3.5 3.6 9.7 15.5 4.0 8.8 1.5 4.3 8.0 6.2 10.1 7.9 10.1 8.9 3.9 21.2 9.4 3.4 1.6 6.8 7.8 2.2 5.7 7.3 3.7 4.1 7.1 5.1 0.4 0.6 0.8 0.2 0.5 7.1 1.2 3.1 5.1 0.5 9.0 2.0 4.4 1.9 1.0 2.1 3.0 3.5 1.7 3.7 2.5 1.1 2.0 3.6 8.2 2.7 2.8 1.1 17.5 1.1 2.2 4.2 5.1 0.3 1.4 4.0 5.1 1.1 2.3 2.1 3.0 6.5 1.7 3.8 2.9 0.5 0.5 6.5 1.7 9.9 2.0 5.6 3.5 0.9 1.2 2.2 6.7 7.9 7.6 0.2 0.9 1.9 1.4 3.6 3.3 10.2 17.8 0.1 2.2 0.1 2.7 0.8 0.2 0.5 0.3 0.1 0.4 0.4 2.4 0.4 0.1 0.4 7.1 1.3 0.8 0.5 0.1 0.6 1.0 1.2 6.4 8.0 2.3 6.1 4.3 3.5 3.5 3.6 4.3 2.2 ICA1 "ICA69, ICAp69" ENSG00000003147 "Islet cell autoantigen 1" Q05084 7 8113184-8262687 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 58.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.2;MCF7: 15.2;RT4: 17.8;SCLC-21H: 24.9;SH-SY5Y: 41.0;SK-BR-3: 19.5;T-47d: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "T-reg: 20.8" "Lineage enriched" "Detected in many" 8 "T-cells: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017646, HPA061452" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA017646: AB_1851382, HPA061452: " "unprognostic (1.39e-1)" "unprognostic (1.37e-1)" "unprognostic (3.74e-1)" "unprognostic (6.83e-3)" "unprognostic (9.49e-2)" "unprognostic (8.57e-3)" "unprognostic (1.37e-2)" "unprognostic (3.54e-1)" "unprognostic (7.61e-2)" "unprognostic (3.42e-1)" "unprognostic (5.84e-2)" "unprognostic (2.62e-1)" "prognostic favourable (4.23e-8)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (4.08e-2)" 8.9 6.1 12.6 4.2 15.3 11.7 13.0 19.4 24.2 10.7 13.2 2.5 8.7 7.7 5.5 8.5 5.8 8.1 10.4 25.7 7.7 7.8 9.1 5.3 9.2 6.9 4.8 12.4 1.6 58.6 13.2 13.5 4.6 10.5 13.7 14.3 2.5 21.2 8.3 2.8 7.0 10.4 3.7 2.8 7.6 17.9 16.0 3.2 0.8 8.1 4.1 5.5 9.6 4.1 0.3 1.7 2.4 1.6 0.7 20.8 1.1 0.0 0.3 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.3 16.2 0.1 1.6 0.0 0.0 0.3 0.7 0.0 0.0 2.4 3.4 0.3 0.0 0.1 2.8 0.5 0.0 1.1 0.0 0.0 11.8 9.5 0.0 0.0 15.2 0.1 0.0 3.7 0.1 0.0 0.0 7.0 6.9 17.8 24.9 41.0 0.0 19.5 0.2 15.8 5.1 6.9 0.0 0.3 0.0 0.3 5.1 2.4 0.0 0.0 2.2 3.4 0.5 1.6 0.1 0.2 0.5 0.4 0.2 3.9 0.3 1.7 0.3 0.2 0.1 2.4 0.7 0.2 0.4 20.8 1.1 12.6 15.3 19.4 24.2 7.7 7.8 4.8 12.4 10.5 3.2 IDO1 "IDO, INDO" ENSG00000131203 "Indoleamine 2,3-dioxygenase 1" P14902 8 39902275-39928444 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.7;placenta: 33.2" "Cell line enriched" "Detected in some" 7 "EFO-21: 35.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 17 "eosinophil: 77.7" "Lineage enriched" "Detected in many" 17 "granulocytes: 77.7" "Region enriched" "Detected in single" 13 "basal ganglia: 30.5" "Low region specificity" "Detected in all" "HPA023072, HPA023149, HPA027772, CAB072820" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol Cytosol "Nucleoplasm, Vesicles, Mitochondria" "CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222" "unprognostic (1.68e-2)" "unprognostic (1.71e-2)" "unprognostic (4.08e-3)" "unprognostic (7.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.09e-2)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "prognostic favourable (5.27e-4)" "prognostic favourable (3.32e-4)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "prognostic unfavourable (1.12e-7)" "unprognostic (4.18e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.97e-2)" 8.7 0.2 0.9 11.2 0.9 0.0 1.4 0.9 0.9 4.0 1.5 0.9 0.9 2.6 2.6 0.9 1.2 0.6 1.3 1.0 0.9 0.0 0.9 0.9 16.8 14.1 0.9 0.9 0.9 0.9 0.0 0.9 33.2 0.9 1.6 2.1 1.9 0.9 0.9 2.5 0.3 5.9 0.9 2.0 6.2 2.2 0.9 0.9 0.9 7.2 0.9 8.9 2.3 0.9 0.0 4.6 77.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.4 2.5 0.1 0.3 0.0 35.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 0.0 0.1 0.0 0.1 0.0 4.5 0.1 77.7 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.9 0.9 0.9 0.9 0.9 0.0 0.9 0.9 0.9 0.9 IDUA MPS1 ENSG00000127415 "Iduronidase, alpha-L-" P35475 4 986997-1004506 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025901, HPA046979, HPA054254" Enhanced Supported Vesicles "Intracellular and membrane" 130000 Vesicles "CAB025901: , HPA046979: , HPA054254: " "unprognostic (3.62e-2)" "unprognostic (9.08e-2)" "prognostic unfavourable (3.13e-4)" "unprognostic (7.23e-2)" "unprognostic (1.45e-1)" "unprognostic (2.31e-2)" "unprognostic (1.83e-1)" "unprognostic (1.67e-1)" "unprognostic (1.43e-2)" "unprognostic (1.89e-3)" "unprognostic (2.64e-2)" "unprognostic (4.61e-3)" "prognostic unfavourable (7.87e-5)" "unprognostic (2.24e-1)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "prognostic favourable (8.04e-5)" 11.0 15.0 14.7 12.0 15.3 10.8 12.9 36.5 15.7 12.4 9.2 10.9 16.9 17.1 13.0 13.4 7.7 12.1 15.9 8.9 13.4 6.5 13.4 10.7 12.8 11.2 11.6 10.0 14.6 22.6 13.0 15.2 4.0 12.8 14.5 6.0 14.1 20.2 15.8 6.2 16.8 11.8 7.3 9.0 15.3 21.3 4.7 12.6 7.6 14.0 3.4 10.0 10.4 11.2 0.8 4.1 0.0 3.8 3.1 4.5 1.1 3.0 5.7 0.0 2.4 13.2 4.7 8.7 8.3 7.3 2.8 1.7 2.0 9.8 1.3 9.3 5.6 1.9 0.3 1.1 0.6 8.3 0.4 4.9 5.9 0.7 5.5 4.0 13.2 9.0 4.1 2.3 0.0 2.0 2.4 0.1 2.7 3.3 2.7 4.2 1.9 5.4 7.5 0.0 1.4 4.6 6.1 0.1 3.8 0.9 0.0 4.7 6.7 3.4 8.6 15.4 1.7 8.6 2.2 32.0 3.6 1.6 7.5 5.4 3.7 0.0 3.5 0.0 3.3 2.7 4.5 0.6 2.7 2.6 4.1 0.8 3.4 2.0 0.0 3.1 3.8 2.5 1.3 1.1 14.7 15.3 36.5 15.7 13.4 6.5 11.6 10.0 12.8 12.6 IFI30 "GILT, IFI-30, IP-30, IP30, MGC32056" ENSG00000216490 "IFI30, lysosomal thiol reductase" P13284 19 18173162-18178117 "Predicted intracellular proteins, Predicted membrane proteins" Immunity Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 348.5" "Cell line enhanced" "Detected in many" "Daudi: 75.3;RPMI-8226: 81.6;SK-BR-3: 55.1;U-266/84: 90.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 348.5" "Group enriched" "Detected in all" 8 "dendritic cells: 145.5;granulocytes: 95.4;monocytes: 348.5" "Low region specificity" "Detected in many" HPA026650 Enhanced Supported Vesicles,Cytosol "Intracellular and membrane" 89000 "Vesicles, Cytosol" "HPA026650: AB_10602237" "unprognostic (4.66e-2)" "unprognostic (1.25e-4)" "unprognostic (2.35e-3)" "unprognostic (7.40e-2)" "unprognostic (1.76e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-3)" "unprognostic (2.40e-1)" "unprognostic (4.01e-2)" "unprognostic (9.19e-3)" "unprognostic (3.04e-1)" "unprognostic (1.19e-1)" "unprognostic (7.29e-11)" "unprognostic (3.50e-1)" "unprognostic (1.62e-2)" "unprognostic (3.39e-2)" "unprognostic (9.59e-3)" 104.2 31.0 5.8 85.5 10.8 28.3 13.9 1.2 5.2 5.3 17.4 6.5 3.2 23.3 5.0 13.7 9.3 15.9 13.1 16.2 5.0 4.0 37.5 60.4 109.7 139.5 12.0 0.8 15.0 14.6 2.0 7.6 123.2 11.0 8.6 18.2 9.2 18.7 4.3 7.2 10.1 28.5 18.9 13.3 140.6 19.4 5.7 7.9 20.6 15.6 9.6 41.2 24.5 8.2 24.3 145.5 95.4 348.5 1.7 1.0 213.4 12.7 6.7 0.0 4.4 1.3 1.8 12.1 1.4 1.8 3.9 10.1 15.2 22.8 75.3 11.6 4.3 10.0 8.0 2.9 0.4 20.0 5.7 0.8 12.5 21.5 12.8 2.2 5.8 7.8 6.8 6.4 2.2 0.2 10.6 47.3 1.9 24.9 1.0 0.2 2.5 6.7 7.3 0.5 81.6 11.6 0.4 0.6 0.8 23.4 55.1 1.3 3.7 0.9 0.3 6.7 4.0 13.8 1.4 1.6 90.3 42.9 18.7 14.9 1.0 2.0 228.9 95.4 1.0 348.5 1.0 24.3 0.7 0.8 145.5 16.8 0.5 0.6 52.5 1.7 230.0 4.3 1.0 213.4 5.8 10.8 1.2 5.2 5.0 4.0 12.0 0.8 11.0 7.9 IFIT2 "cig42, G10P2, GARG-39, IFI-54, IFI54, ISG-54K" ENSG00000119922 "Interferon induced protein with tetratricopeptide repeats 2" P09913 10 89283694-89309276 "Predicted intracellular proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 93.4" "Group enriched" "Detected in many" 4 "BJ hTERT+ SV40 Large T+: 49.6;BJ hTERT+ SV40 Large T+ RasG12V: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 93.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 93.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003408 Approved Approved Vesicles Vesicles "HPA003408: AB_1079100" "unprognostic (1.77e-1)" "unprognostic (2.10e-1)" "unprognostic (2.42e-2)" "unprognostic (2.25e-3)" "unprognostic (1.75e-2)" "unprognostic (9.28e-2)" "unprognostic (6.71e-3)" "unprognostic (2.22e-1)" "unprognostic (5.40e-1)" "unprognostic (1.36e-1)" "unprognostic (7.03e-3)" "unprognostic (1.27e-1)" "prognostic unfavourable (6.99e-4)" "unprognostic (2.92e-2)" "unprognostic (1.03e-2)" "unprognostic (5.33e-3)" "unprognostic (6.46e-2)" 15.5 7.7 10.2 8.9 11.9 31.9 5.5 8.1 10.5 4.5 3.7 15.6 2.1 4.7 3.5 7.4 2.3 6.7 9.7 4.8 10.4 9.2 10.5 14.9 14.4 6.5 23.7 6.7 6.9 2.4 4.5 3.3 11.3 20.4 3.9 3.1 5.2 5.8 4.7 1.8 2.5 4.1 4.6 29.4 18.0 2.6 1.3 17.9 3.9 4.2 0.4 3.7 7.3 3.5 4.0 2.9 93.4 17.0 1.7 2.2 3.4 9.8 0.3 0.1 4.6 4.7 5.2 1.4 3.7 10.4 49.6 39.4 0.0 7.2 1.1 2.1 2.6 10.4 0.2 0.5 5.3 4.1 0.0 1.8 5.3 0.0 8.1 0.2 0.8 2.9 0.2 3.7 0.5 0.2 0.0 0.2 0.7 0.0 1.2 2.3 0.1 2.0 0.7 1.2 0.2 1.6 2.0 0.0 0.0 1.1 0.2 8.9 0.2 0.5 0.3 0.5 0.1 1.4 0.3 0.3 1.7 0.1 0.8 0.8 1.0 17.9 7.0 21.8 2.2 15.1 1.2 4.0 1.7 1.5 2.3 3.5 1.8 1.6 93.4 1.7 17.0 2.9 0.9 3.4 10.2 11.9 8.1 10.5 10.4 9.2 23.7 6.7 20.4 17.9 IFT172 "BBS20, NPHP17, osm-1, SLB, wim" ENSG00000138002 "Intraflagellar transport 172" Q9UG01 2 27444371-27489789 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Ciliopathy, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044893 Uncertain Approved Vesicles Vesicles "HPA044893: AB_10795009" "unprognostic (1.05e-3)" "unprognostic (6.52e-2)" "unprognostic (7.04e-2)" "unprognostic (3.57e-3)" "unprognostic (1.95e-1)" "unprognostic (1.29e-2)" "prognostic unfavourable (6.05e-6)" "unprognostic (6.86e-3)" "unprognostic (1.45e-1)" "unprognostic (8.49e-2)" "unprognostic (1.08e-1)" "unprognostic (1.51e-2)" "unprognostic (4.32e-2)" "unprognostic (9.52e-2)" "unprognostic (5.49e-2)" "unprognostic (1.19e-1)" "unprognostic (5.47e-2)" 5.3 6.4 10.7 4.6 14.2 4.8 7.6 14.1 14.7 9.1 7.0 14.4 9.5 3.7 11.1 8.9 4.9 26.5 6.4 7.5 10.4 8.2 8.4 3.2 8.6 4.3 10.6 11.2 16.1 8.1 30.4 24.5 4.8 13.5 6.8 4.8 11.9 7.9 8.7 5.7 6.7 4.6 8.0 9.6 7.6 5.9 21.3 11.2 3.0 10.8 3.5 4.3 6.6 6.0 3.8 3.7 2.7 2.5 4.9 3.0 1.7 5.5 5.0 7.5 10.7 12.6 11.2 4.9 5.8 4.1 6.5 5.7 5.1 4.9 5.6 8.1 7.4 6.6 12.9 6.2 6.4 3.3 9.4 15.3 9.9 5.5 7.3 8.0 4.2 8.7 3.5 10.2 4.0 10.4 5.2 2.6 2.4 4.1 4.1 6.3 5.2 5.6 0.0 3.7 3.4 5.5 3.5 6.2 8.9 2.6 5.4 8.8 4.9 4.7 11.4 3.6 1.9 3.9 7.7 3.2 1.5 6.4 11.9 2.4 6.0 2.7 2.3 2.1 3.0 2.5 2.4 3.5 1.7 2.4 3.7 3.8 2.6 2.2 1.7 4.9 1.1 3.1 1.0 1.7 10.7 14.2 14.1 14.7 10.4 8.2 10.6 11.2 13.5 11.2 IGDCC3 "HsT18880, PUNC" ENSG00000174498 "Immunoglobulin superfamily DCC subclass member 3" Q8IVU1 15 65327127-65378040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;parathyroid gland: 16.6;placenta: 12.2" "Group enriched" "Detected in some" 5 "AF22: 42.5;CACO-2: 10.7;Hep G2: 33.7" "Cancer enhanced" "Detected in many" "testis cancer: 5.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015713 Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA015713: " "unprognostic (7.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.24e-2)" "unprognostic (7.25e-3)" "unprognostic (6.67e-2)" "unprognostic (7.35e-3)" "unprognostic (3.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-2)" "unprognostic (4.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.77e-5)" "unprognostic (4.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-2)" 0.2 0.6 3.5 0.4 2.1 0.2 1.7 10.8 4.6 1.0 0.5 3.3 0.0 0.3 1.6 0.4 0.2 1.4 0.4 0.4 3.2 2.6 0.6 0.2 0.3 0.2 2.5 1.7 1.7 0.3 16.6 2.9 12.2 2.6 0.5 0.3 0.6 0.2 0.5 0.5 0.4 0.3 0.6 2.2 0.3 0.4 4.7 2.7 3.7 1.7 0.0 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 2.1 10.8 4.6 3.2 2.6 2.5 1.7 2.6 2.7 IGF1R "CD221, IGFIR, IGFR, JTK13, MGC18216" ENSG00000140443 "Insulin like growth factor 1 receptor" P08069 15 98648971-98964530 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 7.7" "Group enriched" "Detected in many" 5 "granulocytes: 7.7;T-cells: 2.9" "Low region specificity" "Detected in all" "CAB010268, HPA045563" Approved Approved Vesicles 36000 Vesicles "CAB010268: AB_671792, HPA045563: " "unprognostic (1.30e-3)" "unprognostic (5.81e-3)" "unprognostic (1.53e-1)" "unprognostic (3.34e-2)" "unprognostic (2.65e-1)" "unprognostic (2.05e-2)" "unprognostic (1.29e-2)" "unprognostic (6.87e-2)" "unprognostic (2.64e-2)" "unprognostic (2.87e-2)" "unprognostic (8.56e-2)" "unprognostic (1.62e-1)" "prognostic favourable (3.75e-7)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" 8.4 12.7 11.5 5.9 13.5 16.3 18.5 23.0 15.7 15.3 13.4 10.4 22.7 4.2 15.3 16.3 9.2 18.9 7.7 11.6 11.7 7.3 17.0 2.0 11.0 4.9 8.0 11.8 23.2 22.5 4.7 13.8 17.5 9.5 21.7 7.2 16.7 12.5 23.2 9.1 13.0 7.5 18.1 8.0 7.3 10.7 12.0 11.5 10.7 16.1 7.0 5.6 12.8 21.6 1.0 0.4 7.7 0.6 1.0 2.9 0.7 3.3 16.5 11.6 0.2 5.8 4.2 7.7 3.7 7.4 1.2 1.1 7.1 8.8 0.8 10.7 7.2 15.8 5.1 15.0 1.0 0.0 5.2 12.5 18.5 14.2 5.1 6.6 1.3 6.6 7.1 2.1 10.2 4.1 0.6 2.9 5.7 23.4 2.5 4.4 10.8 0.9 4.0 9.0 3.0 3.5 20.3 3.9 17.3 26.7 1.5 14.4 8.1 3.1 11.3 1.1 15.0 3.0 5.8 1.0 4.4 2.7 2.2 4.9 2.8 4.0 0.6 1.8 0.9 0.6 0.6 0.4 0.8 0.3 0.4 1.0 2.9 1.0 7.7 1.0 0.5 0.3 0.0 0.7 11.5 13.5 23.0 15.7 11.7 7.3 8.0 11.8 9.5 11.5 IGF2 "C11orf43, FLJ44734, IGF-II" ENSG00000167244 "Insulin like growth factor 2" P01344 11 2129112-2149603 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism, Osteogenesis" "Growth factor, Hormone, Mitogen" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 330.5" "Cell line enhanced" "Detected in some" "CACO-2: 112.8;Hep G2: 77.4;LHCN-M2: 44.5;RH-30: 55.3;SH-SY5Y: 67.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007556, HPA007993" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" 609000000 1700000000 Vesicles "Nucleoplasm, Cytosol" "HPA007556: , HPA007993: AB_1851474" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" "unprognostic (7.08e-2)" "unprognostic (2.30e-3)" "unprognostic (2.59e-1)" "prognostic favourable (7.12e-4)" "unprognostic (7.92e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (3.69e-2)" "unprognostic (1.85e-1)" "unprognostic (1.79e-3)" "unprognostic (2.00e-2)" "unprognostic (8.98e-2)" "unprognostic (8.93e-3)" "unprognostic (5.78e-2)" 16.6 8.0 1.3 4.5 2.0 0.5 23.3 2.3 1.9 23.4 5.0 3.4 4.7 1.0 9.9 32.0 5.2 17.2 4.5 20.5 1.5 1.6 8.1 39.7 1.9 1.1 3.5 1.6 20.4 5.5 0.7 5.0 330.5 7.6 10.4 1.0 33.2 2.6 6.7 21.9 1.7 2.3 7.5 17.0 2.0 3.2 12.4 0.2 1.8 2.6 14.5 1.8 15.2 14.1 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 14.9 0.1 0.4 0.0 112.8 0.0 0.0 1.1 0.0 0.0 0.1 0.9 1.0 0.0 0.0 0.0 0.0 77.4 19.8 0.0 0.0 24.1 0.0 0.1 0.0 0.1 0.0 0.0 44.5 0.2 0.0 0.1 0.1 0.2 0.0 55.3 0.1 0.0 0.1 4.4 67.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 1.3 2.0 2.3 1.4 1.5 1.6 3.5 1.6 7.6 0.2 IGF2R "CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI" ENSG00000197081 "Insulin like growth factor 2 receptor" P11717 6 159969099-160113507 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 59.6;hTERT-HME1: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009661, HPA011332" Supported Enhanced "Golgi apparatus,Vesicles" 150000000 "Golgi apparatus, Vesicles" "CAB009661: AB_2122795, HPA011332: AB_1846276" "prognostic unfavourable (3.01e-4)" "prognostic unfavourable (2.92e-5)" "unprognostic (5.83e-2)" "unprognostic (1.72e-1)" "unprognostic (4.15e-1)" "unprognostic (3.25e-1)" "unprognostic (7.32e-3)" "unprognostic (2.32e-1)" "unprognostic (1.62e-1)" "unprognostic (1.07e-2)" "unprognostic (2.37e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (1.85e-1)" "prognostic unfavourable (6.08e-4)" 28.0 22.2 6.8 13.5 8.1 16.7 39.4 6.4 8.2 14.9 17.3 9.5 13.0 9.4 19.6 16.0 16.7 13.1 17.9 27.9 6.7 6.2 20.6 26.6 32.6 44.7 12.3 3.6 18.0 19.6 23.5 13.6 15.5 10.0 14.1 13.3 13.9 18.2 13.5 62.0 15.9 15.4 16.5 7.6 30.2 14.4 13.8 9.0 37.9 18.5 17.3 14.1 16.3 26.9 0.4 2.9 13.3 2.0 1.0 3.6 0.9 7.7 7.0 12.4 17.4 45.3 25.0 16.8 12.2 26.4 10.1 17.4 10.6 12.2 3.2 13.7 13.4 10.4 9.3 59.6 17.0 16.8 6.6 1.4 12.2 19.1 26.8 7.4 12.1 19.9 19.1 21.0 60.7 6.5 13.9 17.4 15.9 5.7 3.4 7.4 5.5 7.5 8.0 8.5 16.3 14.3 7.8 4.1 9.1 16.5 14.8 16.5 6.2 21.0 9.8 9.8 10.3 21.1 22.3 10.3 14.4 3.3 18.9 10.2 15.1 0.1 2.0 1.1 3.6 0.8 1.4 0.3 1.2 1.7 0.3 0.4 1.0 2.4 13.3 1.0 1.4 2.9 0.7 0.9 6.8 8.1 6.4 8.2 6.7 6.2 12.3 3.6 10.0 9.0 IGFBP3 "BP-53, IBP3" ENSG00000146674 "Insulin like growth factor binding protein 3" P17936 7 45912245-45921874 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 320.7" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 412.2;U-2197: 171.0;U-87 MG: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 28.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB010360 Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" 3247666667 5600000000 Vesicles "Nucleoplasm, Cytosol" "CAB010360: AB_2233528" "unprognostic (4.46e-3)" "unprognostic (4.84e-2)" "prognostic unfavourable (1.08e-4)" "unprognostic (2.30e-1)" "unprognostic (1.15e-1)" "unprognostic (6.54e-2)" "prognostic unfavourable (1.64e-4)" "unprognostic (8.14e-3)" "unprognostic (3.31e-2)" "unprognostic (2.03e-1)" "unprognostic (9.67e-3)" "unprognostic (2.80e-1)" "prognostic unfavourable (5.07e-7)" "unprognostic (2.36e-2)" "unprognostic (4.14e-2)" "unprognostic (2.37e-3)" "unprognostic (2.63e-1)" 47.4 1.6 4.4 10.6 2.7 0.0 52.1 2.7 4.1 44.3 21.3 1.7 3.2 6.9 58.4 8.1 11.7 14.9 5.4 41.6 4.4 2.6 11.1 80.4 11.7 12.7 3.7 1.9 49.2 2.2 0.6 19.2 320.7 4.1 22.5 6.1 9.1 6.4 9.3 13.9 23.9 10.2 22.9 3.8 18.7 8.3 12.1 3.1 2.2 5.6 8.6 8.3 32.0 26.3 0.0 28.9 0.0 0.0 0.0 6.0 1.7 9.3 2.8 5.5 0.0 4.2 1.7 0.0 41.2 7.5 3.5 1.9 0.0 7.6 0.0 13.1 412.2 22.6 0.0 0.1 1.4 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.0 14.4 0.6 0.7 2.6 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.5 0.0 0.0 3.8 2.6 20.4 0.6 1.6 14.2 0.5 0.7 0.0 0.0 0.0 40.7 0.0 171.0 2.3 0.5 0.0 0.0 88.5 0.0 13.7 0.0 0.0 0.0 5.2 0.0 4.3 0.0 6.0 5.6 0.0 0.0 2.8 4.7 0.0 0.0 0.0 28.9 0.3 1.7 4.4 2.7 2.7 4.1 4.4 2.6 3.7 1.9 4.1 3.1 IGFBP5 ENSG00000115461 "Insulin like growth factor binding protein 5" P24593 2 216672105-216695525 "Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 245.3" "Cell line enhanced" "Detected in many" "BJ: 77.9;BJ hTERT+: 207.2;T-47d: 50.4;U-138 MG: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059827, HPA070407" Supported Approved "Nuclear bodies,Golgi apparatus,Vesicles" "Secreted to blood" 109650000 330000000 "Golgi apparatus, Vesicles" "Nuclear bodies" "HPA059827: , HPA070407: " "unprognostic (7.69e-2)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" "prognostic unfavourable (1.78e-4)" "unprognostic (4.58e-2)" "unprognostic (3.47e-1)" "unprognostic (2.04e-1)" "unprognostic (1.76e-1)" "unprognostic (1.32e-1)" "unprognostic (9.58e-2)" "unprognostic (1.12e-1)" "unprognostic (2.41e-2)" "unprognostic (4.04e-2)" "unprognostic (9.62e-3)" "unprognostic (1.55e-1)" "unprognostic (3.28e-2)" "unprognostic (1.91e-3)" 47.3 23.4 6.2 19.2 6.3 0.1 41.3 3.6 6.5 191.7 23.1 19.7 15.8 3.9 94.6 91.0 30.0 96.9 21.4 16.9 8.2 2.4 34.8 7.8 9.3 14.5 12.1 7.4 245.3 3.5 6.5 37.7 32.7 7.0 31.4 7.9 188.5 12.0 15.1 47.0 13.5 14.2 71.8 7.4 7.6 36.9 51.7 12.0 1.5 130.1 34.5 17.6 28.8 45.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 20.1 0.0 23.2 0.7 0.0 77.9 207.2 10.4 1.0 0.0 0.0 0.0 0.3 0.2 0.0 2.4 0.0 0.5 0.0 0.7 20.0 0.4 0.0 10.1 0.0 0.1 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.1 0.2 0.3 0.0 0.0 0.1 6.7 23.1 1.3 0.8 1.3 9.6 0.0 50.4 0.0 7.5 68.7 4.2 10.4 3.7 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 6.2 6.3 3.6 6.5 8.2 2.4 12.1 7.4 7.0 12.0 IGFBPL1 bA113O24.1 ENSG00000137142 "Insulin like growth factor binding protein like 1" Q8WX77 9 38408994-38424447 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2" "Group enriched" "Detected in some" 6 "AF22: 68.0;NTERA-2: 18.7;RH-30: 19.5;SCLC-21H: 70.0;SH-SY5Y: 67.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basal ganglia: 12.5;olfactory region: 16.2" "Low region specificity" "Detected in many" HPA051354 Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" "Nucleoplasm, Vesicles" "HPA051354: " "unprognostic (5.63e-2)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.30e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.94e-1)" "unprognostic (3.92e-2)" "unprognostic (1.59e-2)" "unprognostic (6.67e-2)" 1.6 2.6 3.8 1.1 11.0 0.3 0.4 4.7 4.7 0.7 1.0 1.0 0.0 1.9 2.1 0.5 0.7 1.0 1.9 3.7 3.3 2.3 0.7 0.6 1.2 0.4 1.4 1.5 0.5 1.6 0.4 7.4 1.1 1.8 1.6 0.7 0.2 0.5 2.9 0.3 0.3 1.2 2.1 0.6 0.4 2.5 3.3 1.5 2.6 27.2 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 68.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.1 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 18.7 0.1 0.0 19.5 0.1 0.0 0.0 70.0 67.9 1.1 0.0 0.0 0.3 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 11.0 4.7 4.7 3.3 2.3 1.4 1.5 1.8 1.5 IGIP "C5orf53, LOC492311" ENSG00000182700 "IgA inducing protein" A6NJ69 5 140125935-140129392 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 14.4;ASC TERT1: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041877, HPA048615" Uncertain Approved Vesicles "Secreted to blood" Vesicles "HPA041877: , HPA048615: " "unprognostic (1.15e-1)" "unprognostic (1.12e-1)" "unprognostic (5.85e-2)" "unprognostic (2.00e-2)" "unprognostic (2.46e-1)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (1.10e-1)" "unprognostic (2.38e-1)" "unprognostic (5.05e-2)" "prognostic favourable (3.94e-4)" "unprognostic (1.94e-1)" "prognostic favourable (6.25e-6)" "unprognostic (2.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.98e-2)" "unprognostic (7.77e-2)" 5.1 7.6 13.9 2.0 13.1 0.0 5.3 16.0 13.7 7.3 3.8 3.4 1.6 2.8 3.8 8.0 2.5 3.5 3.8 4.6 13.4 13.7 7.6 6.2 3.8 3.1 17.8 3.3 5.3 3.6 16.2 6.1 3.7 9.8 5.8 3.1 3.7 4.3 7.3 7.7 7.5 3.7 8.2 14.4 3.8 3.4 1.9 9.4 2.0 7.1 2.8 3.0 3.7 3.4 0.6 0.1 1.0 0.5 0.5 2.2 0.1 2.0 0.6 1.0 2.9 14.4 13.9 1.3 5.1 5.1 1.2 1.5 2.0 1.6 3.8 5.5 6.9 2.1 1.1 3.1 2.3 3.3 1.9 0.8 2.8 1.5 3.4 1.0 1.4 4.7 7.9 2.3 4.3 1.5 0.6 1.5 4.4 1.7 1.1 2.5 0.2 1.6 1.2 2.4 1.7 6.8 1.8 1.0 1.5 2.8 1.8 2.9 1.4 3.0 8.9 3.6 0.3 1.2 2.8 3.7 2.4 1.3 3.8 2.6 2.6 0.0 0.2 1.0 0.7 0.1 1.9 0.6 1.0 0.8 0.1 0.5 2.2 1.8 0.0 0.5 0.5 0.1 1.1 0.1 13.9 13.1 16.0 12.9 13.4 13.7 17.8 3.3 9.8 9.4 IGSF8 "CD316, CD81P3, EWI2, PGRL" ENSG00000162729 "Immunoglobulin superfamily member 8" Q969P0 1 160091340-160098943 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.2" "Cell line enhanced" "Detected in all" "SK-MEL-30: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011917, HPA075970" Approved Supported Vesicles 190000 Vesicles "HPA011917: AB_1851536, HPA075970: " "unprognostic (4.08e-1)" "prognostic unfavourable (7.32e-4)" "unprognostic (1.30e-2)" "unprognostic (9.31e-2)" "unprognostic (1.46e-1)" "unprognostic (1.20e-1)" "unprognostic (1.71e-1)" "unprognostic (1.01e-3)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.31e-1)" "unprognostic (2.60e-2)" "unprognostic (2.35e-1)" "unprognostic (3.74e-3)" "unprognostic (1.75e-3)" 9.9 10.4 25.2 9.0 30.3 2.4 11.1 40.9 54.2 9.6 11.8 53.5 6.4 18.2 8.6 16.6 7.0 13.9 8.5 11.6 32.4 24.1 10.4 19.3 10.1 10.3 32.2 29.9 15.1 19.1 9.0 8.7 7.8 25.9 13.8 7.4 11.2 21.0 14.0 6.0 34.0 14.4 5.1 42.6 10.6 9.8 11.5 25.3 6.2 10.0 5.9 6.2 6.0 6.9 14.3 5.6 1.2 4.0 4.7 15.6 6.4 8.8 5.3 6.9 17.6 4.1 2.6 14.6 4.3 5.7 9.3 8.7 6.0 6.1 13.0 16.3 6.3 17.0 2.8 6.4 1.3 15.5 5.0 1.6 5.9 10.3 6.8 4.4 14.5 3.1 13.0 6.0 1.9 1.9 2.2 7.5 2.1 8.4 11.0 10.3 14.6 8.5 6.3 3.5 9.4 8.5 9.2 2.9 12.6 5.0 16.2 58.0 11.5 5.7 1.9 4.1 8.9 7.4 3.5 20.6 22.8 5.8 14.5 1.7 10.7 0.0 2.9 1.2 13.3 4.0 11.7 12.2 11.0 15.4 3.3 14.3 14.8 15.6 0.8 4.7 2.4 5.6 14.9 6.4 25.2 30.3 40.9 54.2 32.4 24.1 32.2 29.9 25.9 25.3 IL13RA1 "CD213a1, IL-13Ra, NR4" ENSG00000131724 "Interleukin 13 receptor subunit alpha 1" P78552 X 118727572-118794539 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 6.9;eosinophil: 7.1;myeloid DC: 10.9;neutrophil: 19.0" "Group enriched" "Detected in many" 6 "dendritic cells: 10.9;granulocytes: 19.0;monocytes: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001587 Approved Nucleoplasm,Vesicles "Intracellular and membrane" 4500000 Vesicles Nucleoplasm "HPA001587: AB_1079133" "unprognostic (5.14e-3)" "unprognostic (4.72e-2)" "unprognostic (7.12e-2)" "unprognostic (7.75e-2)" "unprognostic (8.81e-3)" "unprognostic (3.82e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.44e-1)" "unprognostic (1.90e-1)" "unprognostic (8.21e-2)" "prognostic unfavourable (1.19e-8)" "unprognostic (1.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.82e-2)" "unprognostic (5.08e-2)" 31.5 17.5 9.3 15.3 13.3 2.1 19.8 3.6 10.2 16.6 23.8 12.6 7.2 18.9 16.6 18.0 33.0 15.4 17.7 17.5 11.4 9.4 22.7 73.3 27.7 33.9 15.2 6.0 25.2 12.9 9.5 16.1 15.2 13.4 15.3 25.2 14.5 21.8 13.0 22.3 10.2 37.7 16.3 24.5 17.4 18.5 9.9 11.9 4.8 24.0 20.1 20.0 16.5 15.4 1.9 10.9 19.0 6.9 0.0 0.1 1.7 8.2 10.2 4.9 13.4 11.1 33.1 8.8 17.3 24.1 8.3 10.8 5.9 15.3 0.0 30.5 23.8 7.9 5.3 7.3 9.2 45.1 4.1 1.4 9.3 15.1 6.8 0.1 3.6 30.1 6.7 11.3 13.9 17.2 4.4 0.9 11.7 12.1 0.0 2.2 4.4 9.9 0.0 12.0 0.0 12.4 9.0 1.8 1.7 27.2 10.0 6.8 6.4 7.8 21.9 16.2 7.7 27.2 13.5 0.2 4.1 0.0 35.7 4.2 6.8 0.0 6.9 7.1 0.0 1.7 0.0 1.9 0.0 0.0 10.9 1.8 0.0 0.0 19.0 0.0 0.6 1.9 0.1 1.7 9.3 13.3 3.6 10.2 11.4 9.4 15.2 6.0 13.4 11.9 IL13RA2 "CD213a2, CT19, IL-13R, IL13BP" ENSG00000123496 "Interleukin 13 receptor subunit alpha 2" Q14627 X 115003975-115019977 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 16.1;testis: 31.5" "Group enriched" "Detected in some" 9 "PC-3: 26.4;U-2197: 84.9;U-251 MG: 57.0;U-87 MG: 33.8" "Cancer enhanced" "Detected in many" "glioma: 17.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "olfactory region: 8.7" "Low region specificity" "Detected in many" "HPA045831, HPA067363" Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "Nucleoplasm, Vesicles" "HPA045831: , HPA067363: " "unprognostic (1.97e-1)" "unprognostic (2.83e-1)" "unprognostic (6.62e-4)" "unprognostic (7.39e-2)" "unprognostic (8.45e-2)" "unprognostic (1.80e-1)" "prognostic favourable (3.55e-4)" "unprognostic (3.54e-1)" "unprognostic (2.85e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-3)" "unprognostic (2.19e-2)" "unprognostic (1.53e-5)" "unprognostic (1.58e-1)" "unprognostic (1.63e-1)" "unprognostic (9.70e-3)" "unprognostic (1.20e-1)" 0.5 4.8 3.7 3.9 11.3 0.0 0.8 0.3 3.1 1.2 0.4 2.1 5.7 0.3 0.9 4.4 0.5 0.1 0.8 0.6 5.1 11.2 3.5 9.6 1.0 0.1 1.2 2.6 0.1 0.1 0.5 16.1 2.1 3.9 4.3 0.7 1.6 0.8 3.7 0.0 0.1 0.3 0.4 0.6 0.2 0.1 31.5 1.4 0.0 1.3 0.2 0.2 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.7 0.0 5.8 5.5 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.9 5.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.4 0.0 0.1 0.0 0.0 0.0 3.0 0.0 84.9 57.0 0.0 0.0 0.0 33.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 11.3 0.3 3.1 5.1 11.2 1.2 2.6 3.9 1.4 IL1R1 "CD121A, D2S1473, IL1R, IL1RA" ENSG00000115594 "Interleukin 1 receptor type 1" P14778 2 102064544-102179874 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 93.4;ASC TERT1: 41.7;HHSteC: 29.3;HSkMC: 115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001237, HPA005823, CAB007779, HPA029560" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Secreted to blood" 1000000 "Nucleoplasm, Vesicles" "Plasma membrane, Cytosol" "CAB007779: AB_562073, HPA001237: , HPA005823: , HPA029560: " "unprognostic (6.16e-3)" "unprognostic (3.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (7.10e-2)" "unprognostic (2.01e-1)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (3.16e-1)" "unprognostic (4.26e-2)" "unprognostic (7.77e-2)" "prognostic unfavourable (6.92e-6)" "unprognostic (2.48e-2)" "unprognostic (6.95e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" 48.6 25.2 2.6 18.2 5.2 4.0 92.4 2.4 3.9 47.8 21.0 2.5 34.3 5.2 15.2 30.2 18.2 17.1 25.8 27.0 4.2 2.5 23.7 74.8 40.5 28.0 5.6 1.1 25.1 17.1 16.9 7.3 66.2 10.9 26.0 8.4 8.6 12.7 36.4 15.5 13.5 13.0 15.1 10.0 19.2 15.6 13.4 2.8 3.5 33.6 9.0 9.6 32.0 36.4 0.1 0.1 4.0 0.5 0.8 1.8 0.2 0.2 1.8 0.0 1.5 93.4 41.7 0.6 3.9 17.7 2.8 4.2 0.8 0.4 0.0 2.9 7.8 0.7 0.0 0.3 2.3 7.7 0.0 0.1 0.4 4.3 29.3 0.0 0.0 115.0 0.3 3.1 0.7 1.2 0.4 0.1 4.0 0.7 0.0 0.1 0.1 0.1 0.0 0.2 0.0 2.6 1.9 0.0 0.0 1.7 1.1 0.0 1.6 0.1 0.0 8.0 0.5 13.4 0.3 0.0 0.0 0.0 3.1 0.0 0.5 0.6 0.5 0.1 0.0 0.0 0.7 0.1 1.1 0.0 0.1 0.1 0.0 0.1 4.0 0.8 0.0 0.1 1.8 0.2 2.6 5.2 2.4 3.9 4.2 2.5 5.6 1.1 10.9 2.8 IL1RAP "C3orf13, IL-1RAcP, IL1R3" ENSG00000196083 "Interleukin 1 receptor accessory protein" Q9NPH3 3 190514051-190659750 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.5;liver: 91.8;placenta: 35.9" "Cell line enhanced" "Detected in many" "SK-MEL-30: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "neutrophil: 36.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035293 Uncertain Approved Vesicles,Cytosol "Secreted to blood" 260000000 "Vesicles, Cytosol" "HPA035293: AB_10671511" "unprognostic (6.48e-2)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (8.84e-3)" "unprognostic (2.35e-2)" "unprognostic (6.60e-2)" "unprognostic (2.62e-1)" "unprognostic (1.28e-1)" "prognostic unfavourable (1.31e-4)" "unprognostic (1.72e-1)" "prognostic unfavourable (2.16e-7)" "unprognostic (4.02e-3)" "unprognostic (9.06e-2)" "unprognostic (5.72e-2)" "prognostic unfavourable (6.29e-4)" 3.4 1.7 3.7 5.2 4.5 7.8 2.8 0.8 6.0 2.9 1.8 3.4 0.7 1.1 2.6 1.7 9.1 3.2 5.7 3.3 7.4 2.9 1.9 91.8 6.3 12.6 3.5 2.5 2.2 2.0 1.0 1.4 35.9 5.5 2.1 1.4 1.6 4.7 2.0 1.2 5.8 1.5 3.1 6.3 7.1 2.3 1.0 2.9 2.3 2.2 3.8 3.4 3.3 4.4 0.9 1.4 36.5 2.2 0.1 1.3 0.5 3.8 1.0 1.6 0.2 2.8 2.3 3.0 1.7 3.5 4.0 3.9 1.6 8.6 0.6 17.9 4.7 10.0 0.8 16.7 5.6 0.7 1.0 0.8 1.7 4.1 6.0 5.7 2.8 3.1 6.9 5.8 18.5 1.7 0.1 0.0 1.8 1.8 0.4 2.6 2.5 1.8 2.7 2.5 1.3 1.5 4.1 0.3 0.0 7.8 4.4 71.2 2.8 4.1 2.3 3.1 3.2 9.5 7.8 1.4 0.0 0.1 5.2 5.1 18.2 3.5 1.5 8.5 0.7 1.7 1.3 0.9 0.8 0.9 1.4 0.9 0.8 0.5 36.5 0.1 2.2 0.2 0.8 0.5 3.7 4.5 0.8 6.0 7.4 2.9 3.5 2.5 5.5 2.9 IL20RB "DIRS1, FNDC6, IL-20R2, MGC34923" ENSG00000174564 "Interleukin 20 receptor subunit beta" Q6UXL0 3 136946230-137011085 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 64.5;skin 1: 61.2" "Cell line enriched" "Detected in some" 4 "hTCEpi: 104.1" "Group enriched" "Detected in many" 5 "cervical cancer: 54.5;head and neck cancer: 50.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "cerebellum: 0.6" "Not detected" "Not detected" HPA063914 Approved Vesicles,Cytosol Vesicles Cytosol "HPA063914: " "unprognostic (1.35e-2)" "unprognostic (1.05e-1)" "unprognostic (7.43e-4)" "unprognostic (2.48e-4)" "unprognostic (2.74e-1)" "unprognostic (3.31e-1)" "unprognostic (7.43e-4)" "unprognostic (4.08e-3)" "unprognostic (7.64e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (1.44e-4)" "unprognostic (3.57e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.55e-1)" "unprognostic (3.55e-2)" "unprognostic (1.33e-2)" "unprognostic (5.57e-2)" 1.6 0.0 0.0 0.1 0.0 0.1 4.6 0.0 0.1 13.2 0.2 0.0 0.0 0.0 1.3 0.3 64.5 0.1 0.1 0.3 0.0 0.0 0.1 2.1 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.2 2.8 0.0 1.6 0.3 0.4 4.1 0.2 0.4 61.2 0.1 0.1 0.3 0.0 0.1 0.9 0.0 0.5 0.2 22.6 17.1 0.9 19.2 0.1 0.4 0.0 0.3 0.0 0.6 0.0 4.8 0.0 0.0 0.0 2.9 12.6 0.4 0.1 0.3 0.0 0.1 0.4 0.5 0.0 2.7 1.7 15.7 0.0 25.8 0.1 0.0 0.0 0.0 3.2 0.0 17.4 0.0 0.0 2.1 104.1 0.8 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.5 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 IL27RA "CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1" ENSG00000104998 "Interleukin 27 receptor subunit alpha" Q6UWB1 19 14031748-14053216 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 25.2;lymphoid tissue: 32.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA073441 Approved Vesicles 4100000 Vesicles "HPA073441: " "prognostic favourable (1.74e-6)" "unprognostic (1.99e-1)" "unprognostic (1.55e-1)" "unprognostic (6.09e-2)" "unprognostic (2.03e-3)" "unprognostic (2.28e-1)" "unprognostic (2.05e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.40e-3)" "unprognostic (9.92e-2)" "unprognostic (3.35e-2)" "prognostic unfavourable (2.58e-10)" "unprognostic (5.45e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.87e-3)" 8.4 2.1 2.8 26.0 2.7 3.5 20.6 3.0 3.5 3.5 3.9 1.1 2.7 3.6 3.6 2.0 3.4 4.2 4.1 5.8 3.8 3.6 4.8 2.1 11.8 25.3 2.6 2.3 2.3 3.5 8.1 1.1 2.0 2.5 5.0 3.4 1.2 7.4 2.1 2.8 2.6 9.0 3.0 2.5 18.0 4.1 2.4 1.6 32.3 4.9 2.2 28.3 6.0 6.8 14.6 18.2 5.3 19.7 19.1 25.2 16.9 8.1 3.5 3.6 4.8 0.3 1.9 1.5 3.8 8.0 7.0 10.1 1.7 6.7 0.1 4.1 3.4 1.6 5.6 2.2 5.5 15.7 3.9 19.9 0.8 2.9 0.6 9.5 0.3 1.8 0.9 3.3 0.7 2.8 13.7 14.9 0.3 11.4 7.1 20.7 4.7 2.5 6.2 2.1 7.6 4.3 1.9 3.2 1.7 4.9 0.3 5.5 6.2 5.8 4.4 0.7 8.8 7.1 4.1 15.5 7.4 7.2 0.6 19.4 4.6 5.3 19.7 0.5 22.9 16.3 20.2 14.6 22.7 18.9 18.2 12.8 25.2 19.4 1.5 19.1 7.5 6.8 19.9 16.9 2.8 2.7 3.0 3.5 3.8 3.6 2.6 2.3 2.5 1.6 IL2RG "CD132, CIDX, IMD4, SCIDX1" ENSG00000147168 "Interleukin 2 receptor subunit gamma" P31785 X 71107404-71112108 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 115.3;lymphoid tissue: 169.3" "Cell line enriched" "Detected in some" 6 "Karpas-707: 220.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA046641, HPA049691" Enhanced Approved Vesicles Vesicles "HPA046641: AB_2679733, HPA049691: " "unprognostic (2.97e-3)" "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "prognostic favourable (1.73e-4)" "unprognostic (8.25e-2)" "unprognostic (1.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" "unprognostic (1.91e-3)" "unprognostic (1.23e-2)" "unprognostic (4.36e-1)" "unprognostic (1.45e-1)" "prognostic unfavourable (2.28e-7)" "unprognostic (1.73e-1)" "unprognostic (4.69e-2)" "unprognostic (4.89e-2)" "unprognostic (9.54e-2)" 5.8 1.3 1.4 39.5 1.4 12.8 3.6 0.8 0.9 2.9 16.6 0.9 0.9 8.2 3.0 2.1 5.3 3.1 5.3 2.6 1.4 1.5 3.7 4.7 13.6 70.4 1.8 0.6 2.9 1.5 0.0 1.2 5.3 1.5 3.2 20.8 2.9 10.4 1.8 1.6 2.7 28.6 1.5 2.9 58.7 6.0 2.0 0.9 169.3 3.3 4.2 61.4 7.6 3.1 51.9 30.6 65.6 19.7 94.6 115.3 99.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 17.2 1.2 0.0 0.1 0.0 0.0 0.0 14.4 0.0 2.2 0.0 0.0 0.0 8.9 0.4 0.0 0.0 0.0 0.0 0.0 3.8 220.5 0.0 0.0 31.9 17.4 0.0 0.0 7.3 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 12.6 22.2 11.1 0.2 37.0 0.0 35.2 8.5 13.4 107.2 19.7 105.6 51.9 97.7 110.4 20.3 51.6 68.0 84.9 65.6 94.6 13.5 30.6 115.3 99.0 1.4 1.4 0.8 0.9 1.4 1.5 1.8 0.6 1.5 0.9 IL31RA "CRL, CRL3, GLM-R, Glmr, IL-31RA" ENSG00000164509 "Interleukin 31 receptor A" Q8NI17 5 55851379-55922853 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;tongue: 6.4" "Cell line enhanced" "Detected in some" "HBEC3-KT: 8.9;HHSteC: 7.7;hTERT-HME1: 10.8;U-2 OS: 16.0;U-87 MG: 18.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 6 "amygdala: 10.3" "Group enriched" "Detected in some" 5 "classical monocyte: 2.2;myeloid DC: 1.2" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;monocytes: 2.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.5;hippocampal formation: 1.1" "HPA051532, HPA068114" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA051532: , HPA068114: " "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.13e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-3)" "unprognostic (7.34e-2)" "unprognostic (3.54e-1)" "unprognostic (5.38e-2)" "unprognostic (2.95e-3)" "unprognostic (7.75e-5)" "unprognostic (5.55e-2)" "unprognostic (2.65e-6)" "unprognostic (7.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.02e-1)" "unprognostic (1.76e-2)" 0.3 0.1 10.3 1.0 0.1 5.3 0.2 0.1 0.4 0.2 1.5 0.0 0.0 0.4 1.2 1.8 1.7 0.1 0.2 0.4 1.6 0.2 0.3 0.3 0.5 0.1 0.1 0.0 0.5 0.7 0.0 0.7 0.7 0.0 1.0 0.4 0.4 1.3 0.2 2.6 2.5 0.8 1.8 0.1 0.3 0.5 5.9 0.0 1.4 0.5 6.4 0.5 0.5 2.2 0.0 1.2 0.2 2.2 0.0 0.1 0.4 0.1 1.1 0.0 0.0 0.0 0.4 0.5 0.1 0.5 0.2 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 8.9 1.8 0.0 0.1 0.0 0.0 0.0 7.7 0.0 0.0 6.0 3.0 4.3 10.8 3.3 0.0 0.4 1.4 0.0 0.0 1.4 0.0 6.0 0.0 1.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.5 0.5 16.0 0.0 1.0 0.0 0.0 0.0 18.5 0.0 2.5 0.1 2.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 10.3 0.1 0.1 0.4 1.6 0.2 0.1 0.0 0.0 0.0 IL37 "FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7" ENSG00000125571 "Interleukin 37" Q9NZH6 2 112912971-112918882 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 55.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.8;PC-3: 10.4;RT4: 5.5" "Cancer enriched" "Detected in some" 6 "lung cancer: 6.5" "Cell type enriched" "Detected in single" 28 "NK-cell: 2.8" "Lineage enriched" "Detected in single" 28 "NK-cells: 2.8" "HPA054371, HPA057950" Uncertain Supported Nucleoplasm,Vesicles "Secreted to blood" 76703 "Nucleoplasm, Vesicles" "HPA054371: , HPA057950: " "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" "unprognostic (3.71e-5)" "unprognostic (1.11e-1)" "unprognostic (2.58e-2)" "unprognostic (1.09e-2)" "unprognostic (1.28e-2)" "unprognostic (9.54e-2)" "unprognostic (8.26e-3)" "unprognostic (3.95e-2)" "unprognostic (1.66e-1)" "unprognostic (8.92e-2)" "unprognostic (1.35e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 55.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.9 0.0 0.8 0.1 0.0 0.0 0.2 0.4 4.8 0.3 0.5 0.4 0.5 0.0 0.5 0.3 0.1 0.2 0.8 1.5 0.3 0.0 1.8 0.2 0.8 0.0 0.0 0.3 0.0 0.0 0.5 1.2 0.0 0.0 0.1 1.1 0.0 0.0 1.4 0.5 10.4 0.1 0.0 0.0 0.0 5.5 0.4 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 IL6 "BSF2, HGF, HSF, IFNB2, IL-6" ENSG00000136244 "Interleukin 6" P05231 7 22725884-22732002 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cytokine, Growth factor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 60.1;lymphoid tissue: 48.0" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 221.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 10.0;cerebral cortex: 4.4;hippocampal formation: 3.9;pons and medulla: 12.8" "Group enriched" "Detected in some" 70 "memory B-cell: 6.1;naive B-cell: 7.7" "Lineage enriched" "Detected in single" 77 "B-cells: 7.7" "Not detected" "Not detected" "CAB023406, CAB072821" Supported Approved Vesicles "Secreted to blood" 6103 Vesicles "CAB023406: AB_617317, CAB072821: " "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (1.47e-1)" "unprognostic (1.35e-1)" "unprognostic (3.59e-2)" "unprognostic (9.88e-3)" "unprognostic (1.35e-1)" "unprognostic (3.07e-3)" "unprognostic (3.25e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-2)" "unprognostic (8.57e-2)" "prognostic unfavourable (1.10e-11)" "unprognostic (2.45e-3)" "unprognostic (2.10e-1)" "unprognostic (4.31e-2)" "unprognostic (7.80e-2)" 60.1 5.6 1.4 48.0 10.0 15.3 11.5 0.7 4.4 2.9 8.1 1.2 0.4 0.7 2.1 4.6 14.3 7.8 16.1 21.6 3.9 1.5 1.3 5.2 34.9 3.0 1.8 0.2 5.3 8.3 5.7 14.2 4.5 12.8 6.5 7.5 3.3 3.1 0.8 6.9 2.8 4.5 8.2 7.0 3.5 6.5 3.2 1.2 0.1 4.5 12.7 3.5 34.9 8.4 7.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.8 221.9 4.2 14.2 0.0 0.0 0.0 7.3 1.4 0.1 0.0 0.0 5.6 8.7 0.0 0.0 0.3 0.0 4.7 0.0 0.0 0.5 0.0 42.4 6.1 1.5 0.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 1.3 1.4 0.1 2.6 0.4 0.0 2.5 0.0 10.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 10.0 0.7 4.4 3.9 1.5 1.8 0.2 12.8 1.2 ILVBL "209L8, AHAS, FLJ39061, HACL1L, ILV2H, MGC1269, MGC19535" ENSG00000105135 "IlvB acetolactate synthase like" A1L0T0 19 15114984-15125785 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067682 Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA067682: " "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (3.72e-2)" "prognostic unfavourable (1.52e-4)" "unprognostic (8.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.04e-2)" "unprognostic (2.53e-1)" "unprognostic (3.83e-1)" "unprognostic (5.60e-2)" "unprognostic (1.77e-2)" "unprognostic (2.61e-1)" "prognostic favourable (1.91e-8)" "unprognostic (4.65e-2)" "unprognostic (1.68e-1)" "unprognostic (1.40e-1)" "unprognostic (2.40e-1)" 13.7 22.1 10.4 8.3 13.6 7.7 12.1 12.4 18.9 11.5 34.9 21.3 16.7 29.1 13.4 11.1 18.9 13.8 24.8 32.9 10.5 9.7 24.9 34.8 10.0 13.2 18.5 9.2 15.9 24.7 21.1 16.5 35.9 14.0 11.1 11.0 29.4 16.1 14.9 10.0 19.4 26.8 10.9 14.3 8.3 18.2 14.7 17.7 10.0 28.6 16.7 12.2 14.8 14.5 9.8 17.5 10.8 20.7 15.3 16.9 15.1 21.8 13.3 11.4 13.4 14.9 10.2 13.2 10.3 13.9 12.4 16.0 21.1 53.1 9.5 20.4 11.1 16.6 6.9 12.5 3.6 8.7 13.5 13.9 13.6 23.0 23.9 11.7 12.3 15.2 14.6 7.2 9.5 11.5 5.6 12.4 9.6 50.7 7.8 9.4 10.5 19.4 11.4 10.3 14.8 10.8 10.9 9.5 12.8 6.1 26.8 20.2 12.3 10.1 12.2 18.8 10.4 23.6 14.4 8.7 8.9 4.7 12.0 11.5 14.1 10.8 14.8 3.5 15.1 20.7 16.9 8.6 12.6 15.4 17.5 9.8 16.7 16.9 1.6 15.3 18.7 12.7 12.9 15.1 10.4 13.6 12.4 18.9 10.5 9.7 18.5 9.2 14.0 17.7 INHA ENSG00000123999 "Inhibin alpha subunit" P05111 2 219569162-219575713 "Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 24.2;ovary: 31.5;placenta: 39.3;testis: 77.6" "Cell line enhanced" "Detected in some" "BEWO: 4.6;CAPAN-2: 4.3;HEL: 5.6;SK-BR-3: 13.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "basal ganglia: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000047, HPA019141" Enhanced Approved Vesicles "Secreted to blood" Vesicles "CAB000047: AB_322161, HPA019141: AB_1851789" "unprognostic (8.90e-3)" "unprognostic (2.91e-2)" "unprognostic (2.82e-1)" "unprognostic (7.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.45e-1)" "unprognostic (3.57e-1)" "unprognostic (9.61e-3)" "unprognostic (4.15e-3)" "unprognostic (6.71e-2)" "unprognostic (3.73e-1)" "unprognostic (7.34e-2)" "prognostic unfavourable (4.03e-5)" "unprognostic (4.85e-2)" "unprognostic (7.20e-2)" "unprognostic (1.93e-1)" "unprognostic (4.43e-2)" 0.5 24.2 0.8 0.5 8.4 0.0 0.5 1.7 0.9 0.5 0.5 1.4 0.5 0.0 0.5 1.2 0.5 0.6 0.6 4.8 0.8 0.9 0.5 0.5 0.5 0.5 0.5 0.6 31.5 6.5 0.2 1.5 39.3 0.6 0.5 0.0 0.5 0.9 0.7 0.5 1.1 0.5 0.5 0.5 0.5 0.1 77.6 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 2.5 0.8 0.2 4.6 0.5 0.4 0.7 0.2 0.3 4.3 0.0 0.3 1.0 2.7 0.3 0.7 0.0 0.0 0.8 5.6 2.0 3.0 0.4 0.0 0.0 1.0 1.3 0.0 0.7 0.0 3.4 0.0 0.1 3.1 0.0 0.2 1.7 1.1 0.1 0.2 0.0 0.7 0.3 0.5 1.1 1.6 13.0 0.4 0.8 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 8.4 1.7 0.9 0.8 0.9 0.5 0.6 0.6 0.5 INHBE "activin, MGC4638" ENSG00000139269 "Inhibin beta E subunit" P58166 12 57452323-57459280 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 40 "liver: 127.6" "Cell line enhanced" "Detected in some" "HHSteC: 14.8;Karpas-707: 22.3;U-266/70: 75.2" "Cancer enriched" "Detected in some" 27 "liver cancer: 34.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 0.5" "HPA016843, CAB034017" Enhanced Supported Vesicles "Secreted to blood" 1400000 Vesicles "CAB034017: AB_2233745, HPA016843: AB_1851796" "unprognostic (7.34e-2)" "unprognostic (6.73e-2)" "unprognostic (3.45e-1)" "unprognostic (4.69e-5)" "unprognostic (2.61e-1)" "unprognostic (2.50e-1)" "unprognostic (3.13e-1)" "unprognostic (1.24e-1)" "unprognostic (8.79e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-1)" "unprognostic (2.70e-1)" "prognostic unfavourable (5.66e-8)" "unprognostic (4.09e-3)" "unprognostic (1.56e-1)" "unprognostic (3.57e-2)" "unprognostic (7.52e-3)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 127.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 1.0 0.9 3.1 0.6 0.6 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.8 2.1 0.0 2.6 0.1 0.0 1.0 0.5 0.2 0.1 0.5 0.0 0.3 4.9 0.0 0.0 0.0 3.2 14.8 0.6 0.6 1.4 1.5 0.3 3.3 0.0 1.3 22.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 2.3 0.0 0.0 5.5 0.2 0.0 0.0 2.1 0.1 2.4 0.0 0.0 1.2 0.0 0.1 75.2 2.3 1.0 0.4 0.1 0.1 1.9 0.5 0.5 0.3 0.4 0.4 0.9 0.1 0.2 0.1 1.0 0.2 0.5 3.1 0.6 0.6 0.9 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 INMT ENSG00000241644 "Indolethylamine N-methyltransferase" O95050 7 30697985-30757602 "Enzymes, Predicted intracellular proteins" Detoxification "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 73.5" "Group enriched" "Detected in some" 5 "CACO-2: 18.2;HHSteC: 7.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 22.2" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA061343 Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA061343: " "unprognostic (1.70e-1)" "unprognostic (4.36e-2)" "unprognostic (5.26e-2)" "unprognostic (6.78e-3)" "unprognostic (1.59e-1)" "unprognostic (3.39e-4)" "prognostic favourable (5.72e-4)" "unprognostic (3.08e-2)" "unprognostic (3.94e-2)" "unprognostic (1.59e-1)" "unprognostic (8.51e-2)" "unprognostic (9.07e-2)" "unprognostic (4.97e-2)" "unprognostic (1.62e-2)" "unprognostic (1.43e-2)" "unprognostic (9.71e-2)" "unprognostic (1.58e-2)" 19.7 18.0 0.3 3.0 0.7 0.0 5.9 0.3 0.6 4.9 3.7 1.3 14.0 0.8 9.8 18.9 12.4 16.3 14.7 24.6 0.6 0.4 11.8 24.3 73.5 12.1 1.1 0.8 20.2 4.0 0.7 3.2 12.9 2.5 10.1 1.6 13.0 6.1 19.9 4.7 1.5 3.9 11.3 1.3 6.5 5.0 28.2 0.2 0.5 9.4 3.8 2.8 9.6 6.4 1.7 1.1 4.2 1.0 2.2 1.0 0.6 0.0 0.1 0.1 0.1 1.8 2.5 0.4 0.2 2.3 0.0 0.0 18.2 0.1 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 7.8 0.1 0.3 0.9 0.0 0.0 0.1 0.4 0.1 0.3 0.3 0.1 0.0 0.4 0.8 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.6 0.1 0.7 0.0 0.2 0.1 1.1 0.1 0.8 0.3 0.1 0.8 0.3 0.1 0.2 0.1 0.3 4.2 1.0 0.8 0.7 0.4 0.7 1.2 0.7 0.6 0.4 1.7 1.0 0.8 3.0 2.2 0.4 1.1 0.6 0.6 0.3 0.7 0.3 0.6 0.6 0.4 1.1 0.8 2.5 0.2 INPP5F "hSac2, KIAA0966, SAC2" ENSG00000198825 "Inositol polyphosphate-5-phosphatase F" Q9Y2H2 10 119726097-119829278 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.7" "Cell line enhanced" "Detected in many" "AF22: 36.0;SH-SY5Y: 28.5;SK-MEL-30: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042605 Supported Vesicles Vesicles "HPA042605: AB_10793886" "unprognostic (2.65e-2)" "unprognostic (3.23e-1)" "unprognostic (3.42e-2)" "unprognostic (5.84e-2)" "unprognostic (1.87e-2)" "unprognostic (1.57e-3)" "unprognostic (2.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.09e-2)" "unprognostic (2.09e-1)" "unprognostic (6.46e-2)" "unprognostic (7.78e-2)" "unprognostic (1.02e-1)" "unprognostic (9.91e-2)" "unprognostic (2.96e-2)" "unprognostic (6.21e-2)" 4.6 12.3 17.5 5.9 50.4 3.2 5.7 37.0 52.9 10.9 5.0 5.5 2.2 3.1 11.8 18.0 4.5 4.2 5.5 4.1 24.6 53.1 7.3 2.0 4.2 7.6 23.7 29.1 9.8 4.6 8.9 34.0 8.2 69.7 8.3 6.1 3.4 7.1 8.4 7.5 10.4 3.8 10.8 19.2 4.1 3.8 10.1 7.3 1.4 8.4 1.4 9.3 5.3 4.5 12.2 7.4 1.5 4.5 3.8 6.7 2.2 4.6 3.3 36.0 5.2 3.9 4.0 3.1 6.5 3.6 3.1 3.0 4.8 5.9 3.0 2.5 8.1 5.2 3.9 3.8 4.7 1.9 3.6 2.0 1.6 4.8 5.5 1.3 6.7 4.8 3.5 6.1 6.1 10.4 1.8 4.8 7.3 2.6 1.8 5.4 3.4 4.1 2.4 6.4 0.8 5.2 2.4 2.6 28.5 7.2 2.2 54.3 1.5 1.4 6.9 3.1 4.1 4.0 6.3 5.4 2.4 1.4 3.9 4.6 12.6 1.1 4.0 1.5 1.3 3.5 1.6 8.1 2.8 1.9 7.4 12.2 3.2 1.4 1.0 3.8 4.5 1.8 6.7 2.2 17.5 50.4 37.0 50.5 24.6 53.1 23.7 29.1 69.7 7.3 INSIG1 "CL-6, MGC1405" ENSG00000186480 "Insulin induced gene 1" O15503 7 155297776-155310235 "Plasma proteins, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.4;liver: 143.2" "Cell line enhanced" "Detected in many" "Karpas-707: 152.5;RPMI-8226: 71.5" "Cancer enhanced" "Detected in all" "liver cancer: 142.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "intermediate monocyte: 45.7;non-classical monocyte: 81.4" "Lineage enriched" "Detected in all" 6 "monocytes: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071524 Approved Vesicles Vesicles "HPA071524: " "unprognostic (8.11e-2)" "unprognostic (3.22e-1)" "unprognostic (2.91e-1)" "unprognostic (1.47e-1)" "unprognostic (9.23e-2)" "unprognostic (3.83e-2)" "unprognostic (2.05e-2)" "unprognostic (3.06e-1)" "unprognostic (1.60e-2)" "unprognostic (1.52e-1)" "unprognostic (4.64e-2)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-1)" "prognostic unfavourable (9.62e-4)" "unprognostic (4.97e-2)" 18.4 9.2 8.5 8.3 8.8 9.7 14.1 10.1 14.3 6.0 7.4 21.8 7.5 12.5 5.2 8.3 15.6 4.6 8.0 5.6 10.8 11.6 6.4 143.2 18.5 6.9 8.6 8.3 16.4 27.2 4.6 5.2 17.5 23.9 15.9 6.7 11.9 31.4 3.1 2.4 10.5 14.2 5.1 19.2 4.5 13.4 8.2 8.3 10.7 3.3 6.1 6.9 11.2 5.6 10.0 13.6 10.7 81.4 4.0 12.7 12.5 18.9 3.5 9.4 5.9 25.0 33.4 5.2 1.5 21.6 4.5 30.1 2.1 27.5 12.4 4.4 11.7 10.3 6.4 11.2 5.4 3.8 18.9 3.3 6.5 0.0 12.3 5.7 56.0 20.8 6.2 34.9 3.2 6.0 6.2 152.5 5.8 9.8 28.0 15.1 9.8 2.2 5.2 0.0 71.5 35.7 9.4 7.0 5.6 5.0 3.6 7.9 3.5 19.3 6.8 5.0 1.5 9.5 3.9 37.2 6.5 11.0 22.2 22.5 4.6 3.1 4.9 2.1 8.7 45.7 4.4 7.7 6.0 7.4 13.6 10.0 5.9 6.7 10.7 4.0 81.4 7.7 12.7 12.5 8.5 8.8 10.1 14.3 10.8 11.6 8.6 8.3 23.9 8.3 INSR CD220 ENSG00000171105 "Insulin receptor" P06213 19 7112255-7294034 "CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Carbohydrate metabolism" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 64.5" "Cell line enhanced" "Detected in many" "Karpas-707: 30.6;U-266/70: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 8.8;granulocytes: 5.1;monocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036302, HPA036303" Uncertain Approved "Vesicles,Plasma membrane" 72000 Vesicles "Plasma membrane" "HPA036302: , HPA036303: " "unprognostic (4.64e-2)" "unprognostic (2.42e-1)" "unprognostic (9.65e-3)" "unprognostic (9.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.15e-2)" "unprognostic (2.58e-1)" "unprognostic (5.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.05e-1)" "unprognostic (9.29e-2)" "unprognostic (1.86e-1)" "unprognostic (6.33e-2)" "unprognostic (3.45e-3)" "unprognostic (2.43e-1)" "unprognostic (2.75e-1)" "unprognostic (8.82e-2)" 13.9 14.7 7.1 3.5 8.2 4.5 12.0 12.0 8.2 10.3 15.2 11.7 10.6 8.4 15.5 6.1 4.7 13.1 7.7 17.7 6.4 5.8 18.7 32.5 5.3 2.2 10.1 4.9 28.3 64.5 11.6 11.6 26.2 8.0 10.5 8.9 11.0 12.0 10.6 15.1 7.3 16.0 10.6 6.8 47.3 8.7 6.9 9.7 2.2 17.1 5.0 3.2 11.3 16.0 1.1 8.8 5.1 10.5 0.8 0.7 1.3 3.7 2.1 1.9 2.9 10.6 3.7 6.4 2.1 1.9 1.2 1.2 5.3 4.3 4.7 5.3 3.8 1.0 4.6 0.9 0.7 0.0 3.7 0.0 1.5 11.5 4.6 2.2 3.8 5.7 2.4 0.1 2.8 2.1 5.7 30.6 0.9 1.7 1.6 3.8 1.8 3.3 16.3 1.1 4.1 0.1 15.5 3.7 2.8 3.8 2.0 2.1 0.9 10.8 2.0 2.2 1.4 4.7 2.8 22.6 12.3 10.9 2.6 3.8 0.0 2.0 8.2 5.1 0.2 7.8 0.3 0.8 0.3 0.1 8.8 1.1 0.7 0.1 1.7 0.8 10.5 7.4 0.0 1.3 7.1 8.2 12.0 8.2 6.4 5.8 10.1 4.9 8.0 9.7 INTS13 "ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30" ENSG00000064102 "Integrator complex subunit 13" Q9NVM9 12 26905181-26938326 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039543, HPA040109, HPA073020" Uncertain Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA039543: AB_10795150, HPA040109: , HPA073020: " "unprognostic (2.09e-1)" "unprognostic (8.48e-3)" "unprognostic (2.75e-2)" "unprognostic (1.40e-3)" "unprognostic (3.94e-2)" "unprognostic (3.01e-2)" "prognostic unfavourable (1.17e-10)" "unprognostic (5.22e-3)" "unprognostic (5.28e-2)" "unprognostic (1.67e-2)" "unprognostic (1.78e-3)" "unprognostic (3.75e-3)" "prognostic unfavourable (3.16e-6)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (4.37e-2)" "unprognostic (4.78e-2)" 10.0 20.9 10.5 11.5 14.7 15.3 11.5 11.4 11.4 10.5 10.0 22.3 4.6 9.0 10.6 10.4 14.1 8.1 7.5 10.2 12.3 9.8 12.6 14.3 8.0 14.1 18.8 7.4 9.2 11.9 9.3 17.6 9.2 22.4 10.1 10.4 8.9 9.4 6.6 16.9 11.4 8.5 11.6 30.2 17.9 14.1 10.9 14.1 26.6 10.7 11.6 15.1 16.9 9.6 7.4 6.8 5.1 5.4 16.4 18.7 7.1 9.3 10.3 6.3 13.3 9.0 14.5 8.9 13.0 7.8 12.3 13.9 15.4 12.3 23.5 13.6 7.2 13.3 15.3 12.2 20.9 10.8 9.4 18.4 12.8 12.7 16.2 31.1 11.3 7.9 9.4 20.0 42.6 15.9 19.4 9.3 13.4 10.7 16.2 57.1 27.3 18.5 11.5 18.3 31.4 10.5 8.5 5.0 4.8 11.4 9.0 13.0 12.2 6.8 10.4 14.6 10.8 24.4 15.7 4.9 5.5 34.4 9.7 21.6 10.2 4.2 5.4 5.1 10.5 3.7 15.5 6.8 13.1 12.9 6.8 7.4 9.4 11.5 1.8 16.4 3.2 4.6 18.7 7.1 10.5 14.7 11.4 11.4 12.3 9.8 18.8 7.4 22.4 14.1 INTU "KIAA1284, PDZD6, PDZK6" ENSG00000164066 "Inturned planar cell polarity protein" Q9ULD6 4 127623271-127726737 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036714, HPA036715" Approved Approved Vesicles Vesicles "HPA036714: AB_10670238, HPA036715: " "unprognostic (1.09e-1)" "unprognostic (2.89e-1)" "unprognostic (4.11e-2)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-1)" "unprognostic (2.88e-3)" "unprognostic (4.30e-2)" "unprognostic (2.91e-1)" "unprognostic (1.43e-1)" "unprognostic (3.90e-2)" "unprognostic (1.53e-1)" "unprognostic (1.22e-1)" "unprognostic (9.49e-2)" "unprognostic (3.28e-1)" "unprognostic (2.36e-1)" "unprognostic (5.33e-2)" 4.4 4.8 8.3 3.7 23.0 7.3 8.1 5.6 12.6 7.7 4.0 11.9 5.6 5.9 10.2 14.6 4.0 8.1 4.7 3.2 12.0 8.0 5.7 2.4 4.9 3.4 7.2 8.1 9.9 4.1 4.7 25.8 3.3 12.3 5.2 4.8 9.1 5.2 4.2 3.3 10.6 3.1 4.4 9.1 3.8 6.1 6.9 8.0 0.5 7.9 2.8 2.3 4.6 5.0 1.4 1.5 4.7 0.9 1.0 0.9 0.1 3.3 2.3 12.6 4.7 1.8 4.3 1.0 2.0 1.0 1.3 2.6 1.7 3.1 2.8 3.3 2.0 2.0 9.9 1.9 3.9 1.2 3.0 3.5 3.9 4.2 1.7 3.1 1.8 1.8 2.1 4.2 1.0 3.8 4.2 2.9 1.9 1.6 1.1 1.8 5.9 2.3 1.2 3.1 0.8 2.6 2.6 5.9 4.2 4.3 2.3 1.5 2.7 1.9 3.1 3.6 2.9 3.5 2.8 1.9 2.7 0.9 3.0 1.6 2.2 2.8 0.8 0.5 0.9 0.6 0.8 0.7 0.7 0.6 0.4 1.4 0.7 0.8 4.7 1.0 0.9 1.5 0.4 0.1 8.3 23.0 5.6 12.6 12.0 8.0 7.2 8.1 12.3 8.0 IPO9 "FLJ10402, Imp9" ENSG00000198700 "Importin 9" Q96P70 1 201829141-201884294 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059540 Approved Vesicles,Cytosol "Intracellular and membrane" 30000 Cytosol Vesicles "HPA059540: " "unprognostic (1.20e-1)" "unprognostic (1.37e-1)" "unprognostic (7.44e-3)" "unprognostic (2.02e-2)" "unprognostic (1.13e-1)" "unprognostic (4.99e-2)" "prognostic unfavourable (4.11e-5)" "unprognostic (8.92e-3)" "unprognostic (2.23e-3)" "unprognostic (2.52e-1)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "prognostic unfavourable (2.86e-4)" "unprognostic (5.05e-2)" "unprognostic (2.57e-1)" "unprognostic (3.13e-2)" "prognostic unfavourable (5.78e-4)" 16.8 18.0 27.1 14.2 26.5 11.0 15.2 29.1 27.8 14.2 14.3 18.7 11.0 11.5 19.7 24.2 15.2 17.4 12.2 12.0 22.3 17.9 14.9 23.1 16.5 15.7 17.7 22.8 20.9 16.5 24.9 26.0 18.1 21.2 16.3 18.1 24.7 11.2 14.7 15.4 21.9 13.3 21.5 15.0 18.3 13.4 12.8 17.2 21.1 18.4 8.4 20.3 14.4 13.7 10.9 14.6 10.7 15.3 11.0 13.3 8.3 18.4 19.6 26.9 21.8 15.6 10.6 20.2 14.3 14.5 23.9 23.3 31.4 16.2 11.0 8.1 13.7 17.2 18.2 19.8 20.7 10.0 16.1 8.2 31.9 23.4 11.9 10.7 13.5 11.7 9.1 25.7 21.0 23.9 16.3 10.5 17.0 18.5 12.3 14.0 27.0 6.4 13.2 28.0 10.9 13.0 29.6 22.9 26.0 15.7 25.0 12.6 18.3 13.5 13.0 22.5 20.1 12.6 26.1 7.7 4.7 12.7 11.2 12.6 16.8 10.7 11.7 9.7 12.2 15.3 10.6 10.9 11.9 13.3 14.6 10.3 9.7 10.4 2.9 11.0 14.9 7.7 10.7 8.3 27.1 26.5 29.1 27.8 22.3 17.9 17.7 22.8 21.2 17.2 IQCC FLJ10547 ENSG00000160051 "IQ motif containing C" Q4KMZ1 1 32205661-32208687 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028602, HPA028686" Approved Supported Vesicles Vesicles "HPA028602: AB_10600298, HPA028686: AB_10601985" "unprognostic (1.45e-3)" "unprognostic (4.25e-3)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (2.56e-1)" "unprognostic (4.00e-3)" "unprognostic (7.81e-6)" "prognostic favourable (5.65e-4)" "unprognostic (4.97e-2)" "unprognostic (2.97e-2)" "prognostic favourable (8.23e-5)" "unprognostic (2.00e-1)" "unprognostic (3.28e-1)" "unprognostic (3.12e-3)" "prognostic favourable (3.79e-4)" "unprognostic (4.22e-2)" "unprognostic (1.66e-1)" 2.2 4.2 5.0 3.3 8.2 4.4 5.0 9.7 11.7 3.8 3.5 5.1 4.4 2.5 5.5 10.2 3.1 8.3 3.4 2.8 4.0 4.3 4.3 1.9 2.9 3.5 3.1 5.9 5.4 8.1 5.6 9.5 2.7 3.4 4.3 3.5 4.7 4.8 5.7 4.1 4.9 3.1 3.0 3.1 3.2 4.4 26.6 4.6 4.4 8.3 1.0 3.7 2.8 2.9 5.1 2.8 3.4 1.1 3.9 3.8 1.2 7.6 2.5 6.2 5.8 1.1 2.3 3.9 4.4 5.0 9.2 8.6 6.1 6.8 2.7 4.8 1.3 6.4 6.3 3.8 7.8 4.1 7.1 4.9 5.9 2.6 1.5 5.2 3.3 1.6 4.1 8.1 3.7 1.9 8.5 0.7 4.1 5.3 8.5 5.3 3.9 5.7 12.0 3.8 6.2 3.4 2.9 8.8 3.4 8.7 5.0 4.6 6.1 5.4 2.6 3.4 6.3 4.9 7.4 3.5 2.5 2.4 4.8 4.9 7.0 1.6 1.0 0.4 3.3 1.0 3.1 5.1 3.4 2.5 1.8 2.5 3.8 2.2 3.4 3.9 1.1 2.8 3.7 1.2 5.0 8.2 9.7 11.7 4.0 4.3 3.1 5.9 3.4 4.6 IQGAP2 ENSG00000145703 "IQ motif containing GTPase activating protein 2" Q13576 5 76403249-76708132 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.1" "Cell line enhanced" "Detected in many" "CACO-2: 21.5;Hep G2: 17.8;HMC-1: 63.8;RPMI-8226: 23.3;U-937: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 34.4" "Low region specificity" "Detected in all" "CAB004241, HPA037403, HPA037404" Uncertain Approved "Vesicles,Plasma membrane" 8400000 "Vesicles, Plasma membrane" "CAB004241: AB_2125909, HPA037403: , HPA037404: " "unprognostic (9.46e-2)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (9.03e-3)" "unprognostic (8.85e-2)" "prognostic favourable (5.65e-4)" "unprognostic (5.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "prognostic favourable (9.44e-12)" "unprognostic (3.29e-2)" "unprognostic (9.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.27e-2)" 11.1 11.3 1.4 14.7 1.7 6.3 8.0 1.1 1.2 6.1 21.6 0.6 36.2 16.8 2.6 14.7 3.3 2.7 21.7 4.2 1.6 1.6 13.2 66.1 7.8 13.0 1.3 0.7 4.2 14.8 25.5 2.3 42.5 2.1 9.1 6.8 15.2 18.9 34.3 1.4 3.7 35.7 3.4 2.0 16.5 12.4 30.7 0.4 7.7 12.8 2.8 7.7 4.3 4.2 0.6 7.8 14.9 3.2 4.1 5.9 1.3 0.0 2.8 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.2 0.8 0.0 0.0 3.6 0.0 0.0 2.4 3.5 7.9 2.1 17.8 0.0 4.4 63.8 0.0 0.0 0.0 0.0 0.3 6.9 6.4 0.0 0.0 3.8 12.1 4.4 0.1 1.4 0.0 23.3 0.0 0.0 0.1 0.9 5.0 0.2 0.0 0.0 2.6 0.1 0.0 0.1 0.0 0.0 5.9 0.0 5.5 0.0 16.7 0.9 14.9 3.2 1.8 4.8 2.4 4.0 0.6 5.0 4.1 2.9 0.2 2.0 3.6 6.3 4.1 3.1 7.8 5.9 1.3 1.4 1.7 1.1 1.2 1.6 1.6 1.3 0.7 2.1 0.4 IQSEC1 "ARF-GEP100, BRAG2, GEP100, KIAA0763" ENSG00000144711 "IQ motif and Sec7 domain 1" Q6DN90 3 12897220-13073117 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 34.2;U-266/84: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038143, HPA038144" Uncertain Supported Nucleoli,Vesicles "Nucleoli, Vesicles" "HPA038143: AB_10697241, HPA038144: " "prognostic unfavourable (3.03e-5)" "unprognostic (1.80e-1)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (8.19e-3)" "unprognostic (2.64e-3)" "unprognostic (5.60e-2)" "unprognostic (1.67e-1)" "unprognostic (3.00e-1)" "unprognostic (1.14e-2)" "prognostic favourable (9.07e-4)" "unprognostic (4.42e-1)" "prognostic favourable (3.58e-6)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (1.00e-3)" "unprognostic (4.65e-2)" 17.8 14.1 27.8 12.3 27.0 32.5 7.1 31.9 41.5 9.5 6.7 18.5 3.5 4.8 8.0 4.7 6.1 8.5 7.4 16.0 25.0 17.8 7.0 11.5 12.4 14.8 16.4 24.8 12.3 13.0 25.7 7.8 13.4 36.7 11.6 4.8 17.0 9.3 10.0 21.0 6.2 7.7 8.4 10.6 20.6 6.9 5.6 15.5 2.6 6.3 4.3 14.0 7.8 5.9 6.2 6.8 12.9 4.0 1.8 3.6 2.3 4.9 6.7 6.0 6.8 5.1 7.1 34.2 5.6 4.6 3.7 2.9 4.6 4.4 10.5 6.4 10.5 2.8 4.6 2.9 2.8 7.1 9.7 6.2 4.0 19.6 5.6 0.1 2.6 7.0 5.4 7.6 4.3 3.4 17.5 11.2 2.5 15.8 3.9 6.6 6.3 13.8 5.3 2.0 15.1 2.2 6.4 5.3 9.7 4.0 14.1 3.3 6.0 4.3 9.2 4.1 10.4 3.5 0.7 22.3 30.6 4.1 7.7 3.1 3.3 5.0 3.8 4.8 3.6 4.0 2.7 6.2 2.4 2.7 1.9 6.1 2.4 3.0 12.9 1.8 3.9 6.8 1.7 2.3 27.8 27.0 31.9 41.5 25.0 17.8 16.4 24.8 36.7 15.5 IQSEC2 "KIAA0522, MRX1, MRX18, MRX78" ENSG00000124313 "IQ motif and Sec7 domain 2" Q5JU85 X 53225828-53321350 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.2" "Cell line enhanced" "Detected in many" "A549: 27.2;U-87 MG: 20.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 10.0;plasmacytoid DC: 10.2" "Group enriched" "Detected in many" 15 "dendritic cells: 10.2;monocytes: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003973 Approved Vesicles Vesicles "HPA003973: AB_2280343" "unprognostic (1.85e-1)" "unprognostic (7.77e-2)" "unprognostic (2.61e-2)" "unprognostic (1.32e-1)" "unprognostic (4.66e-3)" "unprognostic (6.02e-2)" "unprognostic (2.80e-1)" "unprognostic (3.78e-2)" "unprognostic (2.82e-1)" "unprognostic (9.05e-2)" "unprognostic (1.57e-1)" "unprognostic (2.59e-1)" "prognostic unfavourable (2.00e-4)" "unprognostic (1.56e-2)" "unprognostic (1.75e-1)" "unprognostic (4.30e-2)" "prognostic favourable (2.38e-4)" 8.1 10.0 16.6 4.3 22.0 1.5 4.7 32.1 34.2 7.0 6.9 3.7 4.9 9.9 4.7 3.5 4.9 8.5 4.9 6.0 19.4 9.0 10.8 1.3 6.5 2.0 6.7 12.7 4.7 5.4 8.1 6.1 2.9 13.4 6.4 5.6 2.8 5.1 7.8 25.6 5.7 10.7 5.9 4.4 3.5 5.5 4.2 5.2 0.2 5.3 4.3 2.6 4.7 4.1 0.2 10.2 0.6 10.0 0.0 0.1 2.2 2.6 27.2 1.0 2.5 3.8 8.4 3.0 4.4 7.7 3.3 6.3 0.7 10.1 0.1 7.2 10.3 3.7 0.9 4.3 2.5 2.7 4.7 3.0 11.9 0.7 8.3 0.1 1.6 6.0 6.6 9.4 5.2 4.6 9.4 3.1 7.1 6.3 0.0 0.5 8.5 11.9 2.0 2.1 3.2 5.1 5.7 1.1 1.0 10.3 6.4 4.1 9.0 1.3 5.3 3.3 6.3 1.8 2.0 0.9 0.1 0.1 20.3 1.9 1.7 0.1 10.0 0.5 0.0 3.6 0.1 0.2 0.0 0.1 5.2 0.1 0.1 0.1 0.6 0.0 1.8 10.2 0.0 2.2 16.6 22.0 32.1 34.2 19.4 9.0 6.7 12.7 13.4 5.2 IRAK1BP1 "AIP70, SIMPL" ENSG00000146243 "Interleukin 1 receptor associated kinase 1 binding protein 1" Q5VVH5 6 78867472-78946440 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 79.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035742, HPA035743" Uncertain Approved Vesicles Vesicles "HPA035742: AB_10670119, HPA035743: " "unprognostic (2.62e-1)" "unprognostic (1.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (5.82e-2)" "unprognostic (2.12e-1)" "unprognostic (2.38e-3)" "unprognostic (3.93e-2)" "unprognostic (6.55e-2)" "unprognostic (2.34e-2)" "unprognostic (1.32e-2)" "unprognostic (9.88e-2)" "unprognostic (2.81e-2)" "unprognostic (4.64e-2)" "unprognostic (1.82e-1)" "unprognostic (3.39e-2)" "unprognostic (2.58e-1)" 2.8 4.0 6.9 3.4 12.4 79.6 3.9 8.8 8.1 6.4 4.1 3.4 6.2 3.5 7.2 7.7 3.2 7.3 5.3 3.6 5.6 4.1 7.0 2.6 4.4 6.0 3.0 6.5 7.0 8.1 4.2 17.9 2.8 4.3 5.2 2.7 5.1 4.2 6.5 2.3 5.7 4.7 4.1 3.6 4.7 5.5 15.4 5.7 8.8 7.6 1.9 2.3 4.5 4.0 1.4 1.6 3.9 1.4 1.3 2.0 0.4 1.6 3.2 5.2 4.6 2.2 4.8 4.5 1.1 2.7 1.1 1.9 3.8 3.0 3.1 1.4 2.5 3.0 9.3 4.4 1.9 4.7 3.8 4.0 4.7 2.0 2.8 9.7 3.7 4.2 4.4 2.0 2.5 3.5 5.1 7.7 1.7 0.8 2.9 6.4 2.4 2.7 1.1 2.9 2.2 4.8 6.5 6.9 8.2 1.5 1.7 1.2 3.8 6.5 3.1 2.7 2.6 1.5 4.0 7.8 4.6 4.8 0.8 0.7 3.1 3.9 0.3 0.4 1.5 0.2 1.1 1.4 1.4 0.8 0.6 0.9 1.9 2.0 2.5 1.3 1.4 1.6 1.6 0.4 6.9 12.4 8.8 8.1 5.6 4.1 3.0 6.5 4.3 5.7 IRAK2 ENSG00000134070 "Interleukin 1 receptor associated kinase 2" O43187 3 10164865-10243743 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 28.7" "Cell line enhanced" "Detected in many" "BEWO: 17.7;BJ hTERT+: 18.4;CAPAN-2: 18.7;RT4: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013483, HPA050520" Uncertain Approved Vesicles Vesicles "CAB013483: , HPA050520: " "unprognostic (1.31e-1)" "unprognostic (2.04e-2)" "unprognostic (1.46e-2)" "unprognostic (4.61e-3)" "unprognostic (8.71e-2)" "unprognostic (9.55e-2)" "prognostic unfavourable (8.35e-4)" "unprognostic (1.89e-2)" "unprognostic (8.01e-2)" "unprognostic (1.24e-1)" "prognostic unfavourable (2.26e-4)" "unprognostic (2.24e-1)" "unprognostic (3.10e-2)" "unprognostic (7.22e-2)" "unprognostic (4.38e-2)" "unprognostic (3.91e-2)" "prognostic favourable (6.60e-5)" 12.1 5.8 3.6 8.6 5.9 28.7 5.4 4.5 7.0 3.3 4.0 12.2 2.3 3.3 3.5 2.6 8.4 2.4 6.8 2.7 3.6 5.2 4.3 15.4 12.7 5.3 10.4 3.7 1.9 3.2 2.4 1.8 3.5 7.8 6.4 3.1 2.1 4.8 3.4 19.6 6.2 6.7 3.4 6.1 5.9 5.2 1.7 8.6 3.9 4.1 2.7 16.7 14.3 7.2 5.0 1.3 2.5 1.2 8.4 7.9 2.5 1.4 4.0 0.1 0.5 4.4 3.7 17.7 1.5 18.4 2.5 2.4 1.9 18.7 0.0 0.5 2.2 0.4 0.4 4.7 3.4 1.1 1.3 0.4 0.9 5.1 2.1 0.0 0.6 2.2 0.8 9.2 12.1 5.1 0.9 5.7 3.0 0.0 0.0 0.9 0.1 3.9 0.8 0.0 0.3 5.5 25.5 0.2 0.1 1.7 0.1 0.2 0.4 0.8 5.3 5.7 0.5 3.5 3.6 1.9 5.6 1.0 12.3 2.4 1.0 0.2 1.2 0.1 7.5 0.7 7.9 5.0 2.2 4.1 1.3 4.5 1.6 3.9 2.5 8.4 0.2 0.1 0.9 2.5 3.6 5.9 4.5 7.0 3.6 5.2 10.4 3.7 7.8 8.6 IRAK3 IRAK-M ENSG00000090376 "Interleukin 1 receptor associated kinase 3" Q9Y616 12 66188879-66254622 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 58.0" "Cell line enhanced" "Detected in some" "ASC diff: 14.7;ASC TERT1: 12.2;HEL: 12.6;HL-60: 16.7;NB-4: 13.3;THP-1: 20.2;U-937: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 5.6;classical monocyte: 13.1;intermediate monocyte: 13.2;myeloid DC: 6.2;neutrophil: 7.2;non-classical monocyte: 20.6" "Group enriched" "Detected in many" 12 "dendritic cells: 6.2;granulocytes: 7.2;monocytes: 20.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043097 Approved Approved Vesicles "Intracellular and membrane" Vesicles "HPA043097: AB_10795612" "unprognostic (7.12e-2)" "unprognostic (1.06e-1)" "unprognostic (2.90e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-1)" "unprognostic (7.56e-3)" "unprognostic (1.49e-1)" "unprognostic (2.46e-1)" "unprognostic (7.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.95e-2)" "unprognostic (8.52e-2)" "prognostic unfavourable (6.23e-4)" "unprognostic (5.58e-2)" "unprognostic (4.64e-2)" "unprognostic (3.41e-2)" "unprognostic (3.23e-2)" 21.8 3.7 2.1 10.6 3.6 58.0 13.4 1.0 2.4 8.7 6.5 2.3 5.5 1.7 6.2 8.6 4.9 7.0 7.6 16.0 2.9 2.1 3.6 2.9 22.1 25.6 4.6 0.3 5.9 2.7 1.3 17.9 6.1 3.7 7.0 3.0 5.5 6.0 5.5 5.5 3.3 4.9 6.4 5.9 25.3 6.2 5.1 2.8 1.0 4.9 4.5 5.4 9.5 11.4 0.4 6.2 7.2 20.6 0.9 0.3 3.6 0.0 0.0 0.2 0.0 14.7 12.2 0.0 1.6 0.0 0.9 1.3 0.0 1.2 0.0 0.8 3.0 0.0 1.8 0.0 0.7 0.0 0.0 12.6 0.7 0.0 7.7 16.7 2.3 7.7 0.0 0.7 0.0 4.3 0.0 0.0 0.5 0.0 0.0 13.3 0.7 0.0 0.0 3.6 0.0 0.1 1.8 0.1 0.0 6.5 0.0 0.7 0.0 20.2 4.6 0.0 0.0 0.0 0.0 0.5 0.1 1.2 0.0 14.7 0.0 5.6 13.1 2.2 0.0 13.2 0.0 0.0 0.0 0.0 6.2 0.4 0.0 0.0 7.2 0.9 20.6 0.0 0.3 3.6 2.1 3.6 1.0 2.4 2.9 2.1 4.6 0.3 3.7 2.8 IRGQ "FKSG27, IRGQ1" ENSG00000167378 "Immunity related GTPase Q" Q8WZA9 19 43584369-43596135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043254, HPA050338" Approved Supported Vesicles 18000 Vesicles "HPA043254: AB_10794178, HPA050338: AB_2681094" "unprognostic (1.98e-1)" "prognostic favourable (5.17e-4)" "unprognostic (2.55e-1)" "unprognostic (2.07e-3)" "unprognostic (9.87e-2)" "unprognostic (3.20e-3)" "prognostic unfavourable (9.60e-4)" "unprognostic (1.96e-2)" "unprognostic (3.98e-1)" "unprognostic (7.48e-2)" "prognostic favourable (3.57e-5)" "unprognostic (9.24e-2)" "prognostic favourable (3.92e-4)" "unprognostic (2.82e-1)" "unprognostic (7.91e-2)" "unprognostic (5.18e-2)" "unprognostic (4.65e-2)" 5.1 6.1 9.0 4.9 8.7 17.4 4.5 17.2 16.0 6.4 4.9 6.5 9.4 5.0 6.7 6.0 5.2 5.7 6.3 9.2 8.2 8.4 9.5 8.9 6.5 3.3 6.7 13.0 8.5 5.8 10.8 7.9 5.4 9.2 6.6 4.6 5.6 5.9 5.8 15.4 5.5 4.7 5.5 6.1 6.6 6.6 4.7 6.5 2.7 5.2 4.5 4.9 5.5 5.4 1.1 1.6 5.4 1.7 1.1 1.2 0.8 3.2 5.4 4.5 9.1 5.0 3.6 4.6 3.0 1.9 3.4 3.5 4.2 2.1 2.0 4.8 3.6 4.7 4.3 2.3 2.1 3.8 3.1 2.8 6.6 4.0 3.1 3.9 4.2 3.6 4.7 4.5 2.4 4.2 4.2 4.3 3.2 2.7 4.8 2.8 2.4 3.0 8.8 4.3 1.7 2.8 6.8 8.6 7.8 7.9 8.3 2.4 5.3 3.5 6.7 11.4 8.4 2.9 4.0 4.5 3.7 3.6 7.0 1.7 9.0 5.4 1.7 0.9 0.9 1.4 0.6 0.8 0.7 0.8 1.0 1.1 1.2 0.7 3.5 1.1 1.4 1.6 0.8 0.8 9.0 8.7 17.2 16.0 8.2 8.4 6.7 13.0 9.2 6.5 IRX3 IRX-1 ENSG00000177508 "Iroquois homeobox 3" P78415 16 54283304-54286763 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 87.8" "Cell line enhanced" "Detected in many" "LHCN-M2: 28.5;NB-4: 47.2;RPTEC TERT1: 56.9;T-47d: 29.4;THP-1: 47.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062522 Approved Vesicles Vesicles "HPA062522: " "unprognostic (4.21e-3)" "unprognostic (4.50e-2)" "unprognostic (2.34e-2)" "unprognostic (1.04e-1)" "unprognostic (3.34e-2)" "unprognostic (2.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.35e-2)" "unprognostic (1.52e-1)" "unprognostic (9.75e-2)" "unprognostic (2.92e-1)" "unprognostic (1.07e-1)" "unprognostic (3.15e-2)" "unprognostic (5.40e-2)" "unprognostic (2.39e-1)" "unprognostic (8.20e-2)" "unprognostic (1.25e-1)" 4.4 2.5 1.8 0.1 2.1 0.0 38.3 3.8 0.7 15.3 0.5 1.5 46.8 0.1 4.0 18.1 14.1 5.3 0.2 46.9 3.2 3.6 9.8 1.0 46.8 1.9 4.6 0.3 1.6 2.1 15.4 3.4 1.0 7.8 10.0 0.0 5.9 20.5 87.8 9.1 33.8 0.2 0.6 8.2 0.2 7.7 1.4 3.2 0.4 8.9 9.1 6.5 2.6 6.6 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.2 0.2 3.7 3.6 2.0 0.8 0.4 1.5 3.4 3.3 0.8 1.0 1.6 0.0 0.5 2.3 6.9 3.0 0.8 4.5 3.3 2.3 0.0 5.0 3.4 0.1 3.8 1.0 0.6 14.4 6.4 2.9 0.0 0.0 0.0 28.5 1.7 7.0 47.2 0.2 0.0 5.3 4.6 0.0 56.9 1.4 2.5 0.4 4.8 12.3 0.5 29.4 47.1 0.8 14.1 1.5 2.5 1.2 0.0 0.0 0.0 9.2 12.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 1.8 2.1 3.8 0.3 3.2 3.6 4.6 0.3 7.8 3.2 IRX4 ENSG00000113430 "Iroquois homeobox 4" P78413 5 1877413-1887236 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2" "Cell line enhanced" "Detected in some" "BEWO: 30.3;HaCaT: 11.3;HBEC3-KT: 6.2;MCF7: 5.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 19 "pons and medulla: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "pons and medulla: 1.9" HPA064094 Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA064094: " "unprognostic (1.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (1.35e-2)" "unprognostic (2.77e-1)" "unprognostic (1.53e-1)" "unprognostic (1.35e-1)" "unprognostic (7.52e-2)" "unprognostic (7.54e-2)" "unprognostic (4.26e-1)" "unprognostic (1.70e-2)" 0.2 0.2 0.1 0.1 0.1 0.3 5.1 0.1 0.2 2.4 0.1 0.1 0.1 0.1 0.1 0.1 11.2 0.1 0.1 11.0 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 2.7 7.8 0.1 0.1 6.7 0.1 1.2 14.2 0.1 1.0 0.1 0.1 0.1 1.7 0.1 0.1 0.1 2.5 2.1 0.1 7.3 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 11.3 0.0 6.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.0 0.0 0.0 5.4 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 2.7 0.1 ISOC1 CGI-111 ENSG00000066583 "Isochorismatase domain containing 1" Q96CN7 5 129094751-129114028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070307 Approved "Endoplasmic reticulum,Vesicles" 1500000 "Endoplasmic reticulum, Vesicles" "HPA070307: " "unprognostic (1.67e-1)" "unprognostic (4.46e-2)" "unprognostic (1.29e-1)" "unprognostic (6.42e-3)" "unprognostic (3.87e-2)" "unprognostic (1.91e-1)" "unprognostic (6.32e-2)" "unprognostic (1.90e-1)" "unprognostic (2.47e-1)" "unprognostic (4.19e-2)" "unprognostic (2.00e-2)" "unprognostic (4.18e-1)" "unprognostic (7.09e-3)" "unprognostic (2.49e-1)" "unprognostic (2.65e-1)" "unprognostic (1.65e-2)" "unprognostic (1.32e-2)" 10.5 13.1 9.2 8.9 9.7 4.1 20.7 2.2 8.4 26.3 14.6 7.5 2.1 12.8 44.3 9.0 17.1 13.6 6.4 48.6 7.3 14.2 13.7 40.3 7.1 10.3 11.3 9.5 14.7 22.0 6.8 18.0 7.5 11.2 9.2 9.1 5.4 19.0 3.8 6.6 11.4 19.6 27.1 11.5 5.8 7.9 5.5 9.2 10.4 9.3 11.2 10.2 8.2 10.9 23.2 15.6 24.2 12.8 26.9 32.8 22.0 8.5 6.8 7.0 10.8 11.6 6.2 31.2 3.7 3.2 4.3 7.6 23.7 12.2 6.1 9.3 2.1 4.7 14.9 11.2 7.9 33.5 17.0 12.2 6.9 17.3 8.2 4.8 4.4 4.0 3.4 6.6 5.8 10.1 13.2 10.7 3.7 34.3 8.9 7.8 10.8 18.6 12.9 20.6 6.0 10.6 17.5 12.0 51.3 10.7 13.6 6.7 11.2 4.0 4.2 4.8 9.2 3.8 12.0 9.0 7.0 10.2 5.4 15.2 5.4 24.2 12.8 18.1 28.5 12.2 31.9 23.2 26.8 30.0 15.6 21.1 23.7 27.9 15.9 26.9 11.5 14.2 32.8 22.0 9.2 9.7 2.2 8.4 7.3 14.2 11.3 9.5 11.2 9.2 IST1 KIAA0174 ENSG00000182149 "IST1, ESCRT-III associated factor" P53990 16 71845996-71931199 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041802, HPA054532" Approved Supported Vesicles 45000 Vesicles "HPA041802: AB_10794491, HPA054532: " "unprognostic (2.15e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-1)" "unprognostic (1.67e-3)" "unprognostic (2.04e-2)" "unprognostic (3.13e-3)" "unprognostic (2.11e-2)" "unprognostic (4.49e-2)" "unprognostic (3.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.31e-1)" "unprognostic (1.02e-1)" "prognostic favourable (4.55e-4)" "unprognostic (1.64e-2)" "unprognostic (7.88e-3)" "unprognostic (8.43e-3)" "prognostic favourable (8.88e-4)" 43.9 41.2 40.4 36.4 48.5 54.9 43.2 42.4 50.8 41.5 51.7 63.2 36.6 39.9 48.1 35.4 44.9 49.6 37.1 40.0 39.9 38.6 54.9 36.4 43.9 45.4 53.4 36.8 49.6 49.8 91.6 55.5 52.1 41.7 40.2 50.0 45.1 39.2 38.4 64.6 45.7 46.5 48.4 56.4 55.8 40.5 45.9 48.9 50.6 47.3 32.8 60.6 44.6 42.6 52.4 52.1 87.3 56.5 52.7 67.6 71.8 16.8 24.9 35.1 22.6 35.4 25.0 29.7 21.1 26.8 29.7 31.2 27.0 23.6 24.1 26.4 24.5 25.5 34.3 22.6 37.9 15.9 16.6 20.2 15.0 43.4 26.8 19.7 28.8 29.5 31.5 26.5 25.7 37.0 27.6 8.9 30.5 28.2 25.5 16.5 40.2 15.5 40.4 19.2 29.4 24.7 24.7 26.5 19.8 23.5 12.4 19.2 22.7 24.6 18.4 22.5 22.3 13.7 16.8 23.4 41.4 66.2 19.1 17.7 27.0 55.5 56.5 67.7 49.0 53.0 53.0 52.4 47.0 51.2 52.1 51.8 50.7 47.4 87.3 52.7 49.6 36.2 67.6 71.8 40.4 48.5 42.4 50.8 39.9 38.6 53.4 36.8 41.7 48.9 ITCH AIP4 ENSG00000078747 "Itchy E3 ubiquitin protein ligase" Q96J02 20 34363235-34511393 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021126, HPA049032, CAB072824, CAB072825" Supported Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: " "unprognostic (2.51e-1)" "unprognostic (6.95e-2)" "unprognostic (1.25e-3)" "unprognostic (3.22e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "unprognostic (9.29e-3)" "unprognostic (1.94e-1)" "unprognostic (3.89e-3)" "unprognostic (1.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (1.30e-1)" "unprognostic (2.24e-1)" "unprognostic (3.23e-2)" "unprognostic (2.21e-1)" 20.7 16.7 18.9 15.4 26.9 20.5 17.5 19.8 26.7 23.9 18.2 37.9 15.2 16.9 18.4 15.1 35.9 14.5 14.5 17.9 20.4 15.9 21.1 46.5 18.5 16.8 29.2 16.5 19.3 17.1 21.6 26.3 26.9 29.0 17.5 20.4 16.7 20.1 18.4 24.0 19.2 20.3 19.8 30.4 17.3 17.3 34.8 32.3 22.3 22.7 13.0 23.6 19.6 21.0 7.3 11.4 19.6 6.2 6.2 11.4 2.7 20.0 13.2 13.5 9.7 14.9 21.3 16.2 16.3 18.7 20.4 20.0 37.2 30.9 9.8 15.8 20.8 25.4 20.5 32.9 24.9 7.4 6.6 28.4 11.2 22.2 15.6 11.6 12.9 10.8 16.8 17.2 27.0 15.3 16.1 17.0 15.9 10.0 17.0 6.2 6.5 15.7 14.3 28.5 22.6 12.1 34.8 8.3 6.1 30.5 11.9 18.3 14.3 10.5 14.8 24.4 14.7 15.9 12.0 13.5 14.1 14.3 15.1 7.5 14.3 3.6 5.8 6.1 10.8 6.2 11.4 7.3 3.8 5.7 4.5 6.9 3.3 4.9 19.6 6.2 3.8 11.4 4.8 2.7 18.9 26.9 19.8 26.7 20.4 15.9 29.2 16.5 29.0 32.3 ITGA7 ENSG00000135424 "Integrin subunit alpha 7" Q13683 12 55684568-55716043 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Cell shape" "Integrin, Receptor" "Congenital muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 66.4;skeletal muscle: 81.3" "Cell line enhanced" "Detected in many" "ASC diff: 29.5;hTEC/SVTERT24-B: 27.9;LHCN-M2: 16.9;SK-MEL-30: 20.4;U-87 MG: 25.2" "Cancer enhanced" "Detected in all" "glioma: 35.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008427 Uncertain Approved "Nuclear speckles,Vesicles,Plasma membrane" 770000 "Plasma membrane" "Nuclear speckles, Vesicles" "HPA008427: AB_1851823" "unprognostic (4.71e-2)" "unprognostic (1.55e-1)" "unprognostic (2.00e-3)" "unprognostic (3.02e-3)" "unprognostic (2.50e-1)" "unprognostic (2.36e-1)" "unprognostic (1.66e-2)" "unprognostic (2.20e-1)" "unprognostic (2.20e-2)" "unprognostic (3.57e-1)" "prognostic favourable (1.75e-4)" "unprognostic (2.85e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-1)" "unprognostic (5.10e-1)" "unprognostic (2.98e-2)" "prognostic unfavourable (9.59e-5)" 46.2 3.4 6.1 7.2 6.8 0.9 20.6 3.6 7.6 6.3 22.4 5.7 5.9 6.6 15.1 13.5 11.6 12.9 14.8 66.4 7.8 2.6 3.1 4.1 3.4 2.9 3.9 7.6 5.1 1.9 3.4 3.1 1.0 5.7 8.9 3.7 5.6 3.3 14.6 81.3 3.6 7.2 33.3 4.5 2.4 10.3 2.9 5.3 0.2 6.5 10.6 2.2 13.6 14.1 0.5 1.7 0.0 1.0 0.0 0.8 0.3 0.1 1.7 3.2 5.2 29.5 5.9 0.3 2.2 3.7 5.0 5.2 3.5 2.8 0.9 3.2 1.4 0.4 2.2 0.1 4.5 0.1 1.6 0.3 1.1 1.3 0.2 0.1 1.1 8.3 0.0 27.9 0.1 0.0 0.4 0.6 16.9 2.1 0.1 1.2 9.0 0.2 0.0 12.2 0.2 0.1 0.0 0.4 1.2 0.2 0.0 20.4 0.3 5.7 0.0 0.5 5.5 0.3 3.5 1.3 0.9 0.3 25.2 3.4 0.3 0.0 0.7 0.0 0.4 1.0 0.0 0.1 0.0 0.8 1.7 0.5 0.3 0.4 0.0 0.0 1.0 0.6 0.0 0.3 6.1 6.8 3.6 7.6 7.8 2.6 3.9 7.6 5.7 5.3 ITGA9 "ALPHA-RLC, ITGA4L, RLC" ENSG00000144668 "Integrin subunit alpha 9" Q13797 3 37452115-37823514 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 4.6;CACO-2: 10.6;HEL: 8.5;HMC-1: 5.0;SH-SY5Y: 12.7;WM-115: 6.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.1" "Lineage enhanced" "Detected in single" "granulocytes: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030609 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Intracellular and membrane" 250000 Vesicles "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA030609: AB_10600815" "unprognostic (2.35e-2)" "unprognostic (3.36e-2)" "unprognostic (5.58e-2)" "unprognostic (3.94e-2)" "unprognostic (4.48e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (8.87e-3)" "unprognostic (3.23e-1)" "unprognostic (2.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-2)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-2)" "unprognostic (3.16e-2)" 8.5 15.5 3.1 5.3 3.7 5.8 9.6 1.6 5.7 17.9 11.1 2.9 5.8 4.6 17.3 7.5 12.3 6.9 17.8 25.0 4.5 2.0 4.6 13.6 8.3 16.8 3.4 2.7 7.5 2.1 2.4 3.0 7.3 2.6 10.0 5.3 8.4 4.7 8.7 3.7 3.5 8.7 16.2 4.0 30.5 10.9 10.2 2.7 1.0 35.4 7.2 3.6 7.4 8.4 0.0 0.7 2.1 0.2 0.0 0.0 0.4 0.2 0.0 4.6 0.3 0.0 0.3 0.1 0.1 0.0 0.0 0.0 10.6 0.0 3.4 1.5 0.0 0.2 4.1 0.0 0.0 0.1 0.6 8.5 0.2 0.2 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.3 0.0 0.2 0.6 12.7 0.1 0.6 0.7 0.0 3.3 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.2 6.6 2.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 3.1 3.7 1.6 5.7 4.5 2.0 3.4 2.7 2.6 2.7 ITIH1 "H1P, IATIH, ITIH" ENSG00000055957 "Inter-alpha-trypsin inhibitor heavy chain 1" P19827 3 52777592-52792068 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 95 "liver: 321.2" "Cell line enhanced" "Detected in some" "ASC diff: 10.7;Hep G2: 3.2;HL-60: 2.5" "Cancer enriched" "Detected in some" 598 "liver cancer: 329.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 3.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041639, HPA042049" Approved Approved Vesicles "Secreted to blood" 4490000 31000000000 Vesicles "HPA041639: AB_10796349, HPA042049: AB_10797379" "unprognostic (1.87e-4)" "unprognostic (1.31e-3)" "unprognostic (2.38e-1)" "unprognostic (8.55e-2)" "unprognostic (1.03e-1)" "unprognostic (2.64e-3)" "prognostic favourable (1.89e-5)" "unprognostic (2.27e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (2.91e-2)" "unprognostic (8.45e-2)" "unprognostic (4.53e-4)" "unprognostic (4.02e-3)" "unprognostic (5.70e-3)" "unprognostic (2.08e-1)" "unprognostic (2.24e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 321.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.3 0.8 0.0 0.9 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.7 0.0 0.0 3.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ITIH4 "H4P, IHRP, ITIHL1" ENSG00000055955 "Inter-alpha-trypsin inhibitor heavy chain family member 4" Q14624 3 52812975-52831479 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 461.4" "Cell line enhanced" "Detected in some" "HDLM-2: 5.4;U-266/70: 6.6" "Cancer enriched" "Detected in single" 27 "liver cancer: 7.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.6" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001835, HPA003948, CAB072872" Enhanced Approved Vesicles "Secreted to blood" 3056667 53000000000 Vesicles "CAB072872: , HPA001835: AB_1079432, HPA003948: AB_1079433" "unprognostic (6.08e-2)" "unprognostic (4.45e-2)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "unprognostic (2.64e-1)" "unprognostic (1.96e-1)" "unprognostic (5.86e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-2)" "unprognostic (1.02e-1)" "unprognostic (2.47e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-14)" "unprognostic (1.71e-3)" "unprognostic (2.96e-2)" "unprognostic (1.52e-1)" "unprognostic (4.21e-5)" 0.5 1.8 0.1 0.1 0.1 1.0 0.1 0.1 0.2 0.4 0.2 0.1 0.1 0.1 0.1 1.3 0.2 0.1 0.1 0.6 0.1 0.0 0.2 461.4 0.2 0.1 0.1 0.2 0.2 22.8 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.2 4.1 0.1 0.1 0.2 0.1 0.5 0.1 0.3 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.3 0.3 0.6 0.6 2.6 0.8 0.0 0.0 0.4 1.0 2.1 1.1 0.0 0.4 0.1 0.0 0.0 0.2 0.3 0.2 1.3 0.0 0.5 1.1 0.0 0.0 0.5 5.4 0.2 2.2 0.0 2.9 0.9 2.5 0.2 0.3 0.4 0.0 0.1 0.0 0.6 1.8 0.0 0.2 0.5 0.7 1.0 0.0 1.8 1.0 0.0 0.8 0.7 0.1 1.0 0.7 0.0 0.4 1.1 0.7 0.2 0.0 0.9 1.0 0.0 6.6 3.1 0.5 0.1 0.7 1.2 0.0 0.6 0.0 0.1 0.1 0.1 0.3 0.7 0.0 0.0 0.2 0.0 0.8 0.6 2.6 0.1 0.3 0.4 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.2 0.1 ITIH5 MGC10848 ENSG00000123243 "Inter-alpha-trypsin inhibitor heavy chain family member 5" 10 7559270-7666998 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 58.6" "Cell line enriched" "Detected in some" 6 "WM-115: 47.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA038305 Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" "Golgi apparatus" Vesicles "HPA038305: AB_10670662" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "unprognostic (3.11e-3)" "unprognostic (6.80e-2)" "unprognostic (1.80e-1)" "unprognostic (5.84e-3)" "unprognostic (1.63e-1)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (2.90e-1)" "unprognostic (5.80e-3)" "unprognostic (6.11e-2)" "unprognostic (1.36e-1)" "unprognostic (6.79e-3)" "unprognostic (2.00e-2)" "unprognostic (4.50e-2)" "unprognostic (3.48e-2)" 42.6 2.4 3.7 15.2 5.0 0.0 33.7 2.9 5.1 8.1 9.4 3.6 4.4 4.1 12.0 8.6 6.9 3.4 18.8 4.8 4.4 4.0 5.3 2.3 6.9 3.2 4.4 4.3 7.2 4.4 1.4 3.1 58.6 4.6 11.0 5.3 12.7 3.4 16.2 4.7 4.1 5.7 37.5 3.9 2.2 5.6 4.0 2.2 0.0 6.4 5.2 5.5 24.0 11.7 0.8 0.4 1.4 0.5 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 8.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 47.1 1.4 0.3 0.3 0.4 0.4 0.5 0.4 0.6 0.4 0.2 0.8 0.6 0.5 1.0 0.5 0.5 0.4 0.5 0.1 3.7 5.0 2.9 5.1 4.4 4.0 4.4 4.3 4.6 2.2 ITM2A "BRICD2A, E25A" ENSG00000078596 "Integral membrane protein 2A" O43736 X 79360384-79367667 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 100.7" "Cell line enriched" "Detected in some" 8 "MOLT-4: 187.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 26.5;eosinophil: 16.8;gdT-cell: 23.2;MAIT T-cell: 17.0;memory CD4 T-cell: 44.6;memory CD8 T-cell: 36.5;naive CD4 T-cell: 48.0;naive CD8 T-cell: 22.6;NK-cell: 25.2;T-reg: 32.4" "Group enriched" "Detected in many" 7 "granulocytes: 26.5;NK-cells: 25.2;T-cells: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000296 Approved "Golgi apparatus,Vesicles,Plasma membrane" Vesicles "Golgi apparatus, Plasma membrane" "HPA000296: " "unprognostic (1.05e-2)" "unprognostic (5.22e-3)" "unprognostic (2.77e-3)" "unprognostic (5.65e-2)" "unprognostic (1.73e-2)" "unprognostic (1.06e-3)" "prognostic favourable (3.66e-6)" "unprognostic (1.57e-1)" "unprognostic (4.94e-2)" "unprognostic (9.85e-2)" "unprognostic (1.33e-2)" "unprognostic (2.57e-1)" "unprognostic (1.04e-2)" "unprognostic (1.56e-1)" "unprognostic (3.31e-1)" "unprognostic (2.18e-1)" "unprognostic (4.30e-1)" 27.2 4.1 27.0 9.1 37.8 13.6 27.4 7.8 25.8 21.8 11.0 16.1 6.5 5.4 16.4 19.4 14.8 15.3 10.6 42.1 33.6 22.5 7.7 2.2 19.0 28.5 34.8 19.5 69.6 6.3 2.7 9.3 10.6 25.8 16.7 11.9 16.2 28.2 8.8 13.2 10.3 8.8 20.9 33.9 8.4 9.6 8.0 12.5 100.7 31.1 14.1 16.5 14.7 16.6 4.7 1.1 26.5 0.2 25.2 48.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.3 0.0 0.4 0.0 7.6 0.0 0.0 0.0 12.2 14.2 2.3 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 187.9 8.5 2.8 0.0 0.0 0.0 0.0 7.3 0.0 0.0 2.1 0.0 0.1 0.0 0.2 0.2 0.3 0.0 0.2 0.0 0.1 23.7 0.0 0.0 0.0 0.0 0.9 26.5 0.1 16.8 23.2 0.2 17.0 4.6 44.6 36.5 0.1 4.7 48.0 22.6 0.8 25.2 0.2 1.1 32.4 22.6 27.0 37.8 7.8 25.8 33.6 22.5 34.8 19.5 25.8 12.5 ITM2B "BRI, BRI2, BRICD2B, E25B, E3-16" ENSG00000136156 "Integral membrane protein 2B" Q9Y287 13 48233158-48270357 "Disease related genes, Predicted membrane proteins" "Amyloidosis, Deafness, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 346.2" "Cell line enhanced" "Detected in many" "HMC-1: 108.7;RPTEC TERT1: 154.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 236.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 236.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029292, HPA071992" Approved Enhanced "Golgi apparatus,Vesicles" "Intracellular and membrane" 2600000 "Golgi apparatus, Vesicles" "HPA029292: AB_10601917, HPA071992: " "unprognostic (4.66e-2)" "unprognostic (2.02e-1)" "unprognostic (1.03e-2)" "unprognostic (1.00e-1)" "unprognostic (4.41e-2)" "unprognostic (6.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "unprognostic (9.88e-2)" "unprognostic (2.42e-1)" "unprognostic (5.89e-2)" "unprognostic (2.87e-2)" "prognostic favourable (3.73e-5)" "unprognostic (4.38e-2)" "unprognostic (4.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.22e-1)" 89.3 79.6 60.6 41.3 61.6 25.0 79.6 87.2 65.8 72.6 58.3 64.9 93.4 83.4 61.2 346.2 71.5 53.2 59.4 86.9 75.9 61.4 198.7 65.1 80.2 75.9 71.7 49.8 100.7 48.5 27.0 63.1 132.0 50.2 66.5 36.0 80.8 75.1 99.8 30.9 73.5 81.0 53.1 90.0 78.5 64.5 44.7 48.3 35.0 73.1 63.0 47.7 63.3 74.5 13.3 23.3 236.4 46.6 17.2 31.7 73.7 8.6 7.5 12.7 23.8 48.5 29.4 18.9 22.9 29.0 11.5 14.6 5.3 41.5 2.3 19.5 16.7 35.3 6.8 16.5 9.7 6.7 16.1 16.4 6.1 14.6 20.9 16.1 108.7 17.6 14.8 6.7 7.5 14.8 4.2 19.9 14.0 5.8 25.9 35.6 34.8 10.2 11.7 12.6 11.7 154.6 40.9 4.3 17.1 20.3 16.7 11.8 10.9 17.1 23.8 9.6 9.6 12.5 11.1 7.8 7.2 0.3 14.0 9.4 21.4 136.9 46.6 141.3 21.3 35.7 28.1 12.0 29.8 26.5 23.3 13.3 31.7 26.5 236.4 17.2 35.5 10.3 28.7 73.7 60.6 61.6 87.2 58.0 75.9 61.4 71.7 49.8 50.2 48.3 ITPKA "IP3-3KA, IP3KA" ENSG00000137825 "Inositol-trisphosphate 3-kinase A" P23677 15 41493393-41503551 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 28.8;intestine: 19.8;stomach 1: 10.7" "Cell line enhanced" "Detected in many" "Hep G2: 22.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 12.3;basal ganglia: 21.2;cerebral cortex: 28.8;hippocampal formation: 10.4;olfactory region: 8.2" "Cell type enriched" "Detected in single" 8 "MAIT T-cell: 4.7" "Lineage enriched" "Detected in single" 13 "T-cells: 4.7" "Group enriched" "Detected in many" 13 "amygdala: 120.1;basal ganglia: 97.6;cerebellum: 62.9;cerebral cortex: 164.4;hippocampal formation: 162.9" "Group enriched" "Detected in many" 7 "amygdala: 12.1;basal ganglia: 40.8;cerebral cortex: 32.2;hippocampal formation: 28.6" HPA040454 Enhanced Approved Approved Vesicles Vesicles "HPA040454: AB_10672897" "unprognostic (5.91e-2)" "unprognostic (2.16e-3)" "unprognostic (4.19e-1)" "unprognostic (3.57e-3)" "prognostic unfavourable (6.77e-4)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.58e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (2.06e-1)" "prognostic unfavourable (3.76e-9)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-3)" "unprognostic (2.10e-2)" 0.4 3.0 12.3 1.1 21.2 0.8 0.4 3.0 28.8 0.6 8.5 0.3 0.0 19.8 0.6 0.5 0.4 0.6 0.6 0.7 10.4 0.9 0.4 0.8 0.4 0.4 1.6 8.2 0.6 2.5 1.7 0.0 0.7 0.3 0.8 3.4 0.0 2.1 0.8 1.4 0.4 19.7 0.7 0.2 0.4 10.7 3.5 0.6 0.0 0.4 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.3 4.7 0.0 4.8 1.3 0.2 5.6 0.0 1.8 10.2 3.0 2.4 2.0 2.1 11.2 0.2 0.0 2.5 0.2 0.5 2.4 0.2 0.1 4.5 3.0 6.8 3.0 22.7 9.2 2.3 0.3 0.1 0.1 1.9 0.6 0.1 8.6 1.3 0.7 3.2 0.2 4.4 0.6 4.0 1.1 1.0 0.4 0.2 0.3 0.5 1.1 2.2 0.0 0.2 0.6 3.4 0.2 4.9 5.1 5.5 8.1 0.7 7.1 0.0 9.1 9.0 1.6 0.0 0.0 0.0 0.3 0.0 4.7 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.3 21.2 3.0 28.8 10.4 0.9 1.6 8.2 0.3 0.6 ITPR1 "ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29" ENSG00000150995 "Inositol 1,4,5-trisphosphate receptor type 1" Q14643 3 4493348-4847840 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Apoptosis, Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 46.6" "Cell line enhanced" "Detected in many" "HDLM-2: 34.3;HeLa: 25.0;HMC-1: 16.5;U-87 MG: 20.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 782.1" "Low region specificity" "Detected in all" "HPA014765, HPA016487" Approved Approved Vesicles 37000 Vesicles "HPA014765: AB_1851843, HPA016487: AB_1851842" "unprognostic (1.92e-1)" "unprognostic (5.04e-2)" "unprognostic (1.34e-1)" "unprognostic (1.75e-1)" "unprognostic (2.16e-2)" "unprognostic (3.61e-2)" "unprognostic (1.60e-1)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.17e-2)" "unprognostic (1.92e-2)" "unprognostic (2.08e-1)" "unprognostic (2.77e-2)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (3.43e-4)" "unprognostic (2.40e-1)" 4.8 8.2 6.1 7.4 18.6 3.2 11.9 39.5 30.2 10.2 7.4 1.7 21.5 2.4 18.4 13.2 7.8 10.1 11.8 5.3 8.7 5.1 8.7 2.5 6.4 7.1 4.8 10.4 14.2 2.7 46.6 7.3 4.6 3.8 15.0 3.7 12.5 9.6 27.4 3.2 3.2 5.0 17.4 3.7 6.0 5.5 3.0 4.3 7.0 19.3 0.6 8.6 14.1 10.6 8.9 3.6 5.4 1.6 1.2 2.2 1.2 0.0 1.2 0.2 0.6 9.8 0.4 3.2 0.2 0.2 0.3 0.3 0.3 0.3 4.3 0.4 0.4 0.0 0.9 1.1 0.5 34.3 1.3 12.4 25.0 1.6 13.5 5.2 16.5 2.6 0.7 1.7 0.5 1.4 1.3 5.0 1.3 0.5 2.3 1.8 0.9 3.8 1.4 0.2 0.3 1.1 1.1 0.1 8.3 2.2 1.4 2.3 0.9 7.5 1.7 0.8 1.4 1.1 1.0 7.6 3.7 2.9 20.4 5.6 1.7 5.4 1.6 1.9 1.5 1.0 1.9 6.6 1.7 1.5 2.1 8.9 2.2 1.9 0.8 1.2 0.7 3.6 1.3 1.2 6.1 18.6 39.5 30.2 8.7 5.1 4.8 10.4 3.8 4.3 ITPR3 IP3R3 ENSG00000096433 "Inositol 1,4,5-trisphosphate receptor type 3" Q14573 6 33620365-33696574 "Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "basophil: 1.8;gdT-cell: 2.8;MAIT T-cell: 2.1;memory B-cell: 1.5;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.0;naive B-cell: 2.0;naive CD4 T-cell: 1.4;naive CD8 T-cell: 1.7;T-reg: 2.4" "Group enriched" "Detected in many" 10 "B-cells: 2.0;granulocytes: 1.8;T-cells: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003915, HPA064704" Approved Uncertain Vesicles Vesicles "HPA003915: AB_1851845, HPA064704: " "unprognostic (2.57e-1)" "unprognostic (2.81e-2)" "unprognostic (1.52e-2)" "unprognostic (2.30e-1)" "unprognostic (5.40e-2)" "unprognostic (1.24e-1)" "unprognostic (2.08e-2)" "unprognostic (6.14e-2)" "unprognostic (3.35e-1)" "unprognostic (3.08e-2)" "unprognostic (4.14e-3)" "unprognostic (1.88e-1)" "unprognostic (6.44e-3)" "unprognostic (5.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.89e-2)" "unprognostic (2.43e-2)" 7.8 6.0 2.0 17.8 2.4 2.6 9.0 1.7 2.3 6.5 39.6 1.0 35.1 14.8 7.7 15.6 10.0 6.7 28.9 7.2 1.8 1.4 8.6 1.2 21.0 9.7 4.4 1.2 7.3 11.0 1.3 3.9 3.9 4.0 7.2 9.5 5.4 12.7 26.0 2.7 27.9 44.0 6.6 3.5 20.0 21.4 20.1 1.9 10.6 28.4 9.7 18.1 5.2 16.5 2.0 0.2 1.8 0.0 0.1 2.8 0.7 21.7 10.2 1.9 0.1 1.9 6.1 12.7 7.5 19.2 9.4 8.6 14.0 17.0 18.6 8.1 5.4 21.5 8.7 20.2 4.9 10.8 7.3 0.0 29.1 15.4 4.4 3.3 2.4 4.4 18.4 23.7 51.6 15.9 7.2 6.0 10.1 10.4 5.5 1.9 1.9 15.1 8.5 0.0 10.9 33.6 15.3 17.8 0.6 12.9 18.9 18.6 6.5 1.7 21.7 12.8 6.4 16.4 16.4 4.2 4.1 8.8 10.3 5.0 7.3 1.8 0.0 0.0 2.8 0.0 2.1 1.5 1.7 2.0 0.2 2.0 1.4 1.7 0.0 0.1 0.0 0.0 2.4 0.7 2.0 2.4 1.7 2.3 1.8 1.4 4.4 1.2 4.0 1.9 ITPRIP "bA127L20.2, DANGER, KIAA1754" ENSG00000148841 "Inositol 1,4,5-trisphosphate receptor interacting protein" Q8IWB1 10 104309698-104338404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 81.5" "Cell line enhanced" "Detected in many" "hTCEpi: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 24.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 24.1" "Low region specificity" "Detected in all" HPA043626 Uncertain Vesicles Vesicles "HPA043626: AB_10963078" "unprognostic (2.45e-2)" "unprognostic (3.06e-1)" "unprognostic (1.59e-2)" "unprognostic (3.22e-2)" "unprognostic (1.08e-2)" "unprognostic (4.20e-1)" "unprognostic (7.87e-2)" "prognostic unfavourable (3.59e-4)" "unprognostic (9.74e-2)" "unprognostic (1.87e-1)" "unprognostic (2.64e-2)" "unprognostic (4.00e-2)" "unprognostic (5.37e-3)" "unprognostic (1.01e-3)" "unprognostic (2.65e-1)" "unprognostic (2.75e-1)" "unprognostic (2.11e-3)" 23.7 5.8 3.5 7.4 3.8 81.5 20.8 0.5 4.3 13.5 5.5 4.5 6.8 1.6 8.5 6.0 29.5 5.6 9.8 33.8 3.0 1.5 6.9 7.2 20.2 9.8 4.4 1.5 19.9 4.4 4.4 7.3 24.4 4.7 8.6 2.5 21.7 6.7 7.3 7.6 26.4 3.8 8.4 3.4 8.8 5.6 8.4 5.2 12.9 14.0 14.6 14.2 13.6 17.3 2.4 4.4 24.1 5.7 3.2 3.4 9.7 2.3 5.8 7.0 3.1 12.3 11.9 4.0 13.0 27.6 9.5 11.9 0.4 1.0 4.1 2.9 8.0 7.6 2.3 6.3 9.9 3.5 2.9 2.4 9.2 1.7 24.3 5.4 4.6 11.0 38.2 19.8 15.9 17.7 10.2 7.8 11.6 0.9 1.1 6.0 5.2 6.8 5.1 3.7 2.4 3.9 1.0 4.0 2.6 2.4 2.8 5.7 0.2 4.1 30.6 19.3 5.1 12.7 12.3 3.0 3.5 2.7 14.1 9.9 9.0 3.5 5.7 9.9 3.4 4.1 3.3 1.9 1.9 1.9 4.4 2.4 2.3 2.0 24.1 3.2 3.7 3.1 1.5 9.7 3.5 3.8 0.5 4.3 3.0 1.5 4.4 1.5 4.7 5.2 ITSN2 "KIAA1256, PRO2015, SH3D1B, SH3P18, SWA, SWAP" ENSG00000198399 "Intersectin 2" Q9NZM3 2 24202864-24360714 "Predicted intracellular proteins" "Differentiation, Endocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036475 Approved Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA036475: AB_10670718" "unprognostic (2.36e-1)" "unprognostic (1.28e-1)" "unprognostic (1.24e-1)" "unprognostic (5.95e-2)" "unprognostic (4.64e-1)" "prognostic favourable (2.98e-4)" "unprognostic (3.32e-2)" "unprognostic (3.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.66e-1)" "unprognostic (2.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.72e-2)" "unprognostic (2.41e-2)" "unprognostic (2.12e-2)" 16.8 18.8 13.4 30.7 14.8 41.4 16.6 15.2 18.3 17.4 16.8 11.5 17.9 11.3 15.1 11.8 31.4 13.3 12.6 17.3 12.0 10.3 15.3 17.7 23.6 31.7 15.0 11.7 16.4 42.6 16.1 27.2 15.9 14.3 19.1 13.5 9.9 17.2 17.2 23.5 20.5 20.2 18.0 13.3 27.8 16.2 9.6 17.0 27.0 35.1 15.6 31.8 19.8 22.9 27.2 10.6 43.0 20.4 8.9 13.0 6.8 15.9 7.8 1.9 5.7 5.7 7.6 17.6 9.7 9.2 4.5 5.4 7.5 8.6 24.8 8.6 8.1 7.3 8.8 6.1 7.6 19.7 8.2 33.7 4.8 8.4 9.6 17.2 19.5 5.9 7.2 7.9 13.9 14.2 9.5 18.9 7.1 6.5 7.1 8.5 3.6 7.7 8.9 22.7 7.4 8.0 30.2 1.3 4.0 7.7 8.3 11.7 5.7 9.3 19.5 9.7 8.5 8.0 9.0 20.8 22.9 26.0 7.7 16.0 8.5 20.6 11.4 19.9 12.4 13.9 13.0 24.1 10.8 10.8 10.6 27.2 11.0 9.9 43.0 8.9 20.4 7.0 11.2 6.8 13.4 14.8 15.2 18.3 12.0 10.3 15.0 11.7 14.3 17.0 JAG2 ENSG00000184916 "Jagged 2" Q9Y219 14 105140981-105168824 "Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 36.0" "Cell line enhanced" "Detected in many" "HaCaT: 32.3;SCLC-21H: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025481, HPA030636, HPA050567" Approved Supported Vesicles,Cytosol 120000 Vesicles Cytosol "CAB025481: , HPA030636: AB_10602607, HPA050567: " "unprognostic (6.74e-2)" "unprognostic (4.49e-2)" "unprognostic (4.28e-2)" "unprognostic (6.97e-3)" "unprognostic (3.50e-1)" "unprognostic (2.13e-2)" "unprognostic (1.01e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-2)" "unprognostic (2.62e-1)" "unprognostic (1.67e-2)" "unprognostic (9.19e-2)" "unprognostic (8.47e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (2.39e-1)" "unprognostic (2.17e-1)" 11.5 2.5 5.4 3.5 6.3 1.3 11.4 6.4 8.4 4.2 3.0 3.5 5.2 3.2 7.5 8.4 8.1 5.0 4.4 9.5 5.6 6.4 3.0 1.5 6.6 2.4 4.5 5.3 2.7 5.8 4.3 15.9 6.8 8.7 7.1 1.7 5.9 12.2 6.9 16.8 36.0 4.3 3.2 2.9 3.7 3.8 4.2 3.0 2.7 4.2 11.0 4.1 5.2 5.6 0.0 0.0 0.0 0.0 0.5 0.3 0.0 8.4 3.4 0.2 0.8 0.0 0.0 10.5 0.1 0.1 0.0 0.0 2.8 10.5 0.0 7.3 0.0 32.3 2.1 10.8 0.0 1.1 5.0 0.0 9.3 0.0 0.1 0.0 2.0 0.1 5.3 0.0 1.2 2.6 2.0 0.0 0.0 3.8 0.0 0.0 1.0 1.2 2.6 2.0 3.6 0.1 2.2 16.6 0.5 2.9 0.7 0.1 8.2 1.2 8.9 0.0 0.9 0.0 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 5.4 6.3 6.4 8.4 5.6 6.4 4.5 5.3 8.7 3.0 JAGN1 "FLJ14602, GL009" ENSG00000171135 "Jagunal homolog 1" Q8N5M9 3 9890554-9894349 "Disease related genes, Predicted membrane proteins" "Immunity, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067610 Approved Vesicles Vesicles "HPA067610: " "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-3)" "unprognostic (1.97e-2)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (2.37e-2)" "unprognostic (6.36e-3)" "unprognostic (9.93e-3)" "unprognostic (2.70e-1)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.65e-2)" "unprognostic (2.49e-1)" 19.7 31.6 9.8 12.7 11.5 6.8 18.4 10.5 15.4 15.8 27.1 14.1 15.7 16.8 16.9 25.7 13.2 16.8 16.6 13.7 9.7 11.6 21.4 39.6 12.1 18.2 10.8 10.7 18.1 42.3 17.0 12.5 19.6 12.6 17.3 19.1 14.3 21.3 14.2 23.2 17.7 29.4 13.3 11.0 12.8 19.3 12.8 9.7 24.1 27.3 13.7 15.0 16.6 21.7 24.8 26.0 39.0 27.9 21.4 25.1 28.4 9.5 16.8 11.8 6.8 36.0 37.9 39.3 13.3 19.8 15.0 15.3 12.0 12.6 15.3 6.0 13.2 8.3 18.6 17.8 14.7 11.2 20.2 18.6 17.3 20.8 30.8 13.4 11.6 36.2 26.8 19.5 22.4 14.2 20.0 10.3 17.0 28.2 10.9 23.1 15.5 21.9 9.3 9.8 18.6 21.3 13.7 7.5 14.3 8.7 9.1 16.5 15.1 16.7 12.0 8.0 8.7 8.7 10.5 19.0 26.6 17.7 10.5 16.0 13.3 39.0 27.9 13.5 22.9 21.2 24.3 24.1 22.7 22.0 25.6 24.8 25.1 23.1 11.2 21.4 15.8 26.0 23.9 28.4 9.8 11.5 10.5 15.4 9.7 11.6 10.8 10.7 12.6 9.7 JCAD KIAA1462 ENSG00000165757 "Junctional cadherin 5 associated" Q9P266 10 30012800-30115494 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 14.8;HUVEC TERT2: 15.3;LHCN-M2: 12.8;TIME: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017956 Enhanced Supported "Vesicles,Cell Junctions" "Vesicles, Cell Junctions" "HPA017956: AB_1852408" "unprognostic (1.78e-1)" "unprognostic (8.33e-2)" "unprognostic (5.37e-2)" "unprognostic (8.07e-2)" "unprognostic (6.32e-2)" "unprognostic (7.09e-2)" "unprognostic (9.36e-2)" "unprognostic (1.28e-1)" "unprognostic (1.16e-1)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (3.08e-2)" "prognostic unfavourable (2.54e-4)" "prognostic unfavourable (2.01e-4)" "unprognostic (1.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.34e-2)" 27.0 7.5 6.2 9.1 12.4 0.5 18.0 2.2 8.8 10.1 29.4 3.2 5.4 1.7 16.5 8.1 5.9 10.8 9.9 16.3 6.2 4.7 6.0 2.0 22.3 3.2 6.7 8.9 11.3 15.7 4.7 4.8 30.5 8.9 14.1 4.1 24.4 2.5 9.7 9.2 3.7 3.7 27.8 6.8 1.2 5.0 13.0 4.4 1.4 13.0 3.9 2.0 18.3 22.8 0.2 0.1 0.8 0.0 0.3 0.2 0.0 7.5 3.4 3.1 0.0 1.9 0.4 4.5 4.1 4.3 0.6 1.0 1.3 0.0 0.0 0.3 14.8 0.1 0.8 0.2 1.7 0.8 1.8 0.0 0.0 0.0 8.5 0.0 0.5 4.8 0.1 10.3 0.7 15.3 0.0 0.0 12.8 0.2 0.0 0.3 0.6 5.2 0.0 1.7 0.0 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.7 34.4 7.8 1.9 2.4 0.3 3.2 0.4 0.0 1.8 5.2 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.0 6.2 12.4 2.2 8.7 6.2 4.7 6.7 8.9 8.9 4.4 JKAMP "C14orf100, CDA06, HSPC213, HSPC327, JAMP" ENSG00000050130 "JNK1/MAPK8 associated membrane protein" Q9P055 14 59484443-59505410 "Cancer-related genes, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031172, HPA071650" Supported Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA031172: AB_10670563, HPA071650: " "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (4.95e-2)" "unprognostic (5.88e-2)" "unprognostic (2.54e-1)" "unprognostic (1.49e-3)" "prognostic unfavourable (3.09e-6)" "unprognostic (2.68e-1)" "unprognostic (3.52e-1)" "unprognostic (1.16e-1)" "unprognostic (3.09e-1)" "unprognostic (3.14e-1)" "prognostic favourable (1.36e-4)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.73e-1)" 19.0 29.5 19.3 13.0 25.5 15.7 24.2 16.7 28.4 17.5 21.3 25.0 18.1 13.8 22.8 19.6 18.6 23.2 21.7 18.3 18.8 29.4 38.9 26.1 22.2 16.2 29.5 19.5 19.7 18.7 42.3 44.5 24.1 36.9 22.9 22.5 22.8 24.9 20.3 15.9 17.5 25.0 20.7 30.3 22.1 18.7 24.6 27.0 18.6 24.6 18.0 14.7 21.0 16.7 14.9 29.0 37.0 31.7 18.0 18.3 21.5 19.7 23.3 20.1 16.4 15.0 19.9 15.3 31.0 26.5 18.3 21.8 7.3 36.2 9.8 27.8 28.6 14.4 14.7 19.1 24.7 29.3 8.4 9.8 15.0 14.5 20.0 16.5 19.4 21.7 21.7 17.1 11.8 18.6 8.9 19.7 34.4 17.8 9.0 12.7 11.0 20.6 10.6 24.4 9.0 31.5 19.6 8.6 15.0 28.1 22.5 16.4 22.7 12.7 24.4 19.3 25.3 17.6 20.3 9.2 16.3 11.4 27.3 11.2 24.2 28.2 25.2 32.5 15.1 29.8 14.6 14.9 16.5 15.9 21.2 13.6 17.7 16.6 37.0 18.0 31.7 29.0 18.3 21.5 19.3 25.5 16.7 28.4 18.8 29.4 29.5 19.5 36.9 27.0 JMJD4 FLJ12517 ENSG00000081692 "Jumonji domain containing 4" Q9H9V9 1 227730425-227735411 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027260, HPA052861" Uncertain Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA027260: AB_10602608, HPA052861: " "unprognostic (1.80e-1)" "unprognostic (1.37e-1)" "unprognostic (4.86e-2)" "unprognostic (2.29e-1)" "unprognostic (1.43e-1)" "unprognostic (2.86e-1)" "unprognostic (1.23e-1)" "unprognostic (6.19e-2)" "unprognostic (1.74e-2)" "unprognostic (4.31e-2)" "unprognostic (8.69e-3)" "unprognostic (8.68e-3)" "prognostic unfavourable (3.16e-4)" "unprognostic (4.45e-2)" "unprognostic (2.82e-1)" "unprognostic (2.05e-1)" "unprognostic (4.68e-1)" 10.1 17.5 9.6 8.3 8.3 5.9 13.1 10.1 17.1 10.1 12.0 9.7 13.1 7.9 11.7 12.8 10.0 13.5 11.7 11.7 10.0 9.6 8.7 19.8 7.9 25.0 9.7 10.0 14.9 17.5 9.5 14.4 12.0 6.3 12.2 4.6 11.8 18.2 11.6 14.9 9.8 8.7 8.3 7.2 13.7 8.6 20.1 3.2 21.5 9.7 11.1 14.4 8.5 6.8 8.5 11.6 2.9 6.4 13.2 12.7 7.0 10.6 15.8 5.2 5.7 5.6 3.2 19.0 6.7 7.1 10.5 6.5 13.5 9.2 14.4 10.3 6.4 10.9 3.5 10.8 1.2 7.7 17.0 8.8 7.9 10.4 10.0 9.2 4.4 5.7 6.9 10.0 7.4 5.4 11.4 4.8 5.1 9.0 11.2 4.8 8.9 24.9 10.4 6.3 12.9 6.2 10.0 10.1 6.8 6.4 23.0 8.6 18.4 10.0 4.6 5.4 5.4 6.4 12.4 8.9 2.7 5.5 5.3 4.5 14.6 2.9 6.4 2.3 10.2 6.4 11.7 8.3 7.9 7.2 5.8 8.5 12.7 11.0 0.6 13.2 3.4 11.6 8.8 7.0 9.6 8.3 10.1 17.1 10.0 9.6 9.7 10.0 6.3 3.2 JTB "hJT, PAR" ENSG00000143543 "Jumping translocation breakpoint" O76095 1 153974269-153977688 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006514 Approved Approved "Vesicles,Actin filaments" Vesicles "Actin filaments" "HPA006514: AB_1079164" "unprognostic (1.33e-1)" "unprognostic (1.77e-1)" "unprognostic (8.01e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (3.40e-1)" "unprognostic (5.66e-3)" "unprognostic (8.62e-3)" "unprognostic (5.60e-2)" "prognostic favourable (7.87e-4)" "unprognostic (1.00e-3)" "unprognostic (8.16e-2)" "prognostic unfavourable (6.65e-9)" "unprognostic (1.36e-1)" "unprognostic (4.25e-1)" "unprognostic (5.48e-2)" "unprognostic (2.58e-3)" 23.9 30.2 28.5 23.0 32.7 43.2 32.6 30.7 32.3 31.8 36.0 23.6 51.3 35.9 25.1 41.0 30.4 26.1 37.1 36.2 25.4 23.9 34.2 81.1 27.7 34.7 27.7 19.8 26.9 106.8 24.8 49.8 30.0 24.4 33.4 36.0 24.9 100.6 45.9 42.1 23.4 45.6 21.6 20.5 35.9 42.4 15.3 25.2 30.5 58.5 32.0 34.0 25.2 33.0 47.4 54.1 60.7 43.0 30.4 46.4 30.2 39.5 27.4 11.8 21.6 38.8 24.1 33.3 28.9 28.2 19.3 19.5 26.3 32.9 37.8 41.0 33.4 36.2 29.8 22.2 15.8 35.6 59.6 21.9 32.6 26.6 40.7 42.2 33.8 22.9 42.0 20.3 24.1 22.8 32.5 27.8 13.5 68.8 30.4 54.2 25.3 48.3 32.2 16.1 75.9 24.4 21.7 32.4 32.8 22.9 66.5 38.7 41.8 61.4 17.8 9.6 16.5 28.9 36.8 41.5 46.3 41.0 23.6 40.6 20.6 32.6 43.0 60.7 29.4 30.3 35.5 47.4 41.1 46.4 33.4 45.2 42.4 33.7 39.9 30.4 33.4 54.1 33.6 30.2 28.5 32.7 30.7 32.3 25.4 23.9 27.7 19.8 24.4 25.2 JUP "CTNNG, DP3, DPIII, PDGB, PKGB" ENSG00000173801 "Junction plakoglobin" P14923 17 41754604-41786931 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cancer-related genes, Cardiomyopathy, Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 146.3;skin 1: 126.1;tongue: 122.8" "Cell line enhanced" "Detected in many" "HaCaT: 126.0;hTCEpi: 63.6;RT4: 77.4;SK-BR-3: 76.5;T-47d: 63.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002139, HPA032047" Supported Supported "Vesicles,Plasma membrane,Cell Junctions" 61000000 "Plasma membrane, Cell Junctions" Vesicles "CAB002139: AB_563468, HPA032047: " "unprognostic (3.96e-3)" "unprognostic (3.40e-1)" "unprognostic (2.32e-1)" "unprognostic (4.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (8.11e-3)" "unprognostic (1.41e-2)" "unprognostic (9.85e-3)" "unprognostic (2.29e-3)" "unprognostic (9.60e-2)" "prognostic favourable (2.06e-10)" "unprognostic (2.50e-1)" "unprognostic (9.49e-2)" "unprognostic (9.05e-2)" "unprognostic (1.51e-2)" 12.5 2.6 2.8 9.5 4.5 3.3 13.0 6.5 3.7 34.5 17.9 8.7 12.3 15.6 12.2 9.6 146.3 13.0 19.0 34.5 3.3 1.6 31.6 11.7 13.2 4.0 5.3 2.2 12.5 12.8 3.6 5.8 42.4 4.0 14.0 8.8 8.3 34.3 14.3 17.6 126.1 36.1 4.3 3.2 4.5 15.4 3.6 4.6 10.8 27.9 122.8 84.8 12.5 55.4 7.9 7.8 14.8 20.6 0.3 0.1 2.9 30.2 25.1 2.5 2.1 0.0 0.0 39.3 1.7 10.4 0.7 0.6 37.9 33.5 0.6 18.7 1.1 126.0 3.6 28.0 0.1 0.0 8.9 1.3 20.0 8.3 4.2 0.8 13.4 0.0 63.6 0.1 5.2 11.2 11.1 11.0 0.0 38.8 0.2 10.9 4.9 4.2 35.4 0.0 22.7 19.4 77.4 6.2 4.6 3.9 76.5 0.2 63.8 0.9 17.6 0.0 1.8 0.8 0.5 0.9 3.4 0.6 0.1 1.4 0.3 1.7 7.6 14.8 0.0 12.8 0.0 7.9 0.0 0.1 7.8 7.4 0.1 0.1 0.3 0.3 20.6 2.5 0.0 2.9 2.8 4.5 6.5 3.7 3.3 1.6 5.3 2.2 4.0 4.6 KAT14 "ATAC2, CRP2BP, CSRP2BP, dJ717M23.1, PRO1194" ENSG00000149474 "Lysine acetyltransferase 14" Q9H8E8 20 18138118-18188387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034224, HPA068443" Uncertain Approved Vesicles Vesicles "CAB034224: AB_2087753, HPA068443: " "unprognostic (4.02e-2)" "unprognostic (1.17e-1)" "unprognostic (8.60e-2)" "unprognostic (9.38e-2)" "unprognostic (3.98e-1)" "unprognostic (1.90e-2)" "unprognostic (3.37e-2)" "unprognostic (3.21e-1)" "unprognostic (4.04e-1)" "unprognostic (2.29e-1)" "unprognostic (7.15e-3)" "unprognostic (1.96e-2)" "prognostic favourable (4.64e-5)" "unprognostic (4.51e-1)" "unprognostic (4.51e-1)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" 9.1 13.1 16.4 8.2 22.3 3.2 13.6 19.9 27.2 13.3 14.6 13.7 12.4 16.1 12.8 17.9 11.0 15.8 11.5 13.1 17.5 15.9 15.7 13.9 10.2 12.0 14.9 16.8 18.6 17.9 20.4 16.5 14.5 14.4 12.5 15.1 10.9 11.4 13.7 28.2 13.8 16.8 12.7 15.6 11.5 19.5 13.2 9.6 11.5 14.7 9.7 13.1 12.7 10.6 10.4 8.4 2.0 10.9 13.3 15.0 8.1 4.6 7.1 5.6 5.9 7.4 5.8 46.9 4.6 5.5 5.0 5.8 24.1 6.1 11.8 3.4 3.5 6.5 6.2 5.9 4.5 4.2 2.7 5.8 1.9 3.9 5.5 6.8 4.8 5.3 8.5 3.7 6.2 4.7 4.3 5.2 6.7 5.3 11.3 3.7 7.9 8.1 6.0 12.9 3.9 6.1 2.6 8.9 4.9 5.8 13.7 7.3 4.9 4.9 3.9 5.8 2.6 4.0 4.5 5.9 11.1 6.4 1.7 3.7 5.2 0.3 6.4 2.0 10.2 6.3 11.7 8.8 10.2 11.8 8.4 10.4 15.0 11.1 0.5 13.3 10.9 7.2 6.3 8.1 16.4 22.3 19.9 27.2 17.5 15.9 14.9 16.8 14.4 9.6 KBTBD4 "BKLHD4, FLJ10450, HSPC252" ENSG00000123444 "Kelch repeat and BTB domain containing 4" Q9NVX7 11 47572197-47579015 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037792, HPA037793" Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA037792: AB_10671633, HPA037793: " "unprognostic (5.52e-2)" "unprognostic (2.23e-1)" "unprognostic (8.36e-3)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (7.32e-2)" "unprognostic (1.21e-1)" "unprognostic (2.09e-1)" "unprognostic (8.73e-3)" "unprognostic (2.78e-1)" "unprognostic (4.04e-2)" "unprognostic (7.22e-2)" "prognostic favourable (2.70e-7)" "unprognostic (4.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.07e-1)" "unprognostic (4.25e-2)" 8.4 13.4 7.9 6.7 15.9 11.7 9.0 16.2 25.8 9.0 9.7 13.6 13.3 6.5 12.3 13.7 8.0 15.5 7.6 9.5 7.5 8.7 12.0 9.4 8.6 10.7 7.0 7.1 13.2 8.4 23.0 11.9 10.0 11.7 12.1 9.2 13.6 8.6 10.5 19.1 10.8 10.3 10.0 6.2 9.9 9.0 11.6 4.6 13.5 12.4 9.4 14.2 10.9 8.1 12.4 6.6 11.8 5.3 12.3 14.7 10.4 5.0 10.5 11.3 9.5 6.9 9.4 4.0 8.5 10.1 11.1 9.6 4.4 9.4 9.3 4.9 9.7 8.4 6.3 11.2 9.5 11.9 10.1 6.7 14.6 4.9 5.1 13.9 13.6 8.5 7.8 4.4 6.0 11.2 5.3 7.2 8.6 12.6 10.2 4.4 6.2 7.5 10.2 15.3 5.9 11.8 10.6 15.7 10.4 7.3 9.8 6.4 16.5 4.5 10.2 8.0 8.9 11.0 8.4 11.2 17.2 12.8 11.1 4.0 8.2 10.7 5.3 11.8 13.7 4.3 14.7 12.4 11.0 12.6 6.6 11.0 11.7 12.5 8.0 12.3 4.1 3.1 12.8 10.4 7.9 15.9 16.2 25.8 7.5 8.7 7.0 7.1 11.7 4.6 KCNAB1 "AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3" ENSG00000169282 "Potassium voltage-gated channel subfamily A member regulatory beta subunit 1" Q14722 3 156037701-156539138 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.1;thyroid gland: 25.7" "Cell line enhanced" "Detected in many" "HEL: 5.8;hTEC/SVTERT24-B: 9.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 300.5" "Low region specificity" "Detected in all" "HPA036110, HPA044550" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" Vesicles "Nucleoplasm, Plasma membrane" "HPA036110: , HPA044550: AB_10797032" "unprognostic (1.52e-1)" "unprognostic (3.73e-1)" "unprognostic (1.33e-1)" "unprognostic (2.98e-4)" "unprognostic (1.24e-2)" "unprognostic (1.64e-1)" "unprognostic (1.81e-1)" "unprognostic (2.83e-2)" "unprognostic (8.51e-2)" "unprognostic (3.72e-2)" "unprognostic (5.87e-2)" "unprognostic (9.70e-2)" "unprognostic (2.17e-3)" "unprognostic (2.60e-1)" "unprognostic (1.95e-1)" "unprognostic (1.06e-1)" "unprognostic (4.00e-1)" 12.6 5.9 7.5 1.1 41.1 1.4 3.5 10.7 16.4 5.7 2.9 4.6 2.5 1.6 3.4 11.9 2.1 2.7 2.7 4.8 12.3 4.3 1.8 2.3 3.1 0.9 3.7 10.3 2.8 3.7 1.8 1.2 1.3 3.0 21.1 1.8 7.2 3.4 17.9 1.7 1.3 1.9 2.6 2.6 4.3 1.3 2.7 12.3 0.0 25.7 1.0 0.5 2.0 3.0 1.0 4.3 2.4 1.2 0.9 2.7 0.4 0.8 0.8 1.2 0.3 0.1 0.0 2.5 2.2 0.0 0.0 0.2 1.7 0.2 0.6 1.1 0.0 0.5 0.0 0.0 0.0 0.6 1.7 5.8 1.0 2.6 0.0 1.6 0.5 0.0 0.0 9.1 0.0 3.6 0.2 0.5 0.4 0.2 0.5 1.0 1.8 0.4 0.9 1.2 4.6 0.0 0.4 1.3 1.4 0.5 1.1 1.1 1.4 0.9 3.7 1.5 0.9 2.4 1.9 3.2 0.7 0.7 4.5 1.9 1.6 2.4 0.6 0.2 1.5 0.7 2.7 0.9 1.4 1.3 0.9 1.0 1.2 1.3 0.1 0.9 1.2 4.3 1.7 0.4 7.5 41.1 10.7 16.4 12.3 4.3 3.7 10.3 3.0 12.3 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.5" "Cell line enhanced" "Detected in some" "RH-30: 7.4;SCLC-21H: 7.0;SH-SY5Y: 4.3" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Region enhanced" "Detected in all" "cerebellum: 67.5" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: , HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.7 2.3 8.2 1.0 10.0 2.9 0.9 67.5 33.3 3.0 1.0 1.0 0.0 1.4 1.5 0.6 1.1 0.9 1.3 0.6 5.6 4.9 0.9 1.1 1.0 1.2 3.3 12.6 1.1 0.9 0.6 1.4 0.7 19.5 1.2 0.8 0.7 1.2 0.7 1.7 1.8 1.2 0.8 1.9 1.0 1.3 2.9 2.0 0.0 1.5 0.0 0.8 2.4 0.5 1.7 0.8 5.8 0.8 0.7 1.1 0.3 0.4 0.1 3.0 1.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.2 0.0 1.1 1.8 0.0 0.3 0.3 2.1 0.6 2.9 0.2 0.3 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.5 1.4 0.0 0.5 0.5 1.1 1.5 0.0 0.7 7.4 0.9 0.0 0.4 7.0 4.3 0.4 0.4 0.0 0.6 0.5 0.1 0.2 2.3 0.3 0.3 0.5 0.6 1.0 0.5 0.3 0.9 5.8 0.7 1.1 1.1 0.7 0.7 0.7 0.9 0.5 0.2 1.7 0.7 0.8 3.8 0.7 0.8 0.8 0.4 0.3 8.2 10.0 67.5 33.3 5.6 4.9 3.3 12.6 19.5 2.0 KCNG1 "K13, KCNG, kH2, Kv6.1" ENSG00000026559 "Potassium voltage-gated channel modifier subfamily G member 1" Q9UIX4 20 51003656-51023129 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 25.8;endometrium 1: 48.3" "Cell line enhanced" "Detected in many" "hTCEpi: 26.3;U-138 MG: 20.0;WM-115: 16.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 27 "naive B-cell: 10.8" "Lineage enriched" "Detected in single" 87 "B-cells: 10.8" "Group enriched" "Detected in many" 5 "amygdala: 21.4;basal ganglia: 17.0;cerebral cortex: 15.2;hippocampal formation: 19.7" "Group enriched" "Detected in all" 4 "amygdala: 16.3;basal ganglia: 12.0;cerebral cortex: 22.5;hippocampal formation: 21.1" "HPA039530, HPA040024" Approved Approved Vesicles Vesicles "HPA039530: AB_10795144, HPA040024: AB_10796338" "unprognostic (1.19e-1)" "unprognostic (4.47e-2)" "unprognostic (8.70e-2)" "unprognostic (3.49e-2)" "unprognostic (4.07e-2)" "unprognostic (5.05e-4)" "unprognostic (2.53e-2)" "unprognostic (3.89e-3)" "unprognostic (3.64e-2)" "unprognostic (3.43e-2)" "unprognostic (8.74e-2)" "unprognostic (8.89e-2)" "unprognostic (1.83e-9)" "unprognostic (1.52e-1)" "unprognostic (7.42e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-2)" 0.5 4.5 13.3 2.9 7.0 0.3 0.7 2.3 11.9 9.6 2.4 1.6 25.8 0.6 48.3 2.8 3.7 11.9 1.9 1.0 7.9 2.9 0.5 0.4 0.5 3.0 2.0 9.5 0.9 3.7 1.3 0.8 9.3 6.7 5.6 1.3 0.7 1.4 18.3 0.3 0.5 7.2 5.8 1.0 3.5 0.8 5.4 2.6 0.0 0.5 0.0 1.4 2.8 3.4 10.8 0.0 0.0 0.1 0.0 0.0 0.1 0.4 1.7 1.3 6.4 0.7 1.7 0.1 5.6 0.0 3.3 2.6 0.1 0.1 0.0 3.5 1.6 1.6 0.8 1.6 3.4 0.2 2.1 0.0 6.2 0.0 11.7 0.0 0.2 3.4 26.3 12.6 12.9 0.8 0.1 0.0 0.3 6.3 0.0 0.1 6.7 11.6 0.0 0.0 0.0 0.0 1.9 1.9 7.3 12.2 14.3 9.2 1.0 0.9 0.3 20.0 11.8 0.1 1.6 0.0 0.0 0.0 5.9 0.4 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 13.3 7.0 2.3 11.9 7.9 2.9 2.0 9.5 6.7 2.6 KCNH1 "eag, eag1, h-eag, Kv10.1" ENSG00000143473 "Potassium voltage-gated channel subfamily H member 1" O95259 1 210676823-211134180 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 20.2" "Cell line enhanced" "Detected in some" "LHCN-M2: 4.2;RH-30: 7.1;RPTEC TERT1: 4.1;SH-SY5Y: 9.0;SK-MEL-30: 8.5;T-47d: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014551, HPA019445" Enhanced Supported Vesicles Vesicles "HPA014551: , HPA019445: AB_1852118" "unprognostic (9.12e-2)" "unprognostic (4.82e-3)" "unprognostic (2.63e-1)" "unprognostic (6.70e-2)" "unprognostic (3.56e-1)" "unprognostic (3.63e-2)" "unprognostic (1.73e-1)" "unprognostic (9.36e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.77e-2)" "unprognostic (1.42e-3)" "unprognostic (1.17e-1)" "unprognostic (8.89e-2)" "unprognostic (1.36e-1)" "unprognostic (9.70e-2)" 0.9 2.3 6.3 1.3 13.3 0.7 0.6 19.1 20.2 1.0 1.3 3.3 0.2 1.2 1.5 1.0 0.9 1.2 1.0 0.7 3.8 1.7 1.0 0.7 0.7 0.7 1.1 7.5 0.8 0.9 0.9 0.8 1.1 1.7 1.3 1.3 0.0 0.8 0.9 0.7 0.9 1.0 1.0 2.1 0.6 1.5 2.4 1.5 0.0 0.8 0.0 0.7 0.9 0.7 0.1 0.7 0.7 0.1 0.1 0.3 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.1 0.6 0.1 1.4 1.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.1 0.0 0.0 7.1 0.0 4.1 0.0 0.3 9.0 1.6 0.1 8.5 6.3 0.0 0.0 1.1 0.1 1.3 0.8 0.0 0.0 0.0 0.2 0.0 0.5 0.7 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.7 0.1 0.0 6.3 13.3 19.1 20.2 3.8 1.7 1.1 7.5 1.7 1.5 KCNIP1 KCHIP1 ENSG00000182132 "Potassium voltage-gated channel interacting protein 1" Q9NZI2 5 170353487-170736632 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2;epididymis: 27.8" "Cell line enriched" "Detected in some" 23 "RPTEC TERT1: 35.9" "Cancer enriched" "Detected in some" 18 "glioma: 22.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022864, HPA066717" Uncertain Approved Vesicles Vesicles "HPA022864: AB_1858712, HPA066717: " "unprognostic (7.75e-5)" "unprognostic (2.66e-2)" "unprognostic (6.78e-2)" "unprognostic (3.22e-4)" "unprognostic (4.51e-2)" "unprognostic (3.49e-1)" "unprognostic (1.25e-2)" "unprognostic (2.69e-1)" "unprognostic (5.46e-2)" "unprognostic (6.62e-3)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (2.55e-1)" "unprognostic (2.58e-2)" "unprognostic (1.63e-1)" "unprognostic (2.39e-1)" "unprognostic (6.05e-2)" 1.1 5.9 20.6 1.2 27.9 0.6 1.9 6.4 31.2 4.0 1.0 6.0 5.2 0.9 2.7 27.8 1.0 2.8 2.9 1.2 11.7 20.5 4.9 0.8 1.9 1.2 12.9 7.3 0.9 2.4 5.1 0.7 2.1 11.1 2.3 1.3 0.8 1.3 7.9 0.8 0.7 1.1 2.1 6.9 2.2 1.1 5.2 5.3 0.0 1.2 0.0 1.2 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 35.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 27.9 6.4 14.6 11.7 20.5 12.9 7.3 11.1 5.3 KCNIP2 KCHIP2 ENSG00000120049 "Potassium voltage-gated channel interacting protein 2" Q9NS61 10 101825974-101843920 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 86.5;brain: 54.5;heart muscle: 74.8" "Cell line enhanced" "Detected in many" "HEL: 19.7;HMC-1: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 1.9;intermediate monocyte: 1.2;memory B-cell: 2.9;naive B-cell: 4.6" "Group enriched" "Detected in many" 5 "B-cells: 4.6;granulocytes: 1.9;monocytes: 1.2" "Group enriched" "Detected in many" 5 "amygdala: 96.2;basal ganglia: 204.2;cerebral cortex: 97.2;hippocampal formation: 151.4;olfactory region: 172.7" "Low region specificity" "Detected in all" HPA066717 Approved Vesicles Vesicles "HPA066717: " "unprognostic (5.92e-2)" "unprognostic (2.16e-1)" "unprognostic (3.48e-3)" "unprognostic (5.77e-4)" "unprognostic (1.34e-1)" "unprognostic (1.31e-3)" "unprognostic (8.80e-2)" "unprognostic (9.11e-3)" "unprognostic (1.14e-1)" "unprognostic (5.34e-2)" "unprognostic (3.18e-2)" "unprognostic (7.20e-2)" "unprognostic (1.49e-9)" "unprognostic (9.85e-2)" "unprognostic (1.81e-1)" "unprognostic (3.27e-1)" "unprognostic (8.37e-4)" 86.5 3.5 15.5 2.0 54.5 0.9 10.4 8.3 26.1 1.8 2.4 2.6 0.0 1.4 2.3 2.4 1.2 2.2 1.9 74.8 19.6 5.0 1.0 1.0 1.4 3.7 4.2 11.3 5.7 1.6 1.2 3.3 1.8 4.3 1.6 2.7 1.7 4.6 2.1 3.8 3.0 1.6 1.8 2.1 2.8 1.6 4.1 9.8 0.0 1.3 0.8 3.9 1.6 0.7 4.6 0.5 1.9 1.2 0.0 0.4 0.4 1.6 2.4 2.5 3.1 1.0 1.1 0.6 1.1 1.0 0.6 0.9 3.6 3.2 1.6 0.9 0.7 1.7 0.8 0.4 0.6 2.2 1.9 19.7 2.4 1.8 0.9 1.3 12.2 2.6 1.7 1.0 1.3 1.0 5.7 1.7 0.9 1.1 0.7 3.8 0.7 0.6 0.9 0.2 1.2 0.9 1.0 7.2 1.1 0.8 0.5 2.3 2.0 0.8 2.1 1.3 2.1 0.5 1.1 1.7 1.7 1.6 1.4 5.0 0.2 0.0 0.1 1.9 0.1 1.2 0.4 2.9 0.3 0.0 0.4 4.6 0.0 0.1 0.0 0.0 0.5 0.5 0.3 0.4 15.5 54.5 8.3 26.1 19.6 5.0 4.2 11.3 4.3 9.8 KCNIP3 "CSEN, DREAM, KCHIP3" ENSG00000115041 "Potassium voltage-gated channel interacting protein 3" Q9Y2W7 2 95297304-95386083 "Predicted intracellular proteins, Transporters" "Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport" "Ion channel, Potassium channel, Repressor, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.8;parathyroid gland: 32.5" "Cell line enhanced" "Detected in many" "A-431: 9.1;BJ hTERT+: 12.4;RPTEC TERT1: 24.4;U-138 MG: 11.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066717, HPA069797" Enhanced Approved Vesicles "Intracellular and membrane" Vesicles "HPA066717: , HPA069797: " "unprognostic (1.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.33e-3)" "prognostic unfavourable (1.58e-5)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" "unprognostic (2.23e-1)" "unprognostic (2.96e-1)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (2.32e-1)" "unprognostic (4.09e-1)" "unprognostic (1.44e-3)" "unprognostic (8.90e-2)" "unprognostic (6.51e-2)" "unprognostic (7.33e-2)" "unprognostic (1.04e-1)" 4.2 1.8 19.8 1.5 20.1 0.7 2.8 3.7 39.8 6.0 4.6 12.9 0.6 2.1 5.8 4.9 3.5 5.3 2.4 3.4 16.7 7.8 4.6 1.2 1.5 1.1 9.1 19.5 8.8 2.5 32.5 5.6 6.5 8.2 5.7 1.8 1.4 6.9 18.6 2.2 3.9 1.9 6.4 6.3 2.2 2.9 9.2 15.9 5.4 19.5 0.0 1.3 4.5 5.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.1 0.0 0.6 4.2 3.7 3.0 0.0 4.3 12.4 7.0 6.5 0.0 0.0 0.0 0.4 5.6 0.1 2.7 0.7 3.0 0.0 1.0 0.0 1.1 0.0 1.5 0.0 0.0 2.1 2.5 1.5 7.0 0.0 0.0 0.0 0.6 5.3 0.0 0.0 0.1 2.5 0.0 0.0 0.0 24.4 0.0 0.5 0.1 0.2 0.2 4.7 0.2 0.0 0.2 11.4 2.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 20.1 3.7 39.8 16.7 7.8 9.1 19.5 8.2 15.9 KCNIP4 "CALP, KCHIP4, MGC44947" ENSG00000185774 "Potassium voltage-gated channel interacting protein 4" Q6PIL6 4 20728616-21948799 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 9.9;SCLC-21H: 7.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022862, HPA066717" Supported Approved Vesicles Vesicles "HPA022862: AB_1852654, HPA066717: " "unprognostic (8.08e-2)" "unprognostic (1.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (9.26e-2)" "unprognostic (1.49e-1)" "unprognostic (2.53e-1)" "unprognostic (2.99e-2)" "unprognostic (1.18e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (3.11e-1)" "unprognostic (1.03e-2)" "unprognostic (2.69e-1)" "unprognostic (4.59e-2)" "unprognostic (2.10e-2)" 1.1 3.6 15.8 2.2 28.3 1.0 0.9 22.4 38.9 15.0 4.2 1.8 0.0 2.4 9.6 1.1 5.6 3.9 2.6 1.8 11.9 16.2 7.8 0.7 1.1 1.1 11.6 19.3 1.9 1.0 0.5 5.1 1.8 16.9 1.0 5.2 3.5 1.4 0.8 1.3 2.3 5.5 7.8 3.9 1.1 1.3 1.3 3.5 0.0 8.9 0.0 0.5 2.7 1.1 0.3 0.7 0.0 0.7 0.8 0.7 0.3 1.7 1.5 2.1 2.1 0.0 0.0 1.1 1.3 0.0 0.0 0.0 1.9 1.6 3.3 1.4 0.5 0.9 0.0 0.1 0.0 0.4 2.3 1.2 2.5 1.1 0.0 3.2 0.5 0.0 0.7 0.0 1.4 0.6 2.0 1.1 0.0 0.6 2.7 1.9 2.8 1.4 0.8 4.1 1.3 9.9 0.9 7.7 4.6 1.4 1.7 2.1 0.9 1.2 2.1 1.1 1.5 2.3 3.1 1.0 0.1 1.2 3.6 2.7 1.7 0.0 0.3 0.0 0.2 0.7 0.7 0.2 0.1 0.2 0.7 0.3 0.5 0.5 0.0 0.8 0.5 0.3 0.2 0.3 15.8 28.3 22.4 33.0 11.9 16.2 11.6 19.3 16.9 3.5 KCNJ15 "IRKK, Kir1.3, Kir4.2" ENSG00000157551 "Potassium voltage-gated channel subfamily J member 15" Q99712 21 38155549-38307357 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 74.8;kidney: 99.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 28.0;HBEC3-KT: 26.9;LHCN-M2: 12.3;RPTEC TERT1: 26.8;RT4: 31.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 29.6" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 21 "neutrophil: 74.8" "Lineage enriched" "Detected in many" 21 "granulocytes: 74.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA016702 Approved Approved "Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Vesicles, Cytosol" "HPA016702: AB_1855560" "unprognostic (6.34e-2)" "unprognostic (5.04e-2)" "unprognostic (7.92e-2)" "unprognostic (2.07e-3)" "unprognostic (1.21e-1)" "unprognostic (3.54e-3)" "unprognostic (2.72e-3)" "unprognostic (3.03e-2)" "unprognostic (6.79e-2)" "unprognostic (2.89e-3)" "unprognostic (3.77e-2)" "unprognostic (1.95e-2)" "prognostic favourable (4.09e-10)" "unprognostic (9.46e-3)" "unprognostic (1.82e-1)" "unprognostic (5.27e-2)" "prognostic favourable (1.95e-4)" 6.0 0.3 0.4 5.3 0.3 3.2 1.4 0.2 0.3 3.5 0.4 0.2 27.1 0.2 0.5 12.8 6.0 0.8 17.7 1.0 0.2 0.1 99.7 1.5 34.1 0.8 0.5 0.2 0.6 16.7 0.0 0.3 1.0 0.6 4.0 0.0 0.2 14.4 26.8 1.0 1.7 0.2 0.9 0.4 6.8 10.7 1.1 0.2 0.4 36.8 3.2 1.9 11.3 4.3 0.0 0.2 74.8 3.5 0.0 0.0 0.7 0.6 0.0 0.1 0.2 5.5 28.0 0.2 0.4 1.9 0.0 0.0 0.0 0.2 0.1 0.0 2.9 9.4 0.0 26.9 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 8.2 2.7 7.0 1.5 1.3 0.1 0.2 12.3 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 26.8 31.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.6 0.1 1.4 0.0 0.7 0.1 0.0 2.2 1.6 0.1 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 0.7 0.4 0.3 0.2 0.3 0.2 0.1 0.5 0.2 0.6 0.2 KCNJ16 "BIR9, Kir5.1" ENSG00000153822 "Potassium voltage-gated channel subfamily J member 16" Q9NPI9 17 70053429-70135608 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 96.5;parathyroid gland: 59.4;thyroid gland: 60.4" "Cell line enriched" "Detected in some" 23 "RPTEC TERT1: 78.9" "Group enriched" "Detected in many" 10 "renal cancer: 37.2;thyroid cancer: 80.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 5.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059563 Approved Uncertain Vesicles Vesicles "HPA059563: " "unprognostic (2.81e-3)" "unprognostic (2.10e-1)" "unprognostic (6.06e-2)" "unprognostic (1.20e-3)" "unprognostic (1.16e-1)" "unprognostic (7.53e-2)" "unprognostic (4.38e-4)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-2)" "unprognostic (3.35e-1)" "unprognostic (1.34e-1)" "prognostic favourable (9.61e-7)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "prognostic favourable (6.58e-4)" "unprognostic (3.88e-1)" 0.4 0.3 4.1 0.3 4.4 0.4 1.5 22.6 6.1 0.3 0.4 1.7 12.6 0.4 0.4 6.4 0.3 2.0 6.5 0.4 6.0 7.2 96.5 0.9 0.5 0.4 8.3 3.4 0.4 15.8 59.4 0.8 0.5 25.5 1.0 0.3 0.0 4.1 14.3 0.4 0.5 1.2 0.2 7.5 1.1 7.4 0.8 5.3 0.0 60.4 0.0 0.2 0.3 0.3 1.1 0.5 5.1 0.2 0.9 1.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 78.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.6 0.9 0.1 1.2 1.0 1.0 0.5 0.1 1.1 0.7 0.6 5.1 0.9 0.1 0.5 1.1 0.3 4.1 4.4 22.6 6.1 6.0 7.2 8.3 3.4 25.5 5.3 KCNK1 "DPK, K2p1.1, TWIK-1" ENSG00000135750 "Potassium two pore domain channel subfamily K member 1" O00180 1 233614004-233672512 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3" "Cell line enhanced" "Detected in many" "HeLa: 20.6;SCLC-21H: 19.4;U-266/70: 44.7;U-266/84: 40.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 75.3" "Cell type enriched" "Detected in single" 98 "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in single" 98 "dendritic cells: 9.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 236.2" "HPA016049, CAB022588" Approved Approved Vesicles Vesicles "CAB022588: , HPA016049: AB_1855571" "unprognostic (7.06e-3)" "unprognostic (1.76e-1)" "unprognostic (4.64e-2)" "unprognostic (7.46e-2)" "unprognostic (9.15e-2)" "unprognostic (1.27e-1)" "prognostic favourable (3.84e-4)" "unprognostic (4.32e-2)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "prognostic unfavourable (7.29e-4)" "unprognostic (1.10e-1)" "prognostic unfavourable (8.69e-8)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" 1.9 3.3 15.2 2.2 12.7 0.3 4.5 75.3 22.8 5.5 11.5 7.9 5.1 12.5 4.5 22.9 12.0 8.4 9.3 20.8 10.3 5.2 7.2 10.8 3.4 0.8 8.9 11.1 3.8 4.4 2.5 11.3 5.0 22.3 4.6 10.6 2.6 7.2 9.3 0.5 8.7 9.6 3.2 12.3 0.8 28.0 0.7 7.8 0.0 5.6 1.6 3.2 4.3 6.5 0.0 9.7 0.0 0.0 0.0 0.0 0.0 10.1 5.5 0.0 0.0 0.0 0.0 15.5 2.7 0.0 0.0 0.0 0.0 16.7 0.0 6.5 2.0 14.7 2.8 4.8 0.0 0.0 4.8 0.0 20.6 0.0 0.1 0.0 0.5 1.2 5.2 0.0 3.8 0.0 2.3 4.4 0.0 3.7 3.6 0.0 3.3 12.5 0.0 0.8 1.1 4.9 8.5 19.4 3.8 10.1 4.5 0.0 1.3 0.0 0.0 0.0 8.2 0.0 0.3 44.7 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 15.2 12.7 75.3 17.1 10.3 5.2 8.9 11.1 22.3 7.8 KCNQ5 Kv7.5 ENSG00000185760 "Potassium voltage-gated channel subfamily Q member 5" Q9NR82 6 72621792-73198851 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 6.6;brain: 23.0;skeletal muscle: 26.1;thyroid gland: 6.9" "Cell line enhanced" "Detected in many" "BJ: 20.1;HL-60: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA016655 Enhanced Approved Vesicles Vesicles "HPA016655: AB_1855557" "unprognostic (4.91e-2)" "unprognostic (1.42e-1)" "unprognostic (4.96e-2)" "unprognostic (3.78e-2)" "unprognostic (2.69e-1)" "unprognostic (2.18e-2)" "unprognostic (3.57e-2)" "unprognostic (1.43e-1)" "unprognostic (6.09e-2)" "unprognostic (8.55e-2)" "unprognostic (7.96e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (1.08e-2)" "unprognostic (2.62e-1)" "unprognostic (8.16e-2)" "unprognostic (1.39e-3)" 0.7 2.8 4.2 3.0 14.9 6.6 1.1 0.6 19.6 0.6 0.9 0.0 0.0 0.8 0.7 0.6 1.7 1.0 0.9 0.6 6.9 2.7 0.6 0.8 0.8 3.4 3.0 7.5 0.7 0.6 0.6 0.5 1.0 23.0 2.4 0.9 2.2 2.1 1.9 26.1 0.6 0.9 1.7 0.9 2.0 0.8 2.0 0.7 1.6 6.9 0.4 3.1 1.2 0.7 2.7 0.5 1.2 0.0 2.2 1.7 0.2 2.5 0.6 0.0 0.1 0.0 0.9 0.0 20.1 3.0 3.0 2.6 0.0 0.0 12.0 0.0 6.8 0.4 0.1 1.2 3.6 0.1 4.2 13.1 0.0 0.0 0.5 17.6 0.0 0.2 0.5 8.6 9.0 0.0 0.7 8.3 5.9 0.1 0.0 7.5 0.7 4.2 0.0 0.6 8.2 1.1 0.0 3.4 1.6 0.0 0.0 8.2 2.5 1.3 0.0 12.5 5.5 0.0 13.3 8.7 0.2 5.5 0.1 8.5 0.7 1.2 0.0 0.0 0.2 0.0 1.1 2.7 0.5 1.5 0.5 1.4 1.7 1.2 0.0 2.2 0.0 0.0 0.0 0.2 4.2 14.9 0.6 19.6 6.9 2.7 3.0 7.5 23.0 0.7 KCNRG ENSG00000198553 "Potassium channel regulator" Q8N5I3 13 50015254-50020922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 27.7;ovary: 17.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001027 Uncertain Vesicles Vesicles "HPA001027: " "unprognostic (1.85e-3)" "unprognostic (1.66e-2)" "unprognostic (1.08e-2)" "prognostic favourable (2.61e-5)" "unprognostic (3.15e-1)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (5.39e-3)" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (1.71e-1)" "unprognostic (5.91e-1)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (4.69e-2)" "unprognostic (1.52e-1)" "unprognostic (9.16e-2)" 0.4 0.2 0.3 0.3 0.3 1.1 0.6 0.9 0.3 1.8 0.3 0.5 0.3 0.3 1.0 4.8 0.6 27.7 0.3 1.0 0.3 0.5 0.6 0.3 9.1 0.3 0.3 0.3 17.1 0.3 0.4 0.4 0.3 0.5 0.5 0.8 0.3 0.3 1.7 0.4 0.8 0.4 0.4 0.3 0.4 0.3 1.7 0.3 0.3 0.4 0.3 0.6 0.3 0.3 2.7 1.2 4.4 1.1 1.3 1.4 0.4 1.0 0.9 3.1 1.0 1.0 1.5 0.5 0.2 2.4 2.0 0.1 3.6 1.0 2.0 0.6 2.9 1.2 2.3 0.8 1.5 1.4 1.5 4.0 1.5 1.6 2.9 3.3 1.1 2.0 2.2 1.5 3.7 3.9 1.6 0.4 2.5 1.2 3.6 3.2 2.1 1.4 2.6 0.0 0.0 1.8 2.6 2.6 5.6 1.1 1.9 1.8 1.5 1.1 1.3 1.8 0.8 1.1 0.8 0.2 0.5 2.1 0.6 1.3 0.4 3.2 1.1 0.7 0.5 1.1 0.7 1.5 0.7 1.0 0.9 2.7 0.8 0.9 4.4 1.3 0.8 1.2 1.4 0.4 0.3 0.3 0.9 0.3 0.3 0.5 0.3 0.3 0.5 0.3 KCNT2 "KCa4.2, SLICK, SLO2.1" ENSG00000162687 "Potassium sodium-activated channel subfamily T member 2" Q6UVM3 1 196225779-196609225 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 3.0;HHSteC: 4.8;NTERA-2: 3.8;SCLC-21H: 10.5;SH-SY5Y: 9.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051218 Uncertain Approved Vesicles Vesicles "HPA051218: " "unprognostic (5.06e-2)" "unprognostic (2.94e-2)" "unprognostic (8.01e-2)" "unprognostic (5.10e-6)" "unprognostic (1.22e-3)" "unprognostic (1.30e-2)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (5.90e-2)" "unprognostic (2.18e-1)" "unprognostic (9.56e-3)" "unprognostic (2.61e-1)" "prognostic unfavourable (1.67e-5)" "unprognostic (3.30e-4)" "unprognostic (2.95e-2)" "unprognostic (4.75e-1)" "unprognostic (1.72e-3)" 3.9 2.8 4.8 1.3 5.5 0.6 2.2 1.4 8.3 1.8 2.3 0.6 0.0 2.1 2.2 1.7 4.0 2.7 5.9 6.8 9.4 3.1 1.8 10.5 5.5 1.3 1.8 5.2 14.9 1.1 0.9 14.1 1.8 3.7 4.2 2.5 2.9 2.6 2.5 1.2 1.9 2.1 2.6 5.2 1.4 2.6 3.3 1.0 0.0 4.5 3.4 1.2 3.3 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.1 0.3 0.0 0.0 1.5 0.3 3.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 1.8 0.0 4.8 0.0 0.0 1.2 0.0 0.5 0.1 0.6 0.1 0.0 0.3 0.0 0.2 0.0 3.8 0.2 0.0 0.3 0.0 0.0 0.8 10.5 9.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 5.5 1.4 8.3 9.4 3.1 1.8 5.2 3.7 1.0 KCTD14 MGC2376 ENSG00000151364 "Potassium channel tetramerization domain containing 14" Q9BQ13 11 78015715-78046191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 15.1;Hep G2: 16.5;RPTEC TERT1: 26.8;U-2 OS: 12.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 5.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA041118, HPA042181" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA041118: AB_10963117, HPA042181: AB_10968059" "unprognostic (7.37e-3)" "unprognostic (4.27e-2)" "unprognostic (7.03e-2)" "unprognostic (6.93e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-2)" "unprognostic (2.04e-3)" "unprognostic (3.26e-1)" "prognostic unfavourable (3.96e-5)" "prognostic favourable (8.01e-4)" "prognostic unfavourable (1.05e-4)" "unprognostic (3.19e-1)" "prognostic favourable (6.92e-5)" "unprognostic (2.42e-2)" "unprognostic (2.05e-1)" "prognostic favourable (5.93e-4)" "unprognostic (1.63e-1)" 2.6 18.9 1.2 1.5 0.8 0.0 11.6 5.5 0.8 6.5 4.8 1.2 40.8 2.5 2.3 10.8 2.1 6.8 10.3 0.7 1.0 1.3 10.7 14.4 9.6 0.3 0.9 0.5 2.4 42.8 6.2 2.5 5.1 1.3 5.3 6.9 5.8 43.9 47.8 0.7 1.5 6.1 0.9 0.8 0.7 12.1 1.9 0.8 0.7 12.4 2.9 3.6 1.4 1.1 0.4 1.4 0.6 1.1 1.1 1.8 0.4 0.0 2.0 0.3 0.3 0.8 0.4 2.1 1.1 0.9 2.0 5.0 7.8 5.1 0.0 5.6 0.6 0.6 0.3 15.1 5.3 0.2 7.7 0.0 1.8 16.5 3.0 0.1 0.0 2.4 0.4 8.2 6.5 0.5 0.1 0.0 0.8 0.1 0.2 0.4 3.8 0.3 0.2 0.0 0.0 26.8 2.0 1.3 0.1 0.0 0.1 2.5 0.8 0.6 0.4 0.1 12.2 0.4 0.2 0.1 0.1 0.1 0.1 0.1 2.2 0.0 0.7 0.6 0.7 0.9 0.5 0.0 0.7 1.8 1.4 0.4 0.8 1.8 0.2 1.1 1.1 1.3 0.0 0.4 1.2 0.8 5.5 0.8 1.0 1.3 0.9 0.5 1.3 0.8 KCTD8 ENSG00000183783 "Potassium channel tetramerization domain containing 8" Q6ZWB6 4 44173909-44448807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.5" "Cell line enhanced" "Detected in some" "HAP1: 4.0;NTERA-2: 2.8;PC-3: 1.7;SCLC-21H: 10.6;U-2 OS: 3.2" "Cancer enhanced" "Detected in some" "glioma: 0.9;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA031562 Enhanced Approved Vesicles Vesicles "HPA031562: AB_10602609" "unprognostic (1.49e-2)" "unprognostic (7.70e-3)" "unprognostic (1.53e-1)" "unprognostic (4.15e-1)" "unprognostic (1.77e-2)" "unprognostic (1.48e-1)" "unprognostic (7.85e-2)" "unprognostic (2.62e-3)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (2.57e-3)" "unprognostic (8.72e-2)" "unprognostic (3.55e-2)" "unprognostic (2.44e-1)" 2.0 1.4 5.4 0.9 12.2 0.7 0.9 19.5 18.9 2.2 1.0 8.5 3.5 0.8 4.2 1.3 0.8 1.1 1.5 1.1 4.8 5.2 2.8 0.7 1.0 0.7 8.9 4.0 4.3 2.4 0.7 0.2 0.7 6.8 1.5 1.1 2.3 1.7 3.1 2.6 0.8 0.9 2.3 8.0 0.7 2.6 3.8 8.3 0.0 8.6 0.4 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.7 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 12.2 19.5 8.5 4.8 5.2 8.9 4.0 6.8 8.3 KDELC2 MGC33424 ENSG00000178202 "KDEL motif containing 2" Q7Z4H8 11 108472105-108498432 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039315, HPA039817, HPA066134" Uncertain Approved Nucleoplasm,Vesicles "Intracellular and membrane" Nucleoplasm Vesicles "HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: " "unprognostic (1.29e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-1)" "unprognostic (7.65e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-2)" "prognostic unfavourable (1.45e-4)" "unprognostic (6.04e-2)" "unprognostic (3.49e-3)" "unprognostic (1.49e-1)" "unprognostic (6.00e-3)" "unprognostic (4.08e-3)" "unprognostic (1.66e-3)" "unprognostic (1.85e-2)" "unprognostic (1.31e-1)" "unprognostic (1.90e-1)" "prognostic unfavourable (6.27e-5)" 20.8 7.8 4.2 12.7 4.7 2.7 19.7 3.6 3.2 27.2 11.1 4.8 9.7 4.1 21.8 21.1 16.1 17.6 18.0 13.3 4.1 4.2 11.4 13.5 12.5 10.0 4.6 2.7 25.6 9.5 19.8 5.1 65.0 4.6 20.6 8.0 13.4 13.0 14.5 8.1 6.9 7.3 24.4 5.0 9.9 8.9 9.5 4.4 10.0 9.2 8.7 6.5 19.5 20.0 0.9 2.0 0.2 1.5 4.5 4.6 1.0 3.1 3.6 14.1 14.4 23.8 27.7 13.5 14.0 13.1 20.1 21.9 17.2 23.4 0.0 8.8 18.2 2.3 10.6 0.3 21.3 5.6 8.2 5.3 4.0 7.9 9.6 13.7 0.0 15.9 4.4 10.6 0.3 16.9 11.8 0.1 30.4 2.3 8.8 7.9 6.1 10.4 0.4 22.0 0.0 3.7 8.8 2.9 9.0 26.5 1.8 3.8 12.7 5.3 16.8 39.0 7.7 3.3 14.5 0.1 0.0 0.0 10.0 14.5 30.9 0.1 0.3 0.0 4.6 1.5 3.9 0.5 2.3 3.8 1.1 0.9 2.4 3.6 0.2 4.5 0.7 2.0 1.9 1.0 4.2 4.7 3.6 3.2 4.1 4.2 4.6 2.7 4.6 4.4 KDELR1 "ERD2, ERD2.1, HDEL" ENSG00000105438 "KDEL endoplasmic reticulum protein retention receptor 1" P24390 19 48382570-48391553 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017455 Approved Supported "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus" "Vesicles, Cytosol" "CAB017455: AB_10615208" "unprognostic (3.10e-2)" "unprognostic (4.17e-2)" "unprognostic (1.64e-1)" "unprognostic (1.87e-1)" "unprognostic (1.94e-1)" "prognostic unfavourable (3.49e-4)" "prognostic unfavourable (1.61e-4)" "unprognostic (2.35e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-1)" "unprognostic (1.51e-1)" "unprognostic (7.55e-2)" "unprognostic (4.97e-2)" "unprognostic (3.81e-1)" "unprognostic (2.74e-1)" "unprognostic (3.06e-1)" "unprognostic (1.68e-2)" 46.9 49.3 22.6 23.4 21.5 14.5 60.6 16.1 28.8 51.8 43.3 24.4 64.8 47.7 44.0 45.2 41.3 40.3 56.5 42.8 20.9 20.4 57.3 81.3 38.0 44.6 18.6 20.4 68.9 61.0 63.5 45.7 81.4 20.9 44.8 47.7 39.7 65.8 69.9 31.8 37.4 59.9 39.6 26.0 33.7 42.5 33.2 18.6 26.2 75.5 32.9 42.3 53.2 54.4 10.6 26.5 6.8 23.3 11.6 12.8 9.3 30.1 43.7 25.4 26.9 57.1 66.8 18.6 29.8 52.8 36.4 41.8 28.8 34.5 12.6 19.6 65.2 27.1 30.5 31.9 34.8 10.1 32.6 10.5 15.5 53.6 49.7 11.7 19.7 63.1 39.4 24.7 26.5 33.8 18.2 23.5 48.3 24.3 11.0 120.2 18.4 17.8 15.7 15.1 19.7 46.2 25.2 25.5 19.8 26.1 23.5 15.6 18.4 14.4 26.1 25.8 21.3 21.3 25.3 66.5 52.0 8.5 16.3 15.8 26.2 5.9 23.3 6.8 11.2 19.8 12.8 10.6 11.0 12.1 17.7 9.6 9.2 9.9 5.9 11.6 16.5 26.5 11.7 9.3 22.6 21.5 16.1 28.8 20.9 20.4 18.6 20.4 20.9 18.6 KIAA0319 NMIG ENSG00000137261 KIAA0319 Q5VV43 6 24544104-24646155 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 23.5" "Cell line enhanced" "Detected in some" "A-431: 3.6;A549: 4.1;HDLM-2: 4.8;SCLC-21H: 7.8;U-266/84: 6.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 1.4;neutrophil: 5.0" "Group enriched" "Detected in many" 32 "B-cells: 1.4;granulocytes: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015607, HPA076313" Enhanced Supported Approved Vesicles "Secreted in brain" Vesicles "HPA015607: AB_1852299, HPA076313: " "unprognostic (1.64e-1)" "unprognostic (2.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (1.77e-1)" "unprognostic (1.72e-2)" "unprognostic (4.65e-2)" "unprognostic (9.70e-2)" "unprognostic (2.21e-5)" "unprognostic (7.88e-4)" "unprognostic (9.53e-4)" "unprognostic (1.44e-6)" "unprognostic (1.20e-1)" "unprognostic (6.97e-2)" "unprognostic (3.13e-1)" "unprognostic (3.41e-2)" 0.9 1.9 9.9 1.3 10.2 0.9 1.1 10.7 23.5 0.9 1.6 4.0 0.0 0.9 0.9 0.9 0.8 4.8 1.4 0.8 9.7 7.7 0.9 0.8 2.2 0.9 5.8 12.1 0.8 3.0 0.8 3.8 1.1 10.2 1.7 1.7 0.0 0.8 0.9 0.8 2.4 1.1 1.1 1.4 1.1 3.2 3.5 2.3 0.0 0.8 0.0 1.1 0.9 0.1 1.4 0.0 5.0 0.0 0.0 0.0 0.0 3.6 4.1 0.2 2.6 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 1.5 1.1 2.0 0.0 1.7 0.7 0.0 0.0 4.8 1.8 0.0 3.5 0.2 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.0 0.5 0.3 0.2 0.0 0.8 0.1 0.2 7.8 0.5 0.1 2.2 0.0 0.8 0.0 0.0 0.0 0.6 0.4 0.7 0.6 6.3 0.3 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 9.9 10.2 10.7 14.9 9.7 7.7 5.8 12.1 10.2 2.3 KIAA0895L LOC653319 ENSG00000196123 "KIAA0895 like" Q68EN5 16 67175602-67184040 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.3;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065996 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA065996: " "unprognostic (8.71e-2)" "unprognostic (1.54e-1)" "unprognostic (8.11e-3)" "unprognostic (2.89e-2)" "unprognostic (2.15e-1)" "unprognostic (4.98e-2)" "unprognostic (1.79e-2)" "unprognostic (4.78e-2)" "unprognostic (4.89e-3)" "unprognostic (2.90e-1)" "prognostic favourable (3.16e-4)" "unprognostic (3.74e-2)" "unprognostic (2.67e-3)" "unprognostic (3.93e-2)" "unprognostic (2.82e-1)" "unprognostic (3.61e-1)" "unprognostic (1.00e-3)" 9.5 20.7 18.1 8.1 19.8 5.2 5.9 46.3 25.0 8.8 6.8 11.5 11.5 10.7 15.4 13.4 6.6 15.0 10.0 7.7 15.1 10.6 9.8 4.6 8.7 3.6 13.0 27.7 21.8 7.6 18.0 24.1 9.5 18.5 10.5 8.8 13.2 8.4 10.3 5.9 9.8 9.5 11.7 16.2 11.0 13.7 13.5 12.4 4.4 13.2 4.3 3.2 7.2 6.8 0.0 2.8 0.0 0.8 0.2 1.1 0.3 2.3 4.0 14.6 9.1 2.7 6.4 9.7 6.3 1.6 2.8 2.6 4.0 2.4 4.4 4.2 2.4 9.1 4.1 3.5 1.7 4.2 5.7 6.4 10.4 3.7 2.1 2.7 13.2 3.6 1.5 3.5 1.3 4.6 6.5 4.3 3.5 3.7 6.6 4.9 3.3 6.6 18.4 7.1 8.2 4.8 5.6 17.3 14.6 7.1 3.6 1.8 8.0 4.7 5.3 9.9 7.0 4.6 2.6 5.6 4.6 4.5 12.5 4.2 5.1 0.0 0.8 0.0 0.2 0.7 0.0 0.0 0.9 1.1 2.3 0.0 0.1 0.2 0.0 0.2 0.4 2.8 0.0 0.3 18.1 19.8 46.3 24.1 15.1 10.6 13.0 27.7 18.5 12.4 KIAA1328 ENSG00000150477 KIAA1328 Q86T90 18 36829106-37232172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040946 Approved Approved "Nuclear speckles,Vesicles,Lipid droplets" "Nuclear speckles" "Vesicles, Lipid droplets" "HPA040946: AB_10794998" "unprognostic (3.66e-2)" "unprognostic (5.37e-4)" "unprognostic (2.76e-2)" "unprognostic (1.55e-3)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (2.46e-2)" "unprognostic (1.51e-3)" "unprognostic (1.99e-1)" "unprognostic (5.05e-2)" "unprognostic (3.18e-3)" "unprognostic (4.85e-2)" "unprognostic (1.06e-4)" "unprognostic (1.77e-1)" "unprognostic (2.25e-2)" "unprognostic (3.36e-2)" "unprognostic (2.64e-3)" 11.1 8.1 14.0 10.7 14.3 23.1 11.1 27.4 13.0 13.7 7.5 13.0 6.1 9.2 12.6 11.1 7.9 9.4 8.3 9.8 10.7 8.5 9.2 7.7 10.4 8.5 12.3 9.0 18.3 6.9 9.0 18.6 9.7 10.3 11.1 7.4 10.9 10.9 9.5 11.4 15.7 9.7 15.8 13.2 8.9 10.7 19.6 14.4 5.4 11.1 9.7 11.5 10.1 11.0 12.7 5.7 17.1 7.4 7.5 10.4 3.6 14.5 4.4 6.5 7.9 2.3 3.1 6.3 5.6 2.1 2.6 1.9 7.7 9.7 9.5 21.1 2.1 6.5 2.6 2.7 3.4 7.4 2.7 12.4 12.0 4.8 1.8 7.9 6.0 3.2 3.0 3.1 2.7 2.3 9.8 23.7 2.6 14.3 5.5 6.0 14.9 7.7 7.9 6.8 7.0 2.5 14.8 7.1 8.2 7.6 9.2 3.7 14.8 4.5 8.0 13.0 19.0 7.5 6.7 18.8 24.0 7.5 6.6 5.7 8.5 17.1 6.8 9.2 9.0 4.8 10.4 7.5 8.0 7.4 3.1 12.7 10.1 8.4 15.1 7.5 7.4 5.7 8.9 3.6 14.0 14.3 27.4 13.0 10.7 8.5 12.3 9.0 10.3 14.4 KIAA1549L "C11orf41, C11orf69, G2, MGC34830" ENSG00000110427 "KIAA1549 like" Q6ZVL6 11 33376466-33674102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 30.4;parathyroid gland: 64.4" "Cell line enhanced" "Detected in many" "TIME: 22.7;U-138 MG: 30.0;WM-115: 20.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010132, HPA051594" Approved Nucleoplasm,Vesicles 27000 Nucleoplasm Vesicles "HPA010132: AB_1078313, HPA051594: " "unprognostic (3.02e-1)" "unprognostic (1.18e-1)" "unprognostic (2.70e-2)" "unprognostic (1.34e-5)" "unprognostic (2.63e-1)" "unprognostic (7.92e-2)" "unprognostic (2.89e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-2)" "unprognostic (2.59e-4)" "unprognostic (8.88e-2)" "unprognostic (1.44e-1)" "unprognostic (3.62e-3)" "unprognostic (1.08e-3)" "unprognostic (8.46e-2)" "unprognostic (4.04e-1)" "unprognostic (1.09e-1)" 0.8 0.9 8.2 0.7 20.5 0.6 1.2 6.2 30.4 0.7 0.7 1.7 0.0 0.6 0.7 0.6 0.9 0.6 0.8 0.6 5.3 2.4 0.9 0.6 0.6 0.7 1.6 17.1 0.7 0.8 64.4 1.0 1.4 2.3 0.7 0.7 0.0 0.7 0.6 0.6 1.9 0.6 0.7 1.1 0.6 0.7 1.3 1.6 0.0 0.6 0.0 1.1 0.9 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 3.3 0.1 0.5 3.7 0.0 13.1 7.7 2.1 1.2 0.0 0.3 10.1 0.1 11.6 0.7 0.4 3.8 3.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.2 5.7 9.3 0.0 9.6 8.2 0.0 0.1 0.0 0.7 4.8 0.0 0.8 0.0 0.0 5.0 1.1 1.2 0.1 0.0 3.1 0.0 0.0 22.7 30.0 6.3 0.7 10.5 0.0 0.0 0.0 7.9 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.2 20.5 6.2 30.4 5.3 2.4 1.6 17.1 2.3 1.6 KIAA1614 ENSG00000135835 KIAA1614 Q5VZ46 1 180913154-180951614 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 58.8;retina: 23.8" "Cell line enhanced" "Detected in many" "RH-30: 12.0;SH-SY5Y: 30.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 58.8" "Cell type enhanced" "Detected in some" "basophil: 4.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.4" "Low region specificity" "Detected in all" "HPA028227, HPA061684" Approved Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA028227: AB_10601765, HPA061684: " "unprognostic (3.23e-1)" "unprognostic (3.60e-2)" "unprognostic (3.17e-2)" "unprognostic (2.15e-2)" "unprognostic (1.05e-1)" "unprognostic (3.55e-2)" "unprognostic (8.76e-3)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.15e-2)" "unprognostic (1.57e-1)" "unprognostic (8.61e-5)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.36e-2)" "unprognostic (1.35e-2)" 4.6 1.5 2.4 1.4 2.6 0.1 2.2 58.8 11.3 4.5 4.6 1.8 0.8 3.0 5.2 1.6 4.6 3.5 3.1 7.5 2.7 1.4 3.0 0.4 3.2 1.1 1.5 3.8 6.3 2.1 0.0 1.3 3.6 3.3 3.5 0.5 23.8 4.6 2.8 2.1 3.0 2.5 4.1 1.4 2.6 2.2 1.2 2.5 0.4 7.6 0.9 0.4 4.3 5.1 0.5 0.5 4.4 0.5 0.5 0.6 0.3 1.1 0.5 0.9 2.0 3.0 7.3 3.2 2.2 2.6 1.1 0.6 1.0 1.1 0.5 2.1 2.7 2.1 0.2 0.0 0.3 0.6 0.9 1.6 0.4 1.4 4.1 1.0 1.1 3.5 0.1 0.1 0.0 1.5 1.3 0.7 0.9 0.9 1.3 0.4 2.2 0.3 0.7 12.0 1.6 1.7 1.0 8.3 30.4 0.6 0.8 4.8 0.8 1.4 3.4 2.3 1.7 2.7 0.8 1.5 2.0 1.0 0.3 0.8 1.5 4.4 0.5 1.2 0.3 0.3 0.4 0.5 0.3 0.3 0.5 0.4 0.6 0.4 0.7 0.5 0.1 0.5 0.2 0.3 2.4 2.6 58.8 11.3 2.7 1.4 1.5 3.8 3.3 2.5 KIAA1755 RP5-1054A22.3 ENSG00000149633 KIAA1755 Q5JYT7 20 38210488-38260772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2" "Cell line enhanced" "Detected in some" "AF22: 39.9;ASC diff: 6.1;ASC TERT1: 9.2;WM-115: 10.1" "Cancer enhanced" "Detected in many" "melanoma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051064 Approved Approved "Nucleoli,Golgi apparatus,Vesicles" Nucleoli "Golgi apparatus, Vesicles" "HPA051064: " "unprognostic (3.98e-3)" "unprognostic (2.20e-2)" "unprognostic (3.79e-1)" "unprognostic (3.01e-3)" "unprognostic (1.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (4.50e-2)" "unprognostic (2.70e-1)" "unprognostic (3.88e-2)" "unprognostic (1.69e-1)" "unprognostic (2.42e-8)" "unprognostic (1.41e-2)" "unprognostic (2.78e-2)" "unprognostic (1.25e-2)" "unprognostic (5.53e-3)" 6.1 2.5 13.6 5.8 27.3 0.7 3.8 4.8 22.1 13.2 8.1 47.2 3.1 2.7 15.5 7.2 5.6 10.0 16.9 11.5 13.9 8.4 4.6 1.7 2.7 4.9 22.7 13.7 14.7 1.5 0.3 3.1 0.4 24.5 7.3 4.7 8.8 6.1 8.2 1.3 1.6 4.5 15.8 20.4 2.8 4.1 2.9 29.2 0.0 2.6 1.6 4.9 6.8 5.4 0.3 0.5 0.9 0.4 0.4 0.7 0.0 1.5 0.1 39.9 0.0 6.1 9.2 0.0 3.9 2.2 0.0 0.0 0.2 1.1 0.0 0.2 1.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.1 0.0 10.1 0.9 0.4 0.1 0.7 0.2 0.5 0.1 0.5 0.6 0.1 0.3 0.4 0.4 0.7 0.4 0.1 0.5 0.0 0.0 13.6 27.3 4.8 15.7 13.9 8.4 22.7 13.7 24.5 29.2 KIAA2026 FLJ20375 ENSG00000183354 KIAA2026 Q5HYC2 9 5881596-6007901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002109 Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA002109: AB_1078071" "unprognostic (7.42e-2)" "unprognostic (2.79e-1)" "unprognostic (3.67e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-3)" "unprognostic (1.61e-1)" "unprognostic (8.74e-2)" "unprognostic (6.86e-2)" "unprognostic (9.19e-2)" "unprognostic (8.41e-3)" "unprognostic (6.49e-2)" "unprognostic (1.52e-1)" "prognostic favourable (8.34e-4)" "unprognostic (2.41e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" 7.0 6.3 10.3 13.7 11.1 6.6 6.7 21.4 12.4 10.2 7.5 8.6 5.7 5.5 9.7 7.0 7.2 6.7 7.4 6.2 11.7 9.0 7.5 5.4 6.4 7.0 16.7 7.1 13.0 6.0 13.9 14.5 8.1 9.9 8.0 5.9 5.9 12.8 15.6 15.3 9.4 6.7 7.7 11.2 9.1 7.8 13.3 12.9 11.0 10.3 3.7 7.5 8.0 17.8 7.0 4.1 9.4 5.9 7.0 7.5 1.2 5.8 2.9 5.9 3.8 4.5 7.2 2.9 4.0 5.6 3.6 3.4 1.8 3.2 7.3 1.5 4.8 3.0 3.4 3.0 5.5 16.8 2.8 21.9 6.4 2.9 3.5 7.7 10.1 4.4 4.1 3.1 5.3 5.6 2.3 13.1 4.6 1.6 4.1 13.3 3.4 2.5 4.6 3.8 3.7 3.9 3.8 8.1 4.8 3.7 3.3 3.0 3.3 9.9 6.7 6.9 4.2 3.5 4.3 10.2 8.0 7.3 3.5 3.6 2.0 5.2 3.4 9.4 6.4 2.6 7.3 7.0 6.2 5.7 1.3 6.1 6.8 7.5 8.8 7.0 5.9 4.1 3.6 1.2 10.3 11.1 21.4 12.4 11.7 9.0 16.7 7.1 9.9 12.9 KIF5C ENSG00000168280 "Kinesin family member 5C" O60282 2 148875250-149026759 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Transport "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 95.8" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 65.3" "Cancer enhanced" "Detected in many" "prostate cancer: 19.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 5.9" "Lineage enriched" "Detected in single" 7 "T-cells: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035210, HPA062272" Enhanced Approved Vesicles Vesicles "HPA035210: AB_10671931, HPA062272: " "unprognostic (1.95e-1)" "unprognostic (2.39e-1)" "unprognostic (2.54e-1)" "unprognostic (4.70e-4)" "unprognostic (1.89e-1)" "unprognostic (3.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.90e-2)" "unprognostic (2.86e-1)" "unprognostic (1.41e-2)" "unprognostic (6.61e-3)" "unprognostic (1.56e-1)" "unprognostic (6.55e-6)" "unprognostic (8.34e-3)" "unprognostic (3.69e-1)" "unprognostic (3.63e-2)" "unprognostic (4.46e-2)" 1.8 10.5 32.0 2.3 31.8 1.3 1.6 33.8 95.8 2.2 2.5 21.7 0.0 1.6 1.8 11.0 1.4 1.6 1.7 1.6 25.4 13.7 1.6 1.2 1.5 1.8 15.8 25.5 3.3 2.5 1.5 12.6 1.3 27.1 21.9 3.2 0.4 1.4 7.5 1.3 1.4 2.3 2.0 20.1 1.6 2.4 13.5 18.3 0.0 3.6 0.0 1.7 2.4 1.0 0.8 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 12.6 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.6 0.0 0.1 0.0 7.3 0.0 1.4 3.7 1.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 12.7 3.9 0.0 0.1 0.0 0.0 2.7 65.3 15.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 1.1 0.0 1.8 1.2 0.2 0.0 4.6 0.2 0.4 0.0 0.0 0.0 0.3 0.0 5.9 0.5 1.1 1.4 0.0 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.7 0.0 32.0 31.8 33.8 40.3 25.4 13.7 15.8 25.5 27.1 18.3 KISS1 ENSG00000170498 "KiSS-1 metastasis suppressor" Q15726 1 204190341-204196486 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "placenta: 267.2" "Group enriched" "Detected in some" 22 "BJ: 54.6;U-2 OS: 22.2" "Cancer enhanced" "Detected in many" "urothelial cancer: 9.2" "Group enriched" "Detected in some" 8 "basal ganglia: 11.3;hypothalamus: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017775, HPA035542" Enhanced Approved Vesicles "Secreted in female reproductive system" Vesicles "CAB017775: , HPA035542: " "unprognostic (9.64e-2)" "unprognostic (1.78e-2)" "unprognostic (1.86e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-1)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.63e-1)" "unprognostic (8.98e-12)" "unprognostic (2.25e-1)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "prognostic favourable (6.29e-6)" 0.2 0.0 0.2 0.2 11.3 0.0 0.2 1.0 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 4.2 1.1 2.7 0.5 0.2 0.2 0.2 0.2 0.4 0.1 2.5 267.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.5 0.2 0.2 0.7 1.4 3.6 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 54.6 0.7 0.9 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 22.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.3 1.0 0.2 0.2 4.2 0.2 0.2 0.2 0.2 KISS1R "AXOR12, GPR54, HOT7T175" ENSG00000116014 "KISS1 receptor" Q969F8 19 917287-921015 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;lymphoid tissue: 12.4" "Cell line enhanced" "Detected in some" "K-562: 10.5;RPMI-8226: 25.7;SCLC-21H: 5.4;SH-SY5Y: 14.4" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;neutrophil: 1.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007156, HPA071913" Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA007156: , HPA071913: " "unprognostic (1.54e-1)" "unprognostic (3.01e-2)" "unprognostic (9.42e-2)" "unprognostic (2.15e-1)" "unprognostic (8.46e-3)" "unprognostic (9.23e-2)" "unprognostic (1.65e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (7.17e-2)" "prognostic unfavourable (3.33e-6)" "unprognostic (1.87e-1)" "unprognostic (8.09e-3)" "unprognostic (1.05e-1)" "unprognostic (2.05e-2)" 0.2 0.2 2.1 2.1 4.1 0.2 0.3 0.1 4.7 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.1 0.2 0.1 0.1 1.0 6.8 1.4 0.1 0.3 12.4 1.1 0.1 0.4 3.6 0.1 2.0 1.0 0.8 0.2 0.2 0.3 0.3 0.1 0.1 0.1 0.7 0.5 1.0 2.4 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.5 0.1 0.6 0.0 1.8 0.0 0.0 2.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 2.8 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.2 0.1 0.0 0.4 0.3 0.7 0.0 25.7 0.0 0.0 5.4 14.4 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.7 0.0 0.0 0.1 2.0 0.6 1.8 0.0 0.0 0.0 0.1 0.0 2.1 4.1 0.1 1.5 1.0 6.8 1.1 0.1 0.8 0.1 KITLG "DFNA69, FPH2, Kitl, KL-1, MGF, SCF, SF, SLF" ENSG00000049130 "KIT ligand" P21583 12 88492793-88580851 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Cell adhesion" "Growth factor" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 81.7;SK-BR-3: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070395 Approved Approved Vesicles "Intracellular and membrane" 150000 Vesicles "HPA070395: " "unprognostic (7.13e-2)" "unprognostic (1.90e-1)" "unprognostic (5.00e-2)" "unprognostic (2.05e-1)" "unprognostic (2.70e-1)" "unprognostic (1.93e-2)" "prognostic unfavourable (4.01e-4)" "unprognostic (2.22e-3)" "unprognostic (5.61e-3)" "unprognostic (7.89e-2)" "unprognostic (5.47e-3)" "unprognostic (5.03e-2)" "prognostic favourable (5.81e-7)" "unprognostic (7.15e-2)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.54e-2)" 10.1 3.8 7.8 8.0 6.4 0.0 11.2 4.8 11.5 9.6 16.1 2.9 8.5 6.2 11.7 8.7 16.7 4.7 13.9 5.6 8.4 3.9 21.9 2.8 22.9 6.1 3.3 7.7 4.4 5.0 1.9 3.2 10.1 4.0 17.9 15.9 7.8 11.8 14.8 4.8 5.3 9.5 21.0 3.7 2.6 13.0 5.8 2.9 0.7 6.5 5.8 6.6 17.5 17.8 0.0 0.2 0.0 0.5 0.0 0.0 0.0 3.4 1.9 1.8 0.2 7.1 15.3 0.0 21.0 15.0 3.6 1.6 81.7 3.3 0.0 0.6 17.6 12.7 2.7 4.7 3.4 0.0 2.4 0.0 2.9 0.6 1.1 0.4 0.0 13.2 5.0 11.4 6.8 4.3 0.0 0.0 1.6 0.6 0.0 0.0 1.2 4.7 0.0 3.3 0.0 6.0 1.7 0.5 1.2 5.1 28.5 0.5 14.6 1.0 2.9 16.5 2.3 19.2 1.6 0.0 0.0 0.0 2.1 0.0 1.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 6.4 4.8 11.5 8.4 3.9 3.3 7.7 4.0 2.9 KLF5 "BTEB2, CKLF, IKLF" ENSG00000102554 "Kruppel like factor 5" Q13887 13 73054976-73077542 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 88.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.8;HaCaT: 34.2;HBEC3-KT: 29.8;hTCEpi: 42.6;RT4: 36.0;SiHa: 30.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 22.2" "Cell type enriched" "Detected in single" 18 "basophil: 16.3" "Lineage enriched" "Detected in single" 106 "granulocytes: 16.3" "Group enriched" "Detected in many" 4 "amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3" "Low region specificity" "Detected in many" HPA040398 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "HPA040398: AB_10673267" "unprognostic (7.90e-3)" "unprognostic (5.11e-2)" "unprognostic (2.03e-2)" "unprognostic (1.56e-1)" "unprognostic (4.69e-2)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (3.97e-2)" "unprognostic (5.82e-1)" "unprognostic (1.47e-2)" "prognostic unfavourable (2.55e-4)" "unprognostic (4.43e-2)" "unprognostic (1.42e-3)" "unprognostic (3.56e-3)" "unprognostic (3.98e-1)" "unprognostic (5.09e-2)" "unprognostic (1.54e-2)" 2.3 1.5 4.1 24.3 22.2 12.9 8.1 0.7 1.2 19.6 74.4 0.4 4.3 28.7 4.8 3.7 88.4 8.3 48.4 1.3 1.4 1.2 3.9 1.2 12.8 0.1 0.9 1.1 5.0 3.5 0.0 7.3 22.8 4.3 17.6 32.9 1.8 26.4 5.4 10.0 59.4 88.1 4.1 2.4 0.8 17.9 12.2 1.4 3.0 20.7 64.4 61.8 23.4 34.1 0.0 0.0 16.3 0.0 0.0 0.1 0.0 5.7 8.1 0.0 0.1 0.3 0.4 9.2 3.4 7.9 1.5 1.9 7.4 29.8 0.1 18.1 3.0 34.2 10.4 29.8 2.4 0.2 2.7 0.1 17.0 0.7 2.1 2.7 0.5 2.2 42.6 0.4 16.7 0.0 0.4 0.6 6.8 2.0 0.5 0.2 0.3 11.5 0.5 7.6 0.6 23.6 36.0 0.7 0.3 30.4 4.9 2.1 0.6 0.6 0.0 2.1 6.2 0.0 1.4 0.9 0.4 1.0 2.9 0.5 2.5 16.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 4.1 22.2 0.7 1.2 1.4 1.2 0.9 1.1 4.3 1.4 KLF6 "BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9" ENSG00000067082 "Kruppel like factor 6" Q99612 10 3775996-3785281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013529, HPA069585" Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "Vesicles, Cytosol" "CAB013529: AB_2533431, HPA069585: " "unprognostic (1.23e-1)" "unprognostic (1.53e-2)" "unprognostic (1.47e-3)" "unprognostic (4.53e-2)" "unprognostic (1.47e-1)" "unprognostic (7.55e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.83e-2)" "unprognostic (1.36e-2)" "unprognostic (2.35e-2)" "prognostic favourable (2.28e-4)" "unprognostic (8.07e-3)" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (1.37e-2)" 69.8 10.0 8.4 26.3 10.6 80.6 101.1 7.4 10.1 28.6 31.7 10.3 9.7 11.0 24.9 28.8 38.6 28.0 38.6 18.6 7.8 5.1 32.2 32.5 46.0 35.8 13.8 4.2 20.2 23.8 7.5 4.7 26.1 11.2 20.1 21.0 13.2 26.9 16.5 57.8 60.2 44.8 42.8 17.0 20.3 26.7 14.3 10.0 12.5 41.0 28.8 21.5 44.7 30.7 15.6 29.8 77.8 18.7 13.0 30.8 23.2 13.0 3.5 6.8 2.2 39.6 39.8 4.3 22.5 11.5 24.1 16.4 9.1 17.6 3.7 5.2 24.3 7.9 4.2 20.7 20.1 18.3 2.5 0.5 4.1 8.6 17.0 2.4 12.9 13.1 39.6 17.1 32.7 24.5 4.1 29.2 30.5 0.9 4.5 3.8 2.5 6.4 3.0 7.0 13.1 23.6 13.0 3.0 2.9 5.5 16.0 33.7 7.9 2.0 31.9 32.5 4.5 19.2 10.3 5.6 18.2 6.9 8.7 3.3 10.0 50.9 17.0 43.7 27.1 14.2 23.9 15.6 30.8 26.8 13.1 12.5 9.6 14.8 77.8 13.0 18.7 29.8 22.2 23.2 8.4 10.6 7.4 10.1 7.8 5.1 13.8 4.2 11.2 10.0 KLHL12 C3IP1 ENSG00000117153 "Kelch like family member 12" Q53G59 1 202891100-202928636 "Predicted intracellular proteins" "ER-Golgi transport, Transport, Ubl conjugation pathway, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071324 Supported "Vesicles,Centriolar satellite" 9600000 "Vesicles, Centriolar satellite" "HPA071324: " "unprognostic (1.69e-2)" "unprognostic (2.84e-1)" "unprognostic (2.95e-2)" "unprognostic (1.97e-1)" "unprognostic (1.93e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-3)" "unprognostic (3.35e-2)" "unprognostic (1.15e-2)" "unprognostic (9.11e-2)" "unprognostic (3.44e-1)" "unprognostic (1.58e-1)" "unprognostic (2.20e-3)" "unprognostic (6.22e-2)" "unprognostic (6.01e-2)" "unprognostic (3.32e-1)" "unprognostic (4.87e-2)" 14.1 18.3 19.3 17.1 20.2 16.1 20.1 18.6 35.5 14.1 18.4 14.2 13.5 13.9 14.7 23.2 17.2 18.5 12.6 25.2 19.2 25.6 21.5 17.1 20.4 29.6 19.6 20.1 18.1 25.6 17.9 19.0 15.0 24.7 19.6 23.2 12.7 13.8 16.6 14.6 13.5 14.3 19.7 25.2 19.4 15.4 41.3 14.6 15.9 19.6 10.1 20.6 16.1 16.2 9.5 12.7 18.4 14.9 10.2 13.3 9.9 10.3 12.5 15.9 17.9 24.7 18.7 18.6 12.6 14.6 15.8 14.5 11.7 17.1 29.0 9.8 14.2 13.3 21.3 17.5 17.4 15.1 9.0 10.2 9.8 11.8 17.9 21.1 17.0 17.8 22.5 13.7 30.1 14.1 25.3 19.3 21.5 14.0 17.6 10.3 22.6 9.5 18.7 27.9 18.5 13.6 12.9 11.8 13.5 15.6 14.3 16.9 26.0 14.9 11.4 15.5 10.9 3.7 11.1 13.9 11.1 24.5 15.2 15.2 14.7 9.2 12.0 18.4 9.1 14.9 13.2 9.5 9.1 10.8 12.7 9.3 9.6 10.3 12.4 10.2 14.7 7.6 13.3 9.9 19.3 20.2 18.6 35.5 19.2 25.6 19.6 20.1 24.7 14.6 KLHL2 MAV ENSG00000109466 "Kelch like family member 2" O95198 4 165207618-165323156 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 10.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051637 Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA051637: " "unprognostic (1.14e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (8.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.56e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (4.42e-2)" "unprognostic (2.06e-1)" "unprognostic (4.67e-1)" "unprognostic (4.88e-2)" "prognostic favourable (3.77e-4)" "unprognostic (4.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-2)" "unprognostic (1.81e-1)" 10.5 11.2 25.1 10.4 36.0 16.4 12.1 9.7 41.6 6.1 5.8 19.6 4.0 5.0 7.0 13.4 15.8 8.9 9.5 5.0 37.2 17.7 13.3 23.8 10.6 9.4 25.7 14.7 3.8 6.6 5.3 18.4 6.9 15.1 7.8 6.5 4.0 16.3 9.7 3.2 4.7 5.6 9.6 25.7 11.1 7.4 5.4 25.0 1.6 11.3 3.4 8.4 10.9 7.2 1.3 1.2 10.8 1.9 0.3 1.6 0.6 8.6 7.9 5.5 5.7 8.5 7.7 5.9 11.7 9.2 6.1 6.6 4.8 6.5 9.0 2.9 5.9 6.0 8.9 6.2 7.9 14.6 3.4 7.5 7.1 7.4 7.5 7.7 10.9 6.4 17.7 5.5 20.8 14.6 3.3 18.9 9.4 3.3 0.2 2.4 3.4 3.6 3.0 4.1 2.7 11.1 8.3 28.4 4.7 7.4 2.7 7.1 1.8 8.7 20.1 4.8 10.0 5.5 7.9 12.3 8.5 7.1 5.9 5.5 9.4 1.9 1.4 1.9 0.8 1.4 0.5 0.4 0.6 0.5 1.2 1.3 1.4 1.6 10.8 0.3 1.9 0.7 0.7 0.6 25.1 36.0 9.7 24.7 37.2 17.7 25.7 14.7 15.1 25.0 KLK8 "HNP, neuropsin, ovasin, PRSS19, TADG14" ENSG00000129455 "Kallikrein related peptidase 8" O60259 19 50996007-51002711 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.6;skin 1: 40.4;tongue: 46.9" "Group enriched" "Detected in some" 7 "A-431: 31.5;CAPAN-2: 41.3;HaCaT: 30.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 29.9;ovarian cancer: 30.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "hippocampal formation: 39.6" "CAB019393, HPA035761" Enhanced Approved Vesicles "Secreted in other tissues" 950000 Vesicles "CAB019393: , HPA035761: " "unprognostic (4.27e-3)" "unprognostic (2.59e-1)" "unprognostic (2.54e-1)" "prognostic unfavourable (2.31e-4)" "unprognostic (5.46e-2)" "prognostic unfavourable (5.72e-4)" "unprognostic (2.95e-1)" "unprognostic (9.02e-2)" "prognostic unfavourable (1.10e-4)" "unprognostic (4.29e-2)" "unprognostic (4.66e-2)" "unprognostic (1.54e-1)" "prognostic unfavourable (6.17e-4)" 1.6 0.0 0.1 0.4 0.1 0.0 4.5 1.0 0.3 8.1 0.7 0.1 0.1 0.0 1.1 0.7 43.6 6.7 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.0 0.1 0.4 0.6 0.3 0.0 0.3 6.0 0.1 0.3 40.4 0.1 0.1 0.6 0.3 0.0 0.7 0.1 0.5 0.3 46.9 11.1 0.3 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.2 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.6 41.3 0.0 0.8 0.0 30.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.3 0.1 0.0 0.1 0.1 0.6 0.1 KLRC3 NKG2-E ENSG00000205810 "Killer cell lectin like receptor C3" Q07444 12 10412312-10420595 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 28.5;brain: 9.7;lymphoid tissue: 6.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.5;HEL: 2.2;HeLa: 11.8;HSkMC: 2.2;U-698: 3.2" "Cancer enriched" "Detected in single" 9 "glioma: 0.6" "Cell type enriched" "Detected in some" 5 "NK-cell: 28.5" "Lineage enriched" "Detected in many" 5 "NK-cells: 28.5" "HPA039910, HPA062570" Approved Uncertain Vesicles Vesicles "HPA039910: , HPA062570: " "unprognostic (8.92e-4)" "unprognostic (4.47e-2)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.07e-3)" "unprognostic (2.48e-1)" "unprognostic (3.22e-1)" "unprognostic (9.12e-2)" "unprognostic (3.52e-3)" "unprognostic (3.09e-1)" "unprognostic (1.08e-1)" "unprognostic (3.15e-1)" 0.1 0.0 4.6 0.2 2.4 2.5 0.0 0.2 9.7 0.0 0.6 1.2 0.7 0.0 0.1 0.3 0.9 0.0 3.7 2.9 0.0 0.6 0.8 2.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.0 2.1 6.9 0.7 0.1 0.1 1.0 0.1 0.0 0.0 0.0 0.3 0.0 28.5 5.6 1.5 0.0 0.0 0.2 0.7 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.2 11.8 0.1 0.0 0.3 0.0 2.2 0.0 0.0 0.2 0.0 0.4 0.2 0.5 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 4.4 0.3 28.5 0.0 0.0 0.0 1.5 KLRG1 "2F1, CLEC15A, MAFA, MAFA-L" ENSG00000139187 "Killer cell lectin like receptor G1" Q96E93 12 8950044-9010760 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 83.1" "Group enriched" "Detected in many" 5 "HEL: 23.0;HUVEC TERT2: 8.1;NTERA-2: 15.8;U-937: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 71.3;MAIT T-cell: 83.1" "Lineage enriched" "Detected in many" 28 "T-cells: 83.1" "Low region specificity" "Detected in some" "HPA051403, HPA076494" Approved Enhanced Vesicles Vesicles "HPA051403: , HPA076494: " "unprognostic (1.54e-2)" "unprognostic (8.42e-4)" "unprognostic (1.06e-1)" "unprognostic (1.28e-1)" "unprognostic (2.94e-1)" "unprognostic (1.53e-4)" "unprognostic (3.05e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-2)" "unprognostic (3.45e-3)" "unprognostic (6.88e-2)" "unprognostic (1.71e-2)" "unprognostic (2.05e-2)" "unprognostic (4.17e-2)" "unprognostic (4.96e-2)" "unprognostic (7.86e-2)" 15.4 3.9 4.4 7.3 5.8 5.6 5.7 12.3 5.0 3.2 3.5 7.1 0.8 1.7 5.6 4.2 2.2 2.6 7.7 5.1 4.4 5.8 3.2 6.4 5.5 17.3 8.3 3.4 2.7 1.9 1.5 5.6 1.5 5.5 4.8 4.7 5.6 3.5 1.8 3.1 2.2 5.0 3.9 5.5 19.0 3.6 2.2 6.8 6.8 2.9 2.3 11.1 8.3 2.6 0.5 1.3 2.4 0.6 2.9 83.1 14.0 0.1 2.2 1.2 1.7 2.0 0.4 1.1 0.3 0.3 0.2 0.7 0.7 0.7 3.1 0.1 0.3 0.2 2.8 0.3 0.3 2.2 1.4 23.0 0.3 1.2 0.5 0.7 1.2 1.4 0.3 0.3 0.0 8.1 1.0 0.3 0.1 0.5 0.5 1.6 15.8 1.5 0.9 0.7 0.0 0.3 0.3 0.3 3.1 0.7 0.4 0.9 0.2 1.0 0.5 0.5 0.7 0.4 1.0 1.0 2.7 1.7 1.4 14.5 0.2 2.4 0.3 0.2 71.3 0.4 83.1 0.5 15.8 43.4 1.3 0.5 4.3 29.9 0.9 2.9 0.6 0.5 1.2 14.0 4.4 5.8 12.3 5.0 4.4 5.8 8.3 3.4 5.5 6.8 KMT2E "HDCMC04P, MLL5" ENSG00000005483 "Lysine methyltransferase 2E" Q8IZD2 7 105014179-105114361 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042866, HPA056125" Approved Approved "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA042866: , HPA056125: " "unprognostic (1.05e-1)" "unprognostic (6.33e-2)" "unprognostic (6.49e-2)" "unprognostic (4.34e-1)" "unprognostic (1.94e-1)" "unprognostic (4.77e-2)" "unprognostic (2.20e-1)" "unprognostic (3.98e-3)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (3.53e-2)" "unprognostic (6.45e-2)" "prognostic unfavourable (3.80e-5)" "unprognostic (1.68e-1)" "unprognostic (1.53e-1)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" 22.7 11.8 18.6 24.5 23.5 44.8 20.9 41.6 22.4 26.4 20.9 18.6 21.7 14.7 25.3 15.8 16.5 18.6 18.2 16.8 20.6 15.1 14.2 11.6 22.8 20.1 22.7 17.4 33.5 15.6 20.5 20.1 18.7 18.6 21.2 20.5 17.6 19.6 19.2 21.3 25.7 18.5 26.2 23.1 21.6 17.9 12.9 27.2 24.6 21.7 15.1 22.7 26.6 21.4 38.2 24.7 72.9 20.8 20.3 30.6 14.7 14.8 10.5 22.3 19.1 13.8 16.6 5.7 11.4 17.1 9.6 11.9 8.5 13.7 12.4 11.4 13.4 11.6 12.3 11.3 16.0 19.9 7.1 12.5 13.8 7.3 13.0 16.7 15.7 11.6 10.6 13.3 14.4 17.4 17.0 35.5 13.6 11.7 26.7 14.3 7.8 8.5 23.0 13.7 14.3 9.5 15.1 12.8 15.4 15.8 13.6 8.6 5.9 10.0 21.4 22.8 15.9 26.0 11.3 27.1 21.4 28.6 15.0 12.8 15.6 48.5 18.0 39.4 30.6 13.6 30.3 35.6 28.4 26.1 12.8 38.2 28.0 26.0 72.9 20.3 20.8 24.7 23.6 14.7 18.6 23.5 41.6 22.4 20.6 15.1 22.7 17.4 18.6 27.2 KRIT1 "CAM, CCM1" ENSG00000001631 "KRIT1, ankyrin repeat containing" O00522 7 92198969-92246166 "Disease related genes, Predicted intracellular proteins" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049606 Supported Uncertain Vesicles Vesicles "HPA049606: " "unprognostic (8.12e-2)" "unprognostic (1.11e-2)" "unprognostic (1.83e-2)" "unprognostic (3.75e-2)" "unprognostic (1.94e-1)" "unprognostic (8.93e-2)" "unprognostic (4.10e-3)" "unprognostic (1.06e-2)" "unprognostic (2.30e-3)" "unprognostic (2.18e-1)" "unprognostic (7.24e-2)" "unprognostic (1.04e-1)" "unprognostic (1.19e-1)" "unprognostic (2.82e-1)" "unprognostic (2.61e-1)" "unprognostic (6.18e-2)" "unprognostic (1.04e-1)" 16.7 16.2 18.0 15.6 22.4 7.1 15.8 32.7 32.0 18.7 16.3 11.7 16.8 14.8 19.3 16.1 15.4 16.2 17.1 19.5 14.7 13.5 17.5 14.0 13.5 14.4 22.1 15.9 23.1 16.6 26.2 46.0 16.3 17.2 17.5 13.5 12.8 17.2 19.6 23.0 13.3 14.6 16.7 20.3 14.7 16.2 23.7 19.9 19.1 25.0 12.6 17.2 19.4 19.8 11.8 8.2 11.7 5.8 12.7 11.4 3.6 18.6 12.9 16.1 17.3 14.4 14.2 15.1 17.6 12.9 11.8 11.4 10.9 19.6 16.8 17.5 10.2 15.7 15.8 10.4 16.3 17.8 18.7 17.1 16.5 7.5 11.3 21.9 20.9 13.3 14.0 11.4 13.3 11.9 33.6 23.6 13.6 17.4 23.9 12.9 16.8 13.3 16.3 23.5 21.2 7.6 16.9 17.6 21.6 21.2 22.6 14.0 13.5 11.9 16.7 22.9 20.4 31.4 12.8 18.5 21.0 31.6 12.9 18.0 21.6 11.7 5.8 5.9 7.8 4.3 8.1 11.8 8.8 10.5 6.0 10.0 11.4 9.9 2.4 12.7 3.2 8.2 8.2 3.6 18.0 22.4 32.7 32.0 14.7 13.5 22.1 15.9 17.2 19.9 KRT222 "KA21, KRT222P, MGC45562" ENSG00000213424 "Keratin 222" Q8N1A0 17 40654665-40665181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 15.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA054586, HPA068724, HPA069774" Enhanced Approved "Vesicles,Lipid droplets" "Vesicles, Lipid droplets" "HPA054586: AB_2682532, HPA068724: , HPA069774: " "unprognostic (2.72e-2)" "unprognostic (4.08e-2)" "unprognostic (1.92e-1)" "unprognostic (2.43e-1)" "unprognostic (1.26e-2)" "unprognostic (3.50e-1)" "unprognostic (1.27e-1)" "unprognostic (6.12e-2)" "unprognostic (5.59e-1)" "unprognostic (2.04e-1)" "unprognostic (1.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-1)" "unprognostic (1.00e-1)" "unprognostic (1.79e-1)" "unprognostic (7.41e-2)" 3.8 5.0 9.6 0.7 18.3 0.6 1.3 15.6 21.7 2.3 1.8 0.2 0.9 1.2 1.9 11.8 1.2 1.2 8.3 1.0 10.0 10.0 1.3 9.4 1.4 1.1 8.6 13.4 0.9 1.7 1.6 5.2 0.6 14.3 3.2 2.3 0.8 0.7 4.6 0.6 0.8 2.3 3.1 3.3 3.4 1.0 1.4 3.3 0.0 1.2 0.3 1.1 2.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 18.3 15.6 21.7 10.0 10.0 8.6 13.4 14.3 3.3 KRT25 KRT25A ENSG00000204897 "Keratin 25" Q7Z3Z0 17 40748021-40755332 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 44.5" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 5.5" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "cerebellum: 9.7" "Group enriched" "Detected in some" 5 "cerebral cortex: 8.3;hippocampal formation: 6.1" "HPA053977, HPA058943" Enhanced Approved Vesicles Vesicles "HPA053977: AB_2682329, HPA058943: AB_2683859" "unprognostic (8.19e-2)" "unprognostic (5.89e-8)" "unprognostic (1.79e-1)" 1.6 0.0 0.0 0.0 0.9 0.0 8.6 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 44.5 0.1 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.0 0.0 0.0 0.0 0.0 1.9 0.0 KRT34 "Ha-4, KRTHA4" ENSG00000131737 "Keratin 34" O76011 17 41377650-41382403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.3;skin 1: 36.0;tongue: 18.2" "Cell line enriched" "Detected in some" 4 "BJ: 64.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055194, HPA072208" Enhanced Approved Nucleoplasm,Vesicles 170000000 "Nucleoplasm, Vesicles" "HPA055194: , HPA072208: " "unprognostic (2.52e-1)" "unprognostic (2.14e-1)" "unprognostic (9.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.86e-3)" "unprognostic (5.12e-7)" "unprognostic (3.84e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.3 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 18.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 64.5 2.8 7.7 15.3 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.9 8.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 L3HYPDH "C14orf149, FLJ25436" ENSG00000126790 "Trans-L-3-hydroxyproline dehydratase" Q96EM0 14 59460363-59484430 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056694 Approved Uncertain Vesicles 16000 Vesicles "HPA056694: " "unprognostic (3.39e-2)" "unprognostic (5.55e-3)" "unprognostic (3.81e-2)" "unprognostic (5.86e-2)" "unprognostic (1.10e-1)" "unprognostic (5.06e-2)" "unprognostic (8.34e-2)" "unprognostic (1.16e-1)" "unprognostic (7.24e-2)" "unprognostic (9.50e-2)" "unprognostic (1.26e-3)" "unprognostic (6.60e-2)" "prognostic unfavourable (1.72e-9)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (1.05e-1)" "unprognostic (1.14e-1)" 17.9 15.4 13.5 13.5 17.1 4.9 22.8 10.4 16.5 12.6 9.9 18.5 10.9 12.3 17.6 10.3 9.8 16.3 13.2 15.9 13.6 7.2 20.2 17.4 11.5 18.5 22.7 9.6 20.1 12.8 23.1 22.5 11.9 18.2 15.5 12.0 12.9 13.6 15.5 8.7 11.0 13.7 14.0 18.4 14.3 11.0 18.9 17.4 6.6 17.9 9.9 15.0 12.7 18.7 2.3 7.9 0.8 7.0 7.0 5.1 2.5 6.1 16.6 3.6 8.5 7.8 20.7 5.1 16.6 13.2 9.6 9.4 3.3 11.1 2.1 7.0 9.2 16.7 5.8 8.9 9.5 3.5 7.5 5.7 14.5 12.0 8.9 5.0 4.1 14.9 6.1 9.6 14.9 11.7 7.4 9.8 9.9 7.3 1.9 8.3 5.8 15.0 2.8 5.9 8.4 15.4 3.5 3.7 5.3 15.6 6.5 5.9 6.8 3.3 16.3 11.3 13.7 8.7 19.4 2.5 1.1 2.0 19.4 4.3 21.9 0.0 5.0 0.8 5.1 7.0 3.4 2.3 2.5 3.0 7.9 2.2 3.9 1.4 0.0 7.0 3.2 4.3 1.1 2.5 13.5 17.1 10.4 16.5 13.6 7.2 22.7 9.6 18.2 17.4 L3MBTL4 "FLJ35936, HsT1031" ENSG00000154655 "L3MBTL4, histone methyl-lysine binding protein" Q8NA19 18 5954706-6415237 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Karpas-707: 5.8;RPMI-8226: 13.6;SCLC-21H: 6.6;SH-SY5Y: 7.2;U-2 OS: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 5.3;NK-cell: 6.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA064194, HPA069042" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA064194: , HPA069042: " "unprognostic (1.33e-3)" "unprognostic (8.98e-2)" "unprognostic (6.31e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.70e-2)" "unprognostic (1.73e-1)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.20e-2)" "unprognostic (5.08e-2)" "unprognostic (1.00e-1)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" 6.3 6.9 8.4 3.7 12.8 2.1 6.8 0.8 8.1 6.2 3.4 12.3 4.8 4.2 4.9 5.4 5.9 6.2 4.3 8.6 9.6 3.5 9.9 12.0 5.9 2.7 13.7 5.5 12.3 14.2 18.8 8.2 1.1 4.6 3.4 3.0 6.0 5.9 9.6 1.4 9.9 4.8 2.0 3.6 4.0 4.4 17.0 13.4 0.6 8.2 2.5 2.3 3.1 7.1 5.3 1.3 0.4 2.2 6.4 1.4 0.8 0.0 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.9 0.1 0.2 2.9 2.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.1 0.3 1.8 3.7 0.0 13.6 0.0 2.4 6.6 7.2 0.0 0.1 0.3 0.0 0.0 0.1 0.1 4.4 0.1 1.7 0.2 0.0 0.1 1.7 0.1 2.1 0.4 2.2 0.1 1.4 0.6 0.1 1.1 0.2 0.2 1.3 5.3 0.3 0.4 0.3 6.4 1.4 0.3 0.1 0.8 8.4 12.8 0.8 8.1 9.6 3.5 13.7 5.5 4.6 13.4 LAMA5 ENSG00000130702 "Laminin subunit alpha 5" O15230 20 62307955-62367312 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 30.3;CACO-2: 41.8;EFO-21: 31.2;TIME: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054609, CAB078157" Enhanced Supported Nucleoplasm,Vesicles "Secreted to extracellular matrix" 1200000 Vesicles Nucleoplasm "CAB078157: , HPA054609: " "unprognostic (8.01e-2)" "unprognostic (2.47e-1)" "unprognostic (1.92e-2)" "unprognostic (3.42e-3)" "unprognostic (1.17e-1)" "unprognostic (9.90e-3)" "unprognostic (4.01e-3)" "unprognostic (5.45e-2)" "unprognostic (8.99e-2)" "unprognostic (1.34e-2)" "unprognostic (5.98e-3)" "unprognostic (2.98e-3)" "unprognostic (4.04e-2)" "unprognostic (9.86e-3)" "unprognostic (2.07e-1)" "unprognostic (9.76e-2)" "unprognostic (1.33e-2)" 22.6 5.9 5.6 8.1 5.9 2.5 16.8 24.0 6.6 16.7 28.0 3.1 18.6 7.6 23.2 13.8 18.0 14.2 27.4 13.7 4.7 2.9 17.0 7.3 19.7 4.4 3.7 2.3 6.9 13.9 8.3 6.0 33.3 5.5 17.4 2.6 18.6 12.7 25.0 9.4 45.2 9.0 25.0 4.5 8.8 13.3 4.4 3.4 2.0 18.4 11.8 10.4 19.4 24.9 0.9 1.2 0.2 0.0 0.0 0.0 0.0 3.9 30.3 0.6 4.0 0.7 8.6 23.3 1.1 0.6 0.9 0.1 41.8 15.7 0.3 31.2 0.0 28.4 0.8 12.1 0.0 0.1 1.7 0.9 27.3 11.9 2.7 0.0 4.5 0.4 8.1 2.1 2.1 4.0 1.8 0.4 0.0 5.8 0.0 0.1 1.9 17.7 0.0 0.3 3.3 7.8 18.5 0.3 12.1 16.7 16.8 0.3 16.6 0.2 36.6 0.4 11.6 0.2 4.9 0.2 0.0 0.1 8.6 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 5.6 5.9 24.0 6.6 4.7 2.9 3.7 2.3 5.5 3.4 LAMB2 "LAMS, NPHS5" ENSG00000172037 "Laminin subunit beta 2" P55268 3 49121114-49133118 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 45.0;fHDF/TERT166: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;myeloid DC: 2.0" "Group enriched" "Detected in many" 9 "dendritic cells: 2.0;monocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000053, HPA001895, HPA050033, CAB078160" Supported Approved Vesicles,Cytosol "Secreted to extracellular matrix" 18000000 Vesicles Cytosol "CAB000053: AB_2313665, CAB078160: , HPA001895: AB_1079227, HPA050033: " "unprognostic (1.12e-2)" "unprognostic (4.40e-2)" "unprognostic (5.14e-3)" "unprognostic (1.10e-1)" "unprognostic (4.08e-1)" "unprognostic (4.01e-1)" "unprognostic (5.59e-2)" "unprognostic (6.80e-2)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (1.26e-1)" "unprognostic (4.96e-2)" "unprognostic (1.21e-3)" "unprognostic (1.78e-1)" "unprognostic (4.38e-2)" "unprognostic (6.20e-2)" "unprognostic (1.24e-2)" 46.1 35.3 7.4 13.0 7.7 0.9 29.0 5.1 8.3 55.0 25.9 10.5 41.3 9.3 43.4 38.6 34.3 27.1 37.7 62.5 9.7 4.1 30.6 29.6 28.2 5.7 8.2 6.1 56.0 12.9 51.7 8.0 41.3 9.9 37.7 7.3 45.1 17.4 39.2 22.7 17.0 23.0 31.5 6.9 16.7 22.7 24.1 8.1 2.1 36.5 21.8 11.4 45.3 38.4 0.0 2.0 0.2 2.4 0.0 0.0 0.4 3.2 8.0 7.4 26.4 43.4 45.0 6.7 28.0 34.7 16.7 16.8 3.8 11.1 0.0 9.7 63.2 10.5 6.4 10.0 11.5 0.0 2.0 1.4 12.6 6.6 29.3 0.0 0.0 39.1 15.0 13.3 13.6 16.3 0.8 0.0 13.5 6.2 0.0 0.0 3.2 6.7 0.0 3.6 0.1 11.7 4.1 0.0 4.4 16.0 9.3 14.6 20.2 0.2 27.0 18.1 7.9 6.4 7.3 0.0 0.0 0.0 8.6 0.0 12.2 0.0 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 7.4 7.7 5.1 8.3 9.7 4.1 8.2 6.1 9.9 8.1 LAMB3 "BM600-125kDa, kalinin-140kDa, LAMNB1, nicein-125kDa" ENSG00000196878 "Laminin subunit beta 3" Q13751 1 209614870-209652466 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Amelogenesis imperfecta, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.6;HaCaT: 64.5;HBEC3-KT: 157.5;hTCEpi: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "myeloid DC: 1.9;neutrophil: 3.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.9;granulocytes: 3.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA007584, HPA008069, CAB078183" Enhanced Approved Vesicles "Secreted to extracellular matrix" 15000 Vesicles "CAB078183: , HPA007584: , HPA008069: AB_1079228" "prognostic favourable (8.43e-4)" "unprognostic (3.08e-2)" "unprognostic (1.46e-2)" "unprognostic (2.88e-2)" "unprognostic (8.00e-2)" "unprognostic (1.60e-3)" "unprognostic (1.75e-1)" "prognostic unfavourable (9.62e-5)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "prognostic unfavourable (2.55e-4)" "unprognostic (1.31e-1)" "prognostic unfavourable (2.43e-5)" "unprognostic (1.02e-1)" "unprognostic (2.38e-1)" "unprognostic (6.01e-2)" "unprognostic (4.92e-3)" 24.5 8.4 1.2 5.5 1.7 3.3 11.7 0.8 4.1 10.2 9.9 0.9 3.2 12.1 7.0 3.1 22.1 6.3 8.4 8.9 1.1 0.8 4.7 4.7 11.0 1.6 1.2 2.2 1.4 2.1 0.0 1.1 16.1 1.1 11.9 6.3 0.8 19.1 10.3 1.9 17.9 22.8 2.7 1.4 2.1 28.7 1.7 0.8 4.9 1.1 35.8 30.2 16.2 13.3 0.1 1.9 3.4 0.5 0.4 0.4 0.1 20.6 3.1 0.0 0.0 2.2 1.4 0.1 0.6 1.8 0.7 1.1 8.1 42.6 0.0 1.8 0.4 64.5 0.0 157.5 1.1 1.5 0.1 0.1 11.0 0.1 0.3 0.1 0.1 0.3 50.4 2.3 31.4 0.7 0.2 0.8 0.2 0.0 0.0 0.1 0.0 8.9 0.0 2.1 18.9 8.7 12.9 0.0 0.0 8.8 1.0 1.8 0.2 1.1 16.5 3.6 7.6 0.1 12.3 0.2 0.3 0.0 5.1 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.4 0.0 1.9 0.1 0.4 0.0 3.4 0.4 0.0 0.0 0.0 0.1 1.2 1.7 0.8 4.1 1.1 0.8 1.2 2.2 1.1 0.8 LAMP2 CD107b ENSG00000005893 "Lysosomal associated membrane protein 2" P13473 X 120427827-120469365 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Autophagy "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 112.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 112.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005272, HPA029100, HPA029101" Supported Approved "Vesicles,Plasma membrane" 820000000 "Vesicles, Plasma membrane" "CAB005272: AB_647855, HPA029100: AB_10795022, HPA029101: " "unprognostic (2.99e-3)" "unprognostic (5.26e-2)" "unprognostic (2.66e-3)" "unprognostic (1.74e-1)" "unprognostic (3.10e-1)" "unprognostic (2.50e-2)" "unprognostic (4.84e-1)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (9.73e-2)" "unprognostic (1.11e-2)" "unprognostic (2.50e-2)" "unprognostic (2.85e-1)" "unprognostic (6.78e-2)" "unprognostic (2.66e-1)" "unprognostic (5.53e-3)" 21.8 33.6 39.9 16.1 87.9 22.6 27.1 16.2 55.5 33.0 18.3 88.7 27.9 25.1 20.8 37.5 34.6 22.4 43.3 20.9 52.5 30.3 55.0 83.7 25.3 14.3 131.0 36.9 22.7 27.4 28.8 20.2 35.4 58.6 37.3 19.7 17.2 47.8 32.9 32.4 26.9 20.5 21.1 84.3 17.9 23.6 11.9 116.9 21.2 33.7 14.3 15.4 21.1 27.0 3.7 11.6 112.9 21.7 5.4 5.8 10.5 11.8 11.7 8.6 11.1 113.5 38.8 23.9 20.5 35.8 20.0 37.4 9.7 21.2 8.4 18.1 35.6 20.0 12.5 15.5 32.6 9.4 8.9 6.6 13.0 13.0 37.8 29.0 18.4 42.0 31.2 26.6 17.6 27.2 7.6 30.0 32.3 21.9 8.0 14.8 6.7 10.4 6.2 14.6 15.0 29.2 8.8 2.9 4.6 22.0 22.4 43.8 13.3 32.4 28.1 28.7 13.9 36.9 55.3 15.1 14.4 5.5 27.4 35.1 68.7 4.9 21.7 41.3 5.0 18.7 4.0 3.1 4.8 4.7 11.6 3.7 4.3 4.1 112.9 5.4 17.3 6.3 5.8 10.5 39.9 87.9 16.2 55.5 52.5 30.3 131.0 36.9 58.6 116.9 LAMP3 "CD208, DC-LAMP, DCLAMP, LAMP, TSC403" ENSG00000078081 "Lysosomal associated membrane protein 3" Q9UQV4 3 183122213-183163839 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lung: 123.9" "Group enriched" "Detected in some" 6 "EFO-21: 57.2;HDLM-2: 14.5;HHSteC: 21.2;hTCEpi: 19.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 7.6" "Group enriched" "Detected in many" 8 "granulocytes: 7.6;T-cells: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB025133, HPA051467" Enhanced Enhanced Vesicles 47000 Vesicles "CAB025133: , HPA051467: " "unprognostic (1.43e-3)" "unprognostic (2.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.99e-3)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (7.67e-2)" "unprognostic (8.64e-2)" "unprognostic (4.95e-2)" "prognostic favourable (9.90e-4)" "unprognostic (1.80e-3)" "unprognostic (5.80e-2)" "prognostic unfavourable (1.89e-7)" "unprognostic (3.12e-1)" "unprognostic (4.13e-2)" "unprognostic (8.35e-2)" "unprognostic (1.29e-1)" 0.5 0.7 0.4 14.1 0.4 0.0 0.5 0.3 0.4 1.0 0.6 0.1 0.6 0.4 0.4 1.0 2.5 0.5 0.8 0.4 0.4 0.4 0.8 0.6 123.9 11.2 0.4 0.1 0.4 8.3 0.0 0.6 1.0 0.6 1.0 1.7 0.2 6.8 1.9 0.4 1.9 1.4 0.8 0.5 2.0 0.8 8.4 0.0 21.3 8.3 3.1 11.3 3.3 0.9 0.4 0.0 7.6 0.1 0.8 6.6 1.1 3.4 0.1 0.0 0.5 0.0 0.0 2.8 0.0 0.9 0.6 0.1 0.8 1.8 0.0 57.2 0.2 0.5 1.2 2.1 0.1 14.5 1.7 0.0 0.1 0.1 21.2 0.0 0.5 0.3 19.4 0.0 2.5 2.6 0.1 3.4 0.1 0.0 0.8 0.1 0.1 0.8 0.0 0.0 0.2 0.0 1.1 0.2 0.1 0.2 0.1 1.5 1.1 0.1 2.7 0.0 1.0 0.1 0.0 1.2 4.3 0.1 0.0 0.0 0.0 0.4 0.1 7.6 0.4 0.0 3.2 0.1 2.7 1.7 0.0 0.4 3.5 2.0 1.9 0.8 0.1 0.0 6.6 1.1 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.1 0.6 0.0 LAMTOR1 "C11orf59, FLJ20625, p18, p27RF-Rho, Pdro, Ragulator1" ENSG00000149357 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 1" Q6IAA8 11 72085895-72103387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002997 Approved Supported "Golgi apparatus,Vesicles,Plasma membrane" 270000 "Golgi apparatus" "Vesicles, Plasma membrane" "HPA002997: AB_1845531" "unprognostic (7.32e-2)" "unprognostic (1.79e-1)" "unprognostic (3.94e-2)" "unprognostic (3.77e-2)" "unprognostic (2.30e-1)" "unprognostic (2.71e-2)" "prognostic unfavourable (3.63e-4)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (1.94e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-3)" "unprognostic (1.78e-3)" "unprognostic (3.08e-1)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" "unprognostic (1.04e-1)" 47.3 55.3 51.3 33.3 55.6 49.7 69.1 23.1 51.1 43.3 40.4 44.1 39.4 35.1 36.0 48.1 42.2 40.7 44.0 59.9 45.4 41.4 58.0 60.5 44.3 71.5 52.5 29.9 38.0 45.0 33.3 37.6 41.6 38.1 39.8 40.2 40.4 45.0 45.5 57.6 33.2 41.8 38.8 49.0 52.9 35.6 22.6 31.9 28.2 61.3 39.4 40.0 32.7 35.0 25.7 57.7 44.9 68.7 19.7 16.4 55.4 17.6 35.0 18.9 23.1 41.7 28.9 19.0 24.6 35.1 38.0 29.0 44.3 24.3 17.8 31.9 38.7 25.7 29.7 49.4 27.4 22.4 19.6 46.7 22.5 29.7 59.4 18.0 27.8 50.0 36.2 40.2 38.3 30.4 19.5 16.5 37.3 55.9 13.9 28.1 17.8 38.4 12.3 32.8 14.3 47.5 37.5 11.5 19.8 24.9 23.4 62.7 34.5 16.1 24.4 26.1 19.2 61.6 17.1 22.2 25.3 13.6 15.2 14.5 19.7 17.7 68.7 44.9 15.0 38.6 14.4 23.8 14.2 14.9 57.7 25.7 12.0 14.6 40.5 19.7 29.3 34.3 16.4 55.4 51.3 55.6 23.1 51.1 45.4 41.4 52.5 29.9 38.1 31.9 LAMTOR2 "ENDAP, MAPBPIP, MAPKSP1AP, p14, Ragulator2, ROBLD3" ENSG00000116586 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2" Q9Y2Q5 1 156054752-156058510 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004126 Approved Approved Nucleoplasm,Vesicles 17000 "Nucleoplasm, Vesicles" "HPA004126: AB_1849916" "unprognostic (2.09e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-2)" "unprognostic (4.52e-2)" "unprognostic (8.64e-2)" "unprognostic (3.90e-2)" "unprognostic (3.79e-1)" "unprognostic (1.66e-2)" "unprognostic (2.06e-1)" "unprognostic (3.41e-2)" "prognostic unfavourable (1.10e-6)" "unprognostic (2.47e-1)" "unprognostic (1.34e-1)" "unprognostic (8.65e-2)" "unprognostic (1.35e-1)" 24.3 33.5 30.3 18.8 27.2 23.4 35.3 14.2 30.6 22.5 27.5 13.8 34.3 24.5 17.0 38.1 27.6 25.4 25.7 37.2 25.8 24.9 31.7 63.5 27.7 37.9 26.4 22.8 11.4 75.2 16.6 18.0 21.1 23.4 18.8 27.5 16.4 35.9 34.3 35.5 20.4 26.2 26.2 19.3 26.0 27.3 12.1 20.3 20.2 20.9 30.2 23.6 21.9 17.0 47.2 89.8 60.4 80.6 32.6 47.6 56.7 15.7 35.7 16.9 23.2 34.4 28.0 18.6 14.1 23.8 17.6 20.2 16.3 26.9 23.3 24.5 27.0 23.2 17.2 37.9 9.9 19.3 26.1 13.5 24.2 21.5 27.3 19.1 22.2 33.0 23.8 18.7 24.0 35.7 12.2 17.5 25.3 31.7 19.7 27.3 17.8 53.6 16.7 12.6 34.0 38.6 23.1 6.5 37.8 17.8 49.8 28.4 35.0 56.3 24.2 14.9 13.7 21.6 13.1 26.4 38.8 13.5 26.6 21.3 15.9 41.8 80.6 60.4 30.9 71.6 30.2 47.2 34.2 33.5 89.8 38.3 26.2 28.2 39.6 32.6 56.5 47.5 47.6 56.7 30.3 27.2 14.2 30.6 25.8 24.9 26.4 22.8 23.4 20.3 LAMTOR4 C7orf59 ENSG00000188186 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4" Q0VGL1 7 100148907-100155944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 206.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 206.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020998 Enhanced Supported Vesicles Vesicles "HPA020998: AB_1845762" "prognostic favourable (2.48e-4)" "prognostic favourable (6.08e-4)" "unprognostic (1.29e-2)" "unprognostic (1.14e-1)" "unprognostic (8.21e-3)" "unprognostic (6.11e-2)" "unprognostic (1.10e-2)" "unprognostic (1.32e-2)" "unprognostic (6.17e-2)" "unprognostic (1.57e-1)" "unprognostic (2.42e-3)" "unprognostic (8.83e-2)" "unprognostic (1.11e-1)" "unprognostic (1.80e-1)" "unprognostic (2.68e-1)" "unprognostic (2.45e-1)" "unprognostic (1.68e-2)" 31.0 30.7 43.8 36.0 40.2 54.7 43.2 20.9 70.6 28.5 41.8 27.9 26.5 28.6 25.0 35.3 32.9 35.9 36.0 42.2 39.5 35.1 36.3 24.9 32.0 44.7 49.5 30.7 30.0 36.9 19.3 28.5 26.8 38.7 30.8 34.5 31.2 35.4 27.5 44.4 84.7 27.2 31.3 47.8 41.5 29.7 21.3 35.2 15.7 37.3 33.1 26.6 31.3 39.6 31.4 35.1 206.0 53.2 17.6 26.5 46.2 19.0 46.3 24.5 30.9 26.1 30.2 19.9 11.4 28.3 21.4 26.5 21.4 30.8 30.8 38.9 17.3 20.1 23.2 29.5 9.2 31.1 65.7 24.5 43.9 36.8 24.6 19.0 35.4 36.1 29.3 22.3 27.7 32.6 23.0 49.6 29.0 90.9 18.4 76.6 26.0 37.3 19.4 20.2 54.7 24.2 23.3 17.3 32.0 21.1 49.8 37.9 20.0 37.7 21.8 20.4 30.5 42.1 18.3 30.1 40.1 57.0 32.6 53.4 29.0 52.0 53.2 183.0 19.6 46.9 16.3 31.4 24.8 20.2 35.1 27.7 25.5 20.5 206.0 17.6 43.4 29.7 26.5 46.2 43.8 40.2 20.9 70.6 39.5 35.1 49.5 30.7 38.7 35.2 LAPTM4A "HUMORF13, KIAA0108, LAPTM4, MBNT, Mtrp" ENSG00000068697 "Lysosomal protein transmembrane 4 alpha" Q15012 2 20032650-20052028 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 131.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031402, HPA031404, HPA068554" Approved Approved "Golgi apparatus,Vesicles,Plasma membrane" "Golgi apparatus, Vesicles" "Plasma membrane" "HPA031402: AB_10669882, HPA031404: AB_10670293, HPA068554: " "unprognostic (2.01e-1)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (5.73e-1)" "unprognostic (6.04e-2)" "unprognostic (3.00e-2)" "unprognostic (1.53e-3)" "unprognostic (5.37e-2)" "unprognostic (1.27e-1)" "unprognostic (3.65e-2)" "prognostic unfavourable (4.37e-4)" "unprognostic (8.70e-2)" "unprognostic (1.05e-2)" "unprognostic (7.78e-3)" "unprognostic (2.18e-2)" "unprognostic (7.98e-3)" "unprognostic (2.36e-1)" 59.2 63.8 23.4 20.1 22.8 19.8 53.6 15.9 23.4 85.7 44.0 25.9 181.0 26.0 80.3 57.4 50.4 53.0 49.9 50.1 22.3 19.0 95.9 83.0 48.7 24.3 22.0 17.3 72.7 63.6 28.9 46.5 137.6 24.9 64.9 28.4 56.8 49.9 175.6 33.6 41.2 44.9 56.4 21.6 34.8 40.7 83.3 18.6 13.7 75.3 37.9 37.7 65.3 57.8 27.2 37.4 82.4 53.4 16.5 19.4 48.0 36.9 20.5 12.6 26.1 131.1 97.5 47.2 47.0 59.0 32.2 36.6 16.0 36.4 6.5 10.9 57.0 36.8 10.4 22.5 29.5 16.0 16.7 10.0 24.2 45.6 50.6 7.6 27.6 65.0 45.9 31.2 35.9 33.2 7.5 12.5 47.6 21.3 4.5 10.1 27.8 18.8 8.0 36.9 12.3 78.7 31.0 20.0 19.3 43.7 36.1 29.5 15.6 6.3 42.3 54.2 19.4 46.5 30.1 20.9 29.9 10.5 42.8 15.3 21.4 82.4 53.4 38.5 14.2 44.2 17.1 27.2 17.0 15.7 37.4 26.2 19.4 17.3 28.1 16.5 50.3 31.3 15.9 48.0 23.4 22.8 15.9 23.4 22.3 19.0 22.0 17.3 24.9 18.6 LATS1 WARTS ENSG00000131023 "Large tumor suppressor kinase 1" O95835 6 149658153-149718256 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031804 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA031804: AB_10601688" "unprognostic (4.02e-3)" "unprognostic (3.80e-3)" "unprognostic (1.28e-2)" "unprognostic (1.00e-1)" "unprognostic (4.40e-2)" "unprognostic (2.09e-1)" "unprognostic (6.15e-3)" "unprognostic (1.29e-2)" "unprognostic (9.67e-2)" "unprognostic (1.02e-2)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (5.62e-2)" "unprognostic (1.92e-1)" "unprognostic (8.43e-2)" "unprognostic (2.63e-1)" "unprognostic (2.65e-1)" 15.4 12.9 17.6 12.5 17.6 19.4 14.7 38.4 16.9 15.9 13.6 17.4 9.5 10.1 17.7 11.8 12.2 14.6 11.1 11.7 15.1 8.8 11.5 11.1 12.7 12.6 18.2 8.8 23.6 12.2 22.3 21.8 17.2 15.5 16.3 12.5 14.1 13.8 11.9 12.4 12.8 14.7 15.8 13.0 13.5 11.6 10.6 19.6 20.5 12.9 6.5 12.8 14.7 14.7 7.4 4.6 9.5 11.4 4.2 8.9 2.9 6.1 4.8 10.2 14.4 9.6 12.6 7.8 8.1 8.2 8.8 8.8 7.8 5.3 9.9 8.3 11.3 8.6 13.3 8.7 13.9 9.1 10.6 20.0 6.1 7.0 8.9 18.7 14.6 8.4 14.0 9.9 17.0 10.9 24.6 10.2 8.6 7.3 9.7 7.7 6.0 4.7 9.5 12.2 4.6 8.1 8.7 6.8 10.9 11.4 8.3 6.0 8.6 16.2 13.4 7.0 11.0 8.3 13.0 8.5 9.3 11.4 6.4 10.6 10.3 9.5 4.2 6.6 8.9 7.7 8.0 5.8 7.0 7.4 4.6 7.4 6.0 7.8 2.9 4.2 11.4 4.1 6.7 2.9 17.6 17.6 38.4 16.9 15.1 8.8 18.2 8.8 15.5 19.6 LBH ENSG00000213626 "Limb bud and heart development" Q53QV2 2 30231531-30323730 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 76.1;NTERA-2: 21.8;U-2 OS: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 28.5;MAIT T-cell: 28.5;memory B-cell: 22.8;memory CD4 T-cell: 21.5;memory CD8 T-cell: 21.6;naive B-cell: 33.4;naive CD4 T-cell: 36.7;naive CD8 T-cell: 31.3;T-reg: 20.7" "Group enriched" "Detected in many" 8 "B-cells: 33.4;T-cells: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034669 Approved Approved Vesicles Vesicles "HPA034669: AB_10600820" "unprognostic (2.13e-2)" "unprognostic (2.34e-2)" "unprognostic (1.78e-1)" "unprognostic (4.77e-3)" "unprognostic (1.23e-3)" "unprognostic (1.57e-1)" "unprognostic (2.69e-1)" "unprognostic (3.65e-3)" "unprognostic (1.93e-1)" "unprognostic (3.24e-2)" "unprognostic (2.54e-1)" "unprognostic (1.60e-1)" "unprognostic (2.32e-2)" "prognostic unfavourable (8.24e-4)" "unprognostic (2.25e-2)" "unprognostic (7.91e-3)" "unprognostic (1.67e-1)" 13.7 3.8 3.7 25.5 5.3 6.7 29.8 1.8 9.2 22.1 10.1 2.7 7.6 3.8 36.4 17.2 12.3 18.2 21.0 59.3 4.5 11.5 15.4 6.0 66.1 53.6 6.2 5.0 44.3 4.5 21.4 6.6 15.9 9.4 10.2 5.1 32.0 45.8 12.0 7.0 11.8 15.1 14.0 3.4 33.5 8.9 8.1 0.8 78.1 48.6 9.5 32.7 13.1 9.5 33.4 2.9 0.9 0.7 4.2 36.7 21.2 0.0 2.8 3.6 0.6 0.9 0.5 0.3 3.6 4.8 1.0 0.1 14.8 3.8 7.1 8.7 76.1 4.9 20.7 0.2 0.1 10.2 0.8 1.1 3.2 0.0 2.9 0.1 1.0 3.4 0.2 1.2 0.0 0.2 3.5 0.0 3.6 0.0 7.9 0.1 21.8 0.1 8.2 19.4 2.4 0.7 1.2 1.0 2.6 5.9 0.5 0.2 0.0 0.3 4.7 7.0 25.7 13.4 0.4 13.9 0.7 0.6 3.1 0.4 2.1 0.1 0.1 0.2 28.5 0.3 28.5 22.8 21.5 21.6 0.2 33.4 36.7 31.3 0.9 4.2 0.7 2.9 20.7 21.2 3.7 5.3 1.8 9.2 4.5 11.5 6.2 5.0 9.4 0.8 LCMT2 "KIAA0547, MGC9534, PPM2, TYW4" ENSG00000168806 "Leucine carboxyl methyltransferase 2" O60294 15 43323649-43330605 "Enzymes, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039401, HPA048176" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA039401: AB_10805478, HPA048176: " "unprognostic (4.32e-2)" "unprognostic (1.44e-1)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "unprognostic (1.99e-1)" "unprognostic (2.27e-1)" "unprognostic (9.08e-2)" "unprognostic (5.14e-2)" "unprognostic (3.52e-2)" "unprognostic (2.20e-1)" "unprognostic (3.33e-3)" "unprognostic (9.57e-2)" "prognostic favourable (5.69e-9)" "unprognostic (2.28e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.57e-1)" 7.9 10.9 6.5 8.3 8.1 2.5 25.9 11.4 10.1 10.8 7.4 7.2 10.6 5.2 10.3 12.7 11.0 10.2 6.7 8.4 6.7 8.4 11.9 9.2 6.2 9.9 6.1 7.6 13.0 8.2 13.7 10.1 6.4 9.6 10.2 7.5 8.9 10.3 13.8 7.9 6.2 8.4 8.6 4.8 9.6 8.7 7.1 9.6 12.2 9.8 11.2 13.9 7.4 9.6 6.3 6.9 5.5 4.0 3.3 10.5 5.0 6.0 4.8 11.3 9.8 12.1 3.7 5.5 7.4 8.9 9.7 10.7 7.1 2.8 5.1 15.2 8.4 14.3 0.0 9.8 7.4 7.9 5.2 9.2 12.9 4.1 7.4 0.0 6.9 5.8 9.5 7.2 6.6 3.1 11.6 6.9 11.6 9.4 10.3 4.3 4.9 4.0 12.2 10.0 5.0 16.9 6.9 15.2 12.9 9.8 8.3 4.2 10.1 14.1 2.6 11.4 5.2 13.0 12.0 4.7 11.0 2.1 7.1 7.6 11.8 2.4 4.0 5.5 4.0 3.8 5.5 5.0 6.7 4.8 6.9 6.3 10.5 6.8 1.3 3.3 3.5 3.9 5.3 5.0 6.5 8.1 11.4 10.1 6.7 8.4 6.1 7.6 9.6 9.6 LDHA ENSG00000134333 "Lactate dehydrogenase A" P00338 11 18394388-18408425 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 249.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015336, CAB069404" Uncertain Supported Vesicles,Cytosol 300000000 Cytosol Vesicles "CAB015336: AB_2134947, CAB069404: " "unprognostic (8.83e-2)" "prognostic unfavourable (2.78e-5)" "unprognostic (3.81e-2)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (4.66e-3)" "prognostic unfavourable (3.26e-8)" "prognostic unfavourable (2.27e-6)" "unprognostic (1.08e-1)" "unprognostic (1.88e-2)" "prognostic unfavourable (8.09e-6)" "unprognostic (1.76e-2)" "prognostic unfavourable (9.69e-9)" "unprognostic (4.15e-2)" "unprognostic (1.89e-1)" "unprognostic (3.07e-1)" "unprognostic (1.05e-2)" 84.2 56.4 24.5 52.6 32.5 64.0 56.0 22.3 40.2 38.1 53.5 13.5 9.1 60.5 24.9 36.2 77.7 29.0 31.6 59.4 24.4 33.0 100.1 249.1 37.1 59.4 29.7 25.7 49.7 34.1 10.5 16.4 49.7 44.3 33.3 51.2 45.9 46.3 37.0 199.6 70.2 128.3 50.7 35.5 45.0 31.2 25.9 23.9 45.0 56.4 90.6 60.1 81.9 44.8 27.6 76.5 29.1 61.2 32.8 52.2 72.1 131.7 82.0 3.1 46.2 72.2 49.3 44.0 127.5 135.5 112.0 166.7 36.6 21.7 99.7 41.9 128.8 106.6 82.0 195.4 242.9 34.0 48.5 34.5 74.9 62.8 17.8 85.1 25.9 49.2 90.1 44.0 44.1 66.1 48.6 48.0 131.1 34.9 70.0 53.9 19.8 102.6 45.4 32.7 83.5 178.0 30.6 24.6 30.4 69.1 57.0 23.6 26.8 20.3 59.5 140.3 50.9 122.1 1.5 38.2 55.9 95.9 200.8 44.1 47.2 28.9 53.1 29.1 38.1 61.2 42.6 27.6 50.2 40.1 76.5 19.2 32.8 33.3 18.1 32.8 59.5 25.8 52.2 72.1 24.5 32.5 22.3 40.2 24.4 33.0 29.7 25.7 44.3 23.9 LDLRAD4 C18orf1 ENSG00000168675 "Low density lipoprotein receptor class A domain containing 4" O15165 18 13217498-13652755 "Predicted intracellular proteins, Predicted membrane proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.4;lymphoid tissue: 49.2" "Cell line enhanced" "Detected in many" "HEL: 15.5;MOLT-4: 47.4;REH: 14.3;U-698: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047633, HPA065246" Approved Supported Vesicles Vesicles "HPA047633: , HPA065246: " "unprognostic (2.52e-1)" "unprognostic (4.31e-3)" "unprognostic (5.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.64e-1)" "unprognostic (3.94e-3)" "unprognostic (9.73e-2)" "unprognostic (2.26e-2)" "unprognostic (2.21e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-1)" "unprognostic (3.64e-1)" "prognostic unfavourable (4.58e-4)" "unprognostic (2.51e-2)" "unprognostic (4.38e-2)" "unprognostic (6.58e-2)" "unprognostic (8.18e-2)" 8.3 6.6 9.6 11.5 22.0 11.9 7.5 10.3 22.9 8.6 6.1 45.4 4.3 9.8 12.9 5.2 5.6 11.0 7.8 17.8 14.6 10.7 3.9 10.4 5.9 11.6 19.9 12.5 3.6 6.2 4.6 8.3 8.0 23.5 10.4 3.3 3.7 4.8 8.3 19.0 4.8 10.9 7.5 30.7 8.9 7.6 8.9 21.2 49.2 5.2 2.5 8.5 7.9 6.7 8.2 8.2 17.2 11.0 12.5 14.5 6.2 0.1 0.2 0.9 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.5 0.2 0.0 0.0 0.0 7.7 0.8 15.5 3.2 0.2 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.0 1.2 47.4 0.6 1.2 5.4 14.3 0.1 0.6 0.0 0.8 1.1 1.6 0.2 1.0 0.0 2.1 4.7 1.4 0.8 5.5 0.1 1.0 2.2 0.2 11.9 0.0 3.5 3.1 12.7 10.3 3.4 10.2 10.3 8.9 7.2 9.7 8.8 5.1 8.2 14.5 12.6 17.2 12.5 11.0 8.2 5.2 6.2 9.6 22.0 10.3 20.6 14.6 10.7 19.9 12.5 23.5 21.2 LGMN "LGMN1, PRSC1" ENSG00000100600 Legumain Q99538 14 92703807-92748702 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "RPMI-8226: 127.6;U-266/70: 70.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 11 "plasmacytoid DC: 54.2" "Lineage enriched" "Detected in many" 11 "dendritic cells: 54.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001426 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" 1200000 Vesicles Nucleoplasm "HPA001426: AB_1079247" "unprognostic (1.19e-1)" "unprognostic (1.16e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" "unprognostic (4.52e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (3.50e-2)" "unprognostic (4.70e-2)" "unprognostic (2.47e-1)" "prognostic favourable (4.70e-4)" "unprognostic (8.06e-2)" "unprognostic (3.64e-2)" "unprognostic (7.18e-3)" "unprognostic (7.24e-2)" 42.9 16.3 8.6 17.4 10.7 3.5 19.9 5.8 17.9 13.3 22.3 11.7 13.9 24.2 12.1 48.1 17.4 14.1 32.7 38.8 10.3 10.1 87.6 44.6 31.5 42.4 8.3 10.1 20.5 14.6 54.4 9.7 113.6 9.9 22.0 24.5 23.2 22.6 8.4 17.3 11.9 37.1 23.3 11.5 58.3 23.7 14.0 7.9 17.2 36.8 19.2 17.3 31.4 18.2 4.7 54.2 0.7 0.8 1.0 4.3 1.7 4.8 7.0 4.7 8.6 14.6 11.8 16.4 10.5 10.0 10.9 12.9 5.4 8.7 2.7 15.5 17.1 12.1 0.0 9.0 5.2 0.2 5.4 0.1 3.9 6.2 4.3 0.1 0.4 8.3 4.4 10.5 6.0 12.9 1.0 22.6 0.7 6.5 1.2 0.2 2.3 4.8 1.2 4.1 127.6 11.8 19.0 5.1 3.5 14.5 8.9 7.5 6.6 0.0 7.0 5.4 6.9 9.7 3.1 70.2 8.2 3.6 3.0 0.1 10.3 0.7 0.4 0.1 0.2 0.8 0.4 4.7 1.4 0.4 5.0 3.4 4.3 2.5 0.5 1.0 0.2 54.2 2.6 1.7 8.6 10.7 5.8 17.9 10.3 10.1 8.3 10.1 9.9 7.9 LGSN "GLULD1, LGS" ENSG00000146166 "Lengsin, lens protein with glutamine synthetase domain" Q5TDP6 6 63275951-63319977 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.2;liver: 9.3" "Cell line enhanced" "Detected in some" "A549: 10.4;BEWO: 5.5;CACO-2: 3.3;HeLa: 3.8;Karpas-707: 2.6" "Cancer enhanced" "Detected in some" "lung cancer: 2.2" "Region enriched" "Detected in single" 7 "pons and medulla: 2.9" "Cell type enhanced" "Detected in some" "neutrophil: 3.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030957, HPA039983" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA030957: AB_10670149, HPA039983: AB_2676784" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (1.12e-1)" "unprognostic (9.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (5.05e-4)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (2.13e-1)" "unprognostic (2.53e-2)" "unprognostic (4.51e-3)" "unprognostic (1.64e-3)" "unprognostic (1.31e-1)" "unprognostic (2.19e-1)" 0.2 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 5.2 9.3 0.7 0.2 0.4 0.2 0.2 0.5 0.0 0.2 2.3 2.9 0.5 0.1 0.2 0.2 0.2 0.3 0.1 0.4 0.2 1.6 0.3 0.8 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 1.0 3.4 0.7 0.3 0.5 0.1 0.1 10.4 0.1 0.1 0.0 0.0 5.5 0.1 0.1 0.0 0.0 3.3 0.1 0.1 0.0 0.0 0.1 0.6 0.4 0.0 0.0 0.0 0.1 3.8 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.0 0.1 1.8 0.1 0.4 0.1 0.1 0.1 0.0 0.2 0.3 0.2 0.0 0.1 1.2 0.0 0.1 0.1 0.1 0.1 1.6 0.7 0.3 0.5 0.3 0.2 0.7 0.5 0.3 0.1 0.7 0.4 0.5 3.4 0.3 0.3 1.0 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.4 0.2 2.9 0.2 LHFPL2 KIAA0206 ENSG00000145685 "LHFPL tetraspan subfamily member 2" Q6ZUX7 5 78485215-78770021 "Predicted membrane proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.0;plasmacytoid DC: 7.9" "Group enriched" "Detected in many" 7 "dendritic cells: 7.9;granulocytes: 8.0;monocytes: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042402 Uncertain Approved "Vesicles,Actin filaments" 110000 "Actin filaments" Vesicles "HPA042402: AB_10794276" "unprognostic (2.19e-2)" "unprognostic (3.86e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-1)" "unprognostic (2.40e-1)" "unprognostic (4.45e-2)" "prognostic unfavourable (2.73e-4)" "unprognostic (3.44e-3)" "unprognostic (2.32e-1)" "unprognostic (8.43e-2)" "unprognostic (3.62e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (3.45e-7)" "unprognostic (3.40e-2)" "unprognostic (3.88e-2)" "unprognostic (1.34e-2)" "unprognostic (7.85e-2)" 17.1 18.2 10.3 16.1 11.7 11.5 34.7 3.5 9.1 15.8 15.4 12.0 14.1 17.6 14.6 15.0 7.6 10.7 17.6 14.1 11.7 7.6 3.8 4.7 17.2 10.3 15.2 7.2 18.7 18.0 9.2 7.3 11.3 12.9 13.3 13.5 18.2 21.4 20.5 4.6 6.7 27.1 16.6 18.0 4.7 10.8 10.9 13.1 5.7 10.3 4.9 10.4 15.4 18.2 0.9 7.9 8.0 4.7 0.0 0.1 1.5 3.5 13.1 4.0 5.2 24.3 7.0 12.3 4.0 10.4 7.1 12.4 4.6 10.5 8.8 1.8 7.9 6.1 3.8 4.3 11.7 0.1 3.4 8.8 2.7 7.8 18.0 0.0 0.0 7.9 17.6 21.6 33.7 16.6 0.0 6.6 16.0 1.8 0.0 0.5 4.4 3.8 1.7 5.6 2.4 2.6 15.6 0.7 5.4 6.6 2.4 22.5 1.4 1.1 10.9 8.2 4.5 22.6 12.0 0.2 0.0 12.7 21.9 0.0 14.7 8.0 4.7 4.8 0.0 1.8 0.1 0.9 0.0 0.0 1.1 0.9 0.0 0.0 1.0 0.0 0.6 7.9 0.1 1.5 10.3 11.7 3.5 9.1 11.7 7.6 15.2 7.2 12.9 13.1 LHFPL3 LHFPL4 ENSG00000187416 "LHFPL tetraspan subfamily member 3" Q86UP9 7 104328656-104907232 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "brain: 36.5" "Cell line enhanced" "Detected in some" "K-562: 2.2;SCLC-21H: 4.0;SH-SY5Y: 5.3;SK-BR-3: 4.5;SK-MEL-30: 2.3" "Cancer enriched" "Detected in some" 12 "glioma: 27.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069691 Approved Vesicles Vesicles "HPA069691: " "unprognostic (1.20e-2)" "unprognostic (6.91e-2)" "unprognostic (4.59e-3)" "unprognostic (5.03e-2)" "unprognostic (2.27e-2)" "unprognostic (2.22e-1)" "unprognostic (1.07e-1)" "unprognostic (6.96e-2)" "unprognostic (5.81e-2)" "unprognostic (5.99e-3)" "unprognostic (8.50e-3)" "unprognostic (3.07e-1)" "unprognostic (1.33e-1)" 0.5 0.6 6.4 0.6 7.7 0.5 0.5 2.3 36.5 4.3 0.8 6.1 0.0 2.0 0.7 0.5 0.5 0.9 0.5 0.5 4.9 5.6 1.4 0.5 2.2 0.5 4.8 4.2 0.7 1.5 0.5 0.1 0.5 5.6 0.7 0.6 3.8 0.5 0.5 0.5 0.7 1.4 0.5 6.0 0.9 0.8 0.7 6.7 0.0 0.5 0.0 0.6 0.5 0.2 0.5 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 4.0 5.3 0.0 4.5 2.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 7.7 2.3 7.1 4.9 5.6 4.8 4.2 5.6 6.7 LIG1 ENSG00000105486 "DNA ligase 1" P18858 19 48115445-48170603 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037015, HPA041431, HPA048071" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "CAB037015: , HPA041431: , HPA048071: " "unprognostic (1.83e-1)" "unprognostic (1.48e-3)" "unprognostic (6.45e-2)" "unprognostic (9.76e-2)" "unprognostic (9.47e-2)" "unprognostic (9.24e-3)" "unprognostic (1.17e-3)" "unprognostic (2.28e-1)" "unprognostic (6.03e-3)" "unprognostic (4.26e-1)" "unprognostic (1.78e-2)" "unprognostic (1.10e-3)" "prognostic unfavourable (5.75e-5)" "unprognostic (3.59e-2)" "unprognostic (4.09e-2)" "unprognostic (1.59e-2)" "unprognostic (1.55e-2)" 4.1 5.6 8.1 25.2 10.4 37.8 6.4 17.2 10.6 6.5 9.2 6.5 8.7 12.0 6.8 6.1 11.0 7.8 6.9 2.6 6.3 5.3 6.0 6.2 5.9 18.6 7.7 7.4 10.8 10.3 9.1 9.7 11.7 8.1 7.5 6.0 4.6 7.2 7.9 6.1 12.5 12.8 3.6 7.1 11.2 6.7 15.1 11.5 34.7 10.7 12.1 16.9 6.6 8.6 10.4 1.3 2.0 5.6 10.9 11.5 4.8 15.7 20.3 21.7 14.0 0.9 1.1 15.7 9.1 6.8 14.8 16.3 11.5 15.5 28.5 5.6 3.8 10.6 8.9 9.0 6.4 15.4 15.4 17.6 14.3 14.8 0.3 21.8 14.6 2.0 0.7 7.9 1.2 7.9 14.9 10.7 7.4 12.6 34.9 32.5 12.3 4.7 30.1 17.0 14.1 4.5 24.1 13.8 13.7 11.0 12.9 3.1 8.3 16.8 7.7 11.8 19.9 9.9 14.2 10.6 16.7 29.0 4.8 12.3 13.0 0.0 1.4 2.0 7.6 5.6 6.8 10.3 8.4 7.6 1.3 10.4 11.5 8.0 1.1 10.9 2.7 1.2 8.9 4.8 8.1 10.4 17.2 10.6 6.3 5.3 7.7 7.4 8.1 11.5 LIPA "CESD, LAL" ENSG00000107798 "Lipase A, lysosomal acid type" P38571 10 89213569-89414557 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 139.0" "Cell line enhanced" "Detected in many" "AN3-CA: 60.3;ASC TERT1: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6" "Group enriched" "Detected in all" 5 "dendritic cells: 23.3;monocytes: 68.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034892, HPA057052" Enhanced Supported Vesicles "Intracellular and membrane" 150000 Vesicles "CAB034892: AB_784329, HPA057052: " "unprognostic (1.27e-1)" "unprognostic (3.23e-1)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (7.14e-2)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (4.28e-2)" "unprognostic (1.08e-1)" "unprognostic (7.30e-3)" "unprognostic (1.39e-2)" "unprognostic (1.40e-1)" "unprognostic (4.42e-2)" "unprognostic (3.42e-2)" "unprognostic (5.71e-2)" 139.0 16.3 15.8 14.4 22.7 7.8 19.9 8.8 21.4 13.4 28.1 61.3 3.4 37.4 10.2 5.2 9.5 9.0 19.4 8.7 22.5 13.8 10.8 49.3 38.5 45.7 41.6 13.4 10.4 9.5 17.5 6.3 17.8 28.4 7.4 16.7 5.7 11.0 8.8 4.1 6.8 65.8 11.3 55.1 87.3 7.9 3.1 37.2 7.0 8.3 4.7 10.0 15.1 8.6 7.0 23.3 3.2 68.4 5.5 8.3 25.5 53.8 8.3 5.5 60.3 56.9 75.6 1.6 28.6 33.5 11.9 21.5 3.2 29.1 9.9 5.6 44.8 54.1 2.4 15.5 8.9 14.0 5.6 4.1 3.5 12.8 15.0 8.0 8.2 33.6 11.1 12.7 6.9 2.3 0.0 18.6 9.3 4.5 6.9 5.4 3.6 9.4 4.5 6.5 9.2 11.0 8.5 1.8 3.8 6.9 9.0 21.0 10.3 10.3 4.3 10.2 2.7 21.8 6.9 9.7 10.2 4.1 12.2 17.6 12.7 0.8 31.8 3.2 8.2 68.4 8.2 6.5 7.3 7.8 23.3 7.0 7.7 8.3 1.4 5.5 35.6 4.7 7.1 25.5 15.8 22.7 8.8 21.4 22.5 13.8 41.6 13.4 28.4 37.2 LIPT2 ENSG00000175536 "Lipoyl(octanoyl) transferase 2" A6NK58 11 74491712-74493733 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Ligase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040249 Approved Approved Vesicles,Centrosome Vesicles Centrosome "HPA040249: AB_10795275" "unprognostic (8.80e-2)" "unprognostic (9.67e-2)" "unprognostic (5.12e-3)" "unprognostic (1.09e-1)" "unprognostic (6.74e-3)" "unprognostic (1.43e-1)" "unprognostic (1.50e-2)" "unprognostic (8.96e-2)" "unprognostic (1.11e-2)" "prognostic favourable (1.63e-4)" "unprognostic (6.11e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-2)" "unprognostic (9.45e-2)" "unprognostic (1.01e-1)" "unprognostic (1.51e-2)" "unprognostic (1.35e-1)" 2.0 4.1 2.6 2.6 3.0 2.1 5.8 2.3 4.3 3.1 4.0 3.4 6.5 5.8 3.4 6.5 3.6 5.8 8.8 2.9 3.3 2.6 8.1 5.3 4.0 8.4 3.5 1.0 6.2 10.8 6.2 4.3 8.3 2.9 4.6 3.6 3.8 5.9 6.9 11.3 2.4 6.3 3.1 2.9 4.2 5.6 19.0 0.8 8.7 6.4 5.5 4.3 4.6 3.8 11.2 7.2 6.6 4.9 8.1 14.8 5.4 2.5 3.2 7.0 3.3 2.9 0.6 9.9 0.9 1.6 4.4 2.8 10.5 3.5 15.5 6.0 0.6 3.7 3.2 2.4 1.7 3.6 3.2 4.5 2.8 2.8 3.3 5.2 6.2 1.6 2.6 2.2 2.9 0.3 3.5 4.4 1.3 4.0 6.9 7.9 6.2 4.2 5.6 7.7 4.3 2.9 8.7 7.1 4.5 6.5 2.0 9.4 6.3 3.9 1.2 1.0 2.6 1.5 2.3 7.3 6.5 10.5 0.8 3.0 3.4 0.0 4.9 6.6 5.9 3.0 8.8 11.2 7.9 7.2 5.3 11.0 14.8 11.2 1.1 8.1 3.7 7.2 3.7 5.4 2.6 3.0 2.3 4.3 3.3 2.6 3.5 1.0 2.9 0.8 LITAF "FLJ38636, PIG7, SIMPLE, TP53I7" ENSG00000189067 "Lipopolysaccharide induced TNF factor" Q99732 16 11547722-11636381 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 202.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 202.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 202.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006960 Approved Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA006960: AB_1079254" "unprognostic (2.26e-1)" "unprognostic (4.96e-2)" "unprognostic (2.32e-3)" "unprognostic (1.03e-1)" "prognostic unfavourable (2.02e-4)" "unprognostic (4.07e-2)" "unprognostic (8.75e-3)" "unprognostic (3.60e-1)" "unprognostic (6.15e-3)" "unprognostic (1.04e-1)" "unprognostic (4.61e-2)" "unprognostic (5.01e-1)" "unprognostic (1.85e-2)" "unprognostic (9.49e-2)" "prognostic unfavourable (6.25e-4)" "unprognostic (3.57e-2)" "unprognostic (1.60e-1)" 55.0 14.1 18.0 49.2 42.4 53.3 65.7 5.0 18.5 50.4 36.4 45.2 20.2 13.9 42.7 28.8 19.6 34.0 35.3 31.5 20.7 15.7 48.9 66.3 73.0 80.6 28.6 13.2 43.1 26.3 15.9 17.1 46.2 42.8 36.2 36.7 26.0 57.3 32.2 18.6 28.5 24.1 41.6 52.1 57.9 26.3 11.0 19.0 18.7 53.3 18.8 36.4 47.4 41.6 14.1 16.9 202.5 10.3 20.2 37.6 35.6 13.7 25.6 16.2 7.8 2.5 1.9 16.4 17.9 55.1 17.0 25.4 10.6 37.1 6.9 22.9 15.1 17.0 6.8 30.0 16.3 52.7 7.1 0.5 22.3 53.7 38.0 2.1 2.3 5.7 58.3 13.9 38.2 0.0 4.2 26.8 0.2 13.1 0.3 31.8 26.4 0.1 2.1 3.5 39.6 14.3 19.4 4.0 12.2 30.9 39.5 31.8 22.1 11.7 0.1 7.1 12.0 4.1 4.1 10.5 23.1 17.7 8.1 16.8 40.5 32.2 10.3 20.8 37.6 9.8 22.8 14.1 23.5 33.5 13.6 13.9 26.8 31.7 202.5 20.2 5.7 16.9 26.2 35.6 18.0 42.4 5.0 18.5 20.7 15.7 28.6 13.2 42.8 19.0 LIX1 "C5orf11, Lft" ENSG00000145721 "Limb and CNS expressed 1" Q8N485 5 97091867-97142872 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 35.9" "Cell line enriched" "Detected in some" 12 "RPTEC TERT1: 26.8" "Cancer enhanced" "Detected in many" "glioma: 13.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive B-cell: 5.9" "Lineage enriched" "Detected in single" 9 "B-cells: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058426 Uncertain Approved "Vesicles,Cytokinetic bridge,Cytosol" Cytosol "Vesicles, Cytokinetic bridge" "HPA058426: " "unprognostic (3.18e-1)" "unprognostic (4.53e-2)" "unprognostic (9.46e-2)" "prognostic unfavourable (2.48e-4)" "unprognostic (8.96e-2)" "unprognostic (6.60e-2)" "unprognostic (1.34e-1)" "unprognostic (4.70e-1)" "unprognostic (7.63e-2)" "unprognostic (1.58e-2)" "unprognostic (3.52e-1)" "unprognostic (2.01e-1)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (1.26e-1)" "unprognostic (9.61e-2)" 1.0 1.2 14.9 1.3 16.9 1.4 1.1 6.1 35.9 1.0 1.3 19.2 1.0 1.2 1.2 1.2 1.0 1.2 1.1 1.1 24.6 10.7 4.9 1.0 1.1 1.6 11.7 13.2 1.0 1.0 1.0 1.2 1.4 12.4 3.0 1.4 3.3 1.1 8.3 1.1 1.1 1.2 1.2 10.1 1.2 1.2 1.1 13.0 0.0 6.5 0.0 1.0 1.0 0.2 5.9 0.1 0.6 0.1 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.2 1.2 0.1 0.0 0.0 5.9 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 14.9 16.9 6.1 11.9 24.6 10.7 11.7 13.2 12.4 13.0 LLGL2 "HGL, Hugl-2" ENSG00000073350 "LLGL2, scribble cell polarity complex component" Q6P1M3 17 75525080-75575208 "Predicted intracellular proteins" "Cell cycle, Cell division, Exocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 25.9;CAPAN-2: 38.2;MCF7: 36.7;RT4: 26.1;SK-BR-3: 36.6;T-47d: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 6.2" "Group enriched" "Detected in many" 6 "dendritic cells: 2.2;NK-cells: 4.1;T-cells: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA022913 Uncertain Supported Vesicles,Cytosol Cytosol Vesicles "HPA022913: AB_1852930" "unprognostic (1.18e-1)" "unprognostic (4.18e-2)" "unprognostic (2.89e-2)" "unprognostic (1.34e-1)" "unprognostic (3.43e-1)" "prognostic favourable (9.25e-4)" "unprognostic (2.60e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (3.49e-1)" "prognostic favourable (6.00e-5)" "unprognostic (6.22e-3)" "prognostic favourable (6.14e-9)" "unprognostic (1.14e-2)" "unprognostic (2.77e-2)" "unprognostic (4.15e-3)" "unprognostic (1.56e-2)" 1.7 3.9 1.5 17.3 4.2 1.4 4.2 5.1 3.7 7.1 27.5 5.2 23.0 22.9 2.8 17.1 24.3 6.4 45.7 1.7 1.7 1.0 35.6 17.1 16.0 2.1 11.2 1.8 4.6 37.5 5.0 8.3 5.1 3.6 6.6 11.9 6.3 21.4 20.0 0.7 13.9 36.0 1.2 2.5 9.6 27.7 4.3 4.9 1.5 13.4 13.0 13.6 7.0 10.6 0.6 2.2 0.3 0.6 4.1 6.2 0.9 16.5 15.4 0.0 2.9 0.0 0.0 6.5 0.1 0.1 0.3 0.2 25.9 38.2 1.1 3.9 0.0 20.9 2.9 2.8 0.0 1.4 5.2 1.1 4.3 9.8 0.1 0.1 2.5 0.0 3.9 0.0 0.6 0.6 2.1 1.5 0.0 36.7 0.9 1.9 2.1 6.1 1.9 0.0 4.1 8.2 26.1 6.4 1.2 3.3 36.6 1.1 27.7 2.6 0.1 0.0 0.1 0.0 0.2 1.8 2.4 0.4 0.1 0.1 0.7 0.0 0.3 0.1 6.2 0.6 1.4 0.6 1.5 4.2 0.3 0.6 0.2 2.5 0.3 4.1 0.2 2.2 1.0 0.9 1.5 4.2 5.1 3.7 1.7 1.0 11.2 1.8 3.6 4.9 LMX1A "LMX1, LMX1.1" ENSG00000162761 "LIM homeobox transcription factor 1 alpha" Q8TE12 1 165201867-165356715 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.3;pituitary gland: 8.0" "Cell line enriched" "Detected in single" 12 "SCLC-21H: 4.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028051, HPA030088" Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA028051: AB_10599731, HPA030088: AB_10601106" "unprognostic (1.73e-1)" "unprognostic (9.57e-2)" "unprognostic (7.58e-2)" "unprognostic (1.59e-1)" "unprognostic (2.17e-1)" "unprognostic (2.82e-1)" "unprognostic (2.63e-1)" "unprognostic (3.22e-2)" "unprognostic (2.10e-3)" "unprognostic (1.51e-1)" "unprognostic (9.82e-3)" 2.2 0.0 0.0 2.0 0.0 0.0 1.2 2.6 0.5 0.5 1.7 3.4 3.1 4.0 0.1 1.3 1.1 0.5 0.2 0.2 0.9 1.5 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.1 8.0 0.0 7.3 0.2 2.1 0.5 1.5 0.3 1.4 0.3 2.2 0.9 0.1 0.0 0.2 4.3 0.3 0.0 0.3 3.5 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.5 0.9 1.5 2.2 0.0 7.3 0.3 LNP1 NP3 ENSG00000206535 "Leukemia NUP98 fusion partner 1" A1A4G5 3 100401193-100456319 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 9.4;cerebral cortex: 11.0;hippocampal formation: 10.1;olfactory region: 9.4" HPA047926 Approved "Nuclear speckles,Vesicles,Cytosol" Vesicles "Nuclear speckles, Cytosol" "HPA047926: " "unprognostic (1.78e-1)" "unprognostic (3.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.40e-3)" "unprognostic (6.33e-3)" "unprognostic (1.17e-1)" "unprognostic (1.34e-1)" "unprognostic (1.66e-3)" "unprognostic (1.81e-1)" "unprognostic (1.75e-2)" "unprognostic (1.58e-2)" "unprognostic (1.74e-2)" "unprognostic (8.28e-3)" "unprognostic (1.43e-1)" "unprognostic (7.98e-2)" "unprognostic (2.11e-1)" "unprognostic (6.08e-2)" 3.1 2.8 6.5 1.7 11.4 0.6 2.7 7.9 9.7 3.4 2.3 1.5 3.4 1.2 4.6 8.4 1.9 4.0 2.7 9.5 5.3 7.2 4.8 7.4 3.8 1.4 5.7 5.6 6.3 4.5 3.0 17.0 3.7 7.4 2.8 2.2 9.0 2.4 3.3 4.3 1.0 1.5 4.5 4.2 1.8 1.9 31.9 3.5 1.6 5.3 0.8 1.7 3.1 1.8 0.9 0.2 0.0 0.4 0.2 2.7 0.8 2.8 1.6 8.3 1.2 5.4 2.3 0.7 2.2 5.5 1.8 2.2 0.6 0.7 2.5 1.0 1.6 1.8 2.2 1.9 2.2 2.6 2.3 6.1 0.8 2.8 1.6 3.5 0.7 2.5 0.7 1.0 4.7 0.4 2.3 9.5 1.6 2.1 4.9 3.5 5.7 12.5 3.8 4.6 5.0 1.7 0.3 8.6 4.3 1.6 2.4 3.4 0.6 0.4 0.6 0.9 8.9 0.8 2.0 11.2 11.9 7.3 2.5 3.0 1.5 0.0 0.4 0.0 1.1 0.2 2.5 0.9 1.1 0.6 0.2 0.9 1.0 1.1 0.0 0.2 0.0 0.0 2.7 0.8 6.5 11.4 7.9 9.7 5.3 7.2 5.7 5.6 7.4 3.5 LNX2 "MGC46315, PDZRN1" ENSG00000139517 "Ligand of numb-protein X 2" Q8N448 13 27545911-27620404 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040698 Approved Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA040698: AB_10673138" "unprognostic (4.97e-2)" "unprognostic (1.97e-2)" "unprognostic (3.29e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.65e-2)" "unprognostic (1.12e-1)" "unprognostic (8.38e-2)" "unprognostic (1.16e-1)" "unprognostic (9.27e-3)" "unprognostic (4.21e-2)" "unprognostic (8.79e-2)" "prognostic favourable (7.09e-13)" "unprognostic (4.18e-3)" "unprognostic (1.67e-1)" "unprognostic (2.21e-1)" "unprognostic (2.84e-2)" 4.6 10.3 2.5 6.7 4.2 2.7 9.8 7.6 4.1 6.0 13.2 2.3 8.3 12.2 4.4 4.3 12.4 4.1 9.7 8.8 2.8 2.9 9.2 24.5 22.1 4.9 3.4 3.1 6.3 24.7 7.6 9.6 10.8 3.7 7.0 9.3 10.2 12.1 9.9 8.0 7.6 19.6 6.5 3.3 4.6 9.0 10.3 2.6 13.4 9.9 4.2 10.0 6.2 8.5 1.6 0.8 5.3 0.9 3.3 2.8 0.6 5.1 2.8 5.4 5.9 5.7 2.6 5.7 4.6 4.0 4.5 4.1 10.2 10.3 7.8 4.0 4.0 9.8 9.6 12.2 5.9 4.7 4.0 9.9 6.0 7.4 9.0 5.3 6.3 2.2 19.0 3.1 12.5 8.1 3.0 3.0 6.5 6.3 7.8 3.5 6.0 3.2 7.2 10.6 4.0 9.9 9.0 13.9 2.9 6.3 12.7 8.0 8.9 4.1 10.3 2.6 3.6 2.6 3.7 2.9 4.9 8.1 1.7 5.1 3.6 5.3 0.9 2.4 1.7 0.3 2.3 1.6 1.8 2.1 0.8 1.3 1.9 1.8 1.1 3.3 0.7 0.4 2.8 0.6 2.5 4.2 7.6 4.1 2.8 2.9 3.4 3.1 3.7 2.6 LOXL4 "FLJ21889, LOXC" ENSG00000138131 "Lysyl oxidase like 4" Q96JB6 10 98247690-98268250 "Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 29.1" "Group enriched" "Detected in some" 5 "BJ hTERT+: 58.7;CAPAN-2: 70.5" "Cancer enhanced" "Detected in all" "melanoma: 44.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.3;plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB033876, HPA037609" Approved Approved Vesicles "Secreted to extracellular matrix" Vesicles "CAB033876: AB_2135101, HPA037609: " "unprognostic (9.91e-3)" "unprognostic (3.97e-2)" "unprognostic (1.81e-2)" "unprognostic (1.43e-2)" "prognostic unfavourable (6.49e-4)" "unprognostic (7.71e-2)" "unprognostic (1.75e-2)" "unprognostic (8.38e-2)" "unprognostic (1.39e-1)" "prognostic unfavourable (9.57e-4)" "unprognostic (2.51e-1)" "unprognostic (4.97e-2)" "unprognostic (5.25e-2)" "unprognostic (5.77e-3)" "unprognostic (1.28e-1)" "unprognostic (6.10e-2)" "unprognostic (7.40e-3)" 6.3 1.8 1.1 1.1 4.2 0.1 10.7 1.0 1.7 20.7 7.3 4.6 1.4 1.4 8.0 4.6 2.3 7.4 4.6 1.8 1.6 0.3 4.4 29.1 3.1 0.6 1.1 1.2 6.1 14.5 1.7 1.4 5.1 8.2 5.1 1.5 3.2 15.7 10.7 14.7 3.1 2.5 7.1 3.0 1.8 2.3 10.8 1.0 1.4 5.7 1.9 1.7 3.1 6.0 0.8 1.2 0.1 0.2 2.3 0.0 0.0 0.0 0.3 0.0 0.0 1.6 7.2 0.2 7.4 58.7 0.6 6.4 1.2 70.5 0.0 6.8 5.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 3.0 1.6 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 13.3 0.7 0.2 0.0 0.0 0.0 0.1 0.0 8.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 2.3 0.0 1.2 0.0 0.0 1.1 4.2 1.0 1.7 1.6 0.3 1.1 1.2 8.2 1.0 LPAR4 "GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9" ENSG00000147145 "Lysophosphatidic acid receptor 4" Q99677 X 78747709-78757094 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8;ovary: 10.0" "Cell line enhanced" "Detected in some" "AF22: 10.1;NTERA-2: 16.4;RH-30: 6.9;U-937: 3.9" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "basophil: 7.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046563, HPA054951, HPA055571" Uncertain Supported "Nuclear bodies,Vesicles,Plasma membrane" "Plasma membrane" "Nuclear bodies, Vesicles" "HPA046563: , HPA054951: , HPA055571: " "unprognostic (1.62e-1)" "unprognostic (3.53e-1)" "unprognostic (1.58e-1)" "unprognostic (5.81e-4)" "unprognostic (3.12e-2)" "unprognostic (4.85e-3)" "unprognostic (2.81e-1)" "unprognostic (2.57e-1)" "unprognostic (6.75e-2)" "unprognostic (6.73e-2)" "unprognostic (8.91e-2)" "unprognostic (4.86e-4)" "unprognostic (2.99e-5)" "unprognostic (9.27e-3)" "unprognostic (1.00e-1)" "unprognostic (3.58e-2)" "unprognostic (6.03e-3)" 1.5 0.2 6.0 1.0 2.1 0.6 2.0 4.9 3.7 1.8 0.9 7.4 0.7 0.2 2.9 0.8 1.8 1.1 2.1 1.9 15.8 1.4 0.3 0.3 0.3 0.2 2.4 4.0 10.0 0.7 0.1 0.7 0.2 3.6 0.6 1.2 0.5 1.0 1.6 0.2 1.6 0.9 1.3 3.8 0.4 1.5 0.8 5.6 0.0 0.6 0.8 1.2 1.4 0.9 0.0 0.5 7.4 0.0 0.0 0.0 0.1 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.6 1.1 1.4 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 2.3 0.0 0.4 1.8 16.4 0.2 0.8 6.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.2 0.0 0.6 1.4 0.0 0.7 0.7 3.9 1.6 7.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 6.0 2.1 4.9 3.5 15.8 1.4 2.4 4.0 3.6 5.6 LPL LIPD ENSG00000175445 "Lipoprotein lipase" P06858 8 19901717-19967258 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease mutation, FDA approved drug targets, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4" "Cell line enriched" "Detected in some" 5 "AF22: 89.3" "Cancer enhanced" "Detected in all" "glioma: 39.2" "Region enhanced" "Detected in many" "basal ganglia: 16.3" "Cell type enhanced" "Detected in some" "non-classical monocyte: 7.1" "Lineage enriched" "Detected in many" 5 "monocytes: 7.1" "Region enhanced" "Detected in many" "basal ganglia: 40.6" "Region enriched" "Detected in all" 4 "basal ganglia: 64.0" HPA048749 Supported Vesicles "Secreted to blood" 880000 Vesicles "HPA048749: " "unprognostic (5.52e-2)" "unprognostic (3.16e-1)" "unprognostic (6.41e-2)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-4)" "unprognostic (1.05e-1)" "unprognostic (6.78e-2)" "unprognostic (8.20e-2)" "unprognostic (2.54e-2)" "unprognostic (5.28e-1)" "unprognostic (1.18e-1)" "unprognostic (4.20e-3)" "unprognostic (4.16e-3)" "unprognostic (1.19e-1)" "prognostic unfavourable (6.07e-4)" 178.6 4.3 2.0 11.4 16.3 0.6 146.2 3.9 8.0 1.0 16.9 0.3 27.3 0.8 1.3 1.1 1.1 0.7 8.2 121.4 2.8 2.3 4.8 0.6 20.7 7.0 4.5 0.7 2.7 1.8 32.6 0.9 7.1 1.7 0.9 1.8 8.4 9.2 85.1 53.8 1.8 3.1 1.3 2.8 0.8 1.8 0.7 3.4 0.0 2.7 9.7 1.0 3.2 6.1 0.0 0.7 1.3 7.1 0.0 0.1 0.4 0.0 0.0 89.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 14.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 7.2 0.0 1.6 1.3 0.0 2.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.4 2.0 16.3 3.9 2.3 2.8 2.3 4.5 0.7 1.7 3.4 LRFN2 "FIGLER2, KIAA1246, SALM1" ENSG00000156564 "Leucine rich repeat and fibronectin type III domain containing 2" Q9ULH4 6 40391586-40587465 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 21.7" "Group enriched" "Detected in some" 5 "REH: 3.4;SH-SY5Y: 10.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 1.8;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;T-cells: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA076660 Enhanced Supported Vesicles Vesicles "HPA076660: " "unprognostic (1.93e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (4.58e-4)" "unprognostic (3.10e-1)" "unprognostic (1.21e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-3)" "unprognostic (4.94e-2)" "unprognostic (1.80e-1)" "unprognostic (9.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (1.64e-1)" "unprognostic (2.98e-1)" "unprognostic (1.16e-1)" "unprognostic (2.66e-4)" 0.5 1.4 5.9 0.5 7.6 1.3 0.6 4.5 21.7 0.5 0.8 0.0 0.0 0.5 0.6 0.4 1.8 0.6 0.6 0.4 5.0 5.2 0.5 0.4 0.4 0.5 2.3 7.4 2.1 0.7 0.4 0.6 0.5 0.9 0.5 0.7 2.7 0.4 0.4 0.4 0.5 0.5 0.5 0.8 3.1 0.7 2.5 0.5 0.0 0.7 0.0 0.6 0.5 0.2 0.0 1.3 0.0 0.0 0.3 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 3.4 0.0 0.0 0.0 0.3 1.4 10.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.4 0.0 0.3 0.0 1.3 0.0 0.2 5.9 7.6 4.5 21.7 5.0 5.2 2.3 7.4 0.9 0.5 LRG1 LRG ENSG00000171236 "Leucine rich alpha-2-glycoprotein 1" P02750 19 4536409-4540474 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 636.5" "Cell line enhanced" "Detected in some" "Hep G2: 8.0;HMC-1: 8.2;SK-BR-3: 8.7;THP-1: 14.5;U-937: 26.8" "Cancer enriched" "Detected in many" 9 "liver cancer: 160.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 19 "neutrophil: 58.9" "Lineage enriched" "Detected in many" 42 "granulocytes: 58.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA001888, HPA001889" Enhanced Approved Vesicles "Secreted to blood" 21000000000 74000000000 Vesicles "HPA001888: AB_1079276, HPA001889: AB_1079275" "unprognostic (5.54e-3)" "unprognostic (1.78e-1)" "unprognostic (1.78e-1)" "unprognostic (1.42e-1)" "unprognostic (2.64e-2)" "unprognostic (1.05e-1)" "unprognostic (1.88e-1)" "unprognostic (1.13e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (1.46e-3)" "unprognostic (9.83e-2)" "prognostic unfavourable (3.66e-6)" "unprognostic (4.06e-2)" "unprognostic (1.45e-1)" "prognostic favourable (3.49e-4)" "unprognostic (2.60e-2)" 1.7 0.9 0.2 3.3 0.4 5.4 0.9 0.2 0.3 1.7 1.3 0.2 2.2 1.1 0.3 1.1 4.5 1.9 3.0 0.9 0.4 0.2 3.5 636.5 2.2 5.7 0.7 0.1 1.5 8.1 0.0 0.7 0.4 0.4 1.1 0.8 0.3 4.1 3.0 0.5 0.8 0.6 0.2 0.3 4.3 2.3 0.5 0.3 0.3 0.9 1.7 3.4 1.4 1.3 0.1 0.3 58.9 1.4 0.0 0.2 0.4 5.8 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.6 4.3 2.1 7.5 0.0 0.8 0.0 0.9 0.0 7.6 0.2 0.1 0.1 8.0 0.0 0.2 8.2 2.3 0.0 0.0 0.0 0.0 5.3 0.1 0.0 0.3 0.0 5.8 0.1 0.0 0.0 0.1 6.1 0.5 1.1 0.0 0.0 0.0 8.7 0.1 2.5 14.5 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 26.8 0.0 0.5 1.4 3.0 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 58.9 0.0 0.2 0.0 0.2 0.4 0.2 0.4 0.2 0.3 0.4 0.2 0.7 0.1 0.4 0.3 LRMP JAW1 ENSG00000118308 "Lymphoid restricted membrane protein" Q12912 12 25004342-25108334 "Predicted intracellular proteins, Predicted membrane proteins" "Fertilization, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;lymphoid tissue: 69.5" "Group enriched" "Detected in some" 6 "Daudi: 94.1;REH: 32.7;U-698: 107.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 51.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA002967, HPA018505" Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA002967: AB_1079161, HPA018505: AB_1851988" "unprognostic (3.78e-2)" "unprognostic (2.59e-3)" "unprognostic (7.54e-2)" "unprognostic (7.08e-3)" "unprognostic (2.36e-1)" "unprognostic (1.48e-3)" "unprognostic (7.98e-2)" "unprognostic (4.08e-2)" "unprognostic (7.32e-2)" "unprognostic (1.15e-1)" "unprognostic (3.59e-2)" "unprognostic (7.97e-2)" "unprognostic (7.25e-3)" "unprognostic (7.72e-2)" "unprognostic (9.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.59e-2)" 5.5 1.4 15.1 51.7 2.9 19.2 4.6 0.4 5.6 1.9 3.6 2.1 0.9 3.2 1.4 1.8 3.9 2.3 3.0 1.7 8.1 1.8 5.5 2.3 5.6 57.8 3.5 4.7 2.3 15.1 0.4 2.1 1.7 7.4 2.8 3.5 1.3 4.1 2.1 0.8 2.7 13.2 1.8 5.3 27.6 3.6 0.7 2.8 67.0 3.6 1.7 69.5 10.4 5.7 17.4 5.7 51.8 12.2 12.0 7.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.1 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.0 5.6 0.0 0.0 0.0 7.2 8.3 0.0 0.0 0.1 0.0 0.0 1.1 6.3 0.0 0.0 7.9 13.4 0.0 0.0 32.7 0.0 9.3 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 0.0 0.0 6.2 1.1 107.6 0.0 3.2 0.0 17.0 5.4 51.8 6.5 10.5 5.4 17.4 4.1 6.6 5.7 13.3 7.1 6.9 39.3 12.0 12.2 5.4 0.7 4.7 15.1 2.9 0.4 5.6 8.1 1.8 3.5 4.7 7.4 2.8 LRP1 "A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A" ENSG00000123384 "LDL receptor related protein 1" Q07954 12 57128493-57213351 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 82.6;ASC TERT1: 83.9;fHDF/TERT166: 36.0;HSkMC: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "classical monocyte: 7.6;intermediate monocyte: 4.0;myeloid DC: 2.8;non-classical monocyte: 3.7" "Group enriched" "Detected in many" 20 "dendritic cells: 2.8;monocytes: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004182, CAB018621, HPA022903" Supported Approved Nucleoplasm,Vesicles "Intracellular and membrane" 88000000 Vesicles Nucleoplasm "CAB018621: AB_627893, HPA004182: , HPA022903: AB_10602426" "unprognostic (1.65e-1)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (2.71e-1)" "unprognostic (5.00e-2)" "unprognostic (4.33e-2)" "unprognostic (3.98e-1)" "unprognostic (8.68e-2)" "unprognostic (1.70e-1)" "unprognostic (3.37e-3)" "unprognostic (1.48e-1)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.52e-5)" "unprognostic (2.81e-3)" "unprognostic (6.13e-2)" "unprognostic (2.80e-2)" "prognostic unfavourable (1.29e-5)" 77.8 12.0 19.8 21.5 21.3 6.1 27.7 28.1 25.3 31.4 19.7 11.9 9.0 17.8 26.9 18.2 19.2 21.0 24.1 26.0 18.6 10.4 6.3 31.4 24.7 5.5 13.9 15.6 56.9 8.8 8.5 8.0 29.4 17.1 21.4 9.5 20.0 14.8 17.0 11.3 15.7 14.2 22.4 14.3 11.3 11.8 11.1 15.4 0.3 13.2 9.3 3.1 22.9 39.4 0.0 2.8 0.1 7.6 0.0 0.2 1.9 1.2 2.3 5.0 4.0 82.6 83.9 15.2 13.9 18.0 4.6 4.5 4.3 2.0 0.0 1.7 36.0 5.5 0.8 1.4 1.6 0.1 0.2 0.0 2.7 9.0 11.3 0.0 2.4 54.3 0.5 10.3 1.2 0.2 0.0 0.2 14.3 0.2 0.0 0.0 5.8 1.4 0.5 28.6 0.2 0.3 0.3 0.2 2.7 3.1 0.1 2.2 0.4 0.2 0.2 16.1 6.0 8.9 0.8 0.1 0.0 0.0 28.2 0.0 3.0 0.0 7.6 0.0 0.0 4.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.2 0.1 0.0 3.7 0.0 0.0 1.9 19.8 21.3 28.1 19.7 18.6 10.4 13.9 15.6 17.1 15.4 LRP1B "LRP-DIT, LRPDIT" ENSG00000168702 "LDL receptor related protein 1B" Q9NZR2 2 140231423-142131701 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7;thyroid gland: 14.9" "Cell line enhanced" "Detected in some" "ASC diff: 4.2;HEK 293: 4.4;HeLa: 2.3;HSkMC: 2.1;U-138 MG: 4.9;U-87 MG: 2.5" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "myeloid DC: 1.4;plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.4" "Low region specificity" "Detected in all" "HPA069094, HPA074788" Approved Approved Vesicles 63000 Vesicles "HPA069094: , HPA074788: " "unprognostic (5.31e-4)" "unprognostic (3.68e-2)" "unprognostic (2.61e-1)" "unprognostic (7.36e-4)" "unprognostic (5.19e-2)" "unprognostic (1.26e-1)" "unprognostic (2.00e-2)" "unprognostic (3.49e-1)" "unprognostic (3.75e-1)" "unprognostic (7.02e-3)" "unprognostic (1.64e-3)" "unprognostic (1.05e-1)" "unprognostic (2.94e-3)" "unprognostic (4.85e-3)" "unprognostic (1.52e-1)" "unprognostic (1.66e-2)" "unprognostic (1.36e-1)" 4.8 4.5 17.6 1.3 14.1 1.2 2.6 23.2 25.7 1.4 1.3 6.5 0.0 1.2 1.3 6.8 1.3 1.9 1.4 1.6 18.3 9.3 2.2 1.6 1.4 1.2 10.8 16.7 3.0 1.2 1.1 12.7 1.2 12.8 3.5 1.3 0.1 2.5 3.8 10.5 1.7 1.3 1.3 8.2 1.2 1.5 1.9 10.6 0.0 14.9 0.0 1.3 1.2 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 4.2 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.9 0.2 0.2 0.6 4.4 0.0 2.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.2 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 17.6 14.1 23.2 21.3 18.3 9.3 10.8 16.7 12.8 10.6 LRP2 "DBS, gp330" ENSG00000081479 "LDL receptor related protein 2" P98164 2 169127109-169362685 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endocytosis, Hearing, Neurogenesis, Transport" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 61.7;parathyroid gland: 61.4" "Group enriched" "Detected in some" 12 "AF22: 21.4;CACO-2: 35.6" "Group enriched" "Detected in many" 6 "breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005980, HPA064792" Enhanced Approved Vesicles,Mitochondria "Vesicles, Mitochondria" "HPA005980: AB_1079278, HPA064792: " "unprognostic (1.87e-1)" "unprognostic (1.04e-3)" "unprognostic (1.32e-3)" "unprognostic (3.65e-3)" "unprognostic (3.18e-2)" "unprognostic (1.60e-2)" "unprognostic (1.64e-3)" "unprognostic (2.99e-1)" "unprognostic (1.94e-1)" "unprognostic (1.39e-1)" "unprognostic (4.09e-2)" "unprognostic (4.38e-1)" "prognostic favourable (3.43e-5)" "unprognostic (1.37e-1)" "unprognostic (4.21e-1)" "unprognostic (2.44e-2)" "unprognostic (1.62e-2)" 1.7 0.4 2.7 0.4 12.9 0.5 7.4 0.7 5.7 0.6 0.4 18.5 0.0 0.4 0.5 4.8 0.4 0.4 0.6 0.5 6.2 3.4 61.7 0.6 1.8 0.4 20.7 1.9 0.4 0.4 61.4 0.4 10.5 8.5 0.5 0.4 7.9 1.1 0.5 0.5 0.5 0.4 0.4 17.2 0.4 0.5 0.6 17.0 0.0 18.2 0.0 0.4 0.4 0.2 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.7 12.9 0.7 5.7 6.2 3.4 20.7 1.9 8.5 17.0 LRR1 "LRR-1, MGC20689, PPIL5" ENSG00000165501 "Leucine rich repeat protein 1" Q96L50 14 49598697-49614672 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 43.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA065703, HPA069364" Approved Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nucleoplasm, Nuclear membrane" Vesicles "HPA065703: , HPA069364: " "unprognostic (2.73e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-2)" "unprognostic (2.26e-2)" "unprognostic (2.85e-2)" "unprognostic (9.34e-2)" "prognostic unfavourable (2.97e-4)" "unprognostic (7.34e-2)" "unprognostic (2.50e-2)" "unprognostic (8.30e-2)" "unprognostic (4.64e-2)" "unprognostic (1.60e-1)" "prognostic unfavourable (4.90e-7)" "unprognostic (6.86e-2)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" "unprognostic (4.04e-2)" 5.7 6.0 1.7 7.8 2.5 14.2 5.0 2.4 2.8 3.2 8.5 2.5 2.6 7.8 4.2 2.8 7.2 3.7 4.6 6.9 1.5 1.1 4.3 5.6 4.5 9.6 2.5 1.6 3.1 6.5 1.3 1.6 4.8 2.3 3.3 6.2 4.3 6.0 5.5 7.5 4.8 7.9 3.5 3.3 8.1 4.9 43.9 2.0 28.0 3.8 7.7 9.2 4.7 4.6 12.5 14.6 20.3 18.8 7.3 12.7 8.5 22.3 16.0 12.8 12.7 2.9 2.1 14.9 12.1 11.1 27.6 25.0 14.4 18.9 20.4 8.4 7.3 14.6 15.3 11.0 19.4 20.7 12.1 9.8 11.6 9.2 2.3 23.2 12.9 2.2 3.8 12.4 5.6 13.1 9.9 13.7 13.6 20.1 27.1 19.4 7.7 21.0 19.1 21.7 14.6 9.3 9.3 12.8 7.2 11.6 13.9 8.4 17.9 15.2 5.0 19.2 31.8 8.4 14.9 7.5 10.8 22.2 9.8 16.3 14.3 16.9 12.3 20.3 9.3 18.8 11.8 12.5 11.9 12.6 12.7 9.2 9.5 10.7 6.6 7.3 13.1 14.6 12.7 8.5 1.7 2.5 2.4 2.8 1.5 1.1 2.5 1.6 2.3 2.0 LRRC15 LIB ENSG00000172061 "Leucine rich repeat containing 15" Q8TF66 3 194355247-194369743 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 48.1" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 47.8;U-138 MG: 9.3;U-87 MG: 25.8" "Cancer enhanced" "Detected in many" "breast cancer: 25.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035503 Uncertain Approved "Vesicles,Plasma membrane" 1800000 Vesicles "Plasma membrane" "HPA035503: AB_10961253" "unprognostic (3.20e-2)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (3.53e-2)" "unprognostic (3.97e-2)" "unprognostic (1.88e-3)" "unprognostic (1.22e-8)" "unprognostic (5.81e-2)" "unprognostic (1.11e-1)" "unprognostic (5.62e-3)" "unprognostic (7.54e-3)" 3.3 0.5 0.5 3.1 0.6 0.0 5.3 0.5 0.5 4.6 2.1 0.2 0.0 0.4 3.5 0.3 1.0 1.3 2.0 1.8 0.5 0.5 0.5 0.5 2.5 0.8 0.5 0.0 3.1 0.8 0.0 0.5 48.1 0.3 0.6 4.2 0.7 1.6 0.0 1.0 9.1 0.8 0.7 0.5 1.3 1.9 0.9 0.0 1.1 1.8 7.7 7.7 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.4 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.3 1.5 1.2 0.0 0.0 0.0 0.0 25.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 LRRC17 "H_RG318M05.3, P37NB" ENSG00000128606 "Leucine rich repeat containing 17" Q8N6Y2 7 102912991-102944949 "Predicted secreted proteins" Osteogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 39.0" "Cell line enriched" "Detected in some" 5 "LHCN-M2: 168.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 17 "eosinophil: 12.0" "Lineage enriched" "Detected in single" 75 "granulocytes: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073458 Approved "Vesicles,Cytokinetic bridge" "Secreted in other tissues" Vesicles "Cytokinetic bridge" "HPA073458: " "unprognostic (1.77e-1)" "unprognostic (7.73e-2)" "unprognostic (4.79e-2)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (4.46e-1)" "unprognostic (1.18e-1)" "unprognostic (9.76e-4)" "unprognostic (6.09e-3)" "unprognostic (2.26e-1)" "unprognostic (2.39e-1)" "prognostic unfavourable (4.12e-6)" "unprognostic (8.57e-3)" "unprognostic (4.48e-2)" "unprognostic (6.17e-2)" "prognostic unfavourable (6.30e-4)" 5.1 1.3 1.1 0.5 1.2 0.0 6.2 1.4 2.0 15.0 1.4 1.5 5.6 0.5 8.3 17.1 5.2 8.9 13.5 6.4 1.2 1.3 1.5 1.4 1.6 1.6 1.1 2.1 39.0 2.6 1.2 1.7 1.8 2.5 7.8 1.4 2.7 2.8 2.5 5.3 2.0 2.6 5.1 1.2 1.2 3.5 5.1 0.2 2.2 2.6 6.7 1.3 6.7 4.2 0.1 0.1 12.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.8 4.2 0.0 0.2 2.4 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 3.9 0.1 2.9 0.0 19.1 0.0 0.0 168.8 0.0 0.0 0.0 0.4 0.0 0.0 33.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.2 2.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 1.2 1.4 2.0 1.2 1.3 1.1 2.1 2.5 0.2 LRRC24 LRRC14OS ENSG00000254402 "Leucine rich repeat containing 24" Q50LG9 8 144522377-144527032 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.9" "Cell line enhanced" "Detected in some" "MCF7: 4.1;SCLC-21H: 4.4;SH-SY5Y: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028171, HPA052250" Enhanced Approved Vesicles Vesicles "HPA028171: , HPA052250: " "unprognostic (1.75e-1)" "unprognostic (5.76e-2)" "unprognostic (2.33e-3)" "unprognostic (3.63e-2)" 2.5 4.0 5.1 1.4 9.3 1.7 1.5 12.3 16.9 2.3 2.1 1.6 0.6 2.0 2.5 1.7 1.7 2.8 1.3 1.5 4.5 7.9 2.2 1.6 2.0 1.4 4.5 8.4 4.5 3.2 9.3 8.4 1.5 5.9 11.4 1.1 10.3 2.8 3.2 2.3 1.7 2.0 1.6 2.1 2.2 1.9 1.5 1.3 0.6 1.6 1.0 1.1 1.4 1.6 0.0 0.5 0.0 0.1 0.1 0.5 0.0 0.3 0.8 0.6 1.5 0.8 0.5 1.8 0.5 0.6 0.6 0.6 0.2 1.6 0.8 3.4 0.2 0.1 0.0 0.0 0.1 1.2 2.2 0.5 1.0 0.3 0.6 0.0 1.0 0.7 0.4 0.5 0.1 0.3 0.9 0.1 0.1 4.1 1.2 1.6 0.1 0.8 1.8 0.1 0.6 0.1 0.5 4.4 12.2 0.4 0.1 0.4 3.7 1.3 0.0 0.1 1.2 0.4 0.2 1.0 0.1 0.1 0.6 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 9.3 12.3 16.9 4.5 7.9 4.5 8.4 5.9 1.3 LRRC37A KIAA0563 ENSG00000176681 "Leucine rich repeat containing 37A" A6NMS7 17 46292733-46337794 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 9.4;testis: 15.2" "Cell line enhanced" "Detected in many" "Daudi: 7.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles Vesicles "HPA042121: , HPA043056: , HPA045090: , HPA049080: " "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.22e-2)" "unprognostic (3.75e-2)" "unprognostic (6.02e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-2)" "unprognostic (5.23e-2)" "unprognostic (5.20e-2)" "unprognostic (8.22e-2)" "unprognostic (2.05e-1)" "unprognostic (2.65e-3)" "unprognostic (3.37e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-2)" "unprognostic (4.30e-2)" 0.9 0.4 1.4 2.0 1.8 1.4 1.7 2.6 1.7 0.7 0.9 0.5 1.1 0.4 1.1 1.0 0.5 1.1 1.5 1.2 0.9 0.6 0.9 1.5 0.6 1.2 0.9 0.5 2.1 0.7 1.3 1.0 1.0 0.9 9.4 1.8 1.3 0.6 0.8 1.2 0.8 15.2 1.2 0.9 1.1 1.1 1.4 1.7 2.1 1.4 2.1 1.5 0.2 0.2 0.2 1.5 0.2 0.3 0.0 0.5 0.1 0.4 0.1 0.2 3.5 0.3 7.8 0.3 0.2 0.3 0.0 0.0 0.0 0.5 1.2 0.4 3.9 2.7 0.6 0.0 0.2 0.0 1.0 0.0 0.0 0.5 0.2 0.5 0.9 0.0 0.3 0.7 1.2 0.0 2.7 2.8 1.8 0.0 1.8 0.4 1.0 0.2 0.6 0.1 0.5 3.6 1.2 1.4 2.3 0.4 0.2 3.5 2.5 0.5 1.2 2.4 2.2 2.1 1.1 1.0 1.0 1.0 0.9 0.8 0.8 1.5 1.1 1.4 1.3 1.1 1.9 2.1 1.4 1.7 1.0 0.2 LRRC37A2 FLJ45049 ENSG00000238083 "Leucine rich repeat containing 37 member A2" A6NM11 17 46511511-46555650 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.5" "Cell line enhanced" "Detected in some" "Daudi: 4.0;THP-1: 4.2" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "eosinophil: 2.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.9" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles Vesicles "HPA042121: , HPA043056: , HPA045090: , HPA049080: " "unprognostic (1.59e-2)" "unprognostic (3.75e-2)" "unprognostic (8.96e-2)" "unprognostic (6.35e-2)" "unprognostic (2.53e-1)" "unprognostic (2.97e-3)" "unprognostic (4.61e-3)" "unprognostic (1.63e-1)" "unprognostic (6.47e-2)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (8.00e-2)" "unprognostic (3.02e-7)" "unprognostic (8.40e-2)" "unprognostic (2.82e-1)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" 0.5 0.0 0.3 0.4 0.7 0.9 0.8 0.9 0.4 0.1 0.4 0.0 0.2 0.1 0.5 0.3 0.0 0.1 0.4 0.4 0.5 0.4 0.7 0.5 0.1 0.3 0.1 0.1 1.2 0.1 0.4 0.9 0.4 0.7 0.6 0.9 0.4 0.5 0.2 0.0 0.5 13.5 0.4 0.5 0.6 0.3 0.2 0.3 2.9 0.1 0.1 0.4 0.0 0.4 0.6 0.3 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.8 0.0 4.0 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.9 0.5 0.7 0.0 0.0 0.0 0.8 0.0 0.3 1.9 0.0 0.8 2.0 0.0 0.3 0.1 0.2 0.1 1.8 0.8 0.4 0.0 1.4 0.2 0.4 0.3 0.0 0.3 1.4 4.2 0.8 2.5 1.9 0.0 0.8 1.3 1.0 0.5 0.2 0.9 1.5 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 LRRC37A3 "FLJ34306, KIAA0563" ENSG00000176809 "Leucine rich repeat containing 37 member A3" O60309 17 64854312-64919480 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042121, HPA043056, HPA045090" Supported Approved Vesicles Vesicles "HPA042121: , HPA043056: , HPA045090: " "unprognostic (2.28e-1)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (4.73e-2)" "unprognostic (2.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.84e-2)" "unprognostic (2.27e-1)" "unprognostic (3.29e-1)" "unprognostic (1.80e-2)" "unprognostic (5.31e-6)" "unprognostic (1.83e-1)" "prognostic unfavourable (3.25e-6)" "unprognostic (2.26e-1)" "unprognostic (4.89e-2)" "unprognostic (5.18e-2)" "unprognostic (7.43e-3)" 4.4 6.6 14.8 5.5 14.0 6.2 8.8 27.9 16.0 4.3 3.6 7.4 5.4 3.2 6.9 16.0 3.9 7.8 6.8 3.8 15.1 15.0 15.7 3.4 4.8 4.3 12.8 7.2 8.4 5.2 5.7 18.8 4.6 12.1 6.7 4.0 8.3 4.3 6.2 6.4 7.1 4.0 4.2 6.6 4.6 4.2 25.8 12.6 7.3 14.3 0.3 3.1 4.6 10.0 2.3 2.3 5.3 1.0 3.1 1.2 0.3 2.4 4.9 4.7 10.6 5.3 3.3 3.4 3.5 2.8 2.5 2.7 2.1 3.7 2.5 1.6 1.8 2.1 1.3 1.0 1.1 3.2 4.8 7.6 2.9 1.5 2.1 2.9 2.0 2.2 1.8 1.7 0.8 1.7 1.5 1.4 1.8 6.6 1.4 4.9 3.7 1.4 1.6 2.5 1.1 5.4 2.3 3.1 11.9 1.3 6.0 1.4 2.6 5.2 5.7 4.3 1.3 1.7 1.8 2.1 1.9 1.9 3.0 12.1 7.3 5.3 0.4 0.7 0.7 0.7 0.8 0.6 1.0 0.4 0.6 2.3 1.2 1.1 2.0 3.1 1.0 2.3 0.9 0.3 14.8 14.0 27.9 16.0 15.1 15.0 12.8 7.2 12.1 12.6 LRRC43 MGC35140 ENSG00000158113 "Leucine rich repeat containing 43" Q8N309 12 122167738-122203471 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.6" "Cell line enhanced" "Detected in some" "HHSteC: 2.8;HSkMC: 3.2;HUVEC TERT2: 6.4;SCLC-21H: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA039425 Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA039425: " "unprognostic (6.42e-3)" "unprognostic (1.33e-1)" "unprognostic (2.71e-1)" "unprognostic (2.83e-3)" "unprognostic (2.48e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.56e-2)" "unprognostic (6.03e-5)" "unprognostic (1.19e-1)" "unprognostic (4.52e-3)" "unprognostic (2.61e-1)" "unprognostic (6.21e-4)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (3.39e-1)" "unprognostic (2.49e-1)" 0.9 0.9 3.0 0.3 5.0 0.8 0.7 1.2 4.6 1.5 0.7 4.1 1.3 1.0 1.4 6.6 0.4 26.6 1.6 1.5 4.5 3.0 3.1 0.5 2.5 0.4 3.1 1.5 3.3 1.2 3.5 3.4 0.5 6.4 1.3 0.5 2.9 1.8 2.2 0.4 0.8 0.5 0.6 1.0 0.8 0.7 10.8 1.8 0.0 2.5 0.0 0.4 0.7 0.3 0.0 0.9 0.0 0.6 2.9 1.9 0.8 0.0 0.0 0.3 0.0 0.3 0.7 0.4 0.0 1.8 0.5 0.5 0.6 0.1 0.0 1.3 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 2.8 0.1 0.6 3.2 0.0 1.0 0.0 6.4 0.0 0.0 1.2 0.0 0.0 1.3 0.0 0.3 0.1 0.0 0.1 0.0 0.3 5.2 1.1 0.0 0.2 0.3 0.8 1.6 0.5 0.0 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.8 0.0 0.0 1.9 0.0 2.9 0.6 0.9 0.0 0.8 3.0 5.0 1.2 4.6 4.5 3.0 3.1 1.5 6.4 1.8 LRRK2 "DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2" ENSG00000188906 "Leucine rich repeat kinase 2" Q5S007 12 40196744-40369285 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Differentiation" "GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 40.4;lung: 50.4" "Cell line enhanced" "Detected in some" "A549: 9.7;ASC TERT1: 10.0;BJ hTERT+: 5.6;RPTEC TERT1: 10.7" "Group enriched" "Detected in many" 7 "lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 40.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 40.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014293, CAB037160" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB037160: AB_1840989, HPA014293: AB_1853353" "unprognostic (2.67e-1)" "unprognostic (1.75e-1)" "unprognostic (6.45e-3)" "unprognostic (1.06e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-3)" "unprognostic (2.71e-1)" "unprognostic (3.14e-1)" "unprognostic (2.25e-1)" "unprognostic (9.07e-2)" "unprognostic (2.76e-1)" "unprognostic (1.23e-1)" "prognostic favourable (3.02e-6)" "unprognostic (2.55e-2)" "unprognostic (3.43e-2)" "unprognostic (2.01e-3)" "unprognostic (5.21e-3)" 3.7 3.4 2.3 7.0 3.9 8.6 3.0 1.7 5.0 5.1 4.5 1.7 2.6 0.7 5.3 2.9 5.3 3.8 4.5 4.0 1.8 1.4 10.6 4.5 50.4 6.8 2.2 3.6 5.8 3.3 10.9 2.5 1.0 1.9 3.6 1.6 3.3 4.2 2.0 5.6 2.6 3.4 6.7 4.9 8.6 2.7 1.2 2.4 0.5 3.9 2.7 4.9 4.6 6.8 0.9 1.5 40.4 5.8 0.0 0.0 0.8 0.0 9.7 0.1 0.0 3.9 10.0 0.1 2.1 5.6 0.4 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.3 0.0 0.4 0.0 0.7 0.3 0.2 0.0 0.7 0.5 0.1 2.5 0.7 0.0 0.2 0.6 0.0 0.0 0.7 0.0 0.0 1.2 0.2 0.1 0.0 0.0 0.0 10.7 0.0 0.1 0.6 0.0 0.2 2.7 2.8 2.2 1.4 1.1 1.1 1.2 0.7 0.0 0.0 0.0 2.3 0.0 0.5 0.0 5.8 1.2 0.0 3.1 0.0 0.9 0.0 0.0 1.5 0.9 0.0 0.0 40.4 0.0 3.0 0.2 0.0 0.8 2.3 3.9 1.7 5.0 1.8 1.4 2.2 3.6 1.9 2.4 LRWD1 "CENP-33, DKFZp434K1815, ORCA" ENSG00000161036 "Leucine rich repeats and WD repeat domain containing 1" Q9UFC0 7 102464929-102473168 "Predicted intracellular proteins" "DNA replication" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "testis: 129.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021320 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA021320: AB_1853372" "unprognostic (1.50e-1)" "unprognostic (1.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.66e-3)" "unprognostic (1.60e-2)" "unprognostic (2.08e-3)" "unprognostic (1.72e-3)" "unprognostic (4.97e-2)" "unprognostic (3.34e-1)" "unprognostic (3.04e-2)" "prognostic favourable (8.71e-5)" "unprognostic (1.00e-1)" "prognostic unfavourable (1.25e-4)" "unprognostic (1.46e-2)" "unprognostic (4.14e-2)" "unprognostic (7.82e-2)" "unprognostic (9.20e-2)" 2.7 4.6 3.6 3.8 5.0 7.6 1.9 7.9 5.8 2.5 2.5 3.4 3.4 2.9 2.8 2.8 2.1 7.1 2.5 2.6 4.3 4.0 4.0 5.1 2.6 4.4 3.4 3.7 3.1 3.4 3.4 4.9 2.0 4.2 2.2 1.6 1.7 3.3 4.0 3.6 2.2 4.3 2.7 2.4 6.6 3.3 129.9 3.8 3.9 2.7 1.6 4.2 2.3 1.8 12.6 9.8 9.2 4.0 9.9 10.4 5.8 7.3 10.2 5.5 15.5 4.2 3.2 8.6 7.8 5.1 13.3 9.2 9.7 4.3 18.1 11.2 5.9 7.8 8.1 7.0 4.0 6.3 15.7 3.7 4.6 6.0 5.6 6.9 7.3 3.0 4.3 15.4 3.3 7.0 17.5 5.6 7.2 22.1 21.0 16.7 11.7 14.7 11.1 5.1 19.5 4.0 4.6 7.3 20.7 8.6 8.2 7.6 4.7 5.8 4.1 7.4 15.8 22.8 12.4 20.6 35.5 17.3 8.2 6.5 12.8 9.1 2.5 9.2 10.4 4.0 9.9 11.1 9.1 9.1 2.8 12.6 5.8 7.4 5.9 9.9 3.5 9.8 9.0 5.8 3.6 5.0 7.9 5.8 4.3 4.0 3.4 3.7 4.2 3.8 LSM1 "CASM, YJL124C" ENSG00000175324 "LSM1 homolog, mRNA degradation associated" O15116 8 38163321-38176730 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024601 Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA024601: AB_1853379" "unprognostic (1.19e-2)" "unprognostic (7.21e-2)" "unprognostic (1.94e-2)" "unprognostic (9.59e-2)" "unprognostic (7.26e-2)" "unprognostic (1.69e-1)" "unprognostic (2.08e-3)" "unprognostic (2.18e-2)" "unprognostic (1.95e-2)" "unprognostic (2.48e-2)" "unprognostic (1.07e-2)" "unprognostic (1.16e-2)" "unprognostic (3.47e-2)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (8.75e-2)" "unprognostic (2.97e-1)" 21.8 27.6 25.5 20.0 23.5 21.6 34.1 20.8 23.2 19.5 23.4 15.3 21.2 20.6 24.9 27.2 24.9 17.8 21.6 44.2 21.2 23.2 35.3 30.7 16.2 22.5 25.1 18.4 18.0 24.7 14.5 23.2 29.8 22.5 21.3 21.5 18.7 27.7 29.0 26.6 17.7 26.3 31.3 17.1 20.5 22.6 17.6 19.9 18.8 25.7 25.6 22.2 23.5 22.7 21.1 38.2 42.8 26.0 19.9 27.3 26.5 21.5 25.3 14.9 18.2 27.4 23.0 13.8 26.4 26.9 24.5 26.2 17.3 14.9 10.7 23.7 31.3 11.5 20.1 21.8 25.8 16.2 25.3 33.7 18.1 21.3 24.3 11.4 21.5 24.0 20.1 21.2 16.8 20.8 26.7 25.5 30.2 22.9 35.5 22.3 23.4 25.8 17.3 16.3 12.6 33.8 24.0 28.0 23.3 11.7 17.5 31.1 13.9 24.5 21.9 21.9 26.9 32.2 20.8 28.2 36.6 21.1 25.3 23.8 22.3 42.8 24.0 32.7 21.8 24.7 23.2 21.1 24.5 23.8 23.2 16.4 22.2 25.5 18.3 19.9 26.0 38.2 27.3 26.5 25.5 23.5 20.8 23.2 21.2 23.2 25.1 18.4 22.5 19.9 LSM14B "bA11M20.3, C20orf40, FAM61B, FLJ25473, FT005, LSM13, RAP55B" ENSG00000149657 "LSM family member 14B" Q9BX40 20 62122461-62135378 "Predicted intracellular proteins" "Translation regulation" "Developmental protein, Ribonucleoprotein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 5.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041274, HPA061189" Approved Supported "Nucleoli fibrillar center,Vesicles" Vesicles "Nucleoli fibrillar center" "HPA041274: , HPA061189: AB_2684448" "unprognostic (2.24e-1)" "unprognostic (2.35e-1)" "unprognostic (2.89e-1)" "unprognostic (1.85e-2)" "unprognostic (1.20e-1)" "unprognostic (1.42e-1)" "prognostic unfavourable (3.61e-5)" "unprognostic (4.99e-2)" "unprognostic (2.28e-1)" "unprognostic (5.43e-2)" "unprognostic (4.93e-3)" "unprognostic (4.69e-2)" "unprognostic (3.34e-3)" "unprognostic (6.61e-2)" "unprognostic (2.00e-1)" "unprognostic (4.53e-3)" "unprognostic (1.98e-1)" 13.6 19.6 21.4 17.3 24.4 20.2 24.0 50.0 38.6 19.5 16.1 15.9 11.9 20.4 21.9 15.6 20.1 16.8 16.1 28.7 20.8 18.9 14.9 15.1 15.3 18.9 17.3 28.2 30.6 26.5 19.4 16.9 13.2 20.4 18.2 13.2 16.8 20.2 16.9 55.5 23.4 19.5 17.9 18.6 18.1 18.3 35.2 12.2 28.8 16.6 20.1 16.7 19.1 17.7 1.4 1.3 5.8 1.1 0.1 1.2 0.2 13.9 13.3 21.2 20.3 9.7 10.2 18.2 14.7 11.0 30.8 13.5 39.0 9.7 14.7 17.1 10.1 20.2 10.2 12.8 15.4 6.0 7.4 35.4 17.0 23.2 13.4 15.1 21.5 8.7 23.2 12.8 11.9 7.8 18.9 10.6 10.7 18.4 25.1 22.8 13.1 19.7 32.8 42.0 11.6 8.3 16.5 29.2 25.3 26.9 23.9 18.9 29.7 19.2 10.1 43.9 30.1 22.6 14.9 13.5 15.9 18.2 19.3 10.1 14.0 0.2 1.1 5.8 1.0 1.0 0.4 1.2 0.7 1.2 0.9 1.4 0.8 0.8 1.8 0.1 0.5 1.3 0.5 0.2 21.4 24.4 50.0 38.6 20.8 18.9 17.3 28.2 20.4 12.2 LSM4 YER112W ENSG00000130520 "LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated" Q9Y4Z0 19 18306230-18323274 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040932 Uncertain Approved Vesicles Vesicles "HPA040932: AB_10795529" "unprognostic (2.71e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (7.42e-3)" "unprognostic (1.98e-1)" "unprognostic (4.09e-2)" "unprognostic (1.10e-3)" "unprognostic (9.80e-2)" "unprognostic (1.57e-1)" "prognostic favourable (1.34e-4)" "unprognostic (8.31e-3)" "unprognostic (1.25e-1)" "prognostic favourable (2.22e-4)" "unprognostic (2.51e-2)" "unprognostic (7.23e-2)" "unprognostic (8.08e-2)" "unprognostic (1.34e-1)" 19.0 41.0 42.7 22.3 37.8 35.8 31.5 23.9 40.7 25.0 41.2 16.4 29.6 38.6 17.9 26.5 31.4 26.6 28.2 33.3 35.1 35.4 37.9 37.9 22.2 41.0 38.6 34.0 20.1 34.2 18.4 25.2 29.4 25.5 21.0 31.9 25.3 21.3 29.7 55.5 21.1 35.6 21.9 24.1 24.3 34.2 50.9 19.2 40.3 27.4 37.5 25.3 18.2 18.6 35.4 77.8 34.5 54.2 42.3 40.6 52.0 47.8 25.5 43.9 39.3 17.4 16.5 49.7 22.1 20.0 29.3 28.1 22.8 51.8 28.3 47.2 23.8 32.4 48.6 46.9 22.5 32.9 85.1 25.5 40.7 27.2 17.1 24.2 15.3 14.9 28.5 27.2 32.4 24.2 53.5 29.9 30.8 78.6 66.4 52.4 56.2 79.9 37.6 19.1 52.6 36.9 17.1 48.9 45.2 18.9 24.2 32.6 23.9 26.3 13.4 17.1 19.6 41.9 41.2 27.6 23.3 32.8 23.0 47.8 29.1 27.8 49.7 34.5 33.8 54.2 40.6 34.6 36.4 34.8 54.8 35.4 39.2 39.2 4.1 42.3 41.8 77.8 34.3 52.0 42.7 37.8 23.9 40.7 35.1 35.4 38.6 34.0 25.5 19.2 LSM8 YJR022W ENSG00000128534 "LSM8 homolog, U6 small nuclear RNA associated" O95777 7 118184032-118192824 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020116 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA020116: AB_1853385" "unprognostic (1.02e-2)" "unprognostic (6.58e-2)" "unprognostic (1.36e-1)" "prognostic unfavourable (9.85e-4)" "unprognostic (3.33e-2)" "unprognostic (7.34e-2)" "unprognostic (1.13e-3)" "unprognostic (1.87e-2)" "unprognostic (1.79e-2)" "unprognostic (9.90e-2)" "unprognostic (5.14e-2)" "unprognostic (1.17e-2)" "prognostic unfavourable (7.46e-6)" "unprognostic (4.82e-2)" "unprognostic (1.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.00e-3)" 27.5 20.8 16.8 30.8 19.7 39.7 27.1 33.1 25.9 18.5 20.1 12.8 18.8 20.6 23.0 25.4 26.2 19.3 16.2 25.1 19.1 10.1 20.2 19.9 23.1 34.1 19.8 17.2 22.9 27.0 13.2 28.3 16.8 20.1 22.3 22.8 13.6 24.5 21.2 21.4 21.9 26.2 23.6 28.3 33.8 22.3 21.0 20.2 30.0 24.6 23.2 38.2 22.1 21.6 29.8 40.6 22.0 28.2 18.2 35.3 16.2 14.4 9.7 22.1 16.8 8.1 13.1 9.0 15.7 13.7 10.9 14.2 7.8 15.2 30.0 32.9 8.2 10.3 13.2 10.2 11.5 15.5 14.2 20.0 20.2 15.6 17.9 26.0 23.2 11.7 12.4 13.4 12.4 11.1 20.8 29.9 13.5 6.6 45.8 65.5 20.0 14.7 14.5 13.1 20.8 11.4 9.7 13.1 16.8 14.0 35.7 30.2 7.4 29.2 9.1 17.5 9.9 20.5 19.6 25.6 18.2 34.7 12.8 31.9 22.2 22.0 21.0 19.1 29.0 28.2 28.1 29.8 32.2 35.3 22.4 26.5 31.2 31.7 7.0 18.2 26.6 40.6 31.4 16.2 16.8 19.7 33.1 25.9 19.1 10.1 19.8 17.2 20.1 20.2 LTK TYK1 ENSG00000062524 "Leukocyte receptor tyrosine kinase" P29376 15 41503638-41513887 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.1" "Cell line enhanced" "Detected in some" "HEL: 5.3;NB-4: 10.3;RH-30: 5.0;THP-1: 15.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "MAIT T-cell: 8.3;plasmacytoid DC: 7.0" "Group enriched" "Detected in many" 10 "dendritic cells: 7.0;T-cells: 8.3" "Low region specificity" "Detected in many" HPA059545 Uncertain Approved Vesicles Vesicles "HPA059545: " "unprognostic (9.47e-4)" "unprognostic (5.52e-4)" "unprognostic (1.51e-1)" "unprognostic (2.49e-1)" "unprognostic (4.12e-1)" "unprognostic (5.65e-3)" "unprognostic (1.74e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "unprognostic (2.81e-3)" "unprognostic (9.36e-3)" "unprognostic (5.36e-2)" "unprognostic (4.68e-2)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" 1.0 0.5 0.5 5.1 1.6 3.1 0.5 2.0 3.2 0.6 8.2 0.5 1.9 10.6 1.3 1.1 1.2 0.3 2.0 2.2 0.5 0.1 3.5 4.3 15.1 0.6 0.5 0.5 1.0 0.5 1.0 0.7 8.9 0.5 0.7 4.8 4.3 11.7 0.5 2.0 0.9 10.7 0.5 0.5 5.5 8.3 2.4 0.8 0.5 0.7 0.5 2.2 0.6 0.7 0.7 7.0 0.0 0.0 0.0 8.3 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.1 0.6 0.9 1.3 2.4 0.0 0.0 0.1 0.7 0.0 2.9 0.0 0.4 0.2 1.4 5.3 0.0 0.0 2.3 0.0 0.0 0.4 0.4 0.0 0.1 0.0 2.0 0.0 2.0 0.0 0.0 10.3 0.4 0.2 0.2 5.0 0.1 0.0 0.0 0.5 3.3 0.1 0.2 0.0 0.2 15.8 0.0 0.0 0.2 0.2 0.0 0.4 0.2 0.2 0.0 0.5 0.9 0.0 0.0 0.0 0.6 0.0 8.3 0.7 0.5 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 7.0 0.0 0.2 0.5 1.6 2.0 3.2 0.5 0.1 0.5 0.5 0.5 0.8 LURAP1 "C1orf190, FLJ25163, LRAP35a" ENSG00000171357 "Leucine rich adaptor protein 1" Q96LR2 1 46203334-46221261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 110.5" "HPA030060, HPA030061" Uncertain Supported Vesicles,Cytosol Cytosol Vesicles "HPA030060: AB_10599997, HPA030061: AB_10601990" "unprognostic (3.88e-2)" "unprognostic (6.21e-2)" "unprognostic (3.22e-3)" "unprognostic (8.82e-2)" "unprognostic (1.91e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-1)" "unprognostic (6.47e-2)" "unprognostic (2.44e-2)" "unprognostic (2.95e-2)" "unprognostic (4.14e-2)" "unprognostic (1.33e-1)" "prognostic favourable (8.81e-8)" "unprognostic (1.32e-2)" "unprognostic (2.80e-1)" "unprognostic (3.11e-2)" "unprognostic (2.39e-2)" 3.0 7.3 7.1 2.2 13.2 3.4 3.9 12.7 12.7 5.8 3.8 15.2 2.2 2.0 5.5 4.9 4.0 4.0 3.7 8.7 6.7 5.8 7.4 1.1 3.2 1.6 18.8 6.0 7.2 1.1 21.5 3.2 2.3 11.2 7.5 2.5 4.7 5.2 9.8 2.5 4.2 1.9 5.6 17.5 3.5 3.7 10.8 13.6 0.0 19.6 0.0 2.1 5.6 5.3 1.0 0.7 6.2 1.1 1.9 0.8 0.3 0.2 0.2 3.0 0.2 4.1 5.6 3.1 2.1 5.4 2.9 3.5 0.1 0.2 0.2 0.1 5.1 0.3 3.2 6.8 2.4 0.6 1.5 0.2 0.7 0.3 1.2 0.2 0.1 2.9 4.6 5.7 2.7 4.2 2.6 0.6 1.7 0.3 0.3 0.3 1.1 0.5 1.1 1.5 0.0 7.6 0.1 0.4 1.2 0.1 0.2 4.9 1.5 0.3 0.2 1.8 2.3 1.5 0.4 0.3 0.1 0.3 1.7 0.3 0.4 1.3 1.1 0.4 0.3 0.5 0.8 0.5 0.4 0.3 0.4 1.0 0.8 0.6 6.2 1.9 0.5 0.7 0.1 0.3 7.1 13.2 12.7 12.7 6.7 5.8 18.8 6.0 11.2 13.6 LUZP1 LUZP ENSG00000169641 "Leucine zipper protein 1" Q86V48 1 23084023-23177808 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028506, HPA028542" Enhanced Uncertain "Vesicles,Actin filaments,Cytosol" "Actin filaments" "Vesicles, Cytosol" "HPA028506: AB_10600083, HPA028542: AB_10601986" "unprognostic (3.04e-2)" "prognostic unfavourable (5.57e-4)" "unprognostic (7.35e-3)" "unprognostic (7.20e-2)" "unprognostic (3.96e-2)" "unprognostic (8.27e-2)" "unprognostic (8.46e-3)" "unprognostic (9.77e-3)" "unprognostic (7.34e-2)" "unprognostic (2.56e-3)" "unprognostic (1.19e-1)" "unprognostic (3.50e-1)" "prognostic favourable (1.46e-7)" "unprognostic (4.49e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-1)" "unprognostic (1.33e-1)" 9.7 10.3 5.2 6.5 10.7 8.3 7.3 7.8 18.2 7.5 11.7 2.5 4.4 15.7 9.6 4.5 7.5 6.6 9.1 9.2 6.3 6.1 8.1 4.0 9.1 4.0 5.4 9.5 6.6 4.4 21.8 4.9 8.6 21.8 7.0 9.4 4.6 7.1 7.1 4.2 6.8 27.1 8.9 5.0 9.4 5.9 20.4 3.4 5.2 7.9 4.7 5.5 7.9 9.9 4.5 11.9 21.5 7.4 4.8 10.5 2.1 9.5 6.6 9.3 10.8 9.6 12.3 6.8 9.4 15.1 11.8 12.5 3.7 4.5 0.2 8.7 15.9 13.0 9.2 25.6 14.5 3.5 6.1 13.5 8.2 3.5 6.3 6.6 8.7 10.8 10.1 17.3 13.7 26.5 4.9 0.8 9.5 2.5 4.5 2.8 7.9 7.2 6.9 14.0 1.1 5.4 6.3 1.7 4.4 22.5 6.4 7.7 3.6 3.5 47.3 13.9 10.6 10.4 9.3 1.2 2.8 3.7 6.2 11.0 11.9 21.5 5.8 6.1 9.3 4.0 10.5 2.4 7.0 5.8 5.6 4.5 5.6 5.5 3.2 4.8 7.4 11.9 3.7 2.1 5.2 10.7 7.8 18.2 6.3 6.1 5.4 9.5 21.8 3.4 LY96 MD-2 ENSG00000154589 "Lymphocyte antigen 96" Q9Y6Y9 8 73991352-74029087 "Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.9;Karpas-707: 52.0;RPMI-8226: 25.1;U-87 MG: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 92.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 92.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053060 Approved Vesicles "Secreted to blood" 95000 Vesicles "HPA053060: " "unprognostic (2.96e-1)" "unprognostic (2.64e-2)" "unprognostic (2.11e-1)" "unprognostic (1.85e-1)" "unprognostic (1.64e-2)" "unprognostic (2.87e-1)" "unprognostic (2.12e-3)" "unprognostic (1.42e-1)" "unprognostic (8.29e-2)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.43e-1)" "prognostic unfavourable (6.38e-11)" "unprognostic (2.87e-2)" "unprognostic (1.29e-2)" "unprognostic (1.60e-2)" "unprognostic (5.90e-2)" 23.4 9.6 5.7 20.9 9.6 7.3 12.6 1.6 7.8 7.5 10.3 2.5 2.7 6.0 6.2 12.3 9.6 7.6 17.1 18.8 11.2 5.8 7.4 10.9 17.3 36.3 11.6 1.9 12.7 3.2 0.7 7.2 21.8 9.2 9.6 7.4 3.9 9.0 3.4 6.0 3.5 7.0 10.0 19.6 47.3 4.9 7.2 6.6 5.3 6.5 5.2 18.4 15.3 16.1 4.0 6.8 92.6 14.2 0.0 3.1 4.6 0.4 0.0 0.1 0.0 10.0 20.9 0.0 13.9 16.9 3.7 8.7 0.0 0.1 4.3 4.8 8.9 0.1 0.0 0.2 9.7 4.6 0.1 0.1 0.0 0.4 5.0 0.7 0.2 6.1 0.1 6.1 1.2 18.5 0.0 52.0 13.4 0.0 1.7 0.5 0.0 0.3 1.7 0.0 25.1 0.7 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.9 14.3 9.7 0.7 5.1 3.3 13.7 6.3 2.6 26.8 0.2 4.1 1.6 14.2 0.0 0.0 12.3 0.2 4.0 2.0 0.3 6.8 1.8 1.3 0.4 92.6 0.0 9.8 5.6 3.1 4.6 5.7 9.6 1.6 7.8 11.2 5.8 11.6 1.9 9.2 6.6 LYN JTK8 ENSG00000254087 "LYN proto-oncogene, Src family tyrosine kinase" P07948 8 55879813-56014168 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.9" "Cell line enhanced" "Detected in many" "HEL: 56.8;HMC-1: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 36.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001231, CAB004492" Enhanced Supported "Golgi apparatus,Vesicles,Plasma membrane" 11000000 "Golgi apparatus, Plasma membrane" Vesicles "CAB004492: AB_627897, HPA001231: AB_1079286" "unprognostic (7.87e-2)" "unprognostic (4.89e-2)" "unprognostic (9.04e-2)" "unprognostic (3.74e-1)" "unprognostic (8.12e-2)" "unprognostic (2.17e-1)" "unprognostic (5.70e-2)" "unprognostic (1.11e-1)" "unprognostic (2.79e-1)" "unprognostic (8.80e-2)" "unprognostic (3.68e-2)" "unprognostic (7.15e-2)" "prognostic unfavourable (3.43e-4)" "unprognostic (2.13e-1)" "unprognostic (2.72e-3)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" 8.8 6.8 4.5 34.0 6.3 33.6 11.1 9.5 4.1 5.3 10.5 5.8 7.2 15.6 3.4 7.8 7.2 6.7 13.7 8.9 4.8 3.6 6.1 13.8 34.6 70.9 7.7 2.1 5.3 9.8 3.1 4.9 19.1 5.6 5.7 6.6 6.3 14.9 8.5 2.7 3.4 16.2 6.6 8.5 69.4 7.4 3.6 5.1 3.8 9.4 5.3 25.8 10.7 7.5 8.4 9.2 36.8 26.5 1.9 0.9 2.7 12.6 7.5 1.7 0.3 0.1 0.0 13.7 9.7 14.2 6.1 4.3 5.2 4.4 12.2 4.3 3.8 5.9 7.1 7.2 5.2 19.8 7.1 56.8 2.3 1.8 1.9 5.7 57.7 0.3 2.5 0.1 4.4 8.2 30.0 26.5 0.9 0.7 0.0 6.0 10.9 0.8 0.9 2.8 1.5 3.9 6.0 1.1 22.0 4.8 0.0 2.0 1.1 13.4 9.6 0.0 2.8 0.0 4.4 8.9 3.2 27.6 0.6 11.3 0.4 2.1 7.2 12.3 0.9 16.8 0.7 8.2 0.2 0.3 6.4 8.4 0.1 0.4 36.8 1.9 26.5 9.2 0.0 2.7 4.5 6.3 9.5 4.1 4.8 3.6 7.7 2.1 5.6 5.1 LYPD3 C4.4A ENSG00000124466 "LY6/PLAUR domain containing 3" O95274 19 43460787-43465660 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 110.5;lymphoid tissue: 75.2;skin 1: 86.4;tongue: 70.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.5;HaCaT: 29.4;MCF7: 32.8;RT4: 31.5;SK-BR-3: 47.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 235.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.9" "Group enriched" "Detected in many" 10 "dendritic cells: 3.5;granulocytes: 3.0;T-cells: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041529, HPA041797, HPA077859" Enhanced Approved "Endoplasmic reticulum,Vesicles" 9700000 "Endoplasmic reticulum, Vesicles" "HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: " "unprognostic (1.07e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (2.80e-1)" "unprognostic (2.67e-2)" "unprognostic (4.90e-3)" "prognostic unfavourable (7.86e-5)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (1.07e-3)" "unprognostic (5.13e-2)" "unprognostic (8.79e-2)" "unprognostic (1.11e-1)" "unprognostic (2.96e-3)" 0.3 0.4 0.3 0.4 0.3 0.8 5.8 0.3 0.3 28.0 0.3 0.3 0.3 0.0 2.1 0.7 110.5 0.5 0.3 0.3 0.3 0.0 0.4 0.3 0.3 0.3 0.3 0.3 0.8 0.3 0.0 0.3 7.4 0.3 1.4 0.0 0.5 21.7 0.3 0.6 86.4 0.4 0.8 0.3 0.3 0.1 0.3 0.3 1.9 0.3 70.6 75.2 4.1 48.3 0.2 3.5 3.0 0.4 0.1 7.9 1.9 11.0 0.1 0.0 0.2 0.1 0.0 4.6 0.4 1.1 0.4 0.5 0.1 12.5 0.0 0.5 0.3 29.4 0.0 1.3 0.2 0.0 0.0 0.2 1.5 0.2 0.1 0.0 0.2 0.5 11.1 0.0 0.1 0.0 0.0 0.0 0.0 32.8 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.3 31.5 0.0 0.0 0.1 47.3 0.5 5.2 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 1.6 0.2 4.2 1.6 3.5 0.0 7.9 6.7 3.0 0.1 0.0 0.4 1.2 1.9 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 LZTS3 "KIAA0552, ProSAPiP1" ENSG00000088899 "Leucine zipper tumor suppressor family member 3" O60299 20 3162617-3173592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.9;salivary gland: 36.2" "Cell line enhanced" "Detected in many" "CACO-2: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031008, HPA031009" Approved Approved Vesicles Vesicles "HPA031008: AB_10601610, HPA031009: AB_10670162" "unprognostic (4.09e-2)" "unprognostic (4.10e-2)" "unprognostic (1.55e-2)" "prognostic unfavourable (7.26e-4)" "unprognostic (1.15e-1)" "unprognostic (6.19e-3)" "unprognostic (2.14e-1)" "prognostic favourable (7.98e-4)" "unprognostic (3.31e-1)" "unprognostic (1.08e-1)" "unprognostic (4.57e-2)" "unprognostic (9.69e-3)" "prognostic favourable (5.92e-8)" "unprognostic (4.63e-2)" "unprognostic (1.85e-1)" "unprognostic (8.47e-2)" "unprognostic (1.38e-1)" 2.4 5.3 17.6 1.4 31.1 1.7 3.5 51.9 45.7 11.5 2.4 4.2 2.1 8.6 4.6 3.7 1.7 6.4 6.8 5.4 16.4 10.7 11.9 2.7 5.6 1.2 7.1 17.4 9.0 17.0 11.8 4.1 2.2 10.5 5.0 2.2 7.4 36.2 7.9 5.1 1.4 6.5 2.7 4.5 1.7 7.7 1.9 6.0 0.0 7.1 0.4 1.0 2.6 1.5 0.2 0.8 0.0 0.0 0.0 0.9 0.0 2.7 2.6 3.7 4.1 5.2 1.5 2.6 2.8 6.0 4.7 7.0 15.0 7.9 4.7 1.5 5.4 1.3 2.0 2.9 3.6 0.1 2.7 0.2 0.5 12.3 11.8 0.2 1.3 1.9 6.5 6.6 2.5 0.7 2.7 1.5 2.3 1.2 0.3 0.6 8.4 2.6 1.2 1.2 5.0 5.9 1.0 14.8 4.5 2.3 3.2 2.2 7.6 0.1 4.2 5.1 9.6 2.0 0.8 3.0 0.4 1.4 2.5 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.8 0.5 0.0 17.6 31.1 51.9 45.7 16.4 10.7 7.1 17.4 10.5 6.0 MAF1 DKFZp586G1123 ENSG00000179632 "MAF1 homolog, negative regulator of RNA polymerase III" Q9H063 8 144104499-144107611 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024821, HPA058548" Uncertain Supported Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA024821: , HPA058548: " "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.71e-2)" "unprognostic (2.21e-1)" "unprognostic (8.51e-2)" "unprognostic (9.67e-2)" "prognostic unfavourable (7.09e-4)" "unprognostic (6.12e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-3)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (9.40e-3)" "unprognostic (9.02e-2)" "unprognostic (2.59e-1)" "unprognostic (2.38e-1)" "unprognostic (3.99e-2)" 26.8 23.2 17.5 18.4 17.5 43.6 35.7 20.5 26.3 27.3 47.2 23.7 22.8 19.5 33.0 22.5 34.4 26.1 33.6 72.5 17.3 15.5 24.1 21.4 21.2 28.2 19.7 18.6 36.3 39.8 25.2 20.8 23.8 14.9 36.8 18.9 23.8 28.7 32.3 114.3 18.7 29.8 50.9 17.2 27.7 28.9 30.2 16.2 35.5 40.4 38.7 22.8 35.2 46.7 48.0 39.9 45.1 34.5 33.2 46.2 32.6 23.9 38.6 17.9 17.9 49.1 24.5 14.6 18.9 31.3 29.6 30.2 14.1 26.7 26.7 32.2 31.6 14.8 24.3 26.7 21.8 23.5 29.4 29.1 26.6 22.1 33.1 12.3 20.0 21.6 31.4 23.7 44.7 31.8 22.5 18.2 17.6 57.2 46.0 22.8 13.4 103.8 18.4 25.1 28.4 18.5 18.1 26.2 21.8 25.1 32.7 30.5 22.2 19.0 19.1 13.8 31.6 24.3 23.7 22.0 16.7 12.5 22.9 23.1 9.1 15.8 34.5 45.1 28.5 26.8 32.3 40.1 41.0 46.2 39.9 48.0 44.2 41.4 19.9 33.2 27.0 29.8 29.2 32.6 17.5 17.5 20.5 26.3 17.3 15.5 19.7 18.6 14.9 16.2 MAK16 "MAK16L, RBM13" ENSG00000198042 "MAK16 homolog" Q9BXY0 8 33484750-33501260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044417, HPA050574" Uncertain Supported Nucleoli,Vesicles Nucleoli Vesicles "HPA044417: , HPA050574: AB_2681181" "unprognostic (2.10e-1)" "unprognostic (1.74e-1)" "unprognostic (8.48e-3)" "unprognostic (2.28e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.00e-4)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (3.66e-4)" "unprognostic (8.04e-2)" "unprognostic (1.20e-1)" "unprognostic (6.74e-2)" "unprognostic (1.47e-1)" 22.3 11.0 10.6 14.9 15.3 13.5 15.2 11.5 17.6 13.2 11.5 12.5 8.3 9.1 20.8 9.1 15.2 13.6 11.3 13.1 10.5 13.4 17.9 20.0 10.5 17.3 11.4 10.3 24.8 15.7 10.4 19.2 13.1 19.2 14.2 11.3 8.9 10.6 10.3 25.2 12.4 10.8 19.7 13.1 17.3 11.9 9.5 7.1 20.3 14.8 14.3 17.4 16.8 11.3 3.8 4.0 0.9 9.4 5.7 6.2 3.3 5.9 8.4 5.9 13.5 7.0 8.4 8.8 10.8 7.1 11.8 11.1 12.5 5.3 21.1 10.7 9.5 7.9 19.7 12.0 15.9 4.5 5.5 19.9 6.0 11.0 10.4 8.0 12.2 8.7 11.1 15.3 18.0 8.6 24.7 12.3 9.8 7.0 28.5 9.7 31.2 5.9 10.2 8.9 9.5 10.0 10.2 15.1 12.0 6.6 9.4 13.0 6.5 8.5 7.6 11.1 8.7 14.3 12.3 6.1 6.7 21.8 6.9 17.2 11.8 0.0 3.2 0.9 4.8 6.8 5.4 3.2 4.7 4.1 3.9 3.8 6.0 6.2 0.7 5.7 9.4 4.0 3.6 3.3 10.6 15.3 11.5 17.6 10.5 13.4 11.4 10.3 19.2 7.1 MAN1B1 "ERManI, MANA-ER, MRT15" ENSG00000177239 "Mannosidase alpha class 1B member 1" Q9UKM7 9 137086927-137109187 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051516 Approved Uncertain Vesicles 540000 Vesicles "HPA051516: " "unprognostic (1.21e-2)" "unprognostic (4.66e-1)" "unprognostic (1.25e-3)" "unprognostic (4.67e-3)" "unprognostic (2.27e-1)" "unprognostic (3.70e-3)" "prognostic unfavourable (1.45e-4)" "unprognostic (1.59e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-2)" "unprognostic (5.93e-3)" "unprognostic (1.75e-1)" "unprognostic (3.55e-2)" "unprognostic (2.28e-1)" "unprognostic (5.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.44e-3)" 20.4 25.4 19.7 13.5 23.7 9.8 18.6 21.6 36.1 24.3 21.6 24.5 20.6 19.8 22.7 28.1 23.1 28.9 25.9 19.5 20.5 21.5 24.3 32.7 20.4 19.9 18.6 25.2 24.2 32.6 23.6 25.1 30.8 18.0 21.2 12.0 22.0 32.7 23.1 12.2 25.4 17.8 18.5 16.4 22.2 21.8 30.3 18.2 19.9 25.1 12.7 19.3 21.0 16.0 13.0 23.0 16.3 24.4 18.0 21.9 18.5 7.2 17.1 5.9 16.9 22.5 19.4 19.8 12.3 26.1 16.5 14.6 8.3 22.9 6.6 41.4 20.6 25.0 3.5 11.9 3.0 9.1 6.0 2.9 15.4 9.6 21.2 5.1 11.4 22.9 22.6 9.6 8.1 10.9 8.0 10.9 11.6 14.7 5.4 12.1 7.9 17.2 3.1 10.0 20.9 13.2 3.6 6.9 6.2 18.2 19.4 12.6 21.5 10.9 15.3 24.4 9.1 18.0 14.4 4.4 3.6 4.3 29.4 6.5 21.0 7.9 20.1 16.3 21.9 21.8 20.5 13.0 17.3 20.6 23.0 11.0 17.0 17.0 5.9 18.0 24.4 16.1 21.5 18.5 19.7 23.7 21.6 36.1 20.5 21.5 18.6 25.2 18.0 18.2 MAN1C1 HMIC ENSG00000117643 "Mannosidase alpha class 1C member 1" Q9NR34 1 25617468-25786207 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 12.5;HSkMC: 46.0;U-266/70: 13.7" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.3" "Lineage enriched" "Detected in many" 5 "T-cells: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048352 Uncertain Uncertain Nucleoplasm,Vesicles 1200000 "Nucleoplasm, Vesicles" "HPA048352: " "unprognostic (2.75e-1)" "unprognostic (5.45e-3)" "unprognostic (5.71e-3)" "unprognostic (2.05e-2)" "unprognostic (1.95e-1)" "unprognostic (8.90e-3)" "unprognostic (4.78e-2)" "prognostic favourable (7.55e-4)" "unprognostic (1.80e-1)" "unprognostic (5.70e-2)" "prognostic favourable (4.79e-4)" "unprognostic (2.51e-1)" "unprognostic (9.09e-3)" "unprognostic (3.18e-2)" "unprognostic (7.23e-2)" "unprognostic (7.44e-2)" "unprognostic (5.18e-2)" 4.6 4.5 4.2 3.0 3.8 0.0 2.2 9.9 8.8 8.6 3.6 1.2 6.6 2.5 2.4 3.9 7.3 3.4 5.2 3.2 10.3 12.1 3.2 4.0 4.2 7.1 0.7 4.4 7.8 8.3 7.2 1.2 1.8 7.5 0.9 2.7 1.9 8.0 6.0 7.0 3.1 1.0 10.7 3.2 4.3 4.0 1.0 0.6 1.1 1.6 0.8 8.3 1.1 0.0 0.1 12.5 2.6 9.3 7.3 3.6 0.1 2.4 0.6 0.2 0.2 0.0 0.1 0.1 0.9 0.1 1.1 0.1 0.2 3.9 0.5 0.2 0.1 0.0 1.1 2.1 5.2 46.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.6 0.0 2.3 3.2 0.0 0.2 7.7 0.2 0.1 0.2 7.3 0.2 0.3 1.9 0.6 1.0 1.5 0.0 0.0 0.7 8.4 0.3 13.7 0.0 0.0 1.9 4.4 0.6 0.4 1.6 0.7 0.6 1.0 0.8 0.4 3.6 1.6 0.6 1.0 8.3 4.8 1.1 0.8 1.3 0.4 0.8 1.1 MAN2B1 "LAMAN, MANB" ENSG00000104774 "Mannosidase alpha class 2B member 1" O00754 19 12646511-12666742 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 42.1;intermediate monocyte: 39.4;myeloid DC: 35.2;non-classical monocyte: 28.4;plasmacytoid DC: 41.9" "Group enriched" "Detected in all" 5 "dendritic cells: 41.9;monocytes: 42.1" "HPA041530, HPA053404" Supported Approved Nucleoplasm,Vesicles "Intracellular and membrane" 3400000 "Nucleoplasm, Vesicles" "HPA041530: AB_10795639, HPA053404: " "unprognostic (6.63e-2)" "unprognostic (3.61e-1)" "unprognostic (2.20e-2)" "unprognostic (5.48e-2)" "unprognostic (3.81e-1)" "unprognostic (1.04e-1)" "unprognostic (1.61e-1)" "unprognostic (1.84e-2)" "unprognostic (9.55e-2)" "unprognostic (1.95e-1)" "unprognostic (2.79e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (1.94e-5)" "unprognostic (4.00e-1)" "unprognostic (4.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.51e-1)" 25.2 15.6 7.9 26.7 11.0 33.4 24.4 4.4 7.0 10.5 15.0 14.0 8.6 14.2 15.3 16.5 12.2 13.4 16.4 19.4 6.4 4.4 13.6 16.3 30.2 68.6 10.0 4.7 12.2 21.7 9.1 7.2 15.8 8.6 13.7 10.6 12.0 22.0 8.1 7.7 18.0 20.0 10.2 11.7 51.3 19.5 6.3 8.2 22.1 11.3 7.8 30.0 18.7 11.2 7.7 41.9 6.5 42.1 2.7 8.4 26.0 16.3 8.4 8.6 10.1 28.8 19.3 24.3 12.2 25.8 10.9 10.7 6.7 6.9 18.0 14.8 9.6 12.9 4.4 8.1 5.2 8.9 13.4 6.2 4.2 10.9 14.6 41.0 42.9 23.0 16.1 6.1 7.7 10.3 7.9 13.6 5.7 12.8 5.5 23.1 7.1 10.7 12.8 11.8 8.9 12.8 19.0 2.7 8.4 12.1 10.4 19.8 16.0 25.4 13.5 14.8 6.1 14.4 11.4 18.2 20.0 8.9 10.0 40.5 16.5 2.2 42.1 6.2 7.5 39.4 8.4 7.7 6.9 6.7 35.2 6.5 3.8 3.8 6.5 2.7 28.4 41.9 6.8 26.0 7.9 11.0 4.4 7.0 6.4 4.4 10.0 4.7 8.6 8.2 MANBA ENSG00000109323 "Mannosidase beta" O00462 4 102630770-102760994 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053478 Approved Supported Vesicles "Intracellular and membrane" 12000000 Vesicles "HPA053478: " "unprognostic (2.29e-2)" "unprognostic (1.40e-1)" "unprognostic (3.80e-1)" "unprognostic (1.70e-1)" "prognostic unfavourable (7.56e-5)" "unprognostic (4.11e-2)" "prognostic unfavourable (3.74e-6)" "unprognostic (1.32e-1)" "unprognostic (2.19e-1)" "unprognostic (4.87e-2)" "unprognostic (7.78e-2)" "unprognostic (1.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-2)" "unprognostic (7.12e-2)" "unprognostic (4.81e-2)" "unprognostic (2.13e-1)" 12.7 23.5 8.5 12.2 11.9 8.6 17.1 13.4 8.4 12.1 9.9 12.9 11.7 8.1 11.6 13.6 9.3 11.0 15.5 12.1 8.7 8.6 11.8 10.3 17.7 20.2 15.1 6.2 16.7 18.1 25.1 18.4 25.0 10.8 12.0 10.8 12.4 27.4 11.4 5.4 7.8 14.0 14.2 15.3 21.3 14.4 4.6 13.5 9.4 19.2 3.6 12.8 17.9 12.6 3.9 9.5 25.2 11.6 3.6 3.1 3.9 7.3 4.1 2.0 1.9 39.0 18.1 5.1 5.1 10.1 2.2 4.4 5.3 8.5 7.9 6.9 7.1 3.5 5.2 11.3 1.8 5.5 2.1 4.5 4.6 8.1 11.9 8.3 20.5 15.4 19.3 9.5 7.9 4.1 7.5 8.2 8.0 3.3 2.0 8.0 2.8 3.4 4.1 4.7 2.2 6.4 8.7 1.3 1.0 6.1 10.5 7.9 15.0 5.7 3.1 6.1 3.0 13.6 2.7 4.3 9.0 0.8 11.0 3.7 4.4 6.2 11.5 25.2 1.8 10.6 1.4 3.8 3.1 2.0 9.5 3.9 3.0 2.0 10.1 3.6 11.6 2.3 1.6 3.9 8.5 11.9 13.4 8.4 8.7 8.6 15.1 6.2 10.8 13.5 MANSC1 "FLJ10298, LOH12CR3" ENSG00000111261 "MANSC domain containing 1" Q9H8J5 12 12326056-12350541 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 29.9;RPTEC TERT1: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 24 "neutrophil: 37.5" "Lineage enriched" "Detected in many" 36 "granulocytes: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007955, HPA007956" Approved Approved "Golgi apparatus,Vesicles" 28000000 "Golgi apparatus, Vesicles" "HPA007955: AB_1079306, HPA007956: AB_1079305" "unprognostic (5.41e-3)" "unprognostic (3.10e-2)" "unprognostic (1.24e-1)" "unprognostic (5.46e-3)" "unprognostic (9.64e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-2)" "unprognostic (8.47e-2)" "unprognostic (9.18e-2)" "unprognostic (5.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.03e-1)" "prognostic favourable (3.30e-5)" "unprognostic (1.15e-2)" "unprognostic (4.46e-2)" "unprognostic (3.65e-1)" "unprognostic (1.03e-2)" 13.1 8.8 9.7 5.1 13.7 4.2 14.7 10.1 18.4 13.5 17.8 7.5 12.9 13.4 15.1 14.1 27.3 11.2 19.3 7.9 9.2 7.6 9.5 7.6 8.4 6.6 6.9 9.0 11.3 26.4 18.5 19.5 11.0 9.0 15.0 18.5 12.8 42.6 15.2 3.6 13.3 13.3 14.4 5.8 8.4 21.3 9.1 6.2 0.0 9.5 16.7 18.2 12.6 12.9 0.2 0.2 37.5 0.5 0.2 1.0 0.1 0.2 3.3 1.0 0.0 3.4 3.3 3.6 2.3 2.7 1.2 1.5 2.7 10.7 0.0 2.5 2.2 0.4 4.2 1.9 0.9 0.0 3.8 4.7 4.1 2.2 0.6 0.7 1.4 2.1 3.1 0.7 0.5 29.9 3.0 0.0 0.4 6.2 0.0 0.3 3.7 1.8 0.1 0.0 0.1 15.5 10.9 1.4 5.9 1.2 10.0 3.4 9.0 3.0 11.7 1.7 1.4 0.4 3.1 0.2 0.1 1.6 1.2 0.0 1.2 1.5 0.5 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.2 1.0 0.1 37.5 0.2 0.1 0.0 0.0 0.1 9.7 13.7 10.1 18.4 9.2 7.6 6.9 9.0 9.0 6.2 MAP1LC3A "ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3" ENSG00000101460 "Microtubule associated protein 1 light chain 3 alpha" Q9H492 20 34546854-34560345 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 19.5;HSkMC: 29.5;SCLC-21H: 18.8;SK-BR-3: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "neutrophil: 30.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007649, CAB037174, HPA042824, HPA052474, HPA052484" Enhanced Supported Vesicles Vesicles "CAB037174: AB_1079382, HPA007649: AB_1853943, HPA042824: , HPA052474: , HPA052484: " "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.02e-1)" "unprognostic (1.99e-2)" "unprognostic (4.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.55e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-2)" "unprognostic (1.98e-1)" "prognostic favourable (5.31e-5)" "unprognostic (2.82e-2)" "unprognostic (1.59e-3)" "unprognostic (3.84e-1)" "unprognostic (1.35e-1)" "unprognostic (7.90e-2)" "unprognostic (2.76e-1)" 29.8 15.1 38.3 10.3 33.6 10.7 16.8 45.6 59.8 15.8 22.7 17.8 9.6 24.2 16.1 15.8 13.6 16.1 18.7 30.3 39.0 46.8 15.3 31.9 11.8 20.4 41.6 46.7 11.9 20.7 17.8 26.6 9.7 38.3 16.9 16.2 13.6 14.2 15.4 29.7 23.3 26.8 18.8 29.0 12.1 13.5 15.7 18.2 1.1 17.6 10.2 24.5 13.0 13.5 3.4 1.4 30.6 1.6 1.1 4.0 1.0 0.0 1.6 1.8 0.0 12.7 17.7 0.0 9.3 8.9 7.0 6.6 0.0 0.1 0.0 0.1 9.4 1.9 0.0 3.5 1.3 2.1 0.7 0.0 6.7 0.0 19.5 0.0 4.2 29.5 0.4 4.7 1.7 4.1 0.0 0.0 7.4 0.0 0.0 0.2 0.6 1.8 0.0 0.0 0.0 0.0 0.0 18.8 10.8 10.6 26.1 0.0 0.1 7.8 7.2 14.9 0.1 2.9 4.0 0.0 1.9 0.0 9.8 0.0 6.1 1.3 1.3 3.6 1.9 1.6 1.4 3.4 2.0 2.0 0.4 1.6 0.6 1.2 30.6 1.1 0.6 1.4 4.0 1.0 38.3 33.6 45.6 59.3 39.0 46.8 41.6 46.7 38.3 18.2 MAP1LC3B ATG8F ENSG00000140941 "Microtubule associated protein 1 light chain 3 beta" Q9GZQ8 16 87383995-87404779 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037216, HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB037216: AB_796155, HPA042824: , HPA052474: , HPA052484: , HPA053767: " "unprognostic (4.70e-3)" "unprognostic (2.89e-1)" "unprognostic (3.21e-1)" "unprognostic (9.70e-3)" "unprognostic (4.28e-1)" "unprognostic (1.79e-2)" "unprognostic (4.98e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "prognostic favourable (2.77e-7)" "prognostic unfavourable (8.97e-4)" "unprognostic (9.66e-2)" "unprognostic (1.14e-1)" "unprognostic (1.60e-1)" 35.8 36.4 37.4 15.3 34.6 89.0 35.9 58.5 46.6 21.2 18.7 25.8 22.9 11.1 22.7 20.0 19.5 17.5 24.5 41.0 35.6 40.5 24.7 22.2 20.6 22.3 49.0 40.2 19.6 15.9 27.9 20.5 31.2 46.7 19.6 20.4 18.6 19.6 22.4 67.4 22.9 13.6 28.3 43.1 18.0 15.8 27.5 28.8 13.6 27.2 23.1 20.9 22.0 31.9 15.5 15.8 50.0 18.6 20.8 21.8 19.9 10.3 6.0 11.8 10.7 35.6 27.6 7.9 20.5 23.6 16.2 11.2 9.7 7.5 6.7 15.8 27.8 9.5 17.2 13.0 23.1 8.8 15.1 7.0 7.7 16.4 59.0 5.0 7.8 36.6 43.2 25.1 60.3 19.2 18.7 14.4 27.4 10.7 8.9 11.2 12.4 14.6 14.1 7.8 6.6 21.7 4.9 9.7 11.1 31.7 5.3 39.6 8.7 6.1 24.2 17.6 11.4 15.9 11.5 19.0 23.3 24.4 25.0 12.1 12.6 48.1 18.6 42.0 17.5 16.5 17.8 15.5 16.9 17.7 14.4 12.8 13.1 13.8 50.0 20.8 17.2 15.8 21.8 19.9 37.4 34.6 58.5 46.6 35.6 40.5 49.0 40.2 46.7 28.8 MAP1LC3B2 ATG8G ENSG00000258102 "Microtubule associated protein 1 light chain 3 beta 2" A6NCE7 12 116548105-116576448 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "blood: 33.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 11.1" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA042824: , HPA052474: , HPA052484: , HPA053767: " "unprognostic (1.50e-1)" "unprognostic (6.94e-2)" "unprognostic (9.14e-2)" "unprognostic (3.89e-3)" "unprognostic (1.62e-1)" "unprognostic (1.22e-1)" "unprognostic (2.43e-3)" "unprognostic (3.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (1.11e-3)" "unprognostic (6.66e-3)" "unprognostic (1.65e-1)" "unprognostic (1.53e-2)" "unprognostic (3.42e-1)" 0.4 3.5 0.4 0.4 0.4 2.0 0.4 0.4 1.8 0.4 0.7 0.4 0.4 2.2 1.0 0.4 0.5 0.0 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.0 0.4 0.4 2.6 0.4 0.2 0.4 0.8 0.4 3.9 1.1 0.8 0.6 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.5 0.7 0.4 7.0 8.0 33.1 10.1 7.2 11.4 8.5 2.6 0.0 0.7 2.9 0.4 1.4 1.6 3.0 0.6 0.2 0.4 3.7 2.6 0.1 3.7 0.7 1.6 1.1 0.8 1.2 0.7 0.0 0.0 0.6 3.1 2.3 1.9 1.8 0.4 1.0 2.3 1.9 0.5 1.6 4.7 0.7 0.9 1.4 2.9 1.6 0.7 2.0 0.4 0.6 0.4 1.4 0.9 4.3 1.2 1.1 11.1 1.5 0.2 0.9 4.0 1.1 3.5 2.6 3.8 2.9 4.6 4.7 1.2 2.4 22.7 9.3 25.1 6.6 8.9 6.2 7.0 7.4 6.3 7.7 6.1 5.1 5.6 33.1 7.2 10.1 8.0 11.4 8.5 MAP3K14 "FTDCR1B, HS, HSNIK, NIK" ENSG00000006062 "Mitogen-activated protein kinase kinase kinase 14" Q99558 17 45263121-45317040 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 22.0;HDLM-2: 22.6;U-251 MG: 22.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027269, HPA027270" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Vesicles, Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "HPA027269: AB_10600302, HPA027270: AB_10600884" "unprognostic (1.05e-2)" "prognostic favourable (5.27e-5)" "unprognostic (2.71e-2)" "unprognostic (9.42e-2)" "unprognostic (5.31e-2)" "unprognostic (2.61e-3)" "unprognostic (2.70e-2)" "unprognostic (1.72e-1)" "unprognostic (3.40e-1)" "unprognostic (3.45e-1)" "unprognostic (1.07e-2)" "unprognostic (1.78e-1)" "prognostic unfavourable (2.78e-4)" "unprognostic (8.82e-2)" "unprognostic (3.49e-2)" "unprognostic (1.03e-2)" "unprognostic (2.28e-1)" 3.7 3.4 3.0 14.7 4.0 3.4 2.7 4.9 3.6 5.0 7.3 4.5 3.5 6.0 5.5 3.3 6.8 4.2 6.2 4.5 3.0 4.4 5.1 4.9 12.0 3.0 0.6 3.5 5.7 3.5 7.7 1.5 4.6 5.2 3.5 4.3 7.5 4.8 14.5 6.1 9.6 5.2 4.1 8.4 4.0 4.5 4.5 7.1 2.2 6.9 18.0 4.9 2.8 9.5 4.8 7.7 3.6 5.6 5.2 2.3 9.4 22.0 2.2 3.9 1.5 3.7 5.6 2.6 1.8 8.3 5.1 3.4 11.6 4.2 13.3 2.7 6.6 1.0 3.5 4.3 22.6 1.7 0.9 6.0 1.5 4.0 0.7 4.4 5.8 2.2 4.1 2.2 1.6 1.8 18.0 4.2 3.4 3.9 1.5 1.2 3.1 5.2 6.7 9.5 6.0 1.9 2.3 1.9 4.0 2.7 2.8 1.7 0.4 3.5 3.8 5.9 3.2 22.1 17.2 6.4 2.2 2.1 2.4 5.1 1.5 3.4 1.6 3.5 3.6 2.0 7.6 2.4 2.5 2.3 9.5 2.6 2.5 7.7 5.6 2.2 4.8 5.2 2.3 MAP3K15 "ASK3, bA723P2.3, FLJ16518" ENSG00000180815 "Mitogen-activated protein kinase kinase kinase 15" Q6ZN16 X 19360056-19515261 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 17.3;brain: 13.2" "Cell line enhanced" "Detected in some" "A549: 3.4;HAP1: 8.6;HEK 293: 7.2;HEL: 2.9;REH: 4.4" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 6 "pons and medulla: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA004006 Approved Vesicles Vesicles "HPA004006: AB_1079358" "unprognostic (2.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.21e-2)" "unprognostic (6.56e-8)" "unprognostic (3.47e-2)" "unprognostic (1.42e-2)" "unprognostic (2.19e-3)" "unprognostic (2.35e-2)" "unprognostic (1.46e-1)" "unprognostic (4.87e-2)" "unprognostic (1.30e-2)" "unprognostic (8.95e-2)" "unprognostic (2.77e-3)" "unprognostic (4.00e-1)" "unprognostic (2.37e-1)" "unprognostic (3.98e-2)" "unprognostic (8.20e-2)" 0.1 17.3 0.5 0.4 0.3 0.5 0.1 2.3 0.1 0.1 0.1 5.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.5 3.6 0.1 0.5 0.0 0.1 0.0 1.3 4.1 0.4 5.7 0.0 13.2 0.1 0.0 4.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 2.6 0.1 2.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 8.6 0.0 0.0 1.4 7.2 2.9 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 2.2 2.2 0.9 4.4 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 2.3 0.1 0.4 0.5 0.1 0.0 13.2 0.0 MAP4K2 "BL44, GCK, RAB8IP" ENSG00000168067 "Mitogen-activated protein kinase kinase kinase kinase 2" Q12851 11 64784914-64803241 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007330 Enhanced Approved Vesicles Vesicles "HPA007330: AB_1079361" "unprognostic (1.66e-1)" "unprognostic (2.83e-1)" "unprognostic (3.07e-3)" "unprognostic (4.37e-3)" "unprognostic (2.67e-1)" "unprognostic (9.23e-2)" "prognostic unfavourable (3.10e-5)" "unprognostic (4.51e-2)" "unprognostic (3.65e-1)" "unprognostic (5.28e-2)" "unprognostic (1.24e-2)" "unprognostic (1.41e-1)" "unprognostic (2.47e-2)" "unprognostic (2.97e-1)" "unprognostic (1.57e-2)" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" 6.9 6.2 9.4 15.2 10.0 19.1 5.8 12.1 15.6 5.2 5.8 10.1 6.9 4.9 6.2 4.0 4.3 4.4 6.3 5.5 9.4 9.2 6.2 3.1 12.0 22.3 8.3 7.3 4.2 7.2 5.2 8.0 12.3 12.5 6.1 4.7 6.7 9.0 8.9 3.4 5.0 9.9 5.6 6.7 22.6 7.1 5.5 6.6 11.5 8.7 3.9 18.8 6.1 5.1 10.8 5.0 8.2 14.8 2.3 9.6 7.1 6.1 5.5 3.6 6.6 3.3 2.0 8.6 4.6 4.3 5.6 3.9 2.4 2.9 10.7 8.6 5.2 1.8 4.4 4.5 3.3 13.9 2.1 18.8 7.7 5.1 4.0 9.9 7.1 2.0 2.3 4.3 2.8 13.6 1.6 1.0 1.7 7.6 5.8 9.9 2.4 7.5 12.2 0.4 12.3 3.1 3.1 4.4 6.3 4.0 5.2 4.1 10.5 15.2 10.5 4.7 10.5 4.3 1.9 1.2 2.4 11.6 4.1 15.0 3.4 2.2 4.2 5.6 5.2 12.2 5.3 10.8 7.0 4.7 4.4 7.6 8.6 6.3 8.2 2.3 14.8 5.0 9.6 7.1 9.4 10.0 12.1 15.6 9.4 9.2 8.3 7.3 12.5 6.6 MAPK8IP3 "JIP3, JSAP1, KIAA1066, syd" ENSG00000138834 "Mitogen-activated protein kinase 8 interacting protein 3" Q9UPT6 16 1706183-1770317 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005580, HPA041785, HPA069311" Approved Approved Vesicles Vesicles "CAB005580: AB_627840, HPA041785: , HPA069311: " "unprognostic (1.49e-1)" "unprognostic (2.22e-1)" "unprognostic (8.28e-3)" "unprognostic (8.32e-2)" "unprognostic (3.90e-1)" "unprognostic (6.83e-3)" "unprognostic (3.66e-2)" "unprognostic (2.41e-2)" "unprognostic (1.55e-1)" "unprognostic (8.67e-2)" "unprognostic (1.57e-2)" "unprognostic (6.91e-3)" "prognostic unfavourable (5.25e-5)" "unprognostic (2.84e-1)" "unprognostic (1.85e-1)" "unprognostic (2.45e-1)" "prognostic favourable (3.95e-4)" 9.6 13.8 29.3 14.0 35.7 24.7 6.7 54.9 56.8 8.4 7.7 25.8 5.7 14.9 10.4 5.4 5.5 7.2 9.2 15.1 24.4 19.4 9.1 7.5 8.5 16.4 20.3 35.7 14.6 21.8 12.0 21.3 9.8 32.9 11.1 5.1 8.8 18.1 9.5 12.8 25.1 13.8 8.0 15.3 20.6 13.8 11.1 22.0 4.6 10.0 2.4 7.7 9.8 7.6 1.5 1.6 2.4 1.3 0.0 1.4 0.4 3.7 7.3 7.7 6.9 3.8 6.5 6.0 6.3 2.4 3.1 2.8 10.1 12.6 4.4 4.0 3.9 7.2 1.9 4.2 1.0 6.9 8.5 5.8 16.6 7.7 5.2 3.7 10.3 12.9 5.6 4.6 2.2 4.2 4.9 8.5 3.3 9.5 5.8 16.5 5.1 4.1 25.7 3.8 7.4 3.9 5.0 16.1 12.8 7.6 7.1 3.0 3.8 5.3 13.0 13.4 7.5 5.7 5.0 19.1 3.3 5.7 3.5 3.9 6.6 0.0 1.3 2.4 1.4 0.3 0.8 1.5 0.3 0.5 0.4 1.4 0.4 0.4 1.1 0.0 0.3 1.6 0.8 0.4 29.3 35.7 54.9 53.1 24.4 19.4 20.3 35.7 32.9 22.0 MARCH3 "MARCH-III, MGC48332, RNF173" ENSG00000173926 "Membrane associated ring-CH-type finger 3" Q86UD3 5 126867714-127030808 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 24.6;HUVEC TERT2: 16.4;TIME: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 8.8;naive B-cell: 13.1" "Lineage enriched" "Detected in many" 5 "B-cells: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043406 Uncertain Supported Vesicles Vesicles "HPA043406: AB_10793947" "unprognostic (5.96e-3)" "unprognostic (1.46e-2)" "unprognostic (1.91e-2)" "unprognostic (4.21e-2)" "unprognostic (9.00e-3)" "unprognostic (1.17e-2)" "unprognostic (7.75e-3)" "unprognostic (9.41e-2)" "unprognostic (8.93e-2)" "unprognostic (2.05e-3)" "unprognostic (3.15e-2)" "unprognostic (1.82e-1)" "unprognostic (5.60e-6)" "unprognostic (7.74e-2)" "unprognostic (7.64e-2)" "unprognostic (1.05e-1)" "unprognostic (3.64e-1)" 11.3 6.0 5.6 11.0 9.4 6.6 6.2 5.3 4.8 2.0 10.8 8.2 0.5 2.4 3.7 3.6 3.4 3.2 10.4 15.2 7.8 6.8 2.0 1.9 5.2 5.2 9.5 2.3 4.0 5.0 1.7 10.8 4.0 12.3 2.9 11.8 9.7 11.2 1.1 11.9 11.5 5.2 6.5 16.0 3.7 5.5 14.2 7.6 2.1 3.6 3.4 5.8 6.5 6.7 13.1 0.7 2.5 0.4 1.9 2.6 0.7 0.3 1.2 2.3 1.2 2.1 2.0 0.7 8.4 3.5 6.8 10.0 1.1 0.5 2.2 0.8 1.3 0.7 2.9 1.5 9.6 0.5 2.7 7.0 1.9 1.1 3.4 2.8 1.8 1.4 0.5 24.6 2.9 16.4 2.9 0.4 5.5 0.8 0.3 1.2 2.0 2.8 0.9 9.4 0.6 0.5 1.2 0.7 0.5 1.9 0.3 1.0 1.7 2.9 19.9 1.3 1.0 7.7 0.9 1.1 1.3 1.3 5.0 2.3 1.1 0.0 0.2 2.5 0.5 0.4 0.1 8.8 0.6 0.3 0.1 13.1 2.4 0.5 0.8 1.9 0.3 0.7 2.6 0.7 5.6 9.4 5.3 4.8 7.8 6.8 9.5 2.3 12.3 7.6 MARCO "SCARA2, SR-A6" ENSG00000019169 "Macrophage receptor with collagenous structure" Q9UEW3 2 118942166-118994660 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 66.3;lung: 65.6;lymphoid tissue: 58.7" "Cell line enhanced" "Detected in some" "HaCaT: 3.9;THP-1: 5.6;U-2 OS: 6.0;U-266/70: 3.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 15.8;intermediate monocyte: 26.7" "Lineage enriched" "Detected in many" 5 "monocytes: 26.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063793 Enhanced Approved "Golgi apparatus,Vesicles" 24000000 "Golgi apparatus" Vesicles "HPA063793: " "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" "unprognostic (5.96e-3)" "unprognostic (3.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.58e-2)" "unprognostic (3.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (6.27e-3)" "unprognostic (5.13e-2)" "unprognostic (2.24e-3)" "unprognostic (1.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (6.55e-2)" 22.8 11.7 0.8 29.6 1.1 0.9 3.3 2.3 1.3 0.3 2.8 0.9 0.0 0.6 0.3 12.9 5.2 13.8 0.8 10.8 0.6 0.4 1.6 66.3 65.6 29.3 1.3 3.1 4.7 0.4 0.2 0.8 2.3 2.7 4.5 0.7 1.0 2.9 0.8 6.8 1.1 1.3 9.6 1.7 58.7 2.2 2.8 0.6 0.0 3.0 0.5 0.4 8.8 1.1 0.0 5.0 0.3 26.7 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 3.9 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.6 0.0 0.0 6.0 0.9 0.0 3.6 0.0 0.2 0.0 1.3 0.0 0.0 15.8 0.0 0.0 26.7 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.3 0.0 3.2 0.4 0.0 3.4 0.8 1.1 2.3 1.3 0.6 0.4 1.3 3.1 2.7 0.6 MARF1 "KIAA0430, LKAP, LMKB, Marf1, PPP1R34" ENSG00000166783 "Meiosis regulator and mRNA stability factor 1" Q9Y4F3 16 15594386-15643166 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.0" "Group enriched" "Detected in many" 4 "B-cells: 6.4;granulocytes: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017992 Uncertain Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA017992: AB_1852921" "unprognostic (2.33e-1)" "unprognostic (6.44e-3)" "unprognostic (8.84e-2)" "unprognostic (3.78e-2)" "unprognostic (1.28e-1)" "unprognostic (6.13e-3)" "unprognostic (2.35e-1)" "unprognostic (2.10e-2)" "unprognostic (2.47e-2)" "unprognostic (6.93e-2)" "unprognostic (8.44e-3)" "unprognostic (1.35e-1)" "unprognostic (6.94e-3)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (8.74e-2)" "unprognostic (7.94e-2)" 12.2 9.1 22.4 12.3 17.7 16.7 11.2 25.9 40.0 16.9 17.2 12.0 7.6 8.9 15.2 7.1 10.7 15.1 11.0 8.8 20.7 15.4 13.0 9.0 10.8 17.2 15.1 18.4 20.8 12.0 18.8 12.0 9.3 16.5 12.8 12.8 9.1 12.4 12.8 20.4 11.9 13.0 15.5 13.6 14.6 12.0 6.8 14.0 11.8 15.5 4.2 26.1 18.8 13.9 6.4 0.8 12.0 1.9 0.8 2.1 0.8 4.2 8.0 10.3 7.4 9.5 13.6 4.2 4.8 6.6 4.4 7.7 1.3 5.9 19.4 9.6 9.5 3.0 6.1 6.7 8.1 6.6 4.2 8.2 7.3 6.1 7.9 9.2 10.8 8.1 7.4 9.7 11.7 11.3 7.1 7.3 8.8 4.0 7.5 4.2 2.8 4.0 10.4 13.5 4.8 3.9 8.2 5.9 7.5 7.1 4.6 8.7 4.9 8.1 11.7 6.6 4.3 11.4 3.9 8.5 7.9 11.8 9.0 6.0 8.6 2.4 1.6 4.3 1.4 1.4 0.8 4.2 2.1 1.4 0.7 6.4 1.9 2.0 12.0 0.8 1.9 0.8 1.9 0.8 22.4 17.7 25.9 40.0 20.7 15.4 15.1 18.4 16.5 14.0 MARVELD3 MRVLDC3 ENSG00000140832 "MARVEL domain containing 3" Q96A59 16 71626161-71642114 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.9;pancreas: 34.5" "Cell line enhanced" "Detected in some" "A-431: 11.5;BEWO: 17.3;CACO-2: 12.8;CAPAN-2: 12.4;HaCaT: 11.7;MCF7: 21.8;RT4: 10.2;SK-BR-3: 10.3;T-47d: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043514, HPA045471" Approved "Vesicles,Intermediate filaments" Vesicles "Intermediate filaments" "HPA043514: AB_10959475, HPA045471: " "unprognostic (1.18e-1)" "unprognostic (3.92e-1)" "unprognostic (9.92e-2)" "unprognostic (5.56e-2)" "unprognostic (1.03e-1)" "unprognostic (6.16e-3)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (2.54e-1)" "unprognostic (8.75e-3)" "unprognostic (3.29e-1)" "unprognostic (5.16e-2)" "prognostic favourable (6.80e-10)" "unprognostic (2.63e-3)" "unprognostic (4.76e-1)" "unprognostic (3.59e-2)" "unprognostic (2.43e-1)" 0.4 0.3 0.4 12.5 0.3 0.0 5.0 0.7 1.2 2.0 35.7 0.3 5.2 17.3 1.3 8.6 4.1 2.1 15.4 0.5 0.5 0.4 14.2 4.3 3.3 0.5 0.3 0.1 1.0 34.5 5.4 1.2 5.3 2.4 6.5 10.5 2.4 10.4 4.3 0.3 3.0 52.9 0.7 0.4 0.4 2.1 1.2 0.1 1.3 8.3 2.3 4.6 3.0 3.4 1.5 1.4 4.1 0.8 1.5 0.8 0.2 11.5 0.4 0.2 0.5 0.0 0.1 17.3 0.0 0.0 0.0 0.0 12.8 12.4 0.1 1.3 0.0 11.7 1.0 5.6 0.0 0.0 6.7 0.0 0.1 3.3 0.0 0.1 0.1 0.5 7.0 0.0 0.1 0.0 0.2 0.1 0.0 21.8 0.1 0.2 1.9 0.1 0.0 0.0 4.6 0.2 10.2 2.1 0.1 0.2 10.3 0.0 14.6 0.2 0.0 0.0 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 4.1 0.8 0.8 0.7 0.5 0.4 0.8 0.8 0.6 0.3 1.5 0.7 0.7 4.0 1.5 0.5 1.4 0.7 0.2 0.4 0.3 0.7 0.5 0.5 0.4 0.3 0.1 2.4 0.1 MAST1 "KIAA0973, SAST" ENSG00000105613 "Microtubule associated serine/threonine kinase 1" Q9Y2H9 19 12833951-12874951 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 51.0" "Cell line enhanced" "Detected in many" "AN3-CA: 14.8;SCLC-21H: 26.2;SH-SY5Y: 13.0;U-266/70: 10.7" "Cancer enhanced" "Detected in many" "glioma: 3.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 3.6;T-reg: 2.0" "Lineage enriched" "Detected in single" 8 "T-cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028181, HPA073106" Enhanced Approved Vesicles Vesicles "HPA028181: AB_10603872, HPA073106: " "unprognostic (6.32e-2)" "unprognostic (3.66e-2)" "unprognostic (3.93e-2)" "unprognostic (2.83e-5)" "unprognostic (1.72e-1)" "unprognostic (4.19e-2)" "unprognostic (2.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "unprognostic (8.89e-3)" "unprognostic (3.43e-2)" "unprognostic (3.84e-3)" "unprognostic (1.19e-1)" "unprognostic (7.04e-2)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" 1.2 5.2 20.4 1.7 13.6 1.6 1.5 51.0 40.1 1.1 1.5 1.4 0.0 1.7 1.3 1.2 1.3 1.2 1.6 1.3 16.1 16.3 1.2 1.3 1.2 1.3 8.8 19.5 1.5 1.6 1.2 10.4 1.2 19.9 1.2 1.3 1.6 1.3 1.2 1.2 4.1 1.6 1.3 4.2 1.2 1.5 3.9 2.7 0.0 1.2 0.0 1.3 1.2 0.2 0.4 0.0 0.0 0.2 0.0 3.6 0.1 2.2 1.0 0.9 14.8 0.0 0.0 1.2 0.1 0.1 0.2 0.6 0.5 0.9 3.6 1.6 0.0 0.0 4.3 0.0 0.0 2.5 2.9 0.3 3.6 1.6 0.0 0.7 0.7 0.3 0.0 0.5 0.5 0.0 3.1 1.9 0.0 0.5 1.5 0.4 4.4 4.5 9.8 2.9 5.1 0.2 0.1 26.2 13.0 0.5 0.9 2.6 2.4 1.3 0.0 1.8 2.8 2.0 0.4 10.7 8.5 2.1 3.3 2.0 0.1 0.0 0.2 0.0 0.0 0.2 3.6 0.1 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 2.0 0.1 20.4 13.6 51.0 34.3 16.1 16.3 8.8 19.5 19.9 2.7 MAX "bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8" ENSG00000125952 "MYC associated factor X" P61244 14 65006174-65102695 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 92.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000328, HPA003474" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "CAB000328: AB_2281783, HPA003474: AB_1079317" "unprognostic (4.50e-3)" "unprognostic (1.51e-3)" "unprognostic (4.08e-2)" "unprognostic (2.87e-1)" "unprognostic (8.37e-2)" "unprognostic (2.42e-2)" "unprognostic (1.13e-3)" "unprognostic (1.30e-3)" "unprognostic (1.53e-2)" "unprognostic (7.36e-3)" "unprognostic (7.19e-2)" "unprognostic (1.66e-2)" "prognostic unfavourable (5.57e-4)" "unprognostic (2.99e-1)" "unprognostic (4.68e-2)" "prognostic favourable (2.12e-4)" "unprognostic (6.03e-2)" 33.4 25.5 31.3 31.5 38.6 68.7 25.8 59.0 38.2 34.6 29.4 37.2 26.3 31.5 34.3 24.0 47.6 38.2 27.9 30.1 29.9 28.4 26.3 21.8 31.4 43.4 37.1 21.6 39.7 20.0 17.4 23.7 30.2 32.7 31.9 25.0 26.8 33.6 37.7 27.8 32.1 40.2 30.7 34.8 42.9 24.8 15.7 40.9 41.3 30.2 22.5 40.7 35.1 40.7 18.7 19.1 87.5 23.6 19.2 30.0 44.8 28.3 11.1 6.8 11.0 18.0 14.1 8.9 10.0 15.3 12.5 15.4 7.1 19.9 23.6 8.4 12.0 14.1 17.1 13.9 9.4 23.8 10.4 36.7 7.3 7.8 21.1 13.8 92.4 16.8 9.9 11.5 12.7 13.8 17.2 9.6 12.6 15.7 31.9 47.6 9.1 18.2 18.1 10.8 10.6 11.5 9.5 14.7 9.6 13.1 14.0 12.8 13.7 17.7 17.2 11.5 13.9 10.6 8.0 11.8 10.0 14.9 14.3 13.3 11.4 87.5 23.6 80.6 21.7 20.1 23.7 18.7 25.4 22.1 19.1 17.6 26.6 22.3 49.5 19.2 17.4 18.3 30.0 44.8 31.3 38.6 59.0 38.2 29.9 28.4 37.1 21.6 32.7 40.9 MBD1 "CXXC3, PCM1" ENSG00000141644 "Methyl-CpG binding domain protein 1" Q9UIS9 18 50266882-50281774 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009017, CAB036003, HPA068850" Approved Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB009017: AB_2095559, CAB036003: , HPA068850: " "unprognostic (2.12e-2)" "unprognostic (5.05e-2)" "unprognostic (6.88e-2)" "unprognostic (5.01e-3)" "unprognostic (9.20e-2)" "unprognostic (6.85e-2)" "prognostic unfavourable (5.08e-6)" "unprognostic (5.91e-2)" "unprognostic (2.61e-2)" "unprognostic (4.65e-2)" "unprognostic (1.96e-3)" "prognostic unfavourable (1.70e-6)" "unprognostic (7.06e-3)" "unprognostic (7.70e-2)" "unprognostic (7.05e-2)" "unprognostic (4.61e-2)" "unprognostic (1.31e-1)" 14.7 21.7 18.0 18.8 20.8 29.4 15.7 27.1 29.4 15.3 17.2 18.8 16.2 18.7 18.4 16.6 21.1 16.4 16.8 19.7 19.2 14.0 17.4 18.9 16.0 20.9 21.8 23.1 20.7 19.7 28.2 24.2 19.4 18.2 18.0 13.9 15.0 19.6 19.5 25.9 24.2 18.3 18.3 15.2 22.6 18.0 72.3 21.5 19.1 19.9 20.0 18.2 19.1 20.0 13.1 11.7 22.2 11.6 14.3 17.4 12.1 10.2 9.7 11.0 12.4 11.8 9.7 11.8 12.4 14.3 17.2 13.3 7.3 8.2 16.3 9.0 12.0 18.6 12.5 21.7 10.0 18.2 8.0 10.3 13.8 7.7 22.9 24.8 21.8 11.3 35.1 19.6 45.0 14.1 12.9 25.6 13.2 9.5 20.8 13.0 10.3 7.8 19.3 8.1 17.7 8.5 4.7 14.5 13.8 9.2 8.8 11.3 11.2 22.8 15.2 18.7 8.6 6.0 12.5 47.6 20.1 17.2 12.1 19.1 16.9 15.2 11.6 22.2 17.4 10.1 16.4 13.0 15.2 14.4 11.7 13.1 15.9 12.8 15.6 14.3 7.9 10.7 13.9 12.1 18.0 20.8 27.1 29.4 19.2 14.0 21.8 23.1 18.2 21.5 MBNL3 "CHCR, FLJ11316, MBLX39, MBXL" ENSG00000076770 "Muscleblind like splicing regulator 3" Q9NUK0 X 132369317-132489968 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 67.0" "Cell line enhanced" "Detected in many" "CACO-2: 38.9;Hep G2: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001584 Enhanced Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA001584: AB_1079326" "unprognostic (3.38e-2)" "unprognostic (1.40e-2)" "unprognostic (1.82e-1)" "prognostic unfavourable (1.57e-4)" "unprognostic (1.87e-1)" "unprognostic (2.67e-3)" "unprognostic (8.74e-2)" "unprognostic (3.46e-2)" "unprognostic (2.19e-2)" "unprognostic (5.77e-3)" "unprognostic (4.36e-3)" "unprognostic (1.65e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.43e-1)" "unprognostic (8.28e-2)" "unprognostic (2.37e-1)" 6.6 10.4 1.8 14.7 1.9 5.1 7.5 0.9 1.6 3.8 5.9 2.8 10.8 4.0 4.8 25.8 9.6 4.6 4.6 14.2 1.6 1.9 5.6 23.5 12.0 16.2 3.0 1.1 5.5 10.4 2.4 6.3 67.0 1.8 5.4 4.7 2.8 5.5 6.1 1.6 5.5 9.7 6.7 3.5 15.2 5.2 23.8 1.9 18.6 3.5 7.9 10.8 8.3 8.3 18.1 12.3 7.2 14.0 13.4 12.5 6.2 2.2 0.0 2.8 0.4 0.5 1.2 5.1 0.1 1.0 0.3 0.0 38.9 7.2 10.2 0.2 0.4 2.5 6.3 2.6 0.2 1.0 2.4 9.1 8.4 53.4 0.5 10.1 3.3 0.5 2.3 0.0 1.1 0.3 0.8 2.9 0.5 6.0 17.2 3.8 0.4 0.5 16.5 3.4 5.8 1.8 5.9 1.0 3.4 4.7 2.7 1.4 1.0 2.6 1.2 2.0 0.4 2.6 2.1 5.9 3.9 15.0 0.4 6.8 6.4 7.2 5.9 3.7 12.5 6.9 11.1 15.0 7.7 8.6 6.2 18.1 7.8 8.7 0.9 13.4 14.0 12.3 1.5 6.2 1.8 1.9 0.9 1.6 1.6 1.9 3.0 1.1 1.8 1.9 MBOAT2 "FLJ14415, FLJ90298, OACT2" ENSG00000143797 "Membrane bound O-acyltransferase domain containing 2" Q6ZWT7 2 8852690-9003813 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 34.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 25.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 6.3;eosinophil: 2.8;neutrophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014836 Uncertain Approved Vesicles Vesicles "HPA014836: AB_1854745" "unprognostic (2.49e-1)" "unprognostic (2.17e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (2.13e-9)" "unprognostic (1.30e-1)" "unprognostic (2.32e-2)" "unprognostic (2.38e-1)" "unprognostic (3.97e-3)" "unprognostic (3.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.03e-3)" "unprognostic (1.70e-1)" "unprognostic (5.90e-2)" "unprognostic (2.23e-1)" "unprognostic (3.04e-2)" "unprognostic (6.66e-2)" "prognostic unfavourable (5.32e-4)" 2.3 2.9 12.8 2.9 18.0 24.2 10.1 10.1 20.2 6.0 8.2 16.6 1.2 3.1 5.3 3.5 14.2 3.7 4.3 5.1 14.7 12.4 8.0 1.3 10.9 2.9 23.3 10.3 6.8 2.1 34.7 5.5 3.8 16.2 16.1 9.3 6.4 5.6 4.1 1.2 12.3 4.3 4.6 18.5 2.5 6.9 2.7 17.8 1.9 5.3 16.1 10.3 4.4 7.5 0.0 0.8 6.7 0.7 0.0 0.2 0.3 8.3 2.5 7.8 3.3 3.5 7.9 4.6 4.0 1.4 5.2 3.5 0.7 13.3 2.4 4.8 9.5 6.4 6.9 8.1 7.9 7.4 11.9 10.0 3.7 0.0 4.4 0.0 3.2 5.7 4.8 5.0 3.4 2.7 8.5 1.9 4.5 2.1 2.9 0.2 3.1 9.9 4.4 12.3 0.1 7.7 1.2 4.7 14.3 4.2 25.1 3.9 4.7 2.8 1.5 9.2 4.9 7.1 11.4 0.7 0.2 2.6 14.5 1.4 3.1 6.3 0.7 2.8 0.0 0.2 0.0 0.0 0.2 0.1 0.8 0.0 0.2 0.1 6.7 0.0 0.2 0.1 0.0 0.3 12.8 18.0 10.1 15.8 14.7 12.4 23.3 10.3 16.2 17.8 MCOLN1 "ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1" ENSG00000090674 "Mucolipin 1" Q9GZU1 19 7522626-7534009 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Ion channel" "Disease mutation, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 30.9;monocytes: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031763, CAB032637, HPA069495" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: " "unprognostic (5.51e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-2)" "unprognostic (3.30e-2)" "unprognostic (2.66e-1)" "unprognostic (4.07e-2)" "unprognostic (8.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.79e-2)" "unprognostic (1.47e-1)" "prognostic favourable (5.60e-5)" "unprognostic (1.36e-1)" "prognostic favourable (5.67e-4)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (1.83e-1)" 18.9 27.5 10.1 10.3 11.9 10.0 10.3 8.2 19.7 7.7 9.6 11.2 7.2 9.6 8.8 9.5 11.2 8.4 11.7 11.7 9.0 9.2 11.5 20.6 17.9 20.6 10.6 10.0 7.8 10.5 9.8 26.0 17.9 13.6 8.8 6.9 9.7 9.2 8.0 14.2 13.9 8.0 9.5 10.4 38.3 8.9 6.5 9.4 7.0 6.2 7.6 5.1 12.5 8.7 1.3 6.2 30.9 28.9 2.8 2.7 4.4 6.3 6.5 3.2 10.8 18.7 6.0 9.2 11.9 9.6 14.4 12.5 5.0 5.6 3.5 14.7 8.0 2.9 5.4 4.1 4.3 6.9 11.9 3.1 6.4 4.0 16.4 3.6 14.0 8.5 9.6 13.8 2.4 6.1 5.9 15.9 8.3 2.1 4.9 3.6 7.1 14.1 6.8 5.4 7.6 5.4 5.5 8.3 10.2 5.1 9.0 15.0 5.4 6.3 7.5 6.9 3.9 27.8 8.8 12.3 18.8 2.5 11.1 5.0 10.3 30.9 13.7 29.7 2.3 27.5 2.0 1.1 2.0 1.9 5.6 1.3 1.9 2.0 12.2 2.8 28.9 6.2 2.7 4.4 10.1 11.9 8.2 19.7 9.0 9.2 10.6 10.0 13.6 9.4 MCUB "CCDC109B, FLJ20647" ENSG00000005059 "Mitochondrial calcium uniporter dominant negative beta subunit" Q9NWR8 4 109560205-109688726 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 39.3;lymphoid tissue: 45.3" "Cell line enhanced" "Detected in many" "Daudi: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048776 Enhanced Approved Nucleoplasm,Vesicles,Mitochondria "Nucleoplasm, Vesicles, Mitochondria" "HPA048776: " "unprognostic (6.12e-3)" "unprognostic (1.70e-2)" "unprognostic (3.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.42e-1)" "unprognostic (1.70e-1)" "unprognostic (1.70e-2)" "unprognostic (3.06e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-3)" "unprognostic (3.40e-1)" "prognostic unfavourable (7.35e-6)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" 11.6 2.2 4.1 21.0 3.2 8.3 16.6 0.4 3.7 8.2 4.9 4.6 1.4 3.5 12.3 5.5 9.2 6.3 7.3 14.9 4.5 4.7 3.9 2.1 7.8 44.2 3.5 2.6 7.5 2.1 2.3 5.1 9.9 6.5 5.4 6.1 4.1 6.5 2.2 4.3 7.6 8.8 8.4 8.5 13.8 4.2 3.6 1.9 45.3 4.7 9.5 24.8 7.3 9.0 14.0 15.7 1.1 16.0 20.0 39.3 25.7 10.3 4.4 2.4 12.6 2.7 7.3 9.5 8.9 5.4 9.8 8.7 0.2 8.3 36.1 1.8 7.6 2.9 9.3 5.4 8.6 23.0 7.3 4.4 4.9 0.6 4.8 8.8 0.1 4.6 1.5 5.9 5.1 13.0 1.2 23.0 7.4 12.6 20.1 0.1 11.4 6.4 7.7 19.1 4.0 11.4 4.6 10.2 4.4 9.5 28.5 2.9 3.5 0.4 9.2 3.9 5.0 20.3 15.4 8.9 6.2 8.7 11.8 1.9 2.6 0.0 16.0 0.2 6.3 9.7 9.0 13.5 26.7 19.0 15.7 14.0 39.3 22.2 1.1 20.0 7.2 11.0 22.4 25.7 4.1 3.2 0.4 3.7 4.5 4.7 3.5 2.6 6.5 1.9 MDK "FLJ27379, MK, NEGF2" ENSG00000110492 Midkine P21741 11 46380756-46383837 "Cancer-related genes, Predicted secreted proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 115.9" "Cell line enhanced" "Detected in many" "AF22: 75.8;NTERA-2: 88.8;REH: 129.2;SH-SY5Y: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.6;neutrophil: 4.9" "Group enriched" "Detected in many" 5 "B-cells: 3.6;granulocytes: 4.9;T-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010055, HPA057126" Uncertain Approved Vesicles "Secreted to blood" 158000 1200000 Vesicles "CAB010055: AB_627949, HPA057126: " "unprognostic (8.87e-3)" "unprognostic (6.65e-2)" "unprognostic (4.02e-2)" "unprognostic (7.24e-2)" "prognostic unfavourable (5.48e-4)" "unprognostic (1.90e-1)" "unprognostic (5.67e-3)" "unprognostic (1.02e-1)" "unprognostic (3.66e-2)" "unprognostic (1.11e-2)" "unprognostic (4.01e-2)" "unprognostic (4.15e-1)" "prognostic unfavourable (3.06e-6)" "unprognostic (8.78e-2)" "unprognostic (1.31e-1)" "unprognostic (3.48e-1)" "unprognostic (1.12e-2)" 8.0 16.2 4.7 11.9 5.6 1.7 13.5 5.3 5.9 62.5 36.3 5.3 13.9 50.6 41.0 33.9 6.5 34.6 35.0 6.4 4.0 5.9 6.1 2.0 8.0 3.6 4.9 4.4 115.9 13.1 8.9 64.8 11.5 5.5 47.7 7.4 59.0 22.2 24.5 4.7 4.1 58.4 16.6 4.0 13.9 21.0 9.3 2.1 22.5 5.2 5.5 12.4 15.3 23.0 3.6 0.2 4.9 0.6 0.2 2.0 1.5 4.8 6.5 75.8 0.2 0.5 6.4 1.8 3.8 7.6 14.6 13.0 49.2 21.6 0.3 53.4 5.6 42.2 42.7 0.0 1.3 15.0 9.0 2.1 0.6 67.3 34.6 0.1 0.3 10.2 1.3 8.9 0.0 21.3 36.4 0.3 8.2 33.5 1.8 0.9 88.8 38.5 129.2 2.8 0.4 0.1 0.1 42.1 110.3 12.6 1.1 1.0 34.6 34.0 5.8 22.5 53.9 0.3 2.6 0.2 1.0 0.4 0.6 1.3 19.5 0.0 0.1 0.0 0.3 0.5 0.0 3.6 0.2 0.5 0.1 1.1 0.2 0.0 4.9 0.2 0.6 0.2 2.0 1.5 4.7 5.6 5.3 5.9 4.0 5.9 4.9 4.4 5.5 2.1 MED23 "CRSP130, CRSP3, DRIP130, Sur2" ENSG00000112282 "Mediator complex subunit 23" Q9ULK4 6 131573966-131628229 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070341 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA070341: " "unprognostic (1.11e-2)" "unprognostic (4.66e-2)" "unprognostic (5.51e-3)" "unprognostic (1.80e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (6.62e-3)" "unprognostic (4.47e-1)" "unprognostic (1.64e-1)" "unprognostic (6.81e-3)" "unprognostic (1.44e-2)" "unprognostic (3.59e-1)" "unprognostic (1.64e-1)" "unprognostic (1.82e-2)" "unprognostic (2.21e-1)" "unprognostic (2.44e-2)" "unprognostic (2.53e-2)" 14.0 17.1 12.1 19.7 12.7 21.8 16.3 23.0 17.6 14.7 12.3 12.1 17.8 12.7 21.6 13.3 14.9 14.6 10.2 10.2 11.7 8.3 12.2 9.6 13.1 15.4 15.9 12.3 20.5 18.7 23.9 16.1 12.3 11.3 13.9 14.4 12.3 19.8 16.8 14.8 15.0 15.4 14.3 11.0 13.7 14.9 13.1 13.3 22.7 18.0 7.4 16.7 16.2 20.7 6.0 6.8 8.8 5.7 15.0 10.9 4.6 5.1 5.8 13.8 17.4 17.2 13.2 12.7 13.1 14.9 12.1 17.7 6.0 7.3 11.6 9.6 13.4 9.4 7.4 8.5 18.9 13.1 10.3 12.1 10.6 10.2 12.5 20.0 20.7 11.5 10.2 13.4 13.7 15.0 15.5 12.2 12.8 8.0 15.1 12.6 6.6 5.8 13.7 8.6 6.9 9.4 7.7 10.4 9.4 9.3 13.1 8.5 3.6 14.1 15.1 9.0 10.3 14.4 11.9 13.0 8.7 16.7 11.1 9.2 12.1 4.5 5.3 8.8 7.3 5.7 10.9 6.0 7.2 8.0 6.8 5.2 7.4 6.7 4.5 15.0 3.9 3.6 7.8 4.6 12.1 12.7 23.0 17.6 11.7 8.3 15.9 12.3 11.3 13.3 MED26 "CRSP7, CRSP70" ENSG00000105085 "Mediator complex subunit 26" O95402 19 16574907-16629062 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA057997, HPA071835" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA057997: , HPA071835: " "unprognostic (2.02e-2)" "prognostic favourable (2.46e-4)" "unprognostic (2.47e-2)" "unprognostic (2.57e-3)" "unprognostic (1.42e-1)" "unprognostic (3.60e-3)" "unprognostic (5.03e-2)" "unprognostic (3.77e-2)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.99e-3)" "unprognostic (2.60e-2)" "prognostic unfavourable (5.50e-5)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.98e-3)" 5.5 4.6 5.9 8.3 6.2 14.0 7.3 8.7 6.2 6.0 5.1 4.2 5.2 4.0 5.7 6.0 6.2 4.3 4.4 4.0 5.1 4.5 3.7 5.9 9.0 7.6 4.8 4.5 6.2 6.8 6.8 5.4 7.9 4.9 5.4 3.3 3.8 7.2 7.9 9.9 7.1 4.8 4.2 4.5 6.8 5.1 34.7 4.6 8.5 5.0 6.0 6.9 4.8 5.7 2.6 4.4 2.3 1.0 1.2 2.3 0.4 9.1 3.5 3.3 7.1 4.3 3.4 9.6 5.3 3.8 5.8 5.3 5.3 5.5 14.7 5.7 3.4 6.9 5.1 5.4 4.0 10.7 10.4 5.7 3.3 4.2 4.2 6.5 5.5 4.0 5.3 4.9 5.2 3.1 9.4 17.7 3.6 9.1 6.8 6.1 7.8 11.5 7.2 5.0 15.9 3.4 3.6 8.7 4.6 4.6 4.6 5.3 3.3 8.6 3.7 7.4 5.9 8.9 7.1 12.4 10.0 11.8 5.2 8.6 4.3 2.3 0.4 0.4 1.6 1.0 0.3 1.4 0.2 0.7 0.8 2.6 1.0 0.2 1.2 1.2 0.4 4.4 2.3 0.4 5.9 6.2 8.7 6.2 5.1 4.5 4.8 4.5 4.9 4.6 MEF2C ENSG00000081189 "Myocyte enhancer factor 2C" Q06413 5 88717117-88904257 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 154.8" "Cell line enhanced" "Detected in many" "Daudi: 23.7;HEL: 52.3;Karpas-707: 28.8;REH: 59.6;WM-115: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 17.2;intermediate monocyte: 19.5;memory B-cell: 32.6;myeloid DC: 22.3;naive B-cell: 48.2;non-classical monocyte: 15.9;plasmacytoid DC: 23.8" "Group enriched" "Detected in many" 5 "B-cells: 48.2;dendritic cells: 23.8;monocytes: 19.5" "Group enriched" "Detected in many" 7 "amygdala: 209.9;basal ganglia: 138.6;cerebral cortex: 403.6;hippocampal formation: 331.6;olfactory region: 196.3" "Group enriched" "Detected in all" 4 "amygdala: 103.2;cerebral cortex: 309.8;hippocampal formation: 290.6;olfactory region: 138.8" "HPA005533, CAB068196, CAB068197" Enhanced Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB068196: , CAB068197: , HPA005533: AB_1079352" "unprognostic (2.74e-1)" "unprognostic (1.64e-2)" "unprognostic (2.37e-2)" "unprognostic (8.78e-2)" "unprognostic (9.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-2)" "unprognostic (3.52e-2)" "unprognostic (8.73e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-1)" "prognostic unfavourable (1.01e-4)" "unprognostic (7.18e-3)" "unprognostic (1.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.42e-2)" 13.9 10.8 17.0 15.0 26.7 3.8 10.7 4.3 52.8 8.2 6.8 6.1 1.5 2.8 10.9 5.4 5.0 6.4 9.8 11.2 11.1 6.8 4.5 4.0 8.3 19.3 6.6 28.0 12.3 2.9 5.2 6.5 14.8 4.8 7.1 5.7 4.6 6.6 6.6 154.8 3.9 7.4 10.8 8.3 16.0 4.5 3.6 4.4 1.6 9.6 3.5 24.0 8.9 5.8 48.2 23.8 5.8 19.5 4.0 0.1 7.2 0.3 0.0 1.7 0.0 1.8 1.1 0.0 0.5 1.0 0.0 0.2 0.0 0.2 23.7 0.1 2.7 0.7 2.2 2.1 0.0 7.2 2.9 52.3 3.1 0.0 0.6 2.3 0.1 5.2 0.0 0.0 0.0 8.2 2.7 28.8 2.1 0.0 0.0 0.0 0.5 1.9 59.6 15.0 11.4 0.0 0.2 0.0 2.0 0.0 0.1 6.9 0.0 13.3 9.4 1.3 0.2 0.1 1.2 21.9 2.5 14.3 0.3 16.2 34.1 0.1 17.2 0.0 0.0 19.5 0.0 32.6 0.0 0.0 22.3 48.2 0.0 0.0 5.8 4.0 15.9 23.8 0.1 7.2 17.0 26.7 4.3 52.8 11.1 6.8 6.6 28.0 4.8 4.4 MEF2D ENSG00000116604 "Myocyte enhancer factor 2D" Q14814 1 156463727-156500828 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 97.8" "Cell line enhanced" "Detected in all" "THP-1: 53.9;U-266/70: 47.4;U-266/84: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004807, HPA007114" Enhanced Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA004807: AB_1079354, HPA007114: AB_1079353" "unprognostic (3.17e-2)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.95e-1)" "unprognostic (8.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (9.96e-2)" "unprognostic (1.96e-2)" "unprognostic (1.97e-1)" "unprognostic (2.50e-1)" "prognostic unfavourable (7.53e-4)" "unprognostic (9.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.45e-1)" 18.1 19.6 14.9 15.7 27.5 47.6 15.5 27.0 40.3 23.8 21.1 12.1 10.5 11.0 28.6 12.9 13.8 19.5 16.6 26.3 11.8 9.6 10.4 10.6 20.0 13.9 8.6 21.1 26.7 22.4 21.4 15.0 16.2 11.6 17.2 10.6 22.3 11.3 18.8 97.8 17.5 14.8 22.0 8.4 17.2 16.1 9.9 9.9 17.2 14.7 19.4 15.6 21.9 19.3 1.7 8.5 8.1 2.0 1.5 2.3 0.8 4.5 8.5 1.8 2.7 4.3 6.0 2.7 6.0 7.8 3.2 3.4 2.7 6.2 10.6 6.9 8.0 4.5 2.1 3.4 1.9 14.4 2.8 2.5 10.4 1.5 5.3 6.2 8.4 6.7 5.8 5.5 7.5 6.0 1.8 18.7 5.0 4.3 4.1 14.3 2.6 4.3 20.4 3.9 12.2 2.7 2.2 2.9 4.6 5.8 12.6 10.0 3.4 53.9 10.0 7.5 7.1 5.5 4.4 47.4 48.8 20.3 6.4 4.9 4.0 1.3 2.0 2.3 1.9 1.1 2.3 1.7 1.4 1.7 1.4 1.7 0.7 1.3 8.1 1.5 1.9 8.5 1.6 0.8 14.9 27.5 27.0 40.3 11.8 9.6 8.6 21.1 11.6 9.9 MEMO1 "C2orf4, CGI-27, MEMO" ENSG00000162959 "Mediator of cell motility 1" Q9Y316 2 31865060-32011230 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042603, HPA057952" Approved Approved Vesicles Vesicles "HPA042603: AB_10806243, HPA057952: " "unprognostic (1.33e-1)" "unprognostic (1.28e-3)" "unprognostic (1.81e-1)" "unprognostic (2.94e-5)" "unprognostic (1.02e-2)" "unprognostic (3.96e-2)" "unprognostic (2.24e-4)" "unprognostic (1.70e-2)" "unprognostic (6.73e-2)" "unprognostic (8.37e-3)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (5.95e-9)" "unprognostic (6.57e-2)" "unprognostic (2.26e-1)" "unprognostic (3.77e-2)" "unprognostic (4.23e-2)" 9.3 14.9 11.5 12.1 24.2 22.4 8.3 23.5 21.5 9.1 9.5 9.4 12.5 9.4 8.9 9.8 19.6 7.8 7.6 19.8 12.9 10.1 9.2 20.0 8.2 16.2 10.2 13.8 6.7 10.2 9.3 13.0 11.4 12.1 11.4 12.0 11.6 9.9 10.5 31.3 11.0 8.9 11.0 9.8 12.4 9.8 33.0 9.1 32.4 8.2 3.9 18.4 14.2 10.6 6.9 17.0 11.4 18.2 8.7 12.0 6.8 31.8 13.9 15.5 14.4 13.7 19.5 27.7 27.4 17.3 15.8 12.3 18.8 18.2 34.0 8.9 18.9 16.2 18.3 24.1 21.1 22.5 10.0 24.5 9.1 22.9 19.1 24.5 20.5 14.5 15.8 15.5 15.9 24.8 17.6 15.7 27.4 14.0 29.2 50.3 22.7 17.5 19.9 17.6 26.3 31.3 31.4 13.1 24.2 14.1 34.5 21.7 14.5 29.6 22.6 22.1 24.3 17.5 30.1 16.5 24.8 29.0 20.1 35.3 17.2 1.2 11.8 11.4 5.6 16.3 4.3 6.9 7.0 6.8 17.0 5.3 5.0 5.1 9.7 8.7 18.2 6.5 12.0 6.8 11.5 24.2 23.5 21.5 12.9 10.1 10.2 13.8 12.1 9.1 METAP1D "MAP1D, Metap1l" ENSG00000172878 "Methionyl aminopeptidase type 1D, mitochondrial" Q6UB28 2 171999583-172082430 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030298, HPA030299" Uncertain Uncertain Vesicles Vesicles "HPA030298: AB_2673419, HPA030299: AB_10602421" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (1.88e-1)" "unprognostic (5.83e-2)" "unprognostic (2.54e-2)" "unprognostic (7.90e-3)" "unprognostic (1.92e-3)" "unprognostic (1.07e-2)" "unprognostic (4.55e-1)" "unprognostic (7.07e-2)" "unprognostic (2.64e-2)" "unprognostic (8.19e-2)" "unprognostic (2.53e-3)" "unprognostic (3.44e-3)" "unprognostic (3.06e-2)" "unprognostic (5.48e-3)" "unprognostic (2.92e-2)" 7.1 7.5 7.2 8.0 8.4 6.3 8.2 6.7 9.2 6.5 6.1 9.6 6.5 5.0 9.0 6.4 5.2 10.3 4.5 6.4 6.0 4.9 5.4 8.3 3.6 8.1 9.3 7.1 18.9 23.8 5.5 13.8 4.1 8.6 8.3 7.1 7.3 9.7 10.3 13.8 7.1 5.9 10.0 7.2 8.6 6.3 5.9 9.5 2.1 5.6 6.3 6.7 5.4 5.7 2.5 0.5 0.2 1.2 1.2 3.6 0.7 3.3 2.6 3.9 13.0 5.8 7.5 8.0 3.8 3.9 6.2 3.9 6.0 4.4 1.7 7.0 4.0 6.1 8.5 6.7 6.3 5.9 10.1 9.4 6.9 7.9 6.2 5.5 2.5 5.7 10.6 6.1 9.9 3.5 13.5 4.8 4.6 4.1 3.1 7.5 7.1 3.2 7.1 3.4 3.0 4.4 4.6 8.1 3.1 2.7 5.6 9.5 6.4 7.5 4.1 7.9 6.3 4.8 3.6 6.0 5.4 3.8 5.6 11.1 7.5 0.0 0.2 0.0 1.3 1.2 0.6 1.2 1.9 0.7 0.5 2.5 1.9 3.6 0.2 1.2 0.2 0.0 1.4 0.7 7.2 8.4 6.7 9.2 6.0 4.9 9.3 7.1 8.6 9.5 METTL23 "C17orf95, LOC124512" ENSG00000181038 "Methyltransferase like 23" Q86XA0 17 76726830-76733936 "Disease related genes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA022889 Approved Vesicles Vesicles "HPA022889: " "unprognostic (5.45e-3)" "unprognostic (1.22e-1)" "unprognostic (1.35e-1)" "unprognostic (1.35e-1)" "unprognostic (7.70e-2)" "unprognostic (1.59e-1)" "prognostic unfavourable (4.18e-6)" "unprognostic (5.22e-2)" "unprognostic (1.76e-1)" "unprognostic (1.73e-2)" "unprognostic (1.03e-3)" "unprognostic (3.21e-2)" "prognostic unfavourable (3.93e-7)" "unprognostic (1.13e-2)" "unprognostic (1.82e-1)" "unprognostic (3.79e-1)" "unprognostic (3.65e-1)" 19.6 21.9 13.4 20.8 14.3 16.3 25.8 12.1 16.2 19.2 19.5 20.6 24.6 15.1 18.8 25.3 22.5 18.5 22.7 17.5 12.6 12.2 25.3 35.1 18.6 32.8 17.8 12.9 23.3 28.3 28.7 23.0 14.1 15.8 22.6 19.2 21.5 21.6 23.7 20.8 18.7 19.6 16.2 14.5 32.3 18.9 43.7 19.5 29.4 38.8 29.5 27.0 19.5 16.4 24.6 22.5 15.2 13.7 23.8 26.7 14.8 25.0 21.9 12.6 11.4 31.3 26.3 12.0 12.8 26.0 16.8 16.4 10.9 17.8 14.2 12.5 16.0 14.1 8.9 22.9 19.1 7.0 21.1 18.2 14.4 20.9 30.8 12.9 16.1 25.2 22.1 20.8 29.1 26.3 17.3 17.7 20.2 14.1 16.0 11.0 9.3 24.8 11.0 21.1 39.1 24.0 12.7 12.0 17.3 12.7 19.7 44.0 27.6 16.3 9.6 19.4 9.7 18.8 22.3 24.4 9.2 14.2 18.5 9.2 17.5 9.2 13.5 15.2 24.0 13.7 26.6 24.6 26.7 26.4 15.1 21.5 26.1 25.7 4.5 23.8 12.0 22.5 26.3 14.8 13.4 14.3 12.1 16.2 12.6 12.2 17.8 12.9 15.8 19.5 METTL6 MGC24132 ENSG00000206562 "Methyltransferase like 6" Q8TCB7 3 15381275-15440566 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035166 Uncertain Approved Vesicles Vesicles "HPA035166: AB_10602709" "unprognostic (2.73e-1)" "unprognostic (3.53e-1)" "unprognostic (2.60e-1)" "unprognostic (1.29e-2)" "unprognostic (6.60e-2)" "unprognostic (2.20e-1)" "prognostic unfavourable (2.66e-6)" "unprognostic (3.98e-1)" "unprognostic (1.82e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (2.19e-2)" "unprognostic (1.68e-2)" "unprognostic (1.27e-2)" "unprognostic (2.81e-1)" "unprognostic (3.77e-2)" "unprognostic (2.46e-1)" 8.6 9.6 19.4 8.6 19.3 5.0 11.7 18.4 18.9 11.7 7.1 16.8 6.2 7.1 10.7 10.6 10.0 11.5 7.7 9.3 13.1 14.3 8.4 7.9 7.8 10.3 13.3 9.6 14.8 10.7 12.5 17.9 11.0 13.7 10.6 8.7 12.0 7.5 11.3 7.8 8.8 6.4 12.4 14.2 8.7 7.8 20.2 11.3 11.8 11.8 3.8 12.0 9.0 8.3 14.1 16.5 15.7 14.0 14.2 14.5 9.4 7.9 13.1 14.3 12.4 12.9 15.1 38.4 14.5 15.9 19.4 19.5 8.3 10.7 13.5 9.5 14.2 6.7 14.9 12.6 19.9 9.4 16.6 13.1 12.9 11.8 25.9 12.4 11.3 13.2 16.3 22.9 10.5 16.6 13.5 13.7 18.9 17.8 13.0 9.7 15.9 16.7 10.0 18.5 13.2 11.1 11.4 6.3 11.5 12.4 12.3 11.8 17.8 10.8 10.7 14.0 8.9 13.6 13.1 14.7 24.8 16.4 14.6 12.1 13.0 9.0 11.1 15.7 13.8 14.0 13.4 10.6 13.1 13.5 12.3 14.1 13.4 14.5 6.7 14.2 13.0 16.5 11.9 9.4 19.4 19.3 18.4 18.9 13.1 14.3 13.3 9.6 13.7 11.3 METTL7B "ALDI, MGC17301" ENSG00000170439 "Methyltransferase like 7B" Q6UX53 12 55681546-55684611 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 35.7;heart muscle: 46.1;intestine: 44.7;liver: 82.4" "Cell line enhanced" "Detected in many" "CACO-2: 11.8;CAPAN-2: 23.9;EFO-21: 17.9;Hep G2: 11.6;LHCN-M2: 19.8;THP-1: 17.5;U-87 MG: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 5.4;myeloid DC: 8.6;naive B-cell: 2.5;non-classical monocyte: 4.0" "Group enriched" "Detected in many" 56 "B-cells: 2.5;dendritic cells: 8.6;monocytes: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038644 Enhanced Supported Vesicles,Microtubules Microtubules Vesicles "HPA038644: " "unprognostic (7.54e-2)" "unprognostic (7.15e-2)" "unprognostic (5.55e-2)" "unprognostic (3.07e-3)" "unprognostic (6.30e-2)" "prognostic unfavourable (2.85e-4)" "unprognostic (2.00e-1)" "unprognostic (2.22e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-2)" "unprognostic (5.33e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-2)" "unprognostic (7.10e-2)" "prognostic favourable (2.37e-4)" "unprognostic (2.43e-1)" 1.3 0.9 1.2 2.1 0.9 0.1 0.5 0.5 2.2 0.4 15.2 3.0 0.0 15.2 0.4 35.7 0.3 0.7 8.1 46.1 4.6 0.6 12.6 82.4 0.8 0.8 1.8 1.5 0.3 1.2 0.0 1.3 4.3 3.2 0.3 6.0 1.4 0.4 0.1 2.7 0.5 44.7 0.4 1.0 3.1 1.0 0.4 0.6 0.0 1.0 0.1 0.0 0.3 0.3 2.5 8.6 0.0 5.4 0.0 0.0 0.4 0.2 9.1 0.0 0.2 1.9 6.7 0.1 0.3 1.3 0.1 0.6 11.8 23.9 4.8 17.9 0.5 0.0 1.7 0.1 0.3 0.0 2.3 0.4 1.5 11.6 0.0 0.2 0.0 1.7 0.0 0.4 0.0 0.0 0.1 0.0 19.8 8.2 0.0 0.1 2.4 1.1 0.0 0.6 1.1 0.2 0.0 0.0 0.1 0.9 0.0 1.6 1.6 17.5 0.0 1.3 1.6 0.2 1.2 0.0 0.2 1.4 18.2 4.1 0.1 0.0 1.0 0.0 0.0 5.4 0.0 0.7 0.0 0.0 8.6 2.5 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.4 1.2 0.9 0.5 2.2 4.6 0.6 1.8 1.5 3.2 0.6 MEX3C "FLJ38871, RKHD2, RNF194" ENSG00000176624 "Mex-3 RNA binding family member C" Q5U5Q3 18 51174550-51218304 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040603 Uncertain Approved Vesicles "Intracellular and membrane" Vesicles "HPA040603: AB_10805714" "unprognostic (1.09e-1)" "unprognostic (2.90e-2)" "unprognostic (8.88e-2)" "unprognostic (8.88e-3)" "unprognostic (2.04e-1)" "unprognostic (7.30e-2)" "prognostic unfavourable (8.49e-5)" "unprognostic (4.34e-2)" "unprognostic (4.43e-1)" "unprognostic (1.05e-2)" "unprognostic (1.03e-2)" "unprognostic (6.75e-2)" "unprognostic (7.99e-2)" "unprognostic (1.82e-1)" "unprognostic (1.48e-1)" "unprognostic (8.01e-2)" "unprognostic (3.17e-1)" 12.6 12.2 13.8 14.5 13.5 27.5 19.4 21.7 13.7 14.7 11.3 10.7 8.8 8.7 13.4 9.5 11.7 11.1 13.0 11.3 15.1 9.1 9.3 10.3 12.0 19.8 16.3 8.3 14.5 10.1 16.6 9.5 11.7 12.3 10.3 9.8 7.6 12.4 10.1 9.0 10.2 12.7 13.6 12.6 16.3 10.5 43.7 12.7 40.0 13.6 9.3 18.4 13.0 17.5 2.8 2.0 10.3 1.3 5.8 3.8 1.5 7.5 4.5 21.8 8.1 12.1 15.0 17.0 10.8 14.1 6.3 7.7 7.2 5.8 15.4 3.8 14.3 13.8 9.4 15.4 12.1 11.3 4.2 3.3 4.5 9.4 19.6 20.9 6.3 12.6 21.7 8.8 27.6 16.2 3.5 27.0 16.2 5.5 15.6 10.4 10.5 4.5 15.8 11.4 15.8 14.5 2.5 9.7 13.3 8.1 4.4 42.5 4.4 11.7 12.1 15.2 10.1 4.6 9.2 19.6 2.9 24.6 10.4 10.6 34.3 10.3 1.3 1.5 3.6 1.3 3.1 2.8 3.8 3.7 2.0 2.1 1.6 3.8 0.7 5.8 0.9 2.0 3.1 1.5 13.8 13.5 21.7 13.7 15.1 9.1 16.3 8.3 12.3 12.7 MFNG ENSG00000100060 "MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" O00587 22 37469063-37486401 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 72.7;lymphoid tissue: 42.1" "Cell line enhanced" "Detected in many" "Daudi: 32.2;HL-60: 40.5;HMC-1: 53.7;HUVEC TERT2: 43.3;U-698: 31.1;U-937: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048936, HPA056479" Approved Approved Vesicles "Intracellular and membrane" 28000 Vesicles "HPA048936: , HPA056479: " "unprognostic (1.21e-1)" "unprognostic (4.17e-3)" "prognostic unfavourable (5.12e-4)" "prognostic favourable (1.65e-4)" "unprognostic (6.41e-3)" "unprognostic (1.00e-2)" "unprognostic (2.64e-1)" "unprognostic (2.36e-2)" "unprognostic (4.64e-2)" "unprognostic (2.91e-2)" "unprognostic (5.44e-2)" "unprognostic (1.42e-1)" "prognostic unfavourable (3.31e-5)" "unprognostic (2.67e-1)" "unprognostic (4.03e-2)" "unprognostic (3.86e-2)" "unprognostic (1.43e-1)" 10.0 4.5 2.6 16.6 5.1 14.4 13.4 1.0 3.3 6.0 6.5 3.0 2.0 3.7 6.5 3.5 4.4 7.1 6.3 6.7 2.8 2.6 6.1 5.6 14.9 42.1 5.6 1.2 3.6 3.7 0.8 2.2 14.0 8.3 5.6 3.7 4.4 5.7 2.5 3.4 3.0 14.1 5.1 4.4 37.6 4.1 2.6 3.6 33.9 6.3 4.5 19.3 8.8 4.2 24.1 40.5 72.7 40.8 40.9 53.3 53.2 1.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.6 32.2 0.1 0.0 2.3 9.4 1.8 0.0 12.7 0.2 24.8 0.1 0.3 0.1 40.5 53.7 0.0 0.5 0.3 0.7 43.3 0.1 15.3 0.0 0.1 4.6 0.5 0.1 0.1 11.9 0.4 24.2 0.1 0.0 19.4 0.1 0.1 0.0 0.0 0.2 2.8 24.1 0.0 1.2 4.8 0.1 0.0 0.1 31.1 0.2 36.4 0.5 36.8 40.1 72.7 41.3 38.8 45.1 21.8 48.0 43.3 40.5 24.1 52.9 45.5 25.5 40.9 40.8 10.1 53.3 53.2 2.6 5.1 1.0 3.3 2.8 2.6 5.6 1.2 8.3 3.6 MFSD14A "DKFZP564L0864, HIAT1" ENSG00000156875 "Major facilitator superfamily domain containing 14A" Q96MC6 1 100038097-100083377 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073681 Approved Vesicles Vesicles "HPA073681: " "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.18e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (2.08e-4)" "unprognostic (2.16e-1)" "unprognostic (7.75e-2)" "unprognostic (2.39e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-1)" "unprognostic (1.18e-1)" "unprognostic (2.41e-1)" "unprognostic (3.84e-1)" "unprognostic (1.05e-1)" "unprognostic (5.15e-2)" 24.3 23.7 21.8 23.9 23.5 55.7 34.7 16.3 28.3 22.0 23.5 30.2 21.2 14.7 29.4 20.6 24.5 22.9 19.3 17.0 19.9 20.8 22.7 21.7 27.1 24.1 24.5 16.8 27.0 29.2 92.6 19.4 25.0 23.6 26.0 17.1 20.5 23.0 32.0 18.8 22.4 18.5 29.3 33.9 20.6 21.7 28.3 22.3 24.4 21.3 15.9 21.0 23.0 22.9 24.1 27.0 47.1 28.1 26.9 29.8 30.8 23.3 9.7 22.0 11.3 25.8 24.5 18.6 17.1 29.3 23.3 27.3 8.2 16.4 17.5 28.0 22.2 22.5 19.5 18.8 22.4 15.3 15.4 17.3 14.9 12.3 22.8 27.7 22.6 19.9 28.9 20.5 26.3 17.8 21.1 34.5 21.4 6.8 20.8 16.3 25.2 14.3 14.7 26.8 17.1 24.8 20.5 22.9 20.4 19.3 28.2 28.3 10.9 28.4 19.5 19.3 13.5 20.1 17.6 32.8 34.5 24.5 20.9 20.3 8.2 32.8 28.1 26.1 25.9 25.2 29.2 24.1 26.5 28.3 27.0 19.4 29.8 27.6 47.1 26.9 20.7 12.6 28.6 30.8 21.8 23.5 16.3 28.3 19.9 20.8 24.5 16.8 23.6 22.3 MFSD3 ENSG00000167700 "Major facilitator superfamily domain containing 3" Q96ES6 8 144509074-144511213 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056013 Uncertain Approved Vesicles Vesicles "HPA056013: " "unprognostic (7.92e-2)" "prognostic unfavourable (5.08e-4)" "unprognostic (2.00e-1)" "unprognostic (5.18e-2)" "unprognostic (6.50e-2)" "unprognostic (3.74e-2)" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (9.41e-2)" "unprognostic (1.06e-1)" "unprognostic (5.49e-2)" "unprognostic (5.29e-2)" "prognostic favourable (5.44e-7)" "unprognostic (4.08e-3)" "unprognostic (2.37e-1)" "unprognostic (1.50e-1)" "unprognostic (9.81e-2)" 7.7 12.3 12.5 7.4 12.5 3.0 7.2 12.0 17.3 5.6 12.7 5.6 19.6 19.8 4.3 12.5 8.0 6.3 10.3 10.2 8.8 9.2 17.7 21.2 8.0 6.4 10.0 15.3 3.5 19.2 14.3 9.7 4.8 10.4 10.5 5.5 5.0 24.0 9.4 23.5 11.3 13.1 3.0 4.6 6.4 12.7 4.1 9.1 4.2 12.8 8.7 5.5 5.8 4.9 4.7 17.2 3.4 6.6 3.2 4.0 3.2 7.7 10.7 2.7 2.3 3.0 2.3 8.9 2.5 2.6 1.4 2.1 3.5 5.5 11.3 8.8 2.3 7.6 1.2 5.9 0.2 5.3 21.9 3.6 9.6 8.8 5.7 1.7 5.0 3.3 11.2 0.9 3.9 3.6 6.7 3.1 3.4 25.8 4.2 9.0 7.2 18.4 4.8 1.4 19.8 6.6 4.6 19.8 9.9 6.4 15.8 5.3 16.5 2.5 3.9 1.9 5.1 2.1 3.4 3.0 1.2 3.8 4.1 5.5 3.2 1.6 6.6 3.4 3.7 5.6 3.5 4.7 3.6 3.8 9.9 2.4 3.5 3.5 0.4 3.2 3.1 17.2 4.0 3.2 12.5 12.5 12.0 17.3 8.8 9.2 10.0 15.3 10.4 9.1 MFSD8 "CLN7, MGC33302" ENSG00000164073 "Major facilitator superfamily domain containing 8" Q8NHS3 4 127917732-127966034 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044802 Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA044802: AB_10963221" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (8.10e-2)" "unprognostic (1.57e-1)" "unprognostic (4.12e-2)" "unprognostic (1.18e-1)" "unprognostic (8.99e-2)" "unprognostic (2.19e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (3.44e-2)" "unprognostic (3.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.61e-3)" "unprognostic (3.14e-1)" "prognostic favourable (2.21e-4)" 8.9 9.6 9.1 11.7 15.4 5.3 13.0 19.6 15.4 12.2 12.1 14.6 9.4 17.1 19.0 11.9 10.3 9.8 9.2 7.5 8.9 10.1 12.6 19.1 9.1 9.7 9.3 11.8 13.2 14.5 16.7 21.5 18.0 15.8 10.2 15.6 14.8 10.9 9.7 7.2 11.0 15.0 12.4 11.8 13.5 12.0 9.4 10.2 12.9 13.6 7.1 15.0 9.9 10.5 7.0 5.8 7.1 8.2 5.4 8.3 4.1 8.3 6.9 7.2 4.0 6.4 5.7 6.2 6.2 8.0 8.1 8.2 4.3 11.9 3.9 12.2 11.2 6.9 8.4 6.3 11.8 9.0 6.7 4.7 7.8 6.6 7.1 5.0 5.9 6.2 2.1 7.6 5.8 8.6 8.1 5.2 11.5 7.6 4.3 1.7 1.4 4.6 4.6 0.5 4.5 5.8 11.8 7.3 2.6 7.8 7.9 3.3 4.6 3.4 4.5 2.7 2.8 10.1 5.8 11.4 18.9 8.8 8.7 4.3 7.3 4.6 5.6 7.1 7.1 6.2 6.2 7.0 7.9 6.6 4.5 3.6 8.3 8.3 6.3 5.4 8.2 5.8 8.0 4.1 9.1 15.4 19.6 15.4 8.9 10.1 9.3 11.8 15.8 10.2 MGAM2 ENSG00000257743 "Maltase-glucoamylase 2 (putative)" Q2M2H8 7 142111749-142222324 "Enzymes, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 61.2;pancreas: 15.6;salivary gland: 35.4" "Cell line enriched" "Detected in single" 7 "RH-30: 5.0" "Group enriched" "Detected in some" 11 "colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Low region specificity" "Detected in all" HPA055697 Enhanced Approved Vesicles,Cytosol Vesicles Cytosol "HPA055697: " "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-3)" "unprognostic (5.65e-2)" "unprognostic (2.19e-2)" "unprognostic (1.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-2)" "unprognostic (5.93e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-1)" "unprognostic (5.50e-4)" "unprognostic (7.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.71e-2)" "unprognostic (9.33e-2)" 0.2 0.1 0.1 2.5 0.1 0.2 1.3 0.1 0.1 0.1 28.8 0.0 0.0 15.0 0.1 0.4 0.1 0.3 7.0 0.1 0.1 0.1 0.1 0.2 0.4 0.0 0.4 0.0 0.1 15.6 0.0 0.1 0.0 0.1 0.1 1.4 0.7 35.4 0.0 0.1 0.2 61.2 0.0 0.5 1.5 0.7 1.0 0.0 0.0 0.1 1.7 0.8 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.0 MGRN1 "KIAA0544, RNF156" ENSG00000102858 "Mahogunin ring finger 1" O60291 16 4616493-4690974 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 16.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007653, HPA008033" Approved Approved Vesicles Vesicles "HPA007653: AB_1846304, HPA008033: " "unprognostic (2.27e-1)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.97e-2)" "unprognostic (4.24e-1)" "unprognostic (1.26e-2)" "unprognostic (9.96e-2)" "unprognostic (1.70e-1)" "unprognostic (4.03e-2)" "unprognostic (9.47e-2)" "unprognostic (6.41e-2)" "unprognostic (2.32e-1)" "unprognostic (9.06e-2)" "unprognostic (1.79e-1)" "unprognostic (5.04e-2)" 18.7 23.1 22.9 24.0 24.3 29.7 19.9 43.1 37.6 16.3 16.6 28.7 16.8 28.9 23.7 13.8 14.7 20.9 20.2 20.7 24.3 18.6 15.9 30.4 21.6 22.2 27.9 21.5 21.3 34.9 19.7 21.5 18.8 18.6 19.0 11.6 20.7 23.8 22.9 29.9 13.5 28.6 20.0 17.2 26.2 25.2 11.5 24.5 12.9 19.7 10.4 11.0 18.7 14.2 1.7 4.1 16.6 3.9 1.4 3.3 2.9 5.2 25.1 13.0 13.3 7.8 7.6 17.8 11.3 8.0 9.6 8.1 16.6 12.6 15.6 14.7 13.7 8.5 10.4 9.3 2.8 21.6 11.5 8.5 17.6 22.8 14.3 12.3 21.2 14.1 6.1 13.3 5.7 9.1 12.4 11.4 6.5 23.1 12.8 16.5 19.2 11.0 23.5 6.8 20.9 8.4 15.4 20.9 17.4 18.8 20.3 11.3 12.3 12.2 16.1 17.8 9.9 50.1 9.7 18.2 14.1 10.5 7.6 12.4 12.8 4.5 3.5 3.4 2.7 3.9 2.5 1.4 1.5 2.3 2.3 1.7 3.3 2.0 16.6 1.4 2.4 4.1 1.7 2.9 22.9 24.3 43.1 37.6 24.3 18.6 27.9 21.5 18.6 24.5 MIA3 "FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077" ENSG00000154305 "MIA family member 3, ER export factor" Q5JRA6 1 222618086-222668012 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055922, HPA056816" Supported Enhanced Vesicles "Intracellular and membrane" 750000 Vesicles "HPA055922: , HPA056816: " "unprognostic (1.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.43e-1)" "unprognostic (6.60e-2)" "unprognostic (1.86e-2)" "unprognostic (8.57e-2)" "unprognostic (1.28e-3)" "unprognostic (5.41e-2)" "unprognostic (2.56e-1)" "unprognostic (5.65e-2)" "unprognostic (6.73e-2)" "unprognostic (1.39e-2)" "prognostic unfavourable (3.73e-4)" "unprognostic (3.57e-2)" "unprognostic (1.83e-1)" "unprognostic (8.62e-3)" "unprognostic (3.26e-1)" 20.5 24.1 21.4 17.4 23.7 25.8 25.0 32.8 25.0 23.3 19.3 10.0 26.2 18.7 23.5 24.4 15.7 18.1 18.5 19.5 18.4 17.4 19.5 63.7 18.4 19.0 17.0 18.8 23.4 34.1 30.2 34.7 22.7 25.6 30.1 23.1 9.9 32.8 31.7 25.5 16.5 23.2 21.3 22.9 23.0 36.6 29.3 19.6 19.5 25.6 19.5 19.3 26.8 19.8 18.6 14.9 29.4 20.1 22.0 18.3 11.1 11.8 9.0 14.0 21.3 44.5 22.4 23.5 17.0 25.5 18.9 22.5 9.3 12.3 9.7 16.3 19.3 20.3 14.9 15.7 19.4 16.8 9.3 13.4 9.3 14.5 40.8 23.0 16.3 20.5 15.1 18.0 31.9 19.7 17.2 23.9 14.2 7.1 17.9 14.9 15.5 12.9 12.2 38.0 23.5 9.7 11.8 15.2 16.0 17.5 15.9 14.2 17.0 15.1 14.3 12.8 9.8 21.6 18.1 27.3 17.3 12.2 16.0 11.1 16.8 23.6 14.6 29.4 17.4 19.5 18.3 18.3 15.0 17.0 10.4 18.6 17.8 17.4 24.8 22.0 20.1 14.9 16.0 11.1 21.4 23.7 32.8 25.0 18.4 17.4 17.0 18.8 25.6 19.6 MIB1 "DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6" ENSG00000101752 "Mindbomb E3 ubiquitin protein ligase 1" Q86YT6 18 21704957-21870957 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019100, CAB037044" Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "CAB037044: AB_1841007, HPA019100: AB_1853934" "unprognostic (1.38e-1)" "unprognostic (6.92e-2)" "unprognostic (7.29e-2)" "unprognostic (6.99e-2)" "unprognostic (5.66e-2)" "unprognostic (3.23e-2)" "unprognostic (8.45e-3)" "unprognostic (2.70e-1)" "unprognostic (5.42e-2)" "unprognostic (4.69e-2)" "unprognostic (3.78e-2)" "unprognostic (4.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.91e-3)" "unprognostic (1.73e-1)" "unprognostic (4.86e-2)" "unprognostic (1.85e-2)" 12.1 9.1 15.3 7.9 20.6 5.9 15.7 16.1 17.4 16.6 10.9 16.3 9.7 6.9 19.1 13.7 11.4 11.5 12.0 9.4 16.3 12.9 15.7 14.1 10.1 9.6 17.4 16.5 17.2 11.7 18.4 11.5 14.9 15.5 14.7 10.1 14.6 12.0 12.6 9.6 12.5 8.4 17.9 13.8 9.4 10.7 11.5 18.1 13.9 19.1 9.8 10.6 13.0 13.8 1.2 1.2 3.5 1.7 2.5 2.0 0.6 8.4 3.3 16.5 11.4 8.8 10.6 3.9 6.8 7.6 4.9 7.1 4.9 3.1 7.2 6.3 9.4 5.7 9.6 9.2 11.1 9.4 4.5 8.0 4.3 6.8 7.2 16.3 3.4 6.8 10.2 5.7 14.7 12.2 11.0 21.3 7.5 4.1 7.8 6.2 4.2 4.4 51.5 13.6 17.8 8.3 7.5 5.4 13.3 11.7 5.4 6.0 3.9 10.7 10.4 12.5 6.3 5.2 9.0 11.2 3.9 11.1 5.3 10.4 7.4 3.5 1.7 0.6 1.0 0.9 1.2 1.2 1.5 1.0 0.6 0.6 1.2 0.9 1.5 2.5 0.5 1.2 2.0 0.6 15.3 20.6 16.1 17.4 16.3 12.9 17.4 16.5 15.5 18.1 MICB PERB11.2 ENSG00000204516 "MHC class I polypeptide-related sequence B" Q29980 6 31494881-31511124 "Disease related genes, Predicted membrane proteins" "Adaptive immunity, Cytolysis, Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 26.5" "Cell line enhanced" "Detected in many" "U-266/70: 11.4;U-266/84: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA064618 Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA064618: " "unprognostic (3.63e-3)" "unprognostic (8.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.51e-2)" "unprognostic (8.44e-2)" "unprognostic (5.94e-2)" "prognostic unfavourable (7.04e-5)" "unprognostic (2.05e-1)" "unprognostic (2.61e-1)" "unprognostic (1.67e-3)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (4.94e-9)" "unprognostic (1.91e-3)" "unprognostic (2.80e-2)" "unprognostic (9.72e-2)" "unprognostic (1.21e-2)" 3.3 1.2 0.8 9.1 0.8 6.1 3.5 3.0 1.0 1.8 1.6 0.9 0.0 1.0 2.1 1.3 2.1 1.1 1.7 2.2 1.0 0.6 2.9 1.3 6.9 7.8 1.2 0.8 1.3 2.9 0.2 0.6 0.8 1.2 1.1 1.9 1.1 1.9 0.7 0.8 1.0 5.0 1.7 1.5 11.7 1.4 2.3 1.1 8.1 2.4 0.7 8.1 3.2 26.5 2.2 2.1 4.1 4.8 1.9 4.4 1.9 2.4 0.8 0.0 0.0 1.5 2.4 0.0 1.7 1.6 2.2 2.8 0.0 0.3 2.7 6.1 3.1 0.6 0.7 2.8 0.8 2.4 2.6 3.2 0.4 1.1 0.5 1.0 2.6 3.1 0.6 3.7 2.2 1.4 3.3 5.8 2.6 0.0 0.9 4.2 0.3 0.4 3.3 0.0 5.8 2.5 0.1 0.0 0.0 1.1 0.0 0.5 1.5 1.1 1.4 1.7 0.0 1.4 0.0 11.4 26.1 6.1 0.4 8.6 3.6 4.1 3.1 4.0 2.9 3.6 3.6 2.2 2.9 3.9 2.1 2.0 1.6 3.1 3.1 1.9 4.8 1.3 4.4 1.9 0.8 0.8 3.0 1.0 1.0 0.6 1.2 0.8 1.2 1.1 MINDY4 "C7orf67, FAM188B, FLJ22374" ENSG00000106125 "MINDY lysine 48 deubiquitinase 4" Q4G0A6 7 30771417-30892387 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 16.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.1;T-cells: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA019475, HPA030129, HPA030130" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565" "unprognostic (2.96e-1)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "unprognostic (2.10e-2)" "unprognostic (1.64e-1)" "unprognostic (4.07e-1)" "unprognostic (6.01e-3)" "unprognostic (3.81e-2)" "unprognostic (5.25e-3)" "unprognostic (1.97e-1)" "unprognostic (5.59e-3)" "unprognostic (2.96e-2)" "unprognostic (1.92e-1)" "unprognostic (9.55e-2)" "unprognostic (1.12e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" 9.3 6.7 9.3 2.6 15.2 4.1 7.0 3.4 15.1 10.8 6.6 5.4 16.6 2.9 15.6 16.2 5.7 20.7 10.0 7.5 8.4 5.1 9.4 3.8 14.2 2.4 4.3 9.5 14.8 5.6 9.6 16.1 6.2 9.0 9.4 4.3 7.8 5.3 15.9 3.7 5.1 3.7 10.8 3.6 2.3 5.8 20.1 5.0 1.5 12.5 3.6 2.2 6.4 6.3 0.0 1.1 0.0 0.3 0.0 2.7 0.7 2.1 5.3 2.7 8.4 2.4 9.5 4.1 3.1 5.3 2.3 2.0 0.0 3.9 0.0 3.6 2.0 2.2 1.8 1.7 2.2 0.0 3.1 1.6 2.8 0.0 3.1 2.3 1.2 4.8 2.8 7.0 1.4 3.4 16.2 1.0 2.0 0.0 1.2 0.7 7.9 1.2 0.4 0.0 0.5 6.3 1.0 5.1 7.0 2.1 11.2 1.2 5.7 1.7 2.0 0.1 1.3 2.4 1.3 2.3 2.9 0.0 4.4 0.1 9.8 0.0 0.1 0.0 0.6 0.0 2.7 0.0 0.8 0.2 1.1 0.0 0.3 0.5 0.0 0.0 0.3 0.0 0.5 0.7 9.3 15.2 3.4 15.1 8.4 5.1 4.3 9.5 9.0 5.0 MITD1 LOC129531 ENSG00000158411 "Microtubule interacting and trafficking domain containing 1" Q8WV92 2 99161427-99181058 "Predicted intracellular proteins" "Cell cycle, Cell division, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036162, HPA036163" Approved Enhanced Vesicles Vesicles "HPA036162: AB_10672236, HPA036163: " "prognostic favourable (5.96e-4)" "unprognostic (1.67e-2)" "unprognostic (3.09e-1)" "unprognostic (2.79e-1)" "unprognostic (2.02e-1)" "unprognostic (8.96e-2)" "prognostic unfavourable (1.47e-6)" "unprognostic (1.39e-1)" "unprognostic (5.35e-2)" "unprognostic (1.01e-2)" "unprognostic (1.09e-1)" "unprognostic (6.31e-3)" "prognostic unfavourable (1.32e-11)" "unprognostic (2.38e-1)" "unprognostic (2.40e-1)" "unprognostic (6.91e-2)" "prognostic favourable (5.46e-8)" 18.8 19.1 19.6 26.3 34.2 11.7 18.8 20.6 30.2 16.6 17.6 13.5 14.4 15.6 17.7 15.5 20.0 16.6 14.2 13.6 21.1 12.5 17.9 17.1 15.2 33.6 29.0 12.5 18.4 13.8 6.6 28.9 16.8 21.6 14.9 21.0 12.7 15.5 13.4 12.8 15.9 18.9 17.8 30.2 25.9 17.4 7.0 33.1 20.2 17.7 14.0 28.4 16.5 26.7 25.0 24.0 22.9 20.8 19.2 21.5 10.3 24.6 6.6 13.5 5.1 16.0 20.8 18.6 11.8 16.7 16.6 22.7 8.1 20.9 17.2 13.7 9.6 18.7 13.2 13.1 27.9 24.4 9.0 15.1 9.9 17.2 23.9 25.4 9.0 16.4 11.3 14.6 14.1 18.7 12.4 10.6 15.0 5.9 24.3 37.7 11.4 13.2 13.7 19.5 14.7 20.9 13.9 4.4 6.6 11.6 10.7 14.6 5.6 20.3 14.0 10.3 13.5 10.8 14.5 12.6 9.8 23.4 18.8 21.6 10.2 12.9 20.8 14.3 15.2 18.1 17.0 25.0 21.5 18.0 17.6 24.9 20.9 16.7 22.9 19.2 16.2 24.0 18.2 10.3 19.6 34.2 20.6 30.2 21.1 12.5 29.0 12.5 21.6 33.1 MKLN1 TWA2 ENSG00000128585 "Muskelin 1" Q9UL63 7 131110096-131496636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 12.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022817, HPA041810" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "HPA022817: AB_1853974, HPA041810: " "unprognostic (1.97e-1)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (3.92e-3)" "unprognostic (1.03e-1)" "unprognostic (4.20e-2)" "unprognostic (1.44e-3)" "unprognostic (4.58e-2)" "unprognostic (1.94e-2)" "unprognostic (1.97e-1)" "unprognostic (2.43e-3)" "unprognostic (1.55e-1)" "unprognostic (9.18e-3)" "unprognostic (1.70e-1)" "unprognostic (4.13e-1)" "unprognostic (1.13e-2)" "unprognostic (2.32e-1)" 22.7 21.1 22.1 15.7 27.6 12.8 34.4 27.5 25.8 18.8 15.0 11.7 26.6 14.2 19.3 19.8 11.8 19.6 11.6 16.7 21.9 14.4 23.0 22.8 19.3 18.7 26.6 17.5 23.2 12.6 20.9 28.8 18.2 25.0 26.4 12.2 10.0 18.1 28.9 28.6 15.4 13.5 20.8 30.3 13.1 14.4 16.9 24.0 14.7 18.0 9.9 12.0 17.8 21.5 2.3 1.6 12.4 1.6 0.9 2.3 0.5 8.3 9.6 8.4 8.5 20.8 18.8 5.1 8.1 18.8 9.2 11.9 4.4 7.2 8.7 5.5 10.0 5.8 8.8 7.7 15.1 8.4 4.3 3.7 7.5 5.1 10.0 6.1 5.4 11.2 5.4 12.5 6.2 8.4 13.5 6.3 11.4 3.1 7.1 6.6 9.6 5.1 4.5 9.9 6.0 10.3 4.9 4.4 9.4 15.8 15.8 7.3 3.1 7.7 8.5 7.2 4.1 13.1 6.5 15.4 5.7 14.9 24.8 7.4 10.5 1.2 1.0 1.7 1.6 1.1 1.2 1.2 1.5 1.3 1.0 2.3 2.3 1.9 12.4 0.9 1.6 1.6 0.9 0.5 22.1 27.6 27.5 25.8 21.9 14.4 26.6 17.5 25.0 24.0 MMD "MMA, PAQR11" ENSG00000108960 "Monocyte to macrophage differentiation associated" Q15546 17 55392613-55421992 "Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 61.1;brain: 40.5;breast: 46.0" "Cell line enhanced" "Detected in many" "ASC diff: 32.1;HSkMC: 58.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026978 Approved Vesicles Vesicles "HPA026978: " "unprognostic (1.33e-1)" "unprognostic (2.92e-2)" "prognostic favourable (3.52e-5)" "prognostic unfavourable (3.88e-4)" "unprognostic (2.48e-1)" "unprognostic (4.16e-2)" "prognostic unfavourable (6.39e-5)" "unprognostic (8.07e-3)" "unprognostic (6.67e-2)" "unprognostic (2.15e-1)" "unprognostic (1.30e-1)" "unprognostic (1.06e-3)" "prognostic unfavourable (2.85e-4)" "unprognostic (3.71e-3)" "unprognostic (7.93e-2)" "prognostic unfavourable (8.62e-4)" "unprognostic (1.12e-2)" 61.1 6.6 33.4 7.1 40.5 5.3 46.0 2.0 23.7 2.6 5.6 4.1 1.7 5.0 3.2 4.9 3.6 1.8 4.7 5.0 26.9 7.5 3.2 6.0 4.7 9.0 11.2 5.1 1.5 1.6 0.9 2.1 13.4 4.6 3.2 6.5 3.2 2.2 4.1 2.5 2.5 4.7 5.4 6.5 8.7 2.4 7.8 5.0 1.4 3.3 1.2 5.6 5.7 4.1 4.1 3.6 9.6 1.6 2.2 4.2 15.9 5.0 12.9 19.1 3.7 32.1 25.4 9.4 3.1 1.4 2.0 2.9 2.0 15.0 7.2 9.3 1.1 0.3 5.2 4.0 4.2 9.5 1.9 2.7 0.7 23.4 8.6 2.5 0.7 58.1 1.3 2.9 3.2 2.5 0.9 5.8 4.2 0.7 7.1 1.9 5.2 3.3 2.9 12.4 2.7 5.5 1.4 1.7 18.2 1.1 2.0 2.9 4.3 4.6 2.3 5.3 6.4 4.2 3.5 2.6 1.2 10.2 7.6 2.1 4.2 9.6 1.3 1.5 1.4 1.6 4.2 3.6 1.6 2.9 3.6 4.1 2.7 2.9 3.8 2.2 1.5 1.1 1.7 15.9 33.4 40.5 2.0 16.9 26.9 7.5 11.2 5.1 4.6 5.0 MMP1 CLG ENSG00000196611 "Matrix metallopeptidase 1" P03956 11 102789920-102798160 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation, Host-virus interaction" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 62.4;stomach 1: 27.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 88.1;HBF TERT88: 87.3;HUVEC TERT2: 229.4;WM-115: 113.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 344.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA004920 Approved Vesicles "Secreted to extracellular matrix" 430000 Vesicles "HPA004920: " "unprognostic (4.11e-3)" "prognostic unfavourable (4.66e-4)" "unprognostic (4.20e-3)" "unprognostic (1.19e-3)" "unprognostic (6.46e-2)" "unprognostic (6.50e-2)" "prognostic unfavourable (4.22e-6)" "unprognostic (7.83e-3)" "unprognostic (2.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.11e-3)" "unprognostic (1.75e-1)" "prognostic unfavourable (9.86e-10)" "unprognostic (1.67e-2)" "unprognostic (1.49e-1)" "unprognostic (1.26e-2)" "unprognostic (5.11e-2)" 0.2 0.1 0.3 12.3 0.3 0.0 0.9 0.3 0.3 0.3 2.7 0.3 0.2 3.2 4.8 0.2 3.3 0.1 62.4 0.4 0.2 0.1 0.7 1.3 4.7 0.2 0.2 0.2 0.2 1.6 0.0 0.2 8.6 0.5 0.7 3.0 0.3 2.0 0.2 0.2 0.3 8.8 0.2 0.4 1.8 27.2 2.2 0.2 0.4 0.3 1.3 0.9 11.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.9 88.1 36.0 9.4 0.7 0.0 0.0 0.4 21.1 0.3 0.0 12.3 87.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 37.0 3.1 229.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 11.9 29.9 0.0 1.3 0.1 0.0 0.0 0.0 0.7 0.0 113.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.3 0.3 0.3 0.3 0.2 0.1 0.2 0.2 0.5 0.2 MMP16 "C8orf57, DKFZp761D112, MT3-MMP" ENSG00000156103 "Matrix metallopeptidase 16" P51512 8 88032009-88328025 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.9" "Cell line enhanced" "Detected in many" "AN3-CA: 20.0;HUVEC TERT2: 8.7;SH-SY5Y: 11.1;U-138 MG: 9.5;WM-115: 19.5" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023693 Uncertain Approved Vesicles,Cytosol "Secreted to extracellular matrix" Cytosol Vesicles "HPA023693: AB_1854025" "unprognostic (2.58e-1)" "unprognostic (2.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.31e-2)" "unprognostic (2.39e-3)" "unprognostic (1.45e-3)" "unprognostic (2.46e-1)" "unprognostic (2.61e-1)" "unprognostic (9.42e-2)" "unprognostic (2.92e-1)" "unprognostic (2.09e-8)" "unprognostic (6.90e-3)" "unprognostic (1.16e-1)" "unprognostic (3.62e-1)" "unprognostic (2.19e-3)" 2.4 1.3 11.0 1.4 6.8 0.5 4.9 8.3 15.9 5.3 2.2 2.9 0.7 0.8 4.9 2.1 1.7 2.1 7.3 2.7 8.7 6.9 0.8 0.9 1.0 1.0 5.5 9.1 3.3 2.1 1.5 1.7 3.0 6.3 3.2 1.7 0.6 1.2 2.4 0.7 1.1 1.3 4.0 4.6 1.5 1.4 1.5 5.5 0.0 3.2 0.7 1.0 2.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.4 20.0 0.7 1.4 0.0 7.3 1.0 2.1 1.2 0.0 0.0 0.0 0.0 3.3 0.0 3.9 0.0 2.5 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.3 1.0 0.0 3.0 0.9 8.7 0.0 0.7 1.1 0.0 0.0 0.0 1.1 2.0 0.2 0.4 0.0 0.4 0.0 0.1 11.1 0.0 0.0 0.1 0.8 0.0 4.8 9.5 5.4 0.1 2.7 0.0 0.0 0.0 3.8 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 6.8 8.3 14.1 8.7 6.9 5.5 9.1 6.3 5.5 MMP19 "MMP18, RASI-1" ENSG00000123342 "Matrix metallopeptidase 19" Q99542 12 55835433-55842966 "Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Angiogenesis, Collagen degradation, Differentiation" "Developmental protein, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 60.7" "Cell line enriched" "Detected in many" 6 "BEWO: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 16 "classical monocyte: 3.2;myeloid DC: 1.0" "Group enriched" "Detected in many" 16 "dendritic cells: 1.0;monocytes: 3.2" "Region enriched" "Detected in single" 6 "olfactory region: 8.8" "Low region specificity" "Detected in all" HPA070804 Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" 800000 "Endoplasmic reticulum, Vesicles" "HPA070804: " "unprognostic (2.61e-1)" "unprognostic (6.56e-2)" "unprognostic (2.28e-2)" "unprognostic (2.42e-1)" "unprognostic (4.77e-3)" "unprognostic (4.77e-3)" "unprognostic (2.01e-2)" "unprognostic (4.03e-2)" "unprognostic (2.85e-2)" "unprognostic (4.30e-2)" "unprognostic (2.37e-1)" "unprognostic (2.09e-1)" "prognostic unfavourable (8.56e-9)" "unprognostic (5.06e-3)" "unprognostic (1.28e-3)" "unprognostic (2.73e-2)" "unprognostic (4.00e-2)" 60.7 1.9 0.2 10.9 0.7 0.0 9.9 0.2 0.5 7.6 3.9 0.4 1.4 0.8 12.7 6.0 3.6 11.8 30.3 4.7 0.6 0.1 4.1 3.0 14.0 15.5 0.5 0.2 7.4 8.1 0.0 0.5 24.5 1.0 2.9 2.8 3.1 2.0 3.5 2.1 2.7 4.1 7.7 0.8 27.4 5.0 2.9 0.2 2.7 3.3 1.8 7.1 5.9 3.5 0.0 1.0 0.1 3.2 0.0 0.0 0.6 0.8 0.0 0.0 0.0 6.2 7.9 55.9 5.9 6.9 2.4 2.8 0.3 0.2 0.0 0.0 8.2 0.0 0.0 1.8 3.3 0.3 0.0 0.0 0.0 0.1 5.1 0.0 0.2 8.2 0.2 1.5 1.5 0.4 0.1 0.0 8.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 1.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9.5 1.5 3.3 0.0 0.2 0.0 0.0 0.0 4.3 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.7 0.2 0.5 0.6 0.1 0.5 0.2 1.0 0.2 MMP2 "CLG4, CLG4A, TBE-1" ENSG00000087245 "Matrix metallopeptidase 2" P08253 16 55389700-55506691 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 335.4;ASC TERT1: 97.7;HSkMC: 83.3;U-138 MG: 91.2;U-87 MG: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001939, CAB002788" Approved Approved Vesicles "Secreted to extracellular matrix" 160000000 Vesicles "CAB002788: , HPA001939: AB_1079395" "unprognostic (7.26e-2)" "unprognostic (1.36e-3)" "unprognostic (1.66e-1)" "unprognostic (2.14e-3)" "unprognostic (5.03e-2)" "unprognostic (1.20e-1)" "unprognostic (1.74e-1)" "unprognostic (9.36e-3)" "unprognostic (4.81e-3)" "unprognostic (3.79e-2)" "unprognostic (4.59e-3)" "unprognostic (6.12e-2)" "unprognostic (1.28e-3)" "unprognostic (1.59e-2)" "unprognostic (8.00e-2)" "unprognostic (8.98e-2)" "unprognostic (4.63e-2)" 197.5 9.0 1.2 13.2 1.6 0.0 136.4 0.8 1.4 74.3 74.4 2.4 36.9 5.6 85.0 123.0 52.3 25.7 115.4 54.0 0.9 0.5 9.4 3.5 38.9 3.9 1.5 1.1 71.0 6.5 0.7 2.2 58.9 2.2 66.8 18.7 36.4 18.6 20.4 68.6 68.2 22.6 57.1 1.8 12.4 20.5 57.0 1.1 1.3 20.6 31.8 9.1 84.1 105.3 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.3 0.2 11.1 0.1 335.4 97.7 18.2 28.7 65.9 5.8 4.6 0.0 0.1 0.0 23.1 50.5 3.1 0.0 0.2 3.3 0.0 0.0 0.0 0.7 0.1 31.7 0.0 0.8 83.3 0.0 29.8 0.2 37.4 0.0 0.1 19.3 0.0 0.0 0.4 8.8 0.0 0.0 2.6 0.0 0.9 0.4 0.1 20.2 5.3 0.0 0.1 0.0 2.0 52.7 91.2 8.7 17.5 3.7 0.0 0.0 0.1 106.8 1.5 16.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 1.2 1.6 0.8 1.4 0.9 0.5 1.5 1.1 2.2 1.1 MMP3 "STMY, STMY1" ENSG00000149968 "Matrix metallopeptidase 3" P08254 11 102835801-102843803 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 177.5;salivary gland: 73.4" "Group enriched" "Detected in some" 17 "BJ: 98.9;BJ hTERT+: 269.1;fHDF/TERT166: 116.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 59.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA007875 Uncertain Supported Vesicles "Secreted to extracellular matrix" 170000 Vesicles "HPA007875: AB_1079396" "unprognostic (2.27e-1)" "prognostic unfavourable (9.73e-4)" "unprognostic (1.63e-3)" "unprognostic (5.11e-3)" "unprognostic (3.78e-1)" "unprognostic (5.11e-2)" "unprognostic (5.26e-6)" "unprognostic (3.46e-2)" "unprognostic (7.14e-2)" "unprognostic (2.87e-1)" "prognostic unfavourable (4.09e-4)" "unprognostic (3.26e-2)" "unprognostic (1.22e-15)" "unprognostic (3.17e-1)" "unprognostic (1.55e-1)" "unprognostic (3.43e-2)" "unprognostic (2.34e-1)" 19.1 0.0 0.2 14.4 0.3 0.0 6.9 0.2 0.5 0.2 1.5 0.3 0.2 1.8 28.3 177.5 0.2 0.0 1.4 0.2 0.2 0.0 0.3 0.5 0.4 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.2 1.2 1.7 0.2 73.4 1.5 7.3 12.6 0.7 5.9 0.2 0.2 2.8 1.4 0.2 0.2 0.6 1.5 0.9 7.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.9 269.1 1.7 0.5 0.0 0.0 0.0 0.0 116.5 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.9 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.2 0.8 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.5 0.2 0.0 0.2 0.2 0.2 0.2 MMP7 "MPSL1, PUMP-1" ENSG00000137673 "Matrix metallopeptidase 7" P09237 11 102520508-102530753 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3" "Cell line enhanced" "Detected in some" "A549: 22.6;CAPAN-2: 126.5;EFO-21: 30.0;RPTEC TERT1: 54.7" "Cancer enhanced" "Detected in all" "pancreatic cancer: 352.1" "Region enriched" "Detected in single" 5 "pons and medulla: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB025869, HPA051358" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" "Nucleoplasm, Vesicles" "CAB025869: , HPA051358: " "unprognostic (1.06e-3)" "unprognostic (9.51e-2)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (7.70e-3)" "unprognostic (7.28e-2)" "prognostic unfavourable (2.53e-4)" "prognostic unfavourable (3.38e-4)" "unprognostic (3.96e-2)" "unprognostic (5.63e-2)" "unprognostic (6.59e-3)" "unprognostic (1.51e-1)" "unprognostic (6.36e-3)" "unprognostic (1.42e-2)" "unprognostic (5.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" 6.8 0.2 0.2 1.2 0.2 0.0 28.8 0.2 0.2 5.2 0.2 0.2 2.1 0.0 17.2 12.3 3.3 16.4 93.0 0.2 0.2 0.2 129.5 1.4 5.0 0.9 0.2 0.2 3.9 23.5 0.0 0.7 2.7 1.3 42.0 0.0 0.2 79.3 6.7 0.2 7.8 0.3 0.5 0.2 0.2 0.9 9.4 0.2 1.2 0.3 1.4 4.5 19.9 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 126.5 0.0 30.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.2 MMRN2 "EMILIN3, EndoGlyx-1, FLJ13465" ENSG00000173269 "Multimerin 2" Q9H8L6 10 86935540-86969481 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "CAPAN-2: 24.1;HUVEC TERT2: 50.5;TIME: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 3.1" "Lineage enriched" "Detected in single" 6 "T-cells: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA020741 Approved Approved Vesicles "Secreted to extracellular matrix" 86000000 Vesicles "HPA020741: AB_1848154" "unprognostic (4.17e-1)" "unprognostic (7.87e-2)" "unprognostic (6.67e-3)" "unprognostic (3.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.08e-2)" "unprognostic (1.75e-3)" "unprognostic (1.43e-1)" "unprognostic (2.09e-2)" "unprognostic (3.11e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (6.17e-3)" "unprognostic (1.54e-3)" "unprognostic (1.25e-1)" "unprognostic (6.44e-2)" "unprognostic (1.66e-1)" 61.0 8.0 5.4 5.7 6.5 0.4 63.6 4.1 6.8 17.2 10.1 3.5 9.5 5.0 19.0 12.0 12.5 12.5 10.2 51.0 8.2 4.9 11.1 11.1 26.1 7.5 5.9 2.5 12.2 5.4 6.7 5.2 41.9 7.4 13.1 4.4 13.8 12.8 15.2 20.2 19.5 8.1 13.9 6.3 30.8 7.5 10.5 6.0 2.0 16.2 17.6 6.2 23.4 42.2 0.5 0.1 0.1 0.3 0.0 3.1 0.1 2.9 0.8 0.1 0.0 0.3 1.8 1.9 1.1 3.0 1.3 1.9 1.7 24.1 0.0 10.4 2.0 5.8 0.0 1.4 1.7 2.1 0.0 0.6 2.3 0.0 0.2 0.0 1.2 0.4 7.2 1.5 10.6 50.5 0.5 9.6 0.5 1.8 0.1 1.1 0.5 1.3 0.0 0.0 0.0 0.5 4.6 1.3 0.0 0.8 1.0 0.3 4.0 0.3 60.3 0.5 3.1 0.5 0.0 0.7 1.0 0.0 1.6 0.0 0.6 0.1 0.3 0.0 0.3 0.0 3.1 0.5 0.9 0.7 0.1 0.2 0.3 0.1 0.1 0.0 0.1 0.0 0.9 0.1 5.4 6.5 4.1 6.8 8.2 4.9 5.9 2.5 7.4 6.0 MOSPD1 dJ473B4 ENSG00000101928 "Motile sperm domain containing 1" Q9UJG1 X 134887626-134915267 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031158 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA031158: AB_10603874" "unprognostic (2.23e-3)" "unprognostic (3.37e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-1)" "unprognostic (1.77e-1)" "unprognostic (3.36e-1)" "unprognostic (6.78e-3)" "unprognostic (5.15e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (6.20e-3)" "unprognostic (4.27e-2)" "unprognostic (6.45e-3)" "unprognostic (2.92e-2)" "unprognostic (2.01e-1)" "unprognostic (5.71e-2)" "unprognostic (1.15e-1)" 11.0 19.7 6.2 6.5 8.0 12.3 7.9 7.8 10.4 11.1 6.9 8.8 5.5 5.4 19.3 12.5 20.5 25.1 6.6 17.4 7.3 6.2 11.8 10.3 8.0 5.5 9.9 7.4 12.9 8.9 10.3 8.1 23.2 21.2 8.1 7.0 10.3 14.6 7.6 17.6 14.5 6.9 10.7 9.0 8.3 7.5 16.4 7.5 10.2 9.1 13.5 10.1 9.5 12.0 6.2 8.3 12.3 6.8 6.0 14.3 5.1 7.9 6.3 5.3 3.6 8.4 4.9 11.6 13.4 24.4 12.9 12.6 15.3 3.2 2.7 18.7 8.5 2.9 8.2 6.9 17.1 8.9 4.8 2.2 16.6 6.2 35.8 6.3 3.9 8.9 8.5 14.5 6.3 9.4 2.8 10.9 15.6 11.1 4.4 2.8 5.4 14.3 3.3 9.4 5.0 5.5 22.8 3.1 3.9 6.8 6.8 23.1 2.7 3.9 4.7 6.4 3.9 23.7 11.9 8.5 11.4 4.3 8.7 10.8 8.3 6.0 6.8 12.3 7.6 5.0 10.0 6.2 9.0 8.3 7.5 5.1 10.2 9.8 4.0 6.0 5.5 8.3 14.3 5.1 6.2 8.0 7.8 10.4 7.3 6.2 9.9 7.4 21.2 7.5 MPLKIP "C7orf11, ORF20, TTDN1" ENSG00000168303 "M-phase specific PLK1 interacting protein" Q8TAP9 7 40126023-40134652 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA058457, HPA065463" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "HPA058457: , HPA065463: " "unprognostic (5.59e-2)" "unprognostic (1.74e-1)" "unprognostic (9.40e-2)" "unprognostic (2.39e-2)" "unprognostic (5.55e-2)" "unprognostic (1.34e-3)" "unprognostic (2.73e-1)" "unprognostic (3.40e-2)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (3.16e-3)" "unprognostic (8.89e-2)" "unprognostic (1.61e-2)" "unprognostic (8.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-2)" "unprognostic (6.08e-2)" 13.7 15.2 11.6 9.3 12.7 8.7 14.8 13.9 12.1 12.7 14.5 12.6 9.5 11.9 11.0 13.6 12.9 10.0 9.3 9.3 11.8 11.4 20.5 52.1 8.7 13.3 15.0 8.8 12.0 17.3 10.1 16.1 13.8 10.4 11.5 11.6 11.1 14.4 10.5 10.1 11.3 13.4 9.2 11.9 12.7 10.8 11.0 12.0 25.5 19.2 7.9 12.8 11.3 12.6 53.8 41.9 52.9 38.0 30.7 45.0 40.9 23.7 7.0 13.0 16.4 13.1 15.5 14.4 8.5 10.1 13.6 13.8 9.5 11.5 19.3 12.6 8.8 29.2 7.8 16.0 17.1 14.8 28.4 14.8 10.3 20.0 15.8 17.4 14.1 14.5 22.2 9.7 12.7 16.4 38.6 14.8 13.8 12.2 17.7 59.2 18.0 23.7 25.9 9.1 25.4 15.1 5.6 19.0 23.6 14.1 13.3 20.5 17.2 26.3 14.8 7.4 22.3 8.9 13.2 24.2 28.5 32.8 12.6 30.0 21.7 43.4 38.0 52.9 28.0 34.3 31.3 53.8 35.9 32.8 39.4 47.0 40.0 35.1 20.4 30.7 31.5 41.9 45.0 40.9 11.6 12.7 13.9 12.1 11.8 11.4 15.0 8.8 10.4 12.0 MPO ENSG00000005381 Myeloperoxidase P05164 17 58269856-58280935 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 315.2" "Group enriched" "Detected in some" 93 "HL-60: 212.9;NB-4: 279.1" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0" "Group enriched" "Detected in many" 30 "dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000059, HPA021147, HPA061464" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" 15000000 Vesicles Nucleoplasm "CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531" "unprognostic (1.91e-1)" "unprognostic (9.08e-2)" "unprognostic (4.62e-2)" "unprognostic (2.90e-2)" "unprognostic (2.13e-3)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (6.92e-2)" "unprognostic (8.34e-3)" "unprognostic (4.91e-2)" "unprognostic (3.07e-3)" "unprognostic (2.83e-1)" "unprognostic (1.14e-2)" "unprognostic (8.05e-2)" 0.2 0.1 0.5 0.1 0.8 315.2 0.1 0.4 1.0 0.1 0.1 1.4 0.0 0.1 0.2 0.2 0.1 0.1 0.1 21.5 0.6 0.8 0.1 1.4 6.9 0.8 0.6 0.0 0.6 0.1 0.1 1.0 2.9 0.4 0.2 0.1 0.2 6.3 0.1 0.7 0.5 0.1 0.1 0.4 17.8 0.1 0.4 0.2 19.7 0.6 0.0 0.5 0.1 0.0 0.0 3.2 2.0 7.6 0.0 0.1 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 212.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 279.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.6 0.0 0.0 3.8 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.1 7.2 0.5 0.8 0.4 1.0 0.6 0.8 0.6 0.0 0.4 0.2 MPPED2 "239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638" ENSG00000066382 "Metallophosphoesterase domain containing 2" Q15777 11 30384493-30586872 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 31.0;thyroid gland: 30.0" "Cell line enhanced" "Detected in some" "HaCaT: 19.4;HAP1: 11.5;RT4: 8.1;SH-SY5Y: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062575 Approved Nucleoli,Vesicles,Mitochondria Nucleoli "Vesicles, Mitochondria" "HPA062575: " "unprognostic (9.60e-3)" "unprognostic (6.12e-3)" "unprognostic (3.70e-3)" "unprognostic (4.56e-2)" "unprognostic (5.46e-2)" "unprognostic (5.04e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-2)" "unprognostic (1.13e-1)" "unprognostic (7.98e-4)" "unprognostic (6.82e-2)" "unprognostic (2.47e-7)" "unprognostic (3.64e-3)" "unprognostic (2.50e-1)" "unprognostic (2.22e-2)" "unprognostic (2.57e-2)" 2.9 7.0 6.3 1.7 19.3 1.1 5.5 4.6 8.9 31.0 4.2 1.8 4.4 1.5 8.3 7.9 1.6 11.1 1.9 4.6 8.5 9.7 12.2 1.2 1.1 0.9 7.0 6.7 1.2 2.5 5.0 10.7 2.5 11.2 15.6 1.4 7.1 12.1 10.1 5.7 1.0 1.4 5.1 4.6 3.1 1.9 3.8 3.4 9.1 30.0 1.2 1.0 4.7 4.9 1.3 0.7 0.3 0.2 2.0 4.8 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 11.5 0.0 0.0 0.0 2.1 0.0 0.2 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 3.2 0.0 0.0 3.1 0.2 0.0 8.1 0.1 6.1 0.0 0.0 3.1 1.8 0.0 0.1 0.0 1.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.9 0.0 4.8 0.0 0.0 0.6 0.4 1.3 1.3 0.2 0.2 2.0 0.0 0.7 0.1 0.2 6.3 19.3 4.6 8.8 8.5 9.7 7.0 6.7 11.2 3.4 MPV17L "FLJ39599, MLPH1, MLPH2, MPV17L1" ENSG00000156968 "MPV17 mitochondrial inner membrane protein like" Q2QL34 16 15395754-15413268 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 33.1" "Cell line enriched" "Detected in many" 4 "HMC-1: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA041180 Uncertain Supported Vesicles Vesicles "HPA041180: AB_10794266" "unprognostic (9.65e-2)" "unprognostic (8.74e-2)" "unprognostic (4.16e-1)" "unprognostic (1.35e-3)" "unprognostic (6.68e-2)" "unprognostic (2.84e-1)" "unprognostic (2.73e-1)" "unprognostic (4.38e-3)" "unprognostic (8.41e-2)" "unprognostic (8.99e-3)" "unprognostic (8.70e-2)" "unprognostic (6.36e-3)" "prognostic favourable (1.48e-11)" "unprognostic (2.84e-1)" "unprognostic (7.60e-2)" "unprognostic (6.61e-3)" "unprognostic (3.87e-2)" 3.1 4.9 6.2 3.7 8.7 8.3 16.0 6.8 8.0 7.1 4.5 10.5 1.6 7.1 4.5 3.1 2.5 3.3 5.7 3.7 7.4 5.4 8.2 12.2 2.3 4.7 5.8 6.1 4.8 33.1 10.6 11.7 1.4 6.3 3.7 2.9 9.7 10.1 5.0 16.0 9.1 5.6 9.4 7.2 3.7 4.1 2.7 7.0 0.0 5.2 1.3 1.6 4.8 2.4 4.0 2.2 5.7 3.6 3.6 2.5 1.2 0.8 1.5 0.6 0.6 0.1 0.1 1.0 0.4 0.0 0.0 0.0 1.5 2.9 1.2 1.2 0.5 1.1 2.9 0.0 0.0 0.8 0.8 5.8 3.5 3.0 0.2 2.7 29.7 0.2 0.3 0.1 0.2 0.0 1.8 2.6 0.0 1.5 0.9 1.7 1.5 1.0 1.5 0.4 1.1 0.4 0.6 4.7 1.6 2.4 6.8 0.2 1.5 2.0 1.9 1.1 0.6 0.9 0.8 1.1 0.4 1.3 0.6 1.3 0.4 3.9 3.6 0.6 2.3 2.7 1.9 2.1 1.5 2.4 1.2 4.0 1.5 2.5 5.7 3.6 1.0 2.2 1.2 1.2 6.2 8.7 6.8 8.0 7.4 5.4 5.8 6.1 6.3 7.0 MPZL1 "FLJ21047, PZR" ENSG00000197965 "Myelin protein zero like 1" O95297 1 167721192-167791919 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 51.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026966, HPA063538" Approved Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA026966: AB_10600931, HPA063538: " "unprognostic (6.54e-2)" "unprognostic (9.26e-3)" "unprognostic (4.59e-2)" "unprognostic (4.88e-1)" "unprognostic (2.18e-1)" "unprognostic (2.57e-2)" "prognostic unfavourable (4.27e-6)" "prognostic unfavourable (3.98e-4)" "unprognostic (1.22e-1)" "unprognostic (3.41e-2)" "unprognostic (2.59e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (3.99e-7)" "unprognostic (3.55e-1)" "unprognostic (2.35e-1)" "prognostic unfavourable (8.08e-4)" "unprognostic (4.21e-2)" 34.4 19.1 13.6 21.4 13.9 3.2 42.0 14.3 13.7 32.2 27.3 15.4 15.9 18.5 34.8 25.2 32.1 30.1 34.3 29.2 12.0 14.0 22.2 20.9 22.2 20.7 14.4 10.0 38.3 25.4 13.7 24.3 34.0 14.3 28.3 28.2 28.0 51.7 19.4 11.0 17.7 26.6 30.5 13.0 19.6 21.3 27.7 10.9 9.7 29.0 25.8 28.0 33.6 35.0 4.2 12.5 51.4 8.9 2.9 2.4 3.0 18.1 26.5 20.8 16.1 67.2 30.5 65.8 28.4 36.7 18.6 23.2 48.9 25.3 6.4 33.3 35.9 30.6 20.7 31.4 15.8 14.5 11.2 5.3 14.1 11.7 41.8 6.2 3.4 27.9 39.7 29.6 33.4 24.7 19.7 13.5 22.0 6.0 20.9 7.4 13.2 11.4 12.8 17.9 28.3 28.5 17.6 12.0 19.9 25.2 26.3 14.6 14.2 3.3 28.0 21.4 9.6 27.3 15.3 20.2 31.3 29.8 30.6 7.3 3.3 1.9 8.1 5.4 0.8 6.8 0.4 4.2 0.8 1.2 10.9 2.5 2.4 0.8 51.4 2.9 8.9 12.5 0.1 3.0 13.6 13.9 14.3 13.7 12.0 14.0 14.4 10.0 14.3 10.9 MREG "DSU, FLJ10116, WDT2" ENSG00000118242 Melanoregulin Q8N565 2 215942805-216034096 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 41.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 24.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068583 Approved Vesicles Vesicles "HPA068583: " "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-1)" "unprognostic (1.20e-2)" "unprognostic (3.24e-1)" "unprognostic (1.13e-2)" "unprognostic (3.70e-1)" "unprognostic (7.37e-2)" "unprognostic (2.39e-1)" "unprognostic (5.85e-3)" "unprognostic (8.11e-3)" "unprognostic (8.93e-2)" "unprognostic (6.38e-3)" "unprognostic (6.62e-3)" "unprognostic (6.92e-2)" "prognostic favourable (4.20e-4)" "unprognostic (9.99e-2)" 5.6 5.8 3.1 4.3 4.5 3.4 16.0 24.4 6.6 6.1 3.6 0.9 11.8 4.2 2.2 5.6 25.8 4.0 1.8 1.7 2.9 3.7 3.8 12.1 12.4 8.3 4.1 2.4 1.6 4.1 6.1 10.6 10.0 6.4 1.8 4.0 18.6 5.0 4.9 1.0 14.3 3.4 1.1 3.0 2.7 4.7 1.6 1.7 9.6 4.6 11.9 18.5 3.5 11.3 2.8 4.9 2.0 0.2 2.0 3.5 0.3 9.4 2.4 2.7 1.5 1.9 1.2 6.4 3.3 2.7 2.3 4.3 12.4 7.4 3.3 3.0 1.9 6.1 8.4 12.4 4.9 6.6 7.2 4.6 2.4 19.0 1.1 2.7 1.7 1.7 5.4 2.6 3.3 1.8 2.5 8.0 1.4 41.7 7.9 2.5 11.1 2.3 4.4 6.4 4.9 5.5 14.0 7.6 4.0 1.9 16.9 17.3 9.4 1.2 0.2 4.4 1.2 2.2 4.8 11.3 6.8 7.8 2.9 10.0 3.4 2.0 0.1 0.2 1.9 0.0 3.5 2.8 1.7 2.8 0.3 1.3 0.8 1.2 0.8 2.0 0.2 4.9 2.9 0.3 3.1 4.5 24.4 6.6 2.9 3.7 4.1 2.4 6.4 1.7 MS4A3 "CD20L, HTM4" ENSG00000149516 "Membrane spanning 4-domains A3" Q96HJ5 11 60056587-60071128 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 196.2;bone marrow: 105.4" "Group enriched" "Detected in some" 4 "HEL: 36.3;K-562: 30.9;NB-4: 25.1;THP-1: 73.3;U-937: 28.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebral cortex: 1.6" "Cell type enriched" "Detected in single" 1061 "basophil: 196.2" "Lineage enriched" "Detected in single" 1963 "granulocytes: 196.2" "Not detected" "Not detected" HPA019210 Supported Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA019210: AB_1854134" "unprognostic (6.37e-3)" "unprognostic (1.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.77e-1)" 0.2 0.0 0.1 0.1 0.3 105.4 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 14.7 0.1 0.1 0.1 0.5 6.8 0.0 0.1 0.0 0.1 0.0 0.0 0.4 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.1 8.6 0.0 1.0 0.0 7.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 196.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 0.0 0.0 0.0 9.5 0.9 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.9 0.0 196.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.0 MSH2 "COCA1, HNPCC, HNPCC1" ENSG00000095002 "MutS homolog 2" P43246 2 47402969-47663146 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009572, HPA066845, CAB070867" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB009572: AB_2144828, CAB070867: , HPA066845: " "unprognostic (2.35e-1)" "unprognostic (1.54e-2)" "unprognostic (2.89e-3)" "prognostic unfavourable (4.44e-4)" "unprognostic (2.23e-1)" "unprognostic (6.31e-3)" "prognostic unfavourable (1.72e-9)" "unprognostic (1.77e-1)" "unprognostic (7.09e-3)" "unprognostic (8.57e-2)" "prognostic unfavourable (4.63e-4)" "unprognostic (5.38e-2)" "unprognostic (3.29e-3)" "unprognostic (1.20e-3)" "unprognostic (5.74e-1)" "unprognostic (8.46e-2)" "unprognostic (1.48e-1)" 7.3 9.8 14.2 12.2 25.5 11.4 14.1 22.6 18.1 9.4 11.6 7.6 5.6 6.5 10.5 13.3 10.8 11.1 4.9 8.4 13.0 14.0 7.3 5.5 7.1 19.7 12.5 17.0 7.9 8.4 15.3 9.1 9.9 18.5 7.9 13.8 12.3 9.4 7.3 6.7 10.3 8.0 7.8 13.8 9.4 6.7 13.4 13.5 37.0 13.9 6.6 21.4 8.5 7.6 7.4 2.9 3.9 4.2 12.2 12.6 6.2 28.0 9.6 26.3 14.1 1.9 5.5 15.9 16.7 8.3 20.8 20.1 18.0 12.1 34.5 22.6 5.9 11.9 19.6 9.5 31.4 17.8 14.6 24.9 11.1 16.3 2.0 24.3 8.8 3.1 2.8 17.7 4.8 11.4 41.4 8.0 15.8 11.2 28.1 18.3 49.4 11.4 37.7 46.9 20.2 9.0 14.9 21.8 23.6 14.8 11.5 11.8 11.5 9.5 4.6 13.8 18.1 14.2 18.6 5.1 18.3 48.4 8.4 18.0 8.5 2.8 1.0 3.9 7.9 4.2 8.6 6.3 7.4 9.5 2.3 7.4 12.6 11.9 0.7 12.2 3.2 2.9 10.1 6.2 14.2 25.5 22.6 18.1 13.0 14.0 12.5 17.0 18.5 13.5 MSH5 G7 ENSG00000204410 "MutS homolog 5" O43196 6 31739948-31762834 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Meiosis" DNA-binding "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "basophil: 9.3" "Lineage enriched" "Detected in many" 9 "granulocytes: 9.3" HPA062688 Approved "Endoplasmic reticulum,Vesicles" Vesicles "Endoplasmic reticulum" "HPA062688: " "unprognostic (3.21e-3)" "unprognostic (2.32e-2)" "unprognostic (2.05e-1)" "unprognostic (4.37e-2)" "unprognostic (4.51e-1)" "unprognostic (9.20e-4)" "unprognostic (7.67e-3)" "unprognostic (2.57e-2)" "unprognostic (1.45e-2)" "unprognostic (2.05e-3)" "unprognostic (4.59e-3)" "unprognostic (2.28e-2)" "unprognostic (5.19e-5)" "unprognostic (3.75e-2)" "unprognostic (8.83e-2)" "unprognostic (9.21e-2)" "unprognostic (9.34e-4)" 3.6 2.7 3.2 8.0 4.4 6.8 4.1 1.6 4.4 3.9 5.8 6.9 9.3 3.0 9.8 8.5 4.7 5.8 15.2 2.0 3.2 2.1 10.5 4.7 4.3 5.7 4.0 3.6 6.9 4.0 1.6 6.5 3.0 4.1 7.9 5.3 12.4 4.7 9.2 2.3 12.3 5.2 6.0 5.7 7.6 6.8 15.9 3.8 12.0 4.3 2.7 10.6 3.6 4.0 1.0 0.5 9.3 0.9 0.1 0.8 0.0 2.0 1.9 2.3 4.7 0.8 0.7 0.7 0.6 0.2 0.8 0.3 1.2 2.6 2.5 0.7 0.5 2.9 0.0 1.2 0.3 0.4 1.1 2.4 0.6 1.4 0.3 1.9 1.9 0.8 0.5 1.9 2.4 0.9 4.8 6.0 0.7 2.6 3.6 4.1 0.9 0.4 1.3 1.0 3.9 1.4 0.4 0.6 2.4 0.8 0.0 0.0 1.3 2.7 0.7 1.7 3.5 0.0 1.5 2.7 1.0 2.8 0.7 3.9 3.6 9.3 0.4 0.0 0.7 0.3 0.2 1.0 0.4 0.2 0.2 0.5 0.1 0.0 0.0 0.1 0.9 0.5 0.8 0.0 3.2 4.4 1.6 4.4 3.2 2.1 4.0 3.6 4.1 3.8 MSH6 GTBP ENSG00000116062 "MutS homolog 6" P52701 2 47695530-47810101 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" DNA-binding "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009091, HPA028376, HPA028446, CAB070870" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182" "unprognostic (5.10e-2)" "unprognostic (5.87e-3)" "unprognostic (3.29e-2)" "prognostic unfavourable (1.34e-4)" "unprognostic (1.98e-1)" "unprognostic (3.09e-2)" "prognostic unfavourable (7.86e-4)" "unprognostic (1.79e-1)" "unprognostic (2.35e-3)" "unprognostic (1.01e-1)" "unprognostic (1.74e-3)" "unprognostic (8.99e-2)" "prognostic unfavourable (1.06e-7)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (9.68e-2)" "unprognostic (3.48e-2)" 13.0 20.5 9.7 13.1 18.8 13.6 13.0 20.5 13.1 17.9 13.3 17.6 10.7 6.1 28.2 11.0 12.4 18.3 8.4 8.6 11.4 8.8 9.5 14.6 11.0 21.7 23.9 9.6 43.2 27.6 16.2 17.3 14.9 15.0 14.6 10.3 8.7 12.0 13.2 10.4 10.3 10.5 22.1 14.9 11.6 11.1 25.1 22.0 40.4 13.4 10.4 25.8 14.2 16.4 8.4 8.4 7.6 9.8 9.7 15.1 5.7 27.2 20.3 37.9 9.0 11.4 12.1 17.1 15.2 13.4 15.7 16.6 14.9 9.5 45.0 22.7 16.4 11.5 34.1 19.3 20.5 19.6 17.0 28.8 16.2 15.1 7.0 28.9 10.6 9.8 6.2 16.0 10.7 9.8 25.0 16.6 15.3 19.6 30.7 13.7 33.3 9.4 73.0 49.7 20.3 9.6 17.8 21.2 23.0 21.1 10.1 9.2 12.0 10.2 6.0 18.3 22.4 13.8 19.6 15.6 21.0 75.4 15.5 18.5 11.2 7.6 5.8 4.9 8.4 9.8 10.4 8.4 9.5 8.3 8.4 8.1 15.1 7.6 3.9 9.7 9.3 4.2 9.5 5.7 9.7 18.8 20.5 13.1 11.4 8.8 23.9 9.6 15.0 22.0 MSLN "CAK1, MPF" ENSG00000102854 Mesothelin Q13421 16 760762-768865 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 85.5;lung: 88.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 102.3;EFO-21: 15.8;HeLa: 31.2;hTCEpi: 22.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 343.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 9.0" "Group enriched" "Detected in many" 59 "dendritic cells: 9.0;monocytes: 2.6" "Low region specificity" "Detected in many" "CAB002216, HPA017172" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" 14000000 Vesicles Nucleoplasm "CAB002216: AB_563874, HPA017172: AB_1853819" "unprognostic (1.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.06e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (3.95e-2)" "unprognostic (2.46e-1)" "unprognostic (9.47e-2)" "unprognostic (8.57e-2)" "unprognostic (4.69e-2)" "prognostic unfavourable (6.66e-4)" "unprognostic (2.63e-1)" "prognostic favourable (5.91e-4)" "unprognostic (2.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.14e-2)" "unprognostic (3.35e-2)" 36.5 0.0 0.4 6.7 0.5 0.7 0.3 0.1 0.4 5.4 5.4 0.8 26.8 2.1 4.8 18.9 3.1 85.5 9.6 4.3 0.4 0.3 2.6 0.2 88.5 0.4 0.6 0.0 22.3 0.4 0.0 0.6 13.7 0.9 1.9 1.2 0.2 14.4 33.1 0.0 0.5 0.7 1.0 0.8 0.1 3.7 2.1 0.0 0.1 0.1 0.6 7.8 1.4 1.3 0.0 9.0 0.0 2.6 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.5 1.8 0.4 1.4 102.3 0.0 15.8 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 31.2 1.1 0.9 0.0 0.0 0.0 22.7 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 5.9 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.4 0.4 0.5 0.1 0.4 0.4 0.3 0.6 0.0 0.9 0.0 MSMP "PC-3, PSMP" ENSG00000215183 "Microseminoprotein, prostate associated" Q1L6U9 9 35752990-35756613 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;pituitary gland: 6.0;placenta: 5.7" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 34.3;PC-3: 43.7" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.9" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA055174 Uncertain Supported Vesicles,Cytosol "Secreted in male reproductive system" Vesicles Cytosol "HPA055174: " 0.5 0.0 1.2 1.1 0.6 0.0 0.8 0.0 0.7 0.2 0.8 0.6 0.0 0.0 0.1 0.0 0.0 0.5 1.9 0.0 0.1 0.1 0.4 0.0 0.4 0.9 3.9 0.0 0.0 0.0 0.0 6.0 5.7 0.8 0.7 0.5 0.0 0.0 0.3 1.3 0.5 1.5 0.3 2.2 0.0 0.1 0.6 0.0 0.0 1.3 0.0 0.2 0.1 0.1 0.0 0.1 3.2 0.3 1.2 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.2 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.7 1.1 0.0 1.2 0.3 0.1 0.3 0.4 1.2 0.6 0.0 0.6 0.1 0.1 3.9 0.0 0.8 0.0 MSS51 "FLJ39565, ZMYND17" ENSG00000166343 "MSS51 mitochondrial translational activator" Q4VC12 10 73423579-73433561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "parathyroid gland: 34.4;skeletal muscle: 66.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "cerebellum: 2.7" "Cell type enhanced" "Detected in some" "gdT-cell: 1.7;naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA038564 Uncertain Vesicles,Cytosol Vesicles Cytosol "HPA038564: AB_10674687" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.40e-3)" "unprognostic (2.06e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-3)" "unprognostic (3.05e-3)" "unprognostic (7.88e-3)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (1.50e-4)" "unprognostic (1.22e-1)" "unprognostic (1.78e-7)" "unprognostic (1.51e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-2)" 2.8 0.3 0.4 0.4 0.4 0.3 0.4 2.7 0.4 0.5 0.5 0.4 0.4 0.2 0.6 0.4 0.9 0.6 0.4 3.9 0.4 0.1 0.4 0.4 0.6 0.4 0.4 0.4 1.1 0.5 34.4 0.7 0.4 0.4 0.8 0.3 0.4 2.3 0.4 66.9 0.8 0.8 0.4 0.4 1.4 0.4 0.4 0.4 0.6 0.4 1.2 0.4 0.5 0.6 0.1 0.0 0.0 0.5 0.0 1.7 0.4 1.2 1.3 3.0 4.7 4.2 6.0 2.6 1.4 1.1 0.6 1.3 0.7 1.5 3.8 0.5 1.5 2.3 1.9 0.4 1.7 1.8 1.5 3.3 2.0 1.1 1.5 2.2 3.1 4.7 1.5 1.3 3.5 0.6 1.1 2.0 2.5 0.5 1.8 3.0 0.9 1.6 1.1 7.7 0.2 1.8 1.9 0.6 1.2 1.0 2.2 1.7 1.9 1.8 2.6 2.3 1.4 0.9 3.0 1.2 3.4 2.0 1.0 3.8 0.6 0.0 0.4 0.0 1.7 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.3 1.2 0.0 0.0 0.5 0.0 0.0 0.4 0.4 0.4 2.7 0.4 0.4 0.1 0.4 0.4 0.4 0.4 MTA3 KIAA1266 ENSG00000057935 "Metastasis associated 1 family member 3" Q9BTC8 2 42494569-42756947 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 74.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039433 Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA039433: AB_10794747" "unprognostic (5.40e-2)" "unprognostic (4.89e-2)" "unprognostic (5.28e-2)" "prognostic unfavourable (2.30e-4)" "unprognostic (4.13e-2)" "unprognostic (2.88e-1)" "prognostic unfavourable (4.69e-4)" "unprognostic (7.55e-2)" "unprognostic (2.04e-1)" "unprognostic (5.43e-2)" "unprognostic (2.27e-1)" "unprognostic (1.58e-1)" "unprognostic (2.64e-2)" "unprognostic (9.03e-2)" "unprognostic (2.05e-1)" "unprognostic (3.47e-1)" "unprognostic (1.28e-2)" 8.8 35.0 19.2 16.7 21.0 1.6 14.6 11.4 23.7 14.5 12.5 10.2 16.8 9.0 17.2 25.0 16.7 14.1 11.3 11.1 18.3 14.0 14.5 7.6 8.3 11.5 12.3 14.6 33.3 15.0 18.3 15.8 16.1 12.5 15.0 14.1 12.6 10.6 20.8 9.8 15.4 8.7 14.3 10.4 6.4 12.5 21.0 9.3 74.3 13.0 7.7 15.0 13.5 13.4 2.9 3.2 7.7 1.9 3.3 8.8 3.3 7.7 8.1 12.1 7.3 9.7 13.6 24.0 4.8 8.7 10.9 9.3 10.2 13.4 25.3 8.4 10.5 4.8 25.6 11.5 16.0 9.3 8.7 4.5 4.7 16.0 10.5 2.7 15.5 14.3 12.9 7.4 7.9 14.6 8.2 2.9 11.9 11.4 17.6 8.5 43.2 4.9 10.2 10.6 0.0 10.9 6.3 6.4 20.9 7.5 23.5 9.9 12.7 3.5 9.1 5.2 8.6 3.9 4.7 6.1 2.8 37.1 6.9 2.8 6.7 7.7 1.9 0.0 4.1 0.7 5.7 2.5 4.4 6.2 3.2 2.9 8.8 5.9 0.3 3.3 1.2 1.0 2.2 3.3 19.2 21.0 11.4 23.7 18.3 14.0 12.3 14.6 12.5 9.3 MTFR2 "DUFD1, FAM54A" ENSG00000146410 "Mitochondrial fission regulator 2" Q6P444 6 136231024-136250335 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.2;lymphoid tissue: 16.8;testis: 13.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029792, HPA029794" Approved Uncertain Vesicles Vesicles "HPA029792: AB_10600210, HPA029794: AB_10600535" "unprognostic (6.49e-3)" "unprognostic (6.29e-2)" "unprognostic (1.65e-1)" "prognostic unfavourable (9.64e-4)" "unprognostic (3.93e-1)" "unprognostic (1.75e-2)" "unprognostic (4.60e-6)" "prognostic unfavourable (8.28e-4)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (6.27e-2)" "unprognostic (6.54e-2)" "unprognostic (1.11e-16)" "unprognostic (8.82e-3)" "unprognostic (1.55e-1)" "unprognostic (4.10e-2)" "unprognostic (3.64e-2)" 1.7 0.9 0.6 5.1 1.5 15.2 0.9 0.9 1.1 0.8 2.9 0.8 0.4 2.8 0.7 0.9 4.5 0.5 1.7 1.0 0.6 0.6 2.5 0.7 1.5 6.4 0.8 0.4 0.9 0.7 0.0 0.7 3.2 1.2 0.7 4.1 0.6 1.3 0.4 1.4 1.9 3.2 0.9 1.1 3.8 1.9 13.5 0.4 16.8 0.4 3.2 5.8 1.1 1.4 1.6 3.0 0.1 2.9 0.0 2.6 1.1 7.1 5.6 4.8 8.9 0.8 1.4 8.6 9.5 6.6 11.3 15.9 9.9 5.9 18.7 5.8 3.8 11.2 10.8 7.0 16.9 10.4 8.3 14.7 4.1 9.0 0.5 26.9 13.9 1.1 1.5 12.6 8.1 6.1 15.8 14.6 8.4 9.6 15.1 22.6 4.8 6.9 13.9 7.7 9.4 4.8 5.6 3.8 3.8 6.0 10.6 5.4 4.4 18.6 3.3 5.6 5.9 19.8 14.5 5.5 13.0 12.4 3.2 18.4 8.6 0.0 0.6 0.0 1.2 2.9 0.4 1.6 1.6 2.6 3.0 1.3 0.2 1.3 0.1 0.0 2.3 2.2 2.2 1.1 0.6 1.5 0.9 1.1 0.6 0.6 0.8 0.4 1.2 0.4 MTHFSD FLJ12998 ENSG00000103248 "Methenyltetrahydrofolate synthetase domain containing" Q2M296 16 86530176-86555235 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041333 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA041333: AB_10795006" "unprognostic (4.09e-2)" "unprognostic (2.52e-2)" "prognostic unfavourable (9.88e-5)" "unprognostic (2.66e-2)" "unprognostic (7.71e-2)" "unprognostic (1.66e-1)" "unprognostic (4.90e-2)" "unprognostic (6.24e-2)" "unprognostic (3.29e-1)" "unprognostic (4.05e-2)" "unprognostic (2.96e-2)" "unprognostic (3.90e-3)" "unprognostic (1.94e-3)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" "unprognostic (4.77e-1)" "unprognostic (5.85e-3)" 12.6 12.6 10.9 10.0 11.4 7.1 13.1 17.1 16.5 12.1 10.8 19.3 18.2 9.1 17.5 15.6 14.4 16.8 11.9 10.0 11.1 7.9 12.2 11.9 10.4 13.3 13.4 13.6 14.8 14.2 24.0 15.8 10.1 14.4 15.9 13.4 16.2 17.2 15.7 14.7 15.6 12.5 14.1 9.5 15.9 12.1 21.5 12.8 14.7 14.7 13.3 14.9 13.3 18.7 8.3 9.9 10.1 7.6 9.3 9.3 7.2 9.3 9.0 8.8 7.7 7.6 11.6 10.8 9.4 7.0 11.9 6.0 7.8 15.9 8.4 10.2 8.2 13.0 9.7 9.2 11.2 5.6 7.9 7.4 11.8 7.3 10.2 5.9 4.3 7.3 14.9 15.3 13.2 7.1 15.9 0.0 8.6 12.0 7.5 9.0 5.8 11.3 22.8 5.2 6.6 6.9 5.8 8.6 5.9 21.4 4.2 7.9 21.4 6.3 7.3 11.6 10.0 7.7 9.0 7.0 8.5 24.8 10.6 9.7 11.3 10.1 7.6 3.8 8.5 5.8 8.8 8.3 9.3 8.5 9.9 6.8 7.8 8.8 3.1 9.3 7.1 4.5 7.6 7.2 10.9 11.4 17.1 16.5 11.1 7.9 13.4 13.6 14.4 12.8 MTMR2 "CMT4B, KIAA1073" ENSG00000087053 "Myotubularin related protein 2" Q13614 11 95832882-95925315 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049831 Approved Supported Vesicles Vesicles "HPA049831: " "unprognostic (1.71e-2)" "unprognostic (2.55e-3)" "unprognostic (7.81e-3)" "unprognostic (4.16e-1)" "unprognostic (4.18e-3)" "unprognostic (5.36e-2)" "prognostic unfavourable (1.61e-8)" "unprognostic (3.23e-3)" "unprognostic (3.42e-2)" "unprognostic (1.77e-2)" "prognostic unfavourable (3.60e-4)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (8.03e-3)" 16.4 10.4 14.2 12.1 19.9 5.3 15.4 14.9 23.3 14.1 13.5 22.6 4.9 8.0 14.1 7.5 15.5 13.3 15.4 13.8 18.1 13.9 16.9 4.5 14.3 13.6 27.5 13.6 14.5 11.0 15.9 8.2 25.1 21.3 17.6 14.5 19.6 18.8 12.3 6.8 9.7 9.5 18.2 30.0 10.5 13.6 29.0 21.8 12.2 11.3 7.7 11.7 13.4 14.3 5.4 6.6 9.7 4.9 11.8 14.2 6.6 9.2 9.9 22.9 16.5 8.0 12.5 19.1 17.3 15.5 17.3 15.6 23.4 18.8 6.6 20.8 18.3 12.9 18.6 18.9 15.5 12.2 9.0 13.9 24.8 13.1 18.4 23.4 11.4 10.4 12.6 22.6 22.7 25.9 17.1 6.4 16.1 6.9 11.6 10.9 18.6 14.1 9.8 13.4 6.3 17.7 49.8 14.6 17.1 17.1 14.5 7.7 11.5 10.0 26.5 20.1 18.5 14.7 15.9 6.0 16.5 6.1 8.5 6.5 20.4 9.7 3.3 1.4 11.4 3.9 12.3 5.4 7.7 14.2 6.6 4.8 4.1 11.0 0.9 11.8 4.9 3.4 6.9 6.6 14.2 19.9 14.9 23.3 18.1 13.9 27.5 13.6 21.3 21.8 MTOR "FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1" ENSG00000198793 "Mechanistic target of rapamycin kinase" P42345 1 11106535-11262507 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB069425, HPA071227" Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "CAB069425: , HPA071227: " "unprognostic (3.18e-1)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (2.45e-3)" "unprognostic (5.50e-2)" "unprognostic (2.55e-2)" "unprognostic (1.39e-1)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "unprognostic (8.24e-3)" "unprognostic (3.48e-2)" "unprognostic (1.88e-1)" "prognostic favourable (1.49e-5)" "unprognostic (1.27e-1)" "unprognostic (2.45e-1)" "unprognostic (6.60e-2)" "unprognostic (7.55e-2)" 11.3 13.9 18.7 13.0 22.5 12.3 14.9 25.2 25.2 11.3 14.5 18.2 10.4 11.2 13.8 23.6 13.1 10.5 15.7 14.2 14.5 13.6 15.8 19.4 10.8 14.3 14.0 14.4 10.7 16.6 26.5 16.0 12.5 15.5 15.2 17.1 14.4 14.2 15.2 24.6 16.5 13.6 15.2 10.4 15.4 13.1 38.6 13.1 16.6 13.2 9.9 15.7 11.7 10.2 3.9 4.0 3.0 6.4 2.6 5.6 2.3 15.2 13.8 18.7 14.1 22.6 10.8 9.3 12.9 12.4 17.2 17.0 14.2 14.1 16.9 11.1 15.2 18.2 25.2 19.7 22.3 13.5 18.4 22.5 28.6 17.9 14.2 21.9 16.8 13.8 15.0 24.6 25.0 21.8 25.1 14.6 12.0 17.4 15.1 16.7 14.1 13.1 15.2 22.0 11.3 15.2 13.8 18.9 13.8 27.6 14.9 16.9 12.1 13.0 23.2 15.1 13.7 11.5 17.2 14.4 13.4 33.3 10.9 23.7 15.8 0.7 2.9 3.0 5.2 6.4 4.3 3.9 3.0 2.7 4.0 3.4 3.6 3.1 2.0 2.6 3.3 3.1 5.6 2.3 18.7 22.5 25.2 25.2 14.5 13.6 14.0 14.4 15.5 13.1 MUC5B "MG1, MUC5" ENSG00000117983 "Mucin 5B, oligomeric mucus/gel-forming" Q9HC84 11 1223066-1262172 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 301.7;lymphoid tissue: 155.1;salivary gland: 192.8" "Cell line enriched" "Detected in some" 7 "PC-3: 51.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008246, CAB009396" Enhanced Supported Vesicles "Secreted in other tissues" 590000 Vesicles "CAB009396: AB_2282256, HPA008246: AB_1854203" "unprognostic (2.01e-2)" "unprognostic (1.46e-1)" "unprognostic (9.39e-2)" "unprognostic (2.76e-3)" "unprognostic (5.46e-2)" "unprognostic (1.22e-1)" "unprognostic (4.89e-2)" "unprognostic (7.80e-3)" "unprognostic (3.75e-1)" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (8.95e-2)" "unprognostic (2.57e-7)" "unprognostic (2.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (8.13e-2)" 0.1 0.1 0.1 0.7 0.1 0.0 0.2 0.1 0.1 67.4 8.4 0.0 0.0 0.0 1.9 0.0 11.6 0.2 301.7 0.1 0.1 0.1 0.1 0.6 2.0 0.0 0.1 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.1 4.6 0.0 192.8 0.0 0.7 0.1 0.3 0.1 0.1 0.1 1.5 0.1 0.0 0.0 0.1 31.6 155.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 MVB12B "C9orf28, FAM125B, FLJ00001" ENSG00000196814 "Multivesicular body subunit 12B" Q9H7P6 9 126326849-126507041 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.2" "Cell line enhanced" "Detected in many" "AF22: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 1.5;gdT-cell: 3.1;MAIT T-cell: 5.7;memory CD4 T-cell: 1.4;memory CD8 T-cell: 5.0;myeloid DC: 2.0;naive CD8 T-cell: 2.2" "Group enriched" "Detected in many" 7 "dendritic cells: 2.0;monocytes: 1.5;T-cells: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043683, HPA049383" Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA043683: , HPA049383: " "unprognostic (3.50e-1)" "unprognostic (1.12e-1)" "unprognostic (6.82e-2)" "unprognostic (9.59e-3)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-2)" "unprognostic (4.45e-3)" "unprognostic (4.33e-1)" "unprognostic (1.05e-1)" "prognostic favourable (7.89e-4)" "unprognostic (2.82e-1)" "unprognostic (1.66e-3)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (5.79e-2)" "unprognostic (1.12e-3)" 5.6 5.5 15.2 4.3 21.2 10.7 5.0 7.3 22.9 6.3 6.1 52.0 2.4 3.7 5.9 3.3 4.3 10.2 3.9 4.6 22.8 15.3 3.4 4.0 17.7 5.9 31.1 9.8 6.6 3.3 8.8 5.3 14.8 28.2 5.9 6.4 5.8 3.1 9.0 21.4 3.3 4.2 6.6 62.2 10.3 4.0 5.4 28.8 4.8 5.7 1.5 2.6 6.9 3.2 0.4 2.0 0.2 1.5 0.1 5.7 1.4 2.9 4.1 22.2 12.2 0.8 0.2 13.2 2.5 2.0 4.5 0.9 3.4 0.1 0.0 1.5 2.3 1.3 6.8 1.2 2.8 4.9 4.3 1.1 0.7 15.1 1.8 1.9 0.9 1.7 2.3 0.9 0.0 3.4 0.0 0.0 3.3 2.4 3.2 6.2 4.8 5.5 4.7 12.1 0.0 0.2 12.2 5.6 10.3 4.1 3.0 2.5 2.9 11.9 5.0 5.1 3.8 2.8 5.1 0.0 0.0 1.2 1.4 8.8 2.7 0.0 1.5 0.2 3.1 0.4 5.7 0.2 1.4 5.0 2.0 0.4 0.3 2.2 0.1 0.1 0.4 0.1 0.0 1.4 15.2 21.2 7.3 15.9 22.8 15.3 31.1 9.8 28.2 28.8 MVK "LRBP, MK" ENSG00000110921 "Mevalonate kinase" Q03426 12 109573255-109598117 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Kinase, Transferase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016961, HPA044110" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA016961: AB_1854220, HPA044110: " "unprognostic (3.10e-1)" "unprognostic (2.27e-2)" "unprognostic (1.85e-1)" "unprognostic (4.43e-2)" "unprognostic (3.66e-2)" "unprognostic (2.08e-2)" "unprognostic (4.30e-2)" "unprognostic (8.98e-2)" "unprognostic (1.05e-1)" "unprognostic (2.73e-2)" "unprognostic (8.23e-2)" "unprognostic (1.30e-1)" "unprognostic (6.43e-2)" "unprognostic (2.09e-1)" "unprognostic (1.58e-1)" "unprognostic (3.88e-1)" "unprognostic (3.28e-1)" 4.7 14.3 6.8 5.9 11.7 6.8 11.2 6.3 13.1 7.1 7.8 16.7 5.1 11.5 4.2 9.5 23.0 5.1 5.3 6.7 7.8 9.0 16.5 33.1 8.7 4.9 12.5 8.3 8.5 9.3 7.0 6.5 5.5 22.5 9.0 6.3 6.4 8.1 5.8 6.3 19.5 6.9 3.7 18.0 3.8 6.1 17.5 10.5 2.8 11.9 8.5 8.8 5.5 9.9 11.5 7.4 3.4 5.9 8.3 12.2 5.4 12.3 10.4 12.7 6.3 4.1 10.1 6.8 4.5 8.4 11.8 12.9 15.0 15.1 8.7 3.5 4.5 15.1 13.5 21.2 5.7 8.5 9.6 4.6 7.1 22.4 12.7 4.9 5.9 11.0 17.9 21.4 5.8 8.0 8.0 8.3 5.3 15.6 5.0 15.7 10.7 16.1 4.6 9.7 17.0 27.2 18.4 11.8 10.2 8.8 25.1 6.2 23.1 8.6 7.0 5.4 7.1 5.2 5.7 7.0 9.2 12.8 6.5 12.7 7.4 0.7 5.9 3.4 12.2 5.8 9.9 8.4 7.4 11.6 7.4 11.5 11.7 8.3 1.7 8.3 3.7 6.2 6.2 5.4 6.8 11.7 6.3 13.1 7.8 9.0 12.5 8.3 22.5 10.5 MYBBP1A "FLJ37886, P160, PAP2, Pol5" ENSG00000132382 "MYB binding protein 1a" Q9BQG0 17 4538897-4555631 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005466 Supported Supported Nucleoli,Vesicles Nucleoli Vesicles "HPA005466: AB_2667327" "unprognostic (8.06e-2)" "unprognostic (2.33e-1)" "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (7.81e-2)" "unprognostic (1.29e-1)" "unprognostic (1.57e-3)" "unprognostic (2.22e-1)" "prognostic unfavourable (8.47e-4)" "unprognostic (1.84e-1)" "prognostic favourable (1.61e-4)" "unprognostic (3.88e-3)" "prognostic unfavourable (5.95e-4)" "unprognostic (1.78e-1)" "unprognostic (1.32e-1)" "prognostic unfavourable (8.12e-4)" "unprognostic (9.70e-2)" 14.1 11.6 13.8 16.5 14.6 13.2 16.2 15.0 21.5 11.3 10.2 14.9 11.1 12.9 15.4 11.7 17.1 15.8 12.4 11.5 11.7 9.2 8.7 21.5 11.6 16.0 15.2 11.1 15.3 23.7 10.5 13.1 7.2 13.0 17.0 7.2 12.7 24.5 15.3 30.8 25.0 12.8 10.9 7.3 15.0 12.9 9.3 12.6 14.6 11.7 18.2 17.6 15.4 13.2 5.3 4.9 0.4 4.9 4.3 5.9 3.8 19.4 31.2 4.1 18.8 5.3 6.2 14.0 13.5 6.0 13.7 10.6 23.0 8.0 26.6 15.8 8.0 24.7 17.0 20.4 6.4 13.3 45.8 12.8 19.3 20.3 8.5 15.0 11.7 9.0 11.7 20.1 10.0 9.1 20.9 12.3 5.8 16.9 17.5 5.9 18.8 16.3 22.7 6.9 17.6 3.2 15.7 8.7 16.7 13.8 9.7 9.1 9.3 6.1 11.7 11.9 10.7 11.1 38.7 11.1 7.5 10.8 11.3 17.6 15.2 0.0 2.8 0.4 5.1 2.7 5.9 5.3 4.2 5.5 4.9 3.3 4.5 4.6 0.1 4.3 4.9 3.5 1.8 3.8 13.8 14.6 15.0 21.5 11.7 9.2 15.2 11.1 13.0 12.6 MYCBP2 "FLJ10106, KIAA0916, PAM" ENSG00000005810 "MYC binding protein 2, E3 ubiquitin protein ligase" O75592 13 77044655-77327050 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Guanine-nucleotide releasing factor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058807 Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA058807: " "unprognostic (1.79e-1)" "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-2)" "unprognostic (8.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-1)" "unprognostic (1.48e-1)" "unprognostic (6.42e-2)" "prognostic favourable (5.01e-5)" "unprognostic (2.63e-1)" "unprognostic (9.84e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" 28.0 13.4 31.0 26.1 28.8 24.1 22.4 31.3 32.7 15.5 10.9 8.1 11.5 8.0 16.2 26.7 18.9 11.7 11.1 13.5 24.1 18.6 12.3 13.2 12.4 29.8 15.3 31.1 22.8 12.6 14.5 17.2 9.6 20.0 17.9 11.5 9.6 12.9 12.4 13.7 57.6 13.6 13.2 14.0 24.1 10.3 14.1 16.2 18.6 11.6 12.6 30.7 13.3 34.0 8.3 4.6 3.3 3.7 4.2 7.3 2.5 7.7 3.9 4.8 5.2 24.0 10.7 2.8 4.9 7.3 4.3 5.5 3.5 4.0 22.1 3.1 9.6 7.1 8.2 9.0 5.8 8.7 8.2 18.7 8.0 7.2 8.2 39.2 6.6 12.0 7.5 3.9 7.9 9.7 3.9 7.0 7.6 4.6 10.7 26.5 2.5 5.0 12.2 4.9 5.3 7.2 7.7 7.5 3.5 5.9 8.6 4.4 3.2 30.1 12.8 4.1 3.4 2.7 4.7 7.6 5.2 15.7 8.3 32.3 4.1 2.0 3.5 3.2 5.8 3.7 5.1 7.9 6.5 5.0 3.2 8.3 7.3 5.8 3.3 4.2 2.5 4.6 7.3 2.5 31.0 28.8 31.3 32.7 24.1 18.6 15.3 31.1 20.0 16.2 MYCBPAP "AMAP-1, DKFZp434N1415" ENSG00000136449 "MYCBP associated protein" Q8TBZ2 17 50508384-50531501 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 81.2" "Cell line enhanced" "Detected in many" "HDLM-2: 7.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023257, HPA024405" Enhanced Approved Vesicles Vesicles "HPA023257: , HPA024405: " "unprognostic (2.05e-2)" "unprognostic (1.79e-2)" "unprognostic (9.13e-3)" "unprognostic (3.98e-5)" "unprognostic (8.62e-4)" "unprognostic (3.65e-2)" "unprognostic (1.52e-3)" "unprognostic (1.61e-1)" "unprognostic (2.38e-3)" "unprognostic (1.11e-1)" "unprognostic (7.32e-4)" "unprognostic (2.52e-1)" "unprognostic (1.39e-4)" "unprognostic (7.15e-2)" "unprognostic (1.97e-1)" "unprognostic (7.37e-2)" "unprognostic (2.02e-2)" 0.5 0.6 1.1 0.4 1.6 0.9 0.4 1.3 1.4 0.9 0.4 1.6 0.8 0.1 1.3 2.2 0.6 3.5 1.0 0.4 1.2 0.8 0.4 0.2 1.1 0.6 0.4 0.9 1.9 0.2 0.4 0.7 0.2 3.5 0.8 0.2 0.6 0.7 1.2 0.6 0.8 0.3 0.7 0.9 0.5 0.3 81.2 0.4 0.3 0.6 0.0 0.4 0.4 0.5 0.3 0.2 2.8 0.4 1.0 1.0 0.3 0.3 1.5 0.8 0.6 2.0 1.3 1.5 0.7 0.4 0.5 0.7 1.4 3.4 0.5 0.2 0.4 0.9 0.4 2.4 0.4 7.8 0.7 2.7 2.6 0.8 1.8 0.1 0.7 2.8 0.6 1.3 4.2 1.5 0.9 0.8 1.6 0.9 0.3 0.7 0.2 1.2 0.4 0.7 0.4 0.1 0.9 1.5 3.5 0.9 0.5 0.6 0.8 1.6 4.3 0.9 1.3 0.3 0.3 4.8 1.6 0.4 1.1 0.5 2.4 1.2 0.4 0.7 0.3 0.3 0.4 0.1 0.4 0.3 0.1 0.3 0.9 0.4 2.8 1.0 0.1 0.2 1.0 0.3 1.1 1.6 1.3 1.4 1.2 0.8 0.4 0.9 3.5 0.4 MYCT1 "FLJ21269, MTLC" ENSG00000120279 "MYC target 1" Q8N699 6 152697895-152724567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 45.9;TIME: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 39 "eosinophil: 20.4" "Lineage enriched" "Detected in single" 190 "granulocytes: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047992 Supported Nucleoplasm,Vesicles 69000 Nucleoplasm Vesicles "HPA047992: " "unprognostic (2.92e-1)" "unprognostic (1.82e-1)" "unprognostic (5.95e-2)" "unprognostic (2.06e-1)" "unprognostic (6.73e-2)" "unprognostic (6.80e-2)" "unprognostic (4.64e-3)" "unprognostic (6.78e-2)" "unprognostic (9.90e-2)" "unprognostic (2.10e-1)" "unprognostic (2.66e-2)" "unprognostic (2.18e-2)" "prognostic unfavourable (4.73e-4)" "unprognostic (1.26e-3)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (3.36e-2)" 37.3 3.1 4.1 4.4 6.3 1.1 27.5 3.0 7.7 16.2 8.4 1.5 5.2 3.1 14.5 9.4 14.4 6.8 9.1 17.2 5.1 4.2 6.9 11.1 24.1 4.9 5.8 1.9 8.2 2.5 3.4 2.7 17.4 6.6 8.8 5.3 8.3 4.0 3.7 14.2 4.8 5.5 10.8 5.4 39.4 4.6 7.7 5.2 0.6 12.5 11.0 2.8 17.0 12.3 0.1 0.0 20.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 45.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.2 0.2 0.5 0.0 0.4 0.0 5.7 0.0 0.0 0.0 0.4 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 4.1 6.3 3.0 7.7 5.1 4.2 5.8 1.9 6.6 5.2 MYD88 ENSG00000172936 "Myeloid differentiation primary response 88" Q99836 3 38138478-38143022 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 68.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009104 Approved Supported Vesicles,Mitochondria,Cytosol Cytosol "Vesicles, Mitochondria" "CAB009104: AB_2146724" "prognostic favourable (8.45e-4)" "unprognostic (1.19e-1)" "unprognostic (4.31e-2)" "unprognostic (2.51e-2)" "unprognostic (4.77e-2)" "unprognostic (4.38e-3)" "unprognostic (4.37e-2)" "unprognostic (3.63e-1)" "unprognostic (1.67e-1)" "unprognostic (7.28e-2)" "unprognostic (1.01e-2)" "unprognostic (7.30e-2)" "unprognostic (2.11e-2)" "unprognostic (4.41e-1)" "unprognostic (4.17e-2)" "unprognostic (1.65e-1)" "unprognostic (2.08e-2)" 25.0 11.3 5.9 19.5 6.9 18.1 14.7 5.2 4.6 10.0 13.4 5.8 5.0 15.1 9.5 12.3 25.5 9.8 12.4 10.4 5.3 3.2 15.1 47.9 25.6 40.1 6.2 3.5 13.3 10.3 5.4 10.4 17.8 6.7 11.3 14.3 8.8 13.9 5.4 3.9 12.5 30.4 10.7 7.0 39.0 12.5 5.8 5.1 28.5 10.4 17.5 30.8 13.9 13.7 7.8 34.7 49.0 68.0 8.3 14.3 34.6 8.1 12.0 1.8 10.7 8.5 11.1 3.7 8.0 13.1 22.6 24.0 7.5 9.9 17.4 4.8 14.3 10.2 14.2 8.0 7.6 13.5 2.9 9.4 6.1 11.4 7.0 11.9 24.6 12.7 8.5 12.8 4.8 12.8 4.1 7.1 11.8 8.2 19.6 3.8 7.6 12.0 8.5 2.3 7.5 11.6 19.0 0.8 3.9 11.3 54.5 7.1 8.5 13.5 11.9 4.4 2.7 20.4 7.6 10.5 11.7 12.9 8.6 20.9 9.6 38.3 37.6 48.1 12.2 56.5 10.4 7.8 11.0 12.2 34.7 6.7 7.7 10.9 49.0 8.3 68.0 16.6 14.3 34.6 5.9 6.9 5.2 4.6 5.3 3.2 6.2 3.5 6.7 5.1 MYEOV OCIM ENSG00000172927 "Myeloma overexpressed" Q96EZ4 11 69294138-69367726 "Predicted membrane proteins" Proto-oncogene "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.4;breast: 16.9;esophagus: 17.3" "Cell line enhanced" "Detected in some" "A-431: 57.8;A549: 27.8;CAPAN-2: 8.5;U-2 OS: 12.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" HPA012949 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA012949: AB_1854241" "unprognostic (1.42e-2)" "unprognostic (8.56e-2)" "unprognostic (7.07e-2)" "unprognostic (3.36e-1)" "unprognostic (5.60e-2)" "unprognostic (7.28e-3)" "unprognostic (7.58e-3)" "prognostic unfavourable (2.00e-4)" "unprognostic (3.49e-1)" "unprognostic (6.33e-2)" "prognostic unfavourable (1.54e-7)" "unprognostic (2.83e-1)" "prognostic unfavourable (1.48e-5)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (3.35e-1)" "unprognostic (3.69e-2)" 29.4 0.2 0.0 2.4 0.0 0.2 16.9 0.1 0.0 2.6 1.1 0.0 0.4 0.4 0.5 8.1 17.3 0.0 1.3 0.1 0.0 0.2 0.2 8.6 0.1 0.2 0.0 0.1 0.1 2.1 0.0 0.1 0.0 0.0 0.1 0.6 0.9 2.0 0.0 0.6 4.9 0.8 0.1 0.0 0.3 10.7 0.4 0.0 0.1 0.1 5.3 13.6 0.2 4.7 0.5 0.0 0.0 0.1 1.0 0.3 2.1 57.8 27.8 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 8.5 0.2 2.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.7 0.8 0.0 0.0 1.2 0.0 0.0 0.0 2.2 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 1.0 0.1 0.8 0.0 12.8 0.0 0.6 0.1 0.6 0.1 0.0 0.2 1.1 0.0 0.1 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 MYL6B MLC1SA ENSG00000196465 "Myosin light chain 6B" P14649 12 56152256-56159647 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.6" "Group enriched" "Detected in all" 5 "B-cells: 5.3;dendritic cells: 15.6;T-cells: 12.0" "Low region specificity" "Detected in all" "HPA038887, HPA046859, HPA063034" Enhanced Approved Vesicles Vesicles "HPA038887: AB_10674842, HPA046859: , HPA063034: " "unprognostic (5.25e-2)" "unprognostic (3.18e-1)" "unprognostic (6.29e-3)" "unprognostic (7.39e-2)" "unprognostic (5.37e-1)" "unprognostic (1.55e-1)" "prognostic unfavourable (2.87e-4)" "unprognostic (4.66e-2)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (1.02e-3)" "unprognostic (3.48e-1)" "unprognostic (1.53e-1)" "unprognostic (3.56e-3)" "unprognostic (3.42e-2)" "unprognostic (3.00e-1)" "unprognostic (3.83e-2)" 5.6 10.0 32.0 4.8 33.1 5.4 8.7 11.9 26.7 13.9 4.1 8.0 8.5 3.0 9.8 12.8 8.4 13.2 9.7 13.6 24.1 21.8 9.3 6.2 4.5 6.9 20.7 21.6 20.0 4.8 17.4 14.1 5.1 13.4 12.6 4.0 11.0 7.3 8.3 129.0 5.1 4.1 8.4 10.7 3.9 5.1 24.9 10.2 11.5 9.9 10.7 8.8 5.6 5.0 5.3 15.6 1.8 2.3 2.0 12.0 3.1 8.2 14.1 38.4 36.6 8.1 29.3 26.8 9.6 42.5 38.3 37.4 10.1 13.7 13.7 21.3 20.6 4.7 18.0 23.4 20.7 24.8 26.1 14.4 14.5 17.7 25.8 10.5 10.1 49.0 9.4 35.4 13.8 41.4 15.2 14.2 31.4 10.7 28.7 34.9 32.2 24.4 30.4 23.8 18.1 29.1 5.5 35.4 51.9 10.7 13.0 19.3 10.7 18.0 22.9 22.5 19.4 11.6 20.5 20.2 11.5 11.4 24.1 10.7 24.6 0.7 2.3 0.7 1.8 2.2 1.0 5.3 3.7 3.0 5.4 3.5 2.7 2.2 1.8 2.0 0.9 15.6 12.0 3.1 32.0 33.1 11.9 26.7 24.1 21.8 20.7 21.6 13.4 10.2 MYLK3 "caMLCK, MLCK" ENSG00000140795 "Myosin light chain kinase 3" Q32MK0 16 46703369-46790407 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1" "Cell line enhanced" "Detected in some" "BEWO: 9.5;HEL: 28.5;K-562: 4.4;SK-BR-3: 6.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "cerebral cortex: 9.8;hippocampal formation: 5.7" "Region enriched" "Detected in some" 5 "hippocampal formation: 5.2" HPA073447 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA073447: " "unprognostic (6.01e-4)" "unprognostic (2.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.77e-2)" "unprognostic (1.84e-1)" "unprognostic (2.94e-3)" "unprognostic (2.60e-1)" "unprognostic (4.73e-2)" "unprognostic (3.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.58e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-2)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.97e-1)" 0.0 0.1 0.7 0.0 1.7 0.1 0.0 0.1 0.2 0.2 0.0 3.8 0.0 0.0 0.1 3.4 2.0 0.8 0.1 62.2 1.5 1.4 0.4 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.2 6.6 1.0 0.0 0.0 1.3 0.0 20.8 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.3 0.0 0.1 31.1 1.1 0.1 0.0 1.2 0.9 2.6 0.7 1.2 0.7 0.2 0.0 0.1 0.1 0.1 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 1.5 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.0 6.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.0 2.5 0.7 0.6 0.6 0.4 0.4 0.7 0.5 0.5 0.3 1.2 0.7 0.7 2.6 1.2 0.5 0.9 0.3 0.2 0.7 1.7 0.1 0.2 1.5 1.4 0.1 0.4 6.6 0.3 MYLK4 SgK085 ENSG00000145949 "Myosin light chain kinase family member 4" Q86YV6 6 2663629-2750966 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 23.6;tongue: 63.6" "Cell line enriched" "Detected in some" 6 "HEL: 12.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA015860 Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoli, Vesicles" "HPA015860: AB_2147922" "unprognostic (1.75e-1)" "unprognostic (2.04e-1)" "unprognostic (1.87e-1)" "unprognostic (5.22e-3)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (7.48e-2)" "unprognostic (2.80e-1)" "unprognostic (5.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.91e-1)" "unprognostic (2.74e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-1)" "unprognostic (1.19e-2)" "unprognostic (4.63e-2)" 0.5 0.3 0.3 0.3 0.4 0.4 0.8 1.4 0.7 0.3 0.3 0.3 0.3 0.1 0.3 0.5 1.0 0.2 0.3 1.0 0.5 0.5 2.6 0.3 0.5 0.3 0.4 0.3 0.3 1.1 0.7 0.7 0.4 0.4 0.4 0.1 0.4 2.4 0.4 23.6 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.0 63.6 1.5 0.5 0.3 0.1 0.8 0.3 0.3 0.9 1.4 0.1 0.3 0.1 0.6 1.1 1.0 1.2 0.6 0.7 1.5 0.5 0.4 0.5 1.0 1.0 1.6 0.8 1.9 0.2 0.4 0.7 0.2 0.6 12.4 0.6 0.1 0.3 0.3 0.6 1.5 0.5 0.1 1.2 0.5 0.1 0.1 0.3 0.5 0.1 1.3 0.2 0.0 0.9 0.0 0.0 0.8 0.3 1.0 0.6 0.3 0.2 0.5 0.4 0.8 0.7 0.5 0.1 0.2 0.4 0.4 0.2 0.1 0.2 0.3 1.2 0.1 0.1 0.1 0.5 0.0 0.3 0.1 0.2 1.4 0.2 0.1 0.6 0.1 0.3 0.9 0.3 0.8 0.1 0.1 0.3 0.4 1.4 0.7 0.5 0.5 0.4 0.3 0.4 0.3 MYMX MINION ENSG00000262179 "Myomixer, myoblast fusion factor" A0A1B0GTQ4 6 44216939-44218236 "Predicted intracellular proteins" Myogenesis "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "adipose tissue: 27.4;blood: 12.2;pancreas: 9.0" "Cell line enriched" "Detected in some" 31 "RH-30: 55.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Cell type enriched" "Detected in single" 115 "plasmacytoid DC: 12.2" "Lineage enriched" "Detected in single" 121 "dendritic cells: 12.2" "Not detected" "Not detected" HPA051451 Approved Approved Vesicles,Mitochondria,Cytosol Vesicles "Mitochondria, Cytosol" "HPA051451: " "unprognostic (1.24e-1)" "unprognostic (8.55e-2)" "unprognostic (6.86e-2)" "unprognostic (6.51e-3)" "unprognostic (2.78e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-2)" "unprognostic (2.10e-3)" "unprognostic (4.32e-1)" "unprognostic (1.77e-1)" "unprognostic (8.71e-2)" "unprognostic (2.70e-2)" "unprognostic (2.01e-4)" "unprognostic (1.63e-2)" "unprognostic (1.33e-2)" "unprognostic (1.77e-2)" "unprognostic (2.67e-1)" 27.4 0.0 0.0 1.0 0.0 0.0 2.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.8 0.0 1.1 0.0 0.5 1.4 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 1.7 0.0 2.2 0.0 0.1 0.0 0.0 1.8 3.2 0.6 0.0 2.8 0.4 0.0 0.4 0.5 0.0 0.0 12.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 55.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 12.2 0.0 0.1 MYO16 "KIAA0865, Myo16b, MYR8, NYAP3, PPP1R107" ENSG00000041515 "Myosin XVI" Q9Y6X6 13 108596152-109208007 "Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell line enhanced" "Detected in some" "AF22: 1.5;SH-SY5Y: 6.5;U-2197: 3.9" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 10 "T-cells: 1.3" "Group enriched" "Detected in all" 4 "basal ganglia: 21.9;olfactory region: 88.9" "Low region specificity" "Detected in all" "HPA040110, HPA058769, HPA071948" Uncertain Approved Vesicles Vesicles "HPA040110: AB_10796339, HPA058769: , HPA071948: " "unprognostic (7.55e-3)" "unprognostic (7.74e-3)" "unprognostic (4.52e-4)" "unprognostic (5.12e-3)" "unprognostic (1.38e-1)" "unprognostic (5.81e-2)" "unprognostic (1.20e-2)" "unprognostic (2.16e-1)" "unprognostic (2.53e-1)" "unprognostic (6.50e-2)" "unprognostic (9.01e-3)" "unprognostic (5.29e-2)" "unprognostic (4.68e-4)" "unprognostic (4.26e-2)" "unprognostic (3.21e-2)" "unprognostic (7.06e-2)" "unprognostic (2.34e-2)" 3.4 2.2 4.0 0.9 3.7 0.4 0.8 2.4 9.2 0.9 0.6 1.5 0.0 0.6 0.5 0.5 1.0 0.5 0.5 2.4 7.5 3.2 0.6 4.8 0.8 0.9 1.8 4.5 0.5 0.7 0.3 5.7 0.6 5.7 1.1 0.6 0.7 0.6 2.0 0.4 0.7 0.5 1.4 5.1 0.5 0.6 3.0 0.0 0.0 0.5 0.0 1.1 0.5 1.2 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.9 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 3.7 2.4 9.2 7.5 3.2 1.8 4.5 5.7 0.0 MYOF "FER1L3, KIAA1207" ENSG00000138119 Myoferlin Q9NZM1 10 93306429-93482317 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 15.9;non-classical monocyte: 18.0" "Group enriched" "Detected in many" 65 "dendritic cells: 6.2;monocytes: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014245 Enhanced Supported "Vesicles,Plasma membrane" 14000 Vesicles "Plasma membrane" "HPA014245: AB_1848495" "unprognostic (3.41e-2)" "unprognostic (3.85e-1)" "unprognostic (2.88e-2)" "unprognostic (7.44e-2)" "unprognostic (3.50e-2)" "unprognostic (8.57e-3)" "unprognostic (3.48e-2)" "unprognostic (7.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "prognostic unfavourable (1.40e-4)" "unprognostic (1.55e-1)" "unprognostic (5.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.94e-2)" "unprognostic (9.17e-2)" "unprognostic (9.18e-2)" 27.5 7.3 2.1 8.9 4.1 0.2 21.7 1.3 2.7 27.0 12.3 5.1 16.0 2.0 27.2 17.7 27.2 16.2 11.4 7.2 3.5 2.1 12.2 1.7 18.7 7.5 5.8 2.5 12.7 3.3 16.1 4.2 31.9 15.0 20.7 12.8 10.1 14.9 17.4 5.7 22.4 6.8 49.0 9.4 10.0 8.8 5.7 4.4 1.5 15.7 14.2 9.4 35.0 20.0 0.0 6.2 0.1 18.0 0.0 0.1 1.1 35.7 33.8 3.6 2.3 25.3 56.3 10.2 31.5 75.3 19.2 19.0 8.2 28.1 0.0 12.6 57.5 54.7 0.2 32.2 14.2 0.2 0.1 0.0 13.2 0.3 8.8 0.0 0.0 29.6 11.2 12.9 53.0 49.7 0.0 0.0 45.1 5.7 0.0 0.1 0.2 30.2 0.0 2.6 0.0 49.8 44.7 0.0 0.0 21.5 4.5 7.9 22.4 0.7 62.1 28.3 1.9 18.6 18.3 0.0 0.0 0.0 20.9 0.4 33.3 0.0 4.3 0.0 0.0 15.9 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.1 0.0 18.0 2.1 0.1 1.1 2.1 4.1 1.3 2.7 3.5 2.1 5.8 2.5 15.0 4.4 MYOM3 FLJ35961 ENSG00000142661 "Myomesin 3" Q5VTT5 1 24056035-24112175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "heart muscle: 59.5;skeletal muscle: 104.6;tongue: 39.7" "Group enriched" "Detected in some" 6 "A549: 5.0;Hep G2: 19.3" "Cancer enhanced" "Detected in some" "renal cancer: 6.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028132, HPA028340" Approved "Golgi apparatus,Vesicles,Cytokinetic bridge" 680000 Vesicles "Golgi apparatus, Cytokinetic bridge" "HPA028132: AB_10599293, HPA028340: " "unprognostic (8.59e-2)" "unprognostic (2.85e-2)" "unprognostic (2.39e-1)" "unprognostic (8.60e-3)" "unprognostic (1.52e-2)" "unprognostic (7.31e-2)" "unprognostic (3.00e-2)" "unprognostic (1.40e-2)" "unprognostic (4.66e-1)" "unprognostic (2.21e-1)" "unprognostic (2.73e-4)" "unprognostic (2.09e-1)" "prognostic favourable (4.28e-6)" "unprognostic (2.77e-2)" "unprognostic (1.60e-3)" "unprognostic (7.75e-2)" "unprognostic (1.68e-1)" 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 6.3 2.7 0.2 0.0 59.5 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 2.7 0.0 104.6 0.4 1.5 0.0 0.0 0.0 0.0 1.9 0.1 0.0 2.7 39.7 2.8 0.2 0.1 0.8 0.4 2.3 0.4 0.2 0.4 0.0 0.1 5.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 1.5 0.0 2.1 0.6 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.8 19.3 0.0 0.1 0.1 0.6 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.1 1.1 0.2 0.6 0.7 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.8 0.4 0.1 0.3 0.4 0.1 0.4 0.2 0.2 0.0 0.8 0.3 0.4 2.3 0.2 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 MYPN MYOP ENSG00000138347 Myopalladin Q86TC9 10 68106117-68212017 "Disease related genes, Predicted intracellular proteins" Actin-binding "Cardiomyopathy, Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3" "Cell line enhanced" "Detected in some" "BJ: 16.3;fHDF/TERT166: 45.8;HBF TERT88: 10.8;LHCN-M2: 19.7" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 0.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 3.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA036299, HPA061494" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA036299: , HPA061494: " "unprognostic (4.75e-2)" "unprognostic (2.20e-1)" "unprognostic (8.14e-3)" "unprognostic (8.62e-3)" "unprognostic (3.91e-1)" "unprognostic (3.36e-3)" "unprognostic (4.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "unprognostic (2.26e-3)" "unprognostic (3.94e-3)" "unprognostic (3.10e-1)" "unprognostic (2.88e-8)" "unprognostic (4.63e-5)" "unprognostic (9.94e-2)" "unprognostic (2.01e-1)" "unprognostic (3.47e-1)" 4.5 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.1 0.0 0.0 23.6 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.5 0.0 0.1 2.1 0.0 114.9 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.9 46.3 3.4 0.0 0.0 0.3 0.1 3.8 0.1 0.2 0.1 0.0 1.1 0.5 0.0 0.0 0.3 1.7 0.0 16.3 8.2 6.1 2.3 0.0 0.0 0.0 0.0 45.8 0.3 0.0 0.1 10.8 0.1 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.8 0.0 3.3 0.3 0.1 0.0 0.1 19.7 3.4 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.3 0.4 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.0 0.0 0.0 1.9 0.0 1.7 3.8 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.1 0.9 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 0.2 0.0 MYT1L "KIAA1106, NZF1, ZC2H2C2, ZC2HC4B" ENSG00000186487 "Myelin transcription factor 1 like" Q9UL68 2 1789113-2331348 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Autism spectrum disorder, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.2" "Group enriched" "Detected in some" 9 "SCLC-21H: 11.0;SH-SY5Y: 8.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.3;naive CD8 T-cell: 1.6" "Group enriched" "Detected in many" 8 "granulocytes: 2.3;T-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060245 Approved Vesicles Vesicles "HPA060245: " "unprognostic (9.90e-3)" "unprognostic (3.74e-1)" "unprognostic (1.30e-1)" "unprognostic (9.61e-3)" "unprognostic (7.17e-2)" "unprognostic (3.73e-2)" "unprognostic (2.44e-1)" "unprognostic (2.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.93e-2)" "unprognostic (2.46e-1)" "unprognostic (7.96e-2)" "unprognostic (1.21e-2)" "unprognostic (1.04e-2)" 1.2 3.4 11.0 1.4 20.0 1.1 1.1 19.5 50.2 1.1 1.2 0.5 0.0 1.1 1.2 1.1 1.3 1.1 1.1 1.1 15.6 10.3 1.1 1.1 1.1 1.2 5.1 14.5 1.1 1.5 1.0 10.7 1.1 6.8 1.3 1.3 0.4 1.1 1.1 1.1 1.1 1.2 1.1 1.5 1.0 1.1 4.6 2.0 0.0 1.1 0.0 1.1 1.1 0.0 0.0 0.2 2.3 0.0 0.0 1.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.6 0.1 0.0 0.0 11.0 8.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.2 0.0 0.6 11.0 20.0 19.5 26.7 15.6 10.3 5.1 14.5 6.8 2.0 NAA35 "bA379P1.1, FLJ21613, FLJ22643, MAK10" ENSG00000135040 "N(alpha)-acetyltransferase 35, NatC auxiliary subunit" Q5VZE5 9 85941146-86022298 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021547, HPA051586" Approved Supported Vesicles Vesicles "HPA021547: AB_1853505, HPA051586: " "unprognostic (5.87e-2)" "unprognostic (2.41e-1)" "unprognostic (4.71e-3)" "unprognostic (9.25e-3)" "unprognostic (2.37e-2)" "unprognostic (6.39e-2)" "prognostic unfavourable (1.16e-7)" "unprognostic (1.86e-1)" "unprognostic (5.22e-3)" "unprognostic (1.56e-1)" "unprognostic (8.30e-2)" "unprognostic (1.09e-1)" "unprognostic (2.36e-3)" "unprognostic (1.88e-1)" "unprognostic (4.34e-2)" "unprognostic (9.18e-2)" "unprognostic (1.07e-2)" 11.3 19.5 15.2 16.4 14.6 9.7 17.1 20.1 17.6 13.4 16.5 12.5 22.9 14.9 20.5 21.0 16.8 13.5 14.4 14.2 16.6 14.0 16.0 14.3 10.8 10.2 14.6 16.2 16.2 16.4 19.1 25.5 16.9 14.4 17.4 19.5 13.0 16.3 20.0 28.7 13.4 17.4 16.4 14.1 10.3 13.4 25.7 15.1 10.0 19.8 15.8 12.7 14.4 13.5 12.2 5.8 8.9 4.7 5.9 9.6 4.4 23.0 16.0 16.1 12.5 9.4 11.4 25.2 14.6 14.3 16.3 13.9 11.0 15.9 7.8 8.6 14.8 32.3 14.6 17.1 17.5 19.6 10.6 17.2 17.5 15.1 17.6 26.3 15.7 11.7 14.9 17.4 25.9 15.3 21.1 15.4 15.4 15.9 14.7 15.3 16.1 16.5 12.6 22.8 12.2 17.8 21.0 14.6 13.0 16.6 14.7 12.8 11.8 11.2 12.1 10.6 13.2 17.5 13.4 20.6 25.2 5.4 13.4 11.4 10.7 2.0 4.6 8.9 7.0 4.7 9.3 12.2 7.7 6.5 5.8 12.2 9.6 7.7 2.1 5.9 3.2 3.8 6.4 4.4 15.2 14.6 20.1 17.6 16.6 14.0 14.6 16.2 14.4 15.1 NACC1 "BEND8, BTBD14B, BTBD30, NAC-1, NAC1" ENSG00000160877 "Nucleus accumbens associated 1" Q96RE7 19 13118103-13141141 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021238, HPA062245, CAB069927" Enhanced Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: " "unprognostic (2.19e-1)" "unprognostic (9.20e-3)" "unprognostic (2.67e-2)" "unprognostic (2.84e-2)" "unprognostic (2.62e-1)" "unprognostic (7.75e-2)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.93e-1)" "unprognostic (8.46e-2)" "unprognostic (2.40e-2)" "unprognostic (3.04e-2)" "unprognostic (7.35e-2)" "unprognostic (2.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.74e-2)" 12.5 13.7 27.2 18.2 22.3 10.0 6.7 19.8 38.7 10.8 16.6 20.1 11.7 16.6 12.8 10.0 17.9 10.5 9.4 13.2 23.6 14.2 10.8 15.6 11.3 14.9 17.1 14.2 7.8 16.8 10.5 10.6 15.4 16.0 11.9 8.4 7.8 15.3 15.6 17.6 10.9 18.3 9.2 17.2 15.2 16.1 18.8 15.4 10.7 9.8 9.6 9.9 13.2 7.9 0.7 0.9 1.8 0.8 0.6 1.3 0.5 27.9 34.0 7.9 17.6 4.5 5.6 21.6 13.7 10.3 13.3 10.4 34.3 12.0 14.0 30.8 11.4 14.0 10.2 25.0 4.9 24.8 16.2 8.9 27.8 24.0 10.7 14.0 25.2 8.5 8.3 13.0 7.1 15.1 19.5 5.6 6.5 57.8 22.5 11.1 35.3 31.5 13.9 9.1 14.0 8.1 30.7 17.2 10.8 13.3 19.6 12.1 17.4 12.9 21.5 28.3 17.7 20.8 24.1 15.5 24.2 11.6 30.3 14.1 17.6 0.1 0.5 0.0 0.8 0.8 0.6 0.7 1.3 0.8 0.9 0.4 0.4 0.7 1.8 0.6 0.6 0.8 0.2 0.5 27.2 22.3 19.8 38.7 23.6 14.2 17.1 14.2 16.0 15.4 NADK FLJ13052 ENSG00000008130 "NAD kinase" O95544 1 1751232-1780457 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 80.4" "Group enriched" "Detected in many" 7 "granulocytes: 80.4;monocytes: 24.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048909, HPA053368" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA048909: , HPA053368: " "unprognostic (1.29e-1)" "unprognostic (4.29e-1)" "unprognostic (7.07e-2)" "unprognostic (6.82e-2)" "unprognostic (1.98e-1)" "unprognostic (1.58e-2)" "unprognostic (3.32e-1)" "unprognostic (9.03e-2)" "unprognostic (7.81e-2)" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (4.54e-3)" "unprognostic (1.40e-1)" "unprognostic (5.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.16e-1)" 24.7 34.3 11.1 19.0 11.9 49.0 25.5 9.9 12.6 12.4 18.2 10.8 14.1 20.3 13.9 14.5 12.5 14.3 17.1 11.9 9.9 7.9 12.7 52.3 17.5 27.0 15.8 8.6 16.9 32.2 8.3 11.9 22.5 10.3 13.7 14.1 13.9 21.4 14.5 10.6 11.7 19.4 14.4 8.3 39.4 22.1 17.3 9.6 10.8 14.0 12.0 19.2 13.7 28.3 1.8 7.2 80.4 24.7 0.5 1.4 10.4 15.1 14.6 13.1 19.2 18.7 13.6 16.9 15.3 13.4 17.5 15.6 15.6 27.9 20.1 11.7 11.3 12.9 14.0 12.1 7.8 19.5 22.3 16.4 22.9 26.9 18.1 23.0 27.7 15.9 11.0 10.8 15.5 16.9 20.1 28.8 13.0 17.4 17.3 20.0 8.9 16.6 22.1 11.2 41.1 15.1 12.6 17.7 13.5 17.1 37.7 15.7 13.0 16.1 16.3 12.8 9.2 13.1 13.7 25.7 11.6 45.0 12.6 25.6 6.6 11.8 21.1 49.5 1.2 24.7 1.4 1.8 0.7 0.9 7.2 1.7 0.5 0.7 80.4 0.5 23.8 5.9 1.0 10.4 11.1 11.9 9.9 12.6 9.9 7.9 15.8 8.6 10.3 9.6 NADSYN1 FLJ10631 ENSG00000172890 "NAD synthetase 1" Q6IA69 11 71453109-71524107 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017798, HPA038523, HPA038524" Approved Approved "Golgi apparatus,Vesicles,Cytosol" Vesicles "Golgi apparatus, Cytosol" "CAB017798: , HPA038523: , HPA038524: " "unprognostic (1.45e-1)" "unprognostic (1.29e-1)" "unprognostic (7.30e-2)" "unprognostic (2.63e-3)" "unprognostic (1.75e-1)" "unprognostic (1.60e-1)" "prognostic unfavourable (5.17e-6)" "unprognostic (1.19e-2)" "unprognostic (4.38e-2)" "unprognostic (1.41e-1)" "unprognostic (9.41e-2)" "unprognostic (1.99e-2)" "prognostic unfavourable (8.72e-5)" "unprognostic (4.12e-3)" "unprognostic (1.38e-1)" "unprognostic (1.54e-2)" "prognostic favourable (5.10e-4)" 14.5 16.9 10.8 23.2 21.2 39.6 14.0 12.2 18.5 12.4 30.6 21.9 24.1 26.3 15.0 17.5 29.1 16.4 33.1 10.6 10.4 9.5 16.5 24.8 18.1 20.5 22.7 9.2 15.6 20.6 13.5 20.2 17.1 15.6 23.9 25.3 12.9 18.0 17.2 9.8 15.0 36.8 13.6 14.6 30.7 19.2 17.4 20.0 26.4 17.3 21.7 29.8 26.1 17.1 9.5 22.3 12.8 19.7 11.9 12.6 13.1 6.1 14.9 4.8 8.8 14.6 21.4 13.3 12.1 10.9 6.3 6.9 12.7 10.5 5.4 13.7 14.1 22.1 6.3 17.2 3.3 10.9 5.1 8.8 10.0 14.2 18.3 17.6 17.0 30.3 27.1 8.1 7.4 22.1 4.5 7.6 8.9 19.3 8.6 11.5 2.9 8.7 10.8 15.3 5.3 15.5 28.6 3.6 5.2 8.6 11.3 22.0 10.0 9.6 26.6 7.0 6.0 12.7 4.6 9.8 4.2 4.6 12.3 10.1 4.8 4.5 19.7 11.8 11.7 17.4 9.9 9.5 10.5 10.6 22.3 7.4 7.0 8.8 12.8 11.9 15.1 16.7 12.6 13.1 10.8 21.2 12.2 18.5 10.4 9.5 22.7 9.2 15.6 20.0 NAP1L3 "MB20, MGC26312, NPL3" ENSG00000186310 "Nucleosome assembly protein 1 like 3" Q99457 X 93670930-93673568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.2" "Cell line enhanced" "Detected in some" "AF22: 10.2;HAP1: 9.9;NTERA-2: 18.1;RH-30: 8.0;U-2 OS: 8.3;U-2197: 12.1" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.9" "Group enriched" "Detected in many" 24 "NK-cells: 4.5;T-cells: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026075 Approved Vesicles Vesicles "HPA026075: AB_1854301" "unprognostic (7.18e-2)" "unprognostic (1.81e-2)" "unprognostic (9.26e-2)" "unprognostic (4.83e-4)" "unprognostic (3.06e-1)" "unprognostic (1.28e-2)" "unprognostic (5.10e-2)" "unprognostic (1.76e-1)" "unprognostic (3.31e-2)" "unprognostic (9.29e-2)" "unprognostic (2.75e-3)" "unprognostic (5.01e-2)" "unprognostic (2.75e-3)" "unprognostic (5.78e-3)" "unprognostic (1.19e-1)" "unprognostic (1.75e-1)" "unprognostic (5.23e-4)" 2.3 10.4 24.4 2.4 25.7 1.2 2.4 44.9 60.2 16.0 2.4 5.3 0.0 1.6 9.5 4.7 1.5 8.1 4.4 8.4 22.0 42.3 2.9 1.4 1.8 2.1 18.5 31.0 13.1 1.5 1.1 7.9 1.6 20.9 3.9 2.3 2.4 1.6 4.6 0.8 1.7 2.0 6.5 13.1 3.6 1.4 11.9 7.0 0.0 4.6 0.0 1.5 3.3 1.2 0.0 0.0 0.2 0.0 4.5 6.9 1.6 0.0 0.1 10.2 7.4 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.6 0.0 9.9 0.0 0.0 0.0 0.2 4.7 0.0 0.1 0.5 0.0 0.3 4.7 0.0 0.5 4.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 18.1 4.2 0.0 8.0 0.0 0.3 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.5 0.0 5.7 8.3 12.1 0.5 7.7 3.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 1.1 0.0 4.3 1.6 0.0 0.0 6.9 4.8 0.2 4.5 0.0 0.0 1.3 1.6 24.4 25.7 44.9 60.2 22.0 42.3 18.5 31.0 20.9 7.0 NBR1 "1A1-3B, CA125, KIAA0049, M17S2" ENSG00000188554 "NBR1, autophagy cargo receptor" Q14596 17 43170481-43211689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022944, HPA022999, HPA023999" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Vesicles "Nucleoplasm, Nuclear bodies" "HPA022944: , HPA022999: AB_1859532, HPA023999: AB_1859533" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (3.26e-2)" "unprognostic (3.28e-2)" "unprognostic (3.27e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (2.98e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "prognostic favourable (2.00e-5)" "unprognostic (1.65e-1)" "unprognostic (4.88e-2)" "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" 26.3 29.5 27.1 17.2 27.3 7.7 28.0 27.3 29.4 25.6 32.9 33.3 29.0 31.0 28.4 25.5 23.1 25.6 20.7 29.8 26.0 22.0 38.3 39.6 21.1 25.4 27.2 21.8 34.1 26.5 55.8 25.0 31.2 22.8 30.1 32.1 20.7 25.5 29.5 62.9 23.9 37.7 24.2 34.2 23.3 23.2 57.0 31.7 29.8 32.1 24.5 19.8 32.5 23.7 9.6 12.6 25.2 21.5 15.5 17.1 14.4 12.5 15.4 13.2 13.9 30.0 31.2 12.7 23.8 47.2 19.8 16.4 8.0 20.0 6.7 24.7 33.0 13.9 15.0 30.7 28.8 20.9 15.9 8.0 19.5 17.1 28.7 6.7 12.4 35.5 34.8 21.6 42.7 30.7 17.1 18.1 26.1 7.1 14.3 4.9 4.2 10.0 4.8 20.7 21.9 25.0 14.3 7.9 14.2 16.4 8.1 23.8 22.1 11.1 25.5 29.1 10.8 13.3 9.4 21.7 17.6 8.8 19.7 9.3 19.9 23.5 16.1 25.2 14.2 15.3 14.6 9.6 12.9 13.7 12.6 6.7 12.4 11.9 23.1 15.5 21.5 8.0 17.1 14.4 27.1 27.3 27.3 29.4 26.0 22.0 27.2 21.8 22.8 31.7 NDFIP2 "KIAA1165, N4wbp5a" ENSG00000102471 "Nedd4 family interacting protein 2" Q9NV92 13 79481124-79556075 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 17.3" "Group enriched" "Detected in many" 18 "granulocytes: 17.3;T-cells: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009160 Uncertain Supported Vesicles Vesicles "HPA009160: AB_1079456" "unprognostic (2.56e-1)" "unprognostic (5.51e-3)" "unprognostic (1.95e-3)" "unprognostic (9.61e-2)" "unprognostic (2.60e-1)" "prognostic unfavourable (5.99e-4)" "unprognostic (1.50e-1)" "unprognostic (5.53e-2)" "unprognostic (2.30e-1)" "unprognostic (3.12e-1)" "unprognostic (1.52e-2)" "unprognostic (2.63e-2)" "prognostic favourable (4.18e-5)" "unprognostic (1.32e-1)" "unprognostic (1.31e-1)" "unprognostic (6.47e-2)" "unprognostic (1.02e-1)" 8.0 13.0 15.3 6.7 28.4 1.2 12.8 8.7 39.6 11.8 24.0 12.0 10.5 27.9 5.8 12.9 36.4 9.4 11.1 13.9 23.6 9.6 25.2 24.7 9.5 6.4 11.6 27.3 4.8 16.9 8.8 7.5 29.7 20.4 12.8 25.8 4.8 15.8 9.3 18.2 39.4 36.1 5.0 12.7 6.1 13.7 9.4 13.8 7.3 10.7 15.7 10.7 16.8 18.8 0.3 0.1 17.3 0.0 0.6 5.0 2.1 36.0 6.2 6.5 8.2 7.9 14.7 12.3 13.3 18.6 14.1 23.6 13.5 40.5 1.5 9.2 17.5 49.4 5.6 23.4 21.4 18.7 15.8 1.6 20.6 7.3 14.5 28.4 5.0 11.6 30.9 9.4 15.0 6.7 7.3 2.8 15.8 5.2 2.3 6.4 4.7 6.3 0.1 12.9 6.7 34.6 21.1 6.6 9.4 15.1 14.7 10.5 12.2 23.9 5.6 4.5 5.8 8.7 8.9 10.7 11.6 5.6 18.6 0.1 18.2 9.7 0.0 17.3 2.6 0.0 2.2 0.2 2.4 2.1 0.0 0.3 5.0 2.8 0.1 0.6 0.0 0.1 2.4 2.1 15.3 28.4 8.7 39.6 23.6 9.6 11.6 27.3 20.4 13.8 NDNF "C4orf31, FLJ23191" ENSG00000173376 "Neuron derived neurotrophic factor" Q8TB73 4 121035613-121073021 "Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 91.6;retina: 41.0" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 22.7;U-266/70: 10.1;U-266/84: 38.7" "Cancer enhanced" "Detected in many" "lung cancer: 12.6" "Region enriched" "Detected in many" 4 "pons and medulla: 7.6" "Cell type enriched" "Detected in single" 11 "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Group enriched" "Detected in many" 4 "basal ganglia: 11.4;olfactory region: 41.7" "Low region specificity" "Detected in all" HPA048881 Supported Vesicles "Secreted in other tissues" Vesicles "HPA048881: " "unprognostic (2.84e-1)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-1)" "unprognostic (3.94e-1)" "unprognostic (6.26e-2)" "unprognostic (2.22e-1)" "unprognostic (2.93e-2)" "unprognostic (6.65e-4)" "unprognostic (2.18e-3)" "unprognostic (6.27e-2)" "unprognostic (3.44e-2)" "prognostic unfavourable (3.26e-4)" "unprognostic (2.38e-3)" "unprognostic (1.20e-1)" "unprognostic (1.18e-4)" "unprognostic (1.74e-1)" 3.8 1.3 1.2 0.4 1.0 0.0 14.2 0.6 1.5 7.2 3.5 1.2 1.7 1.3 3.1 2.2 5.7 10.0 6.9 4.9 1.2 1.5 12.5 0.5 91.6 0.1 1.8 1.2 21.3 0.6 0.4 8.2 28.0 7.6 26.1 4.0 41.0 2.1 2.2 7.5 1.8 3.9 2.6 5.5 0.4 2.2 8.0 0.8 7.0 1.6 9.0 1.4 8.9 11.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 5.1 0.0 6.8 5.6 0.1 0.1 0.2 0.1 0.2 0.7 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.5 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 6.8 0.4 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 5.6 0.0 0.1 0.2 10.1 38.7 0.0 1.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.6 1.5 1.2 1.5 1.8 1.2 7.6 0.8 NDP "EVR2, norrin" ENSG00000124479 "NDP, norrin cystine knot growth factor" Q00604 X 43948776-43973504 "Disease related genes, Predicted secreted proteins" "Sensory transduction, Vision, Wnt signaling pathway" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 40.4" "Cell line enriched" "Detected in some" 17 "U-87 MG: 40.3" "Cancer enhanced" "Detected in many" "glioma: 25.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 14 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003095 Supported Nucleoplasm,Nucleoli,Vesicles "Secreted to extracellular matrix" Vesicles "Nucleoplasm, Nucleoli" "HPA003095: AB_1079457" "unprognostic (1.12e-1)" "unprognostic (7.12e-2)" "unprognostic (2.27e-2)" "unprognostic (2.55e-3)" "unprognostic (6.84e-3)" "unprognostic (1.51e-1)" "unprognostic (9.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" 0.9 0.6 17.3 0.6 18.6 0.5 3.6 14.6 15.0 19.1 0.7 12.6 0.2 0.6 13.6 19.9 0.6 18.0 0.9 1.4 14.0 7.8 0.7 0.5 0.6 0.7 11.0 10.9 40.4 0.6 0.8 0.2 5.3 13.1 6.8 0.7 1.4 0.6 12.4 1.5 1.1 0.6 10.7 7.5 0.6 0.7 1.4 12.2 0.0 1.2 0.0 0.7 1.0 1.7 0.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.9 0.0 0.1 1.0 0.7 0.0 0.0 1.1 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 0.0 0.0 40.3 0.4 2.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.3 18.6 14.6 15.0 14.0 7.8 11.0 10.9 13.1 12.2 NECAP1 DKFZP566B183 ENSG00000089818 "NECAP endocytosis associated 1" Q8NC96 12 8076939-8097859 "Disease related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053980, HPA063300" Uncertain Approved Vesicles,Cytosol Vesicles Cytosol "HPA053980: , HPA063300: " "unprognostic (1.73e-2)" "unprognostic (6.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-3)" "unprognostic (1.03e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (5.79e-3)" "unprognostic (5.72e-3)" "unprognostic (1.03e-1)" "unprognostic (1.72e-2)" "unprognostic (1.89e-2)" "unprognostic (2.64e-1)" "unprognostic (2.06e-1)" "unprognostic (5.94e-2)" 7.5 19.1 25.5 9.2 34.1 6.5 10.5 45.9 53.2 11.9 13.1 9.6 5.1 12.1 8.4 8.1 9.3 12.0 7.8 9.4 27.6 36.8 12.5 11.1 8.5 6.0 19.2 22.1 13.1 17.4 16.3 17.9 11.6 32.5 12.7 13.3 11.1 10.9 10.1 5.0 5.9 11.8 9.0 9.6 7.0 12.0 10.0 7.5 5.3 9.6 4.4 8.0 8.9 5.8 7.0 8.9 25.4 14.3 6.8 12.0 8.5 10.7 9.7 7.1 9.7 16.3 12.4 15.8 23.1 14.0 19.4 19.5 21.0 12.3 5.5 4.0 11.0 7.5 18.8 12.1 16.6 14.7 14.8 6.0 12.5 10.5 14.8 5.6 17.6 15.8 14.7 21.3 26.6 14.0 13.8 8.1 20.5 13.1 9.4 1.8 19.1 9.0 3.7 17.0 5.1 13.4 16.2 11.3 8.8 11.4 16.3 9.0 5.5 4.9 13.6 9.4 18.9 11.0 15.9 5.4 9.4 11.1 16.4 6.2 13.7 18.5 11.5 25.4 8.4 11.5 9.4 6.6 7.9 8.6 8.9 7.0 9.5 8.8 18.8 6.8 14.3 4.8 12.0 8.5 25.5 34.1 45.9 47.0 27.6 36.8 19.2 22.1 32.5 7.5 NEGR1 "IGLON4, KILON, MGC46680, Ntra" ENSG00000172260 "Neuronal growth regulator 1" Q7Z3B1 1 71395940-72282734 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.5" "Cell line enhanced" "Detected in many" "ASC diff: 15.8;TIME: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.1;plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011894 Uncertain Approved "Vesicles,Actin filaments,Cytosol" 390000000 "Vesicles, Actin filaments, Cytosol" "HPA011894: AB_1854363" "unprognostic (2.60e-1)" "unprognostic (1.89e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (7.99e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.94e-2)" "unprognostic (8.15e-2)" "unprognostic (8.73e-2)" "unprognostic (3.38e-2)" "unprognostic (1.36e-1)" "unprognostic (3.31e-5)" "unprognostic (5.89e-3)" "unprognostic (1.31e-1)" "unprognostic (1.43e-3)" "unprognostic (2.11e-4)" 17.5 7.8 18.1 7.6 16.3 2.2 7.3 24.1 41.5 8.0 14.7 2.6 2.4 3.8 7.1 5.9 13.6 5.9 13.5 10.7 11.2 14.8 8.8 1.1 5.4 2.4 8.7 26.3 8.4 6.0 1.5 4.6 4.1 5.9 9.9 10.3 3.2 3.6 7.6 5.9 5.5 6.3 25.5 10.2 1.5 7.6 4.4 3.0 0.3 3.8 1.5 1.6 20.1 9.1 0.5 3.3 1.1 0.4 0.4 0.4 0.1 0.2 0.1 0.4 0.2 15.8 12.5 0.1 11.0 4.1 6.1 7.4 0.1 0.1 0.2 0.1 12.1 0.3 0.0 0.0 13.2 0.2 0.1 0.1 2.2 0.1 1.3 0.2 0.3 6.0 0.0 5.1 0.9 7.1 0.1 0.5 11.2 0.1 0.1 0.2 1.8 6.3 7.6 11.8 0.2 1.0 0.2 0.8 1.0 3.8 0.1 0.1 0.1 0.2 16.1 1.3 13.4 0.6 13.6 0.3 0.2 0.1 3.0 7.3 4.7 1.1 0.4 0.3 0.4 0.2 0.3 0.3 0.3 0.3 3.1 0.5 0.3 0.3 0.8 0.4 0.4 3.3 0.2 0.1 18.1 16.3 24.1 31.8 11.2 14.8 8.7 26.3 5.9 3.0 NEIL2 "FLJ31644, MGC2832, MGC4505, NEH2" ENSG00000154328 "Nei like DNA glycosylase 2" Q969S2 8 11769639-11787346 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA073029, HPA073916" Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA073029: , HPA073916: " "unprognostic (1.52e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (9.88e-2)" "unprognostic (2.18e-2)" "unprognostic (5.72e-2)" "unprognostic (2.70e-1)" "unprognostic (2.88e-2)" "unprognostic (5.46e-2)" "unprognostic (6.85e-2)" "unprognostic (1.99e-3)" "unprognostic (1.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.29e-2)" "unprognostic (1.91e-1)" "unprognostic (2.09e-1)" "unprognostic (4.05e-1)" 10.2 21.8 18.7 6.8 17.7 2.7 10.3 11.8 20.9 11.3 5.6 9.0 7.0 3.6 9.9 15.4 6.5 17.9 6.9 14.2 15.4 20.0 9.3 11.0 7.7 8.4 18.4 16.1 12.6 10.9 7.8 13.2 7.6 20.3 10.5 6.1 9.7 11.5 10.3 24.7 18.1 4.6 10.2 12.3 9.5 5.1 26.8 13.3 1.8 15.5 7.1 7.9 7.4 15.8 14.7 5.5 0.8 2.5 9.1 13.6 4.7 5.1 14.5 9.1 17.7 4.4 8.1 4.1 8.2 6.8 8.0 5.5 4.4 5.6 2.0 3.2 9.8 4.5 8.6 9.0 11.0 6.0 4.3 7.1 3.4 8.6 3.5 3.0 5.3 7.2 13.3 6.9 6.4 7.4 9.9 6.9 9.4 5.4 0.5 3.2 8.1 7.8 8.9 11.7 5.5 9.2 7.7 14.0 11.1 6.4 3.4 11.6 5.4 0.5 9.1 9.1 13.1 2.4 11.4 6.5 13.5 3.6 23.9 10.5 18.4 0.4 1.5 0.1 9.1 2.5 12.1 14.7 9.3 10.8 3.0 11.4 13.6 12.0 0.8 9.1 1.1 5.5 5.8 4.7 18.7 17.7 11.8 19.8 15.4 20.0 18.4 16.1 20.3 13.3 NEK10 FLJ32685 ENSG00000163491 "NIMA related kinase 10" Q6ZWH5 3 27110085-27369460 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.4" "Cell line enhanced" "Detected in many" "BJ: 7.6;LHCN-M2: 10.5;U-2 OS: 8.9" "Cancer enriched" "Detected in single" 5 "breast cancer: 1.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038941 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA038941: AB_10673600" "prognostic favourable (4.20e-4)" "unprognostic (2.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.15e-2)" "unprognostic (3.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-2)" "unprognostic (2.20e-3)" "unprognostic (1.37e-1)" "unprognostic (7.67e-2)" "unprognostic (1.33e-2)" "unprognostic (1.38e-2)" "unprognostic (1.57e-3)" "unprognostic (2.14e-1)" 0.4 0.5 4.5 0.5 14.6 0.4 14.2 0.6 6.8 1.6 2.0 1.1 2.0 2.5 0.9 8.3 2.0 10.5 2.1 3.1 8.4 3.8 1.4 2.5 4.5 0.6 0.8 6.7 2.7 0.8 0.5 9.0 0.3 3.4 1.9 0.7 1.3 0.5 1.4 10.5 0.4 1.0 1.2 0.8 0.6 1.1 31.4 1.3 0.3 0.8 0.3 0.7 1.4 0.4 0.4 0.2 1.9 0.1 0.1 0.6 0.1 1.0 2.0 1.0 1.2 0.9 2.0 0.4 7.6 1.2 2.1 1.9 0.0 0.5 0.7 1.9 3.2 0.1 0.5 0.5 2.3 1.4 0.8 0.2 4.1 3.7 0.2 0.4 1.0 2.4 0.5 3.2 0.1 1.4 0.1 0.7 10.5 0.1 0.8 0.5 0.7 0.3 1.0 0.4 0.3 4.0 0.6 0.2 0.2 1.2 0.4 0.6 6.1 0.4 0.9 5.6 8.9 0.3 0.7 0.3 0.2 0.5 4.8 0.8 2.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.5 0.4 0.0 0.4 0.1 0.5 1.9 0.1 0.0 0.2 0.0 0.1 4.5 14.6 0.6 6.8 8.4 3.8 0.8 6.7 3.4 1.3 NELFCD "HSPC130, NELF-C, NELF-D, TH1, TH1L" ENSG00000101158 "Negative elongation factor complex member C/D" 20 58981208-58995133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050641, HPA066262" Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" "Nucleoplasm, Nuclear bodies" "Vesicles, Cytosol" "HPA050641: , HPA066262: " "unprognostic (1.70e-2)" "unprognostic (1.27e-1)" "unprognostic (2.60e-1)" "prognostic unfavourable (4.98e-5)" "unprognostic (6.20e-2)" "unprognostic (2.42e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (1.47e-1)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.07e-3)" "prognostic unfavourable (3.37e-4)" "unprognostic (4.62e-2)" "unprognostic (2.96e-1)" "unprognostic (9.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" 9.1 11.1 10.2 9.4 13.0 8.8 12.7 18.1 13.7 10.2 10.8 15.2 9.2 8.4 11.2 8.2 14.6 12.5 8.6 9.2 10.9 8.2 16.4 15.9 7.9 11.2 16.7 13.4 15.4 10.3 19.1 18.1 12.1 12.5 10.2 8.9 9.4 14.7 9.1 12.0 11.9 8.8 8.1 11.8 9.2 8.9 26.1 12.4 17.4 14.4 10.0 13.6 9.8 11.3 22.7 29.6 9.4 27.7 19.4 24.6 20.5 12.5 14.5 17.5 18.6 6.0 10.7 11.2 10.2 10.0 31.0 18.0 48.0 18.1 16.6 16.1 10.2 22.0 23.4 25.8 25.1 5.1 16.6 21.9 18.2 37.5 7.2 15.6 15.0 11.3 8.3 11.3 7.9 17.8 29.0 12.7 14.1 49.9 33.7 23.6 10.1 32.2 18.9 14.5 30.7 13.0 19.5 19.3 28.7 31.9 38.5 21.2 41.5 18.3 7.1 23.9 22.7 9.3 16.9 10.1 18.6 16.9 14.2 13.9 20.6 7.2 20.4 9.4 20.3 22.8 23.9 22.7 19.3 24.6 29.6 20.0 18.9 19.9 2.2 19.4 27.7 15.0 17.6 20.5 10.2 13.0 18.1 13.7 10.9 8.2 16.7 13.4 12.5 12.4 NELL2 NRP2 ENSG00000184613 "Neural EGFL like 2" Q99435 12 44508275-44921848 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.8;brain: 73.3;fallopian tube: 35.1" "Cell line enhanced" "Detected in some" "AF22: 40.9;NTERA-2: 16.1;SCLC-21H: 29.7;U-266/70: 10.9;U-266/84: 10.8;U-698: 14.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 33.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 24.5;naive CD8 T-cell: 36.8" "Lineage enriched" "Detected in many" 11 "T-cells: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035714, HPA035715" Uncertain Approved Vesicles "Secreted to blood" 4700000 Vesicles "HPA035714: , HPA035715: AB_10669602" "unprognostic (4.25e-3)" "unprognostic (4.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (7.18e-2)" "unprognostic (5.85e-2)" "unprognostic (2.59e-2)" "unprognostic (4.85e-2)" "unprognostic (2.80e-1)" "prognostic favourable (5.56e-4)" "unprognostic (1.19e-1)" "unprognostic (1.71e-5)" "unprognostic (8.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.60e-3)" "unprognostic (3.75e-2)" 2.0 10.5 22.4 6.1 24.8 4.2 1.6 15.7 73.3 14.9 2.9 3.6 0.0 15.3 1.9 0.8 1.3 35.1 1.7 0.8 40.2 20.4 1.2 1.1 3.4 11.2 6.6 27.0 1.0 1.1 0.6 18.4 0.8 7.5 18.8 1.8 9.3 1.5 1.8 0.7 5.0 8.6 2.2 2.6 3.8 2.1 2.2 2.4 0.4 4.4 0.0 9.1 2.3 2.0 0.0 0.0 0.1 0.0 3.3 36.8 8.5 0.1 0.0 40.9 1.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.1 4.9 0.0 0.1 9.7 0.0 0.0 0.0 10.6 0.1 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 16.1 5.3 0.0 4.9 0.0 0.0 0.0 29.7 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.1 1.5 0.0 0.7 10.9 10.8 14.7 0.1 0.1 0.2 0.0 0.0 0.0 1.6 0.0 8.5 0.0 10.3 18.1 0.0 0.0 24.5 36.8 0.1 3.3 0.0 0.0 0.1 8.5 22.4 24.8 15.7 50.4 40.2 20.4 6.6 27.0 7.5 2.4 NET1 "ARHGEF8, NET1A" ENSG00000173848 "Neuroepithelial cell transforming 1" Q7Z628 10 5412551-5458463 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020068 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA020068: " "unprognostic (1.77e-2)" "unprognostic (1.87e-1)" "unprognostic (3.40e-1)" "unprognostic (4.05e-2)" "unprognostic (3.37e-3)" "unprognostic (2.15e-1)" "prognostic unfavourable (3.87e-5)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "unprognostic (2.77e-2)" "prognostic unfavourable (8.27e-4)" "unprognostic (2.26e-1)" "unprognostic (5.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (2.46e-1)" 19.4 4.8 14.2 25.8 16.7 15.0 39.8 11.8 15.2 30.2 39.3 21.0 32.1 24.1 19.4 25.7 38.2 20.7 25.9 8.4 16.5 12.7 21.3 19.0 9.5 10.5 19.0 9.4 15.2 19.4 2.9 6.6 51.8 20.8 23.0 38.9 20.3 43.0 23.2 16.7 21.8 54.7 33.4 19.9 3.9 33.5 11.8 10.9 14.8 18.1 26.8 20.2 28.0 31.8 1.8 5.9 2.7 1.2 1.0 11.5 2.4 27.9 16.6 11.6 12.9 6.8 3.1 63.7 16.9 9.3 13.7 13.1 9.1 53.3 10.3 7.1 10.3 45.8 14.0 25.6 16.5 9.6 10.1 18.6 5.6 20.3 1.8 5.3 8.1 4.6 15.3 13.5 3.2 7.9 32.8 16.3 7.5 13.3 17.9 7.4 15.6 12.7 11.3 21.4 8.0 8.4 14.0 9.9 5.5 14.9 27.7 5.0 9.2 15.9 7.2 5.2 8.2 8.0 13.7 10.0 5.4 13.5 4.7 8.1 10.8 2.7 0.8 1.8 0.9 1.2 0.0 1.8 1.6 0.5 5.9 0.9 11.5 2.1 0.1 1.0 0.6 2.5 5.1 2.4 14.2 16.7 11.8 15.2 16.5 12.7 19.0 9.4 20.8 10.9 NEU1 NEU ENSG00000204386 "Neuraminidase 1" Q99519 6 31857659-31862906 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015634, HPA021506" Approved Supported "Vesicles,Cell Junctions" 86000 Vesicles "Cell Junctions" "HPA015634: AB_1854386, HPA021506: AB_1854385" "unprognostic (3.84e-2)" "unprognostic (7.47e-2)" "unprognostic (9.64e-2)" "unprognostic (4.65e-2)" "unprognostic (3.00e-1)" "unprognostic (4.42e-3)" "unprognostic (1.38e-3)" "unprognostic (8.58e-3)" "unprognostic (7.49e-2)" "unprognostic (5.21e-2)" "unprognostic (4.44e-3)" "unprognostic (1.27e-1)" "unprognostic (2.70e-2)" "unprognostic (6.22e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (2.13e-3)" 10.5 30.2 8.6 9.4 11.1 5.2 10.5 15.5 14.6 13.4 14.1 7.4 16.1 14.1 9.8 13.9 9.0 8.3 16.1 9.8 8.0 9.5 29.7 24.2 16.1 7.2 9.4 6.6 12.7 20.6 13.6 16.5 19.8 10.3 15.1 9.1 14.7 18.1 13.8 10.0 9.1 23.5 9.8 4.7 13.4 12.7 6.5 10.0 5.8 22.7 7.0 9.6 13.6 9.5 4.2 7.7 15.2 13.4 3.0 5.1 7.4 2.9 3.0 3.0 6.9 10.1 3.8 5.9 2.7 9.3 8.1 11.8 17.4 3.3 1.0 7.0 3.6 1.7 6.3 2.5 3.1 2.5 4.2 1.5 1.8 20.3 18.1 1.9 8.5 6.3 4.7 9.7 5.0 7.2 3.2 7.2 4.1 5.3 1.6 2.9 2.3 2.4 2.1 1.6 10.4 13.3 6.5 2.3 1.3 3.0 4.0 7.1 7.7 8.7 3.0 5.3 3.1 7.4 4.8 8.9 14.2 2.1 3.9 4.8 3.7 6.4 13.4 8.7 5.1 10.3 4.2 3.9 3.9 4.1 7.7 4.2 4.0 3.9 15.2 3.0 9.2 4.3 4.8 7.4 8.6 11.1 15.5 14.6 8.0 9.5 9.4 6.6 10.3 10.0 NEU3 ENSG00000162139 "Neuraminidase 3" Q9UQ49 11 74988134-75018893 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038729, HPA070381" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA038729: , HPA070381: " "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (2.55e-2)" "unprognostic (1.13e-3)" "unprognostic (2.95e-2)" "unprognostic (5.42e-2)" "unprognostic (1.63e-1)" "unprognostic (5.11e-2)" "unprognostic (3.91e-3)" "unprognostic (8.50e-2)" "prognostic favourable (5.98e-4)" "unprognostic (3.57e-3)" "unprognostic (3.80e-2)" "unprognostic (3.79e-1)" "unprognostic (2.38e-1)" "unprognostic (3.73e-1)" "unprognostic (1.84e-1)" 5.4 13.4 3.7 10.5 6.9 17.0 5.4 7.9 9.1 4.0 3.9 3.0 4.1 3.6 5.4 4.8 3.9 4.4 3.6 5.9 4.0 4.5 4.3 6.7 8.7 9.0 3.8 6.6 7.2 7.3 15.1 11.2 3.1 4.2 9.7 5.4 5.6 4.8 4.6 19.1 6.7 4.7 4.0 3.5 5.5 5.1 44.6 3.0 19.0 6.8 3.5 7.5 4.5 3.1 3.2 3.8 5.8 6.4 1.2 4.2 2.2 4.6 4.0 3.4 6.6 2.6 2.5 3.8 4.5 2.9 5.2 4.0 13.7 3.9 13.3 4.6 3.6 4.3 8.3 5.8 7.9 7.0 4.4 11.0 7.5 5.6 2.9 17.2 10.6 3.0 4.9 5.2 8.1 3.7 17.7 10.0 5.9 5.0 16.9 8.9 4.2 5.4 14.9 9.0 11.7 6.4 4.9 6.3 4.0 6.9 4.6 20.3 9.9 4.5 5.6 6.5 6.5 4.3 4.5 8.3 8.0 26.7 1.9 8.9 5.5 2.1 6.4 5.8 4.1 3.7 3.0 2.8 3.2 3.9 3.8 3.2 3.5 4.2 3.3 1.2 4.6 2.7 2.3 2.2 3.7 6.9 7.9 9.1 4.0 4.5 3.8 6.6 4.2 3.0 NEURL1B "DKFZP761M1511, Neur2, RNF67B" ENSG00000214357 "Neuralized E3 ubiquitin protein ligase 1B" A8MQ27 5 172641266-172691540 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 27.0;T-47d: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037612 Approved Supported Vesicles Vesicles "HPA037612: AB_10795573" "unprognostic (3.56e-2)" "unprognostic (8.46e-2)" "unprognostic (6.72e-3)" "unprognostic (2.70e-1)" "unprognostic (1.64e-1)" "unprognostic (1.55e-1)" "unprognostic (6.58e-2)" "unprognostic (2.95e-1)" "unprognostic (2.86e-1)" "unprognostic (1.09e-1)" "unprognostic (7.13e-3)" "unprognostic (6.81e-2)" "prognostic unfavourable (3.00e-6)" "unprognostic (1.79e-1)" "unprognostic (1.40e-1)" "unprognostic (4.67e-2)" "unprognostic (3.22e-3)" 26.6 11.8 7.5 10.3 3.2 1.5 23.9 0.6 7.0 21.4 17.5 5.6 31.2 5.7 26.7 24.7 14.0 15.8 23.0 19.2 10.7 4.2 7.6 4.4 10.5 7.8 3.1 3.2 20.9 4.8 4.1 6.0 5.1 2.7 20.7 11.6 6.1 4.9 28.4 12.3 14.7 12.1 29.1 1.5 0.6 5.9 6.6 2.8 3.6 7.2 13.9 5.4 16.0 30.8 0.0 0.6 0.0 0.2 0.0 0.2 0.0 4.4 2.3 1.2 5.6 0.4 0.2 0.1 5.0 2.2 2.7 3.9 8.5 2.0 0.0 1.4 3.2 1.3 0.5 2.2 1.8 8.1 0.3 6.1 8.1 0.0 0.4 0.0 1.9 0.0 9.7 0.6 2.7 0.4 0.0 1.9 5.7 4.9 1.4 0.1 0.8 0.2 27.0 6.0 0.8 0.1 1.0 1.0 5.8 4.8 7.6 0.2 12.7 0.9 0.8 2.0 11.9 1.4 3.1 0.8 0.2 0.0 5.8 0.1 1.7 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.5 3.2 0.6 7.0 10.7 4.2 3.1 3.2 2.7 2.8 NEURL2 "C20orf163, dJ337O18.6, FLJ30259, Ozz, Ozz-E3" ENSG00000124257 "Neuralized E3 ubiquitin protein ligase 2" Q9BR09 20 45888625-45891287 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043402, HPA059842" Approved Approved Vesicles Vesicles "HPA043402: , HPA059842: " "unprognostic (6.26e-2)" "unprognostic (1.77e-2)" "unprognostic (1.92e-1)" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.23e-3)" "unprognostic (1.07e-1)" "unprognostic (8.04e-2)" "unprognostic (2.90e-1)" "unprognostic (1.73e-3)" "unprognostic (5.58e-2)" "unprognostic (1.99e-2)" "unprognostic (6.94e-2)" "unprognostic (1.97e-1)" "unprognostic (8.12e-2)" "unprognostic (1.58e-1)" 7.9 6.3 2.8 3.0 2.6 1.3 4.8 5.5 3.3 4.6 7.6 2.9 4.5 5.2 5.7 6.0 3.3 5.2 9.0 7.6 1.9 1.6 8.8 12.3 2.4 1.5 1.5 2.3 8.7 2.8 6.2 4.2 3.7 2.7 5.7 2.7 5.9 4.0 3.7 21.6 4.3 10.3 10.2 2.3 4.5 3.3 3.2 1.1 1.1 4.0 21.5 2.1 6.6 2.8 5.4 0.8 3.6 1.3 2.3 3.8 0.9 0.9 0.9 2.4 1.8 4.0 1.6 2.3 1.4 2.1 1.7 0.8 9.8 6.4 1.4 2.1 1.1 3.3 2.0 0.2 1.1 0.8 1.8 0.8 7.1 9.8 5.5 0.7 1.7 3.8 1.4 1.7 0.7 1.6 0.6 2.5 0.9 3.9 1.1 0.7 1.6 3.6 1.9 1.7 0.6 1.0 0.8 5.6 4.6 2.0 5.1 6.1 4.1 2.0 2.5 2.0 1.5 1.3 1.3 8.1 1.4 0.2 2.1 1.0 1.6 0.0 1.3 3.6 0.9 0.7 0.5 5.4 1.8 1.6 0.4 2.6 3.8 3.5 0.7 2.3 0.4 0.8 1.0 0.9 2.8 2.6 5.5 3.0 1.9 1.6 1.5 2.3 2.7 1.1 NFE2L3 Nrf3 ENSG00000050344 "Nuclear factor, erythroid 2 like 3" Q9Y4A8 7 26152240-26187125 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 54.9" "Cell line enhanced" "Detected in many" "BEWO: 43.4;NTERA-2: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055889 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "HPA055889: " "unprognostic (4.99e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-3)" "unprognostic (5.37e-2)" "unprognostic (8.41e-2)" "unprognostic (4.00e-3)" "unprognostic (7.29e-3)" "unprognostic (1.87e-1)" "unprognostic (2.12e-1)" "unprognostic (9.88e-2)" "prognostic unfavourable (6.62e-5)" "unprognostic (2.32e-1)" "prognostic unfavourable (7.58e-12)" "prognostic favourable (2.14e-4)" "unprognostic (2.40e-1)" "unprognostic (8.25e-2)" "unprognostic (4.13e-3)" 3.5 2.5 0.8 7.8 1.2 1.6 4.1 6.2 1.6 1.8 6.7 4.0 2.4 6.2 1.9 1.7 3.1 2.4 7.1 3.6 1.3 1.1 4.2 2.3 5.8 6.9 2.5 0.8 1.7 7.5 0.0 2.1 54.9 2.1 3.7 4.0 2.1 7.7 0.4 3.4 8.2 7.1 0.8 3.7 10.4 5.6 2.5 1.5 11.2 1.6 1.5 8.9 3.1 2.1 1.4 2.8 0.8 1.1 1.1 2.6 0.4 12.5 1.1 0.5 1.3 0.0 0.0 43.4 2.5 4.9 4.9 9.0 8.3 22.0 0.9 16.6 0.2 2.6 1.9 4.2 11.2 8.6 2.7 1.7 1.8 6.1 3.4 1.5 16.8 0.4 0.5 2.0 0.7 11.3 2.6 22.3 0.9 1.7 1.0 2.7 36.4 4.4 1.5 0.1 6.2 6.6 12.4 3.9 4.7 0.0 1.0 0.3 0.6 0.9 23.5 0.4 0.7 0.2 10.1 13.6 21.6 1.0 0.0 5.4 16.8 0.0 1.1 0.0 0.5 1.1 1.6 1.0 2.1 1.0 2.8 1.4 1.2 0.7 0.8 1.1 0.3 0.9 2.6 0.4 0.8 1.2 6.2 1.6 1.3 1.1 2.5 0.8 2.1 1.5 NHLRC1 "bA204B7.2, EPM2B" ENSG00000187566 "NHL repeat containing E3 ubiquitin protein ligase 1" Q6VVB1 6 18120440-18122687 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 9.0;K-562: 7.6;SCLC-21H: 8.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066030 Uncertain Vesicles Vesicles "HPA066030: " "unprognostic (1.61e-1)" "unprognostic (1.39e-1)" "unprognostic (7.95e-2)" "prognostic unfavourable (9.01e-4)" "unprognostic (6.95e-3)" "unprognostic (2.45e-1)" "unprognostic (1.09e-1)" "unprognostic (3.69e-1)" "unprognostic (2.39e-1)" "unprognostic (7.17e-2)" "unprognostic (5.07e-3)" "unprognostic (1.28e-1)" "unprognostic (2.32e-2)" "unprognostic (3.19e-1)" "unprognostic (2.33e-1)" "unprognostic (2.77e-2)" "prognostic favourable (5.30e-4)" 2.5 3.6 5.0 1.8 6.5 2.1 4.6 2.6 8.5 1.9 3.3 7.1 1.7 3.2 2.0 6.1 2.4 3.5 2.7 3.9 5.0 5.1 1.9 9.0 5.1 4.7 5.4 3.9 3.5 12.2 2.4 2.8 1.0 5.2 3.4 3.0 3.3 5.1 2.8 5.2 8.5 4.3 1.8 5.4 2.4 3.0 2.1 3.8 2.4 3.6 0.9 1.8 2.5 1.8 3.3 7.2 0.6 7.2 2.2 2.5 2.6 3.3 2.0 0.8 0.1 1.8 1.7 0.0 3.4 1.1 1.3 0.7 0.1 2.8 0.1 9.0 2.5 4.0 0.0 2.2 1.0 0.1 1.1 0.5 1.0 0.2 2.8 0.0 2.2 2.9 3.3 1.3 1.2 2.8 7.6 0.1 2.8 3.5 0.0 0.0 0.0 2.0 0.0 0.0 0.1 1.8 3.6 8.0 0.1 6.8 5.7 2.0 4.1 2.2 0.5 0.2 1.7 2.4 0.0 0.1 0.0 0.1 0.1 0.0 3.4 0.5 6.6 0.6 1.1 7.2 1.2 3.3 1.7 0.8 7.2 2.3 2.5 1.6 0.5 2.2 3.2 0.9 1.8 2.6 5.0 6.5 2.6 8.5 5.0 5.1 5.4 3.9 5.2 3.8 NIF3L1 "ALS2CR1, CALS-7, MDS015" ENSG00000196290 "NGG1 interacting factor 3 like 1" Q9GZT8 2 200889327-200903930 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036335, HPA036336, HPA061466" Supported Approved Vesicles 8700000 Vesicles "HPA036335: AB_10696654, HPA036336: AB_2675068, HPA061466: " "unprognostic (6.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.72e-1)" "prognostic unfavourable (9.52e-5)" "unprognostic (2.48e-2)" "unprognostic (5.92e-2)" "prognostic unfavourable (2.51e-6)" "unprognostic (1.94e-1)" "unprognostic (8.53e-3)" "unprognostic (6.75e-3)" "unprognostic (3.12e-2)" "unprognostic (2.65e-2)" "unprognostic (6.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.83e-1)" "unprognostic (6.04e-3)" "unprognostic (8.61e-2)" 12.8 21.6 14.4 17.8 29.1 7.2 19.6 21.1 31.0 14.9 16.9 19.3 10.0 12.9 16.0 21.8 17.2 18.4 11.5 16.5 19.6 14.2 19.5 17.6 12.1 19.0 15.1 13.4 17.8 15.6 20.8 12.0 18.0 25.6 14.3 22.9 16.3 16.5 17.0 21.4 16.8 15.2 15.2 17.9 18.7 16.2 15.2 13.2 20.8 16.3 15.8 24.8 15.1 12.4 20.3 18.5 32.6 21.3 20.2 23.9 14.4 15.1 16.5 27.0 16.5 12.3 15.6 18.6 16.8 18.0 35.9 29.1 25.8 17.8 12.3 16.3 14.3 16.9 38.3 22.1 38.6 16.3 36.3 18.4 29.3 27.4 11.1 21.6 12.8 13.0 21.5 23.6 22.7 11.9 26.8 12.6 21.0 20.0 26.5 27.1 31.7 29.3 15.9 15.1 24.0 18.9 16.0 17.1 20.3 14.4 14.7 19.8 14.5 19.9 6.1 17.4 16.3 15.4 15.1 11.5 21.7 26.7 16.8 17.8 16.5 32.6 14.5 18.4 18.3 21.3 19.2 20.3 21.1 23.2 17.8 15.6 23.9 19.7 4.9 20.2 17.8 18.5 19.2 14.4 14.4 29.1 21.1 31.0 19.6 14.2 15.1 13.4 25.6 13.2 NIPBL "DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2" ENSG00000164190 "NIPBL, cohesin loading factor" Q6KC79 5 36876759-37066413 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040834, HPA058239" Approved Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA040834: AB_10796562, HPA058239: " "unprognostic (4.92e-2)" "unprognostic (9.77e-2)" "unprognostic (5.28e-2)" "unprognostic (8.10e-2)" "unprognostic (9.38e-2)" "unprognostic (6.02e-2)" "unprognostic (7.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.85e-2)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (6.39e-2)" "unprognostic (6.59e-2)" "unprognostic (2.33e-1)" "unprognostic (3.41e-1)" "unprognostic (1.04e-1)" "unprognostic (3.40e-2)" 16.8 13.9 13.3 21.9 15.7 22.7 15.8 22.9 15.9 17.3 19.2 10.8 20.1 10.4 18.7 16.5 16.6 14.3 15.9 12.4 13.5 7.1 12.6 13.2 16.0 16.0 17.2 11.1 21.2 14.6 30.0 20.9 17.4 13.5 15.1 13.2 8.5 17.1 24.7 18.9 18.2 18.4 13.2 11.9 18.5 14.7 14.1 19.0 42.5 18.1 14.0 16.9 17.6 29.2 4.8 4.6 11.1 4.3 3.8 4.9 1.9 10.1 6.0 15.7 7.4 10.0 11.0 11.6 8.2 9.1 9.0 7.5 8.4 10.5 15.4 5.3 10.1 8.9 13.4 7.5 13.0 12.6 7.0 18.7 26.7 6.1 6.9 21.8 12.5 8.1 9.3 10.1 13.4 11.3 17.8 11.6 8.4 4.9 14.9 8.3 7.5 5.2 12.8 24.7 5.9 6.4 14.5 11.7 8.2 39.5 10.6 8.4 10.8 12.7 12.2 11.9 13.0 10.1 6.1 8.4 11.2 18.3 6.6 15.0 8.9 10.0 4.1 5.7 4.8 3.2 4.4 4.0 3.9 4.2 3.3 4.8 4.3 4.9 11.1 3.8 4.3 4.6 2.9 1.9 13.3 15.7 22.9 15.9 13.5 7.1 17.2 11.1 13.5 19.0 NKG7 "GIG1, GMP-17" ENSG00000105374 "Natural killer cell granule protein 7" Q16617 19 51371606-51372715 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 270.6;bone marrow: 108.2" "Group enriched" "Detected in some" 5 "NB-4: 58.8;THP-1: 17.5;U-937: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 270.6;MAIT T-cell: 113.5;memory CD8 T-cell: 168.7;naive CD8 T-cell: 130.3;NK-cell: 166.7" "Group enriched" "Detected in all" 46 "NK-cells: 166.7;T-cells: 270.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071454 Approved Vesicles Vesicles "HPA071454: " "unprognostic (1.56e-2)" "unprognostic (1.05e-2)" "unprognostic (6.54e-2)" "prognostic favourable (7.42e-6)" "unprognostic (1.27e-2)" "unprognostic (3.25e-3)" "unprognostic (2.96e-3)" "unprognostic (2.14e-1)" "unprognostic (3.22e-3)" "unprognostic (3.89e-3)" "unprognostic (3.39e-1)" "unprognostic (9.93e-2)" "prognostic unfavourable (3.32e-6)" "unprognostic (7.62e-3)" "unprognostic (2.61e-1)" "unprognostic (1.30e-2)" "unprognostic (6.44e-3)" 7.4 1.8 1.3 11.2 1.7 108.2 3.3 0.7 1.0 2.9 2.2 0.8 0.4 2.2 5.4 6.3 3.8 1.8 10.6 6.0 1.2 1.2 3.2 9.4 26.1 31.0 2.3 0.7 4.1 2.6 0.0 1.8 9.3 1.3 6.8 1.6 6.2 3.5 0.9 5.6 1.0 7.6 2.5 2.8 63.3 2.5 1.9 0.2 7.3 3.1 2.0 16.0 5.1 2.3 1.1 3.2 4.5 4.7 166.7 270.6 141.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.6 0.2 0.0 0.0 6.2 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.7 58.8 0.0 0.1 1.4 3.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 17.5 0.1 0.0 0.0 0.2 0.0 0.8 0.2 0.3 0.0 15.3 0.0 2.2 1.3 0.5 270.6 4.7 113.5 1.1 34.1 168.7 3.2 0.5 11.5 130.3 4.5 166.7 3.6 2.5 0.6 141.5 1.3 1.7 0.7 1.0 1.2 1.2 2.3 0.7 1.3 0.2 NKX2-1 "BCH, NKX2A, TITF1, TTF-1, TTF1" ENSG00000136352 "NK2 homeobox 1" P43699 14 36516392-36521149 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "lung: 51.5;thyroid gland: 122.8" "Cell line enriched" "Detected in some" 28 "SCLC-21H: 47.6" "Group enriched" "Detected in some" 39 "lung cancer: 30.9;thyroid cancer: 103.2" "Group enriched" "Detected in some" 6 "basal ganglia: 2.4;hypothalamus: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 3.4;hypothalamus: 12.0" "Group enriched" "Detected in some" 13 "basal ganglia: 6.4;hypothalamus: 16.1" "CAB000078, CAB053633, HPA074316" Enhanced Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "CAB000078: , CAB053633: AB_442138, HPA074316: " "unprognostic (3.79e-1)" "unprognostic (4.25e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" "unprognostic (1.26e-2)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-1)" "unprognostic (1.83e-2)" "unprognostic (4.18e-1)" 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.5 0.0 0.0 51.5 0.1 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.4 0.0 122.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 47.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.1 0.2 2.5 0.0 0.1 0.1 0.4 NLRC3 "CLR16.2, FLJ00348, NOD3" ENSG00000167984 "NLR family CARD domain containing 3" Q7RTR2 16 3539033-3577400 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.0" "Cell line enhanced" "Detected in some" "HEL: 6.2;HL-60: 12.9;HMC-1: 6.5;NB-4: 13.8;U-698: 19.9;U-937: 9.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA048062 Supported "Vesicles,Centriolar satellite,Cytosol" Cytosol "Vesicles, Centriolar satellite" "HPA048062: " "unprognostic (4.93e-3)" "unprognostic (3.84e-4)" "unprognostic (7.61e-4)" "unprognostic (4.94e-7)" "unprognostic (9.56e-2)" "unprognostic (3.76e-5)" "unprognostic (1.86e-3)" "unprognostic (6.70e-3)" "unprognostic (2.66e-2)" "unprognostic (7.02e-2)" "unprognostic (3.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.40e-2)" "unprognostic (5.13e-2)" "unprognostic (7.15e-3)" "unprognostic (4.54e-2)" "unprognostic (2.08e-2)" 0.2 0.4 0.0 20.1 0.1 2.8 0.0 0.0 0.2 0.4 1.3 0.0 0.2 1.2 1.0 0.1 1.0 0.0 1.8 0.8 0.0 0.6 0.5 6.0 11.2 0.2 0.0 0.1 1.5 0.0 0.0 0.6 0.2 0.9 0.7 0.9 2.7 0.2 0.5 0.0 2.4 0.1 0.0 10.5 1.4 0.0 0.0 27.0 0.4 1.1 18.1 1.6 1.0 1.0 0.0 2.6 0.0 4.7 4.1 3.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 5.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 6.2 0.1 0.0 0.0 12.9 6.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 5.4 13.8 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 3.3 0.4 0.2 0.0 0.2 0.1 0.3 0.0 19.9 0.1 9.7 0.0 2.6 0.0 0.0 3.7 0.0 4.1 1.0 2.7 3.8 0.0 0.8 2.1 2.0 0.0 4.7 0.0 0.0 3.1 3.3 NLRP2 "CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2" ENSG00000022556 "NLR family pyrin domain containing 2" Q9NX02 19 54953130-55001142 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.3" "Cell line enhanced" "Detected in some" "BEWO: 25.1;K-562: 10.4;U-266/84: 11.4" "Cancer enriched" "Detected in many" 7 "testis cancer: 78.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA021183 Supported "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles, Cytosol" "HPA021183: " "unprognostic (1.66e-2)" "unprognostic (9.28e-2)" "unprognostic (6.60e-2)" "unprognostic (6.50e-3)" "unprognostic (1.09e-2)" "unprognostic (4.57e-3)" "unprognostic (4.27e-1)" "unprognostic (1.79e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" "prognostic unfavourable (2.91e-4)" "unprognostic (3.63e-1)" "unprognostic (2.34e-2)" "unprognostic (2.55e-1)" "unprognostic (2.30e-1)" "unprognostic (8.86e-2)" "unprognostic (7.57e-2)" 0.6 0.9 1.1 5.0 3.8 1.7 1.4 0.6 2.7 2.6 2.6 0.9 0.2 2.5 2.1 3.7 10.8 1.0 3.7 0.7 2.0 1.8 4.7 0.9 2.2 5.0 0.8 0.8 1.0 6.1 0.3 1.7 8.1 2.9 2.1 1.2 2.4 4.1 1.6 1.4 3.5 2.9 1.1 1.0 3.0 3.1 14.3 0.9 4.2 3.1 0.2 3.5 4.7 5.6 3.8 1.8 0.6 0.9 3.4 2.6 0.8 2.3 3.9 2.0 0.4 0.1 0.1 25.1 0.1 0.0 0.2 0.1 5.0 0.5 2.6 0.2 0.1 4.1 0.0 4.3 0.2 2.5 0.2 2.5 0.3 0.0 0.3 0.1 0.3 0.1 0.2 0.0 0.1 0.0 10.4 0.3 0.0 0.3 0.2 1.0 3.0 0.0 2.8 0.0 1.5 2.3 0.9 2.4 0.6 0.1 1.1 0.0 3.4 0.8 0.0 0.2 0.5 0.3 0.3 2.7 11.4 0.9 0.3 0.7 0.1 0.6 0.7 0.3 2.6 0.9 1.5 3.8 1.1 1.0 0.6 2.6 0.8 1.5 0.5 3.4 0.5 1.8 1.2 0.8 1.1 3.8 0.6 2.7 2.0 1.8 0.8 0.8 2.9 0.9 NMB "MGC17211, MGC2277, MGC3936" ENSG00000197696 "Neuromedin B" P08949 15 84655129-84658563 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 37.2;brain: 28.5;breast: 59.9" "Cell line enhanced" "Detected in many" "A-431: 27.5" "Cancer enhanced" "Detected in all" "glioma: 93.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 16 "olfactory region: 206.6" "Group enriched" "Detected in many" 6 "olfactory region: 80.6;pons and medulla: 17.5" CAB019302 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted to blood" "Nucleoplasm, Vesicles" "Plasma membrane" "CAB019302: " "unprognostic (2.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-3)" "unprognostic (3.79e-1)" "prognostic favourable (3.43e-4)" "unprognostic (3.81e-1)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (2.17e-1)" "unprognostic (4.36e-1)" "unprognostic (7.24e-2)" "unprognostic (2.10e-1)" "prognostic unfavourable (2.25e-4)" "unprognostic (7.92e-3)" "unprognostic (1.45e-1)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" 37.2 8.0 4.6 2.8 7.5 3.3 59.9 2.4 28.5 4.0 6.5 13.7 1.0 2.3 3.1 3.2 2.5 5.0 4.5 7.0 7.0 12.2 4.4 1.9 3.8 3.6 6.6 3.5 3.4 3.3 2.7 4.2 1.4 5.6 1.9 2.1 2.6 4.6 1.8 2.0 1.8 1.4 2.9 9.9 2.0 2.5 6.4 4.8 2.2 8.9 4.9 1.9 4.7 8.5 7.0 10.4 5.9 0.8 1.3 6.4 2.6 27.5 10.5 1.9 0.4 5.5 2.4 0.2 1.7 3.3 3.7 5.1 3.7 7.6 1.2 4.4 4.4 4.9 10.6 2.1 2.1 10.3 13.3 4.2 4.1 17.1 1.4 2.8 4.6 2.5 0.8 5.8 2.2 5.4 0.0 0.4 2.0 16.1 2.6 9.3 7.8 3.0 8.3 0.0 12.2 3.5 2.2 1.0 12.0 2.7 1.6 12.5 1.8 11.0 1.3 0.7 3.7 3.5 2.6 0.2 3.0 2.6 8.5 15.9 4.4 0.0 0.8 5.9 6.3 0.6 2.3 4.9 5.0 6.4 3.5 7.0 4.8 3.6 1.2 1.3 0.3 10.4 5.6 2.6 4.6 7.5 2.4 8.5 7.0 12.2 6.6 3.5 5.6 4.8 NME6 "IPIA-ALPHA, NM23-H6" ENSG00000172113 "NME/NM23 nucleoside diphosphate kinase 6" O75414 3 48290722-48301685 "Enzymes, Predicted intracellular proteins" "Apoptosis, Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017909 Approved Approved Vesicles Vesicles "HPA017909: AB_1854530" "unprognostic (7.31e-3)" "unprognostic (1.87e-1)" "unprognostic (8.19e-3)" "unprognostic (2.09e-2)" "unprognostic (8.52e-2)" "unprognostic (2.20e-1)" "prognostic unfavourable (2.17e-7)" "unprognostic (1.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.00e-3)" "unprognostic (1.32e-1)" "unprognostic (2.98e-1)" "prognostic favourable (3.18e-5)" "unprognostic (1.98e-2)" "unprognostic (1.57e-2)" "unprognostic (1.23e-1)" "unprognostic (9.50e-2)" 11.7 12.2 7.0 14.4 11.0 7.7 13.5 9.2 10.9 12.2 12.0 11.9 14.6 13.5 16.1 13.2 16.1 16.3 8.8 13.7 9.9 6.8 18.0 17.5 11.1 12.9 9.2 10.3 14.5 20.6 12.1 13.3 22.1 8.8 13.2 12.7 13.5 20.8 17.6 20.1 10.3 13.4 13.3 7.1 14.2 13.4 9.0 8.2 12.6 17.5 14.3 15.1 13.9 15.7 26.4 23.5 43.3 22.7 23.0 25.8 14.3 17.8 11.1 15.2 11.0 12.4 16.7 13.6 17.5 13.5 25.8 19.6 18.6 15.7 18.0 9.1 13.6 6.2 13.7 19.3 15.3 21.4 13.2 11.7 14.9 15.1 16.6 14.8 12.6 13.6 21.2 22.8 27.3 13.8 19.6 13.9 9.6 8.5 12.4 6.4 12.8 14.6 7.4 13.3 15.1 12.9 15.4 4.7 8.0 11.9 13.2 15.6 14.7 13.8 12.4 5.1 20.2 12.6 24.9 16.5 22.3 16.2 9.7 19.7 11.3 22.0 20.1 43.3 25.8 20.7 23.6 26.4 24.2 21.9 23.5 24.4 18.7 17.7 22.5 23.0 22.7 21.1 19.4 14.3 7.0 11.0 9.2 10.9 9.9 6.8 9.2 10.3 8.8 8.2 NMRK2 "ITGB1BP3, MIBP, NRK2" ENSG00000077009 "Nicotinamide riboside kinase 2" Q9NPI5 19 3933103-3942416 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "heart muscle: 271.6;skeletal muscle: 103.2" "Group enriched" "Detected in some" 7 "BEWO: 22.4;NTERA-2: 18.5" "Cancer enhanced" "Detected in some" "renal cancer: 32.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA049909, HPA054792, HPA072450" Approved Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA049909: , HPA054792: , HPA072450: " "unprognostic (3.61e-1)" "unprognostic (5.92e-2)" "unprognostic (1.18e-2)" "unprognostic (2.54e-1)" "unprognostic (1.03e-1)" "unprognostic (7.61e-2)" "unprognostic (3.30e-2)" "prognostic favourable (1.19e-4)" "unprognostic (1.72e-1)" "unprognostic (3.29e-2)" "unprognostic (5.38e-1)" 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.0 0.0 0.0 271.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 1.0 1.9 0.1 103.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 18.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 NOL12 "MGC3731, Nop25, RRP17" ENSG00000273899 "Nucleolar protein 12" Q9UGY1 22 37681673-37693478 "Predicted intracellular proteins" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003547 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA003547: AB_10602012" "unprognostic (3.37e-2)" "prognostic favourable (6.80e-5)" "unprognostic (2.65e-1)" "unprognostic (9.62e-2)" "unprognostic (2.13e-1)" "unprognostic (7.89e-2)" "unprognostic (3.23e-3)" "prognostic favourable (9.41e-4)" "unprognostic (9.96e-2)" "unprognostic (4.62e-2)" "unprognostic (2.18e-3)" "unprognostic (4.60e-2)" "prognostic unfavourable (2.56e-6)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (4.65e-2)" "prognostic favourable (3.24e-4)" 3.8 11.8 9.3 9.5 10.1 14.6 5.0 13.1 10.6 3.6 6.5 7.9 5.4 8.4 4.1 4.6 7.8 6.2 5.6 7.2 7.7 5.2 4.1 4.8 11.0 8.7 6.4 5.4 5.4 5.4 3.9 6.8 7.2 4.5 6.2 4.4 8.9 4.8 7.9 11.4 7.1 4.5 3.7 8.6 5.8 4.8 9.5 7.2 7.4 7.1 8.0 5.8 5.6 8.1 9.6 31.1 17.1 8.5 11.6 6.4 17.0 15.7 11.8 13.4 3.8 4.1 14.8 8.5 3.9 3.9 4.1 8.9 7.1 14.5 5.1 3.8 18.6 6.7 22.5 1.4 15.2 24.5 12.3 12.7 20.2 10.3 29.1 18.1 5.9 7.3 15.3 5.9 7.3 9.1 13.2 3.3 14.8 15.9 21.8 13.5 21.2 21.8 7.6 10.9 8.5 6.0 9.6 18.7 9.9 9.1 13.5 13.0 13.8 10.2 16.2 16.4 11.8 15.7 11.0 13.4 18.7 15.4 21.7 19.0 21.3 14.0 14.2 9.1 14.1 6.5 8.0 8.9 7.9 9.6 8.1 9.1 7.9 31.1 8.5 17.1 7.5 11.6 6.4 NOS1AP "CAPON, KIAA0464" ENSG00000198929 "Nitric oxide synthase 1 adaptor protein" O75052 1 162069774-162370475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.1" "Cell line enhanced" "Detected in many" "A-431: 6.7;HEL: 8.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB018582, HPA030066, HPA055561" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB018582: AB_2251417, HPA030066: , HPA055561: " "unprognostic (7.04e-3)" "unprognostic (2.20e-1)" "unprognostic (1.79e-2)" "unprognostic (3.93e-2)" "unprognostic (1.58e-2)" "unprognostic (4.75e-2)" "unprognostic (2.07e-1)" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.54e-1)" "unprognostic (3.48e-1)" "unprognostic (1.71e-1)" "unprognostic (2.15e-5)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (5.08e-3)" 2.1 7.9 10.2 1.6 7.0 4.8 6.2 23.1 34.1 2.4 3.7 3.1 7.1 2.7 2.4 1.7 2.2 2.6 7.4 2.3 19.0 10.1 2.9 7.6 2.3 1.4 6.5 13.0 1.6 3.5 2.0 2.7 2.2 5.5 2.5 3.9 2.7 4.6 9.7 1.7 2.4 3.1 2.1 4.4 1.3 3.8 4.0 3.1 0.0 1.6 0.2 1.8 1.8 2.2 0.0 0.1 1.1 0.5 0.0 0.3 0.1 6.7 0.0 3.2 1.8 0.1 0.0 0.5 0.6 0.7 0.9 0.8 1.5 1.7 0.0 4.3 0.2 5.1 1.0 0.2 0.3 0.1 3.1 8.1 1.1 1.7 0.0 0.0 0.1 0.3 0.2 0.0 0.2 1.7 0.6 0.1 0.1 3.5 0.6 0.0 2.3 3.0 0.1 1.2 0.2 1.5 2.3 2.6 1.8 1.5 0.3 1.2 1.9 0.4 0.7 0.1 0.8 0.0 1.2 4.6 0.0 0.0 1.0 0.1 0.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 10.2 7.0 23.1 21.1 19.0 10.1 6.5 13.0 5.5 3.1 NOSTRIN MGC20702 ENSG00000163072 "Nitric oxide synthase trafficking" Q8IVI9 2 168786539-168865514 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 51.2" "Group enriched" "Detected in some" 4 "BEWO: 6.8;HEL: 26.1;K-562: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044384, HPA076885" Approved Approved Vesicles,Cytosol Cytosol Vesicles "HPA044384: , HPA076885: " "unprognostic (4.74e-2)" "unprognostic (2.42e-1)" "unprognostic (8.73e-2)" "unprognostic (2.27e-1)" "unprognostic (3.15e-3)" "unprognostic (3.02e-6)" "unprognostic (4.89e-3)" "unprognostic (3.15e-1)" "unprognostic (3.14e-4)" "unprognostic (5.47e-3)" "unprognostic (1.19e-1)" "unprognostic (2.51e-1)" "unprognostic (1.63e-1)" "unprognostic (1.75e-1)" "unprognostic (2.33e-1)" "unprognostic (6.47e-2)" "unprognostic (4.98e-2)" 27.1 11.6 4.4 7.6 5.6 0.2 17.4 2.7 6.0 20.5 11.0 2.3 10.3 10.4 11.9 12.1 7.8 9.0 20.5 9.8 4.8 4.1 27.9 7.8 19.6 3.5 5.8 3.7 11.2 14.8 2.3 4.2 18.5 7.9 9.4 12.5 2.8 51.2 13.6 7.6 4.2 22.3 9.7 5.1 5.6 16.5 11.2 3.9 0.7 8.5 8.6 2.6 7.6 12.8 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.5 0.0 0.0 0.0 6.8 0.2 0.0 0.0 0.0 4.0 4.3 0.0 2.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 26.1 1.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 2.2 0.9 0.0 0.1 0.1 1.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 4.4 5.6 2.7 6.0 4.8 4.1 5.8 3.7 7.9 3.9 NOV "CCN3, IGFBP9" ENSG00000136999 "Nephroblastoma overexpressed" P48745 8 119416306-119424353 "Plasma proteins, Predicted secreted proteins, Transporters" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "adrenal gland: 236.7" "Group enriched" "Detected in many" 5 "BJ hTERT+: 43.0;U-2197: 44.5" "Cancer enhanced" "Detected in all" "melanoma: 62.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 113 "eosinophil: 28.1;neutrophil: 14.0" "Lineage enriched" "Detected in single" 151 "granulocytes: 28.1" "Group enriched" "Detected in many" 7 "amygdala: 134.6;basal ganglia: 51.6;cerebral cortex: 101.0;hippocampal formation: 166.1" "Low region specificity" "Detected in many" "HPA018449, HPA019684, CAB034423" Enhanced Enhanced Vesicles "Secreted to blood" 269030000 2900000 Vesicles "CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190" "unprognostic (5.04e-2)" "unprognostic (1.01e-1)" "unprognostic (7.36e-3)" "unprognostic (1.30e-3)" "unprognostic (9.35e-3)" "unprognostic (4.92e-1)" "unprognostic (8.10e-2)" "unprognostic (6.04e-2)" "unprognostic (1.79e-2)" "unprognostic (9.17e-2)" "unprognostic (1.67e-1)" "unprognostic (3.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.74e-3)" "unprognostic (1.51e-1)" "unprognostic (1.98e-1)" "unprognostic (2.72e-2)" 6.3 236.7 2.2 1.4 7.9 1.0 5.6 3.1 12.3 5.0 2.0 3.6 3.6 1.5 5.8 2.9 1.9 3.0 2.0 5.7 3.5 1.9 4.9 0.9 2.9 1.1 2.1 15.1 1.8 2.7 2.1 13.4 0.8 7.4 5.6 2.2 1.2 1.2 5.0 1.6 3.6 1.5 2.5 2.5 1.0 1.6 2.6 0.0 0.0 6.9 4.8 1.1 3.3 2.5 0.0 0.1 28.1 0.1 0.0 0.0 0.0 0.0 1.0 0.6 0.0 3.9 1.0 0.0 5.7 43.0 5.2 3.0 0.0 0.1 0.0 4.5 7.2 3.6 0.2 0.0 1.7 0.0 0.1 0.0 3.3 0.0 0.1 0.0 0.0 0.2 0.0 2.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 8.6 0.0 0.0 0.0 5.5 0.0 1.3 0.0 2.1 0.0 8.0 0.0 0.0 0.0 3.7 5.7 44.5 1.1 0.0 0.0 0.0 5.9 1.8 4.3 0.0 0.1 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 2.2 7.9 3.1 12.3 3.5 1.9 2.1 15.1 7.4 0.0 NOX3 GP91-3 ENSG00000074771 "NADPH oxidase 3" Q9HBY0 6 155395370-155455903 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "adrenal gland: 1.8" "Cell line enriched" "Detected in single" 9 "MCF7: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA073837 Uncertain Vesicles Vesicles "HPA073837: " "unprognostic (3.42e-1)" 0.0 1.8 0.4 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.6 0.3 0.1 0.0 0.0 0.0 NOXA1 "FLJ25475, NY-CO-31, SDCCAG31" ENSG00000188747 "NADPH oxidase activator 1" Q86UR1 9 137423350-137434406 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 10.4;EFO-21: 9.6;MCF7: 15.9;T-47d: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.5" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA044781 Uncertain Approved Vesicles Vesicles "HPA044781: AB_10960532" "unprognostic (2.15e-1)" "unprognostic (2.86e-1)" "unprognostic (1.55e-3)" "unprognostic (1.42e-3)" "unprognostic (4.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.79e-1)" "unprognostic (3.99e-3)" "unprognostic (2.72e-1)" "unprognostic (1.69e-1)" "unprognostic (5.45e-3)" "unprognostic (1.97e-3)" "prognostic favourable (2.65e-4)" "unprognostic (4.97e-3)" "unprognostic (2.67e-1)" "unprognostic (1.74e-1)" "unprognostic (3.10e-2)" 5.1 7.1 8.5 13.9 13.0 3.8 5.9 9.9 11.8 8.9 16.0 7.5 14.5 23.2 8.4 15.7 11.9 8.2 19.7 3.8 7.5 9.7 11.0 9.2 8.6 4.7 5.1 10.1 9.0 17.4 10.4 13.4 2.1 5.2 8.4 5.2 10.0 25.2 11.3 11.6 21.8 22.6 3.9 4.2 7.8 21.1 3.4 4.0 2.5 10.8 8.1 11.3 5.9 6.5 0.4 1.7 0.1 5.5 1.6 1.0 0.4 1.6 4.1 0.1 3.2 0.3 0.0 2.2 0.3 0.5 0.1 0.2 0.7 10.4 0.0 9.6 0.1 7.0 0.1 0.2 0.0 4.4 3.5 0.0 2.5 1.5 1.0 0.1 2.0 0.3 2.3 0.0 0.1 0.2 0.5 0.6 0.0 15.9 0.0 0.9 0.2 1.4 0.1 0.0 6.1 2.8 3.5 0.9 0.3 0.2 1.7 1.6 15.6 1.3 1.0 0.2 2.2 2.4 0.3 0.6 0.0 0.0 0.2 0.5 0.5 0.0 1.2 0.1 0.1 1.8 0.5 0.4 0.1 0.0 1.7 0.2 0.4 1.0 0.0 1.6 5.5 0.0 0.0 0.4 8.5 13.0 9.9 11.8 7.5 9.7 5.1 10.1 5.2 4.0 NPC1 SLC65A1 ENSG00000141458 "NPC intracellular cholesterol transporter 1" O15118 18 23506184-23586898 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.6" "Cell line enhanced" "Detected in all" "hTERT-HME1: 70.3;U-87 MG: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 32.7" "Group enriched" "Detected in all" 4 "dendritic cells: 32.7;T-cells: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026618, CAB070132, HPA077445" Approved Supported Nucleoplasm,Vesicles 27000 "Nucleoplasm, Vesicles" "CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: " "unprognostic (1.74e-1)" "unprognostic (1.53e-3)" "unprognostic (2.67e-1)" "unprognostic (1.25e-1)" "unprognostic (3.20e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (2.26e-6)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (7.36e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-3)" "unprognostic (2.78e-2)" "unprognostic (1.89e-1)" "unprognostic (2.73e-2)" "unprognostic (1.38e-1)" "unprognostic (2.08e-3)" 13.4 38.8 17.4 11.2 30.9 26.4 15.8 7.1 25.1 10.1 8.7 65.6 3.4 10.2 11.1 11.7 12.8 8.2 11.2 7.1 23.4 14.3 9.9 10.3 17.8 13.0 46.0 15.4 12.0 7.9 51.8 9.9 18.9 27.7 9.7 8.9 12.0 25.4 10.1 13.7 17.0 12.2 10.9 41.4 11.5 12.0 9.5 38.4 7.0 8.3 5.3 10.7 10.8 10.8 3.6 32.7 3.8 5.8 4.6 14.5 4.1 5.3 10.6 4.5 7.4 14.9 11.6 10.5 9.3 20.2 9.9 21.4 7.1 7.8 4.5 7.2 13.4 15.0 5.8 15.9 8.8 3.5 4.6 1.6 9.6 16.0 21.4 6.1 7.3 11.1 15.8 20.8 70.3 9.7 4.8 12.0 11.0 8.1 2.5 3.6 3.2 9.6 3.6 7.2 11.2 23.0 13.3 1.9 3.7 11.1 16.1 13.7 4.0 4.8 12.5 21.0 4.1 8.3 8.0 7.5 23.1 3.1 46.2 5.4 9.4 1.8 4.1 3.8 14.5 3.8 9.8 2.4 5.9 9.9 1.7 3.6 2.7 7.3 3.7 4.6 5.8 32.7 7.7 4.1 17.4 30.9 7.1 25.1 23.4 14.3 46.0 15.4 27.7 38.4 NPHP1 "JBTS4, NPH1, SLSN1" ENSG00000144061 "Nephrocystin 1" O15259 2 110122311-110205066 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 36.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046093, HPA074071" Approved Uncertain Vesicles Vesicles "HPA046093: , HPA074071: " "unprognostic (2.10e-2)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (5.58e-2)" "unprognostic (4.63e-2)" "unprognostic (1.56e-3)" "unprognostic (4.66e-2)" "unprognostic (1.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.66e-2)" "unprognostic (1.29e-2)" "unprognostic (1.08e-1)" "unprognostic (2.93e-3)" "unprognostic (3.35e-2)" "unprognostic (1.82e-1)" "unprognostic (8.64e-2)" 3.1 4.3 8.5 1.8 13.7 0.8 5.1 2.1 7.2 5.6 4.7 4.9 8.8 1.7 7.2 11.3 2.1 19.3 4.3 4.4 9.0 7.5 8.7 1.5 5.7 1.5 3.8 6.2 5.4 3.5 17.7 28.1 2.1 20.3 4.4 2.6 4.6 2.8 8.9 36.7 1.7 1.8 7.2 5.4 1.9 3.7 25.0 7.2 0.0 8.9 3.2 1.3 4.1 3.7 3.5 1.0 1.0 0.3 3.2 1.8 0.7 8.6 2.7 5.7 4.2 3.3 6.9 1.2 2.2 7.2 7.8 7.7 2.8 6.5 0.5 5.8 5.1 4.2 2.7 7.0 9.3 1.6 3.5 0.2 1.7 1.9 4.6 1.3 0.0 4.7 4.2 12.1 3.9 4.9 0.1 0.8 4.6 1.7 0.8 2.1 2.6 4.5 0.0 6.0 0.2 13.2 0.7 3.1 3.1 3.2 3.9 7.9 4.7 1.0 3.1 4.5 3.9 5.0 7.0 2.4 2.5 0.6 13.3 0.2 3.2 0.7 0.1 0.1 1.2 0.3 1.8 2.7 0.9 0.6 1.0 3.5 1.8 1.4 1.0 3.2 0.1 0.1 0.1 0.7 8.5 13.7 2.1 7.2 9.0 7.5 3.8 6.2 20.3 7.2 NPHP4 "KIAA0673, POC10, SLSN4" ENSG00000131697 "Nephrocystin 4" O75161 1 5862811-5992473 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ciliopathy, Disease mutation, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063852, HPA065526" Approved Approved "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies, Vesicles" "HPA063852: , HPA065526: " "unprognostic (1.82e-1)" "unprognostic (1.57e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (5.83e-2)" "unprognostic (2.53e-2)" "unprognostic (1.08e-2)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (1.23e-2)" "unprognostic (7.49e-3)" "unprognostic (9.00e-2)" "unprognostic (1.75e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" 5.6 4.7 7.3 4.7 11.2 7.2 4.9 6.3 12.0 5.4 3.5 4.9 8.9 4.4 5.2 11.9 3.7 17.4 5.7 3.7 6.6 3.9 4.5 2.5 6.7 4.6 2.8 6.4 7.0 4.9 7.1 17.8 3.7 5.4 4.5 2.9 8.3 4.1 5.7 3.7 9.6 4.5 5.3 3.5 4.6 4.3 11.4 3.7 5.8 14.9 3.7 2.6 4.3 4.5 0.5 0.4 2.6 1.0 0.5 0.8 0.4 7.5 4.2 5.6 4.4 5.1 7.4 4.4 4.0 4.1 5.6 4.4 4.0 6.7 4.0 10.0 4.5 7.1 2.8 6.8 2.8 4.9 6.4 3.3 7.7 3.6 3.5 6.6 5.2 5.9 3.4 6.6 4.2 3.9 6.1 4.3 2.5 5.6 8.0 6.6 0.9 4.5 6.9 3.6 6.5 2.5 1.0 17.9 5.5 6.2 4.6 6.6 6.1 7.2 3.5 8.1 3.4 13.3 4.8 5.2 6.8 4.0 3.4 8.3 2.1 2.6 1.0 0.0 0.5 0.2 0.8 0.3 0.5 0.0 0.4 0.5 0.4 0.0 1.4 0.5 0.8 0.3 0.2 0.4 7.3 11.2 6.3 12.0 6.6 3.9 2.8 6.4 5.4 3.7 NPL "C1orf13, DHDPS1, NPL1" ENSG00000135838 "N-acetylneuraminate pyruvate lyase" Q9BXD5 1 182789293-182830384 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.0" "Cell line enhanced" "Detected in many" "Karpas-707: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 76.0" "Group enriched" "Detected in many" 36 "granulocytes: 76.0;monocytes: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028345, HPA075808" Enhanced Approved "Vesicles,Plasma membrane" 190000 Vesicles "Plasma membrane" "HPA028345: AB_10610145, HPA075808: " "unprognostic (2.43e-2)" "unprognostic (5.71e-3)" "unprognostic (1.72e-2)" "unprognostic (1.06e-1)" "unprognostic (1.57e-1)" "unprognostic (3.06e-1)" "prognostic unfavourable (8.05e-4)" "unprognostic (4.41e-2)" "unprognostic (6.54e-3)" "unprognostic (1.45e-1)" "unprognostic (1.49e-1)" "unprognostic (6.18e-2)" "prognostic unfavourable (6.63e-4)" "unprognostic (2.11e-1)" "unprognostic (2.93e-2)" "unprognostic (2.35e-2)" "unprognostic (7.44e-2)" 14.9 6.8 10.9 14.2 12.3 12.4 5.3 3.5 10.2 3.9 5.3 15.0 11.4 2.4 2.5 23.7 8.0 4.1 10.1 4.7 9.2 8.7 37.4 15.4 14.3 20.4 16.0 8.6 2.8 3.2 2.5 2.5 32.9 15.4 4.4 7.4 3.9 5.7 5.8 2.4 6.5 4.8 5.8 15.3 32.1 4.0 4.0 14.4 3.1 3.4 1.3 10.9 11.8 5.5 0.7 1.3 76.0 23.6 0.0 1.3 10.3 2.7 0.5 0.8 0.0 2.4 2.4 0.7 0.9 1.8 1.0 0.5 0.0 1.2 7.3 1.3 0.0 1.1 1.6 2.0 0.2 0.0 1.2 11.6 0.3 0.1 1.3 4.3 6.9 1.9 7.7 0.2 0.0 0.1 8.7 11.7 1.8 0.9 0.2 2.9 9.3 0.9 1.1 0.6 8.9 0.2 6.1 2.6 3.9 4.2 0.2 3.7 2.4 7.1 0.2 1.0 2.0 0.6 0.1 8.4 10.1 7.4 2.1 7.8 3.0 3.6 23.6 18.0 1.0 20.8 0.9 0.3 0.8 0.9 1.3 0.7 0.7 0.9 76.0 0.0 16.0 0.2 1.3 10.3 10.9 12.3 3.5 10.2 9.2 8.7 16.0 8.6 15.4 14.4 NR0B1 "AHC, AHCH, DAX1, DSS" ENSG00000169297 "Nuclear receptor subfamily 0 group B member 1" P51843 X 30304206-30309598 "Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Receptor, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 23.9;testis: 36.0" "Group enriched" "Detected in some" 4 "A549: 34.3;RT4: 10.8" "Cancer enhanced" "Detected in many" "lung cancer: 4.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA061948, HPA067207" Supported "Nuclear speckles,Vesicles,Centriolar satellite" "Nuclear speckles" "Vesicles, Centriolar satellite" "HPA061948: , HPA067207: " "unprognostic (1.50e-2)" "unprognostic (9.68e-2)" "unprognostic (9.47e-3)" "unprognostic (1.23e-1)" "unprognostic (2.81e-1)" "unprognostic (7.45e-3)" "unprognostic (4.83e-2)" "unprognostic (9.00e-2)" "unprognostic (1.33e-3)" 0.4 23.9 1.0 0.0 0.8 0.0 0.2 0.4 1.1 1.3 0.1 1.7 0.0 0.0 0.4 0.9 0.1 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.1 0.0 0.5 0.6 3.5 2.1 0.0 1.6 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.6 0.1 0.7 36.0 0.7 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 5.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.4 1.1 0.9 0.9 0.5 0.6 0.6 0.7 NR1H2 "LXR-b, NER, NER-I, RIP15, UNR" ENSG00000131408 "Nuclear receptor subfamily 1 group H member 2" P55055 19 50329653-50382982 "Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005446, HPA056838, HPA070212" Uncertain Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA005446: , HPA056838: , HPA070212: " "unprognostic (1.31e-1)" "unprognostic (5.35e-2)" "prognostic unfavourable (9.86e-4)" "unprognostic (1.34e-3)" "unprognostic (1.68e-1)" "unprognostic (5.24e-3)" "unprognostic (2.26e-2)" "unprognostic (9.69e-2)" "unprognostic (6.45e-2)" "unprognostic (5.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.88e-1)" "unprognostic (2.69e-2)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (5.12e-2)" "unprognostic (1.69e-3)" 30.1 27.5 24.5 24.7 27.5 98.0 24.4 20.6 33.5 25.1 30.9 23.1 25.2 30.9 31.2 23.1 27.9 26.9 28.7 36.8 23.8 19.4 27.1 31.4 28.3 23.3 31.7 25.9 26.5 37.6 22.0 18.6 30.5 28.1 27.9 10.5 23.2 33.8 33.8 76.2 25.3 30.3 29.9 22.9 29.9 26.7 21.2 29.1 20.4 27.1 24.4 21.7 33.2 27.6 34.1 34.2 63.0 37.7 22.3 28.6 32.5 16.0 42.2 4.1 10.3 12.1 12.8 13.2 22.2 18.9 13.2 15.1 8.7 15.6 10.3 19.9 13.3 15.0 2.6 12.1 3.2 25.7 22.7 9.9 14.2 9.0 23.3 16.3 27.1 13.4 16.6 13.5 9.2 12.0 16.1 21.5 7.4 17.8 11.6 13.4 8.3 36.3 7.0 10.7 17.9 11.3 18.0 4.6 16.1 14.4 17.9 13.9 12.3 13.6 15.1 17.7 14.4 18.0 19.7 26.9 22.2 7.5 35.3 10.8 17.7 39.1 35.9 63.0 27.7 35.0 27.0 34.1 27.4 25.9 34.2 34.1 28.6 24.9 55.4 22.3 37.7 29.5 24.4 32.5 24.5 27.5 20.6 33.5 23.8 19.4 31.7 25.9 28.1 29.1 NRCAM "Bravo, KIAA0343" ENSG00000091129 "Neuronal cell adhesion molecule" Q92823 7 108147623-108456717 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.0" "Cell line enhanced" "Detected in some" "A549: 26.0;AF22: 25.2;EFO-21: 47.1;HMC-1: 50.3;SH-SY5Y: 31.0" "Cancer enriched" "Detected in all" 7 "glioma: 57.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD8 T-cell: 5.5" "Lineage enriched" "Detected in single" 15 "T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012606 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" 70000000 Nucleoplasm "Vesicles, Plasma membrane" "HPA012606: AB_1854636" "unprognostic (2.66e-1)" "unprognostic (2.65e-1)" "unprognostic (2.52e-3)" "unprognostic (2.18e-2)" "unprognostic (4.08e-3)" "unprognostic (1.01e-2)" "unprognostic (4.47e-3)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "unprognostic (4.81e-2)" "unprognostic (9.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.22e-2)" "unprognostic (9.70e-3)" "unprognostic (6.42e-2)" "unprognostic (6.51e-3)" "unprognostic (3.28e-2)" 2.5 28.7 24.5 2.3 23.7 1.2 1.6 16.6 82.0 5.0 1.6 10.5 9.5 1.5 2.6 26.6 1.5 3.7 6.3 1.1 19.1 15.9 5.8 1.3 2.7 1.6 11.8 21.2 2.1 21.5 1.2 14.6 6.4 21.7 1.6 1.6 0.7 2.4 12.1 1.0 1.6 1.5 1.6 10.8 4.2 2.3 2.2 9.9 0.0 4.0 0.0 2.9 1.5 0.8 0.1 0.0 0.3 0.0 0.0 5.5 0.6 0.0 26.0 25.2 0.0 3.1 0.6 0.5 0.1 0.1 0.2 0.4 10.5 0.0 0.0 47.1 0.2 0.1 0.5 0.4 0.2 0.0 3.3 0.0 0.2 0.2 0.0 0.2 50.3 4.2 0.0 0.0 0.1 16.2 0.0 0.2 0.4 9.7 0.1 0.0 3.4 0.0 0.0 7.4 8.5 5.8 0.0 4.9 31.0 0.3 0.0 0.5 0.0 0.0 17.2 1.1 0.2 0.0 4.2 0.0 0.1 0.2 0.1 0.0 14.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.0 0.6 24.5 23.7 16.6 34.7 19.1 15.9 11.8 21.2 21.7 9.9 NREP "C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17" ENSG00000134986 "Neuronal regeneration related protein" Q16612 5 111662621-111997464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 149.5" "Cell line enhanced" "Detected in many" "AF22: 71.1;SH-SY5Y: 77.0" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 149.5" "Group enriched" "Detected in many" 5 "myeloid DC: 16.0;NK-cell: 4.1;plasmacytoid DC: 16.2" "Low lineage specificity" "Detected in many" HPA000545 Approved Approved Vesicles Vesicles "HPA000545: AB_1845721" "unprognostic (2.85e-2)" "unprognostic (1.00e-2)" "unprognostic (2.30e-1)" "unprognostic (1.48e-3)" "unprognostic (4.37e-1)" "unprognostic (2.26e-1)" "unprognostic (8.16e-3)" "unprognostic (1.58e-1)" "unprognostic (6.45e-3)" "unprognostic (1.32e-1)" "unprognostic (3.76e-2)" "unprognostic (2.02e-1)" "unprognostic (4.44e-2)" "prognostic unfavourable (3.09e-4)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (5.76e-3)" 4.2 14.4 14.1 5.0 21.9 7.1 6.4 149.5 45.5 8.2 8.5 6.7 4.3 3.5 21.7 4.1 5.2 4.6 16.0 17.2 15.7 10.5 11.7 11.7 6.3 3.3 11.0 21.5 10.4 2.9 1.7 5.0 28.2 27.8 13.1 5.9 16.1 8.3 18.2 39.6 4.7 3.9 13.1 8.0 8.3 5.6 3.0 4.3 34.1 4.7 8.6 3.8 7.4 6.4 0.9 16.2 0.0 2.6 4.1 1.1 1.4 0.1 1.1 71.1 15.1 3.4 8.0 3.3 23.7 14.0 22.5 37.3 0.1 0.4 11.7 7.4 11.4 0.0 14.7 0.8 11.7 4.7 2.1 9.1 6.0 12.5 4.7 12.1 0.1 7.7 3.7 21.8 7.5 25.4 0.1 1.2 23.3 0.2 47.9 8.5 40.2 5.5 51.6 28.7 3.1 8.6 0.2 16.2 77.0 5.2 0.3 0.5 2.9 33.5 5.0 27.4 9.2 13.4 2.5 5.7 4.6 14.7 6.0 25.6 5.3 0.0 2.6 0.0 0.0 1.3 0.0 0.9 0.1 0.1 16.0 0.8 0.8 1.1 0.0 4.1 0.6 16.2 0.0 1.4 14.1 21.9 149.5 45.5 15.7 10.5 11.0 21.5 27.8 4.3 NRG3 ENSG00000185737 "Neuregulin 3" P56975 10 81875314-82987179 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6" "Cell line enhanced" "Detected in some" "AF22: 1.5;HEK 293: 3.3;HUVEC TERT2: 1.6;SK-MEL-30: 7.2;U-2 OS: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075789 Uncertain Vesicles "Secreted in brain" Vesicles "HPA075789: " "unprognostic (6.15e-3)" "unprognostic (2.43e-2)" "unprognostic (1.65e-5)" "unprognostic (1.89e-1)" "unprognostic (7.03e-4)" "unprognostic (1.85e-2)" "unprognostic (1.06e-1)" "unprognostic (7.05e-2)" "unprognostic (9.33e-2)" "unprognostic (1.82e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-2)" "unprognostic (3.31e-4)" "unprognostic (1.04e-1)" "unprognostic (7.68e-3)" "unprognostic (7.27e-4)" 0.9 1.5 15.6 1.2 8.2 0.6 2.8 1.9 30.6 0.8 0.9 4.8 0.0 0.8 0.7 0.7 0.9 8.0 5.3 0.9 14.5 6.2 1.2 1.5 1.6 0.8 4.9 8.0 0.7 0.9 0.7 1.6 1.2 6.5 0.9 0.9 3.1 5.0 1.1 0.7 0.8 0.9 0.9 5.6 0.8 0.8 3.3 6.0 0.0 0.9 0.0 0.8 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 8.2 1.9 12.8 14.5 6.2 4.9 8.0 6.5 6.0 NRP2 VEGF165R2 ENSG00000118257 "Neuropilin 2" O60462 2 205681990-205798133 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Heparin-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.2;HUVEC TERT2: 30.0;TIME: 28.6;U-251 MG: 58.5;U-87 MG: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.8;naive B-cell: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039980, HPA054974" Enhanced Supported "Vesicles,Plasma membrane" "Secreted in other tissues" 15000000 "Vesicles, Plasma membrane" "HPA039980: AB_10795517, HPA054974: " "unprognostic (4.28e-2)" "unprognostic (1.17e-1)" "unprognostic (8.12e-3)" "unprognostic (3.38e-1)" "unprognostic (1.62e-1)" "unprognostic (1.57e-2)" "unprognostic (9.36e-2)" "unprognostic (3.70e-1)" "unprognostic (2.15e-3)" "unprognostic (2.90e-2)" "unprognostic (2.56e-3)" "unprognostic (4.17e-1)" "prognostic unfavourable (7.68e-7)" "unprognostic (2.22e-3)" "unprognostic (5.45e-2)" "unprognostic (6.41e-3)" "prognostic unfavourable (7.80e-5)" 24.3 14.5 8.7 11.4 7.4 2.6 7.8 1.2 7.0 34.4 35.4 3.9 8.4 3.5 33.7 4.6 24.8 13.1 25.8 4.4 11.5 8.3 3.4 6.2 15.8 4.9 8.9 3.9 33.0 1.4 2.5 6.6 29.9 9.0 18.6 7.0 27.7 2.6 21.0 2.5 3.3 8.2 44.7 8.6 4.7 17.1 3.4 5.2 2.6 7.3 6.0 3.0 39.3 24.6 1.4 0.5 0.0 1.8 0.0 0.0 0.5 0.6 14.1 9.0 0.0 8.2 2.6 2.6 2.2 4.3 2.8 2.7 13.3 34.2 0.0 3.4 7.1 5.4 0.4 4.3 4.6 0.0 1.9 0.1 0.6 0.1 22.2 0.0 0.5 19.5 3.3 3.9 3.5 30.0 0.0 0.0 1.9 0.0 0.0 0.0 11.3 2.5 0.0 0.5 3.1 5.7 0.0 8.1 0.3 0.3 0.0 20.2 0.0 0.1 28.6 12.4 0.1 3.2 58.5 0.0 0.0 0.8 27.6 0.0 25.9 0.0 1.8 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.7 7.4 1.2 3.8 11.5 8.3 8.9 3.9 9.0 5.2 NRSN2 "C20orf98, dJ1103G7.6" ENSG00000125841 "Neurensin 2" Q9GZP1 20 346782-359660 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015967 Approved Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA015967: AB_1854647" "unprognostic (5.67e-2)" "unprognostic (3.47e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (4.05e-2)" "unprognostic (4.48e-2)" "unprognostic (1.48e-1)" "unprognostic (4.96e-2)" "unprognostic (5.92e-2)" "prognostic favourable (1.61e-4)" "unprognostic (6.96e-2)" "unprognostic (1.96e-3)" "unprognostic (2.94e-2)" "unprognostic (1.96e-1)" "unprognostic (7.85e-3)" "unprognostic (1.73e-3)" 8.4 18.6 34.3 6.0 39.3 0.9 7.2 22.7 70.9 12.8 6.6 11.0 4.9 3.5 12.5 16.0 6.1 13.4 9.3 13.5 31.1 24.9 10.1 1.8 8.7 4.1 17.1 28.5 18.3 10.5 26.5 16.3 10.1 27.8 12.2 6.1 12.8 13.3 16.5 1.4 5.0 3.8 16.3 8.7 5.7 5.3 12.8 6.8 1.3 14.9 2.5 4.2 9.4 4.8 9.4 4.8 1.5 1.1 3.4 3.9 1.5 18.7 22.9 13.8 13.0 18.3 20.5 5.4 12.5 24.2 22.7 22.9 12.6 0.4 0.0 4.4 23.1 8.3 11.1 1.9 14.5 0.1 11.2 6.8 10.9 23.8 18.5 0.2 1.1 23.2 1.5 16.2 2.7 15.6 13.4 12.2 19.9 3.3 0.3 5.8 10.6 11.8 10.7 7.7 0.9 22.7 0.1 28.2 20.3 14.9 4.4 21.4 18.3 7.0 10.4 24.4 12.9 0.9 15.2 2.2 0.4 5.1 3.2 0.2 12.8 0.0 1.1 1.5 3.8 0.3 1.1 7.2 1.1 3.9 2.1 9.4 1.6 2.7 0.0 3.4 0.4 4.8 0.9 1.5 34.3 39.3 22.7 70.9 31.1 24.9 17.1 28.5 27.8 6.8 NSMCE1 NSE1 ENSG00000169189 "NSE1 homolog, SMC5-SMC6 complex component" Q8WV22 16 27224991-27268794 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041567, HPA043091" Supported Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA041567: AB_10964260, HPA043091: AB_10962722" "unprognostic (6.27e-2)" "unprognostic (8.17e-2)" "unprognostic (2.52e-2)" "unprognostic (2.48e-3)" "unprognostic (4.17e-1)" "unprognostic (4.52e-3)" "unprognostic (1.59e-1)" "unprognostic (1.06e-1)" "unprognostic (1.79e-1)" "unprognostic (1.22e-1)" "unprognostic (1.93e-1)" "unprognostic (9.91e-2)" "unprognostic (1.40e-1)" "unprognostic (5.45e-3)" "unprognostic (3.58e-1)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 24.0 37.3 26.7 33.3 27.4 16.9 30.1 16.9 27.2 22.2 24.7 31.4 30.8 14.1 23.1 32.5 34.7 36.0 36.7 21.7 24.3 26.3 30.9 37.4 27.1 36.7 31.9 20.9 29.5 45.3 46.7 20.5 21.4 27.1 33.8 21.2 26.0 37.2 31.5 22.5 19.5 23.8 35.4 32.4 20.9 26.2 55.4 19.3 41.5 33.9 25.7 29.3 27.6 20.4 42.0 38.9 31.8 27.7 60.4 41.6 32.6 14.4 20.8 14.3 15.5 23.2 31.2 11.5 15.5 15.8 11.8 12.3 16.1 35.3 28.5 37.2 23.5 15.6 26.7 46.4 15.3 34.8 18.5 13.1 19.3 30.8 40.5 15.3 9.9 30.5 32.4 29.6 56.7 15.8 17.5 9.0 21.7 24.4 20.0 17.0 12.6 14.4 17.6 17.6 44.5 34.1 9.4 15.1 13.7 10.5 14.7 26.4 24.3 18.4 9.8 14.3 9.0 16.3 14.8 27.0 19.4 21.9 30.8 15.2 6.1 31.8 27.7 25.0 25.2 24.3 27.8 24.1 36.0 30.6 38.9 42.0 41.6 32.6 9.0 60.4 22.5 37.7 32.8 32.6 26.7 27.4 16.9 27.2 24.3 26.3 31.9 20.9 27.1 19.3 NSUN7 FLJ14001 ENSG00000179299 "NOP2/Sun RNA methyltransferase family member 7" Q8NE18 4 40749897-40809985 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 39.5" "Cell line enhanced" "Detected in some" "A-431: 3.9;CAPAN-2: 8.6;Karpas-707: 6.3;MCF7: 4.1;RPTEC TERT1: 4.2;T-47d: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA020653 Uncertain Supported Vesicles Vesicles "HPA020653: AB_1848710" "unprognostic (2.32e-1)" "unprognostic (4.22e-1)" "unprognostic (4.77e-2)" "unprognostic (1.50e-1)" "unprognostic (2.79e-2)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (4.01e-3)" "unprognostic (4.37e-2)" "unprognostic (3.06e-1)" "unprognostic (2.24e-1)" "unprognostic (8.42e-2)" "prognostic favourable (2.76e-8)" "unprognostic (3.69e-2)" "unprognostic (1.15e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-2)" 0.7 1.2 0.9 2.8 2.0 0.7 5.1 0.2 1.0 3.2 7.0 2.4 7.3 2.3 5.9 9.7 4.5 9.1 5.4 5.5 1.0 1.9 6.6 0.7 8.1 4.2 1.0 0.5 4.6 14.1 7.7 7.5 2.8 2.6 5.7 3.2 4.3 15.2 10.3 0.1 1.9 6.7 2.6 1.8 3.6 3.8 39.5 0.2 2.4 11.9 1.5 5.3 3.7 1.5 1.1 0.0 6.1 0.1 0.0 0.0 0.0 3.9 0.4 1.9 0.0 0.0 0.0 2.9 0.0 0.3 0.2 0.2 1.5 8.6 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 4.1 0.1 0.0 2.3 0.5 0.1 0.1 0.0 4.2 1.1 1.0 2.3 0.6 2.7 0.0 6.3 0.0 0.2 0.0 3.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.9 2.0 0.2 1.0 1.0 1.9 1.0 0.5 2.6 0.2 NTF3 NGF2 ENSG00000185652 "Neurotrophin 3" P20783 12 5432112-5521536 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.0;BJ hTERT+ SV40 Large T+: 11.9;BJ hTERT+ SV40 Large T+ RasG12V: 15.8;HBF TERT88: 14.7;RT4: 6.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 16 "cerebellum: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 4.1;basal ganglia: 7.4;cerebellum: 12.3;hippocampal formation: 12.3" "Low region specificity" "Detected in all" HPA032001 Uncertain Approved Vesicles "Secreted in other tissues" Vesicles "HPA032001: " "unprognostic (3.04e-2)" "unprognostic (7.46e-2)" "unprognostic (7.33e-3)" "unprognostic (4.66e-3)" "unprognostic (8.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.36e-3)" "unprognostic (7.68e-2)" "unprognostic (1.35e-1)" "unprognostic (2.14e-1)" "unprognostic (1.86e-1)" "unprognostic (2.20e-1)" "unprognostic (7.77e-4)" "unprognostic (4.02e-3)" "unprognostic (1.92e-1)" "unprognostic (8.06e-3)" "unprognostic (4.51e-3)" 4.9 2.7 0.5 2.4 0.5 0.0 5.4 29.2 0.6 12.9 4.7 0.3 5.6 2.7 9.2 6.8 5.0 2.2 5.3 4.1 1.7 0.2 4.3 10.4 2.5 1.0 0.7 0.2 16.8 0.4 0.1 1.3 2.7 1.2 8.9 1.5 8.9 4.6 3.7 3.6 3.7 6.6 11.5 0.4 8.5 3.0 3.5 0.0 0.2 1.2 3.9 2.0 10.4 9.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 5.4 0.0 0.0 0.0 0.0 3.4 9.0 11.9 15.8 0.1 0.2 0.0 5.4 5.6 1.9 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.5 3.7 6.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 29.2 0.6 1.7 0.2 0.7 0.2 1.2 0.0 NTRK1 "MTC, TRK, TRKA" ENSG00000198400 "Neurotrophic receptor tyrosine kinase 1" P04629 1 156815640-156881850 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 15.8;blood: 32.3;brain: 28.3" "Cell line enriched" "Detected in some" 4 "HMC-1: 41.1" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Region enriched" "Detected in many" 5 "pons and medulla: 28.3" "Cell type enriched" "Detected in single" 127 "basophil: 32.3" "Lineage enriched" "Detected in single" 323 "granulocytes: 32.3" "Region enhanced" "Detected in some" "basal ganglia: 8.2" "Low region specificity" "Detected in all" "CAB004606, HPA035799, HPA076570" Approved Approved Vesicles,Cytosol 140000 "Vesicles, Cytosol" "CAB004606: AB_628397, HPA035799: , HPA076570: " "unprognostic (5.89e-3)" "unprognostic (7.56e-2)" "unprognostic (2.74e-2)" "unprognostic (5.99e-3)" "unprognostic (7.26e-2)" "unprognostic (1.43e-3)" "unprognostic (1.56e-1)" "unprognostic (7.42e-3)" "unprognostic (7.63e-2)" "unprognostic (1.35e-1)" "unprognostic (6.73e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-11)" "unprognostic (2.18e-3)" "unprognostic (3.79e-2)" "unprognostic (1.07e-1)" "unprognostic (4.89e-1)" 1.0 15.8 0.5 0.8 6.0 0.9 0.4 0.0 0.7 0.9 1.1 0.1 0.0 0.8 1.6 2.0 0.7 0.6 2.1 1.5 0.0 1.2 2.9 0.2 1.9 0.3 2.1 0.6 0.3 0.3 0.3 1.1 0.5 28.3 2.2 0.2 3.1 1.2 0.5 0.7 0.2 0.4 1.1 1.2 0.2 1.0 2.4 1.5 0.4 0.3 0.0 0.4 0.7 0.8 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.6 0.0 6.6 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 2.1 0.7 0.0 0.0 0.0 1.1 0.0 0.6 1.2 0.0 0.1 0.0 0.0 0.7 9.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 32.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.0 0.0 0.6 0.0 1.2 2.1 0.6 28.3 1.5 NUDT5 "hYSAH1, YSA1H" ENSG00000165609 "Nudix hydrolase 5" Q9UKK9 10 12165325-12196144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019827 Approved Approved Nucleoplasm,Vesicles,Centrosome 660000 Vesicles "Nucleoplasm, Centrosome" "HPA019827: AB_1854704" "unprognostic (2.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (3.77e-3)" "unprognostic (4.91e-2)" "unprognostic (2.54e-2)" "unprognostic (4.60e-2)" "unprognostic (1.32e-1)" "unprognostic (6.39e-3)" "unprognostic (2.06e-1)" "unprognostic (9.97e-2)" "prognostic unfavourable (7.14e-12)" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (3.68e-2)" 19.6 22.0 17.4 18.6 21.2 13.5 20.2 15.4 21.4 16.7 20.4 16.1 15.2 17.3 10.0 16.5 25.8 16.3 12.1 10.0 16.2 14.3 26.0 57.1 16.8 22.7 21.7 12.8 12.5 16.9 19.1 35.7 19.9 18.5 13.4 24.2 13.2 16.7 19.7 5.1 20.6 15.9 11.6 17.9 22.4 14.1 8.0 21.5 28.2 19.1 16.5 29.5 16.2 18.6 22.4 45.9 50.1 19.5 16.2 37.0 20.4 37.3 27.6 33.0 30.7 32.0 31.6 29.3 27.7 17.7 32.7 35.1 39.6 35.7 37.4 24.1 22.4 37.6 46.0 42.9 30.0 30.6 45.0 31.1 33.9 58.1 33.4 20.6 21.9 33.2 25.6 35.6 18.2 41.6 41.6 25.6 29.7 34.3 38.6 24.2 28.7 17.2 35.3 12.0 43.4 30.5 12.9 15.9 23.9 33.6 25.9 38.5 44.4 21.3 26.0 13.9 26.7 38.8 33.8 21.6 37.9 50.3 29.3 26.9 10.3 8.1 19.1 33.5 22.8 19.5 26.2 22.4 24.6 26.8 27.0 18.3 17.0 23.0 50.1 16.2 14.8 45.9 37.0 20.4 17.4 21.2 15.4 21.4 16.2 14.3 21.7 12.8 18.5 21.5 NUP214 "CAIN, CAN, D9S46E, N214" ENSG00000126883 "Nucleoporin 214" P35658 9 131125561-131234670 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 131.5" "Cell line enhanced" "Detected in all" "K-562: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 43.7;neutrophil: 131.5" "Group enriched" "Detected in many" 5 "granulocytes: 131.5;monocytes: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048789 Approved "Nucleoplasm,Vesicles,Focal adhesion sites" 100000 Nucleoplasm "Vesicles, Focal adhesion sites" "HPA048789: " "unprognostic (1.30e-1)" "unprognostic (9.51e-3)" "unprognostic (9.92e-3)" "unprognostic (1.15e-1)" "unprognostic (7.42e-2)" "unprognostic (8.31e-2)" "unprognostic (1.07e-3)" "unprognostic (2.10e-2)" "unprognostic (3.35e-1)" "unprognostic (4.95e-1)" "unprognostic (6.60e-3)" "unprognostic (1.08e-1)" "prognostic favourable (2.39e-5)" "unprognostic (5.49e-2)" "unprognostic (6.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" 16.9 10.3 11.5 13.8 13.9 29.4 12.9 13.0 14.4 10.2 11.4 19.8 10.4 9.0 15.0 13.7 16.1 12.1 10.2 9.7 9.5 8.1 19.0 15.1 11.7 13.3 13.2 8.8 14.2 17.0 16.7 16.9 13.0 11.3 11.1 10.8 15.3 13.0 11.1 15.5 17.5 11.7 11.1 14.3 35.8 12.3 63.7 13.3 27.4 11.8 7.6 16.8 10.7 11.2 1.2 16.8 131.5 43.7 1.2 0.8 17.9 6.7 9.6 8.2 4.9 6.6 6.4 8.6 6.0 6.2 7.8 6.3 7.8 4.9 10.9 4.8 8.2 15.4 11.0 7.8 7.6 7.9 5.4 6.8 13.7 15.2 5.8 10.6 7.3 7.0 7.2 10.0 8.1 8.0 71.4 6.3 8.0 12.5 13.9 16.0 8.9 8.5 4.8 10.3 10.9 9.0 6.2 7.0 7.2 10.0 9.2 5.2 12.1 26.4 6.8 13.8 7.8 9.0 9.6 5.5 10.7 10.5 6.7 6.4 8.3 3.5 43.7 17.3 0.7 18.4 0.8 1.2 0.7 0.6 16.8 1.1 0.7 0.7 131.5 1.2 15.0 1.5 0.4 17.9 11.5 13.9 13.0 14.4 9.5 8.1 13.2 8.8 11.3 13.3 NUP98 NUP96 ENSG00000110713 "Nucleoporin 98" P52948 11 3671083-3797792 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074810 Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA074810: " "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (7.41e-2)" "unprognostic (2.13e-1)" "unprognostic (7.71e-3)" "unprognostic (3.40e-1)" "unprognostic (4.08e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (7.76e-3)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (5.09e-1)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" 20.2 13.5 8.7 23.5 11.7 40.8 23.5 14.2 13.2 18.0 15.3 14.6 17.8 11.2 19.2 17.5 18.6 17.3 17.1 18.2 7.8 8.0 12.8 20.1 20.7 17.4 11.4 8.7 25.5 19.0 25.7 23.6 20.7 12.7 18.6 15.2 17.8 17.4 25.0 35.2 18.5 15.7 20.8 10.4 18.3 16.0 57.0 10.6 27.5 20.9 15.0 26.6 22.6 19.3 8.9 9.9 24.9 10.0 6.1 13.2 8.7 29.8 23.4 19.3 21.3 21.4 17.6 17.0 21.3 24.9 29.3 26.4 25.7 37.1 29.2 10.1 25.5 32.2 33.9 21.0 40.0 20.7 24.5 31.3 19.2 17.6 18.0 39.9 26.4 20.0 14.5 16.1 29.4 22.7 38.9 23.5 31.1 12.2 40.1 13.0 24.4 18.0 24.5 23.5 14.0 16.7 23.6 17.8 11.9 30.9 25.1 14.2 15.4 15.7 16.6 23.5 20.4 25.6 19.4 14.2 24.2 31.0 15.9 17.2 24.7 19.1 7.9 15.5 11.0 10.0 11.0 8.9 10.7 9.7 9.9 7.8 12.2 10.5 24.9 6.1 6.3 2.7 13.2 8.7 8.7 11.7 14.2 13.2 7.8 8.0 11.4 8.7 12.7 10.6 NUS1 "C6orf68, MGC7199, NgBR, TANGO14" ENSG00000153989 "NUS1 dehydrodolichyl diphosphate synthase subunit" Q96E22 6 117675502-117710640 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Angiogenesis, Differentiation, Lipid metabolism" "Developmental protein, Receptor, Transferase" "Congenital disorder of glycosylation, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027504 Supported Approved "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA027504: AB_10603124" "unprognostic (1.21e-2)" "prognostic unfavourable (6.99e-4)" "unprognostic (1.09e-2)" "unprognostic (2.31e-1)" "unprognostic (1.21e-1)" "unprognostic (8.26e-3)" "unprognostic (1.42e-3)" "unprognostic (2.42e-2)" "unprognostic (8.62e-2)" "unprognostic (2.99e-1)" "unprognostic (2.62e-1)" "unprognostic (8.35e-2)" "unprognostic (1.00e-1)" "unprognostic (2.27e-1)" "unprognostic (3.22e-2)" "unprognostic (1.56e-1)" "unprognostic (7.97e-2)" 8.4 10.2 14.7 9.3 14.7 7.0 10.0 8.8 13.4 29.6 9.2 6.8 2.0 7.1 9.6 13.5 9.5 8.8 7.1 8.2 12.7 9.9 13.1 17.4 9.5 8.4 16.4 15.7 8.8 28.9 15.0 20.0 10.6 16.2 9.6 9.3 7.1 13.8 14.9 7.9 6.1 14.4 8.5 7.3 9.1 10.6 5.6 12.2 7.2 16.5 3.1 8.7 9.1 18.0 2.4 8.1 3.3 4.9 4.1 4.5 2.3 10.0 7.4 16.1 18.0 16.3 21.4 39.6 18.5 19.3 15.5 17.9 16.8 11.3 23.9 20.1 17.0 9.2 23.9 18.1 28.9 17.9 22.0 27.3 12.5 30.1 25.1 34.4 16.1 18.7 20.6 16.9 34.7 15.9 32.6 21.3 23.1 11.4 16.1 21.9 18.7 13.6 15.6 11.6 17.1 30.7 10.1 19.1 15.1 11.1 14.5 13.6 9.2 36.1 13.9 9.6 11.9 15.3 26.5 29.6 22.1 25.4 22.7 26.5 19.1 3.3 3.0 1.8 3.1 3.0 4.5 2.4 3.7 4.1 3.2 2.1 3.1 4.0 0.2 4.1 4.9 8.1 3.4 2.3 14.7 14.7 8.8 13.4 12.7 9.9 16.4 15.7 16.2 12.2 NXPE3 "FAM55C, MGC15606" ENSG00000144815 "Neurexophilin and PC-esterase domain family member 3" Q969Y0 3 101779202-101827392 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.6" "Cell line enhanced" "Detected in many" "Karpas-707: 37.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036259 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" 7600 Vesicles Nucleoplasm "HPA036259: AB_10671838" "unprognostic (3.30e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (4.42e-5)" "unprognostic (4.98e-2)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (7.42e-2)" "unprognostic (1.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.57e-3)" "unprognostic (3.43e-1)" "prognostic unfavourable (7.76e-6)" "unprognostic (2.89e-1)" "unprognostic (5.23e-2)" "unprognostic (1.77e-1)" "unprognostic (8.75e-3)" 6.1 4.7 7.2 7.6 16.6 7.8 5.3 6.1 16.2 6.3 5.2 29.5 6.0 2.4 7.9 2.6 4.5 8.2 4.8 12.6 9.8 5.9 3.0 2.5 6.9 10.7 24.0 8.6 5.5 2.6 15.8 6.9 4.7 22.0 6.2 3.4 3.4 4.2 7.5 44.6 2.5 4.9 7.6 9.4 8.7 4.6 5.1 17.2 6.6 5.3 4.1 9.8 7.3 5.0 8.9 11.6 15.9 13.6 6.7 19.5 11.1 7.7 11.8 10.2 3.7 11.0 11.6 2.2 8.6 10.9 10.3 15.1 2.7 0.8 11.4 25.5 9.7 1.7 11.3 9.2 12.9 14.1 3.6 8.7 7.5 7.3 14.6 7.4 8.2 6.6 1.6 8.6 3.1 11.1 1.8 37.3 17.1 4.0 9.8 1.8 5.8 7.3 4.5 12.4 4.8 7.6 1.9 8.1 9.6 3.7 0.9 6.4 1.7 10.6 9.6 11.5 13.7 1.3 8.9 17.7 17.6 13.4 9.8 32.8 2.2 6.3 13.6 15.9 12.7 10.4 8.8 8.9 14.2 13.2 11.6 5.8 19.5 15.5 6.9 6.7 9.9 7.4 16.3 11.1 7.2 16.6 6.1 16.2 9.8 5.9 24.0 8.6 22.0 17.2 NYAP1 "C7orf51, FLJ37538, KIAA1486L" ENSG00000166924 "Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1" Q6ZVC0 7 100483927-100494799 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.8" "Cell line enhanced" "Detected in some" "AF22: 4.4;HUVEC TERT2: 5.6;SH-SY5Y: 13.6" "Cancer enhanced" "Detected in some" "glioma: 4.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022251 Uncertain Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA022251: AB_1848915" "unprognostic (6.59e-4)" "unprognostic (2.67e-2)" "unprognostic (1.82e-2)" "unprognostic (2.51e-4)" "unprognostic (2.89e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-2)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.20e-1)" "unprognostic (3.06e-2)" "unprognostic (4.31e-1)" "unprognostic (8.65e-2)" 3.1 6.3 11.8 1.6 15.2 1.3 1.4 15.4 32.8 1.8 1.6 3.8 0.0 1.6 2.8 1.3 1.5 1.9 1.6 1.2 13.2 12.8 1.9 1.1 1.3 1.4 7.4 13.4 5.7 2.1 1.1 10.2 1.7 11.4 2.9 1.4 1.0 2.3 3.2 1.2 1.9 1.8 2.1 3.9 1.6 2.3 9.0 4.4 0.0 1.2 0.0 1.2 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.4 2.0 2.9 1.9 0.4 0.1 1.4 0.2 0.6 0.6 0.3 0.0 1.5 0.4 0.2 0.9 0.2 0.1 1.9 0.3 0.2 0.4 0.2 2.1 0.0 1.2 1.9 0.0 0.6 0.7 5.6 0.7 0.1 0.1 0.5 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.1 0.0 1.3 13.6 0.5 0.3 1.3 0.2 0.0 2.0 0.0 2.8 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 15.2 15.4 20.6 13.2 12.8 7.4 13.4 11.4 4.4 NYNRIN "CGIN1, FLJ11811, KIAA1305" ENSG00000205978 "NYN domain and retroviral integrase containing" Q9P2P1 14 24398786-24419288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 45.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 9.0;HEL: 9.0;HUVEC TERT2: 22.3;RT4: 18.4;TIME: 10.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 26.6" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Lineage enhanced" "Detected in single" "dendritic cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018945 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA018945: AB_1859538" "unprognostic (9.41e-3)" "unprognostic (3.96e-2)" "unprognostic (2.02e-1)" "unprognostic (4.49e-3)" "unprognostic (5.08e-2)" "unprognostic (1.14e-2)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.44e-3)" "unprognostic (4.21e-1)" "unprognostic (1.01e-1)" "unprognostic (4.51e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (3.39e-1)" "unprognostic (2.43e-1)" 8.1 2.8 2.1 4.3 2.2 0.2 6.8 26.6 2.6 16.7 7.6 2.5 29.6 2.9 14.6 45.9 11.6 13.4 14.5 5.1 2.2 4.2 6.1 3.6 7.5 2.0 1.8 1.8 28.0 2.9 4.5 4.9 10.5 2.4 9.8 4.1 9.1 5.5 20.2 2.5 9.1 4.5 8.0 1.5 5.2 4.5 7.3 1.4 3.5 7.5 8.5 6.5 8.6 10.2 0.0 1.7 0.0 0.1 0.5 0.1 0.0 0.1 0.0 2.9 0.0 4.1 8.5 0.2 1.3 1.4 0.9 1.0 2.0 9.0 0.2 0.4 5.3 0.0 4.7 0.1 1.0 0.0 0.5 9.0 1.2 0.2 3.0 0.0 0.0 8.6 0.3 0.6 0.0 22.3 1.4 0.0 0.1 0.4 0.0 0.4 1.7 0.0 1.1 0.0 0.0 0.0 18.4 0.4 6.4 0.0 0.8 0.1 1.6 1.3 10.8 0.1 5.4 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 2.1 2.2 26.6 2.6 2.2 4.2 1.8 1.8 2.4 1.4 OAZ1 "AZI, MGC138338, OAZ" ENSG00000104904 "Ornithine decarboxylase antizyme 1" P54368 19 2269509-2273490 "Plasma proteins, Predicted intracellular proteins" "Polyamine biosynthesis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009291 Uncertain Approved "Vesicles,Centriolar satellite" Vesicles "Centriolar satellite" "HPA009291: AB_1079519" "unprognostic (2.37e-1)" "unprognostic (9.69e-3)" "unprognostic (1.72e-1)" "unprognostic (6.04e-3)" "unprognostic (9.41e-2)" "unprognostic (1.90e-1)" "prognostic unfavourable (1.73e-4)" "unprognostic (3.75e-2)" "unprognostic (3.19e-2)" "unprognostic (6.22e-2)" "prognostic favourable (4.10e-5)" "unprognostic (3.58e-2)" "unprognostic (2.40e-1)" "unprognostic (8.37e-2)" "unprognostic (1.72e-1)" "unprognostic (2.44e-2)" "unprognostic (6.01e-2)" 50.7 56.5 73.3 47.5 68.2 84.6 67.4 41.5 68.6 27.2 37.8 22.9 31.1 47.8 32.7 33.7 38.6 40.1 34.0 73.7 67.2 53.3 31.8 45.7 50.3 71.4 60.4 52.3 31.2 86.0 11.9 34.6 53.5 39.9 32.1 24.0 27.1 65.6 33.7 137.4 30.4 55.3 37.3 37.0 66.0 41.4 25.0 29.4 31.8 43.8 59.3 40.1 37.2 45.3 69.7 83.1 150.4 136.3 24.4 54.4 160.8 72.9 15.2 11.7 20.0 24.6 39.4 30.5 52.2 36.3 26.4 36.3 21.6 23.7 49.9 28.2 24.2 21.3 11.5 15.7 17.5 66.3 39.8 38.5 15.1 34.0 25.2 53.7 61.0 26.2 27.5 9.9 15.1 29.9 37.3 58.0 29.7 26.7 44.5 56.1 38.5 27.7 37.0 23.4 65.8 24.0 21.2 27.7 29.4 34.3 31.3 57.3 26.1 114.2 38.0 18.8 23.2 80.9 54.7 56.6 23.3 60.9 85.6 84.4 28.4 109.3 116.3 134.1 36.1 117.5 36.0 69.7 39.5 38.3 83.1 66.6 36.9 36.4 150.4 24.4 136.3 56.0 54.4 160.8 73.3 68.2 41.5 68.6 67.2 53.3 60.4 52.3 39.9 29.4 OIP5 "CT86, hMIS18beta, MIS18B" ENSG00000104147 "Opa interacting protein 5" O43482 15 41309268-41332621 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.7;testis: 41.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA052271, HPA059602" Enhanced Supported "Nuclear speckles,Vesicles" "Nuclear speckles, Vesicles" "HPA052271: , HPA059602: " "unprognostic (5.17e-2)" "unprognostic (7.26e-2)" "unprognostic (3.07e-1)" "unprognostic (1.59e-2)" "unprognostic (6.94e-2)" "unprognostic (6.58e-2)" "prognostic unfavourable (1.79e-4)" "prognostic unfavourable (2.26e-4)" "unprognostic (2.71e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (9.34e-5)" "unprognostic (5.51e-2)" "unprognostic (0.00e+0)" "unprognostic (3.84e-2)" "unprognostic (2.02e-1)" "unprognostic (5.75e-2)" "unprognostic (2.86e-2)" 1.3 2.1 0.5 3.8 0.8 7.5 0.7 1.5 1.1 1.1 3.4 0.7 2.3 3.0 0.6 0.6 4.6 0.6 1.3 1.9 0.9 0.4 1.1 1.1 1.0 4.3 0.6 0.4 1.2 0.6 0.0 0.3 1.6 0.5 0.5 3.1 0.2 1.2 1.3 8.3 2.5 3.1 0.6 0.8 2.7 1.4 41.7 0.7 16.7 0.5 6.3 4.0 0.7 1.5 2.5 7.7 1.1 1.3 1.9 5.9 1.7 13.3 7.1 14.0 10.2 0.7 0.9 13.4 8.2 3.8 9.9 10.7 12.6 6.6 7.9 7.2 3.0 20.8 14.2 6.3 7.8 17.1 16.4 16.8 20.7 13.1 0.1 18.3 9.5 0.3 1.3 5.6 5.9 8.4 23.0 15.4 6.6 6.4 10.7 13.7 12.7 15.5 13.3 11.7 12.0 4.4 6.1 22.3 7.4 13.6 13.9 3.8 13.8 10.5 4.1 10.2 15.8 10.1 14.6 7.3 32.2 28.2 2.9 22.4 14.6 0.0 0.8 1.1 0.6 1.3 1.5 2.1 1.8 1.6 1.4 2.5 2.6 1.7 0.0 1.9 0.8 7.7 5.9 1.7 0.5 0.8 1.5 1.1 0.9 0.4 0.6 0.4 0.5 0.7 OLFM3 NOE3 ENSG00000118733 "Olfactomedin 3" Q96PB7 1 101802574-101997030 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.0" "Group enriched" "Detected in some" 11 "AF22: 9.3;HAP1: 6.4;HEL: 5.7;SCLC-21H: 3.7;SH-SY5Y: 3.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050297 Uncertain Vesicles "Secreted in brain" Vesicles "HPA050297: " "unprognostic (4.19e-1)" "unprognostic (4.19e-4)" "unprognostic (1.26e-1)" "unprognostic (4.61e-2)" "unprognostic (2.93e-1)" "unprognostic (1.47e-2)" "unprognostic (3.58e-4)" "unprognostic (2.48e-1)" "unprognostic (5.68e-2)" 0.7 3.2 5.0 1.4 13.7 0.7 0.8 24.2 30.0 0.9 1.8 0.4 0.0 1.0 0.9 1.2 0.7 0.8 0.8 0.7 4.8 7.4 1.5 0.8 0.7 0.7 6.0 11.9 0.8 0.7 0.7 2.4 0.8 16.6 0.7 1.7 0.3 0.8 0.7 0.7 0.7 2.1 1.3 1.5 0.9 1.0 0.9 0.7 0.0 1.2 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.0 3.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 13.7 24.2 26.7 4.8 7.4 6.0 11.9 16.6 0.7 OLFML3 "HNOEL-iso, OLF44" ENSG00000116774 "Olfactomedin like 3" Q9NRN5 1 113979391-114035572 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 83.1;ASC TERT1: 45.4;BJ hTERT+: 51.8;HSkMC: 83.1;LHCN-M2: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "myeloid DC: 5.4" "Lineage enriched" "Detected in single" 11 "dendritic cells: 5.4" "Low region specificity" "Detected in many" HPA027991 Supported Vesicles "Secreted to extracellular matrix" 1500000 Vesicles "HPA027991: " "unprognostic (1.04e-1)" "unprognostic (8.06e-2)" "unprognostic (1.87e-1)" "unprognostic (1.50e-2)" "unprognostic (1.41e-1)" "unprognostic (1.50e-1)" "unprognostic (2.02e-1)" "unprognostic (3.72e-1)" "unprognostic (1.67e-1)" "unprognostic (3.04e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "prognostic unfavourable (3.45e-5)" "unprognostic (6.80e-3)" "unprognostic (1.88e-1)" "unprognostic (2.61e-1)" "unprognostic (4.41e-3)" 25.8 11.8 3.9 9.7 6.6 0.0 25.6 1.4 7.9 75.3 22.7 16.2 17.9 3.9 57.7 41.8 13.8 33.9 31.5 20.3 3.0 2.3 9.7 9.4 18.4 5.7 7.1 4.0 52.6 11.7 1.0 6.6 29.1 8.9 33.1 9.6 41.4 6.1 21.9 5.8 13.5 10.8 29.4 5.1 2.5 19.1 13.3 4.6 0.6 7.8 15.0 7.0 28.0 37.6 0.0 5.4 0.0 0.4 0.0 0.0 0.2 0.0 2.6 1.3 0.0 83.1 45.4 0.0 10.6 51.8 3.7 12.1 3.4 0.0 0.0 0.5 30.4 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 2.5 21.6 0.0 0.0 83.1 0.0 5.2 0.0 0.2 0.0 0.0 82.9 0.0 0.0 0.0 6.3 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.4 30.7 0.1 0.2 2.1 4.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 12.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 3.9 6.6 1.4 7.9 3.0 2.3 7.1 4.0 8.9 4.6 OLR1 "CLEC8A, LOX-1, SCARE1" ENSG00000173391 "Oxidized low density lipoprotein receptor 1" P78380 12 10158301-10172138 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Inflammatory response" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;lung: 46.8;placenta: 53.4" "Cell line enhanced" "Detected in some" "CACO-2: 32.0;HaCaT: 16.8;HHSteC: 33.8;hTCEpi: 15.5;SiHa: 64.4;SK-BR-3: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.9" "Group enriched" "Detected in many" 6 "dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5" "Low region specificity" "Detected in all" HPA050798 Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" "Nucleoplasm, Plasma membrane" Vesicles "HPA050798: AB_2756318" "unprognostic (2.30e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "prognostic unfavourable (8.24e-5)" "unprognostic (6.34e-2)" "unprognostic (6.07e-3)" "unprognostic (5.40e-2)" "unprognostic (2.64e-1)" "unprognostic (1.97e-2)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (4.94e-3)" "unprognostic (3.47e-2)" "unprognostic (1.48e-2)" "unprognostic (1.42e-1)" 2.0 1.9 6.0 14.1 10.3 10.6 2.0 1.3 10.2 1.9 0.5 21.3 0.0 0.8 1.0 0.9 0.5 1.2 3.9 1.1 8.5 6.7 6.9 1.8 46.8 0.5 16.4 4.4 0.4 1.6 2.8 1.9 53.4 12.3 1.4 0.7 0.2 2.0 0.7 0.4 0.5 0.8 1.2 28.5 0.6 1.4 2.8 10.5 0.0 1.5 0.0 0.6 4.3 0.4 0.5 5.9 3.3 1.5 0.3 0.3 1.1 1.8 0.1 0.0 0.1 0.0 0.0 4.4 3.1 0.5 1.9 0.7 32.0 0.0 0.3 0.0 4.1 16.8 0.0 0.1 1.3 0.0 0.0 0.0 1.6 0.0 33.8 0.0 0.0 0.2 15.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 64.4 25.6 0.0 7.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 1.5 2.7 0.2 0.2 0.3 0.3 0.3 0.2 5.9 0.5 0.3 0.3 3.3 0.3 0.4 0.8 0.2 1.1 6.0 10.3 1.3 7.4 8.5 6.7 16.4 4.4 12.3 10.5 ORM1 ENSG00000229314 "Orosomucoid 1" P02763 9 114323056-114326475 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 834.6" "Cell line enriched" "Detected in some" 11 "Hep G2: 157.9" "Cancer enriched" "Detected in many" 16 "liver cancer: 2506.9" "Cell type enriched" "Detected in some" 45 "neutrophil: 53.4" "Lineage enriched" "Detected in many" 45 "granulocytes: 53.4" "CAB006265, HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" 945333333333 120000000000 Vesicles "Golgi apparatus" "CAB006265: AB_425575, HPA046438: , HPA047725: , HPA057726: " "unprognostic (3.85e-1)" "unprognostic (2.12e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (1.16e-1)" "unprognostic (4.85e-2)" "unprognostic (1.74e-1)" "prognostic unfavourable (2.35e-4)" "unprognostic (2.10e-1)" "unprognostic (4.38e-2)" "unprognostic (9.32e-3)" "unprognostic (4.51e-2)" 0.1 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 834.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 157.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 13.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 0.0 0.2 0.0 0.0 0.3 ORM2 "AGP-B, AGP-B', AGP2" ENSG00000228278 "Orosomucoid 2" P19652 9 114329869-114333252 "Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 404.1" "Cell line enriched" "Detected in single" 237 "Hep G2: 133.4" "Cancer enriched" "Detected in many" 34 "liver cancer: 873.1" "Cell type enriched" "Detected in single" 35 "neutrophil: 13.2" "Lineage enriched" "Detected in single" 35 "granulocytes: 13.2" "HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" 422277500 61000000000 Vesicles "Golgi apparatus" "HPA046438: , HPA047725: , HPA057726: " "unprognostic (6.77e-2)" "unprognostic (8.00e-2)" "unprognostic (1.19e-1)" "unprognostic (4.44e-3)" "unprognostic (1.18e-1)" "unprognostic (5.61e-2)" "unprognostic (5.66e-2)" "unprognostic (9.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-2)" "unprognostic (5.76e-2)" "prognostic unfavourable (1.23e-9)" "unprognostic (3.23e-1)" "unprognostic (6.80e-2)" "unprognostic (7.62e-2)" "unprognostic (9.15e-4)" 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 404.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 133.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.0 0.1 OSBPL5 "KIAA1534, ORP5" ENSG00000021762 "Oxysterol binding protein like 5" Q9H0X9 11 3087116-3166739 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 3.1;gdT-cell: 9.3;intermediate monocyte: 4.4;memory CD8 T-cell: 3.4;myeloid DC: 2.7;naive CD8 T-cell: 3.6;NK-cell: 10.0;non-classical monocyte: 10.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038335, HPA038712, HPA058727" Approved Enhanced Vesicles Vesicles "HPA038335: , HPA038712: AB_10675949, HPA058727: AB_2683799" "unprognostic (6.02e-2)" "unprognostic (1.16e-1)" "unprognostic (1.68e-1)" "unprognostic (3.69e-2)" "unprognostic (8.22e-3)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (4.03e-3)" "unprognostic (1.29e-1)" "unprognostic (3.49e-3)" "unprognostic (2.16e-3)" "unprognostic (9.44e-2)" "unprognostic (2.78e-2)" "unprognostic (1.22e-1)" "unprognostic (6.50e-2)" "unprognostic (7.67e-2)" "unprognostic (2.60e-1)" 17.6 7.0 4.2 10.3 6.2 17.8 20.7 4.4 8.8 24.7 15.6 7.5 24.0 9.0 17.1 15.9 8.1 12.6 13.8 10.0 4.6 6.5 8.1 2.7 12.9 10.5 6.9 6.4 9.6 8.4 2.4 6.5 7.8 9.8 15.9 5.2 9.0 17.1 17.5 28.0 17.8 9.6 20.1 11.9 20.3 10.2 4.4 6.3 36.5 9.3 9.6 3.8 14.3 17.7 0.0 2.7 1.0 10.1 10.0 9.3 3.9 1.7 2.7 3.2 3.7 9.7 4.5 0.0 8.8 4.3 3.5 2.5 0.0 5.1 0.0 2.7 4.9 6.5 0.6 2.4 0.5 1.7 2.5 7.3 8.7 0.0 7.9 6.5 1.1 7.0 2.9 1.2 1.3 2.4 2.5 0.0 1.7 4.9 14.2 36.3 2.3 5.7 7.4 4.4 1.0 1.4 1.6 5.4 0.6 3.6 12.9 3.3 5.3 17.3 8.0 4.5 6.1 10.6 1.5 1.8 0.0 0.2 4.7 12.3 5.6 0.2 3.1 1.0 9.3 4.4 1.2 0.0 1.0 3.4 2.7 0.0 0.6 3.6 0.4 10.0 10.1 1.2 0.1 3.9 4.2 6.2 4.4 8.8 4.6 6.5 6.9 6.4 9.8 6.3 OSBPL8 "MST120, MSTP120, ORP8, OSBP10" ENSG00000091039 "Oxysterol binding protein like 8" Q9BZF1 12 76351797-76559809 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001309 Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA001309: AB_1079530" "unprognostic (2.55e-1)" "unprognostic (2.68e-2)" "unprognostic (2.77e-1)" "unprognostic (1.70e-1)" "unprognostic (5.20e-2)" "unprognostic (1.23e-1)" "unprognostic (6.55e-3)" "unprognostic (2.84e-1)" "unprognostic (7.88e-2)" "unprognostic (1.61e-2)" "prognostic unfavourable (9.79e-4)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (5.63e-3)" "unprognostic (2.96e-1)" "unprognostic (1.16e-1)" "unprognostic (3.19e-3)" 29.3 11.4 13.9 18.4 41.9 23.1 17.2 13.7 20.2 20.0 11.5 6.8 8.4 7.5 18.5 10.7 20.1 10.4 15.0 19.3 13.4 12.9 30.2 15.2 20.5 22.7 12.1 13.2 14.9 11.2 12.4 16.5 14.4 13.9 16.2 9.7 9.2 15.8 11.1 21.5 22.9 12.6 15.5 14.8 24.9 12.4 12.8 14.7 41.0 11.7 10.6 24.8 18.0 24.5 11.7 15.8 57.2 15.0 9.9 10.9 8.1 12.3 7.9 17.6 12.5 24.6 34.8 11.2 19.1 26.7 12.2 11.2 11.4 5.1 17.3 10.9 22.6 5.2 13.1 11.0 18.5 14.8 11.6 46.5 7.8 6.8 15.2 29.4 19.0 18.3 21.0 18.2 22.8 10.5 31.8 8.0 20.1 8.5 19.6 14.0 8.6 7.9 10.3 24.1 9.9 9.4 10.5 9.7 10.1 16.3 6.0 11.8 4.5 18.0 24.6 19.9 9.9 20.4 10.2 8.0 12.6 19.1 7.5 16.6 11.5 27.5 15.0 20.1 9.0 10.8 8.5 11.7 9.6 7.3 13.2 11.6 8.7 7.1 57.2 9.9 11.7 15.8 10.9 8.1 13.9 41.9 13.7 19.9 13.4 12.9 12.1 13.2 13.9 14.7 OSBPL9 ENSG00000117859 "Oxysterol binding protein like 9" Q96SU4 1 51577179-51798427 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027378, HPA027397" Supported Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA027378: AB_1854816, HPA027397: AB_1854817" "unprognostic (5.99e-2)" "unprognostic (1.93e-2)" "unprognostic (1.22e-2)" "unprognostic (2.43e-3)" "unprognostic (3.11e-1)" "unprognostic (6.72e-2)" "unprognostic (2.85e-2)" "unprognostic (2.47e-1)" "unprognostic (4.17e-3)" "unprognostic (1.58e-1)" "unprognostic (8.36e-3)" "unprognostic (8.61e-2)" "unprognostic (3.64e-2)" "unprognostic (7.53e-3)" "unprognostic (2.55e-1)" "unprognostic (4.95e-2)" "unprognostic (3.37e-1)" 35.7 28.8 12.6 19.0 20.7 20.3 27.4 30.3 17.6 29.4 15.4 29.8 20.0 13.1 36.3 29.7 18.8 19.4 15.0 27.2 13.5 16.1 35.4 52.6 25.7 18.2 25.1 14.0 29.4 26.9 43.2 27.6 20.8 22.2 37.1 16.6 29.9 18.2 22.4 55.6 15.2 16.4 25.3 28.2 22.5 22.5 20.0 24.8 19.4 28.2 18.5 24.6 27.7 31.6 23.4 19.9 28.7 13.6 12.8 23.2 12.6 21.7 11.2 22.8 5.0 16.3 8.1 40.8 11.2 18.8 18.1 21.6 16.3 16.4 31.8 19.6 12.3 10.1 19.2 19.4 25.8 22.6 14.1 25.1 21.9 33.5 15.8 25.8 13.0 16.3 18.8 20.4 13.5 23.8 47.5 10.4 10.1 15.5 7.4 28.0 31.0 5.2 18.7 33.1 33.7 24.2 17.0 11.3 15.0 9.5 26.1 31.0 12.6 26.0 14.3 5.2 17.4 6.5 19.9 25.4 16.1 37.1 12.8 12.0 8.0 28.7 13.6 25.0 16.1 11.4 23.2 23.4 16.0 16.6 19.9 16.4 17.1 18.1 15.9 12.8 8.6 15.7 15.3 12.6 12.6 20.7 30.3 17.6 13.5 16.1 25.1 14.0 22.2 24.8 OSTM1 "GL, HSPC019" ENSG00000081087 "Osteopetrosis associated transmembrane protein 1" Q86WC4 6 108041409-108165854 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Osteopetrosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010851 Uncertain Approved Nucleoplasm,Vesicles,Cytosol 130000 Cytosol "Nucleoplasm, Vesicles" "HPA010851: AB_1079533" "prognostic unfavourable (4.36e-4)" "unprognostic (4.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (1.72e-3)" "prognostic unfavourable (4.26e-4)" "unprognostic (9.40e-2)" "unprognostic (2.56e-1)" "unprognostic (2.25e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-1)" "prognostic unfavourable (1.34e-6)" "prognostic unfavourable (1.20e-4)" "unprognostic (2.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" 26.3 21.9 9.0 18.1 13.5 5.5 16.7 13.7 17.2 14.4 17.8 12.8 9.9 8.4 21.8 10.3 14.1 15.0 13.5 23.2 10.4 16.5 22.0 15.9 17.0 17.2 11.0 10.5 15.6 9.7 11.8 26.0 24.7 20.0 15.4 12.4 29.7 10.8 19.0 18.0 10.4 12.9 24.7 13.1 21.7 14.3 11.1 10.7 13.6 12.4 8.1 13.9 21.0 19.4 10.8 12.4 20.9 28.1 14.5 16.4 16.9 2.2 6.5 7.8 11.3 23.3 7.6 11.0 16.2 16.3 11.9 19.8 3.9 3.7 5.1 13.4 11.3 4.2 7.6 5.5 18.4 11.7 6.0 10.7 4.2 4.8 18.1 11.8 25.1 11.1 13.8 14.6 11.7 6.0 8.5 18.7 19.2 3.1 2.5 2.7 3.1 5.0 4.2 11.2 2.7 8.5 5.9 0.8 4.6 13.1 3.3 29.0 3.8 17.1 7.3 10.4 3.8 23.0 22.9 7.2 12.3 4.4 30.8 8.0 23.0 16.8 13.9 15.2 15.0 19.9 16.0 10.8 12.8 16.4 12.4 6.2 12.0 15.0 20.9 14.5 28.1 8.9 15.4 16.9 9.0 13.5 13.7 17.2 10.4 16.5 11.0 10.5 20.0 10.7 OTX2 ENSG00000165588 "Orthodenticle homeobox 2" P32243 14 56799905-56810479 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "brain: 27.7;retina: 78.2" "Group enriched" "Detected in some" 545 "HAP1: 62.7;NTERA-2: 52.5" "Cancer enriched" "Detected in single" 27 "testis cancer: 11.6" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;pons and medulla: 27.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA000633, HPA001123" Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA000633: AB_1079538, HPA001123: " "unprognostic (3.82e-1)" "unprognostic (2.56e-2)" "unprognostic (9.28e-2)" 0.2 0.2 0.0 0.2 0.3 0.2 0.2 20.4 0.3 0.2 0.2 3.7 0.0 0.2 0.2 1.0 0.2 0.2 0.2 0.2 1.8 2.7 0.2 0.2 0.2 0.5 4.7 0.0 0.5 0.2 0.2 2.8 0.2 27.7 0.3 0.2 78.2 0.2 1.3 0.2 0.5 0.2 0.2 0.2 0.4 0.2 3.1 2.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 20.4 0.3 1.8 2.7 4.7 0.0 27.7 2.3 OXLD1 "C17orf90, MGC104712" ENSG00000204237 "Oxidoreductase like domain containing 1" Q5BKU9 17 81665036-81666635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056878, HPA057019" Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA056878: , HPA057019: " "unprognostic (1.08e-1)" "prognostic favourable (2.91e-4)" "unprognostic (1.37e-1)" "unprognostic (1.38e-1)" "unprognostic (9.03e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "unprognostic (1.92e-2)" "unprognostic (2.14e-1)" "unprognostic (7.60e-3)" "unprognostic (1.22e-2)" "unprognostic (2.38e-1)" "unprognostic (3.06e-2)" "unprognostic (3.64e-1)" "unprognostic (8.71e-2)" "unprognostic (2.01e-1)" "unprognostic (2.30e-2)" 13.7 12.2 11.0 10.1 11.5 16.0 8.4 6.0 15.1 6.4 12.4 7.0 16.0 14.0 6.5 11.8 10.3 8.7 9.2 11.4 10.2 8.5 9.2 11.9 7.7 9.9 9.6 6.5 4.2 19.6 2.7 4.6 8.2 8.0 8.2 1.9 9.4 27.7 10.8 17.3 12.9 10.3 4.7 7.1 15.1 11.2 18.5 7.1 11.6 10.2 7.2 11.4 7.8 5.6 22.8 23.7 13.3 18.5 25.1 27.9 18.7 7.9 29.3 0.3 6.9 1.8 0.5 5.1 3.2 0.1 0.1 1.1 7.8 7.8 2.4 6.5 0.0 7.0 0.0 4.5 0.0 4.0 14.5 2.2 13.5 19.0 12.5 1.5 6.0 3.1 3.9 1.7 1.8 2.9 3.7 4.1 0.6 19.3 5.8 6.1 3.9 12.7 4.8 0.2 10.3 1.5 4.4 1.5 6.5 1.6 10.5 14.6 15.8 9.0 2.1 6.0 4.2 6.5 4.5 10.5 3.7 3.2 8.2 6.1 6.1 12.9 18.5 13.3 19.1 15.1 20.0 19.7 25.9 22.2 17.2 22.8 27.9 21.5 13.1 25.1 15.6 23.7 21.8 18.7 11.0 11.5 6.0 15.1 10.2 8.5 9.6 6.5 8.0 7.1 OXR1 TLDC3 ENSG00000164830 "Oxidation resistance 1" Q8N573 8 106359476-106752694 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027375, HPA027380, HPA027395" Enhanced Approved Vesicles Vesicles "HPA027375: AB_10600087, HPA027380: AB_10601569, HPA027395: AB_10601554" "unprognostic (8.16e-3)" "unprognostic (1.39e-1)" "unprognostic (5.52e-2)" "unprognostic (3.12e-1)" "unprognostic (4.84e-2)" "unprognostic (2.84e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (2.82e-2)" "unprognostic (2.12e-1)" "prognostic unfavourable (3.85e-4)" "unprognostic (6.59e-2)" "prognostic favourable (5.82e-5)" "unprognostic (1.89e-1)" "unprognostic (1.32e-1)" "unprognostic (2.58e-1)" "unprognostic (2.86e-1)" 18.3 34.2 20.5 14.1 14.6 9.3 16.8 31.2 50.2 19.0 13.9 7.3 34.8 7.9 16.2 33.4 22.0 13.0 12.6 21.4 23.6 23.0 17.9 21.4 15.0 11.4 22.6 18.8 15.9 10.0 15.0 45.7 9.9 25.9 17.5 12.6 7.2 25.3 30.3 26.4 16.1 10.4 12.7 22.8 15.3 15.2 29.1 14.6 15.5 15.2 17.3 10.5 24.1 21.2 8.7 8.1 20.8 13.3 7.8 12.6 5.5 12.1 4.6 13.8 2.8 20.2 24.5 6.4 10.0 11.8 9.3 12.1 4.1 14.7 12.1 11.6 10.6 8.7 7.6 8.7 15.9 10.3 8.7 16.5 6.7 7.4 11.0 5.1 9.6 13.6 13.4 10.0 15.1 10.2 8.3 45.4 10.5 10.8 15.0 7.1 1.8 8.3 4.1 11.1 22.4 10.5 15.4 8.3 2.6 4.4 3.0 10.5 14.5 8.7 7.7 10.5 7.5 9.5 6.3 8.6 5.4 5.1 12.5 1.5 12.8 20.8 6.5 12.4 3.0 12.4 5.0 8.7 5.2 4.7 8.1 5.8 12.6 5.5 3.4 7.8 13.3 5.8 3.7 5.5 20.5 14.6 31.2 50.2 23.6 23.0 22.6 18.8 25.9 14.6 P3H1 "GROS1, LEPRE1, LEPRECAN, MGC117314" ENSG00000117385 "Prolyl 3-hydroxylase 1" Q32P28 1 42746335-42767084 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA012113, HPA016980" Approved Approved Nucleoli,Vesicles "Intracellular and membrane" 13000 Vesicles Nucleoli "HPA012113: , HPA016980: AB_2669498" "unprognostic (3.24e-1)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (4.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.19e-1)" "prognostic unfavourable (4.95e-7)" "unprognostic (5.41e-2)" "unprognostic (2.70e-3)" "unprognostic (9.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" "unprognostic (2.67e-2)" "unprognostic (1.60e-3)" 11.9 11.2 7.1 8.6 6.3 5.2 9.7 6.4 5.3 14.0 7.1 6.0 7.7 2.6 13.8 11.1 6.4 8.8 12.1 8.8 3.8 2.9 7.9 19.9 10.8 10.1 6.1 3.3 13.1 6.8 5.8 15.2 36.1 4.6 7.8 5.7 10.5 6.4 6.5 4.3 7.2 6.6 19.7 3.4 13.3 6.6 13.1 4.7 10.2 7.4 5.3 7.8 11.4 8.5 3.1 16.2 11.0 16.2 11.7 7.9 6.1 2.2 5.8 13.0 30.4 30.8 23.6 5.3 26.8 34.9 19.4 33.1 2.9 4.9 3.3 21.5 50.5 2.0 5.5 6.8 13.4 4.9 6.9 7.8 9.2 8.3 17.9 7.8 9.0 20.1 4.6 19.5 8.4 27.3 4.4 4.2 12.9 1.2 5.0 4.4 14.2 4.2 5.0 19.2 4.5 10.2 1.2 2.7 4.6 16.3 0.4 11.5 0.9 32.8 22.2 14.5 12.8 11.5 10.6 3.8 4.3 3.0 16.6 10.6 20.1 3.5 13.2 11.0 6.0 14.0 6.4 3.1 4.6 5.1 16.2 2.6 3.9 3.9 1.2 11.7 16.2 7.6 7.9 6.1 7.1 6.3 6.4 5.3 3.8 2.9 6.1 3.3 4.6 4.7 P4HA1 "C-P4Halpha(I), P4HA" ENSG00000122884 "Prolyl 4-hydroxylase subunit alpha 1" P13674 10 73007217-73096974 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 105.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007599, HPA026593" Enhanced Supported "Endoplasmic reticulum,Vesicles,Mitochondria" "Intracellular and membrane" "Endoplasmic reticulum" "Vesicles, Mitochondria" "HPA007599: AB_1854891, HPA026593: AB_1854892" "prognostic unfavourable (9.01e-4)" "prognostic unfavourable (3.19e-5)" "unprognostic (2.76e-3)" "unprognostic (3.04e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (1.19e-5)" "unprognostic (2.30e-1)" "prognostic unfavourable (5.10e-4)" "unprognostic (1.28e-1)" "unprognostic (2.29e-1)" "prognostic unfavourable (2.85e-4)" "unprognostic (9.15e-2)" "prognostic unfavourable (9.40e-9)" "unprognostic (3.14e-1)" "unprognostic (4.22e-2)" "unprognostic (1.02e-2)" "unprognostic (5.75e-2)" 16.8 14.4 16.5 10.4 20.2 7.0 47.6 9.9 18.2 18.5 10.9 11.3 7.4 5.6 14.8 12.2 11.6 22.4 14.1 23.9 17.0 10.9 19.0 39.9 18.1 7.5 33.5 4.9 22.3 13.1 11.1 8.6 33.5 25.4 17.9 9.4 8.6 8.5 10.4 63.5 10.3 7.8 15.1 45.8 9.7 11.1 9.7 30.9 4.1 19.4 7.5 7.3 34.4 105.7 6.9 14.8 10.2 17.3 3.4 7.3 6.1 17.3 4.5 13.0 25.3 40.2 30.9 10.9 51.0 46.2 19.7 47.4 7.4 13.5 5.9 19.5 50.4 19.7 8.2 18.6 43.3 7.5 3.1 5.0 4.3 8.8 16.7 9.2 3.5 18.7 10.9 16.8 22.3 9.3 7.8 3.1 17.0 4.6 3.6 8.9 4.6 19.8 3.4 8.7 10.6 11.1 7.5 1.2 7.3 10.4 30.8 12.1 4.7 8.7 8.8 24.2 10.0 6.7 11.8 17.7 6.4 2.8 43.4 13.5 11.7 0.8 13.5 10.2 5.2 16.4 6.7 6.0 6.2 6.0 14.8 6.9 4.6 4.7 7.4 3.4 17.3 11.8 7.3 6.1 16.5 20.2 9.9 18.2 17.0 10.9 33.5 4.9 25.4 30.9 P4HA2 C-P4Halpha(II) ENSG00000072682 "Prolyl 4-hydroxylase subunit alpha 2" O15460 5 132191838-132295315 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 61.3;U-87 MG: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA016997, HPA027824, CAB062557" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" "Endoplasmic reticulum, Vesicles" "CAB062557: , HPA016997: AB_2669501, HPA027824: AB_2672402" "unprognostic (1.30e-3)" "prognostic unfavourable (1.24e-5)" "unprognostic (2.56e-3)" "unprognostic (1.28e-3)" "unprognostic (2.08e-3)" "unprognostic (1.62e-3)" "unprognostic (1.16e-3)" "unprognostic (1.93e-3)" "unprognostic (2.83e-2)" "unprognostic (1.92e-1)" "unprognostic (8.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavourable (2.77e-7)" "unprognostic (2.50e-2)" "unprognostic (1.61e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (3.12e-4)" 10.2 5.6 7.1 6.5 5.4 0.8 12.2 9.5 7.8 14.4 12.5 4.6 6.1 9.8 20.0 35.3 11.6 13.7 9.7 26.1 6.6 7.0 34.4 6.3 16.0 4.3 6.3 4.2 6.7 42.5 6.7 15.8 15.1 9.5 9.3 14.6 15.1 21.1 8.4 7.1 9.3 17.1 23.3 5.1 6.3 12.6 5.1 4.4 4.1 12.2 10.8 5.4 11.3 34.5 0.2 1.0 3.1 1.3 2.6 2.6 0.7 10.1 6.2 2.0 9.9 27.9 33.3 11.3 47.5 40.6 20.2 50.0 14.0 8.9 0.2 14.0 50.8 12.8 6.2 24.8 32.0 7.5 2.1 0.0 9.1 8.4 61.3 0.0 6.1 20.1 36.7 23.9 22.0 10.6 3.6 0.6 24.7 4.0 0.0 0.0 0.5 5.1 0.1 0.6 1.5 5.6 1.9 1.0 2.8 12.1 4.0 8.0 5.0 0.7 16.3 30.7 12.0 9.3 10.2 4.3 4.6 2.0 59.2 0.0 8.5 0.0 1.3 0.0 2.6 1.1 2.4 0.0 1.4 0.4 0.6 0.2 0.0 0.4 3.1 2.6 0.2 1.0 0.0 0.7 7.1 5.4 9.5 7.8 6.6 7.0 6.3 4.2 9.5 4.4 P4HTM "EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4" ENSG00000178467 "Prolyl 4-hydroxylase, transmembrane" Q9NXG6 3 48989886-49007154 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007199 Supported Uncertain Vesicles,Cytosol "Vesicles, Cytosol" "HPA007199: AB_1855272" "unprognostic (1.95e-2)" "unprognostic (3.12e-2)" "unprognostic (9.47e-2)" "prognostic favourable (8.18e-4)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (6.47e-2)" "unprognostic (2.02e-2)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-2)" "prognostic favourable (3.28e-5)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (2.60e-2)" "unprognostic (9.65e-3)" 7.4 25.5 22.1 6.4 28.5 4.7 8.9 17.6 32.9 13.5 10.8 15.9 13.8 10.4 9.7 18.9 5.4 34.7 13.0 18.6 23.0 26.5 14.1 5.4 10.6 5.6 18.7 20.3 11.4 29.9 20.8 35.7 9.6 15.7 15.5 6.7 14.1 16.0 16.5 10.0 4.3 7.8 7.0 14.3 6.3 15.7 11.7 16.4 3.4 21.5 3.3 6.7 7.5 6.1 9.8 7.8 6.7 7.6 4.9 14.4 4.8 3.8 10.5 2.0 0.0 5.9 7.0 0.1 6.9 9.1 5.2 5.6 2.3 20.7 3.3 7.2 8.4 2.0 4.4 2.3 1.5 12.3 7.8 0.0 15.6 0.0 15.7 3.2 0.1 4.0 2.3 5.2 0.4 5.8 0.0 14.3 2.5 16.4 0.4 0.4 2.8 12.4 0.0 0.0 19.2 9.2 5.9 8.2 0.1 7.7 8.3 0.0 7.3 5.3 4.0 3.1 2.7 7.7 5.4 20.4 11.2 0.0 23.0 0.3 3.2 6.7 7.6 4.8 6.4 2.7 8.7 7.0 11.6 10.3 7.8 9.8 12.0 8.3 0.8 4.9 3.6 1.4 14.4 4.8 22.1 28.5 17.6 32.9 23.0 26.5 18.7 20.3 15.7 16.4 PACRGL "C4orf28, MGC29898" ENSG00000163138 "Parkin coregulated like" Q8N7B6 4 20696282-20752907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054666 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA054666: " "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (6.90e-3)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (1.55e-2)" "unprognostic (1.09e-2)" "unprognostic (2.97e-1)" "unprognostic (4.55e-2)" "unprognostic (2.20e-2)" "unprognostic (5.08e-2)" "unprognostic (3.35e-2)" "unprognostic (1.25e-2)" "unprognostic (6.74e-3)" "unprognostic (3.63e-2)" "unprognostic (1.07e-2)" "prognostic favourable (4.85e-4)" 7.9 8.7 12.2 10.7 15.6 3.2 16.5 7.8 19.0 9.1 8.9 9.3 14.6 6.6 13.9 15.1 9.6 14.2 10.0 9.5 14.1 12.4 8.7 4.7 7.7 7.3 12.1 12.9 14.0 6.7 9.7 13.7 7.4 10.5 11.2 9.4 8.4 7.7 11.4 10.1 14.3 7.7 13.1 15.1 6.8 7.7 37.3 10.7 4.5 15.8 10.0 6.3 11.1 8.9 4.3 7.0 1.4 4.7 4.1 6.1 2.9 8.9 7.0 12.3 9.3 16.7 15.5 6.0 11.5 9.1 10.6 12.9 6.3 19.1 9.5 7.7 6.5 4.3 6.9 8.6 18.2 2.9 6.1 6.0 10.5 10.0 8.8 12.3 6.4 10.7 12.9 13.3 12.4 10.7 10.3 5.5 9.0 6.5 12.3 11.4 15.6 9.9 6.6 13.4 5.8 10.6 5.9 20.4 13.4 8.5 4.3 8.6 7.9 7.0 8.3 10.4 9.6 14.3 15.9 5.7 1.6 8.8 15.2 8.3 17.9 0.0 3.1 1.4 2.7 4.7 6.1 4.3 3.0 2.7 5.3 4.0 4.7 3.0 1.2 4.1 3.7 7.0 3.5 2.9 12.2 15.6 7.8 19.0 14.1 12.4 12.1 12.9 10.5 10.7 PACSIN1 SDPI ENSG00000124507 "Protein kinase C and casein kinase substrate in neurons 1" Q9BY11 6 34466061-34535231 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 81.7" "Cell line enhanced" "Detected in some" "MCF7: 9.7;RPMI-8226: 11.3;T-47d: 18.0;U-266/84: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 15.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009929, HPA028852, HPA055491" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: " "unprognostic (3.33e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (2.97e-1)" "unprognostic (1.72e-2)" "unprognostic (2.47e-3)" "unprognostic (2.14e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (6.63e-2)" "unprognostic (3.95e-4)" "unprognostic (9.12e-2)" "unprognostic (3.02e-2)" "unprognostic (4.18e-2)" "unprognostic (9.90e-2)" "unprognostic (5.50e-2)" "unprognostic (9.33e-2)" 1.5 2.1 42.5 2.4 33.8 2.0 1.4 29.3 81.7 1.5 1.7 2.1 0.0 1.8 1.9 1.5 1.4 2.0 1.7 4.7 32.8 21.9 1.6 1.4 1.5 4.4 14.6 32.9 1.7 6.1 1.4 1.2 1.4 31.6 1.8 1.6 5.5 1.6 1.7 1.5 1.4 1.8 1.5 3.7 2.5 2.4 1.9 4.1 0.0 1.4 0.0 3.4 2.0 0.0 0.0 15.0 0.0 0.0 3.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 3.7 0.7 0.0 0.1 1.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 9.7 0.5 0.0 2.4 0.0 0.1 0.0 11.3 0.0 0.3 3.6 0.2 0.0 1.8 0.0 18.0 1.9 0.0 0.0 0.3 0.0 0.0 3.0 13.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 15.0 0.0 0.1 42.5 33.8 29.3 56.3 32.8 21.9 14.6 32.9 31.6 4.1 PACSIN2 SDPII ENSG00000100266 "Protein kinase C and casein kinase substrate in neurons 2" Q9UNF0 22 42835412-43015145 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 37.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049854, HPA056520" Enhanced Supported "Nuclear speckles,Vesicles,Plasma membrane,Cytosol" 83000 "Nuclear speckles, Vesicles, Cytosol" "Plasma membrane" "HPA049854: AB_2680915, HPA056520: AB_2683163" "unprognostic (5.62e-3)" "unprognostic (1.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.64e-3)" "unprognostic (1.63e-2)" "unprognostic (3.96e-1)" "prognostic unfavourable (7.33e-4)" "unprognostic (4.48e-2)" "unprognostic (3.40e-2)" "unprognostic (2.82e-3)" "unprognostic (3.09e-2)" "unprognostic (1.00e-1)" "prognostic favourable (1.09e-13)" "unprognostic (2.87e-1)" "unprognostic (1.11e-1)" "unprognostic (6.20e-2)" "unprognostic (2.95e-1)" 20.1 42.0 19.4 19.4 20.7 14.3 22.9 32.3 21.3 18.7 28.4 17.5 21.1 22.5 20.8 18.9 19.3 17.5 33.3 28.0 17.9 19.5 32.5 20.7 25.8 16.9 20.6 15.7 17.4 77.3 14.3 21.5 33.8 32.4 24.6 23.5 26.6 31.7 16.6 23.9 19.4 25.6 25.1 17.8 22.5 27.8 12.6 19.2 13.1 31.0 15.8 18.4 17.7 17.6 4.7 8.3 37.9 12.6 6.7 4.5 5.0 24.7 26.0 21.9 14.0 11.3 12.1 18.0 22.6 13.7 20.5 17.1 27.0 14.6 11.5 19.2 16.7 17.6 14.3 24.0 13.5 11.7 14.2 18.5 13.3 38.4 16.1 13.0 40.4 11.6 23.7 26.9 11.8 16.7 16.0 8.4 17.5 16.2 13.8 20.5 12.0 11.0 17.0 32.8 7.7 23.5 14.7 14.3 6.4 27.0 18.7 50.7 13.5 17.4 24.7 15.3 19.5 16.9 13.3 6.3 8.6 12.6 14.6 11.6 33.2 7.9 7.0 17.4 2.8 12.6 3.0 4.2 3.2 2.4 8.3 4.7 3.2 2.4 37.9 6.7 12.1 3.1 4.5 5.0 19.4 20.7 32.3 21.3 17.9 19.5 20.6 15.7 32.4 19.2 PADI3 PDI3 ENSG00000142619 "Peptidyl arginine deiminase 3" Q9ULW8 1 17249098-17284233 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0" "Cell line enhanced" "Detected in some" "EFO-21: 13.2;RT4: 15.8;T-47d: 11.9" "Cancer enhanced" "Detected in many" "urothelial cancer: 48.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043739 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA043739: AB_10959466" "unprognostic (4.47e-2)" "unprognostic (9.32e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (3.22e-4)" "unprognostic (1.05e-3)" "unprognostic (6.66e-2)" "unprognostic (3.10e-3)" "unprognostic (5.88e-2)" "unprognostic (2.06e-4)" "unprognostic (1.03e-1)" "unprognostic (3.47e-4)" "unprognostic (1.76e-1)" "prognostic unfavourable (1.55e-11)" "unprognostic (2.40e-2)" "unprognostic (4.73e-3)" "unprognostic (2.64e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 5.1 0.0 0.0 3.2 10.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.6 6.4 0.0 2.3 0.0 9.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 28.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 13.2 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 15.8 0.0 0.0 0.0 2.3 0.1 11.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAG1 "CBP, PAG" ENSG00000076641 "Phosphoprotein membrane anchor with glycosphingolipid microdomains 1" Q9NWQ8 8 80967810-81112068 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 19.1;HMC-1: 25.6;SK-MEL-30: 19.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001632, HPA066527" Enhanced Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA001632: AB_1079557, HPA066527: " "unprognostic (8.30e-2)" "unprognostic (3.84e-2)" "unprognostic (5.89e-2)" "unprognostic (4.79e-2)" "unprognostic (1.55e-1)" "unprognostic (6.91e-2)" "unprognostic (3.71e-3)" "unprognostic (3.84e-2)" "unprognostic (3.73e-2)" "unprognostic (4.52e-2)" "unprognostic (2.93e-1)" "unprognostic (1.46e-1)" "prognostic unfavourable (1.24e-6)" "unprognostic (2.12e-1)" "prognostic unfavourable (6.82e-4)" "unprognostic (1.80e-1)" "unprognostic (1.94e-3)" 5.5 3.8 5.3 20.2 6.1 12.2 4.1 22.3 7.6 2.7 12.3 5.4 2.3 8.6 3.5 2.8 2.9 3.2 12.1 5.5 6.4 4.3 3.2 6.4 20.3 21.2 7.5 4.2 2.6 16.6 0.8 4.2 17.7 7.7 3.9 10.1 10.6 5.0 4.4 3.8 6.2 14.9 3.5 9.9 12.1 5.1 1.4 7.4 15.2 3.4 0.4 15.3 6.2 4.4 2.2 4.1 10.9 13.3 1.6 6.8 2.4 0.0 0.0 2.7 0.1 5.1 4.9 0.1 1.1 8.6 0.5 1.1 0.1 0.0 19.1 0.1 0.3 0.8 0.0 1.0 0.5 0.5 2.5 11.2 0.2 0.0 5.2 1.8 25.6 2.3 0.6 5.0 4.7 0.0 0.1 0.1 8.2 0.1 6.7 0.1 0.2 0.7 5.1 1.3 0.0 0.9 4.1 0.5 1.0 0.0 0.2 19.9 0.6 1.9 0.1 0.6 0.3 0.0 0.6 3.2 0.8 6.8 5.5 6.4 4.7 10.9 1.4 1.9 2.6 6.3 6.5 2.2 6.6 4.6 1.8 1.4 5.4 4.0 2.3 1.6 13.3 4.1 6.8 2.4 5.3 6.1 22.3 7.6 6.4 4.3 7.5 4.2 7.7 7.4 PAGE4 "CT16.7, GAGEC1, PAGE-4" ENSG00000101951 "PAGE family member 4" O60829 X 49829260-49833973 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "epididymis: 129.2;placenta: 199.4;prostate: 58.4" "Cell line enhanced" "Detected in some" "CACO-2: 6.8;U-266/70: 8.4;U-266/84: 30.7" "Group enriched" "Detected in some" 17 "liver cancer: 14.8;prostate cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023880 Enhanced Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA023880: AB_1854930" "unprognostic (8.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-3)" "unprognostic (5.37e-2)" 0.2 0.7 0.5 0.1 0.1 0.0 0.1 0.2 0.2 0.6 0.1 0.2 5.7 0.0 6.6 129.2 0.1 6.8 0.1 0.1 0.4 0.5 0.8 0.1 0.2 0.1 0.1 0.2 0.9 0.1 0.0 0.6 199.4 0.2 58.4 0.0 0.1 0.1 9.8 0.8 0.1 0.1 2.4 0.2 0.1 0.1 2.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.4 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.2 0.2 0.4 0.5 0.1 0.2 0.2 0.1 PAH PH ENSG00000171759 "Phenylalanine hydroxylase" P00439 12 102836885-102958410 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Phenylalanine catabolism" "Allosteric enzyme, Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 65.1;liver: 220.0" "Cell line enriched" "Detected in some" 31 "Hep G2: 71.1" "Cancer enriched" "Detected in some" 17 "liver cancer: 94.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA028407, HPA031642" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" "HPA028407: AB_10601241, HPA031642: AB_2673974" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (4.47e-2)" "unprognostic (9.13e-3)" "unprognostic (5.19e-2)" "unprognostic (5.99e-2)" "prognostic favourable (4.30e-4)" "unprognostic (1.27e-1)" "unprognostic (6.60e-2)" "unprognostic (4.45e-3)" "unprognostic (1.94e-3)" "unprognostic (1.83e-1)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (1.64e-1)" "unprognostic (3.96e-2)" "unprognostic (1.68e-2)" 0.1 1.3 0.5 0.0 0.5 0.0 0.1 0.2 1.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 20.3 0.1 0.8 0.3 65.1 220.0 0.0 0.0 0.3 0.7 0.1 1.7 0.0 1.6 0.0 0.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 2.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 1.0 0.8 0.3 0.3 0.7 0.8 0.4 PAIP2 PAIP2A ENSG00000120727 "Poly(A) binding protein interacting protein 2" Q9BPZ3 5 139341587-139369720 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035945, CAB037212, HPA056766" Approved Supported Vesicles Vesicles "CAB037212: AB_1841072, HPA035945: AB_10672996, HPA056766: " "unprognostic (1.07e-1)" "unprognostic (1.44e-1)" "unprognostic (1.19e-1)" "unprognostic (5.86e-2)" "unprognostic (7.40e-2)" "unprognostic (3.80e-3)" "unprognostic (7.70e-3)" "unprognostic (8.91e-2)" "unprognostic (4.64e-2)" "unprognostic (2.36e-2)" "unprognostic (2.67e-2)" "unprognostic (3.27e-1)" "unprognostic (2.01e-3)" "unprognostic (2.01e-1)" "unprognostic (2.21e-1)" "unprognostic (3.36e-1)" "unprognostic (6.92e-2)" 36.2 57.4 50.8 27.0 46.7 36.3 34.4 64.5 59.9 31.0 27.6 32.0 25.7 16.1 36.0 33.3 26.0 35.2 24.9 62.9 49.7 57.8 39.0 41.8 26.8 36.1 58.4 51.7 44.2 23.7 20.5 47.2 34.2 61.8 32.6 20.6 23.0 32.2 33.0 56.1 17.7 18.2 31.3 57.0 32.0 23.0 59.2 41.0 45.8 30.4 27.0 38.2 30.9 28.2 54.9 45.2 122.8 53.3 49.4 65.5 74.8 20.6 23.5 46.3 27.6 34.7 19.8 22.5 18.9 26.3 24.7 38.8 31.4 20.1 36.6 40.6 14.3 20.6 40.3 26.0 32.8 35.0 31.6 33.7 35.0 28.1 22.4 20.8 24.9 22.4 21.7 18.5 21.2 25.1 32.0 32.5 22.3 27.3 56.4 50.8 27.9 17.1 31.6 58.6 39.7 19.6 37.0 21.5 39.1 28.0 25.9 55.3 50.1 43.8 15.4 13.3 16.3 14.4 15.3 47.5 57.5 38.1 23.4 36.8 13.6 69.9 45.3 107.8 46.7 48.8 51.0 54.9 52.0 53.3 44.1 48.5 60.9 59.5 122.8 49.4 53.3 45.2 65.5 74.8 50.8 46.7 64.5 59.9 49.7 57.8 58.4 51.7 61.8 41.0 PAK2 "PAK65, PAKgamma" ENSG00000180370 "P21 (RAC1) activated kinase 2" Q13177 3 196739857-196832647 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Growth regulation, Host-virus interaction" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB007794 Approved Approved Nucleoplasm,Vesicles 590000 "Nucleoplasm, Vesicles" "CAB007794: AB_562363" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (1.32e-1)" "unprognostic (1.80e-1)" "unprognostic (5.18e-3)" "unprognostic (1.85e-2)" "unprognostic (7.97e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (3.36e-4)" "prognostic unfavourable (9.58e-4)" "unprognostic (1.30e-3)" "unprognostic (4.57e-2)" "unprognostic (1.25e-2)" "unprognostic (1.70e-2)" "unprognostic (3.39e-1)" 28.7 18.9 22.4 27.6 23.5 21.4 56.5 17.4 20.7 19.5 23.0 27.8 17.4 19.0 22.6 19.2 23.4 17.9 20.7 29.0 22.6 22.0 19.5 34.3 35.7 50.2 26.8 13.5 19.9 16.6 30.5 13.0 27.6 22.8 17.7 23.0 12.9 19.6 21.2 34.2 16.3 25.2 23.0 32.1 34.6 18.4 15.9 24.8 44.9 16.9 19.1 31.9 24.1 32.7 6.6 13.7 25.9 12.6 6.6 10.8 7.0 35.2 12.6 17.8 13.0 12.6 16.7 26.4 17.9 14.8 19.5 17.8 29.9 18.1 22.6 51.2 18.1 18.1 18.8 17.0 30.2 10.1 9.1 33.5 14.5 23.5 25.6 32.5 32.2 13.3 14.0 17.4 37.1 19.2 16.1 28.2 18.9 37.2 30.9 16.8 10.6 19.0 28.3 10.1 20.5 17.0 24.8 10.4 11.8 23.9 16.9 13.5 59.3 23.6 19.8 16.2 9.0 16.9 26.3 19.2 33.9 55.7 13.4 32.6 15.3 16.5 10.3 24.5 6.3 12.6 8.5 6.4 7.3 7.1 13.7 6.6 5.4 6.3 25.9 6.6 10.8 5.1 10.8 7.0 22.4 23.5 17.4 20.7 22.6 22.0 26.8 13.5 22.8 24.8 PAPPA2 "PAPP-A2, PAPPE, PLAC3" ENSG00000116183 "Pappalysin 2" Q9BXP8 1 176463171-176845605 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "placenta: 406.4" "Cell line enriched" "Detected in some" 5 "U-87 MG: 20.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018412, HPA018430" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted in female reproductive system" "Endoplasmic reticulum, Vesicles" "HPA018412: AB_1854962, HPA018430: AB_1854961" "unprognostic (2.90e-1)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-2)" "unprognostic (9.04e-2)" "unprognostic (1.60e-3)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.00e-2)" "unprognostic (3.54e-2)" "unprognostic (1.29e-2)" "unprognostic (4.39e-2)" "unprognostic (2.85e-2)" "unprognostic (1.52e-4)" "unprognostic (1.85e-1)" "unprognostic (8.18e-4)" "unprognostic (4.35e-2)" 0.6 0.0 0.6 0.2 0.2 0.0 3.0 0.8 0.3 5.0 0.6 0.2 0.2 0.0 0.3 0.2 0.2 0.2 1.1 0.2 0.2 0.1 11.6 0.7 0.2 0.2 0.2 0.2 0.2 1.5 0.0 1.2 406.4 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.3 0.5 0.2 1.0 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.2 4.5 2.2 3.7 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.8 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.3 1.7 1.4 0.1 0.6 0.3 0.4 0.0 20.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.8 0.3 0.2 0.1 0.2 0.2 0.3 0.2 PAQR4 FLJ30002 ENSG00000162073 "Progestin and adipoQ receptor family member 4" Q8N4S7 16 2969245-2973489 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.4;parathyroid gland: 32.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "non-classical monocyte: 6.7" "Lineage enriched" "Detected in single" 8 "monocytes: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068394 Approved Vesicles Vesicles "HPA068394: " "unprognostic (1.93e-1)" "unprognostic (2.75e-1)" "unprognostic (6.73e-2)" "unprognostic (1.30e-3)" "unprognostic (8.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavourable (6.86e-4)" "unprognostic (2.62e-2)" "unprognostic (7.59e-2)" "unprognostic (9.65e-3)" "unprognostic (5.21e-2)" "unprognostic (8.59e-2)" "prognostic unfavourable (3.01e-6)" "prognostic favourable (1.70e-4)" "unprognostic (1.36e-1)" "unprognostic (3.79e-2)" "unprognostic (6.06e-3)" 3.1 3.2 14.1 5.2 19.2 10.3 2.3 8.0 26.3 2.4 4.8 49.6 1.3 4.9 1.8 1.0 4.2 3.0 5.5 4.2 24.1 11.7 1.7 1.6 3.9 6.3 30.6 11.1 0.4 6.6 32.8 0.9 2.2 19.1 9.6 4.5 16.8 17.0 1.3 12.3 12.3 4.9 2.8 54.4 3.2 7.4 1.6 20.3 3.6 1.5 3.5 7.8 2.1 1.7 0.5 0.9 0.1 6.7 0.0 0.4 0.5 12.7 10.9 12.3 17.8 2.0 3.7 4.1 4.8 5.9 9.0 8.6 6.5 13.7 12.8 6.6 5.6 18.0 12.8 7.6 3.7 13.5 5.6 3.9 21.3 8.9 0.2 8.3 14.2 0.9 4.0 4.9 1.2 5.9 7.6 34.7 7.7 25.6 11.9 8.9 10.4 7.5 23.9 16.2 41.2 6.1 4.4 28.4 13.2 18.0 17.5 13.1 18.7 12.9 3.6 15.8 9.7 7.3 6.8 15.2 10.5 17.0 7.0 11.3 17.3 0.0 1.0 0.1 0.4 0.5 0.0 0.5 0.2 0.1 0.9 0.1 0.0 0.3 0.1 0.0 6.7 0.5 0.1 0.5 14.1 19.2 8.0 21.2 24.1 11.7 30.6 11.1 19.1 20.3 PAQR5 "FLJ20190, MPRG" ENSG00000137819 "Progestin and adipoQ receptor family member 5" Q9NXK6 15 69298947-69407780 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 41.4" "Cell line enhanced" "Detected in many" "A549: 17.1;CAPAN-2: 20.6;fHDF/TERT166: 14.6;HMC-1: 36.2;U-87 MG: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA076729 Approved Vesicles Vesicles "HPA076729: " "unprognostic (4.47e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-1)" "unprognostic (4.05e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (3.58e-3)" "unprognostic (6.12e-3)" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "prognostic unfavourable (2.15e-5)" "unprognostic (2.00e-1)" "prognostic favourable (1.47e-14)" "unprognostic (5.64e-2)" "unprognostic (1.73e-1)" "unprognostic (4.16e-4)" "unprognostic (4.94e-2)" 1.8 15.4 1.9 4.1 2.6 0.7 1.2 1.5 3.1 1.6 12.3 3.0 1.7 1.5 1.1 1.6 9.0 1.0 1.7 1.9 1.8 1.5 41.4 1.0 10.4 0.3 2.0 1.0 0.5 4.8 5.8 0.9 1.0 3.5 1.1 10.8 3.6 1.8 4.2 0.4 3.2 5.2 3.2 3.8 0.2 4.5 1.5 2.2 0.0 0.6 5.7 4.9 2.3 2.6 0.2 0.2 3.5 0.3 0.4 0.7 0.0 5.0 17.1 0.3 0.3 0.7 1.9 0.1 1.6 9.9 1.9 4.2 0.9 20.6 0.0 2.7 14.6 0.3 4.9 0.2 3.4 0.0 0.7 3.0 2.6 0.3 1.3 0.1 36.2 1.0 0.7 8.8 9.5 0.0 0.0 0.2 8.2 0.6 0.0 0.1 1.1 1.5 0.0 0.2 0.9 7.6 0.4 1.5 0.3 2.7 1.0 1.4 0.4 1.2 0.2 5.9 1.9 0.4 0.2 0.1 0.1 0.0 15.1 0.0 1.6 3.5 0.3 0.1 0.3 0.1 0.2 0.1 0.2 0.2 0.1 0.2 0.3 0.7 1.3 0.4 0.2 0.2 0.1 0.0 1.9 2.6 1.5 3.1 1.8 1.5 2.0 1.0 3.5 2.2 PARG ENSG00000227345 "Poly(ADP-ribose) glycohydrolase" Q86W56 10 49818279-49970203 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021819, HPA053007" Enhanced Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA021819: AB_1854974, HPA053007: " "unprognostic (5.77e-3)" "unprognostic (6.74e-2)" "unprognostic (3.06e-2)" "unprognostic (9.90e-2)" "unprognostic (1.22e-2)" "unprognostic (1.33e-1)" "prognostic unfavourable (5.57e-5)" "unprognostic (1.21e-1)" "unprognostic (3.97e-1)" "unprognostic (8.34e-2)" "unprognostic (1.47e-1)" "unprognostic (4.06e-2)" "unprognostic (5.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (8.54e-2)" "unprognostic (1.13e-1)" 4.0 5.6 4.3 4.2 5.4 1.4 5.3 7.8 6.3 4.8 5.1 6.7 4.9 3.0 6.2 4.3 3.6 6.6 4.6 5.9 9.2 5.2 3.5 5.8 4.5 4.7 3.5 8.1 4.7 5.8 4.9 6.1 4.7 5.1 8.1 6.7 5.1 4.7 4.0 5.9 4.7 5.8 4.9 6.9 4.4 4.8 6.9 7.0 12.5 7.7 8.3 9.4 5.5 12.7 10.6 18.7 13.7 9.0 11.2 13.7 12.7 14.0 14.8 14.2 8.5 11.9 9.6 8.3 10.8 14.5 15.7 8.0 16.0 14.7 14.6 9.8 8.7 9.3 10.2 14.1 8.2 7.2 15.5 12.4 20.5 9.0 16.6 8.5 11.1 7.1 15.6 12.7 18.4 24.3 18.6 21.2 11.1 12.0 8.2 12.9 16.3 10.3 16.4 13.3 18.9 7.9 9.1 9.3 11.3 9.6 14.2 9.4 14.1 20.5 15.9 15.0 6.7 12.5 6.2 3.0 5.2 5.5 7.9 6.9 7.1 6.7 7.0 6.9 9.4 9.1 3.0 8.3 7.7 5.4 5.5 5.5 PARM1 "Cipar1, DKFZP564O0823, WSC4" ENSG00000169116 "Prostate androgen-regulated mucin-like protein 1" Q6UWI2 4 74933095-75050115 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 23.9;Karpas-707: 23.4;U-266/70: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 10.1;myeloid DC: 4.6;naive B-cell: 6.4" "Group enriched" "Detected in many" 15 "B-cells: 10.1;dendritic cells: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038236 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles, Cytosol" "HPA038236: AB_10675789" "unprognostic (2.57e-2)" "unprognostic (5.20e-2)" "unprognostic (1.26e-3)" "unprognostic (8.61e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-3)" "unprognostic (3.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.73e-1)" "unprognostic (9.74e-2)" "unprognostic (9.44e-2)" "unprognostic (3.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "prognostic unfavourable (1.78e-4)" "unprognostic (2.23e-1)" 23.1 21.5 5.7 25.0 15.2 0.3 16.4 1.3 29.4 18.7 36.0 1.2 28.5 2.8 20.3 18.0 5.8 12.2 11.5 39.8 6.9 13.0 27.5 1.1 15.1 10.2 3.3 10.3 11.9 29.2 23.2 32.1 16.1 4.8 35.0 45.8 70.2 25.6 27.6 7.4 6.2 8.3 29.3 2.4 9.7 5.5 11.2 1.2 6.3 79.8 3.7 8.0 24.9 19.7 10.1 4.6 0.1 0.5 0.0 0.0 0.7 0.5 1.0 0.9 0.0 23.9 0.1 0.1 0.0 0.1 0.0 0.0 2.0 0.2 0.0 0.1 0.0 0.0 7.8 0.0 0.0 0.1 1.7 0.0 0.0 0.0 4.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 23.4 0.4 0.2 2.5 0.1 2.2 1.4 0.0 2.1 5.9 0.1 4.8 1.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.4 1.5 0.1 2.1 26.2 2.5 6.6 2.5 0.0 0.3 0.0 0.1 0.0 0.0 0.5 0.0 10.1 0.0 0.0 4.6 6.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.7 5.7 15.2 1.3 29.4 6.9 13.0 3.3 10.3 4.8 1.2 PAX5 BSAP ENSG00000196092 "Paired box 5" Q02548 9 36833275-37034185 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 21.6;lymphoid tissue: 33.4" "Group enriched" "Detected in some" 8 "Daudi: 21.0;REH: 61.0;U-698: 27.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "midbrain: 1.6" "Group enriched" "Detected in some" 209 "memory B-cell: 20.1;naive B-cell: 21.6" "Lineage enriched" "Detected in single" 216 "B-cells: 21.6" "Region enriched" "Detected in single" 11 "midbrain: 4.7" "Group enriched" "Detected in some" 6 "hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2" "CAB026269, CAB026869, HPA056394, HPA068498" Enhanced Supported Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "CAB026269: , CAB026869: , HPA056394: , HPA068498: " "unprognostic (4.69e-4)" "unprognostic (3.83e-1)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.46e-2)" "unprognostic (1.11e-3)" "unprognostic (3.15e-1)" "unprognostic (8.96e-2)" "unprognostic (6.03e-2)" "unprognostic (1.01e-1)" 0.4 0.2 0.2 33.4 0.2 5.5 0.2 0.2 0.2 0.2 0.7 0.1 0.0 0.0 0.2 0.0 0.7 0.2 0.4 0.2 0.2 0.3 0.5 0.3 0.3 23.2 1.6 0.0 0.2 0.2 0.0 0.5 0.1 0.2 0.3 0.3 0.4 2.5 0.0 0.6 0.2 8.7 0.0 0.3 16.5 0.7 0.9 0.0 2.3 0.4 0.2 30.1 1.3 0.2 21.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.1 61.0 0.1 0.1 0.0 0.0 4.3 1.0 0.0 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 1.6 0.0 0.2 0.0 PAXIP1 "CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2" ENSG00000157212 "PAX interacting protein 1" Q6ZW49 7 154943687-155003084 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 32.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006694, HPA016950" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA006694: AB_1855011, HPA016950: AB_2669489" "unprognostic (2.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.14e-2)" "unprognostic (2.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (7.39e-3)" "unprognostic (2.65e-2)" "unprognostic (1.34e-3)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (2.36e-1)" "unprognostic (3.28e-2)" "unprognostic (4.99e-3)" "unprognostic (3.98e-1)" "unprognostic (2.44e-3)" "unprognostic (2.30e-1)" 6.0 5.4 5.7 6.2 5.0 9.7 6.3 32.3 5.7 7.8 5.5 5.8 4.5 5.2 6.5 6.7 7.1 5.7 5.0 4.7 6.0 3.4 5.7 6.9 4.7 9.4 5.7 1.4 7.1 8.4 7.2 8.7 7.9 5.6 7.7 5.7 6.9 6.6 5.4 7.1 7.4 6.9 9.3 4.2 6.4 5.9 10.4 6.2 31.2 6.4 4.7 6.9 6.1 5.9 2.2 3.3 1.4 3.1 2.9 6.5 2.5 9.8 8.1 10.7 18.2 4.7 3.9 9.6 4.4 4.6 6.0 7.1 8.9 7.8 12.9 5.5 5.2 7.8 13.7 6.9 7.5 12.9 10.7 9.8 5.8 7.6 3.3 13.3 13.1 3.8 5.2 6.0 2.4 5.7 13.4 8.7 6.0 13.7 28.3 11.1 17.4 5.5 16.2 11.0 14.0 6.2 8.3 8.6 5.5 11.6 8.7 5.4 6.6 11.5 2.9 5.1 0.9 7.2 10.4 8.9 5.2 17.8 12.5 15.7 13.6 0.7 2.3 1.4 2.5 2.6 3.8 1.3 4.0 2.9 2.6 2.2 6.5 1.7 1.0 2.9 3.1 3.3 3.2 2.5 5.7 5.0 32.3 5.7 6.0 3.4 5.7 1.4 5.6 6.2 PBLD "FLJ14767, MAWBP, MAWDBP" ENSG00000108187 "Phenazine biosynthesis like protein domain containing" P30039 10 68282660-68333049 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 47.3;kidney: 74.5;liver: 91.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038035, HPA038036" Enhanced Approved Vesicles 420000 Vesicles "HPA038035: AB_10672470, HPA038036: AB_10675625" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (6.14e-2)" "unprognostic (8.83e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" "prognostic favourable (1.44e-4)" "unprognostic (8.25e-2)" "unprognostic (3.62e-2)" "unprognostic (3.36e-3)" "unprognostic (1.19e-1)" "unprognostic (6.26e-3)" "unprognostic (3.40e-2)" "unprognostic (1.17e-1)" "unprognostic (2.07e-2)" "unprognostic (8.28e-2)" "unprognostic (6.68e-2)" 5.0 5.9 3.6 2.4 6.4 2.5 2.9 2.3 8.0 4.1 9.4 11.8 6.8 47.3 4.5 5.1 1.5 2.3 2.9 3.3 3.9 3.1 74.5 91.4 2.3 2.8 6.7 5.6 2.3 17.9 2.4 2.4 7.0 8.4 2.6 8.0 9.4 2.2 6.2 2.3 1.8 39.3 6.5 4.9 1.6 15.0 2.1 6.2 2.5 1.9 4.3 1.6 4.1 1.6 1.7 5.6 6.4 5.8 3.3 2.3 2.5 3.4 6.9 6.7 4.6 6.1 3.5 3.1 13.9 8.8 5.3 5.5 6.2 8.8 3.9 5.4 9.6 5.3 3.1 3.6 4.6 1.8 5.0 3.1 7.5 5.6 3.0 4.5 3.1 6.2 4.3 3.2 4.0 3.2 2.7 8.6 8.3 5.3 4.1 7.9 1.9 3.0 7.2 8.8 6.3 10.6 5.0 3.9 5.2 9.3 5.4 6.3 18.7 5.4 10.0 5.3 3.8 2.5 2.2 5.2 3.7 5.7 6.3 2.5 1.3 4.2 5.8 2.9 0.9 2.9 1.8 1.7 1.4 0.9 5.6 1.6 2.3 1.6 6.4 3.3 1.7 2.4 2.3 2.5 3.6 6.4 2.3 8.0 3.9 3.1 6.7 5.6 8.4 6.2 PBX4 ENSG00000105717 "PBX homeobox 4" Q9BYU1 19 19561707-19618916 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.9;thyroid gland: 14.4" "Cell line enhanced" "Detected in some" "A-431: 4.0;PC-3: 4.2;RT4: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 2.8;MAIT T-cell: 3.3;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.9;naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.7;T-reg: 5.4" "Lineage enriched" "Detected in single" 14 "T-cells: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049859, HPA056469" Enhanced Approved Vesicles Vesicles "HPA049859: , HPA056469: " "unprognostic (5.36e-3)" "prognostic favourable (8.69e-6)" "unprognostic (9.39e-3)" "unprognostic (1.03e-1)" "unprognostic (1.81e-2)" "unprognostic (1.07e-4)" "unprognostic (2.87e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-1)" "unprognostic (3.86e-2)" "unprognostic (3.17e-1)" "unprognostic (1.13e-2)" "unprognostic (1.44e-6)" "unprognostic (2.20e-2)" "unprognostic (1.45e-1)" "unprognostic (5.89e-2)" "prognostic favourable (5.94e-7)" 1.0 0.5 2.2 4.5 3.4 1.7 1.0 1.2 1.9 0.9 1.6 0.0 4.6 1.1 0.6 1.3 0.8 1.0 7.1 0.6 2.3 2.5 1.0 0.5 1.8 3.6 0.8 1.2 1.2 0.5 0.7 1.7 1.2 1.5 1.1 1.1 0.7 1.4 2.7 0.5 2.0 1.7 0.5 0.7 1.8 1.7 16.9 0.6 6.1 14.4 0.5 9.6 1.4 0.8 0.3 0.0 0.0 0.1 0.0 5.4 0.8 4.0 0.2 1.8 0.0 0.0 0.0 2.1 0.0 1.6 1.7 1.7 0.0 1.4 0.4 0.9 1.0 1.6 2.7 0.0 0.7 0.3 0.8 0.0 0.9 0.1 0.3 0.0 1.3 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.8 1.4 0.1 0.3 4.2 0.8 0.0 0.0 1.1 5.2 1.2 2.3 1.5 0.2 0.8 0.8 0.0 0.0 0.0 1.0 2.1 0.8 0.0 1.7 0.3 0.1 0.2 0.0 0.0 0.0 0.0 2.8 0.0 3.3 0.3 2.0 2.9 0.0 0.0 1.8 1.7 0.0 0.0 0.1 0.0 5.4 0.8 2.2 3.4 1.2 1.9 2.3 2.5 0.8 1.2 1.5 0.6 PBXIP1 HPIP ENSG00000163346 "PBX homeobox interacting protein 1" Q96AQ6 1 154944076-154956123 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "Karpas-707: 156.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006949 Approved Approved Vesicles,Cytosol Vesicles Cytosol "HPA006949: AB_1079572" "unprognostic (6.17e-2)" "unprognostic (6.82e-2)" "prognostic unfavourable (2.73e-4)" "unprognostic (8.94e-2)" "unprognostic (2.16e-1)" "prognostic favourable (7.19e-4)" "unprognostic (1.62e-1)" "prognostic favourable (8.99e-4)" "unprognostic (1.21e-1)" "unprognostic (2.46e-1)" "prognostic favourable (2.64e-4)" "unprognostic (1.20e-2)" "prognostic favourable (9.22e-6)" "unprognostic (3.89e-1)" "unprognostic (4.15e-1)" "unprognostic (2.26e-1)" "unprognostic (1.26e-3)" 25.3 48.1 35.4 24.9 54.9 13.7 19.9 18.3 31.4 26.8 36.2 26.1 28.1 25.5 28.3 29.8 23.6 22.8 31.1 21.9 46.6 28.6 18.1 13.3 22.6 28.6 41.8 34.4 50.1 17.6 42.4 56.7 21.2 47.8 26.4 14.3 38.6 20.7 48.3 57.2 13.2 28.6 52.6 29.0 27.5 28.1 15.9 33.8 27.9 33.1 22.4 26.8 37.5 25.7 9.2 4.0 42.9 6.6 13.0 46.8 14.4 0.9 2.6 4.2 2.8 14.8 4.6 3.1 3.5 7.8 1.7 3.4 0.7 3.5 4.3 11.4 4.2 3.7 1.0 2.2 1.2 2.3 1.6 0.9 3.5 2.7 6.8 1.1 12.0 7.0 3.7 2.1 0.4 6.4 0.5 156.1 4.2 1.5 2.3 3.7 1.6 2.0 2.7 6.1 9.3 4.7 1.9 0.7 5.4 4.5 1.4 3.5 4.4 5.0 6.0 1.7 1.2 1.0 1.0 21.4 17.9 1.0 6.1 1.7 1.3 26.7 2.5 42.9 11.0 3.6 30.4 9.2 29.5 17.2 2.2 5.7 19.7 12.1 23.7 13.0 6.6 4.0 46.8 14.4 35.4 54.9 18.3 31.4 46.6 28.6 41.8 34.4 47.8 33.8 PCBP3 "FLJ44028, PCBP3-OT1, PCBP3OT" ENSG00000183570 "Poly(rC) binding protein 3" P57721 21 45643694-45942454 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.5;HDLM-2: 26.6;HSkMC: 20.4;SH-SY5Y: 23.1;U-87 MG: 12.3;U-937: 14.8" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 5 "cerebellum: 47.4;pons and medulla: 23.0" "Cell type enhanced" "Detected in many" "eosinophil: 5.9" "Group enriched" "Detected in many" 6 "B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6" "Region enriched" "Detected in all" 5 "olfactory region: 280.8" "Region enhanced" "Detected in all" "olfactory region: 184.8" HPA030247 Approved Approved Nucleoplasm,Vesicles,Mitochondria "Nucleoplasm, Mitochondria" Vesicles "HPA030247: AB_10601244" "unprognostic (3.88e-2)" "unprognostic (1.19e-1)" "unprognostic (2.01e-4)" "unprognostic (9.89e-4)" "unprognostic (2.74e-1)" "unprognostic (1.40e-1)" "unprognostic (4.10e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-2)" "unprognostic (1.64e-3)" "unprognostic (1.12e-3)" "unprognostic (1.97e-2)" "unprognostic (1.96e-6)" "unprognostic (8.67e-2)" "unprognostic (2.32e-2)" "unprognostic (8.04e-2)" "unprognostic (1.97e-2)" 6.5 11.7 6.0 11.2 6.7 12.3 6.3 47.4 12.6 3.8 7.9 7.0 2.2 3.1 9.3 12.4 1.4 3.2 4.4 2.7 6.5 7.3 2.2 1.1 1.8 5.0 6.9 3.7 3.4 3.5 0.6 14.8 2.3 23.0 1.5 3.0 20.2 1.7 1.9 1.1 1.6 4.8 12.3 7.3 11.6 3.4 20.5 6.1 22.6 0.8 0.0 4.6 2.3 1.8 2.9 0.0 5.9 0.4 0.6 1.6 0.5 0.0 0.0 0.2 0.0 6.7 14.5 0.0 0.8 0.2 1.5 0.6 0.0 0.0 0.0 0.3 3.9 0.0 0.8 0.0 0.2 26.6 0.0 0.0 0.0 0.0 6.9 0.0 0.0 20.4 0.1 0.2 0.4 0.0 0.0 0.1 0.9 0.3 7.6 1.5 0.4 1.3 0.0 0.0 1.1 0.0 0.0 2.5 23.1 0.5 0.0 0.0 0.0 4.1 0.0 0.0 0.0 6.0 0.0 0.3 1.4 0.0 12.3 14.8 0.5 4.4 0.4 5.9 1.6 0.3 0.3 2.9 0.9 0.0 0.0 1.9 1.5 0.2 1.4 0.6 0.2 0.0 0.8 0.5 6.0 6.7 47.4 6.0 6.5 7.3 6.9 3.7 23.0 6.1 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149315-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0;placenta: 31.1;seminal vesicle: 23.6" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 15.8;MOLT-4: 13.2;TIME: 31.4;U-138 MG: 8.5;U-251 MG: 7.2" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: " "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 1.9 7.6 17.9 1.5 35.5 1.2 1.3 1.7 48.0 3.3 1.5 23.2 4.5 1.3 3.1 1.9 1.6 2.6 1.9 1.8 17.5 12.6 3.7 1.3 2.0 1.2 13.2 16.3 4.1 1.4 1.2 1.7 31.1 13.6 14.7 1.5 1.3 1.8 23.6 1.2 1.3 1.7 2.0 6.8 1.2 1.3 2.9 19.2 0.9 1.5 0.0 1.2 3.6 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 5.1 0.0 0.1 0.0 0.0 4.9 2.7 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.2 0.0 2.4 0.0 13.2 0.0 0.0 0.1 0.3 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 31.4 8.5 0.0 0.0 7.2 0.0 0.0 0.0 0.5 0.0 4.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.9 35.5 1.7 27.7 17.5 12.6 13.2 16.3 13.6 19.2 PCDH17 "PCDH68, PCH68" ENSG00000118946 "Protocadherin 17" O14917 13 57631810-57729311 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;lymphoid tissue: 32.7" "Cell line enhanced" "Detected in some" "AF22: 15.8;HEK 293: 9.9;U-87 MG: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026817 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" 31000 Cytosol "Vesicles, Plasma membrane" "HPA026817: AB_1855044" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-1)" "unprognostic (6.52e-2)" "unprognostic (6.98e-3)" "unprognostic (1.95e-2)" "unprognostic (8.26e-4)" "unprognostic (3.56e-1)" "unprognostic (2.38e-2)" "unprognostic (2.82e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "prognostic unfavourable (3.31e-5)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.40e-2)" 2.0 2.4 8.0 2.1 11.2 0.3 0.9 4.6 18.2 2.9 1.2 6.2 0.3 1.1 2.6 1.3 1.7 2.5 3.6 2.3 6.5 12.1 1.6 1.4 13.5 0.9 7.4 4.8 0.8 6.2 2.0 1.0 4.7 4.4 1.2 1.2 1.1 1.0 1.1 1.8 0.6 0.7 2.6 4.4 32.7 1.8 8.9 7.7 0.0 3.4 0.4 0.8 3.4 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.7 0.0 0.0 1.8 0.0 0.0 0.0 9.9 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.4 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 0.0 1.0 0.0 0.0 0.0 6.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 11.2 4.6 7.8 6.5 12.1 7.4 4.8 4.4 7.7 PCDH20 "FLJ22218, PCDH13" ENSG00000280165 "Protocadherin 20" Q8N6Y1 13 61409685-61415522 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;smooth muscle: 12.7" "Cell line enriched" "Detected in some" 14 "RPTEC TERT1: 33.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062669 Approved "Vesicles,Cytokinetic bridge" Vesicles "Cytokinetic bridge" "HPA062669: " "unprognostic (2.40e-1)" "unprognostic (1.80e-1)" "unprognostic (2.45e-1)" "unprognostic (7.83e-2)" "unprognostic (6.79e-4)" "unprognostic (2.32e-2)" "unprognostic (1.56e-1)" "unprognostic (5.34e-4)" "unprognostic (6.96e-2)" "unprognostic (1.67e-1)" "unprognostic (3.12e-1)" 0.3 1.6 6.7 0.4 5.8 0.0 1.3 0.0 13.1 3.5 4.5 0.0 0.2 1.2 4.3 4.3 1.8 0.2 0.9 4.8 13.4 1.2 1.8 4.7 0.0 8.8 3.8 0.3 0.1 0.0 0.7 1.3 6.9 1.5 2.5 0.0 0.7 1.5 0.1 0.5 1.4 12.7 8.4 1.6 1.5 0.4 6.3 0.0 0.3 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 33.8 0.0 0.5 1.2 0.0 2.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA11 "CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11" ENSG00000249158 "Protocadherin alpha 11" Q9Y5I1 5 140868183-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.3;parathyroid gland: 4.7" "Cell line enhanced" "Detected in some" "AN3-CA: 16.5;EFO-21: 8.6;MCF7: 4.4;T-47d: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077160 Approved "Vesicles,Cell Junctions,Cytoplasmic bodies" "Vesicles, Cell Junctions" "Cytoplasmic bodies" "HPA077160: " "unprognostic (1.54e-2)" "unprognostic (1.83e-3)" "unprognostic (2.75e-1)" "unprognostic (2.59e-1)" "unprognostic (6.98e-3)" "unprognostic (1.36e-1)" "unprognostic (9.28e-3)" "unprognostic (2.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (3.13e-4)" "unprognostic (9.91e-5)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (3.26e-2)" 0.1 0.6 1.0 0.1 1.6 0.0 0.2 7.0 9.3 1.3 0.0 0.0 0.6 0.1 0.0 0.2 1.0 0.0 0.8 1.0 1.2 0.0 0.8 0.0 0.3 0.0 3.3 4.7 1.6 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.9 16.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 8.6 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.1 0.0 4.4 0.0 0.0 3.6 3.1 0.0 0.0 0.0 0.4 1.9 0.8 2.2 0.0 1.8 0.4 5.8 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA6 "CNR2, CNRS2, CRNR2, PCDH-ALPHA6" ENSG00000081842 "Protocadherin alpha 6" Q9UN73 5 140827958-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.7;pituitary gland: 11.2" "Cell line enhanced" "Detected in some" "AF22: 2.9;EFO-21: 12.4;U-2 OS: 5.2;WM-115: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059326, HPA078110" Enhanced Approved Vesicles "Intracellular and membrane" Vesicles "HPA059326: , HPA078110: " "unprognostic (1.15e-1)" "unprognostic (7.00e-2)" "unprognostic (5.07e-1)" "unprognostic (2.79e-1)" "unprognostic (4.39e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-4)" "unprognostic (4.23e-3)" "unprognostic (8.38e-2)" "unprognostic (2.55e-1)" "unprognostic (1.23e-3)" "unprognostic (3.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.66e-3)" "unprognostic (2.56e-1)" "unprognostic (5.66e-3)" "unprognostic (3.55e-2)" 1.1 1.8 2.9 0.8 7.1 0.4 1.6 10.2 10.7 1.9 0.7 2.3 0.0 1.2 2.9 2.3 0.4 1.6 1.6 0.5 3.8 3.8 2.3 0.4 1.1 0.7 4.6 4.1 2.1 3.7 4.7 11.2 0.4 3.6 1.3 0.7 1.6 0.7 0.5 0.4 0.6 1.3 1.4 3.4 0.8 0.7 1.4 3.2 0.0 0.9 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 2.1 1.3 0.6 0.0 1.9 0.0 5.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.1 10.2 9.6 3.8 3.8 4.6 4.1 3.6 3.2 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926369-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "parathyroid gland: 33.3" "Cell line enhanced" "Detected in some" "A549: 8.5;EFO-21: 3.6;hTCEpi: 11.0;PC-3: 6.2;SCLC-21H: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Nucleoli" Vesicles "HPA052775: " "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.3 0.4 0.9 0.3 1.0 0.0 0.0 2.0 2.8 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.0 1.0 1.6 0.2 0.1 0.8 1.0 1.1 0.0 1.5 33.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.8 0.4 0.0 0.0 0.2 0.1 0.5 0.2 0.2 0.1 0.0 0.0 8.5 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.6 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 11.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.2 0.0 0.0 0.0 0.5 0.4 4.9 2.3 0.0 0.6 0.0 0.5 0.0 0.0 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.2 0.1 0.0 0.0 PCDHB14 PCDH-BETA14 ENSG00000120327 "Protocadherin beta 14" Q9Y5E9 5 141222932-141227759 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 13.9;SiHa: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007692, HPA045248" Uncertain Approved Vesicles Vesicles "HPA007692: , HPA045248: AB_10959599" "unprognostic (2.57e-3)" "unprognostic (1.96e-1)" "unprognostic (1.34e-1)" "unprognostic (8.97e-2)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" "unprognostic (2.11e-2)" "unprognostic (2.38e-2)" "unprognostic (6.60e-2)" "unprognostic (2.57e-2)" "unprognostic (1.13e-1)" "unprognostic (2.07e-2)" "prognostic unfavourable (6.09e-4)" "unprognostic (2.58e-1)" "unprognostic (3.12e-2)" "unprognostic (3.77e-2)" "unprognostic (3.90e-2)" 5.3 5.5 6.6 2.7 9.4 0.9 5.7 9.3 13.9 8.7 5.7 6.8 0.8 1.7 11.5 7.6 5.2 5.3 5.9 6.0 6.8 4.7 3.8 2.9 4.0 1.6 3.8 6.6 6.9 6.0 14.2 14.2 3.7 6.1 6.7 3.2 5.4 4.8 6.3 3.2 10.3 2.2 7.8 4.3 3.1 3.3 3.2 4.0 0.0 3.0 4.3 1.6 7.1 4.9 0.3 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.0 3.2 5.9 5.3 6.3 0.4 0.4 5.2 0.5 1.6 0.1 1.0 0.2 4.3 1.4 0.3 0.7 1.0 0.5 0.0 0.1 0.0 1.2 0.1 0.2 0.2 0.2 1.1 4.6 0.1 0.2 0.6 0.0 5.6 2.3 0.5 0.4 0.0 0.4 1.1 3.5 4.0 0.0 0.1 0.2 7.3 13.9 11.3 0.3 1.2 6.0 0.4 1.6 2.1 1.9 8.1 2.1 0.0 0.1 0.1 4.4 0.1 3.5 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.2 0.3 0.7 0.0 0.0 0.0 0.1 0.0 6.6 9.4 9.3 13.9 6.8 4.7 3.8 6.6 6.1 4.0 PCDHB16 "KIAA1621, ME1, PCDH-BETA16, PCDH3X, PCDHB8a" ENSG00000272674 "Protocadherin beta 16" Q9NRJ7 5 141181399-141186399 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.5" "Cell line enhanced" "Detected in some" "AN3-CA: 11.9;T-47d: 6.6;U-138 MG: 26.3;U-2197: 7.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA014668 Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA014668: AB_1855055" "unprognostic (3.44e-3)" "unprognostic (4.03e-2)" "unprognostic (8.14e-2)" "unprognostic (8.60e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-2)" "unprognostic (1.17e-1)" "unprognostic (4.03e-2)" "unprognostic (3.13e-2)" "unprognostic (7.55e-3)" "unprognostic (3.49e-2)" "unprognostic (9.57e-2)" "unprognostic (3.55e-2)" "unprognostic (7.49e-3)" "unprognostic (2.00e-2)" "unprognostic (7.92e-3)" "unprognostic (2.83e-3)" 3.7 2.6 2.1 1.4 2.7 0.2 2.5 9.7 3.1 8.4 1.1 5.3 0.0 0.4 6.4 6.2 3.3 2.8 2.5 4.5 1.8 2.5 1.0 3.2 0.5 1.7 0.4 9.8 2.6 10.9 17.5 1.5 3.4 6.2 1.1 7.1 2.2 1.1 3.6 1.5 1.1 3.5 2.5 1.1 0.5 2.3 5.0 0.0 3.1 0.0 0.3 6.5 3.3 0.9 1.0 1.4 0.6 0.9 0.8 0.1 0.0 0.0 0.6 11.9 5.3 3.8 0.3 0.5 2.7 0.0 0.2 0.0 0.2 0.0 4.4 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.1 6.4 0.3 0.0 0.0 0.9 0.1 0.0 2.2 0.0 0.3 0.1 0.4 1.7 0.2 0.4 2.0 6.6 0.0 0.3 26.3 1.3 7.0 1.3 0.0 0.0 0.0 6.3 0.0 3.3 0.7 0.5 0.4 0.6 0.5 0.3 0.6 0.5 0.6 0.3 0.9 0.8 0.6 1.4 0.9 0.6 1.0 0.5 0.1 PCDHB3 PCDH-BETA3 ENSG00000113205 "Protocadherin beta 3" Q9Y5E6 5 141100473-141103827 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.3" "Cell line enhanced" "Detected in some" "EFO-21: 12.1;HAP1: 3.7;SH-SY5Y: 16.2;U-138 MG: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050296 Uncertain Supported Vesicles Vesicles "HPA050296: " "unprognostic (2.72e-2)" "unprognostic (7.47e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-4)" "unprognostic (9.34e-3)" "unprognostic (3.42e-2)" "unprognostic (2.29e-2)" "unprognostic (3.17e-1)" "unprognostic (1.37e-1)" "unprognostic (3.34e-1)" "unprognostic (8.52e-3)" "unprognostic (3.45e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-3)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (5.18e-4)" 5.7 4.6 3.1 2.6 9.3 0.4 5.9 3.8 6.2 4.8 2.5 2.2 1.3 1.4 8.0 3.0 1.3 3.1 3.1 3.6 3.8 3.0 4.9 0.8 3.3 1.0 3.0 3.8 5.6 3.9 4.4 17.3 1.8 4.0 5.4 2.1 3.4 2.4 2.4 1.9 2.0 2.1 3.8 3.0 1.5 1.8 11.6 2.0 0.0 2.1 2.3 0.7 2.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.3 2.1 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.2 0.0 3.7 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.4 0.0 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.6 16.2 0.0 0.2 0.0 2.0 0.1 0.0 5.7 0.8 0.6 0.3 0.3 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.3 3.8 6.2 3.8 3.0 3.0 3.8 4.0 2.0 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 "Protocadherin gamma subfamily A, 1" Q9Y5H4 5 141330571-141512981 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Cell line enhanced" "Detected in many" "LHCN-M2: 6.9;T-47d: 11.3;WM-115: 5.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008755, HPA010580, HPA036547" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA036547: AB_10669798" "unprognostic (9.50e-4)" "unprognostic (2.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.42e-3)" "unprognostic (3.39e-1)" "unprognostic (3.97e-2)" "unprognostic (2.42e-1)" "unprognostic (5.61e-3)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-3)" "unprognostic (4.76e-2)" "unprognostic (1.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-3)" 1.4 1.3 2.7 0.9 11.7 1.0 1.1 6.8 7.9 1.4 1.2 2.7 0.5 1.0 2.8 3.9 1.3 1.1 0.8 3.9 3.5 2.8 1.2 0.5 1.2 1.0 2.5 2.5 2.9 2.5 2.8 6.1 2.3 5.4 1.5 0.9 2.4 1.1 1.0 1.7 1.5 0.6 1.8 2.4 1.1 0.8 2.7 1.1 0.0 1.3 0.6 0.7 1.2 0.9 1.2 0.9 2.7 0.5 0.8 1.0 0.2 0.1 0.4 0.5 1.9 1.2 2.0 0.3 1.7 1.1 0.5 1.0 0.4 0.2 0.5 2.8 1.0 0.2 0.2 0.3 1.1 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.2 1.7 0.5 0.0 0.7 0.1 0.2 0.8 6.9 0.1 0.2 0.8 0.3 0.3 3.0 2.6 0.3 0.3 0.3 1.7 2.1 0.2 0.9 1.7 11.3 0.4 0.8 3.2 0.7 1.6 0.4 0.3 1.0 0.2 3.8 0.2 5.1 2.7 0.5 0.5 0.7 0.4 0.4 0.7 0.7 0.5 0.2 1.2 1.0 0.8 1.1 0.8 0.5 0.9 0.6 0.2 2.7 11.7 6.8 6.1 3.5 2.8 2.5 2.5 5.4 1.1 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 "Protocadherin gamma subfamily A, 10" Q9Y5H3 5 141412987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 33.7" "Cell line enhanced" "Detected in many" "AF22: 12.0;HSkMC: 13.5;T-47d: 16.0;U-2197: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077276" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA077276: " "unprognostic (2.92e-1)" "unprognostic (2.17e-4)" "unprognostic (1.63e-1)" "unprognostic (3.33e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-2)" "unprognostic (9.99e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.64e-3)" "unprognostic (2.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.06e-1)" "unprognostic (8.83e-3)" 5.2 4.2 7.9 1.6 11.4 1.2 2.7 2.4 33.7 3.6 2.9 9.8 1.2 2.4 3.0 2.4 4.3 3.6 3.7 2.3 9.1 4.4 2.0 6.5 3.5 1.7 5.1 7.2 3.6 1.9 1.4 2.4 7.4 5.3 3.6 2.6 4.9 4.1 4.6 2.0 4.7 2.9 3.1 6.7 2.5 4.7 2.0 6.5 0.0 4.9 1.5 3.3 2.5 3.5 0.9 1.1 1.5 0.7 0.8 1.0 0.2 0.0 0.0 12.0 6.1 5.3 2.3 5.7 2.0 0.1 2.9 4.7 0.2 0.7 0.6 7.9 2.9 0.3 2.8 1.9 2.3 0.7 0.0 0.0 0.3 0.0 2.1 1.2 0.2 13.5 0.3 2.0 0.8 1.1 0.0 0.1 7.3 0.0 0.1 0.3 1.1 0.1 0.1 1.0 0.0 2.0 0.0 1.6 0.6 0.3 0.0 0.3 16.0 1.5 2.6 5.5 0.3 9.4 0.1 0.2 0.9 0.1 2.8 0.0 0.3 1.5 0.3 0.3 1.0 0.4 1.0 0.6 0.4 0.6 0.1 0.9 0.4 0.9 0.9 0.8 0.7 1.1 0.3 0.2 7.9 11.4 2.4 8.5 9.1 4.4 5.1 7.2 5.3 6.5 PCDHGA11 PCDH-GAMMA-A11 ENSG00000253873 "Protocadherin gamma subfamily A, 11" Q9Y5H2 5 141421047-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell line enhanced" "Detected in many" "ASC diff: 14.9;ASC TERT1: 16.1;HSkMC: 11.5;REH: 9.6;SK-MEL-30: 12.4;WM-115: 25.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.13e-2)" "unprognostic (1.78e-3)" "unprognostic (9.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.68e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.16e-3)" "unprognostic (1.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.97e-1)" "unprognostic (2.22e-1)" "unprognostic (3.03e-2)" "unprognostic (3.74e-2)" "unprognostic (3.54e-1)" "unprognostic (4.34e-3)" "unprognostic (1.89e-1)" 3.4 2.5 7.4 2.8 9.4 0.5 2.1 4.1 8.5 2.4 2.5 8.5 0.0 1.2 2.6 1.7 3.1 2.1 2.1 3.4 11.6 1.9 1.9 1.2 2.3 1.8 4.5 5.2 3.8 2.3 1.3 1.9 8.3 5.0 2.5 1.5 3.3 2.8 3.4 2.8 6.6 1.2 3.3 4.9 1.6 1.8 2.2 7.1 0.1 3.4 0.6 1.7 1.7 2.2 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.4 14.9 16.1 0.5 3.2 6.2 2.5 4.0 0.0 0.1 0.3 5.4 3.2 2.1 0.1 0.3 4.0 0.1 1.4 0.0 0.0 0.0 2.5 0.2 0.0 11.5 0.1 4.4 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 9.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.3 1.8 4.5 0.5 0.1 0.4 0.0 0.0 0.2 0.0 0.1 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 7.4 9.4 4.1 8.5 11.6 1.9 4.5 5.2 5.0 7.1 PCDHGA12 "CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12" ENSG00000253159 "Protocadherin gamma subfamily A, 12" O60330 5 141430589-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9" "Cell line enhanced" "Detected in some" "BJ: 7.6;BJ hTERT+: 12.6;fHDF/TERT166: 18.7;HHSteC: 6.1;HSkMC: 14.0;TIME: 6.0" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Low lineage specificity" "Detected in many" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.17e-3)" "unprognostic (2.71e-2)" "unprognostic (1.04e-2)" "unprognostic (2.67e-1)" "unprognostic (2.74e-1)" "unprognostic (5.06e-2)" "unprognostic (1.99e-1)" "unprognostic (9.01e-3)" "unprognostic (1.19e-1)" "unprognostic (4.65e-4)" "unprognostic (2.98e-1)" "unprognostic (3.02e-1)" "unprognostic (1.28e-4)" "unprognostic (8.30e-3)" "unprognostic (1.57e-1)" "unprognostic (2.42e-1)" "unprognostic (6.85e-3)" 5.1 12.7 14.8 2.8 18.9 0.7 2.4 4.7 13.8 4.9 1.8 8.6 0.6 1.4 5.4 2.3 3.5 2.7 11.3 6.5 15.7 5.6 3.1 2.8 6.5 1.6 4.7 7.3 6.2 3.6 2.0 2.7 6.5 8.4 3.5 1.7 3.4 1.7 4.9 1.9 5.1 1.5 5.3 8.4 3.7 2.2 1.6 12.4 0.4 3.0 0.6 1.7 4.5 3.6 3.7 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.6 1.2 0.1 7.6 12.6 0.0 0.0 0.0 0.0 0.4 0.0 18.7 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.0 14.0 0.0 3.7 0.0 4.4 0.0 0.0 2.6 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 6.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 14.8 18.9 4.7 10.4 15.7 5.6 4.7 7.3 8.4 12.4 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 "Protocadherin gamma subfamily A, 2" Q9Y5H1 5 141338760-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ: 5.4;fHDF/TERT166: 6.4;HSkMC: 5.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA038625" Approved Approved "Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA038625: " "unprognostic (2.43e-3)" "unprognostic (2.10e-2)" "unprognostic (1.32e-2)" "unprognostic (4.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.14e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.45e-3)" "unprognostic (9.68e-3)" "unprognostic (1.04e-2)" "unprognostic (1.18e-2)" "unprognostic (2.23e-4)" 5.1 4.3 6.7 2.1 8.0 0.6 4.2 5.2 12.6 6.6 2.6 4.6 1.0 0.9 6.5 5.7 2.4 5.5 5.5 11.1 6.5 4.6 3.3 2.4 4.6 1.1 6.0 2.3 15.3 8.4 9.2 10.6 2.2 7.8 5.3 1.4 13.8 3.3 5.8 2.6 2.9 1.4 5.2 5.6 1.9 2.1 10.4 3.5 0.0 4.3 1.2 1.1 3.2 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 3.9 9.9 0.1 5.4 2.1 0.5 0.9 0.1 0.1 0.1 0.7 6.4 0.2 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.1 0.2 0.1 0.3 2.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.1 1.4 0.3 0.2 0.8 0.0 0.3 0.7 0.0 3.6 0.1 0.7 0.0 3.3 0.9 0.5 0.3 0.1 0.0 0.4 0.0 2.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 8.0 5.2 7.2 6.5 4.6 6.0 2.3 7.8 3.5 PCDHGA3 PCDH-GAMMA-A3 ENSG00000254245 "Protocadherin gamma subfamily A, 3" Q9Y5H0 5 141343829-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "AF22: 11.0;BJ: 3.6;EFO-21: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (6.47e-2)" "unprognostic (4.79e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.53e-2)" "unprognostic (1.03e-1)" "unprognostic (2.35e-1)" "unprognostic (1.85e-1)" "unprognostic (7.44e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (2.32e-3)" "unprognostic (7.12e-3)" "unprognostic (3.31e-2)" "unprognostic (2.52e-4)" 4.0 4.5 11.7 1.4 10.5 0.7 2.5 6.9 13.7 4.7 1.3 7.9 0.0 0.7 4.5 3.5 1.5 2.9 3.5 12.2 8.5 5.8 2.5 2.5 2.6 1.0 6.6 7.7 8.6 3.6 1.8 6.3 5.7 8.7 3.0 1.3 4.6 2.9 3.2 1.5 1.9 1.1 3.6 6.0 1.5 1.2 5.2 3.8 0.0 3.3 1.3 1.0 1.7 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.1 0.2 1.5 0.0 3.6 0.3 0.0 0.1 0.0 0.0 0.1 8.9 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 10.5 6.9 13.7 8.5 5.8 6.6 7.7 8.7 3.8 PCDHGA4 PCDH-GAMMA-A4 ENSG00000262576 "Protocadherin gamma subfamily A, 4" Q9Y5G9 5 141355025-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.2;BJ: 5.6;HSkMC: 5.9;HUVEC TERT2: 5.6;U-87 MG: 8.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 7 "T-cells: 1.9" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.27e-2)" "unprognostic (4.55e-3)" "unprognostic (2.00e-2)" "unprognostic (6.54e-4)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-2)" "unprognostic (5.62e-2)" "unprognostic (3.76e-1)" "unprognostic (6.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.94e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.31e-4)" 5.4 4.7 6.5 1.8 8.3 0.5 3.0 8.5 11.2 4.8 2.0 10.4 1.5 1.2 5.0 3.0 1.9 3.4 3.1 4.8 6.3 5.9 2.0 2.7 3.6 0.9 5.6 8.1 5.8 6.7 8.5 3.4 2.8 6.1 4.1 1.4 3.5 4.3 4.2 1.5 1.8 1.2 5.0 5.9 1.3 1.4 2.7 4.0 0.0 2.6 2.7 0.9 2.3 2.5 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 1.0 0.6 4.5 10.2 0.0 5.6 4.5 0.3 1.1 0.0 0.1 0.9 1.9 4.7 0.1 0.1 0.2 0.6 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.4 5.9 0.2 0.1 0.0 5.6 0.2 0.3 2.4 0.8 0.3 0.2 0.2 0.2 0.3 1.6 0.1 0.3 0.0 0.8 1.7 0.2 0.3 1.1 2.1 0.0 3.6 2.4 0.7 3.1 0.4 0.2 0.3 0.2 8.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.3 8.5 9.3 6.3 5.9 5.6 8.1 6.1 4.0 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.1" "Group enriched" "Detected in some" 7 "ASC diff: 18.4;ASC TERT1: 7.3" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 4.0 2.7 6.1 1.8 9.1 0.9 3.9 19.1 9.6 9.0 2.7 7.7 4.1 1.0 7.6 3.2 3.3 4.7 4.5 4.9 6.9 4.0 1.5 1.2 3.3 1.3 3.2 3.8 6.6 1.7 3.3 3.7 2.7 4.6 5.6 1.6 4.1 2.5 4.0 1.5 3.0 1.5 4.3 6.3 1.4 1.7 1.7 3.7 0.0 1.8 0.9 1.0 2.5 4.2 0.9 0.8 1.6 0.6 1.9 0.7 0.2 0.0 0.4 0.3 0.1 18.4 7.3 0.0 0.8 0.1 0.1 0.3 0.0 0.0 0.8 0.3 0.3 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 1.8 0.2 0.0 0.0 0.6 0.1 0.6 0.7 0.3 0.5 0.7 0.1 0.3 0.9 0.6 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.3 1.6 0.0 1.0 0.6 0.2 1.0 0.7 0.1 1.0 0.1 0.3 0.2 0.7 1.5 0.6 0.6 0.7 0.3 0.3 0.6 0.6 0.4 0.1 0.9 0.7 0.7 1.6 1.9 0.2 0.8 0.4 0.2 6.1 9.1 19.1 9.6 6.9 4.0 3.2 3.8 4.6 3.7 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 "Protocadherin gamma subfamily A, 6" Q9Y5G7 5 141373914-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6" "Cell line enhanced" "Detected in some" "SCLC-21H: 11.0;T-47d: 6.4;WM-115: 13.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (4.49e-2)" "unprognostic (8.91e-3)" "unprognostic (5.45e-2)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (3.86e-3)" "unprognostic (2.02e-2)" "unprognostic (5.26e-2)" "unprognostic (7.44e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-3)" 4.1 3.8 6.1 2.3 8.4 0.8 2.9 19.6 10.8 7.9 3.4 8.3 2.9 1.0 6.9 4.7 2.6 4.3 3.6 3.7 5.0 4.3 2.8 1.7 3.3 1.4 2.9 4.7 9.7 2.5 2.5 4.5 6.9 3.3 4.0 1.6 5.8 4.1 5.3 2.1 4.7 1.5 6.1 2.8 2.8 1.7 2.2 2.9 0.2 3.8 1.2 1.5 4.6 3.6 1.3 0.7 2.8 0.6 0.5 0.8 0.2 0.1 0.3 3.1 0.5 1.5 5.3 0.1 2.3 0.8 1.2 1.2 0.0 0.2 2.1 3.0 3.6 0.5 0.1 0.5 0.8 0.0 0.3 0.0 0.3 0.3 0.8 0.1 0.1 5.7 0.4 0.3 0.1 1.8 0.3 1.3 0.4 0.5 0.7 1.8 0.3 0.1 1.5 0.4 0.0 0.4 0.1 11.0 0.9 0.1 0.3 0.7 6.4 0.1 5.4 0.9 0.4 0.8 0.8 0.4 1.8 0.4 0.9 0.7 13.7 1.8 0.6 0.3 0.8 0.3 0.3 0.8 0.6 0.2 0.1 1.3 0.3 0.5 2.8 0.5 0.3 0.7 0.5 0.2 6.1 8.4 19.6 10.8 5.0 4.3 2.9 4.7 3.3 2.9 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ hTERT+: 17.3;SH-SY5Y: 15.5;T-47d: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 1.7 2.0 3.1 1.3 9.0 0.6 2.1 5.3 14.9 3.5 3.0 7.1 2.1 1.0 4.2 4.1 2.2 3.3 1.9 3.0 5.1 3.3 3.2 1.9 2.2 1.0 5.1 6.6 4.7 2.5 4.6 3.4 4.8 5.4 3.7 1.5 5.8 2.6 3.3 1.6 3.8 1.2 3.0 6.3 1.3 1.4 2.1 5.1 0.0 6.6 1.5 1.0 2.4 2.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 1.9 0.0 5.8 9.9 0.0 2.6 17.3 3.5 5.2 0.0 0.0 0.4 4.3 0.5 0.1 0.0 0.1 2.9 0.0 0.3 0.0 0.4 0.1 1.0 0.0 0.0 4.3 0.1 0.0 0.6 1.4 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 15.5 0.0 0.1 0.1 6.8 0.0 5.2 0.1 0.1 2.5 0.0 0.1 1.5 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.0 5.3 7.7 5.1 3.3 5.1 6.6 5.4 5.1 PCDHGA8 "KIAA0327, PCDH-GAMMA-A8" ENSG00000253767 "Protocadherin gamma subfamily A, 8" Q9Y5G5 5 141390157-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 7.1" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 2.9;neutrophil: 2.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.28e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (4.10e-2)" "unprognostic (7.68e-2)" "unprognostic (2.30e-2)" "unprognostic (1.83e-2)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.35e-2)" "unprognostic (1.49e-3)" "unprognostic (7.59e-2)" "unprognostic (3.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.99e-3)" 0.6 0.7 0.8 0.7 0.6 2.5 0.7 2.3 2.2 1.2 1.2 1.0 7.1 0.4 2.3 1.5 2.1 0.7 0.9 2.0 1.4 0.5 0.5 0.9 1.1 0.7 0.5 0.4 2.6 0.6 0.2 1.9 1.4 3.5 0.9 0.8 0.4 0.8 0.5 2.2 2.5 1.1 0.7 1.6 0.7 0.7 1.0 1.3 1.1 2.4 0.4 0.6 0.6 1.2 0.7 0.4 2.9 0.4 0.5 0.3 0.1 0.3 0.2 1.1 0.6 1.1 2.6 0.6 2.4 1.6 1.7 0.7 0.2 0.4 1.1 1.0 1.8 0.4 0.0 0.0 1.3 0.3 0.2 0.3 0.5 0.3 0.1 0.4 0.8 1.4 0.1 0.5 0.1 0.4 0.2 0.9 0.2 0.2 0.5 0.7 2.7 0.1 1.0 0.2 0.1 0.1 0.3 0.7 0.7 0.3 0.9 0.4 1.2 1.7 2.5 2.6 0.9 0.6 0.2 0.3 0.3 0.4 1.3 0.4 1.3 2.9 0.4 0.5 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.2 0.3 2.8 0.5 0.3 0.4 0.2 0.1 0.8 0.6 2.3 2.2 1.4 0.5 0.5 0.4 3.5 1.3 PCDHGA9 PCDH-GAMMA-A9 ENSG00000261934 "Protocadherin gamma subfamily A, 9" Q9Y5G4 5 141402932-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 5.9;HSkMC: 6.6;TIME: 7.2;U-87 MG: 8.3" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.98e-2)" "unprognostic (7.47e-3)" "unprognostic (9.86e-3)" "unprognostic (2.22e-1)" "unprognostic (4.68e-2)" "unprognostic (4.96e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-3)" "unprognostic (2.26e-1)" "unprognostic (1.79e-1)" "unprognostic (4.48e-3)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-2)" 5.6 5.4 12.0 2.6 12.6 0.9 3.7 11.5 17.3 6.9 2.7 11.2 0.1 2.1 7.6 3.9 4.8 6.3 6.5 3.2 10.3 8.5 3.0 2.8 5.0 2.1 9.6 7.1 9.1 3.0 3.8 3.0 3.6 10.9 5.2 2.7 7.7 3.8 7.3 1.9 5.5 2.0 5.9 13.0 3.6 2.9 2.0 5.9 0.0 4.6 1.4 2.5 4.8 3.7 0.5 0.3 1.0 0.5 0.2 1.0 0.0 0.0 0.3 1.0 2.5 0.2 0.5 0.4 1.2 0.0 1.0 1.1 0.4 0.6 2.0 5.9 3.1 0.1 0.2 0.3 1.1 0.1 0.5 0.0 0.2 0.0 1.8 0.1 0.4 6.6 0.3 0.6 0.5 1.6 0.1 0.3 0.5 0.6 0.3 0.7 0.3 0.1 0.3 0.7 0.0 0.3 0.3 0.7 1.8 0.6 0.1 0.8 1.5 0.7 7.2 0.5 0.5 0.1 3.9 0.3 0.1 0.1 8.3 0.2 1.4 1.0 0.5 0.3 1.0 0.3 0.6 0.3 0.4 0.2 0.1 0.5 0.4 0.7 1.0 0.2 0.2 0.3 0.1 0.0 12.0 12.6 11.5 16.2 10.3 8.5 9.6 7.1 10.9 5.9 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 "Protocadherin gamma subfamily B, 1" Q9Y5G3 5 141350102-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 32.2;pituitary gland: 13.7" "Cell line enhanced" "Detected in some" "ASC diff: 14.9;ASC TERT1: 7.7;T-47d: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076182" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody" "Vesicles, Plasma membrane" "Nucleoplasm, Focal adhesion sites, Midbody" "HPA008755: AB_1079577, HPA010580: , HPA076182: " "unprognostic (1.53e-2)" "unprognostic (1.94e-3)" "unprognostic (3.21e-1)" "unprognostic (4.38e-3)" "unprognostic (2.98e-1)" "unprognostic (8.36e-3)" "unprognostic (2.37e-1)" "unprognostic (9.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.78e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-2)" "unprognostic (1.93e-1)" "unprognostic (7.63e-3)" 2.3 2.7 8.2 1.4 7.5 1.0 2.1 4.3 32.2 2.5 1.4 9.4 0.1 1.2 3.7 2.0 1.7 1.9 2.1 2.2 7.6 5.7 2.1 1.3 2.4 1.2 5.5 5.0 4.1 2.8 1.4 13.7 1.6 7.0 2.5 1.4 2.6 1.7 3.1 1.1 1.4 1.3 3.0 6.9 1.4 1.2 1.5 5.6 0.0 2.5 0.0 1.2 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 2.1 1.8 0.0 14.9 7.7 0.1 1.4 3.6 0.5 0.8 0.2 0.5 0.5 4.7 0.5 0.6 0.4 0.2 0.5 0.0 0.9 0.0 0.2 1.3 0.2 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.2 0.2 3.3 1.9 0.4 0.3 0.2 0.0 0.0 2.8 0.1 0.0 0.0 1.1 0.8 0.0 0.9 0.1 9.6 0.0 1.1 0.2 1.6 1.2 0.0 0.0 2.6 0.3 2.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.5 4.3 9.6 7.6 5.7 5.5 5.0 7.0 5.6 PCDHGB2 PCDH-GAMMA-B2 ENSG00000253910 "Protocadherin gamma subfamily B, 2" Q9Y5G2 5 141360042-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8" "Cancer enriched" "Detected in many" 5 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077526" Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane, Cytosol" Nucleoplasm "HPA008755: AB_1079577, HPA010580: , HPA077526: " "unprognostic (7.14e-3)" "unprognostic (8.79e-3)" "unprognostic (3.21e-2)" "unprognostic (2.17e-1)" "prognostic unfavourable (8.67e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-4)" "unprognostic (2.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.78e-1)" "unprognostic (1.05e-1)" "unprognostic (8.46e-3)" "unprognostic (4.59e-2)" "unprognostic (2.57e-1)" "unprognostic (3.06e-2)" "unprognostic (1.29e-1)" "unprognostic (3.36e-4)" 4.9 3.6 11.3 2.2 9.7 0.9 3.7 8.7 12.2 7.2 2.4 11.6 0.3 1.2 9.2 3.2 3.2 5.6 6.2 4.6 9.3 7.0 2.7 2.7 5.4 1.4 7.0 8.6 9.0 2.6 7.5 3.0 3.9 7.3 4.4 2.8 3.1 2.4 4.4 1.9 2.9 2.1 5.0 7.0 2.2 2.0 1.8 7.8 0.1 2.6 1.3 1.4 2.8 3.3 0.9 0.9 0.5 0.0 0.0 0.7 0.0 0.1 0.3 2.1 0.2 14.4 10.5 0.1 2.2 3.0 0.6 3.4 0.0 0.3 3.8 1.0 1.7 0.5 0.5 0.3 1.0 0.0 0.2 0.0 0.3 0.4 0.6 0.2 0.2 2.7 0.5 0.2 0.1 1.7 0.2 1.2 8.5 0.4 2.9 0.6 0.1 0.9 7.8 2.7 0.2 0.2 0.3 1.6 1.7 0.2 0.4 0.4 3.1 0.2 6.0 3.0 0.7 4.6 3.9 0.2 2.2 0.7 3.3 1.0 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.4 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.0 0.9 0.0 0.0 11.3 9.7 8.7 10.6 9.3 7.0 7.0 8.6 7.3 7.8 PCDHGB3 PCDH-GAMMA-B3 ENSG00000262209 "Protocadherin gamma subfamily B, 3" Q9Y5G1 5 141370264-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 13.2;ASC TERT1: 10.7;TIME: 6.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008755, HPA010580, HPA035822, HPA035823" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA035822: , HPA035823: " "unprognostic (6.93e-3)" "unprognostic (9.10e-4)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (7.83e-2)" "unprognostic (1.92e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.81e-2)" "unprognostic (3.11e-1)" "unprognostic (3.62e-2)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" 4.1 1.7 3.3 1.6 6.5 0.5 3.1 3.5 5.6 3.0 3.0 7.2 0.7 0.7 4.9 3.7 3.3 3.3 2.9 4.6 3.3 2.3 2.9 2.0 2.5 3.7 1.9 3.8 5.2 4.2 4.6 5.4 2.3 2.6 2.6 2.2 3.1 6.6 2.6 1.9 3.3 1.4 4.3 2.9 2.4 2.3 1.5 2.8 0.3 3.4 3.2 3.5 2.7 4.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.4 0.3 13.2 10.7 0.2 1.4 2.4 0.9 1.1 0.0 0.0 2.2 0.4 4.3 0.6 0.0 0.3 0.7 0.0 0.3 0.0 0.3 0.1 0.6 0.1 0.0 2.6 0.6 0.2 0.1 1.2 0.3 1.0 0.3 0.4 0.7 1.0 0.1 0.1 1.8 0.7 0.0 0.2 0.1 3.0 0.6 0.0 0.0 0.3 0.8 0.0 6.7 0.6 0.1 0.7 0.7 0.3 2.0 0.2 0.6 0.6 1.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 6.5 3.5 5.6 3.3 2.3 1.9 3.8 2.6 2.8 PCDHGB4 "CDH20, FIB2, PCDH-GAMMA-B4" ENSG00000253953 "Protocadherin gamma subfamily B, 4" Q9UN71 5 141387698-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 28.5;TIME: 14.3" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "NK-cell: 1.6" "Lineage enriched" "Detected in single" 7 "NK-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.33e-1)" "unprognostic (1.83e-3)" "unprognostic (2.91e-1)" "unprognostic (1.18e-1)" "unprognostic (1.23e-2)" "unprognostic (9.25e-3)" "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.70e-2)" "unprognostic (2.62e-1)" "unprognostic (1.13e-1)" "unprognostic (3.27e-2)" 2.4 2.2 2.4 0.7 4.2 0.0 1.2 1.8 2.1 2.6 1.4 0.2 3.2 3.5 1.1 2.1 0.8 2.8 2.3 4.1 2.9 3.3 2.1 0.0 1.8 5.1 1.9 3.0 2.5 6.2 2.6 0.7 3.0 3.1 1.2 3.4 0.3 1.9 2.0 0.6 0.4 0.9 3.6 0.2 1.6 2.0 0.0 0.2 0.0 0.0 1.6 0.2 0.2 0.0 0.7 7.0 0.0 4.6 5.9 0.8 6.8 28.5 2.8 1.9 0.0 0.0 0.2 5.5 0.2 2.0 0.0 0.0 3.2 0.0 0.0 0.0 0.1 1.6 1.8 0.0 0.0 5.7 0.0 2.7 0.0 4.3 0.2 0.0 0.0 0.0 0.6 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 3.6 2.6 14.3 3.8 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 PCDHGB5 PCDH-GAMMA-B5 ENSG00000276547 "Protocadherin gamma subfamily B, 5" Q9Y5G0 5 141397987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 11.2" "Cell line enhanced" "Detected in many" "ASC diff: 32.2;ASC TERT1: 24.3;BJ hTERT+ SV40 Large T+: 13.9;BJ hTERT+ SV40 Large T+ RasG12V: 15.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (2.71e-3)" "unprognostic (1.95e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (2.35e-1)" "unprognostic (1.20e-1)" "unprognostic (3.64e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.29e-1)" "unprognostic (1.69e-4)" "unprognostic (9.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.25e-4)" 2.1 1.9 0.8 0.3 3.2 0.0 3.6 2.0 4.3 1.4 0.4 2.5 1.9 0.0 2.1 2.5 1.1 2.1 0.8 1.9 0.0 1.6 3.1 6.8 2.6 0.9 1.5 4.9 2.8 11.2 2.1 9.5 1.5 2.2 0.2 3.7 3.2 3.2 1.4 2.6 0.0 1.9 3.0 0.5 0.7 1.0 2.2 0.8 3.5 0.0 0.7 1.9 1.4 0.5 0.2 0.0 0.3 0.0 1.9 0.1 0.0 1.1 0.1 0.0 32.2 24.3 0.6 8.5 0.0 13.9 15.6 1.3 4.6 4.8 11.1 9.4 6.4 0.0 3.5 7.8 0.0 1.4 0.0 0.0 0.0 3.3 0.0 3.1 8.5 0.7 0.8 4.5 4.2 0.1 0.0 0.4 3.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 0.0 9.0 0.0 4.3 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.3 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 "Protocadherin gamma subfamily B, 6" Q9Y5F9 5 141408021-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell line enhanced" "Detected in some" "AF22: 18.2;EFO-21: 6.2;HSkMC: 4.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (2.63e-1)" "unprognostic (7.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-2)" "unprognostic (3.51e-1)" "unprognostic (1.11e-1)" "unprognostic (4.77e-2)" "unprognostic (9.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.27e-1)" "unprognostic (1.21e-2)" "unprognostic (7.71e-4)" 6.7 7.2 8.8 2.6 9.9 1.6 4.4 6.1 26.6 5.8 4.1 10.1 0.3 1.8 7.2 5.7 3.0 5.1 4.4 4.6 8.9 5.7 3.2 9.4 4.4 2.2 6.9 4.4 13.3 5.2 16.1 4.7 6.8 5.9 4.0 2.3 9.0 5.3 5.9 5.7 4.7 2.2 4.8 4.1 4.0 2.5 2.1 6.7 0.3 6.1 1.9 2.1 4.2 5.1 0.8 0.5 3.2 0.4 0.5 0.9 0.2 0.0 0.1 18.2 0.1 0.6 0.7 0.9 1.6 0.0 0.4 1.0 0.2 0.2 1.5 6.2 1.0 0.3 0.0 0.3 1.2 0.0 0.3 0.0 0.2 0.1 1.5 0.1 0.1 4.2 2.0 0.9 0.1 0.6 0.1 0.3 0.1 0.3 0.1 1.2 0.8 0.0 0.2 0.1 0.1 2.9 0.2 0.2 0.3 0.0 0.1 0.1 1.4 0.4 2.9 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.8 1.1 0.4 0.2 0.9 0.3 0.2 0.6 0.4 0.2 0.1 0.8 0.4 0.3 3.2 0.5 0.3 0.5 0.2 0.2 8.8 9.9 6.1 7.9 8.9 5.7 6.9 4.4 5.9 6.7 PCDHGB7 "ME6, PCDH-GAMMA-B7" ENSG00000254122 "Protocadherin gamma subfamily B, 7" Q9Y5F8 5 141417645-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "AN3-CA: 42.5;HSkMC: 13.5" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.22e-2)" "unprognostic (2.55e-2)" "unprognostic (7.39e-3)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (8.40e-2)" "unprognostic (4.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.88e-2)" "unprognostic (3.05e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-2)" 10.1 9.8 12.6 3.8 13.5 0.8 8.0 19.1 12.9 10.2 7.0 16.1 1.2 2.3 11.6 5.0 6.8 7.8 9.2 8.5 14.5 7.9 5.4 3.5 11.6 2.6 10.4 7.3 17.3 5.5 9.5 5.3 11.0 9.4 8.3 3.8 15.5 7.1 12.0 5.6 6.8 3.2 10.5 20.1 5.3 4.5 4.2 14.3 0.6 8.4 3.0 2.3 4.6 6.9 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 42.5 1.0 0.2 0.4 2.8 0.3 1.0 2.1 0.0 2.6 0.3 2.3 5.6 0.7 0.1 0.5 1.0 0.0 0.3 0.0 0.0 0.0 3.2 0.2 0.0 13.5 0.3 0.8 0.4 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 4.7 0.9 0.0 0.1 0.0 4.6 6.3 0.1 0.0 0.0 0.4 0.4 5.5 5.1 0.1 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 12.6 13.5 19.1 12.9 14.5 7.9 10.4 7.3 9.4 14.3 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 23.6" "Cell line enhanced" "Detected in some" "REH: 9.7;SCLC-21H: 8.2;SH-SY5Y: 15.9" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.7 2.9 5.7 0.7 9.5 0.5 0.8 23.6 21.9 1.0 1.1 2.3 0.0 0.6 0.9 1.2 0.8 1.0 1.0 1.3 4.1 10.1 0.6 0.6 1.0 0.9 3.3 4.5 0.8 1.2 0.8 1.3 0.8 8.6 0.8 0.8 1.9 1.0 0.7 1.2 1.5 0.7 0.9 2.3 0.8 0.7 1.5 0.8 0.0 0.7 0.0 1.0 0.6 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.2 0.2 0.8 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.3 0.9 0.9 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.0 1.5 0.0 9.7 0.6 0.0 0.0 0.1 8.2 15.9 0.1 0.0 0.2 0.1 0.3 0.1 0.9 0.1 0.2 0.7 0.2 0.0 0.2 0.6 0.1 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.5 23.6 15.6 4.1 10.1 3.3 4.5 8.6 0.8 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489121-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 43.7" "Cell line enhanced" "Detected in some" "U-138 MG: 16.3;U-251 MG: 7.0;U-87 MG: 10.0" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4" "HPA008755, HPA010580, HPA076140" Supported Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 1.0 1.1 7.4 1.1 34.5 0.9 1.1 3.0 43.7 1.1 1.0 2.8 0.0 0.9 1.4 1.3 1.0 1.2 1.2 2.8 11.8 2.8 0.9 0.9 1.1 0.9 2.2 10.0 1.1 1.0 1.0 1.1 1.0 2.3 1.3 1.0 0.0 0.9 1.6 1.6 1.5 0.9 2.0 0.8 1.0 1.0 1.3 1.1 0.0 1.0 0.0 1.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.7 0.2 0.8 0.6 0.5 0.6 0.0 0.0 0.5 1.6 2.4 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.9 0.8 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.2 0.1 16.3 0.2 0.2 7.0 0.0 0.0 0.0 10.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 34.5 3.0 39.2 11.8 2.8 2.2 10.0 2.3 1.1 PCED1B "FAM113B, MGC16044" ENSG00000179715 "PC-esterase domain containing 1B" Q96HM7 12 47079603-47236662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.1;lymphoid tissue: 40.2" "Cell line enhanced" "Detected in many" "A549: 32.0;K-562: 23.9;SK-BR-3: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043901 Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA043901: AB_10959888" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (3.29e-3)" "unprognostic (1.47e-3)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.32e-2)" "unprognostic (5.13e-2)" "unprognostic (2.36e-3)" "unprognostic (7.74e-2)" "unprognostic (3.39e-1)" "unprognostic (8.74e-2)" "prognostic unfavourable (4.55e-6)" "unprognostic (4.79e-2)" "unprognostic (3.74e-1)" "unprognostic (3.74e-2)" "prognostic favourable (5.36e-5)" 5.7 28.4 4.1 25.9 3.9 7.1 4.4 0.6 3.6 5.1 6.4 5.7 1.2 1.8 7.6 4.6 4.5 6.9 5.8 2.4 2.8 2.3 4.1 2.7 7.8 25.6 3.8 2.9 19.6 2.1 0.6 2.0 3.2 3.7 6.0 2.3 3.3 6.5 2.8 1.0 2.0 8.5 11.7 7.7 20.8 2.9 9.1 3.3 5.7 2.6 1.3 40.2 10.0 4.2 16.5 12.5 1.5 0.8 9.1 32.1 10.9 1.7 32.0 0.8 0.0 0.2 0.0 1.5 1.0 1.7 0.4 0.1 1.6 6.3 5.7 1.8 3.2 4.6 0.0 4.7 0.0 6.6 0.0 0.2 0.3 0.6 0.6 1.3 0.2 0.1 2.1 0.5 3.7 1.4 23.9 5.4 2.2 0.7 0.3 1.1 5.5 0.4 0.1 0.8 4.0 4.9 2.6 0.2 0.0 2.9 15.9 0.0 2.9 2.0 0.4 0.1 0.4 0.0 1.1 5.9 4.1 10.4 1.5 4.4 0.1 0.4 0.3 0.8 14.9 0.7 16.9 16.5 17.9 18.8 2.1 10.1 32.1 29.1 1.5 9.1 0.8 12.5 18.9 10.9 4.1 3.9 0.6 3.6 2.8 2.3 3.8 2.9 3.7 3.3 PCOLCE "PCPE, PCPE1" ENSG00000106333 "Procollagen C-endopeptidase enhancer" Q15113 7 100602177-100608175 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 83.4;BJ hTERT+: 62.1;HSkMC: 95.6;SH-SY5Y: 66.7;U-2197: 117.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017623, HPA042927" Approved Approved "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" 1300000000 "Golgi apparatus, Vesicles" "CAB017623: AB_2251882, HPA042927: " "unprognostic (4.14e-1)" "unprognostic (1.79e-1)" "unprognostic (1.34e-1)" "unprognostic (2.92e-1)" "unprognostic (1.70e-2)" "unprognostic (4.48e-2)" "unprognostic (1.33e-2)" "unprognostic (3.93e-2)" "prognostic unfavourable (9.76e-4)" "unprognostic (2.16e-2)" "unprognostic (1.73e-1)" "unprognostic (6.13e-2)" "prognostic unfavourable (1.68e-5)" "unprognostic (1.04e-2)" "unprognostic (3.21e-2)" "unprognostic (1.63e-2)" "unprognostic (1.43e-2)" 29.5 16.7 0.6 18.1 1.3 0.0 29.3 1.0 2.0 90.4 11.2 1.6 22.8 2.0 42.1 89.9 23.1 29.6 34.3 47.3 0.7 0.7 14.6 73.0 24.5 51.1 3.7 1.9 38.8 7.9 1.2 11.4 23.8 2.9 49.4 4.5 54.6 16.0 19.8 10.0 16.0 7.4 26.1 6.9 10.5 9.1 20.8 0.5 2.4 17.8 20.1 18.4 28.2 34.0 0.8 1.0 1.6 1.0 1.1 1.1 0.1 0.0 0.0 0.1 0.2 29.5 83.4 0.2 34.2 62.1 15.5 13.6 1.2 0.0 0.0 0.0 36.1 0.0 0.0 0.0 1.3 0.2 0.2 0.0 0.5 1.7 8.2 0.0 0.2 95.6 0.0 8.1 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.2 6.8 0.3 0.0 0.1 0.0 0.0 0.0 0.1 66.7 0.0 0.1 0.1 0.1 0.0 0.2 38.5 10.7 117.7 0.0 0.0 0.0 0.0 13.4 0.0 6.4 0.0 0.3 1.6 0.5 1.0 1.1 0.8 0.9 0.6 1.0 0.2 0.6 0.3 0.4 1.1 0.8 0.0 0.4 0.1 0.6 1.3 1.0 2.0 0.7 0.7 3.7 1.9 2.9 0.5 PCP2 "GPSM4, MGC41903" ENSG00000174788 "Purkinje cell protein 2" Q8IVA1 19 7631611-7633748 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 45.5;retina: 20.2;testis: 80.7" "Cell line enhanced" "Detected in some" "HMC-1: 8.9;Karpas-707: 4.5;NB-4: 18.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 14 "cerebellum: 45.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in some" 43 "cerebellum: 2422.3" "Region enriched" "Detected in single" 19 "cerebellum: 135.0" HPA057428 Approved "Nuclear speckles,Vesicles" "Nuclear speckles" Vesicles "HPA057428: " "prognostic favourable (7.93e-4)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.43e-2)" "unprognostic (1.49e-1)" "unprognostic (1.79e-4)" "unprognostic (1.19e-1)" "unprognostic (4.88e-5)" "unprognostic (1.11e-1)" "unprognostic (6.23e-2)" "unprognostic (9.15e-3)" "unprognostic (6.01e-2)" "unprognostic (1.36e-2)" "unprognostic (8.17e-2)" "unprognostic (1.18e-1)" "unprognostic (8.70e-2)" "prognostic favourable (2.76e-5)" 0.5 0.4 0.5 0.5 0.5 1.9 3.3 45.5 0.6 1.0 0.5 0.5 0.5 0.6 0.5 2.0 0.5 1.3 1.2 0.5 0.5 0.0 2.5 1.0 1.2 1.4 0.5 0.5 0.5 1.6 0.3 0.5 0.5 3.2 2.0 0.0 20.2 10.6 1.0 0.5 4.2 0.5 0.5 1.9 1.1 0.9 80.7 0.5 0.5 1.9 0.5 0.6 0.5 0.5 1.0 1.7 2.6 0.3 0.7 1.2 5.2 1.8 0.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 1.6 0.7 1.1 0.0 1.3 0.0 0.2 0.0 0.8 0.6 2.7 2.5 0.1 0.0 0.3 8.9 0.0 0.6 0.0 0.0 0.0 0.2 4.5 0.0 0.3 0.3 18.0 0.4 0.0 0.8 0.2 0.7 0.9 0.1 0.1 0.0 1.4 1.5 0.0 3.9 3.3 0.2 0.0 0.6 0.4 0.1 1.6 0.6 0.2 0.0 2.1 0.0 0.0 0.3 0.0 0.9 0.1 1.2 0.4 0.5 0.5 0.5 1.0 0.8 1.0 2.6 0.7 0.0 1.7 0.2 5.2 0.5 0.5 45.5 0.6 0.5 0.0 0.5 0.5 3.2 0.5 PCSK1N "BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII" ENSG00000102109 "Proprotein convertase subtilisin/kexin type 1 inhibitor" Q9UHG2 X 48831094-48835633 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.9;kidney: 72.9;pituitary gland: 127.7" "Cell line enhanced" "Detected in some" "HEK 293: 19.6;PC-3: 49.6;SCLC-21H: 19.7;SH-SY5Y: 18.2;SiHa: 17.2;U-266/84: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 3.0;memory CD4 T-cell: 6.5;memory CD8 T-cell: 6.3;naive CD4 T-cell: 2.7;naive CD8 T-cell: 8.2;T-reg: 2.1" "Lineage enriched" "Detected in single" 77 "T-cells: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003925, HPA064734" Enhanced Supported Approved Vesicles "Secreted to blood" 5300000 Vesicles "HPA003925: AB_1079582, HPA064734: AB_2685339" "unprognostic (2.44e-3)" "unprognostic (5.86e-2)" "unprognostic (1.94e-1)" "prognostic unfavourable (1.15e-4)" "unprognostic (3.36e-1)" "unprognostic (4.76e-3)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (1.50e-3)" "unprognostic (2.79e-3)" "prognostic favourable (1.36e-4)" "unprognostic (3.34e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" 4.1 27.5 49.1 2.6 72.7 2.1 2.2 15.6 70.3 3.2 9.8 10.8 1.5 12.4 4.4 10.9 2.1 2.3 2.8 2.7 38.5 74.9 72.9 2.1 2.6 2.2 33.5 29.0 2.2 20.0 12.4 127.7 2.3 32.9 4.6 2.7 6.6 2.8 3.1 2.2 2.8 8.5 2.7 18.3 2.4 26.0 3.8 9.8 0.0 2.2 0.0 2.1 2.1 0.5 0.1 0.0 0.0 0.0 0.0 8.2 0.8 0.0 1.8 0.0 5.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.5 0.0 0.2 0.0 0.3 0.0 0.0 19.6 0.0 0.0 2.9 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 2.7 49.6 0.0 0.0 0.1 0.4 0.0 19.7 18.2 17.2 0.0 1.4 0.0 0.0 0.0 0.0 7.6 0.0 1.6 4.5 22.9 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.1 0.0 3.0 0.0 6.5 6.3 0.0 0.1 2.7 8.2 0.0 0.0 0.0 0.0 2.1 0.8 49.1 72.7 15.6 70.3 38.5 74.9 33.5 29.0 32.9 9.8 PCSK2 "NEC2, PC2, SPC2" ENSG00000125851 "Proprotein convertase subtilisin/kexin type 2" P16519 20 17226107-17484578 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 35.0;thyroid gland: 79.5" "Group enriched" "Detected in some" 5 "AF22: 35.8;SCLC-21H: 9.4" "Group enriched" "Detected in many" 6 "pancreatic cancer: 14.6;thyroid cancer: 65.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "basophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049627 Approved Approved Vesicles "Secreted in other tissues" Vesicles "HPA049627: " "unprognostic (2.03e-3)" "unprognostic (1.61e-1)" "unprognostic (3.13e-1)" "unprognostic (2.18e-1)" "unprognostic (2.13e-1)" "unprognostic (6.84e-2)" "unprognostic (3.07e-3)" "unprognostic (4.31e-1)" "unprognostic (5.88e-2)" "unprognostic (2.50e-3)" "unprognostic (2.14e-1)" "unprognostic (7.26e-5)" "unprognostic (2.29e-1)" "unprognostic (1.57e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-1)" 1.6 35.0 16.3 1.7 20.5 1.3 1.3 7.7 27.8 2.9 4.2 1.6 0.0 6.2 0.9 1.2 2.1 2.0 1.4 3.1 18.0 11.1 1.1 1.0 2.2 0.8 4.1 16.2 11.6 23.7 0.9 1.7 1.5 9.0 1.3 2.8 16.6 2.7 2.3 1.0 16.6 3.3 1.3 5.4 0.9 11.9 4.7 3.8 0.0 79.5 0.0 0.9 1.9 1.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 20.5 7.7 27.8 18.0 11.1 4.1 16.2 9.0 3.8 PDCD11 "ALG-4, KIAA0185, RRP5" ENSG00000148843 "Programmed cell death 11" Q14690 10 103396648-103446292 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017924, CAB026472" Approved Supported Nucleoli,Vesicles Nucleoli Vesicles "CAB026472: , HPA017924: AB_10601045" "unprognostic (1.34e-1)" "unprognostic (6.84e-2)" "unprognostic (1.48e-1)" "unprognostic (2.31e-2)" "unprognostic (1.80e-1)" "unprognostic (8.94e-2)" "prognostic unfavourable (2.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.16e-1)" "unprognostic (6.49e-2)" "unprognostic (3.25e-2)" "unprognostic (9.29e-2)" "unprognostic (1.01e-2)" "unprognostic (1.77e-1)" "unprognostic (6.28e-2)" "unprognostic (5.59e-2)" 11.3 11.8 11.6 13.9 12.5 9.6 13.8 12.6 12.0 11.0 10.4 10.6 8.9 8.5 17.3 10.6 17.3 14.3 9.9 10.3 10.5 7.0 11.0 14.0 11.3 14.7 9.9 8.6 16.5 17.2 17.7 14.4 10.9 10.5 12.1 12.0 9.2 11.3 13.0 42.8 22.3 11.1 13.6 9.5 14.7 10.8 22.8 12.4 20.7 10.9 13.8 17.0 11.2 16.8 5.6 5.4 1.4 4.4 3.4 9.1 3.5 10.1 15.1 10.5 29.6 9.2 8.3 11.8 11.2 7.9 11.3 9.3 20.5 10.0 28.0 8.0 8.0 18.2 27.0 14.1 12.8 12.9 18.2 16.3 9.6 16.4 11.0 32.4 11.2 8.6 13.0 17.4 39.8 12.1 26.1 12.6 10.9 11.5 16.2 18.5 21.6 14.6 16.4 15.1 12.7 7.1 10.0 7.1 13.3 7.5 8.9 12.4 8.8 9.2 13.1 8.4 10.6 11.2 20.9 16.1 22.4 26.6 7.4 31.4 6.2 0.1 4.4 1.4 5.7 4.3 9.1 5.6 5.4 4.6 4.7 4.1 4.8 5.6 0.6 3.4 3.6 5.4 3.8 3.5 11.6 12.5 12.6 12.0 10.5 7.0 9.9 8.6 10.5 12.4 PDCD6IP "AIP1, Alix, Hp95" ENSG00000170248 "Programmed cell death 6 interacting protein" Q8WUM4 3 33798352-33869707 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011905, CAB016212, HPA051604" Approved Enhanced Vesicles "Intracellular and membrane" 6200000 Vesicles "CAB016212: AB_673819, HPA011905: AB_1855111, HPA051604: " "unprognostic (1.53e-1)" "unprognostic (2.63e-1)" "prognostic favourable (1.16e-4)" "unprognostic (2.17e-1)" "unprognostic (2.75e-1)" "unprognostic (5.12e-2)" "unprognostic (7.76e-3)" "unprognostic (1.23e-2)" "unprognostic (3.29e-1)" "unprognostic (2.86e-1)" "unprognostic (3.88e-3)" "unprognostic (4.49e-2)" "prognostic favourable (3.90e-9)" "unprognostic (9.61e-2)" "unprognostic (1.89e-1)" "unprognostic (4.78e-1)" "unprognostic (1.11e-1)" 39.1 26.8 18.6 26.2 27.2 16.0 27.0 24.0 31.5 33.8 36.8 26.3 16.5 28.6 33.7 22.7 45.2 27.1 26.2 29.6 20.7 19.7 42.8 41.5 29.9 24.8 22.7 18.1 33.0 21.2 34.9 26.3 43.2 48.9 26.6 34.0 23.0 27.4 20.4 29.5 31.7 57.9 25.9 24.8 32.2 29.1 24.2 16.8 35.9 35.1 25.6 37.3 28.6 31.6 11.8 12.3 10.8 18.2 12.0 9.7 8.9 17.7 18.6 12.0 10.0 31.5 32.5 13.2 22.7 21.8 20.3 21.2 12.8 17.5 25.4 14.2 29.9 15.7 18.6 23.8 23.2 10.6 15.5 21.8 15.3 10.6 21.0 21.7 22.6 25.3 27.7 22.9 27.4 30.1 19.6 10.6 29.4 9.2 13.3 13.1 11.6 23.1 12.7 14.8 16.5 25.3 15.2 5.9 10.6 22.3 26.7 12.0 25.9 20.9 37.2 24.1 12.1 20.0 18.8 10.7 14.3 21.3 22.7 23.9 11.8 6.3 13.4 10.8 8.7 18.2 9.3 11.8 9.6 8.6 12.3 10.1 8.5 8.2 8.1 12.0 17.2 5.7 9.7 8.9 18.6 27.2 24.0 31.5 20.7 19.7 22.7 18.1 48.9 16.8 PDE6G "PDEG, RP57" ENSG00000185527 "Phosphodiesterase 6G" P18545 17 81650459-81663112 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 260.3" "Cell line enhanced" "Detected in some" "Hep G2: 6.4;NB-4: 6.8;NTERA-2: 11.8;REH: 13.7" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 29.7;NK-cell: 57.8" "Group enriched" "Detected in all" 5 "granulocytes: 29.7;NK-cells: 57.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles Vesicles "HPA045118: " "unprognostic (6.16e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.51e-3)" "unprognostic (1.68e-1)" "unprognostic (1.46e-2)" "unprognostic (6.33e-2)" "unprognostic (3.80e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (4.85e-2)" "unprognostic (5.01e-2)" "unprognostic (1.94e-2)" "unprognostic (5.71e-2)" "unprognostic (5.44e-2)" "unprognostic (2.73e-1)" "unprognostic (1.14e-1)" 0.9 1.3 0.4 2.9 0.5 4.7 0.7 0.5 0.6 0.4 0.8 0.5 0.4 0.0 0.4 0.5 0.6 0.3 1.6 0.5 0.5 0.7 3.8 2.6 2.0 13.8 0.6 0.5 0.5 0.4 0.0 0.5 8.6 0.5 0.5 0.5 260.3 0.5 0.4 0.6 0.8 2.8 0.4 0.8 17.9 0.7 2.2 0.5 2.5 0.6 0.4 4.6 2.1 0.4 1.3 8.6 29.7 7.7 57.8 2.4 3.7 0.2 0.3 0.5 0.0 0.3 0.0 0.0 0.3 1.2 1.2 1.3 0.1 0.8 0.6 0.2 0.7 0.1 0.2 0.2 2.9 0.2 0.0 0.9 0.1 6.4 1.0 0.1 0.2 0.0 0.2 1.2 0.0 3.3 0.1 0.3 1.3 0.8 0.1 6.8 11.8 0.4 13.7 0.1 2.1 0.0 0.0 0.1 0.3 0.0 0.3 0.5 0.1 0.8 1.3 0.4 0.1 0.2 0.3 0.1 0.6 1.0 1.6 2.7 0.2 29.7 5.1 8.6 1.2 7.7 0.4 0.8 0.3 0.6 8.6 1.3 0.7 2.4 0.7 57.8 4.2 0.8 0.0 3.7 0.4 0.5 0.5 0.6 0.5 0.7 0.6 0.5 0.5 0.5 PDE6H ENSG00000139053 "Phosphodiesterase 6H" Q13956 12 14973022-14981865 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "retina: 67.4" "Group enriched" "Detected in some" 4 "AN3-CA: 4.2;MOLT-4: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles Vesicles "HPA045118: " "unprognostic (1.47e-3)" "unprognostic (1.07e-2)" 0.1 1.3 1.2 0.2 1.5 9.4 0.1 0.1 4.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 1.0 2.1 0.1 0.1 0.2 0.2 2.2 0.1 0.1 0.1 0.0 0.1 2.5 0.7 0.1 0.1 67.4 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.8 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.6 0.7 0.0 0.0 1.4 0.2 0.0 0.8 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 1.2 1.5 0.1 4.2 1.0 2.1 2.2 0.1 0.7 0.1 PDE9A ENSG00000160191 "Phosphodiesterase 9A" O76083 21 42653636-42775509 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 16.1;EFO-21: 16.2;MCF7: 12.0;NB-4: 17.9;NTERA-2: 22.1;SCLC-21H: 12.3" "Cancer enhanced" "Detected in all" "prostate cancer: 31.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.8" "Group enriched" "Detected in many" 4 "NK-cells: 1.7;T-cells: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011380 Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA011380: AB_1855132" "unprognostic (5.75e-2)" "unprognostic (9.92e-3)" "unprognostic (3.50e-1)" "unprognostic (1.08e-1)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (5.06e-2)" "unprognostic (3.99e-2)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-2)" "unprognostic (5.01e-2)" "unprognostic (1.90e-2)" "unprognostic (4.01e-3)" "unprognostic (1.97e-1)" "unprognostic (6.55e-2)" "unprognostic (1.79e-1)" 6.1 6.6 9.9 6.8 15.2 0.8 9.4 13.7 9.0 3.7 37.1 11.9 14.0 3.0 5.7 18.8 6.1 10.3 7.7 3.5 6.2 7.7 13.2 2.5 4.7 4.6 10.0 4.9 4.1 4.0 4.7 6.0 9.6 6.9 33.2 15.8 9.7 8.8 15.9 2.3 3.8 26.1 22.3 8.0 15.9 8.4 1.5 8.9 4.9 5.2 2.1 4.1 12.6 4.0 0.5 0.9 1.0 0.1 1.7 6.8 0.5 0.0 1.5 16.1 1.9 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.7 9.7 0.0 16.2 0.0 0.0 1.4 5.2 0.0 0.0 5.5 0.0 0.0 3.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 12.0 0.8 17.9 22.1 0.0 0.0 0.0 0.6 11.0 4.4 12.3 7.3 2.7 0.0 0.2 0.1 9.9 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.1 0.6 0.2 0.5 6.8 1.7 1.0 1.7 0.1 0.9 2.2 0.5 9.9 15.2 13.7 6.7 6.2 7.7 10.0 4.9 6.9 8.9 PDGFA "PDGF-A, PDGF1" ENSG00000197461 "Platelet derived growth factor subunit A" P04085 7 497258-520296 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.1" "Cell line enriched" "Detected in many" 4 "WM-115: 80.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005579 Approved Approved "Vesicles,Centriolar satellite" "Secreted to blood" 300000 "Vesicles, Centriolar satellite" "CAB005579: AB_2161916" "unprognostic (2.22e-1)" "unprognostic (2.83e-1)" "unprognostic (1.17e-1)" "unprognostic (1.26e-1)" "prognostic unfavourable (1.75e-4)" "prognostic unfavourable (1.78e-4)" "unprognostic (2.63e-3)" "unprognostic (4.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.85e-1)" "unprognostic (8.26e-2)" "unprognostic (1.07e-2)" "unprognostic (5.87e-2)" "unprognostic (8.35e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (8.67e-4)" 9.5 6.1 13.1 6.6 20.4 2.1 16.5 9.0 16.6 11.1 14.8 33.4 5.8 16.3 15.5 11.2 8.5 12.1 10.0 14.0 14.9 14.2 10.4 5.4 16.5 8.1 29.8 12.5 6.6 54.7 5.7 6.1 21.5 21.1 14.4 12.7 7.4 16.6 10.2 63.1 10.6 20.3 10.7 26.4 11.8 20.9 4.5 22.7 1.6 6.0 8.6 2.7 11.0 12.7 3.0 3.3 11.6 4.6 5.3 3.6 2.9 5.7 3.9 0.4 5.6 1.1 0.2 13.3 1.3 0.7 1.7 1.1 6.0 6.5 0.1 2.3 1.1 14.6 0.4 17.7 0.9 3.2 0.6 0.1 3.2 2.1 7.2 0.6 0.7 0.8 7.0 0.8 5.6 3.2 0.5 0.8 4.1 7.2 0.8 1.3 10.4 0.8 2.9 0.4 0.6 2.3 1.3 0.6 0.4 19.7 1.1 3.3 2.8 0.6 9.5 3.6 10.0 2.1 7.8 0.2 0.3 0.2 3.3 1.8 80.7 11.6 2.6 3.5 2.7 2.9 3.6 3.0 2.7 2.5 2.3 3.0 3.3 3.3 7.6 5.3 4.6 3.3 2.8 2.9 13.1 20.4 9.0 14.5 14.9 14.2 29.8 12.5 21.1 22.7 PDGFB "SIS, SSV" ENSG00000100311 "Platelet derived growth factor subunit B" P01127 22 39223359-39244751 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 29.1;HUVEC TERT2: 22.4;SK-BR-3: 22.2;TIME: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 10.8" "Lineage enriched" "Detected in single" 12 "T-cells: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011604, HPA011972, CAB018341" Supported Approved Vesicles "Secreted to blood" 324500 98000 Vesicles "CAB011604: AB_2162180, CAB018341: AB_2162187, HPA011972: AB_1855134" "unprognostic (4.96e-2)" "unprognostic (8.94e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (9.84e-2)" "unprognostic (4.46e-3)" "unprognostic (4.34e-1)" "prognostic unfavourable (3.67e-5)" "unprognostic (3.22e-2)" "unprognostic (2.07e-1)" "unprognostic (1.05e-1)" "unprognostic (8.68e-2)" "unprognostic (1.84e-3)" "unprognostic (5.12e-3)" "unprognostic (7.47e-2)" "unprognostic (6.50e-2)" "unprognostic (1.03e-1)" 23.5 6.4 10.4 6.4 9.3 0.6 22.5 5.7 13.0 8.3 14.3 12.4 4.2 4.7 10.8 6.5 6.5 5.6 10.8 13.8 9.7 6.1 10.9 3.8 20.8 6.1 14.7 7.3 4.0 8.3 9.2 3.5 37.3 9.6 5.8 3.7 12.1 7.9 8.6 15.2 7.5 6.7 8.9 11.4 5.6 6.2 5.2 10.3 0.8 12.6 8.6 2.3 6.9 5.0 0.0 0.9 0.1 0.4 0.0 10.8 2.3 13.3 1.0 3.5 0.0 0.0 0.0 4.1 0.0 0.1 0.0 0.0 5.3 4.2 0.0 29.1 0.0 5.0 0.2 1.2 0.0 0.0 0.1 0.3 0.4 1.9 1.9 0.0 7.5 0.0 0.1 0.0 0.2 22.4 0.5 2.5 0.8 5.5 0.0 0.0 1.3 1.4 0.0 0.1 9.0 12.1 0.0 0.1 0.0 0.2 22.2 0.1 10.1 0.0 27.8 0.0 2.7 0.0 3.0 0.0 0.1 0.1 0.0 0.6 12.9 0.0 0.0 0.0 8.1 0.1 10.8 0.0 4.7 6.1 0.0 0.0 4.1 2.2 0.1 0.0 0.4 0.9 2.4 2.3 10.4 9.3 5.7 13.0 9.7 6.1 14.7 7.3 9.6 10.3 PDGFD "IEGF, MSTP036, SCDGF-B" ENSG00000170962 "Platelet derived growth factor D" Q9GZP0 11 103907186-104164379 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 48.2" "Group enriched" "Detected in some" 6 "ASC diff: 55.5;HHSteC: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 7.1;gdT-cell: 13.6;memory CD8 T-cell: 5.8;naive CD8 T-cell: 5.1;NK-cell: 12.6" "Group enriched" "Detected in many" 27 "granulocytes: 7.1;NK-cells: 12.6;T-cells: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA046183, HPA066271" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" 24000 "Golgi apparatus, Vesicles" "HPA046183: , HPA066271: " "unprognostic (2.21e-1)" "unprognostic (9.35e-2)" "unprognostic (5.60e-2)" "unprognostic (1.72e-1)" "unprognostic (5.81e-2)" "unprognostic (8.83e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (2.26e-1)" "unprognostic (7.01e-3)" "prognostic unfavourable (9.60e-4)" "unprognostic (1.19e-1)" "unprognostic (6.72e-2)" "unprognostic (3.57e-3)" 26.1 48.2 1.1 10.1 1.5 0.1 21.2 0.6 1.8 13.8 5.6 1.1 15.0 1.5 9.8 10.2 2.7 5.3 20.6 13.9 0.9 1.9 4.3 1.8 2.3 3.5 0.8 1.6 33.4 32.8 5.0 14.4 8.5 6.4 8.5 4.0 16.7 6.0 16.2 9.8 5.1 2.2 4.0 2.1 2.3 8.6 5.4 0.0 1.1 11.5 4.4 4.6 13.5 10.0 0.4 0.0 7.1 0.0 12.6 13.6 2.9 0.0 2.9 1.5 0.0 55.5 1.6 0.0 0.3 0.3 0.2 0.3 0.0 0.5 2.7 0.5 2.7 0.1 0.0 0.0 0.1 0.0 1.2 0.0 0.6 0.1 16.9 0.0 0.0 5.8 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.8 0.0 2.6 0.0 0.0 3.7 0.0 5.3 1.2 0.0 0.7 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 7.1 13.6 0.0 1.1 0.4 1.5 5.8 0.0 0.0 0.1 5.1 0.2 12.6 0.0 0.0 0.1 2.9 1.1 1.5 0.6 1.8 0.9 1.9 0.8 1.6 6.4 0.0 PDGFRB "CD140b, JTK12, PDGFR, PDGFR1" ENSG00000113721 "Platelet derived growth factor receptor beta" P09619 5 150113837-150155872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Chemotaxis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 169.0;ASC TERT1: 58.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.9;non-classical monocyte: 4.1" "Group enriched" "Detected in many" 8 "monocytes: 4.1;T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003842, CAB018144, HPA028499" Enhanced Supported "Golgi apparatus,Vesicles" 35000000 Vesicles "Golgi apparatus" "CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018" "unprognostic (4.75e-2)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (3.27e-1)" "unprognostic (5.61e-2)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (2.12e-2)" "unprognostic (2.57e-3)" "unprognostic (6.72e-2)" "unprognostic (1.25e-1)" "prognostic unfavourable (5.87e-8)" "unprognostic (3.13e-3)" "unprognostic (1.25e-2)" "unprognostic (5.47e-2)" "prognostic unfavourable (8.11e-4)" 61.8 10.4 8.3 11.0 9.1 0.5 66.1 4.6 10.4 73.1 15.7 6.7 6.9 5.1 44.3 17.3 21.7 26.1 51.7 24.2 8.2 3.9 17.0 4.6 28.9 21.5 7.9 8.1 46.5 7.5 10.4 7.7 46.4 7.7 24.2 6.3 22.9 11.2 19.3 29.8 20.3 11.2 29.8 5.0 19.6 9.2 21.5 6.7 1.4 21.4 16.0 7.3 23.6 35.1 0.4 0.1 0.0 4.1 0.0 2.9 0.6 0.0 0.0 1.0 0.0 169.0 58.5 0.3 5.9 24.5 4.1 7.0 0.6 0.0 0.0 0.7 16.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.4 24.0 0.0 0.0 26.3 0.0 5.7 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 1.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 2.2 2.8 0.3 0.0 0.0 0.0 4.1 0.0 0.1 0.0 0.0 0.0 2.9 0.6 0.0 0.4 0.1 0.8 0.1 0.1 0.0 1.3 0.0 0.0 4.1 0.0 0.0 0.6 8.3 9.1 4.6 10.4 8.2 3.9 7.9 8.1 7.7 6.7 PDPK1 PDK1 ENSG00000140992 "3-phosphoinositide dependent protein kinase 1" O15530 16 2537964-2603188 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004272, HPA035199, HPA068961" Supported Approved Vesicles Vesicles "CAB004272: AB_626657, HPA035199: , HPA068961: " "unprognostic (2.67e-2)" "unprognostic (1.63e-1)" "unprognostic (3.12e-3)" "unprognostic (4.21e-2)" "unprognostic (1.34e-1)" "unprognostic (4.69e-3)" "unprognostic (8.37e-2)" "unprognostic (3.18e-2)" "unprognostic (8.17e-2)" "unprognostic (3.70e-2)" "unprognostic (1.52e-2)" "unprognostic (3.28e-2)" "prognostic favourable (1.29e-14)" "unprognostic (2.04e-2)" "unprognostic (5.96e-2)" "unprognostic (1.95e-1)" "unprognostic (2.16e-1)" 11.1 14.9 21.0 11.6 31.9 14.2 14.2 29.6 26.4 10.5 15.6 14.5 10.4 17.2 13.0 14.0 13.8 15.3 10.8 14.8 17.2 13.5 17.6 12.6 13.4 13.5 11.3 20.6 14.8 28.2 34.5 13.9 17.1 16.7 13.6 15.3 12.8 16.5 13.2 18.2 14.1 19.1 12.9 10.9 13.7 13.4 14.2 10.1 14.1 16.1 10.6 13.9 12.3 13.3 5.1 9.1 14.7 9.4 5.4 6.0 4.5 8.4 10.8 13.5 9.0 14.0 11.7 14.3 14.0 9.1 12.6 10.6 10.8 10.1 13.9 9.6 13.6 13.4 16.1 10.1 12.0 24.7 10.9 7.3 14.3 17.9 12.2 12.1 19.4 10.6 18.6 13.5 9.1 11.5 13.6 11.3 14.7 17.8 12.2 8.5 8.5 9.7 25.0 13.5 12.5 12.2 7.5 21.3 11.0 18.2 21.0 7.5 19.4 15.3 14.1 13.8 13.7 13.4 12.1 15.1 14.3 21.7 6.6 8.4 11.9 3.9 7.9 9.0 5.1 9.3 4.8 5.1 4.7 6.0 6.7 4.5 5.3 4.9 14.7 5.4 9.4 9.1 2.3 4.5 21.0 31.9 29.6 26.4 17.2 13.5 11.3 20.6 16.7 10.1 PDPN "aggrus, Gp38, GP40, PA2.26, T1A-2" ENSG00000162493 Podoplanin Q86YL7 1 13583465-13617957 "Predicted membrane proteins" "Cell shape" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.8" "Cell line enhanced" "Detected in some" "AF22: 29.8;EFO-21: 71.6;HAP1: 49.7;HHSteC: 44.1;NTERA-2: 23.0;TIME: 47.6" "Cancer enhanced" "Detected in many" "testis cancer: 102.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.1" "HPA007534, CAB008376, HPA073453" Enhanced Approved Vesicles Vesicles "CAB008376: AB_592530, HPA007534: AB_1857718, HPA073453: " "unprognostic (1.75e-1)" "unprognostic (3.19e-2)" "unprognostic (6.03e-2)" "unprognostic (3.61e-2)" "unprognostic (2.73e-2)" "unprognostic (1.05e-2)" "unprognostic (3.85e-2)" "unprognostic (5.23e-2)" "unprognostic (9.21e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-2)" "unprognostic (5.62e-3)" "unprognostic (9.20e-3)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" "unprognostic (2.78e-2)" 27.7 2.0 6.3 29.8 10.9 0.5 30.3 5.0 6.7 21.4 12.8 11.0 4.1 2.5 16.8 15.3 8.9 19.8 23.7 18.6 5.7 6.5 1.9 0.8 17.8 10.4 10.0 2.4 18.4 3.9 0.7 2.3 71.8 13.5 11.3 6.4 26.6 6.0 8.6 21.9 10.0 7.6 18.6 17.5 0.7 15.1 9.7 7.9 3.2 5.7 9.7 9.9 27.3 28.9 0.4 0.2 3.1 0.4 0.3 0.4 0.1 0.0 0.0 29.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 71.6 1.7 0.1 49.7 8.8 0.0 0.1 9.1 0.0 0.0 0.0 44.1 0.0 0.0 6.0 16.5 3.7 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.6 8.4 7.2 0.1 0.0 0.0 0.0 0.1 17.9 0.0 0.0 1.0 0.4 0.6 0.2 0.2 0.2 0.4 0.3 0.3 0.2 0.4 0.4 0.3 3.1 0.3 0.2 0.2 0.2 0.1 6.3 10.9 5.0 4.8 5.7 6.5 10.0 2.4 13.5 7.9 PDXDC1 KIAA0251 ENSG00000179889 "Pyridoxal dependent decarboxylase domain containing 1" Q6P996 16 14974591-15139339 "Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 91.1" "Cell line enhanced" "Detected in all" "T-47d: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047369, HPA049121, HPA051484" Approved Enhanced "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA047369: , HPA049121: , HPA051484: " "unprognostic (3.67e-2)" "unprognostic (4.99e-1)" "unprognostic (1.97e-3)" "unprognostic (1.84e-1)" "unprognostic (9.08e-2)" "unprognostic (2.18e-1)" "unprognostic (6.47e-3)" "unprognostic (4.97e-2)" "unprognostic (2.43e-1)" "unprognostic (2.74e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "prognostic favourable (3.13e-4)" "unprognostic (4.58e-2)" "unprognostic (8.11e-2)" "unprognostic (2.15e-1)" "unprognostic (2.88e-1)" 10.5 13.2 11.0 11.7 10.7 6.0 27.8 15.4 16.9 13.8 21.6 9.0 11.8 27.7 10.9 16.5 14.2 11.0 16.6 15.5 11.5 8.1 21.9 33.8 11.2 12.7 10.2 10.0 11.2 37.4 17.2 26.0 19.6 12.8 19.6 25.3 13.7 25.2 14.7 22.1 8.8 30.9 13.1 14.9 10.6 24.6 91.1 8.7 6.9 16.3 8.2 9.5 13.4 11.1 11.0 12.8 12.0 8.3 7.7 12.6 7.8 7.8 11.6 12.0 10.0 6.7 8.1 19.8 7.4 6.6 5.5 7.7 14.2 17.2 15.1 16.3 9.9 12.9 8.4 7.6 8.0 9.2 11.5 9.1 19.5 37.2 17.5 7.2 21.8 8.5 7.9 9.6 8.1 5.8 6.7 9.9 13.0 19.3 4.7 3.8 5.8 4.4 7.3 4.9 18.0 8.8 12.8 12.3 8.8 20.0 11.5 19.0 46.4 11.2 9.0 4.3 3.9 4.7 9.5 9.3 9.0 14.6 8.8 6.1 13.6 3.2 8.0 12.0 11.0 8.3 12.6 9.2 8.0 8.9 12.8 11.0 10.0 9.4 1.1 7.7 6.6 5.9 7.0 7.8 11.0 10.7 15.4 16.9 11.5 8.1 10.2 10.0 12.8 8.7 PDZK1 "NHERF3, PDZD1" ENSG00000174827 "PDZ domain containing 1" Q5T2W1 1 145670852-145708148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 49.2;kidney: 124.3" "Group enriched" "Detected in some" 4 "RPTEC TERT1: 42.1;T-47d: 109.4" "Group enriched" "Detected in many" 12 "breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3" "Region enriched" "Detected in single" 17 "cerebellum: 10.0" "Cell type enriched" "Detected in many" 4 "NK-cell: 7.6" "Lineage enriched" "Detected in many" 4 "NK-cells: 7.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005755, HPA006155, CAB008971" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163" "unprognostic (4.56e-3)" "unprognostic (3.07e-1)" "unprognostic (8.79e-2)" "unprognostic (4.41e-2)" "unprognostic (9.15e-2)" "unprognostic (2.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.42e-1)" "unprognostic (2.08e-1)" "unprognostic (3.27e-1)" "unprognostic (2.34e-2)" "unprognostic (9.87e-3)" "prognostic favourable (2.54e-7)" "unprognostic (9.90e-2)" "unprognostic (3.02e-1)" "unprognostic (1.00e-3)" "unprognostic (8.87e-2)" 0.1 0.6 0.2 0.2 0.3 0.0 5.8 10.0 0.2 0.3 16.5 0.2 0.8 13.2 0.3 6.7 0.1 0.1 10.6 0.1 0.2 0.2 124.3 25.7 0.4 0.1 0.3 0.2 0.2 4.2 0.0 0.1 0.9 0.5 0.1 1.3 1.2 0.1 0.1 0.1 0.7 49.2 0.1 0.4 0.2 0.4 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 1.0 1.1 0.5 0.2 7.6 1.8 0.5 1.2 0.2 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 18.5 0.1 0.1 0.2 1.1 0.5 0.0 0.0 0.1 1.7 0.3 0.1 0.4 7.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 1.0 0.1 0.2 0.2 0.5 0.0 1.2 0.2 42.1 0.0 0.1 1.2 0.2 0.3 0.0 109.4 0.1 0.1 0.2 0.2 0.1 0.1 1.5 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.1 1.5 0.2 0.6 1.0 0.4 1.8 0.2 1.0 0.4 0.7 0.4 7.6 0.1 1.1 0.1 0.5 0.2 0.3 10.0 0.2 0.2 0.2 0.3 0.2 0.5 0.1 PEF1 PEF1A ENSG00000162517 "Penta-EF-hand domain containing 1" Q9UBV8 1 31629862-31644896 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061608 Approved Nucleoplasm,Vesicles,Cytosol 660000 "Nucleoplasm, Cytosol" Vesicles "HPA061608: " "unprognostic (2.92e-2)" "prognostic favourable (3.95e-4)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-1)" "unprognostic (8.40e-2)" "prognostic unfavourable (2.88e-4)" "unprognostic (5.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.79e-2)" "unprognostic (1.60e-2)" "unprognostic (2.12e-1)" "unprognostic (1.35e-1)" "unprognostic (8.85e-3)" "unprognostic (2.38e-1)" "unprognostic (1.60e-1)" "unprognostic (2.89e-3)" 34.0 27.0 26.9 15.3 28.7 17.0 27.1 22.5 40.8 26.6 23.4 25.9 21.1 16.2 27.1 46.5 29.7 29.0 26.1 26.4 24.3 23.8 28.3 38.7 24.9 20.8 25.0 17.3 31.1 20.8 31.6 21.6 44.2 28.6 29.8 24.2 25.7 24.8 33.4 25.5 32.5 20.7 31.9 22.4 23.6 20.5 17.8 16.5 27.4 85.9 20.3 30.7 23.7 21.9 39.1 40.4 60.9 39.5 42.0 49.2 48.7 17.3 20.4 17.0 13.1 20.1 21.1 16.4 16.6 28.4 40.1 35.4 12.0 26.3 18.5 23.2 36.9 18.2 32.9 42.3 32.5 23.2 35.6 15.3 16.4 24.0 35.5 14.9 14.5 21.7 48.9 39.2 36.7 38.7 15.8 19.2 28.7 20.5 22.7 14.6 23.6 23.2 22.2 16.6 20.2 31.3 18.9 24.4 14.1 18.9 17.8 24.7 15.8 11.0 20.4 17.4 15.0 29.6 21.8 12.4 12.5 20.0 21.9 22.1 20.8 60.9 39.5 46.2 49.2 35.3 47.5 37.8 42.1 44.6 40.4 39.1 39.9 40.0 40.1 42.0 32.7 37.4 41.9 48.7 26.9 28.7 22.5 40.8 24.3 23.8 25.0 17.3 28.6 16.5 PELI3 MGC35521 ENSG00000174516 "Pellino E3 ubiquitin protein ligase family member 3" Q8N2H9 11 66466327-66477337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033750, HPA038875, HPA062281" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Vesicles" Nucleoli "CAB033750: AB_2161361, HPA038875: , HPA062281: " "unprognostic (1.15e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (1.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.19e-3)" "unprognostic (7.91e-3)" "prognostic favourable (8.19e-4)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.01e-2)" 6.7 9.5 14.5 3.8 17.0 1.8 7.4 19.6 33.1 7.4 8.3 6.7 6.4 4.8 10.3 9.1 10.6 8.2 10.1 7.7 17.4 13.5 4.6 3.2 7.1 4.3 13.0 12.5 15.3 9.9 21.5 8.3 3.8 15.8 11.5 2.9 6.4 10.4 22.3 10.8 11.2 4.7 11.3 6.2 5.0 5.8 6.2 7.8 0.3 8.5 2.7 3.4 9.0 11.8 3.3 3.3 1.3 6.8 1.2 3.1 1.4 15.3 6.5 5.3 4.1 8.5 3.3 4.2 4.9 6.4 4.7 4.0 9.5 3.5 3.8 4.9 5.4 8.2 3.5 6.2 1.9 7.5 3.0 1.0 5.4 2.8 5.4 0.8 7.5 3.1 7.0 4.8 1.7 0.9 1.8 6.1 2.0 9.4 3.1 2.4 3.3 6.7 10.7 3.9 4.0 2.6 4.9 6.4 3.5 2.5 7.1 16.7 8.3 4.2 2.7 4.2 6.4 18.1 4.1 5.6 3.2 2.0 8.7 2.5 3.4 1.3 2.5 0.4 2.5 1.8 2.0 2.8 2.1 3.1 3.3 3.3 2.2 1.8 0.1 1.2 6.8 1.0 2.4 1.4 14.5 17.0 19.6 33.1 17.4 13.5 13.0 12.5 15.8 7.8 PEX11B ENSG00000131779 "Peroxisomal biogenesis factor 11 beta" O96011 1 145911350-145918837 "Disease related genes, Predicted membrane proteins" "Peroxisome biogenesis" "Peroxisome biogenesis disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA017150, HPA050104" Supported Supported Vesicles Vesicles "HPA017150: , HPA050104: " "unprognostic (4.59e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.29e-1)" "unprognostic (3.62e-1)" "unprognostic (1.18e-1)" "prognostic unfavourable (2.67e-4)" "prognostic favourable (6.85e-4)" "unprognostic (1.19e-1)" "unprognostic (4.08e-2)" "unprognostic (2.10e-1)" "unprognostic (8.48e-2)" "unprognostic (6.96e-2)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (7.62e-3)" "unprognostic (4.28e-1)" 12.0 17.3 25.9 13.3 29.5 8.5 24.4 25.1 39.6 19.9 18.2 17.3 21.3 18.4 16.2 27.2 21.6 20.1 14.7 17.9 25.8 28.1 25.4 19.8 14.9 18.4 24.0 20.3 19.7 23.2 20.4 16.4 17.3 26.9 18.2 21.7 15.7 19.0 20.9 23.7 20.6 17.2 16.1 14.7 18.7 18.4 18.0 14.8 21.4 20.3 17.2 25.3 16.7 13.9 42.5 42.8 32.0 29.6 29.5 37.0 34.1 11.2 10.3 9.2 9.0 21.5 16.9 9.5 11.4 15.1 14.9 11.6 4.7 13.2 10.6 12.4 16.1 13.7 8.0 17.0 10.5 11.7 6.0 6.4 6.8 12.1 30.3 19.4 12.0 22.1 21.2 10.1 10.0 19.0 11.7 17.5 23.5 17.8 14.8 18.5 3.3 12.7 13.8 13.8 23.1 25.6 8.0 6.4 10.5 8.6 16.6 10.3 22.9 30.2 16.8 10.1 8.1 13.1 8.2 19.0 21.9 14.9 17.0 11.0 6.9 32.0 29.6 20.6 28.7 26.3 31.2 42.5 32.9 31.0 32.0 37.2 37.0 33.5 14.7 29.5 25.8 42.8 34.8 34.1 25.9 29.5 25.1 39.6 25.8 28.1 24.0 20.3 26.9 14.8 PEX13 ENSG00000162928 "Peroxisomal biogenesis factor 13" Q92968 2 61017225-61051990 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032141, HPA032142, CAB032689" Enhanced Supported Vesicles Vesicles "CAB032689: AB_2162137, HPA032141: AB_2674176, HPA032142: AB_10669676" "unprognostic (2.44e-3)" "unprognostic (4.10e-2)" "unprognostic (7.84e-3)" "unprognostic (2.73e-2)" "unprognostic (1.28e-1)" "unprognostic (5.08e-2)" "unprognostic (2.05e-2)" "unprognostic (1.78e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-2)" "prognostic unfavourable (8.07e-5)" "unprognostic (5.42e-2)" "unprognostic (4.44e-2)" "unprognostic (1.93e-1)" "unprognostic (2.84e-1)" "unprognostic (1.41e-1)" "unprognostic (2.63e-2)" 11.7 11.5 14.2 9.1 14.7 8.4 29.2 21.4 14.9 14.3 13.1 10.3 6.0 13.0 12.3 10.3 15.7 8.9 11.6 16.3 14.1 11.7 17.7 31.8 16.8 13.1 11.7 11.7 16.5 19.5 10.9 18.7 11.9 10.8 19.6 14.1 11.6 13.7 8.7 20.7 11.5 15.3 17.4 12.2 8.2 12.7 18.2 12.3 11.7 18.0 9.7 11.0 13.7 13.3 8.3 7.9 15.1 7.0 8.0 10.5 6.2 10.4 7.7 11.0 14.1 10.6 8.4 17.0 10.9 8.5 7.5 7.7 11.5 15.9 6.8 11.8 10.6 15.7 9.7 13.1 14.2 6.6 6.7 6.2 10.4 18.9 12.6 9.2 7.6 10.2 20.3 10.2 15.8 13.4 15.1 6.1 11.3 9.5 6.9 11.2 12.0 7.8 7.4 12.2 8.5 14.1 26.2 12.5 8.6 12.2 16.6 9.8 11.1 4.8 10.5 14.4 19.2 8.3 9.2 10.0 7.7 17.2 9.1 9.6 10.1 15.1 6.1 8.8 8.3 5.8 7.9 8.3 9.7 9.2 7.9 6.7 10.5 7.9 6.0 8.0 7.0 7.0 8.2 6.2 14.2 14.7 21.4 14.9 14.1 11.7 11.7 11.7 10.8 12.3 PEX2 "PAF-1, PMP35, PXMP3, RNF72, ZWS3" ENSG00000164751 "Peroxisomal biogenesis factor 2" P28328 8 76980258-77001044 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010983, HPA011410, HPA027729" Approved Supported Vesicles Vesicles "HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416" "unprognostic (6.42e-2)" "unprognostic (2.90e-2)" "unprognostic (4.64e-2)" "unprognostic (2.35e-1)" "unprognostic (9.91e-2)" "unprognostic (2.33e-1)" "unprognostic (6.19e-2)" "unprognostic (2.22e-1)" "unprognostic (3.16e-2)" "unprognostic (1.37e-1)" "unprognostic (2.85e-2)" "unprognostic (2.07e-2)" "unprognostic (9.57e-3)" "unprognostic (2.48e-1)" "unprognostic (9.49e-2)" "unprognostic (3.06e-2)" "unprognostic (1.09e-3)" 21.3 30.9 25.4 17.9 23.8 17.3 30.7 20.7 24.6 24.3 23.8 24.1 65.7 22.5 25.7 24.3 21.6 24.1 18.0 22.1 26.9 20.7 31.3 25.3 20.4 27.8 29.8 18.3 20.5 26.4 21.2 32.6 17.4 25.9 25.8 22.9 24.9 28.7 63.6 32.4 17.4 27.2 25.7 30.5 23.1 27.0 14.7 30.9 32.2 34.4 19.0 23.4 24.2 23.5 17.3 17.1 52.4 22.9 28.3 22.3 24.2 27.7 9.4 15.3 15.4 16.4 20.6 8.0 20.8 23.8 16.1 17.8 5.9 24.9 15.8 31.1 18.7 10.7 10.4 15.8 19.6 29.1 8.6 19.3 8.7 9.0 11.1 15.9 15.3 23.1 13.4 12.2 14.6 17.5 10.5 15.2 16.8 8.3 28.0 9.5 9.0 8.5 5.1 12.2 13.1 18.7 19.7 5.4 14.2 13.4 61.0 11.3 19.0 11.5 17.5 14.8 19.5 19.0 10.3 28.3 16.4 27.6 18.8 8.5 16.4 52.4 20.3 35.8 22.3 20.8 19.9 17.3 15.6 17.9 16.9 17.2 20.6 19.6 14.1 28.3 22.9 17.1 17.4 24.2 25.4 23.8 20.7 24.6 26.9 20.7 29.8 18.3 25.9 30.9 PEX6 "PAF-2, PXAAA1" ENSG00000124587 "Peroxisomal biogenesis factor 6" Q13608 6 42963870-42979220 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis" "Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 73.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025924, HPA074179" Supported Supported "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA025924: AB_1855230, HPA074179: " "unprognostic (7.32e-3)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (9.16e-2)" "unprognostic (9.18e-2)" "unprognostic (3.27e-1)" "unprognostic (8.88e-2)" "unprognostic (5.92e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "unprognostic (7.24e-3)" "unprognostic (5.31e-2)" "unprognostic (3.79e-3)" "unprognostic (1.86e-1)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (1.55e-1)" 13.0 14.9 12.1 11.5 18.9 9.0 11.5 21.7 19.0 14.7 16.9 14.6 15.3 9.8 11.9 8.8 18.2 23.4 13.0 10.4 12.9 12.1 11.3 18.8 7.4 17.6 17.3 9.1 20.0 73.2 21.3 18.2 10.6 16.0 17.8 8.5 10.8 15.0 12.8 15.2 14.2 24.6 10.5 9.9 12.8 10.6 10.6 17.2 22.3 21.5 6.9 10.9 11.2 12.4 4.3 4.3 4.8 3.2 4.0 6.1 2.5 17.7 8.5 4.3 16.1 16.1 15.5 4.5 3.1 4.9 2.6 5.4 5.4 5.2 7.2 4.4 7.4 16.8 15.0 16.2 2.7 14.0 7.9 2.4 12.0 3.1 10.9 2.4 5.0 19.3 18.8 10.6 2.9 12.9 12.6 7.4 5.6 2.0 6.3 8.0 5.3 7.5 13.6 7.6 2.9 6.5 5.2 13.6 5.9 2.9 11.6 16.3 22.7 10.9 7.2 8.2 1.6 4.0 7.1 11.1 9.8 9.9 2.8 12.6 6.5 2.1 3.2 4.8 3.0 2.4 5.4 2.6 4.4 6.1 4.3 4.3 5.5 5.1 2.0 4.0 1.5 2.5 2.1 2.5 12.1 18.9 21.7 19.0 12.9 12.1 17.3 9.1 16.0 17.2 PEX7 "PTS2R, RD" ENSG00000112357 "Peroxisomal biogenesis factor 7" O00628 6 136822564-136913937 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049202 Uncertain Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA049202: " "unprognostic (1.36e-2)" "unprognostic (2.07e-2)" "prognostic favourable (1.61e-4)" "unprognostic (4.01e-3)" "unprognostic (2.50e-2)" "unprognostic (6.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.71e-2)" "unprognostic (4.87e-2)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (6.88e-2)" "prognostic favourable (1.85e-10)" "unprognostic (3.57e-1)" "unprognostic (1.44e-1)" "unprognostic (2.52e-2)" "unprognostic (2.65e-1)" 5.5 17.8 8.1 7.0 8.9 4.0 13.5 7.0 10.7 8.7 8.5 7.9 14.0 6.1 5.5 18.9 9.1 8.9 17.0 14.5 7.2 6.7 16.3 10.0 9.2 4.7 8.9 9.5 6.1 43.6 15.5 10.2 6.7 6.9 11.7 9.2 13.6 15.4 18.9 11.7 12.0 6.6 7.5 9.6 4.7 14.5 19.4 5.4 5.9 11.5 7.5 6.8 6.9 7.0 4.6 5.4 4.3 5.3 2.9 6.9 1.8 4.7 4.6 4.6 6.5 6.0 8.9 2.5 6.6 8.3 7.1 7.5 5.7 5.6 1.7 12.6 7.1 6.1 3.3 12.3 8.8 4.9 8.0 6.4 4.6 0.8 14.4 8.0 3.7 8.5 13.0 5.1 10.2 5.3 11.9 5.1 9.7 11.3 3.5 9.9 4.7 7.9 4.7 4.7 4.9 15.4 6.4 8.7 12.6 6.1 8.7 8.5 5.7 10.1 4.0 4.6 2.2 7.2 5.1 7.2 4.7 0.0 3.7 7.3 5.6 0.2 3.0 4.3 2.6 2.5 2.0 4.6 3.4 4.2 5.3 2.9 6.9 4.1 0.5 2.9 5.3 5.4 6.4 1.8 8.1 8.9 7.0 10.7 7.2 6.7 8.9 9.5 6.9 5.4 PFAS "FGARAT, GATD8, KIAA0361, PURL" ENSG00000178921 "Phosphoribosylformylglycinamidine synthase" O15067 17 8247618-8270491 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 28.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022140, HPA022886" Enhanced Approved Vesicles 350000 Vesicles "HPA022140: AB_1855232, HPA022886: AB_1855233" "unprognostic (1.90e-1)" "unprognostic (9.21e-2)" "unprognostic (2.12e-1)" "unprognostic (5.19e-3)" "unprognostic (2.59e-1)" "unprognostic (6.40e-2)" "prognostic unfavourable (9.19e-4)" "unprognostic (3.19e-1)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (5.47e-3)" "unprognostic (1.08e-3)" "unprognostic (9.51e-3)" "unprognostic (3.63e-2)" "unprognostic (6.57e-2)" "unprognostic (2.88e-3)" "unprognostic (3.85e-1)" 15.4 15.3 11.4 14.8 13.0 17.5 12.8 14.6 18.5 11.2 12.4 14.0 10.0 9.8 15.1 11.2 13.2 13.5 14.3 9.7 9.0 8.0 13.0 17.0 9.5 18.5 10.7 12.6 16.6 15.7 11.5 9.2 10.7 10.7 11.5 12.2 12.0 10.6 10.6 11.6 13.6 11.5 14.3 7.9 18.0 11.4 17.2 11.1 29.5 12.8 10.8 16.2 10.4 9.5 9.2 7.1 28.2 2.9 2.7 6.5 1.1 5.9 26.3 13.5 20.2 4.9 4.1 15.6 7.6 2.9 14.1 10.7 12.8 5.4 26.3 12.4 4.5 13.9 31.1 10.0 10.5 11.9 25.4 15.4 24.8 15.9 4.3 12.4 11.5 3.8 2.4 16.3 10.3 11.7 20.6 4.0 5.6 8.9 22.0 10.8 22.5 12.0 33.1 14.0 12.6 6.5 9.9 8.2 12.8 9.5 6.1 8.7 6.0 5.7 8.1 7.9 10.2 14.3 18.8 4.7 8.5 12.9 8.7 17.7 13.2 9.1 2.9 6.5 4.0 2.5 5.2 7.8 5.2 4.6 2.4 9.2 6.5 5.1 28.2 2.7 1.9 7.1 2.7 1.1 11.4 13.0 14.6 18.5 9.0 8.0 10.7 12.6 10.7 11.1 PGBD2 ENSG00000185220 "PiggyBac transposable element derived 2" Q6P3X8 1 248906196-248919946 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029888, HPA029889, HPA029890" Uncertain Supported Vesicles Vesicles "HPA029888: AB_10600088, HPA029889: AB_10611386, HPA029890: AB_10602002" "unprognostic (1.06e-2)" "unprognostic (8.05e-2)" "unprognostic (2.56e-2)" "unprognostic (3.03e-2)" "unprognostic (1.40e-1)" "prognostic favourable (6.08e-4)" "unprognostic (1.94e-2)" "unprognostic (2.11e-2)" "unprognostic (2.71e-3)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (1.18e-2)" "prognostic unfavourable (7.86e-4)" "unprognostic (2.41e-1)" "unprognostic (7.91e-2)" "unprognostic (1.25e-1)" "prognostic favourable (2.05e-4)" 5.8 7.0 5.0 11.1 6.8 5.7 9.5 10.5 7.7 7.6 7.7 11.9 10.2 8.9 8.6 8.2 11.1 6.8 8.6 4.5 5.1 4.6 7.2 11.8 5.7 10.4 7.4 5.4 10.2 14.7 8.3 5.6 12.7 7.8 9.9 9.9 6.0 10.0 12.8 2.9 12.3 11.9 8.4 5.6 17.3 7.9 13.9 8.6 5.5 12.5 3.9 12.2 7.5 18.2 12.7 8.0 13.9 9.1 7.8 10.9 5.7 4.6 6.3 10.0 5.8 8.8 5.8 12.1 4.5 3.9 7.7 7.4 4.7 6.3 12.1 5.7 4.3 7.5 5.9 5.6 9.0 7.1 2.8 11.6 9.8 7.0 5.1 5.9 11.4 5.2 5.9 9.2 5.2 4.4 18.4 10.6 5.6 8.3 3.3 7.0 9.2 7.4 14.3 3.1 3.9 4.6 6.0 3.7 6.5 6.4 9.3 7.2 4.1 11.7 5.4 5.3 5.2 4.6 4.9 10.1 10.1 5.5 5.6 13.3 4.8 13.9 8.8 13.2 9.8 6.2 9.4 12.7 8.6 9.1 8.0 12.6 8.7 10.9 6.5 7.8 9.1 3.8 5.8 5.7 5.0 6.8 10.5 7.7 5.1 4.6 7.4 5.4 7.8 8.6 PGLYRP4 "PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67" ENSG00000163218 "Peptidoglycan recognition protein 4" Q96LB8 1 153330120-153348840 "Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5" "Cell line enhanced" "Detected in some" "HaCaT: 8.0;HDLM-2: 5.2;hTCEpi: 1.7;Karpas-707: 4.3" "Group enriched" "Detected in some" 9 "cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB025879 Supported "Vesicles,Plasma membrane" "Secreted in other tissues" "Vesicles, Plasma membrane" "CAB025879: " "unprognostic (2.76e-2)" "unprognostic (1.19e-1)" "unprognostic (6.10e-2)" "unprognostic (1.34e-2)" "unprognostic (3.61e-3)" "unprognostic (1.46e-1)" "unprognostic (3.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.15e-1)" "unprognostic (1.81e-1)" "unprognostic (1.88e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 8.1 0.0 0.0 0.0 0.1 2.0 0.0 7.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.2 0.2 0.0 1.5 0.0 0.1 19.5 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 13.7 6.5 0.0 8.5 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 5.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PGS1 DKFZP762M186 ENSG00000087157 "Phosphatidylglycerophosphate synthase 1" Q32NB8 17 78378640-78425114 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022526 Approved Approved "Vesicles,Cell Junctions,Intermediate filaments" "Vesicles, Cell Junctions, Intermediate filaments" "HPA022526: AB_1855271" "unprognostic (1.19e-2)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (1.86e-3)" "unprognostic (1.35e-2)" "unprognostic (1.71e-2)" "prognostic unfavourable (1.37e-4)" "unprognostic (5.76e-3)" "unprognostic (3.17e-2)" "unprognostic (8.46e-3)" "prognostic favourable (7.33e-5)" "prognostic unfavourable (9.94e-4)" "prognostic unfavourable (1.16e-5)" "unprognostic (9.94e-2)" "unprognostic (5.60e-2)" "unprognostic (1.33e-1)" "unprognostic (2.72e-2)" 16.4 11.6 14.5 20.8 20.3 41.4 28.2 17.6 17.4 14.4 13.1 18.4 13.2 13.7 17.3 13.2 14.5 16.9 17.2 14.0 15.7 16.1 14.3 8.0 25.5 19.1 21.6 17.0 18.3 14.0 16.0 13.3 24.0 15.3 13.9 10.2 12.9 13.1 16.8 13.8 11.9 15.1 13.4 18.0 22.6 12.6 13.9 18.8 17.7 18.6 7.8 14.3 16.9 32.3 8.0 14.0 26.0 12.6 6.7 11.3 8.4 13.1 11.6 11.3 8.5 10.0 16.0 13.4 12.4 11.9 13.3 14.7 10.8 10.4 13.6 7.5 7.0 10.2 13.4 8.4 10.5 20.4 15.2 14.9 13.8 10.8 9.8 11.2 12.1 16.3 11.1 9.6 8.7 25.4 17.3 9.5 9.0 7.2 25.3 10.1 11.8 11.2 13.3 20.3 11.6 13.0 12.1 15.0 22.8 10.6 11.7 11.3 12.3 13.6 15.9 17.3 12.0 9.2 10.4 10.5 6.2 10.3 13.1 12.6 12.8 1.5 12.6 13.2 8.4 10.4 9.8 7.8 8.8 8.8 14.0 8.0 11.3 8.1 26.0 6.7 4.6 6.6 10.4 8.4 14.5 20.3 17.6 17.4 15.7 16.1 21.6 17.0 15.3 18.8 PHB PHB1 ENSG00000167085 Prohibitin P35232 17 49404049-49414905 "Plasma proteins, Predicted intracellular proteins" "DNA synthesis" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 189.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003280 Supported Supported Vesicles,Mitochondria "Intracellular and membrane" 3800000 Mitochondria Vesicles "HPA003280: AB_1855732" "unprognostic (2.31e-2)" "unprognostic (5.70e-2)" "unprognostic (1.19e-2)" "unprognostic (7.88e-3)" "unprognostic (8.33e-2)" "prognostic unfavourable (1.58e-4)" "prognostic unfavourable (9.91e-4)" "unprognostic (5.81e-2)" "unprognostic (4.40e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (7.36e-2)" "prognostic favourable (3.77e-4)" "unprognostic (5.10e-2)" "unprognostic (1.77e-1)" "unprognostic (2.71e-2)" "unprognostic (3.09e-3)" 27.4 31.6 21.8 19.9 24.9 19.0 30.6 12.9 25.9 21.6 38.9 24.0 17.0 26.9 24.1 17.7 28.6 24.3 18.6 41.6 21.9 20.9 54.0 53.7 19.2 18.5 27.6 21.4 27.1 24.1 27.8 18.8 24.1 22.0 25.3 40.7 24.7 41.8 20.2 41.7 19.5 32.7 26.6 20.5 22.7 25.0 16.6 18.2 23.3 42.5 35.6 22.3 22.4 24.0 33.4 84.6 6.3 28.0 28.4 34.7 40.2 36.1 67.5 16.2 31.8 21.8 17.3 45.1 26.7 17.8 43.4 28.5 189.6 32.5 67.0 49.0 24.6 23.6 44.0 38.6 45.0 29.1 57.9 33.8 43.8 85.7 16.1 66.6 20.9 19.2 26.8 46.9 17.3 31.6 60.2 18.1 28.1 61.5 46.2 41.7 30.1 64.5 37.0 61.6 55.0 29.5 38.3 32.8 27.9 20.2 23.6 37.5 40.2 31.1 27.5 41.2 31.8 32.1 57.3 23.2 63.4 64.8 27.0 44.4 35.6 6.3 25.3 6.2 32.3 28.0 34.7 33.4 28.7 31.0 38.1 29.9 30.4 30.9 2.5 28.4 21.0 84.6 28.1 40.2 21.8 24.9 12.9 25.9 21.9 20.9 27.6 21.4 22.0 18.2 PHF14 KIAA0783 ENSG00000106443 "PHD finger protein 14" O94880 7 10973336-11169630 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000538, HPA017376" Supported Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA000538: AB_1079604, HPA017376: " "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "unprognostic (3.73e-3)" "unprognostic (7.38e-3)" "unprognostic (8.05e-2)" "unprognostic (3.38e-1)" "unprognostic (4.66e-3)" "unprognostic (1.80e-1)" "unprognostic (5.32e-3)" "unprognostic (6.76e-2)" "unprognostic (2.94e-2)" "unprognostic (3.10e-1)" "unprognostic (4.84e-3)" "unprognostic (1.24e-1)" "unprognostic (2.30e-2)" "unprognostic (1.87e-2)" "unprognostic (2.33e-1)" 12.5 10.9 25.0 12.4 20.4 6.4 18.4 21.4 23.8 14.0 12.7 10.7 7.2 10.3 17.9 11.0 10.6 12.4 12.6 7.7 24.7 22.1 12.2 14.8 11.3 12.0 18.5 15.5 20.2 9.8 18.4 21.4 11.0 20.0 13.9 14.3 7.1 10.0 11.5 9.3 11.3 10.1 14.9 16.2 12.9 13.3 12.0 14.9 31.5 12.7 7.6 12.9 11.9 10.6 3.9 5.8 1.6 2.0 3.4 4.6 0.8 6.7 14.1 20.7 21.4 7.3 7.1 9.9 5.3 4.5 6.5 7.1 12.5 12.2 26.5 9.9 5.0 9.5 18.4 6.3 7.1 9.6 7.0 13.1 12.5 16.3 6.7 28.9 12.4 6.4 6.8 7.5 13.8 9.3 17.3 9.5 7.7 8.7 11.4 12.8 17.3 10.1 19.4 13.3 8.3 6.7 13.2 18.6 26.0 8.2 28.1 8.9 14.9 21.3 8.6 9.1 12.1 5.7 10.4 12.1 20.9 18.5 6.3 24.6 21.1 1.6 2.0 1.2 2.9 1.8 2.3 3.9 3.2 3.7 1.2 3.4 4.6 3.8 0.1 3.4 1.6 5.8 4.1 0.8 25.0 20.4 21.4 23.8 24.7 22.1 18.5 15.5 20.0 14.9 PHGR1 ENSG00000233041 "Proline, histidine and glycine rich 1" C9JFL3 15 40351033-40356434 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "intestine: 308.0;lymphoid tissue: 83.6" "Cell line enhanced" "Detected in some" "BEWO: 7.3;HaCaT: 10.3;NB-4: 6.1;RPMI-8226: 5.7;SCLC-21H: 35.7" "Group enriched" "Detected in many" 16 "colorectal cancer: 248.3;stomach cancer: 94.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA068787 Enhanced Approved Vesicles Vesicles "HPA068787: " "prognostic favourable (2.05e-4)" "unprognostic (1.73e-1)" "unprognostic (5.18e-2)" "unprognostic (1.18e-1)" "unprognostic (2.80e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-2)" 0.3 0.1 0.3 83.6 0.3 0.0 0.6 0.3 0.3 0.3 245.3 0.3 0.3 77.9 0.3 0.3 0.4 0.5 4.1 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.4 32.9 0.3 0.4 0.3 0.3 0.3 308.0 1.3 0.3 0.3 15.1 0.3 0.3 0.3 0.3 0.3 0.3 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.1 0.0 0.0 5.7 0.0 0.8 35.7 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 PHKA1 PHKA ENSG00000067177 "Phosphorylase kinase regulatory subunit alpha 1" P46020 X 72578814-72714319 "Disease related genes, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Muscle protein" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 57.4" "Cell line enhanced" "Detected in many" "HDLM-2: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001081 Enhanced Approved Vesicles Vesicles "HPA001081: AB_1079607" "unprognostic (3.68e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (6.84e-4)" "unprognostic (3.52e-1)" "unprognostic (5.48e-2)" "unprognostic (1.23e-2)" "unprognostic (9.64e-2)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (2.18e-1)" "unprognostic (4.76e-1)" "unprognostic (9.45e-3)" "unprognostic (9.94e-2)" "unprognostic (2.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" 2.7 10.3 3.8 1.9 7.2 0.7 3.4 3.2 3.5 2.2 2.1 2.0 7.8 1.0 2.7 4.7 4.8 2.8 2.6 5.5 3.0 3.0 2.1 1.8 1.6 1.0 4.2 1.6 5.8 4.2 16.9 14.2 1.8 4.7 4.3 2.5 6.5 6.8 5.1 57.4 2.5 1.3 3.4 3.1 2.3 3.7 3.5 2.7 0.8 6.5 12.6 2.8 3.1 3.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 8.6 12.1 0.7 7.2 4.3 4.1 7.6 1.6 1.5 0.3 0.1 3.5 7.7 0.0 4.8 0.2 3.4 14.4 5.9 0.4 22.0 14.6 4.0 9.9 3.2 4.5 0.0 0.0 5.5 6.0 1.4 9.9 8.4 6.1 0.0 7.9 6.2 6.1 0.4 9.6 16.3 0.0 0.0 0.0 2.1 4.1 7.6 9.0 7.7 10.1 0.1 3.6 0.3 4.3 0.0 3.7 1.5 4.1 10.1 9.3 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 7.2 3.2 2.9 3.0 3.0 4.2 1.6 4.7 2.7 PHLPP2 "KIAA0931, PHLPPL, PPM3B" ENSG00000040199 "PH domain and leucine rich repeat protein phosphatase 2" Q6ZVD8 16 71637835-71724701 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 29.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048598 Approved Approved Vesicles Vesicles "HPA048598: " "unprognostic (5.67e-2)" "unprognostic (2.00e-1)" "unprognostic (2.29e-2)" "unprognostic (2.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.27e-1)" "unprognostic (1.22e-1)" "unprognostic (3.43e-1)" "unprognostic (1.97e-4)" "unprognostic (3.08e-2)" "unprognostic (8.85e-3)" "unprognostic (6.41e-2)" "unprognostic (4.92e-2)" "unprognostic (8.46e-3)" "unprognostic (8.27e-2)" 6.4 4.7 12.5 7.0 10.9 8.1 8.4 17.4 14.9 4.4 16.6 4.6 4.3 15.8 5.8 4.9 2.7 4.7 4.1 4.6 11.7 9.0 5.4 4.9 4.8 5.0 6.2 14.9 7.2 4.9 10.2 7.3 4.3 12.6 4.7 17.8 13.2 2.9 5.7 5.3 3.0 29.9 7.0 7.6 3.9 4.2 10.8 4.7 1.0 9.9 1.1 4.9 4.7 9.8 2.4 2.2 1.2 0.7 3.5 1.5 0.4 4.8 6.4 7.0 7.8 5.6 6.8 4.0 7.3 6.6 10.6 8.6 5.9 1.6 9.6 2.9 12.0 10.3 10.1 3.7 13.7 3.4 5.5 2.7 5.5 3.8 4.4 2.3 4.2 5.0 2.2 15.0 4.9 3.9 2.4 2.6 7.3 10.2 3.1 1.8 5.5 1.7 5.1 6.2 3.1 5.0 3.7 6.1 3.2 15.7 4.3 2.5 5.3 1.3 5.4 10.7 7.7 4.5 6.0 6.1 4.2 10.0 6.6 1.9 2.3 0.8 0.5 0.2 1.0 0.7 0.9 2.4 0.8 1.5 0.6 1.6 1.1 0.9 1.2 3.5 0.7 2.2 1.3 0.4 12.5 10.9 17.4 14.9 11.7 9.0 6.2 14.9 12.6 4.7 PHOSPHO2 MGC22679 ENSG00000144362 "Phosphatase, orphan 2" Q8TCD6 2 169694454-169701708 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034726, HPA034727" Uncertain Approved Vesicles Vesicles "HPA034726: AB_10602191, HPA034727: " "unprognostic (1.98e-1)" "unprognostic (1.22e-1)" "unprognostic (7.56e-2)" "unprognostic (1.39e-3)" "unprognostic (1.30e-2)" "unprognostic (2.26e-1)" "prognostic unfavourable (3.82e-6)" "unprognostic (4.31e-2)" "unprognostic (2.11e-2)" "unprognostic (5.19e-2)" "unprognostic (1.40e-1)" "unprognostic (2.31e-1)" "prognostic favourable (9.53e-4)" "unprognostic (4.10e-1)" "unprognostic (2.60e-1)" "unprognostic (6.12e-2)" "unprognostic (7.53e-2)" 8.7 4.0 9.0 5.7 9.7 3.3 14.2 14.2 7.8 8.4 8.2 5.8 6.3 8.2 8.6 5.9 4.6 8.1 6.2 5.7 6.7 5.5 7.5 5.0 4.3 3.6 6.0 9.1 8.2 8.9 10.9 21.3 3.9 7.8 17.4 7.8 6.4 10.5 7.8 6.4 5.2 7.9 6.2 9.7 3.4 6.3 25.4 8.0 5.5 13.0 3.9 3.9 9.1 5.7 8.8 4.6 1.5 1.0 10.5 5.7 1.8 5.6 1.6 4.1 5.5 7.8 2.5 16.0 2.5 1.7 3.8 4.3 5.5 4.4 5.5 5.6 1.8 4.4 5.4 3.0 3.2 8.1 6.3 5.5 4.8 9.5 5.1 4.5 5.0 4.5 5.7 4.4 5.9 3.4 9.1 5.7 2.4 5.2 3.1 5.8 5.5 2.1 3.2 2.5 4.3 6.1 17.0 17.2 5.9 5.3 2.8 5.9 7.4 2.7 2.0 4.2 4.0 4.0 2.7 5.5 5.1 4.9 5.0 2.7 4.5 0.0 0.9 1.1 3.9 1.0 5.5 6.8 4.3 3.7 1.0 8.8 5.7 5.6 1.5 10.5 0.9 4.6 4.4 1.8 9.0 9.7 14.2 7.8 6.7 5.5 6.0 9.1 7.8 8.0 PHOX2A "ARIX, CFEOM2, FEOM2, PMX2A" ENSG00000165462 "Paired like homeobox 2a" O14813 11 72239077-72245664 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7" "Cell line enriched" "Detected in single" 228 "SH-SY5Y: 112.7" "Cancer enriched" "Detected in some" 9 "ovarian cancer: 9.3" "Region enriched" "Detected in single" 96 "pons and medulla: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "pons and medulla: 0.8" "Low region specificity" "Detected in some" "HPA053810, HPA065621, HPA078004" Enhanced Enhanced "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" Nucleoplasm "Nuclear membrane, Vesicles, Cytosol" "HPA053810: , HPA065621: , HPA078004: " "unprognostic (5.84e-2)" "unprognostic (8.51e-2)" "unprognostic (5.07e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "unprognostic (9.92e-4)" "unprognostic (3.03e-2)" 0.4 24.6 0.0 9.7 0.0 0.0 0.0 0.0 0.1 0.2 3.3 0.5 0.0 0.4 0.1 0.0 1.4 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 12.1 0.9 0.7 1.7 0.7 3.7 0.0 0.0 3.2 0.3 2.1 0.1 1.6 5.2 0.0 0.0 0.0 0.0 0.0 2.6 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 112.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.1 0.0 PI15 P25TI ENSG00000137558 "Peptidase inhibitor 15" O43692 8 74824537-74855029 "Predicted secreted proteins" "Developmental protein, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "AF22: 15.7;SH-SY5Y: 15.6;SK-MEL-30: 20.7;U-266/70: 5.4" "Group enriched" "Detected in many" 7 "breast cancer: 11.1;melanoma: 8.6;prostate cancer: 18.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006593, HPA030057" Uncertain Approved Vesicles,Cytosol "Secreted in other tissues" Vesicles Cytosol "HPA006593: AB_1078568, HPA030057: AB_10602143" "unprognostic (2.77e-1)" "unprognostic (1.57e-2)" "unprognostic (3.41e-1)" "unprognostic (1.88e-2)" "unprognostic (3.22e-1)" "unprognostic (3.24e-1)" "unprognostic (2.94e-2)" "unprognostic (2.33e-3)" "unprognostic (1.87e-1)" "unprognostic (2.25e-1)" "unprognostic (3.65e-2)" "unprognostic (1.85e-2)" "unprognostic (8.63e-14)" "unprognostic (2.54e-3)" "unprognostic (1.34e-1)" "unprognostic (2.60e-2)" "unprognostic (2.05e-2)" 4.2 1.4 3.7 33.4 6.5 0.2 23.4 0.5 2.2 17.3 8.8 0.0 6.5 0.3 26.5 33.8 1.8 18.5 1.2 18.8 1.3 0.9 2.5 0.4 2.3 4.6 3.5 0.0 28.7 0.5 0.2 0.7 0.4 5.9 21.4 3.3 0.0 1.9 5.2 0.6 0.5 8.3 30.7 6.0 15.2 1.0 2.6 1.7 0.1 0.8 0.9 0.3 7.8 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 15.6 0.0 0.0 20.7 0.3 0.4 0.0 0.0 0.3 0.0 0.1 5.4 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 6.5 0.5 2.2 1.3 0.9 3.5 0.0 5.9 1.7 PICALM "CALM, CLTH" ENSG00000073921 "Phosphatidylinositol binding clathrin assembly protein" Q13492 11 85957684-86069882 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Endocytosis "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 25.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019053, HPA019061" Enhanced Enhanced Vesicles 28000 Vesicles "HPA019053: AB_1855361, HPA019061: AB_1855362" "unprognostic (9.27e-3)" "unprognostic (7.29e-2)" "unprognostic (3.51e-1)" "unprognostic (6.83e-2)" "unprognostic (5.13e-2)" "unprognostic (1.93e-1)" "unprognostic (5.36e-3)" "unprognostic (9.02e-3)" "unprognostic (9.80e-2)" "unprognostic (6.27e-3)" "prognostic unfavourable (6.61e-4)" "unprognostic (4.31e-1)" "prognostic favourable (2.02e-6)" "unprognostic (1.26e-2)" "unprognostic (5.21e-3)" "unprognostic (2.52e-1)" "unprognostic (1.02e-1)" 72.9 24.2 35.6 43.1 51.4 37.1 51.3 30.2 39.7 38.7 35.9 60.0 27.7 39.6 41.6 26.0 41.3 31.5 48.1 41.4 43.7 34.2 63.9 53.8 45.1 35.2 52.0 33.5 38.2 29.7 70.6 23.8 76.7 50.7 29.9 32.0 26.7 31.8 37.0 35.5 35.0 45.3 49.9 70.7 49.5 30.7 22.9 55.1 31.0 30.8 28.5 34.8 44.0 49.2 2.1 7.1 25.8 8.5 3.9 5.3 3.1 28.9 13.8 21.9 15.3 33.6 35.3 41.4 37.3 48.5 29.5 26.1 54.4 39.5 22.6 38.5 59.8 24.0 22.9 27.2 42.7 6.7 8.2 64.2 18.8 17.3 34.3 15.0 28.9 30.6 29.5 55.3 46.1 32.0 41.1 18.7 55.5 17.0 17.6 13.8 12.0 7.9 12.2 33.2 16.0 57.3 24.5 13.3 10.8 45.8 15.5 12.3 21.0 12.2 34.6 54.6 19.0 64.4 29.7 6.7 17.5 20.7 12.9 11.9 36.8 3.6 8.5 4.2 3.9 7.2 3.3 2.1 2.9 5.3 7.1 1.4 3.0 2.7 25.8 3.9 7.2 2.5 3.8 3.1 35.6 51.4 30.2 39.7 43.7 34.2 52.0 33.5 50.7 55.1 PIEZO2 "C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771" ENSG00000154864 "Piezo type mechanosensitive ion channel component 2" Q9H5I5 18 10666483-11148762 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Cell line enhanced" "Detected in some" "AF22: 9.4;BJ hTERT+ SV40 Large T+: 10.5;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HeLa: 23.4;U-266/70: 14.9;U-698: 9.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA015986, HPA031974, HPA031975, HPA040616" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA015986: AB_1848395, HPA031974: AB_10603675, HPA031975: , HPA040616: " "unprognostic (1.36e-1)" "unprognostic (1.92e-1)" "unprognostic (9.21e-2)" "unprognostic (2.53e-2)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.87e-2)" "unprognostic (4.34e-3)" "unprognostic (6.55e-2)" "unprognostic (3.89e-2)" "unprognostic (6.06e-2)" "unprognostic (2.23e-1)" "prognostic unfavourable (9.57e-7)" "unprognostic (1.12e-3)" "unprognostic (1.09e-1)" "unprognostic (9.04e-2)" "unprognostic (1.83e-2)" 0.9 0.3 3.1 0.9 2.3 0.0 1.9 0.1 3.6 0.9 3.3 0.0 0.3 1.6 5.8 0.8 5.9 0.0 5.2 2.1 0.9 4.5 7.4 0.5 5.8 0.6 1.7 0.0 0.6 0.0 3.4 1.3 0.0 3.3 0.0 0.8 0.9 1.9 10.3 2.7 1.4 0.9 1.3 0.2 4.6 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.1 9.4 0.0 0.0 0.0 0.0 0.5 2.7 10.5 14.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 6.7 0.0 0.3 0.0 23.4 5.5 3.3 0.0 0.0 0.0 0.1 2.7 0.7 3.2 0.0 0.2 1.6 0.0 0.1 0.0 2.9 0.0 0.0 0.0 4.1 0.0 3.2 8.1 0.0 0.1 0.0 0.5 0.0 2.7 0.0 0.0 3.8 0.2 0.5 14.9 0.1 9.7 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIGG "FLJ20265, GPI7, LAS21" ENSG00000174227 "Phosphatidylinositol glycan anchor biosynthesis class G" Q5H8A4 4 499210-540196 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015997 Uncertain Uncertain Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA015997: AB_2164679" "unprognostic (3.87e-2)" "unprognostic (5.32e-2)" "unprognostic (5.78e-3)" "unprognostic (2.77e-2)" "unprognostic (2.25e-1)" "unprognostic (1.34e-1)" "unprognostic (3.20e-3)" "unprognostic (3.48e-2)" "unprognostic (4.68e-1)" "unprognostic (2.64e-1)" "unprognostic (7.01e-3)" "unprognostic (6.61e-3)" "unprognostic (9.09e-2)" "unprognostic (1.83e-2)" "unprognostic (1.51e-1)" "unprognostic (4.27e-3)" "unprognostic (2.97e-2)" 16.2 22.0 12.8 19.8 19.7 11.3 17.1 21.3 23.2 13.3 15.6 23.2 21.5 18.8 23.2 28.7 16.7 15.6 17.4 11.5 13.6 12.5 15.5 13.0 15.5 16.5 20.3 16.0 22.1 18.6 31.1 22.9 16.7 17.2 16.9 16.5 19.5 20.9 19.1 10.7 26.6 17.5 19.3 21.8 17.7 17.5 19.9 17.6 16.2 21.9 9.6 15.1 19.5 15.0 4.2 9.2 16.4 7.5 8.1 9.0 4.5 11.0 12.3 11.2 9.4 20.5 14.8 17.6 14.7 17.7 15.7 18.7 12.5 26.3 4.5 10.7 18.5 14.8 10.6 14.3 14.4 4.3 11.3 11.5 15.0 9.7 14.4 15.8 17.3 16.5 24.0 14.5 8.0 11.9 12.6 10.6 13.9 6.7 8.8 13.7 17.9 16.8 9.8 6.9 6.9 14.9 15.3 11.1 14.2 10.6 11.1 10.2 17.8 14.3 18.3 16.3 7.6 8.0 22.6 8.5 11.1 7.3 13.8 11.7 19.9 16.4 5.9 4.7 7.2 7.5 8.3 4.2 5.7 6.9 9.2 3.6 6.2 5.0 4.3 8.1 5.3 8.0 9.0 4.5 12.8 19.7 21.3 23.2 13.6 12.5 20.3 16.0 17.2 17.6 PIGP "DCRC, DSCR5, DSRC" ENSG00000185808 "Phosphatidylinositol glycan anchor biosynthesis class P" P57054 21 37059170-37073170 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026921 Uncertain Approved Vesicles Vesicles "HPA026921: AB_1847874" "unprognostic (4.47e-3)" "unprognostic (9.45e-2)" "unprognostic (3.03e-1)" "unprognostic (2.40e-1)" "unprognostic (2.85e-2)" "unprognostic (1.92e-2)" "unprognostic (1.92e-2)" "unprognostic (5.54e-2)" "unprognostic (1.55e-1)" "unprognostic (1.22e-2)" "unprognostic (4.21e-3)" "unprognostic (1.12e-2)" "unprognostic (1.96e-2)" "unprognostic (1.93e-1)" "unprognostic (5.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.55e-2)" 20.0 30.3 12.3 7.9 13.4 4.2 18.0 6.9 14.3 13.1 13.8 15.6 23.1 9.9 11.7 60.6 12.5 13.9 15.2 27.8 12.3 15.2 19.0 27.4 14.7 9.9 16.1 9.8 15.0 45.4 23.9 28.9 16.2 17.9 21.3 14.3 16.6 22.2 17.4 25.0 7.0 12.8 24.0 24.8 10.1 14.8 19.3 8.4 16.3 20.3 17.3 9.9 17.2 9.2 18.2 16.7 1.7 11.1 8.7 19.3 8.7 9.5 4.5 9.6 5.8 17.3 11.4 6.4 7.7 14.3 7.0 7.9 6.0 20.2 13.1 17.3 11.6 7.7 7.9 8.8 7.4 13.6 13.8 29.8 5.7 8.3 10.5 8.8 6.5 10.3 16.6 12.6 15.8 12.0 17.7 23.5 15.4 6.3 11.7 9.7 7.3 11.1 11.4 4.9 13.8 17.6 5.3 19.7 11.8 21.8 16.4 29.2 14.0 19.3 6.2 5.2 2.5 6.0 7.0 31.3 34.0 15.0 15.0 11.3 17.0 0.2 7.1 1.7 11.3 10.4 14.0 18.2 14.5 12.1 11.1 15.3 19.3 16.7 1.0 8.7 11.1 16.7 10.7 8.7 12.3 13.4 6.9 14.3 12.3 15.2 16.1 9.8 17.9 8.4 PIGQ "GPI1, hGPI1" ENSG00000007541 "Phosphatidylinositol glycan anchor biosynthesis class Q" Q9BRB3 16 566995-584136 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039105, HPA039828, HPA061414" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: " "unprognostic (1.23e-2)" "unprognostic (6.12e-3)" "unprognostic (2.81e-1)" "unprognostic (2.65e-2)" "unprognostic (1.09e-2)" "unprognostic (2.42e-1)" "unprognostic (9.58e-2)" "unprognostic (8.05e-2)" "unprognostic (2.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (8.98e-2)" "prognostic favourable (2.53e-6)" "unprognostic (2.73e-1)" "unprognostic (2.60e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" 13.9 15.7 12.8 8.7 13.9 48.4 8.4 12.8 20.6 8.4 9.7 11.4 16.7 15.4 10.9 23.3 7.2 10.0 13.6 7.4 10.5 11.1 18.9 12.5 13.0 6.2 9.1 13.2 10.4 29.3 18.1 15.3 8.4 9.4 11.2 4.1 15.4 15.5 17.6 12.4 12.8 8.1 5.5 7.2 10.3 13.6 15.3 8.2 11.8 18.4 4.2 7.9 9.8 6.7 5.6 10.5 5.9 6.0 5.5 5.3 3.9 8.5 12.9 4.6 6.4 3.0 1.8 8.7 9.0 3.5 3.9 4.2 9.0 8.0 4.5 11.8 2.0 13.7 2.1 4.0 0.8 13.0 18.9 6.9 14.0 6.4 5.8 6.0 6.5 3.2 6.0 6.5 1.3 3.6 15.4 2.6 1.3 11.1 11.1 6.9 6.2 13.3 21.5 3.8 10.4 3.5 3.4 8.3 13.2 10.2 4.7 6.5 10.7 4.1 8.7 6.6 8.4 7.4 6.2 9.9 2.9 3.6 2.2 3.2 6.4 1.2 4.8 3.0 5.3 5.6 4.6 4.4 4.6 5.1 4.9 5.6 5.1 3.1 5.9 5.5 6.0 10.5 4.2 3.9 12.8 13.9 12.8 20.6 10.5 11.1 9.1 13.2 9.4 8.2 PIGZ "FLJ12768, MGC52163, SMP3" ENSG00000119227 "Phosphatidylinositol glycan anchor biosynthesis class Z" Q86VD9 3 196946343-196969060 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 26.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.3" "Group enriched" "Detected in many" 8 "dendritic cells: 1.6;granulocytes: 1.4;monocytes: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058599, HPA059920" Approved Uncertain Vesicles Vesicles "HPA058599: , HPA059920: " "unprognostic (1.46e-1)" "unprognostic (3.18e-3)" "unprognostic (1.06e-2)" "unprognostic (3.31e-2)" "unprognostic (3.90e-2)" "unprognostic (8.16e-2)" "unprognostic (4.25e-3)" "unprognostic (4.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.44e-2)" "unprognostic (1.30e-1)" "prognostic unfavourable (5.60e-5)" "unprognostic (1.02e-1)" "unprognostic (3.93e-2)" "unprognostic (8.38e-5)" "unprognostic (5.02e-3)" 6.6 3.1 5.7 5.3 8.6 1.9 3.4 18.5 16.3 3.3 26.5 3.2 2.0 2.9 2.3 1.7 3.2 2.8 4.5 6.4 5.3 7.5 1.6 1.6 3.1 2.0 4.4 6.4 0.8 5.9 2.7 2.9 2.1 10.8 4.6 24.5 4.3 4.7 4.6 10.0 4.5 7.4 5.3 2.8 1.8 3.1 1.4 3.0 3.2 1.7 2.8 2.1 9.9 2.9 0.1 1.6 1.4 3.3 0.0 0.2 0.3 2.0 1.4 0.8 3.3 9.1 4.4 0.8 3.0 8.5 2.3 1.9 1.9 1.7 0.3 6.0 6.7 3.4 0.2 0.4 0.6 0.6 0.4 0.9 0.7 7.3 4.3 0.0 3.4 4.4 6.5 0.3 1.1 2.8 0.2 2.6 2.2 3.6 0.3 1.7 0.1 1.1 0.5 0.1 0.6 3.5 3.8 1.3 1.5 4.2 0.3 1.6 8.4 2.9 6.9 1.9 0.5 5.5 1.0 1.2 0.2 0.1 0.4 1.2 0.7 0.0 1.1 0.8 0.2 3.3 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 1.4 0.0 1.4 0.3 0.0 0.3 5.7 8.6 18.5 16.3 5.3 7.5 4.4 6.4 10.8 3.0 PIK3CB PIK3C1 ENSG00000051382 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta" P42338 3 138652699-138834938 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Autophagy, Cell adhesion, Endocytosis" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 41.2;HMC-1: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031938, HPA042288, HPA064207" Approved Supported Nucleoplasm,Nucleoli,Vesicles,Midbody Nucleoplasm "Nucleoli, Vesicles, Midbody" "CAB031938: AB_2165408, HPA042288: , HPA064207: " "unprognostic (4.89e-2)" "unprognostic (1.42e-2)" "unprognostic (5.97e-2)" "unprognostic (7.85e-2)" "unprognostic (4.89e-2)" "unprognostic (6.01e-2)" "prognostic unfavourable (6.42e-4)" "unprognostic (3.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.28e-1)" "prognostic unfavourable (3.99e-5)" "unprognostic (2.15e-1)" "unprognostic (6.18e-3)" "unprognostic (9.33e-2)" "unprognostic (7.82e-2)" "unprognostic (2.79e-1)" "unprognostic (4.59e-2)" 12.5 9.9 10.6 9.7 20.6 17.4 11.5 29.9 25.0 12.4 14.6 11.9 11.7 13.7 9.6 6.9 15.2 10.9 8.7 12.7 12.2 14.2 22.6 9.3 9.5 9.1 11.9 15.2 8.8 20.3 20.2 10.9 18.1 24.1 13.4 15.7 12.2 14.9 15.9 33.4 19.6 16.4 8.3 12.5 9.9 11.0 6.4 10.7 14.4 37.4 7.1 11.9 13.4 11.0 4.6 9.1 11.3 7.8 1.3 6.5 2.6 22.6 9.8 4.2 3.5 3.9 5.2 28.7 5.3 5.1 5.4 5.8 10.5 8.6 9.1 14.5 5.2 9.7 5.5 8.4 9.7 11.6 6.2 41.2 6.7 6.3 4.0 10.0 65.3 4.4 6.5 3.8 7.7 8.1 15.7 6.8 6.7 10.3 5.8 7.0 6.0 9.2 4.2 4.4 6.5 8.3 12.5 3.7 2.7 14.7 6.4 18.9 16.0 23.9 8.5 3.5 4.4 7.5 7.4 11.5 7.5 8.3 8.5 9.7 4.8 7.0 7.8 11.3 4.0 4.5 2.7 4.6 5.2 3.0 9.1 4.1 6.5 4.4 10.0 1.3 4.3 1.4 2.2 2.6 10.6 20.6 29.9 25.0 12.2 14.2 11.9 15.2 24.1 10.7 PIK3CD p110D ENSG00000171608 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta" O00329 1 9651732-9729114 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity" "Kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.0;bone marrow: 32.8;lymphoid tissue: 40.3" "Cell line enhanced" "Detected in many" "HDLM-2: 50.5;NB-4: 21.8;REH: 22.7;THP-1: 22.0;U-937: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015420, HPA044953" Enhanced Approved "Vesicles,Cytokinetic bridge" Vesicles "Cytokinetic bridge" "CAB015420: AB_831654, HPA044953: " "unprognostic (5.73e-3)" "unprognostic (2.75e-3)" "unprognostic (8.93e-2)" "unprognostic (4.05e-2)" "unprognostic (4.71e-2)" "unprognostic (1.40e-2)" "unprognostic (2.13e-1)" "unprognostic (7.42e-2)" "unprognostic (2.78e-2)" "unprognostic (1.54e-2)" "unprognostic (3.46e-2)" "unprognostic (6.75e-2)" "unprognostic (8.65e-3)" "unprognostic (2.09e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" "unprognostic (6.78e-2)" 4.5 2.1 3.4 34.8 7.1 32.8 2.9 3.3 4.3 3.2 3.3 5.5 0.7 3.1 3.7 3.4 3.5 4.0 6.5 2.9 4.2 3.1 4.6 3.3 8.2 40.3 7.4 1.8 5.3 2.2 2.3 2.2 3.3 4.6 3.2 2.1 3.1 11.2 1.8 0.9 2.0 11.4 2.9 5.3 35.5 3.3 3.0 5.7 23.5 4.1 2.3 36.0 5.8 3.6 8.4 14.5 35.0 15.0 14.5 13.7 16.6 2.6 1.7 0.1 0.5 0.4 0.4 0.2 4.1 8.4 9.0 7.4 0.1 1.1 7.1 1.7 3.3 0.8 0.7 3.7 5.7 50.5 0.1 0.8 0.4 3.0 1.8 18.4 6.4 1.5 1.5 10.1 3.4 1.3 2.6 0.0 5.1 0.2 1.7 21.8 0.7 0.5 22.7 4.5 0.2 3.8 0.0 0.5 0.5 0.9 1.7 4.0 0.2 22.0 3.3 2.7 2.8 0.0 3.8 1.6 1.6 10.0 5.8 26.3 1.5 9.6 11.8 21.1 12.9 13.1 13.7 7.8 9.8 11.8 12.5 8.4 12.9 13.4 35.0 14.5 15.0 14.5 7.4 16.6 3.4 7.1 3.3 4.3 4.2 3.1 7.4 1.8 4.6 5.7 PIK3R3 p55 ENSG00000117461 "Phosphoinositide-3-kinase regulatory subunit 3" Q92569 1 46040140-46133036 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Group enriched" "Detected in many" 8 "granulocytes: 8.6;monocytes: 3.1;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005751, HPA071988" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA005751: AB_1855350, HPA071988: " "unprognostic (1.98e-1)" "unprognostic (3.75e-3)" "unprognostic (8.04e-2)" "prognostic favourable (1.93e-4)" "unprognostic (6.32e-2)" "prognostic favourable (3.62e-4)" "unprognostic (4.88e-2)" "unprognostic (3.33e-3)" "unprognostic (4.16e-2)" "unprognostic (4.63e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (9.99e-3)" "unprognostic (2.87e-2)" "unprognostic (9.74e-2)" "unprognostic (6.71e-2)" "unprognostic (8.22e-3)" 33.7 10.9 7.4 7.0 8.2 0.8 24.7 36.4 11.0 16.9 6.3 3.5 9.1 3.3 15.8 11.0 8.4 7.6 10.9 28.7 6.8 8.5 10.4 4.1 20.0 6.0 8.7 3.1 4.6 4.0 18.7 10.2 13.4 10.4 9.0 5.3 13.6 9.4 8.0 14.8 4.6 6.0 12.3 7.1 10.9 7.4 24.0 4.5 5.9 12.7 6.2 5.3 12.3 8.7 0.5 0.6 8.6 3.1 0.1 3.5 0.9 4.6 1.6 21.4 10.8 2.1 0.9 6.8 2.8 2.0 3.7 4.6 0.9 1.4 6.1 8.5 1.0 2.8 7.4 2.5 2.4 4.8 6.7 3.8 19.2 0.7 0.7 3.5 5.3 2.6 1.5 3.9 1.4 7.6 1.4 4.4 5.2 7.1 14.0 2.1 7.5 4.3 18.0 5.7 7.3 9.2 33.3 15.5 11.2 9.0 23.9 2.5 6.6 3.1 14.2 3.9 3.7 0.6 2.7 6.3 6.5 3.7 3.1 4.7 2.0 0.0 0.3 8.6 3.3 0.5 3.0 0.5 0.8 2.9 0.0 0.0 0.3 1.9 0.1 0.1 3.1 0.6 3.5 0.9 7.4 8.2 36.4 8.9 6.8 8.5 8.7 3.1 10.4 4.5 PIK3R4 "p150, VPS15" ENSG00000196455 "Phosphoinositide-3-kinase regulatory subunit 4" Q99570 3 130678935-130746829 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036032, HPA036033" Approved Approved Vesicles,Microtubules Vesicles Microtubules "HPA036032: AB_10610281, HPA036033: " "unprognostic (7.50e-2)" "unprognostic (3.90e-3)" "unprognostic (1.68e-1)" "unprognostic (4.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.28e-1)" "unprognostic (1.34e-1)" "unprognostic (1.21e-1)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (1.02e-3)" "unprognostic (7.26e-2)" "prognostic favourable (4.40e-6)" "unprognostic (8.25e-2)" "unprognostic (3.72e-1)" "unprognostic (2.27e-1)" "unprognostic (1.05e-1)" 15.5 16.2 11.6 11.6 15.9 10.6 14.9 14.7 17.2 16.5 13.1 14.9 9.5 10.3 18.8 12.0 12.9 15.6 12.0 12.2 9.7 10.0 14.9 28.2 13.7 12.4 12.0 11.4 17.8 12.0 40.7 20.6 14.4 17.3 14.1 11.6 14.1 14.0 15.4 14.8 16.0 13.4 14.6 12.1 18.5 13.3 14.9 11.8 29.7 18.1 10.2 13.6 16.5 13.9 8.4 9.6 12.0 8.5 11.5 13.7 7.0 14.1 9.0 13.2 9.5 19.6 15.6 9.2 10.5 12.7 14.6 16.9 11.6 12.1 16.7 13.3 10.6 20.2 21.7 16.4 23.0 10.0 8.0 13.6 10.3 8.0 9.0 20.6 6.8 10.8 11.8 15.5 9.9 13.4 15.7 8.5 12.8 12.4 16.8 6.3 16.6 8.8 11.8 15.4 15.0 9.6 11.6 12.2 8.9 15.1 9.6 10.6 13.2 9.1 10.6 11.2 9.8 12.6 8.4 9.9 9.0 22.0 12.3 7.9 10.4 12.0 7.2 9.2 9.4 8.4 13.7 8.4 8.6 6.9 9.6 5.7 10.1 9.0 6.0 11.5 8.5 3.4 9.3 7.0 11.6 15.9 14.7 17.2 9.7 10.0 12.0 11.4 17.3 11.8 PIKFYVE "FAB1, KIAA0981, MGC40423, p235, PIKfyve, PIP5K, PIP5K3, ZFYVE29" ENSG00000115020 "Phosphoinositide kinase, FYVE-type zinc finger containing" Q9Y2I7 2 208266267-208358751 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042558, HPA042604" Uncertain Supported Vesicles Vesicles "HPA042558: , HPA042604: AB_10796580" "unprognostic (1.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.88e-1)" "unprognostic (3.03e-1)" "unprognostic (2.04e-2)" "prognostic favourable (6.81e-4)" "unprognostic (6.82e-3)" "unprognostic (6.45e-2)" "unprognostic (1.85e-2)" "unprognostic (3.81e-2)" "unprognostic (1.77e-1)" "unprognostic (2.10e-2)" "unprognostic (1.32e-1)" "unprognostic (2.14e-1)" "unprognostic (3.29e-1)" "unprognostic (1.06e-1)" "unprognostic (7.05e-2)" 15.9 13.5 17.7 21.1 21.9 36.1 24.9 25.6 23.1 14.8 12.1 14.0 16.6 9.1 14.7 18.3 11.2 12.6 11.1 12.5 19.4 14.3 16.2 15.2 16.5 23.1 14.4 15.3 15.6 31.5 21.5 17.0 14.1 20.6 17.7 11.5 13.8 13.7 19.7 13.6 12.9 15.3 13.5 24.4 21.7 12.1 19.3 15.8 23.5 18.2 7.8 22.6 12.4 14.0 7.5 2.1 1.4 1.2 5.6 2.6 0.5 5.0 5.0 12.0 9.3 12.1 14.5 5.6 6.2 12.6 7.3 10.0 7.2 4.2 5.8 6.5 10.6 5.2 10.4 6.9 12.5 4.9 6.6 20.8 9.9 6.4 9.2 18.3 18.8 10.8 7.6 8.5 16.0 11.8 14.0 10.5 9.1 2.1 16.6 13.8 9.9 3.8 6.2 9.3 7.9 9.4 7.3 3.8 9.1 6.8 4.4 12.3 2.8 19.8 13.5 9.2 6.1 6.1 5.7 7.4 8.7 12.4 7.3 16.0 9.0 1.4 1.0 0.7 1.7 0.8 1.1 7.5 2.3 2.6 0.9 5.4 1.8 2.1 1.4 5.6 1.2 2.1 1.5 0.5 17.7 21.9 25.6 23.1 19.4 14.3 14.4 15.3 20.6 15.8 PINLYP ENSG00000234465 "Phospholipase A2 inhibitor and LY6/PLAUR domain containing" A6NC86 19 43576800-43583964 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 33.9;HMC-1: 22.6;REH: 13.8;THP-1: 17.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 17.4" "Low lineage specificity" "Detected in many" HPA061218 Uncertain Approved Vesicles "Secreted to blood" Vesicles "HPA061218: " "unprognostic (6.72e-2)" "unprognostic (6.21e-2)" "unprognostic (4.72e-1)" "unprognostic (3.13e-2)" "unprognostic (2.46e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.22e-2)" "unprognostic (5.07e-2)" "unprognostic (2.00e-1)" "unprognostic (2.85e-2)" "unprognostic (1.14e-1)" "unprognostic (4.36e-3)" "unprognostic (1.95e-2)" "unprognostic (1.68e-1)" "unprognostic (1.08e-1)" "unprognostic (3.60e-2)" 3.6 2.0 5.6 1.8 6.5 1.2 4.0 3.7 2.5 7.4 3.9 0.6 6.8 7.1 5.0 13.1 6.6 4.2 4.4 4.6 7.9 0.3 2.9 2.9 4.2 13.1 0.6 0.0 5.6 1.6 4.5 2.0 2.3 8.1 0.0 2.0 1.7 8.3 2.9 3.0 2.1 1.8 4.0 3.3 2.7 4.4 3.2 17.4 6.6 1.2 0.9 3.3 1.5 0.3 0.1 0.9 0.0 1.7 2.2 0.1 0.4 0.6 0.8 2.2 0.0 0.0 0.0 0.1 8.9 2.0 0.0 0.0 0.8 0.0 0.1 33.9 0.3 0.0 5.1 0.0 22.6 5.0 0.3 5.1 0.0 1.4 0.4 0.4 0.3 0.2 4.0 0.5 0.9 0.3 13.8 0.1 0.0 0.4 0.2 0.2 0.0 0.0 0.1 0.0 0.0 17.1 0.6 2.2 0.4 0.0 1.5 0.0 0.0 2.0 7.8 0.0 0.1 6.6 1.2 0.5 2.6 0.8 3.2 1.4 0.8 2.1 1.8 3.2 0.2 3.3 0.0 0.9 0.2 17.4 1.6 1.5 PIP4K2C "FLJ22055, PIP5K2C" ENSG00000166908 "Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma" Q8TBX8 12 57591174-57603418 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028658, HPA058551" Approved Approved Vesicles Vesicles "HPA028658: AB_10601245, HPA058551: " "unprognostic (7.84e-3)" "unprognostic (1.51e-1)" "unprognostic (2.42e-1)" "unprognostic (2.77e-2)" "unprognostic (2.49e-2)" "unprognostic (3.37e-2)" "prognostic unfavourable (7.98e-4)" "unprognostic (3.17e-2)" "unprognostic (6.00e-2)" "unprognostic (5.51e-2)" "unprognostic (1.75e-1)" "unprognostic (1.88e-1)" "prognostic favourable (2.06e-6)" "unprognostic (1.87e-1)" "unprognostic (2.16e-1)" "unprognostic (3.27e-1)" "unprognostic (3.42e-1)" 9.3 13.3 13.9 9.2 25.9 16.7 15.0 18.9 45.5 12.5 17.5 14.6 15.8 11.6 14.2 62.0 20.0 20.0 12.1 10.8 15.4 10.9 26.9 14.4 14.4 9.2 14.3 21.2 12.3 14.9 29.6 13.7 11.1 18.8 16.7 19.4 17.4 18.6 14.6 9.4 18.4 13.3 11.9 12.7 10.7 27.6 25.6 12.1 5.9 17.9 8.5 13.1 14.6 14.1 6.8 5.4 29.7 8.4 9.4 16.1 6.5 18.8 13.4 5.4 6.5 0.0 0.0 17.5 7.9 14.8 14.3 13.3 16.9 27.3 4.1 17.3 9.2 17.3 8.9 15.5 11.5 6.1 10.0 7.4 6.5 11.9 12.6 6.8 13.3 4.9 26.4 5.4 10.1 7.2 9.5 12.4 7.4 18.6 6.1 5.9 10.3 11.6 0.1 49.2 6.1 15.0 32.4 9.1 11.3 17.0 11.4 10.8 31.1 6.4 1.6 7.2 10.0 10.5 8.3 9.6 11.1 9.2 14.2 5.8 11.9 29.7 5.2 15.3 16.1 6.2 10.7 5.9 9.9 12.0 5.4 6.8 9.6 11.5 10.2 9.4 8.4 2.3 12.1 6.5 13.9 25.9 18.9 45.5 15.4 10.9 14.3 21.2 18.8 12.1 PIP5K1B "MSS4, STM7" ENSG00000107242 "Phosphatidylinositol-4-phosphate 5-kinase type 1 beta" O14986 9 68705414-69009176 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 30.3;HEL: 11.3;Hep G2: 9.2;Karpas-707: 6.4;U-266/70: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "eosinophil: 22.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009687 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA009687: AB_1855391" "unprognostic (2.02e-3)" "unprognostic (1.84e-2)" "unprognostic (3.77e-2)" "unprognostic (2.72e-1)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (5.85e-3)" "unprognostic (1.80e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-2)" "unprognostic (2.92e-2)" "prognostic favourable (1.03e-9)" "unprognostic (2.10e-2)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (3.34e-1)" 4.0 9.5 9.4 8.4 6.5 10.2 4.2 33.4 14.6 5.6 26.9 4.1 10.8 26.1 6.1 2.0 1.2 5.0 7.6 24.6 8.1 11.7 6.1 0.8 12.6 2.1 10.4 6.4 1.4 6.7 21.3 8.5 16.8 32.8 3.3 23.1 28.7 11.6 13.6 3.0 2.4 39.7 2.6 3.7 3.1 19.9 17.6 1.5 0.0 1.6 1.9 3.3 3.5 2.9 3.9 0.9 22.1 0.3 0.0 1.0 0.2 0.0 0.0 30.3 0.0 0.1 0.0 5.9 0.0 0.0 0.0 0.0 3.2 0.0 2.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 11.3 0.2 9.2 0.0 0.6 2.8 0.0 1.3 0.0 0.0 0.1 0.5 6.4 0.2 0.7 0.0 0.1 1.5 0.9 0.9 0.1 0.1 0.2 2.3 0.6 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.2 0.0 0.0 11.7 2.2 1.4 0.0 2.1 0.0 3.1 0.3 22.1 0.0 0.0 0.0 3.3 0.2 0.0 0.1 3.9 0.5 0.0 1.2 0.0 0.1 0.9 1.0 0.2 9.4 6.5 33.4 14.6 8.1 11.7 10.4 6.4 32.8 1.5 PITPNA "PITPN, VIB1A" ENSG00000174238 "Phosphatidylinositol transfer protein alpha" Q00169 17 1517718-1562816 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000528 Uncertain Approved Vesicles,Cytosol 100000 Cytosol Vesicles "HPA000528: AB_1079622" "unprognostic (1.54e-1)" "unprognostic (6.63e-2)" "unprognostic (2.43e-1)" "prognostic favourable (2.29e-4)" "unprognostic (7.88e-2)" "unprognostic (8.89e-3)" "unprognostic (2.37e-1)" "unprognostic (1.37e-1)" "unprognostic (7.33e-2)" "unprognostic (3.17e-2)" "prognostic favourable (1.80e-6)" "unprognostic (7.41e-2)" "prognostic favourable (9.35e-4)" "unprognostic (1.72e-1)" "unprognostic (1.23e-1)" "unprognostic (8.10e-2)" "unprognostic (6.81e-3)" 20.2 22.2 31.1 28.1 34.0 38.5 20.8 43.5 54.1 27.5 22.3 21.0 35.0 27.0 29.2 29.8 37.7 33.1 22.2 18.7 30.2 34.2 20.4 22.7 22.5 17.5 34.0 37.5 18.0 17.4 29.3 21.1 31.2 60.7 27.6 27.7 88.0 38.7 33.2 14.3 44.1 42.4 27.0 26.4 21.9 19.7 25.0 18.8 12.4 31.9 15.4 26.8 21.0 23.5 6.4 5.2 12.3 4.0 5.3 7.5 2.5 20.6 23.1 23.6 20.3 26.1 29.0 37.2 23.2 27.0 24.6 18.2 26.6 8.5 26.8 21.1 32.1 26.1 22.5 23.4 34.7 21.9 22.8 14.4 19.9 11.8 26.0 10.0 17.8 21.0 32.0 24.7 26.2 41.9 20.0 14.9 26.4 11.7 25.4 9.1 16.5 11.3 20.4 9.1 15.0 24.6 24.4 8.5 18.6 27.3 20.3 16.6 17.3 8.1 38.3 15.2 13.4 43.6 31.6 9.1 15.4 9.1 26.5 15.7 19.3 5.0 3.7 4.6 3.4 4.0 6.4 6.4 5.1 4.6 5.2 4.2 4.8 4.1 12.3 5.3 2.8 4.1 7.5 2.5 31.1 34.0 43.5 54.1 30.2 34.2 34.0 37.5 60.7 18.8 PITPNB VIB1B ENSG00000180957 "Phosphatidylinositol transfer protein beta" P48739 22 27851669-27920134 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000528 Uncertain Approved Vesicles,Cytosol 150000 Cytosol Vesicles "HPA000528: AB_1079622" "unprognostic (9.29e-2)" "unprognostic (1.64e-1)" "unprognostic (4.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.41e-1)" "prognostic unfavourable (5.28e-4)" "unprognostic (1.34e-1)" "unprognostic (7.52e-3)" "unprognostic (4.78e-2)" "unprognostic (8.22e-3)" "unprognostic (1.56e-3)" "unprognostic (2.42e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (6.28e-2)" "unprognostic (2.89e-2)" "unprognostic (1.64e-1)" 32.5 22.2 29.6 24.8 29.3 14.8 25.0 20.8 38.0 23.9 37.8 16.2 24.5 17.1 32.9 23.8 42.2 21.7 28.4 31.3 24.7 24.5 20.5 43.8 23.9 24.6 25.7 29.0 24.8 22.3 21.8 26.9 38.1 27.2 26.5 24.6 15.1 20.2 31.2 16.1 23.5 21.2 49.6 22.6 20.6 28.8 14.7 21.1 19.9 20.0 15.2 30.9 45.3 43.3 24.4 17.1 20.4 14.7 17.7 27.2 16.9 29.9 13.0 23.9 17.8 21.2 25.7 18.2 29.1 25.5 32.0 31.0 20.5 14.2 20.8 15.5 27.9 31.7 34.0 29.0 45.1 35.5 32.1 21.2 21.1 18.8 22.9 48.3 34.5 22.9 28.4 38.7 40.4 31.1 30.0 43.4 29.2 16.0 20.4 23.8 18.1 17.2 26.1 37.8 30.4 26.5 28.6 28.1 35.2 19.9 24.1 23.5 13.0 17.2 30.4 32.1 47.0 24.3 30.3 17.8 20.8 40.9 27.6 24.0 27.1 20.4 12.8 12.4 22.7 14.7 25.0 24.4 22.2 23.6 17.1 20.8 21.6 21.1 11.6 17.7 13.7 15.4 27.2 16.9 29.6 29.3 20.8 38.0 24.7 24.5 25.7 29.0 27.2 21.1 PITPNM2 "NIR3, RDGB2, RDGBA2" ENSG00000090975 "Phosphatidylinositol transfer protein membrane associated 2" Q9BZ72 12 122983480-123150015 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "lymphoid tissue: 169.5" "Cell line enhanced" "Detected in many" "HEL: 16.5;MOLT-4: 30.5;WM-115: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.7" "Group enriched" "Detected in many" 4 "NK-cells: 4.7;T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003414, HPA003978" Approved Supported Vesicles Vesicles "HPA003414: AB_1855410, HPA003978: AB_1855411" "unprognostic (2.43e-1)" "unprognostic (9.29e-2)" "unprognostic (2.00e-1)" "unprognostic (5.39e-2)" "unprognostic (2.14e-1)" "unprognostic (6.76e-2)" "unprognostic (2.26e-2)" "unprognostic (1.08e-1)" "unprognostic (2.55e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (9.28e-2)" "unprognostic (1.50e-3)" "unprognostic (7.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.19e-2)" "unprognostic (9.99e-2)" 3.4 5.9 3.3 3.2 7.9 3.5 3.1 9.3 8.0 3.9 3.5 2.4 3.2 3.5 3.6 5.2 3.7 2.5 2.2 4.6 2.8 2.2 3.7 4.3 5.1 6.1 2.4 2.6 14.0 2.5 5.3 4.2 3.0 2.3 2.7 1.6 3.7 2.7 3.1 3.3 3.0 3.6 4.5 2.5 3.3 2.7 14.8 2.2 169.5 2.3 2.2 4.3 4.7 2.7 0.8 0.0 0.1 0.1 4.7 2.3 1.6 2.5 5.0 1.6 2.3 1.2 2.2 9.8 0.4 0.6 1.3 0.7 2.2 2.1 0.0 2.2 0.8 7.3 1.3 1.2 0.5 0.1 1.6 16.5 2.9 5.9 0.8 0.6 3.5 1.1 2.2 1.7 1.4 2.6 3.7 0.2 1.6 1.6 30.5 3.4 1.9 2.2 8.8 0.1 6.3 2.4 2.7 1.5 0.5 3.6 3.0 2.4 0.6 1.8 7.6 1.9 2.2 3.1 2.8 0.5 0.5 11.7 4.8 1.2 14.7 0.0 0.0 0.1 2.3 0.0 0.2 0.4 0.6 1.7 0.0 0.8 1.5 1.4 0.0 4.7 0.1 0.0 1.1 1.6 3.3 7.9 9.3 8.0 2.8 2.2 2.4 2.6 2.3 2.2 PKN3 "PKNbeta, UTDP4-1" ENSG00000160447 "Protein kinase N3" Q6P5Z2 9 128702523-128720918 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045390, HPA058305" Uncertain Approved Vesicles Vesicles "HPA045390: , HPA058305: " "unprognostic (4.36e-2)" "unprognostic (5.70e-2)" "unprognostic (2.68e-2)" "unprognostic (7.62e-2)" "unprognostic (2.23e-1)" "unprognostic (2.65e-2)" "unprognostic (6.10e-2)" "unprognostic (8.04e-2)" "unprognostic (1.78e-1)" "unprognostic (3.68e-1)" "unprognostic (1.48e-1)" "unprognostic (7.91e-2)" "unprognostic (8.73e-3)" "unprognostic (6.18e-3)" "unprognostic (9.99e-2)" "unprognostic (7.23e-2)" "unprognostic (2.36e-1)" 11.4 1.8 1.5 6.8 3.8 3.7 10.5 10.1 3.9 4.3 5.8 3.7 4.8 7.7 9.7 2.2 7.1 5.3 10.9 7.3 2.3 1.7 5.0 6.4 8.9 9.1 3.9 1.2 4.0 4.2 3.3 1.4 5.6 4.5 4.2 1.6 4.1 12.9 3.7 7.4 6.7 5.4 4.9 4.4 7.8 7.4 4.3 1.7 9.3 8.1 6.1 5.9 4.4 5.0 0.4 1.0 2.3 0.7 1.0 1.8 0.3 1.3 6.7 5.5 8.3 0.0 0.1 13.6 4.2 1.3 6.2 6.4 0.0 4.9 0.0 4.1 2.2 9.1 6.7 1.0 1.4 4.2 12.6 8.0 32.8 9.6 1.0 1.0 1.4 0.3 0.3 3.3 0.9 12.2 18.3 0.9 1.1 12.6 1.2 4.3 5.1 2.0 19.9 10.4 1.8 2.6 0.8 0.9 4.1 3.1 1.7 3.1 5.9 6.4 10.5 0.0 5.2 9.7 3.1 3.0 1.3 2.6 0.7 1.0 3.8 0.0 0.1 1.4 0.9 0.7 1.8 0.2 0.6 0.8 1.0 0.4 0.8 0.1 2.3 1.0 0.2 0.2 1.0 0.3 1.5 3.8 10.1 3.9 2.3 1.7 3.9 1.2 4.5 1.7 PLA2G15 "GXVPLA2, LLPL, LYPLA3" ENSG00000103066 "Phospholipase A2 group XV" Q8NCC3 16 68245304-68261062 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041702, HPA041727" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" 20000000 "Nucleoplasm, Vesicles" "HPA041702: AB_10794486, HPA041727: AB_10793931" "unprognostic (3.47e-2)" "unprognostic (9.99e-2)" "unprognostic (1.54e-3)" "unprognostic (6.84e-3)" "unprognostic (1.38e-2)" "unprognostic (1.65e-2)" "unprognostic (4.12e-3)" "unprognostic (3.16e-1)" "unprognostic (2.12e-2)" "unprognostic (1.84e-2)" "unprognostic (2.56e-1)" "unprognostic (9.29e-2)" "unprognostic (2.45e-3)" "unprognostic (2.98e-2)" "unprognostic (5.40e-3)" "unprognostic (6.28e-2)" "unprognostic (3.47e-2)" 23.8 9.1 9.6 6.6 9.4 5.6 19.7 16.4 16.1 5.4 6.2 10.0 4.7 5.0 7.7 11.2 5.7 7.2 8.5 31.3 7.9 8.6 24.1 11.8 15.9 23.1 7.5 9.2 7.4 6.4 11.3 9.2 24.4 7.7 6.2 5.7 8.5 7.6 5.8 39.9 10.0 5.3 8.2 6.8 16.2 6.2 9.3 6.2 11.3 10.4 6.8 4.9 9.1 5.0 3.7 8.8 9.4 18.2 1.3 4.5 7.7 4.7 5.0 4.0 12.7 19.2 14.1 9.3 11.8 15.7 17.8 15.0 11.7 8.8 8.6 14.8 16.7 7.3 4.3 5.0 8.2 2.4 6.5 2.5 4.9 9.3 10.3 2.3 12.7 9.6 5.7 17.8 2.8 10.8 3.6 4.6 11.4 10.2 3.2 7.0 2.5 5.8 4.7 5.8 26.6 8.9 4.4 1.3 2.6 15.7 4.7 9.7 12.3 11.5 8.8 15.5 7.6 20.1 7.3 17.2 14.6 10.4 14.2 6.6 5.9 9.4 14.4 9.3 3.1 16.8 3.2 3.3 3.4 4.5 8.8 3.7 4.5 3.7 0.6 1.3 18.2 7.8 3.2 7.7 9.6 9.4 16.4 16.1 7.9 8.6 7.5 9.2 7.7 6.2 PLA2G4F PLA2G4F/Z ENSG00000168907 "Phospholipase A2 group IVF" Q68DD2 15 42139034-42156636 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 30.4;skin 1: 48.1" "Cell line enriched" "Detected in some" 4 "RT4: 13.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042713, HPA056752" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA042713: AB_10793982, HPA056752: " "unprognostic (1.99e-1)" "unprognostic (6.21e-3)" "unprognostic (1.59e-1)" "prognostic unfavourable (2.00e-4)" "unprognostic (1.06e-2)" "unprognostic (2.32e-3)" "unprognostic (1.48e-2)" "unprognostic (5.85e-2)" "unprognostic (2.25e-1)" "unprognostic (4.79e-2)" "unprognostic (6.65e-2)" "unprognostic (1.21e-2)" "unprognostic (9.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" "unprognostic (1.63e-1)" 0.1 0.1 0.0 2.5 0.3 0.3 1.8 0.0 0.1 4.5 11.0 0.0 4.7 4.2 0.4 9.7 10.4 0.2 3.1 1.0 0.0 0.0 10.8 0.2 30.4 0.1 0.0 0.0 0.1 0.1 0.7 4.1 0.3 0.0 3.3 2.5 0.0 5.3 2.8 8.6 48.1 12.3 1.1 0.1 0.2 1.6 0.1 0.0 6.2 1.6 14.9 3.4 2.2 6.3 0.6 0.3 0.2 0.1 0.0 0.3 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.7 0.5 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 3.2 0.0 0.0 0.0 0.1 0.1 0.0 1.2 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 13.2 0.7 0.1 0.0 1.4 0.0 1.4 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLAGL1 "LOT1, ZAC" ENSG00000118495 "PLAG1 like zinc finger 1" Q9UM63 6 143940300-144064599 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 95.0" "Cell line enhanced" "Detected in many" "AF22: 35.0;RH-30: 35.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055706 Supported "Nuclear bodies,Golgi apparatus,Vesicles" "Nuclear bodies" "Golgi apparatus, Vesicles" "HPA055706: " "unprognostic (4.74e-3)" "unprognostic (8.35e-3)" "unprognostic (5.43e-2)" "unprognostic (1.74e-3)" "unprognostic (5.09e-2)" "unprognostic (1.95e-1)" "unprognostic (9.32e-2)" "unprognostic (6.17e-2)" "unprognostic (3.49e-2)" "unprognostic (5.02e-2)" "unprognostic (1.78e-3)" "unprognostic (2.07e-1)" "prognostic unfavourable (4.94e-6)" "prognostic unfavourable (6.61e-4)" "unprognostic (4.69e-2)" "unprognostic (5.17e-3)" "unprognostic (4.93e-3)" 14.6 28.5 2.3 14.8 4.3 7.7 12.3 2.0 7.6 12.9 8.9 4.6 10.0 3.9 19.5 16.3 12.4 7.7 13.0 9.0 5.1 1.5 6.8 1.5 12.1 8.2 2.6 2.2 16.0 11.2 5.2 45.6 95.0 3.6 12.6 8.6 19.3 11.7 7.3 4.5 23.1 7.9 16.8 3.8 6.8 10.9 6.8 2.0 3.9 5.6 24.2 12.0 14.2 18.4 4.1 10.3 16.4 8.1 1.7 1.4 2.3 0.0 1.5 35.0 0.0 13.9 28.6 0.1 12.0 7.7 6.0 12.5 0.1 1.9 0.8 5.9 10.4 0.0 0.2 4.2 11.8 0.9 1.6 14.9 17.5 0.2 4.6 13.3 3.0 21.5 1.5 5.2 4.6 11.8 1.4 0.2 7.1 2.0 5.5 6.2 5.8 1.1 6.7 35.6 0.0 11.2 0.3 3.1 3.4 17.3 0.0 0.0 0.0 16.5 6.8 0.0 12.8 27.7 12.9 3.1 3.0 0.1 9.2 5.5 0.6 3.4 8.1 16.4 1.0 6.2 1.0 2.7 0.9 1.4 10.3 4.1 0.7 1.2 14.8 1.7 1.9 4.6 1.3 2.3 2.3 4.3 2.0 7.6 5.1 1.5 2.6 2.2 3.6 2.0 PLCG2 ENSG00000197943 "Phospholipase C gamma 2" P16885 16 81739097-81962693 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.8" "Cell line enhanced" "Detected in some" "Daudi: 39.6;HMC-1: 19.0;U-698: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004280, HPA020099, HPA020100" Enhanced Approved Vesicles 21000 Vesicles "CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325" "unprognostic (2.86e-2)" "unprognostic (1.34e-1)" "unprognostic (1.09e-3)" "unprognostic (1.10e-1)" "unprognostic (1.58e-1)" "prognostic favourable (6.71e-4)" "unprognostic (6.23e-2)" "unprognostic (5.01e-2)" "unprognostic (2.22e-1)" "unprognostic (4.58e-2)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" "prognostic favourable (4.88e-4)" "unprognostic (1.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-1)" "unprognostic (3.40e-3)" 8.4 3.8 3.3 55.8 4.9 14.1 10.7 1.0 2.4 5.6 10.3 5.3 3.1 8.7 11.2 12.2 6.0 4.7 10.1 4.4 3.3 2.8 20.6 8.8 10.7 35.5 5.2 1.8 2.0 3.6 1.0 1.8 4.1 4.5 4.3 3.6 4.6 8.8 2.8 2.0 4.1 17.6 4.6 8.6 33.6 4.2 2.3 4.2 6.3 5.3 2.6 44.6 7.5 7.7 18.8 3.9 26.8 12.2 14.0 1.1 2.3 0.3 0.7 0.1 0.6 0.0 0.0 0.9 0.0 0.0 0.5 0.2 0.2 1.7 39.6 6.8 0.0 0.9 0.8 0.1 0.3 0.3 0.4 4.7 0.0 0.0 0.2 4.7 19.0 0.0 0.4 0.3 0.2 0.9 0.5 3.3 0.0 1.2 0.5 11.9 0.7 0.2 16.1 0.0 5.0 0.1 0.8 0.3 0.0 1.1 0.3 0.3 0.7 14.6 0.2 0.0 0.7 0.1 0.1 7.9 12.9 87.9 0.0 6.5 0.3 2.8 4.4 26.8 0.7 5.7 0.3 18.8 0.2 1.1 3.9 17.3 0.3 0.8 24.8 14.0 12.2 2.6 0.1 2.3 3.3 4.9 1.0 2.4 3.3 2.8 5.2 1.8 4.5 4.2 PLCH1 "DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3" ENSG00000114805 "Phospholipase C eta 1" Q4KWH8 3 155375580-155745067 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7;testis: 15.8" "Cell line enhanced" "Detected in some" "A549: 8.2;AF22: 26.6;NTERA-2: 14.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036176, HPA057978" Uncertain Enhanced Vesicles Vesicles "HPA036176: AB_10671837, HPA057978: " "unprognostic (1.08e-2)" "unprognostic (3.68e-1)" "unprognostic (2.17e-2)" "unprognostic (1.55e-2)" "unprognostic (3.50e-4)" "unprognostic (6.41e-2)" "unprognostic (2.94e-5)" "unprognostic (5.04e-2)" "unprognostic (2.41e-1)" "unprognostic (2.24e-3)" "unprognostic (4.84e-2)" "unprognostic (1.76e-2)" "prognostic favourable (3.03e-5)" "unprognostic (3.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-2)" 0.3 0.3 3.9 0.7 14.1 0.5 3.9 7.4 14.7 2.1 3.9 5.7 4.1 3.9 1.4 12.9 0.5 12.4 2.4 2.5 4.5 3.6 2.1 0.4 6.1 0.3 3.4 7.3 0.5 2.5 0.8 3.2 0.8 6.5 0.8 3.9 5.6 2.3 3.4 0.6 0.5 3.9 0.5 1.9 0.3 5.8 15.8 2.9 0.0 8.9 0.0 0.4 1.3 0.4 0.1 0.3 0.7 0.0 0.0 1.2 0.9 0.0 8.2 26.6 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.5 6.6 0.0 0.5 0.0 0.0 4.7 0.0 0.0 0.0 2.4 6.6 0.0 0.9 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 1.5 6.1 14.1 1.1 0.6 0.0 0.0 1.6 0.1 2.5 0.6 0.0 6.4 0.0 2.8 0.0 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.9 3.9 14.1 7.4 14.7 4.5 3.6 3.4 7.3 6.5 2.9 PLD5 FLJ40773 ENSG00000180287 "Phospholipase D family member 5" Q8N7P1 1 242082986-242524696 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 54.8;retina: 37.7" "Cell line enhanced" "Detected in some" "A549: 3.9;AF22: 13.7;HDLM-2: 6.8;SH-SY5Y: 3.8;U-2 OS: 4.7" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Region enriched" "Detected in all" 4 "cerebellum: 54.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028389, HPA050367" Approved Vesicles,Mitochondria,Cytosol Mitochondria "Vesicles, Cytosol" "HPA028389: AB_10602145, HPA050367: " "unprognostic (5.20e-2)" "unprognostic (1.05e-1)" "unprognostic (9.14e-2)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (8.77e-2)" "unprognostic (4.36e-1)" "unprognostic (1.95e-1)" "unprognostic (2.08e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-5)" "unprognostic (2.79e-2)" "unprognostic (4.46e-1)" "unprognostic (3.44e-3)" "unprognostic (2.18e-1)" 1.1 5.4 5.0 0.4 3.7 0.4 1.6 54.8 7.6 2.2 0.8 7.7 0.0 0.4 3.5 0.9 1.6 1.8 0.8 0.8 4.4 4.6 1.5 0.5 0.8 3.3 5.4 2.5 6.6 3.1 1.4 7.2 1.5 12.7 2.7 0.6 37.7 2.2 9.3 0.8 0.6 0.5 2.9 6.0 2.2 0.8 4.2 6.2 0.0 1.0 0.0 1.5 0.4 1.0 0.4 0.2 1.0 0.2 0.3 0.4 0.0 0.0 3.9 13.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 6.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.5 2.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.2 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.4 0.3 0.4 1.0 0.3 0.2 0.2 0.2 0.0 5.0 3.7 54.8 5.5 4.4 4.6 5.4 2.5 12.7 6.2 PLEK2 ENSG00000100558 "Pleckstrin 2" Q9NYT0 14 67386983-67412200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 26.4;CAPAN-2: 28.2;HBEC3-KT: 52.6;PC-3: 19.2;TIME: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.0;naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in single" 8 "T-cells: 6.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA001208 Enhanced Uncertain Vesicles,Cytosol Vesicles Cytosol "HPA001208: AB_1079631" "unprognostic (4.41e-3)" "unprognostic (3.77e-1)" "unprognostic (1.15e-1)" "unprognostic (6.23e-2)" "unprognostic (6.88e-2)" "unprognostic (3.17e-3)" "unprognostic (1.18e-2)" "prognostic unfavourable (1.58e-4)" "unprognostic (1.97e-1)" "unprognostic (9.21e-3)" "prognostic unfavourable (8.26e-5)" "unprognostic (1.06e-1)" "unprognostic (3.09e-3)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (8.98e-2)" "unprognostic (4.59e-2)" 1.7 28.8 0.5 7.6 1.1 4.1 1.5 0.5 0.8 2.4 14.9 1.4 1.6 12.4 1.1 14.9 9.7 0.4 7.4 0.5 0.5 0.2 6.0 29.1 1.9 0.5 0.5 0.5 1.0 16.5 2.5 0.9 2.6 0.7 5.1 12.7 0.9 6.9 2.3 1.4 12.1 28.1 1.2 0.7 0.6 8.5 2.4 0.5 13.9 28.6 6.5 6.5 4.8 4.4 0.0 0.8 0.0 0.1 0.0 6.5 1.2 26.4 4.0 0.0 0.0 0.0 0.3 2.6 5.3 0.8 1.2 1.5 14.4 28.2 0.0 5.2 0.7 12.6 0.0 52.6 3.0 0.0 0.2 0.0 6.1 0.1 1.1 0.0 0.0 0.6 3.8 1.4 16.9 4.4 0.1 0.1 0.9 8.4 0.0 0.0 0.1 19.2 0.0 0.0 4.1 9.0 0.7 0.2 0.0 5.0 2.3 1.5 3.5 0.2 20.5 0.0 16.5 0.1 0.1 0.0 0.0 0.1 3.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.7 0.8 0.0 6.5 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.5 1.1 0.5 0.8 0.5 0.2 0.5 0.5 0.7 0.5 PLEKHA6 "KIAA0969, PEPP3" ENSG00000143850 "Pleckstrin homology domain containing A6" Q9Y2H5 1 204218851-204377665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.1" "Cell line enhanced" "Detected in many" "A-431: 20.6;BEWO: 33.5;CAPAN-2: 28.0;RT4: 23.2;SK-BR-3: 20.7;T-47d: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028152 Enhanced Approved "Vesicles,Cell Junctions" "Cell Junctions" Vesicles "HPA028152: AB_10601048" "unprognostic (9.81e-3)" "unprognostic (3.05e-1)" "unprognostic (1.59e-2)" "unprognostic (3.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (1.38e-2)" "unprognostic (9.01e-2)" "unprognostic (3.32e-1)" "unprognostic (9.60e-3)" "unprognostic (1.53e-1)" "unprognostic (5.02e-3)" "unprognostic (1.23e-1)" "unprognostic (8.22e-2)" "unprognostic (5.17e-2)" "prognostic favourable (3.57e-4)" 2.4 4.6 18.2 4.1 27.8 0.4 10.6 60.1 34.5 3.4 23.2 13.4 1.4 18.2 2.6 10.0 13.0 7.4 9.8 11.8 14.2 11.4 20.9 13.9 2.4 0.6 11.5 23.3 2.8 7.6 3.7 17.6 6.3 18.9 9.4 21.9 21.7 5.2 11.2 2.6 2.0 20.8 4.8 19.0 1.9 29.1 2.7 14.2 0.0 2.2 1.3 1.9 7.3 6.1 0.9 1.4 0.1 0.2 0.0 0.4 0.0 20.6 13.0 8.2 0.0 0.1 0.2 33.5 0.7 2.3 0.0 0.1 6.2 28.0 0.1 6.2 0.4 2.3 0.1 2.2 0.1 0.0 1.3 0.0 5.1 8.8 1.2 0.0 0.0 0.3 6.9 0.0 1.8 3.7 0.0 0.0 8.5 9.2 0.0 0.0 2.6 15.9 0.0 0.0 0.0 8.3 23.2 1.7 17.2 9.4 20.7 0.1 19.7 0.1 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 18.2 27.8 60.1 34.5 14.2 11.4 11.5 23.3 18.9 14.2 PLEKHM1 KIAA0356 ENSG00000225190 "Pleckstrin homology and RUN domain containing M1" Q9Y4G2 17 45435900-45490749 "Disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025018, HPA039473" Approved Supported Nucleoli,Vesicles Vesicles Nucleoli "HPA025018: AB_1855465, HPA039473: " "unprognostic (1.52e-1)" "unprognostic (3.13e-2)" "unprognostic (4.29e-2)" "prognostic favourable (1.28e-6)" "unprognostic (8.71e-2)" "unprognostic (3.06e-2)" "prognostic unfavourable (3.25e-4)" "unprognostic (2.20e-2)" "unprognostic (1.88e-1)" "unprognostic (2.93e-2)" "unprognostic (4.02e-1)" "unprognostic (3.93e-2)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.60e-1)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" 8.0 3.6 2.5 3.6 4.5 10.9 5.3 7.6 5.6 6.1 4.1 2.6 0.9 2.2 2.9 2.0 17.2 3.7 3.8 3.9 4.2 1.7 1.7 3.1 4.5 7.3 10.5 2.9 2.5 4.2 3.5 3.6 2.8 4.7 2.6 3.0 3.4 7.6 2.7 6.3 5.8 3.4 2.5 5.3 4.5 3.0 2.4 3.4 6.7 3.8 6.5 10.4 5.2 6.7 2.4 1.3 9.8 1.4 1.3 1.4 0.9 5.8 8.5 1.5 2.8 6.0 2.9 5.3 1.7 3.9 3.0 3.1 2.6 3.2 3.0 5.1 5.6 1.5 3.5 2.1 0.9 11.8 4.1 0.0 3.1 3.5 6.3 0.0 4.4 11.3 6.7 4.8 7.9 9.0 2.9 3.5 4.7 3.6 5.8 1.1 0.9 6.0 2.6 3.1 2.7 4.4 9.0 2.6 2.4 3.0 2.3 3.2 5.2 2.5 10.3 7.3 2.7 5.5 3.0 3.6 3.8 1.2 4.1 1.5 3.0 3.8 1.4 1.3 1.4 1.0 0.8 2.4 1.0 1.1 1.3 1.0 0.7 0.6 9.8 1.3 1.3 1.0 1.2 0.9 2.5 4.5 7.6 5.6 4.2 1.7 10.5 2.9 4.7 3.4 PLEKHM3 "DAPR, PLEKHM1L" ENSG00000178385 "Pleckstrin homology domain containing M3" Q6ZWE6 2 207821288-208025560 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035046 Uncertain Approved Vesicles,Cytosol Cytosol Vesicles "HPA035046: AB_10603128" "unprognostic (3.62e-1)" "unprognostic (1.58e-2)" "unprognostic (8.27e-2)" "unprognostic (3.18e-2)" "unprognostic (5.66e-2)" "unprognostic (4.77e-2)" "unprognostic (6.06e-2)" "unprognostic (8.20e-2)" "unprognostic (4.13e-2)" "unprognostic (2.92e-3)" "unprognostic (2.17e-1)" "unprognostic (1.09e-1)" "unprognostic (4.86e-4)" "unprognostic (2.42e-1)" "unprognostic (3.12e-1)" "unprognostic (5.72e-2)" "unprognostic (1.33e-2)" 6.5 10.9 10.0 4.1 11.2 11.1 5.1 11.8 16.8 5.6 5.0 10.6 2.1 3.3 6.2 3.4 4.2 4.5 4.5 6.6 7.3 7.8 5.1 6.8 6.2 4.3 6.2 11.4 9.1 4.8 17.3 7.2 4.6 13.1 6.4 4.9 6.5 5.4 4.8 5.1 5.2 3.9 5.9 8.6 4.9 4.6 5.3 7.5 4.1 10.6 2.3 4.5 4.8 5.4 2.3 1.9 6.7 2.1 2.0 2.7 0.6 1.5 1.3 3.4 1.9 5.6 5.7 5.1 3.1 3.3 2.5 2.3 1.7 1.3 1.3 3.1 3.5 1.6 3.4 4.4 3.3 2.4 5.3 2.6 4.2 2.7 3.4 2.8 1.5 4.8 5.5 2.8 3.3 2.6 1.6 3.6 3.1 0.8 3.4 1.9 3.3 1.6 2.7 2.9 2.7 1.3 1.7 7.2 3.8 2.8 0.3 3.0 0.9 2.3 3.7 3.9 2.4 2.4 2.0 4.0 4.7 1.3 4.5 1.7 2.9 3.0 2.1 0.9 2.5 0.8 1.0 2.3 2.3 2.2 1.9 1.7 2.7 2.3 6.7 2.0 1.7 1.9 1.3 0.6 10.0 11.2 11.8 16.8 7.3 7.8 6.2 11.4 13.1 7.5 PLEKHS1 "bA211N11.2, C10orf81, FLJ23537" ENSG00000148735 "Pleckstrin homology domain containing S1" Q5SXH7 10 113751454-113783429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 26.8;intestine: 38.8;pancreas: 26.6;salivary gland: 53.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.1;RH-30: 4.3;RT4: 16.9;T-47d: 5.8;U-266/70: 3.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037583 Approved Vesicles,Centrosome Centrosome Vesicles "HPA037583: AB_10671762" "unprognostic (2.64e-1)" "unprognostic (1.64e-2)" "unprognostic (2.74e-2)" "unprognostic (3.60e-2)" "unprognostic (1.07e-1)" "unprognostic (2.63e-2)" "unprognostic (1.74e-2)" "unprognostic (2.36e-2)" "unprognostic (8.43e-2)" "unprognostic (6.82e-2)" "unprognostic (2.57e-1)" "unprognostic (1.21e-2)" "unprognostic (0.00e+0)" "unprognostic (4.00e-3)" "unprognostic (2.19e-1)" "unprognostic (2.27e-1)" "prognostic favourable (1.03e-4)" 0.2 0.1 0.2 1.6 0.2 0.0 11.7 0.2 0.2 26.8 18.5 0.2 10.2 17.0 1.0 2.2 0.8 3.4 6.4 0.2 0.2 0.1 0.6 0.2 4.8 0.2 0.2 0.2 1.3 26.6 0.0 1.9 0.3 0.3 3.5 1.8 0.4 53.1 4.9 0.2 0.7 38.8 0.2 0.2 0.2 2.9 1.1 0.2 0.2 0.2 1.3 2.0 0.8 0.2 0.8 0.5 1.3 0.3 0.7 0.3 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.2 0.1 0.3 0.1 0.3 0.2 9.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.1 4.3 0.1 1.4 16.9 0.1 0.2 0.1 1.4 0.1 5.8 0.0 0.0 0.3 0.1 0.0 0.3 3.4 0.1 0.0 0.0 0.0 2.0 0.8 0.1 0.2 0.3 0.1 0.1 0.8 0.2 0.2 0.0 0.5 0.2 0.3 1.3 0.7 0.3 0.5 0.1 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.3 0.2 PLIN4 "KIAA1881, S3-12" ENSG00000167676 "Perilipin 4" Q96Q06 19 4502180-4518465 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2" "Cell line enriched" "Detected in some" 9 "ASC diff: 75.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enhanced" "Detected in single" "granulocytes: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044682, HPA054657" Enhanced Supported "Vesicles,Lipid droplets,Plasma membrane,Cytosol" 11000 "Lipid droplets, Plasma membrane" "Vesicles, Cytosol" "HPA044682: AB_2679044, HPA054657: AB_2682559" "unprognostic (2.97e-2)" "unprognostic (1.15e-2)" "prognostic unfavourable (8.31e-4)" "prognostic unfavourable (2.31e-4)" "unprognostic (6.65e-2)" "unprognostic (6.77e-2)" "unprognostic (1.03e-1)" "unprognostic (5.23e-2)" "unprognostic (9.89e-3)" "unprognostic (1.05e-1)" "unprognostic (2.95e-2)" "unprognostic (1.81e-1)" "unprognostic (1.90e-1)" "unprognostic (6.09e-3)" "unprognostic (3.10e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" 155.0 1.2 0.9 7.4 0.8 0.8 80.6 0.5 0.9 2.4 8.5 0.6 2.4 0.8 3.7 2.2 3.8 2.5 8.3 15.5 0.6 0.1 0.6 11.1 0.4 2.0 0.8 0.8 2.9 3.3 0.3 0.2 0.3 0.9 2.8 1.2 0.7 6.8 3.9 45.2 1.8 2.4 10.3 1.3 0.4 3.5 0.7 0.8 0.1 0.7 8.2 0.7 5.9 3.9 0.0 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 75.1 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.4 1.1 0.0 0.0 2.4 1.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 8.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.1 0.0 0.9 0.8 0.5 0.9 0.6 0.1 0.8 0.8 0.9 0.8 PLIN5 "LSDA5, LSDP5, MLDP, OXPAT" ENSG00000214456 "Perilipin 5" Q00G26 19 4522531-4535224 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 44.6;salivary gland: 40.3;skeletal muscle: 40.8" "Cell line enhanced" "Detected in some" "BEWO: 5.5;RT4: 5.0;SH-SY5Y: 4.7;T-47d: 10.4" "Cancer enhanced" "Detected in many" "liver cancer: 9.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "neutrophil: 14.7" "Lineage enriched" "Detected in single" 18 "granulocytes: 14.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA077050 Supported "Vesicles,Lipid droplets" "Vesicles, Lipid droplets" "HPA077050: " "prognostic favourable (7.68e-4)" "unprognostic (1.01e-1)" "unprognostic (4.22e-2)" "prognostic unfavourable (8.56e-4)" "unprognostic (1.24e-2)" "unprognostic (6.06e-3)" "prognostic favourable (2.81e-4)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (1.05e-1)" "unprognostic (1.63e-1)" "unprognostic (1.54e-1)" "prognostic favourable (1.97e-4)" "unprognostic (3.18e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "prognostic favourable (2.16e-4)" 20.9 1.7 8.0 2.9 5.2 3.9 6.5 4.2 5.8 1.8 3.3 2.0 10.5 1.6 1.6 5.5 1.9 3.1 1.9 12.0 7.8 1.4 5.8 44.6 2.8 1.5 3.4 2.6 25.8 30.1 0.5 6.2 0.6 3.7 4.5 0.9 3.4 40.3 4.6 40.8 1.7 1.3 1.5 1.7 1.8 11.5 1.4 4.2 0.0 2.2 6.0 1.1 3.7 5.7 0.6 0.4 14.7 0.5 0.8 0.4 0.1 0.5 0.3 1.1 3.8 2.8 0.1 5.5 0.2 0.2 0.2 0.1 0.4 1.0 0.3 1.2 0.2 0.4 0.0 0.0 0.0 0.5 0.4 0.3 1.4 1.7 0.6 0.4 0.9 0.7 0.0 0.0 0.1 0.3 1.2 0.5 0.3 0.9 0.3 0.9 0.7 0.5 0.3 0.2 3.4 0.3 5.0 0.7 4.7 0.5 0.8 0.0 10.4 0.7 1.0 0.6 0.5 0.5 0.3 0.6 0.2 0.2 0.5 1.1 0.2 1.5 0.5 0.8 0.3 0.4 0.2 0.3 0.2 0.2 0.1 0.6 0.3 0.4 14.7 0.8 0.3 0.4 0.2 0.1 8.0 5.2 4.2 5.8 7.8 1.4 3.4 2.6 3.7 4.2 PLOD1 "LH1, LLH, PLOD" ENSG00000083444 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1" Q02809 1 11934205-11975538 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049137, HPA055799" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" 2700000 Vesicles Nucleoplasm "HPA049137: AB_2680649, HPA055799: AB_2682924" "unprognostic (1.00e-1)" "unprognostic (2.69e-3)" "unprognostic (9.21e-3)" "unprognostic (5.43e-2)" "unprognostic (7.53e-3)" "unprognostic (1.12e-2)" "prognostic unfavourable (2.79e-4)" "unprognostic (1.13e-3)" "unprognostic (1.23e-1)" "unprognostic (1.79e-1)" "unprognostic (4.15e-3)" "unprognostic (2.32e-1)" "prognostic unfavourable (1.91e-12)" "unprognostic (2.79e-1)" "unprognostic (7.12e-2)" "unprognostic (5.92e-2)" "prognostic unfavourable (2.43e-4)" 29.0 19.5 14.9 16.8 24.0 7.1 32.1 12.1 17.6 35.8 21.7 17.0 17.7 19.1 34.2 21.1 16.5 24.7 21.3 31.2 17.6 14.8 27.5 51.3 22.2 19.7 24.5 9.9 31.8 30.3 18.2 16.3 41.5 20.8 21.1 12.0 25.1 39.3 22.0 18.3 13.3 20.8 39.0 13.2 21.1 18.6 10.0 22.4 1.7 34.8 11.1 8.2 19.5 69.7 1.6 16.3 17.7 19.4 2.6 9.1 9.3 17.6 15.1 8.3 38.9 56.9 31.9 6.7 52.5 69.7 27.7 47.1 17.2 11.6 10.2 55.5 57.9 14.9 12.1 18.3 19.1 10.6 12.9 5.5 24.3 21.8 35.3 3.4 26.8 38.7 9.6 33.4 13.4 49.0 15.4 5.0 28.8 11.4 0.8 9.2 3.7 22.5 4.1 16.9 22.1 15.9 4.0 3.2 13.2 22.9 15.7 26.4 7.9 8.8 48.4 31.7 23.8 39.6 25.7 11.7 19.1 6.1 70.2 12.1 51.6 0.0 19.4 0.9 9.1 17.2 1.6 1.0 1.6 4.4 16.3 1.6 0.6 3.4 17.7 2.6 15.0 2.4 1.0 9.3 14.9 24.0 12.1 17.6 17.6 14.8 24.5 9.9 20.8 22.4 PLPP5 "DPPL1, HTPAP, PPAPDC1B" ENSG00000147535 "Phospholipid phosphatase 5" Q8NEB5 8 38263130-38269243 "Enzymes, Predicted membrane proteins" Hydrolase "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 77.8" "Cell line enhanced" "Detected in many" "RPMI-8226: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "memory B-cell: 37.2;naive B-cell: 65.4" "Lineage enriched" "Detected in all" 5 "B-cells: 65.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055777 Approved Vesicles Vesicles "HPA055777: " "unprognostic (4.54e-2)" "unprognostic (2.51e-3)" "unprognostic (3.66e-2)" "prognostic favourable (1.48e-5)" "unprognostic (1.80e-2)" "unprognostic (1.27e-2)" "unprognostic (5.58e-2)" "prognostic favourable (8.72e-5)" "unprognostic (9.79e-2)" "prognostic favourable (2.42e-5)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "prognostic unfavourable (8.33e-10)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (1.57e-2)" 5.5 9.3 6.9 11.9 7.9 4.8 8.8 7.5 6.7 11.2 11.5 3.9 33.9 14.4 5.7 30.9 6.6 10.2 21.0 4.6 6.1 6.1 9.6 20.3 7.5 12.0 4.5 5.1 8.4 77.8 4.2 29.9 8.3 6.7 27.9 12.8 16.2 52.0 36.5 2.3 4.7 18.4 5.2 3.5 12.8 16.1 4.6 4.4 3.8 11.9 5.0 14.8 8.0 6.7 65.4 5.3 13.3 3.6 4.3 5.0 3.7 5.4 10.9 6.5 13.3 12.8 12.5 9.0 15.6 19.7 8.0 10.5 5.0 8.4 0.4 13.3 16.1 6.1 5.4 11.4 6.9 3.4 3.5 9.6 4.6 14.6 21.8 2.8 11.7 9.8 11.9 11.1 14.6 12.9 0.4 25.2 9.7 11.3 6.3 4.7 9.9 3.7 6.9 4.8 50.8 20.0 7.1 5.2 7.9 6.4 9.9 9.1 21.3 5.4 7.7 5.7 5.0 9.5 4.1 15.7 10.2 1.6 15.6 7.4 9.7 13.3 2.7 4.5 3.0 2.7 5.0 37.2 3.9 3.8 2.5 65.4 2.0 1.9 1.6 4.3 3.6 5.3 3.4 3.7 6.9 7.9 7.5 6.7 6.1 6.1 4.5 5.1 6.7 4.4 PLPP6 "FLJ46512, FLJ90191, PDP1, PPAPDC2" ENSG00000205808 "Phospholipid phosphatase 6" Q8IY26 9 4662315-4665258 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HDLM-2: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018096 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA018096: AB_1855609" "unprognostic (2.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.03e-1)" "unprognostic (4.36e-3)" "unprognostic (1.17e-1)" "unprognostic (4.38e-2)" "unprognostic (6.95e-3)" "unprognostic (1.33e-1)" "unprognostic (5.26e-2)" "unprognostic (9.06e-2)" "unprognostic (2.20e-2)" "unprognostic (1.45e-1)" "prognostic favourable (3.99e-4)" "unprognostic (2.56e-1)" "unprognostic (2.28e-2)" "unprognostic (2.87e-2)" "unprognostic (5.88e-2)" 4.0 8.3 4.4 7.2 6.8 1.1 7.3 11.9 9.7 5.7 9.4 6.2 4.2 10.2 4.9 13.2 9.2 4.1 9.7 3.0 4.9 4.8 6.3 20.0 4.7 8.3 8.6 6.3 4.2 19.2 8.7 5.5 13.1 9.4 16.9 10.0 4.7 10.4 8.5 2.2 8.6 15.4 3.3 4.9 7.1 10.7 8.4 3.4 16.2 7.2 6.9 9.6 7.4 5.5 4.3 5.1 8.5 5.1 4.7 13.0 5.1 3.8 4.0 4.3 5.3 3.5 3.9 4.3 2.6 3.4 2.1 2.5 1.0 2.6 3.7 1.1 2.6 4.8 3.0 3.7 2.3 46.6 2.8 7.4 3.8 5.3 3.1 2.7 5.6 4.3 3.0 1.6 3.7 3.2 1.2 3.9 2.7 4.1 2.5 7.0 4.0 1.4 2.5 0.0 2.8 3.7 4.4 10.9 5.5 3.1 2.8 1.6 4.0 6.0 3.7 1.9 1.6 2.6 1.7 0.8 2.9 0.9 3.0 1.9 1.7 8.5 5.1 4.1 4.2 4.4 4.6 3.5 7.4 6.3 5.1 4.3 13.0 9.2 2.1 4.7 4.9 3.9 10.0 5.1 4.4 6.8 11.9 9.7 4.9 4.8 8.6 6.3 9.4 3.4 PLPP7 "C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3" ENSG00000160539 "Phospholipid phosphatase 7 (inactive)" Q8NBV4 9 131289459-131359022 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 29.0;skeletal muscle: 107.3" "Cell line enhanced" "Detected in some" "AN3-CA: 10.7;ASC diff: 11.3;ASC TERT1: 8.7;SCLC-21H: 11.1;SH-SY5Y: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070252 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA070252: " "unprognostic (2.19e-1)" "unprognostic (3.07e-1)" "unprognostic (3.07e-2)" "unprognostic (2.71e-1)" "unprognostic (8.78e-2)" "unprognostic (7.03e-2)" "unprognostic (1.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.65e-1)" "unprognostic (3.96e-3)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (3.69e-2)" "unprognostic (1.10e-2)" "unprognostic (7.85e-2)" "unprognostic (9.72e-3)" 3.6 3.7 3.3 1.7 4.6 1.2 2.8 7.7 8.2 2.3 3.2 4.6 0.0 1.5 2.5 3.1 2.5 2.0 2.3 29.0 3.6 3.9 1.9 1.1 1.5 1.3 3.7 4.2 3.9 1.8 1.1 1.7 1.4 3.7 2.6 1.3 2.0 1.6 2.6 107.3 1.3 1.6 2.9 3.2 1.7 1.4 2.2 3.2 0.0 1.2 22.6 1.2 2.1 1.6 1.3 4.6 0.0 5.2 2.3 0.5 1.9 0.0 0.0 2.2 10.7 11.3 8.7 2.2 1.6 1.1 0.3 0.0 0.0 0.0 0.0 0.3 4.3 0.0 0.2 0.0 0.1 0.0 1.9 0.0 0.1 3.4 2.8 0.0 0.0 2.9 0.0 3.1 0.0 0.0 0.2 0.0 5.1 0.1 0.0 0.1 2.5 0.0 0.0 0.0 0.0 2.4 0.0 11.1 8.5 0.0 0.1 0.0 0.3 2.7 0.1 0.1 0.8 0.5 0.0 0.0 0.4 0.0 1.8 0.0 1.7 0.0 5.2 0.0 0.0 3.3 0.0 1.0 0.0 0.0 4.6 1.3 0.4 0.5 0.0 2.3 2.8 2.0 0.0 1.9 3.3 4.6 7.7 8.2 3.6 3.9 3.7 4.2 3.7 3.2 PLXNA3 "6.3, Plxn3, PLXN4, SEX, XAP-6" ENSG00000130827 "Plexin A3" P51805 X 154458281-154477779 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058989 Approved "Nucleoplasm,Vesicles,Plasma membrane" 58000 "Vesicles, Plasma membrane" Nucleoplasm "HPA058989: " "unprognostic (2.79e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-3)" "unprognostic (8.04e-3)" "unprognostic (1.63e-1)" "unprognostic (9.05e-3)" "unprognostic (1.06e-2)" "unprognostic (2.25e-1)" "unprognostic (2.42e-1)" "unprognostic (6.26e-2)" "unprognostic (1.05e-1)" "unprognostic (4.10e-2)" "unprognostic (1.38e-3)" "unprognostic (2.30e-1)" "unprognostic (3.00e-1)" "unprognostic (4.33e-2)" "unprognostic (5.73e-2)" 6.9 7.6 9.8 6.6 9.3 3.5 13.3 25.9 7.4 8.1 6.2 13.8 7.3 7.2 8.6 9.2 5.3 8.3 7.9 6.6 10.5 8.0 5.1 2.5 7.2 7.1 8.7 3.6 16.4 9.9 5.1 35.2 7.4 8.2 9.2 4.8 6.1 13.8 7.5 2.9 19.5 7.2 8.2 8.4 7.0 10.0 5.8 9.8 4.6 9.3 1.8 7.2 6.3 16.4 1.8 0.5 2.7 0.5 2.1 1.0 0.3 8.1 1.6 4.8 12.2 5.1 6.5 6.5 11.7 2.5 2.7 3.8 6.1 3.5 1.5 6.3 12.5 7.2 4.9 5.7 1.0 0.7 3.6 1.5 19.1 3.3 4.0 0.7 6.8 8.8 4.2 4.1 0.3 3.1 3.8 1.3 4.3 10.1 1.4 6.2 1.5 3.7 5.3 0.4 0.5 3.7 5.4 10.2 5.3 4.3 7.8 1.9 4.7 1.7 7.7 6.0 5.5 0.6 4.9 0.9 0.1 2.1 11.2 1.1 1.6 2.7 0.5 0.8 0.8 0.4 0.6 1.8 1.0 0.8 0.1 1.2 0.6 0.8 1.4 2.1 0.3 0.5 0.7 0.3 9.8 9.3 25.9 7.4 10.5 8.0 8.7 3.6 8.2 9.8 PMAIP1 "APR, NOXA" ENSG00000141682 "Phorbol-12-myristate-13-acetate-induced protein 1" Q13794 18 59899948-59904306 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.3;bone marrow: 45.5" "Cell line enhanced" "Detected in many" "U-138 MG: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "basophil: 42.3" "Low lineage specificity" "Detected in all" HPA051063 Uncertain Approved Vesicles Vesicles "HPA051063: " "unprognostic (1.35e-3)" "unprognostic (5.02e-2)" "unprognostic (5.57e-2)" "unprognostic (4.88e-2)" "unprognostic (6.65e-3)" "unprognostic (3.76e-2)" "unprognostic (2.00e-3)" "unprognostic (1.26e-2)" "unprognostic (4.41e-2)" "unprognostic (6.12e-2)" "unprognostic (8.47e-3)" "unprognostic (5.56e-2)" "prognostic unfavourable (3.15e-6)" "unprognostic (2.53e-1)" "unprognostic (7.68e-2)" "unprognostic (8.74e-2)" "unprognostic (1.09e-1)" 1.9 0.4 2.2 9.4 2.4 45.5 3.1 0.9 2.5 6.0 2.8 1.6 0.1 2.2 3.3 1.7 12.4 1.7 4.8 1.3 3.3 2.3 1.3 1.3 10.9 7.8 2.6 0.8 1.6 1.3 5.6 27.3 14.7 3.3 3.0 2.0 0.6 3.9 0.8 1.8 20.2 6.4 1.1 2.3 7.6 1.7 1.7 0.8 12.7 1.3 11.7 18.7 7.3 6.8 10.6 3.7 42.3 9.2 1.9 7.4 4.1 6.4 4.3 1.3 0.4 2.2 18.0 5.0 31.2 21.2 18.3 18.3 0.4 8.1 25.6 4.3 5.8 9.7 5.2 2.9 18.0 8.2 38.7 4.7 6.5 1.1 22.7 16.1 7.2 7.4 7.8 23.9 12.5 6.0 6.3 4.4 6.0 0.6 12.9 4.8 38.3 8.1 13.2 7.3 9.3 10.5 6.0 10.1 8.3 1.5 0.8 17.3 1.3 13.3 22.5 51.9 13.8 2.6 34.6 0.7 0.0 22.4 4.3 9.2 12.1 42.3 5.1 30.5 3.5 7.8 3.1 10.6 1.6 2.2 3.7 7.8 1.4 1.9 16.3 1.9 9.2 3.0 7.4 4.1 2.2 2.4 0.9 2.5 3.3 2.3 2.6 0.8 3.3 0.8 PMEPA1 "STAG1, TMEPAI" ENSG00000124225 "Prostate transmembrane protein, androgen induced 1" Q969W9 20 57648392-57711536 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Signal transduction inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 60.4;prostate: 67.3" "Cell line enhanced" "Detected in many" "SiHa: 39.5;U-2 OS: 25.8;U-251 MG: 90.8;WM-115: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "naive B-cell: 5.2;plasmacytoid DC: 18.4" "Group enriched" "Detected in many" 7 "B-cells: 5.2;dendritic cells: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072291 Supported Vesicles "Intracellular and membrane" Vesicles "HPA072291: " "unprognostic (2.72e-3)" "prognostic unfavourable (2.45e-4)" "unprognostic (5.77e-2)" "unprognostic (1.73e-1)" "unprognostic (6.61e-2)" "unprognostic (2.11e-3)" "unprognostic (3.13e-2)" "prognostic unfavourable (4.73e-5)" "unprognostic (5.53e-1)" "unprognostic (1.32e-3)" "unprognostic (7.83e-3)" "unprognostic (2.02e-1)" "prognostic unfavourable (2.87e-7)" "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (9.87e-3)" "prognostic unfavourable (7.60e-4)" 27.0 7.8 7.5 10.6 34.8 1.3 9.5 2.6 12.6 60.4 10.8 11.0 4.2 4.4 22.1 6.7 7.1 7.7 21.8 10.7 7.5 8.6 5.3 1.7 8.5 4.5 10.2 5.9 6.2 18.6 2.6 5.6 3.0 12.1 67.3 5.7 21.3 11.6 13.3 17.4 6.8 7.6 17.6 8.1 4.0 5.3 3.2 9.1 1.3 5.4 6.0 6.2 8.4 13.0 5.2 18.4 0.1 0.3 0.0 1.6 0.4 5.9 14.5 0.4 0.7 0.4 0.0 0.1 0.9 0.0 0.3 0.1 0.2 18.8 0.0 3.5 1.4 23.0 0.3 19.4 0.2 0.1 0.7 0.0 4.0 0.0 0.3 0.0 0.1 0.2 10.9 0.8 2.4 2.5 0.1 0.2 1.2 12.3 0.7 0.1 1.8 1.8 0.0 7.0 2.1 4.7 0.0 3.4 2.7 39.5 23.5 2.7 3.6 0.7 6.3 3.5 25.8 0.3 90.8 1.1 0.1 0.0 1.6 0.2 45.8 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.6 0.2 0.0 5.2 1.6 0.9 0.1 0.0 0.0 18.4 0.4 0.4 7.5 34.8 2.6 12.6 7.5 8.6 10.2 5.9 12.1 9.1 PMF1 ENSG00000160783 "Polyamine modulated factor 1" Q6P1K2 1 156212993-156240042 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA034583, HPA071854" Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA034583: , HPA071854: " "unprognostic (1.17e-2)" "unprognostic (3.76e-3)" "unprognostic (2.58e-2)" "unprognostic (5.67e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (6.44e-2)" "unprognostic (1.32e-1)" "unprognostic (3.13e-1)" "unprognostic (1.26e-2)" "unprognostic (1.41e-2)" "unprognostic (9.29e-2)" "unprognostic (5.22e-2)" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "unprognostic (1.62e-2)" 20.6 21.7 18.2 19.8 20.4 40.8 23.3 24.3 23.7 27.4 20.3 26.1 25.2 20.1 25.2 27.5 26.4 20.4 24.4 37.9 16.4 15.5 38.0 32.4 21.3 30.5 23.9 17.4 25.1 28.0 23.6 22.8 35.5 17.1 25.5 18.0 27.6 26.8 20.5 65.7 28.9 20.1 20.9 21.3 29.9 22.8 13.4 22.4 23.6 30.5 48.3 29.5 21.6 22.7 22.8 41.1 26.2 36.5 19.9 31.1 29.0 21.1 26.2 28.2 21.3 5.3 11.1 22.0 11.0 15.7 29.9 24.8 32.1 30.6 19.5 24.0 14.1 14.2 28.3 18.4 15.4 13.9 33.7 14.5 20.0 28.6 11.1 20.3 20.1 10.0 18.6 13.4 14.2 22.5 21.5 22.7 14.4 43.2 21.2 26.3 49.1 23.3 23.4 15.1 38.6 31.2 16.0 25.8 32.6 18.3 21.1 14.3 34.3 25.0 12.9 13.0 16.6 14.4 21.6 17.0 17.5 38.3 10.4 19.7 17.9 7.9 36.5 16.4 20.2 25.2 18.1 22.8 19.9 18.8 30.0 21.6 19.4 19.5 26.2 19.9 22.1 41.1 31.1 29.0 18.2 20.4 24.3 23.7 16.4 15.5 23.9 17.4 17.1 22.4 PMF1-BGLAP ENSG00000260238 "PMF1-BGLAP readthrough" 1 156212982-156243332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA034583, HPA071854" Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA034583: , HPA071854: " "unprognostic (8.15e-2)" "unprognostic (1.80e-1)" "unprognostic (8.56e-4)" "unprognostic (1.65e-2)" "unprognostic (4.01e-2)" "unprognostic (1.99e-1)" "prognostic unfavourable (1.50e-4)" "unprognostic (4.66e-2)" "unprognostic (1.28e-1)" "unprognostic (8.52e-3)" "unprognostic (1.85e-4)" "unprognostic (2.39e-1)" "prognostic unfavourable (3.22e-4)" "unprognostic (1.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.31e-3)" "unprognostic (2.36e-1)" 9.8 15.7 16.2 10.3 16.2 12.1 7.8 18.1 14.6 14.6 13.0 13.9 13.4 8.6 13.1 16.3 11.7 15.0 12.9 24.6 14.1 14.2 20.6 17.4 11.0 16.4 12.6 9.0 15.6 15.0 10.4 16.2 19.2 8.8 15.7 7.0 14.8 21.5 13.2 31.8 10.7 10.5 10.9 11.2 14.0 9.5 7.4 11.8 12.5 16.4 26.4 15.8 9.8 11.1 9.8 7.1 10.2 8.9 5.1 10.7 8.1 6.9 7.2 9.5 6.5 2.6 6.7 4.2 6.3 4.1 6.2 5.1 5.4 6.5 6.1 10.6 5.6 4.8 8.9 8.1 3.2 10.5 15.0 4.2 7.0 9.9 12.2 4.1 7.6 8.2 7.6 5.7 5.0 5.9 4.1 9.9 4.4 8.5 3.7 8.9 19.6 13.2 7.0 3.8 9.0 4.8 3.4 6.6 8.4 4.1 1.7 10.9 9.7 16.7 6.4 3.1 3.1 3.9 5.7 6.0 7.2 9.3 4.4 5.5 6.1 3.6 8.9 4.4 4.9 5.8 4.8 4.8 7.7 7.1 6.6 9.8 10.7 6.0 10.2 5.1 6.1 7.1 8.4 8.1 16.2 16.2 18.1 12.8 14.1 14.2 12.6 9.0 8.8 11.8 PODXL "Gp200, PC, PCLP" ENSG00000128567 "Podocalyxin like" O00592 7 131500262-131558217 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 36.0;NTERA-2: 48.7;TIME: 54.4;U-251 MG: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220" Enhanced Approved "Vesicles,Plasma membrane,Centriolar satellite" 43000000 "Plasma membrane, Centriolar satellite" Vesicles "CAB016169: AB_628165, CAB062558: , CAB068219: , CAB068220: , HPA002110: AB_1855512, HPA045507: AB_2679356" "unprognostic (1.26e-1)" "unprognostic (7.68e-2)" "unprognostic (8.28e-3)" "unprognostic (6.46e-3)" "unprognostic (5.16e-3)" "unprognostic (5.85e-2)" "unprognostic (1.63e-2)" "unprognostic (1.05e-1)" "unprognostic (7.95e-3)" "unprognostic (3.52e-1)" "unprognostic (9.20e-3)" "unprognostic (3.40e-1)" "prognostic favourable (2.89e-4)" "unprognostic (2.56e-1)" "unprognostic (8.78e-3)" "unprognostic (3.55e-2)" "unprognostic (1.03e-1)" 8.8 4.9 8.2 3.8 8.9 0.8 7.6 4.8 13.5 11.7 5.0 4.6 16.0 2.8 14.5 2.7 4.4 22.1 7.9 19.3 6.7 6.7 30.6 3.0 14.7 2.6 7.2 5.9 6.1 20.4 7.5 4.0 12.5 15.2 4.5 3.7 15.5 9.1 27.8 5.7 3.8 4.8 12.8 8.1 2.9 4.6 3.5 6.6 0.0 14.0 5.2 2.5 6.1 8.3 1.1 0.3 2.2 0.3 0.4 0.8 0.3 5.0 2.4 4.1 1.8 0.1 0.0 0.3 0.6 0.5 1.8 0.7 12.3 7.9 0.0 11.8 36.0 3.6 4.0 0.0 1.2 0.6 2.0 0.0 15.0 0.2 0.1 0.4 0.4 0.0 0.0 6.5 0.0 14.5 1.2 0.2 1.5 1.4 0.0 0.0 48.7 4.9 2.0 7.3 1.5 0.2 2.2 3.7 0.9 4.4 0.5 0.0 0.4 0.1 54.4 0.7 2.9 7.4 21.6 0.3 0.5 0.1 2.8 2.0 4.3 0.7 0.3 2.2 0.6 0.2 0.5 0.3 0.5 0.8 0.0 1.1 0.4 0.4 1.1 0.4 0.2 0.3 0.4 0.3 8.2 8.9 4.8 13.5 6.7 6.7 7.2 5.9 15.2 6.6 PODXL2 "endoglycan, PODLX2" ENSG00000114631 "Podocalyxin like 2" Q9NZ53 3 127629181-127672809 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.8" "Cell line enhanced" "Detected in many" "RPMI-8226: 32.0;SCLC-21H: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024934, HPA042265" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "CAB024934: , HPA042265: " "unprognostic (2.07e-2)" "unprognostic (2.34e-1)" "unprognostic (7.02e-2)" "unprognostic (1.07e-2)" "unprognostic (9.74e-2)" "unprognostic (1.79e-2)" "unprognostic (8.97e-3)" "unprognostic (1.81e-1)" "unprognostic (3.89e-1)" "unprognostic (2.67e-1)" "unprognostic (4.05e-3)" "unprognostic (3.48e-1)" "unprognostic (2.91e-1)" "unprognostic (1.90e-1)" "unprognostic (2.67e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-3)" 3.0 16.1 19.1 2.6 19.7 1.8 8.1 31.4 42.8 3.0 8.3 9.0 1.6 6.6 4.5 2.5 2.8 4.3 4.4 2.5 22.2 37.3 4.5 1.6 2.1 2.2 21.3 17.5 10.8 12.0 1.2 20.9 1.3 31.5 12.0 7.6 8.7 21.4 2.4 2.8 4.6 6.1 2.0 17.0 2.1 12.2 16.4 7.7 0.6 4.1 1.6 2.7 2.1 0.9 1.6 2.6 0.1 0.8 0.2 2.7 0.7 0.1 3.8 10.6 25.1 0.0 0.0 15.7 1.2 0.0 2.2 0.4 7.9 0.4 9.3 9.5 0.1 0.0 8.6 0.0 0.2 0.0 17.7 0.1 8.8 7.9 0.3 21.0 21.6 0.4 1.8 0.0 0.0 0.6 12.2 0.0 0.8 4.7 0.1 0.0 15.9 18.7 0.0 0.3 32.0 3.1 1.0 47.6 26.8 11.3 24.4 20.7 6.2 10.7 0.1 0.0 4.9 0.4 7.4 0.0 0.0 7.3 0.2 13.7 7.0 0.0 0.2 0.0 0.8 0.8 1.1 1.6 2.7 0.7 0.0 1.3 1.3 0.6 0.1 0.2 0.0 2.6 1.7 0.7 19.1 19.7 31.4 33.8 22.2 37.3 21.3 17.5 31.5 7.7 POGK "BASS2, KIAA15131, KRBOX2, LST003" ENSG00000143157 "Pogo transposable element derived with KRAB domain" Q9P215 1 166839447-166856344 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007838, HPA031630" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA007838: AB_1079651, HPA031630: AB_10601490" "unprognostic (3.48e-2)" "unprognostic (2.03e-2)" "unprognostic (4.31e-2)" "unprognostic (3.18e-3)" "unprognostic (4.20e-2)" "unprognostic (2.59e-1)" "prognostic unfavourable (5.93e-4)" "unprognostic (4.85e-1)" "unprognostic (6.09e-2)" "unprognostic (1.02e-2)" "unprognostic (2.19e-2)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (3.22e-1)" "unprognostic (9.74e-2)" "unprognostic (2.70e-1)" "unprognostic (2.11e-2)" 12.1 10.3 24.3 15.1 27.3 10.4 24.2 18.4 23.6 17.6 13.1 27.6 8.4 10.2 17.6 12.6 16.1 13.5 12.4 11.1 24.4 18.4 15.7 12.0 20.9 13.5 27.7 17.7 19.9 14.8 30.0 10.0 15.1 21.1 12.0 15.4 12.2 12.9 15.2 6.6 20.2 12.1 16.8 30.5 14.5 14.9 6.8 25.6 9.2 13.0 5.2 17.7 16.9 24.2 9.4 10.0 6.3 10.8 9.9 7.3 5.6 15.6 13.3 14.6 17.9 15.5 12.9 8.3 10.9 11.1 14.0 10.6 10.1 13.4 17.6 16.4 11.2 15.7 18.1 14.4 12.8 21.4 12.4 6.9 12.1 7.1 13.2 24.7 19.6 9.7 22.9 15.7 22.5 12.4 23.8 12.0 13.4 7.5 15.3 6.2 23.8 15.3 17.5 8.0 15.5 14.6 38.3 19.1 23.0 15.5 21.5 20.1 20.4 23.1 11.5 14.9 14.8 11.7 19.6 16.9 21.8 23.1 8.3 12.4 14.0 2.8 7.7 6.3 6.7 9.9 7.3 9.4 6.5 7.1 10.0 5.8 6.1 6.3 1.1 9.9 10.8 5.0 5.6 5.6 24.3 27.3 18.4 23.6 24.4 18.4 27.7 17.7 21.1 25.6 POLB ENSG00000070501 "DNA polymerase beta" P06746 8 42338454-42371808 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 73.6" "Cell line enhanced" "Detected in all" "HMC-1: 79.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 73.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011616, HPA049104" Enhanced Uncertain Vesicles Vesicles "CAB011616: AB_731977, HPA049104: " "unprognostic (1.67e-1)" "unprognostic (2.68e-3)" "unprognostic (2.43e-1)" "prognostic unfavourable (1.46e-4)" "unprognostic (8.49e-2)" "unprognostic (2.64e-2)" "unprognostic (4.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.31e-2)" "unprognostic (1.99e-1)" "unprognostic (4.57e-2)" "unprognostic (4.77e-1)" "prognostic unfavourable (2.15e-5)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (4.22e-2)" "prognostic favourable (5.65e-4)" 5.5 8.6 10.1 9.5 10.7 21.9 13.5 73.6 16.6 7.0 5.5 5.8 6.0 4.9 6.2 11.2 12.4 6.3 11.3 16.3 9.8 9.6 7.2 15.8 9.1 11.8 8.4 10.3 10.3 7.7 10.3 11.6 5.0 10.9 11.4 6.3 6.8 22.1 6.9 36.6 10.8 4.9 6.6 10.0 8.1 6.4 29.5 5.4 9.7 7.7 17.2 10.1 11.5 9.2 4.9 33.8 25.1 9.4 7.9 7.2 4.2 10.8 6.5 11.3 22.5 6.3 6.0 9.5 6.9 8.0 11.5 10.6 9.1 12.7 9.8 8.8 4.4 5.5 9.4 8.1 14.2 6.4 10.2 7.1 5.4 12.3 9.7 5.0 79.7 5.3 9.6 8.5 10.0 8.7 15.5 6.3 11.1 6.4 20.7 14.2 15.2 7.5 11.9 11.4 8.4 21.6 8.8 6.4 11.7 8.2 5.5 20.9 14.7 8.6 4.8 5.5 7.7 13.7 6.7 9.2 15.3 13.9 5.5 10.7 14.3 12.5 5.9 17.3 4.9 7.2 5.5 4.9 5.2 5.3 6.1 4.5 5.8 5.4 25.1 7.9 9.4 33.8 7.2 4.2 10.1 10.7 73.6 16.6 9.8 9.6 8.4 10.3 10.9 5.4 POLE2 DPE2 ENSG00000100479 "DNA polymerase epsilon 2, accessory subunit" P56282 14 49643555-49688422 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA replication" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.6;lymphoid tissue: 17.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027555 Uncertain Supported "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA027555: AB_10610282" "unprognostic (1.42e-1)" "unprognostic (6.57e-3)" "unprognostic (3.53e-2)" "unprognostic (7.44e-2)" "unprognostic (2.04e-2)" "unprognostic (4.99e-3)" "unprognostic (7.60e-3)" "unprognostic (2.32e-3)" "unprognostic (1.10e-3)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (1.37e-3)" "unprognostic (5.13e-11)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.50e-3)" 3.3 2.2 1.5 11.6 2.8 17.6 3.4 1.7 1.6 4.4 4.2 1.1 1.5 2.6 2.8 3.5 9.0 2.4 2.3 1.6 1.0 1.2 2.5 5.1 2.2 5.3 1.1 0.3 2.7 5.0 1.4 2.5 4.1 1.4 2.1 5.2 2.6 2.6 0.7 1.1 3.7 7.7 2.9 2.7 5.4 3.0 5.3 2.4 17.6 1.6 10.3 8.4 2.1 4.2 1.2 0.9 0.7 0.0 3.2 2.7 0.5 17.1 8.8 16.7 7.7 0.8 4.9 8.5 9.8 5.0 15.6 18.1 8.8 13.5 10.7 5.6 5.5 10.6 16.7 6.0 18.5 12.5 9.2 15.9 9.7 10.9 0.4 18.9 6.9 1.4 0.4 8.5 1.4 9.0 13.9 6.9 15.6 15.0 19.2 12.4 9.8 20.6 16.4 15.4 9.7 5.6 9.7 12.0 6.9 9.9 5.8 3.1 11.7 6.7 3.2 2.5 18.6 10.4 7.7 5.0 10.2 24.7 4.7 14.0 10.0 0.0 0.0 0.7 0.9 0.0 0.7 1.2 0.9 1.7 0.6 1.2 0.1 0.8 0.0 3.2 0.0 0.9 2.7 0.5 1.5 2.8 1.7 1.6 1.0 1.2 1.1 0.3 1.4 2.4 POLR3H "KIAA1665, RPC8" ENSG00000100413 "RNA polymerase III subunit H" Q9Y535 22 41525804-41544606 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046787 Approved Supported Nucleoplasm,Vesicles,Centrosome Nucleoplasm "Vesicles, Centrosome" "HPA046787: AB_2679806" "unprognostic (1.55e-1)" "unprognostic (6.74e-2)" "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (9.57e-2)" "unprognostic (1.26e-1)" "prognostic unfavourable (2.04e-4)" "unprognostic (2.05e-2)" "unprognostic (1.33e-2)" "unprognostic (5.43e-2)" "prognostic favourable (5.41e-4)" "unprognostic (6.40e-2)" "unprognostic (1.54e-1)" "unprognostic (2.94e-2)" "unprognostic (1.49e-1)" "unprognostic (4.00e-2)" "unprognostic (1.70e-1)" 16.8 14.0 30.0 9.1 28.8 5.5 13.5 21.0 27.4 12.1 7.5 15.8 12.6 6.1 10.5 11.7 17.0 19.0 10.3 14.8 24.0 20.5 10.0 18.9 14.7 10.9 22.2 17.6 22.4 13.7 13.1 11.5 7.9 17.2 11.0 6.8 12.1 12.2 14.2 7.7 14.6 6.2 14.4 14.2 7.2 7.9 14.2 16.5 7.0 15.4 8.2 9.3 8.1 9.1 11.6 11.2 0.6 13.8 3.9 10.2 7.5 16.1 10.9 10.1 14.7 11.1 10.1 6.7 13.6 12.7 23.2 18.7 22.0 5.3 13.8 10.7 22.8 7.4 18.5 22.2 14.6 12.5 22.8 8.2 17.3 10.5 11.5 34.1 14.1 12.6 14.5 30.5 8.2 11.3 17.3 8.9 12.9 15.4 8.7 9.3 7.1 14.2 13.4 7.9 14.3 10.8 9.5 9.8 5.8 17.7 18.0 8.6 7.2 9.7 10.1 13.9 15.0 24.0 18.0 6.7 12.5 20.8 24.2 12.2 13.1 0.0 10.0 0.1 7.3 13.8 10.2 11.6 7.1 8.6 11.2 10.1 10.0 8.1 0.6 3.9 12.7 10.8 4.4 7.5 30.0 28.8 21.0 26.9 24.0 20.5 22.2 17.6 17.2 16.5 POP7 "RPP2, RPP20" ENSG00000172336 "POP7 homolog, ribonuclease P/MRP subunit" O75817 7 100706053-100707495 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021007 Uncertain Supported Nucleoli,Vesicles "Nucleoli, Vesicles" "HPA021007: AB_10963575" "unprognostic (3.19e-1)" "unprognostic (2.45e-2)" "unprognostic (2.72e-2)" "unprognostic (1.80e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (4.99e-5)" "unprognostic (2.98e-2)" "unprognostic (2.28e-1)" "unprognostic (3.12e-2)" "unprognostic (9.50e-2)" "unprognostic (3.88e-1)" "prognostic unfavourable (6.02e-4)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (6.21e-2)" "unprognostic (6.73e-2)" 12.3 16.6 20.5 15.1 21.0 25.3 16.1 25.1 33.2 11.3 14.7 8.7 14.0 17.5 13.9 12.5 20.4 13.4 13.9 19.6 18.3 18.1 13.1 31.4 11.7 18.2 16.8 22.0 13.2 21.2 6.6 11.5 18.1 13.3 16.0 8.1 10.0 24.2 15.8 46.4 22.6 17.6 12.3 12.9 12.3 15.5 7.0 9.4 11.0 11.6 20.5 11.8 11.5 12.5 32.1 30.4 46.4 35.6 42.1 37.0 32.0 24.3 24.2 9.8 17.3 5.2 5.0 19.2 13.8 6.5 15.3 15.2 35.4 15.8 19.8 23.3 6.0 15.5 14.3 16.2 7.6 17.9 43.2 8.9 15.8 34.0 8.8 13.6 10.9 5.8 6.1 15.7 15.5 8.5 31.5 17.7 8.0 69.0 34.1 46.7 30.1 33.5 25.8 10.4 33.5 9.1 13.4 19.7 20.0 11.1 34.4 16.3 11.3 13.8 8.3 21.3 25.6 41.8 27.1 7.5 20.4 35.4 13.4 23.5 23.1 46.4 35.6 38.2 32.4 34.1 29.4 32.1 32.5 31.6 30.4 26.4 29.9 31.1 21.9 42.1 35.3 27.9 37.0 32.0 20.5 21.0 25.1 33.2 18.3 18.1 16.8 22.0 13.3 9.4 POR "CYPOR, FLJ26468" ENSG00000127948 "Cytochrome p450 oxidoreductase" P16435 7 75899200-75986855 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.4" "Cell line enhanced" "Detected in all" "SK-BR-3: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004372, HPA010136" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "CAB004372: AB_627391, HPA010136: AB_1079657" "unprognostic (1.89e-1)" "unprognostic (1.53e-1)" "unprognostic (2.81e-3)" "unprognostic (8.67e-2)" "prognostic unfavourable (8.54e-4)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (4.32e-2)" "unprognostic (1.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (9.31e-2)" "unprognostic (1.71e-1)" "unprognostic (3.94e-2)" "unprognostic (9.89e-2)" 12.8 48.2 7.4 7.5 10.8 3.6 15.0 5.3 16.4 11.0 20.8 9.6 32.1 24.9 9.0 8.2 13.4 12.8 9.9 8.4 7.1 7.2 12.0 78.4 13.7 9.9 5.2 10.1 14.4 12.8 12.1 18.5 18.6 7.1 9.3 5.3 10.8 7.8 58.7 13.1 10.0 24.3 7.0 5.2 11.7 9.8 22.4 5.0 8.2 33.3 9.9 8.6 9.8 10.2 5.7 20.6 26.7 18.4 11.2 9.9 13.9 12.7 27.9 12.8 23.7 48.5 18.4 21.4 5.3 17.5 10.1 14.1 20.9 56.7 12.2 4.9 11.6 6.2 16.8 8.4 4.3 10.4 12.4 5.6 8.2 38.7 33.7 5.6 10.1 37.8 10.6 13.3 9.7 9.4 16.9 5.3 9.1 18.7 6.1 10.1 15.9 15.8 8.7 8.4 13.1 11.4 15.4 13.4 12.8 14.4 73.3 19.3 21.0 9.6 8.4 9.5 10.5 14.3 10.5 5.2 8.0 8.3 13.4 8.6 12.2 26.7 18.4 25.3 9.9 17.7 8.3 5.4 8.4 9.2 20.6 5.7 8.4 7.1 24.3 11.2 13.0 5.8 8.7 13.9 7.4 10.8 5.3 16.4 7.1 7.2 5.2 10.1 7.1 5.0 PORCN "DHOF, MG61, por, PORC, PPN" ENSG00000102312 "Porcupine O-acyltransferase" Q9H237 X 48508962-48520814 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 59.9;LHCN-M2: 20.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049215, HPA058413" Enhanced Approved Vesicles Vesicles "HPA049215: , HPA058413: " "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (1.26e-3)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (2.35e-1)" 4.6 31.4 9.1 4.4 14.1 3.6 4.4 20.0 15.4 12.6 4.6 7.2 12.2 3.4 10.1 3.2 13.9 7.0 6.2 13.4 10.9 9.2 3.3 1.7 5.0 6.6 7.1 8.8 4.9 4.6 6.9 4.1 4.0 8.4 5.0 2.5 7.6 5.8 16.4 5.9 6.8 2.9 6.3 5.5 4.8 5.4 5.4 5.9 2.6 8.5 4.7 5.9 6.5 5.4 4.1 7.2 13.7 5.8 7.8 12.0 4.7 4.3 5.2 1.3 9.1 5.6 3.3 0.5 1.2 2.6 2.0 1.3 0.6 6.7 0.3 5.5 2.8 5.9 1.8 59.9 0.6 2.7 0.6 0.7 3.2 1.2 8.3 0.7 7.8 4.3 7.1 5.8 12.6 1.8 0.3 4.1 20.8 1.2 0.6 0.9 1.6 3.5 1.3 1.6 6.7 3.3 1.7 1.5 2.2 10.4 2.0 2.0 2.3 0.3 1.0 5.2 2.7 12.5 2.2 3.6 2.0 0.5 15.0 1.6 2.9 13.7 5.8 7.1 12.0 5.2 9.4 3.7 8.0 10.0 7.2 4.1 5.4 8.1 1.2 7.8 4.2 3.9 5.2 4.7 9.1 14.1 20.0 14.4 10.9 9.2 7.1 8.8 8.4 5.9 POU2F1 "OCT1, OTF1" ENSG00000143190 "POU class 2 homeobox 1" P14859 1 167220829-167427345 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002608, HPA058559, HPA064323" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB002608: , HPA058559: , HPA064323: " "unprognostic (1.74e-1)" "unprognostic (9.33e-2)" "unprognostic (1.28e-2)" "unprognostic (1.40e-3)" "unprognostic (5.78e-3)" "unprognostic (4.26e-2)" "unprognostic (5.67e-6)" "unprognostic (4.47e-2)" "unprognostic (5.14e-1)" "unprognostic (7.94e-3)" "unprognostic (1.95e-2)" "unprognostic (1.28e-1)" "prognostic unfavourable (2.98e-5)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.17e-2)" 6.9 5.7 15.5 7.3 11.9 12.6 7.2 36.4 13.8 7.7 6.6 9.5 5.2 4.1 7.5 8.4 5.3 6.5 4.3 5.1 14.5 6.7 7.0 5.8 6.6 8.2 7.7 10.8 8.1 6.1 15.5 8.3 9.6 7.1 6.7 6.8 12.0 5.5 6.5 10.5 8.8 6.6 5.5 6.3 9.3 6.1 10.1 10.9 7.4 6.9 4.9 9.7 7.6 6.2 7.5 5.9 8.6 5.9 1.4 4.4 2.2 6.3 5.1 13.3 4.0 1.6 1.6 5.4 0.8 1.4 1.6 1.6 7.4 3.7 7.2 3.4 1.3 4.9 8.1 2.4 2.3 2.9 3.1 5.0 3.5 6.0 1.0 5.5 3.4 1.1 1.4 1.8 3.3 2.1 5.4 4.1 2.1 3.3 5.0 3.6 15.5 2.0 7.3 4.8 3.2 2.8 3.6 8.1 6.1 4.9 3.6 3.3 4.1 6.8 3.4 3.0 4.9 1.8 3.1 4.0 1.8 16.6 1.4 3.4 3.9 8.6 2.3 2.8 4.4 2.7 3.3 7.5 2.3 2.0 2.5 6.8 3.2 2.4 3.3 1.4 5.9 5.9 2.1 2.2 15.5 11.9 36.4 13.8 14.5 6.7 7.7 10.8 7.1 10.9 POU2F2 "OCT2, OTF2" ENSG00000028277 "POU class 2 homeobox 2" P09086 19 42086110-42196585 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 33.1;brain: 12.0;intestine: 10.8;lymphoid tissue: 43.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.1;Daudi: 38.2;hTEC/SVTERT24-B: 15.0;U-266/70: 26.6;U-266/84: 25.7;U-698: 30.3;U-87 MG: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 33.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002513, HPA049056, HPA062096, HPA064404" Enhanced Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB002513: AB_442118, HPA049056: , HPA062096: , HPA064404: " "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-2)" "unprognostic (8.89e-2)" "unprognostic (6.77e-2)" "unprognostic (1.44e-2)" "unprognostic (1.62e-2)" "unprognostic (3.34e-1)" "unprognostic (8.39e-2)" "unprognostic (2.09e-1)" "unprognostic (1.52e-1)" "unprognostic (8.56e-2)" "prognostic unfavourable (7.57e-11)" "unprognostic (2.31e-1)" "unprognostic (1.76e-1)" "unprognostic (2.61e-2)" "unprognostic (1.54e-1)" 1.9 2.0 5.6 43.1 7.4 4.8 1.2 12.0 5.7 0.9 3.2 2.5 0.0 2.1 0.9 1.7 1.4 1.5 2.3 4.8 5.7 5.9 1.6 1.4 3.1 31.4 6.8 1.5 0.7 1.6 0.4 2.1 2.5 6.6 2.5 2.1 1.4 2.1 2.3 0.7 1.2 10.8 1.9 6.5 22.7 3.1 6.0 6.2 1.9 1.3 0.6 30.0 4.3 1.0 13.9 8.0 1.7 33.1 0.6 2.7 4.5 0.3 0.5 0.6 0.0 0.0 1.0 0.1 2.8 18.1 1.8 3.5 0.1 0.5 38.2 1.0 1.0 0.3 0.2 2.9 8.2 0.1 0.1 0.9 0.1 0.0 0.2 0.3 0.7 0.8 0.5 15.0 1.0 1.1 0.4 8.8 0.4 0.2 0.1 2.0 0.1 0.2 0.4 0.0 0.1 0.0 0.2 0.6 0.3 0.1 0.2 0.2 0.0 4.8 1.4 7.8 0.8 0.0 0.3 26.6 25.7 30.3 14.6 0.9 1.0 1.0 10.7 0.1 1.2 19.3 1.1 11.0 1.8 1.6 8.0 13.9 0.9 1.3 1.7 0.6 33.1 1.3 2.7 4.5 5.6 7.4 12.0 5.7 5.7 5.9 6.8 1.5 6.6 6.2 PPA1 "IOPPP, PP, PP1, Ppase, SID6-8061" ENSG00000180817 "Pyrophosphatase (inorganic) 1" Q15181 10 70202830-70233911 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019878, HPA020096" Supported Supported Vesicles 110000 Vesicles "HPA019878: AB_1855601, HPA020096: AB_1855600" "unprognostic (1.50e-1)" "unprognostic (2.85e-1)" "unprognostic (4.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.42e-1)" "unprognostic (4.47e-2)" "unprognostic (2.86e-2)" "unprognostic (9.43e-2)" "unprognostic (3.34e-1)" "unprognostic (1.62e-1)" "unprognostic (2.13e-2)" "unprognostic (3.60e-2)" "unprognostic (1.82e-3)" "unprognostic (5.36e-2)" "unprognostic (2.37e-1)" "unprognostic (3.53e-2)" "unprognostic (2.74e-1)" 46.6 55.5 41.3 36.8 56.0 24.2 88.7 66.8 62.2 34.8 45.7 25.2 43.7 33.2 30.4 59.6 48.6 38.1 31.5 30.0 46.7 54.2 40.7 59.0 39.1 54.6 74.3 47.5 17.9 72.6 23.3 29.5 34.6 60.7 24.4 53.4 26.1 36.8 42.1 37.0 24.6 41.0 32.8 72.7 22.4 32.5 25.1 47.2 20.4 52.0 35.8 44.4 32.7 40.2 21.5 48.9 1.0 17.7 15.5 35.6 25.3 58.1 24.1 21.6 63.6 58.8 51.9 20.2 21.8 41.0 34.2 36.1 73.4 30.9 84.3 19.9 21.7 47.1 63.2 42.5 35.0 79.2 60.1 23.0 24.4 41.9 37.1 56.6 14.6 34.0 50.9 27.4 73.1 41.3 53.6 45.4 32.2 34.1 54.7 53.2 22.5 66.9 33.5 24.7 49.3 71.3 36.6 64.9 21.8 24.0 94.1 18.6 23.5 25.5 18.7 9.5 36.2 31.2 41.3 15.0 32.8 61.7 14.7 79.5 8.3 0.0 17.7 0.4 13.3 13.8 35.6 21.5 30.8 23.1 48.9 13.8 34.2 28.9 1.0 15.5 14.5 11.3 30.1 25.3 41.3 56.0 66.8 62.2 46.7 54.2 74.3 47.5 60.7 47.2 PPARG "NR1C3, PPARG1, PPARG2, PPARgamma" ENSG00000132170 "Peroxisome proliferator activated receptor gamma" P37231 3 12287368-12434356 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 97.6;breast: 102.1" "Cell line enhanced" "Detected in many" "ASC diff: 47.4;ASC TERT1: 27.0;BEWO: 55.9;CAPAN-2: 25.0;HSkMC: 27.8;PC-3: 24.9;RT4: 34.1" "Cancer enhanced" "Detected in all" "urothelial cancer: 33.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.8;intermediate monocyte: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB004282, HPA051239, HPA063663" Approved Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB004282: AB_628115, HPA051239: , HPA063663: " "unprognostic (7.35e-3)" "unprognostic (3.27e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-2)" "unprognostic (2.41e-2)" "unprognostic (5.27e-3)" "prognostic unfavourable (3.41e-5)" "unprognostic (9.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (2.77e-1)" "prognostic favourable (1.59e-8)" "unprognostic (1.51e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-3)" "prognostic favourable (5.52e-5)" 97.6 1.6 1.9 17.1 1.2 0.7 102.1 1.5 1.3 3.1 24.9 0.8 2.1 7.5 3.5 2.2 2.8 2.4 8.7 12.5 1.4 0.9 6.7 5.9 24.8 11.4 1.1 0.9 6.7 1.2 2.8 0.3 26.8 0.9 10.4 13.9 1.1 5.8 1.5 5.0 2.7 9.6 7.4 1.2 7.0 11.9 3.5 0.6 0.9 6.2 4.3 2.1 30.2 14.1 0.0 0.4 0.0 2.3 0.0 0.7 0.3 9.6 8.6 0.0 0.0 47.4 27.0 55.9 0.9 10.4 1.3 0.5 1.8 25.0 0.0 0.0 0.9 3.9 3.4 0.1 0.2 23.2 4.8 0.0 1.9 2.3 12.6 0.0 0.0 27.8 2.3 2.3 9.0 0.1 0.0 0.0 2.0 2.4 0.0 0.1 0.1 24.9 0.0 0.0 0.0 7.1 34.1 0.0 0.2 4.0 1.5 0.5 0.0 7.7 7.8 1.8 2.6 1.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.0 1.8 0.0 0.0 2.3 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 1.9 1.2 1.5 1.3 1.4 0.9 1.1 0.9 0.9 0.6 PPFIA3 "KIAA0654, LPNA3, MGC126567, MGC126569" ENSG00000177380 "PTPRF interacting protein alpha 3" O75145 19 49119389-49151026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 22.1;pituitary gland: 14.9;skin 1: 25.3" "Cell line enhanced" "Detected in many" "PC-3: 23.0;SK-BR-3: 18.8;U-266/70: 13.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 6 "T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043567, HPA050340" Enhanced Uncertain "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center, Vesicles" "HPA043567: , HPA050340: " "prognostic unfavourable (3.09e-4)" "unprognostic (4.70e-2)" "unprognostic (5.14e-3)" "prognostic favourable (8.65e-4)" "unprognostic (3.46e-1)" "prognostic favourable (6.46e-7)" "prognostic unfavourable (2.24e-5)" "unprognostic (1.27e-1)" "unprognostic (8.36e-2)" "unprognostic (9.41e-3)" "unprognostic (5.21e-3)" "unprognostic (8.52e-2)" "unprognostic (1.00e-2)" "unprognostic (1.22e-2)" "unprognostic (1.52e-1)" "unprognostic (3.92e-2)" "unprognostic (1.32e-1)" 1.6 3.9 13.9 1.6 9.3 0.9 2.2 22.1 20.8 1.2 4.3 1.6 1.7 5.1 1.6 1.1 4.4 1.3 1.4 1.4 12.8 12.2 1.1 1.6 1.8 1.6 7.4 13.7 1.0 4.9 4.1 14.9 1.1 7.3 3.4 2.0 1.6 2.7 1.6 1.7 25.3 4.6 1.2 2.4 1.3 2.3 2.1 1.8 0.0 1.8 1.2 2.2 1.1 1.9 0.0 0.0 0.0 0.0 0.2 1.1 0.3 1.9 2.0 2.0 5.1 0.0 0.0 3.9 0.2 0.2 1.0 1.4 1.4 0.8 4.5 2.7 0.2 1.0 3.1 0.4 0.2 4.8 6.8 2.8 1.8 1.0 0.2 1.1 7.3 0.2 1.1 0.6 0.3 0.0 5.4 7.1 0.1 8.7 1.4 1.9 0.9 23.0 4.6 4.0 2.2 0.3 1.0 4.2 5.8 0.8 18.8 2.0 10.4 2.7 0.4 1.1 4.0 0.7 0.1 13.3 10.9 3.3 1.1 4.5 2.6 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.4 0.0 0.0 1.1 0.2 0.0 0.2 0.0 0.0 0.0 0.3 13.9 9.3 22.1 19.8 12.8 12.2 7.4 13.7 7.3 1.8 PPIP5K2 "CFAP160, HISPPD1, KIAA0433, VIP2" ENSG00000145725 "Diphosphoinositol pentakisphosphate kinase 2" O43314 5 103120149-103212799 "Enzymes, Predicted intracellular proteins" Hearing "Kinase, Transferase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037895, HPA038442" Approved Approved Vesicles Vesicles "HPA037895: , HPA038442: AB_10673173" "unprognostic (2.18e-1)" "unprognostic (1.04e-1)" "unprognostic (2.36e-2)" "unprognostic (1.93e-1)" "unprognostic (8.83e-2)" "unprognostic (1.60e-3)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.60e-2)" "unprognostic (8.59e-3)" "unprognostic (1.39e-1)" "unprognostic (2.12e-1)" "unprognostic (4.32e-2)" "unprognostic (1.29e-1)" "unprognostic (4.06e-1)" "prognostic unfavourable (1.12e-4)" "unprognostic (8.80e-2)" 21.6 20.5 12.6 18.2 18.4 37.9 22.3 30.7 24.2 26.1 23.8 9.7 16.0 14.3 22.6 20.3 17.0 18.5 17.7 16.4 13.2 17.6 21.9 22.6 14.8 20.6 19.5 18.7 26.8 25.5 22.3 40.3 21.6 37.2 18.4 22.1 10.5 17.4 21.7 5.7 16.4 20.2 16.0 19.8 27.7 18.6 13.5 16.2 38.5 20.0 12.9 20.3 16.9 18.2 12.1 15.7 24.3 18.2 10.0 11.2 6.7 9.6 9.5 18.4 21.3 15.0 19.4 16.6 20.1 14.0 12.7 17.4 7.9 16.4 22.8 19.7 20.1 5.9 15.9 12.0 20.7 18.0 8.4 28.9 17.8 12.6 11.0 24.9 26.3 12.9 9.0 17.8 16.4 14.0 29.9 21.0 18.7 8.1 21.5 17.5 20.0 22.2 20.5 16.4 31.2 13.5 11.2 10.3 13.5 13.8 14.5 13.6 11.4 16.9 14.0 18.1 8.1 20.1 15.0 13.3 30.2 30.9 10.6 39.6 16.9 23.0 13.4 24.3 8.7 13.8 10.7 12.1 8.4 9.0 15.7 11.3 11.1 11.2 13.0 10.0 18.2 9.3 7.3 6.7 12.6 18.4 30.7 24.2 13.2 17.6 19.5 18.7 37.2 16.2 PPM1J "DKFZp434P1514, FLJ35951, MGC19531, PP2Czeta, PPP2CZ" ENSG00000155367 "Protein phosphatase, Mg2+/Mn2+ dependent 1J" Q5JR12 1 112709994-112715477 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.9;skeletal muscle: 45.1;testis: 31.9" "Cell line enhanced" "Detected in many" "T-47d: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 9 "plasmacytoid DC: 30.9" "Lineage enriched" "Detected in many" 17 "dendritic cells: 30.9" "Region enriched" "Detected in some" 8 "olfactory region: 33.6" "Low region specificity" "Detected in all" HPA046045 Uncertain Approved Vesicles Vesicles "HPA046045: " "unprognostic (8.68e-2)" "unprognostic (5.65e-2)" "unprognostic (3.29e-2)" "unprognostic (2.59e-1)" "unprognostic (2.93e-3)" "unprognostic (2.34e-2)" "unprognostic (3.55e-2)" "unprognostic (3.74e-2)" "unprognostic (2.55e-1)" "unprognostic (9.30e-3)" "unprognostic (3.36e-2)" "unprognostic (7.22e-2)" "unprognostic (1.80e-2)" "unprognostic (1.27e-2)" "unprognostic (1.46e-1)" "unprognostic (2.28e-2)" "unprognostic (9.96e-4)" 0.8 2.3 6.4 0.9 4.8 0.8 1.9 7.8 6.8 0.9 0.7 2.1 1.6 0.7 1.4 14.8 3.0 2.4 1.3 5.4 4.3 4.8 1.2 0.7 0.7 2.4 3.7 4.4 1.3 3.8 2.4 1.1 0.8 3.9 1.4 0.7 1.5 2.3 2.3 45.1 13.3 0.6 1.3 1.6 1.3 0.7 31.9 0.7 1.4 1.6 5.3 1.9 1.6 1.5 0.4 30.9 0.0 1.7 0.0 0.0 0.3 2.7 0.1 1.5 1.7 0.8 1.6 1.2 0.3 0.7 0.3 1.0 1.2 0.8 0.4 0.5 0.8 5.0 1.1 4.6 0.4 0.0 2.7 0.8 0.2 0.1 1.0 0.0 0.2 1.8 3.1 0.9 4.8 2.1 1.0 0.0 1.2 2.8 0.0 0.0 1.7 2.3 0.1 0.2 0.0 2.8 0.1 0.8 0.2 0.6 4.5 1.3 20.0 0.0 1.2 0.3 2.9 0.0 0.2 0.1 0.0 0.0 2.4 0.6 2.7 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.0 3.2 0.4 0.0 0.0 0.0 0.0 1.7 30.9 0.0 0.3 6.4 4.8 7.8 6.8 4.3 4.8 3.7 4.4 3.9 0.7 PPM1N FLJ40125 ENSG00000213889 "Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)" Q8N819 19 45488777-45502510 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 43.7;skeletal muscle: 81.9" "Cell line enhanced" "Detected in many" "RT4: 21.8" "Cancer enhanced" "Detected in many" "testis cancer: 11.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "non-classical monocyte: 43.7" "Lineage enriched" "Detected in all" 10 "monocytes: 43.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA043577 Supported Vesicles Vesicles "HPA043577: " "unprognostic (2.38e-2)" "unprognostic (1.11e-2)" "unprognostic (8.53e-2)" "unprognostic (6.59e-2)" "unprognostic (4.71e-1)" "unprognostic (2.64e-2)" "unprognostic (1.98e-3)" "unprognostic (1.02e-1)" "unprognostic (1.25e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (2.48e-2)" "unprognostic (1.11e-16)" "unprognostic (3.42e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (1.86e-3)" 1.7 0.9 5.4 1.2 4.5 1.3 1.9 0.7 4.1 1.3 1.7 0.1 0.7 0.6 1.5 1.0 2.2 0.8 1.0 0.9 3.3 2.3 1.2 1.5 1.5 1.6 2.6 2.2 0.8 0.5 1.3 1.4 2.4 2.7 2.3 1.0 10.6 1.5 1.4 81.9 2.4 1.4 2.6 3.4 15.7 1.7 2.9 3.5 2.5 0.9 0.0 2.4 4.0 1.9 1.9 4.3 2.3 43.7 1.1 2.9 1.9 1.9 5.1 0.9 3.9 4.5 6.1 11.2 1.4 2.3 0.4 1.7 1.3 12.0 8.1 2.4 1.3 5.7 2.3 1.7 0.7 7.9 3.3 6.4 2.0 1.5 1.1 0.5 13.7 2.5 2.6 2.3 1.3 0.7 7.3 7.3 0.8 1.4 2.2 3.5 3.1 1.1 1.4 1.1 2.3 2.5 21.8 4.4 5.2 0.7 8.4 6.3 2.8 1.9 1.1 6.4 3.9 3.1 1.0 1.2 3.2 1.6 4.7 1.7 5.5 1.7 1.6 1.0 2.2 7.2 2.0 1.9 1.4 2.2 4.3 1.3 1.6 2.9 2.3 1.1 43.7 0.8 1.5 1.9 5.4 4.5 0.7 4.1 3.3 2.3 2.6 2.2 2.7 3.5 PPOX "PPO, VP" ENSG00000143224 "Protoporphyrinogen oxidase" P50336 1 161166410-161178013 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030123, HPA054287" Uncertain Supported "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA030123: AB_10603987, HPA054287: " "unprognostic (1.17e-1)" "unprognostic (4.73e-2)" "unprognostic (9.88e-2)" "unprognostic (2.13e-2)" "unprognostic (3.24e-1)" "unprognostic (1.64e-2)" "unprognostic (9.58e-3)" "unprognostic (1.79e-2)" "unprognostic (9.17e-2)" "unprognostic (1.17e-1)" "unprognostic (2.18e-3)" "unprognostic (7.12e-3)" "prognostic unfavourable (9.89e-4)" "unprognostic (6.12e-2)" "unprognostic (2.23e-1)" "unprognostic (3.27e-1)" "unprognostic (1.80e-2)" 7.3 14.8 11.6 9.1 12.1 31.7 10.2 23.5 16.5 11.0 9.9 13.2 8.5 6.0 11.7 13.5 7.5 33.2 9.5 9.5 11.5 12.5 12.0 9.1 10.2 11.2 14.2 16.1 13.0 13.1 10.5 12.3 10.1 12.1 11.0 6.7 14.4 11.3 14.6 8.5 15.9 7.1 10.0 10.6 12.0 8.2 6.9 13.7 9.2 11.0 6.1 8.7 8.7 8.2 9.8 11.5 6.9 7.7 12.3 16.7 8.9 7.0 6.5 9.8 6.4 7.4 7.9 3.3 4.9 5.7 6.0 8.1 7.7 6.8 5.5 11.8 3.4 4.9 7.5 7.9 5.5 3.8 14.9 6.7 14.7 17.5 7.9 2.2 3.7 6.3 7.9 5.9 8.3 11.4 19.7 8.6 4.4 6.6 8.9 7.0 7.0 14.0 10.8 6.8 13.1 11.4 3.1 7.8 12.5 5.9 8.7 9.8 15.6 10.4 4.0 5.6 6.2 4.8 6.2 15.4 11.2 8.5 5.7 4.9 4.3 6.9 7.7 5.5 12.7 7.7 8.4 9.8 9.8 8.8 11.5 8.6 8.6 8.8 1.6 12.3 5.3 7.2 16.7 8.9 11.6 12.1 23.5 16.5 11.5 12.5 14.2 16.1 12.1 13.7 PPP1R11 "CFAP255, HCG-V, HCGV, TCTE5, Tctex5" ENSG00000204619 "Protein phosphatase 1 regulatory inhibitor subunit 11" O60927 6 30066709-30070333 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Protein phosphatase inhibitor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 93.3" "Cell line enhanced" "Detected in some" "A-431: 19.8;AN3-CA: 26.4;fHDF/TERT166: 14.7;HBEC3-KT: 16.6;HEK 293: 13.6;HEL: 15.9;RPTEC TERT1: 18.4;U-266/84: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043266, HPA060174" Approved Approved Vesicles Vesicles "HPA043266: , HPA060174: " "unprognostic (2.00e-2)" "unprognostic (1.10e-1)" "unprognostic (8.88e-2)" "unprognostic (4.24e-2)" "unprognostic (3.45e-1)" "unprognostic (1.05e-1)" "unprognostic (1.77e-2)" "unprognostic (1.18e-1)" "unprognostic (2.81e-1)" "unprognostic (1.74e-3)" "unprognostic (3.33e-2)" "unprognostic (2.68e-1)" "unprognostic (8.36e-3)" "unprognostic (1.74e-1)" "unprognostic (3.31e-1)" "unprognostic (2.21e-1)" "unprognostic (4.69e-3)" 36.0 18.2 18.5 8.3 21.6 4.4 12.9 9.8 31.7 11.0 27.0 17.3 7.9 33.2 16.0 93.3 26.8 33.7 23.9 16.8 16.6 17.6 18.2 22.6 12.9 13.2 15.5 14.5 26.2 33.1 5.9 8.8 21.1 14.6 13.6 4.6 14.0 20.4 8.8 39.0 37.0 28.6 9.4 13.4 16.0 27.2 18.1 11.4 16.9 20.6 10.9 29.6 15.8 12.4 2.6 2.7 4.4 3.5 0.8 3.2 1.8 19.8 0.0 0.0 26.4 11.7 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 16.6 0.0 0.0 13.6 15.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 18.4 8.6 0.0 0.0 0.0 9.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 17.6 7.7 0.0 0.0 0.0 2.9 2.6 4.4 1.7 3.5 2.0 2.1 1.9 3.1 1.3 2.6 2.7 2.1 2.9 0.8 2.9 2.7 3.2 1.8 18.5 21.6 9.8 31.7 16.6 17.6 15.5 14.5 14.6 11.4 PPP1R15A GADD34 ENSG00000087074 "Protein phosphatase 1 regulatory subunit 15A" O75807 19 48872392-48876057 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Stress response, Translation regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 156.9" "Cell line enhanced" "Detected in all" "HHSteC: 54.6;hTERT-HME1: 94.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 69.8" "Group enriched" "Detected in all" 5 "dendritic cells: 23.8;granulocytes: 69.8" "Low region specificity" "Detected in all" "CAB018395, HPA020240" Approved Uncertain Vesicles Vesicles "CAB018395: AB_2237473, HPA020240: AB_1849404" "unprognostic (2.43e-3)" "unprognostic (3.21e-1)" "unprognostic (7.75e-2)" "unprognostic (1.17e-3)" "unprognostic (2.22e-2)" "unprognostic (6.17e-2)" "prognostic unfavourable (1.95e-4)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.22e-1)" "unprognostic (6.43e-3)" "unprognostic (1.49e-1)" "unprognostic (1.29e-2)" "unprognostic (6.94e-2)" 39.8 29.1 16.2 33.6 12.9 156.9 56.3 12.1 12.8 26.3 19.7 13.6 12.0 12.0 37.8 19.5 28.2 34.0 32.3 42.0 14.6 13.9 18.6 18.6 56.5 10.6 29.5 6.3 24.5 10.9 9.8 16.2 44.7 31.5 28.2 15.6 12.4 9.2 23.6 35.2 40.0 16.0 36.2 17.7 13.3 19.8 14.5 17.8 3.4 18.6 46.7 19.0 41.1 114.7 8.1 23.8 69.8 10.3 2.5 6.1 6.6 9.9 4.3 4.7 3.8 13.7 7.8 7.4 17.5 27.5 20.1 18.2 6.6 5.1 3.4 4.7 12.6 7.2 1.7 9.1 15.2 1.9 2.6 15.6 2.5 3.2 54.6 3.6 22.5 10.6 25.5 27.7 94.1 10.4 20.9 29.1 12.9 1.1 1.9 5.0 1.1 7.9 2.2 4.3 1.1 4.1 11.7 2.6 4.6 9.0 6.2 39.6 2.2 6.5 11.1 24.0 6.0 16.8 10.7 15.7 12.4 3.3 8.8 2.5 28.7 27.4 10.3 17.7 4.9 6.3 4.3 8.1 4.8 4.0 7.3 5.5 2.7 2.4 69.8 2.5 7.1 23.8 6.1 6.6 16.2 12.9 12.1 12.8 14.6 13.9 29.5 6.3 31.5 17.8 PPP1R21 "CCDC128, FLJ16566, KLRAQ1" ENSG00000162869 "Protein phosphatase 1 regulatory subunit 21" Q6ZMI0 2 48440598-48515391 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036791, HPA036792" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA036791: AB_10671713, HPA036792: " "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (2.51e-1)" "prognostic unfavourable (6.83e-4)" "unprognostic (1.57e-2)" "unprognostic (1.01e-1)" "unprognostic (2.78e-3)" "unprognostic (1.44e-2)" "unprognostic (7.46e-2)" "unprognostic (3.00e-1)" "prognostic favourable (8.05e-4)" "unprognostic (1.13e-1)" "prognostic favourable (4.59e-6)" "unprognostic (9.23e-2)" "unprognostic (1.93e-1)" "prognostic favourable (9.87e-4)" "unprognostic (6.60e-2)" 9.0 10.4 16.4 8.9 18.7 8.1 7.9 16.2 21.6 8.3 8.8 15.0 7.9 7.0 15.8 18.8 11.2 13.5 9.8 8.9 13.2 12.2 25.6 10.4 10.0 10.9 17.7 13.6 12.7 7.3 35.5 11.9 11.3 14.4 10.8 9.8 8.4 6.8 10.2 6.4 9.5 9.0 11.9 12.0 11.0 9.4 8.4 15.9 10.4 19.5 2.4 10.8 12.7 8.8 7.7 5.6 14.1 6.0 3.8 7.9 2.3 13.8 6.7 5.8 7.1 14.6 10.8 15.2 8.3 9.3 5.0 6.1 3.7 8.7 9.4 13.7 11.5 7.7 4.8 7.4 10.6 12.0 4.1 10.1 5.7 8.9 10.1 4.5 8.1 13.5 6.8 9.1 11.2 12.7 4.1 15.8 13.8 7.6 8.6 7.3 14.6 7.1 7.2 15.5 10.2 10.6 9.2 7.7 4.8 15.3 4.0 14.7 7.2 7.3 11.3 5.4 6.7 4.8 6.5 11.8 3.3 8.6 8.6 10.2 7.1 14.1 5.4 8.5 4.4 6.0 3.5 5.9 5.2 5.1 5.6 7.7 7.9 6.4 13.0 3.8 5.1 3.5 5.0 2.3 16.4 18.7 16.2 21.6 13.2 12.2 17.7 13.6 14.4 15.9 PPP1R3D PPP1R6 ENSG00000132825 "Protein phosphatase 1 regulatory subunit 3D" O95685 20 59936668-59940297 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041146 Approved Approved Nucleoli,Vesicles,Mitochondria "Vesicles, Mitochondria" Nucleoli "HPA041146: AB_10793870" "unprognostic (2.50e-3)" "unprognostic (3.55e-3)" "unprognostic (6.90e-2)" "unprognostic (1.23e-1)" "unprognostic (7.23e-2)" "unprognostic (5.87e-2)" "unprognostic (5.73e-2)" "unprognostic (2.39e-3)" "unprognostic (5.54e-2)" "unprognostic (3.27e-1)" "unprognostic (3.52e-2)" "unprognostic (1.20e-1)" "unprognostic (1.48e-2)" "prognostic favourable (9.14e-4)" "unprognostic (4.71e-2)" "unprognostic (1.47e-2)" "unprognostic (5.71e-2)" 8.2 6.1 9.3 8.2 9.5 9.9 17.2 8.6 9.5 9.1 8.2 6.4 7.1 9.5 9.0 6.5 13.3 7.4 6.5 11.3 8.4 7.8 7.8 2.0 10.0 16.8 9.5 5.4 8.8 17.5 13.3 12.1 9.8 9.3 12.0 5.6 7.6 9.1 11.2 12.9 9.1 10.1 7.1 8.9 11.2 9.6 4.7 6.6 4.0 8.0 8.8 8.9 9.1 8.8 0.7 1.2 6.0 3.5 0.8 1.0 0.4 4.0 2.4 1.7 3.5 3.8 4.0 14.2 5.3 5.8 6.5 3.1 3.8 5.5 1.7 6.6 4.4 11.8 3.5 3.8 4.2 3.9 2.7 4.4 3.3 2.0 3.5 1.8 12.5 2.8 10.4 2.3 2.0 3.5 0.8 0.4 4.1 6.1 1.5 5.8 1.2 5.9 1.9 0.8 2.5 4.3 6.4 3.2 2.0 6.6 20.0 5.7 7.3 6.5 3.8 3.8 1.6 4.0 0.8 1.4 3.4 0.4 2.8 6.4 2.3 0.6 1.6 6.0 1.0 0.7 0.9 0.7 0.7 0.8 1.2 0.6 0.9 0.6 4.2 0.8 3.5 0.5 1.0 0.4 9.3 9.5 8.6 9.5 8.4 7.8 9.5 5.4 9.3 6.6 PPP1R3F Hb2E ENSG00000049769 "Protein phosphatase 1 regulatory subunit 3F" Q6ZSY5 X 49269843-49301461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "T-reg: 15.3" "Lineage enriched" "Detected in single" 16 "T-cells: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000244, HPA000918" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000244: , HPA000918: AB_2268692" "unprognostic (6.69e-2)" "unprognostic (2.87e-2)" "unprognostic (4.98e-4)" "unprognostic (1.83e-2)" "unprognostic (6.48e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-1)" "unprognostic (5.17e-2)" "unprognostic (1.91e-2)" "unprognostic (2.89e-1)" "prognostic favourable (1.85e-6)" "unprognostic (5.99e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "unprognostic (2.76e-1)" "unprognostic (7.96e-2)" "unprognostic (1.55e-1)" 3.0 7.6 15.9 3.7 13.8 2.7 2.3 17.2 21.2 4.3 3.5 7.6 4.5 2.4 4.7 15.9 5.4 6.7 3.6 16.1 16.0 13.1 3.3 2.8 3.4 4.6 12.3 5.4 7.5 2.6 4.4 8.6 2.4 9.1 4.6 1.7 5.3 5.3 6.1 24.0 3.1 3.1 4.1 11.3 5.1 2.9 4.5 7.3 3.5 5.5 1.9 3.0 3.5 4.8 0.4 0.3 0.0 0.9 0.4 15.3 0.5 2.6 5.4 4.8 5.3 6.6 4.7 2.3 3.1 4.8 2.1 3.3 3.8 3.1 3.1 0.6 2.3 4.2 1.8 1.3 1.1 17.0 5.9 0.3 3.1 0.3 4.3 0.4 1.9 3.3 3.9 2.2 1.7 0.5 0.8 1.3 2.5 9.3 1.2 4.2 14.7 10.2 6.9 4.1 1.0 2.1 1.2 5.6 4.8 1.6 0.6 8.0 4.8 2.7 2.5 5.9 1.2 5.2 2.3 3.9 4.8 2.1 2.0 6.6 7.5 0.0 0.2 0.0 0.2 0.4 1.0 0.4 3.0 1.0 0.2 0.1 2.4 1.1 0.0 0.4 0.9 0.3 15.3 0.5 15.9 13.8 17.2 19.3 16.0 13.1 12.3 5.4 9.1 7.3 PPP3CC "CALNA3, PP2Bgamma" ENSG00000120910 "Protein phosphatase 3 catalytic subunit gamma" P48454 8 22440819-22541142 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023396, CAB024950" Approved Approved Vesicles Vesicles "CAB024950: , HPA023396: AB_1855663" "unprognostic (7.66e-3)" "unprognostic (1.61e-2)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (2.21e-2)" "unprognostic (7.71e-2)" "prognostic favourable (6.80e-5)" "unprognostic (9.25e-2)" "unprognostic (1.97e-1)" "unprognostic (8.84e-2)" "unprognostic (4.05e-2)" "unprognostic (7.16e-2)" "unprognostic (2.35e-2)" "unprognostic (4.00e-1)" "unprognostic (2.78e-2)" "unprognostic (1.64e-2)" 18.0 8.3 6.9 13.7 8.1 15.2 21.1 11.9 12.0 10.3 10.2 10.9 3.7 6.1 13.4 7.8 11.6 9.0 10.7 27.5 7.6 7.3 8.9 8.2 16.5 22.3 7.7 4.9 10.1 9.9 13.7 15.1 12.7 9.9 11.1 7.1 20.7 15.5 6.0 52.4 9.1 9.8 13.5 7.9 14.1 9.5 41.6 6.9 6.8 11.5 13.2 20.0 14.7 11.0 15.5 4.0 6.6 2.9 11.9 16.0 3.9 5.4 4.0 3.6 4.4 9.6 11.9 5.3 7.6 13.5 11.4 12.6 2.3 3.4 20.8 9.4 11.8 3.9 8.3 7.6 14.6 11.9 4.4 4.4 4.6 6.7 13.0 3.2 7.4 7.2 10.6 7.6 7.9 9.8 8.7 27.8 12.7 2.5 7.5 5.2 2.6 5.6 24.5 8.5 6.9 10.6 5.2 2.5 6.0 5.7 3.4 7.8 2.3 5.4 10.5 17.7 3.8 26.8 5.9 13.9 16.7 21.8 9.4 4.2 11.7 3.4 1.6 6.6 11.4 2.0 8.7 15.5 12.9 16.0 3.2 13.9 12.4 10.1 0.4 11.9 2.9 4.0 10.1 3.9 6.9 8.1 11.9 12.0 7.6 7.3 7.7 4.9 9.9 6.9 PPP5C "PP5, PPP5" ENSG00000011485 "Protein phosphatase 5 catalytic subunit" P53041 19 46346994-46392981 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Protein phosphatase" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022641, HPA029065, HPA056933" Approved Supported Vesicles,Cytosol 47000 "Vesicles, Cytosol" "CAB022641: , HPA029065: AB_10610284, HPA056933: " "unprognostic (8.25e-2)" "unprognostic (7.90e-2)" "unprognostic (1.44e-1)" "unprognostic (6.30e-2)" "unprognostic (5.92e-2)" "unprognostic (2.62e-2)" "prognostic unfavourable (3.45e-6)" "unprognostic (1.29e-1)" "unprognostic (1.04e-2)" "unprognostic (8.25e-2)" "unprognostic (5.56e-2)" "unprognostic (2.20e-2)" "unprognostic (3.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.35e-1)" "unprognostic (5.92e-3)" "unprognostic (1.37e-1)" 18.9 24.7 23.0 18.1 28.8 13.4 15.9 25.2 50.8 20.4 21.1 19.4 15.2 18.0 23.0 15.2 20.1 27.8 20.5 48.2 20.8 23.9 22.6 22.1 17.4 19.3 21.9 29.8 16.7 21.5 26.3 23.9 17.3 34.5 19.5 17.5 19.7 21.0 21.4 40.8 16.4 15.3 23.5 16.2 21.7 20.6 19.0 15.3 15.6 18.1 20.5 16.1 17.1 18.1 10.6 11.1 1.9 14.1 14.0 19.8 8.9 19.5 36.8 22.0 16.6 16.6 17.8 10.2 24.3 19.8 29.6 26.7 26.4 15.6 30.0 13.3 17.7 16.1 28.9 28.7 8.9 20.8 39.2 25.0 27.0 18.7 18.5 33.8 17.5 16.2 13.6 20.8 15.5 25.4 24.0 15.5 16.8 21.2 18.9 63.4 16.6 20.1 28.2 19.0 24.0 17.7 26.8 31.3 23.0 20.4 26.0 8.7 16.3 21.6 21.1 13.0 21.6 9.6 25.4 12.5 28.7 36.0 13.9 28.4 21.6 0.0 6.8 1.9 19.8 12.1 12.7 10.6 9.2 15.3 11.1 8.7 8.9 12.0 0.1 14.0 14.1 7.9 9.3 8.9 23.0 28.8 25.2 50.8 20.8 23.9 21.9 29.8 34.5 15.3 PPP6R2 "dJ579N16.1, KIAA0685, SAP190, SAPS2" ENSG00000100239 "Protein phosphatase 6 regulatory subunit 2" O75170 22 50343304-50445090 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030656, CAB034919" Uncertain Supported Vesicles,Cytosol "Vesicles, Cytosol" "CAB034919: AB_2183817, HPA030656: AB_10602926" "unprognostic (1.24e-1)" "unprognostic (1.82e-3)" "unprognostic (1.03e-1)" "prognostic favourable (1.70e-5)" "unprognostic (2.17e-1)" "unprognostic (3.79e-3)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-2)" "prognostic favourable (7.51e-4)" "unprognostic (6.89e-2)" "unprognostic (1.42e-2)" "unprognostic (1.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (7.77e-3)" 16.8 22.1 21.3 19.6 20.7 17.9 32.2 39.0 52.7 13.0 15.8 18.5 20.6 23.1 17.2 13.3 18.6 16.2 17.3 25.6 19.8 18.3 18.7 40.6 19.0 32.8 19.8 22.4 16.8 23.7 19.7 26.7 14.9 19.4 19.8 11.7 20.2 26.3 18.2 47.3 25.8 20.0 21.2 20.4 21.2 22.5 37.8 17.3 21.1 21.1 11.7 18.5 15.6 13.6 9.8 12.3 16.0 10.3 6.4 14.3 8.5 16.1 9.5 14.9 18.9 11.0 11.8 13.4 16.2 17.3 17.3 17.6 8.0 10.0 19.5 8.0 16.0 13.2 9.1 12.0 6.5 10.0 16.9 10.4 18.3 19.7 14.4 24.3 28.6 17.5 13.1 10.4 5.6 15.1 10.6 17.1 12.5 26.1 16.6 17.7 6.1 11.9 23.4 11.4 12.7 12.7 19.2 9.4 12.6 16.6 25.9 13.1 9.3 18.6 17.3 16.2 14.7 13.4 10.6 18.4 4.4 17.2 16.9 12.0 22.2 4.0 9.6 6.3 10.8 10.3 12.7 9.5 7.6 11.5 9.8 9.8 7.4 9.5 16.0 6.4 7.4 12.3 14.3 8.5 21.3 20.7 39.0 52.7 19.8 18.3 19.8 22.4 19.4 17.3 PPT1 "CLN1, INCL, PPT" ENSG00000131238 "Palmitoyl-protein thioesterase 1" P50897 1 40071461-40097727 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 86.0;THP-1: 159.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021546 Supported Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" 130000 "Golgi apparatus, Vesicles" "HPA021546: AB_1855667" "unprognostic (5.02e-2)" "unprognostic (2.73e-1)" "unprognostic (1.64e-1)" "unprognostic (2.06e-3)" "unprognostic (6.68e-2)" "unprognostic (2.83e-2)" "prognostic unfavourable (6.98e-8)" "unprognostic (1.39e-1)" "unprognostic (1.78e-1)" "unprognostic (1.23e-1)" "unprognostic (8.16e-2)" "unprognostic (2.39e-1)" "unprognostic (5.20e-3)" "unprognostic (1.75e-1)" "unprognostic (2.30e-1)" "unprognostic (2.93e-2)" "unprognostic (2.08e-2)" 33.3 27.1 37.6 31.0 41.5 33.3 39.7 35.2 41.0 30.3 21.0 31.5 17.2 12.9 31.3 19.4 18.5 20.7 23.2 18.1 32.7 35.8 29.4 18.4 47.3 48.5 35.3 29.1 24.7 17.4 30.4 21.2 25.9 34.6 28.0 26.0 26.3 22.1 23.6 8.3 13.8 16.6 36.5 33.6 61.3 17.9 13.8 29.1 19.8 18.7 14.4 30.0 23.0 19.8 9.3 77.4 59.9 90.0 7.2 19.1 91.6 10.0 6.8 11.0 6.2 13.3 11.4 21.6 5.6 10.2 13.6 16.8 39.2 16.9 11.5 11.0 5.9 17.7 17.1 10.1 18.7 14.5 17.6 6.0 16.8 19.3 15.1 13.5 14.5 10.7 11.1 10.8 10.1 18.3 13.9 16.8 7.6 20.1 7.7 10.1 20.8 10.6 8.7 14.8 20.0 9.5 18.0 8.8 9.3 11.0 86.0 34.2 12.5 159.9 6.4 6.6 14.2 6.2 16.7 15.1 31.6 11.1 8.5 33.0 12.0 6.2 90.0 48.2 9.9 77.6 11.8 9.3 14.7 11.5 77.4 9.2 19.1 14.7 59.9 7.2 58.3 7.6 16.8 91.6 37.6 41.5 35.2 41.0 32.7 35.8 35.3 29.1 34.6 29.1 PQLC2 FLJ20320 ENSG00000040487 "PQ loop repeat containing 2" Q6ZP29 1 19312326-19329300 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057810 Approved Supported Vesicles Vesicles "HPA057810: " "unprognostic (7.84e-3)" "unprognostic (6.56e-2)" "unprognostic (6.54e-2)" "prognostic favourable (3.50e-4)" "unprognostic (3.77e-3)" "unprognostic (2.19e-1)" "prognostic unfavourable (2.64e-5)" "unprognostic (2.61e-1)" "unprognostic (4.47e-2)" "unprognostic (1.04e-1)" "unprognostic (1.42e-3)" "unprognostic (3.82e-2)" "unprognostic (4.70e-3)" "unprognostic (8.64e-2)" "unprognostic (2.07e-1)" "unprognostic (6.56e-2)" "unprognostic (4.46e-2)" 10.9 19.9 11.7 8.5 12.3 18.4 9.4 28.8 16.2 12.2 13.1 16.8 8.6 16.9 11.5 15.5 9.2 8.8 11.1 9.3 10.6 11.2 11.9 20.3 12.1 11.1 14.3 9.1 10.9 19.4 10.0 19.4 24.8 14.4 11.7 7.7 18.9 12.1 11.0 10.9 15.3 16.2 9.3 12.2 12.2 13.3 13.8 10.9 6.2 14.0 9.2 10.5 8.0 9.0 5.1 16.7 7.8 10.1 2.9 3.4 3.5 8.2 8.7 8.2 13.0 8.0 7.5 10.4 10.4 14.3 14.5 12.4 12.6 10.4 2.6 13.6 7.6 6.2 7.9 9.3 6.6 5.5 9.7 2.0 7.4 13.5 22.9 1.7 3.6 12.4 9.8 20.5 6.5 5.6 14.8 6.1 13.9 7.4 1.1 5.7 7.8 7.8 4.5 10.3 4.6 10.9 5.4 10.1 8.4 7.8 5.3 19.8 8.8 20.4 7.4 12.2 7.1 20.5 9.1 10.8 7.5 1.4 14.9 10.3 9.9 0.9 8.7 7.8 3.2 7.1 2.4 5.1 3.4 2.7 11.1 5.0 1.0 2.1 5.4 2.9 10.1 16.7 3.1 3.5 11.7 12.3 28.8 16.2 10.6 11.2 14.3 9.1 14.4 10.9 PRAF2 "JM4, Yip6a" ENSG00000243279 "PRA1 domain family member 2" O60831 X 49071156-49074071 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 125.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002859, HPA005504, CAB011655" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "CAB011655: , HPA002859: AB_1079672, HPA005504: " "unprognostic (1.50e-1)" "prognostic favourable (7.42e-4)" "unprognostic (1.17e-2)" "unprognostic (1.32e-2)" "unprognostic (4.29e-1)" "unprognostic (3.67e-1)" "prognostic unfavourable (1.66e-6)" "prognostic favourable (2.81e-4)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "prognostic favourable (4.88e-6)" "unprognostic (8.39e-3)" "prognostic unfavourable (5.83e-6)" "unprognostic (4.96e-2)" "unprognostic (1.69e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" 13.5 17.5 25.0 12.3 26.9 6.7 9.0 18.0 39.7 28.1 11.8 26.3 12.6 6.0 22.1 125.1 7.3 15.6 12.3 12.9 25.3 29.9 12.4 6.9 11.5 11.3 26.1 18.9 20.1 6.2 19.7 31.0 9.8 25.5 12.2 10.0 13.0 7.5 29.4 6.8 7.6 6.6 33.2 23.1 10.9 9.2 17.7 17.0 14.4 13.3 3.8 11.9 12.6 10.7 14.6 6.7 16.4 6.4 16.8 29.4 11.1 4.5 9.5 11.1 14.1 40.0 24.3 1.4 16.1 16.9 11.0 12.1 0.5 1.4 0.4 3.9 34.9 4.2 0.4 8.7 12.2 8.3 12.6 3.6 12.3 0.4 41.0 2.3 7.0 30.9 7.5 20.8 15.2 16.8 0.5 1.2 19.1 8.3 14.9 2.8 6.2 0.6 8.2 6.1 0.9 16.3 1.3 7.4 18.5 13.5 7.0 9.2 6.8 1.6 10.1 8.5 11.3 18.2 4.7 20.1 5.1 3.6 20.4 4.1 13.1 16.4 5.9 7.9 18.3 6.4 20.7 14.6 20.1 16.1 6.7 13.6 18.1 19.4 15.4 16.8 4.8 2.6 29.4 11.1 25.0 26.9 18.0 39.7 25.3 29.9 26.1 18.9 25.5 17.0 PRCP "HUMPCP, PCP" ENSG00000137509 Prolylcarboxypeptidase P42785 11 82823502-82970584 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 97.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017065, HPA071115" Approved Supported Vesicles "Intracellular and membrane" 34000000 Vesicles "HPA017065: AB_1855676, HPA071115: " "unprognostic (3.24e-1)" "unprognostic (2.25e-1)" "unprognostic (1.76e-1)" "unprognostic (1.51e-1)" "unprognostic (2.54e-1)" "unprognostic (1.33e-2)" "unprognostic (9.22e-2)" "unprognostic (1.42e-1)" "unprognostic (7.97e-2)" "unprognostic (2.61e-1)" "unprognostic (2.70e-1)" "unprognostic (1.88e-2)" "prognostic favourable (2.65e-6)" "unprognostic (7.16e-2)" "unprognostic (1.73e-2)" "unprognostic (3.49e-1)" "unprognostic (4.07e-1)" 32.6 45.9 25.0 21.5 22.2 13.1 69.5 19.4 23.8 38.8 17.9 17.9 27.6 11.0 30.7 35.5 32.2 24.6 25.6 66.3 25.8 18.9 52.4 52.5 38.1 95.1 27.0 14.8 27.8 23.4 30.6 19.3 59.8 34.9 25.1 18.4 25.1 38.1 34.5 10.3 26.2 15.7 32.8 45.0 25.1 16.8 17.4 17.7 9.8 27.9 24.2 31.7 39.4 30.1 13.1 50.0 31.2 27.9 12.1 6.2 14.7 7.5 8.2 12.6 25.4 97.9 35.9 14.8 16.0 28.6 15.4 22.5 20.3 15.5 10.8 23.4 23.2 11.9 11.5 10.5 18.0 9.6 8.3 7.7 11.4 12.6 18.3 6.9 28.2 26.2 8.3 16.0 15.2 50.8 8.3 15.2 15.7 3.4 1.0 24.7 7.3 7.7 5.6 21.9 12.9 21.5 13.8 5.3 11.5 21.9 12.7 9.0 15.2 9.5 13.2 18.1 18.1 15.6 7.8 14.3 24.4 9.6 7.4 8.4 9.3 15.5 26.4 17.4 5.3 27.9 6.1 9.9 5.3 5.8 50.0 13.1 4.4 6.2 31.2 12.1 21.2 8.9 5.0 14.7 25.0 22.2 19.4 23.8 25.8 18.9 27.0 14.8 34.9 17.7 PRDM10 "KIAA1231, MGC131802, PFM7" ENSG00000170325 "PR/SET domain 10" Q9NQV6 11 129899706-130002835 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026997 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoplasm, Nucleoli fibrillar center, Vesicles" "HPA026997: AB_1855681" "unprognostic (4.40e-2)" "unprognostic (2.17e-1)" "unprognostic (5.32e-3)" "unprognostic (2.03e-1)" "unprognostic (1.50e-1)" "unprognostic (1.52e-3)" "unprognostic (2.19e-2)" "unprognostic (2.48e-1)" "unprognostic (1.87e-3)" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (3.57e-2)" "unprognostic (1.87e-1)" "unprognostic (5.69e-2)" "unprognostic (4.88e-1)" "unprognostic (6.23e-2)" "unprognostic (1.51e-1)" 5.8 5.4 7.6 7.2 8.9 14.2 8.5 20.3 10.4 7.4 7.8 6.4 5.8 6.6 8.2 6.8 8.4 5.4 5.5 4.6 7.7 6.2 5.0 7.3 6.3 6.9 6.6 6.5 7.3 6.2 9.7 11.2 8.3 6.4 7.1 8.0 5.5 6.7 5.4 12.9 12.1 7.0 6.1 6.3 6.7 7.8 5.6 6.3 14.4 6.5 4.7 9.9 6.2 7.0 8.8 3.3 9.4 3.8 7.1 5.0 1.8 2.9 4.0 5.0 3.3 2.3 2.8 3.3 2.5 3.2 2.1 2.7 4.1 3.2 11.9 3.1 2.9 4.0 4.2 2.1 3.4 4.6 4.1 7.8 4.9 3.1 1.5 7.1 32.6 1.9 4.7 3.1 2.0 3.7 4.3 4.5 3.0 3.5 4.7 3.5 3.8 2.9 4.4 3.2 1.8 3.0 5.4 5.5 2.9 3.6 4.2 1.1 2.9 3.0 3.6 4.9 2.2 2.5 3.2 1.1 1.9 16.5 2.2 3.8 4.4 3.9 3.4 8.5 4.5 3.4 4.1 8.8 3.5 3.5 3.3 6.0 5.0 2.4 9.4 7.1 3.8 3.2 4.1 1.8 7.6 8.9 20.3 10.4 7.7 6.2 6.6 6.5 6.4 6.3 PREX1 "KIAA1415, P-REX1" ENSG00000124126 "Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1" Q8TCU6 20 48624252-48827883 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.7;brain: 35.5" "Cell line enhanced" "Detected in many" "MCF7: 43.2;SK-BR-3: 45.3;T-47d: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001927 Supported Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA001927: AB_1079674" "unprognostic (8.07e-2)" "unprognostic (3.16e-2)" "unprognostic (2.15e-2)" "unprognostic (2.55e-1)" "unprognostic (7.47e-2)" "prognostic favourable (8.56e-4)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (5.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.70e-2)" "unprognostic (5.86e-3)" "unprognostic (6.84e-2)" "unprognostic (2.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" 10.8 8.1 20.5 25.1 24.9 32.7 12.4 11.4 25.0 9.6 5.1 35.5 0.2 4.6 3.2 2.7 4.8 3.7 9.5 4.9 21.8 15.5 4.1 4.0 17.7 28.3 26.2 12.1 2.2 3.9 5.2 5.8 8.4 17.4 3.9 4.6 7.7 4.0 2.8 4.6 2.7 8.6 5.6 27.6 28.7 6.1 4.5 23.9 2.8 6.7 1.0 15.1 10.3 2.5 2.0 2.1 11.7 2.7 2.1 9.3 2.2 0.6 1.6 22.0 0.0 0.3 1.6 7.7 0.7 0.9 3.1 0.8 0.1 0.0 4.4 14.0 1.9 0.2 1.1 0.0 2.1 1.0 0.5 0.6 2.5 0.0 1.3 2.3 14.4 1.8 0.0 7.2 0.0 19.0 0.0 0.1 4.1 43.2 0.0 6.8 0.8 1.8 6.4 6.4 2.6 0.1 0.0 4.6 0.7 4.0 45.3 5.0 40.5 18.5 21.2 1.2 4.5 0.0 1.2 0.2 0.9 5.4 20.6 4.8 6.7 5.2 2.3 2.5 5.0 2.7 3.0 2.0 2.7 4.2 2.1 1.7 0.4 1.5 11.7 2.1 2.3 1.7 9.3 2.2 20.5 24.9 11.4 17.7 21.8 15.5 26.2 12.1 17.4 23.9 PRICKLE2 DKFZp686D143 ENSG00000163637 "Prickle planar cell polarity protein 2" Q7Z3G6 3 64092242-64445476 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epilepsy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 18.1;ASC TERT1: 11.3;HSkMC: 16.6;U-87 MG: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.1;NK-cell: 1.1" "Group enriched" "Detected in many" 6 "B-cells: 2.1;NK-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035493 Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA035493: AB_10696504" "unprognostic (2.87e-1)" "unprognostic (4.31e-1)" "unprognostic (4.45e-2)" "unprognostic (1.25e-1)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (1.92e-1)" "unprognostic (3.83e-2)" "unprognostic (3.03e-2)" "unprognostic (6.35e-2)" "unprognostic (1.32e-3)" "unprognostic (1.10e-2)" "unprognostic (1.91e-1)" "unprognostic (9.04e-3)" "unprognostic (1.77e-1)" 26.5 4.9 15.2 6.9 14.2 1.3 19.8 2.6 23.0 24.4 20.4 5.2 13.8 3.9 24.8 13.7 11.2 14.3 12.6 7.8 15.7 8.4 6.0 4.9 13.2 1.8 7.0 13.2 12.7 5.5 13.3 8.7 8.1 8.9 11.0 7.1 8.7 6.1 19.9 2.6 5.3 7.4 22.8 6.2 2.7 11.4 2.9 5.5 0.0 9.9 3.6 2.2 14.9 18.2 2.1 0.0 0.2 0.0 1.1 0.1 0.1 0.0 3.4 0.9 0.0 18.1 11.3 0.0 2.5 3.2 2.1 3.1 5.9 0.1 0.0 0.3 2.4 0.1 0.0 2.3 2.1 2.3 0.1 0.0 0.3 0.0 5.1 0.0 0.0 16.6 2.9 6.0 2.6 1.2 0.0 1.3 2.8 3.2 0.0 0.0 2.2 0.0 0.0 0.1 0.1 3.3 8.3 0.9 0.1 0.0 0.6 0.1 1.2 0.1 0.1 8.9 4.1 2.1 4.9 2.7 0.0 0.5 11.5 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.1 15.2 14.2 2.6 21.6 15.7 8.4 7.0 13.2 8.9 5.5 PRIM1 ENSG00000198056 "DNA primase subunit 1" P49642 12 56731596-56752373 "Predicted intracellular proteins" "DNA replication, Transcription" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040010 Uncertain Supported Vesicles Vesicles "HPA040010: AB_10805599" "unprognostic (3.04e-3)" "unprognostic (1.67e-2)" "unprognostic (2.12e-2)" "unprognostic (1.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.61e-2)" "prognostic unfavourable (2.40e-8)" "unprognostic (4.68e-2)" "unprognostic (2.73e-3)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (1.82e-1)" "unprognostic (1.98e-3)" "unprognostic (3.94e-1)" "unprognostic (2.16e-1)" "unprognostic (5.35e-2)" "unprognostic (6.53e-2)" 5.7 5.2 6.7 9.8 9.3 26.0 10.1 16.0 10.6 6.0 8.2 6.7 5.5 4.5 6.2 4.9 9.6 6.2 3.1 4.0 7.6 4.6 4.5 8.2 5.4 11.1 9.2 4.6 9.7 10.7 7.9 12.3 5.0 7.9 5.2 11.1 5.3 7.0 4.3 6.3 7.9 8.3 6.1 11.8 10.2 6.3 17.0 10.8 28.3 5.1 6.8 13.2 5.6 6.9 8.6 6.3 3.5 6.2 5.3 12.7 4.6 12.2 10.5 14.6 9.0 1.7 2.6 17.2 10.4 8.5 18.5 17.3 11.4 15.8 24.0 8.7 4.8 12.4 17.7 11.3 20.3 11.9 10.9 31.7 6.8 10.9 0.5 38.8 13.4 1.1 2.1 16.3 7.1 6.6 29.9 38.0 10.7 9.0 22.2 14.7 16.3 13.3 25.0 25.7 20.7 4.4 9.3 14.9 13.3 12.4 6.0 5.6 19.4 14.9 3.0 9.6 22.8 10.0 13.1 13.8 27.6 13.6 5.9 16.5 12.7 1.4 1.4 3.5 7.8 3.4 9.0 8.6 10.5 7.5 3.4 8.2 12.7 10.0 0.0 5.3 6.2 6.3 9.1 4.6 6.7 9.3 16.0 10.6 7.6 4.6 9.2 4.6 7.9 10.8 PRKCE ENSG00000171132 "Protein kinase C epsilon" Q02156 2 45651345-46187990 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.5" "Cell line enhanced" "Detected in many" "REH: 19.1;TIME: 19.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 5.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001948, HPA044496, HPA054252" Enhanced Supported Approved Vesicles Vesicles "CAB001948: , HPA044496: , HPA054252: " "unprognostic (1.10e-1)" "unprognostic (1.78e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (2.42e-4)" "unprognostic (9.61e-2)" "unprognostic (5.70e-2)" "unprognostic (1.51e-1)" "prognostic favourable (9.62e-4)" "unprognostic (3.05e-1)" "unprognostic (6.72e-2)" "unprognostic (7.49e-3)" "unprognostic (9.99e-2)" "prognostic favourable (2.63e-7)" "unprognostic (1.21e-1)" "unprognostic (7.11e-2)" "unprognostic (6.43e-3)" "unprognostic (2.23e-2)" 5.5 7.4 15.3 7.2 14.2 9.3 8.1 28.8 36.5 6.6 5.5 3.8 5.9 3.6 5.6 4.6 4.7 7.6 4.7 7.7 22.5 10.0 12.8 15.5 17.5 6.9 6.0 15.0 4.1 4.2 16.3 6.0 10.4 9.1 3.6 4.7 3.7 3.6 8.6 7.2 3.0 3.7 6.2 4.4 4.9 4.4 7.2 3.7 1.5 6.5 1.2 5.4 5.0 6.5 5.5 2.2 1.7 1.4 0.9 1.3 0.6 5.3 2.0 2.8 2.8 4.3 5.1 2.3 3.8 6.8 3.2 3.4 0.5 5.3 8.1 3.6 3.9 1.3 1.8 2.0 4.5 4.8 3.4 0.0 1.4 1.1 4.9 0.6 2.9 4.5 2.2 4.7 3.4 11.6 1.1 1.9 3.6 2.7 2.6 0.3 1.0 1.0 19.1 13.5 8.6 2.9 3.7 2.0 4.3 1.7 5.7 12.3 4.6 1.9 19.2 6.2 6.5 4.5 3.7 0.0 0.0 6.8 5.1 4.5 6.2 0.0 1.2 1.7 1.0 0.4 1.1 3.6 0.7 0.7 2.2 5.5 1.3 0.4 0.4 0.9 1.4 0.9 0.0 0.6 15.3 14.2 28.8 33.2 22.5 10.0 6.0 15.0 9.1 3.7 PRKG1 "PGK, PKG, PRKG1B, PRKGR1B" ENSG00000185532 "Protein kinase, cGMP-dependent, type I" Q13976 10 50990891-52298350 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 11.3;BJ hTERT+: 15.5;fHDF/TERT166: 12.9;U-138 MG: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "basophil: 8.0" "Lineage enriched" "Detected in single" 24 "granulocytes: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007699, CAB009629" Enhanced Approved Vesicles,Cytosol 33000 "Vesicles, Cytosol" "CAB009629: AB_2170663, HPA007699: AB_1079677" "unprognostic (3.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.44e-2)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.86e-1)" "unprognostic (5.54e-1)" "unprognostic (2.23e-1)" "unprognostic (4.94e-1)" "unprognostic (2.05e-2)" "unprognostic (1.22e-2)" "unprognostic (3.40e-1)" "unprognostic (9.26e-2)" "unprognostic (5.50e-3)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (3.78e-4)" 8.0 10.9 5.2 6.6 7.3 0.8 6.9 2.8 5.4 19.2 14.4 2.1 6.8 2.9 22.8 10.7 6.0 9.9 12.6 14.8 7.0 4.9 4.4 2.1 19.5 2.6 3.1 4.8 8.9 2.6 13.7 8.4 11.0 4.6 9.5 6.2 6.2 6.4 9.4 24.9 2.8 5.3 28.2 2.7 2.7 5.9 5.0 3.1 0.2 9.2 12.7 1.2 13.4 15.8 0.1 0.1 8.0 0.1 0.3 0.0 0.1 0.0 0.1 1.4 11.3 5.4 5.2 0.0 4.9 15.5 1.6 2.3 0.1 0.7 0.2 0.0 12.9 0.1 0.0 0.0 1.4 0.0 4.2 0.8 0.3 0.0 4.7 0.0 0.0 6.6 0.0 4.1 0.1 0.0 0.0 0.1 4.3 0.1 0.0 0.0 3.2 1.9 0.0 3.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.1 0.1 0.0 0.0 9.5 1.7 4.8 2.9 1.2 0.5 0.0 8.4 0.0 2.0 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.1 5.2 7.3 2.8 5.4 7.0 4.9 3.1 4.8 4.6 3.1 PRNP "AltPrP, CD230, CJD, GSS, PRIP, PRP" ENSG00000171867 "Prion protein" P04156 20 4686236-4701590 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Growth arrest" Prion "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 108.1" "Lineage enriched" "Detected in all" 6 "granulocytes: 108.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042754, HPA043398" Enhanced Approved "Nuclear membrane,Vesicles,Cytosol" "Intracellular and membrane" 2200000 "Nuclear membrane, Cytosol" Vesicles "HPA042754: AB_10964203, HPA043398: " "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "prognostic unfavourable (2.96e-4)" "prognostic unfavourable (4.64e-4)" "prognostic unfavourable (2.52e-4)" "unprognostic (1.94e-2)" "prognostic unfavourable (7.41e-5)" "unprognostic (7.60e-3)" "unprognostic (2.50e-1)" "unprognostic (7.12e-2)" "unprognostic (3.44e-1)" "unprognostic (1.04e-1)" "unprognostic (6.75e-2)" "unprognostic (7.28e-3)" "unprognostic (3.37e-1)" "unprognostic (2.04e-1)" "unprognostic (1.69e-2)" 24.6 27.3 63.4 14.2 73.1 19.8 30.5 87.5 116.1 42.0 43.4 61.6 8.5 10.6 36.3 17.7 23.0 24.1 31.4 54.1 64.6 48.9 38.5 22.2 22.2 14.7 47.2 65.6 49.6 11.8 20.7 24.9 18.7 71.6 43.8 20.9 34.1 17.1 45.0 21.8 26.7 13.5 40.8 53.1 20.3 18.1 19.1 51.4 2.9 25.6 11.8 16.4 27.0 22.3 4.6 10.5 108.1 11.7 3.6 16.7 10.0 24.2 20.0 4.6 7.1 37.3 22.8 4.1 40.2 57.9 19.5 19.9 6.6 18.8 4.4 9.3 78.3 56.5 5.0 54.7 36.6 3.6 4.3 0.0 2.3 20.6 45.9 7.9 1.8 20.6 78.9 83.4 65.2 16.7 2.3 15.8 22.4 5.4 3.1 4.8 3.7 29.8 3.8 12.2 4.0 9.8 4.3 5.4 0.8 11.4 16.0 57.1 3.3 4.1 25.1 31.8 14.6 17.7 32.6 7.3 14.7 14.8 25.6 5.8 114.4 108.1 11.7 0.8 11.9 9.7 16.7 4.2 9.8 9.4 10.5 4.6 5.8 6.8 0.7 3.6 7.6 3.7 11.4 10.0 63.4 73.1 87.5 90.4 64.6 48.9 47.2 65.6 71.6 51.4 PRPS2 ENSG00000101911 "Phosphoribosyl pyrophosphate synthetase 2" P11908 X 12791355-12824222 "Enzymes, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 138.1;testis: 109.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067599, CAB070417" Enhanced Uncertain Vesicles Vesicles "CAB070417: AB_11152035, HPA067599: " "unprognostic (7.50e-2)" "prognostic favourable (1.90e-4)" "unprognostic (2.09e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-2)" "unprognostic (1.10e-1)" "unprognostic (7.63e-2)" "unprognostic (4.75e-2)" "unprognostic (6.98e-2)" "unprognostic (2.64e-3)" "unprognostic (4.44e-3)" "unprognostic (1.81e-1)" "unprognostic (7.83e-2)" "unprognostic (2.20e-1)" "unprognostic (1.50e-1)" "unprognostic (1.35e-1)" "unprognostic (2.04e-1)" 5.4 20.8 4.0 10.2 8.7 6.1 6.1 3.7 11.5 18.7 13.3 5.7 44.4 4.1 17.0 21.7 9.6 9.6 13.2 3.3 4.0 3.5 10.8 9.0 5.4 10.7 2.7 7.7 75.3 19.9 20.1 2.4 3.2 2.9 14.9 10.2 4.4 11.1 138.1 1.5 10.3 6.3 12.2 3.9 7.6 14.3 109.7 3.1 26.2 7.8 5.5 10.9 15.1 10.2 21.9 17.7 10.5 12.5 15.0 22.7 16.7 31.0 20.6 7.2 13.0 8.9 10.5 4.0 15.5 8.5 17.2 16.7 14.6 25.0 9.1 7.0 7.4 23.6 13.8 16.9 20.3 24.5 29.8 11.2 17.0 13.5 8.2 22.1 11.5 10.1 11.4 12.7 17.0 7.0 8.3 12.7 14.5 21.4 33.7 10.2 15.3 27.8 18.0 30.8 23.3 10.3 25.8 13.9 9.4 18.7 0.7 11.7 18.6 10.0 6.5 13.5 9.8 49.5 16.5 30.0 11.0 21.7 14.2 11.2 21.2 10.5 12.5 5.6 11.7 12.4 13.6 18.0 17.0 11.1 17.7 21.9 22.7 15.3 5.5 15.0 7.7 12.6 14.0 16.7 4.0 8.7 3.7 11.5 4.0 3.5 2.7 7.7 2.9 3.1 PRR15 ENSG00000176532 "Proline rich 15" Q8IV56 7 29563811-29567295 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 66.1" "Cell line enhanced" "Detected in many" "BEWO: 13.2;CAPAN-2: 17.2;HaCaT: 19.9;RT4: 15.2;SK-BR-3: 33.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Lineage enhanced" "Detected in single" "B-cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040996, HPA048121" Enhanced Uncertain "Vesicles,Cell Junctions" Vesicles "Cell Junctions" "HPA040996: , HPA048121: " "unprognostic (5.46e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "prognostic favourable (6.37e-4)" "unprognostic (7.49e-2)" "unprognostic (1.96e-2)" "unprognostic (2.00e-1)" "prognostic unfavourable (7.23e-4)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (3.69e-3)" "unprognostic (1.25e-1)" "prognostic favourable (1.83e-6)" "unprognostic (1.30e-2)" "unprognostic (5.71e-2)" "unprognostic (2.33e-3)" "unprognostic (1.58e-2)" 3.8 0.5 0.7 14.4 0.4 0.0 3.1 0.4 0.8 22.8 58.9 0.8 2.6 24.8 6.8 13.3 0.7 2.9 12.1 1.0 0.6 0.5 12.7 0.5 3.7 0.6 0.4 0.4 4.0 2.0 0.0 2.7 19.0 0.5 2.7 18.5 0.3 4.6 0.9 0.5 0.3 66.1 1.1 1.1 0.4 16.6 1.4 0.4 0.3 1.0 1.0 1.9 7.0 1.9 1.6 0.0 0.0 0.5 0.0 0.0 0.6 7.2 10.3 0.0 0.0 4.0 5.0 13.2 0.3 0.5 0.2 0.1 9.0 17.2 0.0 1.9 2.4 19.9 2.2 0.0 0.0 0.0 1.4 0.5 1.9 9.8 1.3 0.0 0.0 0.0 3.3 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.2 1.4 1.6 8.2 0.0 0.0 9.1 11.9 15.2 0.2 0.1 1.0 33.5 0.0 2.4 0.0 8.8 0.2 0.0 0.0 0.4 0.8 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.4 0.4 0.8 0.6 0.5 0.4 0.4 0.5 0.4 PRR22 MGC24975 ENSG00000212123 "Proline rich 22" Q8IZ63 19 5782960-5784765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 82.5" "Cell line enhanced" "Detected in many" "HMC-1: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044157 Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA044157: AB_10960694" "unprognostic (8.09e-2)" "unprognostic (1.53e-3)" "unprognostic (5.19e-3)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-1)" "unprognostic (3.20e-2)" "unprognostic (2.89e-2)" "unprognostic (1.20e-1)" "unprognostic (3.77e-2)" "unprognostic (3.42e-3)" "unprognostic (9.37e-3)" "unprognostic (4.18e-2)" "unprognostic (9.93e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-1)" "unprognostic (2.79e-3)" 1.1 1.0 1.1 1.7 1.5 2.0 1.1 1.1 1.7 1.1 1.3 1.2 1.1 3.1 1.1 1.1 1.6 2.5 1.1 1.1 1.1 0.7 2.4 4.4 1.1 1.5 1.1 1.1 1.1 2.7 1.0 1.2 1.1 1.1 2.7 0.3 1.1 3.2 1.1 1.1 5.4 3.3 1.1 1.1 2.7 2.4 82.5 1.1 1.1 2.3 1.1 1.1 1.1 1.1 0.2 0.0 0.0 0.2 0.0 0.9 0.1 1.8 3.1 1.3 6.6 0.0 0.2 6.5 1.3 0.5 1.0 1.6 3.1 1.8 2.9 3.7 0.2 2.3 1.0 1.3 0.2 4.5 10.2 1.3 1.3 1.1 0.5 3.1 15.9 0.8 1.1 1.4 0.4 0.2 7.1 0.0 0.8 6.8 3.5 3.8 8.1 3.2 3.4 1.2 4.5 0.2 2.1 1.7 3.2 0.3 2.4 3.6 2.7 2.5 1.0 2.4 6.7 8.6 1.6 9.3 7.2 5.5 0.2 6.2 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.9 0.4 0.0 0.0 0.2 0.0 0.0 0.1 1.1 1.5 1.1 1.1 1.1 0.7 1.1 1.1 1.1 1.1 PRRC1 FLJ32875 ENSG00000164244 "Proline rich coiled-coil 1" Q96M27 5 127517609-127555089 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039212 Supported Approved Vesicles 80000 Vesicles "HPA039212: AB_10794634" "prognostic unfavourable (9.35e-5)" "unprognostic (9.01e-2)" "unprognostic (5.26e-3)" "unprognostic (6.36e-2)" "unprognostic (2.95e-1)" "unprognostic (4.47e-2)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" "unprognostic (6.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.74e-3)" "unprognostic (5.53e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-1)" "unprognostic (2.83e-1)" "unprognostic (3.45e-3)" "unprognostic (2.19e-1)" 19.1 22.3 9.2 13.3 10.2 14.3 19.3 12.7 11.0 24.0 23.3 13.0 24.5 19.5 26.5 21.9 23.0 17.6 18.0 17.2 8.5 8.5 26.5 40.0 17.1 21.1 11.3 8.3 25.2 55.7 28.0 38.6 42.3 10.8 18.2 21.9 17.2 47.6 24.5 13.1 21.3 36.7 17.8 12.5 19.4 18.4 18.0 11.9 30.4 23.4 16.7 28.3 21.7 19.7 14.3 13.3 11.5 11.6 10.1 20.7 9.7 13.0 13.4 20.1 15.2 27.2 34.9 23.5 23.1 26.0 20.7 32.9 22.9 15.4 14.6 24.2 36.8 11.9 15.6 28.7 32.2 20.2 10.9 12.7 13.5 19.8 15.7 11.7 16.7 23.8 21.1 21.9 25.7 22.0 10.9 18.0 23.9 14.8 22.9 12.7 11.5 17.7 8.9 26.6 18.9 16.3 16.5 14.7 11.4 18.1 19.8 17.0 21.2 15.4 25.9 19.1 14.3 22.2 16.2 15.2 11.3 19.2 22.5 18.8 18.7 11.5 9.9 7.7 16.8 11.6 20.7 14.3 14.0 14.5 13.3 10.2 15.6 13.8 3.0 10.1 10.8 9.0 10.9 9.7 9.2 10.2 12.7 11.0 8.5 8.5 11.3 8.3 10.8 11.9 PRRG1 PRGP1 ENSG00000130962 "Proline rich and Gla domain 1" O14668 X 37349275-37457295 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078129 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA078129: " "unprognostic (8.82e-2)" "prognostic unfavourable (4.65e-4)" "unprognostic (8.34e-2)" "unprognostic (2.08e-3)" "unprognostic (1.92e-1)" "unprognostic (5.11e-3)" "unprognostic (2.24e-2)" "unprognostic (7.23e-3)" "unprognostic (1.01e-2)" "unprognostic (1.74e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (8.21e-2)" "prognostic favourable (2.05e-7)" "unprognostic (1.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.48e-1)" 11.6 5.5 12.0 3.1 22.0 0.7 5.8 2.6 18.7 6.7 5.7 35.9 4.6 4.1 6.2 2.5 5.9 4.0 12.4 8.5 17.9 10.7 14.9 10.7 6.3 2.5 31.0 9.9 6.2 2.6 1.2 2.3 10.6 21.3 5.1 6.0 3.0 3.9 11.6 19.3 3.1 4.3 7.5 43.4 4.0 3.4 2.4 23.7 0.0 11.6 2.9 1.6 5.9 4.5 0.6 0.2 2.6 1.7 0.2 0.4 0.1 14.7 3.4 2.7 2.7 9.2 7.5 1.2 6.2 8.4 2.3 4.0 8.1 9.5 0.0 10.9 4.9 4.8 7.4 4.7 3.9 0.0 2.4 2.6 3.5 2.7 11.3 0.0 3.4 11.6 4.0 4.4 3.7 11.7 1.2 0.0 7.8 1.1 0.0 0.0 3.3 7.0 0.0 6.1 0.0 38.6 0.7 0.0 0.0 4.6 7.3 2.8 0.0 1.6 8.3 3.5 2.1 6.8 1.9 0.0 0.0 0.0 3.5 0.0 3.3 2.6 1.7 0.1 0.2 0.5 0.2 0.6 0.1 0.3 0.1 0.4 0.2 0.4 0.8 0.2 0.2 0.2 0.2 0.1 12.0 22.0 2.6 13.9 17.9 10.7 31.0 9.9 21.3 23.7 PRSS1 TRY1 ENSG00000204983 "Serine protease 1" P07477 7 142749468-142753076 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1708 "pancreas: 3057.4" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;HDLM-2: 1.7;RPMI-8226: 6.9;U-2 OS: 4.1;U-251 MG: 1.5;U-266/84: 2.5" "Cancer enriched" "Detected in many" 224 "pancreatic cancer: 1920.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.7" "Low lineage specificity" "Detected in many" "CAB025487, CAB025538, HPA062452, HPA063471" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" 26000000000 Vesicles "Endoplasmic reticulum" "CAB025487: , CAB025538: , HPA062452: , HPA063471: " "unprognostic (6.55e-5)" "unprognostic (5.28e-1)" "unprognostic (7.58e-2)" "prognostic unfavourable (6.41e-6)" "unprognostic (8.26e-2)" "prognostic favourable (7.05e-4)" "unprognostic (1.35e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-1)" "prognostic favourable (4.91e-4)" "unprognostic (3.12e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.6 3057.4 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.0 1.7 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 1.5 0.0 2.5 0.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 PRSS2 TRY2 ENSG00000275896 "Serine protease 2" P07478 7 142760398-142774564 "Enzymes, Plasma proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 708 "pancreas: 6267.9" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 37.2" "Cancer enriched" "Detected in many" 72 "pancreatic cancer: 3463.4" "Group enriched" "Detected in some" 6 "basophil: 5.6;T-reg: 5.1" "Group enriched" "Detected in many" 6 "granulocytes: 5.6;T-cells: 5.1" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" 27000000000 Vesicles "Endoplasmic reticulum" "HPA062452: , HPA063471: " "prognostic favourable (2.32e-4)" "unprognostic (3.80e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-3)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-3)" "unprognostic (1.48e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (3.50e-1)" "unprognostic (5.36e-3)" "unprognostic (1.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6267.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 5.6 0.0 0.7 5.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.5 2.1 0.0 1.6 0.2 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.1 0.3 PRSS27 "CAPH2, MPN" ENSG00000172382 "Serine protease 27" Q9BQR3 16 2712418-2720551 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 94.1;lymphoid tissue: 97.2;tongue: 64.5" "Cell line enhanced" "Detected in some" "BEWO: 5.4;SK-BR-3: 21.8;T-47d: 12.8;U-266/70: 4.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.4;myeloid DC: 1.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;T-cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB024920, HPA028848" Approved Approved Vesicles "Secreted to digestive system" Vesicles "CAB024920: , HPA028848: " "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (3.46e-3)" "unprognostic (5.35e-2)" "unprognostic (5.25e-2)" "unprognostic (2.48e-2)" "unprognostic (2.56e-1)" "unprognostic (3.12e-1)" "unprognostic (4.66e-1)" "unprognostic (1.08e-1)" "unprognostic (3.79e-2)" "unprognostic (4.40e-3)" "unprognostic (4.03e-3)" "unprognostic (2.40e-1)" "unprognostic (2.26e-1)" "unprognostic (2.04e-2)" "unprognostic (1.28e-2)" 0.2 0.3 0.1 0.2 0.5 0.2 0.4 0.7 0.4 15.3 0.2 0.1 0.1 0.1 1.2 0.1 94.1 0.3 0.2 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.1 0.2 0.1 0.1 10.0 0.3 0.2 1.2 0.1 0.2 0.1 0.2 0.1 0.5 0.1 0.3 0.2 64.5 97.2 0.5 24.0 0.1 1.7 0.2 0.0 0.2 1.4 1.2 0.0 0.2 0.5 1.8 0.3 0.6 5.4 0.0 0.2 0.2 0.1 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.1 0.1 0.0 0.9 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.6 0.0 0.9 1.3 0.0 0.8 0.2 0.1 0.1 0.3 0.6 2.6 0.0 21.8 0.5 12.8 1.5 0.0 0.3 0.0 0.0 0.0 4.5 3.1 0.4 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.0 1.7 0.0 0.3 0.7 0.2 0.2 0.0 0.0 0.0 1.2 0.1 0.5 0.7 0.1 0.1 0.4 0.1 0.1 0.1 0.1 PRSS3 "PRSS4, TRY3, TRY4" ENSG00000010438 "Serine protease 3" P35030 9 33750466-33799231 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "pancreas: 984.9" "Cell line enriched" "Detected in some" 8 "PC-3: 121.9" "Group enriched" "Detected in many" 7 "colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 82 "basophil: 39.0" "Lineage enriched" "Detected in single" 82 "granulocytes: 39.0" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" 490000000 Vesicles "Endoplasmic reticulum" "HPA062452: , HPA063471: " "unprognostic (6.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (4.30e-4)" "unprognostic (3.18e-1)" "unprognostic (1.64e-1)" "unprognostic (3.29e-2)" "unprognostic (5.89e-3)" "unprognostic (1.38e-1)" "unprognostic (2.06e-3)" "unprognostic (1.10e-2)" "unprognostic (8.94e-2)" "unprognostic (7.75e-4)" "unprognostic (5.46e-3)" "unprognostic (2.13e-1)" "unprognostic (8.79e-2)" "unprognostic (4.96e-1)" 0.3 0.3 1.6 1.7 1.5 0.2 0.2 2.8 4.2 0.9 8.2 0.0 0.0 2.8 0.2 0.2 2.9 0.2 4.8 0.4 1.2 0.7 0.3 0.4 0.2 0.2 0.3 1.6 0.7 984.9 0.2 0.1 0.2 2.3 0.2 2.3 0.0 0.6 0.2 0.2 2.0 23.9 0.3 0.2 0.2 0.8 0.3 0.0 0.0 0.2 6.6 3.5 0.2 1.3 0.0 0.1 39.0 0.4 0.1 0.3 0.1 1.7 2.0 0.1 0.0 0.0 0.9 0.0 4.8 1.1 0.5 0.2 4.7 0.4 0.0 0.0 2.1 2.1 0.0 4.4 1.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.5 15.9 9.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 121.9 0.0 0.0 0.0 0.0 0.2 0.0 12.3 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 39.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 1.6 1.5 2.8 4.2 1.2 0.7 0.3 1.6 2.3 0.0 PRTG "FLJ25756, IGDCC5" ENSG00000166450 Protogenin Q2VWP7 15 55611546-55743090 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 16.5;thyroid gland: 23.9" "Cell line enriched" "Detected in many" 6 "AF22: 57.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 18 "monocytes: 1.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA032138 Approved "Vesicles,Plasma membrane,Cytosol" Cytosol "Vesicles, Plasma membrane" "HPA032138: AB_10669675" "unprognostic (2.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.32e-1)" "unprognostic (4.64e-2)" "unprognostic (2.07e-2)" "unprognostic (4.96e-4)" "unprognostic (1.82e-4)" "unprognostic (1.31e-1)" "unprognostic (3.19e-1)" "unprognostic (4.76e-3)" "unprognostic (1.37e-1)" "unprognostic (5.32e-2)" "unprognostic (5.67e-2)" "unprognostic (2.42e-6)" "unprognostic (8.81e-2)" "unprognostic (3.17e-2)" "unprognostic (2.70e-1)" 1.3 2.2 1.5 1.1 1.8 0.6 2.4 1.2 2.2 4.7 1.4 3.6 1.1 0.7 11.0 4.6 0.7 2.4 1.0 1.3 1.6 1.6 2.6 0.6 5.0 0.6 3.0 2.0 4.5 0.6 6.4 2.7 6.5 4.3 1.4 0.9 16.5 0.9 1.4 3.9 0.6 0.9 2.9 3.5 0.5 1.5 6.5 2.3 0.0 23.9 0.8 0.9 1.2 1.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.5 1.2 57.4 1.2 0.0 0.0 5.8 0.4 1.7 1.4 2.1 9.6 0.3 0.0 2.4 0.0 0.0 0.2 0.1 2.0 0.0 3.0 0.4 0.4 3.6 0.4 0.4 0.0 0.2 0.0 0.6 1.0 1.0 1.0 0.0 0.8 0.8 0.0 0.0 2.3 1.4 0.0 9.1 0.0 1.1 0.1 0.7 3.3 0.5 0.7 3.1 0.2 0.1 0.1 0.8 0.6 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.5 1.8 1.2 2.2 1.6 1.6 3.0 2.0 4.3 2.3 PRX KIAA1620 ENSG00000105227 Periaxin Q9BXM0 19 40393768-40413366 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 42.1;lung: 31.7;retina: 20.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "midbrain: 42.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Region enriched" "Detected in single" 21 "midbrain: 24.7" HPA001868 Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" "Golgi apparatus, Vesicles, Plasma membrane" "HPA001868: AB_2172440" "unprognostic (1.29e-2)" "unprognostic (3.04e-1)" "unprognostic (2.72e-2)" "unprognostic (9.72e-3)" "unprognostic (2.92e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (3.54e-2)" "unprognostic (5.82e-2)" "unprognostic (3.23e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-2)" "unprognostic (2.03e-3)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (9.97e-2)" 3.4 4.4 4.8 1.0 4.1 1.1 2.7 2.2 5.4 3.0 2.3 1.8 2.8 1.2 3.8 2.0 2.2 3.2 2.4 2.9 4.0 2.2 4.3 0.6 31.7 1.3 42.1 3.7 7.5 5.4 7.3 1.1 6.0 10.3 3.2 0.8 20.6 3.9 4.4 5.4 2.2 1.5 3.3 11.0 1.7 2.4 1.6 3.6 0.0 7.2 6.7 0.9 3.1 2.0 0.3 0.4 0.0 0.3 0.1 1.2 0.2 2.4 2.7 3.3 4.2 2.7 7.0 4.1 2.0 2.3 2.9 2.1 2.3 2.7 0.8 2.6 1.9 1.3 1.1 0.9 1.0 1.2 1.4 0.5 0.9 0.7 3.2 0.2 3.6 4.9 4.9 1.9 1.6 1.5 3.0 0.8 1.5 3.2 1.1 0.8 0.7 2.5 4.8 2.7 2.4 0.5 1.3 0.3 1.5 3.9 3.3 3.0 4.9 1.2 2.2 5.9 4.6 2.3 1.2 8.4 7.3 1.1 1.8 1.3 1.3 0.0 0.3 0.0 0.6 0.2 0.2 0.0 0.4 0.6 0.0 0.3 0.3 1.2 0.0 0.1 0.0 0.4 0.3 0.2 4.8 4.1 2.2 5.4 4.0 2.2 42.1 3.7 10.3 3.6 PSAP "GLBA, SAP1" ENSG00000197746 Prosaposin P07602 10 71816298-71851375 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Lipid metabolism, Sphingolipid metabolism" "Disease mutation, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 296.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 252.0;intermediate monocyte: 322.1;myeloid DC: 97.2;neutrophil: 80.8;non-classical monocyte: 263.2" "Group enriched" "Detected in all" 12 "dendritic cells: 97.2;granulocytes: 80.8;monocytes: 322.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004426, CAB004647" Supported Supported Vesicles "Intracellular and membrane" 86000000 Vesicles "CAB004647: AB_425625, HPA004426: AB_1079701" "unprognostic (4.43e-3)" "unprognostic (2.69e-1)" "unprognostic (1.64e-2)" "unprognostic (8.00e-2)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (8.36e-3)" "unprognostic (2.79e-1)" "unprognostic (3.31e-2)" "unprognostic (3.25e-2)" "unprognostic (2.30e-3)" "unprognostic (2.00e-2)" "unprognostic (3.62e-3)" "unprognostic (6.47e-2)" "unprognostic (4.42e-2)" "unprognostic (2.34e-1)" "unprognostic (2.06e-1)" 151.5 178.6 106.6 95.1 137.9 79.7 93.3 93.2 143.4 136.7 74.4 134.2 89.5 53.7 116.0 118.2 71.7 88.1 129.7 164.0 99.5 93.7 108.5 119.6 125.5 136.8 135.4 128.0 137.1 93.7 134.8 76.0 165.5 106.7 94.1 73.4 118.2 88.1 117.0 151.6 67.6 63.3 133.5 109.3 159.8 87.4 60.5 126.1 84.4 103.1 54.1 61.4 102.8 76.3 13.4 97.2 80.8 322.1 9.5 12.5 306.2 24.6 46.6 30.3 63.2 296.6 170.6 107.0 44.8 133.4 35.3 42.1 43.0 62.9 13.4 92.5 73.1 54.1 11.4 36.4 25.0 26.1 21.5 15.7 21.1 24.3 114.3 10.2 90.3 108.5 84.1 35.2 67.6 62.6 22.3 65.0 43.7 15.7 44.9 15.3 13.9 22.7 9.4 17.3 37.3 41.1 42.4 33.6 29.7 41.9 127.1 168.9 25.8 23.4 81.3 49.9 35.4 33.3 36.5 72.6 55.1 23.8 79.2 20.4 36.6 19.4 252.0 30.1 12.5 322.1 10.3 13.4 10.3 10.8 97.2 11.8 11.3 10.6 80.8 9.5 263.2 48.5 11.3 306.2 106.6 137.9 93.2 143.4 99.5 93.7 135.4 128.0 106.7 126.1 PSD3 "DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942" ENSG00000156011 "Pleckstrin and Sec7 domain containing 3" Q9NYI0 8 18527301-19084730 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.6;LHCN-M2: 22.4;U-87 MG: 24.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002455 Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA002455: " "unprognostic (3.87e-2)" "unprognostic (2.52e-2)" "prognostic favourable (7.55e-4)" "prognostic unfavourable (5.76e-5)" "unprognostic (2.56e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.84e-2)" "unprognostic (7.27e-2)" "unprognostic (3.39e-1)" "unprognostic (2.50e-3)" "unprognostic (2.13e-1)" "unprognostic (7.18e-3)" "unprognostic (3.71e-2)" "unprognostic (8.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.45e-1)" 2.3 15.5 18.3 2.7 40.5 1.3 5.2 51.6 50.7 11.3 5.7 13.4 2.5 4.2 7.8 3.6 4.8 2.6 6.5 21.8 23.2 9.3 2.1 15.6 4.1 2.2 10.0 27.6 16.0 8.3 9.5 9.6 5.6 10.7 3.7 6.5 5.4 3.2 5.5 1.3 3.9 4.3 5.2 7.4 8.4 8.0 12.7 11.4 0.0 5.4 1.4 3.1 6.1 3.3 3.1 0.6 2.3 1.3 1.9 2.0 0.7 5.0 2.6 11.9 0.0 4.3 26.6 0.6 2.7 4.2 2.4 5.1 1.5 2.0 3.0 1.7 10.9 0.4 3.4 4.7 4.7 0.0 3.1 0.2 2.1 0.2 7.8 0.0 0.1 7.0 3.0 13.5 2.4 3.2 0.3 2.4 22.4 1.7 0.0 0.5 2.3 7.0 2.3 10.4 1.3 6.2 6.5 5.1 5.7 1.1 0.5 1.8 0.0 1.2 13.1 7.6 5.3 17.9 2.3 0.2 0.3 6.9 24.0 1.2 2.6 2.3 1.3 1.3 1.0 0.8 1.3 1.6 1.0 0.6 0.5 3.1 0.5 0.6 1.5 1.9 1.1 0.6 2.0 0.7 18.3 40.5 51.6 50.7 23.2 9.3 10.0 27.6 10.7 11.4 PSMA4 "HC9, HsT17706" ENSG00000041357 "Proteasome subunit alpha 4" P25789 15 78540405-78552419 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004973, HPA055466, HPA060613" Supported Supported Nucleoplasm,Vesicles,Cytosol 12000000 "Nucleoplasm, Cytosol" Vesicles "CAB004973: AB_425627, HPA055466: , HPA060613: " "unprognostic (1.80e-1)" "unprognostic (7.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-1)" "unprognostic (4.71e-2)" "unprognostic (5.35e-2)" "unprognostic (6.26e-3)" "unprognostic (1.09e-1)" "unprognostic (3.28e-2)" "unprognostic (2.08e-3)" "unprognostic (2.75e-3)" "unprognostic (1.26e-1)" "prognostic unfavourable (6.74e-10)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.78e-3)" "unprognostic (6.32e-3)" 41.2 38.8 24.9 36.7 25.8 33.4 33.0 25.3 37.5 32.4 38.0 17.9 23.7 39.4 35.3 32.5 49.9 27.1 24.4 37.7 29.8 27.6 55.7 76.3 37.4 45.1 25.5 26.9 31.2 24.4 20.2 25.9 55.4 33.8 35.3 41.3 19.1 26.0 25.0 60.3 26.3 49.1 36.6 28.1 45.5 31.5 36.5 21.4 61.6 42.6 75.0 44.8 41.3 28.3 29.4 61.9 31.4 75.6 37.7 40.0 61.4 40.1 58.2 50.4 44.4 31.8 30.1 39.5 37.8 30.4 46.6 50.0 60.5 58.7 87.7 55.9 34.8 55.0 101.6 41.0 45.1 35.9 70.8 73.6 43.6 48.7 51.6 74.8 45.5 24.3 25.7 39.2 39.1 50.2 78.9 34.4 38.0 57.8 50.4 70.2 47.4 34.2 43.9 66.7 29.4 47.2 70.4 44.5 32.5 60.6 44.3 46.1 40.9 61.6 39.9 34.8 46.5 38.3 64.3 31.5 74.2 82.7 32.6 112.5 38.3 18.8 47.4 31.4 27.8 75.6 28.5 29.4 29.2 29.0 61.9 22.9 23.3 28.3 21.7 37.7 69.7 35.3 40.0 61.4 24.9 25.8 25.3 37.5 29.8 27.6 25.5 26.9 33.8 21.4 PSMB10 "beta2i, LMP10, MECL1, MGC1665" ENSG00000205220 "Proteasome subunit beta 10" P40306 16 67934502-67937087 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 117.3" "Cell line enhanced" "Detected in many" "REH: 36.0;U-266/70: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA030224, HPA030225, CAB034384" Enhanced Supported Vesicles,Cytosol 1400000 Cytosol Vesicles "CAB034384: AB_2171876, HPA030224: , HPA030225: AB_10603231" "unprognostic (1.18e-2)" "unprognostic (1.90e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-3)" "unprognostic (2.00e-1)" "unprognostic (1.85e-2)" "unprognostic (7.22e-2)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-1)" "unprognostic (8.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.32e-2)" "unprognostic (2.97e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-2)" "prognostic favourable (5.44e-4)" 11.5 13.0 9.1 24.9 11.8 23.9 11.4 4.0 7.8 8.0 21.6 5.6 8.5 42.4 9.3 9.5 10.6 12.4 16.6 12.0 6.9 4.9 16.9 17.2 19.5 38.3 9.5 5.6 8.7 61.5 0.9 6.9 11.2 8.5 13.5 6.3 5.8 27.9 11.6 6.9 7.0 35.6 7.7 6.5 49.7 23.8 2.5 7.8 39.2 13.1 10.4 20.5 13.2 8.4 50.8 75.2 100.0 98.1 69.1 68.8 117.3 5.9 5.3 0.4 0.8 0.4 3.5 21.0 2.0 8.5 6.9 9.8 2.7 29.1 21.6 3.7 2.7 8.7 0.1 1.9 0.5 9.6 0.5 7.7 1.8 3.0 12.0 14.3 23.6 5.3 1.2 3.0 0.0 4.0 0.7 8.3 1.9 7.4 28.1 14.7 0.3 2.0 36.0 2.2 29.5 4.7 10.4 0.3 0.4 6.7 11.8 2.6 2.4 31.0 6.7 4.4 1.2 1.9 2.3 40.3 7.2 14.4 10.9 18.7 9.5 57.1 89.4 67.1 68.8 98.1 50.2 50.8 54.0 57.3 74.6 49.1 45.3 50.1 100.0 69.1 71.4 75.2 60.8 117.3 9.1 11.8 4.0 7.8 6.9 4.9 9.5 5.6 8.5 7.8 PSMB8 "beta5i, D6S216E, LMP7, PSMB5i, RING10" ENSG00000204264 "Proteasome subunit beta 8" P28062 6 32840717-32844703 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Immunity" "Hydrolase, Protease, Threonine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046995, HPA050327" Enhanced Approved "Vesicles,Cytokinetic bridge" 3300000 Vesicles "Cytokinetic bridge" "HPA046995: AB_2679896, HPA050327: AB_2681088" "prognostic favourable (5.08e-4)" "unprognostic (4.22e-2)" "unprognostic (2.39e-2)" "prognostic favourable (7.16e-4)" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (7.78e-2)" "unprognostic (1.09e-1)" "unprognostic (5.71e-2)" "unprognostic (1.17e-2)" "unprognostic (2.79e-2)" "unprognostic (1.47e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (4.35e-2)" "unprognostic (1.97e-3)" "unprognostic (7.11e-3)" 17.0 21.9 7.9 34.8 11.7 14.0 14.9 3.6 7.5 10.0 20.8 5.1 8.8 20.1 12.5 15.3 16.6 13.2 23.8 10.6 6.6 5.7 20.9 30.0 29.0 46.3 9.9 5.1 11.3 12.7 3.6 8.2 9.7 8.8 13.5 24.4 9.2 14.6 11.2 5.1 14.7 37.3 11.5 9.0 42.8 19.4 3.9 9.0 32.2 18.7 18.7 29.0 13.9 12.5 28.9 27.4 37.6 33.2 23.3 29.9 52.2 6.3 2.0 0.1 0.0 2.7 7.0 4.4 1.5 10.1 12.4 17.9 0.0 11.2 24.8 4.8 4.1 4.5 1.4 6.0 3.4 10.2 0.0 10.9 1.3 0.4 14.8 0.2 4.1 7.9 2.8 6.9 2.3 8.4 0.3 5.2 3.1 0.0 5.7 6.0 0.0 1.6 15.5 0.8 12.2 10.1 1.8 0.1 0.1 2.2 5.3 3.3 2.4 20.3 2.5 3.7 1.9 3.5 0.2 8.8 8.3 5.5 1.3 14.3 4.6 19.4 29.0 37.4 25.5 33.2 22.1 28.9 21.7 26.4 27.4 26.3 15.1 21.6 37.6 23.3 28.6 23.3 29.9 52.2 7.9 11.7 3.6 7.5 6.6 5.7 9.9 5.1 8.8 9.0 PSMD6 "KIAA0107, p44S10, Rpn7, S10" ENSG00000163636 "Proteasome 26S subunit, non-ATPase 6" Q15008 3 64010549-64024010 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "MCF7: 176.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036921, HPA036922" Uncertain Supported "Golgi apparatus,Vesicles" 8600 Vesicles "Golgi apparatus" "HPA036921: , HPA036922: AB_10670850" "unprognostic (3.44e-2)" "unprognostic (2.03e-1)" "unprognostic (4.76e-3)" "unprognostic (1.95e-1)" "unprognostic (2.43e-1)" "unprognostic (1.82e-1)" "prognostic unfavourable (1.68e-4)" "unprognostic (8.65e-2)" "unprognostic (1.38e-1)" "unprognostic (1.95e-3)" "unprognostic (6.69e-2)" "unprognostic (4.73e-2)" "unprognostic (4.06e-3)" "unprognostic (4.20e-2)" "unprognostic (1.89e-1)" "unprognostic (9.55e-2)" "unprognostic (8.22e-3)" 17.1 27.4 16.1 16.3 19.3 33.8 18.4 15.8 24.2 14.5 16.0 13.2 21.4 12.1 17.9 23.1 23.5 14.5 18.7 31.4 16.2 16.8 24.5 29.1 14.2 20.0 18.4 17.7 13.6 100.6 21.9 16.3 22.2 21.1 15.8 16.2 12.3 20.3 20.1 55.9 20.3 12.9 18.0 16.2 17.0 17.4 41.7 16.2 23.5 14.9 32.4 21.8 15.9 15.1 54.1 53.5 62.3 58.1 47.2 59.6 65.6 12.2 12.7 18.9 13.2 13.3 11.9 16.0 16.9 17.0 29.8 22.0 23.7 10.5 16.7 7.5 17.2 8.4 21.9 19.0 28.1 17.1 13.0 22.3 10.3 15.8 19.6 25.3 14.6 12.8 13.5 24.6 10.8 18.6 22.4 11.3 20.9 176.8 17.4 16.0 23.6 9.0 14.6 12.9 16.6 23.5 17.7 6.8 11.0 12.6 11.2 16.8 9.8 16.1 15.5 13.3 14.1 18.9 27.7 13.7 20.4 25.5 19.5 24.1 15.2 41.0 51.7 60.2 48.8 58.0 51.0 54.1 55.8 53.1 53.5 49.4 56.2 54.3 62.3 47.2 58.1 37.3 59.6 65.6 16.1 19.3 15.8 24.2 16.2 16.8 18.4 17.7 21.1 16.2 PTAFR ENSG00000169403 "Platelet activating factor receptor" P25105 1 28147166-28193936 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 98.3" "Group enriched" "Detected in some" 4 "HBEC3-KT: 14.3;HMC-1: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7" "Group enriched" "Detected in many" 5 "granulocytes: 98.3;monocytes: 28.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027543 Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Vesicles" "Plasma membrane" "HPA027543: AB_10610287" "unprognostic (2.22e-2)" "unprognostic (2.59e-2)" "unprognostic (6.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.75e-1)" "unprognostic (3.74e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.23e-1)" "unprognostic (2.39e-1)" "unprognostic (1.60e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.59e-2)" "unprognostic (5.48e-2)" "unprognostic (1.38e-2)" 5.6 2.3 2.4 16.2 1.9 20.3 2.4 0.6 2.0 6.9 3.4 1.6 3.5 1.8 2.8 1.4 16.8 2.8 7.5 3.5 2.1 2.3 6.4 1.8 9.2 6.1 4.1 1.0 1.5 2.7 0.9 0.7 3.5 1.8 2.6 3.4 0.6 3.4 2.6 1.1 2.8 5.0 3.8 5.1 15.4 2.3 2.2 1.1 2.3 1.4 22.2 21.7 5.9 3.6 1.5 13.2 98.3 28.2 0.0 0.1 10.1 7.5 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 2.1 0.5 0.0 0.0 5.2 0.2 14.3 0.3 0.1 0.2 2.8 0.0 0.3 0.0 0.7 52.4 0.0 2.3 0.1 0.1 0.0 0.2 0.2 0.0 0.5 0.0 7.1 0.2 0.1 0.1 0.0 0.0 3.5 0.8 0.1 0.0 0.0 7.1 0.0 0.1 2.0 0.0 0.1 0.3 0.0 0.0 0.5 0.4 2.1 0.0 0.9 0.2 5.9 28.2 98.3 0.0 8.9 0.1 1.5 0.0 0.0 13.2 0.7 0.0 0.0 85.7 0.0 3.5 0.1 0.1 10.1 2.4 1.9 0.6 2.0 2.1 2.3 4.1 1.0 1.8 1.1 PTGR2 "FLJ39091, ZADH1" ENSG00000140043 "Prostaglandin reductase 2" Q8N8N7 14 73851844-73886827 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA001125 Approved Approved Vesicles 1000000 Vesicles "HPA001125: " "unprognostic (3.82e-2)" "unprognostic (2.79e-2)" "unprognostic (6.05e-2)" "unprognostic (3.26e-1)" "unprognostic (2.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.96e-2)" "unprognostic (2.80e-1)" "unprognostic (8.10e-3)" "unprognostic (6.99e-3)" "unprognostic (5.96e-1)" "prognostic favourable (4.55e-12)" "unprognostic (4.42e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "unprognostic (7.24e-2)" 7.4 14.4 16.0 3.4 17.2 1.6 10.9 8.0 13.3 6.2 8.3 15.3 11.9 13.7 5.8 20.3 6.2 13.9 6.4 29.0 15.0 12.2 22.1 20.9 6.6 3.7 15.2 12.6 9.1 6.4 13.8 12.8 3.2 20.4 10.9 6.9 10.1 7.7 8.9 32.4 8.1 9.9 4.9 16.0 4.1 7.0 11.5 17.2 2.0 14.6 9.1 3.4 5.5 7.0 2.2 3.2 8.4 2.4 2.3 4.0 2.3 5.7 7.9 6.5 3.2 5.3 11.5 5.1 2.0 2.8 2.5 3.8 4.5 14.2 0.6 4.7 2.0 5.9 5.8 4.3 4.6 4.4 2.7 4.0 3.7 1.9 2.6 1.5 1.5 5.3 10.3 3.7 3.1 1.2 5.3 1.2 5.5 8.3 4.0 3.9 7.2 7.9 4.9 2.5 1.0 13.4 5.7 8.7 7.6 5.2 5.5 6.4 28.4 2.5 1.8 3.7 6.9 2.6 4.3 7.0 3.0 1.8 5.7 3.6 4.9 8.4 2.4 1.8 1.6 0.9 1.2 2.1 2.3 1.2 2.6 2.2 4.0 3.2 2.0 2.3 2.2 3.2 2.1 2.3 16.0 17.2 8.0 13.3 15.0 12.2 15.2 12.6 20.4 17.2 PTGS1 "COX1, PGHS-1, PTGHS" ENSG00000095303 "Prostaglandin-endoperoxide synthase 1" P23219 9 122370530-122395703 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Dioxygenase, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 211.4;urinary bladder: 163.9" "Cell line enhanced" "Detected in some" "ASC diff: 28.1;ASC TERT1: 22.3;BJ: 27.3;BJ hTERT+: 37.3;HEL: 17.1;HMC-1: 72.7" "Cancer enhanced" "Detected in all" "ovarian cancer: 53.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 13.0;granulocytes: 14.4;monocytes: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002834, CAB020315" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" 25000000 "Golgi apparatus" Vesicles "CAB020315: , HPA002834: AB_1079711" "unprognostic (4.20e-1)" "unprognostic (6.23e-2)" "unprognostic (1.08e-2)" "unprognostic (2.27e-2)" "unprognostic (5.88e-2)" "unprognostic (2.00e-2)" "unprognostic (1.22e-3)" "unprognostic (3.32e-1)" "unprognostic (2.24e-1)" "unprognostic (3.16e-2)" "unprognostic (1.23e-1)" "unprognostic (1.46e-1)" "prognostic unfavourable (8.68e-4)" "unprognostic (4.03e-2)" "unprognostic (1.78e-2)" "unprognostic (2.08e-1)" "prognostic unfavourable (9.35e-4)" 4.5 1.1 1.8 9.1 3.1 2.6 2.5 0.5 2.7 2.6 35.3 4.6 3.0 3.9 2.5 1.6 25.7 16.7 9.4 4.9 1.9 1.6 3.9 1.8 4.0 1.4 3.5 0.7 3.6 1.0 0.7 2.4 0.8 2.5 60.9 9.3 1.5 1.9 2.3 0.7 55.9 6.5 211.4 4.9 3.6 7.8 1.0 3.1 0.4 1.5 5.3 4.2 163.9 19.5 2.5 13.0 14.4 8.5 1.9 0.1 13.7 0.0 0.1 0.1 0.0 28.1 22.3 0.0 27.3 37.3 0.2 0.2 0.0 0.0 0.9 1.3 4.6 1.7 0.0 2.5 0.2 0.0 0.0 17.1 0.1 0.0 8.1 1.1 72.7 11.4 0.2 1.4 0.0 10.1 0.0 0.0 0.5 0.0 0.0 1.5 0.3 0.1 0.0 0.3 2.0 3.5 0.0 0.1 0.1 0.1 2.3 0.0 0.0 1.9 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 7.4 0.0 12.0 7.6 14.4 0.0 8.5 0.0 1.7 0.0 0.0 13.0 2.5 0.0 0.0 3.5 1.9 6.1 0.9 0.1 13.7 1.8 3.1 0.5 2.7 1.9 1.6 3.5 0.7 2.5 3.1 PTK2 "FADK, FAK, FAK1, PPP1R71" ENSG00000169398 "Protein tyrosine kinase 2" Q05397 8 140657900-141002216 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Angiogenesis "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001842, CAB004036, HPA029671" Approved Supported "Vesicles,Focal adhesion sites,Cytosol" 32000 "Focal adhesion sites" "Vesicles, Cytosol" "CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288" "prognostic unfavourable (3.21e-4)" "unprognostic (3.86e-2)" "unprognostic (1.95e-1)" "prognostic unfavourable (9.11e-4)" "unprognostic (1.93e-1)" "unprognostic (2.28e-1)" "unprognostic (3.02e-2)" "unprognostic (1.27e-1)" "unprognostic (1.97e-1)" "unprognostic (2.96e-2)" "unprognostic (1.06e-2)" "unprognostic (2.38e-1)" "unprognostic (2.80e-2)" "unprognostic (2.94e-2)" "unprognostic (1.11e-1)" "unprognostic (1.53e-1)" "unprognostic (2.90e-2)" 22.6 20.4 36.0 14.4 42.3 3.1 19.3 20.5 40.8 24.9 17.9 55.7 23.5 14.5 20.2 29.9 14.6 18.7 18.4 20.0 43.5 23.9 22.3 17.0 21.5 13.0 41.4 31.4 19.4 18.2 33.1 13.0 42.1 30.0 19.2 20.7 11.0 21.9 25.5 17.9 13.5 16.3 21.9 38.0 12.2 17.5 21.2 46.1 2.8 22.5 10.2 14.0 22.2 17.8 8.6 7.2 1.8 3.9 5.2 5.7 4.1 14.6 23.4 32.5 11.7 13.7 14.7 21.0 14.5 20.2 13.6 13.4 10.2 12.2 8.9 33.0 18.6 17.4 19.1 33.3 20.6 0.1 8.9 19.7 12.9 14.0 18.7 0.0 9.4 10.0 16.4 17.0 24.0 40.1 19.8 0.2 18.2 25.5 0.2 0.2 12.6 26.2 13.1 17.8 0.4 28.7 33.5 12.9 16.1 22.7 7.3 14.7 17.2 0.3 24.2 13.4 25.3 15.8 16.3 0.0 0.1 0.9 17.4 0.1 18.1 1.8 3.9 0.0 0.3 1.6 0.0 6.8 0.8 0.1 5.3 8.6 5.7 2.0 1.7 5.2 0.9 7.2 0.2 4.1 36.0 42.3 20.5 40.8 43.5 23.9 41.4 31.4 30.0 46.1 PTPN22 "Lyp, Lyp1, Lyp2, PTPN8" ENSG00000134242 "Protein tyrosine phosphatase, non-receptor type 22" Q9Y2R2 1 113813811-113871759 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Immunity" "Hydrolase, Protein phosphatase" "Diabetes mellitus, Disease mutation, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.6;lymphoid tissue: 46.0" "Cell line enhanced" "Detected in some" "Daudi: 32.9;HL-60: 13.0;U-266/70: 14.2;U-698: 17.6;U-937: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in single" 10 "cerebellum: 5.9" "Not detected" "Not detected" "HPA004912, CAB012209, HPA013350" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" Nucleoplasm "Vesicles, Plasma membrane" "CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570" "unprognostic (2.25e-2)" "unprognostic (5.31e-3)" "unprognostic (3.48e-1)" "unprognostic (3.33e-4)" "unprognostic (9.14e-2)" "unprognostic (2.47e-3)" "unprognostic (9.60e-2)" "unprognostic (8.14e-2)" "unprognostic (3.71e-1)" "unprognostic (1.82e-1)" "unprognostic (1.62e-1)" "unprognostic (3.02e-1)" "unprognostic (2.75e-6)" "unprognostic (3.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-2)" 4.2 1.4 0.5 17.1 0.8 23.6 1.9 1.0 0.5 2.4 3.3 0.3 1.0 4.1 2.0 2.2 2.0 1.7 3.2 2.5 0.6 0.7 3.4 1.8 9.0 14.9 0.7 0.4 1.5 2.4 0.0 0.9 0.9 1.0 1.7 2.8 1.3 2.7 3.0 0.6 1.0 9.9 0.9 2.1 19.0 3.1 1.1 0.4 46.0 1.5 2.4 12.8 4.8 1.7 7.2 6.2 17.2 3.5 7.5 14.9 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.3 0.0 0.2 32.9 0.0 0.1 0.0 0.0 0.0 0.2 3.1 0.0 4.6 0.0 0.0 0.1 13.0 10.3 2.9 0.0 1.4 0.1 5.1 0.0 7.5 5.0 0.1 9.2 7.4 0.0 0.0 0.5 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 2.3 7.8 0.1 0.1 0.2 14.2 3.0 17.6 5.4 13.4 0.0 10.2 3.5 17.2 12.8 0.9 14.9 7.2 6.5 10.1 6.2 4.7 3.9 9.4 1.7 7.5 0.4 3.7 10.0 4.6 0.5 0.8 1.0 0.5 0.6 0.7 0.7 0.4 1.0 0.4 PTPN9 MEG2 ENSG00000169410 "Protein tyrosine phosphatase, non-receptor type 9" P43378 15 75463251-75579289 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041922 Approved Approved Vesicles Vesicles "HPA041922: AB_10795269" "unprognostic (9.58e-2)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (2.42e-1)" "unprognostic (1.54e-2)" "unprognostic (6.80e-2)" "unprognostic (7.38e-2)" "unprognostic (5.95e-2)" "unprognostic (3.93e-1)" "unprognostic (3.14e-1)" "unprognostic (9.25e-3)" "unprognostic (6.35e-2)" "prognostic favourable (2.49e-6)" "unprognostic (2.26e-1)" "unprognostic (1.05e-1)" "unprognostic (2.71e-1)" "unprognostic (2.39e-1)" 16.8 12.8 15.0 11.8 17.7 9.2 15.7 11.1 20.0 17.4 22.4 10.5 12.0 17.0 18.9 16.4 10.9 16.4 13.5 12.2 13.1 14.6 17.9 14.0 16.0 12.6 11.6 12.4 16.0 12.3 16.6 12.5 18.9 13.2 16.9 19.5 18.4 14.6 21.9 6.8 11.8 30.6 17.6 15.6 15.6 13.4 8.7 7.5 16.3 34.4 8.0 13.9 14.7 15.3 3.3 5.9 4.6 5.7 6.7 7.2 2.9 9.1 11.0 17.2 11.5 12.9 14.2 5.7 13.7 21.4 17.4 15.9 6.6 13.9 14.8 11.1 23.4 13.8 37.0 15.8 17.6 18.3 9.4 8.3 7.9 7.0 19.4 12.5 12.8 18.4 16.6 13.9 21.8 14.5 5.5 5.4 19.6 6.0 8.9 11.8 15.8 5.6 17.5 8.5 4.1 21.9 14.8 6.8 14.1 19.5 10.9 21.0 5.6 21.7 16.7 16.7 5.4 10.9 14.6 8.0 8.3 13.8 9.7 19.1 16.4 4.6 4.3 4.2 7.2 5.7 5.7 3.3 5.0 6.1 5.9 2.3 2.1 3.9 0.7 6.7 5.4 3.9 3.1 2.9 15.0 17.7 11.1 20.0 13.1 14.6 11.6 12.4 13.2 7.5 PTPRA "HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA" ENSG00000132670 "Protein tyrosine phosphatase, receptor type A" P18433 20 2864184-3039076 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029412, CAB034366, HPA069480" Approved Approved Nucleoplasm,Vesicles 21000 Vesicles Nucleoplasm "CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: " "unprognostic (1.39e-1)" "unprognostic (2.05e-1)" "unprognostic (4.58e-2)" "unprognostic (2.39e-3)" "unprognostic (1.15e-1)" "unprognostic (1.62e-1)" "unprognostic (5.43e-3)" "unprognostic (5.34e-2)" "unprognostic (1.55e-1)" "unprognostic (3.24e-1)" "unprognostic (7.33e-2)" "unprognostic (1.16e-1)" "prognostic favourable (3.29e-6)" "unprognostic (1.25e-1)" "unprognostic (4.02e-1)" "unprognostic (1.60e-2)" "unprognostic (4.19e-1)" 21.9 18.5 55.6 14.3 48.6 16.4 23.3 44.5 56.0 29.7 19.7 37.5 9.4 14.7 26.3 18.7 22.7 26.5 21.3 14.0 45.9 41.1 22.1 13.5 21.6 16.9 38.0 46.7 28.6 14.9 41.5 23.4 29.0 52.5 23.5 20.0 18.5 16.7 21.8 8.2 21.0 15.3 25.7 52.6 17.9 16.3 27.4 30.4 20.6 32.4 8.5 20.4 22.9 19.2 7.7 5.7 7.9 6.7 6.2 11.0 3.7 20.5 12.6 36.3 11.1 40.2 73.4 7.7 15.5 30.3 19.2 23.5 15.0 28.6 13.5 12.2 20.7 22.1 14.6 22.1 21.7 20.8 9.4 19.2 5.3 19.0 14.4 19.2 9.1 32.8 22.9 15.8 16.7 26.5 19.2 17.3 19.0 8.4 22.2 21.8 14.0 10.1 17.0 17.6 16.8 16.4 16.0 20.1 19.3 15.0 25.5 23.0 15.9 16.5 18.9 17.1 8.5 19.1 13.6 12.7 17.6 17.8 7.9 18.2 16.0 7.9 4.8 7.5 11.0 4.8 9.0 7.7 7.4 7.9 3.7 5.1 7.4 9.0 6.0 6.2 6.7 5.7 8.1 3.7 55.6 48.6 44.5 56.0 45.9 41.1 38.0 46.7 52.5 30.4 PTPRB PTPB ENSG00000127329 "Protein tyrosine phosphatase, receptor type B" P23467 12 70515866-70637440 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 11.1;HUVEC TERT2: 27.5;TIME: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "memory B-cell: 3.5" "Lineage enriched" "Detected in single" 7 "B-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004782, HPA067868" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" 6700000 "Plasma membrane" "Vesicles, Cell Junctions" "CAB004782: , HPA067868: " "unprognostic (3.18e-1)" "unprognostic (2.99e-6)" "unprognostic (1.56e-1)" "unprognostic (1.80e-1)" "unprognostic (3.55e-2)" "unprognostic (1.77e-2)" "prognostic favourable (6.05e-4)" "unprognostic (4.59e-1)" "unprognostic (2.22e-2)" "unprognostic (1.85e-1)" "unprognostic (2.28e-2)" "unprognostic (1.40e-1)" "prognostic favourable (1.02e-4)" "unprognostic (2.91e-2)" "unprognostic (7.18e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" 23.5 7.0 4.5 5.5 7.0 0.1 22.9 3.6 6.1 11.3 8.0 4.3 7.1 5.3 17.1 8.5 5.8 8.2 11.4 17.6 6.2 5.1 18.7 12.0 39.9 3.3 6.9 4.6 5.5 4.4 4.9 5.7 23.3 7.8 6.1 8.2 16.0 3.6 7.1 11.8 4.7 7.4 13.3 7.3 22.9 5.2 3.7 4.3 0.7 14.0 12.2 2.6 6.5 14.7 3.5 0.1 0.2 0.0 0.4 0.3 0.2 1.9 0.1 0.8 0.1 0.0 0.0 0.4 0.4 1.9 1.0 2.4 0.0 1.5 0.7 11.1 0.3 6.8 0.1 0.3 3.5 0.5 0.3 0.1 0.7 0.4 0.1 0.3 0.0 0.0 0.3 2.7 0.0 27.5 1.5 0.4 0.6 0.0 0.0 0.0 1.0 0.4 0.0 0.7 0.3 5.1 0.7 0.0 0.4 0.7 0.0 1.6 0.0 0.6 40.2 0.4 0.4 0.1 2.3 0.5 0.3 0.3 0.2 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.3 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 4.5 7.0 3.6 6.1 6.2 5.1 6.9 4.6 7.8 4.3 PTPRC "CD45, GP180, LCA, T200" ENSG00000081237 "Protein tyrosine phosphatase, receptor type C" 1 198638457-198757476 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 116.9;lymphoid tissue: 172.5" "Cell line enhanced" "Detected in some" "Daudi: 51.0;HEL: 28.8;HL-60: 26.0;MOLT-4: 38.5;THP-1: 21.4;U-266/70: 23.9;U-266/84: 21.6;U-698: 30.6;U-937: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000052, HPA000440, CAB002800, CAB056154, CAB068221" Enhanced Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: , CAB068221: , HPA000440: AB_1078468" "unprognostic (1.51e-2)" "unprognostic (1.24e-2)" "unprognostic (5.10e-3)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (3.17e-2)" "unprognostic (1.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.08e-2)" "unprognostic (3.95e-1)" "prognostic unfavourable (2.42e-4)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (6.41e-2)" "unprognostic (7.06e-2)" 9.8 2.9 3.4 48.0 6.2 36.1 4.3 1.3 3.5 3.1 5.6 2.8 0.5 4.9 2.9 3.9 4.8 5.6 8.8 4.9 3.9 4.5 4.4 5.2 27.5 93.2 7.9 1.3 2.9 2.1 0.3 2.5 4.5 5.3 4.2 5.8 3.3 10.7 1.0 1.7 2.5 22.2 4.5 13.2 89.3 6.5 2.3 5.3 172.5 4.6 3.9 53.2 13.1 3.7 28.5 42.8 94.7 103.8 53.7 76.1 116.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 51.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 28.8 0.0 0.0 0.0 26.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.8 0.0 0.0 38.5 15.7 0.1 0.1 1.1 0.1 0.1 0.0 0.0 0.3 0.4 0.0 0.1 0.1 0.0 21.4 0.3 0.0 0.2 0.1 0.1 23.9 21.6 30.6 0.0 23.3 0.1 20.8 52.0 56.3 76.1 99.7 64.5 28.5 52.9 72.7 42.8 26.8 60.2 60.3 94.7 53.7 103.8 6.4 54.6 116.9 3.4 6.2 1.3 3.5 3.9 4.5 7.9 1.3 5.3 5.3 PTPRD "HPTP, PTPD" ENSG00000153707 "Protein tyrosine phosphatase, receptor type D" P23468 9 8314246-10612723 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;parathyroid gland: 37.5" "Cell line enhanced" "Detected in some" "AF22: 23.0;HAP1: 5.0;HSkMC: 7.8;NTERA-2: 5.6;RH-30: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054829 Uncertain Approved Nucleoplasm,Vesicles "Intracellular and membrane" 2500000 Vesicles Nucleoplasm "HPA054829: " "unprognostic (4.74e-1)" "unprognostic (4.79e-2)" "unprognostic (1.44e-2)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (9.90e-2)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (1.91e-2)" "unprognostic (2.13e-2)" "unprognostic (7.52e-3)" "unprognostic (2.62e-1)" "prognostic favourable (7.45e-6)" "unprognostic (3.56e-4)" "unprognostic (7.59e-2)" "unprognostic (4.84e-2)" "unprognostic (3.08e-3)" 2.6 1.7 19.7 1.5 19.2 1.1 1.1 27.9 32.1 5.6 5.4 21.7 0.2 4.0 3.6 1.8 1.5 3.6 2.6 3.0 18.0 13.5 11.4 4.2 3.4 0.9 17.9 22.3 12.7 1.7 37.5 4.4 9.4 15.1 3.3 5.3 1.9 1.1 2.0 1.0 1.2 4.6 2.8 29.7 1.4 1.7 2.5 18.5 0.0 3.2 0.0 1.0 2.7 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 23.0 0.0 0.3 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 2.6 4.7 0.6 0.0 0.0 0.0 0.2 7.8 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 2.7 0.0 5.6 1.4 2.8 8.5 0.0 2.1 0.0 3.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.7 19.2 27.9 32.1 18.0 13.5 17.9 22.3 15.1 18.5 PTPRK R-PTP-kappa ENSG00000152894 "Protein tyrosine phosphatase, receptor type K" Q15262 6 127968779-128520674 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6" "Group enriched" "Detected in many" 7 "B-cells: 4.8;T-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054056, HPA054822" Uncertain Supported "Vesicles,Plasma membrane,Cell Junctions" 13000000 "Cell Junctions" "Vesicles, Plasma membrane" "HPA054056: , HPA054822: " "unprognostic (3.15e-2)" "unprognostic (1.07e-2)" "unprognostic (5.79e-3)" "unprognostic (4.95e-3)" "unprognostic (1.89e-2)" "unprognostic (7.26e-2)" "unprognostic (3.27e-1)" "unprognostic (6.06e-2)" "unprognostic (2.04e-1)" "unprognostic (1.08e-1)" "prognostic unfavourable (1.99e-4)" "unprognostic (1.46e-1)" "prognostic favourable (9.33e-5)" "unprognostic (2.10e-1)" "unprognostic (1.55e-1)" "unprognostic (2.59e-1)" "unprognostic (9.32e-2)" 12.0 5.2 18.6 10.7 20.3 1.2 20.9 4.7 24.4 12.2 21.9 25.6 11.2 25.7 12.1 10.3 9.1 13.2 29.6 11.4 17.2 12.6 13.3 23.6 17.4 5.7 20.5 19.3 15.6 25.7 11.4 12.2 17.4 14.9 16.3 23.4 3.9 18.3 17.5 9.1 13.5 27.4 14.6 17.1 6.4 24.6 2.7 23.7 15.3 10.1 6.5 7.6 18.4 15.1 4.8 0.0 0.0 0.0 0.4 1.6 0.2 4.4 4.8 2.9 0.2 6.1 8.2 2.9 12.1 23.5 5.0 4.6 8.0 3.7 0.0 3.7 11.1 12.7 3.0 9.6 7.1 13.4 4.9 0.1 7.4 11.1 7.5 0.0 0.4 6.0 8.9 10.5 14.4 13.7 0.0 0.2 12.3 9.0 6.8 0.0 3.0 6.2 24.5 6.2 0.8 12.4 9.2 15.3 0.0 12.5 14.0 0.7 3.8 0.3 23.1 7.9 5.5 15.3 10.9 0.1 1.6 0.0 10.1 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.0 4.8 0.4 1.6 0.0 0.4 0.0 0.0 0.1 0.2 18.6 20.3 4.7 24.4 17.2 12.6 20.5 19.3 14.9 23.7 PTPRN2 "IA-2beta, ICAAR, KIAA0387, phogrin" ENSG00000155093 "Protein tyrosine phosphatase, receptor type N2" Q92932 7 157539056-158587788 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Protein phosphatase, Receptor" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6;pancreas: 51.3" "Cell line enhanced" "Detected in some" "AF22: 15.3;HDLM-2: 21.5;NB-4: 22.1;SCLC-21H: 12.2;SH-SY5Y: 12.4;THP-1: 10.8;U-87 MG: 15.1" "Cancer enhanced" "Detected in all" "prostate cancer: 40.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006900, HPA007255, HPA026656" Enhanced Approved Vesicles Vesicles "HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912" "unprognostic (2.42e-1)" "unprognostic (4.17e-2)" "unprognostic (7.82e-2)" "unprognostic (2.69e-2)" "prognostic unfavourable (9.37e-5)" "unprognostic (7.12e-3)" "unprognostic (1.04e-1)" "unprognostic (4.55e-2)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-2)" "unprognostic (1.39e-1)" "prognostic favourable (8.68e-4)" "unprognostic (2.60e-2)" "unprognostic (1.48e-1)" "unprognostic (1.43e-3)" "unprognostic (6.16e-2)" 2.1 10.5 20.1 1.7 33.9 1.0 1.1 6.2 40.6 1.7 4.6 2.9 0.0 5.1 2.0 2.9 1.5 6.9 4.7 1.9 18.2 21.3 2.0 1.2 3.1 2.1 11.3 22.3 5.8 51.3 0.5 20.0 1.5 10.3 10.2 3.7 1.5 3.4 2.6 0.8 0.7 4.2 1.6 5.3 7.7 24.2 2.2 5.2 0.0 5.6 0.3 1.7 2.8 0.6 3.4 1.3 14.8 1.1 1.5 3.5 1.1 0.0 0.2 15.3 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.6 0.2 0.0 0.4 0.0 0.0 21.5 0.2 0.0 0.0 2.5 0.6 0.0 0.0 1.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.2 6.3 22.1 3.0 0.7 0.0 0.7 0.1 0.0 0.0 12.2 12.4 0.0 0.0 0.0 0.0 10.8 3.2 5.0 1.9 0.0 0.3 0.1 0.0 0.0 15.1 9.0 3.6 8.7 1.1 1.6 0.9 0.1 0.3 2.3 1.5 1.1 1.3 3.4 1.4 0.9 14.8 1.5 0.0 0.2 3.5 1.1 20.1 33.9 6.2 40.6 18.2 21.3 11.3 22.3 10.3 5.2 PTPRZ1 "phosphacan, PTP18, PTPRZ, PTPZ, RPTPB" ENSG00000106278 "Protein tyrosine phosphatase, receptor type Z1" P23471 7 121873089-122062036 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 118.1" "Group enriched" "Detected in some" 9 "AF22: 92.1;NTERA-2: 25.6;WM-115: 40.3" "Cancer enriched" "Detected in many" 14 "glioma: 175.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015103 Enhanced Approved Vesicles,Cytosol "Secreted in brain" 950000 Cytosol Vesicles "HPA015103: AB_1855946" "unprognostic (8.49e-4)" "unprognostic (3.96e-3)" "unprognostic (4.11e-2)" "unprognostic (1.37e-1)" "unprognostic (9.18e-2)" "unprognostic (2.41e-2)" "unprognostic (8.30e-3)" "unprognostic (3.78e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (9.17e-4)" "unprognostic (1.83e-1)" "unprognostic (8.72e-6)" "unprognostic (2.00e-1)" "unprognostic (2.16e-1)" "unprognostic (8.77e-2)" "prognostic unfavourable (9.36e-4)" 2.0 2.5 33.1 2.3 44.1 1.5 4.0 15.4 118.1 2.4 2.2 19.3 0.0 1.9 1.6 2.0 7.0 1.7 1.9 2.0 39.6 15.9 1.6 1.6 2.1 1.5 18.6 17.8 2.0 3.3 1.5 1.6 1.6 67.6 2.1 2.3 0.8 2.4 2.0 1.5 19.3 1.9 2.4 76.6 2.1 9.8 1.7 23.6 0.0 1.5 1.8 3.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 1.1 0.0 0.1 0.0 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 44.1 15.4 39.6 39.6 15.9 18.6 17.8 67.6 23.6 PUSL1 FLJ90811 ENSG00000169972 "Pseudouridylate synthase-like 1" Q8N0Z8 1 1308567-1311677 "Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032057, HPA039999" Uncertain Enhanced Vesicles Vesicles "HPA032057: AB_10601251, HPA039999: " "unprognostic (2.04e-2)" "unprognostic (1.60e-1)" "unprognostic (2.17e-1)" "unprognostic (1.38e-1)" "unprognostic (1.80e-1)" "unprognostic (3.91e-1)" "prognostic unfavourable (1.33e-4)" "unprognostic (7.55e-2)" "unprognostic (4.35e-2)" "unprognostic (1.47e-1)" "unprognostic (2.44e-2)" "unprognostic (3.91e-2)" "prognostic unfavourable (1.62e-5)" "unprognostic (3.05e-1)" "unprognostic (1.48e-1)" "unprognostic (1.45e-1)" "unprognostic (2.44e-1)" 7.6 11.7 8.0 8.8 6.8 8.8 9.1 9.4 9.2 13.6 9.2 9.8 15.4 9.9 11.2 14.4 17.1 9.1 10.3 9.2 7.9 6.0 9.5 16.2 7.1 7.8 12.2 6.8 11.4 19.5 6.2 13.2 8.0 6.6 12.4 5.0 9.5 23.3 13.7 11.0 17.0 9.6 7.5 6.5 8.8 11.4 8.3 7.7 9.0 10.6 16.7 11.9 10.9 9.8 9.0 11.3 5.8 16.6 8.1 13.4 7.8 10.0 4.5 4.6 7.8 2.2 3.6 6.3 9.1 5.0 9.0 6.1 15.6 6.6 6.1 7.4 4.4 8.2 5.1 8.3 1.6 6.8 33.4 8.5 8.2 9.3 8.5 10.1 8.2 3.5 4.3 4.9 3.8 4.0 10.8 2.8 4.1 8.2 9.5 13.1 6.2 20.0 8.8 3.5 14.5 6.9 3.8 21.3 7.7 7.1 21.3 7.2 5.9 6.7 4.7 5.8 6.0 9.4 8.6 11.2 3.5 26.1 7.2 9.1 3.4 3.6 12.3 5.8 10.6 16.6 10.6 8.9 11.6 8.7 11.3 9.0 7.7 7.7 4.9 8.1 14.0 7.1 13.4 7.8 8.0 6.8 9.4 9.2 7.9 6.0 12.2 6.8 6.6 7.7 PVR "CD155, HVED, Necl-5, NECL5, PVS, Tage4" ENSG00000073008 "Poliovirus receptor" P15151 19 44643798-44663583 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 65.6" "Cell line enhanced" "Detected in many" "TIME: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 5 "dendritic cells: 5.6;monocytes: 8.1" HPA012568 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Secreted - unknown location" 940000000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA012568: AB_1846248" "unprognostic (2.90e-3)" "prognostic unfavourable (1.29e-4)" "unprognostic (3.36e-1)" "unprognostic (2.34e-1)" "unprognostic (7.89e-2)" "unprognostic (2.45e-3)" "unprognostic (3.06e-2)" "prognostic unfavourable (9.30e-4)" "unprognostic (9.05e-3)" "unprognostic (1.69e-1)" "unprognostic (2.09e-3)" "unprognostic (2.64e-3)" "unprognostic (1.69e-1)" "unprognostic (4.97e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-3)" "prognostic unfavourable (2.75e-4)" 10.0 13.9 7.4 7.5 8.1 4.7 9.2 11.0 11.0 6.5 10.6 6.5 4.1 13.7 11.3 5.7 6.6 8.8 9.2 23.5 5.8 10.0 10.6 65.6 14.8 2.4 6.0 6.5 10.4 15.9 9.9 20.7 15.5 9.7 10.4 7.7 6.6 8.5 6.9 19.8 5.5 13.0 11.1 7.0 4.8 12.3 6.0 7.2 2.3 8.5 10.8 3.7 8.3 6.7 0.0 5.6 1.2 8.1 0.6 0.4 2.2 21.5 15.1 1.5 6.1 1.8 2.2 2.6 36.4 10.2 12.0 13.7 8.8 9.2 0.0 21.0 10.5 14.2 5.1 13.8 8.0 2.6 9.9 3.8 9.5 5.9 12.7 1.4 8.3 2.9 6.8 10.5 20.7 13.0 1.8 0.0 5.5 1.9 1.3 1.3 3.4 11.2 0.0 6.9 2.0 25.7 6.6 6.5 7.6 23.1 14.5 5.1 8.2 3.7 52.7 14.5 17.9 10.7 28.4 0.0 2.1 0.0 11.6 7.4 8.2 0.0 6.4 0.0 0.2 6.6 0.0 0.0 0.0 0.4 5.6 0.0 0.2 0.1 1.2 0.6 8.1 0.5 0.0 2.2 7.4 8.1 11.0 11.0 5.8 10.0 6.0 6.5 9.7 7.2 QRICH2 DKFZP434P0316 ENSG00000129646 "Glutamine rich 2" Q9H0J4 17 76274049-76307998 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 27.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052219 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA052219: " "unprognostic (3.11e-2)" "unprognostic (2.44e-3)" "unprognostic (9.11e-3)" "unprognostic (4.42e-3)" "unprognostic (1.35e-1)" "unprognostic (1.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.83e-1)" "unprognostic (2.61e-1)" "unprognostic (8.82e-4)" "unprognostic (3.64e-1)" "unprognostic (1.39e-1)" "unprognostic (6.97e-2)" "unprognostic (7.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.71e-3)" 0.9 0.8 1.2 0.9 2.2 1.9 0.9 5.7 2.0 0.9 0.9 0.9 0.9 0.3 0.9 1.0 1.0 1.2 0.9 0.9 1.4 2.0 0.9 1.1 1.1 0.9 1.4 0.9 0.9 1.3 0.6 0.9 1.4 0.9 0.9 0.8 0.9 5.6 0.9 1.4 1.7 0.9 0.9 1.2 0.9 0.3 27.4 0.9 0.9 3.0 0.9 0.9 0.9 0.9 0.9 0.0 0.0 0.1 0.3 0.4 0.3 1.1 2.5 4.7 5.3 2.6 2.3 2.2 2.2 0.5 1.7 0.5 1.3 0.5 6.5 0.9 1.3 0.5 6.2 1.1 2.0 1.8 3.8 0.5 1.7 5.7 1.3 0.8 2.9 2.1 1.0 1.9 0.1 2.0 3.4 1.2 0.5 3.7 3.4 0.7 1.9 5.1 7.5 3.9 0.2 0.8 2.3 4.3 4.3 1.1 0.6 2.6 1.9 2.7 2.1 1.4 5.0 6.7 2.6 1.7 1.6 0.6 1.5 3.8 1.6 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.2 2.2 5.7 2.0 1.4 2.0 1.4 0.9 0.9 0.9 QRSL1 "DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA" ENSG00000130348 "Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1" Q9H0R6 6 106629578-106668417 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" Ligase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "memory B-cell: 32.6;naive B-cell: 26.1" "Lineage enriched" "Detected in all" 7 "B-cells: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029585, HPA029587" Approved Approved Vesicles,Centrosome Vesicles Centrosome "HPA029585: AB_10599823, HPA029587: AB_10602311" "unprognostic (1.86e-3)" "unprognostic (5.58e-2)" "unprognostic (6.19e-3)" "unprognostic (3.45e-1)" "unprognostic (2.11e-3)" "unprognostic (1.31e-2)" "prognostic unfavourable (7.97e-5)" "unprognostic (8.36e-2)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (4.03e-2)" "unprognostic (1.66e-1)" "prognostic favourable (3.83e-4)" "unprognostic (2.06e-1)" "unprognostic (2.09e-1)" "unprognostic (2.04e-1)" "unprognostic (3.46e-1)" 9.8 10.8 12.4 17.0 14.7 8.5 15.6 10.1 15.6 7.6 11.7 10.1 11.9 11.3 9.5 10.8 10.3 8.5 8.3 13.9 10.4 9.1 15.5 12.5 7.7 21.0 15.8 8.3 10.2 10.8 10.9 11.9 8.7 9.9 8.3 13.7 7.5 10.6 12.5 35.7 8.8 14.8 8.8 11.9 16.7 11.0 10.6 13.7 13.8 13.7 14.6 21.3 8.9 8.6 32.6 4.0 1.6 4.5 2.6 3.1 2.2 6.1 6.4 8.8 12.7 5.7 7.2 12.4 7.0 7.2 9.4 9.4 7.4 5.1 20.5 6.4 7.8 10.9 13.1 8.5 11.9 9.7 10.0 10.0 6.8 7.6 9.0 22.5 9.0 7.0 13.3 10.0 14.8 6.6 18.0 6.7 7.7 6.9 7.2 11.0 9.2 7.5 19.7 11.3 5.2 10.2 7.1 7.7 7.9 5.6 13.1 10.3 8.6 17.5 6.5 6.7 5.5 7.1 10.8 3.9 5.5 12.0 9.1 15.3 9.9 1.6 2.4 0.4 2.6 3.6 2.5 32.6 2.9 2.2 4.0 26.1 2.7 2.6 0.7 2.6 4.5 3.2 3.1 2.2 12.4 14.7 10.1 15.6 10.4 9.1 15.8 8.3 9.9 13.7 QSOX1 QSCN6 ENSG00000116260 "Quiescin sulfhydryl oxidase 1" O00391 1 180154834-180204030 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 172.2" "Cell line enhanced" "Detected in many" "HHSteC: 194.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042127, HPA056243" Uncertain Supported "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" 3200000000 "Golgi apparatus" Vesicles "HPA042127: , HPA056243: " "unprognostic (1.13e-1)" "unprognostic (2.62e-3)" "unprognostic (2.46e-1)" "unprognostic (2.49e-2)" "unprognostic (2.00e-2)" "unprognostic (2.73e-1)" "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.94e-1)" "unprognostic (3.12e-2)" "unprognostic (5.07e-2)" "unprognostic (2.80e-3)" "prognostic unfavourable (1.86e-5)" "unprognostic (3.25e-1)" "unprognostic (2.14e-1)" "unprognostic (3.53e-2)" "unprognostic (1.40e-1)" 15.9 18.7 8.0 14.5 9.5 30.1 12.6 7.3 13.6 23.5 25.3 13.8 24.9 19.8 17.8 44.9 36.8 18.9 91.9 54.4 10.1 9.0 15.4 23.1 42.3 19.5 8.5 9.1 46.5 59.8 6.2 13.5 172.2 13.4 28.0 24.5 12.1 20.6 19.4 18.4 12.3 19.0 33.9 15.5 13.4 52.8 50.3 9.1 6.7 7.8 18.2 18.3 35.8 26.1 2.9 19.2 20.4 25.5 8.0 7.1 11.4 41.5 5.9 1.4 17.7 18.1 37.5 70.5 44.2 44.7 37.8 26.7 0.6 13.4 0.6 27.5 35.3 9.0 1.7 11.9 18.5 2.4 2.7 1.3 3.5 1.8 194.6 4.5 12.8 20.0 5.4 40.3 48.4 55.6 1.8 6.5 24.9 7.2 0.9 8.4 4.8 17.0 1.8 3.2 1.0 6.2 11.9 5.1 5.2 12.9 17.6 8.5 3.2 21.5 65.4 47.4 18.6 31.7 37.3 4.8 7.8 1.1 18.0 14.6 14.2 5.8 25.5 9.5 7.1 14.7 5.3 2.9 4.8 5.0 19.2 1.8 4.4 4.3 20.4 8.0 13.1 3.9 5.5 11.4 8.0 9.5 7.3 13.6 10.1 9.0 8.5 9.1 13.4 9.1 RAB11A YL8 ENSG00000103769 "RAB11A, member RAS oncogene family" P62491 15 65726054-65891991 "Predicted intracellular proteins" "Cell cycle, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013097, HPA051697, HPA060686" Approved Enhanced "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "CAB013097: AB_2533987, HPA051697: , HPA060686: " "unprognostic (4.15e-2)" "unprognostic (5.86e-2)" "unprognostic (1.22e-1)" "unprognostic (8.74e-3)" "unprognostic (6.85e-2)" "unprognostic (6.07e-2)" "unprognostic (3.17e-2)" "unprognostic (7.12e-2)" "unprognostic (8.60e-2)" "unprognostic (4.83e-2)" "prognostic unfavourable (4.37e-4)" "unprognostic (4.29e-2)" "prognostic favourable (1.46e-5)" "unprognostic (9.93e-2)" "unprognostic (1.83e-2)" "unprognostic (5.23e-3)" "unprognostic (1.21e-1)" 43.3 64.1 32.4 27.0 49.6 25.1 35.4 34.9 57.3 41.3 49.9 27.7 30.5 31.4 36.4 31.7 131.6 34.2 42.8 34.5 35.0 40.5 52.4 28.7 38.1 32.8 34.3 36.6 35.6 24.5 32.3 36.6 60.5 60.5 35.8 52.2 33.7 58.3 31.2 27.3 79.8 35.2 34.3 33.1 55.3 47.9 47.4 25.1 32.4 46.2 60.7 62.1 51.7 60.6 18.1 31.5 54.0 33.3 15.1 24.5 59.5 42.0 49.9 51.0 36.9 46.7 43.9 66.7 45.0 45.9 41.1 49.1 45.8 75.8 55.3 46.0 51.5 65.2 80.2 59.6 38.8 36.0 47.9 66.2 36.1 40.5 35.6 31.0 39.4 44.7 67.9 40.3 33.6 90.9 53.1 33.0 57.9 41.8 30.6 24.6 42.5 28.4 26.1 38.7 51.2 110.3 110.6 36.8 39.1 32.4 51.6 41.7 68.2 36.3 68.6 32.6 46.5 31.3 39.7 17.4 41.3 43.0 30.2 52.7 34.9 32.4 32.1 51.8 14.0 29.8 14.3 18.1 21.0 16.6 31.5 14.1 19.8 15.5 54.0 15.1 33.3 20.3 24.5 59.5 32.4 49.6 34.9 57.3 35.0 40.5 34.3 36.6 60.5 25.1 RAB11B H-YPT3 ENSG00000185236 "RAB11B, member RAS oncogene family" Q15907 19 8389981-8404434 "Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054396 Approved "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "HPA054396: " "unprognostic (5.81e-3)" "prognostic favourable (2.08e-4)" "unprognostic (1.13e-2)" "unprognostic (1.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-3)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-1)" "unprognostic (4.78e-2)" "prognostic favourable (7.58e-5)" "unprognostic (1.23e-1)" "prognostic favourable (2.06e-4)" "unprognostic (3.66e-1)" "unprognostic (3.87e-1)" "unprognostic (8.85e-2)" "unprognostic (3.29e-3)" 41.1 38.7 38.1 34.3 51.9 36.5 32.5 43.7 89.0 27.9 29.3 70.8 27.6 46.1 31.0 26.8 38.8 31.0 31.7 56.7 39.6 37.5 40.6 35.9 32.3 32.3 43.6 34.4 35.1 60.5 27.6 35.3 37.9 62.2 32.9 15.0 40.1 57.8 32.7 47.8 40.7 46.4 26.4 48.4 42.9 45.8 25.9 38.5 30.8 71.1 22.1 28.0 33.2 27.1 20.8 28.2 45.6 24.5 24.9 23.8 16.6 21.8 28.9 20.8 19.1 10.7 10.6 15.4 13.0 8.9 9.8 10.3 18.9 18.4 12.8 36.9 10.9 17.2 7.0 18.6 3.2 25.5 33.7 13.6 24.2 23.4 10.3 15.9 25.6 14.7 12.3 10.7 7.1 12.2 14.3 34.4 10.1 20.9 26.8 75.6 29.2 26.2 17.9 13.8 21.5 10.2 32.4 22.5 28.9 16.1 13.4 16.7 17.0 18.0 23.4 37.1 21.4 28.5 20.7 35.6 23.6 15.1 27.8 17.8 24.8 19.9 20.8 45.6 22.6 21.1 15.7 19.1 20.6 23.8 21.8 20.8 20.0 18.6 32.1 24.9 24.5 28.2 19.8 16.6 38.1 51.9 43.7 89.0 39.6 37.5 43.6 34.4 62.2 38.5 RAB11FIP1 "FLJ22524, FLJ22622, Rab11-FIP1, RCP" ENSG00000156675 "RAB11 family interacting protein 1" Q6WKZ4 8 37858618-37899467 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 90.6" "Cell line enhanced" "Detected in many" "K-562: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 39.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 39.0" "Low region specificity" "Detected in single" "CAB017037, HPA023904, HPA024010, HPA025960" Enhanced Enhanced Vesicles Vesicles "CAB017037: , HPA023904: AB_1855990, HPA024010: AB_1855991, HPA025960: AB_1855992" "unprognostic (1.62e-2)" "unprognostic (3.47e-2)" "unprognostic (3.22e-3)" "unprognostic (2.87e-1)" "unprognostic (1.06e-1)" "prognostic favourable (6.61e-4)" "unprognostic (4.32e-1)" "unprognostic (4.50e-3)" "unprognostic (1.58e-1)" "unprognostic (4.72e-2)" "unprognostic (2.82e-3)" "unprognostic (2.73e-2)" "prognostic favourable (1.14e-6)" "unprognostic (4.94e-2)" "unprognostic (8.41e-2)" "unprognostic (9.99e-2)" "unprognostic (1.50e-1)" 6.9 3.2 1.3 16.8 1.0 17.8 7.4 1.8 1.3 8.9 37.1 1.9 17.8 13.8 2.9 8.8 30.9 5.6 31.5 5.9 1.1 1.3 8.4 4.1 64.5 8.4 1.1 0.6 4.7 31.5 3.9 12.9 26.0 6.9 7.0 16.4 9.9 20.9 21.3 3.4 13.8 90.6 5.3 1.3 10.9 15.2 5.4 0.9 16.4 8.5 14.9 34.1 9.6 9.6 2.3 6.9 39.0 7.7 4.1 4.0 3.3 17.2 7.6 0.8 3.4 0.2 0.0 23.5 1.8 2.8 3.3 4.2 17.0 9.9 7.0 5.5 2.1 13.4 6.2 3.9 4.9 18.2 5.8 1.3 4.0 4.9 9.3 3.0 15.7 2.2 5.3 1.2 3.4 0.0 29.7 3.5 1.7 4.1 5.0 4.4 5.1 2.3 1.6 4.2 5.4 17.0 17.7 3.2 3.7 4.5 22.5 5.5 15.2 5.8 0.2 0.1 10.2 0.2 0.3 7.1 8.3 1.9 0.1 4.1 2.4 6.9 7.7 13.7 1.8 3.7 4.0 2.3 1.3 1.2 6.9 1.7 0.8 0.9 39.0 4.1 6.9 4.2 2.9 3.3 1.3 1.0 1.8 1.3 1.1 1.3 1.1 0.6 6.9 0.9 RAB11FIP2 "KIAA0941, nRip11, Rab11-FIP2" ENSG00000107560 "RAB11 family interacting protein 2" Q7L804 10 118004916-118046603 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037726 Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA037726: AB_10672390" "unprognostic (1.97e-1)" "unprognostic (1.68e-2)" "unprognostic (3.61e-1)" "unprognostic (4.45e-2)" "unprognostic (1.30e-1)" "unprognostic (5.58e-2)" "unprognostic (2.17e-2)" "unprognostic (3.34e-2)" "unprognostic (1.83e-2)" "unprognostic (2.15e-1)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "prognostic favourable (9.69e-5)" "unprognostic (1.17e-1)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (2.17e-1)" 8.8 7.1 11.8 6.4 21.6 12.0 7.2 13.3 19.9 11.4 9.7 7.9 19.0 3.8 23.0 29.8 6.8 12.9 8.6 7.2 10.5 7.1 12.8 5.6 7.7 8.5 8.0 12.9 10.7 7.0 8.6 6.6 8.3 11.5 12.7 5.3 6.9 6.2 27.2 6.5 6.3 6.7 20.0 7.5 7.7 15.5 8.6 8.8 10.0 11.8 3.8 5.6 10.5 13.7 2.3 2.6 1.9 1.2 0.9 2.3 0.4 5.2 6.7 5.6 7.1 9.4 12.0 6.1 10.4 12.1 6.4 6.7 5.4 5.6 10.8 8.4 10.6 3.7 7.8 4.6 10.0 2.7 8.2 3.9 6.9 3.7 13.6 7.1 4.2 11.7 8.7 9.1 20.0 3.9 2.8 9.2 8.3 1.9 5.4 5.3 4.8 4.7 4.7 19.9 3.6 9.6 4.2 1.3 10.4 7.3 3.0 12.8 2.3 6.7 5.7 8.6 7.0 10.1 10.3 6.7 5.6 7.0 8.9 12.3 5.3 1.5 1.2 1.4 1.5 0.8 1.4 2.2 1.2 1.5 0.6 2.3 2.3 1.3 1.9 0.9 0.7 2.6 0.6 0.4 11.8 21.6 13.3 19.9 10.5 7.1 8.0 12.9 11.5 8.8 RAB11FIP3 "eferin, KIAA0665, Rab11-FIP3" ENSG00000090565 "RAB11 family interacting protein 3" O75154 16 425619-523011 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 70.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028088, HPA028631, HPA030086" Approved Supported "Vesicles,Cytokinetic bridge,Centriolar satellite" "Vesicles, Cytokinetic bridge, Centriolar satellite" "HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596" "unprognostic (6.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.51e-1)" "prognostic favourable (1.22e-4)" "unprognostic (2.87e-2)" "unprognostic (1.85e-1)" "prognostic unfavourable (9.87e-5)" "unprognostic (6.71e-2)" "unprognostic (4.74e-1)" "unprognostic (9.66e-2)" "prognostic favourable (3.16e-5)" "unprognostic (1.12e-1)" "prognostic favourable (7.99e-4)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.58e-1)" "unprognostic (1.44e-1)" 10.2 13.4 19.3 7.5 16.9 8.7 7.3 29.7 27.4 11.5 10.6 12.2 9.0 13.4 11.9 11.0 8.2 9.5 11.3 14.0 18.7 12.1 70.5 12.2 10.5 8.1 12.0 18.0 13.4 22.2 22.4 14.6 10.0 10.6 11.5 5.4 9.9 13.2 12.6 23.5 12.2 14.6 10.8 8.9 10.2 7.6 13.5 11.9 5.7 8.6 7.4 5.3 9.7 16.6 1.1 0.8 0.1 0.1 0.1 1.5 0.6 4.4 10.1 9.7 8.5 14.3 9.4 8.4 8.4 7.9 7.7 5.6 7.4 2.1 12.2 9.9 12.3 4.6 6.0 8.9 2.7 9.0 8.6 5.5 9.4 21.5 15.3 5.4 6.8 9.0 6.1 7.9 6.9 11.7 2.8 4.8 9.7 13.6 8.8 10.8 8.1 4.1 18.3 7.8 3.2 7.8 2.7 10.1 9.4 8.6 10.5 5.3 5.9 10.1 19.0 11.3 7.5 10.5 5.5 6.7 5.3 14.4 4.3 3.9 8.3 0.0 0.1 0.0 1.5 0.0 1.3 0.8 0.9 0.7 0.5 1.1 0.6 0.3 0.1 0.1 0.0 0.8 0.0 0.6 19.3 16.9 29.7 27.4 18.7 12.1 12.0 18.0 10.6 11.9 RAB11FIP5 "GAF1, KIAA0857, pp75, RIP11" ENSG00000135631 "RAB11 family interacting protein 5" Q9BXF6 2 73073382-73156721 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.4" "Cell line enhanced" "Detected in many" "TIME: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.6" "Lineage enriched" "Detected in single" 18 "T-cells: 2.6" "Low region specificity" "Detected in all" "HPA036406, HPA036407" Enhanced Enhanced "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "HPA036406: , HPA036407: AB_10669778" "unprognostic (1.49e-1)" "unprognostic (4.40e-3)" "unprognostic (1.41e-2)" "unprognostic (2.45e-3)" "unprognostic (1.67e-3)" "unprognostic (3.26e-2)" "unprognostic (1.58e-3)" "unprognostic (4.08e-3)" "unprognostic (2.27e-1)" "prognostic unfavourable (3.87e-4)" "unprognostic (3.23e-3)" "unprognostic (1.45e-1)" "prognostic favourable (2.26e-5)" "unprognostic (1.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.83e-1)" "unprognostic (9.66e-3)" 8.4 5.4 5.3 3.8 9.3 1.5 6.3 9.5 16.7 5.2 4.2 2.8 4.6 3.5 7.9 7.3 5.3 5.6 8.2 7.2 4.9 6.3 14.9 2.3 4.8 2.1 5.6 6.5 6.7 8.4 22.3 4.3 11.4 16.0 5.3 2.1 5.1 9.5 5.9 9.0 5.8 2.6 5.2 2.9 18.9 4.9 46.4 2.5 0.0 3.9 4.7 2.7 5.3 7.4 0.1 0.0 0.0 0.0 0.0 2.6 0.5 12.0 5.4 0.4 3.8 4.0 4.8 7.0 18.2 10.0 6.2 4.8 3.9 3.0 0.0 9.6 9.2 4.9 2.3 5.6 2.8 20.9 6.7 4.4 2.3 2.5 4.9 0.0 0.8 5.8 5.3 7.6 5.0 8.5 3.4 2.4 4.4 0.3 0.0 0.1 2.9 8.6 4.1 4.9 10.2 5.4 1.5 1.8 1.9 6.0 2.5 2.7 1.4 0.2 25.0 15.1 8.8 11.2 9.5 7.9 2.3 0.0 11.8 4.7 1.4 0.0 0.0 0.0 2.6 0.0 0.5 0.0 1.2 1.9 0.0 0.1 0.2 1.5 0.0 0.0 0.0 0.0 0.8 0.5 5.3 9.3 9.5 16.7 4.9 6.3 5.6 6.5 16.0 2.5 RAB12 ENSG00000206418 "RAB12, member RAS oncogene family" Q6IQ22 18 8609445-8639381 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040727 Approved Approved Vesicles Vesicles "HPA040727: AB_10794858" "unprognostic (7.92e-2)" "unprognostic (4.11e-2)" "unprognostic (1.05e-1)" "unprognostic (1.72e-2)" "unprognostic (1.53e-2)" "unprognostic (1.47e-2)" "unprognostic (1.25e-2)" "unprognostic (2.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.29e-3)" "unprognostic (2.67e-1)" "unprognostic (5.72e-2)" "unprognostic (2.02e-1)" "unprognostic (1.63e-1)" "unprognostic (1.46e-1)" "unprognostic (1.61e-1)" "unprognostic (9.11e-2)" 20.0 16.0 18.0 10.2 18.3 7.2 15.6 23.5 22.1 17.2 16.8 13.8 9.2 7.3 18.5 12.3 17.3 13.4 11.2 45.6 16.2 16.2 18.4 20.7 15.8 12.5 13.7 17.8 19.0 7.5 10.4 12.7 17.6 15.3 15.3 10.5 13.7 10.1 18.6 96.4 18.1 10.3 25.4 12.2 16.3 10.8 8.3 10.6 7.7 12.1 21.2 11.9 19.4 20.2 3.2 4.1 7.7 5.1 3.9 3.1 1.3 12.1 7.2 8.5 8.8 25.2 21.5 4.7 16.6 22.9 19.0 22.3 9.8 11.2 4.2 16.2 19.8 7.7 9.7 17.7 23.0 1.7 7.9 3.6 7.7 10.2 23.4 4.6 3.8 21.2 25.1 13.9 17.8 22.8 5.4 6.0 18.3 13.1 5.3 4.7 5.4 6.8 3.7 20.5 4.0 18.4 16.4 14.0 10.0 12.6 17.2 20.8 5.0 7.2 19.0 22.0 12.8 21.9 25.1 4.1 2.3 3.6 16.4 4.4 14.0 7.7 2.2 2.4 2.1 3.6 3.0 3.2 2.3 2.5 1.8 3.0 3.1 3.0 4.1 3.9 5.1 4.1 2.5 1.3 18.0 18.3 23.5 22.1 16.2 16.2 13.7 17.8 15.3 10.6 RAB14 "FBP, RAB-14" ENSG00000119396 "RAB14, member RAS oncogene family" P61106 9 121178137-121223014 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026419, CAB037066" Approved Supported Vesicles 9900000 Vesicles "CAB037066: AB_1841128, HPA026419: AB_1855996" "unprognostic (1.30e-3)" "unprognostic (3.12e-2)" "unprognostic (9.01e-2)" "unprognostic (7.18e-2)" "unprognostic (6.53e-2)" "unprognostic (3.00e-1)" "unprognostic (1.39e-1)" "unprognostic (1.18e-1)" "unprognostic (2.52e-1)" "unprognostic (6.90e-2)" "unprognostic (3.05e-2)" "unprognostic (9.71e-3)" "prognostic favourable (1.79e-8)" "unprognostic (1.38e-1)" "unprognostic (3.17e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" 28.4 29.2 35.7 29.7 37.3 41.4 37.2 36.5 50.2 29.9 30.3 31.4 38.2 28.5 27.9 26.1 50.1 25.6 25.5 24.3 33.3 34.1 37.0 58.7 57.5 38.0 44.5 34.8 27.5 22.7 38.6 25.2 30.7 35.0 29.5 31.5 20.0 29.2 55.5 28.2 42.4 27.4 24.7 43.0 28.1 31.3 23.5 41.4 23.9 32.4 25.8 34.3 27.7 32.3 19.0 23.3 24.0 30.9 19.2 21.5 15.7 21.8 22.3 28.4 23.7 33.1 36.2 22.4 31.1 25.0 24.1 19.2 17.6 23.9 21.0 18.2 29.8 41.8 20.2 23.2 27.3 18.0 13.3 22.7 30.9 17.9 22.9 24.2 27.3 23.0 42.0 24.7 27.3 34.1 17.1 19.3 36.0 20.6 23.4 19.5 16.8 25.2 18.6 30.8 24.5 26.5 31.4 25.1 14.7 37.0 32.9 21.2 34.6 19.2 31.5 25.9 18.9 31.9 21.7 17.4 32.7 21.4 24.3 21.3 33.8 23.4 21.9 24.0 18.0 30.9 17.9 19.0 16.9 19.5 23.3 17.0 20.4 20.2 23.7 19.2 30.2 14.3 21.5 15.7 35.7 37.3 36.5 50.2 33.3 34.1 44.5 34.8 35.0 41.4 RAB15 ENSG00000139998 "RAB15, member RAS oncogene family" P59190 14 64945814-64973226 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.4" "Cell line enhanced" "Detected in many" "HAP1: 37.4;RH-30: 44.7;RT4: 32.7;SK-BR-3: 34.3" "Cancer enhanced" "Detected in all" "testis cancer: 83.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041177 Uncertain Approved "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "HPA041177: AB_10794547" "unprognostic (9.80e-2)" "unprognostic (1.42e-2)" "unprognostic (1.53e-1)" "unprognostic (4.94e-2)" "unprognostic (6.29e-2)" "unprognostic (3.45e-1)" "prognostic unfavourable (4.68e-4)" "unprognostic (7.14e-2)" "unprognostic (3.12e-1)" "unprognostic (4.25e-2)" "unprognostic (2.79e-2)" "unprognostic (2.02e-1)" "unprognostic (1.98e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-2)" "unprognostic (2.82e-2)" 2.3 4.0 16.7 4.2 19.2 0.6 6.3 40.4 32.9 5.7 9.9 2.2 3.2 9.1 2.4 4.5 1.8 1.9 4.7 14.1 21.2 10.8 7.5 11.4 4.3 2.6 7.8 12.6 1.4 5.6 16.2 4.0 11.9 10.2 4.3 15.4 1.9 27.2 3.8 3.9 2.8 9.6 8.6 4.2 1.2 5.3 1.0 2.5 2.4 2.9 0.6 2.2 13.4 1.8 0.0 5.2 0.0 0.1 0.8 0.7 0.1 3.0 16.2 6.0 5.9 1.3 1.9 16.8 1.9 2.7 4.0 3.5 7.6 8.2 0.1 1.1 4.7 3.1 37.4 0.3 2.8 1.0 1.8 3.5 0.3 6.6 0.2 0.1 2.2 1.3 0.7 1.7 0.3 12.4 0.1 0.5 7.0 17.3 4.2 3.1 13.4 2.3 5.2 44.7 0.2 4.6 32.7 19.3 3.7 0.9 34.3 4.3 9.7 3.3 3.1 3.4 14.8 1.6 2.4 0.1 0.1 1.6 0.7 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.1 5.2 0.3 0.1 16.7 19.2 40.4 32.9 21.2 10.8 7.8 12.6 10.2 2.5 RAB20 FLJ20429 ENSG00000139832 "RAB20, member RAS oncogene family" Q9NX57 13 110523066-110561733 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 19.5;SK-BR-3: 35.9;T-47d: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003621, HPA052111, HPA068647" Uncertain Enhanced "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA003621: , HPA052111: , HPA068647: " "unprognostic (5.59e-3)" "unprognostic (1.30e-1)" "unprognostic (3.48e-1)" "unprognostic (1.42e-3)" "unprognostic (1.30e-1)" "unprognostic (3.82e-2)" "unprognostic (1.14e-2)" "unprognostic (5.99e-2)" "unprognostic (9.43e-2)" "unprognostic (2.06e-2)" "unprognostic (9.41e-2)" "unprognostic (2.65e-1)" "prognostic favourable (8.57e-4)" "unprognostic (6.96e-2)" "unprognostic (4.32e-2)" "unprognostic (2.28e-2)" "prognostic favourable (4.48e-4)" 30.9 23.5 3.7 11.9 5.3 11.9 27.5 1.3 4.0 6.9 20.2 5.2 3.0 15.7 6.0 8.8 4.1 6.8 17.8 17.0 5.3 2.5 15.9 38.2 27.8 21.9 7.1 1.8 17.0 14.5 3.2 5.8 12.6 9.1 9.4 8.3 8.5 10.9 3.2 8.8 2.6 23.8 5.0 13.4 32.9 15.0 6.3 3.6 2.5 13.6 1.9 4.2 13.2 13.6 1.9 8.3 13.4 19.4 0.0 3.6 5.6 8.0 1.2 0.8 1.6 5.3 1.4 13.1 0.7 2.5 3.4 5.3 19.5 16.5 0.0 5.8 0.7 3.1 1.6 5.0 1.8 9.0 1.2 8.0 1.5 9.0 3.3 1.1 2.4 2.9 0.8 1.8 0.5 1.3 1.5 0.0 0.7 9.7 0.0 11.6 1.7 3.5 0.7 0.0 3.6 5.9 10.7 0.2 0.9 1.5 35.9 10.9 22.6 12.4 0.9 0.8 1.8 0.0 1.1 0.0 0.0 0.0 11.7 15.8 1.7 2.8 19.4 3.5 0.6 17.0 0.7 1.9 1.6 0.5 8.3 1.2 3.6 1.2 13.4 0.0 12.7 0.4 0.4 5.6 3.7 5.3 1.3 4.0 5.3 2.5 7.1 1.8 9.1 3.6 RAB26 ENSG00000167964 "RAB26, member RAS oncogene family" Q9ULW5 16 2140803-2154165 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;liver: 21.9;pancreas: 24.6;salivary gland: 17.7" "Cell line enhanced" "Detected in many" "A549: 13.6;HeLa: 14.9;MCF7: 8.9;SCLC-21H: 18.9;SK-BR-3: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075624 Uncertain "Vesicles,Plasma membrane,Centrosome" "Intracellular and membrane" "Vesicles, Plasma membrane" Centrosome "HPA075624: " "unprognostic (1.01e-2)" "prognostic favourable (8.20e-5)" "unprognostic (7.25e-2)" "unprognostic (1.52e-1)" "unprognostic (7.34e-2)" "unprognostic (9.41e-3)" "unprognostic (2.81e-2)" "unprognostic (5.10e-2)" "unprognostic (1.82e-2)" "unprognostic (3.55e-2)" "unprognostic (3.75e-2)" "unprognostic (2.14e-1)" "unprognostic (6.48e-2)" "unprognostic (5.68e-2)" "unprognostic (1.23e-1)" "unprognostic (7.16e-2)" "unprognostic (2.92e-3)" 0.6 1.0 13.6 0.4 19.9 0.5 0.9 30.5 13.5 2.0 4.1 0.5 1.5 5.7 0.4 2.3 1.2 0.9 1.1 1.2 18.0 6.2 0.7 21.9 0.6 0.6 5.6 9.1 0.6 24.6 3.1 9.2 0.3 2.5 2.2 5.4 0.7 17.7 1.6 1.1 1.2 6.0 0.4 1.9 0.6 5.3 0.6 3.2 0.0 1.2 0.0 1.1 0.9 0.0 0.8 0.2 0.0 0.1 0.0 1.1 0.7 1.1 13.6 0.0 3.5 0.2 0.1 0.1 0.6 1.1 0.5 0.9 0.4 2.7 0.2 0.9 0.8 2.2 0.7 0.2 0.0 1.5 1.4 0.5 14.9 1.2 0.6 0.0 0.4 0.5 0.1 0.1 0.2 0.3 0.3 0.0 1.6 8.9 0.0 0.6 0.8 1.2 1.1 1.1 2.3 5.2 0.9 18.9 3.7 0.3 17.1 0.6 5.6 0.2 0.6 0.0 2.5 0.2 0.2 2.0 0.1 0.2 0.3 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.1 0.0 0.8 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.7 13.6 19.9 30.5 13.5 18.0 6.2 5.6 9.1 2.5 3.2 RAB30 ENSG00000137502 "RAB30, member RAS oncogene family" Q15771 11 82973133-83071923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 21.6;HDLM-2: 19.3;U-698: 58.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 23.2;naive B-cell: 25.1" "Lineage enriched" "Detected in many" 5 "B-cells: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054514, HPA060565" Approved Enhanced Vesicles Vesicles "HPA054514: , HPA060565: " "unprognostic (3.21e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-1)" "unprognostic (5.18e-2)" "unprognostic (7.21e-2)" "unprognostic (8.06e-2)" "unprognostic (2.91e-2)" "unprognostic (3.14e-2)" "unprognostic (4.36e-1)" "unprognostic (1.71e-2)" "unprognostic (1.53e-1)" "unprognostic (3.75e-2)" "unprognostic (1.64e-2)" "unprognostic (2.37e-1)" "unprognostic (2.42e-1)" "unprognostic (3.93e-2)" "unprognostic (1.85e-1)" 12.2 17.3 15.8 14.5 21.6 12.7 13.8 19.9 22.5 10.3 12.6 30.6 2.2 16.7 10.3 6.7 7.0 7.2 6.5 9.9 17.2 12.2 4.5 8.5 7.4 21.1 27.9 15.0 15.5 4.9 6.0 10.0 10.0 22.8 8.6 14.3 10.9 8.8 6.7 19.8 11.8 20.0 11.6 29.3 10.9 11.2 4.2 29.2 3.3 7.2 5.0 29.0 11.0 8.3 25.1 2.6 0.5 0.4 0.9 5.4 2.7 1.4 1.9 2.0 1.3 4.6 6.6 2.4 3.3 3.4 6.5 3.2 3.5 0.6 21.6 4.1 5.0 1.8 3.0 2.2 4.2 19.3 0.6 5.3 6.2 1.7 1.1 0.6 0.9 4.2 1.5 3.2 2.2 5.3 0.6 5.4 3.9 2.7 0.7 0.1 2.7 3.6 1.5 5.6 8.1 3.8 1.3 2.6 1.7 9.4 2.0 1.0 4.5 0.0 6.5 3.1 6.9 3.1 1.0 8.5 4.5 58.4 1.2 0.5 2.2 0.5 0.3 0.5 2.3 0.1 1.6 23.2 2.2 2.2 0.8 25.1 5.4 4.6 0.5 0.9 0.4 2.6 4.1 2.7 15.8 21.6 19.9 22.5 17.2 12.2 27.9 15.0 22.8 29.2 RAB33A RabS10 ENSG00000134594 "RAB33A, member RAS oncogene family" Q14088 X 130171649-130184870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.3;brain: 32.4" "Cell line enhanced" "Detected in some" "HMC-1: 31.6;Karpas-707: 35.9;U-266/70: 26.3;U-937: 14.9" "Group enriched" "Detected in many" 6 "glioma: 10.7;melanoma: 2.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059737 Uncertain Uncertain Vesicles Vesicles "HPA059737: " "unprognostic (5.40e-2)" "unprognostic (6.64e-3)" "unprognostic (3.48e-2)" "unprognostic (8.47e-3)" "unprognostic (4.88e-2)" "unprognostic (1.17e-2)" "unprognostic (2.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.12e-2)" "unprognostic (4.16e-2)" "unprognostic (3.03e-2)" "unprognostic (8.28e-2)" "unprognostic (7.00e-6)" "unprognostic (2.51e-1)" "unprognostic (6.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.61e-1)" 1.8 2.3 12.5 4.9 11.6 6.8 1.6 15.8 32.4 2.0 1.7 20.8 0.0 1.6 2.1 1.4 1.4 2.2 3.5 10.3 15.9 9.9 1.1 1.5 1.9 11.9 13.0 12.6 2.5 0.8 3.2 1.6 2.3 10.1 1.1 1.9 0.6 1.5 1.0 0.8 1.0 1.9 1.6 21.5 3.3 2.3 1.5 17.3 1.2 1.0 0.0 13.1 3.3 0.6 7.1 3.3 27.3 1.7 5.7 22.9 5.9 0.0 0.0 2.1 0.0 0.9 0.2 0.0 0.2 0.6 0.5 0.9 0.0 0.2 1.6 0.0 0.1 0.0 2.5 0.0 0.5 8.2 0.0 9.4 0.0 0.0 8.8 7.6 31.6 0.3 0.0 0.1 0.3 0.2 0.0 35.9 0.0 0.0 3.5 2.7 0.3 0.3 0.0 0.0 0.4 0.0 0.0 6.9 5.7 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.1 0.0 26.3 7.8 0.0 1.1 14.9 0.0 9.4 0.4 27.3 11.2 0.2 7.0 7.1 10.1 11.1 3.3 2.6 9.8 13.9 1.3 5.7 1.7 0.3 22.9 5.9 12.5 11.6 15.8 18.5 15.9 9.9 13.0 12.6 10.1 17.3 RAB36 ENSG00000100228 "RAB36, member RAS oncogene family" O95755 22 23145326-23164350 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 38.2" "Cell line enhanced" "Detected in many" "RPMI-8226: 17.5;U-266/84: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 12.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059631 Approved Vesicles "Intracellular and membrane" Vesicles "HPA059631: " "unprognostic (2.74e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-2)" "unprognostic (1.23e-2)" "unprognostic (1.15e-2)" "unprognostic (6.60e-2)" "unprognostic (1.22e-1)" "unprognostic (3.46e-1)" "unprognostic (2.49e-2)" "unprognostic (7.94e-2)" "unprognostic (2.02e-3)" "unprognostic (5.56e-3)" "prognostic favourable (4.55e-4)" "unprognostic (7.08e-2)" "unprognostic (7.18e-2)" "unprognostic (1.64e-1)" "unprognostic (3.08e-1)" 2.4 5.9 7.6 2.0 11.9 1.3 3.5 2.7 14.1 6.5 2.8 6.8 9.3 1.4 5.4 12.7 3.0 38.2 6.6 1.9 7.7 8.4 8.2 0.8 6.1 1.7 4.5 9.3 8.1 4.3 1.9 16.6 7.0 5.8 5.1 1.8 4.8 4.6 11.2 1.2 1.9 1.5 4.9 2.6 1.9 2.7 12.8 3.1 0.0 20.7 1.2 1.9 3.6 2.1 1.0 0.3 12.7 0.6 1.7 0.7 0.3 5.5 6.5 5.0 7.6 1.2 2.5 2.0 3.1 6.4 7.0 2.6 0.4 0.0 0.0 3.5 4.1 7.0 0.2 3.7 2.3 0.0 3.0 0.0 0.2 0.6 3.0 0.0 0.9 3.1 1.4 6.5 1.3 1.0 0.3 5.7 0.3 4.4 0.0 0.1 0.6 1.7 0.0 0.0 17.5 9.0 1.0 12.4 5.4 0.2 2.7 1.6 0.0 0.6 0.5 0.9 2.1 2.4 4.5 12.4 17.2 0.0 6.4 0.0 4.1 0.3 0.6 0.0 0.7 0.3 0.4 1.0 0.1 0.2 0.3 0.3 0.5 0.4 12.7 1.7 0.3 0.0 0.1 0.3 7.6 11.9 2.7 14.1 7.7 8.4 4.5 9.3 5.8 3.1 RAB3D "D2-2, GOV, RAB16, RAD3D" ENSG00000105514 "RAB3D, member RAS oncogene family" O95716 19 11322046-11346270 "Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 21.2;Karpas-707: 20.4;MCF7: 23.4;SK-BR-3: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 44.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB018067, HPA063283" Approved Approved Vesicles Vesicles "CAB018067: AB_606903, HPA063283: " "unprognostic (4.71e-3)" "unprognostic (3.00e-1)" "unprognostic (1.79e-1)" "unprognostic (3.99e-3)" "prognostic unfavourable (3.70e-4)" "unprognostic (4.17e-3)" "unprognostic (7.27e-3)" "unprognostic (1.55e-1)" "unprognostic (2.80e-1)" "unprognostic (8.76e-2)" "unprognostic (9.92e-2)" "unprognostic (4.45e-2)" "unprognostic (7.60e-2)" "unprognostic (2.22e-1)" "unprognostic (1.74e-1)" "unprognostic (9.15e-2)" "unprognostic (1.34e-1)" 6.3 3.8 6.4 4.6 8.2 13.2 10.8 7.1 11.9 13.5 7.7 5.0 12.0 7.2 7.9 7.7 30.2 8.0 10.3 9.0 8.1 6.4 10.6 21.6 7.9 8.3 5.3 6.7 7.4 54.7 5.1 5.4 6.4 6.1 15.0 7.8 9.9 22.8 11.0 5.2 42.4 5.7 7.9 4.3 9.2 16.6 5.6 4.1 5.4 14.4 12.0 9.4 8.1 13.3 0.6 9.3 44.6 22.5 0.4 1.5 5.9 0.6 6.2 1.9 7.9 3.2 5.6 0.4 0.5 1.6 1.1 1.1 2.2 0.2 0.2 7.2 3.7 8.5 3.3 5.2 1.0 3.3 0.5 2.4 2.8 2.5 2.0 1.3 6.0 2.4 21.2 0.9 2.3 9.1 0.9 20.4 0.3 23.4 0.9 3.0 1.6 6.4 0.9 0.0 6.9 9.8 6.2 2.2 4.2 1.8 30.6 3.9 18.3 15.2 3.4 1.1 0.3 5.1 0.1 7.0 8.8 1.4 3.8 8.2 1.1 26.0 22.5 23.9 0.9 13.5 1.5 0.6 0.9 0.7 9.3 0.6 0.6 0.7 44.6 0.4 9.9 0.2 1.5 5.9 6.4 8.2 7.1 11.9 8.1 6.4 5.3 6.7 6.1 4.1 RAB40A "Rar-2, RAR2A" ENSG00000172476 "RAB40A, member RAS oncogene family" Q8WXH6 X 103499130-103519489 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 34.0" "Cell line enhanced" "Detected in many" "AF22: 6.4;NTERA-2: 7.1" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 4.2" "Cell type enriched" "Detected in single" 5 "memory B-cell: 1.2" "Lineage enriched" "Detected in single" 5 "B-cells: 1.2" HPA076172 Uncertain Vesicles Vesicles "HPA076172: " "unprognostic (3.49e-1)" "unprognostic (6.01e-2)" "unprognostic (4.33e-2)" "unprognostic (4.49e-3)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (3.82e-2)" "unprognostic (4.43e-1)" "unprognostic (7.36e-4)" "unprognostic (7.85e-3)" "unprognostic (9.39e-5)" "unprognostic (1.43e-1)" "unprognostic (1.11e-3)" 2.0 1.4 0.6 0.6 4.2 0.0 0.8 0.6 1.1 2.8 0.8 0.6 11.9 0.5 5.5 34.0 10.6 2.6 2.9 0.6 0.6 0.9 1.3 0.6 2.0 1.7 0.6 0.6 5.4 0.6 0.6 2.4 0.8 0.8 5.5 0.4 0.6 0.6 6.2 0.6 0.7 0.9 1.3 0.6 0.8 0.5 7.8 0.6 0.6 0.6 0.6 0.6 1.5 2.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.4 1.7 6.4 0.2 1.4 1.9 3.1 1.9 0.4 0.3 0.5 1.3 0.9 1.6 2.4 0.3 0.1 0.4 0.1 0.3 0.0 3.7 0.5 2.9 0.3 0.6 0.1 0.2 1.5 0.3 0.6 0.4 0.3 2.3 1.0 0.6 0.4 0.4 0.2 7.1 1.0 0.0 0.5 0.1 0.1 0.6 2.7 3.3 0.6 0.1 1.3 0.0 0.2 3.2 2.6 1.5 4.0 1.8 1.1 0.7 1.2 2.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.6 4.2 0.6 0.6 0.6 0.9 0.6 0.6 0.8 0.6 RAB40AL "RAR2, RLGP" ENSG00000102128 "RAB40A like" P0C0E4 X 102937272-102938300 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 2.9" "Cell line enhanced" "Detected in some" "BEWO: 2.3;HEK 293: 1.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" HPA076172 Uncertain Vesicles Vesicles "HPA076172: " "unprognostic (1.99e-1)" "unprognostic (3.05e-1)" "unprognostic (1.31e-1)" "unprognostic (1.11e-2)" "unprognostic (1.24e-1)" "unprognostic (1.04e-1)" "unprognostic (2.91e-1)" "unprognostic (1.39e-1)" "unprognostic (3.49e-1)" "unprognostic (1.83e-1)" "unprognostic (1.15e-1)" "unprognostic (2.18e-2)" "unprognostic (5.90e-10)" "unprognostic (4.74e-1)" "unprognostic (1.32e-1)" "unprognostic (5.02e-3)" "unprognostic (2.64e-2)" 0.3 1.0 0.2 0.2 0.3 0.7 0.4 2.1 0.4 0.3 0.4 1.0 0.8 2.9 0.2 0.3 0.7 0.3 0.3 0.3 0.2 0.5 0.5 0.0 0.2 1.0 0.2 0.0 0.9 0.6 0.8 0.1 0.2 0.5 0.0 0.2 0.1 0.6 0.4 0.2 0.1 0.3 0.8 0.2 0.0 0.5 0.0 1.2 0.0 0.3 0.0 0.7 0.0 0.5 0.6 0.8 0.2 0.0 0.0 2.3 0.0 0.2 0.0 0.5 0.0 0.5 0.0 0.6 0.0 0.0 1.2 0.0 0.6 0.2 1.9 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.3 0.3 0.4 0.3 0.3 0.0 0.0 1.4 0.6 0.9 0.6 1.6 0.0 0.3 0.0 0.2 1.0 0.0 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.3 1.4 0.5 0.4 0.3 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 RAB40B "RAR, SEC4L" ENSG00000141542 "RAB40B, member RAS oncogene family" Q12829 17 82654973-82698728 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.4" "Cell line enhanced" "Detected in many" "HEK 293: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.0" "Low lineage specificity" "Detected in all" HPA076172 Approved Vesicles Vesicles "HPA076172: " "unprognostic (2.21e-2)" "unprognostic (7.50e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-1)" "unprognostic (6.03e-2)" "unprognostic (2.34e-2)" "prognostic favourable (9.77e-4)" "unprognostic (1.74e-1)" "unprognostic (3.28e-2)" "unprognostic (1.36e-1)" "unprognostic (3.14e-2)" "prognostic favourable (2.95e-6)" "unprognostic (1.81e-2)" "unprognostic (1.38e-1)" "unprognostic (2.13e-2)" "unprognostic (9.83e-3)" 6.3 7.5 29.7 2.1 43.4 1.0 6.5 9.3 34.2 6.2 12.5 38.3 1.5 7.3 6.5 15.0 5.0 5.8 5.3 13.4 25.8 13.7 15.9 6.4 5.3 2.1 21.3 17.0 8.6 5.0 5.3 5.9 3.3 19.8 8.7 7.9 2.2 8.0 5.9 29.6 8.5 5.3 4.4 28.7 4.0 16.7 3.0 23.2 0.0 4.3 3.9 2.5 4.6 3.4 3.5 10.0 2.1 4.5 2.8 2.6 1.0 4.9 8.1 2.5 7.4 6.3 7.9 3.7 5.5 1.5 3.5 1.1 2.7 1.3 0.6 11.0 5.5 9.0 4.7 4.4 3.1 0.4 23.3 1.9 8.4 7.4 3.1 0.6 2.2 6.7 7.2 2.0 1.5 3.2 5.7 0.7 4.7 6.6 1.9 4.3 0.5 10.7 4.6 6.4 4.2 12.2 9.2 13.7 8.6 3.9 3.5 7.4 7.6 4.0 6.5 9.8 3.0 10.2 4.4 3.9 3.1 7.0 2.3 1.3 1.7 2.1 0.7 0.1 1.6 1.9 2.2 3.5 2.0 2.6 1.2 1.3 2.5 1.3 0.3 2.8 4.5 10.0 2.6 1.0 29.7 43.4 9.3 26.8 25.8 13.7 21.3 17.0 19.8 23.2 RAB40C "RARL, RASL8C" ENSG00000197562 "RAB40C, member RAS oncogene family" Q96S21 16 589357-629272 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 39.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.0" "Low region specificity" "Detected in all" HPA076172 Approved Vesicles Vesicles "HPA076172: " "unprognostic (8.04e-2)" "unprognostic (3.63e-1)" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (5.38e-3)" "unprognostic (1.07e-2)" "prognostic unfavourable (1.18e-4)" "unprognostic (1.23e-1)" "unprognostic (4.61e-2)" "unprognostic (5.78e-2)" "unprognostic (3.45e-2)" "unprognostic (2.90e-1)" "unprognostic (1.37e-3)" "unprognostic (3.89e-2)" "unprognostic (6.20e-2)" "unprognostic (7.48e-2)" "unprognostic (4.00e-3)" 6.8 4.3 9.1 4.8 15.2 5.8 5.3 18.1 29.9 5.2 9.1 5.9 5.3 14.1 6.2 6.5 11.0 7.6 5.1 7.6 9.7 6.5 6.3 5.3 7.7 4.2 6.6 13.2 8.5 39.9 5.7 12.2 7.2 7.5 7.9 5.0 3.3 14.5 7.2 10.5 25.7 14.1 8.0 4.6 4.7 12.6 6.1 6.1 8.7 5.3 4.3 6.0 8.8 7.6 1.3 1.7 14.0 3.0 0.9 2.2 1.2 5.8 12.8 7.5 10.5 4.3 5.4 10.1 7.9 3.7 6.4 5.2 11.3 10.8 6.8 8.6 4.7 13.4 4.6 6.5 1.3 7.1 7.9 3.7 8.6 8.0 7.7 7.8 7.1 4.6 14.4 5.1 5.4 5.2 8.5 7.0 2.8 17.3 7.2 13.7 8.8 7.6 11.8 5.4 10.7 3.7 8.5 10.2 8.3 8.7 19.2 7.3 14.1 15.1 6.4 6.8 9.7 9.0 4.7 6.8 6.5 8.3 4.5 10.4 7.0 1.1 3.0 14.0 0.4 1.8 2.2 1.3 1.5 1.7 1.7 0.9 1.1 0.8 5.3 0.9 0.9 0.7 0.6 1.2 9.1 15.2 18.1 29.9 9.7 6.5 6.6 13.2 7.5 6.1 RAB5B ENSG00000111540 "RAB5B, member RAS oncogene family" P61020 12 55973913-55996683 "Predicted intracellular proteins, RAS pathway related proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010224, HPA068337" Approved Supported Vesicles 1000000 Vesicles "CAB010224: AB_2175453, HPA068337: " "prognostic unfavourable (2.24e-5)" "unprognostic (1.86e-1)" "unprognostic (1.91e-1)" "unprognostic (7.66e-3)" "unprognostic (2.09e-1)" "unprognostic (8.42e-2)" "unprognostic (9.16e-3)" "unprognostic (3.09e-1)" "unprognostic (3.13e-1)" "unprognostic (8.31e-3)" "unprognostic (8.64e-2)" "unprognostic (2.26e-1)" "unprognostic (2.27e-2)" "unprognostic (2.46e-2)" "unprognostic (2.74e-1)" "unprognostic (2.85e-1)" "unprognostic (2.49e-1)" 26.6 27.9 39.9 18.3 56.2 14.3 32.9 42.0 67.4 39.2 34.0 73.3 24.0 24.8 41.2 45.0 48.9 37.2 26.0 39.2 39.3 36.2 33.4 31.8 33.7 18.8 42.2 39.3 42.2 22.7 53.2 25.6 32.2 61.8 37.1 38.8 33.5 31.8 47.5 47.1 42.8 29.3 38.2 58.7 21.2 30.9 27.8 41.0 18.3 30.8 27.2 33.8 40.4 35.3 6.9 5.7 21.9 7.2 5.2 8.5 5.8 18.8 12.6 25.4 18.4 42.3 37.1 22.9 17.5 31.4 21.4 18.1 20.6 24.0 10.4 21.2 32.6 13.9 15.8 23.5 20.2 13.7 12.4 12.3 16.8 11.6 30.5 9.9 19.4 30.0 44.4 20.0 17.1 26.7 10.7 31.2 27.0 12.5 12.5 15.4 11.1 11.0 10.9 15.7 13.5 40.2 31.1 12.8 11.4 22.5 22.4 27.8 32.7 32.0 22.3 14.1 10.5 10.5 6.7 18.5 14.6 6.7 23.3 9.3 11.9 12.1 7.0 21.9 8.5 6.9 7.9 6.9 6.8 7.4 5.7 5.9 7.9 6.1 20.7 5.2 7.2 5.6 5.4 5.8 39.9 56.2 42.0 67.4 39.3 36.2 42.2 39.3 61.8 41.0 RAB8B ENSG00000166128 "RAB8B, member RAS oncogene family" Q92930 15 63189469-63267782 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074534 Supported Nucleoplasm,Vesicles 5200000 Vesicles Nucleoplasm "HPA074534: " "unprognostic (7.67e-2)" "unprognostic (3.33e-2)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.20e-2)" "unprognostic (4.01e-2)" "unprognostic (1.46e-2)" "unprognostic (5.94e-2)" "unprognostic (3.19e-1)" "unprognostic (2.75e-2)" "unprognostic (1.71e-2)" "unprognostic (4.17e-1)" "prognostic unfavourable (2.44e-4)" "unprognostic (1.97e-2)" "unprognostic (3.14e-2)" "unprognostic (4.19e-2)" "unprognostic (7.47e-2)" 21.8 12.1 15.2 20.9 12.9 50.8 22.6 10.1 12.2 15.8 17.7 11.8 7.6 13.6 14.2 8.6 10.9 12.7 18.4 17.5 19.2 14.4 13.7 11.4 27.7 30.8 15.3 12.9 25.2 5.7 6.6 11.7 22.0 16.9 14.3 9.0 9.8 9.3 11.3 7.5 8.2 21.1 14.3 19.5 33.7 9.8 11.8 11.5 38.8 16.4 4.7 27.8 24.4 23.7 10.7 10.4 30.8 14.5 13.1 19.2 14.3 4.7 4.0 15.4 6.3 29.4 24.3 4.6 4.7 10.7 8.5 16.7 4.3 3.9 12.9 4.3 10.1 2.4 13.2 6.4 14.4 19.4 2.6 16.2 3.6 2.8 27.4 6.1 10.3 14.6 3.3 16.1 9.4 21.6 6.3 12.5 15.6 3.1 9.9 3.3 9.6 3.9 8.5 20.5 1.8 6.8 22.4 1.3 3.3 7.1 0.9 13.1 3.4 6.2 24.3 15.9 10.3 8.4 6.3 8.1 8.1 12.3 10.2 17.3 43.2 27.1 14.5 11.9 15.8 13.1 14.4 10.7 12.8 15.0 10.4 10.6 10.0 12.2 30.8 13.1 11.6 1.3 19.2 14.3 15.2 12.9 10.1 12.0 19.2 14.4 15.3 12.9 16.9 11.5 RABEP1 "neurocrescin, RAB5EP, rabaptin-5, RABPT5" ENSG00000029725 "Rabaptin, RAB GTPase binding effector protein 1" Q15276 17 5282265-5385812 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Endocytosis, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004549, HPA019669, HPA024235, HPA024691" Supported Supported Vesicles Vesicles "CAB004549: AB_628192, HPA019669: AB_1856019, HPA024235: AB_1856020, HPA024691: AB_1856021" "unprognostic (3.22e-1)" "unprognostic (2.90e-2)" "unprognostic (2.45e-1)" "unprognostic (8.75e-3)" "unprognostic (1.64e-1)" "unprognostic (8.25e-2)" "unprognostic (3.71e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-2)" "unprognostic (7.73e-2)" "prognostic favourable (6.43e-4)" "unprognostic (1.14e-1)" "unprognostic (6.09e-3)" "unprognostic (7.67e-2)" "unprognostic (2.60e-1)" "unprognostic (1.00e-1)" "unprognostic (9.00e-3)" 19.2 16.7 29.6 18.8 31.1 10.3 31.8 24.1 32.7 16.3 14.2 19.0 12.5 10.9 18.1 18.3 12.7 12.9 15.0 27.4 29.7 25.9 16.6 21.8 13.1 21.1 36.2 24.4 15.5 12.1 38.4 16.3 20.2 31.3 22.2 14.2 10.0 14.8 16.0 41.2 11.6 13.4 20.8 35.6 17.7 15.7 11.8 29.0 21.4 17.6 13.5 25.5 14.5 13.0 37.6 14.2 12.6 19.3 9.1 11.2 6.4 17.9 22.2 23.3 13.0 24.5 24.6 12.8 23.4 17.4 24.5 23.4 19.6 7.5 37.8 19.5 23.5 14.1 34.1 19.3 34.6 24.9 31.2 23.2 27.4 14.9 23.2 15.1 15.3 19.0 13.3 23.5 30.6 21.1 19.7 18.7 21.2 12.4 25.0 12.4 10.7 10.7 23.7 28.0 12.6 12.3 16.4 10.1 15.8 20.6 20.6 19.6 37.4 7.0 18.6 21.0 9.8 21.1 27.2 11.0 12.0 20.3 16.3 24.8 14.3 4.9 9.0 8.7 11.2 9.2 9.8 30.2 8.7 10.6 9.2 37.6 11.1 9.7 12.6 9.1 19.3 14.2 8.0 6.4 29.6 31.1 24.1 32.5 29.7 25.9 36.2 24.4 31.3 29.0 RABEP2 "FLJ23282, FRA" ENSG00000177548 "Rabaptin, RAB GTPase binding effector protein 2" Q9H5N1 16 28904421-28936526 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047641 Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA047641: " "unprognostic (4.93e-2)" "unprognostic (1.21e-2)" "unprognostic (2.13e-2)" "unprognostic (7.06e-2)" "unprognostic (1.44e-1)" "prognostic favourable (5.84e-4)" "unprognostic (2.46e-1)" "unprognostic (1.42e-1)" "unprognostic (8.41e-2)" "unprognostic (6.13e-2)" "unprognostic (1.26e-3)" "unprognostic (5.86e-2)" "prognostic favourable (1.24e-6)" "unprognostic (7.50e-2)" "unprognostic (8.20e-2)" "unprognostic (1.08e-1)" "unprognostic (5.92e-3)" 4.7 13.7 5.4 19.8 10.0 8.5 6.0 4.4 8.6 5.6 7.8 9.9 17.3 14.3 5.9 7.3 11.6 5.3 14.1 8.7 6.5 5.8 10.8 6.6 6.7 35.5 11.9 6.0 5.5 11.3 10.3 11.2 9.1 8.1 17.3 4.1 11.2 16.7 13.9 5.1 17.8 17.5 7.1 6.9 31.5 9.3 8.8 8.4 8.3 9.2 7.5 23.0 10.2 7.6 14.9 3.6 2.4 3.0 5.1 3.5 2.7 8.2 14.0 3.5 6.4 1.9 3.0 6.3 10.1 6.1 7.2 7.0 9.6 7.5 16.0 15.9 3.8 10.5 1.3 5.9 1.2 6.1 5.8 6.2 10.0 13.6 4.3 4.3 19.6 5.0 5.1 8.5 1.4 9.9 3.0 5.8 5.2 19.4 5.6 10.0 4.6 6.5 19.7 3.2 10.8 4.8 11.0 5.5 7.0 4.5 21.6 4.4 17.5 9.7 16.3 11.3 5.4 7.5 9.8 9.0 2.8 12.1 11.8 11.4 8.0 0.5 2.5 2.4 3.5 2.8 2.6 12.2 2.5 3.3 3.6 14.9 2.3 2.1 0.7 5.1 3.0 2.1 2.1 2.7 5.4 10.0 4.4 8.6 6.5 5.8 11.9 6.0 8.1 8.4 RABGGTB ENSG00000137955 "Rab geranylgeranyltransferase beta subunit" P53611 1 75786197-75795079 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026585, HPA027167, HPA030793" Approved Supported Approved Vesicles Vesicles "HPA026585: AB_1856026, HPA027167: AB_1856027, HPA030793: " "unprognostic (4.83e-2)" "unprognostic (3.04e-1)" "unprognostic (2.09e-2)" "unprognostic (2.45e-2)" "unprognostic (9.02e-2)" "unprognostic (3.52e-2)" "prognostic unfavourable (9.80e-5)" "unprognostic (9.62e-3)" "unprognostic (2.93e-1)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (6.95e-2)" "prognostic unfavourable (1.12e-5)" "unprognostic (6.05e-2)" "unprognostic (1.56e-1)" "unprognostic (6.77e-2)" "unprognostic (3.89e-1)" 19.4 31.8 20.2 25.3 20.1 8.7 23.5 25.8 24.2 19.4 18.8 16.8 14.8 18.6 20.9 14.1 15.7 15.6 12.0 27.2 19.1 20.4 40.7 35.8 17.4 13.1 26.3 14.8 18.5 33.2 12.3 26.4 17.3 20.5 15.6 16.2 13.7 25.0 15.8 33.5 9.5 14.5 13.1 29.4 19.0 14.3 11.9 18.0 21.3 17.3 21.6 34.4 12.4 13.3 10.6 12.8 7.6 11.5 6.3 10.7 4.4 17.0 9.7 17.7 6.9 22.3 25.7 10.3 23.3 17.4 22.4 17.9 22.1 4.2 14.4 23.9 12.9 10.6 43.3 18.8 31.6 14.8 11.6 12.4 16.4 37.2 27.6 16.6 7.6 17.1 42.6 20.0 23.1 18.2 20.7 15.0 25.1 7.4 14.0 19.8 14.1 16.7 11.5 26.2 6.6 17.1 9.4 9.6 9.3 5.3 30.1 54.2 5.9 17.0 17.6 14.2 16.1 33.2 44.6 10.1 29.5 10.3 16.4 13.5 6.2 7.6 7.7 4.5 8.8 11.5 10.3 10.6 8.9 8.1 12.8 7.1 10.5 10.7 1.3 6.3 8.0 12.0 8.0 4.4 20.2 20.1 25.8 24.2 19.1 20.4 26.3 14.8 20.5 18.0 RABL2A ENSG00000144134 "RAB, member of RAS oncogene family like 2A" Q9UBK7 2 113627229-113643396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 29.3" "Cell line enhanced" "Detected in many" "MOLT-4: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome Centrosome Vesicles "HPA042642: , HPA042700: , HPA044007: " "unprognostic (7.76e-3)" "unprognostic (7.79e-3)" "unprognostic (7.00e-2)" "unprognostic (2.94e-2)" "unprognostic (1.99e-1)" "unprognostic (4.23e-2)" "unprognostic (4.89e-2)" "unprognostic (6.77e-3)" "unprognostic (6.61e-2)" "unprognostic (7.36e-2)" "unprognostic (5.78e-3)" "unprognostic (4.29e-2)" "prognostic unfavourable (1.20e-4)" "unprognostic (1.89e-2)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (3.19e-5)" 2.2 1.7 6.0 5.9 9.5 1.7 3.3 6.3 20.9 4.3 3.4 4.2 0.4 2.4 4.7 9.0 2.7 29.3 2.8 3.3 7.0 6.0 3.5 3.4 12.9 1.8 4.0 7.5 7.4 2.6 1.2 6.3 1.6 6.4 3.8 2.0 3.8 5.2 12.2 2.2 2.1 2.2 3.6 4.8 2.7 2.1 4.8 4.3 2.0 5.5 2.0 3.1 2.1 2.7 8.8 9.8 2.5 7.6 12.2 10.4 5.5 2.5 4.3 5.9 4.7 4.9 7.2 4.5 2.4 2.0 3.4 2.5 3.7 1.6 3.6 10.3 0.8 2.7 3.0 0.3 2.3 5.0 5.7 1.8 0.1 0.5 4.0 0.7 1.3 2.5 5.1 0.7 1.5 2.5 1.7 0.9 2.1 2.1 12.0 0.9 3.3 1.5 2.2 2.3 1.6 2.4 0.6 2.4 8.3 2.3 2.5 2.1 0.5 3.4 0.6 0.4 0.8 0.9 1.6 3.6 3.7 0.8 7.0 2.7 1.2 0.0 4.8 2.5 7.1 7.6 7.7 8.8 10.4 7.2 7.5 8.0 8.6 6.8 0.5 12.2 7.2 9.8 5.0 5.5 6.0 9.5 6.3 20.9 7.0 6.0 4.0 7.5 6.4 4.3 RABL2B ENSG00000079974 "RAB, member of RAS oncogene family like 2B" Q9UNT1 22 50767501-50783663 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 59.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome Centrosome Vesicles "HPA042642: , HPA042700: , HPA044007: " "unprognostic (2.09e-1)" "unprognostic (1.47e-2)" "unprognostic (1.86e-3)" "prognostic favourable (5.58e-4)" "unprognostic (7.85e-2)" "unprognostic (9.98e-2)" "prognostic unfavourable (4.58e-5)" "unprognostic (3.14e-1)" "unprognostic (6.97e-2)" "unprognostic (7.33e-2)" "unprognostic (1.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.71e-3)" "unprognostic (7.43e-3)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (8.37e-3)" 8.2 8.2 12.4 11.1 22.1 8.1 12.9 19.7 21.2 13.0 8.4 12.7 12.6 7.9 13.9 59.0 8.1 41.9 9.4 5.8 13.1 15.3 10.6 7.0 14.4 13.3 9.9 16.5 17.8 9.6 10.9 16.7 7.4 14.3 10.0 11.0 9.5 9.5 11.6 5.1 13.8 8.6 10.2 9.5 11.5 9.1 12.2 14.5 12.6 17.9 3.5 12.3 9.4 9.2 13.6 13.2 9.2 19.4 10.8 16.8 10.3 13.4 12.3 21.0 16.4 23.6 18.8 15.4 10.1 11.3 8.2 11.3 3.4 11.9 8.7 9.0 14.5 17.7 9.6 11.8 8.9 7.5 13.6 7.5 21.1 8.9 9.8 21.1 8.1 16.0 16.2 10.8 13.6 9.1 5.7 11.0 16.3 17.0 10.5 9.3 8.0 9.2 17.8 12.1 9.1 15.9 13.4 9.0 16.4 12.4 11.0 7.6 10.8 6.6 14.0 7.9 15.8 6.7 6.8 9.3 4.3 4.2 14.9 5.3 11.0 1.0 10.9 9.2 16.8 17.4 12.2 11.2 13.0 13.7 11.6 13.6 15.2 14.7 4.3 10.8 19.4 13.2 13.0 10.3 12.4 22.1 19.7 21.2 13.1 15.3 9.9 16.5 14.3 14.5 RACK1 "Gnb2-rs1, GNB2L1, H12.3" ENSG00000204628 "Receptor for activated C kinase 1" P63244 5 181236909-181248096 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation" "Developmental protein, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004288, HPA021676" Uncertain Supported Nucleoplasm,Vesicles 130000 "Nucleoplasm, Vesicles" "CAB004288: AB_2247471, HPA021676: AB_1849868" "unprognostic (4.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.58e-1)" "unprognostic (2.03e-2)" "unprognostic (1.07e-2)" "unprognostic (7.43e-2)" "prognostic unfavourable (2.98e-6)" "unprognostic (4.19e-1)" "unprognostic (3.04e-1)" "unprognostic (2.00e-1)" "unprognostic (2.07e-1)" "unprognostic (3.81e-1)" "unprognostic (1.05e-3)" "unprognostic (3.67e-1)" "unprognostic (1.78e-1)" "unprognostic (3.50e-1)" "unprognostic (2.62e-1)" 100.5 72.1 32.2 92.0 32.8 74.9 185.3 45.0 34.3 102.3 85.7 36.2 66.0 43.0 86.0 82.9 128.1 98.3 81.8 102.5 29.8 29.2 80.6 113.7 95.7 223.3 38.2 27.6 189.2 330.4 48.8 68.3 72.3 31.8 102.6 61.2 57.8 119.7 66.9 133.8 115.5 72.1 92.8 37.6 107.8 70.5 52.9 32.4 197.4 115.4 117.0 141.8 99.7 113.5 92.9 69.4 19.2 50.8 47.1 81.4 138.7 66.0 56.4 85.7 107.1 131.7 242.1 86.6 59.6 162.6 140.0 141.4 121.0 58.7 134.8 78.1 103.4 45.7 97.8 331.2 103.6 134.1 105.5 46.0 62.4 60.2 164.8 105.8 46.7 231.6 178.6 105.2 146.6 142.3 60.9 99.1 107.4 102.5 104.5 68.0 59.7 51.1 81.6 53.1 112.5 147.8 63.4 71.3 84.1 30.5 101.7 150.0 69.4 92.3 75.0 48.6 44.3 42.7 90.0 74.4 107.0 84.1 46.6 82.7 49.5 19.2 50.8 16.3 45.9 43.6 69.5 91.9 70.3 53.8 69.4 92.9 81.4 65.2 7.8 47.1 37.1 53.3 68.6 138.7 32.2 32.8 45.0 34.3 29.8 29.2 38.2 27.6 31.8 32.4 RAD1 "HRAD1, REC1" ENSG00000113456 "RAD1 checkpoint DNA exonuclease" O60671 5 34905264-34918989 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006692 Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA006692: " "prognostic unfavourable (6.30e-4)" "unprognostic (1.85e-2)" "unprognostic (9.40e-2)" "unprognostic (1.98e-3)" "unprognostic (2.00e-1)" "unprognostic (2.38e-2)" "prognostic unfavourable (1.06e-5)" "unprognostic (1.22e-2)" "unprognostic (2.25e-3)" "unprognostic (1.61e-3)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (3.12e-3)" 3.1 6.5 3.4 3.2 4.9 4.8 4.4 5.2 4.7 5.4 3.2 2.9 4.6 3.8 3.7 3.5 3.3 6.6 3.5 4.4 3.7 3.5 5.6 6.1 2.9 4.0 3.3 3.0 3.4 6.0 5.3 3.1 4.3 3.7 7.4 4.5 3.6 3.3 2.6 3.1 3.7 5.8 5.2 4.7 3.8 4.7 9.4 7.6 7.2 3.1 4.8 9.3 2.6 5.8 6.8 7.2 14.0 5.1 5.9 10.4 9.2 9.0 9.7 8.0 6.4 8.0 15.2 3.3 8.2 5.4 7.9 5.6 10.9 6.8 6.8 8.1 20.7 4.3 8.7 11.1 7.5 5.3 4.8 10.5 7.0 4.6 14.4 9.0 8.2 7.2 11.3 7.9 9.4 10.3 10.4 15.2 5.3 4.7 6.2 7.5 7.9 19.0 13.0 8.5 8.0 9.3 4.2 12.7 9.6 6.5 9.6 5.0 9.1 13.4 6.6 16.8 8.8 7.2 3.0 6.8 5.9 3.1 7.7 8.7 6.5 8.0 2.9 9.4 9.3 8.0 2.3 4.8 2.9 7.6 5.3 2.6 RAD51C "FANCO, RAD51L2" ENSG00000108384 "RAD51 paralog C" O43502 17 58692573-58735611 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045198 Supported "Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol" "Nucleoplasm, Mitochondria, Cytosol" "Vesicles, Cell Junctions" "HPA045198: " "unprognostic (5.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (6.20e-2)" "unprognostic (1.83e-1)" "unprognostic (4.59e-2)" "prognostic unfavourable (8.68e-5)" "unprognostic (3.65e-2)" "unprognostic (2.91e-2)" "unprognostic (1.03e-2)" "prognostic favourable (5.33e-4)" "unprognostic (2.55e-1)" "unprognostic (2.62e-2)" "unprognostic (7.62e-2)" "unprognostic (2.41e-1)" "unprognostic (9.52e-2)" "unprognostic (2.42e-2)" 11.1 22.7 22.1 10.1 20.8 19.4 15.4 20.8 31.0 12.3 13.7 16.0 11.1 7.3 14.3 23.1 13.2 11.8 10.9 24.9 20.2 17.4 13.7 13.9 8.9 19.6 17.2 21.4 13.4 11.2 20.0 18.3 15.1 28.9 18.3 15.0 13.2 10.6 12.7 15.5 10.3 9.6 14.4 14.0 14.4 13.2 18.9 12.7 23.8 12.6 11.7 18.6 12.6 11.8 14.4 13.0 18.8 11.3 11.2 21.7 9.2 15.4 18.0 11.1 12.2 6.1 5.3 25.4 8.5 3.9 11.4 14.5 7.6 10.0 9.1 12.6 5.8 5.9 14.9 12.0 21.3 22.2 30.7 12.8 20.2 28.9 6.0 16.5 11.5 3.1 10.8 12.7 10.3 12.7 19.9 12.5 9.7 77.6 23.3 23.0 3.0 16.7 15.1 17.6 17.2 6.9 9.7 13.8 12.8 6.8 3.3 12.8 10.1 17.5 4.0 9.6 25.6 8.7 10.3 11.8 43.8 26.7 9.8 16.3 11.0 18.8 7.5 9.8 13.7 11.3 13.3 14.1 15.0 14.9 13.0 14.4 16.4 15.4 4.6 11.2 9.8 11.7 21.7 9.2 22.1 20.8 20.8 31.0 20.2 17.4 17.2 21.4 28.9 12.7 RAET1G ULBP5 ENSG00000203722 "Retinoic acid early transcript 1G" Q6H3X3 6 149916878-149923121 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.2;tongue: 18.4" "Cell line enhanced" "Detected in many" "HeLa: 22.9;hTCEpi: 18.3;SiHa: 9.0;U-87 MG: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA062673 Supported Vesicles "Secreted - unknown location" Vesicles "HPA062673: " "unprognostic (4.46e-3)" "unprognostic (4.92e-2)" "unprognostic (1.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-3)" "unprognostic (1.49e-1)" "unprognostic (4.61e-3)" "prognostic unfavourable (5.35e-4)" "unprognostic (3.05e-1)" "unprognostic (1.57e-1)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (1.33e-1)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" "unprognostic (8.85e-2)" "unprognostic (9.11e-2)" 2.5 10.0 0.3 0.6 0.3 0.0 2.5 0.2 1.0 5.6 0.6 0.5 1.4 0.2 0.8 4.3 21.2 0.5 1.2 0.9 0.4 0.2 2.3 0.2 1.3 0.1 0.3 0.1 1.9 0.1 0.1 1.2 0.1 0.5 2.9 0.1 0.8 3.9 2.2 0.4 4.3 0.5 1.8 0.9 0.2 0.6 0.5 0.2 0.2 0.7 18.4 10.7 2.8 5.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 1.0 0.0 1.3 1.9 1.7 0.0 0.6 2.4 1.0 1.5 0.0 1.2 0.0 0.4 1.3 2.0 0.7 4.0 0.8 0.2 1.2 0.4 22.9 0.0 0.5 0.0 0.0 2.6 18.3 2.8 1.3 0.4 0.2 0.1 0.4 1.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.8 2.4 0.3 0.2 9.0 0.3 0.0 0.3 0.2 1.3 0.5 0.4 1.1 0.6 0.0 0.0 0.0 7.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 1.0 0.4 0.2 0.3 0.1 0.5 0.2 RALBP1 "RIP, RIP1, RLIP76" ENSG00000017797 "RalA binding protein 1" Q15311 18 9475009-9538116 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transport "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 10 "neutrophil: 55.1" "Lineage enriched" "Detected in all" 10 "granulocytes: 55.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046010, HPA046651" Approved Approved "Nuclear membrane,Vesicles,Cytosol" Cytosol "Nuclear membrane, Vesicles" "CAB046010: AB_11126824, HPA046651: " "unprognostic (1.23e-1)" "unprognostic (5.84e-3)" "unprognostic (1.58e-1)" "unprognostic (1.74e-2)" "unprognostic (8.24e-2)" "unprognostic (1.12e-1)" "unprognostic (5.72e-2)" "unprognostic (9.90e-2)" "unprognostic (1.53e-1)" "prognostic favourable (8.47e-4)" "unprognostic (4.03e-3)" "unprognostic (1.76e-1)" "prognostic favourable (5.39e-6)" "unprognostic (1.28e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (1.26e-1)" 19.7 14.6 23.2 14.8 24.3 17.9 19.1 27.1 27.2 17.1 20.7 14.0 54.7 12.5 15.9 16.7 33.7 17.5 13.7 21.4 24.7 19.6 30.6 14.2 15.1 14.6 23.1 13.7 18.8 10.4 19.8 15.3 28.8 19.6 24.3 17.4 9.8 17.6 44.8 24.3 47.5 13.4 22.7 20.6 19.3 17.4 8.5 23.1 15.4 15.7 23.4 16.4 24.3 26.3 2.5 5.5 55.1 4.5 4.3 3.2 1.2 22.7 15.4 13.7 15.5 15.8 24.9 18.1 27.6 15.0 14.2 15.3 17.0 22.6 29.0 20.2 25.2 13.1 18.9 20.7 17.8 28.8 18.3 15.4 14.2 12.7 12.9 45.0 17.8 17.3 20.8 19.8 19.8 23.9 21.9 26.8 22.3 18.0 27.0 19.8 10.6 15.7 36.4 24.5 21.3 19.6 31.7 18.5 15.1 23.9 20.9 12.2 12.9 20.9 28.5 42.1 32.4 29.1 32.7 16.6 16.5 31.4 18.3 21.4 15.9 3.1 2.8 4.3 3.2 2.9 2.7 2.5 2.7 2.6 2.4 2.4 2.3 2.9 55.1 4.3 4.5 5.5 1.7 1.2 23.2 24.3 27.1 27.2 24.7 19.6 23.1 13.7 19.6 23.1 RALY "HNRPCL2, P542" ENSG00000125970 "RALY heterogeneous nuclear ribonucleoprotein" Q9UKM9 20 33993646-34108308 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040971, HPA043614" Enhanced Enhanced Nucleoplasm,Vesicles 12000 Nucleoplasm Vesicles "HPA040971: AB_2677230, HPA043614: AB_2678581" "unprognostic (2.06e-1)" "unprognostic (9.54e-3)" "unprognostic (3.72e-2)" "unprognostic (2.28e-1)" "unprognostic (4.68e-2)" "unprognostic (1.01e-1)" "prognostic unfavourable (3.60e-4)" "unprognostic (3.06e-1)" "unprognostic (1.27e-1)" "unprognostic (3.66e-1)" "unprognostic (4.20e-2)" "unprognostic (8.59e-2)" "unprognostic (3.29e-2)" "unprognostic (2.88e-2)" "unprognostic (8.61e-3)" "unprognostic (1.64e-2)" "unprognostic (8.80e-2)" 37.7 23.4 26.3 39.9 30.7 65.2 55.4 22.4 33.9 35.0 43.7 37.6 35.1 41.9 36.4 31.0 41.6 35.2 38.9 51.9 27.3 24.4 39.3 30.3 40.9 53.9 33.0 23.4 38.3 38.5 21.9 20.7 41.9 26.5 34.9 34.9 32.0 38.7 32.7 62.0 39.8 48.8 41.7 40.9 40.4 36.0 56.8 28.9 76.0 76.7 43.6 42.6 33.5 49.7 30.8 40.9 61.6 54.1 54.1 48.4 40.4 36.3 25.2 40.8 31.1 18.3 19.5 33.1 25.5 21.2 34.3 29.6 67.8 33.1 28.7 37.6 21.2 41.1 19.2 39.8 19.5 18.8 19.9 68.0 14.8 67.7 25.4 35.0 34.7 20.7 24.3 25.3 26.0 33.2 28.1 49.2 21.8 35.3 87.1 56.6 21.1 48.7 51.6 55.8 39.0 20.9 23.1 38.9 43.6 42.6 40.8 57.9 41.6 37.3 26.0 70.9 42.9 34.4 31.8 49.3 41.3 51.1 35.6 26.6 32.5 32.9 32.4 61.6 44.3 39.9 33.1 30.8 40.1 48.4 40.9 30.7 35.6 33.6 52.9 54.1 54.1 33.8 42.0 40.4 26.3 30.7 22.4 33.9 27.3 24.4 33.0 23.4 26.5 28.9 RAMP2 ENSG00000131477 "Receptor activity modifying protein 2" O60895 17 42758447-42763041 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 46.0;EFO-21: 30.7;HUVEC TERT2: 13.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 18 "dendritic cells: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052020 Approved Vesicles Vesicles "HPA052020: " "unprognostic (8.64e-2)" "unprognostic (2.12e-2)" "unprognostic (8.03e-2)" "unprognostic (1.16e-2)" "unprognostic (5.24e-2)" "unprognostic (4.13e-3)" "unprognostic (2.68e-2)" "unprognostic (1.04e-1)" "unprognostic (4.50e-2)" "unprognostic (5.18e-2)" "unprognostic (1.02e-2)" "unprognostic (6.79e-2)" "unprognostic (1.28e-2)" "unprognostic (6.96e-3)" "unprognostic (4.42e-2)" "unprognostic (2.20e-1)" "unprognostic (1.25e-1)" 48.6 7.1 8.6 7.6 9.6 0.2 43.4 3.4 15.4 35.1 9.7 10.8 6.1 5.2 49.5 24.2 19.5 17.0 20.4 23.9 9.6 8.5 18.8 14.6 51.5 17.3 13.8 7.7 17.3 9.6 5.6 6.1 56.1 12.5 24.9 9.1 71.1 12.8 12.2 16.2 15.6 11.5 30.9 8.8 15.6 9.2 10.9 3.0 3.9 20.0 30.1 11.7 13.2 23.1 0.0 6.4 0.0 0.1 0.0 0.3 0.0 0.0 0.4 1.9 0.0 46.0 2.3 1.5 0.3 0.7 3.8 1.8 4.2 0.0 0.0 30.7 1.1 0.0 1.7 0.0 3.3 0.0 0.0 0.0 0.3 1.3 1.1 0.0 0.0 1.6 0.0 0.6 0.1 13.8 0.0 0.1 0.2 0.0 0.2 0.3 8.9 0.0 0.0 0.0 0.0 0.2 0.2 1.9 3.8 1.0 0.0 6.3 0.4 1.2 2.5 7.4 2.7 0.1 0.9 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.3 0.0 8.6 9.6 3.4 15.4 9.6 8.5 13.8 7.7 12.5 3.0 RANBP2 "ADANE, ANE1, NUP358" ENSG00000153201 "RAN binding protein 2" P49792 2 108719481-108785811 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway" "RNA-binding, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564" Supported Enhanced "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: , HPA049497: , HPA051675: , HPA067564: " "unprognostic (2.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.22e-1)" "unprognostic (4.37e-2)" "unprognostic (1.28e-2)" "unprognostic (9.30e-2)" "unprognostic (5.47e-2)" "unprognostic (2.91e-1)" "unprognostic (4.02e-2)" "unprognostic (2.54e-1)" "unprognostic (4.23e-1)" "unprognostic (5.23e-2)" "unprognostic (1.62e-2)" "unprognostic (8.74e-2)" "unprognostic (3.08e-1)" "unprognostic (3.40e-2)" "unprognostic (2.53e-1)" 20.5 24.3 14.4 17.0 18.6 35.5 24.4 23.1 22.2 19.8 17.1 12.8 25.5 13.3 19.9 21.5 17.0 19.1 14.8 20.2 12.9 12.5 18.9 19.5 17.7 19.2 15.1 17.0 32.4 24.1 48.5 37.5 18.8 16.5 21.8 15.8 14.3 20.0 31.6 37.5 17.3 17.4 23.2 17.8 16.3 20.9 20.6 15.9 26.6 28.7 18.0 17.5 20.5 19.7 5.6 5.1 8.3 6.3 4.2 8.7 2.3 18.2 11.2 16.1 14.6 18.8 16.9 15.6 16.5 13.1 13.6 12.0 27.8 8.8 28.8 12.8 17.1 15.4 27.5 17.1 19.9 17.5 13.3 30.0 13.9 19.6 11.0 35.0 10.1 14.1 13.1 21.3 16.6 20.8 32.1 16.0 18.0 10.1 15.5 14.3 20.3 13.4 14.6 24.8 13.9 12.1 22.9 23.5 10.8 14.6 12.6 16.0 8.0 16.1 24.8 14.3 18.9 10.0 18.4 13.3 19.6 26.2 11.1 15.8 11.0 8.3 5.3 5.1 7.6 3.4 8.7 5.5 6.3 6.9 4.2 5.6 6.2 6.7 8.3 4.2 6.3 5.1 5.1 2.3 14.4 18.6 23.1 22.2 12.9 12.5 15.1 17.0 16.5 15.9 RANBP6 ENSG00000137040 "RAN binding protein 6" O60518 9 6011043-6015625 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043748, HPA052684" Approved Supported Vesicles Vesicles "HPA043748: AB_10796796, HPA052684: " "unprognostic (1.47e-2)" "unprognostic (8.86e-2)" "unprognostic (1.70e-1)" "unprognostic (6.01e-2)" "unprognostic (3.63e-2)" "unprognostic (1.30e-1)" "unprognostic (3.37e-1)" "unprognostic (3.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.89e-2)" "prognostic favourable (1.34e-7)" "unprognostic (2.42e-1)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (2.61e-1)" 10.6 14.6 11.8 12.6 18.1 27.0 11.7 23.7 27.1 8.6 7.2 8.1 8.6 7.5 9.3 7.5 9.8 8.2 7.8 13.6 12.8 15.8 14.2 15.3 8.4 15.8 19.7 17.3 10.4 10.9 16.1 16.2 15.6 32.0 10.4 7.4 5.4 10.1 9.3 15.1 10.0 11.6 10.5 16.0 14.3 10.9 6.1 15.0 22.3 12.6 9.2 16.0 9.3 7.6 4.2 5.2 7.2 11.1 4.8 8.1 4.4 10.7 5.9 12.2 10.3 10.7 8.5 6.6 13.8 9.6 11.9 9.7 3.2 3.3 14.6 3.8 10.6 6.2 10.7 12.3 13.4 34.4 6.2 38.0 22.3 6.6 6.3 14.4 8.1 9.2 6.8 7.5 7.4 13.8 2.9 12.3 11.4 3.6 10.2 23.3 5.4 5.0 11.0 7.6 6.9 12.6 7.6 6.0 8.9 6.5 4.9 3.7 7.8 9.8 16.3 11.3 6.8 5.5 12.8 7.3 11.7 14.0 6.4 8.6 4.1 7.2 7.2 6.4 4.6 11.1 4.5 4.2 6.7 4.7 4.5 3.7 7.9 7.5 2.3 4.8 7.7 5.2 8.1 4.4 11.8 18.1 23.7 27.1 12.8 15.8 19.7 17.3 32.0 15.0 RANGAP1 "Fug1, KIAA1835, SD" ENSG00000100401 "Ran GTPase activating protein 1" P46060 22 41245611-41286251 "Plasma proteins, Predicted intracellular proteins, Transporters" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004293, HPA050110, HPA062034" Supported Enhanced "Nuclear membrane,Vesicles,Cytosol" "Nuclear membrane" "Vesicles, Cytosol" "CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667" "unprognostic (1.30e-2)" "unprognostic (3.16e-2)" "unprognostic (1.66e-1)" "unprognostic (7.97e-2)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "prognostic unfavourable (1.08e-4)" "unprognostic (8.28e-3)" "unprognostic (8.09e-2)" "unprognostic (9.87e-2)" "unprognostic (5.84e-2)" "unprognostic (7.56e-2)" "unprognostic (7.07e-3)" "prognostic favourable (5.39e-4)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" 12.2 30.7 23.5 16.9 28.4 28.5 16.1 17.6 41.1 8.5 11.8 23.1 7.3 12.7 9.5 9.4 26.1 11.5 13.7 11.5 26.9 30.4 12.0 25.1 11.5 19.5 31.7 28.6 10.6 20.2 11.0 17.7 16.1 28.1 11.4 9.6 7.1 16.3 13.3 12.5 51.6 12.8 12.3 22.0 14.2 16.0 64.3 28.3 22.1 12.7 14.4 21.7 13.3 29.2 8.7 7.6 8.2 14.8 7.1 13.1 9.7 58.7 30.9 20.1 21.0 10.9 9.0 24.5 51.0 27.9 51.4 27.0 37.5 19.4 31.7 41.1 37.3 54.7 36.6 40.1 31.1 25.6 56.8 26.8 30.1 29.2 13.6 43.3 20.2 8.7 19.1 36.6 32.5 26.9 34.4 22.6 29.2 50.4 25.2 35.2 22.0 36.8 31.0 19.9 33.4 20.1 33.7 18.3 12.2 36.2 32.1 18.6 18.9 17.5 41.6 39.4 37.8 21.7 41.8 16.8 22.4 30.2 27.5 30.8 22.7 2.8 9.5 8.2 11.2 11.2 13.1 7.9 11.3 10.3 7.1 8.7 10.5 8.0 2.7 7.1 14.8 7.6 11.6 9.7 23.5 28.4 17.6 41.1 26.9 30.4 31.7 28.6 28.1 28.3 RAPGEF1 "C3G, GRF2" ENSG00000107263 "Rap guanine nucleotide exchange factor 1" Q13905 9 131576770-131740074 "Plasma proteins, Predicted intracellular proteins" Neurogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006426, HPA075984" Approved Supported Vesicles Vesicles "HPA006426: AB_1856070, HPA075984: " "unprognostic (1.00e-1)" "unprognostic (8.19e-2)" "unprognostic (2.12e-2)" "unprognostic (2.43e-2)" "unprognostic (2.34e-1)" "unprognostic (2.38e-1)" "unprognostic (4.11e-2)" "unprognostic (1.74e-1)" "unprognostic (5.50e-2)" "unprognostic (6.04e-2)" "unprognostic (1.94e-2)" "unprognostic (1.62e-1)" "prognostic favourable (1.18e-5)" "unprognostic (5.66e-2)" "unprognostic (1.99e-2)" "unprognostic (1.49e-1)" "unprognostic (3.73e-2)" 16.2 10.8 18.4 21.5 28.0 19.7 18.5 21.8 19.5 9.6 11.5 13.7 6.0 10.1 11.1 6.9 10.3 11.4 10.2 21.5 17.4 16.0 9.4 9.7 16.9 21.7 13.1 10.2 7.4 24.1 9.0 7.3 28.5 13.5 9.0 10.3 16.8 8.5 10.0 83.3 9.2 13.7 13.2 13.0 16.7 12.0 6.8 11.6 12.4 9.9 8.8 25.9 11.3 12.0 9.2 2.9 5.3 3.9 2.0 6.5 2.3 10.4 12.2 12.4 12.5 12.7 13.8 47.6 9.0 18.5 10.5 7.6 15.1 6.9 19.0 11.4 18.2 19.2 14.2 12.6 5.3 44.0 5.8 5.6 20.5 7.9 10.7 23.0 25.7 10.5 23.3 13.7 16.4 19.0 14.9 37.7 13.6 10.9 16.2 8.1 12.5 11.1 16.1 29.0 26.4 4.8 12.7 10.5 10.5 13.2 12.6 13.2 12.0 19.4 20.0 28.4 11.9 17.9 13.7 12.7 11.0 37.5 13.5 9.9 6.8 5.3 2.0 2.6 6.5 3.8 3.7 9.2 4.2 4.2 2.4 5.3 1.1 2.9 2.3 2.0 3.9 2.9 3.0 2.3 18.4 28.0 21.8 18.5 17.4 16.0 13.1 10.2 13.5 11.6 RAPGEF2 "DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF" ENSG00000109756 "Rap guanine nucleotide exchange factor 2" Q9Y4G8 4 159103013-159360174 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, GTPase activation, Guanine-nucleotide releasing factor" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.4" "Group enriched" "Detected in many" 5 "granulocytes: 9.4;NK-cells: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057169 Supported Nucleoplasm,Vesicles,Centrosome "Nucleoplasm, Vesicles, Centrosome" "HPA057169: " "unprognostic (4.88e-2)" "unprognostic (7.42e-2)" "unprognostic (1.67e-2)" "unprognostic (7.79e-3)" "unprognostic (8.16e-2)" "unprognostic (4.71e-3)" "unprognostic (4.20e-3)" "unprognostic (2.33e-1)" "unprognostic (2.17e-1)" "unprognostic (2.65e-2)" "unprognostic (9.71e-2)" "unprognostic (1.07e-1)" "prognostic favourable (1.76e-7)" "unprognostic (2.29e-1)" "unprognostic (2.07e-1)" "unprognostic (2.01e-2)" "unprognostic (1.78e-1)" 16.7 8.0 28.4 8.8 23.8 51.0 16.3 21.5 34.1 12.6 14.5 11.3 10.4 10.9 12.7 7.3 9.9 10.2 14.1 14.9 23.4 15.3 16.4 20.9 18.1 8.5 14.1 29.6 10.2 13.4 20.7 13.8 26.1 16.9 9.3 14.8 10.0 18.7 9.4 15.7 12.7 11.9 14.0 13.9 19.2 13.7 6.7 14.3 9.3 27.5 8.9 7.8 11.9 13.8 0.4 1.4 9.4 1.4 5.2 1.5 0.3 3.2 4.4 21.1 6.5 8.3 9.4 32.4 6.3 8.0 5.8 4.2 13.6 7.3 18.6 2.3 6.3 3.0 7.1 8.1 6.9 3.1 5.0 28.9 9.3 7.8 6.0 3.5 40.0 5.4 4.6 13.9 4.9 16.5 6.3 17.4 7.1 5.7 8.7 0.5 9.0 4.4 7.1 5.3 0.7 5.2 7.5 6.0 8.0 9.3 4.5 7.7 2.2 2.3 17.5 9.2 9.7 11.7 5.2 19.4 11.5 0.3 10.9 1.5 5.5 2.7 1.4 1.0 0.8 0.8 1.0 0.4 0.7 0.5 0.8 0.3 0.9 0.4 9.4 5.2 0.9 1.4 1.5 0.3 28.4 23.8 21.5 34.1 23.4 15.3 14.1 29.6 16.9 14.3 RASA2 GAP1M ENSG00000155903 "RAS p21 protein activator 2" Q15283 3 141487047-141615342 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035374, HPA035375" Approved Approved Vesicles "Intracellular and membrane" Vesicles "HPA035374: AB_10602122, HPA035375: " "unprognostic (1.85e-1)" "unprognostic (8.11e-2)" "unprognostic (1.48e-1)" "unprognostic (2.38e-2)" "unprognostic (1.18e-1)" "unprognostic (3.36e-3)" "unprognostic (9.62e-3)" "unprognostic (2.57e-1)" "unprognostic (1.38e-1)" "unprognostic (9.21e-2)" "unprognostic (4.23e-2)" "unprognostic (8.93e-2)" "prognostic unfavourable (7.62e-7)" "unprognostic (1.17e-1)" "unprognostic (2.56e-1)" "unprognostic (1.61e-1)" "prognostic favourable (4.34e-5)" 12.0 7.4 11.1 25.2 10.6 26.8 14.4 20.8 12.2 13.4 12.7 7.9 7.7 7.7 19.1 11.2 11.6 11.3 9.9 7.4 8.7 9.9 9.3 7.5 14.4 27.1 8.2 7.8 16.2 8.7 9.2 15.0 12.2 8.7 10.5 10.8 11.4 13.2 9.4 6.1 15.7 12.9 12.3 11.2 21.4 8.2 6.7 7.8 25.4 10.1 7.3 23.6 11.8 14.0 10.5 3.4 14.4 5.9 11.5 17.7 5.8 15.6 2.9 6.4 4.8 7.0 8.7 9.1 11.4 22.6 7.4 9.2 6.8 5.2 10.1 7.9 9.9 6.5 4.5 4.9 13.6 5.4 4.4 5.4 2.4 2.5 3.7 10.2 14.2 5.0 4.5 6.7 8.1 9.4 4.8 13.2 7.3 2.3 13.3 8.4 7.3 2.1 5.0 10.8 12.4 7.4 5.7 2.2 4.6 9.1 8.1 8.4 4.0 7.8 7.8 8.8 4.0 12.1 5.1 21.4 6.2 13.6 7.7 7.0 4.3 7.7 3.7 3.8 11.9 3.7 11.7 7.0 10.6 11.9 3.4 10.5 17.7 13.5 14.4 11.5 5.9 2.6 9.7 5.8 11.1 10.6 20.8 12.2 8.7 9.9 8.2 7.8 8.7 7.8 RASA4 "CAPRI, GAPL, KIAA0538" ENSG00000105808 "RAS p21 protein activator 4" O43374 7 102573807-102616757 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 58.0" "Cell line enhanced" "Detected in many" "U-138 MG: 27.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA043010 Uncertain Uncertain Vesicles Vesicles "HPA043010: " "unprognostic (6.44e-2)" "unprognostic (3.64e-2)" "unprognostic (8.93e-3)" "unprognostic (1.69e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (3.44e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (2.29e-1)" "unprognostic (4.62e-3)" "unprognostic (4.19e-2)" "unprognostic (4.81e-2)" "unprognostic (8.87e-3)" "unprognostic (2.47e-2)" "unprognostic (3.34e-1)" "unprognostic (1.18e-2)" 5.5 2.3 4.2 2.5 2.6 1.6 4.4 2.7 4.7 4.9 4.0 3.6 6.3 1.8 1.9 3.6 1.9 1.5 3.6 3.0 3.3 0.2 2.7 3.6 1.9 4.1 2.1 6.8 3.7 4.0 3.3 1.6 2.0 5.6 58.0 5.4 4.3 3.2 1.2 4.1 2.2 0.6 2.2 2.4 3.9 4.7 3.6 11.3 2.2 9.4 1.5 3.7 3.1 0.7 1.2 9.1 1.8 1.6 4.7 0.3 9.3 4.7 3.1 3.3 3.7 2.7 7.1 6.9 14.1 9.1 0.4 0.1 2.3 1.3 2.4 2.0 3.6 0.9 1.8 1.3 2.7 4.3 1.1 0.8 0.4 1.6 3.1 10.5 0.7 3.6 7.1 4.9 0.7 4.7 9.7 2.0 10.2 0.3 3.4 8.9 18.6 1.7 2.1 1.2 1.8 3.6 2.3 27.3 13.3 3.1 2.3 16.6 10.2 6.1 3.4 3.0 3.3 0.4 8.4 0.3 1.9 9.4 3.7 2.8 3.2 2.2 11.3 3.6 3.4 2.4 2.2 1.5 1.2 9.8 3.5 3.1 RASA4B ENSG00000170667 "RAS p21 protein activator 4B" C9J798 7 102482445-102517781 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 47.4" "Cell line enhanced" "Detected in many" "SH-SY5Y: 11.8;U-138 MG: 16.5;U-2 OS: 14.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "classical monocyte: 3.7;intermediate monocyte: 3.7;myeloid DC: 6.2;plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 20 "dendritic cells: 6.2;monocytes: 3.7" HPA043010 Uncertain Uncertain "Vesicles,Cell Junctions" "Cell Junctions" Vesicles "HPA043010: " "unprognostic (1.05e-2)" "unprognostic (1.34e-2)" "unprognostic (1.03e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-2)" "unprognostic (1.55e-1)" "unprognostic (2.10e-1)" "unprognostic (6.79e-2)" "unprognostic (3.08e-3)" "unprognostic (2.31e-1)" "unprognostic (5.44e-4)" "unprognostic (1.18e-2)" "unprognostic (3.77e-2)" "unprognostic (4.37e-3)" "unprognostic (1.10e-1)" 2.9 1.1 2.3 1.4 1.2 0.0 2.1 0.5 4.4 3.2 2.4 2.5 4.1 0.0 0.6 1.5 1.3 0.5 1.8 2.0 0.9 0.1 0.8 1.3 1.1 2.2 0.9 0.0 1.1 1.7 1.5 0.0 0.7 3.7 47.4 1.8 3.0 0.5 0.5 1.9 0.8 0.2 0.3 0.2 1.4 2.3 0.1 6.2 0.0 3.7 0.0 0.2 1.8 0.2 0.9 3.2 0.2 0.5 1.9 0.1 5.7 3.0 1.2 2.9 0.2 0.4 2.2 6.4 6.5 7.6 0.0 0.0 0.0 0.2 0.7 0.3 1.7 0.5 0.0 0.0 0.2 2.1 0.3 0.0 0.0 0.8 0.6 8.1 0.7 2.1 0.0 1.1 0.0 0.9 2.3 1.1 3.6 0.0 0.8 2.2 11.8 0.9 0.2 0.2 0.2 1.5 1.0 16.5 14.1 1.3 0.5 2.7 1.8 0.2 1.9 0.4 2.6 0.0 3.7 0.0 0.2 3.7 0.1 0.1 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.0 0.6 3.9 0.0 1.8 RASGEF1B "FLJ31695, GPIG4" ENSG00000138670 "RasGEF domain family member 1B" Q0VAM2 4 81426393-82044244 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 12.2;Daudi: 15.6;Karpas-707: 10.5;NTERA-2: 7.2;SCLC-21H: 7.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "intermediate monocyte: 7.7;memory B-cell: 6.4;naive B-cell: 8.8;non-classical monocyte: 12.4;plasmacytoid DC: 18.0" "Group enriched" "Detected in many" 5 "B-cells: 8.8;dendritic cells: 18.0;monocytes: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044574 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA044574: AB_10794292" "unprognostic (3.24e-1)" "prognostic favourable (6.40e-4)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (1.19e-1)" "prognostic favourable (1.49e-5)" "unprognostic (4.42e-2)" "unprognostic (6.31e-2)" "unprognostic (4.43e-1)" "unprognostic (4.85e-2)" "unprognostic (1.13e-2)" "unprognostic (3.88e-2)" "prognostic favourable (4.21e-6)" "unprognostic (4.19e-3)" "unprognostic (1.44e-2)" "unprognostic (3.19e-2)" "unprognostic (6.04e-2)" 11.7 5.3 12.2 8.4 18.9 22.2 14.3 3.5 8.4 7.6 8.0 10.0 2.6 10.8 3.0 9.9 10.9 6.6 10.1 4.9 6.2 8.2 9.4 32.8 19.1 9.2 13.0 3.5 3.3 2.5 1.7 12.6 10.3 38.3 3.8 6.0 6.1 9.7 4.2 3.5 20.3 10.7 5.0 8.7 13.2 12.2 1.9 19.3 8.0 3.9 4.7 8.5 4.8 5.6 8.8 18.0 0.8 12.4 2.5 2.0 0.7 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.1 0.0 0.0 0.0 12.2 0.3 15.6 0.0 0.0 0.3 1.0 0.1 0.0 0.1 2.3 1.3 1.0 0.5 0.5 0.3 0.7 0.2 0.5 0.0 0.5 0.0 0.2 10.5 0.0 0.5 5.0 0.5 7.2 3.2 1.5 0.1 5.9 0.5 0.2 7.0 0.1 0.0 2.2 0.0 1.0 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.0 4.7 1.1 0.2 0.2 0.4 2.1 0.2 1.4 7.7 1.5 6.4 1.1 1.1 1.7 8.8 2.0 1.9 0.8 2.5 12.4 18.0 0.3 0.7 12.2 18.9 3.5 8.4 6.2 8.2 13.0 3.5 38.3 19.3 RASL10B "RRP17, VTS58635" ENSG00000270885 "RAS like family 10 member B" Q96S79 17 35731649-35743521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 24.6;skeletal muscle: 26.7" "Cell line enhanced" "Detected in many" "HAP1: 14.0;HHSteC: 16.0;HSkMC: 11.6;NTERA-2: 23.9;REH: 11.6" "Cancer enhanced" "Detected in many" "testis cancer: 14.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046842, HPA057092" Enhanced Approved Vesicles Vesicles "HPA046842: , HPA057092: " "unprognostic (5.78e-2)" "unprognostic (2.15e-2)" "unprognostic (2.36e-2)" "prognostic unfavourable (6.38e-6)" "unprognostic (8.60e-2)" "unprognostic (1.24e-1)" "unprognostic (2.69e-2)" "unprognostic (4.98e-2)" "unprognostic (1.97e-2)" "unprognostic (7.13e-2)" "unprognostic (2.61e-2)" "unprognostic (3.18e-2)" "unprognostic (1.71e-6)" "unprognostic (2.41e-3)" "unprognostic (1.00e-1)" "unprognostic (1.32e-2)" "unprognostic (9.60e-3)" 12.8 0.9 6.3 0.3 9.1 0.2 2.8 0.3 12.3 1.8 0.3 1.0 24.6 0.8 1.3 0.8 0.3 3.9 0.8 10.9 4.7 1.0 1.1 0.4 0.2 0.0 2.8 2.5 4.7 2.5 1.1 2.8 6.3 0.9 0.2 1.1 12.6 15.2 26.7 0.3 0.9 0.9 0.6 0.2 0.3 1.6 2.5 0.0 0.9 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 3.6 0.0 0.6 0.4 1.0 0.6 0.4 2.5 2.1 4.5 0.0 0.0 0.4 0.1 0.0 14.0 0.0 0.8 0.0 4.6 0.0 2.3 5.2 16.0 0.0 0.0 11.6 0.9 0.8 0.0 0.0 3.0 0.0 0.2 0.2 6.3 0.0 23.9 0.0 11.6 6.4 10.4 0.0 0.0 10.7 10.4 0.7 0.2 0.9 1.3 0.7 0.0 1.2 8.6 0.0 0.3 0.0 0.0 2.8 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RASSF10 ENSG00000189431 "Ras association domain family member 10" A6NK89 11 13009577-13012106 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.3" "Group enriched" "Detected in some" 5 "A549: 9.3;CAPAN-2: 8.3;HaCaT: 12.8;HMC-1: 6.4;RPTEC TERT1: 13.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040406 Approved Vesicles,Cytosol Vesicles Cytosol "HPA040406: " "unprognostic (6.71e-2)" "unprognostic (5.12e-2)" "unprognostic (5.06e-2)" "unprognostic (2.41e-3)" "unprognostic (6.25e-3)" "prognostic favourable (2.76e-4)" "unprognostic (3.43e-3)" "unprognostic (8.04e-2)" "unprognostic (5.89e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favourable (4.12e-5)" "unprognostic (4.45e-2)" "unprognostic (1.73e-1)" "unprognostic (2.88e-1)" "unprognostic (1.65e-2)" 0.2 0.0 0.4 0.2 1.0 0.0 3.9 0.0 1.7 1.1 1.4 1.0 0.0 1.8 0.0 1.3 9.3 5.2 2.5 0.2 1.0 4.7 0.0 1.8 0.0 0.0 0.6 1.2 0.0 3.8 0.1 0.0 0.6 1.6 0.5 0.4 8.0 0.1 0.8 4.1 0.6 0.0 0.1 0.0 5.6 2.4 1.0 1.1 0.1 8.1 7.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 9.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.3 0.0 0.6 0.0 12.8 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.3 0.0 0.0 13.0 1.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMS3 ENSG00000144642 "RNA binding motif single stranded interacting protein 3" Q6XE24 3 28574791-30010391 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 14.2;WM-115: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 7.3" "Lineage enriched" "Detected in single" 8 "dendritic cells: 7.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034719 Uncertain Approved Vesicles Vesicles "HPA034719: AB_10670172" "unprognostic (8.39e-2)" "unprognostic (2.54e-2)" "unprognostic (1.02e-1)" "unprognostic (7.08e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-1)" "unprognostic (3.13e-2)" "unprognostic (4.95e-2)" "unprognostic (1.08e-1)" "unprognostic (3.90e-2)" "unprognostic (1.90e-1)" "unprognostic (4.94e-2)" "prognostic unfavourable (1.85e-4)" "unprognostic (2.25e-3)" "unprognostic (3.81e-2)" "unprognostic (8.48e-2)" "unprognostic (3.24e-4)" 16.5 10.3 4.8 3.2 5.6 0.1 9.9 1.6 4.2 10.6 6.6 2.6 7.9 1.7 5.6 9.3 6.0 6.7 8.5 16.5 5.1 2.4 6.2 4.4 12.3 5.6 5.1 3.4 13.3 2.5 10.8 4.8 12.3 8.5 8.4 3.3 10.0 4.6 13.5 9.7 3.3 3.6 13.7 8.6 7.4 4.6 4.9 4.7 3.7 18.6 5.5 2.0 9.3 8.9 0.2 7.3 0.0 0.0 0.0 0.8 0.1 1.4 0.1 6.8 0.1 13.2 8.7 0.0 3.7 2.4 3.9 4.9 0.0 0.2 0.0 3.9 14.2 0.1 0.3 2.7 7.8 0.0 0.5 3.9 5.4 0.0 14.0 0.0 0.0 8.2 1.7 7.0 8.2 5.6 0.0 0.0 5.4 0.0 0.0 0.0 0.2 0.3 0.2 5.1 0.0 1.5 0.0 0.0 13.2 8.8 0.0 0.4 0.0 0.0 11.5 7.7 7.2 9.0 7.5 0.0 0.0 0.5 1.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 7.3 0.6 0.1 4.8 5.6 1.6 4.2 5.1 2.4 5.1 3.4 8.5 4.7 RBP5 CRBPIII ENSG00000139194 "Retinol binding protein 5" P82980 12 7123684-7128942 "Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 99.9;liver: 74.2;lymphoid tissue: 54.3" "Cell line enhanced" "Detected in many" "HEL: 6.8;Hep G2: 15.2;K-562: 31.3" "Group enriched" "Detected in all" 8 "liver cancer: 70.1;renal cancer: 126.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.5;T-reg: 2.4" "Group enriched" "Detected in many" 12 "granulocytes: 1.3;T-cells: 2.4" "Low region specificity" "Detected in all" HPA038723 Enhanced Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA038723: " "unprognostic (5.70e-3)" "unprognostic (7.34e-2)" "unprognostic (2.72e-2)" "unprognostic (1.53e-2)" "unprognostic (1.87e-2)" "unprognostic (1.39e-3)" "unprognostic (2.49e-2)" "prognostic favourable (8.37e-4)" "unprognostic (1.04e-1)" "unprognostic (2.65e-1)" "unprognostic (1.13e-2)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.83e-2)" "unprognostic (3.33e-2)" "unprognostic (4.22e-1)" "prognostic favourable (3.68e-4)" 1.5 2.6 0.3 18.2 0.3 0.7 1.3 0.6 0.3 2.8 1.7 0.1 2.3 1.4 5.3 13.3 2.3 1.5 3.6 2.3 0.3 0.3 99.9 74.2 3.6 54.3 0.2 0.0 3.5 1.3 0.2 1.6 0.1 0.1 2.6 1.6 0.7 5.9 3.3 0.4 0.7 4.4 1.8 0.2 44.3 1.2 1.2 0.0 6.2 2.0 0.7 10.1 2.3 1.4 0.1 0.0 1.3 0.0 0.0 2.4 0.1 1.8 3.1 0.0 1.0 0.0 0.0 0.7 1.1 0.0 0.0 0.2 1.7 1.9 1.1 0.5 0.0 2.2 0.1 0.0 0.0 2.7 0.0 6.8 4.9 15.2 0.0 0.4 2.0 0.3 0.1 0.0 0.0 0.0 31.3 1.4 0.0 0.0 0.1 0.4 0.4 0.1 0.4 0.0 0.1 0.1 2.6 0.1 0.3 2.7 1.1 0.0 0.6 1.1 1.1 1.3 1.3 3.7 0.5 0.6 0.2 0.2 0.9 1.4 0.2 1.3 0.0 0.0 0.4 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 2.4 0.1 0.3 0.3 0.6 0.3 0.3 0.3 0.2 0.0 0.1 0.0 RBSN ZFYVE20 ENSG00000131381 "Rabenosyn, RAB effector" Q9H1K0 3 15070073-15099163 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044878 Approved Supported Vesicles Vesicles "HPA044878: AB_10967610" "unprognostic (6.76e-2)" "unprognostic (2.18e-1)" "unprognostic (3.00e-3)" "unprognostic (1.00e-1)" "unprognostic (8.06e-2)" "unprognostic (3.79e-3)" "unprognostic (1.09e-3)" "unprognostic (1.72e-2)" "unprognostic (3.57e-1)" "unprognostic (1.90e-2)" "unprognostic (2.00e-2)" "unprognostic (9.34e-2)" "unprognostic (2.38e-3)" "unprognostic (4.45e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-1)" "unprognostic (1.78e-1)" 11.6 8.7 18.0 8.7 19.8 21.4 10.7 19.6 26.1 9.9 10.6 21.9 9.4 6.4 12.9 10.2 12.3 11.2 7.7 12.9 16.6 13.7 7.4 9.3 11.3 8.2 16.6 15.3 18.2 7.1 13.3 7.1 10.6 17.0 10.6 7.5 10.9 7.6 13.1 15.7 13.7 7.7 14.5 16.2 9.2 8.6 11.6 16.7 3.6 15.5 7.6 8.1 9.9 9.6 7.9 4.3 13.6 7.3 3.2 9.5 2.9 8.2 12.1 9.9 12.8 11.0 8.2 26.3 9.1 8.9 11.0 10.0 7.3 5.0 5.8 5.3 12.0 5.3 12.6 11.0 9.7 7.3 11.2 6.6 14.4 6.0 7.5 6.6 7.4 8.8 12.5 14.0 9.4 8.8 9.9 6.8 8.2 10.9 3.6 3.3 8.5 9.7 4.8 11.3 6.4 5.7 9.5 2.6 9.3 11.1 6.8 8.1 17.5 4.9 10.7 10.0 10.5 9.6 12.8 6.1 9.1 6.9 9.5 7.5 9.3 9.0 5.4 12.3 5.3 7.3 4.7 5.2 7.2 6.5 4.3 7.9 9.5 6.4 13.6 3.2 6.2 4.1 4.7 2.9 18.0 19.8 19.6 25.3 16.6 13.7 16.6 15.3 17.0 16.7 RC3H2 "FLJ20301, FLJ20713, MNAB, RNF164" ENSG00000056586 "Ring finger and CCCH-type domains 2" Q9HBD1 9 122844556-122905341 "Enzymes, Predicted intracellular proteins, Transcription factors" "Ubl conjugation pathway" "Repressor, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042863, HPA062144" Approved Enhanced Vesicles Vesicles "HPA042863: , HPA062144: " "unprognostic (6.05e-2)" "unprognostic (7.87e-2)" "unprognostic (7.24e-2)" "unprognostic (1.66e-1)" "unprognostic (4.08e-3)" "unprognostic (2.37e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-2)" "unprognostic (1.99e-1)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "prognostic favourable (5.50e-4)" "unprognostic (1.36e-1)" "unprognostic (1.68e-1)" "unprognostic (2.16e-1)" "unprognostic (1.26e-1)" 16.4 10.7 25.4 14.1 28.8 30.6 14.1 18.7 27.6 17.1 13.0 10.5 14.4 11.0 14.6 9.7 16.5 12.2 12.6 15.7 18.1 11.2 15.0 14.8 16.2 19.2 12.3 25.3 14.7 9.7 19.0 16.2 16.3 12.6 11.5 13.1 9.4 13.2 13.9 16.1 13.8 13.0 16.3 14.4 15.2 12.8 12.8 13.2 18.9 15.0 11.5 18.8 14.1 13.7 8.6 9.6 12.4 10.4 4.9 8.9 3.7 9.8 14.3 19.1 10.3 10.2 12.1 10.6 12.6 13.8 14.9 13.0 17.3 10.4 16.5 10.3 16.8 23.1 20.4 14.8 16.4 7.6 8.1 9.4 25.8 11.4 13.4 11.1 15.1 11.6 14.4 14.5 20.6 20.4 13.2 12.1 18.8 13.2 10.9 7.8 9.5 13.3 11.0 31.6 10.6 14.5 7.8 22.5 15.6 22.3 13.8 11.4 16.6 9.4 20.2 11.5 9.6 15.6 22.4 8.5 13.8 18.0 13.1 9.9 12.9 12.4 6.6 8.5 8.9 10.4 7.3 6.5 7.3 8.9 5.8 8.6 7.0 6.8 11.8 4.9 9.3 9.6 7.1 3.7 25.4 28.8 18.7 27.6 18.1 11.2 12.3 25.3 12.6 13.2 RCHY1 "ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363" ENSG00000163743 "Ring finger and CHY zinc finger domain containing 1" Q96PM5 4 75479037-75514764 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030338, HPA030339" Approved Supported Nucleoplasm,Vesicles,Cytosol Cytosol "Nucleoplasm, Vesicles" "HPA030338: , HPA030339: AB_10603232" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "prognostic favourable (9.09e-4)" "unprognostic (1.90e-1)" "unprognostic (3.45e-3)" "unprognostic (1.19e-2)" "unprognostic (7.87e-3)" "unprognostic (5.82e-2)" "unprognostic (1.96e-1)" "unprognostic (1.98e-1)" "unprognostic (7.45e-3)" "unprognostic (4.60e-2)" "prognostic favourable (3.62e-5)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "unprognostic (1.83e-1)" "prognostic favourable (7.89e-5)" 8.8 12.1 15.7 9.9 20.1 15.6 17.8 20.7 16.8 10.2 12.7 9.8 8.7 9.0 11.0 7.5 8.4 12.9 7.2 17.6 14.1 16.2 17.1 12.5 10.4 12.2 15.9 15.7 16.2 10.6 14.9 13.0 10.5 17.1 12.0 14.2 7.7 12.3 11.3 29.7 5.9 9.2 12.4 16.7 12.2 10.3 13.4 15.4 14.9 20.3 8.0 12.7 9.7 12.1 4.4 7.4 18.9 8.8 4.6 7.4 4.3 6.0 3.1 9.4 8.7 9.9 8.7 5.4 4.1 9.6 8.5 10.0 8.6 7.5 10.1 7.8 5.9 3.6 23.8 7.2 13.0 8.2 7.8 13.1 5.9 11.0 8.5 17.6 7.2 8.0 9.1 9.7 9.2 17.1 12.0 10.3 19.8 9.8 16.1 7.1 15.6 5.5 8.7 22.1 8.5 13.2 10.4 14.5 8.0 6.7 15.8 17.4 8.9 8.0 6.7 5.6 5.6 5.0 6.8 10.9 7.8 14.3 6.8 12.5 8.8 18.9 8.8 8.5 4.3 5.2 7.4 4.4 5.3 5.0 7.4 2.2 3.9 5.5 3.7 4.6 4.7 3.8 5.2 4.3 15.7 20.1 20.7 16.8 14.1 16.2 15.9 15.7 17.1 15.4 RCN3 RLP49 ENSG00000142552 "Reticulocalbin 3" Q96D15 19 49527618-49546962 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 52.2;ASC TERT1: 36.1;BJ: 57.0;BJ hTERT+ SV40 Large T+ RasG12V: 33.0;fHDF/TERT166: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 9.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA043134, HPA050402" Uncertain Approved "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" "Endoplasmic reticulum, Vesicles" "HPA043134: , HPA050402: " "unprognostic (7.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.77e-3)" "unprognostic (8.87e-2)" "unprognostic (3.36e-3)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (1.16e-1)" "unprognostic (7.47e-2)" "unprognostic (9.75e-2)" "unprognostic (2.85e-1)" "unprognostic (3.86e-2)" "prognostic unfavourable (5.80e-12)" "unprognostic (5.26e-2)" "unprognostic (3.90e-2)" "unprognostic (1.56e-2)" "unprognostic (4.20e-3)" 19.6 10.9 3.7 18.2 5.3 3.2 15.6 7.2 6.6 36.3 10.7 2.0 9.6 22.2 28.2 33.9 11.4 10.7 26.2 18.2 3.4 3.5 12.6 18.6 12.6 4.4 3.3 2.8 29.5 5.1 2.1 9.0 18.0 6.0 19.4 7.0 10.7 6.2 8.2 10.6 8.2 23.7 16.8 2.9 21.3 7.8 17.3 4.2 1.8 9.9 9.8 7.9 21.5 21.6 0.6 0.5 3.9 0.4 2.3 9.7 1.6 0.5 0.8 0.5 30.3 52.2 36.1 0.3 57.0 14.8 21.5 33.0 0.7 0.2 0.2 3.4 49.8 0.0 1.4 0.1 10.3 0.0 0.4 3.2 0.2 1.6 18.3 0.0 7.5 20.3 0.0 15.0 0.0 8.2 1.4 0.1 17.5 0.6 0.0 0.3 0.2 3.9 0.1 0.7 0.9 0.2 0.0 0.3 1.9 0.0 0.2 0.0 0.2 2.0 19.2 0.3 9.6 24.9 0.0 2.8 8.3 0.5 1.4 1.8 2.4 0.0 0.3 2.2 0.9 0.0 1.0 0.6 2.5 0.9 0.5 0.4 9.7 3.2 3.9 2.3 0.4 0.4 1.9 1.6 3.7 5.3 7.2 6.6 3.4 3.5 3.3 2.8 6.0 4.2 RCOR2 ENSG00000167771 "REST corepressor 2" Q8IZ40 11 63911221-63916844 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.6" "Cell line enhanced" "Detected in some" "AF22: 17.7;NTERA-2: 22.8;SCLC-21H: 35.8;SH-SY5Y: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021638 Uncertain Approved Nucleoplasm,Vesicles,Midbody Nucleoplasm "Vesicles, Midbody" "HPA021638: AB_10960885" "unprognostic (1.96e-2)" "unprognostic (1.15e-1)" "unprognostic (4.10e-2)" "unprognostic (1.98e-3)" "unprognostic (3.10e-2)" "unprognostic (5.86e-2)" "unprognostic (2.33e-4)" "unprognostic (8.64e-2)" "unprognostic (1.46e-1)" "unprognostic (4.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-3)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.51e-1)" "unprognostic (9.93e-2)" "unprognostic (6.06e-3)" 0.8 1.4 3.3 0.7 8.0 0.3 0.7 9.3 16.6 3.0 1.4 3.4 0.0 2.0 3.5 2.6 1.2 3.7 1.6 5.9 4.0 2.6 0.7 0.4 1.0 0.3 2.4 3.8 5.2 1.4 3.2 5.0 1.8 1.8 1.7 1.7 3.3 2.3 1.7 3.1 0.6 1.6 2.5 2.2 0.5 1.2 7.0 2.5 4.1 0.6 0.6 0.3 2.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 17.7 1.2 0.2 1.5 5.3 0.1 0.3 0.2 0.6 0.6 0.1 0.1 0.2 0.4 0.2 7.7 0.0 0.2 0.2 0.9 0.2 0.1 5.6 3.0 0.0 0.1 1.8 0.0 0.3 0.0 0.1 0.9 0.0 0.0 1.5 1.6 6.2 22.8 0.0 5.7 1.0 0.5 0.0 0.0 35.8 23.9 0.1 1.6 0.8 1.3 2.1 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 8.0 9.3 11.0 4.0 2.6 2.4 3.8 1.8 2.5 RDH5 "HSD17B9, RDH1, SDR9C5" ENSG00000135437 "Retinol dehydrogenase 5" Q92781 12 55720367-55724705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Sensory transduction, Steroid metabolism, Vision" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 39.4;retina: 127.9" "Cell line enhanced" "Detected in some" "ASC diff: 19.5;ASC TERT1: 16.8;hTEC/SVTERT24-B: 10.2;LHCN-M2: 10.1;U-87 MG: 18.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063345 Approved Vesicles "Intracellular and membrane" Vesicles "HPA063345: " "unprognostic (1.04e-2)" "unprognostic (6.45e-2)" "unprognostic (1.80e-1)" "unprognostic (2.67e-1)" "unprognostic (3.66e-2)" "unprognostic (1.48e-2)" "unprognostic (1.88e-2)" "unprognostic (1.54e-1)" "unprognostic (5.35e-2)" "unprognostic (4.04e-2)" "unprognostic (4.05e-1)" "unprognostic (1.26e-3)" "unprognostic (7.63e-2)" "unprognostic (8.79e-2)" "unprognostic (3.46e-2)" "unprognostic (2.12e-3)" "unprognostic (3.27e-2)" 39.4 0.7 0.6 2.8 0.8 0.2 14.9 0.5 0.8 1.0 7.6 1.0 1.5 8.6 1.9 4.5 2.4 2.2 4.8 3.9 1.0 0.5 3.7 27.2 0.7 1.6 0.8 0.8 1.4 1.5 0.0 0.6 0.4 1.5 1.8 1.9 127.9 3.2 1.0 3.1 1.0 9.4 8.8 1.1 0.9 2.7 0.9 1.0 0.3 1.1 2.6 0.7 2.0 2.5 0.4 2.3 2.1 0.9 1.5 2.6 0.4 0.4 0.9 0.5 0.3 19.5 16.8 0.4 2.5 2.8 0.5 1.0 0.3 5.2 0.6 0.4 1.4 0.2 0.2 0.0 0.4 0.6 0.8 0.1 1.1 1.3 0.5 0.0 0.2 7.2 0.6 10.2 0.0 0.2 0.1 0.9 10.1 0.4 0.2 0.1 0.2 1.5 0.3 0.3 0.3 0.1 0.5 0.2 0.7 0.1 0.3 2.3 0.4 0.4 0.3 1.0 1.0 0.7 0.6 0.8 0.3 0.1 18.1 0.2 0.2 0.3 0.6 2.1 0.4 0.9 0.2 0.4 1.2 2.6 1.2 0.3 1.0 0.4 0.9 1.5 0.9 2.3 0.2 0.4 0.6 0.8 0.5 0.8 1.0 0.5 0.8 0.8 1.5 1.0 RELL2 "C5orf16, FLJ90583" ENSG00000164620 "RELT like 2" Q8NC24 5 141636950-141641077 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6;parathyroid gland: 27.6" "Cell line enhanced" "Detected in many" "HMC-1: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077928 Uncertain Vesicles Vesicles "HPA077928: " "unprognostic (3.27e-2)" "unprognostic (8.46e-2)" "unprognostic (2.12e-1)" "unprognostic (4.95e-3)" "unprognostic (1.91e-3)" "unprognostic (7.12e-2)" "unprognostic (1.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.69e-2)" "unprognostic (2.12e-2)" "unprognostic (6.76e-4)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (7.85e-2)" "unprognostic (8.74e-3)" "unprognostic (4.31e-2)" "unprognostic (6.58e-2)" 2.0 4.5 6.9 2.4 12.3 2.2 2.3 12.5 27.6 1.4 2.3 2.3 0.0 2.5 1.3 1.8 2.7 1.2 2.4 1.6 10.8 14.5 3.3 1.8 2.7 4.7 17.8 8.4 1.1 2.2 27.6 9.4 7.4 24.9 2.2 2.1 1.7 3.7 1.8 1.0 4.2 1.8 2.2 3.8 5.4 2.3 4.6 2.5 4.6 2.8 1.7 5.0 2.9 0.9 2.5 7.8 1.2 3.5 0.1 5.4 1.9 0.9 3.0 3.0 5.7 2.4 0.7 1.4 2.6 4.8 8.4 12.5 11.3 1.1 0.1 1.2 3.9 4.6 2.8 10.9 2.2 2.7 1.8 6.9 6.5 5.6 3.9 2.2 20.0 1.6 6.8 7.8 5.7 2.3 2.4 3.6 1.9 1.4 4.0 0.8 3.5 1.5 0.2 0.6 4.7 2.7 2.7 5.0 5.5 2.3 11.0 1.8 3.8 5.2 2.0 6.5 2.9 5.1 4.4 2.1 5.7 16.2 3.5 9.6 4.1 0.0 1.4 0.0 3.0 3.5 1.1 2.5 3.2 3.0 2.3 1.5 2.9 1.6 1.2 0.1 2.5 7.8 5.4 1.9 6.9 12.3 12.5 27.6 10.8 14.5 17.8 8.4 24.9 2.5 REPS1 ENSG00000135597 "RALBP1 associated Eps domain containing 1" Q96D71 6 138903493-138988261 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029961, HPA029962" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane, Cytosol" "HPA029961: AB_10603233, HPA029962: " "unprognostic (1.72e-3)" "unprognostic (9.61e-2)" "unprognostic (5.82e-3)" "unprognostic (2.77e-2)" "unprognostic (6.30e-3)" "unprognostic (1.90e-1)" "prognostic unfavourable (9.47e-4)" "unprognostic (3.79e-1)" "unprognostic (2.49e-1)" "unprognostic (9.71e-3)" "unprognostic (4.29e-3)" "unprognostic (4.42e-2)" "unprognostic (2.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.27e-1)" "unprognostic (3.83e-2)" "unprognostic (2.69e-2)" 9.5 9.4 18.9 11.5 22.0 15.5 18.4 25.9 25.5 12.9 12.9 14.8 15.3 11.7 17.5 32.5 20.9 14.6 14.0 17.7 17.7 17.6 12.1 23.1 11.5 13.3 15.1 19.4 17.0 13.9 32.8 28.3 14.0 20.0 13.6 13.7 13.6 21.6 13.4 12.1 22.6 12.2 16.3 10.8 15.8 12.4 27.7 11.7 30.7 13.9 13.5 18.4 14.7 14.3 4.6 6.2 8.0 7.5 5.2 6.9 2.0 12.7 10.1 19.4 24.1 10.9 19.6 21.2 12.5 13.8 14.7 17.7 24.0 11.2 15.5 10.6 17.3 15.1 22.0 18.8 19.5 16.4 18.9 13.0 6.1 14.5 16.6 41.1 21.1 15.9 15.5 26.8 32.6 15.1 17.3 16.0 18.7 21.6 23.2 22.5 18.4 9.6 27.3 11.9 8.8 12.1 19.4 17.3 17.1 11.5 17.6 16.4 8.4 28.4 14.7 8.2 13.7 22.2 17.1 15.8 14.3 21.7 9.7 17.0 11.9 8.0 2.3 3.2 4.2 6.5 6.9 4.6 5.4 5.8 3.4 3.4 5.5 6.5 1.5 5.2 7.5 6.2 5.4 2.0 18.9 22.0 25.9 25.5 17.7 17.6 15.1 19.4 20.0 11.7 REX1BD "C19orf60, FLJ20850, FLJ30108, FLJ34606, FLJ37391" ENSG00000006015 "Required for excision 1-B domain containing" Q96EN9 19 18588685-18592336 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.1" "Cell line enhanced" "Detected in many" "BEWO: 25.2;PC-3: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043414 Approved Approved Vesicles Vesicles "HPA043414: AB_10797141" "unprognostic (1.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "unprognostic (6.78e-3)" "unprognostic (1.22e-1)" "unprognostic (4.87e-3)" "unprognostic (2.52e-2)" "unprognostic (1.45e-1)" "unprognostic (4.60e-1)" "unprognostic (3.10e-1)" "unprognostic (5.50e-3)" "unprognostic (3.24e-2)" "unprognostic (3.19e-2)" "unprognostic (4.02e-2)" "unprognostic (9.27e-2)" "unprognostic (1.48e-1)" "prognostic favourable (8.47e-4)" 29.8 12.6 21.2 15.2 18.2 13.1 9.9 20.7 21.6 9.8 18.3 10.3 17.5 13.0 10.8 13.9 8.7 8.4 11.5 17.6 18.0 16.6 17.7 25.4 11.5 8.5 16.6 18.0 11.9 15.9 5.0 8.3 8.6 14.4 15.8 4.7 8.5 22.2 14.3 100.1 9.7 17.8 8.7 12.3 25.8 24.1 5.2 11.4 7.4 7.4 14.0 8.8 8.1 9.9 44.5 51.8 50.5 55.2 32.5 57.0 49.0 6.7 8.2 0.7 1.3 1.1 1.0 25.2 7.1 1.1 1.7 2.0 1.5 7.8 7.0 23.7 1.3 4.9 0.3 1.6 0.4 7.6 17.0 4.6 3.1 3.8 1.4 3.9 11.3 2.2 1.6 0.8 0.4 2.1 5.7 2.0 0.8 11.2 7.3 6.4 11.1 35.0 8.0 2.1 17.7 2.4 6.1 3.4 13.1 3.3 3.3 7.9 1.8 3.3 7.0 0.7 7.2 9.8 4.1 20.2 6.3 4.1 6.7 7.1 3.3 28.1 55.2 50.5 55.7 47.3 56.8 44.5 57.0 49.9 51.8 34.3 52.6 49.1 31.6 32.5 43.7 44.8 45.1 49.0 21.2 18.2 20.7 21.6 18.0 16.6 16.6 18.0 14.4 11.4 RFC3 "MGC5276, RFC38" ENSG00000133119 "Replication factor C subunit 3" P40938 13 33818049-33966558 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030149 Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA030149: AB_10602921" "unprognostic (3.86e-2)" "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-2)" "unprognostic (5.76e-2)" "unprognostic (3.07e-3)" "unprognostic (3.32e-2)" "unprognostic (4.93e-2)" "unprognostic (9.02e-3)" "unprognostic (4.49e-1)" "unprognostic (6.46e-2)" "unprognostic (4.05e-2)" "unprognostic (5.24e-3)" "unprognostic (4.05e-2)" "unprognostic (1.79e-1)" "unprognostic (5.08e-2)" "unprognostic (2.86e-1)" 8.0 17.7 5.7 19.1 7.2 14.4 10.9 19.9 10.2 7.9 7.5 5.6 5.9 6.9 11.6 8.9 10.3 7.0 6.5 6.2 5.2 5.5 5.4 6.2 6.6 19.1 4.7 5.6 9.6 7.6 3.7 5.9 14.2 8.6 5.7 10.3 7.0 7.8 4.6 6.1 7.5 7.0 6.6 5.6 11.8 6.3 17.8 3.7 34.7 6.1 9.7 19.2 5.2 7.0 8.2 7.9 8.5 7.5 3.3 8.3 4.1 11.4 11.5 22.0 17.7 1.7 2.7 11.9 16.0 7.4 21.5 18.7 15.1 17.8 43.1 6.7 6.2 17.7 27.7 11.3 29.1 16.5 16.6 24.9 13.4 16.3 1.9 30.1 12.0 2.5 1.5 18.5 12.8 7.1 17.3 10.9 12.9 13.4 25.4 14.4 25.8 10.0 9.5 25.6 9.9 6.4 10.3 11.4 20.1 12.0 16.2 8.4 13.0 16.7 3.7 11.4 12.7 14.4 17.0 6.1 8.3 69.1 8.2 17.9 21.7 1.6 5.7 8.5 4.5 7.5 4.9 8.2 5.5 4.7 7.9 7.8 7.4 6.3 1.3 3.3 6.5 3.3 8.3 4.1 5.7 7.2 19.9 10.2 5.2 5.5 4.7 5.6 8.6 3.7 RFFL "CARP-2, CARP2, fring, rififylin, RNF189, RNF34L" ENSG00000092871 "Ring finger and FYVE like domain containing E3 ubiquitin protein ligase" Q8WZ73 17 35005990-35089319 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell line enhanced" "Detected in all" "HDLM-2: 40.5;Karpas-707: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB008096, HPA017910, HPA019492" Approved Approved Vesicles Vesicles "CAB008096: AB_2178607, HPA017910: AB_1856189, HPA019492: AB_1856190" "unprognostic (2.59e-1)" "unprognostic (2.87e-1)" "prognostic favourable (4.92e-4)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" "unprognostic (1.79e-1)" "unprognostic (5.73e-3)" "unprognostic (4.34e-3)" "unprognostic (2.31e-1)" "unprognostic (9.26e-3)" "unprognostic (2.39e-1)" "unprognostic (2.63e-1)" "prognostic unfavourable (2.43e-5)" "unprognostic (1.44e-1)" "unprognostic (1.97e-1)" "unprognostic (8.68e-2)" "unprognostic (1.36e-1)" 5.8 6.1 11.1 9.9 22.9 22.1 6.7 4.4 15.7 6.7 14.6 56.8 5.9 14.8 6.9 5.3 21.6 5.4 11.5 5.8 14.4 10.5 15.4 25.0 6.8 8.9 32.1 7.3 5.2 10.1 8.3 4.9 6.5 30.7 10.7 12.6 4.5 9.6 7.0 12.2 5.2 11.9 7.3 32.1 9.9 13.4 15.7 27.5 13.1 23.0 5.4 15.0 10.2 9.2 4.2 5.2 26.8 7.6 6.7 14.5 7.1 7.7 14.8 3.9 5.5 6.5 9.2 2.1 5.1 8.4 5.3 6.4 5.0 15.5 2.3 6.5 6.5 11.0 6.1 9.9 7.4 40.5 4.2 12.1 3.9 12.3 5.5 7.8 7.3 6.2 5.9 7.9 14.1 5.2 5.7 37.8 4.7 2.5 1.7 7.0 4.6 8.8 5.4 6.3 13.7 7.8 15.6 4.3 5.4 3.2 3.4 3.2 5.2 8.6 10.1 3.1 5.5 3.0 8.3 14.1 11.8 3.6 12.1 5.5 2.8 11.3 7.6 16.3 8.8 4.6 10.6 4.2 9.9 8.3 5.2 4.1 8.5 7.5 26.8 6.7 4.1 0.6 14.5 7.1 11.1 22.9 4.4 15.7 14.4 10.5 32.1 7.3 30.7 27.5 RFT1 CDG1N ENSG00000163933 "RFT1 homolog" Q96AA3 3 53088483-53130462 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA060327, HPA069022" Approved Approved Vesicles Vesicles "HPA060327: , HPA069022: " "unprognostic (5.74e-2)" "unprognostic (1.31e-1)" "unprognostic (1.35e-3)" "unprognostic (5.16e-3)" "unprognostic (2.08e-1)" "unprognostic (2.45e-1)" "prognostic unfavourable (1.69e-4)" "unprognostic (1.09e-1)" "unprognostic (1.22e-1)" "unprognostic (2.70e-1)" "unprognostic (2.81e-2)" "unprognostic (9.26e-2)" "unprognostic (6.48e-2)" "unprognostic (1.96e-1)" "unprognostic (1.22e-1)" "unprognostic (5.06e-2)" "unprognostic (3.54e-2)" 12.9 19.1 10.8 13.8 14.7 7.2 13.2 11.0 19.2 11.9 11.7 17.0 9.6 10.2 16.2 14.0 16.9 13.0 11.0 12.4 10.2 7.4 10.1 17.7 11.6 15.3 10.5 10.5 15.5 43.7 15.4 9.4 13.8 10.6 11.0 13.8 13.4 18.6 11.3 7.0 13.4 10.5 11.6 11.5 14.5 12.8 23.8 11.1 16.8 15.2 9.1 16.3 12.5 12.1 16.5 27.5 25.9 23.1 11.7 14.5 13.6 16.2 15.4 10.6 16.9 12.5 13.3 22.1 14.8 13.9 25.9 23.7 15.2 32.1 21.5 9.3 14.2 17.5 23.9 24.2 23.0 20.2 10.5 21.2 11.2 15.0 21.8 19.3 12.5 14.0 20.5 34.8 25.2 16.4 11.1 19.7 17.0 16.5 18.1 11.4 21.2 20.3 7.5 10.2 32.6 14.3 11.0 6.0 8.2 18.3 13.5 13.3 10.1 27.6 10.8 24.1 15.6 16.4 29.0 12.5 15.0 16.3 17.2 24.8 25.1 25.9 23.1 9.9 13.3 22.4 13.4 12.2 12.5 13.6 24.1 16.5 14.5 14.5 7.7 11.7 15.5 27.5 10.9 13.6 10.8 14.7 11.0 19.2 10.2 7.4 10.5 10.5 10.6 11.1 RFX1 EF-C ENSG00000132005 "Regulatory factor X1" P22670 19 13961538-14007039 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048722, HPA052966" Approved Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA048722: , HPA052966: " "unprognostic (6.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.55e-3)" "unprognostic (2.63e-1)" "unprognostic (5.45e-2)" "prognostic favourable (2.42e-4)" "unprognostic (2.62e-1)" "unprognostic (1.71e-1)" "unprognostic (2.88e-1)" "unprognostic (1.61e-2)" "prognostic favourable (4.92e-4)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.83e-2)" "unprognostic (2.96e-1)" "unprognostic (1.50e-1)" "unprognostic (1.56e-2)" 7.4 7.4 13.1 8.7 13.1 9.8 7.0 36.2 19.3 10.3 6.0 6.2 10.2 10.6 8.0 4.6 8.0 8.5 6.3 7.0 11.7 5.9 7.9 8.6 7.0 7.2 8.6 9.5 10.2 12.5 11.9 18.9 8.0 9.5 8.5 3.1 9.8 12.7 12.4 11.0 7.0 9.2 4.4 6.8 12.0 11.2 21.0 10.8 11.6 10.9 3.4 9.3 6.8 13.6 3.9 3.5 10.8 3.5 3.4 2.0 1.1 6.1 6.3 3.4 4.1 2.0 2.6 10.2 3.4 2.3 4.0 3.5 6.4 6.2 3.5 6.9 1.8 8.1 2.4 2.5 1.4 3.5 13.9 4.0 7.0 5.7 3.8 4.0 8.5 1.9 2.7 3.6 2.1 3.1 10.1 3.9 2.1 9.4 7.3 8.8 7.6 9.5 6.4 3.5 4.9 4.0 3.3 14.1 7.4 5.9 5.2 4.8 5.5 4.2 3.7 7.0 5.7 7.6 5.9 9.3 4.1 2.4 5.6 4.0 6.2 0.7 3.5 1.6 1.4 1.1 1.3 2.9 1.6 1.5 1.7 3.9 1.7 2.0 10.8 3.4 2.0 3.5 1.0 1.1 13.1 13.1 36.2 19.3 11.7 5.9 8.6 9.5 9.5 10.8 RFX3 ENSG00000080298 "Regulatory factor X3" P48380 9 3218297-3526004 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.1;testis: 36.5" "Cell line enhanced" "Detected in many" "AF22: 21.9;HDLM-2: 12.9;SCLC-21H: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035689 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA035689: AB_10671224" "prognostic favourable (1.47e-4)" "unprognostic (8.78e-2)" "unprognostic (1.18e-1)" "unprognostic (5.52e-2)" "unprognostic (2.27e-2)" "unprognostic (1.50e-1)" "unprognostic (8.26e-3)" "unprognostic (3.06e-2)" "unprognostic (1.68e-1)" "unprognostic (6.49e-2)" "unprognostic (7.58e-3)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-1)" "unprognostic (2.52e-1)" "unprognostic (8.89e-3)" 5.2 4.6 17.9 7.6 14.9 11.4 6.7 35.1 19.5 6.9 4.7 6.9 5.0 5.0 6.8 6.3 3.8 22.0 5.2 4.0 12.8 7.5 5.0 4.1 7.2 6.7 6.0 11.9 7.0 5.4 9.0 21.7 5.8 9.9 6.1 5.6 4.2 4.7 4.6 5.7 4.4 5.0 4.0 12.5 5.7 6.6 36.5 11.0 12.7 5.7 2.9 7.5 4.5 7.8 8.3 4.6 8.9 4.8 5.3 9.3 3.2 1.9 2.7 21.9 5.3 0.9 1.0 2.2 0.8 2.3 1.9 1.4 0.8 2.5 3.1 0.9 1.1 1.1 5.3 2.2 3.3 12.9 1.4 5.9 2.9 1.8 1.1 1.2 0.8 1.3 1.0 2.3 3.7 3.2 1.1 3.2 2.0 1.5 3.7 4.3 5.8 1.1 3.9 1.5 0.8 3.0 1.6 11.8 5.2 1.3 0.6 2.0 1.1 3.1 2.0 1.4 3.2 0.7 1.3 1.1 0.5 6.3 1.5 1.4 1.4 3.5 3.2 6.2 8.8 4.8 5.4 6.3 8.1 7.2 3.1 8.3 5.7 7.0 8.9 5.3 1.4 4.6 9.3 3.2 17.9 14.9 35.1 19.5 12.8 7.5 6.0 11.9 9.9 11.0 RGL1 RGL ENSG00000143344 "Ral guanine nucleotide dissociation stimulator like 1" Q9NZL6 1 183636085-183928531 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 18.4;HSkMC: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 5.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019788 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA019788: AB_1856215" "unprognostic (3.08e-1)" "unprognostic (5.25e-3)" "unprognostic (8.73e-2)" "unprognostic (1.24e-2)" "unprognostic (2.34e-1)" "unprognostic (4.79e-3)" "prognostic unfavourable (1.49e-5)" "prognostic favourable (4.32e-4)" "unprognostic (1.12e-1)" "unprognostic (6.34e-2)" "unprognostic (5.77e-3)" "unprognostic (4.59e-2)" "unprognostic (2.63e-3)" "unprognostic (4.87e-2)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (2.88e-2)" 22.1 15.7 22.1 16.9 24.8 1.5 19.7 14.2 23.2 18.1 9.9 25.5 8.8 7.9 17.4 11.5 9.9 14.4 20.3 15.0 21.5 15.0 25.7 14.3 18.4 17.4 18.2 16.3 18.7 6.3 10.5 9.7 14.2 19.1 12.5 11.9 21.0 7.8 11.1 3.0 8.4 9.4 19.8 19.6 37.5 7.6 13.0 20.4 1.7 9.1 2.9 8.9 18.1 12.6 0.0 2.4 0.2 5.2 0.0 1.1 1.2 0.1 0.7 13.5 2.0 18.4 8.5 13.8 6.2 10.5 2.8 3.5 6.0 0.4 0.1 5.8 4.4 0.3 0.9 1.5 2.8 0.2 1.0 0.1 1.4 6.1 4.9 0.2 0.7 28.9 0.3 7.2 1.7 10.5 0.0 10.0 6.0 0.0 1.4 0.1 4.9 0.4 11.7 0.8 11.9 0.7 3.8 1.7 4.0 1.9 2.1 1.0 0.1 0.1 7.7 4.1 1.6 12.7 3.3 1.0 0.2 0.0 4.3 0.1 11.2 0.0 2.1 0.0 0.2 5.2 0.4 0.0 0.8 0.0 2.4 0.0 1.1 0.6 0.2 0.0 1.8 0.0 0.6 1.2 22.1 24.8 14.2 21.9 21.5 15.0 18.2 16.3 19.1 20.4 RGPD1 RGP1 ENSG00000187627 "RANBP2-like and GRIP domain containing 1" P0DJD0 2 86907953-87013976 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.4;placenta: 8.0;testis: 17.7" "Cell line enhanced" "Detected in some" "BEWO: 9.0;MOLT-4: 13.5;NTERA-2: 4.1;RPMI-8226: 3.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA049497: , HPA051675: , HPA067564: " "unprognostic (8.24e-2)" "unprognostic (6.05e-2)" "unprognostic (6.41e-2)" "unprognostic (1.39e-2)" "unprognostic (9.06e-2)" "unprognostic (6.28e-2)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.88e-5)" "unprognostic (2.23e-1)" "unprognostic (2.22e-2)" "unprognostic (5.36e-3)" "unprognostic (1.99e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.0 0.0 0.1 0.2 0.2 1.7 1.1 4.8 8.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.3 0.3 17.7 0.2 0.5 0.0 0.1 1.3 0.0 0.1 0.0 1.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 13.5 0.2 4.1 0.0 0.1 0.1 3.0 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 1.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 1.3 0.5 0.7 0.0 0.2 0.1 0.8 0.0 1.1 0.0 0.0 0.1 0.1 RGPD2 "RANBP2L2, RGP2" ENSG00000185304 "RANBP2-like and GRIP domain containing 2" P0DJD1 2 87755955-87825952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.3;testis: 12.3" "Cell line enhanced" "Detected in some" "BEWO: 11.9;K-562: 4.1;MOLT-4: 13.6;NTERA-2: 5.9;SiHa: 4.8;THP-1: 5.5" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "T-reg: 11.3" "Lineage enriched" "Detected in single" 12 "T-cells: 11.3" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA049497: , HPA051675: , HPA067564: " "unprognostic (4.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.26e-2)" "unprognostic (2.04e-2)" "unprognostic (1.69e-1)" "unprognostic (2.05e-1)" "unprognostic (7.46e-3)" "unprognostic (1.71e-1)" "unprognostic (1.72e-2)" "unprognostic (4.10e-2)" "unprognostic (4.24e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-6)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (5.09e-2)" "unprognostic (2.59e-1)" 0.7 2.1 0.1 0.6 0.2 7.1 0.8 1.3 0.3 4.6 0.8 1.2 1.1 0.0 0.3 2.4 0.0 0.5 0.0 0.2 0.4 0.8 1.2 1.3 0.1 1.7 6.3 0.1 2.7 7.5 0.6 0.1 0.8 0.1 0.6 0.6 1.8 0.0 0.1 0.9 1.7 12.3 0.9 1.6 0.3 0.9 0.9 0.0 0.5 0.1 0.0 11.3 0.4 0.0 0.0 0.7 0.0 0.0 0.0 11.9 0.5 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.1 2.8 0.3 0.0 0.0 4.1 0.3 0.0 0.5 13.6 0.0 5.9 0.0 0.3 0.0 0.3 0.0 0.0 0.0 3.0 4.8 0.1 0.0 0.0 5.5 0.2 0.9 0.1 0.0 0.0 2.7 0.3 0.1 0.0 0.0 0.0 0.2 0.1 0.5 0.2 0.0 0.4 0.9 2.7 0.5 0.0 0.9 1.4 0.2 0.4 0.0 0.0 0.0 11.3 0.4 RGPD3 RGP3 ENSG00000153165 "RANBP2-like and GRIP domain containing 3" A6NKT7 2 106391290-106468376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 11.6" "Group enriched" "Detected in some" 4 "HEL: 3.2;MOLT-4: 10.1;RPMI-8226: 3.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA049497: , HPA051675: , HPA067564: " "unprognostic (2.91e-1)" "unprognostic (1.62e-1)" "unprognostic (5.51e-2)" "unprognostic (6.61e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (6.86e-2)" "unprognostic (3.10e-1)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.44e-1)" "unprognostic (4.74e-3)" "unprognostic (5.05e-2)" "unprognostic (3.70e-1)" "unprognostic (3.42e-1)" "unprognostic (1.34e-1)" 0.2 0.1 0.3 0.0 0.5 0.4 0.4 0.3 0.9 0.2 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.4 1.4 0.7 0.1 0.1 0.6 0.2 0.2 0.7 0.7 0.2 0.2 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.4 0.7 0.1 11.6 0.1 0.2 0.2 0.0 0.1 0.2 0.2 0.2 0.0 1.2 0.2 0.4 0.5 0.4 0.4 0.3 0.5 0.1 0.4 0.5 0.4 0.3 0.5 0.0 0.0 0.1 0.3 0.3 1.2 0.1 0.7 0.3 0.1 3.2 0.3 0.5 0.3 0.1 0.1 0.1 0.3 1.1 0.4 0.3 0.6 0.0 0.5 0.2 10.1 0.1 0.4 0.1 0.0 0.1 3.2 0.1 0.5 0.5 0.1 0.4 0.0 0.2 0.1 0.3 0.2 0.3 0.2 0.6 0.5 0.6 0.6 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.1 0.6 0.5 0.0 0.1 0.7 0.2 0.0 0.0 0.2 0.2 1.2 0.2 RGPD4 "DKFZp686P0288, RGP4" ENSG00000196862 "RANBP2-like and GRIP domain containing 4" Q7Z3J3 2 107826937-107890841 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 8.6" "Cell line enriched" "Detected in single" 12 "U-266/70: 4.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 5 "T-cells: 1.5" "HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA049497: , HPA051675: , HPA067564: " "unprognostic (4.96e-2)" "unprognostic (3.04e-1)" "unprognostic (4.38e-1)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "unprognostic (3.05e-3)" "unprognostic (7.79e-2)" "unprognostic (1.52e-1)" "unprognostic (4.47e-1)" "unprognostic (6.05e-2)" "unprognostic (2.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.3 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.2 0.0 1.5 0.1 RGPD5 "BS-63, DKFZp686I1842, RGP5" ENSG00000015568 "RANBP2-like and GRIP domain containing 5" Q99666 2 109792758-109857695 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 10.5;PC-3: 11.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA045704: , HPA049497: , HPA051675: , HPA067564: " "unprognostic (2.50e-2)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.23e-1)" "unprognostic (4.23e-2)" "unprognostic (3.19e-1)" "unprognostic (3.19e-3)" "unprognostic (3.19e-1)" 4.9 5.0 5.2 2.5 11.7 11.4 9.4 8.2 6.3 6.4 5.2 7.5 6.0 12.3 6.8 6.1 2.6 4.0 3.4 4.4 4.7 4.8 5.3 5.1 5.6 3.0 5.1 4.9 6.0 11.9 3.8 15.1 4.9 5.6 6.4 2.0 8.3 8.5 4.9 7.4 5.2 5.8 6.9 4.9 3.7 8.7 15.7 3.7 1.0 6.8 3.2 2.6 6.3 15.3 6.9 4.3 9.2 3.5 2.8 6.7 0.9 8.3 4.7 1.7 1.8 0.4 0.1 1.6 4.2 1.3 1.6 2.4 9.0 1.0 0.6 5.3 0.7 3.4 1.4 0.3 0.3 1.9 10.5 3.7 3.6 0.2 0.2 0.6 0.5 0.7 2.3 0.9 0.6 0.9 2.3 2.1 0.7 2.3 0.4 1.2 2.4 11.0 3.6 5.8 0.0 0.5 3.0 5.7 3.2 5.0 0.0 1.4 0.1 0.9 5.8 1.8 6.4 0.4 2.3 4.0 0.3 0.6 3.2 0.1 0.7 6.8 3.5 4.1 4.1 1.6 6.7 4.0 3.8 4.0 2.3 6.9 4.9 3.7 9.2 2.8 3.0 4.3 2.9 0.9 5.2 11.7 8.2 6.3 4.7 4.8 5.1 4.9 5.6 3.7 RGPD6 RGP6 ENSG00000183054 "RANBP2-like and GRIP domain containing 6" Q99666 2 110513812-110577185 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA045704: , HPA049497: , HPA051675: , HPA067564: " "unprognostic (1.11e-2)" "unprognostic (6.38e-2)" "unprognostic (1.18e-1)" "unprognostic (3.67e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-1)" "unprognostic (2.91e-2)" "unprognostic (4.14e-4)" "unprognostic (2.04e-1)" 5.6 4.1 3.2 2.4 4.9 6.9 5.5 5.6 8.1 4.5 3.8 2.1 4.9 10.1 2.3 3.8 3.4 4.7 3.8 4.4 3.3 4.7 5.1 2.8 3.4 6.4 6.9 8.5 9.5 5.3 6.0 3.5 3.3 4.4 5.2 6.2 4.1 3.5 2.6 3.2 4.0 19.9 7.5 2.4 3.8 3.7 5.7 3.8 8.1 2.6 2.9 4.1 0.3 13.8 3.4 16.6 12.5 5.0 6.1 1.7 10.1 9.2 8.3 5.9 11.3 5.1 0.3 7.4 8.7 6.1 10.2 5.6 11.0 3.3 5.8 14.6 1.2 7.7 6.2 1.9 1.9 5.5 5.7 10.6 10.9 5.3 6.2 3.4 6.9 4.0 4.4 0.4 11.1 4.3 2.1 8.4 0.1 8.2 7.4 23.5 4.2 5.2 1.1 9.7 0.6 5.6 7.7 9.1 12.2 2.3 10.9 7.7 0.3 0.3 7.2 0.8 3.9 6.8 2.6 3.2 2.4 1.3 4.1 2.5 3.1 2.7 1.7 5.7 3.1 2.5 8.1 2.9 1.6 3.8 0.9 0.3 RGPD8 "RanBP2alpha, RANBP2L1" ENSG00000169629 "RANBP2-like and GRIP domain containing 8" O14715 2 112370092-112434488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.0" "Cell line enhanced" "Detected in many" "HEL: 14.4;hTEC/SVTERT24-B: 12.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA045704: , HPA049497: , HPA051675: , HPA067564: " "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.62e-1)" "unprognostic (7.61e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-3)" "unprognostic (3.17e-3)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.57e-1)" "unprognostic (9.18e-3)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.05e-2)" 2.4 0.9 0.5 1.3 0.9 6.2 2.3 2.6 2.7 1.7 1.5 0.4 1.9 2.1 1.1 1.6 1.4 1.7 0.6 0.8 1.3 2.8 2.4 0.9 0.6 2.2 2.3 2.0 2.8 2.0 1.4 1.0 1.3 1.6 1.5 2.4 1.3 1.5 0.8 1.3 1.2 14.0 2.1 1.4 1.9 1.5 2.9 2.1 3.1 2.4 1.4 5.1 1.2 6.1 2.9 4.5 2.7 1.4 3.0 0.1 2.9 2.2 2.2 1.6 5.2 0.4 0.0 1.9 3.4 2.7 10.7 1.5 2.3 7.5 3.5 14.4 3.8 2.8 1.7 0.1 0.2 0.5 2.0 12.1 3.0 2.0 7.3 0.4 3.3 2.2 6.5 0.8 2.8 3.2 0.0 0.7 0.0 1.0 2.7 2.9 0.6 7.1 0.1 1.6 0.7 3.1 8.5 1.5 2.2 4.8 4.2 0.1 0.0 0.0 0.4 1.7 0.3 3.1 1.3 1.3 3.5 1.0 5.1 1.7 2.3 2.9 1.4 2.9 3.2 2.2 1.0 1.4 2.4 2.1 1.3 1.2 RGS14 ENSG00000169220 "Regulator of G protein signaling 14" O43566 5 177357837-177372601 "Predicted intracellular proteins" "Cell cycle, Cell division" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.9;brain: 76.1" "Cell line enhanced" "Detected in many" "HDLM-2: 39.8;HMC-1: 35.6;NB-4: 15.7;RPMI-8226: 20.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 76.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 11 "amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5" "Group enriched" "Detected in all" 5 "amygdala: 38.0;basal ganglia: 118.5;cerebral cortex: 32.0;hippocampal formation: 90.8" "HPA046847, HPA061819" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments" Nucleoplasm "Vesicles, Plasma membrane, Intermediate filaments" "HPA046847: , HPA061819: " "unprognostic (6.05e-3)" "unprognostic (1.65e-2)" "unprognostic (8.57e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (6.97e-4)" "unprognostic (7.27e-2)" "prognostic unfavourable (1.84e-6)" "unprognostic (1.95e-2)" "unprognostic (4.34e-2)" "unprognostic (2.04e-3)" "unprognostic (2.71e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-2)" "unprognostic (2.78e-2)" 1.9 1.5 7.7 12.5 76.1 17.5 1.3 0.4 8.8 1.7 2.6 1.9 0.6 5.1 1.3 1.4 3.2 6.6 3.4 0.7 17.1 1.9 2.1 6.9 4.3 15.5 2.5 3.6 0.8 1.5 0.1 0.9 1.0 0.8 1.2 0.5 0.7 5.2 1.8 1.6 3.5 5.7 1.2 0.7 12.8 3.7 0.7 4.4 24.2 4.3 1.7 12.9 4.9 1.6 9.2 12.2 43.9 12.3 6.5 20.7 12.4 1.8 0.4 0.7 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.2 1.1 3.7 4.7 2.6 0.0 3.8 0.0 1.2 0.0 39.8 0.1 7.4 0.1 1.5 0.2 5.7 35.6 0.6 0.3 0.2 0.2 0.2 1.2 9.6 0.0 0.1 7.6 15.7 0.6 1.0 3.5 0.0 20.5 0.4 0.1 0.1 0.7 0.0 0.1 3.0 1.3 9.0 0.3 0.0 0.7 0.0 3.4 5.1 2.4 2.0 0.6 10.8 0.8 18.6 12.3 43.9 20.5 11.4 20.7 9.2 19.1 18.7 12.2 8.0 16.0 14.3 43.0 6.5 11.6 5.4 18.2 12.4 7.7 76.1 0.4 8.8 17.1 1.9 2.5 3.6 0.8 4.4 RGS17 "RGS-17, RGSZ2" ENSG00000091844 "Regulator of G protein signaling 17" Q9UGC6 6 153004459-153131249 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell line enhanced" "Detected in many" "ASC TERT1: 13.0;hTERT-HME1: 14.0;LHCN-M2: 13.9;RH-30: 10.0;U-87 MG: 11.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022276, HPA056493" Approved Approved Vesicles Vesicles "HPA022276: AB_10794628, HPA056493: " "unprognostic (2.77e-2)" "unprognostic (6.81e-2)" "unprognostic (3.11e-1)" "unprognostic (1.99e-1)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (1.03e-3)" "unprognostic (3.12e-1)" "unprognostic (3.79e-2)" "unprognostic (7.95e-3)" "unprognostic (1.92e-1)" "unprognostic (5.33e-2)" "unprognostic (5.96e-12)" "unprognostic (2.70e-2)" "unprognostic (2.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" 3.0 1.3 14.2 1.5 12.5 3.3 1.4 16.8 10.1 7.1 1.5 1.2 0.0 1.7 2.2 1.1 3.2 1.3 5.9 1.0 8.1 7.3 0.9 0.6 1.4 1.6 3.2 7.8 2.7 4.4 0.3 7.2 0.6 7.9 5.2 2.0 0.2 1.5 1.6 0.6 1.9 1.8 1.4 4.1 1.2 4.3 3.3 3.0 0.3 8.9 0.0 0.6 3.7 1.5 0.5 0.4 1.4 0.3 2.1 1.6 0.2 0.0 4.3 3.2 0.1 1.5 13.0 0.1 0.3 1.4 1.0 2.7 0.0 0.3 0.2 0.3 0.7 0.2 3.0 3.2 1.5 0.2 0.3 0.5 0.3 0.1 3.5 0.2 1.5 5.5 0.0 5.5 14.0 6.4 0.1 0.2 13.9 2.3 0.1 0.3 2.2 3.5 0.1 10.0 0.1 4.0 1.3 2.2 5.9 0.1 0.0 0.0 0.0 0.2 3.2 2.2 2.7 2.7 3.9 0.2 0.0 0.1 11.8 0.1 3.0 1.4 0.3 0.4 1.6 0.2 0.2 0.2 0.9 0.6 0.2 0.5 0.3 0.9 1.1 2.1 0.3 0.4 0.2 0.2 14.2 12.5 16.8 10.1 8.1 7.3 3.2 7.8 7.9 3.0 RGS6 ENSG00000182732 "Regulator of G protein signaling 6" P49758 14 71932439-72566529 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8" "Group enriched" "Detected in some" 7 "HEL: 8.1;Karpas-707: 29.3" "Group enriched" "Detected in some" 7 "glioma: 3.1;thyroid cancer: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.6;T-reg: 1.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003067 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA003067: AB_1079807" "unprognostic (7.18e-2)" "unprognostic (7.78e-2)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (5.61e-2)" "unprognostic (3.80e-2)" "unprognostic (1.24e-4)" "unprognostic (7.83e-2)" "unprognostic (2.03e-1)" "unprognostic (8.17e-2)" "unprognostic (1.30e-1)" "unprognostic (2.06e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-2)" "unprognostic (8.06e-3)" "unprognostic (2.10e-1)" "unprognostic (3.68e-2)" 6.9 0.8 8.6 1.1 11.1 2.0 4.9 4.0 18.0 7.9 1.8 2.8 0.3 0.8 2.7 4.2 1.0 3.6 1.9 15.7 3.7 7.5 3.3 0.6 1.7 0.5 15.4 9.3 2.3 0.6 10.9 2.6 4.6 20.8 0.7 1.8 1.3 1.3 2.5 1.7 1.4 1.4 2.2 5.2 1.5 0.8 13.9 2.4 0.0 8.5 0.3 1.0 1.1 1.3 0.5 0.4 1.6 0.2 0.6 1.2 4.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 29.3 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.6 0.0 0.4 1.2 4.1 8.6 11.1 4.0 18.0 3.7 7.5 15.4 9.3 20.8 2.4 RGS9 "MGC111763, MGC26458, PERRS, RGS9L" ENSG00000108370 "Regulator of G protein signaling 9" O75916 17 65100812-65227703 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.3" "Group enriched" "Detected in some" 8 "HDLM-2: 22.9;HEL: 9.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "basal ganglia: 47.3" "Group enriched" "Detected in many" 6 "gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7" "Group enriched" "Detected in many" 74 "NK-cells: 3.7;T-cells: 11.0" "Region enriched" "Detected in many" 9 "basal ganglia: 222.4" "Region enriched" "Detected in many" 9 "basal ganglia: 79.8" "HPA013550, HPA014137" Enhanced Supported Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA013550: , HPA014137: " "unprognostic (4.43e-3)" "unprognostic (7.49e-3)" "unprognostic (5.12e-2)" "unprognostic (3.09e-5)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.20e-1)" "unprognostic (4.88e-2)" "prognostic favourable (1.35e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-2)" "unprognostic (4.94e-2)" "unprognostic (3.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.49e-1)" 1.1 1.9 3.3 4.4 47.3 1.0 2.3 4.1 8.9 3.4 5.2 7.2 2.7 3.3 4.2 7.2 4.1 9.5 3.9 1.3 5.4 7.4 2.0 5.0 5.9 5.3 3.5 3.7 6.7 3.7 7.3 7.9 3.0 4.5 8.6 3.4 24.1 3.2 9.2 1.6 1.5 3.6 4.0 3.4 4.3 3.7 1.7 6.6 0.4 4.2 0.5 7.5 5.1 2.4 0.0 0.0 0.0 0.0 3.7 11.0 1.4 0.2 0.0 1.0 0.1 0.1 0.2 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.7 1.6 0.0 0.1 0.0 0.1 0.2 22.9 0.5 9.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 2.8 0.0 1.0 7.4 0.0 0.0 0.0 3.6 0.0 3.7 0.0 0.0 0.0 1.4 3.3 47.3 4.1 4.5 5.4 7.4 3.5 3.7 4.5 6.6 RHBDF1 "C16orf8, Dist1, EGFR-RS, FLJ2235, iRhom1" ENSG00000007384 "Rhomboid 5 homolog 1" Q96CC6 16 58059-76355 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077399 Uncertain Vesicles Vesicles "HPA077399: " "unprognostic (2.62e-1)" "unprognostic (2.86e-2)" "unprognostic (4.76e-2)" "unprognostic (4.04e-2)" "unprognostic (1.51e-2)" "unprognostic (3.69e-2)" "unprognostic (5.60e-3)" "unprognostic (4.54e-3)" "unprognostic (4.51e-2)" "unprognostic (1.02e-1)" "unprognostic (7.81e-3)" "unprognostic (2.09e-1)" "prognostic unfavourable (2.49e-5)" "unprognostic (4.81e-2)" "unprognostic (1.87e-1)" "unprognostic (8.36e-2)" "unprognostic (4.22e-2)" 12.7 3.7 6.2 11.5 9.3 0.3 17.7 3.5 6.2 21.8 10.8 6.1 6.7 5.6 13.0 10.4 17.5 10.6 17.2 15.9 7.0 2.8 8.2 3.8 17.8 4.1 6.9 4.9 18.8 9.6 9.8 4.3 26.5 7.3 19.6 5.5 15.9 20.1 13.5 13.4 22.4 7.5 14.6 5.8 6.1 9.2 7.1 3.1 1.2 11.2 15.7 10.1 16.0 19.4 0.0 0.5 0.0 1.7 0.0 0.4 0.0 4.2 6.9 4.0 9.2 15.7 19.5 13.2 11.8 22.2 8.3 8.0 9.4 15.0 0.2 4.9 12.5 13.6 1.9 7.9 1.4 0.1 2.1 0.1 6.9 2.6 17.6 0.1 7.6 16.2 8.3 21.5 3.6 12.6 1.6 0.2 13.1 23.9 0.0 1.3 3.6 5.9 0.1 4.7 0.3 9.3 4.4 0.1 0.9 3.4 13.1 7.3 20.1 1.5 13.2 13.2 9.3 10.2 3.2 0.1 0.2 0.1 9.2 0.2 20.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.2 9.3 3.5 6.2 7.0 2.8 6.9 4.9 7.3 3.1 RHOBTB3 KIAA0878 ENSG00000164292 "Rho related BTB domain containing 3" O94955 5 95713522-95824383 "Predicted intracellular proteins" Transport Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 86.0" "Cell line enhanced" "Detected in many" "EFO-21: 51.2;HaCaT: 65.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 10.1" "Group enriched" "Detected in many" 4 "granulocytes: 10.1;T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA000265 Uncertain Vesicles Vesicles "HPA000265: " "unprognostic (1.68e-1)" "unprognostic (9.60e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "unprognostic (3.39e-2)" "unprognostic (7.37e-2)" "unprognostic (4.28e-1)" "unprognostic (6.00e-3)" "unprognostic (9.29e-2)" "unprognostic (9.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.56e-3)" "unprognostic (7.01e-3)" "unprognostic (1.15e-1)" "unprognostic (3.23e-1)" "unprognostic (8.21e-2)" 38.7 21.4 27.0 6.4 25.8 4.0 12.8 11.8 23.1 16.4 12.0 26.9 11.8 8.2 7.5 15.5 9.8 7.8 11.0 17.6 26.2 12.8 16.4 11.5 9.5 3.6 20.1 21.3 46.6 59.2 24.1 11.0 86.0 13.0 16.4 11.7 21.7 21.0 12.2 15.3 7.4 9.0 11.2 18.2 6.0 12.1 12.4 21.3 1.8 11.1 4.1 1.6 10.9 12.8 0.8 1.2 10.1 1.5 0.5 2.9 0.9 10.3 4.2 10.3 11.0 38.9 22.6 0.1 18.0 17.2 7.0 11.0 20.0 1.9 0.0 51.2 9.2 65.0 5.5 1.3 12.1 0.4 7.1 3.6 39.6 5.7 30.7 0.8 5.1 36.5 1.0 10.5 0.1 5.4 14.1 2.7 27.8 2.9 1.1 2.8 3.9 6.5 1.5 20.3 1.2 5.9 7.4 18.3 23.7 14.2 6.2 16.7 4.7 5.2 8.6 9.4 40.6 6.3 6.8 2.7 5.3 0.4 2.9 0.2 15.4 0.1 0.9 10.1 2.9 0.5 1.2 0.8 2.1 2.5 0.2 0.2 2.9 0.6 0.7 0.5 1.5 1.2 1.1 0.9 27.0 25.8 11.8 18.6 26.2 12.8 20.1 21.3 13.0 21.3 RHOH "ARHH, RhoH, TTF" ENSG00000168421 "Ras homolog family member H" Q15669 4 40191053-40246967 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.8;lymphoid tissue: 94.7" "Cell line enhanced" "Detected in some" "Daudi: 35.6;HMC-1: 27.4;MOLT-4: 49.6;U-266/70: 19.2;U-266/84: 15.4;U-698: 32.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030345, HPA061314" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA030345: AB_10601607, HPA061314: " "unprognostic (4.00e-2)" "unprognostic (1.83e-4)" "unprognostic (1.24e-2)" "unprognostic (2.22e-5)" "unprognostic (1.35e-1)" "unprognostic (1.32e-3)" "unprognostic (1.16e-1)" "unprognostic (2.73e-2)" "unprognostic (2.30e-2)" "unprognostic (4.30e-2)" "unprognostic (9.07e-2)" "unprognostic (1.38e-1)" "unprognostic (3.31e-6)" "unprognostic (2.96e-1)" "unprognostic (3.91e-2)" "unprognostic (4.46e-2)" "unprognostic (2.44e-2)" 1.8 0.6 0.6 33.8 1.1 21.7 5.2 0.4 0.4 1.3 2.4 0.5 0.4 1.6 2.0 0.9 2.5 1.5 4.1 1.1 0.6 0.7 1.6 1.7 4.8 43.2 0.8 0.2 0.7 0.8 0.0 0.9 0.3 0.8 2.1 2.0 1.0 7.8 0.6 0.5 1.2 15.1 0.7 1.2 33.1 2.7 0.7 0.6 94.7 1.6 1.9 41.0 5.1 1.5 41.2 4.7 32.2 0.2 12.3 54.8 21.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.3 0.0 0.0 0.0 5.8 27.4 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 49.6 3.7 0.6 0.1 5.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.1 0.1 0.0 0.1 0.0 0.0 19.2 15.4 32.9 0.0 1.2 0.0 32.2 0.2 29.6 21.6 0.1 19.4 30.5 34.6 29.1 0.3 41.2 54.8 43.3 1.6 12.3 0.2 4.7 47.0 21.1 0.6 1.1 0.4 0.4 0.6 0.7 0.8 0.2 0.8 0.6 RHOQ "ARHQ, RASL7A, TC10" ENSG00000119729 "Ras homolog family member Q" P17081 2 46541806-46583121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 62.0;ASC TERT1: 48.5;SK-MEL-30: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044938 Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA044938: " "unprognostic (1.24e-1)" "unprognostic (1.30e-2)" "unprognostic (5.82e-2)" "unprognostic (2.07e-2)" "unprognostic (3.61e-2)" "unprognostic (2.89e-2)" "prognostic unfavourable (9.60e-5)" "unprognostic (2.01e-2)" "unprognostic (9.24e-2)" "unprognostic (2.11e-2)" "unprognostic (1.97e-1)" "unprognostic (5.43e-2)" "unprognostic (3.88e-3)" "unprognostic (1.39e-2)" "unprognostic (1.87e-1)" "unprognostic (7.68e-2)" "unprognostic (3.52e-2)" 43.3 13.1 20.9 14.1 19.4 4.9 16.7 6.5 15.1 16.4 16.6 12.7 11.7 4.9 15.5 32.9 9.8 13.8 15.0 65.2 16.8 13.0 13.9 6.0 14.2 10.0 19.5 14.9 16.0 12.9 20.4 8.2 13.8 20.4 14.6 6.9 16.0 9.6 19.2 63.8 7.2 8.9 19.3 15.4 13.2 9.3 6.3 13.4 8.0 18.0 17.2 9.1 17.7 12.1 3.9 2.9 8.9 4.8 0.7 0.8 1.3 4.1 4.3 7.2 10.1 62.0 48.5 0.9 11.9 30.1 5.8 9.1 2.0 1.3 10.1 13.0 21.0 1.7 7.5 3.5 10.6 3.4 5.1 2.3 3.2 7.0 30.3 3.0 3.6 42.9 6.1 7.7 8.3 6.8 4.0 16.8 12.5 2.8 2.3 5.4 7.5 5.4 1.6 13.1 3.4 7.9 8.0 5.7 18.5 4.4 5.9 52.7 3.2 6.9 4.7 19.0 17.7 18.5 4.8 17.3 6.2 10.6 27.7 7.4 6.7 2.7 4.6 7.8 0.7 4.8 0.6 3.4 0.4 0.8 2.9 3.9 0.1 0.6 8.9 0.7 3.4 1.3 0.6 1.3 20.9 19.4 6.5 15.1 16.8 13.0 19.5 14.9 20.4 13.4 RIMBP3 "KIAA1666, RIMBP3.1, RIMBP3A" ENSG00000275793 "RIMS binding protein 3" Q9UFD9 22 18605815-18611919 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 22.0" "Cell line enhanced" "Detected in many" "MOLT-4: 5.9;THP-1: 6.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.55e-2)" "unprognostic (3.95e-3)" "unprognostic (1.62e-1)" "unprognostic (3.95e-2)" "unprognostic (2.29e-2)" "unprognostic (9.81e-3)" "unprognostic (1.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.71e-1)" "unprognostic (4.72e-3)" "unprognostic (6.06e-3)" "unprognostic (9.58e-2)" "unprognostic (8.49e-3)" "unprognostic (7.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.69e-3)" "unprognostic (7.95e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 22.0 0.1 0.2 0.0 0.7 1.1 0.9 1.0 1.7 2.5 1.1 0.8 2.8 1.1 0.9 1.6 0.8 0.1 1.0 3.1 1.4 1.5 0.1 0.0 0.7 1.2 0.3 0.7 0.6 0.0 0.3 2.8 0.9 1.2 0.7 1.1 0.1 3.9 0.1 0.3 0.1 0.6 0.0 0.0 0.5 0.7 1.2 1.3 5.9 3.1 1.2 0.3 2.4 3.5 0.4 0.4 0.2 1.6 0.3 2.5 0.0 0.5 0.3 6.4 0.2 2.1 1.4 1.1 0.5 0.2 0.8 0.6 1.1 1.3 2.3 0.0 1.0 0.9 1.0 0.6 2.5 0.7 1.4 1.4 1.1 0.6 1.8 0.9 0.3 1.7 0.4 0.1 1.2 1.1 RIMBP3B ENSG00000274600 "RIMS binding protein 3B" A6NNM3 22 21383374-21389478 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.6" "Cell line enhanced" "Detected in some" "NB-4: 2.8;RH-30: 3.4;THP-1: 4.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (3.78e-1)" "unprognostic (3.54e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.28e-1)" "unprognostic (5.35e-2)" "unprognostic (4.37e-1)" "unprognostic (3.61e-4)" "unprognostic (1.69e-2)" "unprognostic (7.11e-2)" 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.2 0.0 0.3 0.4 0.4 0.9 1.0 1.5 0.4 0.1 1.7 0.2 0.4 1.1 0.7 0.3 0.5 1.2 0.5 0.9 0.2 0.3 0.3 1.0 0.2 0.0 0.7 0.0 0.1 1.7 1.1 0.6 0.3 0.2 0.0 0.5 0.0 0.1 0.0 0.1 0.2 0.0 0.6 0.3 0.6 0.2 2.0 2.8 0.4 0.4 1.9 3.4 0.0 0.1 0.0 0.5 0.0 1.5 0.0 0.5 0.1 4.8 0.0 0.4 0.4 0.4 0.2 0.1 0.1 0.0 0.9 0.4 1.5 0.0 0.5 0.4 1.1 0.2 1.4 0.1 0.7 1.5 0.4 0.3 1.1 0.7 0.1 1.0 0.9 0.1 1.2 0.4 RIMBP3C ENSG00000183246 "RIMS binding protein 3C" A6NJZ7 22 21545357-21551461 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 16.6" "Cell line enhanced" "Detected in some" "NB-4: 3.2;THP-1: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.74e-1)" "unprognostic (4.05e-2)" "unprognostic (3.49e-2)" "unprognostic (2.18e-1)" "unprognostic (8.30e-2)" "unprognostic (4.53e-2)" "unprognostic (6.65e-2)" "unprognostic (1.15e-3)" "unprognostic (6.23e-2)" "unprognostic (2.17e-6)" "unprognostic (3.04e-1)" "unprognostic (3.29e-1)" "unprognostic (3.76e-6)" "unprognostic (1.66e-2)" 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 16.6 0.0 0.3 0.1 0.0 0.5 1.3 0.9 0.8 1.4 1.7 1.0 0.2 0.0 0.5 0.1 0.1 0.0 0.2 0.1 0.8 0.7 0.3 0.1 0.3 0.0 1.5 0.6 0.5 0.7 0.2 0.1 0.7 0.5 0.5 0.0 0.3 0.2 1.5 0.6 0.0 0.2 0.5 0.1 0.3 0.1 0.0 0.1 0.7 1.7 3.2 0.3 0.2 1.4 0.9 0.1 0.1 0.1 0.7 0.2 0.5 0.4 0.2 0.0 3.5 0.0 1.3 0.6 0.7 0.2 0.5 0.4 0.2 1.3 1.1 1.7 0.9 0.8 0.8 0.5 0.5 1.4 0.5 0.9 0.7 1.3 0.4 1.7 0.6 0.8 1.4 0.7 0.1 0.9 1.0 RINL FLJ45909 ENSG00000187994 "Ras and Rab interactor like" Q6ZS11 19 38867834-38878279 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 17.0;Karpas-707: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042083, HPA042103" Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA042083: AB_10793977, HPA042103: AB_10797380" "unprognostic (1.30e-1)" "prognostic favourable (6.49e-5)" "unprognostic (7.38e-2)" "unprognostic (1.75e-2)" "unprognostic (6.05e-2)" "prognostic favourable (1.64e-4)" "unprognostic (2.61e-2)" "unprognostic (3.64e-2)" "unprognostic (4.87e-2)" "unprognostic (5.95e-2)" "unprognostic (1.85e-1)" "unprognostic (7.90e-2)" "unprognostic (3.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.89e-1)" "unprognostic (3.17e-2)" "unprognostic (6.40e-3)" 5.5 3.7 6.3 10.2 10.3 5.4 10.4 6.5 5.8 2.6 3.9 4.2 6.2 3.4 1.8 2.4 5.3 4.6 6.1 3.9 5.1 6.4 5.0 6.0 7.0 20.4 5.5 3.8 1.7 17.4 4.9 5.7 3.3 5.5 2.6 3.5 5.9 7.9 4.5 3.0 3.2 6.3 2.6 4.5 13.0 6.1 1.4 3.5 7.6 6.4 3.1 15.7 4.3 2.9 16.6 12.3 3.1 2.1 4.1 8.7 2.9 0.0 1.3 0.4 0.2 0.6 0.3 2.6 0.3 0.2 0.3 0.4 2.3 6.9 7.7 3.6 0.4 0.2 1.3 2.9 0.4 1.7 0.8 9.6 2.0 4.9 1.6 5.4 17.0 1.6 0.5 0.9 0.6 3.4 1.9 20.0 0.0 1.2 1.7 3.8 0.6 0.3 1.1 0.1 5.8 1.9 0.2 2.6 1.1 3.1 5.1 2.7 0.6 6.6 2.2 0.1 1.5 0.4 0.0 8.6 7.1 6.1 0.6 3.0 0.4 3.1 0.9 1.5 8.7 2.1 5.5 12.4 5.8 6.3 1.6 16.6 4.6 5.4 2.8 4.1 2.0 12.3 6.1 2.9 6.3 10.3 6.5 5.8 5.1 6.4 5.5 3.8 5.5 3.5 RNASE1 "RAC1, RNS1" ENSG00000129538 "Ribonuclease A family member 1, pancreatic" P07998 14 20801228-20803278 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "pancreas: 809.6" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 73.2;RT4: 28.7;TIME: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 8.0;myeloid DC: 16.1" "Group enriched" "Detected in many" 9 "dendritic cells: 16.1;monocytes: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001140 Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" 1500000000 Vesicles Nucleoplasm "HPA001140: AB_1079816" "unprognostic (2.32e-2)" "unprognostic (3.16e-2)" "unprognostic (9.51e-3)" "unprognostic (7.77e-2)" "unprognostic (6.93e-2)" "unprognostic (1.28e-1)" "unprognostic (3.42e-3)" "unprognostic (6.59e-3)" "unprognostic (4.69e-2)" "unprognostic (7.92e-2)" "unprognostic (6.32e-2)" "unprognostic (3.56e-2)" "unprognostic (5.14e-3)" "unprognostic (1.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.43e-2)" "unprognostic (1.67e-1)" 79.2 48.4 28.7 12.0 38.5 1.6 59.7 4.0 32.2 21.3 33.7 57.8 63.6 16.8 13.6 49.1 19.3 24.3 37.5 70.3 41.2 21.6 33.8 8.6 94.3 23.5 39.0 16.0 19.2 809.6 6.7 4.1 79.0 25.1 23.0 39.8 106.4 15.9 35.6 31.7 10.8 20.6 26.6 52.3 34.5 87.9 86.5 27.1 7.8 11.2 14.3 7.2 29.0 10.9 0.0 16.1 1.3 8.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 73.2 7.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.0 28.7 0.3 0.3 0.0 0.2 0.0 0.0 0.0 38.0 0.0 0.6 0.4 0.0 0.1 0.0 0.0 1.0 0.0 1.0 1.3 8.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 2.0 28.7 38.5 4.0 32.2 41.2 21.6 39.0 16.0 25.1 27.1 RND1 "ARHS, Rho6, RHOS" ENSG00000172602 "Rho family GTPase 1" Q92730 12 48857145-48865898 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;liver: 50.6" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 38.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077800 Supported "Vesicles,Plasma membrane,Actin filaments" "Vesicles, Plasma membrane, Actin filaments" "HPA077800: " "unprognostic (5.60e-2)" "unprognostic (3.21e-2)" "unprognostic (2.23e-1)" "unprognostic (1.16e-1)" "unprognostic (6.90e-2)" "unprognostic (1.32e-3)" "unprognostic (3.59e-2)" "unprognostic (7.43e-2)" "unprognostic (2.21e-3)" "unprognostic (2.97e-1)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (8.38e-3)" "unprognostic (6.18e-2)" "unprognostic (6.60e-2)" "unprognostic (3.35e-3)" 2.9 1.3 9.9 2.6 15.0 2.0 2.8 2.6 21.8 1.4 2.8 1.4 0.2 2.6 4.4 1.5 1.8 1.1 13.3 2.5 7.4 7.6 1.8 50.6 12.3 1.4 7.1 8.6 0.9 2.0 3.2 3.2 1.6 8.6 3.7 2.3 1.0 4.0 1.5 0.6 0.6 2.3 2.6 5.6 0.9 6.1 0.8 2.3 0.0 5.5 2.1 2.4 6.9 2.0 1.7 1.7 0.0 0.0 0.5 1.6 0.2 0.6 4.2 2.1 1.1 0.4 0.0 0.3 0.0 0.2 0.6 0.7 2.6 0.9 3.2 0.8 0.0 0.0 1.7 0.1 0.4 1.0 1.0 0.4 0.0 1.6 0.2 0.9 0.6 0.0 0.1 0.3 0.4 1.1 0.1 3.3 0.0 5.4 0.4 0.2 5.0 0.2 1.0 0.2 1.5 0.6 0.8 0.0 0.5 0.1 38.6 0.1 3.8 0.1 0.2 0.0 0.4 0.0 0.5 1.7 2.8 5.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.6 1.7 0.2 0.1 1.7 1.1 0.7 0.1 0.0 0.5 0.0 0.0 0.4 0.2 9.9 15.0 2.6 20.4 7.4 7.6 7.1 8.6 8.6 2.3 RNF121 FLJ11099 ENSG00000137522 "Ring finger protein 121" Q9H920 11 71928701-71997597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046041 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA046041: AB_10965850" "unprognostic (1.36e-2)" "unprognostic (8.84e-2)" "unprognostic (9.72e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.38e-2)" "unprognostic (1.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (6.54e-2)" "unprognostic (1.85e-2)" "unprognostic (1.90e-1)" "prognostic favourable (2.72e-6)" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (2.57e-2)" "unprognostic (1.70e-1)" 9.8 14.1 18.5 14.0 14.9 6.5 14.1 18.5 16.6 12.6 13.0 12.4 22.4 18.5 17.9 26.3 10.6 14.3 10.8 13.1 11.7 11.7 20.2 16.9 9.4 8.9 12.4 13.4 15.0 15.6 24.1 19.4 18.9 12.1 13.5 13.1 15.7 18.0 19.5 19.2 11.8 18.7 14.1 10.1 10.1 12.8 16.3 13.6 8.9 15.6 8.1 15.3 11.9 10.4 5.9 6.9 8.8 5.5 5.6 7.0 5.1 5.0 10.9 11.3 8.3 11.0 8.6 7.9 9.3 10.1 14.8 15.6 21.3 11.2 4.7 8.2 10.5 11.9 12.4 11.2 16.0 6.7 7.2 7.9 10.7 10.5 8.2 6.8 6.7 8.1 10.1 16.0 9.7 26.4 11.8 5.0 13.0 11.4 4.6 7.8 7.8 11.1 5.9 23.9 4.3 16.8 9.9 8.0 8.6 12.1 10.4 17.0 12.0 5.0 16.4 10.5 10.0 7.0 7.8 6.1 5.5 5.3 9.2 4.4 9.3 8.8 4.1 4.0 5.6 5.5 7.0 5.9 4.7 4.5 3.9 2.2 5.3 5.9 2.1 5.6 3.9 6.9 3.9 5.1 18.5 14.9 18.5 16.6 11.7 11.7 12.4 13.4 12.1 13.6 RNF13 RZF ENSG00000082996 "Ring finger protein 13" O43567 3 149812708-149962139 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 72.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064784 Approved Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA064784: " "unprognostic (1.27e-1)" "unprognostic (2.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.93e-2)" "unprognostic (1.80e-1)" "unprognostic (9.64e-2)" "unprognostic (8.49e-2)" "unprognostic (4.36e-3)" "unprognostic (1.72e-1)" "unprognostic (1.25e-1)" "unprognostic (6.94e-3)" "unprognostic (1.13e-1)" "prognostic favourable (2.00e-8)" "unprognostic (2.95e-1)" "unprognostic (4.11e-2)" "unprognostic (2.17e-1)" "unprognostic (1.79e-1)" 24.0 21.3 30.6 19.0 39.4 9.8 28.5 19.9 30.4 19.0 17.7 39.9 16.2 14.3 16.8 33.7 16.8 15.9 20.4 16.4 40.5 29.7 35.8 39.2 31.7 19.6 60.9 26.8 18.1 19.6 23.5 14.9 32.4 40.7 25.5 20.3 19.5 36.1 20.9 18.0 18.4 16.3 20.4 102.2 25.5 17.0 12.5 51.2 13.3 32.1 18.8 15.9 21.4 16.5 8.8 15.7 72.4 31.5 7.8 8.5 14.6 19.4 12.1 8.2 9.3 32.3 19.8 13.7 10.8 27.8 10.4 15.5 10.6 28.0 8.1 15.8 13.2 18.5 11.0 13.8 14.7 9.9 8.0 9.7 5.6 10.3 21.5 10.4 13.9 20.9 26.3 8.8 23.9 11.5 3.0 16.5 9.3 10.9 7.5 6.9 5.5 9.5 5.4 8.8 34.3 20.2 9.1 4.3 12.5 8.9 13.4 34.7 25.5 11.1 12.0 14.2 5.7 15.0 6.9 28.0 18.4 16.7 11.9 9.8 7.6 12.9 20.3 16.6 6.8 25.2 8.5 8.8 7.6 7.6 15.7 8.3 7.3 7.5 72.4 7.8 31.5 11.2 8.3 14.6 30.6 39.4 19.9 29.2 40.5 29.7 60.9 26.8 40.7 51.2 RNF135 MGC13061 ENSG00000181481 "Ring finger protein 135" Q8IUD6 17 30968785-30999911 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021576, HPA052404" Approved Approved Vesicles Vesicles "HPA021576: AB_1856331, HPA052404: " "unprognostic (1.13e-1)" "unprognostic (1.87e-2)" "unprognostic (6.24e-2)" "unprognostic (2.33e-2)" "unprognostic (2.68e-2)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "unprognostic (1.24e-1)" "unprognostic (4.60e-2)" "unprognostic (4.16e-1)" "unprognostic (1.35e-2)" "unprognostic (2.06e-1)" "prognostic unfavourable (7.51e-5)" "unprognostic (6.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.42e-1)" "unprognostic (4.47e-1)" 18.2 11.6 6.5 15.9 7.1 7.1 28.8 6.4 6.1 16.3 22.2 7.2 16.5 9.7 15.7 16.8 18.4 11.8 14.4 7.4 7.1 4.8 19.5 6.0 19.0 28.0 6.8 2.5 15.1 11.7 15.0 5.9 19.2 6.3 18.1 13.2 13.6 13.3 14.8 7.5 21.4 16.7 13.9 6.1 22.7 10.0 8.8 4.8 6.0 25.0 12.7 18.8 13.0 19.1 11.8 18.4 21.7 25.1 5.4 5.3 9.7 5.8 12.2 0.7 12.1 16.7 13.3 10.3 4.7 7.0 4.6 4.0 0.0 4.4 4.7 6.9 8.9 7.5 6.0 5.7 3.6 4.5 2.6 2.2 3.6 0.0 11.7 5.9 5.1 13.2 30.2 4.8 15.6 7.2 0.0 16.2 7.3 7.8 0.0 6.0 4.9 6.6 12.4 0.0 17.3 6.3 8.4 4.5 0.2 6.7 2.8 6.7 18.5 9.2 6.3 0.0 1.6 7.4 5.3 0.2 0.5 3.4 8.1 10.2 6.2 9.1 24.0 12.1 5.3 21.8 2.9 11.8 2.8 2.7 18.4 11.2 1.5 2.7 21.7 5.4 25.1 6.6 3.8 9.7 6.5 7.1 6.4 6.1 7.1 4.8 6.8 2.5 6.3 4.8 RNF144A "hUIP4, KIAA0161, RNF144, UBCE7IP4" ENSG00000151692 "Ring finger protein 144A" P50876 2 6917392-7068286 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.5" "Cell line enhanced" "Detected in many" "HMC-1: 50.4;SH-SY5Y: 15.3;SK-MEL-30: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.7" "Group enriched" "Detected in many" 7 "granulocytes: 8.7;T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049939 Approved Approved Vesicles Vesicles "HPA049939: " "unprognostic (1.78e-1)" "unprognostic (2.53e-3)" "unprognostic (8.37e-2)" "prognostic unfavourable (6.00e-4)" "unprognostic (6.57e-2)" "prognostic favourable (6.96e-4)" "unprognostic (7.04e-6)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "unprognostic (5.64e-1)" "unprognostic (9.11e-2)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "prognostic unfavourable (7.32e-5)" "unprognostic (1.30e-2)" "unprognostic (3.01e-1)" "unprognostic (1.82e-3)" 12.9 28.8 13.3 4.2 21.2 12.1 11.1 45.5 20.7 17.3 5.2 28.7 9.0 3.0 26.0 8.3 4.7 8.4 7.5 8.0 15.6 11.6 7.5 1.8 5.7 7.9 26.5 12.2 20.0 29.7 21.5 12.5 6.2 13.2 8.7 5.7 5.9 4.0 7.4 8.7 5.7 4.1 12.2 21.8 21.1 2.8 5.0 27.1 3.4 3.2 1.2 5.8 5.8 6.5 0.1 0.2 8.7 0.1 0.8 4.1 0.6 0.3 2.2 11.7 2.4 2.6 5.5 9.0 0.0 0.0 0.4 1.1 0.0 0.2 1.1 1.3 0.1 0.2 3.8 0.0 0.0 0.6 1.0 14.9 0.1 4.4 0.1 0.2 50.4 8.7 0.0 0.8 0.0 0.0 6.4 0.2 0.0 1.8 7.6 0.6 4.3 5.3 5.9 8.5 0.9 0.3 3.9 3.9 15.3 0.2 1.5 15.1 0.6 0.9 0.0 1.5 4.0 4.1 1.7 4.1 1.3 0.0 5.8 3.3 5.5 1.5 0.1 8.7 2.1 0.0 3.0 0.1 2.1 1.5 0.2 0.1 4.1 2.8 0.4 0.8 0.0 0.0 0.8 0.6 13.3 21.2 45.5 20.3 15.6 11.6 26.5 12.2 13.2 27.1 RNF149 FLJ90504 ENSG00000163162 "Ring finger protein 149" Q8NC42 2 101271219-101308701 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 123.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 123.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 123.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011424 Approved Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA011424: AB_1079825" "unprognostic (2.56e-2)" "unprognostic (4.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (3.17e-2)" "unprognostic (5.17e-3)" "unprognostic (4.16e-2)" "unprognostic (4.77e-3)" "unprognostic (5.61e-2)" "unprognostic (1.43e-2)" "unprognostic (5.69e-3)" "unprognostic (1.51e-1)" "prognostic unfavourable (2.04e-8)" "unprognostic (1.39e-1)" "unprognostic (6.16e-2)" "unprognostic (2.70e-1)" "prognostic favourable (2.91e-4)" 20.3 13.4 7.9 29.0 10.9 32.9 13.5 7.9 10.8 12.5 16.6 10.8 11.4 12.3 11.3 12.8 28.9 14.3 14.5 12.1 9.5 9.4 15.1 19.6 24.5 47.4 13.7 6.2 14.3 21.1 14.3 10.6 19.4 11.2 11.1 12.0 12.8 15.8 8.1 8.8 20.2 16.8 9.6 13.9 65.0 13.8 15.2 9.7 17.0 12.7 13.1 24.4 14.9 17.2 2.1 9.3 123.7 21.3 2.3 9.0 9.9 9.6 5.7 4.3 5.5 16.3 16.4 25.5 12.0 15.8 16.2 18.3 14.4 25.6 2.8 14.5 11.8 19.7 6.1 12.2 15.1 8.4 8.4 6.0 5.1 24.3 21.8 6.4 9.7 15.0 20.1 19.2 12.7 29.5 5.2 9.0 16.2 8.2 8.6 6.5 3.0 10.4 5.6 7.2 11.1 19.1 23.7 5.7 4.2 7.2 17.9 17.3 4.8 8.7 19.5 8.2 4.7 12.2 2.6 18.3 10.7 0.1 2.6 9.0 6.0 5.8 13.0 14.8 8.2 20.4 7.4 2.1 7.3 8.1 4.8 1.5 5.1 5.3 123.7 2.3 21.3 9.3 9.0 9.9 7.9 10.9 7.9 10.8 9.5 9.4 13.7 6.2 11.2 9.7 RNF157 KIAA1917 ENSG00000141576 "Ring finger protein 157" Q96PX1 17 76142453-76240373 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.5;skeletal muscle: 52.2;testis: 24.7" "Cell line enhanced" "Detected in many" "HDLM-2: 41.3;U-266/70: 21.9;U-266/84: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.5;T-cells: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021854, HPA021991, HPA023922" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202" "unprognostic (4.21e-1)" "unprognostic (4.62e-2)" "unprognostic (1.55e-2)" "unprognostic (2.63e-3)" "unprognostic (4.93e-2)" "unprognostic (5.06e-2)" "unprognostic (2.07e-3)" "unprognostic (4.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (1.04e-3)" "unprognostic (4.02e-1)" "unprognostic (8.26e-2)" "unprognostic (8.69e-3)" "unprognostic (2.28e-1)" "unprognostic (2.75e-2)" "unprognostic (1.38e-1)" 10.5 3.5 21.0 3.4 19.4 2.3 2.5 10.7 36.5 1.5 7.6 8.0 0.4 8.2 1.9 3.6 1.5 2.4 1.8 3.6 26.4 15.5 5.1 1.4 1.4 4.5 19.7 12.0 1.4 3.6 8.8 2.7 2.1 25.3 1.8 6.6 6.8 1.9 2.0 52.2 1.5 7.3 2.2 11.3 3.0 2.4 24.7 5.9 0.0 3.8 1.5 2.8 1.5 0.5 0.7 0.4 2.5 0.3 1.1 8.5 1.4 0.1 3.4 12.4 4.5 4.0 2.0 5.7 0.1 3.9 0.8 0.4 1.4 1.3 0.0 1.8 0.3 0.1 10.9 0.0 0.7 41.3 3.7 0.0 1.2 1.9 0.6 0.5 4.7 1.1 0.0 1.5 0.0 0.1 6.4 0.1 1.5 3.3 1.8 0.3 2.0 8.8 0.0 0.1 0.0 1.5 1.3 2.2 10.2 2.2 0.0 4.9 0.3 2.1 0.0 0.8 1.0 6.1 3.9 21.9 17.6 0.0 0.3 0.0 6.3 2.5 0.3 0.4 2.3 0.2 4.9 0.3 5.1 4.0 0.2 0.7 8.5 5.5 1.7 1.1 0.3 0.4 2.1 1.4 21.0 19.4 10.7 36.5 26.4 15.5 19.7 12.0 25.3 5.9 RNF182 MGC33993 ENSG00000180537 "Ring finger protein 182" Q8N6D2 6 13924446-13980302 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.9;brain: 17.6" "Cell line enhanced" "Detected in many" "HeLa: 36.3;RPTEC TERT1: 29.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012309 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA012309: AB_1856349" "unprognostic (1.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic unfavourable (4.66e-5)" "unprognostic (6.16e-2)" "unprognostic (2.08e-1)" "unprognostic (9.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.71e-2)" "unprognostic (4.21e-1)" "unprognostic (6.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (9.33e-5)" "unprognostic (6.66e-3)" "unprognostic (1.33e-3)" "unprognostic (1.26e-1)" 1.2 0.7 7.6 0.6 6.2 12.9 1.2 16.6 17.6 1.2 0.7 7.5 2.0 0.8 1.6 2.5 1.0 2.7 0.9 1.0 11.0 7.3 2.6 0.5 5.7 0.8 6.8 8.5 1.1 3.6 0.5 2.0 2.9 14.3 0.9 0.6 2.2 1.9 4.7 0.9 0.8 1.1 1.0 5.1 0.5 0.6 7.0 2.9 0.0 3.0 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.7 5.2 0.0 1.8 2.2 0.3 2.6 3.6 7.4 7.1 0.1 0.0 0.0 0.0 2.8 0.0 6.1 0.0 13.5 0.0 2.0 0.1 36.3 0.0 0.0 0.0 0.0 1.2 0.0 11.3 0.1 0.1 0.2 0.0 5.1 0.0 0.0 0.9 2.9 10.1 1.5 1.2 0.4 29.1 0.0 6.3 6.0 0.2 0.0 10.2 0.0 1.0 2.7 9.0 1.9 0.1 6.0 0.0 0.0 0.0 6.1 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.2 16.6 12.1 11.0 7.3 6.8 8.5 14.3 2.9 RNF26 MGC2642 ENSG00000173456 "Ring finger protein 26" Q9BY78 11 119334527-119337313 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027620 Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA027620: AB_1856356" "unprognostic (9.23e-3)" "unprognostic (3.54e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (3.40e-1)" "unprognostic (1.07e-2)" "prognostic unfavourable (3.19e-4)" "unprognostic (2.14e-2)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (7.24e-3)" "unprognostic (6.22e-2)" "prognostic favourable (3.45e-6)" "unprognostic (9.61e-2)" "unprognostic (3.50e-2)" "unprognostic (4.41e-2)" "prognostic unfavourable (7.73e-4)" 19.0 21.5 13.6 15.4 21.6 25.6 16.9 18.4 38.9 19.8 22.0 17.6 14.5 20.3 31.2 15.6 26.0 24.4 19.8 15.1 17.1 13.8 22.3 28.7 17.3 17.5 15.0 16.6 25.6 18.5 31.4 14.3 27.5 27.2 19.2 18.2 20.2 20.0 28.5 17.6 19.8 21.4 27.0 14.3 19.8 24.3 27.6 13.0 26.7 20.6 14.0 21.1 25.8 18.1 13.8 14.2 7.1 15.5 9.8 16.7 16.2 15.6 17.3 16.2 19.1 16.0 12.7 17.3 17.0 18.4 19.9 15.8 29.2 32.8 13.8 23.6 20.2 28.5 23.0 25.6 12.5 16.5 12.6 36.4 8.1 24.1 12.3 15.2 15.2 13.1 13.2 24.8 22.4 15.1 17.6 21.7 13.6 34.1 13.9 15.8 16.2 22.2 14.5 16.7 11.0 12.2 11.3 11.6 11.2 13.7 17.5 4.5 39.5 12.8 9.9 24.1 16.1 12.6 15.5 5.2 8.5 0.1 8.0 25.8 18.7 7.1 15.5 3.9 16.7 14.5 11.0 9.0 12.7 14.5 14.2 13.8 14.5 12.4 1.1 9.8 14.1 8.1 6.6 16.2 13.6 21.6 18.4 38.9 17.1 13.8 15.0 16.6 27.2 13.0 RNF39 "HZFw1, LIRF" ENSG00000204618 "Ring finger protein 39" Q9H2S5 6 30070266-30075887 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.3;skin 1: 26.4" "Cell line enhanced" "Detected in some" "A-431: 2.9;HEK 293: 2.6;U-266/84: 8.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Group enriched" "Detected in some" 4 "cerebral cortex: 8.0;hippocampal formation: 4.2" "Group enriched" "Detected in some" 6 "cerebellum: 17.9;cerebral cortex: 9.3;hippocampal formation: 5.7" "CAB019278, HPA047115" Uncertain Approved "Vesicles,Plasma membrane,Centrosome" "Vesicles, Plasma membrane, Centrosome" "CAB019278: , HPA047115: " "unprognostic (1.05e-2)" "unprognostic (3.75e-2)" "unprognostic (1.73e-1)" "unprognostic (1.53e-2)" "unprognostic (5.72e-3)" "unprognostic (3.08e-2)" "unprognostic (4.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.22e-2)" "unprognostic (1.59e-2)" "unprognostic (4.45e-3)" "unprognostic (3.61e-2)" "unprognostic (2.06e-4)" "unprognostic (5.61e-2)" "unprognostic (1.31e-1)" "unprognostic (2.04e-1)" "unprognostic (2.57e-2)" 0.3 0.2 0.1 0.3 0.3 0.4 5.1 0.3 0.9 7.3 0.7 0.0 1.1 0.9 0.8 0.3 28.3 0.8 1.1 0.2 0.2 0.1 0.3 0.3 3.6 0.3 0.2 0.0 0.6 2.3 0.4 0.4 9.7 0.3 8.1 0.4 0.6 10.2 0.6 0.4 26.4 0.4 1.0 0.2 0.2 4.3 0.8 0.0 0.3 0.4 10.1 11.7 7.8 12.4 0.0 0.0 1.3 0.0 0.2 0.0 0.0 2.9 0.0 0.7 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 1.6 0.0 1.4 0.0 0.5 2.6 1.1 0.3 0.0 0.0 0.1 0.3 0.0 1.9 0.0 0.2 0.0 0.7 0.6 0.0 1.0 0.0 1.3 0.0 0.0 0.3 0.4 0.0 1.9 0.3 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.5 0.6 0.0 0.3 1.9 8.0 0.7 0.6 0.1 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.4 0.2 0.1 0.2 0.0 0.3 0.0 ROBO3 "FLJ21044, HGPPS, HGPS, RBIG1" ENSG00000154134 "Roundabout guidance receptor 3" Q96MS0 11 124865386-124881470 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 20.1" "Cell line enriched" "Detected in some" 11 "AF22: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 1.4" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Low region specificity" "Detected in all" HPA071053 Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA071053: " "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "unprognostic (4.95e-3)" "unprognostic (3.42e-2)" "unprognostic (3.84e-2)" "unprognostic (6.25e-2)" "unprognostic (6.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (7.15e-2)" "unprognostic (3.75e-8)" "unprognostic (7.27e-3)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (4.91e-3)" 2.4 1.5 1.5 0.5 1.4 1.3 1.7 0.5 3.1 0.8 0.9 0.5 0.5 1.9 1.8 20.1 0.5 2.1 0.5 1.5 1.5 0.6 0.7 0.5 1.7 0.8 1.1 1.1 7.4 0.5 0.2 0.5 1.5 1.0 1.0 0.2 1.0 1.7 0.5 2.6 0.2 2.2 4.5 0.7 3.0 0.8 1.0 0.5 0.8 1.1 0.5 0.5 0.5 1.0 0.0 1.3 1.4 0.3 0.0 0.8 0.0 0.0 0.0 20.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.7 1.0 0.0 1.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.3 0.4 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 1.3 0.8 0.0 1.5 1.4 0.5 2.7 1.5 0.6 1.1 1.1 1.0 0.5 ROS1 "c-ros-1, MCF3, ROS" ENSG00000047936 "ROS proto-oncogene 1, receptor tyrosine kinase" P08922 6 117288300-117425855 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 38.6;lung: 20.2" "Group enriched" "Detected in some" 5 "HSkMC: 9.3;hTCEpi: 19.3;LHCN-M2: 13.4" "Cancer enriched" "Detected in some" 13 "lung cancer: 6.9" "Group enriched" "Detected in some" 10 "cerebral cortex: 7.4;olfactory region: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049098, HPA072424" Uncertain Approved Vesicles Vesicles "HPA049098: , HPA072424: " "unprognostic (8.18e-2)" "unprognostic (4.64e-3)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (7.57e-2)" "unprognostic (2.05e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-1)" "unprognostic (2.79e-2)" "unprognostic (1.00e-2)" "unprognostic (2.42e-1)" "unprognostic (5.20e-2)" "unprognostic (1.56e-12)" "unprognostic (1.09e-2)" "unprognostic (2.81e-1)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" 0.3 0.2 0.2 0.0 0.4 0.0 0.2 0.2 7.4 0.2 0.4 0.0 7.9 0.0 0.2 38.6 0.2 0.2 0.0 0.2 0.2 0.2 0.4 0.2 20.2 0.0 0.2 2.5 0.2 0.2 0.0 0.3 0.7 0.0 0.2 0.3 0.0 0.2 2.3 0.2 0.7 0.3 0.0 0.2 0.2 0.3 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 9.3 19.3 0.2 1.7 0.0 0.0 0.0 13.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.8 0.0 2.3 1.5 0.1 1.8 0.0 0.0 0.0 1.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 7.4 0.2 0.2 0.2 2.5 0.0 0.0 RP9 PAP-1 ENSG00000164610 "RP9, pre-mRNA splicing factor" Q8TA86 7 33094797-33109401 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031523, HPA050778" Uncertain Enhanced Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA031523: AB_10603235, HPA050778: " "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (1.07e-2)" "unprognostic (1.82e-1)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "prognostic unfavourable (2.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.22e-2)" "unprognostic (7.53e-2)" "unprognostic (7.03e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (2.65e-5)" "unprognostic (4.19e-2)" "unprognostic (2.63e-2)" "unprognostic (2.70e-1)" "unprognostic (1.61e-1)" 10.1 13.8 11.7 9.4 16.0 20.7 14.9 17.1 16.0 10.9 12.2 13.0 7.0 10.3 14.6 18.8 8.1 10.0 10.7 19.2 11.1 10.1 11.4 11.5 9.7 19.4 17.4 8.6 14.2 16.9 10.4 14.2 11.7 11.0 14.0 11.8 12.8 15.0 14.4 34.7 10.7 12.5 15.7 11.8 17.2 10.5 15.2 12.6 13.6 15.6 9.0 18.2 13.4 16.0 34.1 11.7 8.1 5.0 5.9 8.4 3.3 9.7 14.0 14.8 16.9 9.4 8.9 7.0 12.4 10.6 14.5 11.6 12.4 7.2 12.4 8.2 10.3 9.8 17.9 10.7 18.6 5.6 11.1 9.1 11.1 11.6 16.6 12.1 6.3 8.9 10.1 16.4 32.5 11.8 16.2 11.4 14.4 20.2 12.9 33.2 12.4 10.1 13.0 12.9 8.2 10.4 9.4 14.3 19.7 8.7 19.6 21.2 10.3 16.8 9.4 14.3 20.1 12.7 20.2 18.6 16.8 24.7 10.1 17.2 27.6 6.4 5.0 8.1 6.6 3.6 6.1 22.0 7.0 7.4 5.3 34.1 8.4 7.8 0.9 5.9 4.6 11.7 5.9 3.3 11.7 16.0 17.1 16.0 11.1 10.1 17.4 8.6 11.0 12.6 RPIA ENSG00000153574 "Ribose 5-phosphate isomerase A" P49247 2 88691644-88750935 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042620, HPA057954" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" 4100000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA042620: AB_10793980, HPA057954: " "unprognostic (3.35e-2)" "unprognostic (1.35e-2)" "unprognostic (6.96e-2)" "unprognostic (9.24e-2)" "unprognostic (4.31e-1)" "unprognostic (8.24e-2)" "prognostic unfavourable (1.46e-5)" "unprognostic (2.73e-3)" "unprognostic (1.82e-3)" "unprognostic (8.70e-2)" "unprognostic (8.82e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (8.53e-6)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (1.01e-2)" "unprognostic (8.79e-3)" 12.9 8.8 6.6 15.6 7.0 43.0 12.1 11.1 6.4 8.1 12.7 6.1 11.0 12.4 11.1 7.3 18.3 8.5 14.0 10.9 5.0 4.9 6.8 6.2 9.0 16.2 7.2 3.8 11.7 26.5 3.6 11.4 26.1 6.5 8.8 13.4 6.0 12.6 8.5 17.6 9.2 12.7 7.7 5.1 15.4 10.4 8.9 7.6 30.7 9.6 10.5 19.3 8.1 11.8 18.5 14.1 21.4 12.5 13.3 22.4 11.6 8.5 5.0 10.2 8.0 7.2 7.4 22.3 4.8 4.5 7.9 5.4 17.8 11.4 43.7 10.4 5.5 5.2 12.6 4.0 12.5 20.7 16.5 17.5 3.2 17.5 7.3 32.0 12.9 6.8 3.4 7.0 11.0 11.1 18.7 7.6 7.4 13.4 35.1 28.0 9.2 8.2 18.4 12.1 10.6 6.5 13.8 7.3 8.3 5.7 7.4 11.0 4.0 13.2 6.3 4.7 12.4 15.4 13.6 5.9 4.8 43.7 4.8 29.1 6.7 5.5 9.7 21.4 11.1 9.8 14.2 18.5 15.5 16.4 14.1 15.4 22.4 18.4 2.3 13.3 12.5 6.8 12.6 11.6 6.6 7.0 11.1 6.4 5.0 4.9 7.2 3.8 6.5 7.6 RPL11 L11 ENSG00000142676 "Ribosomal protein L11" P62913 1 23691742-23696835 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA002734, HPA074839" Approved Approved Vesicles 720000 Vesicles "HPA002734: AB_1079838, HPA074839: " "prognostic favourable (2.55e-4)" "unprognostic (3.98e-2)" "unprognostic (7.77e-2)" "unprognostic (3.30e-2)" "unprognostic (1.21e-1)" "unprognostic (6.70e-2)" "unprognostic (4.51e-3)" "unprognostic (4.94e-2)" "unprognostic (1.70e-2)" "unprognostic (1.25e-1)" "unprognostic (1.61e-1)" "unprognostic (8.92e-2)" "prognostic unfavourable (5.93e-6)" "unprognostic (8.65e-2)" "unprognostic (2.42e-3)" "unprognostic (5.41e-2)" "unprognostic (1.90e-1)" 75.0 46.8 35.1 71.4 74.9 65.8 175.9 33.4 41.1 100.3 69.1 32.9 50.5 30.3 130.0 112.0 87.8 95.9 65.4 79.9 56.0 26.2 56.2 78.8 78.7 222.2 39.5 46.6 148.2 311.5 47.6 43.4 48.3 78.6 85.2 97.7 43.2 204.8 66.6 84.2 92.1 58.0 103.4 47.0 72.3 77.5 52.9 23.2 65.5 91.9 92.2 169.3 73.7 115.4 178.7 93.6 43.4 72.4 79.3 199.1 235.2 37.7 62.0 74.7 38.1 128.2 182.0 26.3 25.5 107.9 97.7 73.1 111.8 42.7 79.0 28.4 86.8 32.4 93.7 126.1 109.5 27.9 125.6 36.8 212.4 147.7 96.1 62.0 30.3 176.7 186.8 82.3 148.6 103.3 42.6 42.8 103.5 117.3 36.0 99.2 18.6 71.0 45.8 36.3 75.0 110.1 67.7 29.5 35.9 20.0 41.7 73.8 30.7 77.2 30.9 24.0 32.8 40.3 32.1 39.3 35.6 55.3 30.3 88.7 27.4 43.4 72.4 22.0 73.6 63.2 125.4 178.7 150.1 107.5 93.6 157.3 199.1 146.6 11.6 79.3 49.8 93.2 109.4 235.2 35.1 74.9 33.4 41.1 56.0 26.2 39.5 46.6 78.6 23.2 RPL7A "L7A, SURF3, TRUP" ENSG00000148303 "Ribosomal protein L7a" P62424 9 133348214-133351426 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046794 Approved Nucleoli,Vesicles 160000 Nucleoli Vesicles "HPA046794: " "unprognostic (5.01e-2)" "unprognostic (1.49e-1)" "unprognostic (8.83e-3)" "unprognostic (1.07e-3)" "unprognostic (4.17e-3)" "unprognostic (7.95e-2)" "prognostic unfavourable (8.99e-4)" "unprognostic (1.98e-1)" "unprognostic (8.88e-2)" "prognostic unfavourable (3.60e-5)" "unprognostic (4.91e-2)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (4.09e-2)" "unprognostic (4.06e-2)" "unprognostic (1.92e-2)" "unprognostic (9.89e-2)" 58.8 72.8 34.9 64.0 39.6 78.6 96.3 33.1 43.2 70.1 66.6 27.6 66.9 38.9 137.4 81.5 96.0 94.8 74.4 48.2 29.5 25.7 51.0 59.3 48.1 159.6 32.7 45.2 164.9 193.1 29.1 50.6 42.4 34.1 90.1 67.6 47.3 204.8 70.0 85.2 91.9 48.6 91.0 35.5 68.1 61.4 78.2 24.0 80.5 77.9 70.1 93.2 75.1 109.7 79.7 56.4 12.1 35.8 50.2 80.4 94.0 45.2 69.0 78.9 78.5 138.7 230.3 75.3 57.1 116.9 103.0 57.6 104.8 59.8 142.1 35.3 99.6 111.1 116.5 137.2 83.2 60.3 65.9 50.0 102.6 101.9 92.0 118.3 59.3 231.6 205.4 74.5 129.3 130.7 95.6 75.0 118.2 153.8 91.7 123.8 85.7 68.1 80.7 98.9 180.8 132.7 58.1 74.1 65.4 46.7 120.5 72.9 131.3 125.4 71.4 68.1 49.0 61.2 67.7 29.3 58.3 87.3 53.1 82.7 52.8 12.1 35.8 7.7 52.2 33.6 77.3 79.7 71.2 64.3 56.4 71.8 80.4 73.5 5.5 50.2 29.3 56.1 54.6 94.0 34.9 39.6 33.1 43.2 29.5 25.7 32.7 45.2 34.1 24.0 RPRD2 "FLJ32145, HSPC099, KIAA0460" ENSG00000163125 "Regulation of nuclear pre-mRNA domain containing 2" Q5VT52 1 150363091-150476566 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061693 Approved Approved Nucleoplasm,Vesicles 91000 "Nucleoplasm, Vesicles" "HPA061693: " "unprognostic (1.68e-1)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (7.25e-2)" "unprognostic (5.67e-3)" "unprognostic (3.79e-2)" "unprognostic (1.75e-2)" "unprognostic (9.03e-2)" "unprognostic (1.50e-1)" "unprognostic (3.93e-2)" "unprognostic (2.52e-1)" "unprognostic (1.27e-1)" "unprognostic (1.10e-3)" "unprognostic (1.11e-1)" "unprognostic (1.71e-1)" "unprognostic (7.92e-2)" "unprognostic (1.38e-1)" 14.0 16.9 16.8 12.0 21.6 13.2 14.0 40.1 22.1 20.2 17.9 21.4 16.6 11.5 21.0 16.4 17.0 24.2 12.2 14.1 16.3 14.1 18.3 12.5 14.0 13.8 16.3 14.1 34.2 17.9 27.5 29.4 10.7 15.2 18.3 16.3 19.8 14.5 19.2 28.5 15.6 13.9 20.1 13.8 16.7 14.2 16.2 17.4 25.6 25.4 10.4 17.3 21.6 17.1 8.0 4.2 6.0 8.6 5.1 9.1 2.5 15.7 12.1 16.0 16.2 16.7 14.2 15.2 11.4 13.7 12.6 12.5 10.4 19.4 25.0 13.2 14.0 17.6 22.5 17.0 13.9 11.5 9.4 14.4 14.3 12.5 12.0 21.5 17.8 15.0 13.0 17.6 23.3 15.6 14.0 27.3 12.8 22.7 18.8 7.0 20.0 13.7 17.4 11.9 25.2 18.6 14.6 17.1 17.3 23.4 20.0 15.2 15.7 19.1 14.2 11.7 12.2 9.8 16.2 16.7 18.4 18.9 11.7 16.2 11.5 6.0 3.6 4.4 8.1 2.4 7.4 7.6 7.6 6.4 3.5 8.0 8.9 8.8 2.0 5.1 8.6 4.2 9.1 2.5 16.8 21.6 40.1 22.1 16.3 14.1 16.3 14.1 15.2 17.4 RPS12 S12 ENSG00000112306 "Ribosomal protein S12" P25398 6 132814441-132817564 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA006124, HPA006365" Approved Supported "Golgi apparatus,Vesicles,Cytosol" 280000 Cytosol "Golgi apparatus, Vesicles" "HPA006124: AB_1856460, HPA006365: " "unprognostic (6.58e-2)" "unprognostic (3.31e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (6.37e-2)" "unprognostic (4.95e-3)" "unprognostic (1.46e-1)" "unprognostic (3.95e-2)" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (7.04e-2)" "prognostic unfavourable (1.06e-4)" "unprognostic (2.04e-1)" "unprognostic (1.05e-1)" "unprognostic (1.26e-1)" "unprognostic (5.66e-2)" 95.6 65.1 66.4 169.3 53.2 199.6 187.3 49.6 66.9 98.4 83.8 42.5 93.7 73.1 106.1 99.2 129.4 88.0 113.7 152.2 56.1 44.6 78.0 108.8 182.0 515.8 67.8 42.0 222.2 403.5 23.2 46.3 87.7 44.5 94.4 82.1 56.5 220.6 71.5 100.5 153.8 79.5 162.6 71.8 122.9 85.4 62.6 52.5 139.6 116.7 155.1 130.9 109.7 196.8 159.2 101.3 17.4 54.3 70.9 211.8 222.0 66.7 50.8 78.9 122.4 152.4 193.7 93.8 85.2 114.9 90.6 87.7 104.4 64.1 148.0 118.2 108.9 65.2 85.6 142.6 83.2 96.9 110.2 100.9 66.6 147.4 170.8 283.6 78.8 207.4 233.9 78.3 277.5 119.0 165.2 98.5 110.0 136.2 119.4 165.2 97.3 83.0 135.2 63.1 93.7 120.4 69.5 67.2 54.8 28.7 184.7 227.9 78.3 288.7 103.5 38.7 111.1 129.7 157.1 148.0 120.5 110.4 127.9 161.1 55.2 17.4 54.3 7.8 95.6 50.7 147.0 159.2 168.0 123.1 73.4 139.3 211.8 174.2 5.7 70.9 40.7 101.3 90.8 222.0 66.4 53.2 49.6 66.9 56.1 44.6 67.8 42.0 44.5 52.5 RPTOR "KIAA1303, KOG1, Mip1, raptor" ENSG00000141564 "Regulatory associated protein of MTOR complex 1" Q8N122 17 80544819-80966371 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013514, HPA064306" Approved Enhanced Vesicles,Lysosomes "Vesicles, Lysosomes" "CAB013514: AB_2533523, HPA064306: " "unprognostic (5.09e-3)" "unprognostic (1.01e-1)" "unprognostic (1.79e-1)" "unprognostic (1.90e-1)" "unprognostic (1.38e-1)" "unprognostic (9.75e-2)" "unprognostic (3.34e-3)" "unprognostic (1.17e-2)" "unprognostic (9.63e-2)" "unprognostic (8.80e-2)" "unprognostic (4.40e-3)" "unprognostic (8.46e-2)" "unprognostic (6.03e-2)" "unprognostic (1.19e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-2)" "unprognostic (1.77e-2)" 13.6 12.3 10.5 11.1 14.5 10.2 9.3 17.5 21.0 12.6 13.1 19.0 9.6 12.2 15.0 9.3 14.2 12.5 8.0 15.5 10.8 10.5 8.3 12.9 11.0 9.0 12.2 9.9 12.8 9.8 14.3 14.1 9.7 12.7 12.0 7.4 15.2 10.4 13.9 23.7 12.3 11.0 13.6 9.5 11.6 11.1 10.3 12.7 16.7 10.2 11.1 11.9 14.3 10.5 2.1 1.9 3.1 2.4 1.7 3.8 1.2 9.6 19.3 4.6 8.2 6.6 5.7 8.6 7.3 6.7 11.6 8.7 15.1 8.6 8.1 5.8 8.9 5.9 7.4 9.8 6.6 2.9 12.0 12.5 10.7 13.6 6.7 11.2 8.9 8.4 6.7 11.9 6.9 11.5 15.5 3.3 6.5 5.3 10.7 4.7 4.9 15.5 5.1 8.4 6.6 3.4 11.0 9.1 9.2 8.9 14.3 8.1 9.3 8.2 5.2 24.5 10.4 7.7 9.3 5.2 1.9 8.0 14.9 5.9 14.9 3.1 0.9 0.0 3.8 2.4 2.5 2.1 1.6 1.8 1.9 1.1 2.3 2.2 0.0 1.7 1.3 1.1 3.6 1.2 10.5 14.5 17.5 21.0 10.8 10.5 12.2 9.9 12.7 12.7 RRAGA "FIP-1, RAGA" ENSG00000155876 "Ras related GTP binding A" Q7L523 9 19049395-19050983 "Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003734 Supported Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA003734: AB_1079851" "unprognostic (6.30e-2)" "unprognostic (4.65e-1)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (7.43e-4)" "unprognostic (6.74e-2)" "unprognostic (2.17e-2)" "unprognostic (2.11e-1)" "unprognostic (2.91e-1)" "unprognostic (2.20e-3)" "unprognostic (3.13e-1)" "unprognostic (2.65e-1)" "unprognostic (1.74e-2)" "unprognostic (4.88e-2)" "unprognostic (2.10e-3)" "unprognostic (1.05e-1)" 39.0 39.0 38.0 21.5 44.9 14.6 33.8 40.1 67.7 36.9 30.4 39.0 39.8 21.8 45.9 46.6 33.7 43.6 28.6 48.3 39.5 46.5 39.0 38.3 27.7 28.4 38.0 41.7 50.2 26.9 38.4 33.3 40.1 43.4 35.7 26.9 25.1 29.5 45.3 57.1 31.6 24.9 47.9 34.3 25.5 27.1 26.1 31.6 27.0 34.3 32.6 26.2 37.3 28.1 20.9 30.9 54.1 38.5 29.5 36.6 35.1 26.0 21.5 17.8 18.5 64.3 41.0 12.3 26.3 31.6 23.0 28.4 8.2 8.1 5.2 14.6 44.2 10.0 15.2 24.8 24.4 22.2 17.1 33.2 30.9 31.6 42.2 4.5 12.6 36.2 24.1 19.6 13.4 27.2 7.4 7.6 47.6 16.5 12.6 27.0 9.9 16.6 9.8 11.6 7.3 34.9 22.9 14.7 18.3 14.4 13.1 13.5 16.8 12.4 21.1 28.0 10.8 19.8 19.5 5.3 8.7 11.7 30.8 7.0 10.1 48.3 32.5 54.1 30.5 35.9 29.7 19.6 31.6 30.1 30.9 20.9 29.4 28.8 22.8 29.5 38.5 22.3 36.6 35.1 38.0 44.9 40.1 67.7 39.5 46.5 38.0 41.7 43.4 31.6 RRAGB ENSG00000083750 "Ras related GTP binding B" Q5VZM2 X 55717739-55758774 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003734 Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA003734: AB_1079851" "unprognostic (2.01e-1)" "unprognostic (2.82e-3)" "prognostic unfavourable (7.60e-4)" "unprognostic (2.44e-2)" "prognostic favourable (3.31e-5)" "unprognostic (2.58e-2)" "unprognostic (2.36e-1)" "prognostic favourable (3.64e-6)" "unprognostic (8.89e-3)" "unprognostic (1.56e-2)" "unprognostic (1.31e-2)" "unprognostic (2.71e-3)" "unprognostic (2.74e-2)" "unprognostic (3.35e-2)" "unprognostic (6.21e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-3)" 11.8 14.8 18.8 8.6 25.8 7.1 14.7 21.2 22.2 14.7 11.4 11.5 11.7 7.1 18.7 36.3 9.2 20.6 12.9 14.5 19.0 24.5 16.0 7.9 10.8 7.5 19.6 20.7 22.8 8.4 21.4 23.7 11.1 17.6 16.6 9.7 12.9 8.9 18.8 13.6 12.0 8.7 17.1 15.8 10.7 9.9 8.9 17.4 7.3 22.6 8.3 8.4 12.3 14.9 12.2 9.1 8.7 8.3 7.7 10.4 5.1 5.9 4.5 5.2 3.9 17.6 17.1 1.3 5.1 9.7 4.5 6.1 2.3 3.9 1.7 37.5 7.0 3.8 4.7 2.8 4.4 2.9 6.2 2.6 5.6 5.3 13.0 4.1 4.1 20.0 11.4 3.4 4.2 6.1 3.5 4.2 7.8 4.2 2.2 5.4 5.3 7.1 8.3 5.7 4.9 7.3 7.5 5.2 4.5 7.1 2.3 7.7 6.6 4.2 3.4 5.5 2.7 5.4 2.7 5.8 7.8 3.3 4.4 8.7 2.5 8.7 6.1 5.2 6.9 8.3 10.0 8.9 8.7 9.4 9.1 12.2 10.4 10.0 1.8 7.7 4.7 5.8 9.6 5.1 18.8 25.8 21.2 22.0 19.0 24.5 19.6 20.7 17.6 17.4 RRAGC "FLJ13311, GTR2" ENSG00000116954 "Ras related GTP binding C" Q9HB90 1 38838198-38859823 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018247, HPA055489" Supported Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA018247: AB_1856475, HPA055489: " "unprognostic (2.04e-2)" "unprognostic (1.58e-1)" "unprognostic (2.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.40e-1)" "unprognostic (1.42e-1)" "prognostic unfavourable (9.97e-9)" "unprognostic (2.14e-1)" "unprognostic (3.61e-2)" "unprognostic (4.98e-2)" "unprognostic (2.23e-2)" "unprognostic (1.71e-1)" "unprognostic (5.13e-2)" "unprognostic (6.38e-2)" "unprognostic (2.69e-1)" "unprognostic (2.77e-1)" "unprognostic (3.82e-2)" 27.8 14.0 18.6 11.9 24.1 20.1 36.5 15.9 22.3 13.4 19.4 13.3 11.0 14.1 14.9 11.1 20.7 11.8 13.6 19.0 16.7 13.8 18.8 13.9 15.0 14.2 18.9 14.1 17.6 12.9 13.9 8.9 27.6 21.4 12.6 13.3 11.9 12.7 13.8 15.5 24.6 13.0 17.0 15.6 12.8 12.9 12.7 15.9 11.2 12.9 8.2 16.0 16.0 14.9 4.9 11.3 7.7 3.3 2.0 4.0 2.0 12.0 5.5 7.2 7.9 38.6 26.2 11.2 11.2 23.0 15.3 16.3 4.2 8.0 7.5 6.5 17.4 7.3 13.4 7.4 12.7 12.2 9.5 7.2 6.7 4.7 47.4 8.4 8.2 23.2 18.8 16.3 21.3 15.9 7.3 15.2 22.1 3.3 6.0 4.8 9.2 9.4 5.9 12.8 5.0 10.8 14.1 3.8 5.6 9.0 6.7 23.4 6.2 6.4 14.1 18.7 7.7 20.4 9.5 12.0 19.2 8.9 17.4 9.5 9.6 0.5 3.3 6.7 2.5 3.0 4.0 4.6 3.7 3.0 3.1 4.9 3.3 3.1 7.7 2.0 2.3 11.3 3.3 2.0 18.6 24.1 15.9 22.3 16.7 13.8 18.9 14.1 21.4 15.9 RRAS R-Ras ENSG00000126458 "RAS related" P10301 19 49635292-49640201 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 13.8;non-classical monocyte: 15.9" "Lineage enriched" "Detected in many" 6 "monocytes: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010160, HPA060364, CAB069439" Uncertain Approved Vesicles 23000 Vesicles "CAB010160: AB_2180086, CAB069439: AB_1622637, HPA060364: " "unprognostic (9.23e-2)" "unprognostic (6.37e-2)" "unprognostic (1.50e-1)" "unprognostic (9.86e-2)" "prognostic unfavourable (1.02e-4)" "unprognostic (8.54e-2)" "unprognostic (4.55e-3)" "prognostic unfavourable (5.28e-4)" "unprognostic (2.16e-2)" "unprognostic (7.58e-2)" "unprognostic (1.39e-3)" "unprognostic (2.30e-2)" "prognostic unfavourable (1.54e-9)" "unprognostic (6.13e-2)" "unprognostic (3.42e-2)" "unprognostic (7.14e-3)" "unprognostic (2.74e-2)" 40.9 14.9 6.3 16.0 7.0 1.7 35.2 2.9 7.3 45.2 48.8 7.0 50.6 14.5 55.3 27.0 53.2 35.2 44.9 56.5 6.2 4.8 24.5 13.7 37.8 12.6 7.0 8.0 28.0 9.0 1.7 6.9 39.2 8.5 62.7 8.8 24.9 19.9 62.1 19.2 11.1 29.4 72.5 6.2 25.1 28.7 23.3 5.8 3.4 26.8 19.1 13.8 79.6 39.4 1.1 2.5 0.1 15.9 0.3 1.2 1.4 16.0 19.9 2.5 5.1 44.6 49.8 0.7 21.3 30.2 10.4 13.6 2.7 27.2 1.0 11.1 31.2 10.8 1.5 21.8 4.3 6.5 1.1 1.9 6.6 1.6 41.5 0.1 4.2 35.0 19.4 13.1 10.5 26.4 1.2 8.0 18.4 6.3 0.0 1.8 0.5 16.2 1.5 6.2 2.9 22.4 3.2 0.0 2.3 8.3 7.5 1.3 10.7 1.5 37.5 30.6 12.3 5.3 6.1 5.9 2.4 0.2 31.8 1.2 9.6 0.0 3.8 0.1 0.4 13.8 0.4 1.1 1.1 0.4 2.5 0.3 1.2 0.3 0.0 0.3 15.9 0.7 0.4 1.4 6.3 7.0 2.9 7.3 6.2 4.8 7.0 8.0 8.5 5.8 RRP12 KIAA0690 ENSG00000052749 "Ribosomal RNA processing 12 homolog" Q5JTH9 10 97356358-97426076 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 62.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049945, HPA074403" Supported "Nucleoli,Vesicles,Plasma membrane,Cytosol" Nucleoli "Vesicles, Plasma membrane, Cytosol" "HPA049945: , HPA074403: " "unprognostic (2.79e-1)" "unprognostic (7.65e-2)" "unprognostic (5.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.42e-1)" "unprognostic (1.73e-1)" "prognostic unfavourable (3.12e-8)" "unprognostic (2.64e-1)" "unprognostic (1.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.94e-2)" "unprognostic (1.82e-1)" "prognostic unfavourable (2.54e-5)" "unprognostic (2.58e-2)" "unprognostic (3.32e-1)" "unprognostic (4.81e-2)" "unprognostic (6.99e-3)" 7.1 8.4 5.9 7.4 11.9 62.6 4.6 3.8 15.7 4.1 4.0 5.4 2.9 5.2 6.4 3.9 7.1 6.4 6.4 8.4 4.4 7.2 4.4 9.3 5.6 6.0 5.9 6.1 6.0 16.4 9.6 10.6 3.9 9.6 5.5 3.6 4.1 6.6 3.9 31.7 8.2 3.8 5.3 3.2 7.1 5.3 13.9 6.1 4.6 4.9 7.2 5.4 4.2 4.3 3.4 4.3 19.3 11.1 1.2 2.4 3.7 15.8 21.1 5.6 12.1 4.3 5.1 12.4 10.0 6.0 10.4 8.1 22.9 14.7 17.4 13.0 6.3 20.4 15.4 11.6 7.0 9.4 18.5 13.4 7.9 17.8 7.2 20.9 17.7 5.3 16.4 25.6 23.7 5.8 19.2 11.7 5.9 20.5 14.1 13.5 24.2 14.3 15.6 7.7 17.2 7.2 8.8 7.6 16.2 8.0 7.7 10.0 18.6 10.9 7.6 7.0 12.0 15.6 31.5 23.9 20.8 20.5 10.0 26.9 7.4 0.2 7.3 4.6 2.0 9.3 2.4 2.9 1.2 1.6 4.3 3.4 1.9 2.1 19.3 1.2 11.1 3.6 0.8 3.7 5.9 11.9 3.8 15.7 4.4 7.2 5.9 6.1 9.6 6.1 RSBN1 "FLJ11220, ROSBIN" ENSG00000081019 "Round spermatid basic protein 1" Q5VWQ0 1 113761832-113812476 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042124, HPA049484" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA042124: AB_10794644, HPA049484: " "unprognostic (3.26e-2)" "unprognostic (1.32e-1)" "unprognostic (1.15e-3)" "unprognostic (2.13e-1)" "unprognostic (3.66e-2)" "unprognostic (2.30e-2)" "unprognostic (5.06e-2)" "unprognostic (6.60e-2)" "unprognostic (1.06e-1)" "unprognostic (1.97e-2)" "unprognostic (1.56e-1)" "unprognostic (3.96e-1)" "unprognostic (1.51e-2)" "unprognostic (4.67e-2)" "unprognostic (1.43e-1)" "unprognostic (1.24e-1)" "unprognostic (1.15e-3)" 10.4 8.4 8.6 9.4 14.6 35.8 10.3 23.9 12.0 17.0 14.4 6.9 8.1 7.7 13.4 8.6 9.7 10.9 8.4 8.1 8.9 9.1 10.4 7.9 11.5 11.8 8.1 7.3 18.3 13.3 17.6 15.1 8.2 8.4 11.5 10.9 9.6 10.1 10.7 17.1 10.7 10.9 11.5 7.2 12.8 8.8 12.4 10.0 22.6 11.8 5.7 12.7 16.6 10.7 20.7 16.4 25.7 9.2 14.3 20.8 7.3 11.8 3.4 11.7 6.9 7.0 8.1 5.6 4.2 9.1 8.6 9.1 4.0 3.6 10.4 6.8 5.2 5.2 8.3 5.2 14.2 10.1 6.0 7.9 3.7 4.5 5.3 14.7 8.5 6.1 5.7 7.4 7.0 6.8 11.8 6.6 6.3 12.2 11.8 8.8 9.9 5.9 21.5 11.4 5.4 5.2 5.1 11.9 9.4 8.1 8.0 7.2 3.8 10.0 8.1 7.8 8.5 11.5 6.8 8.8 6.5 13.2 8.0 9.0 13.0 25.7 9.2 14.6 18.6 6.9 18.8 18.3 20.1 17.1 7.6 20.7 20.8 16.9 17.9 14.3 7.5 16.4 17.4 7.3 8.6 14.6 23.9 12.0 8.9 9.1 8.1 7.3 8.4 10.0 RSPH3 "dJ111C20.1, RSHL2, RSP3" ENSG00000130363 "Radial spoke head 3 homolog" Q86UC2 6 158972871-159000187 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039109, HPA040230" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane, Cytosol" "HPA039109: AB_10794423, HPA040230: AB_10796119" "unprognostic (6.18e-3)" "unprognostic (3.62e-3)" "unprognostic (4.54e-2)" "unprognostic (6.20e-2)" "unprognostic (1.88e-1)" "unprognostic (9.18e-2)" "unprognostic (1.14e-2)" "unprognostic (1.65e-1)" "unprognostic (1.15e-1)" "unprognostic (6.74e-3)" "unprognostic (6.98e-2)" "unprognostic (2.52e-1)" "prognostic favourable (2.19e-4)" "unprognostic (5.89e-2)" "unprognostic (1.67e-1)" "unprognostic (5.14e-2)" "unprognostic (1.79e-2)" 4.9 9.0 7.1 3.8 9.8 3.1 6.2 6.3 12.7 6.8 8.2 7.0 14.3 11.3 7.4 12.8 15.5 10.7 6.0 6.6 8.0 6.8 10.7 5.4 8.5 2.6 4.8 10.6 7.3 8.6 25.9 14.4 5.5 10.4 8.9 6.5 5.5 10.3 14.9 3.8 7.6 12.2 6.6 6.0 3.9 7.5 24.3 7.0 2.1 12.8 5.1 3.9 9.1 8.4 2.3 5.8 13.0 7.7 1.8 1.8 1.6 9.9 5.1 2.3 5.4 5.4 6.9 2.9 7.1 8.2 2.8 3.7 2.0 6.0 2.1 6.5 7.5 7.6 1.5 6.6 3.2 4.8 4.4 2.7 5.0 3.4 5.2 2.5 1.9 8.5 11.8 4.6 8.9 2.7 3.1 3.4 4.6 5.6 1.5 3.1 1.5 3.4 2.4 0.4 2.1 8.8 3.2 3.5 4.4 13.2 4.4 2.5 5.4 6.2 6.4 2.9 7.4 5.6 3.8 3.6 6.9 1.8 12.5 3.3 4.6 0.7 5.2 0.6 0.8 3.6 1.8 1.3 1.2 1.6 5.4 2.3 1.0 1.4 13.0 1.8 7.7 5.8 1.4 1.6 7.1 9.8 6.3 12.7 8.0 6.8 4.8 10.6 10.4 7.0 RSU1 "FLJ31034, RSP-1" ENSG00000148484 "Ras suppressor protein 1" Q15404 10 16590611-16817528 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025927 Uncertain Approved Vesicles 210000000 Vesicles "HPA025927: AB_10610420" "unprognostic (7.33e-2)" "unprognostic (1.42e-1)" "unprognostic (2.08e-1)" "unprognostic (4.89e-1)" "unprognostic (9.56e-3)" "unprognostic (2.91e-2)" "unprognostic (1.25e-3)" "unprognostic (1.99e-1)" "unprognostic (3.83e-2)" "unprognostic (3.72e-2)" "unprognostic (3.30e-2)" "unprognostic (7.79e-2)" "prognostic unfavourable (9.32e-5)" "unprognostic (1.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.48e-1)" "unprognostic (4.53e-2)" 34.3 11.9 11.3 18.5 11.0 18.1 27.3 11.2 9.9 24.6 26.9 13.0 11.7 8.9 33.5 15.9 29.3 21.3 17.3 19.5 11.3 12.4 29.4 19.5 20.4 16.0 13.7 7.4 27.2 36.9 9.2 6.4 48.1 10.2 22.5 18.3 13.0 15.1 21.7 12.7 15.1 15.9 37.2 13.7 30.3 18.3 9.7 11.8 19.6 17.1 16.0 20.3 31.9 20.8 12.2 23.7 17.4 17.7 20.4 23.6 29.8 9.3 6.5 5.3 31.6 28.8 29.8 6.6 23.4 10.1 16.5 17.8 6.0 8.7 9.4 3.8 31.6 8.3 6.4 12.3 17.7 13.9 5.3 29.5 4.2 5.7 12.7 4.5 17.1 14.7 13.0 15.5 4.9 16.8 4.7 6.5 22.0 6.0 10.2 8.0 5.6 3.7 6.8 7.2 6.3 15.5 3.5 2.1 4.2 11.6 7.7 11.5 2.7 11.8 20.7 13.9 4.9 17.4 11.9 5.7 6.9 8.1 18.4 12.8 6.0 17.4 14.7 15.0 18.2 17.7 20.3 11.6 20.8 19.4 23.7 12.2 15.5 19.3 10.4 20.4 16.4 17.7 23.6 29.8 11.3 11.0 11.2 9.4 11.3 12.4 13.7 7.4 10.2 11.8 RTCB "C22orf28, FAAP, HSPC117" ENSG00000100220 "RNA 2',3'-cyclic phosphate and 5'-OH ligase" Q9Y3I0 22 32387582-32412255 "Enzymes, Predicted intracellular proteins" "tRNA processing" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000535, HPA001103" Supported Supported Nucleoplasm,Vesicles,Cytosol 43000 Nucleoplasm "Vesicles, Cytosol" "HPA000535: , HPA001103: AB_1078351" "unprognostic (1.84e-1)" "unprognostic (6.48e-2)" "unprognostic (1.07e-2)" "unprognostic (2.71e-3)" "unprognostic (7.21e-3)" "unprognostic (1.43e-2)" "unprognostic (1.75e-3)" "unprognostic (1.49e-1)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (2.40e-2)" "unprognostic (5.07e-2)" "prognostic favourable (4.25e-5)" "unprognostic (6.91e-2)" "unprognostic (5.35e-2)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" 26.4 30.1 20.1 20.4 29.7 15.1 29.2 22.9 34.5 25.7 35.6 35.2 32.7 51.6 29.7 25.8 30.8 26.9 22.9 26.4 19.6 24.6 42.4 55.1 23.1 22.7 29.1 26.2 29.0 29.4 38.4 29.9 33.7 36.7 27.0 42.3 27.1 29.9 28.6 40.9 46.6 61.7 31.8 24.4 29.3 29.7 30.8 25.5 32.0 32.7 30.1 46.6 26.5 24.2 44.6 51.5 29.0 47.7 37.0 40.5 44.0 31.7 28.6 35.9 26.9 31.4 23.5 28.6 27.9 33.7 44.7 42.5 37.1 13.0 7.9 18.7 32.5 21.7 41.0 40.5 57.9 39.8 41.2 22.5 24.3 33.7 21.6 52.5 20.6 23.0 26.9 44.1 43.0 40.1 26.6 22.5 32.5 26.5 22.3 18.2 20.5 26.2 34.7 38.8 40.6 30.7 27.7 37.1 20.5 30.2 19.6 35.4 21.5 20.5 30.1 24.7 36.4 21.4 26.7 15.7 12.5 28.5 25.5 23.8 32.1 29.0 43.5 27.4 31.7 47.7 35.5 44.6 33.3 33.0 51.5 43.6 39.9 34.6 4.3 37.0 35.5 28.9 40.5 44.0 20.1 29.7 22.9 34.5 19.6 24.6 29.1 26.2 36.7 25.5 RUBCN "KIAA0226, rubicon, rundataxin" ENSG00000145016 "RUN and cysteine rich domain containing beclin 1 interacting protein" Q92622 3 197671393-197749727 "Disease related genes, Predicted intracellular proteins" "Autophagy, Endocytosis, Immunity, Phagocytosis" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050908, HPA054497" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA050908: , HPA054497: " "unprognostic (2.91e-2)" "unprognostic (1.61e-2)" "prognostic unfavourable (6.65e-4)" "unprognostic (1.34e-3)" "unprognostic (1.46e-1)" "unprognostic (1.20e-2)" "prognostic unfavourable (9.91e-5)" "unprognostic (1.99e-1)" "unprognostic (6.71e-2)" "unprognostic (2.86e-2)" "unprognostic (1.71e-1)" "prognostic unfavourable (1.62e-4)" "unprognostic (2.22e-2)" "unprognostic (2.92e-2)" "unprognostic (1.75e-1)" "unprognostic (2.43e-1)" "unprognostic (1.23e-1)" 10.7 8.4 19.3 15.5 24.0 10.7 6.8 30.0 24.6 7.9 9.8 12.4 6.4 10.7 9.1 6.5 14.5 7.7 10.4 10.3 18.1 18.8 7.8 5.7 12.4 19.8 14.6 19.4 14.0 11.0 13.3 16.6 8.5 18.3 7.4 8.8 8.3 7.1 11.2 9.7 11.7 12.0 11.4 15.1 22.3 11.3 22.0 15.8 7.9 7.4 7.0 22.3 9.6 8.0 7.8 14.7 12.8 4.1 1.5 4.4 1.2 14.8 3.5 4.2 8.5 7.4 4.2 4.3 6.9 4.5 8.2 7.0 6.2 4.1 17.1 13.5 7.4 8.1 7.8 3.8 6.7 4.4 6.9 10.4 6.0 2.3 4.3 5.9 8.7 3.5 4.9 7.2 8.6 5.1 5.7 42.7 5.5 12.0 7.0 3.7 3.6 11.5 7.0 4.3 10.6 4.8 6.5 17.0 4.1 5.0 9.8 5.5 14.5 3.9 6.8 5.0 4.8 13.6 9.1 20.2 16.2 13.0 6.6 10.9 4.3 0.6 2.4 12.8 3.6 3.5 2.3 6.6 3.0 4.4 1.4 7.8 2.2 3.0 2.7 1.5 4.1 14.7 3.6 1.2 19.3 24.0 30.0 24.6 18.1 18.8 14.6 19.4 18.3 15.8 RUFY1 "FLJ22251, RABIP4, ZFYVE12" ENSG00000176783 "RUN and FYVE domain containing 1" Q96T51 5 179550558-179610026 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038804 Approved Supported "Nuclear speckles,Vesicles,Cytosol" 9600 "Vesicles, Cytosol" "Nuclear speckles" "HPA038804: AB_10673290" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.50e-1)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (9.74e-2)" "unprognostic (1.31e-1)" "unprognostic (2.73e-2)" "unprognostic (3.60e-1)" "unprognostic (2.08e-1)" "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" 20.9 27.9 19.7 24.7 22.4 21.1 36.9 22.4 18.9 18.2 20.2 16.9 27.9 16.9 22.5 16.9 25.9 18.8 20.7 14.8 19.7 14.8 23.9 17.5 20.8 23.1 18.8 17.1 19.4 19.8 22.6 21.5 17.3 19.7 20.9 15.5 16.4 21.2 18.3 26.7 24.2 18.8 17.5 14.7 27.9 18.6 12.2 20.5 20.1 27.3 14.1 20.1 20.7 34.3 3.2 3.4 7.9 4.5 1.2 2.9 21.5 7.1 11.8 6.3 8.3 12.2 10.1 7.2 12.7 9.1 7.5 8.8 11.4 16.7 11.6 7.2 15.4 6.6 11.5 16.6 8.9 36.6 8.7 20.2 9.0 8.2 12.5 11.2 11.1 10.2 9.2 5.1 14.6 8.2 8.2 11.1 6.7 21.6 11.9 7.8 6.7 5.5 10.7 4.5 10.7 12.6 11.7 6.3 9.0 18.6 12.0 6.6 9.6 13.8 9.8 10.0 3.3 5.3 9.9 6.9 10.6 20.8 9.2 20.3 9.1 7.4 3.4 7.9 1.7 3.6 1.0 2.7 2.0 1.7 3.0 3.2 1.4 1.8 5.9 1.2 4.5 3.4 2.9 21.5 19.7 22.4 22.4 18.9 19.7 14.8 18.8 17.1 19.7 20.5 RUNDC3A "RAP2IP, RPIP8" ENSG00000108309 "RUN domain containing 3A" Q59EK9 17 44308413-44318671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 92.6" "Group enriched" "Detected in some" 6 "SCLC-21H: 34.1;SH-SY5Y: 21.8" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 4 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023548, HPA070733" Enhanced Supported Approved Vesicles Vesicles "HPA023548: AB_1856069, HPA070733: AB_2732162" "unprognostic (3.66e-2)" "unprognostic (3.77e-2)" "unprognostic (3.50e-3)" "unprognostic (1.58e-3)" "unprognostic (3.04e-1)" "unprognostic (2.02e-1)" "unprognostic (3.87e-3)" "unprognostic (2.29e-1)" "unprognostic (4.63e-2)" "unprognostic (3.43e-2)" "unprognostic (1.42e-3)" "unprognostic (1.34e-1)" "unprognostic (8.87e-3)" "unprognostic (1.07e-2)" "unprognostic (5.17e-2)" "unprognostic (9.39e-2)" "unprognostic (1.84e-1)" 1.4 12.9 40.5 1.6 28.5 2.8 1.5 33.0 92.6 1.3 1.8 4.8 0.0 2.2 1.6 1.5 1.5 1.5 1.6 1.8 40.9 20.6 1.7 1.3 1.5 1.4 22.0 23.2 1.7 4.3 2.4 16.1 2.5 15.6 1.5 1.8 1.6 1.4 1.6 1.3 4.1 2.2 1.8 8.0 1.5 3.3 5.2 4.4 0.0 2.4 0.0 1.4 1.5 0.0 0.3 0.1 0.0 0.2 0.1 1.3 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.2 0.2 0.0 0.0 0.5 0.1 0.0 34.1 21.8 0.2 0.0 0.2 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.3 1.3 0.3 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 40.5 28.5 33.0 49.2 40.9 20.6 22.0 23.2 15.6 4.4 RUNX1 "AML1, AMLCR1, CBFA2, PEBP2A2" ENSG00000159216 "Runt related transcription factor 1" Q01196 21 34787801-36004667 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 54.3;lymphoid tissue: 58.6" "Cell line enhanced" "Detected in many" "HEL: 65.0;HMC-1: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA004176, HPA037912" Enhanced Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA004176: AB_1078412, HPA037912: " "unprognostic (4.06e-3)" "unprognostic (2.35e-2)" "unprognostic (1.42e-2)" "unprognostic (1.52e-1)" "unprognostic (5.15e-3)" "unprognostic (2.62e-1)" "unprognostic (5.87e-2)" "unprognostic (1.15e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-3)" "unprognostic (2.33e-2)" "unprognostic (3.47e-2)" "prognostic unfavourable (3.44e-15)" "unprognostic (1.48e-1)" "unprognostic (1.50e-1)" "unprognostic (6.17e-2)" "unprognostic (5.47e-2)" 11.5 3.2 5.2 14.8 7.3 29.8 54.3 1.0 4.3 12.5 4.7 3.8 4.0 3.8 2.9 7.4 6.5 4.6 12.4 7.6 6.1 2.0 4.2 6.7 17.9 13.9 8.5 1.1 6.5 5.8 1.6 5.5 6.4 6.0 9.9 5.1 3.5 29.8 8.8 14.4 8.3 5.1 6.8 12.3 10.6 12.7 2.9 6.6 58.6 4.6 5.7 14.2 11.0 9.1 3.2 3.4 17.0 3.9 1.3 4.8 2.0 13.0 1.0 0.0 0.1 3.4 4.4 8.6 7.4 7.5 4.1 3.1 0.6 10.0 6.4 0.5 6.5 11.8 0.8 8.8 6.0 9.9 1.0 65.0 2.6 3.0 6.3 7.5 39.2 8.5 5.3 12.5 12.4 2.3 4.4 3.8 8.7 2.8 30.3 11.9 0.6 3.8 30.7 22.8 3.9 5.5 5.2 0.3 0.0 7.6 1.9 2.7 3.9 17.6 9.7 6.8 8.8 10.1 11.1 12.5 5.1 6.1 8.5 16.5 9.9 17.0 3.2 6.3 3.4 1.4 3.3 3.2 3.1 3.2 0.9 3.1 4.8 3.8 3.5 1.3 3.9 3.4 4.0 2.0 5.2 7.3 1.0 4.3 6.1 2.0 8.5 1.1 6.0 6.6 RUNX3 "AML2, CBFA3, PEBP2A3" ENSG00000020633 "Runt related transcription factor 3" Q13761 1 24899511-24965121 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.5;lymphoid tissue: 47.6" "Cell line enhanced" "Detected in some" "HDLM-2: 38.7;Karpas-707: 52.1;SK-MEL-30: 28.9;U-266/70: 18.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004195, CAB025416, HPA059006" Enhanced Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "CAB025416: , HPA004195: , HPA059006: " "unprognostic (7.75e-3)" "unprognostic (6.51e-3)" "prognostic unfavourable (8.71e-4)" "unprognostic (1.42e-1)" "unprognostic (7.60e-2)" "unprognostic (1.81e-2)" "unprognostic (6.51e-2)" "unprognostic (6.95e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (4.71e-1)" "prognostic unfavourable (5.59e-5)" "unprognostic (1.10e-1)" "unprognostic (4.42e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" 3.0 1.1 0.9 25.4 1.1 31.5 3.4 0.5 1.0 11.9 8.0 1.2 0.3 2.5 1.7 1.4 3.5 1.7 6.2 1.3 0.9 1.1 2.2 2.3 11.7 28.8 2.8 0.7 1.3 1.0 0.0 1.0 1.3 1.8 2.3 2.3 2.8 6.5 2.2 2.2 9.5 13.7 1.3 1.8 30.6 2.7 2.1 0.8 14.2 1.8 3.1 47.6 8.9 2.2 4.5 1.0 4.3 4.6 18.1 15.1 3.1 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 6.2 6.1 5.3 0.1 3.6 0.0 0.2 38.7 0.6 0.1 0.6 0.0 0.0 1.4 13.4 0.0 0.0 0.0 0.3 0.0 0.0 52.1 0.0 0.0 0.4 12.0 0.2 1.0 0.0 0.0 7.3 0.0 0.1 1.2 0.0 2.4 0.0 28.9 0.0 8.3 0.0 0.0 0.5 0.0 0.1 18.1 12.5 5.9 0.0 13.5 1.4 0.4 0.7 4.3 15.1 3.0 8.1 4.5 5.7 13.2 0.9 3.8 2.8 10.3 0.9 18.1 4.6 1.0 5.7 3.1 0.9 1.1 0.5 1.0 0.9 1.1 2.8 0.7 1.8 0.8 RWDD2A "dJ747H23.2, MGC13523, RWDD2" ENSG00000013392 "RWD domain containing 2A" Q9UIY3 6 83193379-83198932 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030105, HPA030106, HPA030107" Uncertain Approved Vesicles Vesicles "HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009" "unprognostic (2.51e-3)" "unprognostic (1.25e-1)" "unprognostic (2.48e-2)" "unprognostic (1.33e-1)" "unprognostic (1.19e-3)" "unprognostic (3.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "prognostic favourable (3.82e-5)" "prognostic favourable (1.38e-4)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (1.91e-2)" "unprognostic (2.57e-2)" "unprognostic (1.85e-3)" "unprognostic (2.59e-2)" 5.0 10.1 8.5 3.4 10.4 1.0 5.4 11.8 14.6 5.6 4.0 5.9 11.6 4.2 5.7 15.9 3.1 6.5 7.6 7.2 9.4 11.0 7.5 8.1 4.8 3.9 6.5 11.7 7.0 13.4 7.4 9.8 4.2 11.6 19.2 4.3 3.7 16.4 11.3 4.1 3.4 4.0 5.5 4.8 4.1 5.3 14.5 3.9 1.7 10.4 3.1 4.4 5.2 2.8 3.7 6.8 0.7 3.9 0.8 4.6 2.1 2.3 2.1 4.9 9.2 6.0 4.3 3.4 5.2 11.1 3.9 4.8 3.0 1.2 1.7 4.3 6.3 2.3 4.1 3.1 6.1 2.1 4.2 2.1 3.1 6.7 9.2 0.6 1.6 5.6 5.2 5.0 10.5 7.2 3.3 3.1 4.7 3.3 0.7 1.6 1.6 2.1 2.6 10.1 1.1 8.2 2.6 1.7 6.0 3.1 5.1 4.7 3.1 3.1 7.7 2.8 1.8 3.9 2.3 6.9 2.8 1.0 3.2 0.8 3.2 0.5 1.8 0.0 2.4 1.6 3.9 3.7 3.6 3.6 2.0 2.2 4.6 4.5 0.7 0.8 3.9 6.8 4.0 2.1 8.5 10.4 11.8 14.6 9.4 11.0 6.5 11.7 11.6 3.9 RYR1 "CCO, MHS, MHS1, PPP1R137, RYR" ENSG00000196218 "Ryanodine receptor 1" P21817 19 38433699-38587564 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 231.0" "Cell line enhanced" "Detected in some" "HaCaT: 13.7;RH-30: 11.3;SiHa: 22.3;U-2 OS: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 7 "dendritic cells: 5.3;monocytes: 6.3" "Low region specificity" "Detected in some" HPA056416 Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles" Cytosol "HPA056416: " "unprognostic (2.22e-3)" "unprognostic (1.91e-3)" "unprognostic (9.59e-2)" "unprognostic (5.34e-4)" "unprognostic (2.50e-1)" "unprognostic (6.00e-2)" "unprognostic (2.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (3.20e-3)" "unprognostic (3.52e-1)" "unprognostic (2.35e-1)" "unprognostic (1.07e-5)" "unprognostic (1.13e-2)" "unprognostic (8.10e-2)" "unprognostic (6.62e-3)" "unprognostic (1.34e-1)" 5.3 0.7 3.0 0.6 1.9 0.4 0.6 2.7 1.7 0.6 0.4 2.7 0.0 0.4 0.4 6.7 3.0 0.6 0.5 0.4 1.8 4.0 0.5 0.4 0.7 0.6 1.5 1.3 0.4 0.4 0.3 0.3 0.6 1.9 0.9 0.4 0.4 2.2 0.6 231.0 2.4 0.5 0.4 1.1 0.6 0.5 1.6 1.9 0.0 1.6 55.1 3.2 0.6 0.5 0.7 5.3 0.1 6.3 0.0 0.6 0.6 0.0 5.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.0 0.3 0.3 4.7 0.0 13.7 0.2 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.4 1.3 5.6 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 11.3 1.0 0.6 0.0 0.0 1.1 22.3 0.0 0.0 0.5 4.2 0.0 0.0 9.4 0.2 0.0 0.3 0.9 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.4 3.2 0.5 0.4 0.3 0.6 5.3 0.7 0.0 0.0 0.1 0.0 6.3 0.0 0.6 0.6 3.0 1.9 2.7 1.7 1.8 4.0 1.5 1.3 1.9 1.9 RYR3 ENSG00000198838 "Ryanodine receptor 3" Q15413 15 33310945-33866121 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 28.8;skeletal muscle: 26.8" "Cell line enhanced" "Detected in some" "A549: 7.0;RH-30: 10.6;RPTEC TERT1: 5.0" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 31 "basophil: 4.0" "Lineage enriched" "Detected in single" 31 "granulocytes: 4.0" "Low region specificity" "Detected in many" HPA062004 Approved Vesicles Vesicles "HPA062004: " "unprognostic (5.85e-2)" "unprognostic (1.57e-1)" "unprognostic (5.30e-2)" "unprognostic (1.35e-1)" "unprognostic (1.26e-2)" "unprognostic (8.03e-4)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (7.85e-2)" "unprognostic (7.10e-2)" "unprognostic (8.25e-3)" "unprognostic (2.36e-1)" "unprognostic (2.48e-2)" "unprognostic (1.86e-2)" "unprognostic (1.15e-1)" "unprognostic (3.16e-2)" "unprognostic (1.91e-1)" 1.8 2.0 9.9 1.1 15.4 2.5 2.9 4.9 12.4 2.8 4.5 6.0 0.2 1.5 10.2 1.0 2.7 3.9 1.6 1.0 13.3 3.5 1.2 0.9 1.2 0.9 5.6 6.9 1.7 0.8 28.8 1.2 1.0 10.7 1.8 2.9 0.6 1.4 3.9 26.8 1.2 1.3 7.4 5.9 1.4 1.6 1.6 7.9 0.0 1.1 1.5 1.4 2.1 2.6 0.1 0.0 4.0 0.0 0.0 0.1 0.0 0.3 7.0 1.5 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.6 0.1 0.4 0.6 0.0 0.2 0.0 0.0 0.0 0.4 0.2 1.4 0.2 0.0 0.0 1.0 0.7 0.0 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.4 0.2 0.3 1.1 0.1 0.5 10.6 0.2 5.0 0.5 0.1 0.5 0.8 0.0 0.2 0.1 0.3 0.9 0.2 0.1 0.0 0.7 0.3 1.2 0.7 0.5 2.3 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 15.4 4.9 12.4 13.3 3.5 5.6 6.9 10.7 7.9 S100B S100beta ENSG00000160307 "S100 calcium binding protein B" P04271 21 46598962-46605208 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 342.0" "Group enriched" "Detected in some" 7 "SK-MEL-30: 81.0;WM-115: 159.2" "Group enriched" "Detected in all" 58 "glioma: 463.5;melanoma: 495.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 78.0" "Lineage enriched" "Detected in many" 7 "T-cells: 78.0" "Low region specificity" "Detected in all" "CAB000073, HPA015768, CAB078196" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol 120000 "Nucleoplasm, Cytosol" Vesicles "CAB000073: AB_10013383, CAB078196: , HPA015768: AB_1856538" "unprognostic (5.67e-3)" "unprognostic (6.39e-3)" "unprognostic (2.08e-3)" "unprognostic (2.08e-2)" "unprognostic (4.54e-3)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.57e-3)" "unprognostic (6.70e-2)" "unprognostic (4.41e-7)" "unprognostic (3.55e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" 67.7 14.0 60.9 5.6 51.0 2.0 13.2 39.4 151.2 5.2 9.1 101.0 3.0 4.7 1.5 7.6 8.6 2.1 8.3 6.6 74.6 65.4 1.5 1.6 2.9 9.8 152.0 36.5 2.4 3.0 1.1 3.1 1.4 90.3 3.0 8.3 7.4 10.1 15.3 1.3 5.7 7.5 4.3 342.0 5.7 4.3 1.5 46.4 0.0 1.3 1.8 10.8 8.2 1.6 0.1 3.4 0.7 1.9 11.0 78.0 10.6 0.1 0.0 17.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 81.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 1.0 159.2 0.0 0.1 0.0 78.0 1.8 22.4 0.0 0.2 14.5 3.4 0.1 0.6 33.3 0.7 11.0 1.9 0.8 0.0 10.6 60.9 51.0 39.4 37.6 74.6 65.4 152.0 36.5 90.3 46.4 S1PR1 "CD363, D1S3362, edg-1, EDG1" ENSG00000170989 "Sphingosine-1-phosphate receptor 1" P21453 1 101236888-101241518 "Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "Angiogenesis, Chemotaxis" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 88.9" "Cell line enhanced" "Detected in many" "BJ: 19.0;HUVEC TERT2: 53.7;TIME: 29.9;U-251 MG: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010104, HPA075568" Supported Supported Vesicles Vesicles "CAB010104: AB_2238920, HPA075568: " "unprognostic (1.41e-1)" "unprognostic (9.35e-2)" "unprognostic (2.46e-2)" "unprognostic (2.61e-1)" "unprognostic (9.78e-2)" "unprognostic (4.49e-3)" "unprognostic (1.34e-3)" "unprognostic (1.99e-1)" "unprognostic (1.36e-1)" "unprognostic (9.12e-2)" "unprognostic (2.34e-2)" "unprognostic (2.23e-1)" "unprognostic (5.82e-3)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "prognostic unfavourable (8.78e-4)" 72.3 8.4 24.7 16.6 26.2 9.7 46.3 21.6 21.8 13.3 10.5 9.5 2.5 5.7 12.1 5.0 14.7 11.5 17.6 43.5 22.9 15.4 8.9 20.5 35.7 24.5 23.2 14.0 7.9 11.0 13.4 4.7 29.6 21.2 8.9 7.0 9.3 7.5 5.6 21.7 8.2 9.8 19.0 11.0 35.2 8.0 5.8 13.9 4.4 17.0 8.7 15.7 15.2 18.5 27.4 0.2 88.9 0.2 33.4 49.8 30.8 3.5 0.0 3.8 0.0 0.4 9.1 0.0 19.0 3.4 11.5 4.1 0.0 0.1 0.0 4.7 6.6 0.0 0.5 0.2 7.7 1.3 0.3 1.3 0.1 0.0 1.8 0.0 0.8 12.2 0.0 0.0 0.9 53.7 0.0 3.9 3.6 0.0 4.5 0.0 1.0 1.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 29.9 1.9 0.7 0.4 36.8 0.3 0.0 0.2 0.1 0.0 0.1 88.9 0.1 4.9 49.8 0.1 40.2 25.1 45.3 44.1 0.2 27.4 35.7 36.2 1.4 33.4 0.2 0.2 26.8 30.8 24.7 26.2 21.6 16.8 22.9 15.4 23.2 14.0 21.2 13.9 SAFB2 KIAA0138 ENSG00000130254 "Scaffold attachment factor B2" Q14151 19 5586999-5624046 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050894 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA050894: " "unprognostic (7.46e-2)" "unprognostic (3.09e-1)" "unprognostic (7.69e-3)" "prognostic favourable (7.10e-4)" "unprognostic (7.95e-2)" "unprognostic (6.76e-3)" "unprognostic (4.19e-3)" "unprognostic (5.93e-2)" "unprognostic (2.11e-1)" "unprognostic (5.14e-2)" "prognostic favourable (2.53e-4)" "unprognostic (2.23e-2)" "unprognostic (2.82e-3)" "unprognostic (1.17e-2)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "prognostic favourable (2.12e-4)" 25.7 29.6 31.0 29.6 33.7 35.4 17.4 50.8 46.2 27.4 21.6 28.4 23.1 25.8 30.2 27.4 15.7 26.8 19.4 21.0 30.3 24.6 32.2 20.0 18.2 26.8 30.5 26.5 42.8 24.2 31.0 38.4 17.3 28.6 28.4 20.9 21.3 23.6 34.8 38.1 18.9 25.7 24.8 43.4 29.4 20.1 23.4 34.3 23.5 26.9 11.1 25.2 24.1 32.7 11.4 9.3 24.3 9.5 6.4 13.3 5.6 17.8 23.3 17.0 12.5 16.6 10.7 19.8 17.0 9.2 10.6 10.1 29.6 12.9 34.1 15.5 8.5 16.4 20.6 10.6 17.6 23.7 22.1 25.9 23.7 22.9 9.7 21.6 24.5 10.6 11.3 15.6 12.1 10.4 24.8 17.3 12.5 19.9 25.8 20.7 29.0 24.7 32.8 14.7 19.0 12.0 30.5 16.0 14.9 22.5 10.3 13.7 15.3 13.3 16.4 13.2 13.8 16.5 23.1 23.0 20.4 24.8 13.5 18.8 21.5 24.3 9.5 15.8 11.9 8.2 13.3 10.3 10.5 9.2 8.3 11.4 11.7 9.1 18.3 6.4 8.5 9.3 9.5 5.6 31.0 33.7 50.8 46.2 30.3 24.6 30.5 26.5 28.6 34.3 SALL2 "Hsal2, KIAA0360, ZNF795" ENSG00000165821 "Spalt like transcription factor 2" Q9Y467 14 21521081-21537216 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9;parathyroid gland: 36.0" "Cell line enhanced" "Detected in many" "AF22: 46.1;NTERA-2: 34.8;SCLC-21H: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;T-cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004162 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA004162: " "unprognostic (5.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.21e-2)" "prognostic unfavourable (3.97e-4)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (4.58e-3)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "prognostic favourable (1.23e-4)" "unprognostic (7.98e-2)" "unprognostic (2.09e-1)" "unprognostic (5.28e-3)" "unprognostic (2.03e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" 2.6 4.7 11.5 1.6 12.7 0.5 5.3 30.9 21.9 7.5 4.5 10.4 2.9 2.3 10.5 6.0 3.5 11.6 4.0 3.7 11.7 8.9 4.2 1.7 4.8 1.9 7.4 9.3 19.5 3.7 36.0 10.9 1.5 13.5 5.8 2.4 4.3 3.3 10.0 2.1 2.2 3.1 10.5 9.5 2.1 3.2 1.9 11.4 3.7 12.0 0.1 1.9 4.6 4.8 0.3 1.7 0.0 0.0 0.5 3.8 0.6 0.0 0.8 46.1 11.5 0.8 0.7 0.0 1.0 1.4 3.6 3.0 0.8 0.6 0.0 1.0 1.3 0.1 11.2 1.2 4.3 0.7 6.4 0.0 0.4 1.0 1.4 0.0 0.0 3.1 0.3 1.5 0.0 0.9 7.5 0.0 2.9 0.8 7.1 0.0 34.8 0.2 6.7 1.1 0.0 3.3 4.8 15.7 8.8 0.0 0.2 0.1 4.6 0.1 0.0 0.5 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 1.0 0.1 1.5 1.2 0.2 0.3 1.8 3.8 0.0 0.5 0.0 1.7 1.6 0.6 11.5 12.7 30.9 14.3 11.7 8.9 7.4 9.3 13.5 11.4 SAMD11 MGC45873 ENSG00000187634 "Sterile alpha motif domain containing 11" Q96NU1 1 923928-944581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "HEK 293: 37.9;HeLa: 41.9;SCLC-21H: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "NK-cell: 4.7" "Lineage enriched" "Detected in single" 10 "NK-cells: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA030110 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA030110: " "unprognostic (9.96e-2)" "unprognostic (1.75e-1)" "unprognostic (4.11e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-2)" "unprognostic (2.42e-1)" "unprognostic (9.28e-2)" "unprognostic (6.90e-2)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (1.62e-2)" "unprognostic (1.56e-1)" "prognostic unfavourable (3.35e-5)" "unprognostic (3.01e-2)" "unprognostic (1.05e-2)" "unprognostic (3.26e-2)" "unprognostic (1.18e-1)" 2.1 10.0 2.4 5.0 3.0 1.0 1.6 1.6 4.7 4.4 3.0 7.2 2.5 5.1 9.5 7.4 4.2 13.6 4.5 8.5 5.7 4.0 10.0 2.9 2.4 2.1 6.9 2.0 5.9 1.8 0.6 21.9 0.6 5.9 12.4 1.4 16.9 2.4 22.1 1.4 0.3 5.6 6.0 8.8 11.7 5.5 2.7 5.1 0.3 4.6 0.6 0.5 7.2 22.8 0.3 0.0 0.0 0.2 4.7 0.4 0.0 0.1 2.6 0.0 2.4 0.1 0.0 0.8 4.1 0.2 0.2 0.1 0.1 0.8 0.0 8.0 8.5 5.3 2.7 0.0 0.0 0.3 37.9 0.0 41.9 0.1 0.7 0.0 0.3 1.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.8 0.0 0.0 1.6 0.3 0.2 0.5 2.2 0.4 0.0 27.3 8.4 8.6 4.1 0.0 4.8 0.2 0.5 1.4 6.3 0.0 0.9 0.5 0.0 0.1 1.8 0.6 0.0 0.0 0.1 0.0 0.3 0.2 0.4 0.3 0.2 0.2 0.0 0.1 0.1 0.4 0.0 4.7 0.1 0.0 0.0 0.0 2.4 3.0 1.6 4.7 5.7 4.0 6.9 2.0 5.9 5.1 SAMD5 dJ875H10.1 ENSG00000203727 "Sterile alpha motif domain containing 5" Q5TGI4 6 147508927-147737547 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 8.5;Hep G2: 32.6;K-562: 21.9;RH-30: 15.4;WM-115: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067811 Uncertain Supported Vesicles Vesicles "HPA067811: " "unprognostic (4.16e-2)" "unprognostic (4.52e-2)" "unprognostic (9.65e-3)" "unprognostic (1.41e-2)" "unprognostic (1.82e-2)" "unprognostic (5.88e-2)" "prognostic unfavourable (2.23e-4)" "unprognostic (2.31e-1)" "unprognostic (1.54e-1)" "unprognostic (1.61e-2)" "unprognostic (8.55e-3)" "unprognostic (3.09e-2)" "unprognostic (5.40e-3)" "unprognostic (1.72e-1)" "unprognostic (4.51e-2)" "unprognostic (9.82e-3)" "unprognostic (1.50e-1)" 1.6 2.2 1.6 3.4 5.7 0.2 4.9 1.4 4.7 3.9 7.1 0.7 1.9 3.6 10.9 2.2 15.9 1.7 6.6 2.4 2.7 3.4 26.5 12.8 8.0 0.5 1.9 2.2 1.4 2.4 17.3 13.9 14.6 14.1 3.0 10.1 9.8 4.9 3.3 0.8 3.6 5.4 4.0 1.3 1.7 5.5 10.9 2.6 0.0 3.0 6.3 6.5 2.6 3.9 0.7 0.5 1.8 0.4 0.6 0.5 0.1 5.5 0.7 0.7 1.1 0.0 0.0 0.0 1.8 0.7 0.1 0.1 8.5 0.0 0.3 1.9 0.0 0.0 0.1 1.3 0.2 0.0 1.0 0.4 0.7 32.6 0.1 0.0 0.7 0.0 0.0 0.1 0.0 3.6 21.9 0.3 2.5 0.0 0.0 0.0 0.1 1.5 0.0 15.4 3.3 0.0 1.2 0.3 0.0 0.5 0.1 1.4 0.0 0.0 2.5 0.2 0.8 0.2 0.6 0.0 0.5 0.0 0.0 0.0 10.8 1.8 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.1 0.7 0.5 0.4 1.1 0.6 0.4 0.5 0.2 0.1 1.6 5.7 1.4 4.7 2.7 3.4 1.9 2.2 14.1 2.6 SAMD9 "C7orf5, FLJ20073, KIAA2004" ENSG00000205413 "Sterile alpha motif domain containing 9" Q5K651 7 93099513-93118023 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 34.6;lymphoid tissue: 35.4" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021318, HPA021319" Approved Enhanced Vesicles,Cytosol "Vesicles, Cytosol" "HPA021318: AB_2183383, HPA021319: AB_1856554" "unprognostic (3.66e-2)" "unprognostic (5.35e-1)" "unprognostic (8.60e-2)" "prognostic unfavourable (3.14e-4)" "unprognostic (8.96e-2)" "unprognostic (1.38e-1)" "unprognostic (7.48e-2)" "prognostic unfavourable (2.93e-4)" "unprognostic (4.76e-2)" "unprognostic (3.37e-2)" "prognostic unfavourable (8.31e-5)" "unprognostic (6.00e-2)" "prognostic unfavourable (8.40e-7)" "unprognostic (5.91e-2)" "unprognostic (1.37e-2)" "unprognostic (2.18e-2)" "unprognostic (3.64e-1)" 9.6 4.0 2.3 9.2 2.4 5.2 2.6 1.0 1.6 9.3 6.8 0.6 0.9 4.3 2.8 3.0 34.6 2.7 4.3 2.5 1.3 1.5 6.3 3.5 7.8 10.8 2.5 1.1 6.3 2.3 0.1 6.4 11.3 3.1 5.3 7.0 0.7 5.7 1.6 2.4 1.5 12.7 2.2 2.5 21.7 6.3 2.5 1.7 35.4 3.3 9.9 9.5 4.8 9.7 5.5 3.0 15.6 9.8 7.4 7.6 2.6 12.2 1.6 0.4 0.1 5.5 7.0 0.1 4.8 20.1 23.0 30.5 0.1 13.6 5.1 7.6 11.8 14.5 0.0 4.4 7.8 17.4 0.6 7.4 8.2 0.0 2.5 8.3 10.4 3.1 6.4 7.6 2.1 3.4 0.5 12.8 4.8 0.0 12.3 6.8 0.0 3.5 4.1 4.1 5.8 0.1 1.5 2.0 0.2 3.7 1.4 3.9 0.4 4.1 14.8 5.4 1.9 16.1 2.6 7.6 1.4 4.7 5.6 4.9 5.3 15.6 3.6 12.7 7.6 7.0 7.3 5.0 5.9 6.5 3.0 5.5 6.3 5.7 15.5 7.4 9.8 2.1 7.2 2.6 2.3 2.4 1.0 1.6 1.3 1.5 2.5 1.1 3.1 1.7 SAPCD1 "C6orf26, NG23" ENSG00000228727 "Suppressor APC domain containing 1" Q5SSQ6 6 31762799-31764851 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 8.8;skin 1: 14.7" "Cell line enhanced" "Detected in some" "HeLa: 7.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA071699 Approved "Vesicles,Cell Junctions" Vesicles "Cell Junctions" "HPA071699: " "unprognostic (9.25e-4)" "unprognostic (1.32e-1)" "unprognostic (3.41e-2)" "unprognostic (3.28e-1)" "unprognostic (9.34e-2)" "unprognostic (8.02e-4)" "unprognostic (1.63e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (8.16e-3)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "unprognostic (8.15e-10)" "unprognostic (2.65e-2)" "unprognostic (4.45e-1)" "unprognostic (3.57e-1)" "unprognostic (7.98e-5)" 0.8 0.3 0.7 1.6 1.0 4.8 1.8 0.7 1.3 2.0 1.0 1.3 0.7 0.2 1.2 0.8 0.7 1.8 2.5 0.7 0.7 0.8 3.2 0.9 1.4 2.5 1.9 0.7 1.6 0.7 0.2 2.9 3.3 3.9 2.6 1.1 8.8 0.7 1.6 0.7 14.7 1.5 0.7 3.1 2.1 0.8 1.2 0.7 0.7 0.7 0.7 0.7 0.8 0.7 0.0 0.5 0.2 0.1 0.0 0.7 0.0 0.5 0.0 0.0 0.5 0.4 0.8 0.8 0.5 0.2 0.2 0.0 2.9 1.0 0.8 0.1 0.2 1.7 0.0 0.8 0.1 0.0 3.2 3.9 7.7 1.1 0.2 0.4 0.1 0.2 0.0 1.2 1.4 0.5 0.5 1.2 0.0 3.9 2.9 2.4 0.0 0.9 0.4 0.9 0.0 0.6 0.7 1.2 0.6 0.3 0.7 0.5 0.3 0.0 0.3 0.1 3.1 0.0 0.3 2.2 2.1 2.0 0.2 2.8 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.7 1.0 0.7 1.3 0.7 0.8 1.9 0.7 3.9 0.7 SARM1 "KIAA0524, SAMD2, SARM" ENSG00000004139 "Sterile alpha and TIR motif containing 1" Q6SZW1 17 28364356-28404049 "Predicted intracellular proteins" "Differentiation, Immunity, Innate immunity, Neurogenesis" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024359, HPA024759" Uncertain Approved Vesicles "Intracellular and membrane" Vesicles "HPA024359: AB_1856582, HPA024759: AB_1856581" "unprognostic (1.40e-4)" "unprognostic (9.00e-2)" "unprognostic (2.47e-1)" "unprognostic (2.41e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.27e-2)" "unprognostic (1.87e-2)" "unprognostic (7.01e-2)" "unprognostic (2.49e-4)" "unprognostic (6.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (4.84e-2)" "unprognostic (7.62e-4)" 4.3 14.6 9.5 6.9 8.6 2.6 6.0 14.4 9.4 5.4 4.2 6.5 11.2 15.3 7.5 8.9 3.7 7.0 4.5 4.6 6.8 4.4 4.6 8.7 6.2 12.3 4.8 7.6 6.3 13.1 8.0 11.7 2.8 5.4 6.8 4.9 6.1 5.0 11.7 4.0 4.8 9.8 7.7 6.6 7.2 5.8 3.5 4.5 0.9 5.9 2.4 4.4 4.7 5.1 1.3 1.2 0.7 2.4 1.5 2.4 0.8 0.1 2.4 3.0 3.9 2.2 1.6 0.5 1.7 3.2 3.6 2.4 25.4 0.4 0.5 0.1 2.3 1.0 2.1 0.1 3.0 5.4 1.4 0.0 3.6 0.6 1.7 0.0 1.5 1.1 0.1 1.7 0.5 0.1 0.1 2.0 1.0 2.2 0.3 0.0 2.1 0.2 0.9 2.5 0.6 1.2 1.7 8.0 7.5 7.3 1.1 2.8 0.3 0.6 0.3 3.2 0.3 1.2 2.3 3.2 2.1 0.5 3.4 0.2 1.6 0.7 0.7 0.1 1.2 1.2 1.1 0.8 1.7 1.8 1.2 1.3 1.1 1.8 0.6 1.5 2.4 0.4 2.4 0.8 9.5 8.6 14.4 7.7 6.8 4.4 4.8 7.6 5.4 4.5 SARS2 "FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS" ENSG00000104835 "Seryl-tRNA synthetase 2, mitochondrial" Q9NP81 19 38915266-38930896 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA052730, HPA056957" Approved Uncertain Nucleoplasm,Vesicles,Mitochondria "Nucleoplasm, Mitochondria" Vesicles "HPA052730: , HPA056957: " "unprognostic (3.20e-3)" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (3.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.88e-3)" "unprognostic (4.38e-3)" "unprognostic (1.22e-1)" "unprognostic (2.57e-2)" "unprognostic (8.62e-3)" "unprognostic (8.36e-2)" "unprognostic (1.67e-1)" "unprognostic (5.62e-3)" "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.69e-2)" 5.8 16.5 9.9 7.2 12.8 11.1 7.4 10.7 20.4 8.0 9.2 11.3 11.4 12.3 9.0 9.4 12.9 11.5 8.2 12.3 8.3 8.6 13.4 20.6 6.3 11.0 10.9 7.8 9.5 14.4 11.2 11.4 10.7 15.0 11.0 8.5 11.8 13.6 9.9 15.5 15.6 9.9 8.1 7.2 11.3 11.1 8.8 11.5 11.4 13.8 9.5 12.6 11.0 8.3 6.3 12.7 0.4 7.2 6.5 8.0 4.3 5.6 17.3 6.9 4.1 2.9 6.0 9.6 4.0 5.4 9.4 7.5 14.1 7.1 6.4 5.8 5.6 5.4 7.3 11.4 2.4 5.5 9.3 12.8 7.5 12.1 6.9 11.0 12.8 9.0 6.2 6.2 4.2 6.6 11.0 6.4 4.8 12.2 8.2 10.0 7.0 3.5 11.9 6.2 7.0 10.0 13.9 11.9 7.6 5.3 14.4 3.6 7.4 7.4 4.2 5.9 6.7 4.6 3.9 4.6 2.7 5.1 3.7 7.7 4.9 0.0 4.1 0.4 8.0 7.2 6.4 6.3 5.9 8.0 12.7 5.7 4.3 4.9 0.3 6.5 6.4 5.0 6.6 4.3 9.9 12.8 10.7 20.4 8.3 8.6 10.9 7.8 15.0 11.5 SAYSD1 "C6orf64, FLJ11101" ENSG00000112167 "SAYSVFN motif domain containing 1" Q9NPB0 6 39104064-39115189 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 52.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007959 Approved Supported Vesicles Vesicles "HPA007959: AB_1078359" "unprognostic (2.65e-1)" "unprognostic (1.49e-2)" "unprognostic (2.03e-2)" "unprognostic (2.58e-1)" "unprognostic (3.70e-1)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (1.96e-2)" "unprognostic (6.50e-2)" "unprognostic (1.82e-3)" "unprognostic (5.08e-2)" "unprognostic (9.90e-2)" "unprognostic (2.54e-2)" "unprognostic (1.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.27e-1)" "unprognostic (2.00e-3)" 8.2 7.2 7.2 5.7 8.7 5.9 11.2 7.1 9.0 7.9 7.3 8.1 6.9 8.8 7.9 10.5 6.5 8.1 9.3 6.7 7.3 6.9 8.1 8.3 6.3 8.2 9.3 6.5 8.4 9.5 4.9 6.1 6.1 7.0 8.5 7.2 6.4 11.1 8.0 5.6 6.6 8.6 6.3 7.0 6.8 6.9 52.7 7.3 18.2 8.4 5.1 9.0 6.2 7.7 14.8 9.3 19.4 12.2 11.7 19.1 9.5 11.4 7.4 6.7 7.9 11.1 14.7 6.9 5.3 5.8 6.4 6.8 10.6 8.2 10.4 7.7 6.9 7.9 5.8 5.0 6.8 6.5 10.5 6.8 4.5 9.2 9.0 7.7 10.3 10.1 12.4 2.5 6.4 5.9 11.5 6.4 7.2 15.7 12.2 12.8 5.8 3.8 1.7 8.2 4.1 13.4 8.1 18.9 7.6 9.2 8.0 8.1 13.1 10.2 7.6 8.5 6.2 2.6 6.8 0.1 3.2 12.8 4.9 11.2 6.2 7.6 9.0 19.4 12.2 12.2 14.2 13.1 13.3 11.0 9.3 14.8 19.1 15.8 4.3 11.7 11.9 7.4 17.3 9.5 7.2 8.7 7.1 9.0 7.3 6.9 9.3 6.5 7.0 7.3 SBSN "HLAR698, UNQ698" ENSG00000189001 Suprabasin Q6UWP8 19 35523367-35528351 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 105.1;skin 1: 241.3;tongue: 338.1" "Cell line enhanced" "Detected in some" "ASC diff: 19.7;ASC TERT1: 34.4;HSkMC: 46.5;U-2197: 16.0;U-87 MG: 37.7" "Group enriched" "Detected in many" 9 "cervical cancer: 76.5;head and neck cancer: 355.2;melanoma: 153.1" "Region enriched" "Detected in single" 7 "basal ganglia: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA062568, HPA067734" Enhanced Approved Vesicles "Secreted - unknown location" 62000000 Vesicles "HPA062568: AB_2684794, HPA067734: AB_2685894" "unprognostic (1.10e-1)" "unprognostic (1.01e-1)" "unprognostic (2.02e-2)" "unprognostic (1.21e-1)" "unprognostic (1.73e-1)" "unprognostic (1.83e-2)" "unprognostic (1.23e-3)" "unprognostic (3.45e-3)" "unprognostic (2.56e-1)" "unprognostic (4.83e-4)" "unprognostic (4.31e-4)" "unprognostic (6.97e-2)" "unprognostic (9.08e-14)" "unprognostic (6.37e-2)" "unprognostic (6.51e-3)" "unprognostic (2.09e-1)" "unprognostic (1.36e-3)" 0.3 0.0 0.2 0.2 1.6 0.1 11.2 0.2 0.2 65.1 0.2 0.2 0.2 0.0 3.5 0.2 105.1 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.7 0.2 0.2 0.0 0.2 26.8 0.2 1.3 241.3 0.2 0.2 0.2 0.2 0.0 0.2 0.2 1.8 0.2 338.1 51.7 0.4 51.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 19.7 34.4 0.0 1.5 2.2 0.7 0.2 0.0 0.0 0.0 0.3 1.4 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 46.5 2.5 9.3 2.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 5.8 1.2 16.0 0.4 0.1 0.0 0.0 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 SBSPON "C8orf84, RPESP" ENSG00000164764 "Somatomedin B and thrombospondin type 1 domain containing" Q8IVN8 8 73064540-73124088 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 66.7;urinary bladder: 47.9" "Group enriched" "Detected in some" 8 "BJ: 9.8;RPTEC TERT1: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029595 Approved Approved Vesicles "Secreted to extracellular matrix" 19000 Vesicles "HPA029595: AB_10600763" "prognostic favourable (7.18e-4)" "unprognostic (5.08e-3)" "unprognostic (3.24e-1)" "unprognostic (4.41e-2)" "unprognostic (1.75e-1)" "unprognostic (2.31e-1)" "unprognostic (2.78e-2)" "unprognostic (8.65e-2)" "unprognostic (2.92e-1)" "unprognostic (1.46e-1)" "unprognostic (9.54e-2)" "unprognostic (1.06e-1)" "prognostic unfavourable (8.82e-4)" "unprognostic (6.14e-2)" "unprognostic (3.54e-1)" "unprognostic (2.12e-2)" "unprognostic (6.25e-2)" 6.7 3.0 0.6 1.7 0.7 0.3 6.7 2.6 0.7 6.5 4.2 2.9 16.5 0.8 4.9 18.1 9.6 8.2 3.0 3.5 1.1 0.8 14.4 0.6 5.0 2.4 2.5 0.9 9.0 1.2 0.0 1.7 9.3 5.4 19.4 1.1 4.3 4.3 25.4 1.1 1.8 2.6 66.7 15.7 1.1 9.9 5.6 0.7 0.1 3.2 2.5 0.9 47.9 7.6 0.9 1.2 1.1 0.4 1.5 0.8 0.3 0.3 0.2 0.5 0.5 0.0 0.0 1.4 9.8 0.0 0.0 0.0 0.1 0.2 0.4 0.5 0.1 0.2 0.0 0.0 0.0 0.3 0.4 0.3 0.4 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.3 1.0 0.2 0.2 0.2 0.0 17.8 0.1 0.6 0.5 1.0 0.4 0.1 0.2 0.1 0.5 0.2 1.7 0.2 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.7 0.4 0.4 0.6 0.0 0.1 0.4 0.6 0.7 0.1 0.9 0.4 0.8 1.1 1.5 0.4 1.2 0.2 0.3 0.6 0.7 2.6 0.7 1.1 0.8 2.5 0.9 5.4 0.7 SCAMP1 SCAMP37 ENSG00000085365 "Secretory carrier membrane protein 1" O15126 5 78360583-78479071 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044753, CAB079009" Supported Approved "Nucleoplasm,Vesicles,Cell Junctions" "Nucleoplasm, Vesicles, Cell Junctions" "CAB079009: , HPA044753: " "unprognostic (8.25e-2)" "unprognostic (3.65e-2)" "unprognostic (1.40e-3)" "unprognostic (5.34e-3)" "unprognostic (2.60e-1)" "unprognostic (2.57e-3)" "unprognostic (5.51e-2)" "unprognostic (3.43e-2)" "unprognostic (1.31e-1)" "unprognostic (8.23e-3)" "unprognostic (2.35e-2)" "unprognostic (2.56e-1)" "prognostic favourable (1.92e-4)" "unprognostic (8.44e-3)" "unprognostic (7.56e-2)" "unprognostic (3.12e-2)" "unprognostic (4.99e-2)" 7.5 8.3 9.2 4.0 19.3 2.4 10.0 12.8 19.5 8.4 6.4 5.4 9.9 5.3 8.7 9.3 8.6 10.7 6.4 8.0 15.8 10.4 6.2 5.9 3.9 6.5 15.8 8.8 8.8 17.5 14.6 7.6 14.6 12.2 7.3 7.6 10.6 11.0 4.7 5.8 5.3 9.1 9.0 3.9 9.6 4.5 7.1 4.1 14.2 3.8 3.7 8.8 6.3 7.9 14.9 15.3 15.8 10.0 9.9 7.4 12.7 10.1 10.1 31.3 14.0 18.1 15.9 11.8 17.3 9.8 22.3 3.8 24.0 18.9 13.4 17.3 10.4 14.3 22.2 17.5 6.7 13.6 8.7 8.0 7.7 9.0 5.5 6.7 11.9 20.6 11.1 17.7 15.0 3.3 13.6 18.6 15.0 9.5 11.8 8.2 10.4 11.7 16.7 21.6 17.8 15.3 28.8 17.5 10.9 15.5 11.2 21.6 10.1 15.2 10.9 8.0 11.9 9.9 9.5 11.4 11.8 21.2 20.7 9.0 15.3 11.4 12.8 8.2 12.6 9.9 7.9 9.4 9.8 14.9 6.6 7.8 6.8 7.0 10.0 15.8 4.6 9.1 7.4 SCAMP2 ENSG00000140497 "Secretory carrier membrane protein 2" O15127 15 74843730-74873365 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014699, HPA019194" Approved Supported "Golgi apparatus,Vesicles" 110000 "Golgi apparatus, Vesicles" "HPA014699: AB_1856605, HPA019194: AB_1856604" "unprognostic (1.74e-1)" "unprognostic (1.27e-2)" "unprognostic (2.05e-1)" "unprognostic (5.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.53e-2)" "unprognostic (7.23e-2)" "unprognostic (9.73e-3)" "unprognostic (7.26e-2)" "unprognostic (8.44e-2)" "unprognostic (1.97e-1)" "prognostic favourable (1.12e-6)" "unprognostic (3.40e-1)" "unprognostic (1.79e-2)" "unprognostic (1.19e-2)" "unprognostic (3.10e-2)" 28.8 27.9 15.7 32.2 21.9 22.6 38.7 7.6 16.5 20.9 37.8 27.6 24.6 37.7 22.5 27.9 54.7 24.7 27.0 18.8 14.8 10.1 34.2 37.8 28.8 42.1 24.2 11.6 20.5 32.1 42.7 17.6 47.8 17.4 20.3 37.1 17.5 56.4 31.9 18.5 36.1 47.5 17.1 20.1 39.4 33.2 29.2 20.1 25.8 29.2 28.3 38.4 21.4 25.8 37.8 59.5 46.9 51.3 36.6 47.0 47.4 12.6 16.7 7.2 11.1 21.9 11.4 21.5 13.1 16.7 14.0 15.1 23.9 30.1 10.5 17.3 19.7 46.3 21.3 16.3 5.8 41.4 20.9 26.6 9.7 16.4 16.6 13.6 51.2 14.6 29.1 13.2 9.6 13.5 8.8 19.9 9.8 19.4 6.9 15.7 7.1 10.8 12.1 6.6 36.1 16.1 18.3 7.4 7.5 10.7 19.0 12.0 26.1 21.9 12.6 12.1 7.2 13.0 15.2 13.8 20.2 10.7 11.3 32.2 8.8 46.9 51.3 39.4 46.6 48.3 37.6 37.8 42.7 46.9 37.8 32.5 35.6 38.2 34.6 36.6 50.3 59.5 47.0 47.4 15.7 21.9 7.6 16.5 14.8 10.1 24.2 11.6 17.4 20.1 SCAMP3 C1orf3 ENSG00000116521 "Secretory carrier membrane protein 3" O14828 1 155255979-155262430 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071167 Supported Vesicles Vesicles "HPA071167: " "unprognostic (4.31e-2)" "unprognostic (1.30e-2)" "unprognostic (1.07e-2)" "unprognostic (2.17e-2)" "unprognostic (5.33e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (2.92e-5)" "unprognostic (8.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (2.65e-1)" "unprognostic (3.74e-2)" "unprognostic (8.46e-3)" "unprognostic (1.60e-1)" "unprognostic (4.79e-1)" "unprognostic (1.07e-1)" "unprognostic (7.18e-2)" 23.6 41.8 21.0 20.8 25.6 16.8 28.8 22.5 35.5 21.9 19.0 36.1 26.8 24.1 20.7 17.8 27.1 21.9 21.5 37.8 19.8 20.2 33.3 40.8 23.4 25.5 27.1 26.3 22.6 41.5 41.5 20.0 37.0 26.2 23.0 17.3 26.0 33.0 28.1 45.3 30.0 20.9 18.9 30.4 27.0 24.4 14.5 26.4 21.6 27.3 23.6 27.3 23.9 20.8 32.2 32.5 25.6 35.0 29.9 28.7 30.0 13.8 29.7 9.0 17.9 21.9 17.3 9.2 16.6 19.7 18.8 17.7 16.2 19.7 12.8 24.8 19.3 21.6 12.9 12.6 6.9 17.5 23.7 9.0 19.4 13.2 21.9 17.0 15.4 15.1 16.1 23.5 10.8 15.7 16.0 31.1 20.3 27.6 15.6 15.7 17.3 32.6 13.5 7.3 39.4 11.1 12.4 11.7 23.6 11.6 27.2 19.2 29.3 26.5 12.8 21.1 11.9 21.8 24.6 41.3 38.4 15.9 20.8 18.2 24.3 25.6 29.0 23.2 28.7 31.1 25.6 32.2 26.6 26.8 31.6 30.5 24.6 26.3 2.6 29.9 35.0 32.5 26.6 30.0 21.0 25.6 22.5 35.5 19.8 20.2 27.1 26.3 26.2 26.4 SCAMP4 FLJ33847 ENSG00000227500 "Secretory carrier membrane protein 4" Q969E2 19 1905214-1926013 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043284 Approved Approved "Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane" "Golgi apparatus, Vesicles" "Lipid droplets, Plasma membrane" "HPA043284: AB_10806501" "unprognostic (1.60e-1)" "unprognostic (3.62e-1)" "unprognostic (5.04e-2)" "prognostic favourable (4.40e-6)" "unprognostic (2.58e-1)" "unprognostic (4.58e-1)" "prognostic unfavourable (1.92e-5)" "unprognostic (2.04e-1)" "unprognostic (1.58e-1)" "unprognostic (2.55e-1)" "unprognostic (3.01e-3)" "unprognostic (5.66e-2)" "prognostic favourable (3.56e-4)" "unprognostic (6.16e-2)" "unprognostic (1.58e-1)" "unprognostic (3.93e-2)" "unprognostic (1.03e-1)" 17.3 16.5 17.1 16.0 21.7 10.2 18.4 16.5 28.2 19.5 13.2 46.3 21.1 19.3 16.3 20.4 22.0 37.2 19.4 8.5 19.3 19.5 19.9 21.5 19.3 13.9 22.1 14.6 23.7 28.0 12.7 23.2 24.2 27.6 19.5 9.8 21.4 41.1 21.4 9.1 19.2 18.9 12.1 42.1 17.2 21.8 15.9 20.3 10.3 23.8 10.6 18.2 15.7 13.9 6.4 14.2 2.5 5.9 7.1 5.0 3.7 22.8 22.9 10.4 25.4 21.0 13.1 12.5 14.9 13.9 16.3 19.9 18.6 22.1 9.4 14.5 11.9 27.4 9.9 15.1 6.1 14.8 8.9 6.5 8.1 17.8 27.0 6.5 10.1 20.1 9.6 14.2 8.6 11.1 14.8 10.7 9.4 27.4 8.7 12.7 17.1 7.7 10.9 7.6 14.2 20.1 20.3 14.8 19.5 9.4 22.7 12.4 22.1 17.1 11.8 20.1 13.9 35.9 15.7 26.0 25.6 8.4 26.6 11.0 12.9 1.9 5.2 2.0 5.0 5.9 2.7 6.4 3.5 3.2 5.7 4.6 2.1 3.7 2.5 7.1 5.0 14.2 2.7 3.7 17.1 21.7 16.5 28.2 19.3 19.5 22.1 14.6 27.6 20.3 SCARB1 "CD36L1, CLA-1, CLA1, SR-BI, SRB1" ENSG00000073060 "Scavenger receptor class B member 1" Q8WTV0 12 124776856-124882668 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 173.1;liver: 93.7;placenta: 65.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 24.9" "Group enriched" "Detected in many" 5 "dendritic cells: 24.9;monocytes: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066285, CAB070124, HPA072449" Enhanced Approved Vesicles Vesicles "CAB070124: AB_10107658, HPA066285: , HPA072449: " "unprognostic (9.70e-3)" "unprognostic (4.94e-3)" "unprognostic (1.32e-1)" "unprognostic (4.79e-2)" "unprognostic (1.65e-3)" "unprognostic (4.21e-3)" "prognostic unfavourable (1.83e-5)" "prognostic unfavourable (4.02e-4)" "unprognostic (2.30e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-2)" "unprognostic (4.99e-2)" "prognostic unfavourable (1.49e-5)" "unprognostic (3.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.81e-1)" "unprognostic (4.13e-1)" 21.2 173.1 7.9 3.5 21.4 1.8 25.0 4.3 10.1 4.7 28.6 13.4 1.1 8.8 4.3 3.5 2.8 4.7 8.0 3.2 7.4 5.1 2.2 93.7 5.8 5.3 6.3 5.1 14.3 2.9 3.3 4.4 65.9 9.4 4.3 4.9 10.7 8.6 2.3 3.0 6.3 21.3 4.4 5.7 5.0 2.7 7.7 11.4 0.5 4.0 1.1 5.6 3.6 10.0 3.1 24.9 1.2 6.5 0.2 0.4 2.5 9.1 22.2 7.2 28.5 4.8 10.3 0.0 6.4 7.4 8.0 5.1 26.5 29.3 26.5 18.7 4.4 14.0 18.4 43.4 3.8 12.6 18.6 7.4 21.9 42.7 16.3 12.7 6.5 17.6 8.8 15.3 10.9 21.9 14.1 11.4 1.4 18.2 3.9 17.1 6.6 23.0 16.6 5.8 53.0 0.7 12.8 13.6 5.3 35.2 47.5 32.9 26.6 14.5 2.1 1.3 8.7 6.5 10.0 2.7 1.1 4.4 5.2 15.5 12.5 0.0 6.5 0.0 0.2 3.7 0.2 3.1 0.1 0.4 8.2 1.7 0.1 0.1 1.2 0.2 0.5 24.9 0.0 2.5 7.9 21.4 4.3 10.1 7.4 5.1 6.3 5.1 9.4 11.4 SCCPDH "CGI-49, NET11" ENSG00000143653 "Saccharopine dehydrogenase (putative)" Q8NBX0 1 246724047-246768137 "Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 95.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 17 "basophil: 95.3" "Lineage enriched" "Detected in all" 22 "granulocytes: 95.3" "Low region specificity" "Detected in all" "HPA050775, HPA076030" Enhanced Approved Vesicles 2100000 Vesicles "HPA050775: , HPA076030: " "unprognostic (4.25e-1)" "unprognostic (3.11e-1)" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (2.83e-2)" "unprognostic (6.43e-2)" "unprognostic (1.25e-1)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (5.51e-2)" "unprognostic (1.93e-1)" "unprognostic (3.60e-1)" "unprognostic (2.70e-2)" "unprognostic (9.63e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.93e-2)" 14.1 25.8 15.7 6.4 17.5 13.4 11.3 11.3 20.5 10.9 11.7 24.7 8.5 15.1 12.0 8.5 4.8 14.4 9.7 15.8 15.6 19.8 23.0 67.3 9.3 7.3 26.1 15.0 10.6 12.7 15.0 12.7 14.1 21.7 18.1 12.2 7.3 7.4 16.7 23.9 10.7 15.3 10.8 62.1 5.1 12.4 65.1 17.5 8.5 18.2 7.3 4.8 25.0 13.2 1.4 2.3 95.3 3.2 4.2 3.0 2.1 12.8 12.6 9.2 5.5 11.0 14.0 0.1 10.1 14.1 17.1 14.3 7.7 36.3 6.8 13.3 11.6 4.2 7.8 3.0 17.6 9.5 2.8 11.6 11.5 15.3 10.4 22.5 10.0 9.3 1.4 11.5 1.2 18.3 14.4 0.0 17.0 3.1 23.4 28.6 13.8 10.0 19.7 11.8 0.0 52.5 30.4 10.5 11.8 13.7 0.6 8.9 10.2 23.5 11.9 7.9 7.1 19.2 26.0 34.1 11.7 4.1 13.5 30.7 10.4 95.3 3.2 5.5 2.5 2.8 3.0 1.4 0.7 2.1 1.3 1.1 1.0 3.0 0.8 4.2 1.8 2.3 0.5 2.1 15.7 17.5 11.3 20.5 15.6 19.8 26.1 15.0 21.7 17.5 SCG2 "CHGC, SgII, SN" ENSG00000171951 "Secretogranin II" P13521 2 223596940-223602503 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 26.2;HSkMC: 22.4;SCLC-21H: 22.8;SH-SY5Y: 9.9;WM-115: 16.7" "Group enriched" "Detected in many" 8 "glioma: 70.0;pancreatic cancer: 52.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011893, HPA075062" Enhanced Supported Approved "Golgi apparatus,Vesicles" "Secreted to blood" 54000 "Golgi apparatus" Vesicles "HPA011893: AB_1856656, HPA075062: AB_2732277" "unprognostic (2.93e-2)" "unprognostic (1.44e-2)" "unprognostic (1.23e-3)" "unprognostic (6.82e-4)" "unprognostic (2.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.77e-3)" "unprognostic (6.73e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "prognostic favourable (5.58e-4)" "unprognostic (1.34e-1)" "prognostic unfavourable (7.01e-10)" "unprognostic (2.47e-3)" "unprognostic (4.02e-1)" "unprognostic (1.57e-2)" "unprognostic (1.90e-3)" 3.5 133.0 13.3 11.0 94.1 0.9 0.9 5.6 55.9 1.4 5.4 5.8 0.0 17.3 2.1 0.9 1.0 0.8 2.2 1.4 10.5 79.4 1.0 0.8 1.9 0.9 21.7 11.0 1.3 10.7 1.1 76.5 1.1 57.7 2.1 5.5 1.5 0.9 1.3 0.8 1.0 8.0 5.2 10.3 0.8 8.0 0.9 5.0 0.0 3.1 0.0 0.8 1.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.9 4.1 1.1 26.2 0.1 0.2 0.9 1.9 4.9 0.2 0.4 0.0 0.4 0.3 0.1 0.1 0.0 2.5 0.0 0.2 0.0 0.3 0.0 0.3 0.3 2.2 22.4 0.1 2.7 0.9 0.0 0.1 0.2 2.4 0.1 0.0 0.1 3.5 0.0 0.0 0.1 0.0 0.3 0.0 22.8 9.9 0.0 0.2 1.1 0.0 0.0 0.0 2.6 1.0 0.1 1.7 0.0 0.0 0.1 0.7 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 13.3 94.1 5.6 23.0 10.5 79.4 21.7 11.0 57.7 5.0 SCG3 "FLJ90833, SgIII" ENSG00000104112 "Secretogranin III" Q8WXD2 15 51681353-51721031 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 118.3" "Group enriched" "Detected in some" 7 "NTERA-2: 20.0;SCLC-21H: 47.9;SH-SY5Y: 22.6" "Group enriched" "Detected in many" 7 "glioma: 41.0;pancreatic cancer: 15.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006880, CAB033274, HPA053715" Enhanced Supported Supported Vesicles "Secreted in brain" 4800000 Vesicles "CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: " "unprognostic (1.38e-2)" "unprognostic (2.42e-1)" "unprognostic (1.40e-1)" "unprognostic (5.24e-5)" "unprognostic (1.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.74e-1)" "unprognostic (9.93e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (8.17e-2)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.78e-1)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" 1.7 12.9 29.6 2.1 25.4 1.7 1.7 33.4 118.3 1.5 2.4 6.5 0.0 2.9 1.5 1.6 1.6 1.6 1.6 1.5 22.6 23.5 1.5 1.5 1.8 1.7 13.6 37.7 1.5 11.5 1.4 23.7 1.5 27.1 1.6 2.8 1.3 1.5 1.4 1.5 1.8 2.6 1.7 13.2 1.5 8.7 2.9 7.3 0.0 2.1 0.0 1.5 1.6 0.1 0.9 1.2 1.9 0.5 0.3 0.8 0.2 0.0 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 20.0 0.0 0.1 0.0 0.1 0.0 0.2 47.9 22.6 0.1 0.1 0.0 0.0 1.4 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.3 0.1 4.3 0.4 0.4 0.6 0.8 0.2 0.5 0.9 0.6 0.4 0.4 0.7 0.5 0.6 1.9 0.3 0.5 1.2 0.2 0.2 29.6 25.4 33.4 40.6 22.6 23.5 13.6 37.7 27.1 7.3 SCGB2A1 "LPHC, MGB2, MGC71973, UGB3" ENSG00000124939 "Secretoglobin family 2A member 1" O75556 11 62208668-62213939 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix, uterine: 191.8;epididymis: 135.9" "Cell line enriched" "Detected in some" 4 "EFO-21: 13.7" "Group enriched" "Detected in many" 10 "endometrial cancer: 971.9;ovarian cancer: 208.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA034584 Enhanced Approved Vesicles "Secreted in other tissues" Vesicles "HPA034584: AB_10602221" "unprognostic (7.73e-2)" "unprognostic (3.77e-1)" "prognostic favourable (1.22e-4)" "prognostic favourable (1.54e-8)" "unprognostic (2.98e-2)" "unprognostic (1.86e-2)" "unprognostic (3.39e-1)" "unprognostic (1.95e-1)" "unprognostic (2.69e-1)" "unprognostic (6.87e-3)" "prognostic favourable (6.36e-4)" "unprognostic (5.67e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" "unprognostic (3.35e-1)" 0.2 0.0 0.2 0.5 0.2 0.0 6.8 0.2 0.3 191.8 1.0 0.3 20.8 0.0 40.8 135.9 1.0 28.7 2.5 0.4 0.2 0.3 1.2 0.4 0.9 0.2 0.2 0.3 5.6 2.2 0.0 1.5 0.7 0.5 1.2 1.3 0.2 18.8 1.4 0.2 2.3 0.3 0.2 0.2 0.2 4.3 4.5 0.2 0.3 0.8 1.1 3.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 1.0 0.2 0.0 2.5 0.6 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.3 0.5 0.2 SCN8A "CerIII, CIAT, MED, NaCh6, Nav1.6, PN4" ENSG00000196876 "Sodium voltage-gated channel alpha subunit 8" Q9UQD0 12 51590266-51812864 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 27.6;pituitary gland: 9.7" "Cell line enhanced" "Detected in many" "AF22: 11.8;ASC TERT1: 12.4;BJ hTERT+: 11.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022169, HPA043937, HPA073590" Approved "Vesicles,Plasma membrane,Cell Junctions" "Plasma membrane" "Vesicles, Cell Junctions" "CAB022169: , HPA043937: , HPA073590: " "unprognostic (2.96e-2)" "unprognostic (8.49e-2)" "unprognostic (6.93e-2)" "unprognostic (3.52e-6)" "unprognostic (8.13e-2)" "unprognostic (1.51e-2)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.16e-1)" "unprognostic (4.73e-4)" "unprognostic (1.69e-2)" "unprognostic (1.29e-5)" "unprognostic (4.38e-1)" "unprognostic (1.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.75e-2)" 1.1 3.0 9.1 1.5 18.1 1.9 1.9 16.7 27.6 1.0 2.0 1.6 0.0 1.1 1.5 2.0 0.9 1.1 2.5 0.9 12.6 4.5 1.9 4.3 1.0 1.3 3.2 13.7 1.8 3.2 1.5 9.7 0.9 14.8 1.8 2.5 0.9 1.7 1.2 1.0 1.1 1.2 1.0 2.2 1.7 2.7 3.8 1.6 0.0 1.7 0.0 1.2 1.0 0.6 0.4 0.2 0.0 0.0 0.0 1.0 0.0 1.3 1.0 11.8 0.1 1.6 12.4 0.2 6.7 11.0 7.7 7.2 1.9 1.3 0.3 1.5 8.7 0.0 1.9 0.0 9.1 1.2 0.6 0.1 0.1 0.2 0.1 0.2 0.9 1.7 0.0 5.1 1.1 8.2 0.1 0.1 4.8 0.8 1.9 0.1 4.0 3.8 0.0 0.6 0.0 0.0 0.4 4.7 1.9 3.4 1.7 0.2 0.3 0.1 2.2 7.5 5.0 2.7 4.2 0.1 0.1 0.0 1.5 1.6 10.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 1.0 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 9.1 18.1 16.7 25.0 12.6 4.5 3.2 13.7 14.8 1.6 SCRN3 FLJ23142 ENSG00000144306 "Secernin 3" Q0VDG4 2 174395730-174429575 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034689, HPA034690" Approved Approved Vesicles,Cytosol 9300 "Vesicles, Cytosol" "HPA034689: , HPA034690: AB_10670574" "unprognostic (5.39e-3)" "unprognostic (4.58e-2)" "unprognostic (2.06e-2)" "unprognostic (3.58e-1)" "unprognostic (1.91e-1)" "unprognostic (1.89e-1)" "unprognostic (9.89e-2)" "unprognostic (1.57e-1)" "unprognostic (5.14e-2)" "unprognostic (5.85e-2)" "unprognostic (8.81e-2)" "unprognostic (1.30e-1)" "unprognostic (6.62e-3)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" 12.4 15.9 19.2 7.6 18.4 3.7 11.4 13.2 27.0 8.4 10.4 16.7 12.5 15.4 10.3 10.1 14.2 9.1 9.4 21.2 20.2 20.0 17.4 18.0 10.1 10.5 23.5 21.1 11.7 12.1 26.6 20.6 10.9 25.9 13.4 11.3 8.7 10.6 12.3 30.3 11.5 11.5 11.8 27.9 9.3 10.2 8.4 20.2 10.4 17.3 6.2 9.5 11.2 9.1 9.9 6.9 18.5 4.6 5.5 7.5 2.2 9.0 5.6 14.5 13.4 11.3 12.8 8.2 14.0 10.8 10.9 13.0 5.5 6.7 1.7 9.2 13.9 9.1 11.2 12.1 14.0 19.7 10.1 16.9 12.2 4.3 17.0 12.9 8.9 14.3 15.1 20.0 14.7 12.5 11.1 6.6 14.7 10.1 10.6 12.5 7.1 23.8 5.3 15.2 9.9 12.1 9.3 9.4 26.5 9.6 9.6 17.6 12.8 12.5 9.1 12.6 6.6 14.8 11.7 17.5 18.1 0.2 13.8 6.4 12.7 4.8 4.6 1.9 4.6 2.7 3.3 7.0 4.7 4.3 4.3 9.9 7.5 5.9 18.5 5.5 3.6 6.9 4.8 2.2 19.2 18.4 13.2 27.0 20.2 20.0 23.5 21.1 25.9 20.2 SDCBP2 "SITAC18, ST-2" ENSG00000125775 "Syndecan binding protein 2" Q9H190 20 1309909-1329239 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 104.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.4;HBEC3-KT: 12.8;RT4: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054554, HPA064490" Enhanced Approved Vesicles,Cytosol Vesicles Cytosol "HPA054554: , HPA064490: " "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (2.37e-1)" "unprognostic (5.85e-2)" "unprognostic (2.54e-1)" "unprognostic (2.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavourable (2.42e-4)" "unprognostic (1.01e-1)" "unprognostic (3.78e-3)" "prognostic unfavourable (3.07e-4)" "unprognostic (3.17e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "prognostic favourable (3.37e-4)" 1.7 0.4 5.2 10.6 6.7 0.2 1.5 1.5 4.9 6.6 59.4 1.2 0.9 46.1 1.5 9.1 32.4 0.9 35.1 1.3 3.5 3.6 2.5 3.8 3.7 0.9 2.8 1.0 1.2 4.4 0.2 1.4 1.9 1.4 3.7 19.0 1.0 6.4 1.9 1.1 13.4 104.7 2.5 1.1 1.1 34.0 1.5 1.6 1.0 4.0 12.5 24.3 17.0 9.8 1.2 2.6 4.4 2.0 2.1 5.3 1.8 8.7 0.4 1.2 0.4 5.1 4.5 0.8 2.7 5.3 2.5 2.4 1.9 15.4 0.9 1.8 1.0 6.8 0.4 12.8 1.2 0.3 0.9 0.7 0.6 1.2 5.2 0.9 1.0 1.6 9.1 1.9 1.9 8.4 1.2 0.7 0.9 2.1 1.4 2.5 1.2 0.6 1.3 0.6 1.7 1.0 11.9 2.1 1.6 1.3 7.8 3.0 0.4 0.7 5.6 1.3 0.5 2.4 1.0 2.4 2.2 0.9 0.6 3.4 0.8 0.4 2.0 4.4 2.4 0.7 1.8 0.6 3.2 2.5 2.6 1.2 2.7 4.7 2.2 2.1 1.3 1.7 5.3 1.8 5.2 6.7 1.5 4.9 3.5 3.6 2.8 1.0 1.4 1.6 SDF2 ENSG00000132581 "Stromal cell derived factor 2" Q99470 17 28648356-28662189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042799 Approved Vesicles "Intracellular and membrane" Vesicles "HPA042799: AB_10794533" "unprognostic (3.91e-1)" "unprognostic (2.79e-1)" "unprognostic (2.03e-1)" "unprognostic (5.77e-3)" "unprognostic (3.90e-2)" "unprognostic (1.88e-2)" "prognostic unfavourable (1.16e-4)" "unprognostic (2.28e-3)" "unprognostic (3.20e-3)" "unprognostic (3.02e-1)" "unprognostic (1.04e-2)" "unprognostic (1.52e-1)" "unprognostic (1.79e-1)" "unprognostic (1.39e-3)" "unprognostic (2.21e-1)" "unprognostic (7.75e-3)" "unprognostic (6.61e-2)" 13.3 31.8 15.4 10.9 14.9 8.8 17.1 11.2 13.9 17.9 15.8 13.3 26.1 9.6 14.5 28.3 14.4 16.9 14.8 13.3 11.4 13.4 20.1 22.5 14.2 8.8 18.8 11.5 19.9 18.9 10.1 18.9 21.3 16.2 19.1 11.3 11.5 20.7 16.0 13.1 10.2 14.2 14.7 11.4 15.0 13.8 9.5 14.2 11.3 25.2 13.9 14.7 12.8 15.0 11.5 15.3 45.5 12.3 15.1 16.9 13.0 7.4 18.9 8.6 7.3 37.0 10.7 8.0 23.2 15.8 14.5 17.2 10.4 6.8 4.0 21.0 20.5 14.2 11.1 7.3 10.5 23.0 13.7 6.9 8.9 9.7 11.5 4.0 8.9 21.1 9.8 13.2 3.5 13.2 7.0 8.9 16.7 10.9 7.5 8.6 5.9 7.1 5.4 15.4 8.6 13.9 9.0 6.2 6.8 16.4 12.8 11.9 15.1 4.6 17.1 7.4 9.8 9.6 13.0 10.1 15.8 5.5 11.7 5.4 11.3 36.3 12.3 30.5 16.9 9.8 15.5 11.5 13.2 16.3 7.7 10.7 12.5 14.9 45.5 15.1 9.4 15.3 16.6 13.0 15.4 14.9 11.2 13.9 11.4 13.4 18.8 11.5 16.2 14.2 SEC13 "D3S1231E, npp-20, SEC13L1, SEC13R" ENSG00000157020 "SEC13 homolog, nuclear pore and COPII coat complex component" P55735 3 10293131-10321178 "Predicted intracellular proteins, Transporters" "ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035292, HPA057943" Approved Supported Nucleoplasm,Vesicles 15000 "Nucleoplasm, Vesicles" "HPA035292: AB_10959451, HPA057943: " "unprognostic (3.33e-3)" "unprognostic (6.16e-2)" "unprognostic (2.28e-2)" "unprognostic (4.95e-2)" "unprognostic (4.22e-1)" "unprognostic (2.64e-2)" "prognostic unfavourable (1.73e-4)" "unprognostic (2.43e-1)" "unprognostic (2.67e-1)" "unprognostic (1.69e-1)" "unprognostic (4.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (4.60e-1)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" 25.2 30.7 19.0 24.2 24.7 20.6 25.5 16.2 24.9 37.9 47.0 22.6 38.1 47.7 29.6 30.8 30.1 24.7 41.6 30.6 19.5 20.7 33.2 58.3 27.0 19.9 24.7 17.5 24.7 66.8 22.3 48.1 44.1 20.2 23.2 27.9 22.3 63.5 33.4 42.6 25.5 57.1 32.0 21.9 25.9 27.2 26.4 20.5 29.0 38.2 32.8 28.6 25.8 24.2 26.9 60.8 29.1 44.6 23.2 27.7 41.2 20.8 31.7 25.5 9.8 41.5 46.1 84.7 42.7 52.2 49.9 57.7 26.1 17.1 19.1 19.6 67.6 8.5 32.7 38.0 25.6 16.6 34.0 23.3 25.7 63.1 56.9 26.5 20.6 40.8 30.7 52.2 32.6 59.2 24.9 28.3 38.5 43.0 25.9 29.2 28.9 38.4 25.2 18.3 33.9 30.4 15.7 14.3 17.8 18.7 17.4 16.6 22.5 25.9 44.2 20.6 23.5 30.6 36.6 23.5 32.7 44.2 38.9 37.3 33.9 28.0 44.6 28.1 24.5 38.4 27.2 26.9 24.6 23.7 60.8 22.2 20.3 21.2 29.1 23.2 29.5 54.2 27.7 41.2 19.0 24.7 16.2 24.9 19.5 20.7 24.7 17.5 20.2 20.5 SEC23A ENSG00000100934 "Sec23 homolog A, coat complex II component" Q15436 14 39031919-39109646 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043806, HPA069974" Uncertain Approved Nucleoplasm,Vesicles 54000 "Nucleoplasm, Vesicles" "HPA043806: , HPA069974: " "unprognostic (2.40e-1)" "prognostic unfavourable (5.75e-4)" "prognostic favourable (3.56e-4)" "unprognostic (3.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (1.15e-2)" "unprognostic (5.85e-2)" "unprognostic (1.71e-1)" "unprognostic (2.69e-1)" "unprognostic (1.28e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (1.69e-4)" "prognostic unfavourable (2.94e-4)" "unprognostic (1.16e-1)" "unprognostic (2.73e-1)" "unprognostic (1.41e-3)" 23.9 23.5 10.2 16.8 19.1 7.1 22.1 18.6 20.6 21.4 29.6 8.4 14.0 30.2 30.0 16.8 20.3 19.0 17.2 26.5 11.0 14.8 14.4 55.7 13.5 15.5 12.5 12.8 24.3 8.5 4.7 17.2 15.5 19.8 18.6 18.6 16.2 9.8 31.0 31.7 9.6 38.3 52.8 8.3 11.8 16.9 12.3 6.9 12.9 11.8 11.3 11.3 31.9 18.9 15.6 19.8 38.1 21.6 26.0 26.1 17.9 10.6 20.1 17.5 15.5 32.1 36.8 5.3 43.0 37.1 30.6 38.3 20.1 9.0 2.5 10.5 59.9 8.6 22.0 17.3 44.8 8.1 7.6 4.4 16.0 65.2 24.5 7.4 6.8 28.1 9.3 21.1 15.6 25.6 3.2 6.2 23.8 9.9 6.6 3.0 3.9 19.2 9.6 24.2 3.8 16.1 16.2 1.8 4.2 29.8 8.8 9.5 10.9 2.3 28.5 16.2 12.4 23.6 10.8 6.0 7.3 12.0 11.0 6.3 15.5 38.1 21.6 24.2 18.2 18.6 26.1 15.6 23.0 23.4 19.8 14.5 24.2 19.6 19.6 26.0 16.3 17.4 24.0 17.9 10.2 19.1 18.6 20.6 11.0 14.8 12.5 12.8 19.8 6.9 SEC23B "CDA-II, CDAII, CDAN2, HEMPAS" ENSG00000101310 "Sec23 homolog B, coat complex II component" Q15437 20 18507482-18561415 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008216, HPA069974" Uncertain Supported Vesicles Vesicles "HPA008216: AB_1079895, HPA069974: " "unprognostic (4.47e-2)" "unprognostic (2.67e-2)" "unprognostic (3.52e-1)" "prognostic favourable (8.25e-4)" "unprognostic (1.24e-1)" "unprognostic (1.33e-1)" "unprognostic (5.44e-3)" "unprognostic (6.01e-2)" "unprognostic (1.39e-1)" "unprognostic (8.75e-2)" "unprognostic (1.97e-1)" "unprognostic (9.97e-2)" "unprognostic (3.91e-2)" "unprognostic (1.72e-2)" "unprognostic (4.26e-2)" "unprognostic (2.81e-2)" "unprognostic (8.21e-2)" 11.8 32.9 16.5 16.5 19.0 17.2 21.3 13.5 20.0 21.8 16.9 28.8 40.9 12.8 11.2 29.2 24.0 17.4 14.3 8.2 16.2 14.8 27.1 32.8 17.4 15.3 22.3 12.3 13.2 43.1 32.8 31.8 13.1 18.0 19.4 18.9 15.6 69.5 46.3 4.4 14.9 14.9 10.8 22.0 19.7 20.5 23.4 18.3 19.2 34.3 12.7 20.8 12.8 12.5 27.5 44.1 50.8 38.4 32.9 34.1 36.6 24.7 27.9 15.8 14.6 10.7 12.0 35.5 21.0 14.4 26.4 22.7 24.2 22.9 11.5 13.9 16.1 26.7 27.7 38.5 28.5 13.8 12.6 18.7 11.1 36.2 21.8 26.0 23.8 9.0 22.9 38.2 49.0 16.2 21.6 25.4 17.9 25.6 17.8 13.8 14.6 30.1 18.5 24.1 35.9 24.4 25.1 25.1 17.9 24.6 56.6 23.0 24.8 27.6 13.3 16.5 9.0 18.5 25.7 32.1 44.2 17.6 14.1 14.0 23.0 50.8 38.4 42.1 24.7 38.4 34.1 27.5 25.3 26.4 44.1 22.2 23.0 24.1 19.6 32.9 35.9 33.4 29.1 36.6 16.5 19.0 13.5 20.0 16.2 14.8 22.3 12.3 18.0 18.3 SEC23IP p125 ENSG00000107651 "SEC23 interacting protein" Q9Y6Y8 10 119892711-119944658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038403, HPA043305" Approved Enhanced Vesicles Vesicles "HPA038403: AB_10675796, HPA043305: AB_2678416" "unprognostic (4.05e-2)" "unprognostic (5.01e-2)" "unprognostic (8.70e-2)" "unprognostic (1.35e-1)" "unprognostic (3.12e-1)" "unprognostic (1.07e-1)" "unprognostic (9.52e-3)" "unprognostic (1.78e-1)" "unprognostic (3.36e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-1)" "unprognostic (6.81e-3)" "unprognostic (3.43e-2)" 21.6 22.4 11.7 26.3 15.9 21.3 22.0 18.2 16.1 21.3 19.4 19.2 22.8 15.5 25.7 25.7 21.1 20.4 22.0 18.2 18.7 11.4 19.0 32.9 20.0 25.5 10.4 13.0 23.2 21.6 19.3 23.2 21.2 16.8 21.0 21.9 19.1 23.3 27.0 24.3 20.9 20.4 26.0 12.4 20.2 27.5 30.9 11.1 23.3 22.2 15.2 25.4 21.6 18.7 14.3 14.3 15.1 20.6 14.6 17.6 11.1 19.3 23.7 16.2 23.2 16.0 21.0 13.9 19.4 32.2 20.4 24.2 22.8 18.8 21.6 9.0 27.8 16.7 23.6 22.0 30.3 16.9 20.9 17.7 12.5 18.1 21.9 19.9 21.6 24.1 12.0 26.2 24.5 26.2 14.5 16.2 19.8 12.3 18.6 14.0 19.2 17.1 16.7 32.4 11.9 15.1 19.2 7.5 17.4 18.1 12.8 15.4 14.1 12.7 23.2 12.6 12.2 18.6 22.4 21.3 19.1 25.9 20.5 23.9 10.9 15.1 12.3 12.2 14.0 19.3 17.6 14.3 13.9 15.7 14.3 12.1 14.8 13.9 5.0 14.6 20.6 9.0 14.4 11.1 11.7 15.9 18.2 16.1 18.7 11.4 10.4 13.0 16.8 11.1 SEC24A ENSG00000113615 "SEC24 homolog A, COPII coat complex component" O95486 5 134648789-134727823 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038901, HPA056825" Approved Approved "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center, Vesicles" "HPA038901: AB_10674843, HPA056825: " "unprognostic (9.10e-3)" "prognostic unfavourable (3.70e-4)" "unprognostic (2.76e-2)" "unprognostic (4.98e-2)" "unprognostic (2.08e-1)" "unprognostic (4.53e-2)" "unprognostic (1.17e-1)" "unprognostic (6.66e-2)" "unprognostic (2.41e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-2)" "unprognostic (3.54e-1)" "unprognostic (1.18e-3)" "unprognostic (4.77e-2)" "unprognostic (3.00e-2)" "unprognostic (9.37e-3)" "unprognostic (8.97e-2)" 12.5 18.6 7.8 12.9 8.8 15.2 19.9 10.9 8.9 12.9 19.7 6.7 17.7 20.8 12.4 11.0 18.1 9.6 11.9 11.6 7.2 6.7 10.5 43.5 12.7 19.8 6.6 5.8 11.7 18.1 16.6 25.1 22.2 9.7 10.9 13.2 9.8 27.2 25.6 19.7 10.1 33.1 10.8 10.2 14.2 15.4 7.4 7.3 10.7 12.8 11.5 14.3 14.7 12.3 5.6 6.1 8.1 5.8 4.8 7.2 3.0 11.0 6.3 12.0 9.2 17.9 18.2 13.0 17.2 21.4 13.8 24.1 23.4 6.8 8.4 11.7 20.0 6.3 15.0 13.3 24.3 10.2 7.1 7.1 9.9 17.3 12.8 8.3 14.3 11.3 7.6 13.4 9.8 12.6 9.5 13.0 13.8 6.0 7.9 6.1 7.8 4.0 8.1 10.6 9.7 9.2 8.8 5.1 5.2 11.2 5.4 13.7 9.5 6.9 13.7 11.5 4.4 14.5 10.3 23.0 20.1 13.9 13.6 8.9 21.9 8.1 4.9 3.5 4.2 5.8 7.2 5.6 4.6 4.2 6.1 3.7 4.4 5.0 3.0 4.8 5.7 4.1 4.2 3.0 7.8 8.8 10.9 8.9 7.2 6.7 6.6 5.8 9.7 7.3 SEC24B ENSG00000138802 "SEC24 homolog B, COPII coat complex component" O95487 4 109433772-109540896 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038181 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038181: AB_10672472" "unprognostic (1.19e-1)" "unprognostic (4.31e-3)" "unprognostic (8.58e-3)" "unprognostic (9.95e-2)" "unprognostic (1.22e-1)" "unprognostic (1.46e-1)" "unprognostic (6.67e-2)" "unprognostic (3.18e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (2.51e-3)" "unprognostic (7.47e-2)" "prognostic favourable (2.33e-6)" "unprognostic (2.67e-1)" "unprognostic (2.40e-1)" "unprognostic (6.02e-2)" "unprognostic (1.73e-1)" 25.5 20.2 15.8 18.3 16.5 26.6 34.5 26.9 18.9 21.4 20.0 16.8 19.9 15.5 26.2 19.2 22.6 18.9 18.7 20.5 14.2 12.1 18.9 49.5 20.4 17.8 15.7 11.8 24.9 20.4 30.7 27.7 22.3 15.1 19.1 18.3 22.5 20.2 28.3 37.0 25.8 17.4 25.5 14.8 17.4 18.0 12.1 16.7 31.7 20.8 18.3 21.9 24.9 31.1 13.9 15.7 14.6 13.7 15.7 16.1 10.6 11.9 11.0 17.4 13.0 21.2 21.3 10.0 15.7 19.2 13.4 11.9 10.0 13.9 11.1 8.3 23.8 10.2 19.5 15.7 19.9 13.6 9.7 11.6 10.0 10.9 14.3 15.2 13.7 21.0 20.2 15.3 18.5 19.7 17.6 10.2 19.8 9.7 22.0 7.1 6.6 8.8 14.3 15.4 6.4 16.3 15.0 12.3 9.9 12.1 25.9 9.3 7.6 5.9 18.2 15.8 10.6 13.7 11.2 9.9 12.4 10.6 14.0 6.1 12.6 8.2 12.3 14.6 12.3 13.7 13.7 13.9 13.7 12.8 15.7 11.6 16.1 13.2 12.3 15.7 13.2 6.2 11.9 10.6 15.8 16.5 26.9 18.9 14.2 12.1 15.7 11.8 15.1 16.7 SEC24C KIAA0079 ENSG00000176986 "SEC24 homolog C, COPII coat complex component" P53992 10 73744384-73772161 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040196, HPA040213" Supported Supported Vesicles Vesicles "HPA040196: AB_10796449, HPA040213: AB_10796451" "unprognostic (5.06e-2)" "unprognostic (1.00e-2)" "unprognostic (2.17e-1)" "unprognostic (3.54e-1)" "unprognostic (8.46e-2)" "unprognostic (7.23e-2)" "unprognostic (9.06e-2)" "unprognostic (4.55e-2)" "unprognostic (1.64e-1)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-1)" "unprognostic (7.71e-2)" "unprognostic (8.34e-3)" "unprognostic (2.11e-1)" "unprognostic (3.35e-2)" "unprognostic (1.77e-2)" 20.6 34.2 17.8 24.8 24.7 10.8 21.2 30.2 33.5 28.7 23.4 29.4 22.6 22.3 29.1 30.7 49.6 25.5 25.8 23.5 18.3 16.2 25.1 44.9 23.1 23.3 25.8 18.9 28.3 27.6 46.6 35.3 39.1 21.7 29.2 23.6 27.1 35.9 39.7 33.6 25.2 25.1 27.2 18.2 28.9 25.7 29.8 23.6 30.1 31.2 28.4 38.3 24.4 28.3 9.3 12.5 15.4 15.0 14.9 26.3 13.4 20.7 21.0 16.6 29.7 18.1 14.9 13.7 15.7 26.8 21.2 20.0 19.4 14.2 16.5 13.1 21.0 18.1 23.2 20.8 18.4 21.9 16.5 15.3 15.3 20.5 14.4 23.0 21.5 12.7 23.1 18.6 23.2 21.8 18.1 24.1 20.7 18.5 17.1 15.8 10.4 77.1 18.7 13.4 13.5 14.0 11.9 6.0 15.5 12.3 43.2 17.2 31.7 20.4 21.2 9.0 16.3 17.3 18.1 24.6 23.8 24.6 25.5 23.5 10.3 15.4 10.5 9.0 20.4 15.0 26.3 9.3 12.2 15.8 12.5 7.3 9.0 11.8 8.0 14.9 12.4 10.4 7.5 13.4 17.8 24.7 30.2 33.5 18.3 16.2 25.8 18.9 21.7 23.6 SEC24D KIAA0755 ENSG00000150961 "SEC24 homolog D, COPII coat complex component" O94855 4 118722823-118838683 "Disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Craniosynostosis, Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041626, HPA053486" Approved Approved Vesicles Vesicles "HPA041626: AB_10796348, HPA053486: " "unprognostic (9.06e-2)" "unprognostic (3.11e-1)" "unprognostic (3.23e-2)" "unprognostic (8.60e-3)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (1.93e-1)" "unprognostic (2.58e-1)" "unprognostic (9.39e-2)" "unprognostic (3.23e-1)" "unprognostic (1.22e-1)" "unprognostic (6.85e-2)" "prognostic unfavourable (3.42e-6)" "unprognostic (1.09e-3)" "unprognostic (5.64e-2)" "unprognostic (4.30e-3)" "unprognostic (1.37e-1)" 14.7 10.6 3.1 12.5 4.0 7.3 13.9 6.4 6.1 26.8 25.2 2.9 27.9 18.0 25.4 24.6 11.5 16.6 18.6 16.7 4.0 4.0 11.1 65.5 17.9 11.4 3.8 4.7 21.9 32.4 6.1 37.0 33.8 3.8 16.9 16.2 10.1 23.0 38.0 6.5 8.1 41.8 20.2 4.0 19.3 14.3 9.3 2.4 7.6 21.1 8.6 17.0 24.0 15.9 1.8 5.9 15.7 7.0 5.2 6.8 2.4 7.5 4.1 9.4 7.6 26.9 36.0 6.6 32.5 36.2 16.7 20.0 4.2 5.6 5.9 4.6 51.8 2.6 5.1 10.3 18.1 4.9 2.8 6.6 6.4 18.1 27.5 17.2 12.4 21.4 5.8 14.7 24.2 27.5 1.6 18.4 26.1 5.3 8.3 5.1 8.9 6.5 5.1 6.8 10.4 14.9 3.8 5.5 11.2 4.5 23.7 3.9 3.3 13.9 29.8 13.1 4.1 18.6 7.3 14.2 5.2 10.0 28.3 11.0 18.0 5.9 5.5 15.7 3.4 6.2 6.8 1.8 3.5 4.8 5.9 1.4 2.3 2.9 5.1 5.2 7.0 3.1 4.5 2.4 3.1 4.0 6.4 6.1 4.0 4.0 3.8 4.7 3.8 2.4 SEC31A "ABP125, ABP130, KIAA0905, SEC31L1" ENSG00000138674 "SEC31 homolog A, COPII coat complex component" O94979 4 82818661-82901166 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005457 Approved Supported Vesicles,Cytosol 22000 "Vesicles, Cytosol" "HPA005457: AB_1079896" "unprognostic (3.50e-2)" "unprognostic (2.28e-3)" "unprognostic (2.55e-2)" "unprognostic (1.58e-2)" "unprognostic (2.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavourable (3.32e-4)" "unprognostic (6.14e-3)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "unprognostic (4.21e-3)" "unprognostic (3.62e-1)" "unprognostic (1.64e-1)" "unprognostic (5.53e-3)" "unprognostic (2.92e-1)" "unprognostic (2.85e-1)" "prognostic unfavourable (2.69e-4)" 41.3 40.6 22.5 28.0 29.2 30.6 34.5 27.4 30.6 46.4 36.0 26.4 39.2 35.7 53.6 50.2 37.7 34.8 36.1 42.8 23.7 23.8 47.3 57.8 33.9 26.6 25.3 25.3 67.1 79.1 42.7 62.7 54.1 36.0 37.2 38.1 32.6 47.8 46.0 38.7 34.1 51.4 46.2 24.5 28.4 35.9 23.3 23.3 35.7 50.0 31.0 39.5 47.1 37.6 29.4 34.6 34.8 36.0 40.5 40.0 30.5 24.8 11.3 32.7 23.1 58.3 72.7 23.8 46.4 52.0 26.1 32.4 19.5 32.0 32.3 20.4 92.5 11.9 32.2 30.7 36.2 32.9 12.8 19.7 19.4 51.1 58.0 21.0 25.1 69.5 39.0 39.9 45.9 42.3 29.9 32.1 46.4 21.8 27.7 17.0 22.4 10.3 20.7 17.7 23.9 42.1 14.4 21.1 23.5 18.4 32.1 29.9 25.0 23.8 43.2 34.4 17.9 30.1 29.0 24.1 10.3 44.4 34.4 25.4 39.5 34.8 31.1 23.3 32.6 34.8 40.0 29.4 29.2 31.8 34.6 24.4 29.3 28.0 9.5 40.5 36.0 28.9 24.0 30.5 22.5 29.2 27.4 30.6 23.7 23.8 25.3 25.3 36.0 23.3 SEC31B "DKFZP434M183, SEC31B-1, SEC31L2" ENSG00000075826 "SEC31 homolog B, COPII coat complex component" Q9NQW1 10 100486642-100519864 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035882, HPA040819, HPA060052" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles, Cytosol" "HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: " "unprognostic (1.23e-1)" "unprognostic (3.13e-3)" "unprognostic (3.39e-3)" "unprognostic (1.03e-2)" "unprognostic (4.85e-2)" "unprognostic (1.42e-3)" "unprognostic (1.97e-3)" "unprognostic (6.63e-2)" "unprognostic (2.22e-1)" "unprognostic (2.25e-2)" "unprognostic (1.10e-4)" "unprognostic (8.23e-3)" "prognostic unfavourable (6.41e-7)" "unprognostic (2.31e-2)" "unprognostic (2.54e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-4)" 2.8 2.4 3.3 3.2 5.0 6.4 2.6 12.1 11.8 2.7 2.8 5.4 4.3 1.9 3.0 3.5 1.4 2.9 2.6 5.6 3.1 3.6 2.7 3.4 2.4 4.3 3.3 5.6 3.9 0.8 3.9 5.0 2.4 6.3 2.9 2.7 6.1 2.8 2.5 13.6 2.4 2.9 3.2 3.4 4.9 1.9 16.2 3.4 0.0 2.6 5.2 3.6 2.3 1.9 0.9 0.0 0.1 0.2 0.0 2.1 0.1 0.4 0.4 4.5 1.5 1.4 2.5 0.4 0.9 2.0 0.4 1.4 0.4 0.7 1.0 1.3 0.0 0.5 2.4 0.6 1.2 5.5 1.3 2.2 2.9 0.5 1.9 1.6 1.9 3.8 2.3 0.3 2.7 0.8 0.6 2.7 0.1 0.0 2.8 4.9 0.0 0.9 4.3 0.1 1.8 1.4 0.0 0.3 1.5 0.5 0.1 0.9 1.2 0.6 0.0 0.6 0.7 0.4 0.3 2.1 1.0 1.2 0.1 5.3 0.7 0.0 0.1 0.0 0.5 0.2 2.1 0.0 0.0 0.4 0.0 0.9 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 3.3 5.0 12.1 11.8 3.1 3.6 3.3 5.6 6.3 3.4 SEMA3A "coll-1, Hsema-I, SEMA1, SEMAD, SemD" ENSG00000075213 "Semaphorin 3A" Q14563 7 83955777-84492724 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 24.5" "Cell line enhanced" "Detected in many" "AF22: 42.0;BJ: 32.6;fHDF/TERT166: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 4.7" "Lineage enriched" "Detected in single" 15 "monocytes: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029447, HPA052235" Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" 1200000 Vesicles Nucleoplasm "HPA029447: AB_10602302, HPA052235: " "unprognostic (1.20e-1)" "prognostic unfavourable (2.69e-5)" "unprognostic (1.51e-1)" "unprognostic (5.82e-2)" "unprognostic (1.37e-2)" "unprognostic (5.98e-3)" "unprognostic (2.92e-3)" "unprognostic (6.05e-3)" "unprognostic (1.13e-1)" "unprognostic (2.48e-1)" "unprognostic (1.46e-1)" "unprognostic (4.44e-2)" "unprognostic (6.18e-12)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.61e-2)" "unprognostic (1.47e-4)" 9.6 1.1 2.9 5.2 14.6 0.3 3.7 1.0 6.0 7.4 17.8 1.4 0.7 2.3 1.5 3.3 8.6 3.5 8.6 3.7 2.0 2.1 1.3 1.1 4.9 12.9 1.6 6.5 1.4 1.0 1.3 12.0 14.7 11.1 5.0 8.7 8.2 1.5 0.8 1.0 2.7 5.3 24.5 3.3 17.9 5.4 1.8 1.8 0.0 4.2 1.4 2.4 11.9 2.1 0.0 0.2 0.0 4.7 0.3 0.3 0.0 3.6 10.0 42.0 0.0 1.3 1.0 2.7 32.6 19.2 2.7 1.7 3.5 9.8 0.0 1.5 35.5 18.1 0.1 7.8 3.9 0.0 1.3 0.0 1.8 0.0 1.1 0.8 0.0 1.3 0.0 5.9 1.4 10.2 0.0 0.0 1.1 0.1 0.0 0.0 15.7 3.7 0.7 17.9 1.0 6.1 0.2 3.2 1.7 0.2 0.0 0.3 0.1 0.3 5.7 3.7 3.9 10.5 4.7 2.4 1.6 0.0 3.8 1.4 7.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 4.7 0.0 0.0 0.0 2.9 14.6 1.0 6.0 2.0 2.1 1.6 6.5 11.1 1.8 SEMA3E "coll-5, KIAA0331, M-SemaK, SEMAH" ENSG00000170381 "Semaphorin 3E" O15041 7 83363238-83649113 "Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 4.0;SK-BR-3: 20.2;U-2 OS: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029419, HPA063804" Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "HPA029419: AB_10602090, HPA063804: " "unprognostic (4.42e-2)" "unprognostic (1.48e-2)" "unprognostic (7.82e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-1)" "unprognostic (4.27e-2)" "unprognostic (9.36e-2)" "unprognostic (4.09e-2)" "unprognostic (3.25e-1)" "unprognostic (1.42e-1)" "unprognostic (9.09e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-6)" "unprognostic (1.32e-2)" "unprognostic (1.14e-1)" "unprognostic (7.17e-3)" "unprognostic (2.62e-1)" 4.0 1.1 2.4 1.0 12.2 0.6 7.8 2.0 12.2 5.5 6.4 1.9 0.5 2.2 5.4 1.4 4.7 2.3 6.5 0.9 4.0 4.7 1.0 1.0 6.1 0.6 5.9 6.4 0.9 9.6 0.7 1.4 1.1 5.1 15.0 4.9 2.4 6.2 9.1 1.0 2.2 3.6 10.3 6.6 0.7 3.8 0.9 3.1 0.9 2.2 0.5 0.8 9.8 3.3 0.5 0.3 1.4 0.6 0.7 0.5 0.2 0.2 1.1 0.2 0.0 0.5 3.2 0.0 0.0 0.2 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 3.4 0.0 1.3 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.9 0.0 0.0 0.5 1.1 0.0 2.0 0.0 0.0 0.8 0.1 0.0 0.0 20.2 0.0 1.6 0.0 0.0 0.8 6.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 1.4 0.3 0.5 0.3 0.3 0.5 0.3 0.4 0.3 0.3 0.5 0.5 0.5 0.8 0.7 0.6 0.3 0.3 0.2 2.4 12.2 2.0 8.7 4.0 4.7 5.9 6.4 5.1 3.1 SEMA4B "KIAA1745, MGC131831, SEMAC, SemC" ENSG00000185033 "Semaphorin 4B" 15 90160604-90229679 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 51.8;RPTEC TERT1: 32.1;RT4: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 14.7;naive B-cell: 11.8;neutrophil: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 14.7;granulocytes: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013372 Approved Approved "Nucleoplasm,Vesicles,Cell Junctions" "Cell Junctions" "Nucleoplasm, Vesicles" "HPA013372: AB_1856670" "unprognostic (3.33e-2)" "unprognostic (5.96e-2)" "unprognostic (2.23e-2)" "unprognostic (2.50e-2)" "unprognostic (7.78e-2)" "unprognostic (4.48e-2)" "unprognostic (6.34e-3)" "prognostic unfavourable (1.25e-4)" "unprognostic (2.04e-1)" "unprognostic (9.31e-2)" "unprognostic (1.58e-3)" "unprognostic (4.67e-2)" "prognostic unfavourable (3.33e-8)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (3.57e-2)" "unprognostic (7.09e-2)" 7.0 19.8 13.1 13.7 16.7 7.1 13.6 9.1 13.1 16.2 21.7 9.4 18.2 24.0 9.0 12.3 56.7 16.3 20.3 13.8 13.3 7.6 18.6 32.1 11.6 10.0 13.4 11.1 17.0 19.8 9.4 10.8 14.6 15.4 18.1 10.0 15.4 21.3 15.7 4.0 29.0 22.2 13.5 18.8 16.3 22.4 8.3 14.8 12.8 32.7 15.5 27.2 31.6 24.6 14.7 0.9 4.0 2.0 0.3 0.7 1.0 5.8 15.9 1.2 3.8 1.1 0.8 8.8 1.8 3.9 2.2 2.4 1.9 51.8 4.1 20.1 1.3 27.8 1.0 25.8 1.8 23.6 3.3 5.4 3.9 2.6 4.4 0.6 2.5 3.1 11.3 2.4 5.1 2.5 2.6 6.6 1.2 4.3 1.4 2.3 5.4 14.6 1.7 0.9 9.0 32.1 34.9 3.8 3.9 6.3 10.2 2.4 7.1 1.6 5.6 1.8 3.4 3.7 4.0 9.6 11.5 2.0 17.1 4.5 1.8 0.0 2.0 0.3 0.7 1.2 0.5 14.7 0.5 0.4 0.9 11.8 0.4 0.5 4.0 0.3 2.0 0.1 0.1 1.0 13.1 16.7 9.1 13.1 13.3 7.6 13.4 11.1 15.4 14.8 SEMA4D "C9orf164, CD100, coll-4, FLJ39737, SEMAJ" ENSG00000187764 "Semaphorin 4D" Q92854 9 89360787-89498130 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.1;skeletal muscle: 43.3" "Cell line enhanced" "Detected in many" "HDLM-2: 42.9;HMC-1: 33.1;MOLT-4: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015662, HPA023277" Approved Supported "Endoplasmic reticulum,Vesicles" 4100000 Vesicles "Endoplasmic reticulum" "HPA015662: AB_1856671, HPA023277: AB_1856672" "unprognostic (2.94e-2)" "prognostic favourable (4.17e-4)" "unprognostic (1.12e-2)" "unprognostic (8.22e-2)" "unprognostic (1.41e-1)" "unprognostic (1.76e-3)" "unprognostic (1.27e-1)" "unprognostic (1.58e-1)" "unprognostic (7.79e-2)" "unprognostic (2.74e-1)" "unprognostic (3.18e-3)" "unprognostic (1.50e-2)" "unprognostic (2.29e-3)" "unprognostic (3.05e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-1)" "prognostic favourable (4.06e-5)" 3.9 5.6 18.0 18.6 20.7 14.3 3.6 7.7 20.9 4.0 5.9 54.0 3.1 6.1 3.9 7.4 9.3 6.6 7.2 4.9 28.2 18.8 8.4 2.0 6.7 32.0 42.6 15.0 4.1 4.6 4.9 5.3 3.2 27.5 4.9 5.8 2.9 6.7 4.2 43.3 8.8 9.6 3.3 107.1 19.2 9.4 6.1 23.3 25.3 4.9 3.1 27.6 8.3 5.3 2.6 4.6 21.2 4.1 4.7 14.0 7.8 4.0 3.0 2.8 4.1 0.1 0.2 6.5 0.4 0.2 0.8 0.6 2.0 4.6 15.5 1.7 0.0 2.1 2.5 1.2 0.3 42.9 2.5 6.5 1.0 0.2 0.5 8.6 33.1 0.1 0.9 0.2 0.1 1.6 1.5 10.6 0.0 6.7 38.9 10.8 6.9 0.1 12.4 0.9 4.3 5.5 4.2 6.7 4.4 1.1 3.6 0.1 3.4 4.7 1.0 0.0 2.6 0.3 2.0 11.9 5.1 2.2 2.0 10.5 2.5 7.3 4.1 20.4 13.3 3.8 8.0 2.6 10.6 11.1 1.5 1.6 12.2 14.0 21.2 4.7 4.1 4.6 9.5 7.8 18.0 20.7 7.7 20.9 28.2 18.8 42.6 15.0 27.5 23.3 SEMA4G "FLJ20590, KIAA1619" ENSG00000095539 "Semaphorin 4G" Q9NTN9 10 100969518-100985871 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.0;liver: 33.9" "Group enriched" "Detected in many" 4 "A549: 13.7;CACO-2: 13.1;Hep G2: 47.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038362, HPA077752" Uncertain Uncertain "Vesicles,Lipid droplets" "Intracellular and membrane" 840000 "Vesicles, Lipid droplets" "HPA038362: AB_10669524, HPA077752: " "unprognostic (3.90e-3)" "unprognostic (9.43e-3)" "unprognostic (2.84e-1)" "unprognostic (1.13e-2)" "unprognostic (5.55e-2)" "unprognostic (8.11e-2)" "unprognostic (3.28e-1)" "unprognostic (3.71e-2)" "unprognostic (3.63e-1)" "unprognostic (1.41e-2)" "unprognostic (3.09e-2)" "unprognostic (3.14e-1)" "unprognostic (3.93e-2)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.05e-2)" 1.2 5.0 8.2 9.2 5.6 0.2 1.9 17.8 9.0 2.5 34.3 4.9 3.2 25.9 2.1 16.6 1.8 3.1 25.9 1.6 4.9 5.0 9.5 33.9 2.9 1.2 4.2 4.6 9.2 21.3 3.7 4.4 2.2 7.8 8.6 42.3 4.8 4.3 6.1 1.2 7.1 44.0 2.5 2.5 1.8 10.4 2.5 3.7 0.1 9.8 0.5 0.5 2.3 2.4 2.4 1.0 0.4 0.4 0.0 1.3 0.0 0.0 13.7 3.5 1.5 2.2 0.7 3.0 0.5 1.5 0.7 0.7 13.1 2.2 0.2 1.8 0.6 0.9 3.4 0.6 0.6 0.3 2.1 0.7 1.1 47.9 5.7 0.5 0.4 3.7 0.8 0.7 0.4 1.9 1.3 0.1 1.1 0.8 0.2 0.5 0.5 0.8 1.3 0.3 0.6 3.2 0.4 1.1 5.5 0.5 0.9 1.4 3.8 0.6 1.3 0.4 1.6 0.4 0.1 0.4 0.2 0.2 0.4 0.4 0.4 0.0 0.4 0.4 0.3 0.0 0.2 2.4 0.4 1.3 1.0 0.6 0.4 0.2 0.0 0.0 0.2 0.3 0.1 0.0 8.2 5.6 17.8 9.0 4.9 5.0 4.2 4.6 7.8 3.7 SEMA7A "CD108, H-Sema-L, SEMAL" ENSG00000138623 "Semaphorin 7A (John Milton Hagen blood group)" O75326 15 74409289-74433958 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Differentiation, Inflammatory response, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;lymphoid tissue: 34.7;placenta: 54.0" "Cell line enhanced" "Detected in many" "HMC-1: 99.7;hTEC/SVTERT24-B: 39.1;U-251 MG: 57.5;U-87 MG: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 8.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008210, HPA042273" Uncertain Uncertain Vesicles 29000000 Vesicles "HPA008210: , HPA042273: AB_10806234" "unprognostic (2.00e-1)" "unprognostic (2.72e-1)" "unprognostic (2.02e-2)" "unprognostic (5.81e-2)" "unprognostic (6.49e-2)" "unprognostic (8.61e-2)" "unprognostic (2.54e-2)" "unprognostic (4.18e-3)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (5.18e-3)" "unprognostic (1.44e-1)" "prognostic unfavourable (2.45e-11)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (6.25e-2)" "unprognostic (2.57e-2)" 2.2 1.9 5.4 10.4 13.8 12.8 1.4 22.9 27.3 1.3 1.8 19.9 1.4 2.7 4.3 1.8 3.2 1.2 3.3 1.4 10.8 5.7 1.4 1.5 4.4 19.0 28.5 5.7 5.9 0.9 6.4 1.9 54.0 28.6 1.4 1.8 7.8 1.7 3.5 1.4 4.7 6.0 2.0 36.4 34.7 3.7 23.6 15.4 9.0 1.1 0.4 19.7 4.6 1.7 1.4 1.8 8.9 0.0 0.8 0.2 0.0 5.7 0.0 1.7 0.5 2.2 7.4 14.3 26.5 10.7 5.6 8.6 2.2 9.4 0.0 1.5 12.0 1.7 0.5 1.7 5.8 0.4 0.3 10.3 0.0 2.8 0.5 0.3 99.7 5.2 0.0 39.1 2.2 0.0 5.9 3.6 18.1 0.4 1.4 3.4 1.8 4.0 0.2 1.1 1.5 2.3 2.4 0.1 0.1 0.2 4.8 2.1 0.3 2.1 1.0 10.5 7.0 5.0 57.5 0.6 0.4 0.1 33.6 1.2 0.5 3.9 0.0 8.9 0.2 0.0 0.2 1.4 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.8 0.0 1.8 0.0 0.0 5.4 13.8 22.9 27.3 10.8 5.7 28.5 5.7 28.6 15.4 SENP8 "DEN1, HsT17512, NEDP1, PRSC2" ENSG00000166192 "SUMO/sentrin peptidase family member, NEDD8 specific" Q96LD8 15 72114258-72143688 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036273 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA036273: AB_10669985" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-4)" "unprognostic (5.43e-2)" "unprognostic (1.49e-1)" "unprognostic (6.09e-3)" "unprognostic (3.06e-2)" "unprognostic (4.35e-2)" "unprognostic (1.06e-1)" "unprognostic (2.04e-1)" "unprognostic (3.11e-2)" "unprognostic (1.19e-1)" "unprognostic (8.46e-12)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.85e-2)" "unprognostic (1.54e-2)" 2.5 4.8 6.4 3.4 8.1 5.0 4.4 5.7 8.0 4.0 4.0 3.9 6.4 3.8 3.9 6.7 4.8 5.1 4.2 7.7 7.3 6.9 9.3 5.0 3.3 3.1 6.2 7.7 5.3 6.2 3.9 12.7 3.7 8.0 5.9 4.3 4.2 5.6 6.6 11.0 3.5 3.3 4.2 5.0 3.1 4.3 26.5 4.3 2.2 12.0 4.5 2.7 4.9 3.0 3.0 5.7 2.1 5.6 7.1 3.7 2.1 1.9 3.2 6.3 5.0 7.6 9.2 3.5 5.0 3.1 3.0 2.8 2.7 4.5 1.9 7.4 3.2 4.5 9.6 7.7 4.4 2.1 5.3 3.0 4.5 2.2 5.3 3.6 1.7 4.5 7.8 1.9 8.4 2.8 4.6 3.6 7.1 4.9 3.6 4.7 5.0 3.3 2.4 5.4 4.0 7.9 3.4 7.7 2.5 5.3 4.4 5.2 6.7 2.7 2.9 6.1 2.2 10.1 2.5 3.0 3.6 2.3 2.9 5.0 4.3 2.1 1.9 1.4 1.6 3.9 2.3 3.0 2.8 2.5 5.7 1.4 3.1 3.7 0.7 7.1 5.6 1.7 2.1 2.1 6.4 8.1 5.7 8.0 7.3 6.9 6.2 7.7 8.0 4.3 SEPSECS "SLA, SLA/LP" ENSG00000109618 "Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase" Q9HD40 4 25120014-25160442 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "RNA-binding, Transferase, tRNA-binding" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 34.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070409 Approved Vesicles Vesicles "HPA070409: " "unprognostic (1.83e-1)" "unprognostic (4.09e-2)" "unprognostic (6.37e-3)" "unprognostic (5.86e-2)" "unprognostic (9.63e-2)" "unprognostic (4.61e-3)" "unprognostic (1.82e-3)" "unprognostic (6.33e-2)" "unprognostic (1.24e-1)" "unprognostic (3.34e-1)" "unprognostic (2.52e-1)" "unprognostic (3.56e-2)" "unprognostic (4.45e-3)" "unprognostic (4.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.16e-2)" "unprognostic (2.13e-3)" 7.0 6.1 3.8 8.5 6.4 11.8 7.4 5.4 6.0 5.3 13.5 7.8 8.9 11.8 6.7 9.6 5.3 6.5 8.9 5.6 4.8 3.6 10.5 34.2 9.4 9.7 7.2 4.9 8.5 11.3 7.3 5.1 4.4 5.4 4.7 7.8 5.2 6.2 9.2 5.5 10.9 15.3 3.7 7.0 7.5 7.4 8.9 6.8 12.3 7.7 4.8 8.0 6.8 5.5 5.7 5.9 3.2 4.0 3.4 5.5 2.2 2.9 1.6 6.3 3.3 5.7 8.0 5.5 3.1 4.1 3.4 3.4 1.3 7.3 5.4 3.0 3.5 3.6 4.9 3.6 3.8 2.7 1.6 6.7 5.6 2.6 6.4 5.9 8.8 7.5 5.8 2.5 5.7 3.6 10.5 5.5 2.7 1.7 9.4 16.5 2.9 6.2 4.8 7.4 4.8 4.7 3.1 4.7 4.4 2.8 2.2 5.2 4.2 5.7 3.7 5.2 2.7 1.7 2.9 8.7 9.7 6.0 3.2 9.7 3.2 2.4 4.0 2.2 3.6 3.4 3.5 3.4 4.5 4.9 3.4 5.7 4.6 5.5 3.2 3.4 2.4 5.9 2.6 2.2 3.8 6.4 5.4 6.0 4.8 3.6 7.2 4.9 5.4 6.8 SERINC5 "C5orf12, TPO1" ENSG00000164300 "Serine incorporator 5" Q86VE9 5 80111651-80256079 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.6;RT4: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037898, HPA037899" Supported Supported "Vesicles,Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Cytosol" "Vesicles, Centrosome" "HPA037898: AB_10673649, HPA037899: " "unprognostic (2.95e-1)" "unprognostic (1.80e-1)" "unprognostic (4.98e-3)" "unprognostic (1.08e-2)" "unprognostic (5.05e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-2)" "unprognostic (8.00e-2)" "unprognostic (2.10e-1)" "unprognostic (2.68e-2)" "unprognostic (7.71e-2)" "unprognostic (1.62e-1)" "unprognostic (1.40e-2)" "unprognostic (4.81e-2)" "unprognostic (8.09e-2)" "unprognostic (4.93e-2)" "unprognostic (9.17e-2)" 6.9 21.1 9.0 7.8 11.2 3.0 6.7 5.3 15.6 10.2 16.3 28.8 11.2 5.1 6.9 12.9 9.7 9.6 8.4 4.1 9.5 7.3 5.3 26.3 8.0 9.3 13.4 7.0 9.8 7.8 4.2 5.3 24.7 12.1 20.3 17.5 3.6 9.8 8.4 3.1 10.9 9.5 4.4 9.7 8.3 9.7 18.9 15.0 7.8 5.2 6.7 12.3 9.3 7.7 0.8 4.0 6.2 6.9 0.4 17.5 4.7 5.1 9.2 3.1 2.0 4.3 4.6 9.3 4.2 2.8 1.8 1.9 18.5 26.6 0.8 4.3 5.4 14.9 4.2 11.1 2.7 0.7 2.2 0.6 1.1 9.9 1.6 0.6 1.9 5.2 6.2 4.8 12.6 3.4 1.6 4.4 4.9 8.8 10.3 2.5 4.3 3.2 12.3 2.7 1.4 5.5 25.4 0.2 3.0 3.7 8.7 16.3 3.8 3.2 3.7 5.4 1.5 5.4 5.2 5.7 1.6 13.3 10.2 1.8 22.0 6.2 6.9 4.4 1.6 3.4 1.2 0.5 13.9 4.2 4.0 0.8 17.5 10.5 3.6 0.4 1.0 0.9 4.5 4.7 9.0 11.2 5.3 10.9 9.5 7.3 13.4 7.0 12.1 15.0 SERPINA1 "A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1" ENSG00000197249 "Serpin family A member 1" P01009 14 94376747-94390693 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "liver: 3314.2" "Cell line enriched" "Detected in some" 8 "Hep G2: 318.5" "Cancer enriched" "Detected in all" 10 "liver cancer: 3850.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0" "Group enriched" "Detected in many" 5 "granulocytes: 139.3;monocytes: 203.0" "Region enriched" "Detected in many" 6 "cerebellum: 334.2" "HPA000927, HPA001292, CAB013211, CAB016648, CAB073396" Enhanced Enhanced Vesicles "Secreted to blood" 1663100000000 210000000000 Vesicles "CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762" "prognostic favourable (1.61e-5)" "unprognostic (3.37e-1)" "prognostic favourable (5.86e-4)" "unprognostic (1.38e-2)" "unprognostic (1.98e-2)" "unprognostic (5.50e-3)" "unprognostic (3.81e-2)" "unprognostic (6.78e-2)" "unprognostic (2.54e-2)" "unprognostic (7.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.54e-1)" "unprognostic (1.23e-2)" "unprognostic (1.89e-1)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (1.96e-1)" 0.9 0.4 0.7 4.9 1.4 3.0 2.4 0.2 0.7 2.6 7.5 0.5 3.1 6.3 0.8 8.6 0.4 0.7 14.2 1.0 0.4 0.5 74.1 3314.2 13.6 5.3 1.0 0.2 0.6 7.4 0.0 0.4 0.8 0.8 0.6 4.1 0.6 0.9 3.6 0.2 0.3 36.2 1.4 1.3 8.9 7.0 0.8 0.8 0.5 0.8 0.2 0.9 0.5 0.6 0.3 33.5 139.3 203.0 0.2 0.3 100.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 12.6 40.1 0.1 1.1 0.0 0.1 0.0 0.8 0.0 4.9 0.0 0.2 0.1 318.5 0.0 1.1 0.1 0.2 0.4 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.1 0.5 0.1 1.1 0.1 21.5 0.2 0.0 0.0 0.4 0.1 0.1 18.9 0.1 0.1 0.1 5.0 0.1 0.6 0.2 0.1 0.4 0.3 2.8 0.0 0.4 110.2 29.1 0.2 165.9 0.3 0.3 0.1 0.2 33.5 0.1 0.2 0.1 139.3 0.2 203.0 0.7 0.2 100.0 0.7 1.4 0.2 0.7 0.4 0.5 1.0 0.2 0.8 0.8 SERPINB5 "maspin, PI5" ENSG00000206075 "Serpin family B member 5" P36952 18 63476761-63505085 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 99.3;skin 1: 60.7;tongue: 118.8" "Cell line enhanced" "Detected in some" "HaCaT: 143.8;HBEC3-KT: 47.4;hTCEpi: 99.9;hTERT-HME1: 25.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 124.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009570, HPA019025, HPA019132, HPA020136" Enhanced Supported Vesicles "Intracellular and membrane" 660000 Vesicles "CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728" "unprognostic (2.84e-3)" "unprognostic (1.05e-1)" "unprognostic (9.24e-2)" "unprognostic (1.04e-3)" "unprognostic (2.09e-2)" "prognostic unfavourable (1.54e-4)" "unprognostic (1.36e-1)" "unprognostic (3.47e-3)" "prognostic unfavourable (5.71e-6)" "unprognostic (1.28e-1)" "unprognostic (1.84e-6)" "unprognostic (2.57e-1)" "unprognostic (6.58e-2)" "unprognostic (3.14e-1)" "unprognostic (8.38e-2)" 0.2 0.1 0.1 0.9 0.1 0.0 9.7 0.1 0.1 23.6 2.7 0.1 0.7 3.9 2.1 0.5 99.3 0.1 4.3 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 4.1 1.0 0.1 11.1 0.3 0.1 60.7 6.8 0.9 0.1 0.1 2.2 0.4 0.1 5.1 0.1 118.8 41.2 7.1 19.7 0.6 0.5 1.2 0.4 1.0 0.5 0.1 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.4 0.0 143.8 0.0 47.4 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 99.9 0.0 25.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 10.5 0.1 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.4 0.3 0.4 0.2 0.1 0.2 0.2 0.4 0.2 0.6 0.5 0.3 1.2 1.0 0.2 0.5 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 SERPIND1 "D22S673, HC-II, HC2, HCF2, HLS2" ENSG00000099937 "Serpin family D member 1" P05546 22 20773879-20787720 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Chemotaxis, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "liver: 170.8" "Cell line enriched" "Detected in some" 10 "Hep G2: 62.7" "Cancer enriched" "Detected in many" 80 "liver cancer: 334.4" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008639, HPA055767" Supported Approved Vesicles "Secreted to blood" 94000000000 Vesicles "CAB008639: AB_1618010, HPA055767: " "unprognostic (1.68e-1)" "unprognostic (8.27e-2)" "unprognostic (4.40e-2)" "prognostic favourable (4.09e-4)" "unprognostic (5.42e-2)" "unprognostic (1.23e-1)" "unprognostic (1.12e-3)" "unprognostic (1.56e-1)" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-2)" "unprognostic (2.88e-1)" "unprognostic (3.94e-9)" "unprognostic (2.01e-1)" "unprognostic (4.66e-2)" "unprognostic (8.36e-3)" "unprognostic (1.46e-1)" 0.0 0.0 0.0 0.0 2.3 0.0 0.2 0.6 0.9 0.3 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 170.8 0.3 0.0 0.0 0.7 0.3 0.0 3.6 0.1 0.2 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 1.9 2.7 0.7 0.4 1.3 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 62.7 0.0 0.2 0.1 0.0 0.0 0.5 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 4.3 0.0 0.4 0.0 1.0 0.2 1.7 0.4 0.5 0.6 0.1 1.9 0.9 0.7 0.7 1.3 0.2 2.7 0.7 0.1 0.0 2.3 0.6 0.9 0.0 0.0 0.0 0.7 2.6 0.5 SERTM1 C13orf36 ENSG00000180440 "Serine rich and transmembrane domain containing 1" A2A2V5 13 36673912-36697839 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.2;endometrium 1: 30.9;fallopian tube: 25.3" "Group enriched" "Detected in some" 5 "HAP1: 2.6;HEK 293: 3.1;NTERA-2: 7.9;SH-SY5Y: 4.6" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.7" "Group enriched" "Detected in many" 7 "amygdala: 13.9;basal ganglia: 10.1;cerebral cortex: 21.6;hippocampal formation: 26.5;olfactory region: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054814, HPA070485" Uncertain Enhanced Vesicles Vesicles "HPA054814: , HPA070485: " "unprognostic (8.71e-2)" "unprognostic (2.11e-1)" "unprognostic (5.58e-3)" "unprognostic (4.66e-3)" "unprognostic (4.05e-3)" "unprognostic (5.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.63e-2)" "unprognostic (1.00e-8)" "unprognostic (2.51e-2)" "unprognostic (5.60e-2)" "unprognostic (4.44e-2)" 5.0 1.8 13.9 0.5 10.1 0.5 1.2 0.3 30.2 16.4 0.7 1.3 1.8 0.6 30.9 13.5 0.5 25.3 0.5 0.6 26.5 2.0 0.6 0.5 5.6 0.5 1.5 11.6 14.5 0.8 1.0 11.2 0.5 2.4 0.9 0.5 8.2 0.5 1.2 0.5 0.6 0.6 17.4 0.9 0.5 0.9 1.5 0.0 0.0 9.3 0.0 0.5 1.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 3.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 10.1 0.3 21.6 26.5 2.0 1.5 11.6 2.4 0.0 SETDB1 "ESET, KG1T, KIAA0067, KMT1E, TDRD21" ENSG00000143379 "SET domain bifurcated 1" Q15047 1 150926263-150964744 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "U-698: 88.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018142, HPA058484" Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA018142: AB_1856757, HPA058484: " "unprognostic (1.07e-1)" "unprognostic (4.08e-1)" "unprognostic (8.02e-2)" "unprognostic (2.24e-3)" "unprognostic (1.65e-2)" "unprognostic (9.57e-2)" "prognostic unfavourable (8.88e-4)" "unprognostic (6.03e-2)" "unprognostic (9.94e-3)" "unprognostic (7.13e-2)" "unprognostic (1.21e-1)" "unprognostic (6.65e-2)" "prognostic unfavourable (4.25e-4)" "unprognostic (1.59e-1)" "unprognostic (3.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" 16.9 15.4 9.5 21.2 15.9 16.9 17.7 21.6 18.2 18.6 15.4 25.2 18.6 13.0 22.8 18.9 15.6 16.8 14.0 10.9 9.6 8.5 13.3 12.7 15.6 20.7 15.3 13.2 23.9 17.6 21.0 15.4 18.4 13.7 14.9 16.8 20.6 16.1 18.5 20.0 18.0 17.1 17.9 13.7 21.9 15.0 33.5 14.2 24.5 18.6 12.0 20.7 18.6 16.3 11.2 12.8 6.9 14.9 7.6 9.1 5.3 5.7 6.7 9.8 6.4 4.7 6.3 16.3 4.8 5.5 6.9 5.9 4.5 8.0 11.4 6.6 5.3 7.3 9.1 5.1 5.5 5.5 11.3 6.4 6.9 5.2 6.7 11.3 6.1 8.2 5.8 5.7 9.2 8.1 10.8 9.3 4.9 11.1 7.8 6.6 13.4 5.4 9.1 6.3 8.4 5.3 6.6 7.1 13.0 7.3 8.6 5.8 9.3 15.4 5.4 4.0 4.2 4.4 6.7 9.7 10.4 88.6 4.2 4.0 3.9 6.8 10.7 6.9 8.3 14.9 8.7 8.7 7.4 9.1 12.8 11.2 8.3 8.3 6.5 7.6 10.6 8.6 4.7 5.3 9.5 15.9 21.6 18.2 9.6 8.5 15.3 13.2 13.7 14.2 SEZ6L ENSG00000100095 "Seizure related 6 homolog like" Q9BYH1 22 26169474-26383597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 60.8" "Group enriched" "Detected in some" 7 "SCLC-21H: 30.0;SH-SY5Y: 8.0" "Group enriched" "Detected in some" 6 "glioma: 14.6;pancreatic cancer: 3.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 7.4;myeloid DC: 7.2;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 73 "dendritic cells: 7.2;monocytes: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045135 Approved Vesicles 2400000 Vesicles "HPA045135: " "unprognostic (1.01e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.49e-2)" "unprognostic (6.47e-2)" "unprognostic (4.19e-1)" "unprognostic (1.09e-2)" "unprognostic (5.02e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-3)" "unprognostic (7.80e-2)" "unprognostic (2.40e-6)" "unprognostic (4.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.39e-4)" "unprognostic (3.18e-1)" 1.2 12.5 26.4 1.6 11.3 1.3 1.1 20.1 60.8 2.4 1.3 4.3 0.0 1.5 1.1 1.1 1.1 1.1 1.2 2.5 39.1 23.6 1.1 1.1 1.3 1.1 11.2 25.5 1.1 2.7 1.0 3.8 1.1 15.0 1.3 1.4 0.0 1.3 1.2 1.1 1.2 1.6 1.4 5.3 1.3 2.9 1.4 5.4 0.0 1.2 0.0 1.1 1.2 0.2 0.0 7.2 0.0 7.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 30.0 8.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.5 26.4 11.3 20.1 29.3 39.1 23.6 11.2 25.5 15.0 5.4 SGCE DYT11 ENSG00000127990 "Sarcoglycan epsilon" O43556 7 94524204-94656572 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 2.9;memory B-cell: 6.4;naive B-cell: 9.2" "Group enriched" "Detected in many" 4 "B-cells: 9.2;T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074790 Approved "Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane" 50000 "Vesicles, Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA074790: " "unprognostic (3.16e-3)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-3)" "unprognostic (1.12e-1)" "prognostic unfavourable (1.61e-5)" "unprognostic (1.19e-2)" "unprognostic (2.82e-2)" "unprognostic (6.93e-2)" "unprognostic (3.37e-1)" "unprognostic (6.80e-3)" "unprognostic (9.69e-2)" "unprognostic (5.71e-2)" "prognostic unfavourable (1.35e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" 22.4 35.7 16.9 7.5 19.0 0.6 23.2 23.6 18.5 22.5 20.5 16.8 14.0 5.3 23.6 16.8 11.1 17.1 19.0 19.3 17.7 14.3 12.9 8.9 17.3 9.0 21.5 12.9 59.3 12.9 8.7 23.1 31.9 15.0 15.6 9.7 11.2 11.9 22.7 6.1 3.5 8.0 28.1 20.9 15.8 11.2 13.2 17.5 2.9 15.4 6.9 4.4 22.7 16.1 9.2 0.3 0.6 0.1 1.4 2.9 0.5 3.8 12.0 12.2 19.7 19.4 36.5 2.2 14.5 29.3 12.4 18.8 7.5 22.8 3.6 20.7 25.6 2.5 18.3 6.4 16.9 0.6 9.9 0.3 11.8 8.1 15.2 1.1 0.0 29.4 9.0 18.2 23.8 8.7 0.0 28.8 14.4 12.0 0.0 0.0 9.3 9.5 5.4 15.1 7.6 24.0 3.8 7.7 6.2 0.0 16.1 18.4 5.6 0.1 0.0 39.2 13.1 3.6 22.4 14.9 18.5 4.4 14.6 0.0 22.0 0.6 0.1 0.1 2.9 0.1 1.2 6.4 0.9 1.4 0.1 9.2 0.3 1.0 0.5 1.4 0.1 0.3 0.2 0.5 16.9 19.0 23.6 18.5 17.7 14.3 21.5 12.9 15.0 17.5 SGK3 "SGK2, SGKL" ENSG00000104205 "Serum/glucocorticoid regulated kinase family member 3" Q96BR1 8 66667596-66862022 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006699, HPA027146" Supported Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA006699: , HPA027146: AB_1856745" "prognostic favourable (5.52e-6)" "prognostic favourable (8.28e-4)" "unprognostic (8.52e-3)" "unprognostic (1.10e-2)" "unprognostic (3.75e-1)" "unprognostic (1.37e-2)" "unprognostic (2.32e-1)" "unprognostic (1.69e-3)" "unprognostic (9.51e-2)" "unprognostic (8.86e-3)" "prognostic favourable (9.65e-4)" "unprognostic (1.94e-2)" "unprognostic (8.95e-2)" "unprognostic (4.55e-3)" "unprognostic (1.77e-1)" "unprognostic (1.01e-1)" "unprognostic (5.29e-3)" 6.5 5.9 13.9 8.7 20.9 7.7 23.9 9.8 14.8 12.0 10.0 24.0 8.7 8.6 8.0 10.3 7.6 7.8 7.8 5.4 16.1 10.2 14.9 13.6 9.9 8.5 28.8 9.3 9.8 15.6 29.2 14.8 5.9 14.6 7.8 10.7 17.2 7.0 7.7 6.1 12.4 10.8 6.0 32.8 8.2 7.2 8.9 21.9 8.3 17.3 4.3 6.8 6.1 8.0 5.8 13.8 21.4 15.7 6.9 13.3 8.0 11.4 2.9 0.5 1.8 3.5 6.8 6.5 7.3 6.9 4.0 4.2 5.2 7.7 8.6 1.8 8.0 3.7 6.0 4.3 5.0 4.8 10.2 7.8 2.1 5.1 3.5 7.0 9.3 3.3 3.8 1.9 6.7 6.4 1.5 4.2 7.6 1.8 5.5 4.3 1.6 4.0 9.7 4.3 5.8 5.4 2.6 2.5 1.9 3.3 4.9 11.0 23.1 14.0 7.6 3.8 3.4 3.3 2.7 5.2 9.9 9.9 4.4 11.8 3.9 21.4 15.7 6.2 8.1 9.3 13.3 3.7 8.4 8.5 13.8 5.8 9.0 6.9 2.5 6.9 4.4 7.7 5.3 8.0 13.9 20.9 9.8 14.8 16.1 10.2 28.8 9.3 14.6 21.9 SGK494 ENSG00000167524 "Uncharacterized serine/threonine-protein kinase SgK494" 17 28607964-28614200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: " "unprognostic (1.83e-1)" "unprognostic (9.42e-2)" "unprognostic (2.84e-2)" "unprognostic (2.30e-2)" "unprognostic (2.11e-1)" "unprognostic (2.06e-3)" "unprognostic (9.33e-3)" "unprognostic (2.63e-1)" "unprognostic (8.62e-4)" "unprognostic (2.09e-2)" "unprognostic (6.81e-2)" "unprognostic (3.45e-5)" "unprognostic (1.20e-7)" "unprognostic (2.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-3)" 1.6 4.7 10.3 3.5 25.3 10.6 2.3 17.8 25.8 1.9 1.8 0.9 0.4 0.7 2.0 4.5 1.3 2.4 0.8 2.1 8.6 3.7 5.6 1.6 3.2 3.3 2.5 10.7 3.7 1.3 2.0 5.6 3.1 11.2 2.3 4.0 6.3 1.9 3.2 3.8 6.3 2.3 1.9 2.9 3.4 1.3 8.5 4.1 0.1 2.5 0.1 3.5 1.9 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.4 5.2 6.2 5.7 2.0 2.5 4.5 0.8 0.4 2.1 1.9 6.2 0.7 7.1 0.9 2.9 3.1 4.6 2.5 2.7 4.0 6.8 7.4 4.0 3.6 0.2 9.9 5.2 1.2 7.4 7.5 4.2 2.3 7.1 0.6 1.3 7.2 2.5 6.6 6.2 1.0 7.2 8.8 4.7 1.2 6.8 3.8 3.5 4.4 2.4 3.7 3.7 5.5 3.1 4.2 3.6 4.2 5.0 3.9 3.6 8.6 3.1 7.3 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 25.3 17.8 25.8 8.6 3.7 2.5 10.7 11.2 4.1 SH2B1 "FLJ30542, SH2B" ENSG00000178188 "SH2B adaptor protein 1" Q9NRF2 16 28846600-28874212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076175 Approved Vesicles Vesicles "HPA076175: " "unprognostic (3.60e-2)" "unprognostic (1.94e-2)" "unprognostic (8.94e-2)" "unprognostic (2.27e-1)" "unprognostic (3.27e-1)" "unprognostic (3.27e-3)" "unprognostic (6.10e-2)" "prognostic favourable (9.40e-4)" "unprognostic (3.94e-2)" "unprognostic (1.18e-1)" "prognostic favourable (4.38e-4)" "unprognostic (1.39e-2)" "prognostic favourable (2.81e-6)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "prognostic favourable (1.60e-4)" 18.1 29.5 31.5 22.2 32.0 24.6 19.7 45.0 42.3 23.3 24.1 27.7 32.7 33.6 26.0 21.6 19.4 25.7 22.0 23.6 26.0 22.9 27.0 18.2 18.9 26.0 30.1 36.2 39.7 27.1 50.6 33.1 15.4 25.5 25.4 21.6 29.1 35.3 32.6 37.7 29.5 32.0 20.3 22.2 28.9 21.7 19.9 28.0 17.0 33.1 18.8 18.2 20.9 21.2 4.7 4.7 7.1 3.4 1.7 5.3 2.0 12.8 18.9 14.6 18.7 15.4 13.1 12.2 13.4 7.7 10.7 11.6 12.7 21.9 11.9 19.0 10.8 20.6 9.5 15.0 6.0 15.5 12.3 10.6 43.7 19.4 11.7 10.6 10.2 18.2 12.3 14.9 6.0 12.2 16.9 17.6 13.9 17.7 15.9 15.8 18.8 7.7 26.9 8.8 19.9 12.3 9.8 16.7 22.6 6.5 19.1 9.8 15.0 11.5 17.1 12.3 10.4 10.7 10.1 33.6 16.6 13.2 19.1 18.7 12.3 7.1 3.4 2.0 5.3 2.8 5.1 3.9 4.3 3.7 3.0 4.7 3.4 3.1 6.0 1.7 2.7 4.7 4.5 2.0 31.5 32.0 45.0 42.3 26.0 22.9 30.1 36.2 25.5 28.0 SH3BGRL MGC117402 ENSG00000131171 "SH3 domain binding glutamate rich protein like" O75368 X 81201943-81298547 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051248 Approved Approved Vesicles 14000000 Vesicles "HPA051248: " "unprognostic (3.02e-3)" "unprognostic (4.25e-2)" "unprognostic (4.89e-2)" "unprognostic (3.15e-2)" "unprognostic (1.46e-1)" "unprognostic (1.39e-1)" "unprognostic (2.25e-2)" "unprognostic (3.20e-2)" "unprognostic (1.23e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (4.08e-4)" "unprognostic (2.12e-1)" "unprognostic (3.75e-1)" "unprognostic (1.73e-1)" 46.5 35.9 48.6 32.9 40.4 43.2 51.5 11.7 40.4 60.0 70.4 27.3 43.5 25.0 66.2 45.0 49.3 45.0 43.1 24.2 42.4 46.3 41.4 17.6 37.7 46.3 56.7 29.0 40.1 23.1 29.7 59.8 24.3 40.7 55.6 32.1 27.8 34.8 88.1 9.7 19.1 33.6 77.4 67.1 52.7 41.0 26.7 36.0 46.5 33.4 21.4 34.8 81.7 34.9 31.5 41.1 83.4 71.1 23.2 32.6 51.1 0.1 7.0 25.5 29.2 33.7 45.8 1.7 15.6 29.8 5.7 11.8 2.2 21.5 20.9 13.5 22.8 3.8 18.0 11.2 9.2 17.7 6.3 27.7 11.7 1.3 8.1 19.4 54.5 26.5 8.1 8.1 7.2 25.2 9.5 52.0 31.3 9.4 20.2 25.3 20.0 11.3 18.6 11.6 11.0 29.6 9.6 0.0 11.3 0.0 0.7 14.1 8.5 59.5 25.5 16.0 6.4 14.6 6.4 12.1 10.4 19.2 18.3 39.9 11.8 83.4 49.5 71.9 17.6 63.9 19.0 31.5 22.3 20.7 41.1 26.0 20.7 21.6 17.1 23.2 71.1 19.4 32.6 51.1 48.6 40.4 11.7 40.4 42.4 46.3 56.7 29.0 40.7 36.0 SH3BP5L KIAA1720 ENSG00000175137 "SH3 binding domain protein 5 like" Q7L8J4 1 248810446-248826633 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038067, HPA038068" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA038067: AB_2675814, HPA038068: AB_10670651" "unprognostic (2.48e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (4.41e-1)" "unprognostic (2.78e-1)" "unprognostic (2.27e-3)" "unprognostic (1.99e-3)" "unprognostic (5.84e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (1.50e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-2)" "unprognostic (1.55e-1)" "unprognostic (4.99e-2)" "unprognostic (4.66e-2)" 4.1 5.0 5.3 4.0 4.8 3.0 3.3 10.3 8.7 4.1 4.9 6.2 4.9 2.5 7.2 4.7 3.3 6.5 5.5 4.0 4.1 4.5 3.9 4.2 4.2 3.9 4.2 5.9 2.4 5.0 3.9 2.9 5.1 5.7 13.6 8.0 5.6 4.3 5.0 5.4 4.3 3.6 3.6 4.0 4.1 3.7 1.1 1.2 6.2 1.8 0.4 1.5 1.0 9.8 6.2 8.2 9.4 11.8 8.0 10.9 22.3 7.7 13.1 9.9 6.0 8.8 5.0 13.6 18.7 10.6 7.8 9.6 6.3 11.3 2.8 8.1 6.7 4.8 7.2 8.8 9.8 6.5 10.3 14.5 5.6 8.6 13.8 5.2 8.7 3.2 8.3 6.0 14.5 16.0 9.4 5.8 10.0 8.9 4.4 9.6 13.2 6.9 8.6 7.4 9.2 18.1 11.9 16.1 6.9 6.5 34.0 13.0 14.5 4.5 12.0 10.1 6.8 5.5 1.8 5.4 1.1 1.0 1.1 0.5 1.5 0.9 1.2 1.1 0.5 0.4 6.2 0.4 0.4 0.8 0.2 1.0 SH3RF1 "KIAA1494, POSH, RNF142, SH3MD2" ENSG00000154447 "SH3 domain containing ring finger 1" Q7Z6J0 4 169094256-169271105 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 5.9;myeloid DC: 3.4;non-classical monocyte: 8.5" "Group enriched" "Detected in many" 13 "dendritic cells: 3.4;monocytes: 8.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074783 Approved Supported "Vesicles,Intermediate filaments" Vesicles "Intermediate filaments" "HPA074783: " "unprognostic (4.14e-1)" "unprognostic (4.67e-2)" "unprognostic (1.23e-1)" "unprognostic (7.83e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "unprognostic (1.29e-1)" "unprognostic (2.65e-1)" "unprognostic (8.44e-2)" "unprognostic (9.58e-2)" "unprognostic (4.77e-3)" "unprognostic (7.88e-2)" "prognostic favourable (5.51e-8)" "unprognostic (4.43e-2)" "unprognostic (1.63e-1)" "unprognostic (5.99e-2)" "unprognostic (1.77e-1)" 15.2 4.8 13.8 7.2 11.8 3.7 11.1 2.5 12.7 7.5 17.2 15.9 10.8 15.7 6.8 7.2 7.1 6.9 19.7 7.8 17.8 9.3 14.6 9.6 11.3 3.7 13.0 10.9 11.9 12.0 5.2 7.8 8.6 10.3 17.2 16.0 10.7 20.9 10.7 16.2 6.8 17.2 8.8 11.7 4.5 27.6 7.0 11.3 0.9 23.1 7.6 5.5 9.4 6.3 0.4 3.4 0.0 8.5 0.3 0.0 0.7 7.3 6.2 5.6 16.2 6.1 7.6 7.3 20.6 10.0 15.4 7.1 6.1 8.9 0.0 1.0 21.4 4.9 4.5 8.1 17.0 0.0 2.6 4.3 14.1 3.2 13.8 1.5 0.1 4.5 4.5 13.1 10.4 9.4 0.0 0.0 14.2 3.0 1.5 1.4 2.8 5.3 2.3 1.8 0.3 7.0 5.8 4.2 5.1 5.2 8.0 2.0 2.6 0.6 8.5 7.3 5.7 12.1 7.2 0.5 0.0 0.0 8.2 1.5 8.7 0.0 1.4 0.0 0.0 5.9 0.0 0.4 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.3 8.5 0.2 0.0 0.7 13.8 11.8 2.5 12.7 17.8 9.3 13.0 10.9 10.3 11.3 SHANK2 "CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3" ENSG00000162105 "SH3 and multiple ankyrin repeat domains 2" Q9UPX8 11 70467856-71252577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Cell line enhanced" "Detected in many" "Karpas-707: 16.6;MCF7: 9.5;RT4: 15.4;T-47d: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.1" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008174, HPA017220" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles" "Nuclear speckles" "Nucleoplasm, Vesicles" "HPA008174: AB_1856822, HPA017220: " "unprognostic (3.08e-1)" "unprognostic (1.31e-3)" "unprognostic (1.79e-1)" "unprognostic (1.51e-2)" "unprognostic (1.51e-1)" "unprognostic (7.23e-5)" "unprognostic (1.24e-1)" "unprognostic (6.67e-2)" "unprognostic (1.83e-2)" "unprognostic (8.42e-2)" "unprognostic (4.87e-2)" "unprognostic (4.01e-1)" "prognostic favourable (1.94e-6)" "unprognostic (3.46e-2)" "unprognostic (2.34e-1)" "unprognostic (4.03e-2)" "unprognostic (4.80e-2)" 2.1 1.7 16.8 0.8 22.6 0.0 7.3 6.1 24.1 2.8 3.1 2.3 1.9 2.4 1.8 3.1 5.1 7.9 1.1 0.2 12.2 8.1 7.0 4.7 5.5 0.3 3.6 12.9 0.2 11.3 0.0 7.3 2.7 8.7 4.6 2.8 1.4 12.7 3.3 0.1 1.2 2.0 0.6 1.5 1.5 4.7 1.2 3.7 0.0 8.5 0.0 0.5 2.3 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 7.7 4.2 0.0 0.4 0.7 3.1 0.6 0.3 0.0 0.0 8.1 2.9 5.1 1.5 0.0 0.8 0.0 2.9 0.0 0.0 0.2 0.0 0.0 8.4 0.0 0.0 1.7 0.2 1.5 0.0 0.0 0.0 0.0 16.6 1.6 9.5 0.0 0.0 3.3 0.3 0.0 7.6 7.5 3.9 15.4 2.5 1.0 0.0 6.2 0.0 11.8 0.0 0.0 0.1 1.2 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.8 22.6 6.1 24.1 12.2 8.1 3.6 12.9 8.7 3.7 SHISA2 "bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166" ENSG00000180730 "Shisa family member 2" Q6UWI4 13 26044597-26051031 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 12.9;skeletal muscle: 10.2;thyroid gland: 20.8" "Cell line enhanced" "Detected in some" "LHCN-M2: 13.8;NTERA-2: 10.0;RH-30: 32.0;U-2197: 20.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049752, HPA050172" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA049752: , HPA050172: " "unprognostic (2.08e-2)" "unprognostic (3.00e-1)" "unprognostic (2.41e-1)" "unprognostic (9.71e-2)" "unprognostic (6.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-1)" "prognostic favourable (3.30e-4)" "unprognostic (4.03e-2)" "unprognostic (3.10e-1)" "unprognostic (7.45e-2)" "unprognostic (2.17e-2)" "prognostic favourable (2.43e-4)" "unprognostic (5.56e-3)" "unprognostic (2.09e-1)" "unprognostic (3.46e-1)" "unprognostic (1.51e-2)" 0.3 0.0 0.7 0.0 2.0 0.0 12.9 0.0 0.5 1.5 0.0 0.4 0.0 7.9 0.0 0.0 0.3 0.0 2.0 0.6 3.0 0.0 3.7 0.1 1.1 0.0 0.0 0.0 1.7 0.0 0.4 0.0 1.9 0.0 10.2 1.0 0.3 0.0 3.5 0.0 1.6 0.9 20.8 0.3 0.0 0.0 0.8 0.6 2.2 1.1 1.0 5.6 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.6 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.2 2.6 1.0 0.0 0.0 1.2 0.7 0.0 0.0 13.8 0.7 1.4 0.3 10.0 5.0 0.0 32.0 0.2 1.2 4.5 0.3 0.0 0.2 0.0 3.5 0.4 0.1 1.1 0.0 0.5 20.0 4.3 0.0 0.0 0.0 0.0 0.0 2.7 2.2 0.4 1.7 0.6 0.7 1.0 0.6 1.7 0.7 0.3 0.8 3.9 5.6 1.6 1.0 1.1 0.6 0.7 0.4 SHISAL1 KIAA1644 ENSG00000138944 "Shisa like 1" Q3SXP7 22 44243667-44312851 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9" "Cell line enhanced" "Detected in some" "SiHa: 16.7;U-2197: 37.9;U-87 MG: 22.0;WM-115: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051178 Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA051178: " "unprognostic (4.07e-3)" "unprognostic (9.01e-2)" "unprognostic (1.83e-1)" "unprognostic (1.14e-1)" "unprognostic (6.54e-2)" "unprognostic (1.22e-1)" "unprognostic (7.79e-2)" "unprognostic (2.64e-2)" "unprognostic (8.10e-3)" "unprognostic (1.93e-3)" "unprognostic (1.33e-1)" "unprognostic (1.99e-1)" "unprognostic (1.51e-7)" "unprognostic (1.48e-2)" "unprognostic (2.41e-1)" "unprognostic (1.99e-4)" "unprognostic (1.10e-4)" 0.7 1.3 13.8 1.3 3.6 0.0 0.5 1.6 13.0 22.5 7.7 0.5 6.9 1.4 34.2 4.5 1.5 1.9 2.3 0.5 5.4 9.1 0.5 0.5 0.6 0.5 3.6 0.5 1.7 0.6 0.1 0.8 5.7 0.5 5.8 1.5 0.5 0.5 8.9 0.5 0.4 0.8 31.9 0.5 0.5 0.5 1.5 0.5 0.5 0.5 0.5 0.5 11.9 3.3 0.0 0.1 0.7 0.0 0.2 0.1 0.0 0.0 0.1 1.6 0.5 0.0 0.0 0.0 0.4 1.1 1.1 0.6 0.0 0.0 0.0 0.0 1.0 0.0 2.3 0.1 0.1 0.0 1.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 6.1 0.0 16.7 0.0 0.1 0.0 0.1 0.0 6.2 0.9 37.9 0.2 0.0 0.0 0.0 22.0 0.0 12.7 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 0.0 13.8 3.6 1.6 11.8 5.4 9.1 3.6 0.5 0.5 0.5 SHOX "GCFX, PHOG, SHOXY, SS" ENSG00000185960 "Short stature homeobox" O15266 X 624344-659411 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.3;breast: 13.9" "Group enriched" "Detected in some" 4 "BJ: 19.1;BJ hTERT+: 8.8" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 6.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA035141, HPA060931" Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA035141: , HPA060931: " "unprognostic (7.51e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-1)" "unprognostic (6.82e-2)" "unprognostic (2.45e-2)" "unprognostic (2.34e-1)" "unprognostic (9.24e-2)" "unprognostic (9.95e-2)" "unprognostic (5.67e-6)" "unprognostic (1.99e-1)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.38e-1)" 3.8 1.0 0.3 0.7 0.3 3.0 13.9 1.8 0.8 0.3 0.4 0.2 0.2 1.4 0.3 0.6 0.3 0.4 0.4 0.4 0.7 0.3 0.3 0.3 0.3 0.6 0.3 1.4 0.3 0.9 0.0 0.3 4.8 6.3 0.8 0.3 0.2 1.4 0.2 2.8 1.4 1.0 0.2 0.4 1.6 0.4 0.4 0.2 0.2 0.5 0.2 0.2 0.3 0.3 2.2 1.9 5.5 1.8 2.5 1.5 0.8 0.1 0.2 0.1 0.2 0.2 0.1 3.2 19.1 8.8 2.9 3.1 0.3 0.3 0.3 0.1 0.4 0.3 0.2 0.0 0.9 0.2 0.1 0.1 1.3 0.1 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.3 0.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.5 0.0 0.1 0.3 0.2 0.1 0.1 0.9 0.1 0.2 0.1 0.2 0.1 5.5 1.8 1.8 1.4 1.1 1.5 1.6 1.1 1.2 0.5 2.2 1.5 1.5 5.2 2.5 1.5 1.9 1.0 0.8 0.3 0.3 1.8 0.4 0.7 0.3 0.3 1.4 6.3 0.2 SHROOM1 "APXL2, KIAA1960" ENSG00000164403 "Shroom family member 1" Q2M3G4 5 132822141-132830898 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.7;urinary bladder: 37.8" "Cell line enhanced" "Detected in many" "RT4: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 3.7" "Lineage enriched" "Detected in single" 5 "monocytes: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037690, HPA037691" Uncertain Approved Vesicles Vesicles "HPA037690: , HPA037691: " "unprognostic (2.50e-1)" "unprognostic (1.06e-1)" "unprognostic (4.52e-2)" "unprognostic (2.66e-1)" "unprognostic (1.45e-2)" "unprognostic (3.47e-1)" "unprognostic (9.26e-2)" "unprognostic (1.33e-2)" "unprognostic (3.74e-1)" "unprognostic (3.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.01e-2)" "prognostic unfavourable (5.72e-6)" "unprognostic (8.22e-2)" "unprognostic (2.91e-2)" "unprognostic (2.88e-2)" "unprognostic (2.26e-3)" 5.5 2.4 8.2 2.9 13.5 0.7 3.5 8.3 9.6 4.2 12.0 26.3 23.8 6.5 6.4 2.7 2.2 3.8 7.2 2.4 9.5 5.3 3.2 42.7 4.6 1.0 23.8 7.9 2.6 6.7 7.6 3.1 12.4 12.3 35.9 11.9 8.8 6.3 17.0 1.8 1.5 10.0 4.9 13.8 1.3 10.5 1.3 20.5 0.0 3.0 0.6 1.0 37.8 11.6 0.1 0.2 0.7 3.7 0.3 0.1 0.6 6.7 4.1 0.7 0.6 1.2 3.4 7.3 6.8 6.3 5.8 6.5 8.9 4.7 1.2 9.9 4.0 0.7 2.5 4.6 3.6 6.8 7.9 0.2 6.4 8.1 3.5 0.5 2.4 1.5 2.5 4.1 2.5 3.8 5.4 6.6 4.9 3.5 0.1 3.0 1.1 5.7 0.4 0.0 0.6 1.0 19.3 4.7 1.2 6.7 0.6 3.7 4.2 2.3 3.7 6.7 9.0 0.9 8.8 7.1 5.0 0.1 6.6 0.0 2.1 0.5 3.7 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.3 0.8 0.0 0.0 0.6 8.2 13.5 8.3 9.6 9.5 5.3 23.8 7.9 12.3 20.5 SHROOM4 KIAA1202 ENSG00000158352 "Shroom family member 4" Q9ULL8 X 50591647-50814302 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 27.3" "Cell line enhanced" "Detected in some" "EFO-21: 6.0;HUVEC TERT2: 22.8;RH-30: 4.4;RPTEC TERT1: 4.9;TIME: 8.6;WM-115: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "basophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010089, HPA010565" Uncertain Approved "Vesicles,Focal adhesion sites" "Focal adhesion sites" Vesicles "HPA010089: , HPA010565: AB_1079961" "unprognostic (2.55e-2)" "unprognostic (1.43e-1)" "unprognostic (5.56e-2)" "prognostic unfavourable (8.37e-4)" "unprognostic (1.34e-1)" "unprognostic (1.60e-2)" "unprognostic (4.30e-3)" "unprognostic (4.55e-2)" "unprognostic (2.13e-1)" "unprognostic (2.93e-1)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (4.66e-4)" "unprognostic (7.30e-2)" "unprognostic (2.83e-1)" "unprognostic (1.74e-2)" "unprognostic (2.75e-1)" 13.1 3.5 5.9 3.6 12.1 2.4 10.1 1.9 7.7 6.4 2.9 27.3 1.6 2.4 6.8 3.6 5.2 4.3 5.7 8.5 8.3 4.8 9.7 1.9 21.4 1.9 15.9 6.5 2.5 1.9 3.6 3.7 15.3 13.0 3.6 3.0 4.8 3.5 3.7 6.0 3.2 2.6 7.4 19.7 2.1 2.4 1.5 15.8 0.0 6.3 6.7 2.1 4.8 4.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.4 0.1 0.0 6.0 0.7 0.6 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.4 22.8 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 4.4 0.0 4.9 2.1 0.1 0.0 0.0 0.7 1.3 0.0 0.1 8.6 0.0 0.0 0.0 0.6 0.4 0.0 0.0 1.2 0.2 4.4 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 12.1 1.9 7.7 8.3 4.8 15.9 6.5 13.0 15.8 SIAH2 ENSG00000181788 "Siah E3 ubiquitin protein ligase 2" O43255 3 150741127-150763477 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061293, CAB069930" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB069930: AB_1217916, HPA061293: " "prognostic favourable (1.17e-4)" "unprognostic (1.04e-3)" "unprognostic (3.83e-2)" "unprognostic (9.15e-2)" "unprognostic (1.69e-1)" "unprognostic (6.91e-2)" "unprognostic (1.86e-2)" "unprognostic (5.68e-3)" "unprognostic (6.26e-2)" "unprognostic (1.95e-2)" "prognostic unfavourable (8.21e-5)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.38e-2)" "unprognostic (5.56e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-2)" 9.6 48.0 7.6 11.8 10.3 22.7 23.5 10.9 17.2 30.0 10.5 8.4 20.3 7.9 23.5 13.9 28.8 14.9 11.0 10.7 7.2 7.3 8.4 35.5 11.8 19.1 9.9 7.5 19.0 14.6 6.4 8.1 31.4 7.9 18.8 9.2 8.3 11.2 21.7 8.3 19.3 9.5 17.4 9.4 16.9 12.0 8.7 8.6 23.6 11.4 10.6 25.1 22.7 25.6 3.0 3.1 10.0 2.7 1.6 3.6 1.1 16.6 4.1 3.2 6.4 11.1 8.4 13.1 6.9 8.0 8.4 10.3 8.4 7.5 9.3 10.2 7.2 10.3 8.7 6.2 7.9 7.8 6.2 18.2 5.0 27.9 15.9 10.0 5.4 7.6 14.5 5.0 11.5 6.5 4.5 36.7 5.3 20.0 18.3 5.1 10.5 8.2 13.5 7.0 33.3 5.3 5.8 12.5 5.9 5.2 4.9 12.3 32.9 15.1 4.5 5.8 5.2 12.6 9.3 43.7 16.6 13.0 5.5 14.5 2.9 9.5 2.7 10.0 2.1 1.5 3.2 2.5 3.6 3.2 2.4 3.0 1.9 1.9 5.9 1.6 1.5 3.1 2.0 1.1 7.6 10.3 10.9 17.2 7.2 7.3 9.9 7.5 7.9 8.6 SIK1 "msk, SNF1LK" ENSG00000142178 "Salt inducible kinase 1" P57059 21 43414483-43427189 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell cycle, Differentiation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 34.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.7;HeLa: 27.8;hTCEpi: 21.5;LHCN-M2: 21.6;U-266/84: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 10 "B-cells: 2.0;dendritic cells: 1.6" "CAB023801, HPA038211, HPA078064" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB023801: , HPA038211: , HPA078064: " "unprognostic (4.06e-2)" "unprognostic (9.38e-2)" "unprognostic (3.31e-3)" "unprognostic (3.00e-1)" "unprognostic (5.02e-2)" "unprognostic (7.97e-3)" "unprognostic (1.51e-1)" "unprognostic (7.30e-3)" "unprognostic (2.35e-3)" "unprognostic (4.97e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-1)" "unprognostic (3.89e-1)" "unprognostic (9.94e-3)" "unprognostic (3.88e-2)" "unprognostic (2.89e-1)" "unprognostic (1.82e-1)" 8.8 2.3 3.0 3.6 3.0 5.9 7.5 3.0 3.0 13.5 3.0 3.0 3.0 0.0 3.0 3.0 12.9 5.5 10.7 7.1 3.0 0.8 3.0 12.3 5.4 3.0 3.0 3.0 13.7 7.3 3.5 5.7 8.2 3.0 3.9 0.1 3.0 4.6 9.8 5.0 34.5 3.0 3.3 3.0 4.0 5.3 3.0 3.0 3.0 3.9 3.0 3.0 10.5 6.1 2.0 1.6 0.0 0.1 0.0 0.1 0.1 0.5 1.7 2.0 0.0 0.1 0.8 0.7 0.9 0.3 1.6 1.3 2.4 0.0 2.4 0.7 0.2 11.1 1.6 16.7 1.0 0.1 0.5 0.7 27.8 0.9 2.3 0.7 0.1 1.0 21.5 0.4 5.1 0.3 0.1 0.5 21.6 0.1 0.4 1.7 0.8 1.5 0.0 0.3 2.5 1.9 6.3 0.0 0.0 10.9 1.8 0.4 1.1 0.3 3.7 0.4 2.0 0.1 0.0 4.3 15.7 0.4 4.6 2.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.1 0.5 0.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 3.0 3.0 3.0 3.0 3.0 0.8 3.0 3.0 3.0 3.0 SIK1B ENSG00000275993 "Salt inducible kinase 1B (putative)" 21 6111134-6123739 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 29.9;Karpas-707: 40.7;LHCN-M2: 28.0;SiHa: 29.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 6 "B-cells: 1.6;dendritic cells: 5.0;monocytes: 1.7" "HPA038211, HPA078064" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA038211: , HPA078064: " "unprognostic (2.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.57e-2)" "unprognostic (8.85e-2)" "unprognostic (3.32e-2)" "unprognostic (2.44e-1)" "unprognostic (6.58e-3)" "unprognostic (2.62e-2)" "unprognostic (6.56e-2)" "unprognostic (3.15e-2)" "unprognostic (5.52e-3)" "unprognostic (1.01e-2)" "unprognostic (9.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.41e-1)" "unprognostic (2.69e-3)" "unprognostic (7.41e-2)" 9.7 13.7 0.4 3.0 1.7 8.4 5.2 0.4 3.1 2.9 3.0 1.3 4.6 0.9 3.1 1.9 6.8 1.0 15.5 6.2 1.5 1.7 12.3 8.5 1.2 1.8 0.6 10.2 11.2 1.6 2.2 3.2 2.6 5.1 2.3 7.6 3.9 14.3 9.1 2.9 6.1 1.7 2.1 2.0 5.0 1.7 1.0 1.0 0.9 5.6 3.2 7.1 2.7 1.6 5.0 0.0 1.7 0.3 0.5 0.1 3.1 15.7 1.2 1.0 0.2 0.1 2.8 0.4 0.2 0.6 0.3 17.6 2.3 1.1 0.5 0.0 0.3 1.8 0.0 0.2 2.8 0.6 2.4 29.9 3.3 1.1 0.4 0.2 0.4 13.9 1.6 9.1 0.6 0.9 40.7 28.0 1.5 0.3 0.7 1.7 1.8 0.6 7.2 4.7 1.6 5.4 1.5 0.7 29.4 1.9 1.6 0.3 1.3 0.8 0.4 1.6 0.6 6.5 5.6 12.2 0.5 4.5 1.0 1.9 0.0 0.1 0.0 0.1 0.8 0.5 1.6 0.0 0.1 0.7 1.6 0.1 0.1 0.0 0.3 1.7 5.0 0.0 0.1 SIKE1 "FLJ21168, SIKE" ENSG00000052723 "Suppressor of IKBKE 1" Q9BRV8 1 114769479-114780685 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024177, HPA025726" Supported Approved "Vesicles,Focal adhesion sites" "Focal adhesion sites" Vesicles "HPA024177: AB_1848798, HPA025726: AB_1848800" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" "unprognostic (3.53e-2)" "unprognostic (4.52e-3)" "unprognostic (4.10e-1)" "unprognostic (6.04e-2)" "unprognostic (3.37e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-2)" "unprognostic (2.52e-2)" "unprognostic (1.94e-2)" "unprognostic (7.91e-2)" "unprognostic (2.38e-2)" "unprognostic (3.86e-2)" "unprognostic (9.06e-2)" "unprognostic (2.95e-3)" "unprognostic (1.05e-1)" 18.3 15.4 14.5 17.4 15.9 15.3 16.4 23.5 16.3 18.3 17.3 14.5 14.2 16.7 17.2 13.4 18.1 14.3 13.4 20.3 14.2 15.1 24.4 22.2 12.3 19.7 21.1 11.2 17.2 17.5 15.4 22.5 17.1 23.2 15.2 17.3 9.3 17.2 13.9 21.1 21.9 17.5 16.4 19.2 20.6 14.5 11.8 17.9 26.0 19.3 17.1 21.2 17.2 14.2 8.1 9.8 12.3 7.6 9.2 10.3 5.3 8.4 2.4 11.2 10.7 13.6 10.8 12.0 7.0 6.6 10.3 13.9 7.4 4.5 15.8 6.9 5.9 8.2 12.3 8.4 14.0 10.6 7.2 8.7 7.5 7.6 12.8 9.8 7.1 10.5 9.7 7.4 12.0 9.2 13.3 10.2 7.8 37.6 17.3 8.8 25.4 7.3 10.4 23.1 8.0 7.5 7.7 8.5 9.6 11.1 10.9 12.7 6.6 33.1 6.5 8.6 11.4 14.3 9.7 8.6 7.4 15.5 12.3 15.0 18.4 12.3 6.0 7.4 8.6 6.4 10.3 7.9 8.0 7.4 7.8 8.1 9.3 9.9 4.0 9.2 7.6 9.8 6.2 5.3 14.5 15.9 23.5 16.3 14.2 15.1 21.1 11.2 23.2 17.9 SIRPB1 "CD172b, SIRP-BETA-1" ENSG00000101307 "Signal regulatory protein beta 1" "O00241, Q5TFQ8" 20 1563521-1620061 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 137.6" "Group enriched" "Detected in some" 4 "HMC-1: 24.7;NB-4: 32.8;THP-1: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 137.6" "Group enriched" "Detected in many" 6 "granulocytes: 137.6;monocytes: 43.6" HPA047463 Uncertain Uncertain Vesicles 33000000 Vesicles "HPA047463: " "unprognostic (1.88e-2)" "unprognostic (6.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (5.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (7.18e-2)" "unprognostic (4.11e-3)" "unprognostic (9.12e-2)" "unprognostic (6.31e-2)" "unprognostic (4.57e-2)" "unprognostic (2.65e-3)" "unprognostic (5.76e-2)" "unprognostic (2.39e-3)" "unprognostic (5.00e-3)" "unprognostic (1.19e-2)" 23.7 1.8 2.3 18.7 5.4 31.9 1.8 2.7 3.2 1.1 1.4 1.9 0.1 1.0 1.0 0.5 0.9 2.5 7.6 7.2 2.3 1.6 1.5 7.5 19.4 19.5 6.6 0.7 1.9 0.9 0.1 1.5 3.8 3.7 1.2 1.2 1.7 1.8 0.6 0.9 0.9 2.6 2.1 7.2 28.7 1.2 1.2 3.9 2.5 0.9 0.4 2.9 4.1 1.9 0.2 15.2 137.6 43.6 0.7 1.0 19.2 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.3 24.7 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 32.8 0.1 1.5 0.0 0.0 0.0 4.9 0.1 0.0 0.1 0.1 0.0 0.2 0.0 25.4 0.7 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.5 6.0 0.1 0.5 43.6 72.5 0.6 36.3 0.9 0.2 0.6 0.5 15.2 0.2 0.8 0.5 137.6 0.7 29.5 14.5 1.0 19.2 2.3 5.4 2.7 3.2 2.3 1.6 6.6 0.7 3.7 3.9 SIRT7 ENSG00000187531 "Sirtuin 7" Q9NRC8 17 81911939-81921323 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "eosinophil: 17.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037261, HPA053669" Approved Supported "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" Vesicles "CAB037261: AB_1079989, HPA053669: " "unprognostic (8.15e-3)" "unprognostic (3.24e-2)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.46e-1)" "unprognostic (3.36e-2)" "prognostic unfavourable (1.97e-5)" "unprognostic (3.03e-1)" "unprognostic (2.10e-1)" "unprognostic (2.46e-2)" "unprognostic (2.79e-1)" "unprognostic (1.71e-2)" "prognostic unfavourable (1.69e-7)" "unprognostic (4.34e-3)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (2.16e-2)" 6.2 5.9 6.7 10.1 12.8 22.6 6.4 17.0 11.4 8.2 12.9 7.0 9.0 14.3 5.5 4.6 28.8 7.2 10.6 3.9 6.7 2.6 7.9 9.8 7.9 11.3 11.0 6.6 4.8 18.7 4.9 7.8 8.8 7.6 7.1 6.7 3.7 12.7 7.0 5.3 15.7 15.3 5.1 5.7 14.1 18.4 8.9 8.8 8.3 6.7 7.3 16.4 8.3 12.3 3.9 1.8 17.4 3.4 1.3 2.6 1.2 16.0 13.4 1.6 5.8 4.4 4.2 10.8 8.1 6.8 9.6 9.0 11.5 12.8 7.1 6.3 4.5 11.6 6.6 5.0 3.1 6.1 14.2 6.3 6.5 18.0 13.3 8.1 12.9 4.2 15.9 9.1 7.6 7.1 6.7 3.5 4.5 12.6 8.6 11.6 4.2 13.9 5.8 3.5 6.7 9.3 10.5 7.0 9.2 9.3 22.6 10.4 9.4 19.5 5.6 4.2 9.5 8.0 14.7 5.9 1.8 5.2 10.5 11.1 7.0 3.0 2.3 17.4 2.6 3.4 0.9 3.3 2.0 2.1 1.2 3.9 1.8 0.6 3.8 1.3 2.6 1.8 1.0 1.2 6.7 12.8 17.0 11.4 6.7 2.6 11.0 6.6 7.6 8.8 SLA2 "C20orf156, FLJ21992, SLAP-2" ENSG00000101082 "Src like adaptor 2" Q9H6Q3 20 36612318-36646216 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.7;lymphoid tissue: 36.5" "Cell line enriched" "Detected in some" 8 "HEL: 43.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 6 "gdT-cell: 13.9;MAIT T-cell: 11.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 10.8;naive CD8 T-cell: 14.5;NK-cell: 16.5;plasmacytoid DC: 21.7;T-reg: 14.9" "Group enriched" "Detected in many" 8 "dendritic cells: 21.7;NK-cells: 16.5;T-cells: 14.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA053746, HPA058217" Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA053746: , HPA058217: " "unprognostic (4.16e-3)" "prognostic favourable (7.36e-4)" "unprognostic (4.52e-4)" "unprognostic (2.30e-6)" "unprognostic (3.37e-2)" "unprognostic (3.79e-3)" "unprognostic (2.15e-3)" "unprognostic (1.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.84e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "prognostic unfavourable (6.77e-8)" "unprognostic (8.48e-2)" "unprognostic (1.73e-1)" "unprognostic (1.98e-2)" "unprognostic (6.45e-3)" 2.3 0.8 0.7 15.1 0.8 11.3 1.3 1.5 0.5 1.5 3.9 0.2 2.3 2.8 2.0 1.1 1.7 1.4 4.8 1.6 0.7 0.7 1.5 1.9 6.9 17.1 0.7 0.0 1.6 0.8 0.0 1.1 1.6 0.8 1.5 1.8 1.8 6.3 0.4 0.9 0.7 7.5 1.5 1.1 15.9 2.5 1.0 0.3 36.5 1.5 1.1 18.4 3.8 1.3 0.2 21.7 2.3 0.3 16.5 14.9 11.6 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.8 0.2 1.7 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 5.1 3.7 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 3.6 0.0 0.8 0.2 1.6 13.9 0.3 11.7 0.2 11.5 12.9 0.1 0.1 10.8 14.5 2.3 16.5 0.0 21.7 14.9 11.6 0.7 0.8 1.5 0.5 0.7 0.7 0.7 0.0 0.8 0.3 SLAMF7 "19A, CD319, CRACC, CS1" ENSG00000026751 "SLAM family member 7" Q9NQ25 1 160739057-160754821 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.9;lymphoid tissue: 45.0" "Cell line enriched" "Detected in some" 5 "U-266/70: 78.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015445, HPA055945, HPA061654" Enhanced Approved Vesicles 620000 Vesicles "CAB015445: AB_1121905, HPA055945: , HPA061654: " "unprognostic (5.82e-3)" "unprognostic (1.81e-2)" "unprognostic (1.84e-3)" "unprognostic (2.12e-3)" "unprognostic (2.75e-1)" "unprognostic (1.07e-2)" "unprognostic (7.87e-2)" "unprognostic (7.19e-2)" "unprognostic (2.46e-2)" "prognostic favourable (3.93e-4)" "unprognostic (1.08e-1)" "unprognostic (8.13e-2)" "prognostic unfavourable (8.57e-5)" "unprognostic (1.35e-1)" "unprognostic (3.91e-2)" "unprognostic (1.02e-1)" "unprognostic (1.50e-2)" 5.5 1.0 0.7 28.6 0.7 2.3 3.4 0.6 0.7 4.1 11.9 0.2 0.4 11.1 1.9 1.3 6.7 1.6 6.2 1.0 0.7 0.7 2.4 3.1 10.2 24.6 0.8 0.4 2.5 2.2 0.0 0.9 1.3 0.6 1.8 10.2 2.9 15.1 4.8 0.9 2.0 15.8 0.8 1.2 45.0 11.0 1.5 0.4 5.9 2.1 4.2 38.7 11.5 2.6 3.7 27.4 1.1 14.9 17.3 32.9 8.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 2.1 0.0 0.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 78.8 6.7 0.0 2.2 0.0 0.0 0.0 1.6 0.3 32.9 11.0 25.4 3.7 3.5 22.4 7.2 0.6 1.1 13.6 1.1 17.3 14.9 27.4 0.0 8.7 0.7 0.7 0.6 0.7 0.7 0.7 0.8 0.4 0.6 0.4 SLC12A1 NKCC2 ENSG00000074803 "Solute carrier family 12 member 1" Q13621 15 48178438-48304078 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "kidney: 143.2" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 23.7" "Cancer enhanced" "Detected in single" "renal cancer: 1.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 1.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA014967, HPA018107" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA014967: AB_1854503, HPA018107: AB_1854504" "unprognostic (3.52e-2)" "unprognostic (1.30e-2)" "unprognostic (9.65e-2)" "unprognostic (1.74e-2)" "unprognostic (7.77e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-2)" "unprognostic (2.06e-1)" "unprognostic (9.85e-3)" "unprognostic (2.81e-4)" "unprognostic (9.75e-2)" "unprognostic (2.61e-1)" "unprognostic (5.47e-2)" "unprognostic (2.03e-1)" "unprognostic (5.20e-4)" "unprognostic (8.52e-2)" 0.0 0.0 0.3 0.0 1.0 0.0 0.0 1.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 143.2 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.0 0.3 1.0 1.4 1.5 0.1 0.3 0.3 0.4 1.4 0.1 SLC12A2 "BSC, BSC2, NKCC1, PPP1R141" ENSG00000064651 "Solute carrier family 12 member 2" P55011 5 128083766-128189688 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 50.7;salivary gland: 61.2" "Cell line enhanced" "Detected in all" "A549: 31.1;AF22: 32.1" "Cancer enhanced" "Detected in all" "colorectal cancer: 54.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020130, HPA063697" Approved Approved "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA020130: AB_1854502, HPA063697: " "unprognostic (4.61e-2)" "unprognostic (2.63e-1)" "unprognostic (4.20e-3)" "prognostic favourable (8.60e-4)" "unprognostic (3.99e-1)" "unprognostic (5.65e-3)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (3.30e-1)" "unprognostic (2.95e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-1)" "prognostic favourable (7.09e-4)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.79e-1)" "unprognostic (3.88e-3)" 5.5 11.0 10.8 9.4 24.1 2.7 26.2 11.4 18.1 5.1 28.5 37.2 0.0 24.6 5.7 1.9 3.8 4.1 50.7 4.1 15.5 9.9 4.5 2.9 6.5 3.5 36.1 13.5 5.6 5.3 11.2 5.5 3.3 30.0 14.8 36.3 8.5 61.2 2.1 8.5 23.0 28.8 6.6 27.7 2.9 36.3 5.5 26.7 2.0 5.6 6.8 18.3 4.2 3.6 3.6 9.8 0.5 1.2 3.6 3.0 0.4 6.2 31.1 32.1 12.4 8.0 5.2 6.6 5.8 4.4 4.2 4.4 12.4 10.0 9.3 7.9 5.0 19.0 6.1 6.7 6.5 9.3 7.6 2.7 5.5 1.8 2.5 3.3 4.7 5.5 2.4 9.3 5.5 6.8 4.3 6.4 6.5 6.6 5.9 2.8 3.7 10.2 3.3 9.0 3.8 4.9 21.4 5.6 3.6 11.7 5.1 4.6 2.8 1.7 11.4 10.5 7.0 7.9 7.4 5.4 4.8 10.4 5.5 2.0 8.4 0.5 0.7 0.2 1.9 1.2 3.0 2.7 1.8 2.3 0.9 3.6 2.0 2.7 0.3 3.6 0.8 9.8 1.6 0.4 10.8 24.1 11.4 18.1 15.5 9.9 36.1 13.5 30.0 26.7 SLC12A6 "ACCPN, KCC3" ENSG00000140199 "Solute carrier family 12 member 6" Q9UHW9 15 34229996-34338060 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" Neuropathy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 9.4;neutrophil: 18.5" "Lineage enriched" "Detected in many" 8 "granulocytes: 18.5" "Low region specificity" "Detected in all" HPA034563 Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA034563: AB_10603887" "unprognostic (3.53e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (3.60e-1)" "unprognostic (3.55e-2)" "unprognostic (3.41e-2)" "unprognostic (1.36e-1)" "unprognostic (2.88e-1)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.58e-2)" "unprognostic (1.83e-1)" "prognostic favourable (3.33e-6)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (3.87e-2)" "unprognostic (1.41e-1)" 8.7 5.8 7.4 12.4 11.1 27.5 7.0 10.2 14.1 14.7 8.0 12.7 3.6 8.3 6.3 8.7 24.9 4.7 6.3 6.9 6.8 6.9 18.6 4.9 11.5 10.9 9.9 8.4 5.8 5.1 5.4 10.9 5.2 12.5 5.0 7.4 9.7 9.3 4.9 10.5 8.6 10.2 6.0 9.2 11.1 8.0 38.5 10.9 18.2 10.6 8.2 13.6 8.2 21.2 2.0 1.0 18.5 1.4 0.6 2.3 0.7 2.6 3.1 2.0 2.8 6.3 7.4 1.3 3.9 9.1 3.0 4.4 1.8 4.3 1.8 3.7 4.1 26.7 4.7 3.2 3.6 0.7 3.2 14.2 8.0 4.1 3.9 8.5 15.6 4.3 5.7 8.9 18.0 9.2 3.1 4.2 4.1 0.9 0.9 6.8 1.5 3.4 4.3 3.4 1.8 3.4 6.7 4.3 3.2 4.3 0.1 0.9 1.9 2.9 5.7 3.5 2.6 12.2 0.9 3.7 4.1 1.1 4.2 6.3 1.5 9.4 1.1 2.3 0.5 1.4 0.3 1.2 0.8 0.7 0.7 2.0 1.3 1.1 18.5 0.6 0.6 1.0 2.3 0.7 7.4 11.1 10.2 14.1 6.8 6.9 9.9 8.4 12.5 10.9 SLC15A3 "hPTR3, PHT2" ENSG00000110446 "Solute carrier family 15 member 3" Q8IY34 11 60937084-60952530 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 35.8;BJ hTERT+ SV40 Large T+ RasG12V: 43.3;HHSteC: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047880, HPA057642" Approved Supported Vesicles Vesicles "HPA047880: AB_10959455, HPA057642: " "unprognostic (5.61e-2)" "prognostic favourable (4.07e-5)" "unprognostic (8.79e-2)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (9.33e-3)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (9.78e-3)" "unprognostic (6.47e-2)" "unprognostic (4.42e-2)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" 27.2 7.5 7.7 23.5 8.3 36.8 9.3 2.0 7.0 11.0 16.3 10.6 8.1 9.0 10.3 7.4 12.0 8.6 15.4 11.1 8.2 5.4 8.9 9.1 30.1 24.2 12.2 5.9 16.1 6.6 1.9 5.0 26.6 9.8 10.2 6.7 13.2 5.8 5.5 4.0 4.2 14.0 9.7 12.6 40.0 9.8 5.0 8.3 8.6 5.6 6.5 19.3 11.4 9.3 5.0 10.8 15.0 12.5 0.1 1.4 2.2 3.4 0.1 1.3 0.0 7.6 5.4 13.1 0.8 13.3 35.8 43.3 0.0 1.7 5.5 0.1 5.8 1.1 0.0 0.4 1.3 5.5 0.0 0.0 0.0 0.2 21.0 0.2 0.5 3.8 0.1 9.6 0.0 2.1 0.0 1.0 2.2 0.2 0.0 0.8 6.3 0.2 2.4 0.1 1.7 0.0 0.8 0.0 0.0 1.6 6.7 0.5 2.8 4.3 0.0 0.2 1.1 0.7 0.1 0.0 0.0 3.4 2.3 0.1 9.5 0.0 9.5 0.9 0.1 12.5 0.1 5.0 0.0 0.0 6.0 2.4 1.3 1.4 15.0 0.1 6.4 10.8 0.0 2.2 7.7 8.3 2.0 7.0 8.2 5.4 12.2 5.9 9.8 8.3 SLC16A10 "MCT10, TAT1" ENSG00000112394 "Solute carrier family 16 member 10" Q8TF71 6 111087503-111231194 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 25.1;skeletal muscle: 33.4" "Cell line enhanced" "Detected in many" "HAP1: 28.8;HEK 293: 12.4;RPMI-8226: 23.8" "Cancer enriched" "Detected in many" 6 "testis cancer: 4.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.7" "Lineage enriched" "Detected in single" 5 "T-cells: 4.7" "Low region specificity" "Detected in many" HPA016860 Approved Supported "Vesicles,Cell Junctions" "Vesicles, Cell Junctions" "HPA016860: AB_2189211" "unprognostic (2.03e-1)" "unprognostic (2.08e-1)" "unprognostic (6.11e-2)" "unprognostic (3.56e-4)" "unprognostic (2.24e-1)" "unprognostic (2.15e-1)" "unprognostic (1.64e-1)" "unprognostic (1.89e-1)" "unprognostic (1.86e-3)" "unprognostic (5.22e-1)" "unprognostic (1.74e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-3)" "unprognostic (2.73e-1)" "unprognostic (1.60e-1)" "unprognostic (1.33e-1)" "unprognostic (1.91e-1)" 7.6 4.9 1.8 2.4 5.4 0.4 1.1 9.5 2.0 0.8 4.8 1.7 1.7 7.6 0.7 1.6 0.7 1.1 1.0 2.8 1.8 1.0 8.1 9.8 6.1 1.8 0.8 0.5 1.2 25.1 8.9 1.5 17.4 5.6 1.2 1.3 3.6 3.5 6.0 33.4 12.1 6.0 0.8 1.0 2.7 3.9 3.5 0.8 19.6 2.2 1.5 0.9 4.4 1.4 0.5 0.3 0.8 0.2 0.3 4.7 0.3 0.6 0.6 0.2 1.3 0.0 0.0 2.3 0.0 0.1 0.5 0.7 5.0 0.2 4.0 0.9 0.1 0.0 28.8 0.0 0.5 0.0 12.4 4.7 0.3 4.7 0.0 4.9 4.8 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 2.0 6.1 0.6 8.9 1.8 3.5 4.3 23.8 0.0 0.4 6.7 2.1 0.1 0.6 1.1 1.1 0.7 0.0 0.1 1.1 0.3 1.6 1.9 0.0 1.0 0.2 3.7 0.5 0.8 0.2 0.1 0.2 0.2 0.2 0.2 1.1 0.3 0.0 0.5 4.7 4.0 0.8 0.3 0.1 0.3 4.0 0.3 1.8 5.4 9.5 2.0 1.8 1.0 0.8 0.5 5.6 0.8 SLC16A6 "MCT6, MCT7" ENSG00000108932 "Solute carrier family 16 member 6" O15403 17 68267026-68291267 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 32.5" "Cell line enriched" "Detected in some" 13 "SK-MEL-30: 104.5" "Group enriched" "Detected in many" 6 "breast cancer: 10.9;melanoma: 11.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA054459, HPA066328" Uncertain Approved Vesicles Vesicles "HPA054459: , HPA066328: " "unprognostic (2.53e-2)" "unprognostic (2.09e-3)" "unprognostic (8.41e-2)" "unprognostic (6.94e-2)" "unprognostic (3.10e-1)" "unprognostic (5.26e-3)" "unprognostic (5.08e-3)" "unprognostic (5.39e-2)" "unprognostic (1.63e-3)" "unprognostic (1.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.44e-2)" "unprognostic (8.78e-2)" "unprognostic (2.23e-1)" "unprognostic (8.16e-3)" "unprognostic (2.09e-2)" "unprognostic (9.46e-2)" 7.8 3.4 3.0 6.6 6.3 8.1 6.2 3.7 6.2 2.2 0.8 3.1 9.8 0.9 2.8 32.5 12.4 1.5 1.6 1.4 3.2 4.2 0.9 1.4 9.7 4.6 4.7 1.4 1.8 1.2 0.4 2.4 2.4 6.9 0.8 1.0 13.0 3.5 11.0 10.3 4.2 1.2 0.9 2.7 6.3 1.1 2.2 0.9 1.5 3.3 6.6 7.9 3.7 3.3 0.6 2.7 8.5 4.7 1.1 2.9 1.2 0.4 0.3 0.1 0.1 0.1 0.1 3.0 0.1 3.8 0.3 0.2 0.1 0.5 3.4 0.3 0.0 0.1 0.5 0.0 0.1 1.0 0.2 0.2 0.4 4.4 0.6 1.1 0.2 0.1 0.0 0.2 0.2 0.1 0.2 0.7 0.0 3.8 1.6 0.7 0.0 0.1 0.0 0.0 0.4 0.1 0.3 0.8 0.0 0.1 2.0 104.5 3.0 0.7 0.5 1.2 0.2 0.1 0.3 0.8 3.0 3.2 7.9 0.9 0.5 1.1 4.7 0.3 2.9 4.4 1.5 0.6 1.2 2.3 2.7 0.3 0.8 1.6 8.5 1.1 2.2 0.6 2.6 1.2 3.0 6.3 3.7 6.2 3.2 4.2 4.7 1.4 6.9 0.9 SLC18A2 "SVAT, SVMT, VMAT2" ENSG00000165646 "Solute carrier family 18 member A2" Q05940 10 117241073-117279430 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.3;brain: 28.3;cervix, uterine: 31.2" "Cell line enriched" "Detected in some" 20 "HMC-1: 89.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 10 "hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5" "Cell type enriched" "Detected in some" 13 "basophil: 26.3" "Lineage enriched" "Detected in many" 13 "granulocytes: 26.3" "Region enhanced" "Detected in many" "midbrain: 75.4" "Group enriched" "Detected in all" 5 "midbrain: 143.8;pons and medulla: 34.7" HPA073224 Enhanced Supported Vesicles,Centrosome Vesicles Centrosome "HPA073224: " "unprognostic (1.49e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (9.00e-2)" "unprognostic (2.85e-1)" "unprognostic (5.33e-3)" "unprognostic (2.23e-1)" "unprognostic (1.71e-2)" "unprognostic (1.40e-1)" "unprognostic (4.55e-2)" "unprognostic (2.00e-1)" "unprognostic (6.06e-3)" "unprognostic (7.94e-5)" "unprognostic (2.95e-2)" "unprognostic (2.31e-1)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" 1.7 13.9 1.7 3.1 2.0 2.0 2.0 1.7 1.6 31.2 2.3 0.5 2.2 1.5 11.2 4.9 3.0 1.1 15.9 1.0 1.9 9.0 1.1 3.3 7.6 1.5 28.3 0.2 9.7 3.7 0.5 1.6 2.1 26.5 10.8 3.4 3.1 1.0 4.0 1.1 5.8 2.5 5.4 2.9 0.5 3.5 1.5 0.3 14.1 0.6 3.4 2.9 3.1 5.4 0.0 2.0 26.3 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.2 89.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.1 0.0 0.1 0.4 0.0 26.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 2.0 0.0 1.1 1.7 2.0 1.7 1.6 1.9 9.0 28.3 0.2 26.5 0.3 SLC20A1 "Glvr-1, GLVR1, PiT-1" ENSG00000144136 "Solute carrier family 20 member 1" Q8WUM9 2 112645857-112663827 "Predicted membrane proteins, Transporters" "Host-virus interaction, Phosphate transport, Symport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-87 MG: 92.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019279, HPA035834" Approved Approved Vesicles Vesicles "CAB019279: , HPA035834: " "unprognostic (1.81e-1)" "unprognostic (2.18e-1)" "unprognostic (5.38e-2)" "unprognostic (4.03e-3)" "unprognostic (1.39e-1)" "prognostic unfavourable (6.56e-5)" "unprognostic (1.50e-2)" "unprognostic (3.38e-2)" "unprognostic (2.32e-2)" "unprognostic (1.39e-1)" "unprognostic (7.43e-3)" "unprognostic (1.44e-1)" "prognostic unfavourable (3.44e-5)" "unprognostic (6.85e-2)" "unprognostic (1.09e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-3)" 23.4 9.9 11.9 38.8 16.0 51.3 18.9 25.6 29.1 9.4 42.7 10.6 4.7 12.3 11.7 8.6 11.0 12.2 22.7 17.0 12.0 12.3 16.3 40.2 23.1 27.6 13.5 16.8 7.7 25.7 7.4 13.3 59.8 20.6 15.3 19.1 17.8 10.4 12.2 25.6 10.2 21.8 13.1 15.5 23.8 13.8 13.3 9.1 19.0 12.8 9.5 22.4 21.6 14.4 3.8 17.9 12.3 25.2 19.9 27.1 13.0 11.8 9.8 12.8 10.3 9.8 24.0 9.8 32.1 38.4 14.3 18.7 14.8 29.3 21.6 17.8 11.9 12.5 14.0 24.4 21.0 11.8 14.3 18.3 9.9 14.0 14.5 10.4 32.5 12.2 9.7 50.5 35.4 18.2 33.9 22.7 61.9 4.6 14.2 40.5 21.4 26.4 13.5 11.4 6.0 20.7 55.0 11.7 11.0 16.2 9.9 22.1 10.0 7.4 39.4 26.3 17.3 9.1 24.8 9.4 24.2 18.1 92.5 10.1 31.7 3.8 14.5 12.3 24.2 25.2 27.1 3.8 10.4 17.4 10.9 2.1 8.3 13.1 6.1 19.9 14.7 17.9 6.0 13.0 11.9 16.0 25.6 29.1 12.0 12.3 13.5 16.8 20.6 9.1 SLC22A23 "C6orf85, FLJ22174" ENSG00000137266 "Solute carrier family 22 member 23" A1A5C7 6 3268962-3457022 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014697 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA014697: AB_1844371" "unprognostic (4.58e-2)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "prognostic favourable (6.57e-4)" "unprognostic (5.16e-3)" "unprognostic (3.25e-3)" "unprognostic (1.40e-1)" "unprognostic (4.53e-3)" "unprognostic (9.74e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.62e-2)" "prognostic unfavourable (2.39e-4)" "unprognostic (8.91e-2)" "unprognostic (4.30e-1)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" 7.4 2.2 9.0 4.6 16.2 8.1 9.3 8.4 14.8 5.6 17.4 30.8 3.4 19.6 3.6 11.8 16.8 11.3 7.5 2.2 11.0 8.1 6.9 12.6 8.0 3.9 28.6 8.7 3.0 14.9 14.8 6.5 8.3 17.8 14.2 14.4 5.7 10.0 2.8 5.9 14.9 20.3 3.0 17.5 4.6 26.0 7.2 21.0 5.2 4.1 9.8 9.9 3.8 9.9 0.1 0.7 0.8 0.3 0.3 1.4 1.9 2.4 5.7 12.6 14.0 4.5 5.0 16.1 0.4 0.1 0.7 0.3 12.6 0.4 0.6 1.5 2.7 3.6 2.5 6.7 0.2 2.0 7.8 5.9 2.2 11.1 0.6 0.3 0.4 1.2 13.2 12.2 0.6 0.4 5.3 3.4 0.4 2.9 0.5 1.4 4.3 2.3 1.3 0.8 10.0 0.0 15.4 1.4 0.2 3.3 4.8 4.1 18.7 0.1 3.1 7.4 2.3 9.5 1.5 7.6 0.1 0.2 12.9 0.4 4.5 0.0 0.3 0.0 0.4 0.0 0.2 0.0 1.0 0.4 0.2 0.1 1.4 0.9 0.8 0.3 0.2 0.7 0.0 1.9 9.0 16.2 8.4 14.8 11.0 8.1 28.6 8.7 17.8 21.0 SLC22A3 "EMT, OCT3" ENSG00000146477 "Solute carrier family 22 member 3" O75751 6 160348268-160452581 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 98.6" "Cell line enhanced" "Detected in some" "A549: 17.4;HeLa: 23.4;Hep G2: 14.5;RPTEC TERT1: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029750 Approved Approved Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA029750: AB_10603888" "unprognostic (8.61e-2)" "prognostic unfavourable (7.19e-5)" "unprognostic (4.14e-1)" "unprognostic (1.49e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (3.36e-2)" "unprognostic (9.74e-2)" "unprognostic (9.36e-4)" "unprognostic (1.33e-2)" "unprognostic (2.58e-2)" "unprognostic (7.28e-2)" "unprognostic (7.96e-2)" "unprognostic (5.21e-2)" "unprognostic (8.13e-4)" "prognostic unfavourable (7.26e-4)" 4.1 6.9 1.0 2.1 1.3 0.0 5.2 1.8 0.9 7.6 4.1 0.9 4.1 0.2 14.2 11.8 4.1 9.0 9.0 1.1 1.2 1.3 2.4 15.2 12.7 9.7 2.2 0.9 10.3 1.3 0.0 0.9 17.8 1.9 18.9 0.6 0.9 34.5 23.0 98.6 5.1 2.7 10.8 4.4 0.3 2.9 3.4 0.6 0.4 3.4 5.7 2.1 3.2 7.3 0.0 0.0 0.8 0.0 0.1 1.5 0.0 0.0 17.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 4.5 0.0 0.0 0.2 0.0 0.0 0.0 23.4 14.5 0.8 0.0 0.0 0.5 4.4 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 4.9 0.0 0.0 0.0 8.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.0 1.0 1.3 1.8 0.9 1.2 1.3 2.2 0.9 1.9 0.6 SLC23A2 "KIAA0238, SLC23A1, SVCT2, YSPL2" ENSG00000089057 "Solute carrier family 23 member 2" Q9UGH3 20 4852356-5010293 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 55.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052825, HPA059314" Approved Uncertain "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA052825: , HPA059314: " "unprognostic (3.83e-1)" "unprognostic (1.08e-2)" "unprognostic (1.95e-3)" "unprognostic (1.64e-3)" "unprognostic (8.05e-2)" "unprognostic (2.09e-1)" "prognostic favourable (3.35e-4)" "unprognostic (6.22e-3)" "unprognostic (2.08e-1)" "unprognostic (6.36e-3)" "prognostic favourable (7.14e-5)" "unprognostic (1.57e-1)" "unprognostic (1.60e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "prognostic favourable (6.08e-5)" 6.6 55.6 14.7 6.1 17.5 5.4 6.3 15.9 27.2 8.6 4.6 19.3 4.0 5.0 9.5 7.1 4.6 12.4 7.8 5.4 14.4 14.5 6.0 27.7 7.4 7.2 14.9 16.6 29.4 7.5 15.1 12.5 25.1 16.4 9.0 5.0 22.1 4.2 8.4 2.6 8.5 6.3 7.8 17.5 11.7 7.1 8.5 11.4 5.3 18.6 2.2 7.4 18.7 6.4 4.2 6.0 3.1 2.5 0.8 2.8 2.0 10.5 12.4 16.8 6.3 11.8 6.7 21.3 4.5 6.2 5.4 5.0 6.4 12.1 4.8 4.9 6.2 10.3 4.6 12.3 10.2 3.0 8.3 6.7 2.1 24.0 6.7 9.3 4.0 5.6 7.2 13.4 8.1 7.8 4.5 4.1 7.1 3.9 10.2 5.2 5.9 7.7 9.4 11.1 7.2 2.9 17.3 5.6 6.3 8.7 9.2 32.2 5.1 5.5 6.7 12.1 5.6 14.4 8.7 5.8 10.8 13.0 4.3 5.6 18.9 0.0 2.5 0.2 2.8 1.8 2.6 4.2 2.2 2.0 3.6 2.9 2.1 2.1 3.1 0.8 2.1 6.0 1.3 2.0 14.7 17.5 15.9 25.3 14.4 14.5 14.9 16.6 16.4 11.4 SLC25A25 "KIAA1896, MCSC, PCSCL" ENSG00000148339 "Solute carrier family 25 member 25" Q6KCM7 9 128068201-128109245 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020381 Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" "Vesicles, Mitochondria" "HPA020381: AB_1857037" "unprognostic (4.62e-2)" "unprognostic (2.66e-2)" "unprognostic (2.56e-2)" "unprognostic (1.59e-1)" "unprognostic (2.89e-1)" "unprognostic (1.40e-1)" "prognostic favourable (1.01e-4)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.60e-2)" "unprognostic (4.96e-2)" "unprognostic (3.70e-2)" "prognostic favourable (4.65e-6)" "unprognostic (1.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.66e-3)" "unprognostic (1.42e-2)" 29.2 15.8 7.3 8.1 12.8 5.5 10.6 8.8 20.0 14.4 7.2 6.3 20.0 7.9 14.6 8.2 22.7 17.5 31.6 5.6 7.6 9.0 9.5 48.4 12.4 6.7 7.5 8.0 13.6 52.6 12.1 19.0 7.6 15.0 8.5 5.5 13.6 7.6 63.5 31.3 9.5 10.0 17.3 8.7 7.8 10.5 7.3 5.3 5.4 10.8 20.2 9.7 8.6 9.6 2.9 4.6 3.8 8.4 1.5 7.6 3.9 5.8 6.1 8.7 12.6 6.6 5.7 5.8 12.1 11.3 10.2 6.8 11.0 6.1 7.6 3.7 5.6 10.4 6.8 4.0 3.9 8.8 5.6 4.4 12.4 6.5 10.5 5.0 10.1 7.2 3.8 10.0 7.4 6.9 15.8 16.4 6.4 14.1 8.9 5.1 8.8 9.6 8.8 7.5 15.9 3.9 6.1 21.7 9.3 12.7 8.2 16.9 9.0 2.9 4.4 11.6 6.9 8.7 11.9 14.4 25.1 8.1 7.8 2.7 9.5 3.8 2.3 1.2 4.8 7.3 2.4 1.7 5.3 4.8 4.6 2.9 4.5 7.6 0.4 1.5 8.4 1.5 3.9 3.9 7.3 12.8 8.8 20.0 7.6 9.0 7.5 8.0 15.0 5.3 SLC25A35 FLJ40217 ENSG00000125434 "Solute carrier family 25 member 35" Q3KQZ1 17 8287763-8295343 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 44.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA051720 Uncertain Approved Vesicles,Mitochondria "Vesicles, Mitochondria" "HPA051720: " "unprognostic (4.73e-2)" "unprognostic (1.36e-3)" "unprognostic (1.21e-2)" "prognostic favourable (3.37e-7)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (5.27e-2)" "unprognostic (2.58e-1)" "unprognostic (8.30e-2)" "unprognostic (8.96e-3)" "unprognostic (1.18e-1)" "prognostic favourable (1.14e-6)" "unprognostic (5.31e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "prognostic favourable (1.91e-5)" 6.8 8.2 4.0 10.2 8.3 7.4 8.1 2.6 6.0 13.0 7.2 11.1 18.2 8.3 14.1 11.6 5.3 8.6 7.5 4.4 8.2 3.7 14.4 4.4 7.2 8.2 8.9 5.2 3.4 9.6 6.6 12.9 44.4 9.2 8.2 7.9 11.3 6.2 24.9 3.4 4.2 7.2 6.0 9.7 9.4 9.8 20.2 7.2 9.0 9.1 4.1 7.1 7.2 4.6 3.8 7.2 9.0 11.1 3.2 5.6 2.9 4.4 12.3 2.1 9.2 7.1 2.8 5.1 2.9 2.6 3.2 3.6 1.4 11.5 5.1 3.0 3.4 10.0 2.6 3.5 1.7 2.7 3.2 4.3 9.1 1.7 2.6 0.5 11.7 5.8 2.0 6.1 1.1 5.1 1.2 1.8 2.6 2.4 4.6 2.4 0.7 4.1 5.0 1.5 2.2 2.5 11.4 1.1 2.7 8.5 5.1 3.6 11.4 3.3 6.6 2.2 1.7 5.2 2.5 3.9 2.3 1.7 5.6 7.6 5.6 4.5 7.3 9.0 5.5 11.1 4.3 2.6 4.8 5.6 7.2 3.8 1.7 3.5 1.4 3.2 7.8 3.6 4.9 2.9 4.0 8.3 2.6 6.0 8.2 3.7 8.9 5.2 9.2 7.2 SLC26A11 ENSG00000181045 "Solute carrier family 26 member 11" Q86WA9 17 80219699-80253500 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029893 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA029893: AB_10600809" "unprognostic (5.86e-2)" "unprognostic (6.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavourable (1.55e-5)" "unprognostic (3.80e-2)" "unprognostic (2.63e-3)" "prognostic unfavourable (1.82e-6)" "unprognostic (2.05e-2)" "unprognostic (3.54e-2)" "unprognostic (1.03e-1)" "prognostic favourable (1.43e-5)" "unprognostic (2.86e-1)" "unprognostic (3.50e-1)" "unprognostic (9.54e-3)" "unprognostic (8.40e-2)" "unprognostic (8.69e-2)" "unprognostic (7.32e-2)" 9.9 30.9 10.2 10.2 19.3 16.3 8.4 9.1 18.0 11.6 8.2 12.6 14.1 8.7 11.6 14.6 6.9 9.2 10.0 5.1 9.4 30.5 12.4 6.9 12.8 14.3 10.5 17.4 18.3 7.9 14.9 25.6 21.1 17.2 11.8 5.1 15.6 12.2 14.8 6.5 13.1 11.9 11.6 9.3 17.3 7.3 4.8 7.3 1.8 18.1 4.9 6.7 9.8 14.1 0.4 1.3 0.1 2.3 0.1 4.9 1.9 0.5 8.3 9.8 7.6 4.9 3.7 11.4 4.7 5.9 10.7 6.7 9.5 1.7 0.1 9.7 4.9 3.2 5.4 3.5 4.2 11.3 9.8 0.0 10.5 8.8 13.1 0.0 1.5 6.7 5.8 5.1 2.4 9.0 4.1 12.1 6.3 7.8 0.4 0.2 4.4 8.1 0.4 1.1 4.4 9.7 9.1 3.9 12.0 4.8 11.9 12.3 14.3 0.2 6.7 8.6 5.1 7.3 0.5 13.6 5.1 1.3 4.5 0.0 6.9 0.0 2.3 0.0 1.8 0.9 2.6 0.4 3.2 2.6 1.3 0.2 4.9 2.0 0.1 0.1 0.3 0.0 4.0 1.9 10.2 19.3 9.1 18.0 9.4 30.5 10.5 17.4 17.2 7.3 SLC26A2 "DTD, DTDST" ENSG00000155850 "Solute carrier family 26 member 2" P50443 5 149960737-149993455 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 81.9" "Cell line enhanced" "Detected in many" "EFO-21: 23.6;RPTEC TERT1: 54.3;TIME: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041957, HPA058090" Enhanced Approved Vesicles Vesicles "HPA041957: AB_10795646, HPA058090: AB_2683602" "unprognostic (6.64e-2)" "unprognostic (1.53e-1)" "unprognostic (3.03e-2)" "prognostic favourable (7.29e-4)" "unprognostic (2.59e-2)" "unprognostic (5.64e-2)" "prognostic unfavourable (4.66e-4)" "unprognostic (2.59e-1)" "unprognostic (5.64e-2)" "unprognostic (1.19e-1)" "unprognostic (7.43e-2)" "unprognostic (2.10e-1)" "prognostic unfavourable (3.27e-4)" "unprognostic (1.70e-1)" "unprognostic (1.77e-1)" "unprognostic (8.12e-2)" "unprognostic (1.06e-1)" 8.5 15.6 2.6 23.2 3.7 1.3 4.7 6.3 2.3 3.8 81.9 3.0 29.4 5.4 4.8 14.2 8.3 3.1 2.6 3.1 2.5 2.6 3.8 1.6 6.8 5.3 3.7 2.3 5.1 2.9 21.4 11.1 16.9 7.6 6.1 75.0 4.9 27.9 36.7 11.2 6.0 13.4 4.3 5.5 3.0 2.4 2.8 3.0 5.2 2.7 4.4 13.0 4.1 2.8 1.6 1.7 7.0 3.3 2.5 3.0 1.1 3.2 3.0 3.7 6.1 4.5 3.2 0.8 3.1 2.8 2.5 3.0 15.3 1.8 2.5 23.6 3.2 2.3 3.5 7.1 4.5 2.0 2.2 3.2 2.4 1.7 3.4 5.8 5.4 3.5 4.2 4.1 5.4 5.9 0.8 2.5 10.4 1.0 2.2 3.0 1.1 4.7 3.2 5.8 1.3 54.3 14.4 1.1 2.9 5.4 1.3 9.2 2.5 3.4 27.9 5.7 4.3 5.0 3.6 1.8 2.4 1.5 5.2 7.1 8.2 7.0 1.1 0.8 2.5 0.8 3.0 1.3 1.5 2.1 1.7 1.6 2.1 2.2 1.0 2.5 3.3 1.7 2.6 1.1 2.6 3.7 6.3 2.3 2.5 2.6 3.7 2.3 7.6 3.0 SLC27A4 "ACSVL4, FATP4" ENSG00000167114 "Solute carrier family 27 member 4" Q6P1M0 9 128340646-128361470 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 56.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007293, CAB009771" Approved Supported Vesicles Vesicles "CAB009771: AB_2270540, HPA007293: AB_1857062" "unprognostic (7.25e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-1)" "unprognostic (3.92e-3)" "unprognostic (3.74e-2)" "unprognostic (2.03e-1)" "unprognostic (1.85e-3)" "unprognostic (1.31e-3)" "unprognostic (4.51e-1)" "unprognostic (4.69e-2)" "unprognostic (7.72e-2)" "unprognostic (5.07e-2)" "prognostic favourable (2.61e-5)" "unprognostic (7.29e-3)" "unprognostic (2.11e-1)" "unprognostic (3.45e-2)" "unprognostic (8.01e-3)" 7.7 7.1 9.9 7.0 13.6 2.5 4.9 9.4 26.5 6.5 25.7 15.8 5.2 54.0 6.6 5.6 26.1 4.4 9.8 7.7 11.6 15.9 17.7 20.8 5.8 5.0 14.8 9.6 5.6 11.3 9.8 5.4 5.8 21.9 5.7 8.3 6.7 7.5 7.3 6.7 24.3 56.1 8.1 11.6 5.1 8.6 13.2 7.9 6.8 12.7 15.2 14.9 8.5 9.5 3.7 7.2 2.6 6.2 1.9 8.1 3.3 10.2 20.1 10.3 13.2 15.7 4.8 11.8 8.7 5.5 10.0 7.3 14.4 10.0 9.6 7.0 9.3 35.2 12.4 10.0 3.1 9.6 19.0 5.7 17.7 12.4 8.4 10.5 9.2 6.3 13.7 10.4 8.3 11.4 13.5 6.7 9.2 25.2 12.4 10.0 4.6 32.0 15.2 10.1 17.8 17.2 15.4 17.9 9.8 14.5 26.7 9.5 13.3 4.0 16.7 12.1 11.8 13.1 10.7 6.0 8.5 3.1 12.3 6.3 13.6 0.0 4.1 2.6 8.1 5.6 6.1 3.7 5.2 6.4 7.2 1.7 4.1 4.3 1.6 1.9 6.2 6.4 3.6 3.3 9.9 13.6 9.4 26.5 11.6 15.9 14.8 9.6 21.9 7.9 SLC29A3 "ENT3, FLJ11160" ENSG00000198246 "Solute carrier family 29 member 3" Q9BZD2 10 71319258-71381423 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 19.5;Hep G2: 21.7;RT4: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046085, HPA054976, HPA057905" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA046085: , HPA054976: , HPA057905: " "unprognostic (1.73e-1)" "unprognostic (2.38e-3)" "unprognostic (3.23e-3)" "unprognostic (1.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.73e-2)" "prognostic unfavourable (6.07e-6)" "unprognostic (1.28e-1)" "unprognostic (4.71e-1)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (3.80e-2)" "prognostic unfavourable (5.53e-5)" "unprognostic (3.37e-1)" "unprognostic (1.36e-1)" "prognostic favourable (1.16e-4)" "unprognostic (3.43e-3)" 11.3 4.0 6.4 6.6 8.3 1.9 6.8 3.2 12.6 8.3 6.1 11.3 2.4 4.1 12.1 4.6 3.5 9.4 7.4 3.6 8.0 5.5 3.9 12.5 11.1 10.5 9.8 6.5 15.8 7.4 7.1 2.8 24.6 6.7 8.3 6.0 4.6 7.5 5.4 2.1 3.7 4.9 8.9 8.0 9.4 8.9 4.9 7.7 9.3 6.7 1.3 6.2 18.4 10.0 3.6 19.3 2.8 12.9 5.7 4.0 5.6 1.2 7.3 1.0 4.6 4.2 3.3 19.5 1.3 1.4 0.4 0.2 8.0 5.2 4.2 3.9 2.7 11.6 3.3 1.8 0.0 3.3 3.3 1.2 0.6 21.7 2.0 1.0 2.7 3.2 8.0 0.1 0.3 1.9 3.9 4.1 0.5 11.3 2.7 2.1 2.5 2.6 3.3 0.4 3.4 1.6 17.3 5.5 5.8 3.9 12.7 1.0 1.9 2.3 3.0 0.1 2.4 1.3 0.0 1.1 1.8 2.3 5.1 14.3 0.8 2.8 12.9 1.4 4.0 10.1 3.4 3.6 3.2 3.6 19.3 1.5 2.6 3.6 1.0 5.7 6.3 13.6 3.4 5.6 6.4 8.3 3.2 12.6 8.0 5.5 9.8 6.5 6.7 7.7 SLC2A10 GLUT10 ENSG00000197496 "Solute carrier family 2 member 10" O95528 20 46709487-46736347 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 51.5" "Cell line enhanced" "Detected in many" "ASC diff: 19.6;HSkMC: 24.2;SK-MEL-30: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 13.8" "Lineage enriched" "Detected in single" 44 "granulocytes: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041015 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA041015: " "unprognostic (8.94e-3)" "unprognostic (2.62e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (6.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.06e-2)" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (3.63e-3)" "unprognostic (1.25e-2)" "unprognostic (1.05e-1)" "unprognostic (3.00e-1)" "unprognostic (5.96e-2)" 4.7 4.6 2.6 4.3 3.3 0.1 8.7 2.1 3.1 11.4 6.7 2.7 6.7 2.6 5.4 6.6 4.8 5.6 10.2 6.7 3.3 1.4 2.6 51.5 4.8 3.4 2.2 2.0 7.1 22.9 15.0 4.2 8.3 3.8 18.0 8.8 9.8 11.5 11.0 2.1 2.4 3.0 9.7 2.3 1.9 12.4 3.4 1.0 0.8 18.1 4.5 4.6 7.1 5.7 0.0 0.0 13.8 0.0 0.3 0.0 0.0 0.0 0.0 4.7 4.8 19.6 16.7 14.4 9.1 12.5 4.3 5.1 0.3 16.0 0.0 6.9 16.5 0.1 0.0 0.4 2.0 0.0 0.1 1.3 0.0 7.6 13.8 0.0 0.0 24.2 0.4 2.6 0.0 1.7 0.1 0.0 7.2 16.6 0.0 0.4 1.8 1.2 0.0 0.7 0.0 0.0 4.3 0.0 0.7 1.8 3.0 24.8 2.3 3.7 1.0 9.2 4.0 7.2 1.1 0.1 0.0 0.0 0.0 0.0 1.9 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.6 3.3 2.1 3.1 3.3 1.4 2.2 2.0 3.8 1.0 SLC2A8 "GLUT8, GLUTX1" ENSG00000136856 "Solute carrier family 2 member 8" Q9NY64 9 127397138-127408424 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 45.7;Hep G2: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 33.8" "Lineage enriched" "Detected in all" 5 "dendritic cells: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011935 Uncertain Approved Vesicles Vesicles "HPA011935: AB_1849760" "unprognostic (6.49e-2)" "prognostic favourable (2.57e-6)" "unprognostic (9.13e-2)" "unprognostic (1.85e-3)" "unprognostic (4.23e-2)" "unprognostic (9.43e-3)" "unprognostic (2.62e-1)" "unprognostic (1.30e-1)" "unprognostic (6.33e-2)" "unprognostic (1.36e-1)" "prognostic favourable (9.86e-6)" "unprognostic (1.70e-1)" "prognostic favourable (6.55e-6)" "unprognostic (4.25e-2)" "unprognostic (3.55e-1)" "unprognostic (1.59e-3)" "unprognostic (2.04e-3)" 10.9 24.5 11.4 13.3 11.3 3.5 10.4 15.0 15.2 9.0 19.8 11.7 37.0 17.7 9.5 17.4 8.7 6.0 9.4 9.8 10.4 9.3 8.7 25.7 8.1 7.3 12.5 10.2 6.7 12.1 5.7 5.5 13.2 8.7 18.5 6.5 12.5 9.4 28.3 22.6 11.6 17.0 44.1 10.3 11.3 13.1 30.6 9.3 1.2 9.1 6.9 4.3 42.4 9.1 2.4 33.8 6.9 5.6 1.2 6.3 2.0 1.7 7.0 3.2 7.0 0.0 0.0 10.0 2.7 1.8 4.4 2.6 45.7 1.7 2.7 6.2 1.4 9.5 3.8 4.4 1.1 2.6 6.1 0.4 5.5 26.9 4.1 0.0 3.0 0.1 4.1 0.4 1.8 3.4 2.9 6.2 1.7 12.9 0.0 0.0 5.1 11.1 1.0 4.4 7.6 4.1 18.9 5.3 3.6 6.6 11.3 2.4 7.3 1.6 2.9 0.0 4.6 0.3 6.1 19.1 17.8 4.1 3.0 0.0 3.3 0.0 3.0 6.9 4.9 5.6 3.5 2.3 1.6 3.3 4.6 2.4 0.3 1.2 0.2 1.2 5.1 33.8 6.3 2.0 11.4 11.3 15.0 15.2 10.4 9.3 12.5 10.2 8.7 9.3 SLC30A1 "ZNT1, ZRC1" ENSG00000170385 "Solute carrier family 30 member 1" Q9Y6M5 1 211571568-211578742 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 53.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015275, HPA049000" Uncertain Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA015275: AB_1857083, HPA049000: " "unprognostic (1.13e-1)" "unprognostic (2.67e-3)" "unprognostic (6.94e-2)" "unprognostic (1.81e-3)" "unprognostic (3.47e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-2)" "unprognostic (1.82e-3)" "unprognostic (4.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.42e-3)" "unprognostic (4.78e-2)" "unprognostic (2.23e-2)" "unprognostic (3.03e-1)" "unprognostic (2.55e-1)" "unprognostic (1.02e-1)" "unprognostic (4.53e-2)" 11.4 16.6 9.3 7.5 11.4 15.5 17.3 5.2 13.6 13.0 15.3 6.9 4.9 17.2 7.1 7.6 9.0 9.2 12.9 6.1 9.7 7.9 13.4 53.3 12.0 3.5 9.5 8.0 9.5 8.9 8.8 4.8 9.3 8.7 7.3 8.9 7.7 5.9 9.2 3.6 13.9 28.1 7.5 8.3 10.7 6.4 12.5 5.5 3.1 11.0 5.2 4.4 7.7 8.4 0.5 2.5 3.9 4.2 1.3 1.7 1.0 4.6 6.8 3.7 4.8 16.3 7.6 33.1 12.8 9.4 6.8 6.7 2.9 22.2 2.6 11.2 11.7 8.0 5.6 7.4 8.2 6.6 4.2 2.1 13.8 6.8 9.2 7.3 4.7 11.3 18.7 8.7 14.2 4.2 8.2 12.3 8.4 4.2 1.4 4.6 11.5 5.4 4.4 1.8 9.5 21.2 12.5 3.8 6.6 12.5 6.5 28.6 3.3 9.5 6.7 5.1 11.9 17.0 10.1 5.4 8.2 2.1 4.8 7.4 4.4 3.9 3.9 1.3 1.2 4.2 1.7 0.5 0.9 0.8 2.5 0.3 0.9 1.2 0.4 1.3 3.2 1.7 0.8 1.0 9.3 11.4 5.2 13.6 9.7 7.9 9.5 8.0 8.7 5.5 SLC30A2 ZNT2 ENSG00000158014 "Solute carrier family 30 member 2" Q9BRI3 1 26037252-26046133 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 78.0;placenta: 20.0" "Group enriched" "Detected in some" 5 "BEWO: 4.6;RPTEC TERT1: 10.4;WM-115: 6.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 19.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 5 "olfactory region: 1.5" "Low region specificity" "Detected in some" HPA017979 Approved Vesicles Vesicles "HPA017979: AB_1857085" "unprognostic (4.87e-2)" "unprognostic (6.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.79e-3)" "unprognostic (1.11e-1)" "unprognostic (2.37e-2)" "unprognostic (2.25e-2)" "unprognostic (2.59e-1)" "unprognostic (3.67e-2)" "unprognostic (1.02e-1)" "unprognostic (6.99e-2)" "unprognostic (1.10e-1)" "prognostic favourable (2.86e-6)" "unprognostic (9.38e-2)" "unprognostic (3.50e-2)" "unprognostic (1.17e-1)" "unprognostic (3.01e-2)" 0.1 0.7 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.0 1.3 1.1 0.1 0.1 4.0 2.2 0.1 0.1 10.4 0.1 0.2 0.1 0.1 0.1 0.1 78.0 0.1 0.1 20.0 0.1 0.3 0.0 2.0 1.0 1.4 1.7 0.4 0.6 0.1 0.1 0.1 0.1 0.4 0.1 0.1 12.8 0.2 0.1 0.5 0.1 1.5 1.1 3.1 1.0 1.5 0.9 0.4 0.2 0.2 0.2 0.9 0.3 0.1 4.6 0.4 0.1 0.1 0.1 0.9 1.0 0.2 0.9 0.1 0.8 0.2 0.3 0.1 0.6 0.3 0.6 0.7 0.1 0.1 0.6 0.7 0.0 0.2 0.1 0.1 0.0 0.6 1.4 0.0 0.7 0.5 0.9 0.7 0.2 0.3 0.7 0.6 10.4 0.4 0.9 0.5 0.6 1.1 0.4 0.7 0.5 0.5 0.7 1.1 0.6 0.3 1.0 0.5 0.7 0.5 0.6 6.3 3.1 1.0 0.4 0.9 0.4 0.5 0.7 0.6 0.8 0.2 1.5 0.6 0.8 3.1 1.5 0.5 1.1 0.5 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 SLC30A3 ZNT3 ENSG00000115194 "Solute carrier family 30 member 3" Q99726 2 27253684-27275817 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 28.7;epididymis: 41.0;testis: 19.5" "Cell line enhanced" "Detected in some" "HAP1: 8.8;Hep G2: 11.7;REH: 18.9;RH-30: 9.8" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 9 "amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6" "Group enriched" "Detected in many" 7 "amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9" "HPA060505, HPA067637, CAB079044" Enhanced Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol Vesicles "Nucleoplasm, Nucleoli, Cytosol" "CAB079044: , HPA060505: , HPA067637: " "unprognostic (2.05e-4)" "unprognostic (1.17e-1)" "unprognostic (6.84e-4)" "unprognostic (5.26e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (1.43e-2)" "unprognostic (2.93e-2)" "unprognostic (2.64e-2)" "unprognostic (3.05e-1)" "unprognostic (2.20e-1)" "unprognostic (1.89e-1)" "unprognostic (4.65e-12)" "unprognostic (3.23e-2)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (2.63e-4)" 0.5 1.9 15.8 0.5 11.4 0.5 0.4 0.4 28.7 0.5 0.5 0.0 1.9 0.4 0.5 41.0 0.4 0.7 0.4 5.0 10.2 0.8 0.4 0.5 0.5 0.8 1.1 12.1 0.5 0.4 0.6 0.4 0.4 1.6 0.6 0.5 0.7 0.4 0.9 0.4 0.4 0.5 0.5 0.7 0.5 0.4 19.5 0.0 0.0 0.4 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 1.1 0.0 1.5 0.0 0.2 0.1 0.0 0.0 1.0 1.0 0.3 0.4 0.0 0.0 0.0 0.2 8.8 0.0 0.2 0.0 1.0 5.0 0.2 11.7 0.2 0.1 2.0 0.0 0.0 0.5 0.0 0.7 1.4 0.0 0.1 3.8 0.0 0.3 1.4 0.0 18.9 9.8 1.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.7 0.0 0.2 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 15.8 11.4 0.4 28.7 10.2 0.8 1.1 12.1 1.6 0.0 SLC35B1 UGTREL1 ENSG00000121073 "Solute carrier family 35 member B1" P78383 17 49700943-49709014 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048655, HPA057418" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA048655: , HPA057418: " "unprognostic (1.35e-1)" "unprognostic (2.15e-2)" "unprognostic (1.09e-3)" "unprognostic (6.36e-2)" "unprognostic (8.31e-2)" "unprognostic (2.86e-3)" "unprognostic (6.17e-3)" "unprognostic (4.39e-2)" "unprognostic (2.47e-2)" "unprognostic (4.00e-3)" "unprognostic (3.37e-2)" "unprognostic (4.42e-2)" "prognostic unfavourable (5.69e-7)" "unprognostic (6.28e-2)" "unprognostic (7.88e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-2)" 8.5 8.3 8.4 7.4 11.8 8.0 10.7 8.2 14.0 9.3 13.0 9.3 9.2 13.7 7.6 26.5 9.4 9.9 7.3 15.8 8.6 9.2 16.0 46.7 10.1 16.0 9.8 7.9 7.5 22.3 13.5 13.2 12.4 9.9 7.4 13.1 8.4 22.4 12.7 33.7 9.2 27.3 8.0 8.1 10.2 9.3 9.1 7.1 6.5 19.7 13.8 10.8 9.9 6.7 6.6 25.0 8.1 15.1 7.0 9.5 7.9 13.5 22.7 17.0 26.7 15.6 9.8 19.2 14.3 23.3 30.5 24.5 46.7 15.8 9.4 33.6 19.8 10.1 26.8 17.1 33.4 11.5 19.5 11.9 14.9 27.3 27.2 22.2 11.2 10.0 18.8 22.0 27.5 18.8 11.6 27.0 20.9 27.5 16.3 14.4 7.6 25.5 11.0 18.3 25.3 15.0 14.3 14.7 18.9 8.4 6.8 9.8 21.5 15.2 8.0 23.3 10.3 24.9 18.8 14.3 23.5 14.0 15.2 16.9 20.4 8.1 15.1 5.0 9.5 13.5 6.9 6.6 6.5 8.9 16.7 3.6 6.6 6.0 6.7 7.0 9.1 25.0 7.4 7.9 8.4 11.8 8.2 14.0 8.6 9.2 9.8 7.9 9.9 7.1 SLC35B2 UGTrel4 ENSG00000157593 "Solute carrier family 35 member B2" Q8TB61 6 44254096-44257890 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029638 Approved Approved Vesicles Vesicles "HPA029638: AB_10602402" "prognostic unfavourable (7.90e-4)" "unprognostic (2.47e-3)" "unprognostic (2.30e-1)" "unprognostic (1.39e-2)" "unprognostic (2.36e-1)" "unprognostic (1.65e-2)" "prognostic unfavourable (8.59e-5)" "unprognostic (3.84e-1)" "unprognostic (2.51e-1)" "unprognostic (7.03e-3)" "unprognostic (4.27e-2)" "prognostic favourable (6.07e-4)" "unprognostic (3.60e-2)" "unprognostic (1.13e-1)" "unprognostic (4.07e-1)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" 18.0 28.2 14.8 12.6 15.0 10.7 17.7 16.2 24.8 18.3 18.9 35.8 19.0 13.0 22.6 23.4 14.3 18.6 27.1 17.7 15.2 10.9 32.3 35.5 16.1 12.9 17.1 14.6 16.7 38.1 27.4 11.1 26.1 19.8 19.0 20.2 23.8 49.6 20.4 17.5 15.6 16.4 20.5 24.7 18.4 20.6 16.3 18.7 12.2 19.3 17.8 17.6 19.6 14.3 12.9 14.4 21.8 8.6 10.8 21.1 10.2 25.9 14.9 18.7 35.9 30.8 32.6 13.7 28.5 47.1 28.0 34.5 13.1 24.2 5.8 25.7 35.1 24.8 12.7 32.0 19.8 17.2 16.5 11.7 11.8 15.6 28.8 24.9 19.0 33.4 33.7 25.7 12.7 20.5 16.6 25.1 33.5 30.5 9.1 20.8 8.3 17.4 9.2 12.1 29.6 30.2 19.3 23.4 22.4 14.0 15.6 32.0 28.9 22.8 20.3 22.1 14.7 22.0 24.7 19.4 22.1 13.5 29.5 19.9 44.9 21.8 8.6 13.2 21.1 6.5 17.8 12.9 11.9 16.1 7.7 7.7 11.0 14.2 0.7 10.8 2.3 14.4 9.6 10.2 14.8 15.0 16.2 24.8 15.2 10.9 17.1 14.6 19.8 18.7 SLC35F6 "ANT2BP, C2orf18, FLJ20555, TANGO9" ENSG00000213699 "Solute carrier family 35 member F6" Q8N357 2 26764284-26781231 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 47.8;Karpas-707: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034655 Approved Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA034655: AB_10696359" "unprognostic (2.26e-1)" "unprognostic (7.45e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-1)" "unprognostic (7.71e-2)" "unprognostic (1.03e-1)" "prognostic unfavourable (1.11e-4)" "prognostic unfavourable (3.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.35e-1)" "unprognostic (3.24e-1)" "unprognostic (2.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.07e-2)" "unprognostic (9.95e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-2)" 37.3 24.1 9.7 10.5 11.7 6.5 42.2 8.3 15.6 17.9 14.5 16.0 12.4 10.4 14.1 14.0 25.2 12.5 14.4 15.0 10.4 11.6 37.4 25.4 15.3 22.0 12.3 9.3 20.4 12.6 13.1 12.2 26.6 11.9 15.3 9.0 13.8 16.7 14.2 16.7 30.9 14.7 15.4 11.4 14.8 16.3 11.7 9.1 10.5 24.1 20.4 15.5 13.8 18.2 3.1 7.1 7.8 19.0 8.6 8.8 5.9 8.1 14.5 4.4 11.2 15.2 6.9 6.8 4.7 7.2 6.0 5.5 9.1 15.8 2.2 7.9 6.5 10.3 6.3 9.3 4.3 3.8 3.1 2.4 5.6 7.6 47.8 2.7 12.6 10.9 9.6 6.8 22.8 6.9 4.6 42.1 6.0 13.3 3.3 2.4 2.4 3.8 3.0 12.7 3.4 15.9 6.6 3.3 4.4 7.8 12.9 8.4 4.8 2.8 6.3 7.8 8.4 10.7 5.1 8.1 10.2 4.3 8.4 4.6 7.1 7.0 12.0 5.3 8.8 16.5 5.0 3.1 6.1 8.0 7.1 2.5 4.2 6.0 7.8 8.6 19.0 5.5 3.8 5.9 9.7 11.7 8.3 15.6 10.4 11.6 12.3 9.3 11.9 9.1 SLC38A2 "ATA2, KIAA1382, SAT2, SNAT2" ENSG00000134294 "Solute carrier family 38 member 2" Q96QD8 12 46358189-46372867 "Predicted membrane proteins" "Amino-acid transport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 136.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035180 Approved Approved Vesicles Vesicles "HPA035180: AB_10669901" "unprognostic (6.61e-3)" "unprognostic (2.87e-2)" "unprognostic (4.88e-2)" "unprognostic (2.51e-2)" "unprognostic (2.96e-1)" "unprognostic (1.00e-2)" "unprognostic (7.78e-2)" "unprognostic (5.50e-3)" "unprognostic (1.20e-1)" "unprognostic (3.79e-1)" "unprognostic (9.24e-3)" "unprognostic (1.75e-1)" "unprognostic (1.47e-1)" "unprognostic (5.08e-2)" "unprognostic (3.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.68e-2)" 44.7 45.4 19.9 23.3 34.5 27.0 72.0 34.5 40.6 36.2 25.5 23.6 20.0 11.6 45.2 16.2 47.1 36.6 46.8 39.2 24.2 14.0 27.4 102.9 51.9 34.5 54.4 15.2 49.3 27.3 54.3 16.2 76.6 32.6 25.7 17.8 17.7 36.6 20.3 47.8 69.5 25.1 40.4 60.0 28.6 29.2 19.7 43.8 40.7 32.0 35.6 26.2 36.0 49.3 12.1 24.7 17.9 13.5 30.0 15.3 12.7 8.5 20.1 17.5 47.9 40.8 41.1 12.7 40.3 103.6 35.4 29.2 11.9 16.2 0.0 54.3 68.9 29.3 12.1 37.6 34.7 6.8 6.8 11.1 24.5 36.8 62.6 8.9 11.7 41.1 81.8 22.3 136.6 30.0 10.8 17.2 62.7 10.7 10.9 13.2 14.9 21.1 9.9 12.9 21.1 21.7 19.2 11.6 10.0 27.3 7.7 24.6 15.5 21.0 49.3 17.0 13.4 7.2 6.4 19.8 18.7 10.4 16.4 32.6 8.4 17.9 13.5 10.5 14.3 7.8 11.1 12.1 12.0 14.2 20.8 11.9 15.2 15.3 10.5 30.0 10.1 24.7 13.9 12.7 19.9 34.5 34.5 40.6 24.2 14.0 54.4 15.2 32.6 43.8 SLC38A5 "JM24, SN2" ENSG00000017483 "Solute carrier family 38 member 5" Q8WUX1 X 48458537-48470256 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 87.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 53.2;HeLa: 52.4;hTCEpi: 39.6;Karpas-707: 46.8;RPMI-8226: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047411 Approved Approved "Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" Cytosol "HPA047411: AB_10964355" "unprognostic (2.81e-1)" "unprognostic (4.87e-2)" "unprognostic (7.92e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-3)" "unprognostic (1.26e-1)" "unprognostic (7.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.52e-1)" "unprognostic (3.80e-3)" "prognostic unfavourable (2.13e-4)" "unprognostic (2.99e-2)" "prognostic unfavourable (2.22e-16)" "unprognostic (1.27e-3)" "unprognostic (1.45e-1)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" 1.5 0.9 5.3 4.7 7.1 17.3 0.9 3.5 11.6 4.0 4.9 7.7 0.1 5.1 1.8 1.3 3.7 2.0 1.5 2.4 6.9 5.7 0.7 0.4 9.4 3.3 7.0 2.7 3.7 87.7 0.4 0.4 2.8 14.6 5.1 6.4 1.5 4.4 3.7 0.4 8.0 3.5 2.8 7.3 4.8 4.5 0.5 4.6 2.4 7.9 3.6 3.4 4.8 3.1 7.4 8.3 0.3 0.4 5.4 16.2 5.7 22.5 0.0 0.0 0.2 0.4 2.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 23.7 0.0 9.9 34.9 27.0 53.2 0.0 7.5 0.0 12.9 52.4 16.3 3.9 26.3 0.0 3.7 39.6 0.4 0.1 0.4 23.6 46.8 5.3 0.0 5.7 9.1 12.2 0.1 20.9 0.1 86.2 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.0 1.1 0.7 0.1 0.0 0.0 0.0 0.0 0.1 8.5 0.2 0.1 0.1 0.0 0.2 0.2 11.5 0.4 16.2 7.4 12.6 10.8 1.5 4.7 6.0 7.7 0.3 5.4 0.0 8.3 13.0 5.7 5.3 7.1 3.5 11.6 6.9 5.7 7.0 2.7 14.6 4.6 SLC38A9 FLJ90709 ENSG00000177058 "Solute carrier family 38 member 9" Q8NBW4 5 55625845-55773194 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 44.2" "Cell line enhanced" "Detected in all" "BEWO: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043785, HPA061702" Uncertain Supported Vesicles Vesicles "HPA043785: AB_10961859, HPA061702: " "unprognostic (4.80e-2)" "unprognostic (1.18e-1)" "unprognostic (3.26e-2)" "prognostic unfavourable (7.24e-5)" "unprognostic (2.49e-1)" "unprognostic (8.19e-2)" "unprognostic (8.35e-2)" "unprognostic (7.95e-2)" "unprognostic (5.47e-2)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" "unprognostic (4.87e-1)" "unprognostic (4.18e-3)" "unprognostic (1.76e-1)" "unprognostic (2.25e-1)" "unprognostic (2.84e-2)" "unprognostic (1.12e-1)" 7.2 6.3 8.2 6.9 8.0 5.2 6.8 9.9 9.7 6.4 7.5 9.2 6.7 6.6 7.5 5.9 9.0 5.8 7.1 3.9 6.2 6.4 6.7 13.5 6.4 8.4 9.4 6.4 6.9 18.2 10.1 11.8 44.2 8.6 5.9 8.5 6.7 7.6 5.3 5.2 6.2 7.1 7.2 8.8 8.9 7.7 15.8 8.5 13.3 7.1 5.7 11.4 8.7 6.9 10.8 10.8 7.4 11.8 8.9 10.0 6.4 7.9 8.1 6.8 9.1 9.5 9.8 49.1 6.7 9.5 8.1 13.5 13.1 11.0 13.1 11.4 5.5 9.9 9.1 7.9 10.7 7.0 8.6 4.1 8.7 8.7 15.1 7.4 5.0 11.8 9.5 9.0 10.6 9.1 9.0 8.7 7.6 6.8 9.3 7.1 12.6 7.4 7.1 11.4 13.2 11.0 6.4 3.8 6.0 6.9 4.3 11.4 9.3 15.0 12.4 1.7 5.5 12.0 7.0 9.4 19.3 7.9 4.2 7.6 4.7 4.8 11.8 7.4 7.8 10.2 10.0 10.8 6.3 9.0 10.8 6.2 9.2 7.7 2.9 8.9 7.5 10.8 8.1 6.4 8.2 8.0 9.9 9.7 6.2 6.4 9.4 6.4 8.6 8.5 SLC39A3 ZIP3 ENSG00000141873 "Solute carrier family 39 member 3" Q9BRY0 19 2732204-2740152 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 88.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042139, HPA058526" Uncertain Approved Vesicles Vesicles "HPA042139: AB_10793875, HPA058526: " "unprognostic (1.81e-1)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "prognostic favourable (9.76e-5)" "unprognostic (2.26e-1)" "unprognostic (2.44e-2)" "unprognostic (9.88e-3)" "unprognostic (1.01e-1)" "unprognostic (6.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.37e-3)" "unprognostic (4.07e-2)" "unprognostic (1.75e-3)" "unprognostic (9.22e-3)" "unprognostic (6.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.80e-2)" 11.1 15.5 13.3 8.3 18.0 23.9 13.3 10.6 28.0 12.7 10.8 14.0 8.3 10.2 14.3 19.5 10.5 14.6 10.5 11.7 14.4 13.0 11.0 23.6 9.0 11.7 11.5 12.9 11.0 11.9 17.8 15.5 10.6 14.9 10.8 8.8 10.7 12.4 11.7 11.2 8.1 9.4 14.0 11.1 12.9 9.3 50.1 8.8 13.0 12.5 6.8 9.4 14.2 7.8 24.4 38.0 29.6 17.5 13.1 17.5 15.4 11.6 9.5 7.2 17.6 14.9 10.2 7.3 8.5 10.1 15.8 16.2 10.2 7.6 7.2 5.5 14.6 9.5 10.9 11.4 9.9 0.0 7.8 31.9 7.0 10.3 16.4 26.4 46.7 9.1 18.4 11.7 9.6 8.0 34.9 32.4 10.5 7.5 12.9 19.8 7.6 12.7 17.1 4.7 21.6 7.5 9.2 9.9 9.0 7.4 5.3 17.8 9.3 34.6 4.9 11.0 6.1 17.2 12.4 8.8 13.8 6.9 8.3 88.8 13.1 16.4 17.5 29.6 17.5 16.1 15.4 24.4 15.4 14.9 23.4 24.4 12.9 14.5 7.8 13.1 15.5 38.0 9.7 15.4 13.3 18.0 10.6 28.0 14.4 13.0 11.5 12.9 14.9 8.8 SLC39A5 ENSG00000139540 "Solute carrier family 39 member 5" Q6ZMH5 12 56230049-56237846 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 77.8;liver: 38.2;pancreas: 101.1" "Group enriched" "Detected in some" 60 "CACO-2: 22.2;Hep G2: 32.1" "Cancer enhanced" "Detected in many" "liver cancer: 36.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 0.9" "Low region specificity" "Detected in many" HPA018423 Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA018423: AB_1857154" "unprognostic (5.94e-3)" "unprognostic (8.29e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-7)" "unprognostic (1.73e-1)" "unprognostic (7.79e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.93e-3)" "prognostic favourable (5.05e-4)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.96e-4)" 0.2 0.1 0.2 4.1 0.2 0.0 0.2 0.2 0.2 0.2 40.5 0.2 0.2 48.6 0.2 2.3 0.2 0.1 5.9 0.2 0.2 0.1 22.5 38.2 0.2 0.2 0.2 0.2 0.2 101.1 0.0 0.2 0.2 0.2 0.2 9.1 0.2 0.2 0.2 0.2 0.1 77.8 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 22.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 32.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 SLC43A1 "PB39, POV1, R00504" ENSG00000149150 "Solute carrier family 43 member 1" O75387 11 57484534-57515786 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 27.0;liver: 91.8;pancreas: 100.5" "Cell line enhanced" "Detected in many" "Hep G2: 23.5;NB-4: 27.9;U-937: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018813, HPA018826" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" "Golgi apparatus, Vesicles, Plasma membrane" "HPA018813: AB_1857164, HPA018826: AB_1857165" "unprognostic (3.04e-1)" "unprognostic (1.15e-1)" "unprognostic (9.19e-2)" "prognostic favourable (3.19e-4)" "unprognostic (2.51e-2)" "unprognostic (5.48e-2)" "unprognostic (2.32e-1)" "unprognostic (6.71e-3)" "unprognostic (1.63e-1)" "unprognostic (3.12e-2)" "unprognostic (6.06e-2)" "unprognostic (2.72e-1)" "prognostic unfavourable (2.97e-5)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (5.27e-4)" "unprognostic (7.30e-2)" 4.7 3.3 0.8 2.2 0.8 9.3 7.4 0.7 1.3 6.0 4.8 0.9 3.9 2.5 5.0 6.8 4.1 3.3 27.0 3.2 0.7 0.6 3.4 91.8 2.9 3.3 0.8 1.1 6.5 100.5 0.1 1.3 1.8 0.7 6.2 2.8 11.4 14.9 2.1 7.5 5.6 2.6 7.0 0.9 2.5 7.6 3.1 0.7 0.8 7.4 2.9 3.1 7.6 3.5 3.1 8.2 8.1 6.0 6.9 11.1 5.2 0.4 0.6 0.7 7.9 10.3 7.6 0.1 4.1 5.3 1.2 3.0 2.5 1.1 22.7 1.0 3.0 0.3 7.0 0.4 1.5 1.1 1.8 11.7 0.2 23.5 13.6 20.4 2.9 9.6 1.7 2.0 9.2 5.2 16.3 4.2 1.5 0.8 0.1 27.9 2.6 5.3 19.4 3.9 10.1 0.2 0.0 9.3 1.4 0.7 0.1 9.1 0.6 10.4 2.1 1.2 2.9 10.4 0.6 4.8 1.5 13.3 0.6 26.9 1.6 8.1 6.0 0.7 11.1 2.4 9.5 3.1 5.2 8.0 8.2 1.7 5.1 7.2 0.5 6.9 0.1 1.9 9.1 5.2 0.8 0.8 0.7 1.3 0.7 0.6 0.8 1.1 0.7 0.7 SLC43A3 "DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1" ENSG00000134802 "Solute carrier family 43 member 3" Q8NBI5 11 57406954-57427580 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 149.9;thyroid gland: 69.0" "Cell line enhanced" "Detected in many" "HL-60: 69.9;HMC-1: 61.7;RPMI-8226: 78.8;WM-115: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in many" 4 "olfactory region: 12.7" "Low region specificity" "Detected in all" "HPA030551, HPA077244" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" Vesicles "Nucleoplasm, Plasma membrane" "HPA030551: AB_10604094, HPA077244: " "unprognostic (2.64e-1)" "unprognostic (7.63e-2)" "unprognostic (9.67e-3)" "unprognostic (7.41e-3)" "unprognostic (6.59e-3)" "unprognostic (5.30e-3)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (1.36e-1)" "unprognostic (2.26e-1)" "unprognostic (5.73e-2)" "unprognostic (3.97e-2)" "prognostic unfavourable (3.97e-13)" "unprognostic (8.16e-2)" "unprognostic (1.77e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-1)" 32.3 6.3 2.5 12.4 4.3 18.8 16.8 2.2 3.0 11.9 9.6 3.6 2.4 2.7 10.1 6.5 12.6 8.9 11.4 12.5 3.1 1.5 4.2 149.9 16.5 8.8 4.0 1.8 16.0 7.2 1.2 1.8 5.1 3.4 11.6 4.2 9.4 12.2 3.1 15.4 11.0 6.2 10.3 4.7 11.6 6.9 6.8 2.3 10.4 69.0 11.5 13.8 20.3 15.4 2.7 23.6 6.1 36.8 1.1 7.8 14.0 39.3 0.0 2.3 0.0 7.7 11.3 0.1 3.0 13.1 4.5 7.8 0.0 8.6 22.8 1.4 7.2 22.7 6.6 4.0 9.1 0.1 0.0 35.4 13.5 0.0 15.6 69.9 61.7 33.9 0.1 43.9 0.5 12.6 40.4 22.0 17.5 0.0 14.6 44.9 3.4 0.7 30.4 0.4 78.8 10.8 0.0 5.4 0.0 8.7 0.2 36.7 3.4 10.6 6.7 0.2 11.8 29.9 8.6 0.0 0.1 5.7 27.1 25.4 75.2 3.2 28.8 6.1 5.7 34.5 6.5 2.7 4.0 7.8 23.6 2.0 3.1 3.2 2.5 1.1 36.8 23.6 6.9 14.0 2.5 4.3 2.2 3.0 3.1 1.5 4.0 1.8 3.4 2.3 SLC44A2 CTL2 ENSG00000129353 "Solute carrier family 44 member 2" Q8IWA5 19 10602457-10644559 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 61.1;SK-BR-3: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003228, HPA070799" Approved Approved "Vesicles,Cell Junctions" 78000 "Vesicles, Cell Junctions" "HPA003228: AB_1080009, HPA070799: " "unprognostic (6.35e-3)" "unprognostic (5.75e-2)" "unprognostic (4.34e-1)" "unprognostic (3.06e-3)" "unprognostic (4.38e-2)" "unprognostic (8.41e-3)" "unprognostic (1.64e-1)" "unprognostic (2.52e-1)" "unprognostic (2.66e-2)" "unprognostic (4.32e-1)" "prognostic unfavourable (6.01e-4)" "unprognostic (8.63e-2)" "prognostic favourable (1.71e-5)" "unprognostic (1.28e-1)" "unprognostic (1.67e-1)" "unprognostic (8.21e-3)" "unprognostic (3.61e-2)" 29.3 14.2 25.1 21.4 28.3 23.4 31.6 24.2 33.9 24.7 23.0 40.7 21.7 10.5 21.0 17.3 31.8 24.8 24.9 29.1 21.2 17.9 29.4 9.1 39.4 46.7 26.1 18.4 14.2 16.5 21.6 8.6 114.9 31.8 19.9 20.3 36.6 22.1 28.8 51.6 29.0 19.1 19.3 37.5 49.4 44.0 51.6 21.2 30.4 26.9 26.4 39.2 29.0 26.3 19.0 17.8 86.0 45.9 13.1 21.8 22.8 61.1 1.5 13.7 8.2 20.8 12.8 39.2 13.3 32.8 22.0 26.0 13.7 29.3 12.4 17.9 36.8 47.3 2.0 10.2 14.2 0.3 1.7 7.9 7.7 0.5 23.0 0.1 6.6 13.9 13.6 8.3 7.2 16.8 3.7 2.1 33.3 45.0 6.5 5.9 4.8 5.5 13.9 19.5 0.5 7.1 32.5 1.3 8.2 10.5 58.9 1.5 22.9 0.6 15.3 9.9 3.6 11.7 3.3 0.7 1.3 12.2 2.4 5.5 11.0 22.9 7.2 39.3 21.8 19.6 17.2 17.7 15.1 16.5 3.7 19.0 16.5 16.8 86.0 13.1 45.9 17.8 16.5 22.8 25.1 28.3 24.2 33.9 21.2 17.9 26.1 18.4 31.8 21.2 SLC45A3 "IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein" ENSG00000158715 "Solute carrier family 45 member 3" Q96JT2 1 205657851-205680459 "Cancer-related genes, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "prostate: 115.0" "Cell line enriched" "Detected in some" 30 "HMC-1: 138.2" "Cancer enriched" "Detected in all" 49 "prostate cancer: 539.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 226 "basophil: 22.6" "Lineage enriched" "Detected in single" 226 "granulocytes: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019073, HPA019075" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA019073: AB_1857177, HPA019075: AB_1857179" "unprognostic (1.80e-1)" "unprognostic (1.08e-3)" "unprognostic (3.13e-2)" "prognostic unfavourable (4.04e-5)" "unprognostic (6.93e-2)" "unprognostic (2.36e-2)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-2)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (3.16e-1)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "prognostic favourable (7.33e-5)" 0.8 1.5 2.5 1.5 6.2 0.7 0.8 0.4 5.8 1.9 2.1 19.0 0.0 2.1 0.9 0.6 0.9 1.1 1.8 0.7 4.2 2.0 1.1 4.0 1.7 1.6 13.2 1.6 1.0 0.7 0.5 1.9 0.6 7.2 115.0 1.6 0.2 0.9 0.7 2.2 0.9 2.1 0.8 12.4 5.0 6.4 1.4 11.1 0.0 0.5 0.7 0.7 1.5 0.4 0.0 0.0 22.6 0.0 0.0 0.0 0.2 1.5 0.4 0.4 0.4 0.0 0.0 0.3 0.2 0.0 0.5 0.4 1.1 2.9 0.4 0.7 0.0 0.5 0.2 0.5 0.0 0.6 0.4 4.6 0.1 0.3 0.3 0.7 138.2 0.0 0.1 0.3 0.0 1.5 0.7 0.2 0.2 0.3 0.1 1.3 2.0 1.7 0.1 0.6 0.2 0.6 2.1 0.2 0.4 0.2 3.4 0.6 0.7 0.2 1.5 0.2 1.5 0.5 1.1 0.0 0.1 0.0 0.3 0.2 1.1 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 6.2 0.4 5.8 4.2 2.0 13.2 1.6 7.2 11.1 SLC48A1 "FLJ20489, hHRG-1, HRG1" ENSG00000211584 "Solute carrier family 48 member 1" Q6P1K1 12 47753916-47782753 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 90.7" "Cell line enhanced" "Detected in many" "EFO-21: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065396, HPA073994" Approved Supported Vesicles Vesicles "HPA065396: , HPA073994: " "unprognostic (9.60e-2)" "prognostic favourable (4.27e-4)" "unprognostic (1.13e-2)" "unprognostic (1.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "prognostic unfavourable (9.39e-5)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (9.88e-2)" "unprognostic (1.54e-2)" "unprognostic (6.63e-3)" "prognostic favourable (1.34e-6)" "unprognostic (1.45e-1)" "unprognostic (5.96e-2)" "unprognostic (1.52e-1)" "unprognostic (2.72e-2)" 16.2 13.5 27.8 5.0 33.5 7.7 10.7 12.5 39.5 13.1 8.3 90.7 6.7 5.6 11.9 12.7 13.9 21.9 11.5 12.8 32.7 20.8 18.5 6.3 11.7 4.9 44.1 27.9 35.6 10.6 24.3 6.4 13.2 38.6 9.3 8.2 7.4 13.2 18.1 16.7 14.7 5.3 12.7 44.5 11.3 7.7 5.1 39.7 4.9 35.6 6.1 6.0 9.9 7.6 7.1 8.5 23.7 11.9 1.2 5.4 4.0 4.5 14.0 2.2 16.7 14.7 6.3 4.9 3.2 7.1 3.1 3.2 4.4 12.2 2.7 42.0 8.9 17.9 2.8 3.7 2.4 22.7 2.8 19.0 11.7 6.0 8.4 5.0 11.3 3.7 7.6 4.4 5.4 8.6 4.9 11.1 1.9 9.3 2.4 5.2 1.5 6.9 2.3 0.6 14.8 12.4 12.0 2.9 1.3 4.3 5.4 3.0 18.0 4.7 4.7 4.4 5.9 8.3 2.3 9.0 5.5 0.8 5.7 24.1 2.6 0.0 11.9 7.8 3.6 8.5 3.2 7.1 4.4 3.7 8.5 6.3 5.4 4.4 23.7 1.2 4.8 1.6 3.4 4.0 27.8 33.5 12.5 39.5 32.7 20.8 44.1 27.9 38.6 39.7 SLC4A11 "BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1" ENSG00000088836 "Solute carrier family 4 member 11" Q8NBS3 20 3227417-3239559 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Symport, Transport" "Corneal dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 34.4;thyroid gland: 42.7" "Cell line enhanced" "Detected in many" "HaCaT: 35.2;Hep G2: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 1.4;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA018120, HPA058377" Uncertain Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA018120: AB_1857186, HPA058377: " "unprognostic (2.33e-1)" "prognostic favourable (9.03e-4)" "unprognostic (1.18e-2)" "unprognostic (3.05e-2)" "unprognostic (1.00e-1)" "unprognostic (6.52e-2)" "unprognostic (9.66e-3)" "unprognostic (3.73e-2)" "unprognostic (3.10e-3)" "unprognostic (1.52e-3)" "unprognostic (2.94e-1)" "unprognostic (2.64e-1)" "prognostic favourable (6.21e-6)" "unprognostic (7.37e-2)" "unprognostic (4.30e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-3)" 0.8 3.1 3.3 0.8 4.9 0.3 2.4 2.1 2.8 8.6 0.2 1.3 0.8 0.1 0.9 2.0 7.5 1.1 2.2 0.5 3.0 0.6 11.4 0.1 1.3 0.9 1.4 1.1 0.6 0.1 0.4 2.4 0.3 1.8 2.2 0.3 1.1 34.4 5.8 3.5 5.3 0.3 0.2 1.4 0.3 1.9 3.2 1.2 0.2 42.7 3.3 5.1 2.6 2.1 0.0 0.7 0.0 1.4 0.0 1.1 0.4 5.3 7.6 0.9 4.0 2.6 0.7 10.9 2.7 1.7 1.4 0.8 0.5 7.0 0.0 3.1 0.9 35.2 4.2 8.3 0.2 0.0 1.7 0.3 3.3 20.6 1.6 1.9 6.9 0.3 3.4 1.7 1.6 3.5 0.7 4.9 1.4 3.4 0.2 0.2 6.1 10.3 1.2 5.2 1.7 8.5 15.0 0.4 2.5 1.4 8.8 0.2 3.4 3.3 5.9 1.0 3.6 0.2 1.3 0.2 0.3 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.7 0.0 0.3 0.0 0.0 0.0 1.4 0.0 1.1 0.4 3.3 4.9 2.1 2.8 3.0 0.6 1.4 1.1 1.8 1.2 SLC4A1AP "HLC3, kanadaptin" ENSG00000163798 "Solute carrier family 4 member 1 adaptor protein" Q9BWU0 2 27663471-27694976 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036679 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Vesicles" "Plasma membrane" "HPA036679: " "unprognostic (5.63e-2)" "unprognostic (1.01e-1)" "unprognostic (4.62e-2)" "prognostic unfavourable (1.49e-4)" "unprognostic (2.21e-1)" "unprognostic (7.89e-3)" "prognostic unfavourable (3.76e-7)" "unprognostic (1.32e-1)" "unprognostic (7.74e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-1)" "unprognostic (9.66e-2)" "unprognostic (9.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.42e-1)" "unprognostic (2.40e-2)" "prognostic unfavourable (1.79e-4)" 12.3 16.1 18.8 14.2 27.0 12.7 13.9 27.4 29.0 11.5 11.3 15.8 8.7 11.6 12.8 12.2 14.2 12.3 9.8 18.6 17.9 19.6 15.3 15.0 12.8 14.6 17.0 20.5 15.2 13.3 23.8 16.0 14.5 29.1 12.6 12.3 9.0 12.4 12.1 26.0 15.1 12.0 12.5 15.4 13.1 12.5 29.9 16.8 16.1 14.6 14.9 15.1 11.1 11.0 16.7 13.3 40.8 17.9 22.5 19.5 14.1 21.6 12.6 12.8 11.9 13.2 12.2 18.8 18.0 12.5 19.0 15.6 18.4 15.9 13.7 16.8 14.4 15.5 20.4 14.0 17.1 19.1 16.7 15.8 13.3 20.2 16.1 22.5 15.1 10.9 17.8 18.9 18.0 19.3 22.8 15.0 17.5 13.2 15.1 22.1 12.9 12.5 12.6 28.0 15.8 19.6 10.1 13.9 13.7 14.0 19.2 17.3 11.6 14.8 19.5 17.8 16.1 12.3 21.0 24.8 35.1 44.0 19.3 18.2 14.1 40.8 17.7 24.2 17.6 16.9 17.4 13.5 16.1 15.3 13.3 16.7 19.5 16.5 16.5 22.5 17.9 10.7 17.1 14.1 18.8 27.0 27.4 29.0 17.9 19.6 17.0 20.5 29.1 16.8 SLC51B OSTbeta ENSG00000186198 "Solute carrier family 51 beta subunit" Q86UW2 15 65045370-65053396 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 85.0" "Group enriched" "Detected in some" 10 "CACO-2: 16.5;EFO-21: 11.1;Hep G2: 13.8" "Cancer enhanced" "Detected in many" "liver cancer: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008398, HPA008533" Enhanced Approved Vesicles,Mitochondria Mitochondria Vesicles "HPA008398: , HPA008533: AB_1854824" "unprognostic (6.18e-2)" "unprognostic (6.75e-3)" "unprognostic (1.66e-1)" "unprognostic (1.31e-2)" "unprognostic (5.88e-2)" "unprognostic (9.49e-2)" "unprognostic (9.77e-3)" "unprognostic (1.81e-2)" "unprognostic (3.35e-2)" "unprognostic (2.76e-1)" "unprognostic (2.24e-1)" "unprognostic (4.34e-2)" "prognostic favourable (8.46e-5)" "unprognostic (5.87e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.17e-2)" 0.4 0.5 0.4 3.8 0.6 0.0 0.4 0.4 0.8 14.0 34.9 0.4 0.4 28.1 0.9 3.3 0.4 1.0 0.5 0.4 0.5 0.6 7.5 2.4 1.6 0.4 0.6 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.8 9.5 0.4 0.4 0.8 0.4 0.1 85.0 0.4 0.4 0.4 0.2 4.1 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.7 0.1 0.0 0.5 0.3 0.0 1.4 0.2 0.7 0.0 0.1 0.4 0.0 0.0 0.2 0.0 16.5 0.0 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 13.8 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.3 0.4 0.4 0.0 0.0 0.8 0.4 0.0 0.6 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.5 0.0 0.3 0.2 0.0 0.0 0.1 0.3 0.7 0.0 0.1 0.0 0.0 0.3 0.4 0.6 0.4 0.4 0.5 0.6 0.6 0.4 0.4 0.4 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043032-32113029 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "intestine: 274.9" "Cell line enhanced" "Detected in some" "CACO-2: 6.3;NB-4: 2.4;RPMI-8226: 4.8;SCLC-21H: 1.8;SH-SY5Y: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 26 "cerebellum: 8.6" "Low region specificity" "Detected in all" "CAB015467, HPA051805, HPA055106" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB015467: , HPA051805: , HPA055106: " "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favourable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favourable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.2 0.0 0.2 1.3 0.2 0.0 1.5 0.2 0.2 2.2 181.5 0.2 2.9 95.5 0.3 0.8 1.9 0.0 14.1 24.5 0.2 0.0 1.0 0.9 0.3 0.2 0.2 0.2 0.2 0.4 0.0 1.0 0.2 0.2 0.8 1.6 0.2 5.7 3.5 0.2 4.6 274.9 0.2 0.2 0.7 1.2 0.8 0.2 0.2 0.2 3.5 1.5 0.2 2.0 0.3 0.1 0.6 0.8 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.6 0.0 0.0 0.0 0.0 6.3 1.3 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.0 2.4 0.1 0.0 0.0 0.0 4.8 0.0 0.1 1.8 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.8 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 SLC6A11 GAT3 ENSG00000132164 "Solute carrier family 6 member 11" P48066 3 10816200-10940733 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 37.0;esophagus: 10.5;skin 1: 11.5" "Cell line enhanced" "Detected in some" "A-431: 4.6;HaCaT: 12.4;Hep G2: 14.3;hTCEpi: 11.2;NTERA-2: 6.3;T-47d: 4.7" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037981 Supported Supported Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA037981: AB_10671383" "unprognostic (6.04e-2)" "unprognostic (8.01e-2)" "unprognostic (1.21e-7)" "unprognostic (8.60e-2)" "unprognostic (8.68e-2)" "unprognostic (9.72e-3)" "unprognostic (6.39e-3)" "unprognostic (9.77e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (8.78e-2)" "unprognostic (1.51e-3)" "unprognostic (6.06e-2)" "unprognostic (4.44e-2)" "unprognostic (9.83e-2)" "unprognostic (2.31e-2)" 0.8 0.8 11.5 0.7 14.1 0.8 2.9 3.1 23.0 0.9 0.8 5.0 0.0 0.7 1.7 1.1 10.5 1.8 0.7 0.8 8.4 24.5 0.7 0.9 0.8 0.7 37.0 5.9 0.8 1.0 0.7 0.2 1.6 35.4 2.3 0.8 0.4 1.1 0.7 1.0 11.5 0.8 1.0 10.4 1.5 0.7 3.4 9.2 0.0 0.8 0.2 1.1 1.3 0.7 0.5 0.3 1.2 0.4 0.2 0.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 2.0 0.0 0.0 0.2 0.2 0.0 14.3 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 2.8 1.8 4.3 3.6 0.1 0.0 4.7 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.5 0.2 0.2 1.2 0.2 0.4 0.3 0.3 0.0 11.5 14.1 3.1 14.7 8.4 24.5 37.0 5.9 35.4 9.2 SLC6A12 BGT-1 ENSG00000111181 "Solute carrier family 6 member 12" P48065 12 190077-214570 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 22.1;liver: 59.3" "Group enriched" "Detected in some" 12 "Hep G2: 8.3;RPTEC TERT1: 16.7" "Cancer enhanced" "Detected in many" "renal cancer: 11.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 57 "classical monocyte: 6.6;intermediate monocyte: 6.4;myeloid DC: 2.9;neutrophil: 3.7;non-classical monocyte: 8.6" "Group enriched" "Detected in many" 51 "dendritic cells: 2.9;granulocytes: 3.7;monocytes: 8.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034973 Approved Approved Vesicles Vesicles "HPA034973: AB_10610427" "unprognostic (3.48e-1)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (1.70e-1)" "unprognostic (1.09e-1)" "unprognostic (1.88e-2)" "unprognostic (8.30e-2)" "unprognostic (6.96e-3)" "unprognostic (2.70e-2)" "unprognostic (1.85e-2)" "unprognostic (3.68e-1)" "prognostic favourable (2.70e-6)" "unprognostic (2.30e-1)" "unprognostic (4.92e-4)" "unprognostic (3.35e-1)" "unprognostic (4.31e-4)" 0.6 0.8 6.3 1.3 12.9 0.6 0.8 6.6 14.7 0.9 1.0 4.3 0.0 3.7 1.3 5.6 0.5 3.0 1.2 0.7 7.2 4.6 22.1 59.3 2.2 0.8 8.1 4.9 0.7 1.3 0.6 0.3 0.9 9.4 0.6 1.8 0.2 0.6 0.5 0.5 0.7 1.1 1.2 3.1 0.8 2.3 1.6 8.8 0.0 4.5 0.0 0.7 0.9 0.2 0.0 2.9 3.7 8.6 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 8.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.7 0.1 0.0 0.5 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 6.6 0.0 0.0 6.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 3.7 0.0 8.6 0.0 0.0 1.9 6.3 12.9 6.6 14.7 7.2 4.6 8.1 4.9 9.4 8.8 SLC6A14 ENSG00000268104 "Solute carrier family 6 member 14" Q9UN76 X 116436622-116461458 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" Obesity "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5" "Group enriched" "Detected in some" 4 "HeLa: 3.8;Hep G2: 8.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA003193 Uncertain Approved Vesicles Vesicles "HPA003193: AB_2190122" "unprognostic (3.06e-2)" "unprognostic (3.55e-2)" "unprognostic (8.49e-2)" "unprognostic (1.00e-3)" "unprognostic (1.30e-3)" "unprognostic (1.49e-2)" "unprognostic (7.41e-3)" "unprognostic (3.67e-3)" "unprognostic (2.66e-1)" "unprognostic (1.83e-2)" "prognostic unfavourable (9.74e-4)" "unprognostic (1.34e-2)" "unprognostic (3.89e-2)" "unprognostic (2.08e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" 0.0 0.0 0.0 1.5 0.0 0.0 5.9 0.0 0.0 6.3 0.8 0.0 11.8 0.4 0.1 0.0 1.8 0.0 1.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.2 0.5 0.3 0.0 26.3 5.8 0.0 1.1 0.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 23.5 1.2 1.0 1.0 0.4 0.2 1.1 0.4 0.3 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 3.8 8.2 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.2 0.0 1.4 0.5 0.0 0.0 0.1 0.0 1.1 0.4 0.5 0.4 0.1 0.3 0.4 0.2 0.2 0.1 0.4 0.3 0.3 0.4 0.3 0.2 0.2 0.1 0.0 SLC6A15 "FLJ10316, hv7-3, NTT73, SBAT1, V7-3" ENSG00000072041 "Solute carrier family 6 member 15" Q9H2J7 12 84859488-84913615 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0" "Cell line enhanced" "Detected in many" "ASC diff: 30.4;ASC TERT1: 18.8;hTERT-HME1: 43.0;SCLC-21H: 29.3;SK-MEL-30: 21.6" "Cancer enhanced" "Detected in some" "melanoma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008609 Uncertain Approved Nucleoli,Vesicles Nucleoli Vesicles "HPA008609: AB_1857190" "unprognostic (1.01e-4)" "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (6.65e-6)" "unprognostic (1.25e-2)" "unprognostic (2.92e-1)" "unprognostic (7.65e-3)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (7.69e-4)" "unprognostic (2.57e-2)" "unprognostic (3.80e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-3)" 1.4 4.5 18.0 2.2 16.2 1.0 2.3 17.8 31.0 1.7 2.2 5.4 0.0 1.4 2.8 1.1 6.7 1.2 1.3 1.0 10.9 18.2 1.5 1.0 1.3 1.1 10.3 16.9 2.1 1.0 1.0 5.6 8.9 14.7 1.8 1.8 9.2 1.4 1.5 1.0 4.9 2.1 1.6 4.9 1.1 1.3 3.6 12.8 0.0 2.0 1.8 1.8 1.1 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 3.6 0.0 30.4 18.8 0.0 0.0 6.4 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 8.1 0.0 0.0 9.3 0.0 1.5 0.0 11.2 0.0 0.2 10.5 15.7 4.1 43.0 0.1 0.0 0.0 7.7 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 7.6 0.0 9.7 21.6 0.0 0.0 0.0 4.6 2.5 0.0 0.0 0.0 0.0 0.0 8.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.0 16.2 17.8 18.6 10.9 18.2 10.3 16.9 14.7 12.8 SLC6A3 "DAT, DAT1" ENSG00000142319 "Solute carrier family 6 member 3" Q01959 5 1392790-1445430 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 48.4" "Group enriched" "Detected in some" 5 "NTERA-2: 1.2;RPMI-8226: 2.0;SCLC-21H: 3.7" "Cancer enriched" "Detected in some" 18 "renal cancer: 25.7" "Region enriched" "Detected in some" 47 "midbrain: 48.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "midbrain: 96.4;thalamus: 31.8" "Region enriched" "Detected in single" 139 "midbrain: 362.2" "HPA012763, HPA013602, CAB016249, CAB078172" Enhanced Supported Approved Vesicles Vesicles "CAB016249: AB_627402, CAB078172: , HPA012763: , HPA013602: AB_1847484" "unprognostic (2.25e-4)" "unprognostic (2.22e-1)" "unprognostic (8.45e-2)" "unprognostic (5.24e-2)" "unprognostic (7.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.64e-5)" "unprognostic (9.31e-2)" "unprognostic (7.89e-2)" "unprognostic (4.81e-2)" "unprognostic (1.30e-1)" "unprognostic (2.12e-2)" "prognostic unfavourable (3.40e-7)" "unprognostic (6.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.22e-2)" "unprognostic (4.74e-2)" 0.2 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.7 0.0 0.0 0.0 0.3 1.1 0.8 0.1 0.8 0.6 0.1 0.0 0.6 0.3 0.0 3.4 0.0 48.4 0.0 1.5 0.0 0.0 0.0 0.1 1.0 0.7 0.0 1.7 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.8 0.0 2.4 2.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 2.0 0.0 0.1 3.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.6 48.4 0.0 1.0 0.0 SLC6A4 "5-HTT, HTT, OCD1, SERT1" ENSG00000108576 "Solute carrier family 6 member 4" P31645 17 30194319-30236002 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 25.0;lung: 50.5" "Cell line enhanced" "Detected in some" "BEWO: 2.8;CACO-2: 5.4;Hep G2: 14.4" "Cancer enhanced" "Detected in some" "breast cancer: 2.3" "Region enriched" "Detected in single" 36 "pons and medulla: 11.2" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 5 "midbrain: 69.9" "Low region specificity" "Detected in all" "HPA054723, HPA071354, HPA074728" Supported Supported Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA054723: , HPA071354: , HPA074728: " "unprognostic (7.45e-2)" "unprognostic (7.13e-2)" "unprognostic (2.26e-1)" "unprognostic (3.72e-4)" "unprognostic (2.07e-1)" "unprognostic (8.42e-3)" "unprognostic (2.73e-2)" "unprognostic (3.39e-2)" "unprognostic (3.37e-3)" "unprognostic (1.17e-3)" "unprognostic (2.70e-3)" "unprognostic (1.16e-1)" "unprognostic (8.78e-2)" "unprognostic (4.98e-2)" "unprognostic (1.76e-1)" "unprognostic (4.05e-2)" "unprognostic (7.18e-2)" 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.1 6.3 0.1 0.3 1.6 0.9 0.1 0.7 0.1 0.1 0.3 0.1 50.5 0.1 0.1 0.1 0.1 0.6 0.0 0.1 11.3 11.2 0.1 0.0 0.2 0.7 0.1 0.1 0.4 25.0 0.4 0.1 0.1 0.5 0.3 0.1 0.1 0.2 0.1 0.3 0.1 0.3 0.0 0.1 1.0 0.2 0.4 0.3 2.3 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 14.4 1.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.0 1.0 0.0 0.8 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 1.0 0.4 0.2 0.1 0.0 2.3 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 11.2 0.1 SLC7A11 xCT ENSG00000151012 "Solute carrier family 7 member 11" Q9UPY5 4 138164097-138242349 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2" "Cell line enhanced" "Detected in many" "hTCEpi: 28.0;TIME: 30.7;WM-115: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 3.8" "Lineage enriched" "Detected in single" 8 "dendritic cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064215 Approved Vesicles Vesicles "HPA064215: " "unprognostic (3.55e-3)" "unprognostic (4.64e-3)" "unprognostic (2.43e-2)" "unprognostic (7.18e-3)" "unprognostic (2.59e-1)" "unprognostic (8.80e-3)" "unprognostic (2.07e-8)" "unprognostic (1.98e-2)" "unprognostic (1.09e-2)" "prognostic favourable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (4.07e-2)" "unprognostic (2.22e-8)" "unprognostic (3.81e-2)" "unprognostic (3.76e-2)" "unprognostic (2.29e-2)" "unprognostic (1.54e-2)" 1.1 0.9 16.3 4.7 15.8 2.2 1.5 8.2 26.0 2.4 2.0 17.9 0.0 1.5 1.3 13.4 3.3 8.9 3.8 2.5 17.4 6.9 0.9 0.9 2.3 1.5 12.6 16.8 1.7 5.4 1.0 1.2 2.1 17.2 2.0 2.8 0.3 1.6 1.0 0.8 1.9 1.4 1.0 27.2 1.4 9.2 2.2 14.0 0.0 8.9 6.0 2.2 4.0 0.8 0.1 3.8 0.4 0.0 0.1 0.0 0.0 1.6 13.5 6.1 4.7 1.3 1.7 1.6 7.5 5.2 1.7 3.9 1.5 5.7 3.1 9.8 26.0 2.2 3.2 6.4 7.2 5.8 0.6 2.2 12.8 3.4 20.2 5.6 2.1 4.0 28.0 4.8 21.6 21.2 2.9 8.0 8.9 1.2 0.7 0.5 1.2 3.9 0.9 2.0 3.5 1.0 6.4 2.5 0.5 3.2 0.9 11.5 1.4 12.1 30.7 2.2 6.3 3.3 5.9 6.8 3.1 3.1 3.8 3.1 45.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 3.8 0.0 0.0 16.3 15.8 8.2 15.9 17.4 6.9 12.6 16.8 17.2 14.0 SLC7A14 "KIAA1613, PPP1R142" ENSG00000013293 "Solute carrier family 7 member 14" Q8TBB6 3 170459584-170586074 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.4;pituitary gland: 14.5" "Cell line enhanced" "Detected in some" "LHCN-M2: 7.0;SCLC-21H: 7.0" "Group enriched" "Detected in some" 11 "glioma: 0.8;pancreatic cancer: 0.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045929 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Cytosol" "Nucleoplasm, Plasma membrane" "HPA045929: " "unprognostic (1.00e-1)" "unprognostic (9.56e-2)" "unprognostic (1.03e-1)" "unprognostic (4.15e-2)" "unprognostic (1.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.16e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-1)" "unprognostic (6.68e-3)" "unprognostic (6.36e-2)" "unprognostic (3.03e-6)" "unprognostic (1.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.71e-2)" "unprognostic (3.24e-3)" 1.1 5.8 12.1 1.9 17.7 1.4 1.1 14.9 33.4 1.0 1.8 8.0 0.0 1.6 1.1 1.2 1.1 1.1 1.3 1.1 11.5 12.1 1.3 1.2 1.1 1.1 6.7 12.8 1.3 2.4 1.1 14.5 1.1 11.8 1.2 1.9 0.1 1.1 1.1 1.2 1.3 1.7 1.3 9.0 1.1 1.5 1.3 6.3 0.0 1.1 0.0 1.1 1.1 0.3 1.0 0.6 2.1 0.5 0.7 0.6 0.1 0.0 0.0 0.4 0.1 1.2 2.0 0.1 0.6 0.2 0.8 0.8 0.1 0.1 0.1 0.0 0.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 1.8 0.0 0.1 1.2 0.2 0.0 0.2 7.0 0.0 0.0 0.2 0.9 0.1 0.1 0.0 0.1 0.0 0.1 7.0 2.0 0.0 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 2.1 0.5 0.5 0.4 0.3 0.3 0.8 0.3 0.3 0.1 1.0 0.6 0.5 1.2 0.7 0.3 0.6 0.3 0.1 12.1 17.7 14.9 16.9 11.5 12.1 6.7 12.8 11.8 6.3 SLC7A5 "CD98, D16S469E, E16, LAT1, MPE16" ENSG00000103257 "Solute carrier family 7 member 5" Q01650 16 87830023-87869488 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 71.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 106.7;hTCEpi: 183.4;MCF7: 99.4;SiHa: 150.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 15.9" "Lineage enriched" "Detected in many" 11 "dendritic cells: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052673, HPA056077" Approved Supported "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "HPA052673: , HPA056077: " "unprognostic (2.71e-3)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-1)" "unprognostic (3.22e-2)" "unprognostic (2.99e-3)" "unprognostic (1.64e-1)" "prognostic unfavourable (2.43e-4)" "unprognostic (6.86e-2)" "unprognostic (4.46e-2)" "unprognostic (1.27e-1)" "unprognostic (3.17e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (5.93e-2)" "unprognostic (5.52e-3)" "unprognostic (1.64e-2)" "unprognostic (7.19e-3)" 8.2 3.2 18.3 14.7 24.5 71.2 4.3 15.9 45.8 7.9 4.6 16.7 8.9 6.2 5.3 30.4 38.7 3.3 6.4 8.2 19.8 22.1 3.6 9.7 3.8 11.1 23.9 9.6 5.1 12.1 1.5 9.0 28.4 23.4 4.3 3.4 34.9 11.5 15.4 11.2 10.7 5.7 4.8 17.7 6.4 12.7 34.9 19.8 3.7 4.2 16.7 15.0 11.5 7.7 0.5 15.9 0.6 0.0 0.2 1.4 0.4 14.6 55.6 1.0 15.6 0.4 0.9 40.1 11.8 4.3 7.2 4.6 36.2 21.0 13.4 10.5 15.0 66.2 11.5 106.7 5.0 14.1 5.8 11.0 52.2 25.9 16.8 10.2 20.3 3.0 183.4 8.8 65.7 1.4 16.4 15.1 5.7 99.4 12.3 15.1 5.1 13.5 11.9 4.3 20.6 8.0 1.2 9.0 3.5 150.7 30.1 32.3 13.8 13.6 1.1 2.5 16.8 10.4 9.1 19.6 16.0 58.1 9.9 25.5 24.0 0.6 0.0 0.0 1.0 0.0 1.2 0.5 0.5 0.8 0.3 0.0 0.1 0.4 0.1 0.2 0.0 15.9 1.4 0.4 18.3 24.5 15.9 28.1 19.8 22.1 23.9 9.6 23.4 19.8 SLC7A6 "KIAA0245, LAT-2, LAT3, y+LAT-2" ENSG00000103064 "Solute carrier family 7 member 6" Q92536 16 68264516-68301823 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050713 Uncertain Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA050713: " "unprognostic (6.35e-2)" "unprognostic (4.63e-2)" "unprognostic (1.41e-1)" "unprognostic (1.40e-2)" "unprognostic (2.41e-1)" "unprognostic (5.02e-2)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (1.89e-3)" "unprognostic (7.82e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-3)" "prognostic unfavourable (1.84e-4)" 25.9 7.6 5.4 12.9 6.7 6.9 18.7 9.0 8.0 5.3 7.1 3.4 6.7 3.6 5.5 14.0 4.0 7.1 4.7 13.1 5.3 3.3 5.4 2.3 9.8 16.3 3.3 4.6 3.0 3.2 2.5 11.1 16.3 5.4 6.6 10.8 9.0 5.8 5.1 58.8 8.4 9.4 8.3 3.4 9.4 5.3 5.2 3.7 31.8 15.0 8.0 19.6 5.7 8.0 7.2 16.2 5.9 3.6 6.7 12.6 1.7 9.3 9.5 7.1 7.6 21.1 12.7 20.0 11.0 8.0 16.4 13.8 40.8 7.1 18.6 8.7 14.1 14.3 13.8 13.7 17.9 3.8 9.9 9.9 18.8 12.9 3.9 11.6 9.0 8.5 12.0 12.8 6.4 11.0 14.5 3.3 8.9 5.0 15.2 8.1 5.3 3.5 19.3 4.5 15.6 5.7 8.2 10.5 5.7 31.7 8.9 3.7 13.3 6.3 16.1 10.9 8.3 9.1 13.7 7.1 13.3 21.2 6.9 8.6 7.3 2.5 3.6 3.0 4.9 1.7 6.1 6.6 7.3 4.6 3.4 7.2 12.6 7.4 5.9 6.7 1.4 16.2 3.1 1.7 5.4 6.7 9.0 8.0 5.3 3.3 3.3 4.6 5.4 3.7 SLC9A3R1 "EBP50, NHERF, NHERF1" ENSG00000109062 "SLC9A3 regulator 1" O14745 17 74748652-74769353 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Wnt signaling pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 77.3;SK-BR-3: 63.1;T-47d: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001962, HPA009672, HPA027247" Enhanced Approved "Vesicles,Plasma membrane,Centriolar satellite" 9600000 "Plasma membrane" "Vesicles, Centriolar satellite" "CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162" "unprognostic (1.29e-1)" "unprognostic (4.58e-2)" "unprognostic (1.73e-2)" "unprognostic (5.51e-2)" "unprognostic (5.83e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (9.83e-5)" "unprognostic (7.41e-2)" "unprognostic (5.61e-2)" "unprognostic (5.38e-2)" "unprognostic (7.53e-2)" "unprognostic (4.49e-2)" "unprognostic (1.56e-3)" "unprognostic (7.81e-3)" "unprognostic (5.53e-2)" "unprognostic (3.84e-2)" "unprognostic (2.08e-2)" 5.4 33.3 19.8 9.9 23.3 22.6 15.2 21.9 15.1 12.5 30.6 15.2 35.9 57.6 5.4 12.0 74.3 20.5 30.8 5.6 14.2 8.8 36.1 64.9 8.6 13.5 14.3 14.0 5.0 26.5 12.5 4.9 8.3 12.8 10.1 13.4 22.9 41.8 23.3 1.5 11.2 73.3 3.1 12.1 13.8 14.8 5.4 14.1 18.4 5.6 24.3 30.3 7.1 20.3 9.8 14.3 72.7 24.8 45.1 70.4 44.3 13.7 11.3 5.6 5.8 3.4 2.5 25.5 3.3 3.1 8.5 8.3 35.4 8.2 3.0 3.4 7.0 19.7 9.7 6.4 4.0 3.6 9.3 22.6 30.6 47.1 7.0 14.7 15.3 2.0 3.6 6.7 2.9 7.0 7.1 16.2 13.0 77.3 34.7 33.1 5.0 6.7 3.8 6.3 13.6 11.7 9.8 4.9 6.4 3.4 63.1 7.1 122.1 11.8 2.3 2.6 7.7 6.1 5.4 28.2 12.7 5.5 4.3 19.7 1.5 72.7 14.1 65.3 70.4 20.6 46.6 9.8 43.2 59.3 13.7 8.6 25.5 45.2 50.3 45.1 24.8 14.3 47.0 44.3 19.8 23.3 21.9 15.1 14.2 8.8 14.3 14.0 12.8 14.1 SLC9A6 "KIAA0267, NHE6" ENSG00000198689 "Solute carrier family 9 member A6" Q92581 X 135973841-136047269 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059445, HPA059590" Enhanced Supported Vesicles Vesicles "HPA059445: , HPA059590: " "unprognostic (1.35e-1)" "unprognostic (8.28e-3)" "unprognostic (4.36e-1)" "unprognostic (4.93e-2)" "unprognostic (1.84e-1)" "unprognostic (1.19e-1)" "unprognostic (2.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (7.07e-2)" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (4.49e-2)" "unprognostic (5.06e-2)" 4.3 5.7 16.4 4.7 27.6 4.0 3.1 15.3 35.1 5.2 5.2 7.8 1.6 7.5 5.7 3.2 5.6 5.2 4.8 7.2 19.1 24.3 6.2 3.9 5.7 4.7 15.0 15.6 7.4 3.3 9.3 8.6 4.0 22.3 3.6 5.5 4.6 3.3 4.6 5.5 4.1 6.5 6.5 9.5 4.8 5.2 5.1 4.0 3.6 5.9 1.7 5.8 4.7 3.2 5.3 6.8 3.2 8.4 5.9 13.9 6.0 13.0 6.9 7.3 2.7 10.4 10.1 13.1 10.5 11.3 9.1 19.3 6.0 10.5 9.7 24.1 12.1 7.8 9.4 9.4 13.2 7.6 8.6 2.6 11.0 3.5 5.5 7.6 9.2 5.6 8.4 15.0 7.5 7.7 4.8 14.0 10.0 5.8 10.0 2.2 4.1 9.4 6.8 10.9 9.9 6.5 6.6 6.5 4.9 7.6 0.8 6.1 3.2 5.9 10.9 11.3 8.1 16.8 13.6 6.7 14.9 8.6 6.9 13.0 6.3 2.2 6.0 3.2 8.1 8.4 13.9 5.3 9.5 7.9 6.8 4.0 10.6 7.9 2.6 5.9 6.6 4.3 8.0 6.0 16.4 27.6 15.3 25.9 19.1 24.3 15.0 15.6 22.3 4.0 SLC9A7 NHE7 ENSG00000065923 "Solute carrier family 9 member A7" Q96T83 X 46599252-46759172 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Potassium transport, Sodium transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 42.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048938, HPA075385" Approved Supported Vesicles Vesicles "HPA048938: , HPA075385: " "unprognostic (2.77e-1)" "unprognostic (4.68e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (8.58e-4)" "prognostic unfavourable (8.14e-4)" "unprognostic (2.16e-2)" "unprognostic (2.73e-3)" "unprognostic (5.26e-3)" "unprognostic (1.28e-2)" "unprognostic (9.25e-2)" "unprognostic (5.30e-2)" "unprognostic (1.11e-1)" "unprognostic (2.08e-1)" "unprognostic (7.20e-2)" "unprognostic (2.62e-1)" "unprognostic (1.57e-1)" "unprognostic (1.13e-1)" 1.7 7.2 4.4 3.8 42.0 4.4 7.9 7.0 12.4 1.8 1.2 1.8 1.2 1.7 1.2 3.8 3.2 2.5 2.2 2.3 3.3 7.1 3.3 4.1 1.8 7.8 3.6 4.3 6.3 4.6 11.5 13.6 1.4 12.7 6.5 1.3 2.3 7.3 2.9 10.0 2.9 2.7 1.0 2.7 4.7 8.2 1.3 8.2 2.8 6.9 1.7 8.2 2.3 2.2 4.3 6.0 2.1 0.6 1.4 0.7 0.5 7.3 5.6 0.8 2.4 0.9 5.6 3.2 7.0 8.7 4.2 3.4 5.7 7.9 16.1 2.2 11.1 3.4 5.4 7.9 7.7 8.4 2.9 1.6 2.2 2.3 3.5 0.8 13.3 3.5 1.0 11.9 7.9 5.9 0.1 0.3 5.7 11.0 1.8 0.9 3.9 6.7 7.1 0.3 0.2 3.2 8.2 6.1 0.7 3.6 5.4 1.5 7.1 0.3 0.3 9.0 3.0 1.4 4.1 1.7 0.4 8.1 12.8 0.1 2.9 1.0 0.6 0.3 0.6 0.6 0.4 3.4 0.7 0.3 2.4 4.3 0.4 0.5 2.1 1.4 0.6 6.0 0.7 0.5 4.4 42.0 7.0 8.3 3.3 7.1 3.6 4.3 12.7 8.2 SLCO5A1 "OATP-J, OATP5A1, OATPRP4, SLC21A15" ENSG00000137571 "Solute carrier organic anion transporter family member 5A1" Q9H2Y9 8 69667047-69835064 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2" "Cell line enhanced" "Detected in some" "HAP1: 8.8;NTERA-2: 5.9;RPMI-8226: 5.5;SCLC-21H: 6.4;U-266/70: 3.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.7" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "basal ganglia: 2.3;olfactory region: 8.2" HPA025062 Uncertain Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA025062: AB_1857220" "unprognostic (1.30e-3)" "unprognostic (7.35e-3)" "unprognostic (4.13e-2)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (5.70e-2)" "unprognostic (1.46e-2)" "unprognostic (1.51e-1)" "unprognostic (2.37e-4)" "unprognostic (1.75e-1)" "unprognostic (4.48e-4)" "unprognostic (1.74e-2)" "unprognostic (2.92e-6)" "unprognostic (2.20e-1)" "unprognostic (1.23e-1)" "unprognostic (2.13e-1)" "unprognostic (4.50e-2)" 0.7 0.2 0.5 1.5 0.7 1.5 0.2 0.1 0.8 0.3 0.4 0.1 0.0 0.4 0.5 1.5 1.0 0.5 0.4 21.4 0.7 0.7 0.2 0.4 0.3 4.1 0.3 0.3 0.2 0.7 0.0 4.7 0.0 0.5 4.2 0.7 0.6 0.9 0.0 13.9 0.3 0.7 0.2 0.2 0.8 0.3 0.4 0.0 9.5 0.5 16.2 1.7 0.9 0.2 1.7 0.1 0.7 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.0 0.0 2.3 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.1 5.9 0.9 1.0 0.9 5.5 0.1 0.0 6.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.5 0.1 1.2 3.4 0.5 0.0 0.3 0.0 1.7 0.7 0.0 0.1 0.3 0.0 0.0 0.5 0.1 0.2 0.0 1.7 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.0 0.5 0.7 0.1 0.7 0.7 0.7 0.3 0.3 0.5 0.0 SLF2 "C10orf6, FAM178A, FLJ10512, FLJ25012" ENSG00000119906 "SMC5-SMC6 complex localization factor 2" Q8IX21 10 100912569-100965136 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "RH-30: 58.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038499, HPA057568" Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038499: AB_10672520, HPA057568: " "unprognostic (9.05e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-2)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (2.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.66e-2)" "unprognostic (1.54e-2)" "unprognostic (1.16e-3)" "unprognostic (2.85e-1)" "unprognostic (4.90e-2)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" 9.8 20.2 19.5 17.1 26.6 12.1 11.3 21.4 21.4 12.2 10.7 22.0 13.0 9.4 20.9 56.1 9.4 17.3 9.6 11.6 17.8 14.2 10.9 10.2 11.6 15.6 29.4 17.3 29.4 12.3 11.6 26.8 17.4 18.3 14.5 12.1 7.8 10.3 16.0 17.9 15.1 11.5 12.9 22.7 22.0 9.9 26.7 31.3 14.7 11.3 10.5 13.2 10.8 19.9 13.8 9.5 8.6 8.9 10.9 14.0 5.6 9.7 8.0 11.8 12.2 6.2 8.5 4.5 10.3 7.3 9.7 11.8 5.8 6.8 9.0 6.4 4.3 9.9 8.1 3.4 11.8 10.2 6.5 8.4 5.3 11.4 4.6 10.7 9.9 3.9 5.0 7.4 8.0 6.2 5.8 9.0 14.1 6.5 7.2 5.9 5.3 6.0 7.1 58.3 3.1 3.8 5.0 2.5 5.1 6.5 1.7 11.8 10.3 3.9 8.0 11.4 9.5 7.0 11.7 7.2 10.7 7.5 7.8 12.4 5.9 6.8 8.9 8.6 14.0 8.8 12.2 11.1 10.8 11.5 6.5 13.8 12.0 10.6 4.6 10.9 8.8 9.5 9.8 5.6 19.5 26.6 21.4 21.4 17.8 14.2 29.4 17.3 18.3 31.3 SLFN5 MGC19764 ENSG00000166750 "Schlafen family member 5" Q08AF3 17 35243036-35273655 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 33.1;hTERT-HME1: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 11.1;MAIT T-cell: 13.7;memory CD4 T-cell: 13.6;memory CD8 T-cell: 12.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 13.7;NK-cell: 16.8;T-reg: 27.8" "Group enriched" "Detected in many" 7 "NK-cells: 16.8;T-cells: 27.8" "Low region specificity" "Detected in all" HPA017760 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA017760: AB_2189993" "unprognostic (3.43e-1)" "unprognostic (3.26e-1)" "unprognostic (4.66e-2)" "unprognostic (1.60e-1)" "unprognostic (8.35e-2)" "unprognostic (1.15e-3)" "unprognostic (1.70e-2)" "unprognostic (2.29e-1)" "unprognostic (2.81e-1)" "unprognostic (7.01e-2)" "unprognostic (2.41e-3)" "unprognostic (2.39e-1)" "unprognostic (6.05e-3)" "unprognostic (3.27e-1)" "unprognostic (7.77e-2)" "unprognostic (3.92e-1)" "unprognostic (1.48e-1)" 32.9 12.8 2.8 21.2 2.6 2.8 11.5 1.7 3.0 18.9 7.7 6.6 25.3 4.0 13.6 7.7 10.0 9.3 8.3 6.4 3.6 2.8 5.9 4.0 18.6 20.9 4.8 1.2 10.7 5.0 4.5 3.2 9.9 6.0 15.9 5.0 7.9 15.4 43.1 27.5 5.0 8.5 10.9 6.1 25.3 7.6 3.8 2.2 51.4 7.6 7.2 22.3 17.0 8.5 0.7 1.4 1.9 3.0 16.8 27.8 7.1 6.0 3.1 0.4 0.5 9.0 15.9 1.2 15.8 25.0 13.2 14.8 0.0 3.9 0.7 10.2 15.5 25.5 0.3 7.1 9.3 0.1 0.5 0.1 3.3 0.3 33.1 0.4 0.1 18.1 18.0 10.1 44.2 6.0 0.0 9.1 9.2 0.5 7.4 0.3 0.5 2.3 0.0 5.3 0.0 3.4 15.0 1.0 0.0 1.7 1.6 28.1 10.5 0.2 23.6 5.3 2.0 3.8 3.6 1.6 0.1 0.1 15.5 0.0 7.5 1.9 1.7 1.1 11.1 2.7 13.7 0.4 13.6 12.6 1.4 0.7 17.0 13.7 0.7 16.8 3.0 0.5 27.8 7.1 2.8 2.6 1.7 3.0 3.6 2.8 4.8 1.2 6.0 2.2 SMARCA1 "hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI" ENSG00000102038 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1" P28370 X 129446501-129523500 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003335, HPA064712" Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA003335: AB_1080024, HPA064712: " "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (2.30e-1)" "unprognostic (5.06e-2)" "unprognostic (6.21e-2)" "unprognostic (2.16e-2)" "unprognostic (5.44e-2)" "unprognostic (7.15e-2)" "unprognostic (3.41e-2)" "unprognostic (1.53e-1)" "prognostic favourable (3.03e-4)" "unprognostic (9.26e-2)" "prognostic favourable (5.09e-4)" "unprognostic (1.87e-3)" "unprognostic (1.28e-1)" "unprognostic (6.14e-2)" "unprognostic (2.33e-2)" 10.4 44.6 14.5 5.0 15.2 0.4 11.8 12.0 12.0 17.1 11.4 7.7 25.5 3.9 15.8 31.4 9.6 12.0 12.3 19.3 13.9 17.9 13.9 34.1 9.2 2.5 13.1 8.4 42.2 9.0 34.8 29.9 21.0 14.6 23.8 4.3 9.7 9.8 42.9 8.7 4.6 4.8 17.7 14.0 6.9 10.0 33.0 13.1 2.0 26.0 6.8 2.6 16.8 15.3 0.3 0.8 0.0 0.0 1.6 4.3 0.5 6.7 15.1 31.3 20.4 22.8 20.7 10.8 13.8 40.0 20.6 23.4 5.2 24.1 0.0 21.5 25.9 6.4 19.4 8.1 23.3 0.0 3.6 0.0 13.7 28.4 10.0 0.0 0.0 25.9 2.3 14.7 2.8 15.0 3.5 1.7 22.2 0.0 0.1 0.0 12.5 8.7 0.0 16.9 0.0 20.3 8.3 7.5 20.6 1.9 0.2 3.4 14.0 0.1 10.4 13.8 7.1 9.0 7.5 0.0 0.0 0.0 12.2 0.0 8.5 0.0 0.0 0.0 0.5 0.0 0.2 0.3 0.2 0.0 0.0 0.3 4.3 1.3 0.0 1.6 0.0 0.8 0.0 0.5 14.5 15.2 12.0 12.0 13.9 17.9 13.1 8.4 14.6 13.1 SMARCA2 "BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2" ENSG00000080503 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2" P51531 9 1980290-2193624 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Hypotrichosis, Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "HDLM-2: 176.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029981, CAB037276" Enhanced Approved "Nucleoplasm,Vesicles,Intermediate filaments" "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB037276: AB_477083, HPA029981: AB_10602406" "unprognostic (5.34e-2)" "unprognostic (1.99e-2)" "unprognostic (6.27e-2)" "unprognostic (6.53e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (2.62e-1)" "unprognostic (3.97e-1)" "unprognostic (3.60e-3)" "unprognostic (9.64e-2)" "prognostic favourable (1.26e-6)" "unprognostic (3.09e-1)" "unprognostic (2.81e-1)" "unprognostic (8.32e-3)" "unprognostic (8.50e-2)" 23.6 29.6 38.8 21.3 43.6 40.7 30.1 41.6 44.0 23.8 17.3 20.0 38.4 10.3 26.4 30.1 20.4 29.4 22.8 21.2 30.2 30.8 23.4 28.9 20.2 29.5 25.9 32.4 85.0 18.5 104.1 35.0 23.2 24.7 23.2 15.9 22.8 26.1 44.8 41.3 27.0 18.3 26.6 19.7 23.9 15.8 26.5 23.4 20.6 28.0 24.8 27.1 23.7 22.0 9.9 11.3 20.4 8.3 8.6 12.5 4.2 5.2 3.9 2.9 4.2 6.0 7.2 8.8 6.7 5.3 3.1 2.3 0.0 2.1 9.1 2.7 6.1 2.3 1.6 5.6 2.2 176.7 2.5 24.6 10.9 1.9 2.3 10.3 14.5 4.7 2.1 3.1 5.8 4.9 0.8 31.3 5.2 2.1 2.5 8.6 2.9 1.5 11.6 3.7 8.2 7.1 4.8 1.9 1.7 4.3 1.0 1.8 1.9 6.7 5.8 5.0 2.4 3.2 3.2 2.9 3.6 4.1 5.4 3.9 1.3 20.4 4.6 13.1 10.3 6.2 9.9 9.9 9.9 10.5 5.6 8.0 12.5 10.0 13.5 8.6 8.3 11.3 10.4 4.2 38.8 43.6 41.6 44.0 30.2 30.8 25.9 32.4 24.7 23.4 SMARCD1 "BAF60A, CRACD1, Rsc6p" ENSG00000066117 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1" Q96GM5 12 50084972-50100712 "Cancer-related genes, Predicted intracellular proteins" Neurogenesis "Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004101 Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA004101: AB_1080026" "unprognostic (1.88e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.11e-2)" "unprognostic (1.02e-1)" "unprognostic (2.76e-1)" "prognostic unfavourable (2.53e-8)" "unprognostic (3.62e-2)" "unprognostic (1.44e-1)" "unprognostic (4.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.10e-2)" "unprognostic (1.20e-3)" "unprognostic (2.18e-1)" "unprognostic (3.45e-1)" "unprognostic (1.38e-1)" "unprognostic (5.04e-2)" 21.3 24.5 16.4 22.6 22.7 29.9 21.3 27.8 28.2 19.8 19.9 29.5 17.6 18.8 23.6 23.4 23.3 19.9 18.2 15.6 16.3 13.8 25.1 18.3 19.4 26.1 15.7 20.4 24.7 19.6 44.3 17.8 24.7 18.8 20.4 22.4 20.3 21.4 25.9 16.6 19.7 24.0 23.8 18.5 28.1 17.4 34.4 14.9 64.3 24.3 17.9 36.7 19.3 18.2 6.0 6.7 4.4 3.4 3.1 6.9 2.3 8.0 13.6 40.3 23.3 12.6 11.9 20.0 10.1 17.9 29.7 17.4 37.4 12.7 31.6 15.2 19.2 10.4 34.0 26.4 25.7 24.4 25.1 31.1 13.8 21.6 15.0 27.5 12.5 12.0 17.8 17.5 31.8 34.9 26.3 19.6 15.0 19.0 39.9 14.8 50.4 22.4 47.9 10.5 27.6 16.8 19.0 21.8 36.3 21.2 10.8 42.1 24.3 23.1 20.9 15.3 17.1 9.6 20.5 27.7 24.3 28.1 12.4 11.2 17.3 4.4 2.3 4.1 6.1 2.1 5.8 6.0 3.3 3.9 3.6 5.6 2.1 6.9 1.1 3.1 3.4 6.7 5.0 2.3 16.4 22.7 27.8 28.2 16.3 13.8 15.7 20.4 18.8 14.9 SMIM17 ENSG00000268182 "Small integral membrane protein 17" P0DL12 19 56643145-56655766 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in many" 6 "brain: 26.5" "Cell line enhanced" "Detected in some" "AF22: 5.3;HEK 293: 5.2;RH-30: 4.2;SCLC-21H: 4.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "HPA071857, HPA071861" Enhanced Approved Vesicles Vesicles "HPA071857: , HPA071861: " "unprognostic (1.32e-1)" "unprognostic (2.82e-1)" "unprognostic (1.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.62e-1)" "unprognostic (4.57e-2)" "unprognostic (5.84e-2)" "unprognostic (3.00e-2)" "unprognostic (2.51e-1)" "unprognostic (6.50e-2)" "unprognostic (4.64e-2)" "unprognostic (9.02e-3)" "unprognostic (3.46e-3)" "unprognostic (6.26e-2)" "unprognostic (1.01e-1)" "unprognostic (3.71e-3)" "unprognostic (7.51e-3)" 1.8 1.2 7.0 0.6 10.4 0.8 2.4 4.5 17.3 0.9 1.1 0.9 0.0 1.0 2.2 4.8 1.2 1.5 1.0 1.7 6.0 13.8 1.3 0.8 1.3 0.7 5.9 7.7 1.8 1.2 0.5 2.2 1.1 26.5 1.7 1.2 0.4 1.3 2.6 1.1 1.9 0.7 1.4 2.7 1.0 0.7 1.6 0.1 0.0 1.1 0.0 0.8 0.5 0.5 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.2 0.0 5.3 1.5 1.2 0.9 1.1 0.7 0.6 1.2 0.3 0.0 0.2 0.4 0.8 0.3 0.3 0.1 0.4 0.7 0.0 5.2 3.1 0.6 0.8 0.8 2.4 0.4 1.7 0.7 0.0 1.4 0.5 0.1 0.0 1.1 0.0 2.8 0.3 0.0 0.6 1.5 4.2 0.1 0.7 0.0 4.8 0.9 1.2 0.1 0.7 0.0 0.8 0.8 1.8 0.2 0.5 0.5 0.3 0.8 1.3 0.6 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 10.4 4.5 17.3 6.0 13.8 5.9 7.7 26.5 0.1 SMIM3 "C5orf62, MSTP150, NID67" ENSG00000256235 "Small integral membrane protein 3" Q9BZL3 5 150777946-150796734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 24.4;blood: 22.3;bone marrow: 11.4;pancreas: 45.7" "Cell line enhanced" "Detected in many" "ASC diff: 63.1;ASC TERT1: 30.9;LHCN-M2: 28.6;U-87 MG: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075345 Approved Vesicles Vesicles "HPA075345: " "unprognostic (2.33e-1)" "unprognostic (4.05e-2)" "unprognostic (1.35e-2)" "unprognostic (2.70e-2)" "unprognostic (9.45e-2)" "unprognostic (5.65e-2)" "unprognostic (4.57e-3)" "unprognostic (1.47e-1)" "unprognostic (3.90e-1)" "unprognostic (2.05e-2)" "unprognostic (9.71e-3)" "unprognostic (3.46e-3)" "prognostic unfavourable (1.15e-8)" "unprognostic (3.87e-3)" "unprognostic (1.31e-2)" "unprognostic (2.16e-1)" "unprognostic (1.46e-3)" 24.4 5.4 6.1 3.3 5.6 11.4 3.9 3.3 6.2 2.2 3.1 1.8 0.7 1.3 3.0 2.9 2.2 3.0 3.3 3.4 2.6 1.2 2.9 1.1 3.6 0.7 3.0 1.0 3.2 45.7 1.2 1.8 6.4 6.2 3.2 2.3 1.3 1.8 3.3 2.5 2.2 3.9 3.7 2.6 1.9 2.9 1.7 4.3 1.8 2.7 0.7 0.7 3.8 1.8 0.3 18.4 22.3 13.3 3.6 7.2 11.6 2.0 0.6 1.1 9.2 63.1 30.9 2.4 7.9 16.9 2.8 11.7 3.1 5.3 0.0 0.4 8.0 1.6 1.8 1.7 4.3 0.0 0.5 2.9 0.4 1.4 11.2 2.8 20.9 25.8 3.5 8.2 3.8 0.9 0.7 0.0 28.6 1.5 4.1 3.9 0.5 1.8 2.2 0.1 0.0 3.1 1.5 0.2 0.7 1.1 0.1 2.3 3.8 17.8 1.5 13.0 2.3 10.1 4.0 0.0 0.0 0.0 46.9 10.9 1.6 17.9 13.3 22.3 7.2 5.3 4.3 0.3 5.1 4.9 6.2 0.0 5.0 4.3 13.9 3.6 4.8 18.4 0.7 11.6 6.1 5.6 3.3 6.2 2.6 1.2 3.0 1.0 6.2 4.3 SMIM5 C17orf109 ENSG00000204323 "Small integral membrane protein 5" Q71RC9 17 75633434-75641404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.2" "Cell line enhanced" "Detected in some" "HEL: 3.1;MCF7: 14.1;SK-BR-3: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 51 "plasmacytoid DC: 54.2" "Lineage enriched" "Detected in many" 51 "dendritic cells: 54.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065332, HPA071268" Approved Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA065332: , HPA071268: " "unprognostic (6.97e-2)" "prognostic favourable (5.52e-4)" "unprognostic (2.13e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (1.05e-4)" "unprognostic (3.29e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-1)" "unprognostic (2.66e-2)" "unprognostic (3.52e-3)" "unprognostic (1.10e-1)" "prognostic favourable (1.12e-4)" "unprognostic (2.64e-1)" "unprognostic (4.94e-2)" "unprognostic (8.26e-2)" "unprognostic (2.58e-1)" 0.4 0.6 2.1 1.8 10.7 9.9 1.4 1.1 7.5 4.0 4.4 23.5 2.1 9.8 0.7 0.8 14.3 5.5 4.7 5.1 3.7 2.2 13.6 0.5 2.5 1.1 8.8 4.8 1.3 1.1 0.4 1.1 1.9 16.9 1.9 2.8 2.5 8.4 2.2 0.4 7.8 9.5 2.1 10.1 2.4 11.0 0.9 8.9 0.4 9.3 0.9 3.6 4.4 7.3 0.0 54.2 1.0 0.0 0.0 0.0 4.0 2.4 1.6 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.2 3.1 0.4 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 14.1 0.1 0.1 0.1 0.2 0.4 0.5 0.1 0.0 2.8 1.2 0.1 0.0 6.4 0.0 0.9 0.2 0.1 0.3 0.2 0.1 0.2 0.3 0.0 0.1 0.1 0.6 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 54.2 0.0 4.0 2.1 10.7 1.1 7.5 3.7 2.2 8.8 4.8 16.9 8.9 SMIM8 "C6orf162, dJ102H19.2, DKFZP586E1923" ENSG00000111850 "Small integral membrane protein 8" Q96KF7 6 87322583-87399749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007401, HPA067453" Approved Approved Vesicles Vesicles "HPA007401: AB_1078357, HPA067453: " "unprognostic (2.54e-1)" "unprognostic (5.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.90e-1)" "unprognostic (1.56e-2)" "unprognostic (3.16e-2)" "unprognostic (3.09e-2)" "unprognostic (6.17e-2)" "unprognostic (5.31e-2)" "unprognostic (6.12e-3)" "unprognostic (1.86e-5)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (2.01e-1)" "unprognostic (3.06e-2)" "unprognostic (2.86e-2)" "unprognostic (4.01e-1)" 7.8 9.0 13.3 6.3 14.6 9.0 9.1 15.6 15.6 7.4 8.3 7.6 8.5 8.8 11.4 12.2 6.5 7.1 4.7 10.3 17.9 12.5 10.4 12.0 5.6 9.1 12.0 10.8 10.5 8.0 6.1 19.2 5.8 11.9 7.9 8.1 7.8 7.2 7.3 16.2 5.4 7.9 11.3 10.2 6.5 6.3 7.4 8.0 11.0 7.5 4.7 6.5 6.5 8.7 16.0 8.9 13.4 8.4 7.7 18.7 8.5 4.3 3.9 7.9 13.6 4.6 5.3 3.5 4.8 3.7 4.1 7.9 2.6 4.0 8.9 5.8 4.8 5.4 6.3 3.6 7.9 7.8 6.8 13.0 4.3 5.2 4.4 13.4 4.7 4.9 5.1 4.2 4.5 5.8 14.5 14.9 4.6 3.2 8.1 10.8 4.8 5.9 13.1 11.7 5.0 5.2 4.3 13.5 5.6 7.1 4.3 7.7 3.9 13.6 5.6 2.2 6.2 9.1 4.7 6.7 10.9 5.8 7.0 6.5 6.4 5.2 8.1 13.1 10.7 7.7 10.6 16.0 12.6 12.8 8.9 10.4 18.7 16.2 13.4 7.7 8.4 7.5 15.5 8.5 13.3 14.6 15.6 15.6 17.9 12.5 12.0 10.8 11.9 8.0 SMOX "C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO" ENSG00000088826 "Spermine oxidase" Q9NWM0 20 4120980-4187747 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 34.7;Karpas-707: 59.3;RPTEC TERT1: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.1;neutrophil: 3.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047117, HPA060198" Approved Supported "Nucleoplasm,Nuclear membrane,Vesicles" "Nuclear membrane" "Nucleoplasm, Vesicles" "HPA047117: , HPA060198: " "unprognostic (1.24e-2)" "unprognostic (6.55e-2)" "unprognostic (7.24e-3)" "unprognostic (2.77e-1)" "unprognostic (1.40e-1)" "unprognostic (2.32e-1)" "prognostic unfavourable (3.33e-6)" "prognostic unfavourable (1.36e-4)" "unprognostic (4.92e-2)" "unprognostic (3.37e-1)" "unprognostic (7.18e-2)" "unprognostic (7.58e-2)" "prognostic unfavourable (1.06e-4)" "unprognostic (4.08e-2)" "unprognostic (2.64e-3)" "unprognostic (1.26e-2)" "unprognostic (3.07e-1)" 3.5 3.1 26.0 4.1 22.7 24.2 3.4 10.1 29.0 9.6 6.7 23.5 17.6 9.5 10.2 6.9 6.1 4.7 14.0 2.9 28.8 16.2 3.8 4.4 2.1 4.0 25.1 16.5 9.2 28.9 8.7 6.0 5.7 20.7 8.1 1.4 6.5 10.6 10.2 2.5 7.8 7.1 3.9 25.9 2.9 7.4 3.9 24.1 0.3 3.9 3.4 2.6 5.3 5.2 0.1 2.1 3.5 0.9 0.2 0.2 15.3 3.1 34.7 2.4 1.8 1.7 2.5 4.4 4.5 8.7 3.3 2.2 14.2 8.7 0.0 1.5 4.1 6.3 2.0 2.1 1.4 0.0 1.0 6.1 1.1 14.4 10.7 1.1 2.5 9.6 3.9 6.9 2.9 5.8 1.3 59.3 1.9 0.9 2.3 3.4 3.0 4.7 2.0 3.0 8.2 27.3 2.4 0.4 2.1 8.4 0.9 15.6 0.1 1.5 6.9 3.8 3.6 0.6 3.5 2.7 0.4 0.0 3.2 1.5 2.9 0.0 0.9 0.1 0.0 0.4 0.0 0.1 0.2 0.2 2.1 0.0 0.0 0.0 3.5 0.2 0.1 1.0 0.0 15.3 26.0 22.7 10.1 17.6 28.8 16.2 25.1 16.5 20.7 24.1 SMPD2 "ISC1, nSMase" ENSG00000135587 "Sphingomyelin phosphodiesterase 2" O60906 6 109440763-109443919 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA018110, HPA018125" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" "Vesicles, Plasma membrane" "Cell Junctions" "HPA018110: AB_1857292, HPA018125: AB_1857293" "unprognostic (1.61e-1)" "unprognostic (8.01e-2)" "unprognostic (1.97e-1)" "unprognostic (8.79e-3)" "unprognostic (3.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavourable (1.17e-4)" "unprognostic (7.08e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" "prognostic favourable (1.00e-3)" "unprognostic (3.60e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" "unprognostic (1.45e-2)" "prognostic favourable (1.70e-4)" 6.0 6.8 4.2 20.2 4.9 8.5 8.5 5.4 6.4 9.0 12.6 9.8 16.4 10.5 6.1 16.0 17.2 17.4 12.6 5.1 4.9 3.7 10.2 7.8 8.4 9.4 4.7 4.2 6.7 15.5 17.9 8.8 19.5 4.8 10.1 10.2 8.4 16.6 11.9 3.3 16.9 15.4 7.8 4.3 10.1 11.1 35.1 4.7 18.3 10.5 13.5 23.0 6.3 10.1 18.3 13.4 9.3 7.8 6.2 8.0 5.3 8.9 10.4 5.5 8.6 9.6 5.3 18.3 3.0 11.1 7.5 7.2 9.7 7.3 4.9 6.4 6.4 11.5 5.5 13.2 4.5 6.2 14.2 5.7 10.7 6.0 8.1 6.2 6.7 5.6 15.3 6.7 13.3 6.9 10.9 8.7 3.7 12.9 10.0 13.5 1.5 5.0 7.0 2.6 5.3 13.7 15.3 7.2 6.0 5.7 17.8 13.4 5.7 11.9 4.4 3.4 4.9 2.7 11.2 5.9 1.5 3.1 6.6 5.9 6.0 5.7 7.8 9.3 6.6 7.5 7.3 12.8 7.4 8.0 10.2 18.3 5.6 5.7 2.3 6.2 6.6 13.4 7.2 5.3 4.2 4.9 5.4 6.4 4.9 3.7 4.7 4.2 4.8 4.7 SMU1 "BWD, FLJ10805, fSAP57, SMU-1" ENSG00000122692 "SMU1, DNA replication regulator and spliceosomal factor" Q2TAY7 9 33041764-33076659 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019708 Supported Approved Vesicles 16000 Vesicles "HPA019708: AB_1857300" "unprognostic (2.20e-2)" "prognostic favourable (2.66e-4)" "unprognostic (1.17e-1)" "unprognostic (1.58e-1)" "unprognostic (1.80e-2)" "unprognostic (8.44e-2)" "unprognostic (2.59e-3)" "unprognostic (5.06e-2)" "unprognostic (3.04e-2)" "prognostic favourable (1.25e-4)" "unprognostic (4.98e-3)" "unprognostic (3.15e-1)" "prognostic favourable (1.67e-5)" "unprognostic (1.09e-2)" "unprognostic (7.04e-2)" "unprognostic (8.71e-2)" "unprognostic (5.96e-2)" 25.0 20.0 21.7 17.0 22.2 23.3 20.7 29.6 24.5 22.2 18.0 28.3 17.4 14.5 28.3 21.2 18.1 20.6 15.0 17.1 21.3 21.2 19.5 21.9 17.0 19.7 22.1 18.1 26.3 18.7 30.3 26.6 18.2 24.2 21.1 19.1 20.2 20.5 21.0 22.9 21.9 19.6 23.6 23.5 21.0 16.9 16.0 19.5 31.1 24.1 16.5 24.6 20.8 17.7 14.4 21.2 20.7 17.5 12.9 16.5 10.4 15.7 12.5 15.1 13.1 16.4 12.6 11.8 12.4 11.2 17.0 16.9 12.6 6.7 20.0 9.1 15.3 9.7 19.3 14.8 19.0 22.9 9.3 15.0 21.7 14.8 14.3 25.9 14.2 13.1 17.0 15.7 11.2 14.2 13.9 12.9 14.1 7.3 20.2 27.8 20.7 13.4 17.4 12.5 10.8 12.9 11.9 12.8 11.2 16.7 12.1 7.8 11.7 9.5 15.1 10.9 12.2 15.8 14.4 5.8 10.6 23.7 12.2 12.3 7.7 20.7 14.9 11.6 14.1 16.0 15.0 14.4 16.0 13.2 16.6 13.7 16.3 16.5 8.7 12.9 17.5 21.2 13.2 10.4 21.7 22.2 29.6 24.5 21.3 21.2 22.1 18.1 24.2 19.5 SMURF1 KIAA1625 ENSG00000198742 "SMAD specific E3 ubiquitin protein ligase 1" Q9HCE7 7 99027438-99144100 "Enzymes, Predicted intracellular proteins" "Differentiation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019671, HPA055245" Approved Uncertain Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA019671: , HPA055245: " "unprognostic (2.21e-1)" "unprognostic (6.15e-2)" "unprognostic (8.88e-2)" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-1)" "unprognostic (2.15e-2)" "unprognostic (3.92e-3)" "unprognostic (2.58e-1)" "unprognostic (1.46e-1)" "unprognostic (7.83e-2)" "unprognostic (1.68e-1)" "unprognostic (3.81e-1)" "unprognostic (4.62e-2)" 15.0 11.1 8.7 10.5 15.0 23.8 12.4 12.1 16.5 11.8 10.9 20.9 6.9 9.5 11.6 5.7 19.3 10.2 12.5 7.9 9.3 8.4 10.3 10.1 16.0 8.1 15.4 9.4 19.6 22.5 9.0 15.1 15.4 14.9 11.7 10.6 14.3 13.4 9.6 10.7 17.3 10.3 9.8 10.6 9.1 19.5 26.0 11.8 6.6 7.8 6.6 12.7 11.5 13.3 1.2 1.2 2.4 1.9 1.0 2.1 0.6 13.8 7.9 6.4 4.6 5.1 5.4 9.6 7.8 7.5 6.3 5.9 4.0 11.5 4.3 8.4 7.2 7.6 3.6 10.0 6.6 3.3 3.0 2.3 4.6 3.8 4.8 2.6 5.7 4.9 7.0 9.9 11.5 6.0 7.0 7.7 5.8 11.2 4.5 5.5 7.5 8.5 4.3 6.0 2.6 6.9 11.4 2.8 6.4 7.4 9.8 6.8 3.1 5.0 8.7 10.0 10.3 17.9 15.4 6.9 4.7 4.6 5.0 5.2 15.5 2.0 1.4 2.3 1.3 1.5 1.6 0.9 2.1 1.3 1.1 1.2 1.2 1.0 2.4 1.0 1.9 1.2 2.0 0.6 8.7 15.0 12.1 16.5 9.3 8.4 15.4 9.4 14.9 11.8 SMYD4 "KIAA1936, ZMYND21" ENSG00000186532 "SET and MYND domain containing 4" Q8IYR2 17 1779485-1830634 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030059 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA030059: AB_2191728" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (2.47e-1)" "unprognostic (4.23e-2)" "unprognostic (1.13e-2)" "unprognostic (3.66e-2)" "unprognostic (4.03e-2)" "unprognostic (1.04e-1)" "unprognostic (1.79e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-3)" "unprognostic (9.26e-3)" "unprognostic (3.63e-2)" "unprognostic (1.33e-2)" "unprognostic (7.35e-2)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" 10.6 10.0 8.6 13.8 9.6 4.8 11.0 16.3 11.8 9.9 10.8 9.6 9.6 11.5 15.3 8.7 6.3 10.1 7.1 11.0 6.3 6.1 6.1 7.4 8.5 10.4 7.4 6.7 15.5 21.7 5.4 11.3 7.7 9.2 10.1 8.3 10.7 14.1 15.5 19.3 10.6 12.9 10.0 9.2 10.0 7.6 9.2 8.2 12.8 9.1 5.6 12.2 10.8 12.8 6.1 6.3 11.5 4.3 4.1 7.9 3.0 6.0 11.3 11.4 8.1 7.8 5.4 13.3 9.8 5.7 10.5 10.8 18.0 5.2 16.1 6.7 4.0 11.7 10.8 6.4 13.1 4.6 10.9 5.9 12.0 4.8 3.9 5.9 5.8 3.8 5.8 10.7 9.5 5.1 6.1 6.3 8.1 3.7 10.9 4.2 5.2 5.6 13.5 5.8 4.1 4.2 7.3 4.7 6.5 9.1 3.8 9.4 5.5 3.7 5.0 10.3 5.3 8.6 8.5 4.4 5.9 5.8 5.8 5.3 10.0 11.5 3.6 3.2 7.9 4.3 6.5 6.1 4.6 5.0 2.1 3.8 5.3 7.6 2.1 4.1 3.3 6.3 4.8 3.0 8.6 9.6 16.3 11.8 6.3 6.1 7.4 6.7 9.2 8.2 SNAP25 "bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25" ENSG00000132639 "Synaptosome associated protein 25" P60880 20 10218830-10307418 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 356.9" "Group enriched" "Detected in some" 4 "Karpas-707: 10.8;SCLC-21H: 35.7;SH-SY5Y: 21.3;U-87 MG: 25.7" "Group enriched" "Detected in many" 6 "glioma: 28.9;pancreatic cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000360, HPA001830, HPA071013" Enhanced Supported Approved "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: " "unprognostic (1.64e-3)" "unprognostic (7.26e-3)" "unprognostic (4.36e-2)" "unprognostic (2.49e-7)" "unprognostic (6.86e-3)" "unprognostic (5.87e-3)" "unprognostic (1.15e-2)" "unprognostic (9.94e-2)" "unprognostic (3.13e-1)" "unprognostic (5.82e-3)" "unprognostic (4.80e-3)" "unprognostic (8.06e-2)" "unprognostic (1.09e-1)" "unprognostic (6.18e-3)" "unprognostic (2.48e-1)" "unprognostic (6.28e-3)" "unprognostic (1.02e-2)" 2.2 16.4 81.0 3.3 60.0 2.1 3.4 202.9 356.9 2.2 2.8 3.4 3.7 3.2 4.6 6.4 2.2 4.0 2.8 2.4 86.5 37.1 2.5 2.3 2.6 2.2 46.7 65.2 3.7 4.1 2.1 5.5 2.3 97.7 3.1 2.8 4.0 2.2 11.9 2.1 2.2 3.3 4.7 13.9 2.1 4.3 3.2 7.4 0.0 2.3 0.0 2.2 2.6 0.1 0.0 1.6 0.7 0.0 0.0 0.6 0.3 0.0 2.1 1.7 0.0 0.2 0.0 0.0 0.9 0.0 2.2 0.6 0.0 0.0 0.0 1.9 0.0 0.4 0.2 0.0 4.4 0.2 0.1 0.0 2.9 0.3 1.6 0.0 0.2 2.0 0.0 1.8 0.0 0.0 0.0 10.8 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 35.7 21.3 0.3 0.0 0.0 0.0 2.9 0.0 2.3 3.1 0.0 1.0 0.0 5.5 0.0 25.7 0.0 2.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.6 0.3 81.0 60.0 202.9 163.5 86.5 37.1 46.7 65.2 97.7 7.4 SNRK "FLJ20224, HSNFRK, KIAA0096" ENSG00000163788 "SNF related kinase" Q9NRH2 3 43286512-43424764 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 50.8;TIME: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042163 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Vesicles, Plasma membrane, Cell Junctions" Nucleoplasm "HPA042163: AB_10794645" "prognostic favourable (9.28e-4)" "unprognostic (8.46e-2)" "unprognostic (2.79e-3)" "unprognostic (6.41e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-3)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (2.63e-3)" "unprognostic (4.25e-1)" "unprognostic (2.32e-1)" "unprognostic (4.68e-2)" "prognostic favourable (9.41e-5)" "unprognostic (9.21e-3)" "unprognostic (2.04e-1)" "unprognostic (7.06e-3)" "unprognostic (7.38e-2)" 31.5 8.8 9.8 13.1 14.4 41.0 22.6 34.5 21.1 17.6 14.4 7.9 5.9 12.8 20.9 10.5 16.2 11.5 16.4 13.9 11.0 11.0 16.8 20.3 24.7 19.8 11.4 10.6 15.1 18.0 18.4 16.2 26.2 22.5 12.1 9.9 14.7 10.7 9.4 12.5 24.5 17.0 18.7 9.8 25.4 11.2 13.9 7.2 48.4 24.8 13.5 14.4 15.8 19.3 3.2 3.0 20.9 5.5 8.1 10.7 6.5 3.2 2.0 3.7 3.5 11.1 4.0 3.5 3.5 5.9 3.8 3.8 2.7 4.7 5.1 2.8 4.4 2.1 4.3 7.5 4.0 5.9 3.5 5.9 3.7 3.1 5.8 6.6 6.6 4.4 5.2 4.3 7.4 50.8 2.6 6.0 3.5 1.7 6.6 5.8 4.1 9.1 4.6 2.7 5.4 9.9 5.6 2.6 5.5 3.0 3.3 4.2 2.2 8.4 29.5 3.4 3.4 3.9 4.1 9.7 6.9 4.4 2.4 7.9 4.8 4.8 2.8 5.4 7.6 5.5 10.7 2.8 6.7 7.6 3.0 3.2 10.1 10.1 20.9 8.1 5.0 0.9 7.1 6.5 9.8 14.4 34.5 21.1 11.0 11.0 11.4 10.6 22.5 7.2 SNX15 ENSG00000110025 "Sorting nexin 15" Q9NRS6 11 65027408-65040572 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038955 Approved Supported "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Nucleoli, Cytosol" "Vesicles, Plasma membrane" "HPA038955: AB_10672834" "unprognostic (2.00e-2)" "unprognostic (4.90e-2)" "unprognostic (3.93e-1)" "unprognostic (9.61e-4)" "unprognostic (2.79e-1)" "unprognostic (4.06e-3)" "unprognostic (4.45e-3)" "unprognostic (4.74e-2)" "unprognostic (1.09e-1)" "unprognostic (9.55e-2)" "unprognostic (8.93e-3)" "unprognostic (1.79e-2)" "unprognostic (8.84e-2)" "unprognostic (7.86e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.68e-4)" 17.9 13.6 17.1 12.7 18.3 11.6 23.5 25.7 21.9 13.2 22.7 16.7 9.5 19.7 14.2 8.9 15.9 11.4 13.9 15.1 16.2 14.3 15.7 9.8 14.1 14.7 16.3 14.5 18.3 17.7 13.7 8.4 9.5 13.4 15.1 11.6 11.2 15.6 15.4 25.2 17.2 20.4 15.0 17.6 11.3 13.5 7.6 15.8 12.4 14.4 10.1 11.5 14.9 12.5 7.7 8.0 10.9 18.3 3.2 7.1 5.7 17.4 12.9 8.4 8.2 10.1 7.5 4.7 1.7 7.9 13.8 12.7 10.1 13.7 17.8 9.9 9.9 9.8 9.8 8.7 3.8 26.7 8.1 8.9 10.6 16.9 11.0 4.6 14.4 6.3 13.0 14.6 8.4 8.2 15.0 11.4 7.2 10.5 16.3 20.7 9.0 12.8 13.5 5.0 19.1 10.2 3.8 15.2 11.4 14.9 13.5 12.9 13.6 10.7 16.1 14.0 13.4 14.1 7.4 12.3 21.0 17.0 13.7 7.3 4.8 7.8 11.3 10.9 6.9 13.6 5.6 7.7 7.1 6.1 8.0 6.1 5.2 4.7 1.6 3.2 18.3 5.5 6.7 5.7 17.1 18.3 25.7 21.9 16.2 14.3 16.3 14.5 13.4 15.8 SNX16 ENSG00000104497 "Sorting nexin 16" P57768 8 81799581-81842866 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024730, HPA024731, HPA024817" Approved Supported Vesicles Vesicles "HPA024730: AB_10600220, HPA024731: AB_1857346, HPA024817: AB_10602313" "unprognostic (5.50e-2)" "unprognostic (3.20e-2)" "unprognostic (1.40e-1)" "unprognostic (8.41e-3)" "unprognostic (3.21e-3)" "unprognostic (7.54e-3)" "unprognostic (1.24e-3)" "unprognostic (1.33e-1)" "unprognostic (2.12e-1)" "unprognostic (2.18e-1)" "unprognostic (3.94e-2)" "unprognostic (1.43e-1)" "unprognostic (5.73e-3)" "unprognostic (7.60e-3)" "unprognostic (2.30e-1)" "unprognostic (1.35e-1)" "unprognostic (3.65e-1)" 11.7 5.9 6.6 5.8 10.0 9.5 16.2 13.1 14.8 13.7 9.8 3.0 4.2 6.9 10.7 8.1 18.8 7.2 11.9 8.3 7.3 9.6 14.8 7.6 12.1 6.2 11.2 11.4 10.8 4.9 7.9 12.1 5.7 10.2 13.2 7.3 3.8 8.8 8.6 6.6 11.7 11.8 11.7 11.4 17.1 9.4 15.6 8.7 15.3 18.7 7.5 6.5 10.0 15.9 4.5 5.0 11.6 6.1 3.2 6.5 2.6 8.1 2.8 4.2 4.0 14.3 9.2 5.0 10.4 13.2 9.1 13.7 2.0 6.7 1.3 6.0 7.3 7.1 3.7 4.6 14.9 10.8 2.1 4.3 3.6 4.1 11.0 1.8 7.8 7.0 7.9 4.1 8.3 7.5 2.7 16.2 22.6 4.8 9.2 3.3 1.6 4.2 3.9 6.0 1.5 9.2 4.1 6.8 5.5 1.9 2.8 5.4 7.3 3.7 4.2 12.8 9.5 9.2 4.7 9.9 7.4 3.4 5.5 5.6 10.2 11.6 6.1 7.1 2.9 3.8 2.7 2.3 3.7 2.4 5.0 4.5 4.3 3.8 8.3 3.2 3.1 4.0 6.5 2.6 6.6 10.0 13.1 14.8 7.3 9.6 11.2 11.4 10.2 8.7 SNX17 KIAA0064 ENSG00000115234 "Sorting nexin 17" Q15036 2 27370496-27377533 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043867 Supported Supported Vesicles Vesicles "HPA043867: AB_10961129" "unprognostic (2.57e-1)" "unprognostic (7.14e-3)" "unprognostic (1.26e-1)" "unprognostic (2.61e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.06e-3)" "unprognostic (1.86e-1)" "unprognostic (4.73e-2)" "unprognostic (4.38e-2)" "unprognostic (1.04e-2)" "unprognostic (9.25e-2)" "unprognostic (1.33e-1)" "unprognostic (6.20e-2)" "unprognostic (1.37e-1)" "unprognostic (2.39e-1)" "unprognostic (6.32e-3)" 37.7 45.8 27.2 30.5 29.8 22.6 33.4 28.5 51.1 34.1 33.8 34.9 28.7 23.7 39.0 38.5 35.3 41.2 37.7 37.6 26.2 25.8 33.6 61.6 36.7 68.1 29.1 27.0 40.4 37.0 31.5 37.0 32.6 30.3 33.7 29.5 34.0 34.9 37.5 26.4 31.6 29.2 38.1 32.8 48.8 30.5 36.8 21.7 52.3 39.5 28.2 41.3 32.0 29.1 34.3 58.4 38.1 61.1 27.3 35.1 86.6 27.8 46.7 23.0 36.6 40.5 34.2 19.4 30.4 43.7 34.8 27.3 25.2 24.4 21.9 39.8 49.5 17.1 19.6 32.0 27.0 28.1 31.5 22.6 17.2 34.3 42.2 27.6 29.0 34.9 31.0 23.1 31.2 38.1 19.6 23.5 41.5 27.4 32.9 26.0 21.1 30.1 14.8 43.9 43.2 32.4 20.9 27.9 31.7 19.1 27.8 11.4 22.2 17.8 30.3 41.3 22.2 23.2 29.6 42.9 31.1 27.5 38.1 29.3 44.2 33.0 59.1 38.1 30.8 61.1 29.6 33.4 30.0 31.8 58.4 34.3 28.4 30.3 13.9 27.3 60.5 33.0 35.1 86.6 27.2 29.8 28.5 51.1 26.2 25.8 29.1 27.0 30.3 21.7 SNX21 "C20orf161, dJ337O18.4, SNX-L" ENSG00000124104 "Sorting nexin family member 21" Q969T3 20 45833810-45843275 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 16.1;PC-3: 19.6;U-87 MG: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 3.9;classical monocyte: 2.9;eosinophil: 7.3;intermediate monocyte: 5.0;non-classical monocyte: 3.3" "Group enriched" "Detected in many" 6 "granulocytes: 7.3;monocytes: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046359 Approved Approved "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "HPA046359: AB_10963216" "unprognostic (1.97e-1)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.17e-1)" "unprognostic (1.22e-1)" "unprognostic (1.24e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (4.96e-2)" "unprognostic (1.44e-1)" "unprognostic (1.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.46e-1)" "unprognostic (1.33e-2)" "unprognostic (2.18e-1)" 25.4 21.0 10.0 4.4 9.8 1.9 14.1 10.3 18.3 18.8 8.4 8.6 10.3 10.0 17.6 13.8 11.3 14.3 15.3 9.1 7.5 6.4 8.9 5.2 9.5 2.7 7.9 7.5 19.1 4.2 5.5 6.9 6.9 8.8 14.1 2.9 13.6 10.2 11.2 43.4 35.2 6.1 19.8 7.6 6.6 9.3 7.2 6.4 0.0 6.0 14.9 3.7 15.4 12.0 0.2 0.3 7.3 5.0 0.0 1.0 0.7 3.6 4.6 0.8 6.6 3.8 3.4 3.2 4.7 4.2 5.1 3.9 3.4 2.8 0.0 16.1 4.7 4.7 0.1 3.7 0.5 0.4 0.6 0.1 2.3 3.2 2.9 0.0 1.1 2.5 2.1 4.5 0.2 3.1 0.0 0.0 1.7 9.0 0.0 0.3 1.2 19.6 0.0 0.6 0.0 1.6 0.6 0.8 7.3 10.6 10.0 5.6 6.5 0.9 3.4 7.5 5.8 14.0 4.2 0.0 0.5 0.2 17.8 0.0 4.0 3.9 2.9 7.3 0.0 5.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 3.3 0.1 1.0 0.7 10.0 9.8 10.3 18.3 7.5 6.4 7.9 7.5 8.8 6.4 SNX22 FLJ13952 ENSG00000157734 "Sorting nexin 22" Q96L94 15 64151715-64157481 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;thyroid gland: 41.1" "Cell line enriched" "Detected in some" 4 "Daudi: 19.5" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 47.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 6.6;naive B-cell: 11.5" "Lineage enriched" "Detected in many" 9 "B-cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038470 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038470: AB_10673174" "prognostic favourable (2.89e-5)" "unprognostic (8.93e-3)" "unprognostic (2.89e-1)" "unprognostic (3.55e-2)" "unprognostic (3.24e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-1)" "unprognostic (3.05e-2)" "unprognostic (1.94e-1)" "unprognostic (5.29e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.27e-4)" "unprognostic (3.92e-1)" "unprognostic (2.52e-1)" "prognostic favourable (2.19e-4)" "unprognostic (1.74e-2)" 1.1 1.5 11.9 7.6 8.9 10.2 1.2 3.4 16.5 0.7 1.1 23.2 11.8 1.5 1.2 3.5 0.9 0.8 1.3 7.9 13.4 9.0 1.1 1.9 4.7 11.4 13.7 8.1 1.3 1.6 0.4 2.2 1.0 12.3 3.0 0.7 0.0 3.6 8.4 0.7 2.0 2.2 0.9 17.0 6.1 2.1 1.0 6.6 1.6 41.1 0.0 13.3 2.1 0.3 11.5 1.2 0.0 0.2 0.1 0.1 1.6 0.2 0.4 0.9 0.8 0.1 0.0 0.7 0.8 0.0 0.0 0.2 0.4 0.9 19.5 0.5 0.1 0.4 1.7 0.0 0.0 0.1 2.3 0.3 2.2 2.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.6 3.3 0.0 1.1 0.2 0.0 1.3 0.3 4.0 0.3 1.2 0.8 0.8 4.5 0.9 0.2 0.7 0.0 1.9 0.0 0.0 1.1 1.4 0.2 0.5 4.2 1.7 4.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 1.2 11.5 0.0 0.0 0.0 0.1 0.2 0.0 0.1 1.6 11.9 8.9 3.4 9.3 13.4 9.0 13.7 8.1 12.3 6.6 SNX24 SBBI31 ENSG00000064652 "Sorting nexin 24" Q9Y343 5 122843439-123029354 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044566, HPA073934" Approved Approved Vesicles Vesicles "HPA044566: AB_10797034, HPA073934: " "unprognostic (2.63e-1)" "unprognostic (2.50e-1)" "unprognostic (2.73e-1)" "prognostic unfavourable (7.93e-6)" "unprognostic (2.31e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (8.88e-4)" "unprognostic (1.37e-1)" "unprognostic (1.61e-1)" "unprognostic (3.42e-1)" "unprognostic (5.77e-2)" "unprognostic (3.69e-2)" "prognostic favourable (1.28e-4)" "unprognostic (2.03e-1)" "unprognostic (1.10e-1)" "unprognostic (6.94e-2)" "unprognostic (1.50e-2)" 6.7 7.2 10.7 5.2 13.8 3.3 6.5 6.2 14.9 7.3 9.0 20.4 5.9 12.6 9.5 10.4 31.2 6.5 8.9 9.7 11.5 11.1 17.1 11.4 14.2 4.6 25.1 8.9 5.9 8.9 20.9 15.8 24.2 19.7 5.5 10.7 8.2 11.0 5.8 7.2 13.5 14.5 9.5 38.3 6.4 13.1 6.9 16.4 1.0 15.4 12.9 8.2 8.1 11.3 0.7 1.3 0.1 5.9 2.5 2.5 1.2 13.0 6.0 9.5 6.4 3.6 9.2 19.4 11.7 11.0 13.6 17.6 8.2 12.2 0.0 10.0 11.5 2.7 6.0 14.8 20.7 7.1 3.7 1.9 5.6 11.6 18.0 0.1 2.3 7.7 22.0 6.8 26.6 6.6 2.3 10.9 10.2 11.6 0.3 0.4 3.8 3.7 1.6 15.2 6.6 19.5 8.0 5.8 7.0 11.0 8.2 12.2 14.7 4.1 5.4 14.8 11.4 5.8 18.6 3.8 5.0 1.9 12.4 0.2 29.8 0.0 2.8 0.0 1.2 5.4 0.7 0.7 1.3 1.0 1.3 0.6 0.5 0.3 0.1 2.5 5.9 0.3 2.5 1.2 10.7 13.8 6.2 14.9 11.5 11.1 25.1 8.9 19.7 16.4 SNX25 SBBI31 ENSG00000109762 "Sorting nexin 25" Q9H3E2 4 185204237-185370185 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 27.8" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6" "Group enriched" "Detected in many" 4 "B-cells: 3.6;T-cells: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036928 Supported Vesicles Vesicles "HPA036928: AB_10669720" "unprognostic (9.20e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-1)" "unprognostic (4.29e-3)" "unprognostic (8.89e-2)" "unprognostic (5.63e-2)" "unprognostic (1.43e-2)" "unprognostic (6.41e-2)" "unprognostic (5.35e-2)" "unprognostic (2.99e-2)" "unprognostic (4.03e-3)" "unprognostic (1.87e-1)" "unprognostic (3.33e-1)" "unprognostic (1.13e-1)" "unprognostic (1.57e-1)" "unprognostic (1.32e-2)" "unprognostic (8.55e-3)" 3.0 3.7 2.6 2.9 5.3 0.1 4.6 11.9 4.2 2.7 5.6 1.1 3.3 2.8 3.1 4.7 3.9 4.4 3.3 5.6 5.6 4.1 15.1 4.9 4.6 3.4 4.6 7.2 5.7 5.6 7.9 3.0 2.8 4.3 4.8 2.5 3.5 3.1 2.1 4.2 2.6 5.9 8.5 6.0 3.8 2.2 3.6 0.2 0.0 0.2 0.6 1.5 0.2 5.8 3.1 3.9 5.6 10.6 7.9 5.9 18.0 8.6 9.1 7.6 2.6 4.1 16.8 2.0 12.8 2.3 4.5 3.9 10.3 27.8 7.5 2.8 3.8 6.1 6.2 1.9 4.1 5.4 4.3 7.9 4.4 7.9 5.9 16.9 12.0 1.7 0.7 3.3 3.2 3.0 2.4 4.5 4.2 22.1 2.2 8.5 6.2 3.7 1.0 14.7 2.1 2.4 15.2 5.2 3.4 5.0 7.8 15.3 6.2 3.6 8.6 1.4 6.5 0.0 0.0 0.0 0.6 0.2 1.0 2.5 1.3 1.5 0.0 3.6 0.4 0.9 0.0 0.6 0.0 0.2 0.8 0.2 SNX5 ENSG00000089006 "Sorting nexin 5" Q9Y5X3 20 17941597-17968980 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 115.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020679, HPA051187, HPA076450" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "CAB020679: , HPA051187: , HPA076450: " "unprognostic (6.00e-2)" "unprognostic (2.35e-1)" "unprognostic (3.08e-2)" "unprognostic (4.00e-2)" "unprognostic (4.47e-2)" "unprognostic (5.71e-2)" "prognostic unfavourable (2.30e-10)" "unprognostic (1.67e-1)" "unprognostic (6.19e-2)" "unprognostic (1.69e-1)" "unprognostic (2.62e-2)" "unprognostic (1.56e-1)" "unprognostic (1.77e-1)" "unprognostic (3.15e-2)" "unprognostic (6.50e-2)" "unprognostic (3.48e-2)" "unprognostic (2.99e-1)" 23.0 30.7 19.0 29.1 19.7 26.5 20.6 12.8 17.8 17.4 21.1 16.4 16.3 27.3 17.9 40.9 18.5 17.0 17.3 20.0 17.2 14.0 35.9 30.3 18.7 43.8 20.4 14.8 29.4 18.7 17.7 15.4 24.4 15.6 17.6 22.9 17.8 18.1 14.8 34.9 14.5 23.6 14.0 21.8 46.4 18.2 9.8 17.8 25.6 64.4 19.6 27.3 20.5 19.0 32.8 28.8 33.4 34.5 15.2 26.7 19.5 18.4 20.2 8.6 9.4 6.1 10.6 51.6 14.8 8.3 9.5 10.9 19.5 26.2 30.6 9.2 9.3 20.8 12.0 23.2 13.0 7.7 10.7 27.2 8.3 115.7 9.5 19.0 32.8 10.0 10.3 10.3 18.8 13.7 13.1 20.7 11.4 14.4 16.7 16.8 9.2 10.1 19.9 21.9 22.8 11.7 21.5 8.6 4.9 14.1 21.7 19.0 11.8 12.4 10.8 15.1 18.7 9.3 18.5 14.7 22.3 24.8 7.4 6.9 13.1 23.5 23.5 33.4 23.8 32.0 21.6 32.8 21.8 23.2 28.8 30.5 13.2 19.2 1.9 15.2 34.5 14.8 26.7 19.5 19.0 19.7 12.8 17.8 17.2 14.0 20.4 14.8 15.6 17.8 SNX8 Mvp1 ENSG00000106266 "Sorting nexin 8" Q9Y5X2 7 2251770-2354318 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057296, HPA060194" Approved Supported Vesicles Vesicles "HPA057296: , HPA060194: " "unprognostic (2.22e-2)" "unprognostic (3.38e-1)" "unprognostic (9.85e-3)" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (9.32e-2)" "prognostic unfavourable (8.47e-6)" "unprognostic (5.23e-2)" "unprognostic (1.91e-3)" "unprognostic (1.54e-2)" "unprognostic (3.06e-1)" "unprognostic (6.01e-2)" "unprognostic (1.54e-1)" "unprognostic (5.10e-2)" "unprognostic (4.83e-2)" "unprognostic (1.12e-2)" "unprognostic (1.35e-1)" 14.3 7.3 11.7 13.9 12.8 10.1 15.6 11.1 14.2 6.8 8.4 11.4 4.8 11.7 7.3 9.9 11.3 7.7 11.0 14.0 12.0 9.6 8.2 9.1 10.7 24.1 12.7 9.6 9.1 10.8 4.7 7.9 15.4 10.9 4.7 7.8 12.9 8.5 3.9 9.9 9.9 9.6 6.5 17.0 33.1 7.7 20.5 12.5 4.9 9.5 6.9 18.9 9.5 8.5 18.2 13.1 4.5 10.2 1.2 2.0 4.8 17.2 16.9 7.0 9.7 9.7 9.5 16.5 8.4 12.6 14.3 17.8 11.9 13.5 10.1 3.5 9.9 4.6 6.0 4.6 7.3 2.5 5.6 5.6 6.9 9.8 24.8 5.4 9.4 19.0 5.4 17.5 6.8 5.4 11.0 12.0 11.6 11.3 1.8 5.8 12.6 8.4 8.9 14.4 4.6 3.3 8.2 3.4 8.9 7.7 21.3 12.0 15.8 11.8 8.1 12.1 32.2 19.7 10.9 7.8 9.6 9.3 11.9 7.3 32.5 4.5 9.4 3.0 1.8 10.2 1.4 15.5 1.4 1.9 13.1 18.2 1.4 1.6 1.6 1.2 9.6 3.4 2.0 4.8 11.7 12.8 11.1 14.2 12.0 9.6 12.7 9.6 10.9 12.5 SOBP FLJ10159 ENSG00000112320 "Sine oculis binding protein homolog" A7XYQ1 6 107489958-107660167 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 10.8;AN3-CA: 14.0;ASC diff: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "memory B-cell: 3.0;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 14 "B-cells: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029242 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA029242: AB_10603340" "unprognostic (7.11e-2)" "unprognostic (1.35e-3)" "unprognostic (9.01e-2)" "unprognostic (2.04e-3)" "unprognostic (3.09e-1)" "unprognostic (1.12e-1)" "unprognostic (3.80e-2)" "unprognostic (5.63e-2)" "unprognostic (9.84e-2)" "unprognostic (5.35e-3)" "prognostic favourable (1.55e-5)" "unprognostic (6.64e-2)" "unprognostic (2.00e-3)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (1.95e-3)" 7.6 12.0 19.3 4.4 15.6 1.3 3.6 15.1 30.2 12.7 12.8 11.0 2.5 3.7 9.0 5.5 5.6 6.2 7.6 17.0 18.0 12.4 5.8 3.6 5.0 2.9 12.5 14.9 21.6 3.9 10.9 12.0 6.1 9.6 13.0 4.2 7.4 21.1 7.0 22.1 1.5 3.4 14.3 9.6 4.7 5.6 9.1 11.1 1.0 6.1 4.1 3.3 14.8 8.0 4.5 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.3 10.8 14.0 13.2 5.1 1.2 0.0 0.0 0.3 0.6 0.0 0.0 5.7 0.4 0.0 0.0 7.2 0.2 0.2 9.1 6.8 0.7 0.0 6.7 1.7 2.9 0.6 5.3 0.0 5.2 0.0 4.3 0.0 0.3 0.0 2.8 1.3 0.3 2.5 0.9 3.2 1.3 0.0 0.0 0.2 3.5 5.8 1.3 0.0 0.1 0.4 2.0 0.1 3.4 1.2 5.9 0.5 2.7 0.5 3.7 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.2 0.0 4.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 19.3 15.6 15.1 20.6 18.0 12.4 12.5 14.9 9.6 11.1 SOHLH2 "bHLHe81, FLJ20449, SPATA28, TEB1" ENSG00000120669 "Spermatogenesis and oogenesis specific basic helix-loop-helix 2" Q9NX45 13 36168208-36214615 "Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 23.6" "Cell line enhanced" "Detected in some" "A-431: 7.1;HL-60: 9.3;Karpas-707: 10.6;NB-4: 13.6;U-266/84: 13.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" HPA029182 Uncertain Vesicles Vesicles "HPA029182: AB_10602409" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" "unprognostic (1.99e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-2)" "unprognostic (3.01e-2)" "unprognostic (2.95e-1)" "unprognostic (7.88e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-3)" "unprognostic (2.10e-1)" "unprognostic (8.56e-2)" "unprognostic (7.44e-2)" "unprognostic (5.93e-2)" 0.3 0.3 0.9 0.3 2.1 0.5 0.4 0.3 3.5 0.3 1.8 0.3 0.3 0.2 0.3 2.0 0.3 0.2 0.3 0.9 1.2 1.2 0.6 0.3 0.3 0.3 1.2 0.3 0.3 0.3 0.2 0.3 3.5 0.3 1.8 0.0 0.3 0.3 1.2 0.4 0.2 0.3 0.4 0.6 0.3 0.1 23.6 0.3 0.3 0.4 0.3 0.3 1.3 0.3 1.0 0.3 0.5 0.3 0.0 0.5 0.0 7.1 0.2 0.7 0.0 0.6 1.1 4.3 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.1 9.3 0.0 2.0 0.6 0.0 0.0 0.9 0.3 10.6 2.1 0.1 0.0 13.6 0.2 0.0 0.2 0.2 0.8 1.0 0.7 0.1 1.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.8 0.5 0.5 1.4 13.6 0.2 0.8 5.0 0.5 0.0 0.3 0.5 0.2 0.0 0.1 0.1 0.1 0.1 0.0 1.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.9 2.1 0.3 3.5 1.2 1.2 1.2 0.3 0.3 0.3 SOS2 ENSG00000100485 "SOS Ras/Rho guanine nucleotide exchange factor 2" Q07890 14 50117120-50231558 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004577, HPA047368, HPA052689" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB004577: AB_628270, HPA047368: , HPA052689: " "unprognostic (7.99e-2)" "unprognostic (6.17e-2)" "unprognostic (7.80e-2)" "unprognostic (4.93e-2)" "unprognostic (2.81e-2)" "unprognostic (7.64e-2)" "unprognostic (1.56e-1)" "unprognostic (3.08e-1)" "unprognostic (2.01e-1)" "unprognostic (3.88e-1)" "unprognostic (9.99e-2)" "unprognostic (8.21e-2)" "prognostic favourable (8.48e-8)" "unprognostic (2.47e-2)" "unprognostic (1.91e-1)" "unprognostic (1.01e-1)" "unprognostic (6.57e-2)" 16.0 12.9 16.9 10.5 17.8 25.2 13.4 15.8 14.5 12.9 20.1 19.8 23.4 15.5 14.9 17.3 12.7 11.2 11.4 15.3 17.7 13.4 18.4 9.4 12.5 15.6 19.9 9.8 11.8 11.6 38.6 20.5 30.1 15.1 13.0 13.0 11.1 14.3 14.7 37.1 13.0 26.7 18.3 23.1 17.0 12.1 19.2 16.8 14.7 18.7 14.6 10.3 15.3 15.0 1.2 2.1 8.5 2.8 2.4 1.8 0.6 9.5 7.1 14.4 9.6 11.1 12.1 6.8 8.6 9.5 6.5 8.2 3.1 12.7 10.0 7.8 10.9 8.8 7.7 6.5 11.7 16.8 2.8 10.1 5.5 5.3 12.2 11.8 10.8 12.5 16.1 6.1 14.2 14.0 7.7 25.3 15.6 7.9 9.7 9.4 4.4 6.2 10.6 20.0 7.5 10.6 9.1 10.4 12.2 9.5 11.4 11.2 12.6 14.5 15.3 18.0 11.8 8.1 5.6 17.8 19.3 12.5 4.7 6.6 10.6 8.5 1.8 4.1 1.8 1.4 1.5 0.9 1.1 1.3 1.2 1.2 1.3 1.2 7.2 2.4 2.8 2.1 0.1 0.6 16.9 17.8 15.8 14.5 17.7 13.4 19.9 9.8 15.1 16.8 SOX15 "SOX20, SOX26, SOX27" ENSG00000129194 "SRY-box 15" O60248 17 7588178-7590170 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0" "Group enriched" "Detected in some" 7 "A-431: 40.8;HaCaT: 45.9;HBEC3-KT: 18.3;hTCEpi: 18.2" "Cancer enhanced" "Detected in many" "testis cancer: 67.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.1;non-classical monocyte: 10.8" "Lineage enriched" "Detected in many" 4 "monocytes: 10.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA067196, HPA074049" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles" Nucleoplasm "Nucleoli, Golgi apparatus, Vesicles" "HPA067196: , HPA074049: " "unprognostic (5.79e-3)" "unprognostic (6.65e-2)" "unprognostic (1.40e-2)" "unprognostic (2.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.60e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (5.00e-2)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (8.61e-3)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.95e-2)" "unprognostic (2.97e-1)" 1.0 0.8 4.6 1.0 4.1 2.1 1.3 7.2 5.0 7.5 2.6 1.1 1.0 0.7 4.4 1.7 62.7 3.7 1.0 2.9 3.1 4.1 1.3 1.0 1.5 1.0 2.6 1.0 7.0 1.0 0.1 2.0 2.0 3.5 4.1 0.6 1.4 3.4 7.0 1.9 30.0 1.0 1.6 1.4 1.0 0.7 1.3 1.0 1.8 1.0 59.0 38.7 3.6 7.8 0.0 2.4 0.2 10.8 0.0 0.0 0.5 40.8 1.0 0.6 0.3 0.0 0.1 3.2 0.4 0.1 0.3 0.6 0.8 0.2 0.1 0.4 0.0 45.9 0.0 18.3 0.1 1.1 1.2 0.1 0.5 0.1 0.0 0.0 0.9 0.0 18.2 0.2 4.1 0.0 0.9 0.3 0.0 0.3 0.2 0.5 1.2 0.2 0.5 0.6 0.3 0.8 0.2 0.3 0.7 0.5 0.1 0.2 0.3 0.3 0.5 0.4 0.8 0.5 1.4 0.3 0.4 0.5 1.5 0.5 1.0 0.2 2.4 0.0 0.0 7.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 10.8 1.2 0.0 0.5 4.6 4.1 7.2 4.4 3.1 4.1 2.6 1.0 3.5 1.0 SP2 KIAA0048 ENSG00000167182 "Sp2 transcription factor" Q02086 17 47896150-47928957 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003357, CAB010245" Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB010245: AB_2121523, HPA003357: AB_1080070" "unprognostic (1.23e-1)" "unprognostic (1.66e-2)" "unprognostic (6.30e-3)" "unprognostic (5.85e-2)" "unprognostic (1.18e-1)" "unprognostic (6.91e-2)" "unprognostic (5.66e-2)" "unprognostic (2.46e-1)" "unprognostic (6.46e-2)" "unprognostic (2.52e-1)" "unprognostic (1.44e-1)" "unprognostic (5.39e-2)" "prognostic favourable (1.82e-5)" "unprognostic (5.34e-3)" "unprognostic (4.28e-2)" "unprognostic (3.37e-2)" "unprognostic (8.66e-2)" 18.8 15.0 16.9 21.9 20.5 19.1 21.0 28.5 23.4 17.3 16.3 26.9 12.5 16.9 20.5 16.2 19.9 18.3 14.9 20.2 13.8 11.8 17.2 13.3 17.4 22.3 14.1 13.0 20.5 19.7 31.0 14.5 21.4 18.5 16.2 15.8 26.9 18.7 18.2 30.2 19.2 20.8 16.6 17.6 22.2 16.5 23.2 16.3 31.9 21.7 16.0 28.3 18.9 18.0 8.3 6.3 14.3 9.3 12.7 11.5 7.8 16.3 18.9 13.0 11.0 6.4 6.0 12.4 9.6 7.1 10.0 9.1 20.6 8.3 14.2 8.7 12.6 12.6 9.0 8.4 10.6 20.6 12.7 14.4 12.7 10.6 6.0 12.8 17.1 8.7 9.9 11.8 11.1 9.5 15.5 24.2 9.6 22.2 31.6 8.1 5.9 12.6 14.4 17.8 8.9 7.0 26.5 13.0 15.6 8.4 8.9 9.5 12.9 12.2 15.5 17.6 9.4 12.3 14.8 21.6 23.8 12.7 9.6 8.7 14.2 14.3 8.0 12.1 11.5 9.3 10.1 7.0 8.8 10.7 6.3 8.3 10.2 10.3 14.3 12.7 8.1 6.1 8.8 7.8 16.9 20.5 28.5 23.4 13.8 11.8 14.1 13.0 18.5 16.3 SPA17 "CT22, SP17" ENSG00000064199 "Sperm autoantigenic protein 17" Q15506 11 124673798-124697518 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 28.2;testis: 82.1" "Cell line enhanced" "Detected in many" "T-47d: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037568 Enhanced Approved Vesicles Vesicles "HPA037568: AB_10672905" "unprognostic (1.41e-2)" "unprognostic (3.49e-1)" "unprognostic (2.39e-3)" "prognostic favourable (1.03e-4)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.01e-4)" "unprognostic (2.64e-1)" "unprognostic (3.80e-2)" "unprognostic (4.56e-2)" "unprognostic (6.47e-2)" "unprognostic (8.54e-2)" "unprognostic (1.71e-3)" "unprognostic (6.78e-2)" "unprognostic (9.78e-3)" "unprognostic (8.52e-2)" "unprognostic (2.71e-1)" 1.3 2.2 5.6 1.3 6.0 2.3 3.5 1.0 5.8 3.5 3.5 4.3 2.8 1.9 2.7 13.7 2.1 28.2 2.8 2.0 5.6 6.8 5.9 1.1 4.5 1.3 3.9 4.3 3.2 1.8 4.4 8.1 1.4 20.1 2.2 3.9 0.8 1.6 2.7 0.7 1.3 1.6 1.9 3.6 1.0 2.2 82.1 2.7 2.6 7.6 1.6 1.7 1.8 1.3 0.5 3.7 4.2 6.0 0.4 1.3 1.8 11.4 8.5 19.6 8.1 6.3 9.4 10.2 8.5 12.8 8.6 7.4 2.7 24.1 5.2 5.7 12.0 8.1 8.1 14.3 13.6 5.5 5.8 8.1 1.6 5.2 4.5 1.8 3.6 3.8 7.6 15.4 7.9 8.6 11.3 4.7 19.2 9.9 1.2 0.3 9.0 8.1 6.6 3.0 0.0 20.5 5.3 13.1 8.7 18.7 6.3 5.2 39.2 8.5 8.3 10.0 9.1 4.8 10.7 2.1 1.6 3.3 8.7 1.7 10.5 4.2 4.5 0.8 0.7 3.5 0.6 0.4 1.3 0.8 3.7 0.5 1.1 0.8 0.2 0.4 6.0 1.7 1.2 1.8 5.6 6.0 1.0 5.8 5.6 6.8 3.9 4.3 20.1 2.7 SPANXA1 "CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX" ENSG00000198021 "Sperm protein associated with the nucleus, X-linked, family member A1" Q9NS26 X 141583674-141585011 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 14.1" "Cell line enhanced" "Detected in some" "PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXA2 SPANX ENSG00000203926 "SPANX family member A2" Q9NS26 X 141589435-141590772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "testis: 15.5" "Cell line enhanced" "Detected in some" "PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXB1 "CT11.2, SPANXB2, SPANXF1, SPANXF2" ENSG00000227234 "SPANX family member B1" Q9NS25 X 141002591-141003706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 38.5" "Group enriched" "Detected in some" 26 "A-431: 40.4;U-2 OS: 14.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " "unprognostic (8.55e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 40.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.1 1.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXC "CT11.3, CTp11" ENSG00000198573 "SPANX family member C" Q9NY87 X 141241463-141242496 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 27.3" "Group enriched" "Detected in some" 5 "A-431: 13.0;U-2 OS: 6.3" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " "unprognostic (3.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 13.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 6.3 0.0 0.5 0.0 0.0 0.2 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXD "CT11.4, SPANXE" ENSG00000196406 "SPANX family member D" Q9BXN6 X 141697411-141698739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 216 "testis: 21.5" "Group enriched" "Detected in some" 10 "A-431: 5.0;U-2 OS: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 9.6 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPARC ON ENSG00000113140 "Secreted protein acidic and cysteine rich" P09486 5 151661096-151687165 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 230.6;BJ: 188.2;fHDF/TERT166: 297.7;WM-115: 218.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 9.3" "Group enriched" "Detected in many" 7 "granulocytes: 9.3;monocytes: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002306, HPA002989, HPA003020" Supported Approved Vesicles "Secreted to blood" 190000000 Vesicles "CAB002306: AB_563919, HPA002989: AB_1079532, HPA003020: AB_1079531" "unprognostic (3.34e-2)" "unprognostic (8.57e-2)" "unprognostic (1.31e-1)" "unprognostic (3.97e-1)" "unprognostic (7.01e-2)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (8.36e-3)" "unprognostic (5.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.09e-2)" "unprognostic (1.78e-1)" "prognostic unfavourable (3.53e-5)" "unprognostic (2.59e-3)" "unprognostic (1.17e-2)" "unprognostic (3.53e-1)" "unprognostic (4.93e-3)" 178.3 58.3 50.2 47.4 93.3 3.4 68.6 33.8 131.3 115.6 42.8 92.3 22.9 13.2 89.0 65.9 36.9 38.5 177.8 65.5 68.3 100.3 46.3 25.0 66.8 25.4 124.7 18.0 55.1 14.1 36.7 16.8 249.1 153.5 46.3 22.4 47.5 15.8 45.3 31.2 40.2 20.6 144.0 202.0 43.8 20.4 75.2 68.8 7.4 38.6 39.4 14.8 104.6 35.9 0.0 0.8 9.3 3.0 0.0 0.3 40.6 0.2 0.2 55.7 2.6 230.6 78.2 5.2 188.2 62.0 78.0 80.4 0.2 0.1 0.0 44.7 297.7 2.5 7.0 14.3 26.9 0.2 2.6 2.5 0.0 5.1 69.0 0.1 0.2 122.1 20.6 57.4 8.0 107.0 2.3 2.0 44.3 0.0 0.2 1.6 25.7 0.2 0.1 55.3 0.1 0.0 0.0 2.1 4.2 0.1 0.0 25.0 0.2 6.1 126.4 36.4 56.3 16.4 59.1 0.1 0.2 0.2 31.8 0.1 218.8 2.2 3.0 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 9.3 0.0 0.0 0.7 0.0 40.6 50.2 93.3 33.8 24.6 68.3 100.3 124.7 18.0 153.5 68.8 SPATA21 "spergen-2, spergen2" ENSG00000187144 "Spermatogenesis associated 21" Q7Z572 1 16387117-16437424 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "blood: 4.6;testis: 11.3" "Cell line enriched" "Detected in some" 7 "Hep G2: 10.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.6" "Low lineage specificity" "Detected in many" HPA032080 Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA032080: " "unprognostic (3.09e-1)" "unprognostic (8.26e-2)" "unprognostic (5.39e-1)" "unprognostic (1.47e-1)" "unprognostic (2.37e-1)" "unprognostic (5.17e-3)" "unprognostic (1.16e-1)" "unprognostic (2.76e-2)" "unprognostic (1.33e-2)" "unprognostic (1.56e-1)" "unprognostic (5.33e-2)" "unprognostic (3.14e-1)" "unprognostic (2.74e-10)" "unprognostic (1.25e-1)" "unprognostic (1.88e-1)" "unprognostic (1.87e-1)" "unprognostic (9.71e-2)" 0.0 0.2 0.0 0.0 0.1 1.3 0.0 1.1 0.0 0.1 0.0 0.6 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.3 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.1 0.2 0.3 11.3 0.0 0.0 0.3 0.0 1.3 0.6 4.6 0.8 0.9 0.8 0.4 0.2 0.7 0.3 0.7 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 1.5 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.0 1.5 10.7 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.2 0.7 0.2 0.1 0.5 0.2 0.3 0.4 0.3 0.1 0.2 0.0 0.3 0.2 0.0 0.0 1.1 0.6 0.5 0.2 0.3 0.2 0.1 0.4 0.0 0.4 0.4 0.2 0.3 0.3 0.0 4.6 0.5 0.9 0.7 0.8 0.5 1.1 0.7 0.6 0.4 1.3 0.8 0.3 2.3 0.9 0.5 0.6 0.7 0.4 SPATA33 "C16orf55, FLJ31606" ENSG00000167523 "Spermatogenesis associated 33" Q96N06 16 89657802-89671272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 70.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045648, HPA073096" Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA045648: AB_2679405, HPA073096: " "unprognostic (1.05e-2)" "prognostic favourable (1.06e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.37e-1)" "unprognostic (3.97e-1)" "unprognostic (3.63e-2)" "unprognostic (2.03e-3)" "unprognostic (8.82e-2)" "unprognostic (4.02e-2)" "unprognostic (4.52e-2)" "unprognostic (3.26e-1)" "unprognostic (2.04e-1)" "unprognostic (1.60e-1)" 2.0 2.7 6.9 2.8 7.3 3.3 3.2 7.8 7.7 2.9 2.9 4.3 1.8 4.8 3.2 9.2 2.7 14.8 3.7 2.1 6.0 5.7 5.3 2.9 4.3 2.3 4.7 6.5 2.1 3.0 4.0 7.3 1.9 5.3 3.2 3.4 2.5 2.4 2.8 1.5 4.1 5.7 2.6 3.6 3.0 3.8 70.4 4.3 2.4 5.1 2.2 3.1 2.1 2.5 5.7 5.5 5.8 3.3 7.3 6.3 3.6 10.1 9.7 12.1 4.3 3.2 2.8 4.2 6.9 2.8 10.0 4.3 9.1 8.5 1.0 3.7 4.6 13.7 5.3 3.7 7.6 2.0 7.5 1.7 11.8 13.4 1.4 2.1 4.1 2.9 4.4 6.9 3.0 2.2 10.8 1.4 6.5 11.9 6.4 5.5 6.6 7.4 13.0 6.7 3.4 5.9 3.5 11.3 6.2 15.3 2.8 3.7 12.5 2.9 2.1 7.7 9.7 6.4 5.5 3.5 5.2 4.1 7.5 12.2 2.7 5.8 3.3 5.4 5.2 3.2 6.3 5.7 4.7 6.2 2.6 3.2 5.2 4.1 4.1 7.3 2.9 5.5 3.5 3.6 6.9 7.3 7.8 7.7 6.0 5.7 4.7 6.5 5.3 4.3 SPATA6 "FLJ10007, SRF-1, SRF1" ENSG00000132122 "Spermatogenesis associated 6" Q9NWH7 1 48295372-48472208 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 61.8" "Cell line enhanced" "Detected in many" "AN3-CA: 10.4;ASC TERT1: 17.6;HSkMC: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 8.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028234 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Intracellular and membrane" "Golgi apparatus, Vesicles" Nucleoplasm "HPA028234: " "unprognostic (1.36e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (2.87e-2)" "unprognostic (3.22e-1)" "unprognostic (1.68e-1)" "unprognostic (1.77e-2)" "unprognostic (4.69e-3)" "unprognostic (2.40e-2)" "unprognostic (2.61e-2)" "unprognostic (8.41e-2)" "unprognostic (6.50e-2)" "unprognostic (3.41e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-1)" "unprognostic (7.89e-2)" "unprognostic (5.71e-3)" 5.8 8.9 6.2 3.0 12.9 1.5 8.4 2.4 8.9 7.5 5.0 12.9 10.1 3.3 6.9 7.9 4.1 16.2 5.9 4.7 7.8 5.6 6.9 2.4 7.5 7.0 14.9 3.9 9.0 5.2 12.8 21.5 5.3 8.5 6.4 4.6 6.6 6.9 12.2 3.8 5.0 3.7 8.3 10.0 4.1 7.3 61.8 13.4 1.1 10.3 2.4 2.2 6.5 12.2 0.2 1.7 5.2 8.2 0.3 0.6 0.7 0.1 0.9 9.4 10.4 8.8 17.6 1.3 1.0 3.9 0.8 0.7 0.1 0.7 0.0 0.6 1.7 0.2 0.8 2.3 0.7 0.7 1.3 0.1 0.4 0.4 1.8 0.0 0.7 12.5 1.8 1.5 0.5 3.7 0.1 0.0 3.9 0.3 0.1 0.1 4.0 1.0 2.9 0.0 0.9 5.8 1.6 2.3 5.2 3.8 0.4 9.0 2.3 0.5 1.1 1.4 1.4 2.2 1.5 0.0 0.0 0.0 5.8 0.1 6.2 0.0 1.8 5.2 0.1 4.3 0.0 0.2 0.4 0.0 1.7 0.1 0.6 0.5 0.3 0.3 8.2 0.8 0.0 0.7 6.2 12.9 2.4 8.9 7.8 5.6 14.9 3.9 8.5 13.4 SPATC1L C21orf56 ENSG00000160284 "Spermatogenesis and centriole associated 1 like" Q9H0A9 21 46161148-46184476 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.6" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018979, HPA019165, HPA029394" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane, Cytosol" "HPA018979: AB_1845696, HPA019165: AB_1845697, HPA029394: AB_10601148" "unprognostic (1.46e-2)" "unprognostic (3.88e-2)" "unprognostic (3.95e-2)" "unprognostic (4.86e-2)" "unprognostic (6.36e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "prognostic favourable (2.16e-4)" "unprognostic (5.56e-2)" "unprognostic (2.35e-3)" "unprognostic (1.07e-1)" "unprognostic (1.47e-1)" "unprognostic (1.91e-2)" "unprognostic (2.58e-1)" 4.7 11.5 21.5 4.2 31.7 5.1 4.3 13.1 19.0 8.2 5.1 5.6 8.9 5.3 5.3 6.5 4.6 4.0 5.7 5.5 14.4 9.4 4.3 1.5 4.4 5.7 7.8 16.5 10.9 11.7 5.8 7.8 4.7 7.5 16.7 3.6 2.6 9.5 10.1 8.8 7.0 6.3 5.6 5.2 8.1 8.3 23.5 13.6 2.2 3.7 5.0 4.3 4.4 6.4 4.8 5.9 23.6 4.2 4.0 6.9 2.7 1.8 0.0 2.4 4.5 1.4 3.3 1.3 2.6 1.4 1.5 1.1 0.0 1.2 5.8 5.4 3.3 0.3 0.0 2.1 0.4 5.2 4.3 13.8 0.8 3.2 0.1 0.0 5.8 3.4 1.0 0.0 0.0 4.8 23.8 8.7 2.1 3.6 4.4 1.6 9.9 11.8 9.9 3.2 6.4 2.3 0.5 0.7 4.6 2.1 1.2 5.2 3.8 5.3 0.3 4.4 5.3 6.2 4.0 14.6 7.8 4.2 5.8 7.7 4.1 1.0 3.9 23.6 3.0 4.2 3.9 4.7 4.4 4.3 5.9 4.8 6.9 6.8 0.2 4.0 2.9 4.8 4.2 2.7 21.5 31.7 13.1 19.0 14.4 9.4 7.8 16.5 7.5 13.6 SPCS1 "HSPC033, SPC1, SPC12, YJR010C-A" ENSG00000114902 "Signal peptidase complex subunit 1" Q9Y6A9 3 52704955-52711146 "Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046091, HPA055273" Supported Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA046091: AB_10959614, HPA055273: " "unprognostic (5.47e-2)" "unprognostic (4.04e-1)" "prognostic favourable (9.28e-4)" "unprognostic (5.93e-2)" "unprognostic (6.88e-2)" "unprognostic (1.10e-2)" "unprognostic (3.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (5.56e-2)" "unprognostic (3.89e-1)" "unprognostic (1.15e-1)" "prognostic favourable (2.90e-4)" "unprognostic (5.96e-2)" "unprognostic (1.80e-1)" "unprognostic (3.58e-1)" "unprognostic (3.09e-2)" 31.0 53.4 39.7 28.5 41.5 27.5 42.2 24.2 55.3 39.1 46.3 40.8 46.3 47.8 34.9 53.2 39.1 33.9 35.6 39.4 38.0 47.0 62.3 98.7 37.1 68.9 47.2 38.1 34.7 112.1 30.5 48.8 50.9 41.7 41.0 41.6 38.4 87.7 57.8 43.2 34.3 53.4 34.2 48.3 37.4 45.7 57.1 25.5 42.6 55.2 38.3 52.0 36.6 30.2 40.2 123.4 48.5 27.8 22.2 34.1 43.1 21.2 20.1 19.2 24.8 31.0 25.3 32.0 29.5 27.1 26.8 24.1 21.1 31.1 22.8 13.0 26.7 20.5 19.4 27.6 26.1 30.3 23.3 26.8 33.5 29.4 35.1 37.3 44.5 20.7 36.2 29.5 32.2 21.7 22.8 72.3 27.3 20.6 29.4 37.8 36.5 41.9 12.0 17.9 114.5 39.4 26.2 13.9 31.3 29.1 31.2 39.2 34.9 42.7 20.4 24.2 22.7 43.3 34.8 79.8 118.9 32.1 37.6 41.2 31.5 45.3 26.0 48.5 27.8 26.0 32.8 40.2 34.1 30.5 28.4 29.0 32.2 32.8 19.8 22.2 27.8 123.4 33.9 43.1 39.7 41.5 24.2 55.3 38.0 47.0 47.2 38.1 41.7 25.5 SPECC1 "CYTSB, FLJ36955, HCMOGT-1, NSP" ENSG00000128487 "Sperm antigen with calponin homology and coiled-coil domains 1" Q5M775 17 20009344-20319026 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9" "Cell line enhanced" "Detected in many" "SiHa: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021421, HPA021430, HPA061073" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Nucleoplasm, Vesicles" "Nucleoli fibrillar center, Cytosol" "HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: " "unprognostic (1.13e-3)" "unprognostic (2.39e-1)" "unprognostic (1.98e-2)" "unprognostic (8.10e-3)" "unprognostic (8.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "prognostic unfavourable (1.06e-5)" "unprognostic (9.29e-2)" "unprognostic (5.81e-2)" "unprognostic (6.23e-3)" "unprognostic (2.65e-1)" "unprognostic (3.15e-1)" "unprognostic (6.86e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" 10.7 8.3 21.3 7.2 38.0 29.9 8.1 16.0 30.8 7.0 14.9 49.9 0.7 9.5 15.4 6.1 11.4 7.3 20.0 4.1 23.1 15.4 4.3 2.0 5.6 5.7 35.8 21.2 17.0 8.3 3.0 6.8 4.8 29.3 7.3 15.5 3.0 5.9 4.9 4.3 4.8 11.4 11.5 28.2 17.3 9.8 25.8 41.5 0.2 6.7 1.4 6.0 7.0 4.2 2.9 14.7 18.9 9.4 8.5 3.4 3.0 17.2 18.0 9.8 3.2 7.4 3.8 21.1 7.0 5.8 7.1 8.8 29.3 15.4 1.0 22.9 6.0 12.9 7.4 16.7 3.5 5.2 7.9 7.1 19.7 3.2 2.7 0.7 4.2 4.0 17.0 10.0 11.3 0.1 0.8 8.7 5.5 14.7 0.2 3.9 7.8 4.3 4.2 19.7 9.9 17.3 8.7 3.2 3.2 36.8 17.7 7.8 15.6 4.6 0.5 0.9 10.8 1.0 19.0 3.4 4.3 1.4 10.4 5.9 4.1 18.9 9.4 17.8 3.1 5.3 2.9 2.4 1.9 3.4 14.7 2.9 1.8 2.4 8.1 8.5 4.6 4.4 0.9 3.0 21.3 38.0 16.0 30.8 23.1 15.4 35.8 21.2 29.3 41.5 SPEG "APEG1, BPEG, KIAA1297, MGC12676, SPEGalpha, SPEGbeta" ENSG00000072195 "SPEG complex locus" Q15772 2 219434846-219498287 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Differentiation "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 88.7" "Cell line enhanced" "Detected in many" "U-138 MG: 14.7;U-2 OS: 15.0;U-251 MG: 13.7;U-87 MG: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA018904 Enhanced Approved Vesicles Vesicles "HPA018904: AB_1844924" "unprognostic (3.70e-1)" "unprognostic (1.23e-2)" "unprognostic (5.05e-3)" "unprognostic (2.45e-4)" "unprognostic (2.04e-2)" "unprognostic (4.65e-3)" "unprognostic (2.41e-2)" "unprognostic (1.12e-1)" "unprognostic (8.92e-3)" "unprognostic (2.29e-2)" "unprognostic (8.66e-4)" "unprognostic (1.06e-1)" "unprognostic (3.47e-9)" "unprognostic (1.14e-1)" "unprognostic (7.01e-2)" "unprognostic (5.95e-4)" "unprognostic (1.28e-3)" 7.7 7.1 10.1 9.1 7.7 1.2 4.2 10.4 9.8 19.2 45.1 4.1 10.5 5.7 31.6 14.1 13.5 19.0 17.4 17.8 8.7 5.3 2.0 1.4 3.0 1.7 4.0 8.0 7.0 2.9 4.7 10.5 4.8 5.5 16.7 4.5 6.7 7.8 23.0 88.7 2.2 9.2 45.2 9.1 1.9 16.1 3.0 3.9 0.0 2.0 16.8 1.6 22.5 12.6 0.0 0.3 0.0 0.0 0.0 0.5 0.7 4.0 0.3 2.1 3.5 1.1 3.2 1.4 8.7 5.8 5.8 4.4 3.1 1.4 0.0 3.2 6.4 5.1 1.7 2.0 2.3 0.5 1.3 0.4 3.7 0.2 1.5 0.0 0.7 9.3 3.1 5.3 1.3 0.0 3.0 0.0 4.2 1.1 0.1 12.4 4.4 1.6 2.1 4.7 0.7 5.7 0.0 2.3 10.9 0.6 0.0 0.1 0.3 0.1 0.1 14.7 15.0 1.7 13.7 0.5 0.0 0.1 16.6 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.7 10.1 7.7 10.4 9.8 8.7 5.3 4.0 8.0 5.5 3.9 SPG21 "ACP33, BM-019, GL010, MAST" ENSG00000090487 "SPG21, maspardin" Q9NZD8 15 64963021-64990310 "Disease related genes, Predicted intracellular proteins" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 47.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040407, HPA040436" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA040407: , HPA040436: AB_10796454" "unprognostic (7.47e-2)" "unprognostic (2.94e-2)" "unprognostic (5.81e-2)" "unprognostic (2.98e-1)" "unprognostic (1.64e-1)" "unprognostic (5.40e-3)" "unprognostic (7.25e-2)" "unprognostic (1.43e-1)" "unprognostic (4.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.24e-3)" "unprognostic (1.15e-1)" "unprognostic (3.96e-1)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.57e-1)" "unprognostic (3.19e-1)" 34.2 34.0 22.4 27.6 24.3 28.2 48.6 12.6 23.7 31.1 28.7 25.1 38.7 23.8 31.6 73.3 29.4 34.9 30.6 25.3 23.4 22.9 39.2 66.3 33.3 40.4 25.7 17.8 35.6 25.3 26.3 28.4 48.2 18.8 30.0 28.3 33.7 31.9 47.0 35.4 28.9 37.8 30.4 29.3 31.7 31.1 26.8 19.3 33.5 50.1 28.9 26.1 31.4 24.7 9.4 20.4 47.7 35.8 3.9 5.5 11.5 22.3 33.5 16.9 32.0 43.8 43.4 21.2 14.0 47.8 28.0 32.7 15.0 34.9 25.8 21.9 32.8 30.0 48.5 32.9 26.7 10.6 15.6 22.3 22.7 27.0 55.6 21.0 19.8 29.5 37.7 22.2 42.1 33.4 18.5 21.0 34.1 31.9 19.3 18.5 18.7 17.6 20.1 18.1 45.1 28.7 27.2 20.8 18.6 16.6 35.3 31.8 24.1 35.9 16.3 23.8 24.8 33.8 20.9 15.1 25.6 15.1 30.8 56.0 20.0 2.1 35.8 3.8 4.0 21.3 3.7 9.4 3.8 4.1 20.4 8.1 5.5 3.1 47.7 3.9 17.2 6.6 4.3 11.5 22.4 24.3 12.6 23.7 23.4 22.9 25.7 17.8 18.8 19.3 SPHK2 ENSG00000063176 "Sphingosine kinase 2" Q9NRA0 19 48619291-48630717 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065508 Supported Vesicles Vesicles "HPA065508: " "unprognostic (5.33e-2)" "unprognostic (4.11e-2)" "unprognostic (9.61e-2)" "prognostic unfavourable (5.19e-4)" "unprognostic (2.10e-1)" "unprognostic (7.19e-3)" "unprognostic (3.04e-1)" "unprognostic (4.45e-3)" "unprognostic (7.28e-2)" "unprognostic (2.80e-1)" "prognostic favourable (9.30e-4)" "unprognostic (1.25e-1)" "prognostic favourable (2.59e-5)" "unprognostic (1.18e-2)" "unprognostic (9.97e-2)" "unprognostic (4.21e-2)" "unprognostic (7.06e-2)" 9.3 8.9 12.6 9.9 13.0 5.2 5.1 13.6 22.0 7.2 12.9 13.4 4.9 33.2 7.4 4.2 4.9 7.3 7.8 4.7 22.5 14.8 19.3 15.2 6.1 8.7 26.3 14.9 9.1 7.2 15.0 9.5 4.1 22.3 8.7 6.2 7.2 7.5 8.0 6.1 4.3 22.2 4.9 14.1 8.4 11.3 17.2 13.7 4.0 9.1 3.1 5.3 6.2 12.4 10.4 7.4 12.5 9.4 7.2 7.0 4.2 4.0 11.7 4.4 8.0 4.8 2.0 8.3 4.4 3.7 5.2 6.2 20.0 5.4 7.6 3.0 2.8 3.0 4.1 3.6 0.7 8.6 9.6 8.4 5.1 7.0 7.6 5.4 9.3 3.7 1.9 3.6 2.5 2.8 5.5 6.8 2.5 4.2 12.6 33.3 5.8 5.7 11.7 3.5 4.9 2.4 2.7 15.9 12.6 4.2 6.7 4.2 3.6 3.6 4.5 7.4 4.1 5.8 8.8 13.1 15.1 8.4 4.3 6.2 6.7 12.5 8.3 3.6 6.0 9.4 5.9 6.5 4.8 5.8 7.4 10.4 6.6 7.0 3.3 7.2 7.4 6.6 4.6 4.2 12.6 13.0 13.6 22.0 22.5 14.8 26.3 14.9 22.3 13.7 SPINK4 "MGC133107, PEC-60" ENSG00000122711 "Serine peptidase inhibitor, Kazal type 4" O60575 9 33218365-33248567 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 35.8;intestine: 120.9;lymphoid tissue: 24.3" "Cell line enriched" "Detected in some" 6 "HMC-1: 61.9" "Group enriched" "Detected in many" 20 "colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 5.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.1" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Low region specificity" "Detected in many" HPA007286 Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Secreted to digestive system" "Golgi apparatus, Vesicles" Nucleoplasm "HPA007286: AB_1080083" "unprognostic (3.49e-2)" "unprognostic (2.32e-1)" "prognostic favourable (8.85e-5)" "unprognostic (3.09e-4)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (9.66e-2)" "unprognostic (2.43e-1)" "unprognostic (1.24e-1)" "unprognostic (3.25e-1)" "unprognostic (2.42e-3)" 0.2 0.4 0.2 24.3 0.3 0.0 0.2 0.2 0.2 0.2 69.3 0.2 0.2 28.8 0.2 0.2 0.3 0.2 35.8 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.4 0.2 0.2 0.3 110.5 2.5 0.2 0.2 0.3 0.2 120.9 4.6 0.2 0.3 0.5 0.3 0.2 0.2 0.2 0.2 0.2 3.4 0.2 0.0 0.0 5.1 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 10.0 0.4 0.0 0.0 61.9 0.0 0.0 0.0 0.1 0.0 1.3 0.1 0.0 1.3 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.5 5.2 1.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.1 0.0 5.1 0.2 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 SPINK5 "DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI" ENSG00000133710 "Serine peptidase inhibitor, Kazal type 5" Q9NQ38 5 148025683-148137289 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 101.6;esophagus: 313.0;tongue: 97.4" "Cell line enhanced" "Detected in some" "HaCaT: 12.1;HeLa: 17.9;Karpas-707: 15.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 45.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA009067, HPA011351, CAB015347" Enhanced Enhanced Vesicles "Secreted in other tissues" 28000000 Vesicles "CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447" "unprognostic (9.66e-3)" "unprognostic (1.42e-2)" "unprognostic (2.41e-1)" "unprognostic (1.17e-1)" "unprognostic (3.25e-2)" "unprognostic (1.42e-3)" "unprognostic (2.45e-2)" "unprognostic (6.85e-2)" "unprognostic (1.16e-1)" "unprognostic (2.28e-2)" "unprognostic (4.92e-3)" "unprognostic (4.56e-1)" "unprognostic (2.44e-1)" "unprognostic (7.91e-2)" "unprognostic (2.82e-1)" "unprognostic (6.87e-2)" "unprognostic (2.59e-1)" 0.1 0.0 0.2 0.1 0.1 0.0 2.8 0.1 0.2 101.6 0.7 0.2 0.1 0.0 3.2 0.2 313.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.3 0.1 0.2 1.7 0.2 18.1 0.1 0.2 48.6 0.1 0.1 0.1 0.1 0.7 0.2 0.1 3.6 0.3 97.4 65.3 0.3 64.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 1.5 0.0 12.1 0.0 1.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.2 0.7 15.8 0.0 1.7 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 4.6 2.4 0.0 0.5 0.0 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 4.1 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 SPINK9 ENSG00000204909 "Serine peptidase inhibitor, Kazal type 9" Q5DT21 5 148321203-148339849 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "tongue: 65.0" "Cell line enhanced" "Detected in many" "EFO-21: 18.2;U-266/84: 19.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" HPA038288 Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" "Nucleoplasm, Vesicles" "HPA038288: AB_10795400" "unprognostic (1.84e-1)" "unprognostic (4.87e-3)" "unprognostic (2.88e-1)" "unprognostic (9.02e-2)" "unprognostic (5.49e-3)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (2.82e-2)" "unprognostic (1.91e-2)" "unprognostic (3.93e-1)" "unprognostic (2.01e-1)" "unprognostic (3.99e-2)" "unprognostic (1.90e-1)" 1.0 2.3 2.3 2.2 4.0 6.2 1.0 1.3 3.2 1.0 1.2 1.0 1.0 1.1 2.0 1.5 1.5 0.5 1.0 2.3 2.2 3.3 1.3 1.0 1.0 1.9 1.5 1.0 1.4 1.4 0.5 1.4 2.5 1.0 1.8 1.2 1.0 1.0 1.0 2.4 2.7 1.7 1.0 1.1 1.1 2.0 3.8 1.0 2.7 1.0 65.0 1.1 1.2 1.0 3.4 2.7 10.7 2.9 5.8 2.8 0.2 10.9 2.0 2.8 3.0 0.4 1.0 2.4 3.0 0.1 0.2 0.5 4.5 8.4 3.2 18.2 0.2 2.3 0.9 0.6 0.8 4.6 2.2 6.3 6.8 2.0 0.2 2.2 2.6 0.1 0.6 0.3 0.1 0.0 3.8 14.1 0.4 9.4 2.2 3.3 11.2 4.4 2.9 2.8 3.5 1.4 9.0 5.1 5.8 2.9 6.4 1.9 10.4 2.1 6.9 3.3 10.6 3.2 3.4 8.9 19.3 3.2 2.7 1.9 4.5 10.7 2.9 1.3 1.8 1.6 2.1 1.3 2.0 2.1 0.7 3.4 2.6 2.8 10.5 5.8 2.8 2.7 1.3 0.2 2.3 4.0 1.3 3.2 2.2 3.3 1.5 1.0 1.0 1.0 SPIRE2 "KIAA1832, spir-2" ENSG00000204991 "Spire type actin nucleation factor 2" Q8WWL2 16 89818179-89871319 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.6" "Cell line enhanced" "Detected in many" "BEWO: 14.5;T-47d: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041413, HPA049415" Uncertain Approved "Nucleoplasm,Vesicles,Intermediate filaments" Nucleoplasm "Vesicles, Intermediate filaments" "HPA041413: , HPA049415: " "unprognostic (2.92e-1)" "unprognostic (1.39e-1)" "unprognostic (6.07e-3)" "unprognostic (6.96e-2)" "unprognostic (7.40e-2)" "unprognostic (7.31e-2)" "prognostic unfavourable (9.77e-5)" "unprognostic (2.10e-1)" "unprognostic (7.75e-2)" "unprognostic (5.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.95e-3)" "unprognostic (7.21e-3)" "unprognostic (6.65e-2)" "unprognostic (1.30e-1)" "unprognostic (3.27e-2)" "unprognostic (1.59e-2)" 1.5 2.1 7.2 3.9 9.3 2.2 1.7 19.5 11.2 2.1 14.8 2.1 5.9 10.9 2.5 3.2 2.5 9.1 7.6 0.8 6.2 7.8 1.9 4.0 3.2 1.0 5.5 6.1 1.6 3.0 8.4 18.4 40.6 7.4 3.5 11.7 2.7 2.2 5.0 1.2 2.0 12.6 1.9 2.5 1.5 20.2 3.8 1.4 0.0 5.0 0.9 1.3 6.4 4.9 2.1 1.6 5.5 1.4 1.7 1.2 0.6 0.3 6.8 4.3 3.6 1.2 0.8 14.5 2.3 1.3 3.2 1.3 2.6 7.2 4.5 1.0 0.6 7.2 1.9 0.2 1.0 1.8 8.3 0.9 5.6 6.9 1.1 0.3 1.5 1.5 1.7 1.0 0.8 0.1 6.9 1.3 0.9 10.1 0.1 1.5 4.7 4.2 3.4 1.5 1.0 1.6 6.9 11.3 5.8 9.4 4.1 4.1 15.5 2.4 0.3 1.9 4.1 2.6 1.9 0.6 2.9 0.4 2.9 1.6 3.9 4.6 1.4 0.9 1.1 0.7 0.8 1.2 0.9 0.7 0.3 2.1 1.2 1.2 5.5 1.7 1.3 1.6 0.5 0.6 7.2 9.3 19.5 11.2 6.2 7.8 5.5 6.1 7.4 1.4 SPNS1 "HSpin1, LAT, nrs, PP2030, SPIN1, SPINL" ENSG00000169682 "Sphingolipid transporter 1 (putative)" Q9H2V7 16 28974221-28984548 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041995, HPA042988" Enhanced Approved "Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol" Vesicles "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA041995: AB_10959609, HPA042988: AB_10964587" "unprognostic (3.54e-2)" "unprognostic (4.57e-4)" "unprognostic (2.15e-1)" "unprognostic (2.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.66e-1)" "unprognostic (7.86e-5)" "unprognostic (1.01e-1)" "unprognostic (2.00e-1)" "unprognostic (1.27e-1)" "unprognostic (4.12e-2)" "unprognostic (3.02e-3)" "unprognostic (8.85e-7)" "unprognostic (1.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.26e-3)" "unprognostic (1.12e-2)" 23.4 23.9 14.5 22.0 15.9 38.3 24.2 21.0 22.8 18.2 22.1 24.1 20.1 26.9 25.1 21.3 20.9 17.1 26.8 16.1 14.9 12.1 24.1 28.3 33.4 22.6 15.4 17.0 18.3 20.8 29.5 17.2 40.7 15.4 20.1 12.6 19.8 20.8 22.8 21.3 30.9 22.3 26.3 14.5 27.3 20.7 22.3 17.2 31.0 22.0 24.5 17.2 21.2 19.5 3.1 15.6 7.2 23.5 4.2 7.9 10.1 10.2 24.3 9.2 21.4 17.7 9.8 26.3 11.5 11.9 19.2 17.2 22.2 24.7 6.6 28.4 10.3 21.8 14.9 12.7 6.9 7.5 25.3 9.5 23.7 27.5 30.1 10.5 20.6 16.4 17.1 20.7 8.8 17.7 21.3 11.9 9.6 27.4 11.5 30.1 21.8 16.1 14.6 11.1 29.3 10.4 10.0 16.5 21.4 8.2 24.5 17.9 24.4 12.8 14.9 15.7 11.9 21.8 8.8 18.0 14.1 6.1 20.1 16.1 12.6 6.4 18.2 7.2 6.0 23.5 5.0 3.1 6.0 7.9 15.6 2.8 6.2 4.1 3.3 4.2 15.7 6.5 6.8 10.1 14.5 15.9 21.0 22.8 14.9 12.1 15.4 17.0 15.4 17.2 SPOCK1 "SPOCK, testican-1, TIC1" ENSG00000152377 "SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1" Q08629 5 136975298-137598379 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 92.2" "Cell line enhanced" "Detected in many" "AF22: 45.5;ASC diff: 90.4;HUVEC TERT2: 90.4;U-138 MG: 46.0" "Cancer enriched" "Detected in all" 7 "prostate cancer: 83.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 2.5;myeloid DC: 1.6" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;monocytes: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007450, HPA026770" Uncertain Approved Vesicles "Secreted to blood" Vesicles "HPA007450: AB_10603116, HPA026770: " "unprognostic (1.05e-1)" "unprognostic (9.25e-2)" "prognostic unfavourable (1.93e-4)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "prognostic unfavourable (1.93e-5)" "unprognostic (5.83e-3)" "prognostic unfavourable (9.08e-4)" "unprognostic (1.00e-2)" "prognostic unfavourable (4.72e-4)" "unprognostic (9.09e-3)" "unprognostic (1.60e-1)" "prognostic unfavourable (3.77e-5)" "prognostic unfavourable (9.40e-4)" "unprognostic (1.26e-1)" "unprognostic (2.21e-1)" "unprognostic (1.90e-2)" 11.3 31.0 20.6 4.0 30.4 1.5 9.3 68.2 92.2 20.5 7.4 36.0 5.1 2.1 20.5 26.1 5.6 6.8 14.3 38.6 29.9 16.6 18.0 1.4 1.9 1.7 35.5 29.0 3.2 3.7 1.4 3.7 7.6 19.6 48.9 3.6 5.2 2.9 20.7 5.6 3.2 2.6 23.2 21.7 6.8 3.7 15.9 36.0 0.1 3.3 0.0 1.6 8.1 11.5 0.0 1.6 0.4 2.5 0.0 0.0 0.6 0.6 0.1 45.5 0.0 90.4 18.5 0.0 14.8 13.7 32.2 18.1 0.0 0.0 0.0 0.0 30.9 0.6 0.2 10.6 10.1 2.5 0.0 0.0 2.7 0.0 0.6 0.0 0.0 32.2 4.3 19.8 3.5 90.4 0.0 0.0 9.1 0.0 0.0 0.0 2.9 4.2 0.0 0.0 0.0 21.4 1.4 0.5 2.1 7.3 0.1 0.0 0.0 0.1 14.5 46.0 1.6 15.6 4.2 0.0 0.0 0.0 24.9 0.6 20.8 0.0 2.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 20.6 30.4 68.2 28.5 29.9 16.6 35.5 29.0 19.6 36.0 SPON2 DIL1 ENSG00000159674 "Spondin 2" Q9BUD6 4 1166932-1208962 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HHSteC: 53.9;HSkMC: 95.0" "Cancer enriched" "Detected in all" 7 "prostate cancer: 243.7" "Region enhanced" "Detected in many" "cerebellum: 10.7" "Cell type enhanced" "Detected in many" "gdT-cell: 54.2" "Lineage enriched" "Detected in many" 5 "T-cells: 54.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040170, HPA066095" Approved Approved Vesicles "Secreted to blood" 1600000 Vesicles "HPA040170: AB_2676868, HPA066095: " "unprognostic (1.22e-1)" "unprognostic (3.56e-1)" "unprognostic (3.07e-2)" "prognostic favourable (2.03e-4)" "unprognostic (7.64e-2)" "unprognostic (6.28e-2)" "unprognostic (2.70e-3)" "unprognostic (2.28e-3)" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.82e-1)" "unprognostic (1.40e-1)" "unprognostic (1.23e-2)" "unprognostic (2.74e-3)" "unprognostic (1.22e-1)" "unprognostic (2.01e-2)" "prognostic unfavourable (9.22e-4)" 18.5 10.2 0.9 11.7 4.2 7.2 27.9 10.7 3.4 63.7 18.0 1.0 6.4 8.5 46.7 25.7 13.9 11.6 26.6 14.4 1.8 0.0 19.3 35.7 13.9 1.6 0.5 1.5 24.2 4.8 0.1 3.2 44.9 1.9 39.4 3.2 3.4 6.3 7.6 8.9 9.1 14.2 23.1 0.6 6.7 9.6 10.6 0.9 1.1 3.5 21.0 3.0 20.1 22.8 0.2 8.7 2.1 0.4 10.0 54.2 22.7 0.0 0.1 0.0 0.0 1.7 12.9 0.5 1.1 0.6 0.1 0.2 0.0 0.0 0.3 1.8 4.4 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 53.9 0.0 0.2 95.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.8 2.4 0.6 0.1 0.1 0.6 1.3 0.0 0.0 0.3 0.1 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.1 3.9 0.0 0.2 0.4 0.1 0.0 1.3 0.0 0.8 0.1 0.1 54.2 0.2 1.1 0.1 7.6 22.3 0.1 0.2 3.4 22.0 2.1 10.0 0.4 8.7 0.0 22.7 0.9 4.2 10.7 3.4 1.8 0.0 0.5 1.5 1.9 0.9 SPOPL BTBD33 ENSG00000144228 "Speckle type BTB/POZ protein like" Q6IQ16 2 138501801-138573547 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034687 Uncertain Approved Vesicles Vesicles "HPA034687: AB_10670573" "unprognostic (1.39e-3)" "unprognostic (1.24e-1)" "unprognostic (2.48e-2)" "unprognostic (3.02e-2)" "unprognostic (3.37e-1)" "unprognostic (3.12e-2)" "unprognostic (4.42e-2)" "unprognostic (2.41e-1)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" "unprognostic (2.75e-2)" "unprognostic (8.90e-2)" "prognostic favourable (3.63e-4)" "unprognostic (2.25e-2)" "unprognostic (1.15e-1)" "unprognostic (9.09e-2)" "unprognostic (1.91e-3)" 13.6 8.8 17.3 14.9 20.0 17.5 18.8 14.5 17.5 11.1 13.1 10.7 10.1 11.1 15.7 6.3 9.9 9.9 10.7 9.8 13.4 11.3 12.9 13.2 13.7 14.7 16.1 13.1 16.2 9.9 13.2 16.7 9.5 16.0 14.1 13.0 9.3 15.1 19.3 9.0 13.5 13.9 17.8 19.4 15.0 13.0 5.7 17.2 5.7 12.4 6.6 13.4 12.7 13.3 1.8 3.5 9.0 2.6 0.6 0.7 0.9 9.9 3.1 5.7 5.4 4.6 7.9 10.9 7.4 5.6 4.6 5.6 11.2 8.2 10.7 7.2 6.4 3.9 7.4 6.5 9.9 8.3 6.0 6.8 7.2 17.5 4.8 7.4 9.6 5.1 9.7 9.2 8.6 7.5 2.2 15.0 7.8 9.7 0.7 7.0 5.1 5.4 3.8 9.9 6.1 7.3 14.3 6.6 8.2 11.3 10.8 5.4 5.9 8.2 7.4 7.5 6.5 9.4 11.2 21.8 15.9 7.9 12.7 7.0 6.8 0.6 2.6 4.2 0.6 2.4 0.5 1.7 0.5 0.5 3.5 1.8 0.3 0.3 9.0 0.6 1.9 1.5 0.7 0.9 17.3 20.0 14.5 17.5 13.4 11.3 16.1 13.1 16.0 17.2 SPPL2A "IMP3, PSL2" ENSG00000138600 "Signal peptide peptidase like 2A" Q8TCT8 15 50702266-50765808 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036062, HPA067304" Enhanced Supported Vesicles Vesicles "HPA036062: AB_10611670, HPA067304: " "unprognostic (1.66e-1)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (5.82e-3)" "unprognostic (3.71e-1)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" "unprognostic (1.88e-1)" "unprognostic (2.22e-2)" "unprognostic (6.36e-2)" "unprognostic (2.04e-2)" "unprognostic (4.00e-2)" "unprognostic (3.11e-2)" "unprognostic (2.26e-2)" "unprognostic (1.44e-2)" "unprognostic (6.96e-2)" "unprognostic (3.66e-1)" 20.5 23.5 6.9 18.0 8.6 15.0 23.3 6.2 8.1 16.4 29.3 10.8 15.3 24.9 14.5 17.9 18.7 13.0 14.9 37.6 7.8 5.3 23.3 44.8 19.2 23.9 8.3 6.1 13.2 32.7 61.0 11.8 32.2 14.4 14.7 26.9 14.9 21.7 15.5 63.1 15.8 39.2 20.5 8.5 21.2 18.3 10.2 7.4 21.6 15.6 17.4 17.7 19.7 13.9 9.8 19.4 24.0 27.3 11.9 15.4 22.4 15.2 26.5 10.3 13.7 40.9 24.4 16.3 24.6 41.3 22.6 32.3 30.7 17.7 9.5 18.4 48.1 23.0 12.4 14.9 25.3 19.4 7.6 18.0 18.2 15.9 33.8 11.1 29.4 21.2 27.5 18.7 30.3 22.2 13.5 37.4 29.8 35.2 5.2 4.3 4.5 6.0 6.5 16.1 20.8 31.1 35.5 8.3 9.4 14.8 28.6 16.6 20.3 22.1 27.0 36.6 14.7 23.4 28.9 15.2 26.0 10.5 16.5 18.8 24.9 21.2 26.9 24.0 15.4 24.6 9.7 9.8 12.6 13.9 19.4 9.3 7.2 11.5 19.4 11.9 27.3 17.1 15.4 22.4 6.9 8.6 6.2 8.1 7.8 5.3 8.3 6.1 14.4 7.4 SPPL3 "DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4" ENSG00000157837 "Signal peptide peptidase like 3" Q8TCT6 12 120762510-120904371 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004194, HPA059958" Uncertain Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA004194: , HPA059958: " "unprognostic (3.29e-1)" "unprognostic (2.29e-2)" "unprognostic (3.39e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-1)" "unprognostic (7.96e-3)" "prognostic unfavourable (1.29e-5)" "unprognostic (3.17e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (2.44e-1)" "unprognostic (2.66e-1)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (7.54e-2)" "unprognostic (9.40e-2)" 17.8 15.3 18.9 12.8 23.1 13.9 19.4 21.8 31.4 25.2 20.4 25.6 18.4 14.0 23.1 13.3 39.5 23.3 18.2 13.9 17.4 18.3 18.3 14.9 20.8 21.5 19.2 20.6 25.9 19.6 42.4 14.3 21.9 16.5 16.9 21.7 19.1 19.2 22.7 13.8 48.3 18.5 23.5 17.1 19.0 14.2 34.7 20.8 25.2 24.7 22.2 20.6 19.8 29.3 4.1 6.3 7.3 2.9 2.8 4.4 1.5 12.3 12.3 18.7 11.7 24.8 16.8 13.2 9.5 28.4 20.5 16.5 12.8 12.7 11.4 0.1 16.5 15.2 19.1 20.5 21.3 9.0 11.7 9.8 7.4 9.7 26.2 11.2 12.7 16.8 32.9 17.6 16.5 20.1 10.7 5.7 17.6 10.9 14.9 9.0 12.5 8.8 8.9 15.8 8.1 16.1 35.2 12.8 13.8 18.1 8.4 14.3 25.2 7.8 14.9 9.5 13.0 5.8 7.1 13.4 24.0 11.1 14.2 9.4 15.7 7.3 2.9 2.6 3.2 2.8 4.4 3.2 4.0 4.0 4.9 4.1 3.9 4.3 5.5 2.8 2.4 6.3 3.1 1.5 18.9 23.1 21.8 31.4 17.4 18.3 19.2 20.6 16.5 20.8 SPRYD7 "C13orf1, CLLD6" ENSG00000123178 "SPRY domain containing 7" Q5W111 13 49912706-49936490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043934 Approved Approved Vesicles Vesicles "HPA043934: AB_10960545" "unprognostic (1.83e-2)" "prognostic unfavourable (8.48e-6)" "unprognostic (2.57e-1)" "unprognostic (4.95e-2)" "unprognostic (4.45e-1)" "unprognostic (1.87e-3)" "unprognostic (3.54e-2)" "unprognostic (1.12e-1)" "unprognostic (4.05e-1)" "unprognostic (3.12e-3)" "unprognostic (3.34e-3)" "unprognostic (1.17e-1)" "unprognostic (1.01e-1)" "unprognostic (6.53e-2)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.06e-2)" 7.5 13.2 17.1 5.6 15.5 4.5 8.7 14.9 21.0 6.1 11.0 8.9 4.9 9.2 6.8 8.5 10.4 7.4 6.2 16.2 17.2 20.6 12.5 15.3 14.8 4.6 15.8 14.2 8.5 9.4 11.4 10.7 12.3 13.2 10.0 10.0 6.3 7.6 8.1 30.3 8.7 10.3 10.5 12.9 5.8 10.0 17.0 9.6 1.1 10.2 11.9 5.4 8.2 8.0 7.6 3.6 2.4 5.9 9.2 6.4 2.6 6.8 5.9 3.8 4.2 4.7 6.7 8.7 13.5 6.4 9.5 5.5 10.6 5.6 6.7 4.4 9.9 5.9 8.5 12.5 13.4 11.0 7.6 7.1 4.7 7.4 16.0 17.0 5.1 5.7 14.2 8.3 16.5 5.8 8.0 6.1 22.1 4.2 0.6 8.0 1.4 6.7 3.3 6.4 4.1 9.9 5.2 3.2 4.0 4.0 9.0 6.5 8.4 10.6 7.4 8.7 4.8 8.0 13.4 3.8 5.8 5.1 6.8 6.9 9.7 0.8 3.0 2.4 3.1 3.4 6.4 7.6 3.0 4.1 3.6 6.6 2.5 3.7 0.7 9.2 5.9 2.5 4.3 2.6 17.1 15.5 14.9 21.0 17.2 20.6 15.8 14.2 13.2 9.6 SPTAN1 ENSG00000197694 "Spectrin alpha, non-erythrocytic 1" Q13813 9 128552558-128633662 "Disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding, Calmodulin-binding" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004581, HPA007927" Enhanced Approved Vesicles,Microtubules 270000 "Vesicles, Microtubules" "CAB004581: AB_671135, HPA007927: AB_1857435" "unprognostic (1.46e-2)" "unprognostic (2.73e-2)" "unprognostic (1.56e-1)" "unprognostic (9.06e-2)" "unprognostic (3.24e-1)" "unprognostic (4.02e-2)" "unprognostic (2.56e-3)" "unprognostic (2.20e-1)" "unprognostic (1.81e-1)" "unprognostic (1.30e-2)" "unprognostic (2.49e-1)" "unprognostic (1.36e-1)" "prognostic favourable (1.84e-12)" "unprognostic (2.94e-2)" "unprognostic (1.60e-1)" "unprognostic (4.18e-3)" "unprognostic (2.19e-3)" 27.8 18.0 46.4 21.3 54.0 14.7 18.0 80.9 74.7 21.1 22.3 33.3 17.0 14.5 27.5 20.5 22.2 33.1 19.4 37.2 42.6 46.2 19.5 13.8 32.1 20.6 41.8 59.8 32.4 14.2 47.2 18.2 33.1 75.1 20.2 22.0 26.9 16.7 29.3 12.7 40.1 17.9 35.1 31.8 24.2 18.2 26.1 29.9 18.0 22.2 11.4 21.7 19.6 27.5 5.5 2.5 3.2 1.2 5.7 12.8 4.2 23.2 25.8 17.0 18.7 24.9 28.3 13.9 20.0 16.8 22.5 17.0 36.6 16.6 20.4 17.9 30.2 42.9 18.0 20.1 14.0 11.5 10.7 3.4 70.0 20.5 14.1 15.1 11.6 13.5 16.2 37.7 12.8 30.1 1.9 24.2 22.0 16.1 29.1 6.4 21.7 16.2 19.7 20.4 12.9 18.3 20.1 13.2 20.7 65.6 9.1 9.5 15.7 4.3 51.5 15.7 23.2 22.6 15.5 14.8 17.4 11.6 19.1 6.9 14.7 2.5 1.2 3.2 8.9 1.1 12.2 5.5 11.2 8.2 1.9 5.3 7.0 7.2 1.3 5.7 0.9 2.5 12.8 4.2 46.4 54.0 80.9 74.1 42.6 46.2 41.8 59.8 75.1 29.9 SQLE ENSG00000104549 "Squalene epoxidase" Q14534 8 124998497-125022283 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018038, HPA020762" Enhanced Uncertain Vesicles,Cytosol "Vesicles, Cytosol" "HPA018038: , HPA020762: " "unprognostic (1.37e-2)" "unprognostic (6.26e-3)" "unprognostic (5.12e-2)" "unprognostic (9.51e-3)" "unprognostic (4.63e-1)" "prognostic unfavourable (7.42e-4)" "unprognostic (4.76e-3)" "prognostic unfavourable (4.67e-4)" "unprognostic (3.45e-2)" "unprognostic (7.21e-2)" "prognostic unfavourable (2.73e-4)" "unprognostic (7.51e-2)" "prognostic unfavourable (5.70e-4)" "unprognostic (9.71e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-3)" "unprognostic (7.74e-3)" 4.6 15.7 11.1 9.9 13.9 10.4 12.1 8.9 19.9 15.1 11.5 28.8 4.4 15.8 8.9 5.1 40.3 10.0 6.3 4.2 15.4 14.5 7.8 38.1 16.0 8.6 10.8 9.7 17.5 6.3 16.5 9.5 24.7 28.5 13.8 10.1 9.3 10.4 4.7 1.3 23.8 8.7 6.6 36.0 5.6 11.5 29.3 18.7 9.8 5.7 24.2 15.0 5.3 21.6 15.1 12.4 1.2 9.7 9.5 9.0 6.1 25.5 9.9 59.4 17.0 18.5 31.4 6.0 6.7 20.7 9.2 16.9 13.4 37.3 17.6 9.7 8.3 19.5 24.7 37.2 10.7 14.5 52.3 50.2 6.7 34.2 27.2 5.9 14.8 21.4 39.8 27.4 22.6 10.0 28.6 34.3 7.4 42.1 20.3 7.4 24.6 6.8 8.9 10.9 23.9 64.7 29.4 18.6 9.4 13.8 44.4 13.8 11.8 15.4 9.8 3.8 13.4 4.5 6.0 6.2 12.6 24.1 6.4 17.9 6.5 1.2 5.1 0.5 9.0 8.5 4.4 13.6 5.4 8.3 12.4 15.1 7.5 7.8 0.1 9.5 9.7 8.8 5.6 6.1 11.1 13.9 8.9 16.4 15.4 14.5 10.8 9.7 28.5 18.7 SQSTM1 "A170, OSIL, p60, p62, p62B, PDB3" ENSG00000161011 "Sequestosome 1" Q13501 5 179806398-179838078 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Autophagy, Differentiation, Immunity" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 196.4;HHSteC: 135.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004587, HPA064165, HPA068843" Supported Enhanced Vesicles,Cytosol "Vesicles, Cytosol" "CAB004587: AB_628279, HPA064165: , HPA068843: " "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (3.19e-1)" "unprognostic (9.45e-2)" "unprognostic (1.47e-2)" "unprognostic (1.08e-1)" "prognostic unfavourable (2.31e-5)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (5.65e-2)" "unprognostic (1.66e-1)" "unprognostic (1.70e-1)" "unprognostic (9.52e-2)" "unprognostic (3.21e-1)" "unprognostic (8.68e-3)" "unprognostic (4.41e-2)" "unprognostic (2.01e-1)" 47.8 74.5 12.4 21.6 16.0 19.5 60.4 26.2 23.4 25.2 31.7 20.9 39.8 22.9 29.4 27.7 30.8 23.1 45.2 51.9 13.9 12.8 38.6 88.3 33.3 33.4 23.2 16.3 32.3 51.8 22.7 33.6 72.7 15.6 36.2 15.2 28.9 39.0 36.2 102.8 15.3 22.0 36.3 15.5 25.6 40.0 18.9 17.9 18.8 60.4 45.3 17.5 47.9 64.0 27.8 34.2 100.4 58.3 28.2 38.7 52.4 13.9 79.8 3.8 11.4 56.5 39.0 57.4 20.4 61.0 16.2 20.8 15.6 57.7 2.2 56.7 31.2 17.3 7.5 17.2 7.6 196.4 11.7 6.6 28.9 24.4 135.4 6.7 36.3 32.7 21.9 30.3 46.9 16.6 7.0 46.9 34.6 11.0 2.6 6.5 9.4 24.9 5.2 8.4 21.8 24.0 61.1 8.4 7.4 30.2 29.5 72.8 14.7 11.6 36.9 28.4 12.6 26.9 26.1 70.2 73.5 7.3 64.7 11.4 31.5 90.0 58.3 59.9 32.7 39.6 38.7 27.8 28.9 29.2 34.2 27.1 24.0 24.0 100.4 28.2 36.6 14.8 38.7 52.4 12.4 16.0 26.2 23.4 13.9 12.8 23.2 16.3 15.6 17.9 SREBF2 "bHLHd2, SREBP2" ENSG00000198911 "Sterol regulatory element binding transcription factor 2" Q12772 22 41833079-41907308 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031962, HPA031963" Approved Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "HPA031962: AB_10601266, HPA031963: " "unprognostic (6.53e-2)" "unprognostic (6.07e-2)" "unprognostic (1.75e-2)" "unprognostic (1.50e-3)" "unprognostic (3.41e-3)" "unprognostic (9.08e-2)" "unprognostic (5.04e-2)" "unprognostic (1.31e-1)" "unprognostic (4.78e-1)" "unprognostic (1.04e-2)" "unprognostic (2.30e-1)" "unprognostic (9.85e-2)" "prognostic favourable (1.37e-4)" "unprognostic (4.68e-2)" "unprognostic (1.92e-2)" "unprognostic (3.22e-1)" "unprognostic (7.93e-3)" 13.9 45.2 42.9 19.6 41.7 18.2 16.3 51.9 66.5 16.5 27.7 32.7 22.3 26.1 19.4 41.5 42.4 18.9 28.7 33.9 37.3 33.6 18.9 20.4 27.9 21.1 21.7 38.4 22.7 29.7 34.2 17.4 15.8 34.2 22.8 20.9 25.4 29.0 20.0 17.2 32.9 22.3 19.8 24.7 16.0 30.2 13.5 21.0 15.6 14.3 20.5 26.1 17.1 19.0 9.6 8.4 2.0 5.5 1.8 6.4 4.9 18.0 12.9 34.5 32.0 20.2 27.1 19.3 6.0 20.4 7.2 14.8 15.2 24.0 32.3 8.6 14.8 31.1 19.6 40.1 5.1 9.1 21.4 16.1 22.8 15.1 33.8 23.5 11.0 25.4 22.8 18.8 23.6 14.1 16.5 39.0 7.5 23.0 17.0 17.8 21.8 10.0 19.7 19.7 51.8 29.9 19.0 14.0 10.5 13.9 25.6 25.7 16.1 42.0 15.0 9.7 18.2 4.5 7.1 28.5 14.5 25.7 9.5 17.9 14.8 0.0 5.5 2.0 6.4 4.9 4.4 9.6 3.5 4.6 6.6 7.3 3.2 3.6 1.0 1.8 4.0 8.4 2.1 4.9 42.9 41.7 51.9 66.5 37.3 33.6 21.7 38.4 34.2 21.0 SRFBP1 "BUD22, FLJ25286, p49, Rlb1, STRAP" ENSG00000151304 "Serum response factor binding protein 1" Q8NEF9 5 121961961-122075570 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042737, HPA058150" Approved Supported Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Nucleoli" Vesicles "HPA042737: AB_10796583, HPA058150: " "unprognostic (8.94e-2)" "unprognostic (1.80e-1)" "unprognostic (4.68e-2)" "unprognostic (1.61e-2)" "unprognostic (4.14e-1)" "unprognostic (1.18e-1)" "unprognostic (5.07e-3)" "unprognostic (2.03e-1)" "unprognostic (8.96e-3)" "unprognostic (6.31e-3)" "prognostic unfavourable (5.31e-4)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (1.78e-1)" "unprognostic (4.71e-1)" "unprognostic (1.43e-1)" "unprognostic (8.45e-2)" 21.8 9.4 11.6 11.1 15.2 10.1 17.2 15.0 14.8 12.7 10.2 6.1 8.5 9.1 13.0 12.1 14.2 11.1 9.6 10.7 11.8 8.0 14.3 12.6 11.2 12.5 13.1 11.9 17.1 10.6 15.5 20.2 11.5 14.2 12.8 10.9 5.1 13.0 9.5 19.7 10.7 9.5 11.3 16.0 15.4 10.1 9.3 14.9 12.5 15.6 13.8 11.6 14.4 17.5 10.3 9.6 2.6 12.8 7.4 11.5 4.3 10.8 8.0 7.4 11.6 8.5 7.9 12.3 10.4 7.6 11.5 13.5 6.5 10.8 13.7 12.2 6.5 8.0 12.0 14.2 21.5 19.4 6.8 13.1 5.8 6.6 9.1 15.1 11.0 9.5 11.0 14.4 14.3 12.4 12.0 11.2 12.0 4.9 10.4 4.8 10.8 5.3 10.8 17.4 14.3 12.6 11.2 7.6 7.1 9.6 9.5 17.9 9.7 9.1 9.0 17.8 10.9 12.6 15.1 6.0 11.2 15.8 10.2 12.3 15.6 0.6 7.3 2.6 6.6 12.8 8.4 10.3 7.3 7.2 9.6 8.9 8.6 11.5 1.2 7.4 10.1 9.1 6.7 4.3 11.6 15.2 15.0 14.8 11.8 8.0 13.1 11.9 14.2 14.9 SRGAP3 "ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP" ENSG00000196220 "SLIT-ROBO Rho GTPase activating protein 3" O43295 3 8980591-9363053 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.9" "Cell line enhanced" "Detected in some" "AF22: 9.5;HBEC3-KT: 8.2;hTCEpi: 8.2;RT4: 10.9;T-47d: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036959, HPA044074, HPA078079" Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: " "unprognostic (3.63e-3)" "unprognostic (1.12e-3)" "unprognostic (7.61e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.70e-2)" "unprognostic (5.58e-2)" "unprognostic (1.18e-3)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "unprognostic (2.75e-2)" "unprognostic (6.39e-3)" 1.8 6.1 10.6 1.7 20.4 1.2 3.2 32.4 34.9 9.7 2.1 10.5 0.0 1.9 4.4 3.4 2.6 18.5 2.3 2.7 10.0 11.2 4.9 1.4 2.2 2.3 7.5 9.8 7.2 2.4 2.7 5.7 1.9 15.5 4.7 2.5 4.8 5.7 3.2 2.5 4.0 1.7 2.0 6.1 1.7 2.9 4.4 4.8 0.4 3.3 0.6 2.1 6.7 1.4 0.0 1.9 1.9 0.4 1.0 1.3 0.1 0.5 0.5 9.5 0.4 0.6 1.3 1.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.5 0.0 4.8 0.2 8.2 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 5.1 0.8 8.2 0.7 0.8 0.0 0.0 0.0 0.0 0.1 0.2 2.0 0.9 0.7 1.1 0.0 0.0 4.1 10.9 1.1 1.2 0.2 2.9 0.1 10.6 0.0 0.0 0.0 0.4 0.1 0.1 2.8 0.1 0.0 0.8 1.7 0.3 1.2 0.4 1.9 0.0 0.1 0.0 0.0 0.2 0.0 1.9 0.0 0.2 0.0 0.0 1.0 0.1 0.5 1.3 0.1 10.6 20.4 32.4 34.9 10.0 11.2 7.5 9.8 15.5 4.8 SRR "ILV1, ISO1" ENSG00000167720 "Serine racemase" Q9GZT4 17 2303383-2325260 "Enzymes, Predicted intracellular proteins" "Allosteric enzyme, Isomerase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007529, CAB015343" Approved Approved Vesicles Vesicles "CAB015343: AB_2195009, HPA007529: " "unprognostic (2.96e-1)" "unprognostic (7.86e-2)" "unprognostic (6.01e-2)" "prognostic favourable (6.20e-5)" "unprognostic (3.05e-1)" "unprognostic (1.57e-2)" "unprognostic (4.32e-2)" "unprognostic (9.97e-2)" "unprognostic (9.09e-2)" "unprognostic (4.85e-2)" "prognostic favourable (8.16e-4)" "unprognostic (5.17e-2)" "prognostic favourable (2.45e-6)" "unprognostic (6.14e-2)" "unprognostic (1.99e-1)" "unprognostic (1.89e-1)" "unprognostic (5.84e-2)" 11.6 12.6 17.1 7.7 14.7 13.9 16.7 12.2 24.9 8.4 10.4 13.9 11.4 7.9 10.9 11.3 12.9 10.0 9.6 12.6 15.2 13.0 10.3 9.0 10.9 7.0 12.6 15.6 9.8 14.8 11.0 9.7 6.5 12.4 9.6 8.8 10.6 11.9 9.3 16.9 13.4 7.5 15.0 13.2 7.3 9.2 13.8 9.0 13.4 13.8 6.1 6.0 12.1 7.3 9.7 15.5 5.2 12.6 13.9 13.5 8.7 7.2 13.2 24.0 8.9 13.1 13.8 11.7 15.4 9.6 10.2 10.6 12.2 9.2 13.6 2.0 15.9 15.3 6.6 5.6 13.0 15.8 12.9 7.0 9.8 4.6 13.2 2.0 3.9 11.7 5.8 22.8 11.0 14.9 7.2 10.1 22.7 4.3 13.9 2.7 5.0 10.0 23.1 27.2 6.3 11.8 3.3 4.7 12.1 13.4 1.6 7.0 10.5 4.9 11.7 11.0 7.8 12.4 9.1 8.9 12.0 2.5 19.6 6.6 14.9 2.4 8.2 5.2 9.5 8.7 9.9 9.7 12.3 10.1 15.5 8.9 10.4 13.5 1.0 13.9 12.6 10.4 8.9 8.7 17.1 14.7 12.2 24.9 15.2 13.0 12.6 15.6 12.4 9.0 ST14 "HAI, MT-SP1, PRSS14, SNC19, TMPRSS14" ENSG00000149418 "Suppression of tumorigenicity 14" Q9Y5Y6 11 130159562-130210376 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 94.1" "Cell line enhanced" "Detected in some" "CACO-2: 35.7;CAPAN-2: 72.1;HaCaT: 50.5;RPMI-8226: 47.3;SK-BR-3: 33.4;T-47d: 50.5;U-698: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 18.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047014 Approved Nucleoplasm,Vesicles 220000 "Nucleoplasm, Vesicles" "HPA047014: " "unprognostic (1.17e-1)" "unprognostic (1.15e-1)" "unprognostic (9.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.20e-1)" "unprognostic (3.97e-2)" "unprognostic (5.29e-1)" "unprognostic (3.21e-1)" "unprognostic (1.03e-3)" "unprognostic (2.25e-1)" "prognostic favourable (5.03e-11)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.28e-2)" "unprognostic (5.60e-2)" 10.1 1.8 0.7 21.9 1.8 0.5 5.5 0.8 1.4 8.9 48.6 0.5 23.8 33.8 2.8 16.9 38.9 9.7 32.4 1.1 0.5 0.5 30.5 3.2 9.5 7.5 1.8 0.6 3.6 34.3 8.4 9.5 12.7 1.5 12.1 15.4 0.7 25.1 15.8 0.7 17.8 94.1 1.2 1.8 4.0 16.7 2.1 1.5 5.2 24.0 20.1 28.4 8.3 14.9 3.8 18.2 2.3 2.7 0.0 0.1 0.8 26.2 0.0 0.0 0.1 0.0 0.0 14.3 0.0 0.0 0.0 0.0 35.7 72.1 26.0 2.7 0.0 50.5 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.1 0.2 0.1 0.0 0.0 47.3 4.7 21.5 2.9 0.0 0.2 33.4 0.0 50.5 5.1 0.0 0.0 0.4 0.1 0.1 0.0 0.0 34.4 0.0 8.0 0.0 0.0 2.7 2.3 0.0 1.5 0.1 3.8 0.0 0.0 4.5 2.3 0.0 0.0 0.3 0.0 0.2 18.2 0.0 0.8 0.7 1.8 0.8 1.4 0.5 0.5 1.8 0.6 1.5 1.5 ST3GAL2 "SIAT4B, ST3GalA.2, ST3GALII" ENSG00000157350 "ST3 beta-galactoside alpha-2,3-sialyltransferase 2" Q16842 16 70375978-70439237 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017270 Approved Approved Vesicles "Intracellular and membrane" Vesicles "HPA017270: AB_1857523" "unprognostic (2.76e-2)" "unprognostic (6.33e-2)" "unprognostic (3.41e-1)" "unprognostic (1.35e-1)" "unprognostic (4.99e-1)" "unprognostic (1.01e-1)" "prognostic unfavourable (2.79e-4)" "unprognostic (1.14e-2)" "unprognostic (2.21e-1)" "unprognostic (1.91e-2)" "prognostic favourable (2.33e-4)" "unprognostic (9.54e-2)" "prognostic unfavourable (3.34e-6)" "unprognostic (7.42e-2)" "unprognostic (8.83e-3)" "unprognostic (4.64e-2)" "unprognostic (5.20e-2)" 12.6 9.1 9.3 17.2 11.9 14.3 8.9 24.1 10.6 11.3 8.8 5.1 9.3 9.2 13.9 5.6 5.8 9.0 6.8 9.2 10.4 6.0 8.8 12.9 9.3 14.9 5.1 4.7 13.6 4.2 8.8 7.2 8.8 6.8 7.5 4.7 9.9 4.9 9.0 33.3 6.0 10.5 12.0 4.0 17.7 5.4 9.6 5.9 16.0 6.6 4.9 12.6 9.1 12.0 3.2 14.3 11.2 2.2 2.8 4.2 1.1 1.4 8.3 7.2 9.6 3.9 5.3 1.7 5.9 6.3 6.6 3.3 4.9 3.3 4.0 10.6 6.4 1.0 2.9 2.4 3.1 9.5 4.6 17.2 3.4 7.4 4.8 6.2 28.3 4.1 1.4 6.6 1.2 9.0 23.4 3.9 3.6 0.6 6.6 17.1 9.8 4.5 12.6 2.7 5.4 4.4 1.1 3.2 9.5 14.7 0.3 6.5 1.6 7.0 9.6 8.4 10.0 3.5 4.3 8.2 3.2 8.2 9.1 5.2 11.6 2.7 2.0 5.7 2.0 2.2 1.9 1.7 2.4 2.2 1.0 3.2 4.2 3.3 11.2 2.8 1.3 14.3 2.7 1.1 9.3 11.9 24.1 10.6 10.4 6.0 5.1 4.7 6.8 5.9 ST3GAL5 "SIAT9, SIATGM3S, ST3GalV" ENSG00000115525 "ST3 beta-galactoside alpha-2,3-sialyltransferase 5" Q9UNP4 2 85837120-85905199 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 40.1" "Cell line enhanced" "Detected in many" "AN3-CA: 25.6;RT4: 21.7;SK-MEL-30: 17.9;U-266/84: 18.9" "Cancer enhanced" "Detected in all" "thyroid cancer: 41.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034708, HPA040425, HPA068928" Uncertain Approved Vesicles Vesicles "HPA034708: AB_10601594, HPA040425: , HPA068928: " "unprognostic (7.90e-2)" "unprognostic (1.61e-2)" "unprognostic (3.84e-2)" "unprognostic (2.93e-2)" "unprognostic (1.27e-1)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (5.81e-3)" "unprognostic (1.38e-1)" "unprognostic (6.45e-2)" "unprognostic (5.03e-3)" "unprognostic (3.43e-2)" "prognostic unfavourable (2.25e-7)" "unprognostic (2.22e-1)" "unprognostic (5.74e-2)" "prognostic favourable (4.99e-4)" "prognostic favourable (4.48e-4)" 8.0 40.1 15.3 7.2 18.5 4.1 4.2 9.9 34.9 3.3 3.8 18.8 0.0 2.7 8.0 2.9 2.9 4.9 11.8 2.1 14.8 12.0 2.4 7.0 18.0 11.5 14.0 13.4 7.2 2.9 1.5 7.4 24.1 18.1 4.8 5.0 18.7 4.8 2.2 9.5 5.0 3.4 6.2 18.0 11.1 4.1 9.0 13.4 5.5 36.7 0.4 6.9 30.9 7.8 2.5 1.1 1.3 6.1 1.4 1.8 0.5 0.1 12.5 1.1 25.6 10.6 5.7 3.8 2.7 8.4 2.7 2.4 0.2 9.1 0.3 0.0 4.6 0.4 1.6 2.9 3.3 0.1 1.5 0.2 0.5 0.4 8.5 0.1 3.7 3.2 0.4 1.0 0.4 6.4 0.3 14.2 8.6 0.8 0.8 1.4 0.1 0.0 1.6 8.1 5.0 1.4 21.7 1.8 1.8 0.1 0.0 17.9 0.1 0.5 2.1 0.0 1.3 0.0 0.2 14.3 18.9 0.2 2.0 2.6 12.9 0.9 1.8 0.1 1.4 6.1 1.8 2.5 0.8 0.9 1.1 1.5 0.7 0.8 1.3 1.4 5.1 0.4 0.3 0.5 15.3 18.5 9.9 21.9 14.8 12.0 14.0 13.4 18.1 13.4 ST6GALNAC5 "MGC3184, SIAT7E, ST6GalNAcV" ENSG00000117069 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5" Q9BVH7 1 76867441-77065711 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4" "Cell line enhanced" "Detected in some" "AF22: 9.0;fHDF/TERT166: 10.6;HaCaT: 5.1;SH-SY5Y: 7.7;U-2 OS: 8.8;U-251 MG: 4.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.9" "Group enriched" "Detected in many" 4 "amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065593, HPA070354" Uncertain Approved Vesicles "Intracellular and membrane" Vesicles "HPA065593: , HPA070354: " "unprognostic (1.32e-1)" "unprognostic (5.96e-2)" "unprognostic (1.72e-1)" "unprognostic (1.49e-2)" "unprognostic (2.82e-2)" "unprognostic (2.04e-2)" "unprognostic (4.67e-2)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-1)" "unprognostic (1.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.10e-2)" "unprognostic (5.90e-3)" "unprognostic (9.66e-2)" "unprognostic (6.88e-2)" "unprognostic (1.69e-2)" 0.7 10.1 22.1 5.2 22.3 0.4 4.2 0.6 12.7 2.9 3.4 0.3 0.0 1.4 0.9 0.7 3.7 6.9 12.6 1.4 29.4 2.7 0.7 0.6 12.1 1.6 3.0 14.2 6.5 0.8 0.4 8.5 0.9 4.7 4.2 2.7 5.8 1.5 1.6 0.6 1.0 2.1 10.2 0.8 1.0 3.7 1.2 0.2 0.0 0.6 0.0 1.4 4.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.3 0.0 9.0 0.0 0.0 0.0 0.0 0.8 3.1 2.6 0.8 0.0 0.2 0.0 0.0 10.6 5.1 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.6 0.0 0.0 0.7 0.6 0.0 0.1 2.5 7.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 8.8 0.0 4.9 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.1 22.3 0.6 12.7 29.4 2.7 3.0 14.2 4.7 0.2 STAM STAM1 ENSG00000136738 "Signal transducing adaptor molecule" Q92783 10 17644125-17715914 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "T-reg: 33.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034399, HPA043882" Supported Supported Vesicles Vesicles "CAB034399: AB_2197486, HPA043882: " "unprognostic (1.09e-2)" "unprognostic (8.32e-2)" "unprognostic (1.10e-1)" "unprognostic (3.95e-2)" "unprognostic (9.11e-3)" "unprognostic (1.04e-1)" "prognostic unfavourable (3.44e-6)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (8.58e-2)" "unprognostic (1.37e-2)" "unprognostic (8.39e-2)" "unprognostic (1.02e-3)" "unprognostic (1.39e-1)" "unprognostic (2.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.02e-1)" 13.5 16.7 16.8 9.3 21.8 58.5 10.8 23.2 25.4 12.9 9.4 22.7 6.3 11.4 15.0 8.9 14.5 9.6 12.2 23.7 18.4 18.4 14.3 9.5 14.6 10.3 18.6 16.1 15.5 17.2 14.4 13.4 11.7 24.5 12.8 11.0 16.1 12.7 9.4 26.0 11.5 9.7 12.3 20.7 8.8 13.3 10.8 15.0 25.1 15.2 12.5 13.0 13.7 10.6 2.4 4.3 17.2 3.6 7.2 33.4 2.9 14.9 9.6 13.5 6.8 16.6 12.3 5.4 20.9 10.0 21.3 17.2 12.7 15.1 4.1 3.1 17.5 8.4 13.4 11.1 17.4 4.8 6.8 39.3 8.6 22.8 18.2 2.9 21.1 11.4 14.7 17.4 15.0 10.8 13.6 5.6 23.4 5.6 15.8 2.9 7.3 4.9 8.4 12.5 5.5 9.8 6.1 6.2 10.5 11.9 9.0 18.8 13.4 4.8 12.2 12.0 11.8 19.9 9.3 3.6 4.9 7.0 13.7 4.8 7.6 17.2 3.5 5.4 2.9 3.6 2.7 2.4 6.2 3.0 4.3 1.7 4.5 3.6 2.9 7.2 3.2 2.6 33.4 2.9 16.8 21.8 23.2 25.4 18.4 18.4 18.6 16.1 24.5 15.0 STAM2 Hbp ENSG00000115145 "Signal transducing adaptor molecule 2" O75886 2 152116801-152175992 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035528, HPA035529" Enhanced Supported Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA035528: AB_10601606, HPA035529: AB_10672868" "unprognostic (1.53e-1)" "unprognostic (1.79e-1)" "unprognostic (4.81e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (5.16e-2)" "unprognostic (2.76e-2)" "unprognostic (3.15e-2)" "unprognostic (6.54e-2)" "unprognostic (1.20e-1)" "unprognostic (1.22e-1)" "unprognostic (7.92e-2)" "unprognostic (1.11e-2)" "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" 17.8 19.1 17.2 12.4 19.9 4.9 21.3 16.1 19.5 19.6 16.7 17.6 17.2 15.1 18.5 16.0 17.8 21.6 15.6 16.1 15.3 15.4 24.6 17.8 17.6 13.0 19.9 14.4 20.6 20.5 23.1 34.0 16.7 20.4 22.1 18.4 14.5 19.5 19.3 14.3 17.6 19.6 19.8 20.0 14.0 18.8 24.3 21.2 16.0 23.8 13.2 14.7 19.5 16.6 2.3 3.3 14.0 6.5 2.5 2.2 1.7 5.4 5.2 4.9 5.9 12.9 15.4 5.3 11.3 13.0 7.3 9.3 5.2 5.2 7.1 9.0 16.0 5.5 5.4 10.4 11.8 8.7 4.3 5.1 3.7 7.8 14.8 7.4 10.0 11.8 10.0 13.6 18.4 7.8 3.3 5.0 14.9 5.3 3.9 5.8 3.0 7.6 3.2 6.0 3.8 11.4 9.3 2.6 4.0 6.2 5.6 9.3 7.5 6.9 10.2 16.3 5.3 12.8 6.8 4.2 4.3 4.6 12.4 6.0 8.9 14.0 3.5 4.4 1.9 4.7 1.8 1.7 2.0 2.0 2.7 2.3 1.7 2.1 8.8 2.5 6.5 3.3 2.2 1.7 17.2 19.9 16.1 19.5 15.3 15.4 19.9 14.4 20.4 21.2 STAP1 "BRDG1, STAP-1" ENSG00000035720 "Signal transducing adaptor family member 1" Q9ULZ2 4 67558728-67607337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4" "Group enriched" "Detected in some" 5 "Daudi: 62.1;U-698: 27.8" "Cancer enriched" "Detected in many" 7 "renal cancer: 13.0" "Region enriched" "Detected in single" 7 "hippocampal formation: 3.2" "Cell type enhanced" "Detected in many" "memory B-cell: 28.1;naive B-cell: 36.8" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 5 "cerebellum: 2.6" "Low region specificity" "Detected in many" HPA038529 Enhanced Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038529: AB_10673011" "unprognostic (1.14e-4)" "unprognostic (1.49e-3)" "unprognostic (2.30e-2)" "unprognostic (2.17e-1)" "unprognostic (1.63e-3)" "unprognostic (6.30e-4)" "unprognostic (1.95e-3)" "unprognostic (6.95e-3)" "unprognostic (5.18e-2)" "unprognostic (6.38e-3)" "unprognostic (1.47e-1)" "unprognostic (8.43e-3)" "unprognostic (3.11e-2)" "unprognostic (1.49e-2)" "unprognostic (4.69e-2)" "unprognostic (2.71e-2)" "unprognostic (1.40e-1)" 0.7 0.3 0.4 27.8 0.3 2.9 0.6 0.3 0.4 0.7 2.1 0.0 12.3 0.8 0.6 1.2 2.4 0.4 0.7 0.4 3.2 0.3 20.0 0.5 2.7 23.9 0.4 0.0 0.3 0.6 0.0 0.4 0.1 0.2 1.0 1.3 0.3 2.6 5.1 0.4 0.5 9.3 0.1 0.4 26.5 1.1 2.1 0.0 5.9 0.7 0.7 30.4 4.6 0.6 36.8 1.7 7.7 0.0 12.6 2.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 7.9 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 8.9 0.0 1.2 0.0 7.7 0.3 0.0 0.7 28.1 0.7 0.3 0.4 36.8 2.9 0.1 0.3 12.6 0.0 1.7 0.1 1.7 0.4 0.3 0.3 0.4 3.2 0.3 0.4 0.0 0.2 0.0 STARD3 "es64, MLN64" ENSG00000131748 "StAR related lipid transfer domain containing 3" Q14849 17 39637065-39663484 "Cancer-related genes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "SK-BR-3: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017021, HPA024307, HPA073948" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB017021: , HPA024307: , HPA073948: " "unprognostic (1.11e-1)" "unprognostic (2.14e-2)" "unprognostic (6.35e-2)" "unprognostic (8.92e-3)" "unprognostic (2.09e-2)" "unprognostic (2.94e-1)" "prognostic unfavourable (3.60e-5)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (6.25e-3)" "unprognostic (5.88e-2)" "prognostic unfavourable (7.70e-4)" "unprognostic (1.33e-1)" "unprognostic (5.22e-2)" "unprognostic (8.51e-3)" "unprognostic (3.00e-2)" 22.2 34.8 23.3 27.5 28.0 33.5 22.8 27.7 30.1 17.1 23.7 38.1 21.7 26.6 20.6 20.7 22.4 25.6 27.7 17.8 21.0 16.8 18.2 24.0 27.0 31.5 28.5 25.7 21.5 32.7 21.9 23.7 26.9 25.7 19.0 9.7 17.9 21.4 26.7 20.8 24.5 34.2 15.8 27.8 32.3 25.3 26.7 26.1 33.0 21.1 15.1 24.8 28.8 18.7 15.3 23.2 35.3 21.2 21.4 25.3 17.4 7.8 12.3 5.5 9.9 6.7 8.2 8.3 6.4 8.3 8.3 7.6 7.3 12.8 6.9 13.9 5.8 14.9 3.4 7.5 1.9 9.4 12.6 4.7 5.4 8.4 9.5 9.5 10.5 8.9 6.2 9.4 4.5 8.0 10.9 9.0 7.6 6.9 8.9 9.0 6.1 6.8 7.1 9.6 10.3 5.7 8.8 7.0 7.6 4.8 87.9 15.8 10.3 11.4 7.6 11.7 8.1 12.8 11.9 8.6 10.6 5.5 10.4 10.3 12.0 12.5 21.2 29.3 25.3 19.6 18.5 11.9 18.3 19.0 23.2 15.3 18.4 16.9 35.3 21.4 15.6 10.8 20.4 17.4 23.3 28.0 27.7 30.1 21.0 16.8 28.5 25.7 25.7 26.1 STARD3NL "MENTHO, MGC3251" ENSG00000010270 "STARD3 N-terminal like" O95772 7 38178222-38230671 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019204 Enhanced Supported Vesicles Vesicles "HPA019204: AB_2197800" "unprognostic (1.55e-3)" "unprognostic (2.80e-3)" "unprognostic (2.22e-1)" "unprognostic (2.58e-1)" "unprognostic (4.37e-2)" "prognostic unfavourable (2.20e-4)" "prognostic unfavourable (1.44e-5)" "unprognostic (9.64e-2)" "unprognostic (1.89e-1)" "unprognostic (5.37e-2)" "prognostic favourable (8.48e-4)" "unprognostic (1.07e-1)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" "unprognostic (8.09e-3)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 18.3 15.6 28.9 15.3 26.5 23.4 20.3 16.1 37.7 23.2 14.6 22.5 11.8 12.7 23.3 19.8 9.6 19.4 15.5 18.2 27.9 36.7 23.8 11.8 22.4 15.8 34.6 19.4 17.8 11.1 9.5 19.7 33.7 29.8 29.3 16.7 16.4 10.0 16.1 10.6 4.5 13.7 22.9 33.1 17.6 11.8 21.7 15.3 13.4 23.2 5.9 10.2 17.3 16.0 14.4 21.0 27.0 23.4 34.2 27.8 20.8 12.6 13.5 30.0 19.3 20.7 20.7 10.5 20.7 21.4 20.5 27.0 10.7 20.1 10.0 20.9 18.8 13.7 16.4 15.6 31.1 8.9 14.3 20.1 7.6 14.6 18.3 22.1 23.6 19.4 7.8 21.7 17.3 37.1 22.9 17.4 31.4 7.8 12.4 35.6 21.2 10.8 15.4 27.8 4.6 28.6 11.8 12.0 28.2 7.1 18.8 19.5 13.1 29.2 25.2 14.1 20.1 21.9 29.1 18.6 18.7 3.7 28.5 39.4 45.6 14.4 23.4 27.0 27.8 20.0 12.7 14.4 11.7 20.5 21.0 14.1 9.9 19.4 26.3 34.2 21.5 14.9 11.6 20.8 28.9 26.5 16.1 37.7 27.9 36.7 34.6 19.4 29.8 15.3 STARD5 MGC10327 ENSG00000172345 "StAR related lipid transfer domain containing 5" Q9NSY2 15 81309053-81324183 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 59.6" "Cell line enhanced" "Detected in many" "HMC-1: 7.6;RPMI-8226: 7.6;U-266/70: 9.3;U-937: 8.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 20.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040662 Approved Approved Vesicles,Cytosol Vesicles Cytosol "HPA040662: AB_10959593" "unprognostic (5.35e-4)" "unprognostic (1.55e-1)" "unprognostic (2.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (2.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.08e-2)" "unprognostic (8.08e-2)" "unprognostic (6.81e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (4.84e-3)" "unprognostic (7.55e-3)" 2.8 1.0 1.2 8.6 1.5 5.9 2.7 20.8 3.4 14.3 7.7 1.5 6.6 3.5 7.3 22.3 9.2 4.3 4.4 1.9 1.0 1.1 1.4 59.6 4.3 11.1 1.1 1.0 3.2 1.1 0.6 1.0 9.3 1.2 6.1 5.9 1.5 3.2 6.6 0.9 12.4 7.7 3.6 1.9 10.8 3.3 4.4 1.4 1.7 2.5 10.6 9.8 6.1 7.9 2.1 4.8 6.9 4.6 4.8 7.6 5.6 0.4 0.1 0.1 1.2 2.9 3.1 0.2 0.4 0.4 1.0 1.6 0.1 0.1 6.0 0.0 1.8 5.1 1.4 1.2 0.8 0.1 0.5 2.3 0.3 0.5 0.6 3.4 7.6 2.5 2.5 0.3 0.8 0.1 0.7 1.7 0.6 0.2 0.6 4.9 0.4 0.0 0.1 0.9 7.6 0.4 1.7 0.4 0.1 0.2 0.7 0.7 0.7 0.8 0.2 1.7 0.9 1.7 0.1 9.3 1.9 2.4 1.2 8.6 0.5 6.9 3.0 4.2 5.8 4.6 5.0 2.1 5.4 6.1 4.8 1.6 7.6 7.5 2.4 4.8 4.0 2.5 6.3 5.6 1.2 1.5 20.8 3.4 1.0 1.1 1.1 1.0 1.2 1.4 STEAP2 "IPCA-1, PCANAP1, STAMP1, STMP" ENSG00000157214 "STEAP2 metalloreductase" Q8NFT2 7 90167590-90238137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "prostate: 100.2" "Cell line enhanced" "Detected in many" "A549: 13.2;CAPAN-2: 28.4;U-138 MG: 16.5" "Cancer enriched" "Detected in many" 12 "prostate cancer: 88.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029115, HPA055603" Uncertain Supported Vesicles Vesicles "HPA029115: AB_10603894, HPA055603: " "unprognostic (6.26e-3)" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-4)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (7.91e-2)" "unprognostic (1.70e-1)" "unprognostic (9.92e-2)" "unprognostic (1.34e-1)" "unprognostic (2.71e-2)" "unprognostic (9.73e-2)" "unprognostic (6.11e-2)" "unprognostic (9.86e-5)" "unprognostic (3.69e-2)" 10.7 4.1 6.2 9.7 14.5 1.3 13.6 8.7 18.2 7.0 8.3 2.3 2.2 5.7 5.4 3.6 9.1 7.5 8.8 9.4 5.1 5.2 6.5 3.6 10.8 1.6 3.2 11.1 19.5 6.4 10.3 17.6 1.4 6.0 100.2 7.0 3.8 6.8 6.7 2.3 3.5 5.9 9.0 2.9 3.0 9.2 2.3 1.6 1.6 5.8 1.2 2.5 10.4 19.9 1.1 0.4 1.3 0.4 0.3 0.2 0.0 1.8 13.2 0.3 3.7 7.1 6.9 0.2 1.6 3.4 0.2 0.5 2.4 28.4 0.0 0.2 4.4 1.1 2.9 2.0 0.5 0.0 2.8 0.0 0.0 0.6 0.6 0.0 0.0 5.0 0.4 6.9 1.4 3.6 0.0 0.2 3.9 0.0 0.0 0.4 5.4 1.4 0.0 0.0 0.1 6.2 3.9 0.3 1.3 2.0 0.0 0.0 10.0 0.0 3.0 16.5 3.7 2.3 1.4 0.0 0.0 0.0 7.1 0.0 0.6 1.3 0.4 0.5 0.2 0.2 0.1 1.1 0.1 0.1 0.0 0.4 0.2 0.2 1.2 0.3 0.2 0.4 0.0 0.0 6.2 14.5 8.7 18.2 5.1 5.2 3.2 11.1 6.0 1.6 STK11IP "KIAA1898, LIP1, LKB1IP, STK11IP1" ENSG00000144589 "Serine/threonine kinase 11 interacting protein" 2 219597860-219616451 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 14.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036837, HPA036838, HPA053192" Approved Enhanced Vesicles Vesicles "HPA036837: AB_10969754, HPA036838: AB_10672100, HPA053192: " "unprognostic (3.37e-1)" "unprognostic (1.33e-1)" "unprognostic (3.51e-1)" "unprognostic (1.97e-1)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (1.22e-3)" "unprognostic (8.36e-2)" "unprognostic (9.36e-2)" "unprognostic (1.87e-2)" "prognostic favourable (1.63e-4)" "unprognostic (9.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.80e-3)" "unprognostic (9.44e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" 5.7 8.4 10.1 11.9 10.7 15.2 6.4 15.0 9.5 5.8 8.2 6.7 6.7 8.1 9.2 14.3 8.2 9.1 9.5 6.2 7.0 6.5 7.2 5.6 7.4 11.4 5.1 7.5 17.0 9.9 7.0 21.2 12.1 7.0 8.2 7.2 6.2 5.8 6.3 5.1 16.3 7.9 7.5 5.9 10.6 6.4 27.7 6.4 26.5 8.9 7.1 9.6 5.9 6.3 1.7 14.8 5.0 6.1 3.4 2.7 2.1 6.9 10.8 11.6 7.8 4.1 7.4 11.9 6.2 5.4 10.1 8.6 9.9 11.8 4.0 6.3 5.9 17.3 5.5 13.2 7.5 5.9 8.3 10.4 11.0 8.0 5.4 10.8 27.7 7.1 11.9 8.4 4.3 6.1 7.8 6.1 5.6 13.6 6.3 13.5 11.6 6.0 12.0 4.2 3.1 10.0 11.0 7.6 12.1 4.0 9.9 8.1 6.3 10.6 4.6 11.0 9.3 10.4 6.0 6.8 3.0 7.2 8.3 6.0 6.8 1.5 3.9 5.0 2.7 5.7 2.4 1.7 1.3 2.2 7.6 1.5 1.1 1.1 1.3 3.4 6.1 14.8 2.1 2.1 10.1 10.7 15.0 9.5 7.0 6.5 5.1 7.5 7.0 6.4 STK32B "HSA250839, STK32, STKG6, YANK2" ENSG00000152953 "Serine/threonine kinase 32B" Q9NY57 4 5051442-5500998 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 23.6;lymphoid tissue: 33.6" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 11.5;REH: 10.1;U-2197: 18.5;WM-115: 47.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive B-cell: 1.3;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.3;dendritic cells: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058536 Approved Vesicles,Microtubules Microtubules Vesicles "HPA058536: " "unprognostic (4.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.08e-2)" "unprognostic (1.35e-1)" "unprognostic (8.12e-3)" "unprognostic (9.96e-2)" "unprognostic (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (8.82e-2)" "prognostic favourable (1.63e-8)" "unprognostic (8.10e-3)" "unprognostic (5.04e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-3)" 5.2 0.8 6.0 2.1 4.8 2.3 7.3 1.0 5.8 6.0 2.1 5.2 1.6 1.2 5.7 1.6 2.3 2.5 4.7 0.9 4.5 7.6 23.6 0.5 1.3 2.8 5.3 2.2 1.2 4.9 0.8 0.8 5.1 4.2 2.3 2.2 3.0 2.9 1.9 2.1 3.6 1.6 7.0 3.9 0.6 9.5 7.1 2.9 33.6 2.8 2.1 1.9 4.2 6.1 1.3 3.5 0.0 0.5 0.0 0.0 0.0 0.0 5.7 0.3 0.0 0.2 0.4 0.0 4.0 0.5 2.7 0.1 0.0 0.0 0.0 0.8 8.1 0.0 0.6 0.0 1.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 11.5 0.0 0.0 1.4 0.0 0.0 0.8 1.7 0.0 10.1 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 2.9 0.0 1.1 18.5 0.0 0.4 0.0 0.0 0.0 0.0 47.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.0 4.8 1.0 5.8 4.5 7.6 5.3 2.2 4.2 2.9 STK39 "DCHT, SPAK" ENSG00000198648 "Serine/threonine kinase 39" Q9UEW8 2 167954020-168248141 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 35.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046022, HPA061803, HPA062802" Enhanced Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "CAB046022: AB_2196960, HPA061803: , HPA062802: " "prognostic favourable (3.96e-4)" "unprognostic (2.97e-2)" "unprognostic (4.40e-2)" "unprognostic (4.22e-2)" "unprognostic (4.36e-1)" "unprognostic (6.14e-2)" "prognostic unfavourable (5.67e-5)" "unprognostic (3.04e-2)" "unprognostic (8.86e-2)" "unprognostic (9.43e-2)" "unprognostic (3.20e-2)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (9.45e-2)" "unprognostic (8.61e-3)" "unprognostic (1.14e-1)" "unprognostic (6.20e-3)" 6.2 2.1 8.4 4.6 11.0 1.3 3.5 9.3 14.1 4.3 9.1 8.3 1.7 10.5 2.3 4.7 14.1 1.9 5.9 7.6 9.8 7.4 2.9 0.8 2.4 7.3 12.3 9.7 3.2 9.9 5.0 8.2 1.2 14.2 9.9 11.7 7.1 22.8 3.8 2.2 3.4 6.1 4.3 19.0 2.5 11.2 35.5 5.5 7.2 2.2 1.8 8.0 5.6 5.3 0.7 1.0 0.0 0.7 1.9 3.4 0.5 6.6 4.0 15.2 4.8 9.4 13.8 1.5 16.7 12.3 11.2 10.4 0.0 21.6 18.3 4.6 10.8 17.3 9.7 12.2 14.1 5.8 6.0 7.6 4.4 13.5 17.4 10.2 0.8 9.5 17.3 13.3 13.9 7.6 0.1 0.0 23.4 3.8 17.7 3.6 10.5 8.5 25.4 6.0 1.5 8.4 16.5 22.5 9.5 5.8 0.8 6.8 3.0 7.5 7.1 13.6 4.2 9.6 10.9 0.0 0.0 14.7 10.3 9.1 9.1 0.0 0.7 0.0 2.5 0.4 1.3 0.7 1.9 3.4 1.0 0.7 0.4 2.0 0.0 1.9 0.3 0.3 3.3 0.5 8.4 11.0 9.3 14.1 9.8 7.4 12.3 9.7 14.2 5.5 STMN2 "SCG10, SCGN10" ENSG00000104435 "Stathmin 2" Q93045 8 79610814-79666175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 153.3" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 120.5" "Group enriched" "Detected in many" 5 "glioma: 26.1;pancreatic cancer: 10.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 5.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026922 Approved "Endoplasmic reticulum,Vesicles" Vesicles "Endoplasmic reticulum" "HPA026922: AB_1857605" "unprognostic (4.41e-1)" "unprognostic (3.35e-2)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (8.20e-2)" "unprognostic (9.48e-2)" "unprognostic (1.82e-1)" "unprognostic (6.08e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-13)" "unprognostic (1.14e-1)" "unprognostic (3.86e-1)" "unprognostic (5.77e-3)" "unprognostic (9.59e-2)" 1.7 35.4 35.2 5.6 35.0 1.4 2.5 99.8 153.3 5.3 10.7 4.2 0.0 7.7 1.9 1.3 1.8 1.4 3.0 1.3 40.3 71.9 1.4 1.8 1.5 1.6 44.7 60.4 1.4 3.2 1.4 1.5 1.4 102.4 2.5 14.2 2.6 1.7 2.1 1.3 6.4 9.8 4.3 19.0 3.1 2.4 2.2 6.6 0.0 1.3 0.0 1.9 1.5 0.9 0.0 5.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.4 120.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 5.6 0.0 0.0 35.2 35.0 99.8 68.3 40.3 71.9 44.7 60.4 102.4 6.6 STMN4 RB3 ENSG00000015592 "Stathmin 4" Q9H169 8 27235323-27258420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 132.2" "Cell line enriched" "Detected in some" 26 "SCLC-21H: 44.0" "Cancer enriched" "Detected in some" 27 "glioma: 14.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027765 Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA027765: AB_1857607" "unprognostic (1.52e-1)" "unprognostic (3.45e-2)" "unprognostic (2.37e-2)" "unprognostic (3.19e-6)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (8.27e-2)" "unprognostic (1.37e-1)" "unprognostic (3.57e-3)" "unprognostic (2.36e-1)" "unprognostic (2.31e-3)" "unprognostic (9.84e-2)" "unprognostic (1.68e-3)" "unprognostic (1.37e-2)" "unprognostic (5.96e-2)" "unprognostic (4.15e-1)" "unprognostic (7.63e-2)" 1.5 7.9 30.8 1.5 23.4 1.5 1.5 22.2 132.2 1.5 2.3 37.3 0.0 1.8 1.5 2.0 1.5 1.5 1.6 1.4 36.3 27.9 1.5 1.4 1.5 1.5 34.9 37.2 1.4 1.4 1.5 0.0 1.4 21.4 1.5 2.3 0.0 1.5 1.5 1.4 1.5 2.2 1.8 71.8 1.4 1.5 1.6 6.6 0.0 1.4 0.0 1.4 1.5 0.0 1.0 0.9 0.3 0.2 0.1 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.7 0.0 0.1 0.3 0.2 0.4 0.1 1.0 0.7 0.2 0.3 0.1 0.2 0.9 0.4 0.0 30.8 23.4 22.2 34.4 36.3 27.9 34.9 37.2 21.4 6.6 STOM "BND7, EPB7, EPB72" ENSG00000148175 Stomatin P27105 9 121338988-121370304 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 104.0;hTCEpi: 85.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010961, HPA011419" Approved Enhanced "Vesicles,Plasma membrane,Cytosol" 140000000 "Plasma membrane" "Vesicles, Cytosol" "HPA010961: AB_1080111, HPA011419: AB_1080109" "unprognostic (1.11e-1)" "unprognostic (2.15e-2)" "unprognostic (5.27e-2)" "unprognostic (7.93e-2)" "unprognostic (5.68e-3)" "unprognostic (1.65e-2)" "unprognostic (9.20e-3)" "unprognostic (7.86e-2)" "unprognostic (1.76e-1)" "unprognostic (3.59e-2)" "unprognostic (3.32e-1)" "unprognostic (1.26e-1)" "unprognostic (5.23e-2)" "unprognostic (9.15e-3)" "unprognostic (2.27e-2)" "unprognostic (7.82e-2)" "unprognostic (2.99e-2)" 96.0 27.5 29.3 29.7 41.6 89.2 78.6 15.0 19.4 28.7 46.4 23.2 14.6 14.4 35.7 26.7 34.9 28.2 45.2 46.4 27.2 18.5 35.4 114.4 66.0 40.2 24.2 15.1 31.5 11.8 21.0 11.3 77.0 28.1 36.8 16.7 27.7 23.0 28.3 50.6 25.4 25.0 50.4 37.8 48.3 34.5 17.4 23.3 4.4 29.6 25.1 16.1 56.6 51.8 1.4 8.6 5.2 13.2 33.2 43.4 25.8 1.4 9.7 0.8 4.4 104.0 29.9 0.0 25.9 25.7 7.3 11.5 1.2 1.9 11.8 6.4 32.2 2.5 5.4 24.0 13.0 7.2 2.2 27.4 21.3 3.7 56.4 10.1 5.8 49.5 85.0 11.4 15.2 26.0 5.9 15.8 15.8 7.7 0.3 7.7 11.8 3.0 1.4 0.0 25.6 5.7 0.2 1.0 0.1 21.6 19.2 11.1 6.5 8.4 33.0 16.9 5.3 16.8 2.4 6.7 7.3 0.7 6.5 10.2 9.0 3.4 8.5 0.9 43.4 13.2 42.8 1.4 22.0 38.9 8.6 1.1 4.1 22.0 5.2 33.2 9.0 1.5 2.0 25.8 29.3 41.6 15.0 19.4 27.2 18.5 24.2 15.1 28.1 23.3 STPG3 "C9orf173, FLJ40246" ENSG00000197768 "Sperm-tail PG-rich repeat containing 3" Q8N7X2 9 137251261-137253483 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 55.3" "Cell line enhanced" "Detected in some" "HDLM-2: 7.1;RPMI-8226: 3.0;SK-BR-3: 2.9;T-47d: 4.5;U-266/70: 2.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044352 Uncertain Vesicles Vesicles "HPA044352: AB_10965328" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (4.32e-3)" "unprognostic (4.72e-4)" "unprognostic (2.56e-1)" "unprognostic (1.22e-2)" "unprognostic (1.08e-2)" "unprognostic (2.77e-3)" "unprognostic (1.29e-1)" "unprognostic (3.93e-2)" "unprognostic (8.59e-4)" "unprognostic (2.09e-1)" "unprognostic (7.25e-2)" "unprognostic (2.65e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (7.95e-2)" 0.8 0.4 0.2 0.2 0.2 0.1 0.4 0.2 0.2 0.3 0.2 0.2 0.2 4.4 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.0 1.1 1.7 0.2 0.2 0.2 0.2 0.2 1.4 0.0 1.1 0.2 0.2 0.2 0.0 0.2 1.5 0.2 0.2 0.5 3.2 0.2 0.2 0.2 0.5 55.3 0.2 0.2 1.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.9 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.6 2.0 1.2 0.3 0.0 1.0 0.0 0.0 0.0 7.1 0.0 0.1 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 1.3 1.1 0.0 1.7 0.0 0.2 0.0 0.4 0.0 0.0 3.0 0.0 0.0 0.9 0.6 0.4 2.9 0.0 4.5 0.0 0.0 0.8 1.4 0.2 0.0 2.8 1.5 1.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 STT3A "ITM1, MGC9042, STT3-A, TMC" ENSG00000134910 "STT3A, catalytic subunit of the oligosaccharyltransferase complex" P46977 11 125591712-125625215 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 202.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030735 Approved Uncertain Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA030735: AB_10603342" "unprognostic (8.25e-3)" "unprognostic (5.45e-2)" "unprognostic (3.02e-2)" "prognostic favourable (1.32e-4)" "unprognostic (5.10e-2)" "unprognostic (1.72e-2)" "prognostic unfavourable (3.57e-4)" "unprognostic (8.40e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-2)" "unprognostic (8.96e-3)" "unprognostic (1.31e-1)" "prognostic unfavourable (4.96e-4)" "unprognostic (2.60e-2)" "unprognostic (6.38e-2)" "unprognostic (1.28e-1)" "unprognostic (1.82e-2)" 20.6 20.5 8.3 13.1 11.7 8.3 16.9 10.7 13.9 27.8 19.3 17.7 39.6 12.0 30.5 41.4 19.6 20.8 15.1 19.5 8.3 9.1 26.2 67.1 18.7 14.9 9.3 7.7 30.1 59.0 202.3 27.5 35.9 11.6 22.2 17.4 20.8 50.7 41.4 9.5 12.9 19.8 17.1 12.3 21.8 17.7 17.1 6.7 19.2 38.6 13.6 20.8 19.5 18.0 15.0 53.2 27.0 15.5 17.2 27.5 13.4 20.7 18.9 24.2 33.2 45.6 35.4 26.0 38.0 45.4 31.0 38.8 57.5 56.2 27.1 46.2 55.9 38.4 33.5 33.3 41.2 21.1 17.8 63.8 13.1 39.7 50.5 38.1 29.9 27.3 24.2 42.8 83.7 34.5 26.8 40.6 39.0 15.3 15.3 12.2 15.5 20.6 18.2 20.6 40.7 33.8 32.3 15.1 13.0 26.9 44.0 13.5 51.5 27.5 30.8 44.6 16.1 18.8 29.8 12.8 14.9 20.9 17.2 38.6 35.4 27.0 15.5 11.6 19.7 14.8 27.5 15.0 19.1 18.2 21.6 11.6 13.8 16.0 5.4 17.2 13.0 53.2 14.1 13.4 8.3 11.7 10.7 13.9 8.3 9.1 9.3 7.7 11.6 6.7 STX12 "STX13, STX14" ENSG00000117758 "Syntaxin 12" Q86Y82 1 27773183-27824452 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041038, HPA055300" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA041038: AB_10794261, HPA055300: " "unprognostic (3.47e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-1)" "unprognostic (8.16e-3)" "unprognostic (2.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.26e-2)" "unprognostic (3.52e-1)" "unprognostic (1.14e-2)" "unprognostic (2.78e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-1)" "unprognostic (1.91e-2)" "unprognostic (8.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "unprognostic (2.24e-1)" 38.5 20.2 32.2 16.3 29.6 6.3 22.9 25.8 35.9 20.3 19.4 27.3 23.5 22.9 20.4 42.1 25.7 15.0 25.9 15.3 31.2 31.9 23.2 18.5 31.2 16.3 35.5 29.0 15.2 19.5 16.7 19.6 21.1 32.3 20.8 21.4 11.6 17.7 22.2 14.2 17.1 20.9 23.1 36.9 20.0 38.7 9.0 19.9 6.3 67.0 11.0 13.9 19.4 14.8 7.6 14.2 10.1 21.7 5.2 6.4 8.3 8.6 4.2 11.3 7.3 21.5 26.2 5.8 18.3 27.1 16.9 19.2 5.1 11.3 9.5 19.8 24.5 7.3 7.4 9.1 17.0 8.3 8.8 5.4 4.6 5.1 16.9 5.9 11.3 24.5 11.2 23.7 13.6 27.1 7.0 9.5 18.4 3.1 5.1 4.5 4.7 5.9 3.2 9.0 5.7 14.9 14.3 12.7 6.9 8.6 7.4 13.2 5.1 5.3 29.1 8.6 4.9 19.5 6.3 5.7 4.1 5.4 14.0 9.1 12.0 10.1 19.6 7.5 3.7 21.7 6.4 7.6 4.4 5.7 14.2 6.5 4.9 4.1 9.3 5.2 21.0 7.0 4.4 8.3 32.2 29.6 25.8 31.8 31.2 31.9 35.5 29.0 32.3 19.9 STX16 "hsyn16, SYN16" ENSG00000124222 "Syntaxin 16" O14662 20 58651253-58679526 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA041019, HPA042033" Uncertain Enhanced Vesicles Vesicles "HPA041019: AB_10964273, HPA042033: AB_10963935" "unprognostic (7.52e-2)" "unprognostic (1.91e-1)" "unprognostic (7.96e-2)" "unprognostic (1.35e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "prognostic unfavourable (4.18e-4)" "unprognostic (7.32e-2)" "unprognostic (5.11e-2)" "unprognostic (3.51e-2)" "unprognostic (2.80e-3)" "unprognostic (2.41e-2)" "prognostic unfavourable (1.11e-16)" "unprognostic (3.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.56e-1)" "unprognostic (5.89e-2)" 22.1 24.5 41.9 25.3 46.7 36.7 22.3 54.5 43.2 21.9 23.3 35.0 35.9 20.3 30.3 36.9 18.8 26.7 23.4 17.3 36.8 22.4 18.6 20.0 20.5 32.8 43.0 32.8 29.2 23.1 18.5 33.0 20.5 34.0 24.6 21.1 20.9 27.9 28.5 25.9 41.5 23.6 29.4 33.0 31.0 21.7 22.2 42.9 16.6 23.7 15.7 24.7 24.2 24.3 4.7 4.3 14.1 6.2 5.6 6.1 4.0 14.4 8.5 11.2 10.9 20.7 22.1 15.6 18.0 12.2 18.5 11.5 16.5 21.2 16.7 25.2 12.8 21.5 10.2 21.4 15.4 7.8 10.8 10.4 22.3 19.9 20.6 14.8 23.6 24.5 32.9 12.4 18.9 18.6 12.0 14.9 14.9 33.8 11.4 17.9 4.5 14.5 10.6 10.5 11.4 14.1 10.8 7.4 11.3 19.0 33.6 32.3 13.4 19.7 19.7 30.6 14.8 11.6 19.7 30.9 14.3 9.3 22.5 11.5 12.7 14.1 6.2 5.2 5.0 5.6 5.6 2.6 4.5 3.5 4.1 4.7 6.1 5.5 14.0 5.6 4.1 4.3 4.8 4.0 41.9 46.7 54.5 43.2 36.8 22.4 43.0 32.8 34.0 42.9 SULT2B1 HSST2 ENSG00000088002 "Sulfotransferase family 2B member 1" O00204 19 48552075-48599425 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6" "Cell line enhanced" "Detected in some" "A549: 7.1;CAPAN-2: 34.1;MCF7: 20.9;T-47d: 17.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB033013, HPA041724, HPA043539" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "CAB033013: AB_661450, HPA041724: AB_2677638, HPA043539: AB_2678540" "unprognostic (6.55e-2)" "unprognostic (1.47e-1)" "unprognostic (5.28e-3)" "unprognostic (8.74e-2)" "unprognostic (5.00e-2)" "unprognostic (5.97e-2)" "unprognostic (4.43e-2)" "unprognostic (3.29e-3)" "unprognostic (1.62e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-2)" "unprognostic (4.42e-2)" "unprognostic (5.01e-6)" "unprognostic (7.96e-3)" "unprognostic (1.32e-1)" "unprognostic (8.04e-2)" "unprognostic (2.77e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 4.0 0.1 0.2 28.7 0.8 0.0 9.2 2.9 2.2 5.2 91.8 0.3 2.3 0.0 0.1 0.1 2.5 0.1 6.5 0.0 0.2 0.0 0.1 0.2 0.8 0.1 11.4 0.0 6.9 0.0 0.0 12.4 6.9 0.2 45.7 13.4 0.0 0.1 0.0 0.7 0.2 0.0 0.5 1.1 79.6 78.6 0.6 32.0 0.7 1.5 2.5 1.0 1.1 3.1 0.9 5.6 7.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 34.1 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.2 0.0 0.0 3.1 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 20.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 2.9 0.1 17.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.5 0.8 0.4 2.1 0.9 3.1 0.4 1.8 1.4 0.7 0.7 0.6 1.2 1.4 1.1 1.0 1.5 1.1 0.9 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 SUMF2 DKFZp566I1024 ENSG00000129103 "Sulfatase modifying factor 2" Q8NBJ7 7 56064002-56080670 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024040, CAB025743, HPA074892" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" 730000 "Vesicles, Plasma membrane" "CAB025743: , HPA024040: AB_1857651, HPA074892: " "unprognostic (2.93e-1)" "prognostic unfavourable (6.58e-6)" "unprognostic (2.42e-2)" "prognostic favourable (3.96e-4)" "unprognostic (3.87e-2)" "unprognostic (9.11e-3)" "unprognostic (1.69e-2)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.20e-2)" "unprognostic (1.92e-1)" "unprognostic (7.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.74e-2)" "unprognostic (2.64e-1)" "unprognostic (1.99e-3)" "prognostic unfavourable (7.71e-4)" 26.8 38.3 13.0 17.7 17.0 15.4 26.2 10.9 28.2 35.0 31.9 24.8 35.4 31.1 32.2 32.3 23.8 37.8 51.2 16.8 12.8 11.6 36.0 40.4 30.2 25.9 19.8 18.0 28.6 91.0 34.7 18.3 37.5 20.7 29.5 25.0 25.0 39.7 37.1 14.0 23.6 35.1 27.2 19.6 27.0 32.9 16.2 17.6 29.8 33.3 15.1 25.1 29.1 23.1 21.0 43.1 17.1 28.5 15.7 33.4 28.5 63.9 19.4 8.4 39.1 41.8 28.9 13.1 21.0 29.4 17.7 22.0 10.5 52.0 10.1 18.2 30.0 32.5 5.1 24.3 11.8 16.4 8.1 6.5 12.7 9.8 27.1 15.7 20.7 22.9 23.8 15.9 27.7 26.0 20.4 45.1 28.4 14.1 13.4 18.5 11.6 9.9 10.8 8.6 64.5 24.1 7.1 10.0 12.2 26.3 55.8 25.7 55.9 26.3 21.4 16.4 23.5 40.1 17.9 30.7 23.3 15.0 26.9 29.9 52.3 17.1 21.0 7.5 26.2 27.4 33.4 21.0 25.6 26.2 24.8 18.7 28.5 27.7 1.3 15.7 28.5 43.1 26.8 28.5 13.0 17.0 10.9 28.2 12.8 11.6 19.8 18.0 20.7 17.6 SUSD4 FLJ10052 ENSG00000143502 "Sushi domain containing 4" Q5VX71 1 223220819-223364202 "Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.0;esophagus: 33.8" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;RPTEC TERT1: 8.3;SCLC-21H: 28.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 7.4;naive CD4 T-cell: 11.7" "Lineage enriched" "Detected in single" 66 "T-cells: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058296 Uncertain Approved Vesicles "Intracellular and membrane" Vesicles "HPA058296: " "unprognostic (2.90e-1)" "unprognostic (2.90e-3)" "unprognostic (1.27e-3)" "prognostic unfavourable (4.28e-4)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (7.53e-3)" "unprognostic (1.82e-3)" "unprognostic (7.94e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-3)" "unprognostic (1.36e-1)" "unprognostic (6.51e-6)" "unprognostic (3.64e-2)" "unprognostic (5.11e-2)" "unprognostic (3.03e-1)" "unprognostic (7.11e-2)" 0.8 5.2 15.9 1.5 33.0 0.9 8.1 9.9 21.3 3.4 0.9 4.0 4.7 1.5 0.9 24.3 33.8 3.6 1.3 9.6 30.6 14.6 13.7 4.0 3.2 1.9 6.8 12.8 27.8 7.6 8.3 16.5 1.0 6.6 4.4 0.8 1.2 13.2 5.7 1.2 3.5 0.9 0.9 2.4 0.8 7.6 5.1 3.8 0.3 1.5 8.1 13.8 2.7 9.1 0.0 0.0 0.0 0.1 0.1 11.7 1.8 4.2 0.4 0.1 0.0 0.0 0.0 0.1 0.5 0.2 0.7 0.5 4.4 1.3 0.0 1.4 0.1 7.0 0.2 1.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.4 0.0 0.3 3.2 3.0 0.0 0.1 0.8 0.0 0.1 0.0 8.3 1.9 28.5 0.3 0.0 2.3 0.0 1.8 0.2 0.0 1.2 5.1 0.0 2.5 0.5 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.1 6.0 0.0 7.4 1.9 0.0 0.0 11.7 2.1 0.0 0.1 0.0 0.0 1.0 1.8 15.9 33.0 9.9 17.9 30.6 14.6 6.8 12.8 6.6 3.8 SUSD5 KIAA0527 ENSG00000173705 "Sushi domain containing 5" O60279 3 33150042-33219215 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 14.5;HUVEC TERT2: 36.0;LHCN-M2: 13.9;TIME: 14.2" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.9;neutrophil: 1.5" "Group enriched" "Detected in many" 9 "B-cells: 1.9;granulocytes: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052788 Uncertain Uncertain "Golgi apparatus,Vesicles" 4300000 "Golgi apparatus, Vesicles" "HPA052788: " "unprognostic (1.81e-1)" "unprognostic (1.52e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-3)" "unprognostic (1.39e-3)" "unprognostic (4.05e-2)" "unprognostic (3.72e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-3)" "unprognostic (6.45e-2)" "unprognostic (8.46e-2)" "unprognostic (1.89e-2)" 7.6 2.5 7.0 1.5 6.1 0.4 2.5 2.0 13.2 11.0 2.6 4.6 2.3 1.5 7.0 6.5 2.3 7.9 13.1 5.7 6.4 8.1 2.6 1.1 3.0 4.4 6.9 6.9 6.4 1.2 1.0 1.3 0.5 6.3 1.9 2.2 3.7 1.3 10.7 2.2 2.8 2.7 7.7 4.6 3.9 3.3 4.7 3.3 0.0 5.3 2.9 8.1 3.0 3.5 1.9 0.1 1.5 0.1 0.1 0.1 0.1 0.0 0.5 0.6 0.3 0.8 0.1 0.0 4.4 1.5 14.5 4.9 0.0 0.0 0.0 4.1 1.1 0.0 6.3 2.0 6.0 0.1 7.0 0.0 1.0 0.0 0.1 0.0 0.0 0.6 1.1 9.3 1.8 36.0 0.0 0.0 13.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 1.1 0.8 0.8 14.2 0.0 6.9 0.5 2.1 0.0 0.3 0.0 0.1 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.9 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.1 7.0 6.1 2.0 13.2 6.4 8.1 6.9 6.9 6.3 3.3 SV2C ENSG00000122012 "Synaptic vesicle glycoprotein 2C" Q496J9 5 76083172-76353939 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 52.2" "Group enriched" "Detected in some" 5 "Karpas-707: 11.9;SCLC-21H: 4.9;SH-SY5Y: 11.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 52.2;pons and medulla: 26.6" "Cell type enriched" "Detected in single" 14 "basophil: 4.2" "Lineage enriched" "Detected in single" 21 "granulocytes: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040722, HPA040770" Supported Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA040722: AB_10795624, HPA040770: AB_10805828" "unprognostic (7.91e-2)" "unprognostic (2.33e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-2)" "unprognostic (1.07e-1)" "unprognostic (9.93e-2)" "unprognostic (1.09e-2)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (2.34e-2)" "unprognostic (1.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" 0.5 5.5 0.8 1.3 52.2 0.7 1.2 1.2 9.5 0.7 0.8 0.5 0.0 1.0 0.7 0.9 0.6 1.8 0.6 0.8 0.6 8.3 0.4 0.4 0.4 0.5 5.6 1.9 2.6 0.8 0.9 0.8 0.4 26.6 1.0 1.1 1.1 1.7 1.2 0.3 0.7 1.3 1.0 5.8 0.6 1.6 1.0 6.7 0.0 0.5 0.0 0.4 0.6 0.4 0.1 0.1 4.2 0.2 0.1 0.2 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.3 4.9 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.2 0.8 52.2 1.2 9.5 0.6 8.3 5.6 1.9 26.6 6.7 SYBU "FLJ20366, GOLSYN, KIAA1472, OCSYN, SNPHL" ENSG00000147642 Syntabulin Q9NX95 8 109573978-109691791 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 82.7" "Cell line enhanced" "Detected in many" "HaCaT: 13.2;PC-3: 14.9;SK-BR-3: 30.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "memory B-cell: 9.4;naive B-cell: 4.4" "Lineage enriched" "Detected in single" 29 "B-cells: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053057 Uncertain Supported Vesicles Vesicles "HPA053057: " "unprognostic (4.69e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-1)" "prognostic favourable (7.74e-4)" "unprognostic (1.22e-2)" "unprognostic (1.37e-1)" "unprognostic (2.16e-1)" "unprognostic (3.13e-1)" "unprognostic (5.52e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-1)" "unprognostic (6.05e-3)" "unprognostic (6.89e-2)" "unprognostic (4.27e-2)" 17.6 19.7 18.2 2.5 25.5 0.8 13.3 36.8 31.3 7.7 8.7 4.0 11.5 7.1 3.4 7.9 4.1 12.8 6.9 2.6 15.2 23.0 3.3 26.6 5.2 3.1 13.5 17.9 5.5 82.7 1.6 12.4 2.1 14.7 5.1 12.5 3.5 12.6 10.0 2.5 5.3 7.4 5.1 7.2 1.2 8.7 1.7 5.1 0.3 7.6 1.1 5.1 2.9 3.8 9.4 0.1 0.0 0.0 0.0 0.3 0.1 5.1 2.6 2.1 0.0 0.3 0.3 1.4 1.8 0.0 0.0 0.0 4.6 3.1 0.4 0.3 1.4 13.2 0.4 3.5 0.0 0.0 7.1 0.0 7.8 4.6 3.4 0.0 0.0 1.2 4.5 0.0 4.3 1.9 0.2 0.9 2.0 0.1 0.1 0.0 0.4 14.9 0.0 0.0 0.0 5.7 1.2 10.0 1.1 4.7 30.4 1.0 3.8 0.2 2.7 0.1 1.1 0.0 0.8 0.8 0.0 0.3 6.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 9.4 0.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 18.2 25.5 36.8 31.3 15.2 23.0 13.5 17.9 14.7 5.1 SYCE1 "bA108K14.6, C10orf94, CT76" ENSG00000171772 "Synaptonemal complex central element protein 1" Q8N0S2 10 133553901-133569835 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 75.4" "Group enriched" "Detected in some" 8 "K-562: 17.0;U-2 OS: 15.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040208 Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA040208: AB_10796450" "unprognostic (5.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-2)" "unprognostic (1.61e-1)" "unprognostic (3.20e-1)" "unprognostic (5.75e-1)" "unprognostic (5.38e-2)" "unprognostic (3.36e-1)" "unprognostic (2.22e-2)" "unprognostic (7.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" 1.8 1.8 4.9 0.7 5.4 0.3 1.3 8.1 8.2 0.4 0.7 0.9 0.0 0.4 0.8 0.5 0.6 1.4 1.6 0.7 4.0 3.3 0.9 3.9 0.5 1.1 1.5 6.7 1.1 1.5 0.2 0.3 8.6 3.5 1.8 0.6 0.2 0.4 0.6 0.9 0.3 0.5 0.7 1.7 0.8 0.5 75.4 0.0 0.1 1.4 0.1 0.7 0.4 0.0 1.3 2.0 0.3 2.6 0.2 3.2 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.7 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.1 0.0 0.5 0.3 0.3 1.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.2 0.1 0.1 0.1 15.8 0.2 0.3 0.2 0.3 0.4 0.0 0.1 0.0 0.0 1.7 0.3 3.2 1.8 3.0 0.9 2.4 0.8 1.2 1.3 1.4 2.7 0.0 0.2 2.6 2.0 2.2 1.8 4.9 5.4 8.1 8.2 4.0 3.3 1.5 6.7 3.5 0.0 SYK ENSG00000165025 "Spleen associated tyrosine kinase" P43405 9 90801787-90898549 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.5" "Cell line enhanced" "Detected in many" "Daudi: 38.7;HEL: 22.3;HL-60: 30.8;HMC-1: 20.5;REH: 25.8;THP-1: 23.7;U-698: 18.3;U-937: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001384, CAB007773" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" 1000000 "Plasma membrane, Cytosol" Vesicles "CAB007773: AB_562232, HPA001384: AB_1080144" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.69e-2)" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (6.41e-2)" "unprognostic (1.78e-2)" "unprognostic (7.20e-2)" "unprognostic (9.93e-2)" "unprognostic (2.55e-3)" "unprognostic (8.77e-2)" "unprognostic (5.36e-3)" "unprognostic (3.41e-2)" "unprognostic (1.06e-2)" 7.2 3.3 6.0 38.1 9.6 18.2 6.7 1.1 4.5 3.7 10.3 6.7 1.5 12.3 2.3 6.7 16.2 6.9 6.6 5.5 7.2 3.2 8.6 2.5 13.7 36.4 9.1 2.5 2.1 8.9 25.9 3.1 5.0 6.1 4.1 8.3 2.8 8.9 1.8 1.4 8.3 22.2 3.5 11.3 38.5 7.4 5.5 7.9 30.5 18.1 7.8 32.2 8.6 7.5 23.1 24.9 32.8 21.4 8.7 0.1 10.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 38.7 1.1 0.0 6.0 0.8 3.2 0.0 0.0 5.3 22.3 0.0 0.0 0.0 30.8 20.5 0.0 4.4 0.0 0.4 0.0 0.6 3.1 0.0 4.7 0.0 13.5 0.2 0.0 25.8 0.0 10.6 0.8 5.8 2.0 1.8 0.0 2.7 0.0 2.5 23.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.3 0.0 21.7 0.0 1.4 21.4 23.3 0.1 19.0 0.1 23.1 0.0 0.0 24.9 17.5 0.0 0.0 32.8 8.7 16.4 18.5 0.0 10.2 6.0 9.6 1.1 4.5 7.2 3.2 9.1 2.5 6.1 7.9 SYNC "SYNC1, SYNCOILIN" ENSG00000162520 "Syncoilin, intermediate filament protein" Q9H7C4 1 32680360-32703596 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 51.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 26.8;fHDF/TERT166: 38.9;U-138 MG: 34.1;U-2197: 18.1;WM-115: 22.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 5 "monocytes: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028311 Approved Approved "Golgi apparatus,Vesicles,Plasma membrane" "Plasma membrane" "Golgi apparatus, Vesicles" "HPA028311: " "unprognostic (3.99e-1)" "unprognostic (6.04e-3)" "unprognostic (2.02e-2)" "unprognostic (7.60e-3)" "unprognostic (1.99e-2)" "unprognostic (5.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.44e-3)" "unprognostic (1.71e-1)" "unprognostic (1.79e-2)" "unprognostic (5.04e-2)" "unprognostic (3.71e-1)" "unprognostic (1.32e-4)" "unprognostic (1.56e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (8.15e-4)" 4.2 3.2 3.7 5.8 3.9 0.1 6.8 1.1 4.2 5.9 7.2 3.7 1.2 1.5 7.7 7.7 15.6 5.3 4.8 7.9 3.5 3.9 1.4 1.1 4.6 0.6 3.6 2.6 7.9 0.9 2.7 2.8 1.1 3.5 6.1 4.8 4.6 4.1 8.4 51.0 1.6 4.0 28.5 4.5 1.9 6.5 5.4 1.9 0.0 1.9 23.6 2.3 7.8 2.5 0.0 0.3 0.0 1.8 0.0 0.3 0.0 0.0 1.3 0.1 0.0 6.5 10.2 0.0 10.5 26.8 9.1 6.6 0.1 0.1 0.0 0.5 38.9 0.4 0.3 0.2 5.5 0.0 0.0 0.2 4.4 0.9 5.2 0.0 0.0 15.7 0.9 10.1 0.3 2.9 0.0 0.0 7.8 0.0 0.0 0.0 0.1 0.9 0.0 2.0 0.0 10.6 0.0 0.1 0.1 10.6 2.2 0.0 0.6 0.0 1.7 34.1 1.5 18.1 2.7 0.0 0.0 0.0 9.6 0.1 22.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 3.7 3.9 1.1 4.2 3.5 3.9 3.6 2.6 3.5 1.9 SYNDIG1 "C20orf39, FLJ14220, IFITMD5, SynDIG1, TMEM90B" ENSG00000101463 "Synapse differentiation inducing 1" Q9H7V2 20 24469199-24666616 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.3;heart muscle: 28.2" "Cell line enhanced" "Detected in some" "Karpas-707: 8.0;RH-30: 22.8;RPMI-8226: 21.6;SCLC-21H: 5.3;U-87 MG: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044271, HPA059267" Enhanced Vesicles Vesicles "HPA044271: , HPA059267: " "unprognostic (9.33e-2)" "unprognostic (1.83e-2)" "unprognostic (2.17e-1)" "unprognostic (9.56e-2)" "unprognostic (5.03e-2)" "unprognostic (1.27e-1)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (1.62e-1)" "unprognostic (4.69e-2)" "unprognostic (4.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.94e-2)" "unprognostic (7.75e-3)" "unprognostic (2.21e-1)" "prognostic unfavourable (6.16e-6)" "unprognostic (1.40e-3)" 2.6 1.7 12.5 2.1 12.0 0.7 0.8 21.3 22.7 4.5 1.5 23.3 0.3 1.9 2.6 1.5 0.9 5.1 10.0 28.2 12.8 8.8 6.2 0.7 1.1 2.5 14.5 12.9 1.3 1.4 0.9 0.6 0.9 11.5 3.2 1.6 0.5 0.8 14.8 0.6 0.8 2.8 3.1 22.4 1.4 2.2 1.3 16.6 0.1 5.1 0.0 3.1 2.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 22.8 21.6 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 12.0 21.3 19.7 12.8 8.8 14.5 12.9 11.5 16.6 SYNPO2 MYOPODIN ENSG00000172403 "Synaptopodin 2" Q9UMS6 4 118850688-119061247 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 185.8" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 25.8;LHCN-M2: 9.2;SH-SY5Y: 39.3" "Cancer enhanced" "Detected in all" "stomach cancer: 27.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 5 "thalamus: 64.1" "Low region specificity" "Detected in all" "HPA030665, CAB037231, HPA049707, HPA068563" Enhanced Enhanced "Vesicles,Actin filaments" "Vesicles, Actin filaments" "CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: , HPA068563: " "unprognostic (1.50e-2)" "unprognostic (1.73e-2)" "unprognostic (5.32e-2)" "unprognostic (1.50e-2)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (5.71e-4)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (3.52e-1)" "unprognostic (1.39e-1)" "unprognostic (1.66e-1)" "prognostic unfavourable (5.67e-5)" "unprognostic (1.82e-2)" "unprognostic (1.35e-2)" "unprognostic (1.26e-1)" "prognostic unfavourable (3.91e-4)" 11.4 2.3 1.8 9.6 3.9 0.0 7.3 1.0 5.6 26.5 56.0 4.4 20.5 6.5 37.5 23.9 37.0 14.2 19.4 29.0 2.6 1.5 2.4 1.7 3.7 5.7 1.9 5.2 27.9 1.4 0.9 2.6 3.8 3.8 35.9 11.1 21.2 4.1 58.8 185.8 3.7 14.5 88.7 4.0 6.1 29.5 9.6 3.1 3.0 3.7 12.8 2.1 50.7 15.5 1.8 0.2 2.0 0.4 1.2 2.3 0.4 0.1 1.8 0.1 0.0 5.5 1.8 0.3 5.7 6.3 0.2 0.2 0.0 0.3 0.6 0.0 25.8 0.1 0.1 0.1 0.3 2.4 0.0 0.3 0.4 0.0 1.3 0.0 0.1 6.6 0.1 1.8 0.1 0.0 0.0 0.3 9.2 0.1 0.3 3.5 0.6 0.0 0.2 0.6 0.1 0.1 0.1 0.2 39.3 0.2 0.1 0.0 0.0 3.3 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.0 1.9 0.3 2.0 1.2 0.1 1.9 1.3 2.0 1.2 0.1 1.8 2.1 1.3 0.9 1.2 0.4 0.2 2.3 0.4 1.8 3.9 1.0 5.6 2.6 1.5 1.9 5.2 3.8 3.1 SYT10 ENSG00000110975 "Synaptotagmin 10" Q6XYQ8 12 33374238-33439819 "Predicted membrane proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;fallopian tube: 8.1" "Cell line enhanced" "Detected in some" "AF22: 3.7;K-562: 2.2;MCF7: 7.5;NTERA-2: 1.9;RPTEC TERT1: 1.9;RT4: 3.0;SCLC-21H: 3.9" "Cancer enriched" "Detected in single" 5 "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA055426 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA055426: " "unprognostic (3.60e-1)" "unprognostic (4.93e-2)" "unprognostic (9.34e-4)" "unprognostic (5.53e-2)" "unprognostic (3.67e-1)" "unprognostic (4.74e-3)" "unprognostic (3.19e-1)" "unprognostic (1.97e-6)" "unprognostic (4.00e-1)" "unprognostic (2.39e-1)" "unprognostic (2.41e-1)" "unprognostic (1.91e-1)" 0.3 1.5 0.6 0.7 10.1 0.1 0.3 0.2 4.1 2.9 3.6 0.9 3.0 1.0 0.3 0.8 0.3 8.1 0.4 0.5 0.8 3.1 3.3 1.4 0.2 0.1 0.6 3.4 0.4 0.2 0.1 5.8 0.2 14.6 1.6 1.6 0.1 1.8 3.2 0.2 0.2 1.3 0.6 2.7 0.2 1.6 0.6 0.3 0.0 0.2 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 7.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.9 3.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.1 0.2 4.1 0.8 3.1 0.6 3.4 14.6 0.3 SYT13 KIAA1427 ENSG00000019505 "Synaptotagmin 13" Q7L8C5 11 45240301-45286319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.1;gallbladder: 18.8" "Cell line enhanced" "Detected in some" "A549: 11.2;NTERA-2: 5.2;RPTEC TERT1: 34.3;SCLC-21H: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046224, HPA056602" Uncertain Supported Vesicles Vesicles "HPA046224: AB_10961288, HPA056602: " "unprognostic (4.96e-2)" "unprognostic (1.06e-2)" "unprognostic (9.92e-2)" "prognostic unfavourable (7.79e-5)" "unprognostic (1.00e-2)" "unprognostic (4.17e-2)" "unprognostic (3.75e-2)" "unprognostic (9.83e-3)" "unprognostic (2.19e-1)" "unprognostic (7.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.47e-1)" "unprognostic (5.66e-3)" "unprognostic (2.94e-2)" "unprognostic (1.76e-1)" "unprognostic (8.70e-2)" "unprognostic (5.13e-2)" 0.4 4.5 15.8 1.5 15.1 0.4 0.5 19.0 38.1 0.3 10.6 1.2 0.0 10.9 0.6 0.3 0.4 0.5 18.8 4.5 11.8 19.5 8.0 0.6 0.8 0.4 10.6 15.1 0.4 6.4 0.4 9.4 0.4 27.9 2.0 11.2 0.9 1.4 0.4 0.5 0.5 11.1 1.1 2.2 0.5 9.2 1.8 0.3 0.0 1.8 0.0 0.3 0.4 0.2 0.2 0.0 1.4 0.0 0.2 0.2 0.0 0.0 11.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 5.2 0.1 0.0 0.0 0.0 34.3 0.0 9.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.9 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.0 15.8 15.1 19.0 31.1 11.8 19.5 10.6 15.1 27.9 0.3 SYT14 "FLJ34198, sytXIV" ENSG00000143469 "Synaptotagmin 14" Q8NB59 1 209938174-210171389 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.4;pituitary gland: 31.1;testis: 9.5;thyroid gland: 15.9" "Cell line enhanced" "Detected in some" "BJ hTERT+: 13.1;SCLC-21H: 6.8;TIME: 10.9;U-138 MG: 8.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036963 Supported Vesicles Vesicles "HPA036963: AB_10670378" "unprognostic (1.38e-4)" "unprognostic (8.62e-3)" "unprognostic (1.93e-1)" "unprognostic (3.90e-4)" "unprognostic (1.97e-1)" "unprognostic (4.43e-5)" "unprognostic (1.92e-1)" "unprognostic (1.88e-2)" "unprognostic (6.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.81e-1)" "unprognostic (4.85e-3)" "unprognostic (2.30e-4)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (3.33e-3)" 0.7 3.2 5.9 0.8 7.4 0.8 0.6 17.4 10.2 0.6 0.7 3.8 0.0 0.7 1.4 0.8 0.6 0.6 0.6 0.6 4.5 2.6 0.9 0.6 0.7 0.7 3.3 5.9 0.8 1.2 0.6 31.1 0.6 5.0 0.8 0.8 1.1 0.6 0.6 0.7 0.7 0.7 0.7 2.4 0.7 0.9 9.5 3.0 0.0 15.9 0.0 0.6 0.6 0.4 2.0 0.8 2.1 0.5 1.1 0.8 0.1 3.3 0.1 0.0 0.0 0.3 0.0 0.0 2.7 13.1 2.8 1.5 0.0 0.2 0.0 0.1 0.3 4.2 0.0 0.0 3.3 0.6 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 1.9 5.8 0.5 0.0 0.0 5.0 0.0 0.0 0.0 4.5 1.8 0.0 0.1 0.1 0.2 3.0 6.8 3.1 0.0 0.0 5.6 0.0 0.1 10.9 8.3 4.0 0.7 1.4 0.1 0.1 0.0 0.7 0.0 1.9 2.1 0.4 0.6 0.8 0.2 0.4 0.6 0.5 0.4 0.3 2.0 0.4 0.6 1.8 1.1 0.5 0.8 0.4 0.1 5.9 7.4 17.4 10.2 4.5 2.6 3.3 5.9 5.0 3.0 SYT4 "HsT1192, KIAA1342" ENSG00000132872 "Synaptotagmin 4" Q9H2B2 18 43267878-43277650 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.8;pituitary gland: 31.5" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 72.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010574 Approved Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA010574: AB_2668309" "unprognostic (2.91e-3)" "unprognostic (2.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (7.67e-3)" "unprognostic (5.30e-3)" "unprognostic (3.95e-2)" "unprognostic (1.23e-3)" "unprognostic (3.61e-1)" "unprognostic (3.80e-2)" 1.4 17.5 5.7 2.2 24.1 1.0 0.9 60.8 54.6 0.9 1.7 0.9 0.0 1.7 0.9 0.9 1.0 0.9 1.0 1.4 12.9 19.9 1.0 0.9 1.8 1.0 5.9 16.0 1.3 4.7 0.9 31.5 1.0 22.3 1.5 1.7 0.4 1.0 9.8 0.9 1.0 1.7 1.5 5.0 0.9 4.6 2.4 1.4 0.0 1.3 0.0 0.9 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 72.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 24.1 60.8 35.7 12.9 19.9 5.9 16.0 22.3 1.4 SYT6 ENSG00000134207 "Synaptotagmin 6" Q5T7P8 1 114089291-114153919 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.9;kidney: 3.7;pancreas: 11.1" "Group enriched" "Detected in some" 7 "NTERA-2: 20.6;WM-115: 14.6" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basal ganglia: 27.9;olfactory region: 87.2" "Low region specificity" "Detected in many" HPA058362 Approved Vesicles Vesicles "HPA058362: " "unprognostic (7.12e-2)" "unprognostic (2.03e-2)" "unprognostic (3.26e-3)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (2.49e-1)" "unprognostic (4.11e-2)" "unprognostic (3.60e-3)" "unprognostic (1.19e-1)" "unprognostic (4.71e-1)" "unprognostic (5.50e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-1)" "unprognostic (2.11e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-2)" "unprognostic (1.18e-1)" 0.3 2.2 2.6 0.8 6.5 0.3 2.1 0.2 10.4 0.4 0.3 5.1 0.0 0.9 0.4 0.2 0.2 0.3 0.5 0.3 2.3 14.9 3.7 0.3 0.4 0.3 2.8 1.3 2.3 11.1 0.7 0.3 1.4 3.9 1.5 0.6 0.9 1.1 0.2 0.4 0.4 0.5 0.3 4.2 0.3 0.3 0.9 3.3 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.1 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.6 6.5 0.2 9.3 2.3 14.9 2.8 1.3 3.9 3.3 SYTL3 "exophilin-6, SLP3" ENSG00000164674 "Synaptotagmin like 3" Q4VX76 6 158650014-158764876 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 55.6" "Cell line enhanced" "Detected in many" "HMC-1: 16.4;U-138 MG: 12.5;U-2 OS: 13.6;U-266/70: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "basophil: 55.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 55.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA030584, HPA030585, HPA030586" Approved Approved "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center, Vesicles" "HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226" "unprognostic (3.56e-3)" "prognostic favourable (8.84e-5)" "unprognostic (6.37e-2)" "unprognostic (1.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.42e-1)" "unprognostic (7.76e-2)" "unprognostic (5.45e-3)" "unprognostic (9.33e-3)" "unprognostic (1.75e-1)" "unprognostic (3.07e-1)" "unprognostic (5.63e-2)" "unprognostic (8.58e-3)" "unprognostic (1.55e-1)" "unprognostic (6.28e-2)" "unprognostic (2.80e-2)" "unprognostic (1.83e-1)" 8.3 1.5 2.3 9.0 3.7 9.4 3.8 0.8 2.4 5.1 7.4 7.1 0.6 2.9 4.6 5.5 3.6 11.6 7.3 5.3 3.4 2.0 4.7 2.2 20.2 26.7 3.5 1.3 2.5 2.3 0.9 2.1 1.3 5.5 5.3 1.8 4.8 12.4 4.8 11.4 3.0 12.0 3.5 10.4 21.9 5.8 3.2 3.9 2.3 21.7 1.2 24.5 18.8 3.6 0.2 1.3 55.6 4.5 10.9 10.2 4.4 4.8 0.7 0.0 0.3 0.7 0.7 0.2 1.9 1.3 0.5 1.4 0.4 3.9 0.0 0.4 3.4 0.5 0.1 0.6 1.9 9.5 0.2 3.7 0.1 0.0 1.2 1.0 16.4 2.2 1.4 4.1 0.7 0.9 0.2 3.7 4.9 0.2 0.1 1.3 0.1 0.7 0.0 4.0 0.4 1.9 0.2 10.9 0.8 0.7 6.9 0.5 1.3 0.2 5.7 12.5 13.6 0.3 0.4 19.2 4.3 0.4 8.1 5.3 0.4 55.6 4.5 0.2 10.2 0.8 6.0 0.2 4.1 6.8 1.3 0.0 4.5 5.5 9.2 10.9 0.3 0.3 4.1 4.4 2.3 3.7 0.8 2.4 3.4 2.0 3.5 1.3 5.5 3.9 SYTL4 ENSG00000102362 "Synaptotagmin like 4" Q96C24 X 100674491-100732123 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 36.2;ovary: 47.3;pituitary gland: 41.9" "Cell line enhanced" "Detected in many" "HAP1: 14.9;HMC-1: 30.9;RT4: 20.3;TIME: 17.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 5.1" "Lineage enriched" "Detected in single" 9 "granulocytes: 5.1" "Region enriched" "Detected in single" 5 "hypothalamus: 35.1" "Not detected" "Not detected" "HPA001475, HPA001589, HPA075138" Approved Approved Vesicles 6100000 Vesicles "HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: " "unprognostic (7.82e-3)" "unprognostic (1.52e-1)" "unprognostic (3.43e-2)" "unprognostic (6.16e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (5.78e-2)" "unprognostic (1.32e-1)" "unprognostic (3.35e-2)" "unprognostic (2.81e-1)" "unprognostic (1.07e-3)" "unprognostic (5.62e-2)" "prognostic unfavourable (2.09e-4)" "unprognostic (1.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.60e-2)" 3.8 3.1 9.1 2.8 9.5 1.6 4.4 4.3 8.4 18.1 5.3 6.6 4.8 1.7 36.2 5.4 2.6 10.0 2.9 2.1 11.9 6.0 4.2 7.1 3.0 0.7 9.8 2.7 47.3 8.8 1.3 41.9 2.6 9.4 9.2 6.8 1.3 3.8 6.0 4.5 1.4 3.0 22.5 7.8 2.3 5.3 7.8 9.5 0.0 6.2 1.1 1.4 4.3 9.4 0.5 0.3 5.1 0.3 0.5 0.4 2.3 0.1 3.0 0.8 0.0 4.4 2.5 0.0 3.8 2.5 4.1 7.4 0.3 3.8 0.0 1.0 2.7 3.4 14.9 1.3 4.4 0.0 1.3 0.0 5.1 0.2 1.1 0.0 30.9 0.9 0.3 3.7 0.2 10.4 1.4 0.0 1.9 1.0 0.0 0.0 0.6 0.0 0.0 1.2 0.0 3.7 20.3 7.5 0.3 1.5 5.9 0.8 3.6 0.3 17.5 2.1 4.7 10.7 0.9 0.0 0.0 0.0 2.7 0.0 2.4 1.1 0.3 0.5 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.5 0.4 0.2 5.1 0.5 0.2 0.3 0.1 2.3 9.1 9.5 4.3 8.4 11.9 6.0 9.8 2.7 9.4 9.5 SZT2 "C1orf84, FLJ10387, FLJ34502, KIAA0467, RP11-506B15.1, SZT2A, SZT2B" ENSG00000198198 "SZT2, KICSTOR complex subunit" Q5T011 1 43389882-43454247 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029012 Approved Approved "Nucleoplasm,Vesicles,Actin filaments" "Nucleoplasm, Vesicles, Actin filaments" "HPA029012: AB_10600817" "unprognostic (1.35e-1)" "unprognostic (2.55e-1)" "unprognostic (4.14e-1)" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "prognostic favourable (1.47e-7)" "prognostic unfavourable (2.53e-4)" "prognostic favourable (6.20e-4)" "unprognostic (1.54e-1)" "unprognostic (1.81e-2)" "unprognostic (5.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (1.84e-3)" "unprognostic (8.28e-2)" "unprognostic (7.19e-2)" "unprognostic (2.61e-2)" 10.0 8.4 9.0 15.9 12.8 13.5 10.3 16.1 12.9 10.2 10.2 21.7 12.8 8.8 13.7 8.3 9.4 11.3 8.2 8.6 8.7 6.8 7.9 6.1 10.3 11.1 12.4 9.1 14.9 10.8 23.6 16.1 8.1 10.9 10.9 8.9 13.5 11.4 11.6 10.9 17.4 11.6 12.1 9.9 11.0 10.0 12.2 11.1 13.9 16.3 5.9 12.6 12.3 9.6 1.8 3.0 4.9 1.8 1.3 3.0 1.2 6.2 5.9 5.9 5.3 15.2 9.1 8.3 4.8 6.9 6.7 6.6 2.0 7.7 5.8 6.4 8.5 7.6 5.0 8.9 5.1 7.4 4.9 10.5 11.2 3.6 6.0 8.4 8.6 8.1 7.1 11.0 10.2 7.3 4.7 9.2 5.0 3.1 5.7 2.9 4.9 6.4 7.3 6.4 7.8 4.2 7.9 5.7 5.3 9.6 8.9 6.6 5.3 12.9 9.5 7.3 9.2 10.1 8.4 9.6 3.8 4.7 7.6 5.8 5.3 3.8 1.8 4.9 1.5 1.5 3.0 1.4 0.8 0.8 1.5 1.8 1.7 1.3 3.7 1.3 1.7 3.0 1.7 1.2 9.0 12.8 16.1 12.9 8.7 6.8 12.4 9.1 10.9 11.1 TAC3 "NKB, NKNB, ZNEUROK1" ENSG00000166863 "Tachykinin 3" Q9UHF0 12 57010000-57028883 "Disease related genes, Predicted secreted proteins" Neuropeptide "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 133.5" "Cell line enriched" "Detected in some" 5 "K-562: 17.2" "Cancer enriched" "Detected in many" 7 "urothelial cancer: 40.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045919 Supported Supported Approved Vesicles "Secreted in female reproductive system" Vesicles "HPA045919: AB_10960533" "unprognostic (4.53e-2)" "unprognostic (1.97e-2)" "unprognostic (8.41e-2)" "unprognostic (3.00e-2)" "unprognostic (3.61e-2)" "unprognostic (1.76e-2)" "unprognostic (5.99e-2)" "unprognostic (8.41e-2)" "unprognostic (1.34e-1)" "unprognostic (2.03e-1)" "unprognostic (5.28e-2)" "unprognostic (4.71e-14)" "unprognostic (1.58e-2)" "unprognostic (1.76e-1)" "unprognostic (1.01e-1)" "unprognostic (2.39e-1)" 0.5 0.6 3.9 1.5 20.0 0.8 0.5 0.0 11.0 0.5 1.2 0.1 0.0 1.5 0.6 0.5 0.5 0.5 0.6 0.5 4.4 9.5 0.5 0.5 0.5 0.5 0.8 2.1 0.5 0.7 0.5 0.0 133.5 1.5 0.5 1.0 0.3 0.5 0.5 0.5 0.7 3.2 2.0 9.4 0.5 8.1 0.8 0.2 0.0 0.5 0.0 0.6 2.2 0.5 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.5 0.0 0.0 1.6 0.0 1.3 0.4 0.0 3.4 0.0 1.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.3 0.0 0.0 17.2 0.4 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.0 1.7 2.9 0.8 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.9 20.0 0.0 11.0 4.4 9.5 0.8 2.1 1.5 0.2 TACC3 ERIC1 ENSG00000013810 "Transforming acidic coiled-coil containing protein 3" Q9Y6A5 4 1721490-1745176 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 54.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005781, HPA006050, CAB010111, HPA022039" Enhanced Enhanced "Vesicles,Mitotic spindle,Centriolar satellite,Cytosol" "Mitotic spindle, Centriolar satellite, Cytosol" Vesicles "CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: , HPA022039: AB_1857725" "unprognostic (2.95e-1)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (4.35e-2)" "unprognostic (6.58e-2)" "unprognostic (1.84e-2)" "prognostic unfavourable (3.30e-4)" "unprognostic (1.10e-3)" "unprognostic (4.61e-2)" "unprognostic (9.12e-2)" "unprognostic (2.91e-2)" "unprognostic (2.26e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (4.66e-2)" "unprognostic (2.09e-1)" "unprognostic (4.44e-3)" "unprognostic (9.75e-2)" 3.8 2.7 1.1 39.1 1.1 26.0 3.4 2.1 1.4 1.9 4.4 1.1 0.8 4.5 1.8 2.7 8.8 1.6 3.5 2.0 1.4 1.3 2.5 2.4 4.3 20.1 1.3 0.7 1.6 1.0 0.5 1.8 5.7 1.1 1.6 4.9 1.6 3.0 1.2 2.0 2.6 7.7 2.5 1.8 15.6 3.4 58.1 0.9 64.3 1.6 7.3 27.9 3.2 3.0 4.0 10.4 54.8 19.9 3.8 17.9 16.1 25.2 21.0 32.2 18.5 1.7 3.6 18.2 28.6 15.3 32.9 21.8 23.2 30.5 32.2 12.2 15.6 17.1 34.0 20.8 33.5 14.1 18.4 27.3 17.4 21.4 1.6 36.9 23.2 1.5 1.4 20.7 12.0 24.9 24.6 25.5 31.2 20.6 48.6 52.8 34.8 27.6 34.4 22.8 12.9 18.7 38.2 25.1 15.8 17.2 10.9 8.0 21.4 21.4 14.6 19.2 23.0 17.3 43.1 17.9 23.6 51.6 11.1 35.7 27.1 24.7 19.9 17.9 5.5 9.0 6.0 4.0 12.3 7.6 10.4 3.8 17.9 9.8 54.8 3.8 5.5 3.1 17.5 16.1 1.1 1.1 2.1 1.4 1.4 1.3 1.3 0.7 1.1 0.9 TACSTD2 "EGP-1, GA733-1, M1S1, TROP2" ENSG00000184292 "Tumor associated calcium signal transducer 2" P09758 1 58575423-58577773 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Tumor antigen" "Amyloidosis, Corneal dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.9;salivary gland: 56.4" "Cell line enhanced" "Detected in some" "A-431: 74.1;CAPAN-2: 100.5;HaCaT: 100.7;RT4: 34.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 12.4" "Group enriched" "Detected in many" 65 "dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043104, HPA055067, CAB072852" Enhanced Supported "Nucleoli,Vesicles,Plasma membrane" "Plasma membrane" "Nucleoli, Vesicles" "CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687" "unprognostic (1.80e-2)" "unprognostic (3.08e-1)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (5.70e-2)" "unprognostic (2.15e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (7.91e-2)" "prognostic favourable (3.99e-4)" "unprognostic (7.10e-2)" "unprognostic (2.55e-1)" "unprognostic (6.91e-3)" "unprognostic (2.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.7 17.1 0.0 0.0 23.1 0.0 0.0 1.7 2.6 103.9 2.7 0.9 0.0 0.0 0.0 10.4 0.0 8.0 0.0 0.0 0.0 9.0 0.0 0.0 1.5 15.7 0.0 56.4 12.6 0.0 42.1 0.0 0.0 0.0 0.0 7.3 0.0 0.1 20.6 17.7 36.1 0.0 3.7 12.4 3.2 0.0 0.0 1.8 74.1 0.0 0.0 0.1 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 100.5 0.0 9.7 6.3 100.7 0.0 18.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 1.1 4.2 0.0 0.1 0.0 15.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 13.5 34.8 0.0 0.0 3.2 26.8 0.1 17.5 0.1 4.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 12.4 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.8 TAOK1 "FLJ14314, KIAA1361, MAP3K16, MARKK, PSK2, TAO1" ENSG00000160551 "TAO kinase 1" Q7L7X3 17 29390464-29551904 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007669 Approved Approved Vesicles 13000 Vesicles "HPA007669: AB_1080201" "unprognostic (1.46e-1)" "unprognostic (7.15e-3)" "unprognostic (2.70e-2)" "unprognostic (1.52e-1)" "unprognostic (1.81e-2)" "unprognostic (4.85e-2)" "unprognostic (1.28e-2)" "unprognostic (4.31e-2)" "unprognostic (1.15e-1)" "unprognostic (6.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.36e-1)" "unprognostic (2.85e-2)" "unprognostic (5.53e-3)" "unprognostic (3.57e-1)" "unprognostic (1.66e-1)" "unprognostic (2.62e-1)" 17.2 11.5 19.1 11.9 25.0 12.7 13.3 20.1 24.4 15.8 11.9 22.2 7.9 7.1 14.9 10.8 12.7 11.0 11.6 15.3 18.7 15.5 13.6 10.6 13.2 11.1 30.0 17.6 13.5 9.3 31.7 13.7 14.3 21.8 12.0 10.7 10.9 11.1 13.3 15.0 13.8 9.8 17.7 21.0 13.0 10.8 14.3 23.5 11.7 17.7 6.0 11.2 14.5 17.1 2.4 4.8 5.5 2.1 1.4 3.0 0.9 13.6 24.3 19.2 8.2 14.3 18.1 8.1 12.9 13.8 11.9 12.5 13.1 4.8 8.5 12.7 21.0 10.7 17.5 8.9 21.4 17.6 12.9 13.5 14.1 7.0 10.4 14.9 12.5 11.9 11.5 17.5 18.0 16.2 13.8 7.7 15.5 9.1 11.7 5.5 8.1 6.2 10.9 27.1 5.9 11.2 19.7 10.6 13.0 22.2 20.8 13.4 15.0 13.8 23.5 18.2 14.8 15.9 18.0 7.1 15.3 9.8 13.3 9.4 16.4 1.7 1.9 1.5 2.0 2.1 1.6 1.6 2.0 2.4 1.7 2.4 3.0 2.2 5.5 1.4 1.9 4.8 1.2 0.9 19.1 25.0 20.1 22.7 18.7 15.5 30.0 17.6 21.8 23.5 TAPT1 FLJ90013 ENSG00000169762 "Transmembrane anterior posterior transformation 1" Q6NXT6 4 16160505-16227410 "Disease related genes, Predicted membrane proteins" "Chondrogenesis, Cilium biogenesis/degradation, Differentiation, Host-virus interaction, Osteogenesis" "Developmental protein, Receptor" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042567, HPA048658" Approved Approved Vesicles Vesicles "HPA042567: , HPA048658: " "unprognostic (2.34e-1)" "unprognostic (5.84e-2)" "unprognostic (1.41e-2)" "prognostic favourable (9.75e-4)" "unprognostic (2.43e-1)" "unprognostic (2.56e-2)" "unprognostic (2.32e-3)" "unprognostic (3.15e-3)" "unprognostic (1.54e-1)" "unprognostic (6.30e-2)" "prognostic favourable (5.34e-4)" "unprognostic (7.07e-2)" "prognostic favourable (8.52e-4)" "unprognostic (9.00e-2)" "unprognostic (8.52e-2)" "unprognostic (7.25e-3)" "prognostic favourable (4.18e-4)" 10.2 19.2 18.6 7.4 18.0 26.2 13.1 15.0 17.3 10.2 10.1 20.2 8.2 8.3 15.1 12.2 8.2 10.7 10.8 14.4 17.5 13.5 15.8 35.9 14.7 11.0 20.1 10.8 10.8 9.8 14.4 14.5 17.2 13.5 10.2 10.7 11.3 9.4 11.0 38.0 9.8 12.8 12.0 18.5 11.2 9.2 13.1 19.1 15.3 17.8 7.8 9.9 10.1 16.8 6.5 1.8 2.6 0.7 0.9 2.4 0.7 2.9 2.2 3.7 4.3 5.7 4.3 1.6 4.9 3.7 4.6 5.1 2.9 5.2 19.2 5.3 3.0 2.4 3.2 2.4 5.9 1.7 3.9 3.7 3.2 3.1 5.4 7.4 3.9 2.7 4.8 4.5 3.3 2.3 5.7 9.0 4.4 2.1 11.0 6.1 2.4 5.2 27.0 5.3 3.4 7.5 3.1 6.3 5.0 4.5 3.9 5.6 7.1 7.4 4.3 3.9 2.6 2.6 6.2 8.8 7.2 14.6 7.9 18.8 4.5 2.6 0.7 0.2 0.6 0.6 0.2 2.1 1.8 1.0 1.1 6.5 2.4 1.7 1.6 0.9 0.7 1.8 1.3 0.7 18.6 18.0 15.0 16.2 17.5 13.5 20.1 10.8 13.5 19.1 TAX1BP3 TIP-1 ENSG00000213977 "Tax1 binding protein 3" O14907 17 3662896-3668682 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046410, HPA063078" Approved Approved "Nucleoli fibrillar center,Vesicles,Actin filaments" "Nucleoli fibrillar center, Actin filaments" Vesicles "HPA046410: , HPA063078: " "unprognostic (6.15e-2)" "unprognostic (6.46e-3)" "unprognostic (3.37e-1)" "unprognostic (1.32e-1)" "prognostic unfavourable (2.17e-4)" "unprognostic (1.68e-1)" "unprognostic (1.12e-3)" "prognostic unfavourable (1.76e-4)" "unprognostic (1.80e-2)" "unprognostic (5.45e-3)" "unprognostic (5.19e-2)" "unprognostic (2.87e-1)" "prognostic unfavourable (7.90e-4)" "unprognostic (5.12e-2)" "unprognostic (2.10e-1)" "unprognostic (2.10e-3)" "unprognostic (1.92e-1)" 26.0 34.1 14.1 15.8 17.7 4.6 24.3 5.4 16.7 55.5 41.2 30.6 37.6 33.9 34.9 26.5 62.4 22.7 42.5 55.8 16.0 8.5 35.8 27.0 23.9 11.4 28.3 15.8 27.0 21.0 4.7 8.3 34.3 16.0 24.7 24.6 13.7 29.5 52.0 12.3 35.8 71.9 22.7 18.3 14.5 42.6 23.8 23.0 22.6 19.2 43.0 23.3 29.1 40.8 7.9 41.6 44.7 19.4 4.9 9.1 12.6 28.7 51.5 11.3 6.3 37.0 29.9 13.4 36.1 30.1 38.7 22.8 21.7 23.4 3.0 26.4 46.5 45.9 6.3 33.2 15.1 8.1 10.6 4.1 12.9 16.9 32.3 0.6 6.3 45.1 53.1 23.9 11.4 43.4 1.5 2.3 45.5 26.7 8.1 2.3 10.8 18.4 8.0 6.9 2.6 40.4 22.9 2.4 7.2 44.6 19.1 6.1 20.5 3.7 43.4 32.6 12.5 25.6 36.5 0.9 0.4 0.8 19.6 4.7 31.1 44.7 16.9 29.1 7.3 19.4 6.0 7.9 6.8 7.1 14.9 6.5 4.9 6.3 18.8 4.9 17.3 41.6 9.1 12.6 14.1 17.7 5.4 16.7 16.0 8.5 28.3 15.8 16.0 23.0 TBC1D14 KIAA1322 ENSG00000132405 "TBC1 domain family member 14" Q9P2M4 4 6909242-7033118 "Plasma proteins, Predicted intracellular proteins" Autophagy "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036930, HPA067398" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA036930: AB_10670155, HPA067398: " "unprognostic (3.05e-2)" "unprognostic (7.48e-3)" "unprognostic (4.80e-3)" "unprognostic (8.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.78e-3)" "unprognostic (9.63e-2)" "unprognostic (5.25e-2)" "unprognostic (9.71e-2)" "unprognostic (7.65e-2)" "unprognostic (1.80e-1)" "unprognostic (2.90e-1)" "prognostic favourable (5.28e-10)" "unprognostic (1.56e-1)" "unprognostic (3.50e-1)" "unprognostic (5.13e-3)" "unprognostic (4.12e-2)" 20.0 31.2 31.9 24.4 33.8 10.6 22.0 18.1 32.8 16.0 20.2 22.5 17.0 17.3 16.2 21.9 24.3 18.8 15.0 22.9 28.6 27.5 32.1 21.6 20.7 48.4 28.8 20.5 23.3 19.3 23.6 20.7 18.0 29.0 19.6 20.7 26.1 23.2 16.7 35.1 37.3 20.0 17.8 37.3 26.2 35.8 22.4 29.3 24.0 14.9 17.9 19.9 16.7 15.4 5.3 7.5 26.4 8.2 5.5 8.9 6.0 10.3 11.3 12.7 14.2 10.6 8.9 7.7 8.3 9.1 7.8 6.7 11.7 21.7 16.7 4.9 9.9 7.5 21.3 19.1 9.6 4.6 6.9 27.9 7.4 12.2 7.3 12.6 62.9 6.8 27.1 7.4 12.2 7.3 26.4 6.0 9.4 6.7 19.3 12.8 17.2 12.7 24.3 16.8 18.0 11.6 7.3 19.5 13.9 6.9 7.5 25.6 10.4 12.0 7.3 8.6 6.5 7.5 12.2 11.6 26.8 17.1 8.1 16.2 8.3 1.7 8.2 3.5 5.9 5.3 8.9 5.2 6.4 6.3 6.9 5.3 4.9 4.5 26.4 5.5 2.4 7.5 7.5 6.0 31.9 33.8 18.1 28.0 28.6 27.5 28.8 20.5 29.0 29.3 TBC1D22A C22orf4 ENSG00000054611 "TBC1 domain family member 22A" Q8WUA7 22 46762617-47175699 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001173 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA001173: AB_1080212" "unprognostic (1.62e-1)" "unprognostic (5.90e-3)" "unprognostic (1.10e-1)" "unprognostic (4.79e-3)" "unprognostic (3.65e-2)" "unprognostic (7.07e-2)" "prognostic unfavourable (2.42e-4)" "unprognostic (5.95e-2)" "unprognostic (8.17e-2)" "prognostic unfavourable (6.94e-4)" "unprognostic (1.69e-1)" "unprognostic (9.17e-2)" "unprognostic (4.68e-2)" "unprognostic (4.93e-2)" "unprognostic (4.14e-1)" "unprognostic (1.09e-1)" "unprognostic (2.39e-1)" 18.1 17.6 18.3 36.5 16.0 14.0 16.4 10.8 18.5 14.6 23.1 22.4 16.5 22.8 20.6 17.8 24.8 19.6 22.1 15.1 16.1 15.4 18.1 14.8 18.5 26.6 17.3 17.0 16.1 20.5 18.8 15.9 23.2 16.9 12.5 15.3 17.0 23.5 15.5 23.7 22.6 26.3 13.0 18.4 27.2 22.8 14.2 18.2 21.1 17.8 16.5 36.3 16.5 17.3 11.7 10.8 13.2 15.0 4.4 8.6 5.6 13.2 9.2 5.9 7.1 8.6 12.1 7.2 9.1 12.4 10.4 11.3 10.4 10.4 11.6 10.2 13.8 14.7 5.0 14.2 7.3 5.0 14.1 6.6 8.1 19.9 13.2 14.3 5.3 14.1 16.7 7.1 10.0 17.0 4.2 12.5 9.4 6.8 6.3 7.4 5.8 10.5 8.2 6.9 12.5 12.0 6.9 4.8 9.0 8.3 3.2 14.1 7.6 9.5 13.7 8.0 11.5 8.4 5.7 8.4 2.6 7.4 19.8 7.4 4.9 2.1 9.0 5.3 5.9 13.0 5.7 10.8 5.5 5.5 10.8 11.7 3.6 4.0 13.2 4.4 15.0 5.3 8.6 5.6 18.3 16.0 10.8 18.5 16.1 15.4 17.3 17.0 16.9 18.2 TBC1D3 "DKFZp434P2235, PRC17, TBC1D3A" ENSG00000274611 "TBC1 domain family member 3" Q8IZP1 17 38181659-38192541 "Predicted membrane proteins" "GTPase activation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 3.4;intestine: 5.5;lymphoid tissue: 3.5;testis: 5.5" "Cell line enhanced" "Detected in some" "AF22: 9.0;REH: 5.6;U-138 MG: 7.8;U-266/70: 12.1;U-266/84: 4.7;U-698: 6.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 3.4 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.9 1.9 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 5.5 0.0 3.5 0.0 0.0 0.0 2.2 0.0 0.0 0.9 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.6 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 12.1 4.7 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 TBC1D3B "PRC17, TBC1D3I" ENSG00000274808 "TBC1 domain family member 3B" A6NDS4 17 36165681-36176636 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 6.6;testis: 3.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.3;HeLa: 9.7;T-47d: 7.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.94e-2)" "unprognostic (1.49e-1)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.11e-1)" "unprognostic (2.83e-1)" "unprognostic (2.51e-1)" "unprognostic (1.17e-1)" "unprognostic (7.15e-2)" "unprognostic (9.96e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (3.56e-1)" "unprognostic (1.34e-1)" 0.0 0.1 1.0 0.4 0.4 0.1 0.0 0.1 1.2 0.0 0.0 1.0 0.4 0.2 0.0 0.0 0.0 0.2 0.6 0.1 1.3 0.0 0.0 0.2 0.0 0.8 0.8 1.2 6.6 0.5 0.0 2.0 1.9 3.5 0.0 0.1 0.4 0.0 0.0 0.7 0.0 1.0 0.4 0.1 1.4 2.4 1.4 1.8 1.5 1.8 4.8 1.2 0.7 1.3 2.1 0.5 11.3 0.2 0.9 0.7 4.9 0.7 1.1 0.5 2.0 3.8 0.8 9.7 0.7 0.9 0.3 1.4 1.5 2.2 1.5 0.2 0.9 0.7 1.1 0.4 0.1 1.0 4.3 0.5 0.5 1.5 0.4 0.1 1.5 1.4 0.9 1.3 1.1 0.7 0.9 7.9 1.0 2.7 0.5 0.4 3.9 0.5 1.6 1.2 0.5 1.4 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.1 TBC1D3C MGC44903 ENSG00000278299 "TBC1 domain family member 3C" Q6IPX1 17 38057693-38068592 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.3;skin 1: 3.5;testis: 3.4" "Cell line enriched" "Detected in some" 5 "CAPAN-2: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.5 1.2 0.5 0.1 0.0 1.8 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.3 3.5 0.0 0.1 0.0 1.5 3.4 0.0 0.9 0.0 0.0 0.0 0.8 0.3 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 5.2 0.1 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.5 0.2 0.0 1.0 0.0 0.0 5.4 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 TBC1D3D ENSG00000274419 "TBC1 domain family member 3D" A0A087WVF3 17 38003976-38014902 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 7.9;skin 1: 4.2" "Cell line enhanced" "Detected in some" "AF22: 3.8;CAPAN-2: 11.3;HaCaT: 8.2;HeLa: 9.2;RPMI-8226: 4.9;RT4: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.8 1.5 0.8 0.0 0.0 0.8 4.2 7.9 0.0 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.0 0.7 0.2 0.0 0.3 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 2.1 9.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 4.9 0.0 5.5 0.5 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 2.9 1.0 0.0 3.4 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 TBC1D3E ENSG00000278599 "TBC1 domain family member 3E" A0A087X179 17 38127951-38138862 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.9;gallbladder: 3.0;pancreas: 4.3;testis: 4.1" "Cell line enriched" "Detected in some" 4 "HHSteC: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " "unprognostic (1.18e-1)" "unprognostic (3.35e-1)" "unprognostic (3.51e-1)" "unprognostic (4.22e-2)" "unprognostic (6.28e-2)" "unprognostic (1.87e-2)" "unprognostic (5.07e-3)" "unprognostic (1.32e-3)" 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.7 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 9.5 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 TBC1D3F ENSG00000275954 "TBC1 domain family member 3F" 17 36428618-36439566 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 4.8" "Cell line enhanced" "Detected in single" "HL-60: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046969 Uncertain Vesicles Vesicles "HPA046969: " 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 TBC1D3G ENSG00000260287 "TBC1 domain family member 3G" Q6DHY5 17 36323884-36334759 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 8.7" "Group enriched" "Detected in some" 35 "SiHa: 5.4;U-2197: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Supported Approved Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (5.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 TBC1D3H ENSG00000274226 "TBC1 domain family member 3H" P0C7X1 17 36377531-36388423 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "cervix, uterine: 1.6;testis: 5.0;urinary bladder: 3.3" "Cell line enriched" "Detected in some" 10 "CAPAN-2: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Approved Approved Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 TBC1D3I ENSG00000274933 "TBC1 domain family member 3I" A0A087WXS9 17 36253456-36264553 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "skin 1: 1.3;testis: 3.0" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.2 0.0 0.9 0.5 0.0 1.3 0.9 0.0 0.3 0.1 3.0 0.0 0.1 0.2 0.1 0.2 0.7 0.2 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.6 0.0 0.1 0.1 0.2 0.1 10.9 0.1 0.6 0.0 1.6 0.0 0.1 0.0 0.1 0.7 0.7 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.2 0.1 0.9 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.7 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.7 0.0 TBC1D3K ENSG00000273513 "TBC1 domain family member 3K" A0A087X1G2 17 37924415-37935365 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.3;skeletal muscle: 1.1;testis: 4.2" "Group enriched" "Detected in some" 5 "SiHa: 2.2;T-47d: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3L ENSG00000274512 "TBC1 domain family member 3L" B9A6J9 17 37977972-37989048 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 10.8" "Cell line enhanced" "Detected in many" "BEWO: 23.9;NB-4: 22.1" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in many" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " "unprognostic (5.14e-2)" "unprognostic (8.71e-2)" "unprognostic (8.44e-2)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (6.34e-2)" "unprognostic (3.19e-1)" "unprognostic (9.50e-2)" "unprognostic (1.76e-1)" "unprognostic (1.04e-1)" "unprognostic (1.80e-2)" "unprognostic (6.63e-6)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (1.28e-3)" 0.5 2.4 1.8 0.6 1.8 1.3 0.2 1.2 2.4 0.0 2.9 2.4 1.2 0.8 0.0 0.0 0.6 1.0 1.8 0.5 0.3 0.1 0.3 1.4 1.1 3.3 1.3 4.1 10.8 1.0 0.2 2.7 1.8 0.9 0.0 0.3 1.2 0.6 0.3 3.8 0.8 1.0 1.0 0.4 7.4 9.8 4.0 6.0 7.5 6.9 23.9 3.4 2.3 3.1 3.6 5.4 0.1 2.5 0.1 4.3 12.2 3.6 3.2 2.0 7.3 9.3 0.0 15.9 2.3 5.4 1.0 9.3 5.8 8.0 4.0 2.3 4.1 1.9 8.8 5.0 4.0 4.4 22.1 3.8 2.2 2.9 4.6 0.0 9.7 10.2 5.5 7.6 0.0 4.0 4.4 5.8 1.5 9.4 0.0 5.4 4.1 4.6 6.2 2.7 0.0 6.2 3.1 3.5 0.0 0.8 0.9 0.3 0.6 0.0 0.1 0.3 0.9 0.1 0.6 0.6 1.0 3.8 1.0 0.8 0.3 0.3 0.4 TBC1D5 KIAA0210 ENSG00000131374 "TBC1 domain family member 5" Q92609 3 17157162-18444817 "Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035125, HPA035126" Uncertain Supported "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA035125: AB_2674479, HPA035126: AB_10670696" "unprognostic (1.87e-1)" "unprognostic (3.57e-1)" "unprognostic (2.86e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (4.30e-3)" "unprognostic (3.07e-2)" "unprognostic (3.31e-1)" "unprognostic (3.56e-2)" "unprognostic (6.27e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "prognostic favourable (1.75e-7)" "unprognostic (1.25e-1)" "unprognostic (1.56e-1)" "unprognostic (5.72e-2)" "unprognostic (7.07e-2)" 22.2 20.9 24.8 21.3 24.7 21.1 17.7 25.5 25.1 21.0 13.3 25.7 14.5 10.3 17.4 15.9 16.4 22.4 18.5 16.2 24.4 20.0 19.9 13.9 16.9 20.4 25.9 14.9 28.3 17.2 35.3 27.8 16.5 21.4 14.2 13.7 16.6 13.9 17.0 10.3 15.2 13.8 17.7 31.3 24.3 12.9 17.3 24.7 10.0 29.1 9.7 21.2 17.8 20.7 13.5 9.7 12.3 8.6 4.2 8.7 4.6 11.5 13.0 10.7 10.0 21.2 31.2 11.7 12.5 18.3 8.2 7.1 6.3 10.5 21.5 13.6 25.3 3.6 9.4 15.2 17.1 19.0 3.6 20.6 5.3 7.3 13.6 20.0 18.1 20.1 18.2 17.8 10.8 18.6 12.9 20.0 19.9 7.8 9.8 4.6 8.8 13.7 21.6 13.8 15.3 12.3 9.0 4.0 19.1 23.9 5.6 8.5 15.9 16.8 20.1 22.7 10.2 11.7 13.6 11.6 15.7 21.0 17.5 19.1 21.2 10.2 8.6 12.3 6.7 7.1 8.7 11.7 5.1 4.8 9.7 13.5 3.9 4.4 11.5 4.2 6.4 6.3 5.5 4.6 24.8 24.7 25.5 24.6 24.4 20.0 25.9 14.9 21.4 24.7 TBK1 NAK ENSG00000183735 "TANK binding kinase 1" Q9UHD2 12 64451880-64502108 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045797, HPA060211" Uncertain Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA045797: , HPA060211: " "unprognostic (4.73e-2)" "unprognostic (8.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.90e-1)" "unprognostic (1.94e-1)" "unprognostic (1.28e-1)" "prognostic unfavourable (3.30e-4)" "unprognostic (1.26e-1)" "prognostic unfavourable (3.48e-4)" "unprognostic (1.69e-1)" "unprognostic (2.54e-2)" "unprognostic (1.24e-2)" "prognostic unfavourable (4.20e-6)" "unprognostic (4.35e-2)" "unprognostic (1.30e-1)" "unprognostic (1.26e-2)" "unprognostic (9.56e-3)" 19.1 23.3 13.7 16.8 17.1 32.3 19.1 17.8 20.5 14.9 18.3 10.0 14.1 18.0 17.0 15.1 15.3 13.8 15.6 11.7 14.7 15.6 15.4 20.8 17.8 18.3 20.2 13.6 15.6 11.1 13.1 27.2 40.6 21.1 16.3 12.9 10.1 15.0 18.3 24.8 12.1 21.4 17.2 18.8 24.6 14.5 27.9 16.9 3.4 13.3 12.6 16.7 18.4 19.6 9.7 8.2 22.5 11.9 16.3 11.8 5.9 13.4 15.5 8.8 12.9 15.8 16.0 19.5 14.8 21.5 13.9 13.3 8.7 8.2 18.9 12.9 16.0 12.7 11.4 12.4 16.5 17.3 10.8 20.2 11.2 12.0 17.4 20.6 25.3 12.0 11.4 13.9 13.4 18.5 15.5 27.5 17.9 16.5 0.6 16.2 17.7 9.1 9.6 9.8 18.2 15.2 24.5 7.4 10.7 19.5 20.0 14.3 20.5 15.0 17.1 12.6 12.2 10.1 14.4 17.4 30.3 18.4 15.9 11.4 16.2 22.5 7.3 16.6 11.0 11.9 11.8 9.7 8.0 11.0 8.2 7.6 2.8 7.1 15.1 16.3 10.6 1.9 9.5 5.9 13.7 17.1 17.8 20.5 14.7 15.6 20.2 13.6 21.1 16.9 TBX4 ENSG00000121075 "T-box 4" P57082 17 61452404-61485110 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lung: 31.1;placenta: 17.0;prostate: 15.0;smooth muscle: 26.0;urinary bladder: 18.6" "Cell line enhanced" "Detected in some" "BJ: 5.3;Hep G2: 2.1;THP-1: 10.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Region enhanced" "Detected in some" "basal ganglia: 1.6" "CAB032413, HPA044457" Uncertain Approved Vesicles Vesicles "CAB032413: AB_2200705, HPA044457: " "unprognostic (1.03e-2)" "unprognostic (2.05e-2)" "unprognostic (1.43e-1)" "unprognostic (1.63e-3)" "unprognostic (6.07e-2)" "unprognostic (3.80e-2)" "unprognostic (1.25e-2)" "unprognostic (4.14e-2)" "unprognostic (7.77e-3)" "unprognostic (7.41e-2)" "unprognostic (6.83e-2)" "unprognostic (1.38e-1)" "unprognostic (1.46e-8)" "unprognostic (1.92e-1)" "unprognostic (4.41e-2)" "unprognostic (6.15e-2)" "unprognostic (5.39e-2)" 0.5 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.0 0.6 15.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 26.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 18.6 4.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.9 0.1 0.0 0.0 5.3 0.5 0.4 0.4 1.9 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.8 0.0 0.0 2.1 0.5 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.5 0.0 10.5 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 TCEA3 TFIIS.H ENSG00000204219 "Transcription elongation factor A3" O75764 1 23381061-23424740 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 114.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.1;Hep G2: 33.5;SiHa: 11.1;T-47d: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 8.5;naive CD4 T-cell: 14.3" "Lineage enriched" "Detected in many" 5 "T-cells: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044960, HPA055811" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA044960: AB_10964053, HPA055811: " "unprognostic (1.58e-1)" "unprognostic (1.75e-3)" "unprognostic (9.18e-2)" "unprognostic (3.82e-2)" "unprognostic (2.77e-3)" "prognostic favourable (2.56e-4)" "unprognostic (2.86e-2)" "unprognostic (4.70e-3)" "unprognostic (7.37e-3)" "unprognostic (2.85e-1)" "unprognostic (2.22e-2)" "unprognostic (3.27e-1)" "unprognostic (2.23e-1)" "unprognostic (4.01e-1)" "unprognostic (5.20e-2)" "unprognostic (3.15e-1)" "unprognostic (5.58e-2)" 5.4 17.8 2.5 10.7 1.9 0.1 3.6 1.5 1.5 9.1 12.2 2.2 12.0 4.6 3.8 14.5 12.0 6.2 13.0 20.3 2.4 0.8 12.1 38.0 6.0 1.3 1.2 2.3 19.8 60.4 4.5 3.3 2.5 2.2 16.7 12.5 8.7 32.7 15.9 114.0 8.9 11.9 13.7 2.0 1.6 11.5 2.6 1.3 0.5 8.6 58.3 16.0 8.4 6.9 0.0 2.8 0.0 0.7 0.2 14.3 2.5 0.0 0.1 0.3 0.3 1.7 10.1 5.6 3.9 2.6 2.1 1.2 2.5 0.3 0.1 0.4 4.9 5.5 0.4 0.0 1.8 0.0 0.0 0.0 4.2 33.5 1.2 0.5 0.0 6.6 1.8 1.8 0.0 0.2 0.0 0.0 0.7 0.9 0.2 3.6 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.1 11.1 0.5 0.4 17.7 1.6 0.2 0.0 0.1 0.4 0.0 0.3 2.9 0.0 0.3 0.3 0.3 0.0 0.1 0.0 0.5 0.7 0.5 0.0 8.5 1.2 2.8 0.0 14.3 6.3 0.0 0.2 0.2 0.9 0.7 2.5 2.5 1.9 1.5 1.5 2.4 0.8 1.2 2.3 2.2 1.3 TCEANC2 "C1orf83, FLJ32112" ENSG00000116205 "Transcription elongation factor A N-terminal and central domain containing 2" Q96MN5 1 54053587-54112519 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046918 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046918: " "unprognostic (2.80e-1)" "unprognostic (6.19e-2)" "unprognostic (6.56e-3)" "unprognostic (2.34e-1)" "unprognostic (5.12e-3)" "unprognostic (1.35e-3)" "unprognostic (1.73e-5)" "unprognostic (8.64e-2)" "unprognostic (7.93e-3)" "unprognostic (6.59e-2)" "unprognostic (3.55e-1)" "unprognostic (3.52e-2)" "unprognostic (9.63e-2)" "unprognostic (2.26e-3)" "unprognostic (8.57e-2)" "unprognostic (7.51e-3)" "unprognostic (2.08e-1)" 5.9 5.9 7.9 7.6 11.1 6.5 5.9 3.0 7.9 6.1 5.4 13.4 6.6 6.8 5.3 6.2 7.9 5.2 4.4 4.4 8.3 6.4 7.2 4.7 4.8 9.4 10.2 4.5 4.3 6.4 6.6 6.2 6.0 8.8 5.1 8.1 6.5 5.5 4.1 9.4 6.8 6.4 6.3 14.1 8.2 5.2 15.4 8.8 15.7 5.7 3.0 10.8 7.3 5.1 7.8 7.6 10.1 8.9 10.2 6.3 3.8 5.1 2.3 5.9 4.9 4.0 6.3 5.7 5.6 4.3 6.3 5.6 1.4 3.3 4.6 4.9 2.4 5.2 7.8 4.3 8.0 10.2 4.2 6.8 5.5 2.7 2.5 5.0 6.9 4.7 3.7 5.5 3.2 8.0 6.7 4.3 5.2 1.9 10.0 3.7 13.6 3.9 10.0 10.8 6.7 2.3 3.1 5.1 5.4 3.6 5.6 6.7 5.5 9.4 4.2 5.7 3.6 5.5 6.8 9.9 14.3 6.4 4.8 6.9 7.1 5.9 7.3 10.1 4.7 8.9 4.6 7.3 5.4 5.8 7.6 7.8 6.3 6.2 9.4 10.2 6.5 6.9 4.1 3.8 7.9 11.1 3.0 7.9 8.3 6.4 10.2 4.5 8.8 8.8 TCTE1 "D6S46, DRC5, FAP155, MGC33600" ENSG00000146221 "T-complex-associated-testis-expressed 1" Q5JU00 6 44278743-44297688 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "fallopian tube: 17.3;testis: 48.6" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.6;Karpas-707: 3.8;SCLC-21H: 3.1;U-266/70: 1.7;U-266/84: 3.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031739 Uncertain Vesicles Vesicles "HPA031739: AB_10601269" "unprognostic (3.27e-2)" "unprognostic (1.86e-1)" "unprognostic (2.04e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (7.06e-2)" "unprognostic (1.42e-2)" "unprognostic (3.46e-1)" "unprognostic (3.49e-2)" "unprognostic (1.17e-2)" "unprognostic (7.05e-2)" "unprognostic (2.23e-5)" "unprognostic (7.68e-2)" "unprognostic (3.13e-2)" "unprognostic (1.37e-3)" "unprognostic (2.68e-1)" 0.2 0.2 2.2 0.2 2.2 1.1 0.2 5.8 1.8 0.7 0.2 1.1 0.0 0.2 0.6 3.0 0.2 17.3 0.3 0.2 2.8 2.0 0.2 0.2 2.1 0.2 0.8 1.0 2.2 0.3 0.2 0.2 0.2 3.2 0.4 0.2 0.0 0.4 0.4 0.2 0.6 0.3 0.3 0.6 0.3 0.2 48.6 0.3 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.9 0.0 0.1 0.0 0.2 0.1 0.3 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.3 0.1 0.2 0.1 0.6 0.3 0.0 0.0 2.6 0.0 0.1 3.8 0.0 0.3 0.2 0.5 0.2 0.0 0.9 0.4 0.0 0.0 0.1 3.1 1.0 0.0 0.2 1.2 0.0 0.2 0.1 0.0 0.2 0.0 0.0 1.7 3.2 0.3 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.1 0.2 0.0 2.2 2.2 5.8 1.8 2.8 2.0 0.8 1.0 3.2 0.3 TCTN2 "C12orf38, FLJ12975, JBTS24, MKS8, TECT2" ENSG00000168778 "Tectonic family member 2" Q96GX1 12 123671113-123708403 "Disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039900 Enhanced Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA039900: AB_10673366" "unprognostic (3.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.30e-2)" "unprognostic (1.45e-2)" "unprognostic (1.63e-3)" "unprognostic (1.32e-1)" "unprognostic (3.09e-3)" "unprognostic (3.14e-2)" "unprognostic (7.05e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-3)" "unprognostic (2.23e-1)" "unprognostic (1.69e-1)" "unprognostic (2.79e-1)" "unprognostic (2.46e-1)" "unprognostic (7.86e-2)" "unprognostic (2.68e-1)" 5.5 5.5 6.4 5.1 18.1 2.3 8.4 10.5 10.0 11.2 5.6 9.1 12.0 2.9 15.7 14.1 4.1 32.0 7.2 5.4 6.2 10.2 11.8 2.3 9.4 4.0 4.4 8.3 18.0 7.9 16.1 18.8 5.3 18.5 11.0 4.9 17.6 11.9 10.2 1.9 10.2 3.9 7.1 4.2 4.5 6.1 17.2 3.2 3.1 15.6 5.1 4.2 5.9 7.5 4.5 4.7 2.4 1.1 1.4 5.4 0.4 10.7 10.6 8.1 11.2 11.0 12.4 9.4 4.1 7.9 8.5 7.2 6.7 10.8 0.3 6.7 6.4 14.0 4.3 3.7 8.6 2.3 6.5 1.0 7.4 5.0 3.9 2.8 4.1 6.1 7.4 12.0 3.5 11.3 5.7 0.2 6.0 5.6 3.1 5.8 5.0 6.5 3.1 8.0 1.5 10.6 7.8 4.8 6.3 12.7 4.3 5.8 18.3 3.8 7.0 12.0 6.2 10.7 4.9 3.0 6.1 1.0 15.3 0.3 7.1 2.4 0.5 2.2 3.9 1.1 5.4 3.8 4.4 4.0 0.8 4.5 5.0 5.0 0.8 1.4 0.9 4.7 2.5 0.4 6.4 18.1 10.5 10.0 6.2 10.2 4.4 8.3 18.5 3.2 TDGF1 "CR, CRIPTO, Cripto-1" ENSG00000241186 "Teratocarcinoma-derived growth factor 1" P13385 3 46574534-46582463 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7" "Cell line enriched" "Detected in some" 5 "NTERA-2: 45.5" "Group enriched" "Detected in many" 9 "colorectal cancer: 6.4;testis cancer: 27.1" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 12.5;pons and medulla: 9.1" "Low region specificity" "Detected in single" HPA051928 Uncertain Vesicles,Cytosol "Secreted in other tissues" Vesicles Cytosol "HPA051928: " "unprognostic (7.84e-3)" "unprognostic (2.00e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (2.80e-2)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (3.61e-1)" "unprognostic (1.72e-2)" "unprognostic (6.77e-2)" "unprognostic (1.74e-1)" "unprognostic (8.76e-3)" "unprognostic (2.01e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" 0.6 3.9 0.6 0.6 0.8 0.0 0.6 0.6 0.6 0.6 2.1 0.6 0.6 0.2 0.7 1.3 0.6 0.0 0.6 0.6 1.0 0.6 9.9 0.8 0.6 0.6 0.9 0.6 9.7 0.6 0.0 0.6 0.6 0.6 0.6 4.3 1.1 0.6 0.6 1.0 0.0 0.6 0.8 1.0 16.7 2.4 0.6 0.6 5.2 2.1 0.6 0.6 0.6 0.6 1.0 0.7 3.7 0.6 1.5 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 10.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 45.5 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.6 0.5 0.5 0.3 0.3 0.6 0.4 0.3 0.1 1.0 0.6 0.4 3.7 1.5 0.4 0.7 0.2 0.1 0.6 0.8 0.6 0.6 1.0 0.6 0.9 0.6 0.6 0.6 TDRD10 DKFZp434M202 ENSG00000163239 "Tudor domain containing 10" Q5VZ19 1 154502219-154548147 "Cancer-related genes, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 48.4" "Group enriched" "Detected in some" 10 "EFO-21: 2.2;HUVEC TERT2: 7.5;RPMI-8226: 2.1;TIME: 4.0" "Cancer enhanced" "Detected in many" "testis cancer: 5.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054327 Approved Vesicles Vesicles "HPA054327: " "unprognostic (1.30e-1)" "unprognostic (6.33e-2)" "unprognostic (1.78e-1)" "unprognostic (5.33e-3)" "unprognostic (9.69e-3)" "unprognostic (5.80e-3)" "unprognostic (2.99e-1)" "unprognostic (5.97e-3)" "unprognostic (2.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.00e-3)" "unprognostic (1.61e-1)" "unprognostic (1.34e-3)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "prognostic favourable (8.04e-5)" "unprognostic (1.62e-1)" 4.1 1.4 0.7 1.1 0.9 0.0 2.6 0.7 1.4 1.3 0.8 0.9 1.4 0.5 2.1 2.0 1.0 2.1 1.2 2.3 0.7 0.0 1.0 1.5 3.3 1.6 0.9 1.2 4.6 0.7 0.8 0.8 1.4 1.2 1.1 1.1 0.7 0.7 1.0 1.1 0.7 1.0 1.4 1.2 3.5 0.5 48.4 0.8 0.7 4.9 1.5 1.0 1.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 4.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.9 0.7 1.4 0.7 0.0 0.9 1.2 1.2 0.8 TDRP "C8orf42, INM01, TDRP1, TDRP2" ENSG00000180190 "Testis development related protein" Q86YL5 8 489792-545781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 41.9" "Cell line enhanced" "Detected in many" "BEWO: 29.5;HBEC3-KT: 14.2;hTCEpi: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA008462 Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA008462: AB_1845777" "unprognostic (1.17e-1)" "unprognostic (1.88e-1)" "unprognostic (5.51e-2)" "prognostic unfavourable (1.52e-4)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (2.13e-1)" "unprognostic (3.72e-3)" "unprognostic (4.13e-2)" "unprognostic (1.08e-1)" "prognostic favourable (9.37e-4)" "unprognostic (1.74e-1)" "unprognostic (3.43e-2)" "unprognostic (5.46e-4)" "unprognostic (2.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.50e-1)" 5.7 9.0 7.7 6.1 13.1 0.5 11.0 10.4 9.2 8.5 4.9 3.6 8.4 2.3 9.4 9.8 5.7 12.9 9.9 3.7 7.4 10.3 14.3 9.4 9.6 3.9 6.3 3.6 13.0 13.7 15.2 11.1 41.9 8.4 12.5 2.8 17.7 6.2 12.3 2.3 3.3 2.8 5.0 4.6 2.6 3.6 8.1 3.2 3.0 22.7 3.2 6.3 9.9 12.8 0.4 0.0 0.0 0.1 0.0 0.2 1.1 4.9 5.0 8.8 0.0 0.0 0.0 29.5 2.9 1.8 2.7 2.5 0.0 0.0 0.0 1.2 0.9 1.1 0.0 14.2 3.5 0.0 0.4 0.0 0.0 7.4 3.4 0.0 2.1 3.4 11.3 0.0 5.3 0.4 0.6 0.0 2.9 0.0 0.0 0.0 10.4 1.0 0.0 0.0 0.0 9.1 7.4 2.6 4.2 0.0 8.9 2.1 2.9 0.0 0.1 0.1 0.9 0.0 0.2 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 7.7 13.1 10.4 7.5 7.4 10.3 6.3 3.6 8.4 3.2 TECPR1 "DKFZP434B0335, FLJ23419, FLJ90593, KIAA1358" ENSG00000205356 "Tectonin beta-propeller repeat containing 1" Q7Z6L1 7 98214624-98252251 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 63.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021061 Approved Supported Vesicles Vesicles "HPA021061: AB_1847687" "unprognostic (8.10e-3)" "unprognostic (7.89e-2)" "unprognostic (9.05e-3)" "unprognostic (5.00e-3)" "unprognostic (2.03e-1)" "unprognostic (1.11e-2)" "unprognostic (2.49e-2)" "unprognostic (1.45e-2)" "unprognostic (1.72e-1)" "unprognostic (1.88e-1)" "prognostic favourable (8.12e-4)" "unprognostic (2.48e-1)" "unprognostic (2.54e-1)" "unprognostic (1.38e-1)" "unprognostic (3.24e-1)" "unprognostic (9.46e-2)" "unprognostic (6.12e-2)" 6.5 4.7 11.5 8.9 10.6 5.2 6.3 9.0 15.8 4.1 5.9 6.2 5.1 8.4 4.5 5.5 5.8 4.8 7.6 5.9 10.4 9.0 4.6 5.4 9.0 11.0 6.8 12.8 4.0 63.9 4.2 10.2 7.7 9.8 6.9 4.9 8.0 29.5 5.0 6.9 5.4 8.1 4.6 8.5 11.2 9.3 3.3 7.0 6.4 5.9 5.9 6.4 5.1 5.4 3.4 4.1 6.1 7.4 1.6 8.7 3.1 2.9 4.1 5.8 12.5 5.1 3.0 4.3 6.2 3.4 4.9 6.0 3.9 3.7 2.4 10.0 7.1 1.9 3.9 2.9 2.1 5.8 5.6 3.5 5.8 4.2 6.0 4.2 6.9 5.3 2.3 4.7 3.7 17.2 2.3 13.8 3.7 4.8 6.1 4.5 2.3 4.0 5.1 5.9 17.3 3.7 3.2 10.5 11.7 3.6 11.0 5.7 3.3 6.1 17.6 4.7 8.1 12.0 5.1 17.6 6.3 1.2 9.8 3.7 8.7 2.6 4.7 1.4 3.9 5.2 2.4 3.4 5.1 3.1 2.9 3.2 8.7 7.2 6.1 1.6 7.4 4.1 5.1 3.1 11.5 10.6 9.0 15.8 10.4 9.0 6.8 12.8 9.8 7.0 TEP1 "p240, TLP1, TP1, TROVE1, VAULT2" ENSG00000129566 "Telomerase associated protein 1" Q99973 14 20365667-20413429 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029206 Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA029206: AB_10601271" "unprognostic (4.53e-2)" "unprognostic (2.81e-2)" "unprognostic (1.26e-1)" "prognostic favourable (9.58e-4)" "unprognostic (2.27e-1)" "unprognostic (2.76e-1)" "unprognostic (2.66e-2)" "unprognostic (1.43e-1)" "unprognostic (6.81e-2)" "unprognostic (1.42e-2)" "unprognostic (1.92e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.18e-1)" "unprognostic (6.18e-2)" "unprognostic (3.00e-1)" 14.7 10.4 5.4 22.0 8.7 4.5 11.4 5.8 6.6 8.9 24.1 11.2 7.7 27.7 12.9 11.3 9.4 7.9 15.7 9.3 6.3 3.5 9.4 9.2 14.1 15.0 7.7 3.0 9.2 8.7 28.2 11.7 7.0 7.3 10.8 18.1 8.1 11.4 8.3 13.4 10.0 38.3 10.9 12.2 19.5 11.1 3.6 8.7 14.2 11.2 6.6 20.8 9.7 10.9 4.2 8.3 7.8 4.4 0.9 1.8 0.5 7.3 2.9 3.4 3.6 20.7 8.6 5.8 4.9 4.6 3.0 4.2 6.3 7.7 5.7 3.4 14.0 7.2 2.7 9.9 5.3 7.2 2.8 6.9 6.4 4.2 6.2 5.7 12.6 12.0 9.4 6.2 4.8 14.0 2.4 4.6 11.0 4.4 4.3 4.0 1.3 2.7 9.5 8.1 2.0 10.2 10.5 1.0 1.4 3.9 10.1 3.2 5.5 3.9 14.3 12.0 8.5 4.4 1.4 10.3 5.9 3.7 2.8 5.4 4.4 4.1 4.0 0.2 1.8 4.4 1.7 2.9 0.8 1.6 1.3 4.2 0.9 1.1 7.8 0.9 4.4 8.3 1.3 0.5 5.4 8.7 5.8 6.6 6.3 3.5 7.7 3.0 7.3 8.7 TET3 "hCG_40738, MGC22014" ENSG00000187605 "Tet methylcytosine dioxygenase 3" O43151 2 73986404-74108176 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050845 Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA050845: " "unprognostic (1.07e-2)" "unprognostic (1.21e-2)" "unprognostic (3.08e-1)" "unprognostic (1.12e-2)" "unprognostic (4.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.72e-3)" "unprognostic (1.46e-1)" "unprognostic (1.01e-1)" "unprognostic (9.83e-2)" "unprognostic (7.74e-2)" "unprognostic (2.03e-1)" "prognostic unfavourable (3.58e-5)" "unprognostic (2.05e-1)" "unprognostic (5.30e-1)" "unprognostic (1.55e-2)" "unprognostic (1.10e-1)" 2.9 2.3 7.2 6.1 10.8 20.9 3.9 26.0 17.1 3.2 5.1 20.6 0.5 6.7 2.9 1.9 10.2 3.0 3.3 1.6 7.1 3.3 2.6 5.1 5.6 4.3 12.0 9.5 2.9 3.6 3.5 4.2 5.7 12.4 3.6 5.5 5.9 5.9 1.8 1.8 18.9 7.2 2.7 5.3 5.5 5.3 2.1 11.7 0.6 3.4 1.7 5.1 4.0 5.0 1.1 1.4 2.5 2.2 0.4 0.9 0.9 6.1 5.4 10.4 6.3 0.9 1.0 19.1 1.3 1.7 2.5 1.9 11.6 5.8 10.3 2.5 1.7 6.6 9.2 3.6 2.6 4.4 3.6 13.2 4.5 3.9 3.8 13.8 8.2 1.5 9.7 3.0 7.2 3.7 9.0 3.4 1.4 10.2 6.8 9.0 5.8 1.9 10.3 6.5 3.6 2.7 11.5 13.0 11.1 2.8 7.4 3.5 4.7 11.2 4.7 2.6 11.2 1.2 4.6 3.0 1.3 9.0 1.7 9.7 3.4 0.5 2.0 1.0 0.4 2.2 0.9 1.1 0.5 0.5 1.4 0.9 0.7 0.6 2.5 0.4 0.7 1.4 0.0 0.9 7.2 10.8 26.0 17.1 7.1 3.3 12.0 9.5 12.4 11.7 TEX14 CT113 ENSG00000121101 "Testis expressed 14, intercellular bridge forming factor" Q8IWB6 17 58556678-58692055 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "testis: 52.7" "Cell line enhanced" "Detected in some" "HDLM-2: 8.9;Karpas-707: 11.6;MCF7: 4.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030620, HPA077020" Enhanced Approved "Vesicles,Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cytosol" "Vesicles, Cell Junctions" "HPA030620: AB_10601598, HPA077020: " "unprognostic (1.21e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-1)" "unprognostic (9.49e-2)" "unprognostic (2.48e-1)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (6.17e-2)" "unprognostic (2.07e-2)" "unprognostic (1.61e-3)" "unprognostic (2.67e-2)" "unprognostic (8.10e-2)" "unprognostic (1.76e-9)" "unprognostic (1.77e-1)" "unprognostic (2.54e-1)" "unprognostic (5.00e-3)" "unprognostic (5.88e-2)" 0.1 0.1 0.2 0.1 0.3 1.5 0.1 0.9 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.5 0.2 0.0 52.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.2 0.1 0.0 0.2 2.5 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.2 0.0 0.0 0.3 0.0 0.2 8.9 1.3 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.0 0.0 0.1 11.6 0.0 4.7 0.4 0.1 0.6 0.1 0.5 0.4 1.7 0.0 0.1 1.4 0.2 0.0 0.0 0.6 0.4 0.1 0.0 0.1 0.3 0.0 0.0 2.0 0.5 1.1 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.8 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.9 0.2 0.3 0.2 0.2 0.1 0.4 0.1 TFDP2 Dp-2 ENSG00000114126 "Transcription factor Dp-2" Q14188 3 141944428-142149544 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 140.3" "Cell line enhanced" "Detected in all" "MOLT-4: 80.4;REH: 42.8;U-698: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018396, HPA070399" Supported Supported "Nucleoplasm,Vesicles,Mitotic spindle" Nucleoplasm "Vesicles, Mitotic spindle" "CAB018396: AB_2287284, HPA070399: " "unprognostic (1.35e-2)" "prognostic favourable (6.32e-4)" "unprognostic (8.08e-3)" "unprognostic (2.90e-2)" "unprognostic (4.69e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-3)" "unprognostic (2.60e-3)" "unprognostic (5.42e-2)" "unprognostic (1.46e-1)" "unprognostic (5.04e-2)" "unprognostic (2.04e-1)" "prognostic favourable (9.84e-4)" "unprognostic (6.04e-2)" "unprognostic (3.91e-2)" "unprognostic (2.45e-1)" "unprognostic (1.08e-1)" 8.4 8.4 6.1 6.3 8.7 20.7 9.3 9.9 8.6 8.9 11.1 6.5 6.5 10.4 9.9 8.6 8.3 7.2 11.6 12.0 7.5 4.9 14.3 9.5 6.8 5.3 6.0 5.0 11.6 8.8 10.4 19.4 13.5 8.0 9.9 6.6 8.8 7.9 6.9 14.5 8.0 14.6 11.8 8.5 5.3 8.6 51.9 5.4 140.3 10.6 4.8 6.4 9.7 8.0 9.3 16.5 24.6 4.5 18.0 14.7 5.7 6.3 2.9 12.3 9.8 4.1 4.5 27.1 3.2 3.7 5.1 8.3 3.7 6.3 22.5 15.0 3.6 3.8 3.1 6.1 7.2 9.0 5.6 27.1 4.4 4.9 4.0 8.1 9.6 4.2 4.3 5.6 5.4 3.5 10.1 1.2 8.8 4.8 80.4 3.1 9.9 4.0 42.8 8.5 5.2 5.9 3.3 5.4 5.0 10.8 4.0 5.5 9.3 4.2 2.3 4.9 4.5 3.9 4.0 4.2 3.8 70.5 3.9 2.2 2.3 24.6 2.1 22.3 14.7 3.4 5.7 6.6 6.7 7.6 4.8 9.3 10.1 11.8 2.4 18.0 4.5 16.5 6.1 5.7 6.1 8.7 9.9 8.6 7.5 4.9 6.0 5.0 8.0 5.4 TFG "FLJ36137, SPG57, TF6" ENSG00000114354 "TRK-fused gene" Q92734 3 100709331-100748966 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019473, HPA052206" Approved Supported Vesicles,Cytosol Vesicles Cytosol "HPA019473: AB_1857936, HPA052206: " "unprognostic (1.14e-1)" "unprognostic (3.58e-2)" "unprognostic (1.46e-1)" "unprognostic (2.94e-2)" "unprognostic (1.46e-1)" "unprognostic (4.14e-2)" "prognostic unfavourable (5.48e-4)" "unprognostic (3.31e-3)" "unprognostic (1.42e-1)" "unprognostic (3.73e-2)" "prognostic unfavourable (1.50e-4)" "unprognostic (4.58e-3)" "unprognostic (3.72e-2)" "unprognostic (2.82e-1)" "unprognostic (8.55e-2)" "unprognostic (3.33e-1)" "unprognostic (8.45e-2)" 36.4 40.3 27.2 21.9 33.8 29.7 31.0 28.1 40.5 31.2 34.7 33.3 44.2 52.5 31.2 45.8 46.7 29.0 40.8 46.2 28.1 30.7 44.6 68.6 29.9 25.4 28.2 21.5 33.5 49.2 52.3 45.1 63.3 33.7 27.5 40.7 31.9 39.6 45.8 38.6 31.0 67.1 37.5 31.7 28.3 28.9 33.5 23.0 27.6 43.6 42.9 41.2 29.5 30.1 25.8 27.8 43.2 28.4 27.7 26.8 21.8 48.4 26.4 32.9 20.9 41.6 47.2 40.7 35.1 47.3 45.9 54.8 33.3 24.2 6.5 25.8 43.6 36.4 35.4 40.1 54.7 29.8 20.8 24.4 20.3 30.9 46.5 18.0 14.6 38.6 54.1 27.5 48.5 40.6 17.5 18.1 47.4 33.9 15.8 14.3 31.3 39.8 14.0 19.3 21.1 55.7 32.7 26.0 23.8 23.1 30.1 40.9 35.4 24.4 27.1 27.8 33.6 12.8 25.4 15.4 15.5 23.3 44.4 19.7 32.6 43.2 28.3 27.0 21.8 28.4 26.4 25.8 22.6 24.4 27.8 22.9 21.6 21.6 18.7 27.7 26.4 19.4 26.8 21.8 27.2 33.8 28.1 40.5 28.1 30.7 28.2 21.5 33.7 23.0 TGFA ENSG00000163235 "Transforming growth factor alpha" P01135 2 70447280-70554193 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 23.9;CAPAN-2: 29.5;EFO-21: 15.2;HBEC3-KT: 25.7;RPTEC TERT1: 25.9;U-87 MG: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 6.3;eosinophil: 14.0;neutrophil: 14.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042297 Approved Approved Vesicles "Secreted to blood" 57867 Vesicles "HPA042297: AB_10793878" "unprognostic (1.23e-1)" "unprognostic (1.06e-3)" "unprognostic (3.57e-3)" "unprognostic (6.39e-2)" "unprognostic (1.41e-1)" "unprognostic (8.49e-3)" "unprognostic (1.52e-1)" "unprognostic (3.00e-3)" "unprognostic (6.69e-2)" "unprognostic (9.21e-2)" "prognostic unfavourable (1.20e-5)" "unprognostic (7.74e-2)" "unprognostic (3.70e-2)" "unprognostic (1.60e-1)" "unprognostic (9.21e-2)" "prognostic favourable (1.52e-4)" "unprognostic (9.19e-2)" 2.0 0.5 8.4 4.3 10.7 1.2 6.2 3.5 7.9 5.7 9.4 21.4 0.3 7.4 1.2 2.8 23.8 5.7 14.6 0.8 10.7 6.9 12.4 4.0 3.5 4.2 10.9 5.2 0.5 12.0 1.0 0.8 1.7 9.4 2.2 7.3 9.7 6.3 1.2 0.4 10.8 13.7 1.3 22.5 5.1 7.6 2.3 12.8 0.2 7.4 17.4 12.1 5.4 10.8 0.0 0.6 14.7 0.4 0.2 2.7 0.4 23.9 3.8 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 29.5 0.0 15.2 0.1 12.8 0.2 25.7 0.0 0.0 0.5 0.0 0.6 2.0 0.0 0.3 0.0 0.0 10.3 0.0 10.1 0.0 0.0 0.1 0.0 0.9 0.0 0.5 0.4 7.3 0.0 0.1 6.3 25.9 9.3 0.2 0.0 1.9 0.0 0.0 3.3 0.2 0.2 0.1 1.7 0.0 5.2 0.1 0.1 0.0 24.5 0.8 8.8 6.3 0.4 14.0 1.0 0.1 2.7 0.0 0.6 0.6 0.6 0.0 0.3 0.2 14.7 0.2 0.0 0.0 0.0 0.4 8.4 10.7 3.5 7.9 10.7 6.9 10.9 5.2 9.4 12.8 TGFB3 "ARVD, ARVD1" ENSG00000119699 "Transforming growth factor beta 3" P10600 14 75958099-75982991 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Growth factor, Mitogen" "Cancer-related genes, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "SK-BR-3: 49.2;T-47d: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.8" "Lineage enhanced" "Detected in single" "T-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA063582 Approved Vesicles "Secreted to blood" Vesicles "HPA063582: " "unprognostic (7.84e-2)" "unprognostic (1.89e-1)" "unprognostic (4.32e-3)" "unprognostic (1.29e-1)" "unprognostic (3.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.24e-1)" "unprognostic (9.79e-2)" "unprognostic (2.83e-2)" "unprognostic (1.51e-2)" "unprognostic (5.63e-2)" "unprognostic (4.10e-1)" "prognostic unfavourable (4.01e-7)" "unprognostic (6.38e-3)" "unprognostic (1.10e-1)" "unprognostic (1.22e-2)" "unprognostic (3.27e-3)" 6.9 4.7 10.6 8.4 14.0 0.4 7.8 3.2 8.6 29.2 4.1 6.7 13.1 2.3 10.4 21.4 4.4 4.9 21.5 17.9 11.9 6.6 4.8 12.2 8.6 4.2 16.8 7.0 3.1 11.1 6.8 4.6 31.0 8.4 25.8 3.2 10.0 5.0 12.0 13.3 1.5 2.9 20.7 13.0 2.2 4.5 3.8 8.8 4.2 4.4 5.7 8.2 11.6 6.4 0.4 0.1 0.0 0.0 0.0 1.8 0.2 0.3 0.1 0.4 5.4 0.9 1.3 0.1 0.2 0.4 0.2 0.2 0.3 1.3 0.0 0.4 1.0 0.3 1.1 0.1 0.1 0.3 0.5 0.0 1.1 0.6 1.3 0.2 0.3 4.5 0.1 0.4 0.1 1.3 0.5 2.4 0.3 2.4 0.2 0.2 0.1 1.8 1.1 1.6 0.2 0.5 0.2 8.9 2.1 1.6 49.2 0.3 34.5 0.0 0.3 0.8 1.8 0.8 2.2 0.2 0.2 0.1 1.3 0.3 1.3 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.1 0.6 0.0 0.4 1.8 0.5 0.0 0.0 0.0 0.1 0.3 0.2 10.6 14.0 3.2 8.6 11.9 6.6 16.8 7.0 8.4 8.8 TGFBR3L ENSG00000260001 "Transforming growth factor beta receptor 3 like" H3BV60 19 7916145-7919097 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pituitary gland: 56.6" "Cell line enhanced" "Detected in some" "PC-3: 5.6;REH: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 8 "T-cells: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA074356 Enhanced Approved Vesicles Vesicles "HPA074356: " "unprognostic (1.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (2.63e-1)" "unprognostic (7.65e-2)" "unprognostic (9.51e-3)" "unprognostic (1.09e-1)" "unprognostic (6.96e-2)" "unprognostic (3.41e-2)" "unprognostic (2.81e-1)" "unprognostic (2.04e-1)" "unprognostic (3.50e-3)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (1.06e-1)" "unprognostic (8.62e-3)" 0.3 2.0 1.6 0.2 2.8 0.6 0.3 1.9 6.4 5.0 0.6 0.0 0.3 6.0 2.8 0.5 0.3 0.7 0.2 2.1 0.7 0.8 3.7 4.0 0.3 0.1 0.5 1.7 0.3 0.3 0.9 56.6 0.4 1.9 2.5 0.1 0.6 0.8 0.7 0.3 0.5 5.7 2.0 0.6 0.3 0.4 0.5 0.0 0.0 0.3 0.0 0.1 1.1 0.8 0.1 0.3 0.0 0.1 0.0 2.9 0.1 0.1 0.2 0.1 0.5 0.1 0.0 3.3 2.6 0.0 0.2 0.0 0.5 0.0 0.1 3.0 0.1 1.9 0.0 0.0 0.0 3.4 1.1 0.5 0.2 0.6 0.2 1.7 0.3 0.2 0.1 0.0 0.0 0.0 0.7 0.5 0.0 1.5 1.2 0.2 0.6 5.6 13.6 0.0 3.0 0.2 0.0 1.0 2.5 0.3 0.0 0.6 0.9 0.5 0.2 1.8 2.9 2.0 0.9 0.8 0.9 0.8 0.4 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.6 0.1 0.9 1.9 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.3 0.0 0.1 1.6 2.8 1.9 6.4 0.7 0.8 0.5 1.7 1.9 0.0 TGFBRAP1 "TRAP-1, TRAP1, VPS3" ENSG00000135966 "Transforming growth factor beta receptor associated protein 1" Q8WUH2 2 105264391-105330034 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037672, HPA038397" Approved Approved Vesicles Vesicles "HPA037672: , HPA038397: AB_10669782" "unprognostic (1.66e-1)" "unprognostic (1.58e-2)" "unprognostic (8.99e-2)" "unprognostic (4.49e-3)" "unprognostic (3.02e-2)" "unprognostic (6.77e-2)" "unprognostic (5.63e-3)" "unprognostic (9.15e-2)" "unprognostic (2.25e-1)" "unprognostic (2.98e-2)" "unprognostic (2.29e-1)" "unprognostic (8.30e-2)" "unprognostic (8.82e-2)" "unprognostic (3.89e-1)" "unprognostic (1.07e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-2)" 12.7 11.8 9.4 8.9 12.5 23.4 13.6 14.1 18.3 8.3 10.1 15.2 11.1 8.4 11.8 8.4 10.1 9.4 7.1 7.7 9.2 7.2 9.3 6.9 8.8 12.9 11.2 9.9 10.0 11.7 16.4 7.5 12.4 10.9 10.5 10.0 15.5 10.9 13.7 15.3 14.5 10.0 11.2 10.4 11.9 17.1 3.0 11.8 10.3 13.3 9.2 10.5 11.5 12.9 3.3 3.0 3.1 2.5 2.6 5.5 2.0 14.2 11.4 8.3 10.3 9.0 7.2 17.0 10.4 14.4 17.8 17.1 16.6 8.9 14.6 11.3 11.8 8.8 14.7 24.9 14.8 15.4 15.6 19.6 9.0 13.2 8.3 18.1 15.0 8.7 15.0 14.8 13.2 18.9 17.6 7.2 21.5 9.5 12.8 11.7 10.6 9.5 14.6 13.2 21.1 11.0 17.7 16.5 11.0 8.6 17.3 16.9 8.6 11.2 13.5 11.3 17.3 9.3 10.5 7.6 9.1 16.1 8.0 12.7 23.2 1.2 2.5 3.1 5.5 2.0 4.8 2.0 3.7 3.1 1.9 3.3 2.3 3.6 1.0 2.6 1.7 3.0 2.6 2.0 9.4 12.5 14.1 18.3 9.2 7.2 11.2 9.9 10.9 11.8 THAP7 MGC10963 ENSG00000184436 "THAP domain containing 7" Q9BT49 22 20999104-21002196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003083 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA003083: AB_1080264" "unprognostic (6.48e-2)" "unprognostic (2.13e-3)" "unprognostic (3.28e-1)" "unprognostic (4.89e-3)" "unprognostic (1.92e-2)" "unprognostic (1.82e-3)" "unprognostic (5.56e-2)" "unprognostic (1.40e-2)" "unprognostic (2.82e-1)" "unprognostic (2.74e-3)" "unprognostic (1.27e-3)" "unprognostic (2.23e-2)" "unprognostic (9.15e-2)" "unprognostic (2.29e-2)" "unprognostic (1.83e-1)" "unprognostic (3.72e-2)" "unprognostic (3.51e-3)" 11.2 17.1 12.0 10.5 11.5 9.7 11.5 14.8 24.1 16.6 15.0 14.0 19.8 15.6 14.3 11.7 11.6 13.6 16.6 12.5 11.3 11.4 13.1 22.5 11.1 14.8 12.0 11.5 20.2 20.5 11.7 26.8 12.4 11.4 18.8 5.8 18.7 30.2 19.8 44.5 15.0 14.4 12.2 8.9 16.2 15.3 28.6 11.7 12.3 22.1 14.6 14.2 13.0 12.0 23.9 15.7 4.3 11.6 11.0 24.7 12.4 10.4 11.8 3.2 5.4 2.8 3.5 7.1 6.0 5.3 7.3 6.9 6.0 6.1 8.8 5.7 3.4 7.2 2.7 5.5 1.1 8.3 17.4 10.3 9.0 7.0 8.8 9.9 6.4 3.3 6.9 6.4 5.9 3.8 49.2 9.0 4.0 13.4 10.5 6.6 4.6 11.9 8.8 6.4 4.7 3.8 5.4 7.2 6.0 6.9 8.9 9.3 10.2 6.7 2.4 12.0 9.5 7.1 6.0 13.2 7.4 6.7 12.9 6.3 10.3 1.0 11.5 4.3 14.3 11.6 19.0 23.9 17.6 14.8 10.7 18.4 24.7 19.7 1.0 11.0 11.4 15.7 14.5 12.4 12.0 11.5 14.8 24.1 11.3 11.4 12.0 11.5 11.4 11.7 THBS3 ENSG00000169231 "Thrombospondin 3" P49746 1 155195588-155209051 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 23.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA006293, HPA073242" Approved Approved Vesicles "Secreted to extracellular matrix" 4100000 Vesicles "HPA006293: AB_10602898, HPA073242: " "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "prognostic unfavourable (2.43e-4)" "prognostic unfavourable (1.44e-4)" "unprognostic (2.63e-1)" "unprognostic (1.30e-1)" "unprognostic (3.62e-2)" "unprognostic (4.23e-1)" "unprognostic (4.54e-2)" "unprognostic (1.20e-1)" "unprognostic (1.88e-2)" "unprognostic (1.30e-1)" "prognostic unfavourable (2.38e-12)" "unprognostic (2.06e-2)" "unprognostic (9.41e-2)" "unprognostic (8.50e-3)" "unprognostic (2.26e-1)" 10.5 5.5 6.2 12.2 19.5 5.4 15.4 4.7 10.0 20.7 12.6 8.5 8.2 3.4 34.4 24.7 15.1 13.8 19.2 14.4 5.8 3.3 10.1 8.1 8.5 3.2 9.5 6.1 17.5 11.4 12.8 9.5 8.6 7.0 11.4 7.5 8.1 7.5 11.4 5.7 12.9 8.0 24.5 6.1 6.4 8.1 8.3 4.2 1.1 14.3 23.5 7.4 14.4 11.4 1.7 3.5 2.2 4.1 0.9 4.3 2.0 1.7 4.1 15.5 15.7 8.5 9.9 0.9 7.1 10.6 3.3 6.1 0.5 12.9 1.1 8.1 15.7 4.2 0.4 2.6 2.5 2.8 1.0 1.0 4.6 0.6 9.1 0.8 2.1 17.0 9.4 4.9 6.7 6.0 0.8 2.5 3.0 6.2 0.6 1.6 3.5 2.1 13.7 0.6 2.7 6.9 4.4 23.0 13.1 1.8 3.5 3.6 10.4 2.1 4.5 11.1 2.6 2.0 2.4 6.1 0.7 0.3 10.1 0.9 0.9 0.0 4.1 1.6 1.8 2.2 1.1 1.7 2.7 2.2 3.5 0.9 3.0 1.0 2.2 0.9 0.7 0.5 4.3 2.0 6.2 19.5 4.7 10.0 5.8 3.3 9.5 6.1 7.0 4.2 THBS4 ENSG00000113296 "Thrombospondin 4" P35443 5 79991311-80083287 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Tissue remodeling, Unfolded protein response" "Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 69.8;heart muscle: 59.0;skeletal muscle: 61.7;smooth muscle: 94.0" "Cell line enhanced" "Detected in some" "AF22: 5.0;THP-1: 10.7;U-2 OS: 4.6;U-266/70: 4.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 51 "eosinophil: 8.0" "Lineage enriched" "Detected in single" 51 "granulocytes: 8.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB004597, HPA042426" Approved Approved Vesicles "Secreted to extracellular matrix" 420000000 Vesicles "CAB004597: AB_628352, HPA042426: " "unprognostic (1.41e-1)" "unprognostic (5.33e-2)" "unprognostic (4.26e-3)" "unprognostic (3.64e-2)" "unprognostic (9.94e-2)" "unprognostic (8.10e-2)" "unprognostic (5.64e-2)" "unprognostic (7.12e-2)" "unprognostic (1.66e-1)" "unprognostic (2.25e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (1.96e-3)" "unprognostic (2.74e-2)" "unprognostic (3.98e-2)" "unprognostic (1.76e-3)" "prognostic unfavourable (3.33e-4)" 69.8 1.0 7.6 2.1 8.3 3.7 9.7 0.8 4.6 1.1 21.4 2.6 1.2 1.3 12.2 13.6 6.5 1.4 4.1 59.0 6.4 6.4 0.8 0.6 1.0 0.9 8.5 1.9 2.1 23.0 5.5 7.8 0.6 10.7 3.7 3.7 4.9 19.8 2.6 61.7 1.5 1.4 94.0 11.5 0.6 4.0 5.5 2.6 2.0 9.9 39.3 4.1 3.4 2.7 0.1 0.0 8.0 0.0 0.0 0.1 0.0 0.2 0.0 5.0 0.3 0.4 2.2 0.5 0.1 0.2 1.5 0.5 0.1 0.6 0.2 0.2 0.4 0.2 0.2 0.6 1.3 0.2 0.7 0.5 0.0 0.3 2.7 0.0 0.1 1.5 0.3 0.1 0.3 0.0 0.0 0.3 0.3 0.7 0.1 0.0 3.9 0.1 0.0 1.5 0.0 0.3 0.1 4.0 1.2 0.1 0.0 0.4 0.0 10.7 0.0 0.1 4.6 0.3 0.3 4.1 0.1 0.7 1.8 3.4 0.9 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 8.3 0.8 4.6 6.4 6.4 8.5 1.9 10.7 2.6 THOC3 "MGC5469, TEX1" ENSG00000051596 "THO complex 3" Q96J01 5 175917873-176034680 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042764, HPA044009" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA042764: AB_10965055, HPA044009: AB_10959603" "unprognostic (1.13e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-3)" "unprognostic (6.48e-3)" "unprognostic (8.60e-2)" "unprognostic (3.57e-2)" "unprognostic (3.06e-3)" "unprognostic (2.02e-2)" "unprognostic (3.41e-2)" "unprognostic (1.11e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-2)" "unprognostic (8.80e-3)" "unprognostic (3.20e-1)" "unprognostic (2.86e-1)" "unprognostic (3.16e-2)" "unprognostic (2.91e-1)" 2.3 3.5 8.5 2.3 5.8 8.3 6.0 12.5 6.4 4.7 7.3 3.0 3.4 20.0 21.5 4.0 1.6 1.7 8.5 3.2 4.4 6.0 2.8 7.3 2.6 5.3 3.4 0.4 3.7 4.5 3.8 5.9 5.5 4.1 2.6 7.2 4.1 3.0 2.0 4.3 4.5 11.9 5.1 12.5 5.1 7.6 24.0 13.9 4.7 10.5 12.6 41.4 19.2 22.1 12.4 13.1 28.9 12.7 11.4 48.2 13.4 12.5 29.6 34.4 17.5 18.2 28.9 19.4 7.7 19.1 20.0 57.0 31.4 19.8 29.2 15.6 12.3 19.0 4.2 25.5 14.0 9.6 24.3 25.4 12.9 16.2 23.6 13.1 18.7 26.7 17.1 15.6 11.3 45.4 29.9 16.7 30.1 21.1 16.6 25.5 14.8 27.7 13.6 13.7 15.5 23.4 12.4 10.2 11.7 15.7 23.9 6.6 11.5 17.3 7.6 24.8 7.9 4.4 9.0 4.7 13.7 10.5 16.5 16.5 28.3 16.8 13.9 24.0 34.9 21.9 1.3 12.6 9.4 12.9 41.4 19.2 TIAL1 TIAR ENSG00000151923 "TIA1 cytotoxic granule associated RNA binding protein like 1" Q01085 10 119571802-119597029 "Predicted intracellular proteins" Apoptosis RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060962 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA060962: " "unprognostic (1.61e-2)" "unprognostic (9.30e-2)" "unprognostic (1.26e-1)" "unprognostic (3.76e-1)" "unprognostic (5.33e-2)" "unprognostic (3.91e-2)" "prognostic unfavourable (7.81e-6)" "unprognostic (5.54e-2)" "unprognostic (9.21e-2)" "unprognostic (3.89e-3)" "unprognostic (3.74e-1)" "unprognostic (1.32e-3)" "unprognostic (6.48e-3)" "unprognostic (6.35e-2)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (2.26e-2)" 30.0 29.6 31.4 29.4 44.4 39.2 46.6 72.8 47.3 27.7 27.3 26.7 26.9 23.8 35.0 37.9 43.9 27.1 27.9 30.1 32.5 20.4 25.7 35.3 30.2 39.5 48.2 25.0 34.6 35.5 40.2 30.7 33.2 33.6 27.7 34.3 20.3 33.6 32.0 51.5 31.7 32.5 30.3 39.3 33.3 32.5 28.1 47.8 38.0 33.3 23.6 40.9 29.5 45.8 5.7 6.6 4.9 5.9 7.8 8.6 2.6 35.7 23.7 40.5 44.2 24.5 33.7 27.0 31.9 40.3 39.1 37.6 28.2 43.2 35.6 19.7 29.0 33.9 39.7 25.9 51.1 34.8 17.7 26.8 26.2 29.4 29.3 40.4 32.8 28.8 31.9 31.0 52.2 38.1 26.7 38.2 36.3 30.9 35.5 37.3 20.3 19.8 30.6 31.8 23.6 32.4 20.3 14.5 17.2 21.5 20.7 28.4 21.4 24.1 26.4 24.8 21.0 20.3 33.6 25.1 31.5 28.7 23.4 38.5 18.1 3.7 4.5 3.9 7.2 3.6 7.3 5.4 7.4 6.7 4.6 5.7 7.9 8.3 4.9 7.8 5.9 6.6 8.6 2.6 31.4 44.4 72.8 47.3 32.5 20.4 48.2 25.0 33.6 47.8 TIGD6 DKFZp761E2110 ENSG00000164296 "Tigger transposable element derived 6" Q17RP2 5 149993118-150001167 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA044599 Uncertain Approved "Nucleoplasm,Vesicles,Actin filaments" Nucleoplasm "Vesicles, Actin filaments" "HPA044599: AB_10961286" "unprognostic (1.06e-1)" "unprognostic (3.25e-1)" "prognostic favourable (5.35e-4)" "unprognostic (1.94e-2)" "unprognostic (8.18e-2)" "unprognostic (3.00e-2)" "unprognostic (1.30e-3)" "unprognostic (7.48e-2)" "unprognostic (5.96e-2)" "unprognostic (3.85e-2)" "prognostic favourable (5.88e-4)" "unprognostic (1.94e-3)" "unprognostic (1.85e-3)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.33e-3)" "unprognostic (1.18e-1)" 6.9 10.5 5.9 3.9 10.7 2.8 9.9 9.3 9.4 5.8 6.1 10.0 8.9 4.7 6.5 11.1 5.0 6.9 5.1 4.5 6.4 4.7 7.7 7.0 5.3 3.9 7.3 7.1 8.6 6.8 28.0 10.5 5.5 7.1 8.8 5.7 6.4 8.1 12.6 3.8 7.2 5.2 5.9 7.6 5.8 6.1 9.8 8.0 6.1 6.5 3.6 4.3 6.2 6.1 3.5 3.3 2.1 4.0 6.3 8.0 2.6 2.3 6.2 4.2 9.1 12.1 10.0 6.6 6.6 7.0 5.2 5.2 4.0 4.1 1.1 5.9 7.7 4.1 3.7 4.8 6.1 4.9 3.1 1.9 3.2 2.1 10.8 2.7 5.0 10.3 9.2 6.7 8.8 4.0 2.6 5.3 6.3 5.4 3.6 1.2 1.7 5.3 4.1 4.8 2.9 4.9 3.3 3.3 4.2 4.6 7.5 9.3 8.3 4.8 5.3 4.2 3.3 4.6 4.8 3.9 1.5 3.0 6.7 3.0 6.5 0.2 4.0 2.1 2.8 3.9 2.5 2.7 3.8 2.8 3.3 3.5 8.0 5.1 0.0 6.3 2.2 2.2 3.7 2.6 5.9 10.7 9.3 9.4 6.4 4.7 7.3 7.1 7.1 8.0 TIPRL "dJ69E11.3, MGC3794, TIP41, TIPRL1" ENSG00000143155 "TOR signaling pathway regulator" O75663 1 168178933-168202114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027995, HPA054282" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA027995: AB_10602900, HPA054282: " "unprognostic (3.18e-2)" "unprognostic (1.05e-1)" "unprognostic (5.05e-2)" "unprognostic (3.17e-1)" "unprognostic (3.80e-1)" "unprognostic (2.35e-3)" "prognostic unfavourable (1.60e-4)" "unprognostic (5.82e-2)" "unprognostic (3.32e-2)" "unprognostic (1.12e-2)" "unprognostic (4.30e-3)" "unprognostic (1.53e-1)" "prognostic unfavourable (1.45e-8)" "unprognostic (3.23e-1)" "unprognostic (1.57e-1)" "unprognostic (5.55e-2)" "unprognostic (8.61e-2)" 19.6 22.3 17.0 18.6 29.6 29.7 21.4 18.4 29.1 19.4 21.9 11.2 12.9 18.9 25.9 17.7 28.5 17.5 17.1 23.1 17.4 20.5 22.9 38.3 16.2 20.2 18.0 19.3 21.6 22.2 23.8 31.9 19.8 23.1 19.9 22.7 11.4 17.9 18.6 32.0 16.2 23.2 23.5 16.0 19.0 16.1 22.8 12.4 35.2 17.8 21.1 21.2 23.3 18.5 17.7 21.5 36.2 21.4 19.3 23.9 17.7 26.4 11.5 18.2 16.5 14.9 21.6 10.8 19.8 20.9 21.7 19.5 17.9 19.7 18.5 27.4 18.9 32.0 13.5 19.3 21.0 17.8 13.8 17.9 12.0 8.6 26.2 35.6 24.8 17.4 24.8 18.9 25.3 22.8 25.8 26.4 18.7 9.2 31.8 18.5 14.6 20.7 15.6 18.6 25.3 19.5 13.0 11.8 26.3 15.3 21.7 38.8 23.7 36.7 20.7 18.4 21.1 17.2 26.7 28.9 29.9 41.3 12.0 23.6 21.0 36.2 18.7 24.2 16.2 21.4 16.2 17.7 19.0 17.2 21.5 17.7 17.1 16.9 24.2 19.3 21.4 16.1 23.9 17.7 17.0 29.6 18.4 29.1 17.4 20.5 18.0 19.3 23.1 12.4 TLCD2 ENSG00000185561 "TLC domain containing 2" A6NGC4 17 1702790-1710438 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 6.5;ASC TERT1: 7.6;SiHa: 8.1;T-47d: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 4.1;neutrophil: 2.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046063 Uncertain Approved Nucleoli,Vesicles Vesicles Nucleoli "HPA046063: " "unprognostic (1.78e-1)" "unprognostic (6.71e-2)" "unprognostic (2.56e-2)" "unprognostic (1.20e-1)" "unprognostic (8.64e-3)" "unprognostic (1.64e-1)" "unprognostic (3.32e-1)" "unprognostic (4.04e-2)" "unprognostic (7.94e-2)" "unprognostic (7.74e-2)" "unprognostic (2.29e-3)" "unprognostic (2.56e-1)" "prognostic unfavourable (4.36e-5)" "unprognostic (3.77e-2)" "unprognostic (2.82e-1)" "unprognostic (7.79e-2)" "unprognostic (4.44e-2)" 11.3 9.2 0.5 4.7 1.4 1.7 18.4 0.1 1.5 2.7 9.6 0.3 1.7 7.9 1.8 3.1 6.8 2.7 5.6 4.0 0.6 0.4 2.3 14.8 4.6 0.5 1.2 0.4 4.6 1.2 1.5 0.9 1.6 1.9 4.1 5.4 3.0 2.9 3.6 2.2 2.2 18.4 4.3 1.3 1.1 4.5 0.8 0.5 0.3 2.6 1.2 2.7 4.8 6.3 0.7 0.4 4.1 0.4 0.6 0.5 0.1 0.7 1.4 0.8 2.4 6.5 7.6 0.5 1.3 1.2 0.7 0.5 4.6 2.1 0.1 1.3 2.1 6.2 1.0 0.6 0.5 0.2 1.0 0.6 2.0 0.4 3.7 0.0 1.6 6.1 2.2 0.8 1.5 0.5 0.5 0.3 0.6 1.3 0.0 0.3 0.1 0.4 0.1 3.7 0.1 0.4 2.2 0.1 0.3 8.1 0.7 1.2 6.5 0.6 1.7 0.4 2.0 1.4 0.3 0.1 0.0 0.1 0.4 0.2 1.0 4.1 0.4 0.6 0.4 0.2 0.2 0.4 0.5 0.2 0.1 0.7 0.4 0.4 2.7 0.6 0.2 0.4 0.2 0.1 0.5 1.4 0.1 1.5 0.6 0.4 1.2 0.4 1.9 0.5 TLL1 ENSG00000038295 "Tolloid like 1" O43897 4 165873258-166103895 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Differentiation "Developmental protein, Hydrolase, Metalloprotease, Protease" "Atrial septal defect, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6" "Group enriched" "Detected in some" 4 "HeLa: 8.5;Karpas-707: 13.3;PC-3: 4.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 40.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 10 "cerebellum: 132.6" HPA060767 Approved Vesicles "Secreted to extracellular matrix" Vesicles "HPA060767: " "unprognostic (2.17e-1)" "unprognostic (6.45e-4)" "unprognostic (8.60e-2)" "unprognostic (2.65e-5)" "unprognostic (9.85e-2)" "unprognostic (2.51e-4)" "unprognostic (3.37e-2)" "unprognostic (3.61e-2)" "unprognostic (1.56e-1)" "unprognostic (5.07e-4)" "unprognostic (2.86e-2)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (2.13e-3)" "unprognostic (7.76e-2)" "unprognostic (6.91e-3)" "unprognostic (1.21e-5)" 10.1 1.3 1.2 2.6 2.8 0.0 7.9 40.6 2.9 5.0 5.4 0.2 4.2 1.4 3.0 2.7 2.5 2.4 5.4 2.4 2.2 1.7 3.3 0.5 3.1 3.0 1.1 0.6 1.6 4.6 1.1 2.2 13.8 8.5 3.1 2.2 3.3 1.9 1.9 1.6 2.7 4.4 3.3 0.9 0.4 1.7 1.5 0.1 0.0 3.2 1.4 1.6 3.6 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.0 0.5 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.1 0.0 8.5 0.0 0.0 0.0 0.0 0.5 1.5 0.0 1.8 1.4 0.0 13.3 0.0 0.0 0.0 0.2 1.2 4.8 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.8 40.6 2.9 2.2 1.7 1.1 0.6 8.5 0.1 TM2D2 BLP1 ENSG00000169490 "TM2 domain containing 2" Q9BX73 8 38988808-38996824 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047152, HPA050547" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Vesicles, Plasma membrane" "HPA047152: , HPA050547: AB_2681168" "prognostic unfavourable (7.49e-4)" "unprognostic (1.49e-1)" "prognostic favourable (1.71e-4)" "unprognostic (2.55e-2)" "unprognostic (7.02e-2)" "unprognostic (2.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-2)" "unprognostic (2.43e-3)" "unprognostic (4.58e-2)" "unprognostic (1.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-2)" "unprognostic (8.61e-2)" 21.6 26.2 19.9 14.9 24.3 11.3 24.5 18.8 29.6 21.0 15.3 18.4 25.4 17.5 20.1 27.6 17.2 17.9 22.9 19.4 18.7 20.4 32.6 29.0 21.1 18.1 20.5 17.3 23.3 26.8 25.9 17.5 32.6 25.7 22.8 16.6 22.9 18.8 23.4 14.6 18.5 20.7 17.7 16.4 24.3 19.2 26.1 13.9 11.1 39.7 14.9 14.9 16.7 19.5 14.4 33.5 27.2 18.8 17.4 22.8 19.2 13.9 22.5 10.6 14.5 24.7 16.6 14.5 29.7 18.3 22.5 20.5 17.1 12.1 4.9 23.4 21.9 15.2 11.1 17.9 24.6 5.8 8.6 11.2 13.3 18.5 21.8 3.3 14.6 20.1 17.7 17.7 8.6 28.9 12.3 14.6 30.0 8.6 8.1 11.3 13.3 9.0 7.0 13.6 8.2 25.7 11.1 3.5 6.9 11.3 8.0 14.6 19.5 7.0 25.9 18.3 13.7 26.6 14.9 10.3 22.5 8.6 13.9 7.6 12.7 27.2 16.2 14.5 18.0 18.8 19.6 14.3 21.2 19.6 17.0 14.4 20.2 19.6 4.5 17.4 15.6 33.5 22.8 19.2 19.9 24.3 18.8 29.6 18.7 20.4 20.5 17.3 25.7 13.9 TM4SF18 L6D ENSG00000163762 "Transmembrane 4 L six family member 18" Q96CE8 3 149318498-149334414 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 29.1;EFO-21: 61.5;HUVEC TERT2: 20.3;NTERA-2: 14.6" "Cancer enhanced" "Detected in all" "renal cancer: 17.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053639, HPA069378" Approved Approved Vesicles,Cytosol Vesicles Cytosol "HPA053639: , HPA069378: " "unprognostic (2.25e-1)" "unprognostic (3.68e-1)" "unprognostic (4.76e-2)" "unprognostic (1.08e-1)" "unprognostic (9.11e-3)" "unprognostic (1.05e-2)" "prognostic favourable (8.63e-4)" "unprognostic (2.84e-1)" "unprognostic (6.13e-3)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (1.75e-1)" "unprognostic (5.71e-2)" "unprognostic (3.56e-3)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.97e-1)" 17.9 4.8 7.1 4.0 8.8 0.1 14.4 3.7 7.3 7.9 3.5 1.7 4.7 3.1 7.6 7.2 5.4 5.6 9.0 10.8 8.4 6.2 26.6 9.7 7.4 8.0 9.3 1.5 5.4 8.0 4.2 7.4 14.1 12.3 9.1 2.9 11.9 3.5 5.6 9.3 2.7 3.9 12.3 7.4 34.6 3.5 2.6 8.2 0.6 12.0 5.7 4.0 6.0 5.8 0.9 0.6 1.2 0.4 2.8 0.5 0.0 0.0 29.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 61.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.3 0.0 0.0 1.9 0.2 0.0 0.0 14.6 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.7 1.2 0.4 0.4 0.3 0.2 0.1 0.5 0.4 0.2 0.0 0.9 0.4 0.5 0.5 2.8 0.3 0.6 0.1 0.0 7.1 8.8 3.7 7.3 8.4 6.2 9.3 1.5 12.3 8.2 TM7SF2 "ANG1, DHCR14A, NET47" ENSG00000149809 "Transmembrane 7 superfamily member 2" O76062 11 65111845-65116384 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.1" "Cell line enhanced" "Detected in many" "MCF7: 21.6;RPTEC TERT1: 24.9;T-47d: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030691, HPA072704" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "HPA030691: AB_10602480, HPA072704: " "unprognostic (1.62e-1)" "unprognostic (5.23e-2)" "unprognostic (1.70e-2)" "unprognostic (1.78e-1)" "unprognostic (5.74e-2)" "unprognostic (1.10e-1)" "unprognostic (5.98e-2)" "unprognostic (6.06e-2)" "unprognostic (5.72e-2)" "unprognostic (1.74e-2)" "unprognostic (7.06e-2)" "unprognostic (1.69e-1)" "prognostic favourable (8.49e-8)" "unprognostic (8.77e-2)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.44e-2)" 27.7 78.1 6.9 2.2 12.5 2.0 10.0 5.6 21.7 4.7 3.1 22.4 5.1 4.8 1.5 11.0 11.5 6.4 8.5 28.2 7.4 6.6 8.3 38.6 5.1 1.7 10.3 9.6 13.5 22.6 11.8 6.2 2.2 13.2 19.8 2.3 5.4 28.5 3.3 3.3 17.9 2.8 1.3 7.3 1.9 8.8 5.3 8.8 1.9 7.4 13.6 10.4 2.6 6.1 7.4 22.6 1.8 1.0 7.3 7.6 3.0 2.6 3.5 8.3 12.0 3.3 0.2 5.3 0.6 1.3 1.0 1.1 8.6 12.2 5.3 9.4 0.4 4.3 3.7 5.8 0.7 5.0 1.8 3.3 1.0 17.3 6.8 1.3 3.6 1.5 1.8 4.8 0.6 0.9 1.9 4.1 0.3 21.6 2.2 5.7 4.5 4.0 7.1 0.4 12.4 24.9 3.8 9.5 10.6 0.4 9.1 2.1 48.4 3.5 0.6 0.1 1.2 1.2 0.8 9.4 5.9 3.0 0.8 2.0 0.3 0.5 1.0 1.8 5.5 0.8 4.3 7.1 3.5 4.5 0.9 7.4 7.6 5.5 0.7 7.3 0.5 22.6 3.1 3.0 6.9 12.5 5.6 21.7 7.4 6.6 10.3 9.6 13.2 8.8 TM9SF3 SMBP ENSG00000077147 "Transmembrane 9 superfamily member 3" Q9HD45 10 96518109-96587452 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039609 Approved Approved "Golgi apparatus,Vesicles" 320000 Vesicles "Golgi apparatus" "HPA039609: AB_10673535" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (1.43e-2)" "unprognostic (5.11e-2)" "unprognostic (4.95e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-2)" "unprognostic (3.09e-2)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (4.14e-3)" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (8.28e-3)" "unprognostic (6.18e-2)" 28.4 23.9 19.6 31.0 19.3 12.8 24.5 16.0 18.9 29.3 54.2 16.5 49.9 42.9 31.5 27.3 28.4 23.7 57.7 37.3 19.5 19.2 28.7 50.8 25.2 17.0 20.8 13.5 31.3 33.6 27.4 20.3 50.7 18.7 35.6 35.7 18.5 43.0 57.9 18.4 22.4 60.0 21.4 26.3 25.6 69.6 15.4 18.3 27.1 33.1 16.1 26.6 34.7 34.4 3.3 11.2 7.7 3.6 5.5 6.5 2.4 37.0 25.3 28.2 39.4 41.3 30.9 33.9 51.3 38.0 22.3 18.4 30.3 73.4 27.4 28.5 45.2 35.1 25.5 28.2 41.9 30.6 21.9 24.3 22.4 23.7 31.1 49.6 28.4 28.4 28.6 31.4 54.6 24.4 24.1 31.6 33.9 16.9 19.2 19.2 17.9 15.6 23.9 35.7 21.4 31.7 27.6 13.1 29.5 27.1 26.1 26.1 44.9 18.9 42.7 27.8 23.6 27.7 46.8 32.8 37.2 25.4 37.7 34.8 19.3 7.7 3.6 5.5 5.8 3.5 6.5 3.3 6.2 6.3 4.3 2.2 4.8 6.0 4.2 5.5 3.5 11.2 6.0 2.4 19.6 19.3 16.0 18.9 19.5 19.2 20.8 13.5 18.7 18.3 TMBIM1 "LFG3, PP1201, RECS1" ENSG00000135926 "Transmembrane BAX inhibitor motif containing 1" Q969X1 2 218274192-218292586 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012093, HPA070824" Approved Supported Vesicles Vesicles "HPA012093: AB_1858056, HPA070824: " "unprognostic (4.36e-2)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (1.73e-3)" "unprognostic (2.34e-3)" "unprognostic (3.81e-3)" "unprognostic (8.91e-3)" "unprognostic (5.58e-3)" "unprognostic (9.85e-2)" "unprognostic (3.76e-3)" "prognostic unfavourable (4.22e-4)" "unprognostic (1.69e-1)" "prognostic favourable (3.38e-4)" "unprognostic (1.22e-1)" "unprognostic (4.63e-2)" "unprognostic (2.75e-2)" "unprognostic (4.50e-1)" 64.3 34.6 26.5 22.1 45.0 23.0 84.3 11.0 38.3 35.7 42.2 43.1 33.7 41.8 35.0 30.0 86.8 25.1 50.3 34.6 21.0 17.2 50.7 69.3 46.7 34.3 37.5 13.7 27.9 87.6 31.3 15.0 92.7 40.9 31.6 40.1 23.9 40.1 43.7 53.2 49.5 70.6 41.2 50.3 22.7 57.8 13.2 32.5 9.4 66.4 42.1 36.3 57.7 54.5 17.0 19.6 60.3 43.5 13.0 24.0 33.6 26.8 9.7 0.5 7.1 62.9 26.6 29.0 26.4 32.6 15.6 18.0 24.8 66.7 6.1 19.3 38.8 46.0 9.0 59.2 15.4 22.1 3.7 38.9 6.7 29.7 28.5 0.5 38.5 25.1 55.7 32.0 40.9 16.6 24.2 11.5 27.3 1.1 0.4 6.7 0.4 8.7 0.9 4.3 4.8 21.0 84.8 0.5 0.5 8.7 32.4 18.3 8.7 5.9 25.1 28.2 7.8 13.0 9.5 5.6 6.5 2.7 27.7 6.1 15.9 60.3 27.7 59.9 24.0 36.2 20.5 17.0 22.0 19.5 19.6 14.0 14.7 15.8 35.5 13.0 43.5 5.3 23.5 33.6 26.5 45.0 11.0 38.3 21.0 17.2 37.5 13.7 40.9 32.5 TMC7 FLJ21240 ENSG00000170537 "Transmembrane channel like 7" Q7Z402 16 18983934-19063942 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.8;testis: 14.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029465 Uncertain Approved Vesicles Vesicles "HPA029465: AB_10600914" "unprognostic (1.80e-4)" "unprognostic (6.13e-2)" "unprognostic (1.82e-1)" "unprognostic (2.07e-3)" "unprognostic (1.25e-1)" "unprognostic (1.19e-3)" "unprognostic (7.60e-5)" "prognostic unfavourable (3.20e-4)" "unprognostic (7.60e-2)" "unprognostic (1.29e-1)" "prognostic unfavourable (7.64e-4)" "unprognostic (3.39e-1)" "unprognostic (1.00e-1)" "unprognostic (1.75e-1)" "unprognostic (1.94e-1)" "unprognostic (5.66e-2)" "prognostic favourable (9.20e-4)" 3.6 0.7 6.2 1.9 11.4 0.7 2.0 8.5 11.1 1.1 6.7 24.8 0.0 4.4 1.5 1.3 0.9 1.0 2.6 1.6 9.7 5.3 1.0 0.7 5.2 0.7 15.7 6.6 0.7 0.9 1.4 0.7 7.7 12.8 2.8 8.2 0.6 0.7 1.9 1.6 2.0 4.9 2.2 15.7 1.1 5.4 14.9 12.8 0.0 1.6 0.0 0.6 9.6 1.3 1.6 1.2 2.9 0.8 1.6 1.0 0.2 2.0 4.1 1.2 2.0 0.2 1.8 5.5 0.7 1.2 0.7 1.8 1.3 9.6 0.2 9.2 0.7 7.6 3.3 3.2 1.0 0.1 2.4 0.2 3.4 5.9 0.3 0.2 0.1 0.4 4.6 7.4 8.4 3.1 2.3 0.8 3.3 4.6 0.3 0.3 3.5 6.1 0.2 3.6 0.3 1.4 10.0 0.7 2.1 2.3 6.3 0.6 1.8 0.7 2.7 1.2 2.1 1.5 3.6 0.6 1.0 0.3 6.4 0.3 1.1 2.5 0.8 0.8 0.9 0.6 0.5 0.9 0.9 0.7 0.3 1.6 0.9 1.0 2.9 1.6 0.4 1.2 0.5 0.2 6.2 11.4 8.5 8.3 9.7 5.3 15.7 6.6 12.8 12.8 TMCC3 KIAA1145 ENSG00000057704 "Transmembrane and coiled-coil domain family 3" Q9ULS5 12 94567124-94650562 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 17.9;Karpas-707: 24.2;U-266/84: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 19.2;neutrophil: 30.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014272 Approved Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "HPA014272: AB_1858059" "unprognostic (1.03e-1)" "unprognostic (2.54e-1)" "unprognostic (1.52e-3)" "prognostic unfavourable (4.87e-4)" "unprognostic (1.30e-1)" "unprognostic (8.63e-2)" "unprognostic (5.87e-2)" "unprognostic (1.17e-2)" "unprognostic (9.12e-2)" "unprognostic (3.45e-3)" "unprognostic (1.24e-1)" "unprognostic (7.73e-2)" "unprognostic (1.80e-3)" "unprognostic (9.11e-2)" "unprognostic (2.32e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" 10.6 4.0 10.2 7.7 20.9 8.1 9.9 2.7 9.9 11.0 19.7 32.6 6.8 13.1 6.9 3.0 6.1 5.5 4.7 4.4 14.7 10.8 7.4 3.5 5.9 3.9 25.8 7.4 5.2 2.8 5.0 4.7 15.7 17.8 7.7 15.0 7.3 5.8 5.1 20.2 7.0 23.0 7.2 25.5 11.6 6.4 2.2 20.4 0.1 12.0 3.3 5.3 7.2 5.9 2.5 1.1 30.0 3.0 1.3 1.5 1.1 4.3 0.2 1.1 0.0 0.4 1.6 7.9 0.0 0.0 0.2 1.1 0.0 0.9 0.1 0.0 0.0 10.8 6.1 7.3 1.5 1.9 1.5 2.8 0.4 0.0 0.3 0.0 5.9 1.0 1.0 4.1 5.9 17.9 0.1 24.2 0.6 0.2 0.0 0.2 0.5 3.7 0.0 0.3 2.8 1.2 9.2 0.1 0.5 0.1 4.6 0.2 0.0 0.2 10.7 0.0 0.1 0.0 1.9 11.2 16.1 0.1 2.2 0.9 1.0 6.5 1.8 19.2 1.5 2.6 0.1 2.5 0.6 0.8 1.0 1.4 0.0 1.0 30.0 1.3 3.0 1.1 0.0 1.1 10.2 20.9 2.7 9.9 14.7 10.8 25.8 7.4 17.8 20.4 TMED2 "P24A, p24b1, p24beta1, RNP24" ENSG00000086598 "Transmembrane p24 trafficking protein 2" Q15363 12 123584531-123598577 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014060 Approved Supported Vesicles Vesicles "HPA014060: AB_1856389" "unprognostic (6.36e-2)" "unprognostic (3.38e-3)" "unprognostic (5.41e-3)" "unprognostic (1.75e-2)" "unprognostic (2.98e-2)" "prognostic unfavourable (3.36e-6)" "unprognostic (3.57e-3)" "unprognostic (2.20e-2)" "unprognostic (4.31e-2)" "unprognostic (9.76e-3)" "unprognostic (1.03e-2)" "unprognostic (3.94e-2)" "prognostic unfavourable (2.35e-7)" "unprognostic (2.97e-1)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (9.87e-2)" 31.3 31.9 15.7 21.8 21.2 23.5 32.0 13.2 21.5 38.5 31.6 20.4 41.1 27.6 33.4 49.0 41.3 27.4 28.9 41.7 15.7 17.1 32.6 120.1 28.1 29.4 18.2 16.7 37.4 135.4 18.1 36.3 40.0 18.9 33.3 32.8 23.8 90.2 38.0 46.3 27.4 34.2 30.5 22.5 25.6 32.4 17.8 15.0 24.0 49.2 23.8 30.0 34.0 27.8 32.4 69.3 58.9 40.9 39.5 61.2 36.2 41.8 37.3 24.8 42.9 56.6 50.2 59.1 72.8 58.8 46.4 36.8 37.2 36.5 35.9 39.1 72.5 41.9 33.5 39.2 48.8 26.9 28.9 38.7 22.7 48.0 107.6 52.7 33.4 42.2 65.5 39.8 54.1 43.3 39.0 24.6 47.3 31.1 27.9 43.3 35.8 33.6 29.1 40.5 41.7 56.6 63.5 30.9 26.8 48.7 49.0 48.2 83.1 42.8 41.0 39.6 25.0 38.2 40.7 54.5 50.5 30.5 46.7 34.9 46.7 58.9 39.8 39.6 46.8 40.9 61.2 32.4 42.4 44.1 44.2 27.2 34.6 40.3 31.5 39.5 37.8 69.3 38.3 36.2 15.7 21.2 13.2 21.5 15.7 17.1 18.2 16.7 18.9 15.0 TMEM102 "CBAP, FLJ36878" ENSG00000181284 "Transmembrane protein 102" Q8N9M5 17 7435443-7437679 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 11.2;HMC-1: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 7.4" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024433 Uncertain Approved Vesicles Vesicles "HPA024433: AB_1858071" "unprognostic (2.42e-2)" "unprognostic (2.52e-2)" "unprognostic (1.54e-2)" "unprognostic (1.64e-1)" "unprognostic (1.10e-2)" "unprognostic (9.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.61e-1)" "unprognostic (2.91e-2)" "unprognostic (2.69e-2)" "unprognostic (2.69e-1)" "unprognostic (4.95e-2)" "prognostic favourable (9.90e-4)" "unprognostic (1.10e-3)" "unprognostic (8.40e-2)" "unprognostic (1.67e-1)" "unprognostic (1.42e-3)" 6.6 8.6 1.6 5.8 6.0 3.7 8.2 0.9 3.5 3.5 8.0 2.9 7.4 7.1 2.3 3.1 11.7 2.9 6.5 4.1 2.2 0.9 9.1 7.1 6.0 11.9 7.3 0.1 1.9 7.6 3.8 1.5 6.1 3.2 4.8 2.8 2.0 8.3 3.0 4.1 9.6 10.9 1.0 3.7 7.9 6.3 6.9 3.5 17.8 9.1 4.1 13.2 4.8 4.6 1.5 1.2 7.4 2.1 1.9 2.1 0.8 5.4 3.9 0.4 0.0 1.4 0.6 3.1 1.2 1.5 0.8 1.7 2.0 5.8 5.5 5.2 0.6 11.2 1.0 6.1 0.2 5.0 6.9 5.1 2.4 2.0 0.7 3.0 12.9 0.4 5.8 0.4 1.1 2.6 1.9 0.3 0.0 3.3 3.4 5.3 0.2 3.2 5.5 0.4 1.9 5.4 3.6 0.2 3.7 0.6 5.0 1.5 2.6 1.2 3.4 0.2 0.3 0.6 0.1 1.1 1.4 0.8 1.7 2.6 2.5 0.0 0.9 7.4 1.7 1.9 1.0 1.5 1.8 2.1 1.1 1.4 1.4 1.5 0.1 1.9 2.1 1.2 1.6 0.8 1.6 6.0 0.9 3.5 2.2 0.9 7.3 0.1 3.2 3.5 TMEM108 "CT124, MGC3040" ENSG00000144868 "Transmembrane protein 108" Q6UXF1 3 133038391-133397792 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.6" "Cell line enhanced" "Detected in some" "HMC-1: 11.6;LHCN-M2: 6.5;SCLC-21H: 10.0;SH-SY5Y: 44.3" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063350 Enhanced Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane, Cytosol" "Nucleoli, Vesicles" "HPA063350: " "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.07e-3)" "unprognostic (3.17e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.06e-4)" "unprognostic (2.08e-1)" "unprognostic (7.27e-4)" "unprognostic (1.11e-1)" "unprognostic (3.03e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-2)" "unprognostic (6.12e-2)" "unprognostic (1.36e-2)" 2.2 15.1 12.7 2.2 13.8 0.7 2.4 15.6 21.7 3.2 1.8 7.5 0.2 1.1 3.7 1.3 12.7 2.4 1.6 8.4 10.0 8.1 1.0 0.6 12.1 2.5 5.3 13.7 0.8 1.0 6.1 2.8 9.1 4.9 4.0 2.2 16.1 1.8 3.2 25.6 2.2 2.0 10.4 4.4 2.0 2.2 16.8 4.3 0.0 4.1 1.5 3.3 12.0 1.3 0.8 0.4 1.0 0.4 0.6 0.8 0.6 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.4 0.8 3.9 0.0 0.0 0.0 0.0 11.6 0.1 0.0 0.0 0.0 0.6 0.0 0.0 6.5 0.3 0.0 0.1 1.8 0.0 0.0 2.2 0.0 0.5 0.0 10.0 44.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.3 0.8 0.0 1.7 1.0 0.3 0.2 0.5 0.3 0.3 0.3 0.2 0.5 0.0 0.8 0.3 0.4 0.9 0.6 0.4 0.4 0.8 0.6 12.7 13.8 15.6 21.7 10.0 8.1 5.3 13.7 4.9 4.3 TMEM121B CECR6 ENSG00000183307 "Transmembrane protein 121B" Q9BXQ6 22 17116299-17121367 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 14.1" "Cell line enhanced" "Detected in some" "AF22: 6.2;SCLC-21H: 14.7;THP-1: 11.8;U-937: 9.8" "Cancer enhanced" "Detected in some" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 7 "granulocytes: 4.3;monocytes: 3.2" "Group enriched" "Detected in many" 8 "amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0" "Low region specificity" "Detected in many" HPA068790 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" Vesicles "Nucleoplasm, Plasma membrane" "HPA068790: " "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (7.11e-3)" "unprognostic (4.49e-3)" "unprognostic (3.36e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-3)" "unprognostic (5.32e-2)" "unprognostic (1.97e-1)" "unprognostic (2.01e-2)" "unprognostic (6.88e-4)" "unprognostic (6.08e-2)" "unprognostic (3.10e-4)" "unprognostic (1.02e-2)" "unprognostic (4.37e-2)" "unprognostic (3.49e-3)" "unprognostic (1.71e-1)" 1.3 1.8 7.4 2.2 12.0 2.2 2.0 8.1 19.1 1.0 0.8 2.4 0.0 1.1 1.1 2.3 0.8 1.2 1.0 2.3 7.1 4.0 0.8 0.8 0.9 0.8 2.9 6.9 0.9 2.7 0.8 2.0 1.9 2.3 14.1 1.0 0.2 1.2 1.0 2.8 1.5 0.9 1.3 2.5 1.1 1.0 2.4 4.2 0.0 0.6 0.0 0.8 1.0 0.3 0.0 0.5 4.3 3.2 0.0 0.0 0.6 0.0 0.0 6.2 0.8 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.2 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.8 3.1 2.2 0.1 0.2 3.0 0.0 0.3 0.1 14.7 2.2 0.0 0.0 0.3 0.0 11.8 0.6 0.7 0.3 0.2 0.0 0.2 0.3 0.9 0.0 9.8 0.3 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.6 7.4 12.0 8.1 18.0 7.1 4.0 2.9 6.9 2.3 4.2 TMEM123 "KCT3, PORIMIN" ENSG00000152558 "Transmembrane protein 123" Q8N131 11 102396332-102470384 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 140.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026001, HPA062862" Supported "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus" "Vesicles, Cytosol" "CAB026001: , HPA062862: " "unprognostic (2.64e-1)" "unprognostic (8.39e-2)" "unprognostic (4.18e-3)" "unprognostic (1.40e-1)" "unprognostic (7.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (5.36e-4)" "unprognostic (3.08e-1)" "prognostic unfavourable (2.66e-4)" "unprognostic (1.67e-1)" "unprognostic (1.38e-2)" "unprognostic (8.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-2)" "unprognostic (3.65e-2)" 21.3 23.1 18.8 30.1 23.3 39.8 38.6 7.4 18.8 35.2 38.2 19.1 15.1 12.4 65.3 20.8 31.9 21.6 20.8 36.8 20.7 14.0 27.0 95.4 39.5 55.5 22.6 13.7 27.8 24.7 14.5 8.5 23.9 21.1 34.9 19.9 13.9 53.3 22.2 13.2 29.7 17.6 29.7 22.4 39.9 23.7 22.9 24.6 71.9 66.0 20.1 27.1 43.7 39.8 23.3 30.3 48.3 29.2 52.4 55.5 51.3 28.8 25.9 26.8 24.9 34.3 28.1 18.2 22.5 48.8 46.1 51.3 32.8 140.1 48.7 58.1 52.1 31.3 29.1 37.1 51.0 29.3 10.6 25.3 10.2 48.7 30.3 53.7 19.0 31.3 42.3 32.9 49.3 51.5 16.9 0.1 38.0 9.3 46.6 16.8 16.0 23.7 28.7 74.1 46.7 43.9 28.6 12.7 15.0 27.3 37.4 14.8 23.1 21.0 60.3 31.0 34.8 26.8 16.9 18.9 10.5 49.5 9.0 59.9 20.4 30.1 26.8 48.3 26.3 29.2 40.0 16.7 41.3 31.8 30.3 23.3 55.5 46.9 17.6 52.4 24.2 8.1 42.9 51.3 18.8 23.3 7.4 18.8 20.7 14.0 22.6 13.7 21.1 24.6 TMEM131 "CC28, KIAA0257, PRO1048, RW1, YR-23" ENSG00000075568 "Transmembrane protein 131" Q92545 2 97756333-97995891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017678, HPA017682" Approved Uncertain "Vesicles,Intermediate filaments" "Vesicles, Intermediate filaments" "HPA017678: AB_1858086, HPA017682: AB_1858087" "unprognostic (1.16e-2)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (7.42e-2)" "unprognostic (8.58e-2)" "unprognostic (4.18e-2)" "unprognostic (7.59e-3)" "unprognostic (3.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (5.10e-3)" "unprognostic (5.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-1)" "unprognostic (1.77e-1)" 16.6 19.4 13.7 33.6 19.2 15.8 15.6 18.5 19.4 21.0 25.5 19.1 14.5 18.6 21.8 15.7 19.9 17.3 20.1 17.3 11.7 12.1 14.6 15.8 15.7 24.0 14.1 14.0 21.2 22.0 31.4 27.8 30.9 15.0 17.7 24.1 14.6 18.6 12.7 31.4 24.2 23.6 21.1 13.2 22.5 26.3 14.4 15.3 23.2 14.7 16.8 27.6 20.5 16.7 4.5 5.2 7.3 3.5 5.4 5.4 2.2 13.3 8.2 15.5 11.2 16.3 19.8 16.9 19.9 19.5 10.2 12.3 10.6 19.4 21.4 11.0 20.5 9.7 16.2 26.6 15.2 15.1 10.5 15.5 5.8 15.2 18.4 14.4 20.9 18.9 10.9 18.1 18.9 12.5 9.2 22.9 31.0 8.0 10.4 9.2 8.5 17.8 15.3 9.9 9.4 10.5 16.0 17.5 8.5 12.9 8.9 12.2 7.5 13.4 14.8 26.7 12.3 12.8 7.6 9.8 13.4 10.8 20.9 12.7 18.0 7.3 2.8 7.3 4.0 3.5 4.6 4.5 3.4 4.0 3.7 4.2 4.2 5.4 1.9 5.4 3.2 5.2 2.1 2.2 13.7 19.2 18.5 19.4 11.7 12.1 14.1 14.0 15.0 15.3 TMEM131L "DKFZp586H1322, KIAA0922" ENSG00000121210 "Transmembrane 131 like" A2VDJ0 4 153466346-153636711 "Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 69.4" "Cell line enhanced" "Detected in many" "Daudi: 36.5;MOLT-4: 33.9;U-698: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043472, HPA048443" Uncertain Approved "Nucleoli fibrillar center,Vesicles" Vesicles "Nucleoli fibrillar center" "HPA043472: , HPA048443: " "unprognostic (1.12e-1)" "prognostic favourable (6.69e-6)" "unprognostic (1.71e-1)" "unprognostic (3.75e-2)" "unprognostic (8.37e-2)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "unprognostic (3.30e-2)" "unprognostic (3.23e-2)" "unprognostic (4.11e-2)" "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (4.35e-3)" "unprognostic (2.92e-2)" "unprognostic (3.39e-2)" "unprognostic (3.94e-2)" "unprognostic (3.51e-2)" 7.5 1.9 2.1 37.9 6.0 27.3 6.6 0.5 3.0 6.5 5.6 2.3 3.5 1.5 11.9 7.9 6.6 5.0 4.3 5.6 2.5 1.6 3.4 13.0 6.1 27.6 2.2 1.6 4.9 23.0 0.8 6.4 2.5 2.1 5.3 3.1 5.3 10.3 3.2 17.5 5.2 10.0 8.1 3.0 26.5 6.0 3.2 3.9 69.4 4.1 5.5 36.8 7.1 5.8 18.5 13.3 13.6 23.7 14.9 17.9 10.3 2.0 1.3 5.6 5.9 3.3 2.9 0.1 2.9 1.4 2.0 2.6 9.0 1.3 36.5 0.7 3.8 2.0 4.3 5.0 3.1 3.3 3.1 7.1 2.5 2.3 2.2 7.8 0.4 2.7 3.1 2.6 2.5 5.1 6.7 0.1 2.0 3.7 33.9 5.7 5.0 1.9 11.8 5.4 2.3 1.3 0.8 4.2 3.3 2.3 5.1 3.0 1.9 5.8 4.0 2.7 4.9 3.2 2.4 4.0 4.1 43.3 0.8 4.7 2.2 6.1 12.4 13.1 8.5 23.7 11.2 18.5 10.7 7.9 13.3 17.3 17.9 12.0 13.6 14.9 18.6 1.3 12.9 10.3 2.1 6.0 0.5 3.0 2.5 1.6 2.2 1.6 2.1 3.9 TMEM135 FLJ22104 ENSG00000166575 "Transmembrane protein 135" Q86UB9 11 87037844-87323758 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056685, HPA069473" Uncertain Supported Vesicles Vesicles "HPA056685: , HPA069473: " "unprognostic (1.55e-2)" "unprognostic (1.11e-1)" "unprognostic (2.70e-2)" "unprognostic (6.51e-2)" "unprognostic (3.10e-2)" "unprognostic (4.42e-1)" "unprognostic (1.45e-2)" "unprognostic (2.63e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "prognostic favourable (9.02e-4)" "unprognostic (3.48e-2)" "unprognostic (7.34e-2)" "unprognostic (1.35e-2)" "unprognostic (1.80e-1)" 31.6 28.9 10.5 9.5 12.0 5.9 23.3 11.4 14.8 8.3 14.3 12.8 18.9 21.8 15.1 7.8 7.4 8.4 12.6 12.6 9.9 11.3 16.5 31.2 11.7 9.8 13.8 10.2 14.1 9.2 14.7 24.4 13.5 12.9 15.4 12.1 12.8 16.9 17.8 14.9 7.5 20.1 11.1 11.2 8.3 10.1 15.7 11.4 14.1 15.0 6.4 7.0 10.7 9.9 5.9 7.0 2.2 6.0 8.4 10.4 4.5 4.2 6.9 4.8 6.6 15.7 15.1 6.2 3.2 8.5 3.9 8.4 12.1 19.2 12.0 8.4 4.2 4.1 6.6 7.9 4.2 10.5 4.1 9.6 7.3 42.2 8.8 5.2 4.9 17.3 4.8 5.2 3.6 9.8 8.8 16.4 4.2 3.4 12.7 6.1 5.8 5.9 6.7 3.9 9.5 8.8 13.1 2.5 6.3 5.1 14.6 7.0 20.8 5.8 5.2 4.3 5.3 14.7 2.5 6.9 12.4 13.0 3.0 5.9 7.8 0.9 5.8 1.7 9.7 6.0 8.5 5.9 6.3 10.4 6.6 5.2 7.1 6.8 2.2 8.4 2.7 7.0 6.5 4.5 10.5 12.0 11.4 14.8 9.9 11.3 13.8 10.2 12.9 11.4 TMEM136 MGC17839 ENSG00000181264 "Transmembrane protein 136" Q6ZRR5 11 120325129-120333682 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 5.7" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074432 Approved Vesicles,Cytosol Vesicles Cytosol "HPA074432: " "unprognostic (1.02e-1)" "unprognostic (6.56e-2)" "unprognostic (1.49e-2)" "prognostic unfavourable (6.65e-4)" "unprognostic (1.65e-2)" "unprognostic (3.31e-2)" "unprognostic (6.81e-3)" "unprognostic (1.22e-1)" "unprognostic (1.39e-2)" "unprognostic (2.58e-1)" "unprognostic (2.86e-3)" "unprognostic (2.39e-1)" "unprognostic (2.71e-2)" "unprognostic (2.78e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (7.28e-2)" 4.4 18.9 9.1 2.7 13.8 1.0 5.7 5.8 15.1 4.6 2.9 13.8 3.2 2.1 7.6 14.0 2.6 7.4 5.6 19.1 8.2 5.7 4.8 1.9 4.9 4.0 13.0 7.7 9.0 9.7 9.4 7.9 10.4 12.0 8.4 2.3 9.0 2.4 5.9 1.8 2.0 3.1 6.9 13.7 4.2 2.8 5.4 8.8 0.0 7.8 0.7 2.9 3.2 4.1 0.0 5.7 0.0 0.0 0.0 0.9 0.0 1.7 4.5 8.4 8.0 8.4 13.2 2.1 3.7 9.2 6.0 9.7 2.2 7.5 0.0 11.6 2.3 1.2 7.4 2.8 6.7 0.0 4.6 5.5 4.0 3.9 9.4 0.0 0.0 11.4 2.1 8.4 13.1 6.9 1.5 11.1 8.0 2.1 0.0 0.0 3.6 2.8 4.2 3.4 0.6 7.9 1.6 5.4 5.3 5.2 0.6 1.0 6.9 0.2 4.9 6.6 6.7 1.4 2.2 0.1 0.0 0.0 1.9 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.9 0.0 9.1 13.8 5.8 11.5 8.2 5.7 13.0 7.7 12.0 8.8 TMEM145 FLJ90805 ENSG00000167619 "Transmembrane protein 145" Q8NBT3 19 42313325-42325062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 74.5" "Cell line enhanced" "Detected in many" "HMC-1: 11.7;SCLC-21H: 22.2;SH-SY5Y: 10.6" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Region enriched" "Detected in all" 4 "cerebellum: 74.5" "Group enriched" "Detected in some" 8 "basophil: 4.5;neutrophil: 15.5" "Lineage enriched" "Detected in many" 12 "granulocytes: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060462 Enhanced Approved Approved Vesicles Vesicles "HPA060462: " "unprognostic (9.56e-3)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" "unprognostic (6.62e-2)" "unprognostic (2.14e-1)" "unprognostic (4.27e-3)" "unprognostic (1.53e-2)" "unprognostic (9.85e-2)" "unprognostic (4.20e-4)" "unprognostic (7.35e-2)" "unprognostic (7.64e-2)" "unprognostic (2.30e-1)" "unprognostic (6.31e-2)" 1.6 6.2 8.0 1.2 7.7 2.5 1.3 74.5 30.5 0.6 1.2 3.8 0.0 1.7 1.1 1.6 1.0 1.1 1.4 1.3 5.8 8.5 0.9 1.4 0.8 1.5 5.1 7.6 1.2 3.7 3.0 6.4 0.6 9.3 1.2 1.2 2.8 1.1 0.9 2.3 3.3 1.1 1.2 3.9 1.5 2.0 3.3 3.2 0.0 1.3 0.0 1.1 1.0 0.3 1.3 0.8 15.5 0.9 0.6 0.9 0.8 0.5 2.7 2.1 6.4 0.2 0.2 0.8 0.2 0.1 1.0 2.6 0.5 0.7 1.5 0.3 0.6 0.2 1.5 0.4 1.2 6.7 1.6 2.8 2.5 2.4 0.2 1.6 11.7 0.5 0.5 0.4 0.6 1.1 1.5 5.5 0.1 0.6 0.4 1.9 1.3 8.6 0.2 0.6 5.2 0.1 1.0 22.2 10.6 0.9 0.7 1.3 1.9 1.8 0.3 1.8 1.9 1.3 0.7 1.2 3.0 1.4 0.7 1.1 5.1 4.5 0.9 0.9 0.6 0.8 0.3 1.0 0.6 0.4 0.2 1.3 0.6 0.9 15.5 0.6 0.7 0.8 0.4 0.8 8.0 7.7 74.5 18.1 5.8 8.5 5.1 7.6 9.3 3.2 TMEM159 promethin ENSG00000011638 "Transmembrane protein 159" Q96B96 16 21158377-21180616 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 28.7" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basal ganglia: 14.6;cerebellum: 13.7" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018033, HPA063509" Approved Approved Vesicles Vesicles "HPA018033: AB_2204762, HPA063509: " "unprognostic (7.62e-3)" "unprognostic (2.42e-1)" "unprognostic (1.99e-2)" "unprognostic (1.06e-1)" "unprognostic (8.68e-2)" "unprognostic (6.80e-2)" "unprognostic (3.32e-1)" "unprognostic (2.93e-1)" "unprognostic (3.35e-1)" "unprognostic (2.93e-3)" "prognostic unfavourable (1.59e-4)" "unprognostic (2.03e-1)" "prognostic favourable (8.11e-5)" "unprognostic (8.28e-2)" "unprognostic (1.28e-1)" "unprognostic (1.84e-2)" "unprognostic (1.57e-2)" 35.6 12.7 2.2 6.0 14.6 1.8 27.4 13.7 2.8 25.3 13.5 1.0 10.1 2.7 28.3 9.8 37.1 8.4 23.9 32.4 1.4 1.6 11.3 1.2 10.7 7.6 1.2 1.6 22.0 6.1 5.6 1.2 5.3 1.7 29.7 6.4 10.9 35.2 7.9 57.5 32.5 7.3 45.5 1.5 3.6 7.9 10.9 1.4 6.1 17.4 35.5 21.9 43.7 21.1 11.4 11.3 12.2 8.6 7.5 13.1 7.3 5.8 2.7 3.0 11.1 28.7 18.5 1.5 2.7 11.7 1.2 2.2 2.1 8.0 7.6 3.2 8.7 8.8 4.9 4.5 1.3 3.4 1.8 3.5 1.0 3.9 6.7 2.7 9.4 6.8 23.4 6.5 20.8 6.5 2.5 2.3 2.0 10.3 2.0 2.0 2.7 1.7 11.0 1.6 2.8 14.4 17.5 0.3 0.4 7.4 10.1 3.4 16.8 2.1 4.6 1.7 2.2 9.3 0.7 0.2 0.6 2.5 8.3 2.4 1.8 12.2 8.6 8.0 10.1 5.9 8.7 11.4 13.1 8.6 5.0 9.2 9.6 8.8 3.9 7.5 7.1 11.3 13.0 7.3 2.2 14.6 13.7 2.8 1.4 1.6 1.2 1.6 1.7 1.4 TMEM164 "FLJ22679, RP13-360B22.2" ENSG00000157600 "Transmembrane protein 164" Q5U3C3 X 110002631-110182734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 69.7" "Cell line enhanced" "Detected in all" "HMC-1: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 25.9;eosinophil: 7.2;neutrophil: 8.8" "Lineage enriched" "Detected in many" 15 "granulocytes: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038784 Approved Approved "Vesicles,Cell Junctions" Vesicles "Cell Junctions" "HPA038784: AB_10670790" "unprognostic (2.14e-3)" "unprognostic (3.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.65e-3)" "unprognostic (7.94e-2)" "unprognostic (3.97e-2)" "prognostic unfavourable (8.17e-6)" "unprognostic (9.85e-3)" "unprognostic (5.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-2)" "unprognostic (3.95e-1)" "unprognostic (7.66e-2)" "prognostic favourable (3.14e-4)" "unprognostic (1.76e-1)" "unprognostic (1.81e-2)" "unprognostic (4.19e-3)" 15.0 8.6 9.2 6.1 10.9 11.1 9.2 2.6 6.8 3.9 17.0 6.0 36.3 14.5 4.5 4.1 10.5 5.5 8.8 14.7 6.6 5.9 8.4 1.7 35.8 7.6 4.6 3.5 11.9 17.2 11.1 8.7 6.6 7.0 6.2 14.8 18.7 7.6 69.7 32.0 15.2 33.1 4.6 2.9 6.9 9.9 2.2 5.1 4.5 11.4 6.0 5.8 5.0 5.1 0.4 1.4 25.9 1.7 1.1 0.9 0.8 4.7 10.9 9.0 5.8 11.1 8.2 5.5 2.4 5.6 5.1 3.3 8.5 7.5 3.8 16.3 3.7 7.0 7.7 12.6 5.0 10.5 5.3 25.9 5.9 3.5 6.6 11.4 37.1 11.3 22.3 9.1 12.7 9.9 8.0 4.6 9.0 9.5 11.9 14.5 8.0 7.9 5.5 6.9 3.2 8.1 5.0 8.4 9.4 15.3 15.1 7.0 4.4 11.4 22.0 4.3 3.2 5.0 3.4 2.7 3.4 3.1 11.3 14.3 11.5 25.9 1.7 7.2 0.3 1.5 0.9 0.1 0.4 0.3 1.4 0.4 0.2 0.3 8.8 1.1 0.9 0.2 0.5 0.8 9.2 10.9 2.6 6.8 6.6 5.9 4.6 3.5 7.0 5.1 TMEM167A "FLJ30508, MGC23909, TMEM167" ENSG00000174695 "Transmembrane protein 167A" Q8TBQ9 5 83052846-83077863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077278 Approved Vesicles Vesicles "HPA077278: " "unprognostic (5.38e-3)" "unprognostic (2.84e-3)" "unprognostic (3.78e-2)" "unprognostic (4.40e-2)" "unprognostic (1.66e-1)" "unprognostic (3.34e-1)" "unprognostic (4.06e-3)" "unprognostic (7.74e-2)" "unprognostic (9.94e-3)" "unprognostic (3.99e-3)" "unprognostic (2.72e-1)" "unprognostic (4.09e-2)" "unprognostic (2.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.51e-1)" "unprognostic (1.13e-3)" "unprognostic (1.29e-2)" 22.9 38.0 29.3 20.9 31.3 19.8 23.2 24.2 32.8 24.9 18.8 21.8 12.2 20.5 16.9 20.6 16.7 13.1 21.2 21.8 27.8 28.4 26.2 25.3 21.4 16.3 32.9 20.9 12.9 23.6 22.2 32.9 26.1 35.5 18.0 22.8 15.2 21.3 15.9 15.6 16.1 19.7 17.3 26.7 18.2 17.5 9.7 25.3 22.8 22.2 16.1 17.5 18.4 14.3 2.9 8.4 13.2 15.6 3.9 4.3 6.8 13.1 8.0 30.2 26.8 44.5 31.1 27.7 20.8 16.3 13.5 17.8 12.1 17.1 8.4 13.0 24.5 11.1 20.1 27.0 22.5 11.5 12.4 22.7 15.0 18.6 17.4 11.6 14.9 24.3 19.0 17.3 16.4 16.5 12.5 17.1 19.7 11.5 14.1 12.8 31.1 13.7 12.6 19.3 23.1 18.9 10.4 14.3 18.6 13.9 14.6 20.5 26.4 27.5 22.5 8.5 8.4 24.4 18.6 10.0 27.8 8.5 15.6 21.1 20.0 13.2 15.0 6.8 2.6 14.2 3.0 2.9 3.6 3.2 8.4 2.4 3.9 3.0 8.8 3.9 15.6 4.0 4.3 6.8 29.3 31.3 24.2 32.8 27.8 28.4 32.9 20.9 35.5 25.3 TMEM178A "MGC33926, TMEM178" ENSG00000152154 "Transmembrane protein 178A" Q8NBL3 2 39664982-39717963 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 87.4" "Cell line enriched" "Detected in some" 5 "AF22: 55.0" "Cancer enhanced" "Detected in many" "prostate cancer: 19.0" "Region enriched" "Detected in all" 5 "cerebellum: 87.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052128 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA052128: " "unprognostic (3.35e-2)" "unprognostic (3.18e-1)" "unprognostic (5.94e-2)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (5.85e-2)" "unprognostic (3.24e-3)" "unprognostic (1.82e-3)" "unprognostic (2.22e-1)" "unprognostic (9.74e-2)" "unprognostic (5.11e-4)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.80e-3)" "unprognostic (3.46e-2)" "unprognostic (2.83e-2)" "unprognostic (3.01e-3)" 2.9 4.2 13.3 0.9 10.6 0.6 6.8 87.4 35.6 1.6 1.9 6.4 0.0 2.3 3.8 2.0 1.8 3.3 3.1 3.6 16.4 7.4 18.9 2.7 5.8 0.8 10.7 10.9 1.8 2.2 1.3 2.5 3.6 17.0 12.2 2.2 3.7 3.8 2.1 2.3 3.5 2.4 2.9 22.6 1.6 3.5 1.2 5.3 0.0 5.7 0.8 2.2 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 0.1 1.7 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 7.0 0.0 0.6 0.0 0.0 0.4 0.1 10.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 10.6 87.4 18.8 16.4 7.4 10.7 10.9 17.0 5.3 TMEM178B DKFZp547G036 ENSG00000261115 "Transmembrane protein 178B" H3BS89 7 141074232-141480380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5" "Cell line enhanced" "Detected in many" "HAP1: 6.9;HDLM-2: 6.3;NTERA-2: 5.9;RPTEC TERT1: 9.6;SCLC-21H: 7.6;WM-115: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA048771 Uncertain Approved Nucleoli,Vesicles Vesicles Nucleoli "HPA048771: " "unprognostic (7.33e-3)" "unprognostic (2.02e-2)" "unprognostic (2.83e-2)" "unprognostic (7.79e-4)" "unprognostic (1.94e-1)" "unprognostic (1.49e-1)" "unprognostic (2.95e-1)" "unprognostic (1.69e-2)" "unprognostic (6.94e-2)" "unprognostic (2.21e-2)" "unprognostic (7.17e-4)" "unprognostic (1.05e-1)" "prognostic favourable (4.10e-4)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (5.35e-3)" "unprognostic (8.98e-2)" 0.9 1.7 5.2 0.7 7.4 0.1 0.7 3.2 13.4 0.5 0.8 1.0 2.3 0.1 1.1 0.6 1.8 0.3 0.7 11.6 4.8 5.8 2.9 0.6 0.4 1.5 4.9 1.0 0.2 2.6 20.6 18.5 0.1 1.8 2.8 0.4 0.5 4.4 0.8 4.5 0.2 1.2 1.3 2.4 0.8 0.5 0.8 0.4 1.0 9.5 0.1 3.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.6 0.3 1.8 0.1 2.7 0.8 1.0 0.0 0.0 2.2 2.3 0.2 0.0 6.9 0.0 2.3 6.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 5.9 0.0 0.4 1.1 2.9 9.6 2.7 7.6 4.6 0.1 0.3 1.0 1.0 0.0 0.0 0.1 1.1 3.1 0.0 0.1 0.0 0.0 0.5 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 7.4 3.2 9.6 4.8 5.8 4.9 1.0 1.8 0.4 TMEM181 "GPR178, KIAA1423" ENSG00000146433 "Transmembrane protein 181" Q9P2C4 6 158536436-158635428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040189 Approved Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA040189: AB_10793959" "unprognostic (1.93e-2)" "prognostic unfavourable (7.26e-4)" "unprognostic (9.87e-2)" "unprognostic (6.51e-2)" "unprognostic (3.09e-1)" "unprognostic (1.49e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" "prognostic unfavourable (1.09e-4)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (4.07e-2)" "unprognostic (1.46e-1)" "unprognostic (1.93e-1)" "unprognostic (4.36e-1)" "unprognostic (3.26e-1)" 7.1 5.6 32.4 4.8 49.2 3.1 8.6 5.3 36.6 13.4 10.1 4.2 6.5 10.9 8.4 3.9 6.3 5.8 7.3 5.3 18.5 8.7 3.3 6.4 6.7 3.4 5.5 23.3 5.6 18.5 8.1 21.5 6.5 11.2 9.4 11.5 4.3 22.4 10.0 4.9 7.0 12.6 7.8 7.3 7.6 16.3 16.0 8.5 2.3 9.7 2.1 3.2 9.9 7.0 1.0 2.1 7.7 3.4 3.9 4.7 1.4 10.3 6.0 8.5 13.1 22.5 20.7 16.3 23.5 13.8 12.3 14.1 10.2 12.8 4.3 12.2 19.5 15.4 12.6 15.5 19.6 6.4 9.0 8.1 8.9 21.4 18.5 10.1 7.8 17.1 15.3 13.6 18.6 19.6 15.4 5.5 20.0 6.2 4.4 12.7 6.6 7.6 4.4 9.8 4.9 11.7 8.1 25.2 17.3 17.2 16.2 11.2 6.1 14.3 18.7 12.7 8.6 21.0 20.2 3.2 2.2 4.8 15.3 12.7 12.1 7.7 2.2 5.7 4.7 2.3 3.6 0.9 2.7 3.7 1.6 1.0 2.4 3.2 1.6 3.9 3.4 2.1 2.6 1.4 32.4 49.2 5.3 36.6 18.5 8.7 5.5 23.3 11.2 8.5 TMEM182 FLJ30294 ENSG00000170417 "Transmembrane protein 182" Q6ZP80 2 102736905-103019900 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 40.3;skeletal muscle: 53.9;tongue: 37.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA045861 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA045861: " "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (5.10e-2)" "unprognostic (1.12e-4)" "unprognostic (5.35e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-2)" "unprognostic (1.10e-1)" "unprognostic (7.03e-3)" "unprognostic (2.34e-1)" "unprognostic (4.19e-2)" "unprognostic (3.42e-2)" "unprognostic (9.88e-2)" "unprognostic (4.61e-2)" "unprognostic (1.10e-1)" "unprognostic (3.53e-1)" "unprognostic (2.36e-2)" 2.4 1.1 1.2 1.0 1.3 0.3 1.1 1.7 1.8 1.4 1.0 0.5 1.5 1.0 0.6 2.3 1.8 1.1 0.8 40.3 1.2 1.9 1.4 1.7 0.6 0.8 1.2 0.5 1.0 1.1 1.5 6.8 0.8 2.8 1.9 1.0 0.9 3.8 1.2 53.9 0.5 0.9 1.1 1.2 0.8 1.0 0.8 0.4 1.8 2.0 37.8 4.0 1.2 0.7 4.4 3.1 0.3 0.3 2.4 4.1 1.1 4.8 2.8 2.1 6.5 2.7 2.6 7.6 2.6 2.3 2.7 3.8 9.0 6.8 4.0 9.1 0.9 2.8 2.3 3.7 5.6 9.0 1.8 6.0 1.3 5.7 3.1 5.4 4.8 3.3 6.7 4.2 3.8 0.3 4.2 1.6 2.7 3.5 2.9 5.2 3.6 2.9 3.1 5.5 3.8 3.7 4.2 5.4 1.9 3.5 3.9 8.5 3.2 2.9 0.2 4.3 3.1 3.3 3.3 3.9 9.9 3.3 4.4 9.0 6.4 0.0 0.0 0.3 3.9 0.3 3.2 4.4 2.8 2.2 1.3 1.9 3.8 4.1 0.1 2.4 0.3 3.1 0.8 1.1 1.2 1.3 1.7 1.8 1.2 1.9 1.2 0.5 2.8 0.4 TMEM184C "FLJ10846, TMEM34" ENSG00000164168 "Transmembrane protein 184C" Q9NVA4 4 147617383-147672044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054013 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA054013: " "unprognostic (5.45e-3)" "unprognostic (2.49e-2)" "unprognostic (3.93e-3)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (7.72e-3)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "prognostic unfavourable (6.37e-4)" "unprognostic (1.13e-1)" "prognostic favourable (2.31e-7)" "unprognostic (4.68e-2)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.31e-3)" 10.4 18.4 11.3 9.6 13.1 5.5 10.0 12.3 15.9 11.8 13.0 12.3 14.3 11.8 12.4 9.8 10.7 10.0 9.6 14.3 11.8 11.3 18.0 18.7 9.2 7.7 16.1 11.8 15.7 11.6 107.2 10.5 14.0 12.7 12.0 11.6 9.3 12.1 12.8 16.2 9.5 14.8 10.1 14.0 10.0 10.6 8.3 14.1 11.7 32.9 10.3 9.4 11.8 11.2 12.8 17.3 17.7 18.1 14.7 22.8 11.6 9.1 14.3 18.2 13.9 24.9 24.3 11.9 17.1 20.1 12.8 14.8 11.8 17.5 8.5 8.6 13.3 11.0 14.7 13.1 14.1 18.9 8.5 11.0 11.1 8.5 19.2 14.6 16.4 18.1 17.7 14.0 14.7 16.4 14.0 24.0 17.8 13.7 12.7 5.3 11.7 8.4 12.7 6.3 14.7 14.2 17.1 14.2 18.3 9.3 14.6 14.9 14.5 9.2 16.1 16.2 8.8 13.2 10.9 26.3 34.4 11.4 19.0 8.8 17.5 17.7 14.1 15.5 18.0 18.0 22.8 12.3 16.7 16.4 17.3 12.8 15.9 14.8 11.0 14.7 18.1 11.9 15.3 11.6 11.3 13.1 12.3 15.9 11.8 11.3 16.1 11.8 12.7 14.1 TMEM198 "MGC99813, TMEM198A" ENSG00000188760 "Transmembrane protein 198" Q66K66 2 219543663-219550595 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 16.9;SH-SY5Y: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042385, HPA062897" Enhanced Approved Vesicles Vesicles "HPA042385: , HPA062897: " "unprognostic (2.59e-2)" "unprognostic (8.51e-2)" "unprognostic (5.97e-3)" "unprognostic (2.77e-1)" "unprognostic (4.43e-2)" "unprognostic (8.09e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (4.28e-1)" "unprognostic (2.06e-1)" "prognostic favourable (6.89e-4)" "unprognostic (6.39e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" 3.0 9.4 14.4 3.1 10.3 0.9 2.3 14.2 22.0 3.3 2.6 4.1 1.4 16.1 4.0 2.5 2.7 2.5 3.9 3.4 16.5 5.2 3.0 2.6 2.4 1.8 4.1 11.9 10.9 20.0 5.2 13.0 2.6 6.2 4.0 1.8 3.0 7.0 4.3 3.5 2.2 6.4 3.5 7.5 1.8 4.7 5.0 4.9 0.0 4.0 0.5 1.9 3.8 1.2 0.2 2.6 0.1 0.0 0.8 0.4 0.4 0.5 0.1 4.7 8.0 1.0 0.9 4.2 2.4 1.3 2.0 1.7 10.3 1.3 2.1 2.4 1.5 2.8 1.7 1.1 0.4 7.0 2.0 1.7 2.1 8.4 1.4 0.6 4.0 2.1 0.6 0.9 2.3 0.0 6.1 6.8 1.2 1.0 0.1 0.5 6.1 0.7 0.2 2.9 2.4 1.2 1.1 16.9 14.7 0.6 1.7 4.0 0.2 3.3 0.1 2.2 0.9 2.0 1.0 6.6 1.9 2.2 2.0 0.1 2.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 2.6 0.0 0.4 14.4 10.3 14.2 22.0 16.5 5.2 4.1 11.9 6.2 4.9 TMEM2 ENSG00000135048 "Transmembrane protein 2" Q9UHN6 9 71683366-71816690 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 67.6" "Cell line enhanced" "Detected in many" "AF22: 37.7;BEWO: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044889 Approved Supported "Vesicles,Plasma membrane" 130000 "Plasma membrane" Vesicles "HPA044889: AB_10962641" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (6.15e-3)" "unprognostic (1.21e-2)" "unprognostic (2.93e-2)" "unprognostic (3.53e-1)" "unprognostic (3.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.57e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (1.31e-4)" "unprognostic (1.13e-2)" "unprognostic (2.33e-1)" "unprognostic (7.59e-2)" "unprognostic (1.16e-1)" 23.3 3.9 6.0 10.5 4.4 12.4 13.6 8.9 6.0 3.0 18.6 1.9 10.1 12.2 4.5 5.2 4.4 4.9 19.2 9.5 8.6 3.6 9.3 24.9 35.7 14.0 4.0 4.1 3.1 9.2 24.0 9.5 67.6 4.3 5.5 13.1 7.9 9.5 10.2 5.5 6.4 20.0 5.5 5.1 15.6 14.5 3.7 2.4 6.4 8.0 4.6 8.8 11.4 6.8 6.3 0.9 5.5 2.1 0.5 4.1 1.4 5.9 28.8 37.7 1.7 3.9 7.1 35.0 20.3 13.0 14.1 10.4 8.1 8.2 0.1 6.1 5.2 9.0 12.2 2.8 19.2 0.7 3.7 10.3 6.1 21.4 6.1 0.0 2.8 7.3 3.1 10.9 2.4 18.5 1.4 3.0 7.6 5.0 1.2 0.1 7.8 2.8 0.9 11.2 0.8 8.9 19.4 1.9 0.2 5.3 3.7 5.4 2.6 0.4 8.1 9.6 10.8 5.3 10.1 0.6 8.7 0.3 1.8 0.9 12.1 0.2 2.1 5.5 2.7 1.9 0.8 0.7 2.9 2.6 0.9 6.3 4.1 2.0 4.5 0.5 1.8 0.2 3.9 1.4 6.0 4.4 8.9 6.0 8.6 3.6 4.0 4.1 4.3 2.4 TMEM209 "FLJ14803, NET31" ENSG00000146842 "Transmembrane protein 209" Q96SK2 7 130164715-130207770 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031678 Uncertain Approved "Nuclear membrane,Nuclear speckles,Vesicles" "Nuclear membrane, Nuclear speckles, Vesicles" "HPA031678: AB_10603135" "unprognostic (3.03e-1)" "unprognostic (5.06e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.36e-1)" "unprognostic (4.50e-3)" "unprognostic (5.98e-2)" "unprognostic (1.25e-1)" "unprognostic (1.66e-1)" "unprognostic (3.19e-1)" "unprognostic (6.00e-2)" "unprognostic (2.34e-3)" "unprognostic (1.11e-1)" "unprognostic (3.48e-1)" "unprognostic (1.68e-2)" "unprognostic (3.24e-1)" 12.0 33.5 9.9 9.1 12.1 9.4 12.2 12.7 13.3 9.4 12.2 23.8 9.5 10.4 16.4 11.8 8.8 11.2 8.1 7.9 9.9 10.9 11.6 16.9 10.3 12.2 11.6 12.0 13.7 19.8 19.0 18.7 18.6 16.4 10.3 12.9 19.0 16.5 10.3 10.1 11.1 19.0 10.5 19.1 13.3 8.8 17.8 11.3 24.9 18.6 8.0 13.1 11.1 8.9 14.1 10.8 10.0 13.4 13.8 20.5 10.4 9.4 9.1 12.4 15.3 7.2 7.4 9.2 8.6 8.7 7.9 10.6 10.1 17.2 14.0 6.5 5.5 14.2 14.5 10.0 14.1 17.3 8.3 7.3 15.4 6.7 12.8 15.3 7.4 8.2 10.3 15.7 15.7 6.0 23.5 16.5 9.5 12.3 29.1 9.3 18.5 8.1 15.7 13.9 23.2 7.9 12.1 11.1 17.1 19.7 31.7 12.5 10.2 10.3 4.7 14.4 5.6 15.0 20.7 22.0 32.2 29.2 23.4 17.7 22.1 10.0 8.9 9.5 17.0 13.4 17.7 14.1 17.4 15.4 8.6 14.0 20.5 17.3 1.3 13.8 11.3 10.8 17.3 10.4 9.9 12.1 12.7 13.3 9.9 10.9 11.6 12.0 16.4 11.3 TMEM215 ENSG00000188133 "Transmembrane protein 215" Q68D42 9 32783499-32787399 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 8.0;retina: 6.5;testis: 17.9" "Group enriched" "Detected in some" 6 "NTERA-2: 6.4;SH-SY5Y: 1.9" "Cancer enriched" "Detected in single" 14 "thyroid cancer: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052804, HPA063207" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA052804: , HPA063207: " "unprognostic (1.31e-2)" "unprognostic (4.57e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-2)" "unprognostic (5.85e-2)" "unprognostic (4.38e-3)" "unprognostic (2.17e-3)" "unprognostic (2.82e-1)" "unprognostic (2.72e-1)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" "unprognostic (2.32e-2)" 0.1 0.0 1.8 0.4 1.5 0.0 0.1 0.1 0.9 1.9 0.0 0.0 0.0 0.0 8.0 0.9 0.1 0.1 0.0 0.9 0.9 1.5 0.0 0.0 0.1 0.0 1.7 0.2 0.7 0.0 0.0 0.1 0.0 0.6 0.1 0.0 6.5 0.1 0.0 0.3 0.1 0.1 0.0 1.0 0.0 0.0 17.9 0.0 0.0 3.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.1 0.8 0.9 1.5 1.7 0.2 0.6 0.0 TMEM231 "ALYE870, FLJ22167, JBTS20, MKS11, PRO1886" ENSG00000205084 "Transmembrane protein 231" Q9H6L2 16 75536744-75556286 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 58.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA042081 Enhanced Approved Vesicles Vesicles "HPA042081: AB_10795391" "unprognostic (4.29e-2)" "unprognostic (9.84e-2)" "unprognostic (8.07e-2)" "unprognostic (2.71e-3)" "unprognostic (1.03e-1)" "unprognostic (9.34e-2)" "unprognostic (2.90e-2)" "unprognostic (2.81e-1)" "unprognostic (2.92e-1)" "unprognostic (1.69e-2)" "unprognostic (3.34e-3)" "unprognostic (7.84e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (1.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.28e-1)" 3.7 5.3 7.9 2.8 14.7 2.5 4.1 5.0 12.4 7.1 4.1 16.6 3.6 4.0 6.4 10.1 3.1 58.4 4.8 7.9 9.1 9.9 4.7 2.5 7.3 2.7 6.5 9.9 14.3 4.7 6.6 7.7 3.6 14.3 5.4 3.5 6.6 3.1 5.6 1.9 3.3 4.2 7.7 6.2 2.7 3.2 8.5 6.6 0.2 8.0 1.0 2.2 3.5 3.0 5.0 3.2 6.2 0.9 1.0 3.5 1.3 3.9 2.4 6.3 10.5 6.1 15.0 3.4 4.3 5.5 5.4 6.5 1.5 6.3 4.3 6.0 6.2 9.5 0.7 5.0 3.3 0.8 2.6 0.2 3.2 1.4 5.4 2.4 1.9 3.3 6.2 5.4 13.3 3.7 4.2 0.2 1.6 10.0 1.5 4.6 3.7 2.2 0.8 0.9 9.6 6.9 1.4 5.3 3.5 8.7 2.1 3.9 2.0 2.7 5.5 4.2 3.6 2.7 2.3 8.2 7.1 1.3 10.5 1.2 4.1 3.0 0.9 0.6 1.7 0.9 3.5 5.0 1.8 2.9 2.5 2.4 1.6 2.4 6.2 1.0 0.5 3.2 0.5 1.3 7.9 14.7 5.0 12.4 9.1 9.9 6.5 9.9 14.3 6.6 TMEM234 "C1orf91, dJ622L5.7, FLJ90779, RP4-622L5" ENSG00000160055 "Transmembrane protein 234" Q8WY98 1 32214472-32222359 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015049 Uncertain Approved Vesicles Vesicles "HPA015049: AB_1856409" "unprognostic (1.39e-2)" "unprognostic (1.36e-1)" "unprognostic (1.52e-1)" "unprognostic (1.26e-1)" "unprognostic (2.44e-3)" "unprognostic (3.09e-1)" "prognostic unfavourable (2.35e-5)" "unprognostic (2.67e-1)" "unprognostic (1.07e-2)" "unprognostic (6.49e-2)" "unprognostic (2.66e-2)" "unprognostic (1.05e-1)" "prognostic unfavourable (4.12e-5)" "unprognostic (1.95e-1)" "unprognostic (2.44e-1)" "unprognostic (7.92e-2)" "unprognostic (2.37e-2)" 7.9 9.2 7.0 9.5 9.2 5.7 8.6 9.5 12.2 9.4 9.4 9.9 21.9 5.0 9.6 22.2 10.4 11.8 12.3 11.0 7.4 8.4 11.5 7.3 9.8 9.9 6.0 7.6 12.6 10.8 14.5 14.9 12.5 6.6 10.2 9.3 14.8 8.8 25.0 6.3 5.3 7.4 9.6 5.8 9.0 9.4 15.9 4.7 8.6 15.3 4.0 9.4 6.8 9.0 5.2 7.5 23.2 8.3 7.0 6.4 4.1 8.3 6.8 3.6 4.0 10.6 8.4 4.0 12.3 9.1 6.4 4.9 4.6 8.9 2.6 14.4 11.7 7.0 4.6 9.1 5.6 5.4 5.4 5.2 10.1 5.1 8.0 6.2 3.5 10.8 9.7 6.9 5.0 9.4 4.7 1.8 11.1 2.4 2.4 4.9 7.0 5.1 3.3 3.0 2.9 14.4 4.0 4.8 4.8 9.3 5.2 4.0 2.4 2.0 11.1 2.4 3.8 9.2 8.8 3.1 1.6 1.2 7.3 2.3 8.5 11.7 8.0 11.9 4.1 8.3 6.4 4.5 3.3 4.4 7.5 5.2 2.4 3.0 23.2 7.0 5.9 5.6 1.9 4.1 7.0 9.2 9.5 12.2 7.4 8.4 6.0 7.6 6.6 4.7 TMEM241 "C18orf45, FLJ44259, MGC11386" ENSG00000134490 "Transmembrane protein 241" Q24JQ0 18 23197144-23437961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029489, HPA059922" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA029489: , HPA059922: " "unprognostic (1.44e-3)" "unprognostic (1.92e-1)" "unprognostic (7.80e-2)" "unprognostic (1.02e-2)" "unprognostic (1.37e-1)" "unprognostic (6.48e-2)" "unprognostic (1.15e-4)" "unprognostic (7.07e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (1.81e-3)" "unprognostic (9.53e-3)" "unprognostic (1.15e-1)" "unprognostic (1.42e-1)" "unprognostic (2.95e-1)" "unprognostic (4.93e-1)" "prognostic unfavourable (5.80e-4)" 5.8 3.6 6.4 4.3 11.3 2.6 6.3 2.0 11.9 6.0 4.3 4.2 2.2 4.1 5.7 5.0 5.2 4.6 4.5 4.0 3.9 4.0 3.1 5.4 4.3 3.6 3.1 5.2 4.9 6.5 7.0 6.5 6.1 5.2 2.7 6.3 3.5 4.8 2.6 3.4 3.9 2.9 7.6 3.5 4.1 3.7 2.1 2.6 1.9 6.8 4.9 5.1 5.4 4.7 3.0 2.3 1.3 3.1 8.4 2.2 1.4 3.1 6.2 1.2 4.1 6.5 5.8 3.7 1.5 2.0 1.5 3.5 1.2 7.4 11.9 3.4 3.0 6.0 3.3 5.6 5.2 1.4 0.4 2.5 4.5 2.6 3.6 2.6 2.0 6.6 6.1 6.2 7.4 6.8 5.2 4.2 5.5 3.4 2.7 0.5 1.4 1.2 2.0 5.6 11.4 2.6 2.3 4.4 4.2 7.3 3.9 4.7 4.1 1.2 2.6 10.6 2.5 3.7 4.2 8.4 6.4 5.0 3.4 8.0 6.8 1.3 0.7 0.0 1.3 3.1 2.2 1.8 0.2 1.2 2.3 3.0 1.1 1.9 0.0 8.4 1.2 0.7 1.5 1.4 6.4 11.3 2.0 11.9 3.9 4.0 3.1 5.2 5.2 2.6 TMEM248 "C7orf42, FLJ10099, FLJ13090" ENSG00000106609 "Transmembrane protein 248" Q9NWD8 7 66921225-66958551 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016495 Uncertain Approved Vesicles 1200000 Vesicles "HPA016495: AB_1848643" "unprognostic (6.74e-2)" "unprognostic (1.73e-2)" "unprognostic (4.86e-2)" "unprognostic (4.64e-2)" "unprognostic (6.67e-3)" "unprognostic (9.36e-2)" "unprognostic (1.39e-2)" "unprognostic (4.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.54e-2)" "unprognostic (9.18e-2)" "unprognostic (2.80e-3)" "unprognostic (1.30e-1)" "unprognostic (8.96e-2)" "unprognostic (5.11e-2)" "unprognostic (8.28e-2)" "unprognostic (5.57e-2)" 32.2 33.0 23.8 30.2 30.6 11.9 44.6 28.0 28.4 38.7 32.8 23.8 39.0 32.1 40.6 32.9 26.0 36.1 40.7 28.2 24.6 30.4 30.9 46.3 31.6 38.3 20.9 21.3 40.8 58.4 47.2 28.9 35.6 21.0 34.7 32.4 39.4 36.9 36.8 19.1 23.7 44.8 34.7 23.8 32.6 33.7 33.3 20.6 40.1 37.7 24.0 35.9 33.2 40.7 10.7 10.1 8.6 5.2 9.0 9.3 2.3 18.1 21.4 18.1 25.8 41.3 31.8 15.9 22.4 38.6 21.4 23.2 15.5 23.9 18.5 27.4 30.1 16.5 15.5 18.5 26.7 16.9 11.4 13.5 15.3 17.8 26.8 22.4 18.8 28.6 21.6 17.9 15.0 27.8 25.8 12.5 33.9 11.0 21.0 27.7 26.9 14.7 15.4 21.1 31.2 28.9 14.0 12.6 27.1 19.7 36.4 19.8 18.2 20.7 25.6 30.1 14.8 19.6 24.5 15.3 17.2 20.8 25.2 25.0 28.5 2.3 5.0 8.6 7.9 5.2 9.3 9.6 8.5 8.1 3.9 10.7 8.4 8.8 7.4 9.0 3.1 10.1 5.6 2.3 23.8 30.6 28.0 28.4 24.6 30.4 20.9 21.3 21.0 20.6 TMEM25 FLJ14399 ENSG00000149582 "Transmembrane protein 25" Q86YD3 11 118531041-118547280 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 19.4;T-47d: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012163, HPA051562" Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" 4900000 "Golgi apparatus, Vesicles" "HPA012163: AB_1858112, HPA051562: " "unprognostic (1.53e-2)" "unprognostic (7.18e-2)" "unprognostic (2.43e-1)" "unprognostic (6.69e-2)" "unprognostic (3.61e-1)" "unprognostic (6.50e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (1.58e-1)" "unprognostic (3.42e-1)" "unprognostic (1.66e-2)" "unprognostic (8.19e-2)" "prognostic favourable (0.00e+0)" "unprognostic (1.15e-1)" "unprognostic (2.51e-1)" "unprognostic (1.26e-1)" "unprognostic (7.01e-2)" 4.8 15.0 15.0 3.7 23.3 1.7 12.0 28.0 36.5 9.4 19.4 9.5 6.7 35.5 10.1 21.2 9.0 9.2 7.1 6.4 11.9 17.0 14.7 10.6 8.0 3.5 10.7 19.5 19.4 14.1 17.3 15.9 4.9 14.0 12.5 3.2 14.4 16.1 15.5 12.7 6.2 26.2 8.7 9.7 4.0 6.7 3.9 5.1 1.5 12.7 4.3 4.6 8.3 6.1 3.8 3.4 0.5 0.2 6.6 11.1 3.8 1.8 0.4 3.3 5.4 3.5 0.5 3.2 3.0 5.6 2.8 5.7 15.1 10.6 0.2 11.6 2.9 8.4 0.0 10.2 2.5 6.5 6.2 0.3 2.9 3.4 9.2 0.1 0.3 4.3 6.3 3.0 0.5 4.0 1.4 6.7 2.8 2.2 3.2 0.2 2.8 7.3 4.4 2.3 6.6 14.4 0.2 10.0 6.7 2.9 19.4 0.0 25.2 0.3 1.4 1.2 6.3 0.2 0.9 6.7 4.4 1.7 0.2 0.1 0.1 0.5 0.2 0.2 5.6 0.2 7.5 3.8 7.9 3.1 0.5 3.0 11.1 5.8 0.4 6.6 0.2 3.4 6.1 3.8 15.0 23.3 28.0 36.5 11.9 17.0 10.7 19.5 14.0 5.1 TMEM256 "C17orf61, MGC40107" ENSG00000205544 "Transmembrane protein 256" Q8N2U0 17 7402975-7404137 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA062732 Approved Vesicles Vesicles "HPA062732: " "unprognostic (3.82e-2)" "unprognostic (1.93e-1)" "unprognostic (2.91e-1)" "unprognostic (2.77e-2)" "unprognostic (1.05e-1)" "unprognostic (1.74e-3)" "unprognostic (3.69e-2)" "unprognostic (5.73e-2)" "unprognostic (7.45e-2)" "unprognostic (2.12e-2)" "unprognostic (3.22e-2)" "unprognostic (1.91e-1)" "prognostic unfavourable (9.36e-4)" "unprognostic (1.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.03e-1)" "unprognostic (1.19e-2)" 28.7 23.5 23.4 20.7 31.8 19.8 48.2 15.0 32.9 18.7 40.7 12.1 32.8 48.6 18.7 30.7 19.9 22.1 26.1 54.0 20.2 15.8 32.6 54.8 25.3 54.0 25.0 20.1 21.8 73.8 13.0 12.9 9.4 28.4 22.4 16.2 16.8 38.5 39.7 26.3 16.1 42.4 23.6 37.5 18.9 23.0 7.4 16.3 11.1 16.7 24.4 17.1 20.5 18.0 28.2 30.2 5.0 23.5 13.8 19.5 27.3 21.7 28.5 15.3 21.3 26.1 32.7 14.5 10.0 13.9 16.0 15.0 11.3 12.4 18.9 18.5 9.9 18.6 9.6 29.8 11.4 10.0 32.1 12.1 10.8 29.2 18.0 4.1 16.5 28.9 14.0 20.9 17.4 23.0 8.9 12.9 20.1 11.2 14.0 13.6 7.1 18.9 22.5 13.9 21.7 38.3 9.0 1.8 12.9 15.7 12.2 16.4 22.1 7.6 14.3 7.7 14.7 15.5 12.8 11.1 13.5 9.5 20.3 5.7 14.6 3.8 23.5 5.0 14.0 16.9 17.1 28.2 16.8 16.1 21.7 26.3 19.5 17.9 1.4 13.8 12.2 30.2 16.5 27.3 23.4 31.8 15.0 32.9 20.2 15.8 25.0 20.1 28.4 16.3 TMEM270 "MGC26719, WBSCR28" ENSG00000175877 "Transmembrane protein 270" Q6UE05 7 73861159-73865893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 35.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.1;MCF7: 5.3;PC-3: 1.8;RPMI-8226: 1.4;U-2197: 1.4;U-87 MG: 1.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "T-reg: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA077196 Approved Vesicles Vesicles "HPA077196: " "unprognostic (3.84e-2)" "unprognostic (6.91e-2)" "unprognostic (6.87e-5)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (2.81e-3)" "unprognostic (1.34e-1)" "unprognostic (8.31e-3)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-1)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.26e-1)" "unprognostic (1.44e-1)" "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 2.1 0.2 0.0 0.3 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.4 0.0 1.8 0.0 0.0 1.4 0.3 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.1 1.4 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM35A "FLJ14084, TMEM35" ENSG00000126950 "Transmembrane protein 35A" Q53FP2 X 101078720-101096364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;seminal vesicle: 46.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.3;HUVEC TERT2: 31.7;SH-SY5Y: 8.1" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048583 Enhanced Supported "Vesicles,Focal adhesion sites,Cytosol" Vesicles "Focal adhesion sites, Cytosol" "HPA048583: " "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-2)" "unprognostic (3.02e-2)" "unprognostic (3.89e-3)" "unprognostic (2.77e-2)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (3.34e-3)" "unprognostic (9.20e-2)" "unprognostic (4.72e-2)" "unprognostic (3.49e-4)" "unprognostic (5.91e-2)" "unprognostic (1.85e-1)" "unprognostic (1.48e-2)" "unprognostic (9.37e-3)" 3.6 6.7 12.8 1.7 28.2 0.7 1.3 21.2 28.6 3.3 17.3 2.5 6.8 3.5 7.4 3.9 10.4 4.3 3.6 1.1 14.4 33.8 1.1 0.7 2.6 0.8 12.2 10.0 7.7 0.9 6.1 1.5 0.8 30.0 20.5 9.1 2.9 1.0 46.4 1.3 0.9 4.1 11.8 3.9 1.3 3.4 1.8 2.3 0.0 1.3 0.0 0.9 13.3 2.7 0.2 0.0 0.2 0.1 0.6 0.8 0.4 0.0 0.0 3.3 0.0 2.4 6.3 0.0 0.6 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.9 0.0 2.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 2.1 0.0 1.1 0.0 31.7 0.0 0.0 4.0 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 1.4 8.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.5 0.2 0.5 0.2 0.0 0.0 0.6 0.4 0.2 0.6 0.1 0.0 0.8 0.4 12.8 28.2 21.2 28.6 14.4 33.8 12.2 10.0 30.0 2.3 TMEM39A FLJ10902 ENSG00000176142 "Transmembrane protein 39A" Q9NV64 3 119429500-119468830 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039140 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA039140: AB_10673303" "unprognostic (2.16e-1)" "unprognostic (8.75e-2)" "unprognostic (4.25e-2)" "unprognostic (6.86e-2)" "unprognostic (1.56e-2)" "unprognostic (2.81e-1)" "prognostic unfavourable (3.26e-4)" "unprognostic (9.68e-2)" "unprognostic (6.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" "unprognostic (1.66e-2)" "prognostic unfavourable (1.00e-5)" "unprognostic (4.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.88e-1)" "unprognostic (6.41e-2)" 13.7 12.7 5.6 13.0 8.8 9.3 13.2 10.5 6.4 18.3 8.7 10.4 27.0 9.6 20.8 18.3 10.9 13.5 13.4 14.4 5.1 3.8 9.7 16.7 15.2 11.0 8.9 2.4 17.6 37.5 8.3 47.9 19.5 7.6 13.9 9.5 12.1 30.2 30.0 8.7 10.7 10.6 9.6 8.4 11.8 11.5 15.4 8.0 11.3 17.4 9.5 19.2 11.9 13.0 8.6 18.1 11.5 11.2 11.9 13.8 9.2 15.7 7.9 14.1 10.0 28.2 26.4 14.9 15.6 26.8 16.9 23.6 13.9 12.1 6.6 14.8 14.4 16.4 14.6 6.2 18.7 6.5 5.6 8.1 6.0 14.1 19.0 15.0 12.2 16.0 10.3 12.3 30.0 11.2 8.0 19.1 9.4 7.3 7.9 5.5 13.6 15.8 8.6 7.4 14.2 4.9 6.1 6.1 8.6 14.7 8.5 21.1 8.1 14.1 9.6 10.5 10.0 7.3 9.8 22.0 6.2 15.7 15.7 10.9 14.9 11.5 11.2 8.0 13.5 6.2 13.8 8.5 8.4 11.3 13.2 8.6 7.0 7.1 4.7 11.9 4.8 18.1 9.8 9.2 5.6 8.8 10.5 6.4 5.1 3.8 8.9 2.4 7.6 8.0 TMEM39B FLJ10315 ENSG00000121775 "Transmembrane protein 39B" Q9GZU3 1 32072031-32102866 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040191, HPA040224" Approved Approved Vesicles Vesicles "HPA040191: AB_10805706, HPA040224: AB_10795274" "unprognostic (1.74e-2)" "unprognostic (2.20e-2)" "unprognostic (4.38e-2)" "prognostic unfavourable (3.00e-4)" "unprognostic (1.06e-1)" "unprognostic (1.14e-2)" "prognostic unfavourable (2.82e-6)" "unprognostic (1.10e-2)" "unprognostic (3.37e-2)" "unprognostic (1.74e-1)" "unprognostic (3.63e-2)" "unprognostic (4.47e-2)" "prognostic unfavourable (5.11e-9)" "unprognostic (2.20e-1)" "unprognostic (5.80e-2)" "unprognostic (4.45e-2)" "unprognostic (2.10e-1)" 13.4 10.2 6.2 7.4 10.1 6.1 10.8 6.2 14.3 18.2 10.7 11.5 8.2 7.1 18.8 11.9 8.2 11.8 9.4 10.0 5.8 7.9 6.7 13.7 9.3 13.5 7.2 11.7 16.1 6.6 7.8 9.9 16.9 8.3 9.7 8.1 10.8 8.5 13.7 9.9 13.0 8.4 12.6 7.0 9.5 9.0 18.3 7.1 22.9 10.8 10.3 13.1 12.7 11.3 11.5 21.6 5.1 14.1 4.4 10.6 8.3 8.0 2.4 2.9 7.8 9.9 6.0 4.1 7.7 11.8 9.3 9.0 4.2 12.0 8.7 11.6 5.3 9.2 2.3 11.3 2.6 4.8 7.5 5.6 5.2 2.2 12.0 10.1 5.8 8.7 4.2 14.1 10.3 5.6 7.3 7.8 8.0 3.8 6.4 3.0 10.4 5.7 12.0 11.2 12.3 4.1 4.4 7.2 4.3 10.5 5.4 8.1 4.2 4.8 8.4 14.6 9.6 5.3 7.5 3.9 5.9 9.5 8.9 8.7 11.1 2.5 14.1 5.1 5.3 12.0 7.2 11.5 7.9 6.6 14.4 11.5 10.6 8.6 3.7 4.4 8.7 21.6 8.2 8.3 6.2 10.1 6.2 14.3 5.8 7.9 7.2 11.7 8.3 7.1 TMEM45A "DERP7, FLJ10134" ENSG00000181458 "Transmembrane protein 45A" Q9NWC5 3 100492619-100577444 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 118.9" "Cell line enhanced" "Detected in many" "ASC diff: 92.2;ASC TERT1: 27.0;HSkMC: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 3.3;myeloid DC: 2.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062101 Uncertain Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "HPA062101: " "unprognostic (5.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.11e-1)" "unprognostic (1.43e-3)" "unprognostic (7.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.08e-2)" "prognostic unfavourable (7.42e-4)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (6.18e-11)" "unprognostic (1.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.02e-5)" "unprognostic (2.68e-2)" 5.3 5.2 1.6 3.0 7.3 0.6 12.5 0.3 1.9 8.6 2.7 1.9 2.5 1.0 8.5 5.7 4.4 5.2 5.7 5.7 1.3 0.9 1.4 45.2 5.8 5.2 4.4 0.7 6.4 20.2 0.3 25.1 20.2 2.1 5.9 1.8 3.1 23.9 2.2 2.4 118.9 1.7 6.6 2.2 2.2 2.0 5.4 4.4 0.0 6.5 3.7 12.2 7.7 18.5 0.5 2.9 0.9 3.3 0.0 0.5 2.0 6.0 0.4 0.5 2.1 92.2 27.0 0.0 14.5 13.5 2.0 19.0 0.5 0.1 0.0 7.2 9.5 6.9 0.5 2.8 5.2 1.5 1.8 5.0 2.2 1.7 5.8 0.0 0.3 28.4 1.6 3.7 5.6 0.7 0.1 0.7 4.9 0.0 0.0 0.1 0.7 3.6 0.0 5.1 0.0 0.1 0.2 0.6 4.3 3.5 1.8 1.5 0.1 2.8 2.0 14.1 9.9 0.1 3.2 11.9 6.8 0.0 11.1 0.4 9.3 0.0 3.3 0.9 0.3 0.0 0.0 0.5 0.2 0.3 2.9 0.0 0.1 0.5 0.4 0.0 0.5 1.6 0.0 2.0 1.6 7.3 0.3 1.9 1.3 0.9 4.4 0.7 2.1 4.4 TMEM54 CAC-1 ENSG00000121900 "Transmembrane protein 54" Q969K7 1 32894594-32901438 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 76.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA061992 Approved Vesicles Vesicles "HPA061992: " "unprognostic (2.67e-1)" "unprognostic (2.57e-2)" "unprognostic (2.55e-1)" "unprognostic (4.98e-2)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "prognostic unfavourable (3.08e-4)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (2.42e-2)" "unprognostic (3.48e-2)" "unprognostic (9.43e-2)" "unprognostic (6.82e-3)" "unprognostic (2.13e-2)" "unprognostic (9.06e-2)" "unprognostic (3.12e-2)" "unprognostic (3.40e-2)" 3.2 3.3 16.1 21.5 10.7 0.0 8.5 2.7 10.6 10.0 70.0 8.2 7.0 37.9 8.5 9.4 28.8 5.0 24.2 4.5 9.7 9.4 11.4 4.4 7.2 2.4 10.9 5.7 6.2 12.4 9.0 4.7 47.3 6.8 14.7 37.4 7.4 11.8 8.4 1.9 26.9 76.7 7.3 7.3 3.1 35.0 3.7 6.0 1.1 23.6 16.9 14.2 12.5 15.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 31.3 8.5 0.0 8.1 15.6 9.4 30.6 4.6 7.5 11.1 14.4 21.2 50.5 0.0 13.7 6.2 19.3 7.3 27.1 3.4 36.4 1.5 0.0 3.0 1.1 11.3 0.1 0.4 8.0 24.8 17.1 4.7 4.9 4.2 0.0 5.8 33.6 0.0 0.6 2.6 14.8 4.2 12.8 0.1 4.1 40.2 0.4 4.2 3.2 21.0 10.5 22.8 6.1 9.3 11.0 11.7 24.6 9.8 1.1 2.6 3.6 7.8 0.8 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 10.7 2.7 10.6 9.7 9.4 10.9 5.7 6.8 6.0 TMEM63A KIAA0792 ENSG00000196187 "Transmembrane protein 63A" O94886 1 225845536-225882369 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.4" "Cell line enhanced" "Detected in many" "RPMI-8226: 37.7;SK-BR-3: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066504, HPA066936, HPA068918" Enhanced "Vesicles,Centriolar satellite" 96000 "Vesicles, Centriolar satellite" "HPA066504: , HPA066936: , HPA068918: " "unprognostic (5.31e-2)" "unprognostic (3.46e-2)" "unprognostic (2.14e-2)" "prognostic favourable (8.79e-4)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-2)" "unprognostic (2.57e-1)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.92e-2)" 10.5 7.4 14.7 11.6 38.8 18.6 12.2 4.1 23.2 14.3 14.0 91.4 17.3 12.2 12.2 11.2 6.6 13.9 12.9 8.5 30.2 15.1 14.3 15.1 12.6 15.4 59.3 16.4 13.1 22.4 11.6 5.3 11.3 34.9 22.3 17.8 5.7 55.8 19.1 6.9 9.9 13.3 8.8 71.0 14.0 22.9 3.0 49.6 11.2 8.0 4.5 12.4 13.3 9.6 5.4 10.0 5.5 4.1 8.7 16.6 5.7 9.3 2.8 2.4 7.1 19.6 6.8 16.9 7.1 7.7 8.0 8.1 10.2 6.9 2.6 13.2 8.7 14.4 2.6 4.3 3.7 8.7 4.7 11.3 6.5 6.1 4.5 4.2 29.9 7.1 2.7 4.7 2.9 5.1 9.4 2.2 6.3 5.9 3.7 4.3 13.3 4.6 3.7 7.5 37.7 12.2 24.7 0.2 1.3 5.2 42.0 5.1 9.7 4.0 6.1 4.6 3.2 4.2 6.4 0.9 3.4 0.6 4.2 2.4 8.4 5.5 3.2 3.0 9.4 2.7 10.6 5.2 12.1 8.9 2.5 5.4 10.9 6.3 5.1 8.7 4.1 10.0 16.6 5.7 14.7 38.8 4.1 23.0 30.2 15.1 59.3 16.4 34.9 49.6 TMEM68 FLJ32370 ENSG00000167904 "Transmembrane protein 68" Q96MH6 8 55696424-55773407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018216, HPA019173" Uncertain Approved Vesicles Vesicles "HPA018216: AB_2205185, HPA019173: AB_1858129" "unprognostic (4.43e-2)" "unprognostic (3.10e-2)" "unprognostic (8.04e-2)" "unprognostic (2.40e-1)" "unprognostic (4.61e-2)" "unprognostic (1.15e-1)" "unprognostic (3.46e-3)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (3.37e-2)" "unprognostic (3.28e-2)" "unprognostic (1.03e-1)" "unprognostic (3.92e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.41e-2)" "unprognostic (1.63e-1)" 10.4 18.3 14.0 8.4 18.0 10.6 14.6 18.9 20.5 13.0 15.1 16.3 16.0 14.6 15.4 17.9 16.1 25.4 12.5 7.4 13.8 13.2 20.6 14.6 11.3 10.5 12.7 10.2 15.7 13.5 15.9 18.5 15.6 13.2 15.8 16.6 13.1 14.0 12.2 7.8 17.6 18.3 14.4 13.3 12.9 12.0 9.8 11.7 22.7 18.8 13.4 12.3 17.1 13.0 9.2 7.2 21.7 7.7 8.2 10.5 3.9 12.6 7.6 13.0 7.9 11.0 12.7 22.8 11.3 8.7 10.9 10.6 10.8 24.0 13.9 13.4 7.5 16.1 10.1 15.1 12.2 19.1 11.4 16.9 6.9 11.3 12.2 7.1 9.4 8.6 23.2 11.0 26.1 9.9 16.1 14.1 15.9 6.6 17.8 9.8 14.1 4.0 13.1 5.4 8.9 18.1 9.9 10.9 9.6 7.6 12.3 22.2 18.2 9.3 7.7 8.3 10.5 14.3 9.2 12.2 15.2 17.6 11.4 11.9 12.9 21.7 7.1 5.0 7.2 4.4 10.5 9.2 8.6 7.6 7.2 9.2 7.2 10.1 7.9 8.2 7.7 6.4 6.3 3.9 14.0 18.0 18.9 20.5 13.8 13.2 12.7 10.2 13.2 11.7 TMEM87B FLJ14681 ENSG00000153214 "Transmembrane protein 87B" Q96K49 2 112055223-112119318 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035183 Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA035183: AB_10600829" "unprognostic (3.19e-1)" "prognostic unfavourable (3.78e-4)" "unprognostic (1.26e-2)" "unprognostic (1.79e-1)" "unprognostic (1.39e-1)" "prognostic unfavourable (4.28e-4)" "prognostic unfavourable (4.72e-4)" "unprognostic (4.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.07e-2)" "unprognostic (2.87e-2)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.52e-7)" "unprognostic (1.32e-1)" "unprognostic (5.35e-2)" "unprognostic (1.05e-1)" "unprognostic (3.25e-3)" 10.8 14.5 5.6 19.5 7.1 5.1 17.2 6.5 8.5 11.6 20.8 6.6 36.8 22.1 14.5 14.3 14.5 10.1 17.0 7.3 5.8 6.5 10.0 13.1 14.6 25.8 6.6 5.4 9.6 15.8 11.3 22.8 20.1 7.4 23.5 21.3 7.0 18.3 43.8 3.8 12.0 37.9 10.3 8.2 22.4 17.3 5.5 5.7 11.6 12.3 11.0 17.9 13.9 12.0 8.4 3.7 4.9 8.3 4.6 10.1 4.9 10.4 3.3 2.9 13.1 12.4 16.9 11.2 17.9 23.9 11.5 14.2 8.1 14.6 10.0 9.5 23.2 17.7 1.8 10.5 14.7 6.4 2.0 14.0 2.1 6.9 12.1 9.7 15.1 11.2 12.8 14.1 11.4 11.9 8.2 6.8 16.0 6.4 4.5 4.6 2.3 8.6 3.7 4.6 8.2 9.7 15.0 2.4 3.2 7.9 19.4 16.1 10.6 6.8 13.5 11.6 3.6 9.1 3.9 5.5 8.9 6.4 13.2 4.8 8.3 4.9 4.0 3.3 4.7 7.0 8.1 8.4 10.1 6.4 3.6 6.6 9.3 5.1 2.4 4.6 8.3 3.7 9.7 4.9 5.6 7.1 6.5 8.5 5.8 6.5 6.6 5.4 7.4 5.7 TMEM8B "C9orf127, NAG-5, NGX6" ENSG00000137103 "Transmembrane protein 8B" A6NDV4 9 35814451-35865518 "Predicted membrane proteins, Transporters" "Cell adhesion, Growth regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 27.2" "Lineage enriched" "Detected in many" 18 "dendritic cells: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052130, HPA062701" Approved Approved Vesicles Vesicles "HPA052130: , HPA062701: " "unprognostic (5.54e-2)" "unprognostic (3.32e-1)" "unprognostic (3.96e-1)" "unprognostic (3.53e-2)" "unprognostic (3.81e-1)" "unprognostic (1.42e-1)" "unprognostic (4.09e-2)" "unprognostic (2.67e-2)" "unprognostic (2.97e-1)" "unprognostic (1.62e-1)" "prognostic favourable (3.14e-4)" "unprognostic (5.93e-2)" "prognostic favourable (1.89e-15)" "unprognostic (8.00e-2)" "unprognostic (1.26e-1)" "unprognostic (1.68e-2)" "unprognostic (3.29e-2)" 9.7 19.5 28.2 5.7 30.4 3.4 9.4 22.9 34.4 15.5 13.0 16.9 14.9 8.7 18.4 11.5 9.3 18.3 12.1 17.8 25.3 14.1 11.3 4.7 10.4 5.9 12.9 21.2 33.3 14.6 28.4 23.6 7.7 18.3 19.3 9.4 17.5 19.9 24.0 19.1 9.2 8.4 18.1 13.0 8.7 13.1 13.6 15.4 5.6 17.3 5.1 4.9 14.2 11.9 0.9 27.2 0.6 1.5 0.5 0.6 1.1 2.9 3.2 11.2 8.8 12.6 10.6 1.4 2.7 5.2 3.0 3.7 1.3 0.8 2.3 6.4 7.2 1.2 2.9 4.4 2.4 1.8 5.0 0.7 2.2 3.1 8.9 0.2 0.3 9.8 5.8 3.0 3.2 1.7 1.1 6.6 5.2 1.1 6.1 1.3 1.6 4.4 6.8 2.3 5.8 3.1 1.4 2.6 7.8 4.1 1.9 4.0 3.1 1.2 2.7 7.0 2.3 6.9 1.0 8.9 2.7 2.6 6.4 1.2 4.3 0.4 1.5 0.1 0.6 0.3 0.5 0.9 0.6 0.6 4.7 0.9 0.6 0.5 0.6 0.5 0.3 27.2 0.4 1.1 28.2 30.4 22.9 34.4 25.3 14.1 12.9 21.2 18.3 15.4 TMIE DFNB6 ENSG00000181585 "Transmembrane inner ear" Q8NEW7 3 46694528-46710886 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.7;brain: 11.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.3;EFO-21: 5.6;hTCEpi: 3.8;SH-SY5Y: 4.8" "Cancer enriched" "Detected in many" 5 "glioma: 6.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.1" "Lineage enriched" "Detected in single" 17 "T-cells: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038298 Uncertain Uncertain Vesicles,Cytosol "Vesicles, Cytosol" "HPA038298: AB_10675792" "unprognostic (6.59e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-3)" "unprognostic (2.48e-3)" "unprognostic (1.88e-2)" "unprognostic (5.40e-3)" "unprognostic (3.94e-2)" "unprognostic (8.80e-2)" "unprognostic (3.37e-2)" "unprognostic (6.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.35e-2)" "unprognostic (4.58e-2)" "unprognostic (1.23e-1)" "unprognostic (4.41e-2)" "unprognostic (5.29e-2)" "unprognostic (6.78e-2)" 1.2 11.7 6.7 0.7 2.9 0.0 0.5 2.7 7.0 0.8 0.9 2.3 0.4 0.6 0.8 1.2 2.2 1.0 0.4 1.0 5.9 11.4 1.4 0.9 1.8 1.2 5.8 4.8 2.8 0.4 0.0 8.1 0.7 3.8 0.9 0.6 1.1 0.8 1.8 5.8 1.3 0.6 0.7 5.2 1.2 0.3 1.6 1.0 0.4 0.8 1.7 1.3 0.8 0.4 0.0 0.3 0.0 0.1 0.0 6.1 1.2 2.0 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.2 0.0 6.3 0.0 5.6 0.0 0.2 0.4 0.5 0.0 0.0 0.0 1.6 0.1 0.0 1.8 0.0 0.0 0.0 3.8 0.0 2.5 1.0 0.0 0.5 0.0 0.3 0.1 0.0 0.4 0.3 2.4 0.0 0.5 0.2 0.1 0.7 4.8 0.7 0.8 0.1 0.2 1.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.0 1.8 1.0 0.3 0.0 6.1 0.9 0.0 0.0 0.0 0.0 1.0 1.2 6.7 2.9 2.7 7.0 5.9 11.4 5.8 4.8 3.8 1.0 TMSB4X "TB4X, TMSB4" ENSG00000205542 "Thymosin beta 4, X-linked" P62328 X 12975108-12977227 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 1074.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033806 Approved Approved Nucleoplasm,Vesicles,Cytosol 400000000 "Nucleoplasm, Vesicles, Cytosol" "CAB033806: AB_2256019" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.72e-2)" "unprognostic (3.27e-2)" "unprognostic (7.98e-3)" "unprognostic (1.71e-2)" "unprognostic (2.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (6.20e-4)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (3.77e-2)" "unprognostic (1.98e-1)" 122.3 97.5 79.8 105.4 76.4 169.0 87.1 33.2 74.8 92.3 93.3 62.0 59.7 38.5 83.7 67.2 62.7 53.0 92.5 54.9 90.8 67.8 69.6 50.8 134.4 205.2 111.4 84.0 61.9 51.0 4.4 23.4 53.4 74.3 46.6 86.6 31.2 42.3 100.4 28.9 39.6 71.5 75.1 195.6 205.7 98.9 26.4 63.8 96.8 34.4 48.6 154.5 112.2 62.1 296.5 495.3 775.0 554.0 272.7 521.9 1074.5 141.5 118.6 233.1 367.2 285.8 313.3 0.5 75.1 196.5 58.3 100.5 24.4 119.2 33.9 72.6 227.8 62.4 34.5 50.3 78.5 198.2 1.9 42.2 70.3 0.3 66.6 164.9 350.9 145.8 72.2 69.0 60.4 350.3 5.3 0.5 206.3 50.4 196.0 357.9 83.8 81.8 151.1 82.5 138.5 347.1 41.5 24.8 10.5 108.8 5.1 13.8 136.7 167.5 281.7 85.2 42.2 482.6 74.5 110.6 80.3 65.8 130.3 68.4 61.3 544.9 512.5 775.0 364.8 524.7 309.6 296.5 407.3 391.0 495.3 275.6 345.8 349.0 576.0 272.7 554.0 204.1 521.9 1074.5 79.8 76.4 33.2 74.8 90.8 67.8 111.4 84.0 74.3 63.8 TMTC4 "FLJ14624, FLJ22153" ENSG00000125247 "Transmembrane and tetratricopeptide repeat containing 4" Q5T4D3 13 100603927-100675093 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016489 Uncertain Approved Vesicles Vesicles "HPA016489: AB_1858157" "unprognostic (1.49e-1)" "unprognostic (1.87e-1)" "unprognostic (8.34e-2)" "unprognostic (1.35e-1)" "unprognostic (2.43e-2)" "unprognostic (1.96e-1)" "unprognostic (1.50e-2)" "unprognostic (1.96e-1)" "unprognostic (1.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.99e-1)" "unprognostic (6.04e-2)" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" 4.1 4.4 11.4 4.4 13.7 1.9 5.7 10.6 21.8 6.6 7.0 45.7 8.3 8.5 8.7 7.5 4.8 13.2 4.9 3.2 16.9 8.7 11.5 9.8 3.5 3.6 16.9 10.0 5.3 12.8 7.5 3.3 4.0 29.6 7.9 7.6 4.6 6.9 5.6 9.4 6.5 7.3 6.0 25.2 3.9 7.9 9.7 11.3 4.2 7.2 3.9 4.6 7.7 4.3 2.4 6.4 0.2 3.3 1.3 4.4 1.4 4.9 4.2 22.1 11.7 2.9 5.9 24.7 2.8 2.5 2.7 2.2 4.2 9.3 14.9 9.5 2.4 3.5 6.8 3.0 3.2 8.4 4.9 6.3 7.9 6.7 3.1 8.1 0.1 8.3 5.8 1.0 4.9 12.1 4.7 1.9 3.1 4.4 5.9 4.7 5.9 4.2 6.4 3.9 3.3 11.1 3.9 11.4 11.8 5.5 10.7 2.8 7.9 23.0 18.8 2.4 4.2 2.2 4.9 5.0 4.0 2.8 11.8 5.3 7.0 0.0 2.0 0.2 2.7 2.1 2.4 2.0 2.6 4.4 6.4 2.4 3.0 1.1 0.0 1.3 3.3 4.2 3.8 1.4 11.4 13.7 10.6 21.8 16.9 8.7 16.9 10.0 29.6 11.3 TMUB2 MGC3123 ENSG00000168591 "Transmembrane and ubiquitin like domain containing 2" Q71RG4 17 44186970-44191731 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043137 Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA043137: AB_10794388" "unprognostic (4.57e-2)" "unprognostic (1.58e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-2)" "unprognostic (6.37e-2)" "unprognostic (1.85e-2)" "unprognostic (6.43e-3)" "unprognostic (1.07e-1)" "unprognostic (2.05e-1)" "unprognostic (3.35e-2)" "unprognostic (1.80e-1)" "unprognostic (1.58e-1)" "unprognostic (2.12e-1)" "unprognostic (9.75e-3)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "unprognostic (2.78e-3)" 22.5 27.0 21.2 22.6 26.7 39.9 37.6 32.4 39.0 27.3 24.0 25.9 30.5 25.2 27.4 26.4 31.0 24.2 26.6 21.2 21.2 20.4 28.9 29.4 22.9 24.7 19.9 23.1 27.9 33.5 30.7 25.2 38.9 21.0 30.3 23.6 23.3 30.7 34.1 22.9 29.0 29.6 23.4 18.8 40.0 25.8 46.0 19.6 21.1 34.6 20.9 23.1 26.0 25.0 10.0 10.2 29.9 13.3 5.5 8.1 8.2 11.3 22.5 14.3 13.3 22.6 18.0 11.3 15.1 16.4 28.2 28.9 11.6 21.4 7.9 16.4 18.7 21.8 10.1 14.3 17.8 19.4 20.9 8.2 20.4 17.7 23.5 9.2 18.6 21.7 21.0 19.2 12.0 19.7 9.4 23.8 18.4 8.1 12.8 12.4 4.7 19.0 11.7 17.4 12.8 17.9 12.9 11.5 11.7 7.9 7.5 14.9 21.9 12.0 16.2 23.6 14.5 16.5 13.4 17.5 12.7 7.7 18.1 7.9 15.9 29.9 13.3 24.1 8.1 11.7 6.8 7.7 6.7 7.7 8.5 10.0 6.5 7.3 29.3 5.5 11.7 10.2 7.6 8.2 21.2 26.7 32.4 39.0 21.2 20.4 19.9 23.1 21.0 19.6 TNFAIP3 "A20, OTUD7C" ENSG00000118503 "TNF alpha induced protein 3" P21580 6 137867188-137883312 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Inflammatory response, Ubl conjugation pathway" "DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 112.4" "Cell line enhanced" "Detected in many" "Karpas-707: 48.4;REH: 42.0;U-266/84: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA002116, HPA067479" Approved Supported Vesicles Vesicles "HPA002116: AB_1858162, HPA067479: " "unprognostic (5.50e-3)" "unprognostic (9.98e-3)" "unprognostic (3.06e-2)" "unprognostic (1.01e-2)" "unprognostic (4.01e-2)" "unprognostic (9.47e-2)" "unprognostic (5.01e-3)" "unprognostic (4.40e-2)" "unprognostic (2.92e-2)" "unprognostic (2.58e-1)" "unprognostic (1.72e-1)" "unprognostic (2.06e-1)" "prognostic unfavourable (6.05e-4)" "unprognostic (6.06e-2)" "unprognostic (3.55e-3)" "unprognostic (1.27e-1)" "unprognostic (6.29e-2)" 27.4 6.0 1.5 58.6 1.8 112.4 17.2 0.4 1.5 7.7 15.7 3.2 2.6 5.1 9.7 7.3 12.7 12.1 17.0 11.7 2.1 1.3 6.8 8.1 45.1 38.8 2.1 2.6 37.5 7.2 2.1 3.7 14.5 4.6 13.8 6.3 7.2 8.2 3.5 10.7 20.5 17.2 8.2 3.8 25.9 8.0 9.3 2.1 38.6 5.7 9.2 31.4 23.3 9.5 7.1 18.6 10.0 9.7 7.5 20.5 9.0 8.9 1.5 0.5 0.8 3.0 5.1 2.1 5.1 20.0 1.4 1.8 9.9 3.0 2.0 13.2 5.9 6.8 0.3 14.8 2.6 14.6 0.5 2.0 5.2 5.8 3.3 2.7 3.7 4.7 2.1 16.9 16.1 0.8 4.1 48.4 2.4 0.5 14.7 11.5 0.3 0.4 42.0 10.4 1.4 4.4 4.3 0.2 0.0 1.0 1.5 4.4 1.0 3.4 4.0 14.5 1.7 12.9 2.9 15.6 36.1 4.1 5.3 3.5 1.8 5.6 9.7 5.5 14.8 7.1 20.5 6.2 15.1 13.3 10.3 7.1 10.0 7.4 10.0 7.5 3.7 18.6 14.7 9.0 1.5 1.8 0.4 1.5 2.1 1.3 2.1 2.6 4.6 2.1 TNFAIP8L2 FLJ23467 ENSG00000163154 "TNF alpha induced protein 8 like 2" Q6P589 1 151156629-151159749 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 63.1;lymphoid tissue: 38.7" "Cell line enhanced" "Detected in some" "HEL: 12.5;HL-60: 7.3;HMC-1: 19.5;NB-4: 10.6;THP-1: 40.5;U-937: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062742 Approved Vesicles Vesicles "HPA062742: " "unprognostic (3.19e-3)" "unprognostic (1.02e-2)" "unprognostic (6.63e-3)" "unprognostic (2.27e-2)" "unprognostic (1.29e-1)" "unprognostic (6.49e-3)" "unprognostic (1.05e-1)" "unprognostic (9.15e-3)" "prognostic favourable (3.64e-4)" "unprognostic (9.54e-2)" "unprognostic (3.32e-2)" "unprognostic (9.03e-2)" "prognostic unfavourable (3.53e-7)" "unprognostic (1.78e-1)" "unprognostic (3.91e-2)" "unprognostic (4.87e-2)" "unprognostic (2.23e-1)" 8.5 4.2 5.7 13.8 8.8 4.1 2.7 1.3 4.5 2.0 3.2 4.0 0.0 3.9 2.0 2.6 2.1 3.0 4.1 2.8 4.1 3.3 2.9 6.0 8.2 20.9 8.2 2.2 1.8 2.0 0.3 1.9 7.0 7.2 2.6 4.6 1.8 6.4 1.4 1.0 2.7 6.9 3.9 8.0 38.7 2.5 1.0 6.9 21.0 1.8 1.2 12.8 7.2 1.9 17.7 56.4 63.1 50.6 47.1 43.9 44.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.5 0.1 0.0 0.0 7.3 19.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 10.6 0.0 0.0 2.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 40.5 1.0 0.1 0.0 0.0 0.1 0.1 0.0 0.8 0.0 16.0 0.0 53.4 50.6 50.0 23.3 45.4 22.9 15.6 28.8 23.5 56.4 17.7 43.9 31.5 63.1 47.1 41.2 13.3 31.6 44.8 5.7 8.8 1.3 4.5 4.1 3.3 8.2 2.2 7.2 6.9 TNFSF12 "APO3L, DR3LG, TWEAK" ENSG00000239697 "TNF superfamily member 12" O43508 17 7548891-7557890 "Predicted secreted proteins" "Angiogenesis, Apoptosis, Differentiation" "Cytokine, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 11.6;BJ hTERT+: 11.0;HDLM-2: 9.7;HSkMC: 10.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035984, HPA052967" Uncertain Approved Vesicles "Secreted to blood" 853000 150000 Vesicles "HPA035984: , HPA052967: " "unprognostic (2.96e-3)" "unprognostic (2.96e-1)" "unprognostic (4.71e-2)" "prognostic favourable (5.70e-5)" "unprognostic (5.31e-2)" "unprognostic (7.91e-2)" "unprognostic (6.45e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (6.09e-2)" "unprognostic (6.20e-2)" "unprognostic (8.62e-2)" "unprognostic (3.29e-2)" "unprognostic (4.11e-2)" "unprognostic (3.15e-2)" "unprognostic (8.74e-2)" "unprognostic (2.38e-1)" 32.9 16.7 23.0 14.0 16.9 2.9 20.4 15.7 21.8 22.1 27.4 9.5 18.0 9.5 17.6 18.6 24.5 19.8 30.1 23.3 16.3 13.3 15.0 8.8 23.8 16.8 14.8 13.9 31.3 20.6 9.0 8.4 13.4 7.8 27.8 6.2 19.7 26.7 32.7 12.8 8.2 11.3 24.2 9.1 21.6 18.0 7.4 8.5 2.6 11.3 9.6 11.0 26.0 37.7 2.6 2.4 10.5 5.7 2.4 6.9 0.8 0.0 0.0 0.5 0.0 9.0 11.6 2.5 3.9 11.0 4.4 2.7 0.0 1.3 0.0 3.4 9.5 0.9 0.4 0.4 0.4 9.7 1.7 0.6 0.2 0.8 8.8 0.0 0.0 10.1 1.1 1.5 0.1 7.1 0.1 0.0 3.8 0.0 0.0 0.3 0.4 4.9 0.1 0.0 0.1 7.0 0.0 0.0 4.7 1.3 0.0 3.8 0.7 0.4 6.9 6.0 0.5 0.0 2.1 0.0 0.0 0.0 1.1 0.0 5.3 4.0 3.1 10.5 5.2 5.7 6.9 2.6 3.8 2.8 1.8 2.5 4.4 4.1 2.2 2.4 1.4 2.4 4.1 0.8 23.0 16.9 15.7 21.8 16.3 13.3 14.8 13.9 7.8 8.5 TNFSF12-TNFSF13 TWE-PRIL ENSG00000248871 "TNFSF12-TNFSF13 readthrough" 17 7549099-7561601 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.4;fHDF/TERT166: 3.2;HUVEC TERT2: 2.9;U-138 MG: 4.6;U-251 MG: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 3.9;eosinophil: 10.5;intermediate monocyte: 6.5;myeloid DC: 2.7" "Group enriched" "Detected in many" 5 "dendritic cells: 2.7;granulocytes: 10.5;monocytes: 6.5" "Low region specificity" "Detected in many" "HPA004863, HPA035984, HPA052967" Uncertain Approved Vesicles "Intracellular and membrane" Vesicles "HPA004863: AB_1078187, HPA035984: , HPA052967: " "unprognostic (1.59e-1)" "unprognostic (1.48e-1)" "unprognostic (2.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (3.04e-1)" "unprognostic (2.19e-1)" "unprognostic (1.05e-2)" "unprognostic (1.40e-1)" "unprognostic (8.96e-3)" "unprognostic (1.38e-2)" "unprognostic (2.05e-1)" "unprognostic (8.23e-2)" 10.0 8.6 3.2 6.1 3.1 5.6 5.6 3.2 6.1 5.9 3.5 1.9 4.8 2.7 3.8 5.0 7.0 3.1 8.9 4.3 3.1 3.1 3.1 3.1 6.6 7.1 3.1 3.4 5.9 3.3 2.0 3.1 2.4 1.3 8.2 1.7 5.4 4.4 4.4 3.1 3.1 3.6 6.9 3.1 5.6 5.7 3.1 1.6 0.0 3.1 1.9 4.8 7.5 11.5 1.2 2.7 10.5 6.5 0.4 1.1 1.6 0.0 0.4 0.0 0.0 0.0 0.6 0.4 1.3 4.4 1.6 2.4 0.0 0.2 0.0 0.8 3.2 0.0 1.3 0.0 0.9 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.2 0.5 0.9 0.9 0.0 2.9 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 1.6 0.0 0.0 2.1 0.4 0.0 1.1 0.0 0.0 1.3 4.6 0.3 0.0 4.6 0.0 0.0 0.0 1.0 0.0 0.6 0.8 3.9 10.5 0.4 6.5 0.5 0.8 0.7 0.4 2.7 1.2 0.4 0.3 0.5 0.4 0.5 1.4 1.1 1.6 3.2 3.1 3.2 6.1 3.1 3.1 3.1 3.4 1.3 1.6 TNFSF4 "CD252, gp34, OX-40L, TXGP1" ENSG00000117586 "TNF superfamily member 4" P23510 1 173183734-173207313 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins" Cytokine "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.5;testis: 14.4" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 18.3;HHSteC: 7.9;HUVEC TERT2: 35.9;LHCN-M2: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA059579 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA059579: " "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (4.58e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (1.74e-1)" "unprognostic (1.13e-3)" "unprognostic (2.13e-1)" "unprognostic (8.65e-2)" "unprognostic (5.17e-2)" "unprognostic (1.26e-2)" "unprognostic (1.18e-1)" "unprognostic (1.11e-7)" "unprognostic (3.73e-3)" "unprognostic (2.66e-1)" "unprognostic (9.49e-2)" "unprognostic (2.98e-2)" 2.1 4.0 1.7 8.2 2.3 0.9 3.7 4.5 3.4 1.7 1.8 1.0 0.8 0.3 1.5 1.5 1.6 1.4 2.1 2.1 3.0 2.0 1.5 1.6 2.5 11.5 1.9 0.8 2.7 2.1 1.0 3.3 1.2 1.2 2.8 2.5 1.0 0.8 1.0 0.8 0.3 2.5 1.6 1.9 9.7 1.4 14.4 1.2 9.3 0.8 0.8 3.7 1.6 1.6 1.3 2.6 1.7 0.2 3.4 1.2 6.5 0.0 0.0 0.2 0.5 1.2 6.5 0.0 1.8 0.4 0.1 0.1 0.0 0.0 0.0 0.3 18.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.7 7.9 0.1 0.0 2.8 0.1 0.9 0.1 35.9 0.0 0.2 29.9 0.0 0.3 0.1 0.1 0.3 0.8 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.4 0.5 0.1 0.1 3.3 1.9 0.0 0.2 0.3 1.1 0.1 0.8 1.1 0.7 0.9 0.8 1.3 1.2 1.1 1.7 3.4 0.1 2.6 0.9 6.5 1.7 2.3 4.5 3.4 3.0 2.0 1.9 0.8 1.2 1.2 TNNC2 ENSG00000101470 "Troponin C2, fast skeletal type" P02585 20 45823214-45833745 "FDA approved drug targets, Predicted intracellular proteins" "Muscle protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 851.6" "Group enriched" "Detected in some" 7 "Hep G2: 9.7;HSkMC: 15.3;SCLC-21H: 11.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 6.0" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043174, HPA058481" Enhanced Approved Nucleoplasm,Vesicles 63000 Nucleoplasm Vesicles "HPA043174: AB_10806380, HPA058481: " "unprognostic (1.13e-1)" "unprognostic (7.25e-2)" "unprognostic (3.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.21e-5)" "unprognostic (1.80e-2)" "unprognostic (5.72e-3)" "unprognostic (3.12e-3)" "unprognostic (2.19e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (1.05e-1)" "unprognostic (9.03e-3)" "unprognostic (7.15e-3)" "unprognostic (4.79e-1)" "unprognostic (5.23e-2)" "unprognostic (1.13e-1)" 12.0 0.2 0.1 0.1 0.4 0.1 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 2.7 4.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 1.4 0.1 0.0 7.8 0.1 851.6 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.6 169.1 6.6 0.1 0.1 6.0 0.8 2.4 1.1 0.3 4.1 11.9 0.1 0.0 0.2 0.5 1.7 1.2 1.7 0.2 0.4 0.0 0.1 0.2 1.1 0.4 1.2 1.0 0.4 0.0 0.4 0.0 0.0 0.3 0.0 0.9 9.7 0.4 0.3 0.2 15.3 0.2 0.1 0.7 0.0 0.1 0.5 0.2 1.2 0.7 0.1 0.0 0.6 0.2 0.6 0.2 0.3 0.0 11.5 0.5 1.7 0.1 0.4 1.3 0.4 0.5 0.3 0.4 0.9 0.2 1.5 0.4 0.3 1.6 0.1 0.2 0.0 0.7 1.4 0.2 1.1 0.7 6.0 1.5 0.2 0.3 3.8 0.0 0.3 2.4 0.3 0.8 0.8 4.1 11.9 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 TNNI3 "CMD2A, CMH7, TNNC1" ENSG00000129991 "Troponin I3, cardiac type" P19429 19 55151767-55157773 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 367 "heart muscle: 419.3" "Cell line enhanced" "Detected in some" "HEK 293: 8.6;HMC-1: 14.4;K-562: 26.2;THP-1: 6.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "thalamus: 1.0" "CAB009349, HPA046428" Enhanced Approved Vesicles,Cytosol 1700000 Cytosol Vesicles "CAB009349: AB_793465, HPA046428: " "unprognostic (2.12e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-2)" "unprognostic (1.36e-1)" "unprognostic (2.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.37e-3)" "unprognostic (2.13e-1)" "unprognostic (9.62e-3)" "unprognostic (9.40e-2)" "unprognostic (3.34e-2)" "unprognostic (2.17e-3)" "unprognostic (4.02e-3)" "unprognostic (8.89e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (9.82e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 1.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 419.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.7 0.8 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.2 1.1 4.5 0.0 0.6 0.9 0.2 0.0 0.0 8.6 2.0 0.0 1.2 0.4 0.0 14.4 0.0 0.4 0.0 0.2 0.0 26.2 0.5 0.0 0.4 0.1 0.0 0.5 0.3 1.1 0.3 0.0 1.3 0.0 0.0 1.5 0.0 0.0 0.2 2.0 6.6 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 TNPO3 "IPO12, LGMD1F, MTR10A, TRN-SR, TRN-SR2" ENSG00000064419 "Transportin 3" Q9Y5L0 7 128954180-129055173 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039555, HPA041537" Approved Enhanced Vesicles Vesicles "HPA039555: AB_10672000, HPA041537: " "unprognostic (5.76e-2)" "unprognostic (1.72e-2)" "unprognostic (1.97e-1)" "unprognostic (5.49e-3)" "unprognostic (1.05e-1)" "unprognostic (1.74e-1)" "prognostic unfavourable (3.29e-5)" "unprognostic (1.86e-2)" "unprognostic (1.24e-1)" "unprognostic (1.93e-2)" "unprognostic (2.27e-2)" "unprognostic (2.34e-2)" "unprognostic (3.26e-2)" "unprognostic (4.70e-2)" "unprognostic (2.93e-1)" "unprognostic (2.04e-1)" "unprognostic (4.24e-2)" 17.8 24.0 22.6 23.8 20.5 28.9 16.2 29.6 21.4 15.2 18.4 15.8 30.1 15.5 19.7 17.9 26.3 16.1 12.9 16.1 16.6 17.7 19.1 21.6 15.4 20.5 17.7 15.5 20.7 19.8 21.7 19.2 13.9 18.4 16.7 19.7 15.6 19.0 20.4 41.4 19.2 17.8 18.9 16.2 17.2 21.9 36.3 15.1 29.5 22.3 15.9 26.4 22.6 18.1 16.6 15.9 20.9 21.7 14.4 17.4 10.5 20.1 22.8 17.8 30.0 17.3 15.0 15.2 18.1 15.9 17.0 20.1 18.6 18.6 25.3 8.5 19.4 14.9 35.9 17.5 24.5 20.9 15.9 18.6 19.0 14.5 16.5 33.9 15.9 14.0 17.8 20.7 18.6 21.1 42.1 18.2 21.7 14.9 29.3 25.1 50.8 21.1 20.9 16.6 20.6 17.2 19.0 22.1 17.5 19.3 9.1 20.4 10.3 21.2 15.8 21.6 10.7 25.4 24.7 23.5 18.2 35.0 31.3 34.9 37.5 20.6 13.6 20.9 17.4 17.2 15.5 16.6 14.2 15.4 15.9 15.5 14.1 16.1 15.9 14.4 21.7 7.7 14.5 10.5 22.6 20.5 29.6 21.4 16.6 17.7 17.7 15.5 18.4 15.1 TNRC6A "CAGH26, GW182, KIAA1460, TNRC6" ENSG00000090905 "Trinucleotide repeat containing 6A" Q8NDV7 16 24610209-24827632 "Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015305, HPA017869" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA015305: AB_1850454, HPA017869: AB_1850456" "unprognostic (2.64e-1)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.86e-1)" "unprognostic (5.00e-2)" "unprognostic (1.10e-3)" "unprognostic (1.62e-1)" "unprognostic (3.22e-3)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (7.44e-3)" "unprognostic (2.63e-3)" "unprognostic (1.78e-1)" "unprognostic (9.18e-2)" "unprognostic (5.77e-2)" "unprognostic (2.31e-1)" "unprognostic (3.35e-2)" 17.3 23.6 14.7 23.2 15.1 10.2 17.0 25.0 19.3 20.8 17.0 15.6 17.2 10.5 26.6 23.1 12.5 20.2 12.6 13.4 11.3 9.4 13.0 17.0 14.0 16.7 14.5 10.9 26.7 20.1 42.6 25.4 12.6 16.2 16.4 12.8 17.8 16.6 18.6 26.5 16.5 16.0 27.5 19.4 14.2 15.8 11.4 14.7 15.9 19.6 14.9 13.8 16.4 16.4 5.4 5.2 2.3 2.7 3.3 3.9 1.3 11.5 16.1 19.1 10.3 16.6 22.0 10.9 19.8 16.1 14.5 15.9 11.8 9.7 11.7 8.6 19.8 13.1 23.7 16.6 21.8 11.8 12.3 11.7 17.8 16.2 14.3 11.9 8.2 22.1 8.7 18.9 12.5 19.8 17.7 7.5 18.6 13.6 9.9 7.9 27.4 8.1 19.6 14.8 10.5 11.0 10.8 9.4 13.0 13.9 8.6 7.6 9.9 7.9 18.1 18.6 12.7 9.1 13.8 16.5 12.9 19.5 17.3 7.5 13.3 2.3 2.7 1.9 3.0 1.6 2.5 5.2 2.9 2.7 1.0 5.4 3.9 2.7 1.5 3.3 1.6 5.2 2.9 1.3 14.7 15.1 25.0 19.3 11.3 9.4 14.5 10.9 16.2 14.7 TOB1 "APRO5, TOB, TROB, TROB1" ENSG00000141232 "Transducer of ERBB2, 1" P50616 17 50862223-50867978 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047839 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA047839: " "unprognostic (3.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.45e-1)" "unprognostic (6.78e-3)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "unprognostic (3.50e-3)" "unprognostic (1.53e-1)" "unprognostic (3.56e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (5.04e-5)" "prognostic unfavourable (3.37e-4)" "unprognostic (3.92e-3)" "unprognostic (9.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.13e-2)" "unprognostic (6.97e-2)" 14.3 68.4 10.5 10.4 15.7 19.6 29.5 11.3 13.4 20.9 24.2 23.6 24.2 16.9 7.9 12.9 30.2 17.4 42.7 21.7 12.0 11.8 22.5 57.5 17.7 7.5 12.0 10.2 21.5 74.4 30.2 20.0 5.6 13.9 24.5 18.3 36.5 32.4 56.0 60.4 44.7 26.3 23.7 11.9 6.1 28.8 9.0 13.1 8.9 30.3 31.0 13.8 38.8 22.9 7.8 21.3 63.0 25.1 4.8 51.2 25.2 10.9 22.5 7.3 3.0 13.8 6.9 5.6 8.2 20.4 5.4 6.6 9.0 14.1 10.0 15.8 11.2 15.6 4.9 13.9 5.6 5.0 7.2 1.2 26.4 14.9 19.3 5.1 4.9 14.7 17.3 6.2 31.9 2.5 4.1 8.8 11.3 29.8 3.9 4.8 2.6 8.6 3.5 9.3 11.9 21.1 22.8 4.3 10.5 14.0 41.7 4.9 65.7 6.8 3.4 6.2 4.4 6.8 3.9 13.4 14.0 4.7 5.0 2.6 2.3 63.0 10.5 49.9 46.6 18.6 51.2 7.8 43.4 36.4 21.3 6.2 38.4 46.2 23.6 4.8 25.1 6.9 35.9 25.2 10.5 15.7 11.3 13.4 12.0 11.8 12.0 10.2 13.9 13.1 TOR1A "DQ2, DYT1" ENSG00000136827 "Torsin family 1 member A" O14656 9 129812944-129824134 "Disease related genes, Predicted intracellular proteins" "Chaperone, Hydrolase" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012473, HPA051195" Approved Supported "Nuclear membrane,Vesicles" "Intracellular and membrane" "Nuclear membrane, Vesicles" "CAB012473: AB_2240792, HPA051195: " "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.95e-1)" "unprognostic (1.86e-3)" "unprognostic (3.67e-2)" "prognostic unfavourable (5.45e-4)" "unprognostic (2.10e-2)" "unprognostic (1.41e-1)" "unprognostic (4.10e-2)" "unprognostic (2.86e-1)" "unprognostic (1.35e-1)" "unprognostic (3.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.77e-1)" "unprognostic (1.99e-1)" 19.8 26.8 17.8 21.9 19.3 28.0 37.5 19.9 28.4 18.8 19.0 15.5 17.8 15.2 22.5 19.6 15.0 17.4 22.7 18.0 18.4 19.7 20.9 47.1 19.3 34.4 16.1 14.3 20.4 18.8 15.2 15.9 28.9 15.6 20.8 21.3 14.9 18.9 24.7 15.8 17.8 21.0 24.0 15.9 23.1 18.1 11.7 11.3 32.8 22.6 11.9 18.2 21.0 16.1 17.3 24.1 53.3 28.8 24.9 24.0 27.2 13.1 19.8 14.6 16.8 22.3 21.7 19.5 30.8 38.2 27.6 23.7 12.8 19.4 16.2 18.2 39.8 31.1 14.0 20.4 22.7 25.7 13.4 14.5 20.8 12.7 28.1 31.9 27.0 29.3 20.7 26.0 18.9 29.5 25.7 13.1 30.3 32.9 22.7 31.0 21.9 22.6 11.9 23.1 16.4 22.5 16.9 11.1 19.6 31.9 12.5 16.9 25.0 25.1 26.1 27.4 15.6 20.3 23.5 15.0 33.3 14.9 20.3 18.5 21.9 30.0 28.8 53.3 24.0 26.4 20.1 17.3 20.6 21.6 24.1 12.9 17.7 18.3 28.2 24.9 21.3 22.1 22.4 27.2 17.8 19.3 19.9 28.4 18.4 19.7 16.1 14.3 15.6 11.3 TOX4 "C14orf92, KIAA0737, LCP1" ENSG00000092203 "TOX high mobility group box family member 4" O94842 14 21476597-21499175 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017880, HPA027551" Approved Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA017880: AB_1845573, HPA027551: AB_10601701" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.46e-2)" "unprognostic (9.30e-2)" "unprognostic (1.23e-1)" "prognostic unfavourable (3.46e-4)" "unprognostic (8.05e-3)" "unprognostic (2.58e-1)" "unprognostic (5.00e-2)" "unprognostic (3.23e-2)" "unprognostic (2.94e-1)" "prognostic favourable (8.38e-5)" "unprognostic (1.84e-1)" "unprognostic (2.48e-1)" "unprognostic (9.03e-2)" "unprognostic (2.48e-3)" 16.5 15.1 18.0 13.4 24.7 18.8 16.9 19.9 29.8 19.8 17.3 21.0 10.9 12.7 18.9 16.2 21.8 15.6 14.7 19.2 17.0 18.4 14.3 15.8 15.8 13.7 19.3 15.9 17.0 17.0 23.2 15.5 21.3 25.3 15.6 15.9 16.0 19.7 19.2 46.0 20.2 20.0 20.5 17.3 14.7 16.9 18.0 13.3 19.5 17.7 16.6 21.6 18.2 14.4 18.4 23.7 34.1 19.9 19.1 21.4 17.6 12.9 13.8 11.5 10.9 16.7 16.1 15.4 12.6 24.9 26.9 26.0 13.3 15.8 7.9 8.9 20.7 15.8 18.8 19.4 34.5 13.9 7.6 8.8 9.4 18.4 21.7 16.2 14.5 20.9 20.1 21.0 20.3 19.0 10.8 13.6 19.1 11.1 16.0 9.0 6.5 21.8 14.4 11.9 9.1 12.5 16.5 10.7 10.9 12.4 13.3 10.9 12.6 6.2 12.4 13.6 12.9 12.2 11.0 17.9 19.4 17.7 6.6 7.9 14.4 25.2 19.6 27.0 17.3 19.9 18.6 17.0 15.3 16.2 17.7 18.4 16.4 17.9 34.1 19.1 17.7 23.7 21.4 17.6 18.0 24.7 19.9 29.8 17.0 18.4 19.3 15.9 25.3 13.3 TP53I3 PIG3 ENSG00000115129 "Tumor protein p53 inducible protein 3" Q53FA7 2 24077433-24085861 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 55.0" "Cell line enriched" "Detected in many" 6 "T-47d: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB017479, HPA022012, HPA028742" Enhanced Supported Vesicles 200000 Vesicles "CAB017479: AB_2303667, HPA022012: AB_1858202, HPA028742: AB_10603456" "unprognostic (3.66e-2)" "unprognostic (1.41e-3)" "unprognostic (5.55e-2)" "unprognostic (8.04e-2)" "unprognostic (7.10e-3)" "unprognostic (4.47e-1)" "unprognostic (1.09e-2)" "unprognostic (1.53e-3)" "unprognostic (1.17e-1)" "unprognostic (2.83e-2)" "unprognostic (3.52e-2)" "unprognostic (1.75e-1)" "unprognostic (9.89e-2)" "unprognostic (1.40e-1)" "unprognostic (2.86e-1)" "unprognostic (3.67e-2)" "unprognostic (8.57e-3)" 10.3 9.5 2.7 11.7 2.7 6.3 6.3 2.5 3.6 12.0 42.1 3.6 10.5 18.4 8.5 7.0 43.2 6.1 17.8 5.0 1.6 3.2 28.2 11.5 15.7 5.3 2.1 2.0 4.7 20.3 4.0 4.6 13.0 3.3 6.6 15.5 6.7 11.3 6.9 4.9 2.8 55.0 6.1 2.3 5.6 9.0 41.3 1.9 8.6 9.0 10.6 9.0 8.2 21.8 3.6 11.1 11.4 13.4 0.2 0.4 4.0 4.9 16.2 9.5 3.9 7.5 16.8 6.9 4.9 6.1 4.3 6.0 4.1 8.9 0.6 2.8 8.1 1.5 2.4 8.7 2.6 3.7 0.3 1.4 5.7 10.6 4.9 0.6 2.9 18.1 13.9 11.5 2.8 19.3 1.2 4.2 18.1 3.3 0.8 0.1 7.2 6.6 1.7 8.4 0.1 7.2 7.7 1.3 6.1 6.5 1.4 1.0 113.2 1.0 14.2 4.9 12.0 3.3 2.4 1.9 1.2 0.5 1.7 0.0 1.2 7.3 13.4 11.4 0.2 8.5 0.1 3.6 0.2 0.4 11.1 2.6 0.0 0.3 2.8 0.2 3.8 4.8 0.3 4.0 2.7 2.7 2.5 3.6 1.6 3.2 2.1 2.0 3.3 1.9 TPD52L2 "D54, hD54" ENSG00000101150 "Tumor protein D52 like 2" O43399 20 63865228-63891545 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047489 Approved Approved Vesicles,Cytosol 1500000 Vesicles Cytosol "HPA047489: " "unprognostic (1.17e-2)" "unprognostic (2.43e-1)" "unprognostic (3.25e-2)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" "unprognostic (1.46e-2)" "prognostic unfavourable (1.39e-5)" "unprognostic (3.63e-3)" "unprognostic (9.95e-2)" "unprognostic (1.17e-2)" "unprognostic (1.47e-1)" "unprognostic (5.69e-2)" "prognostic unfavourable (1.74e-8)" "unprognostic (2.79e-1)" "unprognostic (7.07e-2)" "unprognostic (3.33e-2)" "unprognostic (3.15e-3)" 48.6 40.9 28.1 33.5 33.6 55.4 43.3 33.4 40.2 40.1 35.8 35.0 34.6 25.3 38.4 29.7 52.2 33.9 32.2 45.3 27.6 30.0 31.0 24.7 30.3 38.3 26.6 34.1 33.4 30.1 20.5 30.6 42.9 33.8 33.8 24.2 29.0 27.4 43.7 32.3 33.9 25.0 48.0 27.4 36.5 28.1 35.0 24.7 19.4 40.9 32.8 31.8 40.9 55.6 13.0 17.6 50.5 25.4 16.7 14.4 23.1 32.7 17.0 10.6 12.9 24.5 39.2 15.8 37.9 33.5 67.6 28.7 62.7 37.6 13.3 42.0 38.1 32.4 21.5 51.6 39.4 7.4 9.0 12.6 22.4 37.9 26.1 16.1 13.1 28.1 58.2 27.1 43.8 30.9 26.2 19.6 26.5 18.2 15.4 20.4 15.3 60.3 21.4 11.7 21.2 26.6 14.7 16.2 18.3 44.7 34.6 30.8 23.5 32.5 32.7 54.4 15.6 31.5 27.6 12.6 19.8 16.1 51.0 15.0 16.7 18.8 25.4 16.7 11.6 19.9 14.4 13.0 12.7 13.1 17.6 11.9 13.0 11.7 50.5 16.7 16.5 8.8 13.8 23.1 28.1 33.6 33.4 40.2 27.6 30.0 26.6 34.1 33.8 24.7 TPI1 ENSG00000111669 "Triosephosphate isomerase 1" P60174 12 6867119-6870948 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Glycolysis" "Isomerase, Lyase" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 234.8;skeletal muscle: 211.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050924, HPA053568" Uncertain Approved Nucleoplasm,Vesicles 270000000 Nucleoplasm Vesicles "HPA050924: AB_2681276, HPA053568: AB_2682193" "unprognostic (2.85e-1)" "unprognostic (5.58e-3)" "unprognostic (1.65e-1)" "unprognostic (1.62e-2)" "unprognostic (6.94e-2)" "unprognostic (2.31e-2)" "prognostic unfavourable (1.04e-5)" "unprognostic (4.14e-3)" "unprognostic (7.49e-2)" "unprognostic (2.13e-2)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (6.54e-4)" "unprognostic (7.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" 20.2 41.2 41.2 24.3 46.9 27.4 83.4 93.2 196.1 27.1 39.1 12.8 18.6 40.1 17.2 22.6 51.0 22.1 33.3 94.9 36.7 33.1 43.1 40.8 48.8 140.2 34.0 34.6 19.9 87.0 32.1 16.8 27.1 70.7 19.0 43.5 21.1 26.0 28.7 211.0 25.8 37.8 29.4 20.8 20.1 21.6 15.7 19.4 14.2 20.2 38.4 38.0 23.0 28.0 55.4 170.3 145.5 148.2 81.2 67.1 234.8 119.2 106.9 56.6 87.6 55.5 58.6 100.1 86.3 95.3 163.1 197.9 110.3 65.6 70.0 17.4 85.1 59.4 134.6 144.2 181.0 92.3 100.3 90.7 78.3 72.7 41.4 103.2 74.5 63.6 60.2 125.8 108.4 99.1 46.9 26.9 125.2 87.8 54.2 87.2 139.7 68.1 31.9 93.2 71.8 102.1 85.1 40.3 67.1 75.3 78.4 41.8 17.9 77.6 61.2 87.5 75.0 56.6 126.5 52.6 21.6 104.6 175.6 64.2 62.7 87.7 146.1 145.5 56.1 148.2 57.0 55.4 56.5 54.5 170.3 44.3 39.9 49.3 61.1 81.2 127.8 30.7 67.1 234.8 41.2 46.9 93.2 196.1 36.7 33.1 34.0 34.6 70.7 19.4 TPK1 "HTPK1, PP20" ENSG00000196511 "Thiamin pyrophosphokinase 1" Q9H3S4 7 144451941-144836395 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AN3-CA: 26.6;CACO-2: 6.3;EFO-21: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021545, HPA021849" Approved Approved Vesicles 78000 Vesicles "HPA021545: AB_1858209, HPA021849: AB_1858210" "unprognostic (4.05e-2)" "unprognostic (3.28e-2)" "unprognostic (2.38e-2)" "unprognostic (3.32e-2)" "unprognostic (2.42e-1)" "unprognostic (1.63e-1)" "unprognostic (7.62e-2)" "unprognostic (6.08e-2)" "unprognostic (2.37e-1)" "unprognostic (1.68e-1)" "unprognostic (3.76e-2)" "unprognostic (6.06e-2)" "unprognostic (1.45e-3)" "unprognostic (3.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (9.22e-3)" 12.2 7.4 5.1 9.6 4.7 3.6 7.6 4.0 7.2 4.3 8.4 4.2 2.4 18.2 5.1 5.0 3.3 3.9 5.4 6.4 5.6 6.6 6.0 6.2 8.8 23.3 4.9 3.1 4.4 3.3 3.6 4.6 7.0 4.4 3.7 8.5 8.9 7.1 4.1 3.0 2.9 13.9 5.1 6.0 15.1 4.0 5.9 2.0 5.1 4.9 4.1 14.2 5.5 3.3 5.4 9.6 3.4 7.4 4.0 5.5 3.8 0.2 0.2 0.2 26.6 0.2 0.2 2.2 0.1 0.1 0.0 0.0 6.3 1.0 0.4 8.1 0.4 0.0 0.5 0.3 0.2 1.6 0.4 0.1 0.1 0.1 0.7 2.0 0.6 0.5 0.5 0.3 0.4 5.1 0.5 1.2 0.1 0.8 0.5 3.0 0.6 2.2 0.2 0.6 0.9 4.1 2.3 0.2 0.0 0.4 0.0 0.4 0.3 3.8 6.1 0.3 0.6 0.5 0.3 0.6 1.4 0.6 0.9 5.1 0.2 0.3 7.3 0.2 3.9 5.3 4.0 5.0 4.4 3.5 9.6 5.4 5.2 4.2 3.4 4.0 7.4 2.3 5.5 3.8 5.1 4.7 4.0 7.2 5.6 6.6 4.9 3.1 4.4 2.0 TPRA1 "FLJ32197, GPR175, TMEM227, TPRA40" ENSG00000163870 "Transmembrane protein adipocyte associated 1" Q86W33 3 127573069-127598251 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019784 Approved Approved Vesicles Vesicles "HPA019784: AB_2670266" "unprognostic (1.52e-1)" "unprognostic (1.33e-2)" "unprognostic (9.41e-3)" "unprognostic (1.66e-2)" "unprognostic (6.91e-3)" "unprognostic (9.74e-2)" "prognostic unfavourable (6.46e-4)" "unprognostic (3.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.91e-1)" "unprognostic (1.17e-1)" "unprognostic (1.11e-1)" "unprognostic (2.02e-2)" "unprognostic (1.73e-2)" "unprognostic (4.42e-2)" "unprognostic (2.09e-1)" "unprognostic (4.28e-2)" 17.6 21.0 14.6 11.4 13.5 22.4 22.1 20.3 16.7 22.6 25.8 15.9 26.9 17.1 21.5 16.7 19.5 21.9 18.2 15.4 14.9 12.4 18.1 23.5 20.4 13.1 16.3 11.6 21.9 30.4 24.0 15.9 35.7 14.0 19.5 11.1 21.0 24.3 19.5 31.3 28.7 18.2 16.9 10.7 17.7 16.8 18.3 12.5 13.9 30.2 15.8 14.5 19.5 19.8 9.5 19.2 13.7 16.3 6.5 14.1 7.3 22.5 16.3 6.5 12.9 25.1 13.9 24.4 14.1 16.0 11.7 10.7 10.5 14.8 19.8 25.8 17.4 23.9 10.7 16.2 6.2 12.5 9.5 13.0 22.1 10.1 27.6 8.2 25.5 13.9 13.7 8.1 20.0 8.8 7.8 18.5 14.3 18.8 9.1 22.2 11.0 12.6 17.1 9.9 17.6 13.8 9.2 13.1 5.1 22.0 27.0 18.0 13.6 19.2 16.1 14.4 8.7 30.8 7.7 15.8 11.7 19.1 15.9 19.7 10.9 3.6 16.3 13.7 10.2 11.0 12.9 9.5 12.4 14.1 19.2 8.2 9.9 10.0 10.3 6.5 9.6 13.4 8.7 7.3 14.6 13.5 20.3 16.7 14.9 12.4 16.3 11.6 14.0 12.5 TPRG1L "FAM79A, FLJ21811, RP11-46F15.3" ENSG00000158109 "Tumor protein p63 regulated 1 like" Q5T0D9 1 3625002-3630127 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063163, CAB079051" Supported Approved Vesicles,Cytosol "Vesicles, Cytosol" "CAB079051: , HPA063163: " "unprognostic (1.92e-1)" "unprognostic (3.26e-3)" "unprognostic (4.46e-2)" "unprognostic (7.99e-2)" "unprognostic (4.50e-2)" "unprognostic (3.35e-1)" "unprognostic (1.46e-1)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (5.37e-2)" "unprognostic (1.50e-1)" "unprognostic (7.83e-3)" "prognostic favourable (1.76e-9)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" 18.3 19.1 34.3 9.7 46.6 14.5 17.4 23.1 57.7 19.3 24.0 12.9 17.2 24.5 16.5 21.2 28.7 24.8 19.3 25.0 32.9 32.8 32.1 34.9 16.8 14.6 25.7 41.7 25.9 17.4 11.7 20.5 12.7 41.4 17.1 23.4 19.1 18.7 25.0 29.5 25.4 28.3 18.1 13.2 13.4 17.4 8.7 13.6 8.0 21.9 17.3 18.2 17.1 16.3 5.1 7.9 17.0 3.2 2.6 7.1 3.2 11.3 8.1 5.0 8.9 38.1 26.5 4.6 16.9 23.4 15.7 10.4 15.2 10.4 4.2 15.1 23.0 17.9 6.0 15.6 13.3 13.3 9.6 5.8 9.5 17.6 23.1 8.5 6.9 19.9 23.0 13.0 13.3 22.1 4.1 15.0 21.8 5.2 6.1 8.8 6.7 19.1 5.1 7.5 10.0 16.2 11.9 14.1 13.9 9.0 18.8 17.9 11.7 7.4 25.1 13.2 3.9 30.0 4.7 13.6 17.6 4.7 7.8 18.7 1.7 12.8 3.2 4.9 5.6 2.6 7.1 4.2 6.4 5.5 2.8 5.1 5.9 6.8 17.0 2.6 2.5 7.9 3.4 3.2 34.3 46.6 23.1 57.7 32.9 32.8 25.7 41.7 41.4 13.6 TRA2A "AWMS1, htra-2-alpha, tra2a" ENSG00000164548 "Transformer 2 alpha homolog" Q13595 7 23504780-23532041 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054018 Uncertain Supported Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA054018: " "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.24e-1)" "unprognostic (6.77e-3)" "unprognostic (8.05e-2)" "unprognostic (3.41e-2)" "prognostic unfavourable (2.07e-5)" "unprognostic (1.28e-2)" "unprognostic (2.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.87e-3)" "unprognostic (6.04e-2)" "prognostic unfavourable (1.79e-6)" "unprognostic (1.46e-2)" "unprognostic (1.52e-2)" "unprognostic (8.74e-2)" "unprognostic (1.36e-3)" 23.4 29.4 27.8 29.5 34.1 70.6 27.4 38.1 27.5 30.3 22.9 29.0 31.6 19.8 32.7 34.5 29.4 25.9 17.6 18.7 28.6 29.3 21.3 21.8 28.6 32.2 35.8 18.5 36.8 27.4 14.9 46.6 24.4 28.2 26.4 30.1 23.7 21.9 26.7 15.7 31.6 22.6 35.2 30.4 33.8 21.1 25.9 37.3 35.6 24.7 20.5 38.0 25.0 31.8 15.5 23.9 20.4 23.0 14.7 21.7 8.2 19.0 21.1 32.7 51.2 17.6 11.1 21.2 24.2 11.5 24.3 20.1 17.3 26.2 35.9 14.0 17.9 31.6 39.2 22.6 30.7 21.6 22.9 22.0 23.3 27.3 18.4 25.6 20.7 13.1 15.7 18.4 23.1 27.7 42.7 17.6 27.6 18.6 31.0 43.1 29.3 21.8 35.4 25.8 21.5 28.2 27.5 28.4 23.1 22.7 26.3 16.2 20.6 28.9 24.9 19.5 27.9 17.8 28.1 19.8 24.7 29.5 16.7 35.0 25.9 11.5 14.9 18.5 21.7 23.0 18.7 15.5 20.3 19.8 16.8 14.4 17.7 20.9 20.4 14.7 20.4 23.9 20.0 8.2 27.8 34.1 38.1 27.5 28.6 29.3 35.8 18.5 28.2 37.3 TRAF3IP2 "ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522" ENSG00000056972 "TRAF3 interacting protein 2" O43734 6 111556454-111606278 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 35.4;U-2197: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036352 Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA036352: AB_10672085" "unprognostic (1.94e-1)" "prognostic unfavourable (3.21e-4)" "unprognostic (1.79e-1)" "prognostic favourable (4.73e-5)" "unprognostic (2.81e-2)" "unprognostic (3.03e-2)" "unprognostic (1.01e-2)" "unprognostic (9.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.13e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "prognostic unfavourable (5.16e-5)" "unprognostic (1.11e-1)" "unprognostic (4.88e-1)" "unprognostic (2.34e-2)" "unprognostic (1.31e-1)" 16.0 13.3 11.9 12.4 12.0 13.4 18.2 3.5 12.5 15.7 16.4 6.0 27.1 16.4 22.4 16.1 24.3 22.5 13.4 7.9 10.2 5.0 9.2 5.6 11.7 8.3 6.1 4.8 8.9 15.5 9.1 11.7 17.9 18.8 11.9 15.8 11.2 19.1 32.6 10.6 30.4 13.6 13.7 13.8 6.3 16.6 3.9 7.7 12.9 16.2 21.0 18.5 11.9 15.9 5.4 2.0 8.0 1.4 2.9 11.8 2.0 7.1 2.4 0.6 3.2 9.4 10.1 4.1 7.2 18.9 3.4 4.4 1.5 4.1 1.1 2.8 9.2 15.7 2.8 28.2 3.9 8.9 1.9 1.3 3.2 3.1 3.2 1.8 5.5 14.7 20.3 8.3 35.4 6.4 3.4 0.3 3.3 6.2 5.4 4.5 2.2 2.6 9.3 3.3 0.7 8.9 11.5 5.5 0.4 3.4 18.8 12.1 8.8 4.9 1.7 4.9 1.8 37.2 7.8 0.2 1.9 3.7 10.3 3.0 11.0 8.0 1.4 3.5 2.9 0.3 10.0 4.6 5.6 3.8 2.0 5.4 5.9 5.5 1.5 2.9 0.1 0.2 11.8 2.0 11.9 12.0 3.5 12.5 10.2 5.0 6.1 4.8 18.8 7.7 TRAF3IP3 T3JAM ENSG00000009790 "TRAF3 interacting protein 3" Q9Y228 1 209756032-209782320 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 86.5;lymphoid tissue: 69.5" "Cell line enhanced" "Detected in some" "HDLM-2: 39.9;Karpas-707: 16.6;MOLT-4: 20.6;NB-4: 23.7;THP-1: 22.4;U-266/70: 24.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040796 Enhanced Approved Vesicles Vesicles "HPA040796: AB_10794861" "prognostic favourable (4.11e-4)" "unprognostic (1.11e-1)" "unprognostic (1.51e-3)" "unprognostic (1.36e-4)" "unprognostic (2.67e-1)" "unprognostic (1.91e-5)" "unprognostic (3.83e-3)" "prognostic favourable (8.15e-4)" "unprognostic (5.30e-2)" "unprognostic (3.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.39e-1)" "unprognostic (1.38e-4)" "unprognostic (3.08e-1)" "unprognostic (2.93e-2)" "unprognostic (3.16e-2)" "unprognostic (4.21e-2)" 2.2 0.8 1.7 30.6 2.1 9.8 1.3 0.6 1.5 1.5 3.8 2.2 0.3 2.3 1.5 1.4 2.5 1.7 4.6 1.2 1.7 1.4 3.4 2.4 5.8 32.6 3.8 0.6 1.2 1.3 0.0 1.0 1.0 2.7 2.2 3.6 1.7 8.4 1.3 0.7 1.1 19.8 1.0 3.8 38.3 4.1 1.4 2.6 69.5 2.4 1.5 33.6 5.7 1.9 43.9 25.3 54.9 29.5 50.1 86.5 56.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 39.9 0.0 3.8 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 20.6 23.7 0.0 0.0 2.4 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 24.6 8.6 1.5 0.0 11.1 0.0 54.9 24.1 24.8 48.9 25.7 51.8 43.9 67.8 55.9 25.3 41.4 76.9 60.8 6.5 50.1 29.5 18.6 86.5 56.3 1.7 2.1 0.6 1.5 1.7 1.4 3.8 0.6 2.7 2.6 TRAF7 "DKFZp586I021, MGC7807, RFWD1, RNF119" ENSG00000131653 "TNF receptor associated factor 7" Q6Q0C0 16 2155698-2178129 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041229 Approved Supported "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA041229: AB_10794194" "unprognostic (1.94e-1)" "unprognostic (5.97e-2)" "unprognostic (1.13e-1)" "unprognostic (4.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (2.77e-3)" "unprognostic (7.08e-2)" "unprognostic (3.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (9.23e-2)" "unprognostic (6.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.43e-1)" "unprognostic (8.48e-2)" 16.0 18.2 18.3 22.3 20.6 28.5 39.1 28.7 25.6 22.1 29.4 9.1 21.1 37.3 20.4 18.3 32.9 21.9 36.9 21.0 18.3 14.8 21.3 47.3 18.3 40.9 13.4 14.7 19.3 41.6 17.7 20.3 19.5 12.8 16.2 16.9 13.0 24.4 23.1 25.5 32.2 37.8 28.8 14.1 21.4 25.1 13.2 10.6 26.1 20.3 30.9 21.9 21.9 28.9 6.7 12.3 7.7 13.9 3.0 7.1 5.2 20.8 26.7 15.3 27.3 15.8 30.0 18.0 16.1 20.3 19.0 17.1 32.4 27.0 13.4 19.1 20.5 24.5 14.3 28.6 7.2 21.1 18.3 19.1 35.6 24.8 21.0 20.3 27.7 29.6 23.9 18.3 24.0 36.7 20.3 18.1 18.0 47.7 20.8 23.6 30.0 13.1 38.9 25.4 26.8 15.3 11.2 30.8 25.6 13.5 25.9 17.6 29.4 25.0 27.6 23.1 32.5 21.5 17.5 26.2 19.4 17.7 13.2 13.2 17.9 3.7 10.0 7.7 5.4 13.9 5.0 6.7 5.3 5.7 12.3 4.9 3.8 4.5 6.9 3.0 9.4 6.0 7.1 5.2 18.3 20.6 28.7 25.6 18.3 14.8 13.4 14.7 12.8 10.6 TRAK2 "ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98" ENSG00000115993 "Trafficking kinesin protein 2" O60296 2 201377207-201451579 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 96.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015827, HPA062163" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA015827: AB_1858238, HPA062163: " "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-2)" "unprognostic (4.31e-2)" "unprognostic (2.78e-1)" "unprognostic (1.76e-1)" "unprognostic (2.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.24e-1)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "prognostic favourable (7.42e-5)" "unprognostic (1.48e-1)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "unprognostic (9.82e-3)" 16.9 13.4 20.4 9.9 23.9 28.0 14.5 11.8 19.4 11.3 14.1 31.5 5.4 7.8 9.1 9.4 10.6 8.9 11.5 42.7 25.6 21.8 15.8 9.2 12.9 9.8 43.1 12.2 6.7 9.0 17.2 11.8 15.0 31.0 8.4 15.5 9.6 14.0 10.2 8.4 5.9 9.4 13.1 96.9 10.8 8.0 4.7 23.2 5.6 22.1 7.1 8.6 10.1 18.8 14.6 3.9 4.6 6.4 10.3 11.3 5.3 3.8 5.6 3.7 13.7 25.5 36.8 4.0 14.2 12.5 10.4 12.2 8.2 3.6 2.5 5.8 19.6 3.9 7.8 4.4 17.9 7.2 4.2 5.6 10.2 6.1 14.1 4.3 6.8 19.7 4.4 10.9 8.8 15.2 4.4 10.9 22.1 5.6 3.4 2.6 4.1 11.3 4.4 9.2 3.9 8.9 5.5 6.9 9.0 7.7 6.2 23.9 4.4 4.6 17.7 16.8 6.3 11.5 8.8 6.0 10.3 3.1 14.2 6.9 8.6 1.8 4.7 4.6 7.6 6.4 6.9 8.0 9.6 6.5 3.9 14.6 6.5 7.0 2.6 10.3 5.4 2.2 11.3 5.3 20.4 23.9 11.8 19.4 25.6 21.8 43.1 12.2 31.0 23.2 TRAPPC2 "hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L" ENSG00000196459 "Trafficking protein particle complex 2" "P0DI81, P0DI82" X 13712244-13734635 "Disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB004665, HPA063308" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" Nucleoplasm "CAB004665: AB_425678, HPA063308: " "unprognostic (1.97e-1)" "prognostic favourable (8.09e-4)" "unprognostic (2.13e-1)" "unprognostic (4.18e-1)" "unprognostic (2.11e-1)" "unprognostic (2.70e-2)" "unprognostic (1.04e-2)" "unprognostic (2.08e-3)" "unprognostic (1.76e-2)" "prognostic favourable (6.35e-4)" "unprognostic (3.50e-2)" "unprognostic (8.24e-2)" "unprognostic (1.93e-1)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (2.36e-1)" "prognostic favourable (7.89e-5)" 6.5 6.4 15.6 9.5 13.7 9.5 9.4 24.1 16.1 10.5 9.4 10.1 8.8 8.2 16.4 8.7 8.5 9.4 7.6 6.4 14.4 14.2 10.1 10.1 7.8 16.1 10.4 13.0 11.7 11.2 8.9 19.5 7.2 11.5 8.9 9.1 10.2 8.1 8.3 4.9 10.3 8.8 16.0 11.5 11.1 10.7 4.3 11.1 4.3 8.8 4.2 16.4 8.1 9.4 11.2 10.7 13.7 6.6 18.5 16.1 9.0 6.7 5.2 8.0 20.6 6.2 4.8 3.3 6.3 5.4 5.0 5.4 4.4 8.3 11.4 10.2 5.2 8.9 10.7 9.0 6.9 11.5 15.9 8.5 12.3 3.5 4.7 11.6 16.4 6.2 5.1 10.7 14.7 4.4 10.7 19.6 5.1 11.1 11.4 15.4 7.7 9.4 11.3 10.7 11.1 7.9 5.0 8.6 11.4 11.6 9.3 8.0 11.6 7.7 5.8 5.1 4.6 9.1 4.0 10.2 9.9 14.3 4.7 8.3 5.2 13.7 4.9 8.6 16.1 6.6 16.0 11.2 12.8 15.8 4.3 11.1 10.8 15.5 10.0 18.5 5.4 10.7 15.3 9.0 15.6 13.7 24.1 16.1 14.4 14.2 10.4 13.0 11.5 11.1 TRAPPC2B "MIP-2A, SEDLP, SEDLP1, TRAPPC2P1" ENSG00000256060 "Trafficking protein particle complex 2B" P0DI82 19 57363511-57365353 "Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA063308 Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA063308: " "unprognostic (8.55e-2)" "unprognostic (1.07e-2)" "unprognostic (4.24e-1)" "unprognostic (5.27e-2)" "unprognostic (1.93e-1)" "unprognostic (6.69e-2)" "unprognostic (1.12e-1)" "unprognostic (4.47e-2)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.47e-1)" "unprognostic (2.05e-1)" "prognostic favourable (1.28e-4)" "unprognostic (1.26e-1)" "unprognostic (4.49e-2)" "unprognostic (9.74e-2)" "unprognostic (1.39e-2)" 14.6 23.3 13.4 9.9 17.1 11.6 17.2 23.8 16.7 11.5 12.5 6.7 12.1 7.0 12.2 15.1 15.4 11.4 13.7 26.5 18.0 14.0 12.9 14.5 12.4 15.0 11.6 14.5 15.8 9.7 12.2 16.4 16.9 18.1 14.3 7.9 9.0 11.4 10.4 28.8 11.5 8.6 12.7 15.1 14.3 10.2 31.2 9.6 12.7 17.6 16.8 13.7 15.4 9.5 26.7 21.5 32.2 13.2 22.8 15.5 13.4 9.1 7.6 10.3 6.6 9.6 10.9 9.5 6.2 14.5 9.5 28.9 3.6 7.1 7.0 8.9 8.4 3.3 5.2 10.4 10.3 3.4 36.2 7.4 12.3 8.0 10.1 7.7 11.4 11.7 13.1 7.6 5.2 7.0 2.2 0.1 11.2 2.6 11.4 6.8 3.5 14.9 5.7 9.8 10.5 10.7 14.4 11.0 8.5 6.5 6.7 5.7 10.5 10.0 7.5 8.8 7.8 4.4 10.3 11.4 14.4 14.1 12.7 4.8 9.0 32.2 13.2 16.3 7.5 11.6 14.7 25.0 15.5 12.3 14.8 26.7 15.0 12.0 15.3 22.8 10.3 21.5 13.4 13.4 13.4 17.1 23.8 16.7 18.0 14.0 11.6 14.5 18.1 9.6 TRAPPC2L HSPC176 ENSG00000167515 "Trafficking protein particle complex 2 like" Q9UL33 16 88856220-88862686 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041714 Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA041714: AB_10793930" "unprognostic (1.27e-2)" "unprognostic (2.32e-3)" "unprognostic (1.46e-1)" "prognostic favourable (3.75e-4)" "unprognostic (2.77e-1)" "unprognostic (2.69e-1)" "unprognostic (5.24e-3)" "unprognostic (2.90e-1)" "unprognostic (2.84e-1)" "unprognostic (6.53e-3)" "unprognostic (1.05e-1)" "unprognostic (2.81e-1)" "unprognostic (1.02e-2)" "unprognostic (1.18e-1)" "unprognostic (1.00e-1)" "unprognostic (5.81e-2)" "unprognostic (1.94e-2)" 22.7 46.1 29.5 18.6 29.2 19.8 22.4 15.9 37.4 18.5 21.8 25.5 16.0 16.2 15.8 40.4 17.4 19.0 25.0 26.0 22.9 24.4 20.2 21.9 13.9 24.3 24.9 22.5 21.5 25.6 8.7 16.0 13.7 22.1 15.8 15.7 20.0 17.3 17.3 53.8 19.0 14.7 14.1 27.3 18.3 21.5 33.9 18.1 11.5 19.2 25.1 16.6 16.1 16.4 41.2 45.6 10.8 39.0 24.6 47.7 40.9 15.8 11.1 18.9 14.3 14.2 18.2 19.5 14.3 16.4 22.2 8.5 30.9 21.0 12.2 25.4 18.2 17.0 25.7 20.6 16.1 10.6 15.4 8.1 11.2 39.0 21.0 22.9 6.5 17.6 13.0 29.9 15.2 17.8 24.2 9.8 15.1 49.5 30.5 70.9 19.0 20.8 29.4 15.7 12.6 17.0 18.4 20.5 10.1 48.6 15.0 13.1 38.5 24.4 14.0 14.7 16.1 19.3 16.2 13.8 23.3 56.7 17.6 34.2 17.5 10.0 39.0 10.8 34.0 31.2 34.2 41.2 39.2 36.6 37.7 35.2 36.9 31.4 6.8 24.6 29.7 45.6 47.7 40.9 29.5 29.2 15.9 37.4 22.9 24.4 24.9 22.5 22.1 18.1 TRAPPC5 "MGC52424, TRS31" ENSG00000181029 "Trafficking protein particle complex 5" Q8IUR0 19 7680843-7687703 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 73.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042221, HPA049064" Uncertain Approved Vesicles Vesicles "HPA042221: , HPA049064: " "unprognostic (3.10e-2)" "unprognostic (5.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.12e-2)" "unprognostic (1.14e-1)" "unprognostic (3.21e-3)" "unprognostic (1.80e-1)" "unprognostic (2.86e-1)" "unprognostic (6.28e-2)" "unprognostic (2.55e-2)" "unprognostic (2.12e-2)" "unprognostic (6.82e-2)" "unprognostic (4.86e-8)" "unprognostic (3.09e-1)" "unprognostic (1.11e-1)" "unprognostic (6.08e-2)" "unprognostic (1.51e-1)" 23.1 35.3 30.1 23.4 31.6 50.9 24.1 18.8 44.9 18.7 24.2 17.7 19.6 27.3 18.4 23.7 31.8 16.0 22.3 27.5 27.8 25.2 32.0 47.9 17.5 32.3 24.1 25.7 21.7 39.1 12.2 19.4 26.7 20.7 21.6 9.4 22.3 42.5 22.4 83.5 26.7 28.1 16.0 17.8 31.2 28.6 46.1 14.8 23.1 27.6 28.3 26.8 20.1 17.0 46.7 70.9 85.7 61.8 14.4 34.1 44.6 13.8 30.2 4.9 13.4 3.9 5.9 14.8 10.9 8.1 10.8 11.0 17.8 9.6 14.4 22.1 7.5 12.8 3.0 11.0 2.1 11.0 46.7 5.4 20.3 37.2 13.8 9.5 10.9 9.7 14.7 8.2 3.7 13.6 7.6 21.2 5.2 43.4 16.2 33.8 15.6 73.9 10.6 6.8 20.7 11.7 33.1 12.9 11.2 9.3 17.7 15.2 14.2 10.3 13.6 13.0 10.8 24.5 10.9 19.3 9.6 9.5 18.1 11.8 17.4 28.9 61.8 23.1 20.0 60.9 19.2 46.7 25.1 22.0 70.9 45.7 25.0 21.7 85.7 14.4 54.3 30.3 34.1 44.6 30.1 31.6 18.8 44.9 27.8 25.2 24.1 25.7 20.7 14.8 TRAPPC9 "IKBKBBP, KIAA1882, MRT13, NIBP, T1, TRS120" ENSG00000167632 "Trafficking protein particle complex 9" Q96Q05 8 139730343-140458579 "Disease related genes, Predicted intracellular proteins" Differentiation "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026579 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA026579: AB_1854459" "unprognostic (1.82e-2)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (8.14e-2)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.76e-2)" "unprognostic (2.31e-1)" "prognostic favourable (5.11e-6)" "unprognostic (2.09e-1)" "unprognostic (9.97e-2)" "unprognostic (2.40e-1)" "unprognostic (1.62e-1)" 9.7 12.0 13.0 14.7 17.9 13.8 8.3 18.3 22.0 11.3 10.3 17.2 12.5 11.3 11.4 9.8 12.1 17.4 12.8 14.7 13.0 13.7 12.2 10.0 9.5 10.6 14.5 11.7 11.5 15.4 42.0 28.2 14.1 15.1 10.4 9.0 17.2 12.7 12.7 38.3 8.8 12.7 10.5 13.2 10.5 11.1 7.9 9.1 24.8 14.2 10.0 15.3 10.1 8.3 6.3 6.3 14.2 5.0 7.5 7.1 4.6 6.9 12.4 5.7 15.3 12.1 7.2 3.8 4.4 7.5 2.5 4.0 4.5 8.2 8.4 10.7 8.9 8.9 7.5 7.1 2.6 12.2 4.6 13.4 7.3 4.4 8.5 3.4 10.8 6.9 6.8 1.9 6.3 9.8 4.8 7.4 4.0 19.2 20.4 4.3 1.7 10.9 8.8 2.1 13.8 8.4 8.5 14.2 8.0 7.3 3.5 7.6 11.2 4.9 5.7 3.4 6.1 8.0 3.5 10.5 7.7 5.8 7.2 7.3 5.5 14.2 4.9 4.0 6.5 5.0 7.1 4.5 4.5 5.1 5.1 6.3 4.7 5.5 7.8 7.5 4.7 6.3 3.3 4.6 13.0 17.9 18.3 22.0 13.0 13.7 14.5 11.7 15.1 9.1 TRIM17 "RBCC, RNF16, terf" ENSG00000162931 "Tripartite motif containing 17" Q9Y577 1 228407940-228416861 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;testis: 18.3" "Cell line enhanced" "Detected in some" "BEWO: 7.6;HEL: 3.5;NTERA-2: 3.2;SH-SY5Y: 4.0;T-47d: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054908 Uncertain Approved Vesicles Vesicles "HPA054908: " "prognostic favourable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (3.06e-2)" "unprognostic (5.45e-2)" "unprognostic (1.25e-1)" "unprognostic (7.74e-3)" "unprognostic (7.42e-3)" "unprognostic (2.02e-1)" "unprognostic (1.17e-2)" "unprognostic (8.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.04e-1)" "unprognostic (5.96e-4)" "unprognostic (3.88e-1)" "unprognostic (4.88e-2)" "unprognostic (6.33e-2)" "unprognostic (3.64e-1)" 1.3 0.8 14.4 1.5 19.1 1.1 1.9 25.8 11.8 1.5 0.9 0.6 1.7 1.4 3.6 1.7 1.3 3.9 1.7 1.5 8.9 3.4 1.2 0.6 1.7 2.0 0.7 9.2 2.2 1.1 0.8 1.0 1.3 2.7 2.0 0.8 1.9 5.9 3.8 0.8 3.5 1.6 1.1 0.9 5.3 1.4 18.3 4.7 0.0 2.9 0.1 1.2 2.5 1.3 1.7 0.6 0.7 0.3 0.0 1.0 0.1 0.3 0.6 0.4 0.4 0.0 0.0 7.6 0.5 0.0 0.0 0.1 1.7 0.9 0.1 1.9 0.0 1.7 0.0 0.0 0.1 0.3 0.7 3.5 1.0 0.2 1.6 0.1 0.3 0.2 0.2 0.1 0.0 0.0 0.2 0.5 0.1 0.1 0.3 0.0 3.2 0.2 0.1 0.1 0.0 0.0 0.8 0.5 4.0 0.0 0.4 0.0 9.4 0.2 0.0 0.3 1.7 0.3 0.1 0.1 0.0 0.2 0.2 0.1 0.3 0.0 0.3 0.7 0.9 0.1 1.0 0.6 0.2 1.0 0.0 1.7 1.0 0.8 0.2 0.0 0.2 0.6 0.0 0.1 14.4 19.1 25.8 11.8 8.9 3.4 0.7 9.2 2.7 4.7 TRIM33 "FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA" ENSG00000197323 "Tripartite motif containing 33" Q9UPN9 1 114392777-114511160 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 48.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004345 Supported Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA004345: AB_1858287" "unprognostic (8.90e-2)" "unprognostic (5.86e-2)" "prognostic favourable (6.20e-4)" "unprognostic (1.09e-2)" "unprognostic (8.42e-3)" "prognostic favourable (8.93e-4)" "unprognostic (1.34e-2)" "unprognostic (1.83e-1)" "unprognostic (6.75e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-2)" "unprognostic (4.84e-2)" "unprognostic (1.99e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" 15.2 12.8 16.9 18.4 19.9 27.1 17.1 38.3 21.8 16.9 14.3 11.0 21.9 10.9 19.8 38.3 16.4 15.0 15.6 10.8 18.1 12.5 17.3 15.0 14.3 15.2 12.1 18.0 19.8 15.7 21.8 22.4 27.2 15.2 16.5 13.0 10.7 16.4 19.1 14.3 19.5 14.8 20.2 12.9 14.9 14.1 29.0 16.3 20.5 17.9 9.8 16.6 17.9 28.7 3.4 4.0 12.2 2.8 4.7 4.4 1.0 12.9 7.0 13.2 9.9 5.6 5.9 22.5 6.6 7.0 9.2 9.8 7.9 5.5 13.8 6.8 7.7 7.5 12.0 7.7 12.7 10.4 7.1 13.3 9.2 9.1 6.2 16.8 11.1 5.6 5.7 10.9 11.2 7.7 16.6 9.8 8.8 48.5 16.9 7.1 17.8 7.1 14.6 20.2 4.5 6.6 20.4 9.2 9.7 12.5 15.1 11.9 6.9 9.2 8.6 6.4 10.5 14.8 9.2 6.9 6.4 14.5 9.1 9.8 18.2 12.2 1.6 7.4 3.5 1.8 3.1 3.4 3.7 3.7 2.0 2.2 2.9 4.4 4.8 4.7 2.8 4.0 2.0 1.0 16.9 19.9 38.3 21.8 18.1 12.5 12.1 18.0 15.2 16.3 TRIM44 "DIPB, MC7" ENSG00000166326 "Tripartite motif containing 44" Q96DX7 11 35662805-35818007 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049053, HPA057633" Approved Approved "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA049053: , HPA057633: " "unprognostic (2.73e-1)" "unprognostic (2.74e-1)" "unprognostic (1.37e-1)" "unprognostic (5.53e-2)" "unprognostic (3.91e-2)" "unprognostic (1.81e-1)" "prognostic unfavourable (5.24e-5)" "unprognostic (9.06e-2)" "unprognostic (5.29e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (8.57e-2)" "unprognostic (1.49e-3)" "unprognostic (2.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-1)" 18.8 18.1 25.2 17.7 31.5 8.2 17.3 34.8 35.1 18.4 18.0 25.1 12.6 16.2 19.4 16.7 14.5 17.9 18.1 17.5 25.8 23.0 28.1 21.9 18.1 18.1 26.7 31.9 17.0 23.5 23.0 21.7 20.2 32.0 16.9 17.7 13.3 16.1 18.8 20.3 11.8 17.9 19.2 29.7 20.3 17.0 12.3 25.1 12.8 23.4 7.2 19.5 19.7 19.4 4.1 4.9 0.9 3.7 3.2 3.4 1.5 10.4 8.9 14.3 6.6 10.9 16.6 0.0 9.8 11.8 12.4 11.3 10.4 7.1 14.0 9.3 12.8 8.2 4.9 11.2 14.0 9.1 9.3 15.0 11.8 5.9 14.5 11.7 13.0 12.5 12.6 7.2 19.8 13.0 23.3 5.0 13.0 6.3 12.3 5.7 8.1 7.8 8.6 37.2 7.5 11.4 14.2 9.9 8.5 14.7 10.6 11.1 15.9 10.0 14.5 15.9 13.1 9.0 11.1 8.5 7.6 0.0 13.1 12.5 11.9 0.4 2.6 0.9 2.6 3.3 2.4 3.0 2.5 2.5 2.1 4.1 3.3 3.4 0.2 3.2 3.7 4.9 0.9 1.5 25.2 31.5 34.8 35.1 25.8 23.0 26.7 31.9 32.0 25.1 TRIM51 "SPRYD5, TRIM51A" ENSG00000124900 "Tripartite motif-containing 51" Q9BSJ1 11 55883297-55891810 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 11.0" "Group enriched" "Detected in some" 124 "SK-MEL-30: 35.2;WM-115: 9.0" "Cancer enriched" "Detected in single" 50 "melanoma: 4.3" "Cell type enriched" "Detected in single" 111 "basophil: 11.0" "Lineage enriched" "Detected in single" 111 "granulocytes: 11.0" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles Vesicles Nucleoli "HPA044988: , HPA077883: " "unprognostic (9.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM62 "DEAR1, FLJ10759" ENSG00000116525 "Tripartite motif containing 62" Q9BVG3 1 33145402-33182059 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050061 Approved "Vesicles,Focal adhesion sites" "Vesicles, Focal adhesion sites" "HPA050061: " "unprognostic (1.57e-1)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" "unprognostic (2.62e-2)" "unprognostic (1.14e-2)" "unprognostic (5.80e-2)" "unprognostic (5.10e-5)" "unprognostic (2.05e-2)" "unprognostic (1.14e-1)" "unprognostic (4.32e-2)" "unprognostic (3.55e-3)" "unprognostic (3.66e-1)" "prognostic unfavourable (7.08e-5)" "unprognostic (2.14e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (2.05e-3)" 4.8 11.8 10.1 6.4 19.2 9.3 6.2 19.0 13.9 5.6 4.9 31.8 1.6 5.6 4.9 6.9 6.9 5.1 4.9 5.3 12.3 10.5 5.3 2.7 5.6 9.6 28.1 9.1 6.7 4.8 7.5 9.2 19.6 15.4 8.7 5.4 5.0 10.8 7.5 6.7 20.5 5.8 6.9 12.8 8.3 6.5 4.0 23.7 8.7 6.3 5.1 10.4 9.8 7.3 3.0 1.8 6.0 3.5 1.7 8.5 2.1 2.9 2.3 20.7 3.4 5.2 2.3 6.3 2.9 8.7 5.4 4.8 2.4 3.0 4.7 3.2 2.6 6.0 4.1 3.8 5.2 4.5 3.2 5.4 2.5 1.9 5.0 1.7 13.5 4.5 3.5 7.2 1.8 5.4 0.8 3.1 5.5 7.8 5.3 1.7 4.9 2.9 6.7 10.9 2.2 3.5 7.7 5.0 3.1 3.2 12.3 13.8 3.4 1.2 5.2 2.3 3.2 6.6 2.2 5.8 2.5 2.3 4.3 3.2 2.8 2.2 2.0 6.0 2.7 3.5 4.6 2.2 4.1 3.7 1.8 3.0 2.8 2.7 4.4 1.7 2.2 0.8 8.5 2.1 10.1 19.2 19.0 13.9 12.3 10.5 28.1 9.1 15.4 23.7 TRIM65 ENSG00000141569 "Tripartite motif containing 65" Q6PJ69 17 75880335-75897003 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021575, HPA021578, HPA064820" Approved Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: " "unprognostic (1.82e-1)" "unprognostic (1.47e-1)" "unprognostic (3.47e-2)" "unprognostic (1.36e-1)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "prognostic unfavourable (4.74e-6)" "unprognostic (5.36e-2)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-2)" "unprognostic (6.00e-3)" "prognostic unfavourable (1.82e-5)" "unprognostic (2.86e-3)" "unprognostic (7.18e-2)" "unprognostic (4.24e-3)" "unprognostic (7.50e-3)" 15.5 8.2 12.8 12.1 20.0 10.8 13.6 26.7 16.6 15.7 12.7 17.6 11.9 13.9 15.7 9.3 14.0 14.4 12.9 11.0 16.5 12.3 11.3 8.2 13.3 14.6 22.4 8.1 17.7 15.7 14.9 12.7 8.1 16.1 12.4 12.0 15.8 14.7 15.2 16.5 21.6 12.8 13.0 11.4 17.2 12.7 5.4 21.3 11.7 13.1 11.0 14.8 12.7 15.4 5.3 3.4 4.4 3.0 5.2 5.9 1.6 13.4 14.7 5.3 14.8 9.7 13.5 2.6 5.5 7.2 9.2 6.8 5.2 11.6 14.6 4.0 5.8 9.4 11.0 12.2 4.0 6.5 19.7 11.7 13.4 7.8 10.3 12.3 12.6 9.7 9.8 6.2 9.9 20.3 18.0 14.6 5.6 14.5 22.3 19.9 12.1 12.2 20.9 7.1 22.9 6.8 5.1 11.8 11.3 8.7 13.2 14.5 15.7 15.0 10.9 19.4 8.9 8.6 10.1 12.3 4.5 3.8 12.3 20.0 8.2 2.8 3.0 4.4 5.2 2.7 5.9 4.1 3.9 5.3 2.7 5.3 4.3 4.2 3.1 5.2 1.5 3.4 3.5 1.6 12.8 20.0 26.7 16.6 16.5 12.3 22.4 8.1 16.1 21.3 TRIM7 "GNIP, RNF90" ENSG00000146054 "Tripartite motif containing 7" Q9C029 5 181193924-181205293 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 81.8;tongue: 34.0" "Cell line enhanced" "Detected in many" "HaCaT: 11.2;HDLM-2: 23.8;PC-3: 13.2;TIME: 10.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 16 "cerebellum: 21.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 4.9;T-cells: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039213 Approved Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA039213: AB_10795173" "unprognostic (6.58e-2)" "unprognostic (1.17e-1)" "unprognostic (5.20e-2)" "unprognostic (1.10e-2)" "unprognostic (6.85e-2)" "unprognostic (1.80e-2)" "unprognostic (3.89e-4)" "unprognostic (3.45e-2)" "unprognostic (3.72e-1)" "unprognostic (1.64e-1)" "unprognostic (3.48e-2)" "unprognostic (1.97e-1)" "unprognostic (7.16e-3)" "unprognostic (1.26e-1)" "unprognostic (3.90e-2)" "unprognostic (6.17e-2)" "unprognostic (1.15e-2)" 1.3 0.9 0.1 0.9 0.5 0.5 3.4 21.7 1.3 2.5 0.8 0.3 1.1 0.5 1.0 6.4 13.0 0.6 1.7 2.2 0.1 0.8 2.2 0.5 0.9 0.6 0.2 0.2 0.6 4.2 1.6 1.9 0.5 0.5 2.0 0.6 0.6 5.9 1.1 81.8 9.5 0.6 0.9 0.3 0.8 1.4 0.9 0.2 0.1 3.3 34.0 13.5 1.6 2.9 0.7 0.8 0.1 4.9 0.5 2.2 1.1 6.1 2.9 0.0 0.3 0.5 0.5 0.1 1.4 0.0 0.5 1.2 0.2 8.0 0.4 4.3 1.7 11.2 3.2 9.2 0.1 23.8 1.3 0.5 7.8 0.1 1.6 0.0 1.3 0.1 7.1 0.2 4.6 2.6 0.3 1.3 0.2 0.8 0.3 0.2 0.0 13.2 0.3 4.2 0.9 3.3 0.0 0.3 0.7 2.9 0.1 4.0 0.7 0.2 10.8 0.1 2.4 0.4 4.2 1.9 0.2 0.7 0.3 0.4 1.0 0.0 4.9 0.1 1.4 1.9 2.2 0.4 1.2 1.4 0.8 0.7 2.2 1.8 0.1 0.5 1.4 0.6 2.2 1.1 0.1 0.5 21.7 1.3 0.1 0.8 0.2 0.2 0.5 0.2 TRIM72 MG53 ENSG00000177238 "Tripartite motif containing 72" Q6ZMU5 16 31214021-31231537 "Predicted intracellular proteins, Transporters" "Exocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "skeletal muscle: 71.6;tongue: 37.7" "Cell line enhanced" "Detected in some" "HL-60: 4.7;LHCN-M2: 8.7;RH-30: 22.6;U-266/70: 14.1" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 12 "cerebellum: 3.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA054909 Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA054909: " "unprognostic (2.61e-1)" "unprognostic (3.21e-3)" "unprognostic (5.07e-2)" "unprognostic (9.77e-2)" "unprognostic (3.71e-1)" "unprognostic (3.13e-1)" "unprognostic (2.01e-3)" "unprognostic (2.80e-1)" "unprognostic (6.57e-2)" "unprognostic (4.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.49e-2)" "unprognostic (2.24e-10)" "unprognostic (7.70e-2)" "unprognostic (6.72e-2)" "unprognostic (4.15e-1)" "unprognostic (4.30e-4)" 2.3 0.1 0.1 0.1 0.2 0.3 0.1 3.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 5.5 1.8 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.0 0.0 1.0 0.0 71.6 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.2 37.7 1.9 0.0 0.0 2.0 1.9 4.9 1.3 2.1 1.3 0.4 0.1 0.1 0.2 0.3 0.1 0.1 0.3 0.2 0.1 0.0 0.0 0.1 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.6 0.3 0.2 4.7 0.2 1.0 0.1 0.0 0.1 0.0 0.3 0.5 8.7 0.2 0.1 0.4 0.2 0.3 0.3 22.6 3.0 0.0 0.3 1.9 0.2 0.2 0.3 0.1 0.2 1.9 0.1 0.2 0.3 0.2 0.1 14.1 1.2 0.2 0.2 0.3 0.2 4.5 1.3 1.5 1.1 1.2 1.0 1.3 1.0 0.9 0.8 2.0 1.3 1.3 4.9 2.1 1.2 1.9 0.8 0.4 0.1 0.2 3.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 TRIM8 "GERP, RNF27" ENSG00000171206 "Tripartite motif containing 8" Q9BZR9 10 102642310-102660680 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023560, HPA023561" Approved Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA023560: AB_10600414, HPA023561: AB_10601861" "unprognostic (4.32e-2)" "unprognostic (6.90e-2)" "unprognostic (3.02e-3)" "unprognostic (1.45e-1)" "unprognostic (1.78e-1)" "unprognostic (5.03e-1)" "unprognostic (3.82e-2)" "unprognostic (1.03e-1)" "unprognostic (2.15e-3)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (1.52e-1)" "unprognostic (9.55e-2)" "unprognostic (1.48e-1)" "unprognostic (3.12e-2)" "unprognostic (8.34e-2)" "unprognostic (1.36e-2)" 31.7 18.4 26.1 23.9 25.2 17.0 18.0 26.1 31.6 31.8 19.5 22.9 15.4 15.8 18.0 14.3 17.8 21.6 19.8 25.0 23.2 18.0 27.2 21.9 23.0 25.4 20.1 20.0 19.3 35.9 24.7 14.7 17.5 16.3 17.4 8.1 19.4 28.5 18.5 34.8 14.6 23.7 13.6 15.7 22.5 21.2 11.7 21.9 48.3 26.6 14.5 30.3 21.4 15.9 9.0 11.9 17.8 5.3 5.5 7.2 3.9 27.6 6.5 6.4 10.5 7.1 14.4 6.0 9.9 20.2 10.8 8.7 11.7 33.4 8.9 26.7 22.0 10.2 4.3 13.3 8.9 9.0 8.4 22.5 5.4 26.7 18.1 5.0 9.0 16.5 7.4 23.7 14.0 14.3 4.2 13.4 8.4 18.0 9.5 16.9 3.5 13.2 4.8 14.4 4.4 12.8 19.5 3.9 7.6 5.5 6.8 13.1 19.2 10.0 26.6 14.5 6.5 8.1 22.2 12.3 8.0 5.2 22.1 12.6 3.6 10.7 4.8 2.6 6.8 4.4 6.7 9.0 7.2 5.3 4.1 7.0 6.4 5.5 17.8 5.5 5.3 11.9 6.9 3.9 26.1 25.2 26.1 31.6 23.2 18.0 20.1 20.0 16.3 21.9 TRIO ARHGEF23 ENSG00000038382 "Trio Rho guanine nucleotide exchange factor" O75962 5 14143702-14532128 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 62.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008157, HPA064664" Supported Approved Vesicles,Cytosol Cytosol Vesicles "HPA008157: AB_1858327, HPA064664: " "unprognostic (6.65e-2)" "unprognostic (4.21e-3)" "unprognostic (1.65e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (9.39e-2)" "unprognostic (4.13e-1)" "unprognostic (2.18e-3)" "unprognostic (2.55e-1)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" "unprognostic (2.02e-1)" "unprognostic (1.82e-1)" "prognostic unfavourable (3.11e-5)" "unprognostic (1.78e-2)" "unprognostic (1.96e-1)" "unprognostic (4.58e-3)" "unprognostic (2.23e-1)" 29.7 13.7 27.6 15.8 18.9 5.8 30.3 32.6 29.7 13.7 18.5 11.3 9.2 8.3 23.1 19.3 10.4 12.2 25.2 15.1 18.9 15.0 11.7 12.6 15.8 10.9 11.0 17.7 28.9 11.5 17.2 19.6 13.7 12.3 16.3 16.5 23.3 10.5 14.0 19.8 16.0 15.6 22.7 11.6 24.2 13.7 11.3 11.5 7.4 10.0 11.9 12.3 15.6 16.9 3.8 2.7 0.3 1.9 4.3 0.6 0.4 12.2 4.4 10.6 5.0 22.7 29.8 12.1 11.3 13.5 9.1 10.5 2.8 4.8 2.8 8.5 15.4 3.7 1.7 5.3 18.9 7.8 2.5 1.5 11.8 3.5 11.8 3.7 4.2 13.9 5.6 32.2 10.3 8.0 0.3 1.9 22.0 2.3 0.0 2.6 2.6 4.0 2.8 6.4 9.4 8.9 5.5 4.8 19.5 9.6 2.5 5.0 1.5 0.5 18.6 17.6 11.2 12.7 13.3 0.0 0.6 3.6 62.5 2.4 4.1 0.3 1.5 0.0 0.1 1.9 0.3 2.0 0.0 0.0 1.4 3.8 0.0 0.0 0.0 4.3 1.4 2.7 0.6 0.4 27.6 18.9 32.6 29.7 18.9 15.0 11.0 17.7 12.3 11.5 TRIP10 "CIP4, HSTP, STOT, STP" ENSG00000125733 "Thyroid hormone receptor interactor 10" Q15642 19 6737925-6751526 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 103.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 19.4" "Lineage enriched" "Detected in many" 12 "dendritic cells: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041934, HPA072625, HPA073886" Approved Supported Nucleoplasm,Vesicles 15000 Vesicles Nucleoplasm "HPA041934: , HPA072625: , HPA073886: " "unprognostic (5.75e-2)" "unprognostic (1.98e-1)" "prognostic unfavourable (3.61e-4)" "unprognostic (2.19e-2)" "unprognostic (6.57e-2)" "prognostic favourable (1.76e-4)" "unprognostic (6.73e-3)" "unprognostic (1.10e-3)" "unprognostic (1.51e-1)" "unprognostic (3.41e-1)" "unprognostic (7.87e-3)" "unprognostic (3.28e-1)" "prognostic unfavourable (4.66e-4)" "unprognostic (1.14e-2)" "unprognostic (1.42e-1)" "unprognostic (8.93e-2)" "unprognostic (8.83e-2)" 19.7 10.7 6.0 9.2 7.2 2.3 16.8 3.7 5.4 25.6 19.1 4.5 20.6 9.7 17.8 16.7 44.8 12.0 17.6 18.1 6.5 1.9 14.0 4.5 19.5 5.4 6.7 3.5 22.4 12.9 7.0 4.8 25.4 7.0 19.2 6.6 20.2 16.1 18.3 103.7 10.4 10.1 20.9 6.7 7.1 11.3 8.7 5.4 2.8 31.7 21.6 21.7 24.3 26.5 1.5 19.4 0.1 0.7 1.6 0.9 0.4 26.6 16.2 5.7 8.6 22.4 23.5 20.5 17.2 19.9 19.7 17.3 21.9 15.4 0.5 23.4 14.5 19.9 12.8 25.1 11.8 16.8 5.1 8.7 15.3 16.7 18.4 0.4 2.7 27.1 17.1 17.5 13.5 20.2 12.7 7.3 14.4 9.0 2.3 6.0 12.1 13.8 3.9 11.7 7.8 16.6 13.3 0.0 6.6 22.7 10.2 6.4 10.7 4.7 39.4 13.3 23.9 34.7 18.1 7.7 4.2 2.6 21.5 2.5 8.7 0.0 0.7 0.0 0.5 0.1 0.7 1.2 0.2 0.9 3.8 1.5 0.3 0.2 0.1 1.6 0.1 19.4 0.0 0.4 6.0 7.2 3.7 5.4 6.5 1.9 6.7 3.5 7.0 5.4 TRPC1 HTRP-1 ENSG00000144935 "Transient receptor potential cation channel subfamily C member 1" P48995 3 142724074-142807888 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 19.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009387, HPA021130" Supported Approved Vesicles Vesicles "CAB009387: AB_2240941, HPA021130: AB_1858361" "unprognostic (1.66e-1)" "unprognostic (7.38e-2)" "unprognostic (1.56e-2)" "unprognostic (4.37e-5)" "unprognostic (5.53e-1)" "unprognostic (1.40e-2)" "unprognostic (5.90e-3)" "unprognostic (1.59e-2)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (8.46e-3)" "unprognostic (6.25e-2)" "prognostic unfavourable (2.72e-5)" "unprognostic (1.44e-3)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.49e-2)" 6.8 8.3 8.5 3.5 13.4 1.2 6.8 23.0 15.9 17.7 8.3 11.4 4.3 2.6 20.4 9.2 6.5 10.1 9.1 15.9 10.0 11.4 6.0 2.0 5.4 3.3 9.4 12.2 24.5 3.0 12.2 14.4 6.1 14.7 12.3 4.9 13.0 3.7 13.6 2.4 6.2 4.7 17.6 11.4 5.0 4.4 8.0 7.9 0.4 8.9 3.9 2.3 9.3 8.9 0.6 0.0 0.0 0.0 0.3 1.3 0.3 3.3 4.7 8.6 1.0 7.8 19.1 3.9 5.3 8.3 6.7 9.8 1.5 0.9 0.0 1.7 5.4 0.3 2.4 2.4 9.6 0.8 3.4 5.2 2.0 2.2 3.2 0.3 0.0 9.1 2.4 6.2 7.4 3.8 0.2 0.0 9.3 2.1 0.3 0.4 4.8 2.5 0.0 4.1 0.0 4.6 0.1 5.5 4.0 6.4 0.0 1.1 2.7 0.0 3.5 8.4 1.3 11.2 7.0 3.5 1.5 1.7 6.4 0.1 2.5 0.0 0.0 0.0 0.2 0.0 1.2 0.6 1.3 0.6 0.0 0.3 1.2 1.3 0.0 0.3 0.0 0.0 0.0 0.3 8.5 13.4 23.0 15.9 10.0 11.4 9.4 12.2 14.7 7.9 TRPM3 "GON-2, KIAA1616, LTRPC3" ENSG00000083067 "Transient receptor potential cation channel subfamily M member 3" Q9HCF6 9 70529063-71446904 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 36.6;kidney: 28.0;retina: 105.2" "Cell line enriched" "Detected in some" 4 "HAP1: 19.0" "Cancer enhanced" "Detected in single" "renal cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "NK-cell: 2.1" "Lineage enriched" "Detected in single" 16 "NK-cells: 2.1" "Low region specificity" "Detected in all" "HPA072650, HPA074393" Enhanced Approved Vesicles Vesicles "HPA072650: , HPA074393: " "unprognostic (3.74e-1)" "unprognostic (6.30e-2)" "unprognostic (4.79e-2)" "unprognostic (4.81e-2)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-2)" "unprognostic (6.10e-2)" "unprognostic (1.15e-2)" "unprognostic (1.82e-7)" "unprognostic (3.51e-2)" "unprognostic (5.64e-2)" "unprognostic (1.74e-2)" "unprognostic (1.50e-2)" 0.9 1.7 6.0 0.7 4.5 1.1 0.8 36.6 5.1 0.8 0.7 9.6 2.1 1.8 2.4 3.0 0.7 1.3 1.3 1.4 9.4 6.0 28.0 0.9 0.8 0.7 8.3 3.5 5.3 1.5 0.7 6.8 0.8 34.8 1.4 0.7 105.2 0.8 5.0 1.1 0.8 0.7 1.0 8.1 1.1 1.6 5.3 5.9 0.0 2.1 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 1.0 0.1 1.2 2.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 19.0 0.0 0.1 0.0 0.1 0.1 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.1 4.4 0.0 0.0 0.0 1.3 0.1 0.0 0.2 0.0 0.9 0.0 1.3 0.0 0.2 0.0 0.3 0.0 0.0 3.5 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 6.0 4.5 36.6 3.8 9.4 6.0 8.3 3.5 34.8 5.9 TRPM7 "CHAK1, LTRPC7, TRP-PLIK" ENSG00000092439 "Transient receptor potential cation channel subfamily M member 7" Q96QT4 15 50552473-50686815 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Necrosis, Transport" "Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 91.8" "Cell line enhanced" "Detected in all" "U-2197: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035522, HPA052173" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Vesicles, Cytosol" "HPA035522: , HPA052173: " "unprognostic (3.14e-2)" "unprognostic (1.86e-1)" "unprognostic (1.58e-1)" "unprognostic (1.42e-2)" "unprognostic (1.89e-1)" "unprognostic (1.60e-2)" "unprognostic (1.85e-2)" "unprognostic (2.59e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (2.91e-1)" "unprognostic (1.59e-2)" "unprognostic (3.20e-2)" "unprognostic (2.08e-1)" "unprognostic (7.59e-2)" "unprognostic (9.45e-2)" "unprognostic (1.97e-1)" 13.3 10.8 6.6 14.7 9.0 12.8 12.1 19.5 9.3 11.8 11.7 8.1 9.7 9.9 16.5 10.7 9.4 11.0 8.2 19.1 5.5 4.9 16.0 20.0 10.8 10.6 12.4 5.2 16.6 11.6 91.8 14.6 14.3 10.2 9.7 10.3 28.6 11.5 13.5 10.8 11.7 12.8 12.8 9.8 11.1 10.3 6.9 10.0 14.5 12.6 6.9 12.6 12.9 12.3 7.0 4.7 4.4 3.4 5.7 7.6 2.0 8.3 8.3 7.0 7.7 20.2 15.2 8.5 10.6 14.7 6.7 8.9 11.4 4.6 18.2 5.2 12.2 14.1 9.3 7.8 9.7 10.1 5.6 14.5 12.8 6.0 18.4 15.0 11.3 14.1 9.2 7.6 14.4 5.4 16.4 14.0 12.2 13.1 9.6 7.3 5.3 5.1 10.6 9.7 8.9 9.4 19.8 5.8 7.4 7.3 11.6 14.2 7.3 16.3 8.2 10.7 5.1 49.9 12.1 9.5 21.0 17.5 11.7 30.7 9.9 3.8 3.4 3.9 6.6 3.2 7.6 5.6 4.8 4.4 3.7 7.0 4.4 5.2 4.4 5.7 3.2 4.7 4.8 2.0 6.6 9.0 19.5 9.3 5.5 4.9 12.4 5.2 10.2 10.0 TRUB1 PUS4 ENSG00000165832 "TruB pseudouridine synthase family member 1" Q8WWH5 10 114938193-114977676 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037914, HPA057552" Approved Supported "Vesicles,Actin filaments" "Vesicles, Actin filaments" "HPA037914: AB_10672399, HPA057552: " "unprognostic (1.98e-1)" "unprognostic (1.91e-2)" "unprognostic (1.27e-2)" "unprognostic (2.93e-2)" "unprognostic (3.20e-3)" "unprognostic (9.79e-2)" "unprognostic (9.26e-2)" "unprognostic (4.89e-2)" "unprognostic (6.87e-2)" "unprognostic (2.51e-2)" "unprognostic (2.26e-2)" "unprognostic (1.56e-1)" "unprognostic (1.50e-3)" "unprognostic (7.54e-2)" "unprognostic (2.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-1)" 7.2 29.0 14.7 7.7 19.5 3.3 10.9 11.5 22.0 10.0 8.9 9.2 7.8 8.4 12.6 9.4 9.9 9.6 8.1 20.2 14.7 15.8 15.4 13.0 6.2 8.7 11.0 10.9 16.8 8.3 13.1 9.6 7.0 18.1 11.7 10.2 7.7 9.5 11.3 8.2 6.6 7.6 10.8 10.2 9.6 7.9 17.9 8.0 12.7 11.9 9.2 9.2 8.7 8.3 9.2 6.0 4.0 8.2 10.2 8.5 6.0 13.6 10.7 10.5 26.1 7.6 10.2 14.2 11.8 13.4 16.0 18.2 8.7 14.1 16.9 13.7 9.2 11.7 14.1 14.6 23.8 12.8 15.2 7.8 5.3 15.5 13.1 14.5 11.7 10.4 20.2 11.3 22.5 9.0 8.0 6.9 18.9 6.6 13.5 11.6 9.9 10.6 13.6 26.6 10.3 21.1 6.9 9.8 10.9 9.9 14.7 25.7 11.7 9.0 8.0 7.4 7.4 11.7 14.3 13.3 10.7 14.2 10.4 18.6 6.6 4.0 3.3 1.1 6.0 5.1 8.5 9.2 6.4 6.3 6.0 7.1 8.5 7.8 0.3 10.2 8.2 5.4 7.6 6.0 14.7 19.5 11.5 22.0 14.7 15.8 11.0 10.9 18.1 8.0 TSLP ENSG00000145777 "Thymic stromal lymphopoietin" Q969D9 5 111070062-111078024 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 12.0;HHSteC: 13.6;hTCEpi: 8.1;hTEC/SVTERT24-B: 17.2;hTERT-HME1: 9.8;U-87 MG: 11.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.1" "Lineage enhanced" "Detected in single" "T-cells: 2.1" HPA056350 Uncertain "Golgi apparatus,Vesicles" "Secreted to blood" 38400 "Golgi apparatus, Vesicles" "HPA056350: " "unprognostic (6.47e-4)" "unprognostic (3.26e-1)" "unprognostic (6.57e-2)" "unprognostic (1.93e-1)" "unprognostic (5.03e-2)" "unprognostic (7.72e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-2)" "unprognostic (5.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.15e-2)" "unprognostic (4.24e-1)" "unprognostic (1.88e-1)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (2.76e-1)" "unprognostic (1.74e-3)" 5.1 1.7 0.7 2.0 1.1 0.2 19.1 0.5 0.8 5.4 4.6 1.4 6.6 1.5 4.2 0.7 14.1 1.1 14.1 18.7 1.4 0.8 1.6 17.3 4.6 1.8 1.2 1.7 1.1 0.8 0.2 1.5 0.4 2.3 16.4 1.7 1.0 3.5 6.8 2.3 1.7 2.7 12.6 4.6 1.0 2.6 7.9 1.1 0.3 4.1 3.2 2.3 10.0 6.0 0.0 0.0 0.0 0.5 0.0 2.1 0.3 0.0 0.0 0.0 1.4 1.8 12.0 0.0 0.0 1.7 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.6 0.0 1.8 2.1 0.1 0.0 13.6 0.3 0.0 0.3 8.1 17.2 9.8 0.0 0.2 0.0 2.4 0.0 1.8 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 3.2 0.0 0.0 11.1 0.2 0.5 0.0 0.5 0.0 0.9 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.5 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 1.1 0.5 0.8 1.4 0.8 1.2 1.7 2.3 1.1 TSPAN1 "NET-1, TSPAN-1" ENSG00000117472 "Tetraspanin 1" O60635 1 46175073-46185958 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.0;testis: 119.0" "Cell line enhanced" "Detected in some" "A-431: 21.2;CAPAN-2: 36.7;HaCaT: 25.6;hTCEpi: 29.8;RPTEC TERT1: 107.6;RT4: 51.6" "Cancer enhanced" "Detected in all" "prostate cancer: 455.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 90 "plasmacytoid DC: 8.9" "Lineage enriched" "Detected in single" 90 "dendritic cells: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA011909 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA011909: AB_2668565" "unprognostic (1.21e-1)" "unprognostic (3.11e-1)" "unprognostic (3.67e-2)" "unprognostic (4.12e-1)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "unprognostic (1.44e-1)" "unprognostic (1.88e-3)" "unprognostic (8.73e-2)" "prognostic favourable (9.28e-6)" "unprognostic (5.90e-2)" "unprognostic (2.61e-1)" "unprognostic (4.90e-2)" "unprognostic (4.30e-2)" 1.7 0.6 1.7 4.8 2.4 0.0 1.5 11.4 3.5 9.0 59.9 1.8 1.5 2.2 1.8 4.6 1.9 13.9 2.6 2.6 2.2 0.0 46.0 1.9 5.7 2.1 2.4 1.7 1.5 1.5 15.4 3.3 1.5 2.1 22.7 70.0 3.3 16.1 7.8 1.5 0.1 18.3 1.9 1.8 1.6 24.6 119.0 1.9 1.6 13.9 1.8 1.9 21.0 1.5 0.0 8.9 0.0 0.0 0.0 0.0 0.0 21.2 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 36.7 0.0 6.9 0.0 25.6 0.0 18.8 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 29.8 0.1 10.6 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.2 107.6 51.6 0.3 0.0 0.0 2.2 0.1 1.5 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 1.7 2.4 11.4 3.5 2.2 0.0 2.4 1.7 2.1 1.9 TSPAN11 ENSG00000110900 "Tetraspanin 11" A1L157 12 30926428-30996599 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 25.6" "Group enriched" "Detected in some" 6 "AF22: 18.5;HSkMC: 18.3;NTERA-2: 14.7;SCLC-21H: 7.1;SH-SY5Y: 14.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA066789 Approved Vesicles Vesicles "HPA066789: " "unprognostic (4.10e-2)" "unprognostic (4.27e-2)" "unprognostic (4.38e-3)" "unprognostic (1.18e-2)" "unprognostic (4.51e-1)" "prognostic favourable (5.28e-4)" "unprognostic (4.28e-2)" "prognostic favourable (3.43e-4)" "unprognostic (7.89e-3)" "unprognostic (8.05e-2)" "unprognostic (1.51e-2)" "unprognostic (3.03e-2)" "unprognostic (5.77e-3)" "unprognostic (2.04e-2)" "unprognostic (5.81e-2)" "unprognostic (2.90e-3)" "unprognostic (1.79e-1)" 3.1 2.5 6.4 16.0 3.8 0.0 2.5 15.2 12.7 9.0 25.6 9.0 3.0 4.4 6.4 7.8 8.8 2.4 12.2 8.8 5.0 4.7 1.6 1.0 8.5 2.6 4.1 3.8 1.9 1.4 0.3 1.5 0.8 3.8 5.4 11.0 12.2 3.8 6.8 0.8 6.5 10.9 8.3 2.6 2.6 4.5 1.6 3.7 0.0 4.0 12.3 8.9 6.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.5 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.5 0.0 1.1 1.6 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 18.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 14.7 0.1 0.0 0.0 0.3 0.0 0.0 7.1 14.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 3.8 15.2 4.3 5.0 4.7 4.1 3.8 3.8 3.7 TSPAN12 "NET-2, TM4SF12" ENSG00000106025 "Tetraspanin 12" O95859 7 120787320-120858402 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 20.8;HUVEC TERT2: 23.2;RH-30: 21.3;RPTEC TERT1: 34.0;RT4: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051570, HPA058244" Uncertain Approved Vesicles,Microtubules Microtubules Vesicles "HPA051570: , HPA058244: AB_2683652" "unprognostic (2.40e-2)" "unprognostic (7.60e-2)" "unprognostic (3.66e-3)" "unprognostic (1.82e-2)" "unprognostic (3.97e-1)" "unprognostic (7.34e-3)" "unprognostic (1.60e-1)" "unprognostic (8.12e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.63e-2)" "unprognostic (1.05e-1)" "unprognostic (9.53e-2)" "unprognostic (7.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.18e-2)" "unprognostic (1.43e-1)" 6.8 40.9 3.1 4.3 3.9 0.0 4.5 2.2 3.3 8.1 19.3 2.1 36.8 13.5 6.1 8.7 3.6 3.7 13.6 22.2 3.2 2.7 40.7 12.6 16.9 1.6 2.7 2.3 2.5 12.8 1.1 10.3 9.9 3.3 7.9 7.1 2.9 33.7 15.1 2.3 1.2 31.0 4.1 1.8 18.4 7.6 3.0 2.2 0.5 18.7 3.5 3.2 10.4 3.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 6.1 0.1 1.3 0.4 5.9 0.1 0.2 0.5 2.0 0.9 1.5 0.0 4.2 0.1 0.1 3.1 0.6 0.7 0.0 20.8 1.1 6.1 0.8 3.3 0.0 1.0 0.1 0.0 0.1 0.1 23.2 0.2 0.7 2.7 0.7 0.0 0.1 9.7 3.7 0.0 21.3 0.7 34.0 25.9 5.0 2.9 0.2 0.5 0.0 3.1 0.7 1.0 5.0 1.5 0.0 2.5 6.4 0.0 0.0 0.7 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.9 2.2 3.3 3.2 2.7 2.7 2.3 3.3 2.2 TSPAN14 "DC-TM4F2, MGC11352, TM4SF14" ENSG00000108219 "Tetraspanin 14" Q8NG11 10 80454166-80533123 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014773, HPA057174" Uncertain Supported Vesicles 170000 Vesicles "HPA014773: AB_2208670, HPA057174: " "unprognostic (7.52e-2)" "prognostic favourable (3.56e-4)" "unprognostic (6.55e-3)" "unprognostic (1.56e-1)" "unprognostic (4.40e-2)" "unprognostic (1.18e-1)" "unprognostic (2.11e-2)" "unprognostic (8.90e-2)" "unprognostic (5.21e-2)" "unprognostic (3.13e-1)" "unprognostic (5.15e-3)" "unprognostic (4.12e-3)" "prognostic favourable (4.20e-4)" "unprognostic (2.52e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (2.57e-3)" 56.8 10.3 15.4 17.2 14.1 22.0 45.1 5.2 16.8 30.0 14.1 15.1 28.1 13.3 18.9 22.4 44.6 22.2 15.1 15.2 13.4 7.7 22.9 16.0 32.9 47.4 18.8 10.8 21.7 14.4 12.3 7.4 39.0 13.0 20.0 12.3 22.7 24.8 16.5 11.3 33.3 17.3 15.3 16.5 28.2 12.6 12.9 14.5 16.0 26.2 19.1 26.7 30.5 28.4 4.4 10.1 16.2 47.7 26.1 29.0 21.3 21.5 31.9 29.6 10.2 45.7 14.6 13.9 11.1 21.3 12.1 8.9 30.7 12.6 7.0 21.4 6.0 22.5 8.3 20.1 9.9 12.3 3.2 19.7 3.8 26.3 15.3 7.3 4.8 14.0 17.9 12.2 22.3 45.0 10.9 5.1 3.4 18.5 10.6 5.2 6.7 0.0 36.8 3.4 1.1 47.4 31.0 6.4 9.7 4.4 30.9 34.2 12.5 17.7 63.6 3.0 12.7 2.9 7.7 2.5 9.1 2.5 10.1 14.9 13.3 3.8 14.8 16.0 29.0 30.4 13.2 4.4 22.7 25.7 10.1 4.2 27.1 25.2 16.2 26.1 47.7 4.0 17.9 21.3 15.4 14.1 5.2 16.8 13.4 7.7 18.8 10.8 13.0 14.5 TSPO "BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS" ENSG00000100300 "Translocator protein" "B1AH88, P30536" 22 43151514-43163242 "Cancer-related genes, FDA approved drug targets, Predicted membrane proteins" "Lipid transport, Transport" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 139.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB011232, HPA046260" Uncertain Approved Vesicles,Mitochondria,Cytosol "Mitochondria, Cytosol" Vesicles "CAB011232: , HPA046260: " "unprognostic (5.29e-3)" "unprognostic (1.41e-1)" "unprognostic (3.31e-1)" "unprognostic (4.02e-3)" "unprognostic (3.95e-1)" "unprognostic (1.46e-2)" "prognostic unfavourable (1.61e-4)" "unprognostic (2.16e-1)" "unprognostic (1.17e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.34e-3)" 33.9 21.2 9.8 17.8 11.0 117.3 48.7 2.7 8.1 24.9 23.9 12.3 10.3 20.5 12.3 13.6 83.2 14.3 36.8 32.1 8.0 5.4 18.0 22.0 39.8 40.0 15.4 5.2 13.3 13.2 4.0 6.7 15.5 9.7 23.1 9.7 16.4 34.6 9.2 13.2 46.6 23.0 12.7 11.4 27.2 39.0 10.5 10.0 9.4 17.9 44.3 50.0 19.1 41.3 22.9 99.9 91.4 139.5 28.5 43.8 104.8 47.1 23.4 1.6 22.2 8.9 29.6 1.7 35.3 17.3 17.8 18.9 4.5 36.1 0.0 24.4 27.3 39.1 4.4 27.3 2.3 7.9 18.4 4.8 25.7 1.6 32.4 10.7 24.2 22.9 45.1 10.5 9.4 42.0 3.9 8.9 18.2 39.4 0.1 29.9 1.9 58.4 10.6 0.0 80.5 22.6 28.5 2.3 10.9 16.7 33.4 41.1 12.5 41.5 43.3 22.0 16.5 22.5 14.8 3.6 0.6 0.4 28.6 34.8 28.2 43.8 139.5 75.3 28.4 86.3 22.2 16.3 39.5 27.8 99.9 22.9 30.4 24.5 91.4 28.5 57.1 17.7 43.8 104.8 9.8 11.0 2.7 8.1 8.0 5.4 15.4 5.2 9.7 10.0 TTC33 OSRF ENSG00000113638 "Tetratricopeptide repeat domain 33" Q6PID6 5 40512333-40755975 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038252, HPA038253" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "HPA038252: AB_10674551, HPA038253: AB_10671739" "unprognostic (2.86e-1)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.04e-3)" "unprognostic (3.01e-2)" "unprognostic (1.99e-1)" "unprognostic (2.01e-1)" "unprognostic (2.60e-1)" "prognostic favourable (1.83e-4)" "unprognostic (8.50e-2)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (4.28e-3)" 11.0 11.8 13.5 6.9 27.7 1.5 11.0 20.4 20.1 11.7 9.9 6.4 8.1 8.2 12.3 7.8 9.1 10.1 9.0 13.4 11.5 12.1 14.7 15.0 9.0 8.9 8.8 19.4 15.2 8.6 15.6 15.1 9.0 13.1 11.5 9.2 7.3 9.3 10.6 24.2 6.4 9.1 10.5 9.5 8.4 8.7 9.0 9.8 14.3 12.8 5.5 9.2 10.8 9.0 7.2 5.3 15.9 10.8 7.8 10.0 8.2 5.1 4.5 8.8 11.3 6.2 8.9 4.1 7.1 7.5 7.8 8.0 2.3 5.4 16.3 4.3 5.3 2.8 8.5 3.8 12.9 18.4 6.4 3.6 15.4 6.4 6.3 9.2 5.2 5.3 7.2 7.3 7.5 10.8 8.3 12.6 9.4 1.3 16.1 8.9 2.7 4.5 15.7 17.6 9.1 8.3 3.2 6.4 7.3 17.8 8.7 9.5 6.9 10.4 7.4 9.4 8.5 5.9 5.8 10.3 11.1 8.9 6.3 12.3 7.4 15.9 6.1 11.1 8.1 9.0 8.7 7.2 8.5 7.5 5.3 6.9 10.0 8.0 9.0 7.8 10.8 3.9 9.0 8.2 13.5 27.7 20.4 20.1 11.5 12.1 8.8 19.4 13.1 9.8 TTI1 "KIAA0406, smg-10" ENSG00000101407 "TELO2 interacting protein 1" O43156 20 37983007-38033468 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034230, HPA068338" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB034230: AB_1564322, HPA068338: " "unprognostic (7.14e-3)" "unprognostic (3.15e-1)" "unprognostic (6.61e-2)" "prognostic unfavourable (3.30e-5)" "unprognostic (1.11e-1)" "unprognostic (5.37e-2)" "prognostic unfavourable (2.40e-7)" "unprognostic (5.05e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (4.49e-2)" "unprognostic (2.36e-1)" "unprognostic (9.03e-2)" "unprognostic (1.94e-1)" "unprognostic (5.80e-2)" "unprognostic (7.56e-3)" "unprognostic (1.34e-1)" 9.2 14.2 16.6 10.5 16.2 9.5 11.1 15.5 16.3 10.8 9.8 16.0 9.2 7.4 12.7 12.7 10.2 12.8 7.3 11.3 10.2 9.0 10.7 15.2 9.6 13.4 14.9 12.9 15.4 24.5 16.6 22.8 13.2 15.6 12.8 13.5 13.9 11.7 14.9 22.0 10.4 9.8 13.8 15.8 12.5 11.3 13.0 14.1 17.6 15.4 4.9 15.3 13.7 10.0 10.2 12.9 17.0 11.6 10.3 13.9 9.1 9.6 14.4 16.0 6.0 6.5 9.2 17.2 11.1 6.5 16.5 14.1 33.6 12.7 16.0 11.5 6.2 15.5 17.9 23.1 16.3 6.4 7.0 21.9 14.3 17.2 7.4 17.5 10.3 7.0 15.3 16.4 10.0 12.2 23.0 11.0 12.4 10.0 23.6 12.2 15.7 15.2 15.5 25.8 18.7 6.3 10.4 14.6 13.0 16.9 30.0 3.8 17.0 8.5 8.0 22.3 14.8 11.8 11.2 9.6 8.3 18.1 13.0 11.6 11.4 12.9 9.8 17.0 11.9 11.6 13.4 10.2 9.3 11.7 12.9 9.7 13.9 11.1 6.2 10.3 6.9 6.3 11.7 9.1 16.6 16.2 15.5 16.3 10.2 9.0 14.9 12.9 15.6 14.1 TTL MGC46235 ENSG00000114999 "Tubulin tyrosine ligase" Q8NG68 2 112482154-112541739 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066819 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA066819: " "unprognostic (1.05e-2)" "unprognostic (3.90e-3)" "unprognostic (2.25e-1)" "unprognostic (3.95e-3)" "unprognostic (9.75e-2)" "unprognostic (1.81e-2)" "prognostic unfavourable (5.65e-4)" "unprognostic (2.95e-1)" "unprognostic (3.65e-1)" "unprognostic (2.10e-1)" "unprognostic (5.48e-2)" "unprognostic (7.19e-2)" "unprognostic (6.12e-2)" "unprognostic (1.30e-1)" "unprognostic (1.45e-1)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" 4.4 4.0 9.9 4.2 11.9 7.1 11.3 5.0 12.5 3.3 4.1 9.2 2.5 3.1 4.6 4.2 5.2 3.2 4.9 10.3 9.4 6.5 3.9 3.3 5.9 4.4 8.1 5.3 3.2 3.8 4.1 2.4 5.3 5.9 3.2 3.9 2.6 3.0 3.7 13.1 6.0 3.2 5.8 5.4 4.0 3.2 3.0 6.5 5.1 4.2 5.2 3.8 4.8 2.9 1.8 1.2 2.7 1.3 1.0 1.3 0.5 3.7 2.8 3.6 8.1 4.4 6.2 1.4 6.4 5.3 6.8 5.9 3.5 1.3 3.5 3.6 5.5 2.6 6.3 3.3 8.3 2.4 3.6 2.9 4.0 4.4 1.9 4.1 1.5 2.8 2.3 9.9 5.3 5.8 4.8 2.8 5.3 1.9 3.5 2.3 3.1 5.8 3.8 4.1 1.9 2.1 2.9 7.7 5.4 5.0 1.7 8.9 1.7 2.4 5.7 8.1 5.9 6.3 4.7 1.5 3.1 2.9 9.0 3.1 3.4 2.7 1.3 1.0 1.3 0.8 1.1 0.8 1.0 1.0 0.4 1.8 0.9 1.1 2.4 1.0 1.1 1.2 0.8 0.5 9.9 11.9 5.0 12.5 9.4 6.5 8.1 5.3 5.9 6.5 TTLL6 FLJ35808 ENSG00000170703 "Tubulin tyrosine ligase like 6" Q8N841 17 48762235-48817214 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.8;intestine: 5.0;testis: 17.6" "Cell line enriched" "Detected in some" 5 "HDLM-2: 9.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA052397 Enhanced Approved Vesicles,Microtubules Microtubules Vesicles "HPA052397: " "unprognostic (5.74e-2)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (2.18e-1)" "unprognostic (8.04e-2)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (1.02e-1)" "unprognostic (1.27e-2)" "unprognostic (2.35e-1)" "unprognostic (2.21e-5)" "unprognostic (1.10e-2)" "unprognostic (6.01e-5)" "unprognostic (1.17e-1)" "unprognostic (3.28e-1)" "unprognostic (6.68e-2)" "unprognostic (2.09e-3)" 0.1 0.0 0.5 3.3 0.5 0.0 0.1 0.1 1.1 0.2 3.6 0.1 1.3 1.6 0.8 0.1 0.1 4.8 1.4 0.1 0.8 0.4 1.8 0.1 1.1 0.1 0.2 1.1 0.8 0.6 0.0 0.3 0.1 0.9 0.1 5.0 0.3 0.1 0.1 0.1 0.0 2.0 0.1 0.1 0.1 0.1 17.6 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.3 0.0 0.0 0.4 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 1.1 0.8 0.4 0.2 1.1 0.9 0.1 TUFT1 ENSG00000143367 "Tuftelin 1" Q9NNX1 1 151540305-151583583 "Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 54.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in some" 8 "cerebellum: 72.2" "HPA028112, HPA054301" Approved Approved Approved Vesicles "Secreted - unknown location" Vesicles "HPA028112: AB_10603224, HPA054301: " "unprognostic (6.16e-2)" "unprognostic (3.76e-1)" "unprognostic (1.38e-1)" "prognostic unfavourable (4.83e-4)" "unprognostic (4.49e-3)" "unprognostic (1.12e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-2)" "unprognostic (8.29e-3)" "unprognostic (9.06e-2)" "unprognostic (6.70e-3)" "unprognostic (7.88e-2)" "unprognostic (2.58e-3)" "unprognostic (1.41e-1)" "unprognostic (1.32e-1)" "unprognostic (1.82e-3)" "unprognostic (4.53e-2)" 3.4 4.0 2.7 3.3 2.5 3.8 11.6 8.5 4.5 13.3 8.1 1.1 6.7 4.6 5.9 6.9 23.4 3.1 9.7 3.0 2.0 4.0 9.4 3.9 5.3 2.2 1.9 3.9 5.4 9.3 7.8 5.7 33.1 3.3 7.5 8.3 3.3 18.8 9.4 1.7 54.9 9.8 9.6 1.8 1.1 7.4 5.0 1.5 0.5 3.6 12.0 14.4 11.9 12.2 1.2 1.6 6.5 1.1 0.2 6.0 0.9 14.3 4.9 3.7 4.2 0.8 0.7 23.4 3.8 3.4 15.3 14.8 15.6 11.5 1.2 24.1 4.5 16.8 6.4 5.9 11.3 9.5 3.2 0.7 8.3 2.3 12.2 0.3 1.7 2.4 7.0 12.0 26.8 1.2 1.2 9.9 4.7 5.9 0.6 0.1 4.3 4.2 0.0 10.4 4.9 12.8 22.3 7.2 2.9 24.7 16.9 2.9 13.4 0.7 3.1 2.7 19.4 17.0 25.6 2.4 4.7 0.1 2.3 0.3 1.7 6.5 1.1 1.1 0.7 0.3 1.4 1.2 1.9 1.0 1.6 0.6 1.7 0.6 4.5 0.2 0.6 0.2 6.0 0.9 2.7 2.5 8.5 4.5 2.0 4.0 1.9 3.9 3.3 1.5 TUSC1 "CCDC89B, TSG-9" ENSG00000198680 "Tumor suppressor candidate 1" Q2TAM9 9 25676389-25678440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051426 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA051426: " "unprognostic (9.84e-2)" "unprognostic (3.56e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-3)" "unprognostic (9.41e-3)" "unprognostic (1.78e-1)" "unprognostic (4.79e-3)" "unprognostic (1.72e-2)" "unprognostic (5.71e-2)" "unprognostic (1.85e-3)" "unprognostic (9.14e-3)" "unprognostic (1.03e-2)" "unprognostic (1.89e-3)" "unprognostic (2.88e-2)" "unprognostic (1.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" 19.8 13.1 10.9 6.2 12.2 3.6 13.8 9.9 17.4 15.3 13.2 10.7 9.7 11.3 17.6 14.0 9.3 15.0 11.0 11.0 10.4 10.5 13.8 12.2 9.3 4.3 12.3 11.3 16.5 10.3 9.6 9.1 17.9 10.4 15.8 8.4 10.2 14.9 14.2 15.6 14.8 11.9 12.1 8.6 7.5 11.8 32.0 11.9 2.9 20.0 11.4 6.7 11.0 14.9 0.6 1.8 0.0 0.8 0.0 0.1 0.0 6.5 1.4 1.4 0.0 4.9 4.1 0.0 5.0 0.0 1.9 2.3 0.1 2.3 0.0 1.5 5.9 0.0 3.5 6.3 1.2 0.0 7.0 25.4 7.5 0.0 2.4 0.0 0.0 4.9 8.9 2.1 5.0 2.1 0.0 0.0 2.2 3.3 0.0 0.1 1.2 6.5 0.0 0.9 0.1 2.6 3.1 0.5 11.5 6.2 5.2 5.1 4.6 7.1 4.4 0.0 9.4 0.1 0.0 0.0 0.0 0.0 6.1 1.7 6.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.8 1.8 0.0 0.0 10.9 12.2 9.9 17.4 10.4 10.5 12.3 11.3 10.4 11.9 TUSC2 "C3orf11, FUS1, PAP, PDAP2" ENSG00000114383 "Tumor suppressor candidate 2" O75896 3 50320027-50328251 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030116 Approved Vesicles,Cytosol Cytosol Vesicles "HPA030116: AB_10602253" "unprognostic (1.58e-2)" "unprognostic (1.55e-1)" "unprognostic (1.73e-1)" "unprognostic (8.46e-2)" "unprognostic (2.73e-1)" "unprognostic (2.81e-1)" "prognostic unfavourable (2.84e-4)" "unprognostic (2.53e-3)" "unprognostic (2.87e-1)" "unprognostic (1.20e-2)" "unprognostic (3.47e-2)" "unprognostic (1.99e-2)" "prognostic favourable (8.70e-7)" "unprognostic (9.22e-3)" "unprognostic (1.98e-1)" "unprognostic (3.15e-1)" "unprognostic (6.34e-3)" 13.4 16.3 28.5 12.2 27.2 9.2 15.1 18.9 38.1 11.9 15.9 11.1 13.9 11.1 10.3 26.2 10.8 18.6 15.5 22.0 26.4 25.8 18.9 18.0 13.5 13.2 26.2 17.0 12.0 15.3 21.3 12.3 15.3 27.3 13.2 15.0 12.2 13.5 17.0 29.9 8.8 12.1 12.3 13.2 14.2 13.9 15.2 8.1 12.0 21.1 15.0 17.2 9.9 8.5 19.5 20.4 26.3 17.3 17.1 22.0 22.9 12.0 10.0 14.1 15.3 15.6 8.1 15.5 9.9 13.3 18.7 15.9 17.6 11.1 20.6 10.8 9.1 7.8 17.1 12.8 16.4 12.1 15.8 10.1 9.4 18.9 13.7 17.8 17.8 8.8 20.8 18.7 9.3 19.2 12.2 9.9 10.7 9.2 18.6 22.9 19.2 14.5 6.5 6.8 16.8 18.7 13.1 7.5 15.6 7.2 12.9 14.2 12.3 21.8 15.1 5.6 13.7 12.7 19.8 24.5 38.0 14.4 12.5 11.9 8.8 10.2 17.3 26.3 20.4 15.3 20.4 19.4 18.1 21.2 11.3 19.5 20.9 22.0 24.5 17.1 13.9 20.4 19.5 22.9 28.5 27.2 18.9 38.1 26.4 25.8 26.2 17.0 27.3 8.1 TVP23A "FAM18A, YDR084C" ENSG00000166676 "Trans-golgi network vesicle protein 23 homolog A" A6NH52 16 10760919-10818794 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.3" "Cell line enhanced" "Detected in some" "NTERA-2: 3.5;SH-SY5Y: 6.0" "Cancer enhanced" "Detected in some" "glioma: 2.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060582 Uncertain Approved Vesicles Vesicles "HPA060582: " "unprognostic (6.70e-4)" "unprognostic (1.64e-3)" "unprognostic (2.38e-2)" "unprognostic (8.24e-3)" "unprognostic (2.72e-2)" "unprognostic (4.39e-5)" "unprognostic (4.96e-2)" "unprognostic (4.68e-2)" "unprognostic (4.42e-2)" "unprognostic (9.22e-2)" "unprognostic (1.73e-2)" "unprognostic (2.42e-1)" "unprognostic (8.78e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.87e-2)" "unprognostic (2.87e-4)" 1.9 4.3 10.1 3.3 11.0 5.5 1.1 5.6 13.3 1.7 1.4 2.3 1.6 2.4 2.4 2.3 1.2 2.3 3.2 2.5 9.4 8.0 1.3 1.5 2.3 6.1 6.6 11.8 8.7 2.0 0.5 3.6 0.8 5.7 4.6 1.4 3.1 2.1 3.7 1.9 2.5 2.6 2.8 2.9 3.2 2.1 2.8 3.1 1.3 1.5 0.0 2.6 2.4 1.4 1.6 3.8 0.8 0.8 0.5 0.8 0.4 0.3 0.8 0.9 1.0 0.0 0.3 0.7 0.2 0.0 0.0 0.1 0.2 0.7 1.3 0.4 0.2 1.1 0.0 0.0 0.0 2.7 0.6 0.4 1.7 1.2 0.0 0.3 1.5 0.4 0.0 0.4 0.0 0.0 0.4 1.2 0.0 0.8 0.8 1.1 3.5 0.1 1.9 0.3 0.3 0.1 1.3 0.5 6.0 0.2 0.6 0.1 0.6 0.5 0.9 1.0 0.8 1.1 0.5 3.2 0.5 0.8 0.9 1.1 0.5 0.6 0.8 0.2 0.6 0.6 0.4 0.9 0.8 0.2 3.8 1.6 0.4 0.4 0.8 0.5 0.6 0.8 0.2 0.4 10.1 11.0 5.6 13.3 9.4 8.0 6.6 11.8 5.7 3.1 TXK "BTKL, PSCTK5, PTK4, RLK, TKL" ENSG00000074966 "TXK tyrosine kinase" P42681 4 48066393-48134256 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Transcription, Transcription regulation" "DNA-binding, Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.5;lymphoid tissue: 49.1;placenta: 28.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.7;HMC-1: 11.0;U-266/70: 5.4;U-266/84: 6.7;WM-115: 24.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 43.5" "Group enriched" "Detected in many" 26 "NK-cells: 43.5;T-cells: 17.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062482 Approved Vesicles Vesicles "HPA062482: " "unprognostic (1.04e-2)" "unprognostic (2.21e-2)" "unprognostic (4.13e-2)" "unprognostic (9.24e-3)" "unprognostic (1.09e-2)" "unprognostic (2.58e-4)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (1.50e-1)" "unprognostic (6.39e-3)" "unprognostic (8.13e-2)" "unprognostic (4.06e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.61e-1)" "unprognostic (2.59e-1)" "unprognostic (2.04e-2)" 1.8 1.5 0.3 15.3 0.4 3.9 1.5 0.2 0.6 0.8 2.1 0.3 0.2 1.3 1.3 11.6 2.4 2.6 1.7 0.7 0.2 0.4 2.1 2.8 4.0 49.1 0.5 0.5 0.5 1.0 0.4 1.3 28.4 0.6 0.9 1.0 1.0 6.1 0.2 0.5 1.7 7.9 0.4 0.4 17.8 1.0 1.7 0.2 14.0 1.9 0.2 19.3 2.4 1.4 0.0 0.1 1.1 0.0 43.5 17.5 10.6 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 4.7 0.0 1.4 0.0 0.2 0.0 0.0 0.4 0.2 0.1 2.3 0.0 0.0 0.0 0.3 11.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.6 0.0 0.0 2.0 0.0 0.8 0.3 0.0 0.0 1.3 1.2 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.4 0.0 0.0 0.3 0.1 5.4 6.7 0.4 0.0 0.4 24.8 1.1 0.0 0.3 13.2 0.0 17.4 0.0 6.8 6.4 0.0 0.0 17.5 11.9 0.8 43.5 0.0 0.1 5.1 10.6 0.3 0.4 0.2 0.6 0.2 0.4 0.5 0.5 0.6 0.2 TYR "OCA1, OCA1A, OCAIA" ENSG00000077498 Tyrosinase P14679 11 89177452-89295759 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase, Tumor antigen" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 70 "retina: 82.0;skin 1: 25.2" "Cell line enriched" "Detected in single" 844 "SK-MEL-30: 84.3" "Cancer enriched" "Detected in single" 1755 "melanoma: 351.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000079, HPA043241, HPA050889, HPA064583" Enhanced Enhanced Vesicles Vesicles "CAB000079: AB_564045, HPA043241: , HPA050889: , HPA064583: " "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (1.85e-3)" "unprognostic (9.75e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 82.0 0.7 0.0 0.0 25.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 84.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 TYRP1 "b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP" ENSG00000107165 "Tyrosinase related protein 1" P17643 9 12685439-12710290 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase" "Albinism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 277.3" "Cell line enriched" "Detected in some" 52 "SK-MEL-30: 173.5" "Cancer enriched" "Detected in some" 262 "melanoma: 313.2" "Region enriched" "Detected in some" 5 "pons and medulla: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "olfactory region: 5.6;thalamus: 2.0" "Low region specificity" "Detected in all" "HPA000937, CAB002520" Enhanced Supported Vesicles 16000 Vesicles "CAB002520: AB_564153, HPA000937: AB_1080437" "unprognostic (7.48e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-1)" "unprognostic (3.16e-3)" "unprognostic (8.10e-2)" "unprognostic (3.82e-3)" "unprognostic (1.53e-1)" "unprognostic (2.25e-3)" "unprognostic (4.46e-1)" "unprognostic (8.71e-2)" "unprognostic (6.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.68e-6)" "unprognostic (1.27e-1)" "unprognostic (5.99e-2)" "unprognostic (1.95e-2)" 0.2 0.0 0.2 0.2 0.3 0.0 1.7 0.2 1.0 0.2 0.5 1.3 0.2 1.6 0.2 0.3 3.6 0.2 1.4 21.5 0.9 0.1 5.7 0.2 2.1 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 5.0 0.2 1.8 277.3 1.1 0.2 1.3 51.1 1.4 0.4 1.1 0.2 0.6 0.5 0.2 0.2 0.2 0.9 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 173.5 2.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 1.0 0.9 0.1 0.2 0.3 5.0 0.2 UBA5 "FLJ23251, UBE1DC1" ENSG00000081307 "Ubiquitin like modifier activating enzyme 5" Q9GZZ9 3 132654446-132678097 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017235 Uncertain Enhanced Vesicles,Cytosol Cytosol Vesicles "HPA017235: AB_1858507" "unprognostic (4.34e-3)" "unprognostic (6.44e-2)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.06e-1)" "unprognostic (3.28e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-2)" "unprognostic (1.84e-2)" "unprognostic (3.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" 14.8 30.3 17.8 12.3 19.8 13.2 17.4 17.9 26.2 14.5 15.0 10.5 27.8 16.2 13.4 24.2 15.1 13.3 12.7 21.2 15.3 16.3 22.7 29.8 13.7 14.8 16.0 25.0 15.1 41.4 29.3 32.7 18.1 21.2 18.8 16.7 11.7 37.8 33.5 32.5 15.7 17.9 14.6 13.6 18.9 18.5 15.3 12.7 17.9 23.5 17.5 17.4 15.1 12.5 11.1 14.1 5.0 6.6 18.9 15.0 7.9 27.0 10.1 17.8 14.6 12.6 14.4 18.7 23.4 24.2 14.7 17.1 18.3 10.1 21.6 17.2 16.9 16.5 17.6 18.4 21.9 20.5 7.5 26.2 16.3 20.5 12.5 32.1 15.4 12.5 10.9 14.0 21.1 16.5 16.3 32.0 16.4 24.0 17.7 12.1 16.2 9.7 15.5 15.6 40.9 13.5 21.0 17.2 15.5 13.7 13.8 19.8 16.6 16.3 14.8 15.6 15.3 7.5 12.2 30.3 20.3 40.0 17.8 11.7 13.9 4.1 5.1 5.0 9.6 5.8 11.6 11.1 10.8 15.0 11.8 6.9 12.9 12.8 1.1 18.9 6.6 14.1 10.7 7.9 17.8 19.8 17.9 26.2 15.3 16.3 16.0 25.0 21.2 12.7 UBA7 "D8, UBA1B, UBE1L, UBE2" ENSG00000182179 "Ubiquitin like modifier activating enzyme 7" P41226 3 49805207-49813946 "Plasma proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 22.3;HEL: 20.8;HMC-1: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB015444, HPA058182" Approved Approved Nucleoplasm,Vesicles,Cytosol 1400000 "Nucleoplasm, Vesicles" Cytosol "CAB015444: AB_793598, HPA058182: " "prognostic favourable (1.55e-4)" "unprognostic (7.07e-3)" "unprognostic (1.59e-2)" "unprognostic (1.61e-2)" "unprognostic (3.77e-1)" "unprognostic (2.31e-2)" "unprognostic (5.08e-3)" "unprognostic (3.61e-2)" "unprognostic (6.33e-2)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "prognostic unfavourable (1.04e-5)" "unprognostic (9.11e-2)" "unprognostic (3.81e-2)" "unprognostic (1.57e-1)" "prognostic favourable (1.48e-4)" 11.3 12.1 6.8 22.0 7.5 16.0 11.5 2.0 6.7 10.8 12.7 14.4 25.4 19.6 17.2 31.6 17.7 12.9 33.1 9.1 6.7 3.9 15.9 11.9 18.8 28.2 6.0 6.2 19.1 9.5 1.4 8.4 8.9 9.4 18.5 12.1 14.2 24.5 34.2 3.3 9.0 25.5 11.3 7.7 35.9 13.2 3.4 5.9 20.4 17.8 18.4 23.5 12.6 13.1 12.4 14.3 24.8 21.7 11.1 11.8 13.0 4.3 0.0 0.3 0.1 12.0 12.7 1.3 2.3 10.4 16.7 22.3 0.0 9.1 0.1 1.8 8.5 2.4 0.0 4.1 1.4 11.1 0.0 20.8 0.2 1.3 8.9 1.9 40.6 19.5 0.2 6.5 0.4 8.3 0.0 1.3 3.8 0.1 4.2 5.1 0.0 0.4 5.4 0.4 0.7 3.4 8.4 0.0 0.3 2.8 4.1 1.4 0.4 13.8 3.7 3.3 0.4 1.4 0.9 0.0 0.0 0.1 9.1 7.4 0.7 13.9 14.7 24.8 11.8 21.7 10.3 12.3 10.8 10.5 14.3 12.4 9.9 8.9 4.6 11.1 17.2 5.2 10.6 13.0 6.8 7.5 2.0 6.7 6.7 3.9 6.0 6.2 9.4 5.9 UBAP1 UBAP ENSG00000165006 "Ubiquitin associated protein 1" Q9NZ09 9 34179005-34252523 "Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019804 Approved Supported "Vesicles,Plasma membrane,Cytosol" Cytosol "Vesicles, Plasma membrane" "HPA019804: AB_1858494" "unprognostic (1.83e-1)" "unprognostic (4.30e-2)" "unprognostic (1.29e-1)" "unprognostic (1.70e-1)" "unprognostic (3.54e-1)" "unprognostic (3.29e-2)" "unprognostic (1.67e-1)" "unprognostic (1.59e-1)" "unprognostic (2.01e-2)" "unprognostic (6.53e-2)" "unprognostic (1.25e-2)" "unprognostic (3.63e-1)" "prognostic favourable (7.49e-6)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.46e-1)" "unprognostic (1.17e-1)" 26.4 34.6 25.7 17.5 25.0 81.9 28.6 29.1 29.5 24.2 26.0 26.5 14.5 16.6 25.3 20.0 40.5 20.4 22.9 34.4 24.0 23.6 25.6 38.6 27.7 17.3 27.0 20.0 26.8 20.7 26.7 19.2 26.8 25.5 20.4 19.0 21.5 19.4 24.3 62.3 22.6 24.6 26.4 26.3 21.4 20.9 33.5 26.0 17.2 23.6 22.1 25.4 29.2 29.5 10.5 17.8 45.9 19.6 17.4 26.5 19.2 20.7 11.6 13.5 14.7 25.0 15.5 11.4 16.6 23.4 18.7 25.5 12.7 8.7 14.5 7.5 24.9 10.7 18.7 26.1 18.0 20.9 8.4 13.0 26.2 13.1 22.8 14.4 17.3 19.1 43.4 22.1 29.1 20.6 9.9 14.6 17.4 8.7 13.2 20.1 14.6 17.5 12.0 9.6 8.4 40.0 13.8 7.7 10.8 18.5 19.3 8.5 9.4 14.3 14.7 9.6 14.9 14.3 15.4 7.2 9.0 15.3 19.3 11.7 28.2 9.0 19.6 24.1 15.4 17.1 26.5 10.5 15.5 16.1 17.8 8.8 15.1 12.3 45.9 17.4 14.5 9.9 19.1 19.2 25.7 25.0 29.1 29.5 24.0 23.6 27.0 20.0 25.5 26.0 UBE2A "HHR6A, RAD6A, UBC2" ENSG00000077721 "Ubiquitin conjugating enzyme E2 A" P49459 X 119574467-119591083 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003875, HPA051765, HPA065898" Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "HPA003875: , HPA051765: , HPA065898: " "unprognostic (2.27e-3)" "prognostic favourable (2.16e-4)" "unprognostic (1.12e-1)" "unprognostic (9.09e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (9.07e-4)" "unprognostic (1.66e-3)" "unprognostic (1.96e-2)" "unprognostic (6.54e-2)" "unprognostic (2.96e-2)" "unprognostic (3.49e-2)" "unprognostic (1.33e-1)" "prognostic unfavourable (2.20e-6)" "unprognostic (9.54e-2)" "unprognostic (3.06e-2)" "unprognostic (1.21e-1)" "unprognostic (7.92e-2)" 24.8 20.6 26.7 23.1 24.6 16.8 32.5 20.2 24.2 23.7 32.8 23.9 20.2 21.7 23.8 26.7 37.2 20.3 21.2 42.2 23.6 22.1 32.2 26.6 22.8 26.3 26.8 19.7 18.7 17.2 24.3 18.2 112.4 24.7 20.4 30.2 20.0 21.0 22.6 46.8 23.6 29.2 27.9 29.1 25.1 20.4 17.0 19.5 36.3 23.2 32.8 31.5 26.7 24.0 21.0 29.0 34.1 36.3 12.8 21.2 17.4 32.5 27.5 17.3 14.6 30.3 37.4 16.2 33.8 30.2 40.3 38.3 14.2 22.4 25.8 34.4 37.2 23.5 24.7 17.9 38.9 35.8 14.6 11.4 22.0 12.7 27.8 28.5 19.6 25.5 25.6 38.6 16.8 27.9 14.0 23.1 45.6 34.5 43.9 26.9 28.8 31.1 22.4 18.4 24.0 32.5 21.4 13.3 13.7 45.0 20.7 24.6 18.0 24.9 27.2 25.9 11.6 51.1 38.1 22.4 36.4 25.3 27.5 36.1 20.2 16.5 22.7 34.1 18.1 35.4 14.3 21.0 15.7 15.8 29.0 18.8 10.0 14.3 30.1 12.8 36.3 23.0 21.2 17.4 26.7 24.6 20.2 24.2 23.6 22.1 26.8 19.7 24.7 19.5 UBE2B "HHR6B, RAD6B, UBC2" ENSG00000119048 "Ubiquitin conjugating enzyme E2 B" P63146 5 134371179-134391992 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 83.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 83.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003875, HPA051765, HPA065898" Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "HPA003875: , HPA051765: , HPA065898: " "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (7.39e-2)" "unprognostic (6.66e-2)" "unprognostic (1.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.56e-1)" "unprognostic (1.27e-1)" "unprognostic (1.91e-1)" "unprognostic (2.44e-1)" "unprognostic (2.49e-1)" "unprognostic (8.39e-2)" "unprognostic (1.64e-3)" "unprognostic (6.30e-3)" "unprognostic (3.42e-2)" "unprognostic (2.04e-1)" "unprognostic (5.52e-2)" 17.7 27.7 20.4 17.0 16.6 25.9 22.8 16.2 28.3 13.8 18.0 7.9 11.6 14.4 19.4 17.0 25.6 13.6 18.3 59.2 20.3 16.4 17.8 19.8 21.8 18.7 13.8 18.7 16.7 26.4 7.8 16.2 27.8 17.6 15.4 15.1 10.2 16.1 18.5 106.5 15.9 16.2 21.6 15.1 16.6 14.1 21.7 12.7 13.2 18.2 34.0 16.3 19.2 22.8 9.6 8.8 83.3 14.1 9.6 14.6 10.5 36.2 9.6 20.0 19.0 17.5 18.9 32.3 27.3 14.4 17.6 21.0 28.9 24.4 19.8 33.0 17.4 14.5 15.1 20.2 19.2 31.4 16.3 10.9 26.5 31.0 20.5 12.9 22.4 16.2 27.5 15.9 13.5 15.0 19.9 36.0 15.8 21.2 20.4 34.1 8.6 9.1 20.6 22.0 27.6 15.7 28.1 27.0 21.1 21.4 10.1 47.4 21.8 35.6 29.7 20.5 14.3 27.5 29.8 30.1 41.2 27.9 23.1 24.4 20.3 34.7 11.5 31.2 9.4 12.5 8.6 9.6 12.0 9.5 7.9 9.6 14.6 12.3 83.3 9.6 14.1 8.8 14.1 10.5 20.4 16.6 16.2 28.3 20.3 16.4 13.8 18.7 17.6 12.7 UBIAD1 "SCCD, TERE1" ENSG00000120942 "UbiA prenyltransferase domain containing 1" Q9Y5Z9 1 11273206-11296049 "Disease related genes, Predicted membrane proteins" "Menaquinone biosynthesis, Ubiquinone biosynthesis" "Prenyltransferase, Transferase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044862 Approved Vesicles Vesicles "HPA044862: " "unprognostic (1.79e-2)" "unprognostic (2.26e-1)" "unprognostic (5.06e-2)" "unprognostic (1.74e-1)" "unprognostic (7.95e-3)" "unprognostic (7.55e-2)" "unprognostic (1.16e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-1)" "unprognostic (2.55e-1)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "prognostic favourable (6.80e-5)" "unprognostic (3.00e-1)" "unprognostic (3.89e-1)" "unprognostic (2.03e-2)" "unprognostic (1.25e-1)" 12.1 11.8 9.2 10.2 11.8 9.2 12.0 10.2 13.1 9.6 9.8 17.6 5.0 7.8 13.0 9.7 8.8 14.4 11.9 11.6 9.0 8.3 9.9 38.1 8.7 18.6 14.1 6.1 17.5 23.4 14.6 10.0 9.1 11.0 10.6 10.0 11.9 11.2 10.2 24.8 11.3 9.5 11.5 15.5 12.9 10.7 17.7 13.6 17.9 12.2 9.6 17.5 11.7 8.7 22.0 10.7 9.5 8.7 9.6 27.0 11.4 8.5 8.5 6.8 13.1 5.1 4.7 9.2 9.5 7.7 10.2 9.4 9.8 8.0 17.0 9.7 6.7 11.8 17.2 11.3 12.5 11.8 14.7 11.4 9.1 13.0 9.2 17.3 9.9 7.1 15.4 13.7 16.4 7.4 13.5 14.1 6.8 8.7 11.1 8.7 8.2 12.7 10.6 15.2 20.5 7.8 5.7 8.4 9.0 10.1 10.0 12.8 7.4 9.1 6.2 9.0 9.7 9.3 12.3 11.5 15.9 31.6 5.7 22.9 11.1 4.8 6.5 9.5 13.1 8.7 14.6 22.0 17.8 13.3 8.6 20.7 27.0 18.3 2.0 9.6 7.3 10.7 16.6 11.4 9.2 11.8 10.2 13.1 9.0 8.3 14.1 6.1 11.0 13.6 UBR1 ENSG00000159459 "Ubiquitin protein ligase E3 component n-recognin 1" Q8IWV7 15 42942897-43106113 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038838 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038838: AB_10673120" "unprognostic (1.07e-2)" "unprognostic (5.02e-2)" "unprognostic (9.77e-2)" "unprognostic (1.55e-2)" "unprognostic (1.89e-2)" "unprognostic (1.29e-1)" "unprognostic (2.67e-1)" "unprognostic (1.49e-1)" "unprognostic (4.79e-1)" "unprognostic (2.97e-2)" "unprognostic (1.93e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (1.89e-1)" 16.7 13.2 13.7 18.3 16.7 28.4 18.8 21.8 18.1 18.2 16.2 14.8 10.5 11.3 21.0 12.9 10.8 15.9 14.2 19.7 10.0 15.4 14.4 10.6 16.6 14.9 11.8 10.5 16.3 16.4 26.3 25.6 16.2 18.9 15.3 12.9 12.5 11.8 16.8 23.6 11.0 14.4 18.2 12.1 14.7 13.8 13.7 14.7 23.2 18.8 9.7 14.3 17.3 19.7 4.6 5.0 5.5 4.2 6.2 7.2 1.8 4.9 7.2 8.3 6.7 13.2 10.2 7.9 12.1 13.4 10.7 13.9 9.1 3.9 5.8 7.2 12.4 8.6 11.9 10.6 12.8 11.9 5.8 22.9 14.4 4.4 9.2 16.1 11.0 11.0 6.0 13.1 10.7 12.0 13.0 8.8 13.3 2.8 8.7 4.8 4.7 7.4 11.4 11.4 5.0 10.8 11.7 8.4 7.5 15.9 8.4 5.6 8.1 8.4 16.5 13.2 8.2 11.7 12.2 10.4 17.6 16.7 9.0 10.2 11.9 4.4 3.0 5.2 5.7 4.2 6.5 4.1 5.9 6.9 2.9 4.6 5.9 7.2 5.5 6.2 3.4 5.0 4.1 1.8 13.7 16.7 21.8 18.1 10.0 15.4 11.8 10.5 18.9 14.7 UBTD1 FLJ11807 ENSG00000165886 "Ubiquitin domain containing 1" Q9HAC8 10 97498868-97571209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.5;neutrophil: 8.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034825 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA034825: AB_10602254" "unprognostic (1.52e-1)" "unprognostic (1.48e-1)" "prognostic unfavourable (5.54e-4)" "unprognostic (2.43e-1)" "unprognostic (1.78e-1)" "unprognostic (3.90e-2)" "unprognostic (3.63e-3)" "unprognostic (1.43e-2)" "unprognostic (1.66e-3)" "unprognostic (9.25e-3)" "unprognostic (2.45e-1)" "unprognostic (4.78e-1)" "unprognostic (6.62e-3)" "unprognostic (8.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-3)" "unprognostic (3.50e-3)" 16.0 5.6 7.7 7.3 7.1 10.2 20.5 5.1 9.0 11.5 4.6 5.8 9.7 2.9 6.6 13.9 8.1 8.3 9.0 23.8 6.8 6.5 15.6 11.2 26.0 8.3 9.1 4.8 8.9 12.9 3.1 7.8 5.3 6.4 6.5 1.5 8.9 10.7 10.8 24.2 22.7 2.5 7.0 6.7 5.3 4.1 30.3 5.7 1.0 12.9 10.9 4.4 10.3 8.6 0.3 1.7 8.5 3.4 0.0 0.4 0.5 9.0 9.0 2.4 11.9 10.1 9.6 2.8 10.4 15.3 11.2 8.6 6.0 7.9 1.1 12.7 7.0 10.9 2.4 13.9 1.5 2.8 4.7 1.1 2.8 7.5 14.6 1.0 3.1 13.1 4.7 12.2 3.0 17.8 0.6 1.7 7.1 4.3 0.4 9.2 3.9 16.6 0.9 4.2 1.0 8.6 3.4 0.8 2.5 4.7 2.9 13.4 10.8 6.8 19.1 14.2 8.7 14.8 13.5 2.2 2.5 0.4 12.0 6.2 7.4 1.3 3.4 7.5 0.2 0.8 0.2 0.3 0.1 0.0 1.7 0.0 0.1 0.0 8.5 0.0 0.9 1.2 0.4 0.5 7.7 7.1 5.1 8.1 6.8 6.5 9.1 4.8 6.4 5.7 UGT3A1 FLJ34658 ENSG00000145626 "UDP glycosyltransferase family 3 member A1" Q6NUS8 5 35951010-36001028 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 44.0;liver: 47.7" "Cell line enriched" "Detected in single" 42 "RH-30: 24.7" "Group enriched" "Detected in some" 15 "liver cancer: 6.7;renal cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047697, HPA056290" Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA047697: , HPA056290: " "unprognostic (2.41e-3)" "unprognostic (4.47e-1)" "unprognostic (4.04e-1)" "unprognostic (4.62e-1)" "unprognostic (1.42e-2)" "unprognostic (6.05e-2)" "unprognostic (9.14e-2)" "unprognostic (1.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 5.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 44.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 3.2 0.1 6.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.4 0.2 0.2 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 UHRF1BP1L KIAA0701 ENSG00000111647 "UHRF1 binding protein 1 like" A0JNW5 12 100028455-100142848 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039671, HPA075150" Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA039671: AB_10794201, HPA075150: " "unprognostic (4.80e-2)" "unprognostic (3.17e-1)" "unprognostic (2.34e-2)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (7.36e-2)" "unprognostic (8.10e-2)" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (5.43e-2)" "unprognostic (1.88e-2)" "unprognostic (2.53e-1)" "unprognostic (2.94e-3)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.28e-2)" 14.9 13.9 15.9 11.4 19.9 31.9 10.8 16.9 26.0 9.5 10.0 8.7 5.3 9.9 9.3 8.8 10.2 8.0 10.6 10.4 18.0 13.7 14.7 28.0 10.6 9.7 14.8 12.0 11.1 4.7 21.5 15.3 13.7 22.6 11.1 9.6 6.9 8.7 11.2 26.2 8.4 11.1 11.2 13.7 11.8 9.0 15.2 9.8 10.0 13.0 8.1 8.1 16.7 8.4 3.8 8.4 22.9 8.4 3.7 3.7 3.4 11.3 12.4 6.9 7.1 10.7 15.2 13.8 17.7 17.9 14.4 10.5 9.1 3.9 9.8 4.6 18.1 4.4 12.9 6.0 14.0 26.1 6.3 6.6 9.9 10.6 9.9 12.3 10.8 8.6 5.1 17.2 12.0 10.0 5.2 10.3 14.0 6.3 7.9 10.7 11.9 11.3 9.0 12.3 9.7 7.3 20.1 11.8 7.3 13.5 15.5 5.2 13.9 14.2 7.9 15.9 8.5 13.7 12.4 12.2 20.8 13.8 8.0 9.4 9.6 12.5 7.6 4.9 2.6 8.4 3.7 3.8 2.9 2.9 8.4 3.4 2.5 3.0 22.9 3.7 6.8 5.1 3.2 3.4 15.9 19.9 16.9 26.0 18.0 13.7 14.8 12.0 22.6 9.8 ULBP2 RAET1H ENSG00000131015 "UL16 binding protein 2" Q9BZM5 6 149942000-149949235 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 10.8" "Cell line enhanced" "Detected in many" "SiHa: 31.7;U-2197: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "gdT-cell: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0" "Lineage enriched" "Detected in single" 7 "T-cells: 5.5" CAB018974 Approved Supported "Vesicles,Plasma membrane" "Secreted in other tissues" "Vesicles, Plasma membrane" "CAB018974: " "unprognostic (2.09e-5)" "prognostic unfavourable (8.07e-4)" "unprognostic (2.38e-3)" "unprognostic (3.90e-1)" "prognostic unfavourable (2.44e-4)" "unprognostic (1.26e-2)" "unprognostic (2.38e-3)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (1.75e-2)" "unprognostic (1.42e-4)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (4.86e-1)" 3.3 1.7 4.5 1.9 2.3 4.3 5.9 5.3 6.5 1.6 0.6 0.0 0.0 0.9 0.6 0.5 10.8 0.5 1.6 4.1 4.4 1.0 1.9 1.7 6.2 1.1 1.0 2.1 0.2 1.6 0.3 1.1 4.4 3.9 0.6 0.7 0.3 1.5 0.4 0.6 1.0 0.4 2.0 0.6 0.5 0.7 3.6 0.1 0.5 3.5 4.6 2.4 4.1 5.2 0.0 0.0 0.0 0.0 0.8 5.5 0.9 9.2 0.8 0.2 2.9 0.5 2.8 1.6 9.5 5.6 10.0 8.2 3.5 5.2 0.0 14.6 10.8 6.6 3.6 8.7 5.8 4.2 1.8 0.5 1.4 0.0 3.5 0.0 0.7 1.3 6.7 8.9 3.9 5.7 1.1 0.0 7.4 6.4 0.8 0.0 0.0 4.9 1.4 2.2 0.0 14.2 2.7 0.3 0.0 31.7 0.6 0.9 0.9 3.9 8.9 6.6 8.2 22.9 11.0 0.0 0.0 0.4 9.4 5.0 4.7 0.0 0.0 0.0 5.5 0.0 0.6 0.0 1.8 3.2 0.0 0.0 0.6 3.9 0.0 0.8 0.0 0.0 3.0 0.9 4.5 2.3 5.3 6.5 4.4 1.0 1.0 2.1 3.9 0.1 ULBP3 RAET1N ENSG00000131019 "UL16 binding protein 3" Q9BZM4 6 150063150-150069095 "Predicted intracellular proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 2.7" "Lineage enriched" "Detected in single" 7 "T-cells: 2.7" "HPA056541, HPA063007" Approved Uncertain "Vesicles,Centriolar satellite" "Intracellular and membrane" Vesicles "Centriolar satellite" "HPA056541: , HPA063007: " "unprognostic (4.87e-2)" "unprognostic (4.49e-2)" "unprognostic (3.14e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (2.99e-2)" "unprognostic (8.47e-2)" "unprognostic (1.96e-1)" "unprognostic (5.87e-2)" "unprognostic (8.71e-2)" "unprognostic (1.66e-2)" "unprognostic (3.54e-2)" "unprognostic (6.26e-2)" "unprognostic (3.43e-1)" "unprognostic (2.12e-1)" "unprognostic (5.45e-2)" "unprognostic (5.16e-2)" 8.0 3.6 1.0 0.4 1.2 0.2 8.2 0.3 2.0 1.9 2.8 0.4 1.1 1.4 1.1 2.1 3.6 3.6 4.4 1.2 1.3 2.3 5.5 2.6 3.1 0.3 0.7 0.6 2.0 1.1 1.9 0.7 1.4 0.8 1.3 1.1 1.7 1.2 0.4 0.7 1.0 1.0 0.8 0.5 0.5 2.9 24.3 0.3 0.3 8.2 5.3 2.1 1.8 3.1 0.3 0.0 0.0 0.0 0.0 2.7 0.5 3.8 1.6 4.6 5.1 1.5 8.7 1.4 4.1 1.9 5.3 5.9 8.3 3.6 0.0 9.3 6.8 6.4 13.7 15.0 5.3 3.4 6.9 0.1 2.3 0.4 2.1 0.0 0.6 7.7 2.9 11.3 6.0 7.0 0.2 0.0 4.7 5.6 0.0 0.0 2.1 12.2 4.4 4.7 0.2 10.6 8.9 0.8 0.1 9.7 6.1 2.1 1.8 1.0 3.7 0.9 7.0 13.8 9.6 0.0 0.0 2.7 7.4 2.0 3.8 0.0 0.0 0.0 1.5 0.0 2.0 0.3 2.0 1.1 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.0 2.7 0.5 1.0 1.2 0.3 2.0 1.3 2.3 0.7 0.6 0.8 0.3 UNC13B "hmunc13, UNC13, Unc13h2" ENSG00000198722 "Unc-13 homolog B" O14795 9 35161992-35405338 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024493, HPA062300" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments" Vesicles "Nucleoplasm, Golgi apparatus, Intermediate filaments" "HPA024493: AB_1858618, HPA062300: " "unprognostic (9.73e-3)" "unprognostic (2.33e-1)" "prognostic favourable (4.96e-4)" "unprognostic (6.56e-2)" "unprognostic (9.93e-2)" "prognostic favourable (8.51e-5)" "unprognostic (7.64e-2)" "prognostic favourable (6.59e-5)" "unprognostic (3.80e-1)" "unprognostic (1.64e-1)" "prognostic favourable (3.71e-4)" "unprognostic (1.74e-1)" "prognostic favourable (4.34e-11)" "unprognostic (2.40e-1)" "unprognostic (1.89e-1)" "unprognostic (1.48e-1)" "unprognostic (2.80e-2)" 11.9 12.1 9.3 9.0 18.3 1.4 10.4 16.6 18.8 12.2 21.4 10.1 35.0 11.5 10.6 8.4 14.9 11.1 14.6 11.1 9.2 7.1 22.1 21.5 37.6 2.2 9.5 9.5 7.9 28.7 21.7 13.7 6.3 10.1 20.5 25.1 27.2 20.7 33.6 21.1 14.6 13.0 12.2 9.4 5.0 15.8 16.2 9.1 0.8 12.5 11.6 5.8 8.6 10.4 0.9 1.9 0.0 0.4 0.0 0.3 0.4 5.4 7.3 8.1 13.0 15.7 8.8 6.9 8.9 4.1 6.6 9.0 6.0 2.5 0.0 4.1 11.6 2.6 20.4 10.4 8.5 0.0 6.5 3.3 20.7 7.7 7.6 1.2 3.8 6.9 8.2 10.5 10.9 21.4 7.4 4.7 7.8 4.2 1.1 0.1 7.3 7.7 0.0 5.0 1.9 9.1 7.1 8.7 9.2 6.3 3.9 6.5 6.7 4.2 19.6 4.6 4.3 7.1 6.8 7.4 8.8 0.0 5.0 10.4 4.6 0.0 0.4 0.0 0.0 0.3 0.0 0.9 0.3 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 9.3 18.3 16.6 18.8 9.2 7.1 9.5 9.5 10.1 9.1 UNC13D Munc13-4 ENSG00000092929 "Unc-13 homolog D" Q70J99 17 75827225-75844717 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Exocytosis "Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 67.1" "Cell line enhanced" "Detected in many" "HEL: 55.1;HMC-1: 57.1;SK-BR-3: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in single" 6 "cerebellum: 5.6" "Low region specificity" "Detected in many" "HPA067117, HPA073525" Enhanced Supported Vesicles,Cytosol 14000000 Cytosol Vesicles "HPA067117: , HPA073525: " "unprognostic (6.79e-3)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (3.62e-4)" "unprognostic (2.98e-2)" "unprognostic (1.42e-3)" "unprognostic (3.93e-1)" "unprognostic (1.37e-2)" "unprognostic (2.74e-1)" "unprognostic (1.31e-2)" "prognostic unfavourable (6.01e-4)" "unprognostic (1.89e-1)" "prognostic unfavourable (5.28e-12)" "unprognostic (3.27e-2)" "unprognostic (5.58e-2)" "unprognostic (1.56e-1)" "unprognostic (8.59e-2)" 4.5 3.3 2.9 17.1 5.2 31.3 4.5 4.1 3.1 5.2 5.2 2.8 1.4 4.5 3.8 1.8 11.5 5.2 8.7 13.0 1.8 1.6 2.6 4.9 30.1 24.9 4.5 1.6 8.7 5.5 0.3 5.3 67.1 3.2 3.1 2.6 2.6 8.0 3.9 3.2 3.0 7.6 2.8 3.7 33.8 7.2 2.2 3.3 23.6 2.4 9.3 24.7 7.0 8.2 4.0 6.9 24.8 13.6 8.2 11.5 7.9 8.3 3.2 0.0 0.0 0.1 0.2 10.4 0.0 0.0 0.0 0.0 8.0 18.8 0.7 10.0 0.0 2.9 0.0 0.5 0.0 0.1 0.1 55.1 24.4 5.1 0.9 20.9 57.1 0.1 0.4 0.1 0.5 3.7 19.0 0.2 0.0 14.2 22.1 10.5 0.2 0.4 7.1 0.2 0.3 0.3 3.3 0.0 15.3 3.6 39.1 0.2 10.5 11.9 10.4 0.1 14.8 0.1 0.0 0.3 1.3 0.8 0.1 6.7 0.0 24.8 8.0 16.4 11.5 9.4 10.4 4.0 6.7 8.1 6.9 2.2 5.3 6.9 22.4 8.2 13.6 4.0 6.0 7.9 2.9 5.2 4.1 3.1 1.8 1.6 4.5 1.6 3.2 3.3 UNC80 "C2orf21, FLJ33496, KIAA1843, UNC-80" ENSG00000144406 "Unc-80 homolog, NALCN channel complex subunit" Q8N2C7 2 209771993-209999300 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 10.0;brain: 27.2;pituitary gland: 20.1;testis: 6.9" "Group enriched" "Detected in some" 5 "AF22: 5.1;SCLC-21H: 8.3;SH-SY5Y: 4.7" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042472, HPA050959" Enhanced Approved "Nuclear bodies,Vesicles" "Nuclear bodies" Vesicles "HPA042472: AB_10965318, HPA050959: " "unprognostic (7.91e-3)" "unprognostic (2.25e-4)" "unprognostic (1.44e-2)" "unprognostic (3.20e-4)" "unprognostic (1.92e-1)" "unprognostic (3.40e-2)" "unprognostic (3.31e-3)" "unprognostic (5.36e-2)" "unprognostic (5.16e-1)" "unprognostic (7.85e-2)" "unprognostic (5.24e-3)" "unprognostic (8.94e-2)" "unprognostic (1.50e-2)" "unprognostic (1.51e-2)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" "unprognostic (7.40e-3)" 0.9 10.0 10.2 0.9 19.3 0.9 0.9 27.2 23.4 1.0 1.0 2.1 0.0 1.0 1.3 1.8 0.9 1.7 3.6 1.0 8.0 7.4 1.0 0.9 1.1 0.8 5.4 13.5 2.1 3.2 1.4 20.1 0.9 14.5 3.2 1.1 3.0 0.9 1.5 0.8 1.2 1.1 1.3 2.2 1.1 1.9 6.9 4.9 0.0 1.5 0.0 0.8 1.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 1.1 0.0 0.0 0.0 8.3 4.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 19.3 27.2 20.2 8.0 7.4 5.4 13.5 14.5 4.9 UPF3A "HUPF3A, RENT3A, UPF3" ENSG00000169062 "UPF3A, regulator of nonsense mediated mRNA decay" Q9H1J1 13 114281584-114305817 "Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018325, HPA061316" Approved Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA018325: AB_1858638, HPA061316: " "unprognostic (9.08e-3)" "unprognostic (1.99e-1)" "unprognostic (1.93e-1)" "unprognostic (3.43e-2)" "unprognostic (2.51e-2)" "unprognostic (1.16e-2)" "unprognostic (6.48e-2)" "unprognostic (1.98e-1)" "unprognostic (9.80e-3)" "unprognostic (1.44e-1)" "prognostic favourable (7.09e-5)" "unprognostic (1.39e-3)" "unprognostic (1.52e-2)" "unprognostic (2.34e-2)" "unprognostic (9.21e-3)" "unprognostic (1.76e-1)" "prognostic favourable (3.71e-4)" 11.3 16.3 16.9 10.9 20.2 11.9 10.9 32.8 21.9 10.4 9.9 18.6 13.0 13.8 13.1 12.3 10.1 13.2 9.2 7.1 16.1 14.9 11.0 7.5 9.2 12.0 20.2 16.0 12.7 15.4 8.1 12.8 8.5 17.2 12.1 8.7 10.0 11.9 16.1 16.1 11.9 11.9 10.2 23.6 11.8 11.2 34.5 16.7 10.7 24.0 7.4 7.9 11.2 9.3 11.7 15.6 4.1 5.5 11.1 9.5 4.3 23.0 6.8 15.1 13.5 7.2 12.7 9.7 17.9 12.9 11.5 12.9 10.3 8.2 22.7 5.2 8.2 12.5 7.4 5.9 14.5 16.6 14.6 19.5 19.4 11.3 12.6 33.9 8.8 8.5 12.3 7.7 9.0 9.1 11.9 10.6 11.4 7.0 13.8 9.1 20.1 6.8 18.0 8.5 13.2 10.2 7.4 17.2 19.0 14.2 22.0 12.8 16.3 30.4 11.6 12.2 20.5 6.6 11.1 23.1 16.0 31.4 22.5 19.5 10.0 1.9 5.5 4.1 6.8 4.4 5.3 11.7 7.1 7.0 6.0 9.1 7.4 6.7 0.8 11.1 5.1 15.6 9.5 4.3 16.9 20.2 32.8 21.9 16.1 14.9 20.2 16.0 17.2 16.7 UPP2 "UDRPASE2, UP2, UPASE2" ENSG00000007001 "Uridine phosphorylase 2" O95045 2 157876702-158136154 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 40.1;liver: 22.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;REH: 1.5" "Cancer enriched" "Detected in some" 6 "liver cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035225, HPA035226" Approved Nucleoplasm,Vesicles,Mitochondria Nucleoplasm "Vesicles, Mitochondria" "HPA035225: AB_10604002, HPA035226: AB_10696503" "unprognostic (1.87e-1)" "unprognostic (2.33e-1)" "unprognostic (4.22e-3)" "unprognostic (1.36e-3)" "unprognostic (2.29e-1)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (5.51e-2)" "unprognostic (5.11e-2)" "unprognostic (1.23e-2)" "unprognostic (4.65e-3)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (4.89e-2)" "unprognostic (2.78e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-2)" 1.2 0.4 1.8 0.3 4.1 0.3 1.6 6.9 2.0 0.4 0.3 1.5 0.7 0.3 1.2 2.4 1.0 0.4 2.5 0.8 2.9 1.2 40.1 22.1 0.3 0.4 1.2 0.9 0.6 0.4 0.3 3.9 0.4 1.3 2.3 0.3 1.1 1.7 0.7 0.3 0.6 0.4 0.3 2.3 0.3 0.3 0.4 1.0 0.0 0.5 0.0 0.7 0.4 0.2 0.8 0.0 1.0 0.1 0.0 0.2 0.0 0.3 0.2 0.6 0.6 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 2.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.1 1.2 1.3 1.5 0.3 0.0 0.3 0.6 0.7 0.4 0.5 0.5 0.0 0.8 0.2 0.0 0.2 0.3 0.0 0.0 1.3 0.1 0.4 0.4 1.3 0.4 1.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.8 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 1.8 4.1 6.9 2.0 2.9 1.2 1.2 0.9 1.3 1.0 UPRT "DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3" ENSG00000094841 "Uracil phosphoribosyltransferase homolog" Q96BW1 X 75274085-75304600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000805 Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA000805: AB_1080482" "unprognostic (3.12e-3)" "unprognostic (5.85e-2)" "unprognostic (1.40e-1)" "unprognostic (2.67e-2)" "unprognostic (2.43e-1)" "unprognostic (1.18e-2)" "unprognostic (4.62e-2)" "unprognostic (1.04e-3)" "unprognostic (9.64e-2)" "unprognostic (1.37e-2)" "unprognostic (1.05e-2)" "unprognostic (2.62e-1)" "prognostic favourable (4.14e-4)" "unprognostic (6.09e-2)" "unprognostic (2.54e-2)" "unprognostic (2.74e-1)" "unprognostic (4.53e-3)" 8.8 15.3 14.6 7.9 15.8 14.9 10.7 20.3 18.7 11.5 9.9 10.8 10.8 14.2 10.0 12.5 13.0 10.2 8.4 12.0 13.1 17.7 15.5 11.3 10.0 10.7 14.9 9.6 8.7 14.1 18.7 19.5 7.6 13.2 12.8 11.0 9.1 13.1 8.6 13.3 7.4 10.5 14.0 10.9 11.0 13.9 3.0 12.4 10.6 13.9 6.5 11.9 9.1 7.9 8.3 11.1 8.9 16.4 14.7 13.3 7.4 7.7 5.5 6.1 5.7 6.6 7.1 5.8 5.4 6.4 5.9 6.6 4.8 5.2 10.8 4.7 5.6 3.4 14.0 4.9 9.5 9.8 5.6 6.8 5.8 6.1 6.4 13.3 14.1 5.4 3.4 8.1 4.2 10.2 7.9 10.9 15.3 3.3 15.0 8.1 12.4 9.0 7.1 16.1 5.2 15.0 4.5 0.4 6.4 7.6 7.9 7.4 3.6 8.5 8.5 7.4 4.5 13.6 4.6 7.4 24.1 10.5 7.9 14.6 4.7 5.1 7.4 8.9 8.3 10.7 9.5 8.3 8.3 8.5 11.1 7.2 10.5 9.3 1.3 14.7 16.4 5.0 13.3 7.4 14.6 15.8 20.3 18.7 13.1 17.7 14.9 9.6 13.2 12.4 URM1 "C9orf74, MGC2668" ENSG00000167118 "Ubiquitin related modifier 1" Q9BTM9 9 128371319-128392016 "Predicted intracellular proteins" "tRNA processing, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053645, HPA065160" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA053645: , HPA065160: " "unprognostic (7.42e-2)" "unprognostic (1.69e-2)" "unprognostic (2.42e-1)" "unprognostic (8.94e-3)" "unprognostic (1.53e-1)" "unprognostic (1.59e-1)" "prognostic unfavourable (6.91e-4)" "unprognostic (3.04e-2)" "unprognostic (9.19e-2)" "unprognostic (5.61e-3)" "unprognostic (2.39e-2)" "unprognostic (2.36e-1)" "prognostic favourable (7.43e-6)" "unprognostic (1.77e-3)" "unprognostic (1.93e-1)" "unprognostic (2.47e-1)" "unprognostic (6.17e-2)" 27.2 28.9 25.4 22.4 25.5 31.3 23.2 19.4 40.9 23.4 26.3 36.0 19.7 30.9 25.0 24.4 26.5 26.9 22.9 32.3 25.0 21.4 25.5 39.1 20.8 28.5 29.2 22.9 23.4 53.2 21.2 19.6 28.6 32.0 23.7 25.2 22.2 29.2 23.9 34.9 24.4 36.6 26.4 31.8 30.6 25.6 19.2 21.4 34.9 28.0 29.7 28.8 23.0 20.5 12.4 16.7 10.2 17.7 11.3 15.5 11.5 9.4 18.5 16.7 11.3 17.0 16.8 15.2 8.7 15.4 22.3 15.4 14.6 15.2 19.0 7.4 19.8 31.7 21.2 19.7 11.3 13.4 14.7 16.0 22.3 17.2 16.6 19.4 16.1 21.8 17.5 17.5 15.0 27.1 21.5 13.5 15.9 21.2 27.6 28.5 21.0 22.2 22.6 21.6 23.9 18.1 8.4 15.0 19.9 16.5 28.0 21.2 26.9 16.1 15.3 16.5 15.7 16.4 15.0 13.0 23.9 19.5 17.3 16.8 20.4 5.6 14.3 10.2 15.5 17.7 13.1 12.3 13.5 14.2 16.7 12.4 13.5 14.4 3.7 11.3 16.1 12.4 14.9 11.5 25.4 25.5 19.4 40.9 25.0 21.4 29.2 22.9 32.0 21.4 USF2 "bHLHb12, FIP" ENSG00000105698 "Upstream transcription factor 2, c-fos interacting" Q15853 19 35268978-35279821 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029764, HPA046567" Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA029764: , HPA046567: " "unprognostic (6.10e-3)" "unprognostic (2.27e-1)" "unprognostic (1.06e-2)" "unprognostic (5.03e-3)" "unprognostic (4.60e-2)" "unprognostic (1.72e-1)" "unprognostic (2.45e-1)" "unprognostic (2.87e-1)" "unprognostic (2.10e-1)" "unprognostic (7.07e-2)" "prognostic favourable (5.12e-5)" "unprognostic (7.75e-2)" "unprognostic (8.12e-2)" "unprognostic (7.47e-2)" "unprognostic (5.75e-2)" "unprognostic (6.90e-2)" "prognostic favourable (3.28e-4)" 40.6 48.6 50.9 42.7 56.8 52.8 53.0 52.5 60.5 23.4 26.2 41.2 25.9 36.5 26.3 23.4 25.8 23.6 23.1 52.6 50.8 35.5 22.1 47.9 29.1 48.8 48.6 43.6 54.1 41.8 34.9 36.4 22.1 40.2 22.5 19.7 31.7 34.0 21.6 108.9 35.1 35.8 24.4 48.5 42.9 30.6 13.0 51.2 22.7 29.9 24.9 32.5 26.8 35.6 7.1 27.3 17.8 5.8 5.8 7.2 3.7 38.0 38.3 20.0 18.8 34.6 17.7 18.8 20.6 24.5 18.8 14.2 17.8 19.7 36.5 33.1 17.6 11.6 18.5 16.1 9.8 61.3 28.5 21.7 22.9 28.4 21.0 36.2 37.4 15.3 22.8 12.3 19.1 12.8 26.0 54.7 14.7 43.6 39.6 14.4 16.6 13.0 38.9 25.4 34.4 15.6 24.3 33.7 25.6 38.4 41.8 69.3 16.8 29.2 21.5 31.9 21.5 20.9 27.6 55.2 55.1 39.6 29.5 23.2 41.5 17.8 4.7 5.7 3.9 5.8 4.8 5.6 4.0 5.1 7.1 7.1 3.6 3.5 4.2 5.8 3.5 27.3 7.2 3.7 50.9 56.8 52.5 60.5 50.8 35.5 48.6 43.6 40.2 51.2 USP27X USP27 ENSG00000273820 "Ubiquitin specific peptidase 27, X-linked" A6NNY8 X 49879948-49882565 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077264 Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA077264: " "unprognostic (4.12e-2)" "unprognostic (9.58e-3)" "unprognostic (2.29e-1)" "unprognostic (4.66e-2)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "prognostic unfavourable (6.14e-4)" "unprognostic (3.10e-3)" "unprognostic (3.91e-2)" "unprognostic (1.31e-2)" "prognostic favourable (9.31e-4)" "unprognostic (5.37e-2)" "unprognostic (7.45e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.58e-1)" 1.8 3.3 1.8 5.9 2.9 0.3 7.7 1.7 7.4 3.9 5.9 4.8 2.2 1.1 12.7 4.1 3.1 4.7 3.8 3.9 2.2 3.5 3.5 6.1 1.9 1.3 3.2 8.8 3.2 4.1 0.8 15.5 2.8 4.1 1.7 4.1 5.2 3.9 7.5 2.6 4.7 3.9 1.3 2.0 1.9 3.8 1.9 2.8 3.2 3.6 2.2 3.7 3.1 1.7 1.0 0.7 0.7 0.3 1.3 0.4 2.1 5.6 6.5 7.5 6.2 5.0 5.4 2.4 4.1 2.8 2.3 10.0 2.5 1.4 2.3 6.4 3.6 9.3 6.2 4.1 2.9 4.3 2.3 1.6 9.2 4.2 0.7 5.1 7.0 4.2 4.0 4.0 3.9 4.6 2.4 4.5 5.3 3.5 2.0 7.0 3.9 3.7 5.6 0.5 4.6 2.1 1.7 4.9 4.8 4.5 5.8 5.2 1.7 2.9 3.3 6.4 5.7 0.9 2.2 0.5 1.0 3.8 2.0 3.6 0.7 0.4 0.1 0.6 0.4 0.8 0.6 0.5 0.3 1.0 1.7 0.8 0.6 0.7 0.3 0.7 0.4 1.3 0.4 USP40 FLJ10785 ENSG00000085982 "Ubiquitin specific peptidase 40" Q9NVE5 2 233475520-233566782 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005821 Uncertain Approved Vesicles Vesicles "HPA005821: AB_1080526" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-1)" "unprognostic (3.70e-1)" "unprognostic (2.15e-1)" "unprognostic (5.30e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-2)" "unprognostic (1.18e-1)" "unprognostic (1.96e-1)" "unprognostic (1.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.45e-1)" "unprognostic (4.09e-2)" "unprognostic (1.90e-2)" "unprognostic (2.53e-2)" 12.5 20.5 11.0 8.2 17.7 3.5 16.1 8.2 13.5 12.4 12.1 26.1 22.5 11.6 16.2 28.1 13.9 13.4 13.2 10.8 11.3 8.5 16.9 15.7 13.9 7.6 22.1 10.1 19.6 17.2 22.8 24.3 16.3 16.5 16.1 11.2 16.4 13.9 19.7 13.6 21.7 15.2 17.1 20.1 11.4 16.3 23.3 18.9 9.8 21.2 9.4 12.0 18.0 11.8 1.9 5.0 0.4 2.8 1.4 2.2 1.4 9.6 11.3 10.4 7.0 15.3 14.3 9.1 9.6 7.4 8.9 9.7 8.0 11.6 0.2 2.8 15.4 17.3 7.9 17.0 12.8 0.0 5.1 7.7 9.3 13.6 13.3 3.2 5.2 13.6 12.3 13.1 18.5 10.2 12.3 1.9 12.5 7.8 3.4 4.7 4.6 9.2 0.0 21.5 4.5 10.6 15.7 5.7 6.2 7.6 7.9 9.8 9.0 7.2 10.1 12.5 7.8 5.2 11.5 3.5 2.6 0.4 16.1 5.8 10.7 0.0 2.7 0.0 1.3 2.8 0.6 1.3 1.5 1.3 4.0 1.9 1.9 2.2 0.4 1.4 2.3 5.0 2.0 1.4 11.0 17.7 8.2 13.5 11.3 8.5 22.1 10.1 16.5 18.9 USP6 "HRP1, Tre-2, TRE17, Tre2, TRESMCR" ENSG00000129204 "Ubiquitin specific peptidase 6" P35125 17 5116438-5175034 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Calmodulin-binding, Hydrolase, Protease, Thiol protease" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skeletal muscle: 18.2;testis: 29.0" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046969 Uncertain Vesicles Vesicles "HPA046969: " "unprognostic (3.89e-2)" "unprognostic (3.79e-3)" "unprognostic (2.50e-1)" "unprognostic (1.85e-1)" "unprognostic (9.32e-2)" "unprognostic (3.50e-3)" "unprognostic (1.29e-1)" "unprognostic (1.67e-2)" "unprognostic (3.45e-2)" "unprognostic (2.46e-2)" "unprognostic (7.91e-4)" "unprognostic (6.28e-3)" "unprognostic (3.24e-4)" "unprognostic (3.75e-2)" "unprognostic (3.13e-1)" "unprognostic (2.71e-1)" "unprognostic (7.09e-4)" 0.3 0.3 0.3 0.3 0.6 0.2 0.4 0.5 0.5 0.3 0.5 0.3 1.2 0.0 0.6 0.6 0.3 0.5 0.4 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.3 0.3 2.6 0.3 0.0 0.4 0.4 0.3 0.4 0.1 0.3 0.3 0.3 18.2 0.6 0.7 0.9 0.3 0.3 0.0 29.0 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.9 1.2 1.9 1.0 0.2 0.4 0.1 2.2 1.0 2.2 1.7 0.4 0.2 2.3 1.9 0.1 0.6 0.4 0.8 1.1 2.2 1.7 1.3 1.0 0.7 0.8 0.5 1.6 1.3 1.7 1.3 0.9 1.2 0.5 2.9 1.1 0.5 0.1 0.2 0.3 0.5 0.3 0.5 2.5 1.9 0.7 1.6 0.1 1.4 2.0 0.2 0.5 0.7 0.9 2.2 1.0 0.1 3.3 2.2 2.2 1.2 1.0 3.3 2.1 1.4 2.0 1.7 1.5 0.0 0.1 2.7 0.1 0.4 0.9 0.4 0.3 0.2 0.6 0.3 0.3 0.3 0.9 0.3 0.4 1.9 0.2 1.0 1.2 0.1 0.1 0.3 0.6 0.5 0.3 0.3 0.1 0.3 0.3 0.3 0.3 USP9X "DFFRX, FAF, MRX99" ENSG00000124486 "Ubiquitin specific peptidase 9, X-linked" Q93008 X 41085635-41236579 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011618, HPA047417, CAB070164" Approved Uncertain Vesicles Vesicles "CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: " "unprognostic (5.42e-3)" "unprognostic (6.42e-2)" "unprognostic (3.19e-3)" "unprognostic (2.94e-2)" "unprognostic (5.99e-2)" "unprognostic (4.76e-1)" "unprognostic (1.82e-2)" "unprognostic (4.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.72e-1)" "unprognostic (7.07e-2)" "unprognostic (1.09e-1)" "unprognostic (5.82e-2)" "unprognostic (1.59e-1)" "unprognostic (4.19e-2)" "unprognostic (2.78e-1)" "unprognostic (1.33e-1)" 18.0 21.8 17.7 14.0 15.9 15.5 16.8 16.6 16.7 18.4 20.6 11.4 25.4 13.2 19.6 19.0 17.3 17.0 17.1 20.9 14.2 14.2 18.5 34.2 16.7 23.1 15.2 15.4 15.7 16.5 45.8 17.0 41.1 12.9 13.4 14.4 13.9 14.2 25.2 42.8 14.8 22.0 17.3 14.0 16.7 16.9 16.9 14.0 21.1 20.3 17.6 16.5 20.3 19.9 6.4 5.5 13.0 5.0 4.9 7.8 3.1 19.0 22.6 20.1 20.5 16.9 17.7 4.6 11.0 14.8 12.5 14.6 10.4 8.9 12.8 6.2 25.0 12.9 34.5 20.0 21.1 16.1 24.8 14.9 21.9 9.3 14.3 12.9 10.9 15.3 9.0 30.0 28.5 19.3 18.0 10.5 19.3 14.0 9.2 5.1 21.2 12.5 10.1 27.5 8.3 11.9 15.8 11.4 10.7 46.2 12.8 12.6 12.4 7.2 20.6 19.2 14.8 18.1 11.8 9.6 11.2 16.4 13.7 5.8 9.5 3.3 4.7 6.0 5.6 4.2 7.8 6.4 6.6 6.2 5.5 4.7 6.7 6.0 13.0 4.9 5.0 4.2 5.6 3.1 17.7 15.9 16.6 16.7 14.2 14.2 15.2 15.4 12.9 14.0 USP9Y DFFRY ENSG00000114374 "Ubiquitin specific peptidase 9, Y-linked" O00507 Y 12701231-12860839 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 16.0;RT4: 8.6" "Cancer enhanced" "Detected in many" "prostate cancer: 5.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.4;dendritic cells: 2.0;T-cells: 2.7" "Not detected" "Not detected" HPA057687 Uncertain Vesicles Vesicles "HPA057687: " "unprognostic (2.63e-1)" "unprognostic (8.97e-2)" "unprognostic (1.10e-5)" "unprognostic (8.46e-3)" "unprognostic (4.93e-2)" "unprognostic (2.53e-2)" "unprognostic (2.77e-1)" "unprognostic (3.17e-2)" "unprognostic (1.71e-1)" "unprognostic (4.05e-2)" "unprognostic (1.41e-4)" "unprognostic (2.28e-1)" "unprognostic (1.19e-2)" "unprognostic (1.42e-1)" 1.2 2.2 1.4 0.9 3.1 1.7 1.1 9.6 4.0 0.0 1.6 1.4 0.0 8.6 4.4 0.0 3.8 2.4 1.8 3.4 2.9 2.2 2.2 1.4 2.1 0.0 2.7 0.0 4.8 1.7 9.3 4.8 2.3 7.6 2.8 2.0 1.8 0.0 1.5 2.2 1.5 2.9 2.8 4.5 3.2 0.0 2.4 2.0 0.1 0.2 0.5 2.7 0.2 0.0 2.2 0.0 0.0 0.0 0.0 2.4 7.1 7.1 3.6 3.9 0.0 0.0 4.0 0.0 5.9 0.0 0.0 0.0 3.2 2.2 0.0 2.5 0.0 7.0 4.0 0.0 0.0 5.9 5.2 0.0 0.0 0.0 0.0 0.0 6.4 0.0 4.0 0.0 1.5 0.0 0.0 2.0 0.8 16.0 8.6 2.8 0.0 0.0 0.0 2.1 0.0 0.0 5.5 4.4 0.0 0.0 3.2 0.0 3.7 7.0 0.1 0.0 0.0 0.0 0.1 0.0 1.9 0.2 2.7 1.2 2.2 1.5 0.3 2.4 2.2 1.3 0.1 0.5 0.0 2.0 1.6 0.2 UTP3 "CRLZ1, DKFZp761F222, FLJ23256, SAS10" ENSG00000132467 "UTP3, small subunit processome component" Q9NQZ2 4 70688479-70690551 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035655, HPA041453" Approved Supported Nucleoli,Vesicles Nucleoli Vesicles "HPA035655: AB_10601832, HPA041453: " "unprognostic (2.44e-2)" "unprognostic (9.70e-2)" "unprognostic (7.36e-3)" "unprognostic (2.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.90e-2)" "unprognostic (6.79e-3)" "unprognostic (2.13e-1)" "unprognostic (3.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (4.44e-3)" "prognostic favourable (3.16e-4)" "unprognostic (4.45e-2)" "unprognostic (7.95e-2)" "unprognostic (2.24e-1)" "unprognostic (2.24e-2)" 19.9 23.4 17.6 21.3 17.9 14.5 17.1 20.1 20.3 15.7 16.1 12.1 12.1 14.3 19.4 14.2 23.5 19.4 13.3 18.9 17.0 12.1 24.5 27.5 16.4 26.7 15.5 16.2 17.2 17.0 16.4 21.2 22.9 18.4 14.5 15.2 9.9 16.0 16.7 18.1 20.1 22.8 18.2 14.7 38.7 19.5 11.5 20.3 33.3 16.5 21.6 27.2 15.5 17.6 7.3 13.6 6.3 12.7 6.5 8.6 5.2 12.0 11.8 15.9 13.2 22.7 17.2 13.7 25.2 16.3 14.5 14.1 15.4 16.2 53.4 15.9 21.5 10.2 23.3 34.5 21.1 16.5 13.3 20.3 15.9 16.5 24.7 30.6 18.1 23.2 20.8 17.7 17.5 19.4 23.1 18.0 23.4 25.1 28.3 17.2 11.1 17.3 12.2 21.9 21.8 26.1 19.6 13.4 18.3 10.7 24.5 15.6 13.5 12.4 21.5 14.8 25.1 14.0 16.1 26.4 19.4 38.8 18.0 15.1 12.9 6.3 11.1 5.5 7.0 12.7 7.3 7.3 5.8 7.8 13.5 6.8 8.6 7.2 0.9 6.5 10.8 13.6 7.0 5.2 17.6 17.9 20.1 20.3 17.0 12.1 15.5 16.2 18.4 20.3 VAC14 "ArPIKfyve, FLJ10305, TAX1BP2" ENSG00000103043 "Vac14, PIKFYVE complex component" Q08AM6 16 70687439-70801161 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027766, HPA075382" Approved Supported Vesicles,Cytosol Vesicles Cytosol "HPA027766: AB_1848651, HPA075382: " "unprognostic (9.25e-2)" "prognostic favourable (8.33e-5)" "unprognostic (2.83e-2)" "unprognostic (1.51e-1)" "unprognostic (8.94e-2)" "unprognostic (2.72e-1)" "unprognostic (2.21e-2)" "unprognostic (8.93e-3)" "unprognostic (1.03e-1)" "unprognostic (1.34e-2)" "unprognostic (7.20e-2)" "unprognostic (3.26e-1)" "prognostic favourable (1.56e-6)" "unprognostic (1.61e-1)" "unprognostic (1.10e-1)" "unprognostic (5.05e-2)" "unprognostic (1.80e-1)" 26.3 26.6 22.9 22.8 21.8 16.3 17.4 15.6 34.9 17.9 18.4 27.0 18.5 19.8 18.8 15.8 21.0 20.9 17.0 22.2 22.9 23.5 25.7 27.1 20.1 34.9 22.3 20.8 19.2 27.8 33.7 21.4 20.1 25.8 17.9 14.1 22.9 24.3 19.4 23.3 24.6 21.6 19.2 22.2 29.0 20.0 21.7 20.6 31.2 26.0 16.3 22.9 21.0 16.3 5.5 9.7 6.6 5.9 3.7 5.5 1.9 11.2 11.2 9.5 10.6 13.8 10.1 14.5 8.2 13.0 15.7 7.3 13.8 18.3 14.5 10.7 9.8 14.3 12.4 13.3 7.4 4.4 13.0 7.3 8.5 17.0 35.7 12.5 15.4 16.7 14.0 23.2 21.2 14.9 12.8 6.6 13.7 16.3 11.6 20.9 16.7 10.6 14.0 6.9 21.4 7.5 7.8 11.3 12.3 27.2 8.3 18.7 12.3 11.8 11.8 20.9 12.0 13.3 8.8 9.5 11.6 27.8 34.9 11.2 9.5 1.3 4.8 6.6 2.9 5.9 2.5 4.0 3.7 5.5 9.7 5.5 3.5 3.1 1.6 3.7 5.4 5.1 2.3 1.9 22.9 21.8 15.6 34.9 22.9 23.5 22.3 20.8 25.8 20.6 VAMP7 "SYBL1, TI-VAMP, VAMP-7" ENSG00000124333 "Vesicle associated membrane protein 7" P51809 X 155881293-155943769 "Predicted intracellular proteins, Predicted membrane proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036733 Approved Supported Vesicles 14000 Vesicles "HPA036733: AB_10672228" "unprognostic (7.54e-3)" "unprognostic (1.35e-2)" "unprognostic (2.07e-1)" "unprognostic (1.04e-1)" "unprognostic (6.15e-3)" "unprognostic (2.70e-2)" "unprognostic (5.77e-2)" "unprognostic (7.95e-2)" "unprognostic (7.18e-2)" "unprognostic (3.38e-3)" "unprognostic (1.02e-1)" "unprognostic (1.15e-1)" "prognostic favourable (2.83e-4)" "unprognostic (1.29e-1)" "unprognostic (3.42e-1)" "unprognostic (2.47e-1)" "unprognostic (2.97e-1)" 11.9 12.7 43.9 9.5 51.2 13.4 51.9 21.2 41.1 38.4 9.3 2.5 2.5 9.6 36.5 6.6 10.4 8.5 9.3 26.9 46.8 12.5 61.4 20.5 10.3 9.8 50.6 44.8 34.5 7.9 12.8 35.0 68.7 58.5 9.4 10.5 2.5 8.3 9.0 12.0 9.3 11.3 12.0 63.0 8.4 8.4 5.6 47.6 2.5 10.4 2.5 11.6 10.2 26.1 6.6 13.5 34.8 13.8 11.2 11.0 10.6 21.9 9.6 6.6 13.7 18.4 17.7 17.8 17.1 15.3 15.5 31.5 10.3 14.4 30.6 31.9 20.5 7.9 14.8 12.0 20.6 12.7 13.0 12.7 14.3 7.3 20.6 26.0 19.9 16.4 12.0 17.3 15.9 17.2 27.1 17.0 17.5 11.0 10.1 14.8 4.7 14.1 7.7 13.0 22.7 20.6 11.1 5.0 14.6 10.1 10.2 15.0 10.0 21.9 18.1 14.3 14.9 20.5 24.2 39.2 49.5 42.9 12.5 31.9 15.9 34.8 12.9 19.7 8.3 13.8 10.5 6.5 9.9 10.2 13.5 6.6 9.2 9.8 11.2 11.2 12.8 7.7 11.0 10.6 43.9 51.2 21.2 41.1 46.8 12.5 50.6 44.8 58.5 47.6 VAV2 ENSG00000160293 "Vav guanine nucleotide exchange factor 2" P52735 9 133761894-133992604 "Plasma proteins, Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 6.4" "Group enriched" "Detected in many" 36 "B-cells: 6.4;dendritic cells: 2.0;monocytes: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003224 Uncertain Approved Vesicles Vesicles "HPA003224: AB_1080554" "unprognostic (1.56e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (1.09e-1)" "unprognostic (3.43e-1)" "unprognostic (1.19e-1)" "unprognostic (6.57e-2)" "unprognostic (1.16e-3)" "unprognostic (1.83e-2)" "unprognostic (3.74e-3)" "unprognostic (4.73e-2)" "unprognostic (9.16e-2)" "prognostic favourable (7.39e-7)" "unprognostic (8.64e-3)" "unprognostic (3.00e-2)" "prognostic unfavourable (4.33e-4)" "unprognostic (3.97e-2)" 6.3 19.2 6.8 13.3 5.6 1.9 8.1 2.8 7.3 7.7 16.6 5.8 9.3 15.5 9.8 9.2 5.4 9.5 21.3 5.7 5.4 6.9 16.0 30.3 17.2 12.5 7.7 5.5 6.1 44.1 8.8 6.5 9.6 9.6 7.8 7.3 9.4 12.1 11.0 1.7 4.6 28.1 7.6 4.7 13.8 7.0 3.5 4.0 3.1 11.6 3.9 13.3 8.6 17.3 6.4 2.0 0.0 3.6 0.0 0.1 0.7 4.8 8.5 13.4 5.4 3.7 6.3 34.6 9.7 5.4 8.2 5.0 12.8 7.5 1.4 7.9 9.6 28.7 12.5 20.9 4.2 8.2 2.9 1.6 10.7 14.3 13.8 3.9 0.6 6.2 13.5 7.2 10.3 9.1 2.8 2.4 5.6 24.5 0.3 1.9 6.5 8.1 13.1 11.3 4.6 18.6 8.7 14.9 10.1 25.5 17.1 3.4 10.4 5.6 7.3 11.7 6.5 11.5 13.3 0.1 0.1 2.6 7.7 3.4 7.1 0.0 1.4 0.0 0.1 3.6 0.0 6.4 0.0 0.1 2.0 4.5 0.0 0.0 0.0 0.0 2.4 1.2 0.0 0.7 6.8 5.6 2.8 7.3 5.4 6.9 7.7 5.5 9.6 4.0 VBP1 "PFD3, PFDN3" ENSG00000155959 "VHL binding protein 1" P61758 X 155197007-155239817 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006260, HPA023230" Approved Supported Vesicles,Cytosol Cytosol Vesicles "CAB006260: AB_425740, HPA023230: AB_1858727" "unprognostic (1.55e-3)" "unprognostic (1.12e-3)" "unprognostic (3.35e-1)" "unprognostic (1.35e-2)" "unprognostic (3.78e-2)" "unprognostic (1.85e-3)" "unprognostic (5.31e-3)" "unprognostic (1.40e-1)" "unprognostic (2.44e-2)" "unprognostic (1.02e-2)" "unprognostic (9.80e-2)" "unprognostic (1.15e-1)" "unprognostic (5.76e-2)" "unprognostic (3.76e-2)" "unprognostic (4.54e-2)" "unprognostic (9.30e-2)" "unprognostic (3.80e-1)" 17.3 19.2 37.8 15.5 28.0 24.5 18.4 26.1 32.5 14.9 16.9 20.6 12.5 12.8 14.9 16.3 17.8 13.8 13.3 35.9 35.4 36.8 22.9 17.4 13.0 21.0 40.9 25.6 15.3 11.8 18.3 22.0 16.9 33.9 18.2 19.2 10.1 11.1 15.6 50.5 10.9 14.3 16.4 46.0 13.9 12.5 8.7 22.9 21.0 18.4 25.6 22.0 16.9 12.8 15.0 18.4 37.0 12.6 13.8 21.6 15.7 35.1 12.7 27.7 18.4 11.5 15.9 8.0 17.5 13.6 23.1 36.2 15.1 18.1 45.3 37.5 14.7 13.9 40.1 16.4 30.0 23.8 28.1 19.0 20.1 11.8 13.7 30.6 15.0 11.8 19.6 19.2 24.3 21.2 37.1 27.0 25.9 14.6 28.8 27.4 16.0 27.4 24.8 22.0 26.5 20.0 16.1 30.1 18.3 12.0 14.2 19.3 12.1 23.7 12.3 18.5 22.9 31.3 43.1 30.5 44.2 79.2 16.4 38.0 22.6 8.5 11.6 37.0 14.4 12.6 16.5 15.0 16.9 17.2 18.4 11.8 19.6 20.7 13.6 13.8 10.4 15.1 21.6 15.7 37.8 28.0 26.1 31.9 35.4 36.8 40.9 25.6 33.9 22.9 VCAN "CSPG2, PG-M" ENSG00000038427 Versican P13611 5 83471465-83582303 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 58.1;HSkMC: 39.6;RPTEC TERT1: 73.9;U-2197: 32.6;U-251 MG: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 55.5;myeloid DC: 21.3" "Group enriched" "Detected in many" 31 "dendritic cells: 21.3;monocytes: 55.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004726, CAB008979" Supported Supported Vesicles "Secreted to blood" 5200000 Vesicles "CAB008979: , HPA004726: AB_1080561" "unprognostic (7.90e-2)" "unprognostic (9.03e-3)" "unprognostic (7.09e-2)" "unprognostic (6.06e-3)" "unprognostic (1.87e-1)" "unprognostic (4.49e-2)" "unprognostic (1.23e-2)" "unprognostic (1.17e-2)" "prognostic unfavourable (7.59e-4)" "unprognostic (4.36e-3)" "unprognostic (2.68e-3)" "unprognostic (2.05e-1)" "prognostic unfavourable (5.17e-4)" "prognostic unfavourable (1.41e-4)" "unprognostic (1.15e-1)" "unprognostic (4.44e-2)" "unprognostic (5.30e-3)" 33.3 18.3 14.8 53.2 10.3 20.1 12.3 4.8 16.2 25.2 8.4 17.9 1.7 3.6 14.5 23.5 9.0 7.6 23.2 35.7 19.8 8.9 8.5 3.1 25.8 21.2 13.9 9.8 5.3 3.2 3.7 2.0 52.0 14.4 8.9 8.9 3.3 6.5 4.1 9.0 9.3 4.7 33.9 18.2 18.4 6.2 8.7 19.4 1.1 5.7 6.5 2.3 24.4 9.8 0.0 21.3 1.2 55.5 0.1 0.1 17.7 0.0 1.0 58.1 0.0 23.7 16.3 0.0 0.4 1.1 0.4 0.3 0.5 0.0 0.0 9.0 21.0 0.0 0.0 0.0 0.3 0.0 1.8 0.4 0.0 0.4 1.1 0.0 0.0 39.6 0.0 24.7 0.2 0.0 0.0 0.0 12.3 0.0 0.1 0.0 9.8 1.9 0.0 12.2 0.0 73.9 0.0 0.7 3.0 0.0 0.0 0.0 0.0 0.1 22.4 17.7 0.1 32.6 33.4 0.0 0.0 0.0 8.1 0.0 3.1 1.2 55.5 0.1 0.1 7.7 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.9 0.1 0.8 0.4 0.0 17.7 14.8 10.3 4.8 9.8 19.8 8.9 13.9 9.8 14.4 19.4 VDAC1 "MGC111064, PORIN" ENSG00000213585 "Voltage dependent anion channel 1" P21796 5 133971915-134005133 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 189.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB005885, HPA030780, CAB072343" Supported Uncertain Vesicles 4800000 Vesicles "CAB005885: AB_2214787, CAB072343: , HPA030780: " "prognostic unfavourable (5.30e-4)" "unprognostic (7.63e-3)" "unprognostic (3.07e-3)" "unprognostic (2.01e-1)" "unprognostic (5.11e-3)" "prognostic unfavourable (4.90e-4)" "prognostic unfavourable (8.49e-4)" "prognostic unfavourable (2.87e-5)" "unprognostic (1.81e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (2.64e-1)" "unprognostic (3.19e-2)" "unprognostic (8.98e-2)" "unprognostic (1.78e-1)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" 22.4 27.0 32.2 18.9 36.6 9.8 22.6 24.4 46.4 13.8 31.3 15.6 20.4 54.0 12.1 42.8 35.2 13.3 25.8 79.0 31.0 32.3 44.9 52.5 16.3 17.3 30.6 29.5 14.6 27.5 31.6 14.1 22.8 41.8 17.9 35.3 23.3 26.6 17.9 189.4 21.9 39.9 18.9 20.7 18.3 32.5 8.3 14.7 16.3 17.3 66.6 25.5 18.9 21.3 18.9 44.7 9.2 36.5 26.5 23.3 20.0 55.7 49.6 45.5 47.1 45.7 64.0 64.2 62.8 46.5 62.5 64.4 101.4 44.9 77.1 47.3 65.5 44.0 64.1 110.6 78.5 45.5 52.8 44.4 53.1 81.1 46.6 40.7 44.1 58.2 59.4 48.5 54.2 60.5 39.5 31.6 81.5 62.2 49.5 40.6 31.8 42.1 45.7 45.5 73.3 97.1 70.6 50.9 28.8 40.0 48.9 62.6 23.5 40.0 49.0 58.9 39.3 53.9 82.1 42.4 41.9 48.4 87.4 54.7 66.9 6.4 26.2 9.2 18.5 36.5 20.4 18.9 19.1 19.3 44.7 13.4 13.7 15.1 2.2 26.5 31.2 13.1 23.3 20.0 32.2 36.6 24.4 46.4 31.0 32.3 30.6 29.5 41.8 14.7 VGF "SCG7, SgVII" ENSG00000128564 "VGF nerve growth factor inducible" O15240 7 101162509-101165593 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 59.4;pituitary gland: 30.4" "Cell line enhanced" "Detected in some" "SH-SY5Y: 35.9;SK-MEL-30: 96.8;U-2 OS: 17.6;WM-115: 29.0" "Cancer enriched" "Detected in many" 6 "melanoma: 236.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055177, HPA072505" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" 1273770 2800000 "Golgi apparatus, Vesicles" "HPA055177: AB_2682728, HPA072505: AB_2686528" "unprognostic (3.04e-2)" "unprognostic (3.45e-1)" "unprognostic (3.19e-3)" "prognostic unfavourable (4.25e-4)" "prognostic unfavourable (3.31e-4)" "unprognostic (1.51e-2)" "unprognostic (2.86e-2)" "unprognostic (1.66e-3)" "unprognostic (2.25e-2)" "unprognostic (8.77e-2)" "unprognostic (3.84e-3)" "unprognostic (3.70e-3)" "unprognostic (9.82e-3)" "unprognostic (3.79e-1)" "unprognostic (7.23e-2)" "unprognostic (4.36e-3)" "unprognostic (2.21e-1)" 3.8 3.1 10.9 2.3 25.2 1.3 1.1 1.3 59.4 1.1 1.5 1.3 0.0 1.3 2.2 1.1 1.1 1.1 1.2 1.2 12.2 51.0 1.4 1.1 1.1 1.1 3.9 22.8 1.1 6.2 1.1 30.4 1.2 41.2 1.2 1.2 0.5 1.1 1.1 1.1 1.4 1.3 1.5 6.6 1.2 3.6 1.4 0.5 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 1.9 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.7 0.4 0.0 4.6 0.0 0.4 3.6 0.4 0.1 0.0 0.0 0.0 0.0 2.9 35.9 0.0 0.1 96.8 0.0 0.0 0.0 0.0 17.6 0.0 0.4 0.0 0.1 0.9 2.8 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 25.2 1.3 59.4 12.2 51.0 3.9 22.8 41.2 0.5 VLDLR "CARMQ1, CHRMQ1, VLDLRCH" ENSG00000147852 "Very low density lipoprotein receptor" P98155 9 2621834-2660053 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Receptor "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 50.5" "Cell line enhanced" "Detected in many" "BEWO: 27.6;THP-1: 28.3;U-87 MG: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "eosinophil: 14.1" "Lineage enriched" "Detected in many" 12 "granulocytes: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032462, HPA051312" Uncertain Approved "Vesicles,Cytokinetic bridge,Centriolar satellite" 180000 "Vesicles, Cytokinetic bridge, Centriolar satellite" "CAB032462: AB_2216805, HPA051312: " "unprognostic (5.31e-2)" "unprognostic (2.65e-1)" "unprognostic (6.92e-2)" "prognostic favourable (5.95e-4)" "unprognostic (1.15e-1)" "unprognostic (2.67e-2)" "unprognostic (2.48e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-2)" "unprognostic (3.79e-2)" "unprognostic (2.33e-1)" "unprognostic (6.75e-2)" "unprognostic (1.48e-2)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (4.34e-2)" 11.3 13.7 7.2 3.7 9.6 1.3 11.2 8.7 7.3 6.9 3.9 12.8 6.5 1.2 12.1 4.3 11.6 15.1 5.5 38.0 7.6 4.5 8.8 2.5 6.9 0.9 13.2 5.3 50.5 20.8 43.6 5.9 9.4 7.7 5.7 2.9 12.3 7.5 4.4 21.2 3.4 1.6 15.7 10.1 5.5 5.8 5.6 10.3 0.0 8.8 12.5 3.9 11.9 6.1 0.1 0.8 14.1 0.1 0.1 1.1 0.0 0.0 3.0 19.1 0.9 2.8 0.2 27.6 8.6 2.8 2.3 6.6 4.8 0.3 0.0 9.3 5.3 0.2 5.3 5.8 7.4 10.1 2.0 0.1 2.5 2.2 3.1 12.0 2.1 1.2 4.2 0.8 0.4 1.1 0.0 16.9 1.3 0.8 2.2 1.6 9.6 1.2 0.2 0.6 0.0 11.0 1.2 4.3 3.0 0.6 1.0 11.9 0.5 28.3 0.3 3.1 5.9 0.0 5.7 12.9 5.2 3.0 20.5 10.0 1.2 0.1 0.1 14.1 0.2 0.0 1.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 2.0 0.1 0.0 0.8 0.0 0.0 7.2 9.6 8.7 7.3 7.6 4.5 13.2 5.3 7.7 10.3 VN1R1 "V1RL1, VNR19I1, ZVNH1, ZVNR1" ENSG00000178201 "Vomeronasal 1 receptor 1" Q9GZP7 19 57454790-57457142 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell line enhanced" "Detected in some" "HEK 293: 6.1;U-266/70: 5.5;U-266/84: 6.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" HPA062209 Uncertain Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA062209: " "unprognostic (7.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (1.51e-2)" "unprognostic (5.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.21e-2)" "unprognostic (5.41e-2)" "unprognostic (5.68e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-2)" "unprognostic (4.59e-5)" 0.1 1.4 2.0 0.3 2.9 0.3 1.5 9.2 3.5 0.2 0.7 0.0 0.5 5.3 0.9 0.8 0.6 1.9 1.9 2.0 0.8 0.9 0.9 0.7 1.5 1.6 0.4 3.6 3.5 1.1 2.0 0.4 0.8 1.3 3.6 4.0 0.5 0.5 1.5 1.1 0.9 1.4 2.7 0.4 0.5 0.3 2.3 0.3 0.5 0.3 0.6 0.4 0.1 0.5 0.1 1.8 1.9 0.1 0.5 0.9 0.4 0.7 0.4 1.8 0.0 0.2 0.2 0.9 0.2 0.0 0.4 0.2 0.7 0.0 6.1 0.9 0.0 0.6 0.3 0.4 1.2 0.7 0.6 0.1 0.4 0.2 0.3 0.9 0.9 0.3 0.4 2.0 0.5 0.6 0.4 1.2 0.9 0.6 1.0 3.3 1.4 0.0 0.5 0.1 0.9 0.6 0.1 1.5 0.2 0.4 0.6 5.5 6.5 0.5 0.5 0.1 1.1 0.5 0.3 0.3 0.4 0.0 0.2 1.3 0.3 0.3 0.2 2.3 0.4 0.3 0.5 0.6 0.2 0.3 0.0 0.1 VPS13D "FLJ10619, KIAA0453" ENSG00000048707 "Vacuolar protein sorting 13 homolog D" Q5THJ4 1 12230032-12512047 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027332, HPA051621" Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA027332: , HPA051621: " "unprognostic (2.97e-1)" "unprognostic (8.47e-2)" "unprognostic (2.89e-2)" "unprognostic (2.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.75e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-3)" "unprognostic (3.33e-1)" "unprognostic (2.00e-2)" "unprognostic (1.57e-1)" "unprognostic (7.77e-2)" "prognostic favourable (7.42e-12)" "unprognostic (5.13e-1)" "unprognostic (1.72e-1)" "unprognostic (4.04e-2)" "unprognostic (8.31e-2)" 11.7 9.8 16.6 8.5 16.4 8.0 16.6 18.5 19.7 19.9 12.5 17.0 11.7 6.9 12.8 15.3 16.1 10.8 10.2 15.8 15.7 13.2 15.4 11.0 12.3 9.9 16.5 13.8 15.9 11.9 28.1 14.1 9.2 13.3 18.6 11.3 14.0 15.1 16.8 30.3 39.2 9.7 17.3 14.8 10.2 12.8 11.6 13.6 8.6 21.7 11.3 14.4 10.8 17.9 4.1 3.9 6.0 1.9 1.7 3.6 0.9 8.0 4.6 5.2 4.0 14.0 11.2 2.4 4.0 6.9 6.8 6.5 3.1 5.7 7.6 5.0 11.2 7.4 9.1 7.7 9.5 4.1 3.0 6.5 7.2 2.5 5.9 9.4 3.4 9.4 11.0 8.7 8.5 10.7 13.3 3.9 6.2 3.7 5.5 3.7 2.1 5.9 4.8 6.3 2.2 4.8 4.8 2.5 3.5 11.5 8.5 8.1 7.3 3.1 11.6 4.2 4.4 10.9 3.2 3.5 2.8 12.0 4.8 6.7 6.4 6.0 1.9 1.4 3.3 1.9 3.5 2.5 3.6 2.3 1.5 4.1 3.2 2.5 2.6 1.7 1.4 3.9 1.7 0.9 16.6 16.4 18.5 19.7 15.7 13.2 16.5 13.8 13.3 13.6 VPS29 "DC15, DC7, PEP11" ENSG00000111237 "VPS29, retromer complex component" Q9UBQ0 12 110491097-110502117 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039748 Uncertain Supported Vesicles,Cytosol 140000 "Vesicles, Cytosol" "HPA039748: AB_10674426" "unprognostic (9.46e-2)" "unprognostic (3.46e-3)" "unprognostic (2.16e-2)" "unprognostic (2.58e-1)" "unprognostic (3.08e-1)" "unprognostic (2.26e-2)" "prognostic unfavourable (2.79e-5)" "unprognostic (1.52e-1)" "unprognostic (3.37e-2)" "prognostic favourable (7.70e-4)" "unprognostic (1.64e-1)" "unprognostic (2.10e-3)" "unprognostic (2.96e-1)" "unprognostic (2.04e-2)" "unprognostic (2.11e-1)" "unprognostic (5.57e-2)" "unprognostic (4.29e-3)" 39.2 34.9 35.6 28.5 38.5 44.4 32.6 23.0 46.6 30.3 38.0 24.4 29.5 33.6 31.5 50.4 51.2 29.0 27.5 35.9 31.5 30.9 62.2 51.2 31.3 33.1 32.8 27.8 27.6 31.4 18.3 31.4 34.5 46.6 41.6 43.5 27.3 34.1 40.6 64.0 25.2 36.2 47.3 28.9 43.1 34.9 17.0 23.8 29.8 38.3 32.9 38.0 51.5 27.4 40.5 67.4 52.7 79.9 41.7 46.0 72.1 31.2 30.7 29.2 20.8 32.9 32.7 23.1 29.7 31.1 30.0 27.2 30.7 27.4 29.0 31.3 29.4 29.9 38.6 27.5 31.5 34.3 30.9 35.4 38.7 25.2 28.7 42.2 31.1 21.5 23.5 25.4 28.1 52.4 33.8 27.2 53.7 15.7 33.0 60.0 16.7 39.5 22.1 29.9 40.7 49.9 46.6 31.5 16.7 33.7 30.0 37.2 40.7 32.7 29.4 26.1 17.2 36.0 34.6 18.6 25.9 34.1 30.4 40.4 27.7 43.9 57.6 52.7 31.9 73.2 35.1 40.5 40.7 37.3 67.4 31.4 37.4 36.8 38.5 41.7 79.9 45.3 46.0 72.1 35.6 38.5 23.0 46.6 31.5 30.9 32.8 27.8 46.6 23.8 VPS36 "C13orf9, CGI-145, Eap45" ENSG00000136100 "Vacuolar protein sorting 36 homolog" Q86VN1 13 52412602-52450628 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039734, HPA043947" Approved Supported "Vesicles,Lysosomes,Plasma membrane,Cell Junctions" "Vesicles, Lysosomes" "Plasma membrane, Cell Junctions" "HPA039734: , HPA043947: " "unprognostic (2.43e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-1)" "unprognostic (2.94e-1)" "unprognostic (1.56e-1)" "unprognostic (2.32e-1)" "unprognostic (6.57e-2)" "unprognostic (7.84e-2)" "unprognostic (3.96e-3)" "unprognostic (1.19e-2)" "unprognostic (9.37e-2)" "unprognostic (5.57e-2)" "prognostic favourable (9.91e-6)" "unprognostic (6.47e-3)" "unprognostic (1.83e-1)" "unprognostic (1.94e-1)" "unprognostic (9.83e-2)" 16.4 14.5 16.5 15.9 22.3 7.0 23.5 36.8 27.7 17.1 21.1 13.6 12.8 23.8 22.4 12.9 24.6 16.6 18.0 20.3 15.4 13.0 22.6 20.2 17.5 15.6 16.2 18.5 20.0 19.0 14.4 20.1 21.7 25.9 20.1 24.7 18.2 21.6 18.3 23.4 44.6 27.9 23.7 13.8 22.3 15.7 4.2 13.8 18.1 20.0 16.8 18.1 20.3 21.7 14.4 14.9 13.9 19.2 19.4 19.3 11.8 3.7 6.3 11.2 7.3 11.6 16.3 9.6 8.7 6.7 8.9 5.4 7.4 12.6 13.3 4.6 12.5 10.7 8.8 10.5 9.9 9.9 8.5 15.6 10.0 6.6 13.9 21.0 17.0 11.4 20.6 6.0 9.9 8.9 11.5 11.8 17.0 4.9 15.3 21.1 10.6 3.3 16.0 6.3 8.1 15.6 9.9 5.7 12.0 6.2 14.8 13.2 8.6 35.0 13.8 5.7 6.9 5.6 9.8 8.8 11.0 14.1 5.9 14.9 13.2 13.9 13.5 10.9 12.1 14.8 19.3 14.4 13.3 15.1 14.3 12.3 12.4 13.2 3.7 19.4 19.2 14.9 14.3 11.8 16.5 22.3 36.8 27.7 15.4 13.0 16.2 18.5 25.9 13.8 VPS37A "FLJ32642, HCRP1, PQBP2, SPG53" ENSG00000155975 "VPS37A, ESCRT-I subunit" Q8NEZ2 8 17246571-17302427 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024705, HPA024781" Supported Approved Vesicles,Centrosome,Cytosol Vesicles "Centrosome, Cytosol" "HPA024705: AB_10601776, HPA024781: AB_10602100" "unprognostic (8.28e-2)" "unprognostic (1.84e-1)" "unprognostic (9.39e-3)" "unprognostic (3.91e-1)" "unprognostic (2.10e-1)" "unprognostic (6.31e-2)" "unprognostic (5.88e-3)" "unprognostic (2.28e-2)" "unprognostic (1.43e-1)" "unprognostic (3.17e-1)" "unprognostic (1.02e-1)" "unprognostic (2.88e-1)" "unprognostic (5.06e-2)" "unprognostic (1.98e-2)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (2.18e-1)" 23.5 21.3 15.1 13.5 15.6 12.8 22.1 23.1 18.1 21.3 23.5 15.8 16.4 18.6 19.1 15.1 22.7 13.3 15.5 34.4 15.8 14.9 23.3 25.9 18.4 14.4 16.6 10.4 21.7 15.8 34.2 20.8 31.6 16.1 20.0 16.2 20.7 15.2 22.7 41.8 16.5 27.3 24.4 20.2 16.4 14.9 27.7 14.6 17.3 18.0 16.4 14.8 27.6 22.7 10.1 11.7 25.0 15.2 20.6 15.5 11.4 7.0 11.7 10.2 8.9 22.6 18.0 11.1 25.3 21.5 23.4 20.2 7.8 6.9 6.1 13.8 20.2 7.0 11.4 11.1 27.7 6.2 3.4 11.2 5.9 8.3 26.5 4.3 10.6 17.5 21.6 21.6 22.2 16.6 8.2 15.8 24.6 4.8 13.1 11.1 10.1 6.1 6.4 11.4 7.2 19.6 9.8 12.2 6.5 10.1 10.1 15.6 6.6 9.1 14.1 14.1 7.2 20.2 13.2 5.0 10.2 7.1 16.1 8.3 14.4 25.0 15.2 13.5 12.9 11.3 15.5 9.9 12.4 12.3 11.7 10.1 11.6 13.8 15.9 20.6 10.0 10.8 11.4 11.4 15.1 15.6 23.1 18.1 15.8 14.9 16.6 10.4 16.1 14.6 VPS37C FLJ20847 ENSG00000167987 "VPS37C, ESCRT-I subunit" A5D8V6 11 61130256-61161617 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043348 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA043348: AB_10794658" "unprognostic (1.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.50e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-1)" "unprognostic (9.01e-2)" "prognostic unfavourable (5.85e-5)" "unprognostic (7.42e-2)" "unprognostic (1.14e-1)" "unprognostic (3.00e-1)" "unprognostic (3.41e-2)" "unprognostic (3.17e-2)" "prognostic favourable (2.37e-7)" "unprognostic (1.99e-1)" "unprognostic (1.08e-1)" "unprognostic (3.85e-1)" "unprognostic (7.05e-2)" 12.8 12.7 15.6 13.8 14.5 9.8 13.9 10.0 17.4 15.4 18.4 16.0 17.3 19.1 16.1 15.0 20.9 14.5 14.3 15.0 15.5 9.2 15.4 12.1 13.9 8.0 12.5 10.2 16.3 22.6 14.7 19.8 19.5 13.4 19.5 12.5 18.2 29.1 18.2 20.6 24.1 26.4 16.7 13.6 13.0 23.7 18.6 15.3 5.9 14.0 14.9 14.4 17.3 14.6 1.1 1.9 6.8 4.5 0.4 0.8 1.0 17.1 7.0 8.9 8.2 4.3 9.2 19.6 8.8 23.4 13.2 8.9 8.1 7.9 4.5 12.3 11.8 9.5 8.0 9.3 6.8 9.8 6.1 5.9 4.8 8.8 13.9 4.5 7.0 8.0 14.3 10.9 13.8 8.5 15.1 7.3 8.6 20.9 0.9 6.6 10.6 10.0 1.6 4.0 10.7 10.0 9.3 5.4 13.3 8.9 26.8 13.9 25.7 11.0 6.4 12.8 9.3 12.6 10.7 3.6 4.9 3.8 11.3 5.5 8.3 0.8 2.5 2.8 0.6 4.5 0.8 1.1 0.4 0.7 1.9 1.1 0.5 0.3 6.8 0.4 4.1 0.3 0.3 1.0 15.6 14.5 10.0 17.4 15.5 9.2 12.5 10.2 13.4 15.3 VPS37D "MGC35352, WBSCR24" ENSG00000176428 "VPS37D, ESCRT-I subunit" Q86XT2 7 73667825-73672112 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040978 Uncertain Approved Vesicles Vesicles "HPA040978: AB_10805833" "unprognostic (2.98e-2)" "unprognostic (2.17e-1)" "unprognostic (1.13e-2)" "unprognostic (7.85e-2)" "unprognostic (1.93e-1)" "unprognostic (3.85e-2)" "unprognostic (2.54e-1)" "unprognostic (3.94e-1)" "unprognostic (8.80e-2)" "unprognostic (1.97e-1)" "prognostic favourable (2.07e-5)" "unprognostic (4.19e-2)" "prognostic favourable (5.80e-9)" "unprognostic (9.63e-2)" "unprognostic (1.67e-1)" "unprognostic (1.25e-2)" "unprognostic (1.43e-1)" 2.6 1.7 7.2 0.8 8.3 0.6 2.9 7.5 9.2 4.7 1.9 3.8 1.7 4.1 3.9 6.9 0.9 6.4 3.2 3.9 6.0 7.6 8.8 6.2 1.8 0.7 5.1 2.6 6.0 5.3 3.8 2.4 1.0 5.3 4.5 0.7 2.2 7.2 5.0 2.8 2.3 2.4 1.9 3.8 1.2 1.9 5.5 3.3 0.8 7.4 0.2 0.5 3.6 5.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.6 2.8 2.3 4.7 1.5 3.1 1.4 1.2 1.9 1.0 1.2 0.3 0.8 1.0 1.1 1.6 0.3 2.4 1.1 0.3 0.4 2.5 0.0 0.2 3.2 4.2 0.0 1.4 2.5 0.7 1.4 0.4 1.1 1.3 0.2 1.4 3.4 0.7 0.1 1.5 4.1 0.1 0.1 0.2 3.8 0.3 4.6 14.8 0.0 2.0 2.7 4.7 0.2 1.7 2.9 3.9 1.7 1.0 1.8 0.2 1.3 6.4 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 7.2 8.3 7.5 7.2 6.0 7.6 5.1 2.6 5.3 3.3 VPS4B "SKD1, SKD1B, VPS4-2" ENSG00000119541 "Vacuolar protein sorting 4 homolog B" O75351 18 63389190-63422483 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040393, CAB046445, HPA057649" Approved Approved "Vesicles,Intermediate filaments" 34000 Vesicles "Intermediate filaments" "CAB046445: AB_10603252, HPA040393: , HPA057649: " "unprognostic (8.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.10e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "prognostic favourable (1.23e-4)" "unprognostic (4.59e-1)" "unprognostic (1.40e-1)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" 16.8 13.0 14.3 14.3 17.2 28.0 17.2 15.4 19.1 19.8 24.0 21.8 15.5 20.0 16.7 12.1 55.0 13.1 15.1 9.9 13.7 16.0 15.6 20.5 14.3 21.6 17.0 14.7 11.9 14.0 17.5 17.4 27.4 23.4 14.3 22.2 9.3 21.8 15.0 9.9 22.1 28.7 15.2 20.2 17.3 18.7 9.0 14.6 27.8 17.0 17.6 31.8 18.6 24.7 20.7 13.6 56.4 20.6 19.1 18.9 15.4 18.4 6.8 7.6 8.3 11.8 16.7 13.2 16.2 15.3 12.4 13.6 5.0 13.2 17.8 10.6 11.8 40.1 9.1 17.7 16.5 12.9 7.3 8.9 9.6 7.7 16.9 30.6 19.5 15.1 27.6 10.9 19.5 11.5 4.4 16.7 17.6 6.4 19.1 9.6 7.9 10.7 16.0 16.2 17.1 15.6 21.7 13.0 11.5 12.2 12.0 18.1 11.5 16.7 17.6 19.2 9.4 7.2 10.6 56.1 26.9 22.9 11.0 14.5 14.2 39.4 16.8 36.0 16.5 16.6 15.4 18.9 17.4 17.0 13.6 20.7 15.8 16.6 56.4 19.1 20.6 13.6 18.9 15.4 14.3 17.2 15.4 19.1 13.7 16.0 17.0 14.7 23.4 14.6 VPS51 "ANG2, ANG3, C11orf2, C11orf3, FFR" ENSG00000149823 "VPS51, GARP complex subunit" Q9UID3 11 65089324-65111860 "Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039650, HPA061447" Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoli "HPA039650: AB_10673147, HPA061447: " "unprognostic (2.36e-2)" "unprognostic (7.58e-2)" "unprognostic (8.35e-2)" "unprognostic (1.56e-1)" "unprognostic (2.11e-2)" "unprognostic (1.64e-1)" "unprognostic (9.72e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (2.03e-3)" "unprognostic (1.56e-1)" "prognostic favourable (2.41e-9)" "unprognostic (7.77e-3)" "unprognostic (4.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.18e-1)" 22.1 19.5 17.5 19.4 24.3 30.3 21.7 29.8 33.8 23.4 30.9 16.9 22.4 31.2 27.7 15.5 22.9 20.9 25.0 27.7 15.9 13.0 18.5 24.7 16.6 35.0 14.5 19.2 53.2 77.6 22.9 14.5 21.7 15.9 22.0 15.7 17.2 54.2 18.4 39.4 32.0 27.7 24.4 13.2 20.5 30.3 17.5 12.6 36.5 34.7 24.4 21.9 24.6 22.4 15.6 14.8 9.9 10.5 21.8 19.8 10.5 21.7 24.0 11.8 14.4 5.3 13.1 22.0 8.6 17.6 17.5 13.0 17.4 28.8 38.0 24.7 16.6 18.7 12.4 19.3 6.4 22.1 18.8 22.6 24.4 16.7 17.3 24.4 20.7 22.6 13.2 13.0 10.8 19.2 23.0 27.3 7.1 29.6 32.7 24.4 19.1 18.4 20.4 5.7 45.8 11.9 24.4 19.7 27.1 6.4 36.6 21.3 29.8 12.2 15.5 11.9 10.4 14.7 12.3 34.9 27.0 21.3 13.2 8.9 8.4 7.0 10.0 9.9 13.3 10.5 15.5 15.3 18.5 19.8 14.8 15.6 16.9 14.7 6.3 21.8 10.3 13.4 11.9 10.5 17.5 24.3 29.8 33.8 15.9 13.0 14.5 19.2 15.9 12.6 VRK3 ENSG00000105053 "Vaccinia related kinase 3" Q8IV63 19 49976467-50025946 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 77.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056489 Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA056489: " "unprognostic (2.09e-1)" "unprognostic (3.14e-2)" "unprognostic (1.26e-1)" "unprognostic (4.94e-3)" "unprognostic (1.23e-1)" "unprognostic (2.22e-3)" "unprognostic (9.78e-2)" "unprognostic (3.47e-1)" "unprognostic (8.79e-2)" "unprognostic (2.48e-1)" "unprognostic (1.31e-2)" "unprognostic (1.43e-1)" "prognostic favourable (1.83e-4)" "unprognostic (9.38e-2)" "unprognostic (2.15e-1)" "unprognostic (1.06e-1)" "prognostic favourable (5.66e-4)" 9.7 11.9 9.2 9.4 12.7 10.7 8.3 12.0 14.1 8.9 13.4 11.9 9.3 13.4 15.7 10.8 8.4 18.0 12.2 7.4 9.3 11.1 16.7 16.2 8.5 13.4 10.4 9.9 11.2 11.5 7.1 11.8 10.7 9.8 9.4 11.7 14.2 14.3 8.5 11.8 7.7 17.3 7.5 11.0 12.8 10.9 77.2 9.1 24.7 14.1 6.0 12.9 9.9 8.0 24.5 19.7 47.3 20.9 33.5 30.1 18.1 16.3 16.9 12.4 13.4 16.5 15.3 12.9 11.8 14.1 17.5 19.3 9.0 18.3 19.7 8.4 11.4 12.2 11.5 10.0 14.2 17.2 23.7 15.3 10.2 15.6 12.4 19.1 27.0 13.7 15.1 10.1 10.7 14.4 18.6 29.4 12.6 6.9 25.8 12.9 6.7 14.6 20.8 13.1 25.1 15.0 17.3 14.0 6.8 11.5 14.2 12.8 13.1 20.4 10.9 18.0 10.5 7.2 9.1 19.1 24.3 10.3 14.4 11.8 12.3 37.0 17.8 32.4 23.8 18.8 19.1 24.5 21.7 22.7 19.7 21.9 22.1 20.4 47.3 33.5 20.9 18.8 30.1 18.1 9.2 12.7 12.0 14.1 9.3 11.1 10.4 9.9 9.8 9.1 VSIG1 MGC44287 ENSG00000101842 "V-set and immunoglobulin domain containing 1" Q86XK7 X 108044970-108079184 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 29.5;stomach 1: 66.6;testis: 87.4" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.7;HUVEC TERT2: 11.6;PC-3: 3.9;TIME: 2.9" "Group enriched" "Detected in many" 17 "lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.7;T-reg: 11.2" "Lineage enriched" "Detected in many" 4 "T-cells: 11.7" "Not detected" "Not detected" "HPA001445, HPA036310, HPA036311" Enhanced Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350" "unprognostic (4.33e-3)" "unprognostic (4.60e-2)" "unprognostic (3.22e-2)" "unprognostic (1.60e-1)" "unprognostic (2.51e-1)" "unprognostic (4.80e-2)" "unprognostic (3.25e-2)" "unprognostic (9.79e-2)" "unprognostic (4.58e-1)" "unprognostic (2.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.25e-1)" "unprognostic (6.31e-7)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-3)" 0.1 0.0 0.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 0.3 0.8 0.1 0.3 0.1 0.2 0.2 0.0 29.5 0.1 0.1 0.1 0.1 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.0 1.3 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 66.6 87.4 0.1 0.1 0.1 0.1 0.4 1.5 0.1 2.6 0.1 0.6 0.1 0.2 11.7 2.5 0.2 1.0 0.0 0.2 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.5 0.0 5.7 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.3 0.4 1.0 0.1 1.9 11.6 0.1 0.3 0.0 0.4 0.4 0.3 0.4 3.9 0.3 0.0 0.0 0.7 1.0 0.2 0.1 0.2 0.2 0.6 0.1 0.0 2.9 0.3 0.9 0.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 1.0 0.0 3.7 2.6 7.7 3.3 0.0 1.0 11.7 5.4 0.4 0.2 0.1 0.1 11.2 2.5 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 VSTM1 UNQ3033 ENSG00000189068 "V-set and transmembrane domain containing 1" Q6UX27 19 54040825-54063953 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 53.5;bone marrow: 39.4" "Group enriched" "Detected in some" 7 "EFO-21: 1.0;HMC-1: 2.5;hTERT-HME1: 3.9;U-2 OS: 3.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 15 "eosinophil: 53.5" "Lineage enriched" "Detected in many" 15 "granulocytes: 53.5" HPA059365 Approved Vesicles "Secreted to blood" Vesicles "HPA059365: " "unprognostic (5.13e-2)" "unprognostic (5.31e-2)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.36e-3)" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (3.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-1)" "unprognostic (9.47e-2)" "unprognostic (1.31e-5)" "unprognostic (3.73e-1)" "unprognostic (1.14e-1)" "unprognostic (9.74e-2)" "unprognostic (4.67e-2)" 0.9 0.2 0.7 0.1 0.2 39.4 0.1 0.0 0.5 0.2 0.1 1.3 0.0 0.1 0.3 0.1 0.1 0.6 0.1 4.2 0.7 0.2 0.5 1.2 4.0 7.2 0.6 0.0 0.2 1.1 0.1 8.7 2.0 0.2 0.1 0.1 0.2 0.1 0.1 2.1 0.1 0.8 0.3 0.1 7.9 0.1 0.5 0.3 3.0 0.4 0.0 0.1 0.8 0.0 0.0 0.0 53.5 3.6 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.0 53.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.6 0.0 0.0 2.1 0.7 0.2 0.0 0.5 0.7 0.2 0.6 0.0 0.2 0.3 VSTM4 "C10orf72, FLJ31737" ENSG00000165633 "V-set and transmembrane domain containing 4" Q8IW00 10 49014245-49115509 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 6.8;RH-30: 7.8;SH-SY5Y: 6.7;U-138 MG: 8.9;U-2197: 20.0;U-87 MG: 9.8" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 22.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017279 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" "Nucleoplasm, Vesicles" "HPA017279: AB_10959519" "unprognostic (8.46e-2)" "unprognostic (5.41e-1)" "unprognostic (1.89e-1)" "unprognostic (2.07e-1)" "unprognostic (1.80e-1)" "unprognostic (2.84e-2)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" "unprognostic (3.03e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.62e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (4.25e-4)" 13.0 31.6 7.2 3.4 6.7 0.4 10.5 3.3 7.1 18.2 6.2 9.3 3.1 2.0 13.2 5.9 6.1 6.5 11.7 10.3 7.2 4.4 9.3 3.0 8.9 7.0 8.9 5.4 27.2 1.3 22.8 4.6 7.7 10.1 11.2 4.4 15.1 2.8 9.2 3.8 4.2 4.1 12.5 7.9 2.8 5.4 7.8 6.0 2.9 20.8 6.9 3.4 9.4 8.6 1.8 0.9 2.7 0.9 1.7 0.7 0.2 0.0 0.1 2.6 0.1 1.1 0.6 0.1 2.1 3.4 0.8 0.2 0.1 0.1 0.1 0.1 4.9 0.1 0.1 0.0 0.3 2.6 1.1 0.1 0.0 0.1 0.1 0.1 0.0 4.1 0.0 3.5 0.0 0.0 6.8 0.1 0.6 0.1 0.0 0.1 0.5 0.0 0.0 7.8 4.0 0.0 0.1 0.1 6.7 0.1 0.1 0.0 0.1 0.2 0.0 8.9 1.1 20.0 0.1 0.0 5.3 0.0 9.8 0.1 0.1 1.9 0.9 0.4 0.6 0.3 0.5 0.8 0.4 0.3 0.2 1.8 0.7 0.6 2.7 1.7 0.5 0.9 0.3 0.2 7.2 6.7 3.3 7.1 7.2 4.4 8.9 5.4 10.1 6.0 VTA1 "C6orf55, HSPC228, My012" ENSG00000009844 "Vesicle trafficking 1" Q9NP79 6 142147162-142224689 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030968, HPA030969" Approved Supported Nucleoplasm,Vesicles,Cytosol 22000 "Nucleoplasm, Vesicles, Cytosol" "HPA030968: AB_10602585, HPA030969: AB_2673679" "prognostic unfavourable (7.02e-4)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.17e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" "prognostic unfavourable (6.58e-6)" "unprognostic (2.83e-2)" "unprognostic (3.61e-1)" "unprognostic (5.18e-2)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (3.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" "unprognostic (1.96e-1)" "unprognostic (3.24e-1)" 18.8 19.5 20.5 15.5 28.2 17.2 20.6 25.0 39.3 17.2 22.0 18.5 9.6 24.2 16.0 17.1 31.4 17.9 14.9 21.2 19.8 20.3 24.9 29.9 13.5 19.3 20.1 20.7 15.3 15.6 16.3 21.7 30.5 30.7 16.8 26.3 11.2 19.4 13.5 48.6 20.9 32.7 17.0 24.0 20.8 14.6 12.9 18.2 33.6 18.0 24.3 24.0 18.4 19.7 29.0 30.9 58.6 38.1 30.9 30.1 36.1 18.1 15.6 25.5 39.0 22.5 24.8 17.6 41.1 24.6 37.7 36.1 26.3 14.2 29.6 27.9 36.8 23.2 27.1 28.1 52.3 20.0 23.8 32.1 16.7 31.4 16.6 49.7 18.6 20.4 32.9 37.6 24.4 24.1 29.7 14.9 31.5 26.4 32.2 25.9 19.1 17.9 29.7 20.4 18.0 29.0 20.1 26.7 20.8 23.1 17.8 20.6 19.3 33.9 17.4 17.0 23.7 28.4 29.5 14.7 25.4 33.7 11.1 27.8 25.8 58.6 31.0 49.5 23.5 38.1 30.1 29.0 26.8 27.4 30.9 26.6 29.8 29.9 19.1 30.9 37.4 19.0 25.7 36.1 20.5 28.2 25.0 39.3 19.8 20.3 20.1 20.7 30.7 18.2 VTI1A "MVti1, Vti1-rp2, Vti1a" ENSG00000151532 "Vesicle transport through interaction with t-SNAREs 1A" Q96AJ9 10 112446998-112818744 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054108 Supported Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA054108: " "unprognostic (9.81e-2)" "unprognostic (6.42e-2)" "unprognostic (4.49e-2)" "unprognostic (1.50e-1)" "unprognostic (1.66e-1)" "unprognostic (2.28e-1)" "prognostic unfavourable (6.50e-5)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (1.22e-1)" "unprognostic (8.05e-2)" "prognostic favourable (7.27e-5)" "unprognostic (3.74e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-3)" "unprognostic (2.61e-1)" 16.8 12.8 14.5 17.9 17.9 25.2 14.6 16.7 18.6 10.0 13.8 14.3 14.4 15.2 11.8 11.6 21.1 9.5 10.3 13.1 13.4 11.1 15.4 11.8 15.7 15.4 12.8 12.2 10.5 12.8 17.4 13.7 11.0 14.6 11.4 17.0 11.2 14.3 13.6 18.4 17.1 16.5 12.8 12.7 16.0 12.3 9.8 13.0 18.8 14.2 9.7 19.6 13.1 15.6 7.3 6.8 14.8 11.7 7.3 8.8 5.5 10.8 9.1 8.7 11.7 13.4 11.9 5.2 11.6 14.8 9.5 10.7 10.2 11.3 11.3 4.5 13.3 13.0 7.4 9.3 13.0 14.1 6.5 9.8 6.6 10.7 9.5 13.5 14.3 9.0 12.1 10.7 22.4 10.1 8.9 14.2 12.5 7.4 10.7 10.4 3.6 5.3 11.3 12.4 5.0 10.0 9.7 3.9 7.6 8.3 7.3 7.6 6.5 7.6 14.0 7.4 6.4 9.0 12.9 6.2 8.7 13.3 12.2 12.5 7.2 8.9 8.9 11.9 7.5 11.7 7.0 7.3 6.3 6.0 6.8 6.7 6.2 6.4 14.8 7.3 10.4 6.4 8.8 5.5 14.5 17.9 16.7 18.6 13.4 11.1 12.8 12.2 14.6 13.0 VTI1B VTI2 ENSG00000100568 "Vesicle transport through interaction with t-SNAREs 1B" Q9UEU0 14 67647075-67674831 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044121, HPA048150, HPA060118" Approved Enhanced "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA044121: , HPA048150: , HPA060118: " "unprognostic (2.26e-1)" "unprognostic (4.83e-2)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (3.00e-2)" "unprognostic (2.36e-3)" "unprognostic (3.25e-3)" "unprognostic (9.12e-2)" "unprognostic (1.90e-2)" "unprognostic (3.86e-1)" "unprognostic (2.60e-1)" "unprognostic (2.11e-2)" "prognostic favourable (3.53e-12)" "unprognostic (8.35e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (8.02e-3)" 37.5 21.4 49.3 14.9 39.3 14.3 32.1 12.6 32.9 11.3 22.8 16.8 16.1 21.3 12.5 42.5 34.1 14.6 22.0 49.6 36.9 30.4 39.0 30.5 14.8 16.3 38.1 20.5 12.7 27.9 20.3 11.3 21.0 24.2 16.2 27.4 15.4 25.7 18.8 31.0 21.8 20.2 22.9 37.1 15.6 20.7 15.4 20.2 8.2 25.9 18.8 19.5 19.4 24.2 18.7 22.4 52.1 29.6 20.1 21.7 18.9 38.3 19.4 11.3 6.5 22.6 13.5 16.4 17.0 10.6 8.2 8.5 9.6 13.8 11.5 14.5 18.9 10.9 12.9 12.9 13.4 11.8 8.2 11.6 11.7 12.3 9.7 7.2 8.4 13.1 14.0 9.1 9.4 9.5 7.6 9.0 12.0 45.5 9.0 26.7 7.3 31.3 10.9 12.8 4.2 12.2 23.1 6.3 13.1 12.0 16.3 24.1 15.2 20.3 13.6 22.9 34.2 18.4 15.7 8.5 9.1 17.7 19.3 13.5 10.5 28.6 23.4 52.1 19.8 29.6 16.9 18.7 17.5 20.2 22.4 16.4 16.7 20.4 10.6 20.1 24.7 14.7 21.7 18.9 49.3 39.3 12.6 32.9 36.9 30.4 38.1 20.5 24.2 20.2 VTN VN ENSG00000109072 Vitronectin P04004 17 28367276-28373091 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "liver: 321.7" "Cell line enriched" "Detected in some" 11 "CACO-2: 164.9" "Cancer enriched" "Detected in many" 85 "liver cancer: 2216.6" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016695, CAB016765, HPA060933" Supported Supported "Endoplasmic reticulum,Vesicles" "Secreted to blood" 224300000000 32000000000 "Endoplasmic reticulum, Vesicles" "CAB016695: AB_1624536, CAB016765: , HPA060933: " "unprognostic (1.19e-1)" "unprognostic (2.12e-1)" "unprognostic (2.29e-2)" "unprognostic (6.13e-2)" "unprognostic (9.74e-2)" "unprognostic (8.42e-2)" "prognostic favourable (3.74e-4)" "unprognostic (6.20e-2)" "unprognostic (3.97e-1)" "unprognostic (8.95e-2)" "unprognostic (3.24e-3)" "unprognostic (1.01e-2)" "prognostic unfavourable (4.10e-11)" "unprognostic (8.82e-3)" "unprognostic (2.27e-1)" "unprognostic (4.86e-3)" "unprognostic (7.09e-2)" 0.2 7.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.2 0.0 0.0 0.0 321.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.2 0.7 2.1 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.0 164.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 8.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 15.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 1.0 0.0 0.9 0.0 0.9 0.9 0.1 0.3 0.6 2.1 0.6 0.7 0.0 0.2 0.0 0.1 VWA8 KIAA0564 ENSG00000102763 "Von Willebrand factor A domain containing 8" A3KMH1 13 41566837-41961120 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039075, HPA045478" Uncertain Approved "Vesicles,Lipid droplets" "Vesicles, Lipid droplets" "HPA039075: , HPA045478: " "unprognostic (9.93e-2)" "unprognostic (4.12e-2)" "unprognostic (2.11e-1)" "unprognostic (2.57e-3)" "unprognostic (4.14e-2)" "unprognostic (1.50e-2)" "prognostic favourable (8.56e-4)" "unprognostic (1.03e-1)" "unprognostic (3.01e-2)" "unprognostic (3.31e-3)" "unprognostic (5.35e-2)" "unprognostic (2.44e-1)" "prognostic favourable (6.38e-14)" "unprognostic (1.84e-2)" "unprognostic (3.07e-2)" "unprognostic (2.12e-1)" "unprognostic (3.26e-1)" 10.1 15.1 7.1 14.1 9.7 6.3 11.0 11.4 10.5 12.2 10.0 8.2 10.4 8.7 14.9 10.7 9.1 8.3 12.1 16.0 6.7 7.9 21.8 25.8 6.8 8.3 8.8 6.0 9.5 11.1 17.2 16.3 6.4 9.8 8.6 9.6 15.1 15.2 8.7 31.4 7.3 11.1 11.9 6.9 6.9 8.9 5.5 5.6 17.5 9.0 16.4 11.8 11.7 6.9 2.5 2.5 1.8 1.5 4.1 4.9 2.4 4.0 5.9 6.1 8.4 5.8 8.4 5.7 6.5 9.5 5.9 4.7 7.8 6.5 10.8 4.4 5.6 14.5 5.6 15.7 7.4 12.2 10.1 10.1 5.7 9.8 6.2 13.3 1.4 9.8 9.8 5.6 13.5 5.8 9.7 7.7 5.2 5.4 7.5 6.8 9.1 5.7 0.0 3.8 11.2 15.8 14.6 3.8 8.2 8.1 12.7 8.9 5.3 10.2 5.3 4.4 4.7 5.7 6.1 8.0 7.5 16.9 4.9 6.5 5.8 1.8 1.1 0.2 3.4 1.1 4.9 2.3 2.0 2.9 2.5 2.5 2.7 3.5 0.7 4.1 1.5 1.5 1.1 2.4 7.1 9.7 11.4 10.5 6.7 7.9 8.8 6.0 9.8 5.6 VWCE "FLJ32009, URG11, VWC1" ENSG00000167992 "Von Willebrand factor C and EGF domains" Q96DN2 11 61258286-61295424 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 19.8;ovary: 10.7" "Cell line enhanced" "Detected in some" "CACO-2: 5.6;Hep G2: 18.9;HSkMC: 11.1;REH: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA040401, HPA043921" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" 1300000 Nucleoplasm "Vesicles, Cytosol" "HPA040401: , HPA043921: " "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (1.15e-1)" "unprognostic (3.96e-3)" "unprognostic (9.27e-4)" "unprognostic (1.21e-2)" "unprognostic (4.01e-4)" "unprognostic (3.04e-2)" "unprognostic (3.42e-2)" "unprognostic (6.58e-4)" "unprognostic (7.20e-2)" "unprognostic (3.01e-1)" "unprognostic (1.25e-2)" "unprognostic (1.92e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-1)" 2.9 1.1 0.9 0.6 1.3 2.3 3.1 0.7 1.3 2.8 1.0 1.4 3.4 0.5 1.4 2.9 1.5 5.7 1.4 1.0 1.3 1.2 0.6 19.8 0.8 0.3 0.4 1.1 10.7 0.1 0.5 0.5 9.1 0.3 1.8 0.6 1.3 1.7 1.0 1.9 0.9 1.1 1.2 0.2 0.9 0.3 1.8 0.5 6.5 0.8 1.0 1.0 1.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.2 1.1 0.4 0.2 1.7 0.0 0.2 5.6 0.0 0.3 0.0 0.4 0.0 2.0 0.0 0.1 0.4 0.0 0.5 0.0 18.9 1.0 0.0 0.1 11.1 0.5 0.5 0.0 1.7 0.2 0.3 0.3 0.0 4.1 0.0 1.6 0.0 10.6 0.1 0.0 0.1 0.1 0.4 0.8 0.0 0.1 0.5 0.7 0.0 0.4 0.2 0.3 0.5 0.1 0.2 0.4 0.9 0.8 0.2 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.7 1.3 1.3 1.2 0.4 1.1 0.3 0.5 WASHC1 "FAM39E, FLJ00038, WASH1" ENSG00000181404 "WASH complex subunit 1" A8K0Z3 9 14521-73865 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002689 Uncertain Supported Vesicles Vesicles "HPA002689: AB_1078803" "unprognostic (9.43e-2)" "unprognostic (1.62e-2)" "unprognostic (3.16e-2)" "unprognostic (1.30e-1)" "unprognostic (1.43e-1)" "unprognostic (2.33e-2)" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (5.00e-1)" "unprognostic (5.40e-3)" "unprognostic (3.37e-3)" "unprognostic (6.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.88e-1)" "unprognostic (3.38e-1)" "unprognostic (2.31e-2)" "unprognostic (1.02e-1)" 1.7 1.5 0.8 2.4 0.4 0.5 0.4 1.1 1.9 4.1 5.4 3.3 3.3 1.2 2.5 1.5 0.0 1.4 2.1 2.5 0.8 0.0 0.6 3.2 0.0 1.2 5.0 4.2 3.7 1.3 3.8 2.1 1.3 0.3 0.3 0.3 0.2 3.5 5.7 4.9 8.7 5.0 5.0 3.4 11.5 7.0 4.3 9.0 7.5 5.1 10.7 10.8 9.7 5.9 5.0 6.7 7.1 4.8 5.8 4.1 14.3 6.3 4.9 2.3 4.9 11.7 4.7 5.1 7.0 4.2 9.3 8.5 3.8 3.7 3.0 4.1 1.8 10.3 18.2 1.8 3.4 9.6 7.7 7.9 14.8 6.5 5.8 6.0 4.4 8.2 4.9 13.2 5.8 13.2 7.0 7.4 9.0 7.1 8.0 8.3 3.5 9.2 8.3 6.4 3.7 7.5 10.1 7.4 2.4 5.9 4.9 5.0 6.2 3.9 3.5 4.0 4.1 5.7 3.3 4.2 3.4 3.6 5.0 8.7 5.1 4.2 3.4 WASHC2A "bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824" ENSG00000099290 "WASH complex subunit 2A" Q641Q2 10 50067888-50133506 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol Vesicles "Nucleoli, Cytosol" "HPA047844: , HPA060975: , HPA061022: " "unprognostic (2.46e-1)" "unprognostic (1.11e-3)" "unprognostic (8.82e-2)" "unprognostic (3.28e-1)" "unprognostic (2.75e-1)" "unprognostic (6.51e-3)" "prognostic unfavourable (6.75e-5)" "unprognostic (4.60e-2)" "unprognostic (2.85e-2)" "unprognostic (2.37e-2)" "unprognostic (9.04e-2)" "unprognostic (2.73e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (4.40e-2)" 24.0 21.0 15.8 31.4 19.3 24.7 27.1 22.5 18.3 19.1 21.2 16.2 12.6 19.4 22.8 15.3 15.7 15.5 14.4 42.9 17.6 13.9 26.1 12.1 20.7 20.2 15.3 15.8 22.5 14.0 21.2 27.0 17.7 22.0 16.7 23.0 13.1 17.5 16.5 15.5 19.2 21.3 16.8 14.6 27.4 16.2 9.4 14.8 27.0 21.4 9.8 20.2 18.4 27.4 6.6 9.0 11.7 13.9 9.0 12.5 8.8 10.9 5.3 9.1 10.6 37.1 20.8 7.4 12.9 27.4 19.2 20.6 12.4 16.5 9.7 8.1 19.2 12.0 13.1 10.9 19.0 9.2 9.5 6.9 10.7 12.4 25.9 11.7 12.0 21.3 13.7 21.0 13.3 14.5 11.2 9.8 23.1 7.8 6.4 19.2 7.4 25.2 9.8 13.2 5.7 13.2 12.7 3.1 9.8 12.0 11.2 17.2 13.8 8.1 21.3 9.8 8.3 27.8 10.6 10.1 20.1 8.3 21.6 21.6 3.9 1.2 10.7 11.7 12.0 13.9 12.5 6.6 10.2 11.0 9.0 6.5 10.2 7.4 5.1 9.0 8.2 5.3 10.4 8.8 15.8 19.3 22.5 18.3 17.6 13.9 15.3 15.8 22.0 14.8 WASHC2C "Em:AC012044.3, FAM21C, KIAA0592" ENSG00000172661 "WASH complex subunit 2C" Q9Y4E1 10 45727200-45792961 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol Vesicles "Nucleoli, Cytosol" "HPA047844: , HPA060975: , HPA061022: " "unprognostic (7.50e-2)" "unprognostic (2.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-2)" "unprognostic (5.98e-3)" "prognostic unfavourable (1.35e-5)" "prognostic favourable (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.00e-3)" "unprognostic (1.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-2)" 17.2 15.8 10.0 33.6 15.7 30.1 27.2 24.9 17.1 16.7 15.8 10.7 15.9 12.2 18.3 17.0 12.3 13.2 13.6 23.2 14.2 10.2 20.6 12.8 17.3 14.8 16.0 8.4 20.2 10.1 22.7 16.5 13.4 16.2 13.4 18.5 13.0 15.3 24.0 17.1 14.8 17.0 15.8 14.0 15.5 12.5 10.1 15.3 19.4 14.9 13.2 14.6 19.3 14.8 10.7 11.4 17.2 20.3 12.2 13.4 11.6 11.1 12.0 9.8 11.1 25.5 22.6 5.9 13.1 21.6 15.5 14.9 7.3 10.9 9.2 8.9 19.3 10.1 10.9 6.0 15.6 8.5 9.1 9.5 14.9 5.6 27.1 9.5 11.8 21.3 14.6 16.8 12.6 15.9 15.1 7.3 19.0 5.8 6.3 16.4 7.1 1.8 7.9 14.4 4.7 11.5 17.5 4.8 10.8 15.2 7.7 18.4 10.4 9.6 26.7 8.1 8.7 21.3 8.7 10.3 15.9 9.1 11.4 22.9 4.3 12.5 16.9 11.0 13.0 18.2 12.5 10.7 10.8 13.4 11.4 9.6 10.8 9.7 17.2 12.2 20.3 8.4 10.1 11.6 10.0 15.7 24.9 17.1 14.2 10.2 16.0 8.4 16.2 15.3 WASHC3 "CCDC53, CGI-116" ENSG00000120860 "WASH complex subunit 3" Q9Y3C0 12 102012927-102062149 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038339 Uncertain Approved Vesicles Vesicles "HPA038339: " "unprognostic (4.25e-2)" "unprognostic (1.61e-2)" "unprognostic (2.28e-1)" "unprognostic (3.45e-3)" "unprognostic (1.21e-2)" "unprognostic (2.42e-1)" "unprognostic (2.11e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.63e-2)" "unprognostic (7.54e-2)" "unprognostic (4.98e-2)" "unprognostic (7.81e-2)" "unprognostic (7.41e-2)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (1.08e-1)" 15.1 22.4 25.3 11.1 24.2 8.4 18.4 11.1 22.0 19.8 17.3 18.6 17.5 10.0 20.5 27.9 17.2 13.5 14.8 23.7 23.3 24.2 29.0 29.1 14.4 13.9 24.6 18.9 13.9 10.3 25.1 22.5 14.7 22.5 19.4 16.6 15.3 13.2 26.9 17.8 12.3 12.3 23.1 27.6 13.6 15.4 61.7 20.0 17.2 18.8 19.3 19.5 17.1 13.9 25.3 22.5 40.2 26.0 21.5 44.5 19.8 6.1 8.4 7.6 4.5 27.2 35.7 7.2 8.6 16.9 12.9 13.9 7.6 5.7 6.6 6.2 18.7 11.1 8.1 20.7 16.7 15.8 4.8 9.2 6.3 10.3 25.3 7.4 5.3 20.8 28.1 16.6 16.7 17.3 5.3 6.8 33.0 8.2 7.8 13.8 2.2 15.4 4.2 10.9 9.6 21.2 10.2 7.1 3.9 11.6 7.9 17.4 10.1 4.8 8.2 14.7 3.7 8.0 6.0 17.2 11.0 8.0 20.4 5.6 6.1 40.2 17.0 35.8 16.0 25.4 18.4 25.3 23.5 20.5 22.5 21.7 17.7 20.6 7.1 21.5 26.0 21.6 44.5 19.8 25.3 24.2 11.1 22.0 23.3 24.2 24.6 18.9 22.5 20.0 WBP4 "FBP21, MGC117310" ENSG00000120688 "WW domain binding protein 4" O75554 13 41061274-41084006 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038965, HPA058738" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" Nucleoplasm "Vesicles, Plasma membrane" "HPA038965: AB_10672836, HPA058738: " "unprognostic (2.56e-1)" "unprognostic (3.69e-3)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (9.30e-2)" "unprognostic (1.76e-3)" "unprognostic (1.54e-2)" "unprognostic (2.13e-2)" "unprognostic (1.34e-2)" "unprognostic (2.05e-2)" "unprognostic (3.71e-3)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "unprognostic (8.52e-2)" "unprognostic (7.65e-3)" "prognostic favourable (2.89e-4)" "unprognostic (2.52e-1)" 14.0 14.2 17.2 7.9 22.1 11.4 11.5 15.8 17.2 12.0 10.7 8.6 8.9 9.6 16.6 14.1 10.9 10.1 8.0 18.8 14.7 15.8 10.5 13.4 8.7 9.0 14.7 19.0 11.8 7.5 8.8 11.3 15.9 15.9 12.5 8.0 4.8 7.2 13.2 76.2 9.4 9.6 14.7 15.0 7.9 8.1 10.0 12.8 12.7 9.6 12.6 9.3 13.3 11.1 10.9 15.2 22.7 16.2 9.7 12.9 5.0 8.8 5.9 16.5 10.6 10.8 16.5 10.1 20.2 14.3 15.9 12.3 9.3 9.5 12.7 8.1 14.1 12.6 6.2 10.0 20.5 13.1 8.7 17.9 5.7 9.4 16.6 11.1 11.7 13.5 15.4 11.6 16.5 13.4 9.5 5.6 16.6 7.5 16.0 12.2 10.0 4.9 15.0 10.2 5.0 14.5 8.8 3.8 9.1 6.4 7.0 9.5 5.7 17.5 11.7 10.0 9.2 13.7 11.6 3.7 4.1 8.9 12.3 8.2 13.6 13.0 11.0 9.7 9.3 9.6 8.5 10.9 11.8 9.9 8.9 10.6 12.9 12.6 22.7 9.7 16.2 15.2 11.3 5.0 17.2 22.1 15.8 17.2 14.7 15.8 14.7 19.0 15.9 12.8 WDR24 "C16orf21, DKFZp434F054, JFP7" ENSG00000127580 "WD repeat domain 24" Q96S15 16 684622-690444 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039506 Approved Supported Vesicles,Cytosol Vesicles Cytosol "HPA039506: AB_10795148" "unprognostic (9.07e-2)" "unprognostic (2.67e-3)" "unprognostic (6.67e-2)" "unprognostic (1.48e-1)" "unprognostic (1.67e-1)" "unprognostic (8.15e-2)" "unprognostic (7.05e-2)" "unprognostic (4.35e-2)" "unprognostic (1.75e-1)" "unprognostic (5.09e-3)" "unprognostic (2.29e-3)" "unprognostic (2.05e-1)" "prognostic favourable (3.75e-6)" "unprognostic (5.38e-2)" "unprognostic (3.16e-1)" "unprognostic (1.52e-1)" "unprognostic (2.82e-2)" 8.8 11.6 10.9 9.8 11.3 9.3 9.2 18.9 17.6 7.6 7.8 8.2 6.5 12.1 10.2 10.2 9.4 9.3 8.5 9.9 9.5 7.8 9.0 15.7 15.3 17.7 8.7 11.1 12.8 14.5 17.0 11.9 9.2 8.8 10.3 3.6 8.8 16.2 8.8 16.9 13.5 10.2 10.0 10.6 13.3 10.5 17.6 9.5 17.9 11.8 7.9 6.5 9.2 7.8 7.1 7.7 6.5 10.3 4.3 10.7 7.1 4.4 10.3 4.8 6.6 4.6 3.3 8.4 5.6 5.0 7.0 6.1 11.2 6.6 6.9 9.8 2.5 7.0 4.6 5.5 1.5 11.6 14.6 4.7 13.8 4.3 7.3 5.7 7.4 5.7 3.7 5.0 4.2 3.8 9.2 7.8 2.6 16.3 10.0 4.2 7.3 8.1 14.9 3.9 12.7 2.3 3.1 11.9 5.4 6.3 11.0 6.2 10.0 5.8 5.6 5.2 5.4 5.6 5.4 16.8 15.2 11.3 3.3 5.7 7.1 6.5 7.5 4.0 10.7 4.5 8.7 7.1 6.9 7.8 7.7 6.4 8.2 7.7 1.8 4.3 10.3 6.2 8.9 7.1 10.9 11.3 18.9 17.6 9.5 7.8 8.7 11.1 8.8 9.5 WDR48 "KIAA1449, P80, SPG60" ENSG00000114742 "WD repeat domain 48" Q8TAF3 3 39051998-39096671 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038421, HPA058015" Approved Supported Vesicles Vesicles "HPA038421: AB_10670780, HPA058015: AB_2683580" "unprognostic (1.95e-1)" "unprognostic (2.14e-1)" "unprognostic (2.99e-2)" "unprognostic (3.78e-1)" "unprognostic (7.68e-2)" "unprognostic (2.34e-3)" "unprognostic (6.14e-3)" "unprognostic (9.87e-3)" "unprognostic (8.02e-2)" "unprognostic (2.22e-2)" "unprognostic (2.28e-1)" "unprognostic (2.14e-2)" "prognostic favourable (1.63e-7)" "unprognostic (2.41e-1)" "unprognostic (2.94e-2)" "unprognostic (1.43e-1)" "unprognostic (1.69e-2)" 16.0 15.0 16.3 9.2 22.0 22.3 13.9 22.3 24.2 15.4 14.0 15.4 19.0 10.1 19.9 9.1 11.9 14.1 10.5 11.8 16.4 14.0 16.5 11.9 10.5 12.1 17.3 16.3 17.0 12.1 21.1 20.2 16.0 20.4 14.5 12.4 9.4 14.0 17.4 14.7 11.3 12.0 14.4 17.4 10.9 11.9 36.8 18.0 21.9 20.4 7.0 15.2 22.6 11.9 12.2 10.1 16.7 12.8 14.9 13.2 9.7 4.8 7.9 16.9 9.8 11.2 13.2 6.4 7.5 10.4 9.8 12.2 5.5 5.3 14.5 4.5 10.0 5.8 15.1 9.6 10.4 35.1 17.4 13.0 11.9 7.3 4.5 9.6 5.8 8.7 8.8 11.0 11.6 10.5 14.7 12.5 7.0 4.4 9.9 3.6 15.6 9.8 4.1 8.6 9.9 8.4 11.2 11.7 13.3 6.4 11.9 9.2 6.8 9.6 9.0 7.4 5.3 7.2 7.1 12.7 21.9 10.5 8.0 7.2 6.5 16.7 6.6 7.2 11.2 9.6 10.5 10.9 11.5 12.4 10.1 12.2 12.4 10.7 9.3 14.9 12.8 6.7 13.2 9.7 16.3 22.0 22.3 24.2 16.4 14.0 17.3 16.3 20.4 18.0 WDR54 FLJ12953 ENSG00000005448 "WD repeat domain 54" Q9H977 2 74421678-74425755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 56.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043257, HPA053558" Enhanced Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA043257: AB_10795981, HPA053558: AB_2682189" "unprognostic (1.12e-1)" "unprognostic (3.68e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (2.62e-1)" "unprognostic (3.06e-3)" "unprognostic (4.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.68e-2)" "unprognostic (1.51e-1)" "unprognostic (7.25e-3)" "unprognostic (3.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.19e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.85e-2)" 4.8 6.3 9.4 5.4 17.0 5.0 4.8 8.4 15.4 7.0 3.9 6.0 10.5 3.0 7.0 7.8 3.1 56.8 7.2 3.4 9.9 11.6 7.9 1.4 8.1 8.6 4.8 13.0 8.4 5.4 21.3 16.0 5.4 7.8 5.0 3.7 10.5 3.9 9.0 1.5 3.5 3.9 6.8 3.5 7.7 5.7 27.6 3.7 20.6 5.8 2.5 8.9 6.2 4.0 12.6 23.1 2.3 5.3 13.2 18.7 10.0 15.9 29.6 14.5 12.6 5.3 9.9 4.5 8.1 16.8 21.5 19.9 2.5 12.6 14.2 8.5 9.1 13.7 10.2 36.5 18.8 10.7 6.3 6.9 16.3 1.6 5.4 10.9 5.7 4.4 10.4 21.7 11.3 11.1 2.8 16.8 11.8 24.7 17.2 11.5 11.1 11.2 14.8 16.4 29.7 18.8 8.0 25.3 19.7 6.4 5.8 9.4 9.4 5.2 5.5 11.0 19.4 11.8 18.1 18.4 9.2 3.6 32.5 6.7 8.0 2.3 4.2 0.3 16.2 5.3 16.3 12.6 18.7 17.4 14.1 11.1 13.2 12.8 0.3 13.2 4.5 23.1 17.5 10.0 9.4 17.0 8.4 15.4 9.9 11.6 4.8 13.0 7.8 3.7 WDR72 FLJ38736 ENSG00000166415 "WD repeat domain 72" Q3MJ13 15 53513741-53762878 "Disease related genes, Predicted intracellular proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 64.1;thyroid gland: 36.3" "Cell line enhanced" "Detected in some" "A549: 9.3;EFO-21: 6.1;NTERA-2: 5.6;RPMI-8226: 15.8;RPTEC TERT1: 10.3;U-266/70: 7.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048212, HPA057410, HPA059819" Uncertain Approved Vesicles Vesicles "HPA048212: , HPA057410: , HPA059819: " "unprognostic (6.39e-4)" "unprognostic (1.41e-1)" "unprognostic (3.19e-2)" "unprognostic (1.79e-2)" "unprognostic (2.63e-2)" "unprognostic (3.37e-2)" "unprognostic (5.54e-2)" "unprognostic (2.20e-1)" "unprognostic (1.13e-1)" "unprognostic (1.26e-1)" "unprognostic (2.78e-2)" "unprognostic (1.09e-2)" "prognostic favourable (3.33e-16)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "prognostic unfavourable (1.80e-4)" "unprognostic (7.67e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.7 0.2 0.1 3.0 0.8 0.6 4.9 0.3 0.8 4.6 0.2 0.1 0.1 64.1 13.1 0.8 0.1 0.1 0.1 0.5 1.3 1.5 0.9 0.8 0.1 0.2 0.1 0.3 11.2 0.4 0.1 1.1 0.6 0.1 0.1 0.1 0.2 1.1 0.1 0.1 36.3 0.4 0.5 0.6 0.1 0.2 0.0 0.1 0.0 0.2 0.8 0.1 0.0 9.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 3.0 0.1 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.1 15.8 10.3 3.3 1.8 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.3 0.5 0.0 0.1 7.3 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.2 0.3 0.5 0.0 0.1 0.3 0.2 0.0 0.2 0.0 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 WDR83 MORG1 ENSG00000123154 "WD repeat domain 83" Q9BRX9 19 12666800-12675832 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042629, HPA042838" Uncertain Approved Nucleoplasm,Vesicles,Centrosome Vesicles "Nucleoplasm, Centrosome" "HPA042629: AB_10794763, HPA042838: AB_10794173" "unprognostic (1.12e-2)" "unprognostic (3.15e-3)" "unprognostic (1.43e-3)" "unprognostic (1.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (3.60e-3)" "unprognostic (2.52e-1)" "unprognostic (1.56e-2)" "prognostic favourable (5.44e-4)" "unprognostic (1.30e-2)" "unprognostic (4.07e-2)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "prognostic favourable (3.12e-4)" 6.4 7.8 10.2 6.2 9.1 8.8 6.5 17.2 14.5 7.1 5.2 9.1 2.3 4.9 5.8 6.1 5.9 11.3 5.2 9.2 8.5 8.9 8.1 5.9 6.0 8.3 12.4 11.6 9.2 11.6 9.4 6.7 4.9 9.1 6.9 2.6 7.7 14.6 6.9 4.6 11.3 6.3 3.8 7.0 7.4 7.1 9.2 10.6 11.7 9.2 2.6 5.8 6.0 5.7 8.8 19.4 5.4 11.1 17.6 11.3 8.6 5.0 8.4 4.8 6.6 9.5 3.5 3.9 4.8 4.5 5.8 6.1 9.8 4.4 7.6 7.0 4.3 5.7 5.6 7.4 1.1 7.7 12.3 6.0 5.6 6.1 7.5 8.3 7.1 6.5 6.0 4.7 3.8 5.8 5.3 0.8 2.6 19.1 12.1 6.8 3.8 14.6 8.6 6.2 7.1 5.5 5.9 10.0 6.7 5.2 7.1 4.2 4.0 8.2 3.1 6.5 2.0 5.1 5.0 19.4 13.0 3.4 10.2 6.4 4.2 4.5 11.1 4.6 9.2 9.6 10.7 8.1 8.9 8.6 11.1 8.8 8.7 11.3 5.4 17.6 4.7 19.4 9.8 8.6 10.2 9.1 17.2 14.5 8.5 8.9 12.4 11.6 9.1 10.6 WDTC1 "ADP, DCAF9, KIAA1037" ENSG00000142784 "WD and tetratricopeptide repeats 1" Q8N5D0 1 27234516-27308633 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028177, HPA028180, HPA028182" Uncertain Supported "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204" "unprognostic (3.18e-2)" "prognostic favourable (4.51e-4)" "unprognostic (5.69e-2)" "unprognostic (8.28e-2)" "unprognostic (3.31e-2)" "unprognostic (2.00e-3)" "unprognostic (1.25e-2)" "unprognostic (9.44e-2)" "unprognostic (2.44e-1)" "unprognostic (5.45e-3)" "unprognostic (1.41e-3)" "unprognostic (1.73e-1)" "prognostic favourable (8.84e-8)" "unprognostic (1.28e-1)" "unprognostic (9.33e-2)" "unprognostic (3.01e-2)" "unprognostic (2.51e-2)" 14.7 17.5 20.2 11.1 22.0 13.2 12.1 21.8 28.4 15.0 15.3 20.7 14.1 13.3 14.5 9.1 12.4 21.1 11.0 29.1 18.0 15.0 13.6 13.0 14.3 13.3 15.8 16.1 15.8 22.3 49.3 12.3 10.9 19.7 14.3 10.1 29.6 20.6 16.5 51.1 20.9 14.2 12.8 15.1 13.2 15.2 28.3 16.5 21.0 19.4 12.1 14.0 15.0 12.3 1.3 1.5 5.6 0.8 0.8 3.3 1.2 13.0 5.7 9.3 0.9 13.3 11.1 3.9 8.1 13.6 8.7 10.6 1.9 13.1 11.0 9.8 16.0 6.8 8.7 12.3 7.5 15.3 14.9 11.5 6.5 5.2 12.0 5.9 15.6 10.5 20.1 10.8 9.9 11.8 11.7 11.9 9.1 7.2 9.6 14.4 4.4 12.4 4.8 6.9 12.3 10.2 2.9 13.7 11.8 10.5 4.5 9.5 6.7 10.4 10.0 7.1 4.4 10.0 3.9 17.2 9.2 5.4 14.6 11.4 8.5 0.3 0.5 5.6 3.3 0.8 1.3 1.3 0.8 1.4 1.5 0.8 0.6 1.5 4.8 0.8 0.6 1.0 0.9 1.2 20.2 22.0 21.8 28.4 18.0 15.0 15.8 16.1 19.7 16.5 WDYHV1 "C8orf32, FLJ10204" ENSG00000156795 "WDYHV motif containing 1" Q96HA8 8 123416725-123467230 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024823, HPA053680" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA024823: AB_1845773, HPA053680: " "unprognostic (9.97e-2)" "unprognostic (4.82e-2)" "unprognostic (3.48e-1)" "prognostic unfavourable (4.93e-5)" "unprognostic (1.69e-1)" "unprognostic (5.00e-2)" "prognostic unfavourable (3.47e-4)" "unprognostic (1.93e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (1.19e-1)" "unprognostic (5.79e-2)" "unprognostic (2.81e-2)" "unprognostic (1.26e-1)" "unprognostic (5.39e-2)" "unprognostic (7.46e-2)" "unprognostic (2.37e-1)" 10.5 15.5 13.2 7.9 13.6 6.3 17.2 14.3 16.8 14.5 9.9 13.9 10.7 5.8 11.2 12.0 10.2 9.8 8.8 24.8 12.8 19.8 13.6 9.1 8.6 11.4 17.0 10.8 20.4 21.3 9.0 12.8 8.2 16.2 13.5 9.5 9.7 8.3 12.5 19.2 9.8 5.4 13.0 17.0 7.9 10.0 17.5 15.6 5.3 14.4 9.1 11.3 10.1 9.1 5.9 7.2 8.7 7.5 13.1 9.2 5.5 9.1 10.8 12.7 6.7 5.5 12.6 5.7 7.6 6.7 7.2 9.2 6.4 6.1 7.3 6.9 5.3 5.3 8.1 8.8 9.7 17.2 7.1 7.9 5.2 8.7 7.8 3.0 3.4 8.5 5.4 9.6 11.8 7.2 5.9 10.1 10.6 28.6 8.8 6.2 5.1 7.4 5.1 8.0 5.8 9.7 8.1 6.5 14.1 7.8 39.8 12.1 6.6 3.3 3.9 9.6 15.1 7.1 9.2 7.6 15.4 9.0 7.8 4.6 6.0 8.7 6.3 2.5 7.8 7.5 8.4 5.2 8.4 7.3 7.2 5.9 6.5 7.4 1.8 13.1 4.0 4.6 9.2 5.5 13.2 13.6 14.3 16.8 12.8 19.8 17.0 10.8 16.2 15.6 WNK3 PRKWNK3 ENSG00000196632 "WNK lysine deficient protein kinase 3" Q9BYP7 X 54192823-54358642 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 31.6;testis: 26.7" "Cell line enhanced" "Detected in some" "AF22: 5.8;AN3-CA: 4.4;HAP1: 6.7;NTERA-2: 11.9;SiHa: 5.8;U-2 OS: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.9" "Group enriched" "Detected in many" 10 "B-cells: 1.1;T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077678 Approved Approved Vesicles Vesicles "HPA077678: " "unprognostic (1.86e-1)" "unprognostic (1.68e-3)" "unprognostic (2.44e-1)" "unprognostic (7.87e-5)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (1.85e-2)" "unprognostic (3.32e-2)" "unprognostic (3.38e-1)" "unprognostic (3.03e-2)" "unprognostic (5.78e-4)" "unprognostic (2.22e-1)" "unprognostic (2.64e-2)" "unprognostic (5.61e-2)" "unprognostic (9.99e-2)" "unprognostic (7.63e-2)" "unprognostic (8.74e-2)" 0.9 5.0 3.9 0.9 4.3 0.8 1.7 3.0 3.6 1.5 0.7 1.7 13.9 1.0 1.3 31.6 1.1 1.8 1.1 1.5 3.9 3.4 2.8 8.7 0.9 1.0 2.3 3.0 5.7 0.9 2.2 14.0 1.2 3.9 2.2 0.7 1.3 1.2 4.8 0.7 0.9 0.7 1.5 3.3 1.0 1.2 26.7 3.5 0.0 1.7 0.0 0.8 1.3 1.9 1.1 0.0 0.1 0.0 0.1 1.9 0.1 0.0 0.0 5.8 4.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.7 0.1 0.2 0.0 1.2 0.0 0.0 0.1 0.2 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.9 0.0 2.8 0.8 0.0 1.1 0.2 1.9 1.8 5.8 0.0 0.7 0.5 0.0 0.3 0.0 5.2 0.0 1.2 0.0 4.0 0.0 1.6 0.0 2.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 1.1 1.9 0.4 0.1 0.1 0.0 0.0 0.0 0.1 3.9 4.3 3.0 3.6 3.9 3.4 2.3 3.0 3.9 3.5 WNT2 "INT1L1, IRP" ENSG00000105989 "Wnt family member 2" P09544 7 117276631-117323289 "Cancer-related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 10.4;lung: 10.9;placenta: 40.9" "Cell line enriched" "Detected in some" 5 "U-2197: 21.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 12.6" "Low region specificity" "Detected in all" HPA020920 Approved Vesicles "Secreted to extracellular matrix" Vesicles "HPA020920: AB_1858850" "unprognostic (1.90e-1)" "unprognostic (6.97e-2)" "unprognostic (2.88e-2)" "unprognostic (4.11e-3)" "unprognostic (9.14e-2)" "unprognostic (2.47e-1)" "unprognostic (2.54e-2)" "unprognostic (2.75e-1)" "unprognostic (2.74e-1)" "unprognostic (5.70e-2)" "unprognostic (1.36e-2)" "unprognostic (1.41e-1)" "unprognostic (3.43e-1)" "unprognostic (4.05e-2)" "unprognostic (2.50e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-1)" 1.8 0.0 0.2 0.1 1.1 0.0 1.4 0.3 2.3 3.0 0.2 0.4 0.4 0.0 10.4 2.7 0.4 1.0 0.2 0.7 0.9 0.9 0.3 0.8 10.9 0.0 0.1 0.5 0.8 0.1 0.0 0.2 40.9 0.5 7.6 0.0 0.9 0.1 0.5 0.0 1.1 0.2 1.2 0.2 1.5 0.1 0.7 0.0 0.0 0.2 0.0 0.1 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.4 2.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.3 2.3 0.9 0.9 0.1 0.5 0.5 0.0 WNT2B "WNT13, XWNT2" ENSG00000134245 "Wnt family member 2B" Q93097 1 112466541-112530165 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 66.7" "Cell line enhanced" "Detected in many" "ASC TERT1: 6.8;HSkMC: 12.9;TIME: 5.2" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047274, HPA066368" Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" Vesicles Nucleoplasm "HPA047274: , HPA066368: " "unprognostic (2.08e-3)" "unprognostic (2.06e-3)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (9.42e-2)" "unprognostic (4.90e-3)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (5.94e-2)" "unprognostic (1.13e-1)" "unprognostic (5.65e-4)" "unprognostic (5.41e-2)" "unprognostic (7.64e-2)" "unprognostic (4.80e-2)" "unprognostic (2.49e-2)" 3.4 1.9 1.7 3.4 4.6 0.2 2.1 2.6 2.9 9.2 12.0 0.8 3.7 3.9 7.5 5.4 7.6 4.4 8.0 3.6 1.6 1.7 1.8 0.5 5.2 0.9 2.0 2.4 28.7 2.0 1.2 1.9 6.0 1.5 7.3 6.8 66.7 1.7 18.3 1.3 13.4 9.1 12.9 3.0 1.2 4.4 16.2 0.8 0.5 1.4 5.6 1.9 10.3 8.5 2.3 1.2 1.7 0.7 0.8 1.2 0.1 0.7 0.4 3.4 0.8 3.4 6.8 0.6 1.4 1.5 0.4 0.6 0.3 0.7 1.8 0.3 1.6 2.1 1.1 0.5 0.3 0.1 0.7 0.2 1.1 0.5 2.9 0.2 0.8 12.9 1.2 0.6 0.2 1.7 0.2 0.3 0.4 0.5 0.1 0.2 0.6 0.5 0.1 0.5 0.0 2.3 0.4 0.5 0.5 1.3 0.2 1.1 0.1 0.4 5.2 0.5 2.0 1.2 0.4 0.2 0.1 0.0 1.4 0.2 1.3 0.9 0.7 1.0 0.9 0.3 0.8 1.4 1.2 1.0 0.3 2.3 0.4 0.7 1.7 0.8 0.5 1.2 0.4 0.1 1.7 4.6 2.6 2.9 1.6 1.7 2.0 2.4 1.5 0.8 WNT3 "INT4, MGC131950, MGC138321, MGC138323" ENSG00000108379 "Wnt family member 3" P56703 17 46762506-46833154 "Disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 7.8;skin 1: 17.2" "Cell line enhanced" "Detected in many" "AF22: 10.1;U-698: 11.1" "Cancer enriched" "Detected in many" 6 "testis cancer: 13.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066281 Approved Vesicles "Secreted to extracellular matrix" Vesicles "HPA066281: " "unprognostic (1.84e-1)" "unprognostic (2.90e-2)" "unprognostic (2.35e-1)" "unprognostic (6.41e-4)" "unprognostic (4.73e-2)" "unprognostic (5.26e-2)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (4.97e-2)" "unprognostic (2.20e-2)" "unprognostic (2.16e-1)" "unprognostic (2.66e-1)" "unprognostic (1.10e-8)" "unprognostic (1.77e-1)" "unprognostic (2.08e-1)" "unprognostic (1.61e-1)" "unprognostic (1.38e-1)" 0.5 0.6 1.0 0.6 3.9 0.4 0.4 1.4 4.7 0.2 0.2 3.8 0.1 4.7 0.3 0.4 0.6 0.4 0.4 0.6 1.4 2.9 0.6 7.8 0.3 2.9 2.1 3.5 0.6 0.3 6.0 0.9 0.7 4.1 0.8 0.6 0.1 1.2 0.3 0.5 17.2 1.4 0.5 1.6 0.5 0.4 2.4 2.3 0.1 0.6 1.4 0.5 0.2 0.3 1.0 1.4 0.2 0.3 0.0 1.2 0.1 2.5 0.0 10.1 0.0 0.0 0.0 0.9 0.8 0.6 1.8 0.0 2.6 2.0 1.9 1.1 0.4 1.2 0.4 0.0 2.2 0.0 0.2 0.0 0.5 2.2 0.0 0.0 0.3 0.0 1.4 0.3 0.6 0.5 1.6 0.0 0.3 0.4 0.0 1.6 0.1 1.1 1.0 1.9 0.1 0.1 0.0 0.2 0.7 1.4 0.0 0.5 0.0 2.4 0.0 3.1 1.3 0.5 0.7 0.3 0.2 11.1 0.5 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.3 1.4 1.2 0.1 1.0 3.9 1.4 4.7 1.4 2.9 2.1 3.5 4.1 2.3 WNT3A ENSG00000154342 "Wnt family member 3A" P56704 1 228007051-228061260 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "lung: 7.4;placenta: 19.9" "Group enriched" "Detected in some" 9 "HEK 293: 2.7;U-2 OS: 9.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066281 Approved Vesicles "Secreted to extracellular matrix" Vesicles "HPA066281: " "unprognostic (9.84e-3)" "prognostic favourable (6.11e-5)" "unprognostic (2.40e-1)" "unprognostic (3.37e-1)" "unprognostic (7.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.19e-1)" "unprognostic (1.96e-1)" "unprognostic (4.22e-2)" "unprognostic (4.12e-2)" "unprognostic (2.16e-1)" "unprognostic (4.80e-3)" "unprognostic (1.99e-1)" "unprognostic (7.26e-2)" "unprognostic (5.43e-3)" "unprognostic (1.54e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.6 0.1 0.1 0.1 0.0 0.1 0.1 2.0 0.2 0.1 0.1 0.1 0.0 0.2 0.1 7.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 19.9 0.1 2.4 0.0 0.1 1.7 0.1 0.1 3.0 0.1 0.1 0.6 0.1 0.0 1.0 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 WNT4 WNT-4 ENSG00000162552 "Wnt family member 4" P56705 1 22117305-22143969 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 34.3;skin 1: 28.6" "Cell line enhanced" "Detected in some" "HaCaT: 10.0;SCLC-21H: 12.2;SK-BR-3: 10.3;T-47d: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "eosinophil: 2.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.8" "Low region specificity" "Detected in many" HPA011397 Uncertain Approved Vesicles "Secreted to extracellular matrix" Vesicles "HPA011397: AB_1858854" "unprognostic (1.85e-1)" "unprognostic (9.08e-2)" "unprognostic (6.67e-3)" "unprognostic (1.75e-2)" "unprognostic (7.17e-2)" "unprognostic (4.30e-3)" "unprognostic (2.77e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (5.34e-4)" "unprognostic (2.14e-2)" "prognostic favourable (4.90e-4)" "unprognostic (1.01e-1)" "unprognostic (2.95e-2)" "unprognostic (4.21e-1)" "unprognostic (2.32e-1)" "unprognostic (4.74e-2)" "unprognostic (9.49e-2)" 0.5 6.5 1.0 0.3 1.0 0.0 1.4 0.6 1.7 4.3 1.7 1.1 1.0 2.0 3.1 6.6 6.9 6.4 6.4 0.6 1.5 3.1 1.1 1.2 1.4 0.3 1.0 1.7 34.3 1.9 0.0 3.7 11.8 1.7 7.7 1.0 1.7 3.0 1.8 2.7 28.6 4.1 1.2 1.5 0.3 2.8 0.9 0.8 1.4 2.2 5.4 2.8 2.0 3.5 0.0 0.0 2.8 0.0 0.0 0.4 0.0 1.5 0.1 3.0 0.1 0.1 0.0 2.7 0.6 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.1 10.0 0.0 0.8 0.0 0.3 0.3 0.3 0.3 0.0 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 1.8 12.2 0.0 0.1 10.3 0.7 4.1 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.6 1.7 1.5 3.1 1.0 1.7 1.7 0.8 WNT5B ENSG00000111186 "Wnt family member 5B" Q9H1J7 12 1529891-1647243 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 51.3;BJ hTERT+: 32.2;BJ hTERT+ SV40 Large T+: 37.6;BJ hTERT+ SV40 Large T+ RasG12V: 31.3;fHDF/TERT166: 35.8;HBF TERT88: 33.1;hTEC/SVTERT24-B: 32.8;U-138 MG: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "classical monocyte: 4.6;eosinophil: 3.5;intermediate monocyte: 2.1;myeloid DC: 2.1" "Group enriched" "Detected in many" 13 "dendritic cells: 2.1;granulocytes: 3.5;monocytes: 4.6" "Low region specificity" "Detected in many" HPA061991 Approved Vesicles "Secreted to extracellular matrix" Vesicles "HPA061991: " "unprognostic (7.44e-2)" "unprognostic (5.59e-2)" "unprognostic (8.14e-2)" "unprognostic (3.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.45e-1)" "unprognostic (5.53e-3)" "unprognostic (1.26e-1)" "unprognostic (1.10e-1)" "unprognostic (3.02e-2)" "unprognostic (4.08e-2)" "unprognostic (2.16e-2)" "unprognostic (1.49e-3)" "unprognostic (1.90e-1)" "unprognostic (2.93e-2)" "unprognostic (2.77e-1)" "unprognostic (2.71e-2)" 4.1 1.7 1.6 6.5 3.4 0.1 4.1 1.0 1.7 8.0 14.1 1.3 19.4 3.0 6.3 6.2 11.9 4.8 3.6 2.9 1.4 3.0 2.7 3.3 2.7 4.0 1.8 0.5 5.3 0.7 13.6 7.1 2.7 2.3 23.4 4.4 5.8 14.2 16.5 0.7 3.4 5.2 17.8 1.4 4.3 4.0 1.7 1.0 2.9 1.2 5.1 5.0 23.3 14.3 0.0 2.1 3.5 4.6 0.0 0.2 1.3 0.0 0.0 0.3 0.0 8.0 14.3 0.0 51.3 32.2 37.6 31.3 1.9 0.2 0.6 0.0 35.8 0.7 0.7 0.0 33.1 11.9 1.7 2.7 0.0 0.0 1.9 0.0 0.0 11.9 0.7 32.8 9.4 0.0 2.0 11.7 8.8 0.0 0.0 0.0 1.3 0.1 0.0 0.5 0.8 0.4 0.0 0.2 0.7 1.0 0.1 0.0 0.0 0.2 0.0 32.6 1.3 12.8 26.1 3.1 0.4 0.1 3.1 0.0 0.3 0.0 4.6 3.5 0.0 2.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 1.3 1.6 3.4 1.0 1.7 1.4 3.0 1.8 0.5 2.3 1.0 XAB2 "HCNP, HCRN, NTC90, SYF1" ENSG00000076924 "XPA binding protein 2" Q9HCS7 19 7619525-7629565 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048751 Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA048751: " "unprognostic (1.13e-1)" "prognostic favourable (4.04e-4)" "unprognostic (1.99e-3)" "prognostic favourable (4.96e-4)" "unprognostic (1.35e-1)" "unprognostic (4.98e-3)" "unprognostic (4.95e-2)" "unprognostic (4.56e-3)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "prognostic favourable (7.47e-4)" "unprognostic (2.69e-1)" "unprognostic (7.43e-3)" "unprognostic (3.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.51e-1)" "unprognostic (1.80e-3)" 13.5 18.4 12.2 13.3 17.8 35.7 17.8 22.9 22.6 16.3 12.1 19.2 12.1 16.3 15.5 12.1 17.8 18.9 12.7 17.5 11.9 10.3 20.1 24.6 13.0 17.0 16.8 11.4 29.6 34.3 11.9 12.2 14.6 13.3 15.2 5.3 13.6 28.7 18.1 18.0 19.5 13.8 13.7 13.4 18.8 22.8 30.2 15.8 24.8 21.4 13.2 15.9 18.6 15.6 15.2 9.0 9.9 14.1 8.9 16.7 13.8 15.4 14.2 8.6 11.2 9.1 6.8 16.8 9.1 10.7 16.2 16.5 18.3 10.2 10.5 18.1 8.4 13.6 12.2 13.2 4.1 18.3 15.7 13.9 12.0 16.0 11.8 18.4 12.6 12.0 11.0 11.4 8.3 9.8 12.4 27.9 5.0 17.1 17.2 28.7 19.6 28.1 19.2 10.9 18.3 6.4 12.2 12.3 14.1 10.3 10.2 8.9 12.9 16.3 9.6 7.4 12.2 16.8 15.3 48.2 28.4 15.2 12.7 15.7 11.0 8.3 12.2 9.9 14.8 11.6 13.6 12.3 13.8 11.0 9.0 15.2 16.7 12.6 7.3 8.9 14.1 7.8 15.8 13.8 12.2 17.8 22.9 22.6 11.9 10.3 16.8 11.4 13.3 15.8 XAGE5 "CT12.5, GAGED5, XAGE-5" ENSG00000171405 "X antigen family member 5" Q8WWM1 X 52812204-52818301 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 6 "testis: 5.1" "Cell line enriched" "Detected in single" 34 "U-2 OS: 22.2" "Cancer enhanced" "Detected in single" "liver cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052507, HPA055941" Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA052507: , HPA055941: " "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XK "Kx, NA, NAC, X1k, XKR1" ENSG00000047597 "X-linked Kx blood group" P51811 X 37685756-37732130 "Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Blood group antigen" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.6" "Cell line enhanced" "Detected in many" "HEL: 24.7;HL-60: 12.7;K-562: 15.9;NB-4: 11.7;RPMI-8226: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 40 "basophil: 9.4;eosinophil: 6.8" "Lineage enriched" "Detected in single" 94 "granulocytes: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019036 Approved Approved Nucleoplasm,Vesicles,Mitochondria Mitochondria "Nucleoplasm, Vesicles" "HPA019036: AB_1846286" "unprognostic (2.37e-2)" "unprognostic (7.13e-3)" "unprognostic (5.03e-2)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "unprognostic (4.56e-1)" "unprognostic (3.59e-2)" "unprognostic (4.00e-2)" "unprognostic (4.77e-3)" "unprognostic (5.07e-2)" "unprognostic (6.63e-2)" "unprognostic (5.90e-2)" "unprognostic (4.44e-8)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" 0.6 2.9 4.9 3.0 5.1 14.0 1.1 10.2 8.3 1.8 16.5 1.2 0.0 12.9 1.2 0.8 2.7 4.8 2.0 8.1 4.7 6.6 1.4 2.1 1.5 0.7 3.0 5.9 1.2 7.9 2.2 3.8 1.4 4.4 2.1 13.8 1.0 8.6 1.5 5.9 1.2 23.6 3.2 1.6 1.2 13.3 3.5 0.2 0.1 1.4 5.9 0.8 2.9 2.5 0.0 0.0 9.4 0.0 0.0 0.0 0.7 9.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 8.2 0.1 0.0 1.5 8.8 0.0 0.0 0.0 2.4 24.7 1.4 0.0 0.0 12.7 2.0 0.0 0.4 0.0 0.0 0.0 15.9 6.3 0.0 0.9 0.1 11.7 3.1 3.2 0.0 0.0 11.2 0.0 0.6 2.3 0.0 0.4 0.8 0.0 1.2 3.1 0.0 0.0 0.4 0.0 1.3 5.4 8.9 0.0 0.1 6.8 0.0 9.4 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 4.9 5.1 10.2 8.3 4.7 6.6 3.0 5.9 4.4 0.2 XKR4 KIAA1889 ENSG00000206579 "XK related 4" Q5GH76 8 55102389-55542054 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.7" "Group enriched" "Detected in some" 11 "REH: 3.6;RPTEC TERT1: 14.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA025072, HPA028083" Uncertain Approved Vesicles Vesicles "HPA025072: AB_1858886, HPA028083: AB_10601025" "unprognostic (7.15e-4)" "unprognostic (1.28e-3)" "unprognostic (6.98e-2)" "unprognostic (5.63e-3)" "unprognostic (7.39e-2)" "unprognostic (5.68e-3)" "unprognostic (6.33e-2)" "unprognostic (5.14e-2)" "unprognostic (1.88e-1)" "unprognostic (2.63e-1)" "unprognostic (2.38e-3)" "unprognostic (6.63e-2)" "unprognostic (3.46e-4)" "unprognostic (2.08e-2)" "unprognostic (2.39e-2)" "unprognostic (7.36e-2)" "unprognostic (4.96e-2)" 1.2 1.4 18.7 4.3 5.6 0.8 0.7 4.4 12.1 2.1 5.1 0.6 0.3 1.5 1.0 1.4 2.5 1.1 1.4 2.6 8.6 4.5 0.9 0.7 0.7 2.0 2.0 8.8 0.9 1.1 0.5 5.3 0.6 2.0 1.2 2.2 2.5 2.0 2.9 0.8 1.4 2.0 3.5 1.2 0.9 1.5 0.9 3.4 0.6 0.7 0.6 2.3 1.0 1.6 0.8 0.3 2.2 0.2 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.6 0.0 0.0 14.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.3 0.2 0.1 0.1 0.6 0.2 0.1 0.0 0.8 0.2 0.3 1.2 0.7 0.1 0.3 0.1 0.1 18.7 5.6 4.4 11.5 8.6 4.5 2.0 8.8 2.0 3.4 XPO1 "CRM1, emb" ENSG00000082898 "Exportin 1" O14980 2 61477849-61538626 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Transport" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010184, HPA042933" Supported Enhanced "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" 170000 "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "CAB010184: AB_2215817, HPA042933: " "unprognostic (7.34e-2)" "unprognostic (7.04e-2)" "unprognostic (6.37e-2)" "unprognostic (1.67e-2)" "unprognostic (5.61e-2)" "unprognostic (1.28e-1)" "prognostic unfavourable (1.84e-5)" "unprognostic (1.84e-1)" "unprognostic (1.99e-3)" "unprognostic (4.43e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-2)" "prognostic unfavourable (3.74e-4)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (2.43e-1)" "unprognostic (5.55e-2)" 20.7 27.9 36.1 28.1 39.6 21.6 35.1 41.5 36.3 28.2 23.2 19.5 26.0 16.5 35.7 35.3 26.1 36.0 20.3 20.1 33.0 19.2 19.5 22.2 22.0 34.5 42.0 19.5 45.0 34.6 33.4 27.6 30.8 33.6 25.8 24.5 18.0 20.2 29.9 34.9 29.8 25.0 28.4 32.1 24.5 21.9 32.1 39.3 51.1 28.2 16.4 35.7 26.0 57.8 6.1 5.4 12.6 5.1 6.2 5.1 2.5 38.8 34.7 47.1 35.3 21.4 28.7 34.7 43.0 27.7 45.2 38.8 46.1 29.2 57.0 30.1 29.4 33.0 71.8 29.8 66.7 34.8 26.4 56.1 35.8 28.8 15.5 56.5 38.4 16.2 22.3 35.7 39.0 36.9 64.7 33.3 41.6 20.4 47.0 24.8 54.8 26.6 42.1 53.8 34.6 20.6 29.5 37.7 20.0 41.8 35.4 20.9 28.9 27.9 24.6 42.5 48.3 34.6 42.2 27.0 44.6 82.7 26.4 48.5 38.3 12.6 5.1 5.8 5.1 5.0 4.7 4.3 3.6 4.5 3.9 6.1 4.3 3.7 12.4 6.2 3.2 5.4 3.2 2.5 36.1 39.6 41.5 36.3 33.0 19.2 42.0 19.5 33.6 39.3 XRCC2 FANCU ENSG00000196584 "X-ray repair cross complementing 2" O43543 7 152644779-152676165 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 12.7;testis: 11.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065153 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA065153: " "unprognostic (9.31e-3)" "unprognostic (8.25e-2)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (9.10e-2)" "unprognostic (2.52e-2)" "unprognostic (3.36e-5)" "unprognostic (9.98e-3)" "unprognostic (5.82e-3)" "unprognostic (4.04e-3)" "unprognostic (1.06e-3)" "unprognostic (2.43e-2)" "unprognostic (1.55e-15)" "unprognostic (4.52e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-1)" "unprognostic (1.73e-2)" 1.3 1.3 3.4 4.5 2.0 5.4 2.4 4.4 2.6 1.6 1.5 2.5 0.6 1.1 1.9 2.2 2.6 1.3 0.6 2.5 3.3 1.1 1.1 1.3 1.4 3.0 1.9 1.9 2.0 1.2 0.4 1.3 7.2 2.7 1.5 2.9 0.6 1.5 1.3 1.1 1.6 1.9 1.3 1.8 1.8 1.5 11.7 2.2 12.7 1.2 1.1 3.6 1.3 1.6 1.8 1.0 3.1 1.1 1.1 1.6 0.6 7.4 4.5 6.6 7.1 0.8 0.7 7.6 5.4 1.9 4.7 4.6 5.6 6.5 10.6 4.2 2.1 5.4 5.3 4.4 8.5 5.0 5.5 7.6 6.0 3.1 0.3 11.3 3.7 0.5 0.4 7.6 2.0 1.6 15.7 9.1 2.7 5.2 10.4 2.7 8.7 4.0 8.4 8.8 5.9 1.4 4.9 6.3 6.0 6.0 2.6 1.1 2.2 2.4 3.1 6.2 2.8 5.8 9.9 3.3 6.4 9.3 3.3 6.1 8.1 2.0 0.9 1.5 1.6 0.6 1.1 1.3 1.3 1.1 0.3 1.8 1.6 0.8 3.1 1.1 1.1 1.0 1.5 0.6 3.4 2.0 4.4 2.6 3.3 1.1 1.9 1.9 2.7 2.2 YBX1 "BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1" ENSG00000065978 "Y-box binding protein 1" P67809 1 42682427-42702349 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Mitogen, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 128.1;testis: 426.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005875, HPA040304, HPA057159" Approved Enhanced Vesicles,Cytosol "Intracellular and membrane" 870000 Cytosol Vesicles "CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: " "unprognostic (8.59e-2)" "unprognostic (5.16e-2)" "unprognostic (9.27e-3)" "unprognostic (2.68e-3)" "unprognostic (7.76e-2)" "unprognostic (8.03e-3)" "prognostic unfavourable (9.87e-10)" "unprognostic (2.80e-2)" "unprognostic (2.31e-2)" "unprognostic (2.79e-3)" "unprognostic (7.51e-2)" "unprognostic (5.52e-2)" "prognostic unfavourable (3.59e-7)" "unprognostic (3.66e-2)" "unprognostic (2.44e-1)" "unprognostic (1.94e-2)" "unprognostic (3.25e-1)" 47.5 20.6 15.6 36.4 18.4 57.6 35.2 13.7 14.4 27.9 44.5 21.2 20.1 25.6 35.1 36.4 40.0 25.6 32.5 57.8 15.2 12.3 33.1 38.1 35.3 49.8 17.6 13.2 30.2 36.7 9.4 12.2 26.1 15.5 32.0 33.1 31.1 26.6 23.0 128.1 22.5 27.1 50.0 21.0 47.9 33.2 426.5 15.9 53.2 31.4 64.1 37.2 39.4 41.0 23.5 26.9 21.8 40.5 11.6 23.0 10.6 91.5 54.0 86.5 86.7 84.3 76.3 77.1 67.6 63.0 94.0 73.8 74.0 85.6 116.2 70.9 67.8 55.5 97.4 102.6 93.4 62.0 90.3 118.6 107.3 94.9 68.0 159.2 88.9 70.2 88.4 93.8 116.2 77.7 123.3 50.7 87.5 57.7 179.8 155.0 195.0 73.0 108.8 155.5 125.6 93.1 67.8 119.7 84.4 66.3 89.8 126.2 29.9 317.1 60.6 66.8 114.0 90.5 137.5 74.3 93.1 132.3 63.2 119.4 70.8 4.3 18.1 21.8 16.3 37.8 19.9 23.5 19.5 15.8 26.9 20.1 16.8 17.2 3.3 11.6 40.5 20.9 23.0 10.6 15.6 18.4 13.7 14.4 15.2 12.3 17.6 13.2 15.5 15.9 YIF1A "54TM, FinGER7, YIF1, YIF1P" ENSG00000174851 "Yip1 interacting factor homolog A, membrane trafficking protein" O95070 11 66284580-66289170 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 138.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014840 Approved Supported "Golgi apparatus,Vesicles,Centriolar satellite" Vesicles "Golgi apparatus, Centriolar satellite" "HPA014840: AB_2217189" "unprognostic (9.35e-2)" "unprognostic (7.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "unprognostic (3.23e-1)" "unprognostic (4.38e-3)" "unprognostic (2.25e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (2.13e-1)" "unprognostic (6.39e-3)" "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.03e-1)" "unprognostic (2.64e-1)" "unprognostic (6.53e-2)" "prognostic unfavourable (8.70e-4)" 16.0 19.7 11.3 12.4 11.7 6.4 18.9 8.0 16.5 17.3 21.4 19.3 18.5 26.1 19.4 24.8 18.5 16.4 24.6 20.1 9.8 9.2 26.2 138.8 16.5 16.0 12.8 9.4 21.2 55.2 18.9 26.8 24.7 12.3 16.8 17.9 16.5 24.4 19.2 32.3 14.3 32.1 19.1 15.2 12.8 19.4 16.9 10.7 16.4 28.2 26.4 17.7 18.2 13.7 27.4 40.4 5.5 38.9 13.3 23.6 26.1 20.6 34.2 10.7 19.5 36.2 39.0 19.6 30.4 32.7 26.0 25.8 32.4 25.4 17.6 29.9 42.7 31.5 16.3 28.6 20.8 20.0 18.7 10.9 26.6 40.1 40.4 15.3 16.6 26.9 38.9 26.8 43.7 24.3 20.3 31.0 22.6 50.2 18.3 16.2 10.8 35.8 14.1 16.4 52.5 22.0 18.8 15.7 15.4 16.4 28.5 26.9 41.9 11.3 21.4 22.0 18.6 44.2 14.0 20.8 21.5 15.8 34.5 14.5 24.2 4.9 28.0 5.5 21.8 38.9 23.6 27.4 18.8 20.3 33.2 22.6 15.1 17.2 2.8 13.3 37.2 40.4 15.2 26.1 11.3 11.7 8.0 16.5 9.8 9.2 12.8 9.4 12.3 10.7 YIF1B FinGER8 ENSG00000167645 "Yip1 interacting factor homolog B, membrane trafficking protein" Q5BJH7 19 38305104-38317273 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039328, HPA055257, HPA062675" Approved Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA039328: , HPA055257: , HPA062675: " "unprognostic (2.51e-1)" "unprognostic (3.34e-1)" "unprognostic (1.38e-1)" "unprognostic (6.81e-2)" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "prognostic unfavourable (4.53e-5)" "unprognostic (1.37e-1)" "unprognostic (1.45e-2)" "unprognostic (5.53e-2)" "prognostic favourable (1.88e-4)" "unprognostic (4.57e-2)" "unprognostic (2.40e-2)" "unprognostic (3.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.64e-1)" "unprognostic (3.94e-3)" 15.8 16.5 18.6 24.1 21.3 46.0 17.1 19.3 34.4 13.9 15.8 27.4 13.9 15.7 12.4 12.4 17.5 14.8 13.0 18.4 21.8 19.6 16.7 59.7 17.6 25.2 23.5 24.0 13.9 21.0 10.8 15.1 18.2 25.9 12.4 12.9 13.5 21.2 12.0 20.3 14.3 14.2 14.2 27.1 24.3 11.5 13.5 20.9 18.2 11.7 16.6 15.7 15.6 12.5 10.8 67.3 38.5 35.9 9.1 14.6 24.3 11.6 30.1 13.5 15.9 19.6 18.3 10.7 28.6 21.9 21.3 31.4 14.6 8.9 20.6 12.6 32.9 7.5 23.8 14.9 8.1 21.8 12.5 31.6 13.5 15.1 27.2 22.0 37.5 15.0 13.4 21.8 9.5 19.7 40.6 57.2 18.9 12.5 23.1 26.4 10.3 9.6 24.0 16.4 31.5 13.6 11.1 9.8 16.4 9.4 21.3 15.2 8.3 44.2 18.8 21.1 21.1 30.3 22.5 21.5 31.6 13.6 27.3 40.6 15.1 15.4 35.9 38.5 14.6 26.2 12.8 10.8 13.8 13.0 67.3 8.4 11.5 11.6 9.8 9.1 14.7 28.4 12.8 24.3 18.6 21.3 19.3 34.4 21.8 19.6 23.5 24.0 25.9 20.9 YIPF4 "FinGER4, MGC11061" ENSG00000119820 "Yip1 domain family member 4" Q9BSR8 2 32277910-32316594 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017884 Supported Supported "Golgi apparatus,Vesicles,Plasma membrane" "Golgi apparatus" "Vesicles, Plasma membrane" "HPA017884: AB_1853855" "unprognostic (5.61e-3)" "unprognostic (8.50e-2)" "unprognostic (3.88e-2)" "unprognostic (3.17e-3)" "unprognostic (3.05e-1)" "unprognostic (7.64e-2)" "unprognostic (3.45e-2)" "unprognostic (3.61e-2)" "unprognostic (3.69e-1)" "unprognostic (8.70e-2)" "unprognostic (4.15e-1)" "unprognostic (1.54e-1)" "unprognostic (2.29e-3)" "unprognostic (1.90e-1)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (6.11e-2)" 15.2 15.3 15.7 12.3 19.2 6.0 19.5 24.9 27.2 15.6 16.0 21.7 16.9 13.6 19.6 17.7 15.3 13.3 12.3 19.1 17.7 16.5 18.7 24.0 13.4 12.9 18.5 13.3 17.9 32.9 14.2 22.3 19.2 17.6 16.1 15.0 15.4 24.1 14.2 16.8 16.5 14.6 15.8 17.7 15.4 14.7 15.2 16.3 18.7 23.6 12.2 13.6 14.6 14.2 5.0 5.8 16.5 6.0 7.0 5.4 4.4 8.3 4.2 8.4 7.5 9.8 12.6 4.4 7.2 7.3 7.6 5.0 5.6 6.4 4.5 5.1 7.8 6.6 8.9 6.3 9.9 7.2 13.8 7.2 9.9 10.1 11.6 9.5 6.2 8.7 12.2 6.8 10.9 6.4 9.8 9.4 8.2 5.5 7.4 10.0 6.8 7.3 5.2 12.4 8.4 8.1 3.6 9.5 9.1 6.2 6.3 10.7 3.5 8.1 7.1 10.1 4.8 7.0 6.8 14.0 17.2 5.4 15.9 9.3 5.5 12.5 6.0 5.9 5.0 5.4 4.3 5.0 5.1 4.7 4.9 4.8 5.4 4.7 16.5 7.0 5.2 5.8 4.7 4.4 15.7 19.2 24.9 18.9 17.7 16.5 18.5 13.3 17.6 16.3 YIPF5 "FinGER5, SMAP-5" ENSG00000145817 "Yip1 domain family member 5" Q969M3 5 144158159-144170714 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042338, HPA073622" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles" "Endoplasmic reticulum, Golgi apparatus, Vesicles" Nucleoplasm "HPA042338: , HPA073622: " "prognostic unfavourable (7.83e-5)" "unprognostic (1.13e-3)" "unprognostic (1.95e-2)" "unprognostic (8.35e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (1.12e-5)" "prognostic unfavourable (3.26e-5)" "unprognostic (2.89e-2)" "unprognostic (1.99e-1)" "unprognostic (3.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.79e-2)" "unprognostic (8.79e-2)" "unprognostic (1.69e-1)" "unprognostic (1.24e-2)" "unprognostic (5.11e-2)" "unprognostic (6.49e-2)" 26.6 26.6 18.4 14.7 21.2 15.8 22.5 19.2 22.6 23.9 22.2 17.2 22.5 26.5 25.7 22.0 27.2 18.9 19.0 18.3 15.1 18.5 23.0 27.8 20.4 21.0 16.2 20.5 19.6 41.7 21.5 45.3 37.1 21.8 16.8 23.4 18.9 32.7 18.3 11.9 24.5 30.5 25.2 19.7 18.8 23.8 20.7 16.2 14.0 20.2 21.2 20.1 24.1 19.9 22.3 27.2 28.8 28.1 23.7 36.7 23.4 11.4 7.7 10.0 7.9 24.0 26.0 9.1 39.2 26.6 17.7 28.6 12.2 12.1 6.3 18.9 42.5 10.6 9.5 19.2 23.9 8.8 8.3 4.6 13.4 12.4 19.4 10.3 7.7 19.6 18.0 15.8 13.0 16.7 4.9 10.6 23.8 6.0 5.0 5.9 6.4 8.4 5.4 14.9 10.4 11.0 10.2 6.8 8.4 13.6 7.3 17.4 15.2 6.8 64.4 20.9 10.1 20.1 15.4 9.7 15.9 8.0 19.9 9.9 15.1 25.6 21.0 28.8 30.3 28.1 34.3 22.3 31.0 33.6 25.0 21.5 32.8 30.8 15.6 23.7 25.4 27.2 36.7 23.4 18.4 21.2 19.2 22.6 15.1 18.5 16.2 20.5 21.8 16.2 YIPF6 "FinGER6, MGC21416" ENSG00000181704 "Yip1 domain family member 6" Q96EC8 X 68498323-68537285 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003720 Uncertain Approved Vesicles Vesicles "HPA003720: AB_1080626" "unprognostic (5.07e-3)" "unprognostic (2.13e-1)" "unprognostic (1.53e-1)" "unprognostic (1.72e-1)" "unprognostic (7.17e-2)" "unprognostic (5.90e-3)" "unprognostic (1.64e-1)" "unprognostic (1.28e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (1.33e-2)" "unprognostic (3.15e-1)" "unprognostic (8.85e-3)" "unprognostic (8.48e-2)" "unprognostic (2.90e-2)" "unprognostic (3.25e-1)" "unprognostic (6.32e-2)" 13.3 15.6 16.5 7.2 17.7 4.9 15.8 12.9 17.1 16.0 12.3 17.3 11.6 11.5 14.0 16.2 13.6 13.7 11.2 11.9 14.9 14.4 19.6 28.3 12.7 6.2 17.6 13.1 11.5 26.8 18.0 32.9 32.4 16.1 21.1 14.6 11.7 16.0 16.1 18.1 10.9 14.4 16.9 17.1 8.8 14.9 6.9 15.3 4.3 22.4 7.4 10.9 13.4 11.4 4.0 3.8 12.4 4.6 3.1 2.7 3.1 11.4 9.4 12.1 4.0 16.8 10.6 11.5 9.3 12.0 7.5 9.5 9.6 12.3 0.1 16.3 8.1 9.3 15.9 6.5 13.1 3.4 9.4 4.7 11.1 9.2 15.3 5.5 7.6 10.1 12.6 10.9 14.4 7.5 7.8 10.7 10.7 10.1 3.2 4.9 12.8 12.1 3.2 14.8 6.4 13.2 11.3 12.7 14.0 14.9 11.1 11.1 7.0 5.6 9.0 7.5 6.6 27.2 17.5 6.3 7.4 2.4 12.9 8.8 13.2 5.4 4.6 5.2 2.7 4.6 1.8 4.0 2.7 2.3 3.3 2.5 2.7 2.4 12.4 3.1 4.2 3.8 2.6 3.1 16.5 17.7 12.9 15.6 14.9 14.4 17.6 13.1 16.1 15.3 YY1 "DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1" ENSG00000100811 "YY1 transcription factor" P25490 14 100238298-100282792 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001119, CAB009392" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" Nucleoplasm "Nucleoli fibrillar center, Vesicles" "CAB009392: AB_2218501, HPA001119: AB_1858930" "unprognostic (7.67e-2)" "unprognostic (8.08e-2)" "unprognostic (2.57e-2)" "prognostic unfavourable (6.13e-4)" "unprognostic (6.75e-3)" "unprognostic (8.31e-3)" "prognostic unfavourable (3.44e-4)" "unprognostic (1.09e-1)" "unprognostic (4.26e-2)" "unprognostic (7.68e-3)" "unprognostic (1.40e-1)" "unprognostic (1.51e-1)" "unprognostic (3.72e-2)" "unprognostic (4.36e-2)" "unprognostic (1.66e-1)" "unprognostic (2.30e-1)" "unprognostic (4.30e-1)" 32.7 28.8 26.3 27.0 25.8 45.3 33.8 33.6 26.4 28.1 37.6 24.9 34.6 26.4 29.5 33.7 34.1 24.4 27.4 38.3 27.6 21.9 31.4 42.8 31.8 30.6 26.5 21.1 26.9 27.7 32.5 23.6 35.2 24.1 29.3 28.2 21.5 25.6 23.1 39.9 27.2 31.0 25.9 26.5 30.6 25.3 22.6 25.8 60.2 40.9 23.3 35.2 29.7 47.0 8.2 6.3 14.2 7.0 12.0 9.0 3.0 23.7 12.5 25.8 20.5 20.6 25.8 28.0 23.6 21.3 25.7 26.0 15.1 39.9 36.3 33.6 20.5 24.9 28.1 24.3 35.1 28.2 22.7 33.8 14.6 19.4 19.1 40.3 29.5 15.6 29.2 17.7 24.4 24.3 26.2 25.4 24.2 29.5 43.8 22.0 27.0 21.6 35.8 35.9 19.7 28.8 23.5 27.5 20.4 31.5 22.7 31.9 35.0 37.0 22.1 16.0 20.0 38.8 20.6 26.6 27.0 50.3 22.2 26.1 20.6 5.1 7.0 14.2 5.5 5.9 7.0 6.3 7.6 7.7 6.1 8.2 7.1 6.8 12.2 12.0 4.5 6.3 9.0 3.0 26.3 25.8 33.6 26.4 27.6 21.9 26.5 21.1 24.1 25.8 ZADH2 MGC45594 ENSG00000180011 "Zinc binding alcohol dehydrogenase domain containing 2" Q8N4Q0 18 75195108-75209348 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021468, HPA053646" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "HPA021468: AB_1858932, HPA053646: " "unprognostic (3.22e-2)" "unprognostic (1.03e-2)" "unprognostic (7.14e-2)" "unprognostic (1.13e-1)" "unprognostic (4.79e-1)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (1.49e-1)" "unprognostic (3.62e-3)" "unprognostic (1.42e-1)" "unprognostic (3.05e-2)" "unprognostic (1.48e-1)" "prognostic favourable (1.02e-6)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (1.94e-4)" "unprognostic (2.23e-1)" 14.1 12.1 15.6 12.5 22.5 12.7 28.1 19.1 24.1 15.5 18.9 10.8 13.6 13.7 12.8 19.0 18.1 13.5 15.7 24.4 17.4 11.3 18.0 23.4 13.3 12.7 12.9 18.4 19.6 19.5 22.4 20.5 26.2 19.3 13.8 21.4 13.5 16.3 14.1 34.5 15.8 24.0 16.9 12.1 15.0 15.5 7.1 11.2 11.2 20.7 15.5 14.5 17.4 15.5 2.7 3.3 12.1 5.2 2.5 4.8 2.3 9.3 6.2 6.6 13.5 10.3 13.4 7.3 16.9 19.7 6.7 8.4 3.8 13.3 6.5 2.7 16.7 12.7 8.2 14.3 4.7 40.6 12.0 14.7 13.7 7.3 7.4 24.7 15.0 14.8 14.3 5.3 12.3 13.7 7.9 24.1 12.7 10.9 6.2 12.2 1.7 14.2 13.3 10.6 21.5 13.0 15.8 12.3 10.1 9.4 9.7 10.7 9.7 12.3 12.1 13.1 10.1 4.1 5.3 3.9 17.1 4.5 8.7 21.5 10.6 1.9 5.0 12.1 4.8 4.2 3.8 2.7 4.1 4.5 3.3 2.5 2.3 3.5 2.7 2.5 5.2 2.5 4.4 2.3 15.6 22.5 19.1 24.1 17.4 11.3 12.9 18.4 19.3 11.2 ZBED6CL C7orf29 ENSG00000188707 "ZBED6 C-terminal like" Q96FA7 7 150329789-150332721 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "adrenal gland: 37.4;parathyroid gland: 11.3" "Cell line enhanced" "Detected in many" "HDLM-2: 40.1;K-562: 17.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA019724, HPA055805" Approved Approved "Nuclear membrane,Vesicles" "Nuclear membrane" Vesicles "HPA019724: AB_1845756, HPA055805: " "prognostic favourable (9.48e-5)" "unprognostic (6.77e-2)" "unprognostic (2.06e-2)" "unprognostic (7.41e-2)" "prognostic unfavourable (3.12e-5)" "unprognostic (3.35e-2)" "unprognostic (2.49e-3)" "unprognostic (2.78e-2)" "unprognostic (3.12e-2)" "unprognostic (3.44e-1)" "prognostic favourable (2.44e-5)" "unprognostic (2.78e-1)" "prognostic unfavourable (1.38e-5)" "unprognostic (1.86e-2)" "unprognostic (7.82e-2)" "unprognostic (8.52e-3)" "unprognostic (1.50e-3)" 0.4 37.4 0.4 2.6 0.4 1.7 0.8 0.3 0.2 1.1 1.4 1.6 2.0 0.2 1.2 1.9 0.4 0.4 0.3 0.6 1.8 5.6 1.5 3.9 0.3 3.1 3.2 11.3 2.5 0.0 1.5 1.5 1.1 0.9 0.1 2.2 2.1 0.6 0.1 2.3 1.7 0.3 1.8 3.7 1.3 0.8 3.6 1.0 2.8 1.0 2.8 3.5 2.4 4.4 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.4 6.2 4.7 2.5 2.2 0.0 1.8 0.0 0.0 0.3 40.1 3.2 3.1 6.6 10.5 1.3 0.0 4.7 0.8 2.4 0.0 0.0 0.2 17.2 6.7 0.0 2.0 7.6 1.8 3.0 0.0 0.0 0.3 5.6 2.1 8.9 8.5 4.9 6.8 1.9 0.3 0.5 2.1 0.1 0.0 0.0 0.0 0.0 5.4 1.5 0.0 0.0 0.0 0.0 0.0 1.0 1.0 2.7 0.7 3.2 2.2 2.4 3.4 0.7 3.6 3.5 2.9 2.8 2.8 0.2 1.0 2.2 2.4 ZBTB39 "KIAA0352, ZNF922" ENSG00000166860 "Zinc finger and BTB domain containing 39" O15060 12 56998834-57006446 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016866, HPA020306" Uncertain Approved Vesicles Vesicles "HPA016866: , HPA020306: " "unprognostic (2.06e-2)" "unprognostic (1.61e-1)" "unprognostic (8.92e-2)" "unprognostic (2.90e-2)" "unprognostic (3.07e-1)" "unprognostic (2.68e-2)" "unprognostic (4.10e-3)" "unprognostic (1.69e-1)" "unprognostic (1.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-3)" "unprognostic (1.76e-1)" "unprognostic (2.34e-1)" "unprognostic (5.74e-2)" "unprognostic (3.46e-1)" "unprognostic (2.54e-2)" "unprognostic (7.00e-2)" 5.5 5.2 6.9 8.5 9.0 10.5 9.6 9.9 10.1 6.0 6.7 11.9 5.5 4.7 9.0 5.9 6.6 7.7 4.5 4.8 6.2 4.8 5.2 9.5 6.3 7.8 7.1 6.7 10.1 8.8 8.4 4.0 8.0 6.9 6.1 5.3 6.5 6.5 7.9 6.0 6.5 8.3 8.2 8.1 12.5 7.5 18.0 7.8 6.4 6.0 5.3 8.9 7.1 6.1 1.8 2.1 2.9 1.3 2.5 2.7 0.9 2.2 3.6 10.3 5.3 2.3 2.5 6.8 2.1 2.7 3.5 2.5 3.7 1.6 7.1 2.8 2.1 3.0 7.9 3.3 3.4 3.2 5.5 7.9 2.2 3.0 2.2 6.0 6.5 1.9 3.2 2.8 4.5 4.0 9.7 6.5 2.5 2.5 8.7 5.0 10.2 3.0 8.4 31.8 3.3 1.6 4.4 5.1 6.6 3.1 4.0 3.1 3.4 6.6 3.1 3.0 6.5 1.4 2.7 8.5 5.5 7.6 1.9 3.4 1.8 2.9 1.3 0.0 1.9 0.9 1.9 1.5 1.9 2.6 1.5 1.8 1.4 2.7 0.0 2.5 0.3 2.1 0.6 0.9 6.9 9.0 9.9 10.1 6.2 4.8 7.1 6.7 6.9 7.8 ZC3H10 "FLJ14451, ZC3HDC10" ENSG00000135482 "Zinc finger CCCH-type containing 10" Q96K80 12 56118159-56127514 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039236, HPA062265" Uncertain Approved Vesicles Vesicles "HPA039236: AB_10795463, HPA062265: " "unprognostic (1.19e-1)" "unprognostic (1.53e-1)" "unprognostic (2.97e-1)" "unprognostic (7.39e-2)" "unprognostic (2.27e-1)" "unprognostic (3.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.53e-2)" "unprognostic (2.07e-2)" "unprognostic (2.80e-1)" "unprognostic (1.31e-5)" "unprognostic (4.42e-2)" "unprognostic (2.69e-2)" "unprognostic (6.45e-2)" "unprognostic (1.40e-1)" "unprognostic (2.58e-2)" "unprognostic (1.21e-1)" 11.3 10.1 7.9 9.0 11.8 4.1 8.6 11.2 10.4 10.9 10.4 12.9 6.5 5.4 13.2 7.3 7.1 8.9 8.9 7.7 7.3 4.7 7.9 8.1 7.7 8.3 11.1 5.9 13.3 11.2 8.2 9.4 7.9 9.2 13.5 4.6 9.0 8.7 9.8 13.6 7.7 7.0 7.4 6.8 11.5 7.7 24.6 12.0 13.3 10.0 5.2 7.2 10.5 9.7 6.2 7.1 7.6 12.7 10.9 7.1 4.7 4.4 8.0 6.4 5.0 7.9 5.4 5.0 5.4 3.6 3.2 2.6 2.1 2.7 4.8 8.9 3.9 6.1 3.3 1.9 2.1 8.5 8.4 7.4 7.5 2.3 4.8 6.6 4.7 3.4 4.4 3.8 4.4 4.8 3.8 9.1 4.2 2.8 7.4 2.9 4.3 6.6 7.4 6.8 4.5 2.7 2.2 6.3 6.1 3.1 4.8 4.9 7.8 6.1 6.9 3.1 7.3 6.1 4.0 7.6 4.7 2.8 4.1 3.3 7.5 3.6 7.0 7.6 6.9 7.9 7.1 5.2 5.5 5.9 7.1 6.2 5.4 5.3 4.9 10.9 12.7 3.3 2.7 4.7 7.9 11.8 11.2 10.4 7.3 4.7 11.1 5.9 9.2 12.0 ZC3H12B "CXorf32, MCPIP2" ENSG00000102053 "Zinc finger CCCH-type containing 12B" Q5HYM0 X 65366638-65507887 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 6.1" "Cell line enhanced" "Detected in many" "AF22: 5.2;Karpas-707: 4.2" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA000836 Uncertain Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" "Endoplasmic reticulum" "Golgi apparatus, Vesicles" "HPA000836: AB_2217374" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (1.38e-1)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (7.44e-3)" "unprognostic (7.86e-3)" "unprognostic (5.46e-2)" "unprognostic (3.32e-1)" "unprognostic (5.76e-2)" "unprognostic (1.12e-3)" "unprognostic (1.28e-1)" "unprognostic (2.61e-1)" "unprognostic (1.11e-2)" "unprognostic (5.08e-2)" "unprognostic (1.45e-2)" "unprognostic (1.71e-2)" 0.3 0.9 2.6 0.5 3.9 0.1 0.5 2.8 6.1 1.9 1.1 0.9 2.6 0.8 0.4 2.0 1.1 0.5 2.8 2.5 1.2 0.5 0.6 0.7 1.7 3.3 0.1 2.7 2.7 0.0 1.8 1.1 0.3 2.4 0.0 0.3 0.9 1.8 1.5 0.4 1.3 0.0 1.5 0.2 1.0 0.7 1.3 0.8 0.7 0.4 0.8 1.8 0.2 0.3 0.4 5.2 0.8 0.0 0.0 0.7 1.3 2.8 0.0 0.8 0.7 0.5 0.8 0.3 1.4 0.8 1.3 0.0 0.1 0.8 3.8 1.7 2.4 0.7 0.1 1.6 0.4 0.2 0.0 0.1 0.0 0.0 0.9 4.2 0.1 0.0 2.2 0.6 2.1 1.1 2.5 0.2 1.0 0.1 0.2 0.2 2.5 0.0 0.2 0.2 0.1 1.3 0.0 0.1 1.0 1.7 0.5 0.9 1.0 1.7 3.3 2.2 0.0 0.6 0.4 0.1 0.6 0.2 0.5 0.9 0.8 0.8 0.2 1.3 1.8 0.8 0.7 0.8 0.2 0.8 0.4 0.2 ZC4H2 "HCA127, KIAA1166, WWS" ENSG00000126970 "Zinc finger C4H2-type containing" Q9NQZ6 X 64915802-65034713 "Disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.1;NTERA-2: 27.8;REH: 20.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049584 Approved Approved Vesicles,Microtubules "Vesicles, Microtubules" "HPA049584: " "unprognostic (9.55e-3)" "unprognostic (1.03e-1)" "unprognostic (4.40e-1)" "unprognostic (1.56e-1)" "unprognostic (7.29e-3)" "unprognostic (9.71e-2)" "unprognostic (1.64e-3)" "unprognostic (9.72e-2)" "unprognostic (2.98e-1)" "unprognostic (3.34e-1)" "unprognostic (2.31e-2)" "unprognostic (6.44e-2)" "unprognostic (1.84e-3)" "unprognostic (2.06e-1)" "unprognostic (1.58e-1)" "prognostic unfavourable (3.51e-5)" "unprognostic (5.34e-2)" 7.0 9.7 11.7 6.6 12.3 4.8 7.4 12.7 15.0 10.4 12.2 15.6 8.1 8.1 12.8 8.4 6.4 12.5 8.0 10.4 10.6 14.7 9.9 10.0 6.4 5.6 11.7 10.8 14.7 5.3 20.0 20.3 2.2 16.9 10.5 9.6 10.0 8.9 12.2 3.2 5.3 7.8 16.2 12.3 6.2 9.5 2.5 12.4 12.7 10.8 2.3 5.4 8.2 6.1 4.7 3.9 0.0 2.0 3.6 7.9 3.0 0.0 1.0 17.1 7.6 0.1 0.0 2.5 3.7 5.6 4.8 8.3 1.2 6.1 2.8 2.0 2.7 0.0 7.2 2.8 4.6 0.0 5.7 5.1 2.6 2.2 1.1 5.1 1.7 3.1 2.3 2.1 4.4 8.0 1.4 6.5 5.2 0.0 14.1 0.0 27.8 6.4 20.4 9.0 0.1 4.1 0.0 0.0 12.0 0.0 0.0 0.7 1.5 0.8 5.1 2.2 5.1 0.2 0.0 1.0 0.1 10.4 6.3 4.4 0.0 0.0 1.3 0.0 3.3 2.0 5.9 4.7 4.8 5.0 1.8 4.1 7.9 4.6 0.0 3.6 0.5 3.9 2.4 3.0 11.7 12.3 12.7 15.0 10.6 14.7 11.7 10.8 16.9 12.4 ZCCHC18 "PNMA7B, SIZN2" ENSG00000166707 "Zinc finger CCHC-type containing 18" P0CG32 X 104112131-104115846 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 9.6;ovary: 9.4" "Cell line enhanced" "Detected in some" "Daudi: 4.5;Karpas-707: 8.4;SH-SY5Y: 5.7" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 19 "B-cells: 3.0;T-cells: 2.2" "Low region specificity" "Detected in all" "HPA034940, HPA078516" Uncertain Approved Vesicles Vesicles "HPA034940: AB_10671098, HPA078516: " "unprognostic (7.20e-2)" "unprognostic (7.71e-4)" "unprognostic (8.29e-2)" "unprognostic (4.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-3)" "unprognostic (2.20e-2)" "unprognostic (3.22e-2)" "unprognostic (7.59e-2)" "unprognostic (3.34e-1)" "unprognostic (4.44e-6)" "unprognostic (4.05e-2)" "unprognostic (1.02e-6)" "unprognostic (3.82e-2)" "unprognostic (4.02e-1)" "unprognostic (3.91e-2)" "unprognostic (4.14e-3)" 0.9 2.3 3.4 3.3 9.4 1.1 2.6 9.6 9.2 1.7 0.9 1.2 0.5 1.1 3.6 1.1 1.0 1.6 1.4 1.2 3.1 7.7 0.5 0.3 1.0 4.9 3.8 4.9 9.4 2.6 0.3 2.3 0.7 4.7 1.5 1.1 1.2 0.5 1.8 1.0 0.5 2.6 1.9 2.5 3.4 1.4 2.2 2.2 0.0 0.4 0.2 5.1 2.0 1.1 3.0 0.0 0.0 0.0 0.1 2.2 0.3 0.0 0.2 3.5 2.4 0.3 0.0 0.2 0.7 0.1 0.6 0.6 0.1 0.0 4.5 0.1 0.2 0.0 2.1 0.0 0.3 1.3 1.7 0.8 0.2 0.0 0.4 2.5 0.8 0.2 0.0 0.4 0.0 0.7 0.0 8.4 0.2 0.0 0.0 0.1 1.9 0.6 3.0 0.8 0.0 0.5 0.3 2.4 5.7 0.2 0.0 0.0 0.0 0.3 1.5 0.1 1.1 0.2 1.0 0.2 0.0 2.2 0.1 2.5 0.7 0.0 0.0 0.0 1.4 0.0 2.2 2.5 1.1 1.7 0.0 3.0 1.2 1.6 0.0 0.1 0.0 0.0 0.8 0.3 3.4 9.4 9.6 7.2 3.1 7.7 3.8 4.9 4.7 2.2 ZCCHC3 "C20orf99, dJ1103G7.7" ENSG00000247315 "Zinc finger CCHC-type containing 3" Q9NUD5 20 296968-300321 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042972 Approved Vesicles Vesicles "HPA042972: AB_10959663" "unprognostic (5.98e-3)" "unprognostic (1.38e-1)" "unprognostic (1.26e-2)" "unprognostic (1.01e-3)" "unprognostic (2.13e-1)" "unprognostic (3.04e-1)" "unprognostic (1.30e-2)" "unprognostic (1.90e-1)" "unprognostic (3.29e-1)" "unprognostic (6.55e-2)" "prognostic favourable (1.29e-4)" "unprognostic (4.30e-1)" "unprognostic (3.34e-3)" "unprognostic (6.33e-2)" "unprognostic (1.88e-1)" "unprognostic (3.67e-1)" "unprognostic (1.74e-2)" 1.5 2.1 1.8 3.1 1.1 1.2 2.1 1.2 1.5 2.0 2.5 0.6 2.6 1.0 1.4 1.4 1.4 1.1 3.3 4.4 1.8 1.5 4.5 1.5 0.9 1.2 2.0 1.2 0.4 1.4 1.0 2.7 1.6 1.4 1.3 3.1 0.9 4.5 4.8 6.1 2.9 2.1 3.7 1.6 8.2 6.4 20.3 10.1 6.6 6.8 12.1 5.2 5.7 5.8 6.0 9.8 4.9 7.4 3.4 3.2 11.5 10.2 5.7 5.5 4.0 9.5 15.1 3.1 30.6 7.7 17.2 4.2 6.6 6.8 3.5 4.2 9.1 18.7 7.7 4.4 3.6 13.1 21.2 18.1 6.9 19.4 9.7 9.5 5.1 5.3 8.6 12.5 6.2 12.5 15.7 5.8 32.4 4.0 6.0 6.0 2.4 6.1 14.1 17.9 14.7 2.1 11.3 5.7 6.1 2.9 4.5 3.4 1.4 3.3 3.2 3.0 2.9 2.0 4.5 3.7 3.5 0.8 2.1 1.3 4.8 2.7 1.6 ZDHHC13 "FLJ10852, FLJ10941, HIP14L" ENSG00000177054 "Zinc finger DHHC-type containing 13" Q8IUH4 11 19117099-19176422 "Enzymes, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016759, HPA018791" Uncertain Enhanced Vesicles Vesicles "HPA016759: AB_1858993, HPA018791: AB_1858992" "unprognostic (1.43e-2)" "unprognostic (4.00e-3)" "unprognostic (1.08e-1)" "unprognostic (1.11e-3)" "unprognostic (2.95e-2)" "unprognostic (1.34e-2)" "unprognostic (1.55e-2)" "unprognostic (1.57e-1)" "unprognostic (3.57e-3)" "unprognostic (3.03e-2)" "unprognostic (1.63e-1)" "unprognostic (2.16e-1)" "unprognostic (6.95e-3)" "unprognostic (1.15e-1)" "unprognostic (7.93e-2)" "unprognostic (2.17e-1)" "unprognostic (2.76e-2)" 4.7 5.2 6.3 9.3 8.0 6.8 7.3 13.2 9.7 8.8 13.2 5.8 7.1 8.7 6.4 5.6 36.4 10.5 6.9 7.7 6.2 7.1 10.8 2.3 4.7 6.9 5.4 5.2 5.8 14.0 10.9 20.1 9.4 9.4 7.1 14.7 6.4 11.2 5.9 2.1 14.9 12.3 4.9 4.7 6.3 14.4 11.2 4.8 15.0 7.7 18.2 27.5 15.3 14.5 6.3 4.3 23.4 5.8 4.3 7.5 3.5 15.8 7.5 7.2 6.1 2.6 3.0 6.9 7.6 7.0 8.5 9.9 4.5 3.8 8.1 5.3 6.3 24.2 10.3 5.0 9.4 10.0 9.0 4.2 4.8 3.6 6.0 5.7 7.3 3.4 5.9 3.6 5.0 53.8 4.0 4.1 8.8 5.1 7.3 4.7 6.0 7.0 8.2 10.0 1.9 8.8 10.5 12.6 9.2 9.1 11.1 4.1 5.2 6.7 15.4 7.6 5.4 11.6 6.1 3.5 10.7 7.5 9.1 5.9 13.2 7.4 3.5 23.4 6.8 5.8 6.1 6.3 5.3 7.5 4.3 4.2 5.1 6.5 4.4 4.3 4.6 4.2 6.8 3.5 6.3 8.0 13.2 9.7 6.2 7.1 5.4 5.2 9.4 4.8 ZDHHC17 "HIP14, HYPH, KIAA0946" ENSG00000186908 "Zinc finger DHHC-type containing 17" Q8IUH5 12 76763588-76853696 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 16.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016807, HPA058674" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA016807: AB_1858999, HPA058674: " "unprognostic (1.06e-1)" "unprognostic (2.26e-2)" "unprognostic (2.63e-2)" "unprognostic (3.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.83e-2)" "unprognostic (2.35e-3)" "unprognostic (3.09e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.56e-3)" "unprognostic (5.42e-2)" "prognostic unfavourable (7.11e-5)" "unprognostic (1.77e-2)" "unprognostic (2.69e-1)" "unprognostic (2.98e-1)" "unprognostic (1.71e-2)" 7.9 7.8 10.0 5.8 14.0 11.3 8.8 18.1 18.1 8.0 5.9 9.2 3.8 3.6 12.0 6.8 6.4 7.0 5.5 6.4 8.7 6.5 9.1 13.1 5.4 7.1 11.3 10.7 11.5 5.2 9.5 10.3 8.7 13.2 7.9 5.4 5.9 5.7 7.3 5.4 5.9 6.4 8.0 10.0 7.1 6.1 6.4 11.6 7.5 6.2 4.1 5.7 5.6 6.3 3.8 16.3 5.8 2.2 1.7 3.6 1.4 5.7 7.1 22.2 11.3 13.4 14.2 10.9 11.7 9.7 7.8 6.9 5.6 4.2 8.0 7.1 11.3 5.5 8.8 7.3 12.2 6.7 9.3 11.6 8.7 8.5 9.0 11.6 10.4 13.3 7.7 7.3 11.0 8.9 12.5 3.7 10.1 5.4 8.3 15.6 16.4 8.1 11.3 7.9 8.7 9.0 8.9 8.7 15.1 12.9 4.7 7.5 10.5 11.7 12.3 10.7 8.1 6.5 6.6 6.0 5.8 8.7 4.0 5.5 11.0 5.7 2.1 5.2 3.6 2.2 2.9 2.6 2.9 2.7 2.6 3.8 3.1 2.6 5.8 1.7 2.1 16.3 1.2 1.4 10.0 14.0 18.1 13.8 8.7 6.5 11.3 10.7 13.2 11.6 ZDHHC20 "DHHC20, FLJ25952" ENSG00000180776 "Zinc finger DHHC-type containing 20" Q5W0Z9 13 21372573-21459370 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014483, HPA014702" Approved Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA014483: AB_1859000, HPA014702: AB_1859001" "unprognostic (1.31e-1)" "unprognostic (2.16e-3)" "unprognostic (7.31e-3)" "unprognostic (8.89e-2)" "unprognostic (3.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.24e-2)" "unprognostic (1.26e-2)" "prognostic unfavourable (6.55e-4)" "unprognostic (1.10e-1)" "prognostic unfavourable (1.01e-4)" "unprognostic (3.76e-2)" "unprognostic (7.65e-2)" "unprognostic (6.15e-2)" "unprognostic (1.13e-2)" 7.5 7.0 8.3 9.4 33.6 14.9 11.3 6.4 15.3 10.3 10.9 21.0 7.6 10.8 9.3 5.6 18.4 7.1 10.0 5.4 12.7 11.8 3.8 7.6 10.6 12.3 47.4 4.9 6.5 6.1 4.0 5.3 10.8 26.1 9.2 9.6 3.1 10.4 9.9 5.5 12.2 15.4 8.9 45.0 8.6 23.1 22.0 35.8 10.4 10.0 5.1 10.9 16.2 9.6 4.6 7.8 8.8 15.2 10.1 10.2 11.1 13.5 7.8 11.4 7.2 10.6 11.2 27.9 14.8 14.9 9.9 8.9 14.2 41.5 14.4 8.0 18.1 22.0 13.1 11.4 18.8 15.7 8.3 25.3 4.9 7.8 6.0 17.1 11.0 10.2 8.0 9.8 6.9 15.3 7.0 6.1 14.7 11.4 23.9 6.5 9.3 7.7 19.2 20.5 5.0 11.8 25.2 10.9 5.0 19.5 12.2 8.0 11.2 8.7 26.6 10.5 10.0 17.6 11.0 6.3 7.7 15.0 7.5 9.9 29.5 8.8 15.2 3.4 10.2 14.2 9.4 4.6 8.8 8.7 7.8 3.7 8.3 8.5 2.7 10.1 12.0 3.9 9.3 11.1 8.3 33.6 6.4 15.3 12.7 11.8 47.4 4.9 26.1 35.8 ZDHHC24 ENSG00000174165 "Zinc finger DHHC-type containing 24" Q6UX98 11 66520637-66546238 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016619 Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA016619: AB_2288672" "unprognostic (2.77e-1)" "unprognostic (2.51e-1)" "unprognostic (2.52e-1)" "unprognostic (1.55e-3)" "prognostic unfavourable (3.28e-4)" "unprognostic (8.76e-2)" "unprognostic (7.74e-3)" "unprognostic (7.11e-2)" "unprognostic (6.20e-2)" "unprognostic (1.41e-1)" "unprognostic (3.73e-2)" "unprognostic (1.48e-1)" "unprognostic (8.10e-2)" "unprognostic (6.99e-3)" "unprognostic (3.10e-1)" "unprognostic (4.88e-1)" "unprognostic (1.35e-1)" 11.7 17.4 10.5 10.3 12.8 14.1 12.3 5.7 15.5 7.7 8.3 13.8 10.8 9.1 9.4 17.0 12.2 9.0 11.3 9.9 10.7 11.8 17.3 13.4 11.1 20.4 12.8 10.3 6.5 19.4 22.6 9.6 13.7 9.3 11.4 7.7 10.0 12.4 13.1 7.9 13.2 9.4 7.1 10.0 16.0 12.4 9.9 10.5 11.7 17.7 7.9 13.4 10.0 7.8 5.8 17.2 2.4 5.5 6.6 7.2 4.6 4.8 7.8 2.6 6.7 6.4 5.3 6.5 4.1 3.5 3.3 2.3 6.8 7.9 1.4 11.2 3.5 12.0 1.9 3.6 2.3 7.0 4.9 3.0 3.8 4.2 6.0 3.0 7.5 6.3 6.5 2.7 3.9 5.5 4.3 4.4 4.1 10.6 5.8 8.5 5.1 6.7 7.5 5.4 9.1 4.0 3.9 3.6 5.7 6.6 6.9 11.3 9.5 2.5 8.5 7.6 2.4 8.8 3.0 6.5 2.0 2.0 6.6 1.4 8.2 2.4 5.5 1.0 6.2 4.8 5.7 5.4 5.0 7.2 6.3 5.8 3.0 5.4 2.4 6.6 4.4 17.2 5.1 4.6 10.5 12.8 5.7 15.5 10.7 11.8 12.8 10.3 9.3 10.5 ZFAND3 "FLJ13222, TEX27" ENSG00000156639 "Zinc finger AN1-type containing 3" Q9H8U3 6 37819499-38154624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016755 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA016755: AB_1859011" "unprognostic (3.32e-1)" "unprognostic (3.04e-2)" "unprognostic (1.36e-1)" "unprognostic (2.89e-2)" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (9.24e-2)" "unprognostic (1.37e-1)" "unprognostic (1.07e-1)" "unprognostic (1.36e-2)" "unprognostic (9.30e-2)" "unprognostic (1.48e-2)" "unprognostic (9.60e-3)" "unprognostic (1.01e-1)" "unprognostic (2.94e-1)" "unprognostic (7.41e-2)" "unprognostic (4.33e-1)" 26.7 27.5 31.0 26.0 31.1 23.9 37.6 26.2 31.4 28.6 27.0 26.6 26.0 24.5 25.9 31.2 22.2 21.4 33.5 30.5 29.9 24.1 31.6 35.6 24.8 26.1 30.4 22.2 23.9 26.1 33.9 31.6 31.4 24.2 23.7 20.2 24.3 20.3 31.0 77.9 19.4 26.9 35.4 33.4 21.9 25.1 60.5 27.3 26.4 32.1 19.7 19.3 30.7 34.0 3.0 4.4 9.2 2.8 2.9 2.6 1.4 17.0 10.6 36.7 26.0 22.2 23.1 12.7 28.6 33.3 25.8 27.6 20.7 10.1 7.1 22.0 30.4 11.8 14.0 21.1 35.5 27.1 8.9 21.5 5.5 19.8 52.1 8.9 18.8 29.0 27.8 27.2 46.3 22.2 10.2 15.1 19.5 14.8 14.0 7.5 10.8 11.1 14.8 14.8 8.6 24.5 29.2 22.7 20.0 16.0 14.1 49.2 21.6 18.9 24.3 27.2 20.7 14.5 17.8 14.8 13.4 21.6 10.2 14.1 28.0 0.7 2.7 8.8 2.6 2.8 1.8 1.9 1.9 2.0 1.3 3.0 1.7 2.6 9.2 2.9 2.1 4.4 2.4 1.4 31.0 31.1 26.2 31.4 29.9 24.1 30.4 22.2 24.2 27.3 ZFP37 ZNF906 ENSG00000136866 "ZFP37 zinc finger protein" Q9Y6Q3 9 113038380-113056759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049112 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA049112: " "unprognostic (3.18e-1)" "unprognostic (9.57e-2)" "unprognostic (5.62e-2)" "unprognostic (3.54e-3)" "prognostic favourable (1.96e-4)" "unprognostic (7.84e-2)" "unprognostic (8.09e-2)" "unprognostic (2.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.53e-2)" "unprognostic (2.51e-2)" "unprognostic (1.38e-3)" "unprognostic (4.22e-2)" "unprognostic (9.46e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-1)" "unprognostic (2.07e-1)" 3.8 4.4 4.9 3.1 19.2 0.9 6.7 10.9 9.9 6.5 3.6 5.3 4.0 2.1 10.5 5.8 3.2 6.3 3.5 3.7 10.5 5.6 5.8 1.7 3.2 2.8 6.7 10.6 17.0 3.2 4.3 8.5 3.2 10.7 6.3 2.9 2.8 3.2 4.8 3.2 3.2 2.5 6.2 9.1 4.7 3.0 5.1 5.9 0.4 6.9 2.4 3.2 4.3 5.6 2.3 0.9 0.2 0.4 1.3 5.6 0.7 0.6 1.8 7.6 6.4 4.3 8.2 3.9 2.4 3.5 2.7 2.2 0.0 1.8 4.3 1.9 2.5 1.6 0.0 0.9 4.2 5.3 0.9 0.2 3.8 1.9 2.3 0.0 0.9 2.3 0.8 3.1 6.2 1.5 0.4 3.8 5.5 0.0 0.0 0.0 7.8 0.0 0.0 10.6 0.6 2.0 0.0 6.5 6.1 7.4 1.6 1.4 6.3 0.0 0.6 6.2 2.7 7.3 3.6 1.5 2.8 0.0 4.8 0.1 3.8 0.2 0.1 0.1 2.5 0.4 1.9 2.3 2.2 2.2 0.9 1.1 1.8 2.5 0.2 1.3 0.0 0.1 5.6 0.7 4.9 19.2 10.9 9.9 10.5 5.6 6.7 10.6 10.7 5.9 ZFP90 "KIAA1954, NK10, ZNF756" ENSG00000184939 "ZFP90 zinc finger protein" Q8TF47 16 68530090-68576072 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029017 Uncertain Supported "Vesicles,Plasma membrane,Centrosome" "Vesicles, Plasma membrane, Centrosome" "HPA029017: AB_10669653" "unprognostic (3.27e-1)" "unprognostic (1.71e-2)" "unprognostic (1.56e-1)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (2.47e-1)" "unprognostic (3.68e-3)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "unprognostic (7.33e-2)" "unprognostic (1.35e-3)" "unprognostic (3.43e-1)" "prognostic favourable (1.78e-4)" "unprognostic (1.47e-2)" "unprognostic (2.37e-1)" "unprognostic (1.33e-1)" "unprognostic (9.60e-2)" 9.6 9.0 16.9 11.5 19.3 7.8 16.2 24.0 19.5 14.2 8.9 18.9 10.4 4.4 15.8 18.2 7.6 14.3 9.5 10.3 15.5 19.8 11.6 7.9 9.6 12.4 16.7 20.5 18.1 8.7 29.1 16.5 8.3 20.0 13.1 9.3 11.4 8.7 13.6 10.0 13.2 8.3 13.6 16.1 13.2 11.2 11.6 19.6 15.8 11.0 3.6 15.5 11.3 9.6 5.8 2.6 7.8 1.9 5.2 8.8 3.0 7.1 7.8 14.7 13.9 13.1 14.0 6.6 6.8 7.8 9.3 10.8 5.5 4.8 7.7 8.8 8.6 6.8 9.0 8.6 10.7 6.7 3.7 1.9 1.5 9.2 10.2 0.0 7.3 12.1 14.2 8.6 12.0 7.4 3.8 2.9 11.4 12.8 7.6 7.4 5.5 5.9 14.1 5.1 5.1 6.4 5.1 16.7 12.7 19.4 1.5 7.3 11.7 10.2 5.3 8.8 5.3 7.4 3.9 5.6 10.4 9.4 2.9 2.7 7.0 7.8 1.7 2.8 6.4 1.9 8.8 5.8 6.0 7.4 2.4 4.1 8.7 7.5 0.5 5.2 1.3 2.6 6.8 3.0 16.9 19.3 24.0 19.5 15.5 19.8 16.7 20.5 20.0 19.6 ZFPM1 "FOG, FOG1, ZC2HC11A, ZNF89A" ENSG00000179588 "Zinc finger protein, FOG family member 1" Q8IX07 16 88453317-88537016 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 30.4" "Cell line enhanced" "Detected in many" "HEL: 14.3;K-562: 21.2" "Cancer enhanced" "Detected in all" "stomach cancer: 12.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046603 Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA046603: " "unprognostic (1.29e-1)" "unprognostic (2.42e-1)" "unprognostic (3.08e-2)" "unprognostic (3.32e-2)" "unprognostic (1.13e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-1)" "unprognostic (7.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (5.58e-2)" "unprognostic (3.05e-2)" "unprognostic (2.49e-4)" "unprognostic (1.99e-2)" "unprognostic (3.32e-1)" "unprognostic (4.89e-2)" "prognostic favourable (4.24e-4)" 4.3 3.7 3.7 7.9 2.9 12.0 2.2 6.8 3.3 2.9 11.2 1.6 4.7 18.5 3.8 4.5 2.8 3.7 30.4 4.7 3.9 3.0 2.7 15.2 5.4 5.5 2.7 1.9 7.3 24.5 1.5 5.6 1.8 2.1 7.0 1.7 7.7 6.9 7.3 2.2 3.8 15.4 1.5 2.1 12.7 21.5 12.7 0.8 15.7 3.8 1.4 9.4 4.8 2.2 0.3 0.6 1.5 0.3 0.6 1.3 0.3 1.1 2.8 2.1 4.5 0.4 0.1 9.2 3.0 0.4 1.0 0.3 9.1 1.1 4.4 2.3 0.4 7.1 0.1 2.5 0.2 3.4 1.9 14.3 5.6 7.9 1.7 0.8 4.8 1.0 1.6 1.0 0.3 1.0 21.2 0.3 0.8 5.4 5.0 5.2 1.4 2.5 1.4 1.0 2.1 1.0 3.6 6.0 9.9 3.7 0.2 2.9 2.3 2.3 3.6 3.8 2.5 1.7 0.6 1.0 0.7 0.4 1.1 1.7 3.7 0.0 0.1 1.5 0.9 0.2 0.2 0.1 0.4 1.3 0.2 0.3 0.3 0.5 0.9 0.6 0.3 0.6 0.1 0.3 3.7 2.9 6.8 3.3 3.9 3.0 2.7 1.9 2.1 0.8 ZFYVE16 "KIAA0305, PPP1R69" ENSG00000039319 "Zinc finger FYVE-type containing 16" Q7Z3T8 5 80408013-80479350 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035935, HPA035936" Supported Enhanced Vesicles,Cytosol "Vesicles, Cytosol" "HPA035935: AB_10672076, HPA035936: AB_10669662" "unprognostic (1.11e-1)" "unprognostic (3.98e-2)" "unprognostic (1.78e-2)" "unprognostic (3.26e-1)" "unprognostic (7.19e-2)" "unprognostic (2.57e-2)" "unprognostic (7.25e-3)" "unprognostic (6.91e-2)" "unprognostic (4.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (2.15e-1)" "unprognostic (3.04e-1)" "unprognostic (4.64e-2)" "unprognostic (4.95e-2)" "unprognostic (6.91e-2)" "unprognostic (4.23e-2)" 10.7 11.9 11.0 10.1 28.9 6.1 11.6 14.9 19.2 21.2 9.0 33.2 7.7 6.7 17.0 6.6 9.6 9.7 14.6 17.6 11.7 9.5 13.1 13.3 11.6 6.8 25.7 16.8 16.8 7.1 13.4 15.0 16.5 37.3 11.5 8.4 9.0 8.6 9.3 12.7 6.4 8.7 12.8 26.9 11.2 8.4 11.7 21.2 3.8 12.6 4.6 5.8 12.8 10.8 2.5 2.3 17.3 3.9 2.4 1.5 0.3 5.6 6.7 11.9 11.5 7.2 7.5 8.0 8.8 7.6 7.9 10.7 4.9 6.6 3.9 6.4 7.2 5.9 8.5 7.2 8.7 2.5 5.6 4.2 9.1 5.5 6.1 1.2 3.2 8.2 4.0 6.6 6.3 9.0 4.1 6.1 8.5 7.2 2.7 1.2 2.8 3.1 5.7 24.8 4.1 6.8 11.1 4.5 10.4 12.6 6.0 41.5 8.4 3.9 7.9 4.8 5.5 7.3 7.3 1.8 3.5 3.9 6.3 3.9 10.6 11.5 3.7 1.8 1.5 2.3 0.8 2.5 0.7 1.3 1.4 2.5 0.6 0.7 17.3 2.4 3.9 2.3 0.8 0.3 11.0 28.9 14.9 19.2 11.7 9.5 25.7 16.8 37.3 21.2 ZFYVE27 "FLJ32919, SPG33" ENSG00000155256 "Zinc finger FYVE-type containing 27" Q5T4F4 10 97737121-97760907 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037523, HPA069876" Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA037523: AB_10672351, HPA069876: " "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "prognostic unfavourable (6.91e-4)" "unprognostic (3.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.30e-2)" "unprognostic (2.48e-2)" "unprognostic (7.15e-2)" "unprognostic (2.05e-3)" "unprognostic (5.24e-2)" "unprognostic (3.38e-3)" "prognostic favourable (7.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.26e-2)" "prognostic favourable (7.80e-4)" 10.1 22.6 16.1 12.7 20.8 20.7 11.8 28.6 33.0 10.3 17.4 15.7 17.4 25.6 11.6 25.4 9.8 17.9 14.1 12.8 17.6 20.7 15.5 18.2 11.3 15.2 15.1 23.4 17.1 15.4 19.6 24.3 14.3 17.6 13.3 17.5 25.6 14.0 11.8 7.9 17.1 24.0 9.4 14.7 18.1 14.9 14.2 13.3 12.2 13.1 5.5 14.7 8.5 10.4 11.2 8.5 13.4 12.6 9.0 15.2 11.7 10.4 12.9 7.8 17.2 8.9 6.2 10.6 10.7 11.3 12.5 12.3 11.4 21.8 16.2 12.3 7.7 23.5 11.2 10.4 6.6 16.6 11.3 7.6 12.7 10.6 11.4 12.2 15.4 10.1 12.6 12.3 9.5 7.0 11.3 10.9 9.3 8.1 9.8 23.2 6.3 10.0 11.3 7.8 7.6 12.0 6.4 6.3 12.2 7.2 6.1 27.7 13.3 12.2 7.4 6.3 7.5 9.6 20.3 12.7 10.7 8.4 15.8 15.8 7.2 7.1 8.4 13.4 15.2 9.1 13.1 10.9 10.5 12.0 8.0 11.2 12.1 12.9 12.1 9.0 12.6 8.5 13.4 11.7 16.1 20.8 28.6 33.0 17.6 20.7 15.1 23.4 17.6 13.3 ZFYVE9 "MADHIP, PPP1R173, SARA, SMADIP" ENSG00000157077 "Zinc finger FYVE-type containing 9" O95405 1 52142094-52346686 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017702, HPA065852, HPA065862" Approved Enhanced Vesicles,Cytosol "Vesicles, Cytosol" "CAB017702: AB_1128462, HPA065852: , HPA065862: " "unprognostic (5.05e-2)" "unprognostic (4.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.51e-1)" "unprognostic (7.15e-2)" "unprognostic (3.87e-1)" "unprognostic (2.87e-3)" "unprognostic (6.11e-2)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (2.47e-2)" "unprognostic (5.36e-2)" "unprognostic (1.17e-3)" "unprognostic (2.14e-1)" "unprognostic (3.69e-1)" "unprognostic (1.99e-3)" "unprognostic (1.73e-2)" 10.2 10.0 13.6 3.8 18.4 1.0 13.0 28.4 27.7 15.5 8.0 9.5 10.1 6.8 14.1 9.1 10.8 12.2 8.1 10.4 13.8 15.7 15.2 10.7 11.3 4.1 13.8 15.8 19.5 16.9 32.3 14.6 7.4 18.7 13.6 9.9 9.6 9.8 13.8 25.5 12.3 7.4 13.3 11.6 4.2 8.6 14.9 8.0 1.5 19.5 8.8 4.2 10.9 13.8 0.4 0.0 0.0 0.0 0.2 2.1 0.4 9.8 4.7 6.8 8.6 16.6 15.0 11.1 8.0 11.1 9.6 11.1 5.4 0.8 0.0 5.0 11.4 3.6 12.0 13.0 14.8 0.0 8.1 2.8 5.4 6.5 11.0 2.5 1.7 10.0 14.7 8.4 19.1 13.9 4.3 1.8 12.8 2.2 3.5 1.8 8.8 8.3 3.1 11.6 0.9 5.5 22.1 5.7 5.8 9.0 7.7 10.4 3.5 3.3 12.8 9.7 3.9 7.4 4.8 2.5 1.5 1.2 6.9 3.1 3.9 0.0 0.0 0.0 0.3 0.0 2.1 0.3 1.6 0.4 0.0 0.4 1.3 0.7 0.0 0.2 0.0 0.0 0.0 0.4 13.6 18.4 28.4 27.7 13.8 15.7 13.8 15.8 18.7 8.0 ZG16B "HRPE773, JCLN2, PRO1567" ENSG00000162078 "Zymogen granule protein 16B" Q96DA0 16 2830169-2839585 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "salivary gland: 1069.4" "Cell line enhanced" "Detected in some" "MCF7: 18.8;SK-BR-3: 17.4;T-47d: 15.9" "Cancer enhanced" "Detected in many" "prostate cancer: 47.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 6.7;intermediate monocyte: 11.4;non-classical monocyte: 7.3" "Lineage enriched" "Detected in many" 7 "monocytes: 11.4" "HPA041125, HPA053549" Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" 1200000 Vesicles Nucleoplasm "HPA041125: AB_10794264, HPA053549: AB_2682184" "unprognostic (5.29e-2)" "unprognostic (2.71e-1)" "unprognostic (4.37e-2)" "prognostic favourable (3.48e-6)" "unprognostic (1.39e-3)" "unprognostic (1.94e-2)" "unprognostic (2.34e-3)" "unprognostic (4.13e-2)" "unprognostic (1.01e-1)" "unprognostic (3.45e-3)" "unprognostic (1.37e-1)" "unprognostic (1.47e-2)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.17e-1)" "unprognostic (1.04e-1)" "unprognostic (8.33e-2)" 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.7 0.2 0.0 0.2 0.1 0.1 0.1 0.5 0.0 1.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.0 0.6 0.0 0.0 0.0 1.6 0.3 0.0 1069.4 0.2 0.1 0.8 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 78.5 3.7 0.2 0.2 0.0 1.1 1.7 11.4 1.1 0.4 1.7 0.0 0.8 0.0 0.0 0.2 1.4 0.1 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.2 0.0 1.5 0.0 3.1 0.0 0.0 0.0 6.3 1.8 1.6 1.2 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.1 2.6 0.2 18.8 0.0 0.3 0.1 3.6 0.0 0.0 5.9 0.1 4.4 0.0 0.0 0.0 17.4 0.0 15.9 0.0 2.2 0.0 0.4 1.3 0.0 0.0 0.3 0.2 0.2 4.5 0.2 1.7 6.7 0.0 0.0 11.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.5 1.1 7.3 0.0 0.4 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZGLP1 "GATAD3, GLP-1, GLP1" ENSG00000220201 "Zinc finger, GATA-like protein 1" P0C6A0 19 10304803-10309880 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 26.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA049855 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA049855: " "unprognostic (1.73e-2)" "unprognostic (3.43e-3)" "unprognostic (1.42e-3)" "unprognostic (1.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-4)" "unprognostic (1.18e-1)" "unprognostic (1.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.10e-2)" "unprognostic (1.10e-4)" "unprognostic (2.82e-2)" "unprognostic (6.57e-7)" "unprognostic (6.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.57e-1)" "unprognostic (2.57e-4)" 0.5 0.9 2.5 2.0 6.5 0.9 1.0 8.0 5.4 1.4 0.9 2.2 2.1 0.7 0.6 2.6 1.8 0.6 2.9 3.4 2.4 3.0 1.0 3.6 1.0 3.9 3.1 1.9 4.8 2.0 3.4 0.3 5.1 2.5 1.4 4.8 1.6 0.2 0.9 2.6 1.4 3.7 5.3 1.4 1.2 0.9 0.3 0.3 0.1 0.3 0.0 1.0 0.1 0.4 1.0 1.4 0.5 0.9 0.4 3.5 0.8 0.2 0.7 1.5 1.0 0.3 1.5 0.7 0.2 1.4 1.0 0.3 0.2 1.3 4.5 1.4 1.3 0.5 0.6 0.0 0.4 0.8 2.1 0.7 0.4 0.2 1.4 1.0 0.9 1.5 0.1 26.0 2.2 1.6 1.4 0.6 0.6 0.6 0.6 1.2 1.4 0.3 0.3 1.2 2.0 0.4 0.5 2.0 2.4 2.0 0.2 5.1 6.0 0.6 0.4 6.6 0.9 0.0 0.3 0.0 1.0 0.1 0.6 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 ZIC5 ENSG00000139800 "Zic family member 5" Q96T25 13 99962964-99971909 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 48.9" "Cell line enhanced" "Detected in some" "AF22: 10.9;HEK 293: 6.3;NTERA-2: 7.5;SCLC-21H: 42.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 24 "cerebellum: 48.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 19.3;cerebellum: 20.7;thalamus: 5.7" "Region enriched" "Detected in many" 6 "cerebellum: 53.2" HPA074045 Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA074045: " "unprognostic (2.78e-5)" "unprognostic (1.71e-2)" "unprognostic (2.44e-2)" "unprognostic (2.29e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.38e-4)" "unprognostic (2.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "unprognostic (3.87e-2)" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (4.94e-2)" 0.1 0.0 1.2 0.0 0.5 0.0 0.1 48.9 4.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.5 0.1 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 10.9 0.9 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 1.6 0.0 0.0 2.2 0.0 0.0 1.9 6.3 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 1.5 0.0 0.0 0.8 0.0 0.8 7.5 0.1 0.9 0.4 0.0 0.0 0.0 42.8 0.0 1.1 1.0 0.0 0.0 1.3 0.0 0.6 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.5 48.9 1.3 1.5 0.5 0.4 0.3 2.0 0.0 ZMIZ1 "FLJ13541, hZIMP10, KIAA1224, MIZ, RAI17, RP11-519K18.1, Zimp10" ENSG00000108175 "Zinc finger MIZ-type containing 1" Q9ULJ6 10 79069035-79316528 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045144 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA045144: AB_10962360" "unprognostic (4.09e-3)" "unprognostic (1.72e-1)" "unprognostic (2.63e-1)" "unprognostic (5.59e-2)" "unprognostic (2.02e-1)" "unprognostic (2.86e-2)" "unprognostic (3.64e-3)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (1.16e-1)" "unprognostic (3.13e-2)" "unprognostic (7.90e-2)" "prognostic favourable (3.64e-7)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (8.22e-2)" "unprognostic (1.34e-2)" 24.7 21.1 15.9 15.8 18.9 20.0 24.1 43.7 35.7 41.5 21.3 23.8 26.0 16.5 42.4 18.0 28.1 22.2 35.5 25.1 19.0 17.1 17.4 13.9 23.5 13.7 22.2 15.7 44.3 20.2 14.6 12.7 18.7 22.1 21.9 13.0 33.3 24.6 26.9 38.0 24.5 21.2 25.6 16.4 36.2 21.4 8.4 21.5 16.0 33.3 22.4 16.5 25.6 30.1 1.0 4.6 5.7 6.1 5.4 2.3 1.8 7.1 9.0 17.1 7.3 17.9 5.1 6.0 6.9 12.5 4.9 2.8 2.6 3.3 3.7 5.6 16.1 10.2 2.8 5.1 2.6 8.0 1.5 13.1 3.4 7.8 12.6 7.2 27.8 6.7 5.7 7.0 5.0 7.8 5.0 19.6 4.1 13.6 7.2 11.3 5.0 13.8 32.2 3.2 3.7 3.6 6.1 17.9 26.2 4.5 55.0 14.2 17.6 7.1 10.9 18.6 7.6 9.3 8.8 3.6 6.3 0.0 24.4 13.0 3.5 1.8 3.7 2.7 2.3 6.1 1.6 1.0 1.6 1.2 4.6 0.4 0.6 1.2 5.7 5.4 5.1 4.5 1.6 1.8 15.9 18.9 43.7 19.1 19.0 17.1 22.2 15.7 22.1 21.5 ZMYND19 MIZIP ENSG00000165724 "Zinc finger MYND-type containing 19" Q96E35 9 137582079-137590490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020642, HPA050761" Supported Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA020642: AB_1859078, HPA050761: " "unprognostic (2.30e-2)" "unprognostic (9.62e-3)" "unprognostic (3.45e-2)" "unprognostic (7.99e-2)" "unprognostic (2.66e-1)" "unprognostic (1.90e-1)" "prognostic unfavourable (1.70e-4)" "unprognostic (1.18e-1)" "unprognostic (2.48e-1)" "unprognostic (1.35e-1)" "unprognostic (9.33e-2)" "unprognostic (1.99e-2)" "unprognostic (2.39e-1)" "unprognostic (9.67e-3)" "unprognostic (4.30e-2)" "unprognostic (1.62e-1)" "unprognostic (1.72e-1)" 9.5 11.6 11.9 10.3 14.2 9.1 15.5 13.1 20.6 8.5 9.2 7.3 12.3 10.1 8.1 7.5 16.5 8.4 8.4 9.5 12.7 11.0 8.1 12.8 9.3 12.3 9.7 13.0 10.7 26.2 8.0 11.5 9.9 10.2 10.8 6.9 7.9 14.2 9.0 13.7 19.1 8.0 11.7 7.4 9.8 14.4 41.8 9.6 9.2 8.2 9.0 10.6 8.5 10.1 1.9 2.6 0.8 4.7 0.4 3.3 0.4 10.5 16.8 16.0 17.3 8.7 8.4 16.2 14.6 9.8 16.1 12.4 19.8 10.8 19.2 16.9 9.6 26.9 19.5 14.6 5.1 12.4 18.9 9.9 31.2 15.3 13.5 21.3 13.1 6.6 22.6 14.6 14.4 8.5 24.0 8.5 9.7 35.7 24.7 32.5 23.2 23.5 27.1 14.1 29.4 9.8 9.0 23.2 15.2 14.1 30.4 12.7 20.4 33.2 8.0 19.9 15.0 29.4 23.5 8.2 19.5 20.6 12.3 16.6 13.6 0.0 0.9 0.8 1.4 4.7 3.3 1.9 1.0 0.7 0.9 1.0 1.6 1.3 0.0 0.4 0.5 2.6 2.7 0.4 11.9 14.2 13.1 20.6 12.7 11.0 9.7 13.0 10.2 9.6 ZNF10 KOX1 ENSG00000256223 "Zinc finger protein 10" P21506 12 133130575-133159465 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 57.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003204 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA003204: AB_1080663" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (4.32e-2)" "unprognostic (1.35e-1)" "unprognostic (6.48e-2)" "unprognostic (2.67e-3)" "unprognostic (1.87e-1)" "unprognostic (6.39e-3)" "unprognostic (4.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.35e-3)" "unprognostic (2.50e-2)" "unprognostic (3.94e-2)" "unprognostic (3.41e-1)" "unprognostic (1.52e-1)" "unprognostic (4.36e-2)" "unprognostic (5.13e-3)" 4.8 12.7 5.7 4.9 11.5 6.3 10.5 13.0 9.9 9.3 7.9 7.8 14.4 3.0 12.7 20.7 5.1 10.2 9.9 6.7 5.0 5.6 7.3 7.6 6.4 4.4 8.5 6.4 18.2 10.3 22.6 57.6 4.2 8.3 12.2 5.4 8.8 6.2 16.4 5.1 7.2 5.6 12.3 8.8 5.0 8.2 12.1 7.9 6.8 17.3 5.1 5.6 8.1 7.2 4.4 4.4 1.8 0.7 8.6 8.8 2.4 3.1 2.0 9.9 0.0 11.1 4.7 6.0 4.0 3.6 5.0 3.4 3.6 2.2 0.0 5.6 4.0 1.6 6.3 3.3 3.7 0.0 5.8 7.3 9.3 3.7 3.3 4.4 2.5 4.9 3.1 5.4 6.0 4.0 5.2 0.0 5.9 1.1 10.6 9.4 10.2 4.1 8.8 6.3 4.9 3.9 7.2 10.0 6.3 8.0 1.1 3.3 6.2 4.3 3.9 3.7 3.4 3.4 3.3 0.2 0.0 11.6 1.1 1.6 3.3 1.1 0.6 1.8 4.0 0.7 4.5 4.2 4.6 5.5 1.7 4.4 8.8 4.4 0.7 8.6 0.5 4.4 1.2 2.4 5.7 11.5 13.0 9.9 5.0 5.6 8.5 6.4 8.3 7.9 ZNF132 pHZ-12 ENSG00000131849 "Zinc finger protein 132" P52740 19 58432814-58440222 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008726 Uncertain Approved "Vesicles,Intermediate filaments" Vesicles "Intermediate filaments" "HPA008726: AB_1080664" "unprognostic (4.86e-2)" "unprognostic (2.03e-1)" "unprognostic (6.79e-3)" "unprognostic (3.06e-2)" "unprognostic (8.16e-2)" "unprognostic (4.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.32e-3)" "unprognostic (5.00e-2)" "unprognostic (1.29e-1)" "prognostic favourable (1.92e-4)" "unprognostic (4.51e-1)" "prognostic favourable (7.26e-13)" "unprognostic (2.70e-1)" "unprognostic (7.65e-2)" "unprognostic (6.09e-2)" "unprognostic (3.72e-1)" 2.9 4.7 4.0 2.5 5.9 0.8 5.1 11.8 8.5 5.9 4.1 6.6 4.5 2.5 4.2 7.2 3.5 7.9 4.7 5.9 6.0 4.5 6.2 2.1 3.6 3.3 4.4 5.5 7.6 4.3 15.3 12.1 3.7 5.9 6.1 2.4 5.4 5.8 6.7 3.7 4.7 2.6 5.9 4.2 4.5 3.6 7.2 6.0 3.1 10.8 2.8 4.3 5.7 6.3 3.9 2.9 2.0 2.6 2.6 5.7 2.1 1.7 2.1 4.8 1.7 5.6 4.6 0.2 3.6 4.5 3.0 2.7 0.1 1.4 4.5 0.3 4.4 1.8 0.0 5.4 2.1 0.7 8.2 0.8 1.4 1.0 5.0 1.7 3.0 5.1 1.9 5.1 3.2 2.6 0.7 0.5 5.6 0.6 1.0 0.1 4.9 1.7 0.6 1.1 1.3 1.8 2.0 4.3 4.4 1.4 1.3 1.5 0.3 4.4 3.3 3.1 0.4 0.8 0.7 5.9 1.1 0.0 1.5 0.1 1.9 0.0 1.9 2.0 2.2 2.2 5.7 2.9 2.9 1.2 2.9 3.9 4.6 3.7 0.2 2.6 2.6 2.4 2.5 2.1 4.0 5.9 11.8 8.5 6.0 4.5 4.4 5.5 5.9 6.0 ZNF133 "pHZ-13, pHZ-66, ZNF150" ENSG00000125846 "Zinc finger protein 133" P52736 20 18288283-18316996 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001493 Supported Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA001493: AB_1080666" "unprognostic (9.09e-3)" "unprognostic (3.24e-1)" "unprognostic (8.27e-3)" "unprognostic (6.82e-2)" "unprognostic (2.20e-2)" "unprognostic (1.54e-2)" "prognostic unfavourable (4.46e-6)" "unprognostic (6.01e-3)" "unprognostic (8.60e-2)" "unprognostic (4.17e-1)" "unprognostic (1.04e-3)" "unprognostic (7.36e-2)" "prognostic unfavourable (2.20e-5)" "unprognostic (5.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (1.52e-1)" 10.0 10.1 12.4 11.4 15.9 5.6 20.8 25.4 18.4 13.9 11.6 14.4 12.6 7.7 18.2 24.9 13.2 14.2 11.2 10.6 12.0 12.0 12.1 9.6 10.6 7.4 10.3 12.1 19.5 12.5 17.9 24.7 12.5 14.1 14.9 10.2 9.2 13.6 13.9 17.2 22.2 8.1 15.7 12.1 12.5 9.9 8.9 13.2 7.1 14.7 9.3 9.5 10.0 12.1 5.4 5.4 3.4 4.5 10.7 8.7 3.5 6.8 7.6 6.0 8.6 14.7 10.2 12.7 6.5 9.6 8.3 12.1 6.0 8.2 1.8 3.9 7.7 15.2 5.7 17.0 7.9 1.9 4.0 4.7 6.4 13.3 11.1 4.0 0.7 9.9 11.7 6.9 20.4 8.0 5.5 2.0 7.1 6.9 4.9 6.5 4.9 7.6 4.3 8.2 4.4 8.1 4.7 8.5 8.7 5.0 13.6 9.3 5.2 10.9 5.6 8.9 4.3 6.2 6.4 6.6 6.6 0.6 2.7 2.7 5.0 1.2 4.3 3.4 8.7 3.0 5.8 4.7 7.4 5.9 5.4 5.4 5.8 6.8 1.5 10.7 4.5 2.8 5.5 3.5 12.4 15.9 25.4 18.4 12.0 12.0 10.3 12.1 14.1 13.2 ZNF143 "pHZ-1, SBF, STAF" ENSG00000166478 "Zinc finger protein 143" P52747 11 9460319-9528524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003263, HPA074818" Supported Approved "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA003263: AB_1080672, HPA074818: " "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (5.51e-2)" "unprognostic (9.72e-2)" "unprognostic (5.09e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (1.76e-5)" "unprognostic (4.87e-3)" "unprognostic (2.57e-3)" "unprognostic (9.56e-2)" "unprognostic (1.26e-3)" "unprognostic (1.06e-1)" "prognostic unfavourable (6.78e-4)" "unprognostic (1.20e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-2)" "unprognostic (7.55e-2)" 22.7 9.8 11.6 13.6 11.7 20.9 16.4 25.4 11.8 16.8 14.7 11.0 12.8 11.8 20.8 19.5 14.7 13.4 10.7 13.2 11.9 10.8 11.9 12.1 14.0 18.0 12.6 8.7 18.8 10.7 10.3 24.0 15.7 11.4 17.4 12.9 11.7 14.9 13.0 27.0 12.8 13.5 16.1 15.2 18.7 11.6 20.4 13.8 27.4 18.8 10.4 17.3 25.0 21.8 13.0 12.0 31.2 15.6 10.2 17.0 10.5 15.0 14.6 18.5 12.1 15.1 14.1 16.7 16.7 13.6 12.9 14.2 20.5 18.8 14.9 7.8 13.6 17.2 17.8 13.3 19.5 14.9 21.6 14.1 21.6 14.2 12.5 19.5 14.2 12.3 16.0 17.5 15.5 12.8 15.1 18.3 14.1 13.0 17.8 8.0 20.6 15.4 16.3 16.8 9.2 11.4 18.5 12.7 12.4 18.5 12.6 10.9 11.7 10.9 12.4 17.2 12.2 11.9 14.7 9.1 15.5 25.5 10.9 11.2 9.7 20.6 14.2 31.2 17.0 13.9 15.3 13.0 15.2 13.8 12.0 11.2 14.2 12.2 25.7 10.2 15.6 5.8 16.6 10.5 11.6 11.7 25.4 11.8 11.9 10.8 12.6 8.7 11.4 13.8 ZNF213 "CR53, ZKSCAN21, ZSCAN53" ENSG00000085644 "Zinc finger protein 213" O14771 16 3129777-3142805 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035000, HPA056750" Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA035000: AB_10669997, HPA056750: " "unprognostic (1.94e-1)" "unprognostic (1.62e-2)" "unprognostic (3.25e-1)" "unprognostic (1.87e-2)" "unprognostic (1.31e-2)" "unprognostic (4.05e-3)" "prognostic unfavourable (6.74e-4)" "unprognostic (4.72e-2)" "unprognostic (1.25e-1)" "unprognostic (2.31e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-1)" "unprognostic (4.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.57e-1)" 5.7 8.2 9.0 6.0 10.3 6.0 5.7 10.8 16.7 5.0 6.2 14.6 4.7 9.3 7.5 5.1 8.4 6.8 6.0 9.1 9.5 7.7 4.4 2.4 6.3 8.8 7.1 9.3 10.3 12.1 8.7 7.3 4.1 9.1 6.5 2.5 6.8 17.4 5.9 11.1 16.9 11.2 6.8 7.6 7.5 6.9 20.1 8.0 7.5 9.2 4.7 5.4 7.1 5.8 4.8 3.2 3.5 2.5 4.0 4.7 1.8 3.3 10.6 4.7 11.2 4.6 3.8 5.9 6.2 2.5 3.3 3.8 3.4 7.0 4.1 6.1 4.0 8.2 2.2 6.8 1.3 8.5 8.2 2.9 11.7 6.6 8.8 7.0 7.6 3.7 8.5 4.6 1.7 2.4 7.4 9.2 2.1 14.5 6.5 8.6 8.1 8.1 8.8 5.5 7.5 2.6 2.3 9.8 8.5 9.3 5.6 4.4 7.3 12.1 6.0 6.7 6.1 7.5 4.3 5.2 4.8 6.3 2.7 9.3 5.1 0.0 1.6 3.4 3.7 2.5 3.2 2.7 3.6 2.4 1.6 4.8 4.7 3.4 3.5 4.0 1.9 3.2 2.0 1.8 9.0 10.3 10.8 16.7 9.5 7.7 7.1 9.3 9.1 8.0 ZNF215 "ZKSCAN11, ZSCAN43" ENSG00000149054 "Zinc finger protein 215" Q9UL58 11 6926404-7001004 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.6" "Cell line enhanced" "Detected in many" "U-698: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA047243, HPA051010" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA047243: , HPA051010: " "unprognostic (2.18e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-2)" "unprognostic (1.08e-1)" "unprognostic (8.18e-2)" "unprognostic (4.76e-2)" "unprognostic (1.01e-4)" "unprognostic (2.02e-1)" "unprognostic (1.50e-2)" "unprognostic (1.05e-1)" "unprognostic (3.44e-1)" "unprognostic (1.45e-2)" "unprognostic (9.01e-3)" "unprognostic (4.29e-3)" "unprognostic (7.89e-2)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" 1.2 1.4 1.5 9.0 1.8 1.4 2.7 0.7 4.0 1.9 4.2 0.3 0.9 4.6 2.3 5.2 2.8 1.4 1.1 1.4 1.2 2.2 2.9 1.6 1.5 6.7 0.7 1.4 1.9 10.4 0.0 0.8 0.7 1.9 2.7 5.5 1.2 4.2 2.0 0.9 1.6 5.5 0.9 1.1 4.8 1.6 6.1 0.0 6.5 2.7 2.1 11.6 3.3 2.2 2.5 2.9 4.0 1.8 1.5 1.4 0.8 2.6 1.2 1.7 0.6 1.3 1.6 5.7 6.1 5.2 3.2 6.3 0.2 0.1 8.5 2.0 3.2 3.0 5.0 6.0 6.0 0.0 6.9 0.1 0.8 0.1 1.2 5.3 0.4 2.8 2.9 0.1 6.5 5.0 10.0 3.0 1.3 0.1 0.2 0.2 8.4 1.7 0.2 0.1 1.0 0.2 4.7 0.1 0.2 0.0 2.1 0.2 0.2 2.1 2.4 2.0 5.7 2.3 0.1 0.4 0.1 17.8 4.5 0.3 1.7 4.0 1.8 0.6 0.8 1.0 0.3 2.5 0.6 1.4 1.7 2.5 1.4 0.8 2.7 1.5 0.5 2.9 0.7 0.8 1.5 1.8 0.7 4.0 1.2 2.2 0.7 1.4 1.9 0.0 ZNF229 ENSG00000278318 "Zinc finger protein 229" Q9UJW7 19 44417519-44448578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 9.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" HPA001494 Uncertain Approved "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA001494: AB_1080692" "unprognostic (2.59e-1)" "unprognostic (7.41e-4)" "unprognostic (2.13e-1)" "unprognostic (1.08e-1)" "unprognostic (3.90e-1)" "unprognostic (2.17e-1)" "unprognostic (3.34e-2)" "unprognostic (7.18e-3)" "unprognostic (1.17e-2)" "unprognostic (4.66e-2)" "unprognostic (4.18e-2)" "unprognostic (5.04e-3)" "prognostic favourable (8.43e-5)" "unprognostic (3.66e-3)" "unprognostic (2.01e-2)" "unprognostic (2.18e-1)" "unprognostic (4.34e-1)" 1.7 4.1 6.6 0.5 8.2 0.4 2.3 7.7 4.0 2.9 1.2 1.5 1.1 1.7 3.6 2.6 1.9 4.8 1.4 3.1 4.8 2.1 1.7 1.4 0.8 1.8 2.2 6.0 0.9 10.5 8.7 2.5 3.9 2.9 0.4 3.4 2.5 2.2 1.9 0.8 0.6 2.7 4.5 1.2 1.2 2.1 3.8 1.5 6.6 0.0 0.8 2.7 0.9 1.4 0.4 0.5 0.1 4.8 1.1 0.4 0.0 4.8 3.8 0.1 4.1 2.7 0.0 5.8 2.5 3.3 4.2 0.0 0.7 0.0 2.7 3.6 2.0 0.0 4.4 2.1 0.0 1.7 0.7 1.0 0.3 6.7 0.1 0.0 4.2 0.1 2.8 9.1 2.9 0.2 0.0 3.7 0.1 0.0 0.0 3.4 1.3 0.0 0.0 1.6 3.0 7.5 1.2 1.2 2.7 0.4 0.0 0.1 0.0 3.0 2.5 0.1 0.8 0.2 5.0 2.8 0.0 0.0 0.0 3.6 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.4 1.4 1.1 0.4 0.0 4.8 0.0 0.4 0.0 0.4 ZNF232 ZSCAN11 ENSG00000167840 "Zinc finger protein 232" Q9UNY5 17 5105541-5123116 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027309, HPA028611" Uncertain Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA027309: AB_10603464, HPA028611: " "unprognostic (4.20e-2)" "unprognostic (2.06e-3)" "unprognostic (3.69e-1)" "unprognostic (5.59e-3)" "unprognostic (5.21e-2)" "unprognostic (5.90e-3)" "prognostic unfavourable (4.66e-4)" "unprognostic (3.12e-2)" "unprognostic (5.46e-3)" "unprognostic (2.49e-2)" "prognostic favourable (6.55e-4)" "unprognostic (3.28e-2)" "unprognostic (3.49e-3)" "unprognostic (2.22e-2)" "unprognostic (2.28e-1)" "unprognostic (1.11e-1)" "unprognostic (8.61e-3)" 6.7 5.2 6.5 6.7 9.5 2.0 7.4 14.3 11.1 6.6 8.2 11.1 7.8 4.5 8.9 10.1 5.5 9.9 5.5 5.9 7.3 5.4 6.6 6.3 6.3 7.0 9.8 5.7 14.3 10.0 3.8 8.7 6.2 8.7 7.6 5.9 6.5 8.8 6.4 7.7 5.5 6.3 8.5 6.2 6.9 7.2 7.5 10.7 6.4 8.0 5.4 6.1 6.3 6.2 11.8 7.4 1.9 2.1 5.4 7.8 3.9 5.5 4.2 6.9 7.0 2.5 1.1 3.7 2.7 1.4 2.7 3.8 6.5 1.4 11.2 3.4 1.0 3.8 4.8 2.8 1.6 4.4 7.3 1.9 9.7 5.8 3.6 0.0 3.4 2.0 3.0 2.9 2.6 1.9 9.4 4.2 3.3 2.7 9.5 3.9 13.5 4.6 8.2 4.4 7.5 2.3 0.8 7.2 4.7 5.4 2.2 4.4 1.1 2.8 3.2 2.7 4.6 2.1 5.3 5.6 8.8 2.8 7.0 0.3 4.5 1.4 2.1 1.9 4.7 1.9 5.5 11.8 5.2 6.2 4.0 11.0 7.8 7.2 0.1 5.4 1.2 7.4 4.2 3.9 6.5 9.5 14.3 11.1 7.3 5.4 9.8 5.7 8.7 10.7 ZNF266 HZF1 ENSG00000174652 "Zinc finger protein 266" Q14584 19 9412598-9435578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA026836, HPA054110" Uncertain Supported "Nucleoplasm,Vesicles,Rods & Rings" Vesicles "Nucleoplasm, Rods & Rings" "HPA026836: , HPA054110: " "unprognostic (2.50e-2)" "prognostic favourable (1.41e-4)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (7.60e-2)" "prognostic favourable (3.94e-6)" "unprognostic (1.72e-2)" "prognostic favourable (4.47e-4)" "unprognostic (4.59e-2)" "unprognostic (9.00e-3)" "prognostic favourable (3.03e-5)" "unprognostic (2.92e-3)" "prognostic unfavourable (1.82e-4)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" "prognostic favourable (9.15e-5)" 14.7 12.1 11.0 21.5 12.5 12.8 17.6 19.0 10.0 21.8 15.7 13.1 9.6 8.6 17.2 55.8 12.7 14.6 12.8 11.7 8.2 5.4 10.9 10.4 15.8 21.0 14.5 4.9 18.9 11.2 12.5 19.8 13.0 11.4 23.8 15.7 14.4 14.4 13.5 9.3 19.1 20.8 17.0 10.9 31.3 13.5 13.0 11.4 34.6 20.8 7.3 23.4 14.4 14.2 6.9 3.8 5.6 5.5 12.6 13.0 5.1 10.6 2.7 7.9 15.1 5.7 11.1 6.4 11.8 10.0 9.8 16.3 5.7 4.6 11.9 7.6 5.8 4.0 10.0 6.3 11.7 3.3 16.5 16.3 14.6 8.3 5.1 9.3 10.1 10.5 8.7 5.3 8.2 7.8 8.5 0.1 9.0 1.0 13.6 45.8 8.3 9.0 6.1 8.2 8.3 7.6 13.3 6.8 10.7 5.4 6.4 6.6 4.7 7.2 7.1 9.1 3.5 13.7 6.0 19.5 25.8 14.2 2.8 8.9 6.8 4.8 4.1 5.6 13.0 4.8 8.5 6.0 7.2 9.2 3.3 6.9 10.6 10.2 3.6 12.6 5.5 3.8 8.7 5.1 11.0 12.5 19.0 10.0 8.2 5.4 14.5 4.9 11.4 11.4 ZNF302 "ZNF135L, ZNF140L, ZNF327" ENSG00000089335 "Zinc finger protein 302" Q9NR11 19 34677639-34686397 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA059503 Approved "Vesicles,Cytokinetic bridge" "Vesicles, Cytokinetic bridge" "HPA059503: " "unprognostic (3.52e-1)" "unprognostic (1.85e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (2.03e-5)" "unprognostic (2.25e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-1)" "unprognostic (1.50e-2)" "unprognostic (4.33e-3)" "unprognostic (1.82e-2)" "unprognostic (4.63e-2)" "unprognostic (3.39e-2)" "prognostic unfavourable (5.41e-4)" "unprognostic (2.34e-1)" "unprognostic (1.21e-1)" "unprognostic (3.94e-2)" "prognostic favourable (9.85e-5)" 12.4 18.0 21.8 12.5 23.7 3.5 23.6 36.5 22.5 16.0 14.3 14.7 16.5 11.7 19.2 21.3 10.0 18.7 10.6 23.6 22.2 18.1 16.4 17.1 13.8 15.5 26.8 18.4 28.6 19.1 26.7 22.8 11.8 21.4 19.1 15.1 13.0 12.4 21.8 29.8 12.4 12.1 18.4 22.8 15.5 12.3 14.0 25.7 12.6 18.8 10.2 15.3 13.7 9.7 17.3 14.1 14.4 7.8 12.0 21.1 6.0 5.7 9.0 18.6 7.2 17.6 13.9 6.4 9.9 12.3 9.2 10.0 6.6 4.8 8.9 12.5 7.2 4.5 9.0 5.6 9.9 0.6 7.7 17.1 9.7 0.2 9.7 0.1 1.2 12.7 8.5 5.3 0.8 7.8 0.0 0.1 14.2 3.0 8.8 9.0 8.3 5.9 6.8 15.5 4.6 9.5 7.5 8.3 13.7 9.0 2.9 11.8 6.7 13.6 7.5 4.0 10.0 3.4 4.8 10.7 18.7 2.8 3.8 1.2 18.8 14.4 7.0 11.2 10.9 6.3 14.8 15.0 12.3 10.2 5.8 17.3 21.1 16.3 3.9 12.0 7.8 14.1 9.6 6.0 21.8 23.7 36.5 22.5 22.2 18.1 26.8 18.4 21.4 25.7 ZNF326 "FLJ20403, ZAN75, Zfp326, ZIRD" ENSG00000162664 "Zinc finger protein 326" Q5BKZ1 1 89995112-90035531 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028450, HPA028461, HPA028466" Supported Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "HPA028450: , HPA028461: AB_10601777, HPA028466: AB_10601677" "prognostic favourable (9.46e-4)" "unprognostic (2.45e-1)" "unprognostic (7.25e-3)" "unprognostic (1.09e-1)" "unprognostic (5.28e-3)" "unprognostic (1.67e-2)" "unprognostic (8.61e-3)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (3.17e-2)" "unprognostic (3.66e-2)" "unprognostic (1.33e-2)" "unprognostic (2.62e-2)" "unprognostic (8.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-1)" "prognostic favourable (2.84e-4)" 12.7 13.4 18.4 12.7 27.8 45.2 17.7 20.2 18.5 11.8 14.1 23.2 16.3 18.5 18.3 17.1 17.5 11.9 13.9 12.5 19.2 15.2 13.4 15.2 11.5 15.3 26.1 14.1 21.8 20.2 14.4 18.0 14.5 22.8 13.3 20.7 23.9 15.7 9.4 19.2 14.5 18.9 17.8 31.3 11.0 14.6 10.6 27.8 17.3 14.1 10.5 15.1 11.9 17.2 6.8 8.4 3.6 6.1 7.8 4.3 2.2 16.9 15.5 24.1 11.5 10.8 5.1 25.5 17.2 6.7 14.3 8.9 14.4 12.3 21.2 12.3 8.8 15.3 25.1 11.2 19.6 12.4 12.0 19.1 15.1 13.0 3.6 22.4 9.4 4.5 5.3 14.2 9.0 8.2 25.5 9.3 11.4 8.0 23.1 12.8 22.7 17.6 16.5 24.5 5.7 11.8 19.0 21.2 13.8 19.8 18.4 8.4 10.1 5.9 11.2 16.8 16.9 14.1 17.0 7.9 7.7 21.2 4.0 17.7 10.7 2.1 5.1 3.6 4.0 6.1 3.2 4.2 3.2 3.4 4.0 6.8 3.2 4.3 2.5 7.8 4.6 8.4 2.8 2.2 18.4 27.8 20.2 18.5 19.2 15.2 26.1 14.1 22.8 27.8 ZNF33A "FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK" ENSG00000189180 "Zinc finger protein 33A" Q06730 10 38010650-38065088 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA005538, HPA056638" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles" "Nucleoli fibrillar center, Endoplasmic reticulum" Vesicles "HPA005538: , HPA056638: " "unprognostic (1.85e-2)" "unprognostic (1.19e-1)" "unprognostic (7.68e-3)" "unprognostic (1.48e-1)" "unprognostic (3.42e-2)" "unprognostic (1.69e-3)" "unprognostic (7.96e-3)" "unprognostic (4.89e-3)" "unprognostic (6.73e-2)" "unprognostic (9.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.75e-2)" "unprognostic (2.14e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-2)" "unprognostic (6.83e-2)" "unprognostic (7.39e-3)" 11.7 13.9 10.6 18.5 13.2 10.9 19.4 34.6 15.9 17.1 14.4 8.9 31.3 13.7 16.1 17.9 14.1 16.2 12.4 11.5 13.5 10.9 16.8 16.9 12.0 14.2 18.2 13.5 16.3 21.8 24.1 49.7 12.0 18.8 17.7 17.0 9.7 18.9 27.7 16.7 14.4 16.9 17.8 17.3 17.4 17.1 6.4 16.4 12.8 18.9 11.0 16.7 16.1 15.9 7.0 6.8 17.2 6.5 4.8 6.8 3.2 10.8 6.1 11.5 9.6 5.5 7.3 8.9 4.9 4.9 6.4 7.1 6.6 9.9 21.2 5.4 6.6 7.2 13.6 8.7 6.0 12.7 15.1 16.8 12.1 8.9 5.7 23.7 14.1 6.2 15.9 4.7 7.3 5.4 8.8 11.4 6.4 7.0 9.8 5.5 11.5 7.2 8.5 7.7 9.8 9.1 10.1 8.7 13.8 7.6 8.5 4.4 10.4 6.4 4.9 5.6 8.3 6.2 3.9 9.0 11.0 12.8 5.2 13.3 2.6 9.6 3.8 6.3 6.2 5.4 5.5 7.0 5.5 4.1 3.6 7.0 6.8 5.3 17.2 4.8 6.5 6.8 3.7 3.2 10.6 13.2 34.6 15.9 13.5 10.9 18.2 13.5 18.8 16.4 ZNF33B "KOX2, KOX31, ZNF11B" ENSG00000196693 "Zinc finger protein 33B" Q06732 10 42574185-42638568 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA005538, HPA056638" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles" "Nucleoli fibrillar center, Endoplasmic reticulum" Vesicles "HPA005538: , HPA056638: " "unprognostic (3.01e-3)" "unprognostic (2.20e-1)" "unprognostic (2.93e-2)" "unprognostic (8.34e-2)" "unprognostic (5.15e-2)" "unprognostic (1.16e-1)" "unprognostic (1.01e-2)" "unprognostic (2.19e-2)" "unprognostic (1.43e-2)" "unprognostic (1.18e-1)" "unprognostic (3.73e-1)" "unprognostic (3.79e-2)" "unprognostic (2.90e-3)" "unprognostic (3.71e-1)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (1.61e-2)" 6.6 8.0 6.1 8.0 6.3 1.9 16.1 19.1 8.0 10.2 9.8 2.2 16.5 6.8 9.3 8.6 8.6 15.0 6.6 4.6 5.6 8.1 16.7 8.2 6.9 8.3 5.1 8.5 19.4 31.8 16.6 29.9 8.1 9.3 14.1 8.2 5.2 16.4 13.9 4.8 9.5 11.4 7.8 5.0 10.9 11.0 3.8 2.8 10.8 20.8 4.1 6.6 11.0 10.2 14.8 8.6 11.3 6.1 6.1 16.9 8.5 9.5 2.4 6.5 6.6 2.4 0.3 8.1 6.3 4.6 3.9 5.4 5.3 11.1 14.4 3.7 2.2 8.2 12.4 4.1 4.4 8.5 9.3 5.7 8.9 8.7 2.8 13.6 4.7 3.9 15.3 2.4 13.0 3.3 7.8 11.0 2.3 4.1 5.3 3.2 7.0 5.8 5.8 6.4 6.1 10.3 13.6 11.7 11.4 3.8 7.9 3.7 10.1 4.1 4.0 2.0 9.5 3.4 6.3 7.2 10.9 4.5 1.4 10.3 1.8 11.3 6.1 5.3 9.0 5.0 12.8 14.8 13.2 9.1 5.3 12.6 16.9 11.9 1.9 6.1 3.9 8.6 10.3 8.5 6.1 6.3 19.1 8.0 5.6 8.1 5.1 8.5 9.3 2.8 ZNF341 dJ553F4.3 ENSG00000131061 "Zinc finger protein 341" Q9BYN7 20 33731657-33792269 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023240, HPA024607, HPA067108" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: " "unprognostic (1.74e-1)" "unprognostic (2.18e-1)" "unprognostic (3.73e-1)" "unprognostic (2.10e-1)" "unprognostic (9.31e-2)" "prognostic favourable (3.93e-4)" "prognostic unfavourable (1.87e-4)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (1.80e-1)" "unprognostic (7.38e-2)" "unprognostic (9.31e-2)" "unprognostic (8.17e-5)" "unprognostic (4.84e-2)" "unprognostic (2.90e-1)" "unprognostic (8.67e-3)" "unprognostic (3.68e-2)" 4.5 4.3 7.3 6.9 10.4 7.7 5.1 10.4 9.1 6.5 4.9 7.2 2.1 5.8 6.5 3.5 6.7 5.4 5.2 4.5 6.8 3.1 3.1 3.6 4.7 5.5 8.8 6.3 5.5 5.4 4.0 5.2 5.4 4.9 4.9 4.9 3.7 5.7 6.9 7.2 8.2 5.0 4.9 4.2 5.8 4.5 7.4 6.9 4.9 4.9 2.9 4.7 6.5 5.5 2.6 1.5 5.9 2.4 2.2 2.4 1.4 1.8 8.1 3.0 4.0 2.9 2.1 11.0 2.8 1.7 2.7 1.3 6.1 5.2 3.7 3.7 1.9 3.5 2.7 4.8 0.9 3.6 2.7 4.2 3.3 2.8 1.0 2.4 4.6 2.0 2.9 2.1 1.2 2.7 2.2 1.5 2.3 3.7 2.2 1.0 2.5 4.2 2.5 1.3 1.8 1.5 6.2 2.1 1.9 8.1 5.4 1.0 6.2 2.1 2.1 3.5 1.2 0.8 2.2 1.2 1.6 2.9 4.3 1.6 2.6 3.5 1.9 5.9 1.9 2.4 1.6 2.6 1.2 1.3 1.5 2.5 1.1 2.4 3.8 2.2 1.5 1.1 1.0 1.4 7.3 10.4 10.4 9.1 6.8 3.1 8.8 6.3 4.9 6.9 ZNF365 "KIAA0844, UAN" ENSG00000138311 "Zinc finger protein 365" "Q70YC4, Q70YC5" 10 62374192-62672011 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.3" "Cell line enhanced" "Detected in many" "HaCaT: 17.2;PC-3: 11.1;U-251 MG: 14.3;U-87 MG: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 3.4;memory CD4 T-cell: 3.1;memory CD8 T-cell: 3.5;naive CD8 T-cell: 3.7;NK-cell: 7.4;T-reg: 7.5" "Group enriched" "Detected in many" 51 "NK-cells: 7.4;T-cells: 7.5" "Group enriched" "Detected in all" 4 "amygdala: 328.0;basal ganglia: 309.9;cerebral cortex: 424.1;hippocampal formation: 348.1;thalamus: 127.9" "Low region specificity" "Detected in all" HPA052446 Enhanced Supported "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "HPA052446: " "unprognostic (7.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.36e-1)" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (4.05e-3)" "unprognostic (1.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.15e-2)" "unprognostic (3.11e-3)" "unprognostic (3.06e-2)" "unprognostic (7.90e-2)" "unprognostic (1.12e-6)" "unprognostic (2.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-4)" "unprognostic (2.89e-2)" 0.9 2.5 11.8 1.0 19.4 1.0 1.3 8.4 41.3 2.0 0.9 13.1 0.0 1.1 1.2 1.5 11.7 1.0 4.0 2.0 9.6 7.4 1.1 1.2 3.1 1.1 7.5 16.0 1.0 1.3 9.0 1.8 1.2 6.9 3.0 1.1 1.0 1.2 3.3 1.0 2.6 0.9 0.9 10.5 1.3 1.0 1.6 9.1 0.0 1.6 0.0 2.2 1.9 1.2 0.1 0.0 0.1 0.1 7.4 7.5 1.0 5.7 0.8 0.5 0.7 0.6 0.3 0.3 4.3 4.5 2.2 1.9 0.6 1.4 0.4 0.7 2.6 17.2 0.5 0.3 2.9 0.2 0.4 0.3 1.5 0.4 0.2 0.3 1.4 0.3 0.3 5.8 0.8 0.7 0.4 0.6 4.2 2.1 0.7 0.5 0.8 11.1 0.4 0.5 0.4 0.5 2.6 0.2 0.9 1.1 0.9 0.4 0.1 0.3 3.1 1.2 5.6 0.6 14.3 0.2 0.5 0.3 10.2 0.6 1.9 0.0 0.0 0.0 3.4 0.1 0.0 0.0 3.1 3.5 0.0 0.1 0.6 3.7 0.1 7.4 0.1 0.0 7.5 1.0 11.8 19.4 8.4 32.3 9.6 7.4 7.5 16.0 6.9 9.1 ZNF37A "KOX21, ZNF37" ENSG00000075407 "Zinc finger protein 37A" P17032 10 38094334-38150293 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003172 Approved Approved Vesicles Vesicles "HPA003172: AB_1080709" "unprognostic (8.64e-2)" "unprognostic (1.24e-1)" "unprognostic (3.22e-1)" "unprognostic (6.87e-2)" "unprognostic (1.17e-2)" "unprognostic (2.31e-2)" "prognostic unfavourable (2.83e-4)" "unprognostic (7.65e-3)" "unprognostic (2.47e-1)" "unprognostic (3.54e-2)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "prognostic unfavourable (2.31e-4)" "unprognostic (4.39e-2)" "unprognostic (1.29e-1)" "unprognostic (3.43e-2)" "unprognostic (3.09e-2)" 8.2 10.1 11.9 9.9 15.3 4.9 9.9 23.2 13.9 11.8 9.9 11.0 6.6 8.0 12.5 10.5 6.9 10.1 8.7 7.8 11.5 9.9 10.4 9.1 10.2 9.2 16.3 10.7 13.5 16.7 20.0 25.0 8.2 12.8 10.3 8.5 9.0 12.7 15.4 6.7 10.7 9.0 16.3 12.0 9.7 10.1 4.1 16.2 8.2 14.0 3.9 9.8 8.5 8.4 5.6 2.9 2.5 4.7 6.4 5.4 1.7 11.5 6.0 5.3 10.0 8.2 8.0 5.8 8.9 3.4 4.1 5.6 4.7 3.4 17.0 2.7 4.9 4.7 9.9 7.5 6.5 10.9 9.4 17.1 6.8 6.7 7.1 17.9 11.1 6.1 12.6 7.1 6.0 5.4 11.1 12.1 8.8 2.7 10.1 2.8 4.7 9.8 7.3 14.6 3.4 4.4 4.5 4.3 7.4 6.1 5.0 5.0 9.1 5.6 9.2 7.8 8.4 7.5 8.6 13.6 14.7 6.7 5.2 12.9 4.9 2.5 2.4 2.2 3.9 1.9 5.1 3.5 4.5 3.9 2.3 5.6 5.4 4.5 2.0 6.4 4.7 2.9 2.4 1.7 11.9 15.3 23.2 13.9 11.5 9.9 16.3 10.7 12.8 16.2 ZNF442 FLJ14356 ENSG00000198342 "Zinc finger protein 442" Q9H7R0 19 12345949-12365905 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 8.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA045738, HPA053407" Uncertain Approved "Nuclear membrane,Vesicles" "Nuclear membrane" Vesicles "HPA045738: AB_10968057, HPA053407: " "unprognostic (2.61e-2)" "unprognostic (3.32e-2)" "unprognostic (1.59e-1)" "unprognostic (7.36e-2)" "unprognostic (1.28e-1)" "unprognostic (5.53e-2)" "unprognostic (6.64e-2)" "unprognostic (2.07e-2)" "unprognostic (3.17e-3)" "unprognostic (1.35e-1)" "unprognostic (7.52e-3)" "unprognostic (1.78e-1)" "unprognostic (1.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.80e-2)" "unprognostic (1.99e-2)" 4.7 3.1 2.8 5.5 6.0 1.5 5.1 8.3 3.8 6.6 3.4 1.0 2.9 1.9 5.5 5.5 3.8 5.5 2.0 3.9 2.6 2.5 8.1 5.2 3.4 3.6 2.7 2.4 17.1 4.8 4.3 5.2 3.1 7.1 6.2 3.9 4.3 3.0 6.8 8.0 3.6 2.6 8.7 5.0 4.7 2.7 3.5 3.4 3.9 5.8 2.5 3.1 8.5 4.6 5.7 1.3 5.0 1.0 1.0 3.4 0.9 0.3 0.1 2.8 3.6 1.8 1.0 0.4 3.8 1.1 3.4 2.7 2.7 0.9 3.2 1.2 2.0 0.8 2.3 1.9 3.3 0.1 0.5 0.2 4.1 2.4 1.4 0.1 3.2 1.5 2.0 1.4 0.5 0.4 4.6 0.4 3.1 2.5 3.8 0.6 2.3 1.6 0.2 4.2 0.1 1.4 2.1 0.2 0.7 0.0 0.2 0.0 3.7 2.5 0.1 4.5 2.2 5.6 2.3 3.4 8.5 0.1 0.2 0.1 1.7 1.0 0.7 5.0 2.0 1.0 1.3 5.7 1.3 1.2 1.3 1.3 3.4 2.1 1.7 1.0 0.9 1.2 0.1 0.9 2.8 6.0 8.3 3.8 2.6 2.5 2.7 2.4 7.1 3.4 ZNF469 KIAA1858 ENSG00000225614 "Zinc finger protein 469" Q96JG9 16 88427471-88440757 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 5.6;BJ hTERT+: 6.1;HeLa: 5.5;SiHa: 6.6;THP-1: 8.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.5" "Low region specificity" "Detected in many" HPA069784 Approved Vesicles Vesicles "HPA069784: " "unprognostic (1.80e-1)" "unprognostic (7.79e-3)" "unprognostic (7.71e-2)" "unprognostic (7.01e-2)" "unprognostic (2.97e-1)" "unprognostic (2.30e-1)" "unprognostic (9.17e-3)" "unprognostic (7.08e-3)" "unprognostic (5.04e-2)" "unprognostic (5.02e-2)" "unprognostic (6.92e-2)" "unprognostic (1.01e-1)" "unprognostic (8.71e-7)" "unprognostic (2.24e-2)" "unprognostic (1.83e-2)" "unprognostic (2.20e-2)" "unprognostic (3.34e-2)" 1.8 0.8 2.5 2.3 2.2 0.1 0.7 0.0 2.2 4.3 0.2 0.4 2.9 0.0 0.2 1.3 2.6 0.4 2.5 1.6 0.0 0.1 0.5 1.3 1.6 4.3 0.8 0.0 0.0 0.5 1.3 0.0 0.6 0.8 1.5 0.2 0.8 2.1 1.6 1.9 0.9 0.3 0.0 0.5 1.7 0.4 0.1 1.5 0.0 0.3 0.0 0.2 0.0 0.0 5.6 0.2 0.0 0.9 1.3 0.0 3.5 6.1 0.8 0.1 0.0 0.2 0.0 0.1 4.7 0.1 0.0 0.0 0.1 0.0 0.0 0.2 5.5 0.0 4.1 0.2 0.1 1.3 0.0 1.4 0.0 3.7 0.0 0.0 1.0 0.5 0.0 0.9 0.7 4.6 0.4 0.0 0.0 0.0 0.0 0.0 2.9 6.6 0.0 0.0 1.2 8.4 4.4 5.0 1.3 2.7 0.9 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 ZNF526 "KIAA1951, MGC4267" ENSG00000167625 "Zinc finger protein 526" Q8TF50 19 42220271-42228201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023070, HPA056609" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA023070: , HPA056609: " "unprognostic (2.04e-1)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.46e-1)" "unprognostic (5.86e-2)" "unprognostic (9.09e-3)" "unprognostic (1.79e-1)" "unprognostic (8.84e-2)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (2.14e-1)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (2.30e-1)" 10.1 7.0 5.9 12.3 9.1 8.5 8.5 14.5 10.0 10.6 8.5 8.6 9.2 8.3 12.2 6.4 8.4 9.3 5.0 6.8 7.5 4.3 7.0 7.6 7.3 9.1 8.7 6.6 12.0 9.0 10.1 11.7 8.6 6.2 9.9 5.6 7.5 11.1 9.1 11.7 13.0 10.1 6.3 4.6 9.1 7.9 11.6 8.1 13.8 7.6 6.1 11.5 9.0 10.3 6.9 6.1 2.5 7.1 4.5 10.7 4.3 7.0 23.1 6.8 6.1 7.9 7.6 5.9 8.3 7.8 8.8 9.7 12.1 5.2 11.6 6.1 8.8 5.3 7.2 9.0 5.6 6.8 8.7 11.6 10.8 11.6 7.3 7.3 7.5 7.5 7.3 8.8 9.2 5.5 11.0 7.4 5.6 9.9 7.3 4.8 4.5 8.3 8.6 8.3 5.2 4.0 13.0 7.0 6.2 9.5 9.6 6.9 3.9 13.2 7.3 10.9 7.5 4.6 10.4 9.0 5.2 8.0 7.3 7.2 9.0 2.5 5.1 1.9 7.0 5.4 10.7 6.9 5.5 6.3 4.2 6.7 6.7 8.3 1.2 4.5 7.1 6.1 5.4 4.3 5.9 9.1 14.5 10.0 7.5 4.3 8.7 6.6 6.2 8.1 ZNF530 KIAA1508 ENSG00000183647 "Zinc finger protein 530" Q6P9A1 19 57599885-57612722 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HEK 293: 37.0;U-266/84: 26.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA045868 Uncertain Approved Vesicles Vesicles "HPA045868: " "unprognostic (1.57e-1)" "unprognostic (3.02e-3)" "unprognostic (5.65e-2)" "unprognostic (2.90e-2)" "unprognostic (3.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "unprognostic (6.80e-2)" "unprognostic (9.69e-3)" "unprognostic (4.98e-3)" "unprognostic (3.19e-2)" "unprognostic (7.84e-3)" "unprognostic (1.47e-1)" "unprognostic (1.70e-1)" "unprognostic (3.11e-1)" "unprognostic (1.86e-2)" "unprognostic (1.06e-1)" 3.2 3.5 6.3 4.7 6.9 7.0 4.4 12.4 7.1 2.5 2.6 2.6 1.4 2.7 2.9 5.3 2.3 2.0 3.1 11.0 5.1 4.4 3.2 2.3 4.6 7.6 5.8 4.0 2.4 4.1 3.2 2.0 3.4 3.3 4.0 2.3 4.5 3.7 3.9 14.6 4.7 2.6 2.1 4.1 5.4 4.6 3.6 3.5 7.2 2.5 2.7 5.6 3.6 2.5 6.5 3.6 3.5 3.1 5.6 6.5 3.4 3.2 2.9 2.1 1.8 0.1 1.0 3.4 2.0 0.8 3.4 1.9 2.0 0.5 0.4 1.6 0.7 1.0 1.7 1.4 3.7 0.1 37.0 6.4 5.4 1.2 0.2 2.3 3.1 0.7 0.8 3.2 0.9 0.7 0.8 1.6 1.1 1.2 3.3 1.8 3.2 7.0 0.4 6.8 3.1 0.6 5.5 2.5 2.3 2.3 0.6 0.6 1.5 3.6 1.0 4.3 2.7 0.9 4.0 7.4 26.9 4.4 2.6 2.5 2.9 1.9 3.1 1.8 6.3 1.9 5.0 6.5 4.3 6.5 3.6 5.8 5.9 4.8 3.5 5.6 2.1 3.5 5.6 3.4 6.3 6.9 12.4 7.1 5.1 4.4 5.8 4.0 3.3 3.5 ZNF540 DKFZp547B0714 ENSG00000171817 "Zinc finger protein 540" Q8NDQ6 19 37551406-37614097 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 30.7" "Cell line enhanced" "Detected in many" "ASC diff: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA003444 Supported Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA003444: AB_1080732" "unprognostic (2.51e-2)" "unprognostic (2.30e-4)" "unprognostic (4.92e-2)" "unprognostic (1.12e-1)" "unprognostic (2.80e-4)" "unprognostic (4.24e-4)" "unprognostic (3.44e-3)" "unprognostic (8.88e-4)" "unprognostic (2.65e-1)" "unprognostic (3.17e-1)" "unprognostic (3.38e-5)" "unprognostic (1.50e-1)" "unprognostic (1.09e-6)" "unprognostic (2.74e-1)" "unprognostic (4.75e-2)" "unprognostic (8.08e-2)" "unprognostic (8.33e-5)" 2.8 9.3 8.6 3.9 29.9 1.2 6.0 23.7 16.7 5.8 4.4 5.0 5.3 3.9 6.0 9.4 3.0 4.2 3.6 9.1 8.6 12.1 6.3 2.6 5.0 6.3 9.0 9.1 13.8 3.8 13.3 30.7 2.3 11.0 7.1 3.6 9.0 6.1 8.9 2.9 6.0 4.5 3.8 7.9 6.3 4.6 11.5 9.5 2.7 14.4 3.1 6.0 3.4 4.0 3.1 0.3 1.2 0.1 3.0 7.1 1.8 0.4 0.0 2.7 2.7 6.9 4.1 0.2 1.0 0.9 1.1 2.1 0.2 0.0 1.2 0.3 2.4 1.0 1.8 0.9 0.9 3.7 2.7 1.0 1.2 0.0 1.8 1.2 2.0 1.9 2.5 0.7 0.0 0.1 0.4 0.0 1.6 0.1 1.7 0.7 0.9 0.5 1.4 1.6 0.8 0.6 0.4 2.8 3.1 1.0 0.3 0.3 1.3 0.7 0.0 1.0 3.1 1.2 0.9 3.7 2.0 2.6 0.0 0.4 0.6 0.0 0.0 1.2 3.9 0.1 3.9 2.9 4.1 4.4 0.1 3.1 6.8 7.1 0.2 3.0 0.0 0.3 4.2 1.8 8.6 29.9 23.7 16.7 8.6 12.1 9.0 9.1 11.0 9.5 ZNF550 MGC41917 ENSG00000251369 "Zinc finger protein 550" Q7Z398 19 57535257-57559863 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003251 Uncertain Approved Vesicles,Microtubules Vesicles Microtubules "HPA003251: AB_1080736" "unprognostic (3.09e-1)" "unprognostic (1.92e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-2)" "unprognostic (1.43e-1)" "unprognostic (2.15e-2)" "unprognostic (1.40e-2)" "unprognostic (3.61e-2)" "unprognostic (2.66e-3)" "unprognostic (3.46e-1)" "unprognostic (4.09e-2)" "prognostic unfavourable (2.21e-4)" "unprognostic (8.33e-2)" "unprognostic (1.59e-1)" "unprognostic (2.69e-2)" "unprognostic (6.68e-3)" "unprognostic (1.52e-1)" 8.7 6.8 8.7 10.5 11.1 7.1 10.2 15.0 10.6 10.1 6.0 8.9 10.0 4.4 10.1 8.1 6.4 8.7 5.6 9.2 8.6 5.5 6.2 6.2 6.6 11.7 10.2 4.6 16.8 7.7 12.5 16.6 10.9 9.1 11.0 5.0 6.5 9.2 8.1 14.2 10.7 8.6 8.4 7.2 12.2 5.9 6.4 9.6 12.8 8.6 4.0 11.6 9.4 7.3 4.7 2.9 2.7 2.4 6.9 9.4 3.3 3.2 2.6 6.6 6.4 2.7 5.5 0.0 4.4 4.0 4.0 1.9 2.7 3.1 1.1 3.2 3.1 2.9 3.6 4.0 5.1 0.1 18.4 8.5 7.4 3.6 3.7 7.8 3.6 4.9 3.3 3.2 10.0 3.2 1.4 0.1 4.9 0.7 11.3 3.4 7.4 4.8 9.5 7.5 8.9 2.4 5.6 6.4 8.4 5.6 3.7 3.2 4.3 5.4 3.6 5.8 3.7 2.1 4.6 18.6 16.6 7.9 2.2 4.7 5.0 1.7 2.2 2.7 5.7 2.4 6.7 3.5 6.9 3.8 2.9 4.7 9.4 5.8 0.6 6.9 1.0 1.3 5.9 3.3 8.7 11.1 15.0 10.6 8.6 5.5 10.2 4.6 9.1 9.6 ZNF569 "FLJ32053, ZAP1" ENSG00000196437 "Zinc finger protein 569" Q5MCW4 19 37411155-37469275 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA052994 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA052994: " "unprognostic (1.40e-1)" "unprognostic (3.37e-1)" "unprognostic (4.95e-2)" "unprognostic (2.18e-2)" "unprognostic (5.44e-2)" "unprognostic (4.79e-2)" "unprognostic (2.95e-2)" "unprognostic (4.00e-1)" "unprognostic (5.08e-2)" "unprognostic (6.50e-3)" "unprognostic (4.01e-3)" "unprognostic (9.41e-2)" "unprognostic (9.70e-2)" "unprognostic (3.04e-2)" "unprognostic (5.77e-2)" "unprognostic (1.91e-2)" "unprognostic (1.37e-1)" 5.8 7.8 10.9 6.1 11.1 7.7 6.6 20.9 10.6 6.9 5.0 6.4 3.8 3.2 7.2 9.5 4.4 6.5 4.5 7.7 8.0 11.2 6.9 6.0 4.6 7.2 8.6 8.7 10.9 3.7 8.8 18.5 5.5 10.6 6.6 3.5 5.2 4.5 5.6 7.2 6.5 4.1 6.3 10.2 6.2 4.2 20.1 11.3 9.6 10.5 3.8 5.9 6.4 4.7 7.2 3.2 7.1 4.0 6.2 11.3 3.2 2.8 5.8 6.6 11.0 5.5 4.9 3.2 5.1 3.1 5.7 6.1 1.9 1.2 3.3 7.5 3.8 1.0 7.3 2.0 6.0 7.6 4.4 8.6 1.4 3.2 3.3 1.6 3.5 3.4 1.3 5.7 0.1 4.5 2.8 0.6 7.9 1.7 10.9 3.7 7.8 4.1 7.0 8.4 3.5 4.0 2.7 5.7 8.9 0.2 1.3 2.9 4.9 6.9 4.4 4.4 9.1 3.4 8.3 9.4 16.0 13.1 0.3 3.6 7.0 4.9 2.6 7.1 8.7 3.3 7.7 6.1 7.8 8.1 2.8 7.2 11.3 8.9 2.7 6.2 4.0 3.2 7.8 3.2 10.9 11.1 20.9 10.6 8.0 11.2 8.6 8.7 10.6 11.3 ZNF586 FLJ20070 ENSG00000083828 "Zinc finger protein 586" Q9NXT0 19 57769655-57819939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 24.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA030306, HPA060782" Approved Approved "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" Vesicles "HPA030306: , HPA060782: " "prognostic favourable (9.83e-5)" "unprognostic (1.60e-2)" "unprognostic (2.93e-1)" "unprognostic (1.72e-3)" "unprognostic (2.52e-2)" "unprognostic (2.60e-1)" "unprognostic (1.10e-2)" "unprognostic (1.02e-3)" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (1.88e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (6.01e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "prognostic favourable (5.36e-4)" 7.6 6.9 11.7 12.3 11.7 27.3 10.6 22.4 13.8 8.5 7.7 6.6 14.7 7.9 9.1 10.0 10.8 8.9 9.2 10.0 11.8 4.4 8.5 7.8 16.5 16.2 9.3 8.7 13.9 8.4 6.6 13.4 9.0 8.4 13.5 8.1 9.8 14.3 18.4 33.3 12.4 10.2 7.7 8.7 16.2 9.8 7.0 13.0 11.6 10.7 8.8 12.2 12.0 11.5 7.2 6.1 20.8 6.6 6.3 10.0 5.2 5.0 4.4 6.0 7.1 3.0 2.7 10.0 3.6 3.5 5.0 2.6 2.0 5.1 10.6 0.4 3.2 3.7 1.1 4.8 9.0 1.6 24.2 8.3 10.0 1.3 5.2 7.9 7.6 4.5 5.6 3.5 5.5 5.8 5.3 0.6 5.8 1.7 8.0 5.6 8.9 11.6 8.1 2.3 13.4 5.7 13.0 8.7 4.0 1.7 5.1 3.8 5.4 6.2 3.2 6.7 3.7 0.3 5.9 11.9 14.7 11.2 3.6 0.9 4.8 4.4 6.6 20.5 6.1 5.5 5.9 5.2 7.9 6.5 6.1 7.2 10.0 9.0 20.8 6.3 3.6 4.7 9.9 5.2 11.7 11.7 22.4 13.8 11.8 4.4 9.3 8.7 8.4 13.0 ZNF605 ENSG00000196458 "Zinc finger protein 605" Q86T29 12 132918308-132956306 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061970, HPA062655" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA061970: , HPA062655: " "unprognostic (2.38e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-2)" "unprognostic (2.98e-2)" "unprognostic (6.38e-2)" "unprognostic (3.83e-2)" "unprognostic (1.16e-6)" "unprognostic (3.62e-1)" "unprognostic (1.15e-1)" "unprognostic (4.03e-1)" "unprognostic (2.13e-2)" "unprognostic (1.10e-2)" "unprognostic (2.89e-1)" "unprognostic (6.58e-2)" "unprognostic (1.10e-1)" "unprognostic (7.53e-2)" "unprognostic (9.06e-3)" 5.5 8.2 10.9 7.6 9.9 3.2 12.2 19.0 12.8 10.1 8.3 8.4 9.5 6.7 10.2 13.1 7.3 9.3 6.6 9.9 10.8 7.9 9.9 8.1 7.6 8.0 7.8 8.2 13.3 8.2 16.9 12.9 10.2 8.1 10.7 6.9 9.9 8.8 9.6 14.6 11.5 8.3 8.2 7.4 7.4 8.7 4.8 9.1 8.5 15.5 6.1 7.5 8.5 9.9 2.6 1.4 1.9 1.2 1.7 3.0 0.8 4.5 3.7 9.5 9.0 5.2 10.9 7.1 6.2 3.6 2.9 2.0 0.6 0.6 1.9 3.4 5.3 2.5 4.1 1.5 3.6 1.5 7.1 8.7 2.9 2.9 4.0 3.6 9.6 6.9 6.9 2.0 4.4 2.2 1.3 0.1 7.2 1.3 4.7 5.1 7.3 5.1 4.4 6.2 1.3 4.9 7.8 6.1 7.0 2.8 1.7 4.3 10.3 10.5 4.3 3.6 5.8 5.3 2.5 0.0 0.0 1.5 0.1 3.0 2.1 1.6 1.2 1.3 1.6 0.8 0.9 2.6 1.4 1.7 0.9 2.2 3.0 1.9 1.9 1.7 0.9 1.4 0.4 0.8 10.9 9.9 19.0 12.8 10.8 7.9 7.8 8.2 8.1 9.1 ZNF613 FLJ13590 ENSG00000176024 "Zinc finger protein 613" Q6PF04 19 51927147-51948759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 25.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026833 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA026833: AB_1859377" "unprognostic (1.10e-1)" "unprognostic (2.57e-1)" "unprognostic (9.27e-2)" "unprognostic (2.84e-1)" "unprognostic (9.31e-3)" "unprognostic (1.79e-1)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-2)" "unprognostic (1.91e-1)" "unprognostic (2.73e-1)" "unprognostic (5.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-3)" "prognostic favourable (1.92e-6)" 4.7 5.3 7.1 3.9 7.4 1.6 9.5 14.2 7.4 5.3 6.5 5.2 1.9 2.8 5.5 5.3 4.7 4.3 3.7 4.3 9.7 4.7 8.7 4.0 4.9 6.3 7.2 4.9 6.5 3.4 7.4 7.0 8.2 8.8 25.4 6.7 5.4 4.5 5.6 3.9 4.5 4.9 5.8 7.5 6.7 4.2 3.5 7.0 9.0 7.3 2.6 5.2 5.8 4.1 10.1 9.6 14.1 11.3 9.5 14.3 7.0 3.1 4.2 6.9 6.9 6.0 6.9 1.7 5.3 8.5 7.1 9.2 1.4 3.7 2.6 2.8 6.6 3.6 6.7 6.6 7.7 0.1 8.6 5.5 3.0 3.9 6.1 0.3 7.9 5.1 7.6 6.7 5.5 7.6 2.5 0.0 7.1 0.6 9.2 4.1 4.9 5.9 5.0 7.3 2.8 6.9 10.8 4.6 4.5 8.5 6.3 5.0 6.6 6.8 4.8 3.1 5.9 2.4 5.6 6.0 0.0 5.1 0.2 0.0 9.3 7.7 7.4 14.1 10.4 7.5 9.3 7.6 11.1 12.1 9.6 10.1 11.2 14.3 7.6 9.5 11.3 4.8 10.0 7.0 7.1 7.4 14.2 7.4 9.7 4.7 7.2 4.9 8.8 7.0 ZNF614 FLJ21941 ENSG00000142556 "Zinc finger protein 614" Q8N883 19 52012765-52030240 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021197 Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA021197: AB_1859380" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (3.24e-2)" "unprognostic (1.30e-1)" "unprognostic (7.67e-3)" "unprognostic (2.68e-1)" "unprognostic (4.74e-3)" "unprognostic (5.07e-3)" "unprognostic (1.09e-1)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.74e-2)" "unprognostic (1.66e-2)" "unprognostic (3.06e-2)" "unprognostic (1.57e-1)" "unprognostic (2.30e-1)" "unprognostic (7.15e-3)" 7.7 7.1 9.9 5.6 9.4 10.1 10.1 15.6 12.5 9.2 7.3 6.6 5.8 4.5 9.5 7.3 6.3 8.8 6.0 7.0 7.9 8.5 6.9 4.7 6.3 8.2 9.3 7.1 14.0 5.1 6.5 13.7 14.2 9.7 16.4 5.5 5.5 5.4 8.9 11.1 7.6 6.3 8.9 13.5 9.7 5.8 13.8 10.7 18.2 14.3 5.1 7.5 8.5 9.6 6.0 5.5 4.3 5.9 9.6 8.1 3.2 3.8 2.8 7.3 9.5 5.2 5.9 1.0 5.1 3.7 4.8 5.9 3.7 2.2 9.6 2.9 4.4 1.7 10.8 6.9 7.2 2.6 15.4 14.5 5.2 7.3 4.3 3.0 7.4 4.5 3.8 4.9 6.9 5.6 7.7 2.2 6.4 1.5 12.4 6.0 8.4 5.2 8.3 14.1 7.9 4.9 9.8 9.8 5.9 3.1 3.9 3.2 5.2 7.6 5.7 4.8 6.6 2.7 6.1 4.4 6.8 14.8 4.5 4.2 6.2 4.3 4.3 3.0 6.5 5.9 7.8 6.0 5.7 6.1 5.5 6.0 8.1 5.3 3.3 9.6 4.5 3.1 5.9 3.2 9.9 9.4 15.6 12.5 7.9 8.5 9.3 7.1 9.7 10.7 ZNF624 KIAA1349 ENSG00000197566 "Zinc finger protein 624" Q9P2J8 17 16620737-16653856 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA023157, HPA023244" Uncertain Approved Vesicles Vesicles "HPA023157: , HPA023244: " "unprognostic (2.47e-1)" "unprognostic (8.75e-2)" "unprognostic (3.51e-2)" "unprognostic (3.97e-3)" "unprognostic (1.64e-1)" "unprognostic (3.77e-2)" "unprognostic (1.24e-1)" "unprognostic (2.18e-1)" "unprognostic (1.10e-2)" "unprognostic (4.76e-2)" "unprognostic (1.40e-1)" "unprognostic (1.62e-1)" "unprognostic (1.75e-2)" "unprognostic (1.52e-1)" "unprognostic (7.88e-2)" "unprognostic (1.09e-1)" "unprognostic (2.97e-1)" 6.1 3.7 5.6 3.6 10.5 2.6 4.9 4.4 7.1 6.2 4.4 7.5 2.0 3.4 6.5 3.0 3.8 5.3 3.2 3.6 5.9 4.6 4.9 2.1 4.9 5.4 14.5 5.8 9.4 2.7 7.0 2.3 7.3 7.6 4.2 4.6 4.1 4.3 4.1 2.2 5.5 3.9 5.2 11.6 8.0 4.7 11.6 11.9 8.9 5.8 2.2 5.2 5.9 4.3 5.6 3.8 3.8 6.9 5.1 5.5 2.1 1.4 2.4 7.2 2.4 3.6 4.3 1.8 2.4 4.1 4.7 4.3 1.2 1.4 3.6 2.1 3.2 2.0 2.0 2.6 5.1 3.8 2.5 4.0 1.4 1.1 3.5 2.7 3.9 4.9 6.0 2.5 5.3 4.1 2.5 0.9 6.0 2.0 6.7 1.1 1.2 1.2 7.1 12.2 1.1 3.1 2.9 2.2 4.3 2.7 2.0 2.9 1.6 1.2 5.9 4.4 1.7 1.7 1.8 1.7 1.2 0.0 2.1 0.0 3.7 2.0 2.2 3.8 3.9 6.9 5.5 3.5 4.2 4.2 3.8 5.6 4.7 2.8 0.5 5.1 2.8 1.1 3.0 2.1 5.6 10.5 4.4 7.1 5.9 4.6 14.5 5.8 7.6 11.9 ZNF626 ENSG00000188171 "Zinc finger protein 626" Q68DY1 19 20620061-20661596 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 13.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA045631 Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" Nucleoplasm "HPA045631: " "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (3.58e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-2)" "unprognostic (2.18e-2)" "unprognostic (6.24e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-2)" "unprognostic (6.51e-3)" "unprognostic (1.92e-1)" "unprognostic (2.49e-1)" "unprognostic (5.10e-2)" "unprognostic (1.73e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (2.31e-1)" 8.1 13.9 10.2 6.0 15.6 4.1 18.5 15.2 14.8 11.2 8.3 12.0 21.6 2.4 13.0 9.5 8.0 14.0 10.7 10.8 10.1 10.1 12.7 6.5 7.2 12.4 10.9 11.1 29.2 9.6 36.3 14.8 8.3 11.0 12.8 4.4 13.6 8.9 23.9 7.3 10.8 6.0 11.9 12.1 7.8 9.1 5.8 11.9 13.6 26.9 4.9 10.7 21.3 9.7 11.4 4.2 11.6 4.3 9.1 8.6 4.2 0.1 0.0 4.3 0.7 5.3 6.9 0.5 4.9 0.5 7.0 6.2 0.2 0.2 0.7 2.5 6.0 0.8 0.0 0.2 8.9 0.0 0.2 0.0 0.1 1.7 9.4 0.1 0.1 12.8 2.2 4.1 2.2 3.3 3.0 0.5 7.3 0.1 0.8 1.1 9.3 2.2 4.3 3.2 1.6 7.0 5.3 1.5 8.3 0.2 0.5 4.4 10.3 0.4 0.0 3.2 0.2 12.7 0.5 6.9 13.8 6.2 0.1 0.1 0.5 0.8 1.1 6.0 7.6 1.0 7.3 7.9 8.0 8.6 3.2 11.4 7.7 6.6 11.6 9.1 4.3 4.2 3.7 4.2 10.2 15.6 15.2 14.8 10.1 10.1 10.9 11.1 11.0 11.9 ZNF638 "MGC26130, NP220, ZFML, Zfp638" ENSG00000075292 "Zinc finger protein 638" Q14966 2 71276561-71435069 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036784, HPA057395" Supported Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA036784: AB_10672478, HPA057395: " "unprognostic (2.58e-2)" "unprognostic (3.15e-1)" "unprognostic (7.57e-2)" "unprognostic (1.26e-3)" "unprognostic (2.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-2)" "unprognostic (5.68e-3)" "unprognostic (2.31e-2)" "unprognostic (1.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.32e-1)" "unprognostic (2.66e-3)" "unprognostic (3.28e-1)" "unprognostic (7.68e-2)" "unprognostic (1.93e-2)" "prognostic favourable (8.73e-5)" 20.7 19.1 22.4 14.9 26.0 18.7 19.8 51.3 25.5 19.8 19.7 23.4 13.0 11.3 26.0 14.8 17.3 20.1 14.3 16.0 20.1 11.9 18.7 22.9 16.4 16.9 25.4 19.9 31.1 15.4 28.9 46.7 16.9 23.9 17.2 14.7 14.1 20.6 15.5 33.2 16.9 15.8 18.4 22.7 16.0 17.3 21.0 29.7 26.0 22.5 11.2 16.1 26.6 17.8 14.8 10.2 32.4 12.8 11.8 14.1 6.0 14.8 21.4 32.9 15.3 19.4 21.4 25.4 17.0 19.7 14.5 13.0 20.4 14.6 24.4 15.8 15.5 12.6 30.5 17.4 21.1 24.8 17.0 32.1 23.4 18.5 16.8 29.2 21.8 13.5 17.0 15.5 29.0 22.2 32.0 14.4 21.0 14.9 20.6 21.7 28.5 13.8 17.7 49.9 17.0 15.5 22.7 25.4 16.7 20.9 14.7 21.4 13.7 18.1 22.7 18.0 26.2 13.3 17.0 11.8 18.2 24.2 15.1 19.2 19.4 32.4 10.1 18.7 11.4 9.5 10.6 14.5 10.6 10.4 7.9 14.8 14.1 10.3 17.1 11.8 12.8 10.2 8.9 6.0 22.4 26.0 51.3 25.5 20.1 11.9 25.4 19.9 23.9 29.7 ZNF644 "BM-005, KIAA1221, MGC60165, MGC70410" ENSG00000122482 "Zinc finger protein 644" Q9H582 1 90915298-91022272 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057795 Uncertain Uncertain Vesicles Vesicles "HPA057795: " "unprognostic (8.20e-2)" "unprognostic (5.86e-3)" "prognostic favourable (4.27e-4)" "prognostic unfavourable (8.39e-4)" "unprognostic (3.19e-3)" "unprognostic (4.62e-3)" "unprognostic (8.04e-2)" "unprognostic (7.01e-2)" "unprognostic (2.44e-2)" "unprognostic (6.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (2.61e-2)" "unprognostic (3.03e-1)" "unprognostic (5.09e-2)" "unprognostic (1.03e-1)" "unprognostic (3.07e-1)" 22.2 14.1 20.7 19.0 20.0 19.4 23.9 34.9 25.1 24.7 17.6 17.8 17.1 11.2 23.8 16.7 17.6 14.4 14.2 14.9 21.7 16.6 15.2 26.2 15.1 19.5 23.7 18.9 21.3 14.4 22.4 24.2 18.2 23.3 18.3 18.7 12.0 20.6 15.3 20.3 14.4 19.1 19.2 25.3 21.6 14.6 17.1 26.5 35.3 26.1 14.9 19.7 19.9 18.3 8.1 7.0 5.0 4.8 12.5 8.6 3.2 12.8 6.2 18.1 10.0 8.5 10.0 10.4 11.2 12.0 12.9 13.8 8.2 4.7 15.8 12.5 8.6 10.2 18.1 13.1 19.1 11.2 10.2 20.4 12.2 11.7 12.1 18.5 6.8 9.4 15.4 12.7 17.4 13.4 14.2 18.2 13.4 4.6 15.0 16.4 16.4 11.6 14.9 29.7 8.8 13.4 11.9 14.9 11.6 13.9 10.9 28.8 7.1 18.7 10.5 14.2 11.8 11.5 17.3 13.0 8.8 21.1 5.8 14.2 7.3 5.0 4.5 5.0 6.2 4.8 7.0 8.1 7.0 7.0 5.8 7.2 8.6 7.5 1.3 12.5 4.7 7.0 5.5 3.2 20.7 20.0 34.9 25.1 21.7 16.6 23.7 18.9 23.3 26.5 ZNF691 Zfp691 ENSG00000164011 "Zinc finger protein 691" Q5VV52 1 42846573-42852477 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062527 Approved Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA062527: " "unprognostic (4.34e-2)" "unprognostic (4.05e-2)" "unprognostic (1.09e-1)" "unprognostic (4.32e-2)" "unprognostic (4.86e-2)" "unprognostic (5.50e-2)" "prognostic unfavourable (7.33e-6)" "unprognostic (1.40e-3)" "unprognostic (2.65e-3)" "unprognostic (5.12e-2)" "prognostic favourable (6.25e-5)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" 7.8 14.6 13.6 11.2 15.5 2.9 15.6 10.8 14.4 12.9 12.6 18.3 14.1 8.8 16.9 21.8 9.1 14.2 8.4 11.4 11.9 9.8 14.2 24.1 9.9 16.0 12.2 12.1 18.6 13.4 19.2 17.3 12.7 12.3 16.8 10.2 12.3 15.2 18.5 10.9 12.8 10.6 13.5 11.9 17.7 10.8 13.9 14.8 17.9 19.3 6.4 16.8 11.8 10.0 20.5 12.5 18.2 11.2 18.4 19.3 12.8 4.5 6.4 13.1 10.8 11.8 9.1 1.7 5.5 6.7 9.0 9.0 4.5 6.8 11.3 8.6 5.1 8.1 12.5 7.2 7.8 20.2 12.7 11.8 17.6 8.1 8.8 4.5 2.5 7.8 8.9 11.2 9.3 9.1 11.4 4.9 8.7 3.6 13.4 6.0 19.5 4.8 9.2 16.4 7.7 8.3 4.4 9.4 9.3 5.6 10.2 9.4 5.6 15.5 4.7 9.0 9.5 5.0 5.9 11.9 9.4 3.3 6.3 5.5 7.5 18.2 11.2 16.0 12.2 9.7 15.7 15.9 16.4 16.4 11.1 20.5 15.8 15.7 6.3 18.4 10.0 12.5 19.3 12.8 13.6 15.5 10.8 14.4 11.9 9.8 12.2 12.1 12.3 14.8 ZNF768 FLJ23436 ENSG00000169957 "Zinc finger protein 768" Q9H5H4 16 30524001-30526821 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024630, HPA066512" Supported Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA024630: AB_1859446, HPA066512: " "unprognostic (2.33e-1)" "unprognostic (6.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" "unprognostic (1.73e-1)" "unprognostic (7.94e-3)" "unprognostic (1.61e-1)" "unprognostic (1.63e-1)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "unprognostic (2.74e-1)" "prognostic favourable (9.30e-6)" "unprognostic (4.49e-2)" "unprognostic (1.94e-1)" "unprognostic (3.13e-1)" "prognostic favourable (6.46e-4)" 11.7 9.2 12.7 12.0 15.6 8.0 17.8 11.1 12.2 11.4 26.0 13.9 11.5 20.4 13.1 7.4 12.6 13.1 11.2 26.2 11.1 9.3 18.9 14.4 8.6 4.7 13.5 6.0 15.9 14.3 25.4 11.5 10.1 11.5 14.2 12.1 13.9 17.5 16.0 56.6 11.2 31.6 16.0 12.8 13.1 11.7 14.0 14.4 3.8 10.1 14.2 7.8 14.1 24.5 3.7 1.8 3.1 1.9 1.8 0.5 0.6 10.0 12.6 14.3 13.9 7.0 8.1 11.3 7.6 8.6 12.7 11.1 8.0 14.0 6.3 11.8 5.3 13.4 9.5 9.1 7.6 14.2 20.1 14.9 8.4 11.1 17.6 9.9 47.2 7.1 20.3 9.7 12.6 8.4 17.3 10.8 6.5 27.7 3.6 23.9 13.4 10.4 18.8 9.5 15.6 9.3 5.2 17.0 18.8 4.3 23.1 29.0 22.8 24.9 5.6 13.4 10.2 7.5 8.4 16.0 11.7 7.8 11.2 15.5 13.4 0.2 1.4 3.1 0.1 1.9 0.4 3.7 0.5 0.2 1.8 1.4 0.4 0.1 1.7 1.8 0.3 1.7 0.1 0.6 12.7 15.6 11.1 12.2 11.1 9.3 13.5 6.0 11.5 14.4 ZNF813 FLJ16542 ENSG00000198346 "Zinc finger protein 813" Q6ZN06 19 53467735-53496255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA056406 Uncertain Approved Vesicles Vesicles "HPA056406: " "unprognostic (1.20e-1)" "unprognostic (3.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.98e-3)" "unprognostic (2.28e-1)" "unprognostic (3.61e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-3)" "unprognostic (3.39e-3)" "unprognostic (1.74e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-2)" "unprognostic (1.25e-3)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.77e-2)" "unprognostic (6.56e-2)" 5.9 3.7 4.0 5.0 4.3 2.5 4.8 3.2 3.6 5.8 4.3 2.5 1.7 3.8 4.1 8.7 4.0 4.1 3.0 2.4 2.5 2.3 5.0 2.5 4.7 4.1 4.6 1.6 4.8 4.1 5.2 3.5 12.7 4.7 10.7 3.7 2.0 4.8 3.3 1.6 4.0 6.3 4.5 6.3 6.5 4.0 4.2 5.2 10.2 5.8 2.8 4.3 6.4 9.5 4.8 2.5 2.4 5.5 6.8 6.8 2.6 0.8 0.8 2.5 4.3 2.2 2.7 6.0 2.3 2.4 1.6 2.3 4.4 2.6 6.6 2.3 2.2 1.4 6.1 2.6 3.1 0.0 9.6 6.6 1.7 5.0 1.2 0.0 7.1 2.3 2.2 1.8 1.3 1.4 3.5 0.1 2.5 1.2 8.5 3.6 3.2 2.3 5.3 5.6 3.2 1.6 17.4 1.1 2.5 0.0 4.4 1.5 1.7 3.2 2.3 0.9 3.2 0.1 2.2 3.6 5.2 7.4 0.0 0.0 4.5 2.4 2.2 1.7 3.7 3.2 3.7 3.4 3.5 4.1 2.5 4.8 6.8 5.2 1.1 6.8 5.5 2.4 2.6 2.6 4.0 4.3 3.2 3.6 2.5 2.3 4.6 1.6 4.7 5.2 ZNF891 ENSG00000214029 "Zinc finger protein 891" A8MT65 12 133106817-133130473 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040301 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA040301: AB_10795380" "unprognostic (3.05e-1)" "unprognostic (9.12e-2)" "unprognostic (3.29e-1)" "unprognostic (3.72e-1)" "unprognostic (7.51e-3)" "unprognostic (5.98e-3)" "unprognostic (1.94e-2)" "unprognostic (7.90e-2)" "unprognostic (2.77e-2)" "unprognostic (1.47e-1)" "unprognostic (1.60e-2)" "unprognostic (6.09e-2)" "unprognostic (5.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.64e-1)" "unprognostic (2.07e-3)" "unprognostic (6.68e-2)" 3.6 5.3 7.0 4.0 9.3 4.2 5.4 13.2 7.2 4.6 4.4 3.6 2.6 3.4 5.5 4.6 2.9 4.0 2.9 3.5 7.9 3.3 3.4 2.9 2.9 4.3 7.8 2.7 6.4 3.8 4.9 8.8 3.0 6.6 3.8 3.5 2.3 4.5 4.0 4.3 6.9 3.3 4.5 7.0 4.5 4.0 14.0 8.9 4.2 5.6 2.9 3.8 4.3 4.5 2.9 1.6 2.3 1.2 2.4 2.7 0.7 1.5 1.7 4.6 0.3 1.9 2.2 3.0 0.8 0.9 1.2 1.0 1.3 0.7 0.3 1.3 1.0 2.1 2.4 1.2 1.3 0.1 2.3 3.8 5.0 1.7 0.9 3.4 2.7 1.6 1.2 1.8 1.6 1.0 2.3 0.8 1.5 1.0 3.8 4.1 2.9 1.9 3.5 2.6 1.5 0.9 2.7 4.6 2.9 3.0 1.1 1.0 3.1 1.4 1.8 2.4 2.4 2.0 1.3 0.5 0.2 3.1 0.6 1.3 1.8 2.0 1.2 1.4 1.8 0.7 1.6 1.9 1.7 1.7 0.6 2.9 2.7 2.3 2.3 2.4 0.8 1.6 1.1 0.7 7.0 9.3 13.2 7.2 7.9 3.3 7.8 2.7 6.6 8.9 ZNHIT6 "BCD1, C1orf181, FLJ20729, NY-BR-75" ENSG00000117174 "Zinc finger HIT-type containing 6" Q9NWK9 1 85649423-85708433 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018132 Uncertain Approved "Nuclear speckles,Vesicles" "Nuclear speckles, Vesicles" "HPA018132: AB_1848789" "unprognostic (1.37e-1)" "unprognostic (4.01e-1)" "unprognostic (1.24e-1)" "unprognostic (2.27e-3)" "unprognostic (1.61e-2)" "unprognostic (1.11e-1)" "prognostic unfavourable (6.08e-6)" "unprognostic (1.11e-1)" "unprognostic (3.89e-2)" "unprognostic (8.48e-2)" "unprognostic (9.91e-3)" "unprognostic (2.92e-2)" "unprognostic (1.27e-3)" "unprognostic (5.91e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (7.37e-2)" 18.5 12.6 20.7 15.9 28.0 15.5 21.5 19.2 25.6 23.5 13.8 21.4 14.2 9.0 20.4 14.9 19.9 14.6 12.0 12.4 22.5 18.8 12.9 10.3 12.9 19.4 21.5 20.5 21.9 11.5 17.4 20.3 15.1 19.5 17.4 14.0 8.1 15.3 15.1 15.7 17.1 12.0 19.8 26.1 14.5 11.0 11.0 26.6 14.8 17.4 13.8 18.9 19.5 25.7 7.6 6.0 1.3 2.3 5.7 6.4 2.5 12.9 9.5 9.0 8.2 19.5 18.4 11.5 17.4 16.9 11.9 11.6 9.4 6.9 10.2 20.9 10.6 11.1 15.4 10.7 19.4 14.4 13.4 20.9 10.7 10.7 17.2 33.8 8.4 17.7 9.9 16.0 14.0 13.9 19.7 13.8 17.9 5.3 19.5 8.3 12.9 16.7 16.1 19.7 11.6 17.9 25.8 8.6 5.6 13.7 18.7 18.5 9.0 8.7 15.9 15.2 10.3 12.9 24.6 8.9 9.1 29.3 3.3 20.9 13.5 1.3 2.1 0.2 5.7 2.3 6.4 5.6 5.1 6.4 3.6 7.6 6.4 6.3 0.3 5.7 1.9 6.0 5.4 2.5 20.7 28.0 19.2 25.6 22.5 18.8 21.5 20.5 19.5 26.6 ZPR1 ZNF259 ENSG00000109917 "ZPR1 zinc finger" O75312 11 116773799-116788050 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022596, HPA030979" Uncertain Approved Vesicles Vesicles "CAB022596: , HPA030979: " "unprognostic (2.12e-2)" "unprognostic (3.55e-1)" "unprognostic (6.22e-2)" "unprognostic (1.44e-1)" "unprognostic (2.32e-1)" "prognostic unfavourable (8.01e-4)" "prognostic unfavourable (5.87e-6)" "unprognostic (1.04e-1)" "unprognostic (1.09e-1)" "unprognostic (9.42e-2)" "unprognostic (4.96e-3)" "unprognostic (4.79e-2)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (1.73e-1)" "unprognostic (1.71e-2)" "unprognostic (6.66e-2)" 19.5 13.2 20.2 15.9 20.5 34.9 17.3 12.0 23.3 13.7 14.0 17.1 11.5 12.4 16.4 16.2 18.0 14.4 14.2 14.7 17.6 14.0 14.2 26.3 15.8 16.5 25.9 18.2 17.6 24.4 12.6 13.2 14.8 19.1 14.3 15.3 9.1 14.1 15.5 28.7 15.5 14.9 18.5 15.8 15.7 17.1 32.4 19.1 13.0 16.9 13.8 20.9 15.9 18.5 20.4 17.7 12.4 16.7 19.0 18.1 14.5 8.5 12.5 7.4 14.1 11.4 12.0 9.9 14.7 11.6 13.3 14.3 31.3 15.6 19.7 26.2 14.6 11.7 20.5 13.5 19.0 12.7 10.1 41.7 6.7 16.8 22.7 18.8 17.5 11.3 19.0 25.3 41.2 14.7 19.7 13.5 19.3 10.6 15.3 23.6 13.6 19.0 12.1 11.4 21.7 12.8 15.0 9.8 16.9 12.0 16.1 10.2 10.9 13.0 12.5 17.3 8.5 10.0 20.7 9.5 7.1 24.2 9.4 33.6 16.5 8.7 16.0 12.4 13.2 16.7 15.6 20.4 18.1 17.1 17.7 17.0 17.9 16.2 2.4 19.0 13.7 12.8 17.6 14.5 20.2 20.5 12.0 23.3 17.6 14.0 25.9 18.2 19.1 19.1 ZSWIM3 "C20orf164, dJ337O18.7, PPP1R174" ENSG00000132801 "Zinc finger SWIM-type containing 3" Q96MP5 20 45857617-45879122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055692, HPA060508" Uncertain Approved "Nucleoli fibrillar center,Vesicles,Cytosol" Vesicles "Nucleoli fibrillar center, Cytosol" "HPA055692: , HPA060508: " "prognostic unfavourable (9.32e-5)" "unprognostic (8.53e-2)" "unprognostic (3.55e-1)" "prognostic unfavourable (4.21e-4)" "unprognostic (4.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.77e-3)" "unprognostic (4.49e-2)" "unprognostic (2.20e-1)" "unprognostic (1.36e-2)" "unprognostic (2.72e-3)" "unprognostic (9.28e-2)" "unprognostic (4.74e-2)" "unprognostic (5.55e-2)" "unprognostic (1.76e-1)" "unprognostic (4.69e-2)" "unprognostic (4.13e-2)" 5.1 9.6 8.3 5.6 8.2 2.2 5.7 15.2 9.6 6.1 6.7 6.3 5.2 7.4 6.7 8.9 5.9 6.8 5.4 6.0 7.3 7.2 5.6 7.0 5.9 9.3 6.2 7.4 9.0 5.0 6.9 9.5 5.3 6.7 6.1 7.3 9.4 5.4 5.4 3.9 6.7 7.4 5.5 6.0 10.5 5.8 9.5 6.3 13.7 5.9 2.9 11.2 6.1 4.7 4.3 3.8 3.2 8.5 3.3 6.3 2.1 2.1 1.7 5.3 3.0 6.5 4.6 3.1 3.3 4.0 6.1 6.1 7.3 3.3 6.6 11.5 2.8 3.5 7.6 3.5 4.6 4.0 3.2 6.4 3.3 4.7 7.9 3.6 8.7 4.2 4.0 4.6 2.9 5.2 5.8 3.2 4.6 10.5 4.9 7.1 2.0 7.2 4.9 4.9 4.8 1.7 1.3 7.0 3.5 5.3 6.2 4.2 3.0 9.4 5.1 6.2 2.0 2.3 2.0 6.9 3.6 4.2 5.2 4.3 2.0 2.1 2.3 3.2 3.0 3.2 6.3 4.3 3.3 4.2 3.8 3.6 3.2 4.3 1.7 3.3 8.5 2.3 4.9 2.1 8.3 8.2 15.2 9.6 7.3 7.2 6.2 7.4 6.7 6.3